,Word,T,P
0,Xylitol,0,0
1,for,0,0
2,prevention,0,1
3,of,0,0
4,acute,1,1
5,otitis,1,1
6,media,1,1
7,.,1,1
8,Anesthesia,0,0
9,for,0,0
10,in,1,1
11,vitro,1,0
12,fertilization,1,1
13,:,1,1
14,the,0,0
15,addition,0,0
16,of,0,0
17,fentanyl,0,0
18,to,0,1
19,1.5,0,0
20,%,0,0
21,lidocaine,0,0
22,.,0,1
23,UNLABELLED,0,0
24,Ultrasonically,0,1
25,guided,0,1
26,transvaginal,0,1
27,oocyte,0,0
28,retrieval,0,1
29,is,0,0
30,relatively,0,0
31,short,0,0
32,procedure,0,0
33,that,0,0
34,is,0,0
35,performed,0,0
36,on,0,0
37,an,0,0
38,out-patient,0,1
39,basis,0,0
40,.,0,1
41,The,0,0
42,optimal,0,0
43,anesthetic,0,0
44,technique,0,0
45,should,0,0
46,allow,0,0
47,good,0,0
48,surgical,0,1
49,anesthesia,0,1
50,with,0,1
51,minimal,0,1
52,side,0,0
53,effects,0,0
54,",",0,0
55,a,0,1
56,short,0,0
57,recovery,0,0
58,time,0,0
59,",",0,0
60,and,0,0
61,",",0,0
62,if,0,0
63,possible,0,0
64,",",0,0
65,a,0,0
66,high,0,0
67,rate,0,0
68,of,0,0
69,successful,0,1
70,pregnancy,0,1
71,.,0,1
72,Spinal,0,0
73,anesthesia,0,0
74,is,0,0
75,often,0,0
76,used,0,0
77,in,0,0
78,this,0,0
79,institution,0,1
80,",",0,0
81,as,0,0
82,well,0,0
83,as,0,0
84,many,0,1
85,others,0,1
86,",",0,1
87,for,0,0
88,this,0,0
89,procedure,0,0
90,.,0,0
91,The,0,0
92,addition,0,0
93,of,0,0
94,fentanyl,0,0
95,may,0,0
96,be,0,0
97,effective,0,0
98,for,0,0
99,both,0,0
100,intraoperative,0,0
101,and,0,0
102,postoperative,0,0
103,pain,0,1
104,relief,0,0
105,.,0,1
106,We,0,0
107,assessed,0,0
108,the,0,0
109,effect,0,0
110,of,0,0
111,adding,0,0
112,fentanyl,0,0
113,to,0,1
114,1.5,0,0
115,%,0,0
116,lidocaine,0,0
117,in,0,1
118,women,1,1
119,undergoing,1,1
120,ultrasonically,1,1
121,guided,1,1
122,oocyte,1,0
123,retrieval,1,1
124,.,1,1
125,Seventy-eight,1,1
126,women,1,1
127,were,0,1
128,randomized,0,1
129,to,0,0
130,receive,0,1
131,45,0,1
132,mg,0,0
133,of,0,1
134,hyperbaric,0,1
135,1.5,0,1
136,%,0,0
137,lidocaine,0,0
138,with,0,1
139,or,0,1
140,without,0,1
141,10,0,1
142,microg,0,0
143,of,0,0
144,fentanyl,0,0
145,.,0,1
146,Visual,0,0
147,analog,0,0
148,scale,0,0
149,(,0,1
150,VAS,0,0
151,),0,1
152,pain,0,1
153,scores,0,0
154,were,0,1
155,lower,0,0
156,in,0,0
157,the,0,0
158,operating,0,0
159,room,0,1
160,(,0,1
161,OR,0,0
162,),0,1
163,(,0,1
164,P,0,0
165,<,0,0
166,0.05,0,0
167,),0,1
168,and,0,0
169,postanesthesia,0,1
170,care,0,1
171,unit,0,1
172,(,0,1
173,PACU,0,1
174,),0,1
175,(,0,1
176,P,0,0
177,<,0,0
178,0.0005,0,0
179,),0,1
180,for,0,0
181,the,0,0
182,group,0,1
183,that,0,0
184,received,0,0
185,fentanyl,0,0
186,.,0,1
187,In,0,0
188,addition,0,0
189,",",0,0
190,the,0,0
191,amount,0,0
192,of,0,0
193,narcotic,0,1
194,required,0,0
195,in,0,0
196,the,0,0
197,PACU,0,0
198,was,0,0
199,less,0,0
200,in,0,0
201,the,0,0
202,fentanyl,0,0
203,group,0,0
204,(,0,1
205,P,0,0
206,<,0,0
207,0.005,0,0
208,),0,0
209,.,0,0
210,There,0,0
211,was,0,0
212,no,0,0
213,difference,0,0
214,in,0,0
215,VAS,0,0
216,scores,0,0
217,the,0,0
218,evening,0,0
219,of,0,0
220,or,0,1
221,24,0,1
222,h,0,0
223,after,0,0
224,the,0,0
225,procedure,0,0
226,.,0,0
227,The,0,0
228,amount,0,0
229,of,0,0
230,analgesics,0,0
231,and,0,1
232,narcotics,0,1
233,required,0,0
234,after,0,1
235,discharge,0,0
236,was,0,0
237,the,0,0
238,same,0,0
239,for,0,0
240,both,0,0
241,groups,0,0
242,.,0,1
243,Timed,0,0
244,variables,0,0
245,",",0,1
246,such,0,0
247,as,0,0
248,time,0,0
249,to,0,0
250,urination,0,0
251,",",0,0
252,ambulation,0,0
253,",",0,0
254,and,0,0
255,discharge,0,0
256,",",0,0
257,were,0,0
258,the,0,0
259,same,0,0
260,for,0,0
261,both,0,0
262,groups,0,0
263,of,0,1
264,women,0,1
265,.,0,1
266,The,0,0
267,addition,0,0
268,of,0,0
269,fentanyl,0,0
270,to,0,0
271,lidocaine,0,0
272,for,0,0
273,transvaginal,0,1
274,oocyte,0,1
275,retrieval,0,1
276,results,0,0
277,in,0,0
278,a,0,0
279,more,0,0
280,comfortable,0,0
281,patient,0,0
282,in,0,0
283,the,0,0
284,OR,0,0
285,and,0,1
286,PACU,0,1
287,.,0,1
288,IMPLICATIONS,0,0
289,This,0,0
290,study,0,0
291,demonstrates,0,0
292,that,0,0
293,when,0,0
294,fentanyl,0,0
295,is,0,0
296,added,0,0
297,to,0,0
298,a,0,0
299,local,0,0
300,anesthetic,0,0
301,",",0,0
302,lidocaine,0,0
303,",",0,0
304,with,0,1
305,spinal,0,1
306,anesthesia,0,1
307,for,0,0
308,egg,0,0
309,retrieval,0,1
310,procedures,0,1
311,",",0,1
312,patients,0,1
313,are,0,0
314,more,0,0
315,comfortable,0,0
316,during,0,0
317,the,0,0
318,procedure,0,0
319,compared,0,0
320,with,0,1
321,those,0,1
322,who,0,1
323,receive,0,1
324,lidocaine,0,0
325,alone,0,0
326,.,0,1
327,In,0,0
328,addition,0,0
329,",",0,0
330,the,0,0
331,narcotic,0,1
332,requirements,0,1
333,of,0,1
334,patients,0,1
335,are,0,0
336,less,0,0
337,in,0,0
338,the,0,0
339,postanesthesia,0,0
340,care,0,1
341,unit,0,1
342,.,0,1
343,Fertility,0,1
344,outcome,0,0
345,after,0,0
346,systemic,0,0
347,methotrexate,0,1
348,and,0,0
349,laparoscopic,0,1
350,salpingostomy,0,1
351,for,0,0
352,tubal,1,1
353,pregnancy,1,1
354,.,1,1
355,Piperacillin/tazobactam,0,1
356,plus,0,0
357,tobramycin,0,0
358,versus,0,0
359,ceftazidime,0,0
360,plus,0,0
361,tobramycin,0,0
362,as,0,0
363,empiric,0,0
364,therapy,0,1
365,for,0,0
366,fever,0,1
367,in,0,0
368,severely,1,1
369,neutropenic,1,1
370,patients,1,1
371,.,1,1
372,The,0,0
373,objective,0,0
374,of,0,0
375,this,0,0
376,trial,0,0
377,was,0,0
378,to,0,0
379,evaluate,0,0
380,the,0,0
381,potential,0,0
382,advantages,0,0
383,of,0,1
384,the,0,0
385,combination,0,0
386,of,0,0
387,piperacillin,0,0
388,and,0,0
389,tazobactam,0,0
390,in,0,0
391,the,0,0
392,control,0,1
393,of,0,0
394,fever,1,1
395,in,1,1
396,neutropenic,1,1
397,patients,1,1
398,.,1,1
399,In,0,0
400,this,0,0
401,single-center,0,1
402,study,0,0
403,",",0,1
404,patients,1,1
405,who,1,1
406,experienced,1,1
407,a,1,1
408,total,1,1
409,of,1,0
410,247,1,1
411,febrile,1,1
412,episodes,1,1
413,were,0,1
414,prospectively,0,1
415,randomized,0,1
416,to,0,0
417,receive,0,1
418,either,0,0
419,our,0,0
420,standard,0,1
421,regimen,0,0
422,",",0,1
423,ceftazidime,0,0
424,3,0,0
425,g/day,0,0
426,(,0,1
427,1,0,0
428,g,0,1
429,t.i.d,0,1
430,.,0,1
431,),0,0
432,plus,0,0
433,tobramycin,0,0
434,3,0,1
435,mg/kg,0,0
436,per,0,1
437,day,0,0
438,(,0,1
439,1.5,0,0
440,mg/kg,0,0
441,b.i.d,0,1
442,.,0,1
443,),0,0
444,",",0,0
445,or,0,1
446,piperacillin,0,0
447,12,0,1
448,g/day,0,0
449,plus,0,0
450,tazobactam,0,0
451,1.5,0,0
452,g/day,0,0
453,(,0,1
454,4,0,0
455,g+0.5,0,0
456,g,0,1
457,t.i.d,0,1
458,.,0,1
459,),0,0
460,plus,0,0
461,tobramycin,0,0
462,3,0,1
463,mg/kg,0,0
464,per,0,1
465,day,0,0
466,(,0,1
467,1.5,0,0
468,mg/kg,0,0
469,b.i.d.,0,0
470,),0,1
471,.,0,1
472,Vancomycin,0,0
473,was,0,0
474,added,0,0
475,in,0,0
476,all,0,1
477,cases,0,1
478,of,0,0
479,persistent,0,1
480,fever,0,1
481,in,0,0
482,the,0,0
483,ceftazidime,0,0
484,arm,0,0
485,",",0,0
486,but,0,0
487,only,0,0
488,when,0,0
489,there,0,0
490,was,0,0
491,microbiologically,0,0
492,documented,0,0
493,resistance,0,0
494,in,0,0
495,the,0,0
496,piperacillin/tazobactam,0,0
497,arm,0,0
498,.,0,1
499,All,1,1
500,247,1,1
501,episodes,1,1
502,were,1,1
503,evaluable,1,1
504,by,0,0
505,intent-to-treat,0,1
506,analysis,0,0
507,.,0,1
508,The,0,0
509,two,0,0
510,populations,0,1
511,were,0,1
512,well,0,0
513,matched,0,1
514,in,0,0
515,terms,0,0
516,of,0,1
517,age,0,1
518,",",0,0
519,gender,0,0
520,",",0,0
521,underlying,0,0
522,disease,0,1
523,",",0,0
524,chemotherapy,0,1
525,received,0,0
526,",",0,0
527,oral,0,0
528,decontamination,0,0
529,",",0,1
530,clinical,0,0
531,and,0,0
532,bacterial,0,0
533,documentation,0,0
534,",",0,0
535,and,0,0
536,severity,0,0
537,and,0,0
538,duration,0,0
539,of,0,0
540,neutropenia,0,0
541,.,0,1
542,Initial,0,0
543,antibacterial,0,0
544,therapy,0,1
545,was,0,0
546,successful,0,1
547,(,0,1
548,apyrexia,0,1
549,at,0,1
550,72,0,1
551,h,0,0
552,",",0,0
553,without,0,1
554,antibiotic,0,0
555,change,0,0
556,),0,0
557,more,0,0
558,frequently,0,0
559,(,0,0
560,P,0,0
561,=,0,1
562,0.008,0,0
563,),0,1
564,with,0,1
565,the,0,1
566,regimen,0,0
567,containing,0,0
568,piperacillin/tazobactam,0,1
569,(,0,1
570,54.4,0,0
571,%,0,0
572,),0,1
573,than,0,0
574,with,0,1
575,the,0,1
576,one,0,1
577,including,0,0
578,ceftazidime,0,0
579,(,0,1
580,37.6,0,0
581,%,0,0
582,),0,1
583,.,0,1
584,Fewer,0,0
585,(,0,0
586,P,0,0
587,=,0,1
588,0.02,0,0
589,),0,1
590,major,0,1
591,infectious,0,1
592,events,0,0
593,(,0,1
594,infectious,0,1
595,death,0,0
596,or,0,1
597,delay,0,1
598,in,0,0
599,treatment,0,0
600,of,0,0
601,underlying,0,1
602,disease,0,1
603,due,0,0
604,to,0,1
605,infection,0,1
606,),0,1
607,were,0,0
608,observed,0,0
609,during,0,0
610,piperacillin/,0,0
611,tazobactam,0,0
612,treatment,0,1
613,(,0,1
614,2.6,0,0
615,%,0,0
616,),0,1
617,than,0,0
618,with,0,1
619,the,0,0
620,ceftazidime,0,0
621,regimen,0,0
622,(,0,1
623,11.3,0,0
624,%,0,0
625,),0,0
626,",",0,0
627,despite,0,0
628,a,0,0
629,lower,0,0
630,frequency,0,0
631,of,0,0
632,glycopeptide,0,0
633,addition,0,0
634,when,0,0
635,piperacillin/tazobactam,0,0
636,was,0,0
637,used,0,0
638,(,0,1
639,54.4,0,0
640,%,0,0
641,versus,0,0
642,77.4,0,1
643,%,0,0
644,),0,1
645,according,0,1
646,to,0,1
647,the,0,1
648,rules,0,0
649,adopted,0,0
650,.,0,1
651,This,0,0
652,trial,0,0
653,confirmed,0,0
654,the,0,0
655,efficacy,0,0
656,of,0,0
657,the,0,0
658,piperacillin/tazobactam,0,0
659,combination,0,0
660,for,0,0
661,empirical,0,0
662,treatment,0,1
663,of,0,0
664,febrile,1,1
665,neutropenic,1,1
666,patients,1,1
667,.,1,1
668,This,0,0
669,antibiotic,0,0
670,combination,0,0
671,permitted,0,0
672,a,0,0
673,dramatic,0,0
674,decrease,0,0
675,in,0,1
676,empiric,0,0
677,glycopeptide,0,1
678,antibiotic,0,0
679,administration,0,0
680,in,0,1
681,such,0,0
682,patients,0,1
683,.,0,1
684,The,0,0
685,TOM,0,1
686,test,0,0
687,:,0,1
688,a,0,0
689,new,0,1
690,instrument,0,0
691,for,0,0
692,assessing,1,0
693,theory,1,0
694,of,1,0
695,mind,1,1
696,in,1,1
697,normal,1,1
698,children,1,1
699,and,1,1
700,children,1,1
701,with,1,1
702,pervasive,1,1
703,developmental,1,1
704,disorders,1,1
705,.,1,1
706,This,0,0
707,article,0,0
708,describes,0,0
709,a,0,0
710,first,0,0
711,attempt,0,0
712,to,0,0
713,investigate,0,0
714,the,0,0
715,reliability,0,0
716,and,0,0
717,validity,0,0
718,of,0,0
719,the,0,0
720,TOM,0,1
721,test,0,0
722,",",0,0
723,a,0,0
724,new,0,0
725,instrument,0,0
726,for,0,0
727,assessing,0,0
728,theory,0,0
729,of,0,0
730,mind,0,1
731,ability,0,0
732,in,0,1
733,normal,1,1
734,children,1,1
735,and,1,1
736,children,1,1
737,with,1,1
738,pervasive,1,1
739,developmental,1,1
740,disorders,1,1
741,(,1,1
742,PDDs,1,1
743,),1,1
744,.,1,1
745,In,0,0
746,Study,0,0
747,1,0,1
748,",",0,1
749,TOM,0,1
750,test,0,0
751,scores,0,0
752,of,0,1
753,normal,1,1
754,children,1,1
755,(,1,1
756,n,1,1
757,=,1,1
758,70,1,1
759,),1,1
760,correlated,0,0
761,positively,0,0
762,with,0,1
763,their,0,0
764,performance,0,0
765,on,0,0
766,other,0,0
767,theory,0,0
768,of,0,1
769,mind,0,1
770,tasks,0,0
771,.,0,1
772,Furthermore,0,0
773,",",0,0
774,young,1,1
775,children,1,1
776,only,0,0
777,succeeded,0,1
778,on,0,0
779,TOM,0,1
780,items,0,0
781,that,0,0
782,tap,0,1
783,the,0,0
784,basic,0,0
785,domains,0,0
786,of,0,1
787,theory,0,1
788,of,0,0
789,mind,0,1
790,(,0,1
791,e.g.,0,0
792,",",0,1
793,emotion,0,0
794,recognition,0,0
795,),0,1
796,",",0,0
797,whereas,0,0
798,older,1,1
799,children,1,1
800,also,0,0
801,passed,0,1
802,items,0,0
803,that,0,0
804,measure,0,0
805,the,0,0
806,more,0,0
807,mature,0,1
808,areas,0,0
809,of,0,1
810,theory,0,1
811,of,0,0
812,mind,0,1
813,(,0,1
814,e.g.,0,0
815,",",0,0
816,understanding,0,0
817,of,0,0
818,humor,0,0
819,",",0,0
820,understanding,0,0
821,of,0,0
822,second-order,0,1
823,beliefs,0,1
824,),0,1
825,.,0,1
826,Taken,0,0
827,together,0,0
828,",",0,0
829,the,0,0
830,findings,0,0
831,of,0,1
832,Study,0,1
833,1,0,1
834,suggest,0,0
835,that,0,0
836,the,0,0
837,TOM,0,1
838,test,0,0
839,is,0,0
840,a,0,0
841,valid,0,0
842,measure,0,0
843,.,0,1
844,Study,0,0
845,2,0,0
846,showed,0,0
847,for,0,0
848,a,0,1
849,separate,0,0
850,sample,0,1
851,of,0,1
852,normal,1,1
853,children,1,1
854,(,1,1
855,n,1,1
856,=,1,1
857,12,1,1
858,),1,1
859,that,0,0
860,the,0,0
861,TOM,0,1
862,test,0,0
863,possesses,0,0
864,sufficient,0,0
865,test-retest,0,0
866,stability,0,0
867,.,0,1
868,Study,0,0
869,3,0,0
870,demonstrated,0,0
871,for,0,0
872,a,0,0
873,sample,1,1
874,of,1,0
875,children,1,1
876,with,1,1
877,PDDs,1,1
878,(,1,1
879,n,1,1
880,=,1,1
881,10,1,1
882,),1,1
883,that,0,0
884,the,0,0
885,interrater,0,0
886,reliability,0,0
887,of,0,0
888,the,0,0
889,TOM,0,1
890,test,0,0
891,is,0,0
892,good,0,0
893,.,0,0
894,Study,0,0
895,4,0,0
896,found,0,0
897,that,0,0
898,children,1,1
899,with,1,1
900,PDDs,1,1
901,(,1,1
902,n,1,1
903,=,1,1
904,20,1,1
905,),1,1
906,had,0,1
907,significantly,0,0
908,lower,0,0
909,TOM,0,1
910,test,0,0
911,scores,0,0
912,than,0,1
913,children,1,1
914,with,1,1
915,other,1,1
916,psychiatric,1,1
917,disorders,1,1
918,(,1,1
919,e.g.,1,0
920,",",0,0
921,children,1,1
922,with,1,1
923,Attention-deficit,1,1
924,Hyperactivity,1,1
925,Disorder,1,1
926,;,1,0
927,n,1,1
928,=,1,1
929,32,1,1
930,),1,0
931,",",0,0
932,a,0,0
933,finding,0,0
934,that,0,0
935,underlines,0,0
936,the,0,0
937,discriminant,0,0
938,validity,0,0
939,of,0,0
940,the,0,0
941,TOM,0,1
942,test,0,0
943,.,0,1
944,Furthermore,0,0
945,",",0,0
946,Study,0,0
947,4,0,0
948,showed,0,0
949,that,0,0
950,intelligence,0,1
951,as,0,0
952,indexed,0,0
953,by,0,0
954,the,0,0
955,Wechsler,0,1
956,Intelligence,0,1
957,Scale,0,1
958,for,0,1
959,Children,0,1
960,was,0,0
961,positively,0,0
962,associated,0,0
963,with,0,1
964,TOM,0,1
965,test,0,1
966,scores,0,0
967,.,0,1
968,Finally,0,0
969,",",0,0
970,in,0,0
971,all,0,0
972,studies,0,0
973,",",0,0
974,the,0,0
975,TOM,0,1
976,test,0,0
977,was,0,0
978,found,0,0
979,to,0,0
980,be,0,0
981,reliable,0,0
982,in,0,0
983,terms,0,0
984,of,0,1
985,internal,0,1
986,consistency,0,0
987,.,0,1
988,Altogether,0,0
989,",",0,0
990,results,0,0
991,indicate,0,0
992,that,0,0
993,the,0,0
994,TOM,0,1
995,test,0,0
996,is,0,0
997,a,0,0
998,reliable,0,0
999,and,0,0
1000,valid,0,0
1001,instrument,0,0
1002,that,0,0
1003,can,0,0
1004,be,0,0
1005,employed,0,0
1006,to,0,0
1007,measure,0,0
1008,various,0,0
1009,aspects,0,0
1010,of,0,1
1011,theory,0,1
1012,of,0,0
1013,mind,0,1
1014,.,0,1
1015,Behavioral,0,1
1016,and,0,1
1017,physiological,0,0
1018,effects,0,0
1019,of,0,1
1020,deep,0,1
1021,pressure,0,1
1022,on,0,0
1023,children,1,1
1024,with,1,1
1025,autism,1,1
1026,:,1,1
1027,a,0,0
1028,pilot,0,0
1029,study,0,0
1030,evaluating,0,0
1031,the,0,0
1032,efficacy,0,0
1033,of,0,0
1034,Grandin,0,1
1035,'s,0,1
1036,Hug,0,1
1037,Machine,0,0
1038,.,0,1
1039,OBJECTIVE,0,0
1040,One,0,1
1041,symptom,0,1
1042,common,0,1
1043,to,0,1
1044,many,0,1
1045,persons,1,1
1046,with,1,1
1047,autism,1,1
1048,is,0,0
1049,a,0,0
1050,high,0,0
1051,arousal,0,0
1052,or,0,1
1053,anxiety,0,1
1054,level,0,0
1055,.,0,1
1056,This,0,0
1057,study,0,0
1058,investigated,0,0
1059,the,0,0
1060,effects,0,0
1061,of,0,0
1062,deep,0,1
1063,pressure,0,0
1064,on,0,0
1065,arousal,0,0
1066,and,0,1
1067,anxiety,0,1
1068,reduction,0,0
1069,in,0,0
1070,autism,0,1
1071,with,0,1
1072,Grandin,0,1
1073,'s,0,1
1074,Hug,0,1
1075,Machine,0,0
1076,",",0,0
1077,a,0,0
1078,device,0,0
1079,that,0,0
1080,allows,0,0
1081,self-administration,0,0
1082,of,0,0
1083,lateral,0,1
1084,body,0,1
1085,pressure,0,0
1086,.,0,1
1087,METHOD,0,0
1088,Twelve,1,1
1089,children,1,1
1090,with,1,1
1091,autism,1,1
1092,were,0,1
1093,randomly,0,1
1094,assigned,0,1
1095,to,0,0
1096,either,0,0
1097,an,0,0
1098,experimental,0,0
1099,group,0,1
1100,(,0,1
1101,receiving,0,1
1102,deep,0,1
1103,pressure,0,1
1104,),0,1
1105,or,0,1
1106,a,0,0
1107,placebo,0,0
1108,group,0,0
1109,(,0,0
1110,not,0,0
1111,receiving,0,1
1112,deep,0,0
1113,pressure,0,0
1114,but,0,0
1115,in,0,0
1116,the,0,0
1117,disengaged,0,1
1118,Hug,0,1
1119,Machine,0,0
1120,),0,1
1121,.,0,1
1122,All,0,1
1123,children,0,1
1124,received,0,1
1125,two,0,1
1126,20-min,0,0
1127,sessions,0,0
1128,a,0,1
1129,week,0,0
1130,over,0,0
1131,a,0,1
1132,6-week,0,0
1133,period,0,0
1134,.,0,1
1135,Arousal,0,0
1136,was,0,0
1137,measured,0,0
1138,behaviorally,0,1
1139,with,0,1
1140,the,0,0
1141,Conners,0,1
1142,Parent,0,1
1143,Rating,0,1
1144,Scale,0,1
1145,and,0,0
1146,physiologically,0,0
1147,with,0,1
1148,galvanic,0,0
1149,skin,0,1
1150,response,0,0
1151,(,0,1
1152,GSR,0,1
1153,),0,1
1154,readings,0,0
1155,.,0,1
1156,RESULTS,0,0
1157,Behavioral,0,1
1158,results,0,0
1159,indicated,0,0
1160,a,0,1
1161,significant,0,0
1162,reduction,0,0
1163,in,0,0
1164,tension,0,0
1165,and,0,0
1166,a,0,0
1167,marginally,0,0
1168,significant,0,0
1169,reduction,0,0
1170,in,0,0
1171,anxiety,0,1
1172,for,0,1
1173,children,0,1
1174,who,0,1
1175,received,0,1
1176,the,0,1
1177,deep,0,0
1178,pressure,0,0
1179,compared,0,0
1180,with,0,1
1181,the,0,1
1182,children,0,1
1183,who,0,1
1184,did,0,1
1185,not,0,1
1186,.,0,0
1187,Additionally,0,0
1188,",",0,0
1189,children,0,1
1190,in,0,0
1191,the,0,1
1192,experimental,0,0
1193,group,0,0
1194,",",0,0
1195,whose,0,1
1196,GSR,0,1
1197,measures,0,0
1198,decreased,0,0
1199,",",0,0
1200,on,0,0
1201,average,0,0
1202,",",0,0
1203,after,0,0
1204,deep,0,1
1205,pressure,0,0
1206,",",0,0
1207,were,0,0
1208,somewhat,0,0
1209,more,0,0
1210,likely,0,0
1211,to,0,0
1212,have,0,0
1213,higher,0,0
1214,GSR,0,0
1215,arousal,0,0
1216,a,0,0
1217,priori,0,0
1218,.,0,1
1219,CONCLUSION,0,0
1220,These,0,1
1221,preliminary,0,0
1222,findings,0,0
1223,support,0,0
1224,the,0,0
1225,hypothesis,0,0
1226,that,0,0
1227,deep,0,0
1228,pressure,0,0
1229,may,0,0
1230,have,0,0
1231,a,0,0
1232,calming,0,0
1233,effect,0,0
1234,for,0,1
1235,persons,0,1
1236,with,0,1
1237,autism,0,1
1238,",",0,0
1239,especially,0,0
1240,those,0,0
1241,with,0,1
1242,high,0,1
1243,levels,0,0
1244,of,0,1
1245,arousal,0,0
1246,or,0,1
1247,anxiety,0,1
1248,.,0,1
1249,Effect,0,0
1250,of,0,0
1251,granulocyte/colony-stimulating,0,0
1252,factor,0,0
1253,on,0,0
1254,the,0,0
1255,onset,0,1
1256,of,0,0
1257,the,0,0
1258,adult,1,1
1259,respiratory,1,1
1260,distress,1,0
1261,syndrome,1,1
1262,.,1,1
1263,To,0,0
1264,evaluate,0,0
1265,the,0,0
1266,effect,0,0
1267,of,0,0
1268,granulocyte/colony-stimulating,0,0
1269,factor,0,0
1270,(,0,1
1271,G-CSF,0,1
1272,),0,1
1273,on,0,0
1274,the,0,0
1275,onset,0,1
1276,of,0,0
1277,the,0,0
1278,adult,0,1
1279,respiratory,0,1
1280,distress,0,0
1281,syndrome,0,1
1282,(,0,1
1283,ARDS,0,1
1284,),0,1
1285,",",0,0
1286,we,0,0
1287,investigated,0,0
1288,whether,0,0
1289,the,0,0
1290,incidence,0,0
1291,of,0,0
1292,ARDS,0,1
1293,due,0,1
1294,to,0,1
1295,pulmonary,0,1
1296,infection,0,1
1297,differed,0,0
1298,between,0,0
1299,the,0,0
1300,G-CSF,1,1
1301,group,1,1
1302,which,1,0
1303,received,1,0
1304,chemotherapy,1,1
1305,with,1,1
1306,G-CSF,1,1
1307,and,1,1
1308,historical,1,1
1309,controls,1,1
1310,without,1,1
1311,G-CSF,1,1
1312,.,1,1
1313,We,0,0
1314,evaluated,0,0
1315,132,1,1
1316,patients,1,1
1317,with,1,1
1318,hematological,1,1
1319,malignancy,1,1
1320,in,1,1
1321,complete,1,1
1322,remission,1,1
1323,without,1,1
1324,any,1,0
1325,main,1,0
1326,organ,1,1
1327,dysfunction,1,1
1328,who,1,1
1329,had,1,1
1330,been,1,1
1331,treated,1,1
1332,between,1,0
1333,April,1,1
1334,1983,1,1
1335,and,1,1
1336,December,1,1
1337,1997,1,1
1338,.,1,1
1339,We,0,0
1340,compared,0,0
1341,the,0,0
1342,incidence,0,0
1343,of,0,0
1344,ARDS,0,1
1345,due,0,1
1346,to,0,1
1347,pulmonary,0,1
1348,infection,0,1
1349,between,0,1
1350,those,0,1
1351,who,1,1
1352,received,1,1
1353,G-CSF,1,1
1354,and,0,1
1355,those,0,1
1356,who,0,1
1357,did,0,1
1358,not,0,1
1359,.,0,0
1360,There,1,0
1361,was,1,0
1362,no,1,0
1363,remarkable,1,0
1364,difference,1,0
1365,in,1,0
1366,the,1,0
1367,number,1,0
1368,of,1,0
1369,patients,1,1
1370,",",1,1
1371,gender,1,0
1372,",",1,0
1373,age,1,1
1374,",",1,0
1375,or,1,0
1376,distribution,1,0
1377,of,1,1
1378,primary,1,1
1379,diseases,1,1
1380,between,1,0
1381,the,1,1
1382,two,1,1
1383,groups,1,0
1384,.,1,1
1385,The,0,0
1386,intensity,0,0
1387,of,0,0
1388,chemotherapy,0,1
1389,was,0,0
1390,not,0,0
1391,considered,0,0
1392,to,0,0
1393,significantly,0,0
1394,differ,0,0
1395,between,0,0
1396,the,0,0
1397,two,0,0
1398,groups,0,0
1399,",",0,1
1400,though,0,0
1401,the,0,0
1402,chemotherapy,0,1
1403,regimens,0,0
1404,administered,0,0
1405,differed,0,0
1406,slightly,0,0
1407,.,0,1
1408,In,0,0
1409,the,0,0
1410,G-CSF,0,1
1411,group,0,0
1412,",",0,0
1413,the,0,0
1414,duration,0,0
1415,of,0,0
1416,neutropenia,0,0
1417,was,0,0
1418,significantly,0,0
1419,shorter,0,0
1420,and,0,0
1421,the,0,0
1422,frequency,0,0
1423,of,0,0
1424,documented,0,1
1425,infection,0,1
1426,was,0,0
1427,significantly,0,0
1428,decreased,0,0
1429,.,0,0
1430,We,0,0
1431,could,0,0
1432,not,0,0
1433,find,0,0
1434,any,0,0
1435,relationship,0,0
1436,between,0,0
1437,ARDS,0,1
1438,due,0,1
1439,to,0,1
1440,pulmonary,0,1
1441,infection,0,1
1442,and,0,0
1443,any,0,0
1444,anticancer,0,0
1445,agent,0,0
1446,or,0,1
1447,antibiotics,0,0
1448,.,0,1
1449,There,0,0
1450,was,0,0
1451,no,0,0
1452,relationship,0,0
1453,between,0,0
1454,the,0,0
1455,kind,0,0
1456,of,0,0
1457,G-CSF,0,1
1458,and,0,1
1459,the,0,0
1460,incidence,0,0
1461,of,0,0
1462,ARDS,0,1
1463,due,0,1
1464,to,0,1
1465,pulmonary,0,1
1466,infection,0,1
1467,(,0,1
1468,per,0,0
1469,chemotherapy,0,1
1470,session,0,0
1471,;,0,1
1472,p,0,0
1473,>,0,1
1474,0.10,0,0
1475,",",0,0
1476,per,0,1
1477,case,0,1
1478,;,0,1
1479,p,0,0
1480,>,0,1
1481,0.30,0,0
1482,",",0,0
1483,chi2,0,0
1484,test,0,0
1485,),0,1
1486,.,0,1
1487,The,0,0
1488,incidence,0,0
1489,of,0,0
1490,ARDS,0,1
1491,due,0,1
1492,to,0,1
1493,pulmonary,0,1
1494,infection,0,1
1495,per,0,1
1496,chemotherapy,0,1
1497,session,0,0
1498,was,0,0
1499,4.21,0,0
1500,%,0,0
1501,",",0,0
1502,and,0,0
1503,showed,0,0
1504,a,0,0
1505,higher,0,0
1506,tendency,0,0
1507,in,0,0
1508,the,0,0
1509,G-CSF,0,1
1510,group,0,1
1511,(,0,1
1512,p,0,0
1513,<,0,0
1514,0.100,0,0
1515,",",0,0
1516,chi2,0,0
1517,test,0,0
1518,),0,1
1519,.,0,1
1520,The,0,0
1521,incidence,0,0
1522,of,0,0
1523,ARDS,0,1
1524,due,0,1
1525,to,0,1
1526,pulmonary,0,1
1527,infection,0,1
1528,per,0,1
1529,case,0,1
1530,was,0,0
1531,25.4,0,0
1532,%,0,0
1533,and,0,0
1534,was,0,0
1535,significantly,0,0
1536,higher,0,0
1537,in,0,0
1538,the,0,0
1539,G-CSF,0,1
1540,group,0,1
1541,(,0,1
1542,p,0,0
1543,<,0,0
1544,0.025,0,0
1545,",",0,0
1546,chi2,0,0
1547,test,0,0
1548,),0,1
1549,.,0,1
1550,The,0,0
1551,incidence,0,0
1552,of,0,0
1553,ARDS,0,1
1554,due,0,1
1555,to,0,1
1556,pulmonary,0,1
1557,infection,0,0
1558,was,0,0
1559,higher,0,0
1560,in,0,0
1561,the,0,0
1562,G-CSF,0,1
1563,group,0,0
1564,than,0,0
1565,in,0,0
1566,the,0,0
1567,controls,0,1
1568,",",0,0
1569,suggesting,0,0
1570,that,0,0
1571,G-CSF,0,1
1572,promotes,0,0
1573,the,0,0
1574,development,0,0
1575,of,0,0
1576,ARDS,0,1
1577,due,0,1
1578,to,0,1
1579,pulmonary,0,1
1580,infection,0,1
1581,.,0,1
1582,Low-dose,0,0
1583,growth,0,0
1584,hormone,0,1
1585,treatment,0,0
1586,with,0,1
1587,diet,0,0
1588,restriction,0,1
1589,accelerates,0,0
1590,body,0,1
1591,fat,0,0
1592,loss,0,0
1593,",",0,0
1594,exerts,0,0
1595,anabolic,0,0
1596,effect,0,0
1597,and,0,0
1598,improves,0,0
1599,growth,0,0
1600,hormone,0,0
1601,secretory,0,1
1602,dysfunction,0,1
1603,in,0,1
1604,obese,1,1
1605,adults,1,1
1606,.,1,1
1607,Growth,0,0
1608,hormone,0,0
1609,(,0,1
1610,GH,0,0
1611,),0,1
1612,can,0,0
1613,induce,0,0
1614,an,0,0
1615,accelerated,0,0
1616,lipolysis,0,1
1617,.,0,1
1618,Impaired,0,1
1619,secretion,0,0
1620,of,0,0
1621,GH,0,0
1622,in,0,1
1623,obesity,0,1
1624,results,0,0
1625,in,0,1
1626,the,0,1
1627,consequent,0,0
1628,loss,0,0
1629,of,0,0
1630,the,0,0
1631,lipolytic,0,1
1632,effect,0,0
1633,of,0,1
1634,GH,0,0
1635,.,0,1
1636,Dietary,0,0
1637,restriction,0,0
1638,as,0,0
1639,a,0,1
1640,basic,0,0
1641,treatment,0,0
1642,for,0,0
1643,obesity,0,1
1644,is,0,0
1645,complicated,0,0
1646,by,0,0
1647,poor,0,1
1648,compliance,0,0
1649,",",0,0
1650,protein,0,0
1651,catabolism,0,0
1652,",",0,0
1653,and,0,0
1654,slow,0,0
1655,rates,0,0
1656,or,0,1
1657,weight,0,1
1658,loss,0,0
1659,.,0,1
1660,GH,0,0
1661,has,0,0
1662,an,0,0
1663,anabolic,0,0
1664,effect,0,0
1665,by,0,0
1666,increasing,0,0
1667,insulin-like,0,0
1668,growth,0,0
1669,factor,0,0
1670,(,0,1
1671,IGF,0,1
1672,),0,1
1673,-I,0,1
1674,.,0,1
1675,We,0,0
1676,investigated,0,0
1677,the,0,0
1678,effects,0,0
1679,of,0,0
1680,GH,0,0
1681,treatment,0,1
1682,and,0,1
1683,dietary,0,0
1684,restriction,0,1
1685,on,0,0
1686,lipolytic,0,1
1687,and,0,1
1688,anabolic,0,1
1689,actions,0,0
1690,",",0,0
1691,as,0,0
1692,well,0,0
1693,as,0,0
1694,the,0,0
1695,consequent,0,0
1696,changes,0,0
1697,in,0,1
1698,insulin,0,1
1699,and,0,1
1700,GH,0,0
1701,secretion,0,0
1702,in,0,0
1703,obesity,1,1
1704,.,1,1
1705,24,1,0
1706,obese,1,1
1707,subjects,1,1
1708,(,1,1
1709,22,1,1
1710,women,1,1
1711,and,1,1
1712,2,1,1
1713,men,1,1
1714,;,1,1
1715,22-46,1,1
1716,years,1,1
1717,old,1,1
1718,),1,1
1719,were,0,1
1720,fed,0,0
1721,a,0,0
1722,diet,0,0
1723,of,0,0
1724,25,0,1
1725,kcal/kg,0,0
1726,ideal,0,1
1727,body,0,1
1728,weight,0,1
1729,(,0,1
1730,IBW,0,1
1731,),0,1
1732,with,0,1
1733,1.2,0,1
1734,g,0,1
1735,protein/kg,0,1
1736,IBW,0,1
1737,daily,0,0
1738,and,0,0
1739,were,0,0
1740,treated,0,1
1741,with,0,1
1742,recombinant,0,0
1743,human,0,1
1744,GH,0,0
1745,(,0,1
1746,n,0,1
1747,=,0,1
1748,12,0,1
1749,",",0,1
1750,0.18,0,0
1751,U/kg,0,1
1752,IBW/week,0,1
1753,),0,1
1754,or,0,1
1755,placebo,0,0
1756,(,0,1
1757,n,0,1
1758,=,0,1
1759,12,0,1
1760,",",0,0
1761,vehicle,0,0
1762,injection,0,0
1763,),0,0
1764,in,0,0
1765,a,0,1
1766,12-week,0,0
1767,randomized,0,1
1768,",",0,1
1769,double-blind,0,0
1770,and,0,0
1771,placebo-controlled,0,1
1772,trial,0,1
1773,.,0,1
1774,GH,0,0
1775,treatment,0,0
1776,caused,0,0
1777,a,0,0
1778,1.6-fold,0,0
1779,increase,0,0
1780,in,0,0
1781,the,0,0
1782,fraction,0,1
1783,of,0,0
1784,body,0,1
1785,weight,0,1
1786,lost,0,1
1787,as,0,0
1788,fat,0,0
1789,and,0,0
1790,a,0,0
1791,greater,0,0
1792,loss,0,0
1793,of,0,0
1794,visceral,0,1
1795,fat,0,1
1796,area,0,0
1797,than,0,0
1798,placebo,0,0
1799,treatment,0,1
1800,(,0,0
1801,35.3,0,1
1802,vs.,0,0
1803,28.5,0,1
1804,%,0,0
1805,",",0,0
1806,p,0,0
1807,<,0,0
1808,0.05,0,0
1809,),0,1
1810,.,0,1
1811,In,0,0
1812,the,0,0
1813,placebo,0,0
1814,group,0,0
1815,",",0,0
1816,there,0,0
1817,was,0,0
1818,a,0,0
1819,loss,0,0
1820,in,0,0
1821,lean,0,1
1822,body,0,1
1823,mass,0,1
1824,(,0,1
1825,-2.62,0,0
1826,+/-,0,1
1827,1.51,0,0
1828,kg,0,1
1829,),0,1
1830,and,0,0
1831,a,0,1
1832,negative,0,0
1833,nitrogen,0,0
1834,balance,0,0
1835,(,0,1
1836,-4.52,0,0
1837,+/-,0,1
1838,3.51,0,0
1839,g/day,0,0
1840,),0,1
1841,.,0,1
1842,By,0,0
1843,contrast,0,0
1844,",",0,0
1845,the,0,0
1846,GH,0,0
1847,group,0,0
1848,increased,0,0
1849,in,0,0
1850,lean,0,1
1851,body,0,1
1852,mass,0,1
1853,(,0,1
1854,1.13,0,0
1855,+/-,0,1
1856,1.04,0,0
1857,kg,0,1
1858,),0,1
1859,and,0,0
1860,had,0,1
1861,a,0,0
1862,positive,0,0
1863,nitrogen,0,0
1864,balance,0,0
1865,(,0,1
1866,1.81,0,0
1867,+/-,0,1
1868,2.06,0,0
1869,g/day,0,0
1870,),0,1
1871,.,0,1
1872,GH,0,0
1873,injections,0,0
1874,caused,0,0
1875,a,0,1
1876,1.6-fold,0,0
1877,increase,0,0
1878,in,0,0
1879,IGF-I,0,1
1880,",",0,1
1881,despite,0,0
1882,caloric,0,0
1883,restriction,0,1
1884,.,0,1
1885,GH,0,0
1886,response,0,0
1887,to,0,1
1888,L-dopa,0,1
1889,stimulation,0,0
1890,was,0,0
1891,blunted,0,0
1892,in,0,0
1893,all,0,1
1894,subjects,0,1
1895,and,0,1
1896,it,0,0
1897,was,0,0
1898,increased,0,0
1899,after,0,0
1900,treatment,0,0
1901,in,0,1
1902,both,0,0
1903,groups,0,0
1904,.,0,1
1905,GH,0,0
1906,treatment,0,0
1907,did,0,0
1908,not,0,0
1909,induce,0,0
1910,a,0,0
1911,further,0,0
1912,increase,0,0
1913,in,0,1
1914,insulin,0,1
1915,levels,0,0
1916,during,0,1
1917,an,0,1
1918,oral,0,0
1919,glucose,0,0
1920,tolerance,0,1
1921,test,0,0
1922,(,0,1
1923,OGTT,0,0
1924,),0,1
1925,but,0,0
1926,significantly,0,0
1927,decreased,0,0
1928,free,0,1
1929,fatty,0,0
1930,acid,0,0
1931,(,0,1
1932,FFA,0,1
1933,),0,1
1934,levels,0,0
1935,during,0,1
1936,OGTT,0,1
1937,.,0,1
1938,The,0,0
1939,decrease,0,0
1940,in,0,0
1941,FFA,0,0
1942,area,0,0
1943,under,0,0
1944,the,0,0
1945,curve,0,0
1946,during,0,0
1947,OGTT,0,0
1948,was,0,0
1949,positively,0,0
1950,correlated,0,0
1951,with,0,1
1952,visceral,0,1
1953,fat,0,1
1954,loss,0,0
1955,.,0,1
1956,This,0,0
1957,study,0,0
1958,demonstrates,0,0
1959,that,0,0
1960,in,0,0
1961,obese,1,1
1962,subjects,1,1
1963,given,0,1
1964,a,0,1
1965,hypocaloric,0,1
1966,diet,0,0
1967,",",0,0
1968,GH,0,0
1969,accelerates,0,0
1970,body,0,1
1971,fat,0,0
1972,loss,0,0
1973,",",0,0
1974,exerts,0,0
1975,anabolic,0,0
1976,effects,0,0
1977,and,0,1
1978,improves,0,0
1979,GH,0,0
1980,secretion,0,0
1981,.,0,1
1982,These,0,0
1983,findings,0,0
1984,suggest,0,0
1985,a,0,1
1986,possible,0,0
1987,therapeutic,0,0
1988,role,0,0
1989,of,0,0
1990,low-dose,0,0
1991,GH,0,0
1992,with,0,1
1993,caloric,0,0
1994,restriction,0,1
1995,for,0,1
1996,obesity,0,1
1997,.,0,1
1998,Inflammatory,0,1
1999,response,0,0
2000,in,0,1
2001,humans,1,1
2002,exposed,1,1
2003,to,1,1
2004,2.0,1,0
2005,ppm,1,1
2006,nitrogen,1,0
2007,dioxide,1,1
2008,.,1,1
2009,Nitrogen,0,0
2010,dioxide,0,0
2011,(,0,1
2012,NO2,0,0
2013,),0,0
2014,is,0,0
2015,a,0,0
2016,common,0,0
2017,indoor,0,0
2018,air,0,1
2019,pollutant,0,0
2020,",",0,0
2021,especially,0,0
2022,in,0,0
2023,homes,0,1
2024,with,0,1
2025,unvented,0,1
2026,combustion,0,1
2027,appliances,0,1
2028,.,0,1
2029,Epidemiological,0,1
2030,studies,0,0
2031,suggest,0,0
2032,that,0,0
2033,children,0,1
2034,living,0,1
2035,in,0,1
2036,homes,0,1
2037,with,0,1
2038,unvented,0,1
2039,heating,0,1
2040,sources,0,0
2041,are,0,0
2042,more,0,0
2043,prone,0,0
2044,to,0,0
2045,respiratory,0,1
2046,infections,0,1
2047,than,0,1
2048,children,0,1
2049,living,0,1
2050,in,0,1
2051,homes,0,1
2052,with,0,1
2053,lower,0,1
2054,levels,0,0
2055,of,0,1
2056,NO2,0,0
2057,.,0,1
2058,However,0,0
2059,",",0,0
2060,experimental,0,0
2061,studies,0,0
2062,in,0,1
2063,which,0,1
2064,human,0,1
2065,volunteers,0,1
2066,were,0,1
2067,exposed,0,1
2068,acutely,0,1
2069,to,0,1
2070,moderate,0,1
2071,levels,0,0
2072,of,0,1
2073,NO2,0,0
2074,(,0,1
2075,0.5-2.0,0,0
2076,ppm,0,1
2077,),0,1
2078,have,0,0
2079,shown,0,0
2080,little,0,0
2081,evidence,0,0
2082,of,0,0
2083,lung,0,1
2084,inflammation,0,1
2085,or,0,1
2086,decreased,0,0
2087,host,0,0
2088,resistance,0,0
2089,capacity,0,0
2090,.,0,1
2091,In,0,0
2092,the,0,0
2093,study,0,0
2094,reported,0,0
2095,here,0,0
2096,",",0,0
2097,8,1,0
2098,healthy,1,1
2099,volunteers,1,1
2100,were,1,1
2101,exposed,1,1
2102,to,1,1
2103,2.0,1,0
2104,ppm,1,1
2105,NO2,1,0
2106,and,1,0
2107,to,1,0
2108,filtered,1,0
2109,air,1,1
2110,for,1,0
2111,4,1,0
2112,h,1,0
2113,while,1,0
2114,undergoing,1,1
2115,intermittent,1,1
2116,moderate,1,1
2117,exercise,1,1
2118,.,1,1
2119,Bronchoalveolar,0,1
2120,lavage,0,0
2121,was,0,0
2122,performed,0,0
2123,the,0,0
2124,following,0,0
2125,morning,0,0
2126,.,0,1
2127,The,0,0
2128,lavage,0,0
2129,was,0,0
2130,divided,0,0
2131,into,0,0
2132,a,0,0
2133,predominantly,0,1
2134,bronchial,0,1
2135,washing,0,0
2136,(,0,1
2137,first,0,0
2138,20,0,1
2139,ml,0,0
2140,of,0,1
2141,lavage,0,1
2142,;,0,1
2143,BL,0,1
2144,),0,1
2145,and,0,0
2146,a,0,0
2147,predominantly,0,1
2148,alveolar,0,0
2149,washing,0,0
2150,(,0,1
2151,BAL,0,1
2152,),0,1
2153,.,0,1
2154,In,0,0
2155,the,0,0
2156,BL,0,0
2157,",",0,0
2158,NO2,0,0
2159,exposure,0,1
2160,caused,0,0
2161,increases,0,0
2162,in,0,1
2163,polymorphonuclear,0,1
2164,neutrophils,0,0
2165,(,0,1
2166,PMNs,0,0
2167,),0,1
2168,",",0,1
2169,interleukin,0,0
2170,6,0,0
2171,(,0,1
2172,IL-6,0,0
2173,),0,1
2174,",",0,0
2175,IL-8,0,0
2176,",",0,0
2177,alpha1-antitrypsin,0,0
2178,",",0,0
2179,and,0,0
2180,tissue,0,1
2181,plasminogen,0,0
2182,activator,0,0
2183,",",0,0
2184,and,0,0
2185,decreases,0,0
2186,in,0,1
2187,epithelial,0,1
2188,cells,0,1
2189,.,0,1
2190,In,0,0
2191,the,0,0
2192,BAL,0,0
2193,",",0,0
2194,there,0,0
2195,were,0,0
2196,no,0,0
2197,NO2-induced,0,0
2198,changes,0,0
2199,in,0,1
2200,either,0,1
2201,cell,0,1
2202,numbers,0,0
2203,or,0,1
2204,soluble,0,1
2205,mediators,0,0
2206,.,0,1
2207,On,0,0
2208,the,0,0
2209,other,0,0
2210,hand,0,0
2211,",",0,1
2212,alveolar,0,0
2213,macrophages,0,1
2214,from,0,1
2215,BAL,0,1
2216,showed,0,0
2217,a,0,0
2218,decrease,0,0
2219,in,0,0
2220,the,0,0
2221,ability,0,0
2222,to,0,0
2223,phagocytose,0,1
2224,unopsonized,0,1
2225,Candida,0,1
2226,albicans,0,1
2227,and,0,1
2228,a,0,1
2229,decrease,0,0
2230,in,0,0
2231,superoxide,0,0
2232,production,0,0
2233,.,0,1
2234,No,0,0
2235,difference,0,0
2236,in,0,0
2237,susceptibility,0,0
2238,to,0,0
2239,virus,0,1
2240,infection,0,1
2241,was,0,0
2242,found,0,0
2243,between,0,0
2244,the,0,0
2245,NO2-,0,1
2246,and,0,1
2247,air-exposed,0,1
2248,macrophages,0,1
2249,.,0,1
2250,No,0,0
2251,changes,0,0
2252,in,0,0
2253,lung,0,1
2254,function,0,0
2255,were,0,0
2256,observed,0,0
2257,",",0,0
2258,but,0,0
2259,the,0,0
2260,aerosol,0,0
2261,bolus,0,0
2262,recovery,0,0
2263,technique,0,0
2264,revealed,0,0
2265,a,0,0
2266,statistically,0,0
2267,significant,0,0
2268,(,0,1
2269,p,0,0
2270,<,0,0
2271,.05,0,0
2272,),0,1
2273,decrease,0,0
2274,in,0,0
2275,the,0,0
2276,fraction,0,1
2277,of,0,0
2278,aerosol,0,1
2279,recovered,0,0
2280,following,0,0
2281,nitrogen,0,0
2282,dioxide,0,0
2283,exposure,0,0
2284,",",0,0
2285,which,0,0
2286,is,0,0
2287,suggestive,0,0
2288,of,0,0
2289,small,0,1
2290,obstructive,0,1
2291,changes,0,0
2292,induced,0,1
2293,by,0,1
2294,NO2,0,0
2295,.,0,1
2296,Anti-emetic,0,1
2297,efficacy,0,0
2298,of,0,1
2299,prophylactic,0,1
2300,granisetron,0,0
2301,compared,0,0
2302,with,0,1
2303,perphenazine,0,1
2304,for,0,0
2305,the,0,0
2306,prevention,0,1
2307,of,0,0
2308,post-operative,1,0
2309,vomiting,1,0
2310,in,1,1
2311,children,1,1
2312,.,1,1
2313,We,0,0
2314,have,0,0
2315,compared,0,0
2316,the,0,0
2317,efficacy,0,0
2318,of,0,0
2319,granisetron,0,0
2320,with,0,1
2321,perphenazine,0,1
2322,in,0,0
2323,the,0,0
2324,prevention,0,1
2325,of,0,0
2326,vomiting,1,0
2327,after,1,0
2328,tonsillectomy,1,1
2329,with,1,1
2330,or,1,1
2331,without,1,1
2332,adenoidectomy,1,1
2333,in,1,1
2334,children,1,1
2335,.,1,1
2336,In,0,0
2337,a,0,0
2338,prospective,0,1
2339,",",0,0
2340,randomized,0,1
2341,",",0,0
2342,double-blind,0,0
2343,study,0,1
2344,",",0,1
2345,90,1,1
2346,paediatric,1,1
2347,patients,1,1
2348,",",1,1
2349,ASA,1,0
2350,I,1,1
2351,",",1,0
2352,aged,1,1
2353,4-10,1,1
2354,years,1,1
2355,",",0,1
2356,received,0,1
2357,granisetron,0,0
2358,40,0,1
2359,mg,0,1
2360,kg-1,0,0
2361,or,0,1
2362,perphenazine,0,1
2363,70,0,1
2364,mg,0,0
2365,kg-1,0,0
2366,(,0,1
2367,n,0,1
2368,=,0,1
2369,45,0,1
2370,each,0,0
2371,),0,0
2372,intravenously,0,1
2373,immediately,0,0
2374,after,0,0
2375,an,0,0
2376,inhalation,0,0
2377,induction,0,0
2378,of,0,0
2379,anaesthesia,0,1
2380,.,0,1
2381,A,0,0
2382,standard,0,0
2383,general,0,1
2384,anaesthetic,0,1
2385,technique,0,0
2386,was,0,0
2387,employed,0,0
2388,throughout,0,0
2389,.,0,1
2390,A,0,0
2391,complete,0,0
2392,response,0,0
2393,",",0,0
2394,defined,0,0
2395,as,0,0
2396,no,0,0
2397,emesis,0,1
2398,with,0,1
2399,no,0,0
2400,need,0,0
2401,for,0,0
2402,another,0,1
2403,rescue,0,0
2404,antiemetic,0,0
2405,",",0,0
2406,during,0,0
2407,the,0,0
2408,first,0,0
2409,3,0,1
2410,h,0,0
2411,(,0,1
2412,0-3,0,0
2413,h,0,0
2414,),0,1
2415,after,0,0
2416,anesthesia,0,1
2417,was,0,0
2418,87,0,1
2419,%,0,0
2420,with,0,1
2421,granisetron,0,0
2422,and,0,1
2423,78,0,1
2424,%,0,0
2425,with,0,1
2426,perphenazine,0,1
2427,(,0,1
2428,P,0,0
2429,=,0,1
2430,0.204,0,0
2431,),0,1
2432,.,0,1
2433,The,0,0
2434,corresponding,0,0
2435,incidence,0,0
2436,during,0,0
2437,the,0,0
2438,next,0,1
2439,21,0,1
2440,h,0,0
2441,(,0,1
2442,3-24,0,0
2443,h,0,0
2444,),0,1
2445,after,0,0
2446,anaesthesia,0,1
2447,was,0,0
2448,87,0,1
2449,%,0,0
2450,and,0,1
2451,62,0,1
2452,%,0,0
2453,(,0,1
2454,P,0,0
2455,=,0,1
2456,0.007,0,0
2457,),0,1
2458,.,0,1
2459,No,0,0
2460,clinically,0,1
2461,serious,0,0
2462,adverse,0,0
2463,events,0,0
2464,were,0,1
2465,observed,0,0
2466,in,0,0
2467,any,0,0
2468,of,0,0
2469,the,0,0
2470,groups,0,0
2471,.,0,1
2472,We,0,0
2473,conclude,0,0
2474,that,0,0
2475,granisetron,0,0
2476,is,0,0
2477,a,0,0
2478,better,0,0
2479,anti-emetic,0,1
2480,than,0,0
2481,perphenazine,0,1
2482,for,0,0
2483,the,0,0
2484,long-term,0,0
2485,prevention,0,1
2486,of,0,0
2487,post-operative,0,0
2488,vomiting,0,0
2489,in,0,1
2490,children,1,1
2491,undergoing,1,1
2492,general,1,1
2493,anaesthesia,1,1
2494,for,1,1
2495,tonsillectomy,1,1
2496,.,1,1
2497,Adjuvant,0,1
2498,L-arginine,0,1
2499,treatment,0,1
2500,for,0,0
2501,in-vitro,0,1
2502,fertilization,0,1
2503,in,0,1
2504,poor,1,1
2505,responder,1,1
2506,patients,1,1
2507,.,1,1
2508,The,0,0
2509,objective,0,0
2510,of,0,0
2511,the,0,0
2512,present,0,0
2513,study,0,0
2514,was,0,0
2515,prospectively,0,1
2516,and,0,0
2517,randomly,0,1
2518,to,0,0
2519,evaluate,0,0
2520,the,0,0
2521,role,0,0
2522,of,0,0
2523,L-arginine,0,1
2524,in,0,1
2525,improving,0,0
2526,uterine,0,1
2527,and,0,1
2528,follicular,0,1
2529,Doppler,0,1
2530,flow,0,0
2531,and,0,0
2532,in,0,0
2533,improving,0,0
2534,ovarian,0,1
2535,response,0,0
2536,to,0,0
2537,gonadotrophin,0,0
2538,in,0,0
2539,poor,1,1
2540,responder,1,1
2541,women,1,1
2542,.,1,1
2543,A,0,0
2544,total,0,1
2545,of,0,0
2546,34,1,1
2547,patients,1,1
2548,undergoing,1,1
2549,assisted,1,1
2550,reproduction,1,1
2551,was,0,0
2552,divided,0,1
2553,in,0,1
2554,two,0,1
2555,groups,0,1
2556,according,0,1
2557,to,0,1
2558,different,0,1
2559,ovarian,0,1
2560,stimulation,0,1
2561,protocols,0,0
2562,:,0,1
2563,(,0,1
2564,i,0,1
2565,),0,1
2566,flare-up,0,1
2567,gonadotrophin-releasing,0,0
2568,hormone,0,1
2569,analogue,0,0
2570,(,0,1
2571,GnRHa,0,1
2572,),0,1
2573,plus,0,0
2574,elevated,0,1
2575,pure,0,1
2576,follicle,0,1
2577,stimulating,0,0
2578,hormone,0,1
2579,(,0,1
2580,pFSH,0,1
2581,),0,1
2582,(,0,1
2583,n,0,1
2584,=,0,1
2585,17,0,1
2586,),0,1
2587,;,0,1
2588,and,0,0
2589,(,0,1
2590,ii,0,1
2591,),0,1
2592,flare-up,0,1
2593,GnRHa,0,1
2594,plus,0,0
2595,elevated,0,1
2596,pFSH,0,1
2597,plus,0,0
2598,oral,0,1
2599,L-arginine,0,1
2600,(,0,1
2601,n,0,1
2602,=,0,1
2603,17,0,1
2604,),0,1
2605,.,0,1
2606,During,0,0
2607,the,0,0
2608,ovarian,0,1
2609,stimulation,0,0
2610,regimen,0,0
2611,",",0,1
2612,the,0,0
2613,patients,0,1
2614,were,0,1
2615,submitted,0,1
2616,to,0,0
2617,hormonal,0,0
2618,(,0,0
2619,oestradiol,0,0
2620,and,0,0
2621,growth,0,0
2622,hormone,0,1
2623,),0,0
2624,",",0,0
2625,ultrasonographic,0,1
2626,(,0,1
2627,follicular,0,1
2628,number,0,0
2629,and,0,0
2630,diameter,0,0
2631,",",0,0
2632,endometrial,0,1
2633,thickness,0,1
2634,),0,1
2635,and,0,1
2636,Doppler,0,1
2637,(,0,1
2638,uterine,0,1
2639,and,0,1
2640,perifollicular,0,1
2641,arteries,0,1
2642,),0,1
2643,evaluations,0,0
2644,.,0,1
2645,Furthermore,0,0
2646,",",0,0
2647,the,0,0
2648,plasma,0,0
2649,and,0,0
2650,follicular,0,1
2651,fluid,0,1
2652,concentrations,0,0
2653,of,0,0
2654,arginine,0,0
2655,",",0,0
2656,citrulline,0,0
2657,",",0,0
2658,nitrite/nitrate,0,0
2659,(,0,1
2660,NO2-/NO3-,0,0
2661,),0,1
2662,",",0,0
2663,and,0,0
2664,insulin-like,0,0
2665,growth,0,0
2666,factor-1,0,0
2667,(,0,1
2668,IGF-1,0,1
2669,),0,1
2670,were,0,1
2671,assayed,0,0
2672,.,0,1
2673,All,0,1
2674,34,1,1
2675,patients,1,1
2676,completed,0,1
2677,the,0,0
2678,study,0,0
2679,.,0,0
2680,In,0,0
2681,the,0,0
2682,L-arginine,0,0
2683,treated,0,1
2684,group,0,0
2685,a,0,0
2686,lower,0,0
2687,cancellation,0,0
2688,rate,0,0
2689,",",0,0
2690,an,0,0
2691,increased,0,0
2692,number,0,0
2693,of,0,1
2694,oocytes,0,1
2695,collected,0,1
2696,",",0,0
2697,and,0,0
2698,embryos,0,1
2699,transferred,0,1
2700,were,0,0
2701,observed,0,0
2702,.,0,1
2703,In,0,0
2704,the,0,0
2705,same,0,0
2706,group,0,0
2707,",",0,0
2708,increased,0,0
2709,plasma,0,0
2710,and,0,0
2711,follicular,0,1
2712,fluid,0,1
2713,concentrations,0,0
2714,of,0,0
2715,arginine,0,0
2716,",",0,0
2717,citrulline,0,0
2718,",",0,0
2719,NO2-/NO3-,0,0
2720,",",0,0
2721,and,0,0
2722,IGF-1,0,0
2723,was,0,0
2724,observed,0,0
2725,.,0,1
2726,Significant,0,0
2727,Doppler,0,0
2728,flow,0,0
2729,improvement,0,0
2730,was,0,0
2731,obtained,0,0
2732,in,0,0
2733,the,0,0
2734,L-arginine,0,0
2735,supplemented,0,0
2736,group,0,1
2737,.,0,1
2738,Three,0,1
2739,pregnancies,0,1
2740,were,0,1
2741,registered,0,1
2742,in,0,0
2743,these,0,0
2744,patients,0,1
2745,.,0,1
2746,No,0,0
2747,pregnancies,0,1
2748,were,0,1
2749,observed,0,0
2750,in,0,0
2751,the,0,0
2752,other,0,0
2753,group,0,1
2754,.,0,1
2755,It,0,0
2756,was,0,0
2757,concluded,0,0
2758,that,0,0
2759,oral,0,1
2760,L-arginine,0,1
2761,supplementation,0,0
2762,in,0,1
2763,poor,1,1
2764,responder,1,0
2765,patients,1,1
2766,may,0,0
2767,improve,0,0
2768,ovarian,0,1
2769,response,0,0
2770,",",0,0
2771,endometrial,0,1
2772,receptivity,0,0
2773,and,0,0
2774,pregnancy,0,1
2775,rate,0,0
2776,.,0,1
2777,Phenobarbital,0,0
2778,compared,0,0
2779,with,0,1
2780,phenytoin,0,0
2781,for,0,0
2782,the,0,0
2783,treatment,0,0
2784,of,0,0
2785,neonatal,1,1
2786,seizures,1,1
2787,.,1,1
2788,BACKGROUND,0,0
2789,Seizures,0,1
2790,occur,0,0
2791,in,0,0
2792,1,0,1
2793,to,0,1
2794,2,0,1
2795,percent,0,1
2796,of,0,1
2797,neonates,1,1
2798,admitted,1,1
2799,to,1,1
2800,an,1,0
2801,intensive,1,1
2802,care,1,1
2803,unit,1,1
2804,.,1,1
2805,The,0,0
2806,treatment,0,0
2807,is,0,0
2808,usually,0,0
2809,with,0,0
2810,either,0,0
2811,phenobarbital,0,0
2812,or,0,0
2813,phenytoin,0,0
2814,",",0,0
2815,but,0,0
2816,the,0,0
2817,efficacy,0,0
2818,of,0,0
2819,the,0,1
2820,two,0,0
2821,drugs,0,0
2822,has,0,0
2823,not,0,0
2824,been,0,0
2825,compared,0,0
2826,directly,0,0
2827,.,0,1
2828,METHODS,0,0
2829,From,0,1
2830,1990,0,1
2831,to,0,1
2832,1995,0,1
2833,",",0,0
2834,we,0,0
2835,studied,0,1
2836,59,1,1
2837,neonates,1,1
2838,with,1,1
2839,seizures,1,1
2840,that,1,0
2841,were,1,1
2842,confirmed,1,0
2843,by,1,0
2844,electroencephalography,1,1
2845,.,1,1
2846,The,0,0
2847,neonates,1,1
2848,were,0,1
2849,randomly,0,1
2850,assigned,0,1
2851,to,0,0
2852,receive,0,0
2853,either,0,0
2854,phenobarbital,0,0
2855,or,0,0
2856,phenytoin,0,0
2857,intravenously,0,1
2858,",",0,0
2859,at,0,0
2860,doses,0,0
2861,sufficient,0,0
2862,to,0,1
2863,achieve,0,0
2864,free,0,1
2865,plasma,0,0
2866,concentrations,0,0
2867,of,0,1
2868,25,0,1
2869,microg,0,0
2870,per,0,1
2871,milliliter,0,1
2872,for,0,0
2873,phenobarbital,0,0
2874,and,0,1
2875,3,0,1
2876,microg,0,0
2877,per,0,1
2878,milliliter,0,1
2879,for,0,1
2880,phenytoin,0,1
2881,.,0,1
2882,Neonates,0,0
2883,whose,0,1
2884,seizures,0,1
2885,were,0,1
2886,not,0,0
2887,controlled,0,0
2888,by,0,0
2889,the,0,0
2890,assigned,0,1
2891,drug,0,0
2892,were,0,1
2893,then,0,0
2894,treated,0,1
2895,with,0,1
2896,both,0,0
2897,drugs,0,0
2898,.,0,1
2899,Seizure,0,1
2900,control,0,0
2901,was,0,0
2902,assessed,0,0
2903,by,0,0
2904,electroencephalographic,0,1
2905,criteria,0,1
2906,.,0,1
2907,RESULTS,0,0
2908,Seizures,0,1
2909,were,0,1
2910,controlled,0,1
2911,in,0,0
2912,13,0,1
2913,of,0,1
2914,the,0,1
2915,30,1,1
2916,neonates,1,1
2917,assigned,1,1
2918,to,1,1
2919,receive,1,1
2920,phenobarbital,1,0
2921,(,0,1
2922,43,0,1
2923,percent,0,1
2924,),0,1
2925,and,0,1
2926,13,0,1
2927,of,0,0
2928,the,0,1
2929,29,1,1
2930,neonates,1,1
2931,assigned,1,1
2932,to,1,1
2933,receive,1,1
2934,phenytoin,1,0
2935,(,0,1
2936,45,0,1
2937,percent,0,1
2938,;,0,1
2939,P=1.00,0,0
2940,),0,0
2941,.,0,0
2942,When,0,0
2943,combined,0,0
2944,treatment,0,0
2945,is,0,0
2946,considered,0,0
2947,",",0,0
2948,seizure,0,1
2949,control,0,1
2950,was,0,0
2951,achieved,0,0
2952,in,0,1
2953,17,0,1
2954,(,0,1
2955,57,0,1
2956,percent,0,1
2957,),0,1
2958,of,0,0
2959,the,0,1
2960,neonates,0,1
2961,assigned,0,1
2962,to,0,0
2963,receive,0,0
2964,phenobarbital,0,0
2965,first,0,0
2966,and,0,0
2967,18,0,1
2968,(,0,1
2969,62,0,1
2970,percent,0,1
2971,),0,1
2972,of,0,0
2973,those,0,1
2974,assigned,0,1
2975,to,0,0
2976,receive,0,0
2977,phenytoin,0,0
2978,first,0,0
2979,(,0,1
2980,P=0.67,0,0
2981,),0,1
2982,.,0,1
2983,The,0,0
2984,severity,0,0
2985,of,0,0
2986,the,0,0
2987,seizures,0,1
2988,was,0,0
2989,a,0,1
2990,stronger,0,0
2991,predictor,0,0
2992,of,0,0
2993,the,0,0
2994,success,0,0
2995,of,0,0
2996,treatment,0,0
2997,than,0,0
2998,was,0,0
2999,the,0,0
3000,assigned,0,1
3001,agent,0,0
3002,.,0,0
3003,Neonates,0,0
3004,with,0,0
3005,mild,0,1
3006,seizures,0,1
3007,or,0,1
3008,with,0,1
3009,seizures,0,1
3010,that,0,0
3011,were,0,1
3012,decreasing,0,0
3013,in,0,0
3014,severity,0,0
3015,before,0,1
3016,treatment,0,0
3017,were,0,0
3018,more,0,0
3019,likely,0,0
3020,to,0,0
3021,have,0,0
3022,their,0,1
3023,seizures,0,1
3024,end,0,0
3025,",",0,0
3026,regardless,0,0
3027,of,0,0
3028,the,0,0
3029,treatment,0,0
3030,assignment,0,0
3031,.,0,1
3032,CONCLUSIONS,0,0
3033,Phenobarbital,0,0
3034,and,0,0
3035,phenytoin,0,0
3036,are,0,0
3037,equally,0,0
3038,but,0,0
3039,incompletely,0,0
3040,effective,0,0
3041,as,0,0
3042,anticonvulsants,0,1
3043,in,0,1
3044,neonates,1,1
3045,.,1,1
3046,With,0,1
3047,either,0,0
3048,drug,0,0
3049,given,0,0
3050,alone,0,0
3051,",",0,0
3052,the,0,0
3053,seizures,0,0
3054,were,0,1
3055,controlled,0,0
3056,in,0,0
3057,fewer,0,0
3058,than,0,0
3059,half,0,1
3060,of,0,0
3061,the,0,0
3062,neonates,0,1
3063,.,0,1
3064,Inhibition,1,0
3065,of,1,0
3066,the,1,0
3067,seasonal,1,1
3068,IgE,1,1
3069,increase,1,0
3070,to,1,1
3071,Dactylis,1,1
3072,glomerata,1,1
3073,by,0,1
3074,daily,0,0
3075,sodium,0,0
3076,chloride,0,0
3077,nasal-sinus,0,1
3078,irrigation,0,0
3079,during,0,0
3080,the,0,0
3081,grass,0,1
3082,pollen,0,0
3083,season,0,1
3084,.,0,1
3085,Use,0,0
3086,of,0,0
3087,the,0,0
3088,oral,0,0
3089,neuraminidase,0,0
3090,inhibitor,0,0
3091,oseltamivir,0,1
3092,in,0,0
3093,experimental,1,1
3094,human,1,1
3095,influenza,1,1
3096,:,1,1
3097,randomized,0,1
3098,controlled,0,0
3099,trials,0,1
3100,for,0,1
3101,prevention,0,1
3102,and,0,1
3103,treatment,0,0
3104,.,0,1
3105,CONTEXT,0,0
3106,Influenza,0,1
3107,virus,0,1
3108,neuraminidase,0,0
3109,is,0,0
3110,thought,0,0
3111,to,0,0
3112,be,0,0
3113,essential,0,1
3114,for,0,0
3115,virus,0,1
3116,replication,0,1
3117,in,0,1
3118,humans,0,1
3119,;,0,1
3120,however,0,0
3121,",",0,0
3122,to,0,0
3123,date,0,0
3124,",",0,0
3125,available,0,0
3126,neuraminidase,0,0
3127,inhibitors,0,0
3128,are,0,0
3129,limited,0,0
3130,to,0,1
3131,zanamivir,0,1
3132,",",0,0
3133,which,0,0
3134,is,0,0
3135,topically,0,0
3136,administered,0,0
3137,.,0,1
3138,OBJECTIVE,0,0
3139,To,0,0
3140,determine,0,0
3141,the,0,0
3142,safety,0,0
3143,",",0,0
3144,tolerability,0,0
3145,",",0,0
3146,and,0,0
3147,antiviral,0,0
3148,activity,0,0
3149,of,0,0
3150,oral,0,0
3151,neuraminidase,0,1
3152,inhibitor,0,0
3153,oseltamivir,0,1
3154,(,0,1
3155,GS4104/Ro64-0796,0,1
3156,),0,1
3157,for,0,0
3158,prevention,0,1
3159,and,0,0
3160,the,0,0
3161,early,0,1
3162,treatment,1,0
3163,of,1,0
3164,influenza,1,1
3165,in,1,0
3166,experimentally,1,1
3167,infected,1,1
3168,humans,1,1
3169,.,1,1
3170,DESIGN,0,1
3171,Two,0,1
3172,randomized,0,1
3173,",",0,0
3174,double-blind,0,0
3175,",",0,1
3176,placebo-controlled,0,1
3177,trials,0,0
3178,conducted,0,1
3179,between,0,0
3180,June,0,1
3181,and,0,1
3182,July,0,1
3183,1997,0,1
3184,.,0,1
3185,SETTING,0,1
3186,Individual,0,0
3187,hotel,0,1
3188,rooms,0,1
3189,;,0,1
3190,2,1,1
3191,large,1,1
3192,US,1,1
3193,university,1,1
3194,medical,1,1
3195,schools,1,1
3196,.,1,1
3197,PARTICIPANTS,0,0
3198,A,1,0
3199,total,1,1
3200,of,1,0
3201,117,1,1
3202,healthy,1,1
3203,adult,1,1
3204,volunteers,1,1
3205,(,1,1
3206,aged,1,1
3207,18-40,1,1
3208,years,1,1
3209,;,1,1
3210,median,1,1
3211,age,1,1
3212,",",1,1
3213,21,1,1
3214,years,1,1
3215,),1,1
3216,who,1,1
3217,were,1,1
3218,susceptible,1,1
3219,(,1,1
3220,hemagglutination-inhibition,1,1
3221,antibody,1,0
3222,titer,1,0
3223,<,1,0
3224,or,1,1
3225,=1:8,1,1
3226,),1,1
3227,.,1,1
3228,INTERVENTIONS,0,0
3229,All,0,1
3230,subjects,0,1
3231,were,0,1
3232,inoculated,0,0
3233,intranasally,0,1
3234,with,0,1
3235,influenza,0,1
3236,A/Texas/36/91,0,1
3237,(,0,1
3238,H1N1,0,0
3239,),0,1
3240,virus,0,1
3241,.,0,1
3242,For,0,0
3243,the,0,0
3244,prophylaxis,0,0
3245,study,0,0
3246,",",0,0
3247,oral,0,0
3248,oseltamivir,0,1
3249,(,0,1
3250,100,0,1
3251,mg,0,0
3252,once,0,0
3253,daily,0,0
3254,[,0,0
3255,n,0,1
3256,=,0,1
3257,12,0,1
3258,],0,1
3259,",",0,1
3260,100,0,0
3261,mg,0,0
3262,twice,0,0
3263,daily,0,0
3264,[,0,0
3265,n,0,1
3266,=,0,1
3267,12,0,1
3268,],0,1
3269,",",0,0
3270,or,0,1
3271,matching,0,1
3272,placebo,0,0
3273,[,0,1
3274,n,0,1
3275,=,0,1
3276,13,0,1
3277,],0,1
3278,",",0,1
3279,starting,0,0
3280,26,0,1
3281,hours,0,1
3282,before,0,1
3283,virus,0,1
3284,inoculation,0,1
3285,),0,1
3286,was,0,0
3287,administered,0,0
3288,.,0,1
3289,For,0,0
3290,the,0,0
3291,treatment,0,0
3292,study,0,0
3293,",",0,0
3294,the,0,0
3295,same,0,0
3296,drug,0,0
3297,was,0,0
3298,given,0,0
3299,(,0,1
3300,20,0,1
3301,mg,0,0
3302,",",0,1
3303,100,0,0
3304,mg,0,0
3305,",",0,1
3306,or,0,1
3307,200,0,1
3308,mg,0,0
3309,twice,0,0
3310,daily,0,0
3311,",",0,0
3312,200,0,0
3313,mg,0,0
3314,once,0,0
3315,daily,0,0
3316,",",0,0
3317,or,0,1
3318,matching,0,1
3319,placebo,0,0
3320,[,0,1
3321,n,0,1
3322,=,0,1
3323,16,0,1
3324,],0,1
3325,",",0,0
3326,in,0,0
3327,each,0,0
3328,group,0,1
3329,starting,0,0
3330,28,0,1
3331,hours,0,0
3332,after,0,1
3333,inoculation,0,1
3334,),0,1
3335,.,0,1
3336,All,0,1
3337,regimens,0,0
3338,were,0,1
3339,continued,0,0
3340,for,0,1
3341,5,0,1
3342,days,0,1
3343,.,0,1
3344,MAIN,0,0
3345,OUTCOME,0,1
3346,MEASURES,0,0
3347,Comparing,0,0
3348,placebo,0,1
3349,groups,0,0
3350,with,0,1
3351,pooled,0,0
3352,treatment,0,1
3353,groups,0,0
3354,",",0,1
3355,for,0,0
3356,prophylaxis,0,0
3357,",",0,0
3358,outcomes,0,0
3359,included,0,1
3360,frequency,0,0
3361,of,0,0
3362,infection,0,1
3363,and,0,1
3364,viral,0,1
3365,shedding,0,0
3366,;,0,1
3367,for,0,0
3368,treatment,0,0
3369,",",0,1
3370,viral,0,0
3371,shedding,0,0
3372,in,0,1
3373,titers,0,0
3374,.,0,1
3375,RESULTS,0,0
3376,In,0,0
3377,the,0,0
3378,prophylaxis,0,0
3379,study,0,0
3380,",",0,1
3381,8,0,1
3382,(,0,1
3383,67,0,1
3384,%,0,0
3385,),0,1
3386,of,0,0
3387,12,0,1
3388,placebo,0,1
3389,and,0,1
3390,8,0,1
3391,(,0,1
3392,38,0,1
3393,%,0,0
3394,),0,1
3395,of,0,0
3396,21,0,1
3397,oseltamivir,0,1
3398,recipients,0,1
3399,became,0,1
3400,infected,0,1
3401,(,0,1
3402,P,0,0
3403,=,0,1
3404,.16,0,0
3405,;,0,1
3406,efficacy,0,0
3407,",",0,0
3408,61,0,1
3409,%,0,0
3410,),0,1
3411,;,0,1
3412,6,0,1
3413,(,0,1
3414,50,0,1
3415,%,0,0
3416,),0,1
3417,placebo,0,0
3418,compared,0,0
3419,with,0,1
3420,0,0,0
3421,oseltamivir,0,1
3422,recipients,0,1
3423,shed,0,0
3424,virus,0,1
3425,(,0,1
3426,P,0,0
3427,<,0,0
3428,.001,0,0
3429,;,0,1
3430,efficacy,0,0
3431,",",0,0
3432,100,0,1
3433,%,0,0
3434,),0,1
3435,",",0,0
3436,and,0,0
3437,33,0,1
3438,%,0,0
3439,of,0,0
3440,placebo,0,0
3441,but,0,0
3442,no,0,0
3443,oseltamivir,0,1
3444,recipient,0,1
3445,had,0,1
3446,infection-related,0,0
3447,respiratory,0,1
3448,illness,0,1
3449,(,0,1
3450,P,0,0
3451,<,0,0
3452,.01,0,0
3453,),0,1
3454,.,0,1
3455,Among,0,1
3456,infected,0,1
3457,subjects,0,1
3458,in,0,1
3459,the,0,0
3460,treatment,0,0
3461,study,0,0
3462,(,0,1
3463,n,0,1
3464,=,0,1
3465,69,0,1
3466,),0,1
3467,",",0,0
3468,the,0,0
3469,viral,0,0
3470,titer,0,0
3471,area,0,0
3472,under,0,0
3473,the,0,0
3474,curve,0,0
3475,of,0,0
3476,the,0,0
3477,combined,0,0
3478,oseltamivir,0,1
3479,groups,0,1
3480,(,0,1
3481,n,0,1
3482,=,0,1
3483,56,0,1
3484,),0,1
3485,was,0,0
3486,lower,0,0
3487,(,0,1
3488,median,0,0
3489,[,0,0
3490,interquartile,0,0
3491,range,0,1
3492,[,0,0
3493,IQR,0,1
3494,],0,1
3495,],0,1
3496,",",0,1
3497,80,0,1
3498,[,0,0
3499,23-151,0,1
3500,],0,1
3501,vs,0,0
3502,273,0,1
3503,[,0,0
3504,79-306,0,0
3505,],0,1
3506,log10,0,0
3507,tissue,0,1
3508,culture-infective,0,0
3509,doses50,0,0
3510,per,0,0
3511,milliliter,0,0
3512,x,0,1
3513,hour,0,0
3514,;,0,1
3515,P,0,0
3516,=,0,1
3517,.02,0,0
3518,),0,1
3519,than,0,0
3520,the,0,0
3521,placebo,0,0
3522,group,0,0
3523,(,0,1
3524,n,0,1
3525,=,0,1
3526,13,0,1
3527,),0,1
3528,",",0,0
3529,and,0,0
3530,the,0,0
3531,median,0,0
3532,(,0,0
3533,IQR,0,1
3534,),0,1
3535,duration,0,0
3536,of,0,0
3537,viral,0,0
3538,shedding,0,0
3539,with,0,1
3540,therapy,0,1
3541,was,0,0
3542,reduced,0,0
3543,from,0,1
3544,107,0,1
3545,(,0,1
3546,83-131,0,1
3547,),0,1
3548,to,0,1
3549,58,0,1
3550,(,0,1
3551,35-59,0,1
3552,),0,1
3553,hours,0,0
3554,(,0,1
3555,P,0,0
3556,=,0,1
3557,.003,0,0
3558,),0,1
3559,.,0,1
3560,Oseltamivir,0,0
3561,treatment,0,0
3562,also,0,0
3563,reduced,0,0
3564,symptom,0,0
3565,scores,0,0
3566,(,0,1
3567,median,0,1
3568,[,0,1
3569,IQR,0,1
3570,],0,1
3571,score-hours,0,0
3572,",",0,1
3573,225,0,1
3574,[,0,1
3575,97-349,0,0
3576,],0,1
3577,vs,0,0
3578,400,0,0
3579,[,0,0
3580,189-645,0,1
3581,],0,1
3582,;,0,1
3583,P,0,0
3584,=,0,1
3585,.05,0,0
3586,),0,1
3587,",",0,0
3588,and,0,0
3589,nasal,0,1
3590,proinflammatory,0,0
3591,cytokine,0,0
3592,levels,0,1
3593,.,0,1
3594,Transient,0,0
3595,mild,0,1
3596,to,0,0
3597,moderate,0,1
3598,nausea,0,0
3599,after,0,0
3600,dosing,0,0
3601,was,0,0
3602,observed,0,0
3603,in,0,1
3604,15,0,1
3605,(,0,1
3606,17,0,1
3607,%,0,0
3608,),0,1
3609,of,0,1
3610,88,0,1
3611,oseltamivir,0,1
3612,and,0,1
3613,2,0,1
3614,(,0,1
3615,7,0,1
3616,%,0,0
3617,),0,1
3618,of,0,0
3619,29,0,1
3620,placebo,0,1
3621,recipients,0,1
3622,(,0,1
3623,95,0,0
3624,%,0,0
3625,confidence,0,0
3626,interval,0,0
3627,for,0,0
3628,difference,0,0
3629,",",0,1
3630,-11,0,0
3631,%,0,0
3632,to,0,1
3633,68,0,1
3634,%,0,0
3635,),0,1
3636,",",0,0
3637,which,0,0
3638,was,0,0
3639,largely,0,0
3640,prevented,0,0
3641,by,0,0
3642,ingestion,0,0
3643,with,0,1
3644,food,0,1
3645,.,0,1
3646,CONCLUSIONS,0,0
3647,In,0,0
3648,these,0,0
3649,trials,0,0
3650,",",0,0
3651,prophylaxis,0,1
3652,and,0,0
3653,early,0,1
3654,treatment,0,0
3655,with,0,1
3656,oral,0,1
3657,oseltamivir,0,1
3658,were,0,1
3659,both,0,0
3660,associated,0,0
3661,with,0,1
3662,significant,0,0
3663,antiviral,0,1
3664,and,0,1
3665,clinical,0,0
3666,effects,0,0
3667,in,0,1
3668,experimental,1,1
3669,human,1,1
3670,influenza,1,1
3671,.,0,1
3672,Granulocyte-macrophage,0,0
3673,colony-stimulating,0,1
3674,factor,0,0
3675,treatment,0,0
3676,before,0,0
3677,doxorubicin,0,0
3678,and,0,1
3679,cyclophosphamide,0,1
3680,chemotherapy,0,1
3681,priming,0,0
3682,in,0,0
3683,women,1,1
3684,with,1,1
3685,early-stage,1,1
3686,breast,1,1
3687,cancer,1,1
3688,.,1,1
3689,PURPOSE,0,0
3690,To,0,0
3691,determine,0,0
3692,if,0,0
3693,inhibition,0,0
3694,of,0,0
3695,stem-cell,0,1
3696,activity,0,0
3697,induced,0,0
3698,by,0,0
3699,granulocyte-macrophage,0,0
3700,colony-stimulating,0,1
3701,factor,0,0
3702,(,0,1
3703,[,0,0
3704,GM-CSF,0,1
3705,],0,1
3706,;,0,1
3707,Sargramostim,0,0
3708,;,0,1
3709,Immunex,0,1
3710,Corporation,0,0
3711,",",0,0
3712,Seattle,0,1
3713,",",0,0
3714,WA,0,0
3715,),0,1
3716,withdrawal,0,0
3717,or,0,1
3718,priming,0,0
3719,protects,0,0
3720,hematopoietic,0,1
3721,stem,0,1
3722,cells,0,0
3723,from,0,1
3724,the,0,1
3725,cytotoxic,0,1
3726,effects,0,0
3727,of,0,1
3728,adjuvant,0,1
3729,chemotherapy,0,1
3730,for,0,0
3731,early-stage,1,1
3732,breast,1,1
3733,cancer,1,1
3734,.,1,1
3735,PATIENTS,0,0
3736,AND,0,0
3737,METHODS,0,0
3738,Serial,0,1
3739,blood,0,1
3740,counts,0,0
3741,were,0,1
3742,performed,0,0
3743,in,0,1
3744,20,1,1
3745,women,1,1
3746,with,1,1
3747,early-stage,1,1
3748,breast,1,1
3749,cancer,1,1
3750,receiving,1,1
3751,four,1,1
3752,courses,1,0
3753,of,1,1
3754,cyclophosphamide,1,1
3755,and,1,1
3756,doxorubicin,1,0
3757,chemotherapy,1,1
3758,.,1,1
3759,By,0,0
3760,a,0,0
3761,double-blind,0,0
3762,",",0,0
3763,placebo-controlled,0,0
3764,",",0,0
3765,balanced,0,0
3766,randomization,0,0
3767,",",0,0
3768,subjects,0,1
3769,received,0,0
3770,GM-CSF,0,0
3771,priming,0,0
3772,on,0,1
3773,days,0,1
3774,5,0,1
3775,to,0,1
3776,1,0,1
3777,for,0,1
3778,courses,0,1
3779,1,0,1
3780,and,0,1
3781,3,0,1
3782,or,0,1
3783,courses,0,1
3784,2,0,1
3785,and,0,1
3786,4,0,0
3787,.,0,1
3788,RESULTS,0,0
3789,Compared,0,0
3790,with,0,1
3791,before,0,0
3792,priming,0,0
3793,",",0,0
3794,after,0,0
3795,priming,0,0
3796,the,0,0
3797,times,0,0
3798,to,0,0
3799,neutrophil,0,0
3800,nadir,0,0
3801,(,0,1
3802,12.8,0,0
3803,+/-,0,1
3804,2.5,0,0
3805,days,0,0
3806,v,0,1
3807,14.8,0,0
3808,+/-,0,0
3809,1.5,0,1
3810,days,0,0
3811,",",0,1
3812,respectively,0,0
3813,;,0,0
3814,P,0,0
3815,=.0001,0,0
3816,),0,1
3817,and,0,0
3818,platelet,0,0
3819,nadir,0,0
3820,(,0,1
3821,mean,0,1
3822,+/-,0,0
3823,SD,0,1
3824,",",0,1
3825,10.1,0,1
3826,+/-,0,1
3827,1.9,0,1
3828,days,0,0
3829,v,0,1
3830,11.1,0,1
3831,+/-,0,0
3832,2.2,0,1
3833,days,0,0
3834,",",0,1
3835,P,0,0
3836,<,0,0
3837,.05,0,0
3838,),0,1
3839,were,0,0
3840,shorter,0,0
3841,",",0,0
3842,indicating,0,0
3843,a,0,0
3844,shift,0,0
3845,of,0,0
3846,cytotoxicity,0,0
3847,to,0,1
3848,later,0,1
3849,progenitors,0,0
3850,.,0,1
3851,The,0,0
3852,neutrophil,0,0
3853,nadir,0,0
3854,was,0,0
3855,similar,0,0
3856,with,0,1
3857,and,0,1
3858,without,0,1
3859,priming,0,0
3860,(,0,1
3861,mean,0,1
3862,+/-,0,0
3863,SD,0,1
3864,",",0,1
3865,490,0,1
3866,+/-,0,0
3867,310/microL,0,1
3868,v,0,1
3869,550,0,1
3870,+/-,0,1
3871,350/microL,0,1
3872,",",0,1
3873,respectively,0,0
3874,;,0,0
3875,P,0,0
3876,=.2,0,0
3877,),0,1
3878,;,0,0
3879,however,0,0
3880,",",0,0
3881,on,0,0
3882,day,0,0
3883,16,0,1
3884,the,0,0
3885,mean,0,1
3886,neutrophil,0,0
3887,count,0,0
3888,was,0,0
3889,higher,0,0
3890,(,0,1
3891,mean,0,1
3892,+/-,0,0
3893,SD,0,1
3894,",",0,1
3895,1030,0,1
3896,+/-,0,0
3897,580/microL,0,1
3898,v,0,1
3899,690,0,1
3900,+/-,0,1
3901,370/microL,0,1
3902,",",0,1
3903,P,0,0
3904,=.004,0,0
3905,),0,1
3906,",",0,0
3907,and,0,0
3908,the,0,0
3909,proportion,0,0
3910,of,0,0
3911,patients,0,1
3912,with,0,1
3913,a,0,1
3914,neutrophil,0,0
3915,count,0,0
3916,less,0,0
3917,than,0,0
3918,500/microL,0,0
3919,was,0,0
3920,lower,0,0
3921,after,0,0
3922,priming,0,0
3923,than,0,0
3924,before,0,1
3925,(,0,1
3926,six,0,1
3927,of,0,1
3928,35,0,1
3929,or,0,1
3930,17,0,1
3931,.,0,1
3932,1,0,0
3933,%,0,0
3934,v,0,0
3935,12,0,1
3936,of,0,1
3937,34,0,1
3938,or,0,1
3939,35.3,0,1
3940,%,0,0
3941,",",0,0
3942,respectively,0,0
3943,;,0,0
3944,P,0,0
3945,=.04,0,0
3946,),0,1
3947,.,0,1
3948,The,0,0
3949,platelet,0,0
3950,nadir,0,0
3951,was,0,0
3952,higher,0,0
3953,(,0,1
3954,mean,0,1
3955,+/-,0,0
3956,SD,0,1
3957,",",0,1
3958,"166,000",0,1
3959,+/-,0,0
3960,"51,000/microL",0,1
3961,after,0,1
3962,priming,0,0
3963,v,0,1
3964,"151,000",0,1
3965,+/-,0,1
3966,"45,000/microL",0,1
3967,before,0,0
3968,priming,0,0
3969,",",0,1
3970,P,0,0
3971,=.007,0,0
3972,),0,1
3973,",",0,0
3974,and,0,0
3975,the,0,0
3976,duration,0,0
3977,of,0,0
3978,thrombocytopenia,0,1
3979,",",0,0
3980,ie,0,0
3981,",",0,0
3982,a,0,0
3983,platelet,0,0
3984,count,0,0
3985,less,0,0
3986,than,0,0
3987,"150,000/microL",0,1
3988,",",0,0
3989,was,0,0
3990,shorter,0,0
3991,(,0,1
3992,1.5,0,0
3993,+/-,0,1
3994,2.1,0,1
3995,days,0,0
3996,v,0,1
3997,2.8,0,0
3998,+/-,0,0
3999,2.9,0,1
4000,days,0,0
4001,",",0,1
4002,P,0,0
4003,=.0025,0,0
4004,),0,1
4005,after,0,0
4006,priming,0,0
4007,.,0,1
4008,Episodes,0,1
4009,of,0,0
4010,fever,0,1
4011,and,0,1
4012,neutropenia,0,0
4013,were,0,0
4014,not,0,0
4015,observed,0,0
4016,.,0,1
4017,CONCLUSIONS,0,0
4018,GM-CSF,0,0
4019,priming,0,0
4020,from,0,1
4021,days,0,1
4022,5,0,1
4023,to,0,1
4024,1,0,1
4025,before,0,0
4026,doxorubicin,0,0
4027,and,0,1
4028,cyclophosphamide,0,1
4029,chemotherapy,0,1
4030,was,0,0
4031,associated,0,0
4032,with,0,1
4033,an,0,0
4034,earlier,0,1
4035,neutrophil,0,0
4036,and,0,0
4037,platelet,0,0
4038,nadir,0,0
4039,.,0,1
4040,On,0,0
4041,day,0,0
4042,16,0,1
4043,",",0,0
4044,a,0,0
4045,higher,0,0
4046,mean,0,1
4047,neutrophil,0,0
4048,count,0,0
4049,and,0,0
4050,a,0,0
4051,lower,0,0
4052,proportion,0,1
4053,of,0,0
4054,patients,0,1
4055,with,0,1
4056,severe,0,1
4057,(,0,1
4058,<,0,0
4059,500/microL,0,1
4060,),0,1
4061,neutropenia,0,0
4062,were,0,1
4063,observed,0,0
4064,.,0,1
4065,Beneficial,0,0
4066,effects,0,0
4067,on,0,0
4068,the,0,0
4069,severity,0,0
4070,and,0,0
4071,duration,0,0
4072,of,0,0
4073,thrombocytopenia,0,1
4074,were,0,1
4075,also,0,0
4076,noted,0,0
4077,.,0,1
4078,These,0,0
4079,observations,0,0
4080,support,0,0
4081,the,0,0
4082,hypothesis,0,0
4083,that,0,0
4084,GM-CSF,0,1
4085,priming,0,1
4086,protects,0,0
4087,hematopoietic,0,1
4088,progenitors,0,1
4089,from,0,1
4090,the,0,1
4091,cytotoxic,0,1
4092,effects,0,0
4093,of,0,1
4094,chemotherapy,0,1
4095,.,0,1
4096,Cholesterol-lowering,0,0
4097,effect,0,0
4098,of,0,0
4099,stanol,0,0
4100,ester,0,0
4101,in,0,0
4102,a,0,1
4103,US,1,0
4104,population,1,1
4105,of,1,0
4106,mildly,1,1
4107,hypercholesterolemic,1,1
4108,men,1,1
4109,and,1,1
4110,women,1,1
4111,:,1,1
4112,a,0,1
4113,randomized,0,1
4114,controlled,0,0
4115,trial,0,1
4116,.,0,1
4117,OBJECTIVE,0,0
4118,To,0,0
4119,determine,0,0
4120,the,0,0
4121,efficacy,0,0
4122,of,0,0
4123,stanol,0,0
4124,esters,0,0
4125,in,0,1
4126,lowering,0,0
4127,cholesterol,0,0
4128,in,0,0
4129,a,0,1
4130,US,1,0
4131,population,1,1
4132,.,1,1
4133,SUBJECTS,0,0
4134,AND,0,0
4135,METHODS,0,0
4136,After,0,1
4137,a,0,1
4138,run-in,0,0
4139,phase,0,1
4140,",",0,1
4141,318,1,1
4142,subjects,1,1
4143,were,0,1
4144,randomized,0,1
4145,to,0,0
4146,receive,0,1
4147,one,0,1
4148,of,0,0
4149,the,0,0
4150,following,0,0
4151,margarine-like,0,0
4152,spreads,0,0
4153,containing,0,1
4154,stanol,0,1
4155,ester,0,0
4156,or,0,1
4157,placebo,0,0
4158,for,0,1
4159,8,0,1
4160,weeks,0,1
4161,:,0,1
4162,EU,0,1
4163,3,0,1
4164,G,0,1
4165,:,0,1
4166,1,0,0
4167,g,0,1
4168,of,0,0
4169,stanol,0,0
4170,(,0,1
4171,ester,0,0
4172,form,0,1
4173,),0,1
4174,per,0,1
4175,8-g,0,0
4176,serving,0,1
4177,of,0,0
4178,a,0,1
4179,European,0,1
4180,formula,0,0
4181,3,0,1
4182,times,0,0
4183,a,0,1
4184,day,0,0
4185,;,0,0
4186,US,0,1
4187,3,0,1
4188,G,0,1
4189,:,0,1
4190,1,0,0
4191,g,0,1
4192,of,0,0
4193,stanol,0,0
4194,(,0,1
4195,ester,0,0
4196,form,0,1
4197,),0,1
4198,per,0,1
4199,8-g,0,0
4200,serving,0,1
4201,of,0,0
4202,a,0,1
4203,US,0,0
4204,reformulation,0,0
4205,3,0,1
4206,times,0,0
4207,a,0,1
4208,day,0,0
4209,;,0,0
4210,US,0,1
4211,2,0,1
4212,G,0,1
4213,:,0,1
4214,0.67,0,0
4215,g,0,1
4216,of,0,0
4217,stanol,0,0
4218,(,0,1
4219,ester,0,0
4220,form,0,1
4221,),0,1
4222,per,0,1
4223,8-g,0,0
4224,serving,0,1
4225,of,0,0
4226,a,0,1
4227,US,0,0
4228,reformulation,0,0
4229,3,0,1
4230,times,0,0
4231,a,0,1
4232,day,0,0
4233,;,0,0
4234,or,0,1
4235,placebo,0,0
4236,spread,0,0
4237,.,0,1
4238,RESULTS,0,0
4239,Mean,0,1
4240,+/-,0,0
4241,SD,0,1
4242,baseline,0,0
4243,total,0,1
4244,cholesterol,0,0
4245,(,0,1
4246,TC,0,1
4247,),0,1
4248,and,0,1
4249,low-density,0,1
4250,lipoprotein,0,0
4251,cholesterol,0,0
4252,(,0,1
4253,LDL-C,0,1
4254,),0,1
4255,levels,0,0
4256,were,0,1
4257,233+/-20,0,1
4258,and,0,1
4259,153+21,0,1
4260,mg+/-dL,0,1
4261,",",0,0
4262,respectively,0,0
4263,.,0,0
4264,In,0,0
4265,the,0,0
4266,US,0,1
4267,3,0,1
4268,G,0,1
4269,group,0,1
4270,",",0,1
4271,3,0,0
4272,g,0,1
4273,daily,0,0
4274,of,0,1
4275,stanol,0,1
4276,esters,0,0
4277,lowered,0,0
4278,TC,0,1
4279,and,0,1
4280,LDL-C,0,1
4281,levels,0,0
4282,by,0,1
4283,6.4,0,0
4284,%,0,0
4285,and,0,1
4286,10.1,0,0
4287,%,0,0
4288,",",0,0
4289,respectively,0,0
4290,.,0,0
4291,There,0,0
4292,was,0,0
4293,a,0,0
4294,dose-dependent,0,0
4295,response,0,0
4296,compared,0,0
4297,with,0,1
4298,2,0,1
4299,g,0,1
4300,daily,0,0
4301,(,0,1
4302,US,0,0
4303,2,0,1
4304,G,0,1
4305,),0,1
4306,.,0,1
4307,Triglyceride,0,0
4308,and,0,0
4309,high-density,0,1
4310,lipoprotein,0,0
4311,cholesterol,0,1
4312,levels,0,1
4313,were,0,1
4314,unchanged,0,0
4315,.,0,1
4316,The,0,0
4317,incidence,0,0
4318,of,0,0
4319,adverse,0,0
4320,effects,0,0
4321,was,0,0
4322,not,0,0
4323,different,0,0
4324,from,0,1
4325,placebo,0,1
4326,.,0,1
4327,Serum,0,0
4328,vitamin,0,0
4329,A,0,1
4330,and,0,0
4331,25-hydroxyvitamin,0,1
4332,D,0,1
4333,levels,0,0
4334,were,0,1
4335,not,0,0
4336,affected,0,0
4337,.,0,1
4338,CONCLUSIONS,0,0
4339,Stanol,0,0
4340,esters,0,0
4341,lowered,0,0
4342,TC,0,1
4343,and,0,1
4344,LDL-C,0,1
4345,levels,0,0
4346,in,0,0
4347,a,0,1
4348,mildly,1,1
4349,hypercholesterolemic,1,1
4350,US,1,0
4351,population,1,1
4352,without,0,1
4353,evidence,0,0
4354,of,0,1
4355,adverse,0,0
4356,effects,0,0
4357,.,0,1
4358,It,0,0
4359,may,0,0
4360,be,0,0
4361,a,0,0
4362,useful,0,0
4363,dietary,0,0
4364,adjunct,0,0
4365,to,0,0
4366,lower,0,0
4367,cholesterol,0,0
4368,.,0,1
4369,Randomised,0,0
4370,controlled,0,0
4371,trial,0,0
4372,of,0,0
4373,patient,0,1
4374,triggered,0,1
4375,and,0,1
4376,conventional,0,1
4377,fast,0,0
4378,rate,0,0
4379,ventilation,0,1
4380,in,0,0
4381,neonatal,1,1
4382,respiratory,1,1
4383,distress,1,0
4384,syndrome,1,1
4385,.,1,1
4386,AIM,0,0
4387,To,0,0
4388,compare,0,0
4389,patient,0,0
4390,triggered,0,0
4391,",",0,0
4392,with,0,1
4393,conventional,0,1
4394,fast,0,0
4395,rate,0,0
4396,",",0,0
4397,ventilation,0,0
4398,in,0,0
4399,a,0,1
4400,randomised,0,0
4401,controlled,0,0
4402,trial,0,0
4403,using,0,0
4404,the,0,0
4405,incidence,0,0
4406,of,0,0
4407,chronic,0,1
4408,lung,0,1
4409,disease,0,1
4410,as,0,0
4411,the,0,0
4412,primary,0,1
4413,outcome,0,0
4414,measure,0,0
4415,.,0,1
4416,METHODS,0,0
4417,Three,1,1
4418,hundred,1,1
4419,and,1,1
4420,eighty,1,1
4421,six,1,1
4422,preterm,1,1
4423,infants,1,1
4424,with,1,1
4425,birthweights,1,1
4426,from,1,1
4427,1000,1,1
4428,to,1,1
4429,2000,1,1
4430,g,1,1
4431,",",1,0
4432,and,1,0
4433,requiring,1,1
4434,ventilation,1,1
4435,for,1,1
4436,respiratory,1,1
4437,distress,1,1
4438,syndrome,1,1
4439,within,1,1
4440,24,1,1
4441,hours,1,0
4442,of,1,1
4443,birth,1,1
4444,",",0,0
4445,were,0,0
4446,randomised,0,0
4447,to,0,0
4448,receive,0,1
4449,either,0,0
4450,conventional,0,0
4451,or,0,1
4452,trigger,0,0
4453,ventilation,0,1
4454,with,0,1
4455,the,0,0
4456,SLE,0,1
4457,2000,0,1
4458,ventilator,0,1
4459,.,0,0
4460,RESULTS,0,0
4461,There,0,0
4462,were,0,0
4463,no,0,0
4464,significant,0,0
4465,differences,0,0
4466,in,0,1
4467,the,0,0
4468,incidence,0,0
4469,of,0,0
4470,chronic,0,1
4471,lung,0,1
4472,disease,0,1
4473,(,0,1
4474,28,0,1
4475,day,0,0
4476,and,0,1
4477,36,0,1
4478,week,0,0
4479,definitions,0,1
4480,),0,1
4481,",",0,0
4482,death,0,0
4483,",",0,0
4484,pneumothorax,0,0
4485,",",0,0
4486,intraventricular,0,0
4487,haemorrhage,0,1
4488,",",0,0
4489,number,0,0
4490,of,0,0
4491,ventilator,0,1
4492,days,0,0
4493,",",0,1
4494,or,0,1
4495,length,0,0
4496,of,0,0
4497,oxygen,0,0
4498,dependency,0,0
4499,between,0,0
4500,groups,0,1
4501,.,0,1
4502,CONCLUSIONS,0,0
4503,Patient,0,0
4504,triggered,0,0
4505,ventilation,0,0
4506,in,0,1
4507,preterm,1,1
4508,infants,1,1
4509,with,1,1
4510,respiratory,1,1
4511,distress,1,0
4512,syndrome,1,1
4513,is,0,0
4514,feasible,0,0
4515,.,0,0
4516,No,0,0
4517,significant,0,0
4518,differences,0,0
4519,",",0,0
4520,when,0,0
4521,compared,0,0
4522,with,0,1
4523,conventional,0,1
4524,fast,0,0
4525,rate,0,0
4526,ventilation,0,1
4527,in,0,0
4528,important,0,0
4529,medium,0,0
4530,and,0,0
4531,longer,0,0
4532,term,0,1
4533,outcome,0,0
4534,measures,0,0
4535,",",0,1
4536,were,0,1
4537,evident,0,0
4538,.,0,1
4539,Sun,1,1
4540,protection,1,0
4541,counseling,1,1
4542,for,1,1
4543,children,1,1
4544,:,1,1
4545,primary,0,1
4546,care,0,1
4547,practice,0,0
4548,patterns,0,1
4549,and,0,1
4550,effect,0,0
4551,of,0,0
4552,an,0,0
4553,intervention,0,0
4554,on,0,0
4555,clinicians,1,1
4556,.,1,1
4557,OBJECTIVES,0,0
4558,To,0,0
4559,describe,0,1
4560,current,0,0
4561,primary,0,1
4562,care,0,1
4563,sun,1,1
4564,protection,1,0
4565,advice,1,0
4566,for,1,1
4567,children,1,1
4568,and,0,1
4569,assess,0,0
4570,the,0,0
4571,effect,0,0
4572,on,0,0
4573,clinicians,0,1
4574,of,0,1
4575,an,0,1
4576,intervention,0,0
4577,to,0,0
4578,enhance,0,0
4579,their,0,0
4580,sun,0,0
4581,protection,0,0
4582,advocacy,0,0
4583,.,0,1
4584,SETTING,0,1
4585,Primary,1,1
4586,care,1,1
4587,practices,1,1
4588,caring,1,1
4589,for,1,1
4590,children,1,1
4591,in,1,1
4592,New,1,1
4593,Hampshire,1,1
4594,with,1,1
4595,special,1,1
4596,attention,1,0
4597,to,1,1
4598,clinicians,1,1
4599,serving,1,1
4600,10,1,1
4601,towns,1,1
4602,that,1,0
4603,were,1,1
4604,involved,1,0
4605,in,1,0
4606,a,1,1
4607,randomized,1,1
4608,controlled,1,0
4609,trial,1,0
4610,of,1,0
4611,the,1,0
4612,multicomponent,1,0
4613,SunSafe,1,1
4614,intervention,1,1
4615,involving,1,1
4616,schools,1,1
4617,",",1,1
4618,recreation,1,0
4619,areas,1,0
4620,",",1,1
4621,and,1,1
4622,primary,1,1
4623,care,1,1
4624,practices,1,1
4625,.,1,1
4626,DESIGN/INTERVENTION,0,0
4627,A,0,0
4628,statewide,0,1
4629,survey,0,1
4630,of,0,0
4631,all,1,0
4632,primary,1,1
4633,care,1,1
4634,clinicians,1,1
4635,serving,1,1
4636,children,1,1
4637,addressed,0,0
4638,their,0,1
4639,self-reported,0,1
4640,sun,0,1
4641,protection,0,0
4642,advocacy,0,0
4643,practices,0,1
4644,.,0,1
4645,Clinicians,1,0
4646,in,1,1
4647,10,1,1
4648,systematically,1,1
4649,selected,1,1
4650,rural,1,1
4651,towns,1,1
4652,were,0,1
4653,involved,0,0
4654,in,0,0
4655,the,0,0
4656,subsequent,0,0
4657,intervention,0,0
4658,study,0,1
4659,.,0,1
4660,The,0,0
4661,primary,0,0
4662,care,0,1
4663,intervention,0,0
4664,provided,0,0
4665,assistance,0,1
4666,to,0,1
4667,practices,0,1
4668,in,0,1
4669,establishing,0,0
4670,an,0,0
4671,office,0,1
4672,system,0,0
4673,that,0,0
4674,promoted,0,0
4675,sun,0,1
4676,protection,0,0
4677,advice,0,0
4678,to,0,1
4679,children,0,1
4680,and,0,1
4681,their,0,1
4682,parents,0,1
4683,during,0,1
4684,office,0,1
4685,visits,0,1
4686,.,0,1
4687,MAIN,0,0
4688,OUTCOME,0,1
4689,MEASURES,0,0
4690,Sun,0,1
4691,protection,0,0
4692,promotion,0,0
4693,activities,0,0
4694,of,0,1
4695,primary,0,1
4696,care,0,1
4697,clinicians,0,1
4698,as,0,0
4699,determined,0,0
4700,by,0,0
4701,their,0,1
4702,self,0,1
4703,report,0,0
4704,",",0,0
4705,research,0,0
4706,assistant,0,0
4707,observation,0,0
4708,",",0,0
4709,and,0,0
4710,parent,0,1
4711,interviews,0,1
4712,.,0,1
4713,RESULTS,0,0
4714,Of,0,1
4715,261,1,1
4716,eligible,1,1
4717,clinicians,1,1
4718,responding,1,1
4719,to,1,1
4720,the,1,0
4721,statewide,1,1
4722,survey,1,0
4723,",",0,0
4724,about,0,0
4725,half,0,1
4726,provide,0,0
4727,sun,0,1
4728,protection,0,0
4729,counseling,0,0
4730,most,0,0
4731,of,0,0
4732,the,0,0
4733,time,0,0
4734,or,0,0
4735,almost,0,0
4736,always,0,0
4737,during,0,0
4738,summer,0,1
4739,well,0,0
4740,care,0,1
4741,visits,0,1
4742,.,0,1
4743,Pediatricians,0,1
4744,do,0,0
4745,so,0,0
4746,more,0,0
4747,often,0,0
4748,than,0,0
4749,family,0,1
4750,physicians,0,1
4751,.,0,1
4752,Clinicians,0,0
4753,involved,0,1
4754,in,0,1
4755,the,0,0
4756,intervention,0,0
4757,increased,0,0
4758,their,0,0
4759,use,0,0
4760,of,0,0
4761,handouts,0,0
4762,",",0,1
4763,waiting,0,1
4764,room,0,1
4765,educational,0,1
4766,materials,0,1
4767,",",0,1
4768,and,0,1
4769,sunscreen,0,1
4770,samples,0,1
4771,.,0,1
4772,Compared,0,0
4773,with,0,1
4774,control,0,1
4775,town,0,1
4776,parents,0,1
4777,",",0,1
4778,parents,0,1
4779,in,0,1
4780,intervention,0,1
4781,towns,0,1
4782,reported,0,1
4783,an,0,0
4784,increase,0,0
4785,in,0,0
4786,clinician,0,0
4787,sun,0,1
4788,protection,0,0
4789,advice,0,0
4790,.,0,0
4791,CONCLUSIONS,0,0
4792,The,0,0
4793,SunSafe,0,1
4794,primary,0,1
4795,care,0,1
4796,intervention,0,0
4797,increased,0,0
4798,sun,0,1
4799,protection,0,0
4800,counseling,0,1
4801,activities,0,0
4802,of,0,1
4803,participating,1,1
4804,clinicians,1,1
4805,.,1,1
4806,A,0,1
4807,single-focus,0,0
4808,preventive,0,1
4809,service,0,1
4810,office,0,1
4811,system,0,0
4812,is,0,0
4813,feasible,0,0
4814,to,0,0
4815,include,0,0
4816,in,0,0
4817,community,0,1
4818,interventions,0,0
4819,to,0,1
4820,promote,0,0
4821,sun,0,1
4822,protection,0,0
4823,.,0,1
4824,Growth,0,0
4825,hormone,0,1
4826,(,0,1
4827,GH,0,0
4828,),0,1
4829,responses,0,0
4830,to,0,0
4831,GH-releasing,0,0
4832,hormone,0,1
4833,alone,0,0
4834,or,0,1
4835,combined,0,0
4836,with,0,1
4837,arginine,0,0
4838,in,0,1
4839,patients,1,1
4840,with,1,1
4841,adrenal,1,1
4842,incidentaloma,1,1
4843,:,1,1
4844,evidence,0,0
4845,for,0,0
4846,enhanced,0,0
4847,somatostatinergic,0,0
4848,tone,0,0
4849,.,0,1
4850,Spontaneous,0,0
4851,and,0,0
4852,stimulated,0,1
4853,GH,0,0
4854,secretion,0,0
4855,is,0,0
4856,blunted,0,0
4857,in,0,0
4858,hypercortisolemic,0,1
4859,states,0,1
4860,due,0,1
4861,to,0,1
4862,increased,0,0
4863,hypothalamic,0,0
4864,somatostatinergic,0,0
4865,tone,0,0
4866,.,0,1
4867,However,0,0
4868,",",0,0
4869,no,0,0
4870,data,0,0
4871,are,0,0
4872,available,0,0
4873,on,0,0
4874,the,0,0
4875,characteristics,0,0
4876,of,0,0
4877,GH,0,0
4878,secretion,0,0
4879,in,0,1
4880,patients,1,1
4881,with,1,1
4882,incidentally,1,1
4883,discovered,1,1
4884,adrenal,1,1
4885,adenomas,1,1
4886,.,1,1
4887,They,0,0
4888,represent,0,0
4889,an,0,0
4890,interesting,0,0
4891,model,0,0
4892,for,0,0
4893,studying,0,1
4894,GH,0,0
4895,secretion,0,0
4896,",",0,0
4897,as,0,0
4898,a,0,0
4899,slight,0,0
4900,degree,0,1
4901,of,0,0
4902,cortisol,0,0
4903,excess,0,0
4904,may,0,0
4905,frequently,0,1
4906,be,0,0
4907,observed,0,0
4908,in,0,0
4909,such,0,0
4910,patients,1,1
4911,who,1,1
4912,do,1,1
4913,not,1,1
4914,present,1,0
4915,with,1,1
4916,any,1,0
4917,clear,1,0
4918,Cushingoid,1,1
4919,sign,1,1
4920,.,1,1
4921,In,0,0
4922,the,0,0
4923,present,0,0
4924,study,0,0
4925,",",0,1
4926,10,1,1
4927,patients,1,1
4928,(,1,1
4929,3,1,1
4930,men,1,1
4931,and,1,1
4932,7,1,1
4933,women,1,1
4934,",",1,1
4935,aged,1,1
4936,48-63,1,1
4937,yr,1,1
4938,),1,1
4939,with,1,1
4940,an,1,1
4941,adrenal,1,1
4942,mass,1,1
4943,discovered,1,1
4944,serendipitously,1,0
4945,underwent,0,1
4946,",",0,0
4947,on,0,0
4948,separate,0,1
4949,occasions,0,0
4950,",",0,1
4951,a,0,1
4952,GHRH,0,0
4953,injection,0,0
4954,alone,0,0
4955,or,0,1
4956,combined,0,0
4957,with,0,1
4958,an,0,0
4959,infusion,0,0
4960,of,0,0
4961,the,0,0
4962,functional,0,0
4963,somatostatin,0,0
4964,antagonist,0,0
4965,",",0,0
4966,arginine,0,0
4967,.,0,1
4968,Thirteen,1,1
4969,age-matched,1,1
4970,healthy,1,1
4971,volunteers,1,1
4972,served,1,1
4973,as,1,1
4974,controls,1,1
4975,.,1,1
4976,Briefly,0,0
4977,",",0,0
4978,arginine,0,0
4979,(,0,1
4980,30,0,1
4981,g,0,1
4982,),0,1
4983,was,0,0
4984,infused,0,0
4985,from,0,1
4986,-30,0,0
4987,to,0,1
4988,0,0,0
4989,min,0,0
4990,",",0,0
4991,and,0,0
4992,GHRH,0,1
4993,(,0,1
4994,100,0,1
4995,microg,0,0
4996,),0,1
4997,was,0,0
4998,injected,0,0
4999,as,0,0
5000,a,0,0
5001,bolus,0,0
5002,at,0,1
5003,0,0,0
5004,min,0,0
5005,",",0,1
5006,with,0,1
5007,measurement,0,0
5008,of,0,0
5009,serum,0,0
5010,GH,0,0
5011,[,0,0
5012,immunoradiometric,0,1
5013,assay,0,0
5014,(,0,1
5015,IRMA,0,0
5016,),0,1
5017,],0,1
5018,every,0,0
5019,15,0,0
5020,min,0,0
5021,for,0,1
5022,150,0,1
5023,min,0,0
5024,.,0,1
5025,Plasma,0,0
5026,IGF-I,0,1
5027,(,0,1
5028,RIA,0,1
5029,after,0,1
5030,acid-ethanol,0,1
5031,extraction,0,1
5032,),0,1
5033,was,0,0
5034,measured,0,0
5035,in,0,0
5036,a,0,0
5037,morning,0,0
5038,sample,0,1
5039,.,0,1
5040,The,0,0
5041,diagnosis,0,1
5042,of,0,0
5043,cortical,0,1
5044,adenoma,0,1
5045,was,0,0
5046,based,0,1
5047,on,0,0
5048,computed,0,0
5049,tomography,0,1
5050,features,0,1
5051,and,0,1
5052,pattern,0,1
5053,of,0,0
5054,uptake,0,0
5055,on,0,0
5056,adrenal,0,1
5057,scintigraphy,0,0
5058,.,0,1
5059,Patients,1,1
5060,with,1,1
5061,obesity,1,1
5062,and/or,1,1
5063,diabetes,1,1
5064,were,1,1
5065,excluded,1,1
5066,.,1,1
5067,The,0,0
5068,study,0,0
5069,design,0,1
5070,included,0,1
5071,also,0,0
5072,an,0,0
5073,endocrine,0,1
5074,work-up,0,1
5075,aimed,0,0
5076,to,0,0
5077,study,0,0
5078,the,0,0
5079,hypothalamic-pituitary-adrenal,0,0
5080,axis,0,0
5081,[,0,0
5082,urinary,0,1
5083,free,0,1
5084,cortisol,0,0
5085,(,0,1
5086,UFC,0,0
5087,),0,1
5088,excretion,0,0
5089,",",0,0
5090,serum,0,0
5091,cortisol,0,0
5092,at,0,1
5093,0800,0,1
5094,h,0,0
5095,",",0,1
5096,plasma,0,0
5097,ACTH,0,1
5098,at,0,1
5099,0800,0,1
5100,h,0,0
5101,",",0,0
5102,morning,0,0
5103,cortisol,0,0
5104,after,0,1
5105,overnight,0,1
5106,1,0,1
5107,mg,0,0
5108,dexamethasone,0,0
5109,],0,1
5110,.,0,1
5111,Five,0,1
5112,of,0,0
5113,10,0,1
5114,patients,0,1
5115,showed,0,0
5116,abnormalities,0,1
5117,of,0,0
5118,the,0,1
5119,hypothalamic-pituitary-adrenal,0,0
5120,axis,0,0
5121,",",0,0
5122,including,0,0
5123,borderline,0,1
5124,or,0,1
5125,increased,0,0
5126,UFC,0,0
5127,excretion,0,0
5128,in,0,1
5129,4,0,0
5130,of,0,1
5131,them,0,1
5132,accompanied,0,0
5133,by,0,0
5134,blunted,0,0
5135,ACTH,0,1
5136,in,0,1
5137,2,0,1
5138,cases,0,1
5139,and,0,1
5140,failure,0,1
5141,of,0,0
5142,cortisol,0,0
5143,to,0,0
5144,suppress,0,0
5145,after,0,0
5146,dexamethasone,0,0
5147,in,0,1
5148,1,0,1
5149,;,0,1
5150,the,0,0
5151,fifth,0,1
5152,patient,0,1
5153,displayed,0,0
5154,low,0,1
5155,ACTH,0,1
5156,and,0,1
5157,resistance,0,0
5158,to,0,0
5159,dexamethasone,0,0
5160,suppression,0,0
5161,.,0,0
5162,However,0,0
5163,",",0,0
5164,all,0,0
5165,patients,0,1
5166,had,0,1
5167,a,0,1
5168,unilateral,0,1
5169,uptake,0,0
5170,of,0,0
5171,the,0,0
5172,tracer,0,0
5173,on,0,0
5174,the,0,0
5175,side,0,0
5176,of,0,0
5177,the,0,0
5178,mass,0,1
5179,with,0,1
5180,suppression,0,0
5181,of,0,0
5182,the,0,0
5183,contralateral,0,1
5184,normal,0,1
5185,adrenal,0,1
5186,gland,0,1
5187,.,0,1
5188,As,0,0
5189,a,0,0
5190,group,0,0
5191,",",0,0
5192,the,0,0
5193,patients,0,1
5194,displayed,0,0
5195,greater,0,0
5196,UFC,0,0
5197,excretion,0,0
5198,and,0,0
5199,lower,0,0
5200,ACTH,0,1
5201,concentrations,0,0
5202,than,0,1
5203,the,0,1
5204,controls,0,1
5205,.,0,1
5206,GH,0,0
5207,release,0,0
5208,after,0,0
5209,GHRH,0,1
5210,treatment,0,1
5211,was,0,0
5212,blunted,0,0
5213,in,0,1
5214,patients,1,1
5215,bearing,1,1
5216,adrenal,1,1
5217,incidentaloma,1,1
5218,compared,0,0
5219,with,0,1
5220,controls,0,1
5221,(,0,1
5222,GH,0,0
5223,peak,0,0
5224,",",0,1
5225,5.7,0,0
5226,+/-,0,0
5227,5.2,0,0
5228,vs.,0,0
5229,18.0,0,0
5230,+/-,0,0
5231,7.0,0,1
5232,microg/L,0,1
5233,;,0,1
5234,P,0,0
5235,<,0,0
5236,0.0001,0,0
5237,),0,1
5238,",",0,1
5239,whereas,0,0
5240,GHRH,0,1
5241,plus,0,0
5242,arginine,0,0
5243,was,0,0
5244,able,0,0
5245,to,0,0
5246,elicit,0,0
5247,a,0,0
5248,comparable,0,0
5249,response,0,0
5250,in,0,0
5251,the,0,1
5252,2,0,1
5253,groups,0,0
5254,(,0,1
5255,GH,0,0
5256,peak,0,0
5257,",",0,1
5258,33.5,0,0
5259,+/-,0,0
5260,20.3,0,1
5261,vs.,0,0
5262,33.7,0,1
5263,+/-,0,0
5264,17.5,0,0
5265,microg/L,0,1
5266,;,0,1
5267,P,0,0
5268,=,0,1
5269,NS,0,0
5270,),0,1
5271,.,0,1
5272,The,0,0
5273,ratio,0,0
5274,between,0,0
5275,GH,0,0
5276,peaks,0,0
5277,after,0,1
5278,GHRH,0,1
5279,plus,0,0
5280,arginine,0,0
5281,and,0,0
5282,after,0,0
5283,GHRH,0,1
5284,plus,0,0
5285,saline,0,0
5286,was,0,0
5287,significantly,0,0
5288,greater,0,0
5289,in,0,0
5290,patients,0,1
5291,than,0,1
5292,in,0,1
5293,controls,0,1
5294,(,0,1
5295,751,0,1
5296,+/-,0,1
5297,531,0,1
5298,%,0,0
5299,vs.,0,0
5300,81,0,1
5301,+/-,0,0
5302,45,0,1
5303,%,0,0
5304,;,0,1
5305,P,0,0
5306,=,0,1
5307,0.0001,0,0
5308,),0,1
5309,.,0,1
5310,Similar,0,0
5311,data,0,0
5312,were,0,1
5313,obtained,0,0
5314,when,0,0
5315,comparing,0,0
5316,GH,0,0
5317,area,0,0
5318,under,0,0
5319,the,0,0
5320,curve,0,0
5321,after,0,0
5322,GHRH,0,1
5323,plus,0,0
5324,saline,0,0
5325,or,0,1
5326,GHRH,0,1
5327,plus,0,0
5328,arginine,0,0
5329,between,0,0
5330,the,0,1
5331,2,0,1
5332,groups,0,0
5333,.,0,1
5334,In,0,0
5335,summary,0,0
5336,",",0,0
5337,the,0,0
5338,present,0,0
5339,data,0,0
5340,suggest,0,0
5341,that,0,0
5342,in,0,1
5343,patients,1,1
5344,with,1,1
5345,incidental,1,1
5346,adrenal,1,1
5347,adenomas,1,1
5348,the,0,0
5349,GH,0,0
5350,response,0,0
5351,to,0,0
5352,GHRH,0,0
5353,is,0,0
5354,blunted,0,0
5355,due,0,0
5356,to,0,1
5357,increased,0,0
5358,somatostatinergic,0,0
5359,tone,0,0
5360,",",0,0
5361,as,0,0
5362,it,0,0
5363,can,0,0
5364,be,0,0
5365,restored,0,0
5366,to,0,0
5367,normal,0,1
5368,by,0,0
5369,pretreatment,0,0
5370,with,0,1
5371,the,0,0
5372,functional,0,0
5373,somatostatin,0,0
5374,antagonist,0,0
5375,arginine,0,0
5376,.,0,1
5377,The,0,0
5378,blunted,0,0
5379,GH,0,0
5380,release,0,0
5381,to,0,0
5382,GHRH,0,0
5383,may,0,0
5384,be,0,0
5385,an,0,0
5386,early,0,1
5387,and,0,0
5388,long,0,1
5389,lasting,0,0
5390,sign,0,1
5391,of,0,1
5392,autonomous,0,1
5393,cortisol,0,0
5394,secretion,0,0
5395,by,0,0
5396,the,0,0
5397,adrenal,0,1
5398,adenoma,0,1
5399,.,0,1
5400,Evaluating,0,0
5401,a,0,1
5402,test,0,0
5403,protocol,0,0
5404,for,0,0
5405,predicting,0,0
5406,maximum,0,0
5407,lactate,0,0
5408,steady,0,0
5409,state,0,1
5410,.,0,1
5411,BACKGROUND,0,0
5412,Maximum,0,0
5413,lactate,0,0
5414,steady,0,0
5415,state,0,1
5416,(,0,1
5417,MLSS,0,1
5418,),0,1
5419,is,0,0
5420,defined,0,0
5421,as,0,0
5422,the,0,0
5423,highest,0,0
5424,steady,0,0
5425,state,0,1
5426,exercise,0,1
5427,level,0,0
5428,one,0,1
5429,can,0,0
5430,maintain,0,0
5431,while,0,0
5432,also,0,0
5433,maintaining,0,0
5434,an,0,0
5435,equilibrium,0,0
5436,between,0,0
5437,the,0,0
5438,elimination,0,0
5439,of,0,0
5440,blood,0,0
5441,lactate,0,0
5442,and,0,0
5443,the,0,0
5444,diffusion,0,0
5445,of,0,0
5446,lactate,0,0
5447,into,0,1
5448,the,0,0
5449,blood,0,0
5450,.,0,0
5451,MLSS,0,0
5452,is,0,0
5453,an,0,0
5454,excellent,0,0
5455,tool,0,0
5456,for,0,0
5457,assessing,0,0
5458,fitness,0,1
5459,level,0,0
5460,",",0,0
5461,predicting,0,0
5462,endurance,0,0
5463,performance,0,0
5464,",",0,0
5465,and,0,0
5466,designing,0,0
5467,training,0,1
5468,programs,0,1
5469,.,0,1
5470,METHODS,0,0
5471,This,0,0
5472,investigation,0,0
5473,assesses,0,0
5474,the,0,0
5475,validity,0,0
5476,of,0,0
5477,the,0,0
5478,Lactate,0,0
5479,Minimum,0,1
5480,Test,0,0
5481,(,0,1
5482,LMT,0,0
5483,),0,1
5484,",",0,0
5485,which,0,0
5486,consists,0,1
5487,of,0,0
5488,inducing,0,0
5489,lactic,0,0
5490,acidosis,0,0
5491,through,0,1
5492,a,0,1
5493,VO2peak,0,0
5494,test,0,0
5495,",",0,0
5496,followed,0,0
5497,by,0,0
5498,an,0,0
5499,eight-minute,0,0
5500,walking,0,0
5501,recovery,0,0
5502,and,0,0
5503,an,0,0
5504,incremental,0,0
5505,exercise,0,0
5506,test,0,0
5507,",",0,0
5508,to,0,0
5509,determine,0,0
5510,if,0,0
5511,the,0,0
5512,running,0,0
5513,velocity,0,0
5514,associated,0,0
5515,with,0,1
5516,the,0,0
5517,minimum,0,0
5518,lactate,0,0
5519,value,0,0
5520,predicts,0,0
5521,the,0,0
5522,MLSS,0,0
5523,velocity,0,0
5524,.,0,1
5525,Following,0,0
5526,this,0,0
5527,LMT,0,0
5528,",",0,0
5529,two,0,0
5530,constant,0,0
5531,velocity,0,1
5532,28-minute,0,0
5533,runs,0,1
5534,were,0,1
5535,performed,0,0
5536,",",0,0
5537,one,0,1
5538,at,0,0
5539,the,0,0
5540,predicted,0,0
5541,MLSS,0,1
5542,velocity,0,0
5543,(,0,1
5544,trial,0,1
5545,1,0,1
5546,),0,1
5547,and,0,0
5548,the,0,0
5549,other,0,0
5550,0.13,0,0
5551,m,0,1
5552,sec-1,0,0
5553,(,0,1
5554,4-8,0,1
5555,%,0,0
5556,),0,1
5557,above,0,0
5558,the,0,0
5559,predicted,0,0
5560,MLSS,0,1
5561,velocity,0,0
5562,(,0,1
5563,trial,0,1
5564,2,0,1
5565,),0,1
5566,.,0,1
5567,Ten,1,1
5568,active,1,1
5569,female,1,1
5570,subjects,1,1
5571,participated,1,1
5572,(,1,1
5573,32,1,1
5574,+/-,1,1
5575,7,1,1
5576,yrs,1,1
5577,(,1,1
5578,mean,1,1
5579,+/-,1,0
5580,SD,1,1
5581,),1,1
5582,;,1,1
5583,65.7,1,1
5584,+/-,1,0
5585,16.4,1,1
5586,kg,1,1
5587,;,1,1
5588,VO2peak,1,0
5589,40.0,1,1
5590,+/-,1,1
5591,7.5,1,1
5592,ml.kg-1.min-1,1,1
5593,),1,1
5594,.,1,1
5595,RESULTS,0,0
5596,During,0,0
5597,trial,0,1
5598,1,0,0
5599,",",0,0
5600,there,0,0
5601,was,0,0
5602,a,0,0
5603,-0.6,0,0
5604,+/-,0,0
5605,0.3,0,0
5606,mmol,0,1
5607,l-1,0,0
5608,(,0,1
5609,mean,0,1
5610,+/-,0,0
5611,SE,0,1
5612,),0,1
5613,change,0,0
5614,in,0,0
5615,lactate,0,0
5616,.,0,1
5617,Based,0,0
5618,on,0,0
5619,a,0,0
5620,definition,0,0
5621,of,0,0
5622,lactate,0,0
5623,steady,0,0
5624,state,0,1
5625,(,0,1
5626,LSS,0,1
5627,),0,1
5628,as,0,0
5629,less,0,0
5630,than,0,0
5631,a,0,1
5632,0.5,0,0
5633,mmol.l-1,0,0
5634,increase,0,0
5635,",",0,0
5636,this,0,0
5637,value,0,0
5638,signified,0,0
5639,LSS,0,0
5640,.,0,1
5641,A,0,0
5642,similar,0,0
5643,comparison,0,0
5644,during,0,1
5645,trial,0,1
5646,2,0,1
5647,revealed,0,0
5648,a,0,1
5649,1.8,0,0
5650,+/-,0,0
5651,0.3,0,0
5652,mmol.l-1,0,0
5653,increase,0,0
5654,in,0,0
5655,lactate,0,0
5656,",",0,0
5657,signifying,0,0
5658,a,0,0
5659,workload,0,0
5660,above,0,0
5661,LSS,0,0
5662,and,0,1
5663,therefore,0,0
5664,confirming,0,0
5665,trial,0,0
5666,1,0,1
5667,as,0,0
5668,the,0,0
5669,maximum,0,0
5670,LSS,0,0
5671,(,0,1
5672,MLSS,0,1
5673,),0,1
5674,.,0,1
5675,CONCLUSIONS,0,0
5676,These,0,1
5677,results,0,0
5678,suggest,0,0
5679,that,0,0
5680,the,0,0
5681,test,0,0
5682,protocol,0,0
5683,accurately,0,0
5684,predicted,0,0
5685,the,0,0
5686,MLSS,0,1
5687,velocity,0,0
5688,.,0,1
5689,Lack,0,1
5690,of,0,0
5691,effect,0,0
5692,of,0,0
5693,a,0,0
5694,low-fat,0,0
5695,",",0,0
5696,high-fiber,0,0
5697,diet,0,0
5698,on,0,0
5699,the,0,0
5700,recurrence,0,0
5701,of,0,0
5702,colorectal,0,1
5703,adenomas,0,1
5704,.,0,1
5705,Polyp,0,0
5706,Prevention,0,1
5707,Trial,0,1
5708,Study,0,1
5709,Group,0,1
5710,.,0,1
5711,BACKGROUND,0,0
5712,We,0,0
5713,tested,0,0
5714,the,0,0
5715,hypothesis,0,0
5716,that,0,0
5717,dietary,0,0
5718,intervention,0,0
5719,can,0,0
5720,inhibit,0,0
5721,the,0,0
5722,development,0,0
5723,of,0,0
5724,recurrent,0,1
5725,colorectal,0,1
5726,adenomas,0,1
5727,",",0,0
5728,which,0,0
5729,are,0,0
5730,precursors,0,0
5731,of,0,1
5732,most,0,1
5733,large-bowel,0,1
5734,cancers,0,1
5735,.,0,1
5736,METHODS,0,0
5737,We,0,0
5738,randomly,0,1
5739,assigned,0,1
5740,2079,1,1
5741,men,1,1
5742,and,1,1
5743,women,1,1
5744,who,1,1
5745,were,1,1
5746,35,1,1
5747,years,1,1
5748,of,1,1
5749,age,1,1
5750,or,1,1
5751,older,1,1
5752,and,1,1
5753,who,1,1
5754,had,1,1
5755,had,1,1
5756,one,1,1
5757,or,1,1
5758,more,1,0
5759,histologically,1,1
5760,confirmed,1,0
5761,colorectal,1,1
5762,adenomas,1,1
5763,removed,1,0
5764,within,1,1
5765,six,1,1
5766,months,1,1
5767,before,1,1
5768,randomization,1,1
5769,to,0,1
5770,one,0,1
5771,of,0,1
5772,two,0,1
5773,groups,0,1
5774,:,0,1
5775,an,0,1
5776,intervention,0,0
5777,group,0,0
5778,given,0,0
5779,intensive,0,1
5780,counseling,0,1
5781,and,0,1
5782,assigned,0,1
5783,to,0,0
5784,follow,0,0
5785,a,0,0
5786,diet,0,0
5787,that,0,0
5788,was,0,0
5789,low,0,1
5790,in,0,0
5791,fat,0,1
5792,(,0,1
5793,20,0,1
5794,percent,0,1
5795,of,0,1
5796,total,0,1
5797,calories,0,1
5798,),0,1
5799,and,0,1
5800,high,0,1
5801,in,0,0
5802,fiber,0,0
5803,(,0,1
5804,18,0,1
5805,g,0,1
5806,of,0,0
5807,dietary,0,0
5808,fiber,0,0
5809,per,0,1
5810,1000,0,1
5811,kcal,0,1
5812,),0,1
5813,and,0,1
5814,fruits,0,1
5815,and,0,1
5816,vegetables,0,1
5817,(,0,1
5818,3.5,0,1
5819,servings,0,0
5820,per,0,1
5821,1000,0,1
5822,kcal,0,1
5823,),0,1
5824,",",0,0
5825,and,0,0
5826,a,0,0
5827,control,0,0
5828,group,0,0
5829,given,0,0
5830,a,0,0
5831,standard,0,0
5832,brochure,0,0
5833,on,0,0
5834,healthy,0,1
5835,eating,0,1
5836,and,0,1
5837,assigned,0,1
5838,to,0,0
5839,follow,0,0
5840,their,0,1
5841,usual,0,1
5842,diet,0,1
5843,.,0,1
5844,Subjects,0,1
5845,entered,0,1
5846,the,0,0
5847,study,0,0
5848,after,0,0
5849,undergoing,0,1
5850,complete,0,1
5851,colonoscopy,0,1
5852,and,0,0
5853,removal,0,0
5854,of,0,1
5855,adenomatous,0,1
5856,polyps,0,1
5857,;,0,1
5858,they,0,1
5859,remained,0,0
5860,in,0,0
5861,the,0,0
5862,study,0,0
5863,for,0,0
5864,approximately,0,1
5865,four,0,1
5866,years,0,1
5867,",",0,1
5868,undergoing,0,1
5869,colonoscopy,0,1
5870,one,0,1
5871,and,0,1
5872,four,0,1
5873,years,0,1
5874,after,0,1
5875,randomization,0,1
5876,.,0,1
5877,RESULTS,0,0
5878,A,1,0
5879,total,1,1
5880,of,1,0
5881,1905,1,1
5882,of,1,0
5883,the,1,1
5884,randomized,1,1
5885,subjects,1,1
5886,(,1,1
5887,91.6,1,0
5888,percent,1,1
5889,),1,1
5890,completed,1,1
5891,the,1,0
5892,study,1,0
5893,.,1,0
5894,Of,0,0
5895,the,0,0
5896,958,0,1
5897,subjects,0,1
5898,in,0,1
5899,the,0,0
5900,intervention,0,0
5901,group,0,0
5902,and,0,0
5903,the,0,0
5904,947,0,1
5905,in,0,0
5906,the,0,0
5907,control,0,1
5908,group,0,1
5909,who,0,1
5910,completed,0,1
5911,the,0,1
5912,study,0,0
5913,",",0,0
5914,39.7,0,0
5915,percent,0,1
5916,and,0,1
5917,39.5,0,0
5918,percent,0,0
5919,",",0,0
5920,respectively,0,0
5921,",",0,0
5922,had,0,0
5923,at,0,0
5924,least,0,1
5925,one,0,1
5926,recurrent,0,1
5927,adenoma,0,1
5928,;,0,0
5929,the,0,0
5930,unadjusted,0,0
5931,risk,0,0
5932,ratio,0,0
5933,was,0,0
5934,1.00,0,0
5935,(,0,1
5936,95,0,0
5937,percent,0,1
5938,confidence,0,0
5939,interval,0,0
5940,",",0,1
5941,0.90,0,0
5942,to,0,1
5943,1.12,0,0
5944,),0,1
5945,.,0,1
5946,Among,0,1
5947,subjects,0,1
5948,with,0,1
5949,recurrent,0,1
5950,adenomas,0,1
5951,",",0,0
5952,the,0,0
5953,mean,0,0
5954,(,0,0
5955,+/-SE,0,1
5956,),0,1
5957,number,0,0
5958,of,0,1
5959,such,0,0
5960,lesions,0,1
5961,was,0,0
5962,1.85+/-0.08,0,1
5963,in,0,0
5964,the,0,0
5965,intervention,0,0
5966,group,0,1
5967,and,0,1
5968,1.84+/-0.07,0,0
5969,in,0,0
5970,the,0,0
5971,control,0,1
5972,group,0,0
5973,.,0,1
5974,The,0,0
5975,rate,0,0
5976,of,0,0
5977,recurrence,0,0
5978,of,0,1
5979,large,0,1
5980,adenomas,0,1
5981,(,0,1
5982,with,0,1
5983,a,0,1
5984,maximal,0,0
5985,diameter,0,0
5986,of,0,0
5987,at,0,1
5988,least,0,1
5989,1,0,1
5990,cm,0,1
5991,),0,1
5992,and,0,0
5993,advanced,0,1
5994,adenomas,0,1
5995,(,0,1
5996,defined,0,1
5997,as,0,0
5998,lesions,0,1
5999,that,0,0
6000,had,0,1
6001,a,0,0
6002,maximal,0,0
6003,diameter,0,0
6004,of,0,0
6005,at,0,1
6006,least,0,1
6007,1,0,1
6008,cm,0,1
6009,or,0,1
6010,at,0,1
6011,least,0,1
6012,25,0,1
6013,percent,0,1
6014,villous,0,1
6015,elements,0,1
6016,or,0,1
6017,evidence,0,0
6018,of,0,0
6019,high-grade,0,1
6020,dysplasia,0,1
6021,",",0,0
6022,including,0,0
6023,carcinoma,0,1
6024,),0,1
6025,did,0,0
6026,not,0,0
6027,differ,0,0
6028,significantly,0,0
6029,between,0,0
6030,the,0,0
6031,two,0,1
6032,groups,0,1
6033,.,0,1
6034,CONCLUSIONS,0,0
6035,Adopting,0,0
6036,a,0,0
6037,diet,0,0
6038,that,0,0
6039,is,0,0
6040,low,0,0
6041,in,0,0
6042,fat,0,1
6043,and,0,1
6044,high,0,1
6045,in,0,0
6046,fiber,0,0
6047,",",0,1
6048,fruits,0,1
6049,",",0,1
6050,and,0,0
6051,vegetables,0,0
6052,does,0,0
6053,not,0,0
6054,influence,0,0
6055,the,0,0
6056,risk,0,0
6057,of,0,0
6058,recurrence,0,0
6059,of,0,0
6060,colorectal,0,1
6061,adenomas,0,1
6062,.,0,1
6063,Human,0,1
6064,motor,0,0
6065,responses,0,0
6066,to,0,1
6067,simultaneous,0,0
6068,aversive,0,0
6069,stimulation,0,0
6070,and,0,0
6071,failure,0,1
6072,on,0,0
6073,a,0,0
6074,valued,0,0
6075,task,0,1
6076,.,0,1
6077,The,0,0
6078,effects,0,0
6079,of,0,0
6080,presentation,0,1
6081,of,0,0
6082,an,0,0
6083,aversive,0,0
6084,stimulus,0,0
6085,and,0,1
6086,simultaneous,0,0
6087,failure,0,1
6088,on,0,0
6089,a,0,1
6090,bogus,0,0
6091,intelligence,0,1
6092,test,0,0
6093,upon,0,0
6094,a,0,1
6095,subject,0,0
6096,'s,0,1
6097,aggressive,0,1
6098,reactions,0,0
6099,were,0,1
6100,studied,0,1
6101,.,0,1
6102,The,0,0
6103,subject,1,0
6104,'s,1,1
6105,fist,1,1
6106,clenching,1,1
6107,was,0,0
6108,used,0,0
6109,as,0,0
6110,an,0,0
6111,indicator,0,0
6112,of,0,0
6113,aggression,0,1
6114,.,0,1
6115,Four,0,0
6116,conditions,0,0
6117,",",0,1
6118,generated,0,0
6119,by,0,0
6120,the,0,0
6121,combinations,0,0
6122,of,0,1
6123,two,0,1
6124,kinds,0,1
6125,of,0,1
6126,stimulus,0,0
6127,delivered,0,1
6128,to,0,1
6129,the,0,0
6130,subjects,0,1
6131,(,0,1
6132,aversive,0,0
6133,or,0,1
6134,nonaversive,0,0
6135,),0,1
6136,and,0,1
6137,two,0,1
6138,outcomes,0,0
6139,of,0,1
6140,the,0,0
6141,task,0,1
6142,(,0,0
6143,failure,0,1
6144,or,0,1
6145,success,0,0
6146,),0,0
6147,",",0,0
6148,were,0,1
6149,investigated,0,0
6150,.,0,1
6151,20,1,0
6152,female,1,1
6153,and,1,1
6154,20,1,1
6155,male,1,1
6156,students,1,1
6157,(,1,1
6158,ages,1,1
6159,:,1,1
6160,17-34,1,1
6161,years,1,1
6162,),1,1
6163,were,0,1
6164,instructed,0,1
6165,",",0,0
6166,upon,0,0
6167,the,0,0
6168,reception,0,1
6169,of,0,0
6170,an,0,1
6171,aversive,0,0
6172,or,0,1
6173,nonaversive,0,0
6174,acoustic,0,0
6175,signal,0,1
6176,",",0,0
6177,to,0,0
6178,press,0,0
6179,with,0,1
6180,the,0,0
6181,right,0,1
6182,hand,0,0
6183,a,0,1
6184,device,0,0
6185,that,0,0
6186,displayed,0,0
6187,a,0,0
6188,slide,0,0
6189,.,0,0
6190,Each,0,0
6191,slide,0,0
6192,presented,0,1
6193,an,0,0
6194,item,0,0
6195,from,0,0
6196,an,0,0
6197,intelligence,0,1
6198,test,0,0
6199,",",0,0
6200,to,0,0
6201,which,0,0
6202,the,0,0
6203,subjects,0,1
6204,were,0,1
6205,either,0,1
6206,allowed,0,0
6207,to,0,0
6208,answer,0,0
6209,successfully,0,0
6210,(,0,0
6211,success,0,0
6212,),0,1
6213,or,0,1
6214,not,0,0
6215,(,0,0
6216,failure,0,1
6217,),0,1
6218,.,0,1
6219,Failure,0,0
6220,increased,0,0
6221,the,0,0
6222,subject,0,0
6223,'s,0,1
6224,autonomic,0,0
6225,arousal,0,0
6226,",",0,0
6227,as,0,0
6228,measured,0,0
6229,by,0,0
6230,photoplethysmographic,0,0
6231,sensors,0,0
6232,",",0,1
6233,in,0,0
6234,all,0,0
6235,stimulation,0,0
6236,conditions,0,0
6237,",",0,0
6238,but,0,0
6239,only,0,0
6240,the,0,0
6241,condition,0,0
6242,with,0,1
6243,aversive,0,0
6244,stimulation,0,0
6245,increased,0,0
6246,the,0,0
6247,speed,0,0
6248,of,0,0
6249,clenching,0,0
6250,.,0,1
6251,This,0,0
6252,was,0,0
6253,interpreted,0,0
6254,as,0,0
6255,indicating,0,0
6256,subject,0,1
6257,'s,0,1
6258,tendencies,0,0
6259,to,0,1
6260,aggression,0,1
6261,.,0,1
6262,These,0,0
6263,results,0,0
6264,are,0,0
6265,discussed,0,0
6266,in,0,0
6267,relation,0,0
6268,to,0,1
6269,the,0,0
6270,effects,0,0
6271,of,0,0
6272,frustration,0,1
6273,.,0,1
6274,Immunogenicity,0,0
6275,and,0,0
6276,reactogenicity,0,0
6277,of,0,0
6278,a,0,1
6279,group,0,1
6280,C,0,0
6281,meningococcal,0,1
6282,conjugate,0,0
6283,vaccine,0,1
6284,compared,0,0
6285,with,0,1
6286,a,0,1
6287,group,0,1
6288,A+C,0,0
6289,meningococcal,0,1
6290,polysaccharide,0,0
6291,vaccine,0,1
6292,in,0,0
6293,adolescents,1,1
6294,in,0,1
6295,a,0,1
6296,randomised,0,1
6297,observer-blind,0,1
6298,controlled,0,0
6299,trial,0,0
6300,.,0,1
6301,This,0,0
6302,study,0,0
6303,evaluated,0,0
6304,the,0,0
6305,immunogenicity,0,0
6306,and,0,0
6307,reactogenicity,0,0
6308,of,0,0
6309,a,0,1
6310,group,0,1
6311,C,0,0
6312,meningococcal,0,1
6313,conjugate,0,0
6314,vaccine,0,1
6315,(,0,1
6316,MenC,0,0
6317,),0,1
6318,compared,0,0
6319,with,0,1
6320,a,0,1
6321,group,0,1
6322,A+C,0,0
6323,meningococcal,0,1
6324,polysaccharide,0,0
6325,vaccine,0,1
6326,(,0,1
6327,MenPS,0,1
6328,),0,1
6329,in,0,1
6330,healthy,1,1
6331,adolescents,1,1
6332,.,1,1
6333,Subjects,0,1
6334,were,0,1
6335,randomised,0,1
6336,to,0,0
6337,receive,0,1
6338,one,0,1
6339,dose,0,0
6340,of,0,0
6341,either,0,1
6342,MenC,0,0
6343,(,0,0
6344,n=92,0,1
6345,),0,1
6346,or,0,1
6347,MenPS,0,1
6348,(,0,1
6349,n=90,0,1
6350,),0,1
6351,.,0,1
6352,Group,0,1
6353,C,0,0
6354,meningococcal,0,1
6355,IgG,0,0
6356,antibody,0,0
6357,concentrations,0,0
6358,and,0,1
6359,bactericidal,0,1
6360,titres,0,0
6361,were,0,1
6362,higher,0,0
6363,in,0,0
6364,the,0,0
6365,MenC,0,0
6366,group,0,0
6367,than,0,0
6368,the,0,0
6369,MenPS,0,0
6370,group,0,1
6371,at,0,1
6372,1,0,1
6373,month,0,1
6374,(,0,1
6375,22.8,0,0
6376,U/ml,0,0
6377,vs,0,0
6378,4.0,0,0
6379,U/ml,0,0
6380,",",0,1
6381,p,0,0
6382,<,0,0
6383,0.001,0,0
6384,",",0,1
6385,and,0,0
6386,87,0,1
6387,vs,0,0
6388,20,0,1
6389,",",0,0
6390,p,0,0
6391,<,0,0
6392,0.001,0,0
6393,",",0,0
6394,respectively,0,0
6395,),0,0
6396,and,0,1
6397,12,0,1
6398,months,0,1
6399,(,0,1
6400,6.1,0,1
6401,U/ml,0,0
6402,vs,0,0
6403,3.0,0,0
6404,U/ml,0,0
6405,",",0,1
6406,p,0,0
6407,<,0,0
6408,0.001,0,0
6409,",",0,1
6410,and,0,0
6411,81.3,0,0
6412,vs,0,0
6413,20.2,0,1
6414,",",0,0
6415,p,0,0
6416,<,0,0
6417,0.001,0,0
6418,",",0,0
6419,respectively,0,0
6420,),0,0
6421,.,0,1
6422,No,0,0
6423,differences,0,0
6424,in,0,0
6425,post,0,1
6426,immunisation,0,1
6427,reaction,0,0
6428,rates,0,0
6429,were,0,1
6430,noted,0,0
6431,between,0,0
6432,the,0,0
6433,two,0,0
6434,vaccinated,0,1
6435,groups,0,0
6436,.,0,1
6437,This,0,0
6438,study,0,0
6439,demonstrated,0,0
6440,the,0,0
6441,safety,0,0
6442,and,0,0
6443,enhanced,0,0
6444,immunogenicity,0,0
6445,of,0,0
6446,the,0,0
6447,candidate,0,1
6448,meningococcal,0,1
6449,conjugate,0,0
6450,vaccine,0,1
6451,as,0,0
6452,compared,0,0
6453,with,0,1
6454,the,0,0
6455,licensed,0,1
6456,polysaccharide,0,0
6457,vaccine,0,1
6458,in,0,1
6459,adolescents,1,1
6460,.,1,1
6461,Comments,0,1
6462,on,0,1
6463,Secretin,0,0
6464,and,0,1
6465,autism,1,1
6466,:,1,1
6467,a,0,1
6468,two-part,0,0
6469,clinical,0,0
6470,investigation,0,1
6471,by,0,0
6472,M.G,0,1
6473,.,0,1
6474,Chez,0,0
6475,et,0,1
6476,al,0,1
6477,.,0,1
6478,Comparison,0,0
6479,of,0,0
6480,a,0,1
6481,5,0,0
6482,day,0,0
6483,regimen,0,0
6484,of,0,0
6485,cefdinir,0,1
6486,with,0,1
6487,a,0,1
6488,10,0,1
6489,day,0,0
6490,regimen,0,0
6491,of,0,0
6492,cefprozil,0,0
6493,for,0,0
6494,treatment,0,0
6495,of,0,1
6496,acute,0,1
6497,exacerbations,0,1
6498,of,0,1
6499,chronic,0,1
6500,bronchitis,0,1
6501,.,0,1
6502,Patients,1,1
6503,with,1,1
6504,acute,1,1
6505,exacerbations,1,1
6506,of,1,1
6507,chronic,1,1
6508,bronchitis,1,1
6509,were,0,1
6510,treated,0,1
6511,with,0,1
6512,cefdinir,0,1
6513,300,0,1
6514,mg,0,0
6515,bd,0,1
6516,for,0,1
6517,5,0,1
6518,days,0,0
6519,or,0,1
6520,cefprozil,0,0
6521,500,0,1
6522,mg,0,0
6523,bd,0,1
6524,for,0,1
6525,10,0,1
6526,days,0,0
6527,in,0,1
6528,a,0,1
6529,prospective,0,1
6530,",",0,0
6531,randomized,0,1
6532,",",0,0
6533,double-blind,0,0
6534,",",0,0
6535,multicentre,0,1
6536,study,0,1
6537,.,0,1
6538,Of,0,0
6539,the,0,0
6540,548,1,1
6541,patients,1,1
6542,enrolled,1,1
6543,",",1,1
6544,281,1,1
6545,(,1,1
6546,51,1,1
6547,%,1,0
6548,),1,1
6549,were,1,1
6550,evaluable,1,1
6551,.,1,1
6552,The,0,0
6553,clinical,0,0
6554,cure,0,0
6555,rates,0,0
6556,at,0,1
6557,the,0,1
6558,test-of-cure,0,0
6559,visit,0,0
6560,were,0,1
6561,80,0,1
6562,%,0,0
6563,(,0,1
6564,114/142,0,1
6565,),0,1
6566,and,0,1
6567,72,0,1
6568,%,0,0
6569,(,0,1
6570,100/139,0,1
6571,),0,1
6572,for,0,0
6573,the,0,0
6574,evaluable,1,1
6575,patients,1,1
6576,treated,1,1
6577,with,1,1
6578,cefdinir,1,1
6579,and,1,0
6580,cefprozil,1,0
6581,",",0,0
6582,respectively,0,0
6583,.,0,1
6584,Respiratory,0,0
6585,tract,0,1
6586,pathogens,0,1
6587,were,0,1
6588,isolated,0,1
6589,from,0,1
6590,409,0,1
6591,(,0,1
6592,75,0,1
6593,%,0,0
6594,),0,1
6595,of,0,0
6596,548,0,1
6597,admission,0,1
6598,sputum,0,1
6599,specimens,0,1
6600,",",0,0
6601,with,0,1
6602,the,0,0
6603,predominant,0,0
6604,pathogens,0,0
6605,being,0,0
6606,Haemophilus,0,1
6607,parainfluenzae,0,1
6608,",",0,0
6609,Haemophilus,0,1
6610,influenzae,0,1
6611,",",0,0
6612,Staphylococcus,0,1
6613,aureus,0,1
6614,and,0,1
6615,Moraxella,0,1
6616,catarrhalis,0,1
6617,.,0,1
6618,The,0,0
6619,microbiological,0,0
6620,eradication,0,1
6621,rates,0,0
6622,at,0,1
6623,the,0,1
6624,test-of-cure,0,0
6625,visit,0,0
6626,were,0,1
6627,81,0,1
6628,%,0,0
6629,(,0,1
6630,157,0,1
6631,of,0,1
6632,193,0,1
6633,pathogens,0,1
6634,),0,1
6635,and,0,1
6636,84,0,1
6637,%,0,0
6638,(,0,1
6639,166,0,1
6640,of,0,1
6641,198,0,1
6642,pathogens,0,1
6643,),0,1
6644,for,0,1
6645,the,0,0
6646,evaluable,0,1
6647,patients,0,1
6648,treated,0,1
6649,with,0,1
6650,cefdinir,0,1
6651,and,0,0
6652,cefprozil,0,0
6653,",",0,0
6654,respectively,0,0
6655,.,0,1
6656,Adverse,0,0
6657,event,0,0
6658,rates,0,0
6659,while,0,0
6660,on,0,0
6661,treatment,0,1
6662,were,0,1
6663,equivalent,0,0
6664,between,0,0
6665,the,0,0
6666,two,0,0
6667,treatment,0,1
6668,groups,0,1
6669,.,0,1
6670,The,0,0
6671,incidence,0,0
6672,of,0,0
6673,diarrhoea,0,1
6674,during,0,0
6675,therapy,0,0
6676,was,0,0
6677,higher,0,0
6678,for,0,1
6679,patients,1,1
6680,treated,1,1
6681,with,1,1
6682,cefdinir,1,1
6683,(,1,1
6684,17,1,1
6685,%,1,0
6686,),1,1
6687,than,1,0
6688,for,1,1
6689,patients,1,1
6690,treated,1,1
6691,with,1,1
6692,cefprozil,1,0
6693,(,1,1
6694,6,1,0
6695,%,1,0
6696,),1,1
6697,(,0,1
6698,P,0,0
6699,<,0,0
6700,0.01,0,0
6701,),0,1
6702,",",0,0
6703,but,0,0
6704,most,0,0
6705,cases,0,1
6706,were,0,1
6707,mild,0,1
6708,and,0,0
6709,did,0,0
6710,not,0,0
6711,lead,0,0
6712,to,0,0
6713,discontinuation,0,0
6714,of,0,0
6715,treatment,0,0
6716,.,0,1
6717,These,0,0
6718,results,0,0
6719,indicate,0,0
6720,that,0,0
6721,a,0,1
6722,5,0,0
6723,day,0,0
6724,regimen,0,0
6725,of,0,0
6726,cefdinir,0,0
6727,is,0,0
6728,as,0,0
6729,effective,0,0
6730,and,0,1
6731,safe,0,0
6732,in,0,0
6733,the,0,0
6734,treatment,0,0
6735,of,0,0
6736,patients,1,1
6737,with,0,1
6738,acute,1,1
6739,exacerbations,1,1
6740,of,1,1
6741,chronic,1,1
6742,bronchitis,1,1
6743,as,0,0
6744,a,0,1
6745,10,0,1
6746,day,0,0
6747,regimen,0,0
6748,of,0,1
6749,cefprozil,0,1
6750,.,0,1
6751,Clinical,0,0
6752,pathway,0,0
6753,for,0,0
6754,fractured,1,1
6755,neck,1,1
6756,of,1,1
6757,femur,1,1
6758,:,1,1
6759,a,0,0
6760,prospective,0,0
6761,",",0,0
6762,controlled,0,0
6763,study,0,1
6764,.,0,1
6765,OBJECTIVE,0,0
6766,To,0,0
6767,assess,0,0
6768,outcomes,0,0
6769,of,0,0
6770,using,0,0
6771,a,0,1
6772,clinical,0,0
6773,pathway,0,0
6774,for,0,1
6775,managing,0,0
6776,patients,1,1
6777,with,1,1
6778,fractured,1,1
6779,neck,1,1
6780,of,1,0
6781,femur,1,1
6782,.,1,1
6783,DESIGN,0,0
6784,Prospective,0,0
6785,",",0,0
6786,pseudorandomised,0,0
6787,",",0,0
6788,controlled,0,0
6789,trial,0,0
6790,.,0,1
6791,SETTING,0,1
6792,St,1,0
6793,Vincent,1,1
6794,'s,1,1
6795,Hospital,1,1
6796,",",1,1
6797,Melbourne,1,1
6798,",",1,0
6799,Victoria,1,1
6800,(,1,0
6801,a,1,1
6802,tertiary,1,1
6803,referral,1,1
6804,",",1,0
6805,university,1,1
6806,teaching,1,1
6807,hospital,1,1
6808,),1,1
6809,",",1,1
6810,1,1,1
6811,October,1,1
6812,1997,1,1
6813,to,1,1
6814,30,1,1
6815,November,1,1
6816,1998,1,1
6817,.,1,1
6818,PARTICIPANTS,0,0
6819,111,1,1
6820,patients,1,1
6821,(,1,1
6822,80,1,1
6823,women,1,1
6824,and,1,1
6825,31,1,1
6826,men,1,1
6827,;,1,1
6828,mean,1,1
6829,age,1,1
6830,",",1,1
6831,81,1,1
6832,years,1,1
6833,),1,1
6834,admitted,1,1
6835,via,1,0
6836,the,1,0
6837,emergency,1,1
6838,department,1,1
6839,with,1,1
6840,a,1,1
6841,primary,1,1
6842,diagnosis,1,1
6843,of,1,0
6844,fractured,1,1
6845,neck,1,1
6846,of,1,0
6847,femur,1,1
6848,.,1,1
6849,INTERVENTIONS,0,0
6850,Management,0,0
6851,guided,0,1
6852,by,0,0
6853,a,0,1
6854,clinical,0,0
6855,pathway,0,0
6856,(,0,1
6857,55,0,1
6858,patients,0,1
6859,),0,1
6860,or,0,1
6861,established,0,0
6862,standard,0,1
6863,of,0,0
6864,care,0,1
6865,(,0,1
6866,control,0,1
6867,group,0,1
6868,",",0,1
6869,56,0,1
6870,patients,0,1
6871,),0,1
6872,.,0,1
6873,MAIN,0,0
6874,OUTCOME,0,1
6875,MEASURES,0,0
6876,Timing,0,0
6877,of,0,1
6878,referrals,0,1
6879,and,0,1
6880,discharge,0,1
6881,planning,0,0
6882,;,0,1
6883,total,0,1
6884,length,0,0
6885,of,0,1
6886,stay,0,0
6887,;,0,1
6888,and,0,0
6889,complication,0,0
6890,and,0,1
6891,readmission,0,1
6892,rates,0,0
6893,within,0,1
6894,28,0,1
6895,days,0,0
6896,of,0,1
6897,discharge,0,1
6898,.,0,1
6899,RESULTS,0,0
6900,Patients,0,1
6901,managed,0,1
6902,according,0,1
6903,to,0,0
6904,the,0,0
6905,clinical,0,0
6906,pathway,0,0
6907,had,0,1
6908,a,0,0
6909,shorter,0,0
6910,total,0,1
6911,stay,0,0
6912,(,0,1
6913,6.6,0,0
6914,versus,0,0
6915,8.0,0,1
6916,days,0,0
6917,;,0,1
6918,P,0,0
6919,=,0,1
6920,0.03,0,0
6921,),0,0
6922,",",0,0
6923,even,0,0
6924,if,0,0
6925,assessment,0,0
6926,for,0,0
6927,placement,0,0
6928,by,0,0
6929,the,0,0
6930,Aged,0,0
6931,Care,0,1
6932,Assessment,0,0
6933,Service,0,1
6934,was,0,0
6935,required,0,0
6936,(,0,1
6937,9.5,0,0
6938,versus,0,0
6939,13.6,0,1
6940,days,0,0
6941,;,0,1
6942,P,0,0
6943,=,0,1
6944,0.03,0,0
6945,),0,0
6946,.,0,0
6947,There,0,0
6948,were,0,0
6949,no,0,0
6950,significant,0,0
6951,differences,0,0
6952,in,0,1
6953,complication,0,0
6954,and,0,1
6955,readmission,0,1
6956,rates,0,0
6957,between,0,0
6958,pathway,0,0
6959,and,0,1
6960,control,1,1
6961,patients,1,1
6962,(,0,1
6963,complication,0,0
6964,rates,0,0
6965,",",0,1
6966,24,0,1
6967,%,0,0
6968,versus,0,0
6969,36,0,1
6970,%,0,0
6971,;,0,0
6972,P,0,0
6973,=,0,1
6974,0.40,0,0
6975,;,0,0
6976,readmission,0,1
6977,rates,0,0
6978,",",0,1
6979,4,0,0
6980,%,0,0
6981,versus,0,0
6982,11,0,1
6983,%,0,0
6984,;,0,1
6985,P,0,0
6986,=,0,1
6987,0.28,0,0
6988,),0,1
6989,.,0,1
6990,CONCLUSION,0,0
6991,Coordinated,0,1
6992,multidisciplinary,0,1
6993,care,0,1
6994,of,0,1
6995,patients,1,1
6996,with,1,1
6997,fractured,1,1
6998,neck,1,1
6999,of,1,1
7000,femur,1,1
7001,reduces,0,0
7002,length,0,0
7003,of,0,0
7004,stay,0,0
7005,without,0,1
7006,increasing,0,0
7007,complications,0,1
7008,.,0,1
7009,Effects,0,1
7010,of,0,1
7011,low-dose,0,0
7012,aspirin,0,0
7013,on,0,0
7014,clinic,0,1
7015,and,0,1
7016,ambulatory,0,1
7017,blood,0,0
7018,pressure,0,0
7019,in,0,0
7020,treated,1,1
7021,hypertensive,1,1
7022,patients,1,1
7023,.,1,1
7024,Collaborative,0,0
7025,Group,0,1
7026,of,0,0
7027,the,0,0
7028,Primary,0,1
7029,Prevention,0,1
7030,Project,0,1
7031,(,0,1
7032,PPP,0,1
7033,),0,1
7034,--,0,1
7035,Hypertension,0,1
7036,study,0,1
7037,.,0,1
7038,Nonsteroidal,0,0
7039,antiinflammatory,0,0
7040,drugs,0,0
7041,may,0,0
7042,affect,0,0
7043,blood,0,0
7044,pressure,0,0
7045,(,0,1
7046,BP,0,1
7047,),0,1
7048,control,0,1
7049,in,0,1
7050,hypertensive,1,1
7051,patients,1,1
7052,receiving,1,1
7053,drug,1,1
7054,treatment,1,0
7055,",",0,0
7056,but,0,0
7057,data,0,0
7058,on,0,0
7059,the,0,1
7060,effects,0,0
7061,of,0,1
7062,low-dose,0,0
7063,aspirin,0,0
7064,are,0,0
7065,scanty,0,0
7066,.,0,0
7067,This,0,0
7068,study,0,0
7069,assessed,0,0
7070,the,0,0
7071,effects,0,0
7072,of,0,0
7073,chronic,0,1
7074,treatment,0,1
7075,with,0,1
7076,low,0,1
7077,doses,0,0
7078,of,0,1
7079,aspirin,0,0
7080,(,0,1
7081,100,0,1
7082,mg/day,0,0
7083,),0,1
7084,on,0,0
7085,clinic,0,1
7086,and,0,1
7087,ambulatory,0,1
7088,systolic,0,1
7089,(,0,1
7090,SBP,0,1
7091,),0,1
7092,and,0,1
7093,diastolic,0,1
7094,(,0,1
7095,DBP,0,1
7096,),0,1
7097,BP,0,1
7098,in,0,1
7099,hypertensives,0,1
7100,on,0,0
7101,chronic,0,1
7102,",",0,1
7103,stable,0,1
7104,antihypertensive,0,1
7105,therapy,0,1
7106,.,0,1
7107,The,0,0
7108,study,0,0
7109,was,0,0
7110,conducted,0,0
7111,in,0,0
7112,the,0,0
7113,framework,0,0
7114,of,0,0
7115,the,0,0
7116,Primary,0,1
7117,Prevention,0,1
7118,Project,0,1
7119,(,0,1
7120,PPP,0,1
7121,),0,1
7122,",",0,0
7123,a,0,0
7124,randomized,0,0
7125,",",0,0
7126,controlled,0,0
7127,factorial,0,0
7128,trial,0,0
7129,on,0,0
7130,the,0,0
7131,preventive,0,1
7132,effect,0,0
7133,of,0,0
7134,aspirin,0,0
7135,or,0,1
7136,vitamin,0,0
7137,E,0,1
7138,in,0,0
7139,people,1,1
7140,with,1,1
7141,one,1,1
7142,or,1,1
7143,more,1,0
7144,cardiovascular,1,1
7145,risk,1,1
7146,factors,1,0
7147,.,1,1
7148,Fifteen,1,1
7149,Italian,1,1
7150,hypertension,1,1
7151,units,1,1
7152,studied,1,1
7153,142,1,1
7154,hypertensive,1,1
7155,patients,1,1
7156,(,1,1
7157,76,1,1
7158,men,1,1
7159,",",1,1
7160,66,1,1
7161,women,1,1
7162,;,1,1
7163,mean,1,1
7164,age,1,1
7165,59,1,1
7166,+/-,1,1
7167,5.9,1,1
7168,years,1,1
7169,),1,1
7170,treated,1,1
7171,with,1,1
7172,different,1,1
7173,antihypertensive,1,1
7174,drugs,1,1
7175,:,1,1
7176,71,0,1
7177,patients,0,1
7178,were,0,1
7179,randomized,0,1
7180,to,0,0
7181,aspirin,0,0
7182,and,0,1
7183,71,0,1
7184,served,0,1
7185,as,0,0
7186,controls,0,1
7187,.,0,1
7188,All,0,1
7189,patients,0,1
7190,underwent,0,1
7191,a,0,1
7192,clinic,0,1
7193,BP,0,1
7194,evaluation,0,0
7195,with,0,1
7196,an,0,0
7197,automatic,0,0
7198,sphygmomanometer,0,1
7199,and,0,0
7200,a,0,0
7201,24-h,0,0
7202,ambulatory,0,1
7203,BP,0,1
7204,monitoring,0,0
7205,",",0,0
7206,at,0,0
7207,baseline,0,0
7208,and,0,1
7209,after,0,1
7210,3,0,1
7211,months,0,1
7212,of,0,1
7213,aspirin,0,0
7214,treatment,0,1
7215,.,0,1
7216,At,0,0
7217,the,0,0
7218,end,0,0
7219,of,0,0
7220,the,0,0
7221,study,0,0
7222,the,0,0
7223,changes,0,0
7224,in,0,1
7225,clinic,0,1
7226,SBP,0,1
7227,and,0,1
7228,DBP,0,1
7229,were,0,0
7230,not,0,0
7231,statistically,0,0
7232,different,0,0
7233,in,0,0
7234,treated,0,1
7235,and,0,1
7236,untreated,0,1
7237,subjects,0,1
7238,.,0,1
7239,Ambulatory,0,1
7240,SBP,0,1
7241,and,0,1
7242,DBP,0,1
7243,after,0,1
7244,3,0,1
7245,months,0,1
7246,of,0,1
7247,aspirin,0,0
7248,treatment,0,1
7249,were,0,1
7250,similar,0,0
7251,to,0,1
7252,baseline,0,0
7253,:,0,1
7254,deltaSBP,0,0
7255,-0.5,0,0
7256,mmHg,0,0
7257,(,0,1
7258,95,0,0
7259,%,0,0
7260,confidence,0,0
7261,intervals,0,0
7262,[,0,1
7263,CI,0,0
7264,],0,1
7265,from,0,1
7266,-1.9,0,0
7267,to,0,0
7268,+2.9,0,0
7269,mm,0,1
7270,Hg,0,1
7271,),0,1
7272,and,0,1
7273,deltaDBP,0,0
7274,-1.1,0,0
7275,mm,0,1
7276,Hg,0,1
7277,(,0,1
7278,95,0,0
7279,%,0,0
7280,CI,0,0
7281,from,0,1
7282,-2.5,0,0
7283,to,0,1
7284,+0.3,0,0
7285,mm,0,1
7286,Hg,0,1
7287,),0,1
7288,.,0,1
7289,The,0,0
7290,pattern,0,0
7291,was,0,0
7292,similar,0,0
7293,in,0,0
7294,the,0,0
7295,control,0,1
7296,group,0,0
7297,.,0,1
7298,No,0,0
7299,interaction,0,0
7300,was,0,0
7301,found,0,0
7302,between,0,0
7303,aspirin,0,0
7304,and,0,0
7305,the,0,0
7306,most,0,0
7307,used,0,0
7308,antihypertensive,0,1
7309,drug,0,1
7310,classes,0,1
7311,(,0,1
7312,angiotensin,0,0
7313,converting,0,1
7314,enzyme,0,1
7315,inhibitors,0,1
7316,and,0,1
7317,calcium,0,1
7318,antagonists,0,0
7319,),0,1
7320,.,0,1
7321,Despite,0,0
7322,the,0,0
7323,relatively,0,0
7324,small,0,0
7325,sample,0,1
7326,size,0,0
7327,our,0,0
7328,results,0,0
7329,seem,0,0
7330,to,0,0
7331,exclude,0,0
7332,any,0,0
7333,significant,0,0
7334,influence,0,0
7335,of,0,0
7336,low-dose,0,0
7337,aspirin,0,0
7338,on,0,0
7339,BP,0,1
7340,control,0,1
7341,in,0,1
7342,hypertensives,0,1
7343,under,0,1
7344,treatment,0,1
7345,.,0,1
7346,Is,0,0
7347,a,0,0
7348,calculated,0,0
7349,total,0,1
7350,hip,0,1
7351,BMD,0,1
7352,of,0,0
7353,clinical,0,0
7354,use,0,0
7355,?,0,1
7356,The,0,0
7357,diagnosis,0,1
7358,of,0,0
7359,osteoporosis,0,1
7360,is,0,0
7361,based,0,0
7362,on,0,0
7363,bone,0,1
7364,mass,0,1
7365,measurement,0,0
7366,.,0,1
7367,To,0,0
7368,avoid,0,0
7369,the,0,0
7370,errors,0,0
7371,associated,0,0
7372,with,0,1
7373,the,0,0
7374,measurement,0,0
7375,of,0,0
7376,spinal,0,1
7377,bone,0,1
7378,density,0,0
7379,the,0,0
7380,total,0,1
7381,hip,0,1
7382,has,0,0
7383,been,0,0
7384,accepted,0,0
7385,as,0,0
7386,the,0,0
7387,standard,0,1
7388,measurement,0,0
7389,site,0,0
7390,.,0,1
7391,This,0,0
7392,information,0,0
7393,is,0,0
7394,not,0,0
7395,available,0,0
7396,for,0,0
7397,many,0,1
7398,early,0,1
7399,measurements,0,0
7400,.,0,1
7401,We,0,0
7402,have,0,0
7403,assessed,0,0
7404,whether,0,0
7405,it,0,0
7406,is,0,0
7407,possible,0,0
7408,to,0,0
7409,derive,0,0
7410,clinically,0,1
7411,useful,0,0
7412,information,0,0
7413,about,0,0
7414,total,0,1
7415,hip,0,1
7416,bone,0,1
7417,mineral,0,0
7418,density,0,0
7419,(,0,1
7420,BMD,0,0
7421,),0,1
7422,from,0,1
7423,measurements,0,0
7424,at,0,1
7425,other,0,1
7426,hip,0,1
7427,sites,0,1
7428,.,0,1
7429,The,0,0
7430,bone,0,0
7431,mass,0,1
7432,measurements,0,0
7433,of,0,1
7434,46,1,1
7435,patients,1,1
7436,participating,1,1
7437,in,1,1
7438,a,1,1
7439,current,1,0
7440,trial,1,0
7441,of,1,0
7442,therapy,1,0
7443,for,1,0
7444,osteoporosis,1,1
7445,were,0,1
7446,reviewed,0,1
7447,.,0,1
7448,The,0,0
7449,total,0,1
7450,hip,0,1
7451,BMD,0,0
7452,as,0,0
7453,directly,0,0
7454,measured,0,0
7455,was,0,0
7456,compared,0,0
7457,with,0,1
7458,that,0,0
7459,obtained,0,0
7460,from,0,0
7461,the,0,0
7462,formula,0,0
7463,:,0,1
7464,Total,0,1
7465,hip,0,1
7466,BMD,0,0
7467,=,0,0
7468,0.48,0,0
7469,x,0,0
7470,Neck,0,1
7471,BMD,0,1
7472,+,0,0
7473,0.62,0,0
7474,x,0,1
7475,Trochanteric,0,1
7476,BMD,0,1
7477,+,0,0
7478,0.03,0,0
7479,.,0,1
7480,In,0,0
7481,30,1,1
7482,patients,1,1
7483,with,1,1
7484,follow-up,1,1
7485,data,1,0
7486,the,0,0
7487,rate,0,0
7488,of,0,0
7489,change,0,0
7490,in,0,0
7491,hip,0,1
7492,BMD,0,0
7493,over,0,0
7494,a,0,1
7495,year,0,0
7496,was,0,0
7497,also,0,0
7498,determined,0,0
7499,by,0,0
7500,both,0,0
7501,methods,0,1
7502,.,0,1
7503,In,0,0
7504,the,0,0
7505,pretreatment,0,0
7506,state,0,0
7507,there,0,0
7508,was,0,0
7509,good,0,0
7510,agreement,0,0
7511,between,0,0
7512,the,0,1
7513,two,0,1
7514,measures,0,0
7515,(,0,1
7516,r2,0,0
7517,=,0,0
7518,0.96,0,0
7519,",",0,0
7520,SEE,0,0
7521,0.012,0,0
7522,g/cm2,0,1
7523,),0,1
7524,.,0,1
7525,If,0,0
7526,the,0,0
7527,formula,0,0
7528,was,0,0
7529,used,0,0
7530,to,0,0
7531,compute,0,0
7532,a,0,0
7533,change,0,0
7534,in,0,0
7535,total,0,1
7536,hip,0,1
7537,BMD,0,0
7538,",",0,0
7539,the,0,0
7540,agreement,0,0
7541,between,0,0
7542,both,0,0
7543,methods,0,1
7544,remained,0,0
7545,good,0,0
7546,.,0,1
7547,However,0,0
7548,",",0,0
7549,the,0,0
7550,standard,0,0
7551,error,0,0
7552,of,0,0
7553,the,0,0
7554,estimate,0,0
7555,of,0,0
7556,the,0,0
7557,change,0,0
7558,represented,0,0
7559,59,0,1
7560,%,0,0
7561,of,0,0
7562,the,0,0
7563,observed,0,0
7564,change,0,0
7565,.,0,0
7566,This,0,0
7567,indicates,0,0
7568,that,0,0
7569,the,0,0
7570,error,0,0
7571,associated,0,0
7572,with,0,1
7573,this,0,0
7574,estimate,0,0
7575,is,0,0
7576,too,0,0
7577,great,0,0
7578,to,0,0
7579,allow,0,0
7580,clinically,0,1
7581,meaningful,0,0
7582,conclusions,0,0
7583,to,0,1
7584,be,0,0
7585,drawn,0,0
7586,from,0,1
7587,calculated,0,0
7588,total,0,1
7589,hip,0,1
7590,BMD,0,1
7591,.,0,1
7592,We,0,0
7593,conclude,0,0
7594,that,0,0
7595,",",0,0
7596,whilst,0,0
7597,it,0,0
7598,may,0,0
7599,be,0,0
7600,possible,0,0
7601,to,0,0
7602,obtain,0,0
7603,reasonable,0,0
7604,point,0,0
7605,estimates,0,0
7606,of,0,1
7607,total,0,1
7608,hip,0,1
7609,BMD,0,1
7610,from,0,1
7611,other,0,1
7612,measures,0,0
7613,in,0,1
7614,the,0,0
7615,hip,0,1
7616,",",0,0
7617,these,0,0
7618,estimates,0,0
7619,are,0,0
7620,too,0,1
7621,imprecise,0,0
7622,to,0,0
7623,allow,0,0
7624,conclusions,0,0
7625,about,0,0
7626,change,0,0
7627,in,0,1
7628,BMD,0,0
7629,to,0,1
7630,be,0,0
7631,made,0,0
7632,.,0,1
7633,Efficacy,0,0
7634,and,0,0
7635,safety,0,0
7636,of,0,0
7637,selamectin,0,0
7638,against,0,1
7639,fleas,0,1
7640,and,0,1
7641,heartworms,0,1
7642,in,0,1
7643,dogs,1,1
7644,and,1,1
7645,cats,1,1
7646,presented,1,1
7647,as,1,1
7648,veterinary,1,1
7649,patients,1,1
7650,in,1,1
7651,North,1,1
7652,America,1,1
7653,.,1,1
7654,A,0,0
7655,series,0,1
7656,of,0,0
7657,randomized,0,1
7658,",",0,0
7659,controlled,0,0
7660,",",0,0
7661,masked,0,1
7662,field,0,0
7663,studies,0,0
7664,was,0,0
7665,conducted,0,1
7666,to,0,0
7667,assess,0,0
7668,the,0,0
7669,efficacy,0,0
7670,and,0,0
7671,safety,0,0
7672,of,0,0
7673,selamectin,0,0
7674,in,0,0
7675,the,0,0
7676,treatment,0,0
7677,of,0,0
7678,flea,0,1
7679,infestations,0,1
7680,on,0,1
7681,dogs,1,1
7682,and,1,1
7683,cats,1,1
7684,",",0,0
7685,and,0,0
7686,in,0,0
7687,the,0,0
7688,prevention,0,1
7689,of,0,0
7690,heartworm,0,1
7691,infection,0,1
7692,in,0,1
7693,dogs,1,1
7694,.,1,1
7695,In,0,0
7696,addition,0,0
7697,",",0,1
7698,observations,0,0
7699,were,0,1
7700,made,0,0
7701,on,0,0
7702,the,0,0
7703,beneficial,0,0
7704,effect,0,0
7705,of,0,0
7706,selamectin,0,0
7707,treatment,0,1
7708,on,0,0
7709,dogs,1,1
7710,and,1,1
7711,cats,1,1
7712,showing,1,1
7713,signs,1,1
7714,of,1,1
7715,flea,1,1
7716,allergy,1,1
7717,dermatitis,1,1
7718,(,1,1
7719,FAD,1,1
7720,),1,1
7721,.,1,1
7722,In,0,0
7723,all,0,0
7724,studies,0,0
7725,selamectin,0,0
7726,was,0,0
7727,applied,0,0
7728,topically,0,0
7729,",",0,0
7730,once,0,0
7731,per,0,0
7732,month,0,0
7733,",",0,0
7734,in,0,0
7735,unit,0,1
7736,doses,0,0
7737,providing,0,0
7738,a,0,1
7739,minimum,0,0
7740,dosage,0,0
7741,of,0,1
7742,6mgkg,0,1
7743,(,0,1
7744,-1,0,0
7745,),0,1
7746,.,0,1
7747,Dogs,1,1
7748,and,1,1
7749,cats,1,1
7750,with,1,1
7751,naturally,1,1
7752,occurring,1,1
7753,flea,1,0
7754,infestations,1,1
7755,",",1,0
7756,some,1,0
7757,of,1,0
7758,which,1,0
7759,also,1,0
7760,had,1,1
7761,signs,1,0
7762,associated,1,0
7763,with,1,1
7764,FAD,1,1
7765,",",0,1
7766,were,0,0
7767,assigned,0,1
7768,randomly,0,1
7769,to,0,0
7770,receive,0,1
7771,three,0,0
7772,months,0,0
7773,of,0,1
7774,topical,0,0
7775,treatment,0,1
7776,with,0,1
7777,selamectin,0,0
7778,(,1,1
7779,220,1,1
7780,dogs,1,1
7781,",",1,1
7782,189,1,1
7783,cats,1,1
7784,),1,1
7785,or,0,1
7786,a,0,1
7787,positive-control,0,0
7788,product,0,0
7789,(,0,1
7790,dogs,0,1
7791,:,0,1
7792,fenthion,0,0
7793,",",0,0
7794,n=81,0,1
7795,;,0,1
7796,cats,0,1
7797,:,0,1
7798,pyrethrins,0,1
7799,",",0,1
7800,n=66,0,1
7801,),0,1
7802,.,0,1
7803,Selamectin,0,0
7804,was,0,0
7805,administered,0,0
7806,on,0,0
7807,days,0,0
7808,0,0,0
7809,",",0,1
7810,30,0,1
7811,",",0,0
7812,and,0,1
7813,60,0,1
7814,.,0,1
7815,Day,0,1
7816,0,0,0
7817,was,0,0
7818,defined,0,0
7819,as,0,0
7820,the,0,0
7821,day,0,0
7822,that,0,0
7823,the,0,0
7824,animal,0,1
7825,first,0,0
7826,received,0,0
7827,treatment,0,0
7828,.,0,1
7829,Flea,0,1
7830,burdens,0,1
7831,were,0,1
7832,assessed,0,0
7833,by,0,0
7834,flea,0,1
7835,comb,0,1
7836,counts,0,0
7837,and,0,1
7838,clinical,0,1
7839,evaluations,0,0
7840,of,0,1
7841,FAD,0,1
7842,were,0,1
7843,performed,0,0
7844,before,0,0
7845,treatment,0,0
7846,",",0,0
7847,and,0,0
7848,on,0,0
7849,days,0,0
7850,14,0,1
7851,",",0,1
7852,30,0,1
7853,",",0,0
7854,60,0,1
7855,",",0,0
7856,and,0,1
7857,90,0,1
7858,.,0,1
7859,On,0,1
7860,days,0,0
7861,30,0,1
7862,",",0,1
7863,60,0,1
7864,",",0,0
7865,and,0,0
7866,90,0,1
7867,",",0,0
7868,mean,0,1
7869,flea,0,1
7870,counts,0,0
7871,in,0,1
7872,selamectin-treated,0,1
7873,dogs,0,1
7874,were,0,1
7875,reduced,0,0
7876,by,0,0
7877,92.1,0,0
7878,",",0,1
7879,99.0,0,0
7880,",",0,0
7881,and,0,0
7882,99.8,0,0
7883,%,0,0
7884,",",0,0
7885,and,0,0
7886,mean,0,1
7887,flea,0,1
7888,counts,0,0
7889,in,0,1
7890,fenthion-treated,0,1
7891,dogs,0,1
7892,were,0,1
7893,reduced,0,0
7894,by,0,0
7895,81.5,0,0
7896,",",0,1
7897,86.8,0,0
7898,",",0,0
7899,and,0,0
7900,86.1,0,0
7901,%,0,0
7902,",",0,0
7903,respectively,0,0
7904,",",0,0
7905,compared,0,0
7906,with,0,1
7907,day,0,1
7908,0,0,0
7909,counts,0,0
7910,.,0,1
7911,Also,0,0
7912,",",0,0
7913,on,0,0
7914,days,0,0
7915,30,0,1
7916,",",0,1
7917,60,0,1
7918,",",0,0
7919,and,0,0
7920,90,0,1
7921,",",0,0
7922,mean,0,1
7923,flea,0,1
7924,counts,0,0
7925,in,0,1
7926,selamectin-treated,0,1
7927,cats,0,1
7928,were,0,1
7929,reduced,0,0
7930,by,0,0
7931,92.5,0,0
7932,",",0,1
7933,98.3,0,0
7934,",",0,0
7935,and,0,0
7936,99.3,0,0
7937,%,0,0
7938,",",0,0
7939,and,0,0
7940,mean,0,1
7941,flea,0,1
7942,counts,0,0
7943,in,0,1
7944,pyrethrin-treated,0,1
7945,cats,0,1
7946,were,0,1
7947,reduced,0,0
7948,by,0,0
7949,66.4,0,1
7950,",",0,1
7951,73.9,0,0
7952,",",0,0
7953,and,0,0
7954,81.3,0,0
7955,%,0,0
7956,",",0,0
7957,respectively,0,0
7958,",",0,0
7959,compared,0,0
7960,with,0,1
7961,day,0,1
7962,0,0,0
7963,counts,0,0
7964,.,0,1
7965,Selamectin,0,0
7966,also,0,0
7967,was,0,0
7968,beneficial,0,0
7969,in,0,1
7970,alleviating,0,0
7971,signs,0,1
7972,in,0,1
7973,dogs,1,1
7974,and,1,1
7975,cats,1,1
7976,diagnosed,1,1
7977,clinically,1,1
7978,with,1,1
7979,FAD,1,1
7980,.,1,1
7981,A,0,0
7982,total,0,1
7983,of,0,1
7984,397,1,1
7985,dogs,1,1
7986,free,1,1
7987,of,1,1
7988,adult,1,1
7989,heartworm,1,1
7990,infection,1,1
7991,from,1,1
7992,four,1,1
7993,heartworm-endemic,1,1
7994,areas,1,0
7995,of,1,1
7996,the,1,1
7997,USA,1,0
7998,were,0,0
7999,allocated,0,1
8000,randomly,0,1
8001,to,0,1
8002,six,0,1
8003,months,0,0
8004,of,0,1
8005,treatment,0,1
8006,with,0,1
8007,selamectin,0,0
8008,(,0,1
8009,n=298,0,1
8010,),0,1
8011,or,0,1
8012,ivermectin,0,0
8013,(,0,1
8014,n=99,0,1
8015,),0,1
8016,.,0,1
8017,Selamectin,0,0
8018,achieved,0,0
8019,a,0,0
8020,heartworm,0,1
8021,prevention,0,1
8022,rate,0,0
8023,of,0,0
8024,100,0,1
8025,%,0,0
8026,",",0,0
8027,with,0,1
8028,all,0,1
8029,dogs,0,1
8030,testing,0,0
8031,negative,0,1
8032,for,0,1
8033,microfilariae,0,1
8034,and,0,1
8035,adult,0,1
8036,heartworm,0,1
8037,antigen,0,0
8038,on,0,0
8039,days,0,0
8040,180,0,1
8041,and,0,1
8042,300,0,1
8043,.,0,1
8044,Selamectin,0,0
8045,was,0,0
8046,administered,0,0
8047,to,0,0
8048,a,0,0
8049,total,0,1
8050,of,0,0
8051,673,1,1
8052,dogs,1,1
8053,and,1,1
8054,347,1,1
8055,cats,1,1
8056,having,0,1
8057,an,0,1
8058,age,0,1
8059,range,0,1
8060,of,0,1
8061,6,0,1
8062,weeks,0,1
8063,to,0,1
8064,19,0,1
8065,years,0,1
8066,(,0,1
8067,3954,0,1
8068,doses,0,1
8069,),0,1
8070,.,0,1
8071,The,0,0
8072,animals,1,1
8073,included,1,1
8074,19,1,1
8075,purebred,1,1
8076,or,1,1
8077,crossbred,1,1
8078,Collies,1,1
8079,(,1,1
8080,Bearded,1,0
8081,",",1,0
8082,Border,1,0
8083,",",1,0
8084,and,1,0
8085,unspecified,1,1
8086,),1,0
8087,.,1,0
8088,There,0,0
8089,were,0,0
8090,no,0,0
8091,serious,0,0
8092,adverse,0,0
8093,events,0,0
8094,.,0,1
8095,Results,0,0
8096,of,0,0
8097,these,0,1
8098,studies,0,0
8099,indicated,0,0
8100,that,0,0
8101,selamectin,0,0
8102,was,0,0
8103,highly,0,0
8104,effective,0,0
8105,in,0,0
8106,the,0,0
8107,control,0,1
8108,of,0,0
8109,flea,0,1
8110,infestations,0,1
8111,in,0,1
8112,dogs,1,1
8113,and,1,1
8114,cats,1,1
8115,without,0,1
8116,the,0,0
8117,need,0,0
8118,for,0,0
8119,simultaneous,0,0
8120,treatment,0,0
8121,of,0,0
8122,the,0,0
8123,environment,0,0
8124,or,0,1
8125,of,0,1
8126,in-contact,0,1
8127,animals,0,1
8128,and,0,1
8129,also,0,0
8130,was,0,0
8131,beneficial,0,0
8132,in,0,1
8133,alleviating,0,0
8134,signs,0,1
8135,associated,0,0
8136,with,0,1
8137,FAD,0,1
8138,.,0,1
8139,Selamectin,0,0
8140,also,0,0
8141,was,0,0
8142,100,0,0
8143,%,0,0
8144,effective,0,0
8145,in,0,0
8146,preventing,0,0
8147,the,0,0
8148,development,0,0
8149,of,0,0
8150,canine,0,1
8151,heartworms,0,1
8152,and,0,1
8153,was,0,0
8154,safe,0,0
8155,for,0,1
8156,topical,0,0
8157,use,0,0
8158,in,0,1
8159,dogs,1,1
8160,and,1,1
8161,cats,1,1
8162,.,1,1
8163,The,0,0
8164,effect,0,0
8165,of,0,0
8166,halothane,0,0
8167,and,0,0
8168,isoflurane,0,0
8169,on,0,0
8170,plasma,0,0
8171,cytokine,0,0
8172,levels,0,0
8173,.,0,1
8174,The,0,0
8175,aim,0,0
8176,of,0,0
8177,this,0,0
8178,study,0,0
8179,was,0,0
8180,to,0,0
8181,investigate,0,0
8182,the,0,0
8183,effect,0,0
8184,of,0,0
8185,halothane,0,0
8186,vs.,0,0
8187,isoflurane,0,0
8188,on,0,0
8189,cytokine,0,0
8190,production,0,0
8191,during,1,1
8192,minor,1,0
8193,elective,1,1
8194,surgery,1,1
8195,.,1,1
8196,Forty,1,1
8197,adult,1,1
8198,patients,1,1
8199,",",1,1
8200,ASA,1,1
8201,I-II,1,1
8202,were,0,1
8203,randomly,0,1
8204,allocated,0,1
8205,to,0,0
8206,receive,0,1
8207,halothane,0,0
8208,or,0,1
8209,isoflurane,0,0
8210,.,0,1
8211,Venous,0,0
8212,samples,0,1
8213,for,0,1
8214,interleukin,0,0
8215,(,0,1
8216,IL,0,1
8217,),0,1
8218,-1beta,0,0
8219,",",0,0
8220,IL-2,0,1
8221,",",0,0
8222,IL-6,0,0
8223,",",0,0
8224,tumour,0,1
8225,necrosis,0,1
8226,factor-alpha,0,0
8227,(,0,1
8228,TNF-alpha,0,1
8229,),0,1
8230,and,0,1
8231,interferon-gamma,0,0
8232,(,0,1
8233,IFN-gamma,0,1
8234,),0,1
8235,were,0,0
8236,taken,0,0
8237,before,0,0
8238,anaesthesia,0,1
8239,",",0,0
8240,before,0,0
8241,incision,0,0
8242,",",0,0
8243,at,0,0
8244,the,0,0
8245,end,0,0
8246,of,0,0
8247,anaesthesia,0,1
8248,and,0,1
8249,24,0,1
8250,h,0,0
8251,postoperatively,0,0
8252,.,0,1
8253,In,0,0
8254,both,0,0
8255,groups,0,0
8256,",",0,1
8257,IL-6,0,0
8258,and,0,1
8259,TNF-alpha,0,1
8260,levels,0,0
8261,remained,0,0
8262,low,0,1
8263,throughout,0,0
8264,the,0,0
8265,study,0,1
8266,period,0,0
8267,.,0,1
8268,Before,0,0
8269,incision,0,0
8270,",",0,0
8271,in,0,0
8272,both,0,0
8273,groups,0,0
8274,IL-1beta,0,1
8275,and,0,1
8276,IFN-gamma,0,0
8277,showed,0,0
8278,a,0,0
8279,decrease,0,0
8280,(,0,0
8281,p,0,0
8282,<,0,0
8283,0.01,0,0
8284,for,0,0
8285,IL-1beta,0,1
8286,in,0,1
8287,isoflurane,0,0
8288,group,0,1
8289,and,0,0
8290,p,0,0
8291,<,0,0
8292,0.05,0,0
8293,for,0,0
8294,the,0,1
8295,others,0,1
8296,),0,1
8297,compared,0,0
8298,with,0,1
8299,pre-induction,0,0
8300,.,0,1
8301,By,0,0
8302,the,0,0
8303,end,0,0
8304,of,0,0
8305,anaesthesia,0,1
8306,and,0,0
8307,surgery,0,1
8308,",",0,0
8309,IL-1beta,0,0
8310,had,0,1
8311,increased,0,0
8312,significantly,0,0
8313,(,0,0
8314,p,0,0
8315,<,0,0
8316,0.05,0,0
8317,),0,1
8318,and,0,1
8319,IFN-gamma,0,0
8320,had,0,1
8321,decreased,0,0
8322,significantly,0,0
8323,(,0,0
8324,p,0,0
8325,<,0,0
8326,0.05,0,0
8327,),0,1
8328,in,0,0
8329,both,0,0
8330,groups,0,0
8331,compared,0,0
8332,with,0,1
8333,pre-incisional,0,1
8334,levels,0,1
8335,.,0,1
8336,By,0,0
8337,24,0,1
8338,h,0,0
8339,postoperatively,0,0
8340,in,0,1
8341,both,0,0
8342,groups,0,0
8343,",",0,1
8344,IL-1beta,0,1
8345,had,0,1
8346,decreased,0,0
8347,significantly,0,0
8348,(,0,0
8349,p,0,0
8350,<,0,0
8351,0.05,0,0
8352,),0,1
8353,",",0,1
8354,whereas,0,0
8355,IFN-gamma,0,0
8356,had,0,1
8357,increased,0,0
8358,significantly,0,0
8359,(,0,0
8360,p,0,0
8361,<,0,0
8362,0.05,0,0
8363,),0,1
8364,compared,0,0
8365,with,0,1
8366,the,0,0
8367,end,0,0
8368,of,0,0
8369,anaesthesia,0,1
8370,and,0,1
8371,surgery,0,1
8372,level,0,0
8373,.,0,1
8374,Pre-incisionally,0,0
8375,",",0,0
8376,IL-2,0,1
8377,increased,0,0
8378,in,0,0
8379,the,0,0
8380,halothane,0,0
8381,group,0,0
8382,(,0,1
8383,p,0,0
8384,<,0,0
8385,0.01,0,0
8386,),0,1
8387,",",0,0
8388,whereas,0,0
8389,it,0,0
8390,decreased,0,0
8391,significantly,0,0
8392,in,0,0
8393,the,0,0
8394,isoflurane,0,0
8395,group,0,0
8396,(,0,1
8397,p,0,0
8398,<,0,0
8399,0.001,0,0
8400,),0,1
8401,compared,0,0
8402,with,0,1
8403,the,0,0
8404,pre-induction,0,0
8405,level,0,0
8406,.,0,1
8407,By,0,0
8408,the,0,0
8409,end,0,0
8410,of,0,0
8411,anaesthesia,0,1
8412,and,0,1
8413,surgery,0,1
8414,and,0,1
8415,by,0,0
8416,24,0,1
8417,h,0,0
8418,postoperatively,0,0
8419,",",0,0
8420,IL-2,0,1
8421,had,0,1
8422,decreased,0,0
8423,significantly,0,0
8424,in,0,0
8425,the,0,0
8426,halothane,0,0
8427,group,0,0
8428,(,0,1
8429,p,0,0
8430,<,0,0
8431,0.001,0,0
8432,),0,1
8433,",",0,0
8434,whereas,0,0
8435,it,0,0
8436,increased,0,0
8437,significantly,0,0
8438,in,0,0
8439,the,0,0
8440,isoflurane,0,0
8441,group,0,0
8442,(,0,1
8443,p,0,0
8444,<,0,0
8445,0.001,0,0
8446,),0,1
8447,compared,0,0
8448,with,0,1
8449,pre-incision,0,0
8450,and,0,0
8451,end,0,0
8452,of,0,0
8453,anaesthesia,0,1
8454,and,0,1
8455,surgery,0,1
8456,levels,0,0
8457,",",0,1
8458,respectively,0,0
8459,.,0,1
8460,Uvulopalatopharyngoplasty,0,1
8461,versus,0,0
8462,laser,0,0
8463,assisted,0,1
8464,uvulopalatoplasty,0,1
8465,for,0,0
8466,the,0,0
8467,treatment,0,0
8468,of,0,0
8469,snoring,1,1
8470,:,1,1
8471,an,0,0
8472,objective,0,0
8473,randomised,0,0
8474,clinical,0,0
8475,trial,0,1
8476,.,0,1
8477,This,0,0
8478,study,0,0
8479,was,0,0
8480,designed,0,0
8481,to,0,0
8482,evaluate,0,0
8483,objectively,0,0
8484,the,0,0
8485,clinical,0,0
8486,effectiveness,0,0
8487,of,0,0
8488,surgery,0,1
8489,for,0,0
8490,snoring,0,1
8491,and,0,0
8492,to,0,0
8493,compare,0,0
8494,the,0,0
8495,results,0,0
8496,of,0,0
8497,conventional,0,1
8498,uvulopalatopharyngoplasty,0,1
8499,(,0,1
8500,UPPP,0,1
8501,),0,1
8502,and,0,0
8503,laser,0,0
8504,assisted,0,1
8505,uvulopalatoplasty,0,1
8506,(,0,1
8507,LAUP,0,0
8508,),0,1
8509,in,0,0
8510,the,0,0
8511,treatment,0,0
8512,of,0,0
8513,snoring,0,1
8514,.,0,1
8515,Patients,1,1
8516,who,1,1
8517,had,1,1
8518,been,1,1
8519,referred,1,1
8520,for,1,0
8521,investigation,1,0
8522,and,1,0
8523,treatment,1,0
8524,of,1,0
8525,their,1,1
8526,snoring,1,1
8527,were,1,0
8528,randomly,1,1
8529,allocated,1,1
8530,to,1,0
8531,receive,1,1
8532,either,1,0
8533,UPPP,1,0
8534,or,1,1
8535,LAUP,1,0
8536,.,1,1
8537,Forty-seven,1,1
8538,patients,1,1
8539,with,1,1
8540,confirmed,1,1
8541,palatal,1,1
8542,flutter,1,1
8543,had,1,1
8544,surgery,1,1
8545,and,1,0
8546,all,1,0
8547,of,1,0
8548,them,1,0
8549,had,1,1
8550,a,1,0
8551,preoperative,1,0
8552,and,1,0
8553,postoperative,1,1
8554,objective,1,0
8555,assessment,1,0
8556,of,1,0
8557,their,1,1
8558,snoring,1,1
8559,loudness,1,0
8560,and,1,0
8561,duration,1,0
8562,in,1,0
8563,the,1,0
8564,home,1,1
8565,.,1,0
8566,The,0,0
8567,recording,0,0
8568,device,0,0
8569,(,0,1
8570,Snore,0,1
8571,Box,0,1
8572,),0,0
8573,is,0,0
8574,simple,0,0
8575,for,0,0
8576,the,0,0
8577,patient,0,0
8578,to,0,0
8579,operate,0,0
8580,",",0,0
8581,portable,0,1
8582,with,0,1
8583,a,0,1
8584,built,0,1
8585,in,0,0
8586,microphone,0,0
8587,",",0,0
8588,and,0,0
8589,able,0,0
8590,to,0,0
8591,produce,0,0
8592,objective,0,0
8593,results,0,0
8594,",",0,0
8595,which,0,0
8596,can,0,0
8597,be,0,0
8598,automatically,0,0
8599,analysed,0,0
8600,.,0,0
8601,Of,0,0
8602,the,0,0
8603,38,0,1
8604,patients,0,1
8605,",",0,1
8606,who,0,1
8607,had,0,1
8608,technically,0,1
8609,valid,0,0
8610,recordings,0,0
8611,",",0,1
8612,22,0,1
8613,underwent,0,1
8614,LAUP,0,1
8615,and,0,1
8616,16,0,1
8617,UPPP,0,1
8618,.,0,1
8619,Overall,0,0
8620,the,0,0
8621,mean,0,0
8622,postoperative,0,0
8623,Snore,0,1
8624,Index,0,0
8625,(,0,1
8626,SI,0,1
8627,),0,1
8628,was,0,0
8629,less,0,0
8630,than,0,0
8631,the,0,0
8632,preoperative,0,1
8633,SI,0,1
8634,(,0,1
8635,P,0,0
8636,<,0,0
8637,0.0001,0,0
8638,),0,1
8639,",",0,0
8640,the,0,0
8641,average,0,0
8642,difference,0,0
8643,being,0,1
8644,78.2,0,0
8645,snores/h,0,0
8646,.,0,0
8647,There,0,0
8648,was,0,0
8649,no,0,0
8650,significant,0,0
8651,difference,0,0
8652,between,0,0
8653,the,0,0
8654,LAUP,0,0
8655,and,0,0
8656,UPPP,0,1
8657,regarding,0,0
8658,the,0,0
8659,fall,0,0
8660,in,0,0
8661,the,0,0
8662,SI,0,1
8663,.,0,1
8664,This,0,0
8665,study,0,0
8666,is,0,0
8667,the,0,0
8668,first,0,0
8669,objective,0,0
8670,comparative,0,0
8671,study,0,0
8672,to,0,0
8673,demonstrate,0,0
8674,the,0,0
8675,effectiveness,0,0
8676,of,0,0
8677,snoring,0,1
8678,surgery,0,1
8679,.,0,1
8680,Randomized,0,0
8681,trial,0,0
8682,of,0,0
8683,a,0,1
8684,stage-of-change,0,0
8685,oriented,0,0
8686,smoking,0,1
8687,cessation,0,0
8688,intervention,0,0
8689,in,0,0
8690,infertile,1,1
8691,and,1,1
8692,pregnant,1,1
8693,women,1,1
8694,.,1,1
8695,OBJECTIVE,0,0
8696,To,0,0
8697,assess,0,0
8698,a,0,0
8699,stage-of-change,0,0
8700,oriented,0,0
8701,smoking,0,1
8702,cessation,0,0
8703,intervention,0,0
8704,for,0,0
8705,infertile,1,1
8706,and,1,1
8707,pregnant,1,1
8708,women,1,1
8709,",",0,1
8710,compared,0,0
8711,with,0,1
8712,standard,0,1
8713,of,0,0
8714,care,0,1
8715,.,0,1
8716,DESIGN,0,0
8717,Randomized,0,0
8718,controlled,0,0
8719,trial,0,1
8720,.,0,1
8721,SETTING,0,1
8722,Three,1,1
8723,university,1,1
8724,teaching,1,1
8725,hospitals,1,1
8726,in,1,1
8727,Hamilton,1,1
8728,",",1,1
8729,Ontario,1,1
8730,",",1,0
8731,Canada,1,1
8732,.,1,1
8733,PATIENT,0,0
8734,(,0,0
8735,S,0,1
8736,),0,1
8737,Infertile,1,1
8738,women,1,1
8739,at,1,1
8740,their,1,1
8741,first,1,0
8742,visit,1,0
8743,to,1,1
8744,a,1,1
8745,tertiary,1,1
8746,referral,1,1
8747,infertility,1,1
8748,clinic,1,1
8749,(,1,1
8750,n,1,1
8751,=,1,1
8752,94,1,1
8753,),1,1
8754,and,1,1
8755,new,1,1
8756,patients,1,1
8757,seeking,1,1
8758,pre-natal,1,1
8759,care,1,1
8760,(,1,1
8761,n,1,1
8762,=,1,1
8763,110,1,1
8764,),1,1
8765,who,1,1
8766,had,1,1
8767,smoked,1,1
8768,>,1,1
8769,/=,1,1
8770,3,1,1
8771,cigarettes,1,1
8772,in,1,1
8773,the,1,1
8774,past,1,1
8775,six,1,1
8776,months,1,1
8777,.,1,1
8778,INTERVENTION,0,0
8779,(,0,0
8780,S,0,1
8781,),0,1
8782,A,0,1
8783,three,0,1
8784,to,0,1
8785,five,0,1
8786,minute,0,0
8787,scripted,0,0
8788,intervention,0,0
8789,and,0,0
8790,booklet,0,1
8791,specific,0,0
8792,to,0,0
8793,the,0,0
8794,woman,0,1
8795,'s,0,1
8796,stage-of-change,0,0
8797,in,0,1
8798,the,0,0
8799,smoking,0,1
8800,continuum,0,1
8801,",",0,0
8802,versus,0,0
8803,standard,0,1
8804,of,0,0
8805,care,0,1
8806,.,0,1
8807,Exhaled,0,0
8808,carbon-monoxide,0,0
8809,(,0,1
8810,CO,0,1
8811,),0,1
8812,monitoring,0,0
8813,was,0,0
8814,used,0,0
8815,to,0,0
8816,validate,0,0
8817,exposure,0,0
8818,in,0,0
8819,both,0,0
8820,groups,0,0
8821,.,0,1
8822,MAIN,0,0
8823,OUTCOME,0,1
8824,MEASURE,0,0
8825,(,0,1
8826,S,0,1
8827,),0,1
8828,Delta,0,0
8829,stage-of-change,0,0
8830,and,0,0
8831,rate,0,0
8832,of,0,0
8833,maintained,0,0
8834,cessation,0,1
8835,at,0,1
8836,12,0,1
8837,months,0,1
8838,post,0,1
8839,follow-up,0,1
8840,.,0,1
8841,RESULT,0,0
8842,(,0,0
8843,S,0,1
8844,),0,1
8845,Intervention,0,1
8846,and,0,1
8847,control,0,1
8848,were,0,0
8849,similarly,0,0
8850,effective,0,0
8851,for,0,0
8852,infertile,0,1
8853,women,0,1
8854,:,0,1
8855,the,0,0
8856,rate,0,0
8857,of,0,0
8858,maintained,0,0
8859,cessation,0,0
8860,rose,0,0
8861,significantly,0,0
8862,from,0,1
8863,4,0,0
8864,%,0,0
8865,to,0,1
8866,24,0,1
8867,%,0,0
8868,over,0,0
8869,twelve,0,1
8870,months,0,0
8871,",",0,1
8872,with,0,1
8873,a,0,0
8874,mean,0,1
8875,delta,0,0
8876,stage-of-change,0,0
8877,0.28,0,0
8878,.,0,1
8879,In,0,0
8880,prenatal,0,1
8881,women,0,1
8882,",",0,1
8883,neither,0,0
8884,approach,0,0
8885,was,0,0
8886,effective,0,0
8887,.,0,1
8888,Maintained,0,0
8889,cessation,0,0
8890,did,0,0
8891,not,0,0
8892,significantly,0,0
8893,change,0,0
8894,from,0,0
8895,0,0,0
8896,to,0,1
8897,12,0,1
8898,months,0,1
8899,(,0,1
8900,19,0,1
8901,%,0,0
8902,to,0,1
8903,18,0,1
8904,%,0,0
8905,),0,1
8906,.,0,1
8907,Mean,0,1
8908,delta,0,0
8909,stage-of-change,0,0
8910,declined,0,0
8911,by,0,0
8912,-0.62,0,0
8913,.,0,1
8914,CONCLUSION,0,0
8915,(,0,0
8916,S,0,1
8917,),0,1
8918,For,0,1
8919,infertile,0,1
8920,women,0,1
8921,",",0,1
8922,basic,0,0
8923,information,0,0
8924,describing,0,0
8925,the,0,0
8926,impact,0,0
8927,of,0,0
8928,smoking,0,1
8929,on,0,0
8930,fertility,0,1
8931,",",0,0
8932,along,0,0
8933,with,0,1
8934,exhaled,0,0
8935,CO,0,1
8936,monitoring,0,0
8937,and,0,0
8938,a,0,0
8939,more,0,0
8940,intensive,0,0
8941,intervention,0,0
8942,were,0,0
8943,both,0,0
8944,highly,0,0
8945,effective,0,0
8946,.,0,1
8947,In,0,0
8948,pregnant,0,1
8949,women,0,1
8950,neither,0,0
8951,approach,0,1
8952,was,0,0
8953,beneficial,0,0
8954,",",0,0
8955,with,0,1
8956,some,0,0
8957,evidence,0,0
8958,of,0,0
8959,post-partum,0,1
8960,relapse,0,1
8961,.,0,1
8962,Onset/offset,0,1
8963,characteristics,0,1
8964,and,0,1
8965,intubating,0,1
8966,conditions,0,1
8967,of,0,1
8968,rapacuronium,0,1
8969,:,0,1
8970,a,0,0
8971,comparison,0,0
8972,with,0,1
8973,rocuronium,0,1
8974,.,0,1
8975,We,0,0
8976,compared,0,0
8977,onset,0,1
8978,and,0,0
8979,offset,0,0
8980,of,0,0
8981,action,0,0
8982,and,0,1
8983,tracheal,1,1
8984,intubating,1,1
8985,conditions,1,1
8986,after,0,1
8987,rapacuronium,0,1
8988,and,0,0
8989,rocuronium,0,0
8990,in,0,1
8991,60,1,1
8992,patients,1,1
8993,in,0,1
8994,a,0,1
8995,randomized,0,1
8996,",",0,0
8997,assessor-blinded,0,0
8998,study,0,1
8999,.,0,1
9000,Following,0,0
9001,induction,0,0
9002,of,0,0
9003,anaesthesia,0,1
9004,with,0,1
9005,propofol,0,0
9006,2.5,0,0
9007,mg,0,0
9008,kg-1,0,0
9009,",",0,0
9010,either,0,0
9011,rapacuronium,0,1
9012,1.5,0,0
9013,mg,0,0
9014,kg-1,0,0
9015,(,0,1
9016,n,0,1
9017,=,0,1
9018,30,0,1
9019,),0,1
9020,or,0,1
9021,rocuronium,0,1
9022,0.6,0,0
9023,mg,0,1
9024,kg-1,0,0
9025,(,0,1
9026,n,0,1
9027,=,0,1
9028,30,0,1
9029,),0,1
9030,was,0,0
9031,administered,0,0
9032,to,0,0
9033,facilitate,0,0
9034,tracheal,0,1
9035,intubation,0,1
9036,.,0,1
9037,Anaesthesia,0,0
9038,was,0,0
9039,maintained,0,0
9040,with,0,1
9041,either,0,0
9042,a,0,1
9043,propofol,0,0
9044,infusion,0,0
9045,(,0,1
9046,100,0,1
9047,micrograms,0,1
9048,kg-1,0,1
9049,min-1,0,0
9050,),0,1
9051,or,0,1
9052,sevoflurane,0,0
9053,(,0,1
9054,1,0,1
9055,%,0,0
9056,end-tidal,0,0
9057,),0,1
9058,with,0,1
9059,66,0,1
9060,%,0,0
9061,nitrous,0,1
9062,oxide,0,0
9063,(,0,1
9064,N2O,0,1
9065,),0,1
9066,",",0,0
9067,n,0,1
9068,=,0,1
9069,15,0,0
9070,in,0,0
9071,each,0,1
9072,subgroup,0,1
9073,.,0,1
9074,Neuromuscular,0,1
9075,monitoring,0,0
9076,was,0,0
9077,performed,0,0
9078,using,0,0
9079,an,0,0
9080,electromyographic,0,0
9081,(,0,1
9082,EMG,0,0
9083,),0,1
9084,device,0,0
9085,(,0,1
9086,Datex,0,0
9087,Relaxograph,0,1
9088,),0,1
9089,.,0,1
9090,The,0,0
9091,lag,0,0
9092,times,0,0
9093,(,0,1
9094,mean,0,1
9095,42,0,1
9096,(,0,1
9097,SD,0,1
9098,11,0,1
9099,),0,1
9100,s,0,1
9101,and,0,1
9102,44,0,1
9103,(,0,1
9104,16,0,1
9105,),0,1
9106,s,0,1
9107,),0,1
9108,",",0,0
9109,maximum,0,0
9110,block,0,1
9111,(,0,1
9112,99,0,1
9113,(,0,1
9114,2,0,1
9115,),0,1
9116,%,0,0
9117,and,0,1
9118,98,0,1
9119,(,0,1
9120,3,0,1
9121,),0,1
9122,%,0,0
9123,),0,1
9124,and,0,1
9125,intubating,0,1
9126,conditions,0,1
9127,at,0,1
9128,60,0,1
9129,s,0,1
9130,(,0,1
9131,good-to-excellent,0,0
9132,in,0,1
9133,86,0,1
9134,%,0,0
9135,and,0,1
9136,84,0,1
9137,%,0,0
9138,of,0,1
9139,patients,0,1
9140,),0,1
9141,were,0,1
9142,similar,0,0
9143,for,0,0
9144,rapacuronium,0,1
9145,and,0,0
9146,rocuronium,0,0
9147,",",0,0
9148,respectively,0,0
9149,.,0,0
9150,The,0,0
9151,onset,0,0
9152,time,0,0
9153,of,0,0
9154,rapacuronium,0,0
9155,was,0,0
9156,shorter,0,0
9157,than,0,0
9158,rocuronium,0,0
9159,(,0,1
9160,87,0,1
9161,(,0,1
9162,20,0,1
9163,),0,1
9164,vs,0,0
9165,141,0,1
9166,(,0,1
9167,65,0,1
9168,),0,1
9169,s,0,0
9170,",",0,1
9171,P,0,0
9172,<,0,0
9173,0.001,0,0
9174,),0,1
9175,",",0,0
9176,and,0,0
9177,the,0,0
9178,degree,0,0
9179,of,0,0
9180,block,0,1
9181,at,0,1
9182,60,0,1
9183,s,0,1
9184,was,0,0
9185,greater,0,0
9186,(,0,1
9187,69,0,1
9188,(,0,1
9189,26,0,1
9190,),0,1
9191,vs,0,0
9192,50,0,1
9193,(,0,1
9194,27,0,1
9195,),0,1
9196,%,0,0
9197,",",0,1
9198,P,0,0
9199,<,0,0
9200,0.05,0,0
9201,),0,1
9202,.,0,1
9203,Twenty-five,0,1
9204,per,0,0
9205,cent,0,1
9206,recovery,0,0
9207,was,0,0
9208,shorter,0,0
9209,with,0,1
9210,rapacuronium,0,0
9211,than,0,0
9212,rocuronium,0,0
9213,during,0,0
9214,propofol,0,0
9215,(,0,1
9216,15.0,0,0
9217,(,0,1
9218,3.2,0,1
9219,),0,1
9220,vs,0,0
9221,39.1,0,1
9222,(,0,1
9223,14.2,0,0
9224,),0,1
9225,min,0,0
9226,",",0,1
9227,P,0,0
9228,<,0,0
9229,0.001,0,0
9230,),0,1
9231,and,0,1
9232,sevoflurane,0,0
9233,(,0,1
9234,15.1,0,0
9235,(,0,1
9236,4.2,0,1
9237,),0,1
9238,vs,0,0
9239,47.8,0,1
9240,(,0,1
9241,19.0,0,1
9242,),0,1
9243,min,0,0
9244,",",0,1
9245,P,0,0
9246,<,0,0
9247,0.001,0,0
9248,),0,1
9249,anaesthesia,0,1
9250,.,0,1
9251,We,0,0
9252,conclude,0,0
9253,that,0,0
9254,rapacuronium,0,1
9255,1.5,0,0
9256,mg,0,0
9257,kg-1,0,0
9258,had,0,0
9259,a,0,0
9260,more,0,0
9261,rapid,0,0
9262,onset,0,0
9263,",",0,0
9264,similar,0,0
9265,intubating,0,1
9266,conditions,0,1
9267,",",0,0
9268,and,0,0
9269,shorter,0,0
9270,recovery,0,0
9271,times,0,0
9272,than,0,1
9273,rocuronium,0,1
9274,0.6,0,0
9275,mg,0,1
9276,kg-1,0,1
9277,.,0,1
9278,Randomized,0,0
9279,",",0,0
9280,placebo-controlled,0,0
9281,trial,0,0
9282,of,0,0
9283,oral,0,0
9284,phytonadione,0,0
9285,for,0,0
9286,excessive,0,0
9287,anticoagulation,0,1
9288,.,0,1
9289,STUDY,0,0
9290,OBJECTIVE,0,0
9291,To,0,0
9292,compare,0,0
9293,the,0,0
9294,efficacy,0,0
9295,of,0,0
9296,managing,0,0
9297,excessive,0,0
9298,anticoagulation,0,0
9299,in,0,0
9300,the,0,0
9301,absence,0,0
9302,of,0,0
9303,bleeding,0,1
9304,by,0,0
9305,either,0,1
9306,omitting,0,0
9307,warfarin,0,0
9308,therapy,0,0
9309,alone,0,0
9310,or,0,1
9311,administering,0,0
9312,oral,0,0
9313,phytonadione,0,0
9314,in,0,0
9315,addition,0,0
9316,to,0,1
9317,omitting,0,0
9318,warfarin,0,0
9319,therapy,0,1
9320,.,0,1
9321,DESIGN,0,0
9322,Randomized,0,0
9323,",",0,0
9324,double-blind,0,0
9325,",",0,0
9326,placebo-controlled,0,0
9327,study,0,1
9328,.,0,1
9329,SETTING,0,1
9330,Clinical,0,0
9331,pharmacy,0,1
9332,anticoagulation,0,0
9333,service,0,1
9334,in,0,0
9335,a,0,0
9336,group,0,0
9337,model,0,0
9338,health,0,1
9339,maintenance,0,0
9340,organization,0,1
9341,.,0,1
9342,SUBJECTS,0,0
9343,Thirty,1,1
9344,nonbleeding,1,1
9345,patients,1,1
9346,with,1,1
9347,international,1,1
9348,normalized,1,1
9349,ratios,1,0
9350,(,1,1
9351,INRs,1,1
9352,),1,1
9353,ranging,1,1
9354,from,1,1
9355,6.0-10.0,1,1
9356,.,1,1
9357,INTERVENTIONS,0,0
9358,Patients,1,1
9359,were,1,1
9360,randomized,1,1
9361,to,1,0
9362,receive,1,1
9363,either,1,0
9364,a,1,0
9365,single,1,0
9366,oral,1,0
9367,dose,1,0
9368,of,1,0
9369,phytonadione,1,0
9370,2.5,1,0
9371,mg,1,0
9372,or,1,1
9373,placebo,1,0
9374,.,1,1
9375,Both,0,0
9376,groups,0,0
9377,omitted,0,0
9378,warfarin,0,1
9379,doses,0,0
9380,until,0,1
9381,the,0,1
9382,INR,0,0
9383,became,0,0
9384,less,0,0
9385,than,0,0
9386,or,0,0
9387,equal,0,1
9388,to,0,1
9389,4.0,0,1
9390,.,0,1
9391,MEASUREMENTS,0,0
9392,AND,0,0
9393,RESULTS,0,1
9394,The,0,0
9395,mean,0,0
9396,calculated,0,0
9397,time,0,0
9398,to,0,0
9399,reach,0,0
9400,an,0,0
9401,INR,0,1
9402,of,0,0
9403,4.0,0,0
9404,was,0,0
9405,significantly,0,0
9406,greater,0,0
9407,in,0,0
9408,the,0,0
9409,placebo,0,0
9410,than,0,0
9411,the,0,0
9412,phytonadione,0,0
9413,group,0,1
9414,(,0,1
9415,2.6,0,0
9416,vs,0,0
9417,1.4,0,0
9418,days,0,0
9419,",",0,1
9420,p=0.006,0,0
9421,),0,1
9422,.,0,1
9423,Overcorrection,0,0
9424,of,0,0
9425,anticoagulation,0,0
9426,was,0,0
9427,significantly,0,0
9428,more,0,0
9429,common,0,0
9430,in,0,0
9431,patients,0,1
9432,receiving,0,1
9433,phytonadione,0,0
9434,.,0,1
9435,Overt,0,0
9436,warfarin,0,0
9437,resistance,0,0
9438,was,0,0
9439,not,0,0
9440,observed,0,0
9441,in,0,0
9442,either,0,0
9443,group,0,1
9444,after,0,0
9445,reinitiating,0,0
9446,warfarin,0,0
9447,therapy,0,1
9448,.,0,1
9449,No,0,0
9450,major,0,0
9451,bleeding,0,1
9452,or,0,1
9453,thromboembolic,0,1
9454,complications,0,0
9455,occurred,0,0
9456,",",0,1
9457,and,0,0
9458,minor,0,0
9459,bleeding,0,1
9460,episodes,0,1
9461,were,0,1
9462,similar,0,0
9463,in,0,1
9464,both,0,0
9465,groups,0,0
9466,.,0,1
9467,CONCLUSION,0,0
9468,The,0,0
9469,addition,0,0
9470,of,0,0
9471,oral,0,1
9472,phytonadione,0,0
9473,2.5,0,0
9474,mg,0,0
9475,reduced,0,0
9476,the,0,0
9477,time,0,0
9478,to,0,0
9479,achieve,0,0
9480,an,0,0
9481,INR,0,1
9482,of,0,0
9483,4.0,0,0
9484,by,0,0
9485,approximately,0,1
9486,1,0,1
9487,day,0,0
9488,compared,0,0
9489,with,0,1
9490,omitting,0,0
9491,warfarin,0,0
9492,therapy,0,1
9493,alone,0,1
9494,.,0,1
9495,Adverse,0,0
9496,events,0,0
9497,did,0,0
9498,not,0,0
9499,differ,0,0
9500,between,0,0
9501,the,0,0
9502,two,0,1
9503,groups,0,0
9504,.,0,1
9505,Both,0,0
9506,strategies,0,0
9507,were,0,1
9508,effective,0,0
9509,in,0,0
9510,managing,0,1
9511,asymptomatic,1,1
9512,patients,1,1
9513,with,1,1
9514,INRs,1,1
9515,of,1,1
9516,6.0-10.0,1,0
9517,.,1,1
9518,Oral,0,0
9519,phytonadione,0,0
9520,may,0,0
9521,be,0,0
9522,most,0,0
9523,appropriate,0,0
9524,for,0,1
9525,patients,1,1
9526,at,1,1
9527,high,1,1
9528,risk,1,1
9529,for,1,0
9530,bleeding,1,1
9531,in,1,1
9532,whom,1,1
9533,the,1,1
9534,benefit,1,1
9535,of,1,0
9536,prompt,1,0
9537,INR,1,1
9538,reduction,1,0
9539,would,1,0
9540,outweigh,1,0
9541,the,1,0
9542,thromboembolic,1,0
9543,risk,1,0
9544,associated,1,0
9545,with,1,1
9546,INR,1,1
9547,overcorrection,1,0
9548,.,1,1
9549,VLDL,0,1
9550,",",0,0
9551,apolipoproteins,0,0
9552,B,0,0
9553,",",0,0
9554,CIII,0,0
9555,",",0,0
9556,and,0,0
9557,E,0,0
9558,",",0,0
9559,and,0,0
9560,risk,0,0
9561,of,0,0
9562,recurrent,0,1
9563,coronary,0,1
9564,events,0,0
9565,in,0,1
9566,the,0,1
9567,Cholesterol,0,0
9568,and,0,0
9569,Recurrent,0,1
9570,Events,0,1
9571,(,0,1
9572,CARE,0,1
9573,),0,1
9574,trial,0,1
9575,.,0,1
9576,BACKGROUND,0,0
9577,Plasma,0,1
9578,triglyceride,0,0
9579,concentration,0,0
9580,has,0,0
9581,been,0,0
9582,an,0,0
9583,inconsistent,0,0
9584,independent,0,0
9585,risk,0,1
9586,factor,0,0
9587,for,0,0
9588,coronary,0,1
9589,heart,0,1
9590,disease,0,1
9591,",",0,0
9592,perhaps,0,0
9593,because,0,0
9594,of,0,0
9595,the,0,0
9596,metabolic,0,0
9597,heterogeneity,0,0
9598,among,0,1
9599,VLDL,0,1
9600,particles,0,0
9601,",",0,1
9602,the,0,0
9603,main,0,0
9604,carriers,0,1
9605,of,0,1
9606,triglycerides,0,0
9607,in,0,1
9608,plasma,0,0
9609,.,0,1
9610,METHODS,0,0
9611,AND,0,0
9612,RESULTS,0,1
9613,We,0,0
9614,conducted,0,1
9615,a,0,0
9616,prospective,0,0
9617,",",0,0
9618,nested,0,0
9619,case-control,0,1
9620,study,0,1
9621,in,0,0
9622,the,0,0
9623,Cholesterol,0,0
9624,and,0,0
9625,Recurrent,0,1
9626,Events,0,1
9627,(,0,1
9628,CARE,0,1
9629,),0,1
9630,trial,0,0
9631,",",0,0
9632,a,0,0
9633,randomized,0,1
9634,placebo-controlled,0,0
9635,trial,0,1
9636,of,0,0
9637,pravastatin,0,0
9638,in,0,1
9639,4159,1,1
9640,patients,1,1
9641,with,1,1
9642,myocardial,1,1
9643,infarction,1,1
9644,and,1,1
9645,average,1,1
9646,LDL,1,1
9647,concentrations,1,0
9648,at,1,1
9649,baseline,1,1
9650,(,1,1
9651,115,1,1
9652,to,1,1
9653,174,1,1
9654,mg/dL,1,0
9655,",",1,1
9656,mean,1,1
9657,139,1,1
9658,mg/dL,1,1
9659,),1,1
9660,.,1,1
9661,Baseline,0,0
9662,concentrations,0,0
9663,of,0,1
9664,VLDL-apolipoprotein,0,1
9665,(,0,1
9666,apo,0,0
9667,),0,1
9668,B,0,1
9669,(,0,1
9670,the,0,0
9671,VLDL,0,1
9672,particle,0,0
9673,concentration,0,0
9674,),0,0
9675,",",0,1
9676,VLDL,0,1
9677,lipids,0,0
9678,",",0,1
9679,and,0,0
9680,apoCIII,0,0
9681,and,0,0
9682,apoE,0,1
9683,in,0,0
9684,VLDL+LDL,0,1
9685,and,0,1
9686,in,0,1
9687,HDL,0,0
9688,were,0,1
9689,compared,0,0
9690,in,0,1
9691,patients,1,1
9692,who,1,1
9693,had,1,1
9694,either,1,1
9695,a,1,0
9696,myocardial,1,1
9697,infarction,1,1
9698,or,1,1
9699,coronary,1,1
9700,death,1,0
9701,(,1,1
9702,cases,1,1
9703,",",1,1
9704,n=418,1,1
9705,),1,0
9706,with,0,1
9707,those,0,1
9708,in,0,1
9709,patients,1,1
9710,who,1,1
9711,did,1,1
9712,not,1,1
9713,have,1,0
9714,a,1,0
9715,cardiovascular,1,0
9716,event,1,0
9717,(,1,0
9718,control,1,0
9719,subjects,1,1
9720,",",1,0
9721,n=370,1,1
9722,),1,1
9723,in,0,1
9724,5,0,1
9725,years,0,1
9726,of,0,1
9727,follow-up,0,1
9728,.,0,1
9729,VLDL-cholesterol,0,0
9730,",",0,0
9731,VLDL-triglyceride,0,0
9732,",",0,0
9733,VLDL-apoB,0,0
9734,",",0,0
9735,apoCIII,0,0
9736,and,0,0
9737,apoE,0,1
9738,in,0,0
9739,VLDL+LDL,0,1
9740,and,0,1
9741,apoE,0,1
9742,in,0,0
9743,HDL,0,0
9744,were,0,1
9745,all,0,0
9746,interrelated,0,0
9747,",",0,0
9748,and,0,0
9749,each,0,0
9750,was,0,0
9751,a,0,0
9752,univariate,0,0
9753,predictor,0,0
9754,of,0,0
9755,subsequent,0,0
9756,coronary,0,1
9757,events,0,0
9758,.,0,1
9759,The,0,0
9760,significant,0,0
9761,independent,0,1
9762,predictors,0,0
9763,were,0,1
9764,VLDL-apoB,0,1
9765,(,0,1
9766,relative,0,0
9767,risk,0,1
9768,[,0,0
9769,RR,0,1
9770,],0,1
9771,3.2,0,0
9772,for,0,0
9773,highest,0,0
9774,to,0,1
9775,lowest,0,0
9776,quintiles,0,0
9777,",",0,1
9778,P,0,0
9779,:,0,1
9780,=0.04,0,0
9781,),0,0
9782,",",0,0
9783,apoCIII,0,0
9784,in,0,0
9785,VLDL+LDL,0,1
9786,(,0,1
9787,RR,0,1
9788,2.3,0,1
9789,",",0,1
9790,P,0,0
9791,:,0,1
9792,=0.04,0,0
9793,),0,0
9794,",",0,0
9795,and,0,0
9796,apoE,0,0
9797,in,0,0
9798,HDL,0,0
9799,(,0,1
9800,RR,0,1
9801,1.8,0,0
9802,",",0,1
9803,P,0,0
9804,:,0,1
9805,=0.02,0,0
9806,),0,1
9807,.,0,1
9808,Plasma,0,0
9809,triglycerides,0,0
9810,",",0,1
9811,a,0,1
9812,univariate,0,0
9813,predictor,0,0
9814,of,0,1
9815,coronary,0,1
9816,events,0,0
9817,(,0,1
9818,RR,0,1
9819,1.6,0,0
9820,",",0,1
9821,P,0,0
9822,:,0,1
9823,=0.03,0,0
9824,),0,0
9825,",",0,0
9826,was,0,0
9827,not,0,0
9828,related,0,0
9829,to,0,1
9830,coronary,0,1
9831,events,0,0
9832,(,0,1
9833,RR,0,1
9834,1.3,0,0
9835,",",0,1
9836,P,0,0
9837,:,0,1
9838,=0.6,0,0
9839,),0,0
9840,when,0,0
9841,apoCIII,0,0
9842,in,0,0
9843,VLDL+LDL,0,1
9844,was,0,0
9845,included,0,1
9846,in,0,0
9847,the,0,0
9848,model,0,0
9849,",",0,0
9850,whereas,0,0
9851,apoCIII,0,0
9852,remained,0,0
9853,significant,0,0
9854,.,0,1
9855,Adjustment,0,0
9856,for,0,0
9857,LDL-,0,0
9858,and,0,1
9859,HDL-cholesterol,0,0
9860,did,0,0
9861,not,0,0
9862,affect,0,0
9863,these,0,0
9864,results,0,0
9865,.,0,1
9866,CONCLUSIONS,0,0
9867,The,0,0
9868,plasma,0,0
9869,concentrations,0,0
9870,of,0,1
9871,VLDL,0,1
9872,particles,0,1
9873,and,0,1
9874,apoCIII,0,1
9875,in,0,0
9876,VLDL,0,1
9877,and,0,1
9878,LDL,0,0
9879,are,0,0
9880,more,0,0
9881,specific,0,0
9882,measures,0,0
9883,of,0,1
9884,coronary,0,1
9885,heart,0,1
9886,disease,0,1
9887,risk,0,1
9888,than,0,0
9889,plasma,0,0
9890,triglycerides,0,0
9891,perhaps,0,0
9892,because,0,1
9893,their,0,0
9894,known,0,1
9895,metabolic,0,1
9896,properties,0,0
9897,link,0,0
9898,them,0,0
9899,more,0,0
9900,closely,0,0
9901,to,0,0
9902,atherosclerosis,0,1
9903,.,0,1
9904,Magnetic,0,1
9905,resonance,0,1
9906,angiography,0,1
9907,for,0,0
9908,monitoring,0,0
9909,prophylactic,0,1
9910,endoscopic,0,1
9911,treatment,0,0
9912,of,0,0
9913,high,0,1
9914,risk,0,1
9915,esophageal,0,1
9916,varices,0,1
9917,.,0,1
9918,BACKGROUND,0,0
9919,AND,0,0
9920,STUDY,0,0
9921,AIMS,0,1
9922,Endoscopic,0,1
9923,injection,0,0
9924,sclerotherapy,0,0
9925,(,0,1
9926,EIS,0,1
9927,),0,1
9928,and,0,0
9929,endoscopic,0,1
9930,variceal,0,1
9931,ligation,0,1
9932,(,0,1
9933,EVL,0,1
9934,),0,1
9935,are,0,0
9936,used,0,0
9937,worldwide,0,0
9938,as,0,0
9939,the,0,0
9940,treatment,0,0
9941,for,0,0
9942,esophageal,0,1
9943,varices,0,1
9944,.,0,1
9945,We,0,0
9946,evaluated,0,0
9947,portal,0,1
9948,hemodynamics,0,0
9949,using,0,1
9950,magnetic,0,1
9951,resonance,0,1
9952,angiography,0,1
9953,(,0,1
9954,MRA,0,1
9955,),0,1
9956,in,0,0
9957,these,0,0
9958,two,0,0
9959,forms,0,1
9960,of,0,1
9961,treatment,0,1
9962,.,0,1
9963,PATIENTS,0,0
9964,AND,0,0
9965,METHODS,0,0
9966,The,0,0
9967,study,0,0
9968,was,0,0
9969,carried,0,0
9970,out,0,1
9971,in,0,1
9972,50,1,1
9973,cirrhotic,1,1
9974,patients,1,1
9975,.,1,1
9976,MRA,0,1
9977,was,0,0
9978,performed,0,0
9979,to,0,0
9980,identify,0,0
9981,the,0,0
9982,hepatofugal,0,0
9983,supply,0,0
9984,vein,0,1
9985,selectively,0,0
9986,for,0,0
9987,esophageal,1,1
9988,varices,1,1
9989,.,1,1
9990,Those,0,1
9991,who,0,1
9992,showed,0,1
9993,a,0,1
9994,positive,0,1
9995,MR,0,1
9996,angiogram,0,1
9997,for,0,0
9998,the,0,0
9999,supply,0,0
10000,vein,0,0
10001,were,0,0
10002,randomly,0,1
10003,allocated,0,1
10004,to,0,0
10005,one,0,1
10006,of,0,1
10007,two,0,1
10008,groups,0,1
10009,",",0,1
10010,using,0,0
10011,the,0,0
10012,sealed,0,1
10013,envelope,0,0
10014,method,0,0
10015,",",0,0
10016,and,0,0
10017,underwent,0,1
10018,either,0,1
10019,EIS,0,1
10020,or,0,1
10021,EVL,0,1
10022,.,0,1
10023,On,0,0
10024,the,0,0
10025,other,0,0
10026,hand,0,0
10027,",",0,0
10028,those,0,0
10029,with,0,1
10030,a,0,0
10031,negative,0,0
10032,angiogram,0,0
10033,received,0,1
10034,only,0,0
10035,EVL,0,1
10036,.,0,1
10037,EIS,0,1
10038,was,0,0
10039,done,0,0
10040,to,0,0
10041,embolize,0,1
10042,esophageal,0,1
10043,varices,0,1
10044,as,0,0
10045,well,0,0
10046,as,0,0
10047,their,0,1
10048,feeders,0,0
10049,by,0,0
10050,intravariceal,0,1
10051,injection,0,0
10052,of,0,0
10053,sclerosant,0,0
10054,under,0,1
10055,fluoroscopic,0,0
10056,guidance,0,0
10057,.,0,1
10058,RESULTS,0,0
10059,A,0,0
10060,positive,0,1
10061,MR,0,1
10062,angiogram,0,1
10063,of,0,0
10064,the,0,0
10065,hepatofugal,0,1
10066,left,0,1
10067,gastric,0,1
10068,vein,0,1
10069,as,0,0
10070,the,0,0
10071,supply,0,0
10072,vein,0,1
10073,was,0,0
10074,observed,0,0
10075,in,0,1
10076,41,1,1
10077,patients,1,1
10078,.,1,1
10079,Nine,1,1
10080,patients,1,1
10081,showed,1,0
10082,negative,1,1
10083,MRA,1,1
10084,results,1,0
10085,.,1,1
10086,Among,0,1
10087,those,0,0
10088,with,0,1
10089,positive,0,1
10090,angiograms,0,0
10091,",",0,1
10092,the,0,0
10093,rate,0,0
10094,of,0,0
10095,eradication,0,0
10096,of,0,0
10097,the,0,0
10098,left,0,1
10099,gastric,0,1
10100,vein,0,0
10101,was,0,0
10102,higher,0,0
10103,in,0,0
10104,the,0,0
10105,EIS-treated,0,1
10106,group,0,0
10107,than,0,0
10108,in,0,0
10109,the,0,0
10110,EVL,0,1
10111,treated,0,1
10112,group,0,1
10113,(,0,1
10114,50,0,1
10115,%,0,0
10116,vs.,0,0
10117,8.6,0,0
10118,%,0,0
10119,),0,1
10120,.,0,1
10121,After,0,0
10122,either,0,0
10123,treatment,0,0
10124,",",0,0
10125,the,0,0
10126,recurrence-free,0,0
10127,rate,0,0
10128,for,0,0
10129,high,0,1
10130,risk,0,1
10131,esophageal,0,1
10132,varices,0,0
10133,was,0,0
10134,higher,0,0
10135,in,0,0
10136,patients,0,1
10137,with,0,1
10138,complete,0,1
10139,eradication,0,1
10140,of,0,0
10141,the,0,0
10142,left,0,1
10143,gastric,0,1
10144,vein,0,1
10145,than,0,0
10146,in,0,0
10147,those,0,1
10148,without,0,1
10149,(,0,1
10150,88,0,0
10151,%,0,0
10152,vs.,0,0
10153,35,0,1
10154,%,0,0
10155,),0,1
10156,.,0,1
10157,In,0,0
10158,patients,0,1
10159,with,0,1
10160,negative,0,1
10161,angiogram,0,1
10162,results,0,0
10163,",",0,1
10164,who,0,1
10165,only,0,1
10166,underwent,0,1
10167,EVL,0,1
10168,",",0,1
10169,high,0,1
10170,risk,0,1
10171,esophageal,0,1
10172,varices,0,1
10173,did,0,0
10174,not,0,0
10175,reappear,0,0
10176,over,0,0
10177,a,0,0
10178,long,0,1
10179,period,0,0
10180,.,0,1
10181,CONCLUSION,0,0
10182,MRA,0,1
10183,is,0,0
10184,useful,0,0
10185,for,0,0
10186,evaluating,0,0
10187,portal,0,1
10188,hemodynamics,0,1
10189,.,0,1
10190,With,0,1
10191,the,0,0
10192,aim,0,0
10193,of,0,0
10194,avoiding,0,0
10195,recurrence,0,0
10196,of,0,1
10197,esophageal,0,1
10198,varices,0,1
10199,",",0,1
10200,EIS,0,1
10201,was,0,0
10202,suitable,0,0
10203,for,0,1
10204,patients,0,1
10205,who,0,1
10206,had,0,1
10207,a,0,1
10208,hepatofugal,0,0
10209,supply,0,0
10210,vein,0,1
10211,for,0,0
10212,the,0,0
10213,varices,0,1
10214,because,0,0
10215,recurrence,0,0
10216,could,0,0
10217,be,0,0
10218,prevented,0,0
10219,by,0,0
10220,embolization,0,0
10221,of,0,0
10222,the,0,0
10223,supply,0,0
10224,vein,0,1
10225,.,0,0
10226,EVL,0,0
10227,may,0,0
10228,be,0,0
10229,expected,0,0
10230,to,0,0
10231,be,0,0
10232,efficacious,0,0
10233,in,0,0
10234,patients,0,1
10235,where,0,1
10236,no,0,0
10237,image,0,0
10238,of,0,0
10239,a,0,1
10240,hepatofugal,0,1
10241,supply,0,0
10242,vein,0,1
10243,is,0,0
10244,found,0,0
10245,on,0,0
10246,MRA,0,1
10247,.,0,1
10248,Effect,0,0
10249,of,0,0
10250,systemic,0,0
10251,penicillin,0,1
10252,on,0,0
10253,pain,0,1
10254,in,0,1
10255,untreated,1,1
10256,irreversible,1,1
10257,pulpitis,1,1
10258,.,1,1
10259,OBJECTIVE,0,0
10260,The,0,0
10261,purpose,0,0
10262,of,0,0
10263,this,0,0
10264,prospective,0,1
10265,",",0,0
10266,randomized,0,1
10267,",",0,0
10268,double-blind,0,0
10269,study,0,1
10270,was,0,0
10271,to,0,0
10272,determine,0,0
10273,the,0,0
10274,effect,0,0
10275,of,0,0
10276,penicillin,0,0
10277,on,0,0
10278,pain,0,1
10279,in,0,1
10280,untreated,1,1
10281,teeth,1,1
10282,diagnosed,1,1
10283,with,1,1
10284,irreversible,1,1
10285,pulpitis,1,1
10286,.,1,1
10287,STUDY,0,0
10288,DESIGN,0,1
10289,Forty,1,1
10290,emergency,1,1
10291,patients,1,1
10292,participated,1,1
10293,",",1,0
10294,and,1,0
10295,each,1,0
10296,had,1,1
10297,a,1,0
10298,clinical,1,0
10299,diagnosis,1,1
10300,of,1,0
10301,an,1,0
10302,irreversible,1,0
10303,pulpitis,1,1
10304,.,1,1
10305,Patients,0,1
10306,randomly,0,1
10307,received,0,1
10308,a,0,0
10309,7-day,0,0
10310,oral,0,0
10311,dose,0,0
10312,(,0,1
10313,28,0,1
10314,capsules,0,0
10315,",",0,1
10316,500,0,1
10317,mg,0,0
10318,each,0,0
10319,",",0,0
10320,to,0,0
10321,be,0,0
10322,taken,0,0
10323,every,0,0
10324,6,0,0
10325,hours,0,0
10326,),0,1
10327,of,0,0
10328,either,0,1
10329,penicillin,0,0
10330,or,0,0
10331,a,0,0
10332,placebo,0,0
10333,control,0,0
10334,in,0,0
10335,a,0,1
10336,double-blind,0,0
10337,manner,0,0
10338,.,0,1
10339,No,0,0
10340,endodontic,0,1
10341,treatment,0,0
10342,was,0,0
10343,performed,0,0
10344,.,0,1
10345,Each,0,0
10346,patient,0,0
10347,also,0,0
10348,received,0,1
10349,ibuprofen,0,0
10350,;,0,0
10351,acetaminophen,0,0
10352,with,0,1
10353,codeine,0,0
10354,(,0,1
10355,30,0,1
10356,mg,0,1
10357,),0,1
10358,;,0,0
10359,and,0,0
10360,a,0,0
10361,7-day,0,0
10362,diary,0,0
10363,to,0,1
10364,record,0,0
10365,pain,0,1
10366,",",0,0
10367,percussion,0,0
10368,pain,0,1
10369,",",0,0
10370,and,0,0
10371,number,0,0
10372,and,0,0
10373,type,0,1
10374,of,0,0
10375,pain,0,1
10376,medication,0,1
10377,taken,0,0
10378,.,0,0
10379,RESULTS,0,0
10380,The,0,0
10381,administration,0,0
10382,of,0,0
10383,penicillin,0,0
10384,did,0,0
10385,not,0,0
10386,significantly,0,0
10387,(,0,0
10388,P,0,0
10389,>,0,1
10390,.05,0,0
10391,),0,1
10392,reduce,0,0
10393,pain,0,1
10394,",",0,0
10395,percussion,0,0
10396,pain,0,1
10397,",",0,0
10398,or,0,0
10399,the,0,0
10400,number,0,0
10401,of,0,0
10402,analgesic,0,0
10403,medications,0,1
10404,taken,0,1
10405,by,0,1
10406,patients,0,1
10407,with,0,1
10408,untreated,0,1
10409,irreversible,0,1
10410,pulpitis,0,1
10411,.,0,1
10412,The,0,0
10413,majority,0,0
10414,of,0,0
10415,patients,0,1
10416,with,0,1
10417,untreated,0,1
10418,irreversible,0,1
10419,pulpitis,0,1
10420,had,0,1
10421,significant,0,0
10422,pain,0,1
10423,and,0,1
10424,required,0,0
10425,analgesics,0,0
10426,to,0,0
10427,manage,0,1
10428,this,0,0
10429,pain,0,1
10430,.,0,1
10431,CONCLUSION,0,0
10432,Penicillin,0,0
10433,should,0,0
10434,not,0,0
10435,be,0,0
10436,prescribed,0,0
10437,for,0,0
10438,untreated,0,1
10439,irreversible,0,1
10440,pulpitis,0,1
10441,because,0,0
10442,penicillin,0,0
10443,is,0,0
10444,ineffective,0,0
10445,for,0,0
10446,pain,0,1
10447,relief,0,0
10448,.,0,1
10449,Somatostatin,0,0
10450,and,0,0
10451,ranitidine,0,0
10452,in,0,0
10453,the,0,0
10454,treatment,0,0
10455,of,0,0
10456,non-variceal,1,1
10457,upper,1,1
10458,gastrointestinal,1,1
10459,bleeding,1,1
10460,:,1,1
10461,a,0,0
10462,prospective,0,0
10463,",",0,0
10464,randomized,0,1
10465,",",0,0
10466,double-blind,0,0
10467,",",0,0
10468,controlled,0,0
10469,study,0,0
10470,.,0,1
10471,BACKGROUND/AIMS,0,0
10472,The,0,0
10473,aim,0,0
10474,of,0,0
10475,this,0,0
10476,study,0,0
10477,was,0,0
10478,to,0,0
10479,compare,0,0
10480,the,0,0
10481,efficacy,0,0
10482,of,0,0
10483,somatostatin,0,0
10484,vs.,0,0
10485,ranitidine,0,0
10486,in,0,0
10487,controlling,0,0
10488,acute,1,1
10489,non-variceal,1,1
10490,gastrointestinal,1,1
10491,bleeding,1,1
10492,.,1,1
10493,METHODOLOGY,0,0
10494,A,1,0
10495,total,1,1
10496,of,1,1
10497,48,1,1
10498,patients,1,1
10499,with,1,1
10500,acute,1,1
10501,upper,1,1
10502,gastrointestinal,1,1
10503,bleeding,1,1
10504,due,1,0
10505,to,1,1
10506,duodenal,1,1
10507,or,1,1
10508,gastric,1,1
10509,ulcer,1,1
10510,were,0,1
10511,divided,0,1
10512,into,0,1
10513,2,0,1
10514,groups,0,1
10515,.,0,1
10516,Group,0,1
10517,I,0,1
10518,consisted,0,1
10519,of,0,1
10520,15,1,1
10521,patients,1,1
10522,with,1,1
10523,Forrest,1,1
10524,IB,1,1
10525,and,0,1
10526,Group,0,1
10527,II,0,1
10528,consisted,0,1
10529,of,0,1
10530,30,1,1
10531,patients,1,1
10532,with,1,1
10533,Forrest,1,1
10534,II,1,1
10535,.,1,1
10536,Two,0,1
10537,regimens,0,0
10538,were,0,1
10539,randomly,0,1
10540,allocated,0,1
10541,to,0,0
10542,all,0,0
10543,patients,0,1
10544,within,0,0
10545,half,0,1
10546,an,0,0
10547,hour,0,0
10548,after,0,0
10549,the,0,0
10550,endoscopic,0,1
10551,procedure,0,0
10552,:,0,1
10553,1,0,1
10554,),0,1
10555,somatostatin-UCB,0,0
10556,250,0,1
10557,mcg,0,0
10558,i.v,0,0
10559,.,0,1
10560,bolus,0,0
10561,followed,0,0
10562,by,0,0
10563,continuous,0,0
10564,i.v,0,0
10565,.,0,1
10566,infusion,0,0
10567,at,0,0
10568,a,0,0
10569,rate,0,0
10570,of,0,0
10571,6,0,0
10572,mg/d,0,0
10573,for,0,1
10574,72,0,1
10575,h,0,0
10576,",",0,1
10577,or,0,1
10578,2,0,1
10579,),0,1
10580,ranitidine,0,0
10581,300,0,1
10582,mg/d,0,0
10583,by,0,0
10584,continuous,0,0
10585,i.v,0,0
10586,.,0,1
10587,infusion,0,0
10588,for,0,0
10589,72,0,1
10590,h.,0,1
10591,RESULTS,0,1
10592,In,0,1
10593,Group,0,1
10594,I,0,1
10595,",",0,0
10596,although,0,0
10597,mean,0,1
10598,blood,0,1
10599,transfusion,0,0
10600,requirements,0,0
10601,(,0,1
10602,no,0,0
10603,.,0,1
10604,of,0,0
10605,units,0,1
10606,),0,1
10607,were,0,1
10608,lower,0,0
10609,in,0,1
10610,patients,0,1
10611,treated,0,1
10612,with,0,1
10613,somatostatin,0,0
10614,than,0,0
10615,in,0,0
10616,those,0,1
10617,treated,0,1
10618,with,0,1
10619,ranitidine,0,0
10620,",",0,0
10621,this,0,0
10622,was,0,0
10623,not,0,0
10624,statistically,0,0
10625,significant,0,0
10626,(,0,1
10627,mean,0,1
10628,+/-,0,1
10629,SD,0,1
10630,:,0,1
10631,2.56,0,0
10632,+/-,0,0
10633,3.05,0,0
10634,vs.,0,0
10635,5.17,0,1
10636,+/-,0,0
10637,4.96,0,0
10638,",",0,1
10639,respectively,0,0
10640,;,0,0
10641,P,0,0
10642,>,0,1
10643,0.05,0,0
10644,),0,1
10645,;,0,0
10646,the,0,0
10647,time,0,0
10648,of,0,0
10649,bleeding,0,1
10650,stop,0,0
10651,was,0,0
10652,shorter,0,0
10653,in,0,0
10654,the,0,0
10655,somatostatin,0,0
10656,group,0,0
10657,than,0,0
10658,in,0,0
10659,the,0,0
10660,ranitidine,0,0
10661,group,0,0
10662,(,0,1
10663,mean,0,1
10664,+/-,0,1
10665,SD,0,1
10666,:,0,1
10667,3.24,0,0
10668,+/-,0,0
10669,2.45,0,1
10670,vs.,0,0
10671,11.25,0,0
10672,+/-,0,0
10673,11.63,0,1
10674,",",0,1
10675,respectively,0,0
10676,;,0,0
10677,P,0,0
10678,=,0,1
10679,0.0383,0,0
10680,),0,1
10681,.,0,1
10682,The,0,0
10683,rebleeding,0,0
10684,and,0,0
10685,the,0,0
10686,mortality,0,0
10687,rates,0,0
10688,did,0,0
10689,not,0,0
10690,differ,0,0
10691,between,0,0
10692,the,0,0
10693,treatment,0,0
10694,groups,0,0
10695,in,0,1
10696,both,0,0
10697,Group,0,1
10698,I,0,1
10699,and,0,1
10700,Group,0,1
10701,II,0,1
10702,.,0,1
10703,CONCLUSIONS,0,0
10704,Somatostatin,0,0
10705,is,0,0
10706,more,0,0
10707,effective,0,0
10708,than,0,0
10709,ranitidine,0,0
10710,in,0,0
10711,controlling,0,0
10712,acute,0,1
10713,non-variceal,0,1
10714,gastrointestinal,0,1
10715,bleeding,0,1
10716,in,0,1
10717,patients,0,1
10718,with,0,1
10719,Forrest,0,1
10720,IB,0,1
10721,bleeding,0,1
10722,activity,0,0
10723,.,0,1
10724,Somatostatin,0,0
10725,has,0,0
10726,no,0,0
10727,additional,0,0
10728,benefit,0,0
10729,in,0,0
10730,those,0,1
10731,with,0,1
10732,Forrest,0,0
10733,II,0,1
10734,bleeding,0,1
10735,activity,0,0
10736,.,0,1
10737,Chemoprevention,0,1
10738,of,0,0
10739,gastric,0,1
10740,dysplasia,0,1
10741,:,0,1
10742,randomized,0,1
10743,trial,0,1
10744,of,0,1
10745,antioxidant,0,0
10746,supplements,0,0
10747,and,0,1
10748,anti-helicobacter,0,1
10749,pylori,0,1
10750,therapy,0,1
10751,.,0,1
10752,BACKGROUND,0,0
10753,Previous,0,0
10754,research,0,0
10755,has,0,0
10756,identified,0,0
10757,a,0,0
10758,high,0,0
10759,risk,0,0
10760,of,0,0
10761,gastric,0,1
10762,carcinoma,0,1
10763,as,0,0
10764,well,0,0
10765,as,0,0
10766,a,0,0
10767,high,0,1
10768,prevalence,0,0
10769,of,0,0
10770,cancer,0,1
10771,precursor,0,0
10772,lesions,0,1
10773,in,0,1
10774,rural,1,1
10775,populations,1,1
10776,living,1,1
10777,in,1,0
10778,the,1,0
10779,province,1,1
10780,of,1,0
10781,Nari?o,1,0
10782,",",1,1
10783,Colombia,1,1
10784,",",1,0
10785,in,1,0
10786,the,1,0
10787,Andes,1,1
10788,Mountains,1,1
10789,.,1,1
10790,METHODS,0,0
10791,A,0,0
10792,randomized,0,1
10793,",",0,0
10794,controlled,0,0
10795,chemoprevention,0,1
10796,trial,0,0
10797,was,0,0
10798,conducted,0,1
10799,in,1,0
10800,subjects,1,1
10801,with,1,1
10802,confirmed,1,1
10803,histologic,1,0
10804,diagnoses,1,1
10805,of,1,1
10806,multifocal,1,1
10807,nonmetaplastic,1,1
10808,atrophy,1,1
10809,and/or,1,1
10810,intestinal,1,1
10811,metaplasia,1,1
10812,",",1,1
10813,two,1,0
10814,precancerous,1,1
10815,lesions,1,1
10816,.,1,1
10817,Individuals,0,1
10818,were,0,1
10819,assigned,0,1
10820,to,0,0
10821,receive,0,1
10822,anti-Helicobacter,0,1
10823,pylori,0,1
10824,triple,0,1
10825,therapy,0,0
10826,and/or,0,1
10827,dietary,0,0
10828,supplementation,0,0
10829,with,0,1
10830,ascorbic,0,0
10831,acid,0,0
10832,",",0,0
10833,beta-carotene,0,0
10834,",",0,0
10835,or,0,1
10836,their,0,1
10837,corresponding,0,0
10838,placebos,0,0
10839,.,0,1
10840,Gastric,0,0
10841,biopsy,0,1
10842,specimens,0,1
10843,taken,0,0
10844,at,0,0
10845,baseline,0,0
10846,were,0,1
10847,compared,0,0
10848,with,0,1
10849,those,0,0
10850,taken,0,0
10851,at,0,1
10852,72,0,1
10853,months,0,1
10854,.,0,1
10855,Relative,0,0
10856,risks,0,0
10857,of,0,1
10858,progression,0,0
10859,",",0,0
10860,no,0,0
10861,change,0,0
10862,",",0,0
10863,and,0,0
10864,regression,0,0
10865,from,0,1
10866,multifocal,0,1
10867,nonmetaplastic,0,1
10868,atrophy,0,1
10869,and,0,1
10870,intestinal,0,1
10871,metaplasia,0,1
10872,were,0,1
10873,analyzed,0,0
10874,with,0,1
10875,multivariate,0,0
10876,polytomous,0,1
10877,logistic,0,0
10878,regression,0,0
10879,models,0,0
10880,to,0,1
10881,estimate,0,0
10882,treatment,0,1
10883,effects,0,0
10884,.,0,1
10885,All,0,1
10886,statistical,0,0
10887,tests,0,0
10888,were,0,1
10889,two-sided,0,0
10890,.,0,1
10891,RESULTS,0,0
10892,All,0,1
10893,three,0,0
10894,basic,0,1
10895,interventions,0,0
10896,resulted,0,0
10897,in,0,0
10898,statistically,0,0
10899,significant,0,0
10900,increases,0,0
10901,in,0,1
10902,the,0,1
10903,rates,0,0
10904,of,0,1
10905,regression,0,0
10906,:,0,1
10907,Relative,0,1
10908,risks,0,0
10909,were,0,1
10910,4.8,0,0
10911,(,0,1
10912,95,0,0
10913,%,0,0
10914,confidence,0,0
10915,interval,0,0
10916,[,0,0
10917,CI,0,0
10918,],0,1
10919,=,0,1
10920,1.6-14.2,0,1
10921,),0,1
10922,for,0,0
10923,anti-H.,0,1
10924,pylori,0,1
10925,treatment,0,0
10926,",",0,1
10927,5,0,0
10928,.,0,1
10929,1,0,0
10930,(,0,1
10931,95,0,0
10932,%,0,0
10933,CI,0,0
10934,=,0,1
10935,1.7-15.0,0,0
10936,),0,1
10937,for,0,0
10938,beta-carotene,0,0
10939,treatment,0,0
10940,",",0,1
10941,and,0,0
10942,5.0,0,0
10943,(,0,1
10944,95,0,0
10945,%,0,0
10946,CI,0,0
10947,=,0,1
10948,1.7-14.4,0,0
10949,),0,1
10950,for,0,1
10951,ascorbic,0,0
10952,acid,0,0
10953,treatment,0,1
10954,in,0,1
10955,subjects,0,1
10956,with,0,1
10957,atrophy,0,1
10958,.,0,1
10959,Corresponding,0,0
10960,relative,0,0
10961,risks,0,0
10962,of,0,1
10963,regression,0,0
10964,in,0,1
10965,subjects,0,1
10966,with,0,1
10967,intestinal,0,1
10968,metaplasia,0,1
10969,were,0,1
10970,3.1,0,0
10971,(,0,1
10972,95,0,0
10973,%,0,0
10974,CI,0,0
10975,=,0,1
10976,1.0-9.3,0,0
10977,),0,1
10978,",",0,1
10979,3.4,0,0
10980,(,0,1
10981,95,0,0
10982,%,0,0
10983,CI,0,0
10984,=,0,1
10985,1.1-9.8,0,0
10986,),0,1
10987,",",0,1
10988,and,0,1
10989,3.3,0,1
10990,(,0,1
10991,95,0,0
10992,%,0,0
10993,CI,0,0
10994,=,0,1
10995,1.1-9.5,0,0
10996,),0,1
10997,.,0,1
10998,Combinations,0,0
10999,of,0,1
11000,treatments,0,0
11001,did,0,0
11002,not,0,0
11003,statistically,0,0
11004,significantly,0,0
11005,increase,0,0
11006,the,0,0
11007,regression,0,0
11008,rates,0,0
11009,.,0,1
11010,Curing,0,0
11011,the,0,0
11012,H.,0,1
11013,pylori,0,1
11014,infection,0,1
11015,(,0,1
11016,which,0,0
11017,occurred,0,0
11018,in,0,0
11019,74,0,1
11020,%,0,0
11021,of,0,0
11022,the,0,0
11023,treated,0,1
11024,subjects,0,1
11025,),0,1
11026,produced,0,0
11027,a,0,1
11028,marked,0,0
11029,and,0,0
11030,statistically,0,0
11031,significant,0,0
11032,increase,0,0
11033,in,0,0
11034,the,0,0
11035,rate,0,0
11036,of,0,0
11037,regression,0,0
11038,of,0,0
11039,the,0,0
11040,precursor,0,0
11041,lesions,0,1
11042,(,0,1
11043,relative,0,0
11044,risks,0,0
11045,=,0,1
11046,8.7,0,0
11047,[,0,1
11048,95,0,0
11049,%,0,0
11050,CI,0,0
11051,=,0,1
11052,2.7-28.2,0,0
11053,],0,1
11054,for,1,1
11055,subjects,1,1
11056,with,1,1
11057,atrophy,1,1
11058,and,0,1
11059,5.4,0,0
11060,[,0,1
11061,95,0,0
11062,%,0,0
11063,CI,0,0
11064,=,0,1
11065,1.7-17.6,0,0
11066,],0,1
11067,for,1,1
11068,subjects,1,1
11069,with,1,1
11070,intestinal,1,1
11071,metaplasia,1,1
11072,),1,1
11073,.,1,1
11074,CONCLUSIONS,0,0
11075,In,0,0
11076,the,1,0
11077,very,1,0
11078,high-risk,1,1
11079,population,1,1
11080,studied,0,1
11081,",",0,0
11082,effective,0,0
11083,anti-H.,0,1
11084,pylori,0,1
11085,treatment,0,0
11086,and,0,0
11087,dietary,0,0
11088,supplementation,0,0
11089,with,0,1
11090,antioxidant,0,0
11091,micronutrients,0,0
11092,may,0,0
11093,interfere,0,0
11094,with,0,0
11095,the,0,0
11096,precancerous,0,1
11097,process,0,0
11098,",",0,0
11099,mostly,0,1
11100,by,0,0
11101,increasing,0,0
11102,the,0,0
11103,rate,0,0
11104,of,0,0
11105,regression,0,0
11106,of,0,0
11107,cancer,0,1
11108,precursor,0,0
11109,lesions,0,1
11110,",",0,0
11111,and,0,0
11112,may,0,0
11113,be,0,0
11114,an,0,0
11115,effective,0,0
11116,strategy,0,0
11117,to,0,0
11118,prevent,0,0
11119,gastric,0,1
11120,carcinoma,0,1
11121,.,0,1
11122,Perioperative,0,1
11123,blood,0,1
11124,transfusions,0,0
11125,",",0,1
11126,with,0,1
11127,or,0,1
11128,without,0,1
11129,allogeneic,0,1
11130,leucocytes,0,0
11131,",",0,1
11132,relate,0,0
11133,to,0,0
11134,survival,0,0
11135,",",0,0
11136,not,0,0
11137,to,0,0
11138,cancer,0,1
11139,recurrence,0,0
11140,.,0,1
11141,BACKGROUND,0,0
11142,Perioperative,0,1
11143,blood,0,0
11144,transfusions,0,0
11145,are,0,0
11146,reported,0,0
11147,to,0,0
11148,be,0,0
11149,related,0,0
11150,to,0,0
11151,cancer,0,1
11152,recurrence,0,0
11153,and,0,0
11154,reduced,0,0
11155,survival,0,0
11156,.,0,1
11157,Different,0,0
11158,underlying,0,0
11159,mechanisms,0,0
11160,have,0,1
11161,been,0,0
11162,proposed,0,0
11163,",",0,0
11164,and,0,0
11165,allogeneic,0,1
11166,leucocytes,0,0
11167,in,0,1
11168,transfused,0,1
11169,blood,0,0
11170,have,0,0
11171,been,0,0
11172,suggested,0,0
11173,to,0,0
11174,contribute,0,0
11175,to,0,0
11176,this,0,0
11177,phenomenon,0,0
11178,.,0,1
11179,METHODS,0,0
11180,Packed,0,1
11181,red,0,1
11182,cells,0,0
11183,without,0,1
11184,buffy,0,1
11185,coat,0,0
11186,(,0,1
11187,PC,0,0
11188,group,0,1
11189,),0,1
11190,were,0,0
11191,compared,0,0
11192,with,0,1
11193,filtered,0,0
11194,",",0,0
11195,leucoreduced,0,0
11196,",",0,0
11197,red,0,1
11198,cells,0,0
11199,(,0,1
11200,LD,0,1
11201,group,0,1
11202,),0,1
11203,in,0,0
11204,a,0,1
11205,randomized,0,1
11206,trial,1,0
11207,of,1,1
11208,697,1,1
11209,patients,1,1
11210,with,1,1
11211,colorectal,1,1
11212,carcinoma,1,1
11213,.,1,1
11214,Five-year,0,0
11215,survival,0,0
11216,and,0,0
11217,cancer,0,1
11218,recurrence,0,0
11219,rates,0,0
11220,were,0,1
11221,determined,0,0
11222,",",0,0
11223,with,0,1
11224,special,0,1
11225,emphasis,0,0
11226,on,0,0
11227,the,0,0
11228,location,0,1
11229,of,0,0
11230,recurrence,0,0
11231,.,0,1
11232,RESULTS,0,0
11233,The,0,0
11234,intention-to-treat,0,0
11235,analysis,0,0
11236,showed,0,0
11237,a,0,0
11238,survival,0,0
11239,rate,0,0
11240,of,0,0
11241,63.6,0,1
11242,per,0,1
11243,cent,0,1
11244,in,0,0
11245,the,0,0
11246,PC,0,0
11247,group,0,1
11248,and,0,1
11249,65.3,0,0
11250,per,0,0
11251,cent,0,1
11252,in,0,0
11253,the,0,0
11254,LD,0,1
11255,group,0,1
11256,(,0,1
11257,P,0,0
11258,=,0,1
11259,0.69,0,0
11260,),0,1
11261,",",0,0
11262,with,0,1
11263,recurrence,0,0
11264,rates,0,0
11265,of,0,1
11266,27.8,0,1
11267,and,0,1
11268,27.9,0,0
11269,per,0,0
11270,cent,0,1
11271,respectively,0,0
11272,.,0,1
11273,The,0,0
11274,observational,0,0
11275,analysis,0,0
11276,showed,0,0
11277,a,0,0
11278,significant,0,0
11279,difference,0,0
11280,in,0,0
11281,survival,0,0
11282,between,0,0
11283,transfused,0,1
11284,and,0,1
11285,non-transfused,0,1
11286,patients,0,1
11287,(,0,1
11288,59.6,0,1
11289,versus,0,0
11290,72.9,0,0
11291,per,0,1
11292,cent,0,1
11293,;,0,1
11294,P,0,0
11295,<,0,0
11296,0.001,0,0
11297,),0,1
11298,.,0,1
11299,The,0,0
11300,difference,0,0
11301,in,0,0
11302,cancer,0,1
11303,recurrence,0,0
11304,rate,0,0
11305,between,0,0
11306,transfused,0,1
11307,and,0,1
11308,non-transfused,0,1
11309,patients,0,1
11310,was,0,0
11311,not,0,0
11312,statistically,0,0
11313,significant,0,0
11314,(,0,1
11315,29.8,0,1
11316,versus,0,0
11317,24.3,0,0
11318,per,0,1
11319,cent,0,1
11320,;,0,1
11321,P,0,0
11322,=,0,1
11323,0.13,0,0
11324,),0,1
11325,.,0,1
11326,Local,0,1
11327,recurrences,0,0
11328,were,0,0
11329,more,0,0
11330,frequent,0,0
11331,in,0,0
11332,transfused,0,1
11333,than,0,1
11334,non-transfused,0,1
11335,patients,0,1
11336,(,0,1
11337,11.9,0,1
11338,versus,0,0
11339,7.6,0,0
11340,per,0,1
11341,cent,0,1
11342,;,0,1
11343,P,0,0
11344,=,0,1
11345,0.09,0,0
11346,),0,1
11347,.,0,1
11348,CONCLUSION,0,0
11349,Leucocyte,0,0
11350,depletion,0,0
11351,of,0,0
11352,perioperative,0,0
11353,transfused,0,0
11354,blood,0,0
11355,has,0,0
11356,no,0,0
11357,effect,0,0
11358,on,0,0
11359,long-term,0,0
11360,survival,0,0
11361,and/or,0,0
11362,cancer,0,1
11363,recurrence,0,0
11364,.,0,1
11365,Perioperative,0,0
11366,blood,0,0
11367,transfusions,0,0
11368,are,0,0
11369,associated,0,0
11370,with,0,1
11371,impaired,0,1
11372,survival,0,0
11373,",",0,0
11374,but,0,0
11375,not,0,0
11376,with,0,1
11377,cancer,0,1
11378,recurrence,0,0
11379,.,0,1
11380,The,0,0
11381,slight,0,0
11382,increase,0,0
11383,in,0,1
11384,local,0,0
11385,recurrence,0,0
11386,rate,0,0
11387,in,0,1
11388,transfused,1,1
11389,patients,1,1
11390,appears,0,0
11391,to,0,0
11392,be,0,0
11393,related,0,0
11394,to,0,0
11395,complicated,0,1
11396,",",0,0
11397,in,0,0
11398,particular,0,0
11399,rectal,0,1
11400,",",0,0
11401,surgery,0,1
11402,.,0,1
11403,Increasing,1,0
11404,the,1,0
11405,reach,1,0
11406,of,1,0
11407,health,1,1
11408,sponsorship,1,1
11409,:,1,1
11410,using,1,0
11411,a,1,0
11412,sponsorship,1,1
11413,kit,1,0
11414,to,1,0
11415,promote,1,0
11416,health,1,1
11417,.,1,1
11418,In,0,0
11419,Australia,1,1
11420,",",0,0
11421,a,0,0
11422,tobacco,0,1
11423,tax,0,0
11424,provides,0,0
11425,funding,0,0
11426,for,0,0
11427,Healthway,0,0
11428,",",0,0
11429,the,0,0
11430,Western,0,1
11431,Australian,0,1
11432,Health,0,0
11433,Promotion,0,1
11434,Foundation,0,1
11435,.,0,1
11436,Healthway,0,0
11437,provides,0,0
11438,sponsorships,0,0
11439,for,0,0
11440,the,0,1
11441,arts,0,1
11442,and,0,1
11443,racing,0,1
11444,and,0,1
11445,sporting,0,1
11446,events,0,0
11447,to,0,1
11448,replace,0,0
11449,funds,0,1
11450,previously,0,1
11451,provided,0,0
11452,by,0,0
11453,tobacco,0,1
11454,companies,0,1
11455,.,0,1
11456,These,0,1
11457,sponsorships,0,0
11458,provide,0,0
11459,visibility,0,0
11460,for,0,0
11461,Healthway,0,1
11462,and,0,1
11463,positive,0,1
11464,health,0,1
11465,messages,0,1
11466,.,0,1
11467,Normally,0,0
11468,",",0,0
11469,Healthway,0,0
11470,staff,0,0
11471,attends,0,1
11472,these,0,0
11473,events,0,0
11474,to,0,0
11475,help,0,0
11476,promote,0,0
11477,health,0,1
11478,messages,0,0
11479,.,0,1
11480,To,0,0
11481,reduce,0,0
11482,Healthway,1,0
11483,staff,1,1
11484,time,0,0
11485,spent,0,0
11486,helping,0,1
11487,event,0,0
11488,organizers,0,1
11489,promote,0,0
11490,health,0,1
11491,messages,0,0
11492,",",0,1
11493,Healthway,0,0
11494,developed,0,1
11495,a,0,0
11496,sponsor,0,0
11497,kit,0,0
11498,of,0,1
11499,promotional,0,0
11500,materials,0,1
11501,which,0,1
11502,communicate,0,0
11503,health,0,0
11504,messages,0,0
11505,without,0,1
11506,requiring,0,1
11507,Healthway,1,1
11508,staff,1,1
11509,to,0,0
11510,attend,0,1
11511,events,0,0
11512,.,0,1
11513,Recognition,0,0
11514,",",0,0
11515,awareness,0,0
11516,",",0,0
11517,comprehension,0,0
11518,",",0,0
11519,and,0,0
11520,acceptance,0,0
11521,of,0,0
11522,health,0,1
11523,messages,0,1
11524,was,0,0
11525,comparable,0,0
11526,at,0,1
11527,events,0,0
11528,that,0,0
11529,featured,0,1
11530,Healthway,0,0
11531,staff,0,1
11532,versus,0,0
11533,the,0,0
11534,sponsor,0,1
11535,kits,0,0
11536,",",0,0
11537,but,0,0
11538,the,0,0
11539,average,0,0
11540,cost,0,0
11541,of,0,0
11542,the,0,0
11543,sponsorship,0,1
11544,kits,0,0
11545,was,0,0
11546,only,0,0
11547,40,0,1
11548,%,0,0
11549,of,0,0
11550,the,0,0
11551,cost,0,0
11552,when,0,0
11553,Healthway,0,1
11554,staff,0,0
11555,was,0,0
11556,featured,0,1
11557,.,0,1
11558,The,0,0
11559,injured,1,1
11560,colon,1,1
11561,:,1,1
11562,therapeutic,0,0
11563,considerations,0,0
11564,.,0,1
11565,A,0,0
11566,prospective,0,0
11567,randomized,0,1
11568,study,1,1
11569,was,1,0
11570,carried,1,0
11571,out,1,1
11572,at,1,0
11573,the,1,0
11574,Detroit,1,1
11575,General,1,1
11576,Hospital,1,1
11577,over,1,0
11578,a,1,1
11579,two,1,0
11580,year,1,1
11581,period,1,0
11582,to,1,0
11583,evaluate,1,0
11584,methods,1,1
11585,of,1,0
11586,management,1,1
11587,in,1,1
11588,165,1,1
11589,patients,1,1
11590,with,1,1
11591,colonic,1,1
11592,injuries,1,1
11593,.,1,1
11594,Results,0,0
11595,of,0,0
11596,the,0,0
11597,study,0,0
11598,show,0,0
11599,that,0,0
11600,primary,0,1
11601,closure,0,0
11602,is,0,0
11603,a,0,0
11604,safe,0,0
11605,and,0,0
11606,reiable,0,0
11607,method,0,0
11608,of,0,0
11609,management,0,0
11610,when,0,0
11611,rigid,0,0
11612,criteria,0,1
11613,are,0,0
11614,incorporated,0,0
11615,in,0,0
11616,an,0,0
11617,ongoing,0,1
11618,protocol,0,0
11619,.,0,1
11620,Moreover,0,0
11621,",",0,0
11622,the,0,0
11623,technic,0,0
11624,of,0,0
11625,exteriorization,0,0
11626,is,0,0
11627,a,0,0
11628,safe,0,0
11629,adjunct,0,0
11630,to,0,1
11631,management,0,0
11632,and,0,0
11633,is,0,0
11634,recommended,0,0
11635,in,0,0
11636,any,1,0
11637,patient,1,0
11638,with,1,1
11639,a,1,1
11640,colonic,1,1
11641,injury,1,1
11642,above,1,1
11643,18,1,1
11644,cm,1,1
11645,in,0,1
11646,which,0,0
11647,one,0,1
11648,suture,0,0
11649,line,0,0
11650,is,0,0
11651,required,0,0
11652,and,0,0
11653,in,0,0
11654,which,0,0
11655,the,0,0
11656,additional,0,0
11657,operating,0,0
11658,time,0,0
11659,of,0,0
11660,twenty,0,1
11661,minutes,0,0
11662,will,0,0
11663,not,0,0
11664,compromise,0,0
11665,the,0,0
11666,management,0,0
11667,of,0,0
11668,secondary,0,1
11669,injuries,0,1
11670,.,0,1
11671,Patients,0,1
11672,not,0,0
11673,fulfilling,0,1
11674,these,0,0
11675,criteria,0,1
11676,should,0,0
11677,have,0,1
11678,primary,0,1
11679,colostomy,0,1
11680,.,0,1
11681,These,0,0
11682,principles,0,0
11683,make,0,0
11684,it,0,0
11685,possible,0,0
11686,to,0,0
11687,reduce,0,0
11688,the,0,0
11689,need,0,0
11690,for,0,0
11691,primary,0,1
11692,colostomy,0,1
11693,to,0,1
11694,approximately,0,1
11695,50,0,1
11696,per,0,0
11697,cent,0,1
11698,in,0,0
11699,a,0,1
11700,large,0,1
11701,ongoing,0,0
11702,group,0,1
11703,of,0,1
11704,patients,1,1
11705,with,1,1
11706,colonic,1,1
11707,injury,1,1
11708,.,1,1
11709,The,0,0
11710,effect,0,0
11711,of,0,0
11712,splinting,1,1
11713,of,1,1
11714,teeth,1,1
11715,in,1,1
11716,combination,1,0
11717,with,1,1
11718,reconstructive,1,1
11719,periodontal,1,1
11720,surgery,1,1
11721,in,1,1
11722,humans,1,1
11723,.,1,1
11724,The,0,0
11725,purpose,0,0
11726,of,0,0
11727,this,0,0
11728,study,0,0
11729,was,0,0
11730,to,0,0
11731,evaluate,0,0
11732,the,0,0
11733,effect,0,0
11734,of,0,0
11735,splinting,0,1
11736,teeth,0,1
11737,on,0,1
11738,the,0,1
11739,results,0,0
11740,of,0,0
11741,periodontal,0,1
11742,reconstructive,0,1
11743,surgery,0,1
11744,using,0,0
11745,a,0,0
11746,specific,0,0
11747,carbonate,0,0
11748,bone,0,1
11749,replacement,0,1
11750,graft,0,1
11751,(,0,1
11752,BRG,0,0
11753,),0,1
11754,material,0,1
11755,.,0,1
11756,Forty-five,1,1
11757,patients,1,1
11758,were,1,1
11759,randomly,1,1
11760,treated,1,1
11761,with,1,1
11762,a,1,1
11763,periodontal,1,1
11764,surgery,1,1
11765,approach,1,1
11766,.,1,1
11767,Natural,0,0
11768,coral,0,0
11769,calcium,0,0
11770,BRG,0,0
11771,was,0,0
11772,utilised,0,0
11773,in,0,1
11774,33,1,1
11775,patients,1,1
11776,.,1,1
11777,This,0,0
11778,33-patient,0,0
11779,group,0,1
11780,was,0,0
11781,divided,0,1
11782,into,0,1
11783,three,0,1
11784,equal,0,1
11785,groups,0,1
11786,.,0,1
11787,In,0,0
11788,the,0,0
11789,presplint,0,0
11790,group,0,0
11791,",",0,0
11792,teeth,0,1
11793,were,0,0
11794,splinted,0,0
11795,to,0,0
11796,at,0,1
11797,least,0,1
11798,two,0,1
11799,rigid,0,1
11800,teeth,0,1
11801,before,0,1
11802,surgery,0,1
11803,",",0,0
11804,in,0,0
11805,the,0,0
11806,postsplint,0,0
11807,group,0,0
11808,",",0,0
11809,teeth,0,1
11810,were,0,0
11811,splinted,0,0
11812,at,0,0
11813,suture,0,0
11814,removal,0,0
11815,",",0,0
11816,and,0,0
11817,in,0,0
11818,the,0,0
11819,nonsplint,0,0
11820,group,0,0
11821,",",0,0
11822,the,0,0
11823,treated,0,1
11824,teeth,0,1
11825,were,0,1
11826,not,0,0
11827,splinted,0,0
11828,at,0,0
11829,all,0,0
11830,.,0,1
11831,In,0,0
11832,12,0,1
11833,patients,0,1
11834,",",0,1
11835,teeth,0,1
11836,were,0,1
11837,treated,0,1
11838,with,0,1
11839,surgical,0,1
11840,debridement,0,1
11841,(,0,1
11842,DEBR,0,0
11843,),0,1
11844,alone,0,0
11845,and,0,0
11846,not,0,0
11847,splinted,0,0
11848,.,0,1
11849,Periodontal,0,1
11850,probing,0,1
11851,depth,0,0
11852,(,0,1
11853,PPD,0,1
11854,),0,1
11855,",",0,0
11856,clinical,0,0
11857,probing,0,1
11858,attachment,0,1
11859,level,0,0
11860,(,0,1
11861,CPAL,0,0
11862,),0,1
11863,",",0,0
11864,and,0,0
11865,tooth,0,1
11866,mobility,0,0
11867,were,0,0
11868,measured,0,0
11869,using,0,0
11870,desmodontometry,0,1
11871,(,0,1
11872,DDM,0,1
11873,),0,1
11874,and,0,0
11875,periotest,0,0
11876,(,0,1
11877,PTV,0,0
11878,),0,1
11879,with,0,1
11880,reproducible,0,0
11881,methods,0,1
11882,before,0,1
11883,surgery,0,1
11884,and,0,1
11885,at,0,1
11886,various,0,0
11887,periods,0,0
11888,up,0,1
11889,to,0,1
11890,1,0,0
11891,year,0,1
11892,afterwards,0,1
11893,.,0,1
11894,A,0,0
11895,decrease,0,0
11896,in,0,0
11897,PPD,0,1
11898,(,0,1
11899,5.4,0,0
11900,mm,0,1
11901,",",0,1
11902,SD,0,1
11903,1.4,0,0
11904,mm,0,1
11905,),0,1
11906,and,0,0
11907,tooth,0,1
11908,mobility,0,0
11909,(,0,1
11910,DDM-horizontal,0,0
11911,257,0,1
11912,microns,0,1
11913,",",0,1
11914,SD,0,1
11915,60,0,1
11916,microns,0,1
11917,),0,1
11918,and,0,1
11919,a,0,0
11920,gain,0,0
11921,of,0,0
11922,CPAL,0,1
11923,(,0,1
11924,5.1,0,0
11925,mm,0,1
11926,",",0,1
11927,SD,0,1
11928,1.4,0,0
11929,mm,0,1
11930,),0,1
11931,were,0,1
11932,seen,0,0
11933,following,0,0
11934,the,0,0
11935,use,0,0
11936,of,0,0
11937,BRG,0,0
11938,in,0,1
11939,presplint,0,1
11940,teeth,0,1
11941,.,0,1
11942,In,0,0
11943,the,0,0
11944,same,0,0
11945,group,0,0
11946,",",0,1
11947,PPD,0,1
11948,and,0,0
11949,tooth,0,1
11950,mobility,0,0
11951,were,0,1
11952,significantly,0,0
11953,reduced,0,0
11954,compared,0,0
11955,to,0,0
11956,nonsplint,0,0
11957,teeth,0,1
11958,.,0,1
11959,DEBR,0,0
11960,alone,0,0
11961,showed,0,0
11962,reductions,0,0
11963,in,0,0
11964,tooth,0,1
11965,mobility,0,0
11966,and,0,0
11967,PPD,0,1
11968,and,0,0
11969,a,0,0
11970,significantly,0,0
11971,smaller,0,0
11972,gain,0,0
11973,in,0,0
11974,CPAL,0,0
11975,than,0,0
11976,in,0,1
11977,presplint,0,1
11978,teeth,0,1
11979,treated,0,1
11980,with,0,1
11981,BRG,0,0
11982,.,0,0
11983,The,0,0
11984,less,0,0
11985,favourable,0,0
11986,improvement,0,0
11987,in,0,1
11988,periodontal,0,1
11989,function,0,0
11990,of,0,0
11991,postsplint,0,0
11992,or,0,1
11993,nonsplint,0,0
11994,teeth,0,1
11995,seemed,0,0
11996,to,0,1
11997,be,0,0
11998,due,0,0
11999,to,0,0
12000,the,0,0
12001,loss,0,0
12002,of,0,0
12003,BRG,0,0
12004,material,0,1
12005,caused,0,0
12006,by,0,0
12007,tooth,0,1
12008,mobility,0,0
12009,.,0,1
12010,These,0,0
12011,results,0,0
12012,indicate,0,0
12013,that,0,0
12014,an,0,0
12015,undisturbed,0,1
12016,wound,0,0
12017,healing,0,0
12018,process,0,0
12019,using,0,0
12020,BRG,0,0
12021,together,0,0
12022,with,0,1
12023,tooth,0,1
12024,stability,0,0
12025,is,0,0
12026,beneficial,0,0
12027,to,0,0
12028,overall,0,0
12029,clinical,0,0
12030,success,0,0
12031,.,0,1
12032,Work-related,1,1
12033,stress,1,1
12034,and,1,1
12035,early,1,1
12036,atherosclerosis,1,1
12037,.,1,1
12038,The,0,0
12039,purpose,0,0
12040,of,0,0
12041,this,0,0
12042,study,0,0
12043,was,0,0
12044,to,0,0
12045,examine,0,0
12046,the,0,0
12047,link,0,0
12048,between,0,0
12049,work-related,0,1
12050,stress,0,1
12051,and,0,1
12052,early,1,1
12053,atherosclerosis,1,1
12054,as,0,0
12055,measured,0,0
12056,by,0,0
12057,common,0,1
12058,carotid,0,1
12059,artery,0,1
12060,intima-media,0,1
12061,thickness,0,1
12062,and,0,1
12063,focal,0,1
12064,lesions,0,1
12065,in,0,1
12066,the,0,1
12067,common,0,0
12068,carotid,0,1
12069,artery,0,1
12070,and,0,0
12071,bifurcation,0,1
12072,.,0,1
12073,Four,1,0
12074,hundred,1,1
12075,sixty-seven,1,1
12076,members,1,1
12077,of,1,1
12078,an,1,1
12079,occupational,1,1
12080,cohort,1,1
12081,(,1,1
12082,total,1,1
12083,N,1,1
12084,=,1,1
12085,573,1,1
12086,),1,1
12087,were,1,1
12088,examined,1,0
12089,via,1,1
12090,questionnaires,1,0
12091,and,1,1
12092,B-mode,1,1
12093,ultrasound,1,1
12094,.,1,1
12095,We,0,0
12096,used,0,0
12097,multiple,0,1
12098,linear,0,0
12099,and,0,1
12100,logistic,0,0
12101,models,0,0
12102,to,0,1
12103,regress,0,1
12104,lesion,0,0
12105,risk,0,0
12106,and,0,0
12107,intima-media,0,0
12108,thickness,0,1
12109,on,0,0
12110,work-related,0,1
12111,stress,0,1
12112,scores,0,0
12113,from,0,1
12114,a,0,1
12115,questionnaire,0,0
12116,administered,0,0
12117,at,0,0
12118,an,0,1
12119,18-month,0,1
12120,follow-up,0,0
12121,examination,0,1
12122,.,0,1
12123,In,0,0
12124,an,0,0
12125,age-adjusted,0,1
12126,model,0,0
12127,",",0,0
12128,the,0,0
12129,prevalence,0,0
12130,of,0,0
12131,carotid,0,1
12132,lesions,0,1
12133,among,0,1
12134,men,0,1
12135,scoring,0,1
12136,in,0,1
12137,the,0,0
12138,highest,0,0
12139,stress,0,0
12140,quintile,0,1
12141,was,0,0
12142,36,0,1
12143,%,0,0
12144,compared,0,0
12145,with,0,1
12146,21,0,1
12147,%,0,0
12148,among,0,1
12149,men,0,1
12150,in,0,1
12151,the,0,0
12152,lowest,0,0
12153,quintile,0,1
12154,.,0,1
12155,We,0,0
12156,also,0,0
12157,observed,0,0
12158,an,0,0
12159,increase,0,0
12160,in,0,0
12161,intima-media,0,0
12162,thickness,0,1
12163,in,0,0
12164,the,0,0
12165,highest,0,0
12166,quintile,0,0
12167,relative,0,0
12168,to,0,1
12169,the,0,0
12170,lowest,0,0
12171,(,0,0
12172,difference,0,0
12173,=,0,1
12174,0.048,0,0
12175,+/-,0,0
12176,0.025,0,0
12177,mm,0,1
12178,),0,1
12179,among,0,1
12180,men,0,1
12181,.,0,1
12182,Among,0,1
12183,women,1,1
12184,",",1,1
12185,stress,1,0
12186,was,0,0
12187,not,0,0
12188,related,0,0
12189,to,0,0
12190,the,0,0
12191,prevalence,0,0
12192,of,0,0
12193,lesions,0,1
12194,or,0,1
12195,intima-media,0,1
12196,thickness,0,1
12197,.,0,1
12198,These,0,0
12199,findings,0,0
12200,suggest,0,0
12201,that,0,0
12202,men,1,1
12203,with,1,1
12204,greater,1,0
12205,work-related,1,1
12206,stress,1,0
12207,are,0,0
12208,at,0,0
12209,increased,0,0
12210,risk,0,1
12211,for,0,0
12212,atherosclerotic,0,1
12213,disease,0,1
12214,.,0,1
12215,Women,0,1
12216,in,0,0
12217,this,0,0
12218,age,0,1
12219,group,0,0
12220,may,0,0
12221,be,0,0
12222,protected,0,0
12223,from,0,1
12224,such,0,0
12225,effects,0,0
12226,",",0,1
12227,or,0,1
12228,current,0,1
12229,work-place,0,0
12230,questionnaires,0,0
12231,may,0,0
12232,not,0,0
12233,accurately,0,0
12234,assess,0,0
12235,stress,0,0
12236,in,0,1
12237,women,0,1
12238,.,0,1
12239,Sun,0,1
12240,protection,0,0
12241,behaviors,0,0
12242,and,0,1
12243,stages,0,1
12244,of,0,0
12245,change,0,0
12246,for,0,0
12247,the,0,0
12248,primary,0,1
12249,prevention,0,1
12250,of,0,1
12251,skin,1,1
12252,cancers,1,1
12253,among,1,1
12254,beachgoers,1,1
12255,in,1,1
12256,southeastern,1,1
12257,New,1,1
12258,England,1,1
12259,.,1,1
12260,Sun,0,0
12261,exposure,0,0
12262,is,0,0
12263,the,0,0
12264,most,0,0
12265,important,0,0
12266,avoidable,0,1
12267,cause,0,0
12268,of,0,1
12269,skin,0,1
12270,cancers,0,1
12271,.,0,1
12272,We,0,0
12273,report,0,0
12274,characteristics,0,0
12275,of,0,0
12276,a,0,1
12277,representative,1,1
12278,sample,1,1
12279,(,1,1
12280,N,1,1
12281,=,1,1
12282,"2,324",1,1
12283,),1,1
12284,of,1,1
12285,beachgoers,1,1
12286,in,1,1
12287,Southeastern,1,1
12288,New,1,1
12289,England,1,1
12290,during,1,0
12291,the,1,0
12292,summer,1,1
12293,of,1,0
12294,1995,1,1
12295,.,1,1
12296,This,0,0
12297,sample,0,1
12298,was,0,0
12299,not,0,0
12300,employing,0,0
12301,adequate,0,0
12302,sun,0,1
12303,protection,0,0
12304,behaviors,0,0
12305,(,0,1
12306,83,0,1
12307,%,0,0
12308,did,0,0
12309,not,0,0
12310,often,0,0
12311,avoid,0,0
12312,the,0,0
12313,sun,0,0
12314,during,0,0
12315,midday,0,1
12316,and,0,1
12317,only,0,0
12318,45,0,1
12319,%,0,0
12320,often,0,1
12321,used,0,0
12322,sunscreen,0,1
12323,),0,1
12324,.,0,1
12325,Important,0,0
12326,demographic,0,0
12327,and,0,1
12328,skin,0,1
12329,cancer,0,1
12330,risk,0,1
12331,factor,0,0
12332,differences,0,0
12333,in,0,1
12334,sun,0,1
12335,protective,0,1
12336,behaviors,0,1
12337,and,0,1
12338,stages,0,1
12339,of,0,0
12340,change,0,0
12341,for,0,0
12342,sun,0,1
12343,protection,0,0
12344,were,0,0
12345,found,0,0
12346,",",0,0
12347,especially,0,0
12348,differences,0,0
12349,based,0,1
12350,on,0,0
12351,age,0,1
12352,",",0,0
12353,gender,0,0
12354,",",0,0
12355,and,0,0
12356,degree,0,0
12357,of,0,0
12358,sun,0,1
12359,sensitivity,0,0
12360,.,0,1
12361,Consistent,0,0
12362,with,0,1
12363,previous,0,1
12364,research,0,1
12365,",",0,0
12366,increased,0,0
12367,age,0,1
12368,",",0,0
12369,female,0,1
12370,gender,0,0
12371,",",0,0
12372,and,0,0
12373,greater,0,0
12374,sun,0,1
12375,sensitivity,0,0
12376,were,0,0
12377,each,0,0
12378,independently,0,0
12379,associated,0,0
12380,with,0,0
12381,more,0,0
12382,sun,0,0
12383,protective,0,0
12384,behaviors,0,0
12385,.,0,1
12386,These,0,1
12387,findings,0,0
12388,underscore,0,0
12389,the,0,0
12390,need,0,0
12391,for,0,0
12392,interventions,0,0
12393,targeting,0,1
12394,high-risk,0,1
12395,populations,0,1
12396,",",0,1
12397,such,0,0
12398,as,0,0
12399,those,0,1
12400,receiving,0,1
12401,high-intensity,0,0
12402,sun,0,1
12403,exposures,0,0
12404,at,0,1
12405,the,0,1
12406,beach,0,1
12407,.,0,1
12408,A,0,0
12409,single-center,0,1
12410,open,0,1
12411,label,0,0
12412,randomized,0,1
12413,trial,0,0
12414,of,0,0
12415,the,0,0
12416,safety,0,0
12417,and,0,0
12418,efficacy,0,0
12419,of,0,0
12420,the,0,0
12421,use,0,0
12422,of,0,0
12423,sirolimus,0,1
12424,versus,0,0
12425,azathioprine,0,0
12426,in,0,0
12427,one-haplotype,1,1
12428,living,1,1
12429,related,1,0
12430,kidney,1,1
12431,transplant,1,1
12432,recipients-preliminary,1,1
12433,results,0,0
12434,.,0,1
12435,L-arginine,0,1
12436,and,0,1
12437,S-nitrosoglutathione,0,0
12438,reduce,0,0
12439,embolization,0,0
12440,in,0,0
12441,humans,1,1
12442,.,1,1
12443,BACKGROUND,0,0
12444,L-Arginine,0,0
12445,reduces,0,0
12446,platelet,0,0
12447,aggregation,0,0
12448,and,0,1
12449,adhesion,0,0
12450,in,0,0
12451,ex,0,1
12452,vivo,0,0
12453,studies,0,0
12454,",",0,0
12455,but,0,0
12456,there,0,0
12457,is,0,0
12458,no,0,0
12459,evidence,0,0
12460,as,0,0
12461,yet,0,0
12462,that,0,0
12463,it,0,0
12464,has,0,0
12465,a,0,0
12466,therapeutic,0,0
12467,effect,0,0
12468,on,0,0
12469,clinical,0,0
12470,end,0,1
12471,points,0,0
12472,.,0,1
12473,Doppler,0,0
12474,ultrasound,0,0
12475,can,0,0
12476,detect,0,0
12477,cerebral,0,1
12478,emboli,0,1
12479,noninvasively,0,1
12480,.,0,1
12481,Such,0,1
12482,embolic,0,0
12483,signals,0,0
12484,are,0,0
12485,common,0,0
12486,after,0,1
12487,carotid,0,1
12488,endarterectomy,0,1
12489,",",0,0
12490,and,0,0
12491,their,0,0
12492,frequency,0,0
12493,predicts,0,0
12494,risk,0,0
12495,of,0,0
12496,stroke,0,1
12497,recurrence,0,0
12498,.,0,1
12499,We,0,0
12500,used,0,0
12501,this,0,0
12502,situation,0,0
12503,to,0,0
12504,determine,0,0
12505,the,0,0
12506,antiplatelet,0,0
12507,efficacy,0,0
12508,of,0,0
12509,L-arginine,0,1
12510,and,0,1
12511,S-nitrosoglutathione,0,0
12512,(,0,1
12513,GSNO,0,1
12514,),0,1
12515,",",0,0
12516,a,0,0
12517,physiological,0,0
12518,nitric,0,0
12519,oxide,0,0
12520,donor,0,1
12521,with,0,1
12522,possible,0,0
12523,platelet,0,0
12524,specificity,0,0
12525,.,0,1
12526,METHODS,0,0
12527,AND,0,0
12528,RESULTS,0,1
12529,Patients,1,1
12530,undergoing,1,1
12531,carotid,1,1
12532,endarterectomy,1,1
12533,were,0,0
12534,randomized,0,1
12535,in,0,0
12536,a,0,1
12537,double-blind,0,0
12538,manner,0,0
12539,between,0,0
12540,L-arginine,0,1
12541,(,1,1
12542,n=14,1,1
12543,),1,1
12544,",",0,0
12545,GSNO,0,1
12546,(,1,1
12547,n=14,1,1
12548,),1,1
12549,",",0,0
12550,or,0,1
12551,placebo,0,0
12552,(,1,1
12553,n=14,1,1
12554,),1,1
12555,administered,0,0
12556,intravenously,0,1
12557,for,0,1
12558,90,0,1
12559,minutes,0,0
12560,",",0,1
12561,starting,0,1
12562,30,0,1
12563,minutes,0,0
12564,after,0,1
12565,skin,0,1
12566,closure,0,1
12567,.,0,1
12568,All,1,1
12569,patients,1,1
12570,were,1,1
12571,pretreated,1,1
12572,with,1,1
12573,aspirin,1,0
12574,and,1,1
12575,given,1,0
12576,heparin,1,0
12577,during,1,1
12578,surgery,1,1
12579,.,1,1
12580,Transcranial,0,0
12581,Doppler,0,1
12582,recordings,0,0
12583,were,0,1
12584,made,0,0
12585,from,0,1
12586,the,0,0
12587,ipsilateral,0,1
12588,middle,0,1
12589,cerebral,0,1
12590,artery,0,1
12591,for,0,1
12592,4,0,0
12593,hours,0,0
12594,after,0,1
12595,surgery,0,1
12596,",",0,1
12597,beginning,0,1
12598,30,0,1
12599,minutes,0,0
12600,after,0,1
12601,skin,0,1
12602,closure,0,1
12603,",",0,0
12604,and,0,0
12605,also,0,0
12606,at,0,0
12607,6,0,0
12608,and,0,1
12609,24,0,1
12610,hours,0,0
12611,.,0,1
12612,There,0,0
12613,were,0,0
12614,highly,0,0
12615,significant,0,0
12616,reductions,0,0
12617,in,0,1
12618,the,0,0
12619,number,0,0
12620,of,0,0
12621,Doppler,0,1
12622,embolic,0,1
12623,signals,0,0
12624,in,0,1
12625,the,0,1
12626,L-arginine,0,0
12627,and,0,1
12628,GSNO,0,1
12629,groups,0,1
12630,;,0,1
12631,first,0,1
12632,4,0,0
12633,hours,0,0
12634,",",0,1
12635,median,0,1
12636,(,0,1
12637,range,0,1
12638,),0,1
12639,number,0,0
12640,of,0,1
12641,embolic,0,1
12642,signals,0,0
12643,",",0,1
12644,placebo,0,1
12645,44.7,0,0
12646,(,0,1
12647,6,0,1
12648,to,0,1
12649,778,0,1
12650,),0,1
12651,",",0,1
12652,L-arginine,0,1
12653,9.5,0,0
12654,(,0,1
12655,0,0,0
12656,to,0,1
12657,225,0,1
12658,),0,1
12659,",",0,0
12660,and,0,0
12661,GSNO,0,1
12662,0.8,0,0
12663,(,0,1
12664,0,0,0
12665,to,0,1
12666,8,0,1
12667,),0,0
12668,",",0,0
12669,both,0,0
12670,P,0,0
12671,<,0,0
12672,0.001,0,0
12673,versus,0,0
12674,control,0,1
12675,values,0,0
12676,.,0,1
12677,The,0,0
12678,reduction,0,0
12679,in,0,0
12680,the,0,0
12681,signals,0,0
12682,persisted,0,0
12683,at,0,1
12684,the,0,0
12685,24-hour,0,0
12686,recording,0,0
12687,.,0,1
12688,CONCLUSIONS,0,0
12689,Intravenous,0,1
12690,L-arginine,0,1
12691,and,0,0
12692,GSNO,0,1
12693,attenuate,0,0
12694,Doppler,0,1
12695,embolic,0,1
12696,signals,0,0
12697,in,0,1
12698,humans,0,1
12699,.,0,1
12700,Modulation,0,0
12701,of,0,0
12702,the,0,0
12703,NO,0,0
12704,system,0,0
12705,with,0,1
12706,these,0,0
12707,agents,0,0
12708,may,0,0
12709,have,0,1
12710,applications,0,0
12711,in,0,0
12712,the,0,0
12713,treatment,0,0
12714,of,0,0
12715,thromboembolic,1,1
12716,disease,1,1
12717,.,1,1
12718,This,0,0
12719,study,0,0
12720,demonstrates,0,0
12721,the,0,0
12722,potential,0,0
12723,application,0,0
12724,of,0,0
12725,ultrasonic,0,1
12726,embolic,0,1
12727,signal,0,1
12728,detection,0,0
12729,to,0,0
12730,examine,0,0
12731,the,0,0
12732,efficacy,0,0
12733,of,0,0
12734,new,0,1
12735,antiplatelet,0,1
12736,agents,0,0
12737,in,0,1
12738,relatively,1,1
12739,small,1,1
12740,numbers,1,0
12741,of,1,1
12742,patients,1,1
12743,.,1,1
12744,Confirmatory,1,1
12745,trials,1,1
12746,:,1,1
12747,symptom,1,1
12748,reduction,1,0
12749,as,1,0
12750,efficacy,1,0
12751,measure,1,0
12752,.,1,1
12753,Dose,0,0
12754,response,0,0
12755,effect,0,0
12756,of,0,0
12757,cyclical,0,0
12758,medroxyprogesterone,0,0
12759,on,0,0
12760,blood,0,0
12761,pressure,0,0
12762,in,0,1
12763,postmenopausal,1,1
12764,women,1,1
12765,.,1,1
12766,OBJECTIVE,0,0
12767,This,0,0
12768,study,0,0
12769,was,0,0
12770,designed,0,0
12771,to,0,0
12772,compare,0,0
12773,with,0,1
12774,placebo,0,0
12775,the,0,0
12776,dose-response,0,0
12777,effect,0,0
12778,of,0,1
12779,cyclical,0,0
12780,doses,0,0
12781,of,0,1
12782,the,0,1
12783,C21,0,0
12784,progestogen,0,0
12785,",",0,0
12786,medroxyprogesterone,0,0
12787,acetate,0,0
12788,(,0,1
12789,MPA,0,1
12790,),0,1
12791,on,0,0
12792,blood,0,0
12793,pressure,0,0
12794,(,0,1
12795,BP,0,1
12796,),0,0
12797,when,0,0
12798,administered,0,0
12799,to,0,0
12800,normotensive,1,1
12801,postmenopausal,1,1
12802,women,1,1
12803,receiving,1,1
12804,a,1,1
12805,fixed,1,0
12806,mid-range,1,1
12807,daily,1,0
12808,dose,1,0
12809,of,1,0
12810,conjugated,1,0
12811,equine,1,1
12812,oestrogen,1,0
12813,(,1,1
12814,CEE,1,1
12815,),1,1
12816,.,1,1
12817,MATERIALS,0,0
12818,AND,0,0
12819,METHODS,0,0
12820,Twenty,1,1
12821,normotensive,1,1
12822,postmenopausal,1,1
12823,women,1,1
12824,(,1,1
12825,median,1,1
12826,age,1,1
12827,53,1,1
12828,years,1,1
12829,),1,1
12830,participated,0,1
12831,in,0,0
12832,the,0,0
12833,study,0,0
12834,which,0,0
12835,used,0,0
12836,a,0,0
12837,double-blind,0,0
12838,crossover,0,0
12839,design,0,1
12840,.,0,0
12841,There,0,0
12842,were,0,0
12843,four,0,0
12844,randomised,0,1
12845,treatment,0,1
12846,phases,0,0
12847,",",0,0
12848,each,0,1
12849,of,0,0
12850,4,0,0
12851,weeks,0,1
12852,duration,0,1
12853,.,0,1
12854,The,0,0
12855,four,0,0
12856,blinded,0,0
12857,treatments,0,0
12858,were,0,1
12859,MPA,0,1
12860,2.5,0,0
12861,mg,0,0
12862,",",0,1
12863,MPA,0,0
12864,5,0,0
12865,mg,0,0
12866,",",0,1
12867,MPA,0,0
12868,10,0,1
12869,mg,0,0
12870,and,0,0
12871,matching,0,1
12872,placebo,0,0
12873,",",0,0
12874,taken,0,0
12875,for,0,0
12876,the,0,0
12877,last,0,1
12878,14,0,1
12879,days,0,0
12880,of,0,1
12881,each,0,1
12882,28,0,1
12883,day,0,0
12884,treatment,0,1
12885,cycle,0,0
12886,.,0,1
12887,CEE,0,0
12888,0.625,0,0
12889,mg,0,0
12890,was,0,0
12891,also,0,0
12892,administered,0,0
12893,once,0,0
12894,daily,0,0
12895,as,0,0
12896,open,0,1
12897,labelled,0,1
12898,tablets,0,0
12899,to,0,1
12900,all,0,1
12901,subjects,0,1
12902,throughout,0,0
12903,the,0,1
12904,study,0,1
12905,.,0,1
12906,Clinic,0,0
12907,BP,0,1
12908,was,0,0
12909,measured,0,0
12910,weekly,0,0
12911,with,0,1
12912,the,0,0
12913,mean,0,1
12914,values,0,0
12915,of,0,1
12916,weeks,0,1
12917,3,0,1
12918,and,0,1
12919,4,0,0
12920,of,0,0
12921,each,0,1
12922,phase,0,0
12923,used,0,0
12924,for,0,0
12925,analysis,0,0
12926,.,0,1
12927,Ambulatory,0,1
12928,BP,0,1
12929,was,0,0
12930,performed,0,0
12931,in,0,0
12932,the,0,0
12933,final,0,0
12934,week,0,0
12935,of,0,0
12936,each,0,0
12937,phase,0,1
12938,.,0,1
12939,RESULTS,0,0
12940,Compared,0,0
12941,with,0,1
12942,the,0,0
12943,placebo,0,0
12944,phase,0,0
12945,",",0,0
12946,end,0,0
12947,of,0,0
12948,phase,0,1
12949,clinic,0,1
12950,BP,0,1
12951,was,0,0
12952,unchanged,0,0
12953,by,0,0
12954,any,0,0
12955,of,0,0
12956,the,0,0
12957,progestogen,0,1
12958,treatments,0,0
12959,.,0,1
12960,There,0,0
12961,was,0,0
12962,a,0,0
12963,dose-dependent,0,0
12964,decrease,0,0
12965,in,0,1
12966,ambulatory,0,1
12967,daytime,0,1
12968,diastolic,0,1
12969,and,0,1
12970,mean,0,1
12971,arterial,0,1
12972,BP,0,1
12973,with,0,1
12974,the,0,0
12975,progestogen,0,1
12976,treatments,0,0
12977,compared,0,0
12978,with,0,1
12979,placebo,0,0
12980,(,0,1
12981,P,0,0
12982,<,0,0
12983,0.05,0,0
12984,),0,1
12985,.,0,1
12986,CONCLUSION,0,0
12987,In,0,0
12988,a,0,0
12989,regimen,0,0
12990,of,0,0
12991,postmenopausal,0,1
12992,hormone,0,1
12993,replacement,0,1
12994,therapy,0,0
12995,with,0,1
12996,a,0,1
12997,fixed,0,0
12998,mid-range,0,1
12999,daily,0,0
13000,dose,0,0
13001,of,0,1
13002,CEE,0,1
13003,combined,0,0
13004,with,0,1
13005,a,0,1
13006,cyclical,0,0
13007,regimen,0,0
13008,of,0,0
13009,a,0,1
13010,C21,0,1
13011,progestogen,0,0
13012,spanning,0,1
13013,the,0,0
13014,current,0,0
13015,clinical,0,0
13016,dose,0,0
13017,range,0,1
13018,",",0,0
13019,the,0,0
13020,progestogen,0,0
13021,has,0,0
13022,either,0,0
13023,no,0,0
13024,effect,0,0
13025,or,0,1
13026,a,0,1
13027,small,0,0
13028,dose-dependent,0,0
13029,reduction,0,0
13030,in,0,0
13031,clinic,0,1
13032,and,0,1
13033,ambulatory,0,1
13034,BPs,0,1
13035,over,0,0
13036,one,0,1
13037,treatment,0,1
13038,cycle,0,0
13039,.,0,1
13040,Rehabilitation,0,1
13041,outcomes,0,0
13042,following,0,0
13043,percutaneous,1,1
13044,coronary,1,1
13045,interventions,1,0
13046,(,1,1
13047,PCI,1,1
13048,),1,1
13049,.,1,1
13050,This,0,0
13051,prospective,0,0
13052,study,0,0
13053,evaluated,0,0
13054,the,0,0
13055,effect,0,0
13056,of,0,0
13057,an,0,0
13058,individualized,0,0
13059,",",0,0
13060,comprehensive,0,0
13061,",",0,0
13062,home-based,0,1
13063,cardiac,0,1
13064,rehabilitation,0,1
13065,program,0,1
13066,combining,0,0
13067,exercise,0,0
13068,training,0,0
13069,with,0,1
13070,risk,0,1
13071,factor,0,0
13072,modification,0,0
13073,and,0,0
13074,psychosocial,0,1
13075,counseling,0,1
13076,on,0,0
13077,risk,0,1
13078,factors,0,0
13079,",",0,1
13080,psychological,0,0
13081,well-being,0,0
13082,",",0,0
13083,functional,0,0
13084,capacity,0,0
13085,",",0,0
13086,and,0,0
13087,work,0,0
13088,resumption,0,1
13089,in,0,1
13090,99,1,1
13091,post-percutaneous,1,1
13092,coronary,1,1
13093,interventions,1,0
13094,(,1,1
13095,PCI,1,1
13096,),1,1
13097,patients,1,1
13098,randomized,0,1
13099,to,0,1
13100,control,0,1
13101,(,0,0
13102,standard,0,1
13103,care,0,1
13104,plus,0,0
13105,telephone,0,1
13106,follow-up,0,0
13107,",",0,0
13108,n=49,0,1
13109,),0,0
13110,or,0,1
13111,intervention,0,0
13112,(,0,0
13113,individualized,0,0
13114,",",0,0
13115,comprehensive,0,0
13116,",",0,0
13117,home-based,0,1
13118,cardiac,0,1
13119,rehabilitation,0,1
13120,",",0,0
13121,n=50,0,1
13122,),0,1
13123,groups,0,1
13124,.,0,1
13125,Data,0,1
13126,were,0,0
13127,collected,0,1
13128,at,0,1
13129,time,0,0
13130,1,0,1
13131,(,0,1
13132,T,0,1
13133,(,0,1
13134,1,0,1
13135,),0,1
13136,),0,1
13137,during,0,0
13138,hospital,0,1
13139,admission,0,1
13140,",",0,1
13141,time,0,0
13142,2,0,1
13143,(,0,1
13144,T,0,1
13145,(,0,1
13146,2,0,1
13147,),0,1
13148,),0,1
13149,approximately,0,1
13150,2,0,1
13151,months,0,0
13152,post-PCI,0,0
13153,",",0,1
13154,and,0,0
13155,time,0,0
13156,3,0,1
13157,(,0,1
13158,T,0,1
13159,(,0,1
13160,3,0,1
13161,),0,1
13162,),0,1
13163,approximately,0,1
13164,12,0,1
13165,months,0,0
13166,post-PCI,0,1
13167,.,0,1
13168,Results,0,0
13169,suggest,0,0
13170,that,0,0
13171,the,0,0
13172,allocation,0,0
13173,to,0,0
13174,an,0,0
13175,individualized,0,0
13176,",",0,0
13177,comprehensive,0,0
13178,",",0,0
13179,home-based,0,1
13180,cardiac,0,1
13181,rehabilitation,0,1
13182,program,0,0
13183,provided,0,0
13184,more,0,0
13185,advantageous,0,0
13186,outcomes,0,0
13187,.,0,1
13188,At,0,0
13189,both,0,0
13190,follow-ups,0,0
13191,",",0,0
13192,the,0,0
13193,intervention,0,0
13194,group,0,0
13195,showed,0,0
13196,within-group,0,0
13197,improvement,0,0
13198,in,0,0
13199,serum,0,0
13200,cholesterol,0,1
13201,levels,0,0
13202,(,0,1
13203,P,0,0
13204,<,0,0
13205,0.02,0,0
13206,;,0,1
13207,P,0,0
13208,<,0,0
13209,0.01,0,0
13210,),0,1
13211,and,0,1
13212,exercise,0,1
13213,participation,0,1
13214,(,0,1
13215,P,0,0
13216,<,0,0
13217,0.001,0,0
13218,;,0,1
13219,P,0,0
13220,<,0,0
13221,0.001,0,0
13222,),0,1
13223,with,0,1
13224,differences,0,0
13225,in,0,1
13226,exercise,0,1
13227,participation,0,0
13228,favoring,0,0
13229,the,0,0
13230,intervention,0,0
13231,group,0,0
13232,(,0,1
13233,P,0,0
13234,<,0,0
13235,0.01,0,0
13236,),0,1
13237,at,0,1
13238,T,0,1
13239,(,0,1
13240,2,0,1
13241,),0,1
13242,.,0,1
13243,Repeated,0,0
13244,measures,0,0
13245,ANOVA,0,1
13246,showed,0,0
13247,significant,0,0
13248,improvements,0,0
13249,over,0,0
13250,time,0,0
13251,in,0,0
13252,body,0,1
13253,mass,0,1
13254,index,0,1
13255,(,0,1
13256,BMI,0,1
13257,),0,1
13258,(,0,1
13259,P,0,0
13260,<,0,0
13261,0.01,0,0
13262,),0,1
13263,",",0,0
13264,psychological,0,0
13265,well-being,0,0
13266,(,0,1
13267,P,0,0
13268,<,0,0
13269,0.001,0,0
13270,),0,1
13271,",",0,0
13272,and,0,0
13273,functional,0,0
13274,capacity,0,0
13275,(,0,1
13276,P,0,0
13277,<,0,0
13278,0.001,0,0
13279,),0,1
13280,for,0,0
13281,both,0,0
13282,groups,0,0
13283,.,0,1
13284,More,0,1
13285,patients,0,1
13286,in,0,0
13287,the,0,0
13288,intervention,0,0
13289,group,0,0
13290,had,0,1
13291,returned,0,0
13292,to,0,0
13293,work,0,0
13294,at,0,0
13295,T,0,1
13296,(,0,1
13297,2,0,1
13298,),0,1
13299,(,0,1
13300,P,0,0
13301,<,0,0
13302,0.001,0,0
13303,),0,1
13304,and,0,0
13305,did,0,0
13306,so,0,0
13307,more,0,0
13308,quickly,0,0
13309,(,0,0
13310,P,0,0
13311,<,0,0
13312,0.01,0,0
13313,),0,1
13314,.,0,1
13315,These,0,0
13316,findings,0,0
13317,suggest,0,0
13318,that,0,0
13319,an,0,0
13320,individualized,0,0
13321,",",0,0
13322,comprehensive,0,0
13323,",",0,0
13324,home-based,0,1
13325,cardiac,0,1
13326,rehabilitation,0,1
13327,program,0,1
13328,improves,0,0
13329,risk,0,0
13330,factor,0,0
13331,profiles,0,0
13332,and,0,1
13333,work,0,1
13334,resumption,0,1
13335,patterns,0,1
13336,for,0,1
13337,patients,1,1
13338,following,1,1
13339,PCI,1,1
13340,.,1,1
13341,Additive,0,0
13342,IOP-reducing,0,1
13343,effect,0,0
13344,of,0,0
13345,latanoprost,0,0
13346,in,0,1
13347,patients,1,1
13348,insufficiently,1,1
13349,controlled,1,0
13350,on,1,0
13351,timolol,1,0
13352,.,1,1
13353,PURPOSE,0,0
13354,To,0,0
13355,evaluate,0,0
13356,the,0,0
13357,effect,0,0
13358,on,0,0
13359,intraocular,0,1
13360,pressure,0,0
13361,(,0,1
13362,IOP,0,1
13363,),0,1
13364,of,0,0
13365,switching,0,1
13366,from,0,1
13367,timolol,0,0
13368,to,0,0
13369,latanoprost,0,0
13370,or,0,1
13371,adding,0,0
13372,latanoprost,0,0
13373,to,0,0
13374,timolol,0,0
13375,in,0,0
13376,patients,1,1
13377,with,1,1
13378,open,1,1
13379,angle,1,0
13380,glaucoma,1,1
13381,or,1,1
13382,ocular,1,1
13383,hypertension,1,1
13384,where,1,0
13385,IOP,1,1
13386,is,1,0
13387,not,1,0
13388,adequately,1,0
13389,controlled,1,0
13390,with,1,1
13391,timolol,1,0
13392,.,1,1
13393,METHODS,0,0
13394,This,0,0
13395,was,0,0
13396,a,0,0
13397,6-week,0,0
13398,",",0,0
13399,double-masked,0,0
13400,",",0,0
13401,randomised,0,0
13402,multi-centre,0,1
13403,study,0,1
13404,.,0,1
13405,53,1,1
13406,patients,1,1
13407,with,1,1
13408,primary,1,1
13409,open,1,1
13410,angle,1,0
13411,glaucoma,1,1
13412,",",1,0
13413,capsular,1,0
13414,glaucoma,1,1
13415,",",1,0
13416,or,1,1
13417,ocular,1,1
13418,hypertension,1,1
13419,with,1,1
13420,an,1,0
13421,IOP,1,1
13422,of,1,0
13423,at,1,1
13424,least,1,1
13425,21,1,1
13426,mmHg,1,0
13427,on,1,0
13428,current,1,1
13429,therapy,1,1
13430,were,1,1
13431,recruited,1,1
13432,.,1,1
13433,After,0,0
13434,a,0,0
13435,run-in,0,0
13436,period,0,0
13437,of,0,0
13438,at,0,1
13439,least,0,1
13440,2,0,1
13441,weeks,0,0
13442,on,0,0
13443,timolol,0,0
13444,",",0,1
13445,5,0,0
13446,mg/ml,0,0
13447,twice,0,0
13448,daily,0,0
13449,",",0,0
13450,patients,0,1
13451,were,0,1
13452,randomised,0,1
13453,to,0,1
13454,one,0,1
13455,of,0,1
13456,three,0,1
13457,groups,0,1
13458,.,0,1
13459,One,0,1
13460,group,0,0
13461,continued,0,0
13462,on,0,0
13463,timolol,0,0
13464,",",0,1
13465,one,0,1
13466,switched,0,0
13467,from,0,1
13468,timolol,0,0
13469,to,0,0
13470,latanoprost,0,0
13471,",",0,0
13472,50,0,0
13473,microg/ml,0,0
13474,once,0,0
13475,daily,0,0
13476,",",0,0
13477,and,0,0
13478,a,0,0
13479,third,0,1
13480,group,0,0
13481,received,0,0
13482,latanoprost,0,0
13483,in,0,0
13484,addition,0,0
13485,to,0,1
13486,timolol,0,0
13487,.,0,0
13488,The,0,0
13489,efficacy,0,0
13490,was,0,0
13491,evaluated,0,0
13492,by,0,0
13493,comparing,0,0
13494,IOP,0,1
13495,at,0,1
13496,9,0,0
13497,AM,0,1
13498,at,0,1
13499,baseline,0,0
13500,and,0,1
13501,after,0,1
13502,6,0,1
13503,weeks,0,1
13504,of,0,1
13505,treatment,0,1
13506,.,0,1
13507,RESULTS,0,0
13508,IOP,0,1
13509,at,0,1
13510,baseline,0,0
13511,and,0,1
13512,after,0,1
13513,6,0,1
13514,weeks,0,1
13515,of,0,1
13516,treatment,0,1
13517,(,0,1
13518,mean,0,1
13519,+/-,0,0
13520,SEM,0,1
13521,),0,1
13522,were,0,1
13523,24.2,0,1
13524,+/-,0,1
13525,0.9,0,0
13526,and,0,1
13527,23.8,0,1
13528,+/-,0,0
13529,1.0,0,0
13530,mmHg,0,0
13531,(,0,1
13532,n,0,1
13533,=,0,1
13534,16,0,1
13535,),0,1
13536,for,0,1
13537,patients,0,1
13538,continuing,0,1
13539,on,0,0
13540,timolol,0,0
13541,",",0,1
13542,26.3,0,0
13543,+/-,0,0
13544,1.2,0,1
13545,and,0,1
13546,19.6,0,1
13547,+/-,0,0
13548,1.1,0,0
13549,mmHg,0,0
13550,(,0,1
13551,n,0,1
13552,=,0,1
13553,17,0,1
13554,),0,1
13555,for,0,1
13556,patients,0,1
13557,switching,0,1
13558,to,0,0
13559,latanoprost,0,0
13560,",",0,0
13561,and,0,0
13562,23.2,0,1
13563,+/-,0,1
13564,1.0,0,0
13565,and,0,1
13566,17.5,0,0
13567,+/-,0,0
13568,0.8,0,1
13569,mmHg,0,0
13570,(,0,1
13571,n,0,1
13572,=,0,1
13573,17,0,1
13574,),0,1
13575,for,0,1
13576,patients,0,1
13577,with,0,1
13578,combined,0,1
13579,treatment,0,1
13580,.,0,1
13581,Adding,0,0
13582,latanoprost,0,0
13583,to,0,0
13584,timolol,0,0
13585,reduced,0,0
13586,IOP,0,1
13587,with,0,1
13588,5.9,0,1
13589,+/-,0,1
13590,0.9,0,0
13591,mmHg,0,0
13592,(,0,1
13593,p,0,0
13594,<,0,0
13595,0.001,0,0
13596,),0,1
13597,and,0,0
13598,switching,0,0
13599,from,0,1
13600,timolol,0,0
13601,to,0,0
13602,latanoprost,0,0
13603,reduced,0,0
13604,IOP,0,1
13605,with,0,1
13606,5.0,0,0
13607,+/-,0,1
13608,0.9,0,0
13609,mmHg,0,0
13610,(,0,1
13611,p,0,0
13612,<,0,0
13613,0.001,0,0
13614,),0,1
13615,",",0,0
13616,which,0,0
13617,caused,0,0
13618,in,0,0
13619,each,0,0
13620,group,0,0
13621,a,0,0
13622,significant,0,0
13623,IOP,0,1
13624,reduction,0,0
13625,of,0,0
13626,about,0,0
13627,25,0,1
13628,%,0,0
13629,.,0,1
13630,CONCLUSIONS,0,0
13631,The,0,0
13632,effect,0,0
13633,of,0,0
13634,latanoprost,0,0
13635,was,0,0
13636,additive,0,0
13637,to,0,0
13638,that,0,0
13639,of,0,0
13640,timolol,0,0
13641,",",0,0
13642,and,0,0
13643,a,0,0
13644,good,0,0
13645,effect,0,0
13646,on,0,0
13647,IOP,0,1
13648,reduction,0,0
13649,was,0,0
13650,also,0,0
13651,achieved,0,0
13652,by,0,0
13653,switching,0,0
13654,from,0,1
13655,timolol,0,0
13656,to,0,0
13657,latanoprost,0,0
13658,",",0,0
13659,suggesting,0,0
13660,that,0,0
13661,a,0,1
13662,switch,0,0
13663,in,0,0
13664,many,0,1
13665,patients,0,1
13666,is,0,0
13667,an,0,0
13668,effective,0,0
13669,alternative,0,0
13670,to,0,1
13671,combination,0,0
13672,treatment,0,1
13673,.,0,1
13674,Brief,0,1
13675,report,0,1
13676,:,0,1
13677,case,0,1
13678,reports,0,1
13679,on,0,0
13680,naltrexone,0,1
13681,use,0,0
13682,in,0,0
13683,children,1,1
13684,with,1,1
13685,autism,1,1
13686,:,1,1
13687,controlled,0,0
13688,observations,0,0
13689,regarding,0,0
13690,benefits,0,0
13691,and,0,1
13692,practical,0,0
13693,issues,0,0
13694,of,0,1
13695,medication,0,1
13696,management,0,1
13697,.,0,1
13698,Comparison,0,0
13699,of,0,0
13700,enoxaparin,0,0
13701,and,0,1
13702,standard,0,1
13703,heparin,0,0
13704,in,0,1
13705,gynaecologic,1,1
13706,oncologic,1,1
13707,surgery,1,1
13708,:,1,1
13709,a,0,1
13710,randomised,0,0
13711,prospective,0,1
13712,double-blind,0,1
13713,clinical,0,0
13714,study,0,1
13715,.,0,1
13716,OBJECTIVE,0,0
13717,This,0,0
13718,study,0,0
13719,aimed,0,0
13720,to,0,0
13721,compare,0,0
13722,the,0,0
13723,haemorrhagic,0,0
13724,complications,0,0
13725,and,0,1
13726,efficacy,0,0
13727,of,0,0
13728,enoxaparin,0,0
13729,",",0,0
13730,a,0,0
13731,low,0,0
13732,molecular,0,0
13733,weight,0,1
13734,heparin,0,0
13735,(,0,1
13736,LMWH,0,0
13737,),0,1
13738,",",0,0
13739,and,0,0
13740,conventional,0,1
13741,standard,0,1
13742,heparin,0,0
13743,(,0,1
13744,SH,0,1
13745,),0,1
13746,in,0,0
13747,gynaecological,1,1
13748,oncologic,1,1
13749,surgery,1,1
13750,.,1,1
13751,MATERIALS,0,0
13752,METHODS,0,0
13753,A,0,1
13754,double,0,0
13755,blind,0,1
13756,",",0,0
13757,randomised,0,0
13758,trial,0,0
13759,was,0,0
13760,performed,0,0
13761,on,0,0
13762,102,1,1
13763,consecutive,1,1
13764,women,1,1
13765,undergoing,1,1
13766,gynaecologic,1,1
13767,cancer,1,1
13768,surgery,1,1
13769,with,1,1
13770,pelvic,1,1
13771,and,1,1
13772,paraaortic,1,1
13773,lymphadenectomy,1,1
13774,.,1,1
13775,The,0,0
13776,women,0,1
13777,were,0,1
13778,separated,0,1
13779,into,0,1
13780,those,0,1
13781,who,0,1
13782,were,0,1
13783,given,0,1
13784,"2,500",0,1
13785,IU,0,0
13786,enoxaparin,0,0
13787,once,0,0
13788,daily,0,0
13789,and,0,0
13790,SH,0,1
13791,in,0,0
13792,a,0,0
13793,dose,0,0
13794,of,0,0
13795,"5,000",0,1
13796,IU,0,0
13797,three,0,1
13798,times,0,0
13799,daily,0,0
13800,.,0,1
13801,The,0,0
13802,groups,0,0
13803,were,0,1
13804,analysed,0,1
13805,for,0,0
13806,intraoperative,0,0
13807,blood,0,0
13808,loss,0,0
13809,",",0,0
13810,drainage,0,1
13811,",",0,0
13812,transfusion,0,0
13813,requirements,0,0
13814,",",0,1
13815,perioperative,0,0
13816,haemoglobin,0,0
13817,decrease,0,0
13818,",",0,0
13819,wound,0,0
13820,haematoma,0,0
13821,",",0,0
13822,and,0,0
13823,clinical,0,0
13824,deep,0,1
13825,venous,0,1
13826,thrombosis,0,1
13827,.,0,1
13828,RESULTS,0,0
13829,The,1,0
13830,two,1,0
13831,groups,1,0
13832,were,1,1
13833,well,1,0
13834,matched,1,1
13835,for,1,0
13836,age,1,1
13837,",",1,0
13838,weight,1,0
13839,",",1,0
13840,and,1,0
13841,other,1,0
13842,factors,1,0
13843,",",0,0
13844,which,0,0
13845,could,0,0
13846,predispose,0,1
13847,to,0,0
13848,the,0,0
13849,development,0,0
13850,of,0,0
13851,deep,0,1
13852,venous,0,1
13853,thrombosis,0,1
13854,(,0,1
13855,DVT,0,1
13856,),0,1
13857,and,0,1
13858,haemorrhage,0,1
13859,.,0,1
13860,No,0,0
13861,patient,0,0
13862,developed,0,1
13863,clinical,0,0
13864,significant,0,0
13865,DVT,0,1
13866,",",0,0
13867,wound,0,0
13868,haematoma,0,0
13869,or,0,1
13870,intra-abdominal,0,1
13871,bleeding,0,0
13872,.,0,0
13873,There,0,0
13874,was,0,0
13875,no,0,0
13876,significant,0,0
13877,difference,0,0
13878,in,0,1
13879,bleeding,0,1
13880,complications,0,0
13881,between,0,0
13882,the,0,1
13883,two,0,1
13884,regimens,0,0
13885,.,0,1
13886,The,0,0
13887,antiFXa,0,0
13888,level,0,0
13889,in,0,0
13890,the,0,0
13891,plasma,0,0
13892,was,0,0
13893,correlated,0,0
13894,strongly,0,0
13895,with,0,1
13896,patient,0,1
13897,weight,0,1
13898,.,0,1
13899,CONCLUSIONS,0,0
13900,A,0,0
13901,dose,0,0
13902,of,0,1
13903,"2,500",0,1
13904,IU,0,0
13905,enoxaparin/day,0,0
13906,does,0,0
13907,not,0,0
13908,cause,0,0
13909,more,0,0
13910,bleeding,0,0
13911,complications,0,0
13912,than,0,1
13913,SH,0,1
13914,"5,000",0,1
13915,IU,0,0
13916,three,0,1
13917,times,0,0
13918,daily,0,0
13919,when,0,0
13920,used,0,0
13921,to,0,0
13922,prevent,0,0
13923,thrombosis,0,1
13924,.,0,0
13925,However,0,0
13926,",",0,0
13927,the,0,0
13928,dose,0,0
13929,of,0,0
13930,enoxaparin,0,0
13931,must,0,0
13932,be,0,0
13933,adjusted,0,0
13934,to,0,0
13935,the,0,0
13936,patient,0,0
13937,'s,0,1
13938,weight,0,1
13939,.,0,1
13940,Children,1,1
13941,'s,1,1
13942,attitudes,1,0
13943,and,1,1
13944,behavioral,1,1
13945,intentions,1,0
13946,toward,1,0
13947,a,1,1
13948,peer,1,1
13949,with,1,1
13950,autistic,1,1
13951,behaviors,1,0
13952,:,1,1
13953,does,0,0
13954,a,0,0
13955,brief,0,0
13956,educational,0,0
13957,intervention,0,0
13958,have,0,0
13959,an,0,0
13960,effect,0,0
13961,?,0,0
13962,This,0,0
13963,study,0,0
13964,examined,0,0
13965,children,1,1
13966,'s,1,1
13967,ratings,1,0
13968,of,1,1
13969,attitudes,1,1
13970,and,1,1
13971,behavioral,1,1
13972,intentions,1,0
13973,toward,1,0
13974,a,1,1
13975,peer,1,1
13976,presented,1,1
13977,with,1,1
13978,or,1,1
13979,without,1,1
13980,autistic,1,1
13981,behaviors,1,0
13982,.,1,1
13983,The,0,0
13984,impact,0,0
13985,of,0,0
13986,information,0,0
13987,about,0,0
13988,autism,0,1
13989,on,0,0
13990,these,0,0
13991,ratings,0,0
13992,was,0,0
13993,investigated,0,0
13994,as,0,0
13995,well,0,0
13996,as,0,0
13997,age,0,1
13998,and,0,1
13999,gender,0,1
14000,effects,0,0
14001,.,0,1
14002,Third-,1,1
14003,and,1,0
14004,sixth-grade,1,1
14005,children,1,1
14006,(,1,1
14007,N,1,1
14008,=,1,1
14009,233,1,1
14010,),1,1
14011,were,0,1
14012,randomly,0,1
14013,assigned,0,1
14014,to,0,0
14015,view,0,0
14016,a,0,0
14017,video,0,0
14018,of,0,0
14019,the,0,0
14020,same,0,0
14021,boy,0,1
14022,in,0,1
14023,one,0,1
14024,of,0,1
14025,three,0,1
14026,conditions,0,1
14027,:,0,1
14028,No,0,0
14029,Autism,0,1
14030,",",0,0
14031,Autism,0,1
14032,",",0,0
14033,or,0,1
14034,Autism/Information,0,1
14035,.,0,1
14036,Children,0,1
14037,at,0,0
14038,both,0,0
14039,grade,0,1
14040,levels,0,0
14041,showed,0,0
14042,less,0,0
14043,positive,0,0
14044,attitudes,0,0
14045,toward,0,0
14046,the,0,0
14047,child,0,1
14048,in,0,0
14049,the,0,0
14050,two,0,0
14051,autism,0,1
14052,conditions,0,1
14053,.,0,1
14054,In,0,0
14055,rating,0,0
14056,their,0,1
14057,own,0,1
14058,behavioral,0,1
14059,intentions,0,1
14060,",",0,1
14061,children,0,1
14062,showed,0,0
14063,no,0,0
14064,differences,0,0
14065,between,0,0
14066,conditions,0,1
14067,.,0,1
14068,However,0,0
14069,",",0,0
14070,in,0,0
14071,attributing,0,0
14072,intentions,0,1
14073,to,0,1
14074,their,0,1
14075,classmates,0,1
14076,",",0,1
14077,older,0,1
14078,children,0,1
14079,and,0,1
14080,girls,0,1
14081,gave,0,0
14082,lower,0,1
14083,ratings,0,0
14084,to,0,0
14085,the,0,0
14086,child,0,1
14087,in,0,0
14088,the,0,0
14089,autism,0,1
14090,conditions,0,1
14091,.,0,1
14092,Information,0,0
14093,about,0,0
14094,autism,0,1
14095,did,0,0
14096,not,0,0
14097,affect,0,0
14098,ratings,0,0
14099,of,0,1
14100,either,0,1
14101,attitudes,0,0
14102,or,0,1
14103,behavioral,0,1
14104,intentions,0,0
14105,as,0,1
14106,ascribed,0,0
14107,to,0,0
14108,self,0,1
14109,or,0,1
14110,others,0,1
14111,.,0,1
14112,Recurrent,0,1
14113,epithelial,0,1
14114,ovarian,0,1
14115,carcinoma,0,1
14116,:,0,1
14117,a,0,0
14118,randomized,0,1
14119,phase,0,1
14120,III,0,1
14121,study,0,1
14122,of,0,0
14123,pegylated,0,0
14124,liposomal,0,0
14125,doxorubicin,0,0
14126,versus,0,0
14127,topotecan,0,0
14128,.,0,1
14129,PURPOSE,0,0
14130,To,0,0
14131,compare,0,0
14132,the,0,0
14133,efficacy,0,0
14134,and,0,0
14135,safety,0,0
14136,of,0,0
14137,pegylated,0,0
14138,liposomal,0,0
14139,doxorubicin,0,1
14140,(,0,1
14141,PLD,0,0
14142,),0,1
14143,and,0,0
14144,topotecan,0,0
14145,in,0,1
14146,patients,1,1
14147,with,1,1
14148,epithelial,1,1
14149,ovarian,1,1
14150,carcinoma,1,1
14151,that,1,0
14152,recurred,1,0
14153,after,1,0
14154,or,1,1
14155,did,1,0
14156,n't,1,0
14157,respond,1,0
14158,to,1,0
14159,first-line,1,0
14160,",",1,0
14161,platinum-based,1,1
14162,chemotherapy,1,1
14163,.,1,1
14164,PATIENTS,0,0
14165,AND,0,0
14166,METHODS,0,0
14167,Patients,1,1
14168,with,1,1
14169,measurable,1,1
14170,and,1,1
14171,assessable,1,1
14172,disease,1,1
14173,were,0,1
14174,randomized,0,1
14175,to,0,0
14176,receive,0,1
14177,either,0,1
14178,PLD,0,0
14179,50,0,1
14180,mg/m,0,1
14181,(,0,1
14182,2,0,1
14183,),0,1
14184,as,0,0
14185,a,0,1
14186,1-hour,0,0
14187,infusion,0,0
14188,every,0,0
14189,4,0,0
14190,weeks,0,0
14191,or,0,1
14192,topotecan,0,0
14193,1.5,0,0
14194,mg/m,0,1
14195,(,0,1
14196,2,0,1
14197,),0,1
14198,/d,0,0
14199,for,0,1
14200,5,0,1
14201,consecutive,0,1
14202,days,0,0
14203,every,0,1
14204,3,0,1
14205,weeks,0,1
14206,.,0,1
14207,Patients,0,1
14208,were,0,0
14209,stratified,0,1
14210,prospectively,0,1
14211,for,0,0
14212,platinum,0,0
14213,sensitivity,0,0
14214,and,0,0
14215,for,0,0
14216,the,0,0
14217,presence,0,0
14218,or,0,0
14219,absence,0,0
14220,of,0,0
14221,bulky,0,1
14222,disease,0,1
14223,.,0,1
14224,RESULTS,0,0
14225,A,1,0
14226,total,1,1
14227,of,1,0
14228,474,1,1
14229,patients,1,1
14230,were,1,1
14231,treated,1,1
14232,(,1,1
14233,239,1,1
14234,PLD,1,1
14235,and,1,1
14236,235,1,1
14237,topotecan,1,0
14238,),1,1
14239,.,1,1
14240,They,0,0
14241,comprised,0,1
14242,the,0,0
14243,intent-to-treat,0,0
14244,population,0,1
14245,.,0,1
14246,The,0,0
14247,overall,0,0
14248,progression-free,0,0
14249,survival,0,0
14250,rates,0,0
14251,were,0,1
14252,similar,0,0
14253,between,0,0
14254,the,0,1
14255,two,0,1
14256,arms,0,0
14257,(,0,1
14258,P,0,0
14259,=.095,0,0
14260,),0,1
14261,.,0,1
14262,The,0,0
14263,overall,0,0
14264,response,0,0
14265,rates,0,0
14266,for,0,1
14267,PLD,0,1
14268,and,0,1
14269,topotecan,0,0
14270,were,0,1
14271,19.7,0,1
14272,%,0,0
14273,and,0,1
14274,17.0,0,0
14275,%,0,0
14276,",",0,0
14277,respectively,0,0
14278,(,0,0
14279,P,0,0
14280,=.390,0,0
14281,),0,1
14282,.,0,1
14283,Median,0,0
14284,overall,0,0
14285,survival,0,0
14286,times,0,0
14287,were,0,1
14288,60,0,1
14289,weeks,0,0
14290,for,0,1
14291,PLD,0,1
14292,and,0,1
14293,56.7,0,1
14294,weeks,0,0
14295,for,0,1
14296,topotecan,0,0
14297,.,0,1
14298,Data,0,0
14299,analyzed,0,0
14300,in,0,1
14301,platinum-sensitive,0,1
14302,patients,0,1
14303,demonstrated,0,0
14304,a,0,1
14305,statistically,0,0
14306,significant,0,0
14307,benefit,0,0
14308,from,0,1
14309,PLD,0,0
14310,for,0,1
14311,progression-free,0,0
14312,survival,0,0
14313,(,0,1
14314,P,0,0
14315,=.037,0,0
14316,),0,0
14317,",",0,0
14318,with,0,1
14319,medians,0,0
14320,of,0,1
14321,28.9,0,1
14322,for,0,0
14323,PLD,0,1
14324,versus,0,0
14325,23.3,0,0
14326,weeks,0,0
14327,for,0,1
14328,topotecan,0,0
14329,.,0,1
14330,For,0,0
14331,overall,0,0
14332,survival,0,0
14333,",",0,1
14334,PLD,0,0
14335,was,0,0
14336,significantly,0,0
14337,superior,0,0
14338,to,0,0
14339,topotecan,0,0
14340,(,0,1
14341,P,0,0
14342,=.008,0,0
14343,),0,0
14344,",",0,0
14345,with,0,1
14346,a,0,0
14347,median,0,0
14348,of,0,0
14349,108,0,1
14350,weeks,0,1
14351,versus,0,0
14352,71.1,0,1
14353,weeks,0,0
14354,.,0,1
14355,The,0,0
14356,platinum-refractory,0,1
14357,subgroup,0,0
14358,demonstrated,0,0
14359,a,0,0
14360,nonstatistically,0,0
14361,significant,0,0
14362,survival,0,0
14363,trend,0,0
14364,in,0,0
14365,favor,0,0
14366,of,0,1
14367,topotecan,0,0
14368,(,0,1
14369,P,0,0
14370,=.455,0,0
14371,),0,1
14372,.,0,1
14373,Severe,0,1
14374,hematologic,0,1
14375,toxicity,0,0
14376,was,0,0
14377,more,0,0
14378,common,0,0
14379,with,0,1
14380,topotecan,0,0
14381,and,0,0
14382,was,0,0
14383,more,0,0
14384,likely,0,0
14385,to,0,0
14386,be,0,0
14387,associated,0,0
14388,with,0,1
14389,dosage,0,0
14390,modification,0,0
14391,",",0,0
14392,or,0,1
14393,growth,0,0
14394,factor,0,0
14395,or,0,1
14396,blood,0,0
14397,product,0,0
14398,utilization,0,0
14399,.,0,0
14400,CONCLUSION,0,0
14401,The,0,0
14402,comparable,0,0
14403,efficacy,0,0
14404,",",0,0
14405,favorable,0,0
14406,safety,0,0
14407,profile,0,0
14408,",",0,0
14409,and,0,0
14410,convenient,0,0
14411,dosing,0,0
14412,support,0,0
14413,the,0,0
14414,role,0,0
14415,of,0,0
14416,PLD,0,0
14417,as,0,0
14418,a,0,1
14419,valuable,0,0
14420,treatment,0,0
14421,option,0,0
14422,in,0,0
14423,this,0,0
14424,patient,0,1
14425,population,0,1
14426,.,0,1
14427,Olanzapine,0,1
14428,versus,0,0
14429,haloperidol,0,0
14430,in,0,0
14431,children,1,1
14432,with,1,1
14433,autistic,1,1
14434,disorder,1,1
14435,:,1,1
14436,an,0,0
14437,open,0,1
14438,pilot,0,0
14439,study,0,1
14440,.,0,1
14441,OBJECTIVES,0,0
14442,Conventional,0,1
14443,neuroleptics,0,1
14444,ameliorate,0,0
14445,symptoms,0,1
14446,in,0,1
14447,children,1,1
14448,with,1,1
14449,autistic,1,1
14450,disorder,1,1
14451,;,1,0
14452,however,0,0
14453,",",0,0
14454,they,0,0
14455,are,0,0
14456,known,0,0
14457,to,0,0
14458,cause,0,0
14459,dyskinesias,0,1
14460,.,0,1
14461,Atypical,0,1
14462,neuroleptics,0,1
14463,",",0,1
14464,including,0,0
14465,olanzapine,0,0
14466,",",0,0
14467,may,0,0
14468,have,0,0
14469,less,0,0
14470,risk,0,0
14471,for,0,0
14472,dyskinesia,0,1
14473,",",0,0
14474,but,0,0
14475,their,0,0
14476,efficacy,0,0
14477,in,0,0
14478,autistic,0,1
14479,disorder,0,1
14480,is,0,0
14481,not,0,0
14482,established,0,0
14483,.,0,0
14484,This,0,0
14485,study,0,0
14486,was,0,0
14487,designed,0,0
14488,to,0,0
14489,investigate,0,0
14490,the,0,0
14491,safety,0,0
14492,and,0,0
14493,effectiveness,0,0
14494,of,0,0
14495,open-label,0,1
14496,olanzapine,0,0
14497,as,0,0
14498,a,0,0
14499,treatment,0,0
14500,for,0,0
14501,children,1,1
14502,with,1,1
14503,autistic,1,1
14504,disorder,1,1
14505,by,0,0
14506,using,0,0
14507,haloperidol,0,0
14508,as,0,0
14509,a,0,1
14510,standard,0,1
14511,comparator,0,0
14512,treatment,0,1
14513,.,0,1
14514,METHOD,0,0
14515,In,0,0
14516,a,0,1
14517,parallel,1,0
14518,groups,1,0
14519,design,1,1
14520,",",1,1
14521,12,1,1
14522,children,1,1
14523,with,1,1
14524,DSM-IV,1,1
14525,autistic,1,1
14526,disorder,1,1
14527,(,1,1
14528,mean,1,1
14529,age,1,1
14530,7.8+/-2.1,1,1
14531,years,1,1
14532,),1,1
14533,were,1,1
14534,randomized,1,1
14535,to,0,1
14536,6,0,1
14537,weeks,0,0
14538,of,0,1
14539,open,0,1
14540,treatment,0,1
14541,with,0,1
14542,olanzapine,0,0
14543,or,0,1
14544,haloperidol,0,0
14545,.,0,1
14546,Mean,0,1
14547,final,0,0
14548,dosages,0,0
14549,were,0,1
14550,7.9+/-2.5,0,0
14551,mg/day,0,0
14552,for,0,0
14553,olanzapine,0,0
14554,and,0,1
14555,1.4+/-0.7,0,1
14556,mg/day,0,0
14557,for,0,1
14558,haloperidol,0,0
14559,.,0,1
14560,Outcome,0,0
14561,measures,0,0
14562,included,0,1
14563,the,0,0
14564,Clinical,0,0
14565,Global,0,1
14566,Impressions,0,0
14567,(,0,1
14568,CGI,0,1
14569,),0,1
14570,and,0,0
14571,the,0,0
14572,Children,0,1
14573,'s,0,1
14574,Psychiatric,0,1
14575,Rating,0,0
14576,Scale,0,1
14577,(,0,1
14578,CPRS,0,0
14579,),0,1
14580,.,0,1
14581,RESULTS,0,0
14582,Both,0,0
14583,groups,0,1
14584,had,0,1
14585,symptom,0,1
14586,reduction,0,0
14587,.,0,1
14588,Five,0,1
14589,of,0,0
14590,six,0,1
14591,in,0,0
14592,the,0,0
14593,olanzapine,0,0
14594,group,0,1
14595,and,0,1
14596,three,0,0
14597,of,0,0
14598,six,0,1
14599,in,0,0
14600,the,0,0
14601,haloperidol,0,0
14602,group,0,0
14603,were,0,0
14604,rated,0,0
14605,as,0,0
14606,responders,0,0
14607,according,0,1
14608,to,0,1
14609,the,0,0
14610,CGI,0,1
14611,Improvement,0,0
14612,item,0,1
14613,.,0,1
14614,Subjects,0,1
14615,showed,0,0
14616,improvement,0,0
14617,on,0,0
14618,the,0,0
14619,CPRS,0,0
14620,Autism,0,1
14621,Factor,0,1
14622,(,0,1
14623,"F1,9",0,1
14624,=,0,1
14625,24.4,0,0
14626,",",0,0
14627,p,0,0
14628,=,0,0
14629,.0008,0,0
14630,),0,1
14631,.,0,1
14632,Side,0,0
14633,effects,0,0
14634,included,0,1
14635,drowsiness,0,0
14636,and,0,0
14637,weight,0,1
14638,gain,0,0
14639,.,0,1
14640,CONCLUSIONS,0,0
14641,The,0,0
14642,findings,0,0
14643,suggest,0,0
14644,that,0,0
14645,olanzapine,0,0
14646,is,0,0
14647,a,0,0
14648,promising,0,0
14649,treatment,0,0
14650,for,0,1
14651,children,1,1
14652,with,1,1
14653,autistic,1,1
14654,disorder,1,1
14655,.,1,1
14656,Further,0,0
14657,placebo-controlled,0,0
14658,and,0,1
14659,long-term,0,0
14660,studies,0,0
14661,of,0,1
14662,olanzapine,0,1
14663,in,0,1
14664,autistic,0,1
14665,disorder,0,1
14666,are,0,0
14667,required,0,0
14668,.,0,1
14669,A,0,0
14670,randomized,0,0
14671,effectiveness,0,0
14672,trial,0,1
14673,of,0,0
14674,collaborative,0,1
14675,care,0,1
14676,for,0,1
14677,patients,1,1
14678,with,1,1
14679,panic,1,1
14680,disorder,1,1
14681,in,1,1
14682,primary,1,1
14683,care,1,1
14684,.,1,1
14685,BACKGROUND,0,0
14686,Effectiveness,0,0
14687,studies,0,0
14688,have,0,1
14689,tested,0,0
14690,interventions,0,0
14691,to,0,1
14692,improve,0,0
14693,quality,0,0
14694,of,0,0
14695,care,0,1
14696,for,0,0
14697,depression,0,1
14698,in,0,1
14699,primary,0,1
14700,care,0,1
14701,",",0,0
14702,but,0,0
14703,none,0,0
14704,",",0,0
14705,to,0,0
14706,our,0,0
14707,knowledge,0,0
14708,",",0,0
14709,have,0,0
14710,been,0,0
14711,completed,0,1
14712,for,0,0
14713,panic,0,1
14714,disorder,0,1
14715,(,0,1
14716,PD,0,1
14717,),0,1
14718,in,0,0
14719,this,0,0
14720,setting,0,1
14721,.,0,0
14722,This,0,0
14723,study,0,0
14724,sought,0,0
14725,to,0,0
14726,test,0,0
14727,the,0,0
14728,clinical,0,0
14729,effectiveness,0,0
14730,of,0,0
14731,PD,0,1
14732,pharmacotherapy,0,1
14733,embedded,0,0
14734,in,0,0
14735,a,0,0
14736,disease,0,1
14737,management,0,0
14738,framework,0,1
14739,of,0,0
14740,collaborative,0,1
14741,care,0,1
14742,(,0,1
14743,CC,0,1
14744,),0,1
14745,.,0,1
14746,METHODS,0,0
14747,One,1,1
14748,hundred,1,1
14749,fifteen,1,1
14750,patients,1,1
14751,with,1,1
14752,PD,1,1
14753,from,1,1
14754,3,1,1
14755,primary,1,1
14756,care,1,1
14757,clinics,1,1
14758,were,0,1
14759,randomized,0,1
14760,to,0,1
14761,CC,0,1
14762,or,0,1
14763,usual,0,1
14764,care,0,1
14765,(,0,1
14766,UC,0,0
14767,),0,1
14768,.,0,1
14769,Patients,0,1
14770,in,0,0
14771,CC,0,1
14772,(,0,1
14773,n,0,1
14774,=,0,1
14775,57,0,1
14776,),0,1
14777,received,0,1
14778,educational,0,1
14779,videotapes,0,0
14780,and,0,1
14781,pamphlets,0,1
14782,;,0,1
14783,pharmacotherapy,0,1
14784,with,0,1
14785,the,0,0
14786,selective,0,1
14787,serotonin,0,0
14788,reuptake,0,0
14789,inhibitor,0,0
14790,paroxetine,0,0
14791,;,0,1
14792,2,0,1
14793,psychiatrist,0,1
14794,visits,0,1
14795,and,0,1
14796,2,0,1
14797,telephone,0,1
14798,calls,0,0
14799,in,0,1
14800,the,0,1
14801,first,0,1
14802,8,0,1
14803,weeks,0,1
14804,;,0,1
14805,and,0,1
14806,up,0,1
14807,to,0,0
14808,5,0,0
14809,telephone,0,1
14810,calls,0,1
14811,between,0,1
14812,3,0,1
14813,and,0,1
14814,12,0,1
14815,months,0,0
14816,',0,1
14817,follow-up,0,1
14818,.,0,1
14819,Usual,0,0
14820,care,0,1
14821,patients,0,1
14822,(,0,1
14823,n,0,1
14824,=,0,1
14825,58,0,1
14826,),0,1
14827,were,0,1
14828,treated,0,1
14829,by,0,0
14830,their,0,1
14831,primary,0,1
14832,care,0,1
14833,physician,0,1
14834,.,0,1
14835,Telephone,0,1
14836,assessments,0,0
14837,of,0,1
14838,panic,0,1
14839,",",0,0
14840,anxiety,0,0
14841,sensitivity,0,0
14842,",",0,0
14843,depression,0,1
14844,",",0,0
14845,and,0,0
14846,disability,0,1
14847,variables,0,0
14848,were,0,1
14849,performed,0,0
14850,at,0,0
14851,3,0,1
14852,",",0,1
14853,6,0,0
14854,",",0,0
14855,9,0,0
14856,",",0,0
14857,and,0,1
14858,12,0,1
14859,months,0,0
14860,',0,1
14861,follow-up,0,1
14862,.,0,1
14863,Adequacy,0,0
14864,of,0,0
14865,pharmacotherapy,0,1
14866,was,0,0
14867,assessed,0,0
14868,with,0,1
14869,an,0,0
14870,algorithm,0,0
14871,based,0,1
14872,on,0,0
14873,a,0,0
14874,review,0,0
14875,of,0,0
14876,efficacy,0,0
14877,studies,0,0
14878,.,0,1
14879,RESULTS,0,0
14880,Patients,0,1
14881,in,0,1
14882,CC,0,1
14883,were,0,0
14884,more,0,0
14885,likely,0,0
14886,to,0,0
14887,receive,0,1
14888,adequate,0,0
14889,(,0,0
14890,type,0,1
14891,",",0,0
14892,dose,0,0
14893,",",0,0
14894,duration,0,0
14895,),0,1
14896,medication,0,0
14897,and,0,0
14898,more,0,0
14899,likely,0,0
14900,to,0,0
14901,adhere,0,0
14902,to,0,0
14903,this,0,0
14904,medication,0,0
14905,at,0,0
14906,3,0,1
14907,and,0,1
14908,6,0,1
14909,months,0,1
14910,.,0,1
14911,Random,0,1
14912,regression,0,0
14913,analyses,0,0
14914,showed,0,0
14915,that,0,0
14916,CC,0,1
14917,patients,0,1
14918,improved,0,0
14919,significantly,0,0
14920,more,0,0
14921,over,0,0
14922,time,0,0
14923,compared,0,0
14924,with,0,1
14925,UC,0,0
14926,patients,0,1
14927,on,0,0
14928,anxiety,0,1
14929,",",0,0
14930,depression,0,1
14931,",",0,0
14932,and,0,0
14933,disability,0,1
14934,measures,0,0
14935,",",0,0
14936,with,0,1
14937,the,0,0
14938,greatest,0,0
14939,effects,0,0
14940,at,0,1
14941,3,0,1
14942,and,0,1
14943,6,0,1
14944,months,0,1
14945,.,0,1
14946,CONCLUSIONS,0,0
14947,Compared,0,0
14948,with,0,1
14949,UC,0,0
14950,",",0,1
14951,CC,0,1
14952,interventions,0,0
14953,significantly,0,0
14954,improved,0,0
14955,both,0,0
14956,quality,0,0
14957,of,0,0
14958,care,0,1
14959,and,0,1
14960,clinical,0,0
14961,and,0,1
14962,functional,0,1
14963,outcomes,0,0
14964,in,0,1
14965,primary,1,1
14966,care,1,1
14967,PD,1,1
14968,patients,1,1
14969,.,1,1
14970,Clinical,0,0
14971,differences,0,0
14972,were,0,1
14973,greatest,0,0
14974,in,0,0
14975,the,0,0
14976,first,0,1
14977,6,0,0
14978,months,0,0
14979,",",0,1
14980,corresponding,0,0
14981,to,0,0
14982,the,0,0
14983,greater,0,0
14984,quality,0,0
14985,of,0,0
14986,care,0,1
14987,and,0,0
14988,the,0,0
14989,greater,0,0
14990,intensity,0,0
14991,of,0,0
14992,intervention,0,1
14993,.,0,1
14994,Dipyridamole,0,0
14995,in,0,1
14996,chronic,1,1
14997,stable,1,1
14998,angina,1,1
14999,pectoris,1,1
15000,;,1,0
15001,a,0,0
15002,randomized,0,0
15003,",",0,0
15004,double,0,0
15005,blind,0,1
15006,",",0,0
15007,placebo-controlled,0,0
15008,",",0,0
15009,parallel,0,0
15010,group,0,1
15011,study,0,1
15012,.,0,1
15013,BACKGROUND,0,0
15014,Oral,0,1
15015,dipyridamole,0,0
15016,induces,0,0
15017,accumulation,0,1
15018,of,0,1
15019,endogenous,0,0
15020,adenosine,0,0
15021,",",0,0
15022,which,0,0
15023,in,0,0
15024,a,0,0
15025,hypoxic,0,0
15026,milieu,0,0
15027,exerts,0,0
15028,experimentally,0,0
15029,an,0,0
15030,angiogenic,0,0
15031,effect,0,0
15032,on,0,0
15033,coronary,0,1
15034,collateral,0,1
15035,circulation,0,0
15036,.,0,1
15037,A,0,0
15038,meta-analysis,0,0
15039,of,0,0
15040,13,0,1
15041,randomized,0,1
15042,placebo-controlled,0,1
15043,trials,0,1
15044,published,0,1
15045,between,0,1
15046,1960,0,1
15047,and,0,1
15048,1992,0,1
15049,showed,0,0
15050,evidence,0,0
15051,of,0,0
15052,benefit,0,0
15053,for,0,0
15054,dipyridamole,0,0
15055,in,0,0
15056,the,0,0
15057,treatment,0,0
15058,of,0,0
15059,angina,0,1
15060,pectoris,0,1
15061,",",0,0
15062,especially,0,0
15063,with,0,1
15064,longer,0,0
15065,duration,0,0
15066,of,0,0
15067,treatment,0,1
15068,.,0,1
15069,Aim,0,0
15070,To,0,0
15071,assess,0,0
15072,the,0,0
15073,efficacy,0,0
15074,and,0,0
15075,safety,0,0
15076,of,0,0
15077,dipyridamole,0,0
15078,in,0,0
15079,the,0,0
15080,treatment,0,0
15081,of,0,0
15082,patients,1,1
15083,with,1,1
15084,chronic,1,1
15085,stable,1,1
15086,angina,1,1
15087,in,1,0
15088,a,1,1
15089,large,1,1
15090,scale,1,0
15091,",",1,0
15092,international,1,1
15093,",",0,0
15094,randomized,0,1
15095,",",0,0
15096,placebo-controlled,0,0
15097,",",0,0
15098,parallel,0,0
15099,group,0,1
15100,study,0,1
15101,.,0,1
15102,METHODS,0,0
15103,Four,1,1
15104,hundred,1,1
15105,patients,1,1
15106,with,1,1
15107,chronic,1,1
15108,stable,1,1
15109,angina,1,1
15110,pectoris,1,1
15111,and,1,0
15112,a,1,0
15113,positive,1,0
15114,treadmill,1,0
15115,exercise,1,0
15116,test,1,0
15117,were,1,1
15118,randomized,1,1
15119,to,0,0
15120,receive,0,1
15121,either,0,0
15122,modified,0,0
15123,release,0,0
15124,dipyridamole,0,0
15125,(,0,1
15126,200,0,1
15127,mg,0,1
15128,b.i.d,0,1
15129,.,0,1
15130,p.o.,0,0
15131,",",0,0
15132,n=198,0,1
15133,),0,1
15134,or,0,1
15135,corresponding,0,0
15136,placebo,0,0
15137,(,0,1
15138,n=202,0,1
15139,),0,1
15140,",",0,1
15141,for,0,1
15142,24,0,1
15143,weeks,0,0
15144,as,0,0
15145,an,0,1
15146,add-on,0,1
15147,to,0,1
15148,conventional,0,1
15149,antianginal,0,1
15150,therapy,0,0
15151,and,0,1
15152,for,0,1
15153,4,0,1
15154,additional,0,1
15155,weeks,0,1
15156,as,0,1
15157,monotherapy,0,1
15158,--,0,1
15159,the,0,0
15160,latter,0,0
15161,after,0,0
15162,withdrawal,0,0
15163,of,0,0
15164,standard,0,1
15165,treatment,0,1
15166,with,0,1
15167,calcium,0,0
15168,antagonists,0,0
15169,and/or,0,1
15170,beta-blockers,0,0
15171,and/or,0,1
15172,long-acting,0,1
15173,(,0,1
15174,prophylactic,0,1
15175,),0,1
15176,nitrates,0,0
15177,.,0,1
15178,RESULTS,0,0
15179,Of,0,1
15180,the,0,1
15181,198,1,1
15182,patients,1,1
15183,randomized,0,1
15184,to,0,0
15185,dipyridamole,0,0
15186,",",0,0
15187,134,0,1
15188,completed,0,1
15189,the,0,0
15190,add-on,0,0
15191,and,0,0
15192,only,0,0
15193,12,0,0
15194,the,0,0
15195,monotherapy,0,1
15196,phase,0,1
15197,.,0,1
15198,Of,0,0
15199,the,0,0
15200,202,0,1
15201,patients,0,1
15202,randomized,0,1
15203,to,0,0
15204,placebo,0,0
15205,",",0,0
15206,162,0,1
15207,reached,0,0
15208,the,0,0
15209,add-on,0,0
15210,and,0,0
15211,only,0,0
15212,12,0,0
15213,the,0,0
15214,monotherapy,0,1
15215,phase,0,1
15216,.,0,1
15217,Serious,0,0
15218,adverse,0,0
15219,events,0,0
15220,occurred,0,0
15221,in,0,1
15222,15,0,1
15223,patients,0,1
15224,with,0,1
15225,dipyridamole,0,0
15226,and,0,1
15227,in,0,1
15228,12,0,1
15229,with,0,1
15230,placebo,0,1
15231,(,0,1
15232,7.6,0,0
15233,%,0,0
15234,vs,0,0
15235,6.0,0,0
15236,",",0,1
15237,P=0.52,0,0
15238,),0,1
15239,.,0,1
15240,Increase,0,0
15241,over,0,0
15242,the,0,0
15243,baseline,0,0
15244,treadmill,0,0
15245,exercise,0,0
15246,test,0,0
15247,was,0,0
15248,similar,0,0
15249,in,0,0
15250,the,0,0
15251,treatment,0,0
15252,groups,0,0
15253,at,0,1
15254,each,0,1
15255,stage,0,1
15256,of,0,0
15257,the,0,0
15258,trial,0,0
15259,for,0,0
15260,all,0,0
15261,the,0,0
15262,main,0,0
15263,efficacy,0,0
15264,parameters,0,0
15265,:,0,1
15266,total,0,1
15267,treadmill,0,0
15268,exercise,0,0
15269,test,0,0
15270,duration,0,0
15271,;,0,1
15272,time,0,0
15273,to,0,1
15274,first,0,0
15275,anginal,0,1
15276,pain,0,1
15277,(,0,1
15278,except,0,0
15279,for,0,0
15280,a,0,1
15281,-13,0,0
15282,s,0,0
15283,difference,0,0
15284,in,0,0
15285,favour,0,0
15286,of,0,0
15287,placebo,0,0
15288,at,0,1
15289,week,0,0
15290,24,0,1
15291,;,0,1
15292,P=0.040,0,0
15293,),0,1
15294,;,0,1
15295,time,0,0
15296,to,0,1
15297,ST,0,1
15298,segment,0,1
15299,depression,0,1
15300,>,0,1
15301,0.1,0,0
15302,mVolt,0,1
15303,(,0,1
15304,except,0,0
15305,for,0,0
15306,a,0,1
15307,+21,0,0
15308,s,0,0
15309,difference,0,0
15310,in,0,0
15311,favour,0,0
15312,of,0,0
15313,dipyridamole,0,0
15314,at,0,1
15315,week,0,0
15316,8,0,1
15317,;,0,1
15318,P=0.024,0,0
15319,;,0,1
15320,this,0,0
15321,latter,0,0
15322,difference,0,0
15323,was,0,0
15324,totally,0,1
15325,attributable,0,0
15326,to,0,1
15327,patients,0,1
15328,with,0,1
15329,lower,0,0
15330,exercise,0,1
15331,tolerance,0,1
15332,--,0,1
15333,Bruce,0,1
15334,stage,0,1
15335,II,0,1
15336,at,0,1
15337,study,0,1
15338,entry,0,1
15339,),0,1
15340,.,0,1
15341,CONCLUSION,0,0
15342,In,0,1
15343,patients,1,1
15344,with,1,1
15345,chronic,1,1
15346,stable,1,1
15347,angina,1,1
15348,treated,1,1
15349,with,1,1
15350,regular,1,1
15351,antianginal,1,1
15352,background,1,0
15353,medication,1,0
15354,",",0,0
15355,the,0,0
15356,use,0,0
15357,of,0,0
15358,oral,0,0
15359,dipyridamole,0,0
15360,is,0,0
15361,safe,0,0
15362,and,0,0
15363,well,0,0
15364,tolerated,0,0
15365,.,0,1
15366,Antianginal,0,0
15367,and,0,0
15368,antiischaemic,0,0
15369,efficacy,0,0
15370,",",0,0
15371,as,0,0
15372,assessed,0,0
15373,by,0,0
15374,exercise,0,0
15375,testing,0,0
15376,",",0,0
15377,is,0,0
15378,comparable,0,0
15379,to,0,0
15380,placebo,0,0
15381,",",0,0
15382,except,0,0
15383,for,0,0
15384,a,0,1
15385,beneficial,0,0
15386,effect,0,0
15387,on,0,0
15388,time,0,0
15389,to,0,0
15390,ischaemia,0,1
15391,after,0,1
15392,2,0,1
15393,months,0,0
15394,",",0,1
15395,totally,0,1
15396,attributable,0,0
15397,to,0,1
15398,patients,0,1
15399,with,0,1
15400,lower,0,0
15401,exercise,0,0
15402,tolerance,0,0
15403,at,0,0
15404,study,0,1
15405,entry,0,1
15406,.,0,1
15407,A,0,0
15408,randomized,0,0
15409,intervention,0,0
15410,to,0,0
15411,improve,0,0
15412,ongoing,0,0
15413,participation,0,0
15414,in,0,1
15415,mammography,1,1
15416,.,1,1
15417,OBJECTIVE,0,0
15418,To,0,0
15419,test,0,0
15420,the,0,0
15421,effectiveness,0,0
15422,of,0,0
15423,interventions,0,0
15424,intended,0,0
15425,to,0,1
15426,increase,0,0
15427,rates,0,0
15428,of,0,0
15429,regular,0,1
15430,breast,0,1
15431,cancer,0,1
15432,screening,0,1
15433,",",0,0
15434,according,0,1
15435,to,0,1
15436,recommended,0,1
15437,guidelines,0,1
15438,.,0,1
15439,STUDY,0,0
15440,DESIGN,0,1
15441,A,0,1
15442,randomized,0,1
15443,controlled,0,0
15444,trial,0,1
15445,of,0,1
15446,2,0,1
15447,outreach,0,1
15448,interventions,0,0
15449,(,0,1
15450,a,0,1
15451,mail,0,0
15452,reminder,0,0
15453,and,0,0
15454,a,0,0
15455,telephone,0,0
15456,reminder,0,0
15457,plus,0,0
15458,appointment,0,1
15459,scheduling,0,0
15460,),0,1
15461,compared,0,0
15462,with,0,1
15463,a,0,1
15464,routine,0,1
15465,publicity,0,1
15466,campaign,0,1
15467,to,0,0
15468,encourage,0,0
15469,continued,0,0
15470,participation,0,0
15471,in,0,0
15472,mammography,0,1
15473,screening,0,1
15474,.,0,1
15475,PARTICIPANTS,0,0
15476,AND,0,0
15477,METHODS,0,0
15478,Participants,1,1
15479,were,1,1
15480,1908,1,1
15481,women,1,1
15482,aged,1,1
15483,50,1,1
15484,to,1,1
15485,75,1,1
15486,years,1,1
15487,continuously,1,0
15488,enrolled,1,1
15489,in,1,0
15490,a,1,1
15491,large,1,1
15492,group-model,1,1
15493,HMO,1,1
15494,during,1,0
15495,the,1,1
15496,study,1,1
15497,who,1,1
15498,underwent,1,1
15499,a,1,1
15500,bilateral,1,0
15501,mammogram,1,1
15502,during,1,0
15503,the,1,0
15504,first,1,0
15505,quarter,1,1
15506,of,1,1
15507,1994,1,1
15508,and,1,1
15509,no,1,0
15510,subsequent,1,0
15511,mammogram,1,1
15512,during,1,0
15513,the,1,0
15514,next,1,1
15515,18,1,1
15516,to,1,1
15517,21,1,1
15518,months,1,1
15519,.,1,1
15520,Data,0,1
15521,were,0,0
15522,obtained,0,0
15523,from,0,1
15524,health,0,1
15525,plan,0,1
15526,administrative,0,1
15527,data,0,1
15528,files,0,1
15529,supplemented,0,0
15530,by,0,0
15531,medical,0,1
15532,chart,0,1
15533,review,0,1
15534,.,0,1
15535,Women,0,1
15536,were,0,0
15537,randomly,0,1
15538,assigned,0,1
15539,to,0,0
15540,receive,0,1
15541,(,0,1
15542,1,0,0
15543,),0,1
15544,a,0,1
15545,mail,0,0
15546,reminder,0,0
15547,",",0,0
15548,(,0,1
15549,2,0,1
15550,),0,1
15551,a,0,1
15552,telephone,0,0
15553,reminder,0,0
15554,",",0,0
15555,or,0,1
15556,(,0,1
15557,3,0,1
15558,),0,1
15559,routine,0,1
15560,publicity,0,1
15561,on,0,0
15562,mammography,0,1
15563,for,0,0
15564,all,0,1
15565,women,0,1
15566,.,0,1
15567,The,0,0
15568,outcome,0,0
15569,measure,0,0
15570,was,0,0
15571,a,0,0
15572,mammogram,0,1
15573,received,0,0
15574,after,0,0
15575,the,0,0
15576,intervention,0,0
15577,period,0,0
15578,and,0,1
15579,within,0,1
15580,2,0,1
15581,years,0,1
15582,of,0,1
15583,the,0,1
15584,initial,0,0
15585,mammogram,0,1
15586,date,0,1
15587,.,0,1
15588,RESULTS,0,0
15589,Bivariate,0,0
15590,and,0,0
15591,multivariate,0,0
15592,statistical,0,0
15593,analyses,0,0
15594,showed,0,0
15595,that,0,0
15596,participation,0,0
15597,was,0,0
15598,significantly,0,0
15599,higher,0,0
15600,for,0,0
15601,women,0,1
15602,contacted,0,1
15603,by,0,0
15604,telephone,0,1
15605,than,0,0
15606,through,0,1
15607,routine,0,1
15608,publicity,0,1
15609,.,0,1
15610,Mail,0,0
15611,reminders,0,0
15612,were,0,0
15613,no,0,0
15614,more,0,0
15615,effective,0,0
15616,than,0,0
15617,a,0,1
15618,routine,0,1
15619,publicity,0,1
15620,campaign,0,1
15621,.,0,1
15622,Primary,0,0
15623,care,0,1
15624,physician,0,1
15625,and,0,1
15626,gynecologist,0,1
15627,visits,0,1
15628,increased,0,0
15629,the,0,0
15630,likelihood,0,0
15631,of,0,0
15632,a,0,1
15633,subsequent,0,0
15634,mammogram,0,1
15635,for,0,1
15636,women,0,1
15637,in,0,1
15638,all,0,1
15639,intervention,0,1
15640,groups,0,0
15641,.,0,1
15642,CONCLUSIONS,0,0
15643,Telephone,0,1
15644,contact,0,0
15645,by,0,0
15646,regular,0,1
15647,health,0,1
15648,plan,0,1
15649,staff,0,0
15650,was,0,0
15651,more,0,0
15652,successful,0,0
15653,than,0,0
15654,publicity,0,1
15655,in,0,0
15656,encouraging,0,0
15657,continued,0,0
15658,participation,0,1
15659,in,0,0
15660,mammography,0,1
15661,screening,0,1
15662,in,0,1
15663,women,0,1
15664,enrolled,0,1
15665,in,0,1
15666,a,0,1
15667,group-model,0,1
15668,managed,0,1
15669,health,0,1
15670,care,0,1
15671,plan,0,0
15672,.,0,1
15673,Because,0,0
15674,mailings,0,0
15675,did,0,0
15676,not,0,0
15677,influence,0,0
15678,participation,0,0
15679,in,0,0
15680,mammography,0,1
15681,screening,0,1
15682,",",0,0
15683,health,0,0
15684,plans,0,0
15685,should,0,0
15686,be,0,0
15687,cautious,0,0
15688,about,0,0
15689,investing,0,0
15690,in,0,1
15691,member,0,1
15692,mailings,0,1
15693,without,0,1
15694,first,0,1
15695,evaluating,0,0
15696,their,0,1
15697,effectiveness,0,0
15698,in,0,0
15699,the,0,0
15700,context,0,0
15701,of,0,0
15702,existing,0,1
15703,outreach,0,1
15704,efforts,0,1
15705,.,0,1
15706,The,0,0
15707,course,0,0
15708,of,0,0
15709,depression,1,1
15710,in,1,1
15711,recent,1,1
15712,onset,1,1
15713,rheumatoid,1,1
15714,arthritis,1,1
15715,:,1,1
15716,the,0,0
15717,predictive,0,0
15718,role,0,0
15719,of,0,0
15720,disability,0,1
15721,",",0,1
15722,illness,0,1
15723,perceptions,0,0
15724,",",0,1
15725,pain,0,1
15726,and,0,0
15727,coping,0,0
15728,.,0,1
15729,BACKGROUND,0,0
15730,This,0,0
15731,study,0,0
15732,aimed,0,0
15733,to,0,0
15734,investigate,0,0
15735,the,0,0
15736,course,0,0
15737,of,0,0
15738,depression,1,1
15739,for,1,1
15740,patients,1,1
15741,with,1,1
15742,recently,1,1
15743,diagnosed,1,1
15744,rheumatoid,1,1
15745,arthritis,1,1
15746,(,1,1
15747,RA,1,1
15748,),1,1
15749,and,1,0
15750,to,1,1
15751,investigate,1,0
15752,predictors,1,0
15753,of,1,0
15754,depression,1,1
15755,.,1,1
15756,METHODS,0,0
15757,Twenty-two,1,1
15758,patients,1,1
15759,with,1,1
15760,a,1,1
15761,history,1,1
15762,of,1,0
15763,recently,1,1
15764,diagnosed,1,1
15765,RA,1,1
15766,of,1,0
15767,less,1,0
15768,than,1,1
15769,2,1,1
15770,years,1,1
15771,were,1,1
15772,assessed,1,0
15773,on,0,0
15774,a,0,0
15775,variety,0,0
15776,of,0,0
15777,clinical,0,0
15778,outcome,0,0
15779,and,0,1
15780,process,0,0
15781,measures,0,0
15782,on,0,1
15783,six,0,1
15784,assessment,0,0
15785,occasions,0,1
15786,over,0,0
15787,a,0,1
15788,21-month,0,1
15789,period,0,0
15790,.,0,1
15791,These,0,1
15792,22,1,1
15793,patients,1,1
15794,constituted,1,1
15795,the,1,0
15796,control,1,0
15797,group,1,0
15798,of,0,0
15799,a,0,0
15800,controlled,0,0
15801,trial,0,0
15802,and,0,0
15803,received,0,1
15804,standard,0,1
15805,outpatient,0,1
15806,clinic,0,1
15807,treatment,0,0
15808,during,0,1
15809,follow-up,0,1
15810,.,0,1
15811,RESULTS,0,0
15812,Patients,1,1
15813,became,1,0
15814,significantly,1,0
15815,more,1,0
15816,depressed,1,0
15817,over,0,0
15818,time,0,0
15819,.,0,1
15820,A,0,0
15821,set,0,0
15822,of,0,0
15823,five,0,1
15824,factors,0,0
15825,were,0,1
15826,found,0,0
15827,to,0,0
15828,consistently,0,0
15829,predict,0,0
15830,depression,0,1
15831,at,0,0
15832,the,0,0
15833,following,0,0
15834,assessment,0,0
15835,.,0,1
15836,These,0,0
15837,were,0,0
15838,initial,0,0
15839,level,0,0
15840,of,0,0
15841,depression,0,1
15842,",",0,0
15843,disability,0,0
15844,",",0,0
15845,pain,0,0
15846,",",0,0
15847,beliefs,0,0
15848,about,0,0
15849,the,0,0
15850,consequences,0,0
15851,of,0,0
15852,arthritis,0,1
15853,and,0,1
15854,coping,0,0
15855,strategies,0,0
15856,.,0,1
15857,CONCLUSIONS,0,0
15858,The,0,0
15859,results,0,0
15860,confirm,0,0
15861,the,0,0
15862,importance,0,0
15863,of,0,0
15864,psychological,0,1
15865,factors,0,0
15866,in,0,1
15867,early,0,1
15868,RA,0,1
15869,and,0,1
15870,their,0,1
15871,relative,0,0
15872,independence,0,0
15873,from,0,1
15874,physical,0,1
15875,findings,0,0
15876,.,0,1
15877,This,0,0
15878,is,0,0
15879,the,0,0
15880,first,0,0
15881,study,0,0
15882,to,0,0
15883,document,0,0
15884,the,0,0
15885,importance,0,0
15886,of,0,0
15887,illness,0,1
15888,perceptions,0,0
15889,in,0,1
15890,recent,0,1
15891,onset,0,1
15892,RA,0,1
15893,.,0,1
15894,Quantitative,0,1
15895,angiographic,0,1
15896,methods,0,1
15897,for,0,1
15898,appropriate,0,1
15899,end-point,0,0
15900,analysis,0,0
15901,",",0,0
15902,edge-effect,0,0
15903,evaluation,0,0
15904,",",0,0
15905,and,0,0
15906,prediction,0,0
15907,of,0,0
15908,recurrent,0,1
15909,restenosis,0,1
15910,after,0,0
15911,coronary,1,1
15912,brachytherapy,1,1
15913,with,1,1
15914,gamma,1,0
15915,irradiation,1,1
15916,.,1,1
15917,OBJECTIVES,0,0
15918,The,0,0
15919,study,0,0
15920,was,0,0
15921,done,0,0
15922,to,0,0
15923,investigate,0,0
15924,the,0,0
15925,relationship,0,0
15926,between,0,0
15927,clinical,0,0
15928,restenosis,0,1
15929,and,0,0
15930,the,0,0
15931,relative,0,0
15932,angiographic,0,0
15933,location,0,1
15934,of,0,0
15935,the,0,0
15936,recurrent,0,1
15937,restenotic,0,1
15938,lesion,0,0
15939,",",0,0
15940,after,0,0
15941,treatment,0,0
15942,of,0,0
15943,in-stent,1,1
15944,restenosis,1,1
15945,with,0,1
15946,vascular,0,0
15947,brachytherapy,0,1
15948,in,0,0
15949,the,0,0
15950,Washington,1,1
15951,Radiation,1,0
15952,for,1,1
15953,In-Stent,1,1
15954,Restenosis,1,1
15955,Trial,1,1
15956,(,1,1
15957,WRIST,1,1
15958,),1,1
15959,.,1,1
15960,BACKGROUND,0,0
15961,Intracoronary,0,0
15962,radiation,0,1
15963,therapy,0,0
15964,reduces,0,0
15965,recurrence,0,0
15966,of,0,0
15967,in-stent,0,1
15968,restenosis,0,1
15969,.,0,1
15970,We,0,0
15971,investigated,0,0
15972,the,0,0
15973,above,0,0
15974,objective,0,0
15975,in,0,1
15976,patients,1,1
15977,enrolled,1,1
15978,in,1,1
15979,WRIST,1,1
15980,.,1,1
15981,METHODS,0,0
15982,The,0,0
15983,WRIST,0,0
15984,study,0,1
15985,randomized,1,1
15986,130,1,1
15987,patients,1,1
15988,to,1,1
15989,double-blinded,1,0
15990,therapy,1,0
15991,with,1,1
15992,gamma,1,0
15993,irradiation,1,1
15994,(,1,1
15995,iridium-192,1,1
15996,[,1,1
15997,(,1,1
15998,192,1,1
15999,),1,1
16000,Ir,1,1
16001,],1,1
16002,),1,1
16003,versus,1,0
16004,placebo,1,0
16005,after,1,0
16006,interventional,1,1
16007,treatment,1,1
16008,of,1,0
16009,diffuse,1,1
16010,in-stent,1,1
16011,restenosis,1,1
16012,.,1,1
16013,After,0,0
16014,the,0,0
16015,intervention,0,0
16016,and,0,0
16017,at,0,0
16018,follow-up,0,0
16019,",",0,1
16020,three,0,0
16021,vessel,0,1
16022,segments,0,1
16023,were,0,1
16024,individually,0,0
16025,analyzed,0,0
16026,with,0,1
16027,quantitative,0,0
16028,coronary,0,1
16029,angiography,0,1
16030,:,0,1
16031,1,0,1
16032,),0,1
16033,the,0,0
16034,stent,0,0
16035,",",0,0
16036,2,0,1
16037,),0,0
16038,the,0,0
16039,radiation,0,0
16040,ribbon,0,0
16041,",",0,0
16042,and,0,0
16043,3,0,0
16044,),0,1
16045,the,0,0
16046,ribbon+margin,0,0
16047,segment,0,0
16048,(,0,1
16049,including,0,1
16050,5,0,0
16051,mm,0,1
16052,on,0,0
16053,either,0,0
16054,end,0,0
16055,of,0,0
16056,the,0,0
16057,injured,0,1
16058,or,0,1
16059,radiation-ribbon,0,1
16060,segment,0,1
16061,),0,1
16062,.,0,1
16063,Receiver,0,0
16064,operator,0,0
16065,curves,0,0
16066,(,0,1
16067,ROC,0,1
16068,),0,1
16069,were,0,1
16070,used,0,0
16071,to,0,0
16072,assess,0,0
16073,the,0,0
16074,value,0,0
16075,of,0,0
16076,the,0,0
16077,follow-up,0,0
16078,percent,0,1
16079,diameter,0,1
16080,stenosis,0,1
16081,(,0,1
16082,DS,0,0
16083,),0,1
16084,for,0,0
16085,each,0,0
16086,of,0,0
16087,the,0,0
16088,three,0,0
16089,analyzed,0,0
16090,segments,0,1
16091,in,0,1
16092,predicting,0,0
16093,target,0,0
16094,vessel,0,1
16095,revascularization,0,1
16096,(,0,1
16097,TVR,0,1
16098,),0,1
16099,.,0,1
16100,RESULTS,0,0
16101,(,0,1
16102,192,0,1
16103,),0,1
16104,Ir,0,1
16105,reduced,0,0
16106,recurrent,0,1
16107,restenosis,0,1
16108,(,0,1
16109,23.7,0,0
16110,%,0,0
16111,vs.,0,0
16112,60.7,0,0
16113,%,0,0
16114,",",0,0
16115,p,0,0
16116,<,0,0
16117,0.001,0,0
16118,),0,1
16119,and,0,0
16120,the,0,0
16121,length,0,0
16122,of,0,0
16123,recurrent,0,1
16124,restenosis,0,1
16125,(,0,1
16126,8.99,0,0
16127,+/-,0,1
16128,4.34,0,0
16129,mm,0,1
16130,vs.,0,0
16131,17.54,0,0
16132,+/-,0,0
16133,10.48,0,0
16134,mm,0,1
16135,",",0,0
16136,p,0,0
16137,<,0,0
16138,0.001,0,0
16139,),0,1
16140,at,0,1
16141,follow-up,0,0
16142,compared,0,0
16143,to,0,0
16144,placebo,0,0
16145,.,0,1
16146,Isolated,0,0
16147,stent,0,0
16148,edge,0,1
16149,(,0,1
16150,3.4,0,0
16151,%,0,0
16152,),0,1
16153,and,0,0
16154,ribbon,0,0
16155,edge,0,1
16156,(,0,1
16157,1.7,0,0
16158,%,0,0
16159,),0,0
16160,restenoses,0,0
16161,were,0,0
16162,infrequent,0,0
16163,in,0,0
16164,both,0,0
16165,groups,0,0
16166,.,0,1
16167,The,0,0
16168,best,0,0
16169,angiographic,0,0
16170,surrogate,0,0
16171,of,0,1
16172,TVR,0,1
16173,was,0,0
16174,the,0,0
16175,50,0,1
16176,%,0,0
16177,follow-up,0,1
16178,DS,0,0
16179,obtained,0,0
16180,from,0,1
16181,the,0,0
16182,ribbon+margin,0,0
16183,analysis,0,0
16184,(,0,1
16185,ROC,0,1
16186,area,0,1
16187,0.806,0,0
16188,),0,1
16189,.,0,1
16190,CONCLUSIONS,0,0
16191,In,0,0
16192,WRIST,0,0
16193,",",0,0
16194,not,0,0
16195,only,0,0
16196,was,0,0
16197,(,0,0
16198,192,0,1
16199,),0,1
16200,Ir,0,1
16201,therapy,0,0
16202,effective,0,0
16203,in,0,0
16204,reducing,0,0
16205,restenosis,0,1
16206,",",0,0
16207,but,0,0
16208,it,0,0
16209,also,0,0
16210,reduced,0,0
16211,the,0,0
16212,lesion,0,0
16213,length,0,0
16214,of,0,0
16215,treatment,0,1
16216,failures,0,1
16217,by,0,1
16218,50,0,1
16219,%,0,0
16220,",",0,0
16221,and,0,0
16222,it,0,0
16223,was,0,0
16224,not,0,0
16225,associated,0,0
16226,with,0,1
16227,edge,0,1
16228,proliferation,0,0
16229,.,0,1
16230,The,0,0
16231,restenosis,0,0
16232,rate,0,0
16233,obtained,0,0
16234,from,0,1
16235,the,0,0
16236,vessel,0,1
16237,segment,0,0
16238,inclusive,0,1
16239,of,0,0
16240,the,0,0
16241,dose,0,0
16242,fall-off,0,0
16243,zones,0,1
16244,was,0,0
16245,the,0,0
16246,best,0,0
16247,correlate,0,0
16248,of,0,0
16249,TVR,0,1
16250,and,0,0
16251,should,0,0
16252,become,0,0
16253,a,0,0
16254,standard,0,0
16255,analysis,0,0
16256,site,0,0
16257,in,0,0
16258,all,0,0
16259,vascular,0,0
16260,brachytherapy,0,1
16261,trials,0,1
16262,.,0,1
16263,Carpal,0,0
16264,tunnel,0,1
16265,release,0,0
16266,by,0,0
16267,limited,0,0
16268,palmar,0,1
16269,incision,0,1
16270,vs,0,0
16271,traditional,0,1
16272,open,0,1
16273,technique,0,0
16274,:,0,1
16275,randomized,0,1
16276,controlled,0,0
16277,trial,0,1
16278,.,0,1
16279,AIM,0,0
16280,To,0,0
16281,compare,0,0
16282,a,0,0
16283,limited,0,0
16284,palmar,0,1
16285,incision,0,1
16286,for,0,0
16287,carpal,0,1
16288,tunnel,0,1
16289,release,0,0
16290,(,0,1
16291,CTR,0,1
16292,),0,1
16293,with,0,1
16294,a,0,1
16295,traditional,0,0
16296,open,0,1
16297,technique,0,0
16298,",",0,0
16299,which,0,0
16300,is,0,0
16301,still,0,0
16302,considered,0,0
16303,the,0,0
16304,gold,0,0
16305,standard,0,1
16306,.,0,1
16307,METHODS,0,0
16308,Seventy-two,1,1
16309,patients,1,1
16310,with,1,1
16311,a,1,1
16312,carpal,1,1
16313,tunnel,1,1
16314,syndrome,1,1
16315,were,1,0
16316,individually,1,0
16317,randomized,1,1
16318,into,1,0
16319,the,1,0
16320,trial,1,0
16321,(,1,0
16322,limited,1,0
16323,incision,1,1
16324,CTR,1,1
16325,),1,1
16326,(,1,1
16327,n=36,1,1
16328,),1,1
16329,and,1,0
16330,control,1,1
16331,group,1,1
16332,(,1,1
16333,traditional,1,0
16334,technique,1,0
16335,CTR,1,1
16336,),1,1
16337,(,1,1
16338,n=36,1,1
16339,),1,1
16340,.,1,1
16341,In,1,0
16342,the,1,0
16343,trial,1,0
16344,group,1,0
16345,",",1,0
16346,skin,1,1
16347,incision,1,0
16348,parallel,1,0
16349,to,1,0
16350,the,1,0
16351,thenar,1,1
16352,crease,1,1
16353,was,1,0
16354,made,1,0
16355,up,1,1
16356,to,1,1
16357,2.5,1,0
16358,cm,1,1
16359,in,1,0
16360,length,1,0
16361,",",1,0
16362,under,1,0
16363,an,1,0
16364,operating,1,0
16365,microscope,1,0
16366,and,1,0
16367,endoscopic,1,1
16368,transillumination,1,1
16369,.,1,1
16370,Skin,1,0
16371,incision,1,0
16372,in,1,0
16373,the,1,0
16374,control,1,1
16375,group,1,0
16376,began,1,1
16377,at,1,0
16378,the,1,0
16379,distal,1,0
16380,border,1,0
16381,of,1,0
16382,the,1,0
16383,carpal,1,1
16384,ligament,1,1
16385,",",1,0
16386,followed,1,0
16387,the,1,0
16388,longitudinal,1,1
16389,crease,1,1
16390,of,1,0
16391,the,1,0
16392,palm,1,1
16393,",",1,0
16394,and,1,0
16395,crossed,1,0
16396,the,1,0
16397,base,1,0
16398,of,1,0
16399,the,1,0
16400,palm,1,1
16401,in,1,0
16402,a,1,1
16403,zigzag,1,0
16404,fashion,1,0
16405,.,1,1
16406,Three,1,1
16407,months,1,0
16408,after,1,1
16409,surgery,1,1
16410,",",0,0
16411,the,0,0
16412,patients,0,1
16413,were,0,1
16414,asked,0,1
16415,about,0,0
16416,symptomatic,0,1
16417,relief,0,0
16418,and,0,1
16419,intervals,0,0
16420,between,0,0
16421,the,0,0
16422,operation,0,1
16423,and,0,0
16424,return,0,0
16425,to,0,0
16426,their,0,1
16427,daily,0,0
16428,activities,0,0
16429,and,0,1
16430,work,0,0
16431,",",0,0
16432,and,0,0
16433,examined,0,0
16434,for,0,0
16435,scar,0,0
16436,tenderness,0,0
16437,and,0,0
16438,esthetic,0,1
16439,outcome,0,0
16440,.,0,1
16441,Distal,0,1
16442,motor,0,0
16443,latency,0,0
16444,",",0,0
16445,conduction,0,0
16446,velocity,0,0
16447,",",0,0
16448,scar,0,0
16449,length,0,0
16450,",",0,0
16451,scar,0,0
16452,width,0,0
16453,",",0,0
16454,and,0,0
16455,operation,0,1
16456,time,0,0
16457,were,0,1
16458,measured,0,0
16459,.,0,0
16460,RESULTS,0,0
16461,There,0,0
16462,were,0,0
16463,no,0,0
16464,differences,0,0
16465,between,0,0
16466,the,0,1
16467,two,0,0
16468,groups,0,0
16469,in,0,1
16470,symptomatic,0,1
16471,relief,0,0
16472,and,0,1
16473,electrophysiological,0,1
16474,parameters,0,0
16475,.,0,1
16476,Intervals,0,0
16477,between,0,0
16478,the,0,0
16479,operation,0,1
16480,and,0,0
16481,return,0,0
16482,to,0,1
16483,daily,0,0
16484,activities,0,0
16485,(,0,1
16486,median,0,1
16487,5,0,1
16488,days,0,0
16489,",",0,1
16490,range,0,1
16491,2-15,0,1
16492,),0,1
16493,were,0,1
16494,shorter,0,0
16495,in,0,0
16496,the,0,0
16497,trial,0,0
16498,group,0,0
16499,than,0,0
16500,in,0,0
16501,the,0,0
16502,control,0,1
16503,group,0,0
16504,(,0,1
16505,median,0,1
16506,10,0,1
16507,days,0,0
16508,",",0,1
16509,range,0,1
16510,2-21,0,1
16511,;,0,1
16512,p,0,0
16513,<,0,0
16514,0.001,0,0
16515,),0,0
16516,",",0,0
16517,as,0,0
16518,well,0,0
16519,as,0,0
16520,the,0,0
16521,intervals,0,0
16522,between,0,0
16523,the,0,0
16524,operation,0,1
16525,and,0,0
16526,return,0,0
16527,to,0,0
16528,work,0,0
16529,(,0,1
16530,median,0,1
16531,15,0,1
16532,days,0,0
16533,",",0,1
16534,range,0,1
16535,5-45,0,0
16536,vs,0,0
16537,median,0,1
16538,30,0,1
16539,days,0,0
16540,",",0,1
16541,range,0,1
16542,10-60,0,0
16543,;,0,1
16544,p,0,0
16545,<,0,0
16546,0.001,0,0
16547,),0,1
16548,.,0,1
16549,Scar/pillar,0,0
16550,tenderness,0,0
16551,",",0,0
16552,scar,0,0
16553,length,0,0
16554,and,0,0
16555,width,0,0
16556,",",0,0
16557,esthetic,0,0
16558,outcome,0,0
16559,",",0,0
16560,and,0,0
16561,operation,0,1
16562,time,0,0
16563,were,0,0
16564,significantly,0,0
16565,better,0,0
16566,in,0,0
16567,the,0,0
16568,trial,0,0
16569,group,0,1
16570,.,0,1
16571,CONCLUSION,0,0
16572,Limited,0,1
16573,palmar,0,1
16574,incision,0,0
16575,CTR,0,0
16576,is,0,0
16577,as,0,0
16578,effective,0,0
16579,and,0,1
16580,safe,0,0
16581,as,0,0
16582,traditional,0,1
16583,CTR,0,1
16584,technique,0,0
16585,",",0,0
16586,but,0,0
16587,with,0,1
16588,better,0,0
16589,postoperative,0,1
16590,recovery,0,0
16591,and,0,1
16592,cosmetic,0,1
16593,results,0,0
16594,.,0,1
16595,The,0,0
16596,Low,0,1
16597,Energy,0,0
16598,Safety,0,0
16599,Study,0,1
16600,(,0,1
16601,LESS,0,1
16602,),0,1
16603,:,0,1
16604,rationale,0,0
16605,",",0,0
16606,design,0,1
16607,",",0,0
16608,patient,0,1
16609,characteristics,0,0
16610,",",0,1
16611,and,0,0
16612,device,0,0
16613,utilization,0,0
16614,.,0,0
16615,BACKGROUND,0,0
16616,A,0,0
16617,10-J,0,1
16618,energy,0,0
16619,safety,0,0
16620,margin,0,0
16621,has,0,0
16622,traditionally,0,0
16623,been,0,0
16624,used,0,0
16625,in,0,0
16626,programming,0,0
16627,implantable,1,1
16628,cardioverter,1,1
16629,defibrillators,1,1
16630,(,1,1
16631,ICDs,1,1
16632,),1,1
16633,.,1,1
16634,The,0,0
16635,Low,0,1
16636,Energy,0,0
16637,Safety,0,0
16638,Study,0,1
16639,(,0,1
16640,LESS,0,0
16641,),0,0
16642,tests,0,0
16643,the,0,0
16644,hypothesis,0,0
16645,that,0,0
16646,programming,0,1
16647,shocks,0,0
16648,to,0,1
16649,lower,0,1
16650,energy,0,0
16651,margins,0,0
16652,is,0,0
16653,safe,0,0
16654,and,0,0
16655,effective,0,0
16656,.,0,1
16657,METHODS,0,0
16658,Patients,1,1
16659,with,1,1
16660,standard,1,1
16661,ICD,1,1
16662,indications,1,1
16663,undergo,1,1
16664,defibrillation,1,0
16665,threshold,1,0
16666,testing,1,0
16667,(,1,1
16668,DFT,1,1
16669,),1,1
16670,at,1,0
16671,the,1,0
16672,time,1,0
16673,of,1,0
16674,ICD,1,1
16675,implant,1,0
16676,",",1,0
16677,with,1,1
16678,reconfirmation,1,0
16679,of,1,0
16680,lowest,1,0
16681,successful,1,1
16682,energy,1,0
16683,twice,1,0
16684,(,1,1
16685,DFT++,1,1
16686,),1,1
16687,.,1,1
16688,Patients,0,1
16689,are,0,0
16690,randomized,0,1
16691,to,0,1
16692,2,0,1
16693,groups,0,1
16694,:,0,1
16695,the,0,0
16696,first,0,0
16697,has,0,0
16698,the,0,0
16699,initial,0,0
16700,2,0,1
16701,shocks,0,0
16702,for,0,1
16703,ventricular,0,1
16704,fibrillation,0,1
16705,conversion,0,0
16706,programmed,0,0
16707,at,0,0
16708,2,0,1
16709,energy,0,0
16710,steps,0,1
16711,above,0,1
16712,DFT++,0,1
16713,(,0,1
16714,typically,0,1
16715,4-6,0,1
16716,J,0,0
16717,",",0,1
16718,maximum,0,0
16719,10,0,1
16720,J,0,1
16721,),0,1
16722,with,0,1
16723,subsequent,0,0
16724,shocks,0,0
16725,at,0,1
16726,maximum,0,0
16727,energy,0,0
16728,",",0,0
16729,and,0,0
16730,the,0,0
16731,second,0,0
16732,has,0,0
16733,all,0,0
16734,shocks,0,0
16735,programmed,0,0
16736,at,0,1
16737,maximum,0,0
16738,energy,0,1
16739,.,0,1
16740,Patients,0,1
16741,are,0,0
16742,followed,0,0
16743,up,0,1
16744,every,0,0
16745,3,0,1
16746,months,0,0
16747,for,0,1
16748,2,0,1
16749,years,0,1
16750,to,0,1
16751,assess,0,0
16752,shock,0,1
16753,conversion,0,0
16754,efficacy,0,0
16755,of,0,1
16756,spontaneous,0,1
16757,arrhythmias,0,1
16758,.,0,1
16759,In,0,0
16760,a,0,0
16761,subgroup,0,1
16762,of,0,0
16763,patients,0,1
16764,",",0,0
16765,there,0,0
16766,is,0,0
16767,a,0,0
16768,second,0,0
16769,randomization,0,0
16770,to,0,1
16771,energy,0,0
16772,levels,0,0
16773,of,0,1
16774,0,0,0
16775,",",0,1
16776,1,0,0
16777,",",0,0
16778,2,0,1
16779,",",0,0
16780,3,0,0
16781,",",0,0
16782,or,0,1
16783,4,0,0
16784,steps,0,1
16785,above,0,1
16786,implant,0,1
16787,DFT++,0,1
16788,for,0,0
16789,conversion,0,0
16790,testing,0,1
16791,of,0,0
16792,3,0,1
16793,induced,0,1
16794,ventricular,0,1
16795,fibrillation,0,1
16796,episodes,0,1
16797,at,0,1
16798,prehospital,0,1
16799,discharge,0,1
16800,",",0,1
16801,3,0,0
16802,months,0,0
16803,",",0,1
16804,and,0,1
16805,12,0,1
16806,months,0,0
16807,after,0,1
16808,implant,0,1
16809,.,0,1
16810,RESULTS,0,0
16811,Enrollment,1,0
16812,is,1,0
16813,complete,1,0
16814,(,1,1
16815,702,1,1
16816,patients,1,1
16817,),1,1
16818,",",0,1
16819,but,0,0
16820,follow-up,0,0
16821,results,0,0
16822,are,0,0
16823,pending,0,0
16824,.,0,0
16825,There,0,0
16826,were,0,0
16827,no,0,0
16828,significant,0,0
16829,variations,0,0
16830,in,0,1
16831,implant,0,1
16832,indications,0,1
16833,and,0,1
16834,baseline,0,0
16835,antiarrhythmic,0,0
16836,drug,0,0
16837,use,0,0
16838,over,0,0
16839,the,0,0
16840,3-year,0,1
16841,enrollment,0,1
16842,period,0,0
16843,",",0,0
16844,although,0,0
16845,an,0,0
16846,increase,0,0
16847,in,0,0
16848,the,0,0
16849,percentage,0,0
16850,of,0,0
16851,dual-chamber,0,1
16852,ICDs,0,1
16853,implanted,0,1
16854,occurred,0,0
16855,",",0,0
16856,with,0,1
16857,the,0,0
16858,majority,0,1
16859,(,0,0
16860,65,0,1
16861,%,0,0
16862,),0,1
16863,of,0,0
16864,implanted,0,1
16865,ICDs,0,1
16866,being,0,1
16867,dual-chamber,0,1
16868,devices,0,0
16869,by,0,0
16870,the,0,0
16871,end,0,0
16872,of,0,0
16873,the,0,0
16874,enrollment,0,1
16875,period,0,0
16876,.,0,1
16877,CONCLUSION,0,0
16878,The,0,0
16879,results,0,0
16880,of,0,0
16881,LESS,0,0
16882,should,0,0
16883,facilitate,0,0
16884,the,0,0
16885,development,0,0
16886,of,0,0
16887,algorithms,0,1
16888,for,0,0
16889,programming,0,0
16890,ICD,0,1
16891,energy,0,0
16892,safety,0,0
16893,margins,0,1
16894,.,0,1
16895,Pacifier,1,0
16896,as,1,0
16897,a,1,1
16898,risk,1,0
16899,factor,1,0
16900,for,1,0
16901,acute,1,1
16902,otitis,1,1
16903,media,1,1
16904,.,1,1
16905,[,0,0
16906,Clinical,0,0
16907,application,0,0
16908,of,0,0
16909,irradiated,0,0
16910,drug-containing,0,1
16911,porcine-cornea,0,1
16912,to,0,1
16913,patients,1,1
16914,with,1,1
16915,ocular,1,1
16916,burns,1,1
16917,],1,1
16918,.,0,1
16919,OBJECTIVE,0,0
16920,To,0,0
16921,explore,0,0
16922,a,0,0
16923,new,0,0
16924,method,0,0
16925,for,0,0
16926,the,0,0
16927,management,0,1
16928,of,0,0
16929,patients,1,1
16930,with,1,1
16931,ocular,1,1
16932,burns,1,1
16933,.,1,1
16934,METHODS,0,0
16935,Fifty-five,1,1
16936,cases,1,1
16937,of,1,1
16938,patients,1,1
16939,with,1,1
16940,ocular,1,1
16941,burns,1,1
16942,(,1,1
16943,in,1,1
16944,88,1,1
16945,eyes,1,1
16946,),1,1
16947,were,0,1
16948,randomly,0,1
16949,divided,0,1
16950,into,0,0
16951,treatment,0,0
16952,and,0,1
16953,control,0,1
16954,groups,0,1
16955,.,0,1
16956,Thirty,0,1
16957,cases,0,1
16958,in,0,1
16959,treatment,0,1
16960,group,0,1
16961,with,0,1
16962,49,1,1
16963,eyes,1,1
16964,were,1,1
16965,transplanted,1,1
16966,with,0,1
16967,irradiated,0,0
16968,drug-containing,0,1
16969,(,0,1
16970,ofloxacin,0,0
16971,",",0,0
16972,acetyl,0,0
16973,cysteine,0,1
16974,and,0,1
16975,reduced,0,0
16976,glutathione,0,0
16977,),0,1
16978,porcine-cornea,0,1
16979,.,0,1
16980,25,0,0
16981,cases,0,1
16982,in,0,1
16983,control,0,1
16984,group,0,1
16985,with,0,1
16986,39,0,1
16987,eyes,0,1
16988,were,0,1
16989,treated,0,1
16990,with,0,1
16991,routine,0,1
16992,program,0,1
16993,.,0,1
16994,RESULTS,0,0
16995,Thirty-two,0,1
16996,eyes,0,1
16997,were,0,1
16998,rescued,0,0
16999,in,0,0
17000,treatment,0,0
17001,group,0,1
17002,with,0,1
17003,the,0,0
17004,cure,0,0
17005,rate,0,0
17006,of,0,0
17007,65.3,0,1
17008,%,0,0
17009,.,0,1
17010,But,0,0
17011,only,0,0
17012,17,0,1
17013,eyes,0,1
17014,were,0,1
17015,saved,0,1
17016,in,0,0
17017,control,0,1
17018,group,0,1
17019,with,0,1
17020,the,0,0
17021,cure,0,0
17022,rate,0,0
17023,of,0,0
17024,43.59,0,1
17025,%,0,0
17026,",",0,0
17027,indicating,0,0
17028,significant,0,0
17029,difference,0,0
17030,of,0,0
17031,the,0,0
17032,cure,0,0
17033,rate,0,0
17034,between,0,0
17035,the,0,1
17036,two,0,1
17037,groups,0,0
17038,(,0,1
17039,P,0,0
17040,<,0,0
17041,0.05,0,0
17042,),0,1
17043,.,0,1
17044,CONCLUSION,0,0
17045,Irradiated,0,0
17046,drug-containing,0,0
17047,porcine-cornea,0,0
17048,might,0,0
17049,well,0,0
17050,be,0,0
17051,an,0,0
17052,ideal,0,0
17053,therapeutic,0,0
17054,material,0,1
17055,for,0,0
17056,the,0,0
17057,management,0,1
17058,of,0,0
17059,patients,1,1
17060,with,1,1
17061,ocular,1,1
17062,burns,1,1
17063,.,1,1
17064,Benefits,0,0
17065,",",0,1
17066,morbidity,0,0
17067,",",0,0
17068,and,0,0
17069,mortality,0,0
17070,associated,0,0
17071,with,0,1
17072,long-term,0,0
17073,administration,0,0
17074,of,0,0
17075,oral,0,1
17076,anticoagulant,0,0
17077,therapy,0,1
17078,to,0,1
17079,patients,1,1
17080,with,1,1
17081,peripheral,1,1
17082,arterial,1,1
17083,bypass,1,1
17084,procedures,1,1
17085,:,1,1
17086,a,0,1
17087,prospective,0,1
17088,randomized,0,1
17089,study,0,1
17090,.,0,1
17091,BACKGROUND,0,0
17092,The,0,0
17093,benefits,0,0
17094,of,0,0
17095,the,0,1
17096,long-term,0,0
17097,administration,0,0
17098,of,0,0
17099,oral,0,1
17100,anticoagulant,0,0
17101,therapy,0,1
17102,remain,0,0
17103,unclear,0,0
17104,in,0,1
17105,patients,1,1
17106,with,1,1
17107,lower,1,0
17108,extremity,1,1
17109,arterial,1,1
17110,bypass,1,1
17111,surgery,1,1
17112,.,1,1
17113,We,0,0
17114,studied,0,0
17115,the,0,0
17116,effect,0,0
17117,of,0,0
17118,warfarin,0,0
17119,plus,0,0
17120,aspirin,0,0
17121,therapy,0,0
17122,(,0,1
17123,WASA,0,1
17124,),0,1
17125,versus,0,0
17126,aspirin,0,0
17127,therapy,0,0
17128,alone,0,0
17129,(,0,1
17130,ASA,0,0
17131,),0,1
17132,on,0,0
17133,patient,0,1
17134,mortality,0,0
17135,",",0,0
17136,morbidity,0,0
17137,and,0,0
17138,bypass,0,1
17139,patency,0,0
17140,rates,0,0
17141,in,0,1
17142,a,0,1
17143,randomized,0,1
17144,clinical,0,0
17145,trial,0,1
17146,.,0,1
17147,METHODS,0,0
17148,In,0,0
17149,a,0,0
17150,multicenter,0,0
17151,",",0,0
17152,prospective,0,0
17153,",",0,0
17154,nonmasked,0,1
17155,clinical,0,0
17156,trial,0,1
17157,",",0,1
17158,831,1,1
17159,patients,1,1
17160,who,1,1
17161,underwent,1,1
17162,peripheral,1,1
17163,arterial,1,1
17164,bypass,1,1
17165,surgery,1,1
17166,were,0,0
17167,compared,0,0
17168,in,0,0
17169,a,0,1
17170,long-term,1,0
17171,treatment,1,0
17172,program,1,1
17173,of,1,0
17174,WASA,1,1
17175,(,0,1
17176,target,0,0
17177,international,0,1
17178,normalized,0,0
17179,ratio,0,0
17180,of,0,1
17181,1.4,0,0
17182,to,0,1
17183,2.8,0,0
17184,;,0,1
17185,325,0,1
17186,mg/day,0,0
17187,),0,1
17188,with,0,1
17189,ASA,0,1
17190,(,0,1
17191,325,0,1
17192,mg/day,0,1
17193,),0,1
17194,.,0,1
17195,The,0,0
17196,primary,0,0
17197,end,0,0
17198,point,0,0
17199,was,0,0
17200,bypass,0,1
17201,patency,0,0
17202,",",0,0
17203,and,0,0
17204,mortality,0,0
17205,and,0,0
17206,morbidity,0,0
17207,were,0,0
17208,the,0,0
17209,secondary,0,1
17210,endpoints,0,0
17211,.,0,1
17212,RESULTS,0,0
17213,There,0,0
17214,were,0,0
17215,133,0,1
17216,deaths,0,0
17217,in,0,1
17218,the,0,1
17219,WASA,0,1
17220,group,0,1
17221,(,0,1
17222,31.8,0,1
17223,%,0,0
17224,),0,1
17225,and,0,1
17226,95,0,0
17227,deaths,0,0
17228,in,0,1
17229,the,0,1
17230,ASA,0,0
17231,group,0,1
17232,(,0,1
17233,23.0,0,1
17234,%,0,0
17235,;,0,1
17236,risk,0,0
17237,ratio,0,0
17238,",",0,1
17239,1.41,0,0
17240,;,0,1
17241,95,0,0
17242,%,0,0
17243,confidence,0,0
17244,interval,0,0
17245,",",0,1
17246,1.09,0,0
17247,to,0,1
17248,1.84,0,0
17249,;,0,1
17250,P,0,0
17251,=.0001,0,0
17252,),0,1
17253,.,0,1
17254,Major,0,1
17255,hemorrhagic,0,1
17256,events,0,0
17257,occurred,0,0
17258,more,0,0
17259,frequently,0,0
17260,in,0,0
17261,the,0,0
17262,WASA,0,1
17263,group,0,1
17264,(,0,1
17265,WASA,0,1
17266,",",0,0
17267,n,0,1
17268,=,0,1
17269,35,0,1
17270,;,0,1
17271,ASA,0,0
17272,",",0,0
17273,n,0,1
17274,=,0,1
17275,15,0,1
17276,;,0,1
17277,P,0,0
17278,=.02,0,0
17279,),0,1
17280,.,0,1
17281,In,0,0
17282,the,0,0
17283,prosthetic,0,1
17284,bypass,0,1
17285,group,0,0
17286,",",0,0
17287,there,0,0
17288,was,0,0
17289,no,0,0
17290,significant,0,0
17291,difference,0,0
17292,in,0,0
17293,patency,0,0
17294,rate,0,0
17295,in,0,0
17296,the,0,0
17297,8-mm,0,0
17298,bypass,0,1
17299,subgroup,0,1
17300,",",0,0
17301,but,0,0
17302,there,0,0
17303,was,0,0
17304,a,0,0
17305,significant,0,0
17306,difference,0,0
17307,in,0,0
17308,patency,0,0
17309,rate,0,0
17310,in,0,0
17311,the,0,0
17312,6-mm,0,0
17313,bypass,0,1
17314,subgroup,0,1
17315,(,0,1
17316,femoral-popliteal,0,1
17317,;,0,1
17318,71.4,0,0
17319,%,0,0
17320,in,0,0
17321,the,0,0
17322,WASA,0,1
17323,group,0,1
17324,versus,0,0
17325,57.9,0,0
17326,%,0,0
17327,in,0,0
17328,the,0,0
17329,ASA,0,0
17330,group,0,1
17331,;,0,1
17332,P,0,0
17333,=.02,0,0
17334,),0,1
17335,.,0,1
17336,In,0,0
17337,the,0,0
17338,vein,0,1
17339,bypass,0,1
17340,group,0,1
17341,",",0,0
17342,patency,0,0
17343,rate,0,0
17344,was,0,0
17345,unaffected,0,0
17346,(,0,1
17347,75.3,0,0
17348,%,0,0
17349,in,0,0
17350,the,0,0
17351,WASA,0,1
17352,group,0,1
17353,versus,0,0
17354,74.9,0,0
17355,%,0,0
17356,in,0,0
17357,the,0,0
17358,ASA,0,0
17359,group,0,1
17360,),0,1
17361,.,0,0
17362,CONCLUSION,0,0
17363,The,0,0
17364,long-term,0,0
17365,administration,0,0
17366,of,0,0
17367,warfarin,0,0
17368,therapy,0,0
17369,when,0,0
17370,combined,0,0
17371,with,0,1
17372,aspirin,0,0
17373,therapy,0,0
17374,has,0,0
17375,only,0,0
17376,a,0,0
17377,few,0,0
17378,selected,0,1
17379,indications,0,0
17380,for,0,0
17381,improvement,0,0
17382,of,0,0
17383,bypass,0,1
17384,patency,0,0
17385,and,0,0
17386,is,0,0
17387,associated,0,0
17388,with,0,1
17389,an,0,0
17390,increased,0,0
17391,risk,0,0
17392,of,0,0
17393,morbidity,0,0
17394,and,0,1
17395,mortality,0,0
17396,.,0,1
17397,Comparison,0,0
17398,of,0,0
17399,comfort,0,0
17400,and,0,1
17401,local,0,0
17402,complications,0,1
17403,after,0,1
17404,cardiac,1,1
17405,catheterization,1,1
17406,.,1,1
17407,The,0,0
17408,purpose,0,0
17409,of,0,0
17410,this,0,0
17411,study,0,0
17412,was,0,0
17413,to,0,0
17414,compare,0,0
17415,the,0,0
17416,effects,0,0
17417,of,0,1
17418,4,0,1
17419,hours,0,0
17420,of,0,1
17421,bed,0,1
17422,rest,0,0
17423,versus,0,0
17424,6,0,1
17425,hours,0,0
17426,of,0,1
17427,bed,0,0
17428,rest,0,0
17429,on,0,0
17430,patients,0,1
17431,',0,1
17432,safety,0,0
17433,",",0,1
17434,comfort,0,0
17435,",",0,0
17436,and,0,0
17437,satisfaction,0,0
17438,levels,0,0
17439,.,0,1
17440,Using,0,0
17441,a,0,0
17442,quasi-experimental,0,1
17443,design,0,1
17444,",",0,0
17445,the,0,0
17446,authors,0,0
17447,studied,0,1
17448,118,1,1
17449,left-heart,1,1
17450,catheterization,1,1
17451,patients,1,1
17452,who,1,1
17453,were,1,1
17454,randomly,1,1
17455,assigned,1,1
17456,to,1,1
17457,4,1,1
17458,hours,1,0
17459,or,1,1
17460,6,1,1
17461,hours,1,0
17462,of,1,1
17463,bed,1,1
17464,rest,1,0
17465,.,1,1
17466,Among,0,0
17467,the,0,0
17468,study,0,1
17469,participants,0,1
17470,",",0,1
17471,only,0,0
17472,1,0,0
17473,in,0,0
17474,the,0,0
17475,6-hour,0,0
17476,group,0,1
17477,had,0,1
17478,significant,0,0
17479,bleeding,0,0
17480,.,0,0
17481,There,0,0
17482,were,0,0
17483,no,0,0
17484,complications,0,0
17485,in,0,0
17486,the,0,1
17487,4-hour,0,0
17488,group,0,0
17489,.,0,0
17490,There,0,0
17491,were,0,0
17492,no,0,0
17493,statistically,0,0
17494,significant,0,0
17495,differences,0,0
17496,between,0,0
17497,the,0,1
17498,two,0,0
17499,groups,0,0
17500,on,0,0
17501,any,0,1
17502,of,0,0
17503,the,0,0
17504,other,0,0
17505,study,0,1
17506,variables,0,0
17507,.,0,1
17508,Given,0,0
17509,the,0,0
17510,lack,0,0
17511,of,0,0
17512,significant,0,0
17513,complications,0,1
17514,for,0,1
17515,the,0,1
17516,4-hour,0,0
17517,group,0,1
17518,and,0,1
17519,similar,0,0
17520,comfort,0,0
17521,levels,0,0
17522,for,0,0
17523,both,0,0
17524,study,0,1
17525,groups,0,0
17526,",",0,1
17527,these,0,0
17528,findings,0,0
17529,suggest,0,0
17530,the,0,0
17531,feasibility,0,0
17532,of,0,0
17533,reducing,0,0
17534,the,0,0
17535,standard,0,1
17536,period,0,0
17537,of,0,0
17538,postcatheterization,0,1
17539,bed,0,0
17540,rest,0,0
17541,from,0,1
17542,6,0,1
17543,hours,0,1
17544,to,0,1
17545,4,0,1
17546,hours,0,0
17547,",",0,0
17548,thereby,0,0
17549,possibly,0,0
17550,lowering,0,0
17551,the,0,0
17552,cost,0,0
17553,of,0,0
17554,the,0,0
17555,outpatient,0,1
17556,procedure,0,0
17557,.,0,1
17558,Mediastinal,0,1
17559,lymphadenectomy,0,1
17560,in,0,1
17561,non-small,1,1
17562,cell,1,1
17563,lung,1,1
17564,cancer,1,1
17565,:,1,1
17566,effectiveness,0,0
17567,in,0,0
17568,patients,1,1
17569,with,1,1
17570,or,1,1
17571,without,1,1
17572,nodal,1,1
17573,micrometastases,1,1
17574,-,0,1
17575,results,0,0
17576,of,0,0
17577,a,0,1
17578,preliminary,0,0
17579,study,0,1
17580,.,0,1
17581,OBJECTIVES,0,0
17582,So,0,0
17583,far,0,0
17584,it,0,0
17585,has,0,0
17586,not,0,0
17587,clearly,0,0
17588,been,0,0
17589,demonstrated,0,0
17590,that,0,0
17591,systematic,0,1
17592,mediastinal,0,1
17593,lymphadenectomy,0,1
17594,improves,0,0
17595,survival,0,0
17596,in,0,0
17597,patients,1,1
17598,with,1,1
17599,non-small,1,1
17600,cell,1,1
17601,lung,1,1
17602,cancer,1,1
17603,.,1,1
17604,One,0,0
17605,explanation,0,0
17606,might,0,0
17607,be,0,0
17608,that,0,0
17609,in,0,0
17610,some,0,1
17611,patients,0,1
17612,an,0,1
17613,early,0,1
17614,spread,0,0
17615,of,0,1
17616,tumor,0,1
17617,cells,0,0
17618,has,0,0
17619,occurred,0,0
17620,which,0,0
17621,might,0,0
17622,not,0,0
17623,be,0,0
17624,curable,0,1
17625,by,0,0
17626,surgical,0,1
17627,means,0,1
17628,.,0,1
17629,To,0,0
17630,test,0,0
17631,this,0,0
17632,hypothesis,0,0
17633,lymph,0,1
17634,nodes,0,1
17635,of,0,0
17636,patients,0,1
17637,which,0,1
17638,were,0,1
17639,treated,0,1
17640,either,0,0
17641,by,0,0
17642,lymph,0,1
17643,node,0,1
17644,sampling,0,0
17645,or,0,1
17646,systematic,0,1
17647,lymphadenectomy,0,1
17648,were,0,1
17649,screened,0,1
17650,for,0,0
17651,micrometastatic,0,1
17652,spread,0,1
17653,of,0,1
17654,tumor,0,1
17655,cells,0,0
17656,and,0,1
17657,the,0,0
17658,influence,0,0
17659,of,0,0
17660,nodal,0,1
17661,micrometastases,0,1
17662,on,0,0
17663,the,0,0
17664,efficacy,0,0
17665,of,0,0
17666,lymphadenectomy,0,1
17667,was,0,0
17668,analyzed,0,0
17669,.,0,1
17670,METHODS,0,0
17671,Lymph,1,1
17672,nodes,1,1
17673,from,1,1
17674,patients,1,1
17675,(,1,1
17676,n=94,1,1
17677,),1,1
17678,which,0,0
17679,were,0,1
17680,included,0,1
17681,in,0,0
17682,a,0,1
17683,randomized,0,1
17684,trial,0,0
17685,of,0,0
17686,lymph,0,1
17687,node,0,1
17688,sampling,0,0
17689,(,0,1
17690,LS,0,0
17691,",",0,0
17692,n=41,0,1
17693,),0,1
17694,versus,0,0
17695,radical,0,1
17696,systematic,0,1
17697,lymphadenectomy,0,1
17698,(,0,1
17699,LA,0,0
17700,",",0,0
17701,n=53,0,1
17702,),0,0
17703,were,0,0
17704,screened,0,1
17705,by,0,0
17706,immunohistochemistry,0,1
17707,for,0,1
17708,disseminated,0,1
17709,tumor,0,1
17710,cells,0,0
17711,using,0,0
17712,the,0,0
17713,antibody,0,0
17714,Ber-Ep4,0,1
17715,.,0,1
17716,The,0,0
17717,median,0,0
17718,observation,0,0
17719,time,0,0
17720,was,0,0
17721,longer,0,0
17722,than,0,1
17723,5,0,1
17724,years,0,1
17725,and,0,1
17726,follow-up,0,1
17727,data,0,0
17728,were,0,1
17729,available,0,0
17730,from,0,1
17731,all,0,1
17732,94,0,1
17733,patients,0,1
17734,.,0,1
17735,Kaplan-Meier,0,0
17736,curves,0,0
17737,were,0,1
17738,calculated,0,0
17739,and,0,0
17740,tested,0,0
17741,for,0,0
17742,statistical,0,0
17743,significance,0,0
17744,using,0,0
17745,the,0,0
17746,log-rank,0,0
17747,test,0,0
17748,.,0,1
17749,RESULTS,0,0
17750,Standard,0,0
17751,histopathological,0,1
17752,analysis,0,0
17753,revealed,0,0
17754,no,0,0
17755,lymph,0,0
17756,node,0,1
17757,involvement,0,1
17758,(,0,0
17759,pN0,0,0
17760,),0,1
17761,in,0,1
17762,61,0,1
17763,patients,0,1
17764,",",0,1
17765,pN1,0,0
17766,disease,0,1
17767,in,0,1
17768,13,0,1
17769,patients,0,1
17770,and,0,1
17771,pN2,0,1
17772,disease,0,1
17773,in,0,1
17774,20,0,1
17775,patients,0,1
17776,without,0,1
17777,significant,0,0
17778,differences,0,0
17779,between,0,1
17780,LA,0,0
17781,and,0,1
17782,LS,0,0
17783,with,0,1
17784,respect,0,0
17785,to,0,0
17786,T-stage,0,1
17787,",",0,0
17788,N-stage,0,1
17789,or,0,1
17790,age,0,1
17791,and,0,0
17792,sex,0,0
17793,of,0,0
17794,the,0,0
17795,patients,0,1
17796,.,0,1
17797,By,0,0
17798,immunohistochemistry,0,0
17799,a,0,1
17800,minimal,0,0
17801,nodal,0,1
17802,spread,0,1
17803,of,0,1
17804,tumor,0,1
17805,cells,0,0
17806,was,0,0
17807,detected,0,0
17808,in,0,0
17809,21,0,1
17810,out,0,1
17811,of,0,1
17812,94,0,1
17813,patients,0,1
17814,(,0,1
17815,LS,0,0
17816,",",0,0
17817,n=10,0,1
17818,(,0,1
17819,24,0,1
17820,%,0,1
17821,),0,1
17822,;,0,1
17823,LA,0,0
17824,",",0,0
17825,n=11,0,1
17826,(,0,1
17827,21,0,1
17828,%,0,0
17829,),0,1
17830,),0,1
17831,.,0,1
17832,Similar,0,0
17833,to,0,0
17834,the,0,0
17835,entire,0,0
17836,group,0,1
17837,of,0,0
17838,patients,0,1
17839,also,0,0
17840,in,0,0
17841,the,0,0
17842,subset,0,1
17843,of,0,0
17844,patients,0,1
17845,with,0,1
17846,nodal,0,1
17847,micrometastases,0,1
17848,the,0,0
17849,type,0,0
17850,of,0,0
17851,lymphadenectomy,0,1
17852,did,0,0
17853,not,0,0
17854,significantly,0,0
17855,influence,0,0
17856,the,0,0
17857,long-term,0,0
17858,survival,0,0
17859,(,0,1
17860,P=0.27,0,0
17861,and,0,1
17862,P=0.39,0,0
17863,",",0,0
17864,respectively,0,0
17865,),0,0
17866,.,0,1
17867,In,0,0
17868,contrast,0,0
17869,",",0,1
17870,in,0,0
17871,patients,0,1
17872,with,0,1
17873,a,0,1
17874,negative,0,0
17875,immunohistochemical,0,0
17876,analysis,0,0
17877,systematic,0,1
17878,lymphadenectomy,0,1
17879,resulted,0,0
17880,in,0,0
17881,an,0,1
17882,improved,0,0
17883,overall,0,0
17884,survival,0,0
17885,(,0,1
17886,P=0.044,0,0
17887,),0,1
17888,.,0,1
17889,CONCLUSIONS,0,0
17890,Our,0,0
17891,data,0,0
17892,provide,0,0
17893,some,0,0
17894,evidence,0,0
17895,that,0,0
17896,systematic,0,0
17897,lymphadenectomy,0,1
17898,improves,0,0
17899,survival,0,0
17900,in,0,0
17901,patients,1,1
17902,without,1,1
17903,an,1,1
17904,early,1,1
17905,locoregional,1,1
17906,spread,1,1
17907,of,1,1
17908,cancer,1,1
17909,cells,1,0
17910,.,1,1
17911,As,0,0
17912,long,0,0
17913,as,0,0
17914,these,0,0
17915,patients,0,1
17916,can,0,0
17917,not,0,0
17918,be,0,0
17919,identified,0,0
17920,preoperatively,0,0
17921,all,0,0
17922,patients,0,1
17923,should,0,0
17924,undergo,0,1
17925,a,0,0
17926,systematic,0,0
17927,mediastinal,0,1
17928,lymphadenectomy,0,1
17929,.,0,1
17930,Effects,0,0
17931,of,0,1
17932,enalapril,0,1
17933,and,0,0
17934,eprosartan,0,0
17935,on,0,0
17936,the,0,0
17937,renal,0,1
17938,vascular,0,0
17939,nitric,0,0
17940,oxide,0,0
17941,system,0,1
17942,in,0,0
17943,human,1,1
17944,essential,1,1
17945,hypertension,1,1
17946,.,1,1
17947,BACKGROUND,0,0
17948,Experimental,0,0
17949,data,0,0
17950,in,0,1
17951,humans,0,1
17952,on,0,0
17953,the,0,0
17954,contribution,0,0
17955,of,0,0
17956,angiotensin-converting,0,1
17957,enzyme,0,1
17958,inhibitors,0,0
17959,and,0,1
17960,angiotensin,0,0
17961,II,0,1
17962,type,0,1
17963,1,0,1
17964,receptor,0,0
17965,blockers,0,0
17966,to,0,1
17967,the,0,0
17968,nitric,0,0
17969,oxide,0,0
17970,system,0,1
17971,of,0,0
17972,the,0,0
17973,renal,0,1
17974,vasculature,0,1
17975,are,0,0
17976,inconsistent,0,0
17977,.,0,1
17978,Enalapril,0,0
17979,and,0,0
17980,eprosartan,0,0
17981,",",0,0
17982,alone,0,0
17983,and,0,0
17984,in,0,0
17985,combination,0,0
17986,",",0,0
17987,were,0,0
17988,used,0,0
17989,to,0,0
17990,determine,0,0
17991,their,0,1
17992,short-term,0,0
17993,effects,0,0
17994,on,0,0
17995,the,0,1
17996,renal,0,1
17997,nitric,0,0
17998,oxide,0,0
17999,system,0,1
18000,and,0,1
18001,renal,0,1
18002,hemodynamics,0,0
18003,of,0,1
18004,human,1,1
18005,subjects,1,1
18006,with,1,1
18007,essential,1,1
18008,hypertension,1,1
18009,.,1,1
18010,METHODS,0,0
18011,Twenty,1,1
18012,male,1,1
18013,",",1,1
18014,white,1,1
18015,patients,1,1
18016,(,1,1
18017,27,1,1
18018,+/-,1,1
18019,1,1,1
18020,years,1,1
18021,),1,1
18022,with,1,1
18023,mild,1,1
18024,essential,1,1
18025,hypertension,1,1
18026,(,1,1
18027,143,1,1
18028,+/-,1,1
18029,11/95,1,1
18030,+/-,1,1
18031,6,1,1
18032,mm,1,1
18033,Hg,1,1
18034,),1,1
18035,were,0,0
18036,included,0,1
18037,in,0,0
18038,a,0,0
18039,double-blind,0,0
18040,",",0,0
18041,randomized,0,0
18042,",",0,0
18043,placebo-controlled,0,0
18044,",",0,0
18045,fourfold,0,0
18046,cross-over,0,0
18047,study,0,1
18048,with,0,1
18049,placebo,0,0
18050,",",0,0
18051,enalapril,0,0
18052,(,0,1
18053,20,0,1
18054,mg/day,0,0
18055,),0,0
18056,",",0,0
18057,eprosartan,0,0
18058,(,0,1
18059,600,0,1
18060,mg/day,0,0
18061,),0,1
18062,",",0,0
18063,or,0,1
18064,combination,0,0
18065,of,0,0
18066,both,0,0
18067,drugs,0,0
18068,(,0,1
18069,10,0,1
18070,and,0,1
18071,300,0,1
18072,mg/day,0,0
18073,",",0,0
18074,respectively,0,0
18075,),0,0
18076,each,0,0
18077,over,0,0
18078,a,0,0
18079,one,0,1
18080,week,0,0
18081,period,0,0
18082,followed,0,0
18083,by,0,0
18084,a,0,1
18085,two-week,0,0
18086,washout,0,0
18087,phase,0,1
18088,.,0,1
18089,After,0,0
18090,each,0,0
18091,study,0,0
18092,phase,0,0
18093,the,0,0
18094,glomerular,0,0
18095,filtration,0,0
18096,rate,0,0
18097,(,0,1
18098,GFR,0,1
18099,),0,1
18100,and,0,1
18101,renal,0,1
18102,plasma,0,0
18103,flow,0,0
18104,(,0,1
18105,RPF,0,1
18106,),0,1
18107,were,0,1
18108,determined,0,0
18109,.,0,1
18110,Basal,0,0
18111,nitric,0,0
18112,oxide,0,0
18113,synthesis,0,0
18114,of,0,0
18115,the,0,0
18116,renal,0,1
18117,vasculature,0,1
18118,was,0,0
18119,assessed,0,0
18120,by,0,0
18121,the,0,0
18122,decrease,0,0
18123,in,0,0
18124,RPF,0,1
18125,after,0,0
18126,inhibition,0,0
18127,of,0,1
18128,nitric,0,0
18129,oxide,0,0
18130,synthase,0,0
18131,with,0,1
18132,NG-monomethyl-L-arginine,0,0
18133,(,0,1
18134,L-NMMA,0,1
18135,;,0,1
18136,4.25,0,0
18137,mg/kg,0,0
18138,),0,1
18139,.,0,1
18140,RESULTS,0,0
18141,After,0,1
18142,one,0,1
18143,week,0,0
18144,of,0,0
18145,therapy,0,0
18146,",",0,0
18147,the,0,0
18148,combination,0,0
18149,therapy,0,0
18150,decreased,0,0
18151,casual,0,1
18152,blood,0,0
18153,pressure,0,0
18154,by,0,0
18155,5,0,1
18156,+/-,0,1
18157,2/3,0,1
18158,+/-,0,1
18159,1,0,1
18160,mm,0,1
18161,Hg,0,1
18162,versus,0,0
18163,placebo,0,0
18164,(,0,1
18165,P,0,0
18166,<,0,0
18167,0.01,0,0
18168,),0,1
18169,.,0,1
18170,Neither,0,0
18171,enalapril,0,0
18172,alone,0,0
18173,(,0,1
18174,-2,0,1
18175,+/-,0,1
18176,2/1,0,1
18177,+/-,0,1
18178,2,0,1
18179,mm,0,1
18180,Hg,0,0
18181,",",0,0
18182,NS,0,0
18183,vs.,0,0
18184,placebo,0,1
18185,),0,1
18186,nor,0,0
18187,eprosartan,0,0
18188,alone,0,0
18189,(,0,1
18190,-1,0,0
18191,+/-,0,1
18192,1/0,0,1
18193,+/-,0,1
18194,2,0,1
18195,mm,0,1
18196,Hg,0,0
18197,",",0,0
18198,NS,0,0
18199,vs.,0,0
18200,placebo,0,1
18201,),0,0
18202,had,0,1
18203,a,0,1
18204,clear-cut,0,0
18205,significant,0,0
18206,effect,0,0
18207,on,0,0
18208,casual,0,1
18209,blood,0,0
18210,pressure,0,0
18211,.,0,1
18212,In,0,0
18213,the,0,0
18214,combination,0,0
18215,phase,0,0
18216,",",0,0
18217,RPF,0,0
18218,increased,0,0
18219,by,0,0
18220,123,0,1
18221,+/-,0,1
18222,36,0,1
18223,mL/min,0,0
18224,(,0,1
18225,P,0,0
18226,<,0,0
18227,0.01,0,0
18228,),0,1
18229,.,0,1
18230,Neither,0,0
18231,enalapril,0,0
18232,alone,0,0
18233,(,0,1
18234,+59,0,0
18235,+/-,0,1
18236,46,0,1
18237,mL/min,0,0
18238,",",0,1
18239,P,0,0
18240,=,0,1
18241,0.21,0,0
18242,),0,1
18243,nor,0,0
18244,eprosartan,0,0
18245,alone,0,0
18246,(,0,1
18247,+113,0,0
18248,+/-,0,1
18249,51,0,1
18250,mL/min,0,0
18251,",",0,1
18252,P,0,0
18253,=,0,1
18254,0.06,0,0
18255,),0,1
18256,had,0,1
18257,a,0,1
18258,clear-cut,0,0
18259,significant,0,0
18260,effect,0,0
18261,on,0,0
18262,RPF,0,1
18263,.,0,1
18264,Changes,0,0
18265,of,0,0
18266,RPF,0,1
18267,induced,0,0
18268,by,0,0
18269,treatment,0,0
18270,correlated,0,0
18271,with,0,1
18272,the,0,0
18273,L-NMMA,0,1
18274,induced,0,0
18275,decrease,0,0
18276,in,0,0
18277,RPF,0,1
18278,in,0,0
18279,the,0,0
18280,combination,0,0
18281,(,0,0
18282,r,0,0
18283,=,0,1
18284,0.70,0,0
18285,",",0,1
18286,P,0,0
18287,<,0,0
18288,0.01,0,0
18289,),0,1
18290,and,0,1
18291,eprosartan,0,0
18292,phase,0,1
18293,(,0,1
18294,r,0,0
18295,=,0,1
18296,0.86,0,0
18297,",",0,1
18298,P,0,0
18299,<,0,0
18300,0.001,0,0
18301,),0,1
18302,",",0,0
18303,but,0,0
18304,not,0,0
18305,in,0,0
18306,the,0,0
18307,enalapril,0,0
18308,phase,0,1
18309,(,0,1
18310,r,0,0
18311,=,0,1
18312,-0.44,0,0
18313,",",0,1
18314,P,0,0
18315,=,0,1
18316,0.10,0,0
18317,),0,1
18318,.,0,1
18319,Renal,0,0
18320,vascular,0,0
18321,resistance,0,0
18322,was,0,0
18323,reduced,0,0
18324,by,0,0
18325,each,0,0
18326,active,0,1
18327,treatment,0,0
18328,with,0,1
18329,the,0,0
18330,most,0,0
18331,prominent,0,0
18332,reduction,0,0
18333,in,0,0
18334,the,0,0
18335,combination,0,0
18336,phase,0,1
18337,.,0,1
18338,GFR,0,0
18339,was,0,0
18340,unaffected,0,0
18341,by,0,0
18342,any,0,0
18343,treatment,0,0
18344,.,0,1
18345,CONCLUSIONS,0,0
18346,In,0,0
18347,contrast,0,1
18348,to,0,1
18349,the,0,0
18350,effects,0,0
18351,of,0,0
18352,either,0,1
18353,substance,0,0
18354,alone,0,0
18355,",",0,0
18356,a,0,0
18357,combination,0,0
18358,of,0,0
18359,half,0,1
18360,the,0,0
18361,dose,0,0
18362,of,0,0
18363,eprosartan,0,0
18364,with,0,1
18365,half,0,1
18366,the,0,0
18367,dose,0,0
18368,of,0,0
18369,enalapril,0,0
18370,had,0,1
18371,a,0,0
18372,prominent,0,0
18373,effect,0,0
18374,on,0,0
18375,renal,0,1
18376,perfusion,0,0
18377,.,0,1
18378,The,0,0
18379,effects,0,0
18380,of,0,0
18381,eprosartan,0,1
18382,on,0,0
18383,RPF,0,1
18384,are,0,0
18385,mediated,0,0
18386,",",0,0
18387,at,0,0
18388,least,0,0
18389,in,0,0
18390,part,0,0
18391,",",0,0
18392,by,0,0
18393,an,0,0
18394,increased,0,0
18395,bioavailability,0,0
18396,of,0,0
18397,nitric,0,0
18398,oxide,0,0
18399,in,0,0
18400,the,0,0
18401,renal,0,1
18402,vasculature,0,1
18403,.,0,1
18404,Detection,0,0
18405,of,0,0
18406,recurrent,1,1
18407,or,1,1
18408,persistent,1,1
18409,nasopharyngeal,1,1
18410,carcinomas,1,1
18411,after,1,0
18412,radiotherapy,1,1
18413,with,0,1
18414,technetium-99m,0,0
18415,methoxyisobutylisonitrile,0,1
18416,single,0,0
18417,photon,0,0
18418,emission,0,1
18419,computed,0,0
18420,tomography,0,0
18421,and,0,0
18422,computed,0,0
18423,tomography,0,1
18424,:,0,1
18425,comparison,0,0
18426,with,0,1
18427,18-fluoro-2-deoxyglucose,0,1
18428,positron,0,1
18429,emission,0,1
18430,tomography,0,0
18431,.,0,1
18432,BACKGROUND,0,0
18433,The,0,0
18434,diagnostic,0,0
18435,accuracy,0,0
18436,of,0,0
18437,technetium-99m,0,0
18438,methoxyisobutylisonitrile,0,1
18439,(,0,1
18440,Tc-MIBI,0,1
18441,),0,1
18442,single,0,0
18443,photon,0,0
18444,emission,0,1
18445,computed,0,0
18446,tomography,0,0
18447,(,0,1
18448,SPECT,0,1
18449,),0,1
18450,and,0,0
18451,computed,0,0
18452,tomography,0,0
18453,(,0,1
18454,CT,0,1
18455,),0,1
18456,of,0,0
18457,the,0,0
18458,head,0,1
18459,and,0,0
18460,neck,0,1
18461,for,0,0
18462,differentiating,0,0
18463,recurrent,0,1
18464,or,0,1
18465,residual,1,0
18466,nasopharyngeal,1,1
18467,carcinomas,1,1
18468,(,1,1
18469,NPC,1,1
18470,),1,1
18471,from,0,1
18472,benign,0,1
18473,lesions,0,1
18474,after,0,1
18475,radiotherapy,0,1
18476,was,0,0
18477,compared,0,0
18478,with,0,1
18479,positron,0,1
18480,emission,0,1
18481,tomography,0,0
18482,(,0,1
18483,PET,0,0
18484,),0,1
18485,with,0,1
18486,18-fluoro-2-deoxyglucose,0,1
18487,(,0,1
18488,FDG,0,1
18489,),0,1
18490,.,0,1
18491,METHODS,0,0
18492,Thirty,1,1
18493,six,1,1
18494,NPC,1,1
18495,patients,1,1
18496,underwent,1,1
18497,head,1,1
18498,and,1,1
18499,neck,1,1
18500,CT,1,0
18501,",",1,1
18502,Tc-MIBI,1,0
18503,SPECT,1,1
18504,",",1,0
18505,and,1,0
18506,FDG-PET,1,1
18507,four,1,1
18508,months,1,0
18509,after,1,1
18510,radiotherapy,1,1
18511,to,0,0
18512,differentiate,0,1
18513,recurrent,0,1
18514,or,0,1
18515,residual,0,0
18516,NPC,0,1
18517,from,0,1
18518,benign,0,1
18519,lesions,0,1
18520,.,0,1
18521,Histopathologic,0,0
18522,examinations,0,1
18523,of,0,1
18524,nasopharyngeal,0,1
18525,biopsies,0,1
18526,were,0,1
18527,performed,0,0
18528,for,0,0
18529,all,0,1
18530,36,1,1
18531,patients,1,1
18532,.,1,1
18533,No,1,0
18534,patients,1,1
18535,had,1,1
18536,multiple,1,1
18537,foci,1,1
18538,of,1,1
18539,NPC,1,1
18540,.,1,1
18541,RESULTS,0,0
18542,Based,0,0
18543,on,0,0
18544,biopsy,0,1
18545,results,0,0
18546,",",0,0
18547,the,0,0
18548,sensitivity,0,0
18549,",",0,0
18550,specificity,0,0
18551,",",0,0
18552,and,0,0
18553,accuracy,0,0
18554,of,0,0
18555,CT,0,1
18556,for,0,1
18557,differentiating,0,0
18558,recurrent,0,1
18559,or,0,1
18560,residual,0,0
18561,NPC,0,1
18562,from,0,1
18563,benign,0,1
18564,lesions,0,1
18565,were,0,1
18566,73,0,1
18567,%,0,0
18568,",",0,1
18569,88,0,0
18570,%,0,0
18571,",",0,1
18572,and,0,0
18573,83,0,1
18574,%,0,0
18575,",",0,0
18576,respectively,0,0
18577,.,0,0
18578,The,0,0
18579,sensitivity,0,0
18580,",",0,0
18581,specificity,0,0
18582,",",0,0
18583,and,0,0
18584,accuracy,0,0
18585,of,0,0
18586,Tc-MIBI,0,1
18587,SPECT,0,1
18588,were,0,1
18589,73,0,1
18590,%,0,0
18591,",",0,1
18592,96,0,1
18593,%,0,0
18594,",",0,1
18595,and,0,0
18596,89,0,1
18597,%,0,0
18598,",",0,0
18599,respectively,0,0
18600,.,0,0
18601,The,0,0
18602,sensitivity,0,0
18603,",",0,0
18604,specificity,0,0
18605,",",0,0
18606,and,0,0
18607,accuracy,0,0
18608,of,0,0
18609,FDG-PET,0,1
18610,were,0,1
18611,100,0,1
18612,%,0,0
18613,",",0,1
18614,96,0,1
18615,%,0,0
18616,",",0,1
18617,and,0,0
18618,97,0,1
18619,%,0,0
18620,",",0,0
18621,respectively,0,0
18622,.,0,1
18623,Combination,0,0
18624,CT,0,0
18625,and,0,1
18626,Tc-MIBI,0,1
18627,SPECT,0,1
18628,for,0,1
18629,28,0,1
18630,NPC,0,1
18631,patients,0,1
18632,with,0,1
18633,congruent,0,1
18634,results,0,0
18635,showed,0,0
18636,the,0,0
18637,same,0,0
18638,sensitivity,0,0
18639,",",0,0
18640,specificity,0,0
18641,",",0,0
18642,and,0,0
18643,accuracy,0,0
18644,of,0,0
18645,100,0,1
18646,%,0,0
18647,",",0,1
18648,96,0,1
18649,%,0,0
18650,",",0,1
18651,and,0,0
18652,96,0,1
18653,%,0,0
18654,",",0,0
18655,respectively,0,0
18656,",",0,0
18657,as,0,0
18658,FDG-PET,0,1
18659,for,0,1
18660,differentiating,0,0
18661,recurrent,0,1
18662,or,0,1
18663,residual,0,0
18664,NPC,0,1
18665,from,0,1
18666,benign,0,1
18667,lesions,0,1
18668,.,0,1
18669,In,0,1
18670,eight,0,1
18671,patients,0,1
18672,with,0,1
18673,incongruent,0,0
18674,results,0,0
18675,between,0,1
18676,CT,0,1
18677,and,0,1
18678,Tc-MIBI,0,1
18679,SPECT,0,1
18680,",",0,0
18681,FDG-PET,0,0
18682,correctly,0,1
18683,differentiated,0,1
18684,two,0,0
18685,benign,0,1
18686,lesions,0,1
18687,and,0,1
18688,six,0,1
18689,recurrent,0,1
18690,or,0,1
18691,residual,0,1
18692,NPCs,0,1
18693,.,0,1
18694,CONCLUSIONS,0,0
18695,In,0,0
18696,detecting,0,0
18697,recurrent,0,1
18698,or,0,1
18699,residual,0,0
18700,NPC,0,1
18701,",",0,0
18702,FDG-PET,0,0
18703,is,0,0
18704,the,0,0
18705,best,0,0
18706,tool,0,0
18707,.,0,1
18708,However,0,0
18709,",",0,0
18710,combined,0,0
18711,use,0,0
18712,of,0,0
18713,CT,0,1
18714,and,0,1
18715,Tc-MIBI,0,0
18716,SPECT,0,1
18717,can,0,0
18718,result,0,0
18719,in,0,0
18720,the,0,0
18721,same,0,0
18722,accuracy,0,0
18723,as,0,0
18724,FDG-PET,0,1
18725,.,0,1
18726,Oat,0,0
18727,ingestion,0,0
18728,reduces,0,0
18729,systolic,0,0
18730,and,0,0
18731,diastolic,0,1
18732,blood,0,0
18733,pressure,0,0
18734,in,0,0
18735,patients,1,1
18736,with,1,1
18737,mild,1,1
18738,or,1,1
18739,borderline,1,1
18740,hypertension,1,1
18741,:,1,1
18742,a,0,0
18743,pilot,0,0
18744,trial,0,0
18745,.,0,1
18746,OBJECTIVES,0,0
18747,We,0,0
18748,assessed,0,0
18749,the,0,0
18750,short-term,0,0
18751,antihypertensive,0,1
18752,effects,0,0
18753,of,0,1
18754,soluble,0,1
18755,fiber-rich,0,1
18756,whole,0,0
18757,oat,0,1
18758,cereals,0,0
18759,when,0,0
18760,added,0,0
18761,to,0,0
18762,a,0,1
18763,standard,0,1
18764,American,0,1
18765,diet,0,1
18766,.,0,1
18767,In,0,0
18768,addition,0,0
18769,",",0,1
18770,multiple,0,1
18771,assessments,0,0
18772,of,0,1
18773,insulin,0,1
18774,sensitivity,0,0
18775,were,0,1
18776,conducted,0,1
18777,.,0,1
18778,STUDY,0,0
18779,DESIGN,0,0
18780,This,0,0
18781,was,0,0
18782,a,0,0
18783,randomized,0,1
18784,",",0,0
18785,controlled,0,0
18786,",",0,0
18787,parallel-group,0,0
18788,pilot,0,1
18789,study,0,1
18790,designed,0,0
18791,to,0,0
18792,compare,0,0
18793,an,0,0
18794,oat,0,0
18795,cereal,0,1
18796,group,0,1
18797,(,0,1
18798,standardized,0,0
18799,to,0,1
18800,5.52,0,0
18801,g/day,0,0
18802,beta-glucan,0,0
18803,),0,1
18804,to,0,1
18805,a,0,1
18806,low-fiber,0,0
18807,cereal,0,1
18808,control,0,1
18809,group,0,0
18810,(,0,0
18811,less,0,0
18812,than,0,1
18813,1.0,0,0
18814,g/day,0,0
18815,total,0,1
18816,fiber,0,0
18817,),0,1
18818,over,0,0
18819,6,0,1
18820,weeks,0,1
18821,.,0,1
18822,POPULATION,0,0
18823,A,1,0
18824,total,1,1
18825,of,1,0
18826,18,1,1
18827,hypertensive,1,1
18828,and,1,1
18829,hyperinsulinemic,1,1
18830,(,1,1
18831,=,1,1
18832,10,1,1
18833,U/mL,1,1
18834,or,1,1
18835,more,1,0
18836,),1,1
18837,men,1,1
18838,and,1,1
18839,women,1,1
18840,completed,1,1
18841,the,1,0
18842,trial,1,0
18843,.,1,1
18844,OUTCOMES,0,0
18845,MEASURED,0,0
18846,Primary,0,1
18847,study,0,1
18848,outcomes,0,0
18849,were,0,1
18850,changes,0,0
18851,in,0,1
18852,systolic,0,1
18853,blood,0,0
18854,pressure,0,0
18855,(,0,1
18856,SBP,0,1
18857,),0,1
18858,and,0,1
18859,diastolic,0,1
18860,blood,0,0
18861,pressure,0,0
18862,(,0,1
18863,DBP,0,1
18864,),0,1
18865,.,0,1
18866,Secondary,0,0
18867,outcomes,0,0
18868,included,0,1
18869,blood,0,0
18870,lipid,0,0
18871,",",0,0
18872,fasting,0,0
18873,glucose,0,0
18874,",",0,0
18875,and,0,0
18876,insulin,0,1
18877,levels,0,0
18878,and,0,1
18879,side,0,0
18880,effects,0,0
18881,related,0,0
18882,to,0,1
18883,elevated,0,1
18884,blood,0,0
18885,pressure,0,0
18886,and,0,0
18887,increased,0,0
18888,dietary,0,0
18889,fiber,0,0
18890,intake,0,0
18891,.,0,0
18892,RESULTS,0,0
18893,The,0,0
18894,oat,0,0
18895,cereal,0,1
18896,group,0,1
18897,experienced,0,1
18898,a,0,1
18899,7.5,0,0
18900,mm,0,1
18901,Hg,0,0
18902,reduction,0,0
18903,in,0,1
18904,SBP,0,1
18905,(,0,1
18906,P,0,0
18907,&,0,1
18908,lt.01,0,1
18909,),0,0
18910,and,0,0
18911,a,0,1
18912,5.5,0,0
18913,mm,0,1
18914,Hg,0,0
18915,reduction,0,0
18916,in,0,1
18917,DBP,0,1
18918,(,0,1
18919,P,0,0
18920,&,0,1
18921,lt.02,0,1
18922,),0,0
18923,",",0,0
18924,while,0,0
18925,there,0,0
18926,was,0,0
18927,virtually,0,0
18928,no,0,0
18929,change,0,0
18930,in,0,0
18931,either,0,1
18932,SBP,0,1
18933,or,0,1
18934,DBP,0,1
18935,in,0,0
18936,the,0,0
18937,control,0,1
18938,group,0,0
18939,.,0,1
18940,In,0,0
18941,the,0,0
18942,oat,0,1
18943,cereal,0,1
18944,group,0,0
18945,",",0,0
18946,a,0,0
18947,trend,0,0
18948,was,0,0
18949,observed,0,0
18950,for,0,0
18951,a,0,1
18952,lower,0,0
18953,total,0,1
18954,insulin,0,0
18955,response,0,0
18956,to,0,0
18957,a,0,0
18958,glucose,0,0
18959,load,0,0
18960,",",0,0
18961,suggesting,0,0
18962,improved,0,0
18963,insulin,0,1
18964,sensitivity,0,0
18965,.,0,1
18966,However,0,0
18967,",",0,0
18968,this,0,0
18969,could,0,0
18970,not,0,0
18971,be,0,0
18972,confirmed,0,0
18973,using,0,0
18974,estimates,0,0
18975,from,0,1
18976,the,0,1
18977,Bergman,0,1
18978,Minimal,0,0
18979,Model,0,1
18980,",",0,0
18981,perhaps,0,0
18982,because,0,0
18983,of,0,0
18984,our,0,1
18985,small,0,1
18986,sample,0,1
18987,size,0,0
18988,.,0,1
18989,The,0,0
18990,oats,0,0
18991,group,0,1
18992,experienced,0,1
18993,a,0,0
18994,significant,0,0
18995,reduction,0,0
18996,in,0,0
18997,both,0,0
18998,total,0,1
18999,cholesterol,0,0
19000,(,0,1
19001,9,0,0
19002,%,0,0
19003,),0,1
19004,and,0,0
19005,low-density,0,1
19006,lipoprotein,0,0
19007,cholesterol,0,0
19008,(,0,1
19009,14,0,1
19010,%,0,0
19011,),0,1
19012,.,0,0
19013,CONCLUSIONS,0,0
19014,The,0,0
19015,addition,0,0
19016,of,0,0
19017,oat,0,1
19018,cereals,0,1
19019,to,0,1
19020,the,0,0
19021,normal,0,1
19022,diet,0,1
19023,of,0,1
19024,patients,1,1
19025,with,1,1
19026,hypertension,1,1
19027,significantly,0,0
19028,reduces,0,0
19029,both,0,0
19030,SBP,0,0
19031,and,0,1
19032,DBP,0,1
19033,.,0,1
19034,Soluble,0,0
19035,fiber-rich,0,1
19036,whole,0,0
19037,oats,0,1
19038,may,0,0
19039,be,0,0
19040,an,0,0
19041,effective,0,0
19042,dietary,0,0
19043,therapy,0,0
19044,in,0,0
19045,the,0,0
19046,prevention,0,1
19047,and,0,0
19048,adjunct,0,0
19049,treatment,0,0
19050,of,0,0
19051,hypertension,0,1
19052,.,0,1
19053,Effect,0,0
19054,of,0,0
19055,cerivastatin,0,0
19056,on,0,1
19057,proteinuria,0,1
19058,and,0,1
19059,urinary,0,1
19060,podocytes,0,1
19061,in,0,1
19062,patients,1,1
19063,with,1,1
19064,chronic,1,1
19065,glomerulonephritis,1,1
19066,.,1,1
19067,BACKGROUND,0,0
19068,We,0,0
19069,previously,0,1
19070,reported,0,1
19071,urinary,0,1
19072,podocytes,0,0
19073,to,0,1
19074,be,0,0
19075,a,0,0
19076,marker,0,0
19077,of,0,0
19078,glomerular,0,1
19079,injury,0,1
19080,.,0,1
19081,The,0,0
19082,aim,0,0
19083,of,0,0
19084,the,0,0
19085,present,0,0
19086,study,0,1
19087,was,0,0
19088,to,0,0
19089,determine,0,0
19090,whether,0,0
19091,cerivastatin,0,0
19092,",",0,0
19093,a,0,0
19094,newly,0,1
19095,developed,0,0
19096,",",0,0
19097,potent,0,1
19098,synthetic,0,0
19099,statin,0,0
19100,",",0,0
19101,affects,0,0
19102,proteinuria,0,0
19103,and,0,0
19104,urinary,0,1
19105,podocyte,0,0
19106,excretion,0,0
19107,in,0,0
19108,patients,1,1
19109,with,1,1
19110,chronic,1,1
19111,glomerulonephritis,1,1
19112,(,1,1
19113,CGN,1,1
19114,),1,1
19115,.,0,1
19116,METHODS,0,0
19117,We,0,0
19118,randomly,0,1
19119,assigned,0,1
19120,40,1,1
19121,normotensive,1,1
19122,hypercholesterolemic,1,1
19123,patients,1,1
19124,with,1,1
19125,CGN,1,1
19126,to,0,0
19127,receive,0,1
19128,either,0,0
19129,cerivastatin,0,0
19130,0.15,0,0
19131,mg/day,0,0
19132,(,0,1
19133,n=20,0,1
19134,),0,1
19135,or,0,1
19136,placebo,0,0
19137,(,0,1
19138,n=20,0,1
19139,),0,1
19140,.,0,1
19141,Subjects,1,1
19142,comprised,1,1
19143,24,1,1
19144,men,1,1
19145,and,1,1
19146,16,1,1
19147,women,1,1
19148,",",1,1
19149,with,1,1
19150,a,1,0
19151,mean,1,1
19152,age,1,1
19153,of,1,1
19154,40.8+/-14.4,1,1
19155,years,1,1
19156,;,1,1
19157,27,1,1
19158,had,1,1
19159,IgA,1,1
19160,nephropathy,1,1
19161,and,1,1
19162,13,1,1
19163,had,1,1
19164,non-IgA,1,1
19165,proliferative,1,1
19166,glomerulonephritis,1,1
19167,.,1,1
19168,Treatment,0,0
19169,was,0,0
19170,continued,0,0
19171,for,0,1
19172,6,0,1
19173,months,0,1
19174,.,0,1
19175,Plasma,0,1
19176,total,0,1
19177,cholesterol,0,0
19178,",",0,0
19179,HDL-cholesterol,0,0
19180,",",0,0
19181,LDL-cholesterol,0,0
19182,and,0,1
19183,triglycerides,0,0
19184,",",0,1
19185,urinary,0,1
19186,protein,0,0
19187,excretion,0,0
19188,and,0,0
19189,the,0,0
19190,number,0,0
19191,of,0,0
19192,podocytes,0,0
19193,were,0,1
19194,measured,0,0
19195,before,0,0
19196,treatment,0,0
19197,and,0,1
19198,at,0,1
19199,3,0,1
19200,and,0,1
19201,6,0,1
19202,months,0,0
19203,after,0,1
19204,treatment,0,1
19205,.,0,1
19206,RESULTS,0,0
19207,After,0,1
19208,6,0,1
19209,months,0,0
19210,",",0,1
19211,a,0,1
19212,significant,0,0
19213,reduction,0,0
19214,in,0,1
19215,total,0,1
19216,cholesterol,0,0
19217,(,0,1
19218,P,0,0
19219,<,0,0
19220,0.001,0,0
19221,),0,1
19222,",",0,1
19223,LDL-cholesterol,0,0
19224,(,0,1
19225,P,0,0
19226,<,0,0
19227,0.001,0,0
19228,),0,1
19229,and,0,1
19230,triglycerides,0,0
19231,(,0,1
19232,P,0,0
19233,<,0,0
19234,0.05,0,0
19235,),0,1
19236,",",0,0
19237,and,0,0
19238,a,0,0
19239,significant,0,0
19240,increase,0,0
19241,in,0,1
19242,HDL-cholesterol,0,0
19243,(,0,1
19244,P,0,0
19245,<,0,0
19246,0.001,0,0
19247,),0,1
19248,were,0,1
19249,observed,0,0
19250,in,0,0
19251,the,0,0
19252,group,0,0
19253,treated,0,1
19254,with,0,1
19255,cerivastatin,0,0
19256,.,0,1
19257,Urinary,0,0
19258,protein,0,0
19259,excretion,0,0
19260,decreased,0,0
19261,from,0,1
19262,1.8+/-0.6,0,0
19263,to,0,1
19264,0.8+/-0.4,0,0
19265,g/day,0,0
19266,",",0,0
19267,(,0,0
19268,P,0,0
19269,<,0,0
19270,0.01,0,0
19271,),0,1
19272,in,0,0
19273,this,0,0
19274,group,0,0
19275,",",0,0
19276,and,0,0
19277,urinary,0,0
19278,podocyte,0,0
19279,excretion,0,0
19280,decreased,0,0
19281,from,0,1
19282,1.6+/-0.6,0,1
19283,to,0,1
19284,0.9+/-0.4,0,0
19285,cells/ml,0,0
19286,(,0,1
19287,P,0,0
19288,<,0,0
19289,0.01,0,0
19290,),0,1
19291,.,0,1
19292,However,0,0
19293,",",0,0
19294,placebo,0,0
19295,showed,0,0
19296,little,0,0
19297,effect,0,0
19298,on,0,0
19299,these,0,0
19300,lipid,0,0
19301,levels,0,0
19302,",",0,1
19303,urinary,0,1
19304,protein,0,0
19305,excretion,0,0
19306,and,0,0
19307,urinary,0,0
19308,podocyte,0,1
19309,excretion,0,0
19310,.,0,1
19311,The,0,0
19312,differences,0,0
19313,between,0,0
19314,the,0,0
19315,cerivastatin,0,0
19316,group,0,0
19317,and,0,0
19318,the,0,0
19319,placebo,0,0
19320,group,0,0
19321,were,0,1
19322,significant,0,0
19323,(,0,1
19324,cholesterol,0,0
19325,",",0,0
19326,P,0,0
19327,<,0,0
19328,0.001,0,0
19329,;,0,1
19330,LDL-cholesterol,0,0
19331,",",0,1
19332,P,0,0
19333,<,0,0
19334,0.001,0,0
19335,;,0,1
19336,triglycerides,0,0
19337,",",0,1
19338,P,0,0
19339,<,0,0
19340,0.05,0,0
19341,;,0,1
19342,HDL-cholesterol,0,0
19343,",",0,1
19344,P,0,0
19345,<,0,0
19346,0.001,0,0
19347,;,0,1
19348,urinary,0,1
19349,protein,0,0
19350,",",0,1
19351,P,0,0
19352,<,0,0
19353,0.01,0,0
19354,;,0,1
19355,and,0,1
19356,urinary,0,1
19357,podocytes,0,0
19358,",",0,1
19359,P,0,0
19360,<,0,0
19361,0.01,0,0
19362,),0,1
19363,.,0,1
19364,CONCLUSION,0,0
19365,Statins,0,0
19366,such,0,0
19367,as,0,0
19368,cerivastatin,0,0
19369,may,0,0
19370,be,0,0
19371,beneficial,0,0
19372,for,0,0
19373,restoration,0,0
19374,of,0,1
19375,injured,0,1
19376,podocytes,0,1
19377,in,0,1
19378,patients,1,1
19379,with,1,1
19380,CGN,1,1
19381,and,1,1
19382,hypercholesterolaemia,1,1
19383,.,1,1
19384,Treatment,0,0
19385,of,0,0
19386,acute,0,1
19387,ischaemic,0,1
19388,stroke,0,1
19389,with,0,1
19390,the,0,0
19391,low-affinity,0,0
19392,",",0,0
19393,use-dependent,0,0
19394,NMDA,0,1
19395,antagonist,0,0
19396,AR-R15896AR,0,1
19397,.,0,1
19398,A,0,0
19399,safety,0,0
19400,and,0,0
19401,tolerability,0,0
19402,study,0,1
19403,.,0,1
19404,BACKGROUND,0,0
19405,AND,0,0
19406,PURPOSE,0,1
19407,A,0,1
19408,low-affinity,0,0
19409,",",0,0
19410,use-dependent,0,0
19411,N-Methyl-D-Aspartate,0,0
19412,(,0,1
19413,NMDA,0,1
19414,),0,1
19415,antagonist,0,0
19416,AR-R15896AR,0,0
19417,has,0,0
19418,neuroprotective,0,0
19419,properties,0,0
19420,in,0,1
19421,animal,1,1
19422,models,1,1
19423,of,1,1
19424,ischaemic,1,1
19425,stroke,1,1
19426,.,1,1
19427,The,0,0
19428,aim,0,0
19429,of,0,0
19430,the,0,0
19431,present,0,0
19432,study,0,1
19433,was,0,0
19434,to,0,0
19435,examine,0,0
19436,the,0,0
19437,safety,0,0
19438,and,0,0
19439,tolerability,0,0
19440,of,0,0
19441,a,0,1
19442,new,0,1
19443,and,0,0
19444,higher,0,0
19445,dosage,0,0
19446,regimen,0,0
19447,that,0,0
19448,would,0,0
19449,enable,0,0
19450,acute,1,1
19451,stroke,1,1
19452,patients,1,1
19453,to,0,1
19454,achieve,0,0
19455,and,0,0
19456,maintain,0,0
19457,neuroprotective,0,0
19458,plasma,0,0
19459,concentrations,0,0
19460,.,0,1
19461,METHODS,0,0
19462,A,0,1
19463,randomised,0,0
19464,",",0,0
19465,multi-centre,0,0
19466,",",0,0
19467,double-blind,0,0
19468,",",0,0
19469,placebo-controlled,0,0
19470,",",0,0
19471,parallel,0,0
19472,group,0,1
19473,study,0,1
19474,was,0,0
19475,carried,0,0
19476,out,0,1
19477,at,0,1
19478,19,1,1
19479,centres,1,1
19480,in,1,1
19481,France,1,1
19482,",",1,1
19483,Germany,1,1
19484,and,1,0
19485,the,1,0
19486,Netherlands,1,1
19487,in,1,0
19488,patients,1,1
19489,with,1,1
19490,a,1,1
19491,clinical,1,0
19492,diagnosis,1,1
19493,of,1,0
19494,acute,1,1
19495,ischaemic,1,1
19496,stroke,1,1
19497,",",1,0
19498,and,1,0
19499,onset,1,1
19500,of,1,0
19501,symptoms,1,1
19502,within,1,1
19503,12,1,1
19504,hours,1,0
19505,before,1,1
19506,start,1,1
19507,of,1,0
19508,study,1,1
19509,drug,1,1
19510,administration,1,0
19511,.,1,1
19512,Two,0,1
19513,loading,0,0
19514,doses,0,0
19515,of,0,1
19516,3.5,0,1
19517,mg/kg,0,0
19518,of,0,1
19519,AR-R15896AR,0,1
19520,over,0,1
19521,60,0,1
19522,minutes,0,0
19523,",",0,1
19524,followed,0,0
19525,by,0,0
19526,a,0,1
19527,2.5,0,0
19528,mg/kg,0,0
19529,infusion,0,0
19530,over,0,0
19531,the,0,0
19532,next,0,1
19533,120,0,1
19534,minutes,0,0
19535,were,0,1
19536,given,0,1
19537,.,0,1
19538,Eight,0,0
19539,hours,0,0
19540,after,0,1
19541,the,0,0
19542,start,0,1
19543,of,0,0
19544,the,0,0
19545,loading,0,0
19546,dose,0,0
19547,infusion,0,0
19548,",",0,0
19549,the,0,0
19550,first,0,0
19551,maintenance,0,0
19552,dose,0,0
19553,(,0,1
19554,120,0,1
19555,mg,0,1
19556,),0,1
19557,was,0,0
19558,administered,0,0
19559,over,0,0
19560,60,0,1
19561,minutes,0,0
19562,.,0,1
19563,Eight,0,0
19564,further,0,0
19565,maintenance,0,1
19566,infusions,0,0
19567,were,0,1
19568,administered,0,0
19569,at,0,1
19570,intervals,0,0
19571,of,0,1
19572,8,0,1
19573,hours,0,0
19574,over,0,0
19575,a,0,1
19576,total,0,1
19577,treatment,0,0
19578,period,0,1
19579,of,0,1
19580,3,0,1
19581,days,0,1
19582,.,0,1
19583,Main,0,0
19584,variables,0,0
19585,were,0,1
19586,safety,0,0
19587,",",0,0
19588,tolerability,0,0
19589,and,0,1
19590,pharmacokinetics,0,0
19591,.,0,1
19592,Follow-up,0,0
19593,assessments,0,0
19594,also,0,0
19595,included,0,1
19596,the,0,0
19597,Barthel,0,0
19598,Index,0,0
19599,(,0,1
19600,BI,0,1
19601,),0,1
19602,and,0,0
19603,the,0,0
19604,NIH,0,0
19605,Stroke,0,1
19606,Scale,0,1
19607,(,0,1
19608,NIHSS,0,1
19609,),0,1
19610,at,0,1
19611,4-7,0,1
19612,days,0,0
19613,after,0,1
19614,the,0,0
19615,end,0,0
19616,of,0,0
19617,the,0,0
19618,last,0,0
19619,infusion,0,0
19620,and,0,1
19621,at,0,1
19622,30,0,1
19623,days,0,0
19624,after,0,1
19625,the,0,0
19626,onset,0,1
19627,of,0,0
19628,stroke,0,1
19629,.,0,1
19630,RESULTS,0,0
19631,103,1,1
19632,patients,1,1
19633,with,1,1
19634,acute,1,1
19635,ischaemic,1,1
19636,stroke,1,1
19637,were,1,1
19638,randomised,1,0
19639,to,0,0
19640,either,0,0
19641,treatment,0,0
19642,with,0,1
19643,AR-R15896AR,0,1
19644,(,0,1
19645,70,0,1
19646,patients,0,1
19647,),0,1
19648,or,0,1
19649,placebo,0,0
19650,(,0,1
19651,33,0,1
19652,patients,0,1
19653,),0,1
19654,.,0,1
19655,Mortality,0,0
19656,was,0,0
19657,not,0,0
19658,significantly,0,0
19659,different,0,0
19660,in,0,0
19661,the,0,0
19662,AR-R15896AR,0,0
19663,group,0,0
19664,compared,0,0
19665,with,0,1
19666,the,0,0
19667,placebo,0,0
19668,group,0,1
19669,(,0,1
19670,10,0,0
19671,%,0,0
19672,vs.,0,0
19673,6,0,0
19674,%,0,0
19675,),0,1
19676,.,0,1
19677,Serious,0,0
19678,adverse,0,0
19679,events,0,0
19680,during,0,1
19681,treatment,0,1
19682,due,0,1
19683,to,0,1
19684,psychiatric,0,1
19685,conditions,0,1
19686,were,0,1
19687,associated,0,0
19688,with,0,1
19689,AR-R15896AR,0,1
19690,(,0,1
19691,3,0,1
19692,vs.,0,0
19693,0,0,0
19694,),0,1
19695,.,0,1
19696,Other,0,0
19697,side,0,0
19698,effects,0,0
19699,were,0,1
19700,more,0,0
19701,common,0,0
19702,in,0,0
19703,the,0,0
19704,group,0,0
19705,treated,0,1
19706,with,0,1
19707,AR-R15896AR,0,1
19708,:,0,1
19709,vomiting,0,0
19710,(,0,1
19711,29,0,1
19712,%,0,0
19713,vs.,0,0
19714,9,0,0
19715,%,0,0
19716,),0,1
19717,",",0,0
19718,nausea,0,0
19719,(,0,1
19720,23,0,1
19721,%,0,0
19722,vs.,0,0
19723,12,0,1
19724,%,0,0
19725,),0,0
19726,",",0,0
19727,fever,0,1
19728,(,0,0
19729,17,0,1
19730,%,0,0
19731,vs.,0,0
19732,12,0,1
19733,%,0,0
19734,),0,1
19735,",",0,0
19736,agitation,0,0
19737,(,0,1
19738,7,0,0
19739,%,0,0
19740,vs.,0,0
19741,3,0,1
19742,%,0,0
19743,),0,1
19744,",",0,0
19745,dizziness,0,0
19746,(,0,1
19747,7,0,0
19748,%,0,0
19749,vs.,0,0
19750,0,0,0
19751,%,0,0
19752,),0,1
19753,",",0,0
19754,and,0,1
19755,hallucinations,0,0
19756,(,0,1
19757,6,0,0
19758,%,0,0
19759,vs.,0,0
19760,0,0,0
19761,%,0,0
19762,),0,1
19763,.,0,1
19764,No,0,0
19765,significant,0,0
19766,difference,0,0
19767,between,0,0
19768,the,0,1
19769,two,0,1
19770,groups,0,0
19771,(,0,1
19772,with,0,1
19773,respect,0,0
19774,to,0,1
19775,the,0,0
19776,proportions,0,0
19777,of,0,1
19778,patients,0,1
19779,with,0,1
19780,favourable,0,0
19781,outcome,0,0
19782,),0,1
19783,was,0,0
19784,detected,0,0
19785,in,0,0
19786,either,0,0
19787,the,0,0
19788,analysis,0,0
19789,of,0,0
19790,the,0,0
19791,BI,0,0
19792,or,0,1
19793,the,0,0
19794,NIHSS,0,1
19795,.,0,1
19796,Pharmacokinetic,0,0
19797,data,0,0
19798,showed,0,0
19799,that,0,0
19800,plasma,0,0
19801,concentrations,0,0
19802,of,0,1
19803,AR-R15896AR,0,1
19804,were,0,1
19805,in,0,0
19806,the,0,0
19807,expected,0,0
19808,neuroprotective,0,0
19809,range,0,1
19810,.,0,1
19811,CONCLUSION,0,0
19812,In,0,0
19813,most,0,0
19814,of,0,0
19815,the,0,0
19816,patients,0,1
19817,with,0,1
19818,acute,0,1
19819,stroke,0,1
19820,receiving,0,1
19821,AR-R15896AR,0,0
19822,the,0,0
19823,intended,0,0
19824,high,0,1
19825,plasma,0,0
19826,levels,0,0
19827,were,0,1
19828,reached,0,0
19829,within,0,0
19830,a,0,1
19831,short,0,0
19832,time,0,0
19833,period,0,0
19834,.,0,1
19835,However,0,0
19836,",",0,0
19837,active,0,0
19838,treatment,0,0
19839,produced,0,0
19840,more,0,0
19841,side,0,0
19842,effects,0,0
19843,than,0,0
19844,placebo,0,0
19845,",",0,0
19846,thus,0,0
19847,indicating,0,0
19848,safety,0,0
19849,concerns,0,0
19850,and,0,1
19851,tolerability,0,0
19852,issues,0,0
19853,for,0,0
19854,use,0,0
19855,in,0,1
19856,high,0,1
19857,doses,0,0
19858,in,0,1
19859,an,0,1
19860,acute,0,1
19861,stroke,0,1
19862,population,0,1
19863,.,0,1
19864,A,0,0
19865,single,0,0
19866,infusion,0,0
19867,of,0,0
19868,intravenous,0,0
19869,ketamine,0,0
19870,improves,0,0
19871,pain,0,0
19872,relief,0,0
19873,in,0,0
19874,patients,1,1
19875,with,1,1
19876,critical,1,0
19877,limb,1,1
19878,ischaemia,1,1
19879,:,1,1
19880,results,0,0
19881,of,0,0
19882,a,0,1
19883,double,0,0
19884,blind,0,1
19885,randomised,0,1
19886,controlled,0,0
19887,trial,0,1
19888,.,0,1
19889,We,0,0
19890,report,0,0
19891,the,0,0
19892,first,0,0
19893,double,0,0
19894,blind,0,1
19895,randomised,0,1
19896,controlled,0,0
19897,trial,0,1
19898,of,0,1
19899,regular,0,1
19900,opioids,0,0
19901,and,0,1
19902,an,0,1
19903,infusion,0,0
19904,of,0,0
19905,low,0,1
19906,dose,0,0
19907,(,0,1
19908,0.6,0,0
19909,mg/kg,0,0
19910,),0,1
19911,intravenous,0,1
19912,ketamine,0,1
19913,compared,0,0
19914,with,0,1
19915,opioids,0,0
19916,and,0,1
19917,placebo,0,1
19918,in,0,0
19919,patients,1,1
19920,with,1,1
19921,allodynia,1,1
19922,",",1,0
19923,hyperalgesia,1,0
19924,and,1,0
19925,hyperpathia,1,1
19926,secondary,1,1
19927,to,1,1
19928,critical,1,0
19929,limb,1,1
19930,ischaemia,1,1
19931,.,1,1
19932,Thirty-five,1,1
19933,patients,1,1
19934,completed,1,1
19935,the,1,0
19936,study,1,0
19937,",",1,0
19938,18,1,1
19939,received,0,1
19940,regular,0,1
19941,opioids,0,0
19942,plus,0,0
19943,ketamine,0,1
19944,",",0,0
19945,while,0,0
19946,17,1,1
19947,received,0,1
19948,regular,0,1
19949,opioids,0,0
19950,plus,0,0
19951,placebo,0,1
19952,.,0,1
19953,Using,0,0
19954,the,0,0
19955,Brief,0,0
19956,Pain,0,1
19957,Inventory,0,1
19958,",",0,0
19959,the,0,0
19960,%,0,0
19961,pain,0,1
19962,relief,0,0
19963,that,0,0
19964,the,0,0
19965,patients,0,1
19966,in,0,0
19967,the,0,0
19968,ketamine,0,0
19969,group,0,0
19970,attributed,0,0
19971,to,0,0
19972,their,0,1
19973,medication,0,0
19974,improved,0,0
19975,significantly,0,0
19976,from,0,1
19977,50,0,1
19978,%,0,0
19979,immediately,0,0
19980,pre-infusion,0,0
19981,to,0,0
19982,65,0,1
19983,%,0,0
19984,24,0,1
19985,h,0,0
19986,post-infusion,0,0
19987,and,0,1
19988,69,0,1
19989,%,0,0
19990,5,0,1
19991,days,0,0
19992,post,0,1
19993,infusion,0,0
19994,.,0,1
19995,Over,0,0
19996,the,0,0
19997,same,0,0
19998,period,0,0
19999,",",0,0
20000,the,0,0
20001,pain,0,1
20002,relief,0,0
20003,achieved,0,0
20004,by,0,0
20005,the,0,0
20006,placebo,0,0
20007,group,0,0
20008,rose,0,0
20009,from,0,1
20010,58,0,1
20011,%,0,0
20012,pre-infusion,0,0
20013,to,0,1
20014,56,0,1
20015,%,0,0
20016,24,0,1
20017,h,0,0
20018,post,0,1
20019,infusion,0,0
20020,and,0,0
20021,then,0,0
20022,50,0,1
20023,%,0,0
20024,relief,0,1
20025,5,0,1
20026,days,0,0
20027,later,0,1
20028,.,0,1
20029,This,0,0
20030,was,0,0
20031,statistically,0,0
20032,significant,0,0
20033,(,0,1
20034,P,0,0
20035,<,0,0
20036,0.05,0,0
20037,),0,1
20038,using,0,0
20039,both,0,0
20040,the,0,0
20041,t-test,0,0
20042,and,0,0
20043,the,0,0
20044,Wilcoxon,0,0
20045,Rank,0,1
20046,Sum,0,1
20047,test,0,0
20048,.,0,1
20049,The,0,0
20050,ketamine,0,0
20051,group,0,0
20052,also,0,0
20053,showed,0,0
20054,a,0,0
20055,statistically,0,0
20056,significant,0,0
20057,difference,0,0
20058,24,0,1
20059,h,0,0
20060,post,0,1
20061,infusion,0,0
20062,of,0,0
20063,the,0,0
20064,effect,0,0
20065,of,0,0
20066,pain,0,1
20067,on,0,0
20068,their,0,1
20069,general,0,1
20070,activity,0,0
20071,(,0,1
20072,P=0.03,0,0
20073,),0,1
20074,and,0,0
20075,on,0,0
20076,their,0,1
20077,enjoyment,0,0
20078,of,0,0
20079,life,0,1
20080,(,0,1
20081,P=0.004,0,0
20082,),0,1
20083,.,0,1
20084,This,0,0
20085,study,0,0
20086,shows,0,0
20087,that,0,0
20088,combining,0,0
20089,a,0,1
20090,single,0,0
20091,infusion,0,0
20092,of,0,0
20093,low,0,1
20094,dose,0,0
20095,ketamine,0,1
20096,with,0,1
20097,regular,0,1
20098,opioid,0,0
20099,analgesia,0,0
20100,can,0,0
20101,result,0,0
20102,in,0,0
20103,a,0,0
20104,significant,0,0
20105,improvement,0,0
20106,in,0,0
20107,pain,0,1
20108,relief,0,0
20109,for,0,0
20110,this,0,0
20111,patient,0,1
20112,group,0,1
20113,.,0,1
20114,Brief,0,1
20115,report,0,1
20116,:,0,1
20117,imitation,0,1
20118,effects,0,0
20119,on,0,1
20120,children,1,1
20121,with,1,1
20122,autism,1,1
20123,.,1,1
20124,Twenty,1,1
20125,children,1,1
20126,with,1,1
20127,autism,1,1
20128,(,1,1
20129,mean,1,1
20130,age,1,1
20131,",",1,1
20132,5,1,1
20133,years,1,1
20134,),1,1
20135,were,1,1
20136,recruited,1,1
20137,for,1,0
20138,the,1,0
20139,study,1,0
20140,from,1,0
20141,a,1,0
20142,school,1,1
20143,for,1,0
20144,children,1,1
20145,with,1,1
20146,autism,1,1
20147,.,1,1
20148,The,0,0
20149,children,0,1
20150,were,0,1
20151,randomly,0,1
20152,assigned,0,1
20153,to,0,0
20154,an,0,0
20155,imitation,1,0
20156,(,1,0
20157,n,1,1
20158,=,1,1
20159,10,1,1
20160,),1,1
20161,or,1,1
20162,contingently,1,1
20163,responsive,1,1
20164,(,1,1
20165,n,1,1
20166,=,1,1
20167,10,1,1
20168,),1,1
20169,interaction,0,0
20170,group,0,1
20171,based,0,1
20172,on,0,0
20173,a,0,0
20174,stratification,0,0
20175,table,0,0
20176,for,0,0
20177,gender,0,0
20178,and,0,1
20179,developmental,0,1
20180,and,0,0
20181,chronological,0,1
20182,age,0,1
20183,.,0,1
20184,The,0,0
20185,sessions,0,0
20186,consisted,0,1
20187,of,0,1
20188,four,0,1
20189,phases,0,0
20190,",",0,1
20191,with,0,1
20192,each,0,0
20193,phase,0,1
20194,lasting,0,0
20195,3,0,1
20196,minutes,0,0
20197,.,0,1
20198,In,0,0
20199,the,0,0
20200,first,0,0
20201,phase,0,0
20202,",",0,0
20203,the,0,0
20204,child,0,1
20205,walked,0,0
20206,into,0,0
20207,a,0,1
20208,room,0,1
20209,that,0,0
20210,was,0,0
20211,furnished,0,0
20212,with,0,1
20213,a,0,0
20214,sofa,0,0
20215,",",0,0
20216,a,0,0
20217,table,0,0
20218,",",0,0
20219,chairs,0,1
20220,",",0,1
20221,and,0,1
20222,two,0,0
20223,sets,0,1
20224,of,0,1
20225,identical,0,1
20226,toys,0,1
20227,.,0,1
20228,An,0,0
20229,adult,0,1
20230,was,0,0
20231,in,0,0
20232,the,0,0
20233,room,0,1
20234,sitting,0,0
20235,very,0,0
20236,still,0,0
20237,like,0,0
20238,a,0,0
20239,statue,0,1
20240,(,0,0
20241,first,0,0
20242,still-face,0,1
20243,condition,0,1
20244,),0,1
20245,.,0,1
20246,In,0,0
20247,the,0,0
20248,second,0,0
20249,phase,0,0
20250,",",0,0
20251,the,0,0
20252,adult,0,1
20253,either,0,0
20254,imitated,0,0
20255,the,0,0
20256,child,0,1
20257,or,0,0
20258,was,0,0
20259,contingently,0,1
20260,responsive,0,1
20261,to,0,0
20262,the,0,0
20263,child,0,1
20264,.,0,0
20265,In,0,0
20266,the,0,0
20267,third,0,1
20268,phase,0,0
20269,",",0,0
20270,the,0,0
20271,adult,0,1
20272,sat,0,0
20273,still,0,0
20274,again,0,0
20275,(,0,0
20276,second,0,1
20277,still-face,0,1
20278,condition,0,1
20279,),0,1
20280,",",0,0
20281,and,0,0
20282,in,0,0
20283,the,0,0
20284,fourth,0,0
20285,phase,0,0
20286,",",0,0
20287,the,0,0
20288,adult,0,1
20289,engaged,0,1
20290,in,0,0
20291,a,0,1
20292,spontaneous,0,1
20293,interaction,0,0
20294,.,0,1
20295,During,0,0
20296,the,0,0
20297,third,0,1
20298,phase,0,1
20299,(,0,1
20300,the,0,0
20301,second,0,1
20302,still-face,0,1
20303,condition,0,1
20304,),0,0
20305,",",0,0
20306,the,0,0
20307,children,0,1
20308,in,0,0
20309,the,0,0
20310,imitation,0,1
20311,group,0,0
20312,spent,0,0
20313,less,0,0
20314,time,0,0
20315,in,0,0
20316,gross,0,1
20317,motor,0,0
20318,activity,0,0
20319,and,0,0
20320,more,0,0
20321,time,0,0
20322,touching,0,0
20323,the,0,0
20324,adult,0,1
20325,",",0,0
20326,as,0,0
20327,if,0,0
20328,attempting,0,0
20329,to,0,0
20330,initiate,0,0
20331,an,0,0
20332,interaction,0,0
20333,.,0,0
20334,The,0,0
20335,contingency,0,0
20336,condition,0,0
20337,appeared,0,0
20338,to,0,0
20339,be,0,0
20340,a,0,0
20341,more,0,0
20342,effective,0,0
20343,way,0,0
20344,to,0,0
20345,facilitate,0,0
20346,a,0,0
20347,distal,0,0
20348,social,0,0
20349,behavior,0,0
20350,(,0,1
20351,attention,0,0
20352,),0,0
20353,",",0,0
20354,whereas,0,0
20355,the,0,0
20356,imitative,0,1
20357,condition,0,0
20358,was,0,0
20359,a,0,0
20360,more,0,0
20361,effective,0,0
20362,way,0,0
20363,to,0,0
20364,facilitate,0,0
20365,a,0,0
20366,proximal,0,1
20367,social,0,0
20368,behavior,0,0
20369,(,0,1
20370,touching,0,1
20371,),0,1
20372,.,0,1
20373,Can,0,0
20374,sedation,0,0
20375,reduce,0,0
20376,the,0,0
20377,cardiac,0,1
20378,stress,0,0
20379,during,0,0
20380,gastrointestinal,0,1
20381,endoscopy,0,1
20382,?,0,1
20383,A,0,0
20384,study,0,0
20385,with,0,1
20386,non-invasive,0,0
20387,automated,0,0
20388,cardiac,0,1
20389,flow,0,0
20390,measurement,0,0
20391,by,0,0
20392,color,0,1
20393,Doppler,0,1
20394,echocardiography,0,0
20395,.,0,1
20396,BACKGROUND,0,0
20397,Upper,1,1
20398,gastrointestinal,1,1
20399,endoscopy,1,1
20400,(,1,1
20401,UGIE,1,0
20402,),1,1
20403,may,0,0
20404,cause,0,0
20405,some,0,0
20406,cardiac,0,1
20407,stress,0,0
20408,.,0,1
20409,The,0,0
20410,effect,0,0
20411,of,0,0
20412,sedation,0,1
20413,on,0,0
20414,hemodynamics,0,0
20415,during,0,1
20416,UGIE,0,0
20417,has,0,0
20418,not,0,0
20419,been,0,0
20420,fully,0,0
20421,studied,0,0
20422,",",0,0
20423,and,0,0
20424,therefore,0,0
20425,the,0,0
20426,aim,0,0
20427,of,0,0
20428,this,0,0
20429,study,0,0
20430,was,0,0
20431,to,0,0
20432,clarify,0,0
20433,whether,0,0
20434,or,0,1
20435,not,0,0
20436,sedation,0,0
20437,can,0,0
20438,reduce,0,0
20439,cardiac,0,1
20440,stress,0,0
20441,dufing,0,1
20442,UGIE,0,0
20443,.,0,1
20444,METHODS,0,0
20445,Eight,1,0
20446,normal,1,1
20447,male,1,1
20448,volunteers,1,1
20449,undergoing,1,1
20450,UGIE,1,0
20451,with,1,1
20452,sedation,1,1
20453,(,1,1
20454,0.1,1,0
20455,mg/kg,1,0
20456,of,1,0
20457,midazolam,1,1
20458,),1,1
20459,and,1,0
20460,without,1,1
20461,it,1,0
20462,(,1,1
20463,two,1,0
20464,endoscopies,1,1
20465,per,1,1
20466,volunteer,1,1
20467,in,1,1
20468,random,1,1
20469,order,1,0
20470,),1,1
20471,were,0,0
20472,monitored,0,0
20473,throughout,0,0
20474,the,0,0
20475,procedure,0,0
20476,by,0,0
20477,means,0,0
20478,of,0,1
20479,electrocardiogram,0,1
20480,",",0,0
20481,blood,0,0
20482,pressure,0,0
20483,and,0,0
20484,peripheral,0,1
20485,oxygen,0,0
20486,saturation,0,0
20487,(,0,1
20488,SpO2,0,1
20489,),0,1
20490,.,0,1
20491,Cardiac,0,0
20492,output,0,0
20493,was,0,0
20494,measured,0,0
20495,at,0,1
20496,six,0,1
20497,points,0,0
20498,before,0,0
20499,",",0,1
20500,during,0,0
20501,and,0,0
20502,after,0,0
20503,endoscopy,0,1
20504,from,0,1
20505,automated,0,0
20506,cardiac,0,1
20507,flow,0,0
20508,measurement,0,0
20509,by,0,0
20510,color,0,1
20511,Doppler,0,1
20512,echocardiography,0,0
20513,.,0,1
20514,Serum,0,0
20515,norepinephrine,0,0
20516,",",0,0
20517,epinephrine,0,0
20518,",",0,0
20519,dopamine,0,0
20520,and,0,1
20521,ACTH,0,1
20522,concentrations,0,0
20523,were,0,1
20524,measured,0,0
20525,before,0,0
20526,and,0,0
20527,after,0,0
20528,the,0,0
20529,examination,0,0
20530,.,0,1
20531,RESULTS,0,0
20532,No,0,0
20533,significant,0,0
20534,differences,0,0
20535,in,0,1
20536,heart,0,1
20537,rate,0,0
20538,",",0,0
20539,systolic,0,0
20540,blood,0,0
20541,pressure,0,0
20542,",",0,0
20543,rate-pressure,0,0
20544,product,0,0
20545,",",0,0
20546,cardiac,0,1
20547,output,0,0
20548,and,0,1
20549,left,0,1
20550,ventricular,0,1
20551,work,0,0
20552,index,0,1
20553,were,0,0
20554,observed,0,0
20555,between,0,0
20556,the,0,0
20557,sedated,0,1
20558,and,0,0
20559,non-sedated,0,1
20560,groups,0,1
20561,.,0,1
20562,SpO2,0,0
20563,hardly,0,0
20564,changed,0,0
20565,during,0,0
20566,endoscopy,0,1
20567,in,0,0
20568,the,0,0
20569,non-sedated,0,1
20570,group,0,0
20571,",",0,0
20572,but,0,0
20573,decreased,0,0
20574,slightly,0,0
20575,in,0,0
20576,the,0,0
20577,sedated,0,1
20578,group,0,0
20579,(,0,1
20580,P,0,0
20581,=,0,1
20582,0.075,0,0
20583,),0,1
20584,.,0,1
20585,Although,0,0
20586,all,0,0
20587,serum,0,0
20588,catecholamine,0,0
20589,concentration,0,0
20590,changes,0,0
20591,were,0,1
20592,within,0,1
20593,normal,0,1
20594,limits,0,0
20595,in,0,1
20596,both,0,0
20597,groups,0,0
20598,",",0,0
20599,after,0,0
20600,endoscopy,0,1
20601,only,0,0
20602,epinephrine,0,0
20603,concentration,0,0
20604,was,0,0
20605,significantly,0,0
20606,lower,0,0
20607,in,0,0
20608,the,0,0
20609,sedated,0,1
20610,group,0,0
20611,than,0,0
20612,in,0,0
20613,the,0,0
20614,non-sedated,0,1
20615,group,0,1
20616,(,0,1
20617,P,0,0
20618,=,0,1
20619,0.0027,0,0
20620,),0,1
20621,.,0,1
20622,CONCLUSIONS,0,0
20623,Conscious,0,1
20624,sedation,0,1
20625,with,0,1
20626,midazolam,0,0
20627,does,0,0
20628,not,0,0
20629,reduce,0,0
20630,the,0,0
20631,cardiac,0,1
20632,stress,0,0
20633,during,0,1
20634,UGIE,0,0
20635,.,0,1
20636,Combining,0,0
20637,weight-loss,0,1
20638,counseling,0,1
20639,with,0,1
20640,the,0,0
20641,weight,0,1
20642,watchers,0,0
20643,plan,0,1
20644,for,0,0
20645,obese,1,1
20646,breast,1,1
20647,cancer,1,1
20648,survivors,1,1
20649,.,1,1
20650,OBJECTIVE,0,0
20651,The,0,0
20652,objective,0,0
20653,was,0,0
20654,to,0,0
20655,develop,0,0
20656,effective,0,0
20657,weight-loss,0,1
20658,methods,0,1
20659,for,0,1
20660,women,1,1
20661,who,1,1
20662,have,1,1
20663,had,1,1
20664,breast,1,1
20665,cancer,1,1
20666,",",0,0
20667,because,0,0
20668,obesity,0,1
20669,may,0,0
20670,result,0,0
20671,in,0,0
20672,an,0,0
20673,adverse,0,0
20674,prognosis,0,0
20675,.,0,1
20676,RESEARCH,0,1
20677,METHODS,0,0
20678,AND,0,0
20679,PROCEDURES,0,0
20680,This,0,0
20681,randomized,0,1
20682,pilot,0,0
20683,study,0,0
20684,tested,0,0
20685,an,0,0
20686,individualized,0,0
20687,approach,0,0
20688,toward,0,0
20689,weight,0,1
20690,loss,0,0
20691,in,0,1
20692,obese,1,1
20693,women,1,1
20694,who,1,1
20695,have,1,1
20696,had,1,1
20697,a,1,0
20698,diagnosis,1,1
20699,of,1,0
20700,breast,1,1
20701,cancer,1,1
20702,.,1,1
20703,An,0,0
20704,individualized,0,0
20705,approach,0,0
20706,was,0,0
20707,applied,0,0
20708,either,0,0
20709,alone,0,0
20710,or,0,1
20711,combined,0,0
20712,with,0,1
20713,the,0,0
20714,commercial,0,0
20715,Weight,0,1
20716,Watchers,0,1
20717,program,0,1
20718,.,0,1
20719,Forty-eight,1,1
20720,women,1,1
20721,(,1,1
20722,body,1,1
20723,mass,1,1
20724,index,1,1
20725,of,1,0
20726,30,1,1
20727,to,1,1
20728,44,1,1
20729,kg/m,1,1
20730,(,1,1
20731,2,1,1
20732,),1,1
20733,),1,1
20734,were,1,1
20735,enrolled,1,1
20736,.,1,1
20737,RESULTS,0,0
20738,Weight,0,1
20739,change,0,0
20740,after,0,1
20741,12,0,1
20742,months,0,1
20743,of,0,1
20744,intervention,0,1
20745,was,0,0
20746,as,0,0
20747,follows,0,0
20748,(,0,0
20749,mean,0,0
20750,+/-,0,0
20751,SD,0,1
20752,),0,1
20753,:,0,1
20754,0.85,0,0
20755,+/-,0,0
20756,6.0,0,1
20757,kg,0,1
20758,in,0,0
20759,the,0,0
20760,control,0,0
20761,group,0,0
20762,",",0,0
20763,-2.6,0,0
20764,+/-,0,0
20765,5.9,0,0
20766,kg,0,1
20767,in,0,0
20768,the,0,0
20769,Weight,0,1
20770,Watchers,0,0
20771,group,0,0
20772,",",0,0
20773,-8.0,0,0
20774,+/-,0,0
20775,5.5,0,0
20776,kg,0,1
20777,in,0,0
20778,the,0,0
20779,individualized,0,0
20780,group,0,0
20781,",",0,0
20782,and,0,0
20783,-9.4,0,0
20784,+/-,0,0
20785,8.6,0,0
20786,kg,0,1
20787,in,0,0
20788,the,0,0
20789,comprehensive,0,0
20790,group,0,1
20791,that,0,0
20792,used,0,0
20793,both,0,0
20794,individualized,0,0
20795,counseling,0,0
20796,and,0,1
20797,Weight,0,1
20798,Watchers,0,1
20799,.,0,1
20800,Weight,0,1
20801,loss,0,0
20802,relative,0,0
20803,to,0,0
20804,control,0,1
20805,was,0,0
20806,statistically,0,0
20807,significant,0,0
20808,in,0,0
20809,the,0,0
20810,comprehensive,0,0
20811,group,0,1
20812,3,0,1
20813,",",0,1
20814,6,0,0
20815,",",0,0
20816,and,0,1
20817,12,0,1
20818,months,0,0
20819,after,0,1
20820,randomization,0,1
20821,",",0,0
20822,whereas,0,0
20823,weight,0,1
20824,loss,0,0
20825,in,0,0
20826,the,0,0
20827,individualized,0,0
20828,group,0,1
20829,was,0,0
20830,significant,0,0
20831,only,0,0
20832,at,0,1
20833,12,0,1
20834,months,0,1
20835,.,0,1
20836,Weight,0,1
20837,loss,0,0
20838,of,0,0
20839,10,0,1
20840,%,0,0
20841,or,0,1
20842,more,0,0
20843,of,0,0
20844,initial,0,0
20845,body,0,1
20846,weight,0,1
20847,was,0,0
20848,observed,0,0
20849,in,0,0
20850,6,0,1
20851,of,0,1
20852,10,0,1
20853,women,0,1
20854,in,0,1
20855,the,0,1
20856,comprehensive,0,0
20857,group,0,1
20858,at,0,1
20859,12,0,1
20860,months,0,1
20861,.,0,1
20862,In,0,0
20863,the,0,0
20864,comprehensive,0,0
20865,and,0,0
20866,Weight,0,1
20867,Watchers-only,0,1
20868,groups,0,0
20869,",",0,1
20870,weight,0,1
20871,loss,0,0
20872,was,0,0
20873,significantly,0,0
20874,related,0,0
20875,to,0,0
20876,frequency,0,0
20877,of,0,0
20878,attendance,0,0
20879,at,0,1
20880,Weight,0,1
20881,Watchers,0,1
20882,meetings,0,1
20883,",",0,1
20884,and,0,0
20885,attendance,0,0
20886,was,0,0
20887,more,0,0
20888,frequent,0,0
20889,in,0,0
20890,the,0,0
20891,comprehensive,0,0
20892,group,0,1
20893,.,0,1
20894,DISCUSSION,0,0
20895,These,0,1
20896,data,0,0
20897,indicate,0,0
20898,that,0,0
20899,the,0,0
20900,most,0,0
20901,weight,0,1
20902,loss,0,0
20903,was,0,0
20904,achieved,0,0
20905,when,0,0
20906,the,0,0
20907,counseling,0,0
20908,approach,0,0
20909,combined,0,0
20910,both,0,0
20911,Weight,0,1
20912,Watchers,0,0
20913,and,0,1
20914,individualized,0,1
20915,contacts,0,1
20916,.,0,1
20917,This,0,0
20918,was,0,0
20919,effective,0,0
20920,even,0,0
20921,though,0,0
20922,most,0,0
20923,of,0,0
20924,the,0,0
20925,individualized,0,0
20926,contacts,0,1
20927,were,0,1
20928,by,0,0
20929,telephone,0,1
20930,.,0,1
20931,Double-blind,0,0
20932,placebo-controlled,0,0
20933,trial,0,1
20934,of,0,1
20935,secretin,0,1
20936,:,0,1
20937,effects,0,0
20938,on,0,0
20939,aberrant,0,1
20940,behavior,0,1
20941,in,0,1
20942,children,1,1
20943,with,1,1
20944,autism,1,1
20945,.,1,1
20946,Secretin,0,0
20947,has,0,0
20948,been,0,0
20949,proposed,0,0
20950,as,0,0
20951,a,0,0
20952,treatment,0,0
20953,alternative,0,0
20954,for,0,0
20955,autistic,1,1
20956,spectrum,1,1
20957,disorders,1,1
20958,",",0,1
20959,but,0,0
20960,empirical,0,0
20961,support,0,0
20962,is,0,0
20963,lacking,0,0
20964,.,0,0
20965,A,0,0
20966,double-blind,0,0
20967,placebo-controlled,0,0
20968,study,0,1
20969,examined,0,0
20970,the,0,0
20971,effect,0,0
20972,of,0,0
20973,a,0,1
20974,single,0,0
20975,dose,0,0
20976,of,0,0
20977,synthetic,0,0
20978,human,0,1
20979,secretin,0,1
20980,on,0,0
20981,aberrant,0,1
20982,behavior,0,1
20983,.,0,1
20984,Parent,1,0
20985,and,1,0
20986,teacher,1,1
20987,data,1,0
20988,from,1,1
20989,the,1,1
20990,Aberrant,1,1
20991,Behavior,1,1
20992,Checklist,1,0
20993,for,0,1
20994,eight,1,1
20995,male,1,1
20996,children,1,1
20997,were,0,1
20998,analyzed,0,0
20999,for,0,0
21000,reliable,0,0
21001,change,0,0
21002,in,0,0
21003,a,0,1
21004,clinical,0,0
21005,replication,0,1
21006,series,0,1
21007,.,0,1
21008,By,0,0
21009,parent,0,1
21010,and,0,1
21011,teacher,0,1
21012,report,0,0
21013,",",0,0
21014,the,0,0
21015,majority,0,0
21016,of,0,0
21017,change,0,0
21018,occurred,0,0
21019,either,0,0
21020,on,0,0
21021,the,0,0
21022,placebo,0,0
21023,trial,0,0
21024,or,0,1
21025,reflected,0,0
21026,deterioration,0,0
21027,subsequent,0,0
21028,to,0,0
21029,secretin,0,0
21030,infusion,0,0
21031,.,0,1
21032,Repeated-measures,0,0
21033,multivariate,0,0
21034,analysis,0,0
21035,of,0,1
21036,variance,0,0
21037,results,0,0
21038,were,0,1
21039,similar,0,0
21040,.,0,1
21041,Results,0,0
21042,are,0,0
21043,consistent,0,0
21044,with,0,1
21045,other,0,1
21046,studies,0,0
21047,",",0,1
21048,suggesting,0,0
21049,that,0,0
21050,secretin,0,0
21051,may,0,0
21052,not,0,0
21053,be,0,0
21054,an,0,0
21055,effective,0,0
21056,treatment,0,0
21057,option,0,0
21058,.,0,1
21059,Monitoring,0,0
21060,tumour,0,1
21061,cells,0,0
21062,in,0,1
21063,the,0,1
21064,peripheral,0,1
21065,blood,0,0
21066,of,0,0
21067,small,1,1
21068,cell,1,1
21069,lung,1,1
21070,cancer,1,1
21071,patients,1,1
21072,.,1,1
21073,BACKGROUND,0,0
21074,Flow,0,0
21075,cytometry,0,0
21076,was,0,0
21077,used,0,0
21078,to,0,0
21079,enumerate,0,1
21080,tumour,0,1
21081,cells,0,0
21082,in,0,1
21083,longitudinal,0,1
21084,studies,0,0
21085,of,0,1
21086,peripheral,0,1
21087,blood,0,0
21088,from,0,1
21089,small,1,1
21090,cell,1,1
21091,lung,1,1
21092,cancer,1,1
21093,(,1,1
21094,SCLC,1,1
21095,),1,1
21096,patients,1,1
21097,",",0,0
21098,together,0,0
21099,with,0,1
21100,magnetic,0,0
21101,bead,0,0
21102,selection,0,0
21103,to,0,0
21104,isolate,0,1
21105,and,0,0
21106,identify,0,0
21107,these,0,0
21108,cells,0,0
21109,.,0,1
21110,As,0,0
21111,part,0,0
21112,of,0,0
21113,a,0,0
21114,trial,0,0
21115,",",0,0
21116,11,1,1
21117,patients,1,1
21118,received,1,1
21119,either,1,1
21120,standard,1,1
21121,(,1,1
21122,four,1,1
21123,weekly,1,1
21124,),1,0
21125,chemotherapy,1,1
21126,with,1,1
21127,ifosfamide,1,0
21128,",",1,0
21129,carboplatin,1,0
21130,",",1,0
21131,and,1,0
21132,etoposide,1,0
21133,(,1,1
21134,ICE,1,1
21135,),1,1
21136,or,1,1
21137,accelerated,1,0
21138,(,1,1
21139,two,1,0
21140,weekly,1,1
21141,),1,1
21142,ICE,1,0
21143,with,1,1
21144,filgrastim,1,0
21145,(,1,1
21146,granulocyte,1,0
21147,colony-stimulating,0,1
21148,factor,0,0
21149,[,0,0
21150,G-CSF,0,1
21151,],0,1
21152,),0,1
21153,and,0,1
21154,autologous,0,1
21155,stem,0,1
21156,cell,0,1
21157,support,0,0
21158,.,0,1
21159,METHODS,0,0
21160,Fresh,0,0
21161,venous,0,1
21162,blood,0,0
21163,was,0,0
21164,taken,0,0
21165,throughout,0,0
21166,treatment,0,0
21167,and,0,1
21168,follow-up,0,0
21169,.,0,1
21170,Aliquots,0,0
21171,were,0,0
21172,stained,0,0
21173,with,0,1
21174,a,0,1
21175,tumour-specific,0,0
21176,antibody,0,0
21177,against,0,0
21178,epithelial,0,1
21179,tissue,0,1
21180,(,0,1
21181,Ber,0,1
21182,EP4,0,1
21183,),0,1
21184,",",0,0
21185,verified,0,0
21186,as,0,0
21187,a,0,1
21188,good,0,0
21189,marker,0,0
21190,of,0,1
21191,SCLC,0,1
21192,cells,0,0
21193,by,0,1
21194,immunohistochemistry,0,1
21195,.,0,1
21196,Matched,0,1
21197,samples,0,0
21198,labelled,0,1
21199,with,0,1
21200,Ber,0,1
21201,EP4,0,1
21202,were,0,1
21203,separated,0,0
21204,magnetically,0,1
21205,by,0,0
21206,adding,0,0
21207,a,0,1
21208,secondary,0,0
21209,bead-antibody,0,0
21210,conjugate,0,0
21211,for,0,0
21212,confirmation,0,0
21213,of,0,0
21214,tumour,0,1
21215,cell,0,1
21216,identity,0,1
21217,.,0,1
21218,RESULTS,0,0
21219,Circulating,0,0
21220,tumour,0,1
21221,cells,0,0
21222,were,0,1
21223,detected,0,0
21224,and,0,0
21225,monitored,0,0
21226,throughout,0,0
21227,treatment,0,1
21228,periods,0,0
21229,.,0,1
21230,An,0,0
21231,initial,0,0
21232,rise,0,0
21233,in,0,1
21234,circulating,0,0
21235,cells,0,0
21236,after,0,1
21237,the,0,1
21238,first,0,0
21239,cycle,0,0
21240,was,0,0
21241,followed,0,0
21242,by,0,0
21243,a,0,0
21244,fall,0,0
21245,in,0,0
21246,both,0,0
21247,treatment,0,0
21248,arms,0,0
21249,to,0,1
21250,baseline,0,1
21251,levels,0,0
21252,set,0,1
21253,by,0,1
21254,normal,0,1
21255,controls,0,1
21256,.,0,1
21257,This,0,0
21258,was,0,0
21259,achieved,0,0
21260,by,0,0
21261,week,0,0
21262,12,0,1
21263,in,0,0
21264,the,0,0
21265,accelerated,0,0
21266,treatment,0,0
21267,arm,0,1
21268,and,0,0
21269,by,0,0
21270,week,0,0
21271,24,0,1
21272,in,0,0
21273,the,0,0
21274,standard,0,1
21275,arm,0,1
21276,.,0,1
21277,CONCLUSIONS,0,0
21278,Flow,0,0
21279,cytometry,0,0
21280,and,0,1
21281,magnetic,0,0
21282,bead,0,0
21283,isolation,0,1
21284,can,0,0
21285,be,0,0
21286,used,0,0
21287,to,0,0
21288,identify,0,0
21289,changes,0,0
21290,in,0,1
21291,numbers,0,0
21292,of,0,1
21293,circulating,0,1
21294,tumour,0,1
21295,cells,0,1
21296,in,0,1
21297,patients,0,1
21298,undergoing,0,1
21299,chemotherapy,0,1
21300,for,0,1
21301,SCLC,0,0
21302,and,0,0
21303,thereafter,0,0
21304,during,0,0
21305,follow-up,0,0
21306,periods,0,0
21307,.,0,1
21308,Absence,0,0
21309,of,0,0
21310,tumour,0,1
21311,cells,0,0
21312,may,0,0
21313,indicate,0,0
21314,a,0,0
21315,more,0,0
21316,favourable,0,0
21317,patient,0,1
21318,group,0,1
21319,who,0,1
21320,would,0,0
21321,benefit,0,1
21322,from,0,0
21323,a,0,0
21324,more,0,0
21325,intense,0,0
21326,course,0,0
21327,of,0,0
21328,treatment,0,1
21329,.,0,1
21330,Is,0,0
21331,periprostatic,0,0
21332,local,0,0
21333,anesthesia,0,1
21334,for,0,0
21335,transrectal,1,1
21336,ultrasound,1,1
21337,guided,1,1
21338,prostate,1,1
21339,biopsy,1,1
21340,associated,0,0
21341,with,0,1
21342,increased,0,0
21343,infectious,0,1
21344,or,0,1
21345,hemorrhagic,0,1
21346,complications,0,1
21347,?,0,1
21348,A,0,1
21349,prospective,0,0
21350,randomized,0,1
21351,trial,0,1
21352,.,0,1
21353,PURPOSE,0,0
21354,Periprostatic,0,1
21355,local,0,0
21356,anesthesia,0,1
21357,for,0,0
21358,prostate,0,1
21359,biopsy,0,1
21360,requires,0,0
21361,2,0,0
21362,or,0,0
21363,more,0,0
21364,extra,0,1
21365,needle,0,1
21366,punctures,0,1
21367,and,0,1
21368,injection,0,0
21369,of,0,0
21370,the,0,0
21371,local,0,0
21372,anesthetic,0,0
21373,through,0,0
21374,the,0,0
21375,highly,0,0
21376,colonized,0,1
21377,rectum,0,1
21378,.,0,1
21379,To,0,0
21380,our,0,0
21381,knowledge,0,0
21382,we,0,0
21383,report,0,0
21384,the,0,0
21385,first,0,0
21386,prospective,0,1
21387,randomized,0,1
21388,trial,0,0
21389,to,0,0
21390,assess,0,0
21391,the,0,0
21392,infectious,0,0
21393,or,0,1
21394,hemorrhagic,0,1
21395,complications,0,0
21396,associated,0,0
21397,with,0,1
21398,this,0,0
21399,method,0,0
21400,.,0,1
21401,MATERIALS,0,0
21402,AND,0,0
21403,METHODS,0,0
21404,A,0,1
21405,total,0,1
21406,of,0,1
21407,100,1,1
21408,consecutive,1,1
21409,patients,1,1
21410,with,1,1
21411,sterile,1,0
21412,urine,1,1
21413,cultures,1,1
21414,underwent,1,1
21415,transrectal,1,1
21416,ultrasound,1,1
21417,guided,1,1
21418,prostate,1,1
21419,biopsy,1,1
21420,.,1,1
21421,They,0,0
21422,were,0,0
21423,randomized,0,1
21424,to,0,0
21425,receive,0,1
21426,a,0,0
21427,periprostatic,0,0
21428,nerve,0,0
21429,block,0,0
21430,or,0,1
21431,no,0,0
21432,anesthesia,0,1
21433,.,0,1
21434,Patients,0,1
21435,were,0,0
21436,evaluated,0,0
21437,for,0,0
21438,the,0,0
21439,amount,0,0
21440,of,0,0
21441,rectal,0,1
21442,and,0,1
21443,urethral,0,1
21444,bleeding,0,1
21445,",",0,1
21446,and,0,0
21447,symptoms,0,1
21448,and,0,1
21449,signs,0,1
21450,of,0,0
21451,infection,0,1
21452,after,0,1
21453,biopsy,0,1
21454,.,0,1
21455,RESULTS,0,0
21456,The,0,0
21457,amount,0,0
21458,of,0,0
21459,urethral,0,1
21460,bleeding,0,1
21461,was,0,0
21462,slight,0,0
21463,and,0,1
21464,similar,0,0
21465,in,0,0
21466,the,0,1
21467,2,0,1
21468,groups,0,1
21469,.,0,1
21470,Rectal,0,1
21471,bleeding,0,0
21472,was,0,0
21473,significantly,0,0
21474,less,0,0
21475,in,0,0
21476,the,0,0
21477,patients,0,1
21478,who,0,1
21479,received,0,1
21480,anesthesia,0,1
21481,.,0,1
21482,High,0,0
21483,fever,0,1
21484,(,0,1
21485,greater,0,0
21486,than,0,1
21487,37.8C,0,1
21488,),0,0
21489,was,0,0
21490,more,0,0
21491,frequent,0,0
21492,in,0,0
21493,the,0,0
21494,nerve,0,0
21495,block,0,0
21496,group,0,1
21497,and,0,1
21498,2,0,1
21499,patients,0,1
21500,in,0,1
21501,this,0,0
21502,group,0,0
21503,required,0,0
21504,rehospitalization,0,1
21505,.,0,1
21506,Bacteriuria,0,1
21507,in,0,0
21508,post-biopsy,0,1
21509,urine,0,1
21510,cultures,0,0
21511,was,0,0
21512,significantly,0,0
21513,more,0,0
21514,common,0,0
21515,in,0,0
21516,the,0,0
21517,anesthesia,0,1
21518,group,0,1
21519,.,0,1
21520,CONCLUSIONS,0,0
21521,Our,0,0
21522,results,0,0
21523,suggest,0,0
21524,that,0,0
21525,periprostatic,0,1
21526,local,0,0
21527,anesthesia,0,1
21528,for,0,0
21529,prostate,0,1
21530,biopsy,0,1
21531,does,0,0
21532,not,0,0
21533,increase,0,0
21534,the,0,0
21535,risk,0,0
21536,of,0,0
21537,urethral,0,1
21538,bleeding,0,1
21539,.,0,1
21540,It,0,0
21541,is,0,0
21542,associated,0,0
21543,with,0,1
21544,a,0,1
21545,decreased,0,0
21546,incidence,0,0
21547,of,0,0
21548,rectal,0,1
21549,bleeding,0,1
21550,",",0,0
21551,presumably,0,0
21552,due,0,0
21553,to,0,0
21554,decreased,0,0
21555,patient,0,1
21556,discomfort,0,0
21557,.,0,1
21558,The,0,0
21559,incidence,0,0
21560,of,0,0
21561,bacteriuria,0,1
21562,was,0,0
21563,significantly,0,0
21564,higher,0,0
21565,in,0,0
21566,the,0,0
21567,anesthesia,0,1
21568,group,0,1
21569,.,0,1
21570,High,0,0
21571,fever,0,1
21572,and,0,0
21573,hospitalization,0,1
21574,due,0,0
21575,to,0,1
21576,infectious,0,1
21577,complications,0,0
21578,were,0,0
21579,also,0,0
21580,more,0,0
21581,common,0,0
21582,in,0,0
21583,the,0,0
21584,local,0,0
21585,anesthesia,0,0
21586,group,0,0
21587,",",0,0
21588,although,0,0
21589,not,0,0
21590,statistically,0,0
21591,significant,0,0
21592,.,0,1
21593,Prospective,0,1
21594,randomized,0,1
21595,trials,0,1
21596,seem,0,0
21597,warranted,0,0
21598,to,0,0
21599,determine,0,0
21600,the,0,0
21601,optimum,0,0
21602,antibiotic,0,0
21603,prophylaxis,0,1
21604,regimen,0,1
21605,in,0,1
21606,patients,0,1
21607,undergoing,0,1
21608,biopsy,0,1
21609,with,0,1
21610,a,0,1
21611,periprostatic,0,1
21612,nerve,0,0
21613,block,0,1
21614,.,0,1
21615,Prognostic,0,1
21616,factor,0,0
21617,analysis,0,0
21618,in,0,0
21619,patients,1,1
21620,with,1,1
21621,advanced,1,1
21622,prostate,1,1
21623,cancer,1,1
21624,treated,1,1
21625,by,1,0
21626,castration,1,1
21627,plus,1,0
21628,anandron,1,1
21629,or,1,1
21630,placebo,1,0
21631,:,1,1
21632,a,0,0
21633,final,0,0
21634,update,0,1
21635,.,0,1
21636,PURPOSE,0,0
21637,Different,0,0
21638,outcome,0,0
21639,results,0,0
21640,have,0,1
21641,been,0,0
21642,published,0,1
21643,in,0,1
21644,trials,0,1
21645,comparing,0,0
21646,maximal,0,0
21647,androgen,0,0
21648,blockade,0,0
21649,(,0,1
21650,MAB,0,1
21651,),0,1
21652,with,0,1
21653,chemical,0,1
21654,or,0,1
21655,surgical,0,1
21656,castration,0,1
21657,alone,0,0
21658,.,0,0
21659,The,0,0
21660,conflicting,0,0
21661,results,0,0
21662,could,0,0
21663,be,0,0
21664,explained,0,0
21665,by,0,0
21666,the,0,0
21667,fact,0,0
21668,that,0,0
21669,patients,0,1
21670,were,0,1
21671,included,0,1
21672,with,0,1
21673,different,0,1
21674,prognostic,0,1
21675,factors,0,0
21676,.,0,1
21677,In,0,0
21678,this,0,0
21679,new,0,1
21680,analysis,0,0
21681,of,0,0
21682,the,0,0
21683,Anandron,0,1
21684,European,0,1
21685,Study,0,0
21686,",",0,1
21687,independent,0,0
21688,prognostic,0,0
21689,factors,0,0
21690,have,0,1
21691,been,0,0
21692,evaluated,0,0
21693,in,0,0
21694,order,0,0
21695,to,0,0
21696,identify,0,0
21697,those,0,0
21698,which,0,0
21699,could,0,0
21700,influence,0,0
21701,the,0,0
21702,study,0,0
21703,outcome,0,0
21704,and,0,0
21705,the,0,0
21706,impact,0,0
21707,of,0,0
21708,the,0,0
21709,treatment,0,0
21710,.,0,1
21711,MATERIAL,0,0
21712,AND,0,0
21713,METHODS,0,0
21714,399,1,1
21715,out,1,1
21716,of,1,1
21717,457,1,1
21718,patients,1,1
21719,recruited,1,1
21720,in,1,0
21721,this,1,0
21722,study,1,0
21723,were,1,0
21724,divided,1,0
21725,in,1,0
21726,a,1,1
21727,good,1,0
21728,or,1,1
21729,poor,1,1
21730,prognostic,1,0
21731,group,1,1
21732,depending,1,1
21733,on,1,0
21734,the,1,0
21735,presence,1,0
21736,of,1,0
21737,two,1,0
21738,or,1,1
21739,more,1,0
21740,poor,1,1
21741,prognostic,1,0
21742,factors,1,0
21743,",",1,1
21744,these,1,0
21745,were,1,0
21746,pain,1,1
21747,requiring,1,1
21748,treatment,1,0
21749,",",1,0
21750,>,1,0
21751,5,1,0
21752,bone,1,0
21753,metastases,1,1
21754,",",1,0
21755,hydronephrosis,1,1
21756,",",1,0
21757,and,1,0
21758,alkaline,1,0
21759,phosphatase,1,1
21760,>,1,1
21761,2,1,1
21762,ULN,1,0
21763,.,1,1
21764,RESULTS,0,0
21765,When,0,1
21766,expressed,0,0
21767,as,0,0
21768,a,0,0
21769,percentage,0,0
21770,",",0,0
21771,the,0,0
21772,improvement,0,0
21773,in,0,0
21774,time,0,0
21775,to,0,0
21776,progression,0,0
21777,",",0,0
21778,overall,0,0
21779,and,0,0
21780,cancer,0,1
21781,specific,0,0
21782,survival,0,0
21783,in,0,0
21784,the,0,0
21785,Anandron,0,1
21786,treated,0,1
21787,patients,0,1
21788,was,0,0
21789,identical,0,1
21790,in,0,1
21791,both,0,0
21792,groups,0,0
21793,.,0,1
21794,In,0,0
21795,absolute,0,0
21796,terms,0,0
21797,this,0,0
21798,improvement,0,0
21799,",",0,0
21800,however,0,0
21801,",",0,0
21802,was,0,0
21803,greater,0,0
21804,in,0,0
21805,the,0,0
21806,good,0,0
21807,prognostic,0,0
21808,group,0,1
21809,.,0,1
21810,CONCLUSION,0,0
21811,In,0,0
21812,comparison,0,0
21813,with,0,1
21814,surgical,0,1
21815,castration,0,1
21816,MAB,0,1
21817,using,0,0
21818,Anandron,0,1
21819,",",0,1
21820,in,0,0
21821,patients,1,1
21822,with,1,1
21823,metastatic,1,1
21824,prostate,1,1
21825,cancer,1,1
21826,improves,0,0
21827,the,0,0
21828,time,0,0
21829,to,0,0
21830,objective,0,0
21831,progression,0,0
21832,",",0,0
21833,overall,0,0
21834,and,0,0
21835,cancer,0,1
21836,specific,0,0
21837,survival,0,0
21838,",",0,0
21839,irrespective,0,0
21840,of,0,0
21841,certain,0,0
21842,poor,0,1
21843,prognostic,0,1
21844,factors,0,0
21845,.,0,1
21846,Examining,0,0
21847,possible,0,0
21848,gender,0,1
21849,differences,0,0
21850,among,0,1
21851,cocaine-dependent,1,1
21852,outpatients,1,1
21853,.,1,1
21854,Potential,0,0
21855,differences,0,0
21856,in,0,1
21857,sociodemographics,0,0
21858,",",0,1
21859,drug,0,0
21860,use,0,0
21861,",",0,0
21862,and,0,0
21863,measures,0,0
21864,of,0,1
21865,treatment,0,1
21866,outcome,0,0
21867,were,0,0
21868,examined,0,0
21869,among,0,1
21870,137,1,1
21871,male,1,1
21872,and,1,1
21873,51,1,1
21874,female,1,1
21875,cocaine-dependent,1,1
21876,outpatients,1,1
21877,.,1,1
21878,More,1,1
21879,women,1,1
21880,than,1,1
21881,men,1,1
21882,were,1,1
21883,unemployed,1,1
21884,",",1,0
21885,received,1,0
21886,public,1,1
21887,assistance,1,0
21888,",",1,0
21889,and,1,0
21890,were,1,0
21891,living,1,1
21892,with,1,1
21893,their,1,1
21894,children,1,1
21895,.,1,1
21896,Women,0,1
21897,reported,0,0
21898,fewer,0,0
21899,years,0,1
21900,of,0,0
21901,regular,0,1
21902,cocaine,0,1
21903,use,0,0
21904,",",0,0
21905,spending,0,1
21906,less,0,0
21907,money,0,0
21908,per,0,0
21909,week,0,0
21910,on,0,0
21911,cocaine,0,0
21912,",",0,0
21913,less,0,0
21914,prior,0,1
21915,treatment,0,0
21916,for,0,0
21917,cocaine,0,1
21918,abuse,0,1
21919,",",0,0
21920,and,0,0
21921,were,0,0
21922,more,0,0
21923,likely,0,0
21924,than,0,0
21925,men,0,1
21926,to,0,1
21927,test,0,0
21928,positive,0,1
21929,for,0,0
21930,cocaine,0,1
21931,at,0,1
21932,intake,0,0
21933,.,0,1
21934,With,0,0
21935,respect,0,0
21936,to,0,1
21937,other,0,0
21938,drug,0,0
21939,use,0,0
21940,",",0,0
21941,fewer,0,0
21942,women,0,1
21943,than,0,1
21944,men,0,1
21945,reported,0,1
21946,using,0,1
21947,sedatives,0,0
21948,and,0,1
21949,tested,0,0
21950,positive,0,1
21951,for,0,1
21952,sedatives,0,1
21953,at,0,1
21954,intake,0,1
21955,.,0,1
21956,Women,0,1
21957,reported,0,0
21958,a,0,0
21959,lower,0,0
21960,frequency,0,0
21961,of,0,0
21962,alcohol,0,1
21963,use,0,0
21964,before,0,0
21965,intake,0,0
21966,",",0,0
21967,and,0,0
21968,fewer,0,0
21969,women,0,1
21970,than,0,1
21971,men,0,1
21972,met,0,1
21973,criteria,0,1
21974,for,0,1
21975,cannabis,0,1
21976,dependence,0,1
21977,.,0,1
21978,Men,0,1
21979,and,0,0
21980,women,0,1
21981,experienced,0,1
21982,comparable,0,0
21983,improvement,0,0
21984,during,0,0
21985,the,0,0
21986,course,0,0
21987,of,0,0
21988,treatment,0,0
21989,and,0,1
21990,follow-up,0,0
21991,.,0,1
21992,Stepwise,0,0
21993,hook,0,1
21994,extension,0,0
21995,technique,0,0
21996,for,0,0
21997,radiofrequency,0,0
21998,ablation,0,1
21999,therapy,0,0
22000,of,0,0
22001,hepatocellular,1,1
22002,carcinoma,1,1
22003,.,1,1
22004,OBJECTIVE,0,0
22005,Our,0,0
22006,study,0,1
22007,was,0,0
22008,designed,0,0
22009,to,0,0
22010,examine,0,0
22011,the,0,0
22012,efficacy,0,0
22013,of,0,0
22014,stepwise,0,0
22015,hook,0,0
22016,extension,0,0
22017,technique,0,0
22018,for,0,0
22019,radiofrequency,0,0
22020,ablation,0,1
22021,(,0,1
22022,RFA,0,0
22023,),0,1
22024,therapy,0,0
22025,of,0,0
22026,hepatocellular,1,1
22027,carcinoma,1,1
22028,in,0,0
22029,a,0,1
22030,randomized,0,1
22031,controlled,0,0
22032,study,0,1
22033,.,0,1
22034,METHOD,0,0
22035,Twenty,1,1
22036,patients,1,1
22037,with,1,1
22038,hepatocellular,1,1
22039,carcinoma,1,1
22040,measuring,1,0
22041,<,1,0
22042,25,1,1
22043,mm,1,1
22044,were,0,1
22045,divided,0,0
22046,randomly,0,1
22047,into,0,1
22048,two,0,0
22049,equal,0,1
22050,groups,0,1
22051,.,0,1
22052,RFA,0,0
22053,was,0,0
22054,applied,0,0
22055,using,0,0
22056,our,0,0
22057,new,0,1
22058,stepwise,0,0
22059,hook,0,0
22060,extension,0,0
22061,technique,0,0
22062,in,0,0
22063,patients,0,1
22064,of,0,1
22065,group,0,1
22066,1,0,1
22067,",",0,0
22068,and,0,0
22069,the,0,0
22070,full,0,0
22071,extension,0,0
22072,method,0,0
22073,in,0,0
22074,group,0,1
22075,2,0,1
22076,.,0,1
22077,The,0,0
22078,10-hook,0,0
22079,electrode,0,0
22080,of,0,0
22081,LeVeen,0,1
22082,needle,0,1
22083,was,0,0
22084,deployed,0,0
22085,in,0,1
22086,four,0,1
22087,steps,0,1
22088,to,0,1
22089,full,0,1
22090,extension,0,0
22091,during,0,0
22092,ablation,0,1
22093,in,0,1
22094,group,0,1
22095,1,0,1
22096,",",0,0
22097,and,0,0
22098,full,0,0
22099,extension,0,0
22100,at,0,0
22101,start,0,1
22102,of,0,0
22103,treatment,0,0
22104,in,0,1
22105,group,0,1
22106,2,0,1
22107,.,0,1
22108,RESULTS,0,0
22109,Roll-off,0,0
22110,was,0,0
22111,achieved,0,0
22112,in,0,0
22113,all,0,1
22114,10,0,1
22115,patients,0,1
22116,of,0,1
22117,group,0,1
22118,1,0,0
22119,",",0,0
22120,indicative,0,0
22121,of,0,0
22122,sufficient,0,0
22123,tumor,0,1
22124,coagulation,0,1
22125,",",0,0
22126,but,0,0
22127,only,0,0
22128,in,0,0
22129,3,0,1
22130,of,0,1
22131,10,0,1
22132,patients,0,1
22133,of,0,1
22134,group,0,1
22135,2,0,1
22136,.,0,1
22137,The,0,0
22138,median,0,0
22139,time,0,0
22140,to,0,0
22141,completion,0,0
22142,of,0,0
22143,treatment,0,0
22144,was,0,0
22145,6,0,0
22146,min,0,0
22147,and,0,1
22148,55,0,1
22149,s,0,0
22150,(,0,1
22151,range,0,1
22152,3,0,1
22153,min,0,0
22154,to,0,1
22155,14,0,1
22156,min,0,0
22157,and,0,1
22158,3,0,1
22159,s,0,1
22160,),0,1
22161,and,0,1
22162,15,0,1
22163,min,0,0
22164,(,0,1
22165,6-15,0,1
22166,min,0,0
22167,),0,0
22168,",",0,0
22169,respectively,0,0
22170,.,0,0
22171,The,0,0
22172,total,0,1
22173,power,0,0
22174,output,0,0
22175,used,0,0
22176,for,0,0
22177,RF,0,0
22178,was,0,0
22179,lower,0,0
22180,in,0,0
22181,group,0,1
22182,1,0,1
22183,than,0,0
22184,in,0,1
22185,group,0,1
22186,2,0,1
22187,(,0,1
22188,median,0,0
22189,271,0,1
22190,vs.,0,0
22191,"1,045",0,1
22192,W.m,0,1
22193,),0,1
22194,.,0,1
22195,The,0,0
22196,diameters,0,0
22197,of,0,1
22198,RFA-induced,0,1
22199,lesions,0,1
22200,were,0,1
22201,not,0,0
22202,significantly,0,0
22203,different,0,0
22204,between,0,0
22205,the,0,1
22206,groups,0,0
22207,(,0,1
22208,group,0,1
22209,1,0,1
22210,:,0,1
22211,27,0,1
22212,",",0,0
22213,range,0,1
22214,23-37,0,1
22215,mm,0,1
22216,;,0,1
22217,group,0,1
22218,2,0,1
22219,:,0,1
22220,23,0,1
22221,",",0,0
22222,0-42,0,0
22223,mm,0,1
22224,),0,1
22225,.,0,1
22226,CONCLUSIONS,0,0
22227,Application,0,0
22228,of,0,1
22229,RFA,0,0
22230,using,0,0
22231,stepwise,0,0
22232,hook,0,1
22233,extension,0,0
22234,technique,0,0
22235,is,0,0
22236,superior,0,0
22237,to,0,0
22238,the,0,0
22239,full,0,0
22240,extension,0,0
22241,method,0,0
22242,since,0,0
22243,it,0,0
22244,produces,0,0
22245,the,0,0
22246,same,0,0
22247,therapeutic,0,0
22248,effects,0,0
22249,within,0,1
22250,a,0,1
22251,short,0,0
22252,period,0,0
22253,using,0,0
22254,a,0,0
22255,lower,0,0
22256,energy,0,0
22257,.,0,1
22258,Tegaserod,0,0
22259,",",0,0
22260,a,0,0
22261,5-hydroxytryptamine,0,0
22262,type,0,1
22263,4,0,0
22264,receptor,0,0
22265,partial,0,1
22266,agonist,0,0
22267,",",0,0
22268,is,0,0
22269,devoid,0,0
22270,of,0,0
22271,electrocardiographic,0,1
22272,effects,0,0
22273,.,0,1
22274,OBJECTIVES,0,0
22275,Certain,0,0
22276,GI,0,1
22277,prokinetic,0,0
22278,agents,0,1
22279,have,0,1
22280,been,0,0
22281,shown,0,0
22282,to,0,0
22283,affect,0,0
22284,cardiac,0,1
22285,repolarization,0,0
22286,",",0,0
22287,which,0,0
22288,may,0,0
22289,be,0,0
22290,associated,0,0
22291,with,0,1
22292,life-threatening,0,1
22293,arrhythmias,0,1
22294,.,0,1
22295,The,0,0
22296,selective,0,0
22297,5-hydroxytryptamine,0,0
22298,type,0,1
22299,4,0,0
22300,receptor,0,0
22301,partial,0,1
22302,agonist,0,0
22303,tegaserod,0,0
22304,is,0,0
22305,a,0,0
22306,novel,0,0
22307,promotile,0,1
22308,agent,0,0
22309,developed,0,1
22310,for,0,0
22311,the,0,0
22312,treatment,0,0
22313,of,0,0
22314,functional,0,1
22315,motility,0,0
22316,disorders,0,1
22317,such,0,0
22318,as,0,1
22319,irritable,0,1
22320,bowel,0,1
22321,syndrome,0,1
22322,(,0,1
22323,IBS,0,0
22324,),0,1
22325,.,0,1
22326,The,0,0
22327,aim,0,0
22328,of,0,0
22329,the,0,0
22330,study,0,0
22331,was,0,0
22332,to,0,0
22333,investigate,0,0
22334,the,0,0
22335,cardiac,0,1
22336,safety,0,0
22337,profile,0,0
22338,of,0,0
22339,tegaserod,0,0
22340,through,0,1
22341,analysis,0,0
22342,of,0,1
22343,electrocardiographic,0,1
22344,data,0,0
22345,from,0,1
22346,clinical,0,1
22347,studies,0,0
22348,conducted,0,1
22349,in,0,1
22350,patients,1,1
22351,with,1,1
22352,IBS,1,0
22353,and,1,1
22354,a,1,0
22355,study,1,0
22356,conducted,1,0
22357,in,1,0
22358,healthy,1,1
22359,male,1,1
22360,subjects,1,1
22361,.,1,1
22362,METHODS,0,0
22363,In,0,1
22364,three,0,1
22365,randomized,0,1
22366,",",0,1
22367,double,0,0
22368,blind,0,1
22369,",",0,0
22370,placebo-controlled,0,0
22371,",",0,0
22372,parallel,0,0
22373,group,0,1
22374,clinical,0,0
22375,studies,0,0
22376,",",0,1
22377,2516,1,1
22378,IBS,1,0
22379,patients,1,1
22380,with,1,1
22381,symptoms,1,1
22382,of,1,1
22383,abdominal,1,1
22384,pain,1,1
22385,and,1,1
22386,constipation,1,1
22387,received,0,1
22388,tegaserod,1,0
22389,2,0,1
22390,or,0,1
22391,6,0,1
22392,mg,0,1
22393,b.i.d,0,1
22394,.,0,1
22395,(,0,0
22396,n,0,1
22397,=,0,1
22398,1679,0,1
22399,),0,1
22400,or,0,1
22401,placebo,0,0
22402,(,0,1
22403,n,0,1
22404,=,0,1
22405,837,0,1
22406,),0,1
22407,for,0,1
22408,12,0,1
22409,wk,0,1
22410,.,0,1
22411,In,1,0
22412,an,1,0
22413,additional,1,0
22414,study,1,0
22415,",",1,1
22416,36,1,1
22417,healthy,1,1
22418,male,1,1
22419,subjects,1,1
22420,received,1,1
22421,iv,1,1
22422,.,1,1
22423,single,1,0
22424,doses,1,0
22425,of,1,1
22426,tegaserod,1,1
22427,(,1,1
22428,0.8,1,0
22429,mg,1,1
22430,to,1,1
22431,20,1,1
22432,mg,1,1
22433,),1,1
22434,or,1,1
22435,placebo,1,1
22436,.,1,1
22437,Standard,0,0
22438,12-lead,0,1
22439,electrocardiograms,0,1
22440,were,0,1
22441,recorded,0,0
22442,at,0,0
22443,baseline,0,0
22444,and,0,1
22445,during,0,0
22446,treatment,0,1
22447,.,0,1
22448,Baseline,0,0
22449,values,0,0
22450,were,0,1
22451,compared,0,0
22452,with,0,1
22453,data,0,0
22454,collected,0,1
22455,during,0,0
22456,the,0,0
22457,treatment,0,0
22458,period,0,0
22459,.,0,0
22460,RESULTS,0,0
22461,The,0,0
22462,proportion,0,0
22463,of,0,0
22464,patients,0,1
22465,with,0,1
22466,prolongation,0,0
22467,of,0,0
22468,the,0,0
22469,QTc,0,0
22470,interval,0,0
22471,was,0,0
22472,the,0,0
22473,same,0,0
22474,for,0,0
22475,placebo,0,0
22476,and,0,0
22477,tegaserod,0,0
22478,",",0,0
22479,as,0,0
22480,was,0,0
22481,the,0,0
22482,frequency,0,0
22483,of,0,0
22484,overall,0,0
22485,electrocardiographic,0,1
22486,abnormalities,0,1
22487,.,0,1
22488,No,0,0
22489,ventricular,0,0
22490,or,0,1
22491,supraventricular,0,1
22492,tachycardia,0,1
22493,was,0,0
22494,observed,0,0
22495,.,0,1
22496,Comparable,0,0
22497,electrocardiographic,0,1
22498,results,0,0
22499,were,0,1
22500,obtained,0,0
22501,during,0,0
22502,placebo,0,0
22503,and,0,1
22504,tegaserod,0,0
22505,treatment,0,0
22506,.,0,1
22507,In,0,0
22508,healthy,1,1
22509,volunteers,1,1
22510,",",0,1
22511,tegaserod,0,0
22512,at,0,0
22513,i.v,0,0
22514,.,0,1
22515,doses,0,0
22516,resulting,0,0
22517,in,0,1
22518,plasma,0,0
22519,concentrations,0,0
22520,up,0,1
22521,to,0,1
22522,100,0,1
22523,times,0,0
22524,those,0,1
22525,measured,0,0
22526,after,0,0
22527,therapeutic,0,1
22528,doses,0,1
22529,(,0,1
22530,6,0,1
22531,mg,0,1
22532,b.i.d,0,1
22533,.,0,1
22534,),0,0
22535,did,0,0
22536,not,0,0
22537,influence,0,0
22538,electrocardiographic,0,1
22539,parameters,0,0
22540,.,0,1
22541,CONCLUSIONS,0,0
22542,Tegaserod,0,0
22543,is,0,0
22544,devoid,0,0
22545,of,0,0
22546,electrocardiographic,0,1
22547,effects,0,0
22548,and,0,0
22549,is,0,0
22550,not,0,0
22551,expected,0,0
22552,to,0,0
22553,adversely,0,0
22554,influence,0,0
22555,cardiac,0,1
22556,function,0,0
22557,.,0,1
22558,These,0,0
22559,data,0,0
22560,confirm,0,0
22561,preclinical,0,1
22562,findings,0,0
22563,.,0,1
22564,Randomized,0,0
22565,trial,0,0
22566,of,0,0
22567,adoptive,0,1
22568,transfer,0,1
22569,of,0,0
22570,melanoma,0,1
22571,tumor-infiltrating,0,0
22572,lymphocytes,0,1
22573,as,0,1
22574,adjuvant,0,1
22575,therapy,0,1
22576,for,0,0
22577,stage,1,1
22578,III,1,1
22579,melanoma,1,1
22580,.,1,1
22581,The,0,0
22582,aim,0,0
22583,of,0,0
22584,this,0,0
22585,study,0,0
22586,was,0,0
22587,to,0,0
22588,demonstrate,0,0
22589,the,0,0
22590,interest,0,0
22591,of,0,0
22592,using,0,1
22593,tumor-infiltrating,0,0
22594,lymphocytes,0,1
22595,(,0,1
22596,TIL,0,1
22597,),0,1
22598,as,0,0
22599,adjuvant,0,1
22600,therapy,0,1
22601,for,0,0
22602,stage,1,1
22603,III,1,1
22604,(,1,1
22605,regional,1,1
22606,lymph,1,1
22607,nodes,1,1
22608,),1,1
22609,melanoma,1,1
22610,.,1,1
22611,After,0,0
22612,lymph,0,1
22613,node,0,1
22614,excision,0,1
22615,",",0,1
22616,patients,1,1
22617,without,1,1
22618,any,1,1
22619,detectable,1,0
22620,metastases,1,1
22621,were,0,1
22622,randomly,0,1
22623,assigned,0,1
22624,to,0,0
22625,receive,0,1
22626,either,0,0
22627,TIL,0,0
22628,plus,0,0
22629,interleukin-2,0,0
22630,(,0,1
22631,IL-2,0,1
22632,),0,1
22633,for,0,1
22634,2,0,1
22635,months,0,0
22636,",",0,1
22637,or,0,1
22638,IL-2,0,1
22639,only,0,0
22640,.,0,1
22641,The,0,0
22642,primary,0,1
22643,endpoint,0,0
22644,was,0,0
22645,determination,0,0
22646,of,0,0
22647,the,0,0
22648,duration,0,0
22649,of,0,0
22650,the,0,0
22651,relapse-free,0,0
22652,interval,0,0
22653,.,0,1
22654,Eighty-eight,1,1
22655,patients,1,1
22656,determined,1,0
22657,as,1,0
22658,eligible,1,1
22659,for,1,1
22660,treatment,1,1
22661,were,1,1
22662,enrolled,1,1
22663,in,1,0
22664,the,1,0
22665,study,1,0
22666,.,1,0
22667,After,0,0
22668,a,0,0
22669,median,0,0
22670,follow-up,0,0
22671,of,0,1
22672,46.9,0,1
22673,months,0,0
22674,",",0,1
22675,for,0,0
22676,the,0,0
22677,study,0,0
22678,population,0,1
22679,the,0,0
22680,analysis,0,0
22681,did,0,0
22682,not,0,0
22683,show,0,0
22684,a,0,0
22685,significant,0,0
22686,extension,0,0
22687,of,0,0
22688,the,0,0
22689,relapse-free,0,0
22690,interval,0,0
22691,or,0,1
22692,overall,0,0
22693,survival,0,0
22694,.,0,1
22695,However,0,0
22696,",",0,0
22697,a,0,0
22698,significant,0,0
22699,interaction,0,0
22700,(,0,1
22701,P,0,0
22702,<,0,0
22703,0.001,0,0
22704,),0,1
22705,was,0,0
22706,found,0,0
22707,between,0,0
22708,the,0,0
22709,treatment,0,0
22710,and,0,0
22711,the,0,0
22712,number,0,0
22713,of,0,0
22714,invaded,0,1
22715,lymph,0,1
22716,nodes,0,1
22717,.,0,1
22718,In,0,0
22719,the,0,0
22720,group,0,0
22721,with,0,1
22722,only,0,0
22723,one,0,1
22724,invaded,0,0
22725,lymph,0,1
22726,node,0,1
22727,",",0,0
22728,the,0,0
22729,estimated,0,0
22730,relapse,0,0
22731,rate,0,0
22732,was,0,0
22733,significantly,0,0
22734,lower,0,0
22735,(,0,0
22736,P,0,0
22737,(,0,1
22738,adjusted,0,0
22739,),0,1
22740,=0.0285,0,0
22741,),0,1
22742,and,0,0
22743,the,0,0
22744,overall,0,0
22745,survival,0,0
22746,was,0,0
22747,increased,0,0
22748,(,0,1
22749,P,0,0
22750,(,0,1
22751,adjusted,0,0
22752,),0,1
22753,=0.039,0,0
22754,),0,1
22755,in,0,0
22756,the,0,0
22757,TIL+IL-2,0,1
22758,arm,0,0
22759,compared,0,0
22760,with,0,1
22761,the,0,0
22762,IL-2,0,1
22763,only,0,0
22764,arm,0,1
22765,.,0,1
22766,No,0,0
22767,differences,0,0
22768,between,0,0
22769,the,0,1
22770,two,0,0
22771,arms,0,0
22772,",",0,1
22773,either,0,1
22774,as,0,0
22775,regards,0,0
22776,the,0,0
22777,duration,0,0
22778,of,0,0
22779,disease-free,0,1
22780,survival,0,0
22781,or,0,1
22782,overall,0,0
22783,survival,0,0
22784,",",0,0
22785,were,0,0
22786,noted,0,0
22787,in,0,0
22788,the,0,0
22789,group,0,0
22790,with,0,1
22791,more,0,0
22792,than,0,1
22793,one,0,1
22794,invaded,0,1
22795,lymph,0,1
22796,node,0,1
22797,whatever,0,0
22798,the,0,0
22799,number,0,0
22800,of,0,0
22801,invaded,0,1
22802,lymph,0,1
22803,nodes,0,1
22804,.,0,1
22805,Treatment,0,0
22806,was,0,0
22807,compatible,0,0
22808,with,0,1
22809,normal,0,1
22810,daily,0,0
22811,activity,0,0
22812,.,0,1
22813,This,0,0
22814,study,0,0
22815,demonstrates,0,0
22816,for,0,0
22817,the,0,0
22818,first,0,0
22819,time,0,0
22820,that,0,0
22821,the,0,0
22822,efficiency,0,0
22823,of,0,0
22824,TIL,0,0
22825,in,0,1
22826,stage,0,1
22827,III,0,1
22828,melanoma,0,1
22829,(,0,1
22830,AJCC,0,0
22831,),0,0
22832,is,0,0
22833,directly,0,0
22834,related,0,0
22835,to,0,0
22836,the,0,0
22837,number,0,0
22838,of,0,0
22839,invaded,0,1
22840,lymph,0,1
22841,nodes,0,1
22842,",",0,0
22843,indicating,0,0
22844,that,0,0
22845,tumor,0,1
22846,burden,0,1
22847,might,0,0
22848,be,0,0
22849,a,0,0
22850,crucial,0,0
22851,factor,0,0
22852,in,0,0
22853,the,0,0
22854,efficacy,0,0
22855,and/or,0,0
22856,in,0,0
22857,vitro,0,0
22858,expansion,0,1
22859,of,0,1
22860,T,0,1
22861,cells,0,0
22862,specific,0,0
22863,for,0,1
22864,autologous,0,1
22865,tumor,0,1
22866,antigen,0,0
22867,",",0,0
22868,a,0,0
22869,finding,0,0
22870,which,0,0
22871,could,0,0
22872,be,0,0
22873,of,0,0
22874,value,0,0
22875,in,0,1
22876,future,0,0
22877,vaccine,0,1
22878,development,0,0
22879,for,0,0
22880,the,0,0
22881,treatment,0,0
22882,of,0,0
22883,melanoma,0,1
22884,.,0,1
22885,Lamivudine,0,1
22886,300,0,1
22887,mg,0,0
22888,QD,0,0
22889,versus,0,0
22890,continued,0,0
22891,lamivudine,0,1
22892,150,0,1
22893,mg,0,1
22894,BID,0,1
22895,with,0,1
22896,stavudine,0,1
22897,and,0,0
22898,a,0,0
22899,protease,0,0
22900,inhibitor,0,0
22901,in,0,1
22902,suppressed,1,1
22903,patients,1,1
22904,.,1,1
22905,PURPOSE,0,0
22906,To,0,0
22907,compare,0,0
22908,the,0,0
22909,efficacy,0,0
22910,(,0,0
22911,sustained,0,0
22912,virologic,0,0
22913,suppression,0,0
22914,),0,1
22915,and,0,0
22916,safety/tolerability,0,0
22917,of,0,0
22918,a,0,1
22919,switch,0,0
22920,to,0,0
22921,lamivudine,0,1
22922,300,0,1
22923,mg,0,0
22924,once,0,1
22925,daily,0,0
22926,(,0,1
22927,QD,0,0
22928,),0,1
22929,versus,0,0
22930,continued,0,0
22931,lamivudine,0,1
22932,150,0,1
22933,mg,0,0
22934,twice,0,0
22935,daily,0,0
22936,(,0,0
22937,BID,0,1
22938,),0,1
22939,in,0,0
22940,virologically,1,1
22941,suppressed,1,0
22942,patients,1,1
22943,(,1,1
22944,HIV-1,1,1
22945,RNA,1,1
22946,<,1,0
22947,400,1,0
22948,copies/mL,1,1
22949,for,1,0
22950,>,1,1
22951,or,1,1
22952,=3,1,1
22953,months,1,1
22954,),1,1
22955,on,1,1
22956,stable,1,1
22957,(,1,1
22958,>,1,1
22959,or,1,1
22960,=6,1,1
22961,months,1,1
22962,),1,1
22963,therapy,1,1
22964,with,1,1
22965,lamivudine,0,1
22966,150,0,1
22967,mg,0,1
22968,BID,0,1
22969,plus,0,0
22970,stavudine,0,1
22971,and,0,0
22972,either,0,0
22973,indinavir,0,1
22974,or,0,1
22975,nelfinavir,0,1
22976,.,0,1
22977,METHOD,0,0
22978,Eighty-nine,1,1
22979,suppressed,1,1
22980,patients,1,1
22981,>,1,1
22982,or,1,1
22983,=18,1,1
22984,years,1,1
22985,old,1,1
22986,with,1,1
22987,CD4,1,1
22988,counts,1,0
22989,>,1,0
22990,50,1,1
22991,cells/mm,1,0
22992,(,1,1
22993,3,1,1
22994,),1,1
22995,were,0,1
22996,enrolled,0,1
22997,in,0,0
22998,this,0,0
22999,phase,0,1
23000,II,0,1
23001,",",0,0
23002,open-label,0,0
23003,",",0,0
23004,multicenter,0,0
23005,",",0,0
23006,randomized,0,0
23007,",",0,0
23008,stratified,0,1
23009,(,0,0
23010,by,0,0
23011,pretrial,0,1
23012,protease,0,1
23013,inhibitor,0,0
23014,[,0,0
23015,PI,0,1
23016,],0,1
23017,),0,1
23018,",",0,0
23019,parallel-group,0,0
23020,clinical,0,0
23021,trial,0,1
23022,.,0,1
23023,Eighty-one,1,1
23024,patients,1,1
23025,received,0,1
23026,either,0,1
23027,lamivudine,0,0
23028,300,0,1
23029,mg,0,1
23030,QD,0,0
23031,(,0,1
23032,n,0,1
23033,=,0,1
23034,39,0,1
23035,),0,1
23036,or,0,1
23037,150,0,1
23038,mg,0,1
23039,BID,0,1
23040,(,0,1
23041,n,0,1
23042,=,0,1
23043,42,0,1
23044,),0,1
23045,with,0,1
23046,their,0,1
23047,pretrial,0,1
23048,stavudine/PI,0,1
23049,regimens,0,0
23050,for,0,1
23051,24,0,1
23052,weeks,0,1
23053,.,0,1
23054,RESULTS,0,0
23055,A,0,0
23056,high,0,0
23057,rate,0,0
23058,of,0,0
23059,virologic,0,0
23060,suppression,0,0
23061,was,0,0
23062,sustained,0,0
23063,with,0,1
23064,both,0,0
23065,regimens,0,0
23066,throughout,0,0
23067,the,0,1
23068,trial,0,0
23069,.,0,1
23070,At,0,0
23071,week,0,0
23072,24,0,1
23073,",",0,1
23074,intent-to-treat,0,0
23075,:,0,1
23076,exposed,0,1
23077,(,0,1
23078,missing,0,1
23079,=,0,0
23080,failure,0,1
23081,),0,0
23082,analyses,0,0
23083,showed,0,0
23084,no,0,0
23085,statistically,0,0
23086,significant,0,0
23087,differences,0,0
23088,in,0,1
23089,the,0,0
23090,percentage,0,0
23091,of,0,0
23092,patients,0,1
23093,with,0,1
23094,HIV-1,0,1
23095,RNA,0,1
23096,<,0,0
23097,400,0,0
23098,copies/mL,0,1
23099,(,0,1
23100,95,0,0
23101,%,0,0
23102,[,0,1
23103,QD,0,0
23104,],0,1
23105,vs.,0,0
23106,90,0,1
23107,%,0,0
23108,[,0,1
23109,BID,0,1
23110,],0,1
23111,),0,1
23112,or,0,1
23113,<,0,0
23114,50,0,1
23115,copies/mL,0,1
23116,(,0,1
23117,82,0,1
23118,%,0,0
23119,[,0,1
23120,QD,0,0
23121,],0,1
23122,vs.,0,0
23123,81,0,1
23124,%,0,0
23125,[,0,1
23126,BID,0,1
23127,],0,1
23128,),0,1
23129,or,0,1
23130,in,0,0
23131,the,0,0
23132,median,0,0
23133,change,0,0
23134,from,0,1
23135,baseline,0,0
23136,in,0,1
23137,CD4,0,1
23138,counts,0,0
23139,(,0,1
23140,+42,0,0
23141,cells/mm,0,0
23142,(,0,1
23143,3,0,1
23144,),0,1
23145,[,0,0
23146,QD,0,0
23147,],0,1
23148,vs.,0,0
23149,+22,0,0
23150,cells/mm,0,0
23151,(,0,1
23152,3,0,0
23153,),0,1
23154,[,0,0
23155,BID,0,1
23156,],0,1
23157,),0,1
23158,.,0,1
23159,Both,0,0
23160,regimens,0,0
23161,were,0,1
23162,well,0,0
23163,tolerated,0,0
23164,.,0,0
23165,No,0,0
23166,patient,0,0
23167,experienced,0,1
23168,virologic,0,0
23169,failure,0,1
23170,",",0,0
23171,clinical,0,0
23172,disease,0,1
23173,progression,0,0
23174,",",0,0
23175,or,0,0
23176,a,0,0
23177,drug-related,0,0
23178,serious,0,0
23179,adverse,0,0
23180,event,0,0
23181,during,0,0
23182,the,0,0
23183,trial,0,0
23184,.,0,1
23185,Self-reported,0,0
23186,medication,0,0
23187,adherence,0,0
23188,was,0,0
23189,high,0,1
23190,in,0,1
23191,both,0,0
23192,groups,0,0
23193,.,0,1
23194,CONCLUSION,0,0
23195,Patients,1,1
23196,who,1,1
23197,experience,1,1
23198,virologic,1,1
23199,suppression,1,0
23200,with,1,1
23201,a,1,1
23202,regimen,1,0
23203,of,1,1
23204,lamivudine,1,1
23205,150,1,1
23206,mg,1,1
23207,BID,1,1
23208,in,1,0
23209,combination,1,0
23210,with,1,1
23211,stavudine/PI,1,1
23212,can,0,0
23213,maintain,0,0
23214,that,0,0
23215,suppression,0,0
23216,by,0,0
23217,continuing,0,0
23218,their,0,1
23219,regimen,0,1
23220,or,0,1
23221,switching,0,1
23222,to,0,0
23223,lamivudine,0,1
23224,300,0,1
23225,mg,0,0
23226,QD,0,0
23227,and,0,0
23228,continuing,0,0
23229,the,0,0
23230,other,0,1
23231,components,0,0
23232,.,0,1
23233,Adverse,0,0
23234,event,0,0
23235,profiles,0,0
23236,were,0,1
23237,comparable,0,0
23238,among,0,1
23239,treatment,0,1
23240,regimens,0,0
23241,",",0,0
23242,and,0,0
23243,no,0,0
23244,new,0,1
23245,safety,0,0
23246,concerns,0,0
23247,were,0,1
23248,raised,0,0
23249,.,0,1
23250,Effects,0,1
23251,of,0,1
23252,two,0,1
23253,types,0,1
23254,of,0,1
23255,social,0,1
23256,support,0,0
23257,and,0,0
23258,education,0,1
23259,on,0,0
23260,adaptation,0,0
23261,to,0,1
23262,early-stage,1,1
23263,breast,1,1
23264,cancer,1,1
23265,.,1,1
23266,A,0,0
23267,Roy,0,0
23268,adaptation,0,0
23269,model-based,0,0
23270,support,0,0
23271,and,0,0
23272,education,0,0
23273,intervention,0,0
23274,for,0,0
23275,women,1,1
23276,with,1,1
23277,early-stage,1,1
23278,breast,1,1
23279,cancer,1,1
23280,was,1,0
23281,tested,1,0
23282,in,0,0
23283,a,1,0
23284,three-group,1,0
23285,",",1,0
23286,three-phase,1,0
23287,randomized,1,1
23288,clinical,1,0
23289,trial,1,1
23290,of,1,0
23291,a,1,0
23292,sample,1,1
23293,of,1,0
23294,125,1,1
23295,women,1,1
23296,.,1,1
23297,The,0,0
23298,experimental,0,0
23299,group,0,1
23300,received,0,1
23301,13,0,1
23302,months,0,0
23303,of,0,1
23304,combined,0,1
23305,individual,0,0
23306,telephone,0,1
23307,and,0,0
23308,in-person,0,0
23309,group,0,1
23310,support,0,0
23311,and,0,0
23312,education,0,0
23313,",",0,0
23314,Control,0,1
23315,Group,0,1
23316,1,0,1
23317,received,0,1
23318,13,0,1
23319,months,0,0
23320,of,0,1
23321,telephone-only,0,1
23322,individual,0,0
23323,support,0,0
23324,and,0,0
23325,education,0,0
23326,",",0,0
23327,and,0,0
23328,Control,0,1
23329,Group,0,1
23330,2,0,1
23331,received,0,1
23332,one-time,0,0
23333,mailed,0,1
23334,educational,0,1
23335,information,0,0
23336,.,0,1
23337,The,0,0
23338,experimental,0,0
23339,group,0,1
23340,and,0,1
23341,Control,0,1
23342,Group,0,1
23343,1,0,0
23344,reported,0,1
23345,less,0,0
23346,mood,0,0
23347,disturbance,0,0
23348,at,0,0
23349,the,0,0
23350,end,0,0
23351,of,0,0
23352,all,0,1
23353,three,0,0
23354,phases,0,0
23355,",",0,1
23356,less,0,0
23357,loneliness,0,0
23358,at,0,0
23359,the,0,0
23360,end,0,0
23361,of,0,0
23362,Phases,0,1
23363,II,0,1
23364,and,0,1
23365,III,0,1
23366,",",0,0
23367,and,0,0
23368,a,0,0
23369,higher-quality,0,0
23370,relationship,0,0
23371,with,0,1
23372,a,0,1
23373,significant,0,0
23374,other,0,0
23375,at,0,0
23376,the,0,0
23377,end,0,0
23378,of,0,0
23379,Phase,0,1
23380,II,0,1
23381,than,0,0
23382,did,0,0
23383,Control,0,1
23384,Group,0,1
23385,2,0,1
23386,.,0,1
23387,No,0,0
23388,group,0,0
23389,differences,0,0
23390,were,0,1
23391,found,0,0
23392,for,0,0
23393,cancer-related,0,1
23394,worry,0,0
23395,or,0,1
23396,well-being,0,0
23397,.,0,1
23398,The,0,0
23399,findings,0,0
23400,suggest,0,0
23401,that,0,0
23402,individual,0,0
23403,telephone,0,1
23404,support,0,0
23405,may,0,0
23406,provide,0,0
23407,an,0,0
23408,effective,0,0
23409,alternative,0,0
23410,to,0,1
23411,in-person,0,0
23412,support,0,0
23413,groups,0,1
23414,.,0,1
23415,Further,0,0
23416,study,0,0
23417,of,0,0
23418,telephone,0,1
23419,interventions,0,0
23420,is,0,0
23421,recommended,0,0
23422,using,0,0
23423,ethnically,0,1
23424,and,0,0
23425,economically,0,1
23426,heterogeneous,0,1
23427,samples,0,1
23428,.,0,1
23429,A,0,0
23430,randomized,0,0
23431,",",0,0
23432,double-blind,0,0
23433,",",0,0
23434,vehicle-controlled,0,0
23435,study,0,0
23436,to,0,1
23437,assess,0,0
23438,5,0,0
23439,%,0,0
23440,imiquimod,0,0
23441,cream,0,0
23442,for,0,0
23443,the,0,0
23444,treatment,0,0
23445,of,1,0
23446,multiple,1,1
23447,actinic,1,1
23448,keratoses,1,1
23449,.,1,1
23450,BACKGROUND,0,0
23451,Actinic,0,1
23452,keratoses,0,1
23453,(,0,1
23454,AKs,0,1
23455,),0,1
23456,are,0,0
23457,precancerous,0,1
23458,epidermal,0,1
23459,lesions,0,1
23460,found,0,0
23461,most,0,0
23462,frequently,0,1
23463,on,0,0
23464,areas,0,0
23465,of,0,1
23466,the,0,0
23467,skin,0,1
23468,exposed,0,0
23469,to,0,0
23470,the,0,0
23471,sun,0,0
23472,.,0,1
23473,Several,0,0
23474,case,0,1
23475,studies,0,0
23476,published,0,0
23477,recently,0,1
23478,have,0,0
23479,indicated,0,0
23480,that,0,0
23481,5,0,1
23482,%,0,0
23483,imiquimod,0,0
23484,cream,0,0
23485,",",0,0
23486,currently,0,1
23487,licensed,0,1
23488,for,0,0
23489,the,0,0
23490,treatment,0,0
23491,of,0,0
23492,genital,0,1
23493,warts,0,1
23494,",",0,1
23495,may,0,0
23496,be,0,0
23497,an,0,0
23498,effective,0,0
23499,treatment,0,0
23500,for,0,1
23501,AK,0,1
23502,.,0,1
23503,OBJECTIVE,0,0
23504,To,0,0
23505,assess,0,0
23506,the,0,0
23507,efficacy,0,0
23508,and,0,0
23509,safety,0,0
23510,of,0,0
23511,imiquimod,0,0
23512,for,0,0
23513,the,0,0
23514,treatment,0,0
23515,of,0,0
23516,AK,0,1
23517,.,0,1
23518,DESIGN,0,0
23519,Patients,0,1
23520,in,0,1
23521,this,0,1
23522,randomized,0,1
23523,",",0,0
23524,double-blind,0,0
23525,",",0,0
23526,vehicle-controlled,0,0
23527,study,0,1
23528,applied,0,0
23529,5,0,0
23530,%,0,0
23531,imiquimod,0,0
23532,cream,0,0
23533,or,0,1
23534,vehicle,0,0
23535,to,0,1
23536,AK,0,1
23537,lesions,0,1
23538,3,0,1
23539,times,0,0
23540,per,0,1
23541,week,0,0
23542,for,0,0
23543,a,0,0
23544,maximum,0,0
23545,of,0,0
23546,12,0,1
23547,weeks,0,0
23548,or,0,1
23549,until,0,1
23550,lesions,0,1
23551,had,0,1
23552,resolved,0,0
23553,.,0,1
23554,In,0,0
23555,the,0,0
23556,event,0,0
23557,of,0,0
23558,an,0,0
23559,adverse,0,0
23560,reaction,0,0
23561,",",0,0
23562,application,0,0
23563,of,0,0
23564,imiquimod,0,0
23565,was,0,0
23566,reduced,0,0
23567,to,0,1
23568,1,0,1
23569,or,0,1
23570,2,0,1
23571,times,0,0
23572,per,0,1
23573,week,0,0
23574,.,0,1
23575,Rest,0,0
23576,periods,0,0
23577,were,0,1
23578,also,0,0
23579,allowed,0,0
23580,if,0,0
23581,necessary,0,0
23582,.,0,1
23583,SETTING,0,1
23584,A,1,0
23585,specialized,1,0
23586,outpatient,1,1
23587,dermatology,1,1
23588,clinic,1,1
23589,within,1,0
23590,a,1,1
23591,state-funded,1,1
23592,hospital,1,1
23593,in,1,1
23594,Germany,1,1
23595,.,1,1
23596,PATIENTS,1,0
23597,The,1,0
23598,study,1,0
23599,population,1,1
23600,was,1,0
23601,aged,1,1
23602,45,1,1
23603,to,1,1
23604,85,1,1
23605,years,1,1
23606,.,1,1
23607,Of,1,1
23608,52,1,1
23609,patients,1,1
23610,screened,1,1
23611,",",1,1
23612,36,1,1
23613,men,1,1
23614,and,1,1
23615,women,1,1
23616,with,1,1
23617,AK,1,1
23618,confirmed,1,1
23619,by,1,0
23620,histological,1,0
23621,diagnosis,1,1
23622,were,1,1
23623,enrolled,1,1
23624,.,1,1
23625,Patients,1,1
23626,were,1,0
23627,excluded,1,1
23628,from,1,1
23629,the,1,0
23630,study,1,0
23631,if,1,0
23632,they,1,0
23633,did,1,0
23634,not,1,0
23635,have,1,0
23636,a,1,0
23637,histological,1,0
23638,diagnosis,1,1
23639,for,1,0
23640,AK,1,0
23641,",",1,1
23642,if,1,0
23643,they,1,0
23644,were,1,1
23645,older,1,1
23646,than,1,1
23647,85,1,1
23648,years,1,1
23649,",",1,1
23650,or,1,1
23651,if,1,0
23652,they,1,0
23653,did,1,0
23654,not,1,0
23655,comply,1,1
23656,with,1,1
23657,the,1,0
23658,protocol,1,0
23659,.,1,1
23660,All,1,1
23661,patients,1,1
23662,had,1,1
23663,responded,1,1
23664,to,1,0
23665,a,1,0
23666,notice,1,0
23667,asking,1,0
23668,for,1,1
23669,volunteers,1,1
23670,.,1,1
23671,MAIN,0,0
23672,OUTCOME,0,1
23673,MEASURES,0,0
23674,The,0,0
23675,number,0,0
23676,and,0,0
23677,appearance,0,0
23678,of,0,1
23679,lesions,0,1
23680,were,0,1
23681,evaluated,0,0
23682,before,0,0
23683,",",0,0
23684,during,0,0
23685,",",0,0
23686,and,0,0
23687,after,0,0
23688,treatment,0,0
23689,.,0,1
23690,All,0,1
23691,adverse,0,0
23692,effects,0,0
23693,were,0,1
23694,recorded,0,0
23695,.,0,1
23696,RESULTS,0,0
23697,Lesions,0,0
23698,treated,0,1
23699,with,0,1
23700,5,0,1
23701,%,0,0
23702,imiquimod,0,0
23703,cream,0,0
23704,were,0,1
23705,clinically,0,1
23706,cleared,0,0
23707,in,0,0
23708,21,0,1
23709,(,0,1
23710,84,0,1
23711,%,0,0
23712,),0,1
23713,of,0,1
23714,25,0,1
23715,patients,0,1
23716,and,0,1
23717,partially,0,0
23718,cleared,0,0
23719,in,0,0
23720,2,0,1
23721,(,0,1
23722,8,0,1
23723,%,0,0
23724,),0,1
23725,.,0,1
23726,Clearance,0,0
23727,was,0,0
23728,histologically,0,1
23729,confirmed,0,1
23730,2,0,1
23731,weeks,0,0
23732,after,0,1
23733,the,0,1
23734,last,0,0
23735,application,0,0
23736,of,0,0
23737,imiquimod,0,0
23738,in,0,1
23739,all,0,0
23740,patients,0,1
23741,clinically,0,1
23742,diagnosed,0,1
23743,as,0,0
23744,lesion,0,1
23745,free,0,1
23746,.,0,1
23747,Only,0,0
23748,10,0,0
23749,%,0,0
23750,of,0,1
23751,patients,0,1
23752,treated,0,1
23753,with,0,1
23754,imiquimod,0,0
23755,were,0,1
23756,clinically,0,1
23757,diagnosed,0,1
23758,with,0,1
23759,recurrence,0,0
23760,1,0,1
23761,year,0,1
23762,after,0,1
23763,treatment,0,0
23764,.,0,1
23765,No,0,0
23766,reduction,0,0
23767,in,0,0
23768,the,0,0
23769,size,0,0
23770,or,0,0
23771,number,0,0
23772,of,0,1
23773,AK,0,1
23774,lesions,0,1
23775,was,0,0
23776,observed,0,0
23777,in,0,1
23778,vehicle-treated,0,1
23779,patients,0,1
23780,.,0,1
23781,Adverse,0,0
23782,effects,0,0
23783,reported,0,1
23784,by,1,1
23785,patients,1,1
23786,treated,1,1
23787,with,1,1
23788,imiquimod,1,0
23789,included,0,1
23790,erythema,0,0
23791,",",0,0
23792,edema,0,0
23793,",",0,0
23794,induration,0,1
23795,",",0,0
23796,vesicles,0,0
23797,",",0,0
23798,erosion,0,0
23799,",",0,0
23800,ulceration,0,1
23801,",",0,0
23802,excoriation,0,1
23803,",",0,0
23804,and,0,0
23805,scabbing,0,0
23806,.,0,1
23807,However,0,0
23808,",",0,0
23809,imiquimod,0,0
23810,was,0,0
23811,well,0,0
23812,tolerated,0,0
23813,since,0,0
23814,all,0,1
23815,patients,0,1
23816,completed,0,1
23817,the,0,0
23818,12-week,0,0
23819,treatment,0,0
23820,.,0,1
23821,Only,0,0
23822,a,0,0
23823,few,0,0
23824,",",0,0
23825,mild,0,1
23826,adverse,0,0
23827,reactions,0,0
23828,to,0,1
23829,the,0,0
23830,vehicle,0,0
23831,cream,0,0
23832,were,0,1
23833,reported,0,1
23834,.,0,1
23835,CONCLUSION,0,0
23836,Application,0,0
23837,of,0,1
23838,5,0,1
23839,%,0,0
23840,imiquimod,0,0
23841,cream,0,1
23842,for,0,1
23843,12,0,1
23844,weeks,0,0
23845,is,0,0
23846,an,0,0
23847,effective,0,0
23848,and,0,0
23849,well-tolerated,0,0
23850,treatment,0,0
23851,for,0,1
23852,AK,0,1
23853,.,0,1
23854,Pharmacokinetic,0,0
23855,and,0,1
23856,safety,0,0
23857,assessments,0,0
23858,of,0,1
23859,galantamine,0,1
23860,and,0,0
23861,risperidone,0,0
23862,after,0,0
23863,the,0,1
23864,two,0,0
23865,drugs,0,0
23866,are,0,0
23867,administered,0,0
23868,alone,0,0
23869,and,0,0
23870,together,0,0
23871,.,0,0
23872,To,0,0
23873,explore,0,0
23874,the,0,0
23875,steady-state,0,0
23876,pharmacokinetic,0,0
23877,profile,0,0
23878,after,0,0
23879,coadministration,0,0
23880,of,0,0
23881,galantamine,0,0
23882,and,0,0
23883,risperidone,0,0
23884,",",0,0
23885,an,0,0
23886,open-label,0,0
23887,",",0,0
23888,randomized,0,1
23889,",",0,0
23890,single-center,0,1
23891,",",0,0
23892,two-way,0,0
23893,crossover,0,1
23894,drug-drug,0,1
23895,interaction,0,0
23896,study,0,1
23897,was,0,0
23898,conducted,0,1
23899,in,0,1
23900,16,1,1
23901,healthy,1,1
23902,elderly,1,1
23903,subjects,1,1
23904,",",1,1
23905,ages,1,1
23906,60,1,1
23907,years,1,1
23908,and,1,1
23909,older,1,1
23910,.,1,1
23911,The,0,0
23912,results,0,0
23913,showed,0,0
23914,that,0,0
23915,risperidone,0,0
23916,",",0,0
23917,when,0,0
23918,administered,0,0
23919,with,0,0
23920,galantamine,0,0
23921,",",0,0
23922,did,0,0
23923,not,0,0
23924,change,0,0
23925,the,0,0
23926,bioavailability,0,0
23927,of,0,0
23928,galantamine,0,0
23929,at,0,1
23930,steady,0,0
23931,state,0,1
23932,.,0,1
23933,In,0,0
23934,addition,0,0
23935,",",0,0
23936,systemic,0,0
23937,exposure,0,0
23938,of,0,0
23939,risperidone,0,0
23940,active,0,1
23941,moiety,0,0
23942,(,0,1
23943,risperidone,0,0
23944,plus,0,0
23945,9-hydroxyrisperidone,0,0
23946,),0,0
23947,",",0,0
23948,the,0,0
23949,most,0,0
23950,clinically,0,1
23951,relevant,0,0
23952,component,0,0
23953,of,0,0
23954,risperidone,0,0
23955,treatment,0,0
23956,",",0,0
23957,was,0,0
23958,not,0,0
23959,affected,0,0
23960,by,0,0
23961,galantamine,0,0
23962,coadministration,0,0
23963,",",0,0
23964,while,0,0
23965,systemic,0,0
23966,exposure,0,1
23967,was,0,0
23968,increased,0,0
23969,by,0,0
23970,approximately,0,1
23971,10,0,1
23972,%,0,0
23973,for,0,0
23974,risperidone,0,0
23975,and,0,0
23976,decreased,0,0
23977,by,0,0
23978,about,0,0
23979,10,0,1
23980,%,0,0
23981,for,0,1
23982,9-hydroxyrisperidone,0,0
23983,(,0,1
23984,active,0,1
23985,metabolite,0,0
23986,of,0,0
23987,risperidone,0,1
23988,),0,1
23989,.,0,1
23990,Galantamine,0,0
23991,and,0,0
23992,risperidone,0,0
23993,were,0,0
23994,both,0,0
23995,safe,0,0
23996,and,0,0
23997,well,0,0
23998,tolerated,0,0
23999,administered,0,0
24000,either,0,0
24001,alone,0,0
24002,or,0,1
24003,together,0,0
24004,.,0,1
24005,Thus,0,0
24006,",",0,0
24007,no,0,0
24008,dose,0,0
24009,adjustment,0,0
24010,for,0,0
24011,either,0,0
24012,risperidone,0,0
24013,orgalantamine,0,0
24014,is,0,0
24015,necessary,0,0
24016,when,0,0
24017,these,0,0
24018,two,0,0
24019,drugs,0,0
24020,are,0,0
24021,administered,0,0
24022,together,0,0
24023,in,0,0
24024,the,0,0
24025,dose,0,0
24026,range,0,1
24027,evaluated,0,0
24028,.,0,1
24029,Risperidone,0,0
24030,improves,0,0
24031,behavior,0,0
24032,in,0,0
24033,children,1,1
24034,with,1,1
24035,autism,1,1
24036,.,1,1
24037,Oxytocin,0,0
24038,infusion,0,0
24039,reduces,0,0
24040,repetitive,0,0
24041,behaviors,0,1
24042,in,0,1
24043,adults,1,1
24044,with,1,1
24045,autistic,1,1
24046,and,1,1
24047,Asperger,1,1
24048,'s,1,1
24049,disorders,1,1
24050,.,1,1
24051,Autism,0,1
24052,is,0,0
24053,a,0,0
24054,neurodevelopmental,0,0
24055,disorder,0,1
24056,characterized,0,0
24057,by,0,0
24058,dysfunction,0,1
24059,in,0,1
24060,three,0,0
24061,core,0,1
24062,behavioral,0,1
24063,domains,0,0
24064,:,0,1
24065,repetitive,0,0
24066,behaviors,0,0
24067,",",0,1
24068,social,0,1
24069,deficits,0,0
24070,",",0,1
24071,and,0,1
24072,language,0,1
24073,abnormalities,0,0
24074,.,0,0
24075,There,0,0
24076,is,0,0
24077,evidence,0,0
24078,that,0,0
24079,abnormalities,0,0
24080,exist,0,0
24081,in,0,0
24082,peptide,0,0
24083,systems,0,0
24084,",",0,0
24085,particularly,0,0
24086,the,0,0
24087,oxytocin,0,0
24088,system,0,0
24089,",",0,0
24090,in,0,0
24091,autism,1,1
24092,spectrum,1,1
24093,patients,1,1
24094,.,1,1
24095,Furthermore,0,0
24096,",",0,0
24097,oxytocin,0,0
24098,and,0,0
24099,the,0,0
24100,closely,0,0
24101,related,0,0
24102,peptide,0,0
24103,vasopressin,0,0
24104,are,0,0
24105,known,0,0
24106,to,0,0
24107,play,0,0
24108,a,0,0
24109,role,0,0
24110,in,0,0
24111,social,0,1
24112,and,0,1
24113,repetitive,0,0
24114,behaviors,0,0
24115,.,0,1
24116,This,0,0
24117,study,0,0
24118,examined,0,0
24119,the,0,0
24120,impact,0,0
24121,of,0,0
24122,oxytocin,0,0
24123,on,0,0
24124,repetitive,0,0
24125,behaviors,0,1
24126,in,0,1
24127,15,1,1
24128,adults,1,1
24129,with,1,1
24130,autism,1,1
24131,or,1,1
24132,Asperger,1,1
24133,'s,1,1
24134,disorder,1,1
24135,via,0,1
24136,randomized,0,1
24137,double-blind,0,1
24138,oxytocin,0,0
24139,and,0,1
24140,placebo,0,1
24141,challenges,0,0
24142,.,0,1
24143,The,0,0
24144,primary,0,0
24145,outcome,0,0
24146,measure,0,0
24147,was,0,0
24148,an,0,0
24149,instrument,0,0
24150,rating,0,0
24151,six,0,1
24152,repetitive,0,0
24153,behaviors,0,1
24154,:,0,1
24155,need,0,0
24156,to,0,0
24157,know,0,0
24158,",",0,0
24159,repeating,0,0
24160,",",0,0
24161,ordering,0,0
24162,",",0,0
24163,need,0,0
24164,to,0,0
24165,tell/ask,0,0
24166,",",0,0
24167,self-injury,0,0
24168,",",0,0
24169,and,0,0
24170,touching,0,0
24171,.,0,1
24172,Patients,0,1
24173,with,0,1
24174,autism,0,1
24175,spectrum,0,1
24176,disorders,0,1
24177,showed,0,0
24178,a,0,1
24179,significant,0,0
24180,reduction,0,0
24181,in,0,1
24182,repetitive,0,0
24183,behaviors,0,0
24184,following,0,1
24185,oxytocin,0,0
24186,infusion,0,0
24187,in,0,0
24188,comparison,0,0
24189,to,0,0
24190,placebo,0,0
24191,infusion,0,0
24192,.,0,1
24193,Repetitive,0,0
24194,behavior,0,0
24195,in,0,0
24196,autism,0,1
24197,spectrum,0,1
24198,disorders,0,1
24199,may,0,0
24200,be,0,0
24201,related,0,0
24202,to,0,0
24203,abnormalities,0,0
24204,in,0,0
24205,the,0,0
24206,oxytocin,0,0
24207,system,0,0
24208,",",0,0
24209,and,0,0
24210,may,0,0
24211,be,0,0
24212,partially,0,0
24213,ameliorated,0,0
24214,by,0,0
24215,synthetic,0,0
24216,oxytocin,0,0
24217,infusion,0,0
24218,.,0,1
24219,Is,0,0
24220,the,0,0
24221,orientation,0,0
24222,of,0,0
24223,the,0,0
24224,apical,1,0
24225,defibrillation,1,0
24226,paddle,1,0
24227,of,1,0
24228,importance,1,0
24229,during,0,1
24230,manual,0,0
24231,external,0,1
24232,defibrillation,0,1
24233,?,0,1
24234,OBJECTIVE,0,0
24235,Transthoracic,0,1
24236,impedance,0,0
24237,(,0,1
24238,TTI,0,0
24239,),0,0
24240,is,0,0
24241,a,0,0
24242,factor,0,0
24243,determining,0,0
24244,the,0,0
24245,magnitude,0,0
24246,of,0,0
24247,the,0,0
24248,transmyocardial,0,0
24249,current,0,0
24250,during,0,1
24251,external,0,1
24252,defibrillation,0,1
24253,.,0,1
24254,Minimising,0,0
24255,TTI,0,0
24256,increases,0,0
24257,the,0,0
24258,chances,0,0
24259,of,0,0
24260,successful,0,1
24261,defibrillation,0,1
24262,.,0,1
24263,Most,0,0
24264,external,0,0
24265,defibrillation,0,0
24266,paddles,0,0
24267,are,0,0
24268,rectangular,0,0
24269,in,0,0
24270,shape,0,0
24271,and,0,0
24272,can,0,0
24273,",",0,0
24274,therefore,0,0
24275,",",0,0
24276,be,0,0
24277,placed,0,0
24278,in,0,0
24279,a,0,1
24280,transverse,0,0
24281,or,0,1
24282,longitudinal,0,1
24283,orientation,0,0
24284,.,0,1
24285,The,0,0
24286,apical,0,0
24287,paddle,0,0
24288,is,0,0
24289,often,0,0
24290,placed,0,0
24291,in,0,0
24292,a,0,1
24293,transverse,0,1
24294,orientation,0,0
24295,.,0,0
24296,This,0,0
24297,may,0,0
24298,theoretically,0,0
24299,result,0,0
24300,in,0,0
24301,a,0,0
24302,higher,0,0
24303,TTI,0,0
24304,than,0,0
24305,a,0,1
24306,longitudinal,0,1
24307,orientation,0,0
24308,because,0,0
24309,of,0,0
24310,poorer,0,0
24311,contact,0,0
24312,at,0,0
24313,the,0,0
24314,lateral,0,1
24315,paddle,0,1
24316,edges,0,0
24317,.,0,1
24318,We,0,0
24319,compared,0,0
24320,TTI,0,0
24321,with,0,1
24322,the,0,0
24323,apical,0,0
24324,paddle,0,0
24325,in,0,0
24326,both,0,0
24327,a,0,0
24328,transverse,0,0
24329,and,0,0
24330,longitudinal,0,1
24331,orientation,0,0
24332,.,0,1
24333,MATERIALS,0,0
24334,AND,0,0
24335,METHODS,0,0
24336,Twenty,1,1
24337,sequential,1,0
24338,anaesthetised,1,1
24339,patients,1,1
24340,were,0,1
24341,studied,0,1
24342,.,0,1
24343,A,0,0
24344,pair,0,0
24345,of,0,0
24346,defibrillator,0,1
24347,paddles,0,0
24348,were,0,1
24349,instrumented,0,1
24350,to,0,0
24351,measure,0,0
24352,paddle,0,0
24353,force,0,1
24354,.,0,1
24355,TTI,0,0
24356,was,0,0
24357,recorded,0,0
24358,pre-operatively,0,1
24359,at,0,0
24360,end-expiration,0,0
24361,with,0,1
24362,the,0,0
24363,apical,0,0
24364,paddle,0,0
24365,in,0,0
24366,both,0,0
24367,longitudinal,0,1
24368,and,0,1
24369,transverse,0,1
24370,orientations,0,0
24371,.,0,1
24372,The,0,0
24373,sternal,0,0
24374,paddle,0,0
24375,was,0,0
24376,placed,0,0
24377,in,0,0
24378,a,0,1
24379,longitudinal,0,1
24380,orientation,0,0
24381,for,0,0
24382,all,0,1
24383,measurements,0,0
24384,.,0,1
24385,RESULTS,0,0
24386,TTI,0,0
24387,decreased,0,0
24388,in,0,0
24389,both,0,0
24390,transverse,0,0
24391,and,0,0
24392,longitudinal,0,1
24393,orientations,0,0
24394,as,0,1
24395,paddle,0,1
24396,force,0,1
24397,increased,0,0
24398,.,0,1
24399,Transverse,0,0
24400,paddle,0,0
24401,orientation,0,0
24402,resulted,0,0
24403,in,0,0
24404,a,0,0
24405,significantly,0,0
24406,(,0,0
24407,P,0,0
24408,<,0,0
24409,0.01,0,0
24410,),0,1
24411,higher,0,0
24412,TTI,0,1
24413,than,0,0
24414,longitudinal,0,1
24415,orientation,0,0
24416,at,0,0
24417,all,0,1
24418,paddle,0,0
24419,forces,0,0
24420,below,0,1
24421,12,0,1
24422,kg,0,1
24423,force,0,1
24424,.,0,1
24425,CONCLUSION,0,0
24426,The,0,0
24427,longitudinal,0,0
24428,orientation,0,0
24429,of,0,0
24430,a,0,1
24431,rectangular,0,0
24432,defibrillation,0,0
24433,paddle,0,0
24434,provides,0,0
24435,a,0,0
24436,lower,0,0
24437,TTI,0,0
24438,than,0,0
24439,orientation,0,0
24440,horizontally,0,0
24441,.,0,1
24442,Dexamethasone,0,0
24443,versus,0,0
24444,prednisone,0,1
24445,and,0,1
24446,daily,0,0
24447,oral,0,0
24448,versus,0,0
24449,weekly,0,1
24450,intravenous,0,0
24451,mercaptopurine,0,0
24452,for,0,1
24453,patients,1,1
24454,with,1,1
24455,standard-risk,1,1
24456,acute,1,1
24457,lymphoblastic,1,1
24458,leukemia,1,1
24459,:,1,1
24460,a,0,0
24461,report,0,0
24462,from,0,0
24463,the,0,0
24464,Children,0,1
24465,'s,0,1
24466,Cancer,0,1
24467,Group,0,1
24468,.,0,1
24469,Conventional,0,0
24470,therapy,0,0
24471,for,0,0
24472,childhood,1,1
24473,acute,1,1
24474,lymphoblastic,1,1
24475,leukemia,1,1
24476,(,1,1
24477,ALL,1,1
24478,),1,0
24479,includes,0,0
24480,prednisone,0,0
24481,and,0,0
24482,oral,0,1
24483,6-mercaptopurine,0,0
24484,.,0,1
24485,Prior,0,1
24486,observations,0,0
24487,suggested,0,0
24488,potential,0,0
24489,advantages,0,0
24490,for,0,1
24491,dexamethasone,0,0
24492,over,0,0
24493,prednisone,0,1
24494,and,0,1
24495,for,0,0
24496,intravenous,0,1
24497,(,0,1
24498,IV,0,1
24499,),0,1
24500,over,0,0
24501,oral,0,1
24502,6-mercaptopurine,0,0
24503,",",0,0
24504,which,0,0
24505,remain,0,0
24506,to,0,0
24507,be,0,0
24508,validated,0,0
24509,.,0,0
24510,We,0,0
24511,report,0,0
24512,the,0,0
24513,results,0,0
24514,of,0,0
24515,a,0,1
24516,randomized,0,1
24517,trial,0,0
24518,of,0,0
24519,more,1,0
24520,than,1,1
24521,1000,1,1
24522,subjects,1,1
24523,that,0,0
24524,examined,0,0
24525,the,0,0
24526,efficacy,0,0
24527,of,0,0
24528,dexamethasone,0,0
24529,and,0,1
24530,IV,0,1
24531,6-mercaptopurine,0,0
24532,.,0,1
24533,Children,1,1
24534,with,1,1
24535,National,1,1
24536,Cancer,1,1
24537,Institute,1,1
24538,standard-risk,1,1
24539,ALL,1,1
24540,were,0,1
24541,randomly,0,1
24542,assigned,0,1
24543,in,0,0
24544,a,0,1
24545,2,0,1
24546,x,0,1
24547,2,0,1
24548,factorial,0,0
24549,design,0,1
24550,to,0,0
24551,receive,0,1
24552,dexamethasone,0,0
24553,(,0,1
24554,6,0,0
24555,mg/m,0,1
24556,(,0,1
24557,2,0,1
24558,),0,1
24559,/d,0,0
24560,),0,1
24561,for,0,1
24562,28,0,1
24563,days,0,0
24564,in,0,1
24565,induction,0,1
24566,",",0,0
24567,plus,0,0
24568,taper,0,0
24569,",",0,0
24570,compared,0,0
24571,with,0,1
24572,prednisone,0,1
24573,(,0,1
24574,40,0,1
24575,mg/m,0,1
24576,(,0,1
24577,2,0,1
24578,),0,1
24579,/d,0,0
24580,),0,1
24581,.,0,1
24582,The,0,0
24583,second,0,0
24584,randomized,0,1
24585,assignment,0,1
24586,was,0,0
24587,for,0,0
24588,daily,0,0
24589,oral,0,1
24590,or,0,1
24591,weekly,0,1
24592,IV,0,1
24593,6-mercaptopurine,0,0
24594,during,0,0
24595,consolidation,0,0
24596,.,0,1
24597,During,0,0
24598,maintenance,0,0
24599,",",0,1
24600,5,0,0
24601,days,0,0
24602,of,0,1
24603,the,0,1
24604,randomized,0,1
24605,steroid,0,0
24606,was,0,0
24607,given,0,0
24608,monthly,0,0
24609,",",0,0
24610,at,0,0
24611,the,0,0
24612,same,0,0
24613,dose,0,0
24614,",",0,0
24615,and,0,0
24616,all,0,0
24617,patients,0,1
24618,received,0,1
24619,daily,0,0
24620,oral,0,1
24621,6-mercaptopurine,0,0
24622,.,0,1
24623,During,0,0
24624,delayed,0,0
24625,intensification,0,0
24626,",",0,0
24627,all,0,0
24628,patients,0,1
24629,received,0,1
24630,a,0,1
24631,dexamethasone,0,0
24632,dosage,0,0
24633,of,0,1
24634,10,0,1
24635,mg/m,0,1
24636,(,0,1
24637,2,0,1
24638,),0,1
24639,/d,0,0
24640,for,0,1
24641,21,0,1
24642,days,0,0
24643,",",0,1
24644,with,0,1
24645,taper,0,0
24646,.,0,1
24647,Intrathecal,0,0
24648,(,0,0
24649,IT,0,1
24650,),0,1
24651,methotrexate,0,0
24652,was,0,0
24653,the,0,0
24654,sole,0,0
24655,central,0,0
24656,nervous,0,1
24657,system-directed,0,0
24658,therapy,0,1
24659,.,0,1
24660,Patients,0,1
24661,randomly,0,1
24662,assigned,0,1
24663,to,0,0
24664,receive,0,1
24665,dexamethasone,0,0
24666,had,0,1
24667,a,0,0
24668,6-year,0,1
24669,isolated,0,1
24670,central,0,1
24671,nervous,0,1
24672,system-relapse,0,1
24673,rate,0,0
24674,of,0,1
24675,3.7,0,1
24676,%,0,0
24677,+/-,0,0
24678,0.8,0,0
24679,%,0,0
24680,",",0,0
24681,compared,0,0
24682,with,0,1
24683,7.1,0,1
24684,%,0,0
24685,+/-,0,0
24686,1.1,0,0
24687,%,0,0
24688,for,0,0
24689,prednisone,0,1
24690,(,0,1
24691,P,0,0
24692,=.01,0,0
24693,),0,0
24694,.,0,0
24695,There,0,0
24696,was,0,0
24697,also,0,0
24698,a,0,0
24699,trend,0,0
24700,toward,0,0
24701,fewer,0,0
24702,isolated,0,1
24703,bone,0,0
24704,marrow,0,1
24705,relapses,0,0
24706,with,0,1
24707,dexamethasone,0,0
24708,.,0,1
24709,The,0,0
24710,6-year,0,0
24711,event-free,0,0
24712,survival,0,0
24713,(,0,1
24714,EFS,0,0
24715,),0,1
24716,was,0,0
24717,85,0,1
24718,%,0,0
24719,+/-,0,0
24720,2,0,1
24721,%,0,0
24722,for,0,0
24723,dexamethasone,0,0
24724,and,0,1
24725,77,0,1
24726,%,0,0
24727,+/-,0,0
24728,2,0,1
24729,%,0,0
24730,for,0,0
24731,prednisone,0,1
24732,(,0,1
24733,P,0,0
24734,=.002,0,0
24735,),0,1
24736,.,0,1
24737,EFS,0,0
24738,was,0,0
24739,similar,0,0
24740,with,0,1
24741,oral,0,1
24742,or,0,1
24743,IV,0,1
24744,6-mercaptopurine,0,0
24745,;,0,1
24746,however,0,0
24747,",",0,0
24748,patients,0,1
24749,assigned,0,1
24750,to,0,1
24751,IV,0,1
24752,6-mercaptopurine,0,0
24753,had,0,1
24754,decreased,0,0
24755,survival,0,0
24756,after,0,0
24757,relapse,0,1
24758,.,0,1
24759,Acute,0,1
24760,intravenous,0,1
24761,L-arginine,0,0
24762,infusion,0,0
24763,decreases,0,0
24764,endothelin-1,0,0
24765,levels,0,0
24766,and,0,1
24767,improves,0,0
24768,endothelial,0,0
24769,function,0,0
24770,in,0,1
24771,patients,1,1
24772,with,1,1
24773,angina,1,1
24774,pectoris,1,1
24775,and,1,1
24776,normal,1,1
24777,coronary,1,1
24778,arteriograms,1,1
24779,:,1,1
24780,correlation,0,0
24781,with,0,1
24782,asymmetric,0,1
24783,dimethylarginine,0,1
24784,levels,0,1
24785,.,0,1
24786,BACKGROUND,0,0
24787,We,0,0
24788,tested,0,0
24789,the,0,0
24790,hypothesis,0,0
24791,that,0,0
24792,asymmetric,0,1
24793,dimethylarginine,0,0
24794,(,0,1
24795,ADMA,0,1
24796,),0,1
24797,levels,0,0
24798,could,0,0
24799,be,0,0
24800,elevated,0,0
24801,and,0,0
24802,influence,0,0
24803,endothelin-1,0,0
24804,and,0,0
24805,nitric,0,0
24806,oxide,0,0
24807,release,0,0
24808,and,0,0
24809,action,0,0
24810,in,0,0
24811,patients,1,1
24812,with,1,1
24813,cardiac,1,1
24814,syndrome,1,1
24815,X,1,1
24816,(,1,1
24817,CSX,1,1
24818,),1,1
24819,.,1,1
24820,In,0,0
24821,addition,0,0
24822,",",0,0
24823,we,0,0
24824,evaluated,0,0
24825,whether,0,0
24826,an,0,0
24827,intravenous,0,0
24828,infusion,0,0
24829,of,0,0
24830,L-arginine,0,0
24831,would,0,0
24832,improve,0,0
24833,endothelial,0,0
24834,function,0,0
24835,in,0,0
24836,these,0,0
24837,subjects,0,1
24838,.,0,1
24839,METHODS,0,0
24840,AND,0,0
24841,RESULTS,0,1
24842,Nine,1,1
24843,patients,1,1
24844,with,1,1
24845,CSX,1,1
24846,and,1,1
24847,14,1,1
24848,control,1,1
24849,subjects,1,1
24850,underwent,1,1
24851,a,1,1
24852,continuous,1,0
24853,infusion,1,0
24854,of,1,1
24855,L-arginine,1,1
24856,(,1,1
24857,0.125,1,0
24858,g/min,1,0
24859,),1,1
24860,or,1,1
24861,saline,1,0
24862,for,1,1
24863,120,1,1
24864,minutes,1,0
24865,.,1,1
24866,Sixty,0,1
24867,minutes,0,0
24868,after,0,1
24869,L-arginine,0,1
24870,or,0,1
24871,saline,0,0
24872,infusions,0,0
24873,",",0,1
24874,an,0,0
24875,intravenous,0,0
24876,insulin,0,0
24877,bolus,0,0
24878,(,0,1
24879,0.1,0,0
24880,U/kg,0,1
24881,),0,1
24882,combined,0,0
24883,with,0,1
24884,a,0,1
24885,euglycemic,0,0
24886,clamp,0,0
24887,was,0,0
24888,performed,0,0
24889,.,0,1
24890,Basal,0,0
24891,ADMA,0,1
24892,and,0,1
24893,endothelin-1,0,0
24894,levels,0,0
24895,were,0,1
24896,higher,0,0
24897,in,0,0
24898,patients,1,1
24899,with,1,1
24900,CSX,1,1
24901,than,0,1
24902,in,0,1
24903,controls,1,1
24904,.,1,1
24905,At,0,0
24906,the,0,0
24907,end,0,0
24908,of,0,0
24909,the,0,0
24910,first,0,0
24911,hour,0,0
24912,of,0,0
24913,infusion,0,0
24914,",",0,0
24915,compared,0,0
24916,with,0,1
24917,saline,0,0
24918,",",0,0
24919,L-arginine,0,0
24920,infusion,0,0
24921,increased,0,0
24922,basal,0,0
24923,forearm,0,1
24924,blood,0,0
24925,flow,0,0
24926,",",0,0
24927,nitrite,0,0
24928,and,0,1
24929,nitrate,0,0
24930,(,0,1
24931,NOx,0,0
24932,),0,1
24933,",",0,0
24934,and,0,0
24935,forearm,0,0
24936,cGMP,0,0
24937,release,0,0
24938,and,0,0
24939,decreased,0,0
24940,endothelin-1,0,0
24941,.,0,1
24942,After,0,0
24943,insulin,0,0
24944,bolus,0,0
24945,",",0,0
24946,during,0,0
24947,saline,0,0
24948,",",0,1
24949,insulin-induced,0,0
24950,NOx,0,0
24951,",",0,0
24952,endothelin-1,0,0
24953,",",0,0
24954,and,0,0
24955,forearm,0,0
24956,cGMP,0,0
24957,release,0,0
24958,was,0,0
24959,almost,0,1
24960,abolished,0,0
24961,.,0,0
24962,Conversely,0,0
24963,",",0,0
24964,L-arginine,0,0
24965,restored,0,0
24966,a,0,0
24967,physiological,0,0
24968,profile,0,0
24969,of,0,0
24970,all,0,1
24971,endothelial,0,0
24972,variables,0,0
24973,compared,0,0
24974,with,0,1
24975,control,0,1
24976,subjects,0,1
24977,.,0,1
24978,In,0,0
24979,control,0,1
24980,subjects,0,1
24981,",",0,0
24982,compared,0,0
24983,with,0,1
24984,saline,0,0
24985,infusion,0,0
24986,",",0,0
24987,L-arginine,0,0
24988,infusion,0,0
24989,did,0,0
24990,not,0,0
24991,modify,0,0
24992,any,0,0
24993,parameter,0,0
24994,.,0,1
24995,ADMA,0,0
24996,levels,0,0
24997,were,0,1
24998,positively,0,0
24999,correlated,0,0
25000,with,0,1
25001,basal,0,1
25002,endothelin-1,0,0
25003,levels,0,0
25004,and,0,1
25005,negatively,0,0
25006,correlated,0,0
25007,with,0,1
25008,insulin-induced,0,1
25009,incremental,0,0
25010,levels,0,1
25011,of,0,1
25012,NOx,0,1
25013,and,0,1
25014,forearm,0,1
25015,cGMP,0,0
25016,release,0,0
25017,.,0,1
25018,CONCLUSIONS,0,0
25019,Plasma,0,1
25020,ADMA,0,1
25021,levels,0,0
25022,are,0,0
25023,increased,0,0
25024,in,0,0
25025,patients,1,1
25026,with,1,1
25027,CSX,1,1
25028,",",0,1
25029,and,0,0
25030,they,0,0
25031,are,0,0
25032,correlated,0,0
25033,with,0,1
25034,increases,0,0
25035,in,0,1
25036,endothelin-1,0,0
25037,and,0,1
25038,reductions,0,0
25039,in,0,1
25040,insulin-induced,0,1
25041,increments,0,0
25042,in,0,1
25043,plasma,0,0
25044,NOx,0,0
25045,and,0,0
25046,cGMP,0,0
25047,",",0,1
25048,effects,0,0
25049,that,0,0
25050,are,0,0
25051,reversed,0,0
25052,by,0,0
25053,intravenous,0,1
25054,L-arginine,0,1
25055,.,0,1
25056,These,0,0
25057,data,0,0
25058,suggest,0,0
25059,that,0,0
25060,increased,0,0
25061,ADMA,0,1
25062,levels,0,0
25063,play,0,0
25064,a,0,0
25065,role,0,0
25066,in,0,0
25067,the,0,0
25068,abnormal,0,1
25069,vascular,0,0
25070,reactivity,0,0
25071,that,0,0
25072,is,0,0
25073,observed,0,0
25074,in,0,0
25075,patients,0,1
25076,with,0,1
25077,CSX,1,1
25078,.,1,1
25079,Intravenous,0,1
25080,levosimendan,0,0
25081,treatment,0,0
25082,is,0,0
25083,cost-effective,0,0
25084,compared,0,0
25085,with,0,1
25086,dobutamine,0,0
25087,in,0,1
25088,severe,1,1
25089,low-output,1,1
25090,heart,1,1
25091,failure,1,1
25092,:,1,1
25093,an,0,0
25094,analysis,0,0
25095,based,0,1
25096,on,0,0
25097,the,0,0
25098,international,0,1
25099,LIDO,0,1
25100,trial,0,1
25101,.,0,1
25102,BACKGROUND,0,0
25103,Levosimendan,0,0
25104,",",0,0
25105,a,0,0
25106,novel,0,0
25107,calcium,0,0
25108,sensitiser,0,0
25109,",",0,0
25110,improves,0,0
25111,cardiac,0,1
25112,performance,0,0
25113,and,0,1
25114,symptoms,0,1
25115,without,0,1
25116,increasing,0,0
25117,oxygen,0,0
25118,consumption,0,0
25119,",",0,0
25120,and,0,0
25121,decreases,0,0
25122,the,0,0
25123,mortality,0,0
25124,of,0,0
25125,patients,1,1
25126,with,1,1
25127,low-output,1,1
25128,heart,1,1
25129,failure,1,1
25130,.,1,1
25131,AIMS,0,0
25132,To,0,0
25133,estimate,0,0
25134,the,0,0
25135,cost-effectiveness,0,0
25136,of,0,0
25137,intravenous,0,1
25138,treatment,0,1
25139,with,0,1
25140,levosimendan,0,0
25141,compared,0,0
25142,with,0,1
25143,dobutamine,0,0
25144,in,0,1
25145,patients,0,1
25146,with,0,1
25147,severe,0,1
25148,low-output,0,1
25149,heart,0,1
25150,failure,0,1
25151,.,0,1
25152,METHODS,0,0
25153,This,0,0
25154,economic,0,0
25155,evaluation,0,0
25156,was,0,0
25157,based,0,1
25158,on,0,0
25159,a,0,1
25160,European,0,1
25161,clinical,0,0
25162,trial,0,1
25163,(,0,1
25164,LIDO,0,1
25165,),0,1
25166,",",0,0
25167,in,0,0
25168,which,0,1
25169,203,1,1
25170,patients,1,1
25171,with,1,1
25172,severe,1,1
25173,heart,1,1
25174,failure,1,1
25175,randomly,0,1
25176,received,0,0
25177,a,0,0
25178,24,0,0
25179,h,0,0
25180,infusion,0,0
25181,with,0,1
25182,either,0,1
25183,levosimendan,0,0
25184,or,0,1
25185,dobutamine,0,0
25186,.,0,1
25187,Survival,0,0
25188,and,0,0
25189,resource,0,0
25190,utilisation,0,0
25191,data,0,0
25192,were,0,1
25193,collected,0,1
25194,for,0,1
25195,6,0,1
25196,months,0,1
25197,;,0,1
25198,survival,0,0
25199,was,0,0
25200,extrapolated,0,0
25201,assuming,0,0
25202,a,0,1
25203,mean,0,1
25204,additional,0,0
25205,lifetime,0,1
25206,of,0,1
25207,3,0,1
25208,years,0,1
25209,based,0,1
25210,on,0,1
25211,data,0,0
25212,from,0,1
25213,the,0,1
25214,Cooperative,0,1
25215,North,0,1
25216,Scandinavian,0,1
25217,Enalapril,0,0
25218,Survival,0,0
25219,Study,0,1
25220,trial,0,1
25221,.,0,1
25222,Costs,0,0
25223,were,0,0
25224,based,0,1
25225,on,0,0
25226,study,0,1
25227,drug,0,1
25228,usage,0,0
25229,and,0,0
25230,hospitalisation,0,0
25231,in,0,0
25232,the,0,0
25233,6-month,0,0
25234,follow-up,0,0
25235,.,0,1
25236,A,0,0
25237,sensitivity,0,0
25238,analysis,0,0
25239,on,0,0
25240,dosage,0,0
25241,of,0,0
25242,drug,0,0
25243,and,0,0
25244,duration,0,0
25245,of,0,0
25246,survival,0,0
25247,was,0,0
25248,performed,0,0
25249,.,0,0
25250,RESULTS,0,0
25251,The,0,0
25252,mean,0,0
25253,survival,0,0
25254,over,0,0
25255,6,0,1
25256,months,0,1
25257,was,0,0
25258,157+/-52,0,1
25259,days,0,0
25260,in,0,1
25261,the,0,0
25262,levosimendan,0,0
25263,group,0,0
25264,and,0,1
25265,139+/-64,0,0
25266,days,0,0
25267,in,0,1
25268,the,0,0
25269,dobutamine,0,0
25270,group,0,0
25271,(,0,1
25272,P,0,0
25273,<,0,0
25274,0.01,0,0
25275,),0,0
25276,.,0,0
25277,When,0,0
25278,extrapolated,0,0
25279,up,0,0
25280,to,0,1
25281,3,0,0
25282,years,0,1
25283,",",0,1
25284,the,0,0
25285,gain,0,0
25286,in,0,0
25287,life,0,1
25288,expectancy,0,1
25289,was,0,0
25290,estimated,0,0
25291,at,0,1
25292,0.35,0,0
25293,years,0,1
25294,(,0,1
25295,discounted,0,1
25296,at,0,1
25297,3,0,1
25298,%,0,1
25299,),0,1
25300,.,0,1
25301,Levosimendan,0,0
25302,increased,0,0
25303,the,0,0
25304,mean,0,0
25305,cost,0,0
25306,per,0,0
25307,patient,0,1
25308,by,0,0
25309,1108,0,1
25310,",",0,1
25311,which,0,0
25312,was,0,0
25313,entirely,0,0
25314,due,0,0
25315,to,0,0
25316,the,0,0
25317,cost,0,0
25318,of,0,0
25319,the,0,0
25320,study,0,1
25321,drug,0,0
25322,.,0,1
25323,The,0,0
25324,incremental,0,0
25325,cost,0,0
25326,per,0,1
25327,life-year,0,0
25328,saved,0,1
25329,(,0,1
25330,LYS,0,0
25331,),0,1
25332,was,0,0
25333,3205,0,1
25334,at,0,0
25335,the,0,0
25336,European,0,1
25337,level,0,0
25338,;,0,0
25339,in,0,0
25340,the,0,0
25341,individual,0,0
25342,countries,0,1
25343,the,0,0
25344,cost,0,0
25345,per,0,0
25346,LYS,0,0
25347,ranged,0,1
25348,between,0,0
25349,3091,0,1
25350,and,0,1
25351,3331,0,1
25352,.,0,1
25353,The,0,0
25354,result,0,0
25355,was,0,0
25356,robust,0,0
25357,in,0,0
25358,the,0,0
25359,sensitivity,0,0
25360,analysis,0,0
25361,.,0,1
25362,CONCLUSIONS,0,0
25363,Although,0,0
25364,the,0,0
25365,patients,0,1
25366,in,0,0
25367,the,0,0
25368,levosimendan,0,0
25369,group,0,0
25370,were,0,1
25371,alive,0,1
25372,for,0,1
25373,more,0,1
25374,days,0,0
25375,and,0,0
25376,thus,0,0
25377,at,0,0
25378,risk,0,0
25379,of,0,0
25380,hospitalisation,0,0
25381,for,0,0
25382,longer,0,0
25383,",",0,0
25384,there,0,0
25385,was,0,0
25386,no,0,0
25387,increase,0,0
25388,in,0,0
25389,hospitalisation,0,1
25390,or,0,1
25391,hospitalisation,0,1
25392,costs,0,1
25393,with,0,1
25394,levosimendan,0,0
25395,treatment,0,1
25396,.,0,1
25397,The,0,0
25398,cost,0,0
25399,per,0,0
25400,LYS,0,0
25401,using,0,1
25402,levosimendan,0,0
25403,compares,0,1
25404,favourably,0,0
25405,with,0,1
25406,other,0,0
25407,cost-effectiveness,0,0
25408,analyses,0,0
25409,in,0,1
25410,cardiology,0,1
25411,.,0,1
25412,Enteral,0,1
25413,nutrition,0,1
25414,with,0,1
25415,eicosapentaenoic,0,0
25416,acid,0,0
25417,",",0,0
25418,gamma-linolenic,0,0
25419,acid,0,0
25420,",",0,1
25421,and,0,1
25422,antioxidants,0,1
25423,reduces,0,0
25424,alveolar,0,1
25425,inflammatory,0,1
25426,mediators,0,0
25427,and,0,1
25428,protein,0,0
25429,influx,0,0
25430,in,1,0
25431,patients,1,1
25432,with,1,1
25433,acute,1,1
25434,respiratory,1,1
25435,distress,1,0
25436,syndrome,1,1
25437,.,1,1
25438,OBJECTIVE,0,0
25439,Previously,0,1
25440,",",0,0
25441,we,0,0
25442,showed,0,0
25443,that,0,0
25444,acute,1,1
25445,respiratory,1,1
25446,distress,1,1
25447,syndrome,1,1
25448,patients,1,1
25449,fed,0,1
25450,an,0,1
25451,enteral,0,1
25452,diet,0,0
25453,containing,0,0
25454,eicosapentaenoic,0,0
25455,acid,0,0
25456,and,0,1
25457,gamma-linolenic,0,0
25458,acid,0,0
25459,and,0,1
25460,elevated,0,1
25461,antioxidants,0,1
25462,(,0,1
25463,EPA+GLA,0,1
25464,;,0,1
25465,Oxepa,0,0
25466,),0,1
25467,had,0,1
25468,significantly,0,0
25469,reduced,0,0
25470,pulmonary,0,1
25471,inflammation,0,1
25472,",",0,0
25473,increased,0,0
25474,oxygenation,0,0
25475,",",0,0
25476,and,0,0
25477,improved,0,0
25478,clinical,0,1
25479,outcomes,0,0
25480,.,0,1
25481,In,0,0
25482,a,0,0
25483,subset,0,1
25484,of,0,0
25485,acute,1,1
25486,respiratory,1,1
25487,distress,1,1
25488,syndrome,1,1
25489,patients,1,1
25490,from,0,1
25491,this,0,0
25492,trial,0,0
25493,",",0,0
25494,we,0,0
25495,performed,0,0
25496,a,0,0
25497,preliminary,0,0
25498,examination,0,0
25499,of,0,0
25500,the,0,0
25501,potential,0,0
25502,mechanisms,0,0
25503,underlying,0,1
25504,these,0,0
25505,clinical,0,0
25506,improvements,0,0
25507,by,0,0
25508,retrospectively,0,1
25509,testing,0,0
25510,the,0,0
25511,hypothesis,0,0
25512,that,0,0
25513,enteral,0,1
25514,feeding,0,1
25515,with,0,1
25516,EPA+GLA,0,1
25517,could,0,0
25518,reduce,0,0
25519,alveolar-capillary,0,0
25520,membrane,0,0
25521,protein,0,0
25522,permeability,0,0
25523,and,0,0
25524,the,0,0
25525,production,0,0
25526,of,0,0
25527,interleukin,0,0
25528,(,0,1
25529,IL,0,1
25530,),0,1
25531,-8,0,0
25532,",",0,0
25533,IL-6,0,0
25534,",",0,0
25535,tumor,0,1
25536,necrosis,0,0
25537,factor-alpha,0,0
25538,",",0,0
25539,and,0,0
25540,leukotriene,0,0
25541,B4,0,0
25542,that,0,0
25543,are,0,0
25544,responsible,0,0
25545,",",0,0
25546,in,0,0
25547,part,0,0
25548,",",0,0
25549,for,0,0
25550,pulmonary,0,1
25551,inflammation,0,1
25552,.,0,1
25553,DESIGN,0,0
25554,Prospective,0,0
25555,",",0,0
25556,randomized,0,0
25557,",",0,0
25558,double-blind,0,0
25559,",",0,0
25560,controlled,0,0
25561,clinical,0,0
25562,trial,0,1
25563,.,0,1
25564,SETTING,0,1
25565,Intensive,1,1
25566,Care,1,1
25567,Unit,1,0
25568,of,1,0
25569,the,1,0
25570,Ohio,1,1
25571,State,1,0
25572,University,1,1
25573,Medical,1,1
25574,Center,1,1
25575,.,1,1
25576,PATIENTS,0,0
25577,A,1,0
25578,total,1,1
25579,of,1,0
25580,67,1,1
25581,patients,1,1
25582,were,1,1
25583,enrolled,1,1
25584,who,1,1
25585,met,1,1
25586,defined,1,1
25587,criteria,1,1
25588,for,1,1
25589,acute,1,1
25590,lung,1,1
25591,injury/acute,1,1
25592,respiratory,1,1
25593,distress,1,0
25594,syndrome,1,1
25595,.,1,0
25596,INTERVENTIONS,0,0
25597,A,0,0
25598,total,0,1
25599,of,0,0
25600,43,0,1
25601,of,0,1
25602,67,0,1
25603,evaluable,0,1
25604,patients,0,1
25605,randomly,0,1
25606,received,0,1
25607,either,0,0
25608,EPA+GLA,0,0
25609,or,0,1
25610,an,0,0
25611,isonitrogenous,0,0
25612,",",0,0
25613,isocaloric,0,0
25614,standard,0,1
25615,diet,0,1
25616,that,0,0
25617,was,0,0
25618,tube,0,1
25619,fed,0,1
25620,at,0,0
25621,a,0,1
25622,minimum,0,0
25623,caloric,0,0
25624,delivery,0,1
25625,of,0,1
25626,75,0,1
25627,%,0,0
25628,of,0,0
25629,basal,0,0
25630,energy,0,0
25631,expenditure,0,0
25632,times,0,0
25633,1.33,0,0
25634,for,0,0
25635,at,0,1
25636,least,0,1
25637,4,0,1
25638,to,0,1
25639,7,0,1
25640,days,0,0
25641,.,0,1
25642,MEASUREMENTS,0,0
25643,AND,0,0
25644,MAIN,0,0
25645,RESULTS,0,1
25646,Bronchoalveolar,0,1
25647,lavage,0,1
25648,(,0,1
25649,BAL,0,1
25650,),0,1
25651,was,0,0
25652,performed,0,0
25653,at,0,0
25654,baseline,0,0
25655,and,0,1
25656,study,0,1
25657,days,0,0
25658,4,0,1
25659,and,0,1
25660,7,0,1
25661,to,0,0
25662,obtain,0,0
25663,BAL,0,1
25664,fluid,0,0
25665,(,0,1
25666,BALF,0,0
25667,),0,1
25668,for,0,0
25669,measurement,0,0
25670,of,0,0
25671,total,0,1
25672,protein,0,0
25673,",",0,0
25674,ceruloplasmin,0,0
25675,",",0,0
25676,and,0,0
25677,transferrin,0,0
25678,",",0,0
25679,total,0,1
25680,neutrophil,0,0
25681,count,0,0
25682,",",0,0
25683,IL-8,0,0
25684,",",0,0
25685,IL-6,0,0
25686,",",0,0
25687,tumor,0,1
25688,necrosis,0,0
25689,factor-alpha,0,0
25690,",",0,0
25691,and,0,0
25692,leukotriene,0,0
25693,B4,0,1
25694,.,0,1
25695,Oxygenation,0,0
25696,",",0,0
25697,measured,0,0
25698,as,0,0
25699,Pao2/Fio2,0,0
25700,",",0,1
25701,was,0,0
25702,assessed,0,0
25703,before,0,1
25704,BAL,0,1
25705,.,0,1
25706,Patients,0,1
25707,fed,0,1
25708,EPA+GLA,0,1
25709,had,0,1
25710,a,0,0
25711,significant,0,0
25712,reduction,0,0
25713,in,0,1
25714,BALF,0,0
25715,ceruloplasmin,0,0
25716,and,0,0
25717,IL-8,0,0
25718,during,0,0
25719,the,0,0
25720,study,0,0
25721,as,0,0
25722,compared,0,0
25723,with,0,1
25724,patients,0,1
25725,fed,0,1
25726,the,0,0
25727,control,0,1
25728,diet,0,0
25729,.,0,1
25730,BALF,0,0
25731,levels,0,0
25732,of,0,1
25733,total,0,1
25734,protein,0,0
25735,",",0,1
25736,neutrophils,0,0
25737,",",0,0
25738,and,0,1
25739,leukotriene,0,0
25740,B4,0,1
25741,tended,0,0
25742,to,0,0
25743,decrease,0,0
25744,in,0,0
25745,EPA+GLA,0,1
25746,patients,0,1
25747,over,0,0
25748,the,0,0
25749,course,0,0
25750,of,0,0
25751,the,0,0
25752,study,0,0
25753,as,0,0
25754,compared,0,0
25755,with,0,1
25756,control,0,1
25757,patients,0,1
25758,.,0,1
25759,BALF,0,0
25760,levels,0,0
25761,of,0,1
25762,IL-6,0,0
25763,declined,0,0
25764,similarly,0,0
25765,during,0,0
25766,the,0,0
25767,study,0,0
25768,in,0,0
25769,both,0,0
25770,groups,0,0
25771,.,0,1
25772,A,0,0
25773,trend,0,0
25774,toward,0,0
25775,a,0,0
25776,reduction,0,0
25777,in,0,0
25778,BALF,0,0
25779,tumor,0,1
25780,necrosis,0,1
25781,factor-alpha,0,0
25782,was,0,0
25783,observed,0,0
25784,on,0,0
25785,study,0,1
25786,day,0,0
25787,7,0,1
25788,in,0,0
25789,the,0,0
25790,EPA+GLA,0,0
25791,group,0,1
25792,as,0,0
25793,compared,0,0
25794,with,0,1
25795,control,0,1
25796,patients,0,1
25797,.,0,1
25798,Significant,0,0
25799,improvements,0,0
25800,in,0,1
25801,oxygenation,0,0
25802,(,0,1
25803,Pao2/Fio2,0,0
25804,),0,1
25805,occurred,0,0
25806,in,0,1
25807,EPA+GLA,0,1
25808,patients,0,1
25809,on,0,0
25810,study,0,1
25811,day,0,0
25812,4,0,0
25813,as,0,0
25814,compared,0,0
25815,with,0,1
25816,controls,0,1
25817,.,0,1
25818,Correlation,0,0
25819,analysis,0,0
25820,revealed,0,0
25821,significant,0,0
25822,relationships,0,0
25823,between,0,1
25824,BALF,0,0
25825,neutrophil,0,0
25826,counts,0,0
25827,and,0,1
25828,indices,0,0
25829,of,0,1
25830,alveolar-capillary,0,1
25831,membrane,0,0
25832,protein,0,0
25833,permeability,0,0
25834,",",0,0
25835,IL-8,0,0
25836,",",0,0
25837,and,0,0
25838,leukotriene,0,0
25839,B4,0,1
25840,.,0,1
25841,CONCLUSIONS,0,0
25842,This,0,0
25843,preliminary,0,0
25844,investigation,0,0
25845,showing,0,0
25846,a,0,0
25847,decrease,0,0
25848,in,0,0
25849,BALF,0,0
25850,levels,0,1
25851,of,0,1
25852,IL-8,0,1
25853,and,0,1
25854,leukotriene,0,0
25855,B4,0,0
25856,and,0,1
25857,the,0,0
25858,associated,0,0
25859,reduction,0,0
25860,of,0,1
25861,BALF,0,0
25862,neutrophils,0,0
25863,and,0,1
25864,alveolar,0,0
25865,membrane,0,0
25866,protein,0,0
25867,permeability,0,0
25868,in,0,0
25869,acute,0,1
25870,respiratory,0,1
25871,distress,0,1
25872,syndrome,0,1
25873,patients,0,1
25874,fed,0,1
25875,EPA+GLA,0,0
25876,support,0,0
25877,",",0,0
25878,in,0,0
25879,part,0,0
25880,",",0,0
25881,the,0,0
25882,potential,0,0
25883,mechanisms,0,0
25884,underlying,0,0
25885,the,0,0
25886,previously,0,1
25887,described,0,0
25888,clinical,0,0
25889,improvements,0,0
25890,with,0,1
25891,this,0,0
25892,diet,0,1
25893,.,0,1
25894,Additional,0,0
25895,controlled,0,0
25896,studies,0,0
25897,are,0,0
25898,needed,0,0
25899,to,0,0
25900,confirm,0,0
25901,these,0,0
25902,findings,0,0
25903,.,0,1
25904,The,0,0
25905,development,0,0
25906,and,0,0
25907,evaluation,0,0
25908,of,0,0
25909,a,0,1
25910,computer-based,0,0
25911,program,0,1
25912,to,0,0
25913,test,0,0
25914,and,0,0
25915,to,0,0
25916,teach,0,0
25917,the,0,0
25918,recognition,0,0
25919,of,0,0
25920,facial,0,1
25921,affect,0,0
25922,.,0,1
25923,Autism,0,0
25924,is,0,0
25925,a,0,0
25926,chronic,0,1
25927,pervasive,0,1
25928,neurodevelopmental,0,1
25929,disorder,0,1
25930,characterized,0,0
25931,by,0,0
25932,the,0,0
25933,early,0,1
25934,onset,0,1
25935,of,0,0
25936,social,0,1
25937,and,0,1
25938,communicative,0,1
25939,impairments,0,1
25940,as,0,0
25941,well,0,0
25942,as,0,0
25943,restricted,0,1
25944,",",0,0
25945,ritualized,0,0
25946,",",0,0
25947,stereotypic,0,1
25948,behavior,0,0
25949,.,0,1
25950,The,0,0
25951,endophenotype,0,1
25952,of,0,0
25953,autism,0,1
25954,includes,0,0
25955,neuropsychological,0,0
25956,deficits,0,0
25957,",",0,1
25958,for,0,0
25959,instance,0,0
25960,a,0,0
25961,lack,0,0
25962,of,0,0
25963,Theory,0,1
25964,of,0,1
25965,Mind,0,1
25966,and,0,1
25967,problems,0,1
25968,recognizing,0,1
25969,facial,0,1
25970,affect,0,0
25971,.,0,1
25972,In,0,0
25973,this,0,0
25974,study,0,0
25975,",",0,0
25976,we,0,0
25977,report,0,0
25978,the,0,0
25979,development,0,0
25980,and,0,0
25981,evaluation,0,0
25982,of,0,0
25983,a,0,1
25984,computer-based,0,0
25985,program,0,1
25986,to,0,0
25987,teach,0,0
25988,and,0,0
25989,test,0,0
25990,the,0,0
25991,ability,0,0
25992,to,0,0
25993,identify,0,0
25994,basic,0,0
25995,facially,0,1
25996,expressed,0,0
25997,emotions,0,0
25998,.,0,1
25999,10,1,1
26000,adolescent,1,1
26001,or,1,1
26002,adult,1,1
26003,subjects,1,1
26004,with,1,1
26005,high-functioning,1,1
26006,autism,1,1
26007,or,1,1
26008,Asperger-syndrome,1,1
26009,were,1,1
26010,included,1,1
26011,in,1,0
26012,the,1,0
26013,investigation,1,0
26014,.,1,0
26015,A,0,0
26016,priori,0,0
26017,the,0,0
26018,facial,0,1
26019,affect,0,0
26020,recognition,0,0
26021,test,0,0
26022,had,0,1
26023,shown,0,0
26024,good,0,0
26025,psychometric,0,1
26026,properties,0,0
26027,in,0,1
26028,a,0,1
26029,normative,0,0
26030,sample,0,1
26031,(,0,1
26032,internal,0,1
26033,consistency,0,0
26034,:,0,1
26035,rtt=.91-.95,0,0
26036,;,0,0
26037,retest,0,0
26038,reliability,0,0
26039,:,0,1
26040,rtt=.89-.92,0,0
26041,),0,1
26042,.,0,1
26043,In,0,0
26044,a,0,0
26045,prepost,0,0
26046,design,0,1
26047,",",0,0
26048,one,0,1
26049,half,0,1
26050,of,0,0
26051,the,0,0
26052,sample,0,1
26053,was,0,0
26054,randomly,0,1
26055,assigned,0,1
26056,to,0,0
26057,receive,0,1
26058,computer,0,0
26059,treatment,0,0
26060,while,0,0
26061,the,0,0
26062,other,0,0
26063,half,0,1
26064,of,0,0
26065,the,0,0
26066,sample,0,1
26067,served,0,1
26068,as,0,0
26069,control,0,1
26070,group,0,1
26071,.,0,1
26072,The,0,0
26073,training,0,0
26074,was,0,0
26075,conducted,0,1
26076,for,0,1
26077,five,0,1
26078,weeks,0,0
26079,",",0,1
26080,consisting,0,1
26081,of,0,1
26082,two,0,1
26083,hours,0,0
26084,training,0,1
26085,a,0,1
26086,week,0,0
26087,.,0,0
26088,The,0,0
26089,trained,0,1
26090,individuals,0,1
26091,improved,0,0
26092,significantly,0,0
26093,on,0,0
26094,the,0,0
26095,affect,0,0
26096,recognition,0,0
26097,task,0,1
26098,",",0,0
26099,but,0,0
26100,not,0,0
26101,on,0,0
26102,any,0,0
26103,other,0,0
26104,measure,0,0
26105,.,0,1
26106,Results,0,0
26107,support,0,0
26108,the,0,0
26109,usefulness,0,0
26110,of,0,0
26111,the,0,0
26112,program,0,0
26113,to,0,0
26114,teach,0,0
26115,the,0,0
26116,detection,0,0
26117,of,0,0
26118,facial,0,1
26119,affect,0,0
26120,.,0,1
26121,However,0,0
26122,",",0,0
26123,the,0,0
26124,improvement,0,0
26125,found,0,0
26126,is,0,0
26127,limited,0,0
26128,to,0,0
26129,a,0,0
26130,circumscribed,0,0
26131,area,0,0
26132,of,0,0
26133,social-communicative,0,1
26134,function,0,0
26135,and,0,0
26136,generalization,0,0
26137,is,0,0
26138,not,0,0
26139,ensured,0,0
26140,.,0,1
26141,Bioavailability,0,0
26142,of,0,1
26143,omega-3,1,0
26144,essential,1,1
26145,fatty,1,0
26146,acids,1,0
26147,from,1,1
26148,perilla,1,0
26149,seed,1,1
26150,oil,1,0
26151,.,1,1
26152,Increased,0,0
26153,dietary,0,0
26154,intake,0,0
26155,of,0,0
26156,fish,0,0
26157,oil,0,0
26158,omega-3,0,0
26159,fatty,0,0
26160,acids,0,0
26161,",",0,1
26162,eicosapentanoic,0,0
26163,acid,0,0
26164,and,0,0
26165,docosohexanoic,0,0
26166,acid,0,0
26167,",",0,0
26168,and,0,0
26169,their,0,0
26170,precursor,0,0
26171,",",0,0
26172,alpha-linolenic,0,0
26173,acid,0,0
26174,(,0,1
26175,ALA,0,1
26176,),0,0
26177,",",0,0
26178,is,0,0
26179,associated,0,0
26180,with,0,1
26181,various,0,0
26182,health,0,1
26183,benefits,0,0
26184,.,0,1
26185,Enteric-coating,0,0
26186,(,0,0
26187,Entrox,0,0
26188,),0,1
26189,",",0,0
26190,which,0,0
26191,improves,0,0
26192,stability,0,0
26193,of,0,0
26194,omega-3,0,0
26195,capsules,0,0
26196,",",0,0
26197,has,0,0
26198,been,0,0
26199,shown,0,0
26200,to,0,0
26201,facilitate,0,0
26202,fish,0,0
26203,oil,0,0
26204,absorption,0,0
26205,after,0,0
26206,chronic,0,1
26207,treatment,0,1
26208,.,0,1
26209,To,0,0
26210,assess,0,0
26211,the,0,0
26212,effect,0,0
26213,of,0,0
26214,Entrox,0,0
26215,coating,0,1
26216,on,0,0
26217,the,0,0
26218,short-term,0,0
26219,bioavailability,0,0
26220,of,0,1
26221,ALA,0,1
26222,administered,0,0
26223,in,0,0
26224,the,0,0
26225,form,0,0
26226,of,0,0
26227,ALA-rich,0,1
26228,Perilla,0,1
26229,seed,0,1
26230,oil,0,0
26231,",",0,1
26232,12,1,1
26233,healthy,1,1
26234,subjects,1,1
26235,(,1,1
26236,6,1,1
26237,males,1,1
26238,and,1,1
26239,6,1,1
26240,females,1,1
26241,),1,1
26242,received,0,1
26243,in,0,0
26244,a,0,1
26245,random,0,1
26246,order,0,0
26247,Entrox-coated,0,0
26248,and,0,1
26249,non-coated,0,1
26250,ALA,0,1
26251,formulations,0,0
26252,",",0,0
26253,each,0,0
26254,as,0,0
26255,a,0,1
26256,single,0,0
26257,6g,0,0
26258,dose,0,0
26259,separated,0,0
26260,by,0,0
26261,a,0,1
26262,3-week,0,0
26263,washout,0,0
26264,period,0,1
26265,.,0,1
26266,Measurements,0,0
26267,of,0,0
26268,plasma,0,0
26269,ALA,0,1
26270,concentrations,0,0
26271,from,0,1
26272,0,0,0
26273,to,0,1
26274,24h,0,0
26275,showed,0,0
26276,no,0,0
26277,difference,0,0
26278,in,0,0
26279,ALA,0,1
26280,pharmacokinetics,0,0
26281,between,0,0
26282,the,0,1
26283,two,0,1
26284,formulations,0,0
26285,.,0,1
26286,However,0,0
26287,",",0,0
26288,significantly,0,0
26289,greater,0,0
26290,increases,0,0
26291,in,0,0
26292,plasma,0,1
26293,ALA,0,1
26294,levels,0,0
26295,from,0,1
26296,baseline,0,1
26297,to,0,1
26298,24h,0,0
26299,were,0,1
26300,observed,0,0
26301,after,0,0
26302,ingestion,0,0
26303,of,0,0
26304,Entrox,0,0
26305,vs.,0,0
26306,non-coated,0,0
26307,product,0,0
26308,",",0,0
26309,suggesting,0,0
26310,a,0,0
26311,possible,0,0
26312,benefit,0,0
26313,of,0,0
26314,Entrox,0,0
26315,with,0,1
26316,long-term,0,0
26317,treatment,0,1
26318,.,0,1
26319,[,0,0
26320,The,0,0
26321,effect,0,0
26322,of,0,0
26323,losartan,0,1
26324,versus,0,0
26325,atenolol,0,0
26326,on,0,0
26327,cardiovascular,0,1
26328,morbidity,0,0
26329,and,0,0
26330,mortality,0,0
26331,in,0,0
26332,patients,1,1
26333,with,1,1
26334,diabetes,1,1
26335,mellitus,1,1
26336,in,1,1
26337,the,1,1
26338,LIFE-study,1,1
26339,],1,1
26340,.,0,1
26341,INTRODUCTION,0,0
26342,The,0,0
26343,most,0,0
26344,suitable,0,0
26345,antihypertensive,0,1
26346,drug,0,0
26347,to,0,0
26348,reduce,0,0
26349,the,0,0
26350,risk,0,0
26351,of,0,0
26352,cardiovascular,0,1
26353,disease,0,1
26354,in,0,1
26355,patients,1,1
26356,with,1,1
26357,hypertension,1,1
26358,and,1,0
26359,diabetes,1,1
26360,is,0,0
26361,unclear,0,0
26362,.,0,0
26363,In,0,0
26364,a,0,0
26365,prespecified,0,0
26366,analysis,0,0
26367,of,0,0
26368,the,0,0
26369,LIFE-study,0,1
26370,we,0,0
26371,compared,0,0
26372,the,0,0
26373,effects,0,0
26374,of,0,0
26375,losartan,0,1
26376,and,0,0
26377,atenolol,0,0
26378,on,0,0
26379,cardiovascular,0,1
26380,morbidity,0,0
26381,and,0,0
26382,mortality,0,0
26383,in,0,1
26384,diabetic,1,1
26385,patients,1,1
26386,.,1,1
26387,MATERIAL,0,0
26388,AND,0,0
26389,METHODS,0,0
26390,A,1,1
26391,total,1,1
26392,of,1,1
26393,1195,1,1
26394,patients,1,1
26395,in,1,1
26396,the,1,1
26397,LIFE-study,1,1
26398,had,1,1
26399,diabetes,1,1
26400,at,0,1
26401,the,0,0
26402,time,0,0
26403,of,0,0
26404,the,0,0
26405,randomisation,0,0
26406,.,0,1
26407,The,0,0
26408,patients,0,1
26409,were,0,1
26410,randomised,0,1
26411,for,0,0
26412,double-blind,0,0
26413,treatment,0,1
26414,with,0,1
26415,losartan,0,1
26416,versus,0,0
26417,atenolol,0,0
26418,.,0,1
26419,The,0,0
26420,patients,1,1
26421,had,1,1
26422,ECG-verified,1,1
26423,left,1,1
26424,ventricular,1,1
26425,hypertrophy,1,1
26426,",",1,0
26427,mean,1,1
26428,age,1,1
26429,67,1,1
26430,years,1,1
26431,",",1,1
26432,blood,1,0
26433,pressure,1,0
26434,177/96,1,1
26435,mmHg,1,0
26436,after,1,1
26437,two,1,1
26438,weeks,1,1
26439,placebo,1,1
26440,run-in,1,1
26441,period,1,1
26442,.,1,1
26443,Patients,1,1
26444,were,1,0
26445,followed,1,1
26446,for,1,0
26447,at,1,1
26448,least,1,1
26449,four,1,1
26450,years,1,1
26451,(,1,1
26452,mean,1,1
26453,4.7,1,1
26454,years,1,1
26455,),1,1
26456,.,1,1
26457,The,0,0
26458,primary,0,1
26459,composite,0,0
26460,endpoint,0,0
26461,was,0,0
26462,cardiovascular,0,1
26463,death,0,0
26464,",",0,0
26465,stroke,0,1
26466,or,0,1
26467,myocardial,0,1
26468,infarction,0,1
26469,.,0,1
26470,RESULTS,0,0
26471,Blood,0,0
26472,pressure,0,0
26473,was,0,0
26474,reduced,0,0
26475,to,0,1
26476,146/79,0,1
26477,and,0,1
26478,148/79,0,1
26479,in,0,1
26480,losartan-treated,0,1
26481,patients,0,1
26482,and,0,1
26483,atenolol-treated,0,1
26484,patients,0,1
26485,",",0,1
26486,respectively,0,0
26487,.,0,0
26488,The,0,0
26489,primary,0,1
26490,endpoint,0,0
26491,occurred,0,0
26492,in,0,1
26493,103,0,1
26494,patients,0,1
26495,assigned,0,1
26496,losartan,0,1
26497,(,0,1
26498,n,0,1
26499,=,0,1
26500,586,0,1
26501,),0,1
26502,and,0,1
26503,139,0,1
26504,assigned,0,1
26505,atenolol,0,0
26506,(,0,1
26507,n,0,1
26508,=,0,1
26509,609,0,1
26510,),0,1
26511,.,0,1
26512,Relative,0,0
26513,risk,0,0
26514,reduction,0,0
26515,24,0,1
26516,%,0,0
26517,(,0,1
26518,p,0,0
26519,<,0,0
26520,0.031,0,0
26521,),0,1
26522,.,0,1
26523,Cardiovascular,0,0
26524,mortality,0,0
26525,was,0,0
26526,reduced,0,0
26527,by,0,0
26528,37,0,1
26529,%,0,0
26530,in,0,0
26531,favour,0,0
26532,of,0,0
26533,losartan,0,1
26534,(,0,1
26535,p,0,0
26536,<,0,0
26537,0.028,0,0
26538,),0,1
26539,",",0,0
26540,and,0,0
26541,all,0,0
26542,cause,0,0
26543,mortality,0,0
26544,by,0,0
26545,39,0,1
26546,%,0,0
26547,(,0,1
26548,p,0,0
26549,<,0,0
26550,0.002,0,0
26551,),0,1
26552,.,0,1
26553,DISCUSSION,0,0
26554,Losartan,0,1
26555,was,0,0
26556,very,0,0
26557,effective,0,0
26558,in,0,0
26559,reducing,0,0
26560,cardiovascular,0,1
26561,morbidity,0,0
26562,and,0,0
26563,mortality,0,0
26564,as,0,0
26565,compared,0,0
26566,to,0,0
26567,atenolol,0,0
26568,.,0,1
26569,These,0,0
26570,results,0,0
26571,will,0,0
26572,have,0,0
26573,a,0,0
26574,major,0,0
26575,impact,0,0
26576,on,0,0
26577,the,0,0
26578,choice,0,0
26579,of,0,0
26580,anti-hypertensive,0,0
26581,treatment,0,1
26582,for,0,1
26583,patients,1,1
26584,with,1,1
26585,hypertension,1,1
26586,and,1,1
26587,diabetes,1,1
26588,.,1,1
26589,Randomized,0,1
26590,controlled,0,0
26591,trial,0,0
26592,evaluating,0,0
26593,the,0,0
26594,clinical,0,0
26595,benefit,0,0
26596,of,0,0
26597,montelukast,0,1
26598,for,0,0
26599,treating,0,0
26600,spring,0,1
26601,seasonal,0,1
26602,allergic,0,1
26603,rhinitis,0,1
26604,.,0,1
26605,BACKGROUND,0,0
26606,Symptoms,0,0
26607,of,0,0
26608,allergic,0,1
26609,rhinitis,0,1
26610,are,0,0
26611,mediated,0,0
26612,in,0,0
26613,part,0,1
26614,by,0,0
26615,cysteinyl,0,1
26616,leukotrienes,0,1
26617,.,0,1
26618,OBJECTIVE,0,0
26619,To,0,0
26620,evaluate,0,0
26621,the,0,0
26622,clinical,0,0
26623,benefit,0,0
26624,of,0,0
26625,montelukast,0,0
26626,",",0,0
26627,a,0,0
26628,cysteinyl,0,1
26629,leukotriene,0,0
26630,receptor,0,0
26631,antagonist,0,0
26632,",",0,0
26633,administered,0,0
26634,once,0,0
26635,daily,0,0
26636,for,0,0
26637,treating,0,1
26638,seasonal,0,1
26639,allergic,0,1
26640,rhinitis,0,1
26641,.,0,1
26642,METHODS,0,0
26643,This,1,0
26644,multicenter,1,0
26645,",",0,0
26646,randomized,0,0
26647,",",0,0
26648,double-blind,0,0
26649,",",0,0
26650,placebo-,0,0
26651,and,0,0
26652,active-controlled,0,1
26653,study,0,1
26654,enrolled,1,1
26655,"1,214",1,1
26656,healthy,1,1
26657,",",1,1
26658,nonsmoking,1,1
26659,outpatients,1,1
26660,aged,1,1
26661,15,1,1
26662,to,1,1
26663,85,1,1
26664,years,1,1
26665,with,1,1
26666,spring,1,1
26667,allergic,1,1
26668,rhinitis,1,1
26669,",",1,0
26670,positive,1,1
26671,skin,1,1
26672,test,1,0
26673,to,1,0
26674,a,1,0
26675,spring,1,0
26676,allergen,1,0
26677,",",1,0
26678,and,1,0
26679,predefined,1,0
26680,daytime,1,0
26681,nasal,1,1
26682,symptoms,1,1
26683,.,1,1
26684,After,0,0
26685,a,0,0
26686,3-,0,1
26687,to,0,1
26688,5-day,0,0
26689,placebo,0,1
26690,run-in,0,1
26691,period,0,1
26692,",",0,1
26693,patients,0,1
26694,were,0,1
26695,randomly,0,1
26696,assigned,0,1
26697,to,0,0
26698,treatment,0,0
26699,with,0,1
26700,montelukast,0,1
26701,10,0,1
26702,mg,0,1
26703,(,0,1
26704,n,0,1
26705,=,0,1
26706,522,0,1
26707,),0,1
26708,",",0,1
26709,loratadine,0,0
26710,10,0,1
26711,mg,0,1
26712,(,0,1
26713,n,0,1
26714,=,0,1
26715,171,0,1
26716,),0,1
26717,",",0,0
26718,or,0,1
26719,placebo,0,0
26720,(,0,1
26721,n,0,1
26722,=,0,1
26723,521,0,1
26724,),0,1
26725,once,0,0
26726,daily,0,0
26727,at,0,0
26728,bedtime,0,1
26729,for,0,1
26730,2,0,1
26731,weeks,0,1
26732,.,0,1
26733,During,0,0
26734,the,0,0
26735,run-in,0,0
26736,and,0,0
26737,treatment,0,1
26738,periods,0,0
26739,",",0,1
26740,symptoms,0,1
26741,were,0,1
26742,evaluated,0,0
26743,in,0,0
26744,a,0,1
26745,daily,0,0
26746,diary,0,0
26747,using,0,0
26748,a,0,1
26749,0,0,0
26750,(,0,0
26751,best,0,0
26752,),0,1
26753,to,0,1
26754,3,0,1
26755,(,0,1
26756,worst,0,0
26757,),0,1
26758,scale,0,0
26759,.,0,1
26760,RESULTS,0,0
26761,Baseline,0,0
26762,characteristics,0,1
26763,of,0,1
26764,randomized,0,1
26765,patients,0,1
26766,were,0,1
26767,clinically,0,1
26768,similar,0,0
26769,in,0,0
26770,the,0,0
26771,three,0,0
26772,treatment,0,1
26773,groups,0,1
26774,.,0,1
26775,Montelukast,0,0
26776,was,0,0
26777,significantly,0,0
26778,more,0,0
26779,effective,0,0
26780,than,0,0
26781,placebo,0,0
26782,(,0,1
26783,P,0,0
26784,=,0,1
26785,0.003,0,0
26786,),0,1
26787,in,0,0
26788,improving,0,0
26789,the,0,0
26790,daytime,0,0
26791,nasal,0,1
26792,symptoms,0,1
26793,score,0,1
26794,(,0,1
26795,difference,0,0
26796,in,0,0
26797,least,0,1
26798,square,0,1
26799,means,0,0
26800,",",0,1
26801,-0.09,0,0
26802,;,0,1
26803,95,0,0
26804,%,0,0
26805,confidence,0,0
26806,interval,0,0
26807,",",0,0
26808,-0.16,0,0
26809,",",0,0
26810,-0.03,0,0
26811,),0,0
26812,averaged,0,0
26813,over,0,0
26814,2,0,1
26815,weeks,0,0
26816,of,0,1
26817,therapy,0,1
26818,.,0,1
26819,The,0,0
26820,treatment,0,0
26821,effect,0,0
26822,of,0,0
26823,montelukast,0,0
26824,was,0,0
26825,significantly,0,0
26826,greater,0,0
26827,(,0,0
26828,P,0,0
26829,<,0,0
26830,0.05,0,0
26831,),0,1
26832,",",0,1
26833,relative,0,0
26834,to,0,0
26835,placebo,0,0
26836,",",0,0
26837,for,0,0
26838,all,0,1
26839,secondary,0,1
26840,endpoints,0,0
26841,",",0,1
26842,including,0,1
26843,nighttime,0,0
26844,symptoms,0,1
26845,and,0,1
26846,daytime,0,1
26847,eye,0,1
26848,symptoms,0,0
26849,",",0,1
26850,patient,0,1
26851,and,0,0
26852,physician,0,1
26853,global,0,0
26854,evaluations,0,0
26855,of,0,1
26856,allergic,0,1
26857,rhinitis,0,1
26858,",",0,0
26859,and,0,0
26860,rhinoconjunctivitis,0,1
26861,quality,0,0
26862,of,0,0
26863,life,0,1
26864,.,0,1
26865,Loratadine,0,0
26866,",",0,0
26867,which,0,0
26868,served,0,1
26869,as,0,0
26870,a,0,1
26871,positive,0,1
26872,control,0,1
26873,",",0,0
26874,was,0,0
26875,significantly,0,0
26876,more,0,0
26877,effective,0,0
26878,than,0,0
26879,placebo,0,0
26880,for,0,1
26881,most,0,0
26882,endpoints,0,0
26883,",",0,0
26884,validating,0,0
26885,the,0,0
26886,study,0,1
26887,results,0,0
26888,.,0,1
26889,Both,0,0
26890,montelukast,0,0
26891,and,0,0
26892,loratadine,0,0
26893,were,0,0
26894,well,0,0
26895,tolerated,0,0
26896,.,0,1
26897,CONCLUSION,0,0
26898,Therapy,0,1
26899,with,0,1
26900,montelukast,0,0
26901,significantly,0,0
26902,improves,0,0
26903,assessments,0,0
26904,of,0,0
26905,symptom,0,1
26906,severity,0,0
26907,as,0,0
26908,well,0,0
26909,as,0,0
26910,quality-of-life,0,0
26911,parameters,0,0
26912,for,0,1
26913,patients,1,1
26914,with,1,1
26915,seasonal,1,1
26916,allergic,1,1
26917,rhinitis,1,1
26918,.,1,1
26919,Effects,0,1
26920,of,0,1
26921,oral,0,1
26922,Lactobacillus,0,0
26923,GG,0,0
26924,on,0,1
26925,enteric,1,1
26926,microflora,1,1
26927,in,1,1
26928,low-birth-weight,1,1
26929,neonates,1,1
26930,.,1,1
26931,BACKGROUND,0,0
26932,Colonization,0,0
26933,patterns,0,1
26934,",",0,0
26935,especially,0,0
26936,by,0,0
26937,anaerobic,0,0
26938,flora,0,1
26939,",",0,1
26940,may,0,0
26941,play,0,0
26942,an,0,0
26943,important,0,0
26944,role,0,0
26945,in,0,1
26946,neonatal,1,1
26947,gut,1,1
26948,function,1,0
26949,.,1,1
26950,Probiotics,0,0
26951,could,0,0
26952,affect,0,0
26953,disease,0,1
26954,risk,0,0
26955,either,0,0
26956,directly,0,0
26957,through,0,0
26958,colonization,0,0
26959,or,0,1
26960,indirectly,0,0
26961,by,0,0
26962,promoting,0,0
26963,changes,0,0
26964,in,0,1
26965,gut,0,1
26966,microbial,0,0
26967,ecology,0,1
26968,.,0,1
26969,METHODS,0,0
26970,To,0,0
26971,study,0,0
26972,the,0,0
26973,ability,0,0
26974,of,0,0
26975,Lactobacillus,0,0
26976,GG,0,0
26977,(,0,1
26978,LGG,0,0
26979,),0,1
26980,to,0,0
26981,colonize,0,0
26982,the,0,0
26983,neonatal,1,1
26984,gut,1,0
26985,and,0,0
26986,modify,0,0
26987,its,0,0
26988,microbial,0,0
26989,ecology,0,1
26990,",",0,0
26991,a,0,0
26992,prospective,0,0
26993,",",0,0
26994,randomized,0,1
26995,study,0,0
26996,was,0,0
26997,performed,0,0
26998,in,0,1
26999,71,1,1
27000,preterm,1,1
27001,infants,1,1
27002,of,1,1
27003,less,1,1
27004,than,1,1
27005,2000,1,1
27006,g,1,1
27007,birth,1,1
27008,weight,1,1
27009,.,1,0
27010,Infants,1,0
27011,less,1,0
27012,than,1,0
27013,1500,1,1
27014,g,1,1
27015,(,0,1
27016,24,0,1
27017,treated,0,1
27018,",",0,1
27019,15,0,1
27020,control,0,1
27021,),0,1
27022,received,0,1
27023,10,0,1
27024,(,0,1
27025,9,0,1
27026,),0,1
27027,LGG,0,0
27028,orally,0,0
27029,twice,0,0
27030,daily,0,0
27031,for,0,0
27032,21,0,1
27033,days,0,0
27034,.,0,1
27035,Those,0,1
27036,infants,1,1
27037,weighing,1,1
27038,1500,1,1
27039,to,1,1
27040,1999,1,1
27041,g,1,1
27042,(,0,1
27043,23,0,1
27044,treated,0,1
27045,",",0,1
27046,9,0,0
27047,control,0,1
27048,),0,1
27049,were,0,0
27050,treated,0,1
27051,for,0,1
27052,8,0,1
27053,days,0,1
27054,.,0,1
27055,Stools,0,0
27056,were,0,0
27057,collected,0,1
27058,before,0,0
27059,treatment,0,0
27060,and,0,1
27061,on,0,0
27062,day,0,0
27063,7,0,1
27064,to,0,1
27065,8,0,1
27066,(,0,1
27067,and,0,1
27068,day,0,0
27069,14,0,1
27070,and,0,1
27071,21,0,1
27072,",",0,0
27073,in,0,0
27074,the,0,0
27075,infants,0,1
27076,weighing,0,1
27077,less,0,1
27078,than,0,1
27079,1500,0,1
27080,g,0,1
27081,),0,1
27082,for,0,0
27083,quantitative,0,0
27084,aerobic,0,1
27085,and,0,1
27086,anaerobic,0,0
27087,cultures,0,1
27088,.,0,1
27089,RESULTS,0,0
27090,Colonization,0,0
27091,with,0,1
27092,LGG,0,0
27093,occurred,0,0
27094,in,0,0
27095,5,0,1
27096,of,0,1
27097,24,0,1
27098,(,0,1
27099,21,0,1
27100,%,0,0
27101,),0,1
27102,infants,0,1
27103,who,0,1
27104,weighed,0,1
27105,less,0,1
27106,than,0,0
27107,1500,0,1
27108,g,0,1
27109,versus,0,0
27110,11,0,1
27111,of,0,1
27112,23,0,1
27113,(,0,1
27114,47,0,1
27115,%,0,0
27116,),0,1
27117,in,0,0
27118,larger,0,1
27119,infants,0,1
27120,.,0,1
27121,Colonization,0,0
27122,was,0,0
27123,limited,0,0
27124,to,0,1
27125,infants,0,1
27126,who,0,1
27127,were,0,1
27128,not,0,1
27129,on,0,0
27130,antibiotics,0,0
27131,within,0,1
27132,7,0,1
27133,days,0,0
27134,of,0,1
27135,treatment,0,1
27136,with,0,1
27137,LGG,0,0
27138,.,0,1
27139,There,0,0
27140,was,0,0
27141,a,0,0
27142,paucity,0,0
27143,of,0,0
27144,bacterial,0,0
27145,species,0,1
27146,at,0,1
27147,baseline,0,0
27148,",",0,0
27149,although,0,0
27150,larger,0,1
27151,infants,0,1
27152,had,0,0
27153,more,0,0
27154,bacterial,0,0
27155,species,0,0
27156,(,0,1
27157,1.59,0,0
27158,+/-,0,1
27159,0.13,0,0
27160,(,0,1
27161,SEM,0,1
27162,),0,1
27163,vs,0,0
27164,1.11,0,0
27165,+/-,0,1
27166,0.12,0,0
27167,;,0,1
27168,P,0,0
27169,<,0,0
27170,0.03,0,0
27171,),0,1
27172,and,0,0
27173,higher,0,0
27174,mean,0,1
27175,log,0,0
27176,colony,0,0
27177,forming,0,0
27178,units,0,1
27179,(,0,1
27180,CFU,0,1
27181,),0,1
27182,(,0,1
27183,8.79,0,0
27184,+/-,0,1
27185,0.43,0,0
27186,vs,0,0
27187,7.22,0,0
27188,+/-,0,1
27189,0.63,0,0
27190,;,0,1
27191,P,0,0
27192,<,0,0
27193,0.05,0,0
27194,),0,1
27195,compared,0,0
27196,with,0,1
27197,infants,0,1
27198,weighing,0,1
27199,less,0,1
27200,than,0,1
27201,1500,0,1
27202,g,0,1
27203,LGG,0,0
27204,.,0,1
27205,Treatment,0,0
27206,in,0,0
27207,infants,1,1
27208,weighing,1,1
27209,less,1,1
27210,than,1,1
27211,1500,1,1
27212,g,1,1
27213,resulted,0,0
27214,in,0,0
27215,a,0,1
27216,significant,0,0
27217,increase,0,0
27218,in,0,1
27219,species,0,0
27220,number,0,0
27221,by,0,1
27222,day,0,0
27223,7,0,1
27224,",",0,0
27225,with,0,1
27226,further,0,0
27227,increases,0,0
27228,by,0,1
27229,day,0,1
27230,21,0,1
27231,.,0,1
27232,This,0,0
27233,increase,0,0
27234,was,0,0
27235,mainly,0,0
27236,the,0,0
27237,result,0,0
27238,of,0,0
27239,increased,0,0
27240,Gram,0,1
27241,(,0,1
27242,+,0,0
27243,),0,1
27244,and,0,1
27245,anaerobic,0,0
27246,species,0,1
27247,.,0,1
27248,No,0,0
27249,difference,0,0
27250,in,0,0
27251,species,0,1
27252,number,0,0
27253,was,0,0
27254,noted,0,0
27255,in,0,1
27256,controls,0,1
27257,.,0,1
27258,Mean,0,1
27259,log,0,0
27260,CFU,0,1
27261,of,0,1
27262,Gram,0,1
27263,(,0,1
27264,-,0,1
27265,),0,1
27266,bacteria,0,0
27267,did,0,0
27268,not,0,0
27269,change,0,0
27270,in,0,0
27271,treated,0,1
27272,infants,0,1
27273,weighing,0,1
27274,less,0,1
27275,than,0,1
27276,1500,0,1
27277,g.,0,0
27278,However,0,0
27279,",",0,0
27280,Gram,0,1
27281,(,0,1
27282,+,0,0
27283,),0,1
27284,mean,0,1
27285,log,0,0
27286,CFU,0,1
27287,showed,0,0
27288,a,0,0
27289,significant,0,0
27290,increase,0,0
27291,on,0,0
27292,day,0,0
27293,21,0,1
27294,(,0,1
27295,6.1,0,1
27296,+/-,0,1
27297,0.9,0,0
27298,),0,1
27299,compared,0,0
27300,with,0,1
27301,day,0,0
27302,0,0,0
27303,(,0,1
27304,3.5,0,1
27305,+/-,0,1
27306,0.9,0,0
27307,),0,1
27308,(,0,1
27309,P,0,0
27310,<,0,0
27311,0.05,0,0
27312,),0,1
27313,.,0,1
27314,No,0,0
27315,significant,0,0
27316,changes,0,0
27317,in,0,1
27318,species,0,1
27319,number,0,0
27320,or,0,1
27321,quantitative,0,0
27322,counts,0,0
27323,were,0,1
27324,noted,0,0
27325,after,0,0
27326,LGG,0,0
27327,treatment,0,0
27328,in,0,0
27329,the,0,0
27330,infants,0,1
27331,weighing,0,1
27332,1500,0,1
27333,to,0,1
27334,1999,0,1
27335,g,0,1
27336,LGG,0,0
27337,was,0,0
27338,well,0,0
27339,tolerated,0,0
27340,in,0,0
27341,all,0,1
27342,infants,0,1
27343,.,0,1
27344,CONCLUSION,0,0
27345,The,0,0
27346,neonatal,0,1
27347,response,0,0
27348,to,0,1
27349,a,0,0
27350,probiotic,0,0
27351,preparation,0,0
27352,is,0,0
27353,dependent,0,0
27354,on,0,0
27355,gestational,0,1
27356,and,0,1
27357,post-natal,0,1
27358,age,0,1
27359,and,0,1
27360,prior,0,1
27361,antibiotic,0,0
27362,exposure,0,1
27363,.,0,1
27364,Although,0,0
27365,LGG,0,0
27366,is,0,0
27367,a,0,0
27368,relatively,0,0
27369,poor,0,0
27370,colonizer,0,1
27371,in,0,1
27372,infants,0,1
27373,",",0,0
27374,especially,0,0
27375,those,0,1
27376,infants,1,1
27377,weighing,1,1
27378,less,1,1
27379,than,1,1
27380,1500,1,1
27381,g,1,1
27382,at,1,0
27383,birth,1,1
27384,",",0,0
27385,it,0,0
27386,does,0,0
27387,appear,0,0
27388,to,0,0
27389,affect,0,0
27390,neonatal,0,1
27391,intestinal,0,1
27392,colonization,0,1
27393,patterns,0,1
27394,.,0,1
27395,Iontophoretic,0,0
27396,administration,0,0
27397,of,0,0
27398,dexamethasone,0,0
27399,sodium,0,0
27400,phosphate,0,0
27401,for,0,0
27402,acute,1,1
27403,epicondylitis,1,1
27404,.,1,1
27405,A,0,0
27406,randomized,0,0
27407,",",0,0
27408,double-blinded,0,0
27409,",",0,0
27410,placebo-controlled,0,0
27411,study,0,1
27412,.,0,1
27413,BACKGROUND,0,0
27414,A,0,0
27415,better,0,0
27416,treatment,0,0
27417,modality,0,0
27418,is,0,0
27419,needed,0,0
27420,to,0,0
27421,control,0,1
27422,the,0,0
27423,pain,1,0
27424,of,1,0
27425,medial,1,0
27426,or,1,1
27427,lateral,1,1
27428,epicondylitis,1,1
27429,(,1,1
27430,tennis,1,1
27431,elbow,1,1
27432,),1,1
27433,.,1,1
27434,HYPOTHESIS,0,0
27435,Dermal,0,0
27436,iontophoretic,0,0
27437,administration,0,0
27438,of,0,0
27439,dexamethasone,0,0
27440,sodium,0,0
27441,phosphate,0,0
27442,will,0,0
27443,be,0,0
27444,significantly,0,0
27445,more,0,0
27446,effective,0,0
27447,in,0,0
27448,controlling,0,0
27449,pain,0,1
27450,than,0,0
27451,a,0,0
27452,placebo,0,0
27453,in,0,0
27454,patients,1,1
27455,with,1,1
27456,medial,1,1
27457,or,1,1
27458,lateral,1,1
27459,elbow,1,1
27460,epicondylitis,1,1
27461,.,1,1
27462,STUDY,0,0
27463,DESIGN,0,1
27464,Randomized,0,1
27465,",",0,0
27466,double-blinded,0,0
27467,",",0,0
27468,placebo-controlled,0,0
27469,study,0,1
27470,.,0,1
27471,METHODS,0,0
27472,On,0,1
27473,six,0,1
27474,occasions,0,1
27475,",",0,1
27476,1,0,1
27477,to,0,1
27478,3,0,1
27479,days,0,0
27480,apart,0,1
27481,within,0,1
27482,15,0,1
27483,days,0,0
27484,",",0,1
27485,199,1,1
27486,patients,1,1
27487,with,1,1
27488,elbow,1,1
27489,epicondylitis,1,1
27490,received,0,1
27491,40,0,1
27492,mA-minutes,0,0
27493,of,0,1
27494,either,0,1
27495,active,0,1
27496,or,0,1
27497,placebo,0,1
27498,treatment,0,1
27499,.,0,1
27500,RESULTS,0,0
27501,Dexamethasone,0,0
27502,produced,0,0
27503,a,0,1
27504,significant,0,0
27505,23-mm,0,1
27506,improvement,0,0
27507,on,0,0
27508,the,0,0
27509,100-mm,0,0
27510,patient,0,1
27511,visual,0,0
27512,analog,0,0
27513,scale,0,1
27514,ratings,0,0
27515,",",0,0
27516,compared,0,0
27517,with,0,1
27518,14,0,1
27519,mm,0,1
27520,for,0,1
27521,placebo,0,1
27522,at,0,1
27523,2,0,1
27524,days,0,1
27525,and,0,1
27526,24,0,1
27527,mm,0,1
27528,compared,0,0
27529,with,0,1
27530,19,0,1
27531,mm,0,1
27532,at,0,1
27533,1,0,1
27534,month,0,0
27535,.,0,1
27536,More,0,1
27537,patients,0,1
27538,treated,0,1
27539,with,0,1
27540,dexamethasone,0,0
27541,than,0,0
27542,those,0,0
27543,treated,0,1
27544,with,0,1
27545,placebo,0,0
27546,scored,0,1
27547,moderate,0,1
27548,or,0,1
27549,better,0,0
27550,on,0,0
27551,the,0,0
27552,investigator,0,0
27553,'s,0,1
27554,global,0,0
27555,improvement,0,0
27556,scale,0,1
27557,(,0,1
27558,52,0,1
27559,%,0,0
27560,versus,0,0
27561,33,0,1
27562,%,0,0
27563,),0,1
27564,at,0,1
27565,2,0,1
27566,days,0,0
27567,",",0,1
27568,but,0,0
27569,the,0,0
27570,difference,0,0
27571,was,0,0
27572,not,0,0
27573,significant,0,0
27574,at,0,1
27575,1,0,1
27576,month,0,1
27577,(,0,1
27578,54,0,1
27579,%,0,0
27580,versus,0,0
27581,49,0,1
27582,%,0,1
27583,),0,1
27584,.,0,1
27585,Investigator-rated,0,0
27586,pain,0,1
27587,and,0,1
27588,tenderness,0,1
27589,scores,0,0
27590,favored,0,0
27591,dexamethasone,0,0
27592,over,0,0
27593,placebo,0,0
27594,at,0,1
27595,2,0,1
27596,days,0,1
27597,.,0,1
27598,Patients,0,1
27599,completing,0,1
27600,six,0,1
27601,treatments,0,0
27602,in,0,1
27603,10,0,1
27604,days,0,0
27605,or,0,1
27606,less,0,0
27607,had,0,0
27608,better,0,0
27609,results,0,0
27610,than,0,0
27611,those,0,1
27612,treated,0,1
27613,over,0,0
27614,a,0,0
27615,longer,0,0
27616,period,0,0
27617,.,0,1
27618,CONCLUSIONS,0,0
27619,Iontophoresis,0,0
27620,treatment,0,0
27621,was,0,0
27622,well,0,0
27623,tolerated,0,0
27624,by,0,0
27625,most,0,1
27626,patients,0,1
27627,and,0,1
27628,was,0,0
27629,effective,0,0
27630,in,0,1
27631,reducing,0,0
27632,symptoms,0,1
27633,of,0,1
27634,epicondylitis,0,1
27635,at,0,1
27636,short-term,0,0
27637,follow-up,0,1
27638,.,0,1
27639,Effect,0,0
27640,of,0,0
27641,a,0,1
27642,high-protein,0,0
27643,",",0,0
27644,energy-restricted,0,0
27645,diet,0,1
27646,on,0,0
27647,weight,0,1
27648,loss,0,0
27649,and,0,0
27650,energy,0,0
27651,expenditure,0,0
27652,after,0,0
27653,weight,0,1
27654,stabilization,0,0
27655,in,0,1
27656,hyperinsulinemic,1,1
27657,subjects,1,1
27658,.,1,1
27659,OBJECTIVE,0,0
27660,To,0,0
27661,determine,0,0
27662,the,0,0
27663,effect,0,0
27664,of,0,0
27665,replacing,0,0
27666,some,0,0
27667,dietary,0,0
27668,carbohydrate,0,0
27669,with,0,1
27670,protein,0,0
27671,",",0,0
27672,during,0,0
27673,energy,0,0
27674,restriction,0,0
27675,",",0,0
27676,on,0,0
27677,weight,0,1
27678,loss,0,0
27679,",",0,0
27680,total,0,1
27681,energy,0,0
27682,expenditure,0,0
27683,(,0,1
27684,TEE,0,0
27685,),0,1
27686,",",0,0
27687,resting,0,0
27688,energy,0,0
27689,expenditure,0,0
27690,(,0,1
27691,REE,0,0
27692,),0,1
27693,",",0,0
27694,respiratory,0,1
27695,quotient,0,0
27696,(,0,1
27697,RQ,0,1
27698,),0,1
27699,",",0,0
27700,and,0,0
27701,the,0,0
27702,thermic,0,0
27703,effect,0,0
27704,of,0,0
27705,feeding,0,1
27706,(,0,1
27707,TEF,0,1
27708,),0,1
27709,in,0,1
27710,subjects,1,1
27711,with,1,1
27712,hyperinsulinemia,1,1
27713,.,1,1
27714,DESIGN,0,0
27715,Parallel,0,0
27716,",",0,0
27717,clinical,0,0
27718,intervention,0,0
27719,study,0,1
27720,of,0,1
27721,12,0,1
27722,weeks,0,1
27723,energy,0,1
27724,restriction,0,1
27725,(,0,1
27726,6.5,0,0
27727,MJ/day,0,1
27728,),0,1
27729,and,0,1
27730,4,0,1
27731,weeks,0,0
27732,energy,0,1
27733,balance,0,0
27734,(,0,1
27735,8.2,0,0
27736,MJ/day,0,0
27737,),0,1
27738,in,0,1
27739,two,0,1
27740,groups,0,1
27741,of,0,1
27742,subjects,0,1
27743,randomly,0,1
27744,assigned,0,1
27745,to,0,0
27746,either,0,0
27747,a,0,0
27748,high-protein,0,0
27749,(,0,0
27750,HP,0,1
27751,),0,1
27752,diet,0,1
27753,(,0,1
27754,27,0,1
27755,%,0,0
27756,of,0,0
27757,energy,0,0
27758,(,0,1
27759,%,0,0
27760,E,0,1
27761,),0,1
27762,as,0,0
27763,protein,0,0
27764,",",0,1
27765,45,0,1
27766,%,0,0
27767,E,0,0
27768,as,0,0
27769,carbohydrate,0,1
27770,),0,1
27771,or,0,1
27772,a,0,1
27773,lower-protein,0,1
27774,(,0,1
27775,LP,0,1
27776,),0,1
27777,diet,0,1
27778,(,0,1
27779,16,0,1
27780,%,0,0
27781,E,0,0
27782,as,0,0
27783,protein,0,0
27784,",",0,1
27785,57,0,1
27786,%,0,0
27787,E,0,0
27788,as,0,0
27789,carbohydrate,0,1
27790,),0,1
27791,.,0,0
27792,SUBJECTS,0,0
27793,A,1,0
27794,total,1,1
27795,of,1,0
27796,36,1,1
27797,obese,1,1
27798,nondiabetic,1,1
27799,volunteers,1,1
27800,with,1,1
27801,hyperinsulinemia,1,1
27802,(,1,1
27803,10,1,1
27804,males/26,1,1
27805,females,1,1
27806,",",1,1
27807,aged,1,1
27808,34-65,1,1
27809,y,1,1
27810,",",1,1
27811,BMI,1,1
27812,28-43,1,1
27813,kg/m,1,1
27814,(,1,1
27815,2,1,1
27816,),1,1
27817,",",1,0
27818,fasting,1,0
27819,insulin,1,0
27820,12-45,1,1
27821,mU/l,1,0
27822,),1,1
27823,.,1,1
27824,MEASUREMENTS,0,0
27825,Body,0,1
27826,weight,0,1
27827,and,0,0
27828,composition,0,0
27829,",",0,0
27830,TEE,0,0
27831,",",0,0
27832,REE,0,0
27833,",",0,0
27834,and,0,0
27835,RQ,0,0
27836,were,0,1
27837,measured,0,0
27838,at,0,0
27839,baseline,0,0
27840,and,0,1
27841,at,0,1
27842,week,0,0
27843,16,0,1
27844,.,0,1
27845,In,0,0
27846,addition,0,0
27847,",",0,0
27848,the,0,0
27849,TEF,0,1
27850,to,0,0
27851,an,0,1
27852,HP,0,0
27853,or,0,1
27854,LP,0,1
27855,meal,0,0
27856,was,0,0
27857,determined,0,0
27858,for,0,0
27859,3,0,1
27860,h,0,0
27861,",",0,0
27862,at,0,0
27863,baseline,0,0
27864,and,0,1
27865,at,0,1
27866,week,0,0
27867,16,0,1
27868,.,0,1
27869,RESULTS,0,0
27870,After,0,1
27871,16,0,1
27872,weeks,0,0
27873,",",0,1
27874,weight,0,1
27875,loss,0,0
27876,was,0,0
27877,similar,0,0
27878,in,0,0
27879,response,0,0
27880,to,0,0
27881,each,0,0
27882,diet,0,0
27883,;,0,0
27884,the,0,0
27885,overall,0,0
27886,decrease,0,0
27887,was,0,0
27888,7.9+/-0.6,0,0
27889,kg,0,1
27890,(,0,1
27891,P,0,0
27892,<,0,0
27893,0.001,0,0
27894,),0,1
27895,",",0,0
27896,of,0,0
27897,which,0,0
27898,6.8+/-0.5,0,1
27899,kg,0,1
27900,was,0,0
27901,fat,0,0
27902,(,0,1
27903,P,0,0
27904,<,0,0
27905,0.001,0,0
27906,),0,1
27907,.,0,1
27908,REE,0,0
27909,fell,0,0
27910,similarly,0,0
27911,with,0,1
27912,each,0,0
27913,diet,0,0
27914,;,0,0
27915,the,0,0
27916,overall,0,0
27917,decrease,0,0
27918,was,0,0
27919,719+/-106,0,0
27920,kJ/day,0,1
27921,(,0,1
27922,P,0,0
27923,<,0,0
27924,0.001,0,0
27925,),0,1
27926,.,0,1
27927,The,0,0
27928,TEF,0,1
27929,was,0,0
27930,2,0,0
27931,%,0,0
27932,greater,0,0
27933,after,0,0
27934,the,0,0
27935,HP,0,0
27936,than,0,0
27937,after,0,0
27938,the,0,0
27939,LP,0,1
27940,meal,0,0
27941,at,0,0
27942,baseline,0,0
27943,(,0,1
27944,P,0,0
27945,<,0,0
27946,0.01,0,0
27947,),0,1
27948,and,0,1
27949,0.8,0,0
27950,%,0,0
27951,greater,0,0
27952,at,0,1
27953,week,0,0
27954,16,0,1
27955,(,0,1
27956,P=0.35,0,0
27957,),0,1
27958,.,0,1
27959,After,0,0
27960,16,0,1
27961,weeks,0,0
27962,",",0,1
27963,the,0,0
27964,TEF,0,1
27965,was,0,0
27966,not,0,0
27967,reduced,0,0
27968,in,0,0
27969,either,0,1
27970,dietary,0,0
27971,group,0,0
27972,.,0,0
27973,There,0,0
27974,was,0,0
27975,no,0,0
27976,change,0,0
27977,in,0,0
27978,TEE,0,0
27979,after,0,1
27980,16,0,1
27981,weeks,0,1
27982,.,0,1
27983,CONCLUSION,0,0
27984,In,0,1
27985,subjects,1,1
27986,with,1,1
27987,hyperinsulinemia,1,1
27988,an,0,1
27989,energy-restrictive,0,1
27990,diet,0,0
27991,containing,0,0
27992,an,0,0
27993,increased,0,0
27994,protein-to-carbohydrate,0,0
27995,ratio,0,0
27996,does,0,0
27997,not,0,0
27998,enhance,0,0
27999,weight,0,0
28000,loss,0,0
28001,or,0,1
28002,significantly,0,0
28003,affect,0,0
28004,energy,0,0
28005,expenditure,0,0
28006,.,0,1
28007,Caloric,0,0
28008,restriction,0,0
28009,",",0,0
28010,rather,0,0
28011,than,0,0
28012,the,0,0
28013,macronutrient,0,0
28014,composition,0,0
28015,of,0,0
28016,the,0,0
28017,diet,0,0
28018,",",0,0
28019,is,0,0
28020,the,0,0
28021,most,0,0
28022,important,0,0
28023,determinant,0,0
28024,of,0,0
28025,weight,0,1
28026,loss,0,1
28027,.,0,1
28028,Comparison,0,0
28029,of,0,0
28030,the,0,0
28031,comet,0,0
28032,assay,0,0
28033,and,0,0
28034,the,0,0
28035,oxygen,0,0
28036,microelectrode,0,0
28037,for,0,0
28038,measuring,0,0
28039,tumor,0,1
28040,oxygenation,0,0
28041,in,0,0
28042,head-and-neck,1,1
28043,cancer,1,1
28044,patients,1,1
28045,.,1,1
28046,PURPOSE,0,0
28047,To,0,0
28048,compare,0,0
28049,the,0,0
28050,Eppendorf,0,1
28051,PO2,0,1
28052,histograph,0,0
28053,and,0,0
28054,the,0,0
28055,alkaline,0,0
28056,comet,0,0
28057,assay,0,0
28058,as,0,0
28059,methods,0,1
28060,of,0,1
28061,measuring,0,0
28062,tumor,0,1
28063,hypoxia,0,1
28064,in,0,0
28065,patients,1,1
28066,with,1,1
28067,head-and-neck,1,1
28068,squamous,1,1
28069,cell,1,1
28070,carcinomas,1,1
28071,.,1,1
28072,MATERIALS,0,0
28073,AND,0,0
28074,METHODS,0,0
28075,As,0,0
28076,part,0,1
28077,of,0,0
28078,a,0,1
28079,larger,0,0
28080,clinical,0,0
28081,trial,0,0
28082,",",0,1
28083,65,1,1
28084,patients,1,1
28085,with,1,1
28086,head-and-neck,1,1
28087,squamous,1,1
28088,cell,1,1
28089,carcinoma,1,1
28090,nodal,1,1
28091,metastasis,1,1
28092,underwent,0,1
28093,tumor,0,1
28094,oxygenation,0,0
28095,measurements,0,0
28096,with,0,1
28097,Eppendorf,0,1
28098,PO2,0,1
28099,histographs,0,0
28100,and,0,1
28101,comet,0,0
28102,assays,0,0
28103,",",0,0
28104,performed,0,0
28105,on,0,0
28106,fine-needle,0,1
28107,aspirates,0,1
28108,at,0,1
28109,1,0,1
28110,and,0,1
28111,2,0,1
28112,min,0,0
28113,after,0,1
28114,5,0,1
28115,Gy,0,1
28116,.,0,1
28117,Fifty-four,1,1
28118,patients,1,1
28119,had,1,1
28120,sufficient,1,0
28121,tumor,1,1
28122,cells,1,0
28123,for,1,1
28124,comet,1,0
28125,analysis,1,0
28126,at,0,1
28127,1,0,1
28128,min,0,0
28129,and,0,1
28130,26,0,1
28131,at,0,1
28132,both,0,0
28133,1,0,1
28134,and,0,1
28135,2,0,1
28136,min,0,0
28137,.,0,1
28138,Individual,0,0
28139,cells,0,0
28140,were,0,1
28141,examined,0,0
28142,for,0,0
28143,DNA,0,1
28144,single-strand,0,0
28145,breaks,0,0
28146,by,0,0
28147,alkaline,0,0
28148,gel,0,0
28149,electrophoresis,0,0
28150,",",0,0
28151,and,0,0
28152,the,0,0
28153,distribution,0,0
28154,of,0,0
28155,values,0,0
28156,was,0,0
28157,quantified,0,0
28158,using,0,0
28159,median,0,0
28160,tail,0,1
28161,moment,0,0
28162,(,0,1
28163,MTM,0,1
28164,),0,1
28165,.,0,1
28166,Nonirradiated,0,0
28167,tumor,0,1
28168,cells,0,0
28169,from,0,1
28170,pretreatment,0,1
28171,fine-needle,0,1
28172,aspirates,0,1
28173,received,0,1
28174,5,0,1
28175,Gy,0,1
28176,in,0,1
28177,vitro,0,0
28178,to,0,0
28179,establish,0,0
28180,the,0,0
28181,oxygenated,0,0
28182,response,0,0
28183,.,0,1
28184,RESULTS,0,0
28185,There,0,0
28186,was,0,0
28187,a,0,0
28188,significant,0,0
28189,correlation,0,0
28190,between,0,0
28191,the,0,0
28192,1-,0,1
28193,and,0,0
28194,2-min,0,0
28195,MTM,0,1
28196,(,0,1
28197,slope,0,0
28198,=,0,0
28199,0.77,0,0
28200,+/-,0,0
28201,0.03,0,0
28202,),0,1
28203,.,0,0
28204,There,0,0
28205,was,0,0
28206,no,0,0
28207,relationship,0,0
28208,between,0,0
28209,DNA,0,0
28210,damage,0,0
28211,in,0,1
28212,tumor,0,1
28213,cells,0,0
28214,irradiated,0,0
28215,in,0,1
28216,vitro,0,0
28217,and,0,1
28218,in,0,0
28219,vivo,0,0
28220,.,0,1
28221,No,0,0
28222,correlation,0,0
28223,was,0,0
28224,found,0,0
28225,between,0,0
28226,Eppendorf,0,1
28227,PO2,0,1
28228,measurements,0,0
28229,and,0,1
28230,comet,0,0
28231,MTM,0,0
28232,.,0,0
28233,There,0,0
28234,was,0,0
28235,a,0,0
28236,statistically,0,0
28237,significant,0,0
28238,correlation,0,0
28239,between,0,0
28240,the,0,0
28241,treatment,0,0
28242,response,0,0
28243,in,0,0
28244,the,0,0
28245,node,0,1
28246,studied,0,1
28247,and,0,0
28248,comet,0,0
28249,MTMs,0,0
28250,",",0,0
28251,whereas,0,0
28252,no,0,0
28253,correlation,0,0
28254,was,0,0
28255,observed,0,0
28256,between,0,0
28257,treatment,0,0
28258,response,0,0
28259,and,0,1
28260,Eppendorf,0,1
28261,measurements,0,0
28262,.,0,1
28263,CONCLUSIONS,0,0
28264,Comet,0,0
28265,assays,0,0
28266,are,0,0
28267,reproducible,0,0
28268,",",0,0
28269,as,0,0
28270,shown,0,0
28271,by,0,0
28272,biopsies,0,1
28273,at,0,1
28274,1,0,1
28275,and,0,1
28276,2,0,1
28277,min,0,0
28278,.,0,1
28279,Intertumor,0,0
28280,variation,0,0
28281,in,0,0
28282,the,0,0
28283,MTM,0,0
28284,is,0,0
28285,not,0,0
28286,a,0,0
28287,result,0,0
28288,of,0,0
28289,intrinsic,0,0
28290,radiosensitivity,0,0
28291,but,0,0
28292,of,0,0
28293,tumor,0,1
28294,hypoxia,0,0
28295,.,0,0
28296,There,0,0
28297,was,0,0
28298,no,0,0
28299,correlation,0,0
28300,between,0,0
28301,Eppendorf,0,1
28302,PO2,0,1
28303,measurements,0,0
28304,and,0,1
28305,comet,0,0
28306,MTM,0,1
28307,.,0,1
28308,Comet,0,0
28309,assays,0,0
28310,were,0,1
28311,better,0,0
28312,than,0,0
28313,Eppendorf,0,1
28314,in,0,1
28315,predicting,0,0
28316,treatment,0,0
28317,response,0,0
28318,as,0,0
28319,an,0,0
28320,end,0,0
28321,point,0,0
28322,for,0,0
28323,short-term,0,0
28324,outcome,0,0
28325,.,0,1
28326,Longer,0,0
28327,follow-up,0,0
28328,is,0,0
28329,needed,0,0
28330,to,0,0
28331,determine,0,0
28332,the,0,0
28333,role,0,0
28334,of,0,0
28335,the,0,0
28336,comet,0,0
28337,assay,0,0
28338,as,0,0
28339,a,0,0
28340,predictor,0,0
28341,for,0,0
28342,locoregional,0,1
28343,tumor,0,1
28344,control,0,1
28345,and,0,1
28346,survivals,0,0
28347,.,0,1
28348,Phase,0,1
28349,III,0,1
28350,trial,0,1
28351,comparing,0,0
28352,whole-pelvic,0,1
28353,versus,0,0
28354,prostate-only,0,1
28355,radiotherapy,0,1
28356,and,0,1
28357,neoadjuvant,0,1
28358,versus,0,0
28359,adjuvant,0,1
28360,combined,0,0
28361,androgen,0,0
28362,suppression,0,0
28363,:,0,1
28364,Radiation,0,0
28365,Therapy,0,1
28366,Oncology,0,1
28367,Group,0,1
28368,9413,0,1
28369,.,0,1
28370,PURPOSE,0,0
28371,This,0,0
28372,trial,0,0
28373,tested,0,0
28374,the,0,0
28375,hypothesis,0,0
28376,that,0,0
28377,combined,0,0
28378,androgen,0,0
28379,suppression,0,0
28380,(,0,0
28381,CAS,0,0
28382,),0,1
28383,and,0,1
28384,whole-pelvic,0,1
28385,(,0,1
28386,WP,0,0
28387,),0,1
28388,radiotherapy,0,1
28389,(,0,1
28390,RT,0,1
28391,),0,1
28392,followed,0,0
28393,by,0,0
28394,a,0,1
28395,boost,0,1
28396,to,0,0
28397,the,0,0
28398,prostate,0,1
28399,improves,0,0
28400,progression-free,0,0
28401,survival,0,0
28402,(,0,1
28403,PFS,0,1
28404,),0,1
28405,by,0,0
28406,10,0,1
28407,%,0,0
28408,compared,0,0
28409,with,0,1
28410,CAS,0,0
28411,and,0,1
28412,prostate-only,0,1
28413,(,0,1
28414,PO,0,0
28415,),0,1
28416,RT,0,1
28417,.,0,1
28418,This,0,0
28419,trial,0,0
28420,also,0,0
28421,tested,0,0
28422,the,0,0
28423,hypothesis,0,0
28424,that,0,0
28425,neoadjuvant,0,1
28426,and,0,1
28427,concurrent,0,1
28428,hormonal,0,1
28429,therapy,0,1
28430,(,0,1
28431,NCHT,0,1
28432,),0,1
28433,improves,0,0
28434,PFS,0,0
28435,compared,0,0
28436,with,0,1
28437,adjuvant,0,1
28438,hormonal,0,1
28439,therapy,0,1
28440,(,0,1
28441,AHT,0,1
28442,),0,1
28443,by,0,0
28444,10,0,1
28445,%,0,0
28446,.,0,1
28447,MATERIALS,0,0
28448,AND,0,0
28449,METHODS,0,0
28450,Eligibility,1,1
28451,included,1,1
28452,localized,1,1
28453,prostate,1,1
28454,cancer,1,1
28455,with,1,1
28456,an,1,1
28457,elevated,1,1
28458,prostate-specific,1,1
28459,antigen,1,0
28460,(,1,1
28461,PSA,1,1
28462,),1,1
28463,<,1,0
28464,or,1,1
28465,=,1,1
28466,100,1,1
28467,ng/mL,1,0
28468,and,1,0
28469,an,1,0
28470,estimated,1,0
28471,risk,1,0
28472,of,1,0
28473,lymph,1,1
28474,node,1,1
28475,(,1,1
28476,LN,1,1
28477,),1,1
28478,involvement,1,1
28479,of,1,1
28480,15,1,1
28481,%,1,0
28482,.,1,1
28483,Between,1,0
28484,April,1,1
28485,1,1,1
28486,",",1,1
28487,1995,1,1
28488,",",1,0
28489,and,1,1
28490,June,1,1
28491,1,1,1
28492,",",1,1
28493,1999,1,1
28494,",",1,1
28495,"1,323",1,1
28496,patients,1,1
28497,were,1,1
28498,accrued,1,1
28499,.,1,1
28500,Patients,0,1
28501,were,0,0
28502,randomly,0,1
28503,assigned,0,1
28504,to,0,0
28505,WP,0,0
28506,+,0,0
28507,NCHT,0,1
28508,",",0,1
28509,PO,0,0
28510,+,0,0
28511,NCHT,0,1
28512,",",0,1
28513,WP,0,0
28514,+,0,0
28515,AHT,0,1
28516,",",0,0
28517,or,0,1
28518,PO,0,0
28519,+,0,0
28520,AHT,0,1
28521,.,0,1
28522,Failure,0,0
28523,for,0,0
28524,PFS,0,1
28525,was,0,0
28526,defined,0,0
28527,as,0,0
28528,the,0,0
28529,first,0,0
28530,occurrence,0,0
28531,of,0,0
28532,local,0,0
28533,",",0,1
28534,regional,0,1
28535,",",0,0
28536,or,0,1
28537,distant,0,1
28538,disease,0,1
28539,;,0,1
28540,PSA,0,1
28541,failure,0,1
28542,;,0,1
28543,or,0,1
28544,death,0,0
28545,for,0,0
28546,any,0,0
28547,cause,0,0
28548,.,0,1
28549,RESULTS,0,0
28550,With,0,1
28551,a,0,1
28552,median,0,0
28553,follow-up,0,0
28554,of,0,1
28555,59.5,0,1
28556,months,0,0
28557,",",0,1
28558,WP,0,0
28559,RT,0,1
28560,was,0,0
28561,associated,0,0
28562,with,0,1
28563,a,0,1
28564,4-year,0,1
28565,PFS,0,1
28566,of,0,1
28567,54,0,1
28568,%,0,0
28569,compared,0,0
28570,with,0,1
28571,47,0,1
28572,%,0,0
28573,in,0,1
28574,patients,0,1
28575,treated,0,1
28576,with,0,1
28577,PO,0,0
28578,RT,0,1
28579,(,0,1
28580,P,0,0
28581,=.022,0,0
28582,),0,1
28583,.,0,1
28584,Patients,0,1
28585,treated,0,1
28586,with,0,1
28587,NCHT,0,1
28588,experienced,0,1
28589,a,0,1
28590,4-year,0,1
28591,PFS,0,1
28592,of,0,1
28593,52,0,1
28594,%,0,0
28595,versus,0,0
28596,49,0,1
28597,%,0,0
28598,for,0,1
28599,AHT,0,1
28600,(,0,1
28601,P,0,0
28602,=.56,0,0
28603,),0,0
28604,.,0,0
28605,When,0,0
28606,comparing,0,0
28607,all,0,0
28608,four,0,1
28609,arms,0,0
28610,",",0,0
28611,there,0,0
28612,was,0,0
28613,a,0,0
28614,progression-free,0,0
28615,difference,0,0
28616,among,0,1
28617,WP,0,0
28618,RT,0,1
28619,+,0,0
28620,NCHT,0,1
28621,",",0,1
28622,PO,0,0
28623,RT,0,1
28624,+,0,0
28625,NCHT,0,1
28626,",",0,1
28627,WP,0,0
28628,RT,0,1
28629,+,0,0
28630,AHT,0,1
28631,",",0,0
28632,and,0,0
28633,PO,0,0
28634,RT,0,1
28635,+,0,0
28636,AHT,0,1
28637,(,0,1
28638,60,0,1
28639,%,0,0
28640,v,0,0
28641,44,0,1
28642,%,0,0
28643,v,0,0
28644,49,0,1
28645,%,0,0
28646,v,0,0
28647,50,0,1
28648,%,0,0
28649,",",0,0
28650,respectively,0,0
28651,;,0,0
28652,P,0,0
28653,=.008,0,0
28654,),0,1
28655,.,0,1
28656,No,0,0
28657,survival,0,0
28658,advantage,0,0
28659,has,0,0
28660,yet,0,0
28661,been,0,0
28662,seen,0,0
28663,.,0,1
28664,CONCLUSION,0,0
28665,WP,0,0
28666,RT,0,1
28667,+,0,0
28668,NCHT,0,1
28669,improves,0,0
28670,PFS,0,0
28671,compared,0,0
28672,with,0,1
28673,PO,0,0
28674,RT,0,1
28675,and,0,1
28676,NCHT,0,1
28677,or,0,1
28678,PO,0,0
28679,RT,0,1
28680,and,0,1
28681,AHT,0,1
28682,",",0,0
28683,and,0,0
28684,compared,0,0
28685,with,0,1
28686,WP,0,0
28687,RT,0,1
28688,+,0,0
28689,AHT,0,1
28690,in,0,1
28691,patients,1,1
28692,with,1,1
28693,a,1,1
28694,risk,1,0
28695,of,1,0
28696,LN,1,1
28697,involvement,1,1
28698,of,1,0
28699,15,1,1
28700,%,1,0
28701,.,1,1
28702,An,0,0
28703,exposure,1,0
28704,prevention,1,1
28705,rating,0,0
28706,method,0,0
28707,for,0,0
28708,intervention,0,1
28709,needs,0,1
28710,assessment,0,0
28711,and,0,1
28712,effectiveness,0,0
28713,evaluation,0,0
28714,.,0,1
28715,This,0,0
28716,article,0,0
28717,describes,0,0
28718,a,0,0
28719,new,0,0
28720,method,0,0
28721,for,0,1
28722,(,0,1
28723,1,0,1
28724,),0,1
28725,systematically,0,1
28726,prioritizing,0,0
28727,needs,0,0
28728,for,0,1
28729,intervention,1,1
28730,on,1,0
28731,hazardous,1,1
28732,substance,1,1
28733,exposures,1,1
28734,in,1,1
28735,manufacturing,1,1
28736,work,1,0
28737,sites,1,1
28738,",",0,1
28739,and,0,1
28740,(,0,1
28741,2,0,1
28742,),0,1
28743,evaluating,0,0
28744,intervention,0,1
28745,effectiveness,0,0
28746,.,0,1
28747,We,0,0
28748,developed,0,0
28749,a,0,0
28750,checklist,0,0
28751,containing,0,0
28752,six,0,1
28753,unique,0,1
28754,sets,0,1
28755,of,0,1
28756,yes/no,0,1
28757,variables,0,0
28758,organized,0,1
28759,in,0,1
28760,a,0,1
28761,2,0,1
28762,x,0,1
28763,3,0,1
28764,matrix,0,0
28765,of,0,0
28766,exposure,0,0
28767,potential,0,0
28768,versus,0,0
28769,protection,0,0
28770,(,0,1
28771,two,0,0
28772,columns,0,1
28773,),0,1
28774,at,0,0
28775,the,0,0
28776,levels,0,0
28777,of,0,1
28778,materials,0,1
28779,",",0,1
28780,processes,0,0
28781,",",0,0
28782,and,0,1
28783,human,0,1
28784,interface,0,0
28785,(,0,1
28786,three,0,1
28787,rows,0,1
28788,),0,1
28789,.,0,1
28790,The,0,0
28791,three,0,0
28792,levels,0,0
28793,correspond,0,1
28794,to,0,0
28795,a,0,0
28796,simplified,0,0
28797,hierarchy,0,1
28798,of,0,1
28799,controls,0,1
28800,.,0,1
28801,Each,0,0
28802,of,0,0
28803,the,0,0
28804,six,0,1
28805,sets,0,0
28806,of,0,1
28807,indicator,0,0
28808,variables,0,0
28809,was,0,0
28810,reduced,0,0
28811,to,0,0
28812,a,0,0
28813,high/moderate/low,0,1
28814,rating,0,0
28815,.,0,1
28816,Ratings,0,0
28817,from,0,1
28818,the,0,0
28819,matrix,0,0
28820,were,0,0
28821,then,0,0
28822,combined,0,0
28823,to,0,0
28824,generate,0,0
28825,a,0,0
28826,single,0,0
28827,overall,0,0
28828,exposure,0,1
28829,prevention,0,1
28830,rating,0,0
28831,for,0,0
28832,each,0,0
28833,area,0,0
28834,.,0,0
28835,Reflecting,0,0
28836,the,0,0
28837,hierarchy,0,1
28838,of,0,0
28839,controls,0,1
28840,",",0,1
28841,material,0,1
28842,factors,0,0
28843,were,0,1
28844,weighted,0,0
28845,highest,0,0
28846,",",0,0
28847,followed,0,0
28848,by,0,0
28849,process,0,0
28850,",",0,0
28851,and,0,0
28852,then,0,0
28853,human,0,1
28854,interface,0,0
28855,.,0,1
28856,The,0,0
28857,checklist,0,0
28858,was,0,0
28859,filled,0,0
28860,out,0,1
28861,by,0,0
28862,an,1,0
28863,industrial,1,1
28864,hygienist,1,1
28865,while,0,0
28866,conducting,0,0
28867,a,0,1
28868,walk-through,1,0
28869,inspection,1,0
28870,(,1,1
28871,N,1,1
28872,=,1,1
28873,131,1,1
28874,manufacturing,1,0
28875,processes/areas,1,1
28876,in,1,1
28877,17,1,1
28878,large,1,1
28879,work,1,1
28880,sites,1,1
28881,),1,1
28882,.,1,1
28883,One,0,1
28884,area,0,0
28885,or,0,1
28886,process,0,0
28887,per,0,0
28888,manufacturing,0,0
28889,department,0,1
28890,was,0,0
28891,assessed,0,0
28892,and,0,0
28893,rated,0,1
28894,.,0,1
28895,Based,0,0
28896,on,0,0
28897,the,0,0
28898,resulting,0,0
28899,Exposure,0,0
28900,Prevention,0,1
28901,ratings,0,0
28902,",",0,1
28903,we,0,0
28904,concluded,0,0
28905,that,0,0
28906,exposures,0,0
28907,were,0,1
28908,well,0,0
28909,controlled,0,0
28910,in,0,0
28911,the,0,0
28912,majority,0,1
28913,of,0,0
28914,areas,0,0
28915,assessed,0,1
28916,(,0,1
28917,64,0,1
28918,%,0,0
28919,with,0,1
28920,rating,0,0
28921,of,0,1
28922,1,0,1
28923,or,0,1
28924,2,0,1
28925,on,0,0
28926,a,0,1
28927,6-point,0,0
28928,scale,0,0
28929,),0,0
28930,",",0,0
28931,that,0,0
28932,there,0,0
28933,is,0,0
28934,some,0,0
28935,room,0,0
28936,for,0,0
28937,improvement,0,0
28938,in,0,1
28939,26,0,1
28940,percent,0,1
28941,of,0,1
28942,areas,0,0
28943,(,0,1
28944,rating,0,0
28945,of,0,1
28946,3,0,1
28947,or,0,1
28948,4,0,0
28949,),0,1
28950,",",0,0
28951,and,0,0
28952,that,0,0
28953,roughly,0,1
28954,10,0,1
28955,percent,0,0
28956,of,0,0
28957,the,0,0
28958,areas,0,0
28959,assessed,0,0
28960,are,0,0
28961,urgently,0,0
28962,in,0,0
28963,need,0,0
28964,of,0,0
28965,intervention,0,0
28966,(,0,1
28967,rated,0,0
28968,as,0,0
28969,5,0,1
28970,or,0,1
28971,6,0,1
28972,),0,1
28973,.,0,1
28974,A,1,0
28975,second,1,0
28976,hygienist,1,1
28977,independently,0,0
28978,assessed,0,0
28979,a,0,0
28980,subset,0,1
28981,of,0,0
28982,areas,0,0
28983,to,0,1
28984,evaluate,0,0
28985,inter-rater,0,0
28986,reliability,0,0
28987,.,0,1
28988,The,0,0
28989,reliability,0,0
28990,of,0,0
28991,the,0,0
28992,overall,0,0
28993,exposure,0,0
28994,prevention,0,1
28995,ratings,0,0
28996,was,0,0
28997,excellent,0,0
28998,(,0,1
28999,weighted,0,0
29000,kappa,0,0
29001,=,0,1
29002,0.84,0,0
29003,),0,1
29004,.,0,1
29005,The,0,0
29006,rating,0,0
29007,scheme,0,0
29008,has,0,0
29009,good,0,0
29010,discriminatory,0,0
29011,power,0,0
29012,and,0,0
29013,reliability,0,0
29014,and,0,0
29015,shows,0,0
29016,promise,0,0
29017,as,0,0
29018,a,0,0
29019,broadly,0,0
29020,applicable,0,0
29021,and,0,0
29022,inexpensive,0,0
29023,tool,0,0
29024,for,0,1
29025,intervention,0,1
29026,needs,0,1
29027,assessment,0,0
29028,and,0,1
29029,effectiveness,0,0
29030,evaluation,0,0
29031,.,0,1
29032,Validation,0,0
29033,studies,0,0
29034,are,0,0
29035,needed,0,0
29036,as,0,0
29037,a,0,1
29038,next,0,1
29039,step,0,0
29040,.,0,1
29041,This,0,0
29042,assessment,0,0
29043,method,0,0
29044,complements,0,0
29045,quantitative,0,0
29046,exposure,0,1
29047,assessment,0,0
29048,with,0,1
29049,an,0,0
29050,upstream,0,0
29051,prevention,0,1
29052,focus,0,1
29053,.,0,1
29054,A,0,0
29055,randomized,0,0
29056,trial,0,0
29057,of,0,0
29058,the,0,0
29059,canalith,0,0
29060,repositioning,0,0
29061,procedure,0,0
29062,.,0,1
29063,OBJECTIVE,0,0
29064,To,0,0
29065,compare,0,0
29066,the,0,0
29067,effectiveness,0,0
29068,and,0,0
29069,complications,0,0
29070,of,0,1
29071,our,0,1
29072,adaptation,0,0
29073,of,0,0
29074,the,0,0
29075,canalith,0,0
29076,repositioning,0,0
29077,procedure,0,0
29078,(,0,1
29079,CRP,0,1
29080,),0,1
29081,with,0,1
29082,the,0,0
29083,expectation,0,0
29084,treatment,0,0
29085,for,0,0
29086,benign,0,1
29087,paroxysmal,0,1
29088,positional,0,0
29089,vertigo,0,1
29090,.,0,1
29091,STUDY,0,0
29092,DESIGN,0,1
29093,A,0,1
29094,randomized,0,1
29095,",",0,0
29096,controlled,0,0
29097,trial,0,0
29098,in,0,0
29099,the,0,0
29100,setting,0,1
29101,of,0,0
29102,a,0,1
29103,neurotological,0,1
29104,clinic,0,1
29105,in,0,1
29106,Thailand,0,1
29107,.,0,1
29108,METHODS,0,0
29109,Fifty-eight,1,1
29110,patients,1,1
29111,with,1,1
29112,posterior,1,1
29113,benign,1,1
29114,paroxysmal,1,1
29115,positional,1,0
29116,vertigo,1,0
29117,were,0,1
29118,randomly,0,1
29119,assigned,0,1
29120,to,0,0
29121,treatment,0,0
29122,and,0,1
29123,control,0,1
29124,groups,0,0
29125,using,0,0
29126,a,0,1
29127,block,0,1
29128,of,0,0
29129,four,0,1
29130,.,0,1
29131,The,0,0
29132,treatment,0,0
29133,group,0,0
29134,was,0,0
29135,treated,0,1
29136,with,0,1
29137,the,0,0
29138,modified,0,0
29139,CRP,0,0
29140,technique,0,0
29141,until,0,0
29142,the,0,0
29143,nystagmus,0,1
29144,disappeared,0,0
29145,.,0,1
29146,A,0,0
29147,mastoid,0,0
29148,oscillator,0,0
29149,was,0,0
29150,not,0,0
29151,used,0,0
29152,",",0,0
29153,nor,0,0
29154,were,0,0
29155,any,0,0
29156,instructions,0,0
29157,given,0,0
29158,for,0,1
29159,patients,0,1
29160,after,0,1
29161,the,0,1
29162,maneuver,0,0
29163,.,0,1
29164,Both,0,0
29165,groups,0,0
29166,recorded,0,0
29167,the,0,0
29168,daily,0,0
29169,grading,0,1
29170,of,0,1
29171,symptoms,0,0
29172,and,0,1
29173,the,0,0
29174,amount,0,0
29175,of,0,0
29176,anti-vertiginous,0,1
29177,drugs,0,0
29178,(,0,1
29179,cinnarizine,0,1
29180,),0,1
29181,taken,0,0
29182,.,0,1
29183,Objective,0,0
29184,and,0,0
29185,subjective,0,0
29186,assessments,0,0
29187,were,0,1
29188,made,0,0
29189,weekly,0,0
29190,until,0,0
29191,the,0,0
29192,nystagmus,0,0
29193,disappeared,0,0
29194,or,0,1
29195,until,0,1
29196,4,0,1
29197,weeks,0,1
29198,had,0,1
29199,passed,0,1
29200,since,0,0
29201,treatment,0,0
29202,began,0,1
29203,.,0,0
29204,RESULTS,0,0
29205,The,0,0
29206,rates,0,0
29207,of,0,0
29208,effectiveness,0,0
29209,of,0,0
29210,CRP,0,1
29211,treatment,0,0
29212,and,0,0
29213,the,0,0
29214,control,0,0
29215,treatment,0,0
29216,for,0,0
29217,benign,0,1
29218,paroxysmal,0,1
29219,positional,0,0
29220,vertigo,0,1
29221,were,0,1
29222,75.9,0,0
29223,%,0,0
29224,and,0,1
29225,48.2,0,0
29226,%,0,0
29227,",",0,0
29228,respectively,0,0
29229,.,0,0
29230,There,0,0
29231,was,0,0
29232,a,0,0
29233,significant,0,0
29234,difference,0,0
29235,in,0,0
29236,the,0,0
29237,treatment,0,0
29238,outcomes,0,0
29239,of,0,0
29240,the,0,1
29241,CRP,0,0
29242,and,0,0
29243,control,0,1
29244,groups,0,0
29245,(,0,1
29246,P,0,0
29247,=.03,0,0
29248,),0,1
29249,.,0,1
29250,The,0,0
29251,CRP,0,0
29252,group,0,0
29253,used,0,0
29254,significantly,0,0
29255,fewer,0,0
29256,drugs,0,0
29257,than,0,0
29258,the,0,0
29259,control,0,1
29260,group,0,0
29261,(,0,1
29262,P,0,0
29263,=.001,0,0
29264,),0,1
29265,.,0,1
29266,Complications,0,0
29267,in,0,0
29268,the,0,1
29269,CRP,0,0
29270,group,0,0
29271,",",0,0
29272,such,0,0
29273,as,0,0
29274,lateral,0,1
29275,canalithiasis,0,1
29276,and,0,0
29277,fainting,0,0
29278,",",0,0
29279,were,0,0
29280,observed,0,0
29281,in,0,1
29282,13.8,0,0
29283,%,0,0
29284,of,0,0
29285,the,0,0
29286,patients,0,1
29287,.,0,1
29288,CONCLUSIONS,0,0
29289,The,0,0
29290,CRP,0,0
29291,was,0,0
29292,more,0,0
29293,effective,0,0
29294,than,0,0
29295,the,0,0
29296,expectation,0,0
29297,treatment,0,0
29298,for,0,0
29299,benign,0,1
29300,paroxysmal,0,1
29301,positional,0,0
29302,vertigo,0,0
29303,insofar,0,0
29304,as,0,0
29305,it,0,0
29306,provided,0,0
29307,faster,0,0
29308,recovery,0,0
29309,and,0,0
29310,required,0,0
29311,less,0,0
29312,dependence,0,0
29313,on,0,0
29314,medication,0,1
29315,.,0,1
29316,Complications,0,0
29317,of,0,0
29318,CRP,0,1
29319,were,0,1
29320,limited,0,0
29321,to,0,1
29322,13.8,0,0
29323,%,0,0
29324,of,0,1
29325,patients,0,1
29326,.,0,1
29327,[,0,0
29328,Long,0,1
29329,term,0,0
29330,observation,0,1
29331,in,0,0
29332,effects,0,0
29333,of,0,1
29334,potassium,0,0
29335,and,0,1
29336,calcium,0,0
29337,supplementation,0,0
29338,on,0,0
29339,arterial,0,1
29340,blood,0,0
29341,pressure,0,0
29342,and,0,0
29343,sodium,0,0
29344,metabolism,0,0
29345,in,0,0
29346,adolescents,1,1
29347,with,1,1
29348,higher,1,0
29349,blood,1,0
29350,pressure,1,0
29351,],1,1
29352,.,0,1
29353,OBJECTIVE,0,0
29354,To,0,0
29355,investigate,0,0
29356,the,0,0
29357,effects,0,0
29358,of,0,0
29359,potassium,0,0
29360,and,0,1
29361,calcium,0,0
29362,supplementation,0,0
29363,in,0,0
29364,table,0,0
29365,salt,0,0
29366,on,0,0
29367,reduction,0,0
29368,of,0,0
29369,arterial,0,1
29370,blood,0,0
29371,pressure,0,0
29372,and,0,0
29373,sodium,0,0
29374,metabolism,0,0
29375,in,0,0
29376,adolescents,1,1
29377,with,1,1
29378,higher,1,0
29379,blood,1,0
29380,pressure,1,0
29381,.,1,1
29382,METHODS,0,0
29383,A,0,1
29384,single,0,0
29385,blind,0,1
29386,placebo-controlled,0,0
29387,trial,0,1
29388,was,0,0
29389,carried,0,0
29390,out,0,1
29391,for,0,1
29392,two,0,1
29393,years,0,1
29394,in,0,1
29395,220,1,1
29396,adolescents,1,1
29397,with,1,1
29398,higher,1,0
29399,blood,1,0
29400,pressure,1,0
29401,",",1,0
29402,aged,1,1
29403,18,1,1
29404,-,1,1
29405,22,1,1
29406,years,1,1
29407,",",1,1
29408,who,1,1
29409,were,1,1
29410,randomly,1,1
29411,divided,1,1
29412,into,1,0
29413,supplementary,1,0
29414,group,1,1
29415,(,1,1
29416,n,1,1
29417,=,1,1
29418,110,1,1
29419,),1,1
29420,and,1,0
29421,control,1,1
29422,group,1,1
29423,(,1,1
29424,n,1,1
29425,=,1,1
29426,110,1,1
29427,),1,1
29428,.,1,1
29429,Each,1,0
29430,of,1,0
29431,the,1,0
29432,subjects,1,1
29433,in,1,0
29434,the,1,1
29435,supplementary,1,0
29436,group,1,1
29437,and,1,0
29438,their,1,1
29439,family,1,1
29440,members,1,1
29441,was,0,0
29442,given,0,1
29443,10,0,1
29444,mmol,0,0
29445,of,0,0
29446,potassium,0,0
29447,and,0,1
29448,10,0,1
29449,mmol,0,0
29450,of,0,0
29451,calcium,0,0
29452,mixed,0,1
29453,in,0,0
29454,their,0,1
29455,table,0,0
29456,salt,0,0
29457,daily,0,0
29458,for,0,1
29459,24,0,1
29460,months,0,1
29461,.,0,1
29462,RESULTS,0,0
29463,Night,0,1
29464,urinary,0,1
29465,sodium,0,0
29466,and,0,1
29467,potassium,0,0
29468,excretion,0,0
29469,increased,0,0
29470,(,0,1
29471,urinary,0,1
29472,Na,0,1
29473,(,0,1
29474,+,0,0
29475,),0,1
29476,",",0,0
29477,P,0,0
29478,<,0,0
29479,0.05,0,0
29480,;,0,1
29481,urinary,0,1
29482,K,0,0
29483,(,0,1
29484,+,0,0
29485,),0,1
29486,",",0,0
29487,P,0,0
29488,<,0,0
29489,0.01,0,0
29490,),0,1
29491,and,0,0
29492,blood,0,0
29493,pressure,0,0
29494,lowered,0,0
29495,by,0,0
29496,5.3,0,1
29497,mm,0,1
29498,Hg/1.8,0,1
29499,mm,0,1
29500,Hg,0,0
29501,in,0,0
29502,average,0,1
29503,from,0,1
29504,the,0,0
29505,baseline,0,0
29506,in,0,0
29507,the,0,0
29508,supplementary,0,0
29509,group,0,1
29510,two,0,1
29511,years,0,1
29512,after,0,1
29513,potassium,0,0
29514,and,0,1
29515,calcium,0,0
29516,supplementation,0,0
29517,",",0,0
29518,as,0,0
29519,compared,0,0
29520,with,0,1
29521,that,0,0
29522,in,0,0
29523,the,0,0
29524,control,0,1
29525,group,0,0
29526,increased,0,0
29527,by,0,0
29528,(,0,1
29529,1.3/1.7,0,1
29530,),0,1
29531,mm,0,1
29532,Hg,0,1
29533,.,0,1
29534,CONCLUSIONS,0,0
29535,Adequate,0,0
29536,supplement,0,0
29537,of,0,0
29538,potassium,0,0
29539,and,0,0
29540,calcium,0,0
29541,in,0,0
29542,daily,0,0
29543,table,0,0
29544,salt,0,0
29545,intake,0,0
29546,was,0,0
29547,an,0,0
29548,effective,0,0
29549,way,0,0
29550,to,0,0
29551,prevent,0,0
29552,form,0,0
29553,hypertension,0,1
29554,and,0,0
29555,could,0,0
29556,promote,0,0
29557,their,0,0
29558,urinary,0,0
29559,sodium,0,0
29560,excretion,0,0
29561,and,0,0
29562,reduction,0,0
29563,of,0,0
29564,arterial,0,1
29565,blood,0,0
29566,pressure,0,0
29567,in,0,0
29568,adolescents,1,1
29569,with,1,1
29570,higher,1,0
29571,blood,1,0
29572,pressure,1,0
29573,.,1,1
29574,Alendronate,0,0
29575,daily,0,0
29576,",",0,0
29577,weekly,0,0
29578,in,0,1
29579,conventional,0,1
29580,tablets,0,1
29581,and,0,1
29582,weekly,0,1
29583,in,0,1
29584,enteric,0,1
29585,tablets,0,1
29586,:,0,1
29587,preliminary,0,0
29588,study,0,1
29589,on,0,0
29590,the,0,0
29591,effects,0,0
29592,in,0,0
29593,bone,0,1
29594,turnover,0,0
29595,markers,0,0
29596,and,0,1
29597,incidence,0,0
29598,of,0,0
29599,side,0,0
29600,effects,0,0
29601,.,0,1
29602,Bisphosphonates,0,0
29603,are,0,0
29604,now,0,0
29605,in,0,0
29606,the,0,0
29607,vanguard,0,0
29608,of,0,0
29609,osteoporosis,0,1
29610,treatment,0,0
29611,.,0,1
29612,Frequently,0,0
29613,",",0,0
29614,gastro-oesophageal,0,1
29615,symptoms,0,1
29616,are,0,0
29617,associated,0,0
29618,with,0,1
29619,these,0,0
29620,drugs,0,0
29621,.,0,1
29622,The,0,0
29623,objective,0,0
29624,of,0,0
29625,this,0,0
29626,study,0,0
29627,was,0,0
29628,to,0,0
29629,compare,0,0
29630,side,0,0
29631,effects,0,0
29632,and,0,1
29633,bone,0,1
29634,turnover,0,0
29635,markers,0,0
29636,in,0,1
29637,postmenopausal,1,1
29638,women,1,1
29639,who,1,1
29640,had,1,1
29641,received,1,1
29642,alendronate,1,0
29643,daily,1,0
29644,or,1,1
29645,weekly,1,1
29646,in,1,1
29647,tablets,1,1
29648,with,1,1
29649,or,1,1
29650,without,1,1
29651,enteric,1,1
29652,coating,1,1
29653,.,1,1
29654,We,0,0
29655,conducted,0,0
29656,a,0,0
29657,randomised,0,0
29658,",",0,0
29659,double-blind,0,0
29660,",",0,0
29661,3-month,0,0
29662,trial,0,0
29663,.,0,1
29664,The,0,0
29665,trial,0,0
29666,involved,0,1
29667,75,1,1
29668,volunteers,1,1
29669,",",1,1
29670,aged,1,1
29671,45-58,1,1
29672,with,1,1
29673,moderate,1,1
29674,to,1,1
29675,severe,1,1
29676,osteopenia,1,1
29677,(,1,0
29678,T-score,1,0
29679,lower,1,0
29680,than,1,0
29681,-2,1,0
29682,SD,1,1
29683,),1,0
29684,assessed,1,0
29685,by,1,0
29686,quantitative,1,0
29687,ultrasound,1,1
29688,.,1,1
29689,Women,0,1
29690,were,0,0
29691,assigned,0,1
29692,randomly,0,1
29693,to,0,0
29694,receive,0,1
29695,:,0,1
29696,(,0,0
29697,a,0,1
29698,),0,1
29699,alendronate,0,0
29700,10mg/day,0,1
29701,:,0,1
29702,(,0,1
29703,b,0,1
29704,),0,1
29705,alendronate,0,0
29706,70,0,1
29707,mg,0,0
29708,once,0,0
29709,a,0,0
29710,week,0,0
29711,:,0,1
29712,or,0,1
29713,(,0,1
29714,c,0,1
29715,),0,1
29716,enteric,0,1
29717,alendronate,0,1
29718,70,0,1
29719,mg,0,0
29720,per,0,1
29721,week,0,0
29722,.,0,1
29723,We,0,0
29724,recorded,0,0
29725,side,0,0
29726,effects,0,0
29727,",",0,1
29728,C-telopeptide,0,0
29729,",",0,0
29730,osteocalcin,0,0
29731,and,0,0
29732,urine,0,1
29733,hydroxyproline,0,0
29734,at,0,0
29735,the,0,0
29736,start,0,1
29737,of,0,0
29738,the,0,0
29739,study,0,0
29740,and,0,0
29741,at,0,1
29742,3,0,1
29743,months,0,1
29744,.,0,1
29745,After,0,1
29746,3,0,0
29747,months,0,0
29748,",",0,1
29749,pyrosis,0,1
29750,(,0,0
29751,heartburn,0,1
29752,),0,1
29753,was,0,0
29754,noted,0,0
29755,by,0,0
29756,seven,0,1
29757,women,0,1
29758,in,0,1
29759,group,0,1
29760,A,0,1
29761,(,0,1
29762,28,0,1
29763,%,0,0
29764,),0,1
29765,",",0,0
29766,three,0,0
29767,in,0,0
29768,group,0,1
29769,B,0,1
29770,(,0,1
29771,12,0,1
29772,%,0,0
29773,),0,1
29774,and,0,1
29775,two,0,0
29776,in,0,0
29777,group,0,1
29778,C,0,1
29779,(,0,1
29780,8,0,1
29781,%,0,1
29782,),0,1
29783,;,0,1
29784,nausea,0,0
29785,:,0,1
29786,by,0,0
29787,one,0,1
29788,woman,0,1
29789,in,0,0
29790,group,0,1
29791,B,0,1
29792,;,0,1
29793,and,0,0
29794,headache,0,1
29795,by,0,0
29796,one,0,1
29797,patient,0,1
29798,in,0,0
29799,each,0,0
29800,group,0,1
29801,.,0,1
29802,C-telopeptide,0,0
29803,(,0,0
29804,A,0,1
29805,:,0,1
29806,40.7,0,0
29807,%,0,0
29808,;,0,1
29809,B,0,1
29810,:,0,1
29811,34.1,0,1
29812,%,0,0
29813,and,0,1
29814,C,0,1
29815,:,0,1
29816,38.5,0,0
29817,%,0,0
29818,),0,1
29819,;,0,1
29820,hydroxyproline,0,0
29821,(,0,1
29822,A,0,1
29823,:,0,1
29824,31.1,0,1
29825,%,0,0
29826,;,0,1
29827,B,0,1
29828,:,0,1
29829,25.3,0,1
29830,%,0,0
29831,and,0,1
29832,C,0,1
29833,:,0,1
29834,31.5,0,0
29835,%,0,0
29836,),0,1
29837,and,0,0
29838,osteocalcin,0,0
29839,(,0,1
29840,A,0,1
29841,:,0,1
29842,27.0,0,0
29843,%,0,0
29844,;,0,1
29845,B,0,1
29846,:,0,1
29847,25.4,0,0
29848,%,0,0
29849,and,0,1
29850,C,0,1
29851,:,0,1
29852,25.1,0,1
29853,%,0,0
29854,),0,1
29855,decreased,0,0
29856,similarly,0,0
29857,in,0,0
29858,the,0,0
29859,three,0,1
29860,groups,0,1
29861,.,0,1
29862,Weekly,0,0
29863,intake,0,0
29864,of,0,0
29865,alendronate,0,0
29866,",",0,0
29867,whether,0,0
29868,conventional,0,1
29869,or,0,1
29870,enteric-coated,0,0
29871,;,0,0
29872,is,0,0
29873,associated,0,0
29874,with,0,1
29875,less,0,0
29876,heartburn,0,1
29877,and,0,0
29878,nausea,0,0
29879,.,0,1
29880,Enteric,0,0
29881,alendronate,0,0
29882,has,0,0
29883,a,0,0
29884,similar,0,0
29885,action,0,0
29886,to,0,1
29887,the,0,0
29888,conventional,0,1
29889,tablets,0,0
29890,on,0,1
29891,biochemical,0,1
29892,markers,0,0
29893,.,0,1
29894,A,0,0
29895,comparative,0,0
29896,study,0,0
29897,of,0,0
29898,a,0,1
29899,new,0,1
29900,food,0,0
29901,supplement,0,0
29902,",",0,0
29903,ViviScal,0,0
29904,",",0,0
29905,with,0,1
29906,fish,0,0
29907,extract,0,1
29908,for,0,0
29909,the,0,0
29910,treatment,0,0
29911,of,0,0
29912,hereditary,1,1
29913,androgenic,1,0
29914,alopecia,1,1
29915,in,1,1
29916,young,1,1
29917,males,1,1
29918,.,1,1
29919,A,0,0
29920,controlled,0,0
29921,",",0,0
29922,randomized,0,1
29923,",",0,0
29924,double-blind,0,0
29925,",",0,0
29926,parallel-group,0,0
29927,study,0,0
29928,compared,0,0
29929,the,0,0
29930,effects,0,0
29931,of,0,1
29932,ViviScal,0,1
29933,(,0,1
29934,a,0,1
29935,new,0,1
29936,food,0,0
29937,supplement,0,0
29938,incorporating,0,0
29939,special,0,1
29940,marine,0,1
29941,extracts,0,1
29942,and,0,1
29943,a,0,1
29944,silica,0,0
29945,compound,0,0
29946,),0,1
29947,with,0,1
29948,those,0,1
29949,of,0,0
29950,a,0,0
29951,fish,0,0
29952,extract,0,0
29953,in,0,0
29954,the,0,0
29955,treatment,0,0
29956,of,0,0
29957,young,1,1
29958,males,1,1
29959,with,1,1
29960,hereditary,1,1
29961,androgenic,1,1
29962,alopecia,1,1
29963,.,1,1
29964,The,0,0
29965,pretreatment,0,0
29966,histological,0,0
29967,diagnosis,0,1
29968,was,0,0
29969,alopecia,1,1
29970,with,1,1
29971,a,1,1
29972,mild,1,1
29973,to,1,0
29974,moderate,1,1
29975,perifollicular,1,1
29976,inflammation,1,1
29977,zone,1,1
29978,.,1,1
29979,The,0,0
29980,study,0,0
29981,consisted,0,1
29982,of,0,1
29983,20,1,1
29984,subjects,1,1
29985,who,1,1
29986,received,1,1
29987,two,1,1
29988,tablets,1,0
29989,of,1,1
29990,ViviScal,1,1
29991,once,1,0
29992,daily,1,0
29993,and,1,1
29994,20,1,1
29995,who,1,1
29996,received,1,1
29997,two,1,1
29998,tablets,1,0
29999,of,1,1
30000,fish,1,0
30001,extract,1,1
30002,once,1,0
30003,daily,1,0
30004,for,1,1
30005,6,1,1
30006,months,1,1
30007,.,1,1
30008,The,1,0
30009,mean,1,0
30010,patient,1,1
30011,age,1,1
30012,and,1,0
30013,mean,1,1
30014,duration,1,0
30015,and,1,0
30016,severity,1,0
30017,of,1,0
30018,baldness,1,1
30019,compared,0,0
30020,well,0,0
30021,between,0,0
30022,the,0,0
30023,two,0,1
30024,groups,0,1
30025,.,0,1
30026,Most,1,0
30027,patients,1,1
30028,had,1,1
30029,been,1,1
30030,treated,1,1
30031,with,1,1
30032,long-term,1,0
30033,topical,1,0
30034,2,1,1
30035,%,1,0
30036,minoxidil,1,1
30037,for,1,0
30038,1,1,1
30039,year,1,1
30040,or,1,1
30041,more,1,0
30042,prior,0,1
30043,to,0,0
30044,the,0,0
30045,study,0,0
30046,.,0,1
30047,At,0,0
30048,baseline,0,0
30049,and,0,1
30050,after,0,1
30051,6,0,1
30052,months,0,1
30053,',0,1
30054,treatment,0,0
30055,",",0,0
30056,a,0,0
30057,biopsy,0,1
30058,was,0,0
30059,taken,0,0
30060,for,0,0
30061,histological,0,0
30062,examination,0,1
30063,.,0,1
30064,A,0,0
30065,non-vellus,0,0
30066,hair,0,1
30067,count,0,0
30068,was,0,0
30069,performed,0,0
30070,at,0,0
30071,baseline,0,0
30072,and,0,1
30073,after,0,0
30074,2,0,1
30075,",",0,1
30076,4,0,0
30077,and,0,1
30078,6,0,1
30079,months,0,0
30080,.,0,1
30081,In,0,0
30082,the,0,0
30083,fish,0,0
30084,extract,0,0
30085,treatment,0,1
30086,group,0,1
30087,three,1,1
30088,patients,1,1
30089,withdrew,1,1
30090,from,1,1
30091,the,1,0
30092,study,1,0
30093,before,1,0
30094,the,1,0
30095,fourth,1,1
30096,month,1,0
30097,due,1,0
30098,to,1,0
30099,lack,1,0
30100,of,1,0
30101,therapeutic,1,0
30102,effect,1,0
30103,.,1,1
30104,After,0,0
30105,6,0,0
30106,months,0,1
30107,',0,1
30108,treatment,0,1
30109,",",0,1
30110,patients,0,1
30111,receiving,0,1
30112,ViviScal,0,1
30113,showed,0,0
30114,a,0,0
30115,mean,0,0
30116,increase,0,0
30117,in,0,1
30118,non-vellus,0,1
30119,hair,0,1
30120,of,0,1
30121,38,0,1
30122,%,0,0
30123,compared,0,0
30124,with,0,1
30125,a,0,1
30126,2,0,1
30127,%,0,0
30128,increase,0,0
30129,in,0,0
30130,the,0,0
30131,fish,0,0
30132,extract,0,0
30133,treatment,0,0
30134,group,0,1
30135,(,0,1
30136,P,0,0
30137,<,0,0
30138,0.0001,0,0
30139,),0,1
30140,.,0,1
30141,In,0,0
30142,the,0,0
30143,ViviScal,0,0
30144,group,0,0
30145,",",0,1
30146,19,0,1
30147,(,0,1
30148,95,0,0
30149,%,0,0
30150,),0,0
30151,subjects,0,1
30152,showed,0,0
30153,both,0,0
30154,clinical,0,0
30155,and,0,0
30156,histological,0,0
30157,cure,0,0
30158,",",0,0
30159,whereas,0,0
30160,none,0,0
30161,treated,0,1
30162,with,0,1
30163,fish,0,0
30164,extract,0,1
30165,showed,0,0
30166,any,0,0
30167,clinical,0,0
30168,or,0,1
30169,histological,0,0
30170,difference,0,0
30171,after,0,1
30172,6,0,1
30173,months,0,1
30174,',0,1
30175,treatment,0,1
30176,(,0,1
30177,P,0,0
30178,<,0,0
30179,0.0001,0,0
30180,),0,1
30181,.,0,1
30182,In,0,0
30183,both,0,0
30184,groups,0,0
30185,",",0,0
30186,a,0,1
30187,minimal,0,0
30188,decrease,0,0
30189,in,0,0
30190,the,0,0
30191,erythemal,0,1
30192,index,0,0
30193,was,0,0
30194,observed,0,0
30195,.,0,1
30196,In,0,0
30197,conclusion,0,0
30198,",",0,0
30199,ViviScal,0,0
30200,appears,0,0
30201,to,0,0
30202,be,0,0
30203,the,0,0
30204,first,0,0
30205,highly,0,0
30206,active,0,1
30207,treatment,0,0
30208,for,0,0
30209,androgenic,0,0
30210,alopecia,0,1
30211,in,0,1
30212,young,0,1
30213,males,0,1
30214,.,0,1
30215,Phonophoresis,0,1
30216,versus,0,0
30217,topical,0,0
30218,application,0,0
30219,of,0,1
30220,ketoprofen,0,0
30221,:,0,1
30222,comparison,0,0
30223,between,0,0
30224,tissue,0,1
30225,and,0,1
30226,plasma,0,0
30227,levels,0,0
30228,.,0,1
30229,BACKGROUND,0,0
30230,AND,0,0
30231,PURPOSE,0,0
30232,Over,0,0
30233,the,0,0
30234,last,0,1
30235,few,0,0
30236,decades,0,0
30237,",",0,1
30238,application,0,0
30239,of,0,0
30240,ultrasound,0,0
30241,has,0,0
30242,been,0,0
30243,attempted,0,0
30244,to,0,0
30245,enhance,0,0
30246,transdermal,0,0
30247,transport,0,0
30248,of,0,1
30249,several,0,1
30250,drugs,0,0
30251,",",0,1
30252,a,0,1
30253,method,0,0
30254,referred,0,1
30255,to,0,0
30256,as,0,0
30257,phonophoresis,0,0
30258,.,0,1
30259,The,0,0
30260,purposes,0,0
30261,of,0,0
30262,this,0,0
30263,study,0,0
30264,were,0,0
30265,to,0,0
30266,examine,0,0
30267,the,0,0
30268,influence,0,0
30269,of,0,0
30270,ultrasound,0,1
30271,on,0,0
30272,the,0,0
30273,transdermal,0,0
30274,delivery,0,0
30275,of,0,0
30276,ketoprofen,0,0
30277,in,0,1
30278,humans,0,1
30279,and,0,1
30280,to,0,0
30281,compare,0,0
30282,the,0,0
30283,concentrations,0,0
30284,found,0,0
30285,after,0,1
30286,continuous,0,0
30287,and,0,1
30288,pulsed,0,1
30289,application,0,0
30290,.,0,1
30291,SUBJECTS,0,0
30292,AND,0,0
30293,METHODS,0,0
30294,Twenty-six,1,1
30295,patients,1,1
30296,with,1,1
30297,knee,1,1
30298,disorders,1,1
30299,requiring,1,1
30300,arthroscopy,1,1
30301,were,0,1
30302,randomly,0,1
30303,assigned,0,1
30304,to,0,0
30305,1,0,1
30306,of,0,1
30307,3,0,1
30308,groups,0,1
30309,.,0,1
30310,Just,0,0
30311,before,0,0
30312,surgery,0,1
30313,",",0,0
30314,phonophoresis,0,0
30315,of,0,0
30316,a,0,0
30317,ketoprofen,0,0
30318,gel,0,0
30319,(,0,1
30320,Fastum,0,1
30321,gel,0,0
30322,),0,1
30323,was,0,0
30324,given,0,0
30325,to,0,0
30326,group,0,1
30327,A,0,1
30328,using,0,0
30329,continuous,0,0
30330,ultrasound,0,1
30331,(,0,1
30332,1,0,1
30333,MHz,0,0
30334,",",0,1
30335,1.5,0,0
30336,W/cm2,0,0
30337,",",0,1
30338,for,0,0
30339,5,0,1
30340,minutes,0,1
30341,),0,1
30342,.,0,1
30343,Group,0,1
30344,B,0,1
30345,received,0,1
30346,the,0,0
30347,same,0,0
30348,treatment,0,0
30349,but,0,0
30350,with,0,1
30351,pulsed,0,1
30352,ultrasound,0,1
30353,(,0,1
30354,100,0,1
30355,Hz,0,1
30356,",",0,1
30357,20,0,1
30358,%,0,0
30359,duty,0,1
30360,cycle,0,0
30361,),0,1
30362,.,0,1
30363,Group,0,1
30364,C,0,0
30365,received,0,1
30366,5,0,1
30367,minutes,0,0
30368,of,0,1
30369,sham,0,0
30370,ultrasound,0,1
30371,with,0,1
30372,the,0,0
30373,ketoprofen,0,0
30374,gel,0,0
30375,.,0,1
30376,The,0,0
30377,ultrasound,0,0
30378,head,0,1
30379,was,0,0
30380,moved,0,1
30381,over,0,0
30382,a,0,1
30383,10-cm2,0,0
30384,area,0,0
30385,using,0,0
30386,small,0,0
30387,",",0,1
30388,continuous,0,0
30389,",",0,1
30390,circular,0,1
30391,movements,0,1
30392,.,0,1
30393,Biopsies,0,1
30394,of,0,0
30395,adipose,0,1
30396,tissue,0,1
30397,and,0,1
30398,synovial,0,1
30399,tissue,0,1
30400,were,0,1
30401,taken,0,0
30402,during,0,0
30403,surgery,0,1
30404,to,0,0
30405,evaluate,0,0
30406,the,0,0
30407,local,0,0
30408,penetration,0,0
30409,of,0,0
30410,the,0,0
30411,drug,0,0
30412,.,0,1
30413,Blood,0,0
30414,samples,0,0
30415,also,0,0
30416,were,0,1
30417,collected,0,0
30418,to,0,0
30419,determine,0,0
30420,whether,0,0
30421,ketoprofen,0,0
30422,entered,0,1
30423,the,0,0
30424,systemic,0,0
30425,circulation,0,0
30426,.,0,1
30427,RESULTS,0,0
30428,The,0,0
30429,concentration,0,0
30430,of,0,0
30431,ketoprofen,0,0
30432,in,0,0
30433,plasma,0,0
30434,was,0,0
30435,negligible,0,0
30436,in,0,0
30437,all,0,1
30438,3,0,1
30439,groups,0,0
30440,.,0,1
30441,The,0,0
30442,concentration,0,0
30443,of,0,0
30444,ketoprofen,0,0
30445,in,0,1
30446,synovial,0,1
30447,tissue,0,1
30448,differed,0,0
30449,from,0,0
30450,that,0,0
30451,in,0,1
30452,fat,0,1
30453,tissue,0,1
30454,.,0,1
30455,A,0,0
30456,difference,0,0
30457,in,0,0
30458,concentration,0,0
30459,of,0,0
30460,ketoprofen,0,0
30461,in,0,1
30462,synovial,0,1
30463,tissue,0,1
30464,was,0,0
30465,found,0,0
30466,between,0,0
30467,group,0,1
30468,C,0,1
30469,and,0,1
30470,groups,0,1
30471,A,0,1
30472,and,0,1
30473,B,0,1
30474,.,0,1
30475,The,0,0
30476,concentration,0,0
30477,of,0,0
30478,ketoprofen,0,0
30479,in,0,1
30480,fat,0,0
30481,tissue,0,1
30482,and,0,1
30483,synovial,0,1
30484,tissue,0,1
30485,was,0,0
30486,consistently,0,0
30487,higher,0,0
30488,in,0,0
30489,group,0,0
30490,B,0,1
30491,than,0,0
30492,in,0,0
30493,group,0,1
30494,A,0,1
30495,.,0,1
30496,DISCUSSION,0,0
30497,AND,0,0
30498,CONCLUSION,0,0
30499,This,0,0
30500,study,0,0
30501,confirms,0,0
30502,that,0,0
30503,phonophoresis,0,0
30504,of,0,0
30505,ketoprofen,0,0
30506,allows,0,0
30507,the,0,0
30508,attainment,0,0
30509,of,0,0
30510,higher,0,0
30511,local,0,0
30512,concentrations,0,0
30513,",",0,1
30514,whereas,0,0
30515,systemic,0,0
30516,exposure,0,0
30517,is,0,0
30518,lower,0,0
30519,.,0,0
30520,The,0,0
30521,results,0,0
30522,indicate,0,0
30523,that,0,0
30524,",",0,0
30525,in,0,0
30526,contrast,0,0
30527,to,0,0
30528,sham,0,0
30529,phonopheresis,0,0
30530,",",0,0
30531,ultrasound,0,0
30532,can,0,0
30533,increase,0,0
30534,the,0,0
30535,transdermal,0,0
30536,delivery,0,0
30537,of,0,0
30538,ketoprofen,0,0
30539,.,0,1
30540,Randomized,0,1
30541,comparison,0,0
30542,of,0,0
30543,interferon,0,1
30544,alpha,0,0
30545,and,0,0
30546,hydroxyurea,0,0
30547,with,0,1
30548,hydroxyurea,0,0
30549,monotherapy,0,1
30550,in,0,1
30551,chronic,0,1
30552,myeloid,0,1
30553,leukemia,0,1
30554,(,0,1
30555,CML-study,0,1
30556,II,0,1
30557,),0,1
30558,:,0,1
30559,prolongation,0,0
30560,of,0,0
30561,survival,0,0
30562,by,0,0
30563,the,0,0
30564,combination,0,0
30565,of,0,0
30566,interferon,0,1
30567,alpha,0,0
30568,and,0,0
30569,hydroxyurea,0,0
30570,.,0,1
30571,The,0,0
30572,optimum,0,0
30573,treatment,0,0
30574,conditions,0,1
30575,of,0,1
30576,interferon,0,1
30577,(,0,1
30578,IFN,0,1
30579,),0,1
30580,alpha,0,0
30581,therapy,0,0
30582,in,0,0
30583,chronic,0,1
30584,myeloid,0,1
30585,leukemia,0,1
30586,(,0,1
30587,CML,0,1
30588,),0,1
30589,are,0,0
30590,still,0,0
30591,controversial,0,0
30592,.,0,1
30593,To,0,0
30594,evaluate,0,0
30595,the,0,0
30596,role,0,0
30597,of,0,0
30598,hydroxyurea,0,0
30599,(,0,1
30600,HU,0,1
30601,),0,1
30602,for,0,0
30603,the,0,0
30604,outcome,0,0
30605,of,0,0
30606,IFN,0,1
30607,therapy,0,0
30608,",",0,0
30609,we,0,0
30610,conducted,0,0
30611,a,0,0
30612,randomized,0,1
30613,trial,0,0
30614,to,0,0
30615,compare,0,0
30616,the,0,0
30617,combination,0,0
30618,of,0,0
30619,IFN,0,1
30620,and,0,1
30621,HU,0,1
30622,vs,0,0
30623,HU,0,0
30624,monotherapy,0,1
30625,(,0,1
30626,CML-study,0,1
30627,II,0,1
30628,),0,1
30629,.,0,1
30630,From,1,1
30631,February,1,1
30632,1991,1,1
30633,to,1,1
30634,December,1,1
30635,1994,1,1
30636,",",1,1
30637,376,1,1
30638,patients,1,1
30639,with,1,1
30640,newly,1,1
30641,diagnosed,1,1
30642,CML,1,1
30643,in,1,0
30644,chronic,1,1
30645,phase,1,1
30646,were,0,1
30647,randomized,0,1
30648,.,0,1
30649,In,0,0
30650,all,0,0
30651,",",0,1
30652,340,1,1
30653,patients,1,1
30654,were,1,1
30655,Ph/BCR-ABL,1,1
30656,positive,1,1
30657,and,1,1
30658,evaluable,1,1
30659,.,1,1
30660,Randomization,0,0
30661,was,0,0
30662,unbalanced,0,0
30663,1:2,0,1
30664,in,0,0
30665,favor,0,0
30666,of,0,0
30667,the,0,0
30668,combination,0,0
30669,therapy,0,0
30670,",",0,0
30671,since,0,0
30672,study,0,1
30673,conditions,0,1
30674,were,0,1
30675,identical,0,1
30676,to,0,1
30677,the,0,0
30678,previous,0,1
30679,CML-study,0,1
30680,I,0,1
30681,and,0,0
30682,it,0,0
30683,had,0,1
30684,been,0,0
30685,planned,0,1
30686,in,0,0
30687,advance,0,1
30688,to,0,0
30689,add,0,0
30690,the,0,0
30691,HU,0,0
30692,patients,0,1
30693,of,0,1
30694,study,0,1
30695,I,0,1
30696,(,0,0
30697,n=194,0,1
30698,),0,0
30699,to,0,0
30700,the,0,0
30701,HU,0,0
30702,control,0,1
30703,group,0,1
30704,.,0,1
30705,Therefore,0,0
30706,",",0,0
30707,a,1,0
30708,total,1,1
30709,of,1,0
30710,534,1,1
30711,patients,1,1
30712,were,1,1
30713,evaluable,1,1
30714,(,1,1
30715,226,1,1
30716,patients,1,1
30717,with,1,1
30718,IFN/HU,1,1
30719,and,1,1
30720,308,1,1
30721,patients,1,1
30722,with,1,1
30723,HU,1,1
30724,),1,1
30725,.,1,1
30726,Analyses,0,0
30727,were,0,1
30728,according,0,1
30729,to,0,1
30730,intention-to-treat,0,1
30731,.,0,1
30732,Median,0,0
30733,observation,0,0
30734,time,0,0
30735,of,0,0
30736,nontransplanted,1,1
30737,living,1,1
30738,patients,1,1
30739,was,0,0
30740,7.6,0,0
30741,years,0,1
30742,(,0,1
30743,7.9,0,1
30744,years,0,1
30745,for,0,1
30746,IFN/HU,0,1
30747,and,0,1
30748,7.3,0,0
30749,years,0,1
30750,for,0,1
30751,HU,0,1
30752,),0,1
30753,.,0,1
30754,The,0,0
30755,risk,0,0
30756,profile,0,0
30757,(,0,1
30758,new,0,1
30759,CML,0,1
30760,score,0,1
30761,),0,1
30762,was,0,0
30763,available,0,1
30764,for,0,1
30765,532,0,1
30766,patients,0,1
30767,:,0,1
30768,200,0,1
30769,patients,0,1
30770,(,0,1
30771,38,0,1
30772,%,0,0
30773,),0,1
30774,were,0,1
30775,low,0,1
30776,",",0,1
30777,239,0,1
30778,patients,0,1
30779,(,0,1
30780,45,0,1
30781,%,0,0
30782,),0,1
30783,intermediate,0,0
30784,",",0,0
30785,and,0,1
30786,93,0,1
30787,patients,0,1
30788,(,0,1
30789,17,0,1
30790,%,0,0
30791,),0,1
30792,high,0,1
30793,risk,0,1
30794,.,0,1
30795,Complete,0,0
30796,hematologic,0,1
30797,response,0,0
30798,rates,0,0
30799,were,0,1
30800,higher,0,0
30801,in,0,1
30802,IFN/HU-treated,0,1
30803,patients,0,1
30804,(,0,1
30805,59,0,1
30806,vs,0,0
30807,32,0,1
30808,%,0,0
30809,),0,1
30810,.,0,1
30811,Of,0,1
30812,169,0,1
30813,evaluable,0,1
30814,IFN/HU-treated,0,1
30815,patients,0,1
30816,(,0,1
30817,75,0,1
30818,%,0,0
30819,),0,1
30820,",",0,1
30821,104,0,1
30822,patients,0,1
30823,(,0,1
30824,62,0,1
30825,%,0,0
30826,),0,1
30827,achieved,0,0
30828,a,0,0
30829,cytogenetic,0,0
30830,response,0,0
30831,that,0,0
30832,was,0,0
30833,complete,0,1
30834,in,0,1
30835,12,0,1
30836,%,0,0
30837,(,0,1
30838,n=21,0,1
30839,),0,1
30840,",",0,0
30841,major,0,1
30842,in,0,1
30843,14,0,1
30844,%,0,0
30845,(,0,1
30846,n=24,0,1
30847,),0,1
30848,",",0,0
30849,and,0,0
30850,at,0,0
30851,least,0,1
30852,minimal,0,1
30853,in,0,1
30854,35,0,1
30855,%,0,0
30856,(,0,1
30857,n=59,0,1
30858,),0,1
30859,.,0,1
30860,Of,0,0
30861,the,0,0
30862,534,1,1
30863,patients,1,1
30864,",",0,1
30865,105,0,1
30866,(,0,1
30867,20,0,1
30868,%,0,0
30869,),0,1
30870,underwent,0,1
30871,allogeneic,0,1
30872,stem,0,1
30873,cell,0,1
30874,transplantation,0,1
30875,in,0,0
30876,first,0,0
30877,chronic,0,1
30878,phase,0,1
30879,.,0,1
30880,In,0,0
30881,the,0,0
30882,low-risk,0,1
30883,group,0,1
30884,",",0,0
30885,65,0,1
30886,of,0,1
30887,200,0,1
30888,patients,0,1
30889,were,0,1
30890,transplanted,0,1
30891,(,0,1
30892,33,0,1
30893,%,0,0
30894,),0,1
30895,",",0,1
30896,30,0,1
30897,(,0,1
30898,13,0,1
30899,%,0,0
30900,),0,1
30901,in,0,0
30902,the,0,0
30903,intermediate-risk,0,1
30904,group,0,0
30905,",",0,1
30906,and,0,0
30907,nine,0,1
30908,(,0,1
30909,10,0,1
30910,%,0,0
30911,),0,1
30912,in,0,0
30913,the,0,0
30914,high-risk,0,1
30915,group,0,1
30916,.,0,1
30917,Duration,0,0
30918,of,0,0
30919,chronic,0,1
30920,phase,0,1
30921,was,0,0
30922,55,0,1
30923,months,0,0
30924,for,0,1
30925,IFN/HU,0,1
30926,and,0,1
30927,41,0,1
30928,months,0,0
30929,for,0,1
30930,HU,0,1
30931,(,0,1
30932,P,0,0
30933,<,0,0
30934,0.0001,0,0
30935,),0,1
30936,.,0,1
30937,Median,0,0
30938,survival,0,0
30939,was,0,0
30940,64,0,1
30941,months,0,0
30942,for,0,1
30943,IFN/HU,0,1
30944,and,0,1
30945,53,0,1
30946,months,0,0
30947,for,0,1
30948,HU-treated,0,1
30949,patients,0,1
30950,(,0,1
30951,P=0.0063,0,0
30952,),0,1
30953,.,0,1
30954,We,0,0
30955,conclude,0,0
30956,that,0,0
30957,IFN,0,1
30958,in,0,0
30959,combination,0,0
30960,with,0,1
30961,HU,0,0
30962,achieves,0,0
30963,a,0,0
30964,significant,0,0
30965,long-term,0,0
30966,survival,0,0
30967,advantage,0,0
30968,over,0,0
30969,HU,0,1
30970,monotherapy,0,1
30971,.,0,1
30972,In,0,0
30973,view,0,0
30974,of,0,0
30975,the,0,0
30976,data,0,0
30977,of,0,1
30978,CML-study,0,1
30979,I,0,1
30980,",",0,0
30981,these,0,0
30982,results,0,0
30983,suggest,0,0
30984,that,0,0
30985,IFN/HU,0,0
30986,is,0,0
30987,also,0,0
30988,superior,0,0
30989,to,0,0
30990,IFN,0,1
30991,alone,0,1
30992,.,0,0
30993,HU,0,0
30994,should,0,0
30995,be,0,0
30996,combined,0,0
30997,with,0,1
30998,IFN,0,1
30999,in,0,1
31000,IFN-based,0,1
31001,therapies,0,0
31002,and,0,1
31003,for,0,1
31004,comparisons,0,0
31005,with,0,1
31006,new,0,1
31007,therapies,0,1
31008,.,0,1
31009,A,0,0
31010,comparison,0,0
31011,of,0,0
31012,magnesium,0,0
31013,sulfate,0,0
31014,and,0,0
31015,nimodipine,0,0
31016,for,0,0
31017,the,0,0
31018,prevention,1,1
31019,of,1,0
31020,eclampsia,1,1
31021,.,1,1
31022,Randomized,0,0
31023,",",0,0
31024,double-blind,0,0
31025,",",0,0
31026,multicenter,0,1
31027,trial,0,1
31028,comparing,0,0
31029,two,0,0
31030,doses,0,0
31031,of,0,1
31032,arzoxifene,0,1
31033,(,0,1
31034,LY353381,0,1
31035,),0,1
31036,in,0,0
31037,hormone-sensitive,1,1
31038,advanced,1,1
31039,or,1,1
31040,metastatic,1,1
31041,breast,1,1
31042,cancer,1,1
31043,patients,1,1
31044,.,1,1
31045,BACKGROUND,0,0
31046,This,0,0
31047,randomized,0,0
31048,",",0,0
31049,double-blind,0,0
31050,",",0,0
31051,phase,0,1
31052,II,0,1
31053,study,0,1
31054,assessed,0,0
31055,two,0,0
31056,doses,0,0
31057,of,0,1
31058,the,0,1
31059,selective,0,1
31060,estrogen,0,0
31061,receptor,0,0
31062,modulator,0,1
31063,arzoxifene,0,1
31064,in,0,0
31065,women,1,1
31066,with,1,1
31067,advanced,1,1
31068,breast,1,1
31069,cancer,1,1
31070,.,1,1
31071,The,0,0
31072,primary,0,0
31073,end,0,0
31074,point,0,0
31075,was,0,0
31076,to,0,0
31077,choose,0,1
31078,the,0,0
31079,best,0,0
31080,of,0,0
31081,two,0,1
31082,doses,0,0
31083,of,0,1
31084,arzoxifene,0,1
31085,based,0,1
31086,on,0,0
31087,the,0,0
31088,response,0,0
31089,rate,0,0
31090,or,0,1
31091,the,0,0
31092,clinical,0,0
31093,benefit,0,0
31094,rate,0,0
31095,(,0,1
31096,CBR,0,1
31097,),0,1
31098,.,0,1
31099,Pharmacokinetics,0,0
31100,and,0,1
31101,toxicities,0,0
31102,were,0,1
31103,also,0,0
31104,assessed,0,0
31105,.,0,1
31106,PATIENTS,0,0
31107,AND,0,0
31108,METHODS,0,0
31109,Ninety-two,1,1
31110,patients,1,1
31111,with,1,1
31112,advanced,1,1
31113,breast,1,1
31114,cancer,1,1
31115,received,1,1
31116,arzoxifene,1,1
31117,20,1,1
31118,or,1,1
31119,50,1,1
31120,mg/day,1,0
31121,.,1,1
31122,Tumor,0,0
31123,response,0,0
31124,was,0,0
31125,assessed,0,0
31126,using,0,0
31127,World,0,1
31128,Health,0,1
31129,Organization,0,1
31130,criteria,0,1
31131,.,0,1
31132,Toxicities,0,0
31133,were,0,1
31134,graded,0,0
31135,according,0,1
31136,to,0,0
31137,the,0,0
31138,National,0,0
31139,Cancer,0,1
31140,Institute,0,1
31141,Common,0,1
31142,Toxicity,0,0
31143,Criteria,0,1
31144,(,0,1
31145,NCI-CTC,0,1
31146,),0,1
31147,system,0,1
31148,.,0,1
31149,Pharmacokinetic,0,0
31150,data,0,0
31151,were,0,1
31152,analyzed,0,0
31153,using,0,0
31154,the,0,0
31155,NONMEM,0,0
31156,software,0,0
31157,program,0,1
31158,(,0,1
31159,GloboMax,0,1
31160,",",0,0
31161,Hanover,0,0
31162,",",0,0
31163,MD,0,0
31164,",",0,0
31165,USA,0,0
31166,),0,1
31167,.,0,1
31168,RESULTS,0,0
31169,Response,0,0
31170,rates,0,0
31171,in,0,1
31172,the,0,1
31173,20,0,1
31174,mg,0,0
31175,arm,0,1
31176,were,0,0
31177,numerically,0,0
31178,higher,0,0
31179,than,0,0
31180,the,0,0
31181,50-mg,0,0
31182,arm,0,1
31183,according,0,1
31184,to,0,0
31185,the,0,0
31186,investigator,0,0
31187,(,0,0
31188,40.5,0,0
31189,%,0,0
31190,versus,0,0
31191,36.4,0,0
31192,%,0,0
31193,),0,1
31194,and,0,0
31195,the,0,0
31196,independent,0,0
31197,review,0,0
31198,panel,0,1
31199,(,0,1
31200,42.9,0,1
31201,%,0,0
31202,versus,0,0
31203,27.3,0,0
31204,%,0,1
31205,),0,1
31206,.,0,1
31207,CBR,0,0
31208,was,0,0
31209,higher,0,0
31210,in,0,0
31211,the,0,0
31212,20,0,1
31213,mg,0,0
31214,arm,0,1
31215,according,0,1
31216,to,0,0
31217,the,0,0
31218,investigator,0,0
31219,(,0,0
31220,64.3,0,1
31221,%,0,0
31222,versus,0,0
31223,61.4,0,0
31224,%,0,0
31225,),0,1
31226,and,0,0
31227,the,0,0
31228,independent,0,0
31229,review,0,0
31230,panel,0,1
31231,(,0,1
31232,59.5,0,1
31233,%,0,0
31234,versus,0,0
31235,47.7,0,1
31236,%,0,1
31237,),0,1
31238,.,0,1
31239,Arzoxifene,0,0
31240,was,0,0
31241,well,0,0
31242,tolerated,0,0
31243,.,0,0
31244,There,0,0
31245,were,0,0
31246,no,0,0
31247,study,0,1
31248,drug-related,0,1
31249,deaths,0,0
31250,.,0,1
31251,Mean,0,1
31252,observed,0,0
31253,steady-state,0,0
31254,plasma,0,0
31255,concentrations,0,0
31256,of,0,1
31257,arzoxifene,0,1
31258,were,0,1
31259,3.62,0,0
31260,and,0,1
31261,7.48,0,0
31262,ng/ml,0,0
31263,for,0,0
31264,the,0,0
31265,20,0,1
31266,and,0,1
31267,50,0,1
31268,mg,0,1
31269,doses,0,0
31270,",",0,1
31271,respectively,0,0
31272,.,0,0
31273,CONCLUSIONS,0,0
31274,There,0,0
31275,were,0,0
31276,no,0,0
31277,significant,0,0
31278,differences,0,0
31279,in,0,1
31280,efficacy,0,0
31281,or,0,1
31282,safety,0,0
31283,between,0,0
31284,20,0,1
31285,and,0,1
31286,50,0,1
31287,mg,0,0
31288,of,0,0
31289,arzoxifene,0,1
31290,.,0,1
31291,Accordingly,0,0
31292,",",0,0
31293,arzoxifene,0,0
31294,20,0,0
31295,mg/day,0,0
31296,was,0,0
31297,selected,0,1
31298,for,0,0
31299,further,0,0
31300,study,0,1
31301,in,0,1
31302,patients,0,1
31303,with,0,1
31304,breast,0,1
31305,cancer,0,1
31306,.,0,1
31307,Efficacy,0,0
31308,and,0,0
31309,tolerability,0,0
31310,of,0,0
31311,donepezil,0,0
31312,in,0,1
31313,vascular,1,1
31314,dementia,1,1
31315,:,1,1
31316,positive,0,1
31317,results,0,0
31318,of,0,1
31319,a,0,1
31320,24-week,0,0
31321,",",0,0
31322,multicenter,0,0
31323,",",0,0
31324,international,0,1
31325,",",0,0
31326,randomized,0,1
31327,",",0,0
31328,placebo-controlled,0,0
31329,clinical,0,0
31330,trial,0,1
31331,.,0,1
31332,BACKGROUND,0,0
31333,AND,0,0
31334,PURPOSE,0,1
31335,Clinical,0,0
31336,observations,0,0
31337,suggest,0,0
31338,that,0,0
31339,patients,1,1
31340,with,1,1
31341,vascular,1,1
31342,dementia,1,1
31343,(,1,1
31344,VaD,1,0
31345,),1,1
31346,may,0,0
31347,benefit,0,0
31348,from,0,0
31349,treatment,0,0
31350,with,0,1
31351,cholinesterase,0,1
31352,inhibitors,0,1
31353,.,0,1
31354,This,0,0
31355,study,0,0
31356,evaluated,0,0
31357,the,0,0
31358,efficacy,0,0
31359,and,0,0
31360,safety,0,0
31361,of,0,0
31362,donepezil,0,0
31363,for,0,1
31364,relieving,0,0
31365,symptoms,0,1
31366,of,0,1
31367,dementia,0,1
31368,in,0,1
31369,VaD,0,0
31370,.,0,1
31371,METHODS,0,0
31372,Patients,1,1
31373,(,1,1
31374,n=603,1,1
31375,;,1,1
31376,mean,1,1
31377,age,1,1
31378,",",1,1
31379,73.9,1,1
31380,years,1,1
31381,;,1,1
31382,55.2,1,1
31383,%,1,0
31384,men,1,1
31385,),1,1
31386,with,1,1
31387,probable,1,1
31388,(,1,1
31389,70.5,1,0
31390,%,1,0
31391,),1,1
31392,or,1,1
31393,possible,1,0
31394,(,1,1
31395,29.5,1,1
31396,%,1,0
31397,),1,1
31398,VaD,1,0
31399,",",1,0
31400,according,1,1
31401,to,1,0
31402,criteria,1,1
31403,of,1,0
31404,the,1,1
31405,National,1,0
31406,Institute,1,1
31407,of,1,1
31408,Neurological,1,1
31409,Disorders,1,1
31410,and,1,1
31411,Stroke,1,1
31412,(,1,1
31413,NINDS,1,1
31414,),1,1
31415,and,1,0
31416,the,1,0
31417,Association,1,0
31418,Internationale,1,1
31419,pour,1,1
31420,la,1,0
31421,Recherche,1,1
31422,et,1,1
31423,l'Enseignement,1,1
31424,en,1,1
31425,Neurosciences,1,1
31426,(,1,1
31427,AIREN,1,0
31428,),1,1
31429,",",0,0
31430,were,0,0
31431,randomized,0,1
31432,to,0,1
31433,24,0,1
31434,weeks,0,0
31435,of,0,1
31436,treatment,0,1
31437,with,0,1
31438,donepezil,0,0
31439,5,0,1
31440,mg/d,0,0
31441,(,0,1
31442,n=198,0,1
31443,),0,1
31444,",",0,1
31445,donepezil,0,0
31446,10,0,1
31447,mg/d,0,0
31448,(,0,1
31449,5,0,0
31450,mg/d,0,0
31451,for,0,1
31452,first,0,1
31453,28,0,1
31454,days,0,1
31455,;,0,1
31456,n=206,0,1
31457,),0,0
31458,",",0,0
31459,or,0,1
31460,placebo,0,0
31461,(,0,1
31462,n=199,0,1
31463,),0,1
31464,.,0,1
31465,Analyses,0,0
31466,were,0,0
31467,based,0,1
31468,on,0,0
31469,the,0,0
31470,intent-to-treat,0,0
31471,population,0,1
31472,.,0,1
31473,RESULTS,0,0
31474,At,0,0
31475,week,0,0
31476,24,0,1
31477,",",0,0
31478,both,0,0
31479,donepezil,0,0
31480,groups,0,0
31481,showed,0,0
31482,significant,0,0
31483,improvement,0,0
31484,in,0,0
31485,cognition,0,0
31486,versus,0,0
31487,placebo,0,0
31488,on,0,0
31489,the,0,0
31490,Alzheimer,0,1
31491,'s,0,1
31492,Disease,0,1
31493,Assessment,0,0
31494,Scale-cognitive,0,1
31495,subscale,0,0
31496,(,0,1
31497,mean,0,1
31498,change,0,0
31499,from,0,1
31500,baseline,0,0
31501,score,0,0
31502,effect,0,0
31503,size,0,0
31504,:,0,1
31505,donepezil,0,0
31506,5,0,0
31507,mg/d,0,0
31508,",",0,1
31509,-1.90,0,0
31510,;,0,1
31511,P=0.001,0,0
31512,;,0,0
31513,donepezil,0,0
31514,10,0,0
31515,mg/d,0,0
31516,",",0,1
31517,-2.33,0,0
31518,;,0,1
31519,P,0,0
31520,<,0,0
31521,0.001,0,0
31522,),0,1
31523,.,0,1
31524,Significant,0,0
31525,improvements,0,0
31526,in,0,1
31527,patients,0,1
31528,',0,1
31529,global,0,0
31530,function,0,0
31531,were,0,1
31532,seen,0,0
31533,versus,0,0
31534,placebo,0,0
31535,at,0,1
31536,week,0,0
31537,24,0,1
31538,(,0,1
31539,observed,0,0
31540,cases,0,1
31541,),0,1
31542,",",0,0
31543,on,0,0
31544,the,0,0
31545,Clinician,0,0
31546,'s,0,1
31547,Interview-Based,0,1
31548,Impression,0,1
31549,of,0,0
31550,Change-Plus,0,1
31551,version,0,0
31552,only,0,0
31553,for,0,0
31554,patients,0,1
31555,on,0,1
31556,donepezil,0,1
31557,5,0,1
31558,mg/d,0,0
31559,(,0,1
31560,P=0.014,0,0
31561,),0,1
31562,",",0,0
31563,and,0,0
31564,on,0,0
31565,the,0,0
31566,Sum,0,1
31567,of,0,0
31568,the,0,0
31569,Boxes,0,0
31570,of,0,0
31571,the,0,0
31572,Clinical,0,0
31573,Dementia,0,1
31574,Rating,0,0
31575,only,0,0
31576,for,0,0
31577,patients,0,1
31578,on,0,1
31579,10,0,1
31580,mg/d,0,0
31581,(,0,1
31582,P=0.007,0,0
31583,),0,1
31584,.,0,1
31585,Donepezil-treated,0,1
31586,patients,0,1
31587,showed,0,0
31588,significant,0,0
31589,benefits,0,0
31590,in,0,1
31591,activities,0,0
31592,of,0,1
31593,daily,0,0
31594,living,0,1
31595,over,0,0
31596,placebo,0,0
31597,on,0,0
31598,the,0,0
31599,Alzheimer,0,1
31600,'s,0,1
31601,Disease,0,1
31602,Functional,0,1
31603,Assessment,0,0
31604,and,0,1
31605,Change,0,1
31606,Scale,0,1
31607,(,0,1
31608,mean,0,1
31609,change,0,0
31610,from,0,1
31611,baseline,0,0
31612,score,0,0
31613,effect,0,0
31614,size,0,0
31615,at,0,1
31616,week,0,0
31617,24,0,1
31618,:,0,1
31619,donepezil,0,0
31620,5,0,0
31621,mg/d,0,0
31622,",",0,0
31623,-1.31,0,0
31624,",",0,1
31625,P=0.02,0,0
31626,;,0,0
31627,donepezil,0,0
31628,10,0,0
31629,mg/d,0,0
31630,",",0,0
31631,-1.31,0,0
31632,",",0,0
31633,P=0.02,0,0
31634,),0,1
31635,.,0,1
31636,Donepezil,0,0
31637,was,0,0
31638,well,0,0
31639,tolerated,0,0
31640,.,0,1
31641,Withdrawal,0,0
31642,rates,0,0
31643,due,0,1
31644,to,0,1
31645,adverse,0,0
31646,events,0,0
31647,were,0,1
31648,relatively,0,1
31649,low,0,0
31650,(,0,0
31651,placebo,0,0
31652,",",0,1
31653,11.1,0,0
31654,%,0,0
31655,;,0,1
31656,donepezil,0,0
31657,5,0,0
31658,mg/d,0,0
31659,",",0,1
31660,11.1,0,0
31661,%,0,0
31662,;,0,1
31663,donepezil,0,0
31664,10,0,1
31665,mg/d,0,0
31666,",",0,1
31667,21.8,0,0
31668,%,0,0
31669,;,0,1
31670,P=0.005,0,0
31671,versus,0,0
31672,placebo,0,1
31673,),0,1
31674,.,0,1
31675,CONCLUSIONS,0,0
31676,These,0,1
31677,data,0,0
31678,demonstrate,0,0
31679,that,0,0
31680,donepezil,0,0
31681,is,0,0
31682,an,0,0
31683,effective,0,0
31684,and,0,0
31685,well-tolerated,0,0
31686,treatment,0,0
31687,for,0,1
31688,VaD,0,0
31689,and,0,1
31690,show,0,0
31691,it,0,0
31692,may,0,0
31693,have,0,0
31694,an,0,0
31695,important,0,0
31696,place,0,0
31697,in,0,0
31698,the,0,0
31699,management,0,0
31700,of,0,0
31701,this,0,0
31702,condition,0,0
31703,.,0,1
31704,T,0,1
31705,lymphocyte,0,1
31706,subsets,0,1
31707,and,0,1
31708,NK,0,1
31709,cell,0,1
31710,cytotoxicity,0,0
31711,in,0,0
31712,chronic,1,1
31713,hemodialysis,1,1
31714,patients,1,1
31715,.,1,1
31716,The,0,0
31717,effect,0,0
31718,of,0,0
31719,recombinant,0,0
31720,human,0,1
31721,erythropoietin,0,0
31722,(,0,1
31723,rHu-EPO,0,1
31724,),0,1
31725,treatment,0,1
31726,.,0,1
31727,We,0,0
31728,investigated,0,0
31729,subpopulations,0,1
31730,of,0,1
31731,T,0,1
31732,lymphocytes,0,0
31733,",",0,1
31734,NK,0,0
31735,cell,0,1
31736,number,0,0
31737,and,0,0
31738,cytotoxic,0,1
31739,activity,0,0
31740,in,0,1
31741,14,1,1
31742,chronic,1,1
31743,uremic,1,1
31744,patients,1,1
31745,on,1,1
31746,regular,1,1
31747,hemodialysis,1,1
31748,treatment,1,1
31749,.,1,1
31750,We,0,0
31751,observed,0,0
31752,a,0,0
31753,significantly,0,0
31754,decreased,0,0
31755,absolute,0,0
31756,lymphocyte,0,0
31757,number,0,0
31758,and,0,0
31759,percentage,0,0
31760,of,0,1
31761,CD3,0,1
31762,cells,0,1
31763,.,0,1
31764,Relative,0,0
31765,numbers,0,0
31766,of,0,1
31767,CD16,0,1
31768,cells,0,0
31769,were,0,1
31770,significantly,0,0
31771,elevated,0,0
31772,",",0,0
31773,but,0,0
31774,NK,0,0
31775,cell,0,1
31776,cytotoxic,0,0
31777,activity,0,0
31778,was,0,0
31779,within,0,0
31780,a,0,1
31781,normal,0,1
31782,range,0,1
31783,.,0,1
31784,Nine,1,1
31785,patients,1,1
31786,with,1,1
31787,chronic,1,1
31788,renal,1,1
31789,anemia,1,1
31790,on,1,0
31791,maintenance,1,0
31792,hemodialysis,1,1
31793,were,0,0
31794,enrolled,0,1
31795,in,0,0
31796,rHu-EPO,0,1
31797,treatment,0,1
31798,trial,0,1
31799,.,0,1
31800,The,0,0
31801,treatment,0,0
31802,was,0,0
31803,continued,0,0
31804,till,0,1
31805,the,0,0
31806,hematocrit,0,0
31807,level,0,0
31808,reached,0,0
31809,30,0,1
31810,%,0,0
31811,.,0,1
31812,Each,0,0
31813,of,0,0
31814,the,0,0
31815,patients,1,1
31816,had,1,1
31817,corrected,0,0
31818,anemia,0,1
31819,and,0,0
31820,well-being,0,0
31821,.,0,1
31822,After,0,0
31823,12,0,1
31824,weeks,0,0
31825,of,0,1
31826,the,0,0
31827,treatment,0,0
31828,we,0,0
31829,observed,0,0
31830,in,0,0
31831,these,0,0
31832,patients,0,1
31833,decreases,0,0
31834,in,0,1
31835,CD3,0,1
31836,",",0,1
31837,CD4,0,1
31838,",",0,0
31839,CD8,0,1
31840,and,0,0
31841,CD16,0,1
31842,cell,0,1
31843,numbers,0,0
31844,and,0,1
31845,elevation,0,1
31846,of,0,0
31847,CD4/CD8,0,1
31848,ratio,0,0
31849,.,0,1
31850,Cytotoxic,0,0
31851,activity,0,0
31852,of,0,1
31853,NK,0,1
31854,cells,0,0
31855,did,0,0
31856,not,0,0
31857,change,0,0
31858,significantly,0,0
31859,.,0,1
31860,Presented,0,0
31861,results,0,0
31862,indicate,0,0
31863,that,0,0
31864,chronic,1,1
31865,hemodialysis,1,1
31866,patients,1,1
31867,have,0,0
31868,significantly,0,0
31869,diminished,0,0
31870,lymphocyte,0,0
31871,number,0,0
31872,.,0,1
31873,rHu,0,0
31874,EPO,0,0
31875,treatment,0,0
31876,affects,0,0
31877,the,0,0
31878,T,0,0
31879,lymphocyte,0,0
31880,subsets,0,0
31881,inducing,0,0
31882,a,0,1
31883,deep,0,0
31884,decrease,0,0
31885,of,0,1
31886,CD8,0,1
31887,and,0,1
31888,CD16,0,1
31889,cell,0,1
31890,percentage,0,0
31891,leading,0,0
31892,to,0,0
31893,normalisation,0,0
31894,of,0,0
31895,the,0,0
31896,CD4/CD8,0,1
31897,ratio,0,0
31898,.,0,1
31899,Shorter,0,1
31900,treatment,0,0
31901,for,0,0
31902,vaginal,1,1
31903,candidosis,1,1
31904,:,1,1
31905,comparison,0,0
31906,between,0,0
31907,single-dose,0,0
31908,oral,0,1
31909,fluconazole,0,1
31910,and,0,1
31911,three-day,0,0
31912,treatment,0,0
31913,with,0,1
31914,local,0,0
31915,miconazole,0,1
31916,.,0,1
31917,Fluconazole,0,0
31918,is,0,0
31919,an,0,0
31920,effective,0,0
31921,",",0,0
31922,simple,0,0
31923,and,0,0
31924,safe,0,0
31925,",",0,0
31926,although,0,0
31927,slightly,0,0
31928,expensive,0,0
31929,",",0,0
31930,agent,0,0
31931,for,0,0
31932,the,0,0
31933,treatment,0,0
31934,of,0,0
31935,vaginal,1,1
31936,candidosis,1,1
31937,.,1,1
31938,Single-dose,0,0
31939,fluconazole,0,0
31940,(,0,1
31941,150,0,1
31942,mg,0,1
31943,),0,1
31944,administered,0,0
31945,orally,0,0
31946,in,0,0
31947,capsule,0,0
31948,form,0,1
31949,was,0,0
31950,compared,0,0
31951,with,0,1
31952,three-day,0,1
31953,local,0,0
31954,treatment,0,1
31955,with,0,1
31956,miconazole,0,1
31957,pessaries,0,0
31958,in,0,1
31959,the,0,0
31960,treatment,1,0
31961,of,1,0
31962,vaginal,1,1
31963,candidosis,1,1
31964,in,1,0
31965,a,1,1
31966,randomized,1,1
31967,study,1,1
31968,in,1,1
31969,Finland,1,1
31970,.,1,1
31971,Cure,0,1
31972,rates,0,0
31973,were,0,1
31974,good,0,0
31975,(,0,1
31976,>,0,1
31977,80,0,1
31978,%,0,0
31979,),0,1
31980,in,0,0
31981,randomized,0,1
31982,patient,0,1
31983,groups,0,0
31984,assessed,0,0
31985,both,0,0
31986,clinically,0,0
31987,and,0,0
31988,by,0,0
31989,the,0,0
31990,results,0,0
31991,of,0,1
31992,yeast,0,1
31993,cultures,0,1
31994,.,0,1
31995,Oral,0,0
31996,administration,0,0
31997,was,0,0
31998,preferred,0,0
31999,to,0,1
32000,local,0,0
32001,therapy,0,1
32002,by,0,0
32003,patients,0,1
32004,in,0,1
32005,both,0,0
32006,the,0,0
32007,miconazole,0,0
32008,and,0,0
32009,fluconazole,0,1
32010,groups,0,1
32011,.,0,1
32012,For,0,0
32013,the,0,0
32014,time,0,0
32015,being,0,0
32016,",",0,0
32017,fluconazole,0,0
32018,is,0,0
32019,not,0,0
32020,recommended,0,0
32021,for,0,0
32022,use,0,0
32023,during,0,0
32024,pregnancy,0,1
32025,or,0,1
32026,lactation,0,1
32027,.,0,1
32028,Topical,0,1
32029,anti-inflammatory,0,1
32030,drugs,0,0
32031,in,0,1
32032,the,0,0
32033,treatment,0,0
32034,of,0,0
32035,allergic,1,1
32036,pollinosic,1,1
32037,conjunctivitis,1,1
32038,:,1,1
32039,a,0,0
32040,comparative,0,0
32041,double-blind,0,0
32042,study,0,1
32043,.,0,1
32044,Anti-inflammatory,0,0
32045,drugs,0,0
32046,",",0,1
32047,i.e,0,1
32048,.,0,1
32049,glucocorticosteroids,0,0
32050,and,0,1
32051,NSAIDs,0,1
32052,(,0,1
32053,nonsteroidal,0,1
32054,anti-inflammatory,0,1
32055,drugs,0,0
32056,),0,1
32057,",",0,0
32058,are,0,0
32059,often,0,0
32060,included,0,1
32061,in,0,0
32062,the,0,0
32063,treatment,0,0
32064,of,0,0
32065,allergic,1,1
32066,conjunctivitis,1,1
32067,.,1,1
32068,The,0,0
32069,present,0,0
32070,study,0,0
32071,compares,0,0
32072,the,0,0
32073,clinical,0,0
32074,efficacy,0,0
32075,and,0,0
32076,safety,0,0
32077,of,0,0
32078,topical,0,0
32079,hydrocortisone,0,1
32080,",",0,0
32081,acetylsalicylic,0,0
32082,acid,0,0
32083,(,0,1
32084,ASA,0,1
32085,),0,1
32086,and,0,0
32087,piroxicam,0,0
32088,compared,0,0
32089,to,0,0
32090,placebo,0,0
32091,.,0,0
32092,The,0,0
32093,trial,0,0
32094,",",0,0
32095,designed,0,0
32096,as,0,0
32097,a,0,0
32098,double-blind,0,0
32099,",",0,0
32100,randomized,0,1
32101,and,0,0
32102,parallel-group,0,0
32103,treatment,0,0
32104,",",0,0
32105,was,0,0
32106,carried,0,0
32107,out,0,1
32108,in,0,0
32109,a,0,0
32110,group,0,1
32111,of,0,0
32112,40,1,1
32113,patients,1,1
32114,suffering,1,1
32115,from,1,1
32116,seasonal,1,1
32117,allergic,1,1
32118,conjunctivitis,1,1
32119,due,1,1
32120,to,1,1
32121,Parietaria,1,1
32122,pollen,1,0
32123,",",1,0
32124,during,1,0
32125,the,1,0
32126,pollen,1,0
32127,season,1,1
32128,(,1,1
32129,June-July,1,0
32130,",",1,1
32131,1990,1,1
32132,),1,1
32133,.,1,1
32134,Patients,0,1
32135,received,0,1
32136,hydrocortisone,0,1
32137,0.1,0,0
32138,%,0,0
32139,solution,0,0
32140,",",0,1
32141,ASA,0,0
32142,1,0,0
32143,%,0,0
32144,solution,0,0
32145,",",0,0
32146,piroxicam,0,0
32147,0.5,0,0
32148,%,0,0
32149,solution,0,0
32150,or,0,1
32151,placebo,0,0
32152,as,0,0
32153,eye,0,1
32154,drops,0,0
32155,",",0,1
32156,all,0,1
32157,one,0,0
32158,drop,0,0
32159,in,0,0
32160,each,0,0
32161,eye,0,1
32162,q.i.d,0,0
32163,.,0,1
32164,for,0,0
32165,14,0,1
32166,days,0,0
32167,.,0,1
32168,The,0,0
32169,symptoms,0,0
32170,were,0,1
32171,evaluated,0,0
32172,at,0,0
32173,baseline,0,0
32174,and,0,0
32175,at,0,0
32176,the,0,0
32177,end,0,0
32178,of,0,0
32179,treatment,0,0
32180,by,0,0
32181,the,0,0
32182,clinician,0,0
32183,and,0,0
32184,by,0,0
32185,patients,0,1
32186,on,0,0
32187,a,0,1
32188,diary,0,0
32189,card,0,1
32190,.,0,1
32191,The,0,0
32192,hydrocortisone,0,0
32193,group,0,0
32194,showed,0,0
32195,a,0,0
32196,rapid,0,0
32197,and,0,0
32198,significant,0,0
32199,improvement,0,0
32200,during,0,0
32201,the,0,0
32202,first,0,0
32203,week,0,0
32204,of,0,0
32205,treatment,0,0
32206,",",0,0
32207,while,0,0
32208,ASA,0,0
32209,and,0,1
32210,piroxicam,0,0
32211,reduced,0,0
32212,symptomatology,0,0
32213,during,0,0
32214,the,0,0
32215,second,0,0
32216,week,0,0
32217,of,0,1
32218,treatment,0,0
32219,;,0,1
32220,this,0,0
32221,difference,0,0
32222,was,0,0
32223,statistically,0,0
32224,significant,0,0
32225,.,0,1
32226,At,0,0
32227,the,0,0
32228,end,0,0
32229,of,0,0
32230,the,0,0
32231,trial,0,0
32232,",",0,0
32233,the,0,0
32234,active,0,1
32235,drugs,0,0
32236,were,0,1
32237,comparable,0,0
32238,with,0,1
32239,regard,0,0
32240,to,0,1
32241,clinical,0,0
32242,efficacy,0,0
32243,.,0,1
32244,A,0,0
32245,statistically,0,0
32246,significant,0,0
32247,difference,0,0
32248,was,0,0
32249,observed,0,0
32250,between,0,0
32251,the,0,0
32252,active,0,1
32253,drugs,0,0
32254,and,0,1
32255,placebo,0,0
32256,",",0,0
32257,while,0,0
32258,no,0,0
32259,statistically,0,0
32260,significant,0,0
32261,difference,0,0
32262,was,0,0
32263,observed,0,0
32264,among,0,0
32265,the,0,1
32266,three,0,1
32267,drugs,0,0
32268,.,0,1
32269,No,0,0
32270,serious,0,0
32271,side-effects,0,0
32272,were,0,1
32273,observed,0,0
32274,.,0,1
32275,The,0,0
32276,results,0,0
32277,demonstrate,0,0
32278,the,0,0
32279,clinical,0,0
32280,efficacy,0,0
32281,of,0,1
32282,anti-inflammatory,0,0
32283,drugs,0,0
32284,in,0,1
32285,the,0,0
32286,treatment,0,0
32287,of,0,0
32288,pollen-induced,0,1
32289,allergic,0,1
32290,conjunctivitis,0,1
32291,;,0,0
32292,they,0,0
32293,also,0,0
32294,suggest,0,0
32295,the,0,0
32296,use,0,0
32297,of,0,0
32298,NSAIDs,0,1
32299,in,0,1
32300,long-term,0,0
32301,treatment,0,0
32302,",",0,0
32303,as,0,0
32304,their,0,0
32305,efficacy,0,0
32306,has,0,0
32307,been,0,0
32308,shown,0,0
32309,to,0,0
32310,be,0,0
32311,closely,0,0
32312,comparable,0,0
32313,to,0,0
32314,that,0,0
32315,of,0,0
32316,steroids,0,0
32317,",",0,1
32318,while,0,0
32319,avoiding,0,0
32320,the,0,0
32321,well-known,0,0
32322,side-effects,0,0
32323,of,0,1
32324,the,0,0
32325,latter,0,0
32326,in,0,0
32327,prolonged,0,0
32328,treatment,0,1
32329,.,0,1
32330,A,0,0
32331,randomized,0,0
32332,trial,0,0
32333,of,0,0
32334,a,0,0
32335,health,0,1
32336,care,0,1
32337,program,0,1
32338,for,0,0
32339,first-time,1,1
32340,adolescent,1,1
32341,mothers,1,1
32342,and,1,1
32343,their,1,1
32344,infants,1,1
32345,.,1,1
32346,To,0,0
32347,test,0,0
32348,the,0,0
32349,effectiveness,0,0
32350,of,0,0
32351,a,0,1
32352,special,0,1
32353,health,0,1
32354,care,0,1
32355,program,0,1
32356,for,0,1
32357,adolescent,1,1
32358,mothers,1,1
32359,(,1,1
32360,17,1,1
32361,years,1,1
32362,old,1,1
32363,or,1,1
32364,younger,1,1
32365,),1,1
32366,and,1,0
32367,their,1,1
32368,infants,1,1
32369,",",1,1
32370,243,1,1
32371,mother-infant,1,1
32372,pairs,1,1
32373,were,1,1
32374,randomly,1,1
32375,assigned,1,1
32376,to,0,0
32377,one,0,1
32378,of,0,1
32379,two,1,1
32380,groups,1,1
32381,.,1,1
32382,All,1,1
32383,of,1,0
32384,the,1,0
32385,mothers,1,1
32386,were,1,1
32387,unwed,1,1
32388,",",1,0
32389,on,1,0
32390,Medicaid,1,1
32391,",",1,1
32392,and,1,0
32393,black,1,1
32394,.,1,1
32395,The,0,0
32396,control,1,0
32397,group,1,0
32398,received,0,1
32399,routine,0,1
32400,well-baby,0,1
32401,care,0,1
32402,.,0,1
32403,The,0,0
32404,experimental,1,0
32405,group,1,1
32406,received,0,1
32407,routine,0,1
32408,care,0,1
32409,and,0,1
32410,services,0,1
32411,that,0,0
32412,included,0,1
32413,rigorous,0,0
32414,follow-up,0,0
32415,",",0,1
32416,discussions,0,0
32417,with,0,1
32418,the,0,0
32419,mother,0,1
32420,about,0,0
32421,her,0,1
32422,plans,0,1
32423,for,0,1
32424,return,0,1
32425,to,0,1
32426,school,0,1
32427,and,0,0
32428,use,0,0
32429,of,0,0
32430,family,0,1
32431,planning,0,0
32432,methods,0,1
32433,",",0,1
32434,and,0,1
32435,extra,0,0
32436,health,0,1
32437,teaching,0,1
32438,.,0,1
32439,The,0,0
32440,dropout,0,0
32441,rate,0,0
32442,in,0,0
32443,the,0,0
32444,experimental,0,0
32445,group,0,1
32446,(,0,1
32447,60,0,1
32448,%,0,0
32449,),0,1
32450,was,0,0
32451,significantly,0,0
32452,less,0,0
32453,after,0,1
32454,18,0,1
32455,months,0,1
32456,than,0,0
32457,the,0,0
32458,control,0,1
32459,group,0,1
32460,(,0,1
32461,82,0,1
32462,%,0,0
32463,),0,1
32464,.,0,1
32465,In,0,0
32466,spite,0,0
32467,of,0,0
32468,the,0,0
32469,high,0,1
32470,dropout,0,0
32471,rate,0,0
32472,",",0,0
32473,91,0,0
32474,%,0,0
32475,of,0,0
32476,the,0,0
32477,mothers,0,1
32478,were,0,1
32479,located,0,1
32480,for,0,0
32481,the,0,0
32482,18,0,1
32483,month,0,0
32484,follow-up,0,0
32485,interview,0,1
32486,.,0,1
32487,The,0,0
32488,repeat,0,0
32489,pregnancy,0,1
32490,rate,0,0
32491,in,0,0
32492,the,0,0
32493,experimental,0,0
32494,group,0,1
32495,was,0,0
32496,12,0,0
32497,%,0,0
32498,after,0,1
32499,18,0,1
32500,months,0,0
32501,",",0,1
32502,and,0,1
32503,28,0,1
32504,%,0,0
32505,in,0,0
32506,the,0,0
32507,control,0,1
32508,group,0,0
32509,.,0,0
32510,There,0,0
32511,was,0,0
32512,no,0,0
32513,significant,0,0
32514,difference,0,0
32515,in,0,0
32516,the,0,0
32517,percentage,0,0
32518,returning,0,0
32519,to,0,1
32520,school,0,1
32521,.,0,1
32522,After,0,0
32523,12,0,1
32524,months,0,0
32525,",",0,1
32526,the,0,0
32527,infants,0,1
32528,in,0,0
32529,the,0,1
32530,experimental,0,0
32531,group,0,0
32532,were,0,0
32533,more,0,0
32534,likely,0,0
32535,to,0,0
32536,be,0,0
32537,fully,0,0
32538,immunized,0,1
32539,(,0,0
32540,33,0,1
32541,%,0,0
32542,),0,1
32543,than,0,0
32544,the,0,0
32545,infants,0,1
32546,in,0,0
32547,the,0,0
32548,control,0,1
32549,group,0,1
32550,(,0,1
32551,18,0,1
32552,%,0,0
32553,),0,1
32554,.,0,1
32555,Mothers,0,1
32556,in,0,0
32557,the,0,1
32558,special,0,1
32559,care,0,1
32560,program,0,1
32561,who,0,1
32562,continued,0,1
32563,to,0,1
32564,attend,0,1
32565,clinic,0,1
32566,used,0,0
32567,the,0,0
32568,emergency,0,1
32569,room,0,0
32570,less,0,0
32571,than,0,0
32572,the,0,1
32573,mothers,0,1
32574,who,0,1
32575,continued,0,1
32576,to,0,1
32577,attend,0,1
32578,in,0,0
32579,the,0,0
32580,control,0,1
32581,group,0,0
32582,.,0,1
32583,These,0,0
32584,results,0,0
32585,suggest,0,0
32586,that,0,0
32587,a,0,1
32588,comprehensive,0,0
32589,health,0,1
32590,care,0,1
32591,program,0,1
32592,is,0,0
32593,one,0,0
32594,way,0,0
32595,to,0,0
32596,bring,0,0
32597,about,0,0
32598,better,0,0
32599,outcomes,0,0
32600,for,0,0
32601,both,0,0
32602,adolescent,0,1
32603,mothers,0,1
32604,and,0,1
32605,their,0,1
32606,infants,0,1
32607,.,0,1
32608,Desmopressin,0,0
32609,has,0,0
32610,no,0,0
32611,beneficial,0,0
32612,effect,0,0
32613,on,0,0
32614,excessive,0,0
32615,postoperative,0,1
32616,bleeding,1,1
32617,or,1,1
32618,blood,1,0
32619,product,1,0
32620,requirements,1,0
32621,associated,1,0
32622,with,1,1
32623,cardiopulmonary,1,1
32624,bypass,1,1
32625,.,1,1
32626,Cardiopulmonary,0,0
32627,bypass,0,1
32628,during,0,0
32629,open-heart,0,1
32630,surgery,0,1
32631,is,0,0
32632,sometimes,0,0
32633,associated,0,0
32634,with,0,1
32635,excessive,0,0
32636,perioperative,0,1
32637,bleeding,0,1
32638,.,0,1
32639,Following,0,0
32640,a,0,0
32641,non-randomized,0,1
32642,study,0,0
32643,suggesting,0,0
32644,that,0,0
32645,desmopressin,0,0
32646,acetate,0,0
32647,(,0,1
32648,desmopressin,0,0
32649,),0,1
32650,reduced,0,0
32651,blood,0,0
32652,product,0,0
32653,requirements,0,0
32654,in,0,1
32655,these,0,0
32656,patients,0,1
32657,",",0,0
32658,we,0,0
32659,conducted,0,0
32660,a,0,0
32661,double-blind,0,0
32662,",",0,0
32663,placebo-controlled,0,0
32664,randomized,0,1
32665,trial,0,1
32666,of,0,0
32667,desmopressin,0,0
32668,(,0,1
32669,0.3,0,0
32670,micrograms/kg,0,0
32671,",",0,0
32672,i.,0,1
32673,v.,0,0
32674,),0,1
32675,in,0,1
32676,92,1,1
32677,patients,1,1
32678,with,1,1
32679,overt,1,1
32680,bleeding,1,1
32681,and,1,0
32682,a,1,0
32683,prolonged,1,0
32684,bleeding,1,1
32685,time,1,0
32686,.,1,1
32687,Mean,0,1
32688,blood,0,0
32689,loss,0,0
32690,during,0,0
32691,the,0,0
32692,first,0,0
32693,24,0,1
32694,h,0,0
32695,post-treatment,0,0
32696,was,0,0
32697,similar,0,0
32698,in,0,0
32699,the,0,0
32700,desmopressin,0,0
32701,and,0,0
32702,placebo,0,1
32703,groups,0,1
32704,(,0,1
32705,582,0,1
32706,vs,0,0
32707,465,0,1
32708,ml,0,0
32709,",",0,0
32710,respectively,0,0
32711,;,0,0
32712,p,0,0
32713,=,0,0
32714,0.15,0,0
32715,),0,1
32716,.,0,1
32717,Red-cell,0,0
32718,(,0,0
32719,p,0,0
32720,=,0,1
32721,0.76,0,0
32722,),0,1
32723,",",0,1
32724,fresh,0,1
32725,frozen,0,1
32726,plasma,0,0
32727,(,0,1
32728,r,0,0
32729,=,0,1
32730,0.66,0,0
32731,),0,1
32732,and,0,1
32733,platelet,0,0
32734,unit,0,1
32735,(,0,1
32736,p,0,0
32737,=,0,1
32738,0.74,0,0
32739,),0,1
32740,requirements,0,1
32741,were,0,1
32742,also,0,0
32743,similar,0,0
32744,.,0,1
32745,The,0,0
32746,haemostatic,0,0
32747,effect,0,0
32748,of,0,0
32749,desmopressin,0,0
32750,has,0,0
32751,been,0,0
32752,attributed,0,0
32753,to,0,0
32754,the,0,0
32755,release,0,0
32756,of,0,0
32757,von,0,1
32758,Willebrand,0,1
32759,factor,0,0
32760,(,0,1
32761,vWF,0,1
32762,),0,1
32763,and,0,0
32764,a,0,1
32765,reduced,0,0
32766,bleeding,0,1
32767,time,0,0
32768,.,0,1
32769,In,0,0
32770,our,0,0
32771,study,0,0
32772,",",0,0
32773,vWF,0,1
32774,and,0,0
32775,factor,0,0
32776,VIII,0,1
32777,:,0,1
32778,C,0,1
32779,levels,0,0
32780,increased,0,0
32781,while,0,0
32782,the,0,0
32783,bleeding,0,1
32784,time,0,0
32785,decreased,0,0
32786,significantly,0,0
32787,at,0,0
32788,90,0,1
32789,min,0,0
32790,and,0,1
32791,24,0,1
32792,h,0,0
32793,in,0,0
32794,both,0,0
32795,groups,0,0
32796,and,0,0
32797,",",0,1
32798,although,0,0
32799,vWF,0,1
32800,and,0,1
32801,factor,0,0
32802,VIII,0,1
32803,:,0,1
32804,C,0,1
32805,levels,0,0
32806,were,0,1
32807,slightly,0,0
32808,higher,0,0
32809,in,0,0
32810,desmopressin-treated,0,0
32811,patients,0,1
32812,at,0,1
32813,90,0,1
32814,min,0,0
32815,",",0,0
32816,the,0,0
32817,difference,0,0
32818,was,0,0
32819,not,0,0
32820,significant,0,0
32821,.,0,1
32822,Thrombin-antithrombin,0,0
32823,III,0,1
32824,complex,0,0
32825,",",0,0
32826,fibrinogen,0,0
32827,degradation,0,0
32828,product,0,0
32829,and,0,0
32830,tissue,0,1
32831,plasminogen,0,1
32832,activator,0,0
32833,levels,0,0
32834,",",0,1
32835,reflecting,0,0
32836,activation,0,0
32837,of,0,0
32838,the,0,0
32839,coagulation,0,1
32840,and,0,0
32841,fibrinolytic,0,0
32842,systems,0,0
32843,",",0,0
32844,respectively,0,0
32845,",",0,0
32846,decreased,0,0
32847,uniformly,0,0
32848,in,0,0
32849,both,0,0
32850,groups,0,0
32851,.,0,1
32852,We,0,0
32853,conclude,0,0
32854,that,0,0
32855,desmopressin,0,0
32856,is,0,0
32857,not,0,0
32858,useful,0,0
32859,in,0,0
32860,reducing,0,0
32861,blood,0,0
32862,loss,0,0
32863,or,0,1
32864,blood,0,0
32865,product,0,0
32866,requirements,0,1
32867,in,0,1
32868,patients,1,1
32869,with,1,1
32870,excessive,1,1
32871,immediate,1,0
32872,postoperative,1,1
32873,bleeding,1,1
32874,.,1,1
32875,Prevention,0,1
32876,of,0,0
32877,acute,0,1
32878,postoperative,0,0
32879,pressure,0,0
32880,rises,0,0
32881,in,0,0
32882,glaucoma,1,1
32883,patients,1,1
32884,undergoing,1,1
32885,cataract,1,1
32886,extraction,1,1
32887,with,1,1
32888,posterior,1,1
32889,chamber,1,1
32890,lens,1,1
32891,implant,1,1
32892,.,1,1
32893,Acute,0,0
32894,elevations,0,0
32895,in,0,1
32896,intraocular,0,1
32897,pressure,0,0
32898,(,0,1
32899,IOP,0,1
32900,),0,0
32901,commonly,0,0
32902,follow,0,0
32903,extracapsular,0,0
32904,cataract,0,1
32905,extraction,0,0
32906,and,0,0
32907,lens,0,1
32908,implant,0,0
32909,in,0,0
32910,glaucoma,1,1
32911,patients,1,1
32912,.,1,1
32913,Thirty,1,1
32914,six,1,1
32915,patients,1,1
32916,with,1,1
32917,glaucoma,1,1
32918,undergoing,1,1
32919,cataract,1,1
32920,extraction,1,1
32921,and,1,0
32922,posterior,1,0
32923,chamber,1,0
32924,lens,1,1
32925,implantation,1,0
32926,received,0,0
32927,one,0,1
32928,of,0,1
32929,three,0,1
32930,treatments,0,0
32931,.,0,1
32932,Group,0,1
32933,1,0,1
32934,:,0,1
32935,500,0,1
32936,mg,0,0
32937,of,0,1
32938,Diamox,0,0
32939,Sustets,0,1
32940,(,0,1
32941,acetazolamide,0,0
32942,),0,1
32943,1,0,0
32944,hour,0,0
32945,preoperatively,0,1
32946,(,0,1
32947,10,0,1
32948,patients,0,1
32949,),0,1
32950,;,0,1
32951,Group,0,1
32952,2,0,1
32953,:,0,1
32954,peroperative,0,1
32955,intracameral,0,0
32956,Miochol,0,1
32957,(,0,1
32958,acetylcholine,0,0
32959,),0,1
32960,(,0,1
32961,11,0,1
32962,patients,0,1
32963,),0,1
32964,;,0,1
32965,Group,0,1
32966,3,0,1
32967,:,0,1
32968,the,0,0
32969,above,0,0
32970,treatments,0,0
32971,combined,0,1
32972,(,0,1
32973,15,0,1
32974,patients,0,1
32975,),0,1
32976,.,0,1
32977,IOPs,0,0
32978,were,0,0
32979,measured,0,0
32980,at,0,0
32981,3,0,1
32982,",",0,1
32983,6,0,0
32984,",",0,0
32985,9,0,0
32986,",",0,0
32987,and,0,1
32988,24,0,1
32989,hours,0,0
32990,postoperatively,0,0
32991,.,0,1
32992,The,0,0
32993,average,0,0
32994,of,0,0
32995,the,0,0
32996,maximum,0,0
32997,pressure,0,0
32998,rises,0,0
32999,above,0,0
33000,the,0,0
33001,preoperative,0,0
33002,level,0,0
33003,over,0,0
33004,the,0,0
33005,24,0,1
33006,hour,0,0
33007,period,0,0
33008,was,0,0
33009,greatest,0,0
33010,for,0,0
33011,the,0,0
33012,group,0,0
33013,receiving,0,1
33014,acetazolamide,0,0
33015,only,0,0
33016,at,0,1
33017,8.9,0,0
33018,mm,0,1
33019,Hg,0,1
33020,;,0,1
33021,for,0,0
33022,the,0,0
33023,acetylcholine,0,0
33024,group,0,0
33025,the,0,0
33026,average,0,0
33027,maximum,0,0
33028,rise,0,0
33029,was,0,0
33030,6.3,0,0
33031,mm,0,1
33032,Hg,0,1
33033,;,0,1
33034,while,0,0
33035,the,0,0
33036,combined,0,0
33037,treatment,0,0
33038,group,0,1
33039,showed,0,0
33040,a,0,0
33041,decrease,0,0
33042,of,0,0
33043,0.7,0,0
33044,mm,0,1
33045,Hg,0,1
33046,.,0,1
33047,IOP,0,0
33048,rises,0,0
33049,of,0,0
33050,>,0,1
33051,6,0,1
33052,mm,0,1
33053,Hg,0,1
33054,were,0,1
33055,seen,0,0
33056,in,0,1
33057,7,0,1
33058,%,0,0
33059,of,0,1
33060,patients,0,1
33061,(,0,1
33062,one,0,1
33063,of,0,1
33064,15,0,1
33065,),0,1
33066,in,0,0
33067,the,0,0
33068,combined,0,0
33069,treatment,0,0
33070,group,0,1
33071,",",0,0
33072,45,0,1
33073,%,0,0
33074,(,0,1
33075,five,0,1
33076,of,0,1
33077,11,0,1
33078,),0,1
33079,of,0,0
33080,the,0,0
33081,acetylcholine,0,0
33082,group,0,0
33083,",",0,0
33084,and,0,0
33085,70,0,1
33086,%,0,0
33087,(,0,1
33088,seven,0,1
33089,of,0,1
33090,10,0,1
33091,),0,1
33092,of,0,0
33093,the,0,0
33094,acetazolamide,0,0
33095,group,0,1
33096,.,0,1
33097,IOP,0,0
33098,rises,0,0
33099,of,0,0
33100,>,0,1
33101,10,0,1
33102,mm,0,1
33103,Hg,0,1
33104,were,0,1
33105,seen,0,0
33106,in,0,1
33107,7,0,1
33108,%,0,0
33109,of,0,0
33110,the,0,0
33111,combined,0,0
33112,treatment,0,0
33113,group,0,0
33114,",",0,0
33115,in,0,0
33116,18,0,1
33117,%,0,0
33118,of,0,0
33119,the,0,0
33120,acetylcholine,0,0
33121,only,0,0
33122,group,0,0
33123,",",0,0
33124,and,0,0
33125,in,0,0
33126,50,0,1
33127,%,0,0
33128,of,0,0
33129,the,0,0
33130,acetazolamide,0,0
33131,only,0,0
33132,group,0,1
33133,.,0,0
33134,A,0,0
33135,pressure,0,0
33136,rise,0,0
33137,>,0,1
33138,20,0,0
33139,mm,0,0
33140,Hg,0,1
33141,was,0,0
33142,seen,0,0
33143,in,0,1
33144,one,0,1
33145,patient,0,1
33146,receiving,0,1
33147,acetazolamide,0,0
33148,only,0,0
33149,and,0,1
33150,one,0,1
33151,patient,0,1
33152,receiving,0,1
33153,acetylcholine,0,0
33154,only,0,0
33155,.,0,0
33156,The,0,0
33157,difference,0,0
33158,between,0,0
33159,the,0,0
33160,acetylcholine,0,0
33161,group,0,0
33162,and,0,0
33163,the,0,0
33164,combined,0,0
33165,group,0,1
33166,for,0,0
33167,rises,0,0
33168,>,0,1
33169,6,0,0
33170,mm,0,1
33171,Hg,0,1
33172,was,0,0
33173,significant,0,0
33174,using,0,0
33175,the,0,0
33176,chi,0,0
33177,2,0,0
33178,test,0,0
33179,while,0,0
33180,the,0,0
33181,acetazolamide,0,0
33182,group,0,0
33183,showed,0,0
33184,a,0,0
33185,significant,0,0
33186,difference,0,0
33187,for,0,0
33188,rises,0,0
33189,>,0,1
33190,6,0,0
33191,and,0,1
33192,10,0,1
33193,mm,0,1
33194,Hg,0,0
33195,compared,0,0
33196,with,0,1
33197,the,0,0
33198,combined,0,0
33199,group,0,0
33200,.,0,1
33201,All,0,1
33202,acute,0,1
33203,pressure,0,0
33204,rises,0,0
33205,were,0,1
33206,recorded,0,0
33207,before,0,0
33208,or,0,1
33209,at,0,1
33210,9,0,1
33211,hours,0,0
33212,following,0,0
33213,operation,0,1
33214,except,0,0
33215,in,0,0
33216,the,0,0
33217,combined,0,0
33218,treatment,0,0
33219,patient,0,0
33220,where,0,0
33221,the,0,0
33222,rise,0,0
33223,occurred,0,0
33224,at,0,1
33225,24,0,1
33226,hours,0,1
33227,.,0,1
33228,To,0,0
33229,prevent,0,0
33230,the,0,0
33231,acute,0,1
33232,IOP,0,1
33233,rises,0,0
33234,seen,0,0
33235,following,0,0
33236,cataract,0,1
33237,surgery,0,1
33238,with,0,1
33239,lens,0,1
33240,implant,0,1
33241,in,0,0
33242,glaucoma,1,1
33243,patients,1,1
33244,we,0,0
33245,recommend,0,0
33246,combined,0,0
33247,ocular,0,1
33248,hypotensive,0,1
33249,therapy,0,1
33250,.,0,1
33251,[,0,0
33252,Mitoxantrone,0,0
33253,(,0,1
33254,MTX,0,0
33255,),0,1
33256,versus,0,0
33257,mitomycin,0,0
33258,C,0,1
33259,(,0,1
33260,MMC,0,1
33261,),0,1
33262,in,0,0
33263,the,0,0
33264,ablative,0,1
33265,treatment,0,0
33266,of,1,0
33267,Ta,1,1
33268,",",1,1
33269,T1,1,0
33270,superficial,1,1
33271,bladder,1,1
33272,tumors,1,1
33273,.,1,1
33274,Phase,0,0
33275,III,0,1
33276,",",0,0
33277,randomized,0,1
33278,prospective,0,1
33279,study,0,1
33280,],0,1
33281,.,0,1
33282,A,0,0
33283,prospective,0,1
33284,randomized,0,1
33285,study,0,1
33286,was,0,0
33287,conducted,0,0
33288,to,0,0
33289,determine,0,0
33290,the,0,0
33291,ablation,0,0
33292,capacity,0,0
33293,of,0,0
33294,mitoxantrone,0,0
33295,in,0,1
33296,Ta-T1,0,1
33297,superficial,0,1
33298,bladder,0,1
33299,tumors,0,1
33300,versus,0,0
33301,mitomycin,0,0
33302,C,0,0
33303,",",0,0
33304,a,0,0
33305,drug,0,0
33306,whose,0,1
33307,intravesical,0,1
33308,ablation,0,1
33309,properties,0,0
33310,are,0,0
33311,well-known,0,0
33312,.,0,1
33313,Fifty-seven,1,1
33314,patients,1,1
33315,comprised,0,1
33316,the,0,0
33317,study,0,0
33318,.,0,0
33319,The,0,0
33320,tumor,0,0
33321,was,0,0
33322,not,0,0
33323,completely,0,0
33324,resected,0,0
33325,when,0,0
33326,the,0,0
33327,patient,0,0
33328,underwent,0,1
33329,TUR,0,1
33330,.,0,1
33331,This,0,0
33332,residual,0,0
33333,tumor,0,1
33334,was,0,0
33335,used,0,0
33336,as,0,0
33337,control,0,1
33338,.,0,1
33339,The,0,0
33340,patients,0,1
33341,were,0,1
33342,treated,0,1
33343,with,0,1
33344,either,0,1
33345,20,0,1
33346,mg,0,0
33347,Mitoxantrone,0,1
33348,or,0,1
33349,40,0,1
33350,mg,0,1
33351,mitomycin,0,1
33352,C,0,1
33353,weekly,0,1
33354,for,0,1
33355,8,0,1
33356,weeks,0,1
33357,and,0,1
33358,two,0,1
33359,other,0,1
33360,instillations,0,0
33361,every,0,1
33362,15,0,1
33363,days,0,0
33364,in,0,1
33365,50,0,1
33366,ml,0,0
33367,saline,0,0
33368,solution,0,1
33369,.,0,1
33370,Response,0,0
33371,to,0,0
33372,therapy,0,0
33373,was,0,0
33374,evaluated,0,0
33375,between,0,0
33376,the,0,0
33377,4th,0,1
33378,and,0,1
33379,8th,0,1
33380,week,0,0
33381,and,0,0
33382,classified,0,1
33383,as,0,0
33384,complete,0,1
33385,response,0,0
33386,(,0,1
33387,CR,0,1
33388,),0,1
33389,",",0,0
33390,defined,0,0
33391,as,0,0
33392,no,0,0
33393,gross,0,0
33394,and,0,0
33395,microscopic,0,0
33396,evidence,0,0
33397,of,0,0
33398,residual,0,0
33399,tumor,0,1
33400,",",0,0
33401,or,0,0
33402,no,0,0
33403,response,0,0
33404,(,0,0
33405,NR,0,1
33406,),0,1
33407,or,0,1
33408,therapeutic,0,0
33409,failure,0,1
33410,.,0,1
33411,CR,0,0
33412,was,0,0
33413,observed,0,0
33414,in,0,1
33415,77.7,0,1
33416,%,0,0
33417,of,0,0
33418,the,0,0
33419,patients,0,1
33420,treated,0,1
33421,with,0,1
33422,mitomycin,0,0
33423,C,0,1
33424,and,0,1
33425,in,0,1
33426,50,0,1
33427,%,0,0
33428,in,0,0
33429,those,0,1
33430,that,0,0
33431,had,0,1
33432,been,0,0
33433,treated,0,1
33434,with,0,1
33435,Mitoxantrone,0,1
33436,.,0,1
33437,Treatment,0,0
33438,was,0,0
33439,discontinued,0,0
33440,because,0,0
33441,of,0,0
33442,side,0,0
33443,effects,0,0
33444,in,0,1
33445,15,0,1
33446,%,0,0
33447,of,0,0
33448,the,0,0
33449,patients,0,1
33450,treated,0,1
33451,with,0,1
33452,mitomycin,0,0
33453,C,0,1
33454,and,0,1
33455,in,0,1
33456,63.4,0,1
33457,%,0,0
33458,of,0,1
33459,those,0,1
33460,who,0,1
33461,received,0,1
33462,Mitoxantrone,0,1
33463,.,0,0
33464,We,0,0
33465,can,0,0
33466,conclude,0,0
33467,from,0,0
33468,the,0,0
33469,results,0,0
33470,of,0,0
33471,the,0,1
33472,present,0,0
33473,study,0,1
33474,that,0,0
33475,Mitoxantrone,0,0
33476,is,0,0
33477,a,0,0
33478,useful,0,0
33479,agent,0,0
33480,for,0,0
33481,ablation,0,1
33482,therapy,0,0
33483,of,0,0
33484,superficial,1,1
33485,bladder,1,1
33486,tumors,1,1
33487,",",0,0
33488,although,0,0
33489,the,0,0
33490,high,0,1
33491,incidence,0,0
33492,of,0,0
33493,severe,0,1
33494,side,0,0
33495,effects,0,0
33496,warrants,0,0
33497,its,0,0
33498,limited,0,1
33499,use,0,0
33500,and,0,1
33501,at,0,1
33502,high,0,1
33503,dilutions,0,1
33504,.,0,1
33505,[,0,0
33506,Unstable,0,1
33507,angina,0,1
33508,:,0,1
33509,comparison,0,0
33510,of,0,0
33511,the,0,0
33512,effects,0,0
33513,of,0,0
33514,diltiazem,0,0
33515,and,0,1
33516,propranolol,0,0
33517,],0,1
33518,.,0,1
33519,PURPOSE,0,0
33520,To,0,0
33521,evaluate,0,0
33522,the,0,0
33523,effects,0,0
33524,of,0,0
33525,diltiazem,0,0
33526,and,0,0
33527,propranolol,0,0
33528,in,0,0
33529,patients,1,1
33530,with,1,1
33531,unstable,1,1
33532,angina,1,1
33533,.,1,1
33534,METHODS,0,0
33535,Fifty-six,1,1
33536,patients,1,1
33537,with,1,1
33538,unstable,1,1
33539,angina,1,1
33540,",",1,0
33541,mean,1,0
33542,age,1,1
33543,of,1,1
33544,55.4,1,1
33545,+/-,1,1
33546,8.5,1,0
33547,",",1,1
33548,41,1,1
33549,men,1,1
33550,and,1,1
33551,15,1,1
33552,women,1,1
33553,",",0,1
33554,were,0,1
33555,evaluated,0,0
33556,in,0,0
33557,a,0,0
33558,randomized,0,1
33559,",",0,0
33560,double-blind,0,0
33561,study,0,1
33562,of,0,1
33563,two,0,1
33564,groups,0,1
33565,of,0,1
33566,patients,0,1
33567,treated,0,1
33568,with,0,1
33569,diltiazem,0,0
33570,or,0,1
33571,propranolol,0,0
33572,at,0,1
33573,total,0,1
33574,daily,0,0
33575,doses,0,0
33576,of,0,1
33577,180,0,1
33578,mg,0,1
33579,and,0,1
33580,120,0,1
33581,mg,0,0
33582,respectively,0,0
33583,during,0,0
33584,the,0,0
33585,first,0,1
33586,48,0,1
33587,hours,0,0
33588,.,0,1
33589,After,0,0
33590,that,0,0
33591,the,0,0
33592,total,0,1
33593,daily,0,0
33594,doses,0,0
33595,was,0,0
33596,adjusted,0,0
33597,to,0,1
33598,240,0,1
33599,mg,0,1
33600,and,0,1
33601,160,0,1
33602,mg,0,0
33603,",",0,0
33604,respectively,0,0
33605,",",0,0
33606,until,0,0
33607,the,0,0
33608,7th,0,0
33609,day,0,0
33610,.,0,1
33611,The,0,0
33612,first,0,0
33613,48,0,1
33614,hours,0,0
33615,",",0,1
33616,four,0,1
33617,times,0,0
33618,daily,0,0
33619,",",0,0
33620,clinical,0,0
33621,evaluation,0,0
33622,",",0,0
33623,CKMB,0,0
33624,data,0,0
33625,",",0,0
33626,ECG,0,0
33627,were,0,1
33628,obtained,0,0
33629,and,0,1
33630,two,0,0
33631,times,0,0
33632,daily,0,0
33633,until,0,1
33634,7th,0,1
33635,day,0,0
33636,.,0,1
33637,A,0,0
33638,coronary,0,1
33639,arteriography,0,1
33640,was,0,0
33641,done,0,0
33642,on,0,0
33643,study,0,1
33644,entry,0,1
33645,.,0,1
33646,RESULTS,0,0
33647,A,0,0
33648,significative,0,0
33649,reduction,0,0
33650,of,0,0
33651,angina,0,1
33652,crisis,0,1
33653,number,0,0
33654,",",0,0
33655,duration,0,0
33656,",",0,0
33657,intensity,0,0
33658,and,0,0
33659,the,0,0
33660,number,0,0
33661,of,0,0
33662,sublingual,0,1
33663,nitrates,0,1
33664,doses,0,1
33665,were,0,1
33666,observed,0,0
33667,equally,0,0
33668,in,0,0
33669,both,0,0
33670,groups,0,0
33671,.,0,1
33672,The,0,0
33673,SAP,0,0
33674,",",0,0
33675,DAP,0,0
33676,",",0,0
33677,HR,0,0
33678,and,0,1
33679,RR,0,1
33680,did,0,0
33681,not,0,0
33682,show,0,0
33683,statistical,0,0
33684,differences,0,0
33685,between,0,1
33686,groups,0,1
33687,.,0,1
33688,Individual,0,0
33689,groups,0,0
33690,analysis,0,0
33691,showed,0,0
33692,significative,0,0
33693,reductions,0,0
33694,of,0,1
33695,SAP,0,1
33696,",",0,1
33697,DAP,0,0
33698,and,0,0
33699,HR,0,0
33700,in,0,0
33701,propranolol,0,0
33702,group,0,1
33703,.,0,1
33704,The,0,0
33705,CKMB,0,0
33706,data,0,0
33707,",",0,1
33708,ECG,0,1
33709,alterations,0,0
33710,and,0,1
33711,coronary,0,1
33712,arteriography,0,1
33713,characteristics,0,1
33714,were,0,1
33715,similar,0,0
33716,.,0,1
33717,CONCLUSION,0,0
33718,Both,0,0
33719,drugs,0,0
33720,were,0,1
33721,effective,0,0
33722,for,0,0
33723,the,0,0
33724,unstable,0,1
33725,angina,0,1
33726,treatment,0,1
33727,.,0,1
33728,A,0,0
33729,prospective,0,0
33730,",",0,0
33731,placebo-controlled,0,0
33732,",",0,0
33733,randomized,0,1
33734,trial,0,0
33735,of,0,0
33736,intravenous,0,1
33737,streptokinase,0,1
33738,and,0,1
33739,angioplasty,0,1
33740,versus,0,0
33741,lone,0,1
33742,angioplasty,0,1
33743,therapy,0,0
33744,of,0,0
33745,acute,0,1
33746,myocardial,0,1
33747,infarction,0,1
33748,.,0,1
33749,BACKGROUND,0,0
33750,The,0,0
33751,value,0,0
33752,of,0,0
33753,routine,0,1
33754,administration,0,0
33755,of,0,0
33756,intravenous,0,1
33757,thrombolytic,0,1
33758,agents,0,1
33759,during,0,1
33760,percutaneous,0,1
33761,transluminal,0,1
33762,coronary,0,1
33763,angioplasty,0,1
33764,(,0,1
33765,PTCA,0,0
33766,),0,1
33767,therapy,0,0
33768,of,0,0
33769,acute,0,1
33770,myocardial,0,1
33771,infarction,0,1
33772,(,0,1
33773,MI,0,1
33774,),0,0
33775,has,0,0
33776,not,0,0
33777,been,0,0
33778,determined,0,0
33779,.,0,1
33780,Therefore,0,0
33781,",",0,0
33782,we,0,0
33783,prospectively,0,1
33784,randomized,0,1
33785,122,1,1
33786,patients,1,1
33787,with,1,1
33788,evolving,1,1
33789,MI,1,1
33790,to,1,1
33791,PTCA,1,0
33792,therapy,1,0
33793,with,1,1
33794,or,1,1
33795,without,1,1
33796,adjunctive,1,1
33797,intravenous,1,1
33798,streptokinase,1,1
33799,therapy,1,1
33800,.,1,1
33801,METHODS,0,0
33802,AND,0,0
33803,RESULTS,0,0
33804,Patients,1,1
33805,with,1,1
33806,ECG,1,1
33807,ST,1,1
33808,segment,1,1
33809,elevation,1,1
33810,who,1,1
33811,presented,1,1
33812,within,1,1
33813,4,1,0
33814,hours,1,0
33815,of,1,1
33816,symptom,1,1
33817,onset,1,1
33818,",",1,0
33819,had,1,0
33820,no,1,0
33821,contraindication,1,0
33822,to,1,0
33823,thrombolytic,1,0
33824,therapy,1,0
33825,",",1,0
33826,and,1,0
33827,were,1,0
33828,not,1,0
33829,in,1,0
33830,cardiogenic,1,1
33831,shock,1,1
33832,were,1,1
33833,enrolled,1,1
33834,.,1,1
33835,They,0,0
33836,were,0,0
33837,treated,0,1
33838,immediately,0,0
33839,with,0,1
33840,intravenous,0,1
33841,heparin,0,0
33842,(,0,1
33843,"10,000",0,1
33844,units,0,1
33845,),0,1
33846,and,0,1
33847,oral,0,1
33848,aspirin,0,0
33849,(,0,1
33850,325,0,1
33851,mg,0,1
33852,),0,1
33853,and,0,0
33854,randomized,0,1
33855,to,0,0
33856,treatment,0,0
33857,with,0,1
33858,placebo,0,0
33859,or,0,1
33860,streptokinase,0,0
33861,(,0,1
33862,1.5,0,1
33863,M,0,1
33864,units,0,1
33865,),0,1
33866,administered,0,0
33867,intravenously,0,1
33868,over,0,0
33869,30,0,1
33870,minutes,0,1
33871,.,0,1
33872,Patients,0,1
33873,then,0,0
33874,were,0,1
33875,taken,0,0
33876,immediately,0,0
33877,to,0,0
33878,the,0,0
33879,catheterization,0,0
33880,laboratory,0,0
33881,",",0,0
33882,and,0,0
33883,those,0,0
33884,with,0,1
33885,suitable,0,0
33886,coronary,0,1
33887,anatomy,0,1
33888,underwent,0,1
33889,immediate,0,0
33890,PTCA,0,1
33891,.,0,1
33892,Subsequent,0,0
33893,clinical,0,0
33894,course,0,0
33895,",",0,0
33896,serial,0,1
33897,radionuclide,0,0
33898,ventriculography,0,0
33899,",",0,0
33900,and,0,0
33901,6-month,0,0
33902,repeat,0,1
33903,angiography,0,1
33904,were,0,1
33905,analyzed,0,0
33906,.,0,1
33907,A,0,0
33908,total,0,1
33909,of,0,0
33910,106,1,1
33911,patients,1,1
33912,were,1,1
33913,treated,1,1
33914,with,1,1
33915,PTCA,1,0
33916,.,1,1
33917,Use,0,0
33918,of,0,0
33919,PTCA,0,0
33920,was,0,0
33921,similar,0,0
33922,for,0,0
33923,placebo,0,1
33924,(,0,1
33925,92,0,1
33926,%,0,0
33927,),0,1
33928,and,0,1
33929,streptokinase,0,0
33930,(,0,1
33931,83,0,1
33932,%,0,0
33933,),0,1
33934,groups,0,1
33935,.,0,1
33936,Angioplasty,0,0
33937,was,0,0
33938,successful,0,1
33939,in,0,1
33940,95,0,0
33941,%,0,0
33942,of,0,1
33943,patients,0,1
33944,",",0,1
33945,with,0,1
33946,no,0,0
33947,difference,0,0
33948,in,0,0
33949,placebo,0,0
33950,(,0,1
33951,93,0,1
33952,%,0,0
33953,),0,1
33954,and,0,1
33955,streptokinase,0,0
33956,(,0,1
33957,98,0,1
33958,%,0,0
33959,),0,1
33960,groups,0,1
33961,.,0,1
33962,Serial,0,1
33963,radionuclide,0,0
33964,ventriculography,0,0
33965,demonstrated,0,0
33966,no,0,0
33967,difference,0,0
33968,in,0,0
33969,24-hour,0,0
33970,(,0,1
33971,52,0,1
33972,+/-,0,1
33973,12,0,1
33974,%,0,0
33975,versus,0,0
33976,50,0,1
33977,+/-,0,0
33978,12,0,1
33979,%,0,0
33980,),0,1
33981,or,0,1
33982,6-week,0,0
33983,(,0,1
33984,51,0,1
33985,+/-,0,1
33986,12,0,1
33987,%,0,0
33988,versus,0,0
33989,51,0,1
33990,+/-,0,0
33991,13,0,1
33992,%,0,0
33993,),0,1
33994,ejection,0,1
33995,fraction,0,1
33996,values,0,0
33997,for,0,1
33998,placebo,0,1
33999,and,0,1
34000,streptokinase,0,0
34001,groups,0,0
34002,",",0,1
34003,respectively,0,0
34004,.,0,1
34005,Contrast,0,0
34006,ventriculography,0,0
34007,demonstrated,0,0
34008,improvement,0,0
34009,in,0,0
34010,immediate,0,0
34011,(,0,1
34012,54,0,1
34013,+/-,0,1
34014,12,0,1
34015,%,0,0
34016,),0,1
34017,versus,0,0
34018,6-month,0,1
34019,(,0,1
34020,60,0,1
34021,+/-,0,1
34022,15,0,1
34023,%,0,0
34024,",",0,0
34025,p,0,0
34026,<,0,0
34027,0.05,0,0
34028,),0,1
34029,values,0,0
34030,for,0,1
34031,the,0,1
34032,overall,0,0
34033,group,0,1
34034,.,0,1
34035,No,0,0
34036,differences,0,0
34037,in,0,1
34038,6-month,0,1
34039,values,0,0
34040,were,0,1
34041,present,0,1
34042,(,0,1
34043,58,0,1
34044,+/-,0,1
34045,15,0,1
34046,%,0,0
34047,versus,0,0
34048,62,0,1
34049,+/-,0,0
34050,15,0,1
34051,%,0,0
34052,",",0,0
34053,p,0,0
34054,=,0,0
34055,NS,0,0
34056,),0,1
34057,for,0,0
34058,placebo,0,0
34059,and,0,1
34060,streptokinase,0,0
34061,groups,0,0
34062,",",0,1
34063,respectively,0,0
34064,.,0,1
34065,Coronary,0,1
34066,angiography,0,0
34067,was,0,0
34068,performed,0,0
34069,in,0,1
34070,75,0,1
34071,%,0,0
34072,of,0,0
34073,the,0,1
34074,90,0,1
34075,patients,0,1
34076,eligible,0,1
34077,for,0,1
34078,restudy,0,0
34079,.,0,1
34080,Arterial,0,0
34081,patency,0,0
34082,was,0,0
34083,87,0,1
34084,%,0,0
34085,at,0,1
34086,6,0,1
34087,months,0,0
34088,",",0,1
34089,and,0,1
34090,coronary,0,1
34091,restenosis,0,1
34092,was,0,0
34093,present,0,0
34094,in,0,1
34095,38,0,1
34096,%,0,0
34097,of,0,1
34098,patients,0,1
34099,.,0,1
34100,No,0,0
34101,differences,0,0
34102,in,0,0
34103,chronic,0,1
34104,patency,0,0
34105,or,0,1
34106,restenosis,0,1
34107,were,0,0
34108,detected,0,0
34109,for,0,0
34110,the,0,0
34111,two,0,0
34112,treatment,0,1
34113,groups,0,1
34114,.,0,1
34115,Although,0,0
34116,adjunctive,0,0
34117,intravenous,0,1
34118,streptokinase,0,1
34119,therapy,0,0
34120,did,0,0
34121,not,0,0
34122,improve,0,0
34123,outcome,0,0
34124,",",0,0
34125,it,0,0
34126,did,0,0
34127,complicate,0,0
34128,the,0,0
34129,hospital,0,1
34130,course,0,0
34131,.,0,1
34132,Hospitalization,0,0
34133,was,0,0
34134,longer,0,0
34135,(,0,1
34136,9.3,0,0
34137,+/-,0,1
34138,5.0,0,0
34139,versus,0,0
34140,7.7,0,0
34141,+/-,0,1
34142,4.4,0,1
34143,days,0,0
34144,",",0,1
34145,p,0,0
34146,=,0,0
34147,0.046,0,0
34148,),0,0
34149,and,0,0
34150,more,0,0
34151,costly,0,0
34152,(,0,0
34153,$,0,1
34154,"25,191",0,1
34155,+/-,0,0
34156,"15,368",0,1
34157,versus,0,0
34158,$,0,1
34159,"19,643",0,1
34160,+/-,0,0
34161,"7,250",0,1
34162,",",0,1
34163,p,0,0
34164,<,0,0
34165,0.02,0,0
34166,),0,1
34167,.,0,1
34168,Transfusion,0,0
34169,rate,0,0
34170,was,0,0
34171,higher,0,0
34172,(,0,1
34173,39,0,1
34174,%,0,0
34175,versus,0,0
34176,8,0,1
34177,%,0,0
34178,",",0,0
34179,p,0,0
34180,=,0,1
34181,0.0001,0,0
34182,),0,1
34183,and,0,0
34184,need,0,0
34185,for,0,0
34186,emergency,0,1
34187,coronary,0,1
34188,bypass,0,1
34189,surgery,0,1
34190,was,0,0
34191,greater,0,0
34192,(,0,1
34193,10.3,0,0
34194,%,0,0
34195,versus,0,0
34196,1.6,0,0
34197,%,0,0
34198,",",0,0
34199,p,0,0
34200,=,0,1
34201,0.03,0,0
34202,),0,1
34203,for,0,0
34204,the,0,0
34205,streptokinase-treated,0,1
34206,patients,0,1
34207,.,0,1
34208,CONCLUSIONS,0,0
34209,Adjunctive,0,0
34210,intravenous,0,1
34211,streptokinase,0,0
34212,therapy,0,0
34213,does,0,0
34214,not,0,0
34215,enhance,0,0
34216,early,0,1
34217,preservation,0,0
34218,of,0,0
34219,ventricular,0,1
34220,function,0,0
34221,",",0,0
34222,improve,0,0
34223,arterial,0,1
34224,patency,0,0
34225,rates,0,0
34226,",",0,0
34227,or,0,1
34228,lower,0,0
34229,restenosis,0,1
34230,rates,0,0
34231,after,0,1
34232,PTCA,0,0
34233,therapy,0,1
34234,of,0,0
34235,acute,0,1
34236,MI,0,1
34237,.,0,1
34238,Hospital,0,0
34239,course,0,0
34240,is,0,0
34241,longer,0,0
34242,",",0,0
34243,more,0,0
34244,expensive,0,0
34245,",",0,0
34246,and,0,0
34247,more,0,0
34248,complicated,0,0
34249,.,0,0
34250,For,0,0
34251,these,0,0
34252,reasons,0,0
34253,",",0,0
34254,PTCA,0,0
34255,therapy,0,0
34256,of,0,0
34257,acute,0,1
34258,MI,0,1
34259,should,0,0
34260,not,0,0
34261,be,0,0
34262,routinely,0,0
34263,performed,0,0
34264,with,0,1
34265,adjunctive,0,1
34266,intravenous,0,1
34267,streptokinase,0,1
34268,therapy,0,1
34269,.,0,1
34270,Prospective,0,1
34271,study,0,1
34272,of,0,0
34273,short,0,1
34274,and,0,1
34275,ultrashort,0,1
34276,regimens,0,0
34277,of,0,1
34278,gonadotropin-releasing,0,0
34279,hormone,0,1
34280,agonist,0,1
34281,in,0,0
34282,an,0,0
34283,in,0,0
34284,vitro,0,0
34285,fertilization,0,1
34286,program,0,1
34287,.,0,1
34288,OBJECTIVE,0,0
34289,To,0,0
34290,assess,0,0
34291,the,0,0
34292,usefulness,0,0
34293,of,0,0
34294,the,0,0
34295,ultrashort,0,0
34296,regimen,0,0
34297,of,0,1
34298,gonadotropin-releasing,1,0
34299,hormone,1,1
34300,agonist,1,1
34301,(,1,1
34302,GnRH-a,1,1
34303,),1,1
34304,in,1,0
34305,ovulation,1,1
34306,induction,1,0
34307,in,1,0
34308,an,1,0
34309,in,1,0
34310,vitro,1,0
34311,fertilization,1,1
34312,(,1,1
34313,IVF,1,1
34314,),1,1
34315,program,1,1
34316,.,1,1
34317,DESIGN,0,0
34318,A,0,0
34319,prospective,0,0
34320,randomized,0,1
34321,trial,0,1
34322,comparing,0,0
34323,short,0,1
34324,and,0,1
34325,ultrashort,0,1
34326,regimens,0,0
34327,of,0,1
34328,GnRH-a,0,1
34329,.,0,1
34330,SETTING,0,1
34331,Aberdeen,0,1
34332,Assisted,0,1
34333,Reproduction,0,1
34334,Unit,0,1
34335,.,0,1
34336,PATIENTS,0,0
34337,Forty-eight,1,1
34338,patients,1,1
34339,having,1,1
34340,IVF,1,1
34341,for,1,0
34342,the,1,0
34343,first,1,0
34344,time,1,0
34345,were,1,1
34346,randomized,1,1
34347,between,0,0
34348,the,0,1
34349,two,0,1
34350,protocols,0,0
34351,.,0,1
34352,MAIN,0,0
34353,OUTCOME,0,1
34354,MEASURES,0,1
34355,Response,0,0
34356,to,0,1
34357,ovarian,0,1
34358,stimulation,0,0
34359,and,0,0
34360,occurrence,0,0
34361,of,0,0
34362,spontaneous,0,1
34363,luteinizing,0,0
34364,hormone,0,1
34365,(,0,1
34366,LH,0,1
34367,),0,1
34368,surges,0,1
34369,.,0,0
34370,RESULTS,0,0
34371,In,0,0
34372,ovulation,0,1
34373,induction,0,0
34374,",",0,0
34375,fertilization,0,0
34376,",",0,0
34377,and,0,0
34378,pregnancy,0,1
34379,rates,0,0
34380,the,0,1
34381,ultrashort,0,0
34382,regimen,0,0
34383,produces,0,0
34384,results,0,0
34385,that,0,0
34386,were,0,1
34387,no,0,0
34388,different,0,0
34389,to,0,0
34390,the,0,0
34391,short,0,1
34392,regimen,0,0
34393,but,0,0
34394,it,0,0
34395,did,0,0
34396,not,0,0
34397,always,0,0
34398,prevent,0,0
34399,an,0,0
34400,LH,0,0
34401,surge,0,0
34402,.,0,1
34403,CONCLUSION,0,0
34404,The,0,0
34405,ultrashort,0,0
34406,regimen,0,0
34407,can,0,0
34408,be,0,0
34409,a,0,0
34410,useful,0,0
34411,alternative,0,0
34412,for,0,0
34413,ovarian,0,1
34414,stimulation,0,0
34415,of,0,1
34416,patients,1,1
34417,undergoing,1,1
34418,IVF,1,1
34419,.,1,1
34420,Remifentanil,0,1
34421,with,0,1
34422,morphine,0,0
34423,transitional,0,1
34424,analgesia,0,0
34425,shortens,0,0
34426,neurological,0,0
34427,recovery,0,0
34428,compared,0,0
34429,to,0,0
34430,fentanyl,0,0
34431,for,0,0
34432,supratentorial,0,1
34433,craniotomy,0,1
34434,.,0,1
34435,PURPOSE,0,0
34436,To,0,0
34437,compare,0,0
34438,the,0,0
34439,recovery,0,0
34440,profiles,0,0
34441,",",0,1
34442,efficacy,0,0
34443,and,0,0
34444,safety,0,0
34445,of,0,0
34446,remifentanil,0,0
34447,and,0,0
34448,morphine,0,0
34449,for,0,0
34450,transitional,0,1
34451,analgesia,0,0
34452,with,0,1
34453,fentanyl,0,0
34454,in,0,1
34455,patients,1,1
34456,undergoing,1,1
34457,elective,1,1
34458,craniotomy,1,1
34459,for,1,0
34460,supratentorial,1,1
34461,mass,1,1
34462,lesions,1,1
34463,.,1,1
34464,METHODS,0,0
34465,Ninety-one,1,1
34466,patients,1,1
34467,were,0,1
34468,enrolled,0,1
34469,in,0,0
34470,this,0,0
34471,prospective,0,1
34472,",",0,0
34473,randomized,0,0
34474,",",0,0
34475,multicentre,0,1
34476,study,0,1
34477,.,0,1
34478,Anesthesia,0,0
34479,was,0,0
34480,induced,0,0
34481,with,0,1
34482,thiopental,0,0
34483,and,0,1
34484,remifentanil,0,0
34485,(,0,1
34486,1.0,0,0
34487,micro,0,1
34488,g,0,1
34489,x,0,1
34490,kg,0,1
34491,(,0,1
34492,-1,0,0
34493,),0,1
34494,bolus,0,0
34495,and,0,0
34496,a,0,1
34497,1,0,0
34498,micro,0,0
34499,g,0,1
34500,x,0,1
34501,kg,0,1
34502,(,0,1
34503,-1,0,0
34504,),0,1
34505,x,0,1
34506,min,0,0
34507,(,0,1
34508,-1,0,0
34509,),0,1
34510,infusion,0,0
34511,),0,1
34512,or,0,1
34513,fentanyl,0,0
34514,(,0,1
34515,1,0,0
34516,micro,0,1
34517,g,0,1
34518,x,0,1
34519,kg,0,1
34520,(,0,1
34521,-1,0,0
34522,),0,1
34523,bolus,0,0
34524,and,0,0
34525,a,0,1
34526,1.0,0,0
34527,micro,0,0
34528,g,0,1
34529,x,0,1
34530,kg,0,1
34531,(,0,1
34532,-1,0,0
34533,),0,1
34534,x,0,1
34535,min,0,0
34536,(,0,1
34537,-1,0,0
34538,),0,1
34539,infusion,0,0
34540,),0,1
34541,.,0,1
34542,The,0,0
34543,opioid,0,0
34544,infusion,0,0
34545,continued,0,0
34546,until,0,0
34547,the,0,0
34548,level,0,0
34549,of,0,0
34550,anesthesia,0,1
34551,was,0,0
34552,deemed,0,0
34553,appropriate,0,0
34554,for,0,1
34555,intubation,0,1
34556,.,0,1
34557,Anesthesia,0,0
34558,was,0,0
34559,maintained,0,0
34560,with,0,1
34561,N,0,1
34562,(,0,1
34563,2,0,1
34564,),0,1
34565,O/O,0,0
34566,(,0,1
34567,2,0,1
34568,),0,1
34569,",",0,1
34570,isoflurane,0,0
34571,0.5,0,0
34572,MAC,0,0
34573,and,0,1
34574,remifentanil,0,0
34575,0.2,0,0
34576,micro,0,0
34577,g,0,1
34578,x,0,1
34579,kg,0,1
34580,(,0,1
34581,-1,0,0
34582,),0,1
34583,x,0,1
34584,min,0,0
34585,(,0,1
34586,-1,0,0
34587,),0,1
34588,or,0,1
34589,fentanyl,0,0
34590,0.04,0,0
34591,micro,0,1
34592,g,0,1
34593,x,0,1
34594,kg,0,1
34595,(,0,1
34596,-1,0,0
34597,),0,1
34598,x,0,1
34599,min,0,0
34600,(,0,1
34601,-1,0,0
34602,),0,1
34603,.,0,1
34604,At,0,0
34605,bone,0,0
34606,flap,0,1
34607,replacement,0,0
34608,",",0,0
34609,either,0,0
34610,morphine,0,0
34611,0.08,0,0
34612,mg,0,0
34613,x,0,1
34614,kg,0,1
34615,(,0,1
34616,-1,0,0
34617,),0,1
34618,(,0,1
34619,remifentanil,0,0
34620,group,0,1
34621,),0,1
34622,or,0,1
34623,saline,0,0
34624,(,0,1
34625,fentanyl,0,0
34626,group,0,1
34627,),0,1
34628,was,0,0
34629,given,0,0
34630,.,0,1
34631,RESULTS,0,0
34632,Systolic,0,1
34633,blood,0,0
34634,pressure,0,0
34635,was,0,0
34636,greater,0,0
34637,in,0,0
34638,those,0,0
34639,receiving,0,1
34640,fentanyl,0,0
34641,during,0,0
34642,induction,0,1
34643,(,0,1
34644,145.6,0,0
34645,+/-17.5,0,0
34646,mmHg,0,0
34647,vs,0,0
34648,128.8,0,1
34649,+/-18.3,0,1
34650,mmHg,0,1
34651,;,0,1
34652,P,0,0
34653,=,0,1
34654,0.006,0,0
34655,),0,1
34656,and,0,1
34657,intubation,0,1
34658,(,0,1
34659,126.9,0,1
34660,+/-17.1,0,1
34661,vs,0,0
34662,110.9,0,0
34663,+/-16.5,0,1
34664,mmHg,0,1
34665,;,0,1
34666,P,0,0
34667,<,0,0
34668,0.001,0,0
34669,),0,1
34670,.,0,1
34671,Median,0,0
34672,time,0,0
34673,to,0,0
34674,tracheal,0,1
34675,extubation,0,1
34676,was,0,0
34677,similar,0,0
34678,but,0,0
34679,less,0,0
34680,variable,0,0
34681,in,0,0
34682,the,0,0
34683,remifentanil,0,0
34684,group,0,0
34685,(,0,1
34686,remifentanil,0,0
34687,=,0,1
34688,8,0,1
34689,min,0,0
34690,:,0,1
34691,range,0,1
34692,=,0,0
34693,2-44,0,0
34694,min,0,0
34695,;,0,1
34696,fentanyl,0,0
34697,=,0,1
34698,8,0,1
34699,min,0,0
34700,:,0,1
34701,range,0,1
34702,=,0,0
34703,1-732,0,0
34704,min,0,0
34705,),0,1
34706,.,0,1
34707,The,0,0
34708,fentanyl,0,0
34709,patients,0,1
34710,required,0,0
34711,a,0,1
34712,longer,0,0
34713,time,0,0
34714,to,0,0
34715,achieve,0,0
34716,the,0,0
34717,first,0,0
34718,normal,0,1
34719,neurological,0,1
34720,score,0,1
34721,(,0,1
34722,fentanyl,0,0
34723,=,0,1
34724,38.0,0,1
34725,min,0,0
34726,;,0,1
34727,remifentanil,0,0
34728,=,0,1
34729,26.0,0,1
34730,min,0,0
34731,;,0,1
34732,P,0,0
34733,=,0,1
34734,0.035,0,0
34735,),0,1
34736,.,0,1
34737,Both,0,0
34738,the,0,0
34739,anesthesiologists,0,1
34740,and,0,0
34741,the,0,0
34742,recovery,0,0
34743,room,0,1
34744,nurses,0,1
34745,rated,0,0
34746,remifentanil,0,0
34747,better,0,0
34748,with,0,1
34749,respect,0,0
34750,to,0,0
34751,level,0,0
34752,of,0,0
34753,consciousness,0,1
34754,.,0,1
34755,Analgesics,0,0
34756,were,0,0
34757,required,0,0
34758,earlier,0,0
34759,in,0,0
34760,patients,0,1
34761,receiving,0,1
34762,remifentanil,0,0
34763,;,0,1
34764,median,0,1
34765,time,0,0
34766,0.5,0,0
34767,vs,0,0
34768,1.08,0,0
34769,hr,0,0
34770,",",0,0
34771,P,0,0
34772,<,0,0
34773,0.001,0,0
34774,.,0,1
34775,CONCLUSIONS,0,0
34776,Remifentanil,0,0
34777,is,0,0
34778,a,0,0
34779,suitable,0,0
34780,alternative,0,0
34781,to,0,0
34782,fentanyl,0,0
34783,in,0,0
34784,supratentorial,0,1
34785,craniotomy,0,1
34786,.,0,1
34787,Time,0,0
34788,to,0,0
34789,preoperative,0,1
34790,neurological,0,0
34791,recovery,0,0
34792,is,0,0
34793,faster,0,0
34794,and,0,0
34795,morphine,0,0
34796,provides,0,0
34797,some,0,0
34798,transitional,0,0
34799,analgesia,0,0
34800,without,0,1
34801,compromising,0,0
34802,the,0,0
34803,quality,0,0
34804,of,0,0
34805,recovery,0,0
34806,.,0,1
34807,Intraperitoneal,0,1
34808,application,0,0
34809,of,0,0
34810,bupivacaine,0,0
34811,plus,0,0
34812,morphine,0,0
34813,for,0,0
34814,pain,0,1
34815,relief,0,0
34816,after,0,0
34817,laparoscopic,1,1
34818,cholecystectomy,1,1
34819,.,1,1
34820,BACKGROUND,0,0
34821,AND,0,0
34822,OBJECTIVE,0,1
34823,Intraperitoneal,0,1
34824,administration,0,0
34825,of,0,0
34826,a,0,1
34827,local,0,0
34828,anaesthetic,0,0
34829,in,0,0
34830,combination,0,0
34831,with,0,1
34832,an,0,0
34833,opioid,0,0
34834,",",0,0
34835,for,0,0
34836,the,0,0
34837,relief,0,0
34838,of,0,0
34839,postoperative,0,0
34840,pain,0,1
34841,",",0,0
34842,has,0,0
34843,already,0,0
34844,been,0,0
34845,reported,0,0
34846,except,0,0
34847,after,0,0
34848,laparoscopic,1,1
34849,cholecystectomy,1,1
34850,.,1,1
34851,This,0,0
34852,study,0,0
34853,was,0,0
34854,aimed,0,0
34855,at,0,0
34856,assessing,0,0
34857,the,0,0
34858,analgesic,0,0
34859,effect,0,0
34860,of,0,0
34861,the,0,0
34862,intraperitoneal,0,0
34863,administration,0,0
34864,of,0,0
34865,bupivacaine,0,0
34866,and,0,0
34867,morphine,0,0
34868,in,0,1
34869,patients,1,1
34870,undergoing,1,1
34871,laparoscopic,1,1
34872,cholecystectomy,1,1
34873,.,1,1
34874,METHODS,0,0
34875,At,0,0
34876,the,0,0
34877,end,0,0
34878,of,0,0
34879,laparoscopic,0,1
34880,cholecystectomy,0,1
34881,",",0,0
34882,in,0,0
34883,a,0,0
34884,double-blind,0,0
34885,",",0,0
34886,randomized,0,1
34887,manner,0,0
34888,",",0,0
34889,one,0,1
34890,of,0,0
34891,the,0,1
34892,following,0,0
34893,injections,0,0
34894,was,0,0
34895,given,0,0
34896,intraperitoneally,0,0
34897,.,0,0
34898,There,0,0
34899,were,0,0
34900,30,1,0
34901,patients,1,1
34902,in,1,1
34903,each,1,1
34904,group,1,1
34905,:,1,1
34906,Group,0,1
34907,1,0,0
34908,",",0,1
34909,physiological,0,0
34910,saline,0,0
34911,30,0,1
34912,mL,0,1
34913,;,0,1
34914,Group,0,1
34915,2,0,0
34916,",",0,1
34917,bupivacaine,0,0
34918,0.25,0,0
34919,%,0,0
34920,30,0,1
34921,mL,0,1
34922,;,0,1
34923,Group,0,1
34924,3,0,0
34925,",",0,1
34926,bupivacaine,0,0
34927,0.25,0,0
34928,%,0,0
34929,30,0,1
34930,mL,0,0
34931,plus,0,0
34932,morphine,0,0
34933,2,0,1
34934,mg,0,1
34935,.,0,1
34936,In,0,0
34937,addition,0,0
34938,",",0,1
34939,Group,0,1
34940,2,0,1
34941,received,0,1
34942,2,0,1
34943,mg,0,1
34944,intravenous,0,1
34945,(,0,1
34946,i.v,0,0
34947,.,0,1
34948,),0,0
34949,morphine,0,0
34950,in,0,1
34951,2,0,1
34952,mL,0,0
34953,saline,0,0
34954,",",0,1
34955,and,0,0
34956,Groups,0,1
34957,1,0,1
34958,and,0,1
34959,3,0,1
34960,",",0,1
34961,2,0,1
34962,mL,0,0
34963,saline,0,0
34964,intravenously,0,1
34965,.,0,1
34966,Patients,0,1
34967,',0,1
34968,postoperative,0,1
34969,pain,0,1
34970,was,0,0
34971,evaluated,0,0
34972,using,0,0
34973,a,0,0
34974,visual,0,0
34975,analogue,0,0
34976,scale,0,0
34977,and,0,0
34978,a,0,0
34979,verbal,0,0
34980,rating,0,0
34981,score,0,0
34982,.,0,1
34983,The,0,0
34984,postoperative,0,0
34985,analgesic,0,0
34986,requirement,0,1
34987,was,0,0
34988,assessed,0,0
34989,by,0,0
34990,the,0,0
34991,total,0,1
34992,dose,0,0
34993,of,0,0
34994,metamizol,0,0
34995,administered,0,0
34996,by,0,0
34997,an,0,1
34998,i.v,0,0
34999,.,0,1
35000,patient-controlled,0,0
35001,analgesia,0,0
35002,(,0,1
35003,PCA,0,1
35004,),0,1
35005,device,0,0
35006,.,0,1
35007,Pain,0,0
35008,",",0,0
35009,vital,0,0
35010,signs,0,1
35011,",",0,1
35012,supplemental,0,1
35013,analgesic,0,0
35014,consumption,0,0
35015,and,0,1
35016,side-effects,0,0
35017,were,0,1
35018,recorded,0,0
35019,for,0,0
35020,all,0,1
35021,patients,0,1
35022,for,0,1
35023,24,0,1
35024,h.,0,1
35025,RESULTS,0,0
35026,There,0,0
35027,were,0,0
35028,no,0,0
35029,differences,0,0
35030,between,0,0
35031,the,0,1
35032,three,0,0
35033,groups,0,0
35034,regarding,0,0
35035,pain,0,1
35036,scores,0,0
35037,(,0,1
35038,at,0,1
35039,rest,0,0
35040,and,0,1
35041,coughing,0,1
35042,),0,0
35043,during,0,0
35044,the,0,0
35045,study,0,0
35046,except,0,0
35047,in,0,0
35048,the,0,1
35049,first,0,0
35050,2,0,1
35051,h,0,0
35052,",",0,0
35053,when,0,0
35054,scores,0,0
35055,were,0,0
35056,lower,0,0
35057,for,0,1
35058,patients,0,1
35059,receiving,0,1
35060,intraperitoneal,0,0
35061,bupivacaine,0,0
35062,plus,0,0
35063,i.v,0,0
35064,.,0,1
35065,morphine,0,0
35066,(,0,0
35067,P,0,0
35068,<,0,0
35069,0.05,0,0
35070,),0,1
35071,.,0,1
35072,Supplemental,0,0
35073,consumption,0,0
35074,of,0,0
35075,metamizol,0,0
35076,was,0,0
35077,significantly,0,0
35078,lower,0,0
35079,(,0,0
35080,P,0,0
35081,<,0,0
35082,0.05,0,0
35083,),0,1
35084,in,0,1
35085,Group,0,1
35086,3,0,1
35087,than,0,0
35088,in,0,1
35089,Group,0,1
35090,1,0,1
35091,during,0,0
35092,the,0,0
35093,first,0,0
35094,6,0,0
35095,h,0,0
35096,after,0,1
35097,surgery,0,1
35098,.,0,1
35099,However,0,0
35100,",",0,0
35101,the,0,0
35102,cumulative,0,0
35103,doses,0,0
35104,of,0,1
35105,metamizol,0,0
35106,were,0,0
35107,also,0,0
35108,lower,0,0
35109,in,0,0
35110,Group,0,1
35111,2,0,1
35112,than,0,0
35113,in,0,1
35114,Groups,0,1
35115,1,0,1
35116,and,0,1
35117,3,0,1
35118,over,0,0
35119,the,0,0
35120,entire,0,1
35121,study,0,1
35122,(,0,1
35123,2025,0,1
35124,+/-,0,0
35125,1044,0,1
35126,mg,0,1
35127,vs.,0,0
35128,4925,0,1
35129,+/-,0,1
35130,1238,0,1
35131,and,0,1
35132,4125,0,1
35133,+/-,0,1
35134,1276mg,0,1
35135,;,0,1
35136,P,0,0
35137,<,0,0
35138,0.05,0,0
35139,),0,1
35140,.,0,1
35141,CONCLUSIONS,0,0
35142,In,0,1
35143,patients,1,1
35144,undergoing,1,1
35145,laparoscopic,1,1
35146,cholecystectomy,1,1
35147,",",0,0
35148,the,0,0
35149,intraperitoneal,0,0
35150,administration,0,0
35151,of,0,0
35152,morphine,0,0
35153,plus,0,0
35154,bupivacaine,0,0
35155,0.25,0,0
35156,%,0,0
35157,reduced,0,0
35158,the,0,0
35159,analgesic,0,0
35160,requirements,0,0
35161,during,0,1
35162,the,0,1
35163,first,0,0
35164,6,0,1
35165,postoperative,0,1
35166,hours,0,0
35167,compared,0,0
35168,with,0,1
35169,the,0,0
35170,control,0,1
35171,group,0,0
35172,.,0,1
35173,However,0,0
35174,",",0,0
35175,the,0,0
35176,combination,0,0
35177,of,0,0
35178,intraperitoneal,0,0
35179,bupivacaine,0,1
35180,0.25,0,0
35181,%,0,0
35182,and,0,1
35183,i.v,0,0
35184,.,0,1
35185,morphine,0,0
35186,was,0,0
35187,more,0,0
35188,effective,0,0
35189,for,0,0
35190,treatment,0,0
35191,of,0,0
35192,pain,0,1
35193,after,0,1
35194,laparoscopic,1,1
35195,cholecystectomy,1,1
35196,.,1,1
35197,Identification,0,0
35198,",",0,0
35199,course,0,0
35200,",",0,0
35201,and,0,0
35202,treatment,0,0
35203,of,0,0
35204,depression,1,1
35205,after,1,0
35206,admission,1,1
35207,for,1,0
35208,a,1,1
35209,cardiac,1,1
35210,condition,1,0
35211,:,1,1
35212,rationale,0,0
35213,and,0,1
35214,patient,0,1
35215,characteristics,0,1
35216,for,0,1
35217,the,0,1
35218,Identifying,0,0
35219,Depression,0,0
35220,As,0,0
35221,a,0,1
35222,Comorbid,0,1
35223,Condition,0,1
35224,(,0,1
35225,IDACC,0,1
35226,),0,1
35227,project,0,1
35228,.,0,1
35229,BACKGROUND,0,0
35230,Given,0,0
35231,the,0,0
35232,prevalence,0,0
35233,of,0,0
35234,cardiovascular,0,1
35235,disease,0,1
35236,and,0,0
35237,the,0,0
35238,high,0,1
35239,rates,0,0
35240,of,0,1
35241,depression,0,1
35242,among,0,1
35243,cardiac,1,1
35244,patients,1,1
35245,",",0,0
35246,there,0,0
35247,is,0,0
35248,a,0,0
35249,need,0,0
35250,to,0,0
35251,develop,0,1
35252,practical,0,0
35253,ways,0,0
35254,to,0,1
35255,identify,0,0
35256,this,0,0
35257,population,0,1
35258,and,0,0
35259,provide,0,0
35260,pragmatic,0,1
35261,general-practitioner-based,0,1
35262,interventions,0,0
35263,for,0,1
35264,managing,0,0
35265,depression,0,1
35266,as,0,0
35267,a,0,0
35268,comorbid,0,1
35269,condition,0,0
35270,.,0,1
35271,METHOD,0,0
35272,The,0,0
35273,Identifying,0,0
35274,Depression,0,0
35275,As,0,0
35276,a,0,1
35277,Comorbid,0,1
35278,Condition,0,1
35279,(,0,1
35280,IDACC,0,1
35281,),0,1
35282,study,0,0
35283,employed,0,0
35284,a,0,0
35285,hybrid,0,0
35286,design,0,1
35287,",",0,0
35288,incorporating,0,0
35289,a,0,0
35290,randomized,0,1
35291,controlled,0,0
35292,trial,0,0
35293,nested,0,0
35294,within,0,0
35295,a,0,1
35296,prospective,0,1
35297,cohort,0,1
35298,study,0,1
35299,.,0,1
35300,IDACC,0,0
35301,screened,0,1
35302,for,0,0
35303,depression,1,1
35304,in,1,1
35305,patients,1,1
35306,hospitalized,1,1
35307,in,1,1
35308,South,1,1
35309,Australia,1,1
35310,for,1,0
35311,a,1,0
35312,range,1,1
35313,of,1,0
35314,cardiac,1,1
35315,conditions,1,1
35316,",",0,1
35317,with,0,1
35318,outcome,0,0
35319,measures,0,0
35320,monitored,0,1
35321,for,0,1
35322,12,0,1
35323,months,0,1
35324,after,0,1
35325,discharge,0,1
35326,.,0,1
35327,The,1,0
35328,subgroup,1,0
35329,identified,1,0
35330,as,1,0
35331,depressed,1,1
35332,was,1,0
35333,entered,1,1
35334,into,1,1
35335,the,1,0
35336,nested,1,1
35337,IDACC,1,1
35338,trial,1,0
35339,",",0,0
35340,which,0,0
35341,tests,0,0
35342,the,0,0
35343,hypothesis,0,0
35344,that,0,0
35345,identifying,0,0
35346,depression,0,1
35347,and,0,0
35348,offering,0,0
35349,an,0,0
35350,evidence-based,0,0
35351,intervention,0,0
35352,to,0,1
35353,general,0,1
35354,practitioners,0,1
35355,",",0,1
35356,incorporating,0,0
35357,multidisciplinary,0,1
35358,telephone,0,1
35359,case,0,0
35360,conferencing,0,0
35361,",",0,0
35362,will,0,0
35363,reduce,0,0
35364,levels,0,0
35365,of,0,0
35366,depression,0,1
35367,",",0,0
35368,improve,0,0
35369,quality,0,0
35370,of,0,0
35371,life,0,0
35372,",",0,0
35373,and,0,0
35374,reduce,0,0
35375,associated,0,0
35376,economic,0,0
35377,costs,0,1
35378,.,0,1
35379,RESULTS,0,0
35380,At,0,0
35381,baseline,0,0
35382,",",0,1
35383,46.3,0,0
35384,%,0,0
35385,of,0,1
35386,1455,1,1
35387,participants,1,1
35388,screened,1,1
35389,were,1,1
35390,classified,1,1
35391,as,1,0
35392,depression,1,1
35393,cases,1,1
35394,on,0,0
35395,the,0,0
35396,basis,0,0
35397,of,0,0
35398,their,0,1
35399,score,0,0
35400,on,0,0
35401,the,0,0
35402,Center,0,1
35403,for,0,1
35404,Epidemiological,0,1
35405,Studies,0,1
35406,Depression,0,1
35407,Scale,0,1
35408,(,0,1
35409,>,0,1
35410,or,0,1
35411,=16,0,1
35412,),0,0
35413,or,0,1
35414,the,0,0
35415,Hospital,0,1
35416,Anxiety,0,0
35417,and,0,1
35418,Depression,0,0
35419,Scale,0,1
35420,(,0,1
35421,>,0,1
35422,or,0,1
35423,=8,0,1
35424,),0,1
35425,.,0,1
35426,Elevated,0,1
35427,scores,0,0
35428,were,0,1
35429,associated,0,0
35430,with,0,1
35431,being,0,1
35432,younger,0,1
35433,",",0,0
35434,female,0,1
35435,",",0,0
35436,divorced,0,1
35437,or,0,0
35438,separated,0,0
35439,",",0,0
35440,not,0,0
35441,employed,0,0
35442,",",0,0
35443,living,0,1
35444,alone,0,0
35445,",",0,0
35446,having,0,1
35447,a,0,0
35448,lower,0,0
35449,level,0,0
35450,of,0,0
35451,education,0,1
35452,",",0,0
35453,and,0,0
35454,having,0,1
35455,poorer,0,0
35456,health,0,1
35457,and,0,0
35458,quality,0,0
35459,of,0,0
35460,life,0,1
35461,.,0,1
35462,Nearly,0,0
35463,one,0,0
35464,fifth,0,1
35465,(,0,1
35466,19.4,0,1
35467,%,0,0
35468,),0,1
35469,of,0,1
35470,participants,0,1
35471,had,0,1
35472,Center,0,1
35473,for,0,1
35474,Epidemiological,0,1
35475,Studies,0,1
35476,Depression,0,1
35477,Scale,0,1
35478,scores,0,0
35479,>,0,0
35480,27,0,1
35481,",",0,0
35482,which,0,0
35483,is,0,0
35484,indicative,0,0
35485,of,0,0
35486,major,0,1
35487,depression,0,1
35488,.,0,1
35489,CONCLUSIONS,0,0
35490,This,0,0
35491,project,0,0
35492,confirms,0,0
35493,",",0,0
35494,in,0,0
35495,an,0,0
35496,Australian,1,1
35497,setting,1,1
35498,",",0,0
35499,the,0,0
35500,high,0,0
35501,prevalence,0,0
35502,of,0,1
35503,depressive,0,1
35504,symptoms,0,1
35505,among,0,1
35506,hospitalized,1,1
35507,cardiac,1,1
35508,patients,1,1
35509,.,1,1
35510,Follow-up,0,0
35511,over,0,0
35512,12,0,1
35513,months,0,0
35514,will,0,0
35515,enhance,0,0
35516,understanding,0,0
35517,of,0,0
35518,the,0,0
35519,natural,0,0
35520,history,0,1
35521,of,0,0
35522,depression,1,1
35523,in,1,1
35524,cardiac,1,1
35525,patients,1,1
35526,",",0,1
35527,while,0,0
35528,the,0,0
35529,nested,0,0
35530,trial,0,0
35531,will,0,0
35532,inform,0,0
35533,on,0,0
35534,effectiveness,0,0
35535,of,0,0
35536,an,0,0
35537,intervention,0,0
35538,involving,0,1
35539,tailored,0,0
35540,advice,0,0
35541,and,0,0
35542,support,0,0
35543,to,0,1
35544,general,0,1
35545,practitioners,0,1
35546,.,0,1
35547,Determination,0,1
35548,of,0,0
35549,vital,0,0
35550,status,0,1
35551,at,0,0
35552,the,0,0
35553,end,0,0
35554,of,0,0
35555,the,0,0
35556,DIG,0,1
35557,trial,0,0
35558,.,0,1
35559,The,0,0
35560,Digitalis,0,1
35561,Investigation,0,1
35562,Group,0,1
35563,(,0,1
35564,DIG,0,1
35565,),0,1
35566,trial,0,0
35567,was,0,0
35568,a,0,0
35569,randomized,0,1
35570,",",0,0
35571,double-blind,0,0
35572,placebo-controlled,0,0
35573,trial,0,1
35574,whose,0,1
35575,primary,0,1
35576,objective,0,1
35577,was,0,0
35578,to,0,0
35579,determine,0,0
35580,whether,0,0
35581,digoxin,0,0
35582,had,0,1
35583,beneficial,0,0
35584,",",0,0
35585,harmful,0,0
35586,",",0,0
35587,or,0,1
35588,no,0,0
35589,effect,0,0
35590,on,0,0
35591,total,0,1
35592,mortality,0,1
35593,in,0,1
35594,patients,1,1
35595,with,1,1
35596,heart,1,1
35597,failure,1,1
35598,who,1,1
35599,were,1,1
35600,in,1,1
35601,sinus,1,1
35602,rhythm,1,1
35603,and,1,0
35604,whose,1,1
35605,ejection,1,1
35606,fraction,1,1
35607,was,1,0
35608,<,1,0
35609,/=0.45,1,1
35610,.,1,1
35611,The,0,0
35612,study,0,0
35613,was,0,0
35614,designed,0,0
35615,as,0,0
35616,a,0,1
35617,large,0,1
35618,simple,0,0
35619,trial,0,1
35620,with,0,1
35621,a,1,1
35622,large,1,1
35623,number,1,0
35624,of,1,1
35625,centers,1,1
35626,(,1,1
35627,302,1,1
35628,),1,1
35629,in,1,0
35630,the,1,1
35631,United,1,1
35632,States,1,1
35633,and,1,1
35634,Canada,1,1
35635,",",1,0
35636,many,1,1
35637,of,1,0
35638,which,1,0
35639,were,1,1
35640,inexperienced,1,0
35641,in,1,0
35642,research,1,1
35643,.,1,1
35644,To,0,0
35645,ensure,0,0
35646,that,0,0
35647,the,0,0
35648,results,0,0
35649,of,0,0
35650,the,0,0
35651,trial,0,0
35652,would,0,0
35653,be,0,0
35654,reported,0,0
35655,accurately,0,0
35656,without,0,1
35657,possible,0,0
35658,bias,0,1
35659,due,0,1
35660,to,0,1
35661,missing,0,1
35662,data,0,0
35663,",",0,1
35664,the,0,0
35665,study,0,0
35666,leadership,0,0
35667,decided,0,0
35668,that,0,0
35669,no,0,0
35670,outcome,0,0
35671,results,0,0
35672,would,0,0
35673,be,0,0
35674,reported,0,0
35675,until,0,0
35676,the,0,0
35677,vital,0,0
35678,status,0,1
35679,at,0,0
35680,the,0,0
35681,end,0,0
35682,of,0,0
35683,the,0,0
35684,study,0,0
35685,was,0,0
35686,known,0,0
35687,for,0,0
35688,at,0,1
35689,least,0,1
35690,97,0,1
35691,%,0,0
35692,of,0,0
35693,the,0,0
35694,study,0,1
35695,participants,0,1
35696,.,0,1
35697,Planning,0,1
35698,for,0,0
35699,closeout,0,0
35700,of,0,0
35701,the,0,0
35702,study,0,0
35703,began,0,1
35704,a,0,0
35705,year,0,0
35706,prior,0,1
35707,to,0,0
35708,the,0,0
35709,common,0,0
35710,end,0,0
35711,date,0,0
35712,of,0,0
35713,December,0,1
35714,31,0,1
35715,",",0,1
35716,1995,0,1
35717,and,0,1
35718,included,0,1
35719,plans,0,1
35720,for,0,1
35721,obtaining,0,1
35722,vital,0,0
35723,status,0,1
35724,on,0,0
35725,December,0,1
35726,31,0,1
35727,",",0,1
35728,1995,0,1
35729,.,0,1
35730,Participants,0,1
35731,were,0,1
35732,given,0,1
35733,postcards,0,0
35734,at,0,1
35735,their,0,1
35736,final,0,0
35737,study,0,1
35738,visit,0,0
35739,to,0,0
35740,be,0,0
35741,completed,0,1
35742,and,0,0
35743,mailed,0,1
35744,on,0,0
35745,or,0,1
35746,after,0,1
35747,January,0,1
35748,1,0,1
35749,",",0,1
35750,1996,0,1
35751,.,0,1
35752,Of,1,1
35753,5602,1,1
35754,postcards,1,1
35755,distributed,1,1
35756,",",1,1
35757,5070,1,1
35758,(,1,1
35759,90.5,1,1
35760,%,1,0
35761,),1,1
35762,were,1,1
35763,completed,1,1
35764,and,1,0
35765,returned,1,1
35766,.,1,1
35767,A,0,0
35768,contract,0,0
35769,search,0,0
35770,agency,0,1
35771,was,0,0
35772,hired,0,1
35773,to,0,0
35774,locate,0,0
35775,the,0,0
35776,remaining,0,1
35777,participants,0,1
35778,.,0,1
35779,Of,1,0
35780,the,1,0
35781,total,1,1
35782,7788,1,1
35783,participants,1,1
35784,entered,1,1
35785,into,1,1
35786,the,1,0
35787,DIG,1,1
35788,trial,1,0
35789,",",1,0
35790,only,1,0
35791,97,1,1
35792,participants,1,1
35793,(,1,1
35794,1.2,1,1
35795,%,1,0
35796,),1,1
35797,could,1,0
35798,not,1,0
35799,have,1,0
35800,their,1,0
35801,vital,1,0
35802,status,1,1
35803,as,1,0
35804,of,1,1
35805,December,1,1
35806,31,1,1
35807,",",1,1
35808,1995,1,1
35809,determined,1,0
35810,.,1,1
35811,It,0,0
35812,is,0,0
35813,recommended,0,0
35814,that,0,0
35815,investigators,0,0
35816,having,0,1
35817,an,0,1
35818,outcome,0,0
35819,measure,0,0
35820,with,0,1
35821,a,0,1
35822,common,0,0
35823,end,0,0
35824,date,0,1
35825,include,0,0
35826,plans,0,0
35827,in,0,1
35828,their,0,1
35829,protocols,0,0
35830,for,0,1
35831,obtaining,0,1
35832,their,0,1
35833,measures,0,0
35834,and,0,1
35835,activate,0,0
35836,those,0,0
35837,plans,0,0
35838,as,0,0
35839,early,0,1
35840,as,0,0
35841,possible,0,0
35842,during,0,0
35843,the,0,0
35844,course,0,0
35845,of,0,0
35846,the,0,0
35847,study,0,1
35848,.,0,1
35849,Effect,0,0
35850,of,0,0
35851,a,0,1
35852,carbohydrate-protein,0,0
35853,supplement,0,0
35854,on,0,0
35855,endurance,0,0
35856,performance,0,0
35857,during,0,0
35858,exercise,0,0
35859,of,0,0
35860,varying,0,0
35861,intensity,0,0
35862,.,0,1
35863,Increasing,0,0
35864,the,0,0
35865,plasma,0,0
35866,glucose,0,0
35867,and,0,1
35868,insulin,0,0
35869,concentrations,0,0
35870,during,0,1
35871,prolonged,0,1
35872,variable,0,1
35873,intensity,0,0
35874,exercise,0,0
35875,by,0,0
35876,supplementing,0,0
35877,with,0,1
35878,carbohydrate,0,0
35879,has,0,0
35880,been,0,0
35881,found,0,0
35882,to,0,0
35883,spare,0,1
35884,muscle,0,0
35885,glycogen,0,0
35886,and,0,0
35887,increase,0,0
35888,aerobic,0,0
35889,endurance,0,0
35890,.,0,1
35891,Furthermore,0,0
35892,",",0,0
35893,the,0,0
35894,addition,0,0
35895,of,0,0
35896,protein,0,0
35897,to,0,0
35898,a,0,0
35899,carbohydrate,0,0
35900,supplement,0,0
35901,will,0,0
35902,enhance,0,0
35903,the,0,0
35904,insulin,0,0
35905,response,0,0
35906,of,0,0
35907,a,0,1
35908,carbohydrate,0,0
35909,supplement,0,0
35910,.,0,1
35911,The,0,0
35912,purpose,0,0
35913,of,0,0
35914,the,0,0
35915,present,0,0
35916,study,0,1
35917,was,0,0
35918,to,0,0
35919,compare,0,0
35920,the,0,0
35921,effects,0,0
35922,of,0,0
35923,a,0,1
35924,carbohydrate,0,0
35925,and,0,0
35926,a,0,0
35927,carbohydrate-protein,0,0
35928,supplement,0,0
35929,on,0,0
35930,aerobic,0,0
35931,endurance,0,1
35932,performance,0,0
35933,.,0,1
35934,Nine,1,1
35935,trained,1,1
35936,cyclists,1,1
35937,exercised,0,1
35938,on,0,1
35939,3,0,1
35940,separate,0,1
35941,occasions,0,1
35942,at,0,1
35943,intensities,0,0
35944,that,0,0
35945,varied,0,0
35946,between,0,0
35947,45,0,1
35948,%,0,0
35949,and,0,1
35950,75,0,1
35951,%,0,0
35952,VO2max,0,1
35953,for,0,1
35954,3,0,1
35955,h,0,0
35956,and,0,0
35957,then,0,0
35958,at,0,0
35959,85,0,1
35960,%,0,0
35961,VO2max,0,0
35962,until,0,1
35963,fatigued,0,1
35964,.,0,1
35965,Supplements,0,0
35966,(,0,1
35967,200,0,1
35968,ml,0,0
35969,),0,1
35970,were,0,0
35971,provided,0,0
35972,every,0,0
35973,20,0,1
35974,min,0,0
35975,and,0,0
35976,consisted,0,1
35977,of,0,0
35978,placebo,0,0
35979,",",0,0
35980,a,0,0
35981,7.75,0,0
35982,%,0,0
35983,carbohydrate,0,0
35984,solution,0,0
35985,",",0,0
35986,and,0,0
35987,a,0,0
35988,7.75,0,0
35989,%,0,0
35990,carbohydrate/1.94,0,0
35991,%,0,0
35992,protein,0,0
35993,solution,0,0
35994,.,0,1
35995,Treatments,0,0
35996,were,0,1
35997,administered,0,0
35998,using,0,0
35999,a,0,1
36000,double-blind,0,0
36001,randomized,0,1
36002,design,0,1
36003,.,0,1
36004,Carbohydrate,0,0
36005,supplementation,0,0
36006,significantly,0,0
36007,increased,0,0
36008,time,0,0
36009,to,0,0
36010,exhaustion,0,0
36011,(,0,1
36012,carbohydrate,0,1
36013,19.7,0,1
36014,+/-,0,1
36015,4.6,0,0
36016,min,0,0
36017,vs.,0,0
36018,placebo,0,1
36019,12.7,0,0
36020,+/-,0,0
36021,3.1,0,0
36022,min,0,0
36023,),0,0
36024,",",0,0
36025,while,0,0
36026,the,0,0
36027,addition,0,0
36028,of,0,0
36029,protein,0,0
36030,enhanced,0,0
36031,the,0,0
36032,effect,0,0
36033,of,0,0
36034,the,0,0
36035,carbohydrate,0,0
36036,supplement,0,0
36037,(,0,1
36038,carbohydrate-protein,0,1
36039,26.9,0,1
36040,+/-,0,1
36041,4.5,0,1
36042,min,0,0
36043,",",0,0
36044,p,0,0
36045,<,0,0
36046,.05,0,0
36047,),0,1
36048,.,0,1
36049,Blood,0,0
36050,glucose,0,0
36051,and,0,1
36052,plasma,0,0
36053,insulin,0,1
36054,levels,0,0
36055,were,0,1
36056,elevated,0,1
36057,above,0,0
36058,placebo,0,0
36059,during,0,0
36060,carbohydrate,0,0
36061,and,0,1
36062,carbohydrate-protein,0,0
36063,supplementation,0,0
36064,",",0,0
36065,but,0,0
36066,no,0,0
36067,differences,0,0
36068,were,0,1
36069,found,0,0
36070,between,0,0
36071,the,0,0
36072,carbohydrate,0,0
36073,and,0,0
36074,carbohydrate-protein,0,1
36075,treatments,0,0
36076,.,0,1
36077,In,0,0
36078,summary,0,0
36079,",",0,1
36080,we,0,0
36081,found,0,0
36082,that,0,0
36083,the,0,0
36084,addition,0,0
36085,of,0,0
36086,protein,0,0
36087,to,0,0
36088,a,0,0
36089,carbohydrate,0,0
36090,supplement,0,0
36091,enhanced,0,0
36092,aerobic,0,0
36093,endurance,0,0
36094,performance,0,0
36095,above,0,0
36096,that,0,0
36097,which,0,0
36098,occurred,0,0
36099,with,0,1
36100,carbohydrate,0,0
36101,alone,0,0
36102,",",0,0
36103,but,0,0
36104,the,0,0
36105,reason,0,0
36106,for,0,0
36107,this,0,0
36108,improvement,0,0
36109,in,0,0
36110,performance,0,0
36111,was,0,0
36112,not,0,0
36113,evident,0,0
36114,.,0,1
36115,The,0,0
36116,efficacy,0,0
36117,of,0,0
36118,sublingual,0,1
36119,immunotherapy,0,0
36120,for,0,0
36121,respiratory,0,1
36122,allergy,0,1
36123,is,0,0
36124,not,0,0
36125,affected,0,0
36126,by,0,0
36127,different,0,1
36128,dosage,0,0
36129,regimens,0,0
36130,in,0,0
36131,the,0,0
36132,induction,0,0
36133,phase,0,1
36134,.,0,1
36135,BACKGROUND,0,0
36136,Sublingual,0,1
36137,administration,0,0
36138,of,0,0
36139,allergens,0,0
36140,is,0,0
36141,a,0,0
36142,safe,0,0
36143,and,0,0
36144,effective,0,0
36145,alternative,0,0
36146,to,0,1
36147,subcutaneous,0,1
36148,immunotherapy,0,0
36149,in,0,1
36150,patients,1,1
36151,with,1,1
36152,respiratory,1,1
36153,allergies,1,1
36154,.,1,1
36155,A,0,0
36156,drawback,0,0
36157,to,0,0
36158,this,0,0
36159,therapeutic,0,0
36160,approach,0,0
36161,is,0,0
36162,the,0,0
36163,relatively,0,0
36164,long,0,1
36165,and,0,0
36166,complex,0,0
36167,management,0,1
36168,of,0,0
36169,the,0,0
36170,induction,0,0
36171,phase,0,1
36172,.,0,1
36173,AIM,0,0
36174,OF,0,1
36175,THE,0,1
36176,STUDY,0,0
36177,To,0,0
36178,determine,0,0
36179,whether,0,0
36180,different,0,0
36181,induction,0,1
36182,regimens,0,0
36183,affect,0,0
36184,the,0,0
36185,outcome,0,0
36186,of,0,0
36187,sublingual,0,1
36188,immunotherapy,0,1
36189,.,0,1
36190,METHODS,0,0
36191,AND,0,0
36192,RESULTS,0,1
36193,Adult,1,1
36194,and,1,1
36195,pediatric,1,1
36196,patients,1,1
36197,with,1,1
36198,allergic,1,1
36199,rhinoconjunctivitis,1,1
36200,and/or,1,1
36201,asthma,1,1
36202,were,1,0
36203,included,1,1
36204,in,1,0
36205,the,1,0
36206,study,1,1
36207,.,1,0
36208,Ten,1,0
36209,subjects,1,1
36210,served,0,0
36211,as,0,0
36212,controls,0,1
36213,and,0,1
36214,received,0,1
36215,symptomatic,0,1
36216,treatments,0,0
36217,.,0,1
36218,Forty-three,1,1
36219,subjects,1,1
36220,were,0,1
36221,allocated,0,1
36222,to,0,1
36223,sublingual,0,1
36224,immunotherapy,0,0
36225,",",0,1
36226,with,0,1
36227,three,0,0
36228,different,0,1
36229,induction,0,1
36230,protocols,0,0
36231,(,0,1
36232,8-,0,1
36233,",",0,1
36234,15-,0,1
36235,and,0,0
36236,20-day,0,0
36237,",",0,0
36238,respectively,0,0
36239,),0,1
36240,.,0,1
36241,Symptom,0,0
36242,and,0,0
36243,medication,0,1
36244,scores,0,0
36245,",",0,1
36246,skin,0,1
36247,test,0,0
36248,results,0,0
36249,and,0,1
36250,(,0,1
36251,in,0,1
36252,asthmatic,0,1
36253,patients,0,1
36254,),0,1
36255,FEV1,0,1
36256,values,0,0
36257,were,0,1
36258,monitored,0,1
36259,for,0,1
36260,two,0,1
36261,years,0,1
36262,.,0,1
36263,Adverse,0,0
36264,effects,0,0
36265,were,0,1
36266,recorded,0,0
36267,.,0,1
36268,All,0,1
36269,induction,0,0
36270,regimens,0,0
36271,produced,0,0
36272,a,0,1
36273,significant,0,0
36274,improvement,0,0
36275,in,0,0
36276,symptom,0,0
36277,and,0,1
36278,medication,0,1
36279,usage,0,0
36280,(,0,1
36281,p,0,0
36282,<,0,0
36283,0.0001,0,0
36284,),0,1
36285,;,0,1
36286,skin,0,1
36287,test,0,0
36288,scores,0,0
36289,decreased,0,0
36290,(,0,1
36291,p,0,0
36292,<,0,0
36293,0.0001,0,0
36294,),0,1
36295,and,0,1
36296,FEV1,0,1
36297,improved,0,0
36298,(,0,1
36299,p,0,0
36300,<,0,0
36301,0.05,0,0
36302,),0,1
36303,.,0,1
36304,In,0,0
36305,contrast,0,0
36306,",",0,0
36307,symptom,0,0
36308,and,0,0
36309,skin,0,1
36310,test,0,0
36311,scores,0,0
36312,did,0,0
36313,not,0,0
36314,significantly,0,0
36315,change,0,0
36316,in,0,0
36317,controls,0,1
36318,.,0,1
36319,No,0,0
36320,relevant,0,0
36321,adverse,0,0
36322,effects,0,0
36323,were,0,1
36324,observed,0,0
36325,with,0,1
36326,any,0,0
36327,of,0,0
36328,the,0,0
36329,induction,0,0
36330,regimens,0,0
36331,.,0,0
36332,CONCLUSIONS,0,0
36333,For,0,1
36334,patients,1,1
36335,with,1,1
36336,respiratory,1,1
36337,allergies,1,1
36338,",",0,1
36339,sublingual,0,1
36340,immunotherapy,0,0
36341,with,0,1
36342,an,0,0
36343,8-day,0,0
36344,induction,0,0
36345,protocol,0,0
36346,is,0,0
36347,safe,0,0
36348,and,0,0
36349,effective,0,0
36350,.,0,1
36351,Our,0,0
36352,results,0,0
36353,encourage,0,0
36354,the,0,0
36355,usage,0,0
36356,of,0,0
36357,shorter,0,0
36358,induction,0,1
36359,regimens,0,0
36360,",",0,0
36361,which,0,0
36362,produce,0,0
36363,better,0,0
36364,compliance,0,0
36365,with,0,1
36366,this,0,0
36367,therapy,0,0
36368,.,0,1
36369,Clinical,0,0
36370,and,0,1
36371,radiographic,0,0
36372,evaluation,0,0
36373,of,0,0
36374,guided,0,1
36375,tissue,0,1
36376,regeneration,0,0
36377,in,0,0
36378,the,0,0
36379,treatment,0,0
36380,of,0,0
36381,class,1,1
36382,II,1,1
36383,furcation,1,1
36384,defects,1,1
36385,.,1,1
36386,A,0,1
36387,randomized,0,0
36388,clinical,0,0
36389,trial,0,1
36390,.,0,1
36391,PURPOSE,0,0
36392,To,0,0
36393,evaluate,0,0
36394,the,0,0
36395,treatment,0,0
36396,outcomes,0,0
36397,after,0,0
36398,guided,0,1
36399,tissue,0,1
36400,regeneration,0,0
36401,(,0,1
36402,GTR,0,0
36403,),0,1
36404,with,0,1
36405,a,0,1
36406,bioabsorbable,0,0
36407,membrane,0,0
36408,in,0,1
36409,Class,1,1
36410,II,1,1
36411,furcation,1,1
36412,defects,1,1
36413,in,0,1
36414,mandibular,0,1
36415,molars,0,1
36416,.,0,1
36417,The,0,0
36418,open,0,0
36419,flap,0,1
36420,debridement,0,1
36421,(,0,1
36422,OFD,0,0
36423,),0,1
36424,was,0,0
36425,used,0,0
36426,as,0,0
36427,the,0,0
36428,control,0,1
36429,.,0,1
36430,METHODS,0,0
36431,Nine,1,1
36432,patients,1,1
36433,",",1,1
36434,with,1,1
36435,two,1,0
36436,comparable,1,0
36437,Class,1,1
36438,II,1,1
36439,furcation,1,1
36440,defects,1,1
36441,were,1,1
36442,included,1,1
36443,in,1,0
36444,the,1,0
36445,study,1,0
36446,.,1,1
36447,After,0,0
36448,initial,0,0
36449,preparation,0,0
36450,",",0,0
36451,the,0,0
36452,defects,0,1
36453,were,0,1
36454,randomly,0,1
36455,assigned,0,1
36456,in,0,0
36457,each,0,0
36458,patient,0,0
36459,to,0,0
36460,either,0,1
36461,GTR-group,1,1
36462,or,1,1
36463,OFD-group,1,1
36464,.,1,1
36465,Clinical,0,0
36466,parameters,0,0
36467,and,0,1
36468,standardized,0,1
36469,radiographs,0,1
36470,were,0,1
36471,obtained,0,0
36472,at,0,0
36473,baseline,0,0
36474,and,0,1
36475,6,0,1
36476,months,0,0
36477,after,0,1
36478,the,0,1
36479,surgeries,0,1
36480,.,0,1
36481,The,0,0
36482,radiographs,0,0
36483,were,0,0
36484,analyzed,0,0
36485,by,0,0
36486,subtraction,0,0
36487,radiography,0,1
36488,.,0,1
36489,RESULTS,0,0
36490,Comparing,0,0
36491,baseline,0,0
36492,to,0,1
36493,6-month,0,1
36494,results,0,0
36495,",",0,1
36496,both,0,0
36497,groups,0,0
36498,showed,0,0
36499,statistically,0,0
36500,significant,0,0
36501,probing,0,1
36502,depth,0,0
36503,reduction,0,0
36504,(,0,1
36505,PD,0,1
36506,),0,1
36507,",",0,0
36508,horizontal,0,0
36509,clinical,0,0
36510,attachment,0,1
36511,level,0,0
36512,(,0,1
36513,CAL-h,0,0
36514,),0,1
36515,gain,0,0
36516,",",0,0
36517,and,0,0
36518,increase,0,0
36519,in,0,0
36520,gingival,0,1
36521,recession,0,1
36522,(,0,1
36523,GR,0,0
36524,),0,1
36525,.,0,1
36526,The,0,0
36527,vertical,0,0
36528,clinical,0,0
36529,attachment,0,1
36530,level,0,0
36531,(,0,1
36532,CAL-v,0,0
36533,),0,1
36534,gain,0,0
36535,was,0,0
36536,statistically,0,0
36537,significant,0,0
36538,only,0,0
36539,for,0,0
36540,the,0,0
36541,OFD-group,0,1
36542,.,0,1
36543,Comparing,0,0
36544,the,0,0
36545,two,0,0
36546,treatments,0,0
36547,",",0,0
36548,no,0,0
36549,statistically,0,0
36550,significant,0,0
36551,differences,0,0
36552,were,0,1
36553,found,0,0
36554,in,0,0
36555,PD,0,1
36556,reduction,0,0
36557,(,0,1
36558,GTR,0,0
36559,:,0,1
36560,1.67,0,0
36561,mm,0,1
36562,;,0,1
36563,OFD,0,1
36564,:,0,1
36565,2.51,0,0
36566,mm,0,1
36567,",",0,1
36568,P,0,0
36569,=,0,1
36570,0.26,0,0
36571,),0,1
36572,",",0,0
36573,CAL-v,0,0
36574,gain,0,0
36575,(,0,1
36576,GTR,0,0
36577,:,0,1
36578,0.62,0,0
36579,mm,0,1
36580,;,0,1
36581,OFD,0,1
36582,:,0,1
36583,1.16,0,0
36584,mm,0,1
36585,",",0,1
36586,P=,0,1
36587,0.37,0,0
36588,),0,1
36589,",",0,0
36590,and,0,0
36591,GR,0,0
36592,increase,0,0
36593,(,0,1
36594,GTR,0,0
36595,:,0,1
36596,1.04,0,0
36597,mm,0,1
36598,;,0,1
36599,OFD,0,1
36600,:,0,1
36601,1.24,0,0
36602,mm,0,1
36603,",",0,1
36604,P,0,0
36605,=,0,1
36606,0.31,0,0
36607,),0,1
36608,.,0,1
36609,GTR,0,0
36610,provided,0,0
36611,complete,0,1
36612,closure,0,1
36613,of,0,0
36614,the,0,0
36615,furcation,0,1
36616,defect,0,1
36617,in,0,1
36618,two,0,1
36619,sites,0,1
36620,and,0,1
36621,superior,0,0
36622,horizontal,0,0
36623,clinical,0,0
36624,attachment,0,1
36625,level,0,0
36626,gain,0,0
36627,(,0,1
36628,GTR,0,0
36629,:,0,1
36630,2.27,0,0
36631,mm,0,1
36632,;,0,1
36633,OFD,0,1
36634,:,0,1
36635,1.01,0,0
36636,mm,0,1
36637,",",0,1
36638,P,0,0
36639,=,0,1
36640,0.05,0,0
36641,),0,1
36642,.,0,1
36643,Subtraction,0,0
36644,radiography,0,0
36645,showed,0,0
36646,significant,0,0
36647,difference,0,0
36648,in,0,0
36649,bone,0,1
36650,height,0,0
36651,change,0,0
36652,between,0,0
36653,GTR-group,0,1
36654,and,0,1
36655,OFD-group,0,1
36656,(,0,1
36657,-0.14,0,0
36658,mm,0,1
36659,and,0,1
36660,0.86,0,0
36661,mm,0,0
36662,",",0,0
36663,respectively,0,0
36664,;,0,0
36665,P,0,0
36666,=,0,1
36667,0.028,0,0
36668,),0,1
36669,at,0,1
36670,6,0,1
36671,months,0,1
36672,.,0,1
36673,Azimilide,0,0
36674,decreases,0,0
36675,recurrent,0,1
36676,ventricular,0,0
36677,tachyarrhythmias,0,1
36678,in,0,1
36679,patients,1,1
36680,with,1,1
36681,implantable,1,1
36682,cardioverter,1,1
36683,defibrillators,1,1
36684,.,1,1
36685,OBJECTIVES,0,0
36686,This,0,0
36687,study,0,0
36688,evaluated,0,0
36689,the,0,0
36690,effects,0,0
36691,of,0,0
36692,azimilide,0,1
36693,dihydrochloride,0,1
36694,(,0,1
36695,AZ,0,1
36696,),0,1
36697,on,0,0
36698,anti-tachycardia,0,1
36699,pacing,0,0
36700,(,0,1
36701,ATP,0,1
36702,),0,1
36703,and,0,1
36704,shock-terminated,0,1
36705,events,0,0
36706,in,0,1
36707,patients,1,1
36708,with,1,1
36709,implantable,1,1
36710,cardioverter,1,1
36711,defibrillators,1,1
36712,(,1,1
36713,ICDs,1,1
36714,),1,1
36715,.,1,1
36716,BACKGROUND,0,0
36717,Animal,0,0
36718,studies,0,0
36719,have,0,0
36720,shown,0,0
36721,the,0,0
36722,effectiveness,0,0
36723,of,0,0
36724,AZ,0,1
36725,for,0,0
36726,therapy,0,0
36727,of,0,1
36728,supraventricular,0,1
36729,and,0,1
36730,ventricular,0,1
36731,tachycardia,0,1
36732,(,0,1
36733,VT,0,1
36734,),0,1
36735,.,0,1
36736,Azimilide,0,0
36737,dihydrochloride,0,0
36738,was,0,0
36739,investigated,0,0
36740,as,0,0
36741,adjunctive,0,1
36742,treatment,0,1
36743,for,0,0
36744,reducing,0,0
36745,the,0,0
36746,frequency,0,0
36747,of,0,0
36748,VT,0,0
36749,and,0,0
36750,",",0,0
36751,thus,0,0
36752,",",0,0
36753,the,0,0
36754,need,0,0
36755,for,0,0
36756,ICD,0,1
36757,therapies,0,0
36758,",",0,1
36759,including,0,1
36760,ATP,0,0
36761,and,0,1
36762,cardioversion/defibrillation,0,1
36763,(,0,1
36764,ICD,0,1
36765,shocks,0,0
36766,),0,1
36767,in,0,1
36768,patients,0,1
36769,with,0,1
36770,inducible,0,1
36771,monomorphic,0,1
36772,VT.,0,1
36773,METHODS,0,0
36774,A,0,1
36775,total,0,1
36776,of,0,1
36777,172,1,1
36778,patients,1,1
36779,were,0,1
36780,randomized,0,1
36781,to,0,0
36782,daily,0,0
36783,treatment,0,0
36784,with,0,1
36785,placebo,0,0
36786,",",0,1
36787,35,0,1
36788,mg,0,0
36789,",",0,1
36790,75,0,1
36791,mg,0,0
36792,",",0,1
36793,or,0,1
36794,125,0,1
36795,mg,0,0
36796,of,0,1
36797,oral,0,1
36798,AZ,0,1
36799,in,0,0
36800,this,0,0
36801,dose-ranging,0,0
36802,pilot,0,0
36803,study,0,1
36804,of,0,0
36805,patients,1,1
36806,with,1,1
36807,ICDs,1,1
36808,.,1,1
36809,The,1,0
36810,majority,1,0
36811,of,1,0
36812,patients,1,1
36813,had,1,1
36814,a,1,1
36815,history,1,1
36816,of,1,0
36817,documented,1,1
36818,remote,1,1
36819,myocardial,1,1
36820,infarction,1,1
36821,and,1,1
36822,congestive,1,1
36823,heart,1,1
36824,failure,1,1
36825,New,1,1
36826,York,1,1
36827,Heart,1,1
36828,Association,1,1
36829,class,1,1
36830,II,1,1
36831,or,1,1
36832,III,1,1
36833,.,1,1
36834,RESULTS,0,0
36835,The,0,0
36836,frequency,0,0
36837,of,0,0
36838,appropriate,0,1
36839,shocks,0,0
36840,and,0,1
36841,ATP,0,0
36842,were,0,1
36843,significantly,0,0
36844,decreased,0,0
36845,among,0,1
36846,AZ-treated,0,1
36847,patients,0,1
36848,compared,0,0
36849,with,0,1
36850,placebo,0,1
36851,patients,0,1
36852,.,0,1
36853,The,0,0
36854,incidence,0,0
36855,of,0,0
36856,ICD,0,1
36857,therapies,0,0
36858,per,0,1
36859,patient-year,0,0
36860,among,0,0
36861,the,0,0
36862,placebo,0,0
36863,group,0,1
36864,was,0,0
36865,36,0,1
36866,",",0,0
36867,and,0,0
36868,it,0,0
36869,was,0,0
36870,10,0,1
36871,",",0,1
36872,12,0,0
36873,",",0,0
36874,and,0,0
36875,9,0,0
36876,among,0,1
36877,35,0,1
36878,mg,0,1
36879,",",0,1
36880,75,0,1
36881,mg,0,0
36882,",",0,1
36883,and,0,1
36884,125,0,1
36885,mg,0,1
36886,AZ,0,1
36887,patients,0,1
36888,",",0,1
36889,respectively,0,0
36890,(,0,0
36891,hazard,0,0
36892,ratio,0,0
36893,=,0,1
36894,0.31,0,0
36895,",",0,0
36896,p,0,0
36897,=,0,1
36898,0.0001,0,0
36899,),0,1
36900,.,0,1
36901,Azimilide,0,0
36902,dihydrochloride,0,0
36903,was,0,0
36904,generally,0,0
36905,well,0,0
36906,tolerated,0,0
36907,and,0,0
36908,did,0,0
36909,not,0,0
36910,affect,0,0
36911,left,0,1
36912,ventricular,0,0
36913,ejection,0,1
36914,fraction,0,1
36915,or,0,1
36916,minimal,0,1
36917,energy,0,0
36918,requirements,0,1
36919,for,0,1
36920,defibrillation,0,1
36921,or,0,1
36922,pacing,0,0
36923,.,0,1
36924,CONCLUSIONS,0,0
36925,Azimilide,0,0
36926,dihydrochloride,0,0
36927,may,0,0
36928,be,0,0
36929,a,0,0
36930,safe,0,0
36931,and,0,0
36932,effective,0,0
36933,drug,0,1
36934,for,0,0
36935,reducing,0,0
36936,the,0,0
36937,frequency,0,0
36938,of,0,0
36939,VT,0,0
36940,and,0,1
36941,ventricular,0,1
36942,fibrillation,0,1
36943,in,0,1
36944,patients,0,1
36945,with,0,1
36946,implanted,0,1
36947,ICDs,0,1
36948,.,0,1
36949,Outcomes,1,1
36950,in,1,1
36951,patients,1,1
36952,with,1,1
36953,diabetes,1,1
36954,mellitus,1,1
36955,undergoing,1,1
36956,percutaneous,1,1
36957,coronary,1,1
36958,intervention,1,0
36959,in,1,0
36960,the,1,0
36961,current,1,1
36962,era,1,0
36963,:,1,1
36964,a,0,0
36965,report,0,0
36966,from,0,0
36967,the,0,0
36968,Prevention,0,1
36969,of,0,0
36970,REStenosis,0,1
36971,with,0,1
36972,Tranilast,0,0
36973,and,0,1
36974,its,0,0
36975,Outcomes,0,0
36976,(,0,1
36977,PRESTO,0,1
36978,),0,1
36979,trial,0,1
36980,.,0,1
36981,BACKGROUND,0,0
36982,Diabetes,0,1
36983,portends,0,0
36984,an,0,0
36985,adverse,0,0
36986,prognosis,0,0
36987,in,0,1
36988,patients,1,1
36989,undergoing,1,1
36990,percutaneous,1,1
36991,coronary,1,1
36992,intervention,1,1
36993,(,1,1
36994,PCI,1,1
36995,),1,1
36996,.,1,1
36997,Whether,0,0
36998,improvements,0,0
36999,in,0,1
37000,current,0,1
37001,clinical,0,0
37002,practice,0,1
37003,(,0,1
37004,stents,0,1
37005,",",0,0
37006,IIb/IIIa,0,1
37007,antagonists,0,0
37008,),0,0
37009,have,0,0
37010,resulted,0,0
37011,in,0,0
37012,substantial,0,0
37013,improvement,0,0
37014,of,0,0
37015,these,0,0
37016,outcomes,0,0
37017,remains,0,0
37018,an,0,0
37019,issue,0,0
37020,.,0,0
37021,The,0,0
37022,aim,0,0
37023,of,0,0
37024,this,0,0
37025,study,0,0
37026,was,0,0
37027,to,0,0
37028,determine,0,0
37029,the,0,0
37030,influence,0,0
37031,of,0,0
37032,diabetes,0,1
37033,on,0,1
37034,9-month,0,1
37035,outcomes,0,0
37036,of,0,1
37037,patients,1,1
37038,undergoing,1,1
37039,PCI,1,1
37040,in,1,1
37041,the,1,0
37042,current,1,0
37043,era,1,0
37044,.,1,1
37045,METHODS,0,0
37046,AND,0,0
37047,RESULTS,0,1
37048,The,1,1
37049,11,1,1
37050,482,1,1
37051,patients,1,1
37052,enrolled,1,1
37053,in,1,1
37054,the,1,0
37055,Prevention,1,1
37056,of,1,0
37057,REStenosis,1,1
37058,with,1,1
37059,Tranilast,1,0
37060,and,1,1
37061,its,1,0
37062,Outcomes,1,0
37063,(,1,1
37064,PRESTO,1,1
37065,),1,1
37066,Trial,1,1
37067,were,0,1
37068,stratified,0,1
37069,according,0,1
37070,to,0,0
37071,the,0,0
37072,presence,0,0
37073,(,0,0
37074,n=2694,0,1
37075,),0,1
37076,or,0,1
37077,absence,0,0
37078,(,0,1
37079,n=8798,0,1
37080,),0,1
37081,of,0,1
37082,diabetes,0,1
37083,.,0,1
37084,Diabetic,0,1
37085,patients,0,1
37086,were,0,1
37087,older,0,1
37088,;,0,0
37089,were,0,0
37090,more,0,0
37091,likely,0,0
37092,to,0,0
37093,be,0,0
37094,female,0,1
37095,;,0,0
37096,had,0,1
37097,a,0,0
37098,higher,0,0
37099,proportion,0,0
37100,of,0,0
37101,congestive,0,1
37102,failure,0,1
37103,",",0,0
37104,hypertension,0,1
37105,",",0,0
37106,prior,0,1
37107,CABG,0,0
37108,",",0,1
37109,and,0,0
37110,unstable,0,1
37111,angina,0,1
37112,;,0,1
37113,and,0,0
37114,had,0,1
37115,higher,0,0
37116,body,0,1
37117,mass,0,1
37118,index,0,0
37119,and,0,0
37120,lower,0,0
37121,ejection,0,1
37122,fraction,0,0
37123,than,0,0
37124,nondiabetic,0,1
37125,patients,0,1
37126,(,0,1
37127,P,0,0
37128,<,0,0
37129,0.01,0,0
37130,for,0,0
37131,all,0,1
37132,comparisons,0,0
37133,),0,1
37134,.,0,1
37135,The,0,0
37136,degree,0,0
37137,of,0,0
37138,multivessel,0,1
37139,disease,0,1
37140,was,0,0
37141,similar,0,0
37142,between,0,0
37143,the,0,1
37144,two,0,1
37145,groups,0,1
37146,.,0,1
37147,American,0,1
37148,College,0,1
37149,of,0,1
37150,Cardiology/American,0,1
37151,Heart,0,1
37152,Association,0,1
37153,type,0,1
37154,C,0,1
37155,lesions,0,1
37156,were,0,1
37157,more,0,0
37158,common,0,1
37159,in,0,0
37160,diabetic,0,1
37161,patients,0,1
37162,(,0,1
37163,17,0,1
37164,%,0,0
37165,versus,0,0
37166,15,0,1
37167,%,0,0
37168,",",0,1
37169,P,0,0
37170,<,0,0
37171,0.01,0,0
37172,),0,1
37173,.,0,1
37174,Angiographic,0,0
37175,and,0,0
37176,procedural,0,1
37177,success,0,0
37178,rates,0,0
37179,and,0,1
37180,in-hospital,0,1
37181,events,0,0
37182,were,0,1
37183,similar,0,0
37184,between,0,0
37185,the,0,1
37186,two,0,1
37187,groups,0,0
37188,.,0,1
37189,The,0,0
37190,primary,0,0
37191,end,0,0
37192,point,0,0
37193,of,0,0
37194,death,0,0
37195,",",0,0
37196,myocardial,0,1
37197,infarction,0,1
37198,",",0,0
37199,or,0,0
37200,target,0,0
37201,vessel,0,1
37202,revascularization,0,1
37203,(,0,1
37204,TVR,0,1
37205,),0,1
37206,was,0,0
37207,analyzed,0,0
37208,as,0,0
37209,time-to-first,0,0
37210,event,0,0
37211,within,0,1
37212,9,0,1
37213,months,0,1
37214,of,0,1
37215,the,0,0
37216,index,0,1
37217,PCI,0,0
37218,.,0,1
37219,After,0,0
37220,adjusting,0,0
37221,for,0,1
37222,certain,0,0
37223,baseline,0,1
37224,characteristics,0,1
37225,",",0,1
37226,diabetes,0,1
37227,was,0,0
37228,independently,0,0
37229,associated,0,0
37230,with,0,1
37231,death,0,0
37232,at,0,1
37233,9,0,1
37234,months,0,1
37235,(,0,1
37236,relative,0,0
37237,risk,0,1
37238,[,0,0
37239,RR,0,1
37240,],0,1
37241,",",0,1
37242,1.87,0,0
37243,;,0,1
37244,95,0,0
37245,%,0,0
37246,CI,0,0
37247,",",0,1
37248,1.31,0,0
37249,to,0,1
37250,2.68,0,0
37251,",",0,1
37252,P,0,0
37253,<,0,0
37254,0.01,0,0
37255,),0,1
37256,and,0,0
37257,with,0,1
37258,an,0,0
37259,increased,0,0
37260,likelihood,0,0
37261,of,0,0
37262,TVR,0,1
37263,(,0,1
37264,RR,0,1
37265,",",0,1
37266,1.27,0,0
37267,;,0,1
37268,95,0,0
37269,%,0,0
37270,CI,0,0
37271,",",0,1
37272,1.14,0,0
37273,to,0,1
37274,1.42,0,0
37275,",",0,1
37276,P,0,0
37277,<,0,0
37278,0.01,0,0
37279,),0,0
37280,",",0,0
37281,as,0,0
37282,well,0,0
37283,as,0,0
37284,the,0,0
37285,composite,0,0
37286,end,0,0
37287,point,0,0
37288,of,0,0
37289,death/myocardial,0,0
37290,infarction/TVR,0,1
37291,(,0,1
37292,RR,0,1
37293,",",0,1
37294,1.26,0,0
37295,;,0,1
37296,95,0,0
37297,%,0,0
37298,CI,0,0
37299,",",0,1
37300,1.13,0,0
37301,to,0,1
37302,1.40,0,0
37303,",",0,1
37304,P,0,0
37305,<,0,0
37306,0.01,0,0
37307,),0,1
37308,.,0,1
37309,CONCLUSIONS,0,0
37310,Despite,0,0
37311,advances,0,0
37312,in,0,1
37313,interventional,0,1
37314,techniques,0,0
37315,",",0,0
37316,diabetes,0,1
37317,remains,0,0
37318,a,0,0
37319,significant,0,0
37320,independent,0,0
37321,predictor,0,0
37322,of,0,1
37323,adverse,0,0
37324,events,0,0
37325,in,0,1
37326,the,0,1
37327,intermediate,0,0
37328,term,0,1
37329,after,0,1
37330,PCI,0,1
37331,.,0,1
37332,Psychoeducational,0,1
37333,group,0,1
37334,intervention,0,1
37335,for,0,0
37336,wives,1,1
37337,of,1,1
37338,men,1,1
37339,with,1,1
37340,prostate,1,1
37341,cancer,1,1
37342,.,1,1
37343,OBJECTIVE,0,0
37344,The,0,0
37345,effects,0,0
37346,of,0,0
37347,a,0,1
37348,6-week,0,0
37349,psychoeducational,0,1
37350,group,0,1
37351,intervention,0,0
37352,on,0,0
37353,the,0,0
37354,distress,0,0
37355,",",0,0
37356,coping,0,0
37357,",",0,0
37358,personal,0,1
37359,growth,0,0
37360,",",0,0
37361,and,0,0
37362,marital,0,1
37363,communication,0,0
37364,of,0,1
37365,wives,1,1
37366,of,1,1
37367,men,1,1
37368,diagnosed,1,1
37369,with,1,1
37370,prostate,1,1
37371,cancer,1,1
37372,were,0,1
37373,evaluated,0,0
37374,using,0,0
37375,a,0,1
37376,randomized,0,1
37377,clinical,0,0
37378,trial,0,1
37379,.,0,1
37380,METHODS,0,0
37381,Sixty,1,1
37382,wives,1,1
37383,completed,0,1
37384,measures,0,0
37385,prior,0,1
37386,to,0,0
37387,random,0,1
37388,assignment,0,0
37389,to,0,0
37390,either,0,0
37391,the,0,0
37392,psychoeducational,0,0
37393,group,0,1
37394,intervention,0,0
37395,or,0,1
37396,a,0,0
37397,no-treatment,0,0
37398,control,0,1
37399,group,0,1
37400,",",0,0
37401,and,0,0
37402,1,0,0
37403,month,0,0
37404,after,0,0
37405,completion,0,0
37406,of,0,0
37407,the,0,0
37408,group,0,1
37409,.,0,1
37410,RESULTS,0,0
37411,No,0,0
37412,differences,0,0
37413,with,0,1
37414,regard,0,0
37415,to,0,1
37416,wives,0,1
37417,',0,1
37418,general,0,1
37419,distress,0,1
37420,or,0,1
37421,cancer-specific,0,0
37422,distress,0,0
37423,were,0,1
37424,noted,0,0
37425,.,0,1
37426,In,0,0
37427,comparison,0,0
37428,with,0,1
37429,the,0,0
37430,control,0,0
37431,group,0,0
37432,",",0,1
37433,participants,0,1
37434,receiving,0,1
37435,the,0,0
37436,intervention,0,0
37437,perceived,0,0
37438,that,0,0
37439,having,0,1
37440,a,0,0
37441,spouse,0,1
37442,with,0,1
37443,prostate,0,1
37444,cancer,0,1
37445,had,0,1
37446,made,0,0
37447,positive,0,1
37448,contributions,0,0
37449,to,0,1
37450,their,0,1
37451,lives,0,1
37452,",",0,1
37453,reported,0,1
37454,gains,0,0
37455,in,0,0
37456,the,0,0
37457,use,0,0
37458,of,0,0
37459,positive,0,1
37460,reappraisal,0,1
37461,coping,0,0
37462,and,0,1
37463,reductions,0,0
37464,in,0,1
37465,denial,0,1
37466,coping,0,0
37467,.,0,1
37468,CONCLUSION,0,0
37469,Although,0,0
37470,the,0,0
37471,psychoeducational,0,1
37472,intervention,0,0
37473,did,0,0
37474,not,0,0
37475,result,0,0
37476,in,0,0
37477,changes,0,0
37478,in,0,1
37479,psychological,0,1
37480,distress,0,1
37481,",",0,1
37482,improvements,0,0
37483,in,0,1
37484,adaptive,0,0
37485,coping,0,0
37486,and,0,1
37487,indicators,0,0
37488,of,0,1
37489,psychological,0,1
37490,growth,0,0
37491,were,0,1
37492,found,0,0
37493,.,0,1
37494,The,0,0
37495,utility,0,0
37496,of,0,0
37497,group,0,1
37498,interventions,0,0
37499,for,0,1
37500,spouses,1,1
37501,of,1,1
37502,men,1,1
37503,with,1,1
37504,prostate,1,1
37505,cancer,1,1
37506,is,0,0
37507,discussed,0,0
37508,.,0,0
37509,Injection,0,0
37510,pain,0,1
37511,and,0,0
37512,postinjection,0,0
37513,pain,0,1
37514,of,0,0
37515,the,0,0
37516,palatal-anterior,1,0
37517,superior,1,0
37518,alveolar,1,0
37519,injection,1,0
37520,",",0,0
37521,administered,0,0
37522,with,0,1
37523,the,0,0
37524,Wand,0,0
37525,Plus,0,1
37526,system,0,1
37527,",",0,0
37528,comparing,0,0
37529,2,0,1
37530,%,0,0
37531,lidocaine,0,0
37532,with,0,1
37533,"1:100,000",0,1
37534,epinephrine,0,0
37535,to,0,1
37536,3,0,1
37537,%,0,0
37538,mepivacaine,0,0
37539,.,0,0
37540,PURPOSE,0,0
37541,The,0,0
37542,purpose,0,0
37543,of,0,0
37544,this,0,0
37545,prospective,0,1
37546,",",0,0
37547,randomized,0,1
37548,",",0,0
37549,double-blind,0,0
37550,study,0,1
37551,was,0,0
37552,to,0,0
37553,compare,0,0
37554,injection,0,0
37555,pain,0,1
37556,and,0,0
37557,postinjection,0,0
37558,pain,0,1
37559,of,0,0
37560,2,0,1
37561,%,0,0
37562,lidocaine,0,0
37563,with,0,1
37564,"1:100,000",0,1
37565,epinephrine,0,0
37566,and,0,1
37567,3,0,1
37568,%,0,0
37569,mepivacaine,0,0
37570,using,0,0
37571,the,0,0
37572,computer-assisted,0,0
37573,Wand,0,0
37574,Plus,0,1
37575,injection,0,0
37576,system,0,0
37577,to,0,0
37578,administer,0,0
37579,the,0,0
37580,palatal-anterior,0,0
37581,superior,0,0
37582,alveolar,0,0
37583,(,0,1
37584,P-ASA,0,1
37585,),0,1
37586,injection,0,0
37587,.,0,1
37588,Additionally,0,0
37589,study,0,0
37590,was,0,0
37591,done,0,0
37592,to,0,0
37593,determine,0,0
37594,if,0,0
37595,the,0,0
37596,use,0,0
37597,of,0,0
37598,topical,0,0
37599,anesthetic,0,0
37600,decreased,0,0
37601,the,0,0
37602,pain,0,1
37603,of,0,0
37604,needle,0,1
37605,insertion,0,1
37606,with,0,1
37607,the,0,0
37608,P-ASA,0,1
37609,injection,0,0
37610,.,0,1
37611,STUDY,0,0
37612,DESIGN,0,0
37613,Using,0,1
37614,a,0,0
37615,crossover,0,0
37616,design,0,1
37617,",",0,1
37618,40,1,1
37619,subjects,1,1
37620,randomly,0,1
37621,received,0,0
37622,",",0,0
37623,in,0,0
37624,a,0,0
37625,double-blind,0,0
37626,manner,0,0
37627,",",0,1
37628,P-ASA,0,1
37629,injections,0,0
37630,of,0,1
37631,1.4,0,0
37632,mL,0,1
37633,of,0,1
37634,2,0,1
37635,%,0,0
37636,lidocaine,0,0
37637,with,0,1
37638,"1:100,000",0,1
37639,epinephrine,0,0
37640,and,0,1
37641,1.4,0,0
37642,mL,0,0
37643,of,0,1
37644,3,0,1
37645,%,0,0
37646,mepivacaine,0,0
37647,",",0,0
37648,at,0,0
37649,2,0,1
37650,separate,0,1
37651,appointments,0,1
37652,.,0,1
37653,The,0,0
37654,P-ASA,0,1
37655,injection,0,0
37656,was,0,0
37657,administered,0,0
37658,",",0,0
37659,utilizing,0,0
37660,the,0,0
37661,Wand,0,0
37662,Plus,0,1
37663,system,0,1
37664,",",0,1
37665,6,0,0
37666,to,0,1
37667,10,0,1
37668,mm,0,1
37669,into,0,1
37670,the,0,0
37671,incisive,0,0
37672,canal,0,1
37673,located,0,1
37674,lingual,0,1
37675,to,0,1
37676,the,0,0
37677,central,0,0
37678,incisors,0,1
37679,.,0,1
37680,The,0,0
37681,pain,0,0
37682,of,0,0
37683,needle,0,1
37684,insertion,0,1
37685,",",0,0
37686,needle,0,1
37687,placement,0,0
37688,",",0,0
37689,solution,0,0
37690,deposition,0,1
37691,and,0,0
37692,postinjection,0,0
37693,pain,0,1
37694,were,0,0
37695,recorded,0,0
37696,on,0,0
37697,a,0,1
37698,Heft-Parker,0,0
37699,visual,0,0
37700,analog,0,0
37701,scale,0,0
37702,for,0,0
37703,the,0,0
37704,2,0,1
37705,P-ASA,0,1
37706,injections,0,0
37707,.,0,1
37708,Eighty,0,1
37709,injections,0,0
37710,were,0,1
37711,randomly,0,1
37712,administered,0,0
37713,in,0,0
37714,the,0,0
37715,study,0,0
37716,",",0,0
37717,40,0,1
37718,using,0,0
37719,topical,0,0
37720,anesthetic,0,1
37721,gel,0,0
37722,and,0,1
37723,40,0,1
37724,using,0,0
37725,a,0,1
37726,placebo,0,0
37727,gel,0,0
37728,.,0,1
37729,RESULTS,0,0
37730,For,0,1
37731,needle,0,1
37732,insertion,0,1
37733,",",0,1
37734,30,0,1
37735,%,0,0
37736,of,0,0
37737,the,0,0
37738,subjects,0,1
37739,reported,0,0
37740,moderate/severe,0,1
37741,pain,0,1
37742,with,0,1
37743,the,0,0
37744,lidocaine,0,0
37745,solution,0,0
37746,and,0,1
37747,43,0,1
37748,%,0,0
37749,reported,0,0
37750,moderate/severe,0,1
37751,pain,0,1
37752,with,0,1
37753,the,0,0
37754,mepivacaine,0,0
37755,solution,0,0
37756,.,0,0
37757,There,0,0
37758,was,0,0
37759,no,0,0
37760,significant,0,0
37761,difference,0,0
37762,(,0,1
37763,P,0,0
37764,>,0,1
37765,.05,0,0
37766,),0,1
37767,between,0,0
37768,the,0,0
37769,topical,0,0
37770,and,0,1
37771,placebo,0,1
37772,groups,0,1
37773,.,0,1
37774,For,0,1
37775,needle,0,1
37776,placement,0,0
37777,into,0,1
37778,the,0,0
37779,incisive,0,0
37780,canal,0,1
37781,",",0,1
37782,54,0,1
37783,%,0,0
37784,of,0,0
37785,the,0,0
37786,subjects,0,1
37787,reported,0,0
37788,moderate/severe,0,1
37789,pain,0,1
37790,with,0,1
37791,the,0,0
37792,lidocaine,0,0
37793,solution,0,0
37794,and,0,1
37795,58,0,1
37796,%,0,0
37797,reported,0,0
37798,moderate/severe,0,1
37799,pain,0,1
37800,with,0,1
37801,the,0,0
37802,mepivacaine,0,0
37803,solution,0,0
37804,.,0,1
37805,For,0,0
37806,anesthetic,0,0
37807,solution,0,0
37808,deposition,0,1
37809,",",0,0
37810,8,0,0
37811,%,0,0
37812,of,0,0
37813,the,0,0
37814,subjects,0,1
37815,reported,0,1
37816,moderate,0,1
37817,pain,0,1
37818,with,0,1
37819,the,0,0
37820,lidocaine,0,0
37821,solution,0,0
37822,and,0,1
37823,12,0,1
37824,%,0,0
37825,reported,0,1
37826,moderate,0,1
37827,pain,0,1
37828,with,0,1
37829,the,0,0
37830,mepivacaine,0,0
37831,solution,0,0
37832,.,0,0
37833,There,0,0
37834,were,0,0
37835,no,0,0
37836,significant,0,0
37837,differences,0,0
37838,(,0,1
37839,P,0,0
37840,>,0,1
37841,.05,0,0
37842,),0,1
37843,between,0,0
37844,the,0,0
37845,lidocaine,0,0
37846,and,0,0
37847,mepivacaine,0,0
37848,solutions,0,0
37849,.,0,1
37850,Regarding,0,0
37851,postinjection,0,0
37852,pain,0,0
37853,",",0,0
37854,when,0,0
37855,anesthesia,0,1
37856,wore,0,0
37857,off,0,0
37858,on,0,0
37859,the,0,0
37860,day,0,0
37861,of,0,0
37862,the,0,0
37863,injection,0,0
37864,",",0,0
37865,20,0,1
37866,%,0,0
37867,of,0,0
37868,the,0,0
37869,subjects,0,1
37870,reported,0,0
37871,moderate/severe,0,1
37872,pain,0,1
37873,with,0,1
37874,the,0,0
37875,lidocaine,0,0
37876,solution,0,0
37877,and,0,1
37878,14,0,1
37879,%,0,0
37880,reported,0,0
37881,moderate/severe,0,1
37882,pain,0,1
37883,with,0,1
37884,the,0,0
37885,mepivacaine,0,0
37886,solution,0,0
37887,.,0,1
37888,Pain,0,0
37889,ratings,0,0
37890,decreased,0,0
37891,over,0,0
37892,the,0,0
37893,next,0,1
37894,3,0,1
37895,days,0,0
37896,.,0,1
37897,There,0,0
37898,were,0,0
37899,no,0,0
37900,significant,0,0
37901,differences,0,0
37902,(,0,1
37903,P,0,0
37904,>,0,1
37905,.05,0,0
37906,),0,1
37907,between,0,0
37908,the,0,0
37909,lidocaine,0,0
37910,and,0,0
37911,mepivacaine,0,0
37912,solutions,0,0
37913,.,0,1
37914,Postinjection,0,0
37915,",",0,0
37916,12,0,1
37917,%,0,0
37918,and,0,1
37919,18,0,1
37920,%,0,0
37921,of,0,0
37922,the,0,0
37923,subjects,0,1
37924,experienced,0,1
37925,temporary,0,0
37926,numbness/paresthesia,0,1
37927,of,0,0
37928,the,0,0
37929,incisive,0,0
37930,papilla,0,1
37931,with,0,1
37932,the,0,0
37933,lidocaine,0,0
37934,and,0,0
37935,mepivacaine,0,0
37936,solutions,0,0
37937,",",0,1
37938,respectively,0,0
37939,.,0,1
37940,Twenty,0,1
37941,percent,0,1
37942,and,0,1
37943,28,0,1
37944,%,0,0
37945,of,0,0
37946,the,0,0
37947,subjects,0,1
37948,had,0,1
37949,incisive,0,1
37950,papilla,0,1
37951,swelling,0,0
37952,or,0,1
37953,soreness,0,0
37954,with,0,1
37955,the,0,0
37956,lidocaine,0,0
37957,and,0,0
37958,mepivacaine,0,0
37959,solutions,0,0
37960,",",0,1
37961,respectively,0,0
37962,.,0,0
37963,There,0,0
37964,were,0,0
37965,no,0,0
37966,significant,0,0
37967,differences,0,0
37968,(,0,1
37969,P,0,0
37970,>,0,1
37971,.05,0,0
37972,),0,1
37973,between,0,0
37974,the,0,0
37975,lidocaine,0,0
37976,and,0,0
37977,mepivacaine,0,0
37978,solutions,0,0
37979,.,0,1
37980,CONCLUSIONS,0,0
37981,The,0,0
37982,P-ASA,0,1
37983,injection,0,0
37984,of,0,0
37985,1.4,0,0
37986,mL,0,1
37987,of,0,1
37988,2,0,1
37989,%,0,0
37990,lidocaine,0,0
37991,with,0,1
37992,"1:100,000",0,1
37993,epinephrine,0,0
37994,or,0,1
37995,3,0,1
37996,%,0,0
37997,mepivacaine,0,0
37998,",",0,0
37999,administered,0,0
38000,with,0,1
38001,the,0,0
38002,Wand,0,0
38003,Plus,0,1
38004,",",0,0
38005,has,0,0
38006,the,0,0
38007,potential,0,0
38008,to,0,0
38009,be,0,0
38010,a,0,0
38011,painful,0,0
38012,injection,0,0
38013,.,0,1
38014,The,0,0
38015,use,0,0
38016,of,0,0
38017,topical,0,0
38018,anesthetic,0,0
38019,did,0,0
38020,not,0,0
38021,significantly,0,0
38022,reduce,0,0
38023,pain,0,1
38024,of,0,0
38025,needle,0,0
38026,insertion,0,0
38027,when,0,0
38028,compared,0,0
38029,to,0,0
38030,a,0,1
38031,placebo,0,0
38032,.,0,0
38033,The,0,0
38034,incidence,0,0
38035,of,0,0
38036,postinjection,0,0
38037,pain,0,1
38038,",",0,0
38039,temporary,0,0
38040,numbness/paresthesia,0,1
38041,",",0,0
38042,and,0,0
38043,incisive,0,0
38044,papilla,0,1
38045,swelling,0,0
38046,or,0,0
38047,soreness,0,0
38048,would,0,0
38049,indicate,0,0
38050,that,0,0
38051,some,0,0
38052,pain,0,1
38053,and,0,0
38054,problems,0,1
38055,occur,0,0
38056,with,0,1
38057,the,0,0
38058,P-ASA,0,1
38059,technique,0,0
38060,",",0,0
38061,regardless,0,0
38062,of,0,0
38063,whether,0,0
38064,2,0,1
38065,%,0,0
38066,lidocaine,0,0
38067,with,0,1
38068,"1:100,000",0,1
38069,epinephrine,0,0
38070,or,0,1
38071,3,0,1
38072,%,0,0
38073,mepivacaine,0,0
38074,is,0,0
38075,used,0,0
38076,.,0,0
38077,Rapid-sequence,0,1
38078,intubation,0,1
38079,of,0,0
38080,head,1,1
38081,trauma,1,1
38082,patients,1,1
38083,:,1,1
38084,prevention,0,1
38085,of,0,0
38086,fasciculations,0,1
38087,with,0,1
38088,pancuronium,0,1
38089,versus,0,0
38090,minidose,0,0
38091,succinylcholine,0,1
38092,.,0,1
38093,INTRODUCTION,0,0
38094,Fasciculations,0,1
38095,during,0,1
38096,rapid-sequence,0,0
38097,intubation,0,1
38098,may,0,0
38099,lead,0,0
38100,to,0,0
38101,increased,0,0
38102,intracranial,0,1
38103,pressure,0,0
38104,and,0,0
38105,emesis,0,1
38106,with,0,1
38107,aspiration,0,1
38108,.,0,1
38109,Standard,0,0
38110,rapid-sequence,0,0
38111,intubation,0,0
38112,requires,0,0
38113,a,0,0
38114,nondepolarizing,0,0
38115,blocking,0,0
38116,agent,0,0
38117,before,0,0
38118,succinylcholine,0,1
38119,administration,0,0
38120,.,0,1
38121,HYPOTHESIS,0,0
38122,Prevention,0,1
38123,of,0,1
38124,fasciculations,0,1
38125,during,0,1
38126,rapid-sequence,0,1
38127,intubation,0,1
38128,of,0,0
38129,head,1,1
38130,trauma,1,1
38131,patients,1,1
38132,can,0,0
38133,be,0,0
38134,accomplished,0,0
38135,as,0,0
38136,safely,0,0
38137,and,0,0
38138,effectively,0,0
38139,with,0,1
38140,minidose,0,0
38141,succinylcholine,0,1
38142,as,0,0
38143,with,0,1
38144,a,0,1
38145,defasciculating,0,0
38146,dose,0,0
38147,of,0,1
38148,pancuronium,0,1
38149,.,0,1
38150,DESIGN,0,0
38151,A,0,0
38152,prospective,0,0
38153,",",0,0
38154,randomized,0,1
38155,",",0,0
38156,double-blind,0,0
38157,study,0,1
38158,.,0,1
38159,SETTING,0,1
38160,An,0,0
38161,inner-city,1,1
38162,county,1,1
38163,trauma,1,1
38164,center,1,1
38165,with,1,1
38166,"70,000",1,1
38167,patient,1,1
38168,visits,1,1
38169,per,1,1
38170,year,1,1
38171,.,1,1
38172,PARTICIPANTS,0,0
38173,Sequential,1,0
38174,adult,1,1
38175,head,1,1
38176,trauma,1,1
38177,patients,1,1
38178,requiring,1,1
38179,rapid-sequence,1,1
38180,intubation,1,1
38181,who,1,1
38182,had,1,1
38183,no,1,1
38184,contraindications,1,0
38185,to,1,0
38186,succinylcholine,1,1
38187,or,1,1
38188,pancuronium,1,1
38189,.,1,1
38190,INTERVENTIONS,0,0
38191,Each,0,0
38192,head,1,1
38193,trauma,1,1
38194,patient,1,1
38195,requiring,0,1
38196,rapid-sequence,0,1
38197,intubation,0,1
38198,who,0,1
38199,met,0,1
38200,the,0,1
38201,inclusion,0,1
38202,criteria,0,1
38203,received,0,1
38204,standard,0,1
38205,rapid-sequence,0,1
38206,intubation,0,1
38207,maneuvers,0,0
38208,and,0,1
38209,lidocaine,0,0
38210,(,0,1
38211,1,0,1
38212,mg/kg,0,0
38213,),0,1
38214,IV,0,1
38215,.,0,1
38216,Patients,0,1
38217,were,0,1
38218,randomized,0,1
38219,to,0,0
38220,receive,0,1
38221,either,0,0
38222,minidose,0,0
38223,succinylcholine,0,1
38224,(,0,1
38225,0.1,0,0
38226,mg/kg,0,0
38227,),0,1
38228,or,0,1
38229,pancuronium,0,1
38230,(,0,1
38231,0.03,0,0
38232,mg/kg,0,0
38233,),0,1
38234,IV,0,1
38235,one,0,1
38236,minute,0,0
38237,prior,0,1
38238,to,0,0
38239,the,0,0
38240,full,0,0
38241,paralytic,0,1
38242,dose,0,0
38243,of,0,0
38244,succinylcholine,0,1
38245,(,0,1
38246,1.5,0,0
38247,mg/kg,0,0
38248,),0,1
38249,IV,0,1
38250,.,0,1
38251,Fasciculations,0,0
38252,were,0,1
38253,recorded,0,0
38254,using,0,0
38255,a,0,1
38256,graded,0,0
38257,visual,0,0
38258,scale,0,1
38259,.,0,1
38260,RESULTS,0,0
38261,Of,0,1
38262,46,1,1
38263,patients,1,1
38264,",",0,1
38265,eight,0,1
38266,of,0,1
38267,19,0,1
38268,(,0,1
38269,42,0,1
38270,%,0,0
38271,),0,1
38272,in,0,0
38273,the,0,0
38274,pancuronium,0,1
38275,group,0,1
38276,and,0,1
38277,six,0,1
38278,of,0,1
38279,27,0,1
38280,(,0,1
38281,22,0,1
38282,%,0,0
38283,),0,1
38284,in,0,0
38285,the,0,0
38286,succinylcholine,0,1
38287,group,0,1
38288,experienced,0,1
38289,fasciculations,0,1
38290,.,0,1
38291,No,0,0
38292,statistically,0,0
38293,significant,0,0
38294,difference,0,0
38295,in,0,1
38296,fasciculations,0,1
38297,was,0,0
38298,detected,0,0
38299,between,0,0
38300,the,0,1
38301,two,0,1
38302,groups,0,0
38303,using,0,1
38304,chi,0,1
38305,2,0,1
38306,analysis,0,0
38307,.,0,1
38308,Complete,0,0
38309,relaxation,0,0
38310,of,0,0
38311,the,0,0
38312,cords,0,1
38313,was,0,0
38314,present,0,0
38315,in,0,0
38316,all,0,1
38317,but,0,0
38318,two,0,0
38319,patients,0,1
38320,",",0,1
38321,one,0,1
38322,in,0,0
38323,each,0,1
38324,group,0,1
38325,.,0,0
38326,No,0,0
38327,patient,0,0
38328,in,0,0
38329,either,0,1
38330,group,0,0
38331,experienced,0,0
38332,emesis,0,1
38333,or,0,1
38334,significant,0,0
38335,dysrhythmias,0,1
38336,.,0,1
38337,CONCLUSION,0,0
38338,Pretreatment,0,0
38339,with,0,1
38340,minidose,0,0
38341,succinylcholine,0,1
38342,causes,0,0
38343,no,0,0
38344,greater,0,0
38345,incidence,0,0
38346,of,0,0
38347,fasciculations,0,1
38348,than,0,1
38349,pancuronium,0,1
38350,in,0,1
38351,rapid-sequence,0,0
38352,intubation,0,1
38353,of,0,0
38354,head,1,1
38355,trauma,1,1
38356,patients,1,1
38357,in,1,1
38358,an,1,1
38359,ED,1,0
38360,setting,1,1
38361,.,1,1
38362,Thus,0,0
38363,succinylcholine,0,0
38364,may,0,0
38365,be,0,0
38366,used,0,0
38367,as,0,0
38368,the,0,0
38369,sole,0,0
38370,paralytic,0,1
38371,agent,0,1
38372,in,0,1
38373,rapid-sequence,0,0
38374,intubation,0,1
38375,of,0,0
38376,head,0,1
38377,trauma,0,1
38378,patients,0,1
38379,.,0,1
38380,Clinical,0,0
38381,effects,0,0
38382,of,0,1
38383,naltrexone,0,1
38384,on,0,0
38385,autistic,1,1
38386,behavior,1,1
38387,.,1,1
38388,Eight,1,0
38389,young,1,1
38390,adults,1,1
38391,who,1,1
38392,were,1,1
38393,diagnosed,1,1
38394,with,1,1
38395,autism,1,1
38396,were,0,1
38397,given,0,0
38398,the,0,0
38399,opiate,0,1
38400,antagonist,0,0
38401,naltrexone,0,0
38402,to,0,0
38403,control,0,1
38404,self-injurious,0,1
38405,behavior,0,0
38406,and,0,1
38407,maladaptive,0,0
38408,idiosyncratic,0,0
38409,mannerisms,0,0
38410,.,0,1
38411,The,0,0
38412,drug,0,0
38413,and,0,0
38414,placebo,0,0
38415,were,0,0
38416,administered,0,0
38417,in,0,0
38418,a,0,1
38419,double-blind,0,0
38420,crossover,0,0
38421,design,0,1
38422,over,0,0
38423,17,0,1
38424,weeks,0,1
38425,.,0,1
38426,Although,0,0
38427,one,0,1
38428,subject,0,1
38429,appeared,0,0
38430,to,0,0
38431,have,0,0
38432,partial,0,1
38433,decreases,0,0
38434,in,0,1
38435,maladaptive,0,1
38436,behaviors,0,0
38437,associated,0,0
38438,with,0,1
38439,naltrexone,0,1
38440,use,0,0
38441,",",0,0
38442,the,0,0
38443,drugs,0,0
38444,",",0,0
38445,as,0,0
38446,administered,0,0
38447,in,0,0
38448,this,0,0
38449,study,0,0
38450,",",0,0
38451,did,0,0
38452,not,0,0
38453,reduce,0,0
38454,the,0,0
38455,self-injurious,0,0
38456,and,0,0
38457,other,0,1
38458,maladaptive,0,0
38459,behaviors,0,0
38460,of,0,1
38461,the,0,1
38462,subjects,0,1
38463,.,0,1
38464,[,0,0
38465,Clinical,0,0
38466,study,0,0
38467,on,0,0
38468,dan,0,1
38469,shao,0,0
38470,tang,0,0
38471,in,0,0
38472,treating,0,0
38473,IgA,0,1
38474,nephropathy,0,1
38475,of,0,0
38476,deficiency,0,1
38477,of,0,0
38478,yin,0,0
38479,with,0,1
38480,damp-heat,0,1
38481,symptom,0,1
38482,],0,1
38483,.,0,1
38484,OBJECTIVE,0,0
38485,To,0,0
38486,explore,0,0
38487,the,0,0
38488,effect,0,0
38489,of,0,0
38490,Dan,0,1
38491,Shao,0,1
38492,Tang,0,1
38493,(,0,1
38494,DST,0,1
38495,),0,1
38496,in,0,0
38497,treating,0,0
38498,IgA,0,1
38499,nephropathy,0,1
38500,(,0,1
38501,IgAN,0,0
38502,),0,1
38503,of,0,0
38504,deficiency,0,1
38505,of,0,0
38506,Yin,0,0
38507,with,0,1
38508,damp-heat,0,1
38509,symptom,0,1
38510,.,0,1
38511,METHODS,0,0
38512,90,1,1
38513,patients,1,1
38514,with,1,1
38515,IgAN,1,1
38516,of,1,0
38517,deficiency,1,1
38518,of,1,0
38519,Yin,1,0
38520,with,1,1
38521,damp-heat,1,1
38522,symptom,1,1
38523,were,0,1
38524,randomly,0,1
38525,divided,0,1
38526,into,0,1
38527,two,0,1
38528,groups,0,1
38529,.,0,1
38530,50,0,1
38531,patients,0,1
38532,in,0,1
38533,treatment,0,1
38534,group,0,1
38535,were,0,0
38536,treated,0,1
38537,with,0,1
38538,DST,0,1
38539,and,0,1
38540,western,0,1
38541,medicine,0,1
38542,and,0,1
38543,40,0,1
38544,patients,0,1
38545,in,0,1
38546,control,0,1
38547,group,0,1
38548,were,0,0
38549,treated,0,1
38550,only,0,0
38551,with,0,1
38552,western,0,1
38553,medicine,0,1
38554,.,0,1
38555,The,0,0
38556,effects,0,0
38557,and,0,1
38558,changes,0,0
38559,of,0,1
38560,the,0,1
38561,indexes,0,0
38562,including,0,1
38563,renal,0,1
38564,function,0,0
38565,",",0,0
38566,hematuria,0,1
38567,",",0,0
38568,proteinuria,0,0
38569,",",0,0
38570,blood,0,0
38571,IgA,0,1
38572,before,0,0
38573,and,0,0
38574,after,0,1
38575,treatment,0,0
38576,were,0,1
38577,observed,0,0
38578,.,0,1
38579,RESULTS,0,0
38580,After,0,1
38581,six,0,1
38582,months,0,1
38583,treatment,0,0
38584,",",0,0
38585,the,0,0
38586,general,0,1
38587,effective,0,0
38588,rate,0,0
38589,in,0,0
38590,treatment,0,0
38591,group,0,1
38592,was,0,0
38593,70.00,0,0
38594,%,0,0
38595,",",0,0
38596,which,0,0
38597,was,0,0
38598,markedly,0,0
38599,higher,0,0
38600,than,0,0
38601,that,0,0
38602,in,0,0
38603,control,0,1
38604,group,0,1
38605,(,0,1
38606,37.50,0,0
38607,%,0,0
38608,",",0,1
38609,P,0,0
38610,<,0,0
38611,0.01,0,0
38612,),0,1
38613,.,0,1
38614,Treatment,0,0
38615,group,0,0
38616,is,0,0
38617,obviously,0,0
38618,better,0,0
38619,than,0,0
38620,control,0,0
38621,group,0,1
38622,on,0,0
38623,decreasing,0,0
38624,hematuria,0,1
38625,",",0,0
38626,proteinuria,0,0
38627,",",0,0
38628,blood,0,0
38629,IgA,0,1
38630,and,0,1
38631,improving,0,0
38632,renal,0,1
38633,function,0,0
38634,(,0,1
38635,P,0,0
38636,<,0,0
38637,0.05,0,0
38638,),0,1
38639,.,0,1
38640,CONCLUSION,0,0
38641,DST,0,0
38642,is,0,0
38643,effective,0,0
38644,on,0,0
38645,IgAN,0,0
38646,of,0,0
38647,deficiency,0,1
38648,of,0,0
38649,Yin,0,0
38650,with,0,1
38651,damp-heat,0,1
38652,symptom,0,1
38653,.,0,1
38654,Short-term,0,0
38655,fluoxetine,0,1
38656,monotherapy,0,1
38657,for,0,0
38658,bipolar,1,1
38659,type,1,1
38660,II,1,1
38661,or,1,1
38662,bipolar,1,1
38663,NOS,1,1
38664,major,1,1
38665,depression,1,1
38666,-,1,1
38667,low,1,1
38668,manic,1,1
38669,switch,1,1
38670,rate,1,0
38671,.,1,1
38672,OBJECTIVES,0,0
38673,Current,0,1
38674,guidelines,0,1
38675,for,0,1
38676,the,0,1
38677,initial,0,0
38678,treatment,0,0
38679,of,0,0
38680,bipolar,1,1
38681,type,1,1
38682,II,1,1
38683,(,1,1
38684,BP,1,1
38685,II,1,1
38686,),1,1
38687,major,1,1
38688,depressive,1,1
38689,episode,1,1
38690,(,1,1
38691,MDE,1,1
38692,),1,1
38693,recommend,0,0
38694,using,0,0
38695,either,0,0
38696,a,0,1
38697,mood,0,0
38698,stabilizer,0,0
38699,alone,0,0
38700,or,0,1
38701,a,0,0
38702,combination,0,0
38703,of,0,0
38704,a,0,0
38705,mood,0,0
38706,stabilizer,0,0
38707,plus,0,0
38708,a,0,0
38709,selective,0,1
38710,serotonin,0,0
38711,re-uptake,0,1
38712,inhibitor,0,0
38713,(,0,1
38714,SSRI,0,1
38715,),0,1
38716,.,0,1
38717,This,0,0
38718,recommendation,0,0
38719,is,0,0
38720,the,0,0
38721,result,0,0
38722,of,0,0
38723,concern,0,0
38724,over,0,0
38725,antidepressant-induced,0,1
38726,manic,0,1
38727,switch,0,1
38728,episodes,0,1
38729,.,0,1
38730,However,0,0
38731,",",0,0
38732,recent,0,0
38733,evidence,0,0
38734,suggests,0,0
38735,that,0,0
38736,the,0,0
38737,manic,0,1
38738,switch,0,0
38739,rate,0,0
38740,may,0,0
38741,be,0,0
38742,low,0,0
38743,in,0,0
38744,BP,0,1
38745,II,0,1
38746,MDE,0,1
38747,during,0,1
38748,SSRI,0,1
38749,therapy,0,1
38750,.,0,1
38751,METHODS,0,0
38752,As,1,0
38753,part,1,1
38754,of,1,0
38755,a,1,0
38756,randomized,1,1
38757,",",1,0
38758,double-blind,1,0
38759,",",1,0
38760,placebo-controlled,1,0
38761,relapse-prevention,1,0
38762,study,1,1
38763,of,1,0
38764,fluoxetine,1,1
38765,monotherapy,1,1
38766,in,1,1
38767,BP,1,1
38768,II,1,1
38769,MDE,1,1
38770,",",1,1
38771,37,1,1
38772,patients,1,1
38773,received,0,1
38774,open-label,0,1
38775,fluoxetine,0,1
38776,20,0,1
38777,mg,0,0
38778,every,0,0
38779,day,0,0
38780,for,0,0
38781,up,0,1
38782,to,0,1
38783,8,0,1
38784,weeks,0,1
38785,.,0,1
38786,Outcome,0,0
38787,measures,0,0
38788,included,0,1
38789,the,0,0
38790,Hamilton,0,1
38791,Depression,0,0
38792,Rating,0,0
38793,(,0,1
38794,HAM-D,0,1
38795,17,0,1
38796,),0,1
38797,rating,0,0
38798,and,0,0
38799,the,0,0
38800,Young,0,1
38801,Mania,0,1
38802,Rating,0,0
38803,(,0,1
38804,YMR,0,1
38805,),0,1
38806,scale,0,0
38807,.,0,1
38808,RESULTS,0,0
38809,Eleven,0,1
38810,of,0,1
38811,23,0,1
38812,patients,0,1
38813,(,0,1
38814,48,0,1
38815,%,0,1
38816,),0,1
38817,who,0,1
38818,completed,0,1
38819,8,0,1
38820,weeks,0,0
38821,of,0,1
38822,fluoxetine,0,1
38823,treatment,0,0
38824,showed,0,0
38825,a,0,1
38826,HAM-D,0,1
38827,17,0,1
38828,reduction,0,0
38829,of,0,0
38830,>,0,1
38831,or,0,1
38832,=50,0,1
38833,%,0,0
38834,",",0,1
38835,while,0,0
38836,14,0,1
38837,(,0,1
38838,38,0,1
38839,%,0,0
38840,),0,1
38841,of,0,0
38842,all,0,1
38843,treated,0,1
38844,patients,0,1
38845,had,0,1
38846,>,0,1
38847,or,0,1
38848,=50,0,1
38849,%,0,0
38850,reduction,0,0
38851,in,0,0
38852,baseline,0,0
38853,HAM-D,0,1
38854,17,0,1
38855,score,0,1
38856,.,0,1
38857,Using,0,0
38858,a,0,0
38859,conservative,0,1
38860,YMR,0,1
38861,score,0,0
38862,of,0,0
38863,>,0,1
38864,or,0,1
38865,=8,0,1
38866,to,0,0
38867,identify,0,0
38868,hypomanic,0,1
38869,symptoms,0,0
38870,",",0,1
38871,the,0,0
38872,frequency,0,0
38873,of,0,0
38874,patients,0,1
38875,with,0,1
38876,YMR,0,1
38877,score,0,1
38878,>,0,1
38879,or,0,1
38880,=8,0,1
38881,during,0,0
38882,fluoxetine,0,0
38883,did,0,0
38884,not,0,0
38885,differ,0,0
38886,from,0,0
38887,that,0,0
38888,seen,0,0
38889,during,0,0
38890,the,0,0
38891,screen,0,1
38892,and,0,0
38893,baseline,0,0
38894,period,0,0
38895,.,0,1
38896,Only,0,0
38897,three,0,0
38898,patients,0,1
38899,(,0,1
38900,7.3,0,0
38901,%,0,0
38902,),0,1
38903,had,0,1
38904,symptoms,0,0
38905,suggestive,0,0
38906,of,0,1
38907,hypomania,0,0
38908,",",0,0
38909,and,0,0
38910,only,0,0
38911,one,0,1
38912,patient,0,1
38913,stopped,0,1
38914,treatment,0,0
38915,because,0,0
38916,of,0,0
38917,a,0,1
38918,rapid,0,0
38919,mood,0,0
38920,swing,0,1
38921,into,0,1
38922,depression,0,1
38923,.,0,1
38924,LIMITATIONS,0,0
38925,Fluoxetine,0,0
38926,was,0,0
38927,given,0,0
38928,at,0,0
38929,a,0,1
38930,fixed,0,0
38931,dose,0,0
38932,of,0,1
38933,20,0,1
38934,mg,0,1
38935,everyday,0,1
38936,.,0,1
38937,Fluoxetine,0,0
38938,was,0,0
38939,prescribed,0,0
38940,in,0,0
38941,an,0,0
38942,open-label,0,1
38943,manner,0,0
38944,",",0,0
38945,and,0,0
38946,the,0,0
38947,sample,0,1
38948,size,0,0
38949,was,0,0
38950,limited,0,0
38951,.,0,1
38952,CONCLUSIONS,0,0
38953,These,0,1
38954,observations,0,0
38955,support,0,0
38956,the,0,0
38957,findings,0,0
38958,of,0,0
38959,a,0,1
38960,low,0,1
38961,manic,0,1
38962,switch,0,1
38963,rate,0,0
38964,during,0,0
38965,SSRI,0,1
38966,monotherapy,0,1
38967,of,0,0
38968,BP,0,1
38969,II,0,1
38970,MDE,0,1
38971,",",0,0
38972,and,0,0
38973,suggest,0,0
38974,that,0,0
38975,fluoxetine,0,0
38976,monotherapy,0,1
38977,may,0,0
38978,be,0,0
38979,a,0,0
38980,safe,0,0
38981,and,0,0
38982,effective,0,0
38983,initial,0,1
38984,treatment,0,1
38985,of,0,1
38986,BP,1,1
38987,II,1,1
38988,MDE,1,1
38989,.,1,1
38990,A,0,0
38991,randomised,0,0
38992,controlled,0,0
38993,trial,0,1
38994,comparing,0,0
38995,Drawtex,0,0
38996,with,0,1
38997,standard,0,1
38998,dressings,0,0
38999,for,0,1
39000,exuding,1,1
39001,wounds,1,1
39002,.,1,1
39003,OBJECTIVE,0,0
39004,This,0,0
39005,randomised,0,0
39006,controlled,0,0
39007,clinical,0,0
39008,trial,0,0
39009,compared,0,0
39010,a,0,0
39011,capillary,0,0
39012,dressing,0,0
39013,(,0,1
39014,Drawtex,0,0
39015,",",0,0
39016,now,0,0
39017,rebranded,0,0
39018,as,0,0
39019,Vibriant,0,1
39020,RCD,0,1
39021,[,0,0
39022,Vibriant,0,1
39023,Technology,0,1
39024,Services,0,1
39025,],0,1
39026,),0,1
39027,with,0,1
39028,routine,0,1
39029,practice,0,0
39030,for,0,1
39031,exuding,1,1
39032,wounds,1,1
39033,greater,1,1
39034,than,1,1
39035,2.5,1,0
39036,x,1,1
39037,2.5,1,0
39038,cm,1,1
39039,.,1,1
39040,METHOD,0,0
39041,The,0,0
39042,target,1,0
39043,population,1,1
39044,was,1,0
39045,300,1,1
39046,control,1,1
39047,and,1,1
39048,300,1,1
39049,test,1,0
39050,subjects,1,1
39051,across,1,1
39052,three,1,1
39053,sites,1,1
39054,in,1,1
39055,the,1,0
39056,UK,1,1
39057,",",1,0
39058,but,1,0
39059,recruitment,1,0
39060,difficulties,1,1
39061,resulted,1,0
39062,in,1,1
39063,only,1,0
39064,125,1,1
39065,patients,1,1
39066,being,1,1
39067,evaluable,1,1
39068,.,1,1
39069,Wound,0,0
39070,progress,0,0
39071,was,0,0
39072,recorded,0,0
39073,by,0,0
39074,nurses,0,1
39075,',0,1
39076,perception,0,0
39077,of,0,0
39078,the,0,0
39079,progress,0,0
39080,of,0,0
39081,wound,0,0
39082,healing,0,0
39083,and,0,0
39084,by,0,0
39085,objective,0,0
39086,digital,0,1
39087,imaging,0,0
39088,.,0,1
39089,In,0,0
39090,the,0,0
39091,final,0,0
39092,analysis,0,0
39093,digital,0,1
39094,images,0,1
39095,were,0,1
39096,randomised,0,1
39097,(,0,0
39098,in,0,0
39099,time,0,0
39100,order,0,0
39101,),0,0
39102,and,0,0
39103,a,0,0
39104,panel,0,1
39105,of,0,1
39106,nurses,0,1
39107,who,0,1
39108,were,0,1
39109,not,0,1
39110,otherwise,0,1
39111,involved,0,0
39112,in,0,0
39113,the,0,0
39114,research,0,1
39115,project,0,0
39116,graded,0,0
39117,the,0,0
39118,wound,0,0
39119,'s,0,1
39120,progress,0,0
39121,.,0,1
39122,RESULTS,0,0
39123,After,0,0
39124,deconvolution,0,0
39125,of,0,0
39126,the,0,0
39127,data,0,0
39128,",",0,0
39129,the,0,0
39130,subjective,0,0
39131,(,0,0
39132,nurse,0,1
39133,perception,0,0
39134,),0,1
39135,method,0,0
39136,of,0,0
39137,evaluation,0,0
39138,determined,0,0
39139,that,0,0
39140,the,0,0
39141,new,0,1
39142,dressing,0,0
39143,resulted,0,0
39144,in,0,0
39145,wound,0,0
39146,improvement,0,0
39147,in,0,1
39148,12.7,0,0
39149,%,0,0
39150,more,0,0
39151,patients,0,1
39152,than,0,0
39153,did,0,1
39154,routine,0,1
39155,practice,0,0
39156,",",0,0
39157,but,0,0
39158,the,0,0
39159,blinded,0,0
39160,assessment,0,0
39161,method,0,0
39162,(,0,0
39163,based,0,1
39164,on,0,0
39165,the,0,0
39166,digital,0,0
39167,images,0,1
39168,),0,1
39169,showed,0,0
39170,that,0,0
39171,routine,0,1
39172,practice,0,0
39173,was,0,0
39174,better,0,0
39175,by,0,0
39176,6.6,0,0
39177,%,0,0
39178,.,0,1
39179,CONCLUSION,0,0
39180,Evaluation,0,0
39181,of,0,0
39182,wound,0,0
39183,progress,0,0
39184,is,0,0
39185,clearly,0,0
39186,difficult,0,0
39187,.,0,1
39188,Human,0,0
39189,nature,0,0
39190,makes,0,0
39191,us,0,0
39192,favour,0,0
39193,novelty,0,0
39194,if,0,0
39195,we,0,0
39196,believe,0,0
39197,it,0,0
39198,is,0,0
39199,going,0,0
39200,to,0,0
39201,be,0,0
39202,better,0,0
39203,.,0,1
39204,Making,0,0
39205,interpretation,0,0
39206,more,0,0
39207,objective,0,0
39208,removed,0,0
39209,that,0,0
39210,bias,0,0
39211,and,0,0
39212,did,0,0
39213,not,0,0
39214,demonstrate,0,0
39215,a,0,0
39216,significant,0,0
39217,advantage,0,0
39218,for,0,0
39219,the,0,0
39220,test,0,0
39221,dressing,0,0
39222,.,0,1
39223,The,0,0
39224,findings,0,0
39225,suggest,0,0
39226,that,0,0
39227,unblinded,0,0
39228,assessment,0,0
39229,by,0,0
39230,trial,0,0
39231,nurses,0,1
39232,is,0,0
39233,unacceptable,0,0
39234,on,0,0
39235,its,0,0
39236,own,0,1
39237,.,0,1
39238,Blinded,0,0
39239,assessments,0,0
39240,may,0,0
39241,miss,0,1
39242,finer,0,0
39243,nuances,0,0
39244,of,0,0
39245,wound,0,1
39246,progression,0,0
39247,",",0,0
39248,but,0,0
39249,are,0,0
39250,likely,0,0
39251,to,0,0
39252,be,0,0
39253,more,0,0
39254,accurate,0,0
39255,.,0,1
39256,The,0,0
39257,authors,0,0
39258,suggest,0,0
39259,that,0,0
39260,the,0,0
39261,true,0,0
39262,result,0,0
39263,lies,0,0
39264,somewhere,0,0
39265,in,0,0
39266,the,0,0
39267,middle,0,1
39268,",",0,0
39269,with,0,1
39270,the,0,0
39271,trial,0,0
39272,dressing,0,0
39273,likely,0,0
39274,to,0,0
39275,be,0,0
39276,as,0,0
39277,effective,0,0
39278,as,0,0
39279,",",0,0
39280,but,0,0
39281,not,0,0
39282,more,0,0
39283,effective,0,0
39284,than,0,0
39285,",",0,0
39286,a,0,0
39287,standard,0,0
39288,dressing,0,0
39289,.,0,1
39290,The,0,0
39291,influence,0,0
39292,of,0,0
39293,pre-,0,0
39294,and,0,1
39295,intraoperative,0,0
39296,positioning,0,0
39297,of,0,0
39298,the,0,0
39299,condyle,0,1
39300,in,0,0
39301,the,0,0
39302,centre,0,1
39303,of,0,0
39304,the,0,0
39305,articular,0,0
39306,fossa,0,1
39307,on,0,0
39308,the,0,0
39309,position,0,0
39310,of,0,0
39311,the,0,0
39312,disc,0,1
39313,in,0,0
39314,orthognathic,1,1
39315,surgery,1,1
39316,.,1,1
39317,A,0,0
39318,magnetic,0,0
39319,resonance,0,1
39320,study,0,1
39321,.,0,1
39322,OBJECTIVE,0,0
39323,We,0,0
39324,investigated,0,0
39325,the,0,0
39326,changes,0,0
39327,in,0,0
39328,the,0,1
39329,temporomandibular,1,1
39330,joint,1,1
39331,(,1,1
39332,TMJ,1,0
39333,),1,1
39334,after,1,1
39335,bilateral,1,1
39336,sagittal,1,1
39337,split,1,1
39338,osteotomy,1,1
39339,of,1,0
39340,the,1,0
39341,mandible,1,1
39342,for,1,0
39343,orthognathic,1,1
39344,surgery,1,1
39345,and,0,0
39346,the,0,0
39347,influence,0,0
39348,of,0,0
39349,positioning,0,0
39350,of,0,0
39351,the,0,0
39352,condylar,0,1
39353,process,0,0
39354,in,0,0
39355,the,0,0
39356,centre,0,1
39357,of,0,0
39358,the,0,0
39359,articular,0,0
39360,fossa,0,1
39361,before,0,0
39362,and,0,0
39363,during,0,0
39364,the,0,0
39365,operation,0,1
39366,for,0,0
39367,preventing,0,0
39368,changes,0,0
39369,in,0,1
39370,the,0,0
39371,TMJ,0,0
39372,postoperatively,0,0
39373,.,0,1
39374,STUDY,0,0
39375,DESIGN,0,1
39376,A,1,1
39377,total,1,1
39378,of,1,1
39379,28,1,1
39380,patients,1,1
39381,with,1,1
39382,mandibular,1,1
39383,retrognathism,1,1
39384,had,1,1
39385,bilateral,1,1
39386,sagittal,1,1
39387,split,1,1
39388,osteotomies,1,1
39389,for,1,1
39390,mandibular,1,1
39391,advancement,1,1
39392,.,1,1
39393,In,0,0
39394,one,0,1
39395,group,0,1
39396,of,0,1
39397,14,1,1
39398,patients,1,1
39399,(,1,1
39400,28,1,1
39401,TMJ,1,1
39402,),1,1
39403,",",0,0
39404,the,0,0
39405,condyles,0,1
39406,were,0,1
39407,placed,0,0
39408,in,0,0
39409,the,0,0
39410,centre,0,1
39411,of,0,0
39412,the,0,0
39413,articular,0,0
39414,fossa,0,1
39415,before,0,0
39416,and,0,0
39417,during,0,0
39418,the,0,0
39419,operation,0,1
39420,",",0,0
39421,and,0,0
39422,in,0,0
39423,the,0,0
39424,other,0,0
39425,group,0,1
39426,they,0,0
39427,were,0,1
39428,not,0,0
39429,.,0,1
39430,Differences,0,0
39431,on,0,0
39432,magnetic,0,1
39433,resonance,0,1
39434,imaging,0,0
39435,(,0,1
39436,MRI,0,1
39437,),0,1
39438,were,0,1
39439,calculated,0,0
39440,and,0,0
39441,the,0,0
39442,results,0,0
39443,were,0,1
39444,evaluated,0,0
39445,.,0,0
39446,RESULTS,0,0
39447,The,0,0
39448,main,0,0
39449,differences,0,0
39450,were,0,1
39451,found,0,0
39452,at,0,0
39453,maximal,0,0
39454,mouth,0,1
39455,opening,0,1
39456,.,0,1
39457,15/28,1,0
39458,TMJs,1,0
39459,(,1,1
39460,54,1,1
39461,%,1,0
39462,),1,1
39463,that,1,0
39464,had,1,1
39465,not,1,0
39466,been,1,0
39467,positioned,1,0
39468,changed,1,0
39469,the,0,0
39470,position,0,0
39471,of,0,0
39472,the,0,0
39473,disc,0,1
39474,from,0,1
39475,physiological,0,0
39476,to,0,1
39477,anterior,0,1
39478,disc,0,1
39479,derangement,0,1
39480,with,0,1
39481,and,0,0
39482,without,0,1
39483,reduction,0,0
39484,postoperatively,0,0
39485,.,0,1
39486,In,0,0
39487,the,0,0
39488,28,1,1
39489,that,1,0
39490,had,1,1
39491,been,1,0
39492,positioned,1,1
39493,",",1,1
39494,changes,1,0
39495,were,1,1
39496,found,1,0
39497,in,1,0
39498,only,1,0
39499,3,1,1
39500,TMJs,1,0
39501,(,1,1
39502,11,1,1
39503,%,1,0
39504,),1,1
39505,postoperatively,1,0
39506,.,1,1
39507,CONCLUSIONS,0,0
39508,Fixing,0,0
39509,the,0,0
39510,condylar,0,1
39511,process,0,0
39512,in,0,0
39513,the,0,0
39514,centre,0,1
39515,of,0,0
39516,the,0,0
39517,articular,0,0
39518,fossa,0,1
39519,intraoperatively,0,1
39520,before,0,0
39521,bilateral,0,1
39522,sagittal,0,1
39523,split,0,1
39524,osteotomy,0,1
39525,is,0,0
39526,a,0,0
39527,factor,0,0
39528,in,0,0
39529,preventing,0,0
39530,postoperative,0,1
39531,structural,0,1
39532,changes,0,0
39533,in,0,1
39534,the,0,1
39535,temporomandibular,0,1
39536,joint,0,1
39537,.,0,1
39538,A,0,0
39539,randomized,0,0
39540,",",0,0
39541,double-blinded,0,0
39542,",",0,0
39543,placebo-controlled,0,0
39544,trial,0,0
39545,of,0,0
39546,phenytoin,0,0
39547,for,0,0
39548,the,0,0
39549,prevention,0,1
39550,of,0,0
39551,early,0,1
39552,posttraumatic,0,1
39553,seizures,0,1
39554,in,0,1
39555,children,0,1
39556,with,0,1
39557,moderate,0,1
39558,to,0,1
39559,severe,0,1
39560,blunt,0,1
39561,head,0,1
39562,injury,0,1
39563,.,0,1
39564,STUDY,0,0
39565,OBJECTIVE,0,0
39566,We,0,0
39567,determine,0,0
39568,the,0,0
39569,efficacy,0,0
39570,of,0,0
39571,prophylactic,0,1
39572,phenytoin,0,1
39573,in,0,0
39574,preventing,0,0
39575,early,0,1
39576,posttraumatic,0,1
39577,seizures,0,1
39578,in,0,1
39579,children,0,1
39580,with,0,1
39581,moderate,0,1
39582,to,0,1
39583,severe,0,1
39584,blunt,0,1
39585,head,0,1
39586,injury,0,1
39587,.,0,1
39588,METHODS,0,0
39589,Children,1,1
39590,younger,1,1
39591,than,1,1
39592,16,1,1
39593,years,1,1
39594,and,1,1
39595,experiencing,1,1
39596,moderate,1,1
39597,to,1,1
39598,severe,1,1
39599,blunt,1,1
39600,head,1,1
39601,injury,1,1
39602,were,0,1
39603,randomized,0,1
39604,to,0,0
39605,receive,0,1
39606,phenytoin,0,0
39607,or,0,1
39608,placebo,0,0
39609,within,0,1
39610,60,0,1
39611,minutes,0,0
39612,of,0,1
39613,presentation,0,1
39614,at,0,1
39615,3,0,1
39616,pediatric,0,1
39617,trauma,0,1
39618,centers,0,1
39619,.,0,1
39620,The,0,0
39621,primary,0,1
39622,endpoint,0,0
39623,was,0,0
39624,posttraumatic,0,1
39625,seizures,0,1
39626,within,0,1
39627,48,0,1
39628,hours,0,1
39629,;,0,1
39630,secondary,0,1
39631,endpoints,0,0
39632,were,0,1
39633,survival,0,0
39634,and,0,1
39635,neurologic,0,1
39636,outcome,0,0
39637,30,0,1
39638,days,0,0
39639,after,0,1
39640,injury,0,1
39641,.,0,1
39642,A,0,0
39643,Bayesian,0,0
39644,decision-theoretic,0,1
39645,clinical,0,0
39646,trial,0,1
39647,design,0,1
39648,was,0,0
39649,used,0,0
39650,to,0,0
39651,determine,0,0
39652,the,0,0
39653,probability,0,0
39654,of,0,0
39655,remaining,0,1
39656,posttraumatic,0,1
39657,seizure,0,1
39658,free,0,1
39659,for,0,0
39660,each,0,0
39661,treatment,0,0
39662,group,1,1
39663,.,1,1
39664,RESULTS,0,0
39665,One,1,1
39666,hundred,1,1
39667,two,1,1
39668,patients,1,1
39669,were,1,1
39670,enrolled,1,1
39671,",",1,0
39672,with,1,1
39673,a,1,0
39674,median,1,0
39675,age,1,1
39676,of,1,1
39677,6.1,1,1
39678,years,1,1
39679,.,1,1
39680,Sixty-eight,1,1
39681,percent,1,1
39682,were,1,1
39683,boys,1,1
39684,.,1,1
39685,The,0,0
39686,2,1,0
39687,treatment,1,1
39688,groups,1,0
39689,were,0,1
39690,well,0,0
39691,matched,0,1
39692,.,0,0
39693,During,0,0
39694,the,0,0
39695,48-hour,0,0
39696,observation,0,0
39697,period,0,0
39698,",",0,1
39699,3,1,0
39700,(,1,1
39701,7,1,1
39702,%,1,0
39703,),1,1
39704,of,1,1
39705,46,1,1
39706,patients,1,1
39707,given,0,1
39708,phenytoin,0,1
39709,and,0,1
39710,3,1,1
39711,(,1,1
39712,5,1,1
39713,%,1,0
39714,),1,1
39715,of,1,1
39716,56,1,1
39717,patients,1,1
39718,given,0,1
39719,placebo,0,0
39720,experienced,0,1
39721,a,0,1
39722,posttraumatic,0,0
39723,seizure,0,0
39724,.,0,0
39725,There,0,0
39726,were,0,0
39727,no,0,0
39728,significant,0,0
39729,differences,0,0
39730,between,0,0
39731,the,0,1
39732,treatment,0,0
39733,groups,1,0
39734,in,0,1
39735,survival,0,0
39736,or,0,1
39737,neurologic,0,0
39738,outcome,0,0
39739,after,0,1
39740,30,0,1
39741,days,0,1
39742,.,0,1
39743,According,0,0
39744,to,0,0
39745,these,0,0
39746,results,0,0
39747,",",0,0
39748,the,0,0
39749,probability,0,0
39750,that,0,0
39751,phenytoin,0,0
39752,has,0,0
39753,the,0,0
39754,originally,0,1
39755,hypothesized,0,0
39756,effect,0,0
39757,of,0,0
39758,reducing,0,0
39759,the,0,0
39760,rate,0,0
39761,of,0,0
39762,early,0,1
39763,posttraumatic,0,1
39764,seizures,0,1
39765,by,0,1
39766,12.5,0,0
39767,%,0,0
39768,is,0,0
39769,0.0053,0,0
39770,.,0,0
39771,The,0,0
39772,probability,0,0
39773,that,0,0
39774,phenytoin,0,0
39775,has,0,0
39776,any,0,0
39777,prophylactic,0,0
39778,efficacy,0,0
39779,is,0,0
39780,0.383,0,0
39781,.,0,0
39782,The,0,0
39783,median,0,0
39784,effect,0,0
39785,size,0,0
39786,in,0,0
39787,this,0,0
39788,trial,0,0
39789,was,0,0
39790,-0.015,0,0
39791,(,1,1
39792,seizure,1,1
39793,rate,1,0
39794,increased,1,0
39795,by,1,0
39796,1.5,1,0
39797,%,1,0
39798,in,1,0
39799,the,1,0
39800,phenytoin,1,0
39801,group,1,0
39802,),1,1
39803,",",0,0
39804,95,0,0
39805,%,0,0
39806,probability,0,0
39807,interval,0,0
39808,-0.127,0,0
39809,to,0,1
39810,0.091,0,0
39811,(,0,1
39812,12.7,0,0
39813,%,0,0
39814,higher,0,0
39815,rate,0,0
39816,of,0,0
39817,posttraumatic,0,1
39818,seizures,0,1
39819,to,0,1
39820,a,0,1
39821,9.1,0,0
39822,%,0,0
39823,lower,0,0
39824,rate,0,0
39825,of,0,0
39826,posttraumatic,0,1
39827,seizures,0,1
39828,with,0,1
39829,phenytoin,0,1
39830,),0,1
39831,.,0,0
39832,CONCLUSION,0,0
39833,The,0,0
39834,rate,0,0
39835,of,0,0
39836,early,0,1
39837,posttraumatic,0,1
39838,seizures,0,1
39839,in,0,1
39840,children,1,1
39841,may,1,0
39842,be,1,0
39843,much,1,0
39844,lower,0,0
39845,than,0,0
39846,previously,0,1
39847,reported,0,0
39848,.,0,0
39849,Phenytoin,0,0
39850,did,0,0
39851,not,0,0
39852,substantially,0,0
39853,reduce,0,0
39854,that,0,0
39855,rate,0,0
39856,.,0,1
39857,Perispinal,0,0
39858,analgesia,0,0
39859,for,0,0
39860,labour,1,1
39861,followed,0,1
39862,by,0,0
39863,patient-controlled,0,0
39864,infusion,0,0
39865,with,0,1
39866,bupivacaine,0,0
39867,and,0,1
39868,sufentanil,0,1
39869,:,0,1
39870,combined,0,0
39871,spinal-epidural,0,1
39872,vs.,0,0
39873,epidural,0,1
39874,analgesia,0,0
39875,alone,0,1
39876,.,0,1
39877,BACKGROUND,0,0
39878,AND,0,0
39879,OBJECTIVE,0,1
39880,Combined,0,0
39881,spinal-epidural,0,0
39882,is,0,0
39883,an,0,0
39884,alternative,0,0
39885,technique,0,0
39886,to,0,1
39887,epidural,0,1
39888,analgesia,0,0
39889,for,0,0
39890,labour,0,1
39891,",",0,0
39892,but,0,0
39893,its,0,0
39894,benefits,0,0
39895,are,0,0
39896,not,0,0
39897,clearly,0,0
39898,identified,0,0
39899,.,0,0
39900,METHODS,0,0
39901,A,0,0
39902,prospective,0,0
39903,",",0,0
39904,blinded,0,0
39905,",",0,0
39906,randomized,0,1
39907,study,0,0
39908,was,0,0
39909,undertaken,0,1
39910,involving,0,1
39911,113,1,1
39912,women,1,1
39913,attending,1,1
39914,a,1,1
39915,university,1,1
39916,hospital,1,1
39917,obstetric,1,1
39918,department,1,1
39919,.,1,1
39920,Analgesia,0,0
39921,was,0,0
39922,initiated,0,0
39923,with,0,1
39924,intrathecal,0,1
39925,bupivacaine,0,1
39926,0.25,0,0
39927,%,0,0
39928,1,0,1
39929,mL,0,0
39930,+,0,0
39931,sufentanil,0,1
39932,5,0,0
39933,microg,0,0
39934,in,0,0
39935,the,0,0
39936,combined,0,0
39937,spinal-epidural,0,1
39938,group,0,1
39939,(,0,1
39940,n,0,1
39941,=,0,1
39942,54,0,1
39943,),0,1
39944,",",0,0
39945,and,0,0
39946,with,0,1
39947,bupivacaine,0,0
39948,0.125,0,0
39949,%,0,0
39950,+,0,0
39951,epinephrine,0,0
39952,2.5,0,0
39953,microg,0,0
39954,mL,0,0
39955,(,0,1
39956,-1,0,0
39957,),0,1
39958,+,0,0
39959,sufentanil,0,1
39960,7.5,0,0
39961,microg,0,0
39962,in,0,0
39963,the,0,0
39964,epidural,0,1
39965,group,0,1
39966,(,0,1
39967,n,0,1
39968,=,0,1
39969,59,0,1
39970,),0,1
39971,.,0,1
39972,In,0,0
39973,both,0,0
39974,cases,0,1
39975,this,0,0
39976,was,0,0
39977,followed,0,0
39978,by,0,0
39979,patient-controlled,0,0
39980,epidural,0,1
39981,analgesia,0,0
39982,with,0,1
39983,bupivacaine,0,0
39984,0.125,0,0
39985,%,0,0
39986,(,0,1
39987,+,0,0
39988,sufentanil,0,1
39989,0.25,0,0
39990,microg,0,0
39991,mL,0,0
39992,(,0,1
39993,-1,0,0
39994,),0,1
39995,),0,1
39996,.,0,1
39997,Duration,0,0
39998,of,0,0
39999,labour,0,1
40000,",",0,0
40001,quality,0,0
40002,of,0,0
40003,analgesia,0,0
40004,and,0,1
40005,side-effects,0,0
40006,were,0,1
40007,compared,0,0
40008,between,0,0
40009,groups,0,1
40010,.,0,1
40011,RESULTS,0,0
40012,In,0,0
40013,the,0,0
40014,combined,0,0
40015,spinal-epidural,0,0
40016,group,0,1
40017,",",0,0
40018,the,0,0
40019,onset,0,0
40020,of,0,0
40021,analgesia,0,0
40022,was,0,0
40023,faster,0,0
40024,(,0,0
40025,5,0,0
40026,vs.,0,0
40027,15,0,1
40028,min,0,0
40029,",",0,1
40030,P,0,0
40031,<,0,0
40032,0.001,0,0
40033,),0,1
40034,",",0,0
40035,the,0,0
40036,consumption,0,0
40037,of,0,0
40038,bupivacaine,0,0
40039,was,0,0
40040,lower,0,0
40041,(,0,0
40042,7.5,0,0
40043,vs.,0,0
40044,11.3,0,0
40045,mg,0,0
40046,h,0,0
40047,(,0,1
40048,-1,0,0
40049,),0,1
40050,",",0,0
40051,P,0,0
40052,=,0,1
40053,0.003,0,0
40054,),0,0
40055,and,0,0
40056,there,0,0
40057,was,0,0
40058,less,0,0
40059,unilateral,0,1
40060,analgesia,0,0
40061,(,0,1
40062,14.8,0,0
40063,%,0,0
40064,vs.,0,0
40065,40.7,0,0
40066,%,0,0
40067,",",0,1
40068,P,0,0
40069,=,0,1
40070,0.002,0,0
40071,),0,1
40072,than,0,0
40073,in,0,0
40074,the,0,0
40075,epidural,0,1
40076,group,0,1
40077,.,0,1
40078,The,1,0
40079,characteristics,1,0
40080,of,1,0
40081,labour,1,1
40082,were,1,1
40083,similar,1,0
40084,in,1,1
40085,both,1,0
40086,groups,1,0
40087,.,1,1
40088,However,0,0
40089,",",0,0
40090,in,0,0
40091,the,0,0
40092,combined,0,0
40093,spinal-epidural,0,0
40094,group,0,0
40095,",",0,0
40096,there,0,0
40097,was,0,0
40098,a,0,0
40099,higher,0,0
40100,incidence,0,0
40101,of,0,0
40102,posterior,0,1
40103,presentation,0,1
40104,(,0,1
40105,25.9,0,0
40106,%,0,0
40107,vs.,0,0
40108,10,0,1
40109,%,0,0
40110,",",0,1
40111,P,0,0
40112,=,0,1
40113,0.03,0,0
40114,),0,1
40115,",",0,0
40116,pruritus,0,0
40117,(,0,1
40118,P,0,0
40119,<,0,0
40120,0.001,0,0
40121,),0,1
40122,",",0,0
40123,hypotension,0,0
40124,(,0,1
40125,P,0,0
40126,=,0,1
40127,0.002,0,0
40128,),0,1
40129,",",0,0
40130,somnolence,0,1
40131,(,0,1
40132,P,0,0
40133,=,0,1
40134,0.01,0,0
40135,),0,1
40136,",",0,0
40137,nausea,0,0
40138,(,0,1
40139,P,0,0
40140,=,0,1
40141,0.02,0,0
40142,),0,1
40143,and,0,1
40144,one,0,1
40145,case,0,1
40146,of,0,0
40147,meningitis,0,1
40148,.,0,1
40149,CONCLUSIONS,0,0
40150,The,0,0
40151,combined,0,0
40152,spinal-epidural,0,1
40153,technique,0,0
40154,provided,0,0
40155,more,0,0
40156,effective,0,0
40157,analgesia,0,0
40158,during,1,0
40159,labour,1,1
40160,than,0,0
40161,epidural,0,0
40162,analgesia,0,0
40163,alone,0,0
40164,but,0,0
40165,offered,0,0
40166,no,0,0
40167,other,0,0
40168,advantage,0,0
40169,.,0,1
40170,It,0,0
40171,induced,0,0
40172,more,0,0
40173,adverse,0,0
40174,effects,0,0
40175,and,0,0
40176,this,0,0
40177,should,0,0
40178,be,0,0
40179,considered,0,0
40180,before,0,0
40181,routinely,0,0
40182,using,0,0
40183,the,0,0
40184,combined,0,0
40185,spinal-epidural,0,1
40186,technique,0,0
40187,.,0,1
40188,Efficacy,0,0
40189,of,0,0
40190,prophylactic,0,1
40191,ondansetron,0,0
40192,in,0,0
40193,a,0,1
40194,patient-controlled,1,0
40195,analgesia,1,0
40196,environment,1,0
40197,.,1,1
40198,We,0,0
40199,conducted,0,0
40200,a,0,0
40201,prospective,0,0
40202,",",0,0
40203,randomized,0,1
40204,",",0,0
40205,double-blind,0,0
40206,",",0,0
40207,placebo-controlled,0,0
40208,trial,0,0
40209,to,0,0
40210,examine,0,0
40211,the,0,0
40212,efficacy,0,0
40213,of,0,0
40214,prophylactic,0,1
40215,ondansetron,0,0
40216,on,0,0
40217,post-operative,0,0
40218,nausea,0,0
40219,and,0,1
40220,vomiting,0,0
40221,(,0,1
40222,PONV,0,0
40223,),0,1
40224,during,0,0
40225,opioid,0,1
40226,patient-controlled,0,0
40227,analgesia,0,0
40228,(,0,1
40229,PCA,0,1
40230,),0,1
40231,.,0,1
40232,In,0,0
40233,total,0,1
40234,",",0,1
40235,374,1,1
40236,patients,1,1
40237,using,1,1
40238,opioid,1,1
40239,PCA,1,1
40240,",",1,0
40241,but,1,0
40242,otherwise,1,1
40243,considered,1,0
40244,to,1,0
40245,be,1,0
40246,low,1,0
40247,risk,1,0
40248,for,1,0
40249,PONV,1,0
40250,",",0,0
40251,were,0,0
40252,randomly,0,1
40253,allocated,0,1
40254,to,0,0
40255,ondansetron,0,0
40256,(,0,1
40257,4,0,0
40258,mg,0,0
40259,given,0,0
40260,intravenously,0,1
40261,and,0,0
40262,16,0,1
40263,mg,0,0
40264,added,0,0
40265,into,0,0
40266,the,0,0
40267,PCA,0,1
40268,pump,0,1
40269,),0,1
40270,or,0,1
40271,saline,0,0
40272,(,0,0
40273,control,0,1
40274,group,0,1
40275,),0,1
40276,.,0,1
40277,PONV,0,0
40278,was,0,0
40279,evaluated,0,0
40280,in,0,0
40281,terms,0,0
40282,of,0,1
40283,nausea,0,0
40284,graded,0,0
40285,on,0,0
40286,a,0,1
40287,visual,0,0
40288,analogue,0,0
40289,scale,0,0
40290,",",0,0
40291,and,0,0
40292,the,0,0
40293,number,0,0
40294,of,0,1
40295,patients,0,1
40296,who,0,1
40297,experienced,0,1
40298,emetic,0,1
40299,episodes,0,1
40300,or,0,1
40301,needed,0,1
40302,rescue,0,0
40303,anti-emetics,0,1
40304,in,0,1
40305,the,0,1
40306,48-h,0,0
40307,post-operative,0,0
40308,period,0,1
40309,.,0,1
40310,Patient,0,0
40311,satisfaction,0,0
40312,for,0,1
40313,PCA,0,1
40314,was,0,0
40315,scored,0,0
40316,at,0,0
40317,the,0,0
40318,end,0,0
40319,of,0,0
40320,the,0,0
40321,evaluation,0,0
40322,period,0,0
40323,.,0,1
40324,The,0,0
40325,only,0,0
40326,difference,0,0
40327,between,0,0
40328,the,0,1
40329,two,0,1
40330,groups,0,0
40331,was,0,0
40332,the,0,0
40333,higher,0,0
40334,number,0,0
40335,of,0,0
40336,headaches,0,1
40337,in,0,1
40338,the,0,0
40339,ondansetron,0,0
40340,group,0,0
40341,.,0,1
40342,In,0,0
40343,patients,0,1
40344,using,0,1
40345,opioid,0,1
40346,PCA,0,1
40347,",",0,0
40348,but,0,0
40349,with,0,1
40350,no,0,0
40351,other,0,0
40352,high,0,1
40353,risk,0,1
40354,factors,0,0
40355,for,0,1
40356,PONV,0,1
40357,",",0,1
40358,prophylactic,0,0
40359,ondansetron,0,0
40360,does,0,0
40361,not,0,0
40362,have,0,0
40363,any,0,0
40364,clinical,0,0
40365,benefit,0,0
40366,.,0,1
40367,Bisphosphonate,0,0
40368,infusions,0,1
40369,:,0,1
40370,patient,0,1
40371,preference,0,0
40372,",",0,0
40373,safety,0,0
40374,and,0,0
40375,clinic,0,1
40376,use,0,0
40377,.,0,1
40378,GOALS,0,0
40379,OF,0,1
40380,WORK,0,1
40381,We,0,1
40382,set,0,0
40383,out,0,0
40384,to,0,0
40385,assess,0,0
40386,the,0,0
40387,preference,0,0
40388,of,0,0
40389,patients,1,1
40390,with,1,1
40391,common,1,1
40392,cancers,1,1
40393,involving,1,1
40394,bone,1,1
40395,receiving,1,1
40396,intravenous,1,1
40397,bisphosphonate,1,0
40398,therapy,1,0
40399,for,0,0
40400,either,0,1
40401,pamidronate,0,0
40402,(,0,0
40403,P,0,0
40404,),0,1
40405,or,0,1
40406,zoledronic,0,0
40407,acid,0,0
40408,(,0,1
40409,Z,0,1
40410,),0,1
40411,and,0,0
40412,their,0,1
40413,preference,0,0
40414,for,0,0
40415,the,0,0
40416,location,0,1
40417,of,0,0
40418,the,0,0
40419,infusion,0,0
40420,(,0,0
40421,clinic,0,1
40422,or,0,1
40423,home,0,1
40424,),0,1
40425,.,0,1
40426,We,0,0
40427,also,0,0
40428,aimed,0,0
40429,to,0,0
40430,monitor,0,0
40431,these,0,0
40432,patients,0,1
40433,',0,1
40434,renal,0,1
40435,safety,0,0
40436,",",0,0
40437,and,0,0
40438,to,0,0
40439,compare,0,0
40440,their,0,0
40441,time,0,0
40442,in,0,0
40443,clinic,0,1
40444,to,0,0
40445,receive,0,1
40446,P,0,0
40447,and,0,1
40448,Z,0,1
40449,infusions,0,1
40450,.,0,1
40451,PATIENTS,0,0
40452,AND,0,0
40453,METHODS,0,0
40454,Enrolled,1,1
40455,in,1,0
40456,the,1,0
40457,study,1,1
40458,were,1,1
40459,184,1,1
40460,patients,1,1
40461,",",0,1
40462,and,0,0
40463,all,0,0
40464,received,0,1
40465,initial,0,0
40466,infusions,0,0
40467,of,0,1
40468,Z,0,1
40469,(,0,1
40470,so,0,0
40471,any,0,0
40472,first,0,0
40473,infusion,0,0
40474,reactions,0,0
40475,did,0,0
40476,not,0,0
40477,confound,0,0
40478,preferences,0,0
40479,for,0,1
40480,P,0,0
40481,),0,1
40482,.,0,1
40483,For,0,0
40484,their,0,1
40485,second,0,1
40486,and,0,1
40487,third,0,1
40488,infusions,0,0
40489,",",0,1
40490,patients,0,1
40491,were,0,1
40492,randomized,0,1
40493,to,0,0
40494,receive,0,1
40495,Z,0,0
40496,then,0,0
40497,P,0,0
40498,or,0,1
40499,P,0,0
40500,then,0,0
40501,Z,0,0
40502,",",0,0
40503,and,0,0
40504,questioned,0,0
40505,on,0,0
40506,their,0,1
40507,preferences,0,0
40508,.,0,1
40509,For,0,1
40510,up,0,0
40511,to,0,1
40512,1,0,1
40513,year,0,1
40514,they,0,0
40515,continued,0,0
40516,on,0,0
40517,Z,0,1
40518,infusions,0,0
40519,every,0,1
40520,3-4,0,1
40521,weeks,0,0
40522,",",0,1
40523,while,0,0
40524,their,0,1
40525,renal,0,1
40526,safety,0,0
40527,was,0,0
40528,monitored,0,0
40529,.,0,1
40530,Where,0,0
40531,practical,0,0
40532,",",0,1
40533,later,0,1
40534,infusions,0,0
40535,were,0,1
40536,given,0,0
40537,at,0,0
40538,home,0,1
40539,(,0,0
40540,rather,0,0
40541,than,0,0
40542,in,0,0
40543,the,0,0
40544,clinic,0,1
40545,),0,1
40546,and,0,1
40547,patients,0,1
40548,questioned,0,1
40549,on,0,0
40550,their,0,1
40551,preferred,0,0
40552,infusion,0,0
40553,location,0,1
40554,.,0,1
40555,In,0,0
40556,a,0,0
40557,convenience,0,0
40558,subset,0,1
40559,of,0,1
40560,43,0,1
40561,patients,0,1
40562,",",0,1
40563,clinic,0,1
40564,use,0,0
40565,for,0,1
40566,Z,0,0
40567,and,0,1
40568,P,0,0
40569,infusions,0,0
40570,was,0,0
40571,also,0,0
40572,measured,0,0
40573,by,0,0
40574,timing,0,0
40575,infusions,0,0
40576,and,0,1
40577,other,0,1
40578,procedures,0,1
40579,.,0,1
40580,MAIN,0,0
40581,RESULTS,0,0
40582,Of,0,1
40583,144,0,1
40584,patients,0,1
40585,who,0,1
40586,received,0,1
40587,a,0,1
40588,third,0,1
40589,infusion,0,0
40590,",",0,1
40591,138,0,1
40592,responded,0,1
40593,to,0,1
40594,questions,0,0
40595,on,0,0
40596,bisphosphonate,0,0
40597,preference,0,0
40598,",",0,0
40599,and,0,0
40600,of,0,0
40601,these,0,0
40602,138,0,1
40603,",",0,0
40604,92,0,1
40605,%,0,0
40606,(,0,1
40607,127,0,1
40608,),0,1
40609,preferred,0,0
40610,Z,0,0
40611,to,0,0
40612,P,0,0
40613,",",0,0
40614,because,0,0
40615,shorter,0,0
40616,infusions,0,0
40617,caused,0,0
40618,less,0,0
40619,disruption,0,0
40620,to,0,0
40621,their,0,1
40622,day,0,0
40623,.,0,1
40624,Only,0,0
40625,12,1,0
40626,%,1,0
40627,of,1,1
40628,eligible,1,1
40629,patients,1,1
40630,(,1,1
40631,16/138,1,1
40632,),1,1
40633,received,0,1
40634,home,0,1
40635,infusions,0,0
40636,",",0,1
40637,but,0,0
40638,13/14,0,0
40639,questioned,0,0
40640,preferred,0,0
40641,this,0,0
40642,location,0,1
40643,.,0,1
40644,Among,0,1
40645,184,0,1
40646,patients,0,1
40647,",",0,1
40648,19,0,1
40649,episodes,0,1
40650,of,0,1
40651,renal,0,1
40652,impairment,0,1
40653,were,0,1
40654,noted,0,0
40655,",",0,0
40656,mostly,0,1
40657,owing,0,0
40658,to,0,0
40659,disease,0,1
40660,progression,0,0
40661,(,0,1
40662,e.g,0,0
40663,.,0,1
40664,obstructive,0,1
40665,uropathy,0,1
40666,),0,1
40667,",",0,0
40668,with,0,1
40669,none,0,0
40670,linked,0,0
40671,to,0,1
40672,Z,0,0
40673,therapy,0,0
40674,.,0,1
40675,The,0,0
40676,mean,0,0
40677,clinic,0,1
40678,time,0,0
40679,taken,0,0
40680,to,0,0
40681,receive,0,1
40682,Z,0,0
40683,and,0,0
40684,any,0,0
40685,concomitant,0,0
40686,therapy,0,0
40687,was,0,0
40688,about,0,0
40689,half,0,1
40690,that,0,0
40691,for,0,0
40692,P,0,0
40693,(,0,1
40694,78,0,1
40695,vs,0,0
40696,161,0,1
40697,min,0,0
40698,),0,1
40699,.,0,1
40700,CONCLUSIONS,0,0
40701,Cancer,1,1
40702,patients,1,1
40703,prefer,0,1
40704,shorter,0,0
40705,bisphosphonate,0,0
40706,infusions-and,0,0
40707,at,0,0
40708,home,0,0
40709,",",0,0
40710,where,0,0
40711,practical,0,0
40712,.,0,0
40713,Regular,0,0
40714,Z,0,0
40715,4,0,1
40716,mg,0,0
40717,infusions,0,0
40718,appear,0,0
40719,to,0,0
40720,be,0,0
40721,safe,0,0
40722,in,0,0
40723,these,0,0
40724,patients,0,1
40725,",",0,0
40726,with,0,1
40727,routine,0,1
40728,monitoring,0,0
40729,of,0,0
40730,serum,0,0
40731,creatinine,0,0
40732,.,0,1
40733,Using,0,0
40734,Z,0,0
40735,rather,0,0
40736,than,0,0
40737,P,0,0
40738,could,0,0
40739,save,0,0
40740,busy,0,0
40741,cancer,0,1
40742,centres,0,1
40743,time,0,0
40744,and,0,1
40745,improve,0,0
40746,patient,0,1
40747,satisfaction,0,0
40748,.,0,1
40749,Improved,0,0
40750,intraoperative,0,0
40751,management,0,1
40752,of,0,0
40753,anastomotic,1,0
40754,bleeding,1,1
40755,during,1,0
40756,aortic,1,1
40757,reconstruction,1,1
40758,:,1,1
40759,results,0,0
40760,of,0,0
40761,a,0,1
40762,randomized,0,1
40763,controlled,0,0
40764,trial,0,0
40765,.,0,1
40766,In,0,0
40767,a,0,0
40768,randomized,0,1
40769,controlled,0,0
40770,trial,0,0
40771,",",0,0
40772,the,0,0
40773,effectiveness,0,0
40774,of,0,0
40775,a,0,1
40776,polymeric,0,0
40777,surgical,0,1
40778,sealant,0,0
40779,(,0,1
40780,CoSeal,0,1
40781,),0,1
40782,was,0,0
40783,compared,0,0
40784,to,0,0
40785,Gelfoam/thrombin,0,0
40786,for,0,0
40787,managing,1,0
40788,anastomotic,1,0
40789,bleeding,1,1
40790,after,1,0
40791,implantation,1,1
40792,of,1,1
40793,Dacron,1,1
40794,grafts,1,1
40795,during,1,1
40796,aortic,1,1
40797,reconstruction,1,1
40798,for,1,1
40799,nonruptured,1,1
40800,aneurysms,1,1
40801,.,1,1
40802,Each,0,0
40803,treatment,0,0
40804,was,0,0
40805,directly,0,0
40806,applied,0,0
40807,to,0,0
40808,the,0,0
40809,suture,0,0
40810,line,0,0
40811,after,0,0
40812,confirmation,0,0
40813,of,0,0
40814,anastomotic,0,0
40815,bleeding,0,1
40816,.,0,1
40817,The,0,0
40818,proportion,0,0
40819,of,0,0
40820,suture,0,0
40821,line,0,0
40822,sites,0,0
40823,that,0,0
40824,achieved,0,0
40825,immediate,0,0
40826,sealing,0,0
40827,and,0,0
40828,the,0,0
40829,proportion,0,0
40830,sealed,0,1
40831,within,0,1
40832,5,0,1
40833,minutes,0,0
40834,were,0,1
40835,determined,0,0
40836,among,0,1
40837,37,1,1
40838,experimental,1,1
40839,(,1,1
40840,59,1,1
40841,sites,1,1
40842,),1,1
40843,and,1,1
40844,17,1,1
40845,control,1,1
40846,subjects,1,1
40847,(,1,1
40848,27,1,1
40849,sites,1,1
40850,),1,1
40851,.,1,1
40852,A,0,0
40853,significantly,0,0
40854,greater,0,0
40855,proportion,0,0
40856,of,0,0
40857,bleeding,0,1
40858,suture,0,0
40859,line,0,1
40860,sites,0,0
40861,treated,0,1
40862,with,0,1
40863,the,0,0
40864,polymeric,0,0
40865,sealant,0,0
40866,achieved,0,0
40867,immediate,0,0
40868,sealing,0,0
40869,following,0,0
40870,reestablishment,0,0
40871,of,0,0
40872,blood,0,0
40873,flow,0,0
40874,compared,0,0
40875,with,0,1
40876,control-treated,0,0
40877,sites,0,1
40878,[,0,1
40879,48,0,1
40880,of,0,1
40881,59,0,1
40882,(,0,1
40883,81,0,1
40884,%,0,0
40885,),0,1
40886,vs,0,0
40887,10,0,0
40888,of,0,0
40889,27,0,1
40890,(,0,1
40891,37,0,1
40892,%,0,1
40893,),0,1
40894,;,0,1
40895,P,0,0
40896,=,0,1
40897,0.002,0,0
40898,],0,1
40899,.,0,1
40900,The,0,0
40901,difference,0,0
40902,between,0,0
40903,treatment,0,1
40904,groups,0,1
40905,was,0,0
40906,maintained,0,1
40907,after,0,1
40908,5,0,1
40909,minutes,0,0
40910,with,0,1
40911,approximately,0,1
40912,85,0,1
40913,per,0,0
40914,cent,0,1
40915,(,0,1
40916,50,0,1
40917,of,0,1
40918,59,0,1
40919,),0,1
40920,of,0,1
40921,CoSeal,0,1
40922,sites,0,1
40923,compared,0,0
40924,to,0,1
40925,just,0,1
40926,over,0,0
40927,one-half,0,0
40928,(,0,1
40929,14,0,1
40930,of,0,1
40931,27,0,1
40932,),0,1
40933,of,0,0
40934,control,0,1
40935,sites,0,0
40936,demonstrating,0,0
40937,ultimate,0,0
40938,sealing,0,0
40939,(,0,1
40940,P,0,0
40941,=,0,1
40942,0.01,0,0
40943,),0,0
40944,.,0,0
40945,There,0,0
40946,were,0,0
40947,no,0,0
40948,adverse,0,0
40949,events,0,0
40950,related,0,0
40951,to,0,1
40952,the,0,0
40953,use,0,0
40954,of,0,0
40955,the,0,0
40956,polymeric,0,0
40957,sealant,0,0
40958,in,0,0
40959,this,0,0
40960,study,0,0
40961,.,0,1
40962,These,0,0
40963,results,0,0
40964,support,0,0
40965,the,0,0
40966,use,0,0
40967,of,0,0
40968,this,0,0
40969,novel,0,0
40970,sealant,0,0
40971,for,0,0
40972,the,0,0
40973,intraoperative,1,0
40974,management,1,1
40975,of,1,0
40976,anastomotic,1,0
40977,bleeding,1,1
40978,during,1,0
40979,aortic,1,1
40980,reconstruction,1,1
40981,procedures,1,1
40982,.,1,1
40983,Primary,0,1
40984,stenting,0,1
40985,of,0,0
40986,occluded,0,0
40987,native,0,1
40988,coronary,0,1
40989,arteries,0,1
40990,:,0,1
40991,final,0,1
40992,results,0,0
40993,of,0,1
40994,the,0,1
40995,Primary,0,1
40996,Stenting,0,0
40997,of,0,1
40998,Occluded,1,1
40999,Native,1,1
41000,Coronary,1,1
41001,Arteries,1,1
41002,(,1,1
41003,PRISON,1,1
41004,),1,1
41005,study,0,1
41006,.,0,1
41007,BACKGROUND,0,0
41008,Primary,0,1
41009,intracoronary,0,0
41010,stent,0,1
41011,placement,0,0
41012,after,0,0
41013,successfully,0,0
41014,crossing,0,0
41015,chronic,0,1
41016,total,1,1
41017,coronary,1,1
41018,occlusions,1,1
41019,may,0,0
41020,decrease,0,0
41021,the,0,0
41022,high,0,0
41023,restenosis,0,1
41024,rate,0,0
41025,at,0,1
41026,long-term,0,0
41027,follow-up,0,0
41028,compared,0,0
41029,with,0,1
41030,conventional,0,1
41031,balloon,0,1
41032,angioplasty,0,1
41033,.,0,1
41034,METHODS,0,0
41035,In,0,0
41036,a,0,1
41037,prospective,0,1
41038,",",0,0
41039,randomized,0,1
41040,trial,0,0
41041,",",0,0
41042,balloon,1,0
41043,angioplasty,1,1
41044,was,0,0
41045,compared,0,0
41046,with,0,1
41047,stent,0,1
41048,implantation,0,1
41049,for,0,0
41050,the,0,0
41051,treatment,0,0
41052,of,0,0
41053,chronic,1,1
41054,total,1,1
41055,occlusions,1,1
41056,.,1,1
41057,Patients,0,1
41058,were,0,0
41059,followed,0,1
41060,for,0,1
41061,12,0,1
41062,months,0,1
41063,with,0,1
41064,angiographic,0,0
41065,follow-up,0,1
41066,at,0,1
41067,6,0,1
41068,months,0,1
41069,.,0,1
41070,Quantitative,0,0
41071,coronary,0,1
41072,analysis,0,0
41073,was,0,0
41074,performed,0,0
41075,by,0,0
41076,an,0,0
41077,independent,0,0
41078,core,0,1
41079,lab,0,0
41080,.,0,0
41081,RESULTS,0,0
41082,A,0,0
41083,total,0,1
41084,of,0,0
41085,200,1,1
41086,patients,1,1
41087,were,1,1
41088,enrolled,1,1
41089,.,1,1
41090,Baseline,0,0
41091,characteristics,0,0
41092,were,0,1
41093,evenly,0,1
41094,distributed,0,1
41095,.,0,0
41096,After,0,0
41097,the,0,0
41098,procedure,0,0
41099,the,0,0
41100,mean,0,1
41101,minimal,0,0
41102,luminal,0,1
41103,diameter,0,1
41104,in,0,0
41105,the,0,0
41106,conventional,0,1
41107,group,0,1
41108,was,0,0
41109,2.34,0,0
41110,+/-,0,0
41111,0.46,0,0
41112,mm,0,1
41113,versus,0,0
41114,2.90,0,0
41115,+/-,0,0
41116,0.41,0,0
41117,mm,0,1
41118,in,0,0
41119,the,0,0
41120,stented,0,1
41121,group,0,0
41122,(,0,1
41123,P,0,0
41124,<,0,0
41125,.0001,0,0
41126,),0,1
41127,.,0,1
41128,The,0,0
41129,6-month,0,0
41130,angiographic,0,0
41131,follow-up,0,0
41132,showed,0,0
41133,a,0,0
41134,mean,0,1
41135,minimal,0,0
41136,luminal,0,1
41137,diameter,0,1
41138,of,0,1
41139,1.57,0,0
41140,+/-,0,1
41141,0.74,0,0
41142,mm,0,1
41143,in,0,0
41144,the,0,0
41145,conventional,0,1
41146,group,0,1
41147,versus,0,0
41148,1.93,0,0
41149,+/-,0,0
41150,0.85,0,0
41151,mm,0,1
41152,in,0,0
41153,the,0,0
41154,stented,0,1
41155,group,0,0
41156,(,0,1
41157,P,0,0
41158,=.009,0,0
41159,),0,1
41160,and,0,0
41161,a,0,1
41162,mean,0,0
41163,diameter,0,0
41164,stenosis,0,1
41165,of,0,0
41166,44.7,0,1
41167,%,0,0
41168,+/-,0,0
41169,25.0,0,0
41170,%,0,0
41171,versus,0,0
41172,35.5,0,1
41173,%,0,0
41174,+/-,0,0
41175,26.5,0,1
41176,%,0,0
41177,(,0,1
41178,P,0,0
41179,=.036,0,0
41180,),0,1
41181,.,0,1
41182,Binary,0,1
41183,angiographic,0,0
41184,restenosis,0,1
41185,(,0,1
41186,>,0,1
41187,50,0,1
41188,%,0,0
41189,diameter,0,1
41190,stenosis,0,1
41191,),0,1
41192,was,0,0
41193,seen,0,0
41194,in,0,1
41195,33,0,1
41196,%,0,0
41197,in,0,0
41198,the,0,0
41199,conventional,0,1
41200,group,0,1
41201,versus,0,0
41202,22,0,1
41203,%,0,0
41204,in,0,0
41205,the,0,0
41206,stented,0,1
41207,group,0,0
41208,(,0,1
41209,P,0,0
41210,=.137,0,0
41211,),0,1
41212,.,0,1
41213,The,0,0
41214,reocclusion,0,0
41215,rates,0,0
41216,were,0,1
41217,7.3,0,0
41218,%,0,0
41219,and,0,1
41220,8.2,0,0
41221,%,0,0
41222,",",0,0
41223,respectively,0,0
41224,(,0,0
41225,P,0,0
41226,=,0,1
41227,1.00,0,0
41228,),0,1
41229,.,0,1
41230,At,0,0
41231,12,0,0
41232,month,0,0
41233,follow-up,0,0
41234,",",0,0
41235,the,0,0
41236,rate,0,0
41237,of,0,0
41238,target,0,0
41239,lesion,0,1
41240,revascularization,0,1
41241,was,0,0
41242,significantly,0,0
41243,higher,0,0
41244,in,0,0
41245,the,0,0
41246,conventional,0,1
41247,group,0,1
41248,(,0,1
41249,29,0,1
41250,%,0,0
41251,versus,0,0
41252,13,0,1
41253,%,0,0
41254,",",0,1
41255,P,0,0
41256,<,0,0
41257,.0001,0,0
41258,),0,1
41259,.,0,1
41260,CONCLUSION,0,0
41261,These,0,1
41262,data,0,0
41263,demonstrate,0,0
41264,that,0,0
41265,stenting,0,1
41266,of,0,1
41267,chronic,1,1
41268,total,1,1
41269,occlusions,1,1
41270,is,0,0
41271,superior,0,0
41272,to,0,0
41273,balloon,0,0
41274,angioplasty,0,1
41275,alone,0,0
41276,with,0,1
41277,a,0,0
41278,statistically,0,0
41279,significant,0,0
41280,reduction,0,0
41281,in,0,0
41282,the,0,0
41283,need,0,0
41284,for,0,0
41285,target,0,0
41286,lesion,0,1
41287,revascularization,0,1
41288,and,0,0
41289,a,0,0
41290,lower,0,0
41291,",",0,0
41292,but,0,0
41293,not,0,0
41294,significant,0,0
41295,",",0,0
41296,restenosis,0,1
41297,rate,0,0
41298,.,0,1
41299,Mouth,0,1
41300,closing,0,0
41301,device,0,0
41302,(,0,1
41303,chinstrap,0,1
41304,),0,0
41305,reduces,0,0
41306,mouth,0,0
41307,leak,0,0
41308,during,0,1
41309,nasal,1,1
41310,CPAP,1,1
41311,.,1,1
41312,BACKGROUND,0,0
41313,AND,0,0
41314,PURPOSE,0,0
41315,Mouth,0,1
41316,leak,0,0
41317,occasionally,0,0
41318,complicates,0,0
41319,continuous,0,0
41320,positive,0,0
41321,airway,0,1
41322,pressure,0,0
41323,(,1,1
41324,CPAP,1,1
41325,),1,1
41326,therapy,1,0
41327,",",0,0
41328,which,0,0
41329,leads,0,0
41330,to,0,0
41331,discomfort,0,0
41332,.,0,1
41333,While,0,0
41334,a,0,0
41335,chinstrap,0,1
41336,prevents,0,0
41337,the,0,0
41338,mouth,0,0
41339,from,0,0
41340,opening,0,0
41341,during,0,0
41342,sleep,0,1
41343,",",0,0
41344,its,0,0
41345,efficacy,0,0
41346,in,0,0
41347,diminishing,0,0
41348,mouth,0,1
41349,leak,0,0
41350,has,0,0
41351,not,0,0
41352,been,0,0
41353,studied,0,1
41354,.,0,1
41355,PATIENTS,0,0
41356,AND,0,0
41357,METHODS,0,0
41358,Fifteen,1,1
41359,patients,1,1
41360,with,1,1
41361,mouth,1,1
41362,leak,1,0
41363,complaining,1,1
41364,of,1,0
41365,mouth,1,1
41366,dryness,1,1
41367,and,1,0
41368,nasal,1,1
41369,obstruction,1,1
41370,underwent,0,1
41371,two,0,1
41372,consecutive,0,1
41373,overnight,0,1
41374,polysomnographies,0,1
41375,",",0,1
41376,one,0,1
41377,with,0,1
41378,a,0,1
41379,chinstrap,0,1
41380,",",0,0
41381,in,0,0
41382,random,0,1
41383,order,0,0
41384,.,0,1
41385,Cephalometry,0,1
41386,with,0,1
41387,and,0,0
41388,without,0,1
41389,a,0,1
41390,chinstrap,0,1
41391,was,0,0
41392,randomly,0,1
41393,performed,0,0
41394,on,0,0
41395,six,1,1
41396,patients,1,1
41397,.,1,1
41398,RESULTS,0,0
41399,With,0,1
41400,the,0,0
41401,chinstrap,0,1
41402,",",0,0
41403,both,0,0
41404,mouth,0,0
41405,leak,0,0
41406,and,0,0
41407,the,0,0
41408,arousal,0,0
41409,index,0,0
41410,decreased,0,0
41411,significantly,0,0
41412,",",0,0
41413,from,0,0
41414,(,0,1
41415,mean+/-SD,0,1
41416,),0,1
41417,42.9+/-23.5,0,1
41418,to,0,1
41419,23.8+/-13.3,0,1
41420,%,0,0
41421,of,0,1
41422,total,0,1
41423,sleep,0,1
41424,time,0,0
41425,(,0,1
41426,TST,0,1
41427,),0,1
41428,",",0,0
41429,and,0,0
41430,from,0,1
41431,33.4+/-18.6,0,1
41432,to,0,1
41433,23.6+/-9.3/sleep,0,1
41434,hour,0,0
41435,",",0,0
41436,respectively,0,0
41437,.,0,0
41438,However,0,0
41439,",",0,0
41440,snoring,0,1
41441,time,0,0
41442,showed,0,0
41443,a,0,0
41444,concomitant,0,0
41445,increase,0,0
41446,from,0,1
41447,6.7+/-14.3,0,1
41448,to,0,1
41449,24.0+/-13.2,0,0
41450,%,0,0
41451,of,0,1
41452,TST,0,1
41453,.,0,1
41454,The,0,0
41455,arousal,0,0
41456,index,0,0
41457,was,0,0
41458,significantly,0,0
41459,higher,0,0
41460,during,0,0
41461,leak,0,0
41462,periods,0,0
41463,",",0,0
41464,and,0,1
41465,its,0,0
41466,changes,0,0
41467,correlated,0,0
41468,positively,0,0
41469,with,0,1
41470,changes,0,0
41471,in,0,1
41472,mouth,0,1
41473,leak,0,0
41474,.,0,1
41475,Cephalometric,0,0
41476,measures,0,0
41477,showed,0,0
41478,a,0,1
41479,significant,0,0
41480,decrease,0,0
41481,in,0,0
41482,anterior,0,1
41483,lower,0,0
41484,facial,0,1
41485,height,0,0
41486,.,0,1
41487,CONCLUSIONS,0,0
41488,The,0,0
41489,chinstrap,0,0
41490,",",0,0
41491,by,0,0
41492,closing,0,0
41493,the,0,0
41494,mouth,0,1
41495,during,0,0
41496,CPAP,0,0
41497,",",0,0
41498,reduces,0,0
41499,mouth,0,0
41500,leak,0,0
41501,and,0,0
41502,therefore,0,0
41503,the,0,0
41504,arousal,0,0
41505,index,0,0
41506,in,0,0
41507,most,0,1
41508,patients,0,1
41509,.,0,1
41510,Nevertheless,0,0
41511,",",0,0
41512,the,0,0
41513,indices,0,0
41514,remained,0,0
41515,unacceptably,0,1
41516,high,0,1
41517,.,0,1
41518,The,0,0
41519,chinstrap,0,0
41520,may,0,0
41521,also,0,0
41522,increase,0,0
41523,snoring,0,1
41524,and,0,0
41525,",",0,0
41526,in,0,0
41527,rare,0,1
41528,cases,0,1
41529,",",0,1
41530,can,0,0
41531,worsen,0,0
41532,the,0,0
41533,respiratory,0,0
41534,disturbance,0,0
41535,index,0,1
41536,.,0,1
41537,Consideration,0,0
41538,of,0,0
41539,these,0,0
41540,potential,0,0
41541,effects,0,0
41542,is,0,0
41543,important,0,0
41544,before,0,0
41545,instituting,0,1
41546,regular,0,1
41547,home,0,1
41548,use,0,0
41549,of,0,0
41550,the,0,0
41551,chinstrap,0,1
41552,.,0,1
41553,Gender,0,1
41554,difference,0,0
41555,in,0,0
41556,the,0,0
41557,response,0,0
41558,to,0,0
41559,an,0,0
41560,angiotensin-converting,0,0
41561,enzyme,0,0
41562,inhibitor,0,0
41563,and,0,0
41564,a,0,0
41565,diuretic,0,0
41566,in,0,1
41567,hypertensive,1,1
41568,patients,1,1
41569,of,1,1
41570,African,1,1
41571,descent,1,1
41572,.,1,1
41573,BACKGROUND,0,0
41574,The,0,0
41575,efficacy,0,0
41576,of,0,0
41577,angiotensin-converting,0,0
41578,enzyme,0,0
41579,(,0,1
41580,ACE,0,1
41581,),0,1
41582,inhibitors,0,0
41583,in,0,1
41584,decreasing,0,0
41585,blood,0,0
41586,pressure,0,0
41587,in,0,1
41588,African,1,1
41589,patients,1,1
41590,is,0,0
41591,controversial,0,0
41592,.,0,0
41593,OBJECTIVE,0,0
41594,We,0,0
41595,examined,0,0
41596,the,0,0
41597,ambulatory,0,1
41598,blood,0,0
41599,pressure,0,0
41600,(,0,1
41601,ABP,0,1
41602,),0,1
41603,response,0,0
41604,to,0,0
41605,a,0,1
41606,diuretic,0,0
41607,and,0,0
41608,an,0,1
41609,ACE,0,1
41610,inhibitor,0,0
41611,in,0,1
41612,hypertensive,0,1
41613,patients,1,1
41614,of,1,1
41615,East,1,1
41616,African,1,1
41617,descent,1,1
41618,and,0,0
41619,evaluated,0,0
41620,the,0,0
41621,individual,0,0
41622,characteristics,0,0
41623,that,0,0
41624,determined,0,0
41625,treatment,0,0
41626,efficacy,0,0
41627,.,0,0
41628,DESIGN,0,0
41629,A,0,0
41630,single-blind,0,0
41631,randomized,0,1
41632,AB/BA,0,0
41633,crossover,0,1
41634,design,0,1
41635,.,0,1
41636,SETTING,0,1
41637,Hypertensive,1,1
41638,families,1,1
41639,of,1,1
41640,East,1,1
41641,African,1,1
41642,descent,1,1
41643,from,1,1
41644,the,1,0
41645,general,1,1
41646,population,1,1
41647,in,1,0
41648,the,1,0
41649,Seychelles,1,1
41650,.,1,1
41651,PARTICIPANTS,0,0
41652,Fifty-two,1,1
41653,(,1,1
41654,29,1,1
41655,men,1,1
41656,and,1,1
41657,23,1,1
41658,women,1,1
41659,),1,1
41660,out,1,1
41661,of,1,1
41662,62,1,1
41663,eligible,1,1
41664,hypertensive,1,1
41665,patients,1,1
41666,were,1,1
41667,included.Main,1,1
41668,outcome,0,0
41669,measures,0,0
41670,ABP,0,1
41671,response,0,0
41672,to,0,1
41673,20,0,1
41674,mg,0,0
41675,lisinopril,0,1
41676,(,0,1
41677,LIS,0,0
41678,),0,1
41679,daily,0,0
41680,and,0,1
41681,25,0,1
41682,mg,0,0
41683,hydrochlorothiazide,0,0
41684,(,0,1
41685,HCT,0,1
41686,),0,1
41687,daily,0,0
41688,given,0,0
41689,for,0,0
41690,a,0,1
41691,4-week,0,0
41692,period,0,0
41693,.,0,1
41694,Results,0,0
41695,The,0,0
41696,daytime,0,0
41697,systolic/diastolic,0,0
41698,ABP,0,1
41699,response,0,0
41700,to,0,1
41701,HCT,0,1
41702,was,0,0
41703,4.9,0,0
41704,[,0,1
41705,95,0,0
41706,%,0,0
41707,confidence,0,0
41708,interval,0,0
41709,(,0,1
41710,CI,0,0
41711,),0,1
41712,1.2-8.6,0,0
41713,],0,1
41714,/3.6,0,1
41715,(,0,1
41716,1.0-6.2,0,0
41717,),0,1
41718,mmHg,0,0
41719,for,0,1
41720,men,0,1
41721,and,0,1
41722,12.9,0,1
41723,(,0,1
41724,9.2-16.6,0,1
41725,),0,1
41726,/6.3,0,0
41727,(,0,1
41728,3.7-8.8,0,0
41729,),0,1
41730,mmHg,0,0
41731,for,0,1
41732,women,0,1
41733,.,0,1
41734,With,0,1
41735,LIS,0,0
41736,the,0,0
41737,response,0,0
41738,was,0,0
41739,18.8,0,1
41740,(,0,1
41741,15.0-22.5,0,0
41742,),0,1
41743,/14.6,0,0
41744,(,0,1
41745,12.0-17.1,0,0
41746,),0,1
41747,mmHg,0,0
41748,for,0,1
41749,men,0,1
41750,and,0,1
41751,12.4,0,1
41752,(,0,1
41753,8.7-16.2,0,0
41754,),0,1
41755,/7.7,0,0
41756,(,0,1
41757,5.1-10.2,0,0
41758,),0,1
41759,mmHg,0,0
41760,for,0,1
41761,women,0,1
41762,.,0,1
41763,The,0,0
41764,night-time,0,0
41765,systolic/diastolic,0,0
41766,response,0,0
41767,to,0,1
41768,HCT,0,1
41769,was,0,0
41770,5.0,0,0
41771,(,0,1
41772,0.6-9.4,0,0
41773,),0,1
41774,/2.7,0,1
41775,[,0,0
41776,(,0,1
41777,-0.4,0,0
41778,),0,1
41779,-5.7,0,0
41780,],0,0
41781,mmHg,0,0
41782,for,0,1
41783,men,0,1
41784,and,0,1
41785,11.5,0,1
41786,(,0,1
41787,7.1-16.0,0,0
41788,),0,1
41789,/5.7,0,1
41790,(,0,1
41791,2.6-8.8,0,0
41792,),0,1
41793,mmHg,0,0
41794,for,0,1
41795,women,0,1
41796,",",0,1
41797,and,0,0
41798,to,0,0
41799,LIS,0,0
41800,was,0,0
41801,18.7,0,0
41802,(,0,1
41803,14.2-22.1,0,1
41804,),0,1
41805,/15.4,0,0
41806,(,0,1
41807,12.4-18.5,0,1
41808,),0,1
41809,mmHg,0,0
41810,for,0,1
41811,men,0,1
41812,and,0,1
41813,3.5,0,0
41814,[,0,0
41815,(,0,1
41816,-1.0,0,0
41817,),0,1
41818,-7.9,0,0
41819,],0,1
41820,/2.3,0,1
41821,[,0,0
41822,(,0,1
41823,-0.8,0,0
41824,),0,1
41825,-5.4,0,0
41826,],0,0
41827,mmHg,0,0
41828,for,0,1
41829,women,0,1
41830,.,0,1
41831,Linear,0,0
41832,regression,0,0
41833,analyses,0,0
41834,showed,0,0
41835,that,0,0
41836,gender,0,0
41837,is,0,0
41838,an,0,0
41839,independent,0,0
41840,predictor,0,0
41841,of,0,0
41842,the,0,0
41843,ABP,0,1
41844,responses,0,0
41845,to,0,1
41846,HCT,0,1
41847,and,0,1
41848,to,0,1
41849,LIS,0,0
41850,.,0,1
41851,CONCLUSIONS,0,0
41852,Hypertensive,0,1
41853,patients,0,1
41854,of,0,1
41855,African,0,1
41856,descent,0,1
41857,responded,0,1
41858,better,0,0
41859,to,0,0
41860,LIS,0,0
41861,than,0,0
41862,to,0,1
41863,HCT,0,1
41864,.,0,1
41865,Men,0,1
41866,responded,0,0
41867,better,0,0
41868,to,0,0
41869,LIS,0,0
41870,than,0,0
41871,to,0,1
41872,HCT,0,1
41873,and,0,1
41874,women,0,1
41875,responded,0,1
41876,similarly,0,0
41877,to,0,0
41878,both,0,0
41879,drugs,0,0
41880,.,0,1
41881,Chronic,0,1
41882,fatigue,0,0
41883,syndrome,0,1
41884,versus,0,0
41885,neuroendocrineimmune,0,1
41886,dysfunction,0,1
41887,syndrome,0,1
41888,:,0,1
41889,differential,0,1
41890,attributions,0,0
41891,.,0,1
41892,Since,0,1
41893,1988,0,1
41894,",",0,0
41895,when,0,0
41896,the,0,0
41897,term,0,0
41898,chronic,0,1
41899,fatigue,0,0
41900,syndrome,0,1
41901,(,0,1
41902,CFS,0,0
41903,),0,1
41904,was,0,0
41905,coined,0,1
41906,",",0,0
41907,considerable,0,0
41908,discussion,0,0
41909,has,0,0
41910,occurred,0,0
41911,about,0,0
41912,stigma,0,0
41913,associated,0,0
41914,with,0,1
41915,this,0,0
41916,diagnostic,0,0
41917,term,0,1
41918,.,0,1
41919,In,0,0
41920,particular,0,0
41921,",",0,1
41922,patients,1,1
41923,with,1,1
41924,CFS,1,1
41925,have,0,0
41926,felt,0,0
41927,that,0,0
41928,this,0,0
41929,term,0,0
41930,trivializes,0,0
41931,the,0,0
41932,serious,0,0
41933,nature,0,1
41934,of,0,0
41935,this,0,0
41936,disorder,0,1
41937,.,0,0
41938,A,0,0
41939,Name,0,0
41940,Change,0,0
41941,Work,0,1
41942,group,0,1
41943,",",0,0
41944,appointed,0,1
41945,by,0,0
41946,the,0,0
41947,CFS,0,0
41948,Coordinating,0,1
41949,Committee,0,1
41950,",",0,0
41951,developed,0,0
41952,an,0,0
41953,umbrella,0,1
41954,term,0,1
41955,:,0,1
41956,chronic,0,1
41957,neuroendocrineimmune,0,1
41958,dysfunction,0,1
41959,syndrome,0,1
41960,(,0,1
41961,CNDS,0,1
41962,),0,1
41963,",",0,0
41964,and,0,0
41965,proposed,0,0
41966,that,0,0
41967,there,0,0
41968,would,0,0
41969,be,0,0
41970,sub-types,0,1
41971,under,0,0
41972,this,0,0
41973,term,0,0
41974,",",0,0
41975,one,0,1
41976,being,0,1
41977,CFS,0,0
41978,.,0,1
41979,The,0,0
41980,present,0,0
41981,study,0,1
41982,examined,0,0
41983,attributions,0,0
41984,of,0,0
41985,this,0,0
41986,new,0,1
41987,umbrella,0,0
41988,term,0,0
41989,when,0,0
41990,compared,0,0
41991,with,0,1
41992,CFS,0,1
41993,.,0,1
41994,Nurses,0,0
41995,and,0,1
41996,physician,0,1
41997,assistants,0,1
41998,(,0,1
41999,PAs,0,1
42000,),0,1
42001,were,0,0
42002,presented,0,1
42003,a,0,0
42004,case,0,0
42005,study,0,0
42006,of,0,0
42007,a,0,0
42008,patient,1,1
42009,with,1,1
42010,symptoms,1,1
42011,of,1,1
42012,CFS,1,1
42013,.,1,1
42014,They,0,0
42015,were,0,0
42016,told,0,0
42017,that,0,0
42018,the,0,0
42019,patient,1,1
42020,had,1,1
42021,either,1,0
42022,chronic,1,1
42023,fatigue,1,0
42024,syndrome,1,1
42025,",",1,0
42026,chronic,1,1
42027,neuroendocrineimmune,1,1
42028,dysfunction,1,1
42029,syndrome,1,1
42030,",",1,0
42031,or,1,1
42032,chronic,1,1
42033,neuroendocrineimmune,1,1
42034,dysfunction,1,1
42035,syndrome,1,1
42036,",",0,0
42037,which,0,0
42038,had,0,1
42039,formerly,0,1
42040,been,0,0
42041,called,0,1
42042,chronic,0,1
42043,fatigue,0,0
42044,syndrome,0,1
42045,.,0,1
42046,The,0,0
42047,different,0,0
42048,terms,0,0
42049,led,0,0
42050,to,0,1
42051,different,0,0
42052,attributions,0,0
42053,",",0,1
42054,with,0,1
42055,PA,0,1
42056,respondents,0,1
42057,rating,0,0
42058,the,0,0
42059,CNDS,0,1
42060,label,0,0
42061,as,0,0
42062,more,0,0
42063,severe,0,1
42064,.,0,0
42065,Results,0,0
42066,suggest,0,0
42067,that,0,0
42068,a,0,0
42069,more,0,0
42070,medical,0,0
42071,sounding,0,0
42072,term,0,1
42073,(,0,1
42074,CNDS,0,1
42075,),0,1
42076,may,0,0
42077,lead,0,0
42078,to,0,0
42079,attributions,0,0
42080,that,0,0
42081,this,0,0
42082,syndrome,0,1
42083,is,0,0
42084,a,0,0
42085,more,0,0
42086,serious,0,0
42087,",",0,0
42088,disabling,0,1
42089,illness,0,1
42090,.,0,1
42091,The,0,0
42092,policy,0,0
42093,implications,0,0
42094,of,0,1
42095,these,0,0
42096,findings,0,0
42097,are,0,0
42098,discussed,0,0
42099,.,0,1
42100,An,0,0
42101,open,0,0
42102,and,0,0
42103,randomized,0,1
42104,study,0,1
42105,comparing,0,0
42106,the,0,0
42107,efficacy,0,0
42108,of,0,0
42109,standard,0,1
42110,danazol,0,0
42111,and,0,0
42112,modified,0,0
42113,triptorelin,0,0
42114,regimens,0,0
42115,for,0,1
42116,postoperative,1,1
42117,disease,1,1
42118,management,1,1
42119,of,1,0
42120,moderate,1,1
42121,to,1,1
42122,severe,1,1
42123,endometriosis,1,1
42124,.,1,1
42125,OBJECTIVE,0,0
42126,To,0,0
42127,compare,0,0
42128,the,0,0
42129,efficacy,0,0
42130,of,0,0
42131,danazol,0,0
42132,and,0,1
42133,triptorelin,0,0
42134,(,0,1
42135,Decapeptyl,0,0
42136,CR,0,1
42137,",",0,0
42138,Ferring,0,1
42139,",",0,0
42140,Kiel,0,1
42141,",",0,0
42142,Germany,0,1
42143,),0,0
42144,in,0,0
42145,the,0,0
42146,management,0,0
42147,of,0,0
42148,moderate,0,1
42149,and,0,1
42150,severe,0,1
42151,endometriosis,0,1
42152,in,0,1
42153,terms,0,0
42154,of,0,1
42155,symptom,0,1
42156,control,0,1
42157,and,0,0
42158,revised,0,1
42159,American,0,1
42160,Fertility,0,1
42161,Society,0,1
42162,(,0,1
42163,AFS,0,0
42164,),0,1
42165,score,0,0
42166,reduction,0,0
42167,",",0,0
42168,and,0,0
42169,to,0,0
42170,evaluate,0,0
42171,the,0,0
42172,hormonal,0,0
42173,profile,0,0
42174,of,0,1
42175,patients,1,1
42176,treated,1,1
42177,with,1,1
42178,triptorelin,1,0
42179,every,1,0
42180,6,1,0
42181,weeks,1,0
42182,.,1,1
42183,DESIGN,0,0
42184,Open,0,0
42185,and,0,1
42186,randomized,0,1
42187,trial,0,1
42188,.,0,1
42189,SETTING,0,1
42190,Kwong,1,1
42191,Wah,1,1
42192,Hospital,1,1
42193,",",1,0
42194,a,1,0
42195,large,1,1
42196,public,1,1
42197,hospital,1,1
42198,in,1,0
42199,an,1,0
42200,urban,1,1
42201,location,1,1
42202,(,1,1
42203,Hong,1,1
42204,Kong,1,1
42205,),1,1
42206,.,1,1
42207,PATIENT,0,0
42208,(,0,0
42209,S,0,1
42210,),0,1
42211,Forty,1,1
42212,patients,1,1
42213,after,1,1
42214,their,1,1
42215,first,1,1
42216,conservative,1,1
42217,operation,1,1
42218,for,1,0
42219,endometriosis,1,1
42220,",",1,0
42221,with,1,1
42222,surgical,1,1
42223,confirmation,1,0
42224,of,1,0
42225,revised,1,1
42226,AFS,1,0
42227,stage,1,1
42228,III,1,1
42229,or,1,1
42230,IV,1,1
42231,endometriosis,1,1
42232,.,1,1
42233,INTERVENTION,0,0
42234,(,0,0
42235,S,0,1
42236,),0,1
42237,Postoperative,0,1
42238,6,0,0
42239,months,0,0
42240,',0,1
42241,therapy,0,1
42242,of,0,1
42243,danazol,0,0
42244,or,0,1
42245,triptorelin,0,0
42246,every,0,0
42247,6,0,0
42248,weeks,0,0
42249,",",0,1
42250,postmedical,0,1
42251,therapy,0,0
42252,second-look,0,1
42253,laparoscopy,0,1
42254,.,0,1
42255,MAIN,0,0
42256,OUTCOME,0,1
42257,MEASURE,0,0
42258,(,0,1
42259,S,0,1
42260,),0,1
42261,Symptom,0,1
42262,control,0,1
42263,and,0,1
42264,patients,0,1
42265,',0,1
42266,tolerance,0,1
42267,during,0,1
42268,medical,0,1
42269,therapy,0,0
42270,",",0,0
42271,posttherapy,0,0
42272,revised,0,0
42273,AFS,0,0
42274,score,0,0
42275,",",0,0
42276,hormonal,0,0
42277,profile,0,0
42278,during,0,0
42279,triptorelin,0,0
42280,therapy,0,1
42281,.,0,1
42282,RESULT,0,0
42283,(,0,0
42284,S,0,1
42285,),0,1
42286,Pain,0,1
42287,control,0,1
42288,was,0,0
42289,similar,0,0
42290,between,0,0
42291,danazol,0,0
42292,and,0,1
42293,triptorelin,0,0
42294,therapy,0,0
42295,.,0,0
42296,There,0,0
42297,was,0,0
42298,less,0,0
42299,breakthrough,0,0
42300,bleeding,0,0
42301,with,0,1
42302,triptorelin,0,0
42303,.,0,1
42304,More,0,1
42305,patients,0,1
42306,failed,0,0
42307,to,0,0
42308,complete,0,1
42309,the,0,0
42310,whole,0,0
42311,course,0,0
42312,of,0,0
42313,danazol,0,0
42314,because,0,1
42315,of,0,0
42316,its,0,0
42317,side,0,0
42318,effects,0,0
42319,.,0,1
42320,The,0,0
42321,revised,0,0
42322,AFS,0,0
42323,score,0,1
42324,at,0,0
42325,second-look,0,1
42326,laparoscopy,0,1
42327,did,0,0
42328,not,0,0
42329,show,0,0
42330,a,0,0
42331,significant,0,0
42332,difference,0,0
42333,between,0,0
42334,the,0,1
42335,two,0,1
42336,medications,0,1
42337,.,0,1
42338,Adequate,0,0
42339,pituitary,0,1
42340,suppression,0,0
42341,was,0,0
42342,observed,0,0
42343,with,0,1
42344,injection,0,0
42345,of,0,0
42346,triptorelin,0,0
42347,every,0,0
42348,6,0,0
42349,weeks,0,0
42350,.,0,1
42351,CONCLUSION,0,0
42352,(,0,0
42353,S,0,1
42354,),0,1
42355,Lengthening,0,0
42356,of,0,1
42357,triptorelin,0,0
42358,administration,0,0
42359,intervals,0,0
42360,from,0,1
42361,4,0,1
42362,weeks,0,1
42363,to,0,1
42364,6,0,1
42365,weeks,0,0
42366,is,0,0
42367,effective,0,0
42368,in,0,0
42369,maintaining,0,0
42370,a,0,1
42371,hypoestrogenic,0,1
42372,state,0,1
42373,.,0,1
42374,Patients,0,1
42375,were,0,0
42376,more,0,0
42377,compliant,0,0
42378,with,0,0
42379,triptorelin,0,0
42380,than,0,0
42381,danazol,0,0
42382,.,0,1
42383,Thus,0,0
42384,",",0,0
42385,triptorelin,0,0
42386,injection,0,0
42387,every,0,0
42388,6,0,0
42389,weeks,0,0
42390,is,0,0
42391,more,0,0
42392,cost-effective,0,0
42393,than,0,0
42394,conventional,0,1
42395,regimens,0,1
42396,.,0,1
42397,Chemotherapy,0,1
42398,for,0,1
42399,patients,1,1
42400,with,1,1
42401,non-small,1,1
42402,cell,1,1
42403,lung,1,1
42404,cancer,1,1
42405,:,1,1
42406,the,0,0
42407,surgical,0,1
42408,setting,0,1
42409,of,0,0
42410,the,0,0
42411,Big,0,1
42412,Lung,0,1
42413,Trial,0,1
42414,.,0,1
42415,OBJECTIVES,0,0
42416,The,0,0
42417,non-small,1,1
42418,cell,1,1
42419,lung,1,1
42420,cancer,1,1
42421,(,1,1
42422,NSCLC,1,1
42423,),1,1
42424,meta-analysis,0,0
42425,suggested,0,0
42426,a,0,0
42427,survival,0,0
42428,benefit,0,0
42429,for,0,0
42430,cisplatin-based,0,0
42431,chemotherapy,0,1
42432,when,0,0
42433,given,0,0
42434,in,0,0
42435,addition,0,0
42436,to,0,0
42437,surgery,0,1
42438,",",0,0
42439,radical,0,1
42440,radiotherapy,0,1
42441,or,0,1
42442,'best,0,0
42443,supportive,0,0
42444,care,0,1
42445,',0,1
42446,.,0,1
42447,However,0,0
42448,",",0,0
42449,it,0,0
42450,included,0,1
42451,many,0,1
42452,small,0,1
42453,trials,0,1
42454,and,0,1
42455,trials,0,1
42456,with,0,1
42457,differing,0,1
42458,eligibility,0,1
42459,criteria,0,1
42460,and,0,1
42461,chemotherapy,0,1
42462,regimens,0,0
42463,.,0,1
42464,The,0,0
42465,aim,0,0
42466,of,0,0
42467,the,0,0
42468,Big,0,1
42469,Lung,0,1
42470,Trial,0,1
42471,was,0,0
42472,therefore,0,0
42473,to,0,0
42474,run,0,0
42475,a,0,0
42476,large,0,1
42477,pragmatic,0,1
42478,trial,0,0
42479,to,0,0
42480,confirm,0,0
42481,the,0,0
42482,survival,0,0
42483,benefits,0,0
42484,seen,0,1
42485,in,0,0
42486,the,0,0
42487,meta-analysis,0,0
42488,.,0,1
42489,METHODS,0,0
42490,In,0,0
42491,the,0,0
42492,surgery,0,1
42493,setting,0,1
42494,",",0,0
42495,a,0,0
42496,total,0,1
42497,of,0,0
42498,381,1,1
42499,patients,1,1
42500,were,1,1
42501,randomised,1,1
42502,to,1,0
42503,chemotherapy,1,1
42504,(,1,0
42505,C,1,0
42506,",",1,1
42507,192,1,1
42508,patients,1,1
42509,),1,1
42510,or,1,1
42511,no,1,0
42512,chemotherapy,1,1
42513,(,1,0
42514,NoC,1,0
42515,",",1,1
42516,189,1,1
42517,patients,1,1
42518,),1,1
42519,.,1,1
42520,C,0,0
42521,was,0,0
42522,three,0,1
42523,3-weekly,0,0
42524,cycles,0,0
42525,of,0,1
42526,cisplatin/vindesine,0,0
42527,",",0,0
42528,mitomycin/ifosfamide/cisplatin,0,0
42529,",",0,0
42530,mitomycin/vinblastine/cisplatin,0,0
42531,or,0,1
42532,vinorelbine/cisplatin,0,0
42533,.,0,1
42534,RESULTS,0,0
42535,Chemotherapy,0,1
42536,was,0,0
42537,given,0,0
42538,before,0,0
42539,surgery,0,1
42540,in,0,0
42541,3,0,1
42542,%,0,0
42543,of,0,0
42544,patients,0,1
42545,whilst,0,1
42546,97,0,1
42547,%,0,0
42548,received,0,1
42549,adjuvant,0,1
42550,chemotherapy,0,1
42551,.,0,1
42552,Baseline,0,0
42553,characteristics,0,0
42554,were,0,1
42555,:,0,1
42556,median,0,1
42557,age,0,1
42558,61,0,1
42559,years,0,1
42560,",",0,1
42561,69,0,1
42562,%,0,0
42563,male,0,1
42564,",",0,0
42565,48,0,1
42566,%,0,0
42567,squamous,0,1
42568,cell,0,1
42569,",",0,1
42570,93,0,1
42571,%,0,0
42572,WHO,0,1
42573,PS,0,1
42574,0-1,0,1
42575,",",0,1
42576,27,0,1
42577,%,0,0
42578,stage,0,1
42579,I,0,1
42580,",",0,0
42581,38,0,1
42582,%,0,0
42583,stage,0,1
42584,II,0,1
42585,",",0,1
42586,and,0,0
42587,34,0,1
42588,%,0,0
42589,stage,0,1
42590,III,0,1
42591,.,0,1
42592,Complete,0,0
42593,resection,0,1
42594,was,0,0
42595,achieved,0,0
42596,in,0,0
42597,approximately,0,1
42598,95,0,0
42599,%,0,0
42600,of,0,1
42601,patients,0,1
42602,.,0,1
42603,In,0,0
42604,the,0,0
42605,C,0,0
42606,group,0,0
42607,",",0,1
42608,13,0,1
42609,%,0,0
42610,received,0,1
42611,no,0,0
42612,chemotherapy,0,1
42613,",",0,0
42614,21,0,1
42615,%,0,0
42616,one,0,1
42617,or,0,1
42618,two,0,1
42619,cycles,0,0
42620,",",0,1
42621,and,0,1
42622,64,0,1
42623,%,0,0
42624,all,0,1
42625,three,0,0
42626,cycles,0,0
42627,of,0,1
42628,their,0,1
42629,prescribed,0,1
42630,chemotherapy,0,1
42631,(,0,1
42632,60,0,1
42633,%,0,0
42634,of,0,0
42635,the,0,0
42636,latter,0,0
42637,with,0,1
42638,no,0,1
42639,delays,0,0
42640,or,0,1
42641,modification,0,0
42642,),0,1
42643,.,0,1
42644,30,0,0
42645,%,0,0
42646,had,0,1
42647,grade,0,1
42648,3/4,0,0
42649,toxicity,0,0
42650,",",0,0
42651,mainly,0,0
42652,haematological,0,0
42653,",",0,0
42654,nausea/vomiting,0,0
42655,and,0,0
42656,neutropenic,0,1
42657,fever,0,1
42658,",",0,1
42659,and,0,1
42660,six,0,1
42661,patients,0,1
42662,were,0,1
42663,reported,0,1
42664,as,0,0
42665,having,0,1
42666,a,0,1
42667,treatment-related,0,0
42668,death,0,0
42669,.,0,1
42670,198,0,1
42671,(,0,1
42672,52,0,1
42673,%,0,0
42674,),0,1
42675,of,0,0
42676,patients,0,1
42677,have,0,1
42678,died,0,1
42679,",",0,0
42680,but,0,0
42681,there,0,0
42682,is,0,0
42683,currently,0,0
42684,no,0,0
42685,evidence,0,0
42686,of,0,0
42687,a,0,0
42688,benefit,0,0
42689,in,0,0
42690,overall,0,0
42691,survival,0,0
42692,to,0,1
42693,the,0,0
42694,C,0,0
42695,group,0,1
42696,:,0,1
42697,HR,0,0
42698,1.02,0,0
42699,(,0,1
42700,95,0,0
42701,%,0,0
42702,CI,0,0
42703,0.77-1.35,0,0
42704,),0,1
42705,",",0,0
42706,P,0,0
42707,=,0,1
42708,0.90,0,0
42709,),0,1
42710,.,0,1
42711,CONCLUSIONS,0,0
42712,This,0,0
42713,trial,0,0
42714,has,0,0
42715,failed,0,0
42716,to,0,0
42717,observe,0,0
42718,a,0,0
42719,survival,0,0
42720,benefit,0,0
42721,with,0,1
42722,adjuvant,0,1
42723,chemotherapy,0,1
42724,following,0,0
42725,complete,0,1
42726,resection,0,1
42727,of,0,0
42728,stage,0,1
42729,I-III,0,1
42730,NSCLC,0,1
42731,.,0,1
42732,However,0,0
42733,",",0,0
42734,the,0,0
42735,hazard,0,0
42736,ratio,0,0
42737,and,0,1
42738,95,0,0
42739,%,0,0
42740,confidence,0,0
42741,intervals,0,0
42742,are,0,0
42743,consistent,0,0
42744,with,0,1
42745,the,0,0
42746,previously,0,1
42747,reported,0,0
42748,meta-analysis,0,0
42749,and,0,1
42750,two,0,0
42751,large,0,1
42752,recently,0,1
42753,reported,0,1
42754,trials,0,0
42755,",",0,0
42756,which,0,0
42757,suggest,0,0
42758,a,0,0
42759,small,0,0
42760,survival,0,0
42761,benefit,0,0
42762,with,0,1
42763,cisplatin-based,0,1
42764,chemotherapy,0,1
42765,.,0,1
42766,Predicting,0,0
42767,the,0,0
42768,costs,0,1
42769,of,0,0
42770,allogeneic,1,1
42771,sibling,1,1
42772,stem-cell,1,1
42773,transplantation,1,1
42774,:,1,1
42775,results,0,0
42776,from,0,1
42777,a,0,1
42778,prospective,0,1
42779,",",0,0
42780,multicenter,0,0
42781,",",0,0
42782,French,1,1
42783,study,1,1
42784,.,1,1
42785,BACKGROUND,0,0
42786,Allogeneic,0,1
42787,hematopoietic,0,1
42788,stem-cell,0,1
42789,transplantation,0,1
42790,is,0,0
42791,a,0,0
42792,widely,0,0
42793,used,0,0
42794,",",0,0
42795,cost-intensive,0,0
42796,procedure,0,0
42797,.,0,1
42798,Our,0,0
42799,purpose,0,0
42800,was,0,0
42801,to,0,0
42802,estimate,0,0
42803,costs,0,0
42804,and,0,0
42805,determine,0,0
42806,cost,0,0
42807,predictors,0,0
42808,.,0,1
42809,METHODS,0,0
42810,We,0,0
42811,used,0,0
42812,data,0,0
42813,from,0,1
42814,a,0,1
42815,prospective,1,1
42816,French,1,1
42817,study,1,1
42818,comparing,1,0
42819,four,1,1
42820,doses,1,1
42821,of,1,1
42822,immunoglobulins,1,1
42823,.,1,1
42824,Resource,0,0
42825,use,0,0
42826,of,0,0
42827,hematopoietic,1,1
42828,stem-cell,1,1
42829,transplant,1,1
42830,recipients,1,1
42831,during,0,1
42832,the,0,1
42833,first,0,1
42834,6,0,1
42835,months,0,1
42836,posttransplant,0,1
42837,",",0,1
42838,both,0,0
42839,inpatient,0,1
42840,and,0,0
42841,ambulatory,0,1
42842,costs,0,0
42843,",",0,1
42844,in,0,1
42845,85,1,1
42846,patients,1,1
42847,from,1,1
42848,five,1,1
42849,centers,1,1
42850,were,1,1
42851,collected,1,1
42852,prospectively,1,1
42853,and,1,0
42854,costed,1,0
42855,.,0,1
42856,Baseline,0,0
42857,data,0,0
42858,and,0,1
42859,clinical,0,0
42860,events,0,0
42861,were,0,1
42862,retrieved,0,1
42863,.,0,1
42864,Protocol-driven,0,1
42865,costs,0,0
42866,were,0,1
42867,excluded,0,1
42868,.,0,1
42869,Multivariable,0,0
42870,analysis,0,0
42871,evaluated,0,0
42872,the,0,0
42873,association,0,0
42874,between,0,0
42875,costs,0,1
42876,and,0,1
42877,patient,1,1
42878,'s,1,1
42879,pretransplant,1,1
42880,status,1,1
42881,and,1,1
42882,transplant-related,1,1
42883,complications,1,1
42884,.,1,1
42885,Because,0,0
42886,of,0,0
42887,the,0,0
42888,absence,0,0
42889,of,0,0
42890,differences,0,0
42891,in,0,1
42892,outcome,0,0
42893,among,0,1
42894,the,0,0
42895,four,0,1
42896,randomization,0,0
42897,groups,0,0
42898,",",0,1
42899,cost,0,0
42900,data,0,0
42901,for,0,1
42902,all,0,1
42903,patients,0,1
42904,were,0,1
42905,pooled,0,0
42906,.,0,1
42907,RESULTS,0,0
42908,Total,0,1
42909,costs,0,1
42910,per,0,1
42911,patient,0,1
42912,were,0,1
42913,the,0,0
42914,following,0,0
42915,:,0,1
42916,mean,0,1
42917,"76,237",0,1
42918,Euros,0,1
42919,;,0,1
42920,standard,0,1
42921,deviation,0,1
42922,"32,565",0,1
42923,Euros,0,1
42924,;,0,1
42925,median,0,1
42926,"69,516",0,1
42927,Euros,0,1
42928,;,0,1
42929,range,0,1
42930,"183,758",0,1
42931,to,0,1
42932,"14,761Euros",0,1
42933,.,0,1
42934,The,0,0
42935,major,0,0
42936,cost,0,0
42937,driver,0,1
42938,was,0,0
42939,hospital,0,1
42940,days,0,0
42941,.,0,1
42942,No,0,0
42943,association,0,0
42944,was,0,0
42945,found,0,0
42946,between,0,0
42947,costs,0,1
42948,and,0,1
42949,baseline,0,0
42950,status,0,1
42951,.,0,1
42952,The,0,0
42953,predictors,0,0
42954,of,0,1
42955,higher,0,0
42956,costs,0,1
42957,(,0,0
42958,adding,0,0
42959,an,0,1
42960,average,0,1
42961,"20,000",0,0
42962,Euros/patient,0,1
42963,),0,1
42964,were,0,0
42965,the,0,0
42966,occurrence,0,0
42967,of,0,0
42968,transplant-related,0,1
42969,complications,0,1
42970,:,0,1
42971,graft-versus-host,0,1
42972,disease,0,1
42973,and,0,1
42974,repeated,0,0
42975,infections,0,1
42976,that,0,0
42977,were,0,1
42978,unpredictable,0,0
42979,before,0,0
42980,transplant,0,1
42981,in,0,0
42982,this,0,0
42983,homogeneous,1,1
42984,group,1,1
42985,of,1,1
42986,patients,1,1
42987,.,1,1
42988,CONCLUSION,0,0
42989,Our,0,1
42990,data,0,0
42991,highlight,0,0
42992,the,0,0
42993,discrepancy,0,0
42994,between,0,0
42995,the,0,0
42996,Diagnosis,0,1
42997,Related,0,0
42998,Group,0,1
42999,prospective,0,1
43000,payment,0,1
43001,system,0,1
43002,and,0,1
43003,actual,0,1
43004,costs,0,1
43005,.,0,1
43006,The,0,0
43007,actual,0,0
43008,cost,0,0
43009,of,0,0
43010,geno-identical,0,1
43011,stem-cell,0,1
43012,transplantation,0,1
43013,results,0,0
43014,from,0,1
43015,posttransplant,0,1
43016,complications,0,0
43017,that,0,0
43018,can,0,0
43019,not,0,0
43020,be,0,0
43021,predicted,0,0
43022,prospectively,0,1
43023,and,0,0
43024,require,0,0
43025,ex,0,0
43026,post,0,0
43027,cost,0,0
43028,adjustment,0,0
43029,.,0,1
43030,Six-month,0,0
43031,trial,0,1
43032,of,0,0
43033,on-demand,0,0
43034,rabeprazole,0,0
43035,10,0,1
43036,mg,0,1
43037,maintains,0,0
43038,symptom,0,1
43039,relief,0,1
43040,in,0,1
43041,patients,1,1
43042,with,1,1
43043,non-erosive,1,1
43044,reflux,1,1
43045,disease,1,1
43046,.,1,1
43047,BACKGROUND,0,0
43048,Compliance,0,0
43049,studies,0,0
43050,have,0,0
43051,shown,0,0
43052,that,0,0
43053,patients,1,1
43054,with,1,1
43055,reflux,1,1
43056,symptoms,1,0
43057,generally,0,1
43058,take,0,0
43059,their,0,0
43060,medication,0,0
43061,only,0,0
43062,when,0,0
43063,experiencing,0,1
43064,these,0,0
43065,symptoms,0,1
43066,.,0,1
43067,AIM,0,0
43068,To,0,0
43069,evaluate,0,0
43070,the,0,0
43071,efficacy,0,0
43072,of,0,0
43073,on-demand,0,0
43074,rabeprazole,0,0
43075,maintenance,0,0
43076,therapy,0,1
43077,in,0,0
43078,patients,1,1
43079,with,1,1
43080,non-erosive,1,1
43081,reflux,1,1
43082,disease,1,1
43083,.,1,1
43084,METHODS,0,0
43085,This,0,0
43086,multicentre,1,0
43087,",",0,0
43088,randomized,0,0
43089,",",0,0
43090,double-blind,0,0
43091,",",0,0
43092,placebo-controlled,0,0
43093,",",0,0
43094,withdrawal,0,0
43095,study,0,1
43096,compared,0,0
43097,6,0,1
43098,months,0,0
43099,of,0,1
43100,on-demand,0,0
43101,treatment,0,1
43102,with,0,1
43103,rabeprazole,0,0
43104,10,0,1
43105,mg,0,0
43106,vs.,0,0
43107,placebo,0,1
43108,.,0,1
43109,Adults,1,1
43110,with,1,1
43111,a,1,1
43112,history,1,1
43113,of,1,0
43114,reflux,1,1
43115,symptoms,1,0
43116,",",1,0
43117,a,1,1
43118,negative,1,0
43119,endoscopy,1,1
43120,",",1,0
43121,and,1,0
43122,>,1,1
43123,or,1,1
43124,=,1,1
43125,3,1,1
43126,days,1,0
43127,of,1,1
43128,moderate,1,1
43129,to,1,1
43130,very,1,0
43131,severe,1,1
43132,heartburn,1,1
43133,in,1,0
43134,the,1,1
43135,7,1,1
43136,days,1,0
43137,before,1,1
43138,enrollment,1,1
43139,(,1,1
43140,N,1,1
43141,=,1,1
43142,535,1,1
43143,),1,1
43144,entered,0,1
43145,4,0,0
43146,weeks,0,0
43147,of,0,1
43148,open-label,0,1
43149,",",0,0
43150,acute,0,1
43151,treatment,0,0
43152,with,0,1
43153,rabeprazole,0,0
43154,10,0,1
43155,mg,0,0
43156,once,0,1
43157,daily,0,0
43158,.,0,1
43159,Patients,1,1
43160,with,1,1
43161,complete,1,1
43162,symptom,1,1
43163,relief,1,0
43164,then,1,0
43165,entered,1,1
43166,the,1,0
43167,on-demand,1,0
43168,phase,1,1
43169,.,1,1
43170,The,0,0
43171,primary,0,1
43172,end-point,0,0
43173,was,0,0
43174,discontinuation,0,0
43175,due,0,0
43176,to,0,0
43177,lack,0,0
43178,of,0,0
43179,heartburn,0,1
43180,control,0,1
43181,during,0,0
43182,the,0,0
43183,on-demand,0,0
43184,phase,0,1
43185,.,0,1
43186,RESULTS,0,0
43187,Eighty-three,0,1
43188,percent,0,1
43189,(,0,1
43190,432,0,1
43191,of,0,1
43192,523,0,1
43193,),0,1
43194,of,0,1
43195,patients,0,1
43196,reported,0,1
43197,complete,0,1
43198,symptom,0,0
43199,relief,0,0
43200,at,0,0
43201,the,0,0
43202,end,0,0
43203,of,0,0
43204,the,0,0
43205,acute,0,1
43206,phase,0,1
43207,.,0,1
43208,During,0,0
43209,on-demand,0,0
43210,treatment,0,1
43211,",",0,1
43212,rates,0,0
43213,of,0,0
43214,discontinuation,0,0
43215,because,0,1
43216,of,0,0
43217,inadequate,0,1
43218,heartburn,0,1
43219,control,0,1
43220,were,0,1
43221,20,0,1
43222,%,0,0
43223,(,0,1
43224,28,0,1
43225,of,0,1
43226,139,0,1
43227,),0,1
43228,for,0,0
43229,placebo,0,1
43230,vs.,0,0
43231,6,0,0
43232,%,0,0
43233,(,0,1
43234,16,0,1
43235,of,0,1
43236,279,0,1
43237,),0,1
43238,for,0,0
43239,rabeprazole,0,0
43240,(,0,1
43241,P,0,0
43242,<,0,0
43243,0.00001,0,0
43244,),0,1
43245,.,0,1
43246,Antacid,0,0
43247,use,0,0
43248,was,0,0
43249,twofold,0,0
43250,higher,0,0
43251,in,0,0
43252,the,0,0
43253,placebo,0,0
43254,group,0,0
43255,vs.,0,0
43256,the,0,0
43257,rabeprazole,0,0
43258,group,0,0
43259,(,0,1
43260,P,0,0
43261,=,0,1
43262,0.0009,0,0
43263,),0,1
43264,.,0,1
43265,CONCLUSIONS,0,0
43266,Rabeprazole,0,0
43267,10,0,1
43268,mg,0,0
43269,once,0,0
43270,daily,0,0
43271,is,0,0
43272,highly,0,0
43273,effective,0,0
43274,in,0,0
43275,acute,0,1
43276,symptom,0,1
43277,relief,0,0
43278,and,0,0
43279,as,0,0
43280,on-demand,0,0
43281,long-term,0,0
43282,maintenance,0,0
43283,therapy,0,0
43284,in,0,0
43285,non-erosive,1,1
43286,reflux,1,1
43287,disease,1,1
43288,patients,1,1
43289,.,1,1
43290,Dihydroergocryptine,0,1
43291,in,0,0
43292,the,0,0
43293,management,0,0
43294,of,0,0
43295,senile,1,1
43296,psycho-organic,1,1
43297,syndrome,1,1
43298,.,1,1
43299,A,0,0
43300,double-blind,0,0
43301,",",0,0
43302,placebo-controlled,0,0
43303,",",0,0
43304,randomized,0,0
43305,study,0,0
43306,is,0,0
43307,described,0,0
43308,of,0,0
43309,an,0,0
43310,assessment,0,0
43311,of,0,0
43312,the,0,0
43313,efficacy,0,0
43314,and,0,0
43315,relative,0,0
43316,safety,0,0
43317,of,0,0
43318,the,0,0
43319,ergot,0,0
43320,alkaloid,0,0
43321,",",0,0
43322,dihydroergocryptine,0,0
43323,",",0,0
43324,on,0,0
43325,52,1,1
43326,patients,1,1
43327,with,1,1
43328,mild,1,1
43329,organic,1,1
43330,brain,1,1
43331,syndrome,1,1
43332,over,1,0
43333,a,1,0
43334,period,1,0
43335,of,1,0
43336,three,1,1
43337,months,1,1
43338,using,1,0
43339,a,1,1
43340,series,1,1
43341,of,1,0
43342,neurophysiological,1,0
43343,tests,1,0
43344,.,1,1
43345,The,0,0
43346,results,0,0
43347,indicated,0,0
43348,that,0,0
43349,short-term,0,0
43350,treatment,0,0
43351,with,0,1
43352,the,0,0
43353,alkaloid,0,0
43354,improved,0,0
43355,memory,0,0
43356,impairment,0,1
43357,.,0,1
43358,The,0,0
43359,side-effects,0,0
43360,were,0,1
43361,mild,0,1
43362,and,0,0
43363,transient,0,0
43364,in,0,0
43365,both,0,0
43366,the,0,0
43367,dihydroergocryptine,0,0
43368,and,0,0
43369,placebo,0,1
43370,groups,0,0
43371,and,0,0
43372,there,0,0
43373,were,0,0
43374,no,0,0
43375,alterations,0,0
43376,in,0,0
43377,blood,0,1
43378,chemistry,0,1
43379,.,0,1
43380,An,0,0
43381,evaluation,0,0
43382,of,0,0
43383,an,0,0
43384,adaptive,0,0
43385,automation,0,0
43386,system,0,1
43387,using,0,0
43388,a,0,0
43389,cognitive,0,0
43390,vigilance,0,0
43391,task,0,1
43392,.,0,1
43393,The,0,0
43394,performance,0,0
43395,of,0,0
43396,an,0,0
43397,adaptive,0,0
43398,automation,0,0
43399,system,0,1
43400,was,0,0
43401,evaluated,0,0
43402,using,0,0
43403,a,0,0
43404,cognitive,0,0
43405,vigilance,0,0
43406,task,0,1
43407,.,0,1
43408,Participants,1,1
43409,responded,0,1
43410,to,0,1
43411,the,0,0
43412,presence,0,0
43413,of,0,0
43414,a,0,1
43415,green,0,1
43416,K,0,0
43417,in,0,0
43418,an,0,0
43419,array,0,0
43420,of,0,0
43421,two,0,0
43422,",",0,1
43423,five,0,1
43424,",",0,0
43425,or,0,1
43426,nine,0,1
43427,distractor,0,0
43428,stimuli,0,0
43429,during,0,1
43430,a,0,1
43431,40-min,0,0
43432,vigil,0,1
43433,.,0,1
43434,The,0,0
43435,array,0,0
43436,with,0,1
43437,the,0,0
43438,target,0,0
43439,stimulus,0,0
43440,was,0,0
43441,presented,0,1
43442,once,0,0
43443,each,0,0
43444,minute,0,0
43445,.,0,1
43446,Participants,1,1
43447,EEG,1,1
43448,was,0,0
43449,recorded,0,0
43450,and,0,0
43451,an,0,0
43452,engagement,0,0
43453,index,0,0
43454,(,0,0
43455,EI,0,1
43456,=,0,0
43457,20,0,0
43458,x,0,0
43459,beta/,0,0
43460,(,0,1
43461,alpha,0,0
43462,+,0,0
43463,theta,0,0
43464,),0,1
43465,),0,1
43466,was,0,0
43467,derived,0,0
43468,.,0,1
43469,In,0,0
43470,the,0,0
43471,negative,0,0
43472,feedback,0,0
43473,condition,0,0
43474,",",0,0
43475,increases,0,0
43476,in,0,0
43477,the,0,0
43478,EI,0,1
43479,caused,0,0
43480,the,0,0
43481,number,0,0
43482,of,0,0
43483,stimuli,0,0
43484,in,0,1
43485,the,0,0
43486,array,0,0
43487,to,0,0
43488,decrease,0,0
43489,while,0,0
43490,decreases,0,0
43491,in,0,1
43492,the,0,1
43493,EI,0,1
43494,caused,0,0
43495,the,0,0
43496,number,0,0
43497,of,0,0
43498,stimuli,0,0
43499,to,0,1
43500,increase,0,0
43501,.,0,1
43502,For,0,0
43503,the,0,0
43504,positive,0,1
43505,feedback,0,0
43506,condition,0,0
43507,",",0,0
43508,increases,0,0
43509,in,0,0
43510,the,0,0
43511,index,0,0
43512,caused,0,0
43513,an,0,0
43514,increase,0,0
43515,in,0,0
43516,the,0,0
43517,array,0,0
43518,size,0,0
43519,(,0,1
43520,AS,0,1
43521,),0,1
43522,while,0,0
43523,decreases,0,0
43524,caused,0,0
43525,a,0,1
43526,decrease,0,0
43527,in,0,0
43528,the,0,0
43529,array,0,0
43530,size,0,0
43531,.,0,1
43532,Each,0,0
43533,experimental,0,0
43534,participant,1,0
43535,had,1,1
43536,a,1,0
43537,yoked,1,0
43538,control,1,1
43539,partner,1,1
43540,who,0,1
43541,received,0,1
43542,the,0,1
43543,same,0,0
43544,pattern,0,1
43545,of,0,1
43546,changes,0,0
43547,in,0,1
43548,array,0,1
43549,irrespective,0,1
43550,of,0,0
43551,their,0,1
43552,engagement,0,1
43553,index,0,1
43554,.,0,1
43555,A,0,0
43556,vigilance,0,0
43557,decrement,0,0
43558,was,0,0
43559,seen,0,0
43560,only,0,0
43561,for,0,0
43562,the,0,0
43563,positive,0,1
43564,feedback,0,0
43565,",",0,0
43566,experimental,1,0
43567,group,1,1
43568,.,1,1
43569,Randomized,0,0
43570,",",0,0
43571,double-blind,0,0
43572,",",0,0
43573,placebo-controlled,0,0
43574,trial,0,0
43575,of,0,0
43576,oral,0,0
43577,sirolimus,0,1
43578,for,0,0
43579,restenosis,0,1
43580,prevention,0,1
43581,in,0,0
43582,patients,1,1
43583,with,1,1
43584,in-stent,1,1
43585,restenosis,1,1
43586,:,1,1
43587,the,0,0
43588,Oral,0,0
43589,Sirolimus,0,1
43590,to,0,1
43591,Inhibit,0,0
43592,Recurrent,0,1
43593,In-stent,0,1
43594,Stenosis,0,1
43595,(,0,1
43596,OSIRIS,0,1
43597,),0,1
43598,trial,0,1
43599,.,0,1
43600,BACKGROUND,0,0
43601,Despite,0,0
43602,recent,0,1
43603,advances,0,0
43604,in,0,1
43605,interventional,0,1
43606,cardiology,0,1
43607,",",0,0
43608,including,0,0
43609,the,0,0
43610,introduction,0,0
43611,of,0,0
43612,drug-eluting,0,1
43613,stents,0,1
43614,for,0,0
43615,de,0,1
43616,novo,0,1
43617,coronary,0,1
43618,lesions,0,1
43619,",",0,1
43620,the,0,0
43621,treatment,0,0
43622,of,0,0
43623,in-stent,0,1
43624,restenosis,0,1
43625,(,0,1
43626,ISR,0,0
43627,),0,0
43628,remains,0,0
43629,a,0,0
43630,challenging,0,0
43631,clinical,0,0
43632,issue,0,1
43633,.,0,1
43634,Given,0,0
43635,the,0,0
43636,efficacy,0,0
43637,of,0,0
43638,systemic,0,0
43639,sirolimus,0,1
43640,administration,0,0
43641,to,0,0
43642,prevent,0,0
43643,neointimal,0,1
43644,hyperplasia,0,1
43645,in,0,1
43646,animal,0,1
43647,models,0,1
43648,and,0,1
43649,to,0,1
43650,halt,0,0
43651,and,0,0
43652,even,0,0
43653,reverse,0,1
43654,the,0,0
43655,progression,0,0
43656,of,0,0
43657,allograft,0,1
43658,vasculopathy,0,1
43659,",",0,0
43660,the,0,0
43661,aim,0,0
43662,of,0,0
43663,the,0,0
43664,present,0,0
43665,double-blind,0,0
43666,",",0,0
43667,placebo-controlled,0,0
43668,study,0,1
43669,was,0,0
43670,to,0,0
43671,evaluate,0,0
43672,the,0,0
43673,efficacy,0,0
43674,of,0,0
43675,a,0,1
43676,10-day,0,0
43677,oral,0,0
43678,sirolimus,0,1
43679,treatment,0,1
43680,with,0,1
43681,2,0,1
43682,different,0,1
43683,loading,0,0
43684,regimens,0,0
43685,for,0,1
43686,the,0,0
43687,prevention,0,1
43688,of,0,0
43689,recurrent,0,1
43690,restenosis,0,1
43691,in,0,1
43692,patients,1,1
43693,with,1,1
43694,ISR,1,0
43695,.,1,1
43696,METHODS,0,0
43697,AND,0,0
43698,RESULTS,0,1
43699,Three,1,1
43700,hundred,1,1
43701,symptomatic,1,1
43702,patients,1,1
43703,with,1,1
43704,ISR,1,0
43705,were,0,1
43706,randomly,0,1
43707,assigned,0,1
43708,to,0,0
43709,1,0,1
43710,of,0,1
43711,3,0,1
43712,treatment,0,1
43713,arms,0,1
43714,:,0,1
43715,placebo,0,1
43716,or,0,1
43717,usual-dose,0,0
43718,or,0,1
43719,high-dose,0,1
43720,sirolimus,0,1
43721,.,0,1
43722,Patients,0,1
43723,received,0,0
43724,a,0,1
43725,cumulative,0,0
43726,loading,0,0
43727,dose,0,0
43728,of,0,0
43729,0,0,0
43730,",",0,1
43731,8,0,0
43732,",",0,0
43733,or,0,1
43734,24,0,0
43735,mg,0,0
43736,of,0,1
43737,sirolimus,0,1
43738,2,0,1
43739,days,0,0
43740,before,0,1
43741,and,0,1
43742,the,0,0
43743,day,0,0
43744,of,0,0
43745,repeat,0,1
43746,intervention,0,0
43747,followed,0,0
43748,by,0,0
43749,maintenance,0,0
43750,therapy,0,1
43751,of,0,0
43752,2,0,1
43753,mg/d,0,0
43754,for,0,1
43755,7,0,1
43756,days,0,1
43757,.,0,1
43758,Angiographic,0,0
43759,restenosis,0,1
43760,at,0,1
43761,6-month,0,1
43762,angiography,0,1
43763,was,0,0
43764,the,0,0
43765,primary,0,1
43766,end,0,0
43767,point,0,0
43768,of,0,0
43769,the,0,0
43770,study,0,1
43771,.,0,1
43772,Restenosis,0,0
43773,was,0,0
43774,significantly,0,0
43775,reduced,0,0
43776,from,0,1
43777,42.2,0,1
43778,%,0,0
43779,to,0,1
43780,38.6,0,0
43781,%,0,0
43782,and,0,1
43783,to,0,1
43784,22.1,0,0
43785,%,0,0
43786,in,0,0
43787,the,0,0
43788,placebo,0,0
43789,",",0,0
43790,usual-dose,0,0
43791,",",0,0
43792,and,0,0
43793,high-dose,0,0
43794,sirolimus,0,1
43795,groups,0,0
43796,",",0,0
43797,respectively,0,0
43798,(,0,0
43799,P=0.005,0,0
43800,),0,1
43801,.,0,1
43802,Similarly,0,0
43803,",",0,0
43804,the,0,0
43805,need,0,0
43806,for,0,0
43807,target,0,0
43808,vessel,0,1
43809,revascularization,0,1
43810,was,0,0
43811,reduced,0,0
43812,from,0,1
43813,25.5,0,1
43814,%,0,0
43815,to,0,1
43816,24.2,0,0
43817,%,0,0
43818,and,0,1
43819,to,0,1
43820,15.2,0,0
43821,%,0,0
43822,in,0,0
43823,the,0,0
43824,placebo,0,0
43825,",",0,0
43826,usual-dose,0,0
43827,",",0,0
43828,and,0,1
43829,high-dose,0,0
43830,groups,0,0
43831,",",0,1
43832,respectively,0,0
43833,(,0,0
43834,P=0.08,0,0
43835,),0,1
43836,.,0,1
43837,The,0,0
43838,sirolimus,0,1
43839,blood,0,0
43840,concentration,0,0
43841,on,0,0
43842,the,0,0
43843,day,0,0
43844,of,0,0
43845,the,0,0
43846,procedure,0,0
43847,correlated,0,0
43848,significantly,0,0
43849,with,0,1
43850,the,0,0
43851,late,0,1
43852,lumen,0,0
43853,loss,0,1
43854,at,0,1
43855,follow-up,0,0
43856,(,0,1
43857,P,0,0
43858,<,0,0
43859,0.001,0,0
43860,),0,1
43861,.,0,1
43862,CONCLUSIONS,0,0
43863,In,0,1
43864,patients,0,1
43865,with,0,1
43866,ISR,0,0
43867,",",0,0
43868,an,0,0
43869,oral,0,0
43870,adjunctive,0,1
43871,sirolimus,0,1
43872,treatment,0,0
43873,with,0,1
43874,an,0,0
43875,intensified,0,1
43876,loading,0,0
43877,regimen,0,1
43878,before,0,1
43879,coronary,0,1
43880,intervention,0,1
43881,resulted,0,0
43882,in,0,0
43883,a,0,1
43884,significant,0,0
43885,improvement,0,0
43886,in,0,0
43887,the,0,0
43888,angiographic,0,0
43889,parameters,0,0
43890,of,0,1
43891,restenosis,0,1
43892,.,0,1
43893,IV,0,1
43894,amantadine,0,1
43895,improves,0,0
43896,chorea,1,1
43897,in,1,0
43898,Huntington,1,1
43899,'s,1,1
43900,disease,1,1
43901,:,1,1
43902,an,0,0
43903,acute,0,1
43904,randomized,0,0
43905,",",0,0
43906,controlled,0,0
43907,study,0,1
43908,.,0,1
43909,A,0,0
43910,comparison,0,0
43911,of,0,0
43912,the,0,0
43913,effects,0,0
43914,of,0,0
43915,anticholinergic,0,0
43916,and,0,0
43917,beta,0,0
43918,2-agonist,0,0
43919,and,0,0
43920,combination,0,0
43921,therapy,0,0
43922,on,0,0
43923,respiratory,0,1
43924,impedance,0,0
43925,in,0,1
43926,COPD,1,1
43927,.,1,1
43928,The,0,0
43929,effects,0,0
43930,of,0,1
43931,three,0,1
43932,different,0,1
43933,regimens,0,0
43934,of,0,1
43935,inhaled,0,1
43936,bronchodilators,0,1
43937,on,0,1
43938,spirometry,0,1
43939,and,0,1
43940,respiratory,0,1
43941,impedance,0,0
43942,as,0,0
43943,measured,0,0
43944,with,0,1
43945,the,0,0
43946,technique,0,0
43947,of,0,0
43948,forced,0,1
43949,oscillations,0,1
43950,were,0,1
43951,compared,0,0
43952,in,0,0
43953,a,0,1
43954,double-blind,0,0
43955,crossover,0,0
43956,study,0,1
43957,in,0,1
43958,22,1,1
43959,patients,1,1
43960,with,1,1
43961,stable,1,1
43962,chronic,1,1
43963,obstructive,1,1
43964,pulmonary,1,1
43965,disease,1,1
43966,(,1,1
43967,FEV1,1,0
43968,less,1,0
43969,than,1,0
43970,70,1,1
43971,percent,1,1
43972,predicted,1,0
43973,),1,1
43974,.,1,1
43975,On,0,0
43976,three,0,0
43977,trial,0,1
43978,days,0,0
43979,",",0,1
43980,patients,0,1
43981,inhaled,0,0
43982,",",0,1
43983,in,0,0
43984,random,0,1
43985,order,0,0
43986,",",0,1
43987,40,0,1
43988,micrograms,0,0
43989,ipratropium,0,0
43990,bromide,0,0
43991,",",0,1
43992,200,0,1
43993,micrograms,0,0
43994,fenoterol,0,1
43995,hydrobromide,0,0
43996,",",0,0
43997,or,0,0
43998,a,0,0
43999,combination,0,0
44000,of,0,0
44001,40,0,1
44002,micrograms,0,1
44003,ipratropium,0,1
44004,and,0,1
44005,100,0,1
44006,micrograms,0,0
44007,fenoterol,0,0
44008,from,0,0
44009,a,0,0
44010,powder,0,0
44011,inhaler,0,0
44012,",",0,0
44013,followed,0,0
44014,by,0,0
44015,a,0,1
44016,second,0,0
44017,dose,0,0
44018,of,0,0
44019,the,0,0
44020,same,0,0
44021,drug,0,0
44022,after,0,1
44023,60,0,1
44024,min,0,0
44025,.,0,1
44026,The,0,0
44027,effects,0,0
44028,were,0,1
44029,measured,0,0
44030,at,0,0
44031,baseline,0,0
44032,and,0,1
44033,20,0,1
44034,",",0,1
44035,40,0,1
44036,",",0,0
44037,60,0,1
44038,",",0,0
44039,and,0,0
44040,120,0,1
44041,min,0,0
44042,after,0,0
44043,the,0,0
44044,first,0,0
44045,inhalation,0,0
44046,.,0,1
44047,No,0,0
44048,significant,0,0
44049,decrease,0,0
44050,in,0,1
44051,total,0,1
44052,respiratory,0,1
44053,resistance,0,0
44054,at,0,1
44055,8,0,1
44056,Hz,0,1
44057,(,0,1
44058,Rrs,0,0
44059,[,0,0
44060,8,0,0
44061,],0,1
44062,),0,1
44063,was,0,0
44064,observed,0,0
44065,after,0,0
44066,ipratropium,0,0
44067,",",0,1
44068,whereas,0,0
44069,Rrs,0,1
44070,(,0,1
44071,8,0,1
44072,),0,1
44073,decreased,0,0
44074,significantly,0,0
44075,20,0,1
44076,min,0,0
44077,after,0,1
44078,fenoterol,0,1
44079,and,0,1
44080,40,0,1
44081,min,0,0
44082,after,0,0
44083,the,0,0
44084,combination,0,0
44085,regimen,0,0
44086,(,0,1
44087,p,0,0
44088,less,0,0
44089,than,0,0
44090,0.05,0,0
44091,),0,1
44092,.,0,1
44093,All,0,1
44094,three,0,0
44095,studied,0,1
44096,drugs,0,0
44097,resulted,0,0
44098,in,0,0
44099,a,0,1
44100,significant,0,0
44101,increase,0,0
44102,in,0,0
44103,the,0,0
44104,reactance,0,0
44105,(,0,0
44106,p,0,0
44107,less,0,0
44108,than,0,0
44109,0.01,0,0
44110,),0,1
44111,and,0,0
44112,decrease,0,0
44113,in,0,0
44114,resonant,0,1
44115,frequency,0,0
44116,.,0,1
44117,Both,0,0
44118,fenoterol,0,0
44119,(,0,0
44120,delta,0,0
44121,FEV1,0,1
44122,34,0,1
44123,percent,0,1
44124,",",0,0
44125,p,0,0
44126,less,0,0
44127,than,0,0
44128,0.0001,0,0
44129,),0,1
44130,and,0,0
44131,the,0,0
44132,combination,0,0
44133,regimen,0,0
44134,(,0,1
44135,delta,0,0
44136,FEV1,0,1
44137,38,0,1
44138,percent,0,1
44139,",",0,0
44140,p,0,0
44141,less,0,0
44142,than,0,0
44143,0.0001,0,0
44144,),0,1
44145,resulted,0,0
44146,in,0,0
44147,a,0,0
44148,significantly,0,0
44149,larger,0,0
44150,increase,0,0
44151,in,0,0
44152,FEV1,0,1
44153,than,0,0
44154,ipratropium,0,0
44155,alone,0,0
44156,(,0,0
44157,delta,0,0
44158,FEV1,0,1
44159,17,0,1
44160,percent,0,1
44161,",",0,0
44162,p,0,0
44163,less,0,0
44164,than,0,0
44165,0.0001,0,0
44166,),0,1
44167,.,0,1
44168,A,0,0
44169,second,0,0
44170,dose,0,0
44171,of,0,0
44172,fenoterol,0,0
44173,and,0,0
44174,of,0,0
44175,the,0,0
44176,combination,0,0
44177,regimen,0,0
44178,resulted,0,0
44179,in,0,0
44180,a,0,1
44181,further,0,0
44182,significant,0,0
44183,increase,0,0
44184,in,0,0
44185,FEV1,0,1
44186,after,0,1
44187,120,0,1
44188,min,0,0
44189,(,0,0
44190,p,0,0
44191,less,0,0
44192,than,0,0
44193,0.05,0,0
44194,),0,1
44195,.,0,1
44196,A,0,0
44197,second,0,0
44198,dose,0,0
44199,of,0,0
44200,ipratropium,0,0
44201,did,0,0
44202,not,0,0
44203,result,0,0
44204,in,0,0
44205,a,0,0
44206,further,0,0
44207,significant,0,0
44208,increase,0,0
44209,in,0,1
44210,FEV1,0,1
44211,.,0,1
44212,The,0,0
44213,changes,0,0
44214,in,0,0
44215,respiratory,0,1
44216,impedance,0,0
44217,were,0,0
44218,qualitatively,0,0
44219,similar,0,0
44220,for,0,0
44221,all,0,1
44222,three,0,0
44223,drug,0,0
44224,regimens,0,0
44225,",",0,0
44226,but,0,0
44227,larger,0,0
44228,in,0,0
44229,absolute,0,0
44230,terms,0,0
44231,after,0,1
44232,fenoterol,0,0
44233,and,0,0
44234,the,0,0
44235,combination,0,0
44236,regimen,0,0
44237,than,0,0
44238,after,0,1
44239,ipratropium,0,0
44240,.,0,1
44241,The,0,0
44242,similar,0,0
44243,effect,0,0
44244,of,0,0
44245,these,0,0
44246,drugs,0,0
44247,on,0,0
44248,the,0,0
44249,reactance,0,0
44250,can,0,0
44251,be,0,0
44252,explained,0,0
44253,by,0,0
44254,an,0,0
44255,increase,0,0
44256,in,0,0
44257,the,0,0
44258,capacitance,0,0
44259,of,0,0
44260,the,0,0
44261,respiratory,0,1
44262,system,0,0
44263,",",0,0
44264,and,0,0
44265,in,0,0
44266,combination,0,0
44267,with,0,1
44268,a,0,0
44269,decrease,0,0
44270,in,0,0
44271,frequency,0,0
44272,dependence,0,0
44273,of,0,0
44274,resistance,0,0
44275,",",0,0
44276,by,0,0
44277,assuming,0,0
44278,a,0,0
44279,decrease,0,0
44280,in,0,0
44281,peripheral,0,1
44282,airway,0,1
44283,resistance,0,0
44284,.,0,1
44285,Evaluation,0,0
44286,of,0,0
44287,additional,0,0
44288,amine,0,0
44289,fluoride/stannous,0,0
44290,fluoride-containing,0,0
44291,mouthrinse,0,0
44292,during,0,0
44293,supportive,0,0
44294,therapy,0,1
44295,in,0,1
44296,patients,1,1
44297,with,1,1
44298,generalized,1,1
44299,aggressive,1,1
44300,periodontitis,1,1
44301,.,1,1
44302,A,0,0
44303,randomized,0,0
44304,",",0,0
44305,crossover,0,0
44306,",",0,0
44307,double-blind,0,0
44308,",",0,0
44309,controlled,0,0
44310,trial,0,0
44311,.,0,1
44312,OBJECTIVES,0,0
44313,The,0,0
44314,objective,0,0
44315,of,0,0
44316,the,0,0
44317,present,0,0
44318,randomized,0,1
44319,controlled,0,0
44320,trial,0,0
44321,was,0,0
44322,to,0,0
44323,evaluate,0,0
44324,the,0,0
44325,efficacy,0,0
44326,of,0,0
44327,a,0,1
44328,mouthrinse,0,0
44329,containing,0,0
44330,a,0,0
44331,combination,0,0
44332,of,0,0
44333,AmF/SnF2,0,1
44334,in,0,1
44335,controlling,0,0
44336,supragingival,0,0
44337,plaque,0,1
44338,accumulation,0,1
44339,and,0,0
44340,gingival,0,1
44341,inflammation,0,1
44342,during,0,0
44343,a,0,1
44344,12-week,0,0
44345,period,0,0
44346,in,0,1
44347,patients,1,1
44348,affected,1,1
44349,by,1,1
44350,generalized,1,1
44351,aggressive,1,1
44352,periodontitis,1,1
44353,(,1,1
44354,GAP,1,1
44355,),1,1
44356,.,1,1
44357,METHODS,0,0
44358,Eighteen,1,1
44359,subjects,1,1
44360,",",1,1
44361,six,1,1
44362,males,1,1
44363,and,1,1
44364,12,1,1
44365,females,1,1
44366,",",1,1
44367,mean,1,1
44368,age,1,1
44369,:,1,1
44370,32.2,1,0
44371,years,1,1
44372,",",1,1
44373,were,1,1
44374,evaluated,1,0
44375,.,1,1
44376,One-half,0,0
44377,of,0,0
44378,the,0,0
44379,patients,0,1
44380,was,0,0
44381,either,0,1
44382,prescribed,0,0
44383,an,0,0
44384,AmF/SnF2-containing,0,0
44385,mouthrinse,0,0
44386,(,0,1
44387,test,0,0
44388,mouthrinse,0,0
44389,),0,0
44390,or,0,1
44391,a,0,0
44392,control,0,0
44393,mouthrinse,0,0
44394,in,0,0
44395,addition,0,0
44396,to,0,1
44397,mechanical,0,1
44398,plaque,0,0
44399,control,0,1
44400,for,0,1
44401,12,0,1
44402,weeks,0,1
44403,.,0,1
44404,After,0,0
44405,a,0,0
44406,2-week,0,0
44407,wash-out,0,0
44408,period,0,0
44409,",",0,0
44410,the,0,0
44411,patients,0,1
44412,received,0,1
44413,the,0,0
44414,alternative,0,0
44415,mouthrinse,0,0
44416,.,0,1
44417,Before,0,0
44418,and,0,0
44419,after,0,0
44420,treatment,0,0
44421,plaque,0,1
44422,index,0,1
44423,(,0,1
44424,PlI,0,0
44425,),0,1
44426,",",0,0
44427,gingival,0,1
44428,index,0,1
44429,(,0,1
44430,GI,0,1
44431,),0,1
44432,",",0,0
44433,angulated,0,0
44434,bleeding,0,0
44435,index,0,1
44436,(,0,1
44437,AngBI,0,1
44438,),0,0
44439,",",0,0
44440,tooth,0,0
44441,stain,0,0
44442,(,0,0
44443,GMSI,0,0
44444,),0,1
44445,",",0,0
44446,and,0,0
44447,tongue,0,1
44448,stain,0,1
44449,were,0,1
44450,recorded,0,0
44451,.,0,1
44452,RESULTS,0,0
44453,Test,0,0
44454,mouthrinse,0,0
44455,resulted,0,0
44456,in,0,0
44457,a,0,0
44458,statistically,0,0
44459,significant,0,0
44460,decrease,0,0
44461,in,0,1
44462,PlI,0,0
44463,(,0,1
44464,p,0,0
44465,=,0,1
44466,0.029,0,0
44467,),0,1
44468,and,0,1
44469,GI,0,1
44470,(,0,1
44471,p,0,0
44472,=,0,1
44473,0.017,0,0
44474,),0,1
44475,.,0,1
44476,After,0,0
44477,treatment,0,0
44478,",",0,1
44479,PlI,0,0
44480,was,0,0
44481,significantly,0,0
44482,lower,0,0
44483,in,0,0
44484,test,0,0
44485,compared,0,0
44486,to,0,0
44487,control,0,1
44488,mouthrinse,0,0
44489,(,0,0
44490,p,0,0
44491,=,0,1
44492,0.027,0,0
44493,),0,1
44494,.,0,1
44495,GMSI,0,0
44496,significantly,0,0
44497,increased,0,0
44498,post-treatment,0,0
44499,for,0,0
44500,both,0,0
44501,mouthrinse,0,0
44502,regimens,0,0
44503,(,0,0
44504,p,0,0
44505,<,0,0
44506,0.001,0,0
44507,),0,1
44508,",",0,0
44509,a,0,0
44510,significantly,0,0
44511,higher,0,0
44512,score,0,0
44513,being,0,0
44514,observed,0,0
44515,for,0,0
44516,the,0,0
44517,test,0,0
44518,compared,0,0
44519,to,0,0
44520,control,0,1
44521,mouthrinse,0,0
44522,(,0,0
44523,p,0,0
44524,=,0,1
44525,0.002,0,0
44526,),0,1
44527,.,0,1
44528,CONCLUSIONS,0,0
44529,The,0,0
44530,12-week,0,0
44531,use,0,0
44532,of,0,0
44533,a,0,1
44534,AmF/SnF2-containing,0,0
44535,mouthrinse,0,0
44536,as,0,0
44537,an,0,0
44538,adjunct,0,0
44539,to,0,0
44540,conventional,0,1
44541,mechanical,0,1
44542,oral,0,1
44543,hygiene,0,1
44544,procedures,0,1
44545,in,0,1
44546,GAP,1,1
44547,patients,1,1
44548,was,0,0
44549,effective,0,0
44550,in,0,0
44551,controlling,0,0
44552,the,0,0
44553,amount,0,0
44554,of,0,0
44555,supragingival,0,0
44556,plaque,0,1
44557,deposits,0,1
44558,.,0,1
44559,Low-dose,0,0
44560,oral,0,1
44561,etoposide-based,0,1
44562,induction,0,1
44563,regimen,0,1
44564,for,0,1
44565,children,1,1
44566,with,1,1
44567,acute,1,1
44568,lymphoblastic,1,1
44569,leukemia,1,1
44570,in,1,1
44571,first,1,0
44572,bone,1,1
44573,marrow,1,1
44574,relapse,1,0
44575,.,1,1
44576,We,0,0
44577,evaluated,0,0
44578,the,0,0
44579,clinical,0,0
44580,response,0,0
44581,to,0,1
44582,low-dose,0,0
44583,etoposide,0,0
44584,in,0,1
44585,relapsed,1,1
44586,acute,1,1
44587,lymphoblastic,1,1
44588,leukemia,1,1
44589,(,1,1
44590,ALL,1,1
44591,),1,0
44592,.,1,0
44593,Of,0,0
44594,the,0,0
44595,45,1,1
44596,patients,1,1
44597,with,1,1
44598,ALL,1,1
44599,in,1,1
44600,first,1,0
44601,bone,1,1
44602,marrow,1,1
44603,relapse,1,0
44604,enrolled,1,1
44605,on,0,0
44606,the,0,0
44607,ALL,0,1
44608,R15,0,0
44609,protocol,0,1
44610,",",0,1
44611,44,0,1
44612,had,0,1
44613,received,0,1
44614,epipodophyllotoxins,0,0
44615,during,0,1
44616,frontline,0,1
44617,therapy,0,1
44618,.,0,1
44619,In,0,0
44620,the,0,0
44621,first,0,0
44622,week,0,0
44623,of,0,0
44624,remission,0,1
44625,induction,0,0
44626,therapy,0,0
44627,",",0,1
44628,patients,0,1
44629,received,0,1
44630,etoposide,0,0
44631,(,0,1
44632,50,0,1
44633,mg/m,0,1
44634,(,0,1
44635,2,0,1
44636,),0,1
44637,per,0,1
44638,day,0,0
44639,),0,1
44640,administered,0,0
44641,orally,0,0
44642,as,0,0
44643,a,0,0
44644,single,0,0
44645,agent,0,0
44646,once,0,0
44647,or,0,0
44648,twice,0,0
44649,daily,0,0
44650,.,0,0
44651,On,0,0
44652,Day,0,1
44653,8,0,1
44654,",",0,1
44655,patients,0,1
44656,started,0,0
44657,to,0,0
44658,receive,0,1
44659,dexamethasone,0,0
44660,",",0,0
44661,vincristine,0,0
44662,",",0,0
44663,and,0,0
44664,L-asparaginase,0,0
44665,.,0,1
44666,Etoposide,0,0
44667,was,0,0
44668,administered,0,0
44669,until,0,1
44670,Day,0,1
44671,22,0,1
44672,.,0,1
44673,Two,0,1
44674,courses,0,0
44675,of,0,1
44676,consolidation,0,0
44677,therapy,0,0
44678,were,0,0
44679,followed,0,0
44680,by,0,0
44681,continuation,0,0
44682,therapy,0,0
44683,or,0,1
44684,hematopoietic,0,1
44685,stem,0,1
44686,cell,0,1
44687,transplantation,0,1
44688,.,0,1
44689,After,0,0
44690,7,0,1
44691,days,0,0
44692,of,0,1
44693,single-agent,0,1
44694,etoposide,0,0
44695,treatment,0,0
44696,",",0,0
44697,peripheral,0,1
44698,blast,0,1
44699,cell,0,1
44700,counts,0,0
44701,(,0,1
44702,P=0.013,0,0
44703,),0,1
44704,and,0,1
44705,percentages,0,0
44706,of,0,1
44707,bone,0,1
44708,marrow,0,1
44709,blasts,0,1
44710,(,0,1
44711,P=0.016,0,0
44712,),0,1
44713,were,0,0
44714,significantly,0,0
44715,reduced,0,0
44716,.,0,0
44717,In,0,0
44718,all,0,0
44719,",",0,0
44720,38,0,1
44721,(,0,1
44722,84.4,0,0
44723,%,0,0
44724,),0,1
44725,attained,0,0
44726,second,0,1
44727,remission,0,1
44728,.,0,1
44729,Only,0,0
44730,time,0,0
44731,to,0,0
44732,relapse,0,0
44733,was,0,0
44734,significantly,0,0
44735,associated,0,0
44736,with,0,1
44737,outcome,0,0
44738,(,0,1
44739,P=0.025,0,0
44740,),0,1
44741,:,0,1
44742,the,0,0
44743,5-year,0,1
44744,event-free,0,0
44745,survival,0,0
44746,estimates,0,0
44747,(,0,1
44748,+/-se,0,1
44749,),0,1
44750,were,0,1
44751,52.0+/-9.6,0,1
44752,%,0,0
44753,for,0,0
44754,those,0,1
44755,with,0,1
44756,late,0,1
44757,relapse,0,1
44758,and,0,1
44759,20.0+/-8.0,0,1
44760,%,0,0
44761,for,0,0
44762,those,0,1
44763,with,0,1
44764,early,0,1
44765,relapse,0,1
44766,.,0,1
44767,We,0,0
44768,conclude,0,0
44769,that,0,0
44770,low-dose,0,0
44771,etoposide,0,0
44772,administered,0,0
44773,orally,0,0
44774,has,0,0
44775,a,0,0
44776,cytoreductive,0,0
44777,effect,0,0
44778,in,0,0
44779,relapsed,0,1
44780,ALL,0,1
44781,.,0,1
44782,Superior,0,1
44783,visual,0,0
44784,search,0,1
44785,in,0,1
44786,adults,1,1
44787,with,1,1
44788,autism,1,1
44789,.,1,1
44790,Recent,0,0
44791,studies,0,0
44792,have,0,0
44793,suggested,0,0
44794,that,0,0
44795,children,0,1
44796,with,0,1
44797,autism,0,1
44798,perform,0,0
44799,better,0,0
44800,than,0,0
44801,matched,0,1
44802,controls,0,1
44803,on,0,0
44804,visual,0,1
44805,search,0,1
44806,tasks,0,0
44807,and,0,1
44808,that,0,0
44809,this,0,0
44810,stems,0,1
44811,from,0,0
44812,a,0,0
44813,superior,0,0
44814,visual,0,0
44815,discrimination,0,0
44816,ability,0,0
44817,.,0,1
44818,This,0,0
44819,study,0,0
44820,assessed,0,0
44821,whether,0,0
44822,these,0,0
44823,findings,0,0
44824,generalize,0,1
44825,from,0,1
44826,children,1,1
44827,to,1,1
44828,adults,1,1
44829,with,1,1
44830,autism,1,1
44831,.,1,1
44832,Experiments,0,0
44833,1,0,1
44834,and,0,1
44835,2,0,1
44836,showed,0,0
44837,that,0,0
44838,",",0,1
44839,like,0,0
44840,children,0,1
44841,",",0,1
44842,adults,1,1
44843,with,1,1
44844,autism,1,1
44845,were,0,1
44846,superior,0,0
44847,to,0,1
44848,controls,0,1
44849,at,0,1
44850,searching,0,1
44851,for,0,1
44852,targets,0,1
44853,.,0,1
44854,Experiment,0,1
44855,3,0,0
44856,showed,0,0
44857,that,0,0
44858,increases,0,0
44859,in,0,1
44860,target-distractor,0,1
44861,similarity,0,0
44862,slowed,0,0
44863,the,0,0
44864,visual,0,0
44865,search,0,0
44866,performance,0,0
44867,of,0,0
44868,the,0,0
44869,control,0,0
44870,group,0,0
44871,significantly,0,0
44872,more,0,0
44873,than,0,0
44874,that,0,0
44875,of,0,0
44876,the,0,0
44877,autism,0,1
44878,group,0,0
44879,",",0,0
44880,suggesting,0,0
44881,that,0,0
44882,the,0,0
44883,adults,0,1
44884,with,0,1
44885,autism,0,1
44886,have,0,0
44887,a,0,0
44888,superior,0,0
44889,visual,0,0
44890,discrimination,0,0
44891,ability,0,0
44892,.,0,1
44893,Thus,0,0
44894,",",0,0
44895,these,0,0
44896,experiments,0,0
44897,replicate,0,1
44898,in,0,1
44899,adults,0,1
44900,previous,0,1
44901,findings,0,0
44902,in,0,1
44903,children,0,1
44904,with,0,1
44905,autism,0,1
44906,.,0,1
44907,Superior,0,0
44908,unique,0,1
44909,item,0,0
44910,detection,0,1
44911,in,0,0
44912,adults,0,1
44913,with,0,1
44914,autism,0,1
44915,",",0,0
44916,stemming,0,0
44917,from,0,1
44918,enhanced,0,0
44919,discrimination,0,0
44920,",",0,0
44921,is,0,0
44922,discussed,0,0
44923,in,0,0
44924,the,0,0
44925,light,0,0
44926,of,0,0
44927,the,0,0
44928,possible,0,0
44929,role,0,0
44930,of,0,0
44931,stimulus,0,0
44932,processing,0,0
44933,disturbances,0,0
44934,in,0,0
44935,the,0,0
44936,disorder,0,1
44937,in,0,0
44938,general,0,1
44939,.,0,1
44940,Absorption,0,0
44941,of,0,0
44942,intramuscular,0,0
44943,phenobarbitone,0,1
44944,in,0,1
44945,children,1,1
44946,with,1,1
44947,severe,1,1
44948,falciparum,1,1
44949,malaria,1,1
44950,.,1,1
44951,The,0,0
44952,absorption,0,0
44953,of,0,0
44954,intramuscular,0,1
44955,phenobarbitone,0,1
44956,7,0,1
44957,mg.kg-1,0,0
44958,was,0,0
44959,studied,0,1
44960,in,0,1
44961,11,1,1
44962,Karen,1,1
44963,children,1,1
44964,aged,1,1
44965,between,1,0
44966,1.7,1,1
44967,and,1,1
44968,11,1,1
44969,y,1,1
44970,with,1,1
44971,severe,1,1
44972,falciparum,1,1
44973,malaria,1,1
44974,.,1,1
44975,Eight,1,0
44976,of,1,0
44977,the,1,1
44978,children,1,1
44979,were,1,1
44980,comatose,1,1
44981,.,1,1
44982,Clinical,0,0
44983,findings,0,0
44984,were,0,1
44985,compared,0,0
44986,with,0,1
44987,those,0,1
44988,in,0,0
44989,9,1,0
44990,further,1,1
44991,children,1,1
44992,with,1,1
44993,severe,1,1
44994,malaria,1,1
44995,of,1,1
44996,similar,1,0
44997,age,1,1
44998,range,1,1
44999,(,1,1
45000,four,1,1
45001,of,1,1
45002,whom,1,1
45003,were,1,1
45004,unconscious,1,1
45005,),1,1
45006,",",0,1
45007,who,0,1
45008,received,0,1
45009,an,0,1
45010,identical,0,0
45011,placebo,0,0
45012,.,0,1
45013,One,0,1
45014,child,0,1
45015,",",0,1
45016,who,0,1
45017,had,0,1
45018,received,0,1
45019,placebo,0,0
45020,",",0,0
45021,had,0,1
45022,repeated,0,0
45023,convulsions,0,0
45024,and,0,1
45025,died,0,1
45026,1,0,0
45027,h,0,0
45028,after,0,0
45029,admission,0,1
45030,to,0,1
45031,hospital,0,1
45032,.,0,1
45033,The,0,0
45034,remainder,0,0
45035,made,0,0
45036,an,0,0
45037,uncomplicated,0,1
45038,recovery,0,0
45039,.,0,0
45040,There,0,0
45041,were,0,0
45042,no,0,0
45043,convulsions,0,0
45044,subsequent,0,0
45045,to,0,0
45046,treatment,0,0
45047,",",0,0
45048,although,0,0
45049,the,0,0
45050,study,0,0
45051,was,0,0
45052,too,0,0
45053,small,0,0
45054,to,0,0
45055,assess,0,0
45056,anticonvulsant,0,0
45057,efficacy,0,0
45058,.,0,0
45059,There,0,0
45060,was,0,0
45061,no,0,0
45062,observable,0,0
45063,toxicity,0,0
45064,",",0,0
45065,but,0,0
45066,phenobarbitone,0,1
45067,recipients,0,1
45068,had,0,1
45069,a,0,1
45070,significant,0,0
45071,tendency,0,0
45072,to,0,0
45073,deepen,0,0
45074,in,0,0
45075,their,0,0
45076,level,0,0
45077,of,0,0
45078,coma,0,1
45079,or,0,1
45080,to,0,0
45081,become,0,0
45082,sleepy,0,0
45083,within,0,0
45084,the,0,0
45085,4,0,0
45086,h,0,0
45087,after,0,0
45088,drug,0,1
45089,administration,0,0
45090,.,0,1
45091,Phenobarbitone,0,0
45092,was,0,0
45093,rapidly,0,0
45094,absorbed,0,0
45095,",",0,0
45096,reaching,0,0
45097,a,0,0
45098,mean,0,1
45099,(,0,0
45100,range,0,1
45101,),0,1
45102,peak,0,0
45103,concentration,0,0
45104,of,0,0
45105,34.2,0,0
45106,[,0,1
45107,29.3-42.6,0,0
45108,],0,1
45109,mumol.l-1,0,0
45110,in,0,0
45111,a,0,1
45112,median,0,0
45113,(,0,0
45114,range,0,1
45115,),0,1
45116,of,0,0
45117,4,0,1
45118,(,0,1
45119,2.5-12,0,1
45120,),0,1
45121,h.,0,1
45122,These,0,1
45123,values,0,0
45124,are,0,0
45125,comparable,0,0
45126,to,0,0
45127,those,0,0
45128,previously,0,1
45129,reported,0,0
45130,in,0,0
45131,healthy,0,1
45132,children,0,1
45133,and,0,1
45134,in,0,1
45135,children,0,1
45136,with,0,1
45137,febrile,0,1
45138,convulsions,0,1
45139,.,0,1
45140,Intramuscular,0,0
45141,phenobarbitone,0,0
45142,is,0,0
45143,well,0,0
45144,absorbed,0,0
45145,in,0,0
45146,children,1,1
45147,with,1,1
45148,severe,1,1
45149,malaria,1,1
45150,;,1,1
45151,the,0,0
45152,optimum,0,0
45153,prophylactic,0,1
45154,anticonvulsant,0,0
45155,dose,0,0
45156,remains,0,0
45157,to,0,0
45158,be,0,0
45159,determined,0,0
45160,.,0,1
45161,Effect,0,0
45162,of,0,0
45163,ibuprofen,0,0
45164,on,0,0
45165,cyclooxygenase,0,0
45166,and,0,1
45167,nitric,0,0
45168,oxide,0,0
45169,synthase,0,0
45170,of,0,0
45171,gastric,0,1
45172,mucosa,0,1
45173,:,0,1
45174,correlation,0,0
45175,with,0,1
45176,endoscopic,0,1
45177,lesions,0,1
45178,and,0,1
45179,adverse,0,0
45180,reactions,0,0
45181,.,0,1
45182,The,0,0
45183,aim,0,0
45184,of,0,0
45185,this,0,0
45186,study,0,0
45187,was,0,0
45188,to,0,0
45189,evaluate,0,0
45190,the,0,0
45191,effect,0,0
45192,of,0,0
45193,ibuprofen,0,0
45194,on,0,0
45195,gastric,0,1
45196,mucosa,0,1
45197,and,0,1
45198,enzymes,0,0
45199,involved,0,1
45200,in,0,1
45201,gastroprotection,0,1
45202,in,0,1
45203,healthy,1,1
45204,volunteers,1,1
45205,.,1,1
45206,Twenty-four,1,1
45207,Helicobacter,1,1
45208,pylori-negative,1,1
45209,subjects,1,1
45210,were,0,1
45211,randomized,0,1
45212,to,0,0
45213,treatment,0,0
45214,with,0,1
45215,ibuprofen,0,0
45216,or,0,1
45217,ibuprofen-arginate,0,0
45218,(,0,1
45219,each,0,0
45220,600,0,1
45221,mg/6,0,0
45222,hr,0,1
45223,during,0,1
45224,3,0,1
45225,days,0,1
45226,),0,1
45227,.,0,1
45228,Endoscopies,0,0
45229,were,0,1
45230,performed,0,0
45231,1,0,0
45232,week,0,0
45233,before,0,0
45234,and,0,0
45235,after,0,1
45236,treatment,0,1
45237,.,0,1
45238,Biopsies,0,1
45239,were,0,0
45240,taken,0,0
45241,from,0,1
45242,the,0,0
45243,gastric,0,1
45244,antrum,0,1
45245,and,0,0
45246,corpus,0,1
45247,for,0,0
45248,determination,0,0
45249,of,0,0
45250,prostaglandin,0,0
45251,E2,0,1
45252,(,0,1
45253,PGE2,0,1
45254,),0,1
45255,by,0,0
45256,ELISA,0,1
45257,and,0,1
45258,cyclooxygenase,0,0
45259,(,0,1
45260,COX-1,0,1
45261,and,0,1
45262,COX-2,0,1
45263,),0,1
45264,and,0,1
45265,nitric,0,0
45266,oxide,0,0
45267,synthase,0,0
45268,(,0,1
45269,eNOS,0,0
45270,and,0,1
45271,iNOS,0,1
45272,),0,1
45273,by,0,0
45274,western,0,1
45275,blot,0,0
45276,.,0,1
45277,All,0,1
45278,subjects,0,1
45279,had,0,1
45280,at,0,1
45281,least,0,1
45282,one,0,1
45283,gastric,0,1
45284,lesion,0,1
45285,except,0,0
45286,for,0,1
45287,two,0,1
45288,individuals,0,1
45289,taking,0,1
45290,ibuprofen-arginate,0,0
45291,.,0,1
45292,Ibuprofen-arginate,0,0
45293,caused,0,0
45294,a,0,0
45295,lower,0,0
45296,rate,0,0
45297,of,0,0
45298,clinical,0,0
45299,adverse,0,0
45300,reactions,0,0
45301,than,0,1
45302,ibuprofen,0,0
45303,.,0,1
45304,Subjects,0,1
45305,with,0,1
45306,gastric,0,1
45307,lesions,0,1
45308,or,0,1
45309,adverse,0,0
45310,reactions,0,0
45311,had,0,1
45312,lower,0,1
45313,PGE2,0,1
45314,levels,0,0
45315,.,0,1
45316,COX-1,0,0
45317,",",0,0
45318,COX-2,0,0
45319,",",0,0
45320,eNOS,0,0
45321,",",0,0
45322,and,0,0
45323,iNOS,0,1
45324,were,0,1
45325,detectable,0,0
45326,in,0,1
45327,all,0,1
45328,subjects,0,1
45329,.,0,1
45330,The,0,0
45331,constitutive,0,0
45332,enzymes,0,0
45333,(,0,1
45334,COX-1,0,1
45335,and,0,1
45336,eNOS,0,1
45337,),0,0
45338,did,0,0
45339,not,0,0
45340,change,0,0
45341,after,0,0
45342,treatment,0,0
45343,.,0,1
45344,COX-2,0,0
45345,was,0,0
45346,higher,0,0
45347,in,0,0
45348,corpus,0,0
45349,than,0,0
45350,antrum,0,1
45351,and,0,1
45352,it,0,0
45353,increased,0,0
45354,after,0,0
45355,ibuprofen,0,0
45356,treatment,0,1
45357,.,0,1
45358,iNOS,0,1
45359,tended,0,0
45360,to,0,0
45361,increase,0,0
45362,mildly,0,1
45363,in,0,0
45364,the,0,0
45365,corpus,0,1
45366,in,0,0
45367,subjects,0,1
45368,with,0,1
45369,adverse,0,0
45370,reactions,0,0
45371,or,0,1
45372,endoscopic,0,1
45373,lesions,0,1
45374,.,0,1
45375,There,0,0
45376,were,0,0
45377,no,0,0
45378,significant,0,0
45379,differences,0,0
45380,between,0,0
45381,ibuprofen,0,0
45382,and,0,0
45383,ibuprofen-arginate,0,0
45384,in,0,0
45385,PGE2,0,1
45386,",",0,0
45387,or,0,1
45388,enzymes,0,1
45389,.,0,1
45390,Sustained,0,1
45391,oral,1,1
45392,health,1,1
45393,improvement,1,0
45394,and,0,0
45395,use,0,0
45396,of,0,1
45397,toothbrushes,0,0
45398,and,0,1
45399,dentifrice,0,0
45400,by,0,0
45401,previous,1,1
45402,users,1,1
45403,of,1,1
45404,traditional,1,1
45405,materials,1,1
45406,in,1,1
45407,a,1,1
45408,rural,1,1
45409,population,1,1
45410,in,1,1
45411,Andhra,1,1
45412,Pradesh,1,1
45413,",",1,1
45414,India,1,1
45415,.,1,1
45416,AIM,0,0
45417,To,0,0
45418,follow-up,0,0
45419,",",0,0
45420,one,0,0
45421,year,0,0
45422,later,0,1
45423,",",0,0
45424,a,0,0
45425,double-blind,0,0
45426,",",0,0
45427,randomised,0,0
45428,study,0,0
45429,",",0,0
45430,which,0,0
45431,investigated,0,0
45432,the,0,0
45433,effect,0,0
45434,of,0,0
45435,regular,0,1
45436,brushing,0,1
45437,with,0,1
45438,dentifrices,0,0
45439,on,0,0
45440,the,0,1
45441,oral,1,0
45442,health,1,0
45443,of,1,0
45444,an,1,0
45445,economically,1,1
45446,disadvantaged,1,1
45447,rural,1,1
45448,population,1,1
45449,in,1,1
45450,Andhra,1,1
45451,Pradesh,1,1
45452,",",1,1
45453,India,1,1
45454,who,1,1
45455,were,1,1
45456,primarily,1,1
45457,users,1,1
45458,of,1,1
45459,traditional,1,1
45460,materials,1,1
45461,.,1,1
45462,SUBJECTS,0,0
45463,150,1,0
45464,of,1,0
45465,the,1,0
45466,original,1,1
45467,study,1,1
45468,population,1,1
45469,.,1,1
45470,METHOD,0,0
45471,Examination,0,1
45472,to,0,0
45473,determine,0,0
45474,whether,0,0
45475,the,0,0
45476,improvements,0,0
45477,in,0,0
45478,oral,0,1
45479,health,0,1
45480,status,0,1
45481,and,0,0
45482,oral,0,0
45483,health,0,1
45484,behaviour,0,0
45485,(,0,0
45486,use,0,0
45487,of,0,0
45488,toothbrush,0,0
45489,and,0,1
45490,dentifrice,0,0
45491,),0,0
45492,",",0,0
45493,being,0,1
45494,unsupported,0,0
45495,",",0,1
45496,had,0,1
45497,been,0,0
45498,sustained,0,0
45499,since,0,0
45500,completion,0,0
45501,of,0,0
45502,the,0,0
45503,original,0,1
45504,study,0,1
45505,.,0,1
45506,RESULTS,0,0
45507,Data,0,1
45508,analysis,0,0
45509,showed,0,0
45510,sustained,0,0
45511,",",0,0
45512,statistically,0,0
45513,significant,0,0
45514,improvements,0,0
45515,in,0,1
45516,gingival,0,1
45517,health,0,1
45518,as,0,0
45519,measured,0,0
45520,by,0,0
45521,gingival,0,1
45522,bleeding,0,1
45523,and,0,1
45524,plaque,0,1
45525,indices,0,0
45526,(,0,1
45527,GBI,0,1
45528,and,0,1
45529,PI,0,1
45530,),0,1
45531,comparing,0,0
45532,users,0,1
45533,and,0,1
45534,non-users,0,1
45535,of,0,1
45536,toothbrushes,0,0
45537,and,0,1
45538,dentifrice,0,0
45539,in,0,0
45540,the,0,0
45541,original,0,1
45542,study,0,1
45543,(,0,1
45544,PI,0,1
45545,:,0,1
45546,p,0,0
45547,=,0,0
45548,0.04,0,0
45549,;,0,0
45550,GBI,0,1
45551,:,0,1
45552,p,0,0
45553,=,0,0
45554,0.03,0,0
45555,),0,0
45556,and,0,0
45557,sustained,0,0
45558,use,0,0
45559,of,0,1
45560,toothbrushes,0,0
45561,and,0,1
45562,dentifrice,0,0
45563,by,0,0
45564,60,0,1
45565,%,0,0
45566,of,0,0
45567,the,0,0
45568,subjects,0,1
45569,at,0,1
45570,follow-up,0,1
45571,one,0,1
45572,year,0,1
45573,later,0,1
45574,.,0,0
45575,CONCLUSIONS,0,0
45576,This,0,0
45577,study,0,0
45578,shows,0,0
45579,a,0,0
45580,beneficial,0,0
45581,effect,0,0
45582,on,0,0
45583,oral,0,1
45584,hygiene,0,1
45585,indices,0,0
45586,following,0,0
45587,the,0,0
45588,introduction,0,0
45589,of,0,0
45590,toothbrushes,0,0
45591,and,0,1
45592,dentifrices,0,0
45593,to,0,1
45594,a,0,1
45595,community,0,0
45596,using,0,0
45597,traditional,0,0
45598,oral,0,1
45599,hygiene,0,1
45600,materials,0,1
45601,and,0,1
45602,sustainability,0,0
45603,of,0,0
45604,use,0,0
45605,of,0,0
45606,these,0,0
45607,materials,0,1
45608,with,0,1
45609,motivation,0,0
45610,and,0,1
45611,support,0,0
45612,.,0,0
45613,It,0,0
45614,may,0,0
45615,therefore,0,0
45616,be,0,0
45617,concluded,0,0
45618,that,0,0
45619,it,0,0
45620,is,0,0
45621,feasible,0,0
45622,to,0,0
45623,achieve,0,0
45624,significant,0,0
45625,use,0,0
45626,of,0,1
45627,conventional,0,1
45628,toothbrushes,0,0
45629,and,0,1
45630,toothpastes,0,0
45631,",",0,1
45632,with,0,1
45633,consequent,0,0
45634,major,0,1
45635,and,0,1
45636,sustained,0,1
45637,improvements,0,0
45638,in,0,1
45639,plaque,0,1
45640,control,0,1
45641,and,0,0
45642,gingival,0,1
45643,health,0,1
45644,in,0,0
45645,a,0,1
45646,disadvantaged,0,1
45647,population,0,1
45648,hitherto,0,1
45649,often,0,0
45650,considered,0,0
45651,as,0,0
45652,not,0,0
45653,amenable,0,0
45654,to,0,1
45655,conventional,0,1
45656,oral,0,0
45657,hygiene,0,1
45658,for,0,1
45659,cultural,0,0
45660,or,0,1
45661,economic,0,0
45662,reasons,0,0
45663,.,0,1
45664,A,0,0
45665,randomized,0,0
45666,multicenter,0,0
45667,trial,0,0
45668,comparing,0,0
45669,resection,0,1
45670,and,0,0
45671,radiochemotherapy,0,0
45672,for,0,0
45673,resectable,1,1
45674,locally,1,1
45675,invasive,1,1
45676,pancreatic,1,1
45677,cancer,1,1
45678,.,1,1
45679,BACKGROUND,0,0
45680,Though,0,0
45681,the,0,0
45682,outcome,0,0
45683,of,0,0
45684,resection,0,1
45685,for,0,0
45686,locally,0,1
45687,invasive,0,1
45688,pancreatic,0,1
45689,cancer,0,1
45690,is,0,0
45691,still,0,0
45692,poor,0,0
45693,",",0,0
45694,it,0,0
45695,has,0,0
45696,gradually,0,0
45697,improved,0,0
45698,in,0,0
45699,Japan,1,1
45700,",",0,0
45701,and,0,0
45702,the,0,0
45703,5-year,0,1
45704,survival,0,0
45705,is,0,0
45706,now,0,0
45707,about,0,0
45708,10,0,1
45709,%,0,0
45710,.,0,1
45711,However,0,0
45712,",",0,0
45713,the,0,0
45714,advantage,0,0
45715,of,0,0
45716,resection,0,1
45717,over,0,0
45718,radiochemotherapy,0,0
45719,has,0,0
45720,not,0,0
45721,yet,0,0
45722,been,0,0
45723,confirmed,0,0
45724,by,0,0
45725,a,0,1
45726,randomized,0,1
45727,trial,0,1
45728,.,0,1
45729,We,0,0
45730,conducted,0,0
45731,this,0,0
45732,study,0,0
45733,to,0,0
45734,compare,0,0
45735,surgical,0,1
45736,resection,0,1
45737,alone,0,0
45738,versus,0,0
45739,radiochemotherapy,0,0
45740,without,0,1
45741,resection,0,1
45742,for,0,0
45743,locally,0,1
45744,invasive,0,1
45745,pancreatic,0,1
45746,cancer,0,1
45747,using,0,0
45748,a,0,0
45749,multicenter,0,0
45750,randomized,0,1
45751,design,0,1
45752,.,0,1
45753,METHODS,0,0
45754,Patients,1,1
45755,with,1,1
45756,pancreatic,1,1
45757,cancer,1,1
45758,who,1,1
45759,met,1,1
45760,our,1,1
45761,preoperative,1,1
45762,criteria,1,1
45763,for,1,1
45764,inclusion,1,1
45765,(,1,1
45766,pancreatic,1,1
45767,cancer,1,1
45768,invading,1,1
45769,the,1,0
45770,pancreatic,1,1
45771,capsule,1,0
45772,without,1,1
45773,involvement,1,1
45774,of,1,0
45775,the,1,0
45776,superior,1,0
45777,mesenteric,1,1
45778,artery,1,1
45779,or,1,1
45780,the,1,0
45781,common,1,0
45782,hepatic,1,0
45783,artery,1,1
45784,",",1,0
45785,or,1,1
45786,without,1,1
45787,distant,1,1
45788,metastasis,1,1
45789,),1,1
45790,underwent,1,1
45791,laparotomy,1,1
45792,.,1,1
45793,Patients,0,1
45794,with,0,1
45795,operative,0,1
45796,findings,0,0
45797,consistent,0,0
45798,with,0,1
45799,our,0,1
45800,criteria,0,1
45801,were,0,1
45802,randomized,0,1
45803,into,0,1
45804,a,0,1
45805,radical,0,1
45806,resection,0,1
45807,group,0,1
45808,and,0,0
45809,a,0,0
45810,radiochemotherapy,0,0
45811,group,0,1
45812,(,0,1
45813,200,0,1
45814,mg/m,0,1
45815,(,0,1
45816,2,0,1
45817,),0,1
45818,/day,0,0
45819,of,0,1
45820,intravenous,0,1
45821,5-fluorouracil,0,0
45822,and,0,1
45823,5040,0,1
45824,cGy,0,1
45825,of,0,0
45826,radiotherapy,0,1
45827,),0,1
45828,without,0,1
45829,resection,0,1
45830,.,0,1
45831,The,0,0
45832,2,0,0
45833,groups,0,0
45834,were,0,1
45835,compared,0,0
45836,for,0,0
45837,mean,0,1
45838,survival,0,0
45839,",",0,0
45840,hazard,0,0
45841,ratio,0,0
45842,",",0,0
45843,1-year,0,0
45844,survival,0,0
45845,",",0,0
45846,quality,0,0
45847,of,0,0
45848,life,0,1
45849,scores,0,0
45850,",",0,1
45851,and,0,0
45852,hematologic,0,1
45853,and,0,0
45854,blood,0,0
45855,chemical,0,1
45856,data,0,0
45857,.,0,1
45858,RESULTS,0,0
45859,Twenty,1,1
45860,patients,1,1
45861,were,1,1
45862,assigned,1,1
45863,to,1,0
45864,the,1,0
45865,resection,1,1
45866,group,1,1
45867,and,1,1
45868,22,1,1
45869,to,1,0
45870,the,1,0
45871,radiochemotherapy,1,0
45872,group,1,0
45873,.,1,0
45874,There,0,0
45875,was,0,0
45876,1,0,0
45877,operative,0,1
45878,death,0,0
45879,.,0,1
45880,The,0,0
45881,surgical,0,1
45882,resection,0,1
45883,group,0,1
45884,had,0,1
45885,better,0,0
45886,results,0,0
45887,than,0,0
45888,the,0,0
45889,radiochemotherapy,0,0
45890,group,0,0
45891,as,0,0
45892,measured,0,0
45893,by,0,0
45894,1-year,0,0
45895,survival,0,0
45896,(,0,1
45897,62,0,1
45898,%,0,0
45899,vs,0,0
45900,32,0,1
45901,%,0,0
45902,",",0,1
45903,P=.05,0,0
45904,),0,0
45905,",",0,0
45906,mean,0,1
45907,survival,0,0
45908,time,0,0
45909,(,0,1
45910,>,0,1
45911,17,0,1
45912,vs,0,0
45913,11,0,1
45914,months,0,0
45915,",",0,1
45916,P,0,0
45917,<,0,0
45918,.03,0,0
45919,),0,1
45920,",",0,0
45921,and,0,0
45922,hazard,0,0
45923,ratio,0,0
45924,(,0,0
45925,0.46,0,0
45926,",",0,1
45927,P=.04,0,1
45928,),0,0
45929,.,0,0
45930,There,0,0
45931,were,0,0
45932,no,0,0
45933,differences,0,0
45934,in,0,0
45935,the,0,0
45936,quality,0,0
45937,of,0,0
45938,life,0,1
45939,score,0,0
45940,or,0,1
45941,laboratory,0,0
45942,data,0,0
45943,apart,0,1
45944,from,0,1
45945,increased,0,0
45946,diarrhea,0,1
45947,after,0,0
45948,surgical,0,1
45949,resection,0,1
45950,.,0,1
45951,CONCLUSIONS,0,0
45952,Locally,1,1
45953,invasive,1,1
45954,pancreatic,1,1
45955,cancer,1,1
45956,without,1,1
45957,distant,1,1
45958,metastases,1,1
45959,and,0,1
45960,major,0,1
45961,arterial,0,1
45962,invasion,0,0
45963,appears,0,0
45964,to,0,0
45965,be,0,0
45966,best,0,0
45967,treated,0,1
45968,by,0,0
45969,surgical,0,1
45970,resection,0,1
45971,.,0,1
45972,Low-intensity,0,0
45973,exercise,0,0
45974,and,0,0
45975,reduction,0,0
45976,of,0,0
45977,the,0,0
45978,risk,0,1
45979,for,0,0
45980,falls,1,0
45981,among,1,1
45982,at-risk,1,1
45983,elders,1,1
45984,.,1,1
45985,BACKGROUND,0,0
45986,Among,0,1
45987,elderly,1,1
45988,persons,1,1
45989,",",0,0
45990,falls,0,0
45991,account,0,0
45992,for,0,0
45993,87,0,1
45994,%,0,0
45995,of,0,0
45996,all,0,1
45997,fractures,0,1
45998,and,0,1
45999,are,0,0
46000,contributing,0,0
46001,factors,0,0
46002,in,0,1
46003,many,0,1
46004,nursing,0,1
46005,home,0,1
46006,admissions,0,1
46007,.,0,1
46008,This,0,0
46009,study,0,0
46010,evaluated,0,0
46011,the,0,0
46012,effect,0,0
46013,of,0,0
46014,an,0,0
46015,easily,0,0
46016,implemented,0,0
46017,",",0,0
46018,low-intensity,0,0
46019,exercise,0,0
46020,program,0,1
46021,on,0,0
46022,the,0,0
46023,incidence,1,0
46024,of,1,0
46025,falls,1,0
46026,and,1,1
46027,the,1,0
46028,time,1,0
46029,to,1,0
46030,first,1,0
46031,fall,1,0
46032,among,1,0
46033,a,1,0
46034,clinically,1,1
46035,defined,1,0
46036,population,1,1
46037,of,1,1
46038,elderly,1,1
46039,men,1,1
46040,and,1,1
46041,women,1,1
46042,.,1,1
46043,METHODS,0,0
46044,This,0,0
46045,community-based,0,1
46046,",",0,0
46047,randomized,0,1
46048,trial,0,0
46049,compared,0,0
46050,the,0,0
46051,exercise,0,0
46052,intervention,0,0
46053,with,0,1
46054,a,0,1
46055,no-intervention,0,0
46056,control,0,1
46057,.,0,1
46058,The,1,0
46059,participants,1,1
46060,were,1,1
46061,294,1,1
46062,men,1,1
46063,and,1,1
46064,women,1,1
46065,",",1,1
46066,aged,1,1
46067,60,1,1
46068,years,1,1
46069,or,1,1
46070,older,1,1
46071,",",1,1
46072,who,1,1
46073,had,1,1
46074,either,1,1
46075,a,1,0
46076,hospital,1,1
46077,admission,1,0
46078,or,1,1
46079,bed,1,0
46080,rest,1,0
46081,for,1,1
46082,2,1,1
46083,days,1,0
46084,or,1,1
46085,more,1,0
46086,within,1,0
46087,the,1,0
46088,previous,1,1
46089,month,1,0
46090,.,1,1
46091,Exercise,0,0
46092,participants,0,1
46093,were,0,1
46094,scheduled,0,1
46095,to,0,0
46096,attend,0,1
46097,exercise,0,0
46098,sessions,0,0
46099,lasting,0,1
46100,45,0,1
46101,minutes,0,0
46102,",",0,1
46103,including,0,1
46104,warm-up,0,0
46105,and,0,1
46106,cool-down,0,0
46107,",",0,1
46108,3,0,1
46109,times,0,0
46110,a,0,1
46111,week,0,0
46112,for,0,0
46113,8,0,1
46114,weeks,0,1
46115,(,0,1
46116,24,0,1
46117,sessions,0,0
46118,),0,1
46119,.,0,1
46120,Assessments,0,0
46121,included,0,1
46122,gait,0,1
46123,and,0,1
46124,balance,0,0
46125,measures,0,0
46126,",",0,1
46127,self-reported,0,1
46128,physical,0,1
46129,function,0,0
46130,",",0,0
46131,the,0,0
46132,number,0,0
46133,of,0,0
46134,medications,0,1
46135,being,0,1
46136,taking,0,1
46137,at,0,0
46138,baseline,0,0
46139,",",0,0
46140,participant,0,0
46141,age,0,1
46142,",",0,0
46143,sex,0,0
46144,",",0,0
46145,and,0,0
46146,history,0,1
46147,of,0,0
46148,falling,0,1
46149,.,0,1
46150,Falls,0,0
46151,were,0,0
46152,tracked,0,0
46153,for,0,0
46154,1,0,0
46155,year,0,1
46156,after,0,0
46157,each,0,0
46158,participant,0,0
46159,'s,0,1
46160,baseline,0,0
46161,assessment,0,0
46162,.,0,1
46163,RESULTS,0,0
46164,29,0,1
46165,%,0,0
46166,of,0,0
46167,the,0,0
46168,study,0,1
46169,participants,0,1
46170,reported,0,1
46171,a,0,1
46172,fall,0,0
46173,during,0,0
46174,the,0,0
46175,study,0,1
46176,period,0,0
46177,.,0,1
46178,The,0,0
46179,effect,0,0
46180,of,0,0
46181,exercise,0,0
46182,in,0,1
46183,preventing,0,0
46184,falls,0,0
46185,varied,0,0
46186,significantly,0,0
46187,by,0,0
46188,baseline,0,0
46189,physical,0,1
46190,function,0,0
46191,level,0,0
46192,(,0,1
46193,p,0,0
46194,<,0,0
46195,or,0,1
46196,=.002,0,0
46197,),0,1
46198,.,0,1
46199,The,0,0
46200,risk,0,0
46201,for,0,0
46202,falls,0,0
46203,decreased,0,0
46204,for,0,1
46205,exercise,0,1
46206,participants,0,1
46207,with,0,1
46208,low,0,1
46209,baseline,0,0
46210,physical,0,1
46211,functioning,0,1
46212,(,0,1
46213,hazard,0,0
46214,ratio,0,0
46215,",",0,0
46216,.51,0,0
46217,),0,1
46218,but,0,0
46219,increased,0,0
46220,for,0,0
46221,exercise,0,1
46222,participants,0,1
46223,with,0,1
46224,high,0,1
46225,baseline,0,0
46226,physical,0,1
46227,functioning,0,1
46228,(,0,1
46229,hazard,0,0
46230,ratio,0,0
46231,",",0,1
46232,3.51,0,0
46233,),0,1
46234,.,0,1
46235,CONCLUSIONS,0,0
46236,This,0,0
46237,easily,0,0
46238,implemented,0,0
46239,",",0,0
46240,low-intensity,0,0
46241,exercise,0,0
46242,program,0,1
46243,appears,0,0
46244,to,0,0
46245,reduce,0,0
46246,the,0,0
46247,risk,0,0
46248,for,0,0
46249,falls,0,0
46250,among,1,1
46251,elderly,1,1
46252,men,1,1
46253,and,1,1
46254,women,1,1
46255,recovering,1,1
46256,from,1,1
46257,recent,1,1
46258,hospitalizations,1,1
46259,",",1,1
46260,bed,1,0
46261,rest,1,0
46262,",",1,0
46263,or,1,1
46264,both,1,0
46265,who,1,1
46266,have,1,1
46267,low,1,1
46268,levels,1,0
46269,of,1,1
46270,physical,1,1
46271,functioning,1,1
46272,.,1,1
46273,Impact,0,0
46274,of,0,0
46275,antioxidants,0,0
46276,",",0,1
46277,zinc,0,0
46278,",",0,0
46279,and,0,0
46280,copper,0,0
46281,on,0,0
46282,cognition,1,0
46283,in,1,0
46284,the,1,0
46285,elderly,1,1
46286,:,1,1
46287,a,0,0
46288,randomized,0,0
46289,",",0,0
46290,controlled,0,0
46291,trial,0,1
46292,.,0,1
46293,Participants,1,1
46294,in,1,0
46295,the,1,1
46296,Age-Related,1,1
46297,Eye,1,1
46298,Disease,1,1
46299,Study,1,0
46300,were,0,1
46301,randomly,0,1
46302,assigned,0,1
46303,to,0,0
46304,receive,0,1
46305,daily,0,0
46306,antioxidants,0,1
46307,(,0,1
46308,vitamin,0,1
46309,C,0,1
46310,",",0,1
46311,500,0,1
46312,mg,0,1
46313,;,0,1
46314,vitamin,0,0
46315,E,0,0
46316,",",0,1
46317,400,0,0
46318,IU,0,0
46319,;,0,1
46320,beta,0,0
46321,carotene,0,0
46322,",",0,0
46323,15,0,1
46324,mg,0,0
46325,),0,1
46326,",",0,0
46327,zinc,0,0
46328,and,0,0
46329,copper,0,0
46330,(,0,0
46331,zinc,0,0
46332,",",0,1
46333,80,0,1
46334,mg,0,1
46335,;,0,1
46336,cupric,0,0
46337,oxide,0,0
46338,",",0,1
46339,2,0,1
46340,mg,0,0
46341,),0,1
46342,",",0,1
46343,antioxidants,0,0
46344,plus,0,0
46345,zinc,0,0
46346,and,0,0
46347,copper,0,0
46348,",",0,0
46349,or,0,1
46350,placebo,0,0
46351,.,0,1
46352,A,0,0
46353,cognitive,0,0
46354,battery,0,1
46355,was,0,0
46356,administered,0,0
46357,to,0,1
46358,"2,166",1,1
46359,elderly,1,1
46360,persons,1,1
46361,after,1,1
46362,a,1,1
46363,median,1,0
46364,of,1,0
46365,6.9,1,0
46366,years,1,1
46367,of,1,1
46368,treatment,1,1
46369,.,1,1
46370,Treatment,0,0
46371,groups,0,0
46372,did,0,0
46373,not,0,0
46374,differ,0,0
46375,on,0,0
46376,any,0,0
46377,of,0,0
46378,the,0,0
46379,six,0,1
46380,cognitive,0,1
46381,tests,0,0
46382,(,0,1
46383,p,0,0
46384,>,0,1
46385,0.05,0,0
46386,for,0,0
46387,all,0,1
46388,),0,1
46389,.,0,1
46390,These,0,0
46391,results,0,0
46392,do,0,0
46393,not,0,0
46394,support,0,0
46395,a,0,0
46396,beneficial,0,0
46397,or,0,1
46398,harmful,0,0
46399,effect,0,0
46400,of,0,1
46401,antioxidants,0,1
46402,or,0,1
46403,zinc,0,0
46404,and,0,0
46405,copper,0,0
46406,on,0,0
46407,cognition,0,0
46408,in,0,1
46409,older,0,1
46410,adults,0,1
46411,.,0,1
46412,Low-dose,0,0
46413,",",0,0
46414,vaginally,0,1
46415,administered,0,0
46416,estrogens,0,0
46417,may,0,0
46418,enhance,0,0
46419,local,0,0
46420,benefits,0,0
46421,of,0,1
46422,systemic,0,1
46423,therapy,0,0
46424,in,0,0
46425,the,0,0
46426,treatment,0,0
46427,of,0,0
46428,urogenital,1,1
46429,atrophy,1,1
46430,in,1,1
46431,postmenopausal,1,1
46432,women,1,1
46433,on,1,0
46434,hormone,1,1
46435,therapy,1,1
46436,.,1,0
46437,BACKGROUND,0,0
46438,When,0,1
46439,genital,0,1
46440,atrophy,0,1
46441,exists,0,0
46442,",",0,1
46443,systemic,0,0
46444,hormone,0,1
46445,therapy,0,0
46446,(,0,1
46447,HT,0,0
46448,),0,0
46449,has,0,0
46450,a,0,0
46451,timing,0,0
46452,until,0,0
46453,to,0,0
46454,induce,0,0
46455,vaginal,0,1
46456,proliferation,0,0
46457,and,0,1
46458,symptomatic,0,1
46459,relieve,0,0
46460,.,0,1
46461,Thus,0,0
46462,",",0,0
46463,in,0,0
46464,order,0,0
46465,to,0,0
46466,obtain,0,0
46467,a,0,0
46468,prompt,0,0
46469,improvement,0,0
46470,",",0,0
46471,the,0,0
46472,association,0,0
46473,of,0,0
46474,local,0,0
46475,therapy,0,0
46476,acting,0,0
46477,on,0,0
46478,the,0,0
46479,genital,0,1
46480,epithelium,0,1
46481,to,0,1
46482,the,0,0
46483,systemic,0,0
46484,treatment,0,0
46485,should,0,0
46486,be,0,0
46487,considered,0,0
46488,.,0,1
46489,OBJECTIVE,0,0
46490,To,0,0
46491,evaluate,0,0
46492,the,0,0
46493,effects,0,0
46494,of,0,0
46495,a,0,1
46496,combined,0,0
46497,therapy,0,0
46498,consisting,0,1
46499,of,0,0
46500,vaginal,0,1
46501,estriol,0,0
46502,with,0,1
46503,transdermal,0,0
46504,17-beta-estradiol,0,1
46505,(,0,1
46506,50,0,1
46507,microg/day,0,1
46508,),0,1
46509,plus,0,0
46510,medroxyprogesterone,0,0
46511,acetate,0,0
46512,(,0,1
46513,5,0,0
46514,mg/day,0,0
46515,),0,1
46516,per,0,0
46517,os,0,0
46518,in,0,0
46519,shortening,0,0
46520,the,0,0
46521,period,0,0
46522,of,0,0
46523,uro-genital,0,1
46524,symptoms,0,1
46525,.,0,1
46526,SUBJECTS,0,0
46527,AND,0,0
46528,METHODS,0,0
46529,In,0,1
46530,a,0,1
46531,randomized,0,1
46532,",",0,0
46533,double,0,0
46534,blind,0,1
46535,",",0,0
46536,controlled,0,0
46537,with,0,1
46538,placebo,0,0
46539,study,0,1
46540,",",0,1
46541,27,1,1
46542,women,1,1
46543,with,1,1
46544,climacteric,1,1
46545,symptoms,1,1
46546,and,1,1
46547,atrophic,1,1
46548,vaginitis,1,1
46549,were,0,1
46550,treated,0,1
46551,for,0,1
46552,4,0,0
46553,months,0,1
46554,with,0,1
46555,HT,0,1
46556,plus,0,0
46557,vaginal,0,1
46558,estriol,0,0
46559,0.5,0,0
46560,mg/day,0,0
46561,(,0,1
46562,group,0,1
46563,E,0,1
46564,),0,1
46565,or,0,1
46566,placebo,0,0
46567,(,0,1
46568,group,0,1
46569,P,0,0
46570,),0,1
46571,.,0,1
46572,Patients,0,1
46573,use,0,0
46574,the,0,0
46575,local,0,0
46576,medication,0,0
46577,daily,0,0
46578,for,0,0
46579,the,0,0
46580,first,0,1
46581,3,0,1
46582,weeks,0,1
46583,and,0,1
46584,twice-weekly,0,1
46585,thereafter,0,0
46586,.,0,1
46587,Before,0,0
46588,entering,0,1
46589,in,0,0
46590,the,0,0
46591,study,0,0
46592,",",0,0
46593,patients,0,1
46594,were,0,1
46595,asked,0,1
46596,about,0,0
46597,HT,0,0
46598,and,0,1
46599,selected,0,1
46600,for,0,0
46601,inclusion,0,1
46602,.,0,1
46603,In,0,0
46604,the,0,0
46605,first,0,0
46606,visit,0,0
46607,",",0,1
46608,electible,0,1
46609,patients,0,1
46610,after,0,1
46611,written,0,1
46612,informed,0,1
46613,consent,0,1
46614,were,0,1
46615,randomized,0,1
46616,to,0,0
46617,receive,1,1
46618,HT,1,0
46619,plus,1,0
46620,local,1,0
46621,estriol,1,0
46622,or,1,1
46623,placebo,1,0
46624,.,1,1
46625,All,0,1
46626,the,0,0
46627,subjects,0,1
46628,had,0,1
46629,baseline,0,0
46630,studies,0,0
46631,",",0,1
46632,including,0,1
46633,medical,0,1
46634,history,0,1
46635,",",0,0
46636,physical,0,0
46637,examination,0,0
46638,",",0,0
46639,blood,0,0
46640,and,0,0
46641,urine,0,1
46642,analysis,0,0
46643,.,0,1
46644,In,0,0
46645,order,0,0
46646,to,0,0
46647,evaluate,0,0
46648,the,0,0
46649,effect,0,0
46650,of,0,0
46651,local,0,0
46652,treatment,0,1
46653,on,0,0
46654,urinary,0,1
46655,and,0,1
46656,genital,0,1
46657,symptoms,0,0
46658,",",0,1
46659,a,0,0
46660,score,0,0
46661,for,0,0
46662,genital,0,1
46663,",",0,1
46664,urinary,0,0
46665,and,0,1
46666,colposcopic,0,1
46667,complaints,0,1
46668,(,0,1
46669,0,0,0
46670,minimum-100,0,1
46671,maximum,0,1
46672,),0,1
46673,was,0,0
46674,developed,0,1
46675,.,0,1
46676,This,0,0
46677,score,0,0
46678,and,0,0
46679,Blatt-Kuperman,0,1
46680,were,0,1
46681,recorded,0,0
46682,and,0,0
46683,performed,0,0
46684,in,0,0
46685,every,0,0
46686,control,0,1
46687,.,0,0
46688,RESULTS,0,0
46689,There,0,0
46690,were,0,0
46691,no,0,0
46692,differences,0,0
46693,on,0,0
46694,climacteric,0,1
46695,symptoms,0,1
46696,relief,0,0
46697,between,0,0
46698,the,0,1
46699,two,0,1
46700,groups,0,0
46701,.,0,1
46702,Additionally,0,0
46703,",",0,0
46704,the,0,0
46705,improvement,0,0
46706,in,0,0
46707,urinary,0,1
46708,symptoms,0,1
46709,at,0,1
46710,the,0,0
46711,end,0,0
46712,of,0,0
46713,the,0,0
46714,study,0,0
46715,was,0,0
46716,similar,0,0
46717,for,0,0
46718,both,0,0
46719,groups,0,0
46720,(,0,1
46721,from,0,1
46722,16.5,0,1
46723,+/-,0,1
46724,6.1,0,1
46725,to,0,1
46726,8.5,0,0
46727,+/-,0,0
46728,2.4,0,1
46729,for,0,1
46730,E,0,1
46731,group,0,1
46732,and,0,1
46733,from,0,1
46734,15.8,0,1
46735,+/-,0,1
46736,7.8,0,0
46737,to,0,1
46738,8.8,0,0
46739,+/-,0,0
46740,2.7,0,1
46741,for,0,1
46742,P,0,0
46743,group,0,1
46744,;,0,1
46745,P,0,0
46746,<,0,0
46747,0.01,0,0
46748,versus,0,0
46749,basal,0,1
46750,),0,1
46751,;,0,0
46752,however,0,0
46753,",",0,0
46754,those,0,0
46755,women,0,1
46756,in,0,0
46757,group,0,1
46758,E,0,1
46759,reached,0,0
46760,significant,0,0
46761,improvement,0,0
46762,on,0,0
46763,urinary,0,1
46764,complaints,0,1
46765,since,0,1
46766,the,0,1
46767,first,0,0
46768,month,0,0
46769,of,0,0
46770,treatment,0,0
46771,.,0,1
46772,Additionally,0,0
46773,",",0,0
46774,a,0,0
46775,significant,0,0
46776,difference,0,0
46777,between,0,0
46778,E,0,1
46779,and,0,1
46780,P,0,0
46781,was,0,0
46782,observed,0,0
46783,at,0,1
46784,months,0,1
46785,2,0,1
46786,and,0,1
46787,3,0,0
46788,",",0,0
46789,although,0,0
46790,no,0,0
46791,differences,0,0
46792,were,0,1
46793,detected,0,0
46794,at,0,0
46795,the,0,0
46796,end,0,0
46797,of,0,0
46798,the,0,0
46799,study,0,1
46800,.,0,1
46801,Papanicolaou,0,0
46802,smear,0,0
46803,showed,0,0
46804,reactive,0,1
46805,or,0,1
46806,reparative,0,1
46807,changes,0,0
46808,and,0,1
46809,karyopyknotic,0,1
46810,index,0,1
46811,exhibited,0,0
46812,a,0,0
46813,significant,0,0
46814,increase,0,0
46815,in,0,1
46816,superficial,0,1
46817,cells,0,0
46818,in,0,1
46819,both,0,0
46820,groups,0,0
46821,and,0,0
46822,at,0,1
46823,the,0,0
46824,end,0,0
46825,of,0,0
46826,the,0,0
46827,study,0,1
46828,.,0,1
46829,CONCLUSIONS,0,0
46830,Adding,0,0
46831,vaginal,0,1
46832,estriol,0,0
46833,to,0,0
46834,HRT,0,0
46835,may,0,0
46836,shorten,0,0
46837,the,0,0
46838,latency,0,0
46839,period,0,0
46840,for,0,1
46841,urinary,0,1
46842,symptoms,0,1
46843,.,0,1
46844,[,0,0
46845,The,0,0
46846,application,0,0
46847,of,0,0
46848,naphcon,0,0
46849,eye,0,1
46850,drops,0,0
46851,during,0,1
46852,Lasik,1,1
46853,surgery,1,1
46854,],1,1
46855,.,0,1
46856,PURPOSE,0,0
46857,To,0,0
46858,evaluate,0,0
46859,the,0,0
46860,effects,0,0
46861,of,0,0
46862,Naphcon,0,1
46863,eye,0,1
46864,drops,0,0
46865,for,0,1
46866,preventing,0,0
46867,conjunctival,1,1
46868,bleeding,1,1
46869,during,1,1
46870,Lasik,1,1
46871,surgery,1,1
46872,.,1,1
46873,METHODS,0,0
46874,One,1,1
46875,hundred,1,1
46876,cases,1,1
46877,(,1,1
46878,200,1,1
46879,eyes,1,1
46880,),1,1
46881,were,0,1
46882,divided,0,1
46883,into,0,1
46884,treating,0,0
46885,group,0,1
46886,and,0,1
46887,control,0,1
46888,group,0,1
46889,randomly,0,1
46890,according,0,1
46891,to,0,0
46892,using,0,0
46893,and,0,0
46894,not,0,0
46895,using,0,0
46896,Naphcon,0,0
46897,eye,0,1
46898,drops,0,0
46899,before,0,1
46900,Lasik,0,1
46901,surgery,0,1
46902,.,0,1
46903,Treating,0,0
46904,group,0,1
46905,patients,0,1
46906,received,0,1
46907,three,0,1
46908,times,0,0
46909,Naphcon,0,1
46910,eye,0,1
46911,drops,0,0
46912,during,0,1
46913,15,0,1
46914,minutes,0,0
46915,before,0,1
46916,surgery,0,1
46917,.,0,1
46918,RESULTS,0,0
46919,The,0,0
46920,incidence,0,0
46921,of,0,0
46922,conjunctival,0,1
46923,bleeding,0,1
46924,from,0,1
46925,treating,0,0
46926,and,0,0
46927,control,0,1
46928,group,0,1
46929,were,0,1
46930,8,0,1
46931,%,0,0
46932,and,0,1
46933,15,0,1
46934,%,0,0
46935,respectively,0,0
46936,.,0,0
46937,There,0,0
46938,was,0,0
46939,significant,0,0
46940,statistical,0,0
46941,difference,0,0
46942,between,0,0
46943,them,0,1
46944,.,0,1
46945,CONCLUSION,0,0
46946,Naphcon,0,0
46947,eye,0,1
46948,drop,0,0
46949,is,0,0
46950,an,0,0
46951,effective,0,0
46952,agent,0,0
46953,to,0,0
46954,prevent,0,0
46955,conjunctival,1,1
46956,bleeding,1,1
46957,.,1,1
46958,Etanercept,0,1
46959,plus,0,0
46960,standard,0,1
46961,therapy,0,0
46962,for,0,1
46963,Wegener,1,1
46964,'s,1,1
46965,granulomatosis,1,1
46966,.,1,1
46967,BACKGROUND,0,0
46968,The,0,0
46969,majority,0,1
46970,of,0,0
46971,patients,1,1
46972,with,1,1
46973,Wegener,1,1
46974,'s,1,1
46975,granulomatosis,1,1
46976,have,1,1
46977,disease,1,1
46978,flares,1,0
46979,after,1,1
46980,conventional,1,1
46981,medications,1,1
46982,are,1,0
46983,tapered,1,0
46984,.,1,0
46985,There,0,0
46986,is,0,0
46987,no,0,0
46988,consistently,0,0
46989,safe,0,0
46990,",",0,0
46991,effective,0,0
46992,treatment,0,0
46993,for,0,0
46994,the,0,0
46995,maintenance,0,0
46996,of,0,0
46997,remission,0,1
46998,.,0,1
46999,METHODS,0,0
47000,We,0,0
47001,conducted,0,1
47002,a,0,0
47003,randomized,0,0
47004,",",0,0
47005,placebo-controlled,0,0
47006,trial,0,1
47007,at,0,1
47008,eight,0,1
47009,centers,0,1
47010,to,0,1
47011,evaluate,0,0
47012,etanercept,0,1
47013,for,0,0
47014,the,0,0
47015,maintenance,0,0
47016,of,0,0
47017,remission,0,1
47018,in,1,1
47019,180,1,1
47020,patients,1,1
47021,with,1,1
47022,Wegener,1,1
47023,'s,1,1
47024,granulomatosis,1,1
47025,.,1,1
47026,The,0,0
47027,primary,0,1
47028,outcome,0,0
47029,was,0,0
47030,sustained,0,0
47031,remission,0,1
47032,",",0,0
47033,defined,0,0
47034,as,0,0
47035,a,0,1
47036,Birmingham,0,1
47037,Vasculitis,0,1
47038,Activity,0,0
47039,Score,0,1
47040,for,0,1
47041,Wegener,0,1
47042,'s,0,1
47043,Granulomatosis,0,1
47044,of,0,1
47045,0,0,0
47046,for,0,1
47047,at,0,1
47048,least,0,1
47049,six,0,1
47050,months,0,1
47051,(,0,1
47052,scores,0,0
47053,can,0,0
47054,range,0,1
47055,from,0,0
47056,0,0,0
47057,to,0,1
47058,67,0,1
47059,",",0,0
47060,with,0,1
47061,higher,0,0
47062,scores,0,0
47063,indicating,0,0
47064,more,0,0
47065,active,0,0
47066,disease,0,1
47067,),0,1
47068,.,0,1
47069,In,0,0
47070,addition,0,0
47071,to,0,0
47072,etanercept,0,1
47073,or,0,0
47074,placebo,0,0
47075,",",0,0
47076,patients,0,1
47077,received,0,1
47078,standard,0,1
47079,therapy,0,0
47080,(,0,1
47081,glucocorticoids,0,0
47082,plus,0,0
47083,cyclophosphamide,0,1
47084,or,0,1
47085,methotrexate,0,1
47086,),0,1
47087,.,0,1
47088,After,0,0
47089,remission,0,0
47090,",",0,1
47091,standard,0,1
47092,medications,0,1
47093,were,0,1
47094,tapered,0,1
47095,according,0,1
47096,to,0,0
47097,the,0,0
47098,protocol,0,0
47099,.,0,0
47100,RESULTS,0,0
47101,The,0,0
47102,mean,0,0
47103,follow-up,0,0
47104,for,0,0
47105,the,0,0
47106,overall,0,0
47107,cohort,0,1
47108,was,0,0
47109,27,0,1
47110,months,0,0
47111,.,0,1
47112,Of,1,1
47113,the,1,0
47114,174,1,1
47115,patients,1,1
47116,who,1,1
47117,could,1,1
47118,be,1,1
47119,evaluated,1,0
47120,",",1,0
47121,126,1,1
47122,(,1,1
47123,72.4,1,1
47124,percent,1,1
47125,),1,1
47126,had,1,1
47127,a,1,0
47128,sustained,1,0
47129,remission,1,0
47130,",",1,0
47131,but,1,0
47132,only,1,0
47133,86,1,1
47134,(,1,1
47135,49.4,1,1
47136,percent,1,1
47137,),1,1
47138,remained,1,0
47139,in,1,0
47140,remission,1,1
47141,for,1,0
47142,the,1,0
47143,remainder,1,1
47144,of,1,0
47145,the,1,0
47146,trial,1,0
47147,.,1,0
47148,There,0,0
47149,were,0,0
47150,no,0,0
47151,significant,0,0
47152,differences,0,0
47153,between,0,0
47154,the,0,0
47155,etanercept,0,1
47156,and,0,0
47157,control,0,1
47158,groups,0,0
47159,in,0,1
47160,the,0,1
47161,rates,0,0
47162,of,0,0
47163,sustained,0,1
47164,remission,0,1
47165,(,0,1
47166,69.7,0,0
47167,percent,0,1
47168,vs.,0,0
47169,75.3,0,0
47170,percent,0,1
47171,",",0,1
47172,P=0.39,0,0
47173,),0,0
47174,",",0,0
47175,sustained,0,1
47176,periods,0,0
47177,of,0,1
47178,low-level,0,1
47179,disease,0,1
47180,activity,0,0
47181,(,0,1
47182,86.5,0,0
47183,percent,0,1
47184,vs.,0,0
47185,90.6,0,0
47186,percent,0,1
47187,",",0,1
47188,P=0.32,0,0
47189,),0,0
47190,",",0,0
47191,or,0,1
47192,the,0,0
47193,time,0,0
47194,required,0,0
47195,to,0,0
47196,achieve,0,0
47197,those,0,1
47198,measures,0,0
47199,.,0,1
47200,Disease,0,1
47201,flares,0,0
47202,were,0,1
47203,common,0,1
47204,in,0,1
47205,both,0,0
47206,groups,0,0
47207,",",0,0
47208,with,0,1
47209,118,0,1
47210,flares,0,0
47211,in,0,1
47212,the,0,0
47213,etanercept,0,1
47214,group,0,1
47215,(,0,1
47216,23,0,1
47217,severe,0,1
47218,and,0,1
47219,95,0,0
47220,limited,0,0
47221,),0,1
47222,and,0,1
47223,134,0,1
47224,in,0,0
47225,the,0,0
47226,control,0,1
47227,group,0,1
47228,(,0,1
47229,25,0,1
47230,severe,0,1
47231,and,0,1
47232,109,0,1
47233,limited,0,1
47234,),0,1
47235,.,0,0
47236,There,0,0
47237,was,0,0
47238,no,0,0
47239,significant,0,0
47240,difference,0,0
47241,between,0,0
47242,the,0,0
47243,etanercept,0,1
47244,and,0,0
47245,control,0,1
47246,groups,0,0
47247,in,0,1
47248,the,0,1
47249,relative,0,0
47250,risk,0,0
47251,of,0,1
47252,disease,0,1
47253,flares,0,0
47254,per,0,1
47255,100,0,1
47256,person-years,0,0
47257,of,0,1
47258,follow-up,0,1
47259,(,0,1
47260,0.89,0,0
47261,",",0,1
47262,P=0.54,0,0
47263,),0,1
47264,.,0,1
47265,During,0,0
47266,the,0,0
47267,study,0,0
47268,",",0,0
47269,56.2,0,0
47270,percent,0,1
47271,of,0,1
47272,patients,0,1
47273,in,0,1
47274,the,0,0
47275,etanercept,0,1
47276,group,0,1
47277,and,0,1
47278,57.1,0,0
47279,percent,0,1
47280,of,0,0
47281,those,0,0
47282,in,0,0
47283,the,0,0
47284,control,0,1
47285,group,0,0
47286,had,0,1
47287,at,0,0
47288,least,0,1
47289,one,0,1
47290,severe,0,1
47291,or,0,1
47292,life-threatening,0,1
47293,adverse,0,0
47294,event,0,0
47295,or,0,1
47296,died,0,1
47297,(,0,1
47298,P=0.90,0,0
47299,),0,1
47300,.,0,1
47301,Solid,0,1
47302,cancers,0,1
47303,developed,0,1
47304,in,0,1
47305,six,0,1
47306,patients,0,1
47307,in,0,1
47308,the,0,0
47309,etanercept,0,1
47310,group,0,0
47311,",",0,0
47312,as,0,0
47313,compared,0,0
47314,with,0,1
47315,none,0,0
47316,in,0,0
47317,the,0,0
47318,control,0,1
47319,group,0,0
47320,(,0,1
47321,P=0.01,0,0
47322,),0,1
47323,.,0,1
47324,CONCLUSIONS,0,0
47325,Etanercept,0,0
47326,is,0,0
47327,not,0,0
47328,effective,0,0
47329,for,0,0
47330,the,0,0
47331,maintenance,1,0
47332,of,1,0
47333,remission,1,1
47334,in,1,1
47335,patients,1,1
47336,with,1,1
47337,Wegener,1,1
47338,'s,1,1
47339,granulomatosis,1,1
47340,.,1,1
47341,Durable,0,0
47342,remissions,0,1
47343,were,0,1
47344,achieved,0,0
47345,in,0,0
47346,only,0,0
47347,a,0,0
47348,minority,0,1
47349,of,0,0
47350,the,0,0
47351,patients,0,1
47352,",",0,0
47353,and,0,0
47354,there,0,0
47355,was,0,0
47356,a,0,0
47357,high,0,0
47358,rate,0,0
47359,of,0,1
47360,treatment-related,0,0
47361,complications,0,1
47362,.,0,1
47363,Randomized,0,1
47364,controlled,0,0
47365,trial,0,0
47366,to,0,0
47367,compare,0,0
47368,the,0,0
47369,early,0,1
47370,and,0,1
47371,mid-term,0,1
47372,results,0,0
47373,of,0,1
47374,stapled,1,1
47375,versus,1,0
47376,open,1,1
47377,hemorrhoidectomy,1,1
47378,.,1,1
47379,BACKGROUND,0,0
47380,The,0,0
47381,new,0,0
47382,technique,0,0
47383,of,0,0
47384,circular,0,1
47385,stapler,0,0
47386,for,0,0
47387,the,0,0
47388,treatment,0,0
47389,of,0,0
47390,hemorrhoids,1,1
47391,has,0,0
47392,shown,0,0
47393,early,0,0
47394,promise,0,0
47395,in,0,1
47396,terms,0,0
47397,of,0,1
47398,minimal,0,1
47399,or,0,1
47400,no,0,0
47401,postoperative,0,0
47402,pain,0,1
47403,",",0,0
47404,early,0,1
47405,discharge,0,1
47406,from,0,1
47407,hospital,0,1
47408,",",0,0
47409,and,0,0
47410,quick,0,0
47411,return,0,0
47412,to,0,0
47413,work,0,0
47414,.,0,0
47415,This,0,0
47416,study,0,0
47417,was,0,0
47418,designed,0,0
47419,to,0,0
47420,compare,0,0
47421,stapled,0,0
47422,technique,0,0
47423,with,0,1
47424,the,0,0
47425,well-accepted,0,0
47426,conventional,0,1
47427,Milligan,1,1
47428,Morgan,1,1
47429,hemorrhoidectomy,1,1
47430,.,1,1
47431,METHODS,0,0
47432,After,0,0
47433,fulfilling,0,1
47434,the,0,0
47435,selection,0,0
47436,criteria,0,1
47437,",",0,1
47438,84,1,1
47439,patients,1,1
47440,were,1,1
47441,randomly,1,1
47442,allocated,1,1
47443,to,1,0
47444,the,1,0
47445,stapled,1,0
47446,(,1,0
47447,n,1,1
47448,=,1,1
47449,42,1,1
47450,),1,1
47451,or,1,1
47452,open,1,1
47453,group,1,1
47454,(,1,1
47455,n,1,1
47456,=,1,1
47457,42,1,1
47458,),1,1
47459,.,1,1
47460,All,1,1
47461,patients,1,1
47462,were,1,1
47463,operated,1,1
47464,on,1,0
47465,under,1,1
47466,spinal,1,1
47467,anesthesia,1,1
47468,.,1,1
47469,The,0,0
47470,2,0,0
47471,techniques,0,0
47472,were,0,1
47473,evaluated,0,0
47474,with,0,1
47475,respect,0,0
47476,to,0,1
47477,the,0,0
47478,operative,0,0
47479,time,0,0
47480,",",0,1
47481,pain,0,1
47482,scores,0,0
47483,",",0,1
47484,complications,0,0
47485,",",0,0
47486,day,0,0
47487,of,0,0
47488,discharge,0,0
47489,",",0,0
47490,return,0,0
47491,to,0,0
47492,work,0,0
47493,",",0,0
47494,and,0,0
47495,level,0,0
47496,of,0,0
47497,satisfaction,0,0
47498,.,0,1
47499,RESULTS,0,0
47500,The,0,0
47501,mean,1,0
47502,age,1,1
47503,of,1,1
47504,patients,1,1
47505,was,1,1
47506,46.02,1,1
47507,years,1,1
47508,(,1,1
47509,SD,1,1
47510,",",1,1
47511,12.33,1,0
47512,),1,1
47513,in,1,0
47514,the,1,0
47515,stapled,1,1
47516,group,1,1
47517,and,1,1
47518,48.64,1,0
47519,years,1,1
47520,(,1,1
47521,14.57,1,0
47522,),1,1
47523,in,1,0
47524,the,1,0
47525,open,1,1
47526,group,1,1
47527,.,1,1
47528,Grade,1,0
47529,III,1,1
47530,or,1,1
47531,IV,1,1
47532,hemorrhoids,1,1
47533,were,1,1
47534,more,1,0
47535,common,1,1
47536,in,1,0
47537,men,1,1
47538,(,1,1
47539,ie,1,1
47540,",",1,1
47541,80.9,1,0
47542,%,1,0
47543,and,1,1
47544,85.7,1,0
47545,%,1,0
47546,in,1,0
47547,the,1,0
47548,stapled,1,1
47549,and,1,0
47550,open,1,1
47551,group,1,0
47552,",",1,0
47553,respectively,1,0
47554,),1,0
47555,.,1,0
47556,The,0,0
47557,mean,0,0
47558,operative,0,1
47559,time,0,0
47560,was,0,0
47561,shorter,0,0
47562,in,0,0
47563,the,0,0
47564,stapled,0,1
47565,group,0,1
47566,24.28,0,0
47567,minutes,0,0
47568,(,0,1
47569,4.25,0,0
47570,),0,1
47571,versus,0,0
47572,45.21,0,1
47573,minutes,0,0
47574,(,0,1
47575,5.36,0,0
47576,),0,1
47577,in,0,0
47578,the,0,0
47579,Milligan-Morgan,0,0
47580,group,0,1
47581,(,0,1
47582,P,0,0
47583,<,0,0
47584,.001,0,0
47585,),0,1
47586,.,0,1
47587,The,0,0
47588,blood,0,0
47589,loss,0,0
47590,",",0,0
47591,pain,0,1
47592,scores,0,0
47593,and,0,1
47594,requirement,0,1
47595,of,0,1
47596,analgesics,0,0
47597,was,0,0
47598,significantly,0,0
47599,less,0,0
47600,in,0,0
47601,the,0,0
47602,stapled,0,1
47603,group,0,1
47604,.,0,1
47605,Mean,0,1
47606,hospital,0,1
47607,stay,0,0
47608,was,0,0
47609,1.24,0,0
47610,days,0,0
47611,(,0,1
47612,0.62,0,0
47613,),0,1
47614,and,0,1
47615,2.76,0,0
47616,days,0,0
47617,(,0,1
47618,1.01,0,0
47619,),0,1
47620,(,0,1
47621,P,0,0
47622,<,0,0
47623,.001,0,0
47624,),0,1
47625,in,0,0
47626,the,0,0
47627,stapled,0,1
47628,and,0,0
47629,open,0,1
47630,group,0,0
47631,",",0,0
47632,respectively,0,0
47633,.,0,1
47634,The,0,0
47635,patients,0,1
47636,in,0,0
47637,the,0,1
47638,stapled,0,1
47639,group,0,1
47640,returned,0,1
47641,to,0,0
47642,work,0,0
47643,or,0,1
47644,routine,0,0
47645,activities,0,0
47646,earlier,0,0
47647,(,0,0
47648,ie,0,0
47649,",",0,0
47650,within,0,1
47651,8.12,0,0
47652,days,0,0
47653,[,0,1
47654,2.48,0,0
47655,],0,1
47656,),0,1
47657,as,0,0
47658,compared,0,0
47659,with,0,1
47660,17.62,0,0
47661,(,0,1
47662,5.59,0,0
47663,),0,1
47664,in,0,0
47665,the,0,0
47666,open,0,1
47667,group,0,1
47668,.,0,1
47669,Only,0,0
47670,88.1,0,0
47671,%,0,0
47672,of,0,1
47673,patients,0,1
47674,were,0,1
47675,satisfied,0,1
47676,by,0,0
47677,the,0,0
47678,open,0,1
47679,method,0,0
47680,compared,0,0
47681,with,0,1
47682,97.6,0,0
47683,%,0,0
47684,after,0,0
47685,the,0,0
47686,stapled,0,1
47687,technique,0,0
47688,.,0,1
47689,The,0,0
47690,median,0,0
47691,follow-up,0,0
47692,period,0,1
47693,was,0,0
47694,11,0,1
47695,months,0,0
47696,with,0,1
47697,a,0,1
47698,maximum,0,0
47699,follow-up,0,0
47700,of,0,1
47701,19,0,1
47702,months,0,0
47703,(,0,1
47704,range,0,1
47705,2-19,0,1
47706,months,0,1
47707,),0,1
47708,.,0,1
47709,CONCLUSIONS,0,0
47710,Stapled,0,0
47711,hemorrhoidectomy,0,1
47712,is,0,0
47713,a,0,0
47714,safe,0,0
47715,and,0,0
47716,effective,0,0
47717,day-care,0,1
47718,procedure,0,0
47719,for,0,0
47720,the,0,0
47721,treatment,0,0
47722,of,0,0
47723,grade,1,1
47724,III,1,1
47725,and,1,1
47726,grade,1,1
47727,IV,1,1
47728,hemorrhoids,1,1
47729,.,1,1
47730,It,0,0
47731,ensures,0,0
47732,lesser,0,0
47733,postoperative,0,0
47734,pain,0,0
47735,",",0,0
47736,early,0,1
47737,discharge,0,0
47738,",",0,0
47739,less,0,0
47740,time,0,0
47741,off,0,0
47742,work,0,0
47743,",",0,1
47744,complications,0,0
47745,similar,0,0
47746,to,0,1
47747,the,0,0
47748,open,0,0
47749,technique,0,0
47750,",",0,0
47751,and,0,0
47752,in,0,0
47753,the,0,0
47754,end,0,0
47755,a,0,0
47756,more,0,0
47757,satisfied,0,0
47758,patient,0,0
47759,with,0,1
47760,no,0,0
47761,perianal,0,1
47762,wound,0,0
47763,.,0,1
47764,However,0,0
47765,",",0,0
47766,more,0,0
47767,such,0,0
47768,randomized,0,0
47769,trials,0,1
47770,are,0,0
47771,essential,0,0
47772,to,0,0
47773,deny,0,0
47774,any,0,0
47775,long-term,0,0
47776,complication,0,0
47777,.,0,1
47778,Enjoyment,0,1
47779,mediates,0,0
47780,effects,0,0
47781,of,0,1
47782,a,0,1
47783,school-based,0,1
47784,physical-activity,0,1
47785,intervention,0,0
47786,.,0,0
47787,PURPOSE,0,0
47788,The,0,0
47789,study,0,0
47790,evaluated,0,0
47791,whether,0,0
47792,targeted,0,1
47793,changes,0,0
47794,in,0,1
47795,factors,0,0
47796,influencing,0,0
47797,enjoyment,0,0
47798,of,0,0
47799,physical,0,1
47800,education,0,1
47801,(,0,1
47802,PE,0,1
47803,),0,1
47804,",",0,0
47805,physical,0,0
47806,activity,0,0
47807,enjoyment,0,0
47808,",",0,0
47809,and,0,0
47810,self-efficacy,0,0
47811,beliefs,0,0
47812,about,0,0
47813,participating,0,1
47814,in,0,1
47815,physical,0,1
47816,activity,0,0
47817,mediated,0,0
47818,the,0,0
47819,effect,0,0
47820,of,0,0
47821,the,0,0
47822,Lifestyle,0,1
47823,Education,0,1
47824,for,0,1
47825,Activity,0,0
47826,Program,0,1
47827,(,0,1
47828,LEAP,0,1
47829,),0,1
47830,intervention,0,0
47831,on,0,0
47832,participation,0,0
47833,in,0,1
47834,physical,0,1
47835,activity,0,0
47836,.,0,1
47837,METHODS,0,0
47838,High,1,1
47839,schools,1,1
47840,(,1,1
47841,N=24,1,1
47842,),1,1
47843,paired,1,0
47844,on,1,0
47845,enrollment,1,1
47846,size,1,0
47847,",",1,0
47848,racial,1,0
47849,composition,1,0
47850,",",1,1
47851,urban,1,1
47852,or,1,1
47853,rural,1,1
47854,location,1,1
47855,",",1,0
47856,and,1,0
47857,class,1,1
47858,structure,1,1
47859,were,1,0
47860,randomized,1,1
47861,into,1,1
47862,control,1,1
47863,(,1,1
47864,N=12,1,1
47865,),1,1
47866,or,1,1
47867,experimental,1,1
47868,(,1,1
47869,N=12,1,1
47870,),1,1
47871,groups,1,0
47872,.,1,1
47873,Of,1,1
47874,the,1,0
47875,4044,1,1
47876,girls,1,1
47877,enrolled,1,1
47878,and,1,1
47879,eligible,1,1
47880,",",1,1
47881,2087,1,1
47882,(,1,1
47883,51.6,1,0
47884,%,1,0
47885,),1,1
47886,participated,1,1
47887,in,1,0
47888,the,1,0
47889,measurement,1,0
47890,component,1,0
47891,of,1,0
47892,the,1,0
47893,study,1,0
47894,.,1,0
47895,There,0,0
47896,were,0,0
47897,1038,1,1
47898,girls,1,1
47899,in,1,1
47900,the,1,0
47901,control,1,1
47902,group,1,1
47903,and,1,1
47904,1049,1,1
47905,girls,1,1
47906,in,1,1
47907,the,1,1
47908,experimental,1,0
47909,group,1,1
47910,.,1,1
47911,INTERVENTION,0,0
47912,LEAP,0,1
47913,was,0,0
47914,a,0,1
47915,comprehensive,0,0
47916,school-based,0,1
47917,intervention,0,1
47918,emphasizing,0,0
47919,changes,0,0
47920,in,0,1
47921,instruction,0,0
47922,and,0,1
47923,school,0,1
47924,environment,0,0
47925,designed,0,0
47926,to,0,0
47927,increase,0,0
47928,physical,0,0
47929,activity,0,0
47930,among,0,1
47931,black,1,1
47932,and,1,1
47933,white,1,1
47934,adolescent,1,1
47935,girls,1,1
47936,.,1,1
47937,It,0,0
47938,was,0,0
47939,organized,0,0
47940,according,0,1
47941,to,0,0
47942,the,0,0
47943,Coordinated,0,1
47944,School,0,1
47945,Health,0,0
47946,Program,0,1
47947,and,0,0
47948,included,0,1
47949,a,0,0
47950,PE,0,1
47951,component,0,0
47952,with,0,1
47953,core,0,1
47954,objectives,0,0
47955,of,0,1
47956,promoting,0,0
47957,enjoyment,0,0
47958,of,0,0
47959,PE,0,1
47960,",",0,1
47961,physical,0,0
47962,activity,0,0
47963,enjoyment,0,0
47964,",",0,0
47965,and,0,0
47966,self-efficacy,0,0
47967,.,0,1
47968,RESULTS,0,0
47969,Latent,0,0
47970,variable,0,1
47971,structural,0,0
47972,equation,0,1
47973,modeling,0,0
47974,indicated,0,0
47975,that,0,0
47976,:,0,1
47977,1,0,1
47978,),0,1
47979,the,0,0
47980,intervention,0,0
47981,had,0,1
47982,direct,0,0
47983,",",0,1
47984,positive,0,1
47985,effects,0,0
47986,on,0,1
47987,physical,0,1
47988,activity,0,0
47989,and,0,1
47990,factors,0,0
47991,influencing,0,0
47992,enjoyment,0,0
47993,of,0,0
47994,PE,0,1
47995,",",0,0
47996,which,0,0
47997,subsequently,0,0
47998,explained,0,0
47999,the,0,0
48000,effects,0,0
48001,of,0,0
48002,increased,0,0
48003,physical,0,1
48004,activity,0,0
48005,enjoyment,0,0
48006,and,0,0
48007,self-efficacy,0,0
48008,on,0,0
48009,increased,0,0
48010,physical,0,1
48011,activity,0,0
48012,;,0,1
48013,and,0,1
48014,2,0,1
48015,),0,1
48016,an,0,0
48017,additional,0,0
48018,",",0,0
48019,indirect,0,0
48020,effect,0,0
48021,of,0,0
48022,physical,0,1
48023,activity,0,0
48024,enjoyment,0,0
48025,on,0,0
48026,physical,0,1
48027,activity,0,0
48028,operated,0,1
48029,by,0,0
48030,an,0,0
48031,influence,0,0
48032,on,0,0
48033,self-efficacy,0,0
48034,.,0,1
48035,CONCLUSIONS,0,0
48036,Increases,0,0
48037,in,0,0
48038,enjoyment,0,0
48039,partially,0,0
48040,mediated,0,0
48041,the,0,0
48042,positive,0,0
48043,effect,0,0
48044,of,0,0
48045,the,0,0
48046,LEAP,0,1
48047,intervention,0,0
48048,.,0,1
48049,To,0,0
48050,our,0,0
48051,knowledge,0,0
48052,",",0,0
48053,we,0,0
48054,have,0,0
48055,provided,0,0
48056,the,0,0
48057,first,0,0
48058,experimental,0,0
48059,evidence,0,0
48060,from,0,1
48061,a,0,1
48062,randomized,0,1
48063,controlled,0,0
48064,trial,0,0
48065,linking,0,0
48066,increased,0,0
48067,enjoyment,0,0
48068,with,0,1
48069,increased,0,0
48070,physical,0,1
48071,activity,0,0
48072,among,0,1
48073,black,1,1
48074,and,1,1
48075,white,1,1
48076,adolescent,1,1
48077,girls,1,1
48078,.,1,1
48079,Effectiveness,0,0
48080,of,0,0
48081,once-daily,0,0
48082,monotherapy,0,1
48083,with,0,1
48084,a,0,1
48085,new,0,1
48086,nifedipine,0,0
48087,sustained,0,1
48088,release,0,0
48089,calcium,0,0
48090,antagonist,0,0
48091,.,0,1
48092,Data,0,0
48093,from,0,1
48094,2,1,1
48095,separate,1,1
48096,multicenter,1,1
48097,",",0,1
48098,double-blind,0,1
48099,clinical,0,0
48100,studies,0,0
48101,following,0,0
48102,the,0,0
48103,same,0,0
48104,protocol,0,0
48105,",",0,0
48106,except,0,0
48107,for,0,0
48108,the,0,0
48109,selection,0,0
48110,of,0,0
48111,doses,0,0
48112,",",0,1
48113,were,0,1
48114,pooled,0,0
48115,to,0,0
48116,evaluate,0,0
48117,the,0,0
48118,efficacy,0,0
48119,and,0,0
48120,tolerability,0,0
48121,of,0,1
48122,fixed,0,0
48123,doses,0,0
48124,of,0,1
48125,a,0,1
48126,new,0,1
48127,sustained-release,0,0
48128,(,0,1
48129,SR,0,0
48130,),0,1
48131,formulation,0,0
48132,of,0,0
48133,nifedipine,0,1
48134,compared,0,0
48135,with,0,1
48136,placebo,0,0
48137,in,0,1
48138,388,1,1
48139,patients,1,1
48140,with,1,1
48141,mild,1,1
48142,to,1,1
48143,moderate,1,1
48144,uncomplicated,1,1
48145,essential,1,1
48146,hypertension,1,1
48147,.,1,1
48148,After,0,0
48149,a,0,0
48150,3-6,0,1
48151,week,0,0
48152,placebo,0,0
48153,washout,0,0
48154,period,0,0
48155,",",0,0
48156,the,0,0
48157,patients,0,1
48158,were,0,1
48159,randomized,0,1
48160,to,0,0
48161,receive,0,0
48162,either,0,0
48163,placebo,0,0
48164,or,0,1
48165,nifedipine,0,1
48166,SR-20,0,0
48167,mg,0,0
48168,(,0,1
48169,study,0,0
48170,I,0,1
48171,only,0,0
48172,),0,0
48173,",",0,0
48174,50,0,1
48175,mg,0,0
48176,",",0,1
48177,100,0,0
48178,mg,0,0
48179,",",0,1
48180,or,0,1
48181,150,0,1
48182,mg,0,0
48183,(,0,0
48184,study,0,1
48185,II,0,1
48186,only,0,0
48187,),0,1
48188,.,0,0
48189,Among,0,1
48190,the,0,0
48191,278,0,1
48192,patients,0,1
48193,who,0,1
48194,completed,0,1
48195,6,0,1
48196,weeks,0,0
48197,of,0,1
48198,active,0,1
48199,therapy,0,0
48200,",",0,0
48201,mean,0,1
48202,supine,0,0
48203,diastolic,0,0
48204,blood,0,0
48205,pressure,0,0
48206,reductions,0,0
48207,from,0,1
48208,pretreatment,0,1
48209,baseline,0,1
48210,were,0,1
48211,5.9,0,0
48212,",",0,1
48213,9.3,0,0
48214,",",0,0
48215,9.2,0,0
48216,",",0,0
48217,11.1,0,0
48218,",",0,0
48219,and,0,0
48220,13.2,0,0
48221,mm,0,1
48222,Hg,0,0
48223,in,0,0
48224,the,0,0
48225,placebo,0,0
48226,",",0,0
48227,20-,0,0
48228,",",0,0
48229,50-,0,1
48230,",",0,0
48231,100-,0,0
48232,",",0,0
48233,and,0,1
48234,150-mg,0,0
48235,groups,0,0
48236,",",0,1
48237,respectively,0,0
48238,.,0,1
48239,The,0,0
48240,reductions,0,0
48241,achieved,0,0
48242,in,0,0
48243,each,0,0
48244,of,0,0
48245,the,0,0
48246,nifedipine,0,1
48247,SR,0,0
48248,groups,0,0
48249,were,0,1
48250,statistically,0,0
48251,significant,0,0
48252,versus,0,0
48253,baseline,0,1
48254,values,0,0
48255,(,0,1
48256,p,0,0
48257,less,0,0
48258,than,0,0
48259,0.001,0,0
48260,),0,1
48261,.,0,1
48262,All,0,1
48263,nifedipine-SR,0,0
48264,doses,0,0
48265,reduced,0,0
48266,supine,0,1
48267,systolic,0,1
48268,blood,0,0
48269,pressure,0,0
48270,significantly,0,0
48271,more,0,0
48272,than,0,0
48273,placebo,0,0
48274,(,0,0
48275,p,0,0
48276,less,0,0
48277,than,0,0
48278,0.001,0,0
48279,),0,1
48280,.,0,1
48281,In,0,0
48282,addition,0,0
48283,",",0,0
48284,there,0,0
48285,was,0,0
48286,a,0,0
48287,significant,0,0
48288,linear,0,0
48289,relationship,0,0
48290,between,0,0
48291,the,0,0
48292,log,0,0
48293,of,0,0
48294,the,0,0
48295,dose,0,0
48296,and,0,0
48297,the,0,0
48298,blood,0,0
48299,pressure,0,0
48300,reduction,0,0
48301,(,0,0
48302,p,0,0
48303,less,0,0
48304,than,0,0
48305,0.05,0,0
48306,),0,1
48307,.,0,1
48308,Automated,0,0
48309,ambulatory,0,1
48310,blood,0,0
48311,pressure,0,1
48312,recordings,0,0
48313,performed,0,0
48314,in,0,1
48315,221,0,1
48316,of,0,1
48317,the,0,1
48318,patients,0,1
48319,showed,0,0
48320,that,0,0
48321,the,0,0
48322,blood,0,0
48323,pressure,0,0
48324,was,0,0
48325,lowered,0,0
48326,evenly,0,1
48327,through,0,0
48328,the,0,0
48329,entire,0,1
48330,24-hour,0,0
48331,dosing,0,0
48332,period,0,0
48333,.,0,1
48334,The,0,0
48335,doses,0,0
48336,that,0,0
48337,were,0,1
48338,effective,0,0
48339,and,0,0
48340,associated,0,0
48341,with,0,1
48342,the,0,0
48343,fewest,0,0
48344,adverse,0,0
48345,reactions,0,0
48346,were,0,1
48347,20,0,1
48348,mg,0,1
48349,and,0,1
48350,50,0,1
48351,mg,0,0
48352,once,0,1
48353,daily,0,0
48354,.,0,1
48355,Low-dose,0,0
48356,angiotensin,0,0
48357,II,0,1
48358,receptor,0,0
48359,antagonists,0,0
48360,and,0,1
48361,angiotensin,0,0
48362,II-converting,0,1
48363,enzyme,0,0
48364,inhibitors,0,0
48365,alone,0,0
48366,or,0,1
48367,in,0,0
48368,combination,0,0
48369,for,0,0
48370,treatment,0,0
48371,of,0,0
48372,primary,0,1
48373,glomerulonephritis,0,1
48374,.,0,1
48375,OBJECTIVE,0,0
48376,The,0,0
48377,renin-angiotensin,0,0
48378,system,0,0
48379,is,0,0
48380,thought,0,0
48381,to,0,0
48382,be,0,0
48383,involved,0,0
48384,in,0,0
48385,the,0,0
48386,progression,0,0
48387,of,0,0
48388,chronic,0,1
48389,renal,0,1
48390,diseases,0,1
48391,of,0,1
48392,both,0,0
48393,diabetic,0,1
48394,and,0,0
48395,non-diabetic,0,1
48396,origin,0,1
48397,.,0,1
48398,It,0,0
48399,has,0,0
48400,been,0,0
48401,confirmed,0,0
48402,that,0,0
48403,angiotensin-converting,0,1
48404,enzyme,0,1
48405,inhibitors,0,0
48406,(,0,1
48407,ACEIs,0,1
48408,),0,1
48409,and,0,0
48410,angiotensin,0,0
48411,II,0,1
48412,receptor,0,0
48413,blockers,0,0
48414,(,0,1
48415,ARBs,0,1
48416,),0,1
48417,reduce,0,0
48418,urinary,0,0
48419,protein,0,0
48420,excretion,0,0
48421,and,0,0
48422,attenuate,0,0
48423,the,0,0
48424,development,0,0
48425,of,0,0
48426,renal,0,1
48427,injury,0,1
48428,.,0,1
48429,Clinical,0,0
48430,data,0,0
48431,comparing,0,0
48432,the,0,1
48433,renal,0,1
48434,effects,0,0
48435,of,0,1
48436,ACEIs,0,1
48437,and,0,1
48438,ARBs,0,1
48439,",",0,0
48440,either,0,0
48441,singly,0,0
48442,or,0,0
48443,in,0,0
48444,combination,0,0
48445,",",0,0
48446,are,0,0
48447,scarce,0,0
48448,and,0,0
48449,usually,0,0
48450,concern,0,0
48451,the,0,0
48452,use,0,0
48453,of,0,0
48454,standard,0,1
48455,or,0,1
48456,high,0,1
48457,doses,0,0
48458,.,0,1
48459,MATERIAL,0,0
48460,AND,0,0
48461,METHODS,0,0
48462,This,0,0
48463,was,0,0
48464,a,0,0
48465,prospective,0,0
48466,",",0,0
48467,randomized,0,1
48468,",",0,0
48469,9-month,0,0
48470,study,0,0
48471,of,0,0
48472,the,0,0
48473,effects,0,0
48474,of,0,1
48475,low,0,1
48476,doses,0,0
48477,of,0,1
48478,losartan,0,1
48479,(,0,1
48480,25,0,1
48481,mg,0,1
48482,;,0,0
48483,n,0,1
48484,=,0,1
48485,18,0,1
48486,),0,1
48487,versus,0,0
48488,enalapril,0,1
48489,(,0,1
48490,10,0,1
48491,mg,0,1
48492,;,0,0
48493,n,0,1
48494,=,0,1
48495,18,0,1
48496,),0,0
48497,versus,0,0
48498,the,0,0
48499,combination,0,0
48500,of,0,0
48501,losartan,0,1
48502,(,0,1
48503,25,0,1
48504,mg,0,1
48505,),0,1
48506,and,0,0
48507,enalapril,0,1
48508,(,0,1
48509,10,0,1
48510,mg,0,1
48511,),0,1
48512,(,0,1
48513,n,0,1
48514,=,0,1
48515,16,0,1
48516,),0,1
48517,on,0,0
48518,proteinuria,0,1
48519,",",0,0
48520,kidney,0,1
48521,function,0,0
48522,and,0,0
48523,metabolic,0,0
48524,profile,0,0
48525,in,0,1
48526,54,1,1
48527,patients,1,1
48528,with,1,1
48529,biopsy-proven,1,1
48530,chronic,1,1
48531,glomerulonephritis,1,1
48532,",",1,0
48533,hypertension,1,1
48534,and,1,0
48535,normal,1,1
48536,or,1,1
48537,slightly,1,0
48538,impaired,1,1
48539,kidney,1,1
48540,function,1,0
48541,.,1,1
48542,The,0,0
48543,clinical,0,0
48544,evaluation,0,0
48545,and,0,1
48546,laboratory,0,1
48547,tests,0,0
48548,were,0,1
48549,performed,0,0
48550,before,0,0
48551,treatment,0,0
48552,(,0,1
48553,baseline,0,0
48554,),0,1
48555,and,0,1
48556,after,0,1
48557,3,0,1
48558,and,0,1
48559,9,0,1
48560,months,0,0
48561,of,0,1
48562,therapy,0,1
48563,.,0,1
48564,RESULTS,0,0
48565,After,0,1
48566,3,0,1
48567,months,0,0
48568,",",0,1
48569,significant,0,0
48570,decreases,0,0
48571,in,0,1
48572,proteinuria,0,1
48573,were,0,1
48574,observed,0,0
48575,in,0,0
48576,all,0,1
48577,groups,0,0
48578,:,0,1
48579,losartan,0,1
48580,",",0,0
48581,22.6,0,0
48582,%,0,0
48583,(,0,1
48584,p,0,0
48585,=,0,1
48586,0.02,0,0
48587,),0,1
48588,;,0,1
48589,enalapril,0,0
48590,",",0,0
48591,43,0,1
48592,%,0,0
48593,(,0,1
48594,p,0,0
48595,=,0,1
48596,0.012,0,0
48597,),0,1
48598,;,0,1
48599,and,0,0
48600,combined,0,0
48601,therapy,0,0
48602,",",0,0
48603,63,0,1
48604,%,0,0
48605,(,0,1
48606,p,0,0
48607,=,0,1
48608,0.001,0,0
48609,),0,1
48610,.,0,1
48611,This,0,0
48612,anti-proteinuric,0,0
48613,effect,0,0
48614,was,0,0
48615,even,0,0
48616,greater,0,0
48617,after,0,1
48618,9,0,0
48619,months,0,1
48620,of,0,1
48621,therapy,0,1
48622,:,0,1
48623,losartan,0,0
48624,",",0,0
48625,44.2,0,0
48626,%,0,0
48627,(,0,1
48628,p,0,0
48629,=,0,1
48630,0.02,0,0
48631,),0,1
48632,;,0,1
48633,enalapril,0,0
48634,",",0,0
48635,49.6,0,0
48636,%,0,0
48637,(,0,1
48638,p,0,0
48639,=,0,1
48640,0.02,0,0
48641,),0,1
48642,;,0,1
48643,and,0,0
48644,combined,0,0
48645,therapy,0,0
48646,",",0,0
48647,51,0,1
48648,%,0,0
48649,(,0,1
48650,p,0,0
48651,=,0,1
48652,0.003,0,0
48653,),0,0
48654,.,0,0
48655,There,0,0
48656,was,0,0
48657,no,0,0
48658,significant,0,0
48659,difference,0,0
48660,between,0,0
48661,losartan,0,1
48662,and,0,0
48663,enalapril,0,0
48664,with,0,1
48665,respect,0,0
48666,to,0,1
48667,their,0,0
48668,impact,0,0
48669,on,0,0
48670,proteinuria,0,1
48671,level,0,1
48672,.,0,1
48673,Proteinuria,0,1
48674,reduction,0,0
48675,was,0,0
48676,significantly,0,0
48677,greater,0,0
48678,in,0,0
48679,patients,0,1
48680,receiving,0,1
48681,combined,0,0
48682,therapy,0,1
48683,in,0,0
48684,comparison,0,0
48685,with,0,1
48686,losartan,0,1
48687,treatment,0,1
48688,after,0,1
48689,3,0,1
48690,months,0,1
48691,of,0,1
48692,therapy,0,1
48693,(,0,1
48694,p,0,0
48695,=,0,1
48696,0.02,0,0
48697,),0,1
48698,.,0,1
48699,Creatinine,0,0
48700,clearance,0,0
48701,and,0,1
48702,serum,0,0
48703,creatinine,0,0
48704,were,0,1
48705,stable,0,1
48706,during,0,0
48707,the,0,0
48708,entire,0,0
48709,study,0,0
48710,period,0,0
48711,in,0,0
48712,all,0,1
48713,patients,0,1
48714,.,0,1
48715,No,0,0
48716,significant,0,0
48717,changes,0,0
48718,in,0,1
48719,lipids,0,0
48720,",",0,1
48721,serum,0,0
48722,uric,0,0
48723,acid,0,0
48724,or,0,1
48725,protein,0,0
48726,levels,0,0
48727,were,0,1
48728,observed,0,0
48729,.,0,1
48730,CONCLUSIONS,0,0
48731,These,0,1
48732,results,0,0
48733,indicate,0,0
48734,that,0,0
48735,proteinuria,0,1
48736,is,0,0
48737,reduced,0,0
48738,by,0,0
48739,low,0,1
48740,doses,0,0
48741,of,0,1
48742,losartan,0,1
48743,or,0,1
48744,enalapril,0,0
48745,.,0,1
48746,The,0,0
48747,combination,0,0
48748,of,0,0
48749,these,0,0
48750,drugs,0,0
48751,seems,0,0
48752,to,0,0
48753,be,0,0
48754,beneficial,0,0
48755,and,0,0
48756,may,0,0
48757,offer,0,0
48758,an,0,0
48759,additional,0,0
48760,renoprotective,0,0
48761,effect,0,0
48762,.,0,0
48763,This,0,0
48764,needs,0,0
48765,to,0,0
48766,be,0,0
48767,confirmed,0,0
48768,in,0,0
48769,a,0,0
48770,study,0,0
48771,with,0,1
48772,a,0,1
48773,larger,0,0
48774,sample,0,1
48775,size,0,0
48776,.,0,1
48777,Dairy,0,1
48778,products,0,0
48779,do,0,0
48780,not,0,0
48781,lead,0,0
48782,to,0,0
48783,alterations,0,0
48784,in,0,1
48785,body,0,1
48786,weight,0,1
48787,or,0,1
48788,fat,0,0
48789,mass,0,1
48790,in,0,1
48791,young,1,1
48792,women,1,1
48793,in,0,1
48794,a,0,1
48795,1-y,0,1
48796,intervention,0,0
48797,.,0,1
48798,BACKGROUND,0,0
48799,Previous,0,1
48800,results,0,0
48801,suggested,0,0
48802,that,0,0
48803,increased,0,0
48804,intake,0,0
48805,of,0,0
48806,dairy,0,1
48807,calcium,0,0
48808,is,0,0
48809,associated,0,0
48810,with,0,1
48811,reduced,0,0
48812,weight,0,1
48813,and,0,1
48814,fat,0,0
48815,mass,0,1
48816,.,0,1
48817,OBJECTIVE,0,0
48818,The,0,0
48819,purpose,0,0
48820,of,0,0
48821,this,0,0
48822,study,0,0
48823,was,0,0
48824,to,0,0
48825,determine,0,0
48826,whether,0,0
48827,long-term,0,0
48828,increases,0,0
48829,in,0,1
48830,consumption,0,0
48831,of,0,0
48832,dairy,0,1
48833,calcium,0,0
48834,alter,0,0
48835,body,0,1
48836,weight,0,1
48837,and,0,0
48838,fat,0,0
48839,mass,0,1
48840,in,0,0
48841,young,1,1
48842,",",1,1
48843,healthy,1,1
48844,women,1,1
48845,.,1,1
48846,DESIGN,0,0
48847,We,0,0
48848,used,0,0
48849,a,0,0
48850,randomized,0,1
48851,",",0,0
48852,1-y,0,1
48853,intervention,0,0
48854,for,0,0
48855,dairy,0,1
48856,calcium,0,0
48857,.,0,1
48858,Subjects,1,1
48859,were,1,1
48860,155,1,1
48861,young,1,1
48862,(,1,1
48863,aged,1,1
48864,18-30,1,1
48865,y,1,1
48866,),1,1
48867,",",1,0
48868,healthy,1,1
48869,",",1,1
48870,normal-weight,1,1
48871,women,1,1
48872,with,1,1
48873,intake,1,0
48874,of,1,0
48875,dietary,1,0
48876,calcium,1,0
48877,<,1,0
48878,800,1,0
48879,mg/d,1,0
48880,and,1,0
48881,energy,1,0
48882,intake,1,0
48883,<,1,0
48884,/=,1,1
48885,2200,1,1
48886,kcal/d,1,1
48887,.,1,1
48888,Women,0,1
48889,were,0,0
48890,randomly,0,1
48891,assigned,0,1
48892,to,0,0
48893,1,0,1
48894,of,0,1
48895,3,0,1
48896,groups,0,1
48897,:,0,1
48898,1,0,1
48899,),0,1
48900,control,0,1
48901,:,0,1
48902,continue,0,0
48903,established,0,1
48904,dietary,0,0
48905,intake,0,0
48906,;,0,1
48907,2,0,1
48908,),0,1
48909,medium,0,1
48910,dairy,0,1
48911,:,0,1
48912,substitute,0,0
48913,dairy,0,1
48914,products,0,0
48915,to,0,1
48916,achieve,0,0
48917,intake,0,0
48918,of,0,0
48919,calcium,0,0
48920,of,0,0
48921,approximately,0,1
48922,1000-1100,0,1
48923,mg/d,0,0
48924,and,0,0
48925,maintain,0,0
48926,isocaloric,0,0
48927,intake,0,0
48928,;,0,1
48929,3,0,1
48930,),0,1
48931,high,0,1
48932,dairy,0,1
48933,:,0,1
48934,substitute,0,0
48935,dairy,0,1
48936,products,0,0
48937,to,0,1
48938,achieve,0,0
48939,intake,0,0
48940,of,0,0
48941,calcium,0,0
48942,of,0,0
48943,1300-1400,0,1
48944,mg/d,0,0
48945,and,0,0
48946,maintain,0,0
48947,isocaloric,0,0
48948,intake,0,0
48949,.,0,1
48950,The,0,0
48951,main,0,0
48952,outcome,0,0
48953,measures,0,0
48954,were,0,1
48955,1-y,0,1
48956,changes,0,0
48957,in,0,1
48958,body,0,1
48959,weight,0,1
48960,(,0,0
48961,in,0,0
48962,kg,0,1
48963,),0,1
48964,and,0,0
48965,fat,0,0
48966,mass,0,1
48967,(,0,1
48968,in,0,0
48969,kg,0,1
48970,),0,1
48971,.,0,1
48972,One,1,1
48973,hundred,1,1
48974,thirty-five,1,1
48975,women,1,1
48976,completed,1,1
48977,the,1,0
48978,trial,1,0
48979,.,1,1
48980,RESULTS,0,0
48981,Mean,0,1
48982,intakes,0,1
48983,of,0,0
48984,calcium,0,0
48985,during,0,0
48986,the,0,0
48987,intervention,0,0
48988,were,0,1
48989,742.4,0,1
48990,+/-,0,0
48991,321.5,0,1
48992,",",0,1
48993,1026.4,0,1
48994,+/-,0,0
48995,311.3,0,1
48996,",",0,1
48997,and,0,1
48998,1131.29,0,1
48999,+/-,0,0
49000,337.2,0,0
49001,mg/d,0,0
49002,for,0,0
49003,the,0,0
49004,control,0,0
49005,",",0,0
49006,medium-dairy,0,1
49007,",",0,0
49008,and,0,0
49009,high-dairy,0,1
49010,groups,0,0
49011,",",0,1
49012,respectively,0,0
49013,(,0,0
49014,P,0,0
49015,<,0,0
49016,0.0001,0,0
49017,),0,1
49018,.,0,1
49019,No,0,0
49020,significant,0,0
49021,differences,0,0
49022,were,0,1
49023,observed,0,0
49024,in,0,0
49025,the,0,0
49026,mean,0,1
49027,1-y,0,1
49028,change,0,0
49029,in,0,0
49030,body,0,1
49031,weight,0,1
49032,between,0,0
49033,the,0,0
49034,control,0,0
49035,",",0,0
49036,medium-dairy,0,1
49037,",",0,0
49038,and,0,0
49039,high-dairy,0,1
49040,groups,0,1
49041,(,0,1
49042,0.8,0,1
49043,+/-,0,0
49044,2.8,0,0
49045,",",0,1
49046,0.7,0,0
49047,+/-,0,0
49048,3.0,0,0
49049,",",0,1
49050,and,0,1
49051,1.5,0,0
49052,+/-,0,0
49053,4.1,0,1
49054,kg,0,1
49055,",",0,0
49056,respectively,0,0
49057,;,0,0
49058,P,0,0
49059,=,0,1
49060,0.45,0,0
49061,),0,1
49062,.,0,1
49063,No,0,0
49064,significant,0,0
49065,differences,0,0
49066,were,0,1
49067,observed,0,0
49068,in,0,0
49069,the,0,0
49070,mean,0,1
49071,1-y,0,1
49072,change,0,0
49073,in,0,1
49074,fat,0,0
49075,mass,0,1
49076,between,0,0
49077,the,0,0
49078,control,0,0
49079,",",0,0
49080,medium-dairy,0,1
49081,",",0,0
49082,and,0,0
49083,high-dairy,0,1
49084,groups,0,1
49085,(,0,1
49086,-0.5,0,0
49087,+/-,0,0
49088,2.5,0,0
49089,",",0,1
49090,0.3,0,0
49091,+/-,0,0
49092,2.7,0,1
49093,",",0,1
49094,and,0,1
49095,0.5,0,0
49096,+/-,0,0
49097,3.5,0,0
49098,kg,0,1
49099,",",0,0
49100,respectively,0,0
49101,;,0,0
49102,P,0,0
49103,=,0,1
49104,0.26,0,0
49105,),0,1
49106,.,0,1
49107,CONCLUSION,0,0
49108,Increased,0,0
49109,intake,0,0
49110,of,0,0
49111,dairy,0,1
49112,products,0,0
49113,does,0,0
49114,not,0,0
49115,alter,0,0
49116,body,0,1
49117,weight,0,1
49118,or,0,1
49119,fat,0,0
49120,mass,0,1
49121,in,0,0
49122,young,1,1
49123,",",1,1
49124,healthy,1,1
49125,women,1,1
49126,over,0,1
49127,1,0,1
49128,y,0,1
49129,.,0,1
49130,Simvastatin,0,1
49131,blunts,0,0
49132,endotoxin-induced,0,0
49133,tissue,0,1
49134,factor,0,0
49135,in,0,0
49136,vivo,0,0
49137,.,0,1
49138,BACKGROUND,0,0
49139,Beyond,0,0
49140,lipid,0,0
49141,lowering,0,0
49142,",",0,0
49143,various,0,0
49144,antiinflammatory,0,0
49145,properties,0,0
49146,have,0,1
49147,been,0,0
49148,ascribed,0,0
49149,to,0,1
49150,statins,0,0
49151,.,0,1
49152,Moreover,0,0
49153,",",0,0
49154,in,0,0
49155,vitro,0,0
49156,studies,0,0
49157,have,0,0
49158,suggested,0,0
49159,the,0,0
49160,presence,0,0
49161,of,0,0
49162,anticoagulant,0,0
49163,effects,0,0
49164,of,0,1
49165,3-hydroxy-3-methylglutaryl,0,1
49166,coenzyme,0,0
49167,A,0,1
49168,reductase,0,0
49169,inhibitors,0,0
49170,",",0,1
49171,as,0,0
49172,lipopolysaccharide,0,0
49173,(,0,1
49174,LPS,0,1
49175,),0,1
49176,-induced,0,1
49177,monocyte,0,0
49178,tissue,0,1
49179,factor,0,0
49180,(,0,1
49181,TF,0,1
49182,),0,1
49183,was,0,0
49184,suppressed,0,0
49185,.,0,1
49186,In,0,0
49187,this,0,0
49188,study,0,0
49189,",",0,0
49190,we,0,0
49191,examined,0,0
49192,the,0,0
49193,role,0,0
49194,of,0,0
49195,statins,0,0
49196,in,0,1
49197,experimental,0,1
49198,endotoxemia,1,1
49199,on,0,0
49200,inflammatory,0,0
49201,and,0,1
49202,procoagulant,0,0
49203,responses,0,0
49204,in,0,1
49205,vivo,0,0
49206,.,0,1
49207,METHODS,0,0
49208,AND,0,0
49209,RESULTS,0,0
49210,In,0,1
49211,this,0,0
49212,double-blind,0,0
49213,",",0,0
49214,placebo-controlled,0,0
49215,",",0,0
49216,parallel-group,0,0
49217,study,0,1
49218,",",0,1
49219,20,1,1
49220,healthy,1,1
49221,",",1,1
49222,male,1,1
49223,subjects,1,1
49224,were,0,1
49225,randomized,0,1
49226,to,0,0
49227,receive,0,0
49228,either,0,0
49229,simvastatin,0,0
49230,(,0,0
49231,80,0,1
49232,mg/d,0,0
49233,),0,1
49234,or,0,1
49235,placebo,0,0
49236,for,0,1
49237,4,0,0
49238,days,0,0
49239,before,0,1
49240,intravenous,0,1
49241,administration,0,0
49242,of,0,1
49243,LPS,0,1
49244,(,0,1
49245,20,0,1
49246,IU/kg,0,1
49247,IV,0,1
49248,),0,1
49249,.,0,1
49250,Plasma,0,0
49251,high-sensitive,0,0
49252,C-reactive,0,1
49253,protein,0,0
49254,(,0,1
49255,hsCRP,0,0
49256,),0,1
49257,",",0,0
49258,monocyte,0,0
49259,chemoattractant,0,0
49260,protein,0,0
49261,(,0,1
49262,MCP-1,0,1
49263,),0,1
49264,",",0,0
49265,sCD40L,0,0
49266,",",0,0
49267,sCD40,0,0
49268,",",0,0
49269,and,0,0
49270,prothrombin,0,0
49271,fragment,0,1
49272,F1+2,0,1
49273,(,0,1
49274,F1.2,0,1
49275,),0,1
49276,were,0,0
49277,determined,0,0
49278,by,0,0
49279,ELISAs,0,1
49280,at,0,1
49281,baseline,0,0
49282,and,0,1
49283,at,0,1
49284,4,0,0
49285,and,0,1
49286,8,0,1
49287,hours,0,0
49288,after,0,1
49289,LPS,0,1
49290,administration,0,0
49291,.,0,1
49292,Monocyte,0,0
49293,TF,0,1
49294,expression,0,0
49295,and,0,1
49296,monocyte-platelet,0,0
49297,aggregates,0,1
49298,were,0,1
49299,measured,0,0
49300,by,0,0
49301,whole-blood,0,0
49302,flow,0,0
49303,cytometry,0,0
49304,over,0,0
49305,the,0,0
49306,same,0,0
49307,time,0,0
49308,course,0,0
49309,.,0,1
49310,The,0,0
49311,increases,0,0
49312,in,0,0
49313,hsCRP,0,1
49314,and,0,1
49315,MCP-1,0,1
49316,",",0,0
49317,both,0,0
49318,known,0,1
49319,inducers,0,0
49320,of,0,1
49321,TF,0,1
49322,",",0,0
49323,were,0,0
49324,significantly,0,0
49325,suppressed,0,0
49326,by,0,0
49327,statin,0,0
49328,treatment,0,0
49329,after,0,0
49330,LPS,0,1
49331,challenge,0,0
49332,.,0,1
49333,Statin,0,0
49334,premedication,0,0
49335,blunted,0,0
49336,the,0,0
49337,increase,0,0
49338,of,0,0
49339,monocyte,0,0
49340,TF,0,1
49341,expression,0,0
49342,in,0,0
49343,response,0,0
49344,to,0,1
49345,LPS,0,0
49346,.,0,1
49347,In,0,0
49348,parallel,0,0
49349,",",0,1
49350,endotoxin-induced,0,0
49351,formation,0,0
49352,of,0,1
49353,F1.2,0,0
49354,was,0,0
49355,significantly,0,0
49356,reduced,0,0
49357,by,0,0
49358,simvastatin,0,0
49359,after,0,1
49360,4,0,0
49361,and,0,1
49362,8,0,1
49363,hours,0,0
49364,.,0,1
49365,LPS,0,0
49366,infusion,0,0
49367,affected,0,0
49368,neither,0,0
49369,the,0,0
49370,formation,0,0
49371,and,0,0
49372,activation,0,0
49373,of,0,0
49374,monocyte-platelet,0,0
49375,aggregates,0,1
49376,nor,0,1
49377,plasma,0,0
49378,levels,0,0
49379,of,0,1
49380,sCD40,0,1
49381,and,0,1
49382,sCD40L,0,1
49383,.,0,1
49384,CONCLUSIONS,0,0
49385,Simvastatin,0,0
49386,suppresses,0,0
49387,the,0,0
49388,inflammatory,0,0
49389,response,0,0
49390,to,0,0
49391,endotoxin,0,0
49392,and,0,0
49393,blunts,0,0
49394,monocyte,0,0
49395,TF,0,1
49396,expression,0,0
49397,but,0,0
49398,does,0,0
49399,not,0,0
49400,affect,0,0
49401,platelet,0,0
49402,activation,0,0
49403,.,0,1
49404,Disc,0,1
49405,coablation,0,1
49406,and,0,1
49407,epidural,0,1
49408,injection,0,0
49409,of,0,1
49410,steroids,0,0
49411,:,0,1
49412,a,0,1
49413,comparison,0,0
49414,of,0,0
49415,strategies,0,0
49416,in,0,1
49417,the,0,0
49418,treatment,0,0
49419,of,0,0
49420,mechanical,1,1
49421,spinal,1,1
49422,discogenic,1,1
49423,pain,1,1
49424,.,1,1
49425,In,0,0
49426,this,0,0
49427,study,0,1
49428,two,0,0
49429,strategies,0,0
49430,in,0,1
49431,the,0,0
49432,treatment,0,0
49433,of,0,0
49434,Mechanical,0,1
49435,Spinal,0,1
49436,Discogenic,0,1
49437,Pain,0,1
49438,have,0,0
49439,been,0,0
49440,compared,0,0
49441,:,0,1
49442,Disc,0,1
49443,Coablation,0,1
49444,and,0,1
49445,Epidural,0,1
49446,Injection,0,0
49447,of,0,1
49448,Steroids,0,1
49449,.,0,1
49450,In,1,0
49451,2003,1,1
49452,50,1,1
49453,patients,1,1
49454,treated,1,1
49455,with,1,1
49456,one,1,1
49457,or,1,1
49458,two,1,1
49459,epidural,1,1
49460,injections,1,0
49461,have,1,1
49462,been,1,0
49463,selected,1,1
49464,ad,1,1
49465,random,1,1
49466,and,1,1
49467,50,1,1
49468,patients,1,1
49469,treated,1,1
49470,with,1,1
49471,disc,1,1
49472,coablation,1,1
49473,.,1,1
49474,Comparison,0,0
49475,of,0,0
49476,the,0,0
49477,data,0,0
49478,indicated,0,0
49479,an,0,0
49480,improvement,0,0
49481,of,0,0
49482,average,0,0
49483,VAS,0,0
49484,when,0,0
49485,relaxed,0,1
49486,for,0,0
49487,both,0,0
49488,groups,0,0
49489,(,0,1
49490,p,0,0
49491,<,0,0
49492,0.01,0,0
49493,),0,1
49494,",",0,0
49495,while,0,0
49496,after,0,0
49497,slight-moderate,0,1
49498,strain,0,0
49499,",",0,0
49500,this,0,0
49501,value,0,0
49502,was,0,0
49503,significant,0,0
49504,only,0,0
49505,after,0,0
49506,coablation,0,1
49507,(,0,1
49508,p,0,0
49509,<,0,0
49510,0.001,0,0
49511,),0,1
49512,.,0,1
49513,Finally,0,0
49514,",",0,0
49515,average,0,0
49516,VAS,0,0
49517,was,0,0
49518,clearly,0,0
49519,lower,0,0
49520,(,0,0
49521,p,0,0
49522,<,0,0
49523,0.01,0,0
49524,),0,1
49525,after,0,0
49526,coablation,0,1
49527,as,0,0
49528,compared,0,0
49529,to,0,1
49530,epidural,0,1
49531,injections,0,0
49532,.,0,1
49533,Automatic,1,1
49534,detection,1,1
49535,of,1,1
49536,red,1,1
49537,lesions,1,1
49538,in,1,1
49539,digital,1,1
49540,color,1,1
49541,fundus,1,1
49542,photographs,1,0
49543,.,1,1
49544,The,0,0
49545,robust,0,0
49546,detection,0,0
49547,of,0,1
49548,red,0,1
49549,lesions,0,1
49550,in,0,1
49551,digital,1,1
49552,color,1,1
49553,fundus,1,1
49554,photographs,1,0
49555,is,0,0
49556,a,0,0
49557,critical,0,0
49558,step,0,0
49559,in,0,0
49560,the,0,0
49561,development,0,0
49562,of,0,0
49563,automated,0,0
49564,screening,0,1
49565,systems,0,0
49566,for,0,1
49567,diabetic,1,1
49568,retinopathy,1,1
49569,.,1,1
49570,In,0,0
49571,this,0,0
49572,paper,0,0
49573,",",0,0
49574,a,0,0
49575,novel,0,0
49576,red,0,1
49577,lesion,0,1
49578,detection,0,0
49579,method,0,0
49580,is,0,0
49581,presented,0,0
49582,based,0,0
49583,on,0,0
49584,a,0,1
49585,hybrid,0,1
49586,approach,0,0
49587,",",0,0
49588,combining,0,0
49589,prior,0,1
49590,works,0,0
49591,by,0,1
49592,Spencer,0,1
49593,et,0,1
49594,al,0,1
49595,.,0,1
49596,(,0,0
49597,1996,0,1
49598,),0,1
49599,and,0,1
49600,Frame,0,0
49601,et,0,1
49602,al,0,1
49603,.,0,1
49604,(,0,0
49605,1998,0,1
49606,),0,1
49607,with,0,1
49608,two,0,1
49609,important,0,0
49610,new,0,1
49611,contributions,0,0
49612,.,0,1
49613,The,0,0
49614,first,0,0
49615,contribution,0,0
49616,is,0,0
49617,a,0,0
49618,new,0,0
49619,red,0,1
49620,lesion,0,1
49621,candidate,0,1
49622,detection,0,0
49623,system,0,0
49624,based,0,1
49625,on,0,0
49626,pixel,0,1
49627,classification,0,1
49628,.,0,1
49629,Using,0,0
49630,this,0,0
49631,technique,0,0
49632,",",0,0
49633,vasculature,0,1
49634,and,0,1
49635,red,0,1
49636,lesions,0,1
49637,are,0,0
49638,separated,0,0
49639,from,0,1
49640,the,0,0
49641,background,0,0
49642,of,0,0
49643,the,0,0
49644,image,0,0
49645,.,0,1
49646,After,0,0
49647,removal,0,0
49648,of,0,0
49649,the,0,0
49650,connected,0,0
49651,vasculature,0,1
49652,the,0,0
49653,remaining,0,0
49654,objects,0,1
49655,are,0,0
49656,considered,0,0
49657,possible,0,0
49658,red,0,1
49659,lesions,0,1
49660,.,0,1
49661,Second,0,0
49662,",",0,0
49663,an,0,0
49664,extensive,0,0
49665,number,0,0
49666,of,0,1
49667,new,0,1
49668,features,0,1
49669,are,0,0
49670,added,0,0
49671,to,0,0
49672,those,0,0
49673,proposed,0,0
49674,by,0,0
49675,Spencer-Frame,0,1
49676,.,0,1
49677,The,0,0
49678,detected,0,0
49679,candidate,0,1
49680,objects,0,1
49681,are,0,0
49682,classified,0,1
49683,using,0,0
49684,all,0,1
49685,features,0,1
49686,and,0,0
49687,a,0,1
49688,k-nearest,0,0
49689,neighbor,0,1
49690,classifier,0,1
49691,.,0,1
49692,An,0,0
49693,extensive,0,0
49694,evaluation,0,0
49695,was,0,0
49696,performed,0,0
49697,on,0,0
49698,a,0,0
49699,test,0,0
49700,set,0,0
49701,composed,0,1
49702,of,0,0
49703,images,0,0
49704,representative,0,1
49705,of,0,0
49706,those,0,0
49707,normally,0,0
49708,found,0,0
49709,in,0,0
49710,a,0,0
49711,screening,0,1
49712,set,0,0
49713,.,0,0
49714,When,0,0
49715,determining,0,0
49716,whether,0,0
49717,an,0,0
49718,image,0,0
49719,contains,0,0
49720,red,0,0
49721,lesions,0,0
49722,the,0,0
49723,system,0,0
49724,achieves,0,0
49725,a,0,0
49726,sensitivity,0,0
49727,of,0,0
49728,100,0,1
49729,%,0,0
49730,at,0,0
49731,a,0,0
49732,specificity,0,0
49733,of,0,0
49734,87,0,1
49735,%,0,0
49736,.,0,1
49737,The,0,0
49738,method,0,0
49739,is,0,0
49740,compared,0,0
49741,with,0,1
49742,several,0,1
49743,different,0,1
49744,automatic,0,1
49745,systems,0,0
49746,and,0,1
49747,is,0,0
49748,shown,0,0
49749,to,0,0
49750,outperform,0,0
49751,them,0,0
49752,all,0,0
49753,.,0,0
49754,Performance,0,0
49755,is,0,0
49756,close,0,0
49757,to,0,0
49758,that,0,0
49759,of,0,0
49760,a,0,0
49761,human,0,1
49762,expert,0,1
49763,examining,0,0
49764,the,0,0
49765,images,0,0
49766,for,0,0
49767,the,0,0
49768,presence,0,0
49769,of,0,0
49770,red,0,1
49771,lesions,0,1
49772,.,0,1
49773,Efficacy,0,0
49774,of,0,0
49775,physiotherapy,0,1
49776,management,0,1
49777,of,0,0
49778,knee,1,1
49779,joint,1,1
49780,osteoarthritis,1,1
49781,:,1,1
49782,a,0,0
49783,randomised,0,0
49784,",",0,0
49785,double,0,0
49786,blind,0,1
49787,",",0,0
49788,placebo,0,0
49789,controlled,0,0
49790,trial,0,0
49791,.,0,1
49792,OBJECTIVE,0,0
49793,To,0,0
49794,determine,0,0
49795,whether,0,0
49796,a,0,0
49797,multimodal,0,0
49798,physiotherapy,0,1
49799,programme,0,1
49800,including,0,0
49801,taping,0,0
49802,",",0,1
49803,exercises,0,0
49804,",",0,0
49805,and,0,0
49806,massage,0,0
49807,is,0,0
49808,effective,0,0
49809,for,0,0
49810,knee,1,1
49811,osteoarthritis,1,1
49812,",",0,0
49813,and,0,0
49814,if,0,0
49815,benefits,0,0
49816,can,0,0
49817,be,0,0
49818,maintained,0,0
49819,with,0,1
49820,self,0,1
49821,management,0,1
49822,.,0,1
49823,METHODS,0,0
49824,Randomised,0,0
49825,",",0,0
49826,double,0,0
49827,blind,0,1
49828,",",0,0
49829,placebo,0,0
49830,controlled,0,0
49831,trial,0,1
49832,;,0,1
49833,140,1,1
49834,community,1,1
49835,volunteers,1,1
49836,with,1,1
49837,knee,1,1
49838,osteoarthritis,1,1
49839,participated,1,1
49840,and,1,1
49841,119,1,1
49842,completed,1,1
49843,the,1,0
49844,trial,1,0
49845,.,1,1
49846,Physiotherapy,0,0
49847,and,0,0
49848,placebo,0,1
49849,interventions,0,0
49850,were,0,1
49851,applied,0,0
49852,by,0,0
49853,10,0,1
49854,physiotherapists,0,1
49855,in,0,1
49856,private,0,1
49857,practices,0,1
49858,for,0,1
49859,12,0,1
49860,weeks,0,1
49861,.,0,1
49862,Physiotherapy,0,0
49863,included,0,1
49864,exercise,0,0
49865,",",0,0
49866,massage,0,0
49867,",",0,0
49868,taping,0,0
49869,",",0,0
49870,and,0,0
49871,mobilisation,0,0
49872,",",0,0
49873,followed,0,0
49874,by,0,0
49875,12,0,1
49876,weeks,0,1
49877,of,0,1
49878,self,0,1
49879,management,0,1
49880,.,0,1
49881,Placebo,0,0
49882,was,0,0
49883,sham,0,0
49884,ultrasound,0,1
49885,and,0,1
49886,light,0,0
49887,application,0,0
49888,of,0,0
49889,a,0,1
49890,non-therapeutic,0,1
49891,gel,0,0
49892,",",0,0
49893,followed,0,0
49894,by,0,0
49895,no,0,0
49896,treatment,0,0
49897,.,0,1
49898,Primary,0,1
49899,outcomes,0,0
49900,were,0,1
49901,pain,0,1
49902,measured,0,0
49903,by,0,0
49904,visual,0,0
49905,analogue,0,0
49906,scale,0,0
49907,and,0,1
49908,patient,0,1
49909,global,0,0
49910,change,0,0
49911,.,0,1
49912,Secondary,0,0
49913,measures,0,0
49914,included,0,1
49915,WOMAC,0,0
49916,",",0,0
49917,knee,0,1
49918,pain,0,1
49919,scale,0,0
49920,",",0,0
49921,SF-36,0,0
49922,",",0,0
49923,assessment,0,0
49924,of,0,0
49925,quality,0,0
49926,of,0,0
49927,life,0,1
49928,index,0,1
49929,",",0,0
49930,quadriceps,0,0
49931,strength,0,0
49932,",",0,0
49933,and,0,0
49934,balance,0,0
49935,test,0,0
49936,.,0,1
49937,RESULTS,0,0
49938,Using,0,0
49939,an,0,0
49940,intention,0,0
49941,to,0,0
49942,treat,0,1
49943,analysis,0,0
49944,",",0,0
49945,physiotherapy,1,1
49946,and,1,0
49947,placebo,1,1
49948,groups,1,0
49949,showed,0,0
49950,similar,0,0
49951,pain,0,1
49952,reductions,0,0
49953,at,0,1
49954,12,0,1
49955,weeks,0,1
49956,:,0,1
49957,-2.2,0,0
49958,cm,0,1
49959,(,0,1
49960,95,0,0
49961,%,0,0
49962,CI,0,0
49963,",",0,1
49964,-2.6,0,0
49965,to,0,0
49966,-1.7,0,0
49967,),0,0
49968,and,0,0
49969,-2.0,0,0
49970,cm,0,1
49971,(,0,1
49972,-2.5,0,0
49973,to,0,0
49974,-1.5,0,0
49975,),0,0
49976,",",0,0
49977,respectively,0,0
49978,.,0,1
49979,At,0,0
49980,24,0,1
49981,weeks,0,0
49982,",",0,1
49983,pain,0,1
49984,remained,0,0
49985,reduced,0,0
49986,from,0,1
49987,baseline,0,0
49988,in,0,1
49989,both,0,0
49990,groups,0,0
49991,:,0,1
49992,-2.1,0,0
49993,(,0,1
49994,-2.6,0,0
49995,to,0,0
49996,-1.6,0,0
49997,),0,0
49998,and,0,0
49999,-1.6,0,0
50000,(,0,1
50001,-2.2,0,0
50002,to,0,0
50003,-1.0,0,0
50004,),0,0
50005,",",0,0
50006,respectively,0,0
50007,.,0,1
50008,Global,0,0
50009,improvement,0,0
50010,was,0,0
50011,reported,0,0
50012,by,0,0
50013,70,0,1
50014,%,0,0
50015,of,0,1
50016,physiotherapy,0,1
50017,participants,0,1
50018,(,0,1
50019,51/73,0,1
50020,),0,1
50021,at,0,1
50022,12,0,1
50023,weeks,0,0
50024,and,0,1
50025,by,0,1
50026,59,0,1
50027,%,0,0
50028,(,0,1
50029,43/73,0,1
50030,),0,1
50031,at,0,1
50032,24,0,1
50033,weeks,0,1
50034,.,0,1
50035,Similarly,0,0
50036,",",0,0
50037,global,0,0
50038,improvement,0,0
50039,was,0,0
50040,reported,0,0
50041,by,0,0
50042,72,0,1
50043,%,0,0
50044,of,0,1
50045,placebo,0,1
50046,participants,0,1
50047,(,0,1
50048,48/67,0,1
50049,),0,1
50050,at,0,1
50051,12,0,1
50052,weeks,0,0
50053,and,0,1
50054,by,0,1
50055,49,0,1
50056,%,0,0
50057,(,0,1
50058,33/67,0,0
50059,),0,1
50060,at,0,1
50061,24,0,1
50062,weeks,0,0
50063,(,0,1
50064,all,0,1
50065,p,0,0
50066,>,0,0
50067,0.05,0,0
50068,),0,1
50069,.,0,1
50070,CONCLUSIONS,0,0
50071,The,0,0
50072,physiotherapy,0,0
50073,programme,0,0
50074,tested,0,0
50075,in,0,0
50076,this,0,0
50077,trial,0,0
50078,was,0,0
50079,no,0,0
50080,more,0,0
50081,effective,0,0
50082,than,0,0
50083,regular,0,1
50084,contact,0,0
50085,with,0,1
50086,a,0,0
50087,therapist,0,0
50088,at,0,0
50089,reducing,0,0
50090,pain,0,1
50091,and,0,1
50092,disability,0,1
50093,.,0,1
50094,Uterine,0,1
50095,incision,0,1
50096,closure,0,1
50097,at,0,0
50098,caesarean,0,1
50099,section,0,1
50100,:,0,1
50101,a,0,0
50102,randomised,0,0
50103,comparative,0,0
50104,study,0,1
50105,of,0,0
50106,intraperitoneal,0,0
50107,closure,0,1
50108,and,0,0
50109,closure,0,1
50110,after,0,0
50111,temporary,0,0
50112,exteriorisation,0,1
50113,.,0,1
50114,BACKGROUND,0,0
50115,The,0,0
50116,safety,0,0
50117,of,0,0
50118,the,0,0
50119,technique,0,0
50120,of,0,0
50121,uterine,0,1
50122,exteriorization,0,1
50123,at,0,1
50124,caesarean,0,1
50125,section,0,1
50126,though,0,0
50127,popular,0,0
50128,among,0,1
50129,obstetricians,0,1
50130,",",0,0
50131,remains,0,0
50132,controversial,0,0
50133,.,0,0
50134,OBJECTIVE,0,0
50135,To,0,0
50136,evaluate,0,0
50137,the,0,0
50138,influence,0,0
50139,of,0,0
50140,exteriorization,0,1
50141,of,0,0
50142,uterus,0,1
50143,during,0,1
50144,uterine,0,1
50145,repair,0,1
50146,on,0,0
50147,caesarean,0,1
50148,morbidity,0,0
50149,.,0,1
50150,METHODS,0,0
50151,A,0,1
50152,randomized,0,1
50153,comparative,0,0
50154,study,0,1
50155,of,0,1
50156,136,1,1
50157,women,1,1
50158,undergoing,1,1
50159,primary,1,1
50160,caesarean,1,1
50161,delivery,1,1
50162,at,1,1
50163,Havana,1,1
50164,Specialist,1,1
50165,Hospital,1,1
50166,Lagos,1,1
50167,Nigeria,1,1
50168,.,1,1
50169,Data,0,0
50170,on,0,0
50171,operation,0,1
50172,time,0,0
50173,",",0,0
50174,estimated,0,0
50175,blood,0,0
50176,loss,0,0
50177,",",0,1
50178,postoperative,0,0
50179,morbidities,0,1
50180,were,0,1
50181,collected,0,1
50182,and,0,0
50183,analysed,0,1
50184,with,0,1
50185,comparison,0,0
50186,between,0,0
50187,the,0,1
50188,two,0,1
50189,groups,0,0
50190,using,0,1
50191,chi,0,1
50192,square,0,0
50193,",",0,1
50194,Fischer,0,1
50195,'s,0,1
50196,exact,0,0
50197,test,0,0
50198,and,0,0
50199,t-test,0,0
50200,as,0,0
50201,appropriate,0,0
50202,.,0,1
50203,RESULTS,0,0
50204,The,0,0
50205,mean,0,0
50206,operative,0,1
50207,time,0,0
50208,",",0,0
50209,estimated,0,0
50210,blood,0,0
50211,loss,0,0
50212,",",0,0
50213,transfusion,0,0
50214,rate,0,0
50215,and,0,0
50216,postoperative,0,0
50217,anemia,0,1
50218,rate,0,0
50219,were,0,0
50220,significantly,0,0
50221,less,0,0
50222,in,0,0
50223,the,0,0
50224,exteriorized,0,1
50225,group,0,0
50226,than,0,0
50227,the,0,0
50228,intraperitoneal,0,0
50229,group,0,1
50230,(,0,1
50231,p,0,0
50232,=,0,1
50233,0.000,0,0
50234,",",0,1
50235,"0.009,0.048",0,0
50236,0.038,0,0
50237,and,0,1
50238,0.028,0,0
50239,respectively,0,0
50240,),0,0
50241,",",0,0
50242,but,0,0
50243,not,0,0
50244,in,0,0
50245,other,0,0
50246,outcome,0,0
50247,measures,0,0
50248,.,0,1
50249,CONCLUSION,0,0
50250,With,0,1
50251,shorter,0,0
50252,operative,0,1
50253,time,0,0
50254,",",0,0
50255,less,0,0
50256,blood,0,0
50257,loss,0,0
50258,and,0,0
50259,similar,0,0
50260,morbidity,0,0
50261,profile,0,0
50262,exteriorization,0,1
50263,of,0,0
50264,uterus,0,1
50265,during,0,1
50266,caesarean,0,1
50267,section,0,1
50268,seems,0,0
50269,to,0,0
50270,be,0,0
50271,preferred,0,0
50272,except,0,0
50273,where,0,0
50274,it,0,0
50275,is,0,0
50276,not,0,0
50277,possible,0,0
50278,because,0,0
50279,of,0,1
50280,adhesions,0,1
50281,and,0,1
50282,surgeons,0,1
50283,inexperience,0,0
50284,.,0,1
50285,Fulvestrant,0,0
50286,versus,0,0
50287,anastrozole,0,0
50288,for,0,0
50289,the,0,0
50290,treatment,0,0
50291,of,0,0
50292,advanced,0,1
50293,breast,0,1
50294,carcinoma,0,1
50295,:,0,1
50296,a,0,0
50297,prospectively,0,1
50298,planned,0,0
50299,combined,0,0
50300,survival,0,0
50301,analysis,0,0
50302,of,0,1
50303,two,0,1
50304,multicenter,0,1
50305,trials,0,1
50306,.,0,1
50307,BACKGROUND,0,0
50308,Fulvestrant,0,0
50309,is,0,0
50310,an,0,0
50311,estrogen,0,0
50312,receptor,0,0
50313,antagonist,0,0
50314,with,0,1
50315,no,0,0
50316,agonist,0,1
50317,effects,0,0
50318,.,0,1
50319,In,0,0
50320,the,0,0
50321,second-line,0,0
50322,treatment,0,0
50323,of,0,0
50324,advanced,0,1
50325,breast,0,1
50326,carcinoma,0,1
50327,",",0,0
50328,fulvestrant,0,0
50329,was,0,0
50330,shown,0,0
50331,previously,0,1
50332,to,0,0
50333,be,0,0
50334,as,0,0
50335,effective,0,0
50336,as,0,0
50337,the,0,0
50338,third-generation,0,1
50339,aromatase,0,0
50340,inhibitor,0,0
50341,",",0,0
50342,anastrozole,0,0
50343,",",0,0
50344,in,0,0
50345,terms,0,0
50346,of,0,1
50347,time,0,0
50348,to,0,0
50349,disease,0,1
50350,progression,0,0
50351,and,0,0
50352,objective,0,0
50353,response,0,0
50354,rates,0,0
50355,.,0,1
50356,The,0,0
50357,authors,0,0
50358,reported,0,0
50359,the,0,0
50360,overall,0,0
50361,survival,0,0
50362,results,0,0
50363,from,0,1
50364,these,0,1
50365,studies,0,0
50366,.,0,1
50367,METHODS,0,0
50368,A,0,0
50369,prospectively,0,1
50370,planned,0,0
50371,",",0,0
50372,combined,0,0
50373,",",0,0
50374,overall,0,0
50375,survival,0,0
50376,analysis,0,0
50377,was,0,0
50378,performed,0,0
50379,",",0,0
50380,including,0,0
50381,data,0,0
50382,from,0,1
50383,two,0,1
50384,Phase,0,1
50385,III,0,1
50386,trials,0,1
50387,that,0,0
50388,compared,0,0
50389,the,0,0
50390,efficacy,0,0
50391,and,0,0
50392,tolerability,0,0
50393,of,0,0
50394,fulvestrant,0,1
50395,(,0,1
50396,250,0,0
50397,mg,0,1
50398,monthly,0,0
50399,;,0,0
50400,n,0,1
50401,=,0,1
50402,428,0,1
50403,),0,1
50404,with,0,1
50405,anastrozole,0,0
50406,(,0,1
50407,1,0,1
50408,mg,0,1
50409,daily,0,0
50410,;,0,0
50411,n,0,1
50412,=,0,1
50413,423,0,1
50414,),0,0
50415,in,0,0
50416,the,0,0
50417,treatment,0,0
50418,of,0,0
50419,postmenopausal,1,1
50420,women,1,1
50421,with,1,1
50422,advanced,1,1
50423,breast,1,1
50424,carcinoma,1,1
50425,who,1,1
50426,had,1,1
50427,disease,1,1
50428,progression,1,0
50429,after,1,0
50430,receipt,1,1
50431,of,1,0
50432,previous,1,1
50433,endocrine,1,1
50434,treatment,1,1
50435,.,1,1
50436,RESULTS,0,0
50437,At,0,0
50438,an,0,1
50439,extended,0,1
50440,median,0,0
50441,follow-up,0,1
50442,of,0,1
50443,27.0,0,1
50444,months,0,1
50445,(,0,1
50446,range,0,1
50447,",",0,1
50448,0-66.9,0,0
50449,months,0,0
50450,),0,1
50451,",",0,1
50452,319,1,1
50453,(,1,1
50454,74.5,1,1
50455,%,1,0
50456,),1,1
50457,patients,1,1
50458,in,1,1
50459,the,1,1
50460,fulvestrant,1,0
50461,group,1,1
50462,and,1,1
50463,322,1,1
50464,(,1,1
50465,76.1,1,0
50466,%,1,0
50467,),1,1
50468,patients,1,1
50469,in,1,1
50470,the,1,1
50471,anastrozole,1,0
50472,group,1,1
50473,had,0,1
50474,died,0,1
50475,.,0,1
50476,Prolonged,0,0
50477,survival,0,0
50478,was,0,0
50479,observed,0,0
50480,with,0,1
50481,both,0,0
50482,drugs,0,0
50483,",",0,0
50484,with,0,1
50485,10-20,0,0
50486,%,0,0
50487,of,0,0
50488,patients,0,1
50489,still,0,1
50490,alive,0,1
50491,>,0,1
50492,5,0,1
50493,years,0,1
50494,after,0,1
50495,randomization,0,1
50496,.,0,1
50497,The,0,0
50498,median,0,0
50499,overall,0,0
50500,survival,0,0
50501,was,0,0
50502,similar,0,0
50503,between,0,0
50504,treatments,0,0
50505,",",0,1
50506,being,0,1
50507,27.4,0,1
50508,months,0,1
50509,and,0,1
50510,27.7,0,1
50511,months,0,0
50512,in,0,1
50513,fulvestrant,0,1
50514,and,0,1
50515,anastrozole-treated,0,1
50516,patients,0,1
50517,",",0,1
50518,respectively,0,0
50519,(,0,0
50520,hazards,0,0
50521,ratio,0,0
50522,",",0,1
50523,0.98,0,0
50524,;,0,1
50525,95,0,0
50526,%,0,0
50527,confidence,0,0
50528,interval,0,0
50529,",",0,1
50530,0.84-1.15,0,0
50531,;,0,1
50532,P,0,0
50533,=,0,1
50534,0.809,0,0
50535,),0,1
50536,.,0,1
50537,Fulvestrant,0,0
50538,continued,0,0
50539,to,0,0
50540,be,0,0
50541,well,0,0
50542,tolerated,0,0
50543,",",0,0
50544,and,0,0
50545,was,0,0
50546,associated,0,0
50547,with,0,1
50548,a,0,0
50549,significantly,0,0
50550,lower,0,0
50551,incidence,0,0
50552,of,0,0
50553,joint,0,1
50554,disorders,0,1
50555,compared,0,0
50556,with,0,1
50557,anastrozole,0,0
50558,(,0,1
50559,P,0,0
50560,=,0,1
50561,0.0234,0,0
50562,),0,1
50563,.,0,1
50564,CONCLUSIONS,0,0
50565,The,0,0
50566,current,0,0
50567,analysis,0,0
50568,showed,0,0
50569,that,0,0
50570,fulvestrant,0,1
50571,was,0,0
50572,similar,0,0
50573,to,0,0
50574,anastrozole,0,0
50575,with,0,1
50576,respect,0,0
50577,to,0,1
50578,overall,0,0
50579,survival,0,0
50580,in,0,0
50581,the,0,0
50582,second-line,0,0
50583,treatment,0,0
50584,of,0,1
50585,postmenopausal,1,1
50586,women,1,1
50587,with,1,1
50588,advanced,1,1
50589,breast,1,1
50590,carcinoma,1,1
50591,.,1,1
50592,Efficacy,0,0
50593,of,0,0
50594,rofecoxib,0,0
50595,",",0,0
50596,celecoxib,0,0
50597,",",0,0
50598,and,0,0
50599,acetaminophen,0,0
50600,in,0,0
50601,patients,1,1
50602,with,1,1
50603,osteoarthritis,1,1
50604,of,1,0
50605,the,1,0
50606,knee,1,1
50607,.,1,0
50608,A,0,0
50609,combined,0,0
50610,analysis,0,0
50611,of,0,0
50612,the,0,0
50613,VACT,0,0
50614,studies,0,0
50615,.,0,1
50616,OBJECTIVE,0,0
50617,To,0,0
50618,compare,0,0
50619,efficacy,0,0
50620,among,0,1
50621,1578,1,1
50622,patients,1,1
50623,with,1,1
50624,osteoarthritis,1,1
50625,randomized,0,1
50626,to,0,0
50627,take,0,0
50628,acetaminophen,0,0
50629,4000,0,0
50630,mg,0,0
50631,(,0,1
50632,n=269,0,1
50633,),0,1
50634,",",0,1
50635,celecoxib,0,0
50636,200,0,1
50637,mg,0,0
50638,(,0,1
50639,n=523,0,1
50640,),0,0
50641,",",0,0
50642,rofecoxib,0,0
50643,12.5,0,0
50644,mg,0,0
50645,(,0,1
50646,n=259,0,1
50647,),0,1
50648,",",0,0
50649,or,0,1
50650,rofecoxib,0,0
50651,25,0,1
50652,mg,0,0
50653,(,0,1
50654,n=527,0,1
50655,),0,1
50656,in,0,0
50657,a,0,1
50658,double,0,0
50659,blind,0,1
50660,trial,0,1
50661,[,0,0
50662,Vioxx,0,1
50663,",",0,0
50664,Acetaminophen,0,0
50665,",",0,0
50666,Celecoxib,0,0
50667,Trial,0,1
50668,(,0,1
50669,VACT2,0,0
50670,),0,1
50671,],0,1
50672,.,0,1
50673,Results,0,0
50674,were,0,0
50675,also,0,0
50676,pooled,0,0
50677,with,0,1
50678,the,0,0
50679,similarly,0,0
50680,designed,0,0
50681,VACT1,0,0
50682,trial,0,1
50683,.,0,1
50684,METHODS,0,0
50685,Patients,0,1
50686,evaluated,0,1
50687,over,0,1
50688,Days,0,1
50689,1,0,1
50690,to,0,1
50691,6,0,1
50692,and,0,1
50693,6,0,1
50694,weeks,0,0
50695,with,0,1
50696,Patient,0,1
50697,Global,0,1
50698,Assessment,0,0
50699,of,0,1
50700,Response,0,0
50701,to,0,1
50702,Therapy,0,1
50703,(,0,1
50704,PGART,0,0
50705,),0,1
50706,and,0,1
50707,Western,0,1
50708,Ontario,0,1
50709,and,0,1
50710,McMaster,0,1
50711,Universities,0,1
50712,(,0,1
50713,WOMAC,0,0
50714,),0,1
50715,Osteoarthritis,0,1
50716,Index,0,1
50717,.,0,1
50718,RESULTS,0,0
50719,For,0,1
50720,VACT2,0,0
50721,",",0,1
50722,median,0,0
50723,time,0,0
50724,to,0,1
50725,good,0,0
50726,or,0,1
50727,excellent,0,0
50728,PGART,0,0
50729,response,0,0
50730,was,0,0
50731,6,0,0
50732,",",0,1
50733,5,0,0
50734,",",0,0
50735,4,0,0
50736,",",0,0
50737,and,0,1
50738,3,0,1
50739,days,0,0
50740,for,0,1
50741,acetaminophen,0,0
50742,",",0,0
50743,celecoxib,0,0
50744,",",0,0
50745,rofecoxib,0,0
50746,12.5,0,0
50747,mg,0,0
50748,",",0,0
50749,and,0,0
50750,rofecoxib,0,0
50751,25,0,0
50752,mg,0,0
50753,(,0,1
50754,COX-2,0,1
50755,inhibitors,0,1
50756,vs,0,0
50757,acetaminophen,0,0
50758,",",0,0
50759,p,0,0
50760,<,0,0
50761,or=0.035,0,0
50762,;,0,1
50763,rofecoxib,0,0
50764,25,0,1
50765,mg,0,0
50766,vs,0,0
50767,celecoxib,0,0
50768,",",0,0
50769,p=0.01,0,0
50770,),0,1
50771,.,0,1
50772,WOMAC,0,0
50773,response,0,0
50774,over,0,0
50775,the,0,0
50776,first,0,1
50777,6,0,1
50778,days,0,0
50779,was,0,0
50780,greater,0,0
50781,(,0,1
50782,p,0,0
50783,<,0,0
50784,0.05,0,0
50785,),0,1
50786,with,0,1
50787,both,0,0
50788,rofecoxib,0,0
50789,doses,0,0
50790,than,0,0
50791,acetaminophen,0,0
50792,and,0,1
50793,celecoxib,0,0
50794,.,0,1
50795,At,0,0
50796,Week,0,1
50797,6,0,0
50798,",",0,0
50799,all,0,0
50800,COX-2,0,1
50801,inhibitors,0,0
50802,provided,0,0
50803,significantly,0,0
50804,greater,0,0
50805,efficacy,0,0
50806,than,0,0
50807,acetaminophen,0,0
50808,.,0,1
50809,Good,0,1
50810,or,0,1
50811,excellent,0,0
50812,PGART,0,0
50813,was,0,0
50814,numerically,0,0
50815,",",0,0
50816,but,0,0
50817,not,0,0
50818,significantly,0,0
50819,",",0,0
50820,greater,0,0
50821,with,0,1
50822,rofecoxib,0,0
50823,25,0,1
50824,mg,0,1
50825,(,0,1
50826,55.4,0,1
50827,%,0,0
50828,),0,1
50829,than,0,0
50830,celecoxib,0,1
50831,(,0,1
50832,50.6,0,0
50833,%,0,0
50834,),0,1
50835,at,0,1
50836,Week,0,1
50837,6,0,1
50838,;,0,1
50839,a,0,1
50840,significant,0,0
50841,difference,0,0
50842,was,0,0
50843,seen,0,0
50844,at,0,1
50845,Weeks,0,0
50846,2,0,1
50847,(,0,1
50848,6.9,0,0
50849,",",0,1
50850,p=0.022,0,0
50851,),0,1
50852,and,0,1
50853,4,0,0
50854,(,0,1
50855,6.7,0,0
50856,",",0,1
50857,p=0.027,0,0
50858,),0,0
50859,and,0,1
50860,over,0,0
50861,6,0,1
50862,weeks,0,1
50863,with,0,1
50864,analysis,0,0
50865,of,0,0
50866,all,0,1
50867,5,0,1
50868,PGART,0,0
50869,categories,0,1
50870,of,0,1
50871,response,0,0
50872,(,0,1
50873,p=0.035,0,0
50874,),0,1
50875,.,0,1
50876,Rofecoxib,0,0
50877,25,0,1
50878,mg,0,0
50879,provided,0,0
50880,greater,0,0
50881,response,0,0
50882,(,0,0
50883,p,0,0
50884,<,0,0
50885,0.05,0,0
50886,),0,1
50887,than,0,0
50888,celecoxib,0,1
50889,on,0,1
50890,WOMAC,0,0
50891,subscales,0,0
50892,.,0,1
50893,Pooled,0,0
50894,analysis,0,0
50895,of,0,0
50896,VACT1/VACT2,0,0
50897,demonstrated,0,0
50898,greater,0,0
50899,PGART,0,0
50900,(,0,0
50901,p=0.023,0,0
50902,),0,1
50903,with,0,1
50904,rofecoxib,0,0
50905,25,0,1
50906,mg,0,1
50907,(,0,1
50908,56.1,0,1
50909,%,0,0
50910,),0,1
50911,than,0,0
50912,celecoxib,0,1
50913,(,0,1
50914,49.8,0,1
50915,%,0,0
50916,),0,1
50917,at,0,1
50918,6,0,1
50919,weeks,0,0
50920,and,0,1
50921,greater,0,0
50922,response,0,0
50923,to,0,0
50924,all,0,0
50925,other,0,0
50926,PGART,0,0
50927,and,0,1
50928,WOMAC,0,0
50929,endpoints,0,0
50930,",",0,1
50931,and,0,0
50932,confirmed,0,0
50933,superiority,0,0
50934,of,0,1
50935,COX-2,0,1
50936,inhibitors,0,0
50937,to,0,1
50938,acetaminophen,0,0
50939,.,0,1
50940,Overall,0,0
50941,",",0,0
50942,tolerability,0,0
50943,of,0,0
50944,the,0,0
50945,study,0,1
50946,medications,0,0
50947,was,0,0
50948,generally,0,1
50949,good,0,0
50950,and,0,1
50951,similar,0,0
50952,.,0,0
50953,There,0,0
50954,was,0,0
50955,no,0,0
50956,significant,0,0
50957,difference,0,0
50958,between,0,0
50959,treatment,0,1
50960,groups,0,0
50961,in,0,0
50962,the,0,0
50963,percentage,0,0
50964,of,0,1
50965,patients,0,1
50966,who,0,1
50967,experienced,0,1
50968,a,0,1
50969,clinical,0,0
50970,adverse,0,0
50971,experience,0,1
50972,(,0,1
50973,AE,0,0
50974,),0,1
50975,.,0,1
50976,The,0,0
50977,incidence,0,0
50978,of,0,0
50979,discontinuations,0,0
50980,due,0,1
50981,to,0,1
50982,an,0,1
50983,AE,0,0
50984,was,0,0
50985,significantly,0,0
50986,lower,0,0
50987,with,0,1
50988,celecoxib,0,0
50989,(,0,1
50990,2.5,0,0
50991,%,0,0
50992,),0,1
50993,compared,0,0
50994,to,0,1
50995,rofecoxib,0,0
50996,25,0,1
50997,mg,0,0
50998,(,0,1
50999,6.3,0,0
51000,%,0,0
51001,",",0,0
51002,p=0.004,0,0
51003,),0,0
51004,or,0,1
51005,acetaminophen,0,0
51006,(,0,1
51007,7.8,0,0
51008,%,0,0
51009,",",0,0
51010,p,0,0
51011,<,0,0
51012,0.001,0,0
51013,),0,1
51014,",",0,0
51015,and,0,0
51016,did,0,0
51017,not,0,0
51018,differ,0,0
51019,significantly,0,0
51020,from,0,1
51021,rofecoxib,0,0
51022,12.5,0,0
51023,mg,0,1
51024,(,0,1
51025,4.6,0,1
51026,%,0,0
51027,),0,1
51028,.,0,1
51029,Discontinuation,0,0
51030,rates,0,0
51031,due,0,1
51032,to,0,1
51033,edema,0,1
51034,and,0,0
51035,hypertension,0,1
51036,related,0,0
51037,AE,0,0
51038,were,0,1
51039,similar,0,0
51040,among,0,1
51041,all,0,1
51042,COX-2,0,1
51043,inhibitors,0,0
51044,.,0,1
51045,CONCLUSION,0,0
51046,Rofecoxib,0,0
51047,and,0,1
51048,celecoxib,0,0
51049,provided,0,0
51050,superior,0,0
51051,efficacy,0,0
51052,to,0,0
51053,acetaminophen,0,0
51054,.,0,0
51055,There,0,0
51056,was,0,0
51057,a,0,0
51058,more,0,0
51059,rapid,0,0
51060,and,0,0
51061,greater,0,0
51062,response,0,0
51063,with,0,1
51064,rofecoxib,0,0
51065,25,0,1
51066,mg,0,1
51067,than,0,0
51068,celecoxib,0,1
51069,200,0,1
51070,mg.,0,1
51071,Rofecoxib,0,0
51072,12.5,0,0
51073,mg,0,0
51074,demonstrated,0,0
51075,greater,0,0
51076,efficacy,0,0
51077,than,0,0
51078,celecoxib,0,1
51079,200,0,1
51080,mg,0,0
51081,over,0,0
51082,the,0,0
51083,first,0,1
51084,6,0,0
51085,days,0,0
51086,",",0,1
51087,and,0,0
51088,was,0,0
51089,similar,0,0
51090,over,0,1
51091,6,0,1
51092,weeks,0,1
51093,.,0,1
51094,All,0,1
51095,study,0,0
51096,medications,0,0
51097,were,0,1
51098,generally,0,0
51099,well,0,0
51100,tolerated,0,0
51101,.,0,1
51102,Combined,0,0
51103,therapy,0,0
51104,for,0,0
51105,obese,1,1
51106,type,1,1
51107,2,1,1
51108,diabetes,1,1
51109,:,1,1
51110,suppertime,0,1
51111,mixed,0,0
51112,insulin,0,1
51113,with,0,1
51114,daytime,0,0
51115,sulfonylurea,0,1
51116,.,0,1
51117,Combined,0,0
51118,insulin,0,0
51119,and,0,0
51120,sulfonylurea,0,0
51121,therapy,0,0
51122,for,0,1
51123,type,0,1
51124,2,0,1
51125,diabetes,0,1
51126,may,0,0
51127,improve,0,0
51128,the,0,0
51129,effectiveness,0,0
51130,of,0,0
51131,a,0,1
51132,single,0,0
51133,injection,0,0
51134,of,0,0
51135,insulin,0,0
51136,",",0,0
51137,thereby,0,0
51138,postponing,0,0
51139,the,0,0
51140,need,0,0
51141,for,0,0
51142,multiple,0,1
51143,injections,0,0
51144,.,0,1
51145,This,0,0
51146,concept,0,0
51147,was,0,0
51148,tested,0,0
51149,in,0,1
51150,21,1,1
51151,obese,1,1
51152,subjects,1,1
51153,imperfectly,1,1
51154,controlled,1,0
51155,by,1,0
51156,20,1,1
51157,mg,1,1
51158,of,1,1
51159,glyburide,1,1
51160,daily,1,0
51161,in,0,1
51162,a,0,1
51163,double,0,0
51164,masked,0,0
51165,",",0,0
51166,placebo-controlled,0,0
51167,",",0,0
51168,parallel,0,0
51169,design,0,1
51170,",",0,0
51171,16-week,0,1
51172,protocol,0,1
51173,.,0,1
51174,Premixed,0,0
51175,70,0,1
51176,%,0,0
51177,NPH/30,0,0
51178,%,0,0
51179,Regular,0,1
51180,insulin,0,0
51181,was,0,0
51182,taken,0,0
51183,before,0,0
51184,supper,0,0
51185,",",0,0
51186,and,0,0
51187,the,0,0
51188,dosage,0,0
51189,was,0,0
51190,adjusted,0,0
51191,weekly,0,0
51192,by,0,0
51193,an,0,0
51194,algorithm,0,0
51195,seeking,0,1
51196,nearly,0,1
51197,normal,0,1
51198,fasting,0,0
51199,glycemia,0,1
51200,.,0,1
51201,Eleven,1,1
51202,subjects,1,1
51203,using,1,1
51204,insulin,1,1
51205,plus,1,0
51206,10,1,1
51207,mg,1,0
51208,glyburide,1,1
51209,before,0,1
51210,breakfast,0,0
51211,had,0,1
51212,lower,0,0
51213,mean,0,1
51214,fasting,0,0
51215,glucose,0,0
51216,at,0,1
51217,10-16,0,1
51218,weeks,0,1
51219,than,0,1
51220,10,0,1
51221,subjects,0,1
51222,using,0,0
51223,insulin,0,1
51224,with,0,1
51225,placebo,0,0
51226,(,0,1
51227,mean,0,1
51228,+/-,0,1
51229,SEM,0,1
51230,;,0,1
51231,5.9,0,1
51232,+/-,0,0
51233,0.3,0,0
51234,versus,0,0
51235,7.5,0,1
51236,+/-,0,0
51237,0.7,0,0
51238,mmol/L,0,0
51239,;,0,0
51240,p,0,0
51241,less,0,0
51242,than,0,0
51243,0.05,0,0
51244,),0,1
51245,",",0,0
51246,and,0,0
51247,had,0,0
51248,a,0,0
51249,greater,0,0
51250,decrement,0,0
51251,of,0,0
51252,glycosylated,0,0
51253,hemoglobin,0,0
51254,from,0,1
51255,baseline,0,0
51256,values,0,0
51257,(,0,1
51258,1.3,0,1
51259,+/-,0,1
51260,0.1,0,1
51261,versus,0,0
51262,0.8,0,1
51263,+/-,0,0
51264,0.2,0,1
51265,%,0,0
51266,A1,0,0
51267,",",0,0
51268,p,0,0
51269,less,0,0
51270,than,0,0
51271,0.05,0,0
51272,),0,1
51273,.,0,1
51274,After,0,0
51275,16,0,1
51276,weeks,0,0
51277,the,0,1
51278,combined,0,0
51279,therapy,0,0
51280,group,0,1
51281,used,0,0
51282,half,0,1
51283,as,0,0
51284,much,0,0
51285,insulin,0,1
51286,as,0,0
51287,the,0,0
51288,insulin-only,0,1
51289,group,0,1
51290,(,0,1
51291,50,0,1
51292,+/-,0,1
51293,5,0,1
51294,versus,0,0
51295,101,0,1
51296,+/-,0,0
51297,13,0,1
51298,units/d,0,0
51299,;,0,0
51300,p,0,0
51301,less,0,0
51302,than,0,0
51303,0.01,0,0
51304,),0,1
51305,.,0,1
51306,Fasting,0,0
51307,serum,0,0
51308,free,0,1
51309,insulin,0,1
51310,values,0,0
51311,increased,0,0
51312,58,0,1
51313,%,0,0
51314,from,0,1
51315,baseline,0,0
51316,after,0,0
51317,insulin,0,0
51318,therapy,0,0
51319,in,0,0
51320,the,0,0
51321,insulin-only,0,1
51322,group,0,0
51323,(,0,0
51324,p,0,0
51325,less,0,0
51326,than,0,0
51327,0.05,0,0
51328,),0,1
51329,but,0,0
51330,did,0,0
51331,not,0,0
51332,increase,0,0
51333,with,0,1
51334,combined,0,0
51335,therapy,0,1
51336,.,0,1
51337,Weight,0,1
51338,gain,0,0
51339,was,0,0
51340,similar,0,0
51341,in,0,0
51342,the,0,1
51343,two,0,1
51344,groups,0,0
51345,.,0,1
51346,These,0,1
51347,data,0,0
51348,support,0,0
51349,this,0,0
51350,form,0,0
51351,of,0,0
51352,combined,0,0
51353,therapy,0,1
51354,as,0,0
51355,one,0,1
51356,option,0,0
51357,for,0,0
51358,treating,0,1
51359,obese,1,1
51360,persons,1,1
51361,with,1,1
51362,type,1,1
51363,2,1,1
51364,diabetes,1,1
51365,no,0,0
51366,longer,0,0
51367,responsive,0,0
51368,to,0,0
51369,oral,0,0
51370,therapy,0,0
51371,alone,0,1
51372,.,0,1
51373,Lanthanum,0,0
51374,carbonate,0,0
51375,(,0,1
51376,Fosrenol,0,1
51377,),0,1
51378,efficacy,0,0
51379,and,0,0
51380,tolerability,0,0
51381,in,0,0
51382,the,0,0
51383,treatment,0,0
51384,of,0,0
51385,hyperphosphatemic,1,1
51386,patients,1,1
51387,with,1,1
51388,end-stage,1,1
51389,renal,1,1
51390,disease,1,1
51391,.,1,1
51392,AIMS,0,0
51393,High,0,0
51394,serum,0,0
51395,phosphorus,0,1
51396,levels,0,0
51397,are,0,0
51398,a,0,0
51399,common,0,0
51400,problem,0,1
51401,in,0,1
51402,patients,1,1
51403,receiving,1,1
51404,long-term,1,0
51405,dialysis,1,1
51406,treatment,1,1
51407,.,1,1
51408,Lanthanum,0,0
51409,carbonate,0,0
51410,(,0,1
51411,Fosrenol,0,0
51412,),0,0
51413,is,0,0
51414,a,0,0
51415,new,0,0
51416,non-aluminum,0,0
51417,",",0,1
51418,non-calcium,0,0
51419,phosphate,0,0
51420,binder,0,0
51421,developed,0,1
51422,for,0,0
51423,the,0,0
51424,treatment,0,0
51425,of,0,0
51426,hyperphosphatemia,0,0
51427,in,0,1
51428,patients,1,1
51429,with,1,1
51430,end-stage,1,1
51431,renal,1,1
51432,disease,1,1
51433,(,1,1
51434,ESRD,1,1
51435,),1,1
51436,.,1,1
51437,We,0,0
51438,report,0,0
51439,data,0,0
51440,from,0,1
51441,a,0,1
51442,recent,0,1
51443,trial,0,0
51444,",",0,0
51445,which,0,0
51446,",",0,0
51447,for,0,0
51448,the,0,0
51449,first,0,0
51450,time,0,0
51451,",",0,0
51452,assessed,0,0
51453,the,0,0
51454,efficacy,0,0
51455,and,0,0
51456,tolerability,0,0
51457,of,0,0
51458,lanthanum,0,0
51459,carbonate,0,0
51460,treatment,0,0
51461,",",0,0
51462,compared,0,0
51463,with,0,1
51464,placebo,0,0
51465,",",0,0
51466,in,0,0
51467,Chinese,1,1
51468,patients,1,1
51469,with,1,1
51470,ESRD,1,1
51471,.,1,1
51472,PATIENTS,0,0
51473,AND,0,0
51474,METHODS,0,0
51475,Following,0,1
51476,a,0,1
51477,one-,0,0
51478,to,0,0
51479,three-week,0,1
51480,washout,0,0
51481,phase,0,1
51482,and,0,0
51483,a,0,0
51484,four-week,0,0
51485,",",0,0
51486,open-label,0,1
51487,lanthanum,0,0
51488,carbonate,0,0
51489,dose-titration,0,0
51490,phase,0,0
51491,",",0,0
51492,male,1,1
51493,and,1,0
51494,female,1,1
51495,hemodialysis,1,1
51496,patients,1,1
51497,were,0,1
51498,randomized,0,1
51499,(,0,1
51500,1:1,0,1
51501,),0,1
51502,to,0,0
51503,receive,0,1
51504,either,0,0
51505,lanthanum,0,0
51506,carbonate,0,0
51507,or,0,1
51508,placebo,0,0
51509,for,0,1
51510,four,0,1
51511,weeks,0,1
51512,.,0,1
51513,The,0,0
51514,primary,0,0
51515,efficacy,0,0
51516,parameter,0,0
51517,of,0,0
51518,the,0,0
51519,study,0,0
51520,was,0,0
51521,the,0,0
51522,control,0,0
51523,of,0,0
51524,serum,0,0
51525,phosphorus,0,1
51526,levels,0,0
51527,(,0,1
51528,<,0,0
51529,or,0,1
51530,=1.8,0,0
51531,mmol/l,0,0
51532,[,0,0
51533,<,0,0
51534,or,0,1
51535,=,0,1
51536,5.6,0,0
51537,mg/dl,0,0
51538,],0,1
51539,),0,1
51540,.,0,1
51541,Secondary,0,0
51542,endpoints,0,0
51543,included,0,1
51544,the,0,0
51545,profile,0,0
51546,of,0,0
51547,serum,0,0
51548,phosphorus,0,1
51549,during,0,0
51550,titration,0,0
51551,and,0,1
51552,parathyroid,0,0
51553,hormone,0,0
51554,",",0,0
51555,calcium,0,0
51556,",",0,0
51557,and,0,0
51558,calcium,0,0
51559,x,0,1
51560,phosphorus,0,1
51561,(,0,1
51562,Ca,0,1
51563,x,0,1
51564,P,0,0
51565,),0,1
51566,product,0,0
51567,levels,0,0
51568,.,0,1
51569,The,0,0
51570,safety,0,0
51571,and,0,0
51572,tolerability,0,0
51573,of,0,0
51574,lanthanum,0,0
51575,carbonate,0,0
51576,were,0,0
51577,assessed,0,0
51578,by,0,0
51579,monitoring,0,0
51580,adverse,0,0
51581,events,0,0
51582,throughout,0,0
51583,the,0,1
51584,study,0,1
51585,.,0,1
51586,RESULTS,0,0
51587,Mean,0,1
51588,serum,0,0
51589,phosphorus,0,0
51590,level,0,0
51591,at,0,0
51592,the,0,0
51593,end,0,0
51594,of,0,0
51595,washout,0,0
51596,was,0,0
51597,2.5,0,0
51598,+/-,0,0
51599,0.5,0,0
51600,mmol/l,0,0
51601,(,0,1
51602,7.7,0,0
51603,+/-,0,1
51604,1.5,0,1
51605,mg/dl,0,0
51606,;,0,1
51607,n=73,1,1
51608,),1,0
51609,",",0,0
51610,and,0,0
51611,there,0,0
51612,was,0,0
51613,no,0,0
51614,evidence,0,0
51615,of,0,0
51616,a,0,0
51617,difference,0,0
51618,in,0,0
51619,levels,0,0
51620,between,0,0
51621,the,0,1
51622,treatment,0,0
51623,groups,0,0
51624,pre-randomization,0,1
51625,.,0,1
51626,At,0,0
51627,the,0,0
51628,end,0,0
51629,of,0,0
51630,the,0,0
51631,study,0,0
51632,",",0,0
51633,lanthanum,0,0
51634,carbonate-treated,0,1
51635,patients,0,1
51636,had,0,1
51637,significantly,0,0
51638,lower,0,0
51639,phosphorus,0,1
51640,levels,0,0
51641,(,0,1
51642,1.6,0,1
51643,+/-,0,1
51644,0.5,0,0
51645,mmol/l,0,0
51646,[,0,1
51647,5.1,0,0
51648,+/-,0,0
51649,1.5,0,1
51650,mg/dl,0,0
51651,],0,1
51652,;,0,1
51653,n=30,1,1
51654,),1,0
51655,than,0,0
51656,those,0,1
51657,receiving,0,1
51658,placebo,0,0
51659,(,0,1
51660,2.3,0,1
51661,+/-,0,1
51662,0.4,0,1
51663,mmol/l,0,0
51664,[,0,1
51665,7.2,0,1
51666,+/-,0,0
51667,1.3,0,0
51668,mg/dl,0,0
51669,],0,1
51670,;,0,1
51671,n=31,1,1
51672,;,1,0
51673,p,0,0
51674,<,0,0
51675,0.001,0,0
51676,),0,1
51677,.,0,1
51678,In,0,0
51679,addition,0,0
51680,",",0,0
51681,a,0,0
51682,significantly,0,0
51683,higher,0,0
51684,proportion,0,1
51685,of,0,0
51686,patients,0,1
51687,receiving,0,1
51688,lanthanum,0,0
51689,carbonate,0,0
51690,had,0,1
51691,controlled,0,0
51692,serum,0,0
51693,phosphorus,0,1
51694,levels,0,0
51695,(,0,1
51696,60,0,1
51697,%,0,0
51698,),0,1
51699,compared,0,0
51700,with,0,1
51701,the,0,0
51702,placebo,0,0
51703,group,0,1
51704,(,0,1
51705,10,0,1
51706,%,0,0
51707,;,0,0
51708,p,0,0
51709,<,0,0
51710,0.001,0,0
51711,),0,1
51712,.,0,1
51713,Ca,0,0
51714,x,0,1
51715,P,0,0
51716,product,0,0
51717,levels,0,0
51718,were,0,1
51719,also,0,0
51720,significantly,0,0
51721,lower,0,0
51722,in,0,0
51723,the,0,0
51724,lanthanum,0,0
51725,carbonate,0,0
51726,group,0,1
51727,at,0,0
51728,the,0,0
51729,end,0,0
51730,of,0,0
51731,randomized,0,1
51732,treatment,0,1
51733,(,0,1
51734,p,0,0
51735,<,0,0
51736,0.001,0,0
51737,),0,1
51738,.,0,1
51739,Lanthanum,0,0
51740,carbonate,0,0
51741,was,0,0
51742,well,0,0
51743,tolerated,0,0
51744,;,0,0
51745,only,0,0
51746,one,0,1
51747,serious,0,0
51748,adverse,0,0
51749,event,0,0
51750,was,0,0
51751,reported,0,0
51752,",",0,0
51753,which,0,0
51754,was,0,0
51755,unrelated,0,1
51756,to,0,1
51757,treatment,0,1
51758,.,0,1
51759,CONCLUSIONS,0,0
51760,Lanthanum,0,0
51761,carbonate,0,0
51762,was,0,0
51763,shown,0,0
51764,to,0,0
51765,be,0,0
51766,an,0,0
51767,effective,0,0
51768,and,0,0
51769,well-tolerated,0,0
51770,phosphate,0,0
51771,binder,0,0
51772,for,0,0
51773,the,0,0
51774,treatment,0,0
51775,of,0,0
51776,hyperphosphatemia,0,0
51777,in,0,1
51778,Chinese,1,1
51779,patients,1,1
51780,with,1,1
51781,ESRD,1,1
51782,.,1,1
51783,This,0,0
51784,finding,0,0
51785,supports,0,0
51786,the,0,0
51787,results,0,0
51788,of,0,0
51789,previous,0,1
51790,US,0,1
51791,and,0,1
51792,European,0,1
51793,studies,0,0
51794,",",0,0
51795,which,0,0
51796,have,0,0
51797,also,0,0
51798,shown,0,0
51799,that,0,0
51800,lanthanum,0,0
51801,carbonate,0,0
51802,treatment,0,0
51803,effectively,0,0
51804,controls,0,1
51805,serum,0,0
51806,phosphorus,0,0
51807,levels,0,1
51808,.,0,1
51809,The,0,0
51810,effect,0,0
51811,of,0,0
51812,venlafaxine,0,0
51813,on,0,0
51814,ongoing,0,0
51815,and,0,0
51816,experimentally,0,1
51817,induced,0,0
51818,pain,0,1
51819,in,0,1
51820,neuropathic,1,1
51821,pain,1,1
51822,patients,1,1
51823,:,1,1
51824,a,0,1
51825,double,0,0
51826,blind,0,1
51827,",",0,0
51828,placebo,0,0
51829,controlled,0,0
51830,study,0,1
51831,.,0,1
51832,BACKGROUND,0,0
51833,AND,0,0
51834,AIM,0,0
51835,The,0,0
51836,aim,0,0
51837,of,0,0
51838,this,0,0
51839,randomized,0,1
51840,double,0,0
51841,blind,0,1
51842,placebo,0,0
51843,controlled,0,0
51844,study,0,0
51845,was,0,0
51846,to,0,0
51847,investigate,0,0
51848,the,0,0
51849,effectiveness,0,0
51850,and,0,0
51851,the,0,0
51852,safety,0,0
51853,of,0,0
51854,venlafaxine,0,1
51855,XR,0,1
51856,75,0,1
51857,and,0,1
51858,150,0,1
51859,mg,0,0
51860,on,0,0
51861,ongoing,0,1
51862,pain,0,1
51863,and,0,1
51864,on,0,0
51865,quantitative,0,0
51866,sensory,0,1
51867,tests,0,0
51868,in,0,1
51869,60,1,1
51870,patients,1,1
51871,with,1,1
51872,neuropathic,1,1
51873,pain,1,1
51874,for,1,1
51875,8,1,1
51876,weeks,1,1
51877,.,1,1
51878,METHODS,0,0
51879,Evaluation,0,0
51880,parameters,0,0
51881,consisted,0,1
51882,of,0,0
51883,ongoing,0,1
51884,pain,0,1
51885,intensity,0,0
51886,(,0,1
51887,VAS,0,0
51888,),0,1
51889,",",0,0
51890,patient,0,0
51891,satisfaction,0,0
51892,",",0,1
51893,side,0,0
51894,effects,0,0
51895,",",0,1
51896,global,0,0
51897,efficacy,0,0
51898,and,0,1
51899,tolerance,0,1
51900,.,0,1
51901,Quantitative,0,0
51902,sensory,0,0
51903,measurements,0,0
51904,taken,0,0
51905,from,0,1
51906,the,0,0
51907,affected,0,0
51908,area,0,0
51909,before,0,0
51910,and,0,0
51911,after,0,0
51912,the,0,0
51913,drug,0,0
51914,treatment,0,0
51915,included,0,1
51916,pin-prick,0,0
51917,hyperalgesia,0,0
51918,",",0,0
51919,allodynia,0,0
51920,",",0,0
51921,detection,0,0
51922,and,0,0
51923,pain,0,1
51924,thresholds,0,0
51925,to,0,1
51926,electrical,0,0
51927,and,0,1
51928,heat,0,1
51929,stimuli,0,0
51930,",",0,1
51931,temporal,0,0
51932,summation,0,0
51933,of,0,0
51934,repetitive,0,0
51935,electrical,0,0
51936,and,0,1
51937,heat,0,1
51938,stimuli,0,0
51939,.,0,1
51940,RESULTS,1,0
51941,A,1,0
51942,total,1,1
51943,of,1,0
51944,55,1,1
51945,patients,1,1
51946,completed,1,1
51947,the,1,0
51948,study,1,0
51949,.,1,1
51950,VAS,0,0
51951,scores,0,0
51952,decreased,0,0
51953,significantly,0,0
51954,compared,0,0
51955,to,0,0
51956,the,0,0
51957,baseline,0,0
51958,measurements,0,0
51959,in,0,1
51960,all,0,1
51961,groups,0,0
51962,.,0,0
51963,There,0,0
51964,was,0,0
51965,no,0,0
51966,significant,0,0
51967,difference,0,0
51968,between,0,0
51969,the,0,0
51970,groups,1,0
51971,regarding,1,0
51972,pain,1,1
51973,intensity,1,0
51974,and,1,0
51975,escape,1,1
51976,medication,1,1
51977,.,1,1
51978,The,0,0
51979,areas,0,0
51980,of,0,0
51981,allodynia,0,1
51982,and,0,1
51983,pin-prick,0,0
51984,hyperalgesia,0,0
51985,decreased,0,0
51986,significantly,0,0
51987,in,0,0
51988,venlafaxine,0,1
51989,groups,0,1
51990,compared,0,0
51991,to,0,1
51992,the,0,0
51993,placebo,0,0
51994,.,0,0
51995,There,0,0
51996,was,0,0
51997,no,0,0
51998,significant,0,0
51999,difference,0,0
52000,between,0,0
52001,the,0,0
52002,groups,0,0
52003,regarding,0,0
52004,the,0,1
52005,detection,0,1
52006,thresholds,0,0
52007,(,0,1
52008,electrical,0,0
52009,and,0,1
52010,heat,0,1
52011,),0,1
52012,.,0,1
52013,The,0,0
52014,pain,0,0
52015,threshold,0,0
52016,and,0,0
52017,the,0,0
52018,summation,0,0
52019,threshold,0,0
52020,to,0,1
52021,electrical,0,0
52022,stimuli,0,0
52023,and,0,1
52024,the,0,0
52025,summation,0,0
52026,threshold,0,0
52027,to,0,0
52028,heat,0,1
52029,stimuli,0,0
52030,increased,0,0
52031,significantly,0,0
52032,following,0,0
52033,treatment,0,0
52034,in,0,0
52035,both,0,0
52036,venlafaxine,0,1
52037,groups,0,0
52038,.,0,1
52039,In,0,0
52040,addition,0,0
52041,",",0,0
52042,the,0,0
52043,degree,0,0
52044,of,0,0
52045,the,0,0
52046,temporal,0,0
52047,summation,0,0
52048,to,0,1
52049,electrical,0,0
52050,and,0,1
52051,heat,0,1
52052,stimuli,0,0
52053,decreased,0,0
52054,significantly,0,0
52055,following,0,0
52056,treatment,0,0
52057,in,0,0
52058,both,0,0
52059,venlafaxine,0,1
52060,groups,0,0
52061,compared,0,0
52062,to,0,1
52063,the,0,0
52064,placebo,0,0
52065,.,0,0
52066,CONCLUSION,0,0
52067,The,0,0
52068,study,0,0
52069,showed,0,0
52070,significant,0,0
52071,effect,0,0
52072,of,0,0
52073,venlafaxine,0,0
52074,in,0,1
52075,the,0,0
52076,manifestations,0,0
52077,of,0,0
52078,hyperalgesia,0,1
52079,and,0,1
52080,temporal,0,0
52081,summation,0,0
52082,",",0,0
52083,but,0,0
52084,not,0,0
52085,on,0,0
52086,the,0,0
52087,ongoing,0,0
52088,pain,0,1
52089,intensity,0,0
52090,.,0,1
52091,Furthermore,0,0
52092,",",0,0
52093,the,0,0
52094,quantitative,0,0
52095,sensory,0,1
52096,tests,0,0
52097,provided,0,0
52098,complementing,0,0
52099,information,0,0
52100,to,0,1
52101,the,0,0
52102,clinical,0,0
52103,measures,0,0
52104,.,0,1
52105,D-dimer,0,0
52106,predicts,0,0
52107,outcome,0,0
52108,after,0,0
52109,aneurysmal,0,1
52110,subarachnoid,1,1
52111,hemorrhage,1,1
52112,:,1,1
52113,no,0,0
52114,effect,0,0
52115,of,0,0
52116,thromboprophylaxis,0,1
52117,on,0,0
52118,coagulation,0,1
52119,activity,0,0
52120,.,0,1
52121,OBJECTIVE,0,0
52122,Approximately,0,0
52123,one-third,0,0
52124,of,0,0
52125,all,0,1
52126,patients,1,1
52127,with,1,1
52128,acute,1,1
52129,nontraumatic,1,1
52130,subarachnoid,1,1
52131,hemorrhage,1,1
52132,(,1,1
52133,SAH,1,1
52134,),1,1
52135,experience,0,1
52136,complications,0,1
52137,owing,0,0
52138,to,0,1
52139,delayed,0,1
52140,ischemic,0,1
52141,deficit,0,1
52142,.,0,1
52143,We,0,0
52144,reported,0,0
52145,recently,0,1
52146,that,0,0
52147,enoxaparin,0,0
52148,40,0,1
52149,mg,0,0
52150,once,0,0
52151,daily,0,0
52152,for,0,1
52153,10,0,1
52154,days,0,0
52155,seems,0,0
52156,safe,0,0
52157,and,0,0
52158,demonstrates,0,0
52159,thromboprophylactic,0,0
52160,efficacy,0,0
52161,",",0,0
52162,but,0,0
52163,it,0,0
52164,failed,0,0
52165,to,0,0
52166,improve,0,0
52167,outcome,0,0
52168,in,0,0
52169,a,0,1
52170,randomized,0,1
52171,SAH,0,1
52172,trial,0,1
52173,.,0,1
52174,In,0,0
52175,the,0,0
52176,present,0,0
52177,study,0,0
52178,",",0,0
52179,we,0,0
52180,assessed,0,0
52181,hemostatic,0,0
52182,variables,0,0
52183,associated,0,0
52184,with,0,1
52185,clinical,0,0
52186,status,0,1
52187,and,0,0
52188,outcome,0,0
52189,of,0,0
52190,SAH,0,1
52191,.,0,1
52192,We,0,0
52193,also,0,0
52194,monitored,0,0
52195,the,0,0
52196,effect,0,0
52197,of,0,0
52198,enoxaparin,0,0
52199,on,0,0
52200,activation,0,0
52201,of,0,0
52202,coagulation,0,1
52203,and,0,0
52204,fibrinolysis,0,0
52205,after,0,0
52206,closure,0,1
52207,of,0,0
52208,the,0,0
52209,ruptured,0,1
52210,aneurysm,0,1
52211,.,0,1
52212,METHODS,0,0
52213,Blood,0,1
52214,samples,0,1
52215,to,0,1
52216,measure,0,0
52217,activation,0,0
52218,of,0,0
52219,coagulation,0,1
52220,and,0,1
52221,fibrinolysis,0,0
52222,were,0,0
52223,collected,0,1
52224,from,0,1
52225,42,1,1
52226,patients,1,1
52227,participating,1,1
52228,in,1,1
52229,the,1,0
52230,enoxaparin,1,0
52231,trial,1,0
52232,for,1,0
52233,acute,1,1
52234,aneurysmal,1,1
52235,SAH,1,1
52236,at,1,1
52237,four,1,1
52238,time,1,0
52239,points,1,0
52240,:,1,1
52241,1,1,1
52242,),1,1
52243,at,1,1
52244,hospital,1,1
52245,admission,1,1
52246,;,1,1
52247,2,1,1
52248,),1,1
52249,12,1,1
52250,to,1,1
52251,24,1,1
52252,hours,1,0
52253,after,1,1
52254,aneurysm,1,1
52255,surgery,1,1
52256,but,1,0
52257,before,1,0
52258,initiation,1,0
52259,of,1,0
52260,enoxaparin,1,1
52261,therapy,1,1
52262,;,1,1
52263,3,1,1
52264,),1,1
52265,3,1,1
52266,hours,1,0
52267,after,1,1
52268,the,1,1
52269,first,1,0
52270,dose,1,0
52271,;,1,1
52272,and,1,1
52273,4,1,0
52274,),1,1
52275,at,1,0
52276,the,1,0
52277,conclusion,1,0
52278,of,1,0
52279,treatment,1,1
52280,.,1,1
52281,RESULTS,0,0
52282,At,0,0
52283,admission,0,1
52284,",",0,1
52285,several,0,0
52286,variables,0,0
52287,of,0,1
52288,coagulation,0,1
52289,and,0,1
52290,fibrinolysis,0,0
52291,were,0,1
52292,elevated,0,1
52293,and,0,0
52294,correlated,0,0
52295,well,0,0
52296,with,0,1
52297,clinical,0,0
52298,status,0,1
52299,.,0,1
52300,Specifically,0,0
52301,",",0,0
52302,D-dimer,0,0
52303,levels,0,0
52304,at,0,1
52305,all,0,1
52306,four,0,1
52307,time,0,0
52308,points,0,0
52309,correlated,0,0
52310,with,0,1
52311,patients,0,1
52312,',0,1
52313,long-term,0,1
52314,outcomes,0,0
52315,.,0,1
52316,A,0,0
52317,single,0,0
52318,dose,0,0
52319,of,0,0
52320,enoxaparin,0,0
52321,suppressed,0,0
52322,early,0,1
52323,coagulation,0,1
52324,activity,0,0
52325,",",0,0
52326,but,0,0
52327,thrombin,0,0
52328,generation,0,0
52329,was,0,0
52330,not,0,0
52331,inhibited,0,0
52332,during,0,0
52333,thromboprophylaxis,0,1
52334,.,0,1
52335,However,0,0
52336,",",0,0
52337,PAI-1,0,0
52338,activity,0,0
52339,was,0,0
52340,suppressed,0,0
52341,.,0,1
52342,CONCLUSION,0,0
52343,D-dimer,0,0
52344,offers,0,0
52345,a,0,0
52346,useful,0,0
52347,laboratory,0,0
52348,tool,0,0
52349,for,0,0
52350,assessing,0,0
52351,early,0,1
52352,and,0,1
52353,late,0,1
52354,clinical,0,0
52355,severity,0,0
52356,of,0,1
52357,SAH,0,1
52358,.,0,1
52359,A,0,0
52360,thromboprophylactic,0,0
52361,dose,0,0
52362,of,0,0
52363,enoxaparin,0,0
52364,inhibited,0,0
52365,PAI-1,0,1
52366,activity,0,0
52367,but,0,0
52368,failed,0,0
52369,to,0,0
52370,down-regulate,0,0
52371,coagulation,0,1
52372,activity,0,0
52373,and,0,1
52374,D-dimer,0,0
52375,.,0,1
52376,These,0,0
52377,findings,0,0
52378,are,0,0
52379,compatible,0,0
52380,with,0,1
52381,the,0,0
52382,lack,0,0
52383,of,0,0
52384,efficacy,0,0
52385,of,0,0
52386,enoxaparin,0,0
52387,in,0,0
52388,reducing,0,0
52389,ischemic,0,1
52390,deficit,0,1
52391,after,0,1
52392,SAH,0,1
52393,.,0,1
52394,Risperidone,0,0
52395,treatment,0,0
52396,of,0,0
52397,autistic,0,1
52398,disorder,0,1
52399,:,0,1
52400,longer-term,0,0
52401,benefits,0,0
52402,and,0,1
52403,blinded,0,0
52404,discontinuation,0,0
52405,after,0,1
52406,6,0,1
52407,months,0,1
52408,.,0,1
52409,OBJECTIVE,0,0
52410,Risperidone,0,0
52411,is,0,0
52412,effective,0,0
52413,for,0,0
52414,short-term,0,0
52415,treatment,0,1
52416,of,0,0
52417,aggression,0,1
52418,",",0,1
52419,temper,0,0
52420,outbursts,0,1
52421,",",0,1
52422,and,0,1
52423,self-injurious,0,1
52424,behavior,0,1
52425,in,0,1
52426,children,1,1
52427,with,1,1
52428,autism,1,1
52429,.,1,1
52430,Because,0,0
52431,these,0,0
52432,behaviors,0,0
52433,may,0,0
52434,be,0,0
52435,chronic,0,0
52436,",",0,0
52437,there,0,0
52438,is,0,0
52439,a,0,0
52440,need,0,0
52441,to,0,0
52442,establish,0,0
52443,the,0,0
52444,efficacy,0,0
52445,and,0,0
52446,safety,0,0
52447,of,0,0
52448,longer-term,0,0
52449,treatment,0,0
52450,with,0,1
52451,this,0,0
52452,agent,0,0
52453,.,0,1
52454,METHOD,0,0
52455,The,0,0
52456,authors,0,0
52457,conducted,0,1
52458,a,0,1
52459,multisite,0,1
52460,",",0,0
52461,two-part,0,0
52462,study,0,1
52463,of,0,0
52464,risperidone,1,0
52465,in,1,1
52466,children,1,1
52467,ages,1,1
52468,5,1,1
52469,to,1,1
52470,17,1,1
52471,years,1,1
52472,with,1,1
52473,autism,1,1
52474,accompanied,1,0
52475,by,1,0
52476,severe,1,1
52477,tantrums,1,1
52478,",",1,1
52479,aggression,1,1
52480,",",1,0
52481,and/or,1,0
52482,self-injurious,1,1
52483,behavior,1,1
52484,who,1,1
52485,showed,1,1
52486,a,1,1
52487,positive,1,0
52488,response,1,0
52489,in,1,0
52490,an,1,0
52491,earlier,1,1
52492,8-week,1,0
52493,trial,1,0
52494,.,1,1
52495,Part,0,0
52496,I,0,0
52497,consisted,0,1
52498,of,0,0
52499,4-month,0,1
52500,open-label,0,1
52501,treatment,0,1
52502,with,0,1
52503,risperidone,0,0
52504,",",0,0
52505,starting,0,0
52506,at,0,0
52507,the,0,0
52508,established,0,0
52509,optimal,0,0
52510,dose,0,0
52511,;,0,1
52512,part,0,1
52513,II,0,1
52514,was,0,0
52515,an,0,0
52516,8-week,0,0
52517,randomized,0,1
52518,",",0,0
52519,double-blind,0,0
52520,",",0,0
52521,placebo-substitution,0,0
52522,study,0,1
52523,of,0,0
52524,risperidone,0,0
52525,withdrawal,0,0
52526,.,0,1
52527,Primary,0,1
52528,outcome,0,0
52529,measures,0,0
52530,were,0,1
52531,the,0,0
52532,Aberrant,0,1
52533,Behavior,0,1
52534,Checklist,0,0
52535,irritability,0,0
52536,subscale,0,0
52537,and,0,0
52538,the,0,0
52539,Clinical,0,0
52540,Global,0,1
52541,Impression,0,0
52542,improvement,0,0
52543,scale,0,0
52544,.,0,1
52545,RESULTS,0,0
52546,Part,1,1
52547,I,1,1
52548,included,1,1
52549,63,1,1
52550,children,1,1
52551,.,1,1
52552,The,0,0
52553,mean,0,0
52554,risperidone,0,0
52555,dose,0,0
52556,was,0,0
52557,1.96,0,0
52558,mg/day,0,0
52559,at,0,1
52560,entry,0,1
52561,and,0,1
52562,remained,0,0
52563,stable,0,1
52564,over,0,1
52565,16,0,1
52566,weeks,0,1
52567,of,0,1
52568,open,0,1
52569,treatment,0,1
52570,.,0,1
52571,The,0,0
52572,change,0,0
52573,on,0,0
52574,the,0,0
52575,Aberrant,0,1
52576,Behavior,0,1
52577,Checklist,0,0
52578,irritability,0,0
52579,subscale,0,0
52580,was,0,0
52581,small,0,1
52582,and,0,1
52583,clinically,0,1
52584,insignificant,0,0
52585,.,0,1
52586,Reasons,0,0
52587,for,0,0
52588,discontinuation,0,0
52589,of,0,0
52590,part,0,1
52591,I,0,1
52592,included,0,1
52593,loss,0,0
52594,of,0,0
52595,efficacy,0,0
52596,(,0,1
52597,N=5,0,1
52598,),0,1
52599,and,0,1
52600,adverse,0,0
52601,effects,0,0
52602,(,0,1
52603,N=1,0,1
52604,),0,1
52605,.,0,1
52606,The,0,0
52607,subjects,0,1
52608,gained,0,0
52609,an,0,0
52610,average,0,0
52611,of,0,0
52612,5.1,0,1
52613,kg,0,1
52614,.,0,1
52615,Part,1,1
52616,II,1,1
52617,included,1,1
52618,32,1,1
52619,patients,1,1
52620,.,1,1
52621,The,0,0
52622,relapse,0,0
52623,rates,0,0
52624,were,0,1
52625,62.5,0,0
52626,%,0,0
52627,for,0,0
52628,gradual,0,1
52629,placebo,0,1
52630,substitution,0,0
52631,and,0,1
52632,12.5,0,0
52633,%,0,0
52634,for,0,0
52635,continued,0,0
52636,risperidone,0,1
52637,;,0,0
52638,this,0,0
52639,difference,0,0
52640,was,0,0
52641,statistically,0,0
52642,significant,0,0
52643,.,0,1
52644,CONCLUSIONS,0,0
52645,Risperidone,0,0
52646,showed,0,0
52647,persistent,0,1
52648,efficacy,0,0
52649,and,0,1
52650,good,0,0
52651,tolerability,0,0
52652,for,0,0
52653,intermediate-length,0,0
52654,treatment,0,1
52655,of,0,1
52656,children,1,1
52657,with,1,1
52658,autism,1,1
52659,characterized,1,0
52660,by,1,0
52661,tantrums,1,1
52662,",",1,1
52663,aggression,1,1
52664,",",1,0
52665,and/or,1,0
52666,self-injurious,1,1
52667,behavior,1,1
52668,.,1,1
52669,Discontinuation,0,0
52670,after,0,0
52671,6,0,1
52672,months,0,1
52673,was,0,0
52674,associated,0,0
52675,with,0,1
52676,a,0,1
52677,rapid,0,0
52678,return,0,0
52679,of,0,0
52680,disruptive,0,1
52681,and,0,1
52682,aggressive,0,1
52683,behavior,0,0
52684,in,0,1
52685,most,0,1
52686,subjects,0,1
52687,.,0,1
52688,Tolerance,0,1
52689,and,0,0
52690,efficacy,0,0
52691,of,0,0
52692,combined,0,0
52693,diethylcarbamazine,0,0
52694,and,0,0
52695,albendazole,0,0
52696,for,0,0
52697,treatment,0,0
52698,of,0,0
52699,Wuchereria,1,1
52700,bancrofti,1,1
52701,and,1,1
52702,intestinal,1,1
52703,helminth,1,1
52704,infections,1,1
52705,in,1,1
52706,Haitian,1,1
52707,children,1,1
52708,.,1,1
52709,This,0,0
52710,randomized,0,0
52711,",",0,0
52712,placebo-controlled,0,0
52713,trial,0,0
52714,investigated,0,0
52715,the,0,0
52716,tolerance,0,0
52717,",",0,0
52718,efficacy,0,0
52719,",",0,0
52720,and,0,0
52721,nutritional,0,0
52722,benefit,0,0
52723,of,0,0
52724,combining,0,0
52725,chemotherapeutic,0,0
52726,treatment,0,1
52727,of,0,1
52728,intestinal,0,1
52729,helminths,0,1
52730,and,0,1
52731,lymphatic,0,1
52732,filariasis,0,1
52733,.,0,1
52734,Children,1,1
52735,were,1,0
52736,infected,1,1
52737,with,1,1
52738,Ascaris,1,1
52739,(,1,1
52740,30.7,1,1
52741,%,1,0
52742,),1,1
52743,",",1,0
52744,Trichuris,1,0
52745,(,1,1
52746,53.4,1,1
52747,%,1,0
52748,),1,1
52749,",",1,0
52750,and,1,0
52751,hookworm,1,1
52752,(,1,1
52753,9.7,1,0
52754,%,1,0
52755,),1,1
52756,with,1,1
52757,69.9,1,1
52758,%,1,0
52759,having,1,1
52760,more,1,0
52761,than,1,0
52762,one,1,1
52763,of,1,1
52764,these,1,0
52765,parasites,1,1
52766,.,1,1
52767,A,0,0
52768,total,0,1
52769,of,0,0
52770,15.8,0,1
52771,%,0,0
52772,of,0,0
52773,the,0,0
52774,children,1,1
52775,had,1,1
52776,Wuchereria,1,1
52777,bancrofti,1,1
52778,microfilariae,1,1
52779,.,1,1
52780,Children,1,1
52781,were,0,0
52782,randomly,0,1
52783,assigned,0,1
52784,treatment,0,0
52785,with,0,1
52786,placebo,0,0
52787,",",0,0
52788,albendazole,0,0
52789,(,0,1
52790,ALB,0,1
52791,),0,1
52792,",",0,0
52793,diethylcarbamazine,0,0
52794,(,0,1
52795,DEC,0,1
52796,),0,1
52797,",",0,0
52798,or,0,1
52799,combined,0,0
52800,therapy,0,0
52801,.,0,1
52802,The,0,0
52803,combination,0,0
52804,of,0,0
52805,DEC/ALB,0,1
52806,reduced,0,0
52807,microfilarial,0,1
52808,density,0,0
52809,compared,0,0
52810,with,0,1
52811,placebo,0,0
52812,",",0,0
52813,ALB,0,0
52814,",",0,0
52815,or,0,1
52816,DEC,0,0
52817,(,0,1
52818,P,0,0
52819,<,0,0
52820,or,0,1
52821,=,0,1
52822,0.03,0,0
52823,),0,1
52824,.,0,1
52825,Albendazole,0,0
52826,and,0,0
52827,DEC/ALB,0,1
52828,reduced,0,0
52829,the,0,0
52830,prevalence,0,0
52831,of,0,0
52832,Ascaris,0,1
52833,",",0,1
52834,Trichuris,0,0
52835,",",0,0
52836,and,0,0
52837,hookworm,0,1
52838,more,0,0
52839,than,0,0
52840,placebo,0,0
52841,or,0,1
52842,DEC,0,1
52843,(,0,1
52844,P,0,0
52845,<,0,0
52846,or,0,1
52847,=,0,1
52848,0.03,0,0
52849,),0,1
52850,.,0,1
52851,Among,0,1
52852,Trichuris-infected,1,1
52853,children,1,1
52854,",",0,1
52855,those,0,1
52856,receiving,0,1
52857,ALB,0,0
52858,and,0,1
52859,DEC/ALB,0,1
52860,demonstrated,0,0
52861,greater,0,0
52862,gains,0,0
52863,in,0,0
52864,weight,0,1
52865,compared,0,0
52866,with,0,1
52867,placebo,0,0
52868,(,0,1
52869,P,0,0
52870,<,0,0
52871,or,0,1
52872,=,0,1
52873,0.05,0,0
52874,),0,1
52875,.,0,1
52876,Albendazole,0,0
52877,and,0,0
52878,DEC/ALB,0,1
52879,were,0,1
52880,equally,0,0
52881,efficacious,0,0
52882,in,0,0
52883,treating,0,1
52884,intestinal,0,1
52885,helminths,0,1
52886,and,0,1
52887,for,0,1
52888,children,1,1
52889,with,1,1
52890,W.,1,1
52891,bancrofti,1,1
52892,microfilaremia,1,1
52893,",",0,0
52894,DEC/ALB,0,0
52895,was,0,0
52896,more,0,0
52897,effective,0,0
52898,than,0,0
52899,DEC,0,0
52900,",",0,0
52901,with,0,1
52902,no,0,0
52903,increase,0,0
52904,in,0,0
52905,severity,0,0
52906,of,0,1
52907,adverse,0,0
52908,reactions,0,0
52909,.,0,1
52910,Trichuris,0,1
52911,infections,0,1
52912,in,0,1
52913,pigs,1,1
52914,:,1,1
52915,a,0,1
52916,treatment,0,0
52917,trial,0,0
52918,in,0,0
52919,the,0,0
52920,field,0,0
52921,.,0,1
52922,Investigation,1,1
52923,of,1,0
52924,maxillary,1,1
52925,tooth,1,1
52926,sizes,1,0
52927,in,1,1
52928,patients,1,1
52929,with,1,1
52930,palatal,1,1
52931,canine,1,1
52932,displacement,1,1
52933,.,1,1
52934,AIM,0,0
52935,The,0,0
52936,aim,0,0
52937,of,0,0
52938,this,0,0
52939,retrospective,0,1
52940,trial,0,0
52941,was,0,0
52942,to,0,0
52943,investigate,0,0
52944,differences,0,0
52945,in,0,1
52946,mesiodistal,0,1
52947,and,0,1
52948,vestibulo-oral,0,1
52949,crown,0,1
52950,sizes,0,0
52951,of,0,0
52952,naturally,0,1
52953,",",0,0
52954,fully-erupted,0,1
52955,permanent,0,1
52956,maxillary,0,1
52957,teeth,0,1
52958,between,0,1
52959,patients,1,1
52960,with,1,1
52961,and,1,1
52962,without,1,1
52963,palatal,1,1
52964,canine,1,1
52965,displacement,1,1
52966,.,1,1
52967,PATIENTS,0,0
52968,AND,0,0
52969,METHOD,0,1
52970,115,1,1
52971,patients,1,1
52972,(,1,1
52973,mean,1,1
52974,age,1,1
52975,:,1,1
52976,14,1,1
52977,years,1,1
52978,10,1,1
52979,months,1,1
52980,;,1,1
52981,females,1,1
52982,:,1,1
52983,77,1,1
52984,males,1,1
52985,:,1,1
52986,38,1,1
52987,),1,1
52988,treated,1,1
52989,in,1,0
52990,the,1,0
52991,Department,1,1
52992,of,1,0
52993,Orthodontics,1,1
52994,",",1,1
52995,University,1,1
52996,of,1,0
52997,Munich,1,1
52998,were,1,1
52999,included,1,1
53000,in,1,0
53001,the,1,0
53002,study,1,1
53003,.,1,1
53004,65,1,1
53005,of,1,0
53006,the,1,1
53007,patients,1,1
53008,showed,1,0
53009,at,1,1
53010,least,1,1
53011,one,1,1
53012,palatally-displaced,1,1
53013,canine,1,1
53014,.,1,1
53015,Diagnosis,1,0
53016,and,1,0
53017,the,1,0
53018,location,1,1
53019,of,1,0
53020,the,1,0
53021,displacement,1,0
53022,were,1,0
53023,determined,1,0
53024,on,1,0
53025,the,1,0
53026,basis,1,0
53027,of,1,0
53028,standardized,1,0
53029,radiographs,1,1
53030,and,1,0
53031,confirmed,1,0
53032,by,1,0
53033,surgical,1,1
53034,documentation,1,1
53035,.,1,1
53036,Each,1,0
53037,maxillary,1,1
53038,tooth,1,1
53039,'s,1,1
53040,mesiodistal,1,1
53041,and,1,1
53042,vestibulo-oral,1,0
53043,width,1,0
53044,was,1,0
53045,measured,1,0
53046,using,1,0
53047,a,1,0
53048,dial,1,1
53049,caliper,1,0
53050,on,1,0
53051,each,1,0
53052,dental,1,1
53053,cast,1,0
53054,.,1,1
53055,Excluded,1,0
53056,were,1,1
53057,partially-erupted,1,1
53058,teeth,1,1
53059,and,1,1
53060,surfaces,1,1
53061,with,1,1
53062,caries,1,1
53063,or,1,1
53064,restorations,1,1
53065,that,1,0
53066,had,1,1
53067,to,1,0
53068,be,1,0
53069,measured,1,0
53070,.,1,0
53071,An,0,0
53072,analysis,0,0
53073,of,0,0
53074,available,0,1
53075,space,0,1
53076,was,0,0
53077,made,0,0
53078,by,0,0
53079,evaluating,0,0
53080,the,0,0
53081,pre-treatment,0,0
53082,dental,0,1
53083,casts,0,1
53084,of,0,1
53085,all,0,1
53086,patients,0,1
53087,included,0,1
53088,in,0,0
53089,the,0,0
53090,study,0,1
53091,.,0,1
53092,RESULTS,0,0
53093,Comparing,0,0
53094,the,0,0
53095,tooth,0,1
53096,widths,0,0
53097,of,0,1
53098,patients,0,1
53099,with,0,1
53100,unilateral,0,1
53101,canine,0,1
53102,displacement,0,0
53103,with,0,1
53104,the,0,0
53105,corresponding,0,1
53106,contralateral,0,1
53107,quadrants,0,0
53108,",",0,1
53109,we,0,0
53110,noted,0,0
53111,a,0,0
53112,statistically,0,0
53113,significant,0,0
53114,difference,0,0
53115,",",0,0
53116,namely,0,0
53117,that,0,0
53118,the,0,0
53119,central,0,0
53120,and,0,1
53121,lateral,0,1
53122,incisors,0,1
53123,and,0,1
53124,the,0,1
53125,canines,0,1
53126,of,0,0
53127,the,0,1
53128,affected,0,0
53129,side,0,0
53130,were,0,1
53131,narrower,0,0
53132,than,0,0
53133,those,0,0
53134,of,0,0
53135,the,0,0
53136,non-affected,0,1
53137,side,0,0
53138,in,0,0
53139,the,0,0
53140,same,0,0
53141,patient,0,1
53142,.,0,1
53143,Moreover,0,0
53144,",",0,0
53145,the,0,0
53146,displaced,0,1
53147,upper,0,1
53148,canines,0,1
53149,showed,0,0
53150,an,0,0
53151,increase,0,0
53152,in,0,0
53153,vestibulo-oral,0,0
53154,dimension,0,1
53155,.,0,1
53156,Overall,0,0
53157,tooth,0,1
53158,width,0,0
53159,(,0,1
53160,including,0,0
53161,all,0,0
53162,tooth,0,1
53163,groups,0,0
53164,),0,1
53165,in,0,1
53166,patients,0,1
53167,with,0,1
53168,palatally-displaced,0,1
53169,canines,0,1
53170,was,0,0
53171,significantly,0,0
53172,less,0,0
53173,than,0,0
53174,that,0,0
53175,in,0,0
53176,the,0,0
53177,control,0,1
53178,group,0,0
53179,.,0,1
53180,However,0,0
53181,",",0,0
53182,when,0,0
53183,comparing,0,0
53184,the,0,0
53185,crown,0,1
53186,diameters,0,1
53187,of,0,1
53188,unilaterally-,0,1
53189,and,0,1
53190,bilaterally-affected,0,1
53191,patients,0,1
53192,",",0,1
53193,no,0,0
53194,differences,0,0
53195,in,0,0
53196,tooth-size,0,1
53197,were,0,1
53198,observed,0,0
53199,.,0,1
53200,The,0,0
53201,space-analysis,0,0
53202,showed,0,0
53203,excessive,0,0
53204,dental-arch,0,1
53205,space,0,1
53206,in,0,1
53207,patients,0,1
53208,with,0,1
53209,a,0,1
53210,palatally-displaced,0,1
53211,canine,0,1
53212,.,0,1
53213,CONCLUSION,0,0
53214,Patients,0,1
53215,affected,0,1
53216,by,0,1
53217,palatal,0,1
53218,canine,0,1
53219,displacement,0,0
53220,showed,0,0
53221,significantly,0,0
53222,smaller,0,0
53223,maxillary,0,1
53224,tooth,0,1
53225,size,0,0
53226,.,0,1
53227,A,0,0
53228,single,0,0
53229,dose,0,0
53230,of,0,1
53231,gabapentin,0,0
53232,reduces,0,0
53233,acute,0,1
53234,pain,0,1
53235,and,0,0
53236,allodynia,0,1
53237,in,0,0
53238,patients,1,1
53239,with,1,1
53240,herpes,1,1
53241,zoster,1,1
53242,.,1,1
53243,This,0,0
53244,randomized,0,0
53245,",",0,0
53246,double-blind,0,0
53247,",",0,0
53248,placebo-controlled,0,0
53249,crossover,0,0
53250,study,0,1
53251,measured,0,0
53252,the,0,0
53253,effect,0,0
53254,of,0,0
53255,a,0,1
53256,single,0,0
53257,dose,0,0
53258,of,0,0
53259,oral,0,1
53260,gabapentin,0,0
53261,(,0,1
53262,900,0,1
53263,mg,0,1
53264,),0,1
53265,on,0,0
53266,pain,0,1
53267,and,0,1
53268,allodynia,0,0
53269,associated,0,0
53270,with,0,1
53271,herpes,0,1
53272,zoster,0,1
53273,.,0,1
53274,Pain,0,0
53275,severity,0,0
53276,decreased,0,0
53277,by,0,0
53278,66,0,1
53279,%,0,0
53280,with,0,1
53281,gabapentin,0,0
53282,compared,0,0
53283,to,0,1
53284,33,0,1
53285,%,0,0
53286,with,0,1
53287,placebo,0,1
53288,.,0,1
53289,Reductions,0,0
53290,in,0,0
53291,allodynia,0,1
53292,area,0,0
53293,and,0,0
53294,severity,0,0
53295,",",0,0
53296,and,0,0
53297,overall,0,0
53298,pain,0,1
53299,relief,0,0
53300,",",0,0
53301,were,0,0
53302,also,0,0
53303,greater,0,0
53304,with,0,1
53305,gabapentin,0,0
53306,.,0,1
53307,Economic,1,0
53308,evaluation,1,0
53309,of,1,0
53310,a,1,1
53311,nursing-led,1,1
53312,inpatient,1,1
53313,unit,1,1
53314,:,1,1
53315,the,0,0
53316,impact,0,0
53317,of,0,0
53318,findings,0,0
53319,on,0,1
53320,management,0,1
53321,decisions,0,0
53322,of,0,1
53323,service,0,1
53324,utility,0,0
53325,and,0,0
53326,sustainability,0,0
53327,.,0,1
53328,AIMS,0,0
53329,The,0,0
53330,nursing-led,0,1
53331,inpatient,0,1
53332,unit,0,1
53333,is,0,0
53334,designed,0,0
53335,to,0,0
53336,substitute,0,0
53337,for,0,0
53338,a,0,0
53339,period,0,0
53340,of,0,0
53341,care,0,1
53342,in,0,1
53343,acute,0,1
53344,hospital,0,1
53345,wards,0,1
53346,and,0,1
53347,to,0,1
53348,improve,0,0
53349,patient,0,0
53350,outcome,0,0
53351,prior,0,1
53352,to,0,0
53353,discharge,0,0
53354,to,0,0
53355,the,0,0
53356,community,0,1
53357,.,0,0
53358,This,0,0
53359,paper,0,0
53360,aims,0,0
53361,to,0,0
53362,evaluate,0,0
53363,the,0,0
53364,cost,0,0
53365,",",0,0
53366,from,0,0
53367,the,0,0
53368,UK,0,1
53369,National,0,1
53370,Health,0,0
53371,Service,0,1
53372,perspective,0,0
53373,",",0,0
53374,of,0,0
53375,transfer,1,1
53376,to,1,1
53377,a,1,0
53378,nursing-led,1,1
53379,inpatient,1,1
53380,unit,1,1
53381,for,1,0
53382,intermediate,1,1
53383,care,1,1
53384,and,0,0
53385,to,0,0
53386,discuss,0,0
53387,the,0,0
53388,impact,0,0
53389,of,0,0
53390,these,0,0
53391,findings,0,0
53392,to,0,0
53393,the,0,0
53394,future,0,0
53395,development,0,0
53396,and,0,0
53397,sustainability,0,0
53398,of,0,0
53399,the,0,0
53400,nursing-led,0,1
53401,inpatient,0,1
53402,unit,0,1
53403,.,0,1
53404,BACKGROUND,0,0
53405,Recent,0,1
53406,economic,0,0
53407,analyses,0,0
53408,have,0,0
53409,showed,0,0
53410,that,0,0
53411,nursing-led,1,1
53412,inpatient,1,1
53413,units,1,1
53414,are,0,0
53415,associated,0,0
53416,with,0,1
53417,increased,0,0
53418,costs,0,1
53419,of,0,1
53420,care,0,1
53421,with,0,1
53422,length,0,0
53423,of,0,0
53424,stay,0,0
53425,as,0,0
53426,the,0,0
53427,main,0,0
53428,driver,0,1
53429,of,0,1
53430,inpatient,0,1
53431,costs,0,1
53432,.,0,1
53433,METHOD,0,0
53434,The,0,0
53435,cost-effectiveness,0,0
53436,analysis,0,0
53437,was,0,0
53438,part,0,0
53439,of,0,0
53440,a,0,1
53441,randomized-controlled,0,1
53442,trial,0,0
53443,with,0,1
53444,a,0,1
53445,sample,1,1
53446,size,1,0
53447,of,1,0
53448,175,1,1
53449,",",1,1
53450,of,1,0
53451,which,1,0
53452,89,1,1
53453,were,1,1
53454,in,1,0
53455,the,1,0
53456,nursing-led,1,1
53457,inpatient,1,1
53458,unit,1,1
53459,arm,1,1
53460,and,1,1
53461,86,1,1
53462,in,1,0
53463,the,1,0
53464,control,1,1
53465,arm,1,1
53466,.,1,1
53467,Resource,0,0
53468,use,0,0
53469,data,0,0
53470,included,0,1
53471,length,0,0
53472,of,0,0
53473,stay,0,0
53474,",",0,1
53475,investigations,0,0
53476,performed,0,0
53477,",",0,1
53478,multiprofessional,0,1
53479,input,0,0
53480,and,0,0
53481,nursing,0,1
53482,input,0,1
53483,.,0,1
53484,Clinical,0,0
53485,outcome,0,0
53486,was,0,0
53487,measured,0,0
53488,using,0,0
53489,Barthel,0,0
53490,Index,0,0
53491,",",0,0
53492,a,0,0
53493,functional,0,0
53494,status,0,1
53495,measure,0,0
53496,.,0,1
53497,RESULTS,0,0
53498,Cost,0,0
53499,per,0,1
53500,day,0,0
53501,was,0,0
53502,lower,0,0
53503,on,0,0
53504,the,0,0
53505,nursing-led,0,1
53506,inpatient,0,1
53507,unit,0,1
53508,although,0,0
53509,cost,0,0
53510,per,0,1
53511,hospital,0,1
53512,stay,0,0
53513,was,0,0
53514,higher,0,0
53515,due,0,0
53516,to,0,0
53517,significantly,0,0
53518,increased,0,0
53519,length,0,0
53520,of,0,0
53521,stay,0,0
53522,.,0,1
53523,Postdischarge,0,0
53524,community,0,1
53525,care,0,1
53526,costs,0,0
53527,were,0,1
53528,lower,0,0
53529,.,0,1
53530,The,0,0
53531,incremental,0,0
53532,cost-effectiveness,0,0
53533,ratio,0,0
53534,of,0,0
53535,the,0,0
53536,treatment,0,0
53537,was,0,0
53538,1044,0,1
53539,pounds,0,1
53540,sterling,0,1
53541,per,0,1
53542,point,0,0
53543,improvement,0,0
53544,of,0,0
53545,the,0,0
53546,Barthel,0,0
53547,Index,0,0
53548,.,0,1
53549,CONCLUSIONS,0,0
53550,The,0,0
53551,nursing-led,0,1
53552,inpatient,0,1
53553,unit,0,1
53554,was,0,0
53555,associated,0,0
53556,with,0,1
53557,higher,0,0
53558,costs,0,1
53559,however,0,0
53560,",",0,0
53561,the,0,0
53562,question,0,0
53563,of,0,0
53564,whether,0,0
53565,the,0,0
53566,nursing-led,0,1
53567,inpatient,0,1
53568,unit,0,1
53569,is,0,0
53570,cost-effective,0,0
53571,has,0,0
53572,not,0,0
53573,been,0,0
53574,clearly,0,0
53575,answered,0,0
53576,because,0,0
53577,of,0,0
53578,the,0,0
53579,limited,0,0
53580,follow-up,0,0
53581,period,0,0
53582,of,0,0
53583,the,0,0
53584,study,0,0
53585,.,0,0
53586,The,0,0
53587,increased,0,0
53588,cost,0,0
53589,of,0,0
53590,care,0,1
53591,on,0,0
53592,the,0,0
53593,nursing-led,0,1
53594,inpatient,0,1
53595,unit,0,1
53596,was,0,0
53597,not,0,0
53598,a,0,0
53599,major,0,0
53600,factor,0,0
53601,in,0,1
53602,local,0,0
53603,management,0,1
53604,decisions,0,0
53605,about,0,0
53606,the,0,0
53607,future,0,0
53608,of,0,0
53609,the,0,0
53610,unit,0,1
53611,.,0,1
53612,The,0,0
53613,changes,0,0
53614,in,0,0
53615,the,0,0
53616,context,0,0
53617,of,0,0
53618,service,0,1
53619,provision,0,0
53620,within,0,0
53621,which,0,0
53622,the,0,0
53623,nursing-led,0,1
53624,inpatient,0,1
53625,unit,0,1
53626,operated,0,1
53627,as,0,0
53628,a,0,0
53629,result,0,0
53630,of,0,0
53631,substantial,0,0
53632,investment,0,0
53633,in,0,1
53634,intermediate,0,1
53635,care,0,1
53636,did,0,0
53637,have,0,0
53638,a,0,0
53639,major,0,0
53640,impact,0,0
53641,.,0,1
53642,Double,0,1
53643,blind,0,1
53644,",",0,0
53645,placebo,0,0
53646,controlled,0,0
53647,study,0,0
53648,of,0,0
53649,metronidazole,1,0
53650,as,1,0
53651,a,1,1
53652,disease,1,1
53653,modifying,1,0
53654,agent,1,0
53655,in,1,0
53656,the,1,0
53657,treatment,1,0
53658,of,1,0
53659,rheumatoid,1,1
53660,arthritis,1,1
53661,.,1,1
53662,Anecdotal,0,0
53663,reports,0,0
53664,suggest,0,0
53665,that,0,0
53666,metronidazole,0,0
53667,may,0,0
53668,have,0,0
53669,disease,0,1
53670,modifying,0,0
53671,activity,0,0
53672,in,0,0
53673,the,0,0
53674,treatment,1,0
53675,of,1,0
53676,rheumatoid,1,1
53677,arthritis,1,1
53678,.,1,1
53679,To,0,0
53680,assess,0,0
53681,possible,0,0
53682,beneficial,0,0
53683,effects,0,0
53684,a,0,1
53685,double,0,0
53686,blind,0,1
53687,",",0,0
53688,comparative,0,0
53689,trial,0,0
53690,of,0,0
53691,metronidazole,0,0
53692,and,0,1
53693,placebo,0,0
53694,was,0,0
53695,performed,0,0
53696,.,0,1
53697,Fifty,1,1
53698,patients,1,1
53699,with,1,1
53700,active,1,1
53701,rheumatoid,1,1
53702,arthritis,1,1
53703,were,1,0
53704,randomly,1,1
53705,allocated,1,1
53706,to,1,0
53707,receive,1,1
53708,active,1,1
53709,drug,1,0
53710,(,1,1
53711,n,1,1
53712,=,1,1
53713,24,1,1
53714,),1,1
53715,or,1,1
53716,placebo,1,0
53717,(,1,1
53718,n,1,1
53719,=,1,1
53720,26,1,1
53721,),1,1
53722,and,1,0
53723,reviewed,1,1
53724,at,1,1
53725,weeks,1,0
53726,0,1,0
53727,",",1,1
53728,1,1,0
53729,",",1,0
53730,4,1,0
53731,",",1,0
53732,8,1,0
53733,",",1,0
53734,12,1,1
53735,",",1,0
53736,16,1,1
53737,",",1,0
53738,and,1,1
53739,24,1,1
53740,.,1,1
53741,Detailed,0,0
53742,assessment,0,0
53743,of,0,0
53744,drug,0,0
53745,safety,0,0
53746,",",0,0
53747,biochemical,0,0
53748,and,0,1
53749,haematological,0,1
53750,parameters,0,0
53751,",",0,1
53752,and,0,0
53753,efficacy,0,0
53754,was,0,0
53755,made,0,0
53756,at,0,0
53757,these,0,0
53758,dates,0,1
53759,.,0,1
53760,Dose,0,0
53761,regimen,0,0
53762,was,0,0
53763,400,0,0
53764,mg,0,0
53765,twice,0,0
53766,daily,0,0
53767,from,0,1
53768,weeks,0,0
53769,0,0,0
53770,to,0,1
53771,eight,0,1
53772,",",0,0
53773,increasing,0,0
53774,to,0,1
53775,400,0,1
53776,mg,0,1
53777,three,0,1
53778,times,0,0
53779,a,0,1
53780,day,0,0
53781,from,0,1
53782,weeks,0,1
53783,nine,0,1
53784,to,0,1
53785,24,0,1
53786,provided,0,0
53787,that,0,0
53788,no,0,0
53789,adverse,0,0
53790,effects,0,0
53791,were,0,1
53792,recorded,0,0
53793,.,0,1
53794,Most,0,0
53795,patients,0,1
53796,were,0,1
53797,unable,0,0
53798,to,0,0
53799,tolerate,0,0
53800,metronidazole,0,0
53801,because,0,0
53802,of,0,0
53803,side,0,0
53804,effects,0,0
53805,or,0,1
53806,lack,0,0
53807,of,0,0
53808,efficacy,0,0
53809,",",0,0
53810,with,0,1
53811,only,0,0
53812,five,0,1
53813,(,0,1
53814,21,0,1
53815,%,0,0
53816,),0,1
53817,continuing,0,0
53818,to,0,0
53819,take,0,0
53820,the,0,0
53821,drug,0,0
53822,at,0,1
53823,24,0,1
53824,weeks,0,1
53825,.,0,1
53826,For,0,1
53827,those,0,1
53828,patients,0,1
53829,attaining,0,1
53830,12,0,1
53831,weeks,0,1
53832,of,0,1
53833,treatment,0,1
53834,an,0,1
53835,overall,0,0
53836,improvement,0,0
53837,in,0,1
53838,articular,0,1
53839,index,0,1
53840,and,0,0
53841,morning,0,0
53842,stiffness,0,0
53843,was,0,0
53844,found,0,0
53845,.,0,1
53846,No,0,0
53847,improvement,0,0
53848,in,0,0
53849,laboratory,0,1
53850,indices,0,0
53851,of,0,1
53852,disease,0,1
53853,activity,0,0
53854,was,0,0
53855,seen,0,0
53856,",",0,0
53857,however,0,0
53858,.,0,0
53859,In,0,0
53860,this,0,0
53861,study,0,0
53862,metronidazole,0,0
53863,did,0,0
53864,not,0,0
53865,have,0,0
53866,disease,0,1
53867,modifying,0,0
53868,properties,0,0
53869,and,0,1
53870,was,0,0
53871,unacceptably,0,0
53872,toxic,0,1
53873,.,0,1
53874,[,0,1
53875,Effect,0,0
53876,of,0,0
53877,Yufeining,0,0
53878,on,0,0
53879,induced,0,1
53880,sputum,0,1
53881,interleukin-8,0,0
53882,in,0,1
53883,patients,1,1
53884,with,1,1
53885,chronic,1,1
53886,obstructive,1,1
53887,pulmonary,1,1
53888,disease,1,1
53889,at,1,0
53890,the,1,0
53891,stable,1,1
53892,phase,1,1
53893,],1,1
53894,.,1,1
53895,OBJECTIVE,0,0
53896,To,0,0
53897,evaluate,0,0
53898,the,0,0
53899,effect,0,0
53900,of,0,0
53901,Yufeining,0,0
53902,",",0,0
53903,a,0,0
53904,traditional,0,0
53905,Chinese,0,1
53906,medicine,0,1
53907,",",0,0
53908,on,0,0
53909,induced,0,0
53910,sputum,0,1
53911,interleukin-8,0,0
53912,(,0,1
53913,IL-8,0,1
53914,),0,1
53915,in,0,1
53916,patients,1,1
53917,with,1,1
53918,chronic,1,1
53919,obstructive,1,1
53920,pulmonary,1,1
53921,disease,1,1
53922,(,1,1
53923,COPD,1,1
53924,),1,1
53925,at,1,0
53926,the,1,0
53927,stable,1,1
53928,phase,1,1
53929,.,1,1
53930,METHODS,0,0
53931,Thirty-six,1,1
53932,patients,1,1
53933,with,1,1
53934,COPD,1,1
53935,were,0,1
53936,divided,0,1
53937,into,0,1
53938,trial,0,1
53939,group,0,1
53940,(,0,1
53941,18,0,1
53942,cases,0,1
53943,),0,1
53944,and,0,1
53945,control,0,1
53946,group,0,1
53947,(,0,1
53948,18,0,1
53949,cases,0,1
53950,),0,1
53951,randomly,0,1
53952,.,0,1
53953,The,0,0
53954,trial,0,0
53955,group,0,0
53956,was,0,0
53957,treated,0,1
53958,with,0,1
53959,Yufeining,0,1
53960,pills,0,0
53961,taken,0,0
53962,orally,0,1
53963,for,0,0
53964,half,0,1
53965,a,0,1
53966,year,0,0
53967,;,0,0
53968,the,0,0
53969,control,0,0
53970,group,0,0
53971,was,0,0
53972,not,0,0
53973,given,0,0
53974,any,0,0
53975,medicine,0,1
53976,.,0,1
53977,Routine,0,0
53978,lung,0,1
53979,function,0,0
53980,was,0,0
53981,recorded,0,0
53982,before,0,0
53983,and,0,0
53984,after,0,1
53985,treatment,0,1
53986,.,0,1
53987,Total,0,0
53988,cell,0,1
53989,count,0,0
53990,(,0,1
53991,TCC,0,1
53992,),0,1
53993,",",0,0
53994,differential,0,0
53995,cell,0,1
53996,counts,0,0
53997,(,0,1
53998,DCCs,0,1
53999,),0,1
54000,and,0,0
54001,IL-8,0,1
54002,in,0,0
54003,induced,0,0
54004,sputum,0,1
54005,were,0,1
54006,determined,0,0
54007,at,0,0
54008,the,0,0
54009,baseline,0,0
54010,and,0,1
54011,6,0,0
54012,months,0,0
54013,later,0,1
54014,.,0,1
54015,RESULTS,0,0
54016,The,0,0
54017,indices,0,0
54018,of,0,0
54019,lung,0,1
54020,function,0,0
54021,improved,0,0
54022,significantly,0,0
54023,after,0,1
54024,6,0,1
54025,months,0,1
54026,',0,1
54027,treatment,0,1
54028,in,0,1
54029,trial,0,1
54030,group,0,1
54031,(,0,1
54032,P,0,0
54033,<,0,0
54034,0.05,0,0
54035,),0,1
54036,;,0,1
54037,TCC,0,1
54038,and,0,1
54039,absolute,0,0
54040,neutrophil,0,0
54041,count,0,0
54042,decreased,0,0
54043,significantly,0,0
54044,compared,0,0
54045,with,0,1
54046,baseline,0,0
54047,in,0,0
54048,the,0,0
54049,trial,0,0
54050,group,0,0
54051,(,0,1
54052,P,0,0
54053,<,0,0
54054,0.05,0,0
54055,),0,1
54056,;,0,1
54057,Sputum,0,1
54058,IL-8,0,1
54059,concentration,0,0
54060,dropped,0,0
54061,significantly,0,0
54062,after,0,1
54063,6,0,1
54064,months,0,1
54065,',0,1
54066,treatment,0,0
54067,",",0,1
54068,from,0,0
54069,a,0,0
54070,mean,0,1
54071,of,0,0
54072,5.216,0,0
54073,+/-,0,1
54074,2.914,0,0
54075,microg/L,0,0
54076,to,0,1
54077,4.222,0,0
54078,+/-,0,0
54079,2.140,0,0
54080,microg/L,0,0
54081,(,0,1
54082,P,0,0
54083,<,0,0
54084,0.05,0,0
54085,),0,0
54086,.,0,0
54087,There,0,0
54088,were,0,0
54089,insignificant,0,0
54090,changes,0,0
54091,in,0,1
54092,the,0,1
54093,parameters,0,0
54094,in,0,0
54095,the,0,0
54096,control,0,0
54097,group,0,0
54098,between,0,0
54099,baseline,0,0
54100,and,0,1
54101,6,0,0
54102,months,0,0
54103,later,0,1
54104,.,0,1
54105,CONCLUSION,0,0
54106,Yufeining,0,0
54107,could,0,0
54108,improve,0,0
54109,lung,0,1
54110,function,0,0
54111,",",0,0
54112,decrease,0,0
54113,sputum,0,1
54114,TCC,0,1
54115,",",0,0
54116,absolute,0,0
54117,neutrophil,0,0
54118,count,0,0
54119,and,0,0
54120,IL-8,0,0
54121,concentration,0,0
54122,",",0,0
54123,and,0,0
54124,relieve,0,0
54125,airway,0,0
54126,inflammation,0,0
54127,in,0,0
54128,patients,1,1
54129,with,1,1
54130,COPD,1,1
54131,in,1,1
54132,the,1,0
54133,stable,1,1
54134,phase,1,1
54135,.,1,1
54136,[,0,0
54137,A,0,1
54138,clinical,0,0
54139,study,0,0
54140,on,0,0
54141,the,0,0
54142,effect,0,0
54143,of,0,0
54144,Yinxing,0,1
54145,Damo,0,1
54146,combined,0,0
54147,with,0,1
54148,betahistine,0,0
54149,hydrochloride,0,0
54150,injection,0,0
54151,on,0,0
54152,vertebral,1,1
54153,basilar,1,1
54154,artery,1,1
54155,ischemic,1,1
54156,vertigo,1,0
54157,],1,1
54158,.,0,1
54159,OBJECTIVE,0,0
54160,To,0,0
54161,evaluate,0,0
54162,the,0,0
54163,therapeutic,0,0
54164,efficacy,0,0
54165,of,0,0
54166,Yinxing,0,1
54167,Damo,0,1
54168,(,0,1
54169,YXDM,0,0
54170,),0,1
54171,combined,0,0
54172,with,0,1
54173,Betahistine,0,1
54174,Hydrochloride,0,1
54175,Injection,0,0
54176,(,0,1
54177,BHI,0,0
54178,),0,1
54179,on,0,0
54180,vertebra,0,1
54181,basilar,0,1
54182,artery,0,1
54183,ischemic,0,1
54184,vertigo,0,0
54185,(,0,1
54186,VBIV,0,1
54187,),0,1
54188,.,0,1
54189,METHODS,0,0
54190,Ninety,1,1
54191,patients,1,1
54192,with,1,1
54193,VBIV,1,1
54194,were,1,1
54195,randomly,1,1
54196,divided,1,1
54197,into,1,1
54198,two,1,1
54199,groups,1,1
54200,;,1,1
54201,45,0,1
54202,patients,0,1
54203,(,0,1
54204,the,0,0
54205,treated,0,1
54206,group,0,1
54207,),0,1
54208,were,0,0
54209,treated,0,1
54210,with,0,1
54211,YXDM,0,0
54212,and,0,1
54213,BHI,0,0
54214,intravenous,0,1
54215,dripping,0,0
54216,",",0,0
54217,once,0,0
54218,a,0,0
54219,day,0,0
54220,for,0,0
54221,14,0,1
54222,days,0,0
54223,.,0,1
54224,Another,1,1
54225,45,1,1
54226,patients,1,1
54227,(,1,1
54228,control,1,1
54229,group,1,1
54230,),1,0
54231,were,0,0
54232,treated,0,1
54233,with,0,1
54234,Xueshuantong,0,1
54235,and,0,1
54236,BHI,0,0
54237,intravenous,0,1
54238,dripping,0,0
54239,",",0,0
54240,once,0,0
54241,daily,0,0
54242,for,0,1
54243,14,0,1
54244,days,0,0
54245,.,0,1
54246,The,0,0
54247,clinical,0,0
54248,syndromes,0,1
54249,and,0,1
54250,the,0,0
54251,index,0,0
54252,of,0,0
54253,the,0,0
54254,transcranial,0,0
54255,Doppler,0,1
54256,(,0,1
54257,TCD,0,1
54258,),0,1
54259,and,0,0
54260,hemorheology,0,0
54261,were,0,1
54262,observed,0,0
54263,.,0,0
54264,RESULTS,0,0
54265,The,0,0
54266,total,0,1
54267,effective,0,0
54268,rate,0,0
54269,was,0,0
54270,100,0,1
54271,%,0,0
54272,in,0,0
54273,the,0,0
54274,treated,0,1
54275,group,0,0
54276,",",0,0
54277,which,0,0
54278,was,0,0
54279,better,0,0
54280,than,0,0
54281,that,0,0
54282,in,0,0
54283,the,0,0
54284,control,0,1
54285,group,0,1
54286,90.5,0,0
54287,%,0,0
54288,",",0,0
54289,(,0,0
54290,P,0,0
54291,<,0,0
54292,0.05,0,0
54293,),0,1
54294,.,0,1
54295,The,0,0
54296,indexes,0,0
54297,of,0,1
54298,TCD,0,1
54299,and,0,1
54300,hemorheology,0,0
54301,in,0,0
54302,the,0,0
54303,treated,0,1
54304,group,0,0
54305,were,0,1
54306,obviously,0,0
54307,improved,0,0
54308,after,0,0
54309,treatment,0,0
54310,",",0,0
54311,(,0,0
54312,P,0,0
54313,<,0,0
54314,0.01,0,0
54315,),0,1
54316,.,0,1
54317,CONCLUSION,0,0
54318,YXDM,0,0
54319,combined,0,0
54320,with,0,1
54321,BHT,0,1
54322,injection,0,0
54323,had,0,0
54324,better,0,0
54325,effect,0,0
54326,in,0,0
54327,treating,0,0
54328,patients,0,1
54329,with,0,1
54330,VBIV,0,1
54331,is,0,0
54332,an,0,0
54333,ideal,0,0
54334,drug,0,0
54335,for,0,1
54336,VBIV,0,1
54337,.,0,1
54338,Pulse,0,0
54339,versus,0,0
54340,continuous,0,0
54341,terbinafine,0,0
54342,for,0,1
54343,onychomycosis,1,1
54344,:,1,1
54345,a,0,0
54346,randomized,0,1
54347,",",0,0
54348,double-blind,0,0
54349,",",0,0
54350,controlled,0,0
54351,trial,0,1
54352,.,0,1
54353,BACKGROUND,0,0
54354,Effective,0,0
54355,treatments,0,0
54356,for,0,0
54357,onychomycosis,0,1
54358,are,0,0
54359,expensive,0,0
54360,.,0,1
54361,Previous,0,0
54362,studies,0,0
54363,suggest,0,0
54364,that,0,0
54365,less,0,0
54366,costly,0,0
54367,",",0,0
54368,pulsed,0,1
54369,doses,0,0
54370,of,0,1
54371,antifungal,0,0
54372,medications,0,1
54373,may,0,0
54374,be,0,0
54375,as,0,0
54376,effective,0,0
54377,as,0,0
54378,standard,0,1
54379,",",0,1
54380,continuous,0,0
54381,doses,0,0
54382,.,0,1
54383,Terbinafine,0,0
54384,is,0,0
54385,the,0,0
54386,current,0,0
54387,treatment,0,0
54388,of,0,0
54389,choice,0,0
54390,for,0,1
54391,toenail,0,1
54392,onychomycosis,0,1
54393,.,0,1
54394,OBJECTIVE,0,0
54395,Our,0,0
54396,purpose,0,0
54397,was,0,0
54398,to,0,0
54399,determine,0,0
54400,whether,0,0
54401,pulse-dose,0,0
54402,terbinafine,0,0
54403,is,0,0
54404,as,0,0
54405,effective,0,0
54406,as,0,0
54407,standard,0,1
54408,continuous-dose,0,0
54409,terbinafine,0,0
54410,for,0,0
54411,treatment,0,0
54412,of,0,0
54413,toenail,0,1
54414,onychomycosis,0,1
54415,.,0,1
54416,METHODS,0,0
54417,We,0,0
54418,conducted,0,1
54419,a,0,0
54420,double-blind,0,0
54421,",",0,0
54422,randomized,0,0
54423,",",0,0
54424,noninferiority,0,0
54425,",",0,0
54426,clinical,0,0
54427,intervention,0,0
54428,trial,0,0
54429,in,0,0
54430,the,0,0
54431,Minneapolis,1,1
54432,Veterans,1,1
54433,Affairs,1,1
54434,Medical,1,1
54435,Center,1,1
54436,.,1,1
54437,The,1,0
54438,main,1,0
54439,inclusion,1,1
54440,criteria,1,1
54441,for,1,1
54442,participants,1,1
54443,were,1,1
54444,a,1,1
54445,positive,1,0
54446,dermatophyte,1,1
54447,culture,1,0
54448,and,1,0
54449,at,1,1
54450,least,1,1
54451,25,1,1
54452,%,1,0
54453,distal,1,1
54454,subungual,1,1
54455,clinical,1,0
54456,involvement,1,1
54457,.,1,1
54458,Six,1,0
54459,hundred,1,1
54460,eighteen,1,1
54461,volunteers,1,1
54462,were,1,1
54463,screened,1,1
54464,;,1,1
54465,306,1,1
54466,were,1,1
54467,randomized,1,1
54468,.,1,1
54469,Terbinafine,0,0
54470,",",0,0
54471,250,0,0
54472,mg,0,0
54473,daily,0,0
54474,for,0,1
54475,3,0,1
54476,months,0,1
54477,(,0,1
54478,continuous,0,1
54479,),0,1
54480,or,0,1
54481,terbinafine,0,0
54482,",",0,1
54483,500,0,1
54484,mg,0,0
54485,daily,0,0
54486,for,0,1
54487,1,0,0
54488,week,0,0
54489,per,0,0
54490,month,0,0
54491,for,0,1
54492,3,0,1
54493,months,0,1
54494,(,0,1
54495,pulse,0,0
54496,),0,1
54497,was,0,0
54498,administered,0,0
54499,.,0,1
54500,The,0,0
54501,primary,0,0
54502,outcome,0,0
54503,measure,0,0
54504,was,0,0
54505,mycological,0,1
54506,cure,0,0
54507,of,0,0
54508,the,0,0
54509,target,0,0
54510,toenail,0,1
54511,at,0,1
54512,18,0,1
54513,months,0,1
54514,.,0,1
54515,Secondary,0,0
54516,outcome,0,0
54517,measures,0,0
54518,included,0,1
54519,clinical,0,0
54520,cure,0,0
54521,and,0,1
54522,complete,0,1
54523,(,0,1
54524,clinical,0,0
54525,plus,0,0
54526,mycological,0,1
54527,),0,1
54528,cure,0,0
54529,of,0,0
54530,the,0,0
54531,target,0,0
54532,toenail,0,1
54533,and,0,0
54534,complete,0,1
54535,cure,0,0
54536,of,0,0
54537,all,0,1
54538,10,0,1
54539,toenails,0,1
54540,.,0,1
54541,RESULTS,0,0
54542,Results,0,0
54543,of,0,0
54544,an,0,1
54545,intent-to-treat,0,0
54546,analysis,0,0
54547,did,0,0
54548,not,0,0
54549,meet,0,1
54550,the,0,0
54551,prespecified,0,0
54552,criterion,0,1
54553,for,0,0
54554,noninferiority,0,0
54555,but,0,0
54556,did,0,0
54557,demonstrate,0,0
54558,the,0,0
54559,superiority,0,0
54560,of,0,0
54561,continuous-dose,0,0
54562,terbinafine,0,0
54563,for,0,1
54564,:,0,1
54565,mycological,0,1
54566,cure,0,0
54567,of,0,0
54568,the,0,0
54569,target,0,0
54570,toenail,0,1
54571,(,0,1
54572,70.9,0,1
54573,%,0,0
54574,[,0,1
54575,105/148,0,1
54576,],0,1
54577,vs,0,0
54578,58.7,0,1
54579,%,0,0
54580,[,0,0
54581,84/143,0,1
54582,],0,1
54583,;,0,1
54584,P,0,0
54585,=.03,0,0
54586,",",0,0
54587,relative,0,0
54588,risk,0,1
54589,[,0,0
54590,RR,0,1
54591,],0,1
54592,of,0,1
54593,1.21,0,0
54594,[,0,1
54595,95,0,0
54596,%,0,0
54597,confidence,0,0
54598,interval,0,0
54599,(,0,1
54600,CI,0,0
54601,),0,1
54602,",",0,0
54603,1.02-1.43,0,0
54604,],0,1
54605,),0,1
54606,;,0,1
54607,clinical,0,0
54608,cure,0,0
54609,of,0,0
54610,the,0,0
54611,target,0,0
54612,toenail,0,1
54613,(,0,1
54614,44.6,0,1
54615,%,0,0
54616,[,0,1
54617,66/148,0,1
54618,],0,1
54619,vs,0,0
54620,29.3,0,1
54621,%,0,0
54622,[,0,0
54623,42/143,0,1
54624,],0,1
54625,;,0,1
54626,P,0,0
54627,=.007,0,0
54628,",",0,1
54629,RR,0,1
54630,=1.52,0,1
54631,[,0,1
54632,95,0,0
54633,%,0,0
54634,CI,0,0
54635,",",0,1
54636,1.11-2.07,0,0
54637,),0,1
54638,;,0,1
54639,complete,0,1
54640,cure,0,0
54641,of,0,0
54642,the,0,0
54643,target,0,0
54644,toenail,0,1
54645,(,0,1
54646,40.5,0,0
54647,%,0,0
54648,[,0,1
54649,60/148,0,1
54650,],0,1
54651,vs,0,0
54652,28.0,0,0
54653,%,0,0
54654,[,0,0
54655,40/143,0,1
54656,],0,1
54657,;,0,1
54658,P,0,0
54659,=.02,0,0
54660,",",0,1
54661,RR=1.45,0,0
54662,[,0,0
54663,95,0,0
54664,%,0,0
54665,CI,0,0
54666,",",0,1
54667,1.04-2.01,0,0
54668,),0,1
54669,;,0,1
54670,and,0,1
54671,complete,0,1
54672,cure,0,0
54673,of,0,0
54674,all,0,1
54675,10,0,1
54676,toenails,0,1
54677,(,0,1
54678,25.2,0,1
54679,%,0,0
54680,[,0,1
54681,36/143,0,1
54682,],0,1
54683,vs,0,0
54684,14.7,0,0
54685,%,0,0
54686,[,0,0
54687,21/143,0,1
54688,],0,1
54689,;,0,1
54690,P,0,0
54691,=.03,0,0
54692,",",0,1
54693,RR,0,1
54694,=1.71,0,0
54695,[,0,1
54696,95,0,0
54697,%,0,0
54698,CI,0,0
54699,",",0,1
54700,1.05-2.79,0,0
54701,),0,1
54702,.,0,1
54703,Tolerability,0,0
54704,of,0,0
54705,the,0,0
54706,regimens,0,0
54707,did,0,0
54708,not,0,0
54709,differ,0,0
54710,significantly,0,0
54711,between,0,0
54712,the,0,0
54713,groups,0,0
54714,(,0,1
54715,chi2,0,0
54716,=1.63,0,0
54717,;,0,1
54718,P,0,0
54719,=.65,0,0
54720,),0,1
54721,.,0,1
54722,LIMITATIONS,0,0
54723,The,1,0
54724,study,1,0
54725,population,1,1
54726,primarily,1,0
54727,consisted,1,1
54728,of,1,0
54729,older,1,1
54730,men,1,1
54731,with,1,1
54732,severe,1,1
54733,onychomycosis,1,1
54734,.,1,1
54735,CONCLUSIONS,0,0
54736,This,0,0
54737,study,0,0
54738,demonstrated,0,0
54739,the,0,0
54740,superiority,0,0
54741,of,0,0
54742,continuous-,0,0
54743,over,0,0
54744,pulse-dose,0,0
54745,terbinafine,0,0
54746,.,0,1
54747,We,0,0
54748,also,0,0
54749,found,0,0
54750,this,0,0
54751,expensive,0,0
54752,therapy,0,0
54753,to,0,0
54754,be,0,0
54755,much,0,0
54756,less,0,0
54757,effective,0,0
54758,than,0,0
54759,previously,0,1
54760,believed,0,0
54761,",",0,0
54762,particularly,0,0
54763,for,0,0
54764,achieving,0,0
54765,complete,0,1
54766,cure,0,0
54767,of,0,0
54768,all,0,1
54769,10,0,1
54770,toenails,0,1
54771,.,0,1
54772,Addition,0,0
54773,of,0,0
54774,fexofenadine,0,0
54775,to,0,0
54776,inhaled,0,0
54777,corticosteroid,0,0
54778,therapy,0,0
54779,to,0,0
54780,reduce,0,0
54781,inflammatory,1,0
54782,biomarkers,1,1
54783,in,1,1
54784,atopic,1,1
54785,asthma,1,1
54786,.,1,1
54787,BACKGROUND,0,0
54788,We,0,0
54789,previously,0,1
54790,showed,0,0
54791,that,0,0
54792,H1-antihistamines,0,1
54793,may,0,0
54794,shift,0,0
54795,the,0,0
54796,PC20,0,0
54797,(,0,0
54798,provocation,0,0
54799,concentration,0,0
54800,that,0,0
54801,caused,0,0
54802,a,0,0
54803,decrease,0,0
54804,in,0,0
54805,forced,0,0
54806,expiratory,0,0
54807,volume,0,0
54808,in,0,1
54809,1,0,0
54810,second,0,1
54811,of,0,1
54812,20,0,1
54813,%,0,0
54814,),0,1
54815,threshold,0,0
54816,to,0,0
54817,adenosine,0,0
54818,monophosphate,0,0
54819,(,0,0
54820,AMP,0,1
54821,),0,1
54822,challenge,0,0
54823,but,0,0
54824,may,0,0
54825,paradoxically,0,0
54826,prolong,0,0
54827,recovery,0,0
54828,.,0,1
54829,OBJECTIVES,0,0
54830,To,0,0
54831,measure,0,0
54832,AMP,0,1
54833,recovery,0,0
54834,using,0,0
54835,a,0,1
54836,constant,0,0
54837,predetermined,0,1
54838,AMP,0,1
54839,PC20,0,1
54840,and,0,0
54841,to,0,0
54842,evaluate,0,0
54843,whether,0,0
54844,fexofenadine,0,0
54845,use,0,0
54846,confers,0,0
54847,add-on,0,1
54848,effects,0,0
54849,to,0,1
54850,treatment,0,0
54851,with,0,1
54852,either,0,0
54853,fluticasone,0,0
54854,propionate,0,0
54855,alone,0,0
54856,or,0,1
54857,combined,0,0
54858,fluticasone,0,0
54859,propionate-salmeterol,0,1
54860,.,0,1
54861,METHODS,0,0
54862,Fourteen,1,1
54863,atopic,1,1
54864,patients,1,1
54865,with,1,1
54866,mild-to-moderate,1,1
54867,asthma,1,1
54868,(,1,1
54869,forced,1,0
54870,expiratory,1,0
54871,volume,1,0
54872,in,1,1
54873,1,1,0
54874,second,1,1
54875,of,1,1
54876,76,1,1
54877,%,1,0
54878,),1,1
54879,completed,0,1
54880,a,0,0
54881,double-blind,0,0
54882,",",0,0
54883,randomized,0,0
54884,",",0,0
54885,crossover,0,0
54886,study,0,0
54887,consisting,0,1
54888,of,0,0
54889,3-week,0,1
54890,treatment,0,1
54891,blocks,0,0
54892,of,0,0
54893,either,0,1
54894,fluticasone,0,0
54895,propionate-salmeterol,0,1
54896,",",0,1
54897,250,0,0
54898,microg,0,0
54899,twice,0,0
54900,daily,0,0
54901,",",0,0
54902,or,0,0
54903,fluticasone,0,0
54904,propionate,0,0
54905,alone,0,0
54906,",",0,0
54907,250,0,0
54908,microg,0,0
54909,twice,0,0
54910,daily,0,0
54911,",",0,0
54912,in,0,0
54913,conjunction,0,0
54914,with,0,1
54915,either,0,0
54916,fexofenadine,0,0
54917,",",0,0
54918,180,0,1
54919,mg,0,0
54920,once,0,0
54921,daily,0,0
54922,",",0,0
54923,or,0,1
54924,matched,0,1
54925,placebo,0,0
54926,.,0,1
54927,Recovery,0,0
54928,after,0,0
54929,a,0,1
54930,predetermined,0,1
54931,AMP,0,1
54932,PC20,0,1
54933,challenge,0,0
54934,was,0,0
54935,measured,0,0
54936,(,0,1
54937,primary,0,1
54938,outcome,0,0
54939,),0,0
54940,",",0,0
54941,along,0,0
54942,with,0,1
54943,exhaled,0,0
54944,nitric,0,1
54945,oxide,0,1
54946,levels,0,0
54947,",",0,1
54948,plasma,0,0
54949,eosinophil,0,0
54950,cationic,0,0
54951,protein,0,0
54952,levels,0,0
54953,",",0,1
54954,peripheral,0,1
54955,eosinophil,0,0
54956,counts,0,0
54957,",",0,1
54958,pulmonary,0,1
54959,function,0,0
54960,",",0,0
54961,diary,0,0
54962,card,0,1
54963,outcomes,0,0
54964,",",0,1
54965,and,0,0
54966,quality,0,0
54967,of,0,0
54968,life,0,1
54969,(,0,1
54970,all,0,1
54971,secondary,0,1
54972,outcomes,0,0
54973,),0,1
54974,.,0,1
54975,RESULTS,0,0
54976,There,0,0
54977,were,0,0
54978,no,0,0
54979,differences,0,0
54980,in,0,0
54981,any,0,1
54982,of,0,0
54983,the,0,0
54984,primary,0,1
54985,or,0,1
54986,secondary,0,0
54987,outcomes,0,0
54988,when,0,0
54989,fexofenadine,0,0
54990,was,0,0
54991,added,0,0
54992,to,0,0
54993,treatment,0,0
54994,with,0,1
54995,either,0,1
54996,fluticasone,0,0
54997,propionate-salmeterol,0,1
54998,or,0,1
54999,fluticasone,0,0
55000,propionate,0,0
55001,alone,0,0
55002,.,0,0
55003,The,0,0
55004,mean,0,0
55005,AMP,0,1
55006,recovery,0,0
55007,time,0,0
55008,was,0,0
55009,25.0,0,0
55010,vs,0,0
55011,23.4,0,1
55012,minutes,0,0
55013,for,0,1
55014,fexofenadine,0,0
55015,and,0,0
55016,placebo,0,0
55017,",",0,0
55018,respectively,0,0
55019,",",0,0
55020,as,0,0
55021,add-on,0,1
55022,to,0,1
55023,fluticasone-salmeterol,0,1
55024,and,0,1
55025,22.5,0,0
55026,vs,0,0
55027,23.9,0,1
55028,minutes,0,0
55029,",",0,0
55030,respectively,0,0
55031,",",0,0
55032,as,0,0
55033,add-on,0,0
55034,to,0,0
55035,fluticasone,0,0
55036,alone,0,0
55037,.,0,1
55038,CONCLUSION,0,0
55039,Fexofenadine,0,0
55040,did,0,0
55041,not,0,0
55042,affect,0,0
55043,recovery,0,0
55044,to,0,0
55045,a,0,0
55046,fixed,0,0
55047,dose,0,0
55048,of,0,0
55049,AMP,0,1
55050,challenge,0,0
55051,or,0,1
55052,any,0,0
55053,other,0,0
55054,surrogate,0,0
55055,inflammatory,0,0
55056,markers,0,0
55057,when,0,0
55058,given,0,1
55059,as,0,0
55060,add-on,0,1
55061,therapy,0,1
55062,to,0,1
55063,corticosteroid-treatedatopic,1,1
55064,asthmatic,1,1
55065,patients,1,1
55066,.,1,1
55067,Antipyretic,0,1
55068,efficacy,0,0
55069,of,0,0
55070,ibuprofen,0,0
55071,vs,0,0
55072,acetaminophen,0,0
55073,.,0,1
55074,OBJECTIVE,0,0
55075,To,0,0
55076,compare,0,0
55077,the,0,0
55078,antipyretic,0,0
55079,efficacy,0,0
55080,of,0,0
55081,ibuprofen,0,0
55082,",",0,0
55083,placebo,0,0
55084,",",0,0
55085,and,0,0
55086,acetaminophen,0,0
55087,.,0,1
55088,DESIGN,0,0
55089,Double-dummy,0,0
55090,",",0,0
55091,double-blind,0,0
55092,",",0,0
55093,randomized,0,0
55094,",",0,0
55095,placebo-controlled,0,0
55096,trial,0,1
55097,.,0,1
55098,SETTING,0,1
55099,Emergency,0,1
55100,department,0,1
55101,and,0,1
55102,inpatient,0,1
55103,units,0,1
55104,of,0,1
55105,a,0,1
55106,large,0,1
55107,",",0,0
55108,metropolitan,1,1
55109,",",1,0
55110,university-based,1,1
55111,",",1,1
55112,children,1,1
55113,'s,1,1
55114,hospital,1,1
55115,in,1,1
55116,Michigan,1,1
55117,.,1,1
55118,PARTICIPANTS,0,0
55119,37,1,1
55120,otherwise,1,1
55121,healthy,1,1
55122,children,1,1
55123,aged,1,1
55124,2,1,1
55125,to,1,1
55126,12,1,1
55127,years,1,1
55128,with,1,1
55129,acute,1,1
55130,",",1,0
55131,intercurrent,1,0
55132,",",1,0
55133,febrile,1,1
55134,illness,1,1
55135,.,1,1
55136,INTERVENTIONS,0,0
55137,Each,0,0
55138,child,1,1
55139,was,0,0
55140,randomly,0,1
55141,assigned,0,1
55142,to,0,0
55143,receive,0,1
55144,a,0,0
55145,single,0,0
55146,dose,0,0
55147,of,0,0
55148,acetaminophen,0,0
55149,(,0,1
55150,10,0,1
55151,mg/kg,0,0
55152,),0,1
55153,",",0,0
55154,ibuprofen,0,0
55155,(,0,1
55156,7.5,0,0
55157,or,0,1
55158,10,0,1
55159,mg/kg,0,0
55160,),0,1
55161,",",0,0
55162,or,0,1
55163,placebo,0,0
55164,.,0,1
55165,MEASUREMENTS/MAIN,0,0
55166,RESULTS,0,0
55167,Oral,0,1
55168,temperature,0,1
55169,was,0,0
55170,measured,0,0
55171,before,0,0
55172,dosing,0,0
55173,",",0,1
55174,30,0,1
55175,minutes,0,0
55176,after,0,1
55177,dosing,0,0
55178,",",0,0
55179,and,0,0
55180,hourly,0,0
55181,thereafter,0,0
55182,for,0,0
55183,8,0,1
55184,hours,0,0
55185,after,0,1
55186,the,0,1
55187,dose,0,0
55188,.,0,1
55189,Patients,0,1
55190,were,0,0
55191,monitored,0,0
55192,for,0,1
55193,adverse,0,0
55194,effects,0,0
55195,during,0,1
55196,the,0,0
55197,study,0,1
55198,and,0,1
55199,24,0,1
55200,hours,0,0
55201,after,0,1
55202,administration,0,0
55203,of,0,0
55204,the,0,0
55205,assigned,0,1
55206,drug,0,0
55207,.,0,1
55208,All,0,1
55209,three,0,0
55210,active,0,1
55211,treatments,0,0
55212,produced,0,0
55213,significant,0,0
55214,antipyresis,0,0
55215,compared,0,0
55216,with,0,1
55217,placebo,0,1
55218,.,0,1
55219,Ibuprofen,0,0
55220,provided,0,0
55221,greater,0,0
55222,temperature,0,0
55223,decrement,0,0
55224,and,0,0
55225,longer,0,0
55226,duration,0,0
55227,of,0,0
55228,antipyresis,0,0
55229,than,0,0
55230,acetaminophen,0,0
55231,when,0,0
55232,the,0,0
55233,two,0,0
55234,drugs,0,0
55235,were,0,1
55236,administered,0,0
55237,in,0,0
55238,approximately,0,1
55239,equal,0,1
55240,doses,0,0
55241,.,0,1
55242,No,0,0
55243,adverse,0,0
55244,effects,0,0
55245,were,0,1
55246,observed,0,0
55247,in,0,0
55248,any,0,0
55249,treatment,0,0
55250,group,0,1
55251,.,0,1
55252,CONCLUSION,0,0
55253,Ibuprofen,0,0
55254,is,0,0
55255,a,0,0
55256,potent,0,0
55257,antipyretic,0,0
55258,agent,0,0
55259,and,0,0
55260,is,0,0
55261,a,0,0
55262,safe,0,0
55263,alternative,0,0
55264,for,0,0
55265,the,0,0
55266,selected,0,1
55267,febrile,1,1
55268,child,1,1
55269,who,0,1
55270,may,0,0
55271,benefit,0,1
55272,from,0,0
55273,antipyretic,0,0
55274,medication,0,1
55275,but,0,0
55276,who,0,1
55277,either,0,1
55278,can,0,0
55279,not,0,0
55280,take,0,0
55281,or,0,0
55282,does,0,0
55283,not,0,0
55284,achieve,0,0
55285,satisfactory,0,0
55286,antipyresis,0,0
55287,with,0,1
55288,acetaminophen,0,0
55289,.,0,1
55290,Adhesion-prevention,0,1
55291,effects,0,0
55292,of,0,1
55293,fibrin,0,0
55294,sealants,0,0
55295,after,1,1
55296,laparoscopic,1,1
55297,myomectomy,1,1
55298,as,0,0
55299,determined,0,0
55300,by,0,0
55301,second-look,0,1
55302,laparoscopy,0,1
55303,:,0,1
55304,a,0,0
55305,prospective,0,0
55306,",",0,0
55307,randomized,0,1
55308,",",0,0
55309,controlled,0,0
55310,study,0,1
55311,.,0,1
55312,OBJECTIVE,0,0
55313,To,0,0
55314,examine,0,0
55315,the,0,0
55316,adhesion,0,0
55317,prevention,0,1
55318,effects,0,0
55319,of,0,1
55320,2,0,1
55321,types,0,1
55322,of,0,1
55323,fibrin,0,0
55324,sealant,0,0
55325,after,1,0
55326,laparoscopic,1,1
55327,myomectomy,1,1
55328,(,1,1
55329,LM,1,1
55330,),1,1
55331,.,1,1
55332,STUDY,0,0
55333,DESIGN,0,1
55334,A,0,1
55335,prospective,0,1
55336,",",0,0
55337,randomized,0,1
55338,study,0,0
55339,(,1,1
55340,Canadian,1,1
55341,Task,1,1
55342,Force,1,1
55343,I,1,1
55344,),1,1
55345,was,0,0
55346,conducted,0,1
55347,at,0,0
55348,a,0,1
55349,University-affiliated,1,1
55350,hospital,1,1
55351,.,1,1
55352,A,1,0
55353,total,1,1
55354,of,1,0
55355,91,1,1
55356,patients,1,1
55357,showing,1,0
55358,a,1,1
55359,minimal,1,0
55360,myoma,1,1
55361,>,1,1
55362,5,1,0
55363,cm,1,1
55364,",",1,0
55365,excluding,1,0
55366,pedunculated,1,1
55367,myomas,1,1
55368,",",1,0
55369,underwent,1,1
55370,LM,1,1
55371,alone,1,1
55372,:,1,1
55373,32,1,1
55374,patients,1,1
55375,in,1,1
55376,the,1,0
55377,control,1,0
55378,group,1,0
55379,",",1,0
55380,29,1,1
55381,in,1,0
55382,the,1,0
55383,fibrin,1,0
55384,gel,1,0
55385,group,1,1
55386,and,1,1
55387,30,1,1
55388,patients,1,1
55389,in,1,1
55390,the,1,1
55391,fibrin,1,0
55392,sheet,1,0
55393,group,1,1
55394,.,1,1
55395,After,0,0
55396,LM,0,0
55397,",",0,1
55398,postoperative,0,0
55399,adhesions,0,0
55400,were,0,1
55401,evaluated,0,0
55402,by,0,0
55403,second-look,0,1
55404,laparoscopy,0,1
55405,.,0,1
55406,The,0,0
55407,frequency,0,0
55408,of,0,0
55409,postoperative,0,1
55410,adhesions,0,0
55411,was,0,0
55412,the,0,0
55413,main,0,0
55414,outcome,0,0
55415,.,0,1
55416,RESULTS,0,0
55417,The,0,0
55418,frequency,0,0
55419,of,0,0
55420,postoperative,0,1
55421,adhesions,0,0
55422,of,0,1
55423,the,0,0
55424,uterus,0,1
55425,was,0,0
55426,significantly,0,0
55427,lower,0,0
55428,(,0,0
55429,p,0,0
55430,<,0,0
55431,0.05,0,0
55432,),0,1
55433,in,0,0
55434,the,0,0
55435,fibrin,0,0
55436,gel,0,0
55437,group,0,0
55438,",",0,0
55439,with,0,1
55440,20/32,0,1
55441,(,0,1
55442,62.5,0,0
55443,%,0,0
55444,),0,1
55445,in,0,0
55446,the,0,0
55447,control,0,0
55448,group,0,0
55449,",",0,1
55450,10/29,0,1
55451,(,0,1
55452,34.5,0,0
55453,%,0,0
55454,),0,1
55455,in,0,0
55456,the,0,0
55457,fibrin,0,0
55458,gel,0,0
55459,group,0,1
55460,and,0,1
55461,20/30,0,0
55462,(,0,1
55463,67.7,0,0
55464,%,0,0
55465,),0,1
55466,in,0,0
55467,the,0,0
55468,fibrin,0,0
55469,sheet,0,0
55470,group,0,1
55471,.,0,1
55472,Although,0,0
55473,no,0,0
55474,significant,0,0
55475,differences,0,0
55476,were,0,1
55477,found,0,0
55478,in,0,0
55479,the,0,0
55480,incidence,0,0
55481,of,0,0
55482,de,0,1
55483,novo,0,1
55484,adnexal,0,1
55485,adhesions,0,0
55486,",",0,1
55487,the,0,0
55488,lowest,0,0
55489,rate,0,0
55490,was,0,0
55491,found,0,0
55492,in,0,0
55493,the,0,0
55494,fibrin,0,0
55495,gel,0,0
55496,group,0,0
55497,",",0,0
55498,with,0,1
55499,4/32,0,1
55500,patients,0,1
55501,(,0,1
55502,12.5,0,0
55503,%,0,0
55504,),0,1
55505,in,0,0
55506,the,0,0
55507,control,0,0
55508,group,0,0
55509,",",0,1
55510,2/29,0,1
55511,patients,0,1
55512,(,0,1
55513,6.8,0,0
55514,%,0,0
55515,),0,1
55516,in,0,0
55517,the,0,0
55518,fibrin,0,0
55519,gel,0,0
55520,group,0,1
55521,and,0,1
55522,5/30,0,1
55523,patients,0,1
55524,(,0,1
55525,16.7,0,1
55526,%,0,0
55527,),0,1
55528,in,0,0
55529,the,0,0
55530,fibrin,0,0
55531,sheet,0,0
55532,group,0,1
55533,.,0,1
55534,No,0,0
55535,bilateral,0,0
55536,adnexal,0,1
55537,adhesions,0,0
55538,were,0,1
55539,observed,0,0
55540,in,0,0
55541,the,0,1
55542,3,0,1
55543,groups,0,1
55544,.,0,1
55545,CONCLUSION,0,0
55546,After,0,1
55547,LM,0,1
55548,for,0,0
55549,myomas,0,1
55550,as,0,0
55551,large,0,1
55552,as,0,0
55553,>,0,1
55554,or,0,1
55555,=,0,1
55556,5,0,0
55557,cm,0,1
55558,",",0,1
55559,postoperative,0,0
55560,adhesions,0,0
55561,were,0,1
55562,observed,0,0
55563,in,0,0
55564,>,0,1
55565,or,0,1
55566,=,0,1
55567,50,0,1
55568,%,0,0
55569,of,0,1
55570,patients,0,1
55571,.,0,1
55572,The,0,0
55573,use,0,0
55574,of,0,0
55575,fibrin,0,0
55576,gel,0,0
55577,after,0,0
55578,LM,0,1
55579,is,0,0
55580,recommended,0,0
55581,.,0,0
55582,A,0,0
55583,comparison,0,0
55584,of,0,0
55585,two,0,1
55586,double-injection,0,1
55587,techniques,0,0
55588,for,0,1
55589,peribulbar,1,0
55590,block,1,1
55591,analgesia,1,0
55592,:,1,1
55593,infero-temporal,0,0
55594,plus,0,0
55595,supero-medial,0,1
55596,vs.,0,0
55597,infero-temporal,0,1
55598,plus,0,0
55599,medial-percaruncular,0,1
55600,.,0,1
55601,BACKGROUND,0,0
55602,Combinations,0,0
55603,of,0,1
55604,infero-temporal,0,1
55605,and,0,1
55606,either,0,1
55607,supero-nasal,0,0
55608,(,0,1
55609,'inferior-superior,0,0
55610,',0,1
55611,),0,1
55612,or,0,1
55613,medial,0,0
55614,percaruncular,0,1
55615,(,0,1
55616,'inferior-medial,0,0
55617,',0,1
55618,),0,1
55619,injections,0,0
55620,are,0,0
55621,popular,0,0
55622,double-injection,0,1
55623,techniques,0,0
55624,for,0,1
55625,establishing,0,0
55626,peribulbar,0,0
55627,block,0,1
55628,analgesia,0,0
55629,.,0,1
55630,This,0,0
55631,study,0,0
55632,compared,0,0
55633,the,0,0
55634,efficacy,0,0
55635,of,0,0
55636,these,0,0
55637,two,0,0
55638,techniques,0,0
55639,in,0,1
55640,achieving,0,0
55641,ocular,0,1
55642,and,0,1
55643,lid,0,1
55644,akinesia,0,1
55645,.,0,1
55646,METHODS,0,0
55647,One,1,1
55648,hundred,1,1
55649,patients,1,1
55650,were,1,1
55651,randomized,1,1
55652,to,0,0
55653,receive,0,1
55654,inferior-superior,0,0
55655,or,0,1
55656,inferior-medial,0,0
55657,injections,0,0
55658,in,0,1
55659,a,0,1
55660,study,0,0
55661,in,0,0
55662,which,0,0
55663,injectate,0,0
55664,",",0,0
55665,injectate,0,0
55666,volumes,0,0
55667,",",0,1
55668,5-min,0,0
55669,ocular,0,1
55670,akinesia,0,1
55671,scoring,0,1
55672,(,0,1
55673,0-8,0,0
55674,),0,1
55675,",",0,0
55676,lid,0,1
55677,scoring,0,1
55678,(,0,1
55679,0-2,0,1
55680,),0,1
55681,and,0,1
55682,supplemental,0,1
55683,injection,0,0
55684,protocols,0,0
55685,were,0,1
55686,standardized,0,1
55687,.,0,1
55688,The,0,0
55689,numbers,0,0
55690,of,0,1
55691,supplemental,0,1
55692,injections,0,0
55693,required,0,0
55694,at,0,1
55695,each,0,0
55696,observation,0,0
55697,period,0,0
55698,and,0,0
55699,the,0,0
55700,total,0,1
55701,volume,0,0
55702,of,0,0
55703,injectate,0,0
55704,required,0,0
55705,to,0,0
55706,produce,0,0
55707,ocular,0,1
55708,and,0,0
55709,lid,0,1
55710,akinesia,0,0
55711,were,0,1
55712,compared,0,0
55713,.,0,0
55714,RESULTS,0,0
55715,The,0,0
55716,two,0,0
55717,test,0,0
55718,groups,0,0
55719,were,0,1
55720,demographically,0,1
55721,similar,0,0
55722,.,0,1
55723,The,0,0
55724,inferior-medial,0,0
55725,combination,0,0
55726,achieved,0,0
55727,greater,0,0
55728,ocular,0,1
55729,akinesia,0,0
55730,than,0,0
55731,the,0,0
55732,inferior-superior,0,0
55733,combination,0,0
55734,5,0,0
55735,min,0,0
55736,after,0,0
55737,the,0,0
55738,initial,0,1
55739,injections,0,0
55740,(,0,1
55741,mean,0,1
55742,score,0,1
55743,+/-,0,0
55744,standard,0,1
55745,deviation,0,1
55746,of,0,1
55747,1.74,0,0
55748,+/-,0,0
55749,1.86,0,1
55750,vs.,0,0
55751,2.66,0,0
55752,+/-,0,1
55753,2.39,0,0
55754,;,0,1
55755,P,0,0
55756,<,0,0
55757,0.05,0,0
55758,),0,1
55759,",",0,0
55760,with,0,1
55761,a,0,0
55762,reduced,0,0
55763,requirement,0,1
55764,for,0,1
55765,supplementary,0,0
55766,injections,0,0
55767,(,0,1
55768,3,0,1
55769,vs.,0,0
55770,23,0,1
55771,supplementary,0,1
55772,injections,0,0
55773,;,0,1
55774,P,0,0
55775,<,0,0
55776,0.025,0,0
55777,),0,1
55778,.,0,1
55779,The,0,0
55780,inferior-superior,0,0
55781,technique,0,0
55782,achieved,0,0
55783,greater,0,0
55784,lid,0,1
55785,akinesia,0,0
55786,at,0,1
55787,5,0,0
55788,min,0,0
55789,than,0,0
55790,the,0,0
55791,inferior-medial,0,0
55792,technique,0,0
55793,(,0,1
55794,mean,0,1
55795,score,0,1
55796,+/-,0,0
55797,standard,0,1
55798,deviation,0,1
55799,of,0,1
55800,0.7,0,0
55801,+/-,0,0
55802,0.9,0,0
55803,vs.,0,0
55804,0.3,0,0
55805,+/-,0,1
55806,0.58,0,0
55807,;,0,1
55808,P,0,0
55809,<,0,0
55810,0.005,0,0
55811,),0,1
55812,.,0,1
55813,A,0,0
55814,medial,0,0
55815,subconjunctival,0,0
55816,hemorrhage,0,1
55817,occurred,0,0
55818,in,0,0
55819,one,0,1
55820,patient,0,1
55821,in,0,0
55822,the,0,0
55823,inferior-medial,0,0
55824,group,0,1
55825,.,0,1
55826,CONCLUSION,0,0
55827,Compared,0,0
55828,with,0,1
55829,the,0,0
55830,inferior-superior,0,0
55831,technique,0,0
55832,",",0,0
55833,the,0,0
55834,inferior-medial,0,0
55835,combination,0,0
55836,achieved,0,0
55837,more,0,0
55838,rapid,0,0
55839,ocular,0,0
55840,akinesia,0,0
55841,with,0,1
55842,less,0,0
55843,need,0,0
55844,for,0,0
55845,supplementation,0,0
55846,",",0,0
55847,but,0,0
55848,induced,0,0
55849,less,0,0
55850,efficient,0,0
55851,lid,0,0
55852,akinesia,0,1
55853,and,0,0
55854,had,0,1
55855,a,0,0
55856,propensity,0,0
55857,to,0,0
55858,cause,0,0
55859,iatrogenic,0,1
55860,subconjunctival,0,1
55861,hemorrhage,0,1
55862,.,0,1
55863,The,0,0
55864,latter,0,0
55865,complication,0,0
55866,is,0,0
55867,considered,0,0
55868,by,0,0
55869,our,0,1
55870,surgeons,0,1
55871,to,0,0
55872,be,0,0
55873,a,0,0
55874,contraindication,0,0
55875,to,0,0
55876,the,0,0
55877,inferior-medial,0,0
55878,technique,0,0
55879,in,0,1
55880,patients,1,1
55881,undergoing,1,1
55882,trabeculectomy,1,1
55883,.,1,1
55884,Effects,0,0
55885,of,0,1
55886,supplementation,0,0
55887,of,0,0
55888,whole,0,0
55889,corn,0,0
55890,germ,0,1
55891,on,0,0
55892,reproductive,0,1
55893,performance,0,0
55894,",",0,0
55895,calf,0,0
55896,performance,0,0
55897,",",0,0
55898,and,0,0
55899,leptin,0,0
55900,concentration,0,0
55901,in,0,0
55902,primiparous,1,1
55903,and,1,1
55904,mature,1,1
55905,beef,1,1
55906,cows,1,1
55907,.,1,1
55908,A,0,0
55909,2-yr,0,0
55910,study,0,1
55911,using,0,0
55912,primiparous,1,1
55913,and,1,1
55914,multiparous,1,1
55915,",",1,0
55916,spring-calving,1,1
55917,",",1,0
55918,crossbred,1,1
55919,beef,1,1
55920,cows,1,1
55921,was,0,0
55922,conducted,0,1
55923,to,0,0
55924,evaluate,0,0
55925,the,0,0
55926,effects,0,0
55927,of,0,0
55928,supplemental,0,1
55929,whole,0,0
55930,corn,0,0
55931,germ,0,1
55932,on,0,0
55933,reproductive,0,1
55934,performance,0,0
55935,",",0,0
55936,calf,0,0
55937,performance,0,0
55938,",",0,0
55939,and,0,0
55940,serum,0,0
55941,leptin,0,0
55942,concentrations,0,0
55943,.,0,1
55944,Each,0,0
55945,year,0,0
55946,",",0,0
55947,cows,1,1
55948,were,0,1
55949,blocked,0,0
55950,by,0,0
55951,age,0,1
55952,and,0,1
55953,BCS,0,1
55954,and,0,0
55955,assigned,0,1
55956,randomly,0,1
55957,to,0,0
55958,one,0,1
55959,of,0,1
55960,three,0,1
55961,treatments,0,0
55962,:,0,1
55963,PRE,0,1
55964,(,0,1
55965,n,0,1
55966,=,0,1
55967,115,0,1
55968,),0,1
55969,cows,0,1
55970,received,0,1
55971,1.14,0,0
55972,kg/d,0,0
55973,(,0,1
55974,DM,0,1
55975,basis,0,0
55976,),0,1
55977,of,0,0
55978,whole,0,0
55979,corn,0,0
55980,germ,0,1
55981,for,0,0
55982,approximately,0,1
55983,45,0,1
55984,d,0,0
55985,before,0,1
55986,calving,0,1
55987,;,0,1
55988,POST,0,1
55989,(,0,1
55990,n,0,1
55991,=,0,1
55992,109,0,1
55993,),0,1
55994,cows,0,1
55995,were,0,1
55996,fed,0,1
55997,1.14,0,0
55998,kg/d,0,0
55999,of,0,1
56000,whole,0,0
56001,corn,0,0
56002,germ,0,1
56003,for,0,0
56004,approximately,0,1
56005,45,0,1
56006,d,0,0
56007,after,0,1
56008,calving,0,1
56009,;,0,0
56010,and,0,1
56011,control,0,1
56012,cows,0,1
56013,(,0,1
56014,n,0,1
56015,=,0,1
56016,118,0,1
56017,),0,1
56018,were,0,1
56019,fed,0,1
56020,similar,0,0
56021,energy,0,0
56022,and,0,0
56023,protein,0,0
56024,from,0,1
56025,dry-rolled,0,1
56026,corn,0,1
56027,(,0,1
56028,1.82,0,0
56029,kg,0,1
56030,of,0,1
56031,DM/d,0,1
56032,),0,1
56033,for,0,1
56034,45,0,1
56035,d,0,1
56036,before,0,0
56037,and,0,1
56038,after,0,1
56039,calving,0,1
56040,.,0,1
56041,Additionally,0,0
56042,",",0,0
56043,PRE,0,0
56044,cows,0,1
56045,were,0,1
56046,grouped,0,1
56047,with,0,1
56048,controls,0,1
56049,after,0,1
56050,calving,0,1
56051,",",0,0
56052,and,0,1
56053,POST,0,1
56054,cows,0,1
56055,were,0,1
56056,grouped,0,1
56057,with,0,1
56058,control,0,1
56059,cows,0,1
56060,before,0,1
56061,calving,0,1
56062,",",0,0
56063,so,0,0
56064,that,0,0
56065,corn,0,0
56066,germ-supplemented,0,0
56067,cows,0,1
56068,received,0,1
56069,the,0,0
56070,control,0,0
56071,supplement,0,0
56072,in,0,0
56073,the,0,0
56074,alternate,0,0
56075,feeding,0,1
56076,period,0,1
56077,.,0,1
56078,Cow,0,1
56079,BW,0,1
56080,(,0,1
56081,538,0,1
56082,+/-,0,1
56083,13,0,1
56084,kg,0,1
56085,),0,1
56086,and,0,1
56087,BCS,0,1
56088,(,0,1
56089,5.4,0,0
56090,+/-,0,1
56091,0.13,0,0
56092,),0,1
56093,did,0,0
56094,not,0,0
56095,differ,0,0
56096,among,0,0
56097,treatments,0,0
56098,at,0,1
56099,any,0,1
56100,time,0,0
56101,during,0,0
56102,the,0,0
56103,experiment,0,1
56104,.,0,1
56105,Calf,0,0
56106,birth,0,1
56107,weight,0,1
56108,(,0,1
56109,39,0,1
56110,+/-,0,1
56111,2,0,1
56112,kg,0,1
56113,),0,1
56114,",",0,0
56115,weaning,0,1
56116,weight,0,1
56117,(,0,1
56118,225,0,1
56119,+/-,0,1
56120,7,0,1
56121,kg,0,1
56122,),0,1
56123,",",0,0
56124,and,0,0
56125,age-adjusted,0,1
56126,weaning,0,1
56127,weight,0,1
56128,(,0,1
56129,234,0,1
56130,+/-,0,1
56131,8,0,1
56132,kg,0,1
56133,),0,1
56134,did,0,0
56135,not,0,0
56136,differ,0,0
56137,because,0,0
56138,of,0,0
56139,dam,0,1
56140,supplementation,0,0
56141,regimen,0,1
56142,.,0,1
56143,Treatment,0,0
56144,did,0,0
56145,not,0,0
56146,affect,0,0
56147,the,0,0
56148,proportion,0,0
56149,of,0,0
56150,cows,0,1
56151,exhibiting,0,1
56152,ovarian,0,1
56153,luteal,0,1
56154,activity,0,0
56155,before,0,0
56156,the,0,0
56157,start,0,1
56158,of,0,0
56159,the,0,0
56160,breeding,0,1
56161,season,0,1
56162,(,0,1
56163,67,0,1
56164,%,0,0
56165,),0,1
56166,or,0,1
56167,pregnancy,0,1
56168,rate,0,0
56169,(,0,1
56170,91,0,1
56171,%,0,0
56172,),0,1
56173,.,0,1
56174,The,0,0
56175,interval,0,0
56176,from,0,1
56177,exposure,0,1
56178,to,0,1
56179,bulls,0,1
56180,until,0,1
56181,subsequent,0,0
56182,calving,0,1
56183,did,0,0
56184,not,0,0
56185,differ,0,0
56186,(,0,0
56187,P,0,0
56188,=,0,1
56189,0.16,0,0
56190,),0,1
56191,among,0,1
56192,PRE,0,1
56193,(,0,1
56194,298,0,1
56195,+/-,0,1
56196,2.3,0,1
56197,d,0,1
56198,),0,1
56199,",",0,0
56200,POST,0,1
56201,(,0,1
56202,303,0,1
56203,+/-,0,1
56204,2.6,0,1
56205,d,0,1
56206,),0,1
56207,",",0,0
56208,and,0,0
56209,control,0,1
56210,(,0,1
56211,304,0,1
56212,+/-,0,1
56213,2.3,0,1
56214,d,0,0
56215,),0,1
56216,cows,0,1
56217,.,0,1
56218,Leptin,0,0
56219,concentrations,0,0
56220,did,0,0
56221,not,0,0
56222,differ,0,0
56223,among,0,0
56224,treatments,0,0
56225,and,0,1
56226,were,0,1
56227,2.15,0,1
56228,+/-,0,0
56229,0.75,0,0
56230,",",0,1
56231,1.88,0,0
56232,+/-,0,0
56233,0.76,0,0
56234,",",0,1
56235,and,0,1
56236,1.91,0,0
56237,+/-,0,0
56238,0.75,0,0
56239,ng/mL,0,1
56240,for,0,0
56241,control,0,1
56242,",",0,0
56243,POST,0,0
56244,",",0,0
56245,and,0,0
56246,PRE,0,0
56247,cows,0,1
56248,",",0,1
56249,respectively,0,0
56250,.,0,1
56251,Age,0,0
56252,and,0,0
56253,week,0,0
56254,relative,0,0
56255,to,0,0
56256,calving,0,1
56257,influenced,0,0
56258,leptin,0,1
56259,concentration,0,0
56260,.,0,1
56261,Primiparous,1,1
56262,cows,1,1
56263,had,0,1
56264,similar,0,0
56265,leptin,0,0
56266,concentrations,0,0
56267,to,0,1
56268,3-yr-old,0,1
56269,and,0,1
56270,mature,0,1
56271,cows,1,1
56272,for,0,1
56273,wk,0,1
56274,-7,0,0
56275,and,0,0
56276,-6,0,0
56277,relative,0,0
56278,to,0,0
56279,calving,0,1
56280,",",0,0
56281,but,0,0
56282,lower,0,0
56283,(,0,1
56284,P,0,0
56285,<,0,0
56286,0.10,0,0
56287,),0,1
56288,concentrations,0,0
56289,than,0,1
56290,mature,0,1
56291,cows,0,1
56292,for,0,1
56293,wk,0,1
56294,-5,0,0
56295,",",0,0
56296,and,0,0
56297,lower,0,0
56298,(,0,1
56299,P,0,0
56300,<,0,0
56301,0.05,0,0
56302,),0,1
56303,concentrations,0,0
56304,than,0,1
56305,either,0,1
56306,3-yr-old,0,1
56307,or,0,1
56308,mature,0,1
56309,cows,0,1
56310,for,0,1
56311,wk,0,1
56312,-4,0,0
56313,to,0,0
56314,+7,0,0
56315,relative,0,0
56316,to,0,1
56317,calving,0,1
56318,.,0,1
56319,Serum,0,1
56320,leptin,0,0
56321,was,0,0
56322,correlated,0,0
56323,with,0,1
56324,BCS,0,1
56325,(,0,1
56326,P,0,0
56327,<,0,0
56328,0.0001,0,0
56329,;,0,0
56330,r,0,0
56331,=,0,0
56332,0.35,0,0
56333,),0,0
56334,at,0,0
56335,initiation,0,0
56336,of,0,0
56337,the,0,0
56338,feeding,0,1
56339,period,0,0
56340,and,0,1
56341,was,0,0
56342,correlated,0,0
56343,with,0,1
56344,BCS,0,1
56345,(,0,1
56346,P,0,0
56347,=,0,1
56348,0.02,0,0
56349,;,0,0
56350,r,0,0
56351,=,0,0
56352,0.12,0,0
56353,),0,0
56354,and,0,1
56355,weight,0,1
56356,(,0,1
56357,P,0,0
56358,<,0,0
56359,0.01,0,0
56360,;,0,0
56361,r,0,0
56362,=,0,0
56363,0.14,0,0
56364,),0,0
56365,at,0,0
56366,the,0,0
56367,completion,0,0
56368,of,0,0
56369,the,0,0
56370,supplement,0,0
56371,period,0,0
56372,",",0,0
56373,but,0,0
56374,it,0,0
56375,was,0,0
56376,not,0,0
56377,correlated,0,0
56378,with,0,1
56379,initial,0,1
56380,BW,0,1
56381,or,0,1
56382,interim,0,0
56383,BCS,0,1
56384,.,0,1
56385,Calving,0,1
56386,interval,0,0
56387,was,0,0
56388,not,0,0
56389,correlated,0,0
56390,(,0,0
56391,P,0,0
56392,>,0,1
56393,0.12,0,0
56394,),0,1
56395,with,0,1
56396,weekly,0,1
56397,measures,0,0
56398,of,0,1
56399,serum,0,0
56400,leptin,0,0
56401,concentration,0,0
56402,.,0,1
56403,Supplementing,0,0
56404,beef,1,1
56405,cows,1,1
56406,with,0,1
56407,whole,0,0
56408,corn,0,0
56409,germ,0,1
56410,had,0,1
56411,no,0,0
56412,effect,0,0
56413,on,0,0
56414,cow,0,1
56415,performance,0,0
56416,",",0,0
56417,calf,0,0
56418,performance,0,0
56419,",",0,0
56420,or,0,1
56421,serum,0,0
56422,leptin,0,0
56423,concentrations,0,0
56424,of,0,1
56425,cows,0,1
56426,.,0,1
56427,Differential,0,1
56428,effects,0,0
56429,of,0,1
56430,two,0,1
56431,dihydropyridine,0,1
56432,calcium,0,0
56433,antagonists,0,0
56434,in,0,1
56435,humans,0,1
56436,.,0,1
56437,We,0,0
56438,studied,0,0
56439,the,0,0
56440,effects,0,0
56441,after,0,1
56442,single,0,1
56443,doses,0,0
56444,of,0,1
56445,niguldipine,0,1
56446,(,0,1
56447,0.3,0,0
56448,",",0,1
56449,0.6,0,0
56450,",",0,0
56451,and,0,0
56452,0.9,0,0
56453,mg,0,0
56454,intravenously,0,1
56455,;,0,1
56456,8,0,1
56457,and,0,1
56458,16,0,1
56459,mg,0,0
56460,orally,0,1
56461,),0,1
56462,and,0,0
56463,nifedipine,0,1
56464,(,0,1
56465,2,0,1
56466,mg,0,1
56467,intravenously,0,1
56468,;,0,1
56469,20,0,1
56470,mg,0,0
56471,orally,0,1
56472,),0,1
56473,in,0,0
56474,healthy,1,1
56475,male,1,1
56476,volunteers,1,1
56477,in,0,1
56478,randomized,0,1
56479,placebo-controlled,0,1
56480,experiments,0,1
56481,.,0,1
56482,Total,0,0
56483,peripheral,0,1
56484,resistance,0,0
56485,(,0,1
56486,TPR,0,1
56487,),0,1
56488,",",0,0
56489,heart,0,1
56490,rate-corrected,0,0
56491,electromechanical,0,1
56492,systole,0,1
56493,(,0,1
56494,QS2c,0,1
56495,),0,1
56496,",",0,0
56497,and,0,0
56498,preejection,0,0
56499,period,0,0
56500,(,0,1
56501,PEPc,0,1
56502,),0,1
56503,were,0,0
56504,assessed,0,0
56505,noninvasively,0,0
56506,.,0,1
56507,Both,0,0
56508,drugs,0,0
56509,induced,0,0
56510,a,0,1
56511,similar,0,0
56512,pronounced,0,0
56513,decreased,0,0
56514,in,0,0
56515,TRP,0,1
56516,",",0,1
56517,indicating,0,0
56518,peripheral,0,1
56519,vasodilation,0,0
56520,",",0,0
56521,followed,0,0
56522,by,0,0
56523,increasing,0,0
56524,heart,0,1
56525,rate,0,0
56526,and,0,0
56527,cardiac,0,1
56528,output,0,0
56529,",",0,0
56530,a,0,0
56531,decrease,0,0
56532,in,0,0
56533,diastolic,0,1
56534,blood,0,0
56535,pressure,0,0
56536,",",0,0
56537,and,0,0
56538,a,0,0
56539,shortening,0,0
56540,of,0,0
56541,the,0,0
56542,PEPc,0,1
56543,.,0,1
56544,QS2c,0,0
56545,was,0,0
56546,unchanged,0,0
56547,after,0,1
56548,niguldipine,0,1
56549,.,0,1
56550,The,0,0
56551,prolongation,0,0
56552,of,0,0
56553,QS2c,0,1
56554,after,0,1
56555,oral,0,0
56556,nifedipine,0,1
56557,is,0,0
56558,suggestive,0,0
56559,of,0,0
56560,a,0,1
56561,negative,0,0
56562,inotropic,0,0
56563,effect,0,0
56564,.,0,1
56565,We,0,0
56566,conclude,0,0
56567,that,0,0
56568,the,0,0
56569,vasodilatory,0,0
56570,effects,0,0
56571,of,0,1
56572,dihydropyridines,0,0
56573,may,0,0
56574,(,0,1
56575,as,0,0
56576,for,0,0
56577,nifedipine,0,1
56578,),0,0
56579,or,0,1
56580,may,0,0
56581,not,0,0
56582,(,0,0
56583,as,0,0
56584,for,0,0
56585,niguldipine,0,1
56586,),0,1
56587,be,0,0
56588,associated,0,0
56589,with,0,1
56590,changes,0,0
56591,that,0,0
56592,are,0,0
56593,suggestive,0,0
56594,of,0,0
56595,negative,0,1
56596,inotropic,0,0
56597,effects,0,0
56598,",",0,0
56599,and,0,0
56600,that,0,0
56601,this,0,0
56602,difference,0,0
56603,is,0,0
56604,detectable,0,0
56605,by,0,0
56606,noninvasive,0,0
56607,methods,0,1
56608,in,0,1
56609,healthy,1,1
56610,subjects,1,1
56611,.,1,1
56612,Long-term,0,1
56613,effects,0,0
56614,of,0,1
56615,risperidone,0,1
56616,in,0,1
56617,children,1,1
56618,with,1,1
56619,autism,1,1
56620,spectrum,1,1
56621,disorders,1,1
56622,:,1,1
56623,a,0,1
56624,placebo,0,0
56625,discontinuation,0,0
56626,study,0,1
56627,.,0,1
56628,OBJECTIVE,0,0
56629,The,0,0
56630,short-term,0,0
56631,benefit,0,0
56632,of,0,0
56633,risperidone,0,0
56634,in,0,0
56635,ameliorating,0,0
56636,severe,0,1
56637,disruptive,0,1
56638,behavior,0,0
56639,in,0,1
56640,pediatric,1,1
56641,patients,1,1
56642,with,1,1
56643,autism,1,1
56644,spectrum,1,1
56645,disorders,1,1
56646,is,0,0
56647,well,0,0
56648,established,0,0
56649,;,0,0
56650,however,0,0
56651,",",0,0
56652,only,0,0
56653,one,0,1
56654,placebo-controlled,0,0
56655,",",0,1
56656,long-term,0,0
56657,study,0,1
56658,of,0,0
56659,efficacy,0,0
56660,is,0,0
56661,available,0,0
56662,.,0,1
56663,METHOD,0,0
56664,Thirty-six,1,1
56665,children,1,1
56666,with,1,1
56667,an,1,1
56668,autism,1,1
56669,spectrum,1,1
56670,disorder,1,1
56671,(,1,1
56672,5-17,1,1
56673,years,1,1
56674,old,1,1
56675,),1,1
56676,accompanied,1,0
56677,by,1,0
56678,severe,1,1
56679,tantrums,1,1
56680,",",1,1
56681,aggression,1,1
56682,",",1,0
56683,or,1,1
56684,self-injurious,1,1
56685,behavior,1,0
56686,",",0,0
56687,started,0,0
56688,8-week,0,0
56689,open-label,0,1
56690,treatment,0,1
56691,with,0,1
56692,risperidone,0,0
56693,.,0,1
56694,Responders,0,0
56695,(,0,0
56696,n,0,1
56697,=,0,1
56698,26,0,1
56699,),0,1
56700,continued,0,0
56701,treatment,0,0
56702,for,0,0
56703,another,0,1
56704,16,0,1
56705,weeks,0,0
56706,",",0,1
56707,followed,0,0
56708,by,0,0
56709,a,0,1
56710,double-blind,0,0
56711,discontinuation,0,0
56712,(,0,0
56713,n,0,1
56714,=,0,1
56715,24,0,1
56716,;,0,0
56717,two,0,1
56718,patients,0,1
56719,discontinued,0,0
56720,treatment,0,0
56721,because,0,0
56722,of,0,0
56723,weight,0,1
56724,gain,0,0
56725,),0,1
56726,consisting,0,1
56727,of,0,0
56728,either,0,1
56729,3,0,1
56730,weeks,0,0
56731,of,0,1
56732,taper,0,0
56733,and,0,1
56734,5,0,1
56735,weeks,0,0
56736,of,0,1
56737,placebo,0,1
56738,only,0,0
56739,or,0,1
56740,continuing,0,0
56741,use,0,0
56742,of,0,1
56743,risperidone,0,0
56744,.,0,1
56745,Relapse,0,0
56746,was,0,0
56747,defined,0,0
56748,as,0,0
56749,a,0,1
56750,significant,0,0
56751,deterioration,0,0
56752,of,0,1
56753,symptoms,0,0
56754,based,0,1
56755,on,0,0
56756,clinical,0,0
56757,judgment,0,0
56758,and,0,0
56759,a,0,0
56760,parent,0,1
56761,questionnaire,0,0
56762,.,0,1
56763,RESULTS,0,0
56764,Risperidone,0,0
56765,was,0,0
56766,superior,0,0
56767,to,0,0
56768,placebo,0,0
56769,in,0,0
56770,preventing,0,0
56771,relapse,0,1
56772,:,0,1
56773,this,0,0
56774,occurred,0,0
56775,in,0,0
56776,3,0,1
56777,of,0,1
56778,12,0,1
56779,patients,0,1
56780,continuing,0,1
56781,on,0,0
56782,risperidone,0,1
56783,versus,0,0
56784,8,0,1
56785,of,0,1
56786,12,0,1
56787,who,0,1
56788,switched,0,1
56789,to,0,1
56790,placebo,0,0
56791,(,0,1
56792,p,0,0
56793,=,0,1
56794,.049,0,0
56795,),0,1
56796,.,0,1
56797,Weight,0,1
56798,gain,0,0
56799,",",0,0
56800,increased,0,0
56801,appetite,0,0
56802,",",0,0
56803,anxiety,0,0
56804,",",0,0
56805,and,0,0
56806,fatigue,0,0
56807,were,0,0
56808,the,0,0
56809,most,0,0
56810,frequently,0,0
56811,reported,0,0
56812,side,0,0
56813,effects,0,0
56814,.,0,1
56815,CONCLUSIONS,0,0
56816,This,0,0
56817,study,0,0
56818,indicates,0,0
56819,the,0,0
56820,effectiveness,0,0
56821,of,0,0
56822,risperidone,0,0
56823,during,0,0
56824,a,0,0
56825,period,0,0
56826,of,0,0
56827,several,0,1
56828,months,0,0
56829,",",0,1
56830,reducing,0,0
56831,disruptive,0,1
56832,behavior,0,0
56833,in,0,0
56834,about,0,0
56835,half,0,1
56836,of,0,0
56837,the,0,0
56838,children,1,1
56839,with,1,1
56840,autism,1,1
56841,spectrum,1,1
56842,disorders,1,1
56843,.,1,1
56844,The,0,0
56845,results,0,0
56846,provide,0,0
56847,a,0,0
56848,rationale,0,0
56849,for,0,0
56850,the,0,0
56851,continuing,0,0
56852,use,0,0
56853,of,0,0
56854,risperidone,0,0
56855,beyond,0,1
56856,6,0,1
56857,months,0,0
56858,",",0,1
56859,although,0,0
56860,considerable,0,0
56861,weight,0,1
56862,gain,0,0
56863,can,0,0
56864,limit,0,0
56865,the,0,0
56866,use,0,0
56867,of,0,0
56868,this,0,0
56869,agent,0,0
56870,.,0,1
56871,The,0,0
56872,evaluation,0,0
56873,of,0,0
56874,pulmonary,0,1
56875,hypertension,0,1
56876,using,0,0
56877,right,0,1
56878,ventricular,0,1
56879,myocardial,0,1
56880,isovolumic,0,0
56881,relaxation,0,0
56882,time,0,0
56883,.,0,1
56884,Right,0,0
56885,ventricular,0,0
56886,(,0,1
56887,RV,0,0
56888,),0,1
56889,blood,0,0
56890,pool-derived,0,0
56891,isovolumic,0,0
56892,relaxation,0,0
56893,time,0,0
56894,(,0,1
56895,IVRT,0,1
56896,),0,0
56897,correlates,0,0
56898,well,0,0
56899,with,0,1
56900,systolic,0,1
56901,pulmonary,0,1
56902,arterial,0,1
56903,pressure,0,0
56904,(,0,1
56905,PAP,0,1
56906,),0,1
56907,.,0,1
56908,However,0,0
56909,",",0,0
56910,because,0,0
56911,of,0,0
56912,complex,0,1
56913,parameter,0,0
56914,derivation,0,0
56915,",",0,0
56916,the,0,0
56917,method,0,0
56918,is,0,0
56919,rarely,0,0
56920,used,0,0
56921,.,0,0
56922,The,0,0
56923,aim,0,0
56924,of,0,0
56925,this,0,0
56926,study,0,0
56927,was,0,0
56928,to,0,0
56929,validate,0,0
56930,the,0,0
56931,measurement,0,0
56932,of,0,0
56933,myocardial,0,1
56934,velocity,0,0
56935,imaging-derived,0,1
56936,RV,0,1
56937,IVRT,0,1
56938,(,0,1
56939,IVRT,0,1
56940,',0,1
56941,),0,0
56942,against,0,1
56943,invasively,0,1
56944,measured,0,0
56945,PAP,0,1
56946,.,0,1
56947,Transthoracic,0,1
56948,echocardiography,0,0
56949,with,0,1
56950,myocardial,0,1
56951,velocity,0,0
56952,imaging,0,0
56953,and,0,0
56954,right,0,1
56955,heart,0,1
56956,catheterization,0,1
56957,were,0,0
56958,performed,0,0
56959,in,0,1
56960,33,1,1
56961,patients,1,1
56962,with,1,1
56963,pulmonary,1,1
56964,hypertension,1,1
56965,.,1,1
56966,Blood,0,0
56967,pool,0,1
56968,IVRT,0,1
56969,and,0,1
56970,myocardial,0,1
56971,IVRTs,0,1
56972,for,0,0
56973,the,0,0
56974,tricuspid,0,0
56975,valve,0,1
56976,annulus,0,1
56977,ring,0,1
56978,",",0,0
56979,basal,0,0
56980,and,0,0
56981,apical,0,0
56982,RV,0,0
56983,free,0,1
56984,wall,0,1
56985,segments,0,1
56986,were,0,1
56987,measured,0,0
56988,and,0,0
56989,compared,0,0
56990,with,0,1
56991,data,0,0
56992,from,0,1
56993,33,1,1
56994,age-,1,1
56995,and,1,1
56996,sex-matched,1,1
56997,control,1,1
56998,subjects,1,1
56999,.,1,1
57000,Measured,0,0
57001,IVRTs,0,0
57002,were,0,0
57003,significantly,0,0
57004,longer,0,0
57005,in,0,0
57006,patients,0,1
57007,with,0,1
57008,pulmonary,0,1
57009,hypertension,0,1
57010,than,0,0
57011,in,0,1
57012,control,0,1
57013,subjects,0,1
57014,.,0,1
57015,The,0,0
57016,strongest,0,0
57017,correlation,0,0
57018,(,0,1
57019,R,0,1
57020,=,0,1
57021,0.74,0,0
57022,",",0,1
57023,P,0,0
57024,<,0,0
57025,.0001,0,0
57026,),0,1
57027,was,0,0
57028,found,0,0
57029,between,0,0
57030,systolic,0,1
57031,PAP,0,1
57032,and,0,0
57033,the,0,0
57034,heart,0,1
57035,rate-corrected,0,0
57036,IVRT,0,1
57037,',0,1
57038,derived,0,0
57039,from,0,1
57040,the,0,0
57041,basal,0,0
57042,RV,0,0
57043,free,0,1
57044,wall,0,1
57045,segment,0,1
57046,.,0,1
57047,The,0,0
57048,basal,0,0
57049,segment,0,0
57050,IVRT,0,1
57051,',0,1
57052,corrected,0,0
57053,for,0,1
57054,heart,0,1
57055,rate,0,0
57056,correlates,0,0
57057,well,0,0
57058,with,0,1
57059,the,0,0
57060,invasive,0,1
57061,PAP,0,1
57062,measurement,0,0
57063,and,0,0
57064,",",0,0
57065,therefore,0,0
57066,",",0,0
57067,can,0,0
57068,be,0,0
57069,used,0,0
57070,to,0,0
57071,predict,0,0
57072,systolic,0,1
57073,PAP,0,1
57074,.,0,1
57075,It,0,0
57076,can,0,0
57077,even,0,0
57078,be,0,0
57079,considered,0,0
57080,as,0,0
57081,an,0,0
57082,alternative,0,0
57083,to,0,0
57084,tricuspid,0,1
57085,regurgitation-derived,0,0
57086,PAP,0,1
57087,systolic,0,0
57088,when,0,0
57089,tricuspid,0,0
57090,regurgitation,0,0
57091,is,0,0
57092,nonrecordable,0,0
57093,.,0,0
57094,A,0,0
57095,proposed,0,0
57096,method,0,0
57097,to,0,0
57098,derive,0,0
57099,systolic,0,0
57100,PAP,0,1
57101,should,0,0
57102,be,0,0
57103,used,0,0
57104,while,0,0
57105,screening,0,1
57106,the,0,0
57107,patients,0,1
57108,at,0,0
57109,risk,0,1
57110,for,0,1
57111,pulmonary,0,1
57112,hypertension,0,1
57113,",",0,0
57114,monitoring,0,0
57115,the,0,0
57116,disease,0,1
57117,progression,0,0
57118,and,0,0
57119,the,0,0
57120,effect,0,0
57121,of,0,0
57122,treatment,0,1
57123,.,0,1
57124,Randomized,0,0
57125,",",0,0
57126,controlled,0,0
57127,",",0,0
57128,crossover,0,0
57129,trial,0,0
57130,of,0,0
57131,methylphenidate,0,0
57132,in,0,1
57133,pervasive,0,1
57134,developmental,0,1
57135,disorders,0,1
57136,with,0,1
57137,hyperactivity,0,1
57138,.,0,1
57139,CONTEXT,0,0
57140,Hyperactivity,0,0
57141,and,0,0
57142,inattention,0,1
57143,are,0,0
57144,common,0,0
57145,symptoms,0,1
57146,in,0,1
57147,children,0,1
57148,with,0,1
57149,autistic,0,1
57150,disorder,0,1
57151,and,0,1
57152,related,0,0
57153,pervasive,0,1
57154,developmental,0,1
57155,disorders,0,1
57156,",",0,1
57157,but,0,0
57158,studies,0,0
57159,of,0,1
57160,stimulants,0,1
57161,in,0,1
57162,these,0,0
57163,conditions,0,1
57164,have,0,0
57165,been,0,1
57166,inconclusive,0,0
57167,.,0,1
57168,OBJECTIVES,0,0
57169,To,0,0
57170,determine,0,0
57171,the,0,0
57172,efficacy,0,0
57173,and,0,0
57174,safety,0,0
57175,of,0,0
57176,methylphenidate,0,0
57177,hydrochloride,1,0
57178,in,1,1
57179,children,1,1
57180,with,0,1
57181,pervasive,0,1
57182,developmental,0,1
57183,disorders,0,1
57184,and,0,1
57185,hyperactivity,0,1
57186,.,0,1
57187,DESIGN,0,0
57188,Double-blind,0,0
57189,",",0,0
57190,placebo-controlled,0,0
57191,",",0,0
57192,crossover,0,0
57193,trial,0,0
57194,followed,0,1
57195,by,0,0
57196,open-label,0,1
57197,continuation,0,1
57198,.,0,1
57199,SETTING,0,1
57200,Five,0,1
57201,academic,0,1
57202,outpatient,0,1
57203,clinics,0,1
57204,.,0,1
57205,PARTICIPANTS,0,0
57206,Seventy-two,1,1
57207,drug-free,1,1
57208,children,1,1
57209,",",1,1
57210,aged,1,1
57211,5,1,0
57212,to,1,1
57213,14,1,1
57214,years,1,1
57215,",",1,1
57216,with,1,1
57217,pervasive,1,1
57218,developmental,1,1
57219,disorders,1,1
57220,accompanied,1,0
57221,by,1,1
57222,moderate,1,1
57223,to,1,1
57224,severe,1,1
57225,hyperactivity,1,1
57226,.,1,1
57227,INTERVENTIONS,0,0
57228,Prior,0,1
57229,to,0,1
57230,randomization,0,0
57231,",",0,1
57232,subjects,1,1
57233,entered,0,1
57234,a,0,1
57235,1-week,0,0
57236,test-dose,0,0
57237,phase,0,1
57238,in,0,0
57239,which,0,0
57240,each,0,0
57241,subject,0,0
57242,received,0,0
57243,placebo,0,0
57244,for,0,0
57245,1,0,1
57246,day,0,0
57247,followed,0,1
57248,by,0,0
57249,increasing,0,0
57250,doses,0,0
57251,of,0,1
57252,methylphenidate,0,1
57253,(,0,1
57254,low,0,0
57255,",",0,0
57256,medium,0,0
57257,",",0,0
57258,and,0,0
57259,high,0,1
57260,doses,0,0
57261,),0,1
57262,that,0,0
57263,were,0,1
57264,each,0,0
57265,given,0,0
57266,for,0,0
57267,2,0,1
57268,days,0,0
57269,.,0,1
57270,The,0,0
57271,low,0,0
57272,",",0,0
57273,medium,0,0
57274,",",0,0
57275,and,0,0
57276,high,0,1
57277,doses,0,0
57278,of,0,1
57279,methylphenidate,0,1
57280,hydrochloride,0,0
57281,were,0,0
57282,based,0,1
57283,on,0,0
57284,weight,0,1
57285,",",0,0
57286,and,0,0
57287,they,0,0
57288,ranged,0,0
57289,from,0,1
57290,7.5,0,1
57291,mg/d,0,0
57292,to,0,1
57293,50.0,0,1
57294,mg/d,0,0
57295,in,0,1
57296,divided,0,1
57297,doses,0,1
57298,.,0,1
57299,Subjects,1,1
57300,who,1,1
57301,tolerated,1,1
57302,the,1,1
57303,test,1,0
57304,dose,1,0
57305,(,0,1
57306,n,0,1
57307,=,0,1
57308,66,0,1
57309,),0,1
57310,were,0,1
57311,assigned,0,1
57312,to,0,0
57313,receive,0,1
57314,placebo,0,0
57315,for,0,0
57316,1,0,1
57317,week,0,0
57318,and,0,1
57319,then,0,0
57320,3,0,1
57321,methylphenidate,0,0
57322,doses,0,0
57323,in,0,1
57324,random,0,1
57325,order,0,0
57326,during,0,0
57327,a,0,0
57328,double-blind,0,0
57329,",",0,0
57330,crossover,0,0
57331,phase,0,1
57332,.,0,1
57333,Children,1,1
57334,responding,1,0
57335,to,1,0
57336,methylphenidate,1,0
57337,then,0,0
57338,entered,0,1
57339,8,0,0
57340,weeks,0,0
57341,of,0,1
57342,open-label,0,1
57343,treatment,0,0
57344,at,0,0
57345,the,0,0
57346,individually,0,0
57347,determined,0,0
57348,best,0,0
57349,dose,0,0
57350,.,0,1
57351,MAIN,0,0
57352,OUTCOME,0,1
57353,MEASURES,0,0
57354,The,0,0
57355,primary,0,1
57356,outcome,0,0
57357,measure,0,0
57358,was,0,0
57359,the,0,0
57360,teacher-rated,0,0
57361,hyperactivity,0,1
57362,subscale,0,0
57363,of,0,0
57364,the,0,0
57365,Aberrant,0,1
57366,Behavior,0,1
57367,Checklist,0,0
57368,.,0,1
57369,Response,0,0
57370,was,0,0
57371,defined,0,0
57372,as,0,0
57373,much,0,0
57374,improved,0,0
57375,or,0,1
57376,very,0,0
57377,much,0,0
57378,improved,0,0
57379,on,0,0
57380,the,0,0
57381,Clinical,0,0
57382,Global,0,1
57383,Impressions,0,0
57384,Improvement,0,0
57385,item,0,0
57386,coupled,0,0
57387,with,0,1
57388,considerable,0,0
57389,reductions,0,0
57390,in,0,1
57391,the,0,1
57392,parent-rated,0,1
57393,and/or,0,1
57394,teacher-rated,0,1
57395,Aberrant,0,1
57396,Behavior,0,1
57397,Checklist,0,0
57398,hyperactivity,0,1
57399,subscale,0,0
57400,score,0,0
57401,.,0,1
57402,RESULTS,0,0
57403,Methylphenidate,0,1
57404,was,0,0
57405,superior,0,0
57406,to,0,0
57407,placebo,0,0
57408,on,0,0
57409,the,0,0
57410,primary,0,1
57411,outcome,0,0
57412,measure,0,0
57413,",",0,0
57414,with,0,1
57415,effect,0,0
57416,sizes,0,0
57417,ranging,0,1
57418,from,0,1
57419,0.20,0,0
57420,to,0,1
57421,0.54,0,0
57422,depending,0,1
57423,on,0,0
57424,dose,0,0
57425,and,0,1
57426,rater,0,0
57427,.,0,1
57428,Thirty-five,1,1
57429,(,1,1
57430,49,1,1
57431,%,1,0
57432,),1,1
57433,of,1,0
57434,72,1,1
57435,enrolled,1,1
57436,subjects,1,1
57437,were,0,1
57438,classified,0,1
57439,as,0,0
57440,methylphenidate,0,1
57441,responders,0,0
57442,.,0,1
57443,Adverse,0,0
57444,effects,0,0
57445,led,0,0
57446,to,0,1
57447,the,0,0
57448,discontinuation,0,0
57449,of,0,0
57450,study,0,1
57451,medication,0,1
57452,in,0,1
57453,13,1,1
57454,(,1,1
57455,18,1,1
57456,%,1,0
57457,),1,1
57458,of,1,1
57459,72,1,1
57460,subjects,1,1
57461,.,1,1
57462,CONCLUSIONS,0,0
57463,Methylphenidate,0,1
57464,was,0,0
57465,often,0,0
57466,efficacious,0,0
57467,in,0,0
57468,treating,0,0
57469,hyperactivity,0,1
57470,associated,0,0
57471,with,0,1
57472,pervasive,0,1
57473,developmental,0,1
57474,disorders,0,1
57475,",",0,0
57476,but,0,0
57477,the,0,0
57478,magnitude,0,0
57479,of,0,0
57480,response,0,0
57481,was,0,0
57482,less,0,0
57483,than,0,0
57484,that,0,0
57485,seen,0,0
57486,in,0,0
57487,typically,0,1
57488,developing,0,1
57489,children,0,1
57490,with,0,1
57491,attention-deficit/hyperactivity,0,1
57492,disorder,0,1
57493,.,0,1
57494,Adverse,0,0
57495,effects,0,0
57496,were,0,0
57497,more,0,0
57498,frequent,0,0
57499,.,0,0
57500,Intervention,0,1
57501,pilot,0,1
57502,for,0,0
57503,parents,1,1
57504,of,1,1
57505,children,1,1
57506,with,1,1
57507,autistic,1,1
57508,spectrum,1,1
57509,disorder,1,1
57510,.,1,1
57511,Parents,1,0
57512,of,1,1
57513,children,1,1
57514,who,1,1
57515,receive,1,1
57516,the,1,1
57517,diagnosis,1,1
57518,of,1,0
57519,autistic,1,1
57520,spectrum,1,1
57521,disorder,1,1
57522,(,1,1
57523,ASD,1,1
57524,),1,1
57525,experience,0,1
57526,a,0,1
57527,situational,0,0
57528,crisis,0,1
57529,related,0,0
57530,to,0,0
57531,receiving,0,1
57532,the,0,0
57533,diagnosis,0,1
57534,",",0,0
57535,which,0,0
57536,causes,0,0
57537,feelings,0,0
57538,of,0,0
57539,distress,0,1
57540,and,0,1
57541,urgency,0,0
57542,to,0,1
57543,access,0,1
57544,services,0,1
57545,for,0,1
57546,the,0,1
57547,affected,0,0
57548,child,0,1
57549,.,0,1
57550,This,0,0
57551,paper,0,0
57552,describes,0,0
57553,a,0,0
57554,randomized,1,0
57555,trial,1,0
57556,(,1,1
57557,n,1,1
57558,=,1,1
57559,31,1,1
57560,),1,1
57561,that,1,0
57562,was,1,0
57563,conducted,1,0
57564,at,1,0
57565,a,1,1
57566,regional,1,1
57567,diagnostic,1,0
57568,center,1,1
57569,of,1,0
57570,a,1,1
57571,large,1,1
57572,metropolitan,1,1
57573,children,1,1
57574,'s,1,1
57575,hospital,1,1
57576,to,0,1
57577,(,0,0
57578,a,0,1
57579,),0,0
57580,refine,0,0
57581,a,0,0
57582,nursing,0,1
57583,intervention,0,0
57584,designed,0,0
57585,for,0,0
57586,parents,1,1
57587,of,1,1
57588,children,1,1
57589,with,1,1
57590,ASD,1,1
57591,and,0,1
57592,(,0,1
57593,b,0,1
57594,),0,0
57595,to,0,0
57596,identify,0,0
57597,methodological,0,0
57598,revisions,0,0
57599,for,0,0
57600,a,0,1
57601,larger,0,0
57602,study,0,0
57603,.,0,0
57604,A,0,0
57605,secondary,0,0
57606,purpose,0,0
57607,was,0,0
57608,to,0,0
57609,test,0,0
57610,the,0,0
57611,effects,0,0
57612,of,0,0
57613,a,0,1
57614,post-diagnosis,0,0
57615,nursing,0,1
57616,intervention,0,1
57617,on,0,0
57618,parents,0,1
57619,',0,1
57620,reports,0,1
57621,of,0,1
57622,stress,0,0
57623,",",0,0
57624,impact,0,0
57625,of,0,0
57626,event,0,0
57627,(,0,1
57628,diagnosis,0,1
57629,),0,1
57630,",",0,0
57631,and,0,0
57632,use,0,0
57633,of,0,0
57634,services,0,1
57635,after,0,1
57636,a,0,1
57637,child,1,1
57638,is,1,0
57639,newly,1,1
57640,diagnosed,1,1
57641,with,1,1
57642,ASD,1,1
57643,.,1,1
57644,The,0,0
57645,intervention,0,0
57646,consisted,0,1
57647,of,0,0
57648,usual,0,1
57649,care,0,1
57650,plus,0,0
57651,3,0,1
57652,hours,0,0
57653,contact,0,0
57654,with,0,1
57655,a,0,1
57656,pediatric,0,1
57657,nurse,0,1
57658,practitioner,0,1
57659,(,0,1
57660,PNP,0,0
57661,),0,1
57662,for,0,0
57663,counseling,0,0
57664,",",0,0
57665,instruction,0,0
57666,",",0,0
57667,and,0,0
57668,assistance,0,0
57669,with,0,1
57670,implementation,0,0
57671,of,0,0
57672,the,0,0
57673,recommended,0,0
57674,treatment,0,0
57675,plan,0,0
57676,.,0,1
57677,The,0,0
57678,control,0,0
57679,group,0,0
57680,received,0,0
57681,only,0,0
57682,the,0,0
57683,usual,0,0
57684,care,0,1
57685,post-diagnosis,0,0
57686,",",0,0
57687,which,0,0
57688,consisted,0,1
57689,of,0,0
57690,a,0,1
57691,1-hour,0,0
57692,consultation,0,1
57693,session,0,0
57694,to,0,0
57695,receive,0,1
57696,the,0,0
57697,results,0,0
57698,of,0,1
57699,diagnostic,0,1
57700,tests,0,0
57701,and,0,1
57702,a,0,1
57703,written,0,0
57704,copy,0,0
57705,of,0,0
57706,the,0,0
57707,recommended,0,0
57708,treatment,0,0
57709,plan,0,0
57710,provided,0,0
57711,by,0,0
57712,a,0,1
57713,developmental,0,1
57714,pediatrician,0,1
57715,and/or,0,1
57716,PNP,0,0
57717,.,0,1
57718,Between,0,0
57719,group,0,1
57720,differences,0,0
57721,in,0,1
57722,measures,0,0
57723,of,0,1
57724,impact,0,0
57725,of,0,0
57726,event,0,0
57727,and,0,1
57728,perceived,0,0
57729,stress,0,0
57730,were,0,0
57731,not,0,0
57732,statistically,0,0
57733,significant,0,0
57734,.,0,1
57735,This,0,0
57736,was,0,0
57737,attributed,0,0
57738,to,0,0
57739,a,0,0
57740,small,0,0
57741,sample,0,1
57742,size,0,0
57743,.,0,1
57744,A,0,0
57745,larger,0,0
57746,study,0,0
57747,is,0,0
57748,feasible,0,0
57749,and,0,0
57750,recommended,0,0
57751,with,0,1
57752,an,0,0
57753,expanded,0,0
57754,nursing,0,1
57755,intervention,0,0
57756,and,0,0
57757,a,0,0
57758,significantly,0,0
57759,larger,0,0
57760,sample,0,1
57761,recruited,0,1
57762,from,0,1
57763,an,0,0
57764,additional,0,0
57765,recruitment,0,0
57766,site,0,1
57767,.,0,1
57768,Nurses,0,0
57769,working,0,1
57770,with,0,1
57771,this,0,0
57772,special,0,0
57773,population,0,1
57774,must,0,0
57775,recognize,0,1
57776,that,0,0
57777,parents,0,1
57778,have,0,1
57779,information,0,0
57780,and,0,1
57781,counseling,0,1
57782,needs,0,0
57783,that,0,0
57784,begin,0,1
57785,after,0,0
57786,they,0,0
57787,receive,0,1
57788,the,0,0
57789,diagnosis,0,1
57790,of,0,0
57791,ASD,0,1
57792,for,0,1
57793,their,0,1
57794,child,0,1
57795,and,0,0
57796,can,0,0
57797,address,0,0
57798,these,0,0
57799,needs,0,0
57800,with,0,1
57801,a,0,1
57802,standardized,0,0
57803,nursing,0,1
57804,intervention,0,1
57805,.,0,1
57806,Comparison,0,0
57807,of,0,0
57808,a,0,1
57809,biopsychosocial,0,1
57810,therapy,0,0
57811,(,0,1
57812,BT,0,0
57813,),0,1
57814,with,0,1
57815,a,0,1
57816,conventional,0,1
57817,biomedical,0,1
57818,therapy,0,1
57819,(,0,1
57820,MT,0,0
57821,),0,1
57822,of,0,0
57823,subacute,0,1
57824,low,0,1
57825,back,0,1
57826,pain,0,1
57827,in,0,0
57828,the,0,0
57829,first,0,0
57830,episode,0,1
57831,of,0,0
57832,sick,0,1
57833,leave,0,1
57834,:,0,1
57835,a,0,0
57836,randomized,0,1
57837,controlled,0,0
57838,trial,0,0
57839,.,0,1
57840,This,0,0
57841,randomized,0,0
57842,controlled,0,0
57843,clinical,0,0
57844,trial,0,0
57845,compares,0,0
57846,the,0,0
57847,effectiveness,0,0
57848,of,0,0
57849,a,0,1
57850,biopsychosocial,0,1
57851,treatment,0,0
57852,with,0,1
57853,a,0,1
57854,solely,0,0
57855,conventional,0,1
57856,biomedical,0,1
57857,therapy,0,1
57858,in,0,1
57859,patients,0,1
57860,with,0,1
57861,subacute,0,1
57862,low,0,1
57863,back,0,1
57864,pain,0,1
57865,using,0,0
57866,parameters,0,0
57867,for,0,1
57868,pain,0,1
57869,intensity,0,0
57870,",",0,0
57871,functional,0,0
57872,status,0,1
57873,",",0,0
57874,depressive,0,1
57875,dysfunction,0,1
57876,and,0,0
57877,work,0,0
57878,performance,0,0
57879,.,0,1
57880,Sixty-four,1,1
57881,patients,1,1
57882,with,1,1
57883,a,1,1
57884,first-time,1,1
57885,sick,1,1
57886,leave,1,1
57887,between,1,0
57888,3,1,1
57889,and,1,1
57890,12,1,1
57891,weeks,1,1
57892,due,1,1
57893,to,1,1
57894,low,1,1
57895,back,1,1
57896,pain,1,0
57897,were,0,0
57898,randomly,0,1
57899,assigned,0,1
57900,to,0,0
57901,either,0,0
57902,a,0,0
57903,conventional,0,0
57904,biomedical,0,1
57905,therapy,0,1
57906,(,0,1
57907,MT,0,0
57908,;,0,1
57909,n=33,0,1
57910,),0,0
57911,group,0,0
57912,",",0,0
57913,or,0,0
57914,a,0,0
57915,biopsychosocial,0,1
57916,therapy,0,0
57917,(,0,1
57918,BT,0,0
57919,;,0,1
57920,n=31,0,1
57921,),0,1
57922,group,0,1
57923,including,0,0
57924,a,0,0
57925,psychotherapeutic,0,1
57926,module,0,1
57927,;,0,0
57928,both,0,0
57929,in,0,0
57930,accordance,0,0
57931,with,0,1
57932,a,0,1
57933,standardized,0,1
57934,3,0,1
57935,weeks,0,1
57936,inpatient,0,1
57937,treatment,0,1
57938,.,0,1
57939,Pain,0,0
57940,intensity,0,0
57941,",",0,0
57942,functional,0,0
57943,back,0,1
57944,capacity,0,0
57945,",",0,0
57946,clinical,0,0
57947,parameters,0,0
57948,and,0,1
57949,depressive,0,1
57950,dysfunction,0,1
57951,revealed,0,0
57952,significant,0,0
57953,improvement,0,0
57954,in,0,0
57955,both,0,0
57956,treatment,0,0
57957,groups,0,0
57958,at,0,1
57959,end,0,1
57960,of,0,1
57961,3,0,1
57962,weeks,0,1
57963,therapy,0,1
57964,(,0,1
57965,T1,0,0
57966,),0,1
57967,.,0,1
57968,However,0,0
57969,",",0,0
57970,at,0,0
57971,6,0,1
57972,months,0,1
57973,(,0,1
57974,T2,0,1
57975,),0,1
57976,",",0,0
57977,analysis,0,0
57978,revealed,0,0
57979,significant,0,0
57980,better,0,0
57981,results,0,0
57982,for,0,0
57983,nearly,0,1
57984,all,0,0
57985,parameters,0,0
57986,in,0,0
57987,the,0,1
57988,BT,0,0
57989,group,0,1
57990,that,0,0
57991,showed,0,0
57992,further,0,0
57993,improvement,0,0
57994,from,0,1
57995,T1,0,0
57996,to,0,1
57997,T2,0,1
57998,",",0,0
57999,whereas,0,0
58000,the,0,0
58001,values,0,0
58002,in,0,0
58003,the,0,1
58004,MT,0,0
58005,group,0,0
58006,deteriorated,0,1
58007,from,0,1
58008,T1,0,0
58009,back,0,1
58010,to,0,0
58011,the,0,0
58012,baseline,0,0
58013,values,0,0
58014,.,0,1
58015,During,0,0
58016,the,0,0
58017,2-year,0,0
58018,period,0,0
58019,after,0,0
58020,therapy,0,0
58021,",",0,1
58022,10,0,1
58023,%,0,0
58024,in,0,1
58025,MT,0,0
58026,and,0,1
58027,59,0,1
58028,%,0,0
58029,in,0,1
58030,BT,0,0
58031,required,0,0
58032,no,0,0
58033,further,0,0
58034,sick,0,1
58035,leave,0,1
58036,due,0,0
58037,to,0,0
58038,low,0,1
58039,back,0,1
58040,pain,0,1
58041,.,0,1
58042,The,0,0
58043,results,0,0
58044,of,0,0
58045,the,0,0
58046,study,0,0
58047,indicate,0,0
58048,that,0,0
58049,a,0,1
58050,psychotherapeutic,0,0
58051,element,0,0
58052,in,0,0
58053,the,0,0
58054,treatment,0,0
58055,of,0,0
58056,low,0,1
58057,back,0,1
58058,pain,0,1
58059,appears,0,0
58060,to,0,0
58061,positively,0,0
58062,influence,0,0
58063,pain,0,0
58064,",",0,0
58065,functional,0,0
58066,status,0,1
58067,and,0,0
58068,work,0,0
58069,performance,0,0
58070,when,0,0
58071,conducted,0,1
58072,at,0,0
58073,an,0,0
58074,early,0,1
58075,stage,0,1
58076,of,0,0
58077,chronification,0,0
58078,and,0,0
58079,helps,0,0
58080,in,0,0
58081,the,0,0
58082,achievement,0,0
58083,of,0,0
58084,a,0,0
58085,better,0,0
58086,outcome,0,0
58087,.,0,1
58088,Phytase,0,0
58089,and,0,1
58090,1alpha-hydroxycholecalciferol,0,0
58091,supplementation,0,0
58092,of,0,1
58093,broiler,1,1
58094,chickens,1,1
58095,during,1,0
58096,the,1,0
58097,starting,1,0
58098,and,1,0
58099,growing/finishing,1,1
58100,phases,1,1
58101,.,1,1
58102,Supplemental,0,0
58103,1alpha-hydroxycholecalciferol,0,0
58104,(,0,1
58105,1alpha-OHD3,0,0
58106,),0,1
58107,has,0,0
58108,been,0,0
58109,shown,0,0
58110,to,0,0
58111,have,0,0
58112,qualitatively,0,0
58113,similar,0,0
58114,and,0,0
58115,quantitatively,0,0
58116,additive,0,0
58117,effects,0,0
58118,to,0,1
58119,exogenous,0,0
58120,phytase,0,0
58121,.,0,1
58122,Two,0,1
58123,experiments,0,0
58124,were,0,1
58125,conducted,0,1
58126,from,0,1
58127,0,0,0
58128,to,0,1
58129,35,0,1
58130,d,0,0
58131,in,0,1
58132,floor,0,1
58133,pens,0,1
58134,to,0,0
58135,determine,0,0
58136,the,0,0
58137,additive,0,0
58138,effect,0,0
58139,of,0,0
58140,phytase,0,0
58141,and,0,0
58142,1alpha-OHD3,0,0
58143,when,0,0
58144,supplemented,0,0
58145,to,0,0
58146,Ca-,0,1
58147,and,0,1
58148,P-deficient,0,1
58149,diets,0,0
58150,.,0,1
58151,In,0,0
58152,both,0,0
58153,experiments,0,0
58154,",",0,0
58155,at,1,1
58156,least,1,1
58157,4,1,1
58158,replicates,1,1
58159,per,1,1
58160,treatment,1,1
58161,(,1,1
58162,50,1,1
58163,chicks,1,1
58164,per,1,1
58165,replicate,1,1
58166,),1,1
58167,were,1,1
58168,used,1,0
58169,.,1,1
58170,Corn-soybean-meal-and,1,0
58171,soybean-oil-based,1,0
58172,diets,1,0
58173,were,1,1
58174,fed,1,1
58175,and,1,1
58176,birds,1,1
58177,were,1,1
58178,raised,1,0
58179,in,1,0
58180,a,1,1
58181,house,1,1
58182,impervious,1,0
58183,to,1,0
58184,ultraviolet,1,1
58185,light,1,0
58186,.,1,0
58187,During,0,0
58188,the,0,0
58189,starter,0,1
58190,phase,0,1
58191,(,0,1
58192,ST,0,1
58193,),0,1
58194,",",0,0
58195,from,0,1
58196,0,0,0
58197,to,0,1
58198,18,0,1
58199,d,0,0
58200,",",0,1
58201,chicks,0,1
58202,were,0,1
58203,fed,0,1
58204,a,0,1
58205,23,0,1
58206,%,0,0
58207,CP,0,1
58208,diet,0,1
58209,containing,0,0
58210,0.60,0,0
58211,%,0,0
58212,Ca,0,1
58213,and,0,1
58214,0.47,0,0
58215,%,0,0
58216,total,0,1
58217,P,0,0
58218,(,0,1
58219,tP,0,1
58220,),0,1
58221,.,0,1
58222,During,0,0
58223,the,0,0
58224,grower/finisher,0,1
58225,phase,0,1
58226,(,0,1
58227,GF,0,1
58228,),0,1
58229,",",0,0
58230,from,0,1
58231,19,0,1
58232,to,0,1
58233,35,0,1
58234,d,0,0
58235,",",0,1
58236,birds,0,1
58237,were,0,1
58238,fed,0,1
58239,a,0,1
58240,19,0,1
58241,%,0,0
58242,CP,0,1
58243,diet,0,1
58244,containing,0,0
58245,0.30,0,0
58246,%,0,0
58247,Ca,0,1
58248,and,0,1
58249,0.37,0,0
58250,%,0,0
58251,tP,0,1
58252,.,0,1
58253,A,0,0
58254,combination,0,0
58255,of,0,0
58256,"1,000",0,0
58257,phytase,0,0
58258,units/kg,0,0
58259,of,0,0
58260,Natuphos,0,0
58261,phytase,0,0
58262,and,0,1
58263,5,0,0
58264,microg/kg,0,0
58265,of,0,1
58266,1alpha-OHD3,0,0
58267,(,0,1
58268,P+1A,0,1
58269,),0,1
58270,was,0,0
58271,supplemented,0,0
58272,to,0,0
58273,some,0,0
58274,of,0,0
58275,the,0,0
58276,feed,0,0
58277,during,0,0
58278,the,0,0
58279,ST,0,1
58280,and,0,1
58281,GF,0,1
58282,.,0,1
58283,Diets,0,0
58284,containing,0,0
58285,adequate,0,1
58286,Ca,0,1
58287,and,0,1
58288,P,0,0
58289,were,0,1
58290,also,0,0
58291,fed,0,0
58292,during,0,0
58293,the,0,0
58294,ST,0,1
58295,(,0,1
58296,0.90,0,0
58297,%,0,0
58298,Ca,0,1
58299,",",0,1
58300,0.68,0,0
58301,%,0,0
58302,tP,0,1
58303,),0,1
58304,and,0,1
58305,GF,0,1
58306,(,0,1
58307,0.80,0,0
58308,%,0,0
58309,Ca,0,1
58310,",",0,1
58311,0.67,0,0
58312,%,0,0
58313,tP,0,1
58314,),0,1
58315,.,0,1
58316,Performance,0,0
58317,characteristics,0,0
58318,and,0,1
58319,the,0,0
58320,incidence,0,0
58321,of,0,0
58322,rickets,0,1
58323,and,0,1
58324,tibial,0,1
58325,dyschondroplasia,0,1
58326,were,0,1
58327,measured,0,0
58328,at,0,1
58329,18,0,1
58330,and,0,1
58331,35,0,1
58332,d.,0,1
58333,In,0,1
58334,experiment,0,1
58335,1,0,1
58336,",",0,1
58337,unsupplemented,0,1
58338,chicks,0,1
58339,performed,0,0
58340,well,0,0
58341,but,0,0
58342,had,0,1
58343,considerable,0,0
58344,leg,0,1
58345,problems,0,1
58346,.,0,1
58347,Chicks,0,1
58348,fed,0,0
58349,P+1A,0,0
58350,during,0,0
58351,the,0,0
58352,ST,0,1
58353,or,0,1
58354,GF,0,0
58355,did,0,0
58356,not,0,0
58357,perform,0,0
58358,as,0,0
58359,well,0,0
58360,as,0,0
58361,birds,0,1
58362,fed,0,1
58363,P+1A,0,1
58364,throughout,0,0
58365,.,0,1
58366,Birds,0,1
58367,fed,0,1
58368,P+1A,0,1
58369,throughout,0,0
58370,performed,0,0
58371,as,0,0
58372,well,0,0
58373,birds,0,1
58374,fed,0,1
58375,the,0,1
58376,adequate,0,0
58377,diets,0,0
58378,without,0,1
58379,any,0,1
58380,indication,0,0
58381,of,0,0
58382,leg,0,1
58383,problems,0,1
58384,.,0,1
58385,In,0,0
58386,experiment,0,1
58387,2,0,1
58388,",",0,1
58389,unsupplemented,0,1
58390,birds,0,1
58391,performed,0,0
58392,similarly,0,0
58393,to,0,1
58394,unsupplemented,0,0
58395,birds,1,1
58396,in,1,1
58397,experiment,1,1
58398,1,1,1
58399,.,1,1
58400,However,0,0
58401,",",0,0
58402,chicks,0,1
58403,fed,0,1
58404,the,0,0
58405,supplements,0,0
58406,or,0,1
58407,the,0,1
58408,control,0,1
58409,diets,0,0
58410,did,0,0
58411,not,0,0
58412,perform,0,0
58413,as,0,0
58414,well,0,0
58415,or,0,0
58416,accumulate,0,1
58417,as,0,0
58418,much,0,0
58419,bone,0,1
58420,ash,0,1
58421,as,0,0
58422,birds,1,1
58423,in,1,1
58424,experiment,1,1
58425,1,1,1
58426,",",0,0
58427,although,0,0
58428,the,0,0
58429,diets,0,0
58430,were,0,1
58431,formulated,0,0
58432,identically,0,0
58433,in,0,0
58434,both,0,0
58435,experiments,0,0
58436,.,0,1
58437,Diets,0,0
58438,with,0,1
58439,as,0,0
58440,little,0,0
58441,as,0,0
58442,0.30,0,0
58443,%,0,0
58444,Ca,0,1
58445,and,0,1
58446,0.37,0,0
58447,%,0,0
58448,tP,0,1
58449,appear,0,0
58450,to,0,0
58451,be,0,0
58452,adequate,0,0
58453,for,0,0
58454,broilers,0,1
58455,older,0,1
58456,than,0,1
58457,18,0,1
58458,d,0,1
58459,if,0,0
58460,supplemented,0,0
58461,with,0,1
58462,the,0,0
58463,correct,0,0
58464,amounts,0,0
58465,of,0,1
58466,phytase,0,0
58467,and,0,1
58468,1alpha-OHD3,0,0
58469,.,0,1
58470,However,0,0
58471,",",0,0
58472,there,0,0
58473,are,0,0
58474,unknown,0,0
58475,variables,0,0
58476,that,0,0
58477,may,0,0
58478,limit,0,0
58479,the,0,0
58480,potential,0,0
58481,of,0,0
58482,broilers,0,1
58483,in,0,1
58484,terms,0,0
58485,of,0,1
58486,bone,0,1
58487,mineralization,0,0
58488,and,0,0
58489,bone,0,0
58490,pathology,0,1
58491,",",0,0
58492,even,0,0
58493,when,0,0
58494,adequate,0,0
58495,diets,0,0
58496,are,0,0
58497,fed,0,1
58498,.,0,1
58499,[,0,0
58500,Local,0,1
58501,therapy,0,0
58502,of,0,0
58503,grade,1,1
58504,1,1,1
58505,and,1,1
58506,2,1,1
58507,hemorrhoids,1,1
58508,.,1,1
58509,Effectiveness,0,0
58510,of,0,0
58511,a,0,0
58512,combination,0,0
58513,preparation,0,0
58514,with,0,1
58515,standardized,0,0
58516,blood,0,0
58517,leech,0,0
58518,extract,0,1
58519,],0,1
58520,.,0,1
58521,AIMS,0,0
58522,Testing,0,0
58523,the,0,0
58524,effectiveness,0,0
58525,of,0,0
58526,a,0,1
58527,topical,0,0
58528,combination,0,0
58529,preparation,0,0
58530,containing,0,0
58531,standardized,0,0
58532,leech,0,0
58533,extract,0,1
58534,",",0,0
58535,polidocanol,0,0
58536,and,0,0
58537,allantoin,0,0
58538,.,0,1
58539,STUDY,0,0
58540,DESIGN,0,1
58541,Placebo-controlled,0,0
58542,",",0,0
58543,double-blind,0,0
58544,study,0,1
58545,in,0,1
58546,80,1,1
58547,patients,1,1
58548,with,1,1
58549,first,1,1
58550,and,1,1
58551,second,1,1
58552,degree,1,1
58553,hemorrhoids,1,1
58554,;,1,1
58555,duration,0,0
58556,of,0,0
58557,treatment,0,1
58558,one,0,1
58559,week,0,0
58560,;,0,1
58561,examinations,0,1
58562,performed,0,0
58563,on,0,0
58564,admission,0,1
58565,and,0,1
58566,on,0,0
58567,days,0,0
58568,3,0,1
58569,",",0,1
58570,4,0,0
58571,",",0,1
58572,5,0,0
58573,and,0,1
58574,8,0,1
58575,.,0,1
58576,RESULTS,0,0
58577,Both,0,0
58578,the,0,0
58579,subjective,0,0
58580,and,0,0
58581,objective,0,0
58582,symptoms,0,1
58583,and,0,1
58584,signs,0,1
58585,improved,0,0
58586,during,0,1
58587,the,0,0
58588,one,0,1
58589,week,0,0
58590,of,0,0
58591,treatment,0,0
58592,statistically,0,0
58593,significantly,0,0
58594,more,0,0
58595,rapidly,0,0
58596,under,0,0
58597,the,0,0
58598,test,0,0
58599,preparation,0,0
58600,as,0,0
58601,compared,0,0
58602,with,0,1
58603,placebo,0,1
58604,.,0,1
58605,Histologically,0,1
58606,demonstrable,0,0
58607,signs,0,1
58608,of,0,1
58609,inflammation,0,1
58610,were,0,1
58611,more,0,0
58612,clearly,0,0
58613,improved,0,0
58614,in,0,0
58615,the,0,0
58616,preparation,0,0
58617,group,0,0
58618,than,0,0
58619,in,0,0
58620,the,0,0
58621,placebo,0,0
58622,group,0,0
58623,.,0,1
58624,No,0,0
58625,side,0,0
58626,effects,0,0
58627,were,0,1
58628,observed,0,0
58629,.,0,0
58630,CONCLUSIONS,0,0
58631,The,0,0
58632,good,0,0
58633,efficacy,0,0
58634,and,0,0
58635,tolerability,0,0
58636,of,0,0
58637,a,0,1
58638,topical,0,0
58639,therapeutic,0,0
58640,preparation,0,1
58641,in,0,1
58642,first,1,0
58643,and,1,1
58644,second,1,1
58645,degree,1,1
58646,hemorrhoids,1,1
58647,have,0,0
58648,been,0,0
58649,convincingly,0,0
58650,demonstrated,0,0
58651,.,0,1
58652,Cross-over,0,1
58653,trial,0,1
58654,of,0,0
58655,intensive,0,1
58656,monotherapy,0,1
58657,with,0,1
58658,atorvastatin,0,0
58659,and,0,1
58660,combined,0,0
58661,therapy,0,0
58662,with,0,1
58663,atorvastatin,0,0
58664,and,0,0
58665,colestimide,0,0
58666,for,0,0
58667,Japanese,1,1
58668,familial,1,1
58669,hypercholesterolemia,1,1
58670,.,1,1
58671,BACKGROUND,0,0
58672,In,0,0
58673,familial,1,1
58674,hypercholesterolemia,1,1
58675,(,1,1
58676,FH,1,1
58677,),1,1
58678,",",0,0
58679,low-density,0,1
58680,lipoprotein-cholesterol,0,0
58681,(,0,1
58682,LDL-C,0,1
58683,),0,1
58684,-lowering,0,0
58685,therapy,0,0
58686,is,0,0
58687,important,0,0
58688,to,0,0
58689,avoid,0,0
58690,predisposition,0,1
58691,to,0,0
58692,coronary,0,1
58693,artery,0,1
58694,disease,0,1
58695,.,0,1
58696,This,0,0
58697,study,0,0
58698,investigated,0,0
58699,the,0,0
58700,advantages,0,0
58701,of,0,0
58702,combined,0,0
58703,therapy,0,1
58704,with,0,1
58705,atorvastatin,0,0
58706,and,0,1
58707,colestimide,0,0
58708,vs,0,0
58709,intensive,0,1
58710,monotherapy,0,1
58711,with,0,1
58712,atorvastatin,0,0
58713,.,0,1
58714,METHODS,0,0
58715,AND,0,0
58716,RESULTS,0,0
58717,The,0,0
58718,trial,0,0
58719,used,0,0
58720,a,0,0
58721,randomized,0,1
58722,cross-over,0,0
58723,design,0,1
58724,consisting,0,1
58725,of,0,0
58726,2,0,1
58727,16-week,0,1
58728,periods,0,0
58729,of,0,1
58730,open-label,0,1
58731,drug,0,1
58732,therapy,0,0
58733,.,0,1
58734,Among,0,1
58735,the,0,0
58736,24,1,1
58737,initial,1,1
58738,patients,1,1
58739,",",1,1
58740,17,1,1
58741,heterozygous,1,1
58742,FH,1,1
58743,patients,1,1
58744,(,1,1
58745,age,1,1
58746,:,1,1
58747,54.1,1,1
58748,years,1,1
58749,;,1,1
58750,5,1,1
58751,males,1,1
58752,),1,1
58753,were,0,1
58754,enrolled,0,1
58755,after,0,1
58756,20,0,1
58757,mg/day,0,0
58758,atorvastatin,0,0
58759,failed,0,0
58760,to,0,0
58761,achieve,0,0
58762,their,0,0
58763,target,0,0
58764,level,0,0
58765,.,0,1
58766,The,0,0
58767,patients,0,1
58768,received,0,1
58769,20,0,1
58770,mg/day,0,0
58771,atorvastatin,0,1
58772,and,0,1
58773,3,0,1
58774,g/day,0,0
58775,colestimide,0,1
58776,or,0,1
58777,40,0,1
58778,mg/day,0,0
58779,atorvastatin,0,1
58780,.,0,1
58781,Fifteen,1,1
58782,patients,1,1
58783,completed,1,1
58784,the,1,0
58785,trial,1,0
58786,and,0,0
58787,their,0,1
58788,LDL-C,0,1
58789,reduced,0,0
58790,from,0,1
58791,5.07,0,0
58792,+/-,0,1
58793,1.10,0,0
58794,mmol/L,0,0
58795,to,0,1
58796,3.76,0,0
58797,+/-,0,0
58798,0.90,0,0
58799,mmol/L,0,0
58800,with,0,1
58801,the,0,0
58802,combined,0,0
58803,therapy,0,0
58804,and,0,1
58805,to,0,1
58806,3.81,0,0
58807,+/-,0,0
58808,0.50,0,0
58809,mmol/L,0,0
58810,with,0,1
58811,the,0,0
58812,intensive,0,1
58813,monotherapy,0,1
58814,.,0,1
58815,Although,0,0
58816,the,0,0
58817,2,0,1
58818,therapies,0,0
58819,showed,0,0
58820,comparable,0,0
58821,mean,0,1
58822,effects,0,0
58823,for,0,1
58824,decreasing,0,0
58825,LDL-C,0,1
58826,",",0,1
58827,similar,0,0
58828,adverse,0,0
58829,reaction,0,0
58830,and,0,0
58831,cost,0,0
58832,",",0,0
58833,each,0,0
58834,therapy,0,0
58835,was,0,0
58836,predominantly,0,0
58837,more,0,0
58838,effective,0,0
58839,in,0,0
58840,some,0,0
58841,patients,0,1
58842,than,0,0
58843,in,0,1
58844,others,0,1
58845,.,0,1
58846,The,0,0
58847,triglyceride,0,0
58848,and,0,0
58849,high-density,0,1
58850,lipoprotein,0,0
58851,cholesterol,0,1
58852,levels,0,1
58853,were,0,1
58854,similar,0,0
58855,in,0,1
58856,both,0,0
58857,therapies,0,0
58858,.,0,1
58859,CONCLUSIONS,0,0
58860,To,0,0
58861,achieve,0,0
58862,the,0,0
58863,therapeutic,0,0
58864,target,0,0
58865,of,0,0
58866,LDL-C,0,1
58867,level,0,0
58868,for,0,0
58869,refractory,0,1
58870,FH,0,1
58871,",",0,0
58872,the,0,0
58873,LDL-C-lowering,0,0
58874,therapy,0,0
58875,selected,0,1
58876,can,0,0
58877,be,0,0
58878,either,0,0
58879,intensive,0,1
58880,monotherapy,0,1
58881,or,0,1
58882,combined,0,0
58883,therapy,0,0
58884,as,0,0
58885,the,0,0
58886,next,0,0
58887,to,0,0
58888,standard,0,1
58889,statin,0,0
58890,therapy,0,0
58891,.,0,1
58892,Playing,0,0
58893,on,0,0
58894,the,0,0
58895,typewriter,0,0
58896,",",0,0
58897,typing,0,0
58898,on,0,0
58899,the,0,0
58900,piano,0,0
58901,:,0,1
58902,manipulation,0,0
58903,knowledge,0,0
58904,of,0,1
58905,objects,0,1
58906,.,0,1
58907,Two,0,1
58908,experiments,0,0
58909,investigated,0,0
58910,sensory/motor-based,1,0
58911,functional,1,0
58912,knowledge,1,0
58913,of,1,1
58914,man-made,1,1
58915,objects,1,1
58916,:,1,1
58917,manipulation,0,1
58918,features,0,1
58919,associated,0,0
58920,with,0,1
58921,the,0,0
58922,actual,0,0
58923,usage,0,0
58924,of,0,1
58925,objects,0,1
58926,.,0,1
58927,In,0,0
58928,Experiment,0,1
58929,1,0,1
58930,",",0,0
58931,a,0,0
58932,series,0,0
58933,of,0,0
58934,prime-target,0,1
58935,pairs,0,1
58936,was,0,0
58937,presented,0,1
58938,auditorily,0,1
58939,",",0,0
58940,and,0,0
58941,participants,1,1
58942,were,0,1
58943,asked,0,1
58944,to,0,0
58945,make,0,0
58946,a,0,0
58947,lexical,0,0
58948,decision,0,0
58949,on,0,0
58950,the,0,0
58951,target,0,0
58952,word,0,0
58953,.,0,1
58954,Participants,1,1
58955,made,0,0
58956,a,0,0
58957,significantly,0,0
58958,faster,0,0
58959,decision,0,0
58960,about,0,0
58961,the,0,0
58962,target,0,0
58963,word,0,0
58964,(,0,1
58965,e.g,0,0
58966,.,0,1
58967,'typewriter,0,0
58968,',0,1
58969,),0,0
58970,following,0,0
58971,a,0,1
58972,related,0,0
58973,prime,0,0
58974,that,0,0
58975,shared,0,0
58976,manipulation,0,0
58977,features,0,1
58978,with,0,1
58979,the,0,0
58980,target,0,0
58981,(,0,0
58982,e.g,0,0
58983,.,0,1
58984,'piano,0,1
58985,',0,1
58986,),0,0
58987,than,0,0
58988,an,0,1
58989,unrelated,0,1
58990,prime,0,0
58991,(,0,1
58992,e.g,0,0
58993,.,0,1
58994,'blanket,0,0
58995,',0,1
58996,),0,1
58997,.,0,1
58998,In,0,0
58999,Experiment,0,1
59000,2,0,1
59001,",",0,1
59002,participants,1,1
59003,',1,1
59004,eye,0,1
59005,movements,0,1
59006,were,0,0
59007,monitored,0,0
59008,when,0,0
59009,they,0,0
59010,viewed,0,0
59011,a,0,0
59012,visual,0,0
59013,display,0,0
59014,on,0,0
59015,a,0,0
59016,computer,0,0
59017,screen,0,1
59018,while,0,0
59019,listening,0,0
59020,to,0,1
59021,a,0,1
59022,concurrent,0,0
59023,auditory,0,1
59024,input,0,1
59025,.,0,1
59026,Participants,1,1
59027,were,0,1
59028,instructed,0,1
59029,to,0,0
59030,simply,0,0
59031,identify,0,0
59032,the,0,0
59033,auditory,0,0
59034,input,0,0
59035,and,0,0
59036,touch,0,0
59037,the,0,0
59038,corresponding,0,0
59039,object,0,0
59040,on,0,0
59041,the,0,0
59042,computer,0,0
59043,display,0,0
59044,.,0,1
59045,Participants,1,1
59046,fixated,0,1
59047,an,0,1
59048,object,0,0
59049,picture,0,1
59050,(,0,1
59051,e.g,0,0
59052,.,0,1
59053,typewriter,0,0
59054,),0,0
59055,related,0,0
59056,to,0,0
59057,a,0,0
59058,target,0,0
59059,word,0,0
59060,(,0,1
59061,e.g,0,0
59062,.,0,1
59063,'piano,0,0
59064,',0,1
59065,),0,0
59066,significantly,0,0
59067,more,0,0
59068,often,0,0
59069,than,0,0
59070,an,0,0
59071,unrelated,0,1
59072,object,0,1
59073,picture,0,1
59074,(,0,1
59075,e.g,0,0
59076,.,0,1
59077,bucket,0,0
59078,),0,0
59079,as,0,0
59080,well,0,0
59081,as,0,0
59082,a,0,0
59083,visually,0,0
59084,matched,0,1
59085,control,0,1
59086,(,0,1
59087,e.g,0,0
59088,.,0,1
59089,couch,0,0
59090,),0,1
59091,.,0,1
59092,Results,0,0
59093,of,0,0
59094,the,0,1
59095,two,0,0
59096,experiments,0,0
59097,suggest,0,0
59098,that,0,0
59099,manipulation,0,0
59100,knowledge,0,0
59101,of,0,0
59102,words,0,0
59103,is,0,0
59104,retrieved,0,0
59105,without,0,0
59106,conscious,0,1
59107,effort,0,1
59108,and,0,0
59109,that,0,0
59110,manipulation,0,0
59111,knowledge,0,0
59112,constitutes,0,0
59113,a,0,0
59114,part,0,0
59115,of,0,0
59116,the,0,0
59117,lexical-semantic,0,0
59118,representation,0,0
59119,of,0,1
59120,objects,0,1
59121,.,0,1
59122,Performance,0,0
59123,of,0,0
59124,a,0,0
59125,modified,0,0
59126,starch,0,0
59127,hydrophilic,0,0
59128,matrix,0,0
59129,for,0,0
59130,the,0,0
59131,sustained,0,0
59132,release,0,0
59133,of,0,0
59134,theophylline,0,0
59135,in,0,1
59136,healthy,1,1
59137,volunteers,1,1
59138,.,1,1
59139,Two,0,1
59140,experimental,0,0
59141,formulations,0,0
59142,of,0,1
59143,theophylline,0,0
59144,with,0,1
59145,a,0,1
59146,hydrophilic,0,0
59147,starch,0,0
59148,matrix,0,1
59149,were,0,0
59150,evaluated,0,0
59151,for,0,0
59152,their,0,1
59153,sustained-release,0,0
59154,characteristics,0,1
59155,after,0,1
59156,single,0,1
59157,administration,0,0
59158,in,0,1
59159,healthy,1,1
59160,human,1,1
59161,volunteers,1,1
59162,.,1,1
59163,Theo-dur,0,0
59164,was,0,0
59165,chosen,0,0
59166,as,0,0
59167,a,0,1
59168,reference,0,0
59169,sustained-release,0,0
59170,formulation,0,0
59171,.,0,1
59172,In,0,0
59173,a,0,0
59174,first,0,0
59175,study,0,0
59176,",",0,0
59177,the,0,0
59178,extent,0,0
59179,of,0,0
59180,absorption,0,0
59181,was,0,0
59182,similar,0,0
59183,for,0,0
59184,a,0,1
59185,syrup,0,1
59186,",",0,0
59187,for,0,0
59188,Theo-dur,0,0
59189,",",0,0
59190,and,0,0
59191,for,0,0
59192,the,0,0
59193,experimental,0,0
59194,formulation,0,0
59195,of,0,0
59196,theophylline,0,0
59197,with,0,1
59198,70,0,1
59199,%,0,0
59200,drum-dried,0,1
59201,corn,0,0
59202,starch,0,0
59203,as,0,0
59204,the,0,0
59205,sustained-release,0,0
59206,agent,0,0
59207,(,0,1
59208,DDCS-70,0,1
59209,),0,1
59210,.,0,1
59211,The,0,0
59212,maximal,0,0
59213,plasma,0,0
59214,concentration,0,0
59215,(,0,1
59216,Cmax,0,0
59217,),0,1
59218,was,0,0
59219,significantly,0,0
59220,lower,0,0
59221,",",0,0
59222,and,0,0
59223,the,0,0
59224,time,0,0
59225,to,0,0
59226,reach,0,0
59227,Cmax,0,0
59228,as,0,0
59229,well,0,0
59230,as,0,0
59231,the,0,0
59232,time,0,0
59233,span,0,1
59234,during,0,0
59235,which,0,0
59236,the,0,0
59237,plasma,0,0
59238,concentration,0,0
59239,was,0,0
59240,at,0,0
59241,least,0,1
59242,75,0,1
59243,%,0,0
59244,of,0,0
59245,the,0,0
59246,Cmax,0,0
59247,were,0,0
59248,significantly,0,0
59249,higher,0,0
59250,for,0,0
59251,Theo-dur,0,0
59252,than,0,0
59253,for,0,0
59254,the,0,0
59255,DDCS-70,0,1
59256,formulation,0,0
59257,.,0,1
59258,A,0,0
59259,sustained-release,0,0
59260,profile,0,0
59261,",",0,0
59262,as,0,0
59263,for,0,0
59264,Theo-dur,0,1
59265,",",0,0
59266,was,0,0
59267,not,0,0
59268,reached,0,0
59269,for,0,0
59270,DDCS-70,0,1
59271,.,0,1
59272,In,0,0
59273,a,0,0
59274,second,0,0
59275,study,0,0
59276,the,0,0
59277,influence,0,0
59278,of,0,0
59279,the,0,0
59280,starch,0,0
59281,:,0,1
59282,drug,0,0
59283,ratio,0,0
59284,on,0,0
59285,the,0,0
59286,bioavailability,0,0
59287,was,0,0
59288,investigated,0,0
59289,.,0,1
59290,The,0,0
59291,decrease,0,0
59292,in,0,0
59293,starch,0,0
59294,content,0,0
59295,from,0,1
59296,70,0,1
59297,to,0,1
59298,50,0,1
59299,%,0,0
59300,of,0,0
59301,the,0,0
59302,formulation,0,0
59303,did,0,0
59304,not,0,0
59305,improve,0,0
59306,the,0,0
59307,plasma,0,0
59308,concentration-time,0,0
59309,profile,0,0
59310,towards,0,0
59311,a,0,1
59312,sustained-release,0,0
59313,profile,0,0
59314,.,0,1
59315,Does,0,0
59316,a,0,0
59317,first,0,0
59318,trimester,0,1
59319,dating,0,1
59320,scan,0,0
59321,using,0,1
59322,crown,0,1
59323,rump,0,1
59324,length,0,0
59325,measurement,0,0
59326,reduce,0,0
59327,the,0,0
59328,rate,0,0
59329,of,0,0
59330,induction,0,0
59331,of,0,0
59332,labour,0,1
59333,for,0,1
59334,prolonged,0,0
59335,pregnancy,0,1
59336,?,0,1
59337,An,0,0
59338,uncompleted,0,0
59339,randomised,0,1
59340,controlled,0,0
59341,trial,0,1
59342,of,0,1
59343,463,1,1
59344,women,1,1
59345,.,1,1
59346,OBJECTIVE,0,0
59347,To,0,0
59348,evaluate,0,0
59349,the,0,0
59350,effect,0,0
59351,of,0,0
59352,a,0,1
59353,first,0,0
59354,trimester,0,1
59355,ultrasound,0,1
59356,dating,0,1
59357,scan,0,0
59358,on,0,0
59359,the,0,0
59360,rate,0,0
59361,of,0,0
59362,induction,0,0
59363,of,0,0
59364,labour,0,1
59365,for,0,1
59366,prolonged,0,0
59367,pregnancy,0,1
59368,.,0,1
59369,DESIGN,0,0
59370,Randomised,0,0
59371,controlled,0,0
59372,trial,0,0
59373,to,0,0
59374,include,0,0
59375,400,1,0
59376,women,1,1
59377,in,1,1
59378,each,1,1
59379,arm,1,0
59380,of,1,0
59381,the,1,0
59382,trial,1,0
59383,.,1,1
59384,SETTING,0,1
59385,Participating,1,1
59386,general,1,1
59387,practices,1,1
59388,and,1,1
59389,a,1,1
59390,district,1,1
59391,general,1,1
59392,teaching,1,1
59393,hospital,1,1
59394,.,1,1
59395,POPULATION,0,0
59396,Women,1,1
59397,attending,1,1
59398,their,1,1
59399,general,1,1
59400,practitioner,1,1
59401,in,1,0
59402,the,1,0
59403,first,1,0
59404,trimester,1,1
59405,to,1,0
59406,confirm,1,0
59407,pregnancy,1,0
59408,",",1,1
59409,in,1,1
59410,whom,1,1
59411,a,1,1
59412,first,1,1
59413,trimester,1,1
59414,ultrasound,1,1
59415,scan,1,0
59416,was,1,0
59417,not,1,0
59418,indicated,1,0
59419,.,1,1
59420,METHODS,0,0
59421,Women,0,1
59422,randomised,0,1
59423,to,0,0
59424,the,0,0
59425,study,0,0
59426,group,0,0
59427,(,0,1
59428,scan,0,0
59429,group,0,1
59430,),0,1
59431,underwent,0,1
59432,an,0,0
59433,ultrasound,0,0
59434,dating,0,0
59435,scan,0,0
59436,between,0,0
59437,8,0,1
59438,and,0,1
59439,12,0,1
59440,weeks,0,0
59441,",",0,1
59442,measuring,0,0
59443,crown-rump,0,1
59444,length,0,0
59445,.,0,1
59446,The,0,0
59447,estimated,0,0
59448,date,0,0
59449,of,0,0
59450,delivery,0,0
59451,(,0,1
59452,EDD,0,1
59453,),0,1
59454,was,0,0
59455,changed,0,0
59456,if,0,0
59457,there,0,0
59458,was,0,0
59459,a,0,0
59460,discrepancy,0,0
59461,of,0,0
59462,more,0,0
59463,than,0,1
59464,5,0,0
59465,days,0,0
59466,from,0,1
59467,the,0,0
59468,gestation,0,1
59469,",",0,0
59470,calculated,0,0
59471,from,0,0
59472,the,0,0
59473,last,0,0
59474,menstrual,0,1
59475,period,0,1
59476,(,0,1
59477,LMP,0,1
59478,),0,1
59479,.,0,1
59480,For,0,0
59481,the,0,0
59482,remaining,0,1
59483,women,0,1
59484,(,0,1
59485,no-scan,0,0
59486,group,0,1
59487,),0,1
59488,",",0,0
59489,gestation,0,1
59490,was,0,0
59491,determined,0,0
59492,using,0,0
59493,the,0,0
59494,LMP,0,1
59495,.,0,1
59496,MAIN,0,0
59497,OUTCOME,0,1
59498,MEASURES,0,0
59499,The,0,0
59500,rate,0,0
59501,of,0,0
59502,induction,0,0
59503,of,0,0
59504,labour,0,1
59505,for,0,1
59506,prolonged,0,0
59507,pregnancy,0,1
59508,.,0,1
59509,RESULTS,0,0
59510,Due,0,0
59511,to,0,1
59512,circumstances,0,0
59513,beyond,0,1
59514,the,0,1
59515,researchers,0,0
59516,',0,1
59517,control,0,1
59518,",",0,1
59519,recruitment,0,0
59520,was,0,0
59521,abandoned,0,0
59522,when,0,0
59523,463,1,1
59524,women,1,1
59525,had,1,1
59526,been,1,1
59527,enrolled,1,1
59528,.,1,1
59529,The,0,0
59530,EDD,0,1
59531,was,0,0
59532,adjusted,0,0
59533,in,0,1
59534,13,0,1
59535,(,0,1
59536,5.7,0,0
59537,%,0,0
59538,),0,1
59539,women,0,1
59540,in,0,1
59541,the,0,1
59542,scan,0,0
59543,group,0,0
59544,and,0,1
59545,in,0,1
59546,2,0,1
59547,(,0,1
59548,0.9,0,0
59549,%,0,0
59550,),0,1
59551,in,0,0
59552,the,0,0
59553,no-scan,0,0
59554,group,0,0
59555,.,0,0
59556,There,0,0
59557,was,0,0
59558,no,0,0
59559,difference,0,0
59560,in,0,0
59561,the,0,0
59562,rate,0,0
59563,of,0,0
59564,induction,0,1
59565,for,0,1
59566,prolonged,0,0
59567,pregnancy,0,1
59568,between,0,0
59569,the,0,0
59570,scan,0,0
59571,(,0,1
59572,19,0,1
59573,[,0,1
59574,8.2,0,0
59575,%,0,0
59576,],0,1
59577,),0,0
59578,and,0,0
59579,the,0,0
59580,no-scan,0,0
59581,(,0,1
59582,17,0,1
59583,[,0,1
59584,7.4,0,0
59585,%,0,0
59586,],0,1
59587,),0,1
59588,groups,0,0
59589,(,0,1
59590,relative,0,0
59591,risk,0,1
59592,1.10,0,0
59593,;,0,1
59594,95,0,0
59595,%,0,0
59596,CI,0,0
59597,0.59-2.07,0,0
59598,),0,1
59599,.,0,1
59600,CONCLUSIONS,0,0
59601,Acknowledging,0,0
59602,the,0,0
59603,reduced,0,0
59604,numbers,0,0
59605,recruited,0,1
59606,for,0,0
59607,study,0,0
59608,",",0,0
59609,it,0,0
59610,is,0,0
59611,concluded,0,0
59612,that,0,0
59613,there,0,0
59614,is,0,0
59615,no,0,0
59616,evidence,0,0
59617,that,0,0
59618,a,0,1
59619,first,0,0
59620,trimester,0,1
59621,ultrasound,0,1
59622,dating,0,1
59623,scan,0,1
59624,reduces,0,0
59625,the,0,0
59626,rate,0,0
59627,of,0,0
59628,induction,0,0
59629,of,0,0
59630,labour,0,1
59631,for,0,1
59632,prolonged,0,0
59633,pregnancy,0,1
59634,and,0,0
59635,may,0,0
59636,result,0,0
59637,in,0,0
59638,a,0,0
59639,more,0,0
59640,expensive,0,0
59641,healthcare,0,0
59642,strategy,0,0
59643,.,0,1
59644,Project,1,0
59645,Towards,1,1
59646,No,1,0
59647,Drug,1,1
59648,Abuse,1,0
59649,:,1,1
59650,long-term,0,0
59651,substance,0,1
59652,use,0,0
59653,outcomes,0,0
59654,evaluation,0,0
59655,.,0,0
59656,OBJECTIVES,0,0
59657,This,0,0
59658,paper,0,0
59659,presents,0,0
59660,up,0,0
59661,to,0,0
59662,5,0,1
59663,years,0,1
59664,post-program,0,0
59665,outcomes,0,0
59666,of,0,1
59667,Project,1,1
59668,Towards,1,1
59669,No,1,0
59670,Drug,1,1
59671,Abuse,1,0
59672,(,1,1
59673,Project,1,1
59674,TND,1,1
59675,),1,0
59676,",",1,0
59677,a,1,0
59678,drug,1,0
59679,abuse,1,1
59680,prevention,1,1
59681,program,1,1
59682,conducted,1,1
59683,in,1,0
59684,South,1,1
59685,California,1,1
59686,alternative,1,0
59687,high,1,1
59688,school,1,1
59689,system,1,1
59690,during,1,1
59691,years,1,1
59692,1994-1999,1,1
59693,.,1,1
59694,METHODS,0,0
59695,The,0,0
59696,effects,0,0
59697,of,0,0
59698,a,0,1
59699,9-session,0,0
59700,health,0,1
59701,motivation,0,0
59702,--,0,1
59703,social,0,1
59704,skills,0,0
59705,--,0,1
59706,decision-making,0,0
59707,curriculum,0,1
59708,were,0,1
59709,evaluated,0,0
59710,.,0,1
59711,Twenty-one,1,1
59712,schools,1,1
59713,recruited,0,1
59714,were,0,1
59715,randomly,0,1
59716,assigned,0,1
59717,to,0,0
59718,standard,0,1
59719,care,0,1
59720,(,0,0
59721,control,0,1
59722,),0,0
59723,",",0,0
59724,classroom,0,0
59725,only,0,0
59726,",",0,0
59727,or,0,0
59728,a,0,0
59729,classroom,0,0
59730,plus,0,0
59731,semester-long,0,1
59732,school-as-community,0,1
59733,component,0,1
59734,.,0,1
59735,Last,0,0
59736,30-day,0,0
59737,use,0,0
59738,of,0,1
59739,cigarettes,0,1
59740,",",0,1
59741,alcohol,0,1
59742,",",0,0
59743,marijuana,0,0
59744,",",0,0
59745,and,0,0
59746,hard,0,1
59747,drugs,0,0
59748,were,0,1
59749,assessed,0,0
59750,at,0,1
59751,three,0,1
59752,time,0,0
59753,intervals,0,0
59754,:,0,1
59755,short-term,0,0
59756,(,0,1
59757,year,0,1
59758,1,0,1
59759,),0,1
59760,",",0,1
59761,middle-term,0,1
59762,(,0,1
59763,years,0,1
59764,2,0,1
59765,or,0,1
59766,3,0,1
59767,),0,1
59768,",",0,0
59769,and,0,0
59770,long-term,0,0
59771,(,0,1
59772,years,0,1
59773,4,0,1
59774,or,0,1
59775,5,0,1
59776,),0,1
59777,.,0,1
59778,Multilevel,0,0
59779,random,0,1
59780,coefficients,0,0
59781,modeling,0,1
59782,were,0,1
59783,employed,0,0
59784,to,0,0
59785,estimate,0,0
59786,the,0,0
59787,adjusted,0,0
59788,levels,0,0
59789,of,0,1
59790,substance,0,1
59791,use,0,0
59792,.,0,1
59793,RESULTS,0,0
59794,Among,1,1
59795,1578,1,1
59796,baseline,1,1
59797,subjects,1,1
59798,",",1,1
59799,follow-up,1,1
59800,data,1,0
59801,were,1,1
59802,available,1,1
59803,for,1,1
59804,68,1,1
59805,%,1,0
59806,(,1,1
59807,year,1,1
59808,1,1,1
59809,),1,1
59810,",",1,1
59811,66,1,1
59812,%,1,0
59813,(,1,1
59814,years,1,1
59815,2,1,1
59816,or,1,1
59817,3,1,1
59818,),1,1
59819,",",1,1
59820,and,1,0
59821,46,1,1
59822,%,1,0
59823,(,1,1
59824,years,1,1
59825,4,1,1
59826,or,1,1
59827,5,1,1
59828,),1,1
59829,of,1,1
59830,subjects,1,1
59831,",",1,1
59832,respectively,1,0
59833,.,1,1
59834,Results,0,0
59835,revealed,0,0
59836,significant,0,0
59837,positive,0,1
59838,long-term,0,1
59839,program,0,1
59840,effects,0,0
59841,for,0,1
59842,hard,0,1
59843,drug,0,1
59844,use,0,0
59845,at,0,1
59846,year,0,1
59847,4,0,1
59848,or,0,1
59849,5,0,0
59850,for,0,0
59851,the,0,0
59852,two,0,0
59853,program,0,1
59854,interventions,0,0
59855,(,0,1
59856,P,0,0
59857,=,0,1
59858,0.02,0,0
59859,),0,1
59860,.,0,1
59861,CONCLUSIONS,0,0
59862,Project,0,1
59863,TND,0,1
59864,reduced,0,0
59865,hard,0,0
59866,drug,0,0
59867,use,0,0
59868,in,0,0
59869,the,0,0
59870,46,0,1
59871,%,0,0
59872,who,0,1
59873,were,0,1
59874,successfully,0,1
59875,followed,0,0
59876,.,0,0
59877,It,0,0
59878,is,0,0
59879,the,0,0
59880,first,0,0
59881,program,0,1
59882,to,0,0
59883,demonstrate,0,0
59884,long-term,0,0
59885,self-reported,0,1
59886,behavioral,0,1
59887,effects,0,0
59888,on,0,1
59889,hard,0,1
59890,drug,0,1
59891,use,0,0
59892,among,0,1
59893,high-risk,1,1
59894,youth,1,1
59895,by,0,0
59896,using,0,0
59897,a,0,1
59898,school-based,0,1
59899,",",0,0
59900,limited-session,0,1
59901,model,0,0
59902,.,0,1
59903,Evaluating,0,0
59904,erectile,1,1
59905,dysfunction,1,1
59906,:,1,1
59907,oral,0,0
59908,sildenafil,0,1
59909,versus,0,0
59910,intracavernosal,0,1
59911,injection,0,0
59912,of,0,0
59913,papaverine,0,0
59914,.,0,1
59915,BACKGROUND,0,0
59916,Intracavernosal,0,0
59917,injection,0,0
59918,of,0,1
59919,vasoactive,0,0
59920,drugs,0,0
59921,is,0,0
59922,an,0,0
59923,established,0,0
59924,method,0,0
59925,of,0,0
59926,evaluating,0,0
59927,erectile,0,1
59928,dysfunction,0,1
59929,.,0,1
59930,However,0,0
59931,",",0,0
59932,it,0,0
59933,is,0,0
59934,invasive,0,0
59935,and,0,0
59936,may,0,0
59937,be,0,0
59938,associated,0,0
59939,with,0,1
59940,pain,0,1
59941,and,0,1
59942,priapism,0,1
59943,.,0,1
59944,We,0,0
59945,investigated,0,0
59946,the,0,0
59947,use,0,0
59948,of,0,0
59949,oral,0,0
59950,sildenafil,0,1
59951,as,0,0
59952,a,0,1
59953,possible,0,0
59954,substitute,0,0
59955,for,0,1
59956,intracavernosal,0,1
59957,agents,0,1
59958,.,0,1
59959,METHODS,0,0
59960,Men,1,1
59961,with,1,1
59962,erectile,1,1
59963,dysfunction,1,1
59964,were,1,1
59965,randomized,1,1
59966,into,1,1
59967,two,1,1
59968,groups,1,1
59969,of,1,1
59970,25,1,1
59971,each,1,1
59972,.,1,1
59973,One,0,0
59974,group,0,1
59975,of,0,1
59976,25,1,1
59977,men,1,1
59978,received,0,1
59979,injection,0,0
59980,papaverine,0,0
59981,initially,0,1
59982,followed,0,0
59983,by,0,0
59984,oral,0,0
59985,sildenafil,0,1
59986,",",0,0
59987,and,0,0
59988,another,0,1
59989,25,0,1
59990,received,0,1
59991,oral,0,1
59992,sildenafil,0,0
59993,followed,0,1
59994,by,0,0
59995,injection,0,0
59996,papaverine,0,0
59997,.,0,1
59998,Genital,0,0
59999,self-stimulation,0,0
60000,was,0,0
60001,used,0,0
60002,in,0,0
60003,both,0,0
60004,the,0,0
60005,groups,0,0
60006,.,0,1
60007,Penile,0,1
60008,length,0,0
60009,and,0,0
60010,circumference,0,0
60011,as,0,0
60012,well,0,0
60013,as,0,0
60014,angle,0,0
60015,of,0,0
60016,erection,0,0
60017,",",0,0
60018,before,0,0
60019,and,0,0
60020,after,0,0
60021,each,0,0
60022,medication,0,0
60023,",",0,0
60024,were,0,0
60025,recorded,0,0
60026,.,0,1
60027,Two,0,1
60028,days,0,0
60029,later,0,1
60030,",",0,0
60031,the,0,0
60032,intervention,0,0
60033,arms,0,0
60034,were,0,1
60035,crossed,0,0
60036,over,0,0
60037,.,0,1
60038,Subjective,0,0
60039,responses,0,0
60040,were,0,1
60041,obtained,0,0
60042,.,0,1
60043,The,0,0
60044,effect,0,0
60045,of,0,0
60046,medication,0,1
60047,on,0,0
60048,each,0,0
60049,outcome,0,0
60050,variable,0,0
60051,was,0,0
60052,studied,0,1
60053,by,0,0
60054,using,0,0
60055,analysis,0,0
60056,of,0,1
60057,variance,0,0
60058,models,0,1
60059,in,0,1
60060,relation,0,0
60061,to,0,0
60062,patient,0,0
60063,",",0,0
60064,period,0,0
60065,and,0,0
60066,medication,0,1
60067,.,0,0
60068,RESULTS,0,0
60069,There,0,0
60070,was,0,0
60071,statistically,0,0
60072,significant,0,0
60073,improvement,0,0
60074,from,0,1
60075,the,0,0
60076,baseline,0,0
60077,value,0,0
60078,in,0,0
60079,both,0,0
60080,the,0,0
60081,arms,0,0
60082,",",0,0
60083,i.e,0,1
60084,injection,0,0
60085,papaverine,0,0
60086,and,0,0
60087,oral,0,0
60088,sildenafil,0,1
60089,(,0,1
60090,p,0,0
60091,<,0,0
60092,0.001,0,0
60093,",",0,0
60094,p,0,0
60095,<,0,0
60096,0.001,0,0
60097,",",0,0
60098,respectively,0,0
60099,),0,0
60100,for,0,0
60101,both,0,0
60102,penile,0,1
60103,length,0,0
60104,and,0,1
60105,circumference,0,0
60106,.,0,1
60107,No,0,0
60108,significant,0,0
60109,difference,0,0
60110,was,0,0
60111,observed,0,0
60112,between,0,0
60113,the,0,1
60114,two,0,0
60115,medications,0,0
60116,in,0,1
60117,the,0,1
60118,outcome,0,0
60119,measures,0,0
60120,.,0,1
60121,CONCLCUSION,0,0
60122,:,0,1
60123,Oral,0,1
60124,sildenafil,0,0
60125,was,0,0
60126,as,0,0
60127,effective,0,0
60128,as,0,0
60129,injection,0,0
60130,papaverine,0,0
60131,in,0,0
60132,evaluating,0,0
60133,erectile,1,1
60134,dysfunction,1,1
60135,.,1,1
60136,Phase,0,1
60137,III,0,1
60138,study,0,1
60139,of,0,1
60140,two,0,1
60141,different,0,1
60142,dosing,0,0
60143,schedules,0,0
60144,of,0,1
60145,erythropoietin,0,0
60146,in,0,1
60147,anemic,1,1
60148,patients,1,1
60149,with,1,1
60150,cancer,1,1
60151,.,1,1
60152,PURPOSE,0,0
60153,To,0,0
60154,compare,0,0
60155,maintenance,0,0
60156,epoetin,0,0
60157,alfa,0,0
60158,administered,0,0
60159,once,0,0
60160,every,0,0
60161,3,0,0
60162,weeks,0,0
60163,with,0,1
60164,continued,0,1
60165,weekly,0,1
60166,epoetin,0,0
60167,alfa,0,0
60168,for,0,0
60169,patients,1,1
60170,with,1,1
60171,cancer-associated,1,1
60172,anemia,1,1
60173,.,1,1
60174,PATIENTS,0,0
60175,AND,0,0
60176,METHODS,0,0
60177,Eligible,1,1
60178,patients,1,1
60179,were,1,1
60180,randomly,1,1
60181,assigned,1,1
60182,at,1,0
60183,enrollment,1,1
60184,to,0,1
60185,receive,0,1
60186,three,0,0
60187,weekly,0,1
60188,doses,0,0
60189,of,0,1
60190,epoetin,0,0
60191,alfa,0,0
60192,"40,000",0,1
60193,U,0,1
60194,subcutaneously,0,1
60195,(,0,1
60196,SC,0,1
60197,),0,1
60198,",",0,0
60199,followed,0,0
60200,by,0,0
60201,either,0,1
60202,standard,0,1
60203,weekly,0,0
60204,epoetin,0,0
60205,alfa,0,0
60206,(,0,1
60207,40K,0,1
60208,arm,0,1
60209,),0,1
60210,or,0,1
60211,"120,000",0,1
60212,U,0,1
60213,of,0,0
60214,epoetin,0,0
60215,alfa,0,0
60216,(,0,1
60217,120K,0,1
60218,arm,0,1
60219,),0,1
60220,SC,0,1
60221,every,0,1
60222,3,0,0
60223,weeks,0,0
60224,for,0,1
60225,18,0,1
60226,additional,0,1
60227,weeks,0,1
60228,.,0,1
60229,RESULTS,0,0
60230,Three,1,1
60231,hundred,1,1
60232,sixty-five,1,1
60233,patients,1,1
60234,were,1,1
60235,enrolled,1,1
60236,.,1,1
60237,One,1,1
60238,hundred,1,1
60239,eighty-three,1,1
60240,patients,1,1
60241,were,1,1
60242,assigned,1,1
60243,to,1,0
60244,the,1,0
60245,40K,1,1
60246,arm,1,0
60247,",",1,1
60248,and,1,0
60249,182,1,1
60250,were,1,1
60251,assigned,1,1
60252,to,1,0
60253,the,1,0
60254,120K,1,0
60255,arm,1,0
60256,.,1,0
60257,There,0,0
60258,was,0,0
60259,no,0,0
60260,difference,0,0
60261,in,0,0
60262,the,0,0
60263,proportion,0,1
60264,of,0,0
60265,patients,0,1
60266,requiring,0,1
60267,transfusions,0,0
60268,during,0,1
60269,the,0,0
60270,study,0,1
60271,(,0,0
60272,23,0,1
60273,%,0,0
60274,in,0,1
60275,40K,0,1
60276,arm,0,1
60277,and,0,1
60278,18,0,1
60279,%,0,0
60280,in,0,1
60281,120K,0,1
60282,arm,0,1
60283,",",0,1
60284,P,0,0
60285,=,0,1
60286,.22,0,0
60287,),0,1
60288,or,0,1
60289,specifically,0,0
60290,during,0,0
60291,the,0,0
60292,maintenance,0,0
60293,phase,0,1
60294,(,0,1
60295,13,0,1
60296,%,0,0
60297,in,0,1
60298,40K,0,1
60299,arm,0,1
60300,v,0,0
60301,15,0,1
60302,%,0,0
60303,in,0,1
60304,120K,0,1
60305,arm,0,1
60306,",",0,1
60307,P,0,0
60308,=,0,1
60309,.58,0,0
60310,),0,1
60311,.,0,1
60312,Patients,0,1
60313,randomly,0,1
60314,assigned,0,1
60315,to,0,0
60316,the,0,0
60317,40K,0,1
60318,arm,0,0
60319,were,0,0
60320,more,0,0
60321,likely,0,0
60322,to,0,0
60323,have,0,0
60324,a,0,0
60325,>,0,0
60326,or,0,1
60327,=,0,1
60328,2,0,1
60329,or,0,1
60330,>,0,1
60331,or,0,1
60332,=,0,1
60333,3,0,0
60334,g/dL,0,1
60335,hemoglobin,0,0
60336,(,0,1
60337,Hb,0,0
60338,),0,1
60339,increment,0,0
60340,",",0,0
60341,were,0,0
60342,more,0,0
60343,likely,0,0
60344,to,0,0
60345,have,0,0
60346,a,0,0
60347,drug,0,0
60348,dose,0,0
60349,held,0,0
60350,because,0,0
60351,of,0,0
60352,high,0,1
60353,Hb,0,0
60354,",",0,1
60355,and,0,0
60356,had,0,1
60357,higher,0,0
60358,mean,0,1
60359,end-of-study,0,0
60360,Hb,0,1
60361,levels,0,1
60362,.,0,1
60363,Toxicities,0,0
60364,",",0,0
60365,including,0,0
60366,thromboembolism,0,1
60367,",",0,0
60368,and,0,0
60369,overall,0,0
60370,survival,0,0
60371,were,0,1
60372,similar,0,0
60373,.,0,1
60374,Patients,0,1
60375,in,0,0
60376,the,0,1
60377,40K,0,1
60378,arm,0,0
60379,had,0,1
60380,a,0,0
60381,higher,0,0
60382,global,0,0
60383,quality,0,0
60384,of,0,0
60385,life,0,1
60386,(,0,1
60387,QOL,0,0
60388,),0,1
60389,at,0,0
60390,baseline,0,0
60391,for,0,1
60392,unclear,0,0
60393,reasons,0,0
60394,",",0,1
60395,whereas,0,0
60396,patients,0,1
60397,in,0,1
60398,the,0,1
60399,120K,0,1
60400,arm,0,0
60401,had,0,1
60402,a,0,0
60403,greater,0,0
60404,global,0,0
60405,QOL,0,0
60406,improvement,0,0
60407,during,0,0
60408,the,0,0
60409,study,0,0
60410,",",0,0
60411,so,0,0
60412,end-of-study,0,0
60413,QOL,0,1
60414,was,0,0
60415,equivalent,0,0
60416,.,0,1
60417,CONCLUSION,0,0
60418,After,0,1
60419,three,0,1
60420,weekly,0,1
60421,doses,0,0
60422,of,0,1
60423,epoetin,0,0
60424,alfa,0,0
60425,"40,000",0,1
60426,U,0,0
60427,",",0,0
60428,a,0,0
60429,dose,0,0
60430,of,0,0
60431,"120,000",0,1
60432,U,0,1
60433,can,0,0
60434,be,0,0
60435,administered,0,0
60436,safely,0,0
60437,once,0,0
60438,every,0,0
60439,3,0,0
60440,weeks,0,0
60441,without,0,1
60442,increasing,0,0
60443,transfusion,0,0
60444,needs,0,1
60445,or,0,1
60446,sacrificing,0,0
60447,QOL,0,0
60448,.,0,1
60449,The,0,0
60450,Hb,0,0
60451,increment,0,0
60452,is,0,0
60453,somewhat,0,0
60454,greater,0,0
60455,with,0,1
60456,continued,0,0
60457,weekly,0,1
60458,epoetin,0,0
60459,alfa,0,0
60460,.,0,1
60461,Lack,0,0
60462,of,0,0
60463,blinding,0,0
60464,as,0,0
60465,a,0,1
60466,result,0,0
60467,of,0,0
60468,different,0,1
60469,treatment,0,0
60470,schedules,0,0
60471,may,0,0
60472,have,0,1
60473,confounded,0,0
60474,results,0,0
60475,.,0,1
60476,The,0,0
60477,effect,0,0
60478,of,0,0
60479,a,0,1
60480,parent-implemented,0,0
60481,imitation,0,0
60482,intervention,0,0
60483,on,0,0
60484,spontaneous,0,1
60485,imitation,0,1
60486,skills,0,0
60487,in,0,1
60488,young,1,1
60489,children,1,1
60490,with,1,1
60491,autism,1,1
60492,.,1,1
60493,Children,1,1
60494,with,1,1
60495,autism,1,1
60496,exhibit,0,1
60497,significant,0,0
60498,deficits,0,1
60499,in,0,1
60500,their,0,1
60501,ability,0,0
60502,to,0,0
60503,spontaneously,0,0
60504,imitate,0,0
60505,the,0,0
60506,play,0,0
60507,actions,0,0
60508,and,0,1
60509,descriptive,0,1
60510,gestures,0,1
60511,of,0,1
60512,others,0,1
60513,.,0,1
60514,Reciprocal,0,0
60515,imitation,0,0
60516,training,0,0
60517,(,0,1
60518,RIT,0,1
60519,),0,0
60520,is,0,0
60521,a,0,0
60522,naturalistic,0,0
60523,imitation,0,1
60524,intervention,0,0
60525,designed,0,0
60526,to,0,0
60527,teach,0,0
60528,spontaneous,0,1
60529,imitation,0,1
60530,skills,0,0
60531,during,0,1
60532,play,0,0
60533,.,0,1
60534,This,0,0
60535,study,0,0
60536,assessed,0,0
60537,the,0,0
60538,effectiveness,0,0
60539,of,0,0
60540,parent-implemented,0,1
60541,RIT,0,1
60542,using,0,0
60543,a,0,1
60544,multiple-baseline,0,0
60545,design,0,1
60546,across,0,1
60547,three,1,1
60548,young,1,1
60549,children,1,1
60550,with,1,1
60551,autism,1,1
60552,and,1,1
60553,their,1,1
60554,mothers,1,1
60555,.,1,1
60556,After,0,0
60557,an,0,0
60558,initial,0,0
60559,baseline,0,0
60560,",",0,1
60561,mothers,0,1
60562,were,0,1
60563,taught,0,1
60564,to,0,0
60565,implement,0,0
60566,RIT,0,1
60567,techniques,0,0
60568,with,0,1
60569,their,0,1
60570,child,0,1
60571,twice,0,0
60572,a,0,0
60573,week,0,0
60574,for,0,0
60575,10,0,1
60576,weeks,0,0
60577,in,0,1
60578,a,0,1
60579,clinic,0,1
60580,setting,0,1
60581,.,0,1
60582,Two,0,1
60583,mothers,0,1
60584,were,0,1
60585,taught,0,1
60586,to,0,0
60587,use,0,0
60588,RIT,0,0
60589,to,0,0
60590,teach,0,0
60591,object,0,0
60592,imitation,0,1
60593,.,0,1
60594,The,0,0
60595,third,0,1
60596,mother,0,1
60597,was,0,0
60598,taught,0,0
60599,to,0,0
60600,use,0,0
60601,RIT,0,0
60602,to,0,0
60603,target,0,0
60604,both,0,0
60605,object,0,0
60606,and,0,0
60607,gesture,0,1
60608,imitation,0,1
60609,in,0,0
60610,a,0,1
60611,multiple-baseline,0,0
60612,design,0,1
60613,across,0,1
60614,behaviors,0,0
60615,.,0,1
60616,Generalization,0,0
60617,was,0,0
60618,assessed,0,0
60619,in,0,0
60620,the,0,0
60621,families,0,1
60622,',0,1
60623,homes,0,1
60624,at,0,1
60625,the,0,0
60626,end,0,0
60627,of,0,0
60628,treatment,0,0
60629,and,0,0
60630,a,0,0
60631,1-month,0,0
60632,follow-up,0,0
60633,.,0,1
60634,Parents,0,0
60635,learned,0,0
60636,to,0,0
60637,use,0,0
60638,the,0,0
60639,intervention,0,0
60640,strategies,0,0
60641,and,0,1
60642,their,0,1
60643,children,0,1
60644,exhibited,0,0
60645,increases,0,0
60646,in,0,1
60647,spontaneous,0,1
60648,imitation,0,1
60649,.,0,1
60650,These,0,0
60651,findings,0,0
60652,replicate,0,1
60653,the,0,0
60654,results,0,0
60655,from,0,1
60656,previous,0,1
60657,studies,0,0
60658,",",0,1
60659,indicating,0,0
60660,that,0,0
60661,RIT,0,1
60662,is,0,0
60663,effective,0,0
60664,for,0,0
60665,teaching,0,1
60666,imitation,0,1
60667,skills,0,0
60668,to,0,1
60669,young,1,1
60670,children,1,1
60671,with,1,1
60672,autism,1,1
60673,in,0,0
60674,a,0,1
60675,naturalistic,0,0
60676,setting,0,1
60677,and,0,0
60678,extend,0,0
60679,the,0,0
60680,findings,0,0
60681,to,0,1
60682,parents,1,1
60683,.,1,1
60684,A,0,0
60685,comparison,0,0
60686,of,0,0
60687,home,0,1
60688,measurement,0,0
60689,and,0,0
60690,ambulatory,0,1
60691,monitoring,0,0
60692,of,0,0
60693,blood,0,0
60694,pressure,0,0
60695,in,0,0
60696,the,0,0
60697,adjustment,0,0
60698,of,0,0
60699,antihypertensive,1,1
60700,treatment,1,1
60701,.,1,1
60702,BACKGROUND,0,0
60703,The,0,0
60704,purpose,0,0
60705,of,0,0
60706,this,0,0
60707,study,0,0
60708,was,0,0
60709,to,0,0
60710,compare,0,0
60711,home,0,1
60712,and,0,0
60713,ambulatory,0,1
60714,blood,0,0
60715,pressure,0,0
60716,(,0,1
60717,BP,0,1
60718,),0,1
60719,in,0,0
60720,the,0,0
60721,adjustment,0,0
60722,of,0,0
60723,antihypertensive,0,1
60724,treatment,0,1
60725,.,0,1
60726,METHODS,0,0
60727,After,0,0
60728,a,0,1
60729,4-week,0,0
60730,washout,0,0
60731,period,0,0
60732,",",0,1
60733,patients,1,1
60734,whose,1,1
60735,untreated,1,1
60736,daytime,1,1
60737,diastolic,1,1
60738,ambulatory,1,1
60739,BP,1,1
60740,averaged,1,0
60741,>,1,1
60742,or,1,1
60743,=,1,1
60744,85,1,1
60745,mm,1,1
60746,Hg,1,1
60747,were,0,1
60748,randomized,0,1
60749,to,0,0
60750,be,0,0
60751,treated,0,1
60752,according,0,1
60753,to,0,0
60754,their,0,1
60755,ambulatory,0,1
60756,or,0,1
60757,home,0,1
60758,BP,0,1
60759,.,0,1
60760,Antihypertensive,0,1
60761,treatment,0,0
60762,was,0,0
60763,adjusted,0,0
60764,at,0,1
60765,6-week,0,1
60766,intervals,0,0
60767,according,0,1
60768,to,0,1
60769,the,0,0
60770,mean,0,1
60771,daytime,0,0
60772,ambulatory,0,1
60773,diastolic,0,1
60774,BP,0,1
60775,or,0,1
60776,the,0,0
60777,mean,0,0
60778,home,0,1
60779,diastolic,0,1
60780,BP,0,1
60781,",",0,0
60782,depending,0,0
60783,on,0,0
60784,the,0,0
60785,patient,0,1
60786,'s,0,1
60787,randomization,0,0
60788,group,0,1
60789,.,0,1
60790,If,0,0
60791,the,0,0
60792,diastolic,0,1
60793,BP,0,1
60794,stayed,0,1
60795,above,0,0
60796,80,0,1
60797,mm,0,1
60798,Hg,0,0
60799,",",0,0
60800,the,0,0
60801,physician,0,1
60802,blinded,0,0
60803,to,0,0
60804,randomization,0,0
60805,intensified,0,1
60806,hypertensive,0,1
60807,treatment,0,1
60808,.,0,1
60809,RESULTS,0,0
60810,Ninety-eight,1,1
60811,patients,1,1
60812,completed,1,1
60813,the,1,0
60814,study,1,0
60815,.,1,0
60816,During,0,0
60817,the,0,0
60818,24-week,0,0
60819,follow-up,0,0
60820,period,0,1
60821,both,0,0
60822,systolic,0,0
60823,and,0,0
60824,diastolic,0,1
60825,BP,0,1
60826,decreased,0,0
60827,significantly,0,0
60828,within,0,0
60829,both,0,0
60830,groups,0,0
60831,(,0,1
60832,P,0,0
60833,<,0,0
60834,.001,0,0
60835,),0,1
60836,.,0,1
60837,At,0,0
60838,the,0,0
60839,end,0,0
60840,of,0,0
60841,the,0,0
60842,study,0,0
60843,",",0,0
60844,the,0,0
60845,systolic/diastolic,0,0
60846,differences,0,0
60847,between,0,0
60848,ambulatory,0,1
60849,(,0,1
60850,n,0,1
60851,=,0,1
60852,46,0,1
60853,),0,1
60854,and,0,1
60855,home,0,1
60856,(,0,1
60857,n,0,1
60858,=,0,1
60859,52,0,1
60860,),0,1
60861,BP,0,1
60862,groups,0,1
60863,in,0,1
60864,home,0,1
60865,",",0,0
60866,daytime,0,0
60867,ambulatory,0,1
60868,",",0,0
60869,night-time,0,0
60870,ambulatory,0,1
60871,",",0,0
60872,and,0,0
60873,24-h,0,0
60874,ambulatory,0,1
60875,BP,0,1
60876,changes,0,0
60877,averaged,0,1
60878,2.6/2.6,0,1
60879,mm,0,1
60880,Hg,0,1
60881,",",0,1
60882,0.6/1.7,0,1
60883,mm,0,1
60884,Hg,0,1
60885,",",0,1
60886,1.0/1.4,0,0
60887,mm,0,1
60888,Hg,0,0
60889,",",0,1
60890,and,0,0
60891,0.6/1.5,0,0
60892,mm,0,1
60893,Hg,0,0
60894,",",0,0
60895,respectively,0,0
60896,(,0,0
60897,P,0,0
60898,range,0,1
60899,.06,0,0
60900,to,0,0
60901,.75,0,0
60902,),0,0
60903,A,0,1
60904,nonsignificant,0,0
60905,trend,0,0
60906,to,0,0
60907,more,0,0
60908,intensive,0,0
60909,drug,0,0
60910,therapy,0,0
60911,in,0,0
60912,the,0,0
60913,ambulatory,0,1
60914,BP,0,1
60915,group,0,1
60916,and,0,0
60917,a,0,0
60918,nonsignificant,0,0
60919,trend,0,0
60920,to,0,1
60921,larger,0,0
60922,share,0,0
60923,of,0,0
60924,patients,0,1
60925,reaching,0,1
60926,(,0,1
60927,57.7,0,1
60928,%,0,0
60929,v,0,0
60930,43.5,0,0
60931,%,0,0
60932,",",0,1
60933,P,0,0
60934,=,0,1
60935,.16,0,0
60936,),0,1
60937,the,0,0
60938,target,0,0
60939,pressure,0,0
60940,in,0,0
60941,the,0,0
60942,home,0,1
60943,BP,0,1
60944,group,0,1
60945,was,0,0
60946,observed,0,0
60947,due,0,0
60948,to,0,1
60949,the,0,0
60950,3.8,0,0
60951,mm,0,1
60952,Hg,0,0
60953,difference,0,0
60954,in,0,0
60955,ambulatory,0,1
60956,and,0,1
60957,home,0,1
60958,diastolic,0,1
60959,BP,0,1
60960,at,0,1
60961,randomization,0,0
60962,.,0,1
60963,CONCLUSIONS,0,0
60964,The,0,0
60965,adjustment,0,0
60966,of,0,0
60967,antihypertensive,0,1
60968,treatment,0,0
60969,based,0,1
60970,on,0,0
60971,either,0,1
60972,ambulatory,0,1
60973,or,0,1
60974,home,0,1
60975,BP,0,1
60976,measurement,0,0
60977,led,0,0
60978,to,0,0
60979,good,0,0
60980,BP,0,1
60981,control,0,1
60982,.,0,1
60983,No,0,0
60984,significant,0,0
60985,between-group,0,0
60986,differences,0,0
60987,in,0,1
60988,BP,0,1
60989,changes,0,0
60990,were,0,1
60991,seen,0,0
60992,at,0,0
60993,the,0,0
60994,end,0,0
60995,of,0,0
60996,the,0,0
60997,study,0,1
60998,.,0,1
60999,Additional,0,0
61000,research,0,0
61001,is,0,0
61002,needed,0,0
61003,to,0,0
61004,provide,0,0
61005,more,0,0
61006,conclusive,0,0
61007,results,0,0
61008,.,0,1
61009,Effects,0,1
61010,on,0,1
61011,parental,0,1
61012,mental,0,1
61013,health,0,1
61014,of,0,0
61015,an,0,0
61016,education,0,1
61017,and,0,0
61018,skills,0,0
61019,training,0,0
61020,program,0,1
61021,for,0,1
61022,parents,1,1
61023,of,1,1
61024,young,1,1
61025,children,1,1
61026,with,1,1
61027,autism,1,1
61028,:,1,1
61029,a,0,0
61030,randomized,0,1
61031,controlled,0,0
61032,trial,0,1
61033,.,0,1
61034,OBJECTIVE,0,0
61035,To,0,0
61036,determine,0,0
61037,the,0,0
61038,impact,0,0
61039,of,0,0
61040,a,0,0
61041,parent,0,1
61042,education,0,0
61043,and,0,0
61044,behavior,0,0
61045,management,0,1
61046,intervention,0,0
61047,(,0,1
61048,PEBM,0,0
61049,),0,1
61050,on,0,0
61051,the,0,0
61052,mental,0,1
61053,health,0,1
61054,and,0,0
61055,adjustment,0,0
61056,of,0,0
61057,parents,1,1
61058,with,1,1
61059,preschool,1,1
61060,children,1,1
61061,with,1,1
61062,autism,1,1
61063,.,1,1
61064,METHOD,0,0
61065,A,0,1
61066,randomized,0,1
61067,",",0,1
61068,group-comparison,0,0
61069,design,0,1
61070,involving,0,1
61071,a,0,0
61072,parent,0,1
61073,education,0,0
61074,and,0,0
61075,counseling,0,0
61076,intervention,0,0
61077,to,0,0
61078,control,0,1
61079,for,0,0
61080,nonspecific,0,1
61081,therapist,0,1
61082,effects,0,0
61083,and,0,1
61084,a,0,1
61085,control,0,0
61086,sample,0,1
61087,was,0,0
61088,used,0,0
61089,.,0,1
61090,Two,1,1
61091,metropolitan,1,1
61092,and,1,1
61093,two,1,1
61094,rural,1,1
61095,regions,1,1
61096,were,0,1
61097,randomly,0,1
61098,allocated,0,1
61099,to,0,0
61100,intervention,0,1
61101,groups,0,0
61102,(,0,1
61103,n,0,1
61104,=,0,1
61105,70,0,1
61106,),0,1
61107,or,0,1
61108,control,0,1
61109,(,0,1
61110,n,0,1
61111,=,0,1
61112,35,0,1
61113,),0,1
61114,.,0,1
61115,The,1,0
61116,parents,1,1
61117,of,1,1
61118,consecutive,1,1
61119,children,1,1
61120,with,1,1
61121,autism,1,1
61122,(,1,1
61123,2,1,1
61124,(,1,1
61125,1/2,1,1
61126,),1,1
61127,-5,1,1
61128,years,1,1
61129,old,1,1
61130,),1,1
61131,from,1,1
61132,the,1,0
61133,autism,1,1
61134,assessment,1,0
61135,services,1,1
61136,for,1,0
61137,the,1,1
61138,intervention,1,1
61139,regions,1,0
61140,were,0,1
61141,then,0,0
61142,randomly,0,1
61143,allocated,0,1
61144,to,0,0
61145,either,0,0
61146,a,0,0
61147,20-week,0,0
61148,manual-based,0,0
61149,parent,0,1
61150,education,0,1
61151,and,0,0
61152,behavior,0,0
61153,management,0,1
61154,intervention,0,0
61155,(,0,1
61156,n,0,1
61157,=,0,1
61158,35,0,1
61159,),0,1
61160,or,0,1
61161,a,0,1
61162,manual-based,0,0
61163,parent,0,1
61164,education,0,1
61165,and,0,0
61166,counseling,0,0
61167,intervention,0,0
61168,(,0,1
61169,n,0,1
61170,=,0,1
61171,35,0,1
61172,),0,1
61173,.,0,1
61174,The,0,0
61175,main,0,0
61176,outcome,0,0
61177,measure,0,0
61178,of,0,0
61179,parental,0,1
61180,mental,0,1
61181,health,0,1
61182,was,0,0
61183,the,0,0
61184,General,0,1
61185,Health,0,0
61186,Questionnaire,0,0
61187,used,0,0
61188,pre-,0,0
61189,and,0,0
61190,postintervention,0,0
61191,and,0,0
61192,at,0,0
61193,6-month,0,1
61194,follow-up,0,1
61195,.,0,1
61196,RESULTS,0,0
61197,Both,0,0
61198,treatments,0,0
61199,resulted,0,0
61200,in,0,1
61201,significant,0,0
61202,and,0,1
61203,progressive,0,1
61204,improvement,0,0
61205,in,0,1
61206,overall,0,0
61207,mental,0,1
61208,health,0,1
61209,at,0,1
61210,follow-up,0,0
61211,(,0,1
61212,F,0,1
61213,=,0,1
61214,2,0,1
61215,",",0,1
61216,97,0,0
61217,",",0,0
61218,p,0,0
61219,=.007,0,0
61220,),0,1
61221,and,0,0
61222,mental,0,1
61223,health,0,1
61224,significantly,0,0
61225,improved,0,0
61226,over,0,0
61227,time,0,0
61228,in,0,0
61229,the,0,0
61230,54,0,1
61231,%,0,0
61232,of,0,1
61233,principal,0,1
61234,caregivers,0,1
61235,who,0,1
61236,had,0,1
61237,the,0,1
61238,highest,0,0
61239,levels,0,0
61240,of,0,1
61241,mental,0,1
61242,health,0,1
61243,problems,0,1
61244,.,0,1
61245,The,0,0
61246,parent,0,0
61247,education,0,0
61248,and,0,0
61249,behavior,0,0
61250,management,0,1
61251,intervention,0,0
61252,was,0,0
61253,effective,0,0
61254,in,0,0
61255,alleviating,0,0
61256,a,0,1
61257,greater,0,0
61258,percentage,0,0
61259,of,0,0
61260,anxiety,0,1
61261,",",0,0
61262,insomnia,0,1
61263,",",0,0
61264,and,0,0
61265,somatic,0,1
61266,symptoms,0,1
61267,and,0,1
61268,family,0,1
61269,dysfunction,0,1
61270,than,0,0
61271,parent,0,1
61272,education,0,1
61273,and,0,0
61274,counseling,0,0
61275,at,0,0
61276,6-month,0,1
61277,follow-up,0,0
61278,.,0,1
61279,CONCLUSIONS,0,0
61280,A,0,0
61281,20-week,0,0
61282,parent,0,1
61283,education,0,1
61284,and,0,1
61285,skills,0,0
61286,training,0,0
61287,program,0,1
61288,for,0,1
61289,parents,1,1
61290,of,1,1
61291,young,1,1
61292,children,1,1
61293,newly,1,1
61294,diagnosed,1,1
61295,with,1,1
61296,autism,1,1
61297,provides,0,0
61298,significant,0,0
61299,improvements,0,0
61300,in,0,1
61301,parental,0,1
61302,mental,0,1
61303,health,0,1
61304,and,0,0
61305,adjustment,0,0
61306,",",0,0
61307,justifying,0,0
61308,its,0,0
61309,addition,0,0
61310,to,0,1
61311,early,0,1
61312,intervention,0,1
61313,programs,0,1
61314,at,0,1
61315,least,0,1
61316,for,0,1
61317,parents,1,1
61318,with,1,1
61319,mental,1,1
61320,health,1,1
61321,problems,1,1
61322,.,1,1
61323,Local,0,1
61324,immunotherapy,0,0
61325,by,0,0
61326,inhalation,0,0
61327,of,0,0
61328,a,0,0
61329,powder,0,0
61330,extract,0,0
61331,in,0,0
61332,asthma,0,1
61333,due,0,1
61334,to,0,1
61335,house,0,1
61336,dust,0,1
61337,mite,0,1
61338,Dermatophagoides,0,1
61339,pteronyssinus,0,1
61340,:,0,1
61341,a,0,0
61342,double-blind,0,0
61343,comparison,0,0
61344,with,0,1
61345,parenteral,0,1
61346,immunotherapy,0,1
61347,.,0,1
61348,To,0,0
61349,verify,0,0
61350,the,0,0
61351,efficacy,0,0
61352,and,0,0
61353,the,0,0
61354,tolerability,0,0
61355,of,0,0
61356,local,0,0
61357,immunotherapy,0,0
61358,(,0,1
61359,LI,0,0
61360,),0,1
61361,by,0,0
61362,inhalation,0,1
61363,of,0,0
61364,a,0,0
61365,powder,0,0
61366,extract,0,0
61367,of,0,0
61368,house,0,1
61369,dust,0,1
61370,mite,0,1
61371,(,0,1
61372,HDM,0,0
61373,),0,1
61374,",",0,0
61375,in,0,0
61376,comparison,0,0
61377,with,0,1
61378,parenteral,0,1
61379,immunotherapy,0,0
61380,(,0,1
61381,PI,0,1
61382,),0,1
61383,by,0,0
61384,injection,0,0
61385,",",0,1
61386,10,1,1
61387,patients,1,1
61388,with,1,1
61389,asthma,1,1
61390,due,1,1
61391,to,1,1
61392,HDM,1,0
61393,were,0,1
61394,studied,0,1
61395,in,0,0
61396,a,0,1
61397,blind,0,1
61398,fashion,0,0
61399,.,0,1
61400,5,0,0
61401,patients,0,1
61402,(,0,1
61403,Group,0,1
61404,A,0,1
61405,),0,1
61406,underwent,0,1
61407,LI,0,1
61408,and,0,1
61409,subcutaneous,0,1
61410,injections,0,0
61411,of,0,1
61412,placebo,0,1
61413,",",0,1
61414,5,0,1
61415,patients,0,1
61416,(,0,1
61417,Group,0,1
61418,B,0,1
61419,),0,1
61420,underwent,0,1
61421,PI,0,1
61422,and,0,0
61423,inhalation,0,0
61424,of,0,0
61425,lactose,0,1
61426,for,0,1
61427,6,0,1
61428,months,0,1
61429,.,0,1
61430,In,0,0
61431,both,0,0
61432,groups,0,0
61433,each,0,0
61434,inhalation,0,1
61435,was,0,0
61436,preceded,0,0
61437,by,0,0
61438,premedication,0,1
61439,with,0,1
61440,disodium,0,0
61441,cromoglycate,0,0
61442,(,0,1
61443,DSCG,0,1
61444,),0,1
61445,(,0,1
61446,40,0,1
61447,mg,0,1
61448,),0,1
61449,.,0,1
61450,In,0,0
61451,Group,0,1
61452,A,0,1
61453,a,0,1
61454,significant,0,0
61455,decrease,0,0
61456,in,0,1
61457,symptoms,0,1
61458,score,0,1
61459,and,0,1
61460,in,0,0
61461,peak,0,0
61462,expiratory,0,0
61463,flow,0,0
61464,(,0,1
61465,PEF,0,1
61466,),0,1
61467,-derived,0,1
61468,parameters,0,0
61469,was,0,0
61470,observed,0,0
61471,already,0,1
61472,after,0,1
61473,3,0,1
61474,months,0,1
61475,of,0,1
61476,treatment,0,1
61477,",",0,1
61478,and,0,1
61479,2,0,1
61480,patients,0,1
61481,lost,0,1
61482,the,0,0
61483,late,0,1
61484,component,0,0
61485,of,0,0
61486,the,0,0
61487,bronchial,0,1
61488,response,0,0
61489,to,0,0
61490,the,0,0
61491,challenge,0,0
61492,with,0,1
61493,HDM,0,0
61494,.,0,1
61495,No,0,0
61496,significant,0,0
61497,variation,0,0
61498,was,0,0
61499,found,0,0
61500,in,0,0
61501,bronchial,0,1
61502,responsiveness,0,0
61503,to,0,0
61504,methacholine,0,0
61505,and,0,0
61506,ultrasonically,0,1
61507,nebulized,0,0
61508,distilled,0,0
61509,water,0,0
61510,(,0,1
61511,UNDW,0,1
61512,),0,1
61513,and,0,0
61514,in,0,1
61515,immunologic,0,0
61516,humoral,0,0
61517,and,0,1
61518,cellular,0,1
61519,parameters,0,0
61520,in,0,1
61521,peripheral,0,1
61522,blood,0,0
61523,after,0,0
61524,treatment,0,0
61525,in,0,0
61526,either,0,1
61527,group,0,1
61528,.,0,0
61529,No,0,0
61530,local,0,0
61531,important,0,0
61532,adverse,0,0
61533,reactions,0,0
61534,were,0,1
61535,observed,0,0
61536,in,0,0
61537,Group,0,1
61538,A,0,1
61539,and,0,0
61540,no,0,0
61541,systemic,0,0
61542,side,0,0
61543,effects,0,0
61544,were,0,1
61545,observed,0,0
61546,in,0,0
61547,either,0,1
61548,group,0,1
61549,.,0,0
61550,We,0,0
61551,conclude,0,0
61552,that,0,0
61553,LI,0,0
61554,is,0,0
61555,as,0,0
61556,effective,0,0
61557,as,0,0
61558,PI,0,1
61559,",",0,0
61560,but,0,0
61561,more,0,0
61562,rapid,0,0
61563,in,0,0
61564,its,0,0
61565,action,0,0
61566,",",0,0
61567,in,0,0
61568,the,0,0
61569,treatment,0,0
61570,of,0,0
61571,asthma,0,1
61572,due,0,1
61573,to,0,1
61574,HDM,0,0
61575,.,0,1
61576,Moreover,0,0
61577,",",0,0
61578,LI,0,0
61579,is,0,0
61580,locally,0,0
61581,well,0,0
61582,tolerated,0,0
61583,",",0,0
61584,providing,0,0
61585,DSCG,0,0
61586,is,0,0
61587,inhaled,0,0
61588,before,0,0
61589,each,0,0
61590,therapeutic,0,0
61591,inhalation,0,0
61592,",",0,0
61593,and,0,0
61594,does,0,0
61595,not,0,0
61596,induce,0,0
61597,systemic,0,0
61598,side,0,0
61599,effects,0,0
61600,.,0,1
61601,A,0,0
61602,randomised,0,0
61603,trial,0,0
61604,comparing,0,0
61605,holmium,0,1
61606,laser,0,0
61607,enucleation,0,1
61608,versus,0,0
61609,transurethral,0,1
61610,resection,0,1
61611,in,0,0
61612,the,0,0
61613,treatment,1,0
61614,of,1,0
61615,prostates,1,1
61616,larger,1,1
61617,than,1,1
61618,40,1,1
61619,grams,1,1
61620,:,1,1
61621,results,0,0
61622,at,0,1
61623,2,0,1
61624,years,0,1
61625,.,0,1
61626,OBJECTIVE,0,0
61627,To,0,0
61628,compare,0,0
61629,holmium,0,1
61630,laser,0,0
61631,enucleation,0,1
61632,of,0,0
61633,the,0,0
61634,prostate,0,1
61635,(,0,0
61636,HoLEP,0,0
61637,),0,1
61638,with,0,1
61639,transurethral,0,1
61640,resection,0,1
61641,of,0,0
61642,the,0,0
61643,prostate,0,1
61644,(,0,0
61645,TURP,0,1
61646,),0,1
61647,for,0,0
61648,treatment,0,1
61649,of,0,1
61650,men,1,1
61651,with,1,1
61652,bladder,1,1
61653,outflow,1,1
61654,obstruction,1,1
61655,(,1,1
61656,BOO,1,1
61657,),1,1
61658,secondary,1,0
61659,to,1,0
61660,benign,1,1
61661,prostatic,1,1
61662,hyperplasia,1,1
61663,with,1,1
61664,a,1,0
61665,minimum,1,0
61666,of,1,0
61667,24-month,1,1
61668,follow-up,1,1
61669,.,1,1
61670,PATIENTS,0,0
61671,AND,0,1
61672,METHODS,0,1
61673,Sixty-one,1,1
61674,patients,1,1
61675,were,0,1
61676,randomised,0,1
61677,to,0,0
61678,either,0,1
61679,HoLEP,0,0
61680,or,0,1
61681,TURP,0,1
61682,.,0,1
61683,All,1,1
61684,patients,1,1
61685,had,1,1
61686,BOO,1,1
61687,proven,1,1
61688,on,1,0
61689,urodynamic,1,1
61690,studies,1,0
61691,pre-operatively,1,1
61692,(,1,1
61693,prostate,1,1
61694,size,1,0
61695,40-200,1,1
61696,g,1,1
61697,),1,1
61698,.,1,1
61699,One,0,1
61700,patient,0,0
61701,died,0,1
61702,before,0,0
61703,treatment,0,0
61704,",",0,0
61705,which,0,0
61706,left,0,1
61707,30,1,1
61708,patients,1,1
61709,in,1,1
61710,each,1,1
61711,group,1,1
61712,.,1,1
61713,Perioperative,0,0
61714,data,0,0
61715,",",0,0
61716,as,0,0
61717,well,0,0
61718,as,0,0
61719,symptom,0,0
61720,scores,0,0
61721,",",0,1
61722,Quality,0,0
61723,of,0,0
61724,Life,0,0
61725,(,0,1
61726,QoL,0,0
61727,),0,0
61728,scores,0,0
61729,",",0,0
61730,and,0,0
61731,maximum,0,0
61732,urinary,0,1
61733,flow,0,0
61734,rates,0,0
61735,(,0,1
61736,Qmax,0,1
61737,),0,1
61738,were,0,0
61739,obtained,0,0
61740,at,0,0
61741,one,0,1
61742,",",0,1
61743,three,0,0
61744,",",0,0
61745,"six,12",0,0
61746,",",0,0
61747,and,0,1
61748,24,0,1
61749,months,0,1
61750,.,0,1
61751,Post-void,0,0
61752,residual,0,0
61753,volumes,0,0
61754,",",0,1
61755,transrectal,0,1
61756,ultrasound,0,1
61757,(,0,1
61758,TRUS,0,1
61759,),0,1
61760,volumes,0,0
61761,",",0,1
61762,and,0,0
61763,pressure,0,0
61764,flow,0,0
61765,studies,0,0
61766,were,0,1
61767,obtained,0,0
61768,six,0,1
61769,months,0,0
61770,post-operatively,0,1
61771,.,0,1
61772,Continence,0,0
61773,and,0,0
61774,potency,0,0
61775,data,0,0
61776,were,0,1
61777,also,0,0
61778,recorded,0,0
61779,.,0,0
61780,RESULTS,0,0
61781,There,0,0
61782,were,0,0
61783,no,0,0
61784,significant,0,0
61785,differences,0,0
61786,between,0,0
61787,the,0,1
61788,two,0,0
61789,surgical,0,1
61790,groups,0,1
61791,pre-operatively,0,1
61792,.,0,1
61793,Mean,0,1
61794,pre-operative,0,0
61795,TRUS,0,1
61796,volume,0,0
61797,was,0,0
61798,77.8+/-5.6,0,1
61799,g,0,1
61800,(,0,1
61801,42-152,0,1
61802,),0,1
61803,in,0,0
61804,the,0,0
61805,HoLEP,0,0
61806,group,0,1
61807,and,0,1
61808,70.0+/-5.0,0,0
61809,g,0,1
61810,(,0,1
61811,46-156,0,1
61812,),0,1
61813,in,0,0
61814,the,0,0
61815,TURP,0,1
61816,group,0,1
61817,.,0,1
61818,Patients,0,1
61819,in,0,0
61820,the,0,1
61821,HoLEP,0,0
61822,group,0,0
61823,had,0,1
61824,shorter,0,0
61825,catheter,0,1
61826,times,0,0
61827,and,0,1
61828,hospital,0,1
61829,stays,0,0
61830,.,0,1
61831,More,0,1
61832,prostate,0,1
61833,tissue,0,1
61834,was,0,0
61835,retrieved,0,0
61836,in,0,0
61837,the,0,0
61838,HoLEP,0,0
61839,group,0,1
61840,.,0,1
61841,At,0,0
61842,six,0,1
61843,months,0,0
61844,",",0,1
61845,HoLEP,0,0
61846,was,0,0
61847,urodynamically,0,1
61848,superior,0,0
61849,to,0,0
61850,TURP,0,1
61851,in,0,0
61852,relieving,0,0
61853,BOO,0,1
61854,.,0,1
61855,At,0,0
61856,24,0,1
61857,months,0,0
61858,",",0,0
61859,there,0,0
61860,was,0,0
61861,no,0,0
61862,significant,0,0
61863,difference,0,0
61864,between,0,0
61865,the,0,0
61866,two,0,0
61867,surgical,0,1
61868,groups,0,1
61869,with,0,1
61870,respect,0,0
61871,to,0,1
61872,American,0,1
61873,Urology,0,1
61874,Association,0,1
61875,scores,0,0
61876,",",0,0
61877,QoL,0,0
61878,scores,0,0
61879,",",0,0
61880,or,0,0
61881,Qmax,0,1
61882,values,0,0
61883,;,0,1
61884,however,0,0
61885,",",0,1
61886,two,0,0
61887,patients,0,1
61888,in,0,1
61889,the,0,1
61890,TURP,0,1
61891,group,0,0
61892,required,0,0
61893,re-operation,0,0
61894,.,0,1
61895,CONCLUSIONS,0,0
61896,HoLEP,0,0
61897,has,0,0
61898,less,0,0
61899,perioperative,0,0
61900,morbidity,0,0
61901,and,0,0
61902,produces,0,0
61903,superior,0,0
61904,urodynamic,0,0
61905,outcomes,0,0
61906,than,0,1
61907,TURP,0,1
61908,",",0,0
61909,when,0,0
61910,treating,0,0
61911,prostates,0,1
61912,>,0,1
61913,40,0,1
61914,g.,0,1
61915,At,0,1
61916,24,0,1
61917,months,0,1
61918,of,0,1
61919,follow-up,0,0
61920,",",0,0
61921,HoLEP,0,0
61922,is,0,0
61923,equivalent,0,0
61924,to,0,0
61925,TURP,0,1
61926,.,0,1
61927,Effects,0,1
61928,of,0,1
61929,short-,0,1
61930,and,0,1
61931,long-term,0,0
61932,risperidone,0,0
61933,treatment,1,0
61934,on,1,0
61935,prolactin,1,0
61936,levels,1,1
61937,in,1,1
61938,children,1,1
61939,with,1,1
61940,autism,1,1
61941,.,1,1
61942,BACKGROUND,0,0
61943,The,0,0
61944,effects,0,0
61945,of,0,0
61946,short-,0,1
61947,and,0,1
61948,long-term,0,0
61949,risperidone,0,0
61950,treatment,0,0
61951,on,0,0
61952,serum,0,0
61953,prolactin,0,0
61954,were,0,0
61955,assessed,0,0
61956,in,0,1
61957,children,1,1
61958,and,1,1
61959,adolescents,1,1
61960,with,1,1
61961,autism,1,1
61962,.,1,1
61963,METHODS,0,0
61964,Patients,1,1
61965,with,1,1
61966,autism,1,1
61967,(,1,1
61968,N,1,1
61969,=,1,1
61970,101,1,1
61971,",",1,1
61972,5-17,1,1
61973,years,1,1
61974,of,1,1
61975,age,1,1
61976,),1,1
61977,were,0,1
61978,randomized,0,1
61979,to,0,0
61980,an,0,0
61981,8-week,0,0
61982,trial,0,0
61983,of,0,0
61984,risperidone,0,0
61985,or,0,1
61986,placebo,0,0
61987,and,0,0
61988,63,1,1
61989,then,1,0
61990,took,1,1
61991,part,1,0
61992,in,1,0
61993,a,1,1
61994,4-month,1,1
61995,open-label,1,1
61996,follow-up,1,1
61997,phase,1,1
61998,.,1,1
61999,Serum,0,1
62000,samples,0,1
62001,were,0,1
62002,obtained,0,0
62003,at,0,1
62004,Baseline,0,0
62005,and,0,1
62006,Week-8,0,1
62007,(,0,1
62008,N,0,1
62009,=,0,1
62010,78,0,1
62011,),0,1
62012,",",0,0
62013,and,0,0
62014,at,0,0
62015,6-month,0,1
62016,(,0,1
62017,N,0,1
62018,=,0,1
62019,43,0,1
62020,),0,1
62021,and,0,1
62022,22-month,0,1
62023,(,0,1
62024,N,0,1
62025,=,0,1
62026,30,0,1
62027,),0,1
62028,follow-up,0,0
62029,.,0,1
62030,Serum,0,1
62031,prolactin,0,0
62032,was,0,0
62033,determined,0,0
62034,by,0,0
62035,immunoradiometric,0,1
62036,assay,0,1
62037,;,0,1
62038,dopamine,0,1
62039,type-2,0,1
62040,receptor,0,0
62041,(,0,1
62042,DRD2,0,1
62043,),0,1
62044,polymorphisms,0,0
62045,were,0,1
62046,genotyped,0,1
62047,.,0,1
62048,RESULTS,0,0
62049,Baseline,0,0
62050,prolactin,0,1
62051,levels,0,0
62052,were,0,1
62053,similar,0,0
62054,in,0,0
62055,the,0,0
62056,risperidone,0,0
62057,(,0,0
62058,N,0,1
62059,=,0,1
62060,42,0,1
62061,),0,1
62062,and,0,1
62063,placebo,0,0
62064,(,0,1
62065,N,0,1
62066,=,0,1
62067,36,0,1
62068,),0,1
62069,groups,0,1
62070,(,0,1
62071,9.3,0,1
62072,+/-,0,1
62073,7.5,0,1
62074,and,0,1
62075,9.3,0,1
62076,+/-,0,0
62077,7.6,0,0
62078,ng/ml,0,0
62079,",",0,0
62080,respectively,0,0
62081,),0,0
62082,.,0,1
62083,After,0,0
62084,8,0,1
62085,weeks,0,1
62086,of,0,1
62087,risperidone,0,0
62088,",",0,0
62089,prolactin,0,0
62090,increased,0,0
62091,to,0,1
62092,39.0,0,1
62093,+/-,0,0
62094,19.2,0,0
62095,ng/ml,0,0
62096,",",0,0
62097,compared,0,0
62098,with,0,1
62099,10.1,0,1
62100,+/-,0,1
62101,8.8,0,0
62102,ng/ml,0,0
62103,for,0,0
62104,placebo,0,0
62105,(,0,1
62106,p,0,0
62107,<,0,0
62108,.0001,0,0
62109,),0,1
62110,.,0,1
62111,Prolactin,0,0
62112,levels,0,0
62113,were,0,1
62114,also,0,0
62115,significantly,0,0
62116,increased,0,0
62117,at,0,1
62118,6,0,1
62119,months,0,1
62120,(,0,1
62121,32.4,0,1
62122,+/-,0,1
62123,17.8,0,1
62124,ng/ml,0,0
62125,;,0,0
62126,N,0,1
62127,=,0,0
62128,43,0,0
62129,",",0,0
62130,p,0,0
62131,<,0,0
62132,.0001,0,0
62133,),0,1
62134,and,0,1
62135,at,0,1
62136,22,0,1
62137,months,0,1
62138,(,0,1
62139,N,0,1
62140,=,0,1
62141,30,0,1
62142,",",0,1
62143,25.3,0,1
62144,+/-,0,0
62145,15.6,0,0
62146,ng/ml,0,0
62147,",",0,0
62148,p,0,0
62149,<,0,0
62150,.0001,0,0
62151,),0,1
62152,.,0,1
62153,Prolactin,0,0
62154,levels,0,0
62155,were,0,1
62156,not,0,0
62157,associated,0,0
62158,with,0,1
62159,adverse,0,0
62160,effects,0,0
62161,and,0,1
62162,DRD2,0,1
62163,alleles,0,0
62164,(,0,1
62165,Taq1A,0,1
62166,",",0,1
62167,-141C,0,0
62168,Ins/Del,0,0
62169,",",0,1
62170,C957T,0,0
62171,),0,0
62172,did,0,0
62173,not,0,0
62174,significantly,0,0
62175,influence,0,0
62176,baseline,0,0
62177,levels,0,0
62178,or,0,1
62179,risperidone-induced,0,1
62180,increases,0,0
62181,in,0,1
62182,prolactin,0,1
62183,.,0,1
62184,CONCLUSIONS,0,0
62185,Risperidone,0,0
62186,treatment,0,0
62187,was,0,0
62188,associated,0,0
62189,with,0,1
62190,two-,0,0
62191,to,0,1
62192,four-fold,0,0
62193,mean,0,1
62194,increases,0,0
62195,in,0,1
62196,serum,0,0
62197,prolactin,0,0
62198,in,0,0
62199,children,1,1
62200,with,1,1
62201,autism,1,1
62202,.,1,1
62203,Although,0,0
62204,risperidone-induced,0,1
62205,increases,0,0
62206,tended,0,0
62207,to,0,0
62208,diminish,0,0
62209,with,0,1
62210,time,0,0
62211,",",0,0
62212,further,0,0
62213,research,0,1
62214,on,0,0
62215,the,0,0
62216,consequences,0,0
62217,of,0,0
62218,long-term,0,1
62219,prolactin,0,1
62220,elevations,0,0
62221,in,0,1
62222,children,1,1
62223,and,1,1
62224,adolescents,1,1
62225,is,0,0
62226,needed,0,0
62227,.,0,0
62228,[,0,1
62229,Rapidity,0,1
62230,of,0,0
62231,pain,0,1
62232,relief,0,0
62233,",",0,0
62234,medication,0,0
62235,requirement,0,1
62236,and,0,0
62237,patient,1,1
62238,satisfaction,1,0
62239,with,1,1
62240,reflux,1,1
62241,treatment,1,0
62242,in,0,0
62243,the,0,0
62244,physician,0,1
62245,'s,0,1
62246,office,0,1
62247,],0,1
62248,.,0,1
62249,Treatment,0,0
62250,of,0,0
62251,gastroesophageal,1,1
62252,reflux,1,1
62253,disease,1,1
62254,(,1,1
62255,GERD,1,1
62256,),1,1
62257,with,0,1
62258,proton,0,0
62259,pump,0,1
62260,inhibitors,0,0
62261,was,0,0
62262,investigated,0,0
62263,in,0,1
62264,three,0,0
62265,controlled,0,0
62266,prospective,0,1
62267,",",0,1
62268,randomized,0,1
62269,open,0,1
62270,studies,0,0
62271,.,0,1
62272,Lansoprazole,0,0
62273,",",0,0
62274,omeprazole,0,0
62275,MUPS,0,0
62276,and,0,1
62277,esomeprazole,0,0
62278,were,0,0
62279,compared,0,0
62280,under,0,1
62281,doctor,0,1
62282,'s,0,1
62283,office,0,1
62284,conditions,0,1
62285,.,0,1
62286,The,0,0
62287,outcomes,0,0
62288,of,0,0
62289,interest,0,0
62290,were,0,1
62291,the,0,0
62292,rapidity,0,0
62293,of,0,0
62294,pain,0,1
62295,relief,0,0
62296,achieved,0,0
62297,with,0,1
62298,a,0,1
62299,single,0,0
62300,dose,0,0
62301,",",0,0
62302,effectiveness,0,0
62303,and,0,0
62304,patient,0,1
62305,satisfaction,0,0
62306,with,0,1
62307,on,0,0
62308,demand,0,0
62309,therapy,0,0
62310,.,0,1
62311,In,0,0
62312,the,0,0
62313,first,0,0
62314,study,0,0
62315,",",0,1
62316,180,1,1
62317,patients,1,1
62318,with,1,1
62319,chronic,1,1
62320,and,1,1
62321,prolonged,1,0
62322,episodes,1,1
62323,of,1,1
62324,reflux,1,1
62325,were,1,1
62326,investigated,1,0
62327,.,1,1
62328,Time,0,0
62329,to,0,0
62330,pain,0,1
62331,relief,0,0
62332,following,0,0
62333,a,0,0
62334,single,0,0
62335,dose,0,0
62336,was,0,0
62337,1.1,0,0
62338,+/-,0,1
62339,0.8,0,1
62340,hours,0,1
62341,with,0,1
62342,30,0,1
62343,mg,0,1
62344,lansoprazole,0,0
62345,",",0,1
62346,3.0,0,0
62347,+/-,0,1
62348,2.5,0,1
62349,hours,0,1
62350,with,0,1
62351,20,0,1
62352,mgomeprazole,0,0
62353,MUPS,0,1
62354,and,0,1
62355,2.1,0,1
62356,+/-,0,1
62357,1.2,0,1
62358,hours,0,1
62359,with,0,1
62360,40,0,1
62361,mg,0,1
62362,esomeprazole,0,0
62363,.,0,1
62364,Studies,0,0
62365,2,0,1
62366,and,0,1
62367,3,0,1
62368,were,0,1
62369,designed,0,0
62370,as,0,0
62371,cross-over,0,1
62372,studies,0,0
62373,intended,0,0
62374,to,0,1
62375,investigate,0,0
62376,drug,0,0
62377,consumption,0,0
62378,.,0,1
62379,In,0,0
62380,study,0,0
62381,2,0,1
62382,",",0,0
62383,the,0,0
62384,amount,0,0
62385,of,0,0
62386,lansoprazole,0,0
62387,consumed,0,1
62388,was,0,0
62389,approximately,0,1
62390,50,0,1
62391,%,0,0
62392,less,0,0
62393,than,0,0
62394,that,0,0
62395,of,0,0
62396,omeprazole,0,0
62397,",",0,0
62398,and,0,0
62399,this,0,0
62400,translated,0,0
62401,to,0,0
62402,81,0,1
62403,%,0,0
62404,patient,0,1
62405,satisfaction,0,0
62406,with,0,1
62407,lansoprazole,0,0
62408,compared,0,0
62409,with,0,1
62410,only,0,0
62411,9.5,0,0
62412,%,0,0
62413,for,0,1
62414,omeprazole,0,0
62415,.,0,1
62416,In,0,0
62417,study,0,1
62418,3,0,1
62419,comparing,0,0
62420,lansoprazole,0,0
62421,and,0,0
62422,esomeprazole,0,0
62423,",",0,0
62424,consumption,0,0
62425,of,0,0
62426,the,0,0
62427,former,0,1
62428,was,0,0
62429,85,0,1
62430,%,0,0
62431,that,0,0
62432,of,0,0
62433,the,0,0
62434,latter,0,0
62435,.,0,1
62436,58,0,1
62437,%,0,0
62438,of,0,0
62439,the,0,0
62440,patients,0,1
62441,opted,0,1
62442,to,0,0
62443,continuetreatment,0,0
62444,with,0,1
62445,lansoprazole,0,0
62446,",",0,0
62447,compared,0,0
62448,with,0,1
62449,only,0,0
62450,25,0,1
62451,%,0,0
62452,in,0,0
62453,the,0,0
62454,case,0,0
62455,of,0,0
62456,esomeprazole,0,0
62457,.,0,1
62458,The,0,0
62459,appreciably,0,0
62460,greater,0,0
62461,patient,0,0
62462,satisfaction,0,0
62463,with,0,1
62464,lansoprazole,0,0
62465,was,0,0
62466,due,0,0
62467,tothe,0,0
62468,faster,0,0
62469,pain,0,0
62470,relief,0,0
62471,achieved,0,0
62472,with,0,1
62473,this,0,0
62474,drug,0,0
62475,.,0,1
62476,Different,0,0
62477,loss,0,0
62478,of,0,1
62479,BMD,0,0
62480,using,0,0
62481,uncemented,0,1
62482,press-fit,0,1
62483,and,0,1
62484,whole,0,0
62485,polyethylene,0,0
62486,cups,0,0
62487,fixed,0,0
62488,with,0,1
62489,cement,0,0
62490,:,0,1
62491,repeated,0,0
62492,DXA,0,1
62493,studies,0,0
62494,in,0,1
62495,96,1,1
62496,hips,1,1
62497,randomized,1,1
62498,to,1,1
62499,3,1,1
62500,types,1,1
62501,of,1,1
62502,fixation,1,1
62503,.,1,1
62504,BACKGROUND,0,0
62505,In,0,1
62506,cemented,0,1
62507,THA,0,1
62508,",",0,1
62509,aseptic,0,1
62510,loosening,0,0
62511,of,0,0
62512,the,0,0
62513,cup,0,0
62514,is,0,0
62515,more,0,0
62516,common,0,0
62517,than,0,0
62518,loosening,0,0
62519,of,0,0
62520,the,0,0
62521,stem,0,0
62522,",",0,0
62523,while,0,0
62524,periprosthetic,0,1
62525,osteolysis,0,1
62526,of,0,0
62527,the,0,0
62528,socket,0,0
62529,resulting,0,0
62530,in,0,0
62531,difficult,0,1
62532,reconstruction,0,1
62533,problems,0,1
62534,has,0,0
62535,emerged,0,0
62536,as,0,0
62537,the,0,0
62538,most,0,0
62539,significant,0,0
62540,problem,0,1
62541,with,0,1
62542,cementless,0,1
62543,cup,0,1
62544,fixation,0,1
62545,.,0,1
62546,PATIENTS,0,0
62547,AND,0,0
62548,METHODS,0,0
62549,90,1,1
62550,patients,1,1
62551,(,1,1
62552,96,1,1
62553,hips,1,1
62554,),1,1
62555,scheduled,1,1
62556,for,1,1
62557,THA,1,1
62558,were,0,1
62559,stratified,0,1
62560,in,0,1
62561,three,0,1
62562,groups,0,1
62563,according,0,1
62564,to,0,1
62565,the,0,0
62566,method,0,0
62567,of,0,0
62568,fixation,0,1
62569,of,0,0
62570,the,0,0
62571,acetabular,0,1
62572,component,0,0
62573,:,0,1
62574,acrylic,0,0
62575,bone,0,1
62576,cement,0,0
62577,with,0,1
62578,fluoride,0,0
62579,(,0,1
62580,Cemex-F,0,0
62581,),0,1
62582,",",0,0
62583,porous-coated,0,1
62584,press-fit,0,1
62585,cup,0,1
62586,with,0,1
62587,ceramic,0,1
62588,coating,0,1
62589,(,0,1
62590,Trilogy,0,0
62591,",",0,0
62592,uncemented,0,1
62593,),0,0
62594,and,0,0
62595,acrylic,0,0
62596,cement,0,0
62597,with,0,1
62598,gentamicin,0,0
62599,(,0,1
62600,Palacos,0,0
62601,),0,1
62602,.,0,1
62603,All,1,1
62604,patients,1,1
62605,received,1,1
62606,the,1,0
62607,Spectron,1,0
62608,EF,1,1
62609,stem,1,1
62610,.,1,1
62611,Acetabular,0,0
62612,bone,0,0
62613,mineral,0,0
62614,density,0,0
62615,was,0,0
62616,measured,0,0
62617,with,0,1
62618,dual-energy,0,1
62619,X-ray,0,1
62620,absorptiometry,0,1
62621,(,0,1
62622,DXA,0,1
62623,),0,1
62624,1,0,0
62625,week,0,0
62626,postoperatively,0,0
62627,",",0,0
62628,and,0,0
62629,after,0,0
62630,12,0,1
62631,and,0,1
62632,24,0,1
62633,months,0,0
62634,.,0,1
62635,The,0,0
62636,periprosthetic,0,1
62637,BMD,0,0
62638,was,0,0
62639,evaluated,0,0
62640,in,0,1
62641,5,0,1
62642,ROIs,0,0
62643,positioned,0,1
62644,around,0,0
62645,the,0,0
62646,acetabular,0,1
62647,component,0,0
62648,.,0,1
62649,RESULTS,0,0
62650,In,0,0
62651,the,0,0
62652,uncemented,0,1
62653,sockets,0,0
62654,",",0,1
62655,the,0,0
62656,BMD,0,0
62657,had,0,1
62658,decreased,0,0
62659,proximally,0,0
62660,and,0,0
62661,medially,0,0
62662,to,0,0
62663,the,0,0
62664,cup,0,1
62665,after,0,1
62666,2,0,1
62667,years,0,1
62668,.,0,1
62669,The,0,0
62670,difference,0,0
62671,was,0,0
62672,significant,0,0
62673,in,0,0
62674,the,0,0
62675,proximal,0,1
62676,region,0,1
62677,as,0,0
62678,compared,0,0
62679,to,0,0
62680,the,0,0
62681,control,0,0
62682,group,0,0
62683,(,0,1
62684,Palacos,0,0
62685,),0,1
62686,.,0,1
62687,No,0,0
62688,difference,0,0
62689,was,0,0
62690,noted,0,0
62691,between,0,0
62692,the,0,1
62693,2,0,1
62694,groups,0,0
62695,with,0,1
62696,cemented,0,1
62697,components,0,0
62698,after,0,1
62699,2,0,1
62700,years,0,1
62701,.,0,1
62702,Stepwise,0,0
62703,linear,0,0
62704,regression,0,0
62705,analysis,0,0
62706,showed,0,0
62707,that,0,0
62708,loss,0,0
62709,of,0,1
62710,periprosthetic,0,1
62711,BMD,0,1
62712,in,0,0
62713,the,0,0
62714,proximal,0,1
62715,high-pressure,0,0
62716,region,0,1
62717,after,0,1
62718,2,0,1
62719,years,0,1
62720,increased,0,0
62721,with,0,1
62722,higher,0,0
62723,postoperative,0,0
62724,BMD,0,0
62725,and,0,0
62726,when,0,0
62727,the,0,0
62728,uncemented,0,0
62729,design,0,1
62730,had,0,1
62731,been,0,1
62732,used,0,0
62733,.,0,1
62734,INTERPRETATION,0,0
62735,Contrary,0,0
62736,to,0,1
62737,previous,0,1
62738,studies,0,0
62739,of,0,1
62740,cemented,0,1
62741,stems,0,1
62742,",",0,1
62743,the,0,0
62744,use,0,0
62745,of,0,0
62746,fluoride,0,0
62747,cement,0,0
62748,did,0,0
62749,not,0,0
62750,influence,0,0
62751,the,0,0
62752,periprosthetic,0,1
62753,BMD,0,1
62754,2,0,1
62755,years,0,1
62756,after,0,1
62757,the,0,1
62758,examination,0,0
62759,.,0,1
62760,Increased,0,0
62761,loss,0,0
62762,of,0,0
62763,BMD,0,0
62764,with,0,1
62765,use,0,0
62766,of,0,1
62767,uncemented,0,1
62768,press-fit,0,1
62769,cups,0,1
62770,in,0,1
62771,the,0,0
62772,region,0,1
62773,in,0,0
62774,which,0,1
62775,osteolytic,0,1
62776,lesions,0,1
62777,are,0,0
62778,commonly,0,0
62779,found,0,0
62780,suggests,0,0
62781,that,0,0
62782,stress,0,0
62783,shielding,0,0
62784,may,0,0
62785,initiate,0,0
62786,the,0,0
62787,development,0,0
62788,of,0,0
62789,this,0,0
62790,complication,0,0
62791,.,0,1
62792,Longer,0,0
62793,follow-up,0,0
62794,will,0,0
62795,",",0,0
62796,however,0,0
62797,",",0,0
62798,be,0,0
62799,necessary,0,0
62800,to,0,0
62801,substantiate,0,0
62802,this,0,0
62803,hypothesis,0,0
62804,.,0,1
62805,Dexamethasone,0,0
62806,effectively,0,0
62807,reduces,0,0
62808,postoperative,0,0
62809,nausea,0,0
62810,and,0,0
62811,vomiting,0,0
62812,in,0,0
62813,a,0,1
62814,general,1,1
62815,surgical,1,1
62816,adult,1,1
62817,patient,1,1
62818,population,1,1
62819,.,1,1
62820,BACKGROUND,0,0
62821,Postoperative,0,0
62822,nausea,0,0
62823,and,0,0
62824,vomiting,0,0
62825,(,0,1
62826,PONV,0,0
62827,),0,0
62828,is,0,0
62829,still,0,0
62830,a,0,0
62831,common,0,0
62832,and,0,0
62833,major,0,1
62834,complication,0,0
62835,for,0,1
62836,surgical,1,1
62837,patients,1,1
62838,",",0,0
62839,which,0,0
62840,may,0,0
62841,delay,0,1
62842,post-anesthetic,0,0
62843,care,0,1
62844,unit,0,1
62845,discharge,0,0
62846,",",0,0
62847,prolong,0,0
62848,hospital,0,1
62849,stay,0,0
62850,and,0,0
62851,thus,0,0
62852,increase,0,0
62853,the,0,0
62854,cost,0,0
62855,of,0,0
62856,hospitalization,0,1
62857,.,0,1
62858,It,0,0
62859,is,0,0
62860,understood,0,0
62861,that,0,0
62862,PONV,0,0
62863,is,0,0
62864,a,0,0
62865,multi-factorial,0,0
62866,outcome,0,0
62867,and,0,0
62868,occurs,0,0
62869,more,0,0
62870,often,0,0
62871,with,0,0
62872,general,0,1
62873,anesthesia,0,1
62874,than,0,0
62875,with,0,1
62876,other,0,1
62877,anesthetic,0,1
62878,methods,0,1
62879,.,0,1
62880,Prophylactic,0,0
62881,administration,0,0
62882,of,0,1
62883,antihistamines,0,1
62884,",",0,1
62885,antidopaminergics,0,0
62886,",",0,1
62887,anticholinergics,0,0
62888,",",0,1
62889,phenothiazines,0,1
62890,",",0,1
62891,serotonin,0,0
62892,antagonist,0,0
62893,",",0,1
62894,steroids,0,0
62895,and,0,0
62896,even,0,0
62897,acupuncture,0,0
62898,has,0,0
62899,been,0,0
62900,shown,0,0
62901,to,0,0
62902,be,0,0
62903,effective,0,0
62904,.,0,0
62905,However,0,0
62906,",",0,0
62907,expenses,0,0
62908,and,0,1
62909,side,0,0
62910,effects,0,0
62911,of,0,1
62912,these,0,0
62913,agents,0,0
62914,have,0,0
62915,also,0,0
62916,been,0,0
62917,a,0,0
62918,concern,0,0
62919,for,0,0
62920,clinical,0,1
62921,doctors,0,1
62922,.,0,1
62923,The,0,0
62924,aim,0,0
62925,for,0,0
62926,this,0,0
62927,prospective,0,1
62928,study,0,1
62929,was,0,0
62930,to,0,0
62931,find,0,0
62932,an,0,0
62933,agent,0,0
62934,that,0,0
62935,is,0,0
62936,cost,0,0
62937,effective,0,0
62938,and,0,1
62939,side,0,0
62940,effect,0,0
62941,free,0,1
62942,(,0,1
62943,or,0,1
62944,at,0,0
62945,least,0,0
62946,with,0,1
62947,a,0,1
62948,low,0,0
62949,incidence,0,0
62950,of,0,1
62951,side,0,0
62952,effects,0,0
62953,),0,1
62954,for,0,0
62955,the,0,0
62956,prevention,0,1
62957,of,0,0
62958,PONV,0,1
62959,.,0,1
62960,METHODS,0,0
62961,A,1,0
62962,total,1,1
62963,of,1,0
62964,700,1,1
62965,adult,1,1
62966,surgical,1,1
62967,patients,1,1
62968,who,1,1
62969,planned,1,1
62970,to,1,1
62971,have,1,0
62972,surgery,1,1
62973,under,1,0
62974,general,1,1
62975,anesthesia,1,1
62976,were,0,1
62977,enrolled,0,1
62978,in,0,0
62979,this,0,0
62980,double-blinded,0,0
62981,",",0,0
62982,randomized,0,1
62983,and,0,0
62984,placebo-controlled,0,1
62985,study,0,1
62986,.,0,1
62987,Group,0,1
62988,P,0,0
62989,received,0,1
62990,the,0,0
62991,placebo,0,0
62992,(,0,0
62993,0.9,0,0
62994,%,0,0
62995,normal,0,1
62996,saline,0,0
62997,2,0,1
62998,ml,0,0
62999,),0,1
63000,and,0,1
63001,Group,0,1
63002,D,0,1
63003,received,0,1
63004,10,0,1
63005,mg,0,0
63006,dexamethasone,0,0
63007,intravenously,0,1
63008,right,0,1
63009,before,0,0
63010,the,0,0
63011,induction,0,0
63012,of,0,0
63013,anesthesia,0,1
63014,.,0,1
63015,RESULTS,0,0
63016,We,0,0
63017,found,0,0
63018,that,0,0
63019,during,0,0
63020,the,0,0
63021,postoperative,0,0
63022,period,0,0
63023,of,0,0
63024,1-8,0,1
63025,h,0,0
63026,",",0,1
63027,patients,0,1
63028,in,0,1
63029,Group,0,1
63030,D,0,1
63031,reported,0,0
63032,a,0,0
63033,lower,0,0
63034,incidence,0,0
63035,of,0,0
63036,PONV,0,1
63037,(,0,1
63038,24,0,1
63039,%,0,0
63040,),0,1
63041,than,0,0
63042,those,0,1
63043,in,0,0
63044,Group,0,1
63045,P,0,0
63046,(,0,1
63047,39,0,1
63048,%,0,0
63049,",",0,0
63050,p,0,0
63051,<,0,0
63052,0.001,0,0
63053,),0,1
63054,.,0,1
63055,Patients,0,1
63056,in,0,0
63057,Group,0,1
63058,D,0,1
63059,also,0,0
63060,requested,0,1
63061,less,0,0
63062,rescue,0,1
63063,anti-emetic,0,1
63064,(,0,1
63065,17,0,1
63066,%,0,0
63067,),0,1
63068,than,0,0
63069,those,0,1
63070,in,0,0
63071,Group,0,1
63072,P,0,0
63073,(,0,1
63074,30,0,1
63075,%,0,0
63076,",",0,0
63077,p,0,0
63078,<,0,0
63079,0.05,0,0
63080,),0,1
63081,.,0,1
63082,The,0,0
63083,same,0,0
63084,phenomenon,0,0
63085,was,0,0
63086,also,0,0
63087,noted,0,0
63088,in,0,0
63089,the,0,0
63090,8-to-24-hour,0,1
63091,interval,0,0
63092,(,0,1
63093,PONV,0,0
63094,4,0,0
63095,%,0,0
63096,vs.,0,0
63097,12,0,1
63098,%,0,0
63099,",",0,0
63100,p,0,0
63101,<,0,0
63102,0.05,0,0
63103,and,0,0
63104,rescue,0,1
63105,anti-emetic,0,1
63106,3,0,0
63107,%,0,0
63108,vs.,0,0
63109,9,0,0
63110,%,0,0
63111,",",0,0
63112,p,0,0
63113,<,0,0
63114,0.05,0,0
63115,in,0,1
63116,Group,0,1
63117,D,0,1
63118,vs.,0,0
63119,Group,0,1
63120,P,0,0
63121,",",0,0
63122,respectively,0,0
63123,.,0,1
63124,),0,0
63125,CONCLUSIONS,0,0
63126,We,0,0
63127,conclude,0,0
63128,that,0,0
63129,the,0,0
63130,prophylactic,0,1
63131,intravenous,0,1
63132,administration,0,0
63133,of,0,1
63134,10,0,1
63135,mg,0,0
63136,dexamethasone,0,0
63137,immediately,0,0
63138,before,0,0
63139,the,0,0
63140,induction,0,0
63141,of,0,0
63142,anesthesia,0,0
63143,is,0,0
63144,effective,0,0
63145,in,0,0
63146,preventing,0,0
63147,PONV,0,0
63148,in,0,1
63149,the,0,0
63150,general,1,1
63151,surgical,1,1
63152,adult,1,1
63153,patient,1,1
63154,population,1,1
63155,.,1,1
63156,Recovery,0,0
63157,after,0,0
63158,prolonged,1,0
63159,anaesthesia,1,1
63160,for,1,0
63161,acoustic,1,0
63162,neuroma,1,1
63163,surgery,1,1
63164,:,1,1
63165,desflurane,0,0
63166,versus,0,0
63167,isoflurane,0,0
63168,.,0,1
63169,In,0,0
63170,this,0,0
63171,study,0,0
63172,",",0,0
63173,33,1,1
63174,patients,1,1
63175,were,0,1
63176,randomly,0,1
63177,assigned,0,1
63178,to,0,0
63179,receive,0,1
63180,desflurane,0,0
63181,(,0,0
63182,D,0,1
63183,),0,1
63184,or,0,1
63185,isoflurane,0,0
63186,(,0,1
63187,I,0,1
63188,),0,1
63189,for,0,0
63190,acoustic,1,1
63191,neuroma,1,1
63192,surgery,1,1
63193,.,1,1
63194,The,0,0
63195,time,0,0
63196,from,0,0
63197,end,0,0
63198,of,0,0
63199,the,0,0
63200,procedure,0,0
63201,to,0,0
63202,spontaneous,0,1
63203,breathing,0,0
63204,",",0,0
63205,extubation,0,0
63206,",",0,0
63207,eye-opening,0,0
63208,",",0,0
63209,hand-squeezing,0,0
63210,to,0,0
63211,command,0,0
63212,",",0,0
63213,and,0,0
63214,ability,0,0
63215,to,0,0
63216,state,0,1
63217,name,0,0
63218,",",0,0
63219,birthdate,0,0
63220,and,0,0
63221,phone,0,0
63222,number,0,0
63223,were,0,1
63224,recorded,0,0
63225,.,0,1
63226,The,0,0
63227,Steward,0,0
63228,recovery,0,0
63229,score,0,0
63230,was,0,0
63231,also,0,0
63232,recorded,0,0
63233,every,0,0
63234,five,0,1
63235,minutes,0,0
63236,during,0,1
63237,the,0,1
63238,first,0,1
63239,20,0,1
63240,minutes,0,0
63241,postoperatively,0,0
63242,and,0,0
63243,then,0,0
63244,every,0,0
63245,10,0,1
63246,to,0,1
63247,15,0,1
63248,minutes,0,0
63249,.,0,1
63250,Groups,0,0
63251,were,0,1
63252,similar,0,0
63253,regarding,0,0
63254,patient,0,1
63255,characteristics,0,0
63256,",",0,0
63257,depth,0,0
63258,of,0,0
63259,anaesthesia,0,1
63260,",",0,0
63261,sufentanil,0,0
63262,total,0,1
63263,dose,0,0
63264,",",0,0
63265,anaesthesia,0,1
63266,duration,0,0
63267,(,0,1
63268,D,0,1
63269,:,0,1
63270,349.1,0,1
63271,+/-,0,0
63272,19.1,0,0
63273,min,0,0
63274,;,0,1
63275,I,0,1
63276,:,0,1
63277,349.2,0,1
63278,+/-,0,0
63279,22.9,0,1
63280,min,0,0
63281,),0,1
63282,",",0,1
63283,haemodynamic/respiratory,0,1
63284,parameters,0,0
63285,",",0,1
63286,and,0,1
63287,surgical,0,1
63288,conditions,0,1
63289,(,0,1
63290,assessed,0,0
63291,by,0,0
63292,a,0,0
63293,bleeding,0,1
63294,score,0,0
63295,),0,1
63296,.,0,1
63297,The,0,0
63298,emergence,0,0
63299,time,0,0
63300,in,0,0
63301,the,0,0
63302,D,0,0
63303,group,0,0
63304,was,0,0
63305,significantly,0,0
63306,faster,0,0
63307,than,0,0
63308,the,0,0
63309,I,0,1
63310,group,0,0
63311,(,0,1
63312,D,0,1
63313,:,0,1
63314,14.9,0,1
63315,+/-,0,0
63316,2.4,0,0
63317,min,0,0
63318,vs,0,0
63319,I,0,1
63320,:,0,1
63321,29.2,0,1
63322,+/-,0,0
63323,2.4,0,0
63324,min,0,0
63325,for,0,0
63326,eye-opening,0,1
63327,),0,1
63328,.,0,1
63329,Full,0,0
63330,recovery,0,0
63331,also,0,0
63332,occurred,0,0
63333,earlier,0,0
63334,in,0,0
63335,the,0,0
63336,D,0,0
63337,group,0,1
63338,(,0,1
63339,D,0,1
63340,:,0,1
63341,22.1,0,1
63342,+/-,0,0
63343,3.1,0,0
63344,min,0,0
63345,vs,0,0
63346,I,0,1
63347,:,0,1
63348,37.6,0,1
63349,+/-,0,0
63350,4.0,0,0
63351,min,0,0
63352,",",0,0
63353,P,0,0
63354,<,0,0
63355,0.005,0,0
63356,for,0,0
63357,stating,0,0
63358,name,0,0
63359,),0,1
63360,.,0,1
63361,Steward,0,0
63362,recovery,0,0
63363,scores,0,0
63364,were,0,0
63365,also,0,0
63366,better,0,0
63367,during,0,0
63368,the,0,0
63369,first,0,0
63370,postoperative,0,0
63371,hour,0,0
63372,in,0,0
63373,the,0,0
63374,D,0,0
63375,group,0,1
63376,(,0,1
63377,D,0,1
63378,:,0,1
63379,40,0,1
63380,min,0,0
63381,vs,0,0
63382,I,0,1
63383,:,0,1
63384,90,0,1
63385,min,0,0
63386,",",0,0
63387,P,0,0
63388,<,0,0
63389,0.005,0,0
63390,for,0,0
63391,100,0,1
63392,%,0,0
63393,of,0,1
63394,patients,0,1
63395,with,0,1
63396,Steward,0,0
63397,score,0,1
63398,of,0,1
63399,6,0,1
63400,),0,1
63401,.,0,1
63402,The,0,0
63403,results,0,0
63404,indicate,0,0
63405,that,0,0
63406,desflurane,0,0
63407,is,0,0
63408,associated,0,0
63409,with,0,1
63410,similar,0,0
63411,operating,0,1
63412,conditions,0,0
63413,and,0,0
63414,faster,0,0
63415,postoperative,0,0
63416,recovery,0,0
63417,following,0,0
63418,acoustic,1,0
63419,neuroma,1,1
63420,surgery,1,1
63421,.,1,1
63422,The,0,0
63423,faster,0,0
63424,recovery,0,0
63425,following,0,0
63426,desflurane,0,0
63427,may,0,0
63428,be,0,0
63429,desirable,0,0
63430,after,0,0
63431,long,0,1
63432,surgical,0,1
63433,procedures,0,1
63434,",",0,1
63435,enabling,0,0
63436,the,0,0
63437,patient,0,1
63438,'s,0,1
63439,full,0,1
63440,cooperation,0,1
63441,and,0,1
63442,facilitating,0,0
63443,early,0,1
63444,diagnosis,0,1
63445,of,0,0
63446,any,0,0
63447,potential,0,0
63448,neurological,0,1
63449,deficit,0,1
63450,.,0,1
63451,Psychological,0,1
63452,well-being,0,0
63453,correlates,0,0
63454,with,0,1
63455,free,0,1
63456,thyroxine,0,1
63457,but,0,0
63458,not,0,0
63459,free,0,1
63460,"3,5,3'-triiodothyronine",0,1
63461,levels,0,1
63462,in,0,1
63463,patients,1,1
63464,on,1,1
63465,thyroid,1,1
63466,hormone,1,1
63467,replacement,1,1
63468,.,1,1
63469,CONTEXT,0,0
63470,AND,0,0
63471,OBJECTIVE,0,0
63472,An,0,0
63473,association,0,0
63474,between,0,0
63475,mood,0,1
63476,disorders,0,1
63477,and,0,1
63478,overt,0,1
63479,thyroid,0,1
63480,dysfunction,0,1
63481,is,0,0
63482,well,0,0
63483,established,0,0
63484,",",0,0
63485,but,0,0
63486,there,0,0
63487,are,0,0
63488,few,0,0
63489,data,0,0
63490,on,0,0
63491,the,0,0
63492,potential,0,0
63493,for,0,0
63494,thyroid,0,1
63495,hormone,0,0
63496,levels,0,0
63497,closer,0,0
63498,to,0,0
63499,the,0,0
63500,reference,0,0
63501,range,0,1
63502,to,0,0
63503,correlate,0,0
63504,with,0,1
63505,psychological,0,0
63506,well-being,0,0
63507,.,0,1
63508,DESIGN,0,0
63509,",",0,0
63510,SETTING,0,1
63511,",",0,0
63512,AND,0,0
63513,PATIENTS,0,1
63514,We,0,0
63515,analyzed,0,0
63516,the,0,0
63517,relationship,0,0
63518,between,0,0
63519,psychological,0,1
63520,well-being,0,0
63521,and,0,1
63522,free,0,1
63523,T,0,1
63524,(,0,1
63525,4,0,1
63526,),0,1
63527,(,0,1
63528,fT4,0,1
63529,),0,1
63530,",",0,0
63531,free,0,1
63532,T,0,1
63533,(,0,1
63534,3,0,1
63535,),0,1
63536,(,0,1
63537,fT3,0,1
63538,),0,1
63539,",",0,0
63540,TSH,0,1
63541,",",0,0
63542,and,0,0
63543,total,0,1
63544,rT,0,1
63545,(,0,1
63546,3,0,1
63547,),0,1
63548,in,0,1
63549,697,1,1
63550,patients,1,1
63551,on,1,1
63552,thyroid,1,1
63553,hormone,1,1
63554,replacement,1,1
63555,therapy,1,0
63556,at,1,0
63557,entry,1,1
63558,to,1,1
63559,a,1,0
63560,randomized,1,0
63561,",",1,0
63562,controlled,1,0
63563,trial,1,0
63564,of,1,0
63565,combined,1,0
63566,T,1,1
63567,(,1,1
63568,4,1,1
63569,),1,1
63570,and,1,1
63571,T,1,1
63572,(,1,1
63573,3,1,1
63574,),1,1
63575,replacement,1,1
63576,therapy,1,0
63577,.,1,1
63578,All,1,1
63579,patients,1,1
63580,were,1,1
63581,on,1,0
63582,100,1,1
63583,mug,1,0
63584,or,1,1
63585,more,1,0
63586,T,1,1
63587,(,1,1
63588,4,1,1
63589,),1,1
63590,.,1,1
63591,INTERVENTIONS,0,0
63592,AND,0,0
63593,MAIN,0,0
63594,OUTCOME,0,1
63595,MEASURES,0,0
63596,Psychological,0,1
63597,well-being,0,0
63598,was,0,0
63599,assessed,0,0
63600,with,0,1
63601,General,0,1
63602,Health,0,1
63603,Questionnaire-12,0,0
63604,(,0,1
63605,GHQ-12,0,1
63606,),0,1
63607,",",0,0
63608,Thyroid,0,1
63609,Symptom,0,1
63610,Questionnaire,0,0
63611,",",0,0
63612,and,0,0
63613,Hospital,0,1
63614,Anxiety,0,1
63615,and,0,1
63616,Depression,0,0
63617,Scale,0,1
63618,.,0,1
63619,RESULTS,0,0
63620,fT,0,1
63621,(,0,1
63622,4,0,0
63623,),0,1
63624,and,0,1
63625,TSH,0,1
63626,showed,0,0
63627,a,0,0
63628,strong,0,0
63629,correlation,0,0
63630,with,0,1
63631,GHQ-12,0,1
63632,scores,0,0
63633,(,0,1
63634,fT4,0,1
63635,-,0,1
63636,b,0,1
63637,:,0,1
63638,-0.16,0,0
63639,",",0,0
63640,P,0,0
63641,=,0,1
63642,0.005,0,0
63643,;,0,1
63644,TSH,0,1
63645,-,0,1
63646,b,0,1
63647,:,0,1
63648,0.663,0,0
63649,",",0,1
63650,P,0,0
63651,=,0,1
63652,0.04,0,0
63653,),0,1
63654,.,0,1
63655,No,0,0
63656,correlations,0,0
63657,were,0,1
63658,seen,0,0
63659,between,0,0
63660,the,0,0
63661,GHQ,0,1
63662,scores,0,0
63663,and,0,1
63664,fT3,0,1
63665,(,0,1
63666,b,0,1
63667,:,0,1
63668,0.318,0,0
63669,",",0,1
63670,P,0,0
63671,=,0,1
63672,0.275,0,0
63673,),0,1
63674,",",0,0
63675,rT,0,0
63676,(,0,1
63677,3,0,1
63678,),0,1
63679,(,0,1
63680,b,0,1
63681,:,0,1
63682,0.095,0,0
63683,",",0,1
63684,P,0,0
63685,=,0,1
63686,0.95,0,0
63687,),0,1
63688,",",0,0
63689,rT,0,0
63690,(,0,1
63691,3,0,1
63692,),0,1
63693,to,0,0
63694,fT4,0,1
63695,ratio,0,0
63696,(,0,1
63697,b,0,1
63698,:,0,1
63699,71.83,0,0
63700,",",0,1
63701,P,0,0
63702,=,0,1
63703,0.09,0,0
63704,),0,1
63705,or,0,1
63706,fT3,0,1
63707,to,0,0
63708,rT,0,1
63709,(,0,1
63710,3,0,1
63711,),0,1
63712,ratio,0,0
63713,(,0,1
63714,b,0,1
63715,:,0,1
63716,0.05,0,0
63717,",",0,1
63718,P,0,0
63719,=,0,1
63720,0.32,0,0
63721,),0,1
63722,.,0,1
63723,The,0,0
63724,correlations,0,0
63725,remained,0,0
63726,when,0,0
63727,the,0,0
63728,data,0,0
63729,set,0,0
63730,was,0,0
63731,limited,0,0
63732,to,0,1
63733,patients,0,1
63734,with,0,1
63735,TSH,0,1
63736,in,0,0
63737,the,0,0
63738,range,0,1
63739,0.3-4.0,0,0
63740,mIU/liter,0,1
63741,.,0,1
63742,Similar,0,0
63743,correlations,0,0
63744,were,0,1
63745,seen,0,0
63746,with,0,1
63747,the,0,0
63748,Thyroid,0,1
63749,Symptom,0,1
63750,Questionnaire,0,0
63751,",",0,0
63752,although,0,0
63753,not,0,0
63754,with,0,1
63755,the,0,0
63756,Hospital,0,1
63757,Anxiety,0,0
63758,and,0,1
63759,Depression,0,1
63760,Scale,0,1
63761,scores,0,0
63762,.,0,1
63763,CONCLUSIONS,0,0
63764,Differences,0,0
63765,in,0,1
63766,fT4,0,1
63767,and,0,1
63768,TSH,0,1
63769,concentration,0,0
63770,",",0,0
63771,even,0,0
63772,within,0,0
63773,the,0,0
63774,reference,0,0
63775,range,0,0
63776,",",0,0
63777,may,0,0
63778,be,0,0
63779,a,0,0
63780,determinant,0,0
63781,of,0,0
63782,psychological,0,0
63783,well-being,0,0
63784,in,0,1
63785,treated,1,1
63786,hypothyroid,1,1
63787,patients,1,1
63788,although,0,0
63789,not,0,0
63790,necessarily,0,0
63791,with,0,1
63792,symptoms,0,0
63793,typical,0,1
63794,of,0,1
63795,anxiety,0,1
63796,or,0,1
63797,depression,0,1
63798,.,0,1
63799,Analysis,0,1
63800,of,0,0
63801,face,0,0
63802,gaze,0,1
63803,in,0,0
63804,autism,1,1
63805,using,0,1
63806,Bubbles,0,1
63807,.,0,1
63808,One,0,1
63809,of,0,0
63810,the,0,0
63811,components,0,0
63812,of,0,0
63813,abnormal,0,1
63814,social,0,1
63815,functioning,0,1
63816,in,0,0
63817,autism,1,1
63818,is,0,0
63819,an,0,0
63820,impaired,0,0
63821,ability,0,0
63822,to,0,0
63823,direct,0,0
63824,eye,0,1
63825,gaze,0,0
63826,onto,0,0
63827,other,0,1
63828,people,0,1
63829,'s,0,1
63830,faces,0,1
63831,in,0,0
63832,social,0,0
63833,situations,0,0
63834,.,0,1
63835,Here,0,0
63836,",",0,0
63837,we,0,0
63838,investigated,0,0
63839,the,0,0
63840,relationship,0,0
63841,between,0,0
63842,gaze,0,0
63843,onto,0,0
63844,the,0,0
63845,eye,0,1
63846,and,0,0
63847,mouth,0,1
63848,regions,0,0
63849,of,0,0
63850,faces,0,0
63851,",",0,0
63852,and,0,0
63853,the,0,0
63854,visual,0,0
63855,information,0,0
63856,that,0,0
63857,was,0,0
63858,present,0,0
63859,within,0,1
63860,those,0,1
63861,regions,0,1
63862,.,0,1
63863,We,0,0
63864,used,0,0
63865,the,0,0
63866,Bubbles,0,0
63867,method,0,0
63868,to,0,0
63869,vary,0,0
63870,the,0,0
63871,facial,0,1
63872,information,0,0
63873,available,0,0
63874,on,0,0
63875,any,0,0
63876,given,0,0
63877,trial,0,0
63878,by,0,0
63879,revealing,0,0
63880,only,0,0
63881,small,0,1
63882,parts,0,0
63883,of,0,1
63884,the,0,0
63885,face,0,0
63886,",",0,0
63887,and,0,0
63888,measured,0,0
63889,the,0,0
63890,eye,0,1
63891,movements,0,0
63892,made,0,1
63893,as,0,0
63894,participants,0,1
63895,viewed,0,1
63896,these,0,1
63897,stimuli,0,0
63898,.,0,1
63899,Compared,1,0
63900,to,1,0
63901,ten,1,1
63902,IQ-,1,0
63903,and,1,0
63904,age-matched,1,1
63905,healthy,1,1
63906,controls,1,1
63907,",",1,1
63908,eight,1,1
63909,participants,1,1
63910,with,1,1
63911,autism,1,1
63912,showed,0,0
63913,less,0,0
63914,fixation,0,1
63915,specificity,0,0
63916,to,0,1
63917,the,0,0
63918,eyes,0,1
63919,and,0,0
63920,mouth,0,1
63921,",",0,0
63922,a,0,0
63923,greater,0,0
63924,tendency,0,0
63925,to,0,0
63926,saccade,0,0
63927,away,0,0
63928,from,0,0
63929,the,0,0
63930,eyes,0,0
63931,when,0,0
63932,information,0,0
63933,was,0,0
63934,present,0,0
63935,in,0,1
63936,those,0,1
63937,regions,0,0
63938,",",0,0
63939,and,0,1
63940,abnormal,0,1
63941,directionality,0,0
63942,of,0,1
63943,saccades,0,1
63944,.,0,1
63945,The,0,0
63946,findings,0,0
63947,provide,0,0
63948,novel,0,0
63949,detail,0,0
63950,to,0,1
63951,the,0,0
63952,abnormal,0,0
63953,way,0,0
63954,in,0,1
63955,which,0,0
63956,people,0,1
63957,with,0,1
63958,autism,0,1
63959,look,0,0
63960,at,0,0
63961,faces,0,0
63962,",",0,0
63963,an,0,0
63964,impairment,0,1
63965,that,0,0
63966,likely,0,0
63967,influences,0,0
63968,all,0,0
63969,subsequent,0,0
63970,face,0,0
63971,processing,0,0
63972,.,0,1
63973,Specific,0,1
63974,immunoglobulin,0,1
63975,for,0,0
63976,treatment,0,0
63977,of,0,0
63978,whooping,1,1
63979,cough,1,1
63980,.,1,1
63981,Immunoglobulin,0,0
63982,treatment,0,0
63983,for,0,0
63984,whooping,0,1
63985,cough,0,1
63986,(,0,1
63987,pertussis,0,0
63988,),0,0
63989,is,0,0
63990,widely,0,0
63991,believed,0,0
63992,to,0,0
63993,be,0,0
63994,ineffective,0,0
63995,although,0,0
63996,there,0,0
63997,are,0,0
63998,sound,0,0
63999,reasons,0,0
64000,for,0,1
64001,regarding,0,0
64002,the,0,0
64003,condition,0,0
64004,as,0,0
64005,a,0,1
64006,toxin-induced,0,0
64007,disease,0,1
64008,.,0,1
64009,We,0,0
64010,wondered,0,0
64011,whether,0,0
64012,the,0,0
64013,lack,0,0
64014,of,0,0
64015,success,0,0
64016,with,0,1
64017,pertussis,0,1
64018,immunoglobulins,0,0
64019,might,0,0
64020,be,0,0
64021,attributable,0,0
64022,to,0,0
64023,inadequate,0,1
64024,dose,0,0
64025,",",0,0
64026,so,0,0
64027,we,0,0
64028,designed,0,0
64029,a,0,0
64030,randomised,0,0
64031,",",0,0
64032,double-blind,0,0
64033,",",0,0
64034,placebo-controlled,0,0
64035,trial,0,1
64036,of,0,1
64037,two,0,1
64038,immunoglobulin,0,1
64039,preparations,0,0
64040,.,0,1
64041,The,0,0
64042,study,0,0
64043,was,0,0
64044,conducted,0,1
64045,at,0,1
64046,three,1,1
64047,Swedish,1,1
64048,hospitals,1,1
64049,.,1,1
64050,We,0,0
64051,enrolled,0,1
64052,73,1,1
64053,children,1,1
64054,aged,1,1
64055,less,1,0
64056,than,1,1
64057,36,1,1
64058,months,1,1
64059,who,1,1
64060,were,1,1
64061,admitted,1,1
64062,with,1,1
64063,a,1,1
64064,clinical,1,0
64065,diagnosis,1,1
64066,of,1,0
64067,whooping,1,1
64068,cough,1,1
64069,.,1,1
64070,On,0,0
64071,admission,0,0
64072,they,0,1
64073,were,0,1
64074,assigned,0,1
64075,to,0,1
64076,one,0,1
64077,of,0,1
64078,three,0,1
64079,groups,0,1
64080,:,0,1
64081,(,0,1
64082,a,0,1
64083,),0,0
64084,monocomponent,0,0
64085,pertussis,0,1
64086,toxoid,0,1
64087,vaccine,0,1
64088,;,0,1
64089,(,0,1
64090,b,0,1
64091,),0,1
64092,two-component,0,0
64093,acellular,0,0
64094,vaccine,0,1
64095,also,0,0
64096,containing,0,0
64097,filamentous,0,0
64098,haemagglutinin,0,1
64099,;,0,1
64100,or,0,1
64101,(,0,1
64102,c,0,1
64103,),0,1
64104,20,0,1
64105,%,0,0
64106,albumin,0,0
64107,solution,0,0
64108,(,0,1
64109,placebo,0,1
64110,),0,1
64111,.,0,1
64112,The,0,0
64113,immunoglobulins,0,0
64114,had,0,1
64115,a,0,1
64116,high,0,0
64117,antitoxin,0,0
64118,content,0,0
64119,and,0,0
64120,had,0,1
64121,been,0,0
64122,raised,0,0
64123,with,0,1
64124,acellular,0,0
64125,pertussis,0,1
64126,vaccines,0,0
64127,.,0,1
64128,Diagnosis,0,1
64129,of,0,0
64130,pertussis,0,1
64131,was,0,0
64132,confirmed,0,0
64133,by,0,0
64134,laboratory,0,1
64135,tests,0,0
64136,and,0,1
64137,the,0,0
64138,follow-up,0,0
64139,was,0,0
64140,completed,0,1
64141,in,0,1
64142,67,0,1
64143,children,0,1
64144,.,0,1
64145,The,0,0
64146,main,0,0
64147,study,0,1
64148,group,0,1
64149,consisted,0,1
64150,of,0,1
64151,47,1,1
64152,children,1,1
64153,with,1,1
64154,less,1,1
64155,than,1,0
64156,or,1,1
64157,equal,1,1
64158,to,1,1
64159,14,1,1
64160,days,1,0
64161,of,1,1
64162,disease,1,1
64163,before,1,1
64164,therapy,1,0
64165,.,1,1
64166,Duration,0,0
64167,of,0,0
64168,whoops,0,1
64169,post-treatment,0,0
64170,was,0,0
64171,8.7,0,0
64172,days,0,0
64173,(,0,1
64174,95,0,0
64175,%,0,0
64176,Cl,0,0
64177,4.8,0,0
64178,",",0,1
64179,12.6,0,0
64180,),0,1
64181,in,0,0
64182,the,0,1
64183,33,0,1
64184,children,0,1
64185,receiving,0,1
64186,immunoglobulin,0,1
64187,vs,0,0
64188,20.6,0,1
64189,(,0,1
64190,95,0,0
64191,%,0,0
64192,Cl,0,0
64193,11.9,0,0
64194,",",0,1
64195,29.3,0,1
64196,),0,1
64197,in,0,0
64198,the,0,0
64199,14,0,1
64200,receiving,0,1
64201,placebo,0,0
64202,(,0,1
64203,p,0,0
64204,=,0,1
64205,0.0041,0,0
64206,),0,1
64207,.,0,1
64208,Mean,0,1
64209,number,0,0
64210,of,0,1
64211,whoops,0,1
64212,during,0,1
64213,the,0,1
64214,first,0,0
64215,week,0,0
64216,of,0,0
64217,follow-up,0,0
64218,was,0,0
64219,also,0,0
64220,significantly,0,0
64221,reduced,0,0
64222,(,0,0
64223,p,0,0
64224,=,0,1
64225,0.0196,0,0
64226,),0,1
64227,.,0,1
64228,We,0,0
64229,found,0,0
64230,that,0,0
64231,early,0,1
64232,treatment,0,1
64233,was,0,0
64234,important,0,0
64235,",",0,0
64236,since,0,0
64237,the,0,0
64238,effect,0,0
64239,on,0,0
64240,duration,0,0
64241,of,0,1
64242,whoops,0,1
64243,was,0,0
64244,most,0,0
64245,pronounced,0,0
64246,when,0,0
64247,disease,0,1
64248,duration,0,0
64249,before,0,0
64250,treatment,0,0
64251,was,0,0
64252,less,0,0
64253,than,0,0
64254,or,0,1
64255,equal,0,1
64256,to,0,1
64257,7,0,1
64258,days,0,0
64259,.,0,1
64260,There,0,0
64261,were,0,0
64262,no,0,0
64263,significant,0,0
64264,differences,0,0
64265,between,0,0
64266,the,0,1
64267,two,0,0
64268,immunoglobulin,0,1
64269,preparations,0,0
64270,.,0,1
64271,High-dose,0,0
64272,specific,0,0
64273,pertussis,0,1
64274,immunoglobulin,0,0
64275,with,0,1
64276,a,0,1
64277,high,0,1
64278,antitoxin,0,0
64279,concentration,0,0
64280,has,0,0
64281,a,0,0
64282,beneficial,0,0
64283,effect,0,0
64284,in,0,0
64285,the,0,0
64286,treatment,0,0
64287,of,0,0
64288,whooping,0,1
64289,cough,0,1
64290,.,0,1
64291,Long-term,0,1
64292,follow-up,0,0
64293,of,0,0
64294,the,0,0
64295,Stockholm,0,1
64296,randomized,0,1
64297,trials,0,0
64298,of,0,1
64299,postoperative,0,1
64300,radiation,0,1
64301,therapy,0,0
64302,versus,0,0
64303,adjuvant,0,1
64304,chemotherapy,0,1
64305,among,0,1
64306,'high,1,1
64307,risk,1,1
64308,',1,1
64309,pre-,1,0
64310,and,1,1
64311,postmenopausal,1,1
64312,breast,1,1
64313,cancer,1,1
64314,patients,1,1
64315,.,1,1
64316,For,0,1
64317,many,0,1
64318,years,0,1
64319,",",0,1
64320,loco-regional,0,1
64321,radiotherapy,0,1
64322,was,0,0
64323,the,0,0
64324,standard,0,1
64325,postoperative,0,0
64326,treatment,0,1
64327,for,0,1
64328,node,1,1
64329,positive,1,1
64330,breast,1,1
64331,cancer,1,1
64332,patients,1,1
64333,in,1,1
64334,Sweden,1,1
64335,.,1,1
64336,Because,0,0
64337,of,0,0
64338,encouraging,0,0
64339,results,0,0
64340,from,0,1
64341,trials,0,1
64342,of,0,1
64343,adjuvant,0,1
64344,chemotherapy,0,1
64345,in,0,0
64346,the,0,0
64347,mid,0,0
64348,1970s,0,1
64349,",",0,0
64350,the,1,0
64351,Stockholm,1,1
64352,Breast,1,1
64353,Cancer,1,1
64354,Study,1,1
64355,Group,1,1
64356,decided,0,0
64357,to,0,0
64358,directly,0,0
64359,compare,0,0
64360,postoperative,0,0
64361,radiation,0,1
64362,(,0,1
64363,RT,0,1
64364,),0,1
64365,with,0,1
64366,adjuvant,0,1
64367,CMF-type,0,1
64368,chemotherapy,0,1
64369,(,0,1
64370,CT,0,1
64371,),0,1
64372,.,0,1
64373,Long-term,0,0
64374,results,0,0
64375,are,0,0
64376,presented,0,1
64377,from,0,1
64378,two,0,1
64379,randomized,0,1
64380,trials,0,1
64381,of,0,1
64382,RT,0,1
64383,versus,0,0
64384,CT,0,1
64385,in,0,0
64386,pre-,1,0
64387,(,1,1
64388,n,1,1
64389,=,1,1
64390,547,1,1
64391,),1,1
64392,and,1,1
64393,postmenopausal,1,1
64394,(,1,1
64395,n,1,1
64396,=,1,1
64397,679,1,1
64398,),1,1
64399,patients,1,1
64400,",",1,0
64401,respectively,1,0
64402,",",1,0
64403,with,1,1
64404,node,1,1
64405,positive,1,1
64406,disease,1,1
64407,or,1,1
64408,a,1,0
64409,tumour,1,1
64410,diameter,1,1
64411,>,1,1
64412,30,1,1
64413,mm,1,1
64414,.,1,1
64415,RT,0,0
64416,substantially,0,0
64417,reduced,0,0
64418,loco-regional,0,1
64419,recurrences,0,0
64420,among,0,1
64421,both,0,0
64422,pre-,0,0
64423,and,0,1
64424,postmenopausal,0,1
64425,patients,0,1
64426,(,0,1
64427,relative,0,0
64428,hazard,0,0
64429,RT,0,1
64430,versus,0,0
64431,CT,0,1
64432,:,0,1
64433,0.67,0,0
64434,and,0,1
64435,0.43,0,0
64436,",",0,0
64437,respectively,0,0
64438,),0,0
64439,.,0,1
64440,Among,0,1
64441,premenopausal,0,1
64442,patients,0,1
64443,distant,0,1
64444,metastases,0,1
64445,occurred,0,0
64446,less,0,0
64447,frequently,0,0
64448,in,0,0
64449,the,0,0
64450,CT,0,0
64451,group,0,1
64452,(,0,1
64453,relative,0,0
64454,hazard,0,0
64455,:,0,1
64456,1.68,0,0
64457,",",0,0
64458,p,0,0
64459,>,0,1
64460,0.001,0,0
64461,),0,1
64462,resulting,0,0
64463,in,0,0
64464,an,0,1
64465,improved,0,0
64466,recurrence-free,0,0
64467,survival,0,0
64468,(,0,1
64469,p,0,0
64470,=,0,1
64471,0.04,0,0
64472,),0,1
64473,.,0,1
64474,Overall,0,0
64475,survival,0,0
64476,was,0,0
64477,also,0,0
64478,better,0,0
64479,with,0,1
64480,CT,0,0
64481,(,0,1
64482,cumulative,0,0
64483,survival,0,0
64484,at,0,1
64485,15,0,1
64486,years,0,1
64487,:,0,1
64488,50,0,1
64489,%,0,0
64490,and,0,1
64491,44,0,1
64492,%,0,0
64493,in,0,0
64494,the,0,0
64495,CT,0,0
64496,and,0,1
64497,RT,0,1
64498,groups,0,0
64499,",",0,1
64500,respectively,0,0
64501,),0,0
64502,but,0,0
64503,the,0,0
64504,difference,0,0
64505,was,0,0
64506,not,0,0
64507,statistically,0,0
64508,significant,0,0
64509,.,0,1
64510,Among,0,1
64511,the,0,0
64512,postmenopausal,0,1
64513,patients,0,1
64514,there,0,0
64515,were,0,0
64516,no,0,0
64517,substantial,0,0
64518,differences,0,0
64519,in,0,1
64520,terms,0,0
64521,of,0,1
64522,recurrence-free,0,0
64523,or,0,1
64524,overall,0,0
64525,survival,0,0
64526,between,0,0
64527,the,0,0
64528,treatment,0,1
64529,groups,0,0
64530,.,0,1
64531,The,0,0
64532,risk,0,0
64533,of,0,0
64534,a,0,1
64535,second,0,1
64536,primary,0,1
64537,malignancy,0,1
64538,",",0,0
64539,however,0,0
64540,",",0,0
64541,was,0,0
64542,doubled,0,0
64543,in,0,0
64544,the,0,0
64545,RT,0,1
64546,group,0,1
64547,(,0,1
64548,p,0,0
64549,>,0,1
64550,0.01,0,0
64551,),0,1
64552,.,0,1
64553,The,0,0
64554,most,0,0
64555,pronounced,0,0
64556,excess,0,1
64557,concerned,0,1
64558,second,0,1
64559,lung,0,1
64560,cancers,0,1
64561,occurring,0,1
64562,after,0,1
64563,10,0,1
64564,years,0,1
64565,.,0,1
64566,The,0,0
64567,cumulative,0,0
64568,incidence,0,0
64569,at,0,1
64570,20,0,1
64571,years,0,1
64572,was,0,0
64573,estimated,0,0
64574,at,0,1
64575,0.3,0,0
64576,%,0,0
64577,and,0,1
64578,3.7,0,0
64579,%,0,0
64580,in,0,0
64581,the,0,0
64582,CT,0,0
64583,and,0,1
64584,RT,0,1
64585,groups,0,0
64586,",",0,1
64587,respectively,0,0
64588,.,0,1
64589,The,0,0
64590,trials,0,0
64591,illustrate,0,0
64592,the,0,0
64593,role,0,0
64594,of,0,0
64595,radiotherapy,0,1
64596,in,0,0
64597,preventing,0,0
64598,loco-regional,0,1
64599,recurrences,0,0
64600,among,0,1
64601,high-risk,0,1
64602,patients,0,1
64603,",",0,0
64604,as,0,0
64605,well,0,0
64606,as,0,0
64607,the,0,0
64608,need,0,0
64609,for,0,0
64610,systemic,0,0
64611,treatment,0,0
64612,to,0,0
64613,control,0,1
64614,the,0,0
64615,disease,0,1
64616,systemically,0,0
64617,.,0,1
64618,Effects,0,1
64619,of,0,1
64620,sensory-level,0,1
64621,high-volt,0,1
64622,pulsed,0,1
64623,electrical,0,0
64624,current,0,1
64625,ondelayed-onset,1,1
64626,muscle,1,0
64627,soreness,1,0
64628,.,1,1
64629,Ten,1,1
64630,healthy,1,1
64631,males,1,1
64632,and,1,1
64633,ten,1,1
64634,healthy,1,1
64635,females,1,1
64636,aged,1,1
64637,21.5,1,1
64638,+/-,1,1
64639,3.2,1,1
64640,years,1,1
64641,(,1,1
64642,mean,1,1
64643,+/-,1,0
64644,s,1,1
64645,),1,1
64646,participated,1,1
64647,in,1,0
64648,the,1,0
64649,study,1,0
64650,",",0,0
64651,which,0,0
64652,was,0,0
64653,designed,0,0
64654,to,0,0
64655,evaluate,0,0
64656,the,0,0
64657,effectiveness,0,0
64658,of,0,0
64659,sensory,0,1
64660,level-high,0,1
64661,volt,0,0
64662,pulsed,0,1
64663,electrical,0,0
64664,current,0,1
64665,(,0,1
64666,HVPC,0,0
64667,),0,1
64668,on,0,0
64669,delayed-onset,1,1
64670,muscle,1,0
64671,soreness,1,0
64672,(,1,1
64673,DOMS,1,1
64674,),1,1
64675,.,1,1
64676,Arm,0,1
64677,discomfort,0,0
64678,",",0,0
64679,elbow,0,1
64680,extension,0,0
64681,range,0,1
64682,of,0,0
64683,motion,0,1
64684,and,0,1
64685,isometric,0,0
64686,elbow,0,1
64687,flexion,0,1
64688,strength,0,0
64689,were,0,0
64690,obtained,0,0
64691,as,0,0
64692,baseline,0,1
64693,measurements,0,0
64694,.,0,1
64695,Delayed-onset,0,0
64696,muscle,0,0
64697,soreness,0,0
64698,was,0,0
64699,induced,0,0
64700,in,0,0
64701,the,0,0
64702,participants,0,1
64703,',0,1
64704,dominant,0,1
64705,or,0,1
64706,non-dominant,0,1
64707,arm,0,1
64708,using,0,1
64709,two,0,0
64710,sets,0,1
64711,of,0,1
64712,20,0,1
64713,maximal,0,0
64714,eccentric,0,1
64715,elbow,0,1
64716,flexion,0,1
64717,contractions,0,1
64718,.,0,1
64719,After,0,0
64720,the,0,0
64721,induction,0,0
64722,of,0,0
64723,DOMS,0,0
64724,",",0,1
64725,the,0,0
64726,participants,0,1
64727,were,0,1
64728,randomly,0,1
64729,divided,0,0
64730,into,0,0
64731,an,0,0
64732,experimental,0,0
64733,condition,0,0
64734,(,0,1
64735,HVPC,0,0
64736,),0,1
64737,or,0,1
64738,a,0,1
64739,placebo,0,0
64740,condition,0,0
64741,.,0,1
64742,The,0,0
64743,experimental,0,0
64744,condition,0,0
64745,consisted,0,1
64746,of,0,0
64747,20,0,1
64748,min,0,0
64749,of,0,0
64750,HVPC,0,0
64751,immediately,0,0
64752,after,0,0
64753,the,0,0
64754,induction,0,0
64755,of,0,0
64756,DOMS,0,1
64757,",",0,1
64758,and,0,0
64759,20,0,1
64760,min,0,0
64761,every,0,0
64762,24,0,0
64763,h,0,0
64764,for,0,1
64765,three,0,1
64766,consecutive,0,1
64767,days,0,0
64768,thereafter,0,0
64769,.,0,1
64770,The,0,0
64771,participants,0,1
64772,in,0,0
64773,the,0,0
64774,placebo,0,0
64775,condition,0,0
64776,received,0,0
64777,an,0,0
64778,intervention,0,0
64779,similar,0,0
64780,in,0,1
64781,design,0,1
64782,;,0,0
64783,however,0,0
64784,",",0,0
64785,no,0,0
64786,electrical,0,0
64787,current,0,0
64788,was,0,0
64789,administered,0,0
64790,.,0,1
64791,Baseline,0,0
64792,measurements,0,0
64793,were,0,1
64794,reevaluated,0,1
64795,at,0,0
64796,24,0,1
64797,",",0,1
64798,48,0,1
64799,",",0,1
64800,72,0,1
64801,and,0,1
64802,96,0,1
64803,h,0,0
64804,after,0,0
64805,the,0,0
64806,induction,0,0
64807,of,0,0
64808,DOMS,0,1
64809,.,0,1
64810,Three,0,1
64811,weeks,0,0
64812,later,0,1
64813,",",0,0
64814,the,0,0
64815,participants,0,1
64816,returned,0,1
64817,and,0,0
64818,the,0,0
64819,protocol,0,0
64820,was,0,0
64821,repeated,0,0
64822,on,0,0
64823,the,0,0
64824,contralateral,0,1
64825,limb,0,0
64826,",",0,0
64827,using,0,0
64828,the,0,0
64829,opposite,0,0
64830,intervention,0,0
64831,(,0,1
64832,HVPC,0,0
64833,or,0,1
64834,placebo,0,1
64835,),0,1
64836,.,0,1
64837,Repeated-measures,0,0
64838,analysis,0,0
64839,of,0,0
64840,variance,0,0
64841,revealed,0,0
64842,a,0,0
64843,significant,0,0
64844,increase,0,0
64845,in,0,1
64846,overall,0,0
64847,arm,0,1
64848,discomfort,0,0
64849,",",0,0
64850,decrease,0,0
64851,in,0,0
64852,elbow,0,1
64853,extension,0,1
64854,and,0,0
64855,decrease,0,0
64856,in,0,0
64857,isometric,0,0
64858,strength,0,0
64859,for,0,0
64860,both,0,0
64861,conditions,0,1
64862,over,0,0
64863,time,0,0
64864,.,0,1
64865,No,0,0
64866,significant,0,0
64867,main,0,0
64868,effect,0,0
64869,of,0,0
64870,treatment,0,0
64871,",",0,0
64872,or,0,1
64873,time-by-treatment,0,0
64874,interaction,0,0
64875,",",0,0
64876,was,0,0
64877,found,0,0
64878,for,0,0
64879,the,0,0
64880,HVPC,0,0
64881,condition,0,0
64882,when,0,0
64883,compared,0,0
64884,with,0,0
64885,the,0,0
64886,placebo,0,0
64887,condition,0,0
64888,for,0,0
64889,any,0,1
64890,variable,0,1
64891,.,0,1
64892,Sensory-level,0,0
64893,HVPC,0,0
64894,",",0,1
64895,as,0,0
64896,utilized,0,0
64897,in,0,0
64898,our,0,0
64899,application,0,0
64900,",",0,0
64901,was,0,0
64902,ineffective,0,0
64903,in,0,0
64904,reducing,0,0
64905,the,0,0
64906,measured,0,0
64907,variables,0,0
64908,associated,0,0
64909,with,0,1
64910,DOMS,0,1
64911,.,0,1
64912,Left,0,0
64913,thoracoabdominal,0,1
64914,approach,0,1
64915,versus,0,0
64916,abdominal-transhiatal,0,1
64917,approach,0,1
64918,for,0,0
64919,gastric,1,1
64920,cancer,1,1
64921,of,1,0
64922,the,1,0
64923,cardia,1,1
64924,or,1,1
64925,subcardia,1,1
64926,:,1,1
64927,a,0,1
64928,randomised,0,0
64929,controlled,0,0
64930,trial,0,1
64931,.,0,1
64932,BACKGROUND,0,0
64933,Because,0,1
64934,of,0,0
64935,the,0,0
64936,inaccessibility,0,0
64937,of,0,0
64938,mediastinal,0,1
64939,nodal,0,1
64940,metastases,0,1
64941,",",0,1
64942,the,0,0
64943,left,0,1
64944,thoracoabdominal,0,1
64945,approach,0,1
64946,(,0,1
64947,LTA,0,0
64948,),0,0
64949,has,0,0
64950,often,0,0
64951,been,0,0
64952,used,0,0
64953,to,0,0
64954,treat,0,1
64955,gastric,1,1
64956,cancer,1,1
64957,of,1,0
64958,the,1,0
64959,cardia,1,1
64960,or,1,1
64961,subcardia,1,1
64962,.,1,1
64963,In,0,0
64964,a,0,0
64965,randomised,0,1
64966,phase,0,1
64967,III,0,1
64968,study,0,1
64969,",",0,0
64970,we,0,0
64971,aimed,0,0
64972,to,0,0
64973,compare,0,0
64974,LTA,0,0
64975,with,0,1
64976,the,0,0
64977,abdominal-transhiatal,0,1
64978,approach,0,0
64979,(,0,1
64980,TH,0,1
64981,),0,1
64982,in,0,0
64983,the,0,0
64984,treatment,0,0
64985,of,0,0
64986,these,0,0
64987,tumours,0,1
64988,.,0,1
64989,METHODS,0,0
64990,Between,1,1
64991,July,1,1
64992,",",1,1
64993,1995,1,1
64994,",",1,0
64995,and,1,0
64996,December,1,1
64997,",",1,0
64998,2003,1,1
64999,",",1,1
65000,167,1,1
65001,patients,1,1
65002,were,1,1
65003,enrolled,1,1
65004,from,1,1
65005,27,1,1
65006,Japanese,1,1
65007,hospitals,1,1
65008,and,0,1
65009,randomly,0,1
65010,assigned,0,1
65011,to,0,0
65012,TH,0,0
65013,(,0,1
65014,n=82,0,1
65015,),0,1
65016,or,0,1
65017,LTA,0,0
65018,(,0,1
65019,n=85,0,1
65020,),0,1
65021,.,0,1
65022,The,0,0
65023,primary,0,1
65024,endpoint,0,0
65025,was,0,0
65026,overall,0,0
65027,survival,0,0
65028,",",0,0
65029,and,0,0
65030,secondary,0,1
65031,endpoints,0,0
65032,were,0,1
65033,disease-free,0,1
65034,survival,0,0
65035,",",0,0
65036,postoperative,0,0
65037,morbidity,0,0
65038,and,0,0
65039,hospital,0,1
65040,mortality,0,0
65041,",",0,0
65042,and,0,0
65043,postoperative,0,1
65044,symptoms,0,1
65045,and,0,1
65046,change,0,0
65047,of,0,0
65048,respiratory,0,1
65049,function,0,0
65050,.,0,1
65051,The,1,0
65052,projected,1,0
65053,sample,1,1
65054,size,1,0
65055,was,1,0
65056,302,1,1
65057,.,1,1
65058,After,1,0
65059,the,1,0
65060,first,1,0
65061,interim,1,0
65062,analysis,1,0
65063,",",1,0
65064,the,1,0
65065,predicted,1,0
65066,probability,1,0
65067,of,1,1
65068,LTA,1,0
65069,having,1,1
65070,a,1,0
65071,significantly,1,0
65072,better,1,0
65073,overall,1,0
65074,survival,1,0
65075,than,1,0
65076,TH,1,0
65077,at,1,1
65078,the,1,0
65079,final,1,0
65080,analysis,1,0
65081,was,1,0
65082,only,1,0
65083,3.65,1,0
65084,%,1,0
65085,",",1,0
65086,and,1,0
65087,the,1,0
65088,trial,1,0
65089,was,1,0
65090,closed,1,0
65091,immediately,1,0
65092,.,1,1
65093,Analysis,0,0
65094,was,0,0
65095,by,0,0
65096,intention,0,0
65097,to,0,1
65098,treat,0,1
65099,.,0,0
65100,This,0,0
65101,study,0,0
65102,is,0,0
65103,registered,0,0
65104,with,0,0
65105,",",0,0
65106,number,0,0
65107,NCT00149266,0,0
65108,.,0,1
65109,FINDINGS,0,0
65110,5-year,0,1
65111,overall,0,0
65112,survival,0,0
65113,was,0,0
65114,52.3,0,1
65115,%,0,0
65116,(,0,1
65117,95,0,0
65118,%,0,0
65119,CI,0,0
65120,40.4-64.1,0,0
65121,),0,1
65122,in,0,0
65123,the,0,0
65124,TH,0,0
65125,group,0,1
65126,and,0,1
65127,37.9,0,0
65128,%,0,0
65129,(,0,1
65130,26.1-49.6,0,0
65131,),0,1
65132,in,0,0
65133,the,0,0
65134,LTA,0,0
65135,group,0,1
65136,.,0,1
65137,The,0,0
65138,hazard,0,0
65139,ratio,0,0
65140,of,0,0
65141,death,0,0
65142,for,0,1
65143,LTA,0,0
65144,compared,0,0
65145,with,0,1
65146,TH,0,1
65147,was,0,0
65148,1.36,0,0
65149,(,0,1
65150,0.89-2.08,0,0
65151,",",0,1
65152,p=0.92,0,0
65153,),0,1
65154,.,0,1
65155,Three,0,1
65156,patients,0,1
65157,died,0,1
65158,in,0,0
65159,hospital,0,1
65160,after,0,1
65161,LTA,0,0
65162,but,0,0
65163,none,0,1
65164,after,0,1
65165,TH,0,1
65166,.,0,1
65167,Morbidity,0,0
65168,was,0,0
65169,worse,0,0
65170,after,0,0
65171,LTA,0,0
65172,than,0,0
65173,after,0,1
65174,TH,0,1
65175,.,0,1
65176,INTERPRETATION,0,0
65177,Because,0,1
65178,LTA,0,0
65179,does,0,0
65180,not,0,0
65181,improve,0,0
65182,survival,0,0
65183,after,0,0
65184,TH,0,0
65185,and,0,0
65186,leads,0,0
65187,to,0,0
65188,increased,0,0
65189,morbidity,0,0
65190,in,0,0
65191,patients,1,1
65192,with,1,1
65193,cancer,1,1
65194,of,1,0
65195,the,1,0
65196,cardia,1,1
65197,or,1,0
65198,subcardia,1,1
65199,",",0,0
65200,LTA,0,0
65201,can,0,0
65202,not,0,0
65203,be,0,0
65204,justified,0,0
65205,to,0,0
65206,treat,0,1
65207,these,0,0
65208,tumours,0,1
65209,.,0,1
65210,Dietary,0,1
65211,sodium,0,0
65212,intake,0,0
65213,modulates,0,0
65214,myocardial,1,0
65215,relaxation,1,0
65216,responsiveness,0,0
65217,to,0,0
65218,angiotensin,0,0
65219,II,0,1
65220,.,0,1
65221,Dietary,0,0
65222,sodium,0,0
65223,alters,0,0
65224,renovascular,0,1
65225,responsiveness,0,0
65226,to,0,0
65227,angiotensin,0,0
65228,II,0,1
65229,(,0,1
65230,Ang,0,0
65231,II,0,1
65232,),0,1
65233,in,0,1
65234,normal,1,1
65235,subjects,1,1
65236,.,1,1
65237,Evidence,0,0
65238,supports,0,0
65239,a,0,0
65240,connection,0,0
65241,among,0,0
65242,dietary,0,0
65243,sodium,0,0
65244,",",0,0
65245,the,0,0
65246,rennin-angiotensin,0,0
65247,system,0,0
65248,",",0,0
65249,and,0,0
65250,myocardial,0,1
65251,function,0,0
65252,.,0,1
65253,The,0,0
65254,authors,0,0
65255,hypothesized,0,0
65256,that,0,0
65257,a,0,1
65258,similar,0,0
65259,relationship,0,0
65260,would,0,0
65261,exist,0,0
65262,in,0,0
65263,the,0,0
65264,heart,0,1
65265,",",0,0
65266,and,0,0
65267,that,0,0
65268,the,0,0
65269,pattern,0,1
65270,of,0,0
65271,responses,0,0
65272,would,0,0
65273,be,0,0
65274,qualitatively,0,0
65275,similar,0,0
65276,to,0,0
65277,the,0,0
65278,renal,0,1
65279,vasculature,0,1
65280,.,0,1
65281,Thirteen,1,1
65282,healthy,1,1
65283,volunteers,1,1
65284,(,1,1
65285,aged,1,1
65286,38.6,1,0
65287,+/-,1,1
65288,4,1,1
65289,years,1,1
65290,),1,1
65291,entered,0,1
65292,a,0,1
65293,2,0,0
65294,week,0,0
65295,crossover,0,1
65296,design,0,1
65297,study,0,1
65298,(,0,1
65299,week,0,0
65300,1,0,0
65301,",",0,0
65302,high,0,1
65303,sodium,0,0
65304,diet,0,1
65305,[,0,0
65306,HS,0,1
65307,],0,1
65308,>,0,1
65309,200,0,1
65310,mmol,0,1
65311,Na/day,0,0
65312,;,0,1
65313,week,0,0
65314,2,0,1
65315,",",0,0
65316,low,0,1
65317,sodium,0,0
65318,diet,0,1
65319,[,0,0
65320,LS,0,0
65321,],0,1
65322,",",0,1
65323,<,0,0
65324,10,0,1
65325,mmol,0,0
65326,Na/day,0,1
65327,),0,1
65328,to,0,0
65329,investigate,0,0
65330,the,0,0
65331,influence,0,0
65332,of,0,0
65333,dietary,0,0
65334,sodium,0,0
65335,and,0,1
65336,Ang,0,0
65337,II,0,1
65338,on,0,0
65339,myocardial,0,1
65340,relaxation,0,0
65341,and,0,1
65342,renal,0,1
65343,blood,0,0
65344,flow,0,0
65345,(,0,1
65346,RBF,0,1
65347,),0,1
65348,.,0,1
65349,At,0,0
65350,the,0,0
65351,end,0,0
65352,of,0,0
65353,each,0,0
65354,study,0,0
65355,week,0,0
65356,",",0,0
65357,the,0,0
65358,authors,0,0
65359,assessed,0,0
65360,diastolic,0,1
65361,function,0,0
65362,(,0,1
65363,myocardial,0,1
65364,relaxation,0,0
65365,velocities,0,0
65366,[,0,1
65367,E,0,0
65368,',0,1
65369,],0,1
65370,using,0,1
65371,tissue,0,1
65372,Doppler,0,1
65373,imaging,0,0
65374,),0,1
65375,and,0,1
65376,RBF,0,1
65377,(,0,1
65378,para-aminohippurate,0,0
65379,clearance,0,0
65380,),0,1
65381,at,0,0
65382,baseline,0,0
65383,and,0,1
65384,after,0,0
65385,infusion,0,0
65386,of,0,1
65387,Ang,0,0
65388,II,0,1
65389,(,0,1
65390,3,0,0
65391,ng/kg/min,0,1
65392,x,0,1
65393,45,0,1
65394,min,0,0
65395,),0,1
65396,.,0,1
65397,On,0,0
65398,HS,0,1
65399,diet,0,1
65400,",",0,0
65401,E,0,0
65402,',0,1
65403,and,0,1
65404,RBF,0,1
65405,were,0,1
65406,higher,0,0
65407,than,0,0
65408,on,0,0
65409,LS,0,0
65410,diet,0,1
65411,(,0,1
65412,E,0,1
65413,',0,1
65414,14.0,0,0
65415,+/-,0,1
65416,1.2,0,1
65417,vs,0,0
65418,12.6,0,1
65419,+/-,0,1
65420,1.0,0,0
65421,cm/s,0,0
65422,",",0,1
65423,P,0,0
65424,=,0,1
65425,0.02,0,0
65426,;,0,1
65427,RBF,0,1
65428,596,0,1
65429,+/-,0,1
65430,24,0,1
65431,vs,0,0
65432,563,0,1
65433,+/-,0,1
65434,26,0,1
65435,mL/min,0,0
65436,",",0,1
65437,P,0,0
65438,=,0,1
65439,0.02,0,0
65440,),0,1
65441,.,0,1
65442,Dietary,0,0
65443,sodium,0,0
65444,significantly,0,0
65445,modulated,0,0
65446,E,0,0
65447,',0,1
65448,and,0,1
65449,RBF,0,1
65450,responsiveness,0,0
65451,to,0,1
65452,Ang,0,0
65453,II,0,1
65454,infusion,0,0
65455,in,0,0
65456,like,0,0
65457,manner,0,0
65458,.,0,1
65459,HS,0,1
65460,was,0,0
65461,associated,0,0
65462,with,0,1
65463,increased,0,0
65464,responsiveness,0,0
65465,compared,0,0
65466,with,0,1
65467,a,0,1
65468,blunted,0,0
65469,LS,0,0
65470,response,0,0
65471,(,0,1
65472,HS,0,1
65473,DeltaE,0,0
65474,',0,1
65475,-1.4,0,0
65476,+/-,0,1
65477,0.4,0,1
65478,cm/s,0,0
65479,vs,0,0
65480,LS,0,0
65481,DeltaE,0,0
65482,',0,1
65483,-0.1,0,0
65484,+/-,0,1
65485,0.3,0,0
65486,cm/s,0,0
65487,",",0,1
65488,P,0,0
65489,=,0,1
65490,0.02,0,0
65491,;,0,1
65492,HS,0,1
65493,DeltaRBF,0,1
65494,-135.2,0,0
65495,+/-,0,0
65496,13.2,0,1
65497,vs,0,0
65498,LS,0,0
65499,DeltaRBF,0,1
65500,-62.5,0,0
65501,+/-,0,0
65502,10.1,0,1
65503,mL/min,0,0
65504,",",0,1
65505,P,0,0
65506,<,0,0
65507,0.01,0,0
65508,),0,1
65509,.,0,1
65510,The,0,0
65511,authors,0,0
65512,describe,0,1
65513,for,0,0
65514,the,0,0
65515,first,0,0
65516,time,0,0
65517,that,0,0
65518,dietary,0,0
65519,sodium,0,0
65520,modulates,0,0
65521,myocardial,0,0
65522,relaxation,0,0
65523,and,0,1
65524,responsiveness,0,0
65525,to,0,1
65526,Ang,0,0
65527,II,0,1
65528,.,0,1
65529,It,0,0
65530,is,0,0
65531,important,0,0
65532,to,0,0
65533,consider,0,0
65534,dietary,0,0
65535,sodium,0,0
65536,intake,0,0
65537,when,0,0
65538,assessing,0,0
65539,diastolic,0,0
65540,function,0,0
65541,.,0,1
65542,Ang,0,0
65543,II,0,1
65544,may,0,0
65545,play,0,0
65546,a,0,0
65547,role,0,0
65548,in,0,0
65549,the,0,0
65550,interaction,0,0
65551,between,0,0
65552,dietary,0,0
65553,sodium,0,0
65554,and,0,1
65555,myocardial,0,1
65556,relaxation,0,0
65557,.,0,1
65558,Future,0,0
65559,research,0,0
65560,will,0,0
65561,investigate,0,0
65562,whether,0,0
65563,abnormalities,0,0
65564,in,0,1
65565,these,0,0
65566,mechanisms,0,0
65567,play,0,0
65568,a,0,0
65569,role,0,0
65570,in,0,0
65571,disorders,0,1
65572,of,0,1
65573,diastolic,0,1
65574,function,0,0
65575,.,0,1
65576,The,0,0
65577,efficacy,0,0
65578,of,0,0
65579,conventional,0,1
65580,PCNL,0,1
65581,and,0,1
65582,two,0,1
65583,modifications,0,0
65584,to,0,1
65585,standard,0,1
65586,procedure,0,0
65587,.,0,1
65588,OBJECTIVE,0,0
65589,To,0,0
65590,compare,0,0
65591,the,0,0
65592,efficacy,0,0
65593,of,0,0
65594,conventional,0,1
65595,Percutaneous,1,1
65596,Nephrolithotomy,1,1
65597,(,1,1
65598,PCNL,1,1
65599,),1,1
65600,with,0,1
65601,two,0,1
65602,of,0,1
65603,its,0,0
65604,modified,0,1
65605,procedures,0,1
65606,.,0,1
65607,METHODS,0,0
65608,A,0,1
65609,randomized,0,1
65610,controlled,0,0
65611,trial,0,0
65612,",",0,0
65613,was,0,0
65614,performed,0,0
65615,on,0,0
65616,60,1,1
65617,patients,1,1
65618,undergoing,1,1
65619,PCNL,1,1
65620,.,1,1
65621,Cases,1,0
65622,of,1,0
65623,renal,1,1
65624,stone,1,1
65625,regardless,1,0
65626,of,1,0
65627,stone,1,1
65628,size,1,0
65629,and,1,0
65630,configuration,1,1
65631,",",1,0
65632,having,1,1
65633,pre-operative,1,0
65634,negative,1,1
65635,urine,1,1
65636,culture,1,0
65637,",",1,0
65638,no,1,0
65639,coagulopathy,1,0
65640,",",1,0
65641,and,1,0
65642,no,1,0
65643,visible,1,0
65644,residual,1,0
65645,stone,1,1
65646,in,1,1
65647,intra-operative,1,0
65648,fluoroscopy,1,0
65649,",",1,0
65650,were,1,0
65651,included,1,1
65652,.,1,1
65653,They,0,0
65654,were,0,0
65655,randomly,0,1
65656,divided,0,1
65657,into,0,1
65658,3,0,1
65659,groups,0,1
65660,of,0,1
65661,20,0,1
65662,cases,0,1
65663,each,0,1
65664,with,0,1
65665,nephrostomy,0,1
65666,tube,0,1
65667,(,0,1
65668,NT,0,1
65669,),0,1
65670,and,0,1
65671,temporary,0,0
65672,ureteral,0,1
65673,catheter,0,1
65674,(,0,1
65675,TU,0,1
65676,),0,1
65677,in,0,0
65678,group,0,1
65679,A,0,1
65680,",",0,0
65681,only,0,0
65682,TU,0,0
65683,in,0,0
65684,group,0,1
65685,B,0,1
65686,and,0,0
65687,only,0,0
65688,indwelling,0,1
65689,ureteral,0,1
65690,catheter,0,1
65691,(,0,1
65692,IU,0,0
65693,),0,1
65694,in,0,0
65695,group,0,1
65696,C.,0,0
65697,Mean,1,1
65698,age,1,1
65699,of,1,1
65700,cases,1,1
65701,were,1,1
65702,43.2,1,1
65703,(,1,1
65704,25-70,1,1
65705,),1,1
65706,",",1,1
65707,40.1,1,0
65708,(,1,1
65709,25-73,1,1
65710,),1,1
65711,",",1,1
65712,and,1,1
65713,44,1,1
65714,(,1,1
65715,25-70,1,1
65716,),1,1
65717,years,1,1
65718,in,1,1
65719,groups,1,1
65720,A,1,1
65721,",",1,1
65722,B,1,1
65723,and,1,0
65724,C,1,0
65725,",",1,0
65726,respectively,1,0
65727,(,0,0
65728,P,0,0
65729,=,0,1
65730,0.6,0,1
65731,),0,1
65732,.,0,1
65733,Procedures,0,0
65734,were,0,0
65735,performed,0,0
65736,under,0,1
65737,general,0,1
65738,anaesthesia,0,1
65739,",",0,0
65740,using,0,0
65741,standard,0,1
65742,techniques,0,0
65743,for,0,1
65744,access,0,1
65745,and,0,1
65746,lithotomy,0,1
65747,.,0,1
65748,Forty-eight,0,1
65749,hours,0,0
65750,",",0,1
65751,2,0,1
65752,weeks,0,0
65753,and,0,1
65754,3,0,1
65755,months,0,0
65756,after,0,1
65757,PCNL,0,1
65758,",",0,1
65759,plain,0,1
65760,X-ray,0,0
65761,abdomen,0,0
65762,",",0,1
65763,ultrasonography,0,1
65764,and,0,0
65765,IVP,0,0
65766,were,0,1
65767,performed,0,0
65768,for,0,0
65769,each,0,0
65770,case,0,0
65771,.,0,1
65772,RESULTS,0,0
65773,Only,0,0
65774,one,0,1
65775,case,0,0
65776,in,0,0
65777,group,0,1
65778,A,0,1
65779,had,0,1
65780,urinary,0,0
65781,leakage,0,0
65782,after,0,0
65783,removal,0,0
65784,of,0,0
65785,nephrostomy,0,1
65786,tube,0,1
65787,.,0,1
65788,No,0,0
65789,cases,0,0
65790,in,0,0
65791,the,0,1
65792,other,0,1
65793,two,0,1
65794,groups,0,1
65795,encountered,0,1
65796,this,0,0
65797,problem,0,0
65798,.,0,0
65799,There,0,0
65800,was,0,0
65801,no,0,0
65802,haemorrhagic,0,0
65803,episode,0,1
65804,.,0,1
65805,Ultrasonic,0,0
65806,evaluation,0,0
65807,showed,0,0
65808,mild,0,1
65809,residue,0,0
65810,in,0,1
65811,3,0,1
65812,",",0,1
65813,1,0,1
65814,and,0,1
65815,1,0,1
65816,cases,0,1
65817,of,0,1
65818,groups,0,1
65819,A,0,1
65820,",",0,1
65821,B,0,1
65822,and,0,0
65823,C,0,0
65824,",",0,0
65825,respectively,0,0
65826,(,0,0
65827,P,0,0
65828,=,0,1
65829,0.2,0,1
65830,),0,1
65831,.,0,1
65832,No,0,0
65833,collective,0,0
65834,fluid,0,1
65835,was,0,0
65836,found,0,0
65837,in,0,0
65838,these,0,0
65839,groups,0,0
65840,.,0,1
65841,IVP,0,0
65842,showed,0,0
65843,dilatation,0,1
65844,without,0,1
65845,obstruction,0,1
65846,in,0,1
65847,3,0,1
65848,subjects,0,1
65849,of,0,1
65850,group,0,1
65851,A,0,1
65852,and,0,0
65853,none,0,0
65854,in,0,0
65855,group,0,1
65856,B,0,1
65857,or,0,1
65858,C,0,1
65859,(,0,1
65860,P,0,0
65861,=,0,1
65862,0.03,0,0
65863,),0,1
65864,.,0,1
65865,CONCLUSION,0,0
65866,Tubeless,0,0
65867,PCNL,0,1
65868,seems,0,0
65869,to,0,0
65870,be,0,0
65871,accompanied,0,0
65872,by,0,0
65873,better,0,0
65874,outcome,0,0
65875,.,0,0
65876,So,0,0
65877,",",0,0
65878,further,0,0
65879,evaluation,0,0
65880,on,0,0
65881,more,0,0
65882,patients,0,1
65883,seems,0,0
65884,necessary,0,0
65885,.,0,1
65886,Randomized,0,1
65887,controlled,0,0
65888,trial,0,0
65889,of,0,0
65890,melatonin,0,0
65891,for,0,1
65892,children,1,1
65893,with,1,1
65894,autistic,1,1
65895,spectrum,1,1
65896,disorders,1,1
65897,and,1,1
65898,sleep,1,1
65899,problems,1,1
65900,.,1,1
65901,BACKGROUND,0,0
65902,Melatonin,0,0
65903,is,0,0
65904,often,0,0
65905,used,0,0
65906,for,0,0
65907,autistic,1,1
65908,children,1,1
65909,with,1,1
65910,sleep,1,1
65911,disorders,1,1
65912,",",0,0
65913,despite,0,0
65914,a,0,0
65915,lack,0,0
65916,of,0,0
65917,published,0,0
65918,evidence,0,0
65919,in,0,0
65920,this,0,0
65921,population,0,1
65922,.,0,1
65923,METHODS,0,0
65924,A,0,1
65925,randomized,0,1
65926,",",0,1
65927,placebo-controlled,0,0
65928,double-blind,0,0
65929,crossover,0,0
65930,trial,0,0
65931,of,0,0
65932,melatonin,0,0
65933,was,0,0
65934,undertaken,0,1
65935,in,0,1
65936,11,1,1
65937,children,1,1
65938,with,1,1
65939,autistic,1,1
65940,spectrum,1,1
65941,disorder,1,1
65942,(,1,1
65943,ASD,1,1
65944,),1,1
65945,.,1,1
65946,RESULTS,0,0
65947,Seven,1,1
65948,children,1,1
65949,completed,1,1
65950,the,1,0
65951,trial,1,0
65952,.,1,1
65953,Sleep,0,0
65954,latency,0,0
65955,was,0,0
65956,2.6,0,0
65957,h,0,0
65958,[,0,1
65959,95,0,0
65960,%,0,0
65961,confidence,0,0
65962,intervals,0,0
65963,(,0,1
65964,CI,0,0
65965,),0,1
65966,2.28-2.93,0,0
65967,],0,1
65968,baseline,0,0
65969,",",0,1
65970,1.91,0,0
65971,h,0,0
65972,(,0,1
65973,95,0,0
65974,%,0,0
65975,CI,0,0
65976,1.78-2.03,0,0
65977,),0,1
65978,with,0,1
65979,placebo,0,1
65980,and,0,1
65981,1.06,0,0
65982,h,0,0
65983,(,0,1
65984,95,0,0
65985,%,0,0
65986,CI,0,0
65987,0.98-1.13,0,0
65988,),0,1
65989,with,0,1
65990,melatonin,0,1
65991,.,0,1
65992,Wakings,0,0
65993,per,0,0
65994,night,0,1
65995,were,0,1
65996,0.35,0,0
65997,(,0,1
65998,95,0,0
65999,%,0,0
66000,CI,0,0
66001,0.18-0.53,0,0
66002,),0,1
66003,baseline,0,0
66004,",",0,1
66005,0.26,0,0
66006,(,0,1
66007,95,0,0
66008,%,0,0
66009,CI,0,0
66010,0.20-0.34,0,0
66011,),0,1
66012,with,0,1
66013,placebo,0,1
66014,and,0,1
66015,0.08,0,0
66016,(,0,1
66017,95,0,0
66018,%,0,0
66019,CI,0,0
66020,0.04-0.12,0,0
66021,),0,1
66022,with,0,1
66023,melatonin,0,1
66024,.,0,1
66025,Total,0,0
66026,sleep,0,1
66027,duration,0,0
66028,was,0,0
66029,8.05,0,0
66030,h,0,0
66031,(,0,1
66032,95,0,0
66033,%,0,0
66034,CI,0,0
66035,7.65-8.44,0,0
66036,),0,1
66037,baseline,0,0
66038,",",0,1
66039,8.75,0,0
66040,h,0,0
66041,(,0,1
66042,95,0,0
66043,%,0,0
66044,CI,0,0
66045,8.56-8.98,0,0
66046,),0,1
66047,with,0,1
66048,placebo,0,1
66049,and,0,1
66050,9.84,0,0
66051,h,0,0
66052,(,0,1
66053,95,0,0
66054,%,0,0
66055,CI,0,0
66056,9.68-9.99,0,0
66057,),0,1
66058,with,0,1
66059,melatonin,0,1
66060,.,0,1
66061,CONCLUSIONS,0,0
66062,Although,0,0
66063,the,0,0
66064,study,0,0
66065,was,0,0
66066,small,0,1
66067,owing,0,0
66068,to,0,1
66069,recruitment,0,0
66070,difficulties,0,0
66071,",",0,0
66072,it,0,0
66073,still,0,0
66074,provides,0,0
66075,evidence,0,0
66076,of,0,0
66077,effectiveness,0,0
66078,of,0,0
66079,melatonin,0,0
66080,in,0,1
66081,children,1,1
66082,with,1,1
66083,sleep,1,1
66084,difficulties,1,1
66085,and,1,1
66086,ASD,1,1
66087,",",0,0
66088,which,0,0
66089,we,0,0
66090,predict,0,0
66091,a,0,0
66092,larger,0,0
66093,study,0,0
66094,would,0,0
66095,confirm,0,0
66096,.,0,0
66097,Anecortave,0,0
66098,acetate,0,0
66099,treatment,0,0
66100,for,0,1
66101,retinal,1,1
66102,angiomatous,1,1
66103,proliferation,1,0
66104,:,1,1
66105,a,0,0
66106,pilot,0,0
66107,study,0,0
66108,.,0,0
66109,PURPOSE,0,0
66110,The,0,0
66111,purpose,0,0
66112,of,0,0
66113,this,0,0
66114,study,0,0
66115,was,0,0
66116,to,0,0
66117,evaluate,0,0
66118,anecortave,0,0
66119,acetate,0,0
66120,treatment,0,1
66121,of,0,0
66122,retinal,1,1
66123,angiomatous,1,1
66124,proliferation,1,0
66125,(,1,1
66126,RAP,1,1
66127,),1,1
66128,",",0,0
66129,a,0,0
66130,neovascular,0,1
66131,form,0,0
66132,of,0,0
66133,age-related,0,0
66134,macular,0,1
66135,degeneration,0,1
66136,",",0,0
66137,with,0,1
66138,specific,0,0
66139,regard,0,0
66140,to,0,0
66141,inhibition,0,0
66142,of,0,0
66143,neovascularization,0,1
66144,and,0,0
66145,maintenance,0,0
66146,of,0,0
66147,vision,0,0
66148,.,0,1
66149,METHODS,0,0
66150,Thirty-four,1,1
66151,patients,1,1
66152,with,1,1
66153,RAP,1,1
66154,with,1,1
66155,any,1,0
66156,stage,1,1
66157,of,1,0
66158,neovascularization,1,1
66159,were,0,1
66160,randomized,0,1
66161,1:1:1,0,0
66162,for,0,0
66163,treatment,0,1
66164,with,0,1
66165,three,0,1
66166,different,0,1
66167,quantities,0,1
66168,(,0,1
66169,30,0,1
66170,mg,0,0
66171,",",0,1
66172,15,0,0
66173,mg,0,0
66174,",",0,1
66175,3,0,0
66176,mg,0,0
66177,),0,1
66178,of,0,0
66179,anecortave,0,0
66180,acetate,0,0
66181,sterile,0,0
66182,suspension,0,0
66183,for,0,0
66184,juxtascleral,0,1
66185,administration,0,0
66186,.,0,1
66187,Best-corrected,0,0
66188,visual,0,0
66189,acuity,0,0
66190,(,0,1
66191,Early,0,1
66192,Treatment,0,0
66193,Diabetic,0,1
66194,Retinopathy,0,1
66195,Study,0,1
66196,chart,0,1
66197,),0,1
66198,",",0,0
66199,intraocular,0,1
66200,pressure,0,0
66201,measurement,0,0
66202,",",0,0
66203,biomicroscopy,0,0
66204,",",0,0
66205,funduscopy,0,0
66206,",",0,0
66207,digital,0,0
66208,fluorescein,0,0
66209,",",0,0
66210,and,0,0
66211,indocyanine,0,0
66212,green,0,1
66213,angiography,0,1
66214,were,0,1
66215,recorded,0,0
66216,at,0,0
66217,baseline,0,0
66218,and,0,1
66219,at,0,1
66220,3,0,1
66221,months,0,1
66222,.,0,1
66223,A,0,0
66224,6-month,0,0
66225,retreatment,0,0
66226,interval,0,0
66227,was,0,0
66228,established,0,0
66229,for,0,0
66230,this,0,0
66231,study,0,0
66232,with,0,1
66233,a,0,0
66234,follow-up,0,0
66235,of,0,0
66236,12,0,1
66237,months,0,1
66238,.,0,1
66239,In,0,0
66240,selected,0,1
66241,patients,0,1
66242,optical,0,1
66243,coherence,0,0
66244,tomography,0,1
66245,was,0,0
66246,performed,0,0
66247,.,0,1
66248,The,0,0
66249,outcomes,0,0
66250,were,0,1
66251,mean,0,1
66252,changes,0,0
66253,in,0,1
66254,visual,0,0
66255,acuity,0,0
66256,and,0,0
66257,lesion,0,0
66258,size,0,0
66259,at,0,1
66260,1,0,1
66261,year,0,1
66262,.,0,1
66263,RESULTS,0,0
66264,The,0,0
66265,detachment,0,0
66266,of,0,0
66267,the,0,0
66268,neurosensory,0,0
66269,retina,0,0
66270,and,0,1
66271,retinal,0,1
66272,pigment,0,1
66273,epithelium,0,1
66274,improved,0,0
66275,in,0,0
66276,all,0,1
66277,eyes,0,1
66278,",",0,0
66279,but,0,0
66280,all,0,0
66281,neovascular,0,1
66282,lesions,0,1
66283,increased,0,0
66284,in,0,1
66285,size,0,0
66286,.,0,1
66287,Vision,0,0
66288,loss,0,0
66289,occurred,0,0
66290,in,0,0
66291,the,0,0
66292,majority,0,1
66293,of,0,0
66294,study,0,1
66295,eyes,0,1
66296,(,0,1
66297,22,0,1
66298,out,0,1
66299,of,0,1
66300,34,0,1
66301,eyes,0,1
66302,",",0,1
66303,64.7,0,0
66304,%,0,0
66305,),0,1
66306,independent,0,0
66307,of,0,0
66308,the,0,0
66309,concentration,0,0
66310,administered,0,0
66311,.,0,1
66312,CONCLUSION,0,0
66313,The,0,0
66314,results,0,0
66315,suggest,0,0
66316,that,0,0
66317,a,0,1
66318,posterior,0,1
66319,juxtascleral,0,1
66320,injection,0,0
66321,of,0,0
66322,anecortave,0,0
66323,acetate,0,1
66324,reduces,0,0
66325,capillary,0,0
66326,permeability,0,0
66327,in,0,1
66328,patients,1,1
66329,with,1,1
66330,RAP,1,1
66331,.,1,1
66332,However,0,0
66333,",",0,0
66334,in,0,0
66335,spite,0,0
66336,of,0,0
66337,improvement,0,0
66338,of,0,0
66339,the,0,0
66340,exudation,0,0
66341,there,0,0
66342,is,0,0
66343,a,0,0
66344,progression,0,0
66345,of,0,0
66346,neovascularization,0,1
66347,and,0,0
66348,a,0,0
66349,significant,0,0
66350,loss,0,0
66351,of,0,0
66352,vision,0,0
66353,in,0,0
66354,all,0,0
66355,these,0,0
66356,patients,0,1
66357,.,0,1
66358,Like,0,0
66359,other,0,0
66360,monotherapeutic,0,1
66361,methods,0,1
66362,used,0,0
66363,to,0,0
66364,treat,0,1
66365,this,0,0
66366,variant,0,1
66367,of,0,0
66368,neovascular,0,1
66369,age-related,0,1
66370,macular,0,1
66371,degeneration,0,1
66372,",",0,0
66373,anecortave,0,0
66374,acetate,0,0
66375,alone,0,0
66376,does,0,0
66377,not,0,0
66378,appear,0,0
66379,to,0,0
66380,benefit,0,0
66381,these,0,0
66382,patients,0,1
66383,.,0,1
66384,Future,0,0
66385,studies,0,0
66386,should,0,0
66387,investigate,0,0
66388,a,0,0
66389,combination,0,0
66390,form,0,0
66391,of,0,0
66392,therapy,0,1
66393,.,0,1
66394,Long-term,0,1
66395,results,0,0
66396,of,0,1
66397,the,0,1
66398,MRC,1,0
66399,AML10,1,0
66400,trial,1,1
66401,.,1,1
66402,Comparison,0,0
66403,of,0,0
66404,the,0,0
66405,effectiveness,0,0
66406,of,0,0
66407,fennel,0,0
66408,and,0,1
66409,mefenamic,0,0
66410,acid,0,0
66411,on,0,0
66412,pain,0,1
66413,intensity,0,0
66414,in,0,0
66415,dysmenorrhoea,1,1
66416,.,1,1
66417,A,0,0
66418,study,0,0
66419,in,0,0
66420,Kerman,1,1
66421,",",1,1
66422,Islamic,1,1
66423,Republic,1,1
66424,of,1,0
66425,Iran,1,1
66426,in,1,1
66427,2002,1,1
66428,compared,0,0
66429,the,0,0
66430,effectiveness,0,0
66431,of,0,0
66432,fennel,0,0
66433,and,0,1
66434,mefenamic,0,0
66435,acid,0,0
66436,on,0,0
66437,pain,0,1
66438,relief,0,0
66439,in,0,0
66440,primary,1,1
66441,dysmenorrhoea,1,1
66442,.,1,1
66443,Two,1,1
66444,groups,1,0
66445,of,1,1
66446,high-school,1,1
66447,girls,1,1
66448,(,1,1
66449,mean,1,1
66450,age,1,1
66451,13,1,1
66452,years,1,1
66453,),1,1
66454,suffering,1,1
66455,dysmenorrhoea,1,1
66456,were,1,1
66457,randomized,1,1
66458,to,0,0
66459,receive,0,1
66460,fennel,0,0
66461,extract,0,0
66462,(,0,1
66463,n,0,1
66464,=,0,1
66465,55,0,1
66466,),0,1
66467,or,0,1
66468,mefenamic,0,1
66469,acid,0,0
66470,(,0,1
66471,n,0,1
66472,=,0,1
66473,55,0,1
66474,),0,1
66475,for,0,1
66476,2,0,1
66477,months,0,1
66478,.,0,1
66479,In,0,0
66480,the,0,0
66481,fennel,0,0
66482,group,0,0
66483,",",0,0
66484,80,0,1
66485,%,0,0
66486,of,0,1
66487,girls,0,1
66488,and,0,1
66489,in,0,1
66490,the,0,0
66491,mefenamic,0,0
66492,acid,0,0
66493,group,0,1
66494,",",0,0
66495,73,0,1
66496,%,0,0
66497,of,0,1
66498,girls,0,1
66499,showed,0,0
66500,complete,0,1
66501,pain,0,1
66502,relief,0,0
66503,or,0,1
66504,pain,0,1
66505,decrease,0,0
66506,",",0,0
66507,while,0,0
66508,80,0,1
66509,%,0,0
66510,in,0,0
66511,the,0,0
66512,fennel,0,0
66513,group,0,1
66514,and,0,1
66515,62,0,1
66516,%,0,0
66517,in,0,0
66518,the,0,0
66519,mefenamic,0,0
66520,acid,0,0
66521,group,0,0
66522,no,0,0
66523,longer,0,0
66524,needed,0,0
66525,to,0,0
66526,rest,0,0
66527,.,0,0
66528,There,0,0
66529,was,0,0
66530,no,0,0
66531,significant,0,0
66532,difference,0,0
66533,between,0,0
66534,the,0,1
66535,2,0,1
66536,groups,0,0
66537,in,0,1
66538,the,0,0
66539,level,0,0
66540,of,0,0
66541,pain,0,1
66542,relief,0,0
66543,.,0,1
66544,Prevention,0,1
66545,of,0,0
66546,bone,0,0
66547,loss,0,0
66548,in,0,0
66549,survivors,1,1
66550,of,1,1
66551,breast,1,1
66552,cancer,1,1
66553,:,1,1
66554,A,0,1
66555,randomized,0,1
66556,",",0,0
66557,double-blind,0,0
66558,",",0,0
66559,placebo-controlled,0,0
66560,clinical,0,0
66561,trial,0,1
66562,.,0,1
66563,BACKGROUND,0,0
66564,Few,0,1
66565,data,0,0
66566,are,0,0
66567,available,0,0
66568,on,0,0
66569,the,0,0
66570,safety,0,0
66571,and,0,0
66572,efficacy,0,0
66573,of,0,0
66574,once-weekly,0,0
66575,oral,0,1
66576,bisphosphonate,0,0
66577,therapy,0,0
66578,in,0,0
66579,breast,1,1
66580,cancer,1,1
66581,survivors,1,1
66582,.,1,1
66583,OBJECTIVE,0,0
66584,Our,0,0
66585,objective,0,0
66586,was,0,0
66587,to,0,0
66588,determine,0,0
66589,whether,0,0
66590,risedronate,0,0
66591,",",0,1
66592,35,0,1
66593,mg,0,0
66594,weekly,0,0
66595,",",0,0
66596,is,0,0
66597,efficacious,0,0
66598,and,0,0
66599,safe,0,0
66600,in,0,0
66601,preventing,0,0
66602,bone,0,1
66603,loss,0,0
66604,associated,0,0
66605,with,0,1
66606,chemotherapy-induced,0,1
66607,menopause,0,1
66608,.,0,1
66609,DESIGN,0,0
66610,The,0,0
66611,study,0,0
66612,was,0,0
66613,a,0,0
66614,randomized,0,1
66615,",",0,0
66616,double-blind,0,0
66617,",",0,0
66618,placebo-controlled,0,0
66619,clinical,0,0
66620,trial,0,1
66621,over,0,0
66622,12,0,1
66623,months,0,1
66624,.,0,1
66625,SETTING,0,1
66626,AND,0,0
66627,PARTICIPANTS,0,1
66628,Participants,1,1
66629,included,1,1
66630,87,1,1
66631,newly,1,1
66632,postmenopausal,1,1
66633,women,1,1
66634,with,1,1
66635,status,1,1
66636,post,1,1
66637,chemotherapy,1,1
66638,",",1,0
66639,recruited,1,1
66640,from,1,0
66641,a,1,0
66642,breast,1,1
66643,cancer,1,1
66644,clinic,1,1
66645,in,1,0
66646,an,1,1
66647,academic,1,1
66648,medical,1,1
66649,center,1,1
66650,.,1,1
66651,INTERVENTION,0,0
66652,Participants,0,1
66653,were,0,1
66654,randomly,0,1
66655,assigned,0,1
66656,to,0,0
66657,receive,0,1
66658,risedronate,0,0
66659,35,0,1
66660,mg/wk,0,0
66661,or,0,1
66662,placebo,0,0
66663,.,0,1
66664,MAIN,0,0
66665,OUTCOME,0,1
66666,MEASURES,0,0
66667,The,0,1
66668,primary,0,1
66669,outcomes,0,0
66670,were,0,1
66671,the,0,1
66672,12-month,0,0
66673,changes,0,0
66674,in,0,1
66675,spine,0,1
66676,and,0,1
66677,hip,0,1
66678,bone,0,1
66679,mineral,0,0
66680,density,0,0
66681,.,0,1
66682,Secondary,0,0
66683,outcomes,0,0
66684,included,0,1
66685,changes,0,0
66686,in,0,1
66687,markers,0,0
66688,of,0,1
66689,bone,0,1
66690,resorption,0,0
66691,(,0,1
66692,urine,0,1
66693,N-telopeptide,0,0
66694,cross-linked,0,0
66695,collagen,0,0
66696,type,0,1
66697,I,0,1
66698,),0,1
66699,and,0,0
66700,formation,0,0
66701,(,0,0
66702,osteocalcin,0,0
66703,",",0,1
66704,N-terminal,0,0
66705,propeptide,0,0
66706,of,0,0
66707,type,0,1
66708,I,0,1
66709,procollagen,0,0
66710,",",0,0
66711,and,0,0
66712,bone-specific,0,0
66713,alkaline,0,0
66714,phosphatase,0,1
66715,),0,1
66716,.,0,1
66717,RESULTS,0,0
66718,After,0,1
66719,12,0,1
66720,months,0,0
66721,",",0,1
66722,bone,0,1
66723,mineral,0,0
66724,density,0,0
66725,increased,0,0
66726,by,0,0
66727,1.2,0,0
66728,%,0,0
66729,at,0,0
66730,the,0,0
66731,spine,0,1
66732,and,0,0
66733,1.3,0,0
66734,%,0,0
66735,at,0,0
66736,the,0,0
66737,hip,0,1
66738,in,0,0
66739,women,0,1
66740,on,0,0
66741,risedronate,0,0
66742,vs.,0,0
66743,significant,0,0
66744,decreases,0,0
66745,for,0,1
66746,women,0,1
66747,in,0,1
66748,the,0,0
66749,placebo,0,0
66750,group,0,1
66751,of,0,0
66752,0.9,0,0
66753,%,0,0
66754,at,0,0
66755,the,0,0
66756,spine,0,1
66757,and,0,0
66758,0.8,0,0
66759,%,0,0
66760,at,0,0
66761,the,0,0
66762,hip,0,1
66763,(,0,0
66764,P,0,0
66765,<,0,0
66766,0.01,0,0
66767,",",0,0
66768,difference,0,0
66769,between,0,0
66770,groups,0,1
66771,),0,1
66772,.,0,1
66773,N-telopeptide,0,0
66774,cross-linked,0,0
66775,collagen,0,0
66776,type,0,1
66777,I,0,1
66778,",",0,0
66779,a,0,0
66780,marker,0,0
66781,of,0,0
66782,bone,0,0
66783,resorption,0,0
66784,",",0,0
66785,decreased,0,0
66786,by,0,0
66787,19.3,0,1
66788,%,0,0
66789,",",0,0
66790,and,0,0
66791,N-terminal,0,0
66792,propeptide,0,0
66793,of,0,0
66794,type,0,1
66795,I,0,1
66796,procollagen,0,0
66797,",",0,0
66798,a,0,0
66799,marker,0,0
66800,of,0,0
66801,bone,0,0
66802,formation,0,0
66803,",",0,0
66804,decreased,0,0
66805,by,0,0
66806,26.6,0,0
66807,%,0,0
66808,in,0,1
66809,participants,0,1
66810,on,0,1
66811,active,0,1
66812,therapy,0,0
66813,compared,0,0
66814,with,0,1
66815,increases,0,0
66816,in,0,1
66817,the,0,0
66818,control,0,1
66819,group,0,1
66820,.,0,1
66821,Risedronate,0,0
66822,was,0,0
66823,well,0,0
66824,tolerated,0,0
66825,",",0,0
66826,and,0,0
66827,the,0,0
66828,retention,0,0
66829,rate,0,0
66830,was,0,0
66831,95,0,0
66832,%,0,0
66833,at,0,1
66834,1,0,1
66835,yr,0,1
66836,.,0,1
66837,CONCLUSIONS,0,0
66838,Risedronate,0,0
66839,once,0,0
66840,weekly,0,0
66841,prevented,0,0
66842,bone,0,0
66843,loss,0,0
66844,and,0,1
66845,reduced,0,0
66846,bone,0,1
66847,turnover,0,0
66848,in,0,0
66849,women,1,1
66850,with,1,1
66851,breast,1,1
66852,cancer,1,1
66853,treated,1,1
66854,with,1,1
66855,chemotherapy,1,1
66856,.,1,1
66857,Early,0,1
66858,measures,0,0
66859,to,0,1
66860,prevent,0,0
66861,bone,0,0
66862,loss,0,0
66863,should,0,0
66864,be,0,0
66865,considered,0,0
66866,in,0,0
66867,this,0,0
66868,cohort,0,1
66869,of,0,0
66870,breast,1,1
66871,cancer,1,1
66872,survivors,1,1
66873,.,1,1
66874,Endocrine,0,1
66875,response,0,0
66876,to,0,0
66877,cataract,1,1
66878,surgery,1,1
66879,under,1,0
66880,total,1,1
66881,intravenous,1,1
66882,anaesthesia,1,1
66883,",",1,0
66884,local,1,0
66885,anaesthesia,1,1
66886,under,1,1
66887,sedation,1,1
66888,or,1,1
66889,local,1,0
66890,anaesthesia,1,1
66891,alone,1,1
66892,:,1,1
66893,a,0,0
66894,comparative,0,0
66895,study,0,1
66896,.,0,1
66897,A,0,0
66898,double-blind,0,0
66899,placebo-controlled,0,0
66900,pilot,0,1
66901,study,0,1
66902,of,0,0
66903,olanzapine,0,0
66904,in,0,1
66905,childhood/adolescent,1,1
66906,pervasive,1,1
66907,developmental,1,1
66908,disorder,1,1
66909,.,1,1
66910,Atypical,0,0
66911,antipsychotics,0,1
66912,have,0,1
66913,been,0,0
66914,shown,0,0
66915,to,0,0
66916,improve,0,0
66917,disruptive,0,1
66918,and,0,0
66919,repetitive,0,0
66920,behaviors,0,0
66921,in,0,1
66922,pervasive,0,1
66923,developmental,0,1
66924,disorders,0,1
66925,(,0,1
66926,PDDs,0,1
66927,),0,1
66928,",",0,0
66929,but,0,0
66930,they,0,0
66931,require,0,0
66932,assessment,0,0
66933,of,0,0
66934,potential,0,0
66935,side,0,0
66936,effects,0,0
66937,.,0,1
66938,This,0,0
66939,is,0,0
66940,the,0,0
66941,first,0,0
66942,placebo-controlled,0,0
66943,trial,0,1
66944,of,0,0
66945,olanzapine,0,0
66946,in,0,0
66947,the,0,0
66948,treatment,0,0
66949,of,0,0
66950,children,0,1
66951,and,0,1
66952,adolescents,0,1
66953,with,0,1
66954,PDD,0,1
66955,.,0,1
66956,Eleven,1,1
66957,patients,1,1
66958,with,1,1
66959,a,1,1
66960,diagnosis,1,1
66961,of,1,0
66962,either,1,0
66963,autism,1,1
66964,",",1,0
66965,Asperger,1,1
66966,'s,1,1
66967,syndrome,1,1
66968,",",1,1
66969,or,1,1
66970,PDD,1,1
66971,not,1,0
66972,otherwise,1,1
66973,specified,1,0
66974,(,1,0
66975,PDD-NOS,1,1
66976,),1,1
66977,and,1,1
66978,aged,1,1
66979,6-14,1,1
66980,years,1,1
66981,were,0,1
66982,randomized,0,1
66983,into,0,1
66984,an,0,0
66985,8-week,0,0
66986,double-blind,0,0
66987,",",0,0
66988,placebo-controlled,0,0
66989,",",0,0
66990,parallel,0,0
66991,treatment,0,0
66992,study,0,1
66993,with,0,1
66994,olanzapine,0,0
66995,.,0,0
66996,There,0,0
66997,was,0,0
66998,a,0,0
66999,significant,0,0
67000,linear,0,0
67001,trend,0,0
67002,x,0,1
67003,group,0,1
67004,interaction,0,0
67005,on,0,0
67006,the,0,0
67007,Clinical,0,0
67008,Global,0,1
67009,Impressions-,0,1
67010,Improvement,0,0
67011,(,0,1
67012,CGI-I,0,1
67013,),0,1
67014,and,0,1
67015,50,0,1
67016,%,0,0
67017,on,0,0
67018,olanzapine,0,0
67019,versus,0,0
67020,20,0,1
67021,%,0,0
67022,on,0,0
67023,placebo,0,0
67024,were,0,1
67025,responders,0,0
67026,.,0,1
67027,Olanzapine,0,0
67028,was,0,0
67029,associated,0,0
67030,with,0,1
67031,significant,0,0
67032,weight,0,1
67033,gain,0,0
67034,(,0,1
67035,7.5,0,1
67036,+/-,0,1
67037,4.8,0,0
67038,lbs,0,1
67039,vs.,0,0
67040,1.5,0,1
67041,+/-,0,0
67042,1.5,0,0
67043,lbs,0,1
67044,on,0,0
67045,placebo,0,1
67046,),0,1
67047,.,0,0
67048,Olanzapine,0,0
67049,may,0,0
67050,be,0,0
67051,a,0,0
67052,promising,0,0
67053,treatment,0,0
67054,for,0,0
67055,improving,0,0
67056,global,0,0
67057,functioning,0,1
67058,of,0,0
67059,PDDs,0,1
67060,",",0,0
67061,but,0,0
67062,the,0,0
67063,risk,0,0
67064,of,0,0
67065,significant,0,0
67066,weight,0,1
67067,gain,0,0
67068,remains,0,0
67069,a,0,0
67070,concern,0,0
67071,.,0,1
67072,Additional,0,0
67073,studies,0,0
67074,are,0,0
67075,needed,0,0
67076,to,0,0
67077,determine,0,0
67078,the,0,0
67079,efficacy,0,0
67080,and,0,0
67081,safety,0,0
67082,of,0,0
67083,olanzapine,0,0
67084,in,0,0
67085,the,0,0
67086,treatment,0,0
67087,of,0,0
67088,children,0,1
67089,with,0,1
67090,PDD,0,1
67091,.,0,1
67092,Neuropsychological,0,1
67093,effects,0,0
67094,of,0,1
67095,risperidone,0,1
67096,in,0,1
67097,children,1,1
67098,with,1,1
67099,pervasive,1,1
67100,developmental,1,1
67101,disorders,1,1
67102,:,1,1
67103,a,0,1
67104,blinded,0,0
67105,discontinuation,0,0
67106,study,0,1
67107,.,0,1
67108,OBJECTIVE,0,0
67109,Little,0,0
67110,is,0,0
67111,known,0,0
67112,about,0,0
67113,the,0,0
67114,neuropsychological,0,1
67115,effects,0,0
67116,of,0,1
67117,risperidone,0,1
67118,in,0,1
67119,children,1,1
67120,with,1,1
67121,pervasive,1,1
67122,developmental,1,1
67123,disorders,1,1
67124,.,1,1
67125,METHOD,0,0
67126,Twenty-four,1,1
67127,children,1,1
67128,(,1,1
67129,aged,1,1
67130,5-17,1,1
67131,years,1,1
67132,),1,1
67133,with,1,1
67134,pervasive,1,1
67135,developmental,1,1
67136,disorders,1,1
67137,and,1,1
67138,co-morbid,1,1
67139,disruptive,1,1
67140,behavior,1,1
67141,who,1,1
67142,responded,1,1
67143,favorably,1,1
67144,to,1,0
67145,open-label,1,0
67146,treatment,1,0
67147,with,1,1
67148,risperidone,1,0
67149,as,1,0
67150,part,1,0
67151,of,1,0
67152,a,1,0
67153,previously,1,1
67154,described,1,0
67155,controlled,1,0
67156,discontinuation,1,0
67157,study,1,1
67158,completed,0,1
67159,two,0,0
67160,different,0,1
67161,computerized,0,1
67162,attention,0,0
67163,tasks,0,0
67164,at,0,1
67165,baseline,0,0
67166,",",0,1
67167,weeks,0,0
67168,4,0,0
67169,",",0,1
67170,8,0,0
67171,",",0,0
67172,and,0,0
67173,24,0,1
67174,of,0,0
67175,open-label,0,1
67176,treatment,0,0
67177,",",0,0
67178,and,0,0
67179,",",0,0
67180,at,0,1
67181,8,0,1
67182,weeks,0,1
67183,after,0,1
67184,random,0,1
67185,assignment,0,1
67186,to,0,0
67187,either,0,0
67188,placebo,0,0
67189,or,0,1
67190,risperidone,0,0
67191,.,0,1
67192,The,0,0
67193,primary,0,1
67194,efficacy,0,0
67195,measures,0,0
67196,were,0,1
67197,response,0,0
67198,latencies,0,0
67199,to,0,1
67200,visually,0,1
67201,presented,0,1
67202,stimuli,0,0
67203,requiring,0,1
67204,two,0,1
67205,different,0,1
67206,types,0,1
67207,of,0,1
67208,attention-controlled,0,1
67209,processing,0,0
67210,",",0,0
67211,i.e.,0,0
67212,",",0,0
67213,focused,0,0
67214,and,0,0
67215,divided,0,1
67216,attention,0,0
67217,.,0,0
67218,RESULTS,0,0
67219,About,0,0
67220,half,0,1
67221,of,0,0
67222,the,0,0
67223,clinical,0,0
67224,responders,0,0
67225,did,0,0
67226,not,0,0
67227,produce,0,0
67228,valid,0,0
67229,performance,0,0
67230,measures,0,0
67231,.,0,1
67232,These,0,0
67233,could,0,0
67234,be,0,0
67235,shown,0,0
67236,to,0,0
67237,be,0,0
67238,of,0,0
67239,younger,0,1
67240,mental,0,1
67241,age,0,1
67242,and,0,0
67243,less,0,0
67244,adaptive,0,0
67245,as,0,0
67246,measured,0,0
67247,by,0,0
67248,the,0,0
67249,Vineland,0,1
67250,Behavior,0,1
67251,Scales,0,0
67252,.,0,1
67253,For,0,0
67254,the,0,0
67255,valid,0,0
67256,task,0,1
67257,performers,0,1
67258,divided,0,1
67259,attention,0,0
67260,(,0,1
67261,serial,0,1
67262,search,0,1
67263,in,0,0
67264,working,0,1
67265,memory,0,1
67266,),0,1
67267,was,0,0
67268,shown,0,0
67269,to,0,0
67270,regress,0,1
67271,in,0,0
67272,the,0,0
67273,placebo,0,0
67274,group,0,0
67275,(,0,1
67276,n,0,1
67277,=,0,1
67278,7,0,1
67279,),0,1
67280,",",0,0
67281,while,0,0
67282,in,0,0
67283,the,0,0
67284,risperidone,0,0
67285,group,0,0
67286,(,0,1
67287,n,0,1
67288,=,0,1
67289,7,0,1
67290,),0,0
67291,there,0,0
67292,was,0,0
67293,further,0,0
67294,improvement,0,0
67295,.,0,1
67296,No,0,0
67297,such,0,0
67298,group,0,1
67299,difference,0,0
67300,was,0,0
67301,found,0,0
67302,for,0,0
67303,focused,0,1
67304,attention,0,0
67305,.,0,1
67306,CONCLUSIONS,0,0
67307,The,0,0
67308,study,0,0
67309,suggests,0,0
67310,a,0,0
67311,beneficial,0,0
67312,effect,0,0
67313,of,0,0
67314,risperidone,0,0
67315,after,0,1
67316,several,0,1
67317,months,0,1
67318,of,0,1
67319,treatment,0,1
67320,",",0,0
67321,enhancing,0,0
67322,divided,0,0
67323,attention,0,0
67324,in,0,0
67325,children,1,1
67326,with,1,1
67327,pervasive,1,1
67328,developmental,1,1
67329,disorders,1,1
67330,.,1,1
67331,[,0,0
67332,The,0,0
67333,effects,0,0
67334,of,0,0
67335,antidepressant,0,1
67336,treatment,0,1
67337,on,0,0
67338,efficacy,0,0
67339,of,0,0
67340,antihypertensive,0,1
67341,therapy,0,1
67342,in,0,1
67343,elderly,1,1
67344,hypertension,1,1
67345,],1,1
67346,.,0,1
67347,OBJECTIVE,0,0
67348,To,0,0
67349,explore,0,0
67350,the,0,0
67351,effect,0,0
67352,of,0,0
67353,antidepressant,0,1
67354,treatment,0,1
67355,on,0,0
67356,antihypertensive,0,1
67357,therapy,0,1
67358,of,0,0
67359,senile,1,1
67360,hypertension,1,1
67361,.,1,1
67362,METHODS,0,0
67363,138,1,1
67364,cases,1,1
67365,of,1,1
67366,senile,1,1
67367,hypertension,1,1
67368,complicating,1,1
67369,with,1,1
67370,depression,1,1
67371,were,1,1
67372,studied,1,1
67373,.,1,1
67374,103,1,1
67375,senile,1,1
67376,hypertensive,1,1
67377,patients,1,1
67378,without,1,1
67379,depression,1,1
67380,in,1,0
67381,the,1,0
67382,same,1,0
67383,period,1,0
67384,served,1,1
67385,as,1,0
67386,controls,1,1
67387,.,1,1
67388,The,0,0
67389,patients,0,1
67390,were,0,1
67391,randomly,0,1
67392,divided,0,1
67393,into,0,1
67394,3,0,1
67395,groups,0,1
67396,as,0,0
67397,A,0,1
67398,",",0,1
67399,B,0,1
67400,and,0,0
67401,C,0,0
67402,for,0,0
67403,study,0,1
67404,.,0,1
67405,12.5,0,0
67406,mg/d,0,0
67407,hydrochlorothiazide,0,0
67408,and,0,1
67409,30,0,1
67410,mg/d,0,0
67411,release-controlling,0,1
67412,tablets,0,1
67413,of,0,1
67414,nifedipine,0,1
67415,were,0,1
67416,orally,0,0
67417,administrated,0,0
67418,as,0,0
67419,basic,0,0
67420,antihypertensive,0,1
67421,medication,0,1
67422,each,0,1
67423,group,0,1
67424,.,0,1
67425,Besides,0,0
67426,",",0,0
67427,20,0,1
67428,mg/d,0,0
67429,fluoxetine,0,0
67430,was,0,0
67431,additionally,0,0
67432,given,0,0
67433,to,0,1
67434,groups,0,1
67435,A,0,1
67436,and,0,1
67437,one,0,1
67438,tablet,0,0
67439,of,0,0
67440,almitrine,0,1
67441,l/d,0,1
67442,and,0,1
67443,20,0,1
67444,mg,0,1
67445,oryzanol,0,0
67446,3/d,0,1
67447,were,0,1
67448,given,0,0
67449,to,0,0
67450,group,0,1
67451,B,0,1
67452,.,0,1
67453,The,0,0
67454,treatment,0,0
67455,lasted,0,0
67456,12,0,1
67457,weeks,0,1
67458,.,0,1
67459,RESULTS,0,0
67460,In,0,0
67461,comparison,0,0
67462,with,0,1
67463,pre-treatment,0,0
67464,",",0,0
67465,the,0,0
67466,blood,0,0
67467,pressure,0,0
67468,at,0,0
67469,base,0,0
67470,line,0,0
67471,in,0,0
67472,sitting,0,1
67473,position,0,1
67474,and,0,0
67475,the,0,0
67476,average,0,1
67477,circadian,0,0
67478,SBP,0,1
67479,and,0,1
67480,DBP,0,1
67481,monitored,0,0
67482,with,0,1
67483,24-hour,0,0
67484,ambulatory,0,1
67485,blood,0,0
67486,pressure,0,0
67487,monitoring,0,0
67488,(,0,1
67489,ABPM,0,1
67490,),0,1
67491,was,0,0
67492,remarkably,0,0
67493,decreased,0,0
67494,in,0,0
67495,group,0,1
67496,A,0,1
67497,with,0,1
67498,statistical,0,0
67499,significance,0,0
67500,(,0,1
67501,P,0,0
67502,<,0,0
67503,0.01,0,0
67504,),0,1
67505,.,0,1
67506,These,0,0
67507,blood,0,0
67508,pressure,0,0
67509,parameters,0,0
67510,in,0,1
67511,group,0,1
67512,B,0,1
67513,were,0,1
67514,also,0,0
67515,decreased,0,0
67516,as,0,0
67517,compared,0,0
67518,ith,0,1
67519,the,0,0
67520,pretreatment,0,0
67521,level,0,0
67522,brt,0,0
67523,with,0,1
67524,less,0,0
67525,statistical,0,0
67526,significance,0,0
67527,(,0,1
67528,P,0,0
67529,>,0,1
67530,0.05,0,0
67531,),0,1
67532,.,0,1
67533,It,0,0
67534,was,0,0
67535,also,0,0
67536,noted,0,0
67537,tha,0,1
67538,with,0,1
67539,the,0,0
67540,addition,0,0
67541,of,0,0
67542,antidepressant,0,1
67543,fluoxetine,0,1
67544,",",0,0
67545,the,0,0
67546,manifestations,0,0
67547,of,0,0
67548,depression,0,1
67549,ere,0,1
67550,alleviated,0,0
67551,as,0,0
67552,shown,0,0
67553,by,0,0
67554,Hamilton,0,1
67555,depression,0,1
67556,(,0,1
67557,HAMD,0,1
67558,),0,1
67559,scale,0,0
67560,.,0,1
67561,untoward,0,0
67562,reactions,0,0
67563,such,0,0
67564,as,0,0
67565,nausea,0,0
67566,",",0,0
67567,perspiration,0,0
67568,and,0,0
67569,skin,0,1
67570,rash,0,1
67571,were,0,0
67572,noted,0,0
67573,in,0,0
67574,a,0,1
67575,few,0,0
67576,patients,0,1
67577,",",0,1
67578,but,0,0
67579,none,0,0
67580,withdrew,0,0
67581,from,0,1
67582,the,0,0
67583,study,0,1
67584,.,0,1
67585,CONCLUSIONS,0,0
67586,Antidepressant,0,0
67587,and,0,1
67588,antianxiety,0,0
67589,treatment,0,0
67590,is,0,0
67591,of,0,0
67592,benefit,0,0
67593,to,0,1
67594,the,0,0
67595,antihypertensive,0,0
67596,therapy,0,0
67597,in,0,1
67598,senile,0,1
67599,hypertensive,0,1
67600,patients,0,1
67601,with,0,1
67602,complications,0,1
67603,of,0,1
67604,depression,0,1
67605,and/or,0,1
67606,anxiety,0,1
67607,neurosis,0,1
67608,.,0,1
67609,Based,0,0
67610,on,0,0
67611,the,0,0
67612,results,0,0
67613,of,0,0
67614,this,0,0
67615,study,0,0
67616,",",0,0
67617,it,0,0
67618,is,0,0
67619,suggested,0,0
67620,that,0,0
67621,routine,0,1
67622,administration,0,0
67623,of,0,1
67624,antidepressants,0,0
67625,and,0,1
67626,antianxiety,0,1
67627,drugs,0,0
67628,should,0,0
67629,be,0,0
67630,carried,0,0
67631,out,0,1
67632,in,0,0
67633,senile,1,1
67634,hypertensive,1,1
67635,patients,1,1
67636,complicating,0,1
67637,with,0,1
67638,depression,0,1
67639,or,0,1
67640,anxiety,0,1
67641,.,0,1
67642,A,0,0
67643,randomized,0,0
67644,controlled,0,0
67645,trial,0,1
67646,of,0,0
67647,a,0,1
67648,cognitive,0,0
67649,behavioural,0,0
67650,intervention,0,1
67651,for,0,0
67652,anger,0,0
67653,management,0,1
67654,in,0,1
67655,children,1,1
67656,diagnosed,1,1
67657,with,1,1
67658,Asperger,1,1
67659,syndrome,1,1
67660,.,1,1
67661,The,0,0
67662,purpose,0,0
67663,of,0,0
67664,the,0,0
67665,study,0,0
67666,described,0,0
67667,was,0,0
67668,to,0,0
67669,evaluate,0,0
67670,the,0,0
67671,effectiveness,0,0
67672,of,0,0
67673,a,0,1
67674,cognitive,0,0
67675,behavioural,0,0
67676,intervention,0,1
67677,for,0,0
67678,anger,0,0
67679,management,0,1
67680,with,0,1
67681,children,1,1
67682,diagnosed,1,1
67683,with,1,1
67684,Asperger,1,1
67685,syndrome,1,1
67686,.,1,1
67687,Forty-five,1,1
67688,children,1,1
67689,and,1,1
67690,their,1,1
67691,parents,1,1
67692,were,0,1
67693,randomly,0,1
67694,assigned,0,1
67695,to,0,0
67696,either,0,0
67697,intervention,0,0
67698,or,0,1
67699,wait-list,0,0
67700,control,0,1
67701,conditions,0,1
67702,.,0,1
67703,Children,0,1
67704,in,0,0
67705,the,0,0
67706,intervention,0,0
67707,participated,0,1
67708,in,0,0
67709,six,0,1
67710,2-h,0,0
67711,weekly,0,1
67712,sessions,0,0
67713,while,0,1
67714,parents,0,1
67715,participated,0,1
67716,in,0,0
67717,a,0,0
67718,larger,0,0
67719,parent,0,1
67720,group,0,0
67721,.,0,1
67722,Parent,0,1
67723,reports,0,0
67724,indicated,0,0
67725,a,0,1
67726,significant,0,0
67727,decrease,0,0
67728,in,0,1
67729,episodes,0,1
67730,of,0,1
67731,anger,0,1
67732,following,0,0
67733,intervention,0,0
67734,and,0,0
67735,a,0,0
67736,significant,0,0
67737,increase,0,0
67738,in,0,0
67739,their,0,1
67740,own,0,1
67741,confidence,0,0
67742,in,0,0
67743,managing,0,0
67744,anger,0,0
67745,in,0,0
67746,their,0,1
67747,child,0,1
67748,.,0,1
67749,Qualitative,0,0
67750,information,0,0
67751,gathered,0,1
67752,from,0,1
67753,parents,0,1
67754,and,0,1
67755,teachers,0,1
67756,indicated,0,0
67757,some,0,0
67758,generalization,0,1
67759,of,0,0
67760,strategies,0,0
67761,learned,0,1
67762,in,0,1
67763,the,0,0
67764,clinic,0,1
67765,setting,0,1
67766,to,0,0
67767,both,0,0
67768,home,0,1
67769,and,0,0
67770,school,0,1
67771,settings,0,1
67772,.,0,1
67773,Limitations,0,0
67774,of,0,0
67775,the,0,0
67776,study,0,1
67777,and,0,0
67778,suggestions,0,0
67779,for,0,1
67780,future,0,0
67781,research,0,1
67782,are,0,0
67783,also,0,0
67784,discussed,0,0
67785,.,0,1
67786,Predictors,0,0
67787,of,0,1
67788,mental,0,1
67789,health,0,1
67790,problems,0,1
67791,and,0,1
67792,negative,0,1
67793,caregiving,0,1
67794,experiences,0,1
67795,in,0,1
67796,carers,1,1
67797,of,1,1
67798,adolescents,1,1
67799,with,1,1
67800,bulimia,1,1
67801,nervosa,1,1
67802,.,1,1
67803,OBJECTIVE,0,0
67804,This,0,0
67805,exploratory,0,0
67806,study,0,0
67807,focuses,0,0
67808,on,0,0
67809,the,0,0
67810,mental,0,1
67811,health,0,1
67812,(,0,1
67813,MH,0,1
67814,),0,1
67815,and,0,0
67816,caregiving,0,0
67817,experience,0,1
67818,of,0,1
67819,carers,0,1
67820,of,0,1
67821,adolescents,1,1
67822,with,1,1
67823,Bulimia,1,1
67824,Nervosa,1,1
67825,(,1,1
67826,BN,1,1
67827,),1,1
67828,/Eating,1,0
67829,Disorder,1,1
67830,not,1,0
67831,otherwise,1,1
67832,specified,1,0
67833,(,1,0
67834,EDNOS,1,1
67835,),1,1
67836,",",0,0
67837,aiming,0,0
67838,to,0,0
67839,determine,0,0
67840,:,0,1
67841,levels,0,0
67842,of,0,1
67843,MH,0,1
67844,problems,0,1
67845,in,0,1
67846,carers,0,1
67847,and,0,1
67848,if,0,0
67849,a,0,1
67850,negative,0,0
67851,experience,0,1
67852,of,0,1
67853,caregiving,0,0
67854,predicts,0,0
67855,carer,0,1
67856,MH,0,1
67857,status,0,1
67858,and,0,1
67859,which,0,0
67860,factors,0,0
67861,predict,0,0
67862,a,0,0
67863,negative,0,0
67864,experience,0,1
67865,of,0,0
67866,caregiving,0,1
67867,.,0,1
67868,METHOD,0,0
67869,Hundred,1,1
67870,and,1,1
67871,twelve,1,1
67872,carers,1,1
67873,and,1,1
67874,68,1,1
67875,adolescents,1,1
67876,with,1,1
67877,BN/EDNOS,1,1
67878,completed,1,1
67879,self-report,1,1
67880,measures,1,0
67881,(,1,1
67882,General,1,1
67883,Health,1,0
67884,Questionnaire,1,0
67885,",",1,0
67886,Experience,1,0
67887,of,1,0
67888,Caregiving,1,0
67889,Inventory,1,1
67890,",",1,0
67891,Level,1,0
67892,of,1,0
67893,Expressed,1,1
67894,Emotion,1,0
67895,",",1,1
67896,Self-report,1,0
67897,Family,1,1
67898,Inventory,1,1
67899,",",1,0
67900,Inventory,1,1
67901,of,1,0
67902,Interpersonal,1,1
67903,Problems,1,1
67904,),1,1
67905,.,0,1
67906,RESULTS,0,0
67907,Over,0,0
67908,half,0,1
67909,of,0,0
67910,the,0,0
67911,carers,0,1
67912,reported,0,0
67913,some,0,1
67914,MH,0,1
67915,problems,0,1
67916,and,0,1
67917,a,0,1
67918,minority,0,1
67919,(,0,0
67920,5.4,0,0
67921,%,0,0
67922,),0,1
67923,were,0,1
67924,experiencing,0,1
67925,considerable,0,0
67926,difficulties,0,1
67927,.,0,1
67928,A,0,0
67929,negative,0,0
67930,experience,0,1
67931,of,0,0
67932,caregiving,0,0
67933,predicted,0,0
67934,carer,0,1
67935,MH,0,1
67936,status,0,1
67937,.,0,1
67938,Higher,0,0
67939,weekly,0,0
67940,contact,0,0
67941,hours,0,0
67942,and,0,1
67943,patient,0,1
67944,ratings,0,0
67945,of,0,1
67946,expressed,0,1
67947,emotion,0,0
67948,(,0,1
67949,EE,0,1
67950,),0,1
67951,predicted,0,0
67952,a,0,0
67953,negative,0,0
67954,experience,0,1
67955,of,0,0
67956,caregiving,0,1
67957,.,0,1
67958,CONCLUSIONS,0,0
67959,Interventions,0,0
67960,focusing,0,1
67961,on,0,1
67962,reducing,0,0
67963,EE,0,1
67964,and,0,1
67965,contact,0,0
67966,hours,0,0
67967,could,0,0
67968,prove,0,0
67969,beneficial,0,0
67970,for,0,0
67971,both,0,0
67972,patient,1,1
67973,and,0,0
67974,caregiver,1,1
67975,outcomes,0,0
67976,.,0,1
67977,Topical,0,1
67978,retapamulin,0,1
67979,ointment,0,1
67980,(,0,1
67981,1,0,0
67982,%,0,0
67983,",",0,0
67984,wt/wt,0,0
67985,),0,0
67986,twice,0,0
67987,daily,0,0
67988,for,0,0
67989,5,0,0
67990,days,0,0
67991,versus,0,0
67992,oral,0,1
67993,cephalexin,0,0
67994,twice,0,0
67995,daily,0,0
67996,for,0,0
67997,10,0,1
67998,days,0,0
67999,in,0,1
68000,the,0,0
68001,treatment,0,0
68002,of,0,0
68003,secondarily,1,1
68004,infected,1,1
68005,dermatitis,1,1
68006,:,1,1
68007,results,0,0
68008,of,0,0
68009,a,0,1
68010,randomized,0,1
68011,controlled,0,0
68012,trial,0,1
68013,.,0,1
68014,BACKGROUND,0,0
68015,New,0,1
68016,antibacterial,0,0
68017,agents,0,1
68018,with,0,1
68019,activity,0,0
68020,against,0,1
68021,pathogenic,0,0
68022,strains,0,1
68023,resistant,0,1
68024,to,0,1
68025,established,0,0
68026,antibiotics,0,0
68027,are,0,0
68028,needed,0,0
68029,to,0,0
68030,treat,0,1
68031,patients,1,1
68032,with,1,1
68033,secondarily,1,1
68034,infected,1,1
68035,dermatitis,1,1
68036,(,1,1
68037,SID,1,1
68038,),1,1
68039,.,1,1
68040,OBJECTIVE,0,0
68041,We,0,0
68042,sought,0,0
68043,to,0,0
68044,determine,0,0
68045,the,0,0
68046,clinical,0,0
68047,safety,0,0
68048,and,0,0
68049,efficacy,0,0
68050,of,0,0
68051,topical,0,0
68052,retapamulin,0,1
68053,ointment,0,1
68054,1,0,0
68055,%,0,0
68056,versus,0,0
68057,oral,0,0
68058,cephalexin,0,0
68059,for,0,0
68060,the,0,0
68061,treatment,0,0
68062,of,0,0
68063,SID,0,1
68064,.,0,1
68065,METHODS,0,0
68066,Patients,1,1
68067,with,1,1
68068,SID,1,1
68069,were,0,1
68070,randomly,0,1
68071,assigned,0,1
68072,to,0,0
68073,retapamulin,0,1
68074,ointment,0,0
68075,1,0,1
68076,%,0,0
68077,(,0,1
68078,twice,0,0
68079,daily,0,0
68080,[,0,0
68081,bid,0,0
68082,],0,1
68083,),0,1
68084,for,0,1
68085,5,0,1
68086,days,0,0
68087,",",0,1
68088,or,0,1
68089,oral,0,0
68090,cephalexin,0,0
68091,(,0,1
68092,500,0,1
68093,mg,0,1
68094,bid,0,0
68095,),0,1
68096,for,0,1
68097,10,0,1
68098,days,0,0
68099,.,0,1
68100,The,0,0
68101,primary,0,1
68102,efficacy,0,0
68103,end,0,0
68104,point,0,0
68105,was,0,0
68106,clinical,0,0
68107,response,0,0
68108,at,0,1
68109,follow-up,0,0
68110,.,0,1
68111,Secondary,0,0
68112,outcomes,0,0
68113,included,0,1
68114,microbiologic,0,0
68115,response,0,0
68116,at,0,0
68117,follow-up,0,0
68118,",",0,0
68119,safety,0,0
68120,",",0,0
68121,and,0,0
68122,compliance,0,0
68123,.,0,1
68124,RESULTS,0,0
68125,Retapamulin,0,0
68126,was,0,0
68127,as,0,0
68128,effective,0,0
68129,as,0,0
68130,cephalexin,0,0
68131,(,0,1
68132,clinical,0,0
68133,success,0,0
68134,rates,0,0
68135,at,0,1
68136,follow-up,0,1
68137,:,0,1
68138,85.9,0,0
68139,%,0,0
68140,and,0,1
68141,89.7,0,0
68142,%,0,0
68143,",",0,0
68144,respectively,0,0
68145,),0,1
68146,.,0,1
68147,Microbiologic,0,0
68148,success,0,0
68149,rates,0,0
68150,at,0,1
68151,follow-up,0,1
68152,were,0,1
68153,87.2,0,0
68154,%,0,0
68155,for,0,0
68156,retapamulin,0,1
68157,and,0,1
68158,91.8,0,0
68159,%,0,0
68160,for,0,1
68161,cephalexin,0,0
68162,.,0,1
68163,Retapamulin,0,0
68164,was,0,0
68165,well,0,0
68166,tolerated,0,0
68167,and,0,0
68168,the,0,0
68169,topical,0,0
68170,formulation,0,0
68171,was,0,0
68172,preferred,0,0
68173,over,0,0
68174,the,0,0
68175,oral,0,0
68176,drug,0,0
68177,.,0,1
68178,LIMITATIONS,0,0
68179,An,0,0
68180,imbalance,0,0
68181,existed,0,0
68182,in,0,0
68183,the,0,0
68184,number,0,0
68185,of,0,0
68186,patients,0,1
68187,with,0,1
68188,the,0,1
68189,clinical,0,0
68190,outcome,0,0
68191,unable,0,0
68192,to,0,0
68193,determine,0,0
68194,(,0,1
68195,15,0,1
68196,retapamulin,0,1
68197,",",0,1
68198,2,0,1
68199,cephalexin,0,0
68200,),0,0
68201,",",0,0
68202,mainly,0,0
68203,because,0,0
68204,of,0,0
68205,their,0,1
68206,failure,0,1
68207,to,0,0
68208,attend,0,1
68209,the,0,0
68210,study,0,0
68211,visit,0,0
68212,.,0,1
68213,If,0,0
68214,those,0,1
68215,who,0,1
68216,failed,0,1
68217,to,0,1
68218,attend,0,1
68219,visits,0,1
68220,(,0,1
68221,who,0,1
68222,did,0,1
68223,not,0,1
68224,withdraw,0,0
68225,as,0,0
68226,a,0,0
68227,result,0,0
68228,of,0,0
68229,drug-related,0,1
68230,events,0,0
68231,),0,1
68232,are,0,0
68233,removed,0,0
68234,from,0,1
68235,the,0,0
68236,analysis,0,0
68237,",",0,0
68238,the,0,0
68239,clinical,0,0
68240,success,0,0
68241,rates,0,0
68242,are,0,0
68243,89.9,0,0
68244,%,0,0
68245,for,0,0
68246,retapamulin,0,1
68247,and,0,1
68248,89.7,0,0
68249,%,0,0
68250,for,0,1
68251,cephalexin,0,0
68252,.,0,1
68253,CONCLUSIONS,0,0
68254,Retapamulin,0,0
68255,ointment,0,1
68256,1,0,1
68257,%,0,0
68258,(,0,1
68259,bid,0,0
68260,),0,1
68261,for,0,1
68262,5,0,1
68263,days,0,0
68264,was,0,0
68265,as,0,0
68266,effective,0,0
68267,as,0,0
68268,oral,0,1
68269,cephalexin,0,0
68270,(,0,1
68271,bid,0,0
68272,),0,1
68273,for,0,1
68274,10,0,1
68275,days,0,0
68276,in,0,1
68277,treatment,0,1
68278,of,0,1
68279,patients,1,1
68280,with,1,1
68281,SID,1,1
68282,",",0,1
68283,and,0,0
68284,was,0,0
68285,well,0,0
68286,tolerated,0,0
68287,.,0,1
68288,Parent,0,1
68289,satisfaction,0,0
68290,in,0,0
68291,a,0,1
68292,multi-site,0,1
68293,acute,0,1
68294,trial,0,1
68295,of,0,0
68296,risperidone,0,0
68297,in,0,1
68298,children,0,1
68299,with,0,1
68300,autism,0,1
68301,:,0,1
68302,a,0,0
68303,social,0,0
68304,validity,0,0
68305,study,0,1
68306,.,0,1
68307,RATIONALE,0,0
68308,Subjects,0,1
68309,who,0,1
68310,view,0,1
68311,experimental,0,1
68312,procedures,0,1
68313,as,0,0
68314,worthwhile,0,0
68315,are,0,0
68316,more,0,0
68317,likely,0,0
68318,to,0,0
68319,participate,0,1
68320,in,0,0
68321,clinical,0,0
68322,trials,0,1
68323,and,0,1
68324,comply,0,1
68325,with,0,1
68326,study,0,1
68327,procedures,0,1
68328,.,0,1
68329,Designing,0,0
68330,studies,0,0
68331,that,0,0
68332,consider,0,0
68333,the,0,0
68334,consumer,0,0
68335,'s,0,1
68336,perspective,0,0
68337,will,0,0
68338,help,0,0
68339,to,0,0
68340,forge,0,0
68341,a,0,0
68342,better,0,0
68343,alliance,0,0
68344,between,0,0
68345,participants,0,1
68346,and,0,1
68347,researchers,0,1
68348,.,0,1
68349,OBJECTIVE,0,0
68350,Participant,0,1
68351,satisfaction,0,0
68352,is,0,0
68353,seldom,0,0
68354,assessed,0,0
68355,in,0,0
68356,pharmacological,0,0
68357,research,0,1
68358,.,0,1
68359,In,0,0
68360,this,0,0
68361,paper,0,0
68362,",",0,0
68363,we,0,0
68364,report,0,0
68365,on,0,0
68366,parent,0,1
68367,satisfaction,0,0
68368,in,0,0
68369,a,0,1
68370,randomized,0,1
68371,clinical,0,0
68372,trial,0,1
68373,in,0,1
68374,children,1,1
68375,with,1,1
68376,autistic,1,1
68377,disorder,1,1
68378,and,1,0
68379,severely,1,1
68380,disruptive,1,1
68381,behavior,1,0
68382,.,1,1
68383,METHOD,0,0
68384,Parents,1,1
68385,of,1,1
68386,101,1,1
68387,children,1,1
68388,with,1,1
68389,autism,1,1
68390,who,1,1
68391,had,1,1
68392,participated,1,1
68393,in,1,0
68394,a,1,1
68395,multi-site,1,1
68396,8-week,1,0
68397,double-blind,1,1
68398,clinical,1,0
68399,trial,1,1
68400,of,1,0
68401,risperidone,1,0
68402,were,1,1
68403,given,1,0
68404,a,1,0
68405,questionnaire,1,0
68406,at,1,0
68407,the,1,0
68408,end,1,0
68409,to,1,0
68410,elicit,1,0
68411,their,1,1
68412,perceptions,1,0
68413,of,1,0
68414,the,1,0
68415,appropriateness,1,0
68416,and,1,0
68417,acceptability,1,0
68418,of,1,0
68419,clinical,1,0
68420,trial,1,1
68421,procedures,1,1
68422,.,1,1
68423,RESULTS,0,0
68424,Ninety-six,1,1
68425,(,1,1
68426,95.0,1,0
68427,%,1,0
68428,),1,1
68429,parents,1,1
68430,returned,1,1
68431,the,1,0
68432,questionnaire,1,0
68433,.,1,0
68434,Of,0,0
68435,these,0,0
68436,",",0,0
68437,80.0,0,0
68438,to,0,1
68439,96.8,0,1
68440,%,0,0
68441,",",0,0
68442,depending,0,0
68443,on,0,0
68444,the,0,0
68445,question,0,0
68446,",",0,0
68447,expressed,0,0
68448,satisfaction,0,0
68449,with,0,1
68450,their,0,1
68451,child,0,1
68452,'s,0,1
68453,research,0,1
68454,participation,0,1
68455,regardless,0,0
68456,of,0,0
68457,treatment,0,0
68458,outcome,0,0
68459,or,0,1
68460,assignment,0,0
68461,to,0,1
68462,active,0,1
68463,drug,0,0
68464,or,0,1
68465,placebo,0,0
68466,.,0,1
68467,In,0,0
68468,all,0,0
68469,",",0,0
68470,90.5,0,0
68471,%,0,0
68472,of,0,1
68473,parents,0,1
68474,indicated,0,0
68475,that,0,0
68476,they,0,0
68477,would,0,0
68478,definitely,0,0
68479,recommend,0,0
68480,the,0,0
68481,clinical,0,0
68482,trial,0,0
68483,to,0,1
68484,other,0,1
68485,families,0,1
68486,with,0,1
68487,similar,0,0
68488,children,0,1
68489,.,0,1
68490,A,0,0
68491,total,0,1
68492,of,0,0
68493,92.7,0,1
68494,%,0,0
68495,indicated,0,0
68496,that,0,0
68497,they,0,0
68498,would,0,0
68499,rejoin,0,0
68500,the,0,0
68501,clinical,0,0
68502,trial,0,0
68503,if,0,0
68504,they,0,0
68505,had,0,1
68506,to,0,0
68507,do,0,0
68508,it,0,0
68509,all,0,0
68510,over,0,0
68511,again,0,0
68512,.,0,0
68513,Ethnic,0,0
68514,minority,0,1
68515,subjects,0,1
68516,were,0,0
68517,more,0,0
68518,satisfied,0,0
68519,than,0,0
68520,white,0,1
68521,participants,0,1
68522,with,0,1
68523,the,0,0
68524,use,0,0
68525,of,0,0
68526,learning,0,0
68527,tests,0,0
68528,.,0,1
68529,CONCLUSIONS,0,0
68530,Parents,0,1
68531,of,0,1
68532,children,0,1
68533,participating,0,1
68534,in,0,0
68535,this,0,0
68536,trial,0,0
68537,were,0,0
68538,highly,0,0
68539,satisfied,0,1
68540,and,0,0
68541,supportive,0,0
68542,of,0,0
68543,the,0,0
68544,clinical,0,0
68545,trial,0,1
68546,procedures,0,1
68547,.,0,1
68548,Random,0,1
68549,assignment,0,0
68550,to,0,1
68551,drug,0,0
68552,or,0,1
68553,placebo,0,0
68554,and,0,0
68555,the,0,0
68556,clinical,0,0
68557,response,0,0
68558,of,0,1
68559,their,0,1
68560,children,0,1
68561,did,0,0
68562,not,0,0
68563,appear,0,0
68564,to,0,0
68565,influence,0,0
68566,their,0,1
68567,views,0,0
68568,.,0,1
68569,Further,0,0
68570,satisfaction,0,0
68571,studies,0,0
68572,of,0,0
68573,this,0,0
68574,sort,0,0
68575,are,0,0
68576,encouraged,0,0
68577,.,0,1
68578,A,0,0
68579,double-blind,0,0
68580,placebo-controlled,0,0
68581,trial,0,1
68582,of,0,0
68583,zonisamide,0,1
68584,(,0,1
68585,zonegran,0,1
68586,),0,1
68587,in,0,0
68588,the,0,0
68589,treatment,0,0
68590,of,0,0
68591,essential,0,1
68592,tremor,0,1
68593,.,0,1
68594,Medical,0,0
68595,therapy,0,0
68596,for,0,0
68597,essential,1,1
68598,tremor,1,1
68599,(,1,1
68600,ET,1,0
68601,),1,1
68602,",",0,0
68603,a,0,0
68604,common,0,0
68605,movement,0,0
68606,disorder,0,1
68607,",",0,0
68608,is,0,0
68609,often,0,0
68610,inadequate,0,1
68611,.,0,1
68612,We,0,0
68613,performed,0,0
68614,a,0,0
68615,double-blind,0,0
68616,placebo-controlled,0,0
68617,randomized,0,1
68618,trial,0,0
68619,to,0,0
68620,evaluate,0,0
68621,the,0,0
68622,efficacy,0,0
68623,and,0,0
68624,tolerability,0,0
68625,of,0,0
68626,zonisamide,0,1
68627,(,0,1
68628,ZNS,0,0
68629,),0,1
68630,",",0,0
68631,an,0,0
68632,antiepileptic,0,0
68633,agent,0,0
68634,",",0,0
68635,in,0,0
68636,treating,0,0
68637,ET,0,1
68638,.,0,1
68639,Twenty,1,1
68640,patients,1,1
68641,(,1,1
68642,mean,1,1
68643,age,1,1
68644,",",1,1
68645,60,1,1
68646,+/-,1,1
68647,15,1,1
68648,years,1,1
68649,),1,1
68650,with,1,1
68651,ET,1,0
68652,were,0,1
68653,randomized,0,1
68654,to,0,0
68655,receive,0,1
68656,ZNS,0,0
68657,or,0,1
68658,placebo,0,0
68659,.,0,1
68660,ZNS,0,0
68661,was,0,0
68662,initiated,0,0
68663,at,0,0
68664,a,0,0
68665,dosage,0,0
68666,of,0,0
68667,100,0,1
68668,mg/day,0,0
68669,and,0,1
68670,escalated,0,0
68671,to,0,1
68672,200,0,1
68673,mg/day,0,0
68674,at,0,1
68675,day,0,1
68676,14,0,1
68677,.,0,1
68678,Patients,0,1
68679,were,0,0
68680,evaluated,0,0
68681,by,0,0
68682,accelerometry,0,0
68683,and,0,0
68684,the,0,0
68685,Fahn-Tolosa-Marin,0,0
68686,(,0,1
68687,FTM,0,0
68688,),0,1
68689,rating,0,0
68690,scale,0,0
68691,at,0,0
68692,baseline,0,0
68693,and,0,1
68694,days,0,0
68695,14,0,1
68696,and,0,1
68697,28,0,1
68698,",",0,0
68699,as,0,0
68700,well,0,0
68701,as,0,0
68702,the,0,0
68703,Clinical,0,0
68704,Global,0,1
68705,Impression,0,0
68706,(,0,1
68707,CGI-C,0,0
68708,),0,1
68709,scale,0,0
68710,at,0,1
68711,day,0,0
68712,28,0,1
68713,.,0,1
68714,At,0,0
68715,endpoint,0,0
68716,",",0,1
68717,subjects,0,1
68718,assigned,0,1
68719,to,0,1
68720,ZNS,0,0
68721,were,0,1
68722,taking,0,1
68723,a,0,0
68724,mean,0,1
68725,dosage,0,0
68726,of,0,1
68727,160,0,1
68728,+/-,0,1
68729,50,0,1
68730,mg/day,0,0
68731,.,0,0
68732,There,0,0
68733,were,0,0
68734,no,0,0
68735,significant,0,0
68736,improvements,0,0
68737,in,0,1
68738,the,0,1
68739,FTM,0,0
68740,total,0,1
68741,score,0,0
68742,or,0,1
68743,its,0,0
68744,subsections,0,1
68745,.,0,1
68746,Tremor,0,0
68747,amplitude,0,0
68748,as,0,0
68749,assessed,0,0
68750,by,0,0
68751,accelerometry,0,0
68752,significantly,0,0
68753,improved,0,0
68754,in,0,0
68755,the,0,0
68756,ZNS,0,0
68757,group,0,1
68758,compared,0,0
68759,to,0,0
68760,the,0,0
68761,placebo,0,0
68762,group,0,0
68763,at,0,0
68764,endpoint,0,0
68765,relative,0,0
68766,to,0,0
68767,baseline,0,0
68768,(,0,1
68769,-0.50,0,0
68770,+/-,0,0
68771,0.72,0,0
68772,vs.,0,0
68773,0.30,0,0
68774,+/-,0,0
68775,0.79,0,0
68776,m/s,0,1
68777,(,0,1
68778,2,0,1
68779,),0,1
68780,;,0,1
68781,P,0,0
68782,=,0,1
68783,0.03,0,0
68784,),0,1
68785,.,0,1
68786,On,0,0
68787,the,0,0
68788,CGI-C,0,0
68789,",",0,0
68790,60,0,1
68791,%,0,0
68792,(,0,1
68793,n,0,1
68794,=,0,1
68795,6,0,1
68796,),0,1
68797,of,0,1
68798,patients,0,1
68799,in,0,1
68800,the,0,1
68801,ZNS,0,0
68802,group,0,0
68803,felt,0,1
68804,that,0,0
68805,their,0,1
68806,tremor,0,1
68807,was,0,0
68808,unchanged,0,0
68809,",",0,0
68810,while,0,0
68811,the,0,0
68812,remaining,0,1
68813,patients,0,1
68814,felt,0,1
68815,that,0,0
68816,their,0,1
68817,tremor,0,1
68818,was,0,0
68819,minimally,0,1
68820,improved,0,0
68821,.,0,1
68822,Thirty,0,1
68823,percent,0,1
68824,(,0,1
68825,n,0,1
68826,=,0,1
68827,3,0,1
68828,),0,1
68829,of,0,1
68830,patients,0,1
68831,taking,0,1
68832,ZNS,0,0
68833,discontinued,0,0
68834,the,0,0
68835,study,0,0
68836,due,0,0
68837,to,0,1
68838,side,0,0
68839,effects,0,0
68840,(,0,1
68841,fatigue,0,0
68842,",",0,0
68843,headache,0,0
68844,",",0,0
68845,paresthesias,0,0
68846,),0,1
68847,while,0,0
68848,taking,0,1
68849,100,0,1
68850,mg,0,1
68851,per,0,1
68852,day,0,0
68853,.,0,1
68854,ZNS,0,0
68855,did,0,0
68856,not,0,0
68857,provide,0,0
68858,significant,0,0
68859,improvements,0,0
68860,in,0,1
68861,clinical,0,1
68862,rating,0,0
68863,scales,0,0
68864,at,0,1
68865,study,0,1
68866,endpoint,0,0
68867,compared,0,0
68868,to,0,0
68869,placebo,0,0
68870,and,0,0
68871,was,0,0
68872,only,0,0
68873,modestly,0,0
68874,well,0,0
68875,tolerated,0,0
68876,.,0,1
68877,ZNS,0,0
68878,was,0,0
68879,effective,0,0
68880,in,0,0
68881,reducing,0,0
68882,tremor,0,1
68883,amplitude,0,0
68884,as,0,0
68885,measured,0,0
68886,by,0,0
68887,accelerometry,0,1
68888,.,0,1
68889,Cognitive-behavioural,0,1
68890,stress,0,0
68891,management,0,1
68892,with,0,1
68893,HIV-positive,1,1
68894,homosexual,1,1
68895,men,1,1
68896,:,1,1
68897,mechanisms,0,0
68898,of,0,1
68899,sustained,0,1
68900,reductions,0,0
68901,in,0,1
68902,depressive,0,1
68903,symptoms,0,1
68904,.,0,1
68905,BACKGROUND,0,0
68906,We,0,0
68907,examined,0,0
68908,the,0,0
68909,sustained,0,0
68910,efficacy,0,0
68911,of,0,0
68912,a,0,1
68913,group-based,0,0
68914,cognitive-behavioural,0,1
68915,stress,0,1
68916,management,0,1
68917,(,0,1
68918,CBSM,0,1
68919,),0,1
68920,intervention,0,0
68921,in,0,0
68922,comparison,0,0
68923,to,0,1
68924,a,0,0
68925,modified,0,0
68926,wait-list,0,0
68927,control,0,1
68928,condition,0,0
68929,on,0,0
68930,measures,0,0
68931,of,0,1
68932,mood,0,0
68933,",",0,0
68934,coping,0,0
68935,and,0,0
68936,social,0,0
68937,support,0,0
68938,in,0,0
68939,mildly,1,1
68940,symptomatic,1,1
68941,HIV-positive,1,1
68942,homosexual,1,1
68943,and,1,1
68944,bisexual,1,1
68945,men,1,1
68946,.,1,1
68947,Participants,1,1
68948,were,1,0
68949,recruited,1,1
68950,largely,1,0
68951,during,1,0
68952,the,1,0
68953,era,1,0
68954,prior,1,1
68955,to,1,0
68956,highly,1,0
68957,active,1,1
68958,antiretroviral,1,1
68959,therapy,1,1
68960,(,1,1
68961,HAART,1,1
68962,;,1,1
68963,1992-1997,1,1
68964,),1,1
68965,.,1,1
68966,METHODS,0,0
68967,Men,1,1
68968,were,0,1
68969,randomized,0,1
68970,to,0,0
68971,either,0,0
68972,a,0,0
68973,10-week,0,0
68974,",",0,0
68975,group-based,0,1
68976,CBSM,0,1
68977,intervention,0,1
68978,(,0,1
68979,n,0,1
68980,=,0,1
68981,83,0,1
68982,),0,1
68983,or,0,1
68984,a,1,1
68985,psychoeducational,1,0
68986,seminar,1,0
68987,group,1,1
68988,(,1,1
68989,n,1,1
68990,=,1,1
68991,46,1,1
68992,),1,1
68993,.,1,1
68994,All,0,1
68995,participants,0,1
68996,completed,0,1
68997,a,0,1
68998,battery,0,1
68999,of,0,0
69000,psychosocial,0,1
69001,questionnaires,0,0
69002,administered,0,0
69003,by,0,0
69004,a,0,0
69005,research,0,0
69006,assistant,0,0
69007,at,0,0
69008,baseline,0,0
69009,",",0,0
69010,immediately,0,0
69011,following,0,0
69012,the,0,0
69013,10-week,0,1
69014,CBSM,0,1
69015,intervention,0,0
69016,period,0,0
69017,",",0,0
69018,and,0,0
69019,at,0,0
69020,a,0,1
69021,6-month,0,0
69022,follow-up,0,0
69023,.,0,1
69024,RESULTS,0,0
69025,Men,1,1
69026,in,1,0
69027,the,1,0
69028,CBSM,1,1
69029,group,1,0
69030,maintained,0,0
69031,previously,0,1
69032,observed,0,0
69033,effects,0,0
69034,on,0,1
69035,depressive,0,1
69036,symptoms,0,1
69037,and,0,1
69038,perceived,0,0
69039,social,0,0
69040,support,0,0
69041,.,0,1
69042,These,0,0
69043,sustained,0,0
69044,effects,0,0
69045,of,0,1
69046,CBSM,0,1
69047,on,0,1
69048,depressive,0,1
69049,symptoms,0,1
69050,were,0,1
69051,mediated,0,0
69052,by,0,0
69053,10-week,0,1
69054,increases,0,0
69055,in,0,1
69056,cognitive,0,1
69057,coping,0,0
69058,(,0,1
69059,i.e,0,1
69060,.,0,1
69061,positive,0,0
69062,reframing,0,0
69063,),0,1
69064,.,0,1
69065,DISCUSSION,0,0
69066,CBSM,0,0
69067,appears,0,0
69068,to,0,0
69069,be,0,0
69070,a,0,0
69071,potentially,0,0
69072,efficacious,0,0
69073,treatment,0,0
69074,that,0,0
69075,reduces,0,0
69076,and,0,0
69077,maintains,0,0
69078,lower,0,1
69079,levels,0,0
69080,of,0,0
69081,depressive,0,1
69082,symptoms,0,0
69083,and,0,0
69084,enhances,0,0
69085,social,0,0
69086,support,0,0
69087,in,0,1
69088,HIV-positive,1,1
69089,homosexual,1,1
69090,and,1,1
69091,bisexual,1,1
69092,men,1,1
69093,.,1,1
69094,In,0,0
69095,particular,0,0
69096,",",0,1
69097,changes,0,0
69098,in,0,1
69099,positive,0,1
69100,reframing,0,0
69101,during,0,0
69102,the,0,0
69103,10-week,0,1
69104,intervention,0,0
69105,period,0,0
69106,remain,0,0
69107,a,0,0
69108,crucial,0,0
69109,factor,0,0
69110,contributing,0,0
69111,to,0,1
69112,sustained,0,1
69113,reductions,0,0
69114,in,0,1
69115,depressive,0,1
69116,symptoms,0,1
69117,.,0,1
69118,Continuous,0,1
69119,pralidoxime,0,0
69120,infusion,0,0
69121,versus,0,0
69122,repeated,0,0
69123,bolus,0,0
69124,injection,0,0
69125,to,0,0
69126,treat,0,1
69127,organophosphorus,1,1
69128,pesticide,1,1
69129,poisoning,1,1
69130,:,1,1
69131,a,0,1
69132,randomised,0,0
69133,controlled,0,0
69134,trial,0,1
69135,.,0,1
69136,BACKGROUND,0,0
69137,The,0,0
69138,role,0,0
69139,of,0,0
69140,oximes,0,0
69141,for,0,1
69142,the,0,0
69143,treatment,0,0
69144,of,0,0
69145,organophosphorus,1,1
69146,pesticide,1,1
69147,poisoning,1,0
69148,has,0,0
69149,not,0,0
69150,been,0,0
69151,conclusively,0,0
69152,established,0,0
69153,.,0,1
69154,We,0,0
69155,aimed,0,0
69156,to,0,0
69157,assess,0,0
69158,the,0,0
69159,effectiveness,0,0
69160,of,0,0
69161,a,0,1
69162,constant,0,0
69163,pralidoxime,0,0
69164,infusion,0,0
69165,compared,0,0
69166,with,0,1
69167,repeated,0,0
69168,bolus,0,0
69169,doses,0,0
69170,to,0,1
69171,treat,0,1
69172,patients,1,1
69173,with,1,1
69174,moderately,1,1
69175,severe,1,1
69176,poisoning,1,1
69177,from,1,1
69178,organophosphorus,1,1
69179,pesticides,1,1
69180,.,1,1
69181,METHODS,0,0
69182,200,1,1
69183,patients,1,1
69184,were,1,1
69185,recruited,1,1
69186,to,1,0
69187,our,1,0
69188,single-centre,1,1
69189,",",1,1
69190,open,1,1
69191,randomised,1,1
69192,controlled,1,0
69193,trial,1,0
69194,after,1,0
69195,moderately,1,1
69196,severe,1,1
69197,poisoning,1,1
69198,by,1,0
69199,anticholinesterase,1,1
69200,pesticide,1,1
69201,.,1,1
69202,All,0,1
69203,were,0,0
69204,given,0,0
69205,a,0,1
69206,2,0,0
69207,g,0,1
69208,loading,0,0
69209,dose,0,0
69210,of,0,0
69211,pralidoxime,0,0
69212,over,0,1
69213,30,0,1
69214,min,0,0
69215,.,0,1
69216,Patients,0,1
69217,were,0,0
69218,then,0,0
69219,randomly,0,1
69220,assigned,0,1
69221,to,0,0
69222,control,0,1
69223,and,0,0
69224,study,0,1
69225,groups,0,1
69226,.,0,1
69227,Controls,0,1
69228,were,0,0
69229,given,0,0
69230,a,0,0
69231,bolus,0,0
69232,dose,0,0
69233,of,0,0
69234,1,0,1
69235,g,0,1
69236,pralidoxime,0,0
69237,over,0,0
69238,1,0,1
69239,h,0,0
69240,every,0,1
69241,4,0,0
69242,h,0,0
69243,for,0,1
69244,48,0,1
69245,h.,0,1
69246,The,0,0
69247,study,0,0
69248,group,0,0
69249,had,0,1
69250,a,0,0
69251,constant,0,0
69252,infusion,0,0
69253,of,0,1
69254,1,0,0
69255,g,0,1
69256,over,0,0
69257,an,0,0
69258,hour,0,0
69259,every,0,0
69260,hour,0,0
69261,for,0,0
69262,48,0,1
69263,h.,0,1
69264,Thereafter,0,0
69265,",",0,0
69266,all,0,0
69267,patients,0,1
69268,were,0,1
69269,given,0,1
69270,1,0,1
69271,g,0,1
69272,every,0,0
69273,4,0,0
69274,h,0,0
69275,until,0,0
69276,they,0,0
69277,could,0,0
69278,be,0,0
69279,weaned,0,0
69280,from,0,1
69281,ventilators,0,1
69282,.,0,1
69283,Analysis,0,0
69284,was,0,0
69285,by,0,0
69286,intention,0,0
69287,to,0,1
69288,treat,0,1
69289,.,0,1
69290,Primary,0,0
69291,outcome,0,0
69292,measures,0,0
69293,were,0,1
69294,median,0,1
69295,atropine,0,0
69296,dose,0,0
69297,needed,0,0
69298,within,0,1
69299,24,0,1
69300,h,0,0
69301,",",0,0
69302,proportion,0,0
69303,of,0,1
69304,patients,0,1
69305,who,0,1
69306,needed,0,1
69307,intubation,0,1
69308,",",0,0
69309,and,0,0
69310,number,0,0
69311,of,0,0
69312,days,0,0
69313,on,0,1
69314,ventilation,0,1
69315,.,0,1
69316,The,0,0
69317,study,0,0
69318,is,0,0
69319,registered,0,0
69320,at,0,0
69321,http,0,0
69322,:,0,1
69323,//www.clinicaltrials.gov,0,0
69324,with,0,1
69325,the,0,0
69326,identifier,0,1
69327,NCT00333944,0,1
69328,.,0,1
69329,FINDINGS,0,0
69330,100,1,1
69331,patients,1,1
69332,were,1,1
69333,assigned,1,1
69334,the,1,0
69335,high-dose,1,0
69336,regimen,1,0
69337,",",0,1
69338,and,0,1
69339,100,1,0
69340,the,1,0
69341,control,1,1
69342,regimen,1,0
69343,.,1,0
69344,There,0,0
69345,were,0,0
69346,no,0,0
69347,drop-outs,0,1
69348,.,0,1
69349,Patients,1,1
69350,receiving,1,1
69351,the,1,0
69352,high-dose,1,1
69353,pralidoxime,1,0
69354,regimen,1,0
69355,required,0,0
69356,less,0,0
69357,atropine,0,0
69358,during,0,0
69359,the,0,0
69360,first,0,0
69361,24,0,1
69362,h,0,0
69363,than,0,1
69364,controls,0,1
69365,(,0,1
69366,median,0,1
69367,6,0,1
69368,mg,0,1
69369,vs,0,0
69370,30,0,1
69371,mg,0,1
69372,;,0,1
69373,difference,0,0
69374,24,0,1
69375,mg,0,1
69376,[,0,0
69377,95,0,0
69378,%,0,0
69379,CI,0,0
69380,24-26,0,1
69381,",",0,0
69382,p,0,0
69383,<,0,0
69384,0.0001,0,0
69385,],0,1
69386,),0,1
69387,.,0,1
69388,88,0,0
69389,(,0,1
69390,88,0,1
69391,%,0,0
69392,),0,1
69393,and,0,1
69394,64,0,1
69395,(,0,1
69396,64,0,1
69397,%,0,0
69398,),0,1
69399,of,0,1
69400,controls,0,1
69401,and,0,1
69402,high-dose,0,1
69403,patients,0,1
69404,",",0,0
69405,respectively,0,0
69406,",",0,0
69407,needed,0,0
69408,intubation,0,0
69409,during,0,0
69410,admission,0,1
69411,to,0,1
69412,hospital,0,1
69413,(,0,1
69414,relative,0,0
69415,risk=0.72,0,0
69416,",",0,0
69417,0.62-0.86,0,0
69418,",",0,0
69419,p=0.0001,0,0
69420,),0,1
69421,.,0,1
69422,Control,0,1
69423,patients,0,1
69424,required,0,0
69425,ventilatory,0,1
69426,support,0,0
69427,for,0,0
69428,longer,0,0
69429,(,0,1
69430,median,0,1
69431,10,0,1
69432,days,0,0
69433,vs,0,0
69434,5,0,1
69435,days,0,0
69436,;,0,1
69437,difference,0,0
69438,5,0,1
69439,days,0,0
69440,[,0,1
69441,5-6,0,1
69442,",",0,0
69443,p,0,0
69444,<,0,0
69445,0.0001,0,0
69446,],0,1
69447,),0,1
69448,.,0,0
69449,INTERPRETATION,0,0
69450,A,0,0
69451,high-dose,0,0
69452,regimen,0,0
69453,of,0,0
69454,pralidoxime,0,0
69455,",",0,0
69456,consisting,0,1
69457,of,0,0
69458,a,0,1
69459,constant,0,0
69460,infusion,0,0
69461,of,0,1
69462,1,0,0
69463,g/h,0,0
69464,for,0,1
69465,48,0,1
69466,h,0,0
69467,after,0,0
69468,a,0,1
69469,2,0,1
69470,g,0,1
69471,loading,0,0
69472,dose,0,0
69473,",",0,0
69474,reduces,0,0
69475,morbidity,0,0
69476,and,0,0
69477,mortality,0,0
69478,in,0,0
69479,moderately,1,1
69480,severe,1,1
69481,cases,1,1
69482,of,1,1
69483,acute,1,1
69484,organophosphorus-pesticide,1,1
69485,poisoning,1,1
69486,.,1,1
69487,Xuezhikang,0,0
69488,",",0,0
69489,an,0,0
69490,extract,0,0
69491,of,0,0
69492,cholestin,0,0
69493,",",0,0
69494,decreases,0,0
69495,plasma,0,0
69496,inflammatory,0,0
69497,markers,0,0
69498,and,0,1
69499,endothelin-1,0,0
69500,",",0,0
69501,improve,0,0
69502,exercise-induced,0,0
69503,ischemia,0,1
69504,and,0,1
69505,subjective,0,0
69506,feelings,0,0
69507,in,0,1
69508,patients,1,1
69509,with,1,1
69510,cardiac,1,1
69511,syndrome,1,1
69512,X,1,1
69513,.,1,1
69514,Previous,0,0
69515,studies,0,0
69516,have,0,0
69517,demonstrated,0,0
69518,that,0,0
69519,Xuezhikang,0,0
69520,",",0,0
69521,an,0,0
69522,extract,0,0
69523,of,0,0
69524,cholestin,0,0
69525,",",0,0
69526,available,0,0
69527,from,0,1
69528,Chinese,0,1
69529,red,0,1
69530,yeast,0,0
69531,rice,0,0
69532,",",0,0
69533,could,0,0
69534,effectively,0,0
69535,modify,0,0
69536,lipid,0,0
69537,profile,0,0
69538,.,0,1
69539,The,0,0
69540,present,0,0
69541,study,0,1
69542,was,0,0
69543,undertaken,0,0
69544,to,0,0
69545,investigate,0,0
69546,whether,0,0
69547,Xuezhikang,0,0
69548,could,0,0
69549,modify,0,0
69550,endothelin-1,0,0
69551,(,0,1
69552,ET-1,0,0
69553,),0,1
69554,",",0,0
69555,interleukin-6,0,0
69556,(,0,1
69557,IL-6,0,0
69558,),0,1
69559,",",0,0
69560,high-sensitivity,0,0
69561,C-reactive,0,1
69562,protein,0,0
69563,(,0,1
69564,CRP,0,1
69565,),0,1
69566,and,0,1
69567,exercise-induced,0,0
69568,ischemia,0,1
69569,in,0,1
69570,patients,1,1
69571,with,1,1
69572,cardiac,1,1
69573,syndrome,1,1
69574,X,1,1
69575,(,1,1
69576,CSX,1,1
69577,),1,1
69578,.,1,1
69579,Thirty-six,1,1
69580,patients,1,1
69581,with,1,1
69582,CSX,1,1
69583,were,0,1
69584,randomly,0,1
69585,assigned,0,1
69586,to,0,0
69587,1200,0,1
69588,mg/d,0,0
69589,of,0,1
69590,Xuezhikang,0,0
69591,or,0,1
69592,placebo,0,0
69593,group,0,0
69594,(,0,0
69595,n=18,0,1
69596,respectively,0,0
69597,),0,0
69598,.,0,1
69599,Blood,0,0
69600,samples,0,0
69601,were,0,1
69602,drawn,0,0
69603,at,0,1
69604,day,0,0
69605,0,0,0
69606,and,0,1
69607,day,0,0
69608,90,0,1
69609,for,0,0
69610,measuring,0,0
69611,above,0,1
69612,parameters,0,0
69613,.,0,1
69614,The,0,0
69615,treadmill,0,0
69616,exercise,0,0
69617,tests,0,0
69618,and,0,1
69619,subjective,0,0
69620,feelings,0,0
69621,were,0,1
69622,also,0,0
69623,assessed,0,0
69624,at,0,0
69625,day,0,0
69626,0,0,0
69627,and,0,1
69628,day,0,1
69629,90,0,1
69630,.,0,1
69631,The,0,0
69632,data,0,0
69633,showed,0,0
69634,that,0,0
69635,Xuezhikang,0,0
69636,therapy,0,0
69637,resulted,0,0
69638,in,0,0
69639,significant,0,0
69640,reductions,0,0
69641,in,0,1
69642,total,0,1
69643,cholesterol,0,0
69644,(,0,1
69645,TC,0,0
69646,",",0,1
69647,19,0,1
69648,%,0,0
69649,),0,1
69650,",",0,0
69651,low-density,0,1
69652,lipoprotein,0,0
69653,cholesterol,0,0
69654,(,0,1
69655,LDL-C,0,1
69656,),0,1
69657,(,0,1
69658,26,0,1
69659,%,0,0
69660,),0,1
69661,",",0,0
69662,and,0,1
69663,triglycerides,0,0
69664,(,0,1
69665,TG,0,0
69666,),0,1
69667,compared,0,0
69668,with,0,1
69669,baseline,0,0
69670,(,0,1
69671,16,0,1
69672,%,0,0
69673,",",0,0
69674,p,0,0
69675,<,0,0
69676,0.01,0,0
69677,respectively,0,0
69678,),0,1
69679,.,0,0
69680,The,0,0
69681,data,0,0
69682,also,0,0
69683,showed,0,0
69684,that,0,0
69685,Xuezhikang,0,0
69686,led,0,0
69687,significantly,0,0
69688,to,0,0
69689,reductions,0,0
69690,in,0,1
69691,median,0,1
69692,and,0,1
69693,log-CRP,0,0
69694,levels,0,1
69695,(,0,1
69696,38,0,1
69697,%,0,0
69698,and,0,1
69699,44,0,1
69700,%,0,0
69701,",",0,0
69702,p,0,0
69703,<,0,0
69704,0.01,0,0
69705,respectively,0,0
69706,),0,0
69707,",",0,0
69708,IL-6,0,0
69709,(,0,1
69710,20,0,1
69711,%,0,0
69712,",",0,0
69713,p,0,0
69714,<,0,0
69715,0.01,0,0
69716,),0,1
69717,",",0,0
69718,and,0,0
69719,ET-1,0,0
69720,(,0,1
69721,47,0,1
69722,%,0,0
69723,",",0,0
69724,p,0,0
69725,<,0,0
69726,0.01,0,0
69727,),0,1
69728,compared,0,0
69729,with,0,1
69730,baseline,0,0
69731,.,0,1
69732,The,0,0
69733,exercise,0,0
69734,duration,0,0
69735,",",0,0
69736,and,0,0
69737,time,0,0
69738,to,0,1
69739,1,0,1
69740,mm,0,1
69741,ST-segment,0,1
69742,depression,0,1
69743,was,0,0
69744,significantly,0,0
69745,prolonged,0,0
69746,after,0,0
69747,Xuezhikang,0,0
69748,therapy,0,1
69749,(,0,1
69750,9,0,0
69751,%,0,0
69752,and,0,1
69753,6,0,0
69754,%,0,0
69755,",",0,0
69756,p,0,0
69757,<,0,0
69758,0.05,0,0
69759,respectively,0,0
69760,),0,0
69761,accompanied,0,0
69762,by,0,0
69763,improvement,0,0
69764,of,0,1
69765,subjective,0,0
69766,feelings,0,0
69767,.,0,1
69768,Data,0,0
69769,suggested,0,0
69770,that,0,0
69771,the,0,0
69772,benefit,0,0
69773,of,0,0
69774,Xuezhikang,0,0
69775,resulted,0,0
69776,in,0,0
69777,significant,0,0
69778,modification,0,0
69779,vascular,0,0
69780,function,0,0
69781,by,0,0
69782,reduction,0,0
69783,of,0,0
69784,ET-1,0,0
69785,",",0,1
69786,inflammatory,0,0
69787,markers,0,0
69788,and,0,1
69789,LDL,0,1
69790,cholesterol,0,0
69791,",",0,0
69792,which,0,0
69793,may,0,0
69794,be,0,0
69795,clinically,0,0
69796,important,0,0
69797,for,0,0
69798,patients,1,1
69799,with,1,1
69800,CSX,1,1
69801,.,1,1
69802,Unpacking,0,0
69803,attitude,1,0
69804,certainty,1,0
69805,:,1,1
69806,attitude,0,0
69807,clarity,0,0
69808,and,0,0
69809,attitude,0,0
69810,correctness,0,1
69811,.,0,1
69812,Attitude,1,0
69813,certainty,1,0
69814,has,0,0
69815,been,0,0
69816,the,0,0
69817,subject,0,0
69818,of,0,0
69819,considerable,0,0
69820,attention,0,0
69821,in,0,0
69822,the,0,0
69823,attitudes,0,0
69824,and,0,0
69825,persuasion,0,0
69826,literature,0,0
69827,.,0,1
69828,The,0,0
69829,present,0,0
69830,research,0,0
69831,identifies,0,1
69832,2,0,0
69833,aspects,0,0
69834,of,0,1
69835,attitude,1,0
69836,certainty,1,0
69837,and,0,0
69838,provides,0,0
69839,evidence,0,0
69840,for,0,0
69841,the,0,0
69842,distinctness,0,0
69843,of,0,0
69844,the,0,0
69845,constructs,0,0
69846,.,0,1
69847,Specifically,0,0
69848,",",0,0
69849,it,0,0
69850,is,0,0
69851,proposed,0,0
69852,that,0,0
69853,attitude,0,0
69854,certainty,0,0
69855,can,0,0
69856,be,0,0
69857,conceptualized,0,0
69858,",",0,0
69859,and,0,0
69860,empirically,0,0
69861,separated,0,0
69862,",",0,0
69863,in,0,0
69864,terms,0,0
69865,of,0,1
69866,attitude,0,0
69867,clarity,0,0
69868,(,0,0
69869,the,0,0
69870,subjective,0,0
69871,sense,0,0
69872,that,0,0
69873,one,0,1
69874,knows,0,0
69875,what,0,0
69876,one,0,1
69877,'s,0,1
69878,attitude,0,0
69879,is,0,0
69880,),0,0
69881,and,0,0
69882,attitude,0,0
69883,correctness,0,0
69884,(,0,0
69885,the,0,0
69886,subjective,0,0
69887,sense,0,0
69888,that,0,0
69889,one,0,1
69890,'s,0,1
69891,attitude,0,0
69892,is,0,0
69893,correct,0,0
69894,or,0,1
69895,valid,0,1
69896,),0,1
69897,.,0,1
69898,Experiment,0,1
69899,1,0,1
69900,uses,0,0
69901,factor,1,0
69902,analysis,1,0
69903,and,1,1
69904,correlational,1,1
69905,data,1,0
69906,to,0,1
69907,provide,0,0
69908,evidence,0,0
69909,for,0,0
69910,viewing,0,0
69911,attitude,0,0
69912,clarity,0,0
69913,and,0,0
69914,attitude,0,0
69915,correctness,0,0
69916,as,0,0
69917,separate,0,1
69918,constructs,0,1
69919,.,0,1
69920,Experiments,0,0
69921,2,0,1
69922,and,0,1
69923,3,0,1
69924,demonstrate,0,0
69925,that,0,0
69926,attitude,0,0
69927,clarity,0,0
69928,and,0,0
69929,attitude,0,0
69930,correctness,0,0
69931,can,0,0
69932,have,0,0
69933,distinct,0,0
69934,antecedents,0,1
69935,(,0,1
69936,repeated,0,0
69937,expression,0,0
69938,and,0,0
69939,consensus,0,1
69940,feedback,0,0
69941,",",0,0
69942,respectively,0,0
69943,),0,1
69944,.,0,1
69945,Experiment,0,1
69946,4,0,0
69947,reveals,0,0
69948,that,0,0
69949,these,0,0
69950,constructs,0,0
69951,each,0,0
69952,play,0,0
69953,an,0,0
69954,independent,0,0
69955,role,0,0
69956,in,0,0
69957,persuasion,0,0
69958,and,0,1
69959,resistance,0,0
69960,situations,0,0
69961,.,0,1
69962,As,0,0
69963,clarity,0,0
69964,and,0,1
69965,correctness,0,0
69966,increase,0,0
69967,",",0,0
69968,attitudes,0,0
69969,become,0,0
69970,more,0,0
69971,resistant,0,0
69972,to,0,0
69973,counterattitudinal,0,0
69974,persuasive,0,1
69975,messages,0,1
69976,.,0,1
69977,These,0,1
69978,findings,0,0
69979,are,0,0
69980,discussed,0,0
69981,in,0,0
69982,relation,0,0
69983,to,0,1
69984,the,0,0
69985,existing,1,0
69986,attitude,1,0
69987,strength,1,0
69988,literature,0,0
69989,.,0,1
69990,Relationship,0,0
69991,of,0,0
69992,dietary,0,0
69993,intake,0,0
69994,to,0,1
69995,gastrointestinal,0,1
69996,symptoms,0,1
69997,in,0,1
69998,children,1,1
69999,with,1,1
70000,autistic,1,1
70001,spectrum,1,1
70002,disorders,1,1
70003,.,1,1
70004,BACKGROUND,0,0
70005,Gastrointestinal,0,1
70006,(,0,1
70007,GI,0,1
70008,),0,1
70009,symptoms,0,1
70010,and,0,1
70011,abnormalities,0,1
70012,in,0,1
70013,stool,0,0
70014,consistency,0,0
70015,are,0,0
70016,frequently,0,0
70017,reported,0,0
70018,by,0,0
70019,parents,1,1
70020,of,1,1
70021,children,1,1
70022,with,1,1
70023,autism,1,1
70024,spectrum,1,1
70025,disorders,1,1
70026,(,1,1
70027,ASD,1,1
70028,),1,1
70029,.,1,1
70030,The,0,0
70031,purpose,0,0
70032,of,0,0
70033,this,0,0
70034,study,0,0
70035,was,0,0
70036,to,0,1
70037,1,0,1
70038,),0,1
70039,describe,0,1
70040,dietary,0,0
70041,intake,0,0
70042,of,0,0
70043,a,0,0
70044,cohort,0,1
70045,of,0,0
70046,children,0,1
70047,with,0,1
70048,ASD,0,1
70049,compared,0,0
70050,with,0,1
70051,normative,0,1
70052,data,0,1
70053,and,0,1
70054,2,0,1
70055,),0,1
70056,determine,0,0
70057,whether,0,0
70058,GI,0,1
70059,symptoms,0,1
70060,and,0,1
70061,stool,0,0
70062,consistency,0,0
70063,are,0,0
70064,related,0,0
70065,to,0,1
70066,dietary,0,0
70067,intake,0,0
70068,.,0,1
70069,METHODS,0,0
70070,Data,1,1
70071,from,1,1
70072,diet,1,1
70073,diaries,1,1
70074,of,1,1
70075,children,1,1
70076,(,1,1
70077,3-8,1,1
70078,years,1,1
70079,),1,1
70080,with,1,1
70081,ASD,1,1
70082,(,1,1
70083,n,1,1
70084,=,1,1
70085,62,1,1
70086,),1,1
70087,were,1,1
70088,analyzed,1,0
70089,by,0,0
70090,a,0,1
70091,registered,0,1
70092,pediatric,0,1
70093,dietician,0,0
70094,to,0,0
70095,compare,0,0
70096,to,0,1
70097,RDA,0,1
70098,standards,0,1
70099,for,0,1
70100,total,0,1
70101,calories,0,1
70102,",",0,1
70103,protein,0,0
70104,",",0,0
70105,carbohydrate,0,0
70106,",",0,0
70107,and,0,0
70108,fat,0,0
70109,.,0,1
70110,Dietary,0,0
70111,intake,0,0
70112,was,0,0
70113,correlated,0,0
70114,with,0,1
70115,descriptors,0,0
70116,of,0,1
70117,stool,0,1
70118,consistency,0,0
70119,using,0,0
70120,cumulative,0,0
70121,logistic,0,0
70122,regression,0,0
70123,methods,0,1
70124,.,0,1
70125,RESULTS,0,0
70126,Intake,0,0
70127,of,0,1
70128,calories,0,1
70129,",",0,1
70130,carbohydrates,0,0
70131,",",0,0
70132,and,0,0
70133,fat,0,0
70134,were,0,0
70135,in,0,0
70136,the,0,0
70137,average,0,1
70138,range,0,1
70139,;,0,0
70140,protein,0,0
70141,intake,0,0
70142,was,0,0
70143,increased,0,0
70144,(,0,1
70145,211,0,1
70146,%,0,0
70147,of,0,1
70148,RDA,0,1
70149,),0,1
70150,.,0,1
70151,Reported,0,0
70152,frequency,0,0
70153,of,0,1
70154,GI,0,1
70155,abnormalities,0,1
70156,",",0,1
70157,including,0,1
70158,abnormal,0,1
70159,stool,0,1
70160,consistency,0,0
70161,(,0,0
70162,e.g.,0,0
70163,",",0,1
70164,bulky,0,1
70165,or,0,1
70166,loose,0,1
70167,),0,1
70168,",",0,0
70169,was,0,0
70170,increased,0,0
70171,(,0,1
70172,54,0,1
70173,%,0,0
70174,),0,1
70175,.,0,0
70176,No,0,0
70177,statistically,0,0
70178,significant,0,0
70179,relationships,0,0
70180,between,0,0
70181,stool,0,1
70182,consistency,0,0
70183,and,0,0
70184,dietary,0,0
70185,intake,0,0
70186,were,0,1
70187,observed,0,0
70188,.,0,1
70189,CONCLUSIONS,0,0
70190,In,0,0
70191,this,0,0
70192,sample,0,1
70193,",",0,0
70194,there,0,0
70195,was,0,0
70196,a,0,0
70197,high,0,0
70198,rate,0,0
70199,of,0,0
70200,reported,0,1
70201,gastrointestinal,0,1
70202,symptoms,0,0
70203,",",0,1
70204,despite,0,0
70205,lack,0,0
70206,of,0,1
70207,medical,0,1
70208,causes,0,0
70209,.,0,1
70210,Intake,0,0
70211,was,0,0
70212,adequate,0,0
70213,for,0,1
70214,calories,0,1
70215,and,0,1
70216,carbohydrates,0,1
70217,and,0,1
70218,increased,0,0
70219,for,0,0
70220,protein,0,0
70221,.,0,1
70222,The,0,0
70223,children,1,1
70224,did,0,0
70225,not,0,0
70226,exhibit,0,0
70227,excessive,0,0
70228,carbohydrate,0,0
70229,intake,0,0
70230,.,0,0
70231,There,0,0
70232,was,0,0
70233,no,0,0
70234,association,0,0
70235,of,0,0
70236,nutrient,0,1
70237,intake,0,0
70238,to,0,1
70239,changes,0,0
70240,in,0,1
70241,stool,0,1
70242,consistency,0,0
70243,.,0,1
70244,Does,0,0
70245,ambient,0,1
70246,light,0,0
70247,contribute,0,0
70248,to,0,0
70249,the,0,0
70250,therapeutic,0,0
70251,effects,0,0
70252,of,0,1
70253,topical,0,0
70254,photodynamic,0,1
70255,therapy,0,1
70256,(,0,1
70257,PDT,0,1
70258,),0,1
70259,using,0,0
70260,aminolevulinic,0,1
70261,acid,0,0
70262,HCl,0,0
70263,(,0,1
70264,ALA,0,1
70265,),0,1
70266,?,0,1
70267,Role,0,0
70268,of,0,0
70269,diltiazem,0,0
70270,in,0,0
70271,the,0,0
70272,treatment,0,0
70273,of,0,0
70274,silent,0,1
70275,myocardial,0,1
70276,ischemia,0,1
70277,.,0,1
70278,Silent,0,0
70279,myocardial,0,1
70280,ischemia,0,1
70281,is,0,0
70282,a,0,0
70283,frequent,0,0
70284,finding,0,0
70285,when,0,0
70286,Holter,0,1
70287,monitoring,0,0
70288,is,0,0
70289,done,0,0
70290,in,0,0
70291,patients,1,1
70292,with,1,1
70293,advanced,1,1
70294,coronary,1,1
70295,disease,1,1
70296,.,1,1
70297,Silent,0,0
70298,ischemia,0,0
70299,is,0,0
70300,associated,0,0
70301,with,0,0
70302,a,0,0
70303,worse,0,0
70304,prognosis,0,0
70305,in,0,0
70306,patients,0,1
70307,with,0,1
70308,stable,0,1
70309,or,0,1
70310,unstable,0,1
70311,angina,0,1
70312,",",0,1
70313,survivors,0,1
70314,of,0,0
70315,myocardial,0,1
70316,infarction,0,1
70317,",",0,1
70318,and,0,0
70319,populations,0,1
70320,at,0,1
70321,risk,0,1
70322,for,0,1
70323,coronary,0,1
70324,disease,0,1
70325,.,0,1
70326,Whether,0,0
70327,medical,0,1
70328,therapy,0,1
70329,for,0,0
70330,silent,0,0
70331,ischemia,0,1
70332,improves,0,0
70333,prognosis,0,0
70334,is,0,0
70335,not,0,0
70336,known,0,0
70337,.,0,0
70338,In,0,0
70339,a,0,0
70340,randomized,0,1
70341,",",0,0
70342,placebo-controlled,0,0
70343,",",0,0
70344,multicenter,0,0
70345,trial,0,1
70346,of,0,1
70347,60,1,1
70348,patients,1,1
70349,with,1,1
70350,documented,1,1
70351,coronary,1,1
70352,disease,1,1
70353,",",1,0
70354,positive,1,1
70355,exercise,1,1
70356,tests,1,0
70357,",",1,1
70358,and,1,1
70359,ischemic,1,1
70360,episodes,1,1
70361,on,1,1
70362,Holter,1,1
70363,monitoring,1,0
70364,",",0,0
70365,long-acting,0,0
70366,diltiazem,0,0
70367,reduced,0,0
70368,ischemic,0,1
70369,episodes,0,1
70370,by,0,1
70371,50,0,1
70372,%,0,0
70373,compared,0,0
70374,to,0,0
70375,placebo,0,0
70376,",",0,0
70377,from,0,0
70378,a,0,0
70379,mean,0,1
70380,of,0,0
70381,5.6,0,0
70382,to,0,1
70383,2.8,0,0
70384,(,0,0
70385,p,0,0
70386,less,0,0
70387,than,0,0
70388,0.0001,0,0
70389,),0,1
70390,.,0,1
70391,Efficacy,0,0
70392,was,0,0
70393,maintained,0,0
70394,over,0,0
70395,24,0,1
70396,h,0,0
70397,and,0,1
70398,diltiazem,0,0
70399,also,0,0
70400,significantly,0,0
70401,improved,0,0
70402,exercise,0,0
70403,test,0,0
70404,parameters,0,0
70405,.,0,1
70406,Three,0,1
70407,smaller,0,0
70408,studies,0,0
70409,also,0,0
70410,demonstrated,0,0
70411,that,0,0
70412,diltiazem,0,0
70413,effectively,0,0
70414,reduces,0,0
70415,ambulatory,0,0
70416,ischemia,0,0
70417,;,0,0
70418,however,0,0
70419,",",0,0
70420,results,0,0
70421,with,0,1
70422,nifedipine,0,1
70423,are,0,0
70424,conflicting,0,0
70425,",",0,0
70426,with,0,1
70427,several,0,1
70428,studies,0,0
70429,showing,0,0
70430,no,0,1
70431,benefit,0,0
70432,.,0,1
70433,In,0,0
70434,contrast,0,0
70435,",",0,1
70436,beta-blockers,0,0
70437,reliably,0,0
70438,reduce,0,0
70439,ischemic,0,1
70440,episodes,0,1
70441,.,0,1
70442,The,0,0
70443,role,0,0
70444,of,0,0
70445,medical,0,1
70446,therapy,0,1
70447,for,0,0
70448,silent,0,0
70449,ischemia,0,1
70450,will,0,0
70451,be,0,0
70452,clarified,0,0
70453,only,0,0
70454,when,0,0
70455,its,0,0
70456,effect,0,0
70457,upon,0,0
70458,morbidity,0,0
70459,and,0,0
70460,mortality,0,0
70461,are,0,0
70462,determined,0,0
70463,.,0,1
70464,[,0,1
70465,Effect,0,0
70466,of,0,0
70467,ulinastatin,0,0
70468,on,0,0
70469,inflammatory,1,1
70470,responses,1,0
70471,induced,1,1
70472,by,1,1
70473,oesophagectomy,1,1
70474,],1,1
70475,.,0,1
70476,OBJECTIVE,0,0
70477,To,0,0
70478,examine,0,0
70479,the,0,0
70480,effect,0,0
70481,of,0,0
70482,ulinastatin,0,0
70483,(,0,1
70484,UTI,0,0
70485,),0,1
70486,on,0,0
70487,the,0,0
70488,inflammatory,1,0
70489,responses,1,0
70490,induced,1,1
70491,by,1,0
70492,oesophagectomy,1,1
70493,.,1,1
70494,METHODS,0,0
70495,Forty,1,1
70496,patients,1,1
70497,with,1,1
70498,esophageal,1,1
70499,cancer,1,1
70500,(,1,1
70501,without,1,1
70502,serious,1,0
70503,hypertension,1,1
70504,",",1,0
70505,heart,1,1
70506,disease,1,1
70507,",",1,0
70508,or,1,1
70509,respiratory,1,1
70510,function,1,0
70511,impairment,1,1
70512,",",1,0
70513,including,1,1
70514,34,1,1
70515,men,1,1
70516,and,1,1
70517,6,1,1
70518,women,1,1
70519,aged,1,1
70520,46,1,1
70521,to,1,1
70522,70,1,1
70523,years,1,1
70524,),1,1
70525,scheduled,1,1
70526,for,1,0
70527,oesophagectomy,1,1
70528,via,1,1
70529,left,1,1
70530,thoracotomy,1,1
70531,were,1,1
70532,randomly,1,1
70533,divided,1,1
70534,into,1,0
70535,control,1,1
70536,group,1,1
70537,(,1,1
70538,n=20,1,1
70539,),1,1
70540,and,1,0
70541,UTI,1,0
70542,group,1,1
70543,(,1,0
70544,n=20,1,1
70545,),1,1
70546,.,1,1
70547,Anesthesia,0,0
70548,induction,0,0
70549,and,0,1
70550,perioperative,0,0
70551,management,0,1
70552,followed,0,0
70553,the,0,0
70554,same,0,0
70555,protocols,0,0
70556,in,0,1
70557,the,0,1
70558,two,0,0
70559,groups,0,0
70560,",",0,1
70561,and,0,0
70562,in,0,0
70563,UTI,0,0
70564,group,0,1
70565,",",0,1
70566,patients,0,1
70567,received,0,1
70568,5000,0,1
70569,U/kg,0,1
70570,UTI,0,0
70571,while,0,0
70572,those,0,1
70573,in,0,0
70574,the,0,0
70575,control,0,1
70576,group,0,0
70577,were,0,0
70578,given,0,0
70579,the,0,0
70580,same,0,0
70581,volume,0,0
70582,of,0,0
70583,saline,0,0
70584,.,0,1
70585,Before,0,0
70586,operation,0,1
70587,(,0,1
70588,T,0,1
70589,(,0,1
70590,1,0,1
70591,),0,1
70592,),0,1
70593,",",0,1
70594,10,0,1
70595,min,0,0
70596,after,0,0
70597,recovery,0,0
70598,of,0,0
70599,two-lung,0,0
70600,ventilation,0,1
70601,(,0,1
70602,T,0,1
70603,(,0,1
70604,2,0,1
70605,),0,1
70606,),0,1
70607,",",0,0
70608,and,0,0
70609,24,0,1
70610,h,0,0
70611,(,0,1
70612,T,0,1
70613,(,0,1
70614,3,0,1
70615,),0,1
70616,),0,1
70617,and,0,1
70618,48,0,1
70619,h,0,0
70620,(,0,1
70621,T,0,1
70622,(,0,1
70623,4,0,1
70624,),0,1
70625,),0,1
70626,after,0,0
70627,operation,0,1
70628,",",0,0
70629,the,0,0
70630,venous,0,1
70631,blood,0,0
70632,sample,0,1
70633,was,0,0
70634,taken,0,0
70635,from,0,1
70636,the,0,0
70637,internal,0,0
70638,jugular,0,1
70639,vein,0,1
70640,and,0,0
70641,the,0,0
70642,plasma,0,0
70643,was,0,0
70644,separated,0,0
70645,and,0,0
70646,stored,0,0
70647,at,0,1
70648,-70,0,1
70649,degrees,0,1
70650,C,0,1
70651,for,0,1
70652,later,0,1
70653,analysis,0,0
70654,of,0,0
70655,IL-6,0,0
70656,and,0,1
70657,IL-8,0,1
70658,with,0,1
70659,enzyme-linked,0,1
70660,immunosorbent,0,0
70661,assay,0,0
70662,(,0,1
70663,ELISA,0,1
70664,),0,1
70665,.,0,1
70666,The,0,0
70667,bronchoalveoar,0,1
70668,lavage,0,0
70669,fluid,0,1
70670,(,0,1
70671,BAFL,0,1
70672,),0,1
70673,was,0,0
70674,also,0,0
70675,collected,0,0
70676,at,0,0
70677,T,0,1
70678,(,0,1
70679,1,0,1
70680,),0,1
70681,and,0,1
70682,T,0,1
70683,(,0,1
70684,2,0,1
70685,),0,1
70686,for,0,1
70687,IL-6,0,0
70688,and,0,1
70689,IL-8,0,1
70690,detection,0,1
70691,.,0,1
70692,RESULTS,0,0
70693,IL-6,0,0
70694,",",0,1
70695,IL-8,0,1
70696,levels,0,0
70697,in,0,1
70698,the,0,0
70699,plasma,0,0
70700,and,0,0
70701,BALF,0,0
70702,collected,0,1
70703,at,0,0
70704,T,0,1
70705,(,0,1
70706,2,0,1
70707,),0,1
70708,-T,0,1
70709,(,0,1
70710,4,0,0
70711,),0,1
70712,increased,0,0
70713,significantly,0,0
70714,as,0,0
70715,compared,0,0
70716,with,0,1
70717,those,0,1
70718,in,0,0
70719,samples,0,0
70720,collected,0,1
70721,at,0,1
70722,T,0,1
70723,(,0,1
70724,1,0,1
70725,),0,1
70726,",",0,0
70727,and,0,0
70728,their,0,1
70729,peak,0,0
70730,concentration,0,0
70731,inplasma,0,1
70732,and,0,1
70733,BALF,0,0
70734,samples,0,1
70735,were,0,1
70736,similar,0,0
70737,.,0,1
70738,IL-6,0,0
70739,and,0,0
70740,IL-8,0,1
70741,levels,0,0
70742,in,0,1
70743,the,0,1
70744,UTI,0,0
70745,group,0,0
70746,were,0,0
70747,significantly,0,0
70748,lower,0,0
70749,than,0,0
70750,those,0,0
70751,in,0,0
70752,the,0,0
70753,control,0,0
70754,group,0,0
70755,during,0,0
70756,the,0,0
70757,time,0,0
70758,points,0,0
70759,of,0,1
70760,T,0,1
70761,(,0,1
70762,2,0,1
70763,),0,1
70764,-T,0,1
70765,(,0,1
70766,4,0,1
70767,),0,1
70768,.,0,1
70769,CONCLUSION,0,0
70770,Inflammatory,0,0
70771,responses,0,0
70772,occur,0,0
70773,during,0,0
70774,and,0,0
70775,after,0,0
70776,oesophagectomy,0,1
70777,",",0,0
70778,which,0,0
70779,can,0,0
70780,be,0,0
70781,inhibited,0,0
70782,with,0,1
70783,UTI,0,1
70784,.,0,1
70785,Granulocyte-macrophage,0,0
70786,colony-stimulating,0,1
70787,factor,0,0
70788,(,0,1
70789,GM-CSF,0,0
70790,),0,1
70791,as,0,0
70792,adjunct,0,0
70793,therapy,0,1
70794,in,0,1
70795,relapsed,1,1
70796,Hodgkin,1,1
70797,disease,1,1
70798,.,1,1
70799,OBJECTIVE,0,0
70800,To,0,0
70801,determine,0,0
70802,the,0,0
70803,clinical,0,0
70804,and,0,1
70805,economic,0,0
70806,effects,0,0
70807,of,0,1
70808,granulocyte,0,0
70809,macrophage,0,1
70810,colony-stimulating,0,1
70811,factor,0,0
70812,(,0,1
70813,GM-CSF,0,0
70814,),0,1
70815,as,0,0
70816,adjunct,0,0
70817,therapy,0,1
70818,in,0,1
70819,relapsed,1,1
70820,or,1,1
70821,refractory,1,1
70822,Hodgkin,1,1
70823,disease,1,1
70824,.,1,1
70825,DESIGN,0,0
70826,A,0,0
70827,randomized,0,0
70828,",",0,0
70829,double-blind,0,0
70830,",",0,0
70831,phase,0,1
70832,III,0,1
70833,clinical,0,0
70834,trial,0,1
70835,.,0,1
70836,SETTING,0,1
70837,A,0,0
70838,tertiary,1,1
70839,referral,1,1
70840,center,1,1
70841,.,1,1
70842,PATIENTS,0,0
70843,Twenty-four,1,1
70844,patients,1,1
70845,(,1,1
70846,twelve,1,1
70847,of,1,1
70848,whom,1,1
70849,were,1,1
70850,controls,1,1
70851,),1,1
70852,treated,1,1
70853,with,1,1
70854,high-dose,1,1
70855,chemotherapy,1,1
70856,and,1,1
70857,autologous,1,1
70858,bone,1,1
70859,marrow,1,1
70860,transplantation,1,1
70861,.,1,1
70862,MAIN,0,0
70863,RESULTS,0,0
70864,The,0,1
70865,12,0,1
70866,patients,0,1
70867,treated,0,1
70868,with,0,1
70869,GM-CSF,0,0
70870,",",0,0
70871,when,0,0
70872,compared,0,0
70873,with,0,1
70874,placebo,0,0
70875,recipients,0,1
70876,",",0,0
70877,had,0,1
70878,shorter,0,0
70879,periods,0,0
70880,of,0,0
70881,neutropenia,0,1
70882,(,0,1
70883,median,0,0
70884,duration,0,0
70885,of,0,0
70886,an,0,0
70887,absolute,0,0
70888,neutrophil,0,0
70889,count,0,0
70890,of,0,0
70891,less,0,0
70892,than,0,1
70893,1000,0,0
70894,cells/mm3,0,1
70895,",",0,1
70896,16,0,1
70897,days,0,0
70898,compared,0,0
70899,with,0,1
70900,27,0,1
70901,days,0,1
70902,;,0,1
70903,P,0,0
70904,=,0,1
70905,0.02,0,0
70906,),0,0
70907,",",0,1
70908,shorter,0,0
70909,periods,0,0
70910,of,0,0
70911,platelet-transfusion,0,1
70912,dependency,0,0
70913,(,0,1
70914,median,0,0
70915,duration,0,0
70916,",",0,1
70917,13.5,0,0
70918,days,0,0
70919,compared,0,0
70920,with,0,1
70921,21,0,1
70922,days,0,1
70923,;,0,1
70924,P,0,0
70925,=,0,1
70926,0.03,0,0
70927,),0,1
70928,",",0,0
70929,and,0,0
70930,shorter,0,0
70931,hospitalizations,0,1
70932,(,0,1
70933,median,0,1
70934,hospital,0,1
70935,stay,0,0
70936,",",0,1
70937,32,0,1
70938,days,0,0
70939,compared,0,0
70940,with,0,1
70941,40.5,0,1
70942,days,0,1
70943,;,0,1
70944,P,0,0
70945,=,0,1
70946,0.004,0,0
70947,),0,1
70948,.,0,1
70949,Other,0,0
70950,clinical,0,0
70951,outcomes,0,0
70952,",",0,1
70953,such,0,0
70954,as,0,0
70955,frequency,0,0
70956,and,0,0
70957,severity,0,0
70958,of,0,0
70959,toxicities,0,0
70960,",",0,1
70961,development,0,0
70962,of,0,0
70963,pneumonia,0,1
70964,or,0,1
70965,infection,0,1
70966,",",0,0
70967,in-hospital,0,0
70968,death,0,0
70969,",",0,0
70970,and,0,0
70971,response,0,0
70972,rate,0,0
70973,were,0,1
70974,similar,0,0
70975,in,0,0
70976,the,0,1
70977,two,0,1
70978,groups,0,1
70979,.,0,1
70980,Actuarial,0,1
70981,long-term,0,0
70982,disease-free,0,1
70983,survival,0,0
70984,was,0,0
70985,64,0,1
70986,%,0,0
70987,for,0,1
70988,patients,0,1
70989,treated,0,1
70990,with,0,1
70991,GM-CSF,0,1
70992,and,0,1
70993,58,0,1
70994,%,0,0
70995,for,0,1
70996,patients,0,1
70997,who,0,1
70998,received,0,1
70999,placebo,0,1
71000,after,0,1
71001,32,0,1
71002,months,0,1
71003,of,0,1
71004,follow-up,0,1
71005,(,0,1
71006,P,0,0
71007,=,0,1
71008,0.15,0,0
71009,),0,1
71010,.,0,1
71011,The,0,0
71012,group,0,0
71013,treated,0,1
71014,with,0,1
71015,GM-CSF,0,0
71016,had,0,1
71017,lower,0,0
71018,total,0,1
71019,charges,0,0
71020,after,0,1
71021,infusion,0,0
71022,of,0,0
71023,autologous,0,1
71024,marrow,0,1
71025,than,0,0
71026,the,0,0
71027,placebo,0,0
71028,group,0,0
71029,(,0,1
71030,median,0,1
71031,in-hospital,0,0
71032,charges,0,1
71033,",",0,1
71034,$,0,1
71035,"39,800",0,1
71036,compared,0,0
71037,with,0,1
71038,$,0,1
71039,"62,500",0,1
71040,;,0,1
71041,P,0,0
71042,=,0,1
71043,0.005,0,0
71044,),0,1
71045,because,0,0
71046,of,0,0
71047,lower,0,0
71048,post-infusion,0,0
71049,charges,0,0
71050,for,0,1
71051,room,0,1
71052,and,0,0
71053,board,0,0
71054,",",0,0
71055,antibiotic,0,0
71056,therapy,0,0
71057,",",0,1
71058,transfusions,0,0
71059,",",0,1
71060,laboratory,0,1
71061,tests,0,0
71062,",",0,1
71063,and,0,1
71064,physical,0,1
71065,therapy,0,1
71066,visits,0,1
71067,.,0,1
71068,CONCLUSIONS,0,0
71069,Administration,0,0
71070,of,0,1
71071,GM-CSF,0,0
71072,was,0,0
71073,associated,0,0
71074,with,0,1
71075,acceleration,0,0
71076,of,0,0
71077,myeloid,0,1
71078,and,0,1
71079,platelet,0,0
71080,recovery,0,0
71081,and,0,0
71082,was,0,0
71083,cost,0,0
71084,effective,0,0
71085,in,0,0
71086,the,0,0
71087,treatment,0,0
71088,of,0,0
71089,patients,1,1
71090,with,1,1
71091,relapsed,1,1
71092,Hodgkin,1,1
71093,disease,1,1
71094,who,1,1
71095,received,1,1
71096,intensive,1,1
71097,chemotherapy,1,1
71098,.,1,1
71099,The,0,0
71100,patient,1,0
71101,experience,1,1
71102,of,0,0
71103,community,0,1
71104,hospital,0,1
71105,--,0,1
71106,the,0,0
71107,process,0,0
71108,of,0,0
71109,care,0,1
71110,as,0,0
71111,a,0,0
71112,determinant,0,0
71113,of,0,0
71114,satisfaction,0,0
71115,.,0,1
71116,AIMS,0,0
71117,AND,0,0
71118,OBJECTIVES,0,0
71119,We,0,1
71120,report,0,0
71121,findings,0,0
71122,from,0,1
71123,a,0,1
71124,qualitative,0,0
71125,study,0,0
71126,to,0,0
71127,identify,0,0
71128,patient,1,1
71129,views,1,0
71130,of,1,1
71131,community,1,1
71132,hospital,1,1
71133,care,1,1
71134,.,1,1
71135,We,0,0
71136,consider,0,0
71137,how,0,0
71138,far,0,1
71139,these,0,0
71140,were,0,0
71141,in,0,0
71142,accord,0,0
71143,with,0,1
71144,the,0,0
71145,hospital,0,1
71146,staffs,0,1
71147,',0,1
71148,views,0,0
71149,.,0,1
71150,This,0,0
71151,constituted,0,0
71152,part,0,0
71153,of,0,0
71154,a,0,1
71155,wider,0,0
71156,randomized,0,1
71157,controlled,0,0
71158,trial,0,0
71159,(,0,1
71160,RCT,0,1
71161,),0,1
71162,.,0,1
71163,The,0,0
71164,methodological,0,0
71165,challenges,0,0
71166,in,0,1
71167,seeking,0,1
71168,to,0,0
71169,identify,0,0
71170,patient,0,1
71171,satisfaction,0,0
71172,and,0,1
71173,in,0,0
71174,linking,0,0
71175,qualitative,0,0
71176,findings,0,0
71177,with,0,1
71178,trial,0,1
71179,results,0,0
71180,are,0,0
71181,explored,0,0
71182,.,0,1
71183,DESIGN,0,0
71184,A,1,0
71185,sample,1,1
71186,of,1,0
71187,13,1,1
71188,patients,1,1
71189,randomized,1,1
71190,to,1,1
71191,the,1,0
71192,community,1,0
71193,hospital,1,1
71194,arm,1,0
71195,of,1,0
71196,the,1,0
71197,RCT,1,0
71198,joined,1,1
71199,the,1,0
71200,qualitative,1,0
71201,study,1,1
71202,.,1,1
71203,Official,0,0
71204,documentation,0,0
71205,from,0,1
71206,the,0,0
71207,hospital,0,1
71208,were,0,0
71209,accessed,0,0
71210,and,0,1
71211,six,0,1
71212,staff,0,1
71213,interviewed,0,1
71214,to,0,0
71215,identify,0,0
71216,assumptions,0,0
71217,underlying,0,1
71218,practice,0,1
71219,.,0,1
71220,RESULTS,0,0
71221,Analysis,0,1
71222,of,0,1
71223,interviews,0,1
71224,identified,0,1
71225,a,0,1
71226,complex,0,0
71227,picture,0,1
71228,concerning,0,0
71229,expectations,0,0
71230,These,0,1
71231,could,0,0
71232,be,0,0
71233,classified,0,0
71234,as,0,0
71235,ideal,0,0
71236,",",0,0
71237,realistic,0,0
71238,",",0,0
71239,normative,0,0
71240,and,0,1
71241,unformed,0,0
71242,.,0,1
71243,The,0,0
71244,hospital,0,1
71245,philosophy,0,0
71246,and,0,1
71247,staff,0,1
71248,views,0,0
71249,about,0,0
71250,service,0,1
71251,delivery,0,0
71252,were,0,0
71253,closely,0,0
71254,in,0,0
71255,harmony,0,0
71256,",",0,0
71257,they,0,0
71258,delivered,0,0
71259,rehabilitation,0,1
71260,in,0,0
71261,a,0,1
71262,home-based,0,1
71263,atmosphere,0,1
71264,.,0,1
71265,The,0,0
71266,formal,0,0
71267,",",0,0
71268,or,0,1
71269,'hard,0,0
71270,',0,1
71271,",",0,1
71272,process,0,0
71273,of,0,0
71274,rehabilitation,0,1
71275,was,0,0
71276,not,0,0
71277,well,0,0
71278,understood,0,0
71279,by,0,0
71280,patients,0,1
71281,.,0,1
71282,They,0,0
71283,were,0,0
71284,primarily,0,0
71285,concerned,0,0
71286,with,0,1
71287,'soft,0,0
71288,',0,1
71289,or,0,1
71290,process,0,1
71291,issues,0,0
71292,--,0,1
71293,where,0,0
71294,and,0,0
71295,how,0,0
71296,care,0,1
71297,was,0,0
71298,delivered,0,1
71299,.,0,1
71300,CONCLUSIONS,0,0
71301,We,0,0
71302,identify,0,0
71303,a,0,0
71304,model,0,0
71305,of,0,0
71306,community,0,1
71307,hospital,0,1
71308,care,0,1
71309,that,0,0
71310,incorporates,0,0
71311,technical,0,0
71312,aspects,0,0
71313,of,0,1
71314,rehabilitation,0,1
71315,within,0,1
71316,a,0,1
71317,human,0,1
71318,approach,0,0
71319,that,0,0
71320,is,0,0
71321,welcomed,0,0
71322,by,0,0
71323,patients,1,1
71324,.,1,1
71325,If,0,0
71326,patients,1,1
71327,are,0,0
71328,to,0,0
71329,be,0,0
71330,able,0,0
71331,to,0,0
71332,participate,0,1
71333,in,0,0
71334,making,0,0
71335,informed,0,1
71336,decisions,0,0
71337,about,0,0
71338,care,0,1
71339,",",0,0
71340,the,0,0
71341,rationale,0,0
71342,for,0,0
71343,the,0,0
71344,activities,0,0
71345,of,0,0
71346,staff,0,1
71347,need,0,0
71348,to,0,0
71349,be,0,0
71350,more,0,0
71351,clearly,0,0
71352,explained,0,0
71353,.,0,1
71354,Recommendations,0,0
71355,are,0,0
71356,made,0,0
71357,about,0,0
71358,the,0,0
71359,appropriate,0,0
71360,scope,0,0
71361,of,0,1
71362,qualitative,0,0
71363,findings,0,0
71364,in,0,1
71365,the,0,0
71366,context,0,0
71367,of,0,0
71368,trials,0,0
71369,and,0,1
71370,about,0,0
71371,techniques,0,0
71372,to,0,1
71373,access,0,1
71374,patient,1,1
71375,views,0,0
71376,in,0,1
71377,areas,0,0
71378,where,0,0
71379,they,0,1
71380,have,0,0
71381,difficulty,0,0
71382,in,0,0
71383,expressing,0,1
71384,critical,0,1
71385,impressions,0,1
71386,.,0,1
71387,Ciprofloxacin/dexamethasone,0,0
71388,drops,0,0
71389,decrease,0,0
71390,the,0,0
71391,incidence,0,0
71392,of,0,0
71393,physician,0,1
71394,and,0,1
71395,patient,0,1
71396,outcomes,0,0
71397,of,0,1
71398,otorrhea,0,1
71399,after,0,1
71400,tube,0,1
71401,placement,0,1
71402,.,0,1
71403,OBJECTIVE,0,0
71404,To,0,0
71405,evaluate,0,0
71406,ciprofloxacin,0,1
71407,0.3,0,0
71408,%,0,1
71409,/dexamethasone,0,0
71410,0.1,0,0
71411,%,0,0
71412,(,0,1
71413,CIPRODEX,0,0
71414,",",0,0
71415,Alcon,0,0
71416,",",0,0
71417,Ft.,0,1
71418,Worth,0,1
71419,",",0,1
71420,TX,0,1
71421,),0,0
71422,for,0,0
71423,the,0,0
71424,prevention,0,1
71425,of,0,0
71426,early,0,1
71427,post-operative,0,0
71428,otorrhea,0,1
71429,following,0,0
71430,TT,0,1
71431,placement,0,1
71432,.,0,1
71433,METHODS,0,0
71434,This,0,0
71435,was,0,0
71436,a,0,0
71437,single-center,0,1
71438,",",0,0
71439,randomized,0,1
71440,",",0,0
71441,evaluator-blinded,0,0
71442,",",0,0
71443,parallel-group,0,0
71444,study,0,1
71445,.,0,1
71446,Two,1,1
71447,hundred,1,1
71448,children,1,1
71449,undergoing,1,1
71450,bilateral,1,1
71451,TT,1,1
71452,placement,1,0
71453,were,1,0
71454,categorized,1,1
71455,as,1,0
71456,having,1,1
71457,unilateral,1,1
71458,(,1,1
71459,wet/dry,1,0
71460,),1,1
71461,",",1,1
71462,bilateral,1,1
71463,(,1,1
71464,wet/wet,1,0
71465,),1,1
71466,",",1,0
71467,or,1,1
71468,no,1,0
71469,(,1,0
71470,dry/dry,1,0
71471,),1,1
71472,effusion,1,1
71473,at,1,0
71474,the,1,0
71475,time,1,0
71476,of,1,0
71477,surgery,1,1
71478,.,1,1
71479,All,0,1
71480,patients,0,1
71481,received,0,1
71482,Ciprodex,0,0
71483,or,0,1
71484,no,0,0
71485,treatment,0,0
71486,for,0,0
71487,5,0,1
71488,days,0,0
71489,post-operatively,0,1
71490,and,0,0
71491,returned,0,1
71492,at,0,1
71493,2,0,1
71494,weeks,0,1
71495,.,0,1
71496,RESULTS,0,0
71497,Physician-observed,0,0
71498,otorrhea,0,1
71499,was,0,0
71500,reported,0,0
71501,in,0,1
71502,5,0,1
71503,(,0,1
71504,4.95,0,0
71505,%,0,0
71506,),0,1
71507,patients,0,1
71508,receiving,0,1
71509,Ciprodex,0,0
71510,and,0,1
71511,39,0,1
71512,(,0,1
71513,39.39,0,0
71514,%,0,0
71515,),0,1
71516,patients,0,1
71517,receiving,0,1
71518,no,0,0
71519,treatment,0,0
71520,(,0,0
71521,p,0,0
71522,<,0,0
71523,0.0001,0,0
71524,),0,1
71525,.,0,1
71526,Treatment,0,0
71527,decreased,0,0
71528,otorrhea,0,0
71529,in,0,1
71530,all,0,1
71531,groups,0,0
71532,",",0,0
71533,while,0,0
71534,the,0,0
71535,greatest,0,0
71536,benefit,0,0
71537,was,0,0
71538,observed,0,0
71539,in,0,0
71540,patients,0,1
71541,with,0,1
71542,bilateral,0,1
71543,effusion,0,1
71544,(,0,1
71545,93,0,1
71546,%,0,0
71547,reduction,0,0
71548,),0,1
71549,.,0,1
71550,Ciprodex,0,0
71551,treatment,0,0
71552,also,0,0
71553,decreased,0,0
71554,the,0,0
71555,rate,0,0
71556,of,0,0
71557,clinically,0,1
71558,diagnosed,0,1
71559,otitis,0,1
71560,media,0,1
71561,(,0,1
71562,OM,0,1
71563,),0,1
71564,and,0,0
71565,effusion,0,1
71566,following,0,0
71567,TT,0,1
71568,placement,0,0
71569,(,0,1
71570,p,0,0
71571,<,0,0
71572,or,0,1
71573,=0.0006,0,0
71574,),0,1
71575,.,0,1
71576,CONCLUSION,0,0
71577,Ciprodex,0,0
71578,reduced,0,0
71579,early,0,1
71580,post-operative,0,0
71581,otorrhea,0,1
71582,",",0,0
71583,clinically,0,1
71584,diagnosed,0,1
71585,OM,0,0
71586,and,0,1
71587,effusion,0,1
71588,following,0,0
71589,TT,0,1
71590,insertion,0,1
71591,.,0,1
71592,The,0,0
71593,greatest,0,0
71594,reduction,0,0
71595,in,0,0
71596,otorrhea,0,1
71597,was,0,0
71598,observed,0,0
71599,in,0,0
71600,patients,1,1
71601,with,1,1
71602,bilateral,1,1
71603,effusion,1,1
71604,at,1,0
71605,the,1,0
71606,time,1,0
71607,of,1,0
71608,surgery,1,1
71609,.,1,1
71610,The,0,0
71611,study,0,0
71612,of,0,0
71613,inhibiting,0,0
71614,systematic,0,1
71615,inflammatory,0,0
71616,response,0,0
71617,syndrome,0,1
71618,by,0,0
71619,applying,0,0
71620,xenogenic,0,0
71621,(,0,1
71622,porcine,0,1
71623,),0,1
71624,acellular,0,0
71625,dermal,0,0
71626,matrix,0,1
71627,on,0,0
71628,second-degree,1,1
71629,burns,1,1
71630,.,1,1
71631,OBJECTIVE,0,0
71632,To,0,0
71633,investigate,0,0
71634,the,0,0
71635,influence,0,0
71636,of,0,0
71637,xenogenic,0,0
71638,(,0,1
71639,porcine,0,1
71640,),0,1
71641,acellular,0,0
71642,dermal,0,0
71643,matrix,0,0
71644,on,0,0
71645,the,0,0
71646,systematic,0,0
71647,inflammatory,0,0
71648,reaction,0,0
71649,syndrome,0,1
71650,(,0,1
71651,SIRS,0,1
71652,),0,1
71653,",",0,0
71654,and,0,0
71655,the,0,0
71656,reaction,0,0
71657,of,0,0
71658,burn,1,1
71659,patients,1,1
71660,to,0,1
71661,tissue,0,1
71662,damage,0,0
71663,upon,0,0
71664,application,0,0
71665,to,0,1
71666,second-degree,1,1
71667,burn,1,1
71668,wounds,1,1
71669,.,1,1
71670,METHOD,0,0
71671,Seventy-two,1,1
71672,cases,1,1
71673,of,1,1
71674,patients,1,1
71675,with,1,1
71676,acute,1,1
71677,second-degree,1,1
71678,burns,1,1
71679,were,1,1
71680,enrolled,1,1
71681,in,1,0
71682,the,1,0
71683,study,1,1
71684,.,1,1
71685,According,0,0
71686,to,0,0
71687,the,0,0
71688,total,0,1
71689,burn,0,1
71690,surface,0,0
71691,area,0,0
71692,(,0,1
71693,TBSA,0,1
71694,),0,1
71695,and,0,0
71696,the,0,0
71697,treatment,0,0
71698,methods,0,1
71699,",",0,0
71700,we,0,0
71701,randomly,0,1
71702,divided,0,1
71703,the,0,0
71704,patients,0,1
71705,into,0,1
71706,four,0,1
71707,groups,0,1
71708,.,0,1
71709,Group,0,1
71710,A,0,1
71711,(,0,1
71712,treatment,0,0
71713,group,0,1
71714,),0,1
71715,:,0,1
71716,patients,1,1
71717,with,1,1
71718,less,1,1
71719,than,1,1
71720,30,1,1
71721,%,1,0
71722,TBSA,1,1
71723,covered,1,0
71724,with,1,1
71725,xenogenic,1,1
71726,acellular,1,0
71727,dermal,1,1
71728,matrix,1,1
71729,.,1,1
71730,Group,0,1
71731,B,0,0
71732,(,0,0
71733,control,0,1
71734,group,0,1
71735,),0,1
71736,:,0,1
71737,patients,1,1
71738,with,1,1
71739,less,1,1
71740,than,1,1
71741,30,1,1
71742,%,1,0
71743,TBSA,1,1
71744,covered,1,0
71745,with,1,1
71746,betadine,1,0
71747,ointment,1,1
71748,gauzes,1,1
71749,.,1,1
71750,Group,0,1
71751,C,0,0
71752,(,0,1
71753,treatment,0,0
71754,group,0,1
71755,),0,1
71756,:,0,1
71757,patients,1,1
71758,with,1,1
71759,more,1,1
71760,than,1,1
71761,30,1,1
71762,%,1,0
71763,TBSA,1,1
71764,covered,1,0
71765,with,1,1
71766,porcine,1,1
71767,acellular,1,0
71768,dermal,1,1
71769,matrix,1,1
71770,.,1,1
71771,Group,0,1
71772,D,0,0
71773,(,0,0
71774,control,0,1
71775,group,0,1
71776,),0,1
71777,:,0,1
71778,patients,1,1
71779,with,1,1
71780,more,1,1
71781,than,1,1
71782,30,1,1
71783,%,1,0
71784,TBSA,1,1
71785,covered,1,0
71786,with,1,1
71787,betadine,1,0
71788,ointment,1,1
71789,gauzes,1,1
71790,.,1,1
71791,Serum,0,1
71792,level,0,0
71793,of,0,0
71794,C-reactive,0,1
71795,protein,0,0
71796,(,0,1
71797,CRP,0,1
71798,),0,1
71799,was,0,0
71800,measured,0,0
71801,by,0,0
71802,single,0,0
71803,radial,0,1
71804,immunodiffusion,0,0
71805,method,0,0
71806,on,0,0
71807,1,0,1
71808,",",0,1
71809,4,0,0
71810,",",0,1
71811,7,0,1
71812,and,0,1
71813,14,0,1
71814,days,0,0
71815,postburn,0,1
71816,.,0,0
71817,RESULTS,0,0
71818,The,0,0
71819,serum,0,0
71820,level,0,0
71821,of,0,0
71822,CRP,0,1
71823,in,0,1
71824,group,0,1
71825,A,0,1
71826,was,0,0
71827,significantly,0,0
71828,less,0,0
71829,than,0,0
71830,that,0,0
71831,of,0,0
71832,in,0,0
71833,group,0,1
71834,B,0,1
71835,(,0,1
71836,P,0,0
71837,<,0,0
71838,0.05,0,0
71839,),0,1
71840,on,0,1
71841,days,0,0
71842,4,0,1
71843,",",0,1
71844,7,0,1
71845,and,0,1
71846,14,0,1
71847,.,0,1
71848,The,0,0
71849,serum,0,0
71850,level,0,0
71851,of,0,0
71852,CRP,0,1
71853,in,0,1
71854,group,0,1
71855,C,0,0
71856,increased,0,0
71857,slowly,0,0
71858,",",0,0
71859,descended,0,0
71860,quickly,0,0
71861,and,0,0
71862,was,0,0
71863,significantly,0,0
71864,less,0,0
71865,than,0,0
71866,that,0,0
71867,of,0,0
71868,in,0,0
71869,group,0,1
71870,D,0,1
71871,on,0,1
71872,days,0,0
71873,4,0,1
71874,",",0,1
71875,7,0,1
71876,and,0,1
71877,14,0,1
71878,.,0,1
71879,CONCLUSION,0,0
71880,The,0,0
71881,application,0,0
71882,of,0,0
71883,xenogenic,0,0
71884,(,0,1
71885,porcine,0,1
71886,),0,1
71887,acellular,0,0
71888,dermal,0,0
71889,matrix,0,1
71890,on,0,0
71891,second-degree,1,1
71892,burn,1,1
71893,wound,1,0
71894,can,0,0
71895,decrease,0,0
71896,serum,0,0
71897,level,0,0
71898,of,0,0
71899,CRP,0,0
71900,of,0,1
71901,the,0,0
71902,patients,0,1
71903,",",0,0
71904,which,0,0
71905,may,0,0
71906,play,0,0
71907,an,0,0
71908,important,0,0
71909,role,0,0
71910,in,0,0
71911,reducing,0,0
71912,SIRS,0,1
71913,and,0,1
71914,sepsis,0,1
71915,incidence,0,0
71916,.,0,1
71917,Immediately,0,0
71918,restored,0,0
71919,",",0,0
71920,single-tapered,0,0
71921,implants,1,1
71922,in,1,1
71923,the,1,1
71924,anterior,1,1
71925,maxilla,1,1
71926,:,1,1
71927,prosthodontic,0,1
71928,and,0,1
71929,aesthetic,0,1
71930,outcomes,0,0
71931,after,0,1
71932,1,0,1
71933,year,0,1
71934,.,0,1
71935,BACKGROUND,0,0
71936,Conventional,0,1
71937,implant,0,1
71938,protocols,0,0
71939,advocate,0,0
71940,a,0,0
71941,two-stage,0,0
71942,technique,0,0
71943,with,0,1
71944,a,0,0
71945,load-free,0,0
71946,",",0,0
71947,submerged,0,0
71948,healing,0,0
71949,period,0,1
71950,.,0,1
71951,Recent,0,0
71952,studies,0,0
71953,suggest,0,0
71954,that,0,0
71955,immediate,0,0
71956,restoration,0,1
71957,of,0,1
71958,single,0,0
71959,implants,0,1
71960,may,0,0
71961,be,0,0
71962,a,0,0
71963,viable,0,0
71964,treatment,0,0
71965,option,0,0
71966,.,0,0
71967,PURPOSE,0,0
71968,The,0,0
71969,purpose,0,0
71970,of,0,0
71971,this,0,0
71972,study,0,0
71973,was,0,0
71974,to,0,0
71975,evaluate,0,0
71976,prosthodontic,1,1
71977,and,1,0
71978,aesthetic,1,1
71979,peri-implant,1,1
71980,mucosal,0,1
71981,outcomes,0,0
71982,of,0,0
71983,immediately,1,0
71984,restored,1,0
71985,",",1,0
71986,Southern,1,1
71987,single-tapered,1,1
71988,implants,1,1
71989,in,1,1
71990,the,1,1
71991,anterior,1,1
71992,maxilla,1,1
71993,after,1,1
71994,1,1,1
71995,year,1,1
71996,.,1,1
71997,MATERIALS,0,0
71998,AND,0,0
71999,METHODS,0,0
72000,Participants,1,1
72001,(,1,1
72002,mean,1,1
72003,age,1,1
72004,:,1,1
72005,43.25,1,1
72006,years,1,1
72007,;,1,1
72008,range,1,1
72009,:,1,1
72010,23-71,1,1
72011,years,1,1
72012,),1,1
72013,satisfying,1,0
72014,specified,1,1
72015,inclusion,1,1
72016,criteria,1,1
72017,were,0,1
72018,randomly,0,1
72019,allocated,0,1
72020,to,0,0
72021,conventional,0,1
72022,two-stage,0,1
72023,restoration,0,0
72024,(,0,1
72025,control,0,1
72026,group,0,1
72027,;,0,1
72028,n=14,0,1
72029,),0,1
72030,and,0,0
72031,immediate,0,0
72032,restoration,0,1
72033,groups,0,0
72034,(,0,1
72035,test,0,0
72036,group,0,1
72037,;,0,0
72038,n,0,1
72039,=14,0,1
72040,),0,0
72041,in,0,0
72042,a,0,1
72043,randomized,0,1
72044,controlled,0,0
72045,clinical,0,0
72046,trial,0,1
72047,.,0,1
72048,Tapered,0,0
72049,",",0,0
72050,roughened-surface,0,0
72051,Southern,0,1
72052,implants,0,1
72053,were,0,1
72054,placed,0,0
72055,using,0,0
72056,a,0,0
72057,standardized,0,0
72058,technique,0,0
72059,",",0,0
72060,and,0,0
72061,implant,0,0
72062,level,0,0
72063,bone,0,1
72064,impressions,0,0
72065,were,0,1
72066,made,0,1
72067,.,0,1
72068,Provisional,0,0
72069,screw-retained,0,1
72070,crowns,0,1
72071,",",0,1
72072,out,0,1
72073,of,0,0
72074,occlusion,0,1
72075,",",0,0
72076,were,0,0
72077,placed,0,0
72078,at,0,0
72079,second-stage,0,1
72080,surgery,0,1
72081,after,0,1
72082,26,0,1
72083,weeks,0,0
72084,for,0,1
72085,the,0,1
72086,conventional,0,1
72087,restoration,0,0
72088,group,0,1
72089,",",0,0
72090,and,0,0
72091,within,0,1
72092,4,0,0
72093,hours,0,0
72094,of,0,1
72095,implant,0,1
72096,placement,0,0
72097,for,0,0
72098,the,0,0
72099,immediate,0,0
72100,restoration,0,0
72101,group,0,1
72102,.,0,1
72103,Both,0,0
72104,groups,0,0
72105,had,0,1
72106,definitive,0,1
72107,screw-retained,0,1
72108,metal-ceramic,0,1
72109,crowns,0,1
72110,placed,0,0
72111,in,0,1
72112,occlusion,0,1
72113,8,0,1
72114,weeks,0,0
72115,later,0,1
72116,.,0,1
72117,Peri-implant,0,0
72118,mucosal,0,0
72119,response,0,0
72120,and,0,0
72121,papilla,0,1
72122,index,0,1
72123,were,0,1
72124,recorded,0,0
72125,4,0,0
72126,weeks,0,0
72127,after,0,1
72128,definitive,0,1
72129,crown,0,1
72130,placement,0,0
72131,to,0,0
72132,allow,0,0
72133,for,0,0
72134,mucosal,0,1
72135,maturation,0,0
72136,and,0,1
72137,at,0,1
72138,1,0,1
72139,year,0,1
72140,.,0,1
72141,Prosthodontic,0,1
72142,and,0,0
72143,aesthetic,0,1
72144,outcomes,0,0
72145,were,0,1
72146,assessed,0,0
72147,using,0,0
72148,established,0,1
72149,criteria,0,1
72150,.,0,0
72151,RESULTS,0,0
72152,There,0,0
72153,were,0,0
72154,no,0,0
72155,significant,0,0
72156,differences,0,0
72157,within,0,1
72158,",",0,1
72159,or,0,1
72160,between,0,0
72161,",",0,0
72162,the,0,0
72163,control,0,0
72164,and,0,0
72165,test,0,0
72166,groups,0,0
72167,for,0,0
72168,age,0,1
72169,",",0,0
72170,gender,0,0
72171,",",0,0
72172,bone,0,0
72173,quality,0,0
72174,or,0,1
72175,quantity,0,0
72176,",",0,0
72177,implant,0,1
72178,stability,0,0
72179,measurements,0,0
72180,at,0,1
72181,surgery,0,1
72182,",",0,0
72183,or,0,1
72184,implant,0,1
72185,length,0,0
72186,.,0,0
72187,There,0,0
72188,were,0,0
72189,no,0,0
72190,significant,0,0
72191,differences,0,0
72192,in,0,1
72193,the,0,1
72194,implant,0,0
72195,success,0,0
72196,rate,0,0
72197,as,0,0
72198,determined,0,0
72199,by,0,0
72200,radiographic,0,1
72201,bone,0,1
72202,loss,0,0
72203,and,0,1
72204,stability,0,0
72205,tests,0,0
72206,after,0,1
72207,1,0,1
72208,year,0,1
72209,.,0,0
72210,There,0,0
72211,were,0,0
72212,no,0,0
72213,significant,0,0
72214,differences,0,0
72215,in,0,1
72216,prosthodontic,0,1
72217,maintenance,0,0
72218,",",0,0
72219,peri-implant,0,0
72220,mucosal,0,0
72221,response,0,0
72222,",",0,0
72223,and,0,0
72224,papilla,0,1
72225,index,0,0
72226,between,0,0
72227,the,0,1
72228,two,0,0
72229,groups,0,0
72230,over,0,1
72231,1,0,1
72232,year,0,1
72233,.,0,1
72234,CONCLUSIONS,0,0
72235,Tapered,0,0
72236,",",0,1
72237,roughened-surface,0,0
72238,implants,0,1
72239,immediately,0,0
72240,restored,0,0
72241,with,0,1
72242,single,0,1
72243,provisional,0,1
72244,crowns,0,1
72245,at,0,1
72246,surgery,0,1
72247,and,0,1
72248,definitive,0,1
72249,crowns,0,1
72250,8,0,1
72251,weeks,0,1
72252,later,0,1
72253,were,0,1
72254,as,0,0
72255,prosthodontically,0,1
72256,and,0,0
72257,aesthetically,0,0
72258,successful,0,0
72259,as,0,0
72260,conventionally,0,1
72261,restored,0,0
72262,two-stage,0,1
72263,implants,0,1
72264,during,0,1
72265,the,0,1
72266,first,0,0
72267,year,0,1
72268,of,0,0
72269,service,0,1
72270,.,0,1
72271,Restoring,0,0
72272,single,0,0
72273,implants,0,1
72274,immediately,0,0
72275,with,0,1
72276,screw-retained,0,1
72277,crowns,0,1
72278,is,0,0
72279,an,0,0
72280,efficient,0,0
72281,procedure,0,0
72282,",",0,0
72283,but,0,0
72284,the,0,0
72285,short-term,0,0
72286,outcome,0,0
72287,is,0,0
72288,by,0,0
72289,no,0,0
72290,means,0,0
72291,superior,0,0
72292,to,0,0
72293,a,0,1
72294,conventional,0,0
72295,two-stage,0,1
72296,approach,0,1
72297,.,0,1
72298,Enhanced,0,1
72299,inotropic,0,0
72300,state,0,1
72301,of,0,0
72302,the,0,0
72303,failing,0,1
72304,left,0,1
72305,ventricle,0,0
72306,by,0,0
72307,cardiac,0,1
72308,contractility,0,0
72309,modulation,0,0
72310,electrical,0,0
72311,signals,0,0
72312,is,0,0
72313,not,0,0
72314,associated,0,0
72315,with,0,1
72316,increased,0,0
72317,myocardial,0,1
72318,oxygen,0,0
72319,consumption,0,0
72320,.,0,1
72321,BACKGROUND,0,0
72322,Previous,0,1
72323,studies,0,0
72324,in,0,1
72325,patients,1,1
72326,and,1,1
72327,in,1,1
72328,dogs,1,1
72329,with,1,1
72330,experimentally,1,1
72331,induced,1,0
72332,heart,1,1
72333,failure,1,1
72334,(,1,1
72335,HF,1,1
72336,),1,1
72337,showed,0,0
72338,that,0,0
72339,electrical,0,0
72340,signals,0,0
72341,applied,0,0
72342,to,0,1
72343,the,0,0
72344,failing,0,1
72345,myocardium,0,0
72346,during,0,0
72347,the,0,0
72348,absolute,0,0
72349,refractory,0,1
72350,period,0,0
72351,improved,0,0
72352,left,0,1
72353,ventricular,0,1
72354,(,0,1
72355,LV,0,1
72356,),0,1
72357,function,0,0
72358,.,0,1
72359,We,0,0
72360,examined,0,0
72361,the,0,0
72362,effects,0,0
72363,these,0,0
72364,same,0,0
72365,cardiac,0,1
72366,contractility,0,0
72367,modulating,0,0
72368,(,0,1
72369,CCM,0,0
72370,),0,1
72371,electrical,0,0
72372,signals,0,0
72373,on,0,1
72374,myocardial,0,1
72375,oxygen,0,0
72376,consumption,0,0
72377,(,0,1
72378,MVO,0,1
72379,(,0,1
72380,2,0,1
72381,),0,1
72382,),0,1
72383,in,0,0
72384,both,1,0
72385,patients,1,1
72386,and,1,1
72387,dogs,1,1
72388,with,1,1
72389,chronic,1,1
72390,HF,1,1
72391,.,1,1
72392,METHODS,0,0
72393,AND,0,0
72394,RESULTS,0,1
72395,Six,1,1
72396,dogs,1,1
72397,with,1,1
72398,microembolizations-induced,1,1
72399,HF,1,1
72400,and,1,1
72401,9,1,1
72402,HF,1,1
72403,patients,1,1
72404,underwent,1,1
72405,CCM,1,1
72406,leads,1,0
72407,and,1,1
72408,generator,1,1
72409,(,1,1
72410,OPTIMIZER,1,0
72411,II,1,1
72412,),1,1
72413,implantation,1,1
72414,.,1,1
72415,After,0,0
72416,baseline,0,0
72417,measurements,0,0
72418,",",0,1
72419,CCM,0,1
72420,signals,0,0
72421,were,0,1
72422,delivered,0,0
72423,continuously,0,0
72424,for,0,1
72425,2,0,1
72426,hours,0,1
72427,in,0,1
72428,dogs,0,1
72429,and,0,1
72430,for,0,1
72431,30,0,1
72432,minutes,0,0
72433,in,0,1
72434,patients,0,1
72435,.,0,1
72436,MVO,0,1
72437,(,0,1
72438,2,0,1
72439,),0,1
72440,was,0,0
72441,measured,0,0
72442,before,0,0
72443,and,0,1
72444,after,0,1
72445,CCM,0,0
72446,therapy,0,1
72447,.,0,1
72448,In,0,0
72449,dogs,0,1
72450,",",0,1
72451,CCM,0,0
72452,therapy,0,0
72453,increased,0,0
72454,LV,0,1
72455,ejection,0,1
72456,fraction,0,1
72457,at,0,1
72458,2,0,1
72459,hours,0,1
72460,(,0,1
72461,26,0,1
72462,+/-,0,1
72463,1,0,1
72464,versus,0,0
72465,31,0,1
72466,+/-,0,0
72467,2,0,1
72468,%,0,0
72469,",",0,1
72470,P,0,0
72471,=,0,1
72472,.001,0,0
72473,),0,1
72474,without,0,1
72475,increasing,0,0
72476,MVO,0,1
72477,(,0,1
72478,2,0,1
72479,),0,1
72480,(,0,1
72481,257,0,1
72482,+/-,0,1
72483,41,0,1
72484,versus,0,0
72485,180,0,1
72486,+/-,0,0
72487,34,0,1
72488,micromol/min,0,0
72489,),0,1
72490,.,0,1
72491,In,0,0
72492,patients,0,1
72493,",",0,1
72494,CCM,0,0
72495,therapy,0,0
72496,increased,0,0
72497,LV,0,1
72498,peak,0,0
72499,+dP/dt,0,1
72500,by,0,0
72501,10.1,0,1
72502,+/-,0,1
72503,1.5,0,1
72504,%,0,0
72505,.,0,1
72506,As,0,0
72507,with,0,1
72508,dogs,0,1
72509,",",0,1
72510,the,0,0
72511,increase,0,0
72512,in,0,0
72513,LV,0,1
72514,function,0,0
72515,after,0,1
72516,30,0,1
72517,minutes,0,0
72518,of,0,1
72519,CCM,0,1
72520,therapy,0,0
72521,was,0,0
72522,not,0,0
72523,associated,0,0
72524,with,0,1
72525,increased,0,0
72526,MVO,0,1
72527,(,0,1
72528,2,0,1
72529,),0,1
72530,(,0,1
72531,13.6,0,0
72532,+/-,0,1
72533,9.7,0,1
72534,versus,0,0
72535,12.5,0,0
72536,+/-,0,0
72537,7.2,0,1
72538,mL,0,1
72539,O,0,0
72540,(,0,1
72541,2,0,1
72542,),0,1
72543,/min,0,0
72544,),0,1
72545,.,0,0
72546,CONCLUSIONS,0,0
72547,The,0,0
72548,study,0,0
72549,results,0,0
72550,suggest,0,0
72551,that,0,0
72552,unlike,0,0
72553,cAMP-dependent,0,0
72554,positive,0,1
72555,inotropic,0,0
72556,drugs,0,0
72557,",",0,0
72558,the,0,0
72559,increase,0,0
72560,in,0,0
72561,LV,0,1
72562,function,0,0
72563,during,0,0
72564,CCM,0,0
72565,therapy,0,0
72566,is,0,0
72567,elicited,0,0
72568,without,0,0
72569,increasing,0,0
72570,MVO,0,1
72571,(,0,1
72572,2,0,1
72573,),0,1
72574,.,0,1
72575,Effects,0,0
72576,of,0,1
72577,application,0,0
72578,in,0,0
72579,spring,0,1
72580,of,0,0
72581,urea,0,0
72582,fertiliser,0,1
72583,on,0,0
72584,aspects,0,0
72585,of,0,1
72586,reproductive,0,1
72587,performance,0,0
72588,of,0,0
72589,pasture-fed,1,1
72590,dairy,1,1
72591,cows,1,1
72592,.,1,1
72593,AIMS,0,0
72594,To,0,0
72595,assess,0,0
72596,if,0,0
72597,raising,0,0
72598,concentrations,0,0
72599,of,0,1
72600,crude,0,1
72601,protein,0,0
72602,(,0,1
72603,CP,0,0
72604,),0,1
72605,in,0,0
72606,pasture,0,1
72607,in,0,0
72608,spring,0,1
72609,by,0,0
72610,the,0,0
72611,frequent,0,0
72612,application,0,0
72613,of,0,0
72614,urea,0,0
72615,fertiliser,0,1
72616,would,0,0
72617,affect,0,0
72618,ovarian,0,1
72619,follicular,0,1
72620,dynamics,0,0
72621,",",0,1
72622,luteal,0,1
72623,function,0,0
72624,",",0,0
72625,onset,0,0
72626,of,0,0
72627,oestrus,0,1
72628,and,0,1
72629,reproductive,0,1
72630,performance,0,0
72631,of,0,1
72632,dairy,1,1
72633,cows,1,1
72634,under,1,1
72635,farming,1,1
72636,conditions,1,1
72637,in,1,1
72638,New,1,1
72639,Zealand,1,1
72640,.,1,1
72641,METHODS,0,0
72642,Spring-calved,1,1
72643,dairy,1,1
72644,cows,1,1
72645,were,1,1
72646,grazed,1,1
72647,for,1,1
72648,101,1,1
72649,days,1,1
72650,in,1,1
72651,paddocks,1,1
72652,that,1,0
72653,were,1,1
72654,either,1,0
72655,not,1,0
72656,fertilised,1,0
72657,(,1,1
72658,Control,1,1
72659,;,1,1
72660,n=20,1,1
72661,),1,0
72662,during,1,0
72663,the,1,0
72664,course,1,0
72665,of,1,0
72666,the,1,0
72667,study,1,0
72668,",",1,0
72669,or,1,1
72670,were,1,0
72671,fertilised,1,0
72672,with,1,1
72673,40-50,1,0
72674,kg,1,1
72675,nitrogen,1,0
72676,(,1,1
72677,N,1,1
72678,),1,1
72679,/ha,1,0
72680,every,1,0
72681,4-6,1,1
72682,weeks,1,0
72683,(,1,1
72684,High-N,1,1
72685,;,1,1
72686,n=20,1,1
72687,),1,1
72688,.,1,1
72689,Similar,0,0
72690,generous,0,1
72691,pasture,0,1
72692,allowances,0,1
72693,were,0,1
72694,offered,0,0
72695,to,0,1
72696,both,0,0
72697,groups,0,0
72698,.,0,1
72699,Concentrations,0,0
72700,of,0,0
72701,CP,0,1
72702,in,0,0
72703,pasture,0,1
72704,",",0,0
72705,urea,0,0
72706,in,0,0
72707,serum,0,0
72708,and,0,0
72709,progesterone,0,0
72710,in,0,0
72711,milk,0,1
72712,were,0,1
72713,measured,0,0
72714,.,0,1
72715,Ovarian,0,0
72716,follicular,0,1
72717,and,0,1
72718,luteal,0,1
72719,dynamics,0,0
72720,were,0,1
72721,determined,0,0
72722,using,0,0
72723,ultrasonography,0,1
72724,.,0,1
72725,Oestrous,0,0
72726,behaviour,0,0
72727,and,0,0
72728,the,0,0
72729,number,0,0
72730,",",0,0
72731,time,0,0
72732,and,0,0
72733,outcome,0,0
72734,of,0,1
72735,inseminations,0,1
72736,were,0,1
72737,also,0,0
72738,recorded,0,0
72739,.,0,1
72740,RESULTS,0,0
72741,Mean,0,1
72742,concentrations,0,0
72743,of,0,1
72744,CP,0,1
72745,in,0,1
72746,pasture,0,1
72747,and,0,0
72748,urea,0,0
72749,in,0,0
72750,serum,0,0
72751,was,0,0
72752,higher,0,0
72753,in,0,0
72754,the,0,0
72755,High-N,0,1
72756,than,0,0
72757,the,0,0
72758,Control,0,1
72759,group,0,1
72760,(,0,1
72761,25.2,0,1
72762,vs,0,0
72763,21.6,0,1
72764,and,0,1
72765,8.3,0,0
72766,vs,0,0
72767,5.4,0,0
72768,mmol/L,0,0
72769,for,0,1
72770,CP,0,0
72771,and,0,1
72772,urea,0,0
72773,",",0,0
72774,respectively,0,0
72775,;,0,0
72776,p,0,0
72777,<,0,0
72778,0.001,0,0
72779,),0,1
72780,.,0,1
72781,Intervals,0,0
72782,between,0,0
72783,calving,0,1
72784,and,0,1
72785,first,0,0
72786,oestrus,0,1
72787,",",0,0
72788,first,0,0
72789,insemination,0,1
72790,and,0,0
72791,conception,0,0
72792,",",0,0
72793,the,0,0
72794,time,0,0
72795,of,0,0
72796,first,0,0
72797,emergence,0,1
72798,of,0,0
72799,a,0,1
72800,dominant,0,0
72801,follicle,0,1
72802,",",0,0
72803,milk,0,0
72804,progesterone,0,0
72805,concentration,0,0
72806,",",0,0
72807,and,0,0
72808,the,0,0
72809,diameter,0,0
72810,of,0,0
72811,the,0,0
72812,corpus,0,0
72813,luteum,0,1
72814,(,0,1
72815,CL,0,1
72816,),0,1
72817,in,0,0
72818,the,0,0
72819,first,0,0
72820,luteal,0,1
72821,phase,0,1
72822,did,0,0
72823,not,0,0
72824,differ,0,0
72825,significantly,0,0
72826,between,0,0
72827,groups,0,0
72828,.,0,1
72829,The,0,0
72830,interval,0,0
72831,from,0,1
72832,calving,0,1
72833,to,0,1
72834,first,0,0
72835,ovulation,0,1
72836,tended,0,0
72837,(,0,1
72838,p=0.10,0,0
72839,),0,0
72840,to,0,0
72841,be,0,0
72842,lower,0,0
72843,and,0,0
72844,the,0,0
72845,diameter,0,0
72846,of,0,0
72847,the,0,0
72848,dominant,0,0
72849,follicle,0,1
72850,of,0,0
72851,the,0,0
72852,oestrous,0,1
72853,cycle,0,0
72854,at,0,0
72855,which,0,0
72856,cows,0,1
72857,conceived,0,0
72858,was,0,0
72859,greater,0,0
72860,(,0,1
72861,p=0.02,0,0
72862,),0,1
72863,in,0,0
72864,Control,0,1
72865,than,0,1
72866,High-N,0,1
72867,cows,0,1
72868,.,0,1
72869,CONCLUSIONS,0,0
72870,The,0,0
72871,use,0,0
72872,of,0,0
72873,large,0,1
72874,amounts,0,0
72875,of,0,1
72876,urea,0,0
72877,fertiliser,0,1
72878,during,0,0
72879,spring,0,1
72880,and,0,0
72881,the,0,0
72882,consequent,0,0
72883,increases,0,0
72884,in,0,1
72885,concentrations,0,0
72886,of,0,1
72887,CP,0,1
72888,in,0,1
72889,pasture,0,1
72890,and,0,0
72891,urea,0,0
72892,in,0,0
72893,serum,0,0
72894,did,0,0
72895,not,0,0
72896,negatively,0,0
72897,affect,0,0
72898,any,0,0
72899,of,0,0
72900,the,0,0
72901,parameters,0,0
72902,of,0,0
72903,reproductive,0,1
72904,performance,0,0
72905,of,0,0
72906,pasture-fed,1,1
72907,dairy,1,1
72908,cows,1,1
72909,that,0,0
72910,were,0,1
72911,assessed,0,0
72912,in,0,0
72913,this,0,0
72914,study,0,1
72915,.,0,1
72916,Temporal,0,1
72917,judgements,0,0
72918,of,0,1
72919,internal,0,1
72920,and,0,1
72921,external,0,1
72922,events,0,0
72923,in,0,1
72924,persons,1,1
72925,with,1,1
72926,and,1,1
72927,without,1,1
72928,autism,1,1
72929,.,1,0
72930,When,0,0
72931,participants,0,1
72932,make,0,0
72933,judgments,0,0
72934,about,0,0
72935,the,0,0
72936,onset,0,1
72937,of,0,0
72938,self-initiated,0,0
72939,movements,0,0
72940,they,0,0
72941,typically,0,1
72942,report,0,0
72943,the,0,0
72944,movement,0,0
72945,occurred,0,0
72946,earlier,0,1
72947,than,0,0
72948,it,0,0
72949,had,0,1
72950,[,0,0
72951,Obhi,0,0
72952,",",0,1
72953,S.,0,1
72954,S.,0,1
72955,",",0,0
72956,&,0,1
72957,Haggard,0,1
72958,",",0,1
72959,P.,0,1
72960,(,0,1
72961,2004,0,1
72962,),0,1
72963,.,0,1
72964,Free,0,0
72965,will,0,0
72966,and,0,0
72967,free,0,0
72968,wo,0,0
72969,n't,0,1
72970,.,0,0
72971,American,0,1
72972,Scientific,0,0
72973,",",0,1
72974,92,0,1
72975,",",0,0
72976,358-365.,0,1
72977,],0,1
72978,.,0,1
72979,One,0,0
72980,interpretation,0,0
72981,is,0,0
72982,that,0,0
72983,feed-forward,0,0
72984,processes,0,0
72985,lead,0,0
72986,to,0,0
72987,awareness,0,0
72988,of,0,0
72989,the,0,0
72990,movement,0,0
72991,prior,0,1
72992,to,0,0
72993,execution,0,0
72994,.,0,1
72995,Because,0,0
72996,individuals,1,1
72997,with,1,1
72998,autism,1,1
72999,experience,0,1
73000,reduced,0,0
73001,preparatory,0,0
73002,activity,0,0
73003,prior,0,1
73004,to,0,0
73005,a,0,0
73006,voluntary,0,1
73007,movement,0,0
73008,",",0,0
73009,the,0,0
73010,present,0,0
73011,study,0,1
73012,sought,0,0
73013,to,0,0
73014,determine,0,0
73015,whether,0,0
73016,these,0,0
73017,anticipatory,0,0
73018,biases,0,0
73019,are,0,0
73020,exhibited,0,0
73021,by,0,0
73022,persons,1,1
73023,with,1,1
73024,autism,1,1
73025,.,1,1
73026,Participants,0,1
73027,watched,0,1
73028,a,0,1
73029,dot,0,0
73030,move,0,0
73031,in,0,0
73032,a,0,1
73033,circle,0,1
73034,and,0,0
73035,pressed,0,0
73036,the,0,0
73037,spacebar,0,0
73038,any,0,0
73039,time,0,0
73040,after,0,0
73041,one,0,1
73042,revolution,0,1
73043,.,0,1
73044,A,0,0
73045,tone,0,0
73046,either,0,0
73047,followed,0,0
73048,the,0,0
73049,participants,0,1
73050,',0,1
73051,voluntary,0,1
73052,movement,0,1
73053,or,0,1
73054,was,0,0
73055,computer,0,0
73056,generated,0,1
73057,.,0,1
73058,Participants,0,1
73059,in,0,0
73060,both,0,0
73061,groups,0,0
73062,made,0,1
73063,anticipatory,0,1
73064,judgements,0,0
73065,regarding,0,0
73066,movement,0,1
73067,initiation,0,0
73068,(,0,0
73069,approximately,0,1
73070,100,0,1
73071,ms,0,1
73072,),0,0
73073,.,0,0
73074,When,0,0
73075,the,0,0
73076,movement,0,0
73077,and,0,0
73078,tone,0,0
73079,occurred,0,0
73080,together,0,0
73081,this,0,0
73082,anticipatory,0,0
73083,bias,0,0
73084,was,0,0
73085,also,0,0
73086,present,0,0
73087,",",0,0
73088,regardless,0,0
73089,of,0,0
73090,which,0,0
73091,event,0,0
73092,participants,0,1
73093,focused,0,1
73094,on,0,1
73095,.,0,1
73096,Individuals,1,1
73097,with,1,1
73098,autism,1,1
73099,appear,0,0
73100,to,0,0
73101,have,0,0
73102,access,0,0
73103,to,0,0
73104,a,0,0
73105,similar,0,0
73106,representation,0,0
73107,of,0,1
73108,voluntary,0,1
73109,movements,0,0
73110,",",0,0
73111,however,0,0
73112,this,0,0
73113,representation,0,0
73114,may,0,0
73115,be,0,0
73116,more,0,0
73117,variable,0,0
73118,.,0,0
73119,Preliminary,0,0
73120,analysis,0,0
73121,of,0,0
73122,the,0,0
73123,final,0,0
73124,multicenter,0,0
73125,investigation,0,0
73126,of,0,0
73127,rheopheresis,0,0
73128,for,0,0
73129,age,1,1
73130,related,1,0
73131,macular,1,1
73132,degeneration,1,1
73133,(,1,1
73134,AMD,1,0
73135,),1,1
73136,trial,0,0
73137,(,0,1
73138,MIRA-1,0,0
73139,),0,1
73140,results,0,0
73141,.,0,1
73142,PURPOSE,0,0
73143,To,0,0
73144,present,0,0
73145,an,0,0
73146,initial,0,0
73147,evaluation,0,0
73148,of,0,0
73149,the,0,0
73150,final,0,0
73151,data,0,0
73152,from,0,1
73153,the,0,0
73154,Multicenter,0,1
73155,Investigation,0,1
73156,of,0,0
73157,Rheopheresis,0,1
73158,for,0,1
73159,age-related,0,1
73160,macular,0,1
73161,degeneration,0,1
73162,(,0,1
73163,AMD,0,0
73164,),0,1
73165,(,0,1
73166,MIRA-1,0,0
73167,),0,1
73168,trial,0,0
73169,.,0,1
73170,This,0,0
73171,was,0,0
73172,a,0,0
73173,12-month,0,0
73174,randomized,0,1
73175,",",0,0
73176,prospective,0,0
73177,",",0,0
73178,multicenter,0,0
73179,",",0,0
73180,double-masked,0,0
73181,",",0,0
73182,placebo-controlled,0,0
73183,",",0,0
73184,Food,0,1
73185,and,0,1
73186,Drug,0,1
73187,Administration,0,0
73188,approved,0,1
73189,clinical,0,0
73190,trial,0,1
73191,designed,0,0
73192,to,0,0
73193,compare,0,0
73194,rheopheresis,0,0
73195,treatment,0,0
73196,with,0,1
73197,placebo-control,0,0
73198,treatment,0,1
73199,.,0,1
73200,METHODS,0,0
73201,Patients,1,1
73202,that,1,0
73203,had,1,1
73204,nonexudative,1,1
73205,age-related,1,1
73206,macular,1,1
73207,degeneration,1,1
73208,(,1,1
73209,AMD,1,0
73210,),1,1
73211,and,1,1
73212,certain,1,0
73213,hemorheologic,1,0
73214,abnormalities,1,1
73215,were,0,1
73216,randomized,0,1
73217,to,0,0
73218,either,0,0
73219,rheopheresis,0,0
73220,or,0,1
73221,sham,0,0
73222,treatment,0,0
73223,in,0,0
73224,a,0,1
73225,2:1,0,1
73226,fashion,0,0
73227,.,0,1
73228,Best-corrected,0,0
73229,visual,0,0
73230,acuity,0,0
73231,was,0,0
73232,determined,0,0
73233,before,0,0
73234,and,0,0
73235,at,0,0
73236,3,0,1
73237,",",0,1
73238,6,0,0
73239,",",0,0
73240,9,0,0
73241,",",0,0
73242,and,0,1
73243,12,0,1
73244,months,0,0
73245,following,0,1
73246,treatment,0,1
73247,.,0,1
73248,Adverse,0,0
73249,events,0,0
73250,were,0,1
73251,also,0,0
73252,recorded,0,0
73253,.,0,0
73254,RESULTS,0,0
73255,A,1,0
73256,total,1,1
73257,of,1,0
73258,216,1,1
73259,patients,1,1
73260,were,0,1
73261,randomized,0,1
73262,.,0,1
73263,Of,0,0
73264,these,0,0
73265,",",0,0
73266,18,0,1
73267,were,0,0
73268,not,0,0
73269,included,0,1
73270,in,0,0
73271,the,0,0
73272,vision,0,0
73273,or,0,1
73274,adverse,0,0
73275,events,0,0
73276,evaluation,0,1
73277,because,0,1
73278,they,0,0
73279,did,0,0
73280,not,0,0
73281,complete,0,1
73282,one,0,1
73283,treatment,0,0
73284,.,0,1
73285,This,0,0
73286,decreased,0,0
73287,the,0,0
73288,number,0,0
73289,of,0,0
73290,patients,0,1
73291,that,0,0
73292,were,0,1
73293,evaluated,0,0
73294,for,0,1
73295,adverse,0,0
73296,events,0,0
73297,to,0,1
73298,198,1,1
73299,patients,1,1
73300,.,1,1
73301,In,0,0
73302,this,0,0
73303,group,0,0
73304,",",0,0
73305,there,0,0
73306,were,0,0
73307,27,0,1
73308,serious,0,1
73309,adverse,0,0
73310,events,0,0
73311,",",0,1
73312,but,0,0
73313,only,0,0
73314,1.8,0,0
73315,%,0,0
73316,of,0,1
73317,treatments,0,0
73318,were,0,1
73319,suspended,0,1
73320,because,0,0
73321,of,0,1
73322,adverse,0,0
73323,events,0,0
73324,.,0,1
73325,At,0,0
73326,12,0,1
73327,months,0,0
73328,",",0,0
73329,there,0,0
73330,were,0,0
73331,104,0,1
73332,treated,0,1
73333,patients,0,1
73334,and,0,1
73335,63,0,1
73336,placebo,0,1
73337,patients,0,1
73338,that,0,0
73339,had,0,1
73340,follow-up,0,0
73341,.,0,1
73342,The,0,0
73343,treated,0,1
73344,patients,0,1
73345,had,0,1
73346,a,0,1
73347,logMAR,0,0
73348,vision,0,0
73349,improvement,0,0
73350,of,0,0
73351,0.02,0,0
73352,+/-,0,1
73353,0.213,0,0
73354,",",0,0
73355,and,0,0
73356,the,0,0
73357,placebo,0,0
73358,patients,0,1
73359,had,0,1
73360,a,0,1
73361,vision,0,0
73362,improvement,0,0
73363,of,0,0
73364,0.02,0,0
73365,+/-,0,1
73366,0.20,0,0
73367,.,0,1
73368,This,0,0
73369,was,0,0
73370,not,0,0
73371,statistically,0,0
73372,significant,0,0
73373,(,0,1
73374,P,0,0
73375,=,0,1
73376,.977,0,0
73377,),0,1
73378,.,0,1
73379,The,0,0
73380,repeated,0,0
73381,measure,0,0
73382,P,0,0
73383,value,0,0
73384,for,0,0
73385,the,0,0
73386,entire,0,0
73387,time,0,0
73388,interval,0,0
73389,was,0,0
73390,not,0,0
73391,significant,0,0
73392,(,0,1
73393,P,0,0
73394,=,0,1
73395,.69,0,0
73396,),0,0
73397,.,0,0
73398,There,0,0
73399,appeared,0,0
73400,to,0,0
73401,be,0,0
73402,patients,0,1
73403,entered,0,1
73404,into,0,1
73405,the,0,0
73406,study,0,0
73407,that,0,0
73408,did,0,0
73409,not,0,0
73410,meet,0,1
73411,inclusion,0,1
73412,criteria,0,1
73413,.,0,1
73414,Excluding,0,0
73415,37,0,1
73416,%,0,0
73417,of,0,0
73418,the,0,0
73419,treated,0,1
73420,patients,0,1
73421,and,0,1
73422,29,0,1
73423,%,0,0
73424,of,0,0
73425,the,0,0
73426,placebo,0,0
73427,data,0,0
73428,from,0,1
73429,the,0,0
73430,analysis,0,0
73431,",",0,0
73432,there,0,0
73433,appeared,0,0
73434,to,0,0
73435,be,0,0
73436,statistically,0,0
73437,significant,0,0
73438,improvement,0,0
73439,in,0,0
73440,the,0,0
73441,treated,0,1
73442,patients,0,1
73443,compared,0,0
73444,to,0,1
73445,the,0,0
73446,control,0,1
73447,patients,0,1
73448,at,0,1
73449,1,0,1
73450,year,0,1
73451,with,0,1
73452,a,0,1
73453,P,0,0
73454,value,0,0
73455,of,0,0
73456,.001,0,0
73457,(,0,1
73458,repeated,0,0
73459,measures,0,0
73460,P,0,0
73461,value,0,0
73462,=,0,1
73463,.01,0,0
73464,),0,1
73465,.,0,1
73466,CONCLUSIONS,0,0
73467,At,0,0
73468,best,0,0
73469,this,0,0
73470,was,0,0
73471,a,0,0
73472,flawed,0,0
73473,study,0,0
73474,in,0,0
73475,that,0,0
73476,37,0,1
73477,%,0,0
73478,of,0,0
73479,the,0,0
73480,treated,0,1
73481,cases,0,1
73482,did,0,0
73483,not,0,0
73484,meet,0,1
73485,inclusion,0,1
73486,criteria,0,1
73487,",",0,0
73488,and,0,0
73489,at,0,0
73490,worst,0,0
73491,there,0,0
73492,was,0,0
73493,no,0,0
73494,evidence,0,0
73495,of,0,0
73496,effect,0,0
73497,.,0,1
73498,Even,0,0
73499,though,0,0
73500,the,0,0
73501,number,0,0
73502,of,0,0
73503,serious,0,1
73504,adverse,0,0
73505,events,0,0
73506,is,0,0
73507,small,0,0
73508,",",0,0
73509,because,0,0
73510,this,0,0
73511,study,0,0
73512,did,0,0
73513,not,0,0
73514,show,0,0
73515,an,0,0
73516,effect,0,0
73517,in,0,0
73518,the,0,0
73519,intent-to-treat,0,0
73520,group,0,0
73521,",",0,0
73522,rheopheresis,0,0
73523,should,0,0
73524,not,0,0
73525,be,0,0
73526,performed,0,0
73527,for,0,0
73528,AMD,0,0
73529,outside,0,1
73530,of,0,0
73531,an,0,0
73532,approved,0,1
73533,randomized,0,1
73534,controlled,0,0
73535,trial,0,1
73536,.,0,1
73537,Fine,0,1
73538,needle,0,1
73539,aspiration,0,1
73540,coupled,0,0
73541,with,0,1
73542,real-time,0,0
73543,PCR,0,1
73544,:,0,1
73545,a,0,1
73546,painless,0,1
73547,methodology,0,0
73548,to,0,0
73549,study,0,1
73550,adaptive,0,0
73551,functional,0,1
73552,changes,0,0
73553,in,0,1
73554,skeletal,0,1
73555,muscle,0,1
73556,.,0,1
73557,BACKGROUND,0,0
73558,AND,0,0
73559,AIM,0,0
73560,In,0,1
73561,this,0,0
73562,study,0,0
73563,we,0,0
73564,developed,0,1
73565,a,0,0
73566,new,0,1
73567,methodology,0,0
73568,for,0,0
73569,obtaining,0,0
73570,human,0,1
73571,skeletal,0,1
73572,muscle,0,1
73573,samples,0,1
73574,to,0,1
73575,evaluate,0,0
73576,gene,0,0
73577,expression,0,0
73578,.,0,1
73579,This,0,0
73580,approach,0,0
73581,is,0,0
73582,based,0,0
73583,on,0,0
73584,a,0,1
73585,fine,0,1
73586,needle,0,1
73587,aspiration,0,1
73588,technique,0,0
73589,",",0,0
73590,which,0,0
73591,allows,0,0
73592,us,0,0
73593,to,0,0
73594,extract,0,0
73595,a,0,0
73596,small,0,0
73597,tissue,0,1
73598,sample,0,1
73599,in,0,0
73600,a,0,0
73601,significantly,0,0
73602,less,0,0
73603,invasive,0,0
73604,manner,0,0
73605,than,0,0
73606,with,0,1
73607,classic,0,1
73608,biopsy,0,1
73609,.,0,1
73610,METHODS,0,0
73611,AND,0,0
73612,RESULTS,0,1
73613,Multiplex,0,0
73614,tandem,0,1
73615,RT-PCR,0,0
73616,was,0,0
73617,used,0,0
73618,to,0,0
73619,determine,0,0
73620,the,0,0
73621,mRNA,0,0
73622,levels,0,0
73623,of,0,1
73624,genes,0,0
73625,involved,0,1
73626,in,0,1
73627,ATP,0,0
73628,production,0,0
73629,and,0,1
73630,mitochondrial,0,0
73631,biogenesis,0,0
73632,in,0,0
73633,muscle,0,0
73634,tissue,0,1
73635,.,0,1
73636,Samples,0,0
73637,of,0,0
73638,vastus,0,1
73639,lateralis,0,1
73640,muscle,0,0
73641,were,0,1
73642,obtained,0,0
73643,from,0,1
73644,21,1,1
73645,healthy,1,1
73646,subjects,1,1
73647,with,1,1
73648,different,1,1
73649,fitness,1,1
73650,levels,1,0
73651,.,1,1
73652,The,0,0
73653,principal,0,0
73654,findings,0,0
73655,in,0,1
73656,our,0,1
73657,study,0,0
73658,show,0,0
73659,a,0,0
73660,strong,0,0
73661,correlation,0,0
73662,between,0,0
73663,PGC-1alpha,0,0
73664,and,0,1
73665,COX5B,0,1
73666,(,0,1
73667,p,0,0
73668,<,0,0
73669,0.001,0,0
73670,),0,1
73671,and,0,1
73672,between,0,0
73673,PGC-1alpha,0,0
73674,and,0,1
73675,MT-CO2,0,1
73676,(,0,1
73677,p=0.017,0,0
73678,),0,1
73679,expression,0,0
73680,.,0,1
73681,Furthermore,0,0
73682,",",0,0
73683,a,0,0
73684,significant,0,0
73685,positive,0,1
73686,correlation,0,0
73687,between,0,0
73688,mtDNA,0,1
73689,content,0,0
73690,and,0,0
73691,the,0,0
73692,percentage,0,0
73693,of,0,0
73694,MHCI,0,1
73695,present,0,0
73696,in,0,0
73697,the,0,0
73698,aspired,0,1
73699,samples,0,1
73700,were,0,1
73701,found,0,0
73702,(,0,1
73703,p=0.028,0,0
73704,),0,1
73705,.,0,1
73706,These,0,0
73707,data,0,0
73708,are,0,0
73709,in,0,0
73710,agreement,0,0
73711,with,0,1
73712,current,0,0
73713,knowledge,0,0
73714,on,0,0
73715,skeletal,0,1
73716,muscle,0,0
73717,physiology,0,0
73718,and,0,0
73719,show,0,0
73720,the,0,0
73721,reliability,0,0
73722,of,0,0
73723,the,0,0
73724,proposed,0,0
73725,method,0,0
73726,.,0,0
73727,CONCLUSION,0,0
73728,This,0,0
73729,painless,0,1
73730,methodology,0,0
73731,can,0,0
73732,be,0,0
73733,used,0,0
73734,to,0,0
73735,investigate,0,0
73736,",",0,0
73737,in,0,0
73738,vivo,0,0
73739,",",0,0
73740,human,0,1
73741,muscle,0,0
73742,RNA,0,1
73743,and,0,1
73744,DNA,0,1
73745,adaptations,0,0
73746,in,0,1
73747,response,0,0
73748,to,0,1
73749,either,0,1
73750,physiological,0,0
73751,and/or,0,0
73752,pharmacological,0,0
73753,stimuli,0,0
73754,.,0,1
73755,This,0,0
73756,method,0,0
73757,has,0,0
73758,major,0,0
73759,clinical,0,0
73760,relevance,0,0
73761,",",0,0
73762,such,0,0
73763,as,0,0
73764,its,0,0
73765,application,0,0
73766,in,0,0
73767,clarifying,0,0
73768,the,0,0
73769,mechanisms,0,0
73770,underling,0,0
73771,metabolic,0,1
73772,and,0,1
73773,systemic,0,1
73774,disorders,0,1
73775,.,0,1
73776,Trace,0,1
73777,element,0,0
73778,supplementation,0,0
73779,after,0,1
73780,major,1,1
73781,burns,1,1
73782,modulates,0,0
73783,antioxidant,0,0
73784,status,0,0
73785,and,0,1
73786,clinical,0,0
73787,course,0,0
73788,by,0,0
73789,way,0,0
73790,of,0,0
73791,increased,0,0
73792,tissue,0,1
73793,trace,0,0
73794,element,0,1
73795,concentrations,0,0
73796,.,0,1
73797,BACKGROUND,0,0
73798,After,0,1
73799,major,1,1
73800,burns,1,1
73801,",",1,1
73802,patients,1,1
73803,can,0,0
73804,develop,0,1
73805,nutritional,1,0
73806,deficiencies,1,1
73807,including,1,1
73808,trace,1,0
73809,element,1,1
73810,(,1,1
73811,TE,1,1
73812,),1,1
73813,deficiencies,1,1
73814,.,1,1
73815,Various,0,1
73816,complications,0,0
73817,",",0,1
73818,such,0,0
73819,as,0,0
73820,infections,0,1
73821,and,0,1
73822,delayed,0,1
73823,wound,0,0
73824,healing,0,0
73825,",",0,0
73826,influence,0,0
73827,the,0,0
73828,clinical,0,0
73829,course,0,0
73830,of,0,1
73831,such,0,0
73832,patients,0,1
73833,.,0,1
73834,OBJECTIVES,0,0
73835,We,0,0
73836,aimed,0,0
73837,to,0,0
73838,investigate,0,0
73839,the,0,0
73840,effects,0,0
73841,of,0,0
73842,large,0,1
73843,",",0,1
73844,intravenous,0,1
73845,doses,0,0
73846,of,0,1
73847,TE,0,1
73848,supplements,0,0
73849,on,0,0
73850,circulating,0,0
73851,and,0,1
73852,cutaneous,0,1
73853,TE,0,1
73854,tissue,0,1
73855,concentrations,0,0
73856,",",0,1
73857,on,0,0
73858,antioxidant,0,0
73859,status,0,1
73860,",",0,0
73861,and,0,0
73862,on,0,0
73863,clinical,0,0
73864,outcome,0,0
73865,after,0,1
73866,major,1,1
73867,burns,1,1
73868,.,1,1
73869,DESIGN,0,0
73870,This,0,0
73871,was,0,0
73872,a,0,0
73873,prospective,0,0
73874,",",0,0
73875,randomized,0,1
73876,",",0,0
73877,placebo-controlled,0,0
73878,trial,0,1
73879,in,0,1
73880,21,1,1
73881,patients,1,1
73882,aged,1,1
73883,35,1,1
73884,+/-,1,0
73885,11,1,1
73886,y,1,1
73887,(,1,1
73888,x,1,1
73889,+/-,1,0
73890,SD,1,1
73891,),1,1
73892,with,1,1
73893,burns,1,1
73894,on,1,1
73895,45,1,1
73896,+/-,1,1
73897,21,1,1
73898,%,1,0
73899,of,1,0
73900,their,1,1
73901,body,1,1
73902,surface,1,0
73903,area,1,0
73904,.,1,1
73905,Intravenous,0,0
73906,copper,0,0
73907,",",0,0
73908,selenium,0,0
73909,",",0,0
73910,and,0,0
73911,zinc,0,0
73912,(,0,1
73913,TE,0,0
73914,group,0,1
73915,),0,1
73916,or,0,1
73917,vehicle,0,0
73918,(,0,1
73919,V,0,0
73920,group,0,1
73921,),0,1
73922,was,0,0
73923,given,0,0
73924,with,0,1
73925,a,0,1
73926,saline,0,0
73927,solution,0,0
73928,for,0,0
73929,14-21,0,1
73930,d.,0,1
73931,Blood,0,1
73932,and,0,1
73933,urine,0,1
73934,samples,0,1
73935,were,0,1
73936,collected,0,1
73937,until,0,1
73938,day,0,0
73939,20,0,1
73940,",",0,0
73941,and,0,0
73942,skin,0,1
73943,biopsy,0,1
73944,specimens,0,1
73945,were,0,1
73946,collected,0,1
73947,on,0,0
73948,days,0,0
73949,3,0,1
73950,",",0,1
73951,10,0,1
73952,",",0,0
73953,and,0,1
73954,20,0,1
73955,.,0,1
73956,RESULTS,0,0
73957,The,0,0
73958,age,0,1
73959,of,0,0
73960,the,0,0
73961,patients,0,1
73962,and,0,0
73963,the,0,0
73964,severity,0,0
73965,of,0,0
73966,their,0,1
73967,burns,0,1
73968,did,0,0
73969,not,0,0
73970,differ,0,0
73971,significantly,0,0
73972,between,0,0
73973,the,0,0
73974,groups,0,0
73975,.,0,1
73976,Plasma,0,1
73977,TE,0,0
73978,concentrations,0,0
73979,were,0,1
73980,significantly,0,0
73981,higher,0,0
73982,in,0,0
73983,the,0,0
73984,TE,0,0
73985,group,0,1
73986,.,0,1
73987,In,0,0
73988,burned,0,1
73989,areas,0,0
73990,",",0,1
73991,skin,0,1
73992,contents,0,0
73993,of,0,1
73994,both,0,0
73995,selenium,0,0
73996,(,0,0
73997,P=0.05,0,0
73998,),0,1
73999,and,0,0
74000,zinc,0,0
74001,(,0,1
74002,P=0.04,0,0
74003,),0,1
74004,increased,0,0
74005,significantly,0,0
74006,by,0,0
74007,day,0,0
74008,20,0,1
74009,.,0,1
74010,Plasma,0,0
74011,and,0,0
74012,tissue,0,1
74013,antioxidant,0,0
74014,status,0,1
74015,was,0,0
74016,improved,0,0
74017,by,0,0
74018,supplementation,0,0
74019,.,0,1
74020,The,0,0
74021,number,0,0
74022,of,0,0
74023,infections,0,1
74024,in,0,1
74025,the,0,1
74026,first,0,0
74027,30,0,1
74028,d,0,0
74029,was,0,0
74030,significantly,0,0
74031,lower,0,0
74032,in,0,0
74033,the,0,0
74034,TE,0,0
74035,group,0,1
74036,(,0,1
74037,P=0.015,0,0
74038,),0,1
74039,",",0,0
74040,with,0,1
74041,a,0,0
74042,median,0,0
74043,number,0,0
74044,of,0,1
74045,2,0,1
74046,versus,0,0
74047,4,0,1
74048,infections,0,1
74049,per,0,1
74050,patient,0,1
74051,in,0,0
74052,the,0,0
74053,TE,0,0
74054,and,0,1
74055,V,0,0
74056,groups,0,0
74057,",",0,0
74058,respectively,0,0
74059,",",0,0
74060,as,0,0
74061,a,0,0
74062,result,0,0
74063,of,0,0
74064,a,0,0
74065,reduction,0,0
74066,in,0,0
74067,pulmonary,0,1
74068,infections,0,1
74069,(,0,1
74070,P=0.03,0,0
74071,),0,1
74072,.,0,1
74073,Wound,0,0
74074,healing,0,0
74075,was,0,0
74076,improved,0,0
74077,in,0,0
74078,the,0,0
74079,TE,0,0
74080,group,0,0
74081,",",0,0
74082,with,0,1
74083,lower,0,0
74084,requirements,0,1
74085,for,0,0
74086,regrafting,0,1
74087,(,0,1
74088,P=0.02,0,0
74089,),0,1
74090,.,0,1
74091,CONCLUSIONS,0,0
74092,TE,0,0
74093,supplementation,0,0
74094,was,0,0
74095,associated,0,0
74096,with,0,1
74097,higher,0,0
74098,circulating,0,0
74099,plasma,0,0
74100,and,0,0
74101,skin,0,1
74102,tissue,0,1
74103,contents,0,0
74104,of,0,1
74105,selenium,0,1
74106,and,0,1
74107,zinc,0,0
74108,and,0,0
74109,improved,0,0
74110,antioxidant,0,0
74111,status,0,1
74112,.,0,1
74113,These,0,0
74114,changes,0,0
74115,were,0,1
74116,associated,0,0
74117,with,0,1
74118,improved,0,0
74119,clinical,0,0
74120,outcome,0,0
74121,",",0,0
74122,including,0,0
74123,fewer,0,0
74124,pulmonary,0,1
74125,infections,0,0
74126,and,0,1
74127,better,0,0
74128,wound,0,0
74129,healing,0,0
74130,.,0,1
74131,Supplementation,0,0
74132,with,0,1
74133,iron,0,0
74134,and,0,1
74135,riboflavin,0,0
74136,enhances,0,0
74137,dark,0,1
74138,adaptation,0,0
74139,response,0,0
74140,to,0,0
74141,vitamin,0,0
74142,A-fortified,0,0
74143,rice,0,0
74144,in,0,0
74145,iron-deficient,1,1
74146,",",1,1
74147,pregnant,1,1
74148,",",1,0
74149,nightblind,1,1
74150,Nepali,1,1
74151,women,1,1
74152,.,1,1
74153,BACKGROUND,0,0
74154,Nightblindness,0,1
74155,affects,0,0
74156,16-52,0,0
74157,%,0,0
74158,of,0,1
74159,pregnant,0,1
74160,women,0,1
74161,in,0,1
74162,areas,0,1
74163,of,0,1
74164,Nepal,0,1
74165,and,0,1
74166,in,0,0
74167,some,0,1
74168,cases,0,1
74169,persists,0,0
74170,after,0,1
74171,vitamin,0,0
74172,A,0,1
74173,treatment,0,0
74174,.,0,1
74175,Iron,0,0
74176,and,0,0
74177,riboflavin,0,0
74178,affect,0,0
74179,vitamin,0,0
74180,A,0,1
74181,utilization,0,0
74182,and,0,0
74183,photoreceptor,0,0
74184,function,0,0
74185,",",0,0
74186,respectively,0,0
74187,",",0,0
74188,and,0,0
74189,pilot,0,0
74190,data,0,0
74191,in,0,0
74192,the,0,0
74193,study,0,0
74194,population,0,1
74195,showed,0,0
74196,a,0,0
74197,high,0,0
74198,prevalence,0,0
74199,of,0,0
74200,iron,0,0
74201,and,0,1
74202,riboflavin,0,0
74203,deficiencies,0,1
74204,.,0,1
74205,OBJECTIVE,0,0
74206,The,0,0
74207,objective,0,0
74208,was,0,0
74209,to,0,0
74210,assess,0,0
74211,the,0,0
74212,effect,0,0
74213,of,0,0
74214,supplemental,0,1
74215,iron,0,0
74216,and,0,0
74217,riboflavin,0,0
74218,on,0,0
74219,pupillary,0,1
74220,threshold,0,0
74221,(,0,1
74222,PT,0,1
74223,),0,1
74224,and,0,1
74225,plasma,0,0
74226,retinol,0,0
74227,in,0,0
74228,nightblind,0,1
74229,",",0,1
74230,pregnant,1,1
74231,Nepali,1,1
74232,women,1,1
74233,given,1,1
74234,vitamin,1,1
74235,A-fortified,1,1
74236,rice,1,0
74237,.,1,1
74238,DESIGN,0,0
74239,Nightblind,1,1
74240,pregnant,1,1
74241,women,1,1
74242,were,0,1
74243,randomly,0,1
74244,assigned,0,1
74245,to,0,0
74246,receive,0,1
74247,",",0,0
74248,6,0,0
74249,d/wk,0,0
74250,under,0,1
74251,supervision,0,0
74252,for,0,1
74253,6,0,0
74254,wk,0,1
74255,",",0,0
74256,a,0,0
74257,vitamin,0,0
74258,A-fortified,0,0
74259,rice,0,0
74260,curry,0,1
74261,dish,0,1
74262,providing,0,0
74263,850,0,1
74264,microg,0,0
74265,retinal,0,1
74266,activity,0,0
74267,equivalents/d,0,0
74268,with,0,1
74269,either,0,0
74270,a,0,0
74271,30-mg,0,0
74272,Fe,0,1
74273,and,0,1
74274,6-mg,0,0
74275,riboflavin,0,0
74276,(,0,1
74277,FeR,0,1
74278,+,0,0
74279,VA,0,1
74280,),0,1
74281,capsule,0,0
74282,or,0,1
74283,a,0,0
74284,placebo,0,0
74285,control,0,1
74286,(,0,0
74287,VA,0,0
74288,only,0,0
74289,),0,1
74290,capsule,0,0
74291,.,0,1
74292,Hemoglobin,0,0
74293,",",0,0
74294,erythrocyte,0,0
74295,riboflavin,0,0
74296,",",0,0
74297,and,0,0
74298,plasma,0,0
74299,ferritin,0,0
74300,and,0,0
74301,retinol,0,0
74302,were,0,0
74303,measured,0,0
74304,before,0,0
74305,and,0,0
74306,after,0,0
74307,the,0,0
74308,intervention,0,0
74309,.,0,1
74310,Dark,0,0
74311,adaptation,0,0
74312,was,0,0
74313,assessed,0,0
74314,by,0,0
74315,PT,0,1
74316,score,0,1
74317,.,0,1
74318,RESULTS,0,0
74319,Women,0,1
74320,who,0,1
74321,were,0,1
74322,iron,0,1
74323,deficient,0,1
74324,at,0,1
74325,baseline,0,0
74326,(,0,1
74327,n=38,0,1
74328,),0,1
74329,had,0,1
74330,significantly,0,0
74331,greater,0,0
74332,improvement,0,0
74333,in,0,0
74334,PT,0,1
74335,score,0,0
74336,with,0,1
74337,iron,0,0
74338,and,0,1
74339,riboflavin,0,0
74340,supplementation,0,0
74341,than,0,0
74342,without,0,1
74343,(,0,1
74344,P=0.05,0,0
74345,),0,1
74346,.,0,1
74347,Iron,0,0
74348,and,0,0
74349,riboflavin,0,0
74350,supplements,0,0
74351,significantly,0,0
74352,reduced,0,0
74353,the,0,0
74354,prevalences,0,0
74355,of,0,0
74356,riboflavin,0,0
74357,deficiency,0,1
74358,(,0,1
74359,from,0,1
74360,60,0,1
74361,%,0,0
74362,to,0,1
74363,6,0,1
74364,%,0,0
74365,;,0,1
74366,P,0,0
74367,<,0,0
74368,0.0001,0,0
74369,),0,1
74370,",",0,0
74371,iron,0,0
74372,deficiency,0,1
74373,anemia,0,1
74374,(,0,1
74375,from,0,1
74376,35,0,1
74377,%,0,0
74378,to,0,1
74379,15,0,1
74380,%,0,0
74381,;,0,1
74382,P,0,0
74383,<,0,0
74384,0.007,0,0
74385,),0,1
74386,",",0,0
74387,and,0,0
74388,abnormal,0,1
74389,PT,0,1
74390,(,0,1
74391,from,0,1
74392,87,0,1
74393,%,0,0
74394,to,0,1
74395,30,0,1
74396,%,0,0
74397,;,0,1
74398,P,0,0
74399,<,0,0
74400,0.05,0,0
74401,),0,1
74402,from,0,1
74403,baseline,0,0
74404,.,0,1
74405,Mean,0,1
74406,increases,0,0
74407,in,0,1
74408,erythrocyte,0,1
74409,riboflavin,0,0
74410,(,0,1
74411,P,0,0
74412,<,0,0
74413,0.0001,0,0
74414,),0,1
74415,and,0,1
74416,plasma,0,0
74417,ferritin,0,0
74418,(,0,1
74419,P=0.01,0,0
74420,),0,1
74421,were,0,0
74422,greater,0,0
74423,in,0,0
74424,the,0,0
74425,FeR,0,1
74426,+,0,0
74427,VA,0,1
74428,group,0,1
74429,than,0,0
74430,in,0,0
74431,the,0,0
74432,VA,0,0
74433,only,0,0
74434,group,0,1
74435,.,0,1
74436,CONCLUSIONS,0,0
74437,Iron,0,0
74438,deficiency,0,1
74439,may,0,0
74440,limit,0,0
74441,the,0,0
74442,efficacy,0,0
74443,of,0,0
74444,vitamin,0,0
74445,A,0,1
74446,to,0,0
74447,normalize,0,0
74448,dark,0,0
74449,adaptation,0,0
74450,in,0,1
74451,pregnant,1,1
74452,Nepali,1,1
74453,women,1,1
74454,.,1,1
74455,Further,0,0
74456,studies,0,0
74457,are,0,0
74458,needed,0,0
74459,to,0,0
74460,assess,0,0
74461,the,0,0
74462,effect,0,0
74463,of,0,0
74464,simultaneous,0,0
74465,delivery,0,1
74466,of,0,0
74467,iron,0,0
74468,and,0,0
74469,vitamin,0,0
74470,A,0,1
74471,for,0,0
74472,the,0,0
74473,treatment,0,0
74474,of,0,0
74475,nightblindness,0,1
74476,.,0,1
74477,Randomized,0,0
74478,trial,0,0
74479,of,0,0
74480,an,0,0
74481,allogeneic,0,1
74482,melanoma,0,1
74483,lysate,0,0
74484,vaccine,0,1
74485,with,0,1
74486,low-dose,0,0
74487,interferon,0,1
74488,Alfa-2b,0,0
74489,compared,0,0
74490,with,0,1
74491,high-dose,0,1
74492,interferon,0,1
74493,Alfa-2b,0,0
74494,for,0,0
74495,Resected,1,1
74496,stage,1,1
74497,III,1,1
74498,cutaneous,1,1
74499,melanoma,1,1
74500,.,1,1
74501,PURPOSE,0,0
74502,To,0,0
74503,compare,0,0
74504,the,0,0
74505,overall,0,0
74506,survival,0,0
74507,(,0,1
74508,OS,0,0
74509,),0,1
74510,of,0,0
74511,patients,1,1
74512,with,1,1
74513,resected,1,1
74514,stage,1,1
74515,III,1,1
74516,melanoma,1,1
74517,administered,0,0
74518,active,0,1
74519,specific,0,0
74520,immunotherapy,0,0
74521,and,0,1
74522,low-dose,0,0
74523,interferon,0,1
74524,alfa-2b,0,0
74525,(,0,1
74526,IFN-alpha-2b,0,0
74527,),0,1
74528,with,0,1
74529,the,0,0
74530,OS,0,0
74531,achieved,0,0
74532,using,0,0
74533,high-dose,0,1
74534,IFN-alpha-2b,0,0
74535,.,0,1
74536,PATIENTS,0,0
74537,AND,0,0
74538,METHODS,0,0
74539,An,0,0
74540,Ad,1,1
74541,Hoc,1,1
74542,Melanoma,1,1
74543,Working,1,1
74544,Group,1,1
74545,of,1,1
74546,25,1,1
74547,investigators,1,1
74548,treated,1,1
74549,604,1,1
74550,patients,1,1
74551,from,1,1
74552,April,1,1
74553,1997,1,1
74554,to,1,1
74555,January,1,1
74556,2003,1,1
74557,.,1,1
74558,Patients,0,1
74559,were,0,0
74560,stratified,0,1
74561,by,0,0
74562,sex,0,0
74563,and,0,0
74564,number,0,0
74565,of,0,1
74566,nodes,0,1
74567,and,0,1
74568,were,0,1
74569,randomly,0,1
74570,assigned,0,1
74571,to,0,0
74572,receive,0,1
74573,either,0,1
74574,2,0,1
74575,years,0,1
74576,of,0,1
74577,treatment,0,1
74578,with,0,1
74579,active,0,1
74580,specific,0,0
74581,immunotherapy,0,0
74582,with,0,1
74583,allogeneic,0,1
74584,melanoma,0,1
74585,lysates,0,1
74586,and,0,1
74587,low-dose,0,0
74588,IFN-alpha-2b,0,0
74589,(,0,1
74590,arm,0,1
74591,1,0,1
74592,),0,1
74593,or,0,1
74594,high-dose,0,0
74595,IFN-alpha-2b,0,0
74596,alone,0,1
74597,for,0,0
74598,1,0,0
74599,year,0,1
74600,(,0,1
74601,arm,0,1
74602,2,0,1
74603,),0,1
74604,.,0,1
74605,Active,0,0
74606,specific,0,0
74607,immunotherapy,0,0
74608,was,0,0
74609,injected,0,0
74610,subcutaneously,0,1
74611,(,0,1
74612,SC,0,1
74613,),0,1
74614,weekly,0,1
74615,for,0,1
74616,4,0,0
74617,weeks,0,0
74618,",",0,1
74619,at,0,1
74620,week,0,0
74621,8,0,1
74622,",",0,0
74623,and,0,0
74624,bimonthly,0,0
74625,thereafter,0,0
74626,.,0,1
74627,IFN-alpha-2b,0,0
74628,SC,0,1
74629,was,0,0
74630,begun,0,0
74631,on,0,0
74632,week,0,0
74633,4,0,0
74634,and,0,1
74635,continued,0,0
74636,thrice,0,0
74637,weekly,0,1
74638,at,0,1
74639,5,0,0
74640,MU/m2,0,1
74641,for,0,1
74642,2,0,1
74643,years,0,1
74644,.,0,1
74645,IFN-alpha-2b,0,0
74646,in,0,0
74647,arm,0,1
74648,2,0,1
74649,was,0,0
74650,administered,0,0
74651,according,0,1
74652,to,0,0
74653,the,0,0
74654,Eastern,0,1
74655,Cooperative,0,1
74656,Oncology,0,1
74657,Group,0,1
74658,1684,0,1
74659,study,0,1
74660,regimen,0,1
74661,.,0,1
74662,RESULTS,0,0
74663,Median,0,1
74664,follow-up,0,0
74665,time,0,0
74666,was,0,0
74667,32,0,1
74668,months,0,0
74669,for,0,1
74670,all,0,1
74671,patients,0,1
74672,and,0,1
74673,42,0,1
74674,months,0,0
74675,for,0,1
74676,surviving,0,1
74677,patients,0,1
74678,.,0,1
74679,Median,0,1
74680,OS,0,0
74681,time,0,0
74682,exceeds,0,0
74683,84,0,1
74684,months,0,0
74685,in,0,1
74686,arm,0,1
74687,1,0,0
74688,and,0,0
74689,is,0,0
74690,83,0,1
74691,months,0,0
74692,in,0,1
74693,arm,0,1
74694,2,0,1
74695,(,0,1
74696,P,0,0
74697,=,0,1
74698,.56,0,0
74699,),0,1
74700,.,0,1
74701,Five-year,0,1
74702,OS,0,0
74703,rate,0,0
74704,is,0,0
74705,61,0,1
74706,%,0,0
74707,in,0,1
74708,arm,0,1
74709,1,0,1
74710,and,0,1
74711,57,0,1
74712,%,0,0
74713,in,0,1
74714,arm,0,1
74715,2,0,1
74716,.,0,1
74717,Estimated,0,0
74718,5-year,0,1
74719,relapse-free,0,0
74720,survival,0,0
74721,(,0,1
74722,RFS,0,1
74723,),0,0
74724,rate,0,0
74725,is,0,0
74726,50,0,0
74727,%,0,0
74728,in,0,1
74729,arm,0,1
74730,1,0,1
74731,and,0,1
74732,48,0,1
74733,%,0,0
74734,in,0,1
74735,arm,0,1
74736,2,0,1
74737,",",0,0
74738,with,0,1
74739,median,0,1
74740,RFS,0,1
74741,times,0,0
74742,of,0,1
74743,58,0,1
74744,and,0,1
74745,50,0,1
74746,months,0,0
74747,",",0,1
74748,respectively,0,0
74749,.,0,0
74750,The,0,0
74751,incidence,0,0
74752,of,0,0
74753,serious,0,1
74754,adverse,0,0
74755,events,0,0
74756,as,0,0
74757,a,0,1
74758,result,0,0
74759,of,0,0
74760,treatment,0,0
74761,was,0,0
74762,the,0,0
74763,same,0,0
74764,in,0,0
74765,both,0,0
74766,arms,0,0
74767,",",0,0
74768,but,0,0
74769,more,0,0
74770,severe,0,1
74771,neuropsychiatric,0,1
74772,toxicity,0,0
74773,was,0,0
74774,seen,0,0
74775,in,0,0
74776,arm,0,1
74777,2,0,1
74778,.,0,1
74779,CONCLUSION,0,0
74780,OS,0,0
74781,and,0,1
74782,RFS,0,1
74783,achieved,0,0
74784,by,0,0
74785,active,0,1
74786,specific,0,0
74787,immunotherapy,0,0
74788,and,0,1
74789,low-dose,0,0
74790,IFN-alpha-2b,0,0
74791,were,0,1
74792,indistinguishable,0,0
74793,from,0,1
74794,those,0,1
74795,achieved,0,0
74796,by,0,0
74797,high-dose,0,1
74798,IFN-alpha-2b,0,0
74799,.,0,1
74800,Long,0,1
74801,RFS,0,1
74802,and,0,1
74803,OS,0,0
74804,times,0,0
74805,were,0,1
74806,observed,0,0
74807,in,0,0
74808,both,0,0
74809,treatment,0,1
74810,arms,0,1
74811,.,0,1
74812,Comparison,0,0
74813,of,0,1
74814,self-administered,0,1
74815,vaginal,0,1
74816,misoprostol,0,1
74817,versus,0,0
74818,placebo,0,0
74819,for,0,0
74820,cervical,0,1
74821,ripening,0,1
74822,prior,0,1
74823,to,0,1
74824,operative,0,1
74825,hysteroscopy,0,1
74826,using,0,0
74827,a,0,0
74828,sequential,0,0
74829,trial,0,0
74830,design,0,1
74831,.,0,1
74832,OBJECTIVE,0,0
74833,To,0,0
74834,compare,0,0
74835,the,0,0
74836,impact,0,0
74837,of,0,0
74838,1000-microgram,0,0
74839,self-administered,0,1
74840,vaginal,0,1
74841,misoprostol,0,1
74842,versus,0,0
74843,self-administered,0,1
74844,vaginal,0,1
74845,placebo,0,0
74846,at,0,0
74847,home,0,1
74848,on,0,0
74849,preoperative,0,1
74850,cervical,0,1
74851,ripening,0,1
74852,in,0,0
74853,both,0,0
74854,premenopausal,1,1
74855,and,1,0
74856,postmenopausal,1,1
74857,women,1,1
74858,prior,1,1
74859,to,1,0
74860,outpatient,1,1
74861,resectoscopy,1,1
74862,.,1,1
74863,DESIGN,0,0
74864,Randomised,0,0
74865,",",0,0
74866,double-blind,0,0
74867,",",0,0
74868,placebo-controlled,0,0
74869,sequential,0,0
74870,trial,0,1
74871,.,0,1
74872,SETTING,0,1
74873,Norwegian,1,1
74874,university,1,1
74875,teaching,1,1
74876,hospital,1,1
74877,.,1,1
74878,SAMPLE,0,0
74879,Premenopausal,1,1
74880,and,1,1
74881,postmenopausal,1,1
74882,women,1,1
74883,referred,1,1
74884,to,1,0
74885,outpatient,1,1
74886,resectoscopy,1,1
74887,.,1,1
74888,METHODS,0,0
74889,The,0,0
74890,women,0,1
74891,were,0,1
74892,randomised,0,1
74893,to,0,0
74894,either,0,1
74895,1000,0,0
74896,micrograms,0,0
74897,of,0,1
74898,self-administered,0,1
74899,vaginal,0,1
74900,misoprostol,0,1
74901,or,0,1
74902,self-administered,0,1
74903,vaginal,0,1
74904,placebo,0,0
74905,the,0,0
74906,evening,0,0
74907,before,0,0
74908,outpatient,0,1
74909,resectoscopy,0,1
74910,.,0,1
74911,MAIN,0,0
74912,OUTCOME,0,1
74913,MEASURES,0,1
74914,Preoperative,0,1
74915,cervical,0,1
74916,dilatation,0,1
74917,",",0,0
74918,acceptability,0,0
74919,and,0,1
74920,complications,0,1
74921,.,0,1
74922,RESULTS,0,0
74923,(,0,0
74924,a,0,1
74925,),0,1
74926,Intraoperative,0,1
74927,findings,0,0
74928,and,0,1
74929,distribution,0,1
74930,of,0,0
74931,cervical,0,1
74932,dilatation,0,1
74933,in,0,0
74934,the,0,0
74935,two,0,0
74936,treatment,0,1
74937,groups,0,1
74938,.,0,1
74939,Values,0,0
74940,are,0,0
74941,given,0,0
74942,as,0,0
74943,median,0,1
74944,(,0,1
74945,range,0,1
74946,),0,1
74947,or,0,1
74948,n,0,1
74949,(,0,1
74950,%,0,0
74951,),0,1
74952,.,0,1
74953,(,0,0
74954,b,0,0
74955,),0,1
74956,Acceptability,0,0
74957,in,0,0
74958,the,0,0
74959,two,0,0
74960,treatment,0,1
74961,groups,0,1
74962,.,0,1
74963,Values,0,0
74964,are,0,0
74965,given,0,0
74966,as,0,0
74967,completely,0,0
74968,acceptable,0,0
74969,",",0,0
74970,n,0,1
74971,(,0,1
74972,%,0,0
74973,),0,1
74974,;,0,0
74975,fairly,0,0
74976,acceptable,0,0
74977,",",0,0
74978,n,0,1
74979,(,0,1
74980,%,0,0
74981,),0,1
74982,;,0,0
74983,fairly,0,0
74984,unacceptable,0,0
74985,",",0,0
74986,n,0,1
74987,(,0,1
74988,%,0,0
74989,),0,1
74990,and,0,0
74991,completely,0,0
74992,unacceptable,0,0
74993,",",0,0
74994,n,0,1
74995,(,0,1
74996,%,0,0
74997,),0,1
74998,.,0,1
74999,(,0,0
75000,c,0,1
75001,),0,1
75002,Pain,0,1
75003,in,0,0
75004,the,0,0
75005,two,0,0
75006,treatment,0,1
75007,groups,0,1
75008,.,0,1
75009,Pain,0,0
75010,was,0,0
75011,measured,0,0
75012,with,0,1
75013,a,0,1
75014,visual,0,0
75015,analogue,0,0
75016,scale,0,0
75017,score,0,0
75018,",",0,1
75019,scale,0,0
75020,ranges,0,1
75021,from,0,1
75022,0,0,0
75023,(,0,1
75024,no,0,0
75025,pain,0,1
75026,),0,1
75027,to,0,1
75028,10,0,1
75029,(,0,1
75030,unbearable,0,1
75031,pain,0,1
75032,),0,1
75033,.,0,1
75034,Values,0,0
75035,are,0,0
75036,given,0,0
75037,as,0,0
75038,median,0,1
75039,(,0,1
75040,range,0,1
75041,),0,1
75042,.,0,1
75043,(,0,0
75044,d,0,0
75045,),0,1
75046,Occurrence,0,0
75047,of,0,1
75048,adverse,0,0
75049,effects,0,0
75050,in,0,1
75051,the,0,1
75052,two,0,0
75053,treatment,0,1
75054,groups,0,1
75055,.,0,1
75056,Values,0,0
75057,are,0,0
75058,given,0,0
75059,as,0,0
75060,n,0,1
75061,(,0,1
75062,%,0,0
75063,),0,1
75064,.,0,1
75065,(,0,0
75066,e,0,0
75067,),0,1
75068,Complications,0,0
75069,",",0,1
75070,given,0,1
75071,as,0,0
75072,n,0,1
75073,(,0,1
75074,%,0,0
75075,),0,1
75076,.,0,1
75077,Ropivacaine,0,0
75078,versus,0,0
75079,lidocaine,0,0
75080,in,0,0
75081,digital,1,0
75082,nerve,1,1
75083,blocks,1,0
75084,:,1,1
75085,a,0,1
75086,prospective,0,1
75087,study,0,1
75088,.,0,1
75089,BACKGROUND,0,0
75090,Ropivacaine,0,0
75091,is,0,0
75092,a,0,0
75093,relatively,0,0
75094,new,0,1
75095,long-acting,0,1
75096,amide,0,0
75097,local,0,0
75098,anesthetic,0,0
75099,.,0,1
75100,Since,0,0
75101,its,0,0
75102,introduction,0,0
75103,in,0,0
75104,1996,0,1
75105,",",0,0
75106,it,0,0
75107,has,0,0
75108,been,0,0
75109,used,0,0
75110,for,0,0
75111,subcutaneous,0,1
75112,infiltration,0,0
75113,;,0,1
75114,epidural,0,1
75115,",",0,0
75116,intrathecal,0,1
75117,",",0,0
75118,and,0,0
75119,peripheral,0,1
75120,nerve,0,0
75121,block,0,1
75122,surgery,0,1
75123,;,0,1
75124,and,0,0
75125,postoperative,0,0
75126,analgesia,0,0
75127,.,0,1
75128,However,0,0
75129,",",0,0
75130,it,0,0
75131,has,0,0
75132,never,0,0
75133,been,0,0
75134,used,0,0
75135,for,0,1
75136,digital,0,1
75137,blocks,0,1
75138,.,0,1
75139,This,0,0
75140,prospective,0,0
75141,",",0,0
75142,randomized,0,1
75143,",",0,0
75144,double-blind,0,0
75145,study,0,0
75146,compares,0,0
75147,the,0,0
75148,digital,0,0
75149,block,0,1
75150,results,0,0
75151,following,0,0
75152,the,0,0
75153,administration,0,0
75154,of,0,0
75155,2.5,0,0
75156,ml,0,0
75157,of,0,1
75158,0.75,0,0
75159,%,0,0
75160,ropivacaine,0,0
75161,solution,0,0
75162,and,0,1
75163,2.5,0,0
75164,ml,0,0
75165,of,0,1
75166,2,0,1
75167,%,0,0
75168,lidocaine,0,0
75169,solution,0,0
75170,.,0,1
75171,METHODS,0,0
75172,From,1,1
75173,March,1,1
75174,of,1,1
75175,1999,1,1
75176,to,1,1
75177,March,1,1
75178,of,1,0
75179,2001,1,1
75180,",",1,1
75181,70,1,1
75182,adult,1,1
75183,patients,1,1
75184,who,1,1
75185,underwent,1,1
75186,immediate,1,1
75187,reconstruction,1,1
75188,for,1,1
75189,traumatic,1,1
75190,injuries,1,1
75191,of,1,1
75192,the,1,1
75193,digits,1,0
75194,were,0,1
75195,prospectively,0,1
75196,randomized,0,1
75197,into,0,1
75198,two,0,1
75199,groups,0,1
75200,.,0,1
75201,Group,0,1
75202,A,0,1
75203,(,0,1
75204,n,0,1
75205,=,0,1
75206,35,0,1
75207,),0,1
75208,received,0,1
75209,2.5,0,0
75210,ml,0,0
75211,0.75,0,0
75212,%,0,0
75213,ropivacaine,0,0
75214,and,0,0
75215,group,0,1
75216,B,0,1
75217,(,0,1
75218,n,0,1
75219,=,0,1
75220,35,0,1
75221,),0,1
75222,received,0,1
75223,2.5,0,0
75224,ml,0,0
75225,of,0,1
75226,2,0,1
75227,%,0,0
75228,lidocaine,0,0
75229,for,0,0
75230,digital,0,0
75231,anesthesia,0,1
75232,.,0,1
75233,Onset,0,0
75234,time,0,0
75235,of,0,0
75236,anesthetic,0,0
75237,action,0,0
75238,",",0,0
75239,duration,0,0
75240,of,0,0
75241,anesthesia,0,1
75242,",",0,0
75243,time,0,0
75244,until,0,0
75245,first,0,0
75246,postoperative,0,1
75247,requirement,0,1
75248,for,0,0
75249,pain,0,1
75250,medication,0,1
75251,",",0,0
75252,and,0,0
75253,digital-brachial,0,1
75254,artery,0,1
75255,systolic,0,1
75256,blood,0,0
75257,pressure,0,0
75258,index,0,1
75259,were,0,1
75260,recorded,0,0
75261,and,0,0
75262,evaluated,0,0
75263,.,0,1
75264,Local,0,1
75265,vascular,0,0
75266,effects,0,0
75267,were,0,1
75268,observed,0,0
75269,visually,0,1
75270,.,0,1
75271,RESULTS,0,0
75272,No,0,0
75273,side,0,0
75274,effects,0,0
75275,were,0,1
75276,observed,0,0
75277,.,0,1
75278,Lidocaine,0,0
75279,had,0,1
75280,the,0,0
75281,quickest,0,0
75282,onset,0,1
75283,of,0,0
75284,anesthesia,0,0
75285,",",0,0
75286,with,0,1
75287,a,0,0
75288,mean,0,1
75289,time,0,0
75290,of,0,1
75291,1.3,0,0
75292,minutes,0,0
75293,(,0,1
75294,range,0,1
75295,",",0,1
75296,1,0,0
75297,to,0,1
75298,2.7,0,1
75299,minutes,0,0
75300,),0,1
75301,.,0,1
75302,Ropivacaine,0,0
75303,had,0,1
75304,a,0,0
75305,mean,0,0
75306,onset,0,1
75307,time,0,0
75308,of,0,1
75309,4.5,0,1
75310,minutes,0,0
75311,(,0,1
75312,range,0,1
75313,",",0,1
75314,3.5,0,0
75315,to,0,1
75316,5.5,0,1
75317,minutes,0,0
75318,),0,1
75319,.,0,1
75320,The,0,0
75321,mean,0,0
75322,duration,0,0
75323,of,0,0
75324,postoperative,0,0
75325,anesthesia,0,1
75326,for,0,0
75327,lidocaine,0,0
75328,was,0,0
75329,2.4,0,0
75330,hours,0,0
75331,(,0,1
75332,range,0,1
75333,",",0,1
75334,1.4,0,0
75335,to,0,1
75336,4,0,1
75337,hours,0,0
75338,),0,1
75339,",",0,0
75340,compared,0,0
75341,with,0,1
75342,21.5,0,0
75343,hours,0,0
75344,for,0,1
75345,ropivacaine,0,0
75346,and,0,0
75347,less,0,0
75348,requirement,0,0
75349,for,0,0
75350,analgesics,0,0
75351,during,0,1
75352,the,0,1
75353,first,0,0
75354,24,0,1
75355,postoperative,0,1
75356,hours,0,0
75357,(,0,1
75358,p,0,0
75359,<,0,0
75360,0.05,0,0
75361,),0,1
75362,(,0,1
75363,range,0,1
75364,",",0,1
75365,19,0,1
75366,to,0,1
75367,23,0,1
75368,hours,0,1
75369,),0,1
75370,.,0,1
75371,No,0,0
75372,significant,0,0
75373,difference,0,0
75374,was,0,0
75375,found,0,0
75376,between,0,0
75377,the,0,0
75378,digital-brachial,0,1
75379,artery,0,1
75380,systolic,0,1
75381,blood,0,0
75382,pressure,0,0
75383,index,0,0
75384,of,0,0
75385,group,0,1
75386,A,0,1
75387,compared,0,0
75388,with,0,1
75389,group,0,1
75390,B,0,1
75391,.,0,1
75392,CONCLUSIONS,0,0
75393,Ropivacaine,0,0
75394,can,0,0
75395,be,0,0
75396,used,0,0
75397,effectively,0,0
75398,as,0,0
75399,a,0,0
75400,local,0,0
75401,anesthetic,0,0
75402,for,0,0
75403,digital,1,0
75404,nerve,1,1
75405,blocks,1,1
75406,.,1,1
75407,It,0,0
75408,can,0,0
75409,be,0,0
75410,used,0,0
75411,for,0,0
75412,prolonged,0,0
75413,operations,0,1
75414,(,0,1
75415,>,0,1
75416,1.5,0,1
75417,hours,0,0
75418,),0,1
75419,without,0,1
75420,additional,0,1
75421,injections,0,0
75422,and,0,1
75423,can,0,0
75424,provide,0,0
75425,long-lasting,0,0
75426,postoperative,0,0
75427,analgesia,0,1
75428,.,0,1
75429,A,0,0
75430,comparison,0,0
75431,of,0,0
75432,acceptance-,0,1
75433,and,0,1
75434,control-based,0,1
75435,strategies,0,0
75436,for,0,1
75437,coping,0,0
75438,with,0,1
75439,food,0,1
75440,cravings,0,1
75441,:,0,1
75442,an,0,1
75443,analog,0,0
75444,study,0,0
75445,.,0,1
75446,The,0,0
75447,present,0,0
75448,study,0,0
75449,utilized,0,0
75450,an,0,0
75451,analog,0,0
75452,paradigm,0,0
75453,to,0,0
75454,investigate,0,0
75455,the,0,0
75456,effectiveness,0,0
75457,of,0,0
75458,two,0,1
75459,strategies,0,0
75460,for,0,1
75461,coping,0,0
75462,with,0,1
75463,food,0,1
75464,cravings,0,0
75465,",",0,1
75466,which,0,0
75467,was,0,0
75468,theorized,0,0
75469,to,0,0
75470,be,0,0
75471,critical,0,0
75472,to,0,0
75473,the,0,0
75474,maintenance,0,0
75475,of,0,0
75476,weight,0,1
75477,loss,0,1
75478,.,0,1
75479,Ninety-eight,1,1
75480,undergraduate,1,1
75481,students,1,1
75482,were,1,1
75483,given,1,1
75484,transparent,1,0
75485,boxes,1,0
75486,of,1,1
75487,chocolate,1,1
75488,Hershey,1,1
75489,'s,1,1
75490,Kisses,1,1
75491,and,0,1
75492,instructed,0,1
75493,to,0,0
75494,keep,0,0
75495,the,0,0
75496,chocolates,0,0
75497,with,0,1
75498,them,0,1
75499,",",0,0
75500,but,0,0
75501,not,0,0
75502,to,0,0
75503,eat,0,1
75504,them,0,0
75505,",",0,0
75506,for,0,0
75507,48,0,1
75508,h.,0,1
75509,Before,0,0
75510,receiving,0,1
75511,the,0,0
75512,Kisses,0,1
75513,",",0,0
75514,participants,0,1
75515,were,0,1
75516,randomized,0,1
75517,to,0,0
75518,receive,0,1
75519,either,0,0
75520,(,0,0
75521,a,0,0
75522,),0,0
75523,no,0,0
75524,intervention,0,0
75525,",",0,0
75526,(,0,0
75527,b,0,1
75528,),0,1
75529,instruction,0,0
75530,in,0,1
75531,control-based,0,1
75532,coping,0,1
75533,strategies,0,0
75534,such,0,0
75535,as,0,1
75536,distraction,0,1
75537,and,0,1
75538,cognitive,0,0
75539,restructuring,0,0
75540,",",0,0
75541,or,0,1
75542,(,0,0
75543,c,0,1
75544,),0,1
75545,instruction,0,0
75546,in,0,1
75547,acceptance-based,0,0
75548,strategies,0,0
75549,such,0,0
75550,as,0,1
75551,experiential,0,1
75552,acceptance,0,1
75553,and,0,1
75554,defusion,0,0
75555,techniques,0,0
75556,.,0,1
75557,Measures,0,0
75558,included,0,1
75559,the,0,0
75560,Power,0,1
75561,of,0,0
75562,Food,0,1
75563,Scale,0,1
75564,(,0,1
75565,PFS,0,1
75566,;,0,1
75567,a,0,0
75568,measure,0,0
75569,of,0,0
75570,psychological,0,1
75571,sensitivity,0,0
75572,to,0,0
75573,the,0,0
75574,food,0,0
75575,environment,0,0
75576,),0,0
75577,",",0,1
75578,self-report,0,1
75579,ratings,0,0
75580,of,0,1
75581,chocolate,0,1
75582,cravings,0,0
75583,and,0,1
75584,surreptitiously,0,1
75585,recorded,0,0
75586,chocolate,0,0
75587,consumption,0,0
75588,.,0,1
75589,Results,0,0
75590,suggested,0,0
75591,that,0,0
75592,the,0,0
75593,effect,0,0
75594,of,0,0
75595,the,0,0
75596,intervention,0,0
75597,depended,0,0
75598,on,0,0
75599,baseline,0,0
75600,PFS,0,1
75601,levels,0,0
75602,",",0,1
75603,such,0,0
75604,that,0,0
75605,acceptance-based,0,1
75606,strategies,0,0
75607,were,0,1
75608,associated,0,0
75609,with,0,1
75610,better,0,0
75611,outcomes,0,0
75612,(,0,1
75613,cravings,0,0
75614,",",0,1
75615,consumption,0,0
75616,),0,0
75617,among,0,0
75618,those,0,1
75619,reporting,0,0
75620,the,0,0
75621,highest,0,0
75622,susceptibility,0,0
75623,to,0,0
75624,the,0,0
75625,presence,0,0
75626,of,0,0
75627,food,0,0
75628,",",0,0
75629,but,0,0
75630,greater,0,0
75631,cravings,0,0
75632,among,0,1
75633,those,0,1
75634,who,0,1
75635,scored,0,1
75636,lowest,0,1
75637,on,0,0
75638,the,0,0
75639,PFS,0,1
75640,.,0,1
75641,It,0,0
75642,was,0,0
75643,observed,0,0
75644,that,0,0
75645,craving,0,1
75646,self-report,0,1
75647,measures,0,0
75648,predicted,0,0
75649,chocolate,0,1
75650,consumption,0,0
75651,",",0,0
75652,and,0,0
75653,baseline,0,0
75654,PFS,0,1
75655,levels,0,0
75656,predicted,0,0
75657,both,0,0
75658,cravings,0,0
75659,and,0,1
75660,consumption,0,0
75661,.,0,1
75662,Results,0,0
75663,are,0,0
75664,discussed,0,0
75665,in,0,0
75666,terms,0,0
75667,of,0,1
75668,the,0,1
75669,implications,0,0
75670,for,0,0
75671,weight,0,1
75672,loss,0,1
75673,maintenance,0,1
75674,strategies,0,0
75675,.,0,1
75676,Lowering,0,0
75677,of,0,0
75678,glucose,0,0
75679,in,0,1
75680,critical,0,0
75681,care,0,1
75682,:,0,1
75683,a,0,0
75684,randomized,0,1
75685,pilot,0,0
75686,trial,0,1
75687,.,0,1
75688,BACKGROUND,0,0
75689,Similar,0,0
75690,to,0,0
75691,cardiac,0,1
75692,surgery,0,1
75693,patients,0,1
75694,",",0,1
75695,medical-surgical,1,1
75696,critically,1,1
75697,ill,1,1
75698,patients,1,1
75699,may,0,0
75700,benefit,0,0
75701,from,0,0
75702,intensive,0,1
75703,insulin,0,1
75704,therapy,0,0
75705,.,0,1
75706,The,0,0
75707,objectives,0,0
75708,of,0,0
75709,this,0,0
75710,pilot,0,0
75711,trial,0,0
75712,were,0,0
75713,to,0,0
75714,evaluate,0,0
75715,the,0,0
75716,feasibility,0,0
75717,of,0,0
75718,a,0,1
75719,randomized,0,1
75720,trial,0,0
75721,of,0,0
75722,intensive,0,1
75723,insulin,0,1
75724,therapy,0,0
75725,with,0,1
75726,respect,0,0
75727,to,0,0
75728,(,0,0
75729,a,0,1
75730,),0,0
75731,achieving,0,0
75732,target,0,1
75733,glucose,0,0
75734,values,0,0
75735,in,0,1
75736,the,0,1
75737,2,0,1
75738,ranges,0,1
75739,of,0,1
75740,5,0,1
75741,to,0,1
75742,7,0,1
75743,and,0,1
75744,8,0,1
75745,to,0,1
75746,10,0,1
75747,mmol/L,0,0
75748,and,0,1
75749,(,0,1
75750,b,0,1
75751,),0,1
75752,uncovering,0,0
75753,problems,0,1
75754,with,0,1
75755,the,0,0
75756,protocol,0,0
75757,in,0,0
75758,anticipation,0,1
75759,of,0,0
75760,a,0,0
75761,larger,0,0
75762,trial,0,0
75763,.,0,0
75764,SETTING,0,1
75765,The,0,0
75766,trial,0,0
75767,was,0,0
75768,conducted,0,0
75769,in,0,0
75770,a,0,1
75771,15-bed,1,1
75772,medical-surgical,1,1
75773,university-affiliated,1,1
75774,intensive,1,1
75775,care,1,1
75776,unit,1,1
75777,(,1,1
75778,ICU,1,1
75779,),1,1
75780,.,1,1
75781,METHODS,0,0
75782,We,0,0
75783,included,0,1
75784,patients,1,1
75785,older,1,1
75786,than,1,1
75787,18,1,1
75788,years,1,1
75789,",",1,1
75790,expected,1,0
75791,to,1,0
75792,be,1,0
75793,in,1,0
75794,ICU,1,0
75795,for,1,0
75796,more,1,0
75797,than,1,1
75798,72,1,1
75799,hours,1,0
75800,",",1,1
75801,with,1,1
75802,a,1,0
75803,glucose,1,0
75804,value,1,0
75805,of,1,0
75806,more,1,0
75807,than,1,1
75808,10,1,1
75809,mmol/L,1,0
75810,within,1,1
75811,48,1,1
75812,hours,1,0
75813,of,1,1
75814,ICU,1,1
75815,admission,1,1
75816,.,1,1
75817,Exclusion,1,0
75818,criteria,1,1
75819,were,1,1
75820,diabetic,1,1
75821,ketoacidosis,1,1
75822,",",1,1
75823,severe,1,1
75824,hepatic,1,0
75825,failure,1,1
75826,or,1,1
75827,hepatic,1,0
75828,resection,1,1
75829,",",1,0
75830,pancreatitis,1,1
75831,",",1,0
75832,glucose,1,0
75833,of,1,0
75834,less,1,0
75835,than,1,1
75836,2.2,1,0
75837,mmol/L,1,0
75838,on,1,0
75839,admission,1,1
75840,to,1,0
75841,hospital,1,1
75842,",",1,0
75843,insulin,1,0
75844,infusion,1,0
75845,on,1,0
75846,admission,1,1
75847,to,1,1
75848,ICU,1,0
75849,",",1,0
75850,planned,1,0
75851,withdrawal,1,0
75852,of,1,0
75853,life,1,1
75854,support,1,0
75855,",",1,0
75856,and,1,0
75857,inability,1,0
75858,to,1,0
75859,obtain,1,0
75860,informed,1,0
75861,consent,1,1
75862,.,1,1
75863,Patients,0,1
75864,underwent,0,1
75865,concealed,0,1
75866,random,0,1
75867,allocation,0,0
75868,to,0,0
75869,a,0,0
75870,target,0,0
75871,glucose,0,0
75872,range,0,1
75873,of,0,1
75874,5,0,1
75875,to,0,1
75876,7,0,1
75877,or,0,1
75878,8,0,1
75879,to,0,1
75880,10,0,1
75881,mmol/L,0,0
75882,using,0,1
75883,pretested,0,1
75884,algorithms,0,1
75885,of,0,1
75886,insulin,0,1
75887,infusions,0,1
75888,.,0,1
75889,Dedicated,0,0
75890,glucometer,0,0
75891,measurement,0,0
75892,of,0,0
75893,arterial,0,1
75894,glucose,0,1
75895,values,0,0
75896,was,0,0
75897,calibrated,0,1
75898,daily,0,0
75899,to,0,1
75900,values,0,0
75901,measured,0,0
75902,in,0,0
75903,the,0,0
75904,laboratory,0,0
75905,.,0,1
75906,RESULTS,0,0
75907,We,1,0
75908,enrolled,1,1
75909,20,1,1
75910,patients,1,1
75911,with,1,1
75912,a,1,1
75913,mean,1,1
75914,(,1,0
75915,SD,1,1
75916,),1,1
75917,Acute,1,1
75918,Physiology,1,1
75919,and,1,1
75920,Chronic,1,1
75921,Health,1,0
75922,Evaluation,1,0
75923,(,1,1
75924,APACHE,1,1
75925,),1,1
75926,II,1,1
75927,score,1,1
75928,of,1,1
75929,32,1,1
75930,(,1,1
75931,10.2,1,0
75932,),1,1
75933,;,1,1
75934,14,1,1
75935,were,1,1
75936,insulin-dependent,1,1
75937,pre-ICU,1,1
75938,",",1,0
75939,and,1,0
75940,all,1,0
75941,were,1,1
75942,medical,1,1
75943,admissions,1,1
75944,.,1,1
75945,Mean,0,1
75946,glucose,0,0
75947,values,0,0
75948,were,0,1
75949,different,0,0
75950,in,0,0
75951,the,0,1
75952,2,0,1
75953,groups,0,0
75954,(,0,1
75955,7.1,0,1
75956,+/-,0,1
75957,2.6,0,1
75958,vs,0,0
75959,9.4,0,1
75960,+/-,0,1
75961,2.1,0,0
75962,mmol/L,0,0
75963,",",0,1
75964,P,0,0
75965,<,0,0
75966,.001,0,0
75967,),0,1
75968,.,0,1
75969,Although,0,0
75970,the,0,0
75971,intensive,0,1
75972,insulin,0,0
75973,therapy,0,0
75974,group,0,0
75975,had,0,0
75976,more,0,0
75977,glucose,0,0
75978,measurements,0,0
75979,performed,0,0
75980,than,0,0
75981,the,0,0
75982,control,0,0
75983,group,0,0
75984,",",0,0
75985,a,0,0
75986,similar,0,0
75987,proportion,0,1
75988,of,0,1
75989,values,0,0
75990,were,0,1
75991,within,0,1
75992,the,0,0
75993,target,0,0
75994,range,0,1
75995,(,0,1
75996,682,0,1
75997,[,0,1
75998,42.4,0,0
75999,%,0,0
76000,],0,1
76001,of,0,1
76002,1607,0,1
76003,values,0,0
76004,in,0,1
76005,the,0,1
76006,5-,0,1
76007,to,0,0
76008,7-mmol/L,0,0
76009,range,0,1
76010,;,0,1
76011,250,0,1
76012,[,0,0
76013,38.7,0,1
76014,%,0,0
76015,],0,1
76016,of,0,1
76017,660,0,1
76018,values,0,0
76019,in,0,1
76020,the,0,1
76021,8-,0,1
76022,to,0,0
76023,10-mmol/L,0,0
76024,range,0,1
76025,",",0,1
76026,P,0,0
76027,=,0,1
76028,.35,0,0
76029,),0,1
76030,.,0,1
76031,Glucose,0,0
76032,values,0,0
76033,of,0,0
76034,less,0,1
76035,than,0,1
76036,2.5,0,0
76037,mmol/L,0,0
76038,developed,0,1
76039,7,0,1
76040,times,0,0
76041,in,0,1
76042,5,0,1
76043,patients,0,1
76044,",",0,1
76045,4,0,1
76046,of,0,1
76047,whom,0,1
76048,were,0,1
76049,in,0,1
76050,the,0,0
76051,intensive,0,1
76052,insulin,0,0
76053,therapy,0,1
76054,group,0,1
76055,;,0,0
76056,however,0,0
76057,",",0,0
76058,no,0,0
76059,adverse,0,0
76060,consequences,0,0
76061,were,0,1
76062,documented,0,1
76063,.,0,1
76064,As,0,0
76065,expected,0,0
76066,",",0,0
76067,there,0,0
76068,were,0,0
76069,no,0,0
76070,differences,0,0
76071,in,0,0
76072,clinically,0,1
76073,important,0,0
76074,outcomes,0,0
76075,.,0,1
76076,CONCLUSIONS,0,0
76077,In,0,0
76078,this,0,0
76079,pilot,0,0
76080,trial,0,0
76081,of,0,1
76082,ICU,1,1
76083,patients,1,1
76084,with,1,1
76085,high,1,1
76086,illness,1,1
76087,severity,1,0
76088,",",0,1
76089,glucose,0,0
76090,values,0,0
76091,were,0,1
76092,in,0,1
76093,the,0,0
76094,2,0,0
76095,target,0,0
76096,ranges,0,1
76097,only,0,0
76098,40,0,0
76099,%,0,0
76100,of,0,0
76101,the,0,0
76102,time,0,0
76103,",",0,0
76104,using,0,0
76105,well-accepted,0,0
76106,initiation,0,0
76107,and,0,0
76108,maintenance,0,0
76109,insulin,0,0
76110,infusion,0,0
76111,algorithms,0,1
76112,.,0,1
76113,A,0,0
76114,large,0,1
76115,randomized,0,1
76116,trial,0,1
76117,of,0,0
76118,glycemic,0,0
76119,control,0,1
76120,is,0,0
76121,feasible,0,0
76122,in,0,0
76123,this,0,0
76124,population,0,1
76125,to,0,0
76126,examine,0,0
76127,clinically,0,1
76128,important,0,0
76129,outcomes,0,0
76130,",",0,0
76131,but,0,0
76132,will,0,0
76133,require,0,0
76134,refined,0,0
76135,insulin,0,0
76136,algorithms,0,0
76137,and,0,0
76138,more,0,0
76139,comprehensive,0,0
76140,behavior,0,0
76141,change,0,0
76142,strategies,0,0
76143,to,0,1
76144,achieve,0,0
76145,target,0,0
76146,values,0,0
76147,.,0,1
76148,Effect,0,0
76149,of,0,0
76150,low-intensity,0,0
76151,back,0,1
76152,exercise,0,0
76153,on,0,0
76154,quality,0,0
76155,of,0,0
76156,life,0,0
76157,and,0,0
76158,back,0,1
76159,extensor,0,1
76160,strength,0,0
76161,in,0,1
76162,patients,1,1
76163,with,1,1
76164,osteoporosis,1,1
76165,:,1,1
76166,a,0,0
76167,randomized,0,1
76168,controlled,0,0
76169,trial,0,1
76170,.,0,1
76171,UNLABELLED,0,0
76172,Randomized,0,0
76173,controlled,0,0
76174,study,0,1
76175,in,0,1
76176,80,1,1
76177,postmenopausal,1,1
76178,women,1,1
76179,with,1,1
76180,osteoporosis,1,1
76181,was,0,0
76182,conducted,0,0
76183,to,0,0
76184,investigate,0,0
76185,the,0,0
76186,effect,0,0
76187,of,0,0
76188,a,0,0
76189,home-based,0,0
76190,",",0,0
76191,simple,0,0
76192,",",0,0
76193,low-intensity,0,0
76194,exercise,0,1
76195,.,0,1
76196,Low-intensity,0,0
76197,back-strengthening,0,0
76198,exercise,0,1
76199,was,0,0
76200,effective,0,0
76201,in,0,0
76202,improving,0,0
76203,the,0,0
76204,quality,0,0
76205,of,0,0
76206,life,0,0
76207,and,0,0
76208,back,0,1
76209,extensor,0,1
76210,strength,0,0
76211,.,0,1
76212,INTRODUCTION,0,0
76213,AND,0,0
76214,HYPOTHESIS,0,0
76215,Back-strengthening,0,0
76216,exercise,0,0
76217,is,0,0
76218,effective,0,0
76219,in,0,0
76220,increasing,0,0
76221,back,0,1
76222,extensor,0,1
76223,strength,0,0
76224,and,0,0
76225,decreasing,0,0
76226,risk,0,1
76227,of,0,1
76228,vertebral,0,1
76229,fractures,0,1
76230,.,0,1
76231,We,0,0
76232,hypothesized,0,0
76233,that,0,0
76234,a,0,0
76235,home-based,0,0
76236,",",0,0
76237,simple,0,0
76238,",",0,0
76239,low-intensity,0,0
76240,exercise,0,0
76241,could,0,0
76242,enhance,0,0
76243,back,0,0
76244,extensor,0,1
76245,strength,0,0
76246,and,0,0
76247,improve,0,0
76248,the,0,0
76249,quality,0,0
76250,of,0,0
76251,life,0,1
76252,and/or,0,1
76253,spinal,0,1
76254,range,0,1
76255,of,0,0
76256,motion,0,1
76257,in,0,1
76258,postmenopausal,1,1
76259,women,1,1
76260,in,0,1
76261,a,0,1
76262,short-term,0,0
76263,follow-up,0,0
76264,.,0,1
76265,METHODS,0,0
76266,Eighty,1,1
76267,postmenopausal,1,1
76268,women,1,1
76269,with,1,1
76270,osteoporosis,1,1
76271,were,1,1
76272,randomly,1,1
76273,assigned,1,1
76274,to,1,0
76275,a,1,0
76276,control,1,0
76277,group,1,0
76278,(,1,1
76279,n,1,1
76280,=,1,1
76281,38,1,1
76282,),1,1
76283,or,1,1
76284,an,1,0
76285,exercise,1,0
76286,group,1,0
76287,(,1,1
76288,n,1,1
76289,=,1,1
76290,42,1,1
76291,),1,1
76292,.,1,1
76293,Subjects,0,1
76294,were,0,1
76295,instructed,0,1
76296,to,0,0
76297,lift,0,0
76298,their,0,1
76299,upper,0,1
76300,trunk,0,1
76301,from,0,1
76302,a,0,0
76303,prone,0,0
76304,position,0,0
76305,antigravity,0,0
76306,and,0,0
76307,maintain,0,0
76308,the,0,0
76309,neutral,0,0
76310,position,0,1
76311,.,0,1
76312,Isometric,0,0
76313,back,0,1
76314,extensor,0,1
76315,strength,0,0
76316,",",0,0
76317,spinal,0,1
76318,range,0,1
76319,of,0,0
76320,motion,0,0
76321,",",0,1
76322,and,0,0
76323,scores,0,0
76324,for,0,0
76325,quality,0,0
76326,of,0,0
76327,life,0,1
76328,were,0,1
76329,evaluated,0,0
76330,at,0,0
76331,baseline,0,0
76332,and,0,1
76333,4,0,1
76334,months,0,1
76335,.,0,1
76336,RESULTS,0,0
76337,Back,0,0
76338,extensor,0,1
76339,strength,0,0
76340,significantly,0,0
76341,increased,0,0
76342,both,0,0
76343,in,0,0
76344,the,0,0
76345,exercise,0,0
76346,group,0,1
76347,(,0,1
76348,26,0,1
76349,%,0,0
76350,),0,1
76351,and,0,0
76352,in,0,0
76353,the,0,0
76354,control,0,1
76355,group,0,1
76356,(,0,1
76357,11,0,1
76358,%,0,0
76359,),0,1
76360,.,0,1
76361,Scores,0,0
76362,for,0,0
76363,quality,0,0
76364,of,0,0
76365,life,0,1
76366,increased,0,0
76367,in,0,0
76368,the,0,0
76369,exercise,0,0
76370,group,0,1
76371,(,0,1
76372,7,0,1
76373,%,0,0
76374,),0,0
76375,",",0,0
76376,whereas,0,0
76377,it,0,0
76378,remained,0,0
76379,unchanged,0,0
76380,in,0,0
76381,the,0,0
76382,control,0,1
76383,group,0,1
76384,(,0,1
76385,0,0,0
76386,%,0,0
76387,),0,0
76388,.,0,0
76389,There,0,0
76390,was,0,0
76391,a,0,0
76392,significant,0,0
76393,difference,0,0
76394,in,0,0
76395,quality,0,0
76396,of,0,0
76397,life,0,1
76398,score,0,0
76399,between,0,0
76400,the,0,0
76401,groups,0,0
76402,(,0,1
76403,p,0,0
76404,=,0,1
76405,0.012,0,0
76406,),0,1
76407,.,0,1
76408,CONCLUSIONS,0,0
76409,Low-intensity,0,0
76410,back-strengthening,0,1
76411,exercise,0,0
76412,was,0,0
76413,effective,0,0
76414,in,0,0
76415,improving,0,0
76416,the,0,0
76417,quality,0,0
76418,of,0,0
76419,life,0,0
76420,and,0,0
76421,back,0,1
76422,extensor,0,1
76423,strength,0,0
76424,in,0,1
76425,patients,1,1
76426,with,1,1
76427,osteoporosis,1,1
76428,.,1,1
76429,Codeine/acetaminophen,0,0
76430,and,0,1
76431,hydrocodone/acetaminophen,0,0
76432,combination,0,0
76433,tablets,0,0
76434,for,0,0
76435,the,0,0
76436,management,0,0
76437,of,0,0
76438,chronic,1,1
76439,cancer,1,1
76440,pain,1,1
76441,in,1,1
76442,adults,1,1
76443,:,1,1
76444,a,0,1
76445,23-day,0,1
76446,",",0,0
76447,prospective,0,1
76448,",",0,0
76449,double-blind,0,0
76450,",",0,0
76451,randomized,0,1
76452,",",0,0
76453,parallel-group,0,0
76454,study,0,1
76455,.,0,1
76456,BACKGROUND,0,0
76457,Analgesics,0,0
76458,are,0,0
76459,an,0,1
76460,essential,0,0
76461,component,0,0
76462,of,0,0
76463,the,0,0
76464,treatment,0,0
76465,of,0,0
76466,cancer-associated,0,1
76467,pain,0,1
76468,.,0,1
76469,Pharmacologic,0,0
76470,treatment,0,0
76471,is,0,0
76472,usually,0,0
76473,begun,0,0
76474,with,0,1
76475,nonopioid,0,1
76476,analgesics,0,0
76477,",",0,1
76478,most,0,0
76479,frequently,0,1
76480,acetaminophen,0,0
76481,.,0,0
76482,If,0,0
76483,pain,0,0
76484,relief,0,0
76485,is,0,0
76486,not,0,0
76487,achieved,0,0
76488,",",0,0
76489,the,0,0
76490,so-called,0,1
76491,weak,0,0
76492,opioids,0,0
76493,",",0,1
76494,such,0,0
76495,as,0,0
76496,codeine,0,0
76497,and,0,0
76498,hydrocodone,0,0
76499,",",0,0
76500,may,0,0
76501,be,0,0
76502,used,0,0
76503,in,0,0
76504,combination,0,0
76505,with,0,1
76506,acetaminophen,0,0
76507,.,0,1
76508,Adverse,0,0
76509,effects,0,0
76510,(,0,1
76511,AEs,0,0
76512,),0,1
76513,of,0,0
76514,the,0,0
76515,opioids,0,0
76516,include,0,0
76517,constipation,0,1
76518,",",0,0
76519,somnolence,0,0
76520,",",0,0
76521,nausea,0,0
76522,",",0,0
76523,and,0,0
76524,vomiting,0,0
76525,.,0,1
76526,Based,0,0
76527,on,0,0
76528,the,0,0
76529,results,0,0
76530,of,0,0
76531,a,0,1
76532,literature,0,0
76533,search,0,0
76534,",",0,1
76535,data,0,0
76536,comparing,0,0
76537,the,0,1
76538,effects,0,0
76539,of,0,0
76540,the,0,0
76541,opioids,0,0
76542,are,0,0
76543,lacking,0,1
76544,.,0,1
76545,OBJECTIVE,0,0
76546,The,0,0
76547,purpose,0,0
76548,of,0,0
76549,this,0,0
76550,study,0,0
76551,was,0,0
76552,to,0,0
76553,compare,0,0
76554,the,0,0
76555,analgesic,0,0
76556,efficacy,0,0
76557,and,0,0
76558,tolerability,0,0
76559,of,0,0
76560,codeine,0,0
76561,phosphate,0,0
76562,versus,0,0
76563,hydrocodone,0,0
76564,bitartrate,0,0
76565,in,0,0
76566,combination,0,0
76567,with,0,1
76568,acetaminophen,0,0
76569,in,0,0
76570,the,0,0
76571,relief,0,0
76572,of,0,0
76573,cancer-related,0,1
76574,pain,0,1
76575,.,0,1
76576,METHODS,0,0
76577,This,0,0
76578,23-day,0,1
76579,",",0,0
76580,prospective,0,1
76581,",",0,0
76582,double-blind,0,0
76583,",",0,0
76584,randomized,0,1
76585,",",0,0
76586,parallel-group,0,0
76587,study,0,1
76588,was,0,0
76589,conducted,0,1
76590,at,0,1
76591,3,0,1
76592,Colombian,0,1
76593,centers,0,1
76594,:,0,1
76595,University,0,1
76596,Libre,0,1
76597,",",0,1
76598,Social,0,0
76599,Security,0,1
76600,Institute,0,1
76601,",",0,0
76602,and,0,0
76603,General,0,1
76604,Hospital,0,1
76605,of,0,0
76606,Medell?n,0,1
76607,",",0,1
76608,Cali,0,1
76609,",",0,0
76610,Colombia,0,1
76611,.,0,1
76612,Outpatients,1,1
76613,with,1,1
76614,cancer,1,1
76615,were,1,1
76616,eligible,1,1
76617,for,1,0
76618,the,1,0
76619,study,1,0
76620,if,1,0
76621,they,1,0
76622,were,1,1
76623,aged,1,1
76624,>,1,1
76625,-18,1,1
76626,years,1,1
76627,and,1,1
76628,had,1,1
76629,chronic,1,1
76630,(,1,0
76631,duration,1,0
76632,",",1,0
76633,>,1,0
76634,/=,1,1
76635,3,1,0
76636,months,1,0
76637,),1,1
76638,moderate,1,1
76639,to,1,0
76640,severe,1,1
76641,cancer-related,1,1
76642,pain,1,1
76643,(,1,1
76644,score,1,0
76645,on,1,0
76646,10-cm,1,1
76647,visual,1,0
76648,analog,1,0
76649,scale,1,1
76650,[,1,0
76651,VAS,1,0
76652,],1,1
76653,",",1,1
76654,>,1,1
76655,3,1,0
76656,cm,1,1
76657,[,1,0
76658,moderate,1,1
76659,],1,1
76660,;,1,1
76661,score,1,0
76662,on,1,0
76663,a,1,1
76664,4-point,1,0
76665,verbal,1,0
76666,pain-intensity,1,0
76667,scale,1,0
76668,",",1,0
76669,>,1,0
76670,1,1,0
76671,[,1,0
76672,moderate,1,1
76673,],1,1
76674,),1,1
76675,.,1,1
76676,Eligible,0,0
76677,patients,0,1
76678,were,0,1
76679,randomly,0,1
76680,assigned,0,1
76681,to,0,0
76682,receive,0,1
76683,1,0,0
76684,tablet,0,0
76685,of,0,0
76686,codeine/acetaminophen,0,0
76687,(,0,1
76688,C/A,0,1
76689,),0,1
76690,30/500,0,0
76691,mg,0,0
76692,or,0,1
76693,hydrocodone/acetaminophen,0,0
76694,(,0,1
76695,H/A,0,1
76696,),0,1
76697,5/500,0,1
76698,mg,0,1
76699,PO,0,0
76700,q4h,0,1
76701,(,0,1
76702,total,0,1
76703,daily,0,0
76704,doses,0,0
76705,",",0,1
76706,150/2500,0,1
76707,and,0,1
76708,25/2500,0,1
76709,mg,0,0
76710,",",0,0
76711,respectively,0,0
76712,),0,0
76713,for,0,0
76714,23,0,1
76715,days,0,0
76716,.,0,1
76717,In,0,0
76718,both,0,0
76719,groups,0,0
76720,",",0,0
76721,if,0,0
76722,pain,0,1
76723,intensity,0,0
76724,was,0,0
76725,rated,0,0
76726,as,0,0
76727,>,0,1
76728,3,0,1
76729,on,0,0
76730,the,0,0
76731,VAS,0,0
76732,at,0,0
76733,week,0,0
76734,1,0,1
76735,or,0,1
76736,2,0,1
76737,",",0,0
76738,the,0,0
76739,dosage,0,0
76740,was,0,0
76741,doubled,0,0
76742,.,0,1
76743,The,0,0
76744,primary,0,0
76745,end,0,0
76746,point,0,0
76747,was,0,0
76748,the,0,0
76749,proportion,0,0
76750,of,0,1
76751,patients,0,1
76752,who,0,1
76753,achieved,0,1
76754,pain,0,1
76755,relief,0,0
76756,(,0,0
76757,defined,0,0
76758,as,0,0
76759,a,0,0
76760,score,0,0
76761,of,0,0
76762,>,0,1
76763,1,0,1
76764,on,0,0
76765,a,0,1
76766,5-point,0,0
76767,verbal,0,0
76768,rating,0,0
76769,scale,0,0
76770,[,0,0
76771,VRS,0,0
76772,],0,1
76773,(,0,1
76774,0,0,0
76775,=,0,1
76776,none,0,1
76777,;,0,1
76778,1,0,0
76779,=,0,0
76780,a,0,1
76781,little,0,0
76782,;,0,1
76783,2,0,1
76784,=,0,1
76785,some,0,1
76786,;,0,1
76787,3,0,0
76788,=,0,0
76789,a,0,1
76790,lot,0,1
76791,;,0,0
76792,and,0,1
76793,4,0,0
76794,=,0,1
76795,complete,0,1
76796,),0,1
76797,on,0,0
76798,study,0,1
76799,days,0,1
76800,1,0,1
76801,and,0,1
76802,2,0,1
76803,and,0,1
76804,weeks,0,1
76805,1,0,1
76806,",",0,1
76807,2,0,0
76808,",",0,0
76809,and,0,1
76810,3,0,0
76811,.,0,1
76812,The,0,0
76813,secondary,0,0
76814,end,0,0
76815,point,0,0
76816,was,0,0
76817,the,0,0
76818,proportion,0,0
76819,of,0,0
76820,patients,0,1
76821,in,0,1
76822,whom,0,1
76823,pain,0,1
76824,was,0,1
76825,decreased,0,0
76826,(,0,0
76827,VAS,0,0
76828,score,0,0
76829,",",0,0
76830,<,0,0
76831,-,0,0
76832,3,0,1
76833,cm,0,1
76834,),0,1
76835,.,0,1
76836,AEs,0,0
76837,were,0,0
76838,self-reported,0,0
76839,on,0,0
76840,a,0,1
76841,4-point,0,0
76842,VRS,0,0
76843,(,0,1
76844,0,0,0
76845,=,0,1
76846,absent,0,1
76847,;,0,1
76848,1,0,1
76849,=,0,1
76850,mild,0,1
76851,;,0,1
76852,2,0,1
76853,=,0,1
76854,moderate,0,1
76855,;,0,1
76856,and,0,1
76857,3,0,0
76858,=,0,0
76859,severe,0,1
76860,),0,1
76861,.,0,1
76862,RESULTS,0,0
76863,Of,0,1
76864,the,1,1
76865,121,1,1
76866,patients,1,1
76867,who,1,1
76868,participated,1,1
76869,",",1,1
76870,59,0,1
76871,received,0,1
76872,C/A,0,1
76873,and,0,1
76874,62,0,1
76875,received,0,1
76876,H/A,0,1
76877,.,0,1
76878,Of,1,0
76879,the,1,0
76880,total,1,1
76881,number,1,0
76882,of,1,1
76883,cases,1,1
76884,",",1,1
76885,59,1,1
76886,%,1,0
76887,were,1,1
76888,aged,1,1
76889,60,1,1
76890,to,1,1
76891,89,1,1
76892,years,1,1
76893,",",1,1
76894,and,1,1
76895,55,1,1
76896,%,1,0
76897,were,1,1
76898,men,1,1
76899,.,1,1
76900,At,0,0
76901,baseline,0,0
76902,",",0,1
76903,88,0,0
76904,%,0,0
76905,of,0,0
76906,the,0,0
76907,patients,0,1
76908,described,0,0
76909,their,0,1
76910,pain,0,1
76911,intensity,0,0
76912,as,0,0
76913,moderate,0,1
76914,;,0,1
76915,12,0,1
76916,%,0,0
76917,",",0,1
76918,severe,0,1
76919,.,0,1
76920,Of,0,0
76921,the,0,1
76922,patients,0,1
76923,who,0,1
76924,received,0,1
76925,C/A,0,1
76926,",",0,1
76927,58,0,1
76928,%,0,0
76929,responded,0,1
76930,to,0,0
76931,the,0,0
76932,initial,0,0
76933,dosage,0,0
76934,of,0,1
76935,150/2500,0,1
76936,mg/d,0,0
76937,",",0,1
76938,and,0,0
76939,8,0,0
76940,%,0,0
76941,of,0,0
76942,the,0,0
76943,patients,0,1
76944,responded,0,1
76945,to,0,1
76946,the,0,0
76947,double,0,0
76948,dosage,0,0
76949,;,0,1
76950,34,0,1
76951,%,0,0
76952,did,0,0
76953,not,0,0
76954,experience,0,0
76955,pain,0,1
76956,relief,0,0
76957,.,0,1
76958,In,0,0
76959,patients,0,1
76960,with,0,1
76961,H/A,0,1
76962,",",0,1
76963,pain,0,1
76964,was,0,0
76965,reported,0,0
76966,as,0,0
76967,absent,0,1
76968,or,0,1
76969,mild,0,1
76970,in,0,1
76971,56,0,1
76972,%,0,0
76973,of,0,1
76974,patients,0,1
76975,at,0,1
76976,the,0,0
76977,starting,0,0
76978,dosage,0,0
76979,of,0,1
76980,25/2500,0,1
76981,mg/d,0,0
76982,;,0,1
76983,an,0,1
76984,additional,0,0
76985,15,0,1
76986,%,0,0
76987,of,0,0
76988,the,0,0
76989,patients,0,1
76990,responded,0,1
76991,to,0,1
76992,the,0,0
76993,double,0,0
76994,dosage,0,0
76995,;,0,1
76996,the,0,0
76997,remaining,0,1
76998,29,0,1
76999,%,0,0
77000,of,0,1
77001,patients,0,1
77002,did,0,0
77003,not,0,0
77004,experience,0,0
77005,any,0,0
77006,pain,0,1
77007,relief,0,0
77008,.,0,1
77009,None,0,0
77010,of,0,0
77011,the,0,0
77012,between-group,0,0
77013,differences,0,0
77014,in,0,1
77015,response,0,1
77016,rates,0,0
77017,were,0,1
77018,significant,0,0
77019,.,0,1
77020,The,0,0
77021,most,0,0
77022,common,0,0
77023,AEs,0,0
77024,in,0,0
77025,the,0,0
77026,C/A,0,1
77027,and,0,1
77028,H/A,0,1
77029,groups,0,0
77030,were,0,1
77031,constipation,0,1
77032,(,0,1
77033,36,0,1
77034,%,0,0
77035,and,0,1
77036,29,0,1
77037,%,0,0
77038,",",0,0
77039,respectively,0,0
77040,),0,0
77041,",",0,0
77042,dizziness,0,0
77043,(,0,1
77044,24,0,1
77045,%,0,0
77046,and,0,1
77047,19,0,1
77048,%,0,0
77049,),0,1
77050,",",0,0
77051,vomiting,0,0
77052,(,0,1
77053,24,0,1
77054,%,0,0
77055,and,0,1
77056,16,0,1
77057,%,0,0
77058,),0,1
77059,",",0,0
77060,and,0,0
77061,dry,0,1
77062,mouth,0,1
77063,(,0,1
77064,15,0,1
77065,%,0,0
77066,and,0,1
77067,18,0,1
77068,%,0,0
77069,),0,0
77070,",",0,0
77071,with,0,1
77072,no,0,0
77073,significant,0,0
77074,differences,0,0
77075,between,0,1
77076,groups,0,1
77077,.,0,1
77078,CONCLUSION,0,0
77079,In,0,0
77080,this,0,0
77081,study,0,0
77082,",",0,0
77083,efficacy,0,0
77084,and,0,0
77085,tolerability,0,0
77086,were,0,1
77087,comparable,0,0
77088,between,0,0
77089,C/A,0,1
77090,and,0,1
77091,H/A,0,1
77092,over,0,0
77093,23,0,1
77094,days,0,0
77095,of,0,1
77096,treatment,0,1
77097,in,0,1
77098,these,1,0
77099,patients,1,1
77100,with,1,1
77101,moderate,1,1
77102,or,1,1
77103,severe,1,1
77104,",",1,0
77105,chronic,1,1
77106,",",1,0
77107,cancer-related,1,1
77108,pain,1,1
77109,.,1,1
77110,The,0,0
77111,peroxisome,0,0
77112,proliferator-activated,0,0
77113,receptor-gamma,0,0
77114,agonist,0,1
77115,pioglitazone,0,0
77116,increases,0,0
77117,number,0,0
77118,and,0,0
77119,function,0,0
77120,of,0,0
77121,endothelial,0,1
77122,progenitor,0,1
77123,cells,0,0
77124,in,0,1
77125,patients,1,1
77126,with,1,1
77127,coronary,1,1
77128,artery,1,1
77129,disease,1,1
77130,and,1,1
77131,normal,1,1
77132,glucose,1,0
77133,tolerance,1,1
77134,.,1,1
77135,OBJECTIVE,0,0
77136,Peroxisome,0,0
77137,proliferator-activated,0,0
77138,receptor-gamma,0,0
77139,(,0,1
77140,PPAR,0,0
77141,gamma,0,0
77142,),0,0
77143,agonists,0,0
77144,(,0,0
77145,thiazolidinediones,0,0
77146,[,0,1
77147,TZDs,0,1
77148,],0,1
77149,),0,1
77150,are,0,0
77151,used,0,0
77152,for,0,0
77153,the,0,0
77154,treatment,0,0
77155,of,0,0
77156,diabetes,0,1
77157,.,0,1
77158,Bone,0,0
77159,marrow-derived,0,0
77160,endothelial,0,1
77161,progenitor,0,1
77162,cells,0,0
77163,(,0,1
77164,EPCs,0,1
77165,),0,1
77166,improve,0,0
77167,vascular,0,0
77168,function,0,0
77169,and,0,0
77170,predict,0,0
77171,cardiovascular,0,1
77172,risk,0,1
77173,.,0,1
77174,The,0,0
77175,effect,0,0
77176,of,0,0
77177,pioglitazone,0,0
77178,therapy,0,0
77179,on,0,0
77180,EPCs,0,0
77181,was,0,0
77182,examined,0,0
77183,.,0,1
77184,RESEARCH,0,1
77185,DESIGN,0,1
77186,AND,0,0
77187,METHODS,0,0
77188,AND,0,0
77189,RESULTS,0,1
77190,We,0,0
77191,performed,0,0
77192,a,0,0
77193,prospective,0,0
77194,",",0,0
77195,randomized,0,1
77196,",",0,0
77197,double-blind,0,0
77198,study,0,1
77199,on,0,0
77200,patients,1,1
77201,with,1,1
77202,documented,1,1
77203,stable,1,1
77204,coronary,1,1
77205,artery,1,1
77206,disease,1,1
77207,and,1,1
77208,normal,1,1
77209,glucose,1,0
77210,tolerance,1,1
77211,.,1,1
77212,Of,0,1
77213,54,1,1
77214,patients,1,1
77215,with,1,1
77216,normal,1,1
77217,fasting,1,1
77218,glucose,1,0
77219,levels,1,1
77220,",",1,1
77221,18,1,1
77222,showed,1,0
77223,impaired,1,1
77224,glucose,1,0
77225,tolerance,1,1
77226,and,1,1
77227,36,1,1
77228,patients,1,1
77229,with,1,1
77230,normal,1,1
77231,glucose,1,0
77232,tolerance,1,1
77233,were,1,1
77234,randomized,1,1
77235,to,0,1
77236,30-day,0,0
77237,treatment,0,0
77238,with,0,1
77239,pioglitazone,0,1
77240,(,0,1
77241,45,0,1
77242,mg,0,1
77243,),0,1
77244,or,0,1
77245,placebo,0,0
77246,in,0,0
77247,addition,0,0
77248,to,0,0
77249,optimal,0,0
77250,medical,0,1
77251,therapy,0,0
77252,.,0,1
77253,All,0,1
77254,patients,0,1
77255,in,0,0
77256,the,0,1
77257,TZD,0,0
77258,group,0,0
77259,showed,0,0
77260,an,0,0
77261,increase,0,0
77262,of,0,0
77263,adiponectin,0,0
77264,levels,0,0
77265,as,0,0
77266,an,0,1
77267,indicator,0,0
77268,of,0,0
77269,compliance,0,0
77270,(,0,1
77271,11.4,0,0
77272,+/-,0,1
77273,1.1,0,1
77274,to,0,1
77275,36.8,0,1
77276,+/-,0,0
77277,2.1,0,1
77278,microg/ml,0,0
77279,;,0,1
77280,P,0,0
77281,<,0,0
77282,0.001,0,0
77283,),0,1
77284,.,0,1
77285,TZD,0,0
77286,",",0,0
77287,but,0,0
77288,not,0,0
77289,placebo,0,0
77290,",",0,0
77291,decreased,0,0
77292,mean,0,1
77293,high-sensitivity,0,0
77294,C-reactive,0,1
77295,protein,0,0
77296,to,0,1
77297,43,0,1
77298,+/-,0,0
77299,19,0,1
77300,%,0,0
77301,(,0,1
77302,P,0,0
77303,<,0,0
77304,0.05,0,0
77305,),0,1
77306,.,0,1
77307,Pioglitazone,0,0
77308,increased,0,0
77309,CD34,0,1
77310,(,0,1
77311,+,0,0
77312,),0,1
77313,/kinase,0,0
77314,insert,0,0
77315,domain,0,0
77316,receptor,0,0
77317,(,0,1
77318,+,0,0
77319,),0,1
77320,EPCs,0,0
77321,to,0,1
77322,142,0,1
77323,+/-,0,0
77324,9,0,1
77325,%,0,0
77326,and,0,1
77327,cultured,0,1
77328,"1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-labeled",0,0
77329,acetylated,0,0
77330,LDL,0,1
77331,(,0,1
77332,+,0,0
77333,),0,1
77334,/lectin,0,0
77335,(,0,1
77336,+,0,0
77337,),0,1
77338,EPCs,0,0
77339,to,0,1
77340,180,0,1
77341,+/-,0,0
77342,3,0,1
77343,%,0,0
77344,(,0,1
77345,P,0,0
77346,<,0,0
77347,0.05,0,0
77348,),0,1
77349,.,0,1
77350,EPC,0,1
77351,numbers,0,0
77352,were,0,1
77353,not,0,0
77354,changed,0,0
77355,in,0,0
77356,the,0,0
77357,placebo,0,0
77358,group,0,1
77359,.,0,1
77360,TZD,0,0
77361,increased,0,0
77362,the,0,0
77363,SDF-1-induced,0,0
77364,migratory,0,0
77365,capacity,0,0
77366,to,0,1
77367,146,0,1
77368,+/-,0,0
77369,9,0,0
77370,%,0,0
77371,per,0,1
77372,EPC,0,1
77373,number,0,0
77374,(,0,1
77375,P,0,0
77376,<,0,0
77377,0.05,0,0
77378,),0,1
77379,and,0,0
77380,upregulated,0,1
77381,the,0,0
77382,clonogenic,0,0
77383,potential,0,0
77384,of,0,0
77385,EPCs,0,0
77386,",",0,0
77387,increasing,0,0
77388,the,0,0
77389,colony-forming,0,0
77390,units,0,1
77391,to,0,1
77392,172,0,1
77393,+/-,0,0
77394,12,0,1
77395,%,0,0
77396,(,0,1
77397,P,0,0
77398,<,0,0
77399,0.001,0,0
77400,),0,1
77401,.,0,1
77402,In,0,0
77403,cultured,0,0
77404,human,0,1
77405,EPCs,0,0
77406,",",0,1
77407,TZD,0,0
77408,increased,0,0
77409,EPC,0,1
77410,numbers,0,0
77411,and,0,1
77412,migration,0,1
77413,and,0,1
77414,reduced,0,0
77415,NADPH-oxidase,0,1
77416,activity,0,0
77417,.,0,1
77418,The,0,0
77419,TZD,0,0
77420,effect,0,0
77421,was,0,0
77422,reversed,0,0
77423,by,0,0
77424,the,0,0
77425,PPAR,0,0
77426,gamma,0,0
77427,antagonist,0,0
77428,GW9662,0,0
77429,and,0,0
77430,mimicked,0,0
77431,by,0,0
77432,treatment,0,0
77433,with,0,1
77434,adiponectin,0,0
77435,.,0,1
77436,CONCLUSIONS,0,0
77437,The,0,0
77438,PPAR,0,0
77439,gamma,0,0
77440,agonist,0,0
77441,pioglitazone,0,0
77442,increases,0,0
77443,the,0,0
77444,number,0,0
77445,and,0,0
77446,function,0,0
77447,of,0,0
77448,EPCs,0,1
77449,in,0,1
77450,patients,1,1
77451,with,1,1
77452,coronary,1,1
77453,artery,1,1
77454,disease,1,1
77455,.,1,1
77456,The,0,0
77457,effect,0,0
77458,represents,0,0
77459,a,0,0
77460,potential,0,0
77461,regenerative,0,1
77462,mechanism,0,0
77463,in,0,0
77464,atherosclerosis,0,1
77465,and,0,0
77466,is,0,0
77467,observed,0,0
77468,in,0,0
77469,normoglycemic,1,1
77470,individuals,1,1
77471,with,1,1
77472,stable,1,1
77473,coronary,1,1
77474,artery,1,1
77475,disease,1,1
77476,.,1,1
77477,Efficacy,0,0
77478,of,0,0
77479,amantadine,0,1
77480,on,0,0
77481,quality,0,0
77482,of,0,0
77483,life,0,1
77484,in,0,1
77485,patients,1,1
77486,with,1,1
77487,chronic,1,1
77488,hepatitis,1,1
77489,C,1,0
77490,treated,1,1
77491,with,1,1
77492,interferon-alpha,1,0
77493,and,1,1
77494,ribavirin,1,1
77495,:,1,1
77496,results,0,0
77497,from,0,1
77498,a,0,1
77499,randomized,0,1
77500,",",0,0
77501,placebo-controlled,0,0
77502,",",0,0
77503,double-blind,0,0
77504,trial,0,0
77505,.,0,1
77506,AIM,0,0
77507,The,0,0
77508,aim,0,0
77509,of,0,0
77510,this,0,0
77511,study,0,0
77512,was,0,0
77513,to,0,0
77514,investigate,0,0
77515,whether,0,0
77516,amantadine,0,1
77517,reduces,0,0
77518,deterioration,0,1
77519,of,0,0
77520,quality,0,0
77521,of,0,0
77522,life,0,1
77523,in,0,1
77524,patients,1,1
77525,with,1,1
77526,chronic,1,1
77527,hepatitis,1,1
77528,C,1,1
77529,during,1,0
77530,and,1,0
77531,after,1,0
77532,treatment,1,0
77533,with,1,1
77534,interferon-alpha,1,0
77535,(,1,1
77536,IFN-alpha,1,0
77537,),1,1
77538,and,1,1
77539,ribavirin,1,1
77540,.,1,1
77541,PATIENTS,0,0
77542,AND,0,0
77543,METHODS,0,0
77544,In,0,1
77545,this,0,0
77546,randomized,0,1
77547,",",0,0
77548,prospective,0,0
77549,",",0,0
77550,placebo-controlled,0,0
77551,",",0,0
77552,multicenter,0,0
77553,trial,0,0
77554,",",0,0
77555,previously,1,1
77556,untreated,1,1
77557,patients,1,1
77558,with,1,1
77559,chronic,1,1
77560,hepatitis,1,1
77561,C,1,1
77562,were,0,1
77563,treated,0,1
77564,with,0,1
77565,IFN-alpha,0,0
77566,plus,0,0
77567,ribavirin,0,1
77568,[,0,0
77569,17,0,1
77570,],0,1
77571,and,0,0
77572,randomized,0,1
77573,for,0,0
77574,treatment,0,0
77575,with,0,1
77576,amantadine,0,1
77577,(,0,1
77578,200,0,1
77579,mg/day,0,0
77580,",",0,0
77581,orally,0,0
77582,",",0,0
77583,n=136,0,1
77584,),0,0
77585,or,0,1
77586,placebo,0,0
77587,(,0,1
77588,n=131,0,1
77589,),0,1
77590,.,0,1
77591,Quality,0,0
77592,of,0,0
77593,life,0,1
77594,was,0,0
77595,assessed,0,0
77596,with,0,1
77597,the,0,0
77598,'Profile,0,0
77599,of,0,1
77600,Mood,0,1
77601,States,0,1
77602,',0,1
77603,scale,0,1
77604,and,0,1
77605,the,0,0
77606,'Everyday,0,1
77607,Life,0,0
77608,',0,1
77609,questionnaire,0,0
77610,at,0,1
77611,baseline,0,0
77612,",",0,0
77613,treatment,0,0
77614,week,0,0
77615,(,0,1
77616,TW,0,1
77617,),0,1
77618,8,0,1
77619,",",0,1
77620,TW24,0,0
77621,",",0,0
77622,TW48,0,0
77623,",",0,0
77624,and,0,0
77625,at,0,0
77626,follow-up,0,0
77627,.,0,1
77628,RESULTS,0,0
77629,Early,0,1
77630,during,0,0
77631,treatment,0,1
77632,at,0,1
77633,TW8,0,1
77634,",",0,0
77635,quality,0,0
77636,of,0,0
77637,life,0,0
77638,was,0,0
77639,not,0,0
77640,different,0,0
77641,between,0,0
77642,patients,1,1
77643,in,1,1
77644,the,1,0
77645,control,1,0
77646,and,1,0
77647,the,1,0
77648,amantadine,1,1
77649,group,1,0
77650,.,1,1
77651,At,0,0
77652,TW24,0,0
77653,",",0,0
77654,the,0,0
77655,control,0,0
77656,group,0,0
77657,but,0,0
77658,not,0,0
77659,the,0,0
77660,amantadine,0,0
77661,group,0,0
77662,",",0,0
77663,however,0,0
77664,",",0,0
77665,showed,0,0
77666,significant,0,0
77667,deterioration,0,0
77668,of,0,0
77669,the,0,0
77670,modalities,0,0
77671,depression,0,1
77672,",",0,0
77673,fatigue,0,0
77674,",",0,0
77675,and,0,0
77676,vigor,0,0
77677,compared,0,0
77678,with,0,1
77679,baseline,0,0
77680,.,0,1
77681,Especially,0,0
77682,",",0,0
77683,nonresponders,0,0
77684,in,0,0
77685,the,0,0
77686,amantadine,0,1
77687,group,0,0
77688,showed,0,0
77689,significantly,0,0
77690,lower,0,0
77691,deterioration,0,0
77692,of,0,0
77693,depression,0,1
77694,",",0,0
77695,anger,0,0
77696,",",0,0
77697,mind,0,0
77698,function,0,0
77699,",",0,0
77700,everyday,0,0
77701,life,0,0
77702,",",0,0
77703,and,0,0
77704,zest,0,0
77705,for,0,0
77706,life,0,1
77707,than,0,0
77708,those,0,0
77709,in,0,0
77710,the,0,0
77711,placebo,0,0
77712,group,0,0
77713,.,0,1
77714,After,0,0
77715,treatment,0,0
77716,",",0,0
77717,the,0,0
77718,beneficial,0,0
77719,effects,0,0
77720,of,0,1
77721,amantadine,0,1
77722,disappeared,0,0
77723,.,0,0
77724,CONCLUSION,0,0
77725,The,0,0
77726,addition,0,0
77727,of,0,0
77728,amantadine,0,1
77729,to,0,1
77730,IFN-alpha,0,0
77731,plus,0,0
77732,ribavirin,0,0
77733,combination,0,0
77734,therapy,0,0
77735,may,0,0
77736,reduce,0,0
77737,deterioration,0,0
77738,of,0,0
77739,depression,0,1
77740,",",0,0
77741,fatigue,0,0
77742,",",0,0
77743,and,0,0
77744,vigor,0,0
77745,during,0,0
77746,treatment,0,0
77747,but,0,0
77748,does,0,0
77749,not,0,0
77750,affect,0,0
77751,quality,0,0
77752,of,0,0
77753,life,0,1
77754,after,0,1
77755,treatment,0,1
77756,.,0,1
77757,The,0,0
77758,EUROSCAN,1,0
77759,Study,1,0
77760,.,1,1
77761,EUROSCAN,1,0
77762,Steering,1,1
77763,Committee,1,1
77764,.,1,1
77765,Clinical,0,0
77766,benefit,0,0
77767,with,0,1
77768,docetaxel,0,0
77769,plus,0,0
77770,fluorouracil,0,0
77771,and,0,1
77772,cisplatin,0,0
77773,compared,0,0
77774,with,0,1
77775,cisplatin,0,0
77776,and,0,0
77777,fluorouracil,0,0
77778,in,0,0
77779,a,0,1
77780,phase,0,1
77781,III,0,1
77782,trial,0,1
77783,of,0,0
77784,advanced,1,1
77785,gastric,1,1
77786,or,1,1
77787,gastroesophageal,1,1
77788,cancer,1,1
77789,adenocarcinoma,1,1
77790,:,1,1
77791,the,0,0
77792,V-325,0,1
77793,Study,0,1
77794,Group,0,1
77795,.,0,1
77796,PURPOSE,0,0
77797,For,1,1
77798,patients,1,1
77799,with,1,1
77800,advanced,1,1
77801,gastric,1,1
77802,or,1,1
77803,gastroesophageal,1,1
77804,cancer,1,1
77805,(,1,1
77806,AGGEC,1,0
77807,),1,1
77808,providing,0,0
77809,clinical,0,0
77810,benefit,0,0
77811,with,0,1
77812,improved,0,0
77813,palliation,0,1
77814,is,0,0
77815,highly,0,0
77816,desirable,0,0
77817,.,0,0
77818,However,0,0
77819,",",0,0
77820,a,0,0
77821,prospective,0,0
77822,evaluation,0,0
77823,of,0,0
77824,clinical,0,0
77825,benefit,0,0
77826,in,0,1
77827,AGGEC,0,0
77828,patients,0,1
77829,has,0,0
77830,never,0,1
77831,before,0,0
77832,been,0,0
77833,reported,0,0
77834,in,0,0
77835,a,0,1
77836,phase,0,1
77837,III,0,1
77838,setting,0,1
77839,.,0,1
77840,PATIENTS,0,0
77841,AND,0,0
77842,METHODS,0,0
77843,In,1,1
77844,a,1,1
77845,multinational,1,1
77846,trial,1,0
77847,(,1,1
77848,V325,1,0
77849,),1,1
77850,",",1,1
77851,445,1,1
77852,patients,1,1
77853,were,1,1
77854,randomly,1,1
77855,assigned,1,1
77856,and,1,0
77857,treated,1,1
77858,with,0,1
77859,either,0,1
77860,docetaxel,0,0
77861,plus,0,0
77862,cisplatin,0,0
77863,and,0,1
77864,fluorouracil,0,0
77865,(,0,1
77866,DCF,0,1
77867,),0,1
77868,or,0,1
77869,cisplatin,0,0
77870,and,0,0
77871,fluorouracil,0,0
77872,(,0,1
77873,CF,0,1
77874,),0,1
77875,.,0,1
77876,Clinical,0,0
77877,benefit,0,0
77878,was,0,0
77879,prospectively,0,1
77880,evaluated,0,0
77881,in,0,0
77882,this,0,0
77883,trial,0,0
77884,as,0,0
77885,a,0,1
77886,secondary,0,0
77887,end,0,0
77888,point,0,0
77889,.,0,1
77890,The,0,0
77891,primary,0,0
77892,measure,0,0
77893,for,0,0
77894,clinical,0,0
77895,benefit,0,0
77896,analysis,0,0
77897,was,0,0
77898,time,0,0
77899,to,0,0
77900,definitive,0,0
77901,worsening,0,0
77902,by,0,0
77903,one,0,1
77904,or,0,1
77905,more,0,0
77906,categories,0,1
77907,of,0,0
77908,Karnofsky,0,1
77909,performance,0,0
77910,status,0,1
77911,(,0,1
77912,KPS,0,1
77913,),0,1
77914,.,0,1
77915,Secondary,0,0
77916,clinical,0,0
77917,benefit,0,0
77918,end,0,0
77919,points,0,0
77920,included,0,1
77921,time,0,0
77922,to,0,1
77923,5,0,0
77924,%,0,0
77925,definitive,0,1
77926,weight,0,1
77927,loss,0,0
77928,",",0,0
77929,time,0,0
77930,to,0,0
77931,definitive,0,0
77932,worsening,0,0
77933,of,0,0
77934,appetite,0,0
77935,by,0,0
77936,one,0,1
77937,grade,0,1
77938,",",0,0
77939,pain-free,0,0
77940,survival,0,0
77941,(,0,1
77942,defined,0,0
77943,as,0,0
77944,time,0,0
77945,to,0,1
77946,first,0,0
77947,appearance,0,0
77948,of,0,0
77949,pain,0,1
77950,),0,1
77951,",",0,0
77952,and,0,0
77953,time,0,0
77954,to,0,1
77955,first,0,0
77956,cancer,0,1
77957,pain-related,0,1
77958,opioid,0,1
77959,intake,0,0
77960,.,0,1
77961,Clinical,0,0
77962,benefit,0,0
77963,assessments,0,0
77964,were,0,1
77965,recorded,0,0
77966,at,0,0
77967,each,0,0
77968,clinic,0,1
77969,visit,0,0
77970,.,0,1
77971,RESULTS,0,0
77972,Clinical,0,0
77973,benefit,0,0
77974,assessments,0,0
77975,were,0,1
77976,performed,0,0
77977,in,0,0
77978,more,0,0
77979,than,0,1
77980,75,0,1
77981,%,0,0
77982,of,0,1
77983,patients,0,1
77984,throughout,0,1
77985,V325,0,1
77986,.,0,1
77987,DCF,0,0
77988,significantly,0,0
77989,prolonged,0,0
77990,time,0,0
77991,to,0,1
77992,definitive,0,0
77993,worsening,0,0
77994,of,0,1
77995,KPS,0,1
77996,compared,0,0
77997,with,0,1
77998,CF,0,1
77999,(,0,1
78000,median,0,0
78001,",",0,1
78002,6.1,0,0
78003,v,0,0
78004,4.8,0,0
78005,months,0,0
78006,;,0,1
78007,hazard,0,0
78008,ratio,0,0
78009,",",0,0
78010,1.38,0,0
78011,;,0,1
78012,95,0,0
78013,%,0,0
78014,CI,0,0
78015,",",0,1
78016,1.08,0,0
78017,to,0,1
78018,1.76,0,0
78019,;,0,1
78020,log-rank,0,0
78021,P,0,0
78022,=,0,1
78023,.009,0,0
78024,),0,1
78025,.,0,1
78026,Although,0,0
78027,time,0,0
78028,to,0,1
78029,definitive,0,0
78030,weight,0,1
78031,loss,0,0
78032,and,0,0
78033,time,0,0
78034,to,0,1
78035,definitive,0,0
78036,worsening,0,0
78037,of,0,0
78038,appetite,0,0
78039,favored,0,0
78040,DCF,0,0
78041,",",0,0
78042,the,0,0
78043,results,0,0
78044,were,0,0
78045,not,0,0
78046,statistically,0,0
78047,significant,0,0
78048,.,0,1
78049,Pain-free,0,0
78050,survival,0,0
78051,and,0,1
78052,time,0,0
78053,to,0,1
78054,first,0,0
78055,cancer,0,1
78056,pain-related,0,1
78057,opioid,0,1
78058,intake,0,0
78059,were,0,1
78060,comparable,0,0
78061,.,0,1
78062,CONCLUSION,0,0
78063,To,0,0
78064,our,0,0
78065,knowledge,0,0
78066,",",0,0
78067,V325,0,0
78068,is,0,0
78069,the,0,0
78070,first,0,0
78071,phase,0,1
78072,III,0,1
78073,trial,0,0
78074,to,0,0
78075,report,0,0
78076,clinical,0,0
78077,benefit,0,0
78078,in,0,1
78079,AGGEC,0,1
78080,patients,0,1
78081,.,0,1
78082,Clinical,0,0
78083,benefit,0,0
78084,was,0,0
78085,assessed,0,0
78086,beyond,0,1
78087,protocol-specific,0,0
78088,chemotherapy,0,1
78089,.,0,1
78090,The,0,0
78091,addition,0,0
78092,of,0,0
78093,D,0,1
78094,to,0,1
78095,CF,0,0
78096,not,0,0
78097,only,0,0
78098,significantly,0,0
78099,improved,0,0
78100,clinical,0,0
78101,benefit,0,0
78102,but,0,0
78103,also,0,0
78104,improved,0,0
78105,quality,0,0
78106,of,0,0
78107,life,0,0
78108,",",0,0
78109,time,0,0
78110,to,0,0
78111,progression,0,0
78112,",",0,0
78113,and,0,0
78114,overall,0,0
78115,survival,0,0
78116,compared,0,0
78117,with,0,1
78118,CF,0,1
78119,.,0,1
78120,[,0,1
78121,Effect,0,0
78122,of,0,0
78123,electroacununcture,0,0
78124,on,0,0
78125,sex,0,1
78126,hormone,0,1
78127,levels,0,0
78128,in,0,1
78129,patients,1,1
78130,with,1,1
78131,Sj?gren,1,1
78132,'s,1,1
78133,syndrome,1,1
78134,],1,1
78135,.,1,1
78136,OBJECTIVE,0,0
78137,To,0,0
78138,observe,0,0
78139,the,0,0
78140,effect,0,0
78141,of,0,0
78142,electroacupuncture,0,0
78143,(,0,1
78144,EA,0,1
78145,),0,1
78146,on,0,0
78147,serum,0,0
78148,testosterone,0,0
78149,(,0,1
78150,T,0,1
78151,),0,0
78152,",",0,0
78153,estradiol,0,0
78154,(,0,1
78155,F2,0,0
78156,),0,0
78157,",",0,0
78158,luteotropic,0,0
78159,hormone,0,0
78160,(,0,0
78161,LH,0,1
78162,),0,1
78163,",",0,0
78164,follicle-stimulating,0,0
78165,hormone,0,1
78166,(,0,1
78167,FSH,0,1
78168,),0,1
78169,",",0,0
78170,progesterone,0,0
78171,(,0,1
78172,P,0,0
78173,),0,1
78174,",",0,0
78175,and,0,0
78176,prolactin,0,0
78177,(,0,1
78178,PRL,0,0
78179,),0,1
78180,in,1,1
78181,patients,1,1
78182,with,1,1
78183,Sj?gren,1,1
78184,'s,1,1
78185,Syndrome,1,1
78186,(,1,1
78187,SS,1,1
78188,),1,1
78189,in,1,0
78190,order,0,0
78191,to,0,0
78192,analyze,0,0
78193,the,0,0
78194,correlation,0,0
78195,between,0,0
78196,the,0,0
78197,adjustment,0,0
78198,effect,0,0
78199,of,0,0
78200,EA,0,1
78201,and,0,1
78202,changes,0,0
78203,of,0,1
78204,hormone,0,1
78205,levels,0,1
78206,.,0,1
78207,METHODS,1,0
78208,Fifty-seven,1,1
78209,middle-aged,1,1
78210,and,1,1
78211,old,1,1
78212,women,1,1
78213,with,1,1
78214,SS,1,1
78215,were,1,1
78216,divided,0,1
78217,into,0,1
78218,medication,0,1
78219,group,0,1
78220,(,0,1
78221,n=27,0,1
78222,),0,1
78223,and,0,0
78224,acupuncture,0,1
78225,group,0,0
78226,(,0,0
78227,n=30,0,1
78228,),0,1
78229,.,0,1
78230,Patients,0,1
78231,in,0,0
78232,acupuncture,0,1
78233,group,0,1
78234,were,0,0
78235,treated,0,1
78236,with,0,1
78237,EA,0,1
78238,(,0,1
78239,80,0,1
78240,Hz,0,1
78241,",",0,1
78242,2.5,0,0
78243,mA,0,1
78244,),0,1
78245,of,0,0
78246,Shenshu,0,1
78247,(,0,1
78248,BL,0,1
78249,23,0,1
78250,),0,1
78251,",",0,1
78252,Taixi,0,1
78253,(,0,1
78254,KI,0,1
78255,3,0,1
78256,),0,1
78257,",",0,1
78258,Hegu,0,1
78259,(,0,1
78260,LI,0,1
78261,4,0,1
78262,),0,0
78263,",",0,0
78264,etc,0,0
78265,.,0,1
78266,for,0,0
78267,30,0,1
78268,min,0,0
78269,",",0,0
78270,once,0,0
78271,every,0,0
78272,other,0,0
78273,day,0,0
78274,",",0,0
78275,and,0,0
78276,those,0,0
78277,of,0,0
78278,medication,0,0
78279,group,0,1
78280,were,0,0
78281,treated,0,1
78282,with,0,1
78283,oral,0,0
78284,administration,0,0
78285,of,0,0
78286,hydroxyl-chloroquine,0,1
78287,(,0,1
78288,6,0,1
78289,mg/kg,0,0
78290,per,0,1
78291,day,0,1
78292,),0,1
78293,",",0,0
78294,oral,0,0
78295,transfer,0,1
78296,agent,0,0
78297,liquid,0,0
78298,",",0,0
78299,Vit,0,0
78300,B1,0,0
78301,",",0,1
78302,Vit,0,1
78303,B2,0,1
78304,",",0,1
78305,Vit,0,1
78306,C,0,0
78307,",",0,0
78308,fish-liver,0,1
78309,oil,0,0
78310,",",0,1
78311,one,0,1
78312,tablet/time,0,0
78313,",",0,0
78314,t.i.d.,0,0
78315,",",0,0
78316,and,0,0
78317,pilocarpine,0,1
78318,(,0,1
78319,20,0,1
78320,mg/d,0,0
78321,),0,0
78322,",",0,0
78323,continuously,0,0
78324,for,0,0
78325,2,0,1
78326,months,0,1
78327,.,0,1
78328,Venous,0,1
78329,blood,0,0
78330,samples,0,1
78331,were,0,1
78332,collected,0,1
78333,before,0,0
78334,and,0,0
78335,after,0,0
78336,the,0,0
78337,treatment,0,0
78338,to,0,0
78339,examine,0,0
78340,contents,0,0
78341,of,0,0
78342,the,0,1
78343,abovementioned,0,0
78344,sex,0,0
78345,hormones,0,0
78346,by,0,0
78347,using,0,1
78348,electro-chemiluminescent,0,0
78349,immunoassay,0,1
78350,(,0,1
78351,CLIA,0,1
78352,),0,1
78353,.,0,1
78354,RESULTS,0,0
78355,(,0,1
78356,1,0,1
78357,),0,1
78358,Before,0,0
78359,the,0,0
78360,treatment,0,0
78361,",",0,0
78362,no,0,0
78363,significant,0,0
78364,differences,0,0
78365,were,0,1
78366,found,0,0
78367,between,0,0
78368,two,0,1
78369,groups,0,1
78370,in,0,1
78371,the,0,1
78372,levels,0,0
78373,of,0,0
78374,serum,0,0
78375,T,0,1
78376,",",0,0
78377,E2,0,1
78378,",",0,0
78379,LH,0,0
78380,",",0,0
78381,FSH,0,0
78382,",",0,0
78383,P,0,0
78384,and,0,1
78385,PRL,0,0
78386,(,0,1
78387,P,0,0
78388,>,0,1
78389,0.05,0,0
78390,),0,1
78391,.,0,1
78392,After,0,0
78393,the,0,0
78394,treatment,0,0
78395,",",0,0
78396,self-comparison,0,0
78397,of,0,0
78398,each,0,0
78399,group,0,0
78400,showed,0,0
78401,that,0,0
78402,serum,0,0
78403,EF,0,1
78404,and,0,1
78405,T,0,1
78406,contents,0,0
78407,in,0,1
78408,acupuncture,0,1
78409,group,0,1
78410,increased,0,0
78411,significantly,0,0
78412,(,0,1
78413,P,0,0
78414,<,0,0
78415,0.01,0,0
78416,),0,1
78417,and,0,1
78418,serum,0,0
78419,LH,0,1
78420,content,0,0
78421,decreased,0,0
78422,significantly,0,0
78423,(,0,1
78424,P,0,0
78425,<,0,0
78426,0.01,0,0
78427,),0,1
78428,;,0,1
78429,while,0,0
78430,in,0,0
78431,medication,0,1
78432,group,0,0
78433,",",0,0
78434,only,0,0
78435,serum,0,0
78436,LH,0,0
78437,decreased,0,0
78438,markedly,0,0
78439,(,0,1
78440,P,0,0
78441,<,0,0
78442,0.05,0,0
78443,),0,1
78444,in,0,0
78445,comparison,0,0
78446,with,0,1
78447,its,0,0
78448,basic,0,0
78449,value,0,0
78450,of,0,0
78451,pretreatment,0,0
78452,.,0,1
78453,No,0,0
78454,significant,0,0
78455,changes,0,0
78456,were,0,1
78457,found,0,0
78458,in,0,0
78459,serum,0,0
78460,P,0,0
78461,",",0,1
78462,FSH,0,0
78463,and,0,1
78464,PRL,0,0
78465,levels,0,0
78466,in,0,1
78467,both,0,0
78468,groups,0,0
78469,after,0,0
78470,the,0,0
78471,treatment,0,0
78472,(,0,0
78473,P,0,0
78474,>,0,1
78475,0.05,0,0
78476,),0,1
78477,.,0,1
78478,The,0,0
78479,results,0,0
78480,suggested,0,0
78481,that,0,0
78482,the,0,0
78483,therapeutic,0,0
78484,effect,0,0
78485,of,0,0
78486,acupuncture,0,1
78487,group,0,1
78488,was,0,0
78489,better,0,0
78490,than,0,0
78491,that,0,0
78492,of,0,0
78493,medication,0,0
78494,group,0,1
78495,in,0,0
78496,regulating,0,0
78497,multiple,0,1
78498,sex,0,1
78499,hormones,0,1
78500,.,0,1
78501,CONCLUSION,0,0
78502,EA,0,0
78503,can,0,0
78504,effectively,0,0
78505,adjust,0,0
78506,E2,0,1
78507,",",0,0
78508,T,0,1
78509,and,0,1
78510,LH,0,1
78511,levels,0,0
78512,in,0,1
78513,Sj?gren,1,1
78514,'s,1,1
78515,Syndrome,1,1
78516,patients,1,1
78517,and,1,1
78518,improve,0,0
78519,most,0,0
78520,patients,0,1
78521,',0,1
78522,clinical,0,1
78523,symptoms,0,1
78524,",",0,1
78525,and,0,0
78526,the,0,0
78527,therapeutic,0,0
78528,effect,0,0
78529,of,0,0
78530,EA,0,0
78531,is,0,0
78532,better,0,0
78533,than,0,0
78534,that,0,0
78535,of,0,0
78536,medication,0,1
78537,.,0,1
78538,Eight,0,1
78539,in-office,0,0
78540,tooth,0,1
78541,whitening,0,0
78542,systems,0,0
78543,evaluated,0,0
78544,in,0,1
78545,vivo,0,0
78546,:,0,1
78547,a,0,0
78548,pilot,0,0
78549,study,0,0
78550,.,0,1
78551,This,0,0
78552,in,0,0
78553,vivo,0,0
78554,pilot,0,1
78555,study,0,1
78556,evaluated,0,0
78557,eight,0,1
78558,products,0,0
78559,with,0,1
78560,hydrogen,0,0
78561,peroxide,0,0
78562,(,0,1
78563,HP,0,1
78564,),0,1
78565,concentrations,0,0
78566,ranging,0,1
78567,from,0,1
78568,15,0,1
78569,%,0,0
78570,to,0,1
78571,35,0,1
78572,%,0,0
78573,.,0,1
78574,The,0,0
78575,treatment,0,0
78576,contact,0,0
78577,time,0,0
78578,varied,0,0
78579,from,0,1
78580,15,0,1
78581,minutes,0,0
78582,to,0,1
78583,60,0,1
78584,minutes,0,0
78585,.,0,1
78586,Patients,1,1
78587,were,0,0
78588,evaluated,0,0
78589,for,0,0
78590,color,0,1
78591,at,0,0
78592,baseline,0,0
78593,",",0,0
78594,immediately,1,0
78595,after,1,0
78596,treatment,1,0
78597,and,0,1
78598,at,0,0
78599,one,0,1
78600,",",0,1
78601,two,0,0
78602,",",0,1
78603,four,0,1
78604,and,0,1
78605,six,0,1
78606,weeks,0,0
78607,after,0,1
78608,treatment,0,1
78609,using,0,0
78610,a,0,0
78611,colorimeter,0,0
78612,",",0,0
78613,shade,0,0
78614,guide,0,0
78615,and,0,1
78616,photos,0,0
78617,.,0,1
78618,All,0,1
78619,eight,0,1
78620,products,0,0
78621,were,0,1
78622,effective,0,0
78623,in,0,0
78624,bleaching,0,1
78625,teeth,0,1
78626,.,0,1
78627,Colorimeter,0,0
78628,data,0,0
78629,for,0,0
78630,deltaE,0,0
78631,immediately,0,0
78632,after,0,0
78633,treatment,0,0
78634,was,0,0
78635,6.77,0,0
78636,.,0,1
78637,At,0,0
78638,one,0,1
78639,and,0,1
78640,six,0,1
78641,weeks,0,0
78642,after,0,1
78643,bleaching,0,0
78644,",",0,0
78645,there,0,0
78646,were,0,0
78647,51,0,0
78648,%,0,0
78649,and,0,1
78650,65,0,1
78651,%,0,0
78652,reductions,0,0
78653,in,0,1
78654,deltaE,0,0
78655,",",0,0
78656,respectively,0,0
78657,.,0,1
78658,Clinical,0,0
78659,application,0,0
78660,of,0,0
78661,C-reactive,0,1
78662,protein,0,0
78663,across,0,0
78664,the,1,0
78665,spectrum,1,1
78666,of,1,0
78667,acute,1,1
78668,coronary,1,1
78669,syndromes,1,1
78670,.,1,1
78671,BACKGROUND,0,0
78672,High-sensitivity,0,0
78673,C-reactive,0,1
78674,protein,0,0
78675,(,0,1
78676,hsCRP,0,0
78677,),0,0
78678,is,0,0
78679,associated,0,0
78680,with,0,1
78681,adverse,0,0
78682,cardiovascular,0,1
78683,outcomes,0,0
78684,in,0,1
78685,acute,1,1
78686,coronary,1,1
78687,syndromes,1,1
78688,(,1,1
78689,ACS,1,1
78690,),1,1
78691,.,1,1
78692,The,0,0
78693,ability,0,0
78694,to,0,0
78695,formulate,0,0
78696,recommendations,0,0
78697,regarding,0,0
78698,clinical,0,0
78699,use,0,0
78700,of,0,0
78701,hsCRP,0,0
78702,is,0,0
78703,limited,0,0
78704,by,0,0
78705,a,0,0
78706,paucity,0,0
78707,of,0,0
78708,data,0,0
78709,regarding,0,0
78710,several,0,1
78711,key,0,0
78712,issues,0,1
78713,.,0,1
78714,The,0,0
78715,purpose,0,0
78716,of,0,0
78717,this,0,0
78718,study,0,0
78719,was,0,0
78720,to,0,0
78721,evaluate,0,0
78722,hsCRP,0,0
78723,across,0,0
78724,the,0,0
78725,spectrum,0,1
78726,of,0,0
78727,ACS,0,1
78728,.,0,1
78729,METHODS,0,0
78730,hsCRP,0,0
78731,was,0,0
78732,measured,0,0
78733,on,0,0
78734,admission,0,1
78735,in,0,1
78736,3225,1,1
78737,patients,1,1
78738,with,1,1
78739,ACS,1,1
78740,.,1,1
78741,hsCRP,0,0
78742,concentrations,0,0
78743,were,0,1
78744,compared,0,0
78745,in,0,1
78746,patients,0,1
78747,who,0,1
78748,suffered,0,1
78749,an,0,1
78750,adverse,0,0
78751,cardiac,0,1
78752,outcome,0,0
78753,within,0,1
78754,10,0,1
78755,months,0,1
78756,of,0,1
78757,study,0,1
78758,entry,0,1
78759,and,0,1
78760,in,0,1
78761,patients,0,1
78762,who,0,1
78763,had,0,1
78764,no,0,1
78765,adverse,0,0
78766,event,0,0
78767,.,0,1
78768,Because,0,0
78769,of,0,0
78770,heterogeneity,0,0
78771,in,0,0
78772,the,0,0
78773,relationship,0,0
78774,between,0,0
78775,hsCRP,0,0
78776,and,0,1
78777,clinical,0,0
78778,outcomes,0,0
78779,",",0,1
78780,evaluation,0,0
78781,was,0,0
78782,limited,0,0
78783,to,0,1
78784,patients,0,1
78785,from,0,1
78786,whom,0,1
78787,samples,0,1
78788,were,0,1
78789,collected,0,1
78790,within,0,1
78791,48,0,1
78792,h,0,0
78793,of,0,0
78794,symptom,0,1
78795,onset,0,1
78796,.,0,1
78797,RESULTS,0,0
78798,Patients,0,1
78799,in,0,1
78800,the,0,1
78801,highest,0,0
78802,quartile,0,0
78803,of,0,0
78804,hsCRP,0,0
78805,compared,0,0
78806,to,0,0
78807,those,0,0
78808,in,0,0
78809,the,0,0
78810,lowest,0,0
78811,quartile,0,0
78812,were,0,1
78813,at,0,0
78814,increased,0,0
78815,risk,0,1
78816,of,0,0
78817,death,0,0
78818,at,0,1
78819,30,0,1
78820,days,0,0
78821,[,0,1
78822,adjusted,0,0
78823,hazard,0,0
78824,ratio,0,0
78825,(,0,1
78826,adjHR,0,0
78827,),0,1
78828,4.6,0,0
78829,",",0,0
78830,P,0,0
78831,<,0,0
78832,0.001,0,0
78833,],0,0
78834,and,0,1
78835,10,0,1
78836,months,0,0
78837,(,0,1
78838,adjHR,0,0
78839,3.9,0,0
78840,",",0,1
78841,P,0,0
78842,<,0,0
78843,0.001,0,0
78844,),0,1
78845,.,0,1
78846,In,0,0
78847,patients,0,1
78848,with,0,1
78849,unstable,0,1
78850,angina/non-ST-elevation,0,1
78851,myocardial,0,1
78852,infarction,0,1
78853,(,0,1
78854,STEMI,0,1
78855,),0,1
78856,",",0,0
78857,hsCRP,0,0
78858,>,0,1
78859,3,0,1
78860,mg/L,0,1
78861,was,0,0
78862,associated,0,0
78863,with,0,1
78864,increased,0,0
78865,10-month,0,1
78866,mortality,0,0
78867,(,0,1
78868,adjHR,0,0
78869,2.3,0,1
78870,",",0,1
78871,P,0,0
78872,=,0,1
78873,0.002,0,0
78874,),0,0
78875,",",0,0
78876,whereas,0,0
78877,in,0,0
78878,STEMI,0,1
78879,a,0,1
78880,relationship,0,0
78881,with,0,1
78882,mortality,0,0
78883,was,0,0
78884,seen,0,0
78885,at,0,1
78886,hsCRP,0,1
78887,>,0,1
78888,10,0,1
78889,mg/L,0,1
78890,(,0,1
78891,adjHR,0,0
78892,3.0,0,0
78893,",",0,1
78894,P,0,0
78895,=,0,1
78896,0.008,0,0
78897,),0,1
78898,.,0,1
78899,Increased,0,0
78900,concentrations,0,0
78901,of,0,1
78902,hsCRP,0,1
78903,were,0,1
78904,strongly,0,0
78905,associated,0,0
78906,with,0,1
78907,the,0,0
78908,development,0,0
78909,of,0,0
78910,heart,0,1
78911,failure,0,1
78912,at,0,1
78913,30,0,1
78914,days,0,0
78915,(,0,1
78916,adjHR,0,0
78917,8.2,0,0
78918,",",0,1
78919,P,0,0
78920,=,0,1
78921,0.001,0,0
78922,),0,1
78923,and,0,1
78924,10,0,1
78925,months,0,0
78926,(,0,1
78927,adjHR,0,0
78928,2.6,0,0
78929,",",0,1
78930,P,0,0
78931,=,0,1
78932,0.014,0,0
78933,),0,1
78934,.,0,1
78935,CONCLUSION,0,0
78936,Increased,0,1
78937,baseline,0,0
78938,concentrations,0,0
78939,of,0,0
78940,hsCRP,0,1
78941,are,0,0
78942,strongly,0,0
78943,associated,0,0
78944,with,0,1
78945,mortality,0,0
78946,and,0,1
78947,heart,0,1
78948,failure,0,1
78949,across,0,0
78950,the,0,0
78951,ACS,0,1
78952,spectrum,0,1
78953,.,0,1
78954,hsCRP,0,0
78955,measurement,0,0
78956,should,0,0
78957,be,0,0
78958,performed,0,0
78959,early,0,1
78960,after,0,0
78961,presentation,0,1
78962,and,0,1
78963,index,0,1
78964,diagnosis-specific,0,0
78965,cutpoints,0,0
78966,should,0,0
78967,be,0,0
78968,used,0,0
78969,.,0,1
78970,[,0,0
78971,Observation,0,1
78972,on,0,0
78973,therapeutic,0,0
78974,effect,0,0
78975,of,0,0
78976,acupuncture,0,1
78977,on,0,0
78978,early,1,1
78979,peripheral,1,1
78980,facial,1,1
78981,paralysis,1,1
78982,],1,1
78983,.,0,1
78984,OBJECTIVE,0,0
78985,To,0,0
78986,observe,0,0
78987,therapeutic,0,0
78988,effects,0,0
78989,of,0,1
78990,acupuncture,0,1
78991,at,0,1
78992,different,0,1
78993,opportunities,0,1
78994,on,0,1
78995,peripheral,1,1
78996,facial,1,1
78997,paralysis,1,1
78998,.,1,1
78999,METHODS,0,0
79000,Fifty-two,1,1
79001,cases,1,1
79002,were,0,1
79003,randomly,0,1
79004,divided,0,0
79005,into,0,0
79006,a,0,0
79007,treatment,0,0
79008,group,0,0
79009,(,0,1
79010,n=28,0,1
79011,),0,1
79012,and,0,0
79013,a,0,0
79014,control,0,0
79015,group,0,0
79016,(,0,0
79017,n=24,0,1
79018,),0,1
79019,.,0,0
79020,The,0,0
79021,treatment,0,0
79022,group,0,0
79023,at,0,0
79024,the,0,0
79025,acute,0,1
79026,stage,0,1
79027,(,0,1
79028,1-10,0,1
79029,days,0,1
79030,),0,1
79031,were,0,1
79032,treated,0,1
79033,with,0,1
79034,acupuncture,0,1
79035,at,0,1
79036,Dicang,0,1
79037,(,0,1
79038,ST,0,1
79039,4,0,1
79040,),0,1
79041,",",0,1
79042,Jiache,0,1
79043,(,0,1
79044,ST,0,1
79045,6,0,1
79046,),0,1
79047,",",0,1
79048,Yangbai,0,1
79049,(,0,1
79050,GB,0,0
79051,14,0,1
79052,),0,0
79053,",",0,0
79054,etc.,0,0
79055,",",0,0
79056,with,0,1
79057,less,0,0
79058,than,0,1
79059,4,0,0
79060,points,0,0
79061,selected,0,1
79062,on,0,0
79063,the,0,0
79064,face,0,0
79065,and,0,0
79066,with,0,1
79067,shallow,0,1
79068,puncture,0,0
79069,",",0,1
79070,and,0,1
79071,10,0,1
79072,days,0,0
79073,later,0,1
79074,electroacupuncture,0,0
79075,were,0,0
79076,added,0,0
79077,at,0,1
79078,acupoints,0,0
79079,selected,0,1
79080,routinely,0,1
79081,;,0,0
79082,the,0,0
79083,control,0,0
79084,group,0,0
79085,were,0,0
79086,treated,0,1
79087,with,0,1
79088,the,0,0
79089,same,0,0
79090,methods,0,1
79091,as,0,0
79092,the,0,0
79093,treatment,0,0
79094,group,0,0
79095,but,0,0
79096,acupuncture,0,0
79097,was,0,0
79098,not,0,0
79099,given,0,0
79100,at,0,0
79101,the,0,0
79102,acute,0,1
79103,stage,0,1
79104,.,0,1
79105,RESULTS,0,0
79106,The,0,0
79107,cured,0,0
79108,rate,0,0
79109,of,0,1
79110,78.6,0,1
79111,%,0,0
79112,in,0,0
79113,the,0,0
79114,treatment,0,0
79115,group,0,0
79116,was,0,0
79117,significantly,0,0
79118,higher,0,0
79119,than,0,0
79120,50.0,0,0
79121,%,0,0
79122,in,0,0
79123,the,0,0
79124,control,0,1
79125,group,0,0
79126,(,0,1
79127,P,0,0
79128,<,0,0
79129,0.05,0,0
79130,),0,1
79131,.,0,1
79132,CONCLUSION,0,0
79133,Early,0,1
79134,acupuncture,0,0
79135,is,0,0
79136,a,0,0
79137,key,0,0
79138,for,0,0
79139,achieving,0,0
79140,the,0,0
79141,best,0,0
79142,therapeutic,0,0
79143,effect,0,0
79144,on,0,0
79145,facial,1,1
79146,paralysis,1,1
79147,.,1,1
79148,Prevention,0,1
79149,of,0,0
79150,type,1,1
79151,2,1,1
79152,(,1,1
79153,non-insulin-dependent,1,1
79154,),1,1
79155,diabetes,1,1
79156,mellitus,1,1
79157,by,0,0
79158,diet,0,1
79159,and,0,1
79160,physical,0,1
79161,exercise,0,1
79162,.,0,1
79163,The,0,0
79164,6-year,0,0
79165,Malm?,0,1
79166,feasibility,0,0
79167,study,0,1
79168,.,0,1
79169,From,0,0
79170,a,0,0
79171,previously,0,1
79172,reported,0,0
79173,5-year,0,1
79174,screening,0,1
79175,programme,0,1
79176,of,1,1
79177,"6,956",1,1
79178,47-49-year-old,1,1
79179,Malm?,1,1
79180,males,1,1
79181,",",1,0
79182,a,1,0
79183,series,1,1
79184,of,1,0
79185,41,1,1
79186,subjects,1,1
79187,with,1,1
79188,early-stage,1,1
79189,Type,1,1
79190,2,1,1
79191,(,1,1
79192,non-insulin-dependent,1,1
79193,),1,1
79194,diabetes,1,1
79195,mellitus,1,1
79196,and,1,0
79197,181,1,1
79198,subjects,1,1
79199,with,1,1
79200,impaired,1,1
79201,glucose,1,0
79202,tolerance,1,1
79203,were,1,1
79204,selected,0,1
79205,for,0,0
79206,prospective,0,1
79207,study,0,1
79208,and,0,0
79209,to,0,0
79210,test,0,0
79211,the,0,0
79212,feasibility,0,0
79213,aspect,0,0
79214,of,0,0
79215,long-term,0,0
79216,intervention,0,1
79217,with,0,1
79218,an,0,0
79219,emphasis,0,0
79220,on,0,0
79221,life-style,0,1
79222,changes,0,0
79223,.,0,1
79224,A,0,0
79225,5-year,0,0
79226,protocol,0,0
79227,",",0,0
79228,including,0,0
79229,an,0,0
79230,initial,0,1
79231,6-months,0,0
79232,(,0,1
79233,randomised,0,1
79234,),0,1
79235,pilot,0,0
79236,study,0,0
79237,",",0,0
79238,consisting,0,1
79239,of,0,0
79240,dietary,0,0
79241,treatment,0,1
79242,and/or,0,0
79243,increase,0,0
79244,of,0,0
79245,physical,0,1
79246,activity,0,0
79247,or,0,1
79248,training,0,0
79249,with,0,1
79250,annual,0,1
79251,check-ups,0,1
79252,",",0,1
79253,was,0,0
79254,completed,0,1
79255,by,0,0
79256,90,0,1
79257,%,0,0
79258,of,0,1
79259,subjects,0,1
79260,.,0,1
79261,Body,0,1
79262,weight,0,0
79263,was,0,0
79264,reduced,0,0
79265,by,0,0
79266,2.3-3.7,0,0
79267,%,0,0
79268,among,0,1
79269,participants,0,1
79270,",",0,1
79271,whereas,0,0
79272,values,0,0
79273,increased,0,0
79274,by,0,1
79275,0.5-1.7,0,1
79276,%,0,0
79277,in,0,1
79278,non-intervened,0,1
79279,subjects,0,1
79280,with,0,1
79281,impaired,0,1
79282,glucose,0,0
79283,tolerance,0,1
79284,and,0,1
79285,in,0,0
79286,normal,0,1
79287,control,0,1
79288,subjects,0,1
79289,(,0,1
79290,p,0,0
79291,less,0,0
79292,than,0,0
79293,0.0001,0,0
79294,),0,1
79295,;,0,1
79296,maximal,0,0
79297,oxygen,0,0
79298,uptake,0,0
79299,(,0,1
79300,ml.min-1.kg-1,0,0
79301,),0,1
79302,was,0,0
79303,increased,0,0
79304,by,0,0
79305,10-14,0,1
79306,%,0,0
79307,vs,0,0
79308,decreased,0,0
79309,by,0,0
79310,5-9,0,1
79311,%,0,0
79312,",",0,0
79313,respectively,0,0
79314,(,0,0
79315,p,0,0
79316,less,0,0
79317,than,0,0
79318,0.0001,0,0
79319,),0,1
79320,.,0,1
79321,Glucose,0,0
79322,tolerance,0,1
79323,was,0,0
79324,normalized,0,0
79325,in,0,0
79326,greater,0,0
79327,than,0,1
79328,50,0,1
79329,%,0,0
79330,of,0,1
79331,subjects,0,1
79332,with,0,1
79333,impaired,0,1
79334,glucose,0,0
79335,tolerance,0,1
79336,",",0,0
79337,the,0,0
79338,accumulated,0,0
79339,incidence,0,0
79340,of,0,1
79341,diabetes,0,1
79342,was,0,0
79343,10.6,0,0
79344,%,0,0
79345,",",0,0
79346,and,0,0
79347,more,0,0
79348,than,0,0
79349,50,0,1
79350,%,0,0
79351,of,0,0
79352,the,0,0
79353,diabetic,0,1
79354,patients,0,1
79355,were,0,1
79356,in,0,0
79357,remission,0,1
79358,after,0,0
79359,a,0,1
79360,mean,0,1
79361,follow-up,0,0
79362,of,0,1
79363,6,0,1
79364,years,0,1
79365,.,0,1
79366,Blood,0,0
79367,pressure,0,0
79368,",",0,0
79369,lipids,0,0
79370,",",0,0
79371,and,0,0
79372,hyperinsulinaemia,0,1
79373,were,0,1
79374,reduced,0,0
79375,and,0,0
79376,early,0,1
79377,insulin,0,1
79378,responsiveness,0,0
79379,to,0,0
79380,glucose,0,0
79381,loading,0,0
79382,preserved,0,1
79383,.,0,1
79384,Improvement,0,0
79385,in,0,0
79386,glucose,0,0
79387,tolerance,0,1
79388,was,0,0
79389,correlated,0,0
79390,to,0,0
79391,weight,0,1
79392,reduction,0,0
79393,(,0,0
79394,r,0,0
79395,=,0,1
79396,0.19,0,0
79397,",",0,0
79398,p,0,0
79399,less,0,0
79400,than,0,0
79401,0.02,0,0
79402,),0,1
79403,and,0,1
79404,increased,0,0
79405,fitness,0,1
79406,(,0,1
79407,r,0,0
79408,=,0,1
79409,0.22,0,0
79410,",",0,0
79411,p,0,0
79412,less,0,0
79413,than,0,0
79414,0.02,0,0
79415,),0,1
79416,.,0,1
79417,Treatment,0,0
79418,was,0,0
79419,safe,0,0
79420,",",0,0
79421,and,0,0
79422,mortality,0,0
79423,was,0,0
79424,low,0,0
79425,(,0,1
79426,in,0,1
79427,fact,0,0
79428,33,0,1
79429,%,0,0
79430,lower,0,0
79431,than,0,0
79432,in,0,0
79433,the,0,0
79434,remainder,0,1
79435,of,0,0
79436,the,0,0
79437,cohort,0,1
79438,),0,1
79439,.,0,1
79440,(,0,0
79441,ABSTRACT,0,0
79442,TRUNCATED,0,1
79443,AT,0,1
79444,250,0,1
79445,WORDS,0,1
79446,),0,1
79447,[,0,0
79448,Clinical,0,0
79449,study,0,1
79450,of,0,0
79451,the,0,0
79452,efficacy,0,0
79453,of,0,0
79454,and,0,1
79455,tolerance,0,1
79456,to,0,0
79457,nimesulide,0,0
79458,in,0,0
79459,suppository,0,0
79460,formulation,0,0
79461,in,0,1
79462,pain-inflammatory,0,1
79463,pathologies,0,1
79464,of,0,1
79465,the,0,0
79466,ear,0,1
79467,",",0,0
79468,nose,0,0
79469,",",0,0
79470,and,0,0
79471,throat,0,1
79472,],0,1
79473,.,0,1
79474,The,0,0
79475,efficacy,0,0
79476,and,0,0
79477,tolerability,0,0
79478,of,0,0
79479,a,0,1
79480,new,0,1
79481,pharmaceutical,0,0
79482,form,0,1
79483,of,0,0
79484,the,0,0
79485,non-steroid,0,0
79486,anti-inflammatory,0,0
79487,drug,0,1
79488,.,0,1
79489,Nimesulide,0,0
79490,have,0,0
79491,been,0,0
79492,studied,0,1
79493,in,0,0
79494,a,0,1
79495,double,0,0
79496,blind,0,1
79497,study,0,1
79498,compared,0,0
79499,with,0,1
79500,flurbiprofen,0,0
79501,",",0,1
79502,in,0,0
79503,98,1,1
79504,patients,1,1
79505,aged,1,1
79506,between,1,1
79507,18,1,1
79508,and,1,1
79509,75,1,1
79510,suffering,1,1
79511,from,1,1
79512,pain-inflammatory,1,1
79513,pathologies,1,1
79514,of,1,1
79515,ENT,1,1
79516,nature,1,1
79517,.,1,1
79518,Both,0,0
79519,drugs,0,0
79520,",",0,0
79521,administered,0,0
79522,in,0,0
79523,a,0,0
79524,dose,0,0
79525,of,0,0
79526,one,0,1
79527,suppository,0,0
79528,twice,0,0
79529,a,0,0
79530,day,0,0
79531,for,0,0
79532,7,0,1
79533,days,0,0
79534,",",0,1
79535,showed,0,0
79536,marked,0,0
79537,anti-inflammatory,0,0
79538,",",0,1
79539,analgesic,0,0
79540,and,0,0
79541,antipyretic,0,0
79542,activity,0,0
79543,and,0,0
79544,produced,0,0
79545,a,0,0
79546,significant,0,0
79547,",",0,0
79548,progressive,0,0
79549,improvement,0,0
79550,in,0,0
79551,the,0,0
79552,typical,0,1
79553,symptoms,0,0
79554,of,0,1
79555,the,0,0
79556,inflammatory,0,0
79557,state,0,1
79558,up,0,1
79559,to,0,1
79560,their,0,1
79561,complete,0,1
79562,remission,0,1
79563,.,0,1
79564,Nimesulide,0,0
79565,evidenced,0,0
79566,greater,0,0
79567,speed,0,0
79568,and,0,0
79569,duration,0,0
79570,of,0,0
79571,therapeutic,0,0
79572,action,0,0
79573,.,0,1
79574,Assessment,0,0
79575,on,0,0
79576,the,0,0
79577,effectiveness,0,0
79578,and,0,0
79579,tolerability,0,0
79580,as,0,0
79581,expressed,0,0
79582,separately,0,0
79583,by,0,0
79584,the,0,0
79585,physician,0,1
79586,and,0,0
79587,patient,0,1
79588,were,0,1
79589,positive,0,1
79590,in,0,0
79591,almost,0,1
79592,all,0,0
79593,cases,0,0
79594,of,0,0
79595,both,0,1
79596,treatments,0,0
79597,.,0,1
79598,Expectancies,0,1
79599,",",0,1
79600,not,0,0
79601,aroma,0,0
79602,",",0,0
79603,explain,0,0
79604,impact,0,0
79605,of,0,0
79606,lavender,0,0
79607,aromatherapy,0,0
79608,on,0,0
79609,psychophysiological,0,0
79610,indices,0,0
79611,of,0,1
79612,relaxation,0,0
79613,in,0,1
79614,young,1,1
79615,healthy,1,1
79616,women,1,1
79617,.,1,1
79618,OBJECTIVES,0,0
79619,In,0,0
79620,aromatherapy,0,0
79621,",",0,0
79622,lavender,0,0
79623,aroma,0,0
79624,is,0,0
79625,reputed,0,0
79626,to,0,0
79627,assist,0,0
79628,with,0,1
79629,relaxation,0,0
79630,.,0,1
79631,However,0,0
79632,",",0,0
79633,while,0,0
79634,there,0,0
79635,is,0,0
79636,much,0,0
79637,anecdotal,0,0
79638,evidence,0,0
79639,to,0,0
79640,that,0,0
79641,effect,0,0
79642,",",0,0
79643,the,0,0
79644,empirical,0,0
79645,literature,0,0
79646,is,0,0
79647,very,0,0
79648,inconsistent,0,0
79649,.,0,1
79650,Failure,0,0
79651,to,0,0
79652,employ,0,1
79653,adequate,0,0
79654,placebos,0,0
79655,",",0,1
79656,proper,0,0
79657,blinding,0,0
79658,",",0,1
79659,objective,0,0
79660,measures,0,0
79661,",",0,1
79662,or,0,1
79663,screening,0,1
79664,of,0,1
79665,prior,0,1
79666,beliefs,0,0
79667,about,0,0
79668,aromatherapy,0,1
79669,means,0,0
79670,that,0,0
79671,many,0,1
79672,previous,0,1
79673,findings,0,0
79674,could,0,0
79675,have,0,0
79676,been,0,0
79677,influenced,0,0
79678,by,0,0
79679,expectancy,0,1
79680,biases,0,0
79681,.,0,1
79682,The,0,0
79683,present,0,0
79684,study,0,1
79685,sought,0,0
79686,to,0,0
79687,establish,0,0
79688,whether,0,0
79689,lavender,0,0
79690,aroma,0,1
79691,and/or,0,1
79692,expectancies,0,1
79693,affect,0,0
79694,post-stress,0,0
79695,relaxation,0,0
79696,.,0,1
79697,DESIGN,0,0
79698,A,0,0
79699,double-blind,0,0
79700,",",0,0
79701,3,0,0
79702,(,0,1
79703,aroma,0,1
79704,),0,1
79705,x,0,1
79706,3,0,0
79707,(,0,0
79708,instruction,0,0
79709,),0,1
79710,x,0,1
79711,10,0,0
79712,(,0,0
79713,time,0,0
79714,in,0,1
79715,minutes,0,0
79716,),0,1
79717,mixed-factorial,0,1
79718,placebo-controlled,0,1
79719,trial,0,1
79720,.,0,1
79721,METHOD,0,0
79722,In,0,0
79723,a,0,0
79724,laboratory,0,0
79725,",",0,0
79726,96,1,1
79727,healthy,1,1
79728,undergraduate,1,1
79729,women,1,1
79730,were,0,1
79731,exposed,0,1
79732,to,0,0
79733,lavender,0,0
79734,",",0,0
79735,placebo,0,0
79736,",",0,0
79737,or,0,0
79738,no,0,0
79739,aroma,0,0
79740,during,0,0
79741,physiologically,0,0
79742,assessed,0,0
79743,relaxation,0,0
79744,after,0,0
79745,an,0,0
79746,arousing,0,0
79747,cognitive,0,0
79748,task,0,1
79749,.,0,0
79750,Where,0,0
79751,an,0,0
79752,aroma,0,0
79753,was,0,0
79754,presented,0,1
79755,",",0,0
79756,an,0,0
79757,instructional,0,0
79758,priming,0,0
79759,procedure,0,0
79760,was,0,0
79761,used,0,0
79762,to,0,0
79763,manipulate,0,0
79764,participants,0,1
79765,',0,1
79766,expectancies,0,1
79767,about,0,0
79768,the,0,0
79769,aroma,0,0
79770,'s,0,1
79771,likely,0,0
79772,impact,0,0
79773,on,0,0
79774,their,0,1
79775,ability,0,0
79776,to,0,0
79777,relax,0,0
79778,.,0,1
79779,RESULTS,0,0
79780,Results,0,0
79781,showed,0,0
79782,no,0,0
79783,effect,0,0
79784,of,0,0
79785,aroma,0,1
79786,on,0,0
79787,galvanic,0,0
79788,skin,0,1
79789,response,0,0
79790,during,0,0
79791,relaxation,0,0
79792,.,0,1
79793,However,0,0
79794,",",0,0
79795,the,0,0
79796,nature,0,0
79797,of,0,0
79798,instructional,0,0
79799,prime,0,1
79800,was,0,0
79801,associated,0,0
79802,with,0,1
79803,relaxation,0,0
79804,patterns,0,1
79805,:,0,1
79806,when,0,0
79807,expecting,0,0
79808,the,0,0
79809,aroma,0,0
79810,to,0,0
79811,inhibit,0,0
79812,them,0,0
79813,",",0,0
79814,participants,0,1
79815,relaxed,0,1
79816,more,0,0
79817,;,0,0
79818,when,0,0
79819,expecting,0,0
79820,facilitation,0,0
79821,",",0,1
79822,participants,0,1
79823,relaxed,0,0
79824,less,0,0
79825,.,0,0
79826,The,0,0
79827,effect,0,0
79828,was,0,0
79829,not,0,0
79830,seen,0,0
79831,with,0,1
79832,regard,0,0
79833,to,0,1
79834,self-reported,0,1
79835,relaxation,0,0
79836,(,0,1
79837,as,0,0
79838,represented,0,1
79839,by,0,0
79840,changes,0,0
79841,in,0,1
79842,state,0,1
79843,anxiety,0,1
79844,),0,1
79845,and,0,0
79846,was,0,0
79847,independent,0,0
79848,of,0,1
79849,ratings,0,0
79850,of,0,1
79851,attitudes,0,1
79852,towards,0,0
79853,aromatherapy,0,1
79854,.,0,1
79855,CONCLUSIONS,0,0
79856,The,0,0
79857,findings,0,0
79858,imply,0,0
79859,that,0,0
79860,the,0,0
79861,previous,0,1
79862,associations,0,0
79863,of,0,1
79864,lavender,0,1
79865,aroma,0,1
79866,with,0,1
79867,assisted,0,1
79868,relaxation,0,0
79869,may,0,0
79870,have,0,0
79871,been,0,0
79872,influenced,0,0
79873,by,0,0
79874,expectancy,0,1
79875,biases,0,0
79876,",",0,0
79877,and,0,0
79878,that,0,0
79879,the,0,0
79880,relevant,0,0
79881,expectancies,0,0
79882,are,0,0
79883,easily,0,0
79884,manipulable,0,1
79885,.,0,1
79886,Small-diameter,0,1
79887,hysteroscopy,0,1
79888,with,0,1
79889,Versapoint,0,1
79890,versus,0,0
79891,resectoscopy,0,1
79892,with,0,1
79893,a,0,1
79894,unipolar,0,1
79895,knife,0,0
79896,for,0,0
79897,the,0,0
79898,treatment,0,0
79899,of,0,0
79900,septate,1,1
79901,uterus,1,1
79902,:,1,1
79903,a,0,0
79904,prospective,0,1
79905,randomized,0,1
79906,study,0,1
79907,.,0,1
79908,STUDY,0,0
79909,OBJECTIVE,0,0
79910,To,0,0
79911,compare,0,0
79912,2,0,1
79913,procedures,0,1
79914,for,0,1
79915,metroplasty,0,1
79916,:,0,1
79917,resectoscopy,0,1
79918,with,0,1
79919,monopolar,0,0
79920,knife,0,1
79921,versus,0,0
79922,small-diameter,0,1
79923,hysteroscopy,0,1
79924,fitted,0,0
79925,with,0,1
79926,a,0,1
79927,Versapoint,0,1
79928,device,0,0
79929,.,0,1
79930,DESIGN,0,0
79931,Prospective,0,1
79932,randomized,0,1
79933,study,0,1
79934,(,0,1
79935,Canadian,0,1
79936,Task,0,1
79937,Force,0,1
79938,classification,0,1
79939,I,0,1
79940,),0,1
79941,.,0,1
79942,SETTING,0,1
79943,Endoscopic,1,1
79944,gynecology,1,1
79945,units,1,1
79946,at,1,1
79947,tertiary,1,1
79948,care,1,1
79949,university,1,1
79950,hospitals,1,1
79951,.,1,1
79952,PATIENTS,0,0
79953,One,1,1
79954,hundred-sixty,1,1
79955,patients,1,1
79956,with,1,1
79957,septate,1,1
79958,uterus,1,1
79959,and,1,1
79960,a,1,1
79961,history,1,1
79962,of,1,0
79963,recurrent,1,1
79964,abortion,1,1
79965,or,1,1
79966,primary,1,1
79967,infertility,1,1
79968,undergoing,1,1
79969,hysteroscopic,1,1
79970,metroplasty,1,1
79971,from,1,1
79972,2001,1,1
79973,to,1,1
79974,2005,1,1
79975,.,1,1
79976,INTERVENTIONS,0,0
79977,Hysteroscopic,0,1
79978,resection,0,1
79979,of,0,0
79980,the,0,0
79981,uterine,0,1
79982,septum,0,1
79983,performed,0,0
79984,with,0,1
79985,either,0,1
79986,a,0,1
79987,26F,0,0
79988,resectoscope,0,1
79989,with,0,1
79990,unipolar,0,1
79991,knife,0,1
79992,(,0,1
79993,80,0,1
79994,women,0,1
79995,",",0,1
79996,group,0,1
79997,A,0,1
79998,),0,1
79999,or,0,1
80000,a,0,1
80001,5-mm,0,0
80002,diameter,0,0
80003,hysteroscope,0,1
80004,with,0,1
80005,Versapoint,0,1
80006,device,0,0
80007,(,0,1
80008,80,0,1
80009,women,0,1
80010,",",0,1
80011,group,0,1
80012,B,0,1
80013,),0,1
80014,.,0,1
80015,All,0,1
80016,patients,0,1
80017,were,0,1
80018,managed,0,1
80019,expectantly,0,1
80020,",",0,0
80021,with,0,1
80022,follow-up,0,0
80023,lasting,0,1
80024,1,0,1
80025,year,0,1
80026,.,0,1
80027,MEASUREMENTS,0,0
80028,AND,0,0
80029,MAIN,0,0
80030,RESULTS,0,1
80031,Operative,0,1
80032,parameters,0,0
80033,(,0,1
80034,operative,0,1
80035,time,0,0
80036,",",0,0
80037,fluid,0,0
80038,absorption,0,0
80039,",",0,1
80040,complications,0,0
80041,",",0,0
80042,need,0,0
80043,for,0,0
80044,second,0,1
80045,intervention,0,1
80046,),0,1
80047,and,0,0
80048,reproductive,0,1
80049,outcome,0,0
80050,parameters,0,0
80051,(,0,1
80052,pregnancy,0,1
80053,",",0,0
80054,abortion,0,1
80055,",",0,0
80056,term,0,0
80057,and,0,0
80058,preterm,0,1
80059,delivery,0,0
80060,",",0,0
80061,modality,0,0
80062,of,0,0
80063,delivery,0,0
80064,",",0,0
80065,cervical,0,1
80066,cerclage,0,1
80067,),0,1
80068,were,0,1
80069,measured,0,0
80070,.,0,1
80071,Operative,0,0
80072,time,0,0
80073,and,0,1
80074,fluid,0,1
80075,absorption,0,0
80076,were,0,0
80077,significantly,0,0
80078,greater,0,0
80079,in,0,0
80080,group,0,0
80081,A,0,1
80082,than,0,0
80083,in,0,0
80084,group,0,1
80085,B,0,1
80086,(,0,1
80087,23.4,0,1
80088,+/-,0,1
80089,5.7,0,1
80090,vs,0,0
80091,16.9,0,0
80092,+/-,0,1
80093,4.7,0,1
80094,minutes,0,0
80095,and,0,1
80096,486.4,0,1
80097,+/-,0,1
80098,170.0,0,1
80099,vs,0,0
80100,222.1,0,0
80101,+/-,0,1
80102,104.9,0,1
80103,mL,0,0
80104,",",0,0
80105,respectively,0,0
80106,),0,0
80107,.,0,0
80108,The,0,0
80109,cumulative,0,0
80110,complication,0,0
80111,rate,0,0
80112,was,0,0
80113,significantly,0,0
80114,lower,0,0
80115,in,0,0
80116,group,0,0
80117,B,0,1
80118,than,0,0
80119,in,0,0
80120,group,0,1
80121,A,0,1
80122,.,0,1
80123,No,0,0
80124,difference,0,0
80125,in,0,0
80126,any,0,0
80127,of,0,0
80128,the,0,0
80129,reproductive,0,1
80130,parameters,0,0
80131,was,0,0
80132,observed,0,0
80133,between,0,0
80134,the,0,1
80135,2,0,1
80136,groups,0,1
80137,:,0,1
80138,pregnancy,0,1
80139,and,0,1
80140,delivery,0,1
80141,rates,0,0
80142,were,0,1
80143,70,0,1
80144,%,0,0
80145,and,0,1
80146,81.6,0,0
80147,%,0,0
80148,in,0,0
80149,group,0,1
80150,A,0,1
80151,vs,0,0
80152,76.9,0,0
80153,%,0,0
80154,and,0,1
80155,84,0,1
80156,%,0,0
80157,in,0,0
80158,group,0,1
80159,B,0,1
80160,.,0,1
80161,Nine,0,1
80162,women,0,1
80163,(,0,1
80164,18.4,0,0
80165,%,0,0
80166,),0,1
80167,from,0,1
80168,group,0,1
80169,B,0,1
80170,and,0,1
80171,8,0,1
80172,women,0,1
80173,(,0,1
80174,16,0,1
80175,%,0,0
80176,),0,1
80177,from,0,1
80178,group,0,1
80179,B,0,1
80180,experienced,0,1
80181,spontaneous,0,1
80182,abortions,0,1
80183,.,0,1
80184,Most,0,0
80185,patients,0,1
80186,(,0,1
80187,54/82,0,1
80188,),0,1
80189,delivered,0,1
80190,by,0,0
80191,cesarean,0,1
80192,section,0,1
80193,without,0,1
80194,differences,0,0
80195,according,0,1
80196,to,0,1
80197,the,0,0
80198,hysteroscopic,0,1
80199,technique,0,0
80200,used,0,0
80201,for,0,0
80202,metroplasty,0,1
80203,(,0,1
80204,65,0,1
80205,%,0,0
80206,in,0,0
80207,group,0,1
80208,A,0,1
80209,vs,0,0
80210,67.7,0,0
80211,%,0,0
80212,in,0,0
80213,group,0,1
80214,B,0,1
80215,),0,1
80216,or,0,1
80217,to,0,0
80218,the,0,0
80219,gestational,0,1
80220,age,0,1
80221,(,0,1
80222,65.1,0,0
80223,%,0,0
80224,of,0,0
80225,term,0,1
80226,and,0,1
80227,68.7,0,1
80228,%,0,0
80229,of,0,1
80230,preterm,0,1
80231,deliveries,0,1
80232,),0,1
80233,.,0,1
80234,CONCLUSIONS,0,0
80235,Small-diameter,0,0
80236,hysteroscopy,0,1
80237,with,0,1
80238,bipolar,0,1
80239,electrode,0,0
80240,for,0,0
80241,the,0,0
80242,incision,0,0
80243,of,0,0
80244,uterine,0,1
80245,septum,0,1
80246,is,0,0
80247,as,0,0
80248,effective,0,0
80249,as,0,0
80250,resectoscopy,0,1
80251,with,0,1
80252,unipolar,0,1
80253,electrode,0,1
80254,regarding,0,0
80255,reproductive,0,1
80256,outcome,0,0
80257,and,0,0
80258,is,0,0
80259,associated,0,0
80260,with,0,1
80261,shorter,0,0
80262,operating,0,0
80263,time,0,0
80264,and,0,0
80265,lower,0,0
80266,complication,0,0
80267,rate,0,0
80268,.,0,1
80269,Severe,0,1
80270,enteropathy,0,1
80271,among,0,1
80272,patients,1,1
80273,with,1,1
80274,stage,1,1
80275,II/III,1,0
80276,colon,1,1
80277,cancer,1,1
80278,treated,0,1
80279,on,0,0
80280,a,0,1
80281,randomized,0,1
80282,trial,0,0
80283,of,0,0
80284,bolus,0,0
80285,5-fluorouracil/leucovorin,0,1
80286,plus,0,0
80287,or,0,1
80288,minus,0,1
80289,oxaliplatin,0,0
80290,:,0,1
80291,a,0,0
80292,prospective,0,1
80293,analysis,0,0
80294,.,0,1
80295,BACKGROUND,0,0
80296,Cases,0,0
80297,of,0,1
80298,severe,0,1
80299,gastrointestinal,0,1
80300,toxicity,0,0
80301,were,0,1
80302,monitored,0,0
80303,prospectively,0,1
80304,during,0,0
80305,NSABP,0,1
80306,C-07,0,1
80307,",",0,0
80308,a,0,0
80309,randomized,0,1
80310,clinical,0,0
80311,trial,0,1
80312,of,0,0
80313,adjuvant,0,1
80314,therapy,0,1
80315,for,0,1
80316,patients,1,1
80317,with,1,1
80318,stage,1,1
80319,II/III,1,0
80320,colon,1,1
80321,cancer,1,1
80322,.,1,1
80323,METHODS,0,0
80324,Patients,0,1
80325,were,0,1
80326,treated,0,1
80327,with,0,1
80328,weekly,0,1
80329,bolus,0,0
80330,5-fluorouracil,0,0
80331,(,0,1
80332,5-FU,0,1
80333,),0,1
80334,and,0,1
80335,leucovorin,0,0
80336,(,0,1
80337,FL,0,1
80338,;,0,1
80339,Roswell,0,1
80340,Park,0,1
80341,Regimen,0,1
80342,),0,1
80343,or,0,1
80344,the,0,0
80345,same,0,0
80346,regimen,0,0
80347,plus,0,0
80348,oxaliplatin,0,0
80349,(,0,1
80350,FLOX,0,1
80351,),0,1
80352,.,0,1
80353,RESULTS,0,0
80354,Of,0,1
80355,1857,1,1
80356,patients,1,1
80357,",",1,1
80358,79,1,1
80359,(,1,1
80360,4.3,1,0
80361,%,1,0
80362,),1,1
80363,developed,1,1
80364,a,1,0
80365,syndrome,1,1
80366,of,1,0
80367,bowel,1,1
80368,wall,1,1
80369,injury,1,1
80370,(,1,1
80371,BWI,1,1
80372,",",1,1
80373,small,1,0
80374,or,1,1
80375,large,1,1
80376,),1,1
80377,characterized,1,0
80378,by,1,0
80379,hospitalization,1,1
80380,for,1,0
80381,the,1,0
80382,management,1,0
80383,of,1,0
80384,severe,1,1
80385,diarrhea,1,1
80386,or,1,1
80387,dehydration,1,0
80388,and,1,1
80389,radiographic,1,0
80390,or,1,1
80391,endoscopic,1,1
80392,evidence,1,0
80393,of,1,0
80394,bowel,1,1
80395,wall,1,1
80396,thickening,1,1
80397,or,1,1
80398,ulceration,1,1
80399,.,1,1
80400,Fifty-one,0,1
80401,(,0,1
80402,64.6,0,1
80403,%,0,0
80404,),0,1
80405,of,0,0
80406,these,0,0
80407,adverse,0,0
80408,events,0,0
80409,occurred,0,0
80410,in,0,1
80411,patients,0,1
80412,treated,0,1
80413,with,0,1
80414,FLOX,0,1
80415,and,0,1
80416,28,0,1
80417,(,0,1
80418,35.4,0,1
80419,%,0,0
80420,),0,1
80421,in,0,0
80422,those,0,1
80423,treated,0,1
80424,with,0,1
80425,FL,0,1
80426,(,0,1
80427,P,0,0
80428,<,0,0
80429,.01,0,0
80430,),0,1
80431,.,0,1
80432,Enteric,0,0
80433,sepsis,0,1
80434,(,0,1
80435,ES,0,1
80436,),0,1
80437,",",0,0
80438,characterized,0,0
80439,by,0,0
80440,grade,0,1
80441,3,0,0
80442,or,0,1
80443,greater,0,0
80444,diarrhea,0,1
80445,and,0,0
80446,grade,0,1
80447,4,0,0
80448,neutropenia,0,0
80449,with,0,1
80450,or,0,1
80451,without,0,1
80452,proven,0,1
80453,bacteremia,0,1
80454,occurred,0,0
80455,in,0,1
80456,22,0,1
80457,patients,0,1
80458,treated,0,1
80459,with,0,1
80460,FLOX,0,1
80461,",",0,1
80462,versus,0,0
80463,8,0,0
80464,in,0,0
80465,those,0,1
80466,treated,0,1
80467,with,0,1
80468,FL,0,1
80469,(,0,1
80470,P,0,0
80471,=,0,1
80472,.01,0,0
80473,),0,1
80474,.,0,1
80475,Patients,0,1
80476,>,0,1
80477,60,0,1
80478,years,0,1
80479,were,0,1
80480,at,0,1
80481,higher,0,0
80482,risk,0,1
80483,for,0,0
80484,BWI,0,1
80485,after,0,0
80486,treatment,0,0
80487,with,0,1
80488,FLOX,0,1
80489,(,0,1
80490,6.7,0,0
80491,%,0,0
80492,),0,1
80493,versus,0,0
80494,treatment,0,0
80495,with,0,1
80496,FL,0,1
80497,(,0,1
80498,2.9,0,0
80499,%,0,0
80500,",",0,1
80501,P,0,0
80502,<,0,0
80503,.01,0,0
80504,),0,1
80505,.,0,1
80506,Female,0,1
80507,patients,0,1
80508,had,0,1
80509,a,0,1
80510,higher,0,0
80511,incidence,0,0
80512,of,0,0
80513,BWI,0,1
80514,with,0,1
80515,FLOX,0,1
80516,(,0,1
80517,9.1,0,0
80518,%,0,0
80519,),0,1
80520,than,0,0
80521,with,0,1
80522,FL,0,1
80523,(,0,1
80524,3.9,0,0
80525,%,0,0
80526,",",0,1
80527,P,0,0
80528,<,0,0
80529,.01,0,0
80530,),0,1
80531,.,0,1
80532,Severe,0,1
80533,gastrointestinal,0,1
80534,toxicity,0,0
80535,usually,0,0
80536,occurred,0,0
80537,during,0,0
80538,the,0,0
80539,third,0,1
80540,or,0,1
80541,fourth,0,1
80542,week,0,0
80543,on,0,0
80544,the,0,0
80545,first,0,0
80546,cycle,0,0
80547,of,0,0
80548,therapy,0,0
80549,",",0,0
80550,required,0,0
80551,hospitalization,0,1
80552,",",0,0
80553,and,0,0
80554,was,0,0
80555,managed,0,1
80556,with,0,1
80557,fluids,0,1
80558,",",0,1
80559,antidiarrheals,0,1
80560,",",0,1
80561,and,0,1
80562,antibiotics,0,0
80563,.,0,1
80564,There,0,0
80565,were,0,0
80566,5,0,0
80567,deaths,0,0
80568,(,0,1
80569,0.3,0,0
80570,%,0,0
80571,),0,1
80572,due,0,0
80573,to,0,0
80574,enteropathy,0,1
80575,",",0,0
80576,2,0,0
80577,related,0,0
80578,to,0,1
80579,ES,0,1
80580,and,0,1
80581,3,0,1
80582,related,0,0
80583,to,0,1
80584,both,0,0
80585,BWI,0,1
80586,and,0,1
80587,ES,0,1
80588,.,0,1
80589,Seventy-one,0,1
80590,percent,0,1
80591,of,0,1
80592,patients,0,1
80593,resumed,0,1
80594,treatment,0,1
80595,with,0,1
80596,FL,0,1
80597,after,0,1
80598,recovery,0,0
80599,.,0,1
80600,CONCLUSIONS,0,0
80601,Patients,0,1
80602,treated,0,1
80603,with,0,1
80604,adjuvant,0,1
80605,FL,0,1
80606,should,0,0
80607,be,0,0
80608,closely,0,0
80609,monitored,0,0
80610,for,0,0
80611,diarrhea,0,1
80612,and,0,0
80613,aggressively,0,1
80614,managed,0,1
80615,",",0,0
80616,especially,0,0
80617,if,0,0
80618,oxaliplatin,0,0
80619,has,0,0
80620,been,0,0
80621,added,0,0
80622,to,0,1
80623,the,0,0
80624,regimen,0,0
80625,.,0,1
80626,Society,0,1
80627,.,0,1
80628,Transcutaneous,0,1
80629,electrical,0,0
80630,nerve,0,1
80631,stimulation,0,0
80632,combined,0,0
80633,with,0,1
80634,task-related,0,1
80635,training,0,1
80636,improves,0,0
80637,lower,0,1
80638,limb,0,1
80639,functions,0,0
80640,in,0,1
80641,subjects,1,1
80642,with,1,1
80643,chronic,1,1
80644,stroke,1,1
80645,.,1,1
80646,BACKGROUND,0,0
80647,AND,0,0
80648,PURPOSE,0,1
80649,Previous,0,1
80650,studies,0,0
80651,have,0,0
80652,shown,0,0
80653,that,0,0
80654,repeated,0,0
80655,sensory,0,0
80656,inputs,0,1
80657,could,0,0
80658,enhance,0,0
80659,brain,0,0
80660,plasticity,0,0
80661,and,0,0
80662,cortical,0,1
80663,motor,0,0
80664,output,0,0
80665,.,0,1
80666,The,0,0
80667,purpose,0,0
80668,of,0,0
80669,this,0,0
80670,study,0,0
80671,was,0,0
80672,to,0,0
80673,investigate,0,0
80674,whether,0,0
80675,combining,0,0
80676,electrically,0,0
80677,induced,0,0
80678,sensory,0,0
80679,inputs,0,1
80680,through,0,1
80681,transcutaneous,0,1
80682,electrical,0,0
80683,nerve,0,1
80684,stimulation,0,0
80685,(,0,1
80686,TENS,0,0
80687,),0,1
80688,with,0,1
80689,task-related,0,1
80690,training,0,1
80691,(,0,1
80692,TRT,0,1
80693,),0,1
80694,in,0,0
80695,a,0,1
80696,home-based,0,0
80697,program,0,1
80698,would,0,0
80699,augment,0,0
80700,voluntary,0,0
80701,motor,0,0
80702,output,0,0
80703,in,0,0
80704,chronic,1,1
80705,stroke,1,1
80706,survivors,1,0
80707,better,0,0
80708,than,0,0
80709,either,0,0
80710,treatment,0,0
80711,alone,0,0
80712,or,0,1
80713,no,0,0
80714,treatment,0,0
80715,.,0,1
80716,METHODS,0,0
80717,Eighty-eight,1,1
80718,patients,1,1
80719,with,1,1
80720,stroke,1,1
80721,were,0,1
80722,assigned,0,1
80723,randomly,0,1
80724,to,0,0
80725,receive,0,0
80726,a,0,0
80727,home-based,0,0
80728,program,0,1
80729,of,0,0
80730,(,0,1
80731,1,0,1
80732,),0,1
80733,TENS,0,0
80734,",",0,0
80735,(,0,1
80736,2,0,1
80737,),0,1
80738,TENS+TRT,0,0
80739,",",0,0
80740,(,0,1
80741,3,0,1
80742,),0,1
80743,placebo,0,0
80744,TENS+TRT,0,0
80745,",",0,0
80746,or,0,1
80747,(,0,1
80748,4,0,0
80749,),0,1
80750,no,0,0
80751,treatment,0,0
80752,(,0,0
80753,control,0,1
80754,),0,1
80755,5,0,1
80756,days,0,0
80757,a,0,1
80758,week,0,0
80759,for,0,0
80760,4,0,1
80761,weeks,0,1
80762,.,0,1
80763,Outcome,0,0
80764,measurements,0,0
80765,included,0,1
80766,Composite,0,0
80767,Spasticity,0,1
80768,Scale,0,1
80769,",",0,1
80770,peak,0,0
80771,torques,0,0
80772,generated,0,1
80773,during,0,1
80774,maximum,0,0
80775,isometric,0,1
80776,voluntary,0,1
80777,contraction,0,1
80778,of,0,1
80779,ankle,0,1
80780,dorsiflexors,0,1
80781,and,0,1
80782,plantarflexors,0,1
80783,",",0,0
80784,and,0,0
80785,gait,0,0
80786,velocity,0,0
80787,recorded,0,0
80788,at,0,0
80789,baseline,0,0
80790,",",0,1
80791,after,0,0
80792,2,0,1
80793,and,0,1
80794,4,0,1
80795,weeks,0,0
80796,of,0,1
80797,treatment,0,1
80798,",",0,1
80799,and,0,1
80800,4,0,0
80801,weeks,0,0
80802,after,0,1
80803,treatment,0,1
80804,ended,0,1
80805,.,0,0
80806,RESULTS,0,0
80807,When,0,0
80808,compared,0,0
80809,with,0,1
80810,TENS,0,0
80811,",",0,0
80812,the,0,0
80813,combined,0,0
80814,TENS+TRT,0,0
80815,group,0,1
80816,showed,0,0
80817,significantly,0,0
80818,greater,0,0
80819,improvement,0,0
80820,in,0,0
80821,ankle,0,1
80822,dorsiflexion,0,1
80823,torque,0,0
80824,at,0,1
80825,follow-up,0,0
80826,and,0,1
80827,in,0,1
80828,ankle,0,1
80829,plantarflexion,0,1
80830,torque,0,0
80831,at,0,1
80832,week,0,0
80833,2,0,1
80834,and,0,1
80835,follow-up,0,0
80836,(,0,1
80837,P,0,0
80838,<,0,0
80839,0.01,0,0
80840,),0,0
80841,.,0,0
80842,When,0,0
80843,compared,0,0
80844,with,0,0
80845,placebo+TRT,0,0
80846,",",0,0
80847,the,0,0
80848,TENS+TRT,0,0
80849,group,0,0
80850,produced,0,0
80851,earlier,0,0
80852,and,0,0
80853,greater,0,0
80854,reduction,0,0
80855,of,0,0
80856,plantarflexor,0,0
80857,spasticity,0,1
80858,and,0,0
80859,improvement,0,0
80860,in,0,0
80861,ankle,0,1
80862,dorsiflexion,0,1
80863,torque,0,0
80864,at,0,1
80865,week,0,0
80866,2,0,1
80867,(,0,1
80868,P,0,0
80869,<,0,0
80870,0.01,0,0
80871,),0,0
80872,.,0,0
80873,When,0,0
80874,compared,0,0
80875,with,0,1
80876,all,0,1
80877,3,0,1
80878,groups,0,0
80879,",",0,1
80880,the,0,0
80881,TENS+TRT,0,0
80882,group,0,0
80883,showed,0,0
80884,significantly,0,0
80885,greater,0,0
80886,improvement,0,0
80887,in,0,0
80888,gait,0,1
80889,velocity,0,0
80890,(,0,1
80891,P,0,0
80892,<,0,0
80893,0.01,0,0
80894,),0,1
80895,.,0,1
80896,CONCLUSIONS,0,0
80897,In,0,1
80898,patients,1,1
80899,with,1,1
80900,chronic,1,1
80901,stroke,1,1
80902,",",0,1
80903,20,0,1
80904,sessions,0,0
80905,of,0,1
80906,a,0,1
80907,combined,0,0
80908,TENS+TRT,0,0
80909,home-based,0,1
80910,program,0,1
80911,decreased,0,0
80912,plantarflexor,0,0
80913,spasticity,0,1
80914,",",0,0
80915,improved,0,0
80916,dorsiflexor,0,1
80917,and,0,0
80918,plantarflexor,0,0
80919,strength,0,0
80920,",",0,0
80921,and,0,0
80922,increased,0,0
80923,gait,0,0
80924,velocity,0,0
80925,significantly,0,0
80926,more,0,0
80927,than,0,0
80928,TENS,0,0
80929,alone,0,0
80930,",",0,0
80931,placebo+TRT,0,0
80932,",",0,0
80933,or,0,0
80934,no,0,0
80935,treatment,0,0
80936,.,0,1
80937,Such,0,0
80938,improvements,0,0
80939,can,0,0
80940,even,0,0
80941,be,0,0
80942,maintained,0,0
80943,4,0,0
80944,weeks,0,0
80945,after,0,1
80946,treatment,0,1
80947,ended,0,1
80948,.,0,1
80949,Letrozole,0,1
80950,in,0,0
80951,the,0,0
80952,neoadjuvant,0,1
80953,setting,0,1
80954,:,0,1
80955,the,0,0
80956,P024,0,1
80957,trial,0,0
80958,.,0,1
80959,Neoadjuvant,0,1
80960,chemotherapy,0,1
80961,trials,0,0
80962,have,0,0
80963,consistently,0,0
80964,reported,0,0
80965,lower,0,0
80966,response,0,0
80967,rates,0,0
80968,in,0,1
80969,hormone,0,1
80970,receptor-positive,0,1
80971,(,0,1
80972,HR+,0,1
80973,),0,1
80974,breast,0,1
80975,cancer,0,1
80976,when,0,0
80977,compared,0,0
80978,with,0,1
80979,HR-,0,1
80980,cases,0,1
80981,.,0,1
80982,Preoperative,0,0
80983,endocrine,0,1
80984,therapy,0,0
80985,has,0,0
80986,therefore,0,0
80987,become,0,0
80988,a,0,0
80989,logical,0,0
80990,alternative,0,0
80991,and,0,0
80992,has,0,0
80993,gained,0,0
80994,considerable,0,0
80995,momentum,0,0
80996,from,0,1
80997,the,0,0
80998,finding,0,0
80999,that,0,0
81000,aromatase,0,1
81001,inhibitors,0,0
81002,(,0,1
81003,AIs,0,1
81004,),0,0
81005,are,0,0
81006,more,0,0
81007,effective,0,0
81008,than,0,0
81009,tamoxifen,0,1
81010,for,0,1
81011,HR+,0,1
81012,breast,0,1
81013,cancer,0,1
81014,in,0,0
81015,both,0,0
81016,the,0,0
81017,neoadjuvant,0,1
81018,and,0,0
81019,adjuvant,0,1
81020,settings,0,1
81021,.,0,1
81022,The,0,0
81023,most,0,0
81024,convincing,0,0
81025,neoadjuvant,0,1
81026,trial,0,0
81027,to,0,0
81028,demonstrate,0,0
81029,the,0,0
81030,superiority,0,0
81031,of,0,0
81032,an,0,1
81033,AI,0,0
81034,versus,0,0
81035,tamoxifen,0,1
81036,was,0,0
81037,the,0,0
81038,P024,0,0
81039,study,0,0
81040,",",0,0
81041,a,0,0
81042,large,0,1
81043,multinational,1,1
81044,double-blind,0,1
81045,trial,0,1
81046,in,0,1
81047,postmenopausal,1,1
81048,women,1,1
81049,with,1,1
81050,HR+,1,1
81051,breast,1,1
81052,cancer,1,1
81053,ineligible,1,1
81054,for,1,1
81055,breast-conserving,1,1
81056,surgery,1,1
81057,.,1,1
81058,The,0,0
81059,overall,0,0
81060,response,0,0
81061,rate,0,0
81062,(,0,1
81063,ORR,0,1
81064,),0,1
81065,was,0,0
81066,55,0,1
81067,%,0,0
81068,for,0,0
81069,letrozole,0,0
81070,and,0,1
81071,36,0,1
81072,%,0,0
81073,for,0,0
81074,tamoxifen,0,1
81075,(,0,1
81076,P,0,0
81077,<,0,0
81078,0.001,0,0
81079,),0,1
81080,.,0,0
81081,Significantly,0,0
81082,more,0,0
81083,letrozole-treated,0,1
81084,patients,0,1
81085,underwent,0,1
81086,breast-conserving,0,1
81087,surgery,0,1
81088,(,0,0
81089,45,0,1
81090,vs.,0,0
81091,35,0,1
81092,%,0,0
81093,",",0,0
81094,respectively,0,0
81095,;,0,0
81096,P=0.022,0,0
81097,),0,1
81098,.,0,1
81099,In,0,0
81100,addition,0,0
81101,",",0,1
81102,ORR,0,0
81103,was,0,0
81104,significantly,0,0
81105,higher,0,0
81106,with,0,1
81107,letrozole,0,0
81108,than,0,0
81109,tamoxifen,0,1
81110,in,0,0
81111,the,0,0
81112,human,0,1
81113,epidermal,0,1
81114,growth,0,0
81115,factor,0,0
81116,receptor,0,0
81117,HER1/HER2+,0,1
81118,subgroup,0,1
81119,(,0,1
81120,P=0.0004,0,0
81121,),0,1
81122,.,0,1
81123,The,0,0
81124,clinical,0,0
81125,efficacy,0,0
81126,of,0,0
81127,letrozole,0,0
81128,in,0,1
81129,HER2+,0,1
81130,breast,0,1
81131,cancer,0,1
81132,was,0,0
81133,confirmed,0,0
81134,by,0,0
81135,fluorescent,0,0
81136,in,0,1
81137,situ,0,0
81138,hybridization,0,0
81139,analysis,0,0
81140,and,0,0
81141,was,0,0
81142,found,0,0
81143,to,0,0
81144,be,0,0
81145,comparable,0,0
81146,to,0,0
81147,that,0,0
81148,of,0,0
81149,HER2-,0,1
81150,cases,0,1
81151,(,0,1
81152,ORR,0,1
81153,71,0,1
81154,%,0,0
81155,in,0,0
81156,both,0,0
81157,subsets,0,1
81158,),0,1
81159,.,0,1
81160,Biomarker,0,0
81161,studies,0,0
81162,confirmed,0,1
81163,the,0,0
81164,superiority,0,0
81165,of,0,0
81166,letrozole,0,0
81167,in,0,0
81168,centrally,0,0
81169,assessed,0,0
81170,estrogen,0,0
81171,receptor-positive,0,1
81172,(,0,1
81173,ER+,0,0
81174,),0,1
81175,tumors,0,1
81176,and,0,1
81177,found,0,0
81178,a,0,0
81179,strong,0,0
81180,relationship,0,0
81181,with,0,1
81182,the,0,0
81183,degree,0,1
81184,of,0,0
81185,ER,0,0
81186,positivity,0,0
81187,for,0,0
81188,both,0,0
81189,agents,0,0
81190,.,0,1
81191,Interestingly,0,0
81192,",",0,0
81193,letrozole,0,0
81194,was,0,0
81195,effective,0,0
81196,even,0,0
81197,in,0,0
81198,marginally,0,0
81199,ER+,0,0
81200,tumors,0,1
81201,and,0,0
81202,",",0,1
81203,unlike,0,0
81204,tamoxifen,0,0
81205,",",0,0
81206,consistently,0,0
81207,reduced,0,0
81208,the,0,0
81209,expression,0,0
81210,from,0,1
81211,estrogen-regulated,0,1
81212,genes,0,0
81213,(,0,1
81214,progesterone,0,1
81215,receptor,0,0
81216,and,0,0
81217,trefoil,0,0
81218,factor,0,0
81219,1,0,1
81220,),0,1
81221,.,0,1
81222,Furthermore,0,0
81223,",",0,0
81224,when,0,0
81225,analyzed,0,0
81226,by,0,0
81227,Ki67,0,0
81228,immunohistochemistry,0,1
81229,",",0,0
81230,letrozole,0,0
81231,was,0,0
81232,significantly,0,0
81233,more,0,0
81234,effective,0,0
81235,than,0,0
81236,tamoxifen,0,1
81237,in,0,0
81238,reducing,0,0
81239,tumor,0,1
81240,proliferation,0,0
81241,(,0,1
81242,P=0.0009,0,0
81243,),0,1
81244,.,0,1
81245,Thus,0,1
81246,",",0,0
81247,neoadjuvant,0,0
81248,letrozole,0,0
81249,is,0,0
81250,safe,0,0
81251,and,0,0
81252,superior,0,0
81253,to,0,0
81254,tamoxifen,0,1
81255,in,0,0
81256,the,0,0
81257,treatment,0,0
81258,of,0,0
81259,postmenopausal,1,1
81260,women,1,1
81261,with,1,1
81262,HR+,1,1
81263,locally,1,1
81264,advanced,1,1
81265,breast,1,1
81266,cancer,1,1
81267,.,1,1
81268,Midazolam,0,1
81269,as,0,0
81270,a,0,1
81271,main,0,0
81272,anesthesia,0,1
81273,induction,0,1
81274,agent,0,0
81275,--,0,1
81276,a,0,0
81277,comparison,0,0
81278,with,0,1
81279,thiopental,0,0
81280,and,0,1
81281,diazepam,0,1
81282,.,0,1
81283,A,0,0
81284,clinical,0,0
81285,randomized,0,1
81286,investigation,0,1
81287,was,0,0
81288,undertaken,0,0
81289,to,0,0
81290,determine,0,0
81291,the,0,0
81292,value,0,0
81293,of,0,0
81294,midazolam,0,1
81295,as,0,0
81296,a,0,1
81297,narcotic,0,1
81298,adjuvant,0,1
81299,for,0,0
81300,anesthetic,0,0
81301,induction,0,1
81302,.,0,1
81303,Thirty,1,1
81304,ASA,1,0
81305,I-II,1,1
81306,adult,1,1
81307,patients,1,1
81308,undergoing,1,1
81309,selective,1,1
81310,surgery,1,1
81311,were,0,1
81312,allocated,0,1
81313,randomly,0,1
81314,into,0,1
81315,two,0,1
81316,groups,0,1
81317,to,0,1
81318,receive,0,1
81319,one,0,1
81320,of,0,0
81321,the,0,1
81322,following,0,0
81323,agents,0,0
81324,:,0,1
81325,midazolam,0,1
81326,0.3,0,0
81327,mg/kg,0,0
81328,",",0,1
81329,thiopental,0,0
81330,5,0,0
81331,mg/kg,0,0
81332,",",0,0
81333,or,0,1
81334,diazepam,0,1
81335,0.4,0,0
81336,mg/kg,0,0
81337,.,0,1
81338,The,0,0
81339,induction,0,0
81340,time,0,0
81341,as,0,0
81342,measured,0,0
81343,from,0,1
81344,the,0,0
81345,onset,0,1
81346,of,0,0
81347,injection,0,0
81348,to,0,0
81349,loss,0,0
81350,of,0,0
81351,the,0,0
81352,eyelash,0,1
81353,reflex,0,0
81354,was,0,0
81355,shortest,0,0
81356,in,0,0
81357,the,0,0
81358,case,0,0
81359,of,0,0
81360,thiopental,0,0
81361,;,0,1
81362,while,0,0
81363,a,0,0
81364,lower,0,0
81365,frequency,0,0
81366,of,0,0
81367,apnea,0,1
81368,",",0,0
81369,lesser,0,0
81370,suppression,0,0
81371,of,0,0
81372,circulation,0,0
81373,",",0,0
81374,and,0,0
81375,lack,0,0
81376,of,0,0
81377,venous,0,1
81378,irritation,0,0
81379,were,0,1
81380,points,0,0
81381,favoring,0,0
81382,midazolam,0,1
81383,.,0,1
81384,However,0,0
81385,",",0,0
81386,further,0,0
81387,study,0,0
81388,is,0,0
81389,needed,0,0
81390,to,0,0
81391,clarify,0,0
81392,the,0,0
81393,moderate,0,1
81394,cardiovascular,0,1
81395,response,0,0
81396,seen,0,0
81397,during,0,0
81398,intubation,0,1
81399,in,0,1
81400,some,0,0
81401,cases,0,1
81402,as,0,0
81403,well,0,0
81404,as,0,0
81405,to,0,0
81406,elucidate,0,0
81407,any,0,0
81408,patient,0,0
81409,population,0,1
81410,differences,0,0
81411,.,0,1
81412,Covariation,0,0
81413,of,0,0
81414,adolescent,1,1
81415,physical,1,1
81416,activity,1,0
81417,and,0,1
81418,dietary,0,0
81419,behaviors,0,0
81420,over,0,1
81421,12,0,1
81422,months,0,1
81423,.,0,1
81424,PURPOSE,0,0
81425,This,0,0
81426,study,0,0
81427,examined,0,0
81428,covariation,0,0
81429,among,0,1
81430,changes,0,0
81431,in,0,1
81432,dietary,0,0
81433,",",0,1
81434,physical,0,0
81435,activity,0,0
81436,",",0,0
81437,and,0,0
81438,sedentary,0,1
81439,behaviors,0,0
81440,over,0,1
81441,12,0,1
81442,months,0,1
81443,among,0,1
81444,adolescents,1,1
81445,participating,1,1
81446,in,1,0
81447,a,1,1
81448,health,1,1
81449,behavior,1,0
81450,intervention,1,0
81451,.,1,1
81452,Evidence,0,0
81453,of,0,0
81454,covariation,0,0
81455,among,0,0
81456,behaviors,0,0
81457,would,0,0
81458,suggest,0,0
81459,multi-behavior,0,0
81460,interventions,0,0
81461,could,0,0
81462,have,0,1
81463,synergistic,0,0
81464,effects,0,0
81465,.,0,1
81466,METHODS,0,0
81467,Prospective,0,1
81468,analyses,0,0
81469,were,0,1
81470,conducted,0,1
81471,with,0,1
81472,baseline,0,0
81473,and,0,1
81474,12-month,0,0
81475,assessments,0,0
81476,from,0,1
81477,a,0,1
81478,randomized,0,1
81479,controlled,0,0
81480,trial,0,0
81481,to,0,0
81482,promote,0,0
81483,improved,0,0
81484,diet,0,0
81485,",",0,1
81486,physical,0,0
81487,activity,0,0
81488,",",0,0
81489,and,0,0
81490,sedentary,0,1
81491,behaviors,0,0
81492,(,0,1
81493,experimental,0,1
81494,condition,0,1
81495,),0,1
81496,or,0,1
81497,SUN,0,1
81498,protection,0,0
81499,behaviors,0,0
81500,(,0,1
81501,comparison,0,0
81502,condition,0,1
81503,),0,1
81504,.,0,1
81505,Participants,1,1
81506,were,1,1
81507,adolescent,1,1
81508,girls,1,1
81509,and,1,1
81510,boys,1,1
81511,(,1,1
81512,N,1,1
81513,=,1,1
81514,878,1,1
81515,),1,1
81516,aged,1,1
81517,11-15,1,1
81518,years,1,1
81519,on,1,1
81520,entry,1,1
81521,.,1,1
81522,The,0,0
81523,main,0,0
81524,outcomes,0,0
81525,were,0,1
81526,:,0,1
81527,diet,0,0
81528,",",0,0
81529,based,0,1
81530,on,0,0
81531,multiple,0,1
81532,24-hour,0,1
81533,recalls,0,0
81534,(,0,1
81535,total,0,1
81536,fat,0,1
81537,",",0,1
81538,grams,0,1
81539,of,0,0
81540,fiber,0,0
81541,",",0,1
81542,servings,0,0
81543,of,0,0
81544,fruit,0,1
81545,and,0,1
81546,vegetables,0,0
81547,",",0,1
81548,total,0,1
81549,calories,0,1
81550,),0,1
81551,;,0,1
81552,average,0,1
81553,daily,0,0
81554,energy,0,0
81555,expenditure,0,0
81556,(,0,1
81557,kcals/kg,0,0
81558,),0,1
81559,based,0,1
81560,on,0,0
81561,7-day,0,0
81562,physical,0,1
81563,activity,0,0
81564,recall,0,0
81565,interviews,0,1
81566,;,0,1
81567,daily,0,0
81568,minutes,0,0
81569,of,0,1
81570,moderate-vigorous,0,1
81571,physical,0,1
81572,activity,0,0
81573,minutes,0,0
81574,from,0,1
81575,accelerometery,0,1
81576,;,0,1
81577,and,0,1
81578,self-reported,0,1
81579,daily,0,0
81580,hours,0,0
81581,of,0,1
81582,sedentary,0,1
81583,behavior,0,1
81584,.,0,1
81585,RESULTS,0,0
81586,Covariation,0,0
81587,was,0,0
81588,found,0,0
81589,between,0,0
81590,fat,0,1
81591,and,0,1
81592,calories,0,1
81593,(,0,1
81594,r,0,0
81595,=,0,1
81596,.16,0,0
81597,),0,1
81598,",",0,0
81599,fiber,0,0
81600,and,0,1
81601,calories,0,1
81602,(,0,1
81603,r,0,0
81604,=,0,1
81605,.53,0,0
81606,),0,1
81607,",",0,0
81608,fiber,0,0
81609,and,0,1
81610,fruit/vegetables,0,0
81611,(,0,1
81612,r,0,0
81613,=,0,1
81614,.53,0,0
81615,),0,1
81616,",",0,1
81617,calories,0,1
81618,and,0,1
81619,fruit/vegetables,0,1
81620,(,0,1
81621,r,0,0
81622,=,0,1
81623,.34,0,0
81624,),0,1
81625,",",0,0
81626,and,0,0
81627,fruit,0,1
81628,and,0,1
81629,vegetables,0,0
81630,and,0,1
81631,sedentary,0,1
81632,behavior,0,0
81633,(,0,1
81634,r,0,0
81635,=,0,1
81636,-.12,0,0
81637,),0,1
81638,for,0,0
81639,the,0,0
81640,total,0,1
81641,sample,0,1
81642,(,0,0
81643,all,0,0
81644,p,0,0
81645,values,0,0
81646,<,0,0
81647,.01,0,0
81648,),0,1
81649,.,0,1
81650,The,0,0
81651,pattern,0,1
81652,of,0,0
81653,findings,0,0
81654,was,0,0
81655,similar,0,0
81656,for,0,1
81657,most,0,1
81658,subgroups,0,0
81659,defined,0,1
81660,by,0,0
81661,gender,0,0
81662,and,0,1
81663,study,0,1
81664,condition,0,0
81665,.,0,0
81666,CONCLUSIONS,0,0
81667,The,0,0
81668,strongest,0,0
81669,covariation,0,0
81670,was,0,0
81671,observed,0,0
81672,for,0,1
81673,diet,0,1
81674,variables,0,0
81675,that,0,0
81676,are,0,0
81677,inherently,0,0
81678,related,0,0
81679,(,0,1
81680,calories,0,1
81681,and,0,1
81682,fat,0,0
81683,",",0,0
81684,fiber,0,0
81685,",",0,0
81686,and,0,0
81687,fruit/vegetables,0,0
81688,),0,1
81689,.,0,1
81690,Little,0,0
81691,covariation,0,0
81692,was,0,0
81693,detected,0,0
81694,within,0,0
81695,or,0,1
81696,between,0,0
81697,other,0,0
81698,diet,0,1
81699,",",0,1
81700,physical,0,1
81701,activity,0,0
81702,and,0,1
81703,sedentary,0,1
81704,behavior,0,1
81705,domains,0,0
81706,suggesting,0,0
81707,that,0,0
81708,interventions,0,0
81709,to,0,1
81710,improve,0,0
81711,these,0,0
81712,behaviors,0,0
81713,in,0,0
81714,adolescents,1,1
81715,need,0,1
81716,to,0,0
81717,include,0,0
81718,specific,0,0
81719,program,0,1
81720,components,0,0
81721,for,0,0
81722,each,0,1
81723,target,0,0
81724,behavior,0,0
81725,of,0,0
81726,interest,0,0
81727,.,0,1
81728,Chlorhexidine-based,0,0
81729,antiseptic,0,0
81730,solution,0,0
81731,vs,0,0
81732,alcohol-based,0,0
81733,povidone-iodine,0,0
81734,for,0,1
81735,central,0,0
81736,venous,0,1
81737,catheter,0,1
81738,care,0,1
81739,.,0,1
81740,BACKGROUND,0,0
81741,Although,0,0
81742,chlorhexidine-based,0,0
81743,solutions,0,0
81744,and,0,1
81745,alcohol-based,0,0
81746,povidone-iodine,0,0
81747,have,0,0
81748,been,0,0
81749,shown,0,0
81750,to,0,0
81751,be,0,0
81752,more,0,0
81753,efficient,0,0
81754,than,0,0
81755,aqueous,0,0
81756,povidone-iodine,0,0
81757,for,0,0
81758,skin,0,1
81759,disinfection,0,0
81760,at,0,0
81761,catheter,1,1
81762,insertion,1,1
81763,sites,1,0
81764,",",0,1
81765,their,0,1
81766,abilities,0,0
81767,to,0,1
81768,reduce,0,0
81769,catheter-related,0,0
81770,infection,0,1
81771,have,0,0
81772,never,0,1
81773,been,0,0
81774,compared,0,0
81775,.,0,1
81776,METHODS,0,0
81777,Consecutively,1,1
81778,scheduled,1,1
81779,central,1,0
81780,venous,1,1
81781,catheters,1,1
81782,inserted,1,1
81783,into,1,1
81784,jugular,1,1
81785,or,1,1
81786,subclavian,1,1
81787,veins,1,1
81788,were,0,1
81789,randomly,0,1
81790,assigned,0,1
81791,to,0,0
81792,be,0,0
81793,disinfected,0,1
81794,with,0,1
81795,5,0,0
81796,%,0,0
81797,povidone-iodine,0,0
81798,in,0,1
81799,70,0,1
81800,%,0,0
81801,ethanol,0,0
81802,or,0,1
81803,with,0,1
81804,a,0,0
81805,combination,0,0
81806,of,0,0
81807,0.25,0,0
81808,%,0,0
81809,chlorhexidine,0,0
81810,gluconate,0,0
81811,",",0,0
81812,0.025,0,0
81813,%,0,0
81814,benzalkonium,0,0
81815,chloride,0,0
81816,",",0,0
81817,and,0,0
81818,4,0,0
81819,%,0,0
81820,benzylic,0,0
81821,alcohol,0,1
81822,.,0,1
81823,Solutions,0,0
81824,were,0,0
81825,used,0,0
81826,for,0,0
81827,skin,0,1
81828,disinfection,0,0
81829,before,0,0
81830,catheter,0,1
81831,insertion,0,1
81832,(,0,1
81833,2,0,1
81834,consecutive,0,1
81835,30-second,0,0
81836,applications,0,0
81837,separated,0,1
81838,by,0,0
81839,a,0,0
81840,period,0,0
81841,sufficiently,0,0
81842,long,0,0
81843,to,0,0
81844,allow,0,0
81845,for,0,0
81846,dryness,0,1
81847,),0,1
81848,and,0,0
81849,then,0,0
81850,as,0,0
81851,single,0,0
81852,applications,0,0
81853,during,0,1
81854,subsequent,0,1
81855,dressing,0,1
81856,changes,0,0
81857,(,0,1
81858,every,0,1
81859,72,0,1
81860,hours,0,0
81861,",",0,1
81862,or,0,1
81863,earlier,0,1
81864,if,0,0
81865,soiled,0,0
81866,or,0,1
81867,wet,0,1
81868,),0,1
81869,.,0,1
81870,RESULTS,0,0
81871,Of,0,1
81872,538,1,1
81873,catheters,1,1
81874,randomized,1,1
81875,",",1,1
81876,481,1,1
81877,(,1,1
81878,89.4,1,0
81879,%,1,0
81880,),1,1
81881,produced,1,0
81882,evaluable,1,1
81883,culture,1,1
81884,results,1,0
81885,.,1,1
81886,Compared,0,0
81887,with,0,1
81888,povidone-iodine,0,0
81889,",",0,0
81890,the,0,0
81891,chlorhexidine-based,0,0
81892,solution,0,0
81893,was,0,0
81894,associated,0,0
81895,with,0,1
81896,a,0,1
81897,50,0,1
81898,%,0,0
81899,decrease,0,0
81900,in,0,0
81901,the,0,0
81902,incidence,0,0
81903,of,0,0
81904,catheter,0,1
81905,colonization,0,1
81906,(,0,1
81907,11.6,0,0
81908,%,0,0
81909,vs,0,0
81910,22.2,0,1
81911,%,0,0
81912,[,0,1
81913,P,0,0
81914,=,0,1
81915,.002,0,0
81916,],0,1
81917,;,0,1
81918,incidence,0,0
81919,density,0,0
81920,",",0,0
81921,9.7,0,0
81922,vs,0,0
81923,18.3,0,0
81924,per,0,1
81925,1000,0,1
81926,catheter-days,0,1
81927,),0,1
81928,and,0,0
81929,with,0,1
81930,a,0,0
81931,trend,0,0
81932,toward,0,0
81933,lower,0,0
81934,rates,0,0
81935,of,0,0
81936,catheter-related,0,0
81937,bloodstream,0,1
81938,infection,0,1
81939,(,0,1
81940,1.7,0,0
81941,%,0,0
81942,vs,0,0
81943,4.2,0,1
81944,%,0,0
81945,[,0,1
81946,P,0,0
81947,=,0,1
81948,.09,0,0
81949,],0,1
81950,;,0,1
81951,incidence,0,0
81952,density,0,0
81953,",",0,0
81954,1.4,0,0
81955,vs,0,0
81956,3.4,0,0
81957,per,0,1
81958,1000,0,1
81959,catheter-days,0,1
81960,),0,1
81961,.,0,1
81962,Independent,0,0
81963,risk,0,0
81964,factors,0,0
81965,for,0,1
81966,catheter,0,1
81967,colonization,0,0
81968,were,0,1
81969,catheter,0,0
81970,insertion,0,0
81971,into,0,1
81972,the,0,0
81973,jugular,0,1
81974,vein,0,1
81975,(,0,1
81976,adjusted,0,0
81977,relative,0,0
81978,risk,0,0
81979,",",0,1
81980,2.01,0,0
81981,;,0,1
81982,95,0,0
81983,%,0,0
81984,confidence,0,0
81985,interval,0,0
81986,",",0,0
81987,1.24-3.24,0,0
81988,),0,1
81989,and,0,0
81990,use,0,0
81991,of,0,0
81992,povidone-iodine,0,0
81993,(,0,1
81994,adjusted,0,0
81995,relative,0,0
81996,risk,0,0
81997,",",0,1
81998,1.87,0,0
81999,;,0,1
82000,95,0,0
82001,%,0,0
82002,confidence,0,0
82003,interval,0,0
82004,",",0,0
82005,1.18-2.96,0,0
82006,),0,1
82007,.,0,1
82008,CONCLUSION,0,0
82009,Chlorhexidine-based,0,0
82010,solutions,0,0
82011,should,0,0
82012,be,0,0
82013,considered,0,0
82014,as,0,0
82015,a,0,0
82016,replacement,0,0
82017,for,0,0
82018,povidone-iodine,0,0
82019,(,0,1
82020,including,0,0
82021,alcohol-based,0,0
82022,),0,1
82023,formulations,0,0
82024,in,0,1
82025,efforts,0,0
82026,to,0,1
82027,prevent,0,0
82028,catheter-related,0,0
82029,infection,0,1
82030,.,0,1
82031,Mode,0,1
82032,of,0,0
82033,ventilation,0,1
82034,during,0,1
82035,cardiopulmonary,0,1
82036,bypass,0,1
82037,does,0,0
82038,not,0,0
82039,affect,0,0
82040,immediate,0,0
82041,postbypass,0,0
82042,oxygenation,0,0
82043,in,0,0
82044,pediatric,1,1
82045,cardiac,1,1
82046,patients,1,1
82047,.,1,1
82048,STUDY,0,0
82049,OBJECTIVE,0,0
82050,To,0,0
82051,investigate,0,0
82052,the,0,0
82053,impact,0,0
82054,of,0,0
82055,different,0,1
82056,modes,0,0
82057,of,0,1
82058,ventilation,0,1
82059,during,0,1
82060,cardiopulmonary,0,1
82061,bypass,0,1
82062,(,0,1
82063,CPB,0,0
82064,),0,1
82065,on,0,0
82066,immediate,0,0
82067,postbypass,0,1
82068,oxygenation,0,0
82069,in,0,0
82070,pediatric,1,1
82071,cardiac,1,1
82072,surgery,1,1
82073,.,1,1
82074,DESIGN,0,0
82075,Prospective,0,0
82076,",",0,0
82077,randomized,0,1
82078,clinical,0,0
82079,trial,0,1
82080,.,0,1
82081,SETTING,0,1
82082,University,0,1
82083,hospital,0,1
82084,.,0,1
82085,PATIENTS,0,0
82086,50,1,1
82087,pediatric,1,1
82088,patients,1,1
82089,(,1,1
82090,18,1,1
82091,girls,1,1
82092,",",1,1
82093,32,1,1
82094,boys,1,1
82095,),1,1
82096,",",1,1
82097,aged,1,1
82098,4,1,0
82099,months,1,1
82100,to,1,1
82101,15,1,1
82102,years,1,1
82103,",",1,1
82104,undergoing,1,1
82105,elective,1,1
82106,repair,1,1
82107,of,1,0
82108,congenital,1,1
82109,heart,1,1
82110,disease,1,1
82111,.,1,1
82112,INTERVENTIONS,0,0
82113,Patients,0,1
82114,were,0,1
82115,randomized,0,1
82116,to,0,0
82117,receive,0,1
82118,one,0,1
82119,of,0,1
82120,5,0,1
82121,modes,0,0
82122,of,0,1
82123,ventilation,0,1
82124,during,0,1
82125,bypass,0,1
82126,.,0,1
82127,Groups,0,0
82128,1,0,0
82129,and,0,1
82130,2,0,1
82131,received,0,1
82132,high-frequency/low-volume,0,0
82133,ventilation,0,1
82134,with,0,1
82135,100,0,1
82136,%,0,0
82137,(,0,1
82138,group,0,1
82139,1,0,1
82140,),0,1
82141,or,0,1
82142,21,0,1
82143,%,0,0
82144,oxygen,0,0
82145,(,0,1
82146,group,0,1
82147,2,0,1
82148,),0,1
82149,.,0,1
82150,Groups,0,0
82151,3,0,0
82152,and,0,1
82153,4,0,0
82154,received,0,1
82155,continuous,0,0
82156,positive,0,1
82157,airway,0,1
82158,pressure,0,0
82159,of,0,0
82160,5,0,1
82161,cm,0,1
82162,H,0,1
82163,(,0,1
82164,2,0,1
82165,),0,1
82166,O,0,0
82167,with,0,1
82168,100,0,1
82169,%,0,0
82170,(,0,1
82171,group,0,1
82172,3,0,1
82173,),0,1
82174,or,0,1
82175,21,0,1
82176,%,0,0
82177,oxygen,0,0
82178,(,0,1
82179,group,0,1
82180,4,0,1
82181,),0,1
82182,;,0,1
82183,and,0,0
82184,in,0,0
82185,group,0,1
82186,5,0,0
82187,",",0,0
82188,each,0,0
82189,patient,0,0
82190,'s,0,1
82191,airway,0,1
82192,was,0,0
82193,disconnected,0,0
82194,from,0,1
82195,the,0,0
82196,ventilator,0,1
82197,(,0,0
82198,passive,0,0
82199,deflation,0,0
82200,),0,1
82201,.,0,1
82202,MEASUREMENTS,0,0
82203,Blood,0,0
82204,gas,0,1
82205,analysis,0,0
82206,and,0,1
82207,spirometry,0,1
82208,data,0,0
82209,were,0,1
82210,recorded,0,0
82211,5,0,1
82212,minutes,0,0
82213,before,0,1
82214,chest,0,1
82215,opening,0,1
82216,",",0,1
82217,5,0,0
82218,minutes,0,0
82219,before,0,1
82220,inducing,0,0
82221,bypass,0,1
82222,",",0,1
82223,5,0,0
82224,minutes,0,0
82225,after,0,1
82226,weaning,0,1
82227,from,0,1
82228,bypass,0,1
82229,",",0,1
82230,and,0,1
82231,5,0,0
82232,minutes,0,0
82233,after,0,1
82234,chest,0,1
82235,closure,0,1
82236,.,0,1
82237,MAIN,0,0
82238,RESULTS,0,0
82239,There,0,0
82240,were,0,0
82241,no,0,0
82242,differences,0,0
82243,in,0,1
82244,Pao,0,1
82245,(,0,1
82246,2,0,1
82247,),0,1
82248,values,0,0
82249,among,0,1
82250,the,0,1
82251,5,0,1
82252,groups,0,0
82253,studied,0,1
82254,and,0,1
82255,at,0,0
82256,the,0,0
82257,different,0,0
82258,time,0,0
82259,points,0,0
82260,.,0,1
82261,Lung,0,0
82262,compliance,0,0
82263,was,0,0
82264,higher,0,0
82265,5,0,1
82266,minutes,0,0
82267,before,0,1
82268,bypass,0,1
82269,in,0,1
82270,group,0,1
82271,1,0,1
82272,versus,0,0
82273,group,0,1
82274,5,0,1
82275,(,0,1
82276,34,0,1
82277,+/-,0,1
82278,13,0,1
82279,mL/cm,0,0
82280,H,0,1
82281,(,0,1
82282,2,0,1
82283,),0,1
82284,O,0,0
82285,vs,0,0
82286,20,0,1
82287,+/-,0,0
82288,9,0,1
82289,mL/cm,0,0
82290,H,0,1
82291,(,0,1
82292,2,0,1
82293,),0,1
82294,O,0,0
82295,;,0,1
82296,P,0,0
82297,=,0,1
82298,0.048,0,0
82299,),0,1
82300,.,0,1
82301,CONCLUSIONS,0,0
82302,Mode,0,0
82303,of,0,0
82304,ventilation,0,1
82305,during,0,1
82306,CPB,0,0
82307,did,0,0
82308,not,0,0
82309,affect,0,0
82310,immediate,0,0
82311,postbypass,0,1
82312,oxygenation,0,0
82313,.,0,1
82314,Effect,0,0
82315,of,0,0
82316,a,0,1
82317,dental,0,1
82318,cream,0,0
82319,containing,0,0
82320,amorphous,0,0
82321,cream,0,1
82322,phosphate,0,0
82323,complexes,0,0
82324,on,0,0
82325,white,0,1
82326,spot,0,1
82327,lesion,0,1
82328,regression,0,0
82329,assessed,0,0
82330,by,0,0
82331,laser,0,0
82332,fluorescence,0,0
82333,.,0,1
82334,PURPOSE,0,0
82335,To,0,0
82336,investigate,0,0
82337,and,0,0
82338,compare,0,0
82339,the,0,0
82340,effects,0,0
82341,of,0,0
82342,a,0,1
82343,dental,0,1
82344,cream,0,0
82345,containing,0,0
82346,complexes,0,0
82347,of,0,1
82348,casein,0,1
82349,phosphoprotein-amorphous,0,1
82350,calcium,0,0
82351,phosphate,0,0
82352,(,0,1
82353,CPP-ACP,0,1
82354,),0,1
82355,and,0,1
82356,fluoride,0,1
82357,mouthwashes,0,0
82358,on,0,0
82359,the,0,0
82360,regression,0,0
82361,of,0,0
82362,white,1,1
82363,spot,1,1
82364,lesions,1,1
82365,(,1,1
82366,WSL,1,1
82367,),1,1
82368,.,1,1
82369,MATERIALS,0,0
82370,AND,0,0
82371,METHODS,0,0
82372,The,0,0
82373,study,0,0
82374,group,0,0
82375,consisted,0,1
82376,of,0,0
82377,26,1,1
82378,healthy,1,1
82379,adolescents,1,1
82380,(,1,1
82381,mean,1,1
82382,age,1,1
82383,14.6,1,1
82384,years,1,1
82385,),1,1
82386,exhibiting,1,1
82387,60,1,1
82388,teeth,1,1
82389,with,1,1
82390,152,1,1
82391,visible,1,1
82392,WSL,1,1
82393,sites,1,1
82394,on,1,1
82395,incisors,1,1
82396,and,1,1
82397,canines,1,1
82398,immediately,1,0
82399,after,1,0
82400,debonding,1,0
82401,of,1,0
82402,fixed,1,0
82403,orthodontic,1,1
82404,appliances,1,1
82405,.,1,1
82406,After,0,0
82407,bracket,0,0
82408,removal,0,0
82409,",",0,0
82410,professional,0,1
82411,tooth,0,1
82412,cleaning,0,0
82413,and,0,0
82414,drying,0,0
82415,",",0,0
82416,a,0,0
82417,visual,0,0
82418,scoring,0,1
82419,(,0,1
82420,0-4,0,1
82421,),0,1
82422,and,0,0
82423,laser,0,0
82424,fluorescence,0,0
82425,(,0,0
82426,LF,0,0
82427,),0,1
82428,readings,0,0
82429,were,0,1
82430,carried,0,0
82431,out,0,1
82432,.,0,1
82433,The,0,0
82434,patients,0,1
82435,were,0,1
82436,randomly,0,1
82437,assigned,0,1
82438,to,0,1
82439,two,0,0
82440,different,0,1
82441,treatment,0,1
82442,protocols,0,0
82443,with,0,1
82444,the,0,0
82445,aim,0,0
82446,of,0,0
82447,remineralising,0,0
82448,the,0,1
82449,lesions,0,1
82450,:,0,1
82451,A,0,1
82452,),0,0
82453,daily,0,0
82454,topical,0,0
82455,applications,0,0
82456,of,0,1
82457,a,0,1
82458,dental,0,1
82459,cream,0,0
82460,containing,0,0
82461,CPP-ACP,0,1
82462,(,0,1
82463,Topacal,0,1
82464,),0,1
82465,for,0,1
82466,3,0,1
82467,months,0,1
82468,followed,0,1
82469,by,0,0
82470,a,0,1
82471,3-month,0,0
82472,period,0,0
82473,of,0,0
82474,daily,0,0
82475,toothbrushing,0,0
82476,with,0,1
82477,fluoridated,0,1
82478,dentifrice,0,0
82479,",",0,0
82480,or,0,1
82481,B,0,1
82482,),0,1
82483,daily,0,0
82484,0.05,0,0
82485,%,0,0
82486,sodium,0,0
82487,fluoride,0,0
82488,mouthwash,0,0
82489,combined,0,0
82490,with,0,1
82491,fluoridated,0,1
82492,dentifrice,0,0
82493,for,0,1
82494,6,0,1
82495,months,0,1
82496,.,0,1
82497,The,0,0
82498,registrations,0,0
82499,were,0,1
82500,repeated,0,0
82501,after,0,0
82502,1,0,1
82503,",",0,1
82504,3,0,0
82505,",",0,1
82506,6,0,0
82507,and,0,1
82508,12,0,1
82509,months,0,0
82510,and,0,1
82511,follow-up,0,1
82512,data,0,0
82513,were,0,1
82514,compared,0,0
82515,with,0,1
82516,baseline,0,0
82517,with,0,1
82518,aid,0,0
82519,of,0,0
82520,chi-square,0,0
82521,and,0,1
82522,paired,0,1
82523,t-tests,0,0
82524,.,0,1
82525,RESULTS,0,0
82526,A,0,0
82527,significant,0,0
82528,improvement,0,0
82529,of,0,0
82530,the,0,0
82531,clinical,0,0
82532,WSL-scores,0,0
82533,was,0,0
82534,found,0,0
82535,over,0,0
82536,time,0,0
82537,in,0,1
82538,both,0,0
82539,groups,0,0
82540,",",0,0
82541,but,0,0
82542,there,0,0
82543,was,0,0
82544,a,0,0
82545,statistically,0,0
82546,significant,0,0
82547,difference,0,0
82548,(,0,1
82549,p,0,0
82550,<,0,0
82551,0.01,0,0
82552,),0,1
82553,concerning,0,0
82554,the,0,0
82555,number,0,0
82556,of,0,0
82557,sites,0,1
82558,that,0,0
82559,totally,0,1
82560,disappeared,0,0
82561,after,0,0
82562,12,0,1
82563,months,0,1
82564,in,0,1
82565,favour,0,0
82566,of,0,0
82567,the,0,0
82568,CPP-ACP,0,0
82569,regime,0,0
82570,",",0,1
82571,63,0,1
82572,%,0,0
82573,compared,0,0
82574,with,0,1
82575,25,0,1
82576,%,0,0
82577,respectively,0,0
82578,.,0,1
82579,The,0,0
82580,clinical,0,0
82581,registrations,0,1
82582,were,0,1
82583,mirrored,0,0
82584,by,0,0
82585,a,0,0
82586,statistically,0,0
82587,significant,0,0
82588,decrease,0,0
82589,(,0,1
82590,p,0,0
82591,<,0,0
82592,0.05,0,0
82593,),0,1
82594,in,0,0
82595,the,0,1
82596,LF,0,0
82597,readings,0,0
82598,at,0,1
82599,the,0,1
82600,6-,0,1
82601,and,0,1
82602,12-month,0,1
82603,follow-ups,0,0
82604,compared,0,0
82605,with,0,1
82606,baseline,0,0
82607,.,0,1
82608,No,0,0
82609,significant,0,0
82610,differences,0,0
82611,were,0,1
82612,displayed,0,0
82613,between,0,0
82614,the,0,0
82615,groups,0,0
82616,.,0,1
82617,CONCLUSIONS,0,0
82618,Clinical,0,0
82619,scoring,0,1
82620,and,0,1
82621,LF,0,0
82622,assessment,0,0
82623,suggested,0,0
82624,that,0,0
82625,both,0,0
82626,regimens,0,0
82627,could,0,0
82628,promote,0,0
82629,regression,0,0
82630,of,0,0
82631,WSL,0,1
82632,after,0,0
82633,debonding,0,1
82634,of,0,0
82635,fixed,0,0
82636,orthodontic,0,1
82637,appliances,0,1
82638,.,0,1
82639,The,0,0
82640,visual,0,0
82641,evaluation,0,0
82642,suggested,0,0
82643,an,0,0
82644,aesthetically,0,0
82645,more,0,0
82646,favourable,0,0
82647,outcome,0,0
82648,of,0,0
82649,the,0,0
82650,amorphous,0,0
82651,calcium,0,0
82652,phosphate,0,1
82653,treatments,0,0
82654,.,0,1
82655,The,0,0
82656,value-congruence,0,0
82657,model,0,0
82658,of,0,0
82659,memory,0,0
82660,for,0,1
82661,emotional,0,0
82662,experiences,0,1
82663,:,0,1
82664,an,0,1
82665,explanation,0,0
82666,for,0,0
82667,cultural,1,0
82668,differences,1,0
82669,in,1,1
82670,emotional,1,1
82671,self-reports,1,1
82672,.,1,1
82673,In,0,1
82674,3,0,0
82675,studies,0,0
82676,",",0,1
82677,the,0,0
82678,authors,0,0
82679,found,0,0
82680,support,0,0
82681,for,0,0
82682,the,0,0
82683,value-congruence,0,0
82684,model,0,0
82685,that,0,0
82686,accounts,0,0
82687,for,0,0
82688,cultural,0,0
82689,variations,0,0
82690,in,0,1
82691,memory,0,1
82692,for,0,1
82693,emotional,0,0
82694,experiences,0,1
82695,.,0,1
82696,In,0,0
82697,Study,0,0
82698,1,0,1
82699,",",0,1
82700,the,0,0
82701,authors,0,0
82702,found,0,0
82703,that,0,0
82704,in,0,0
82705,the,0,0
82706,made-in-the-U.S.,0,1
82707,scenario,0,0
82708,condition,0,0
82709,",",0,1
82710,European,1,1
82711,Americans,1,1
82712,were,1,1
82713,more,1,1
82714,accurate,1,0
82715,than,1,0
82716,were,1,1
82717,Asian,1,1
82718,Americans,1,1
82719,in,0,1
82720,their,0,1
82721,retrospective,0,1
82722,frequency,0,0
82723,judgments,0,0
82724,of,0,1
82725,emotions,0,0
82726,.,0,1
82727,However,0,0
82728,",",0,0
82729,in,0,0
82730,the,0,0
82731,made-in-Japan,0,0
82732,scenario,0,0
82733,condition,0,0
82734,",",0,1
82735,European,1,1
82736,Americans,1,1
82737,were,0,1
82738,less,0,1
82739,accurate,0,0
82740,than,0,0
82741,were,0,1
82742,Asian,1,1
82743,Americans,1,1
82744,.,1,1
82745,In,0,1
82746,Study,0,0
82747,2,0,1
82748,",",0,1
82749,the,0,0
82750,authors,0,0
82751,demonstrated,0,0
82752,that,0,0
82753,value,0,0
82754,orientation,0,0
82755,mediates,0,0
82756,the,0,0
82757,CulturexType,0,0
82758,of,0,0
82759,Event,0,0
82760,congruence,0,0
82761,effect,0,0
82762,.,0,1
82763,In,0,0
82764,Study,0,0
82765,3,0,1
82766,(,0,0
82767,a,0,0
82768,daily,0,0
82769,event,0,0
82770,sampling,0,0
82771,study,0,1
82772,),0,0
82773,",",0,0
82774,the,0,0
82775,authors,0,0
82776,showed,0,0
82777,that,0,0
82778,the,0,0
82779,congruence,0,0
82780,effect,0,0
82781,was,0,0
82782,explained,0,0
82783,by,0,0
82784,the,0,0
82785,importance,0,0
82786,of,0,0
82787,parental,0,1
82788,approval,0,1
82789,.,0,1
82790,In,0,0
82791,sum,0,0
82792,",",0,1
82793,emotional,0,0
82794,events,0,0
82795,congruent,0,1
82796,with,0,1
82797,personal,0,1
82798,values,0,0
82799,remain,0,1
82800,in,0,0
82801,memory,0,0
82802,longer,0,0
82803,and,0,0
82804,influence,0,0
82805,retrospective,0,1
82806,frequency,0,0
82807,judgments,0,0
82808,of,0,0
82809,emotion,0,0
82810,more,0,0
82811,than,0,0
82812,do,0,0
82813,incongruent,0,0
82814,events,0,0
82815,.,0,1
82816,Cost-effectiveness,0,0
82817,of,0,0
82818,clopidogrel,0,1
82819,in,0,1
82820,acute,1,1
82821,coronary,1,1
82822,syndromes,1,1
82823,in,1,1
82824,Canada,1,1
82825,:,1,1
82826,a,0,1
82827,long-term,0,0
82828,analysis,0,0
82829,based,0,1
82830,on,0,0
82831,the,0,0
82832,CURE,0,0
82833,trial,0,0
82834,.,0,1
82835,BACKGROUND,0,0
82836,Cardiovascular,0,0
82837,diseases,0,1
82838,account,0,0
82839,for,0,0
82840,nearly,0,1
82841,20,0,1
82842,%,0,0
82843,of,0,0
82844,all,0,1
82845,hospitalizations,0,1
82846,in,0,1
82847,Canada,0,1
82848,and,0,1
82849,consume,0,1
82850,12,0,0
82851,%,0,0
82852,of,0,0
82853,the,0,0
82854,total,0,1
82855,cost,0,0
82856,of,0,0
82857,all,0,1
82858,illnesses,0,1
82859,.,0,1
82860,With,0,1
82861,increasing,0,0
82862,trends,0,0
82863,of,0,1
82864,cardiovascular,0,1
82865,disease,0,1
82866,and,0,1
82867,increasing,0,0
82868,costs,0,1
82869,of,0,1
82870,care,0,1
82871,",",0,0
82872,development,0,0
82873,of,0,0
82874,cost-effective,0,0
82875,strategies,0,0
82876,is,0,0
82877,vital,0,0
82878,.,0,0
82879,The,0,0
82880,Clopidogrel,0,0
82881,in,0,0
82882,Unstable,0,1
82883,angina,0,1
82884,to,0,0
82885,prevent,0,0
82886,Recurrent,0,1
82887,Events,0,0
82888,(,0,1
82889,CURE,0,1
82890,),0,1
82891,trial,0,0
82892,demonstrated,0,0
82893,the,0,0
82894,effectiveness,0,0
82895,of,0,0
82896,clopidogrel,0,1
82897,plus,0,0
82898,acetylsalicylic,0,0
82899,acid,0,0
82900,(,0,1
82901,ASA,0,1
82902,),0,1
82903,compared,0,0
82904,with,0,1
82905,ASA,0,0
82906,alone,0,1
82907,in,0,0
82908,reducing,0,0
82909,cardiovascular,0,1
82910,events,0,0
82911,in,0,1
82912,patients,1,1
82913,with,1,1
82914,acute,1,1
82915,coronary,1,1
82916,syndromes,1,1
82917,and,1,1
82918,",",1,1
82919,in,1,0
82920,addition,1,0
82921,",",1,1
82922,patients,1,1
82923,undergoing,1,1
82924,percutaneous,1,1
82925,coronary,1,1
82926,intervention,1,0
82927,in,1,0
82928,the,1,0
82929,Percutaneous,1,1
82930,Coronary,1,1
82931,Intervention,1,1
82932,in,1,1
82933,CURE,1,0
82934,(,1,1
82935,PCI-CURE,1,1
82936,),1,1
82937,trial,1,1
82938,.,1,1
82939,OBJECTIVE,0,0
82940,To,0,0
82941,assess,0,0
82942,the,0,0
82943,cost-effectiveness,0,0
82944,of,0,0
82945,clopidogrel,0,0
82946,in,0,0
82947,the,0,0
82948,Canadian,1,1
82949,health,1,1
82950,care,1,1
82951,system,1,1
82952,.,1,1
82953,METHODS,0,0
82954,Estimates,0,0
82955,of,0,1
82956,hospitalization,0,1
82957,costs,0,1
82958,were,0,1
82959,based,0,1
82960,on,0,0
82961,the,0,0
82962,2003,0,1
82963,cost,0,0
82964,schedules,0,0
82965,released,0,0
82966,by,0,0
82967,the,0,0
82968,Health,0,0
82969,Funding,0,0
82970,and,0,1
82971,Costing,0,0
82972,Branch,0,1
82973,of,0,0
82974,the,0,0
82975,Alberta,0,1
82976,Health,0,0
82977,and,0,1
82978,Wellness,0,0
82979,",",0,0
82980,as,0,0
82981,well,0,0
82982,as,0,0
82983,on,0,0
82984,the,0,0
82985,Case,0,0
82986,Mix,0,0
82987,Group,0,1
82988,classification,0,1
82989,system,0,1
82990,.,0,1
82991,Life,0,0
82992,expectancy,0,0
82993,beyond,0,1
82994,the,0,0
82995,trial,0,0
82996,was,0,0
82997,estimated,0,0
82998,from,0,1
82999,the,0,0
83000,Saskatchewan,0,1
83001,Health,0,0
83002,Database,0,1
83003,.,0,1
83004,Cost-effectiveness,0,0
83005,was,0,0
83006,expressed,0,0
83007,as,0,0
83008,the,0,0
83009,incremental,0,0
83010,cost-effectiveness,0,0
83011,ratio,0,0
83012,",",0,0
83013,and,0,0
83014,bootstrap,0,0
83015,methods,0,1
83016,were,0,1
83017,used,0,0
83018,to,0,0
83019,estimate,0,0
83020,the,0,0
83021,joint,0,0
83022,distribution,0,1
83023,of,0,1
83024,costs,0,1
83025,and,0,1
83026,effectiveness,0,0
83027,.,0,1
83028,RESULTS,0,0
83029,Clopidogrel,0,0
83030,was,0,0
83031,shown,0,0
83032,to,0,0
83033,be,0,0
83034,cost-effective,0,0
83035,",",0,0
83036,with,0,1
83037,incremental,0,0
83038,cost-effectiveness,0,0
83039,ratios,0,0
83040,less,0,1
83041,than,0,1
83042,$,0,0
83043,"10,000",0,1
83044,per,0,1
83045,event,0,0
83046,prevented,0,0
83047,and,0,0
83048,less,0,0
83049,than,0,0
83050,$,0,0
83051,"4,000",0,1
83052,per,0,1
83053,life-year,0,0
83054,gained,0,0
83055,.,0,1
83056,The,0,0
83057,probability,0,0
83058,of,0,0
83059,clopidogrel,0,0
83060,resulting,0,0
83061,in,0,0
83062,cost,0,0
83063,per,0,1
83064,life-year,0,0
83065,gained,0,0
83066,of,0,0
83067,less,0,0
83068,than,0,0
83069,$,0,0
83070,"20,000",0,1
83071,was,0,0
83072,0.975,0,0
83073,for,0,1
83074,CURE,1,1
83075,patients,1,1
83076,and,0,1
83077,0.904,0,0
83078,for,0,1
83079,PCI-CURE,1,1
83080,patients,1,1
83081,.,1,1
83082,CONCLUSIONS,0,0
83083,The,0,0
83084,economic,0,0
83085,analysis,0,0
83086,demonstrated,0,0
83087,that,0,0
83088,clopidogrel,0,0
83089,combination,0,0
83090,therapy,0,0
83091,is,0,0
83092,not,0,0
83093,only,0,0
83094,cost-effective,0,0
83095,as,0,0
83096,antiplatelet,0,1
83097,therapy,0,0
83098,compared,0,0
83099,with,0,1
83100,ASA,0,0
83101,alone,0,0
83102,",",0,0
83103,but,0,0
83104,it,0,0
83105,is,0,0
83106,also,0,0
83107,cost-effective,0,0
83108,compared,0,0
83109,with,0,1
83110,other,0,0
83111,commonly,0,1
83112,used,0,0
83113,and,0,0
83114,openly,0,0
83115,reimbursed,0,1
83116,cardiovascular,0,1
83117,therapies,0,0
83118,in,0,1
83119,the,0,1
83120,Canadian,0,1
83121,health,0,1
83122,care,0,1
83123,system,0,1
83124,.,0,1
83125,Intra-operative,0,1
83126,antibiotic,0,0
83127,prophylaxis,0,1
83128,in,0,1
83129,neurosurgery,1,1
83130,.,1,1
83131,A,0,0
83132,prospective,0,0
83133,",",0,0
83134,randomized,0,1
83135,",",0,0
83136,controlled,0,0
83137,study,0,0
83138,on,0,0
83139,cefotiam,0,0
83140,.,0,1
83141,In,0,0
83142,this,0,0
83143,prospective,0,1
83144,",",0,0
83145,randomized,0,1
83146,and,0,0
83147,controlled,0,0
83148,study,0,0
83149,the,0,0
83150,effect,0,0
83151,of,0,0
83152,cefotiam,0,0
83153,for,0,0
83154,the,0,0
83155,prevention,0,1
83156,of,0,0
83157,wound,0,1
83158,infections,0,1
83159,following,0,1
83160,trepanations,1,1
83161,was,0,0
83162,investigated,0,0
83163,.,0,1
83164,The,0,0
83165,main,0,0
83166,interest,0,0
83167,was,0,0
83168,centered,0,1
83169,on,0,0
83170,the,0,0
83171,rate,0,0
83172,of,0,0
83173,post-operative,0,0
83174,bone,0,1
83175,flap,0,1
83176,infections,0,1
83177,requiring,0,1
83178,operative,0,1
83179,revision,0,1
83180,.,0,1
83181,Administration,0,0
83182,of,0,0
83183,cefotiam,0,0
83184,was,0,0
83185,randomized,0,1
83186,for,0,1
83187,patients,1,1
83188,undergoing,1,1
83189,major,1,1
83190,craniotomies,1,1
83191,.,1,1
83192,The,0,0
83193,antibiotic,0,0
83194,was,0,0
83195,administered,0,0
83196,intravenously,0,1
83197,in,0,0
83198,a,0,0
83199,single,0,0
83200,dose,0,0
83201,of,0,1
83202,2,0,1
83203,g,0,1
83204,with,0,1
83205,induction,0,0
83206,of,0,0
83207,anaesthesia,0,1
83208,.,0,1
83209,Only,1,0
83210,clean,1,1
83211,or,1,1
83212,clean,1,1
83213,contaminated,1,1
83214,cases,1,1
83215,were,1,1
83216,included,1,1
83217,.,1,1
83218,Excluded,1,0
83219,were,1,0
83220,contaminated,1,0
83221,cases,1,1
83222,",",1,1
83223,operations,1,1
83224,with,1,1
83225,a,1,1
83226,transnasal-transsphenoidal,1,1
83227,approach,1,0
83228,",",1,1
83229,shunt-operations,1,1
83230,and,1,1
83231,patients,1,1
83232,with,1,1
83233,any,1,1
83234,other,1,0
83235,preoperative,1,1
83236,infection,1,1
83237,or,1,1
83238,antibiotic,1,0
83239,therapy,1,1
83240,.,1,1
83241,Outpatients,1,1
83242,were,1,1
83243,excluded,1,1
83244,due,1,1
83245,to,1,1
83246,difficulties,1,1
83247,in,1,1
83248,obtaining,1,1
83249,sufficient,1,0
83250,clinical,1,1
83251,information,1,1
83252,.,1,1
83253,From,1,1
83254,originally,1,1
83255,918,1,1
83256,consecutive,1,1
83257,patients,1,1
83258,operated,1,1
83259,on,1,1
83260,711,1,1
83261,fulfilled,1,1
83262,the,1,0
83263,entry,1,1
83264,criteria,1,1
83265,.,1,1
83266,With,1,1
83267,regard,1,0
83268,to,1,0
83269,age,1,1
83270,",",1,0
83271,sex,1,0
83272,",",1,0
83273,diagnosis,1,1
83274,and,1,0
83275,the,1,0
83276,site,1,0
83277,of,1,0
83278,te,1,0
83279,trepanation,1,1
83280,",",1,1
83281,control,1,1
83282,patients,1,1
83283,(,1,1
83284,n,1,1
83285,=,1,1
83286,355,1,1
83287,),1,1
83288,and,1,1
83289,cefotiam,1,0
83290,treated,1,1
83291,patients,1,1
83292,(,1,1
83293,n,1,1
83294,=,1,1
83295,356,1,1
83296,),1,1
83297,were,1,1
83298,shown,1,0
83299,to,1,0
83300,be,1,0
83301,comparable,1,0
83302,.,1,1
83303,In,0,0
83304,the,0,0
83305,various,0,0
83306,subgroups,0,0
83307,formed,0,1
83308,for,0,1
83309,different,1,1
83310,primary,1,1
83311,diagnoses,1,1
83312,",",1,1
83313,concomitant,1,0
83314,steroidal,1,1
83315,therapy,1,0
83316,and,0,0
83317,concomitant,1,0
83318,severe,1,1
83319,internal,1,1
83320,medical,1,1
83321,diseases,1,1
83322,cefotiam,0,1
83323,treated,0,1
83324,patients,0,1
83325,and,0,1
83326,controls,0,1
83327,were,0,1
83328,comparable,0,0
83329,as,0,0
83330,well,0,0
83331,.,0,0
83332,A,0,0
83333,highly,0,0
83334,significant,0,0
83335,difference,0,0
83336,for,0,0
83337,bone,0,1
83338,flap,0,0
83339,infection,0,1
83340,could,0,0
83341,be,0,0
83342,shown,0,0
83343,with,0,1
83344,0.3,0,0
83345,%,0,0
83346,in,0,0
83347,the,0,0
83348,cefotiam,0,0
83349,group,0,1
83350,versus,0,0
83351,5.1,0,0
83352,%,0,0
83353,in,0,0
83354,the,0,0
83355,control,0,1
83356,group,0,0
83357,(,0,0
83358,p,0,0
83359,less,0,0
83360,than,0,0
83361,0.001,0,0
83362,),0,1
83363,.,0,1
83364,The,0,0
83365,overall,0,0
83366,rate,0,0
83367,of,0,0
83368,post-operative,0,0
83369,deep,0,1
83370,wound,0,1
83371,infections,0,1
83372,including,0,1
83373,meningitis,0,1
83374,and,0,1
83375,abscesses,0,0
83376,was,0,0
83377,also,0,0
83378,significantly,0,0
83379,(,0,0
83380,p,0,0
83381,less,0,0
83382,than,0,0
83383,0.005,0,0
83384,),0,1
83385,different,0,1
83386,with,0,1
83387,3.1,0,0
83388,%,0,0
83389,in,0,0
83390,the,0,0
83391,cefotiam,0,0
83392,versus,0,0
83393,9.0,0,0
83394,%,0,0
83395,in,0,0
83396,the,0,0
83397,control,0,1
83398,group,0,0
83399,.,0,1
83400,Thus,0,1
83401,it,0,0
83402,was,0,0
83403,concluded,0,0
83404,that,0,0
83405,a,0,1
83406,single,0,0
83407,dose,0,0
83408,of,0,0
83409,cefotiam,0,0
83410,significantly,0,0
83411,reduces,0,0
83412,post-operative,0,0
83413,deep,0,0
83414,wound,0,1
83415,infection,0,1
83416,.,0,1
83417,Several,0,1
83418,indicators,0,0
83419,of,0,1
83420,oxidative,0,0
83421,stress,0,0
83422,",",0,0
83423,immunity,0,0
83424,",",0,0
83425,and,0,0
83426,illness,0,1
83427,improved,0,0
83428,in,0,1
83429,trained,1,1
83430,men,1,1
83431,consuming,0,1
83432,an,0,1
83433,encapsulated,0,0
83434,juice,0,0
83435,powder,0,0
83436,concentrate,0,0
83437,for,0,1
83438,28,0,1
83439,weeks,0,1
83440,.,0,1
83441,Phytonutrients,0,0
83442,from,0,1
83443,plant,0,1
83444,foods,0,1
83445,provide,0,0
83446,numerous,0,1
83447,antioxidants,0,1
83448,.,0,1
83449,We,0,0
83450,hypothesized,0,0
83451,that,0,0
83452,supplementation,0,0
83453,for,0,0
83454,28,0,1
83455,wk,0,1
83456,with,0,1
83457,a,0,0
83458,commercially,0,0
83459,available,0,0
83460,encapsulated,0,0
83461,juice,0,0
83462,powder,0,0
83463,concentrate,0,0
83464,(,0,1
83465,JPC,0,0
83466,),0,1
83467,could,0,0
83468,influence,0,0
83469,indicators,0,0
83470,of,0,0
83471,oxidative,0,0
83472,stress,0,0
83473,",",0,0
83474,immunity,0,0
83475,",",0,0
83476,and,0,0
83477,illness,0,1
83478,.,0,1
83479,Trained,1,1
83480,men,1,1
83481,(,1,1
83482,n,1,1
83483,=,1,1
83484,41,1,1
83485,;,1,0
83486,34,1,1
83487,+/-,1,0
83488,5,1,1
83489,y,1,1
83490,;,1,1
83491,maximum,1,0
83492,oxygen,1,0
83493,uptake,1,0
83494,=,1,1
83495,55,1,1
83496,+/-,1,1
83497,7,1,1
83498,mL,1,0
83499,x,1,1
83500,kg,1,1
83501,(,1,1
83502,-1,1,0
83503,),1,1
83504,x,1,1
83505,min,1,0
83506,(,1,1
83507,-1,1,0
83508,),1,1
83509,),1,1
83510,from,1,1
83511,a,1,1
83512,homogenous,1,1
83513,police,1,1
83514,Special,1,1
83515,Forces,1,1
83516,unit,1,1
83517,were,0,1
83518,randomly,0,1
83519,assigned,0,1
83520,in,0,0
83521,a,0,1
83522,double,0,0
83523,blind,0,1
83524,manner,0,0
83525,to,0,0
83526,either,0,1
83527,JPC,0,0
83528,(,0,1
83529,n,0,1
83530,=,0,1
83531,21,0,1
83532,),0,1
83533,or,0,1
83534,placebo,0,0
83535,(,0,1
83536,n,0,1
83537,=,0,1
83538,20,0,1
83539,),0,1
83540,.,0,1
83541,We,0,0
83542,used,0,0
83543,multiple,0,1
83544,7-d,0,1
83545,food,0,1
83546,records,0,1
83547,to,0,1
83548,assess,0,0
83549,dietary,0,0
83550,intake,0,0
83551,and,0,1
83552,found,0,0
83553,inadequate,1,1
83554,mean,1,1
83555,daily,1,0
83556,fruit,1,1
83557,and,1,1
83558,vegetable,1,1
83559,consumption,1,0
83560,(,1,1
83561,3.2,1,1
83562,+/-,1,1
83563,1.2,1,1
83564,servings,1,1
83565,),1,1
83566,.,1,1
83567,The,0,0
83568,group,0,0
83569,physician,0,1
83570,documented,0,0
83571,all,0,0
83572,duty,0,1
83573,days,0,0
83574,lost,0,1
83575,due,0,0
83576,to,0,1
83577,illness,0,1
83578,.,0,1
83579,We,0,0
83580,collected,0,0
83581,plasma,0,0
83582,at,0,0
83583,baseline,0,0
83584,and,0,0
83585,study,0,1
83586,wk,0,1
83587,4,0,0
83588,",",0,1
83589,8,0,0
83590,",",0,0
83591,16,0,1
83592,",",0,0
83593,and,0,0
83594,28,0,1
83595,for,0,0
83596,analysis,0,0
83597,of,0,1
83598,carbonyl,0,0
83599,groups,0,1
83600,on,0,0
83601,protein,0,0
83602,(,0,1
83603,CP,0,1
83604,),0,1
83605,and,0,1
83606,TNFalpha,0,0
83607,.,0,1
83608,Over,0,0
83609,the,0,0
83610,28-wk,0,1
83611,investigation,0,0
83612,",",0,1
83613,CP,0,0
83614,was,0,0
83615,lower,0,0
83616,in,0,0
83617,the,0,0
83618,JPC,0,0
83619,group,0,0
83620,",",0,0
83621,with,0,1
83622,both,0,0
83623,a,0,0
83624,treatment,0,0
83625,and,0,0
83626,a,0,0
83627,time,0,0
83628,x,0,1
83629,treatment,0,0
83630,interaction,0,0
83631,(,0,1
83632,P,0,0
83633,<,0,0
83634,0.05,0,0
83635,),0,1
83636,.,0,1
83637,Concentrations,0,0
83638,of,0,0
83639,both,0,0
83640,CP,0,0
83641,and,0,0
83642,TNFalpha,0,0
83643,at,0,1
83644,16,0,1
83645,and,0,1
83646,28,0,1
83647,wk,0,0
83648,were,0,1
83649,lower,0,0
83650,in,0,0
83651,the,0,0
83652,JPC,0,0
83653,than,0,0
83654,in,0,0
83655,the,0,0
83656,placebo,0,0
83657,group,0,0
83658,(,0,1
83659,P,0,0
83660,<,0,0
83661,0.001,0,0
83662,),0,1
83663,.,0,1
83664,TNFalpha,0,0
83665,increased,0,0
83666,during,0,0
83667,the,0,0
83668,first,0,0
83669,8,0,1
83670,wk,0,1
83671,followed,0,0
83672,by,0,0
83673,a,0,0
83674,decrease,0,0
83675,in,0,0
83676,both,0,0
83677,groups,0,0
83678,for,0,0
83679,the,0,1
83680,following,0,0
83681,20,0,1
83682,wk,0,1
83683,(,0,1
83684,P,0,0
83685,<,0,0
83686,0.001,0,0
83687,),0,1
83688,.,0,1
83689,Over,0,0
83690,the,0,0
83691,final,0,0
83692,20,0,1
83693,wk,0,1
83694,of,0,0
83695,the,0,0
83696,study,0,0
83697,",",0,0
83698,the,0,0
83699,placebo,0,0
83700,group,0,0
83701,tended,0,0
83702,to,0,0
83703,have,0,0
83704,more,0,0
83705,days,0,0
83706,of,0,0
83707,illness,0,1
83708,than,0,0
83709,the,0,0
83710,JPC,0,0
83711,group,0,1
83712,(,0,1
83713,P,0,0
83714,=,0,1
83715,0.068,0,0
83716,),0,1
83717,.,0,1
83718,These,0,0
83719,data,0,0
83720,suggest,0,0
83721,beneficial,0,0
83722,JPC,0,0
83723,effects,0,0
83724,with,0,1
83725,regard,0,0
83726,to,0,0
83727,reduction,0,0
83728,of,0,0
83729,duty,0,1
83730,days,0,0
83731,lost,0,1
83732,due,0,0
83733,to,0,0
83734,illness,0,1
83735,and,0,0
83736,reduction,0,0
83737,of,0,0
83738,CP,0,0
83739,and,0,1
83740,TNFalpha,0,0
83741,concentrations,0,0
83742,in,0,1
83743,this,0,0
83744,group,1,1
83745,of,1,0
83746,trained,1,1
83747,men,1,1
83748,over,1,1
83749,28,1,1
83750,wk,1,1
83751,.,1,1
83752,Intensive,0,1
83753,insulin,0,0
83754,therapy,0,0
83755,improves,0,0
83756,endothelial,0,0
83757,function,0,0
83758,and,0,1
83759,microvascular,0,1
83760,reactivity,0,0
83761,in,0,1
83762,young,1,1
83763,people,1,1
83764,with,1,1
83765,type,1,1
83766,1,1,1
83767,diabetes,1,1
83768,.,1,1
83769,AIMS/HYPOTHESIS,0,0
83770,Macrovascular,0,0
83771,disease,0,1
83772,is,0,0
83773,an,0,0
83774,important,0,0
83775,cause,0,0
83776,of,0,0
83777,the,0,0
83778,increased,0,0
83779,morbidity,0,0
83780,and,0,1
83781,mortality,0,0
83782,rates,0,0
83783,associated,0,0
83784,with,0,1
83785,type,0,1
83786,1,0,1
83787,diabetes,0,1
83788,",",0,1
83789,and,0,0
83790,this,0,0
83791,vascular,0,0
83792,impairment,0,0
83793,begins,0,0
83794,in,0,0
83795,childhood,0,1
83796,.,0,1
83797,The,0,0
83798,aim,0,0
83799,of,0,0
83800,this,0,0
83801,study,0,0
83802,was,0,0
83803,to,0,0
83804,determine,0,0
83805,whether,0,0
83806,introducing,0,0
83807,intensive,0,1
83808,diabetes,0,1
83809,management,0,1
83810,[,0,1
83811,intensive,0,1
83812,insulin,0,0
83813,therapy,0,0
83814,(,0,1
83815,IIT,0,1
83816,),0,1
83817,and,0,0
83818,'Sweet,0,1
83819,Talk,0,1
83820,',0,1
83821,text-messaging,0,0
83822,support,0,0
83823,],0,1
83824,produces,0,0
83825,measurable,0,0
83826,improvements,0,0
83827,in,0,1
83828,endothelial,0,1
83829,function,0,0
83830,.,0,1
83831,METHODS,0,0
83832,One,1,1
83833,hundred,1,1
83834,and,1,1
83835,twenty-six,1,1
83836,patients,1,1
83837,fulfilled,1,1
83838,the,1,0
83839,eligibility,1,1
83840,criteria,1,1
83841,(,1,1
83842,type,1,1
83843,1,1,1
83844,diabetes,1,1
83845,for,1,1
83846,>,1,1
83847,1,1,1
83848,year,1,1
83849,;,1,1
83850,on,1,0
83851,conventional,1,1
83852,insulin,1,1
83853,therapy,1,0
83854,(,1,1
83855,CIT,1,1
83856,),1,1
83857,;,1,0
83858,aged,1,1
83859,between,1,0
83860,8,1,1
83861,and,1,1
83862,18,1,1
83863,years,1,1
83864,),1,1
83865,",",1,1
83866,of,1,1
83867,whom,1,1
83868,92,1,1
83869,enrolled,1,1
83870,.,1,1
83871,Patients,0,1
83872,were,0,1
83873,randomised,0,1
83874,to,0,1
83875,group,0,1
83876,1,0,0
83877,",",0,0
83878,CIT,0,1
83879,only,0,0
83880,(,0,1
83881,n=28,0,1
83882,),0,1
83883,;,0,1
83884,group,0,1
83885,2,0,1
83886,",",0,1
83887,CIT,0,1
83888,and,0,1
83889,Sweet,0,1
83890,Talk,0,1
83891,(,0,1
83892,n=33,0,1
83893,),0,1
83894,;,0,0
83895,or,0,1
83896,group,0,1
83897,3,0,0
83898,",",0,1
83899,IIT,0,1
83900,and,0,1
83901,Sweet,0,1
83902,Talk,0,1
83903,(,0,1
83904,n=31,0,1
83905,),0,1
83906,.,0,1
83907,Vascular,0,1
83908,assessments,0,0
83909,(,0,1
83910,including,0,1
83911,measures,0,0
83912,of,0,1
83913,endothelial,0,1
83914,damage,0,0
83915,",",0,0
83916,activation,0,0
83917,",",0,0
83918,dysfunction,0,1
83919,and,0,0
83920,oxidative,0,0
83921,stress,0,1
83922,),0,1
83923,and,0,1
83924,HbA1c,0,0
83925,were,0,1
83926,performed,0,0
83927,at,0,0
83928,baseline,0,0
83929,and,0,0
83930,repeated,0,0
83931,after,0,1
83932,12,0,1
83933,months,0,1
83934,of,0,1
83935,the,0,1
83936,study,0,1
83937,.,0,1
83938,RESULTS,0,0
83939,Glycaemic,0,1
83940,control,0,1
83941,deteriorated,0,1
83942,in,0,0
83943,patients,0,1
83944,on,0,1
83945,CIT,0,1
83946,",",0,1
83947,but,0,0
83948,improved,0,0
83949,significantly,0,0
83950,in,0,0
83951,patients,0,1
83952,allocated,0,1
83953,to,0,1
83954,IIT,0,1
83955,(,0,1
83956,p=0.007,0,0
83957,),0,1
83958,.,0,1
83959,IIT,0,1
83960,was,0,0
83961,associated,0,0
83962,with,0,1
83963,significantly,0,0
83964,greater,0,0
83965,improvements,0,0
83966,in,0,1
83967,E-selectin,0,0
83968,(,0,1
83969,p,0,0
83970,<,0,0
83971,0.0001,0,0
83972,),0,1
83973,than,0,0
83974,CIT,0,1
83975,(,0,1
83976,group,0,1
83977,1,0,0
83978,",",0,0
83979,p=0.026,0,0
83980,and,0,0
83981,group,0,1
83982,2,0,1
83983,",",0,0
83984,p=0.053,0,0
83985,),0,1
83986,.,0,1
83987,Vascular,0,1
83988,responses,0,0
83989,to,0,1
83990,acetylcholine,0,0
83991,improved,0,0
83992,in,0,0
83993,patients,0,1
83994,on,0,1
83995,IIT,0,1
83996,(,0,1
83997,p=0.017,0,0
83998,),0,1
83999,",",0,0
84000,but,0,0
84001,not,0,0
84002,in,0,0
84003,patients,0,1
84004,receiving,0,1
84005,CIT,0,1
84006,.,0,1
84007,These,0,1
84008,changes,0,0
84009,were,0,1
84010,all,0,0
84011,independent,0,0
84012,of,0,0
84013,HbA1c,0,0
84014,level,0,0
84015,.,0,1
84016,CONCLUSIONS/INTERPRETATION,0,0
84017,IIT,0,1
84018,appears,0,0
84019,to,0,0
84020,be,0,0
84021,associated,0,0
84022,with,0,1
84023,improvements,0,0
84024,in,0,1
84025,vascular,0,1
84026,markers,0,0
84027,",",0,0
84028,independently,0,0
84029,of,0,0
84030,changes,0,0
84031,in,0,1
84032,HbA1c,0,0
84033,",",0,0
84034,suggesting,0,0
84035,that,0,0
84036,IIT,0,1
84037,may,0,0
84038,confer,0,0
84039,vascular,0,0
84040,protection,0,0
84041,in,0,0
84042,addition,0,0
84043,to,0,1
84044,improving,0,0
84045,glycaemic,0,0
84046,control,0,1
84047,.,0,1
84048,Improving,0,0
84049,the,0,0
84050,transition,1,1
84051,from,1,1
84052,residential,1,1
84053,to,1,1
84054,outpatient,1,1
84055,addiction,1,1
84056,treatment,0,1
84057,:,0,1
84058,gender,0,0
84059,differences,0,0
84060,in,0,1
84061,response,0,0
84062,to,0,0
84063,supportive,0,0
84064,telephone,0,1
84065,calls,0,0
84066,.,0,1
84067,Substance,0,0
84068,use,0,0
84069,relapse,0,0
84070,rates,0,0
84071,are,0,0
84072,often,0,0
84073,high,0,1
84074,in,0,0
84075,the,0,1
84076,first,0,0
84077,months,0,0
84078,after,0,1
84079,discharge,0,1
84080,from,0,1
84081,inpatient,0,1
84082,substance,0,1
84083,abuse,0,1
84084,treatment,0,0
84085,",",0,0
84086,and,0,0
84087,patient,0,1
84088,adherence,0,0
84089,to,0,1
84090,aftercare,0,1
84091,plans,0,0
84092,is,0,0
84093,often,0,0
84094,low,0,0
84095,.,0,1
84096,Four,1,0
84097,residential,1,1
84098,addiction,1,1
84099,treatment,1,1
84100,centers,1,1
84101,participated,0,1
84102,in,0,0
84103,a,0,0
84104,feasibility,0,0
84105,study,0,0
84106,designed,0,0
84107,to,0,0
84108,estimate,0,0
84109,the,0,0
84110,efficacy,0,0
84111,of,0,0
84112,a,0,1
84113,post-discharge,0,0
84114,telephone,0,1
84115,intervention,0,0
84116,intended,0,0
84117,to,0,0
84118,encourage,0,0
84119,compliance,0,0
84120,with,0,1
84121,aftercare,0,1
84122,.,0,1
84123,A,1,0
84124,total,1,1
84125,of,1,0
84126,282,1,1
84127,participants,1,1
84128,(,1,1
84129,100,1,1
84130,women,1,1
84131,",",1,1
84132,182,1,1
84133,men,1,1
84134,),1,1
84135,with,1,1
84136,substance,1,1
84137,use,1,0
84138,disorders,1,1
84139,were,1,1
84140,included,1,1
84141,in,1,0
84142,this,1,0
84143,secondary,1,0
84144,analysis,1,0
84145,.,1,1
84146,The,0,0
84147,findings,0,0
84148,revealed,0,0
84149,that,0,0
84150,women,0,1
84151,were,0,0
84152,more,0,0
84153,likely,0,0
84154,than,0,0
84155,men,0,1
84156,to,0,1
84157,attend,0,1
84158,aftercare,0,1
84159,.,0,0
84160,This,0,0
84161,gender,0,0
84162,effect,0,0
84163,persisted,0,0
84164,after,0,0
84165,adjustment,0,0
84166,for,0,0
84167,a,0,0
84168,number,0,0
84169,of,0,0
84170,potential,0,0
84171,mediators,0,0
84172,.,0,1
84173,A,0,0
84174,randomised,0,0
84175,double-blind,0,0
84176,trial,0,1
84177,of,0,0
84178,cyclosporin,0,0
84179,and,0,0
84180,azathioprine,0,0
84181,in,0,0
84182,refractory,1,1
84183,rheumatoid,1,1
84184,arthritis,1,1
84185,.,1,1
84186,Fifty-two,1,1
84187,patients,1,1
84188,with,1,1
84189,severe,1,1
84190,rheumatoid,1,1
84191,arthritis,1,1
84192,(,1,1
84193,RA,1,1
84194,),1,1
84195,from,1,1
84196,four,1,1
84197,Australian,1,1
84198,centres,1,1
84199,were,0,1
84200,randomised,0,1
84201,to,0,0
84202,receive,0,1
84203,cyclosporin,0,0
84204,A,0,1
84205,(,0,1
84206,CSA,0,1
84207,),0,1
84208,(,0,1
84209,n,0,1
84210,=,0,1
84211,25,0,1
84212,),0,1
84213,or,0,1
84214,azathioprine,0,0
84215,(,0,1
84216,AZA,0,1
84217,),0,1
84218,(,0,1
84219,n,0,1
84220,=,0,1
84221,27,0,1
84222,),0,1
84223,for,0,1
84224,six,0,1
84225,months,0,1
84226,.,0,1
84227,Initial,0,0
84228,mean,0,1
84229,doses,0,0
84230,of,0,1
84231,CSA,0,1
84232,and,0,1
84233,AZA,0,1
84234,were,0,1
84235,4.2,0,1
84236,mg/kg,0,0
84237,and,0,1
84238,1.7,0,0
84239,mg/kg,0,0
84240,respectively,0,0
84241,.,0,1
84242,The,0,0
84243,mean,0,0
84244,doses,0,0
84245,of,0,1
84246,CSA,0,1
84247,and,0,1
84248,AZA,0,1
84249,at,0,1
84250,six,0,1
84251,months,0,1
84252,were,0,1
84253,3.4,0,1
84254,mg/kg,0,0
84255,and,0,1
84256,1.9,0,1
84257,mg/kg,0,0
84258,.,0,1
84259,Assessments,0,0
84260,of,0,1
84261,side-effects,0,0
84262,and,0,1
84263,outcomes,0,0
84264,of,0,1
84265,benefit,0,0
84266,were,0,1
84267,made,0,0
84268,monthly,0,0
84269,by,0,0
84270,independent,0,0
84271,",",0,1
84272,blinded,0,0
84273,observers,0,1
84274,.,0,1
84275,Both,0,0
84276,treatment,0,0
84277,groups,0,0
84278,exhibited,0,0
84279,statistically,0,0
84280,significant,0,0
84281,improvement,0,0
84282,in,0,1
84283,standard,0,1
84284,outcome,0,0
84285,parameters,0,0
84286,when,0,0
84287,compared,0,0
84288,with,0,1
84289,baseline,0,1
84290,values,0,0
84291,.,0,1
84292,However,0,0
84293,",",0,0
84294,there,0,0
84295,were,0,0
84296,no,0,0
84297,statistically,0,0
84298,significant,0,0
84299,differences,0,0
84300,in,0,1
84301,these,0,0
84302,parameters,0,0
84303,between,0,0
84304,the,0,1
84305,two,0,1
84306,groups,0,0
84307,.,0,1
84308,There,0,0
84309,was,0,0
84310,a,0,0
84311,mean,0,0
84312,increase,0,0
84313,in,0,1
84314,serum,0,0
84315,creatinine,0,0
84316,concentration,0,0
84317,associated,0,0
84318,with,0,1
84319,CSA,0,1
84320,;,0,1
84321,no,0,0
84322,persons,0,1
84323,were,0,1
84324,withdrawn,0,0
84325,from,0,1
84326,the,0,0
84327,study,0,0
84328,for,0,0
84329,this,0,0
84330,reason,0,0
84331,.,0,1
84332,Seven,1,0
84333,CSA,1,0
84334,recipients,1,1
84335,(,1,1
84336,three,1,1
84337,gastrointestinal,1,1
84338,symptoms,1,1
84339,",",1,1
84340,two,1,1
84341,neurological,1,1
84342,symptoms,1,1
84343,",",1,1
84344,two,1,1
84345,other,1,1
84346,),1,1
84347,and,1,1
84348,12,1,1
84349,AZA,1,1
84350,recipients,1,1
84351,(,1,1
84352,six,1,1
84353,gastrointestinal,1,1
84354,symptoms,1,1
84355,",",1,1
84356,four,1,1
84357,inefficacy,1,0
84358,",",1,1
84359,two,1,0
84360,other,1,1
84361,),1,1
84362,withdrew,1,0
84363,from,1,1
84364,treatment,1,0
84365,prematurely,1,1
84366,.,1,1
84367,Seven,0,0
84368,CSA,0,0
84369,recipients,0,1
84370,became,0,1
84371,hypertensive,0,1
84372,and,0,1
84373,four,0,1
84374,required,0,0
84375,anti-hypertensive,0,1
84376,therapy,0,1
84377,.,0,1
84378,Adverse,0,0
84379,events,0,0
84380,not,0,1
84381,requiring,0,1
84382,cessation,0,0
84383,of,0,0
84384,therapy,0,0
84385,were,0,1
84386,more,0,0
84387,commonly,0,0
84388,seen,0,0
84389,among,0,1
84390,CSA,0,1
84391,patients,0,1
84392,.,0,1
84393,In,0,0
84394,this,0,0
84395,group,0,0
84396,of,0,0
84397,severely,1,1
84398,affected,1,0
84399,patients,1,1
84400,with,1,1
84401,RA,1,1
84402,both,0,0
84403,cyclosporin,0,0
84404,and,0,0
84405,azathioprine,0,0
84406,were,0,1
84407,effective,0,0
84408,therapies,0,0
84409,.,0,1
84410,CSA,0,0
84411,toxicities,0,0
84412,were,0,1
84413,predictable,0,0
84414,and,0,1
84415,manageable,0,0
84416,but,0,0
84417,required,0,0
84418,close,0,0
84419,monitoring,0,0
84420,.,0,1
84421,Feasibility,0,0
84422,of,0,1
84423,two,0,1
84424,dose-dense,0,0
84425,FEC,0,0
84426,regimens,0,0
84427,with,0,1
84428,growth,0,0
84429,factor,0,0
84430,support,0,0
84431,for,0,0
84432,adjuvant,0,1
84433,therapy,0,1
84434,in,0,1
84435,patients,1,1
84436,with,1,1
84437,early,1,1
84438,breast,1,1
84439,cancer,1,1
84440,:,1,1
84441,results,0,0
84442,from,0,1
84443,a,0,1
84444,randomised,0,0
84445,study,0,0
84446,of,0,0
84447,the,0,0
84448,Central,0,0
84449,European,0,1
84450,Cooperative,0,1
84451,Oncology,0,1
84452,Group,0,1
84453,(,0,1
84454,CECOG,0,1
84455,),0,1
84456,.,0,1
84457,Addition,0,0
84458,of,0,0
84459,epirubicin,0,0
84460,to,0,0
84461,adjuvant,0,0
84462,chemotherapy,0,1
84463,can,0,0
84464,provide,0,0
84465,important,0,0
84466,benefits,0,0
84467,for,0,1
84468,patients,1,1
84469,with,1,1
84470,early,1,1
84471,breast,1,1
84472,cancer,1,1
84473,",",0,0
84474,but,0,0
84475,the,0,0
84476,optimal,0,0
84477,dose,0,0
84478,remains,0,0
84479,unclear,0,0
84480,.,0,1
84481,Further,0,0
84482,improvements,0,0
84483,can,0,0
84484,be,0,0
84485,achieved,0,0
84486,with,0,1
84487,dose-dense,0,0
84488,regimens,0,0
84489,",",0,1
84490,but,0,0
84491,densification,0,0
84492,of,0,0
84493,fluorouracil/epirubicin/cyclophosphamide,0,0
84494,(,0,1
84495,FEC,0,0
84496,),0,1
84497,has,0,0
84498,proved,0,0
84499,difficult,0,0
84500,",",0,0
84501,with,0,1
84502,FEC,0,1
84503,(,0,1
84504,60,0,1
84505,),0,1
84506,providing,0,0
84507,little,0,0
84508,benefit,0,0
84509,over,0,0
84510,standard,0,1
84511,chemotherapy,0,1
84512,and,0,1
84513,FEC,0,1
84514,(,0,1
84515,100,0,1
84516,),0,1
84517,associated,0,0
84518,with,0,1
84519,toxicity,0,0
84520,.,0,1
84521,We,0,0
84522,investigated,0,0
84523,the,0,0
84524,feasibility,0,0
84525,of,0,0
84526,two,0,1
84527,intermediate,0,1
84528,dose-dense,0,1
84529,FEC,0,1
84530,regimens,0,1
84531,.,0,1
84532,Patients,0,1
84533,were,0,1
84534,randomised,0,1
84535,to,0,1
84536,six,0,1
84537,cycles,0,0
84538,of,0,1
84539,FEC,0,1
84540,(,0,1
84541,75,0,1
84542,),0,1
84543,or,0,1
84544,FEC,0,1
84545,(,0,1
84546,90,0,1
84547,),0,1
84548,",",0,0
84549,with,0,1
84550,all,0,1
84551,three,0,0
84552,drugs,0,0
84553,given,0,1
84554,on,0,1
84555,day,0,0
84556,1,0,1
84557,of,0,0
84558,each,0,1
84559,14-day,0,0
84560,cycle,0,0
84561,.,0,1
84562,Patients,0,1
84563,also,0,0
84564,received,0,1
84565,pegfilgrastim,0,0
84566,6,0,0
84567,mg,0,0
84568,as,0,0
84569,a,0,1
84570,single,0,0
84571,subcutaneous,0,1
84572,injection,0,0
84573,on,0,0
84574,day,0,0
84575,2,0,1
84576,of,0,0
84577,each,0,1
84578,cycle,0,0
84579,.,0,0
84580,The,0,0
84581,primary,0,0
84582,efficacy,0,0
84583,endpoint,0,0
84584,was,0,0
84585,the,0,0
84586,proportion,0,0
84587,of,0,0
84588,subjects,0,1
84589,receiving,0,1
84590,>,0,1
84591,or,0,1
84592,=85,0,1
84593,%,0,0
84594,relative,0,0
84595,dose,0,0
84596,intensity,0,0
84597,and,0,1
84598,was,0,0
84599,achieved,0,0
84600,by,0,0
84601,96,0,1
84602,%,0,0
84603,and,0,1
84604,88,0,0
84605,%,0,0
84606,of,0,1
84607,patients,0,1
84608,in,0,1
84609,the,0,1
84610,FEC,0,1
84611,(,0,1
84612,75,0,1
84613,),0,1
84614,and,0,1
84615,FEC,0,1
84616,(,0,1
84617,90,0,1
84618,),0,1
84619,arms,0,0
84620,",",0,1
84621,respectively,0,0
84622,.,0,1
84623,Of,0,0
84624,147,0,1
84625,FEC,0,1
84626,(,0,1
84627,75,0,1
84628,),0,1
84629,infusions,0,0
84630,",",0,1
84631,4.1,0,1
84632,%,0,0
84633,were,0,1
84634,delayed,0,0
84635,",",0,0
84636,while,0,0
84637,9.8,0,0
84638,%,0,0
84639,of,0,1
84640,143,0,1
84641,FEC,0,1
84642,(,0,1
84643,90,0,1
84644,),0,1
84645,infusions,0,0
84646,were,0,1
84647,delayed,0,1
84648,.,0,1
84649,The,0,0
84650,most,0,0
84651,common,0,0
84652,reasons,0,0
84653,for,0,1
84654,delay,0,1
84655,were,0,1
84656,adverse,0,0
84657,events,0,0
84658,and,0,1
84659,personal/logistical,0,1
84660,reasons,0,0
84661,.,0,1
84662,One,0,1
84663,dose,0,0
84664,reduction,0,0
84665,occurred,0,0
84666,during,0,0
84667,the,0,0
84668,study,0,0
84669,(,0,0
84670,FEC,0,1
84671,(,0,1
84672,90,0,1
84673,),0,1
84674,),0,1
84675,",",0,0
84676,related,0,0
84677,to,0,0
84678,diarrhoea,0,1
84679,.,0,0
84680,Grade,0,0
84681,3-4,0,0
84682,haematological,0,1
84683,toxicities,0,0
84684,were,0,1
84685,reported,0,1
84686,in,0,1
84687,two,0,1
84688,patients,0,1
84689,in,0,1
84690,the,0,1
84691,FEC,0,1
84692,(,0,1
84693,90,0,1
84694,),0,1
84695,arm,0,0
84696,.,0,0
84697,There,0,0
84698,were,0,0
84699,no,0,0
84700,incidences,0,0
84701,of,0,0
84702,febrile,0,1
84703,neutropenia,0,0
84704,during,0,0
84705,the,0,0
84706,study,0,0
84707,.,0,0
84708,The,0,0
84709,most,0,0
84710,common,0,1
84711,adverse,0,0
84712,events,0,0
84713,were,0,1
84714,increases,0,0
84715,in,0,1
84716,liver,0,1
84717,enzymes,0,1
84718,and,0,1
84719,gastrointestinal,0,1
84720,events,0,0
84721,;,0,1
84722,no,0,0
84723,event,0,0
84724,resulted,0,0
84725,in,0,0
84726,discontinuation,0,0
84727,.,0,1
84728,Only,0,0
84729,one,0,0
84730,patient,0,1
84731,(,0,1
84732,FEC,0,1
84733,(,0,1
84734,90,0,1
84735,),0,1
84736,),0,1
84737,experienced,0,1
84738,serious,0,0
84739,adverse,0,0
84740,events,0,0
84741,(,0,1
84742,vomiting,0,0
84743,and,0,0
84744,throat,0,1
84745,oedema,0,1
84746,),0,0
84747,.,0,1
84748,In,0,0
84749,conclusion,0,0
84750,",",0,1
84751,dose-dense,0,0
84752,FEC,0,1
84753,(,0,1
84754,75,0,1
84755,),0,1
84756,and,0,1
84757,FEC,0,1
84758,(,0,1
84759,90,0,1
84760,),0,1
84761,are,0,0
84762,feasible,0,0
84763,with,0,1
84764,pegfilgrastim,0,0
84765,support,0,0
84766,.,0,1
84767,These,0,0
84768,regimens,0,0
84769,are,0,0
84770,associated,0,0
84771,with,0,1
84772,a,0,0
84773,very,0,0
84774,low,0,0
84775,risk,0,0
84776,of,0,1
84777,Grade,0,0
84778,3-4,0,1
84779,toxicity,0,0
84780,.,0,1
84781,Osteosarcoma,0,1
84782,:,0,1
84783,the,0,0
84784,addition,0,0
84785,of,0,0
84786,muramyl,0,0
84787,tripeptide,0,0
84788,to,0,0
84789,chemotherapy,0,1
84790,improves,0,0
84791,overall,0,0
84792,survival,0,0
84793,--,0,1
84794,a,0,0
84795,report,0,0
84796,from,0,0
84797,the,0,0
84798,Children,1,1
84799,'s,1,1
84800,Oncology,1,1
84801,Group,1,1
84802,.,1,1
84803,PURPOSE,0,0
84804,To,0,0
84805,compare,0,0
84806,three-drug,0,0
84807,chemotherapy,0,1
84808,with,0,1
84809,cisplatin,0,0
84810,",",0,0
84811,doxorubicin,0,0
84812,",",0,0
84813,and,0,0
84814,methotrexate,0,0
84815,with,0,1
84816,four-drug,0,1
84817,chemotherapy,0,1
84818,with,0,1
84819,cisplatin,0,0
84820,",",0,0
84821,doxorubicin,0,0
84822,",",0,0
84823,methotrexate,0,0
84824,",",0,0
84825,and,0,0
84826,ifosfamide,0,0
84827,for,0,0
84828,the,0,0
84829,treatment,0,0
84830,of,0,0
84831,osteosarcoma,0,1
84832,.,0,1
84833,To,0,0
84834,determine,0,0
84835,whether,0,0
84836,the,0,0
84837,addition,0,0
84838,of,0,0
84839,muramyl,0,0
84840,tripeptide,0,0
84841,(,0,1
84842,MTP,0,1
84843,),0,1
84844,to,0,0
84845,chemotherapy,0,1
84846,enhances,0,0
84847,event-free,0,0
84848,survival,0,0
84849,(,0,1
84850,EFS,0,0
84851,),0,1
84852,and,0,1
84853,overall,0,0
84854,survival,0,0
84855,in,0,0
84856,newly,0,1
84857,diagnosed,0,1
84858,patients,0,1
84859,with,0,1
84860,osteosarcoma,0,1
84861,.,0,1
84862,PATIENTS,0,0
84863,AND,0,0
84864,METHODS,0,0
84865,Six,1,1
84866,hundred,1,1
84867,sixty-two,1,1
84868,patients,1,1
84869,with,1,1
84870,osteosarcoma,1,1
84871,without,1,1
84872,clinically,1,1
84873,detectable,1,0
84874,metastatic,1,1
84875,disease,1,1
84876,and,1,0
84877,whose,1,1
84878,disease,1,1
84879,was,1,1
84880,considered,1,0
84881,resectable,1,1
84882,received,1,1
84883,one,1,1
84884,of,1,0
84885,four,1,1
84886,prospectively,1,1
84887,randomized,1,1
84888,treatments,1,0
84889,.,1,1
84890,All,0,1
84891,patients,0,1
84892,received,0,1
84893,identical,0,1
84894,cumulative,0,0
84895,doses,0,0
84896,of,0,1
84897,cisplatin,0,0
84898,",",0,0
84899,doxorubicin,0,0
84900,",",0,0
84901,and,0,0
84902,methotrexate,0,0
84903,and,0,1
84904,underwent,0,1
84905,definitive,0,1
84906,surgical,0,1
84907,resection,0,1
84908,of,0,0
84909,primary,0,1
84910,tumor,0,1
84911,.,0,1
84912,Patients,0,1
84913,were,0,0
84914,randomly,0,1
84915,assigned,0,1
84916,to,0,0
84917,receive,0,0
84918,or,0,1
84919,not,0,0
84920,to,0,0
84921,receive,0,0
84922,ifosfamide,0,1
84923,and/or,0,0
84924,MTP,0,1
84925,in,0,0
84926,a,0,1
84927,2,0,1
84928,x,0,1
84929,2,0,1
84930,factorial,0,0
84931,design,0,1
84932,.,0,1
84933,The,0,0
84934,primary,0,1
84935,end,0,0
84936,points,0,0
84937,for,0,1
84938,analysis,0,0
84939,were,0,1
84940,EFS,0,0
84941,and,0,1
84942,overall,0,0
84943,survival,0,0
84944,.,0,1
84945,RESULTS,0,0
84946,In,0,0
84947,the,0,0
84948,current,0,0
84949,analysis,0,0
84950,",",0,0
84951,there,0,0
84952,was,0,0
84953,no,0,0
84954,evidence,0,0
84955,of,0,0
84956,interaction,0,0
84957,",",0,0
84958,and,0,0
84959,we,0,0
84960,were,0,1
84961,able,0,0
84962,to,0,0
84963,examine,0,0
84964,each,0,0
84965,intervention,0,0
84966,separately,0,0
84967,.,0,0
84968,The,0,0
84969,chemotherapy,0,0
84970,regimens,0,0
84971,resulted,0,0
84972,in,0,0
84973,similar,0,0
84974,EFS,0,0
84975,and,0,1
84976,overall,0,0
84977,survival,0,0
84978,.,0,0
84979,There,0,0
84980,was,0,0
84981,a,0,0
84982,trend,0,0
84983,toward,0,0
84984,better,0,0
84985,EFS,0,0
84986,with,0,1
84987,the,0,0
84988,addition,0,0
84989,of,0,0
84990,MTP,0,1
84991,(,0,1
84992,P,0,0
84993,=,0,1
84994,.08,0,0
84995,),0,1
84996,.,0,1
84997,The,0,0
84998,addition,0,0
84999,of,0,0
85000,MTP,0,0
85001,to,0,1
85002,chemotherapy,0,1
85003,improved,0,0
85004,6-year,0,1
85005,overall,0,0
85006,survival,0,0
85007,from,0,1
85008,70,0,1
85009,%,0,0
85010,to,0,1
85011,78,0,1
85012,%,0,0
85013,(,0,1
85014,P,0,0
85015,=,0,1
85016,.03,0,0
85017,),0,1
85018,.,0,1
85019,The,0,0
85020,hazard,0,0
85021,ratio,0,0
85022,for,0,0
85023,overall,0,0
85024,survival,0,0
85025,with,0,1
85026,the,0,0
85027,addition,0,0
85028,of,0,0
85029,MTP,0,1
85030,was,0,0
85031,0.71,0,0
85032,(,0,1
85033,95,0,0
85034,%,0,0
85035,CI,0,0
85036,",",0,1
85037,0.52,0,0
85038,to,0,1
85039,0.96,0,0
85040,),0,1
85041,.,0,1
85042,CONCLUSION,0,0
85043,The,0,0
85044,addition,0,0
85045,of,0,0
85046,ifosfamide,0,0
85047,to,0,0
85048,cisplatin,0,0
85049,",",0,0
85050,doxorubicin,0,0
85051,",",0,0
85052,and,0,0
85053,methotrexate,0,0
85054,did,0,0
85055,not,0,0
85056,enhance,0,0
85057,EFS,0,0
85058,or,0,1
85059,overall,0,0
85060,survival,0,0
85061,for,0,1
85062,patients,0,1
85063,with,0,1
85064,osteosarcoma,0,1
85065,.,0,1
85066,The,0,0
85067,addition,0,0
85068,of,0,0
85069,MTP,0,0
85070,to,0,1
85071,chemotherapy,0,1
85072,resulted,0,0
85073,in,0,0
85074,a,0,0
85075,statistically,0,0
85076,significant,0,0
85077,improvement,0,0
85078,in,0,1
85079,overall,0,0
85080,survival,0,0
85081,and,0,0
85082,a,0,0
85083,trend,0,0
85084,toward,0,0
85085,better,0,0
85086,EFS,0,0
85087,.,0,1
85088,Effect,0,0
85089,of,0,0
85090,a,0,1
85091,nutrition,0,0
85092,intervention,0,0
85093,during,0,0
85094,early,0,1
85095,childhood,0,1
85096,on,0,0
85097,economic,0,0
85098,productivity,0,0
85099,in,0,1
85100,Guatemalan,1,1
85101,adults,1,1
85102,.,1,1
85103,BACKGROUND,0,0
85104,Substantial,0,0
85105,",",0,0
85106,but,0,0
85107,indirect,0,0
85108,",",0,0
85109,evidence,0,0
85110,suggests,0,0
85111,that,0,0
85112,improving,0,0
85113,nutrition,0,1
85114,in,0,1
85115,early,0,1
85116,childhood,0,1
85117,in,0,1
85118,developing,0,1
85119,countries,0,1
85120,is,0,0
85121,a,0,0
85122,long-term,0,0
85123,economic,0,0
85124,investment,0,0
85125,.,0,1
85126,We,0,0
85127,investigated,0,0
85128,the,0,0
85129,direct,0,0
85130,effect,0,0
85131,of,0,0
85132,a,0,0
85133,nutrition,0,0
85134,intervention,0,0
85135,in,0,0
85136,early,0,1
85137,childhood,0,1
85138,on,0,0
85139,adult,0,1
85140,economic,0,0
85141,productivity,0,0
85142,.,0,1
85143,METHODS,0,0
85144,We,0,0
85145,obtained,0,0
85146,economic,0,0
85147,data,0,0
85148,from,0,1
85149,1424,1,1
85150,Guatemalan,1,1
85151,individuals,1,1
85152,(,1,1
85153,aged,1,1
85154,25-42,1,1
85155,years,1,1
85156,),1,1
85157,between,1,1
85158,2002,1,1
85159,and,1,1
85160,2004,1,1
85161,.,1,1
85162,They,0,0
85163,accounted,1,0
85164,for,1,0
85165,60,1,1
85166,%,1,0
85167,of,1,0
85168,the,1,1
85169,2392,1,1
85170,children,1,1
85171,(,1,1
85172,aged,1,1
85173,0-7,1,1
85174,years,1,1
85175,),1,1
85176,who,1,1
85177,had,1,1
85178,been,1,1
85179,enrolled,1,1
85180,in,1,0
85181,a,1,0
85182,nutrition,1,1
85183,intervention,1,0
85184,study,1,1
85185,during,1,0
85186,1969-77,1,1
85187,.,1,1
85188,In,0,0
85189,this,0,0
85190,initial,0,0
85191,study,0,0
85192,",",0,1
85193,two,0,0
85194,villages,0,1
85195,were,0,1
85196,randomly,0,1
85197,assigned,0,1
85198,a,0,0
85199,nutritious,0,1
85200,supplement,0,0
85201,(,0,1
85202,atole,0,1
85203,),0,1
85204,for,0,0
85205,all,0,1
85206,children,0,1
85207,and,0,1
85208,two,0,1
85209,villages,0,1
85210,a,0,0
85211,less,0,0
85212,nutritious,0,0
85213,one,0,0
85214,(,0,1
85215,fresco,0,1
85216,),0,1
85217,.,0,1
85218,We,0,0
85219,estimated,0,0
85220,annual,0,0
85221,income,0,0
85222,",",0,1
85223,hours,0,0
85224,worked,0,1
85225,",",0,1
85226,and,0,0
85227,average,0,1
85228,hourly,0,1
85229,wages,0,1
85230,from,0,1
85231,all,0,1
85232,economic,0,0
85233,activities,0,0
85234,.,0,1
85235,We,0,0
85236,used,0,0
85237,linear,0,0
85238,regression,0,0
85239,models,0,0
85240,",",0,0
85241,adjusting,0,0
85242,for,0,0
85243,potentially,0,0
85244,confounding,0,0
85245,factors,0,0
85246,",",0,1
85247,to,0,0
85248,assess,0,0
85249,the,0,0
85250,relation,0,0
85251,between,0,0
85252,economic,0,0
85253,variables,0,0
85254,and,0,1
85255,exposure,0,0
85256,to,0,0
85257,atole,0,1
85258,or,0,0
85259,fresco,0,1
85260,at,0,1
85261,specific,0,0
85262,ages,0,1
85263,between,0,0
85264,birth,0,1
85265,and,0,1
85266,7,0,1
85267,years,0,1
85268,.,0,1
85269,FINDINGS,0,0
85270,Exposure,0,0
85271,to,0,0
85272,atole,0,1
85273,before,0,0
85274,",",0,0
85275,but,0,0
85276,not,0,0
85277,after,0,0
85278,",",0,0
85279,age,0,1
85280,3,0,1
85281,years,0,1
85282,was,0,0
85283,associated,0,0
85284,with,0,1
85285,higher,0,0
85286,hourly,0,1
85287,wages,0,0
85288,",",0,0
85289,but,0,0
85290,only,0,0
85291,for,0,0
85292,men,0,1
85293,.,0,1
85294,For,0,1
85295,exposure,0,0
85296,to,0,0
85297,atole,0,1
85298,from,0,1
85299,0,0,0
85300,to,0,1
85301,2,0,1
85302,years,0,1
85303,",",0,1
85304,the,0,0
85305,increase,0,0
85306,was,0,0
85307,US,0,0
85308,$,0,1
85309,0.67,0,0
85310,per,0,1
85311,hour,0,0
85312,(,0,1
85313,95,0,0
85314,%,0,0
85315,CI,0,0
85316,0.16-1.17,0,0
85317,),0,1
85318,",",0,0
85319,which,0,0
85320,meant,0,0
85321,a,0,1
85322,46,0,1
85323,%,0,0
85324,increase,0,0
85325,in,0,1
85326,average,0,1
85327,wages,0,1
85328,.,0,1
85329,There,0,0
85330,was,0,0
85331,a,0,0
85332,non-significant,0,0
85333,tendency,0,0
85334,for,0,1
85335,hours,0,0
85336,worked,0,1
85337,to,0,1
85338,be,0,0
85339,reduced,0,0
85340,and,0,0
85341,for,0,1
85342,annual,0,1
85343,incomes,0,1
85344,to,0,1
85345,be,0,0
85346,greater,0,0
85347,for,0,0
85348,those,0,0
85349,exposed,0,0
85350,to,0,0
85351,atole,0,1
85352,from,0,1
85353,0,0,0
85354,to,0,1
85355,2,0,1
85356,years,0,1
85357,.,0,1
85358,INTERPRETATION,0,0
85359,Improving,0,0
85360,nutrition,0,1
85361,in,0,1
85362,early,0,1
85363,childhood,0,1
85364,led,0,0
85365,to,0,1
85366,substantial,0,0
85367,increases,0,0
85368,in,0,1
85369,wage,0,1
85370,rates,0,0
85371,for,0,1
85372,men,0,1
85373,",",0,0
85374,which,0,0
85375,suggests,0,0
85376,that,0,0
85377,investments,0,0
85378,in,0,1
85379,early,0,1
85380,childhood,0,1
85381,nutrition,0,1
85382,can,0,0
85383,be,0,0
85384,long-term,0,0
85385,drivers,0,1
85386,of,0,1
85387,economic,0,0
85388,growth,0,1
85389,.,0,1
85390,The,0,0
85391,impact,0,0
85392,of,0,0
85393,fasting,0,0
85394,and,0,1
85395,treatment,0,0
85396,omission,0,0
85397,on,0,0
85398,susceptibility,0,0
85399,to,0,0
85400,hypoglycaemia,0,1
85401,in,0,0
85402,children,1,1
85403,and,1,1
85404,adolescents,1,1
85405,with,1,1
85406,GH,1,0
85407,and,1,1
85408,cortisol,1,0
85409,insufficiency,1,1
85410,.,1,1
85411,OBJECTIVE,0,0
85412,Hypoglycaemia,0,0
85413,may,0,0
85414,be,0,0
85415,a,0,0
85416,frequent,0,0
85417,occurrence,0,0
85418,in,0,1
85419,young,1,1
85420,GH,1,0
85421,deficient,1,1
85422,patients,1,1
85423,and,0,1
85424,so,0,1
85425,we,0,0
85426,studied,0,0
85427,the,0,0
85428,response,0,0
85429,to,0,0
85430,fasting,0,0
85431,in,0,1
85432,children,1,1
85433,and,1,1
85434,adolescents,1,1
85435,with,1,1
85436,GH,1,0
85437,and/or,1,1
85438,cortisol,1,0
85439,deficiency,1,1
85440,.,1,1
85441,METHODS,0,0
85442,A,1,0
85443,total,1,1
85444,of,1,1
85445,20,1,1
85446,patients,1,1
85447,(,1,1
85448,2-18,1,1
85449,years,1,1
85450,),1,1
85451,fasted,1,1
85452,for,1,0
85453,14,1,1
85454,h,1,0
85455,(,1,1
85456,22.00-12.00,1,0
85457,h,1,0
85458,),1,1
85459,on,1,0
85460,two,1,1
85461,occasions,1,1
85462,as,0,0
85463,part,0,1
85464,of,0,0
85465,a,0,1
85466,randomized,0,1
85467,cross-over,0,0
85468,study,0,1
85469,.,0,1
85470,Fourteen,1,1
85471,had,1,1
85472,pituitary,1,1
85473,hormone,1,1
85474,deficiency,1,1
85475,(,1,1
85476,PHD,1,1
85477,),1,1
85478,including,1,1
85479,GH,1,0
85480,deficiency,1,1
85481,(,1,1
85482,GHD,1,0
85483,),1,1
85484,.,1,1
85485,Of,1,0
85486,the,1,0
85487,14,1,1
85488,patients,1,1
85489,",",1,1
85490,seven,1,1
85491,were,1,1
85492,ACTH,1,1
85493,sufficient,1,0
85494,(,1,1
85495,PHDC+,1,1
85496,),1,1
85497,and,1,1
85498,seven,1,1
85499,ACTH,1,1
85500,deficient,1,1
85501,(,1,1
85502,PHDC-,1,1
85503,),1,1
85504,.,1,1
85505,Six,1,0
85506,had,1,1
85507,primary,1,1
85508,adrenal,1,1
85509,failure,1,1
85510,(,1,1
85511,PAF,1,1
85512,),1,1
85513,.,1,1
85514,Subjects,0,1
85515,administered,0,0
85516,or,0,1
85517,omitted,0,0
85518,their,0,1
85519,normal,0,1
85520,dose,0,0
85521,of,0,0
85522,evening,0,0
85523,GH,0,0
85524,and/or,0,1
85525,morning,0,0
85526,hydrocortisone,0,1
85527,.,0,1
85528,Glucose,0,0
85529,",",0,0
85530,insulin,0,0
85531,",",0,0
85532,GH,0,0
85533,",",0,0
85534,cortisol,0,0
85535,",",0,0
85536,ketones,0,0
85537,and,0,1
85538,catecholamines,0,1
85539,were,0,1
85540,measured,0,0
85541,at,0,1
85542,04.00,0,0
85543,h,0,0
85544,and,0,0
85545,regularly,0,1
85546,from,0,1
85547,07.00,0,0
85548,to,0,1
85549,12.00,0,0
85550,h.,0,1
85551,Insulin,0,1
85552,sensitivity,0,0
85553,was,0,0
85554,assessed,0,0
85555,by,0,0
85556,HOMA,0,1
85557,and,0,1
85558,hypoglycaemia,0,1
85559,defined,0,0
85560,as,0,0
85561,a,0,0
85562,blood,0,0
85563,glucose,0,0
85564,(,0,1
85565,BG,0,1
85566,),0,1
85567,<,0,0
85568,/=,0,1
85569,3.3,0,1
85570,mmol/l,0,0
85571,.,0,1
85572,RESULTS,0,0
85573,BG,0,1
85574,was,0,0
85575,related,0,0
85576,to,0,0
85577,age,0,1
85578,and,0,0
85579,body,0,1
85580,mass,0,1
85581,index,0,0
85582,on,0,0
85583,treatment,0,0
85584,but,0,0
85585,no,0,0
85586,subject,0,0
85587,became,0,0
85588,hypoglycaemic,0,0
85589,on,0,0
85590,or,0,1
85591,off,0,0
85592,therapy,0,0
85593,prior,0,1
85594,to,0,0
85595,07.00,0,0
85596,h.,0,1
85597,Five,0,1
85598,children,0,1
85599,(,0,1
85600,aged,0,1
85601,3,0,1
85602,",",0,1
85603,4,0,0
85604,",",0,0
85605,7,0,1
85606,",",0,1
85607,8,0,1
85608,and,0,1
85609,11,0,1
85610,years,0,1
85611,),0,1
85612,were,0,1
85613,hypoglycaemic,0,1
85614,between,0,0
85615,07.00,0,0
85616,and,0,1
85617,12.00,0,0
85618,h,0,0
85619,off,0,0
85620,treatment,0,0
85621,.,0,0
85622,There,0,0
85623,was,0,0
85624,a,0,0
85625,positive,0,0
85626,relationship,0,0
85627,between,0,0
85628,GH,0,0
85629,AUC,0,0
85630,and,0,1
85631,minimum,0,0
85632,BG,0,1
85633,in,0,1
85634,patients,0,1
85635,with,0,1
85636,PHD,0,1
85637,on,0,0
85638,treatment,0,0
85639,(,0,1
85640,r,0,0
85641,(,0,1
85642,2,0,1
85643,),0,1
85644,=,0,1
85645,0.45,0,0
85646,",",0,1
85647,P,0,0
85648,=,0,1
85649,0.012,0,0
85650,),0,1
85651,with,0,1
85652,increased,0,0
85653,insulin,0,0
85654,sensitivity,0,0
85655,off,0,0
85656,treatment,0,1
85657,.,0,1
85658,Increased,0,0
85659,cortisol,0,0
85660,levels,0,0
85661,were,0,1
85662,seen,0,1
85663,in,0,1
85664,PHDC+,0,1
85665,patients,0,1
85666,off,0,0
85667,GH,0,0
85668,(,0,1
85669,P,0,0
85670,<,0,0
85671,0.001,0,0
85672,),0,1
85673,.,0,1
85674,A,0,0
85675,negative,0,0
85676,relationship,0,0
85677,was,0,0
85678,observed,0,0
85679,between,0,0
85680,minimum,0,0
85681,BG,0,1
85682,and,0,1
85683,adrenaline,0,0
85684,(,0,1
85685,r,0,0
85686,(,0,1
85687,2,0,1
85688,),0,1
85689,=,0,1
85690,0.37,0,0
85691,",",0,1
85692,P,0,0
85693,=,0,1
85694,0.01,0,0
85695,),0,1
85696,",",0,1
85697,ketone,0,0
85698,bodies,0,1
85699,(,0,1
85700,r,0,0
85701,(,0,1
85702,2,0,1
85703,),0,1
85704,=,0,0
85705,-0.20,0,0
85706,",",0,0
85707,P,0,0
85708,=,0,1
85709,0.05,0,0
85710,),0,1
85711,and,0,1
85712,NEFA,0,1
85713,(,0,1
85714,r,0,0
85715,(,0,1
85716,2,0,1
85717,),0,1
85718,=,0,0
85719,-0.35,0,0
85720,",",0,0
85721,P,0,0
85722,=,0,1
85723,0.02,0,0
85724,),0,1
85725,.,0,1
85726,Noradrenaline,0,0
85727,levels,0,0
85728,were,0,1
85729,reduced,0,0
85730,in,0,0
85731,patients,1,1
85732,with,1,1
85733,PHDC-,1,1
85734,.,1,1
85735,Low,0,1
85736,BMI,0,0
85737,(,0,1
85738,on,0,0
85739,treatment,0,1
85740,),0,1
85741,and,0,0
85742,young,0,1
85743,age,0,1
85744,(,0,1
85745,off,0,0
85746,treatment,0,1
85747,),0,1
85748,were,0,1
85749,determinants,0,0
85750,of,0,1
85751,low,0,1
85752,BG,0,1
85753,levels,0,0
85754,in,0,1
85755,a,0,1
85756,multiple,0,1
85757,regression,0,0
85758,model,0,0
85759,.,0,1
85760,CONCLUSIONS,0,0
85761,Unrecognized,0,0
85762,overnight,0,0
85763,hypoglycaemia,0,1
85764,in,0,1
85765,children,1,1
85766,and,1,1
85767,adolescents,1,1
85768,on,0,0
85769,pituitary,0,1
85770,hormone,0,1
85771,replacement,0,0
85772,is,0,0
85773,uncommon,0,0
85774,but,0,0
85775,BG,0,1
85776,levels,0,0
85777,quickly,0,0
85778,become,0,0
85779,abnormal,0,0
85780,when,0,0
85781,treatment,0,1
85782,and,0,0
85783,meals,0,1
85784,are,0,0
85785,omitted,0,0
85786,.,0,1
85787,The,0,0
85788,insulin,0,0
85789,antagonistic,0,0
85790,actions,0,0
85791,of,0,1
85792,GH,0,0
85793,are,0,0
85794,important,0,0
85795,in,0,0
85796,preventing,0,0
85797,hypoglycaemia,0,1
85798,.,0,1
85799,Patients,1,1
85800,with,1,1
85801,PHD,1,1
85802,have,0,0
85803,altered,0,1
85804,sympathetic,0,0
85805,nerve,0,0
85806,activity,0,0
85807,.,0,1
85808,[,0,1
85809,Effects,0,0
85810,of,0,1
85811,early,0,1
85812,acupuncture,0,1
85813,on,0,0
85814,motor,0,0
85815,function,0,0
85816,of,0,0
85817,the,0,0
85818,limb,0,0
85819,in,0,0
85820,the,0,0
85821,severe,1,1
85822,head,1,1
85823,injury,1,1
85824,patients,1,1
85825,],1,1
85826,.,0,1
85827,UNLABELLED,0,0
85828,OBJECTIVE,0,0
85829,;,0,0
85830,To,0,0
85831,observe,0,0
85832,the,0,0
85833,effects,0,0
85834,of,0,0
85835,early,0,1
85836,acupuncture,0,1
85837,on,0,0
85838,motor,0,0
85839,function,0,0
85840,of,0,0
85841,the,0,0
85842,limb,0,0
85843,in,0,0
85844,the,0,0
85845,severe,1,1
85846,head,1,1
85847,injury,1,1
85848,patients,1,1
85849,.,1,1
85850,METHODS,0,0
85851,Ninety-six,1,1
85852,patients,1,1
85853,were,0,1
85854,randomly,0,1
85855,divided,0,0
85856,into,0,0
85857,an,0,0
85858,observation,0,0
85859,group,0,0
85860,and,0,0
85861,a,0,0
85862,control,0,0
85863,group,0,0
85864,",",0,1
85865,48,1,1
85866,cases,1,1
85867,in,1,1
85868,each,1,1
85869,group,1,1
85870,.,1,0
85871,The,0,0
85872,patient,0,0
85873,in,0,0
85874,the,0,0
85875,control,0,1
85876,group,0,0
85877,were,0,0
85878,treated,0,1
85879,by,0,0
85880,routine,0,1
85881,treatment,0,1
85882,of,0,0
85883,neurosurgical,0,1
85884,operation,0,1
85885,and,0,0
85886,drug,0,0
85887,treatment,0,0
85888,(,0,1
85889,Mannitol,0,0
85890,",",0,1
85891,Citioline,0,0
85892,Sodium,0,0
85893,",",0,0
85894,Cefeazidime,0,0
85895,",",0,0
85896,etc.,0,0
85897,),0,1
85898,.,0,1
85899,While,0,0
85900,the,0,0
85901,patient,0,0
85902,in,0,0
85903,the,0,0
85904,observation,0,0
85905,group,0,0
85906,were,0,0
85907,treated,0,1
85908,by,0,0
85909,the,0,0
85910,routine,0,1
85911,treatment,0,0
85912,and,0,0
85913,acupuncture,0,1
85914,treatment,0,0
85915,48,0,1
85916,h,0,0
85917,(,0,1
85918,-1,0,0
85919,),0,1
85920,week,0,0
85921,after,0,0
85922,operation,0,1
85923,in,0,1
85924,different,0,1
85925,stages,0,1
85926,with,0,1
85927,different,0,1
85928,acupoints,0,0
85929,selected,0,1
85930,when,0,0
85931,the,0,0
85932,situation,0,0
85933,was,0,0
85934,stable,0,1
85935,.,0,1
85936,The,0,0
85937,selected,0,1
85938,main,0,0
85939,points,0,0
85940,were,0,1
85941,Neiguan,0,0
85942,(,0,1
85943,PC,0,1
85944,6,0,1
85945,),0,1
85946,",",0,1
85947,Qu-chi,0,1
85948,(,0,1
85949,LI,0,1
85950,11,0,1
85951,),0,1
85952,",",0,1
85953,Waiguan,0,1
85954,(,0,1
85955,TE,0,1
85956,5,0,1
85957,),0,1
85958,",",0,1
85959,Hegu,0,1
85960,(,0,1
85961,LI,0,1
85962,4,0,1
85963,),0,1
85964,",",0,1
85965,Binao,0,1
85966,(,0,1
85967,LI,0,1
85968,14,0,1
85969,),0,1
85970,",",0,1
85971,Jianyu,0,1
85972,(,0,1
85973,LI,0,1
85974,15,0,1
85975,),0,1
85976,",",0,1
85977,Fengshi,0,1
85978,(,0,1
85979,GB,0,0
85980,31,0,1
85981,),0,1
85982,",",0,1
85983,Xuehai,0,1
85984,(,0,1
85985,SP,0,1
85986,10,0,1
85987,),0,1
85988,",",0,1
85989,Yinlingquan,0,1
85990,(,0,1
85991,SP,0,1
85992,9,0,1
85993,),0,1
85994,",",0,1
85995,Sanyinjiao,0,0
85996,(,0,1
85997,SP,0,1
85998,6,0,1
85999,),0,1
86000,",",0,1
86001,Taichong,0,0
86002,(,0,1
86003,LR,0,0
86004,3,0,1
86005,),0,0
86006,",",0,0
86007,etc..,0,0
86008,The,0,0
86009,limb,0,0
86010,motor,0,0
86011,function,0,0
86012,was,0,0
86013,evaluated,0,0
86014,with,0,1
86015,Fugl-Meyer,0,1
86016,Assessment,0,0
86017,(,0,1
86018,FMA,0,1
86019,),0,1
86020,scale,0,0
86021,before,0,0
86022,treatment,0,0
86023,and,0,1
86024,after,0,0
86025,10-week,0,1
86026,treatment,0,1
86027,.,0,1
86028,RESULTS,0,0
86029,There,0,0
86030,was,0,0
86031,a,0,0
86032,significant,0,0
86033,improvement,0,0
86034,in,0,0
86035,the,0,0
86036,FMA,0,0
86037,score,0,0
86038,in,0,0
86039,the,0,1
86040,two,0,0
86041,groups,0,0
86042,after,0,1
86043,the,0,0
86044,treatment,0,0
86045,(,0,0
86046,P,0,0
86047,<,0,0
86048,0.01,0,0
86049,),0,1
86050,.,0,1
86051,The,0,0
86052,comparison,0,0
86053,between,0,0
86054,the,0,1
86055,two,0,0
86056,groups,0,0
86057,after,0,1
86058,the,0,0
86059,treatment,0,0
86060,showed,0,0
86061,that,0,0
86062,the,0,0
86063,improvement,0,0
86064,of,0,0
86065,FMA,0,1
86066,score,0,0
86067,in,0,0
86068,the,0,0
86069,observation,0,0
86070,group,0,0
86071,was,0,0
86072,significantly,0,0
86073,better,0,0
86074,than,0,0
86075,the,0,0
86076,control,0,1
86077,group,0,0
86078,(,0,0
86079,P,0,0
86080,<,0,0
86081,0.05,0,0
86082,or,0,1
86083,P,0,0
86084,<,0,0
86085,0.01,0,0
86086,),0,1
86087,.,0,1
86088,CONCLUSION,0,0
86089,Early,0,0
86090,acupuncture,0,0
86091,can,0,0
86092,improve,0,0
86093,the,0,0
86094,limb,0,0
86095,motor,0,0
86096,function,0,0
86097,in,0,0
86098,the,0,0
86099,severe,1,1
86100,head,1,1
86101,injury,1,1
86102,patients,1,1
86103,.,1,1
86104,Microtensile,0,0
86105,bond,0,0
86106,strength,0,0
86107,of,0,0
86108,a,0,1
86109,repair,0,1
86110,composite,0,0
86111,to,0,1
86112,leucite-reinforced,0,0
86113,feldspathic,0,1
86114,ceramic,0,1
86115,.,0,1
86116,The,0,0
86117,purpose,0,0
86118,of,0,0
86119,this,0,0
86120,study,0,0
86121,was,0,0
86122,to,0,0
86123,evaluate,0,0
86124,the,0,0
86125,microtensile,0,0
86126,bond,0,0
86127,strength,0,0
86128,of,0,0
86129,a,0,1
86130,repair,0,1
86131,composite,0,0
86132,resin,0,1
86133,to,0,1
86134,a,0,1
86135,leucite-reinforced,0,0
86136,feldspathic,0,1
86137,ceramic,0,1
86138,(,0,1
86139,Omega,0,1
86140,900,0,1
86141,",",0,1
86142,VITA,0,1
86143,),0,1
86144,submitted,0,1
86145,to,0,1
86146,two,0,1
86147,surface,0,1
86148,conditionings,0,1
86149,methods,0,1
86150,:,0,1
86151,1,0,1
86152,),0,1
86153,etching,0,0
86154,with,0,1
86155,hydrofluoric,0,1
86156,acid,0,0
86157,+,0,0
86158,silane,0,1
86159,application,0,0
86160,or,0,1
86161,2,0,1
86162,),0,1
86163,tribochemical,0,0
86164,silica,0,1
86165,coating,0,1
86166,.,0,1
86167,The,0,0
86168,null,0,0
86169,hypothesis,0,0
86170,is,0,0
86171,that,0,0
86172,both,0,0
86173,surface,0,0
86174,treatments,0,0
86175,can,0,0
86176,generate,0,0
86177,similar,0,0
86178,bond,0,0
86179,strengths,0,0
86180,.,0,1
86181,Ten,1,1
86182,ceramic,1,1
86183,blocks,1,1
86184,(,1,1
86185,6x6x6,1,0
86186,mm,1,1
86187,),1,1
86188,were,1,1
86189,fabricated,1,0
86190,and,1,0
86191,randomly,1,1
86192,assigned,1,1
86193,to,1,1
86194,2,1,1
86195,groups,1,1
86196,(,1,1
86197,n=5,1,1
86198,),1,1
86199,",",1,0
86200,according,1,0
86201,to,1,0
86202,the,1,0
86203,conditioning,1,0
86204,method,1,0
86205,:,1,1
86206,G1-,1,1
86207,10,1,1
86208,%,1,0
86209,hydrofluoric,1,1
86210,acid,1,0
86211,application,1,0
86212,for,1,0
86213,2,1,1
86214,min,1,0
86215,plus,1,0
86216,rinsing,1,0
86217,and,1,0
86218,drying,1,0
86219,",",1,0
86220,followed,1,0
86221,by,1,0
86222,silane,1,1
86223,application,1,0
86224,for,1,1
86225,30,1,1
86226,s,1,1
86227,;,1,1
86228,G2-,1,1
86229,airborne,0,1
86230,particle,0,1
86231,abrasion,0,0
86232,with,0,1
86233,30,0,1
86234,microm,0,0
86235,silica,0,1
86236,oxide,0,1
86237,particles,0,1
86238,(,0,1
86239,CoJet-Sand,0,1
86240,),0,1
86241,for,0,1
86242,20,0,1
86243,s,0,1
86244,using,0,1
86245,a,0,1
86246,chairside,0,0
86247,air-abrasion,0,0
86248,device,0,0
86249,(,0,1
86250,CoJet,0,1
86251,System,0,1
86252,),0,1
86253,",",0,0
86254,followed,0,0
86255,by,0,0
86256,silane,0,1
86257,application,0,0
86258,for,0,0
86259,5,0,1
86260,min,0,0
86261,.,0,1
86262,Single,0,0
86263,Bond,0,1
86264,adhesive,0,0
86265,system,0,1
86266,was,0,0
86267,applied,0,0
86268,to,0,1
86269,the,0,0
86270,surfaces,0,0
86271,and,0,1
86272,light,0,0
86273,cured,0,1
86274,(,0,1
86275,40,0,1
86276,s,0,1
86277,),0,1
86278,.,0,1
86279,Z-250,0,0
86280,composite,0,0
86281,resin,0,1
86282,was,0,0
86283,placed,0,0
86284,incrementally,0,0
86285,on,0,0
86286,the,0,0
86287,treated,0,1
86288,ceramic,0,1
86289,surface,0,0
86290,to,0,0
86291,build,0,0
86292,a,0,0
86293,6x6x6,0,0
86294,mm,0,1
86295,block,0,1
86296,.,0,1
86297,Bar,0,0
86298,specimens,0,1
86299,with,0,1
86300,an,0,0
86301,adhesive,0,0
86302,area,0,0
86303,of,0,0
86304,approximately,0,1
86305,1,0,1
86306,+/-,0,0
86307,0.1,0,1
86308,mm,0,1
86309,(,0,1
86310,2,0,1
86311,),0,1
86312,were,0,1
86313,obtained,0,0
86314,from,0,1
86315,the,0,0
86316,composite-ceramic,0,1
86317,blocks,0,0
86318,(,0,1
86319,6,0,1
86320,per,0,1
86321,block,0,1
86322,and,0,1
86323,30,0,1
86324,per,0,1
86325,group,0,1
86326,),0,1
86327,for,0,0
86328,microtensile,0,0
86329,testing,0,0
86330,.,0,0
86331,No,0,0
86332,statistically,0,0
86333,significant,0,0
86334,difference,0,0
86335,was,0,0
86336,observed,0,0
86337,between,0,0
86338,G1,0,1
86339,(,0,1
86340,10.19,0,0
86341,+/-,0,1
86342,3.1,0,1
86343,MPa,0,1
86344,),0,1
86345,and,0,1
86346,G2,0,0
86347,(,0,1
86348,10.17,0,0
86349,+/-,0,1
86350,3.1,0,1
86351,MPa,0,1
86352,),0,1
86353,(,0,1
86354,p=0.982,0,0
86355,),0,1
86356,(,0,1
86357,Student,0,0
86358,'s,0,1
86359,t,0,0
86360,test,0,1
86361,;,0,1
86362,?,0,1
86363,=,0,0
86364,0.05,0,0
86365,),0,1
86366,.,0,1
86367,The,0,0
86368,null,0,0
86369,hypothesis,0,0
86370,was,0,0
86371,",",0,0
86372,therefore,0,0
86373,",",0,0
86374,accepted,0,0
86375,.,0,1
86376,In,0,0
86377,conclusion,0,0
86378,",",0,0
86379,both,0,0
86380,surface,0,0
86381,conditioning,0,0
86382,methods,0,1
86383,provided,0,0
86384,similar,0,0
86385,microtensile,0,0
86386,bond,0,0
86387,strengths,0,0
86388,between,0,0
86389,the,0,0
86390,repair,0,1
86391,composite,0,0
86392,resin,0,1
86393,and,0,0
86394,the,0,0
86395,ceramic,0,1
86396,.,0,1
86397,Further,0,0
86398,studies,0,0
86399,using,0,1
86400,long-term,0,1
86401,aging,0,1
86402,procedures,0,1
86403,should,0,0
86404,be,0,0
86405,conducted,0,0
86406,.,0,1
86407,Prognosis,0,1
86408,of,0,0
86409,advanced,1,1
86410,hepatocellular,1,1
86411,carcinoma,1,1
86412,:,1,1
86413,comparison,0,0
86414,of,0,0
86415,three,0,1
86416,staging,0,1
86417,systems,0,0
86418,in,0,1
86419,two,0,1
86420,French,1,1
86421,clinical,1,1
86422,trials,1,1
86423,.,1,1
86424,OBJECTIVE,0,0
86425,The,0,0
86426,objective,0,0
86427,of,0,0
86428,this,0,0
86429,study,0,0
86430,was,0,0
86431,to,0,0
86432,assess,0,0
86433,the,0,0
86434,performance,0,0
86435,of,0,0
86436,three,0,1
86437,staging,0,1
86438,systems,0,0
86439,[,0,1
86440,Okuda,0,0
86441,",",0,0
86442,Cancer,1,1
86443,of,1,0
86444,the,1,0
86445,Liver,1,1
86446,Italian,1,1
86447,Program,1,1
86448,(,1,1
86449,CLIP,1,1
86450,),1,1
86451,and,0,1
86452,Barcelona,1,1
86453,Clinic,1,1
86454,Liver,1,1
86455,Cancer,1,1
86456,group,1,1
86457,(,1,1
86458,BCLC,1,0
86459,),1,1
86460,],1,1
86461,",",0,0
86462,for,0,0
86463,predicting,0,0
86464,survival,0,0
86465,in,0,1
86466,patients,1,1
86467,with,1,1
86468,hepatocellular,1,1
86469,carcinoma,1,1
86470,(,1,1
86471,HCC,1,0
86472,),1,1
86473,and,0,0
86474,to,0,0
86475,explore,0,0
86476,how,0,0
86477,to,0,0
86478,improve,0,0
86479,prognostic,0,0
86480,classification,0,1
86481,among,0,1
86482,French,1,1
86483,patients,1,1
86484,with,1,1
86485,HCC,1,1
86486,whose,1,1
86487,main,1,0
86488,etiology,1,1
86489,is,1,0
86490,alcoholic,1,1
86491,cirrhosis,1,1
86492,.,1,1
86493,METHODS,0,0
86494,We,1,0
86495,have,1,0
86496,pooled,1,0
86497,two,1,0
86498,randomized,1,1
86499,clinical,1,1
86500,trials,1,1
86501,in,1,1
86502,palliative,1,1
86503,condition,1,0
86504,from,1,1
86505,the,1,0
86506,F?d?ration,1,0
86507,Francophone,1,1
86508,de,1,1
86509,Cancerologie,1,1
86510,Digestive,1,1
86511,.,1,1
86512,They,1,0
86513,had,1,1
86514,included,1,1
86515,416,1,1
86516,and,1,1
86517,122,1,1
86518,patients,1,1
86519,.,1,1
86520,Performances,0,0
86521,of,0,0
86522,Okuda,0,0
86523,",",0,1
86524,CLIP,0,1
86525,and,0,1
86526,BCLC,0,0
86527,scores,0,0
86528,have,0,1
86529,been,0,0
86530,compared,0,0
86531,using,0,0
86532,Akaike,0,1
86533,information,0,0
86534,criterion,0,1
86535,",",0,0
86536,discriminatory,0,0
86537,ability,0,0
86538,(,0,1
86539,Harrell,0,1
86540,'s,0,1
86541,C,0,0
86542,and,0,1
86543,the,0,0
86544,Royston,0,1
86545,'s,0,1
86546,D,0,1
86547,statistics,0,0
86548,),0,1
86549,",",0,0
86550,monotonicity,0,0
86551,of,0,0
86552,gradients,0,0
86553,and,0,1
86554,predictive,0,0
86555,accuracy,0,0
86556,(,0,1
86557,Schemper,0,1
86558,statistics,0,0
86559,Vs,0,1
86560,),0,1
86561,.,0,1
86562,To,0,0
86563,explore,0,0
86564,how,0,0
86565,to,0,0
86566,improve,0,0
86567,classifications,0,1
86568,",",0,1
86569,univariate,0,0
86570,and,0,1
86571,multivariate,0,0
86572,Cox,0,0
86573,model,0,1
86574,analyses,0,0
86575,were,0,1
86576,carried,0,0
86577,out,0,1
86578,.,0,0
86579,RESULTS,0,0
86580,The,0,0
86581,pooled,0,0
86582,database,0,1
86583,included,1,1
86584,538,1,1
86585,patients,1,1
86586,.,1,1
86587,The,0,0
86588,median,0,0
86589,survival,0,0
86590,was,0,0
86591,5.3,0,0
86592,months,0,1
86593,(,0,1
86594,95,0,0
86595,%,0,0
86596,confidence,0,0
86597,interval,0,0
86598,4.6-6.2,0,0
86599,),0,1
86600,.,0,1
86601,For,0,0
86602,all,0,0
86603,statistics,0,0
86604,CLIP,0,1
86605,staging,0,1
86606,system,0,0
86607,had,0,0
86608,a,0,0
86609,better,0,0
86610,prognostic,0,0
86611,ability,0,0
86612,.,0,1
86613,Performances,0,0
86614,of,0,0
86615,all,0,1
86616,staging,0,1
86617,systems,0,0
86618,were,0,1
86619,rather,0,0
86620,disappointing,0,0
86621,.,0,1
86622,World,0,1
86623,Health,0,0
86624,Organization,0,1
86625,performance,0,0
86626,status,0,1
86627,(,0,1
86628,WHO,0,1
86629,PS,0,1
86630,),0,1
86631,for,0,0
86632,CLIP,0,1
86633,or,0,1
86634,alpha-fetoprotein,0,0
86635,for,0,0
86636,BCLC,0,0
86637,allowed,0,0
86638,a,0,0
86639,significant,0,0
86640,improvement,0,0
86641,of,0,0
86642,prognostic,0,0
86643,information,0,1
86644,.,0,1
86645,CONCLUSION,0,0
86646,Our,0,0
86647,results,0,0
86648,indicate,0,0
86649,that,0,0
86650,CLIP,0,1
86651,staging,0,1
86652,seems,0,0
86653,to,0,0
86654,be,0,0
86655,most,0,0
86656,adapted,0,0
86657,to,0,0
86658,palliative,0,1
86659,setting,0,1
86660,and,0,0
86661,that,0,0
86662,it,0,0
86663,could,0,0
86664,be,0,0
86665,better,0,0
86666,by,0,0
86667,associating,0,0
86668,WHO,0,1
86669,PS,0,1
86670,.,0,1
86671,Closure,0,1
86672,of,0,0
86673,the,0,0
86674,femoral,0,1
86675,artery,0,1
86676,after,1,1
86677,cardiac,1,1
86678,catheterization,1,1
86679,:,1,1
86680,a,0,0
86681,comparison,0,0
86682,of,0,0
86683,Angio-Seal,0,0
86684,",",0,1
86685,StarClose,0,0
86686,",",0,0
86687,and,0,0
86688,manual,0,0
86689,compression,0,0
86690,.,0,1
86691,OBJECTIVES,0,0
86692,To,0,0
86693,compare,0,0
86694,Angio-Seal,0,0
86695,(,0,1
86696,AS,0,1
86697,),0,1
86698,and,0,1
86699,StarClose,0,0
86700,(,0,1
86701,SC,0,1
86702,),0,1
86703,and,0,1
86704,manual,0,0
86705,compression,0,0
86706,(,0,1
86707,MC,0,1
86708,),0,1
86709,on,0,0
86710,efficacy,0,0
86711,of,0,0
86712,hemostasis,0,0
86713,",",0,0
86714,complication,0,0
86715,rate,0,0
86716,",",0,0
86717,safety,0,0
86718,of,0,0
86719,early,0,1
86720,mobilization,0,0
86721,",",0,0
86722,and,0,0
86723,patient,0,1
86724,comfort,0,0
86725,.,0,1
86726,BACKGROUND,0,0
86727,Closure,0,0
86728,of,0,0
86729,the,0,0
86730,femoral,0,1
86731,artery,0,1
86732,after,0,1
86733,cardiac,0,1
86734,catheterization,0,1
86735,can,0,0
86736,be,0,0
86737,obtained,0,0
86738,through,0,1
86739,different,0,1
86740,methods,0,1
86741,.,0,1
86742,Today,0,0
86743,",",0,0
86744,physicians,0,1
86745,can,0,0
86746,choose,0,1
86747,from,0,0
86748,a,0,0
86749,number,0,0
86750,of,0,0
86751,different,0,1
86752,devices,0,0
86753,to,0,1
86754,achieve,0,0
86755,arterial,0,1
86756,closure,0,1
86757,.,0,1
86758,METHODS,0,0
86759,In,0,0
86760,a,0,1
86761,prospective,0,1
86762,trial,0,1
86763,450,1,1
86764,patients,1,1
86765,were,0,1
86766,randomized,0,1
86767,to,0,0
86768,AS,0,1
86769,",",0,0
86770,SC,0,1
86771,",",0,0
86772,or,0,1
86773,MC,0,1
86774,.,0,1
86775,Patients,0,1
86776,were,0,1
86777,mobilized,0,1
86778,1,0,1
86779,to,0,1
86780,2,0,1
86781,hr,0,0
86782,after,0,0
86783,device,0,0
86784,placement,0,0
86785,",",0,0
86786,and,0,0
86787,6,0,0
86788,hr,0,0
86789,after,0,1
86790,MC,0,1
86791,.,0,1
86792,Data,0,0
86793,were,0,0
86794,collected,0,1
86795,during,0,0
86796,hospital,0,1
86797,admission,0,1
86798,and,0,0
86799,by,0,0
86800,telephone,0,1
86801,at,0,1
86802,one,0,1
86803,month,0,0
86804,after,0,1
86805,hospital,0,1
86806,discharge,0,1
86807,.,0,1
86808,RESULTS,0,0
86809,Devices,0,1
86810,were,0,1
86811,used,0,0
86812,in,0,1
86813,138/150,0,1
86814,allocated,0,1
86815,to,0,1
86816,AS,0,1
86817,and,0,1
86818,124/150,0,1
86819,allocated,0,1
86820,to,0,1
86821,SC,0,1
86822,patients,0,1
86823,(,0,1
86824,92,0,1
86825,%,0,0
86826,vs.,0,0
86827,83,0,1
86828,%,0,0
86829,",",0,1
86830,P,0,0
86831,=,0,1
86832,0.015,0,0
86833,),0,1
86834,Patients,0,1
86835,with,0,1
86836,MC,0,1
86837,experienced,0,1
86838,more,0,0
86839,pain,0,1
86840,during,0,0
86841,sheath,0,0
86842,removal,0,1
86843,than,0,0
86844,patients,0,1
86845,receiving,0,1
86846,a,0,1
86847,device,0,0
86848,",",0,0
86849,and,0,0
86850,rated,0,0
86851,their,0,0
86852,period,0,0
86853,of,0,0
86854,bed,0,0
86855,rest,0,0
86856,as,0,0
86857,less,0,0
86858,comfortable,0,0
86859,.,0,0
86860,Oozing,0,0
86861,and,0,0
86862,need,0,0
86863,for,0,0
86864,pressure,0,0
86865,bandage,0,0
86866,at,0,0
86867,the,0,0
86868,puncture,0,0
86869,site,0,0
86870,were,0,0
86871,observed,0,0
86872,in,0,0
86873,37,0,1
86874,AS,0,1
86875,patients,0,1
86876,and,0,1
86877,57,0,1
86878,SC,0,1
86879,patients,0,1
86880,(,0,1
86881,25,0,1
86882,%,0,0
86883,vs.,0,0
86884,38,0,1
86885,%,0,0
86886,",",0,1
86887,P,0,0
86888,=,0,1
86889,0.002,0,0
86890,),0,1
86891,.,0,1
86892,Hematoma,0,0
86893,occurred,0,0
86894,in,0,0
86895,15,0,1
86896,AS,0,1
86897,patients,0,1
86898,",",0,1
86899,in,0,1
86900,17,0,1
86901,SC,0,1
86902,patients,0,1
86903,",",0,1
86904,and,0,1
86905,in,0,0
86906,14,0,1
86907,MC,0,1
86908,patients,0,1
86909,(,0,1
86910,11,0,1
86911,vs.,0,0
86912,14,0,1
86913,vs.,0,0
86914,9,0,0
86915,%,0,0
86916,",",0,0
86917,ns,0,0
86918,),0,1
86919,.,0,0
86920,CONCLUSION,0,0
86921,There,0,0
86922,is,0,0
86923,no,0,0
86924,difference,0,0
86925,in,0,0
86926,safety,0,0
86927,between,0,0
86928,the,0,1
86929,three,0,0
86930,methods,0,1
86931,of,0,1
86932,arterial,0,1
86933,closure,0,1
86934,.,0,1
86935,SC,0,0
86936,was,0,0
86937,more,0,0
86938,often,0,0
86939,not,0,0
86940,used,0,0
86941,or,0,0
86942,successfully,0,0
86943,deployed,0,0
86944,.,0,1
86945,SC,0,0
86946,patients,0,1
86947,more,0,0
86948,often,0,0
86949,had,0,0
86950,continuing,0,0
86951,oozing,0,0
86952,.,0,1
86953,On,0,0
86954,patient,0,0
86955,comfort,0,0
86956,",",0,1
86957,closure,0,1
86958,devices,0,0
86959,performed,0,0
86960,better,0,0
86961,than,0,0
86962,MC,0,1
86963,.,0,1
86964,Early,0,0
86965,ambulation,0,0
86966,in,0,1
86967,patients,0,1
86968,with,0,1
86969,a,0,1
86970,closure,0,0
86971,device,0,0
86972,is,0,0
86973,safe,0,0
86974,.,0,0
86975,AS,0,0
86976,is,0,0
86977,the,0,0
86978,preferred,0,0
86979,method,0,0
86980,of,0,0
86981,arterial,0,1
86982,closure,0,1
86983,after,0,1
86984,cardiac,0,1
86985,catheterization,0,1
86986,.,0,1
86987,Effect,0,0
86988,of,0,0
86989,finasteride,0,1
86990,treatment,0,1
86991,on,0,0
86992,suburethral,0,0
86993,prostatic,0,1
86994,microvessel,0,0
86995,density,0,0
86996,in,0,0
86997,patients,1,1
86998,with,1,1
86999,hematuria,1,1
87000,related,1,0
87001,to,1,1
87002,benign,1,1
87003,prostate,1,1
87004,hyperplasia,1,1
87005,.,1,1
87006,INTRODUCTION,0,0
87007,In,0,0
87008,the,0,0
87009,present,0,0
87010,study,0,1
87011,we,0,0
87012,evaluated,0,0
87013,the,0,0
87014,effect,0,0
87015,of,0,0
87016,short-term,0,0
87017,finasteride,0,1
87018,treatment,0,1
87019,on,0,0
87020,microvessel,0,0
87021,density,0,0
87022,(,0,1
87023,MVD,0,0
87024,),0,0
87025,which,0,0
87026,is,0,0
87027,an,0,0
87028,indicator,0,0
87029,of,0,0
87030,prostatic,0,1
87031,angiogenesis,0,1
87032,in,0,1
87033,patients,1,1
87034,with,1,1
87035,hematuria,1,1
87036,secondary,1,1
87037,to,1,1
87038,benign,1,1
87039,prostatic,1,1
87040,hyperplasia,1,1
87041,(,1,1
87042,BPH,1,1
87043,),1,1
87044,.,1,1
87045,MATERIALS,0,0
87046,AND,0,0
87047,METHODS,0,1
87048,30,1,1
87049,patients,1,1
87050,who,1,1
87051,were,1,1
87052,candidates,1,1
87053,for,1,1
87054,BPH,1,1
87055,surgery,1,1
87056,were,0,0
87057,prospectively,0,1
87058,included,0,1
87059,in,0,0
87060,the,0,0
87061,study,0,0
87062,.,0,1
87063,All,1,1
87064,patients,1,1
87065,had,1,1
87066,history,1,1
87067,of,1,0
87068,gross,1,1
87069,hematuria,1,1
87070,and,1,0
87071,evaluated,1,0
87072,by,1,0
87073,ultrasonography,1,1
87074,and,1,1
87075,cystoscopy,1,0
87076,.,1,1
87077,The,0,0
87078,patients,0,1
87079,were,0,1
87080,randomized,0,1
87081,two,0,0
87082,groups,0,1
87083,before,0,1
87084,surgery,0,1
87085,.,0,1
87086,The,0,0
87087,treatment,0,0
87088,group,0,0
87089,consisted,0,1
87090,of,0,1
87091,13,0,1
87092,patients,0,1
87093,who,0,1
87094,were,0,1
87095,given,0,1
87096,5,0,1
87097,mg,0,1
87098,finasteride,0,1
87099,daily,0,0
87100,for,0,1
87101,4,0,0
87102,weeks,0,0
87103,before,0,1
87104,surgery,0,1
87105,.,0,0
87106,The,0,0
87107,control,0,0
87108,group,0,0
87109,consisted,0,1
87110,of,0,1
87111,17,0,1
87112,patients,0,1
87113,who,0,1
87114,did,0,1
87115,not,0,1
87116,receive,0,0
87117,finasteride,0,0
87118,before,0,0
87119,surgery,0,1
87120,.,0,1
87121,During,0,0
87122,surgery,0,1
87123,",",0,0
87124,resected,0,1
87125,suburethral,0,0
87126,and,0,1
87127,hyperplastic,0,1
87128,prostate,0,1
87129,specimens,0,1
87130,were,0,1
87131,sent,0,1
87132,for,0,0
87133,histopathologic,0,1
87134,MVD,0,0
87135,determination,0,0
87136,separately,0,0
87137,.,0,1
87138,RESULTS,0,0
87139,Mean,0,1
87140,MVD,0,0
87141,in,0,0
87142,the,0,0
87143,suburethral,0,0
87144,portion,0,0
87145,of,0,0
87146,prostate,0,1
87147,was,0,0
87148,significantly,0,0
87149,lower,0,0
87150,in,0,0
87151,patients,0,1
87152,treated,0,1
87153,with,0,1
87154,finasteride,0,0
87155,when,0,0
87156,compared,0,0
87157,with,0,1
87158,controls,0,1
87159,(,0,1
87160,9.08,0,1
87161,+/-,0,1
87162,5.6,0,0
87163,and,0,1
87164,13.94,0,0
87165,+/-,0,0
87166,5.90,0,0
87167,",",0,0
87168,respectively,0,0
87169,",",0,0
87170,p,0,0
87171,<,0,0
87172,0.05,0,0
87173,),0,1
87174,.,0,1
87175,Mean,0,1
87176,MVD,0,0
87177,for,0,0
87178,the,0,0
87179,hyperplastic,0,1
87180,portion,0,0
87181,of,0,0
87182,prostate,0,1
87183,was,0,0
87184,similar,0,0
87185,for,0,0
87186,the,0,0
87187,finasteride,0,0
87188,and,0,0
87189,control,0,1
87190,groups,0,1
87191,(,0,1
87192,14.21,0,1
87193,+/-,0,1
87194,7.10,0,0
87195,and,0,1
87196,19.75,0,0
87197,+/-,0,0
87198,9.73,0,0
87199,",",0,0
87200,respectively,0,0
87201,",",0,0
87202,p,0,0
87203,>,0,1
87204,0.05,0,0
87205,),0,1
87206,.,0,1
87207,CONCLUSION,0,0
87208,The,0,0
87209,potential,0,0
87210,role,0,0
87211,of,0,0
87212,finasteride,0,1
87213,on,0,1
87214,hematuria,0,1
87215,related,0,0
87216,to,0,0
87217,BPH,0,0
87218,may,0,0
87219,be,0,0
87220,the,0,0
87221,suppressive,0,0
87222,effect,0,0
87223,on,0,0
87224,MVD,0,0
87225,in,0,1
87226,the,0,0
87227,suburethral,0,0
87228,tissue,0,1
87229,of,0,0
87230,prostate,0,1
87231,.,0,1
87232,Determinants,0,1
87233,of,0,1
87234,improvement,0,0
87235,in,0,0
87236,walking,0,0
87237,capacity,0,1
87238,among,0,1
87239,individuals,1,1
87240,with,1,1
87241,chronic,1,1
87242,stroke,1,1
87243,following,0,0
87244,a,0,0
87245,multi-dimensional,0,0
87246,exercise,0,0
87247,program,0,1
87248,.,0,1
87249,OBJECTIVE,0,0
87250,To,0,0
87251,identify,0,0
87252,the,0,0
87253,determinants,0,0
87254,of,0,0
87255,improvement,0,0
87256,in,0,0
87257,walking,0,0
87258,capacity,0,0
87259,following,0,0
87260,therapeutic,0,0
87261,exercise,0,1
87262,in,0,1
87263,chronic,1,1
87264,stroke,1,1
87265,survivors,1,1
87266,.,1,1
87267,DESIGN,0,0
87268,A,0,0
87269,secondary,0,0
87270,analysis,0,0
87271,of,0,1
87272,data,0,0
87273,obtained,0,0
87274,from,0,1
87275,a,0,0
87276,prospective,0,1
87277,",",0,0
87278,single-blind,0,0
87279,",",0,0
87280,randomized,0,1
87281,controlled,0,0
87282,intervention,0,0
87283,trial,0,1
87284,.,0,1
87285,SUBJECTS,0,0
87286,Sixty-three,1,1
87287,community-dwelling,1,1
87288,individuals,1,1
87289,(,1,1
87290,mean,1,1
87291,age,1,1
87292,=,1,1
87293,65,1,1
87294,years,1,1
87295,",",1,1
87296,age,1,1
87297,range,1,1
87298,=,1,1
87299,50-87,1,1
87300,years,1,1
87301,),1,1
87302,with,1,1
87303,a,1,1
87304,chronic,1,1
87305,stroke,1,1
87306,(,1,1
87307,post-stroke,1,1
87308,duration,1,1
87309,:,1,1
87310,mean,1,1
87311,=,1,1
87312,5.5,1,0
87313,years,1,1
87314,",",1,1
87315,range,1,1
87316,=,1,1
87317,1-28,1,0
87318,years,1,1
87319,),1,1
87320,.,1,1
87321,METHODS,0,0
87322,Subjects,0,1
87323,were,0,1
87324,randomized,0,1
87325,into,0,1
87326,a,0,1
87327,leg,0,1
87328,exercise,0,0
87329,group,0,1
87330,(,0,1
87331,n,0,1
87332,=,0,1
87333,32,0,1
87334,),0,1
87335,or,0,1
87336,an,0,0
87337,arm,0,0
87338,exercise,0,0
87339,group,0,1
87340,(,0,1
87341,n,0,1
87342,=,0,1
87343,31,0,1
87344,),0,1
87345,.,0,1
87346,Subjects,0,1
87347,in,0,0
87348,each,0,1
87349,group,0,1
87350,underwent,0,1
87351,3,0,1
87352,1-hour,0,0
87353,exercise,0,1
87354,sessions,0,0
87355,per,0,1
87356,week,0,0
87357,for,0,1
87358,19,0,1
87359,weeks,0,1
87360,.,0,1
87361,Walking,0,0
87362,capacity,0,0
87363,",",0,0
87364,cardiorespiratory,0,0
87365,fitness,0,0
87366,",",0,0
87367,isometric,0,0
87368,knee,0,1
87369,extensor,0,1
87370,muscle,0,0
87371,strength,0,0
87372,",",0,0
87373,balance,0,0
87374,ability,0,0
87375,",",0,0
87376,and,0,0
87377,balance,0,0
87378,confidence,0,0
87379,were,0,0
87380,evaluated,0,0
87381,before,0,0
87382,and,0,0
87383,after,0,1
87384,the,0,0
87385,interventions,0,0
87386,.,0,1
87387,Multiple,0,0
87388,regression,0,0
87389,analysis,0,0
87390,was,0,0
87391,performed,0,0
87392,to,0,0
87393,identify,0,0
87394,the,0,0
87395,determinants,0,0
87396,of,0,0
87397,improvement,0,0
87398,in,0,0
87399,walking,0,0
87400,capacity,0,0
87401,.,0,1
87402,RESULTS,0,0
87403,After,0,0
87404,controlling,0,0
87405,for,0,0
87406,age,0,1
87407,",",0,0
87408,gender,0,0
87409,",",0,0
87410,post-stroke,0,1
87411,duration,0,0
87412,",",0,0
87413,and,0,0
87414,baseline,0,0
87415,walking,0,0
87416,capacity,0,0
87417,",",0,0
87418,gain,0,0
87419,in,0,0
87420,paretic,0,1
87421,leg,0,1
87422,muscle,0,0
87423,strength,0,0
87424,and,0,0
87425,peak,0,0
87426,oxygen,0,0
87427,consumption,0,0
87428,remained,0,0
87429,independently,0,0
87430,associated,0,0
87431,with,0,1
87432,gain,0,0
87433,in,0,0
87434,walking,0,0
87435,capacity,0,0
87436,(,0,1
87437,R2,0,1
87438,=,0,1
87439,0.229,0,0
87440,),0,1
87441,.,0,1
87442,CONCLUSION,0,0
87443,Enhancement,0,0
87444,of,0,0
87445,cardiorespiratory,0,1
87446,fitness,0,1
87447,and,0,0
87448,paretic,0,1
87449,leg,0,1
87450,muscle,0,0
87451,strength,0,0
87452,are,0,0
87453,both,0,0
87454,significant,0,0
87455,determinants,0,0
87456,in,0,1
87457,improving,0,0
87458,walking,0,0
87459,capacity,0,1
87460,among,0,1
87461,chronic,0,1
87462,stroke,0,1
87463,survivors,0,1
87464,.,0,1
87465,However,0,0
87466,",",0,0
87467,the,0,0
87468,rather,0,0
87469,weak,0,0
87470,relationship,0,0
87471,(,0,1
87472,R2,0,1
87473,=,0,1
87474,0.229,0,0
87475,),0,0
87476,indicates,0,0
87477,that,0,0
87478,other,0,0
87479,factors,0,0
87480,not,0,0
87481,measured,0,0
87482,in,0,0
87483,this,0,0
87484,study,0,0
87485,may,0,0
87486,also,0,0
87487,contribute,0,0
87488,to,0,0
87489,the,0,0
87490,improvement,0,0
87491,in,0,0
87492,walking,0,0
87493,capacity,0,1
87494,.,0,1
87495,The,0,0
87496,effects,0,0
87497,of,0,0
87498,strength,0,0
87499,training,0,0
87500,on,0,0
87501,central,0,0
87502,arterial,0,1
87503,compliance,0,0
87504,in,0,1
87505,middle-aged,1,1
87506,and,1,1
87507,older,1,1
87508,adults,1,1
87509,.,1,1
87510,BACKGROUND,0,0
87511,Contrary,0,0
87512,to,0,0
87513,aerobic,0,0
87514,exercise,0,0
87515,",",0,0
87516,strength,0,0
87517,training,0,0
87518,(,0,1
87519,ST,0,1
87520,),0,1
87521,is,0,0
87522,associated,0,0
87523,with,0,1
87524,decreased,1,0
87525,central,1,1
87526,arterial,1,1
87527,compliance,1,0
87528,in,1,1
87529,young,1,1
87530,men,1,1
87531,.,1,1
87532,It,0,0
87533,is,0,0
87534,unknown,0,0
87535,whether,0,0
87536,ST,0,1
87537,",",0,1
87538,with,0,1
87539,or,0,1
87540,without,0,1
87541,concurrent,0,1
87542,endurance,0,0
87543,training,0,0
87544,",",0,0
87545,would,0,0
87546,have,0,0
87547,a,0,0
87548,similar,0,0
87549,effect,0,0
87550,in,0,1
87551,older,1,1
87552,adults,1,1
87553,with,1,1
87554,reduced,1,0
87555,baseline,1,0
87556,arterial,1,1
87557,compliance,1,0
87558,.,1,1
87559,OBJECTIVE,0,0
87560,The,0,0
87561,primary,0,1
87562,aim,0,0
87563,of,0,0
87564,this,0,0
87565,study,0,0
87566,was,0,0
87567,to,0,0
87568,determine,0,0
87569,the,0,0
87570,effect,0,0
87571,of,0,0
87572,a,0,1
87573,ST,0,1
87574,program,0,1
87575,on,0,0
87576,central,0,0
87577,arterial,0,1
87578,compliance,0,0
87579,in,0,1
87580,middle-aged,1,1
87581,and,1,1
87582,older,1,1
87583,adults,1,1
87584,.,1,1
87585,DESIGN,0,0
87586,Randomized,0,0
87587,",",0,0
87588,controlled,0,0
87589,intervention,0,0
87590,study,0,1
87591,in,0,0
87592,which,0,1
87593,37,1,1
87594,healthy,1,1
87595,",",1,1
87596,sedentary,1,1
87597,men,1,1
87598,and,1,1
87599,women,1,1
87600,(,1,1
87601,52+/-2,1,1
87602,years,1,1
87603,),1,1
87604,performed,1,1
87605,13,1,1
87606,weeks,1,0
87607,of,1,1
87608,ST,1,1
87609,(,1,1
87610,n=13,1,1
87611,),1,1
87612,",",1,0
87613,ST+aerobic,1,1
87614,exercise,1,0
87615,(,1,1
87616,n=12,1,1
87617,),1,1
87618,or,1,1
87619,stretching,1,0
87620,exercises,1,0
87621,as,0,0
87622,a,0,1
87623,control,0,1
87624,group,0,0
87625,(,0,0
87626,n=12,0,1
87627,),0,1
87628,.,0,1
87629,METHODS,0,0
87630,Participants,1,1
87631,were,1,1
87632,rigorously,1,0
87633,screened,1,1
87634,for,1,0
87635,cardiovascular,1,1
87636,disease,1,1
87637,and,1,1
87638,underwent,1,1
87639,pre-post,1,0
87640,testing,1,1
87641,for,1,1
87642,carotid,1,1
87643,arterial,1,1
87644,compliance,1,0
87645,(,1,1
87646,via,1,1
87647,simultaneous,1,0
87648,ultrasound,1,1
87649,and,1,0
87650,applanation,1,0
87651,tonometry,1,1
87652,),1,0
87653,",",1,0
87654,carotid-femoral,1,0
87655,pulse,1,0
87656,wave,1,0
87657,velocity,1,0
87658,",",1,0
87659,plasma,1,0
87660,endothelin-1,1,0
87661,and,1,1
87662,angiotensin,1,0
87663,II,1,1
87664,concentrations,1,0
87665,and,1,1
87666,carotid,1,1
87667,artery,1,1
87668,vasoreactivity,1,1
87669,(,1,1
87670,cold,1,1
87671,pressor,1,0
87672,test,1,0
87673,),1,1
87674,.,0,1
87675,RESULTS,0,0
87676,ST,0,1
87677,performed,0,0
87678,alone,0,0
87679,",",0,0
87680,or,0,0
87681,in,0,0
87682,conjunction,0,0
87683,with,0,1
87684,aerobic,0,0
87685,exercise,0,1
87686,",",0,0
87687,improved,0,0
87688,maximal,0,0
87689,muscle,0,0
87690,strength,0,0
87691,and,0,0
87692,increased,0,0
87693,total,0,1
87694,lean,0,1
87695,body,0,1
87696,mass,0,1
87697,(,0,0
87698,both,0,0
87699,P,0,0
87700,<,0,0
87701,0.01,0,0
87702,),0,1
87703,.,0,1
87704,No,0,0
87705,significant,0,0
87706,changes,0,0
87707,were,0,1
87708,observed,0,0
87709,in,0,0
87710,carotid,0,1
87711,artery,0,1
87712,compliance,0,0
87713,or,0,1
87714,carotid-femoral,0,1
87715,pulse,0,0
87716,wave,0,1
87717,velocity,0,0
87718,following,0,0
87719,ST,0,1
87720,or,0,1
87721,ST+aerobic,0,1
87722,exercise,0,1
87723,.,0,1
87724,Carotid,0,0
87725,artery,0,1
87726,compliance,0,0
87727,increased,0,0
87728,significantly,0,0
87729,(,0,1
87730,23,0,1
87731,%,0,0
87732,),0,1
87733,following,0,0
87734,stretching,0,0
87735,which,0,0
87736,may,0,0
87737,be,0,0
87738,attributed,0,0
87739,to,0,0
87740,a,0,0
87741,reduction,0,0
87742,in,0,0
87743,carotid,0,1
87744,pulse,0,0
87745,pressure,0,0
87746,.,0,1
87747,No,0,0
87748,significant,0,0
87749,changes,0,0
87750,were,0,1
87751,observed,0,0
87752,in,0,0
87753,plasma,0,0
87754,vasoconstrictor,0,0
87755,hormones,0,0
87756,or,0,1
87757,carotid,0,1
87758,artery,0,1
87759,vasoreactivity,0,1
87760,following,0,0
87761,the,0,0
87762,interventions,0,0
87763,.,0,1
87764,CONCLUSION,0,0
87765,Thirteen,0,1
87766,weeks,0,0
87767,of,0,1
87768,moderate,0,1
87769,ST,0,1
87770,two,0,1
87771,or,0,1
87772,three,0,1
87773,times,0,0
87774,per,0,1
87775,week,0,0
87776,does,0,0
87777,not,0,0
87778,reduce,0,0
87779,central,0,0
87780,arterial,0,1
87781,compliance,0,0
87782,in,0,1
87783,middle-aged,1,1
87784,and,1,1
87785,older,1,1
87786,adults,1,1
87787,.,1,1
87788,Genital,0,1
87789,responsiveness,0,0
87790,in,0,1
87791,healthy,1,1
87792,women,1,1
87793,with,1,1
87794,and,1,1
87795,without,1,1
87796,sexual,1,1
87797,arousal,1,1
87798,disorder,1,1
87799,.,1,1
87800,INTRODUCTION,0,0
87801,Most,0,0
87802,pharmacological,0,1
87803,treatments,0,0
87804,that,0,0
87805,are,0,0
87806,currently,0,1
87807,being,0,0
87808,developed,0,1
87809,for,0,1
87810,women,1,1
87811,with,1,1
87812,sexual,1,1
87813,arousal,1,0
87814,disorder,1,1
87815,are,0,0
87816,aimed,0,0
87817,at,0,0
87818,remedying,0,0
87819,a,0,1
87820,vasculogenic,0,1
87821,deficit,0,1
87822,.,0,1
87823,AIM,0,0
87824,This,0,0
87825,study,0,0
87826,investigated,0,0
87827,whether,0,0
87828,pre-,1,0
87829,and,1,1
87830,postmenopausal,1,1
87831,women,1,1
87832,with,1,1
87833,sexual,1,1
87834,arousal,1,0
87835,disorder,1,1
87836,are,0,0
87837,less,0,0
87838,genitally,0,1
87839,responsive,0,0
87840,to,0,1
87841,visual,0,0
87842,sexual,0,1
87843,stimuli,0,0
87844,than,0,0
87845,pre-,0,0
87846,and,0,1
87847,postmenopausal,0,1
87848,women,0,1
87849,without,0,1
87850,sexual,0,1
87851,problems,0,1
87852,.,0,1
87853,METHOD,0,0
87854,Twenty-nine,1,1
87855,medically,1,1
87856,healthy,1,1
87857,women,1,1
87858,with,1,1
87859,sexual,1,1
87860,arousal,1,0
87861,disorder,1,1
87862,(,1,1
87863,15,1,1
87864,premenopausal,1,1
87865,and,1,1
87866,14,1,1
87867,postmenopausal,1,1
87868,),1,1
87869,",",1,0
87870,diagnosed,1,1
87871,using,1,0
87872,the,1,0
87873,Diagnostic,1,1
87874,and,1,0
87875,Statistical,1,0
87876,Manual,1,1
87877,of,1,1
87878,Mental,1,1
87879,Disorders,1,1
87880,",",1,1
87881,4th,1,1
87882,Edition,1,0
87883,(,1,1
87884,DSM-IV,1,1
87885,),1,1
87886,criteria,1,1
87887,",",1,0
87888,and,1,0
87889,30,1,1
87890,age-matched,1,1
87891,women,1,1
87892,without,1,1
87893,sexual,1,1
87894,problems,1,1
87895,(,1,1
87896,16,1,1
87897,premenopausal,1,1
87898,and,1,1
87899,14,1,1
87900,postmenopausal,1,1
87901,),1,1
87902,were,0,1
87903,shown,0,0
87904,sexual,0,1
87905,stimuli,0,0
87906,depicting,0,1
87907,cunnilingus,0,1
87908,and,0,1
87909,intercourse,0,1
87910,.,0,1
87911,MAIN,0,0
87912,OUTCOME,0,1
87913,MEASURE,0,0
87914,Genital,0,1
87915,arousal,0,0
87916,was,0,0
87917,assessed,0,0
87918,as,0,0
87919,vaginal,0,1
87920,pulse,0,0
87921,amplitude,0,0
87922,(,0,1
87923,VPA,0,1
87924,),0,1
87925,using,0,0
87926,vaginal,0,1
87927,photoplethysmography,0,0
87928,.,0,1
87929,RESULTS,0,0
87930,Results,0,0
87931,showed,0,0
87932,no,0,0
87933,significant,0,0
87934,differences,0,0
87935,between,0,0
87936,the,0,1
87937,two,0,0
87938,groups,0,0
87939,in,0,1
87940,mean,0,1
87941,and,0,1
87942,maximum,0,0
87943,VPA,0,0
87944,",",0,0
87945,nor,0,0
87946,in,0,0
87947,latency,0,0
87948,of,0,0
87949,VPA,0,1
87950,response,0,0
87951,.,0,1
87952,CONCLUSION,0,0
87953,Women,1,1
87954,with,1,1
87955,sexual,1,1
87956,arousal,1,0
87957,disorder,1,1
87958,diagnosed,1,1
87959,according,1,1
87960,to,1,1
87961,DSM-IV,1,1
87962,criteria,0,1
87963,were,0,0
87964,not,0,0
87965,less,0,0
87966,genitally,0,1
87967,responsive,0,0
87968,to,0,1
87969,visual,0,0
87970,sexual,0,1
87971,stimuli,0,1
87972,than,0,1
87973,women,0,1
87974,without,0,1
87975,such,0,0
87976,problems,0,1
87977,.,0,1
87978,These,0,1
87979,findings,0,0
87980,are,0,0
87981,in,0,0
87982,line,0,0
87983,with,0,1
87984,previous,0,1
87985,studies,0,0
87986,.,0,1
87987,The,0,0
87988,sexual,0,0
87989,problems,0,1
87990,these,0,1
87991,women,0,1
87992,report,0,0
87993,are,0,0
87994,clearly,0,0
87995,not,0,0
87996,related,0,0
87997,to,0,0
87998,their,0,1
87999,potential,0,0
88000,to,0,0
88001,become,0,0
88002,genitally,0,1
88003,aroused,0,0
88004,.,0,0
88005,We,0,0
88006,argue,0,0
88007,that,0,0
88008,the,0,0
88009,DSM-IV,0,1
88010,criteria,0,1
88011,for,0,1
88012,sexual,0,1
88013,arousal,0,0
88014,disorder,0,1
88015,are,0,0
88016,in,0,0
88017,need,0,0
88018,of,0,0
88019,revision,0,1
88020,.,0,1
88021,In,0,0
88022,medically,1,1
88023,healthy,1,1
88024,women,1,1
88025,",",0,1
88026,impaired,0,1
88027,genital,0,1
88028,responsiveness,0,0
88029,is,0,0
88030,not,0,0
88031,a,0,0
88032,valid,0,0
88033,diagnostic,0,0
88034,criterion,0,1
88035,.,0,1
88036,Effect,0,0
88037,of,0,0
88038,prophylactic,0,1
88039,transluminal,0,1
88040,balloon,0,1
88041,angioplasty,0,1
88042,on,0,0
88043,cerebral,0,1
88044,vasospasm,0,0
88045,and,0,0
88046,outcome,0,0
88047,in,0,0
88048,patients,1,1
88049,with,1,1
88050,Fisher,1,1
88051,grade,1,1
88052,III,1,1
88053,subarachnoid,1,1
88054,hemorrhage,1,1
88055,:,1,1
88056,results,0,0
88057,of,0,0
88058,a,0,1
88059,phase,0,1
88060,II,0,1
88061,multicenter,0,1
88062,",",0,0
88063,randomized,0,0
88064,",",0,0
88065,clinical,0,0
88066,trial,0,1
88067,.,0,1
88068,BACKGROUND,0,0
88069,AND,0,0
88070,PURPOSE,0,0
88071,Cerebral,0,1
88072,vasospasm,0,0
88073,continues,0,0
88074,to,0,0
88075,be,0,0
88076,a,0,0
88077,major,0,0
88078,cause,0,0
88079,of,0,0
88080,poor,0,1
88081,outcome,0,0
88082,in,0,1
88083,patients,1,1
88084,with,1,1
88085,ruptured,1,1
88086,aneurysms,1,1
88087,.,1,1
88088,Prophylactic,0,0
88089,Transluminal,0,1
88090,Balloon,0,0
88091,Angioplasty,0,1
88092,(,0,1
88093,pTBA,0,1
88094,),0,1
88095,appeared,0,0
88096,to,0,0
88097,prevent,0,0
88098,delayed,0,1
88099,ischemic,0,1
88100,neurological,0,1
88101,deficit,0,1
88102,in,0,0
88103,a,0,0
88104,pilot,0,0
88105,study,0,0
88106,.,0,1
88107,A,0,0
88108,phase,0,0
88109,II,0,1
88110,multicenter,0,1
88111,randomized,0,1
88112,clinical,0,0
88113,trial,0,0
88114,was,0,0
88115,subsequently,0,0
88116,designed,0,0
88117,.,0,1
88118,METHODS,0,0
88119,One,1,1
88120,hundred,1,1
88121,and,1,1
88122,seventy,1,1
88123,patients,1,1
88124,with,1,1
88125,Fisher,1,1
88126,Grade,1,0
88127,III,1,1
88128,subarachnoid,1,1
88129,hemorrhage,1,1
88130,were,1,1
88131,enrolled,1,1
88132,in,1,0
88133,the,1,0
88134,study,1,0
88135,.,1,0
88136,Of,0,0
88137,these,0,0
88138,",",0,1
88139,85,0,1
88140,patients,0,1
88141,were,0,1
88142,randomized,0,1
88143,to,0,0
88144,the,0,0
88145,treatment,0,0
88146,group,0,0
88147,and,0,0
88148,underwent,0,1
88149,pTBA,0,1
88150,within,0,1
88151,96,0,1
88152,hours,0,0
88153,after,0,1
88154,subarachnoid,0,1
88155,hemorrhage,0,1
88156,.,0,1
88157,Main,0,0
88158,end,0,0
88159,points,0,0
88160,of,0,0
88161,the,0,0
88162,study,0,0
88163,included,0,1
88164,the,0,0
88165,3-month,0,0
88166,dichotomized,0,0
88167,Glasgow,0,1
88168,Outcome,0,0
88169,Score,0,1
88170,(,0,1
88171,GOS,0,0
88172,),0,1
88173,",",0,0
88174,development,0,0
88175,of,0,0
88176,delayed,0,1
88177,ischemic,0,1
88178,neurological,0,1
88179,deficit,0,1
88180,(,0,1
88181,DIND,0,0
88182,),0,1
88183,",",0,0
88184,occurrence,0,0
88185,of,0,0
88186,Transcranial,0,0
88187,Doppler,0,1
88188,(,0,1
88189,TCD,0,1
88190,),0,1
88191,vasospasm,0,0
88192,",",0,0
88193,and,0,0
88194,length,0,0
88195,of,0,0
88196,stay,0,0
88197,in,0,0
88198,the,0,0
88199,ICU,0,0
88200,and,0,0
88201,hospital,0,1
88202,.,0,0
88203,RESULTS,0,0
88204,The,0,0
88205,incidence,0,0
88206,of,0,0
88207,DIND,0,0
88208,was,0,0
88209,lower,0,0
88210,in,0,0
88211,the,0,0
88212,pTBA,0,1
88213,group,0,0
88214,(,0,1
88215,P=0.30,0,0
88216,),0,1
88217,and,0,1
88218,fewer,0,0
88219,patients,0,1
88220,required,0,0
88221,therapeutic,0,0
88222,angioplasty,0,1
88223,to,0,0
88224,treat,0,1
88225,DIND,0,0
88226,(,0,1
88227,P=0.03,0,0
88228,),0,1
88229,.,0,1
88230,Overall,0,0
88231,pTBA,0,1
88232,resulted,0,0
88233,in,0,0
88234,an,0,0
88235,absolute,0,0
88236,risk,0,0
88237,reduction,0,0
88238,of,0,0
88239,5.9,0,0
88240,%,0,0
88241,and,0,0
88242,a,0,0
88243,relative,0,0
88244,risk,0,0
88245,reduction,0,0
88246,of,0,0
88247,10.4,0,0
88248,%,0,0
88249,unfavorable,0,0
88250,outcome,0,0
88251,(,0,1
88252,P=0.54,0,0
88253,),0,1
88254,.,0,1
88255,Good,0,1
88256,grade,0,1
88257,patients,0,1
88258,had,0,1
88259,absolute,0,0
88260,and,0,1
88261,relative,0,0
88262,risk,0,1
88263,reductions,0,0
88264,of,0,1
88265,respectively,0,1
88266,9.5,0,0
88267,and,0,1
88268,29.4,0,1
88269,%,0,0
88270,(,0,1
88271,P=0.73,0,0
88272,),0,1
88273,.,0,1
88274,Length,0,0
88275,of,0,0
88276,stay,0,0
88277,in,0,1
88278,ICU,0,0
88279,and,0,1
88280,hospital,0,1
88281,was,0,0
88282,similar,0,0
88283,in,0,1
88284,both,0,0
88285,groups,0,1
88286,.,0,1
88287,Four,0,1
88288,patients,0,1
88289,had,0,1
88290,a,0,1
88291,procedure-related,0,0
88292,vessel,0,1
88293,perforation,0,0
88294,",",0,0
88295,of,0,0
88296,which,0,1
88297,three,0,1
88298,patients,0,1
88299,died,0,1
88300,.,0,1
88301,CONCLUSIONS,0,0
88302,While,0,1
88303,the,0,0
88304,trial,0,0
88305,is,0,0
88306,unsuccessful,0,0
88307,as,0,0
88308,defined,0,1
88309,by,0,0
88310,the,0,0
88311,primary,0,1
88312,end,0,0
88313,point,0,0
88314,(,0,1
88315,GOS,0,0
88316,),0,1
88317,",",0,0
88318,proof,0,0
88319,of,0,0
88320,concept,0,0
88321,is,0,0
88322,confirmed,0,0
88323,by,0,0
88324,these,0,0
88325,results,0,0
88326,.,0,1
88327,Fewer,0,0
88328,patients,0,1
88329,tend,0,0
88330,to,0,0
88331,develop,0,0
88332,vasospasm,0,0
88333,after,0,0
88334,treatment,0,0
88335,with,0,1
88336,pTBA,0,1
88337,and,0,0
88338,there,0,0
88339,is,0,0
88340,a,0,0
88341,statistically,0,0
88342,significantly,0,0
88343,decreased,0,0
88344,need,0,0
88345,for,0,0
88346,therapeutic,0,0
88347,angioplasty,0,1
88348,.,0,1
88349,pTBA,0,0
88350,does,0,0
88351,not,0,0
88352,improve,0,0
88353,the,0,0
88354,poor,0,0
88355,outcome,0,0
88356,of,0,1
88357,patients,1,1
88358,with,1,1
88359,Fisher,1,1
88360,grade,1,1
88361,III,1,1
88362,subarachnoid,1,1
88363,hemorrhage,1,1
88364,.,1,1
88365,A,0,1
88366,pilot,0,1
88367,group,0,1
88368,therapy,0,0
88369,for,0,0
88370,functional,1,0
88371,memory,1,1
88372,disorder,1,1
88373,.,1,1
88374,Effect,0,0
88375,of,0,0
88376,adhesive,0,0
88377,system,0,1
88378,type,0,1
88379,and,0,0
88380,tooth,0,1
88381,region,0,1
88382,on,0,0
88383,the,0,0
88384,bond,0,0
88385,strength,0,0
88386,to,0,0
88387,dentin,0,1
88388,.,0,0
88389,PURPOSE,0,0
88390,This,0,0
88391,study,0,0
88392,evaluated,0,0
88393,the,0,0
88394,bond,0,0
88395,strength,0,0
88396,of,0,0
88397,two,0,1
88398,etch-and-rinse,0,0
88399,adhesive,0,1
88400,systems,0,0
88401,(,0,1
88402,two-,0,0
88403,and,0,1
88404,three-step,0,1
88405,),0,0
88406,and,0,0
88407,a,0,1
88408,self-etching,0,0
88409,system,0,0
88410,to,0,0
88411,coronal,0,0
88412,and,0,0
88413,root,0,1
88414,canal,0,1
88415,dentin,0,1
88416,.,0,1
88417,MATERIALS,0,0
88418,AND,0,0
88419,METHODS,0,0
88420,The,1,0
88421,root,1,1
88422,canals,1,1
88423,of,1,1
88424,30,1,1
88425,human,1,1
88426,incisors,1,1
88427,and,1,1
88428,canines,1,1
88429,were,0,1
88430,instrumented,0,1
88431,and,0,0
88432,prepared,0,0
88433,with,0,1
88434,burs,0,0
88435,.,0,1
88436,The,0,0
88437,posts,0,0
88438,used,0,0
88439,for,0,1
88440,luting,0,0
88441,were,0,1
88442,duplicated,0,1
88443,with,0,1
88444,dual,0,0
88445,resin,0,1
88446,cement,0,0
88447,(,0,1
88448,Duo-link,0,0
88449,),0,1
88450,inside,0,0
88451,Aestheti,0,1
88452,Plus,0,1
88453,#,0,0
88454,2,0,1
88455,molds,0,1
88456,.,0,1
88457,Thus,0,1
88458,",",0,0
88459,three,0,0
88460,groups,0,0
88461,were,0,1
88462,formed,0,1
88463,(,0,1
88464,n,0,1
88465,=,0,1
88466,10,0,1
88467,),0,1
88468,according,0,1
88469,to,0,0
88470,the,0,0
88471,adhesive,0,0
88472,system,0,1
88473,employed,0,0
88474,:,0,1
88475,All-Bond,0,0
88476,2,0,1
88477,(,0,1
88478,TE3,0,1
88479,),0,1
88480,+,0,0
88481,resin,0,1
88482,cement,0,0
88483,post,0,1
88484,(,0,1
88485,rcp,0,1
88486,),0,0
88487,+,0,0
88488,Duo-link,0,0
88489,(,0,0
88490,Dl,0,1
88491,),0,1
88492,;,0,1
88493,One-Step,0,1
88494,Plus,0,1
88495,(,0,1
88496,TE2,0,0
88497,),0,1
88498,+,0,0
88499,rcp,0,1
88500,+,0,0
88501,Dl,0,1
88502,;,0,1
88503,Tyrian/One-Step,0,1
88504,Plus,0,1
88505,(,0,1
88506,SE,0,1
88507,),0,1
88508,+,0,0
88509,rcp,0,1
88510,+,0,0
88511,Dl,0,1
88512,.,0,1
88513,Afterwards,0,0
88514,",",0,0
88515,8,0,1
88516,transverse,0,1
88517,sections,0,1
88518,(,0,1
88519,1.5,0,1
88520,mm,0,1
88521,),0,1
88522,were,0,0
88523,cut,0,0
88524,from,0,1
88525,4,0,0
88526,mm,0,1
88527,above,0,1
88528,the,0,0
88529,CEJ,0,0
88530,up,0,1
88531,to,0,1
88532,4,0,0
88533,mm,0,1
88534,short,0,1
88535,of,0,1
88536,the,0,0
88537,root,0,1
88538,canal,0,0
88539,apex,0,0
88540,",",0,0
88541,comprising,0,1
88542,coronal,0,0
88543,and,0,1
88544,root,0,1
88545,canal,0,1
88546,dentin,0,1
88547,.,0,1
88548,The,0,0
88549,sections,0,0
88550,were,0,1
88551,submitted,0,1
88552,to,0,1
88553,push-out,0,0
88554,testing,0,0
88555,in,0,0
88556,a,0,1
88557,universal,0,0
88558,testing,0,0
88559,machine,0,1
88560,EMIC,0,1
88561,(,0,1
88562,1,0,1
88563,mm/min,0,1
88564,),0,1
88565,.,0,1
88566,Bond,0,1
88567,strength,0,0
88568,data,0,0
88569,were,0,1
88570,analyzed,0,0
88571,with,0,1
88572,two-way,0,1
88573,repeated,0,0
88574,measures,0,0
88575,ANOVA,0,1
88576,and,0,1
88577,Tukey,0,0
88578,'s,0,1
88579,test,0,0
88580,(,0,1
88581,p,0,0
88582,<,0,0
88583,0.05,0,0
88584,),0,1
88585,.,0,1
88586,RESULTS,0,0
88587,The,0,0
88588,relationship,0,0
88589,between,0,0
88590,the,0,0
88591,adhesives,0,0
88592,was,0,0
88593,not,0,0
88594,the,0,0
88595,same,0,0
88596,in,0,0
88597,the,0,1
88598,different,0,0
88599,regions,0,1
88600,(,0,1
88601,p,0,0
88602,<,0,0
88603,0.05,0,0
88604,),0,1
88605,.,0,1
88606,Comparison,0,0
88607,of,0,0
88608,the,0,0
88609,means,0,0
88610,achieved,0,0
88611,with,0,1
88612,the,0,0
88613,adhesives,0,0
88614,in,0,0
88615,each,0,1
88616,region,0,1
88617,(,0,1
88618,Tukey,0,0
88619,;,0,0
88620,p,0,0
88621,<,0,0
88622,0.05,0,0
88623,),0,1
88624,revealed,0,0
88625,that,0,0
88626,TE3,0,1
88627,(,0,1
88628,mean,0,1
88629,+/-,0,0
88630,standard,0,1
88631,deviation,0,1
88632,:,0,1
88633,5.22,0,0
88634,+/-,0,1
88635,1.70,0,1
88636,),0,1
88637,was,0,0
88638,higher,0,0
88639,than,0,0
88640,TE2,0,0
88641,(,0,1
88642,2.60,0,0
88643,+/-,0,1
88644,1.74,0,0
88645,),0,1
88646,and,0,1
88647,SE,0,1
88648,(,0,1
88649,1.68,0,1
88650,+/-,0,1
88651,1.85,0,0
88652,),0,1
88653,.,0,1
88654,CONCLUSION,0,0
88655,Under,0,1
88656,the,0,0
88657,experimental,0,1
88658,conditions,0,0
88659,",",0,1
88660,better,0,0
88661,bonding,0,0
88662,to,0,0
88663,dentin,0,1
88664,was,0,0
88665,achieved,0,0
88666,using,0,0
88667,the,0,0
88668,three-step,0,0
88669,etch-and-rinse,0,0
88670,system,0,0
88671,",",0,0
88672,especially,0,0
88673,in,0,0
88674,the,0,0
88675,coronal,0,0
88676,region,0,1
88677,.,0,1
88678,Therefore,0,0
88679,",",0,0
88680,the,0,0
88681,traditional,0,0
88682,etch-and-rinse,0,0
88683,three-step,0,1
88684,adhesive,0,0
88685,system,0,0
88686,seems,0,0
88687,to,0,0
88688,be,0,0
88689,the,0,0
88690,best,0,0
88691,choice,0,0
88692,for,0,0
88693,teeth,0,1
88694,needing,0,1
88695,adhesive,0,0
88696,endodontic,0,1
88697,restorations,0,1
88698,.,0,1
88699,Multiple,0,1
88700,sclerosis,0,1
88701,risk,0,1
88702,after,0,0
88703,optic,1,1
88704,neuritis,1,1
88705,:,1,1
88706,final,0,0
88707,optic,0,1
88708,neuritis,0,1
88709,treatment,0,0
88710,trial,0,0
88711,follow-up,0,0
88712,.,0,1
88713,OBJECTIVE,0,0
88714,To,0,0
88715,assess,0,0
88716,the,0,0
88717,risk,0,0
88718,of,0,0
88719,developing,0,1
88720,multiple,0,1
88721,sclerosis,0,1
88722,(,0,1
88723,MS,0,1
88724,),0,1
88725,after,0,0
88726,optic,1,1
88727,neuritis,1,1
88728,and,0,1
88729,the,0,0
88730,factors,0,0
88731,predictive,0,0
88732,of,0,0
88733,high,0,1
88734,and,0,1
88735,low,0,1
88736,risk,0,1
88737,.,0,1
88738,DESIGN,0,0
88739,Subjects,1,1
88740,in,1,1
88741,the,1,1
88742,Optic,1,0
88743,Neuritis,1,1
88744,Treatment,1,0
88745,Trial,1,1
88746,",",1,1
88747,who,1,1
88748,were,1,1
88749,enrolled,1,1
88750,between,1,0
88751,July,1,1
88752,1,1,1
88753,",",1,1
88754,1988,1,1
88755,",",1,0
88756,and,1,1
88757,June,1,1
88758,30,1,1
88759,",",1,1
88760,1991,1,1
88761,",",1,0
88762,were,1,0
88763,followed,1,0
88764,up,1,0
88765,prospectively,1,1
88766,for,1,1
88767,15,1,1
88768,years,1,1
88769,",",1,1
88770,with,1,1
88771,the,1,0
88772,final,1,0
88773,examination,1,0
88774,in,1,1
88775,2006,1,1
88776,.,1,1
88777,SETTING,0,1
88778,Neurologic,1,1
88779,and,1,1
88780,ophthalmologic,1,1
88781,examinations,1,1
88782,at,1,1
88783,13,1,1
88784,clinical,1,1
88785,sites,1,1
88786,.,1,1
88787,PARTICIPANTS,0,1
88788,Three,1,1
88789,hundred,1,1
88790,eighty-nine,1,1
88791,subjects,1,1
88792,with,1,1
88793,acute,1,1
88794,optic,1,1
88795,neuritis,1,1
88796,.,1,1
88797,MAIN,0,0
88798,OUTCOME,0,1
88799,MEASURES,0,0
88800,Development,0,0
88801,of,0,1
88802,MS,0,1
88803,and,0,1
88804,neurologic,0,1
88805,disability,0,1
88806,assessment,0,0
88807,.,0,0
88808,RESULTS,0,0
88809,The,0,0
88810,cumulative,0,0
88811,probability,0,0
88812,of,0,0
88813,developing,0,1
88814,MS,0,1
88815,by,0,1
88816,15,0,1
88817,years,0,1
88818,after,0,1
88819,onset,0,1
88820,of,0,0
88821,optic,0,1
88822,neuritis,0,1
88823,was,0,0
88824,50,0,1
88825,%,0,0
88826,(,0,1
88827,95,0,0
88828,%,0,0
88829,confidence,0,0
88830,interval,0,0
88831,",",0,0
88832,44,0,1
88833,%,0,0
88834,-56,0,0
88835,%,0,0
88836,),0,0
88837,and,0,0
88838,strongly,0,0
88839,related,0,0
88840,to,0,0
88841,presence,0,0
88842,of,0,0
88843,lesions,0,1
88844,on,0,0
88845,a,0,1
88846,baseline,0,0
88847,non-contrast-enhanced,0,1
88848,magnetic,0,1
88849,resonance,0,1
88850,imaging,0,0
88851,(,0,1
88852,MRI,0,0
88853,),0,1
88854,of,0,0
88855,the,0,0
88856,brain,0,1
88857,.,0,1
88858,Twenty-five,0,1
88859,percent,0,1
88860,of,0,1
88861,patients,0,1
88862,with,0,1
88863,no,0,1
88864,lesions,0,1
88865,on,0,0
88866,baseline,0,1
88867,brain,0,1
88868,MRI,0,0
88869,developed,0,1
88870,MS,0,0
88871,during,0,1
88872,follow-up,0,0
88873,compared,0,0
88874,with,0,1
88875,72,0,1
88876,%,0,0
88877,of,0,1
88878,patients,0,1
88879,with,0,1
88880,1,0,1
88881,or,0,1
88882,more,0,1
88883,lesions,0,1
88884,.,0,1
88885,After,0,1
88886,10,0,1
88887,years,0,1
88888,",",0,1
88889,the,0,0
88890,risk,0,0
88891,of,0,0
88892,developing,0,1
88893,MS,0,0
88894,was,0,0
88895,very,0,0
88896,low,0,1
88897,for,0,0
88898,patients,0,1
88899,without,0,1
88900,baseline,0,1
88901,lesions,0,1
88902,but,0,0
88903,remained,0,0
88904,substantial,0,0
88905,for,0,0
88906,those,0,1
88907,with,0,1
88908,lesions,0,1
88909,.,0,1
88910,Among,0,1
88911,patients,0,1
88912,without,0,1
88913,lesions,0,1
88914,on,0,1
88915,MRI,0,1
88916,",",0,1
88917,baseline,0,0
88918,factors,0,0
88919,associated,0,0
88920,with,0,1
88921,a,0,0
88922,substantially,0,0
88923,lower,0,0
88924,risk,0,0
88925,for,0,0
88926,MS,0,1
88927,included,0,1
88928,male,0,1
88929,sex,0,0
88930,",",0,0
88931,optic,0,0
88932,disc,0,1
88933,swelling,0,0
88934,",",0,0
88935,and,0,0
88936,certain,0,0
88937,atypical,0,1
88938,features,0,1
88939,of,0,1
88940,optic,0,1
88941,neuritis,0,1
88942,.,0,1
88943,CONCLUSIONS,0,0
88944,The,0,0
88945,presence,0,0
88946,of,0,0
88947,brain,0,1
88948,MRI,0,1
88949,abnormalities,0,0
88950,at,0,1
88951,the,0,0
88952,time,0,0
88953,of,0,0
88954,an,0,0
88955,optic,0,0
88956,neuritis,0,1
88957,attack,0,1
88958,is,0,0
88959,a,0,0
88960,strong,0,0
88961,predictor,0,0
88962,of,0,0
88963,the,0,0
88964,15-year,0,1
88965,risk,0,0
88966,of,0,1
88967,MS,0,1
88968,.,0,1
88969,In,0,0
88970,the,0,0
88971,absence,0,0
88972,of,0,0
88973,MRI-detected,0,1
88974,lesions,0,1
88975,",",0,1
88976,male,0,1
88977,sex,0,0
88978,",",0,0
88979,optic,0,0
88980,disc,0,1
88981,swelling,0,0
88982,",",0,0
88983,and,0,0
88984,atypical,0,1
88985,clinical,0,0
88986,features,0,1
88987,of,0,1
88988,optic,0,1
88989,neuritis,0,1
88990,are,0,0
88991,associated,0,0
88992,with,0,1
88993,a,0,1
88994,low,0,0
88995,likelihood,0,0
88996,of,0,0
88997,developing,0,1
88998,MS,0,1
88999,.,0,1
89000,This,0,0
89001,natural,0,0
89002,history,0,1
89003,information,0,0
89004,is,0,0
89005,important,0,0
89006,when,0,0
89007,considering,0,0
89008,prophylactic,0,0
89009,treatment,0,1
89010,for,0,0
89011,MS,0,0
89012,at,0,0
89013,the,0,0
89014,time,0,0
89015,of,0,0
89016,a,0,1
89017,first,0,0
89018,acute,0,1
89019,onset,0,1
89020,of,0,0
89021,optic,0,1
89022,neuritis,0,1
89023,.,0,1
89024,Onset,0,1
89025,of,0,0
89026,action,0,0
89027,of,0,0
89028,ciclesonide,0,0
89029,once,0,0
89030,daily,0,0
89031,in,0,0
89032,the,0,0
89033,treatment,0,0
89034,of,0,0
89035,seasonal,0,1
89036,allergic,0,1
89037,rhinitis,0,1
89038,.,0,1
89039,Ciclesonide,0,0
89040,is,0,0
89041,an,0,0
89042,intranasal,0,0
89043,corticosteroid,0,0
89044,approved,0,1
89045,for,0,0
89046,the,0,0
89047,treatment,0,0
89048,of,0,0
89049,allergic,0,1
89050,rhinitis,0,1
89051,.,0,1
89052,We,0,0
89053,conducted,0,0
89054,a,0,0
89055,randomized,0,0
89056,",",0,0
89057,double-blind,0,0
89058,",",0,0
89059,parallel-group,0,0
89060,",",0,0
89061,placebo-controlled,0,0
89062,study,0,0
89063,to,0,0
89064,evaluate,0,0
89065,the,0,0
89066,time,0,0
89067,to,0,0
89068,onset,0,1
89069,of,0,0
89070,action,0,0
89071,of,0,1
89072,ciclesonide,0,1
89073,200,0,1
89074,microg,0,0
89075,once,0,0
89076,daily,0,0
89077,in,0,0
89078,502,1,1
89079,adults,1,1
89080,with,1,1
89081,seasonal,1,1
89082,allergic,1,1
89083,rhinitis,1,1
89084,of,1,0
89085,at,1,1
89086,least,1,1
89087,2,1,1
89088,years,1,1
89089,',1,1
89090,duration,1,1
89091,.,1,1
89092,To,0,0
89093,trigger,0,0
89094,immunologic,0,0
89095,priming,0,0
89096,",",0,0
89097,patients,1,1
89098,underwent,1,1
89099,between,1,0
89100,one,1,1
89101,and,1,1
89102,five,1,1
89103,priming,1,0
89104,sessions,1,0
89105,with,1,1
89106,exposure,1,1
89107,to,1,1
89108,"3,500",1,1
89109,grains/m,1,1
89110,(,1,1
89111,3,1,1
89112,),1,1
89113,(,1,1
89114,+/-500,1,1
89115,),1,1
89116,of,1,0
89117,ragweed,1,1
89118,pollen,1,0
89119,in,1,0
89120,an,1,0
89121,environmental,1,1
89122,exposure,1,0
89123,chamber,1,1
89124,.,1,1
89125,The,0,0
89126,criteria,0,1
89127,for,0,0
89128,a,0,1
89129,successful,0,1
89130,priming,0,0
89131,session,0,0
89132,were,0,0
89133,a,0,0
89134,patient-assessed,0,0
89135,instantaneous,0,0
89136,total,0,1
89137,nasal,0,1
89138,symptom,0,0
89139,score,0,0
89140,of,0,0
89141,at,0,1
89142,least,0,1
89143,6,0,0
89144,(,0,1
89145,of,0,0
89146,a,0,1
89147,possible,0,0
89148,12,0,1
89149,),0,1
89150,and,0,0
89151,a,0,1
89152,nasal,0,1
89153,congestion,0,0
89154,or,0,1
89155,rhinorrhea,0,1
89156,score,0,0
89157,of,0,0
89158,at,0,1
89159,least,0,1
89160,2,0,1
89161,(,0,1
89162,of,0,0
89163,a,0,1
89164,possible,0,0
89165,3,0,1
89166,),0,1
89167,90,0,1
89168,minutes,0,0
89169,after,0,1
89170,allergen,0,0
89171,exposure,0,0
89172,during,0,0
89173,at,0,1
89174,least,0,1
89175,two,0,1
89176,consecutive,0,1
89177,priming,0,1
89178,sessions,0,0
89179,.,0,1
89180,Patients,1,1
89181,were,0,0
89182,then,0,0
89183,randomly,0,1
89184,assigned,0,1
89185,to,0,0
89186,receive,0,1
89187,either,0,0
89188,a,0,0
89189,single,0,0
89190,dose,0,0
89191,of,0,1
89192,ciclesonide,0,1
89193,200,0,1
89194,microg,0,0
89195,(,0,1
89196,n,0,1
89197,=,0,1
89198,251,0,1
89199,),0,1
89200,or,0,1
89201,placebo,0,0
89202,(,0,1
89203,n,0,1
89204,=,0,1
89205,251,0,1
89206,),0,1
89207,administered,0,0
89208,intranasally,0,1
89209,.,0,0
89210,The,0,0
89211,difference,0,0
89212,in,0,0
89213,the,0,0
89214,change,0,0
89215,from,0,1
89216,baseline,0,0
89217,total,0,1
89218,nasal,0,1
89219,symptom,0,1
89220,scores,0,0
89221,in,0,1
89222,the,0,1
89223,two,0,1
89224,groups,0,0
89225,was,0,0
89226,assessed,0,0
89227,hourly,0,0
89228,for,0,1
89229,12,0,1
89230,hours,0,0
89231,after,0,1
89232,administration,0,0
89233,.,0,1
89234,Onset,0,0
89235,of,0,0
89236,action,0,0
89237,was,0,0
89238,determined,0,0
89239,to,0,0
89240,have,0,0
89241,taken,0,0
89242,place,0,0
89243,the,0,0
89244,first,0,0
89245,time,0,0
89246,that,0,0
89247,the,0,0
89248,effects,0,0
89249,of,0,0
89250,ciclesonide,0,0
89251,",",0,0
89252,as,0,0
89253,reflected,0,0
89254,in,0,0
89255,the,0,0
89256,total,0,1
89257,nasal,0,1
89258,symptom,0,1
89259,score,0,0
89260,",",0,0
89261,were,0,0
89262,significantly,0,0
89263,greater,0,0
89264,than,0,0
89265,those,0,0
89266,of,0,0
89267,placebo,0,0
89268,at,0,0
89269,a,0,1
89270,particular,0,0
89271,hourly,0,0
89272,assessment,0,0
89273,",",0,0
89274,provided,0,0
89275,that,0,0
89276,the,0,0
89277,subsequent,0,0
89278,hourly,0,0
89279,assessment,0,0
89280,also,0,0
89281,showed,0,0
89282,a,0,0
89283,statistically,0,0
89284,significant,0,0
89285,difference,0,0
89286,.,0,1
89287,The,0,0
89288,onset,0,0
89289,of,0,0
89290,action,0,0
89291,of,0,0
89292,ciclesonide,0,0
89293,occurred,0,0
89294,within,0,1
89295,1,0,0
89296,hour,0,0
89297,of,0,0
89298,administration,0,0
89299,(,0,1
89300,p,0,0
89301,=,0,0
89302,0.01,0,0
89303,vs.,0,0
89304,placebo,0,0
89305,),0,0
89306,",",0,0
89307,and,0,0
89308,the,0,0
89309,significant,0,0
89310,difference,0,0
89311,in,0,1
89312,total,0,1
89313,nasal,0,1
89314,symptom,0,1
89315,scores,0,0
89316,between,0,0
89317,ciclesonide,0,1
89318,and,0,1
89319,placebo,0,0
89320,was,0,0
89321,maintained,0,0
89322,through,0,1
89323,post-treatment,0,0
89324,hour,0,0
89325,12,0,1
89326,(,0,0
89327,p,0,0
89328,=,0,1
89329,0.018,0,0
89330,),0,1
89331,.,0,1
89332,Comparison,0,0
89333,of,0,0
89334,amantadine,0,1
89335,and,0,1
89336,desipramine,0,0
89337,combined,0,0
89338,with,0,1
89339,psychotherapy,0,1
89340,for,0,0
89341,treatment,0,0
89342,of,0,0
89343,cocaine,1,1
89344,dependence,1,1
89345,.,1,1
89346,We,0,0
89347,conducted,0,0
89348,a,0,0
89349,single-blind,0,0
89350,",",0,0
89351,random,0,1
89352,assignment,0,0
89353,",",0,0
89354,placebo-controlled,0,0
89355,",",0,0
89356,12-week,0,0
89357,comparison,0,0
89358,of,0,0
89359,desipramine,0,1
89360,hydrochloride,0,0
89361,and,0,1
89362,amantadine,0,1
89363,hydrochloride,0,0
89364,as,0,0
89365,adjunctive,0,1
89366,treatments,0,0
89367,to,0,1
89368,counseling,0,1
89369,for,0,0
89370,cocaine,0,1
89371,dependence,0,1
89372,.,0,1
89373,Subjects,1,1
89374,were,1,1
89375,54,1,1
89376,outpatients,1,1
89377,who,1,1
89378,met,1,1
89379,DSM,1,1
89380,III-R,1,1
89381,criteria,1,1
89382,for,1,1
89383,active,1,1
89384,cocaine,1,1
89385,dependence,1,1
89386,and,1,1
89387,who,1,1
89388,completed,1,1
89389,a,1,1
89390,minimum,1,0
89391,of,1,0
89392,2,1,1
89393,weeks,1,1
89394,of,1,1
89395,treatment,1,1
89396,.,1,1
89397,Subjects,0,1
89398,treated,0,1
89399,with,0,1
89400,fixed,0,0
89401,doses,0,1
89402,of,0,1
89403,200,0,1
89404,mg/day,0,1
89405,desipramine,0,1
89406,(,0,1
89407,N,0,1
89408,=,0,1
89409,17,0,1
89410,),0,1
89411,",",0,1
89412,400,0,0
89413,mg/day,0,0
89414,amantadine-placebo,0,0
89415,(,0,1
89416,N,0,1
89417,=,0,1
89418,16,0,1
89419,),0,1
89420,",",0,0
89421,and,0,0
89422,placebo,0,0
89423,(,0,1
89424,N,0,1
89425,=,0,1
89426,21,0,1
89427,),0,1
89428,did,1,0
89429,not,1,0
89430,differ,1,0
89431,for,1,0
89432,lifetime,1,1
89433,cocaine,1,1
89434,use,1,0
89435,",",1,1
89436,lifetime,1,1
89437,histories,1,1
89438,of,1,1
89439,psychopathology,1,1
89440,",",1,1
89441,admission,1,0
89442,scores,1,0
89443,on,1,1
89444,psychometric,1,1
89445,assessments,1,0
89446,",",1,1
89447,and,1,1
89448,sociodemographics,1,0
89449,.,1,1
89450,All,0,1
89451,treatment,0,0
89452,groups,0,0
89453,demonstrated,0,0
89454,dramatic,0,0
89455,and,0,1
89456,persistent,0,1
89457,decreases,0,0
89458,in,0,1
89459,cocaine,0,1
89460,use,0,0
89461,",",0,0
89462,craving,0,0
89463,for,0,0
89464,cocaine,0,1
89465,",",0,0
89466,and,0,0
89467,psychiatric,0,1
89468,symptoms,0,1
89469,consequent,0,0
89470,to,0,1
89471,treatment,0,0
89472,.,0,0
89473,Although,0,0
89474,there,0,0
89475,was,0,0
89476,a,0,0
89477,trend,0,0
89478,for,0,0
89479,more,0,0
89480,dropouts,0,1
89481,by,0,0
89482,subjects,0,1
89483,taking,0,1
89484,desipramine,0,0
89485,",",0,0
89486,there,0,0
89487,were,0,0
89488,no,0,0
89489,significant,0,0
89490,differences,0,0
89491,among,0,1
89492,treatment,0,1
89493,groups,0,1
89494,regarding,0,0
89495,retention,0,0
89496,in,0,0
89497,treatment,0,0
89498,",",0,0
89499,craving,0,0
89500,for,0,0
89501,cocaine,0,1
89502,",",0,0
89503,and,0,0
89504,decreased,0,0
89505,cocaine,0,1
89506,use,0,0
89507,confirmed,0,0
89508,by,0,0
89509,urine,0,1
89510,toxicology,0,1
89511,.,0,0
89512,There,0,0
89513,was,0,0
89514,a,0,0
89515,trend,0,0
89516,for,0,0
89517,subjects,0,1
89518,treated,0,1
89519,with,0,1
89520,desipramine,0,0
89521,to,0,0
89522,maintain,0,0
89523,longer,0,0
89524,periods,0,0
89525,of,0,0
89526,cocaine,0,1
89527,abstinence,0,1
89528,.,0,1
89529,Mean,0,1
89530,plasma,0,0
89531,concentration,0,0
89532,of,0,0
89533,desipramine,0,0
89534,in,0,0
89535,a,0,0
89536,subsample,0,1
89537,of,0,0
89538,our,0,1
89539,subjects,0,1
89540,was,0,0
89541,less,0,0
89542,than,0,0
89543,that,0,0
89544,recommended,0,0
89545,for,0,0
89546,treatment,0,0
89547,of,0,0
89548,depression,0,1
89549,",",0,0
89550,thus,0,0
89551,the,0,0
89552,dosage,0,0
89553,of,0,0
89554,desipramine,0,0
89555,may,0,0
89556,have,0,0
89557,been,0,0
89558,subtherapeutic,0,0
89559,.,0,1
89560,The,0,0
89561,effect,0,0
89562,of,0,0
89563,acupressure,0,0
89564,at,0,0
89565,the,0,0
89566,extra,0,1
89567,1,0,0
89568,point,0,0
89569,on,0,0
89570,subjective,0,0
89571,and,0,1
89572,autonomic,0,1
89573,responses,0,0
89574,to,0,1
89575,needle,0,1
89576,insertion,0,0
89577,.,0,1
89578,BACKGROUND,0,0
89579,Premedication,0,1
89580,with,0,1
89581,sedatives,0,0
89582,can,0,0
89583,decrease,0,0
89584,the,0,0
89585,discomfort,0,0
89586,associated,0,0
89587,with,0,1
89588,invasive,0,1
89589,anesthetic,0,1
89590,procedures,0,1
89591,.,0,1
89592,Some,0,1
89593,researchers,0,0
89594,have,0,0
89595,shown,0,0
89596,that,0,0
89597,acupressure,0,0
89598,on,0,0
89599,the,0,0
89600,acupuncture,0,1
89601,extra,0,1
89602,1,0,0
89603,point,0,0
89604,is,0,0
89605,effective,0,0
89606,for,0,0
89607,sedation,0,1
89608,.,0,1
89609,We,0,0
89610,investigated,0,0
89611,whether,0,0
89612,acupressure,0,0
89613,on,0,0
89614,the,0,0
89615,extra,0,1
89616,1,0,0
89617,point,0,0
89618,could,0,0
89619,alleviate,0,0
89620,the,0,0
89621,pain,0,0
89622,of,0,0
89623,needle,0,1
89624,insertion,0,1
89625,.,0,1
89626,METHODS,0,0
89627,We,0,0
89628,investigated,0,0
89629,the,0,0
89630,effect,0,0
89631,of,0,0
89632,acupressure,0,0
89633,at,0,0
89634,the,0,0
89635,extra,0,1
89636,1,0,0
89637,point,0,0
89638,or,0,1
89639,a,0,0
89640,sham,0,0
89641,point,0,0
89642,on,0,0
89643,needle,0,1
89644,insertion,0,1
89645,using,0,0
89646,verbal,0,0
89647,rating,0,0
89648,scale,0,0
89649,(,0,1
89650,VRS,0,0
89651,),0,1
89652,pain,0,1
89653,scores,0,0
89654,and,0,1
89655,heart,0,1
89656,rate,0,0
89657,variability,0,0
89658,(,0,1
89659,HRV,0,1
89660,),0,1
89661,.,0,1
89662,Twenty-two,1,1
89663,healthy,1,1
89664,female,1,1
89665,volunteers,1,1
89666,were,0,1
89667,randomly,0,1
89668,allocated,0,1
89669,to,0,1
89670,two,0,1
89671,groups,0,1
89672,:,0,1
89673,the,0,1
89674,extra,1,0
89675,1,1,0
89676,group,1,1
89677,received,0,1
89678,acupressure,0,0
89679,at,0,0
89680,the,0,0
89681,extra,0,1
89682,1,0,0
89683,point,0,0
89684,",",0,0
89685,and,0,0
89686,the,0,0
89687,sham,0,0
89688,group,0,0
89689,received,0,0
89690,acupressure,0,0
89691,at,0,0
89692,a,0,1
89693,sham,0,0
89694,point,0,0
89695,.,0,1
89696,After,0,0
89697,starting,0,0
89698,the,0,0
89699,electrocardiogram,0,0
89700,record,0,0
89701,",",0,0
89702,a,0,0
89703,27-gauge,0,0
89704,needle,0,1
89705,was,0,0
89706,inserted,0,0
89707,into,0,0
89708,the,0,0
89709,skin,0,1
89710,of,0,0
89711,a,0,1
89712,forearm,0,1
89713,.,0,1
89714,Thereafter,0,0
89715,",",0,0
89716,another,0,1
89717,needle,0,0
89718,was,0,0
89719,inserted,0,0
89720,into,0,0
89721,the,0,0
89722,skin,0,1
89723,of,0,0
89724,the,0,0
89725,other,0,0
89726,forearm,0,0
89727,during,0,1
89728,acupressure,0,0
89729,.,0,1
89730,RESULTS,0,0
89731,Acupressure,0,0
89732,at,0,0
89733,the,0,0
89734,extra,0,1
89735,1,0,0
89736,point,0,0
89737,significantly,0,0
89738,reduced,0,0
89739,the,0,0
89740,VRS,0,0
89741,",",0,0
89742,but,0,0
89743,acupressure,0,0
89744,at,0,0
89745,the,0,0
89746,sham,0,0
89747,increased,0,0
89748,the,0,0
89749,VRS,0,0
89750,.,0,1
89751,Acupressure,0,0
89752,at,0,0
89753,the,0,0
89754,extra,0,1
89755,1,0,0
89756,significantly,0,0
89757,reduced,0,0
89758,the,0,0
89759,low,0,0
89760,frequency/high,0,0
89761,frequency,0,0
89762,ratio,0,0
89763,of,0,0
89764,HRV,0,1
89765,responding,0,1
89766,to,0,0
89767,needle,0,1
89768,insertion,0,0
89769,.,0,1
89770,CONCLUSIONS,0,0
89771,Acupressure,0,0
89772,at,0,0
89773,the,0,0
89774,extra,0,1
89775,1,0,0
89776,point,0,0
89777,significantly,0,0
89778,reduced,0,0
89779,needle,0,1
89780,insertion,0,1
89781,pain,0,1
89782,compared,0,0
89783,with,0,1
89784,acupressure,0,0
89785,at,0,0
89786,the,0,0
89787,sham,0,0
89788,point,0,0
89789,.,0,1
89790,Also,0,0
89791,",",0,0
89792,acupressure,0,0
89793,at,0,0
89794,the,0,0
89795,extra,0,1
89796,1,0,0
89797,point,0,0
89798,significantly,0,0
89799,reduced,0,0
89800,the,0,0
89801,low,0,0
89802,frequency/high,0,0
89803,frequency,0,0
89804,ratio,0,0
89805,of,0,0
89806,HRV,0,1
89807,responding,0,0
89808,to,0,0
89809,needle,0,1
89810,insertion,0,0
89811,",",0,0
89812,which,0,0
89813,implies,0,0
89814,a,0,0
89815,reduction,0,0
89816,in,0,0
89817,sympathetic,0,0
89818,nervous,0,1
89819,system,0,1
89820,activity,0,0
89821,.,0,1
89822,Less,0,0
89823,tachycardia,0,1
89824,in,0,0
89825,adults,1,1
89826,when,0,0
89827,using,0,1
89828,atropine,0,0
89829,0.9,0,0
89830,mg,0,0
89831,compared,0,0
89832,with,0,1
89833,1.2,0,1
89834,mg,0,1
89835,plus,0,0
89836,neostigmine,0,1
89837,2.5,0,0
89838,mg,0,1
89839,.,0,1
89840,OBJECTIVE,0,0
89841,Compare,0,0
89842,the,0,0
89843,increase,0,0
89844,in,0,0
89845,heart,0,1
89846,rate,0,0
89847,in,1,0
89848,adults,1,1
89849,after,0,1
89850,0.9,0,1
89851,vs.,0,0
89852,1.2,0,0
89853,mg,0,0
89854,of,0,1
89855,atropine,0,0
89856,plus,0,0
89857,neostigmine,0,1
89858,2.5,0,0
89859,mg,0,0
89860,as,0,0
89861,the,0,0
89862,non-depolarizing,0,0
89863,muscle,0,0
89864,relaxant,0,1
89865,reversal,0,0
89866,agent,0,0
89867,.,0,1
89868,MATERIAL,0,0
89869,AND,0,0
89870,METHOD,0,1
89871,A,0,1
89872,randomized,0,1
89873,",",0,0
89874,double,0,0
89875,blind,0,1
89876,",",0,0
89877,controlled,0,0
89878,trial,0,0
89879,on,0,0
89880,46,1,1
89881,adults,1,1
89882,ASA,1,1
89883,I-II,1,1
89884,",",1,0
89885,undergoing,1,1
89886,elective,1,1
89887,gynecological,1,1
89888,or,1,1
89889,general,1,1
89890,surgery,1,1
89891,with,1,1
89892,balanced,1,0
89893,general,1,1
89894,anesthesia,1,1
89895,was,0,0
89896,performed,0,0
89897,.,0,1
89898,The,0,0
89899,subjects,0,1
89900,were,0,1
89901,randomized,0,1
89902,into,0,1
89903,two,0,1
89904,groups,0,0
89905,",",0,1
89906,After,0,1
89907,surgery,0,1
89908,",",0,0
89909,the,0,0
89910,study,0,0
89911,group,0,1
89912,received,0,1
89913,0.9,0,0
89914,mg,0,0
89915,of,0,0
89916,atropine,0,0
89917,",",0,0
89918,while,0,0
89919,the,0,0
89920,control,0,1
89921,group,0,1
89922,received,0,1
89923,1.2,0,0
89924,mg,0,0
89925,of,0,0
89926,atropine,0,0
89927,.,0,1
89928,Both,0,0
89929,groups,0,0
89930,received,0,1
89931,2.5,0,0
89932,mg,0,0
89933,of,0,0
89934,neostigmine,0,0
89935,simultaneously,0,0
89936,.,0,0
89937,RESULTS,0,0
89938,The,0,0
89939,heart,0,1
89940,rate,0,0
89941,and,0,0
89942,blood,0,0
89943,pressure,0,0
89944,were,0,0
89945,taken,0,0
89946,at,0,0
89947,0,0,0
89948,",",0,1
89949,1,0,0
89950,",",0,0
89951,2,0,1
89952,",",0,0
89953,3,0,0
89954,",",0,0
89955,4,0,0
89956,",",0,0
89957,5,0,0
89958,",",0,0
89959,6,0,0
89960,",",0,0
89961,7,0,1
89962,",",0,0
89963,8,0,0
89964,",",0,0
89965,9,0,0
89966,",",0,0
89967,10,0,1
89968,",",0,0
89969,15,0,1
89970,",",0,0
89971,20,0,1
89972,",",0,0
89973,25,0,1
89974,",",0,0
89975,and,0,0
89976,30,0,1
89977,min,0,0
89978,after,0,0
89979,the,0,0
89980,injection,0,0
89981,.,0,0
89982,The,0,0
89983,increase,0,0
89984,in,0,0
89985,heart,0,1
89986,rate,0,0
89987,and,0,0
89988,blood,0,0
89989,pressure,0,0
89990,between,0,0
89991,the,0,1
89992,two,0,1
89993,groups,0,0
89994,were,0,1
89995,compared,0,0
89996,.,0,1
89997,The,0,0
89998,heart,0,1
89999,rate,0,0
90000,(,0,1
90001,at,0,0
90002,3,0,1
90003,",",0,1
90004,4,0,0
90005,",",0,0
90006,5,0,0
90007,",",0,0
90008,and,0,0
90009,6,0,0
90010,min,0,0
90011,),0,1
90012,of,0,0
90013,patients,0,1
90014,in,0,1
90015,the,0,0
90016,study,0,0
90017,group,0,0
90018,increased,0,0
90019,significantly,0,0
90020,less,0,0
90021,than,0,0
90022,that,0,0
90023,of,0,0
90024,patients,0,1
90025,in,0,1
90026,the,0,0
90027,control,0,1
90028,group,0,0
90029,.,0,0
90030,There,0,0
90031,was,0,0
90032,no,0,0
90033,significant,0,0
90034,difference,0,0
90035,in,0,0
90036,blood,0,0
90037,pressure,0,0
90038,between,0,0
90039,groups,0,0
90040,and,0,1
90041,no,0,1
90042,side,0,0
90043,effects,0,0
90044,occurred,0,0
90045,.,0,1
90046,CONCLUSION,0,0
90047,The,0,0
90048,authors,0,0
90049,conclude,0,0
90050,that,0,0
90051,0.9,0,0
90052,mg,0,1
90053,of,0,0
90054,atropine,0,0
90055,with,0,1
90056,2.5,0,0
90057,mg,0,0
90058,neostigmine,0,1
90059,can,0,0
90060,be,0,0
90061,safely,0,0
90062,used,0,0
90063,as,0,0
90064,the,0,0
90065,reversal,0,0
90066,agent,0,0
90067,for,0,0
90068,a,0,1
90069,non-depolarizing,0,0
90070,muscle,0,0
90071,relaxant,0,0
90072,",",0,0
90073,particularly,0,0
90074,in,0,0
90075,patients,0,1
90076,for,0,1
90077,whom,0,1
90078,any,0,1
90079,increase,0,0
90080,in,0,0
90081,heart,0,1
90082,rate,0,0
90083,would,0,0
90084,be,0,0
90085,harmful,0,0
90086,.,0,1
90087,Smoking,0,1
90088,cessation,0,1
90089,with,0,1
90090,smokeless,0,1
90091,tobacco,0,1
90092,and,0,0
90093,group,0,1
90094,therapy,0,0
90095,:,0,1
90096,an,0,0
90097,open,0,0
90098,",",0,0
90099,randomized,0,1
90100,",",0,0
90101,controlled,0,0
90102,trial,0,0
90103,.,0,1
90104,Smokeless,0,0
90105,tobacco,0,1
90106,might,0,0
90107,be,0,0
90108,effective,0,0
90109,as,0,0
90110,an,0,0
90111,adjunct,0,0
90112,for,0,0
90113,smoking,0,1
90114,cessation,0,1
90115,.,0,1
90116,We,0,0
90117,evaluated,0,0
90118,the,0,0
90119,efficacy,0,0
90120,of,0,0
90121,smokeless,0,1
90122,tobacco,0,1
90123,and,0,0
90124,group,0,1
90125,support,0,0
90126,for,0,0
90127,smoking,0,1
90128,cessation,0,0
90129,in,0,0
90130,an,0,0
90131,open,0,1
90132,",",0,0
90133,randomized,0,1
90134,study,0,0
90135,that,0,0
90136,compared,0,0
90137,smokeless,0,1
90138,tobacco,0,1
90139,plus,0,0
90140,group,0,1
90141,support,0,0
90142,versus,0,0
90143,group,0,0
90144,support,0,0
90145,only,0,0
90146,.,0,0
90147,The,0,0
90148,study,1,0
90149,enrolled,1,1
90150,263,1,1
90151,healthy,1,1
90152,smokers,1,1
90153,(,1,1
90154,M,1,1
90155,(,1,1
90156,age,1,1
90157,),1,1
90158,=,1,0
90159,49,1,1
90160,years,1,1
90161,),1,1
90162,who,1,1
90163,smoked,1,1
90164,a,1,1
90165,mean,1,1
90166,of,1,0
90167,24,1,1
90168,cigarettes/day,1,1
90169,",",1,0
90170,with,1,1
90171,a,1,0
90172,mean,1,1
90173,of,1,0
90174,31,1,1
90175,pack-years,1,1
90176,.,1,1
90177,Smokeless,0,0
90178,tobacco,0,1
90179,was,0,0
90180,provided,0,0
90181,for,0,1
90182,7,0,1
90183,weeks,0,1
90184,(,0,1
90185,or,0,1
90186,up,0,1
90187,to,0,1
90188,12,0,1
90189,),0,1
90190,",",0,0
90191,combined,0,0
90192,with,0,1
90193,eight,0,1
90194,group,0,1
90195,support,0,0
90196,visits,0,0
90197,provided,0,0
90198,by,0,1
90199,nurses,0,1
90200,.,0,1
90201,The,0,0
90202,control,0,0
90203,group,0,0
90204,received,0,0
90205,group,0,0
90206,support,0,0
90207,only,0,0
90208,.,0,1
90209,Smoking,0,0
90210,cessation,0,0
90211,rates,0,0
90212,were,0,1
90213,statistically,0,0
90214,significantly,0,0
90215,better,0,0
90216,in,0,0
90217,the,0,0
90218,smokeless,0,1
90219,tobacco,0,1
90220,group,0,1
90221,than,0,0
90222,in,0,0
90223,the,0,0
90224,control,0,0
90225,group,0,0
90226,during,0,0
90227,the,0,0
90228,first,0,1
90229,7,0,1
90230,weeks,0,1
90231,.,0,1
90232,Point-prevalence,0,0
90233,abstinence,0,0
90234,rates,0,0
90235,at,0,1
90236,7,0,1
90237,weeks,0,1
90238,were,0,1
90239,36.4,0,0
90240,%,0,0
90241,versus,0,0
90242,20.8,0,0
90243,%,0,0
90244,(,0,0
90245,OR,0,0
90246,=,0,0
90247,2.52,0,0
90248,",",0,0
90249,p,0,0
90250,=,0,0
90251,.001,0,0
90252,),0,0
90253,",",0,0
90254,respectively,0,0
90255,;,0,0
90256,and,0,0
90257,continuous,0,0
90258,abstinence,0,1
90259,rates,0,0
90260,from,0,1
90261,weeks,0,1
90262,4,0,1
90263,to,0,1
90264,7,0,1
90265,were,0,1
90266,31.5,0,0
90267,%,0,0
90268,versus,0,0
90269,19.2,0,0
90270,%,0,0
90271,(,0,0
90272,OR,0,0
90273,=,0,0
90274,1.94,0,0
90275,",",0,0
90276,p,0,0
90277,=,0,0
90278,.023,0,0
90279,),0,0
90280,",",0,0
90281,respectively,0,0
90282,.,0,0
90283,The,0,0
90284,primary,0,1
90285,outcomes,0,0
90286,(,0,1
90287,i.e.,0,0
90288,",",0,1
90289,6-month,0,0
90290,point,0,0
90291,prevalence,0,1
90292,),0,1
90293,were,0,1
90294,23.1,0,0
90295,%,0,0
90296,versus,0,0
90297,20.8,0,0
90298,%,0,0
90299,",",0,0
90300,respectively,0,0
90301,(,0,0
90302,OR,0,0
90303,=,0,0
90304,1.31,0,0
90305,",",0,0
90306,ns,0,0
90307,),0,1
90308,.,0,1
90309,Smokeless,0,0
90310,tobacco,0,1
90311,was,0,0
90312,relatively,0,0
90313,well,0,0
90314,tolerated,0,0
90315,",",0,0
90316,although,0,0
90317,15,0,1
90318,subjects,0,1
90319,(,0,1
90320,11.2,0,0
90321,%,0,0
90322,),0,1
90323,stopped,0,1
90324,use,0,0
90325,due,0,0
90326,to,0,1
90327,adverse,0,0
90328,events,0,0
90329,.,0,1
90330,A,0,0
90331,total,0,1
90332,of,0,0
90333,25,0,1
90334,subjects,0,1
90335,(,0,1
90336,17.5,0,0
90337,%,0,0
90338,),0,1
90339,were,0,0
90340,still,0,0
90341,using,0,0
90342,smokeless,0,1
90343,tobacco,0,1
90344,after,0,1
90345,6,0,1
90346,months,0,1
90347,.,0,1
90348,This,0,0
90349,trial,0,0
90350,demonstrated,0,0
90351,short-term,0,0
90352,efficacy,0,0
90353,of,0,0
90354,smokeless,0,1
90355,tobacco,0,1
90356,in,0,0
90357,combination,0,0
90358,with,0,1
90359,group,0,1
90360,support,0,0
90361,for,0,0
90362,smoking,0,1
90363,cessation,0,0
90364,but,0,0
90365,no,0,0
90366,long-term,0,0
90367,efficacy,0,0
90368,.,0,1
90369,A,0,0
90370,controlled,0,0
90371,comparison,0,0
90372,between,0,0
90373,single,0,0
90374,doses,0,0
90375,of,0,1
90376,intravenous,0,1
90377,and,0,1
90378,intramuscular,0,0
90379,morphine,0,0
90380,with,0,1
90381,respect,0,0
90382,to,0,1
90383,analgesic,0,0
90384,effects,0,0
90385,and,0,1
90386,patient,0,1
90387,safety,0,0
90388,.,0,1
90389,UNLABELLED,0,0
90390,BACKGROUND,0,0
90391,AND,0,0
90392,AIM,0,1
90393,OF,0,1
90394,INVESTIGATION,0,1
90395,:,0,1
90396,Intramuscular,0,1
90397,(,0,1
90398,IM,0,1
90399,),0,0
90400,administration,0,0
90401,has,0,0
90402,been,0,0
90403,considered,0,0
90404,to,0,0
90405,be,0,0
90406,safer,0,0
90407,than,0,0
90408,intravenous,0,1
90409,(,0,1
90410,IV,0,1
90411,),0,1
90412,for,0,0
90413,opioids,0,1
90414,on,0,1
90415,wards,0,1
90416,",",0,1
90417,but,0,0
90418,a,0,0
90419,comparative,0,0
90420,knowledge,0,0
90421,of,0,0
90422,patient,0,1
90423,safety,0,0
90424,and,0,1
90425,analgesic,0,0
90426,potency,0,0
90427,following,0,0
90428,a,0,0
90429,single,0,0
90430,dose,0,0
90431,of,0,1
90432,IV,0,1
90433,and,0,1
90434,IM,0,1
90435,administration,0,0
90436,is,0,0
90437,lacking,0,0
90438,.,0,0
90439,This,0,0
90440,study,0,0
90441,was,0,0
90442,carried,0,0
90443,out,0,0
90444,to,0,0
90445,compare,0,0
90446,patient,0,1
90447,safety,0,0
90448,and,0,1
90449,analgesic,0,0
90450,efficacy,0,0
90451,of,0,0
90452,a,0,1
90453,single,0,0
90454,and,0,0
90455,high,0,1
90456,dose,0,0
90457,of,0,0
90458,morphine,0,0
90459,given,0,1
90460,IM,0,1
90461,or,0,1
90462,IV,0,1
90463,for,0,0
90464,post-operative,1,0
90465,pain,1,1
90466,management,1,1
90467,.,1,1
90468,MATERIALS,0,0
90469,AND,0,0
90470,METHODS,0,0
90471,Thirty-eight,1,1
90472,patients,1,1
90473,with,1,1
90474,post-operative,1,1
90475,pain,1,1
90476,following,1,0
90477,hip,1,1
90478,replacement,1,1
90479,surgery,1,1
90480,were,0,1
90481,given,0,0
90482,IM,0,1
90483,or,0,1
90484,IV,0,1
90485,morphine,0,0
90486,10,0,0
90487,mg,0,0
90488,at,0,0
90489,a,0,1
90490,specified,0,0
90491,pain,0,1
90492,level,0,0
90493,.,0,1
90494,The,0,0
90495,study,0,0
90496,was,0,0
90497,randomized,0,1
90498,and,0,1
90499,double,0,0
90500,blinded,0,0
90501,.,0,1
90502,Time,0,0
90503,to,0,0
90504,onset,0,1
90505,of,0,0
90506,analgesic,0,0
90507,effect,0,0
90508,(,0,1
90509,11-point,0,0
90510,numeric,0,0
90511,rating,0,0
90512,scale,0,0
90513,),0,0
90514,",",0,0
90515,respiratory,0,1
90516,function,0,0
90517,(,0,1
90518,p,0,0
90519,(,0,1
90520,a,0,1
90521,),0,0
90522,CO2,0,1
90523,",",0,0
90524,p,0,0
90525,(,0,0
90526,a,0,1
90527,),0,0
90528,O2,0,0
90529,",",0,0
90530,and,0,0
90531,respiratory,0,1
90532,rate,0,0
90533,),0,1
90534,",",0,0
90535,level,0,0
90536,of,0,0
90537,sedation,0,1
90538,(,0,1
90539,5-point,0,0
90540,verbal,0,0
90541,rating,0,0
90542,scale,0,0
90543,),0,0
90544,",",0,0
90545,and,0,0
90546,hemodynamic,0,0
90547,function,0,0
90548,were,0,1
90549,recorded,0,0
90550,.,0,1
90551,RESULTS,0,0
90552,In,0,0
90553,the,0,0
90554,IV,0,0
90555,group,0,0
90556,there,0,0
90557,was,0,0
90558,a,0,0
90559,slight,0,0
90560,but,0,0
90561,significant,0,0
90562,increase,0,0
90563,in,0,0
90564,p,0,0
90565,(,0,1
90566,a,0,1
90567,),0,0
90568,CO2,0,1
90569,after,0,1
90570,5,0,1
90571,",",0,1
90572,10,0,1
90573,",",0,0
90574,and,0,1
90575,15,0,1
90576,min,0,0
90577,compared,0,0
90578,with,0,1
90579,the,0,0
90580,IM,0,1
90581,group,0,1
90582,(,0,0
90583,5.2,0,0
90584,vs.,0,0
90585,4.8,0,0
90586,",",0,1
90587,5.4,0,0
90588,",",0,0
90589,vs.,0,0
90590,5.0,0,0
90591,and,0,0
90592,5.5,0,1
90593,vs.,0,0
90594,5.1,0,0
90595,kPa,0,0
90596,",",0,0
90597,respectively,0,0
90598,),0,0
90599,.,0,0
90600,The,0,0
90601,IV,0,0
90602,group,0,0
90603,had,0,1
90604,a,0,0
90605,significantly,0,0
90606,faster,0,0
90607,onset,0,0
90608,of,0,0
90609,analgesic,0,0
90610,effect,0,0
90611,than,0,0
90612,the,0,0
90613,IM,0,1
90614,group,0,1
90615,(,0,0
90616,5,0,1
90617,vs.,0,0
90618,20,0,1
90619,min,0,0
90620,),0,1
90621,.,0,1
90622,Between,0,1
90623,5,0,0
90624,and,0,1
90625,25,0,1
90626,min,0,0
90627,after,0,1
90628,morphine,0,0
90629,administration,0,0
90630,",",0,0
90631,pain,0,1
90632,status,0,1
90633,in,0,0
90634,the,0,0
90635,IV,0,1
90636,group,0,0
90637,was,0,0
90638,significantly,0,0
90639,improved,0,0
90640,compared,0,0
90641,with,0,1
90642,the,0,0
90643,IM,0,1
90644,group,0,1
90645,.,0,1
90646,Patients,0,1
90647,in,0,0
90648,the,0,1
90649,IV,0,1
90650,group,0,0
90651,were,0,0
90652,slightly,0,0
90653,more,0,0
90654,sedated,0,0
90655,than,0,0
90656,the,0,0
90657,IM,0,1
90658,group,0,1
90659,5,0,1
90660,and,0,1
90661,10,0,1
90662,min,0,0
90663,after,0,1
90664,morphine,0,0
90665,.,0,1
90666,CONCLUSION,0,0
90667,A,0,1
90668,10,0,0
90669,mg,0,0
90670,bolus,0,0
90671,dose,0,0
90672,of,0,0
90673,IV,0,1
90674,morphine,0,0
90675,given,0,0
90676,to,0,1
90677,patients,0,1
90678,with,0,1
90679,moderate,0,1
90680,pain,0,1
90681,after,0,0
90682,surgery,0,1
90683,does,0,0
90684,not,0,0
90685,cause,0,0
90686,severe,0,1
90687,respiratory,0,1
90688,depression,0,1
90689,",",0,0
90690,but,0,0
90691,provides,0,0
90692,more,0,0
90693,rapid,0,0
90694,and,0,0
90695,better,0,0
90696,initial,0,0
90697,analgesia,0,0
90698,than,0,1
90699,10,0,1
90700,mg,0,1
90701,given,0,1
90702,IM,0,1
90703,.,0,1
90704,IV,0,0
90705,morphine,0,0
90706,even,0,0
90707,at,0,0
90708,a,0,0
90709,dose,0,0
90710,as,0,0
90711,high,0,1
90712,as,0,0
90713,10,0,1
90714,mg,0,0
90715,IV,0,0
90716,is,0,0
90717,well,0,0
90718,tolerated,0,0
90719,if,0,0
90720,there,0,0
90721,is,0,0
90722,a,0,0
90723,certain,0,0
90724,level,0,0
90725,of,0,0
90726,pain,0,1
90727,at,0,0
90728,its,0,0
90729,administration,0,0
90730,.,0,1
90731,The,0,0
90732,safety,0,0
90733,of,0,0
90734,IV,0,1
90735,morphine,0,0
90736,on,0,0
90737,the,0,0
90738,general,0,1
90739,ward,0,1
90740,needs,0,0
90741,to,0,0
90742,be,0,0
90743,further,0,0
90744,explored,0,0
90745,in,0,0
90746,adequately,0,1
90747,controlled,0,1
90748,studies,0,0
90749,.,0,1
90750,Long-term,0,1
90751,follow-up,0,0
90752,of,0,0
90753,a,0,1
90754,phase,0,1
90755,I/II,0,0
90756,randomized,0,1
90757,",",0,0
90758,placebo-controlled,0,0
90759,trial,0,0
90760,of,0,0
90761,palifermin,0,0
90762,to,0,0
90763,prevent,0,0
90764,graft-versus-host,1,0
90765,disease,1,1
90766,(,1,1
90767,GVHD,1,1
90768,),1,1
90769,after,1,0
90770,related,1,0
90771,donor,1,1
90772,allogeneic,1,1
90773,hematopoietic,1,1
90774,cell,1,1
90775,transplantation,1,1
90776,(,1,1
90777,HCT,1,1
90778,),1,1
90779,.,1,1
90780,We,0,0
90781,previously,0,1
90782,conducted,0,0
90783,a,0,0
90784,randomized,0,0
90785,",",0,0
90786,double-blind,0,0
90787,",",0,0
90788,placebo-controlled,0,0
90789,study,1,0
90790,conducted,1,1
90791,from,1,1
90792,2000,1,1
90793,to,1,1
90794,2003,1,1
90795,of,1,0
90796,palifermin,1,0
90797,",",1,0
90798,a,1,0
90799,recombinant,1,0
90800,human,1,1
90801,keratinocyte,1,0
90802,growth,1,0
90803,factor,1,0
90804,",",1,0
90805,dosed,1,0
90806,from,1,1
90807,240,1,1
90808,microg/kg,1,0
90809,to,1,1
90810,720,1,1
90811,microg/kg,1,0
90812,",",1,1
90813,in,1,0
90814,100,1,1
90815,allogeneic,1,1
90816,hematopoietic,1,1
90817,stem,1,1
90818,cell,1,1
90819,transplantation,1,1
90820,(,1,1
90821,HCT,1,1
90822,),1,1
90823,recipients,1,1
90824,.,1,1
90825,Treatment,0,0
90826,with,0,1
90827,palifermin,0,0
90828,showed,0,0
90829,beneficial,0,0
90830,effects,0,0
90831,on,0,0
90832,mucositis,0,0
90833,",",0,0
90834,but,0,0
90835,no,0,0
90836,significant,0,0
90837,effect,0,0
90838,on,0,0
90839,engraftment,0,1
90840,",",0,1
90841,acute,0,1
90842,graft-versus-host,0,1
90843,disease,0,1
90844,(,0,1
90845,GVHD,0,1
90846,),0,1
90847,",",0,0
90848,or,0,1
90849,early,0,1
90850,survival,0,0
90851,.,0,1
90852,In,0,0
90853,addition,0,0
90854,to,0,0
90855,the,0,0
90856,effect,0,0
90857,of,0,0
90858,palifermin,0,0
90859,on,0,0
90860,mucosa,0,1
90861,",",0,1
90862,other,0,0
90863,pleotrophic,0,0
90864,effects,0,0
90865,",",0,0
90866,including,0,0
90867,more,0,0
90868,rapid,0,0
90869,immune,0,0
90870,reconstitution,0,1
90871,",",0,0
90872,have,0,0
90873,been,0,0
90874,seen,0,0
90875,in,0,0
90876,experimental,0,1
90877,transplant,0,1
90878,models,0,1
90879,.,0,1
90880,Therefore,0,0
90881,",",0,0
90882,we,0,0
90883,investigated,0,0
90884,whether,0,0
90885,with,0,1
90886,longer,0,0
90887,follow-up,0,0
90888,we,0,0
90889,could,0,0
90890,detect,0,0
90891,additional,0,0
90892,differences,0,0
90893,between,0,0
90894,the,0,1
90895,palifermin-treated,0,1
90896,and,0,1
90897,placebo,0,1
90898,cohorts,0,1
90899,.,0,1
90900,We,0,0
90901,found,0,0
90902,no,0,0
90903,differences,0,0
90904,in,0,1
90905,CMV,0,1
90906,or,0,1
90907,invasive,0,1
90908,fungal,0,1
90909,infections,0,1
90910,",",0,1
90911,chronic,0,1
90912,GVHD,0,1
90913,",",0,1
90914,or,0,1
90915,long-term,0,0
90916,survival,0,0
90917,between,0,0
90918,cohorts,0,1
90919,.,0,1
90920,We,0,0
90921,conclude,0,0
90922,that,0,0
90923,the,0,0
90924,benefits,0,0
90925,of,0,0
90926,palifermin,0,0
90927,appear,0,0
90928,primarily,0,0
90929,to,0,0
90930,be,0,0
90931,limited,0,0
90932,to,0,0
90933,ameliorating,0,0
90934,mucotoxicity,0,0
90935,when,0,0
90936,given,0,0
90937,to,0,0
90938,allogeneic,1,1
90939,HCT,1,1
90940,recipients,1,1
90941,.,1,1
90942,Randomized,0,1
90943,controlled,0,0
90944,trial,0,1
90945,of,0,0
90946,collaborative,0,1
90947,care,0,1
90948,management,0,1
90949,of,0,0
90950,depression,1,1
90951,among,1,1
90952,low-income,1,1
90953,patients,1,1
90954,with,1,1
90955,cancer,1,1
90956,.,1,1
90957,PURPOSE,0,0
90958,To,0,0
90959,determine,0,0
90960,the,0,0
90961,effectiveness,0,0
90962,of,0,0
90963,the,0,0
90964,Alleviating,0,0
90965,Depression,0,1
90966,Among,0,1
90967,Patients,1,1
90968,With,1,1
90969,Cancer,1,1
90970,(,0,1
90971,ADAPt-C,0,0
90972,),0,1
90973,collaborative,0,0
90974,care,0,1
90975,management,0,1
90976,for,0,0
90977,major,0,1
90978,depression,0,1
90979,or,0,1
90980,dysthymia,0,1
90981,.,0,1
90982,PATIENTS,0,0
90983,AND,0,0
90984,METHODS,0,0
90985,Study,1,1
90986,patients,1,1
90987,included,1,1
90988,472,1,1
90989,low-income,1,1
90990,",",1,0
90991,predominantly,1,1
90992,female,1,1
90993,Hispanic,1,1
90994,patients,1,1
90995,with,1,1
90996,cancer,1,1
90997,age,1,1
90998,>,1,1
90999,or=,1,1
91000,18,1,1
91001,years,1,1
91002,with,1,1
91003,major,1,1
91004,depression,1,1
91005,(,1,1
91006,49,1,1
91007,%,1,0
91008,),1,1
91009,",",1,0
91010,dysthymia,1,1
91011,(,1,1
91012,5,1,0
91013,%,1,0
91014,),1,1
91015,",",1,0
91016,or,1,1
91017,both,1,0
91018,(,1,0
91019,46,1,1
91020,%,1,0
91021,),1,1
91022,.,1,1
91023,Patients,1,1
91024,were,1,0
91025,randomly,1,1
91026,assigned,1,1
91027,to,1,0
91028,intervention,1,0
91029,(,1,1
91030,n,1,1
91031,=,1,1
91032,242,1,1
91033,),1,1
91034,or,1,1
91035,enhanced,1,0
91036,usual,1,1
91037,care,1,1
91038,(,1,1
91039,EUC,1,1
91040,;,1,1
91041,n,1,1
91042,=,1,1
91043,230,1,1
91044,),1,1
91045,.,1,1
91046,Intervention,0,1
91047,patients,0,1
91048,had,0,1
91049,access,0,0
91050,for,0,0
91051,up,0,1
91052,to,0,1
91053,12,0,1
91054,months,0,0
91055,to,0,1
91056,a,0,1
91057,depression,0,1
91058,clinical,0,0
91059,specialist,0,1
91060,(,0,1
91061,supervised,0,1
91062,by,0,0
91063,a,0,1
91064,psychiatrist,0,1
91065,),0,1
91066,who,0,1
91067,offered,0,1
91068,education,0,1
91069,",",0,0
91070,structured,0,0
91071,psychotherapy,0,1
91072,",",0,0
91073,and,0,0
91074,maintenance/relapse,0,0
91075,prevention,0,1
91076,support,0,0
91077,.,0,1
91078,The,0,0
91079,psychiatrist,0,0
91080,prescribed,0,0
91081,antidepressant,0,1
91082,medications,0,1
91083,for,0,1
91084,patients,0,1
91085,preferring,0,1
91086,or,0,1
91087,assessed,0,0
91088,to,0,0
91089,require,0,0
91090,medication,0,1
91091,.,0,1
91092,RESULTS,0,0
91093,At,0,1
91094,12,0,1
91095,months,0,1
91096,",",0,1
91097,63,0,1
91098,%,0,0
91099,of,0,1
91100,intervention,0,1
91101,patients,0,1
91102,had,0,1
91103,a,0,1
91104,50,0,1
91105,%,0,0
91106,or,0,1
91107,greater,0,0
91108,reduction,0,0
91109,in,0,0
91110,depressive,0,1
91111,symptoms,0,1
91112,from,0,1
91113,baseline,0,1
91114,as,0,0
91115,assessed,0,0
91116,by,0,0
91117,the,0,0
91118,Patient,0,0
91119,Health,0,0
91120,Questionnaire-9,0,0
91121,(,0,1
91122,PHQ-9,0,1
91123,),0,1
91124,depression,0,1
91125,scale,0,0
91126,compared,0,0
91127,with,0,1
91128,50,0,1
91129,%,0,0
91130,of,0,1
91131,EUC,0,1
91132,patients,0,1
91133,(,0,1
91134,odds,0,1
91135,ratio,0,1
91136,[,0,0
91137,OR,0,0
91138,],0,1
91139,=,0,1
91140,1.98,0,0
91141,;,0,0
91142,95,0,0
91143,%,0,0
91144,CI,0,0
91145,",",0,1
91146,1.16,0,0
91147,to,0,1
91148,3.38,0,0
91149,;,0,1
91150,P,0,0
91151,=,0,1
91152,.01,0,0
91153,),0,1
91154,.,0,1
91155,Improvement,0,0
91156,was,0,0
91157,also,0,0
91158,found,0,0
91159,for,0,0
91160,5-point,0,0
91161,decrease,0,0
91162,in,0,1
91163,PHQ-9,0,0
91164,score,0,1
91165,among,0,1
91166,72.2,0,0
91167,%,0,0
91168,of,0,1
91169,intervention,0,1
91170,patients,0,1
91171,compared,0,0
91172,with,0,1
91173,59.7,0,1
91174,%,0,0
91175,of,0,1
91176,EUC,0,1
91177,patients,0,1
91178,(,0,1
91179,OR,0,0
91180,=,0,1
91181,1.99,0,0
91182,;,0,0
91183,95,0,0
91184,%,0,0
91185,CI,0,0
91186,",",0,1
91187,1.14,0,0
91188,to,0,1
91189,3.50,0,0
91190,;,0,1
91191,P,0,0
91192,=,0,1
91193,.02,0,0
91194,),0,1
91195,.,0,1
91196,Intervention,0,1
91197,patients,0,1
91198,also,0,0
91199,experienced,0,1
91200,greater,0,0
91201,rates,0,0
91202,of,0,0
91203,depression,0,1
91204,treatment,0,1
91205,(,0,1
91206,72.3,0,1
91207,%,0,0
91208,v,0,0
91209,10.4,0,0
91210,%,0,0
91211,of,0,1
91212,EUC,0,1
91213,patients,0,1
91214,;,0,1
91215,P,0,0
91216,<,0,0
91217,.0001,0,0
91218,),0,1
91219,and,0,0
91220,significantly,0,0
91221,better,0,0
91222,quality-of-life,0,0
91223,outcomes,0,0
91224,",",0,1
91225,including,0,0
91226,social/family,0,0
91227,(,0,0
91228,adjusted,0,0
91229,mean,0,1
91230,difference,0,0
91231,between,0,0
91232,groups,0,0
91233,",",0,1
91234,2.7,0,1
91235,;,0,1
91236,95,0,0
91237,%,0,0
91238,CI,0,0
91239,",",0,1
91240,1.22,0,0
91241,to,0,1
91242,4.17,0,0
91243,;,0,1
91244,P,0,0
91245,<,0,0
91246,.001,0,0
91247,),0,1
91248,",",0,0
91249,emotional,0,0
91250,(,0,1
91251,adjusted,0,0
91252,mean,0,1
91253,difference,0,0
91254,",",0,1
91255,1.29,0,0
91256,;,0,1
91257,95,0,0
91258,%,0,0
91259,CI,0,0
91260,",",0,1
91261,0.26,0,0
91262,to,0,1
91263,2.22,0,0
91264,;,0,1
91265,P,0,0
91266,=,0,1
91267,.01,0,0
91268,),0,1
91269,",",0,0
91270,functional,0,0
91271,(,0,1
91272,adjusted,0,0
91273,mean,0,1
91274,difference,0,0
91275,",",0,1
91276,1.34,0,0
91277,;,0,1
91278,95,0,0
91279,%,0,0
91280,CI,0,0
91281,",",0,1
91282,0.08,0,0
91283,to,0,1
91284,2.59,0,0
91285,;,0,1
91286,P,0,0
91287,=,0,1
91288,.04,0,0
91289,),0,1
91290,",",0,0
91291,and,0,0
91292,physical,0,1
91293,well-being,0,0
91294,(,0,1
91295,adjusted,0,0
91296,mean,0,1
91297,difference,0,0
91298,",",0,1
91299,2.79,0,0
91300,;,0,1
91301,95,0,0
91302,%,0,0
91303,CI,0,0
91304,",",0,1
91305,0.49,0,0
91306,to,0,1
91307,5.1,0,1
91308,;,0,1
91309,P,0,0
91310,=,0,1
91311,.02,0,0
91312,),0,1
91313,.,0,1
91314,CONCLUSION,0,0
91315,ADAPt-C,0,0
91316,collaborative,0,0
91317,care,0,1
91318,is,0,0
91319,feasible,0,0
91320,and,0,0
91321,results,0,0
91322,in,0,1
91323,significant,0,0
91324,reduction,0,0
91325,in,0,1
91326,depressive,0,1
91327,symptoms,0,1
91328,",",0,1
91329,improvement,0,0
91330,in,0,0
91331,quality,0,0
91332,of,0,0
91333,life,0,0
91334,",",0,0
91335,and,0,0
91336,lower,0,0
91337,pain,0,1
91338,levels,0,0
91339,compared,0,0
91340,with,0,1
91341,EUC,0,1
91342,for,0,1
91343,patients,1,1
91344,with,1,1
91345,depressive,1,1
91346,disorders,1,1
91347,in,1,1
91348,a,1,1
91349,low-income,1,1
91350,",",1,0
91351,predominantly,1,1
91352,Hispanic,1,1
91353,population,1,1
91354,in,1,1
91355,public,1,1
91356,sector,1,1
91357,oncology,1,1
91358,clinics,1,1
91359,.,1,1
91360,CASTLE,0,0
91361,data,1,0
91362,show,1,0
91363,no,1,0
91364,gender,1,0
91365,differences,1,0
91366,.,1,1
91367,Safety,0,0
91368,of,0,0
91369,ferumoxytol,0,0
91370,in,0,1
91371,patients,1,1
91372,with,1,1
91373,anemia,1,1
91374,and,1,1
91375,CKD,1,1
91376,.,1,1
91377,BACKGROUND,0,0
91378,Iron,0,0
91379,deficiency,0,1
91380,anemia,0,1
91381,is,0,0
91382,a,0,0
91383,common,0,0
91384,complication,0,0
91385,in,0,1
91386,patients,1,1
91387,with,1,1
91388,chronic,1,1
91389,kidney,1,1
91390,disease,1,1
91391,(,1,1
91392,CKD,1,1
91393,),1,1
91394,.,1,1
91395,Currently,0,1
91396,available,0,0
91397,intravenous,0,1
91398,(,0,1
91399,IV,0,1
91400,),0,1
91401,iron,0,0
91402,replacement,0,1
91403,therapies,0,0
91404,have,0,0
91405,either,0,1
91406,inconvenient,0,0
91407,regimens,0,0
91408,of,0,1
91409,administration,0,0
91410,or,0,1
91411,adverse,0,0
91412,event,0,0
91413,profiles,0,0
91414,that,0,0
91415,limit,0,0
91416,their,0,0
91417,utility,0,0
91418,in,0,0
91419,the,0,0
91420,outpatient,1,1
91421,setting,0,1
91422,.,0,1
91423,Ferumoxytol,0,0
91424,is,0,0
91425,a,0,0
91426,novel,0,0
91427,",",0,0
91428,semisynthetic,0,1
91429,",",0,0
91430,carbohydrate-coated,0,0
91431,",",0,0
91432,superparamagnetic,0,0
91433,iron,0,0
91434,oxide,0,0
91435,nanoparticle,0,0
91436,that,0,0
91437,is,0,0
91438,administered,0,0
91439,IV,0,0
91440,as,0,0
91441,an,0,1
91442,injection,0,0
91443,.,0,0
91444,The,0,0
91445,main,0,0
91446,objective,0,0
91447,of,0,0
91448,this,0,0
91449,study,0,0
91450,was,0,0
91451,to,0,0
91452,assess,0,0
91453,the,0,0
91454,safety,0,0
91455,of,0,0
91456,ferumoxytol,0,0
91457,for,0,0
91458,the,0,0
91459,treatment,0,0
91460,of,0,0
91461,patients,1,1
91462,with,1,1
91463,CKD,1,1
91464,stages,1,1
91465,1,1,0
91466,to,1,0
91467,5,1,1
91468,and,1,1
91469,5D,1,0
91470,.,1,1
91471,STUDY,0,0
91472,DESIGN,0,1
91473,Phase,0,1
91474,3,0,1
91475,",",0,0
91476,randomized,0,1
91477,",",0,0
91478,double-blind,0,0
91479,",",0,0
91480,placebo-controlled,0,0
91481,",",0,0
91482,crossover,0,0
91483,",",0,0
91484,multicenter,0,0
91485,study,0,0
91486,of,0,0
91487,a,0,1
91488,single,0,0
91489,510-mg,0,1
91490,dose,0,0
91491,of,0,0
91492,ferumoxytol,0,0
91493,versus,0,0
91494,saline,0,0
91495,as,0,0
91496,placebo,0,1
91497,.,0,1
91498,SETTING,0,1
91499,&,0,1
91500,PARTICIPANTS,0,1
91501,750,1,1
91502,patients,1,1
91503,with,1,1
91504,CKD,1,1
91505,stages,1,1
91506,1,1,0
91507,to,1,0
91508,5,1,1
91509,and,1,1
91510,5D,1,0
91511,.,1,1
91512,INTERVENTION,0,0
91513,An,0,0
91514,IV,0,0
91515,injection,0,0
91516,of,0,0
91517,either,0,1
91518,17,0,1
91519,mL,0,0
91520,of,0,0
91521,ferumoxytol,0,0
91522,or,0,1
91523,saline,0,0
91524,placebo,0,0
91525,over,0,0
91526,17,0,1
91527,seconds,0,0
91528,on,0,1
91529,day,0,1
91530,0,0,0
91531,and,0,0
91532,the,0,0
91533,alternate,0,0
91534,agent,0,0
91535,on,0,0
91536,day,0,0
91537,7,0,1
91538,.,0,1
91539,OUTCOMES,0,0
91540,&,0,1
91541,MEASUREMENTS,0,0
91542,Descriptive,0,1
91543,comparison,0,0
91544,of,0,1
91545,adverse,0,0
91546,events,0,0
91547,",",0,1
91548,laboratory,0,1
91549,tests,0,0
91550,",",0,1
91551,and,0,1
91552,vital,0,1
91553,signs,0,1
91554,.,0,1
91555,RESULTS,0,0
91556,Of,0,1
91557,750,1,1
91558,randomly,1,1
91559,assigned,1,1
91560,patients,1,1
91561,with,1,1
91562,CKD,1,1
91563,",",1,1
91564,60,1,1
91565,%,1,0
91566,were,1,0
91567,not,1,0
91568,on,1,0
91569,dialysis,1,1
91570,therapy,1,1
91571,.,1,1
91572,713,1,1
91573,patients,1,1
91574,received,1,1
91575,ferumoxytol,1,0
91576,",",1,1
91577,and,1,1
91578,711,1,1
91579,received,1,1
91580,placebo,1,0
91581,.,1,0
91582,There,0,0
91583,were,0,0
91584,420,1,0
91585,adverse,1,0
91586,events,1,0
91587,reported,1,1
91588,;,1,1
91589,242,1,1
91590,in,1,1
91591,152,1,1
91592,patients,1,1
91593,(,1,1
91594,21.3,1,0
91595,%,1,0
91596,),1,1
91597,with,1,1
91598,ferumoxytol,1,0
91599,and,1,1
91600,178,1,1
91601,in,1,1
91602,119,1,1
91603,patients,1,1
91604,(,1,1
91605,16.7,1,1
91606,%,1,0
91607,),1,1
91608,with,1,1
91609,placebo,1,0
91610,.,1,1
91611,The,0,0
91612,incidence,0,0
91613,of,0,0
91614,related,0,0
91615,adverse,0,0
91616,events,0,0
91617,was,0,0
91618,5.2,0,0
91619,%,0,0
91620,with,0,1
91621,ferumoxytol,0,0
91622,and,0,1
91623,4.5,0,0
91624,%,0,0
91625,with,0,1
91626,placebo,0,0
91627,.,0,1
91628,The,0,0
91629,most,0,0
91630,common,0,0
91631,related,0,0
91632,adverse,0,0
91633,events,0,0
91634,after,0,1
91635,each,0,1
91636,treatment,0,0
91637,included,0,1
91638,symptoms,0,0
91639,related,0,0
91640,to,0,1
91641,the,0,0
91642,injection/infusion,0,0
91643,site,0,0
91644,",",0,0
91645,dizziness,0,0
91646,",",0,0
91647,pruritus,0,0
91648,",",0,0
91649,headache,0,0
91650,",",0,0
91651,fatigue,0,0
91652,",",0,0
91653,and,0,0
91654,nausea,0,0
91655,.,0,1
91656,Serious,0,0
91657,adverse,0,0
91658,events,0,0
91659,occurred,0,0
91660,in,0,1
91661,21,0,1
91662,patients,0,1
91663,(,0,1
91664,2.9,0,1
91665,%,0,0
91666,),0,1
91667,after,0,0
91668,ferumoxytol,0,0
91669,and,0,1
91670,13,0,1
91671,patients,0,1
91672,(,0,1
91673,1.8,0,1
91674,%,0,0
91675,),0,1
91676,after,0,0
91677,placebo,0,1
91678,.,0,1
91679,Serious,0,0
91680,related,0,0
91681,adverse,0,0
91682,events,0,0
91683,were,0,1
91684,observed,0,0
91685,in,0,1
91686,1,0,1
91687,patient,0,1
91688,(,0,1
91689,0.1,0,0
91690,%,0,0
91691,),0,1
91692,after,0,0
91693,each,0,1
91694,treatment,0,0
91695,.,0,0
91696,There,0,0
91697,was,0,0
91698,no,0,0
91699,meaningful,0,0
91700,decrease,0,0
91701,in,0,0
91702,blood,0,0
91703,pressure,0,0
91704,after,0,0
91705,administration,0,0
91706,of,0,0
91707,ferumoxytol,0,0
91708,or,0,1
91709,placebo,0,0
91710,.,0,1
91711,LIMITATIONS,0,0
91712,Follow-up,0,0
91713,was,0,0
91714,7,0,1
91715,days,0,0
91716,after,0,1
91717,each,0,1
91718,study,0,1
91719,treatment,0,0
91720,.,0,1
91721,CONCLUSIONS,0,0
91722,Ferumoxytol,0,0
91723,is,0,0
91724,well,0,0
91725,tolerated,0,0
91726,and,0,0
91727,has,0,0
91728,a,0,0
91729,safety,0,0
91730,profile,0,0
91731,similar,0,0
91732,to,0,0
91733,placebo,0,0
91734,in,0,0
91735,anemic,1,1
91736,patients,1,1
91737,with,1,1
91738,CKD,1,1
91739,stages,1,1
91740,1,1,0
91741,to,1,0
91742,5,1,1
91743,and,1,1
91744,5D,1,0
91745,.,1,1
91746,Development,0,0
91747,of,0,1
91748,autistic,1,1
91749,children,1,1
91750,based,0,1
91751,on,0,1
91752,maternal,0,1
91753,responses,0,0
91754,to,0,1
91755,the,0,1
91756,Autism,0,1
91757,Behavior,0,1
91758,Checklist,0,0
91759,.,0,1
91760,BACKGROUND,0,0
91761,language,0,0
91762,and,0,1
91763,speech-language,0,1
91764,intervention,0,1
91765,.,0,1
91766,AIM,0,0
91767,to,0,0
91768,evaluate,0,0
91769,the,0,0
91770,development,0,0
91771,process,0,0
91772,of,0,1
91773,autistic,1,1
91774,children,1,1
91775,",",0,1
91776,in,0,0
91777,a,0,1
91778,direct,0,0
91779,and,0,0
91780,indirect,0,0
91781,intervention,0,1
91782,context,0,0
91783,based,0,1
91784,on,0,0
91785,the,0,0
91786,responses,0,0
91787,of,0,1
91788,mothers,0,1
91789,to,0,1
91790,the,0,1
91791,Autism,0,1
91792,Behavior,0,1
91793,Checklist,0,0
91794,.,0,1
91795,METHOD,0,0
91796,the,0,0
91797,research,0,0
91798,sample,0,1
91799,consisted,0,1
91800,of,0,1
91801,11,1,1
91802,mothers,1,1
91803,of,1,1
91804,children,1,1
91805,diagnosed,1,1
91806,",",1,1
91807,according,1,0
91808,to,1,0
91809,the,1,1
91810,criteria,1,1
91811,established,1,0
91812,by,1,0
91813,the,1,0
91814,DSM,1,1
91815,IVtr,1,0
91816,(,1,1
91817,APA,1,1
91818,",",1,1
91819,2002,1,1
91820,),1,0
91821,",",1,0
91822,with,1,1
91823,autism,1,1
91824,(,1,1
91825,six,1,1
91826,),1,1
91827,and,1,1
91828,with,1,1
91829,Asperger,1,1
91830,Syndrome,1,1
91831,(,1,1
91832,five,1,1
91833,),1,1
91834,and,1,1
91835,who,1,1
91836,were,1,1
91837,seen,1,1
91838,at,1,0
91839,the,1,0
91840,Investigation,1,0
91841,Laboratory,1,1
91842,of,1,1
91843,Global,1,1
91844,Developmental,1,1
91845,Disorders,1,1
91846,of,1,0
91847,the,1,0
91848,Federal,1,1
91849,University,1,1
91850,of,1,1
91851,S?o,1,1
91852,Paulo,1,1
91853,.,1,1
91854,These,0,1
91855,children,0,1
91856,were,0,1
91857,randomly,0,1
91858,divided,0,1
91859,into,0,1
91860,two,0,1
91861,groups,0,1
91862,:,0,1
91863,Six,0,1
91864,were,0,1
91865,receiving,0,1
91866,both,0,0
91867,direct,0,0
91868,and,0,0
91869,indirect,0,0
91870,intervention,0,1
91871,(,0,1
91872,TG,0,0
91873,),0,1
91874,",",0,0
91875,and,0,1
91876,five,0,1
91877,were,0,1
91878,receiving,0,1
91879,indirect,0,0
91880,intervention,0,1
91881,exclusively,0,1
91882,(,0,1
91883,OG,0,0
91884,),0,1
91885,.,0,1
91886,The,0,0
91887,Autism,0,1
91888,Behavior,0,1
91889,Checklist,0,0
91890,(,0,1
91891,Krug,0,0
91892,et,0,1
91893,al.,0,1
91894,",",0,0
91895,1993,0,1
91896,),0,1
91897,was,0,0
91898,used,0,0
91899,",",0,0
91900,adapted,0,0
91901,to,0,0
91902,the,1,0
91903,Portuguese,1,1
91904,language,1,0
91905,by,0,0
91906,Marteleto,0,1
91907,(,0,1
91908,2003,0,1
91909,),0,1
91910,.,0,1
91911,This,0,0
91912,behavior,0,0
91913,checklist,0,0
91914,(,0,1
91915,57,0,1
91916,items,0,0
91917,),0,1
91918,allows,0,0
91919,the,0,0
91920,detailed,0,0
91921,description,0,0
91922,of,0,1
91923,non-adaptable,0,1
91924,characteristics,0,1
91925,regarding,0,0
91926,the,0,1
91927,following,0,1
91928,areas,0,0
91929,:,0,1
91930,sensory,0,0
91931,",",0,0
91932,use,0,0
91933,of,0,0
91934,the,0,0
91935,body,0,1
91936,and,0,0
91937,object,0,0
91938,",",0,0
91939,Language,0,0
91940,",",0,0
91941,Psycho-social,0,0
91942,and,0,1
91943,Relational,0,0
91944,.,0,1
91945,The,0,0
91946,questionnaire,0,0
91947,was,0,0
91948,filled,0,0
91949,in,0,0
91950,during,0,0
91951,an,0,0
91952,interview,0,1
91953,on,0,0
91954,three,0,1
91955,occasions,0,1
91956,:,0,1
91957,at,0,1
91958,the,0,0
91959,beginning,0,0
91960,of,0,0
91961,intervention,0,0
91962,",",0,1
91963,after,0,0
91964,six,0,1
91965,months,0,1
91966,and,0,1
91967,at,0,1
91968,the,0,0
91969,end,0,0
91970,of,0,0
91971,12,0,1
91972,months,0,1
91973,.,0,1
91974,RESULTS,0,0
91975,after,0,0
91976,statistical,0,0
91977,analysis,0,0
91978,it,0,0
91979,was,0,0
91980,observed,0,0
91981,that,0,0
91982,there,0,0
91983,was,0,0
91984,a,0,0
91985,greater,0,0
91986,development,0,0
91987,in,0,0
91988,the,0,0
91989,total,0,1
91990,scores,0,0
91991,and,0,1
91992,in,0,1
91993,the,0,0
91994,areas,0,0
91995,of,0,0
91996,language,0,1
91997,",",0,1
91998,psycho-social,0,0
91999,and,0,0
92000,relational,0,0
92001,for,0,0
92002,the,0,0
92003,TG,0,0
92004,.,0,0
92005,This,0,0
92006,suggests,0,0
92007,a,0,0
92008,greater,0,0
92009,development,0,0
92010,pattern,0,1
92011,during,0,0
92012,the,0,0
92013,studied,0,1
92014,period,0,0
92015,for,0,0
92016,this,0,0
92017,group,0,1
92018,.,0,1
92019,CONCLUSION,0,0
92020,the,1,0
92021,mothers,1,1
92022,of,0,0
92023,both,0,0
92024,groups,0,0
92025,observed,0,0
92026,behavioral,0,1
92027,changes,0,0
92028,.,0,1
92029,The,0,0
92030,better,0,0
92031,scores,0,0
92032,observed,0,0
92033,for,0,0
92034,the,0,0
92035,TG,0,0
92036,is,0,0
92037,probably,0,0
92038,related,0,0
92039,to,0,0
92040,the,0,0
92041,effectiveness,0,0
92042,of,0,0
92043,direct,0,0
92044,intervention,0,0
92045,",",0,0
92046,and,0,0
92047,not,0,0
92048,to,0,0
92049,the,0,0
92050,lack,0,0
92051,of,0,0
92052,attention,0,0
92053,of,1,1
92054,parents,1,1
92055,in,0,1
92056,the,0,0
92057,OG,0,0
92058,in,0,0
92059,recognizing,0,1
92060,behavioral,0,1
92061,changes,0,0
92062,in,0,1
92063,their,0,1
92064,children,0,1
92065,.,0,1
92066,Bacterial,0,1
92067,ribosomal,0,1
92068,immunostimulants,0,0
92069,prime,0,1
92070,alveolar,0,1
92071,macrophages,0,1
92072,in,0,1
92073,vivo,0,0
92074,to,0,0
92075,produce,0,0
92076,interleukin,0,0
92077,1,0,0
92078,in,0,1
92079,vitro,0,0
92080,.,0,1
92081,Alveolar,0,0
92082,macrophages,0,1
92083,(,0,1
92084,AMs,0,1
92085,),0,1
92086,may,0,0
92087,play,0,0
92088,a,0,0
92089,key,0,0
92090,role,0,0
92091,in,0,1
92092,human,0,1
92093,respiratory,0,1
92094,immune,0,0
92095,defenses,0,0
92096,",",0,0
92097,partially,0,0
92098,by,0,0
92099,synthesizing,0,0
92100,and,0,1
92101,releasing,0,0
92102,interleukin,0,0
92103,1,0,1
92104,(,0,1
92105,IL,0,1
92106,=,0,1
92107,1,0,1
92108,),0,1
92109,.,0,1
92110,D53,0,0
92111,(,0,0
92112,Ribomunyl,0,1
92113,),0,1
92114,",",0,0
92115,a,0,0
92116,composite,0,0
92117,bacterial,0,0
92118,ribosomal,0,0
92119,immunostimulant,0,0
92120,",",0,0
92121,has,0,0
92122,been,0,0
92123,recognized,0,0
92124,as,0,0
92125,an,0,0
92126,efficient,0,0
92127,prevention,0,1
92128,of,0,0
92129,respiratory,0,1
92130,tract,0,1
92131,infections,0,1
92132,.,0,1
92133,In,0,0
92134,vitro,0,0
92135,",",0,0
92136,D53,0,0
92137,enhances,0,0
92138,the,0,0
92139,IL-1,0,0
92140,production,0,0
92141,by,0,0
92142,mouse,0,1
92143,spleen,0,1
92144,adherent,0,1
92145,cells,0,0
92146,.,0,1
92147,A,0,1
92148,thymocyte,0,0
92149,proliferative,0,1
92150,response,0,0
92151,assay,0,0
92152,was,0,0
92153,used,0,0
92154,to,0,0
92155,evaluate,0,0
92156,the,0,0
92157,in,0,0
92158,vitro,0,0
92159,IL-1,0,1
92160,production,0,0
92161,by,0,0
92162,AMs,0,1
92163,in,0,1
92164,healthy,1,1
92165,subjects,1,1
92166,who,1,1
92167,received,1,1
92168,D53,1,1
92169,immunostimulant,1,0
92170,.,1,1
92171,Twelve,1,1
92172,nonsmoking,1,1
92173,healthy,1,1
92174,subjects,1,1
92175,took,0,1
92176,part,0,1
92177,in,0,0
92178,a,0,1
92179,prospective,0,1
92180,double-blind,0,0
92181,placebo,0,0
92182,control,0,1
92183,study,0,1
92184,.,0,1
92185,On,0,0
92186,day,0,0
92187,1,0,0
92188,",",0,0
92189,a,0,0
92190,first,0,0
92191,bronchoalveolar,0,1
92192,lavage,0,1
92193,(,0,1
92194,BAL,0,1
92195,),0,1
92196,was,0,0
92197,performed,0,0
92198,to,0,0
92199,assess,0,0
92200,IL-1,0,1
92201,production,0,0
92202,by,0,0
92203,unstimulated,0,0
92204,and,0,1
92205,lipopolysaccharide,0,0
92206,(,0,1
92207,LPS,0,1
92208,),0,1
92209,stimulated,0,1
92210,AM,0,1
92211,.,0,1
92212,Then,0,0
92213,",",0,0
92214,subjects,0,1
92215,were,0,1
92216,randomized,0,1
92217,to,0,0
92218,receive,0,1
92219,D53,0,1
92220,(,0,1
92221,n,0,1
92222,=,0,1
92223,6,0,1
92224,),0,1
92225,or,0,1
92226,its,0,0
92227,placebo,0,0
92228,(,0,1
92229,n,0,1
92230,=,0,1
92231,6,0,1
92232,),0,1
92233,by,0,0
92234,both,0,0
92235,oral,0,0
92236,and,0,0
92237,subcutaneous,0,1
92238,injection,0,0
92239,routes,0,0
92240,from,0,1
92241,day,0,1
92242,1,0,1
92243,to,0,1
92244,day,0,1
92245,15,0,1
92246,.,0,1
92247,On,0,0
92248,day,0,0
92249,15,0,1
92250,",",0,0
92251,a,0,0
92252,second,0,0
92253,BAL,0,1
92254,was,0,0
92255,done,0,0
92256,and,0,1
92257,AM,0,1
92258,IL-1,0,1
92259,production,0,0
92260,was,0,0
92261,again,0,0
92262,tested,0,0
92263,.,0,1
92264,IL-1,0,1
92265,production,0,0
92266,on,0,0
92267,day,0,0
92268,15,0,1
92269,did,0,0
92270,not,0,0
92271,significantly,0,0
92272,differ,0,0
92273,from,0,0
92274,day,0,0
92275,1,0,1
92276,in,0,0
92277,both,0,0
92278,D53-treated,0,1
92279,and,0,0
92280,placebo,0,1
92281,groups,0,0
92282,either,0,0
92283,when,0,0
92284,AMs,0,1
92285,were,0,0
92286,unstimulated,0,0
92287,or,0,1
92288,were,0,1
92289,stimulated,0,0
92290,with,0,1
92291,concentrations,0,0
92292,of,0,1
92293,LPS,0,1
92294,resulting,0,0
92295,in,0,0
92296,maximal,0,0
92297,IL-1,0,1
92298,production,0,0
92299,.,0,1
92300,However,0,0
92301,",",0,0
92302,in,0,0
92303,the,0,0
92304,D53-treated,0,1
92305,group,0,0
92306,",",0,0
92307,but,0,0
92308,not,0,0
92309,in,0,0
92310,the,0,0
92311,placebo,0,0
92312,group,0,0
92313,",",0,0
92314,IL-1,0,1
92315,production,0,0
92316,induced,0,0
92317,by,0,0
92318,low,0,1
92319,LPS,0,1
92320,concentration,0,0
92321,(,0,1
92322,5,0,0
92323,mg/L,0,1
92324,),0,1
92325,was,0,0
92326,significantly,0,0
92327,higher,0,0
92328,(,0,0
92329,mean,0,1
92330,+/-,0,1
92331,SEM,0,1
92332,:,0,1
92333,"1,238",0,1
92334,+/-,0,1
92335,287,0,1
92336,U/10,0,1
92337,(,0,1
92338,6,0,1
92339,),0,1
92340,AM,0,1
92341,),0,1
92342,on,0,0
92343,day,0,0
92344,15,0,1
92345,in,0,0
92346,comparison,0,0
92347,with,0,1
92348,day,0,0
92349,1,0,1
92350,(,0,1
92351,577,0,1
92352,+/-,0,1
92353,113,0,1
92354,U/10,0,1
92355,(,0,1
92356,6,0,0
92357,),0,1
92358,AM,0,1
92359,;,0,0
92360,p,0,0
92361,less,0,0
92362,than,0,0
92363,0.05,0,0
92364,",",0,1
92365,Wilcoxon,0,0
92366,W,0,0
92367,test,0,0
92368,),0,1
92369,and,0,0
92370,in,0,0
92371,comparison,0,0
92372,with,0,1
92373,the,0,0
92374,control,0,1
92375,group,0,0
92376,(,0,1
92377,day,0,0
92378,15,0,1
92379,IL-1,0,1
92380,production,0,0
92381,induced,0,0
92382,by,0,0
92383,5,0,1
92384,mg/L,0,1
92385,LPS,0,0
92386,",",0,1
92387,758,0,1
92388,+/-,0,0
92389,175,0,1
92390,U/10,0,1
92391,(,0,1
92392,6,0,0
92393,),0,1
92394,AM,0,1
92395,;,0,0
92396,p,0,0
92397,less,0,0
92398,than,0,0
92399,0.05,0,0
92400,",",0,1
92401,Mann-Whitney,0,0
92402,U,0,1
92403,test,0,0
92404,),0,1
92405,.,0,1
92406,Moreover,0,0
92407,",",0,0
92408,in,0,0
92409,the,0,0
92410,D53-treated,0,1
92411,group,0,0
92412,",",0,0
92413,the,0,0
92414,optimal,0,0
92415,LPS,0,0
92416,concentration,0,0
92417,(,0,1
92418,ie,0,1
92419,",",0,1
92420,LPS,0,0
92421,concentration,0,0
92422,that,0,0
92423,induced,0,0
92424,maximal,0,0
92425,IL-1,0,1
92426,production,0,0
92427,),0,0
92428,was,0,0
92429,significantly,0,0
92430,lower,0,0
92431,on,0,0
92432,day,0,0
92433,15,0,1
92434,(,0,1
92435,mean,0,1
92436,+/-,0,1
92437,SD,0,1
92438,:,0,1
92439,11,0,1
92440,+/-,0,0
92441,7,0,1
92442,mg/L,0,1
92443,),0,1
92444,than,0,0
92445,on,0,0
92446,day,0,1
92447,1,0,1
92448,(,0,1
92449,16,0,1
92450,+/-,0,1
92451,7,0,1
92452,mg/L,0,1
92453,;,0,0
92454,p,0,0
92455,less,0,0
92456,than,0,0
92457,0.05,0,0
92458,Wilcoxon,0,0
92459,W,0,1
92460,test,0,0
92461,),0,1
92462,.,0,1
92463,We,0,0
92464,conclude,0,0
92465,that,0,0
92466,D53,0,1
92467,immunostimulant,0,0
92468,in,0,1
92469,vivo,0,0
92470,primes,0,1
92471,AM,0,1
92472,to,0,0
92473,produce,0,0
92474,IL-1,0,1
92475,following,0,0
92476,low,0,1
92477,LPS,0,1
92478,concentration,0,0
92479,stimulation,0,0
92480,.,0,0
92481,This,0,0
92482,may,0,0
92483,partially,0,0
92484,explain,0,0
92485,the,0,0
92486,protective,0,0
92487,effect,0,0
92488,of,0,0
92489,D53,0,1
92490,immunostimulant,0,1
92491,against,0,0
92492,respiratory,1,1
92493,tract,1,1
92494,infection,1,1
92495,.,1,1
92496,Effect,0,0
92497,of,0,0
92498,diltiazem,0,0
92499,on,0,0
92500,symptomatic,1,1
92501,and,1,1
92502,asymptomatic,1,1
92503,episodes,1,1
92504,of,1,1
92505,ST,1,1
92506,segment,1,1
92507,depression,1,1
92508,occurring,1,1
92509,during,1,0
92510,daily,1,0
92511,life,1,1
92512,and,1,0
92513,during,1,0
92514,exercise,1,1
92515,.,1,1
92516,BACKGROUND,0,0
92517,Silent,0,1
92518,myocardial,0,1
92519,ischemia,0,1
92520,is,0,0
92521,an,0,0
92522,adverse,0,0
92523,prognostic,0,0
92524,marker,0,0
92525,in,0,1
92526,patients,1,1
92527,with,1,1
92528,coronary,1,1
92529,disease,1,1
92530,;,1,0
92531,however,0,0
92532,",",0,0
92533,controlled,0,0
92534,data,0,0
92535,on,0,0
92536,the,0,0
92537,effect,0,0
92538,of,0,0
92539,treatment,0,0
92540,are,0,0
92541,sparse,0,0
92542,and,0,0
92543,contradictory,0,0
92544,",",0,0
92545,and,0,0
92546,the,0,0
92547,relations,0,0
92548,among,0,0
92549,the,0,0
92550,occurrence,0,0
92551,of,0,0
92552,ST,0,1
92553,segment,0,1
92554,depression,0,1
92555,",",0,0
92556,drug,0,0
92557,efficacy,0,0
92558,",",0,0
92559,and,0,0
92560,heart,0,1
92561,rate,0,0
92562,are,0,0
92563,unclear,0,0
92564,.,0,1
92565,METHODS,0,0
92566,AND,0,0
92567,RESULTS,0,1
92568,Sixty,1,1
92569,patients,1,1
92570,with,1,1
92571,stable,1,1
92572,coronary,1,1
92573,artery,1,1
92574,disease,1,1
92575,",",1,0
92576,a,1,0
92577,positive,1,0
92578,treadmill,1,0
92579,exercise,1,0
92580,test,1,0
92581,and,1,1
92582,asymptomatic,1,1
92583,ST,1,1
92584,segment,1,1
92585,depression,1,1
92586,on,1,0
92587,ambulatory,1,1
92588,electrocardiographic,1,1
92589,recording,1,1
92590,were,1,1
92591,assessed,1,0
92592,in,1,0
92593,a,1,0
92594,multicenter,1,0
92595,",",1,0
92596,double-blind,1,0
92597,",",1,0
92598,placebo-controlled,1,0
92599,",",1,0
92600,cross-over,1,0
92601,trial,1,1
92602,.,1,1
92603,Treadmill,0,0
92604,exercise,0,0
92605,tests,0,0
92606,and,0,1
92607,72-hour,0,1
92608,electrocardiographic,0,1
92609,recordings,0,1
92610,were,0,1
92611,obtained,0,0
92612,at,0,0
92613,the,0,0
92614,end,0,0
92615,of,0,0
92616,two,0,0
92617,2-week,0,0
92618,treatment,0,1
92619,periods,0,0
92620,with,0,1
92621,sustained-release,0,1
92622,diltiazem,0,0
92623,180,0,1
92624,mg,0,0
92625,b.i.d,0,1
92626,.,0,1
92627,or,0,0
92628,equivalent,0,0
92629,placebo,0,1
92630,.,0,1
92631,Episodes,0,1
92632,of,0,0
92633,asymptomatic,0,1
92634,ST,0,1
92635,depression,0,1
92636,decreased,0,0
92637,by,0,0
92638,50,0,1
92639,%,0,0
92640,or,0,1
92641,more,0,0
92642,in,0,1
92643,70,0,1
92644,%,0,0
92645,of,0,0
92646,the,0,0
92647,patients,0,1
92648,from,0,1
92649,a,0,1
92650,median,0,0
92651,number,0,0
92652,of,0,1
92653,4.5,0,0
92654,(,0,1
92655,range,0,1
92656,",",0,0
92657,0-19,0,1
92658,),0,1
92659,to,0,1
92660,1.5,0,0
92661,(,0,1
92662,range,0,1
92663,",",0,0
92664,0-13,0,1
92665,),0,1
92666,(,0,1
92667,p,0,0
92668,=,0,1
92669,0.0001,0,0
92670,),0,1
92671,;,0,1
92672,their,0,1
92673,cumulative,0,0
92674,duration,0,0
92675,also,0,0
92676,decreased,0,0
92677,from,0,1
92678,78.5,0,1
92679,(,0,1
92680,range,0,1
92681,",",0,0
92682,0-60,0,0
92683,),0,1
92684,to,0,1
92685,24.5,0,0
92686,(,0,1
92687,range,0,1
92688,",",0,0
92689,0-411,0,0
92690,),0,1
92691,minutes,0,0
92692,(,0,1
92693,p,0,0
92694,=,0,1
92695,0.001,0,0
92696,),0,1
92697,.,0,1
92698,No,0,0
92699,circadian,0,0
92700,variation,0,0
92701,was,0,0
92702,found,0,0
92703,in,0,0
92704,the,0,0
92705,efficacy,0,0
92706,of,0,0
92707,diltiazem,0,0
92708,.,0,1
92709,The,0,0
92710,occurrence,0,0
92711,of,0,0
92712,ischemic,0,1
92713,type,0,1
92714,ST,0,1
92715,segment,0,1
92716,depression,0,1
92717,was,0,0
92718,modulated,0,0
92719,by,0,0
92720,changes,0,0
92721,in,0,1
92722,heart,0,1
92723,rate,0,0
92724,rather,0,0
92725,than,0,0
92726,by,0,0
92727,absolute,0,0
92728,heart,0,1
92729,rate,0,0
92730,.,0,1
92731,Diltiazem,0,0
92732,also,0,0
92733,improved,0,0
92734,exercise,0,0
92735,test,0,0
92736,end,0,0
92737,points,0,0
92738,but,0,0
92739,to,0,0
92740,a,0,0
92741,lesser,0,0
92742,extent,0,0
92743,.,0,1
92744,Time,0,0
92745,to,0,0
92746,ST,0,1
92747,segment,0,1
92748,depression,0,1
92749,increased,0,0
92750,to,0,1
92751,341,0,1
92752,+/-,0,0
92753,148,0,1
92754,from,0,1
92755,296,0,1
92756,+/-,0,1
92757,154,0,1
92758,seconds,0,0
92759,(,0,1
92760,p,0,0
92761,=,0,1
92762,0.005,0,0
92763,),0,1
92764,.,0,1
92765,Although,0,0
92766,less,0,0
92767,frequent,0,1
92768,with,0,1
92769,diltiazem,0,0
92770,administration,0,0
92771,(,0,1
92772,45,0,1
92773,versus,0,0
92774,54,0,1
92775,patients,0,1
92776,",",0,0
92777,p,0,0
92778,less,0,0
92779,than,0,0
92780,0.03,0,0
92781,),0,1
92782,",",0,1
92783,exercise-induced,0,0
92784,ST,0,1
92785,depression,0,1
92786,was,0,0
92787,more,0,0
92788,often,0,0
92789,asymptomatic,0,1
92790,(,0,1
92791,98,0,1
92792,%,0,0
92793,versus,0,0
92794,72,0,1
92795,%,0,0
92796,of,0,1
92797,patients,0,1
92798,",",0,0
92799,p,0,0
92800,less,0,0
92801,than,0,0
92802,0.0001,0,0
92803,),0,1
92804,.,0,1
92805,CONCLUSIONS,0,0
92806,Diltiazem,0,0
92807,reduces,0,0
92808,the,0,0
92809,frequency,0,0
92810,and,0,0
92811,severity,0,0
92812,of,0,0
92813,ischemic,0,1
92814,type,0,1
92815,ST,0,1
92816,depression,0,1
92817,in,0,1
92818,patients,1,1
92819,with,1,1
92820,stable,1,1
92821,coronary,1,1
92822,artery,1,1
92823,disease,1,1
92824,.,1,1
92825,A,0,1
92826,randomized,0,1
92827,comparison,0,0
92828,of,0,0
92829,parecoxib/valdecoxib,0,0
92830,and,0,0
92831,placebo,0,0
92832,for,0,0
92833,the,0,0
92834,prevention,0,1
92835,of,0,0
92836,cystoid,0,1
92837,macular,0,1
92838,edema,0,1
92839,after,0,0
92840,scleral,1,1
92841,buckling,1,1
92842,surgery,1,1
92843,.,1,1
92844,AIMS,0,0
92845,To,0,0
92846,assess,0,0
92847,the,0,0
92848,impact,0,0
92849,of,0,0
92850,valdecoxib,0,0
92851,on,0,0
92852,the,0,0
92853,incidence,0,0
92854,of,0,0
92855,macular,0,1
92856,edema,0,1
92857,",",0,0
92858,after,0,0
92859,scleral,0,1
92860,buckling,0,1
92861,surgery,0,1
92862,.,0,1
92863,METHODS,0,0
92864,Prospective,0,1
92865,randomized,0,1
92866,double,0,0
92867,masked,0,1
92868,placebo,0,0
92869,controlled,0,0
92870,study,0,1
92871,.,0,1
92872,Patients,1,1
92873,undergoing,1,1
92874,scleral,1,1
92875,buckle,1,1
92876,surgery,1,1
92877,over,1,0
92878,18,1,1
92879,months,1,1
92880,were,0,1
92881,recruited,0,1
92882,and,0,0
92883,randomized,0,1
92884,to,0,0
92885,receive,0,1
92886,either,0,0
92887,oral,0,0
92888,valdecoxib,0,0
92889,or,0,1
92890,placebo,0,1
92891,.,0,1
92892,Patients,0,1
92893,also,0,0
92894,received,0,1
92895,two,0,0
92896,doses,0,0
92897,of,0,1
92898,either,0,1
92899,parecoxib,0,0
92900,(,0,0
92901,pro-drug,0,0
92902,of,0,0
92903,valdecoxib,0,0
92904,),0,1
92905,intravenously,0,1
92906,40,0,1
92907,mg,0,0
92908,6,0,1
92909,hourly,0,1
92910,day,0,0
92911,one,0,1
92912,postoperative,0,0
92913,or,0,1
92914,identical,0,0
92915,placebo,0,0
92916,injection,0,0
92917,Patients,0,1
92918,underwent,0,1
92919,retinal,0,1
92920,examination,0,1
92921,",",0,0
92922,optical,0,0
92923,coherence,0,0
92924,tomography,0,1
92925,and,0,0
92926,retinal,0,1
92927,thickness,0,0
92928,analyzer,0,0
92929,scan,0,0
92930,of,0,0
92931,the,0,0
92932,macula,0,0
92933,preoperatively,0,0
92934,",",0,0
92935,and,0,0
92936,at,0,1
92937,2,0,1
92938,and,0,1
92939,6,0,1
92940,weeks,0,0
92941,postoperatively,0,0
92942,.,0,1
92943,Outcome,0,0
92944,measures,0,0
92945,were,0,1
92946,the,0,0
92947,incidence,0,0
92948,of,0,0
92949,macular,0,1
92950,edema,0,1
92951,",",0,0
92952,retinal,0,1
92953,thickness,0,0
92954,",",0,0
92955,visual,0,0
92956,acuity,0,0
92957,",",0,0
92958,contrast,0,0
92959,sensitivity,0,0
92960,and,0,0
92961,presence,0,0
92962,of,0,0
92963,persistent,0,1
92964,subretinal,0,1
92965,fluid,0,1
92966,.,0,1
92967,RESULTS,0,0
92968,Interim,0,0
92969,analysis,0,0
92970,was,0,0
92971,performed,0,0
92972,with,0,1
92973,116,1,1
92974,patients,1,1
92975,were,1,1
92976,recruited,1,1
92977,",",1,1
92978,58,1,1
92979,to,1,0
92980,each,1,0
92981,treatment,1,0
92982,arm,1,0
92983,.,1,1
92984,The,0,0
92985,incidence,0,0
92986,of,0,0
92987,macular,0,1
92988,edema,0,1
92989,in,0,0
92990,all,0,1
92991,patients,0,1
92992,was,0,0
92993,5,0,1
92994,%,0,0
92995,at,0,1
92996,visit,0,1
92997,1,0,1
92998,and,0,1
92999,2.2,0,0
93000,%,0,0
93001,at,0,1
93002,visit,0,0
93003,2,0,1
93004,postoperatively,0,0
93005,.,0,1
93006,This,0,0
93007,incidence,0,0
93008,was,0,0
93009,much,0,0
93010,lower,0,0
93011,than,0,0
93012,the,0,0
93013,expected,0,0
93014,incidence,0,0
93015,used,0,0
93016,in,0,0
93017,the,0,0
93018,power,0,0
93019,calculation,0,0
93020,to,0,0
93021,determine,0,0
93022,study,0,1
93023,size,0,0
93024,.,0,1
93025,It,0,0
93026,was,0,0
93027,therefore,0,0
93028,apparent,0,0
93029,that,0,0
93030,a,0,0
93031,much,0,0
93032,larger,0,0
93033,study,0,0
93034,population,0,1
93035,would,0,0
93036,be,0,0
93037,required,0,0
93038,to,0,0
93039,test,0,0
93040,for,0,0
93041,an,0,0
93042,effect,0,0
93043,and,0,0
93044,that,0,0
93045,this,0,0
93046,was,0,0
93047,not,0,0
93048,achievable,0,0
93049,within,0,0
93050,the,0,0
93051,study,0,0
93052,time,0,0
93053,period,0,0
93054,.,0,1
93055,The,0,0
93056,study,0,0
93057,was,0,0
93058,therefore,0,0
93059,terminated,0,0
93060,early,0,0
93061,.,0,0
93062,There,0,0
93063,was,0,0
93064,no,0,0
93065,evidence,0,0
93066,of,0,0
93067,a,0,0
93068,difference,0,0
93069,between,0,0
93070,COX,0,1
93071,2,0,1
93072,inhibitor,0,0
93073,and,0,1
93074,placebo,0,0
93075,groups,0,0
93076,in,0,0
93077,the,0,0
93078,incidence,0,0
93079,of,0,0
93080,edema,0,1
93081,",",0,0
93082,retinal,0,1
93083,thickness,0,0
93084,or,0,1
93085,visual,0,0
93086,outcome,0,0
93087,.,0,1
93088,The,0,0
93089,presence,0,0
93090,of,0,0
93091,residual,0,0
93092,subretinal,0,1
93093,fluid,0,1
93094,at,0,0
93095,the,0,0
93096,macula,0,0
93097,was,0,0
93098,significantly,0,0
93099,reduced,0,0
93100,by,0,0
93101,COX,0,1
93102,2,0,1
93103,inhibitor,0,0
93104,treatment,0,0
93105,.,0,0
93106,CONCLUSIONS,0,0
93107,The,0,0
93108,rate,0,0
93109,of,0,0
93110,cystoid,0,1
93111,macular,0,1
93112,edema,0,1
93113,after,0,0
93114,scleral,0,1
93115,buckling,0,1
93116,surgery,0,1
93117,is,0,0
93118,low,0,0
93119,and,0,0
93120,is,0,0
93121,not,0,0
93122,influenced,0,0
93123,by,0,0
93124,prophylactic,0,1
93125,use,0,0
93126,of,0,0
93127,valdecoxib,0,0
93128,.,0,1
93129,The,0,0
93130,rate,0,0
93131,of,0,0
93132,residual,0,0
93133,subretinal,0,1
93134,fluid,0,1
93135,was,0,0
93136,reduced,0,0
93137,by,0,0
93138,COX,0,1
93139,2,0,1
93140,inhibitor,0,0
93141,treatment,0,1
93142,.,0,1
93143,Enhanced,0,0
93144,antiinflammatory,0,0
93145,therapy,0,0
93146,has,0,0
93147,the,0,0
93148,potential,0,0
93149,to,0,0
93150,improve,0,0
93151,outcomes,0,0
93152,in,0,1
93153,scleral,0,1
93154,buckling,0,1
93155,surgery,0,1
93156,.,0,1
93157,Effect,0,0
93158,of,0,0
93159,recombinant,0,0
93160,adenovirus-p53,0,1
93161,combined,0,0
93162,with,0,1
93163,radiotherapy,0,1
93164,on,0,0
93165,long-term,0,0
93166,prognosis,0,1
93167,of,0,0
93168,advanced,1,1
93169,nasopharyngeal,1,1
93170,carcinoma,1,1
93171,.,1,1
93172,PURPOSE,0,0
93173,To,0,0
93174,centrally,0,0
93175,assess,0,0
93176,the,0,0
93177,safety,0,0
93178,",",0,0
93179,efficacy,0,0
93180,",",0,0
93181,and,0,0
93182,6-year,0,1
93183,follow-up,0,0
93184,of,0,0
93185,recombinant,0,0
93186,adenovirus-p53,0,1
93187,(,0,1
93188,rAd-p53,0,1
93189,),0,1
93190,combined,0,0
93191,with,0,1
93192,radiotherapy,0,1
93193,(,0,1
93194,RT,0,1
93195,),0,1
93196,for,0,0
93197,patients,1,1
93198,with,1,1
93199,nasopharyngeal,1,1
93200,carcinoma,1,1
93201,(,1,1
93202,NPC,1,1
93203,),1,1
93204,.,1,1
93205,PATIENTS,0,0
93206,AND,0,0
93207,METHODS,0,0
93208,A,0,1
93209,randomized,0,1
93210,controlled,0,0
93211,clinical,0,0
93212,study,0,1
93213,on,0,0
93214,rAd-p53,0,0
93215,combined,0,0
93216,with,0,1
93217,RT,0,1
93218,in,0,1
93219,42,1,1
93220,patients,1,1
93221,with,1,1
93222,NPC,1,1
93223,was,1,0
93224,compared,1,0
93225,with,1,1
93226,a,1,0
93227,control,1,0
93228,group,1,1
93229,of,1,1
93230,40,1,1
93231,patients,1,1
93232,with,1,1
93233,NPC,1,1
93234,treated,1,1
93235,with,1,1
93236,RT,1,1
93237,alone,1,1
93238,.,1,1
93239,In,0,0
93240,the,0,0
93241,group,0,0
93242,receiving,0,1
93243,rAd-p53,0,0
93244,combined,0,0
93245,with,0,1
93246,RT,0,1
93247,",",0,1
93248,rAd-p53,0,0
93249,was,0,0
93250,intratumorally,0,0
93251,injected,0,0
93252,once,0,0
93253,a,0,0
93254,week,0,0
93255,for,0,0
93256,8,0,1
93257,weeks,0,1
93258,.,0,1
93259,Concurrent,0,0
93260,RT,0,1
93261,(,0,1
93262,70,0,1
93263,Gy,0,1
93264,in,0,1
93265,35,0,1
93266,fractions,0,1
93267,),0,1
93268,was,0,0
93269,given,0,0
93270,to,0,0
93271,the,0,0
93272,nasopharyngeal,0,1
93273,tumor,0,1
93274,and,0,0
93275,neck,0,1
93276,lymph,0,1
93277,node,0,1
93278,.,0,1
93279,Patients,0,1
93280,and,0,1
93281,tumors,0,1
93282,were,0,1
93283,monitored,0,0
93284,for,0,1
93285,adverse,0,0
93286,events,0,0
93287,and,0,1
93288,responses,0,1
93289,.,0,1
93290,RESULTS,0,0
93291,rAd-p53-specific,0,0
93292,p53,0,0
93293,mRNA,0,0
93294,was,0,0
93295,detected,0,0
93296,in,0,0
93297,postinjection,0,0
93298,of,0,1
93299,rAd-p53,0,1
93300,biopsies,0,1
93301,from,0,1
93302,16,0,1
93303,(,0,1
93304,94.1,0,1
93305,%,0,0
93306,),0,1
93307,of,0,1
93308,17,0,1
93309,patients,0,1
93310,.,0,1
93311,Upregulation,0,0
93312,of,0,0
93313,p21/WAF1,0,0
93314,and,0,1
93315,Bax,0,0
93316,and,0,0
93317,downregulation,0,0
93318,of,0,0
93319,vascular,0,0
93320,endothelial,0,1
93321,growth,0,0
93322,factor,0,0
93323,were,0,0
93324,observed,0,0
93325,in,0,0
93326,postinjection,0,0
93327,tumor,0,1
93328,biopsy,0,1
93329,.,0,1
93330,Complete,0,0
93331,response,0,0
93332,rate,0,0
93333,in,0,0
93334,the,0,0
93335,group,0,0
93336,receiving,0,1
93337,rAd-p53,0,0
93338,combined,0,0
93339,with,0,1
93340,RT,0,1
93341,was,0,0
93342,observed,0,0
93343,at,0,1
93344,2.73,0,0
93345,times,0,0
93346,that,0,0
93347,of,0,0
93348,the,0,0
93349,group,0,1
93350,receiving,0,1
93351,RT,0,1
93352,alone,0,1
93353,(,0,1
93354,66.7,0,0
93355,%,0,0
93356,v,0,0
93357,24.4,0,1
93358,%,0,0
93359,),0,1
93360,.,0,1
93361,Six-year,0,0
93362,follow-up,0,0
93363,data,0,0
93364,showed,0,0
93365,that,0,0
93366,rAd-p53,0,0
93367,significantly,0,0
93368,increased,0,0
93369,the,0,0
93370,5-year,0,1
93371,locoregional,0,1
93372,tumor,0,1
93373,control,0,1
93374,rate,0,0
93375,by,0,0
93376,25.3,0,1
93377,%,0,0
93378,for,0,1
93379,patients,1,1
93380,with,1,1
93381,NPC,1,1
93382,treated,0,1
93383,with,0,1
93384,irradiation,0,1
93385,(,0,1
93386,P,0,0
93387,=,0,1
93388,.002,0,0
93389,),0,1
93390,.,0,1
93391,The,0,0
93392,5-year,0,1
93393,overall,0,0
93394,survival,0,0
93395,rate,0,0
93396,and,0,1
93397,5-year,0,1
93398,disease-free,0,1
93399,survival,0,0
93400,rate,0,0
93401,of,0,0
93402,the,0,0
93403,group,0,0
93404,receiving,0,1
93405,rAd-p53,0,0
93406,combined,0,0
93407,with,0,1
93408,RT,0,1
93409,were,0,1
93410,7.5,0,0
93411,%,0,0
93412,(,0,1
93413,P,0,0
93414,=,0,1
93415,.34,0,0
93416,),0,1
93417,and,0,1
93418,11.7,0,0
93419,%,0,0
93420,(,0,1
93421,P,0,0
93422,=,0,1
93423,.21,0,0
93424,),0,1
93425,higher,0,0
93426,than,0,0
93427,those,0,0
93428,of,0,0
93429,the,0,0
93430,group,0,1
93431,receiving,0,1
93432,RT,0,1
93433,alone,0,1
93434,.,0,1
93435,No,0,0
93436,dose-limiting,0,0
93437,toxicity,0,0
93438,or,0,1
93439,adverse,0,0
93440,events,0,0
93441,appeared,0,0
93442,",",0,0
93443,except,0,0
93444,for,0,0
93445,transient,0,0
93446,fever,0,1
93447,after,0,0
93448,rAd-p53,0,0
93449,administration,0,0
93450,.,0,1
93451,CONCLUSION,0,0
93452,In,0,1
93453,patients,1,1
93454,with,1,1
93455,NPC,1,1
93456,",",0,1
93457,rAd-p53,0,0
93458,was,0,0
93459,safe,0,0
93460,and,0,0
93461,biologically,0,0
93462,active,0,1
93463,.,0,1
93464,Our,0,0
93465,results,0,0
93466,indicated,0,0
93467,that,0,0
93468,rAd-p53,0,1
93469,improves,0,0
93470,radiotherapeutic,0,1
93471,tumor,0,1
93472,control,0,1
93473,and,0,0
93474,survival,0,0
93475,rate,0,0
93476,in,0,1
93477,patients,1,1
93478,with,1,1
93479,NPC,1,1
93480,.,1,1
93481,Detection,0,0
93482,of,0,0
93483,traumatic,0,1
93484,arthrotomy,0,1
93485,of,0,0
93486,the,0,0
93487,knee,0,1
93488,using,0,0
93489,the,0,0
93490,saline,0,0
93491,solution,0,0
93492,load,0,0
93493,test,0,0
93494,.,0,1
93495,BACKGROUND,0,0
93496,The,0,0
93497,saline,0,0
93498,solution,0,0
93499,load,0,0
93500,test,0,0
93501,helps,0,0
93502,to,0,0
93503,determine,0,0
93504,if,0,0
93505,a,0,0
93506,wound,0,0
93507,extends,0,0
93508,into,0,0
93509,the,0,0
93510,knee,0,1
93511,joint,0,1
93512,.,0,1
93513,Little,0,0
93514,is,0,0
93515,known,0,0
93516,about,0,0
93517,the,0,0
93518,volume,0,0
93519,of,0,0
93520,injected,0,0
93521,intra-articular,0,0
93522,saline,0,0
93523,solution,0,0
93524,that,0,0
93525,is,0,0
93526,needed,0,0
93527,to,0,0
93528,effectively,0,0
93529,rule,0,0
93530,in,0,0
93531,or,0,0
93532,rule,0,0
93533,out,0,0
93534,a,0,0
93535,traumatic,0,1
93536,arthrotomy,0,1
93537,of,0,0
93538,the,0,0
93539,knee,0,1
93540,.,0,0
93541,The,0,0
93542,purpose,0,0
93543,of,0,0
93544,the,0,0
93545,present,0,0
93546,study,0,1
93547,was,0,0
93548,to,0,0
93549,determine,0,0
93550,the,0,0
93551,appropriate,0,0
93552,volume,0,0
93553,and,0,1
93554,needle,0,1
93555,location,0,1
93556,for,0,0
93557,the,0,0
93558,diagnosis,0,1
93559,of,0,0
93560,a,0,1
93561,traumatic,0,1
93562,knee,0,1
93563,arthrotomy,0,1
93564,and,0,0
93565,to,0,0
93566,assess,0,0
93567,the,0,0
93568,effect,0,0
93569,of,0,0
93570,associated,0,0
93571,variables,0,0
93572,",",0,1
93573,including,0,0
93574,knee,0,1
93575,circumference,0,0
93576,",",0,0
93577,body,0,1
93578,mass,0,1
93579,index,0,0
93580,",",0,0
93581,and,0,0
93582,sex,0,0
93583,.,0,1
93584,METHODS,0,0
93585,Fifty-six,1,1
93586,consecutive,1,1
93587,patients,1,1
93588,scheduled,1,1
93589,for,1,1
93590,knee,1,1
93591,arthroscopy,1,1
93592,were,0,1
93593,enrolled,0,1
93594,.,0,1
93595,A,0,0
93596,standard,0,0
93597,inferolateral,0,0
93598,arthroscopic,0,1
93599,portal,0,1
93600,was,0,0
93601,made,0,0
93602,with,0,1
93603,a,0,1
93604,single,0,0
93605,stab,0,1
93606,incision,0,1
93607,with,0,1
93608,use,0,0
93609,of,0,0
93610,a,0,1
93611,number-11,0,0
93612,blade,0,0
93613,.,0,1
93614,Injection,0,0
93615,sites,0,0
93616,were,0,1
93617,randomized,0,1
93618,to,0,0
93619,either,0,0
93620,a,0,0
93621,superomedial,0,0
93622,or,0,1
93623,inferomedial,0,0
93624,location,0,1
93625,.,0,1
93626,The,0,0
93627,injection,0,0
93628,of,0,0
93629,normal,0,1
93630,saline,0,0
93631,solution,0,0
93632,at,0,0
93633,a,0,0
93634,rate,0,0
93635,of,0,0
93636,5,0,1
93637,mL/sec,0,1
93638,through,0,1
93639,an,0,1
93640,18-gauge,0,0
93641,needle,0,1
93642,was,0,0
93643,continued,0,0
93644,while,0,0
93645,the,0,0
93646,knee,0,1
93647,was,0,0
93648,moved,0,1
93649,through,0,0
93650,a,0,0
93651,range,0,1
93652,of,0,0
93653,motion,0,1
93654,until,0,1
93655,fluid,0,0
93656,extravasated,0,1
93657,from,0,1
93658,the,0,0
93659,iatrogenic,0,1
93660,laceration,0,1
93661,.,0,1
93662,The,0,0
93663,volume,0,0
93664,of,0,0
93665,injected,0,0
93666,fluid,0,1
93667,was,0,0
93668,recorded,0,0
93669,.,0,0
93670,RESULTS,0,0
93671,The,0,0
93672,study,0,0
93673,group,0,0
93674,included,0,1
93675,thirty-one,1,1
93676,female,1,1
93677,patients,1,1
93678,and,1,1
93679,twenty-five,1,1
93680,male,1,1
93681,patients,1,1
93682,with,1,1
93683,a,1,1
93684,combined,1,0
93685,average,1,0
93686,age,1,1
93687,of,1,1
93688,fifty,1,1
93689,years,1,1
93690,and,1,1
93691,an,1,1
93692,average,1,0
93693,body,1,1
93694,mass,1,1
93695,index,1,1
93696,of,1,1
93697,30.9,1,1
93698,.,1,1
93699,In,0,0
93700,order,0,0
93701,to,0,0
93702,effectively,0,0
93703,diagnose,0,0
93704,50,0,1
93705,%,0,0
93706,of,0,0
93707,the,0,0
93708,arthrotomies,0,1
93709,",",0,1
93710,75,0,1
93711,mL,0,0
93712,of,0,0
93713,injected,0,0
93714,fluid,0,1
93715,was,0,0
93716,needed,0,0
93717,;,0,1
93718,the,0,0
93719,volumes,0,0
93720,that,0,0
93721,were,0,1
93722,needed,0,0
93723,in,0,0
93724,order,0,0
93725,to,0,0
93726,effectively,0,0
93727,diagnose,0,0
93728,75,0,1
93729,%,0,0
93730,",",0,1
93731,90,0,1
93732,%,0,0
93733,",",0,1
93734,95,0,0
93735,%,0,0
93736,",",0,1
93737,and,0,0
93738,99,0,1
93739,%,0,0
93740,of,0,0
93741,the,0,0
93742,arthrotomies,0,1
93743,were,0,1
93744,110,0,1
93745,",",0,1
93746,145,0,1
93747,",",0,0
93748,155,0,1
93749,",",0,0
93750,and,0,0
93751,175,0,1
93752,mL,0,0
93753,",",0,0
93754,respectively,0,0
93755,.,0,0
93756,The,0,0
93757,mean,0,0
93758,volumes,0,0
93759,of,0,1
93760,injected,0,0
93761,fluid,0,1
93762,needed,0,0
93763,for,0,0
93764,a,0,1
93765,positive,0,1
93766,result,0,0
93767,at,0,0
93768,the,0,0
93769,inferomedial,0,0
93770,and,0,0
93771,superomedial,0,1
93772,needle,0,1
93773,locations,0,1
93774,were,0,1
93775,64.0,0,1
93776,and,0,1
93777,95.2,0,1
93778,mL,0,0
93779,",",0,0
93780,respectively,0,0
93781,;,0,0
93782,this,0,0
93783,difference,0,0
93784,was,0,0
93785,significant,0,0
93786,(,0,1
93787,p,0,0
93788,=,0,1
93789,0.01,0,0
93790,),0,0
93791,.,0,0
93792,There,0,0
93793,was,0,0
93794,no,0,0
93795,correlation,0,0
93796,between,0,0
93797,necessary,0,0
93798,injection,0,0
93799,volume,0,0
93800,and,0,0
93801,sex,0,0
93802,",",0,0
93803,body,0,1
93804,mass,0,1
93805,index,0,0
93806,",",0,0
93807,or,0,0
93808,knee,0,1
93809,circumference,0,0
93810,.,0,1
93811,CONCLUSIONS,0,0
93812,In,0,0
93813,order,0,0
93814,to,0,1
93815,detect,0,0
93816,95,0,0
93817,%,0,0
93818,of,0,1
93819,1-cm,0,1
93820,inferolateral,0,1
93821,arthrotomies,0,1
93822,of,0,1
93823,the,0,0
93824,knee,0,1
93825,with,0,1
93826,use,0,0
93827,of,0,0
93828,the,0,0
93829,saline,0,0
93830,solution,0,0
93831,load,0,0
93832,test,0,0
93833,",",0,0
93834,155,0,1
93835,mL,0,0
93836,must,0,0
93837,be,0,0
93838,injected,0,0
93839,.,0,1
93840,An,0,0
93841,inferomedial,0,0
93842,injection,0,0
93843,location,0,1
93844,requires,0,0
93845,significantly,0,0
93846,less,0,0
93847,fluid,0,0
93848,than,0,0
93849,a,0,1
93850,superomedial,0,1
93851,injection,0,0
93852,location,0,1
93853,does,0,0
93854,for,0,0
93855,the,0,0
93856,diagnosis,0,1
93857,of,0,0
93858,inferolateral,0,0
93859,arthrotomies,0,1
93860,of,0,1
93861,the,0,1
93862,knee,0,1
93863,.,0,1
93864,Effects,0,1
93865,of,0,1
93866,static,0,0
93867,stretching,0,0
93868,on,0,0
93869,repeated,0,0
93870,sprint,0,0
93871,and,0,0
93872,change,0,0
93873,of,0,0
93874,direction,0,0
93875,performance,0,0
93876,.,0,1
93877,PURPOSE,0,0
93878,To,0,0
93879,examine,0,0
93880,the,0,0
93881,effects,0,0
93882,of,0,0
93883,static,0,0
93884,stretching,0,0
93885,during,0,0
93886,the,0,0
93887,recovery,0,0
93888,periods,0,0
93889,of,0,1
93890,field-based,0,1
93891,team,0,1
93892,sports,0,1
93893,on,0,0
93894,subsequent,0,0
93895,repeated,0,0
93896,sprint,0,0
93897,ability,0,0
93898,(,0,1
93899,RSA,0,1
93900,),0,1
93901,and,0,0
93902,change,0,0
93903,of,0,0
93904,direction,0,0
93905,speed,0,0
93906,(,0,1
93907,CODS,0,1
93908,),0,1
93909,performance,0,0
93910,.,0,1
93911,METHODS,0,0
93912,On,0,1
93913,four,0,1
93914,separate,0,1
93915,occasions,0,1
93916,",",0,1
93917,12,1,1
93918,male,1,1
93919,team-sport,1,1
93920,players,1,1
93921,performed,0,0
93922,a,0,1
93923,standardized,0,0
93924,warm-up,0,0
93925,",",0,0
93926,followed,0,0
93927,by,0,0
93928,a,0,0
93929,test,0,0
93930,of,0,0
93931,either,0,1
93932,RSA,0,1
93933,or,0,1
93934,CODS,0,0
93935,(,0,1
93936,on,0,1
93937,two,0,1
93938,occasions,0,1
93939,each,0,1
93940,),0,1
93941,in,0,0
93942,a,0,1
93943,counterbalanced,0,0
93944,design,0,1
93945,.,0,1
93946,Both,0,0
93947,tests,0,0
93948,involved,0,1
93949,three,0,1
93950,sets,0,1
93951,of,0,1
93952,six,0,1
93953,maximal,0,1
93954,sprint,0,0
93955,repetitions,0,0
93956,",",0,0
93957,with,0,1
93958,a,0,0
93959,4-min,0,0
93960,recovery,0,0
93961,between,0,0
93962,sets,0,1
93963,.,0,1
93964,During,0,0
93965,the,0,0
93966,break,0,0
93967,between,0,0
93968,sets,0,0
93969,",",0,1
93970,the,0,0
93971,participants,1,1
93972,either,0,1
93973,rested,0,0
93974,(,0,0
93975,control,0,1
93976,[,0,0
93977,CON,0,1
93978,],0,1
93979,),0,1
93980,or,0,1
93981,completed,0,1
93982,a,0,0
93983,static,0,0
93984,stretching,0,0
93985,protocol,0,1
93986,(,0,1
93987,static,0,0
93988,stretch,0,0
93989,[,0,0
93990,SS,0,1
93991,],0,1
93992,),0,1
93993,.,0,1
93994,The,0,0
93995,RSA,0,0
93996,test,0,0
93997,involved,0,1
93998,straight-line,0,0
93999,sprints,0,0
94000,",",0,1
94001,whereas,0,0
94002,the,0,0
94003,CODS,0,0
94004,test,0,0
94005,required,0,0
94006,a,0,0
94007,change,0,0
94008,of,0,0
94009,direction,0,0
94010,(,0,1
94011,100,0,1
94012,degrees,0,1
94013,),0,1
94014,every,0,0
94015,4,0,0
94016,m,0,1
94017,(,0,1
94018,total,0,1
94019,of,0,1
94020,four,0,1
94021,),0,1
94022,.,0,1
94023,Mean,0,1
94024,",",0,0
94025,total,0,1
94026,(,0,0
94027,sum,0,0
94028,of,0,1
94029,six,0,1
94030,sprints,0,1
94031,),0,1
94032,",",0,0
94033,first,0,0
94034,",",0,0
94035,and,0,0
94036,best,0,0
94037,sprint,0,0
94038,times,0,0
94039,(,0,1
94040,MST,0,1
94041,",",0,0
94042,TST,0,0
94043,",",0,0
94044,FST,0,1
94045,",",0,0
94046,and,0,0
94047,BST,0,0
94048,",",0,0
94049,respectively,0,0
94050,),0,0
94051,were,0,0
94052,recorded,0,0
94053,for,0,0
94054,each,0,0
94055,set,0,0
94056,.,0,0
94057,RESULTS,0,0
94058,There,0,0
94059,was,0,0
94060,a,0,0
94061,consistent,0,0
94062,tendency,0,0
94063,for,0,1
94064,RSA,0,1
94065,times,0,0
94066,to,0,0
94067,be,0,0
94068,slower,0,0
94069,after,0,0
94070,the,0,0
94071,static,0,0
94072,stretching,0,0
94073,intervention,0,0
94074,",",0,0
94075,which,0,0
94076,was,0,0
94077,supported,0,0
94078,by,0,0
94079,statistical,0,0
94080,significance,0,0
94081,for,0,1
94082,three,0,1
94083,performance,0,0
94084,variables,0,0
94085,(,0,1
94086,MST,0,1
94087,0-5,0,1
94088,m,0,1
94089,set,0,0
94090,2,0,1
94091,",",0,1
94092,MST,0,1
94093,0-20,0,1
94094,m,0,1
94095,set,0,0
94096,2,0,1
94097,",",0,0
94098,and,0,0
94099,TST,0,1
94100,set,0,1
94101,2,0,1
94102,;,0,1
94103,P,0,0
94104,<,0,0
94105,0.05,0,0
94106,),0,1
94107,.,0,1
94108,This,0,0
94109,tendency,0,0
94110,was,0,0
94111,also,0,0
94112,supported,0,0
94113,by,0,0
94114,moderate,0,1
94115,effect,0,0
94116,sizes,0,0
94117,and,0,1
94118,qualitative,0,1
94119,indications,0,1
94120,of,0,1
94121,likely,0,0
94122,harmful,0,0
94123,or,0,1
94124,detrimental,0,0
94125,effects,0,0
94126,associated,0,0
94127,with,0,1
94128,RSA-SS,0,1
94129,.,0,1
94130,Further,0,0
94131,",",0,0
94132,sprint,0,0
94133,times,0,0
94134,again,0,0
94135,tended,0,0
94136,to,0,0
94137,be,0,0
94138,slower,0,0
94139,in,0,0
94140,the,0,0
94141,CODS-SS,0,0
94142,trial,0,0
94143,compared,0,0
94144,with,0,1
94145,the,0,0
94146,CODS-CON,0,0
94147,across,0,0
94148,all,0,1
94149,sprint,0,0
94150,variables,0,0
94151,",",0,0
94152,with,0,1
94153,a,0,0
94154,significantly,0,0
94155,slower,0,0
94156,(,0,0
94157,P,0,0
94158,<,0,0
94159,0.05,0,0
94160,),0,1
94161,BST,0,1
94162,recorded,0,0
94163,for,0,0
94164,set,0,0
94165,3,0,1
94166,after,0,1
94167,static,0,0
94168,stretching,0,0
94169,.,0,1
94170,CONCLUSION,0,0
94171,These,0,1
94172,results,0,0
94173,suggest,0,0
94174,that,0,0
94175,an,0,0
94176,acute,0,1
94177,bout,0,0
94178,(,0,1
94179,4,0,0
94180,min,0,0
94181,),0,1
94182,of,0,0
94183,static,0,0
94184,stretching,0,0
94185,of,0,0
94186,the,0,0
94187,lower,0,0
94188,limbs,0,1
94189,during,0,0
94190,recovery,0,0
94191,periods,0,0
94192,between,0,0
94193,efforts,0,0
94194,may,0,0
94195,compromise,0,1
94196,RSA,0,0
94197,performance,0,0
94198,but,0,0
94199,has,0,0
94200,less,0,0
94201,effect,0,0
94202,on,0,0
94203,CODS,0,1
94204,performance,0,0
94205,.,0,1
94206,Recommendations,0,1
94207,for,0,1
94208,implementing,0,0
94209,stereotactic,0,1
94210,radiotherapy,0,1
94211,in,0,1
94212,peripheral,1,1
94213,stage,1,1
94214,IA,1,1
94215,non-small,1,1
94216,cell,1,1
94217,lung,1,1
94218,cancer,1,1
94219,:,1,1
94220,report,0,0
94221,from,0,1
94222,the,0,0
94223,Quality,0,0
94224,Assurance,0,0
94225,Working,0,1
94226,Party,0,1
94227,of,0,0
94228,the,0,0
94229,randomised,0,1
94230,phase,0,1
94231,III,0,1
94232,ROSEL,0,1
94233,study,0,1
94234,.,0,1
94235,BACKGROUND,0,0
94236,A,0,1
94237,phase,0,1
94238,III,0,1
94239,multi-centre,0,1
94240,randomised,0,1
94241,trial,0,0
94242,(,0,1
94243,ROSEL,0,1
94244,),0,1
94245,has,0,0
94246,been,0,0
94247,initiated,0,0
94248,to,0,0
94249,establish,0,0
94250,the,0,0
94251,role,0,0
94252,of,0,0
94253,stereotactic,0,1
94254,radiotherapy,0,1
94255,in,0,1
94256,patients,1,1
94257,with,1,1
94258,operable,1,1
94259,stage,1,1
94260,IA,1,1
94261,lung,1,1
94262,cancer,1,1
94263,.,1,1
94264,Due,0,0
94265,to,0,0
94266,rapid,0,1
94267,changes,0,0
94268,in,0,0
94269,radiotherapy,0,1
94270,technology,0,0
94271,and,0,1
94272,evolving,0,0
94273,techniques,0,0
94274,for,0,1
94275,image-guided,0,1
94276,delivery,0,1
94277,",",0,1
94278,guidelines,0,1
94279,had,0,1
94280,to,0,1
94281,be,0,0
94282,developed,0,1
94283,in,0,0
94284,order,0,0
94285,to,0,0
94286,ensure,0,0
94287,uniformity,0,0
94288,in,0,0
94289,implementation,0,0
94290,of,0,0
94291,stereotactic,0,1
94292,radiotherapy,0,1
94293,in,0,0
94294,this,0,0
94295,multi-centre,0,1
94296,study,0,1
94297,.,0,1
94298,METHODS/DESIGN,0,0
94299,A,0,1
94300,Quality,0,0
94301,Assurance,0,1
94302,Working,0,1
94303,Party,0,1
94304,was,0,0
94305,formed,0,1
94306,by,0,0
94307,radiation,0,1
94308,oncologists,0,1
94309,and,0,1
94310,clinical,0,1
94311,physicists,0,1
94312,from,0,1
94313,both,0,0
94314,academic,0,1
94315,as,0,0
94316,well,0,0
94317,as,0,0
94318,non-academic,0,1
94319,hospitals,0,1
94320,that,0,0
94321,had,0,1
94322,already,0,1
94323,implemented,0,0
94324,stereotactic,0,0
94325,radiotherapy,0,1
94326,for,0,0
94327,lung,0,1
94328,cancer,0,1
94329,.,0,1
94330,A,0,0
94331,literature,0,0
94332,survey,0,1
94333,was,0,0
94334,conducted,0,1
94335,and,0,1
94336,consensus,0,1
94337,meetings,0,1
94338,were,0,1
94339,held,0,0
94340,in,0,0
94341,which,0,0
94342,both,0,0
94343,the,0,0
94344,knowledge,0,0
94345,from,0,0
94346,the,0,0
94347,literature,0,0
94348,and,0,0
94349,clinical,0,0
94350,experience,0,1
94351,were,0,1
94352,pooled,0,0
94353,.,0,1
94354,In,0,0
94355,addition,0,0
94356,",",0,0
94357,a,1,0
94358,planning,1,0
94359,study,1,0
94360,was,1,0
94361,performed,1,0
94362,in,1,1
94363,26,1,1
94364,stage,1,1
94365,I,1,1
94366,patients,1,1
94367,",",1,1
94368,of,1,0
94369,which,1,0
94370,22,1,1
94371,were,1,1
94372,stage,1,1
94373,1A,1,1
94374,",",0,0
94375,in,0,0
94376,order,0,0
94377,to,0,0
94378,develop,0,0
94379,and,0,0
94380,evaluate,0,0
94381,the,0,0
94382,planning,0,0
94383,guidelines,0,1
94384,.,0,1
94385,Plans,0,0
94386,were,0,1
94387,optimised,0,0
94388,according,0,1
94389,to,0,1
94390,parameters,0,0
94391,adopted,0,0
94392,from,0,1
94393,RTOG,0,1
94394,trials,0,1
94395,using,0,0
94396,both,0,0
94397,an,0,0
94398,algorithm,0,0
94399,with,0,1
94400,a,0,1
94401,simple,0,0
94402,homogeneity,0,0
94403,correction,0,1
94404,(,0,1
94405,Type,0,1
94406,A,0,1
94407,),0,1
94408,and,0,0
94409,a,0,0
94410,more,0,0
94411,advanced,0,1
94412,algorithm,0,0
94413,(,0,1
94414,Type,0,1
94415,B,0,1
94416,),0,1
94417,.,0,1
94418,Dose,0,0
94419,conformity,0,0
94420,requirements,0,0
94421,were,0,1
94422,then,0,0
94423,formulated,0,0
94424,based,0,1
94425,on,0,0
94426,these,0,0
94427,results,0,0
94428,.,0,1
94429,CONCLUSION,0,0
94430,Based,0,0
94431,on,0,0
94432,current,0,1
94433,literature,0,0
94434,and,0,1
94435,expert,0,1
94436,experience,0,1
94437,",",0,1
94438,guidelines,0,1
94439,were,0,1
94440,formulated,0,0
94441,for,0,0
94442,this,0,0
94443,phase,0,1
94444,III,0,1
94445,study,0,1
94446,of,0,0
94447,stereotactic,0,1
94448,radiotherapy,0,1
94449,versus,0,0
94450,surgery,0,1
94451,.,0,1
94452,These,0,0
94453,guidelines,0,0
94454,can,0,0
94455,serve,0,0
94456,to,0,0
94457,facilitate,0,0
94458,the,0,0
94459,design,0,0
94460,of,0,0
94461,future,0,0
94462,multi-centre,0,1
94463,clinical,0,1
94464,trials,0,1
94465,of,0,1
94466,stereotactic,0,1
94467,radiotherapy,0,1
94468,in,0,1
94469,other,0,1
94470,patient,0,1
94471,groups,0,0
94472,and,0,0
94473,aid,0,0
94474,a,0,0
94475,more,0,0
94476,uniform,0,0
94477,implementation,0,0
94478,of,0,0
94479,this,0,0
94480,technique,0,0
94481,outside,0,1
94482,clinical,0,1
94483,trials,0,1
94484,.,0,1
94485,A,0,0
94486,double-blind,0,0
94487,",",0,0
94488,placebo-controlled,0,0
94489,trial,0,0
94490,of,0,0
94491,oral,0,1
94492,human,0,1
94493,immunoglobulin,0,1
94494,for,0,0
94495,gastrointestinal,1,1
94496,dysfunction,1,1
94497,in,1,1
94498,children,1,1
94499,with,1,1
94500,autistic,1,1
94501,disorder,1,1
94502,.,1,1
94503,Controversy,0,0
94504,exists,0,0
94505,regarding,0,0
94506,the,0,0
94507,extent,0,0
94508,and,0,0
94509,possible,0,0
94510,causal,0,0
94511,relationship,0,0
94512,between,0,0
94513,gastrointestinal,0,1
94514,symptoms,0,1
94515,and,0,1
94516,autism,0,1
94517,.,0,1
94518,A,0,0
94519,randomized,0,0
94520,",",0,0
94521,double-blind,0,0
94522,",",0,0
94523,placebo-controlled,0,0
94524,",",0,1
94525,parallel,0,0
94526,groups,0,0
94527,",",0,1
94528,dose-ranging,0,0
94529,study,0,1
94530,of,0,0
94531,oral,0,0
94532,",",0,1
94533,human,0,1
94534,immunoglobulin,0,0
94535,(,0,1
94536,IGOH,0,1
94537,140,0,1
94538,",",0,1
94539,420,0,1
94540,",",0,0
94541,or,0,1
94542,840,0,1
94543,mg/day,0,1
94544,),0,1
94545,was,0,0
94546,utilized,0,0
94547,with,0,1
94548,125,1,1
94549,children,1,1
94550,(,1,1
94551,ages,1,1
94552,2-17,1,1
94553,years,1,1
94554,),1,1
94555,with,1,1
94556,autism,1,1
94557,and,1,1
94558,persistent,1,1
94559,GI,1,1
94560,symptoms,1,1
94561,.,1,1
94562,Endpoint,0,0
94563,analysis,0,0
94564,revealed,0,0
94565,no,0,0
94566,significant,0,0
94567,differences,0,0
94568,across,0,1
94569,treatment,0,1
94570,groups,0,0
94571,on,0,0
94572,a,0,1
94573,modified,0,0
94574,global,0,0
94575,improvement,0,0
94576,scale,0,0
94577,(,0,0
94578,validated,0,0
94579,in,0,0
94580,irritable,0,1
94581,bowel,0,1
94582,syndrome,0,1
94583,studies,0,0
94584,),0,1
94585,",",0,0
94586,number,0,0
94587,of,0,0
94588,daily,0,0
94589,bowel,0,1
94590,movements,0,0
94591,",",0,1
94592,days,0,0
94593,of,0,0
94594,constipation,0,1
94595,",",0,0
94596,or,0,0
94597,severity,0,0
94598,of,0,0
94599,problem,0,1
94600,behaviors,0,0
94601,.,0,1
94602,IGOH,0,0
94603,was,0,0
94604,well-tolerated,0,0
94605,;,0,0
94606,there,0,0
94607,were,0,0
94608,no,0,0
94609,serious,0,0
94610,adverse,0,0
94611,events,0,0
94612,.,0,1
94613,This,0,0
94614,study,0,0
94615,demonstrates,0,0
94616,the,0,0
94617,importance,0,0
94618,of,0,0
94619,conducting,0,0
94620,rigorous,0,1
94621,trials,0,1
94622,in,0,1
94623,children,1,1
94624,with,1,1
94625,autism,1,1
94626,and,0,0
94627,casts,0,0
94628,doubt,0,0
94629,on,0,0
94630,one,0,1
94631,GI,0,1
94632,mechanism,0,0
94633,presumed,0,1
94634,to,0,0
94635,exert,0,0
94636,etiological,0,1
94637,and/or,0,1
94638,symptomatic,0,1
94639,effects,0,0
94640,in,0,1
94641,this,0,0
94642,population,0,1
94643,.,0,1
94644,Randomized,0,1
94645,prospective,0,1
94646,study,0,1
94647,to,0,0
94648,evaluate,0,0
94649,child,1,1
94650,abuse,1,1
94651,documentation,1,0
94652,in,1,0
94653,the,1,0
94654,emergency,1,1
94655,department,1,1
94656,.,1,1
94657,OBJECTIVES,0,0
94658,The,0,0
94659,objective,0,0
94660,was,0,0
94661,to,0,0
94662,determine,0,0
94663,whether,0,0
94664,an,0,0
94665,educational,0,1
94666,intervention,0,0
94667,for,0,0
94668,health,0,1
94669,care,0,1
94670,providers,0,1
94671,would,0,0
94672,result,0,0
94673,in,0,0
94674,improved,0,0
94675,documentation,0,1
94676,of,0,1
94677,cases,0,1
94678,of,0,1
94679,possible,0,0
94680,physical,1,1
94681,child,1,1
94682,abuse,1,1
94683,in,1,0
94684,children,1,1
94685,<,1,1
94686,36,1,1
94687,months,1,1
94688,old,1,1
94689,treated,1,1
94690,in,1,0
94691,the,1,0
94692,emergency,1,1
94693,department,1,1
94694,(,1,1
94695,ED,1,1
94696,),1,1
94697,setting,1,1
94698,.,1,1
94699,METHODS,0,0
94700,This,0,0
94701,study,0,0
94702,had,0,1
94703,a,0,0
94704,statewide,0,1
94705,group-randomized,0,0
94706,prospective,0,1
94707,trial,0,1
94708,design,0,1
94709,.,0,1
94710,Participating,0,1
94711,EDs,1,1
94712,were,0,1
94713,randomized,0,1
94714,to,0,1
94715,one,0,1
94716,of,0,1
94717,three,0,1
94718,intervention,0,1
94719,groups,0,1
94720,:,0,1
94721,no,0,0
94722,intervention,0,0
94723,",",0,0
94724,partial,0,0
94725,intervention,0,0
94726,",",0,0
94727,or,0,1
94728,full,0,1
94729,intervention,0,1
94730,.,0,1
94731,Medical,1,0
94732,records,1,1
94733,for,1,1
94734,children,1,1
94735,<,1,1
94736,36,1,1
94737,months,1,0
94738,of,1,1
94739,age,1,1
94740,were,0,1
94741,abstracted,0,0
94742,before,0,0
94743,",",0,0
94744,during,0,0
94745,",",0,0
94746,and,0,0
94747,after,0,0
94748,the,0,0
94749,intervention,0,0
94750,periods,0,0
94751,for,0,1
94752,specific,0,1
94753,documentation,0,1
94754,elements,0,1
94755,.,0,1
94756,The,0,0
94757,main,0,0
94758,outcome,0,0
94759,measure,0,0
94760,was,0,0
94761,the,0,0
94762,change,0,0
94763,in,0,0
94764,documentation,0,0
94765,from,0,1
94766,baseline,0,0
94767,.,0,1
94768,Generalized,0,1
94769,estimating,0,0
94770,equations,0,0
94771,(,0,1
94772,GEEs,0,1
94773,),0,1
94774,were,0,1
94775,used,0,0
94776,to,0,0
94777,test,0,0
94778,for,0,0
94779,intervention,0,0
94780,effect,0,0
94781,.,0,0
94782,RESULTS,0,0
94783,A,1,0
94784,total,1,1
94785,of,1,0
94786,"1,575",1,1
94787,charts,1,1
94788,from,1,1
94789,14,1,1
94790,hospitals,1,1
94791,EDs,1,1
94792,were,1,1
94793,abstracted,1,1
94794,.,1,1
94795,Hospital,0,1
94796,and,0,0
94797,demographic,0,1
94798,characteristics,0,1
94799,were,0,1
94800,similar,0,0
94801,across,0,0
94802,intervention,0,1
94803,groups,0,0
94804,.,0,1
94805,There,0,0
94806,were,0,0
94807,922,0,1
94808,(,0,1
94809,59,0,1
94810,%,0,0
94811,),0,1
94812,injury,0,1
94813,visits,0,1
94814,and,0,1
94815,653,0,1
94816,(,0,1
94817,41,0,1
94818,%,0,0
94819,),0,1
94820,noninjury,0,1
94821,visits,0,1
94822,.,0,1
94823,For,0,0
94824,each,0,0
94825,specific,0,0
94826,documentation,0,0
94827,element,0,0
94828,",",0,0
94829,a,0,0
94830,GEE,0,0
94831,model,0,0
94832,gave,0,0
94833,p-values,0,0
94834,of,0,1
94835,>,0,1
94836,0.2,0,1
94837,in,0,1
94838,independent,0,1
94839,tests,0,0
94840,",",0,1
94841,indicating,0,0
94842,no,0,0
94843,evidence,0,0
94844,of,0,0
94845,significant,0,0
94846,change,0,0
94847,in,0,0
94848,documentation,0,0
94849,after,0,0
94850,the,0,0
94851,intervention,0,0
94852,.,0,0
94853,Even,0,0
94854,among,0,0
94855,the,0,0
94856,26,0,1
94857,charts,0,1
94858,in,0,1
94859,which,0,0
94860,the,0,0
94861,possibility,0,0
94862,of,0,0
94863,physical,0,1
94864,abuse,0,1
94865,was,0,0
94866,noted,0,0
94867,",",0,0
94868,documentation,0,0
94869,remained,0,0
94870,variable,0,0
94871,.,0,1
94872,CONCLUSIONS,0,0
94873,The,0,0
94874,educational,0,1
94875,interventions,0,0
94876,studied,0,1
94877,did,0,0
94878,not,0,0
94879,improve,0,0
94880,ED,0,0
94881,documentation,0,0
94882,of,0,0
94883,cases,0,1
94884,of,0,1
94885,possible,0,0
94886,physical,0,1
94887,child,0,1
94888,abuse,0,1
94889,.,0,1
94890,The,0,0
94891,need,0,0
94892,for,0,0
94893,improved,0,0
94894,health,0,1
94895,care,0,1
94896,provider,0,1
94897,education,0,1
94898,in,0,0
94899,child,0,1
94900,abuse,0,1
94901,identification,0,1
94902,and,0,1
94903,documentation,0,1
94904,remains,0,0
94905,.,0,1
94906,Future,0,0
94907,innovative,0,0
94908,educational,0,1
94909,studies,0,0
94910,to,0,1
94911,improve,0,0
94912,recognition,0,0
94913,of,0,0
94914,abuse,0,1
94915,are,0,0
94916,warranted,0,0
94917,.,0,1
94918,Elastic,0,1
94919,stable,0,1
94920,intramedullary,0,1
94921,nailing,0,1
94922,versus,0,0
94923,nonoperative,0,1
94924,treatment,0,0
94925,of,0,0
94926,displaced,1,1
94927,midshaft,1,1
94928,clavicular,1,1
94929,fractures-a,1,1
94930,randomized,0,1
94931,",",0,0
94932,controlled,0,0
94933,",",0,0
94934,clinical,0,0
94935,trial,0,1
94936,.,0,1
94937,OBJECTIVE,0,0
94938,To,0,0
94939,compare,0,0
94940,elastic,0,0
94941,stable,0,1
94942,intramedullary,0,1
94943,nailing,0,1
94944,(,0,1
94945,ESIN,0,1
94946,),0,1
94947,with,0,1
94948,nonoperative,0,1
94949,treatment,0,0
94950,of,0,0
94951,fully,1,0
94952,displaced,1,1
94953,midshaft,1,1
94954,clavicular,1,1
94955,fractures,1,1
94956,in,1,1
94957,adults,1,1
94958,.,1,1
94959,DESIGN,0,0
94960,The,0,0
94961,study,0,0
94962,was,0,0
94963,a,0,0
94964,randomized,0,1
94965,",",0,0
94966,controlled,0,0
94967,",",0,0
94968,clinical,0,0
94969,trial,0,1
94970,.,0,1
94971,SETTING,0,1
94972,Level,1,0
94973,1,1,1
94974,trauma,1,1
94975,center,1,1
94976,.,1,1
94977,PATIENTS,0,0
94978,AND,0,0
94979,METHODS,0,0
94980,Sixty,1,1
94981,patients,1,1
94982,between,1,1
94983,18,1,1
94984,and,1,1
94985,65,1,1
94986,years,1,1
94987,of,1,1
94988,age,1,1
94989,participated,1,1
94990,and,1,0
94991,completed,1,1
94992,the,1,0
94993,study,1,0
94994,.,1,1
94995,They,0,0
94996,were,0,0
94997,randomized,0,1
94998,to,0,0
94999,either,0,1
95000,operative,0,0
95001,or,0,1
95002,nonoperative,0,1
95003,treatment,0,0
95004,with,0,1
95005,a,0,1
95006,2-year,0,1
95007,follow-up,0,0
95008,.,0,1
95009,INTERVENTION,0,0
95010,Thirty,0,1
95011,patients,0,1
95012,were,0,1
95013,treated,0,1
95014,with,0,1
95015,a,0,1
95016,simple,0,0
95017,shoulder,0,1
95018,sling,0,1
95019,and,0,1
95020,30,0,1
95021,patients,0,1
95022,with,0,1
95023,ESIN,0,1
95024,within,0,1
95025,3,0,1
95026,days,0,0
95027,after,0,1
95028,trauma,0,1
95029,.,0,1
95030,MAIN,0,0
95031,OUTCOME,0,1
95032,MEASUREMENT,0,0
95033,Complications,0,0
95034,after,0,1
95035,operative,0,1
95036,and,0,1
95037,nonoperative,0,1
95038,treatments,0,0
95039,",",0,1
95040,Disabilities,0,0
95041,of,0,0
95042,the,0,0
95043,Arm,0,1
95044,",",0,0
95045,Shoulder,0,1
95046,and,0,1
95047,Hand,0,1
95048,(,0,1
95049,DASH,0,1
95050,),0,1
95051,score,0,0
95052,and,0,1
95053,Constant,0,0
95054,Shoulder,0,1
95055,Score,0,1
95056,for,0,1
95057,outcome,0,0
95058,measurement,0,0
95059,",",0,0
95060,and,0,0
95061,clavicular,0,1
95062,shortening,0,0
95063,.,0,1
95064,RESULTS,0,0
95065,Fracture,0,1
95066,union,0,1
95067,was,0,0
95068,achieved,0,0
95069,in,0,0
95070,all,0,1
95071,patients,0,1
95072,in,0,0
95073,the,0,1
95074,operative,0,0
95075,group,0,0
95076,",",0,0
95077,whereas,0,0
95078,nonunion,0,1
95079,was,0,0
95080,observed,0,0
95081,in,0,0
95082,3,0,1
95083,of,0,1
95084,30,0,1
95085,patients,0,1
95086,of,0,1
95087,the,0,1
95088,nonoperative,0,1
95089,group,0,1
95090,.,0,1
95091,Two,0,1
95092,symptomatic,0,1
95093,malunions,0,1
95094,required,0,0
95095,corrective,0,1
95096,osteotomy,0,1
95097,in,0,0
95098,the,0,0
95099,nonoperative,0,1
95100,group,0,1
95101,.,0,1
95102,Medial,0,0
95103,nail,0,1
95104,protrusion,0,1
95105,occurred,0,0
95106,in,0,1
95107,7,0,1
95108,cases,0,1
95109,in,0,1
95110,the,0,1
95111,operative,0,1
95112,group,0,1
95113,.,0,1
95114,Implant,0,0
95115,failure,0,1
95116,with,0,1
95117,revision,0,1
95118,surgery,0,1
95119,was,0,0
95120,necessary,0,0
95121,in,0,1
95122,2,0,1
95123,patients,0,1
95124,after,0,1
95125,an,0,1
95126,additional,0,0
95127,adequate,0,0
95128,trauma,0,1
95129,.,0,1
95130,DASH,0,0
95131,scores,0,0
95132,were,0,1
95133,lower,0,0
95134,in,0,0
95135,the,0,0
95136,operative,0,0
95137,group,0,0
95138,throughout,0,0
95139,the,0,0
95140,first,0,1
95141,6,0,1
95142,months,0,1
95143,and,0,1
95144,2,0,1
95145,years,0,1
95146,after,0,1
95147,trauma,0,1
95148,",",0,0
95149,with,0,1
95150,a,0,0
95151,significant,0,0
95152,difference,0,0
95153,during,0,0
95154,the,0,0
95155,first,0,1
95156,18,0,1
95157,weeks,0,1
95158,.,0,1
95159,Constant,0,0
95160,scores,0,0
95161,were,0,1
95162,significantly,0,0
95163,higher,0,0
95164,after,0,1
95165,6,0,0
95166,months,0,1
95167,and,0,1
95168,2,0,1
95169,years,0,1
95170,after,0,1
95171,intramedullary,0,1
95172,stabilization,0,1
95173,.,0,1
95174,Patients,0,1
95175,in,0,0
95176,the,0,1
95177,operative,0,1
95178,group,0,0
95179,showed,0,0
95180,a,0,0
95181,significant,0,0
95182,improvement,0,0
95183,of,0,0
95184,posttraumatic,0,1
95185,clavicular,0,1
95186,shortening,0,1
95187,;,0,1
95188,they,0,0
95189,were,0,0
95190,also,0,0
95191,more,0,0
95192,satisfied,0,0
95193,with,0,0
95194,cosmetic,0,0
95195,appearance,0,0
95196,and,0,1
95197,overall,0,0
95198,outcome,0,0
95199,.,0,1
95200,CONCLUSIONS,0,0
95201,ESIN,0,0
95202,of,0,0
95203,displaced,0,1
95204,midshaft,0,1
95205,clavicular,0,1
95206,fractures,0,1
95207,resulted,0,0
95208,in,0,0
95209,a,0,0
95210,lower,0,0
95211,rate,0,0
95212,of,0,0
95213,nonunion,0,1
95214,and,0,1
95215,delayed,0,0
95216,union,0,1
95217,",",0,0
95218,a,0,0
95219,faster,0,0
95220,return,0,0
95221,to,0,0
95222,daily,0,0
95223,activities,0,0
95224,",",0,1
95225,and,0,0
95226,a,0,0
95227,better,0,0
95228,functional,0,0
95229,outcome,0,0
95230,.,0,1
95231,Clavicular,0,1
95232,shortening,0,0
95233,was,0,0
95234,significantly,0,0
95235,lower,0,0
95236,",",0,0
95237,and,0,0
95238,overall,0,0
95239,satisfaction,0,0
95240,was,0,0
95241,higher,0,0
95242,in,0,0
95243,the,0,0
95244,operative,0,1
95245,group,0,1
95246,.,0,1
95247,BNP-guided,0,1
95248,vs,0,0
95249,symptom-guided,0,1
95250,heart,0,1
95251,failure,0,1
95252,therapy,0,0
95253,:,0,1
95254,the,0,0
95255,Trial,0,1
95256,of,0,0
95257,Intensified,0,1
95258,vs,0,0
95259,Standard,0,1
95260,Medical,0,1
95261,Therapy,0,1
95262,in,1,1
95263,Elderly,1,1
95264,Patients,1,1
95265,With,1,1
95266,Congestive,1,1
95267,Heart,1,1
95268,Failure,1,1
95269,(,1,1
95270,TIME-CHF,1,1
95271,),1,1
95272,randomized,0,1
95273,trial,0,0
95274,.,0,1
95275,CONTEXT,0,0
95276,It,0,0
95277,is,0,0
95278,uncertain,0,0
95279,whether,0,0
95280,intensified,0,1
95281,heart,0,1
95282,failure,0,1
95283,therapy,0,0
95284,guided,0,1
95285,by,0,0
95286,N-terminal,0,0
95287,brain,0,1
95288,natriuretic,0,1
95289,peptide,0,0
95290,(,0,1
95291,BNP,0,1
95292,),0,1
95293,is,0,0
95294,superior,0,0
95295,to,0,0
95296,symptom-guided,0,1
95297,therapy,0,1
95298,.,0,1
95299,OBJECTIVE,0,0
95300,To,0,0
95301,compare,0,0
95302,18-month,0,1
95303,outcomes,0,0
95304,of,0,1
95305,N-terminal,0,1
95306,BNP-guided,0,1
95307,vs,0,0
95308,symptom-guided,0,1
95309,heart,0,1
95310,failure,0,1
95311,therapy,0,0
95312,.,0,1
95313,DESIGN,0,0
95314,",",0,0
95315,SETTING,0,1
95316,",",0,0
95317,AND,0,0
95318,PATIENTS,0,1
95319,Randomized,0,0
95320,controlled,0,0
95321,multicenter,0,0
95322,Trial,0,0
95323,of,0,0
95324,Intensified,0,1
95325,vs,0,0
95326,Standard,0,1
95327,Medical,0,1
95328,Therapy,0,1
95329,in,0,1
95330,Elderly,1,1
95331,Patients,1,1
95332,With,1,1
95333,Congestive,1,1
95334,Heart,1,1
95335,Failure,1,1
95336,(,1,1
95337,TIME-CHF,1,1
95338,),1,1
95339,of,1,1
95340,499,1,1
95341,patients,1,1
95342,aged,1,1
95343,60,1,1
95344,years,1,1
95345,or,1,1
95346,older,1,1
95347,with,1,1
95348,systolic,1,1
95349,heart,1,1
95350,failure,1,1
95351,(,1,0
95352,ejection,1,1
95353,fraction,1,1
95354,<,1,0
95355,or,1,1
95356,=,1,1
95357,45,1,1
95358,%,1,0
95359,),1,1
95360,",",1,0
95361,New,1,1
95362,York,1,1
95363,Heart,1,1
95364,Association,1,1
95365,(,1,1
95366,NYHA,1,1
95367,),1,1
95368,class,1,1
95369,of,1,0
95370,II,1,1
95371,or,1,1
95372,greater,1,0
95373,",",1,0
95374,prior,1,0
95375,hospitalization,1,1
95376,for,1,0
95377,heart,1,1
95378,failure,1,1
95379,within,1,1
95380,1,1,0
95381,year,1,1
95382,",",1,0
95383,and,1,0
95384,N-terminal,1,0
95385,BNP,1,1
95386,level,1,0
95387,of,1,1
95388,2,1,1
95389,or,1,1
95390,more,1,0
95391,times,1,0
95392,the,1,0
95393,upper,1,1
95394,limit,1,0
95395,of,1,1
95396,normal,1,1
95397,.,1,1
95398,The,0,0
95399,study,0,0
95400,had,0,1
95401,an,0,0
95402,18-month,0,1
95403,follow-up,0,0
95404,and,0,1
95405,it,0,0
95406,was,0,0
95407,conducted,0,1
95408,at,0,1
95409,15,1,1
95410,outpatient,1,1
95411,centers,1,1
95412,in,1,1
95413,Switzerland,1,1
95414,and,1,1
95415,Germany,1,1
95416,between,1,0
95417,January,1,1
95418,2003,1,1
95419,and,1,1
95420,June,1,1
95421,2008,1,1
95422,.,1,1
95423,INTERVENTION,0,0
95424,Uptitration,0,0
95425,of,0,1
95426,guideline-based,0,1
95427,treatments,0,0
95428,to,0,1
95429,reduce,0,0
95430,symptoms,0,0
95431,to,0,1
95432,NYHA,0,1
95433,class,0,1
95434,of,0,0
95435,II,0,1
95436,or,0,1
95437,less,0,0
95438,(,0,1
95439,symptom-guided,0,1
95440,therapy,0,1
95441,),0,1
95442,and,0,0
95443,BNP,0,1
95444,level,0,0
95445,of,0,1
95446,2,0,1
95447,times,0,0
95448,or,0,1
95449,less,0,0
95450,the,0,0
95451,upper,0,0
95452,limit,0,0
95453,of,0,0
95454,normal,0,1
95455,and,0,1
95456,symptoms,0,1
95457,to,0,1
95458,NYHA,0,1
95459,class,0,1
95460,of,0,0
95461,II,0,1
95462,or,0,1
95463,less,0,0
95464,(,0,1
95465,BNP-guided,0,0
95466,therapy,0,1
95467,),0,1
95468,.,0,1
95469,MAIN,0,0
95470,OUTCOME,0,1
95471,MEASURES,0,1
95472,Primary,0,1
95473,outcomes,0,0
95474,were,0,1
95475,18-month,0,1
95476,survival,0,0
95477,free,0,1
95478,of,0,1
95479,all-cause,0,1
95480,hospitalizations,0,1
95481,and,0,1
95482,quality,0,0
95483,of,0,0
95484,life,0,1
95485,as,0,0
95486,assessed,0,0
95487,by,0,0
95488,structured,0,1
95489,validated,0,1
95490,questionnaires,0,1
95491,.,0,1
95492,RESULTS,0,0
95493,Heart,0,1
95494,failure,0,1
95495,therapy,0,0
95496,guided,0,1
95497,by,0,0
95498,N-terminal,0,0
95499,BNP,0,1
95500,and,0,1
95501,symptom-guided,0,1
95502,therapy,0,0
95503,resulted,0,0
95504,in,0,0
95505,similar,0,0
95506,rates,0,0
95507,of,0,1
95508,survival,0,0
95509,free,0,1
95510,of,0,1
95511,all-cause,0,1
95512,hospitalizations,0,1
95513,(,0,1
95514,41,0,1
95515,%,0,0
95516,vs,0,0
95517,40,0,1
95518,%,0,0
95519,",",0,0
95520,respectively,0,0
95521,;,0,0
95522,hazard,0,0
95523,ratio,0,0
95524,[,0,0
95525,HR,0,0
95526,],0,1
95527,",",0,1
95528,0.91,0,0
95529,[,0,0
95530,95,0,0
95531,%,0,0
95532,CI,0,0
95533,",",0,0
95534,0.72-1.14,0,0
95535,],0,1
95536,;,0,1
95537,P,0,0
95538,=,0,1
95539,.39,0,0
95540,),0,1
95541,.,0,1
95542,Patients,0,1
95543,',0,1
95544,quality-of-life,0,0
95545,metrics,0,0
95546,improved,0,0
95547,over,0,1
95548,18,0,1
95549,months,0,1
95550,of,0,1
95551,follow-up,0,1
95552,but,0,0
95553,these,0,0
95554,improvements,0,0
95555,were,0,1
95556,similar,0,0
95557,in,0,0
95558,both,0,0
95559,the,0,0
95560,N-terminal,0,0
95561,BNP-guided,0,1
95562,and,0,1
95563,symptom-guided,0,1
95564,strategies,0,0
95565,.,0,1
95566,Compared,0,0
95567,with,0,1
95568,the,0,0
95569,symptom-guided,0,1
95570,group,0,0
95571,",",0,1
95572,survival,0,0
95573,free,0,1
95574,of,0,0
95575,hospitalization,0,1
95576,for,0,0
95577,heart,0,1
95578,failure,0,1
95579,",",0,0
95580,a,0,0
95581,secondary,0,0
95582,end,0,0
95583,point,0,0
95584,",",0,0
95585,was,0,0
95586,higher,0,0
95587,among,0,0
95588,those,0,0
95589,in,0,0
95590,the,0,0
95591,N-terminal,0,0
95592,BNP-guided,0,0
95593,group,0,1
95594,(,0,1
95595,72,0,1
95596,%,0,0
95597,vs,0,0
95598,62,0,1
95599,%,0,0
95600,",",0,0
95601,respectively,0,0
95602,;,0,0
95603,HR,0,0
95604,",",0,1
95605,0.68,0,0
95606,[,0,0
95607,95,0,0
95608,%,0,0
95609,CI,0,0
95610,",",0,0
95611,0.50-0.92,0,0
95612,],0,1
95613,;,0,1
95614,P,0,0
95615,=,0,1
95616,.01,0,0
95617,),0,1
95618,.,0,1
95619,Heart,0,0
95620,failure,0,1
95621,therapy,0,0
95622,guided,0,1
95623,by,0,0
95624,N-terminal,0,0
95625,BNP,0,1
95626,improved,0,0
95627,outcomes,0,0
95628,in,0,1
95629,patients,1,1
95630,aged,1,1
95631,60,1,1
95632,to,1,1
95633,75,1,1
95634,years,1,1
95635,but,0,0
95636,not,0,0
95637,in,0,0
95638,those,1,0
95639,aged,1,1
95640,75,1,1
95641,years,1,1
95642,or,1,1
95643,older,1,1
95644,(,0,1
95645,P,0,0
95646,<,0,0
95647,.02,0,0
95648,for,0,0
95649,interaction,0,0
95650,),0,1
95651,CONCLUSION,0,0
95652,Heart,0,1
95653,failure,0,1
95654,therapy,0,0
95655,guided,0,1
95656,by,0,0
95657,N-terminal,0,0
95658,BNP,0,1
95659,did,0,0
95660,not,0,0
95661,improve,0,0
95662,overall,0,0
95663,clinical,0,0
95664,outcomes,0,0
95665,or,0,1
95666,quality,0,0
95667,of,0,0
95668,life,0,1
95669,compared,0,0
95670,with,0,1
95671,symptom-guided,0,1
95672,treatment,0,1
95673,.,0,1
95674,TRIAL,0,0
95675,REGISTRATION,0,0
95676,isrctn.org,0,1
95677,Identifier,0,1
95678,:,0,1
95679,ISRCTN43596477,0,1
95680,.,0,1
95681,Development,0,0
95682,of,0,0
95683,a,0,1
95684,telehealth,0,0
95685,intervention,0,0
95686,for,0,0
95687,head,1,1
95688,and,1,1
95689,neck,1,1
95690,cancer,1,1
95691,patients,1,1
95692,.,1,1
95693,Treatment,0,0
95694,for,0,0
95695,head,1,1
95696,and,1,1
95697,neck,1,1
95698,cancer,1,1
95699,precipitates,0,0
95700,a,0,0
95701,myriad,0,0
95702,of,0,0
95703,distressing,0,1
95704,symptoms,0,1
95705,.,0,1
95706,Patients,0,1
95707,may,0,0
95708,be,0,0
95709,isolated,0,0
95710,both,0,0
95711,physically,0,0
95712,and,0,0
95713,socially,0,0
95714,and,0,0
95715,may,0,0
95716,lack,0,0
95717,the,0,0
95718,self-efficacy,0,0
95719,to,0,0
95720,report,0,0
95721,problems,0,1
95722,and,0,0
95723,participate,0,1
95724,as,0,0
95725,partners,0,1
95726,in,0,1
95727,their,0,1
95728,care,0,1
95729,.,0,1
95730,The,0,0
95731,goal,0,0
95732,of,0,0
95733,this,0,0
95734,project,0,1
95735,was,0,0
95736,to,0,0
95737,design,0,1
95738,a,0,0
95739,telehealth,0,0
95740,intervention,0,0
95741,to,0,0
95742,address,0,0
95743,such,0,0
95744,isolation,0,0
95745,",",0,0
95746,develop,0,0
95747,patient,0,0
95748,self-efficacy,0,0
95749,",",0,0
95750,and,0,0
95751,improve,0,0
95752,symptom,0,0
95753,management,0,0
95754,during,0,0
95755,the,0,0
95756,treatment,0,0
95757,experience,0,1
95758,.,0,1
95759,Participatory,0,0
95760,action,0,0
95761,research,0,1
95762,and,0,0
95763,a,0,0
95764,review,0,0
95765,of,0,0
95766,the,0,0
95767,literature,0,0
95768,were,0,0
95769,used,0,0
95770,to,0,0
95771,develop,0,0
95772,electronically,0,1
95773,administered,0,0
95774,symptom,0,0
95775,management,0,1
95776,algorithms,0,1
95777,addressing,0,0
95778,all,0,1
95779,major,0,1
95780,symptoms,0,0
95781,experienced,0,1
95782,by,0,1
95783,patients,1,1
95784,undergoing,1,1
95785,treatment,1,1
95786,for,1,0
95787,head,1,1
95788,and,1,1
95789,neck,1,1
95790,cancers,1,1
95791,.,1,1
95792,Daily,0,1
95793,questions,0,0
95794,and,0,1
95795,related,0,1
95796,messages,0,0
95797,were,0,1
95798,then,0,0
95799,programmed,0,0
95800,into,0,0
95801,an,0,0
95802,easy-to-use,0,0
95803,telehealth,0,0
95804,messaging,0,0
95805,device,0,0
95806,",",0,0
95807,the,0,0
95808,Health,0,0
95809,Buddy,0,1
95810,(,0,1
95811,R,0,1
95812,),0,1
95813,.,0,1
95814,Clinician,0,0
95815,and,0,0
95816,patient,0,1
95817,acceptance,0,0
95818,",",0,0
95819,feasibility,0,0
95820,",",0,0
95821,and,0,0
95822,technology,0,0
95823,issues,0,0
95824,were,0,1
95825,measured,0,0
95826,.,0,1
95827,Using,0,0
95828,participatory,0,0
95829,action,0,0
95830,research,0,0
95831,is,0,0
95832,an,0,0
95833,effective,0,0
95834,means,0,0
95835,for,0,1
95836,developing,0,1
95837,electronic,0,1
95838,algorithms,0,1
95839,acceptable,0,0
95840,to,0,1
95841,both,0,0
95842,clinicians,0,1
95843,and,0,1
95844,patients,0,1
95845,.,0,1
95846,The,0,0
95847,use,0,0
95848,of,0,0
95849,a,0,1
95850,simple,0,0
95851,tele-messaging,0,0
95852,device,0,0
95853,as,0,0
95854,an,0,0
95855,adjunct,0,0
95856,to,0,0
95857,symptom,0,0
95858,management,0,0
95859,is,0,0
95860,feasible,0,0
95861,",",0,0
95862,affordable,0,0
95863,",",0,0
95864,and,0,0
95865,acceptable,0,0
95866,to,0,1
95867,patients,0,1
95868,.,0,1
95869,This,0,0
95870,telehealth,0,0
95871,intervention,0,0
95872,provides,0,0
95873,support,0,0
95874,and,0,0
95875,education,0,1
95876,to,0,1
95877,patients,1,1
95878,undergoing,1,1
95879,treatment,1,1
95880,for,1,0
95881,head,1,1
95882,and,1,1
95883,neck,1,1
95884,cancers,1,1
95885,.,1,1
95886,Comparison,0,0
95887,of,0,0
95888,injection,1,0
95889,comfort,1,0
95890,of,0,0
95891,a,0,1
95892,new,0,1
95893,category,0,1
95894,of,0,0
95895,cohesive,1,1
95896,hyaluronic,1,0
95897,acid,1,0
95898,filler,1,0
95899,with,0,1
95900,preincorporated,0,0
95901,lidocaine,0,0
95902,and,0,0
95903,a,0,0
95904,hyaluronic,0,0
95905,acid,0,0
95906,filler,0,0
95907,alone,0,0
95908,.,0,0
95909,BACKGROUND,0,0
95910,A,0,0
95911,smooth,0,0
95912,",",0,0
95913,cohesive,0,0
95914,",",0,0
95915,24-mg/mL,0,0
95916,hyaluronic,0,0
95917,acid,0,0
95918,(,0,1
95919,HA,0,1
95920,),0,1
95921,gel,0,0
95922,with,0,1
95923,uniform,0,0
95924,consistency,0,0
95925,",",0,0
95926,even,0,0
95927,flow,0,0
95928,characteristics,0,0
95929,",",0,1
95930,and,0,0
95931,extended,0,1
95932,duration,0,0
95933,was,0,0
95934,designed,0,0
95935,for,0,0
95936,injection,0,0
95937,into,0,1
95938,the,0,0
95939,mid,0,0
95940,to,0,0
95941,deep,0,1
95942,dermis,0,1
95943,.,0,1
95944,OBJECTIVE,0,0
95945,To,0,0
95946,compare,0,0
95947,injection,0,0
95948,pain,0,1
95949,of,0,0
95950,a,0,1
95951,HA,0,1
95952,gel,0,0
95953,with,0,1
95954,preincorporated,0,0
95955,lidocaine,0,0
95956,with,0,1
95957,that,0,0
95958,with,0,1
95959,a,0,0
95960,non-lidocaine,0,0
95961,formulation,0,0
95962,.,0,1
95963,METHODS,0,0
95964,&,0,1
95965,MATERIALS,0,1
95966,This,0,0
95967,double-blind,0,0
95968,study,0,0
95969,at,0,1
95970,three,1,1
95971,centers,1,1
95972,enrolled,1,1
95973,60,1,1
95974,subjects,1,1
95975,",",1,1
95976,injected,1,0
95977,with,1,1
95978,both,1,0
95979,products,1,0
95980,",",1,0
95981,randomly,1,1
95982,assigned,1,1
95983,to,1,0
95984,left,1,1
95985,or,1,1
95986,right,1,1
95987,nasolabial,1,1
95988,fold,1,1
95989,.,1,1
95990,The,0,0
95991,injecting,0,0
95992,physician,0,1
95993,assessed,0,0
95994,severity,0,0
95995,of,0,0
95996,pain,0,1
95997,and,0,0
95998,ease,0,0
95999,of,0,0
96000,injection,0,0
96001,.,0,1
96002,Subjects,1,1
96003,used,1,0
96004,a,1,1
96005,visual,1,0
96006,analog,1,0
96007,scale,1,0
96008,(,1,1
96009,0-10,1,0
96010,),1,1
96011,for,1,0
96012,pain,1,1
96013,assessment,1,0
96014,.,1,1
96015,Adverse,0,0
96016,events,0,0
96017,were,0,1
96018,recorded,0,0
96019,.,0,1
96020,RESULTS,0,0
96021,Physician,0,0
96022,assessment,0,0
96023,of,0,0
96024,injection,0,0
96025,pain,0,1
96026,was,0,0
96027,none,0,0
96028,or,0,1
96029,mild,0,1
96030,in,0,1
96031,81,0,1
96032,%,0,0
96033,of,0,0
96034,HA,0,1
96035,gel,0,0
96036,injections,0,0
96037,with,0,1
96038,preincorporated,0,0
96039,lidocaine,0,0
96040,and,0,1
96041,36,0,1
96042,%,0,0
96043,of,0,1
96044,HA-alone,0,0
96045,injections,0,0
96046,(,0,1
96047,p,0,0
96048,<,0,0
96049,.001,0,0
96050,),0,1
96051,.,0,1
96052,Mean,0,1
96053,pain,0,1
96054,assessment,0,0
96055,by,0,0
96056,subjects,0,1
96057,was,0,0
96058,3.6,0,1
96059,for,0,1
96060,HA+lidocaine,0,1
96061,and,0,1
96062,5.8,0,0
96063,for,0,0
96064,HA,0,1
96065,alone,0,1
96066,(,0,1
96067,p,0,0
96068,<,0,0
96069,.001,0,0
96070,),0,1
96071,.,0,1
96072,Ninety-five,0,1
96073,percent,0,0
96074,of,0,0
96075,the,0,0
96076,injections,0,0
96077,were,0,1
96078,considered,0,1
96079,easy,0,0
96080,or,0,1
96081,very,0,0
96082,easy,0,0
96083,;,0,0
96084,a,0,1
96085,greater,0,0
96086,percentage,0,0
96087,of,0,0
96088,HA+lidocaine,0,1
96089,injections,0,0
96090,were,0,1
96091,rated,0,0
96092,very,0,0
96093,easy,0,0
96094,.,0,1
96095,Mild,0,0
96096,to,0,0
96097,moderate,0,1
96098,adverse,0,0
96099,events,0,0
96100,were,0,1
96101,reported,0,1
96102,for,0,0
96103,both,0,0
96104,products,0,0
96105,.,0,1
96106,CONCLUSION,0,0
96107,The,0,0
96108,smooth,0,0
96109,",",0,0
96110,cohesive,0,1
96111,HA,0,1
96112,gel,0,0
96113,with,0,1
96114,preincorporated,0,0
96115,lidocaine,0,0
96116,increased,0,0
96117,subject,0,0
96118,comfort,0,0
96119,during,0,0
96120,treatment,0,0
96121,and,0,0
96122,improved,0,0
96123,the,0,0
96124,injection,0,0
96125,experience,0,1
96126,.,0,1
96127,A,0,1
96128,comparison,0,0
96129,of,0,0
96130,single-dose,0,0
96131,cefixime,0,0
96132,with,0,1
96133,ceftriaxone,0,0
96134,as,0,0
96135,treatment,0,0
96136,for,0,1
96137,uncomplicated,1,1
96138,gonorrhea,1,1
96139,.,1,1
96140,The,0,0
96141,Gonorrhea,0,1
96142,Treatment,0,0
96143,Study,0,1
96144,Group,0,1
96145,.,0,1
96146,BACKGROUND,0,0
96147,Because,0,1
96148,of,0,0
96149,the,0,0
96150,widespread,0,0
96151,existence,0,0
96152,of,0,0
96153,Neisseria,0,1
96154,gonorrhoeae,0,1
96155,resistant,0,1
96156,to,0,0
96157,penicillin,0,0
96158,or,0,0
96159,tetracycline,0,0
96160,",",0,0
96161,ceftriaxone,0,0
96162,is,0,0
96163,now,0,0
96164,recommended,0,0
96165,for,0,0
96166,the,0,0
96167,treatment,0,0
96168,of,0,0
96169,gonorrhea,0,1
96170,.,0,0
96171,There,0,0
96172,is,0,0
96173,",",0,0
96174,however,0,0
96175,",",0,0
96176,a,0,0
96177,need,0,0
96178,for,0,0
96179,effective,0,0
96180,antibiotics,0,0
96181,that,0,0
96182,can,0,0
96183,be,0,0
96184,administered,0,0
96185,orally,0,0
96186,as,0,0
96187,an,0,0
96188,alternative,0,0
96189,to,0,0
96190,ceftriaxone,0,0
96191,",",0,0
96192,which,0,0
96193,requires,0,0
96194,intramuscular,0,0
96195,administration,0,0
96196,.,0,1
96197,Cefixime,0,0
96198,is,0,0
96199,an,0,0
96200,orally,0,0
96201,absorbed,0,0
96202,cephalosporin,0,0
96203,that,0,0
96204,is,0,0
96205,active,0,0
96206,against,0,0
96207,resistant,0,1
96208,gonococci,0,1
96209,and,0,0
96210,has,0,0
96211,pharmacokinetic,0,0
96212,activity,0,0
96213,suitable,0,0
96214,for,0,1
96215,single-dose,0,0
96216,administration,0,0
96217,.,0,1
96218,METHODS,0,0
96219,AND,0,0
96220,RESULTS,0,0
96221,In,0,1
96222,a,0,1
96223,randomized,0,1
96224,",",0,0
96225,unblinded,1,0
96226,multicenter,1,0
96227,study,1,1
96228,of,1,1
96229,209,1,1
96230,men,1,1
96231,and,1,1
96232,124,1,1
96233,women,1,1
96234,with,1,1
96235,uncomplicated,1,1
96236,gonorrhea,1,1
96237,",",0,0
96238,we,0,0
96239,compared,0,0
96240,three,0,0
96241,single-dose,0,0
96242,treatment,0,1
96243,regimens,0,0
96244,:,0,1
96245,400,0,1
96246,mg,0,1
96247,or,0,1
96248,800,0,0
96249,mg,0,0
96250,of,0,0
96251,cefixime,0,0
96252,",",0,0
96253,administered,0,0
96254,orally,0,0
96255,",",0,0
96256,and,0,0
96257,250,0,0
96258,mg,0,0
96259,of,0,0
96260,ceftriaxone,0,0
96261,administered,0,0
96262,intramuscularly,0,1
96263,.,0,1
96264,The,0,0
96265,overall,0,0
96266,cure,0,0
96267,rates,0,0
96268,were,0,1
96269,96,0,1
96270,percent,0,1
96271,for,0,0
96272,the,0,0
96273,400-mg,0,0
96274,dose,0,0
96275,of,0,0
96276,cefixime,0,0
96277,(,0,1
96278,89,0,1
96279,of,0,1
96280,93,0,1
96281,patients,0,1
96282,),0,1
96283,(,0,1
96284,95,0,0
96285,percent,0,1
96286,confidence,0,0
96287,interval,0,0
96288,",",0,0
96289,93.5,0,0
96290,percent,0,1
96291,to,0,1
96292,97.8,0,1
96293,percent,0,1
96294,),0,1
96295,;,0,1
96296,98,0,1
96297,percent,0,1
96298,for,0,0
96299,the,0,0
96300,800-mg,0,0
96301,dose,0,0
96302,of,0,0
96303,cefixime,0,0
96304,(,0,1
96305,86,0,1
96306,of,0,1
96307,88,0,1
96308,patients,0,1
96309,),0,1
96310,(,0,1
96311,95,0,0
96312,percent,0,1
96313,confidence,0,0
96314,interval,0,0
96315,",",0,0
96316,94.6,0,0
96317,percent,0,1
96318,to,0,1
96319,100,0,1
96320,percent,0,1
96321,),0,1
96322,;,0,1
96323,and,0,1
96324,98,0,1
96325,percent,0,1
96326,for,0,0
96327,ceftriaxone,0,0
96328,(,0,1
96329,92,0,1
96330,of,0,1
96331,94,0,1
96332,patients,0,1
96333,),0,1
96334,(,0,1
96335,95,0,0
96336,percent,0,1
96337,confidence,0,0
96338,interval,0,0
96339,",",0,1
96340,94.9,0,0
96341,to,0,1
96342,100,0,1
96343,percent,0,1
96344,),0,1
96345,.,0,1
96346,The,0,0
96347,cure,0,0
96348,rates,0,0
96349,were,0,1
96350,similar,0,0
96351,in,0,1
96352,men,0,1
96353,and,0,1
96354,women,0,1
96355,",",0,1
96356,and,0,1
96357,pharyngeal,0,1
96358,infection,0,1
96359,was,0,0
96360,eradicated,0,1
96361,in,0,0
96362,20,0,1
96363,of,0,1
96364,22,0,1
96365,patients,0,1
96366,(,0,1
96367,91,0,1
96368,percent,0,1
96369,),0,1
96370,.,0,1
96371,Thirty-nine,0,1
96372,percent,0,1
96373,of,0,1
96374,303,0,1
96375,pretreatment,0,1
96376,gonococcal,0,1
96377,isolates,0,1
96378,had,0,1
96379,one,0,1
96380,or,0,1
96381,more,0,0
96382,types,0,1
96383,of,0,0
96384,antimicrobial,0,0
96385,resistance,0,0
96386,;,0,0
96387,the,0,0
96388,efficacy,0,0
96389,of,0,0
96390,all,0,1
96391,three,0,0
96392,regimens,0,0
96393,was,0,0
96394,independent,0,0
96395,of,0,0
96396,the,0,0
96397,resistance,0,0
96398,pattern,0,1
96399,.,0,1
96400,Chlamydia,0,0
96401,trachomatis,0,0
96402,infection,0,1
96403,persisted,0,0
96404,in,0,0
96405,at,0,0
96406,least,0,1
96407,half,0,1
96408,the,0,0
96409,patients,0,1
96410,infected,0,1
96411,in,0,0
96412,each,0,0
96413,treatment,0,0
96414,group,0,0
96415,.,0,1
96416,All,0,1
96417,three,0,0
96418,regimens,0,0
96419,were,0,1
96420,well,0,0
96421,tolerated,0,0
96422,.,0,1
96423,CONCLUSIONS,0,0
96424,In,0,0
96425,the,0,0
96426,treatment,0,0
96427,of,0,0
96428,uncomplicated,0,1
96429,gonorrhea,0,1
96430,",",0,0
96431,a,0,0
96432,single,0,0
96433,dose,0,0
96434,of,0,0
96435,cefixime,0,0
96436,(,0,1
96437,400,0,0
96438,or,0,1
96439,800,0,0
96440,mg,0,1
96441,),0,1
96442,given,0,0
96443,orally,0,0
96444,appears,0,0
96445,to,0,0
96446,be,0,0
96447,as,0,0
96448,effective,0,0
96449,as,0,0
96450,the,0,0
96451,currently,0,1
96452,recommended,0,0
96453,regimen,0,0
96454,of,0,1
96455,ceftriaxone,0,0
96456,(,0,1
96457,250,0,0
96458,mg,0,0
96459,given,0,0
96460,intramuscularly,0,1
96461,),0,1
96462,.,0,1
96463,Cardiovascular,0,1
96464,safety,0,0
96465,and,0,1
96466,gastrointestinal,0,1
96467,tolerability,0,0
96468,of,0,0
96469,etoricoxib,0,0
96470,vs,0,0
96471,diclofenac,0,0
96472,in,0,0
96473,a,0,1
96474,randomized,0,1
96475,controlled,0,0
96476,clinical,0,0
96477,trial,0,0
96478,(,0,1
96479,The,0,0
96480,MEDAL,0,1
96481,study,0,1
96482,),0,1
96483,.,0,1
96484,OBJECTIVE,0,0
96485,To,0,0
96486,compare,0,0
96487,cardiovascular,0,1
96488,(,0,1
96489,CV,0,1
96490,),0,1
96491,and,0,1
96492,other,0,0
96493,safety,0,0
96494,and,0,1
96495,efficacy,0,0
96496,parameters,0,0
96497,of,0,1
96498,etoricoxib,0,1
96499,60,0,1
96500,and,0,1
96501,90,0,1
96502,mg,0,0
96503,",",0,0
96504,and,0,0
96505,diclofenac,0,0
96506,150,0,0
96507,mg.,0,0
96508,METHODS,0,0
96509,This,0,0
96510,double-blind,0,0
96511,study,0,0
96512,randomized,0,1
96513,OA,1,1
96514,patients,1,1
96515,to,0,1
96516,etoricoxib,0,1
96517,90,0,1
96518,mg,0,0
96519,",",0,0
96520,then,0,0
96521,to,0,1
96522,60,0,1
96523,mg,0,0
96524,once,0,1
96525,daily,0,0
96526,vs,0,0
96527,diclofenac,0,0
96528,75,0,1
96529,mg,0,0
96530,twice,0,1
96531,daily,0,0
96532,;,0,0
96533,RA,1,1
96534,patients,1,1
96535,were,0,1
96536,randomized,0,1
96537,to,0,0
96538,etoricoxib,0,0
96539,90,0,1
96540,mg,0,0
96541,once,0,1
96542,daily,0,0
96543,or,0,1
96544,diclofenac,0,0
96545,75,0,1
96546,mg,0,0
96547,twice,0,0
96548,daily,0,0
96549,.,0,0
96550,The,0,0
96551,primary,0,1
96552,endpoint,0,0
96553,was,0,0
96554,non-inferiority,0,0
96555,of,0,0
96556,etoricoxib,0,0
96557,vs,0,0
96558,diclofenac,0,0
96559,for,0,0
96560,thrombotic,0,1
96561,CV,0,1
96562,events,0,0
96563,(,0,1
96564,95,0,0
96565,%,0,0
96566,CI,0,0
96567,upper,0,1
96568,bound,0,0
96569,of,0,0
96570,hazard,0,0
96571,ratio,0,0
96572,<,0,0
96573,1.30,0,0
96574,),0,1
96575,.,0,1
96576,Other,0,0
96577,safety,0,0
96578,and,0,1
96579,efficacy,0,0
96580,parameters,0,0
96581,were,0,1
96582,evaluated,0,0
96583,in,0,0
96584,cohorts,0,1
96585,of,0,1
96586,patients,0,1
96587,based,0,1
96588,on,0,0
96589,etoricoxib,0,0
96590,dose,0,0
96591,and,0,0
96592,disease,0,1
96593,.,0,0
96594,RESULTS,0,0
96595,A,1,0
96596,total,1,1
96597,of,1,0
96598,23,1,1
96599,504,1,1
96600,patients,1,1
96601,were,0,1
96602,randomized,0,1
96603,with,0,1
96604,mean,0,1
96605,treatment,0,0
96606,duration,0,0
96607,from,0,1
96608,19.4,0,1
96609,to,0,1
96610,20.8,0,1
96611,months,0,0
96612,.,0,1
96613,The,0,0
96614,thrombotic,0,1
96615,CV,0,0
96616,risk,0,1
96617,hazard,0,0
96618,ratio,0,0
96619,(,0,1
96620,HR,0,0
96621,),0,1
96622,(,0,1
96623,etoricoxib,0,0
96624,to,0,0
96625,diclofenac,0,0
96626,),0,1
96627,was,0,0
96628,0.96,0,0
96629,(,0,1
96630,95,0,0
96631,%,0,0
96632,CI,0,0
96633,0.81,0,0
96634,",",0,1
96635,1.15,0,0
96636,),0,0
96637,",",0,0
96638,consistent,0,0
96639,with,0,1
96640,non-inferiority,0,0
96641,of,0,0
96642,etoricoxib,0,0
96643,to,0,1
96644,diclofenac,0,0
96645,.,0,1
96646,The,0,0
96647,cumulative,0,0
96648,gastrointestinal,0,1
96649,(,0,1
96650,GI,0,1
96651,),0,1
96652,/liver,0,1
96653,adverse,0,0
96654,events,0,0
96655,(,0,1
96656,AEs,0,0
96657,),0,1
96658,discontinuation,0,0
96659,rate,0,0
96660,was,0,0
96661,significantly,0,0
96662,lower,0,0
96663,for,0,0
96664,etoricoxib,0,0
96665,than,0,0
96666,diclofenac,0,0
96667,in,0,0
96668,each,0,0
96669,patient,0,1
96670,cohort,0,1
96671,;,0,1
96672,HR,0,0
96673,(,0,1
96674,95,0,0
96675,%,0,0
96676,CI,0,0
96677,),0,1
96678,of,0,1
96679,0.46,0,0
96680,(,0,1
96681,0.39,0,0
96682,",",0,1
96683,0.54,0,0
96684,),0,1
96685,",",0,1
96686,0.52,0,0
96687,(,0,1
96688,0.42,0,0
96689,",",0,1
96690,0.63,0,0
96691,),0,1
96692,and,0,1
96693,0.49,0,0
96694,(,0,1
96695,0.39,0,0
96696,",",0,1
96697,0.62,0,0
96698,),0,1
96699,for,0,0
96700,the,0,0
96701,60,0,1
96702,mg,0,0
96703,OA,0,1
96704,",",0,1
96705,90,0,1
96706,mg,0,0
96707,OA,0,1
96708,and,0,1
96709,RA,0,1
96710,cohorts,0,1
96711,.,0,1
96712,The,0,0
96713,maximum,0,0
96714,average,0,0
96715,change,0,0
96716,in,0,1
96717,systolic,0,1
96718,blood,0,0
96719,pressure,0,0
96720,(,0,1
96721,BP,0,1
96722,),0,1
96723,with,0,1
96724,etoricoxib,0,0
96725,was,0,0
96726,3.4-3.6,0,0
96727,mmHg,0,0
96728,(,0,1
96729,diastolic,0,1
96730,BP,0,1
96731,:,0,1
96732,1.0-1.5,0,0
96733,mmHg,0,0
96734,),0,0
96735,",",0,0
96736,while,0,0
96737,diclofenac,0,0
96738,produced,0,0
96739,a,0,0
96740,maximum,0,0
96741,average,0,0
96742,change,0,0
96743,of,0,0
96744,0.9-1.9,0,0
96745,mmHg,0,0
96746,(,0,1
96747,diastolic,0,1
96748,BP,0,1
96749,:,0,1
96750,0.0-0.5,0,0
96751,mmHg,0,0
96752,),0,1
96753,.,0,1
96754,Both,0,0
96755,agents,0,0
96756,resulted,0,0
96757,in,0,1
96758,similar,0,0
96759,efficacy,0,0
96760,regardless,0,0
96761,of,0,0
96762,etoricoxib,0,0
96763,dose,0,0
96764,.,0,1
96765,CONCLUSION,0,0
96766,Long-term,0,0
96767,etoricoxib,0,0
96768,use,0,0
96769,is,0,0
96770,associated,0,0
96771,with,0,0
96772,a,0,0
96773,risk,0,0
96774,of,0,0
96775,thrombotic,0,1
96776,CV,0,1
96777,events,0,0
96778,comparable,0,0
96779,with,0,1
96780,that,0,0
96781,of,0,0
96782,diclofenac,0,0
96783,.,0,1
96784,Compared,0,0
96785,with,0,1
96786,diclofenac,0,0
96787,",",0,0
96788,etoricoxib,0,0
96789,demonstrated,0,0
96790,a,0,0
96791,greater,0,0
96792,risk,0,0
96793,of,0,0
96794,renovascular,0,1
96795,AEs,0,0
96796,",",0,0
96797,but,0,0
96798,a,0,0
96799,more,0,0
96800,favourable,0,0
96801,GI/liver,0,0
96802,tolerability,0,0
96803,profile,0,0
96804,.,0,1
96805,[,0,1
96806,Efficacy,0,0
96807,of,0,0
96808,immunomodulating,0,0
96809,treatment,0,1
96810,in,0,1
96811,patients,1,1
96812,with,1,1
96813,different,1,1
96814,degrees,1,1
96815,of,1,1
96816,immunosuppression,1,1
96817,],1,1
96818,.,0,1
96819,Immunodepression,0,0
96820,is,0,0
96821,a,0,0
96822,common,0,0
96823,condition,0,0
96824,in,0,1
96825,patients,0,1
96826,undergoing,0,1
96827,elective,0,1
96828,operations,0,1
96829,and,0,1
96830,it,0,0
96831,constitutes,0,0
96832,a,0,0
96833,high,0,0
96834,risk,0,0
96835,for,0,0
96836,the,0,0
96837,onset,0,1
96838,of,0,0
96839,postoperative,0,1
96840,infective,0,1
96841,complications,0,1
96842,.,0,1
96843,The,0,0
96844,use,0,0
96845,of,0,0
96846,immunomodulatory,0,0
96847,drugs,0,0
96848,has,0,0
96849,proved,0,0
96850,useful,0,0
96851,in,0,0
96852,the,0,0
96853,prophylaxis,0,0
96854,of,0,0
96855,these,0,0
96856,complications,0,0
96857,",",0,0
96858,although,0,0
96859,the,0,0
96860,precise,0,0
96861,indications,0,0
96862,for,0,1
96863,each,0,0
96864,drug,0,0
96865,have,0,0
96866,not,0,0
96867,yet,0,0
96868,been,0,0
96869,clearly,0,0
96870,codified,0,1
96871,.,0,0
96872,The,0,0
96873,present,0,0
96874,study,0,1
96875,aimed,0,0
96876,to,0,0
96877,assess,0,0
96878,the,0,0
96879,effects,0,0
96880,of,0,0
96881,thymostimulin,0,1
96882,in,0,1
96883,patients,1,1
96884,with,1,1
96885,different,1,1
96886,degrees,1,1
96887,of,1,1
96888,immunodepression,1,1
96889,",",0,0
96890,by,0,0
96891,evaluating,0,0
96892,both,0,0
96893,the,0,0
96894,incidence,0,0
96895,of,0,0
96896,postoperative,0,1
96897,infections,0,1
96898,and,0,1
96899,the,0,1
96900,changes,0,0
96901,induced,0,0
96902,in,0,1
96903,various,0,0
96904,immunological,0,0
96905,parameters,0,0
96906,.,0,1
96907,The,0,0
96908,results,0,0
96909,obtained,0,0
96910,indicated,0,0
96911,that,0,0
96912,those,0,1
96913,subjects,0,1
96914,with,0,1
96915,the,0,0
96916,highest,0,0
96917,degree,0,0
96918,of,0,0
96919,immunodepression,0,1
96920,(,0,1
96921,hypo-anergic,0,1
96922,),0,1
96923,benefited,0,1
96924,most,0,0
96925,from,0,1
96926,drug,0,0
96927,therapy,0,0
96928,in,0,0
96929,comparison,0,0
96930,to,0,0
96931,those,0,0
96932,with,0,1
96933,a,0,0
96934,lesser,0,0
96935,degree,0,0
96936,of,0,0
96937,immunodepression,0,0
96938,(,0,0
96939,relatively,0,0
96940,hypo-ergic,0,1
96941,),0,0
96942,.,0,1
96943,The,0,0
96944,advantages,0,0
96945,were,0,1
96946,evident,0,0
96947,in,0,1
96948,hypo-anergic,0,1
96949,subjects,0,1
96950,both,0,0
96951,with,0,1
96952,regard,0,0
96953,to,0,0
96954,the,0,0
96955,frequency,0,0
96956,of,0,0
96957,early,0,1
96958,postoperative,0,1
96959,infections,0,1
96960,",",0,1
96961,and,0,0
96962,with,0,1
96963,regard,0,0
96964,to,0,1
96965,immunological,0,0
96966,parameters,0,0
96967,.,0,1
96968,On,0,0
96969,the,0,0
96970,other,0,0
96971,hand,0,0
96972,",",0,0
96973,in,0,0
96974,relatively,0,1
96975,hypo-ergic,0,1
96976,subjects,0,1
96977,",",0,1
96978,benefits,0,0
96979,were,0,1
96980,limited,0,0
96981,to,0,0
96982,the,0,0
96983,improvement,0,0
96984,of,0,0
96985,some,0,0
96986,immunological,0,0
96987,parameters,0,0
96988,.,0,1
96989,In,0,0
96990,our,0,0
96991,opinion,0,0
96992,",",0,0
96993,the,0,0
96994,use,0,0
96995,of,0,0
96996,thymostimulin,0,0
96997,is,0,0
96998,of,0,0
96999,particular,0,0
97000,use,0,0
97001,only,0,0
97002,in,0,0
97003,those,0,1
97004,subjects,0,1
97005,with,0,1
97006,marked,0,1
97007,immunodepression,0,1
97008,since,0,0
97009,the,0,0
97010,incidence,0,0
97011,of,0,0
97012,post-operative,0,0
97013,sepsis,0,1
97014,is,0,0
97015,highest,0,0
97016,in,0,0
97017,this,0,0
97018,group,0,1
97019,.,0,1
97020,Using,0,1
97021,a,0,1
97022,novel,0,0
97023,wound,0,0
97024,model,0,0
97025,to,0,0
97026,investigate,0,0
97027,the,0,0
97028,healing,0,0
97029,properties,0,0
97030,of,0,1
97031,products,0,1
97032,for,0,1
97033,superficial,0,1
97034,wounds,0,1
97035,.,0,1
97036,OBJECTIVE,0,0
97037,To,0,0
97038,establish,0,0
97039,a,0,0
97040,new,0,0
97041,wound,0,0
97042,model,0,0
97043,that,0,0
97044,can,0,0
97045,induce,0,0
97046,uniform,0,0
97047,abrasions,0,0
97048,and,0,1
97049,use,0,0
97050,it,0,0
97051,to,0,0
97052,assess,0,0
97053,the,0,0
97054,healing,0,0
97055,properties,0,0
97056,of,0,0
97057,a,0,1
97058,range,0,1
97059,of,0,0
97060,products,0,0
97061,commonly,0,1
97062,applied,0,0
97063,to,0,0
97064,these,0,0
97065,wounds,0,1
97066,.,0,1
97067,METHOD,0,0
97068,Ten,1,1
97069,healthy,1,1
97070,volunteers,1,1
97071,were,0,1
97072,enrolled,0,1
97073,into,0,1
97074,an,0,0
97075,open-label,0,1
97076,",",0,0
97077,randomised,0,0
97078,",",0,0
97079,intra-individual,0,0
97080,comparison,0,0
97081,pilot,0,1
97082,study,0,1
97083,.,0,1
97084,Five,0,0
97085,standardised,0,0
97086,",",0,1
97087,superficial,0,1
97088,abrasions,0,0
97089,were,0,1
97090,induced,0,0
97091,on,0,0
97092,their,0,1
97093,forearms,0,1
97094,by,0,0
97095,repeatedly,0,1
97096,scrubbing,0,0
97097,the,0,0
97098,skin,0,1
97099,with,0,1
97100,a,0,1
97101,surgical,0,1
97102,brush,0,0
97103,until,0,1
97104,the,0,0
97105,first,0,0
97106,signs,0,1
97107,of,0,1
97108,uniform,0,1
97109,glistening,0,0
97110,and,0,0
97111,punctuate,0,0
97112,bleeding,0,1
97113,were,0,1
97114,observed,0,0
97115,.,0,1
97116,Three,0,1
97117,products,0,0
97118,that,0,0
97119,promote,0,0
97120,a,0,0
97121,moist,0,1
97122,wound,0,0
97123,environment,0,0
97124,(,0,0
97125,polyurethane,0,0
97126,",",0,0
97127,hydrocolloid,0,0
97128,",",0,0
97129,hydrogel,0,0
97130,),0,1
97131,and,0,1
97132,two,0,1
97133,standard,0,1
97134,plasters,0,0
97135,were,0,1
97136,randomly,0,1
97137,allocated,0,1
97138,to,0,0
97139,the,0,0
97140,test,0,0
97141,areas,0,0
97142,.,0,1
97143,RESULTS,0,0
97144,Evaluation,0,0
97145,of,0,0
97146,wound,0,0
97147,healing,0,0
97148,on,0,0
97149,days,0,0
97150,2,0,1
97151,",",0,1
97152,5,0,0
97153,",",0,1
97154,8,0,1
97155,and,0,1
97156,14,0,1
97157,+/-,0,1
97158,1,0,1
97159,showed,0,0
97160,best,0,0
97161,results,0,0
97162,for,0,0
97163,the,0,0
97164,polyurethane,0,0
97165,and,0,0
97166,hydrocolloid,0,0
97167,plasters,0,1
97168,.,0,1
97169,Visible,0,0
97170,re-epithelialisation,0,0
97171,was,0,0
97172,recorded,0,0
97173,on,0,0
97174,days,0,0
97175,5,0,1
97176,and,0,1
97177,8,0,1
97178,.,0,1
97179,More,0,1
97180,than,0,0
97181,50,0,1
97182,%,0,0
97183,of,0,0
97184,the,0,0
97185,wound,0,0
97186,area,0,0
97187,had,0,1
97188,closed,0,1
97189,.,0,1
97190,Video,0,0
97191,microscope,0,0
97192,images,0,0
97193,support,0,0
97194,these,0,0
97195,findings,0,0
97196,.,0,1
97197,The,0,0
97198,investigator,0,0
97199,and,0,0
97200,volunteers,0,1
97201,assessed,0,1
97202,cosmetic,0,1
97203,outcomes,0,0
97204,on,0,1
97205,day,0,1
97206,31,0,1
97207,+/-,0,1
97208,2,0,1
97209,.,0,1
97210,Best,0,0
97211,results,0,0
97212,were,0,1
97213,obtained,0,0
97214,for,0,0
97215,the,0,0
97216,polyurethane,0,0
97217,and,0,0
97218,hydrocolloid,0,0
97219,products,0,0
97220,",",0,1
97221,which,0,0
97222,had,0,1
97223,high,0,1
97224,mean,0,1
97225,scores,0,0
97226,close,0,0
97227,to,0,0
97228,the,0,0
97229,maximum,0,0
97230,of,0,0
97231,10,0,1
97232,.,0,1
97233,Histological,0,0
97234,examination,0,0
97235,of,0,1
97236,biopsies,0,1
97237,taken,0,0
97238,from,0,1
97239,the,0,0
97240,abrasions,0,0
97241,of,0,1
97242,two,0,1
97243,volunteers,0,1
97244,showed,0,0
97245,the,0,0
97246,dermis,0,1
97247,remained,0,0
97248,intact,0,0
97249,",",0,0
97250,making,0,0
97251,the,0,0
97252,model,0,0
97253,highly,0,0
97254,suitable,0,0
97255,for,0,0
97256,the,0,0
97257,study,0,0
97258,of,0,0
97259,superficial,0,1
97260,wounds,0,1
97261,.,0,1
97262,CONCLUSION,0,0
97263,Uniform,0,0
97264,and,0,1
97265,identical,0,1
97266,standardised,0,0
97267,wounds,0,1
97268,created,0,0
97269,using,0,0
97270,an,0,0
97271,abrasive,0,0
97272,brush,0,0
97273,technique,0,0
97274,can,0,0
97275,be,0,0
97276,used,0,0
97277,to,0,0
97278,reliably,0,0
97279,detect,0,0
97280,differences,0,0
97281,in,0,1
97282,the,0,0
97283,performance,0,0
97284,of,0,0
97285,plasters,0,0
97286,intended,0,0
97287,for,0,1
97288,superficial,1,1
97289,wounds,1,1
97290,.,1,1
97291,In,0,0
97292,general,0,1
97293,",",0,1
97294,products,0,0
97295,that,0,0
97296,promote,0,0
97297,a,0,0
97298,moist,0,1
97299,wound,0,0
97300,environment,0,0
97301,produced,0,0
97302,better,0,0
97303,results,0,0
97304,than,0,0
97305,those,0,1
97306,that,0,0
97307,promote,0,0
97308,a,0,0
97309,dry,0,0
97310,wound,0,0
97311,environment,0,0
97312,",",0,0
97313,with,0,1
97314,an,0,0
97315,earlier,0,0
97316,onset,0,1
97317,of,0,0
97318,healing,0,0
97319,and,0,1
97320,better,0,0
97321,healing,0,0
97322,outcomes,0,0
97323,.,0,1
97324,Superficial,0,1
97325,cutaneous,0,1
97326,wounds,0,1
97327,treated,0,1
97328,with,0,1
97329,polyurethane,0,0
97330,or,0,1
97331,hydrocolloid,0,0
97332,products,0,0
97333,demonstrated,0,0
97334,superior,0,0
97335,rates,0,0
97336,of,0,1
97337,re-epithelialisation,0,1
97338,and,0,1
97339,overall,0,0
97340,cosmetic,0,1
97341,outcomes,0,0
97342,.,0,1
97343,DECLARATION,0,0
97344,OF,0,1
97345,INTEREST,0,0
97346,This,0,0
97347,study,0,0
97348,was,0,0
97349,funded,0,1
97350,by,0,0
97351,Beiersdorf,0,1
97352,AG,0,1
97353,.,0,1
97354,Neither,0,0
97355,author,0,0
97356,has,0,0
97357,any,0,0
97358,interest,0,0
97359,in,0,0
97360,the,0,0
97361,sponsor,0,1
97362,'s,0,1
97363,commercial,0,1
97364,activities,0,0
97365,.,0,1
97366,A,0,0
97367,randomized,0,0
97368,",",0,0
97369,controlled,0,0
97370,study,0,0
97371,on,0,0
97372,the,0,0
97373,influence,0,0
97374,of,0,0
97375,acetaminophen,0,0
97376,",",0,0
97377,diclofenac,0,0
97378,",",0,0
97379,or,0,0
97380,naproxen,0,0
97381,on,0,0
97382,aspirin-induced,0,0
97383,inhibition,0,0
97384,of,0,0
97385,platelet,0,0
97386,aggregation,0,0
97387,.,0,1
97388,Nonsteroidal,0,0
97389,anti-inflammatory,0,0
97390,drugs,0,0
97391,(,0,1
97392,NSAID,0,1
97393,),0,1
97394,may,0,0
97395,interfere,0,0
97396,with,0,1
97397,aspirin,0,0
97398,(,0,1
97399,acetylsalicylic,0,0
97400,acid,0,0
97401,),0,1
97402,and,0,0
97403,increase,0,0
97404,the,0,0
97405,risk,0,0
97406,for,0,0
97407,cardiovascular,0,1
97408,events,0,0
97409,.,0,1
97410,The,0,0
97411,clinical,0,0
97412,relevance,0,0
97413,is,0,0
97414,uncertain,0,0
97415,.,0,0
97416,The,0,0
97417,aim,0,0
97418,of,0,0
97419,this,0,0
97420,study,0,0
97421,was,0,0
97422,to,0,0
97423,analyse,0,0
97424,the,0,0
97425,influence,0,0
97426,of,0,0
97427,a,0,0
97428,co-administration,0,0
97429,of,0,0
97430,aspirin,0,0
97431,and,0,1
97432,NSAID,0,1
97433,on,0,0
97434,platelet,0,0
97435,aggregation,0,0
97436,.,0,1
97437,In,0,0
97438,a,0,0
97439,randomized,0,1
97440,",",0,0
97441,placebo,0,0
97442,controlled,0,0
97443,trial,0,0
97444,",",0,0
97445,eleven,1,1
97446,healthy,1,1
97447,volunteers,1,1
97448,were,0,1
97449,studied,0,1
97450,during,0,1
97451,4,0,0
97452,separate,0,1
97453,study,0,1
97454,periods,0,0
97455,of,0,1
97456,4,0,1
97457,days,0,0
97458,each,0,1
97459,.,0,1
97460,Individuals,0,0
97461,were,0,0
97462,treated,0,1
97463,on,0,0
97464,each,0,0
97465,occasion,0,1
97466,with,0,1
97467,100,0,1
97468,mg,0,0
97469,aspirin,0,0
97470,daily,0,0
97471,in,0,0
97472,combination,0,0
97473,with,0,1
97474,either,0,1
97475,3,0,1
97476,x,0,1
97477,1,0,1
97478,g,0,1
97479,acetaminophen,0,0
97480,",",0,0
97481,3,0,0
97482,x,0,1
97483,50,0,1
97484,mg,0,0
97485,diclofenac,0,0
97486,",",0,0
97487,3,0,0
97488,x,0,1
97489,250,0,1
97490,mg,0,0
97491,naproxen,0,0
97492,",",0,0
97493,or,0,1
97494,3,0,1
97495,x,0,1
97496,1,0,1
97497,placebo,0,1
97498,.,0,1
97499,Primary,0,0
97500,hemostasis,0,0
97501,was,0,0
97502,assessed,0,0
97503,with,0,1
97504,a,0,0
97505,platelet,0,0
97506,function,0,0
97507,analyser,0,0
97508,(,0,1
97509,PFA-100,0,0
97510,),0,1
97511,",",0,0
97512,which,0,0
97513,measures,0,0
97514,the,0,0
97515,closure,0,0
97516,time,0,0
97517,(,0,1
97518,CT,0,1
97519,),0,1
97520,of,0,0
97521,a,0,1
97522,collagen-,0,0
97523,and,0,0
97524,epinephrine-coated,0,0
97525,pore,0,1
97526,by,0,0
97527,aggregating,0,0
97528,platelets,0,1
97529,in,0,1
97530,flowing,0,1
97531,blood,0,0
97532,.,0,1
97533,Naproxen,0,0
97534,enhanced,0,0
97535,the,0,0
97536,anti-aggregatory,0,0
97537,action,0,0
97538,of,0,0
97539,aspirin,0,0
97540,after,0,1
97541,24,0,1
97542,h,0,0
97543,(,0,1
97544,CT,0,0
97545,rising,0,1
97546,from,0,1
97547,104+/-16,0,1
97548,s,0,1
97549,at,0,1
97550,baseline,0,0
97551,to,0,1
97552,212+/-69,0,1
97553,s,0,1
97554,at,0,1
97555,24,0,1
97556,h,0,0
97557,",",0,1
97558,P,0,0
97559,<,0,0
97560,0.001,0,0
97561,),0,1
97562,",",0,0
97563,which,0,0
97564,was,0,0
97565,not,0,0
97566,seen,0,0
97567,with,0,1
97568,any,0,0
97569,other,0,0
97570,drug,0,0
97571,combination,0,0
97572,.,0,1
97573,Diclofenac,0,0
97574,reduced,0,0
97575,the,0,0
97576,anti-aggregatory,0,0
97577,action,0,0
97578,of,0,0
97579,aspirin,0,0
97580,in,0,0
97581,the,0,0
97582,first,0,1
97583,two,0,0
97584,days,0,0
97585,",",0,1
97586,since,0,0
97587,the,0,0
97588,CT,0,0
97589,did,0,0
97590,not,0,0
97591,rise,0,0
97592,significantly,0,0
97593,(,0,0
97594,109+/-19,0,0
97595,s,0,1
97596,",",0,0
97597,148+/-56,0,1
97598,s,0,0
97599,",",0,0
97600,and,0,0
97601,168+/-66,0,0
97602,s,0,1
97603,at,0,1
97604,0,0,0
97605,h,0,0
97606,",",0,1
97607,24,0,0
97608,h,0,0
97609,",",0,1
97610,48,0,1
97611,h,0,0
97612,",",0,0
97613,respectively,0,0
97614,",",0,0
97615,P,0,0
97616,>,0,1
97617,0.05,0,0
97618,),0,1
97619,.,0,1
97620,Acetaminophen,0,0
97621,had,0,1
97622,no,0,0
97623,effect,0,0
97624,compared,0,0
97625,with,0,1
97626,placebo,0,0
97627,.,0,1
97628,After,0,0
97629,4,0,0
97630,days,0,0
97631,of,0,1
97632,treatment,0,1
97633,platelet,0,0
97634,aggregation,0,0
97635,was,0,0
97636,similarly,0,0
97637,inhibited,0,0
97638,by,0,0
97639,all,0,1
97640,combinations,0,0
97641,.,0,1
97642,We,0,0
97643,conclude,0,0
97644,that,0,0
97645,a,0,0
97646,co-administration,0,0
97647,of,0,0
97648,NSAID,0,1
97649,and,0,0
97650,aspirin,0,0
97651,may,0,0
97652,interfere,0,0
97653,with,0,0
97654,platelet,0,0
97655,inhibition,0,0
97656,at,0,0
97657,the,0,0
97658,beginning,0,0
97659,of,0,0
97660,a,0,0
97661,treatment,0,0
97662,with,0,1
97663,an,0,0
97664,increase,0,0
97665,of,0,0
97666,naproxen,0,0
97667,and,0,1
97668,a,0,0
97669,decrease,0,0
97670,of,0,0
97671,diclofenac,0,0
97672,.,0,1
97673,This,0,0
97674,effect,0,0
97675,is,0,0
97676,lost,0,0
97677,after,0,0
97678,4,0,0
97679,days,0,0
97680,",",0,1
97681,suggesting,0,0
97682,that,0,0
97683,a,0,1
97684,regular,0,1
97685,daily,0,0
97686,co-administration,0,0
97687,of,0,0
97688,NSAID,0,0
97689,does,0,0
97690,not,0,0
97691,have,0,0
97692,an,0,0
97693,influence,0,0
97694,on,0,0
97695,platelet,0,0
97696,inhibition,0,0
97697,by,0,0
97698,aspirin,0,0
97699,.,0,1
97700,Ongoing,0,1
97701,Telmisartan,0,1
97702,Alone,0,0
97703,and,0,1
97704,in,0,0
97705,Combination,0,0
97706,With,0,1
97707,Ramipril,0,0
97708,Global,0,1
97709,Endpoint,0,0
97710,Trial,0,1
97711,(,0,1
97712,ONTARGET,0,1
97713,),0,1
97714,:,0,1
97715,implications,0,0
97716,for,0,1
97717,reduced,0,0
97718,cardiovascular,0,1
97719,risk,0,1
97720,.,0,1
97721,The,0,0
97722,recently,0,1
97723,published,0,0
97724,Ongoing,0,0
97725,Telmisartan,0,1
97726,Alone,0,0
97727,and,0,1
97728,in,0,0
97729,Combination,0,0
97730,With,0,1
97731,Ramipril,0,0
97732,Global,0,1
97733,Endpoint,0,0
97734,Trial,0,1
97735,(,0,1
97736,ONTARGET,0,1
97737,),0,1
97738,in,0,1
97739,patients,1,1
97740,with,1,1
97741,vascular,1,1
97742,disease,1,1
97743,or,1,1
97744,high-risk,1,1
97745,diabetes,1,1
97746,",",0,1
97747,as,0,0
97748,the,0,0
97749,largest,0,1
97750,published,0,0
97751,comparative,0,0
97752,trial,0,0
97753,of,0,0
97754,these,0,0
97755,agent,0,0
97756,classes,0,0
97757,",",0,0
97758,provides,0,0
97759,further,0,0
97760,evidence,0,0
97761,concerning,0,0
97762,the,0,0
97763,comparison,0,0
97764,between,0,0
97765,the,0,0
97766,angiotensin-receptor,0,0
97767,blockers,0,0
97768,(,0,1
97769,ARBs,0,1
97770,),0,1
97771,and,0,0
97772,the,0,0
97773,angiotensin-converting,0,0
97774,enzyme,0,0
97775,inhibitors,0,0
97776,(,0,1
97777,ACEIs,0,1
97778,),0,1
97779,.,0,1
97780,In,0,0
97781,this,0,0
97782,trial,0,0
97783,",",0,0
97784,telmisartan,0,0
97785,(,0,0
97786,an,0,0
97787,ARB,0,1
97788,),0,1
97789,was,0,0
97790,non-inferior,0,0
97791,to,0,0
97792,ramipril,0,0
97793,(,0,0
97794,an,0,0
97795,ACEI,0,1
97796,),0,1
97797,in,0,0
97798,reducing,0,0
97799,fatal,0,1
97800,and,0,1
97801,nonfatal,0,1
97802,cardiovascular,0,1
97803,events,0,0
97804,.,0,1
97805,Moreover,0,0
97806,",",0,0
97807,ONTARGET,0,0
97808,is,0,0
97809,an,0,0
97810,example,0,0
97811,of,0,0
97812,a,0,1
97813,high-quality,0,0
97814,noninferiority,0,0
97815,trial,0,0
97816,.,0,1
97817,However,0,0
97818,",",0,0
97819,the,0,0
97820,combination,0,0
97821,of,0,0
97822,the,0,1
97823,2,0,1
97824,agents,0,0
97825,was,0,0
97826,associated,0,0
97827,with,0,1
97828,more,0,0
97829,adverse,0,0
97830,effects,0,0
97831,without,0,1
97832,an,0,1
97833,increase,0,0
97834,in,0,0
97835,benefit,0,0
97836,.,0,1
97837,The,0,0
97838,study,0,0
97839,differed,0,0
97840,from,0,1
97841,several,0,1
97842,other,0,1
97843,comparative,0,0
97844,studies,0,0
97845,in,0,1
97846,which,0,0
97847,the,0,0
97848,dose,0,0
97849,and,0,0
97850,choice,0,0
97851,of,0,0
97852,ACEI,0,1
97853,was,0,0
97854,left,0,1
97855,to,0,1
97856,individual,0,0
97857,physicians,0,1
97858,.,0,1
97859,Further,0,0
97860,",",0,0
97861,in,0,0
97862,ONTARGET,0,0
97863,",",0,0
97864,the,0,0
97865,ACEI,0,1
97866,was,0,0
97867,not,0,0
97868,titrated,0,0
97869,to,0,0
97870,the,0,0
97871,maximum,0,0
97872,dose,0,0
97873,and,0,1
97874,patients,0,1
97875,with,0,1
97876,heart,0,1
97877,failure,0,1
97878,were,0,1
97879,excluded,0,1
97880,.,0,1
97881,Pulse,0,0
97882,oximeter,0,0
97883,perfusion,0,0
97884,index,0,0
97885,as,0,0
97886,an,0,0
97887,early,0,1
97888,indicator,0,0
97889,of,0,0
97890,sympathectomy,0,1
97891,after,0,1
97892,epidural,0,1
97893,anesthesia,0,1
97894,.,0,1
97895,BACKGROUND,0,0
97896,The,0,0
97897,pulse,0,0
97898,oximeter,0,0
97899,perfusion,0,0
97900,index,0,1
97901,(,0,1
97902,PI,0,1
97903,),0,1
97904,has,0,0
97905,been,0,0
97906,used,0,0
97907,to,0,0
97908,indicate,0,0
97909,sympathectomy-induced,0,0
97910,vasodilatation,0,0
97911,.,0,1
97912,We,0,0
97913,hypothesized,0,0
97914,that,0,0
97915,pulse,0,0
97916,oximeter,0,0
97917,PI,0,1
97918,provides,0,0
97919,an,0,0
97920,earlier,0,0
97921,and,0,0
97922,clearer,0,0
97923,indication,0,0
97924,of,0,0
97925,sympathectomy,0,1
97926,following,0,0
97927,epidural,0,1
97928,anesthesia,0,1
97929,than,0,1
97930,skin,0,1
97931,temperature,0,1
97932,and,0,1
97933,arterial,0,1
97934,pressure,0,0
97935,.,0,1
97936,METHODS,0,0
97937,Forty,1,1
97938,patients,1,1
97939,received,1,1
97940,lumbar,1,1
97941,epidural,1,1
97942,catheters,1,1
97943,.,1,1
97944,Patients,0,1
97945,were,0,1
97946,randomized,0,1
97947,to,0,0
97948,receive,0,1
97949,either,0,1
97950,10,0,1
97951,ml,0,0
97952,0.5,0,0
97953,%,0,0
97954,bupivacaine,0,0
97955,or,0,1
97956,10,0,1
97957,ml,0,0
97958,0.25,0,0
97959,%,0,0
97960,bupivacaine,0,0
97961,.,0,1
97962,PI,0,1
97963,in,0,0
97964,the,0,0
97965,toe,0,1
97966,",",0,0
97967,mean,0,1
97968,arterial,0,1
97969,pressure,0,0
97970,(,0,1
97971,MAP,0,1
97972,),0,1
97973,and,0,1
97974,toe,0,1
97975,temperature,0,0
97976,were,0,1
97977,all,0,0
97978,assessed,0,0
97979,at,0,0
97980,baseline,0,0
97981,and,0,1
97982,at,0,0
97983,5,0,0
97984,",",0,1
97985,10,0,1
97986,and,0,1
97987,20,0,1
97988,min,0,0
97989,following,0,0
97990,epidural,0,1
97991,anesthesia,0,1
97992,.,0,1
97993,The,0,0
97994,effect,0,0
97995,of,0,0
97996,epidural,0,1
97997,anesthesia,0,1
97998,over,0,0
97999,time,0,0
98000,was,0,0
98001,assessed,0,0
98002,by,0,0
98003,repeated,0,0
98004,measures,0,0
98005,analysis,0,0
98006,of,0,1
98007,variance,0,0
98008,.,0,1
98009,Additionally,0,0
98010,",",0,0
98011,we,0,0
98012,defined,0,0
98013,clinically,0,1
98014,evident,0,0
98015,sympathectomy,0,1
98016,criteria,0,1
98017,(,0,1
98018,a,0,1
98019,100,0,1
98020,%,0,0
98021,increase,0,0
98022,in,0,0
98023,the,0,0
98024,PI,0,1
98025,",",0,0
98026,a,0,0
98027,15,0,0
98028,%,0,0
98029,decrease,0,0
98030,in,0,0
98031,MAP,0,1
98032,and,0,1
98033,a,0,1
98034,1,0,1
98035,degrees,0,0
98036,C,0,1
98037,increase,0,0
98038,in,0,0
98039,toe,0,1
98040,temperature,0,1
98041,),0,1
98042,.,0,1
98043,The,0,0
98044,numbers,0,0
98045,of,0,1
98046,patients,0,1
98047,demonstrating,0,0
98048,these,0,0
98049,changes,0,0
98050,for,0,0
98051,each,0,1
98052,test,0,0
98053,were,0,0
98054,compared,0,0
98055,using,0,0
98056,the,0,0
98057,McNemar,0,0
98058,test,0,0
98059,for,0,0
98060,each,0,0
98061,time,0,0
98062,point,0,0
98063,.,0,1
98064,RESULTS,0,0
98065,Twenty-nine,1,1
98066,subjects,1,1
98067,had,0,1
98068,photoplethysmography,0,0
98069,signals,0,0
98070,that,0,0
98071,met,0,1
98072,a,0,0
98073,priori,0,0
98074,signal,0,1
98075,quality,0,0
98076,criteria,0,1
98077,for,0,1
98078,analysis,0,0
98079,.,0,1
98080,By,0,0
98081,20,0,1
98082,min,0,0
98083,",",0,1
98084,PI,0,1
98085,increased,0,0
98086,by,0,0
98087,326,0,1
98088,%,0,0
98089,",",0,0
98090,compared,0,0
98091,with,0,1
98092,a,0,1
98093,10,0,1
98094,%,0,0
98095,decrease,0,0
98096,and,0,0
98097,a,0,1
98098,3,0,0
98099,%,0,0
98100,increase,0,0
98101,in,0,0
98102,MAP,0,1
98103,and,0,1
98104,toe,0,1
98105,temperature,0,0
98106,",",0,0
98107,respectively,0,0
98108,.,0,1
98109,For,0,0
98110,PI,0,1
98111,15/29,0,1
98112,",",0,1
98113,26/29,0,1
98114,and,0,1
98115,29/29,0,1
98116,of,0,0
98117,the,0,1
98118,subjects,0,1
98119,met,0,1
98120,the,0,0
98121,sympathectomy,0,0
98122,criteria,0,1
98123,at,0,1
98124,5,0,1
98125,",",0,1
98126,10,0,1
98127,and,0,1
98128,20,0,1
98129,min,0,0
98130,",",0,0
98131,respectively,0,0
98132,",",0,0
98133,compared,0,0
98134,with,0,1
98135,4/29,0,1
98136,",",0,1
98137,6/29,0,1
98138,and,0,1
98139,18/29,0,1
98140,for,0,1
98141,MAP,0,1
98142,changes,0,0
98143,and,0,1
98144,3/29,0,1
98145,",",0,1
98146,8/29,0,1
98147,and,0,1
98148,14/29,0,1
98149,for,0,0
98150,toe,0,1
98151,temperature,0,1
98152,changes,0,0
98153,.,0,1
98154,CONCLUSIONS,0,0
98155,PI,0,1
98156,was,0,0
98157,an,0,0
98158,earlier,0,0
98159,",",0,0
98160,clearer,0,0
98161,and,0,0
98162,more,0,0
98163,sensitive,0,0
98164,indicator,0,0
98165,of,0,0
98166,the,0,0
98167,development,0,0
98168,of,0,0
98169,epidural-induced,0,0
98170,sympathectomy,0,1
98171,than,0,0
98172,either,0,1
98173,skin,0,1
98174,temperature,0,0
98175,or,0,1
98176,MAP,0,1
98177,.,0,1
98178,Perioperative,0,1
98179,fever,0,1
98180,and,0,0
98181,outcome,0,0
98182,in,0,1
98183,surgical,1,1
98184,patients,1,1
98185,with,1,1
98186,aneurysmal,1,1
98187,subarachnoid,1,1
98188,hemorrhage,1,1
98189,.,1,1
98190,OBJECTIVE,0,0
98191,We,0,0
98192,examined,0,0
98193,the,0,0
98194,incidence,0,0
98195,of,0,0
98196,perioperative,0,0
98197,fever,0,1
98198,and,0,0
98199,its,0,0
98200,relationship,0,0
98201,to,0,0
98202,outcome,0,0
98203,among,1,1
98204,patients,1,1
98205,enrolled,1,1
98206,in,1,1
98207,the,1,0
98208,Intraoperative,1,0
98209,Hypothermia,1,1
98210,for,1,1
98211,Aneurysm,1,1
98212,Surgery,1,1
98213,Trial,1,1
98214,.,1,1
98215,METHODS,0,0
98216,One,1,1
98217,thousand,1,1
98218,patients,1,1
98219,with,1,1
98220,initial,1,1
98221,World,1,1
98222,Federation,1,1
98223,of,1,1
98224,Neurological,1,1
98225,Surgeons,1,1
98226,grades,1,1
98227,of,1,1
98228,I,1,1
98229,to,1,1
98230,III,1,1
98231,undergoing,1,1
98232,clipping,1,1
98233,of,1,1
98234,intracranial,1,1
98235,aneurysms,1,1
98236,after,1,1
98237,subarachnoid,1,1
98238,hemorrhage,1,1
98239,were,1,1
98240,randomized,1,1
98241,to,1,0
98242,intraoperative,1,0
98243,normothermia,1,1
98244,(,1,1
98245,36,1,1
98246,degrees,1,1
98247,C-37,1,0
98248,degrees,1,1
98249,C,1,1
98250,),1,1
98251,or,1,1
98252,hypothermia,1,1
98253,(,1,1
98254,32.5,1,1
98255,degrees,1,1
98256,C-33.5,1,0
98257,degrees,1,1
98258,C,1,1
98259,),1,1
98260,.,1,1
98261,Fever,0,1
98262,(,0,1
98263,>,0,1
98264,or,0,1
98265,=38.5,0,1
98266,degrees,0,0
98267,C,0,1
98268,),0,1
98269,and,0,1
98270,other,0,1
98271,complications,0,1
98272,(,0,1
98273,including,0,1
98274,infections,0,1
98275,),0,1
98276,occurring,0,1
98277,between,0,0
98278,admission,0,1
98279,and,0,1
98280,discharge,0,1
98281,(,0,0
98282,or,0,1
98283,death,0,0
98284,),0,1
98285,were,0,1
98286,recorded,0,0
98287,.,0,1
98288,Functional,0,0
98289,and,0,0
98290,neuropsychologic,0,1
98291,outcomes,0,0
98292,were,0,1
98293,assessed,0,1
98294,3,0,1
98295,months,0,0
98296,postoperatively,0,0
98297,.,0,1
98298,The,0,0
98299,primary,0,0
98300,outcome,0,0
98301,variable,0,0
98302,for,0,0
98303,the,0,0
98304,trial,0,0
98305,was,0,0
98306,dichotomized,0,0
98307,Glasgow,0,1
98308,Outcome,0,0
98309,Scale,0,1
98310,(,0,1
98311,good,0,0
98312,outcome,0,0
98313,versus,0,0
98314,all,0,1
98315,others,0,1
98316,),0,1
98317,.,0,1
98318,RESULTS,0,0
98319,Fever,0,1
98320,was,0,0
98321,reported,0,1
98322,in,0,1
98323,41,0,1
98324,%,0,0
98325,of,0,1
98326,patients,0,1
98327,.,0,1
98328,In,0,0
98329,97,0,0
98330,%,0,0
98331,of,0,0
98332,these,0,0
98333,",",0,0
98334,fever,0,0
98335,occurred,0,0
98336,in,0,0
98337,the,0,0
98338,postoperative,0,0
98339,period,0,0
98340,.,0,1
98341,The,0,0
98342,median,0,0
98343,time,0,0
98344,from,0,1
98345,surgery,0,1
98346,to,0,0
98347,first,0,0
98348,fever,0,1
98349,was,0,0
98350,3,0,1
98351,days,0,0
98352,.,0,1
98353,All,0,1
98354,measures,0,0
98355,of,0,0
98356,outcome,0,0
98357,were,0,1
98358,worse,0,0
98359,in,0,1
98360,patients,0,1
98361,who,0,1
98362,developed,0,1
98363,fever,0,1
98364,",",0,0
98365,even,0,0
98366,in,0,0
98367,those,0,1
98368,without,0,1
98369,infections,0,1
98370,or,0,1
98371,who,0,1
98372,were,0,1
98373,World,0,1
98374,Federation,0,1
98375,of,0,1
98376,Neurological,0,1
98377,Surgeons,0,1
98378,grade,0,1
98379,I.,0,0
98380,Logistic,0,0
98381,regression,0,0
98382,analyses,0,0
98383,were,0,1
98384,performed,0,0
98385,to,0,0
98386,adjust,0,0
98387,for,0,0
98388,differences,0,0
98389,in,0,1
98390,preoperative,0,1
98391,factors,0,0
98392,(,0,1
98393,e.g.,0,0
98394,",",0,0
98395,age,0,1
98396,",",0,0
98397,Fisher,0,0
98398,grade,0,1
98399,",",0,0
98400,initial,0,0
98401,neurological,0,1
98402,status,0,1
98403,),0,1
98404,.,0,1
98405,This,0,0
98406,demonstrated,0,0
98407,that,0,0
98408,fever,0,1
98409,continued,0,0
98410,to,0,0
98411,be,0,0
98412,significantly,0,0
98413,associated,0,0
98414,with,0,1
98415,most,0,1
98416,outcome,0,0
98417,measures,0,0
98418,",",0,0
98419,even,0,0
98420,when,0,0
98421,infection,0,1
98422,was,0,0
98423,added,0,0
98424,to,0,0
98425,the,0,0
98426,model,0,0
98427,.,0,0
98428,An,0,0
98429,alternative,0,0
98430,stepwise,0,0
98431,model,0,0
98432,selection,0,0
98433,process,0,0
98434,including,0,0
98435,all,0,1
98436,fever-related,0,1
98437,measures,0,0
98438,from,0,1
98439,the,0,0
98440,preoperative,0,0
98441,and,0,0
98442,intraoperative,0,0
98443,period,0,0
98444,(,0,1
98445,e.g.,0,0
98446,",",0,0
98447,hydrocephalus,0,1
98448,",",0,0
98449,duration,0,0
98450,of,0,0
98451,surgery,0,1
98452,",",0,0
98453,intraoperative,0,0
98454,blood,0,0
98455,loss,0,0
98456,),0,0
98457,resulted,0,0
98458,in,0,0
98459,the,0,0
98460,loss,0,0
98461,of,0,0
98462,significance,0,0
98463,for,0,1
98464,dichotomized,0,1
98465,Glasgow,0,1
98466,Outcome,0,0
98467,Scale,0,1
98468,",",0,0
98469,but,0,0
98470,significant,0,0
98471,associations,0,0
98472,between,0,0
98473,fever,0,1
98474,and,0,1
98475,several,0,1
98476,other,0,1
98477,outcome,0,0
98478,measures,0,0
98479,remained,0,1
98480,.,0,1
98481,After,0,0
98482,adding,0,0
98483,postoperative,0,1
98484,delayed,0,1
98485,ischemic,0,1
98486,neurological,0,1
98487,deficits,0,1
98488,to,0,1
98489,the,0,0
98490,model,0,0
98491,",",0,0
98492,only,0,0
98493,worsened,0,1
98494,National,0,0
98495,Institutes,0,1
98496,of,0,1
98497,Health,0,1
98498,Stroke,0,1
98499,Scale,0,1
98500,score,0,0
98501,",",0,0
98502,Barthel,0,0
98503,Activities,0,1
98504,of,0,1
98505,Daily,0,1
98506,Living,0,1
98507,index,0,1
98508,",",0,0
98509,and,0,0
98510,discharge,0,0
98511,destination,0,1
98512,(,0,0
98513,home,0,1
98514,versus,0,0
98515,other,0,1
98516,),0,1
98517,remained,0,0
98518,independently,0,0
98519,associated,0,0
98520,with,0,1
98521,fever,0,1
98522,.,0,1
98523,CONCLUSION,0,0
98524,These,0,1
98525,findings,0,0
98526,suggest,0,0
98527,that,0,0
98528,fever,0,1
98529,is,0,0
98530,associated,0,0
98531,with,0,1
98532,worsened,0,0
98533,outcome,0,0
98534,in,0,1
98535,surgical,1,1
98536,subarachnoid,1,1
98537,hemorrhage,1,1
98538,patients,1,1
98539,",",0,0
98540,although,0,0
98541,",",0,0
98542,because,0,0
98543,the,0,0
98544,association,0,0
98545,between,0,0
98546,fever,0,1
98547,and,0,0
98548,the,0,0
98549,primary,0,1
98550,outcome,0,0
98551,measure,0,0
98552,for,0,0
98553,the,0,0
98554,trial,0,0
98555,is,0,0
98556,dependent,0,0
98557,on,0,0
98558,the,0,1
98559,covariates,0,0
98560,used,0,0
98561,in,0,0
98562,the,0,0
98563,analysis,0,0
98564,(,0,0
98565,particularly,0,0
98566,operative,0,1
98567,events,0,0
98568,and,0,1
98569,delayed,0,1
98570,ischemic,0,1
98571,neurological,0,1
98572,deficits,0,1
98573,),0,1
98574,",",0,0
98575,we,0,0
98576,can,0,0
98577,not,0,0
98578,rule,0,0
98579,out,0,0
98580,the,0,0
98581,possibility,0,0
98582,that,0,0
98583,fever,0,1
98584,is,0,0
98585,a,0,0
98586,marker,0,0
98587,for,0,0
98588,other,0,1
98589,events,0,0
98590,.,0,1
98591,Only,0,0
98592,a,0,0
98593,formal,0,0
98594,trial,0,0
98595,of,0,0
98596,fever,0,1
98597,treatment,0,0
98598,or,0,0
98599,prevention,0,1
98600,can,0,0
98601,address,0,0
98602,this,0,0
98603,issue,0,0
98604,.,0,1
98605,Clinical,0,0
98606,impact,0,0
98607,of,0,0
98608,leak,0,0
98609,compensation,0,1
98610,during,0,0
98611,non-invasive,0,0
98612,ventilation,0,1
98613,.,0,1
98614,BACKGROUND,0,0
98615,This,0,0
98616,study,0,0
98617,aimed,0,0
98618,to,0,0
98619,assess,0,0
98620,the,0,0
98621,impact,0,0
98622,of,0,0
98623,leak,0,0
98624,compensation,0,1
98625,capabilities,0,0
98626,during,0,1
98627,pressure-,0,0
98628,and,0,1
98629,volume-limited,0,1
98630,non-invasive,1,0
98631,positive-pressure,1,0
98632,ventilation,1,1
98633,(,1,1
98634,NPPV,1,1
98635,),1,1
98636,in,0,1
98637,COPD,0,1
98638,patients,0,1
98639,.,0,1
98640,METHODS,0,0
98641,Fourteen,1,1
98642,patients,1,1
98643,with,1,1
98644,stable,1,1
98645,hypercapnic,1,1
98646,COPD,1,1
98647,who,1,1
98648,were,1,1
98649,receiving,1,1
98650,long-term,1,0
98651,NPPV,1,1
98652,were,1,1
98653,included,1,1
98654,in,1,0
98655,the,1,0
98656,study,1,0
98657,.,1,0
98658,For,0,0
98659,both,0,0
98660,modes,0,0
98661,of,0,0
98662,NPPV,0,1
98663,",",0,0
98664,a,0,0
98665,full,0,0
98666,face,0,0
98667,mask,0,0
98668,and,0,0
98669,an,0,0
98670,artificial,0,0
98671,leak,0,0
98672,in,0,0
98673,the,0,0
98674,ventilatory,0,0
98675,circuit,0,0
98676,were,0,0
98677,used,0,0
98678,at,0,1
98679,three,0,1
98680,different,0,1
98681,settings,0,1
98682,",",0,1
98683,and,0,0
98684,applied,0,0
98685,during,0,0
98686,daytime,0,0
98687,NPPV,0,1
98688,",",0,0
98689,either,0,0
98690,without,0,0
98691,leakage,0,0
98692,(,0,1
98693,setting,0,1
98694,I,0,1
98695,),0,0
98696,",",0,0
98697,with,0,1
98698,leakage,0,0
98699,during,0,0
98700,inspiration,0,0
98701,only,0,0
98702,(,0,0
98703,setting,0,1
98704,II,0,1
98705,),0,1
98706,",",0,0
98707,and,0,0
98708,with,0,1
98709,leakage,0,0
98710,during,0,0
98711,inspiration,0,0
98712,and,0,1
98713,expiration,0,1
98714,(,0,1
98715,setting,0,1
98716,III,0,1
98717,),0,1
98718,.,0,1
98719,Ventilation,0,0
98720,pattern,0,1
98721,was,0,0
98722,pneumotachy-graphically,0,1
98723,recorded,0,0
98724,.,0,1
98725,RESULTS,0,0
98726,NPPV,0,0
98727,was,0,0
98728,feasible,0,0
98729,with,0,1
98730,negligible,0,0
98731,leak,0,1
98732,volumes,0,0
98733,",",0,1
98734,indicating,0,0
98735,optimal,0,0
98736,mask,0,1
98737,fitting,0,0
98738,during,0,0
98739,the,0,0
98740,daytime,0,0
98741,(,0,0
98742,setting,0,1
98743,I,0,1
98744,),0,1
98745,.,0,1
98746,In,0,0
98747,the,0,0
98748,presence,0,0
98749,of,0,0
98750,leakage,0,1
98751,(,0,1
98752,settings,0,1
98753,II,0,1
98754,and,0,1
98755,III,0,1
98756,),0,0
98757,",",0,0
98758,the,0,0
98759,attempt,0,0
98760,to,0,0
98761,compensate,0,0
98762,for,0,0
98763,leak,0,0
98764,was,0,0
98765,only,0,0
98766,evident,0,0
98767,during,0,0
98768,pressure-limited,0,1
98769,NPPV,0,1
98770,",",0,0
98771,since,0,0
98772,inspiratory,0,1
98773,volumes,0,0
98774,delivered,0,1
98775,by,0,0
98776,the,0,0
98777,ventilator,0,1
98778,increased,0,0
98779,from,0,1
98780,726+/-129,0,1
98781,(,0,1
98782,setting,0,1
98783,I,0,1
98784,),0,1
98785,to,0,1
98786,1104+/-164,0,1
98787,(,0,1
98788,setting,0,1
98789,II,0,1
98790,),0,1
98791,",",0,0
98792,and,0,0
98793,to,0,0
98794,1257+/-166,0,1
98795,(,0,1
98796,setting,0,1
98797,III,0,1
98798,),0,1
98799,ml,0,0
98800,during,0,1
98801,pressure-limited,0,1
98802,NPPV,0,1
98803,",",0,0
98804,respectively,0,0
98805,(,0,0
98806,all,0,0
98807,p,0,0
98808,<,0,0
98809,0.001,0,0
98810,),0,1
98811,;,0,0
98812,however,0,0
98813,",",0,0
98814,they,0,0
98815,remained,0,0
98816,stable,0,1
98817,during,0,1
98818,volume-limited,0,1
98819,NPPV,0,1
98820,.,0,1
98821,Leak,0,0
98822,compensation,0,0
98823,resulted,0,0
98824,in,0,0
98825,a,0,0
98826,decrease,0,0
98827,in,0,0
98828,leakage-induced,0,0
98829,dyspnea,0,1
98830,.,0,1
98831,However,0,0
98832,",",0,0
98833,83,0,1
98834,%,0,0
98835,/87,0,1
98836,%,0,0
98837,(,0,1
98838,setting,0,1
98839,II/III,0,0
98840,),0,1
98841,of,0,0
98842,the,0,0
98843,additionally-delivered,0,0
98844,inspiratory,0,0
98845,volume,0,0
98846,during,0,0
98847,pressure-limited,0,1
98848,NPPV,0,1
98849,was,0,0
98850,also,0,0
98851,lost,0,1
98852,via,0,0
98853,leakage,0,1
98854,.,0,1
98855,Expiratory,0,0
98856,volume,0,0
98857,was,0,0
98858,higher,0,0
98859,in,0,0
98860,setting,0,1
98861,II,0,1
98862,compared,0,0
98863,to,0,1
98864,setting,0,1
98865,III,0,1
98866,(,0,0
98867,both,0,0
98868,p,0,0
98869,<,0,0
98870,0.001,0,0
98871,),0,1
98872,",",0,0
98873,indicating,0,0
98874,the,0,0
98875,presence,0,0
98876,of,0,0
98877,significant,0,0
98878,expiratory,0,0
98879,leakage,0,1
98880,.,0,1
98881,CONCLUSIONS,0,0
98882,The,0,0
98883,attempt,0,0
98884,at,0,0
98885,leak,0,0
98886,compensation,0,0
98887,largely,0,0
98888,feeds,0,0
98889,the,0,0
98890,leakage,0,0
98891,itself,0,0
98892,and,0,0
98893,only,0,0
98894,results,0,0
98895,in,0,0
98896,a,0,1
98897,marginal,0,0
98898,increase,0,0
98899,of,0,0
98900,tidal,0,0
98901,volume,0,0
98902,.,0,1
98903,However,0,0
98904,",",0,0
98905,pressure-limited,0,0
98906,--,0,1
98907,but,0,0
98908,not,0,0
98909,volume-limited,0,0
98910,--,0,1
98911,NPPV,0,1
98912,results,0,0
98913,in,0,1
98914,a,0,1
98915,clinically-important,0,1
98916,leak,0,0
98917,compensation,0,1
98918,in,0,1
98919,vivo,0,0
98920,.,0,1
98921,TRIAL,0,0
98922,REGISTRATION,0,0
98923,www.uniklinik-freiburg.de/zks/live/uklregister/Oeffentlich.html,0,1
98924,Identifier,0,1
98925,:,0,1
98926,UKF001272,0,1
98927,.,0,1
98928,Lack,0,1
98929,of,0,0
98930,efficacy,0,0
98931,of,0,0
98932,citalopram,0,0
98933,in,0,1
98934,children,1,1
98935,with,1,1
98936,autism,1,1
98937,spectrum,1,1
98938,disorders,1,1
98939,and,1,1
98940,high,1,1
98941,levels,1,0
98942,of,1,1
98943,repetitive,1,0
98944,behavior,1,1
98945,:,1,1
98946,citalopram,0,0
98947,ineffective,0,0
98948,in,0,0
98949,children,1,1
98950,with,1,1
98951,autism,1,1
98952,.,1,1
98953,CONTEXT,0,0
98954,Selective,0,1
98955,serotonin,0,0
98956,reuptake,0,0
98957,inhibitors,0,0
98958,are,0,0
98959,widely,0,0
98960,prescribed,0,0
98961,for,0,0
98962,children,1,1
98963,with,1,1
98964,autism,1,1
98965,spectrum,1,1
98966,disorders,1,1
98967,.,1,1
98968,OBJECTIVES,0,0
98969,To,0,0
98970,determine,0,0
98971,the,0,0
98972,efficacy,0,0
98973,and,0,0
98974,safety,0,0
98975,of,0,0
98976,citalopram,0,0
98977,hydrobromide,0,0
98978,therapy,0,0
98979,for,0,0
98980,repetitive,0,0
98981,behavior,0,1
98982,in,0,1
98983,children,1,1
98984,with,1,1
98985,autism,1,1
98986,spectrum,1,1
98987,disorders,1,1
98988,.,1,1
98989,DESIGN,0,1
98990,National,0,0
98991,Institutes,0,1
98992,of,0,1
98993,Health-sponsored,0,1
98994,randomized,0,1
98995,controlled,0,0
98996,trial,0,1
98997,.,0,1
98998,SETTING,0,1
98999,Six,1,1
99000,academic,1,1
99001,centers,1,1
99002,",",1,1
99003,including,1,1
99004,Mount,1,0
99005,Sinai,1,1
99006,School,1,1
99007,of,1,0
99008,Medicine,1,1
99009,",",1,1
99010,North,1,1
99011,Shore-Long,1,1
99012,Island,1,1
99013,Jewish,1,1
99014,Health,1,0
99015,System,1,1
99016,",",1,0
99017,University,1,1
99018,of,1,0
99019,North,1,1
99020,Carolina,1,1
99021,at,1,1
99022,Chapel,1,1
99023,Hill,1,1
99024,",",1,0
99025,University,1,1
99026,of,1,0
99027,California,1,1
99028,at,1,1
99029,Los,1,1
99030,Angeles,1,1
99031,",",1,1
99032,Yale,1,1
99033,University,1,1
99034,",",1,0
99035,and,1,0
99036,Dartmouth,1,1
99037,Medical,1,1
99038,School,1,1
99039,.,1,1
99040,PARTICIPANTS,0,0
99041,One,1,1
99042,hundred,1,1
99043,forty-nine,1,1
99044,volunteers,1,1
99045,5,1,1
99046,to,1,1
99047,17,1,1
99048,years,1,1
99049,old,1,1
99050,(,1,1
99051,mean,1,1
99052,[,1,1
99053,SD,1,1
99054,],1,1
99055,age,1,1
99056,",",1,1
99057,9.4,1,0
99058,[,1,1
99059,3.1,1,1
99060,],1,1
99061,years,1,1
99062,),1,1
99063,were,0,1
99064,randomized,0,1
99065,to,0,0
99066,receive,0,1
99067,citalopram,0,0
99068,(,0,0
99069,n,0,1
99070,=,0,1
99071,73,0,1
99072,),0,1
99073,or,0,1
99074,placebo,0,0
99075,(,0,1
99076,n,0,1
99077,=,0,1
99078,76,0,1
99079,),0,1
99080,.,0,1
99081,Participants,1,1
99082,had,1,1
99083,autistic,1,1
99084,spectrum,1,1
99085,disorders,1,1
99086,",",1,1
99087,Asperger,1,1
99088,disorder,1,1
99089,",",1,0
99090,or,1,1
99091,pervasive,1,1
99092,developmental,1,1
99093,disorder,1,1
99094,",",1,0
99095,not,1,0
99096,otherwise,1,1
99097,specified,1,0
99098,;,1,0
99099,had,1,1
99100,illness,1,1
99101,severity,1,0
99102,ratings,1,0
99103,of,1,1
99104,at,1,1
99105,least,1,1
99106,moderate,1,1
99107,on,1,0
99108,the,1,0
99109,Clinical,1,0
99110,Global,1,1
99111,Impressions,1,0
99112,",",1,0
99113,Severity,1,0
99114,of,1,0
99115,Illness,1,1
99116,Scale,1,1
99117,;,1,1
99118,and,1,0
99119,scored,1,0
99120,at,1,0
99121,least,1,1
99122,moderate,1,1
99123,on,1,0
99124,compulsive,1,1
99125,behaviors,1,0
99126,measured,1,0
99127,with,1,1
99128,the,1,0
99129,Children,1,1
99130,'s,1,1
99131,Yale-Brown,1,1
99132,Obsessive,1,1
99133,Compulsive,1,1
99134,Scales,1,0
99135,modified,1,0
99136,for,1,0
99137,pervasive,1,1
99138,developmental,1,1
99139,disorders,1,1
99140,.,1,1
99141,INTERVENTIONS,0,1
99142,Twelve,0,1
99143,weeks,0,0
99144,of,0,1
99145,citalopram,0,0
99146,hydrobromide,0,0
99147,(,0,1
99148,10,0,1
99149,mg/5,0,1
99150,mL,0,0
99151,),0,0
99152,or,0,1
99153,placebo,0,0
99154,.,0,1
99155,The,0,0
99156,mean,0,0
99157,(,0,0
99158,SD,0,1
99159,),0,1
99160,maximum,0,0
99161,dosage,0,0
99162,of,0,0
99163,citalopram,0,0
99164,hydrobromide,0,0
99165,was,0,0
99166,16.5,0,0
99167,(,0,1
99168,6.5,0,0
99169,),0,1
99170,mg/d,0,0
99171,by,0,0
99172,mouth,0,1
99173,(,0,1
99174,maximum,0,0
99175,",",0,1
99176,20,0,1
99177,mg/d,0,0
99178,),0,1
99179,.,0,1
99180,MAIN,0,0
99181,OUTCOME,0,1
99182,MEASURES,0,0
99183,Positive,0,1
99184,response,0,0
99185,was,0,0
99186,defined,0,0
99187,by,0,0
99188,a,0,0
99189,score,0,0
99190,of,0,0
99191,much,0,0
99192,improved,0,0
99193,or,0,1
99194,very,0,0
99195,much,0,0
99196,improved,0,0
99197,on,0,0
99198,the,0,0
99199,Clinical,0,0
99200,Global,0,1
99201,Impressions,0,0
99202,",",0,1
99203,Improvement,0,0
99204,subscale,0,0
99205,.,0,1
99206,An,0,0
99207,important,0,0
99208,secondary,0,0
99209,outcome,0,0
99210,was,0,0
99211,the,0,0
99212,score,0,0
99213,on,0,0
99214,the,0,0
99215,Children,0,1
99216,'s,0,1
99217,Yale-Brown,0,1
99218,Obsessive,0,1
99219,Compulsive,0,1
99220,Scales,0,0
99221,modified,0,0
99222,for,0,0
99223,pervasive,0,1
99224,developmental,0,1
99225,disorders,0,1
99226,.,0,1
99227,Adverse,0,0
99228,events,0,0
99229,were,0,1
99230,systematically,0,1
99231,elicited,0,0
99232,using,0,0
99233,the,0,0
99234,Safety,0,0
99235,Monitoring,0,0
99236,Uniform,0,1
99237,Report,0,1
99238,Form,0,1
99239,.,0,1
99240,RESULTS,0,0
99241,There,0,0
99242,was,0,0
99243,no,0,0
99244,significant,0,0
99245,difference,0,0
99246,in,0,0
99247,the,0,0
99248,rate,0,0
99249,of,0,0
99250,positive,0,1
99251,response,0,0
99252,on,0,0
99253,the,0,0
99254,Clinical,0,0
99255,Global,0,1
99256,Impressions,0,0
99257,",",0,1
99258,Improvement,0,0
99259,subscale,0,0
99260,between,0,0
99261,the,0,0
99262,citalopram-treated,0,1
99263,group,0,1
99264,(,0,1
99265,32.9,0,1
99266,%,0,0
99267,),0,1
99268,and,0,0
99269,the,0,0
99270,placebo,0,0
99271,group,0,1
99272,(,0,1
99273,34.2,0,0
99274,%,0,0
99275,),0,1
99276,(,0,1
99277,relative,0,0
99278,risk,0,1
99279,",",0,1
99280,0.96,0,0
99281,;,0,1
99282,95,0,0
99283,%,0,0
99284,confidence,0,0
99285,interval,0,0
99286,",",0,1
99287,0.61-1.51,0,0
99288,;,0,1
99289,P,0,0
99290,>,0,1
99291,.99,0,0
99292,),0,0
99293,.,0,0
99294,There,0,0
99295,was,0,0
99296,no,0,0
99297,difference,0,0
99298,in,0,0
99299,score,0,0
99300,reduction,0,0
99301,on,0,0
99302,the,0,0
99303,Children,0,1
99304,'s,0,1
99305,Yale-Brown,0,1
99306,Obsessive,0,1
99307,Compulsive,0,1
99308,Scales,0,0
99309,modified,0,0
99310,for,0,0
99311,pervasive,0,1
99312,developmental,0,1
99313,disorders,0,1
99314,from,0,1
99315,baseline,0,1
99316,(,0,1
99317,mean,0,1
99318,[,0,1
99319,SD,0,1
99320,],0,1
99321,",",0,0
99322,-2.0,0,0
99323,[,0,0
99324,3.4,0,0
99325,],0,1
99326,points,0,0
99327,for,0,1
99328,the,0,1
99329,citalopram-treated,0,1
99330,group,0,1
99331,and,0,1
99332,-1.9,0,0
99333,[,0,0
99334,2.5,0,0
99335,],0,1
99336,points,0,0
99337,for,0,0
99338,the,0,0
99339,placebo,0,0
99340,group,0,1
99341,;,0,1
99342,P,0,0
99343,=,0,1
99344,.81,0,0
99345,),0,1
99346,.,0,1
99347,Citalopram,0,0
99348,use,0,0
99349,was,0,0
99350,significantly,0,0
99351,more,0,0
99352,likely,0,0
99353,to,0,0
99354,be,0,0
99355,associated,0,0
99356,with,0,1
99357,adverse,0,0
99358,events,0,0
99359,",",0,1
99360,particularly,0,0
99361,increased,0,0
99362,energy,0,0
99363,level,0,0
99364,",",0,0
99365,impulsiveness,0,0
99366,",",0,0
99367,decreased,0,0
99368,concentration,0,0
99369,",",0,0
99370,hyperactivity,0,1
99371,",",0,0
99372,stereotypy,0,0
99373,",",0,0
99374,diarrhea,0,1
99375,",",0,0
99376,insomnia,0,1
99377,",",0,0
99378,and,0,0
99379,dry,0,1
99380,skin,0,1
99381,or,0,1
99382,pruritus,0,1
99383,.,0,1
99384,CONCLUSION,0,0
99385,Results,0,0
99386,of,0,0
99387,this,0,0
99388,trial,0,0
99389,do,0,0
99390,not,0,0
99391,support,0,0
99392,the,0,0
99393,use,0,0
99394,of,0,0
99395,citalopram,0,0
99396,for,0,0
99397,the,0,0
99398,treatment,0,0
99399,of,0,0
99400,repetitive,0,0
99401,behavior,0,1
99402,in,0,1
99403,children,0,1
99404,and,0,1
99405,adolescents,0,1
99406,with,0,1
99407,autism,0,1
99408,spectrum,0,1
99409,disorders,0,1
99410,.,0,1
99411,Trial,0,1
99412,Registration,0,0
99413,clinicaltrials.gov,0,1
99414,Identifier,0,1
99415,:,0,1
99416,NCT00086645,0,0
99417,.,0,1
99418,Loss,0,1
99419,of,0,0
99420,autonomy,0,0
99421,among,0,1
99422,elderly,1,1
99423,patients,1,1
99424,after,1,1
99425,a,1,1
99426,stay,1,0
99427,in,1,0
99428,a,1,1
99429,medical,1,1
99430,intensive,1,1
99431,care,1,1
99432,unit,1,1
99433,(,1,1
99434,ICU,1,1
99435,),1,1
99436,:,1,1
99437,a,0,1
99438,randomized,0,1
99439,study,0,0
99440,of,0,0
99441,the,0,0
99442,benefit,0,0
99443,of,0,0
99444,transfer,0,1
99445,to,0,1
99446,a,0,0
99447,geriatric,0,1
99448,ward,0,1
99449,.,0,1
99450,In,0,0
99451,order,0,0
99452,to,0,1
99453,evaluate,0,0
99454,changes,0,0
99455,in,0,0
99456,the,0,1
99457,functional,0,0
99458,autonomy,0,0
99459,of,0,1
99460,elderly,1,1
99461,patients,1,1
99462,after,1,1
99463,a,1,1
99464,stay,1,0
99465,in,1,0
99466,a,1,1
99467,medical,1,1
99468,intensive,1,1
99469,care,1,1
99470,unit,1,1
99471,(,1,1
99472,ICU,1,0
99473,),1,1
99474,",",0,0
99475,and,0,0
99476,the,0,0
99477,impact,0,0
99478,of,0,0
99479,post-ICU,0,0
99480,management,0,1
99481,in,0,1
99482,geriatric,0,1
99483,ward,0,1
99484,",",0,0
99485,we,0,0
99486,included,0,1
99487,in,0,0
99488,a,0,1
99489,randomized,0,1
99490,controlled,0,0
99491,trial,0,1
99492,45,1,1
99493,patients,1,1
99494,aged,1,1
99495,>,1,1
99496,or=75,1,1
99497,years,1,1
99498,.,1,1
99499,They,0,0
99500,were,0,0
99501,assessed,0,0
99502,for,0,0
99503,functional,0,0
99504,autonomy,0,1
99505,before,0,1
99506,ICU,0,0
99507,stay,0,0
99508,",",0,0
99509,just,0,0
99510,after,0,0
99511,ICU,0,0
99512,discharge,0,0
99513,",",0,0
99514,just,0,0
99515,after,0,0
99516,hospital,0,1
99517,discharge,0,1
99518,",",0,1
99519,and,0,1
99520,6,0,0
99521,months,0,0
99522,later,0,1
99523,.,0,1
99524,The,0,0
99525,patients,1,1
99526,were,0,1
99527,randomly,0,1
99528,divided,0,1
99529,into,0,1
99530,two,0,0
99531,post-ICU,0,1
99532,management,0,1
99533,groups,0,1
99534,:,0,1
99535,geriatric,0,1
99536,ward,0,1
99537,and,0,1
99538,standard,0,1
99539,care,0,1
99540,.,0,1
99541,Autonomy,0,0
99542,was,0,0
99543,usually,0,0
99544,recovered,0,0
99545,rapidly,0,0
99546,",",0,0
99547,but,0,0
99548,the,0,0
99549,degree,0,0
99550,of,0,0
99551,recovery,0,0
99552,depended,0,0
99553,on,0,0
99554,the,0,0
99555,patient,0,1
99556,'s,0,1
99557,previous,0,1
99558,autonomy,0,1
99559,(,0,1
99560,p,0,0
99561,<,0,0
99562,0.0001,0,0
99563,),0,1
99564,.,0,1
99565,At,0,0
99566,the,0,0
99567,last,0,0
99568,assessment,0,0
99569,",",0,1
99570,41,0,1
99571,%,0,0
99572,of,0,0
99573,the,0,0
99574,patients,0,1
99575,had,0,1
99576,recovered,0,0
99577,their,0,1
99578,previous,0,1
99579,autonomy,0,0
99580,.,0,1
99581,The,0,0
99582,mean,0,1
99583,Barthel,0,1
99584,indexes,0,0
99585,were,0,1
99586,81.5+/-30.4,0,0
99587,in,0,0
99588,the,0,0
99589,geriatric,0,1
99590,management,0,1
99591,arm,0,1
99592,and,0,0
99593,70.5+/-33.4,0,0
99594,in,0,0
99595,the,0,0
99596,standard,0,1
99597,management,0,1
99598,arm,0,1
99599,(,0,1
99600,p=0.4,0,0
99601,),0,1
99602,.,0,1
99603,The,0,0
99604,study,0,0
99605,was,0,0
99606,prematurely,0,1
99607,ended,0,1
99608,due,0,0
99609,to,0,1
99610,insufficient,0,0
99611,recruitment,0,0
99612,flow,0,0
99613,.,0,1
99614,These,0,0
99615,results,0,0
99616,underline,0,0
99617,the,0,0
99618,rapid,0,0
99619,loss,0,0
99620,of,0,0
99621,autonomy,0,0
99622,after,0,0
99623,a,0,0
99624,stay,0,0
99625,in,0,0
99626,a,0,1
99627,medical,0,1
99628,ICU,0,0
99629,.,0,1
99630,Early,0,0
99631,specific,0,0
99632,intervention,0,0
99633,to,0,0
99634,improve,0,0
99635,the,0,0
99636,autonomy,0,0
99637,of,0,0
99638,elderly,1,1
99639,patients,1,1
99640,seems,0,0
99641,an,0,0
99642,attractive,0,0
99643,solution,0,0
99644,that,0,0
99645,could,0,0
99646,be,0,0
99647,assessed,0,0
99648,by,0,0
99649,randomized,0,1
99650,controlled,0,0
99651,trial,0,1
99652,.,0,1
99653,Above,0,0
99654,all,0,0
99655,",",0,0
99656,our,0,0
99657,results,0,0
99658,should,0,0
99659,also,0,0
99660,serve,0,0
99661,as,0,0
99662,a,0,0
99663,basis,0,0
99664,for,0,0
99665,further,0,0
99666,controlled,0,0
99667,randomized,0,1
99668,studies,0,0
99669,in,0,1
99670,this,0,0
99671,setting,0,1
99672,.,0,1
99673,Pharmacokinetic-,0,0
99674,pharmacodynamic,0,0
99675,analysis,0,0
99676,of,0,0
99677,the,0,0
99678,role,0,0
99679,of,0,0
99680,CYP2C19,0,1
99681,genotypes,0,0
99682,in,0,1
99683,short-term,0,0
99684,rabeprazole-based,0,0
99685,triple,0,1
99686,therapy,0,1
99687,against,0,0
99688,Helicobacter,0,1
99689,pylori,0,1
99690,.,0,1
99691,AIMS,0,0
99692,The,0,0
99693,aim,0,0
99694,was,0,0
99695,to,0,0
99696,explore,0,0
99697,the,0,0
99698,role,0,0
99699,of,0,0
99700,CYP2C19,0,1
99701,polymorphism,0,0
99702,in,0,0
99703,short-term,0,0
99704,rabeprazole-based,0,0
99705,triple,0,1
99706,therapy,0,1
99707,against,0,1
99708,Helicobacter,1,1
99709,pylori,1,1
99710,infection,1,1
99711,.,1,1
99712,METHODS,0,0
99713,Patients,1,1
99714,with,1,1
99715,H.,1,1
99716,pylori,1,1
99717,infection,1,1
99718,were,0,0
99719,tested,0,0
99720,for,0,0
99721,CYP2C19,0,1
99722,genotype,0,1
99723,as,0,0
99724,poor,0,1
99725,metabolizers,0,1
99726,(,0,1
99727,PMs,0,1
99728,),0,1
99729,or,0,1
99730,extensive,0,1
99731,metabolizers,0,1
99732,(,0,1
99733,EMs,0,0
99734,",",0,1
99735,homozygous,0,1
99736,EM,0,1
99737,or,0,1
99738,heterozygous,0,1
99739,EM,0,1
99740,),0,1
99741,and,0,0
99742,given,0,0
99743,rabeprazole,0,0
99744,for,0,1
99745,7,0,1
99746,days,0,1
99747,.,0,1
99748,Antibiotics,0,0
99749,(,0,1
99750,clarithromycin,0,0
99751,and,0,0
99752,amoxicillin,0,0
99753,),0,1
99754,were,0,0
99755,given,0,0
99756,on,0,0
99757,days,0,0
99758,1-4,0,1
99759,",",0,1
99760,days,0,0
99761,4-7,0,1
99762,",",0,1
99763,or,0,1
99764,days,0,0
99765,1-7,0,1
99766,.,0,1
99767,A,0,0
99768,direct,0,0
99769,link,0,0
99770,model,0,0
99771,with,0,1
99772,an,0,0
99773,effect,0,0
99774,compartment,0,0
99775,was,0,0
99776,used,0,0
99777,in,0,0
99778,the,0,0
99779,population,0,1
99780,pharmacokinetic-pharmacodynamic,0,0
99781,analysis,0,0
99782,.,0,1
99783,The,0,0
99784,status,0,0
99785,of,0,0
99786,H.,0,1
99787,pylori,0,1
99788,infection,0,1
99789,was,0,0
99790,evaluated,0,0
99791,.,0,1
99792,RESULTS,0,0
99793,Rabeprazole,0,0
99794,clearance,0,0
99795,was,0,0
99796,lower,0,0
99797,in,0,0
99798,CYP2C19,0,1
99799,PMs,0,0
99800,than,0,0
99801,in,0,1
99802,EMs,0,0
99803,(,0,1
99804,with,0,1
99805,average,0,1
99806,values,0,0
99807,of,0,0
99808,10.7,0,1
99809,vs.,0,0
99810,16.8,0,0
99811,l,0,0
99812,h,0,0
99813,(,0,1
99814,-1,0,0
99815,),0,1
99816,in,0,1
99817,PMs,0,0
99818,and,0,1
99819,EMs,0,0
99820,",",0,0
99821,respectively,0,0
99822,),0,0
99823,",",0,0
99824,resulting,0,0
99825,in,0,0
99826,higher,0,0
99827,plasma,0,0
99828,levels,0,0
99829,in,0,1
99830,the,0,1
99831,former,0,1
99832,group,0,1
99833,.,0,1
99834,The,0,0
99835,values,0,0
99836,of,0,1
99837,EC,0,1
99838,(,0,1
99839,50,0,1
99840,),0,1
99841,and,0,1
99842,k,0,1
99843,(,0,1
99844,eo,0,0
99845,),0,1
99846,of,0,0
99847,gastrin,0,0
99848,response,0,0
99849,increased,0,0
99850,with,0,1
99851,multiple,0,1
99852,doses,0,0
99853,of,0,1
99854,rabeprazole,0,0
99855,.,0,1
99856,The,0,0
99857,k,0,0
99858,(,0,0
99859,eo,0,1
99860,),0,1
99861,values,0,0
99862,were,0,1
99863,lower,0,0
99864,in,0,0
99865,CYP2C19,0,1
99866,PMs,0,0
99867,than,0,0
99868,in,0,0
99869,EMs,0,0
99870,on,0,0
99871,day,0,0
99872,1,0,1
99873,(,0,0
99874,0.012,0,0
99875,vs.,0,0
99876,0.017,0,0
99877,x,0,1
99878,10,0,1
99879,(,0,1
99880,-4,0,0
99881,),0,1
99882,l,0,0
99883,min,0,0
99884,(,0,1
99885,-1,0,0
99886,),0,1
99887,),0,1
99888,",",0,0
99889,and,0,0
99890,higher,0,0
99891,than,0,0
99892,in,0,0
99893,EMs,0,0
99894,on,0,0
99895,day,0,0
99896,4,0,1
99897,(,0,0
99898,0.804,0,0
99899,vs.,0,0
99900,0.169,0,0
99901,x,0,1
99902,10,0,1
99903,(,0,1
99904,-4,0,0
99905,),0,1
99906,l,0,0
99907,min,0,0
99908,(,0,1
99909,-1,0,0
99910,),0,1
99911,),0,1
99912,of,0,0
99913,rabeprazole,0,0
99914,treatment,0,0
99915,.,0,1
99916,The,0,0
99917,predicted,0,0
99918,gastrin-time,0,0
99919,profile,0,0
99920,showed,0,0
99921,a,0,0
99922,higher,0,0
99923,response,0,0
99924,in,0,0
99925,CYP2C19,0,1
99926,PMs,0,0
99927,than,0,0
99928,in,0,0
99929,EMs,0,1
99930,on,0,1
99931,days,0,1
99932,4,0,1
99933,and,0,1
99934,7,0,1
99935,.,0,1
99936,Helicobacter,0,1
99937,pylori,0,1
99938,was,0,0
99939,eradicated,0,0
99940,in,0,0
99941,all,0,1
99942,CYP2C19,0,1
99943,PMs,0,0
99944,except,0,0
99945,in,0,1
99946,one,0,1
99947,patient,0,1
99948,infected,0,1
99949,by,0,0
99950,a,0,1
99951,resistant,0,1
99952,strain,0,0
99953,.,0,1
99954,In,0,0
99955,contrast,0,0
99956,",",0,0
99957,in,0,0
99958,CYP2C19,0,1
99959,EMs,0,0
99960,the,0,0
99961,eradication,0,1
99962,rates,0,0
99963,ranged,0,1
99964,from,0,1
99965,58,0,1
99966,to,0,1
99967,85,0,1
99968,%,0,0
99969,.,0,1
99970,CONCLUSIONS,0,0
99971,CYP2C19,0,0
99972,genotypes,0,0
99973,play,0,0
99974,a,0,0
99975,role,0,0
99976,in,0,0
99977,H.,0,1
99978,pylori,0,1
99979,eradication,0,1
99980,therapy,0,0
99981,.,0,1
99982,Rabeprazole-based,0,0
99983,short-term,0,0
99984,triple,0,0
99985,therapy,0,0
99986,may,0,0
99987,be,0,0
99988,applicable,0,0
99989,in,0,0
99990,CYP2C19,0,1
99991,PMs,0,0
99992,for,0,1
99993,H.,0,1
99994,pylori,0,1
99995,eradication,0,1
99996,.,0,1
99997,Verapamil,0,1
99998,augmentation,0,1
99999,of,0,0
100000,lithium,0,0
100001,treatment,0,0
100002,improves,0,0
100003,outcome,0,0
100004,in,0,0
100005,mania,0,1
100006,unresponsive,0,1
100007,to,0,0
100008,lithium,0,0
100009,alone,0,0
100010,:,0,1
100011,preliminary,0,0
100012,findings,0,0
100013,and,0,1
100014,a,0,1
100015,discussion,0,0
100016,of,0,0
100017,therapeutic,0,1
100018,mechanisms,0,0
100019,.,0,1
100020,OBJECTIVES,0,0
100021,Attenuation,0,0
100022,of,0,0
100023,protein,0,0
100024,kinase,0,0
100025,C,0,1
100026,(,0,1
100027,PKC,0,1
100028,),0,0
100029,is,0,0
100030,a,0,0
100031,mechanism,0,0
100032,common,0,0
100033,to,0,1
100034,both,0,0
100035,established,0,0
100036,(,0,0
100037,lithium,0,0
100038,",",0,0
100039,valproate,0,1
100040,),0,0
100041,and,0,0
100042,some,0,0
100043,novel,0,0
100044,(,0,0
100045,tamoxifen,0,1
100046,),0,1
100047,antimanic,0,1
100048,agents,0,1
100049,.,0,1
100050,Verapamil,0,0
100051,",",0,0
100052,although,0,0
100053,primarily,0,0
100054,known,0,1
100055,as,0,0
100056,a,0,0
100057,calcium,0,0
100058,channel,0,0
100059,blocker,0,0
100060,",",0,0
100061,also,0,0
100062,has,0,0
100063,PKC,0,0
100064,inhibitory,0,0
100065,activity,0,0
100066,.,0,1
100067,Verapamil,0,0
100068,has,0,0
100069,shown,0,0
100070,antimanic,0,0
100071,activity,0,0
100072,in,0,0
100073,some,0,0
100074,but,0,0
100075,not,0,0
100076,all,0,0
100077,studies,0,0
100078,.,0,1
100079,Therefore,0,0
100080,",",0,0
100081,we,0,0
100082,investigated,0,0
100083,verapamil,0,0
100084,",",0,0
100085,used,0,0
100086,alone,0,0
100087,or,0,1
100088,as,0,0
100089,an,0,0
100090,adjunctive,0,0
100091,treatment,0,0
100092,",",0,0
100093,in,0,0
100094,manic,1,1
100095,patients,1,1
100096,who,1,1
100097,did,1,1
100098,not,1,1
100099,respond,1,0
100100,to,1,0
100101,an,1,0
100102,initial,1,0
100103,adequate,1,0
100104,trial,1,1
100105,of,1,0
100106,lithium,1,0
100107,.,1,1
100108,METHODS,0,0
100109,Each,0,0
100110,study,0,0
100111,phase,0,1
100112,lasted,0,1
100113,three,0,1
100114,weeks,0,1
100115,.,0,1
100116,Subjects,0,1
100117,were,0,0
100118,treated,0,1
100119,openly,0,0
100120,with,0,1
100121,lithium,0,0
100122,in,0,1
100123,Phase,0,1
100124,1,0,1
100125,(,1,1
100126,n,1,1
100127,=,1,1
100128,45,1,1
100129,),1,1
100130,.,0,1
100131,Those,0,1
100132,who,0,1
100133,failed,0,1
100134,to,0,1
100135,respond,0,0
100136,were,0,0
100137,randomly,0,1
100138,assigned,0,1
100139,to,0,0
100140,double-blind,0,0
100141,treatment,0,0
100142,in,0,0
100143,Phase,0,1
100144,2,0,1
100145,with,0,1
100146,either,0,1
100147,verapamil,0,1
100148,(,0,0
100149,n,0,1
100150,=,0,1
100151,10,0,1
100152,),0,1
100153,or,0,1
100154,continued-lithium,0,1
100155,(,0,1
100156,n,0,1
100157,=,0,1
100158,8,0,1
100159,),0,1
100160,.,0,1
100161,Phase,0,1
100162,2,0,1
100163,nonresponders,0,0
100164,(,0,1
100165,n,0,1
100166,=,0,1
100167,10,0,1
100168,),0,1
100169,were,0,1
100170,assigned,0,1
100171,to,0,0
100172,combined,0,0
100173,verapamil/lithium,0,0
100174,in,0,0
100175,Phase,0,1
100176,3,0,1
100177,.,0,1
100178,RESULTS,0,0
100179,Response,0,0
100180,in,0,1
100181,Phase,0,1
100182,2,0,1
100183,did,0,0
100184,not,0,0
100185,differ,0,0
100186,significantly,0,0
100187,between,0,0
100188,verapamil,0,0
100189,and,0,1
100190,continued-lithium,0,1
100191,.,0,1
100192,During,0,0
100193,Phase,0,1
100194,3,0,1
100195,",",0,0
100196,response,0,0
100197,to,0,0
100198,combined,0,0
100199,treatment,0,0
100200,was,0,0
100201,significantly,0,0
100202,better,0,0
100203,than,0,0
100204,overall,0,0
100205,response,0,0
100206,to,0,0
100207,monotherapy,0,1
100208,in,0,0
100209,Phase,0,1
100210,2,0,1
100211,(,0,1
100212,Fisher,0,0
100213,'s,0,1
100214,Exact,0,0
100215,test,0,0
100216,",",0,0
100217,p,0,0
100218,=,0,1
100219,0.043,0,0
100220,),0,1
100221,.,0,1
100222,Mania,0,1
100223,ratings,0,0
100224,improved,0,0
100225,during,0,1
100226,combined,0,0
100227,treatment,0,1
100228,in,0,1
100229,Phase,0,1
100230,3,0,1
100231,by,0,0
100232,88.2,0,1
100233,%,0,0
100234,(,0,1
100235,linear,0,0
100236,mixed,0,1
100237,model,0,0
100238,analysis,0,0
100239,",",0,0
100240,F,0,1
100241,=,0,0
100242,4.34,0,0
100243,",",0,0
100244,p,0,0
100245,=,0,1
100246,0.013,0,0
100247,),0,1
100248,",",0,0
100249,compared,0,0
100250,with,0,1
100251,10.5,0,0
100252,%,0,0
100253,improvement,0,0
100254,during,0,1
100255,Phase,0,1
100256,2,0,1
100257,.,0,1
100258,CONCLUSIONS,0,0
100259,In,0,0
100260,this,0,0
100261,preliminary,0,0
100262,investigation,0,0
100263,",",0,0
100264,verapamil,0,0
100265,monotherapy,0,1
100266,did,0,0
100267,not,0,0
100268,demonstrate,0,0
100269,antimanic,0,1
100270,efficacy,0,0
100271,.,0,1
100272,By,0,0
100273,contrast,0,0
100274,",",0,0
100275,the,0,0
100276,combination,0,0
100277,of,0,0
100278,verapamil,0,1
100279,plus,0,0
100280,lithium,0,0
100281,was,0,0
100282,highly,0,0
100283,efficacious,0,0
100284,.,0,1
100285,Our,0,0
100286,findings,0,0
100287,thus,0,0
100288,suggest,0,0
100289,that,0,0
100290,verapamil,0,1
100291,may,0,0
100292,have,0,0
100293,potential,0,0
100294,utility,0,0
100295,as,0,0
100296,an,0,0
100297,adjunct,0,0
100298,to,0,0
100299,lithium,0,0
100300,.,0,1
100301,This,0,0
100302,effect,0,0
100303,may,0,0
100304,be,0,0
100305,mediated,0,0
100306,by,0,0
100307,additive,0,0
100308,actions,0,0
100309,on,0,1
100310,PKC,0,1
100311,inhibition,0,0
100312,",",0,0
100313,which,0,0
100314,may,0,0
100315,be,0,0
100316,an,0,0
100317,important,0,0
100318,mechanism,0,0
100319,for,0,1
100320,antimanic,0,1
100321,agents,0,1
100322,in,0,1
100323,general,0,1
100324,.,0,1
100325,Prognostic,0,1
100326,value,0,0
100327,of,0,0
100328,postoperative,0,1
100329,CEA,0,1
100330,clearance,0,0
100331,in,0,0
100332,rectal,1,1
100333,cancer,1,1
100334,patients,1,1
100335,with,1,1
100336,high,1,1
100337,preoperative,1,1
100338,CEA,1,1
100339,levels,1,1
100340,.,1,1
100341,PURPOSE,0,0
100342,We,0,0
100343,determined,0,0
100344,the,0,0
100345,prognostic,0,0
100346,value,0,0
100347,of,0,0
100348,carcinoembryonic,0,0
100349,antigen,0,1
100350,(,0,1
100351,CEA,0,1
100352,),0,1
100353,clearance,0,0
100354,after,0,0
100355,tumor,0,1
100356,resection,0,1
100357,with,0,1
100358,serial,0,1
100359,evaluation,0,0
100360,of,0,0
100361,postoperative,0,1
100362,CEA,0,1
100363,levels,0,0
100364,in,0,1
100365,rectal,1,1
100366,cancer,1,1
100367,.,1,1
100368,METHODS,0,0
100369,Between,1,1
100370,1994,1,1
100371,and,1,1
100372,2004,1,1
100373,",",1,0
100374,we,1,0
100375,retrospectively,1,1
100376,reviewed,1,1
100377,122,1,1
100378,patients,1,1
100379,with,1,1
100380,rectal,1,1
100381,cancer,1,1
100382,whose,1,1
100383,serum,1,0
100384,CEA,1,1
100385,levels,1,0
100386,were,1,1
100387,measured,1,0
100388,on,1,0
100389,the,1,0
100390,preoperative,1,0
100391,day,1,0
100392,and,1,1
100393,postoperative,1,1
100394,days,1,1
100395,7,1,1
100396,and,1,1
100397,30,1,1
100398,.,1,1
100399,Patients,1,1
100400,with,1,1
100401,preoperative,1,1
100402,CEA,1,1
100403,levels,1,1
100404,<,1,0
100405,5.0,1,0
100406,ng/ml,1,0
100407,were,1,1
100408,excluded,1,1
100409,.,1,1
100410,An,0,0
100411,exponential,0,0
100412,trend,0,0
100413,line,0,0
100414,was,0,0
100415,drawn,0,0
100416,using,0,0
100417,the,0,0
100418,three,0,0
100419,CEA,0,1
100420,values,0,0
100421,.,0,1
100422,Patients,1,1
100423,were,1,0
100424,categorized,1,1
100425,into,1,1
100426,three,1,1
100427,groups,1,1
100428,based,1,1
100429,on,1,1
100430,R,1,1
100431,(,1,1
100432,2,1,1
100433,),1,1
100434,values,1,0
100435,calculated,0,0
100436,through,0,1
100437,trend,0,0
100438,line,0,0
100439,",",0,0
100440,which,0,0
100441,indicates,0,0
100442,the,0,0
100443,correlation,0,0
100444,coefficient,0,0
100445,between,0,0
100446,exponential,0,0
100447,graph,0,0
100448,and,0,1
100449,measured,0,0
100450,CEA,0,1
100451,values,0,0
100452,:,0,1
100453,exponential,1,0
100454,decrease,1,0
100455,group,1,1
100456,(,0,1
100457,group,0,1
100458,1,0,1
100459,:,0,1
100460,0.9,0,0
100461,<,0,0
100462,R,0,1
100463,(,0,1
100464,2,0,1
100465,),0,1
100466,<,0,0
100467,or,0,1
100468,=,0,1
100469,1.0,0,0
100470,),0,0
100471,",",0,0
100472,nearly,1,0
100473,exponential,1,0
100474,decrease,1,0
100475,group,1,1
100476,(,0,1
100477,group,0,1
100478,2,0,1
100479,:,0,1
100480,0.5,0,0
100481,<,0,0
100482,R,0,1
100483,(,0,1
100484,2,0,1
100485,),0,1
100486,<,0,0
100487,or,0,1
100488,=,0,1
100489,0.9,0,0
100490,),0,0
100491,",",0,0
100492,and,0,0
100493,randomized,1,1
100494,clearance,1,0
100495,group,1,1
100496,(,0,1
100497,group,0,1
100498,3,0,1
100499,:,0,1
100500,0.5,0,0
100501,<,0,0
100502,or,0,1
100503,=,0,1
100504,R,0,1
100505,(,0,1
100506,2,0,1
100507,),0,1
100508,),0,1
100509,.,0,1
100510,We,0,0
100511,then,0,0
100512,analyzed,0,0
100513,the,0,0
100514,CEA,0,1
100515,clearance,0,0
100516,pattern,0,1
100517,as,0,0
100518,a,0,1
100519,prognostic,0,0
100520,indicator,0,0
100521,.,0,1
100522,RESULTS,0,0
100523,With,0,1
100524,a,0,1
100525,median,0,0
100526,follow-up,0,0
100527,of,0,1
100528,57,0,1
100529,months,0,0
100530,",",0,1
100531,the,0,0
100532,5-year,0,1
100533,overall,0,0
100534,survival,0,0
100535,was,0,0
100536,62.3,0,0
100537,%,0,0
100538,vs.,0,0
100539,48.1,0,0
100540,%,0,0
100541,vs.,0,0
100542,25,0,1
100543,%,0,0
100544,and,0,0
100545,the,0,0
100546,5-year,0,1
100547,disease-free,0,1
100548,survival,0,0
100549,was,0,0
100550,58.6,0,0
100551,%,0,0
100552,vs.,0,0
100553,52.7,0,0
100554,%,0,0
100555,vs.,0,0
100556,25,0,1
100557,%,0,0
100558,among,0,1
100559,groups,0,1
100560,1,0,1
100561,",",0,1
100562,2,0,0
100563,",",0,0
100564,and,0,1
100565,3,0,0
100566,(,0,1
100567,P,0,0
100568,=,0,1
100569,0.014,0,0
100570,",",0,1
100571,P,0,0
100572,=,0,0
100573,0.027,0,0
100574,",",0,0
100575,respectively,0,0
100576,),0,0
100577,in,0,0
100578,patients,1,1
100579,with,1,1
100580,stage,1,1
100581,III,1,1
100582,rectal,1,1
100583,cancer,1,1
100584,.,1,1
100585,For,0,0
100586,those,0,0
100587,with,0,1
100588,stage,0,1
100589,II,0,1
100590,rectal,0,1
100591,cancer,0,1
100592,",",0,0
100593,the,0,0
100594,5-year,0,1
100595,overall,0,0
100596,survival,0,0
100597,rate,0,0
100598,of,0,0
100599,group,0,1
100600,1,0,1
100601,was,0,0
100602,significantly,0,0
100603,better,0,0
100604,than,0,0
100605,groups,0,0
100606,2,0,1
100607,and,0,1
100608,3,0,1
100609,(,0,1
100610,88.8,0,0
100611,%,0,0
100612,vs.,0,0
100613,74.1,0,0
100614,%,0,0
100615,",",0,0
100616,respectively,0,0
100617,",",0,0
100618,P,0,0
100619,=,0,1
100620,0.021,0,0
100621,),0,1
100622,.,0,1
100623,CONCLUSIONS,0,0
100624,The,0,0
100625,postoperative,0,0
100626,pattern,0,1
100627,of,0,0
100628,CEA,0,1
100629,clearance,0,0
100630,is,0,0
100631,a,0,0
100632,useful,0,0
100633,prognostic,0,0
100634,determinant,0,0
100635,in,0,1
100636,patients,1,1
100637,with,1,1
100638,rectal,1,1
100639,cancer,1,1
100640,.,1,1
100641,Patients,1,1
100642,with,1,1
100643,a,1,1
100644,randomized,1,1
100645,pattern,1,1
100646,of,1,0
100647,CEA,1,1
100648,clearance,1,0
100649,after,0,0
100650,tumor,0,1
100651,resection,0,1
100652,should,0,0
100653,be,0,0
100654,regarded,0,0
100655,as,0,0
100656,having,0,1
100657,the,0,0
100658,possibility,0,0
100659,of,0,0
100660,a,0,1
100661,persistent,0,1
100662,CEA,0,1
100663,source,0,0
100664,and,0,0
100665,may,0,0
100666,require,0,0
100667,consideration,0,0
100668,of,0,0
100669,intensive,0,1
100670,follow-up,0,1
100671,or,0,1
100672,adjuvant,0,1
100673,therapy,0,1
100674,.,0,1
100675,Preliminary,0,0
100676,evaluation,0,0
100677,of,0,0
100678,psychoeducational,0,1
100679,support,0,0
100680,interventions,0,0
100681,on,0,0
100682,quality,0,0
100683,of,0,0
100684,life,0,1
100685,in,0,1
100686,rural,1,1
100687,breast,1,1
100688,cancer,1,1
100689,survivors,1,1
100690,after,1,1
100691,primary,1,1
100692,treatment,1,1
100693,.,1,1
100694,Although,0,0
100695,most,0,0
100696,cancer,1,1
100697,survivors,1,1
100698,are,0,0
100699,at,0,0
100700,risk,0,1
100701,for,0,0
100702,being,0,1
100703,lost,0,1
100704,in,0,0
100705,the,0,0
100706,transition,0,1
100707,from,0,1
100708,treatment,0,0
100709,to,0,0
100710,survivorship,0,0
100711,",",0,0
100712,rural,1,1
100713,breast,1,1
100714,cancer,1,1
100715,survivors,1,1
100716,face,0,1
100717,special,0,1
100718,challenges,0,0
100719,that,0,0
100720,might,0,0
100721,place,0,0
100722,them,0,0
100723,at,0,0
100724,particular,0,0
100725,risk,0,1
100726,.,0,1
100727,This,0,0
100728,small-scale,0,0
100729,preliminary,0,0
100730,study,0,1
100731,had,0,1
100732,2,0,1
100733,specific,0,1
100734,aims,0,0
100735,:,0,1
100736,(,0,1
100737,aim,0,0
100738,1,0,1
100739,),0,1
100740,establish,0,0
100741,the,0,0
100742,feasibility,0,0
100743,of,0,0
100744,rural,0,1
100745,breast,0,1
100746,cancer,0,1
100747,survivors,0,1
100748,participation,0,1
100749,in,0,0
100750,a,0,1
100751,longitudinal,0,1
100752,quality,0,0
100753,of,0,0
100754,life,0,1
100755,(,0,1
100756,QOL,0,0
100757,),0,1
100758,intervention,0,0
100759,trial,0,1
100760,and,0,0
100761,(,0,0
100762,aim,0,0
100763,2,0,1
100764,),0,0
100765,determine,0,0
100766,the,0,0
100767,effects,0,0
100768,of,0,0
100769,the,0,1
100770,Breast,0,1
100771,Cancer,0,1
100772,Education,0,1
100773,Intervention,0,1
100774,(,0,1
100775,BCEI,0,1
100776,),0,1
100777,on,0,0
100778,overall,0,0
100779,QOL,0,1
100780,.,0,1
100781,Fifty-three,1,1
100782,rural,1,1
100783,breast,1,1
100784,cancer,1,1
100785,survivors,1,1
100786,were,0,1
100787,randomized,0,1
100788,to,0,0
100789,either,0,0
100790,an,0,0
100791,experimental,0,0
100792,(,0,1
100793,n,0,1
100794,=,0,1
100795,27,0,1
100796,),0,1
100797,or,0,1
100798,a,0,1
100799,wait-control,0,1
100800,arm,0,1
100801,(,0,1
100802,n,0,1
100803,=,0,1
100804,26,0,1
100805,),0,1
100806,.,0,1
100807,Participants,0,1
100808,in,0,0
100809,the,0,1
100810,experimental,0,0
100811,arm,0,0
100812,received,0,1
100813,the,0,0
100814,BCEI,0,1
100815,consisting,0,1
100816,of,0,1
100817,3,0,1
100818,face-to-face,0,0
100819,education,0,1
100820,and,0,1
100821,support,0,0
100822,sessions,0,0
100823,and,0,1
100824,2,0,1
100825,face-to-face,0,0
100826,and,0,1
100827,3,0,1
100828,telephone,0,1
100829,follow-up,0,1
100830,sessions,0,0
100831,",",0,1
100832,along,0,0
100833,with,0,1
100834,supplemental,0,1
100835,written,0,1
100836,and,0,1
100837,audiotape,0,0
100838,materials,0,1
100839,over,0,0
100840,a,0,1
100841,6-month,0,0
100842,period,0,0
100843,.,0,1
100844,Breast,0,1
100845,Cancer,0,1
100846,Education,0,1
100847,Intervention,0,1
100848,modules,0,1
100849,and,0,1
100850,interventions,0,1
100851,are,0,0
100852,organized,0,0
100853,within,0,0
100854,a,0,1
100855,QOL,0,0
100856,framework,0,1
100857,.,0,1
100858,To,0,0
100859,address,0,0
100860,the,0,0
100861,possible,0,0
100862,effects,0,0
100863,of,0,1
100864,attention,0,0
100865,",",0,1
100866,wait-control,0,1
100867,participants,0,1
100868,received,0,1
100869,3,0,1
100870,face-to-face,0,0
100871,sessions,0,0
100872,and,0,1
100873,3,0,1
100874,telephone,0,1
100875,sessions,0,0
100876,during,0,1
100877,the,0,1
100878,first,0,1
100879,6,0,0
100880,months,0,1
100881,of,0,1
100882,participation,0,1
100883,in,0,0
100884,the,0,0
100885,study,0,0
100886,",",0,0
100887,but,0,0
100888,not,0,0
100889,the,0,0
100890,BCEI,0,1
100891,intervention,0,0
100892,.,0,1
100893,Research,0,1
100894,questions,0,0
100895,addressing,0,0
100896,aim,0,0
100897,1,0,1
100898,were,0,0
100899,as,0,0
100900,follows,0,0
100901,:,0,1
100902,(,0,0
100903,a,0,0
100904,),0,0
100905,can,0,0
100906,rural,0,1
100907,breast,0,1
100908,cancer,0,1
100909,survivors,0,1
100910,be,0,0
100911,recruited,0,1
100912,into,0,0
100913,a,0,1
100914,longitudinal,0,1
100915,intervention,0,0
100916,trial,0,0
100917,",",0,0
100918,and,0,0
100919,(,0,0
100920,b,0,0
100921,),0,1
100922,can,0,0
100923,their,0,1
100924,participation,0,0
100925,be,0,0
100926,retained,0,0
100927,.,0,1
100928,Research,0,1
100929,questions,0,0
100930,for,0,1
100931,aim,0,1
100932,2,0,1
100933,were,0,0
100934,as,0,0
100935,follows,0,0
100936,:,0,1
100937,(,0,0
100938,a,0,0
100939,),0,1
100940,do,0,1
100941,participants,0,1
100942,who,0,1
100943,received,0,1
100944,the,0,1
100945,BCEI,0,1
100946,show,0,0
100947,improvement,0,0
100948,in,0,0
100949,overall,0,0
100950,QOL,0,1
100951,",",0,1
100952,and,0,0
100953,(,0,0
100954,b,0,0
100955,),0,0
100956,is,0,0
100957,the,0,0
100958,QOL,0,0
100959,improvement,0,0
100960,sustained,0,1
100961,over,0,0
100962,time,0,0
100963,.,0,1
100964,Data,0,0
100965,were,0,1
100966,analyzed,0,0
100967,using,0,0
100968,repeated-measures,0,0
100969,general,0,1
100970,linear,0,0
100971,mixed,0,1
100972,models,0,1
100973,.,0,1
100974,Results,0,0
100975,demonstrated,0,0
100976,the,0,0
100977,ability,0,0
100978,to,0,0
100979,recruit,0,1
100980,and,0,0
100981,retain,0,0
100982,53,0,1
100983,rural,0,1
100984,breast,0,1
100985,cancer,0,1
100986,survivors,0,1
100987,",",0,0
100988,that,0,0
100989,the,0,0
100990,experimental,0,0
100991,arm,0,0
100992,showed,0,0
100993,improvement,0,0
100994,in,0,0
100995,overall,0,0
100996,QOL,0,1
100997,(,0,1
100998,P,0,0
100999,=,0,1
101000,.013,0,0
101001,),0,1
101002,",",0,0
101003,and,0,0
101004,that,0,0
101005,there,0,0
101006,were,0,0
101007,significant,0,0
101008,differences,0,0
101009,in,0,1
101010,overall,0,0
101011,QOL,0,1
101012,between,0,0
101013,the,0,0
101014,experimental,0,0
101015,and,0,1
101016,wait-control,0,1
101017,groups,0,0
101018,at,0,1
101019,both,0,1
101020,months,0,0
101021,3,0,1
101022,and,0,1
101023,6,0,0
101024,.,0,1
101025,Thus,0,1
101026,",",0,0
101027,it,0,0
101028,appears,0,0
101029,that,0,0
101030,at,0,0
101031,least,0,1
101032,some,0,0
101033,rural,1,1
101034,breast,1,1
101035,cancer,1,1
101036,survivors,1,1
101037,can,0,0
101038,and,0,1
101039,will,0,0
101040,participate,0,1
101041,in,0,0
101042,a,0,0
101043,larger,0,0
101044,trial,0,0
101045,and,0,0
101046,will,0,0
101047,maintain,0,0
101048,their,0,0
101049,participation,0,0
101050,and,0,0
101051,that,0,0
101052,those,0,0
101053,that,0,0
101054,do,0,0
101055,participate,0,0
101056,experience,0,1
101057,significant,0,0
101058,QOL,0,1
101059,benefit,0,0
101060,.,0,1
101061,Long-term,0,1
101062,(,0,1
101063,96-week,0,0
101064,),0,1
101065,follow-up,0,0
101066,of,0,0
101067,antiretroviral-na?ve,1,1
101068,HIV-infected,1,1
101069,patients,1,1
101070,treated,1,1
101071,with,1,1
101072,first-line,1,1
101073,lopinavir/ritonavir,1,1
101074,monotherapy,1,1
101075,in,1,0
101076,the,1,0
101077,MONARK,1,0
101078,trial,1,0
101079,.,1,1
101080,BACKGROUND,0,0
101081,The,0,0
101082,toxicities,0,0
101083,",",0,0
101084,cost,0,0
101085,and,0,0
101086,complexity,0,0
101087,of,0,1
101088,triple,0,1
101089,combinations,0,0
101090,warrant,0,0
101091,the,0,0
101092,search,0,0
101093,for,0,0
101094,other,0,1
101095,treatment,0,1
101096,options,0,0
101097,",",0,1
101098,such,0,0
101099,as,0,0
101100,boosted,0,0
101101,protease,0,1
101102,inhibitor,0,0
101103,(,0,1
101104,PI,0,1
101105,),0,1
101106,monotherapy,0,1
101107,.,0,1
101108,MONotherapy,1,0
101109,AntiRetroviral,1,1
101110,Kaletra,1,0
101111,(,1,1
101112,MONARK,1,0
101113,),1,0
101114,is,1,0
101115,the,1,0
101116,first,1,0
101117,randomized,1,1
101118,trial,1,1
101119,comparing,1,0
101120,lopinavir/ritonavir,1,1
101121,monotherapy,1,1
101122,to,1,0
101123,triple,1,0
101124,combination,1,0
101125,therapy,1,0
101126,with,1,1
101127,zidovudine/lamivudine,1,1
101128,and,1,0
101129,lopinavir/ritonavir,1,1
101130,in,1,1
101131,antiretroviral-na?ve,1,1
101132,patients,1,1
101133,.,1,1
101134,METHODS,0,0
101135,A,0,0
101136,total,0,1
101137,of,0,1
101138,136,1,1
101139,antiretroviral-na?ve,1,1
101140,patients,1,1
101141,",",1,1
101142,with,1,1
101143,a,1,0
101144,CD4,1,1
101145,cell,1,1
101146,count,1,0
101147,above,1,1
101148,100,1,1
101149,cells/microL,1,1
101150,and,1,0
101151,a,1,0
101152,plasma,1,0
101153,HIV,1,1
101154,RNA,1,1
101155,below,1,1
101156,"100,000",1,1
101157,HIV-1,1,1
101158,RNA,1,1
101159,copies/mL,1,1
101160,",",1,0
101161,were,1,0
101162,randomized,0,1
101163,and,0,0
101164,dosed,0,0
101165,with,0,1
101166,either,0,1
101167,lopinavir/ritonavir,0,1
101168,monotherapy,0,1
101169,(,0,1
101170,n,0,1
101171,=,0,1
101172,83,0,1
101173,),0,1
101174,or,0,1
101175,lopinavir/ritonavir,0,1
101176,+,0,0
101177,zidovudine/lamivudine,0,1
101178,(,0,1
101179,n,0,1
101180,=,0,1
101181,53,0,1
101182,),0,1
101183,.,1,1
101184,We,1,0
101185,focus,1,0
101186,here,1,0
101187,on,1,0
101188,patients,1,1
101189,in,1,1
101190,the,1,0
101191,lopinavir/ritonavir,1,1
101192,monotherapy,1,1
101193,arm,1,1
101194,followed,1,0
101195,to,1,0
101196,week,1,0
101197,96,1,1
101198,.,1,1
101199,The,1,0
101200,intent-to-treat,0,0
101201,(,0,0
101202,ITT,0,1
101203,),0,1
101204,analysis,0,0
101205,initially,0,1
101206,involved,0,0
101207,all,0,0
101208,patients,0,1
101209,randomized,0,1
101210,to,0,1
101211,lopinavir/ritonavir,0,1
101212,monotherapy,0,1
101213,(,0,0
101214,n,0,1
101215,=,0,1
101216,83,0,1
101217,),0,1
101218,",",0,0
101219,and,0,0
101220,then,0,0
101221,focused,0,0
101222,on,0,1
101223,patients,0,1
101224,who,0,1
101225,had,0,1
101226,an,0,1
101227,HIV,0,1
101228,RNA,0,1
101229,<,0,0
101230,50,0,1
101231,copies/mL,0,1
101232,at,0,1
101233,week,0,0
101234,48,0,1
101235,(,0,1
101236,n,0,1
101237,=,0,1
101238,56,0,1
101239,),0,1
101240,.,0,1
101241,RESULTS,0,0
101242,At,0,0
101243,week,0,0
101244,96,0,1
101245,",",0,1
101246,39,0,1
101247,of,0,1
101248,83,0,1
101249,patients,0,1
101250,(,0,1
101251,47,0,1
101252,%,0,0
101253,),0,1
101254,had,0,1
101255,HIV,0,1
101256,RNA,0,1
101257,<,0,0
101258,50,0,1
101259,copies/mL,0,1
101260,",",0,1
101261,five,0,1
101262,of,0,1
101263,83,0,1
101264,had,0,1
101265,HIV,0,1
101266,RNA,0,1
101267,between,0,0
101268,50,0,1
101269,and,0,1
101270,400,0,0
101271,copies/mL,0,0
101272,",",0,1
101273,and,0,0
101274,three,0,0
101275,of,0,1
101276,83,0,1
101277,had,0,1
101278,HIV,0,1
101279,RNA,0,1
101280,>,0,1
101281,400,0,0
101282,copies/mL,0,1
101283,.,0,1
101284,Focusing,0,0
101285,on,0,0
101286,the,0,1
101287,56,0,1
101288,patients,0,1
101289,with,0,1
101290,an,0,1
101291,HIV,0,1
101292,RNA,0,1
101293,<,0,0
101294,50,0,1
101295,copies/mL,0,1
101296,at,0,1
101297,week,0,0
101298,48,0,1
101299,",",0,1
101300,38,0,1
101301,of,0,1
101302,56,0,1
101303,patients,0,1
101304,(,0,1
101305,68,0,1
101306,%,0,0
101307,),0,1
101308,had,0,1
101309,a,0,0
101310,sustained,0,0
101311,HIV,0,1
101312,RNA,0,1
101313,<,0,0
101314,50,0,1
101315,copies/mL,0,1
101316,to,0,1
101317,week,0,0
101318,96,0,1
101319,.,0,1
101320,To,0,0
101321,week,0,0
101322,96,0,1
101323,",",0,0
101324,a,0,0
101325,total,0,1
101326,of,0,0
101327,28,0,1
101328,patients,0,1
101329,(,0,1
101330,34,0,1
101331,%,0,0
101332,),0,1
101333,had,0,1
101334,discontinued,0,0
101335,the,0,0
101336,study,0,0
101337,treatment,0,0
101338,.,0,1
101339,In,0,0
101340,addition,0,0
101341,",",0,0
101342,the,0,0
101343,allocated,0,1
101344,treatment,0,0
101345,was,0,0
101346,changed,0,0
101347,for,0,1
101348,seven,0,1
101349,patients,0,1
101350,.,0,1
101351,PI-associated,0,0
101352,resistance,0,0
101353,mutations,0,1
101354,were,0,1
101355,evident,0,0
101356,in,0,1
101357,five,0,1
101358,of,0,1
101359,83,0,1
101360,patients,0,1
101361,in,0,1
101362,the,0,0
101363,monotherapy,0,1
101364,arm,0,0
101365,from,0,1
101366,baseline,0,0
101367,to,0,1
101368,week,0,0
101369,96,0,1
101370,.,0,1
101371,CONCLUSION,0,0
101372,By,0,0
101373,ITT,0,1
101374,analysis,0,0
101375,",",0,0
101376,39,0,1
101377,of,0,0
101378,the,0,1
101379,83,0,1
101380,patients,0,1
101381,initially,0,1
101382,randomized,0,1
101383,to,0,0
101384,lopinavir/ritonavir,0,1
101385,monotherapy,0,1
101386,had,0,1
101387,HIV,0,1
101388,RNA,0,1
101389,<,0,0
101390,50,0,1
101391,copies/mL,0,1
101392,at,0,1
101393,week,0,0
101394,96,0,1
101395,.,0,1
101396,The,0,0
101397,occurrence,0,0
101398,in,0,0
101399,some,0,0
101400,patients,0,1
101401,of,0,0
101402,low-level,0,1
101403,viraemia,0,0
101404,(,0,1
101405,50-500,0,1
101406,copies/mL,0,0
101407,),0,1
101408,may,0,0
101409,increase,0,0
101410,the,0,0
101411,risk,0,0
101412,of,0,0
101413,drug,0,1
101414,resistance,0,0
101415,.,0,1
101416,First-line,0,0
101417,lopinavir/ritonavir,0,0
101418,monotherapy,0,1
101419,can,0,0
101420,not,0,0
101421,be,0,0
101422,systematically,0,0
101423,recommended,0,0
101424,.,0,1
101425,Large-dose,0,1
101426,intravenous,0,1
101427,ferric,0,0
101428,carboxymaltose,0,0
101429,injection,0,0
101430,for,0,0
101431,iron,1,0
101432,deficiency,1,1
101433,anemia,1,1
101434,in,1,0
101435,heavy,1,1
101436,uterine,1,1
101437,bleeding,1,1
101438,:,1,1
101439,a,0,0
101440,randomized,0,0
101441,",",0,0
101442,controlled,0,0
101443,trial,0,0
101444,.,0,0
101445,BACKGROUND,0,0
101446,The,0,0
101447,objective,0,0
101448,was,0,0
101449,to,0,0
101450,evaluate,0,0
101451,efficacy,0,0
101452,and,0,0
101453,safety,0,0
101454,of,0,0
101455,rapid,0,0
101456,",",0,1
101457,large-dose,0,0
101458,intravenous,0,1
101459,(,0,1
101460,IV,0,1
101461,),0,1
101462,administration,0,0
101463,of,0,0
101464,ferric,0,0
101465,carboxymaltose,0,0
101466,compared,0,0
101467,to,0,1
101468,oral,0,0
101469,iron,0,0
101470,in,0,0
101471,correcting,0,0
101472,iron,0,0
101473,deficiency,0,1
101474,anemia,0,1
101475,due,0,0
101476,to,0,1
101477,heavy,0,1
101478,uterine,0,1
101479,bleeding,0,1
101480,.,0,1
101481,STUDY,0,0
101482,DESIGN,0,1
101483,AND,0,0
101484,METHODS,0,0
101485,In,0,1
101486,a,0,0
101487,randomized,0,1
101488,",",0,0
101489,controlled,0,0
101490,trial,0,0
101491,",",0,1
101492,477,1,1
101493,women,1,1
101494,with,1,1
101495,anemia,1,1
101496,",",1,0
101497,iron,1,0
101498,deficiency,1,1
101499,",",1,0
101500,and,1,0
101501,heavy,1,1
101502,uterine,1,1
101503,bleeding,1,1
101504,were,1,1
101505,assigned,1,1
101506,to,0,0
101507,receive,0,1
101508,either,0,0
101509,IV,0,0
101510,ferric,0,0
101511,carboxymaltose,0,0
101512,(,0,1
101513,<,0,0
101514,or=1000,0,1
101515,mg,0,1
101516,over,0,0
101517,15,0,1
101518,min,0,0
101519,",",0,1
101520,repeated,0,0
101521,weekly,0,0
101522,to,0,0
101523,achieve,0,0
101524,a,0,0
101525,total,0,1
101526,calculated,0,0
101527,replacement,0,1
101528,dose,0,0
101529,),0,1
101530,or,0,1
101531,325,0,1
101532,mg,0,0
101533,of,0,0
101534,ferrous,0,0
101535,sulfate,0,0
101536,(,0,1
101537,65,0,1
101538,mg,0,1
101539,elemental,0,1
101540,iron,0,0
101541,),0,1
101542,prescribed,0,0
101543,orally,0,0
101544,thrice,0,0
101545,daily,0,0
101546,for,0,1
101547,6,0,1
101548,weeks,0,1
101549,.,0,1
101550,RESULTS,0,0
101551,Compared,0,0
101552,to,0,0
101553,those,0,1
101554,assigned,0,1
101555,to,0,0
101556,ferrous,0,0
101557,sulfate,0,0
101558,",",0,1
101559,more,0,0
101560,patients,0,1
101561,assigned,0,1
101562,to,0,0
101563,ferric,0,0
101564,carboxymaltose,0,0
101565,responded,0,1
101566,with,0,1
101567,a,0,1
101568,hemoglobin,0,0
101569,(,0,0
101570,Hb,0,0
101571,),0,1
101572,increase,0,0
101573,of,0,1
101574,2.0,0,0
101575,g/dL,0,1
101576,or,0,1
101577,more,0,0
101578,(,0,1
101579,82,0,0
101580,%,0,0
101581,vs.,0,0
101582,62,0,1
101583,%,0,0
101584,",",0,1
101585,95,0,0
101586,%,0,0
101587,confidence,0,0
101588,interval,0,0
101589,for,0,0
101590,treatment,0,0
101591,difference,0,0
101592,12.2-28.3,0,0
101593,",",0,0
101594,p,0,0
101595,<,0,0
101596,0.001,0,0
101597,),0,0
101598,",",0,0
101599,more,0,0
101600,achieved,0,0
101601,a,0,0
101602,3.0,0,0
101603,g/dL,0,0
101604,or,0,1
101605,more,0,0
101606,increase,0,0
101607,(,0,0
101608,53,0,1
101609,%,0,0
101610,vs.,0,0
101611,36,0,1
101612,%,0,0
101613,",",0,0
101614,p,0,0
101615,<,0,0
101616,0.001,0,0
101617,),0,1
101618,",",0,0
101619,and,0,0
101620,more,0,0
101621,achieved,0,0
101622,correction,0,0
101623,(,0,1
101624,Hb,0,0
101625,>,0,1
101626,or=,0,1
101627,12,0,1
101628,g/dL,0,1
101629,),0,1
101630,of,0,0
101631,anemia,0,1
101632,(,0,1
101633,73,0,1
101634,%,0,0
101635,vs.,0,0
101636,50,0,1
101637,%,0,0
101638,",",0,0
101639,p,0,0
101640,<,0,0
101641,0.001,0,0
101642,),0,1
101643,.,0,1
101644,Patients,0,1
101645,treated,0,1
101646,with,0,1
101647,ferric,0,0
101648,carboxymaltose,0,0
101649,compared,0,0
101650,to,0,0
101651,those,0,1
101652,prescribed,0,0
101653,ferrous,0,0
101654,sulfate,0,0
101655,reported,0,1
101656,greater,0,0
101657,gains,0,0
101658,in,0,0
101659,vitality,0,0
101660,and,0,1
101661,physical,0,1
101662,function,0,0
101663,and,0,0
101664,experienced,0,1
101665,greater,0,0
101666,improvement,0,0
101667,in,0,0
101668,symptoms,0,1
101669,of,0,1
101670,fatigue,0,0
101671,(,0,1
101672,p,0,0
101673,<,0,0
101674,0.05,0,0
101675,),0,0
101676,.,0,0
101677,There,0,0
101678,were,0,0
101679,no,0,0
101680,serious,0,0
101681,adverse,0,0
101682,drug,0,1
101683,events,0,0
101684,.,0,1
101685,CONCLUSIONS,0,0
101686,In,0,1
101687,patients,1,1
101688,with,1,1
101689,iron,1,0
101690,deficiency,1,1
101691,anemia,1,1
101692,due,1,0
101693,to,1,1
101694,heavy,1,1
101695,uterine,1,1
101696,bleeding,1,1
101697,",",0,1
101698,rapid,0,0
101699,IV,0,1
101700,administration,0,0
101701,of,0,1
101702,large,0,1
101703,doses,0,0
101704,of,0,1
101705,a,0,1
101706,new,0,1
101707,iron,0,0
101708,agent,0,0
101709,",",0,0
101710,ferric,0,0
101711,carboxymaltose,0,0
101712,",",0,0
101713,is,0,0
101714,more,0,0
101715,effective,0,0
101716,than,0,0
101717,oral,0,1
101718,iron,0,0
101719,therapy,0,0
101720,in,0,0
101721,correcting,0,0
101722,anemia,0,1
101723,",",0,0
101724,replenishing,0,0
101725,iron,0,0
101726,stores,0,1
101727,",",0,1
101728,and,0,0
101729,improving,0,0
101730,quality,0,0
101731,of,0,1
101732,life,0,1
101733,.,0,1
101734,Azelnidipine,0,0
101735,and,0,0
101736,amlodipine,0,0
101737,anti-coronary,0,1
101738,atherosclerosis,0,1
101739,trial,0,1
101740,in,0,1
101741,hypertensive,1,1
101742,patients,1,1
101743,undergoing,1,1
101744,coronary,1,1
101745,intervention,1,1
101746,by,1,0
101747,serial,1,1
101748,volumetric,1,0
101749,intravascular,1,1
101750,ultrasound,1,1
101751,analysis,1,0
101752,in,1,0
101753,Juntendo,1,1
101754,university,1,1
101755,(,1,1
101756,ALPS-J,1,1
101757,),1,1
101758,.,0,1
101759,PURPOSE,0,0
101760,Many,0,1
101761,trials,0,1
101762,have,0,0
101763,shown,0,0
101764,that,0,0
101765,calcium,0,0
101766,channel,0,0
101767,blockers,0,0
101768,(,0,1
101769,CCBs,0,1
101770,),0,1
101771,can,0,0
101772,reduce,0,0
101773,the,0,0
101774,cardiovascular,0,0
101775,(,0,0
101776,CV,0,1
101777,),0,1
101778,events,0,0
101779,in,0,1
101780,patients,1,1
101781,with,1,1
101782,coronary,1,1
101783,artery,1,1
101784,disease,1,1
101785,(,1,1
101786,CAD,1,0
101787,),1,1
101788,.,1,1
101789,The,0,0
101790,mechanisms,0,0
101791,of,0,0
101792,this,0,0
101793,effect,0,0
101794,could,0,0
101795,be,0,0
101796,associated,0,0
101797,with,0,1
101798,plaque,0,1
101799,regression,0,0
101800,due,0,0
101801,to,0,1
101802,the,0,0
101803,anti-atherosclerotic,0,1
101804,properties,0,0
101805,of,0,1
101806,CCBs,0,1
101807,.,0,1
101808,The,0,0
101809,goal,0,0
101810,of,0,0
101811,this,0,0
101812,study,0,0
101813,is,0,0
101814,to,0,0
101815,determine,0,0
101816,the,0,0
101817,effects,0,0
101818,of,0,0
101819,CCB,0,1
101820,on,0,0
101821,volumetric,0,0
101822,quantitative,0,1
101823,changes,0,0
101824,of,0,1
101825,coronary,0,1
101826,plaques,0,1
101827,accessed,0,1
101828,by,0,0
101829,intravascular,0,1
101830,ultrasound,0,1
101831,(,0,1
101832,IVUS,0,1
101833,),0,1
101834,.,0,1
101835,To,0,0
101836,confirm,0,0
101837,this,0,0
101838,hypothesis,0,0
101839,",",0,0
101840,a,0,0
101841,multicenter,0,0
101842,randomized,0,1
101843,trial,0,0
101844,of,0,0
101845,CCBs,0,1
101846,treatment,0,1
101847,with,0,1
101848,azelnidipine,0,0
101849,or,0,1
101850,amlodipine,0,0
101851,will,0,0
101852,be,0,0
101853,conducted,0,0
101854,in,0,0
101855,hypertensive,1,1
101856,CAD,1,1
101857,patients,1,1
101858,undergoing,1,1
101859,elective,1,1
101860,percutaneous,1,1
101861,coronary,1,1
101862,intervention,1,1
101863,(,1,1
101864,PCI,1,1
101865,),1,1
101866,.,1,1
101867,METHODS,0,0
101868,AND,0,0
101869,RESULTS,0,1
101870,Patients,1,1
101871,who,1,1
101872,have,1,1
101873,hypertension,1,1
101874,and,1,0
101875,are,1,0
101876,scheduled,1,1
101877,for,1,0
101878,PCI,1,1
101879,will,1,0
101880,be,1,0
101881,enrolled,1,1
101882,.,1,0
101883,Subjects,0,1
101884,will,0,0
101885,be,0,0
101886,randomized,0,0
101887,to,0,0
101888,azelnidipine,0,0
101889,or,0,1
101890,amlodipine,0,0
101891,and,0,0
101892,observed,0,0
101893,for,0,1
101894,48,0,1
101895,weeks,0,1
101896,.,0,1
101897,The,0,0
101898,primary,0,0
101899,endpoint,0,0
101900,will,0,0
101901,be,0,0
101902,the,0,0
101903,percent,0,0
101904,change,0,0
101905,of,0,0
101906,coronary,0,1
101907,plaque,0,1
101908,volume,0,0
101909,.,0,1
101910,The,0,0
101911,secondary,0,0
101912,endpoint,0,0
101913,will,0,0
101914,include,0,0
101915,inflammatory,0,0
101916,markers,0,0
101917,",",0,1
101918,antioxidant,0,0
101919,activity,0,0
101920,",",0,0
101921,and,0,0
101922,incidence,0,0
101923,of,0,0
101924,composite,0,0
101925,cardiovascular,0,1
101926,events,0,0
101927,.,0,1
101928,CONCLUSIONS,0,0
101929,In,0,0
101930,this,0,0
101931,study,0,0
101932,",",0,0
101933,we,0,0
101934,will,0,0
101935,investigate,0,0
101936,the,0,0
101937,improvement,0,0
101938,of,0,0
101939,coronary,0,1
101940,plaque,0,1
101941,with,0,1
101942,IVUS,0,1
101943,by,0,0
101944,treatment,0,1
101945,with,0,1
101946,two,0,0
101947,dihydropyridine,0,0
101948,CCBs,0,1
101949,in,0,1
101950,hypertensive,1,1
101951,patients,1,1
101952,undergoing,1,1
101953,elective,1,1
101954,PCI,1,1
101955,.,1,1
101956,This,0,0
101957,result,0,0
101958,will,0,0
101959,lead,0,0
101960,to,0,0
101961,the,0,0
101962,discovery,0,0
101963,of,0,0
101964,more,0,0
101965,effective,0,0
101966,drug,0,0
101967,therapy,0,0
101968,for,0,0
101969,inhibition,0,0
101970,of,0,1
101971,coronary,0,1
101972,events,0,0
101973,.,0,1
101974,Double-blind,0,1
101975,placebo-controlled,0,0
101976,trial,0,1
101977,of,0,0
101978,pentoxifylline,0,0
101979,added,0,0
101980,to,0,0
101981,risperidone,0,1
101982,:,0,1
101983,effects,0,0
101984,on,0,0
101985,aberrant,0,1
101986,behavior,0,1
101987,in,0,1
101988,children,1,1
101989,with,1,1
101990,autism,1,1
101991,.,1,0
101992,BACKGROUND,0,0
101993,There,0,0
101994,are,0,0
101995,several,0,0
101996,lines,0,0
101997,of,0,1
101998,evidence,0,0
101999,to,0,0
102000,indicate,0,0
102001,that,0,0
102002,the,0,0
102003,immune,0,0
102004,system,0,0
102005,plays,0,0
102006,an,0,0
102007,important,0,0
102008,role,0,0
102009,in,0,0
102010,the,0,0
102011,pathophysiology,0,0
102012,of,0,0
102013,autism,0,1
102014,.,0,1
102015,The,0,0
102016,objective,0,0
102017,of,0,0
102018,this,0,0
102019,study,0,0
102020,was,0,0
102021,to,0,0
102022,access,0,0
102023,the,0,0
102024,effects,0,0
102025,of,0,0
102026,pentoxifylline,0,0
102027,plus,0,0
102028,risperidone,0,0
102029,in,0,0
102030,the,0,0
102031,treatment,0,0
102032,of,0,0
102033,autistic,0,1
102034,disorder,0,1
102035,.,0,1
102036,METHODS,0,0
102037,Forty,1,1
102038,children,1,1
102039,between,1,0
102040,the,1,1
102041,ages,1,1
102042,4,1,0
102043,and,1,1
102044,12,1,1
102045,years,1,1
102046,with,1,1
102047,a,1,1
102048,DSM,1,1
102049,IV-TR,1,0
102050,clinical,1,0
102051,diagnosis,1,1
102052,of,1,0
102053,autism,1,1
102054,were,1,1
102055,recruited,1,1
102056,.,1,1
102057,The,1,0
102058,children,1,1
102059,presented,1,1
102060,with,1,1
102061,a,1,1
102062,chief,1,0
102063,complaint,1,1
102064,of,1,0
102065,severely,1,1
102066,disruptive,1,1
102067,symptoms,1,0
102068,related,1,0
102069,to,1,1
102070,autistic,1,1
102071,disorder,1,1
102072,.,1,1
102073,Patients,0,1
102074,were,0,0
102075,randomly,0,1
102076,allocated,0,1
102077,to,0,0
102078,pentoxifylline+risperidone,0,0
102079,or,0,0
102080,placebo+risperidone,0,0
102081,for,0,0
102082,a,0,0
102083,10-week,0,0
102084,",",0,0
102085,double-blind,0,0
102086,",",0,0
102087,placebo-controlled,0,0
102088,study,0,1
102089,.,0,1
102090,The,0,0
102091,dose,0,0
102092,of,0,0
102093,risperidone,0,0
102094,was,0,0
102095,titrated,0,0
102096,up,0,1
102097,to,0,0
102098,3,0,0
102099,mg/day,0,0
102100,",",0,0
102101,pentoxifylline,0,0
102102,was,0,0
102103,titrated,0,0
102104,to,0,1
102105,600,0,1
102106,mg/day,0,1
102107,.,0,1
102108,Patients,0,1
102109,were,0,0
102110,assessed,0,0
102111,at,0,0
102112,baseline,0,0
102113,and,0,1
102114,after,0,0
102115,2,0,1
102116,",",0,1
102117,4,0,0
102118,",",0,0
102119,6,0,0
102120,",",0,1
102121,8,0,1
102122,and,0,1
102123,10,0,1
102124,weeks,0,0
102125,of,0,1
102126,starting,0,1
102127,medication,0,1
102128,.,0,1
102129,The,0,0
102130,measure,0,0
102131,of,0,0
102132,the,0,0
102133,outcome,0,0
102134,was,0,0
102135,the,0,0
102136,Aberrant,0,1
102137,Behavior,0,1
102138,Checklist-Community,0,1
102139,(,0,1
102140,ABC-C,0,1
102141,),0,1
102142,.,0,1
102143,RESULTS,0,0
102144,The,0,0
102145,difference,0,0
102146,between,0,0
102147,the,0,1
102148,two,0,1
102149,protocols,0,0
102150,was,0,0
102151,significant,0,0
102152,as,0,0
102153,the,0,0
102154,group,0,1
102155,that,0,0
102156,received,0,1
102157,pentoxifylline,0,0
102158,had,0,1
102159,greater,0,0
102160,reduction,0,0
102161,in,0,0
102162,ABC-C,0,1
102163,subscale,0,0
102164,scores,0,0
102165,for,0,1
102166,Irritability,0,1
102167,",",0,1
102168,Lethargy/Social,0,1
102169,Withdrawal,0,1
102170,",",0,1
102171,Stereotypic,0,1
102172,Behavior,0,0
102173,",",0,1
102174,Hyperactivity/Noncompliance,0,1
102175,and,0,1
102176,Inappropriate,0,0
102177,Speech,0,1
102178,.,0,1
102179,CONCLUSION,0,0
102180,The,0,0
102181,results,0,0
102182,suggest,0,0
102183,that,0,0
102184,combination,0,0
102185,of,0,1
102186,atypical,0,1
102187,antipsychotic,0,1
102188,medications,0,1
102189,and,0,0
102190,pentoxifylline,0,0
102191,might,0,0
102192,have,0,0
102193,synergistic,0,0
102194,effects,0,0
102195,in,0,1
102196,treatment,0,1
102197,of,0,1
102198,behavioral,0,1
102199,problems,0,1
102200,of,0,1
102201,children,1,1
102202,with,1,1
102203,autism,1,1
102204,.,1,1
102205,The,0,0
102206,experience,0,0
102207,of,0,0
102208,pleasure,0,0
102209,before,0,0
102210,and,0,1
102211,after,0,0
102212,hearing,1,1
102213,rehabilitation,1,1
102214,.,1,1
102215,Hearing,1,0
102216,loss,1,0
102217,may,0,0
102218,lead,0,0
102219,to,0,0
102220,major,0,1
102221,changes,0,0
102222,in,0,1
102223,the,0,1
102224,social,0,0
102225,and,0,1
102226,emotional,0,0
102227,aspects,0,0
102228,of,0,1
102229,daily,0,0
102230,life,0,1
102231,.,0,1
102232,This,0,0
102233,follow-up,0,0
102234,study,0,0
102235,investigated,0,0
102236,the,0,0
102237,effect,0,0
102238,of,0,0
102239,hearing-aid,0,1
102240,use,0,0
102241,on,0,0
102242,emotional,0,0
102243,experience,0,1
102244,in,0,1
102245,adults,1,1
102246,with,1,1
102247,hearing,1,1
102248,impairment,1,1
102249,.,1,1
102250,Thirteen,1,1
102251,individuals,1,1
102252,with,1,1
102253,impaired,1,1
102254,hearing,1,1
102255,were,1,1
102256,tested,1,0
102257,before,1,0
102258,and,1,1
102259,after,1,1
102260,6,1,1
102261,months,1,1
102262,of,1,1
102263,hearing-aid,1,1
102264,use,1,0
102265,",",0,0
102266,and,0,0
102267,were,0,0
102268,compared,0,0
102269,with,0,1
102270,19,1,1
102271,individuals,1,1
102272,who,1,1
102273,had,1,1
102274,worn,1,1
102275,hearing,1,1
102276,aids,1,1
102277,for,1,1
102278,many,1,1
102279,years,1,1
102280,.,1,1
102281,The,0,0
102282,participants,0,1
102283,reported,0,1
102284,their,0,1
102285,daily,0,0
102286,emotional,0,0
102287,experiences,0,0
102288,",",0,1
102289,by,0,0
102290,completing,0,0
102291,questionnaires,0,0
102292,relating,0,0
102293,to,0,1
102294,sensory,0,1
102295,and,0,1
102296,social,0,1
102297,pleasure,0,0
102298,.,0,1
102299,After,0,0
102300,6,0,0
102301,months,0,1
102302,of,0,1
102303,hearing-aid,0,1
102304,use,0,0
102305,",",0,1
102306,individuals,0,1
102307,experienced,0,1
102308,more,0,0
102309,physical,0,1
102310,and,0,0
102311,social,0,0
102312,pleasure,0,0
102313,",",0,1
102314,whereas,0,0
102315,individuals,0,1
102316,using,0,1
102317,hearing,0,1
102318,aids,0,1
102319,for,0,1
102320,long,0,1
102321,periods,0,0
102322,of,0,1
102323,time,0,0
102324,reported,0,1
102325,similar,0,0
102326,levels,0,0
102327,of,0,1
102328,pleasure,0,0
102329,at,0,0
102330,the,0,0
102331,beginning,0,0
102332,and,0,0
102333,at,0,0
102334,the,0,0
102335,end,0,0
102336,of,0,0
102337,a,0,1
102338,6-month,0,0
102339,interval,0,0
102340,.,0,1
102341,The,0,0
102342,participants,0,1
102343,also,0,0
102344,performed,0,0
102345,a,0,0
102346,visual,0,0
102347,task,0,1
102348,",",0,0
102349,in,0,0
102350,which,0,0
102351,they,0,0
102352,rated,0,0
102353,the,0,0
102354,intensity,0,0
102355,of,0,0
102356,pleasure,0,0
102357,they,0,0
102358,experienced,0,1
102359,in,0,0
102360,response,0,0
102361,to,0,0
102362,emotionally,0,0
102363,positive,0,1
102364,and,0,1
102365,neutral,0,1
102366,pictures,0,0
102367,differing,0,1
102368,in,0,1
102369,luminance,0,0
102370,contrast,0,1
102371,.,0,1
102372,In,0,0
102373,this,0,0
102374,task,0,1
102375,",",0,0
102376,pleasure,0,0
102377,typically,0,1
102378,decreases,0,0
102379,with,0,0
102380,decreasing,0,0
102381,contrast,0,1
102382,of,0,0
102383,the,0,0
102384,positive,0,1
102385,images,0,0
102386,displayed,0,0
102387,.,0,1
102388,Once,0,0
102389,they,0,0
102390,had,0,1
102391,been,0,0
102392,fitted,0,0
102393,with,0,1
102394,hearing,0,1
102395,aids,0,1
102396,",",0,1
102397,the,0,0
102398,participants,0,1
102399,reported,0,1
102400,lower,0,0
102401,levels,0,0
102402,of,0,0
102403,pleasure,0,0
102404,",",0,0
102405,especially,0,0
102406,at,0,0
102407,low,0,1
102408,contrast,0,1
102409,.,0,1
102410,These,0,0
102411,findings,0,0
102412,highlight,0,0
102413,that,0,0
102414,the,0,0
102415,anhedonia,0,0
102416,scales,0,0
102417,provide,0,0
102418,a,0,0
102419,measure,0,0
102420,sensitive,0,0
102421,to,0,1
102422,emotional,0,0
102423,improvements,0,0
102424,that,0,0
102425,accompany,0,0
102426,the,0,0
102427,partial,0,0
102428,restoration,0,0
102429,of,0,0
102430,hearing,0,1
102431,function,0,0
102432,",",0,0
102433,although,0,0
102434,these,0,0
102435,scales,0,0
102436,were,0,0
102437,not,0,0
102438,specifically,0,0
102439,designed,0,0
102440,for,0,0
102441,hearing-impaired,0,1
102442,populations,0,1
102443,.,0,1
102444,In,0,0
102445,contrast,0,0
102446,",",0,0
102447,the,0,0
102448,surprising,0,0
102449,decrease,0,0
102450,in,0,1
102451,pleasure,0,0
102452,ratings,0,0
102453,for,0,1
102454,pictures,0,1
102455,after,0,1
102456,the,0,0
102457,introduction,0,0
102458,of,0,0
102459,hearing-aid,0,1
102460,use,0,0
102461,may,0,0
102462,be,0,0
102463,because,0,0
102464,of,0,0
102465,the,0,0
102466,compensation,0,0
102467,of,0,0
102468,hearing,0,1
102469,loss,0,0
102470,by,0,0
102471,changes,0,0
102472,in,0,1
102473,visual,0,1
102474,attention,0,1
102475,functions,0,0
102476,.,0,1
102477,Direct,0,1
102478,evidence,0,0
102479,for,0,0
102480,spinal,0,1
102481,cord,0,1
102482,involvement,0,1
102483,in,0,0
102484,placebo,0,0
102485,analgesia,0,0
102486,.,0,1
102487,Placebo,0,0
102488,analgesia,0,0
102489,is,0,0
102490,a,0,0
102491,prime,0,0
102492,example,0,0
102493,of,0,0
102494,the,0,0
102495,impact,0,0
102496,that,0,0
102497,psychological,0,0
102498,factors,0,0
102499,have,0,1
102500,on,0,0
102501,pain,0,1
102502,perception,0,0
102503,.,0,1
102504,We,0,0
102505,used,0,0
102506,functional,0,0
102507,magnetic,0,0
102508,resonance,0,1
102509,imaging,0,0
102510,of,0,0
102511,the,0,0
102512,human,0,1
102513,spinal,0,1
102514,cord,0,1
102515,to,0,0
102516,test,0,0
102517,the,0,0
102518,hypothesis,0,0
102519,that,0,0
102520,placebo,0,0
102521,analgesia,0,0
102522,results,0,0
102523,in,0,1
102524,a,0,1
102525,reduction,0,0
102526,of,0,0
102527,nociceptive,1,0
102528,processing,1,0
102529,in,1,0
102530,the,1,0
102531,spinal,1,1
102532,cord,1,1
102533,.,1,1
102534,In,0,0
102535,line,0,0
102536,with,0,1
102537,behavioral,0,1
102538,data,0,0
102539,that,0,0
102540,show,0,0
102541,decreased,1,0
102542,pain,1,1
102543,responses,1,0
102544,under,1,1
102545,placebo,1,1
102546,",",0,0
102547,pain-related,0,0
102548,activity,0,0
102549,in,0,0
102550,the,0,0
102551,spinal,0,1
102552,cord,0,1
102553,is,0,0
102554,strongly,0,0
102555,reduced,0,0
102556,under,0,0
102557,placebo,0,0
102558,.,0,1
102559,These,0,0
102560,results,0,0
102561,provide,0,0
102562,direct,0,0
102563,evidence,0,0
102564,for,0,0
102565,spinal,0,1
102566,inhibition,0,0
102567,as,0,0
102568,one,0,1
102569,mechanism,0,0
102570,of,0,0
102571,placebo,0,0
102572,analgesia,0,0
102573,and,0,0
102574,highlight,0,0
102575,that,0,0
102576,psychological,0,0
102577,factors,0,0
102578,can,0,0
102579,act,0,1
102580,on,0,0
102581,the,0,0
102582,earliest,0,1
102583,stages,0,1
102584,of,0,1
102585,pain,0,1
102586,processing,0,0
102587,in,0,0
102588,the,0,0
102589,central,0,0
102590,nervous,0,1
102591,system,0,1
102592,.,0,1
102593,Patterns,0,1
102594,of,0,0
102595,management,1,1
102596,of,1,0
102597,atrial,1,1
102598,fibrillation,1,1
102599,complicating,1,1
102600,coronary,1,1
102601,artery,1,1
102602,bypass,1,1
102603,grafting,1,1
102604,:,1,1
102605,Results,0,0
102606,from,0,1
102607,the,0,0
102608,PRoject,0,1
102609,of,0,0
102610,Ex-vivo,0,0
102611,Vein,0,1
102612,graft,0,1
102613,ENgineering,0,0
102614,via,0,1
102615,Transfection,0,0
102616,IV,0,1
102617,(,0,1
102618,PREVENT-IV,0,0
102619,),0,1
102620,Trial,0,1
102621,.,0,1
102622,BACKGROUND,0,0
102623,Current,0,1
102624,practice,0,0
102625,related,0,0
102626,to,0,0
102627,the,0,0
102628,management,1,0
102629,of,1,0
102630,atrial,1,1
102631,fibrillation,1,1
102632,(,1,1
102633,AF,1,1
102634,),1,1
102635,complicating,1,1
102636,coronary,1,1
102637,artery,1,1
102638,bypass,1,1
102639,grafting,1,1
102640,(,1,1
102641,CABG,1,0
102642,),1,1
102643,is,0,0
102644,uncertain,0,0
102645,.,0,1
102646,METHODS,0,0
102647,We,0,0
102648,examined,0,0
102649,management,0,1
102650,of,0,0
102651,post-CABG,1,0
102652,AF,1,1
102653,in,1,0
102654,the,1,0
102655,PREVENT-IV,1,0
102656,trial,1,0
102657,",",0,0
102658,and,0,0
102659,we,0,0
102660,explored,0,0
102661,patterns,0,1
102662,of,0,0
102663,use,0,0
102664,of,0,1
102665,postoperative,0,1
102666,rhythm,0,1
102667,versus,0,0
102668,rate,0,0
102669,control,0,1
102670,and,0,0
102671,anticoagulation,0,0
102672,for,0,0
102673,AF,0,1
102674,by,0,0
102675,geographic,1,1
102676,region,1,1
102677,and,0,0
102678,type,1,1
102679,of,1,0
102680,site,1,0
102681,.,1,1
102682,We,0,0
102683,also,0,0
102684,compared,0,0
102685,outcomes,0,0
102686,of,0,1
102687,patients,1,1
102688,who,1,1
102689,developed,1,1
102690,post-CABG,1,1
102691,AF,1,1
102692,(,1,1
102693,663,1,1
102694,),1,1
102695,with,1,1
102696,those,1,1
102697,who,1,1
102698,did,1,1
102699,not,1,1
102700,(,1,1
102701,"2,131",1,1
102702,),1,1
102703,.,1,1
102704,RESULTS,0,0
102705,The,0,0
102706,incidence,0,0
102707,of,0,0
102708,AF,0,1
102709,was,0,0
102710,24,0,1
102711,%,0,0
102712,.,0,1
102713,Post-CABG,0,0
102714,AF,0,1
102715,was,0,0
102716,treated,0,1
102717,with,0,1
102718,a,0,0
102719,rhythm,0,1
102720,control,0,0
102721,strategy,0,0
102722,in,0,1
102723,81,0,1
102724,%,0,0
102725,of,0,1
102726,patients,0,1
102727,and,0,1
102728,with,0,1
102729,warfarin,0,0
102730,in,0,1
102731,23,0,1
102732,%,0,0
102733,of,0,1
102734,patients,0,1
102735,.,0,1
102736,Although,0,0
102737,there,0,0
102738,were,0,0
102739,significant,0,0
102740,variations,0,0
102741,across,0,1
102742,sites,0,1
102743,in,0,1
102744,the,0,0
102745,management,0,0
102746,of,0,0
102747,post-CABG,0,0
102748,AF,0,1
102749,",",0,1
102750,patterns,0,1
102751,of,0,0
102752,use,0,0
102753,of,0,1
102754,postoperative,0,1
102755,rhythm,0,1
102756,versus,0,0
102757,rate,0,0
102758,control,0,1
102759,and,0,0
102760,anticoagulation,0,0
102761,did,0,0
102762,not,0,0
102763,differ,0,0
102764,by,0,0
102765,geographic,0,1
102766,region,0,1
102767,or,0,1
102768,by,0,0
102769,whether,0,0
102770,or,0,1
102771,not,0,0
102772,the,0,0
102773,enrolling,0,1
102774,site,0,0
102775,was,0,0
102776,an,0,0
102777,academic,0,1
102778,institution,0,1
102779,.,0,1
102780,Mortality,0,0
102781,was,0,0
102782,higher,0,0
102783,in,0,0
102784,patients,1,1
102785,with,1,1
102786,post-CABG,1,1
102787,AF,0,1
102788,than,0,1
102789,patients,1,1
102790,without,1,1
102791,AF,1,1
102792,at,0,1
102793,30,0,1
102794,days,0,1
102795,(,0,1
102796,1.5,0,1
102797,%,0,0
102798,vs,0,0
102799,0.7,0,0
102800,%,0,0
102801,",",0,1
102802,P,0,0
102803,=,0,1
102804,.01,0,0
102805,),0,1
102806,but,0,0
102807,not,0,0
102808,at,0,1
102809,3,0,1
102810,years,0,1
102811,(,0,1
102812,6.9,0,1
102813,%,0,0
102814,vs,0,0
102815,4.9,0,0
102816,%,0,0
102817,",",0,1
102818,P,0,0
102819,=,0,1
102820,.41,0,0
102821,),0,0
102822,.,0,0
102823,There,0,0
102824,was,0,0
102825,a,0,0
102826,trend,0,0
102827,toward,0,0
102828,a,0,0
102829,higher,0,0
102830,risk,0,0
102831,of,0,0
102832,mortality,0,0
102833,or,0,1
102834,stroke,0,1
102835,at,0,1
102836,30,0,1
102837,days,0,1
102838,in,0,1
102839,patients,1,1
102840,with,1,1
102841,AF,1,1
102842,(,0,1
102843,2.4,0,0
102844,%,0,0
102845,vs,0,0
102846,1.9,0,0
102847,%,0,0
102848,",",0,1
102849,P,0,0
102850,=,0,1
102851,.08,0,0
102852,),0,1
102853,.,0,1
102854,CONCLUSION,0,0
102855,Although,0,0
102856,a,0,1
102857,rhythm,0,1
102858,control,0,1
102859,strategy,0,0
102860,was,0,0
102861,used,0,0
102862,in,0,0
102863,most,0,0
102864,of,0,0
102865,the,0,0
102866,patients,0,1
102867,in,0,0
102868,this,0,0
102869,trial,0,0
102870,and,0,0
102871,the,0,0
102872,overall,0,0
102873,rate,0,0
102874,of,0,0
102875,use,0,0
102876,of,0,0
102877,warfarin,0,0
102878,was,0,0
102879,low,0,0
102880,",",0,0
102881,the,0,0
102882,significance,0,0
102883,of,0,0
102884,these,0,0
102885,findings,0,0
102886,is,0,0
102887,uncertain,0,0
102888,because,0,0
102889,of,0,0
102890,the,0,0
102891,lack,0,0
102892,of,0,0
102893,data,0,0
102894,from,0,1
102895,randomized,0,1
102896,clinical,0,1
102897,trials,0,1
102898,.,0,1
102899,The,0,0
102900,substantial,0,0
102901,variations,0,0
102902,in,0,1
102903,the,0,0
102904,management,0,0
102905,of,0,0
102906,post-CABG,0,0
102907,AF,0,1
102908,across,0,0
102909,sites,0,1
102910,are,0,0
102911,likely,0,0
102912,because,0,1
102913,of,0,1
102914,definitive,0,1
102915,data,0,0
102916,on,0,0
102917,the,0,0
102918,most,0,0
102919,effective,0,0
102920,therapies,0,0
102921,",",0,1
102922,highlighting,0,0
102923,the,0,0
102924,need,0,0
102925,for,0,0
102926,clinical,0,0
102927,trials,0,1
102928,on,0,0
102929,rate,0,0
102930,versus,0,0
102931,rhythm,0,1
102932,control,0,1
102933,and,0,0
102934,on,0,0
102935,anticoagulation,0,0
102936,for,0,0
102937,AF,0,1
102938,in,0,0
102939,this,0,0
102940,setting,0,1
102941,.,0,1
102942,Immunologic,0,1
102943,profiles,0,0
102944,of,0,1
102945,persons,0,1
102946,recruited,0,1
102947,for,0,1
102948,a,0,0
102949,randomized,0,1
102950,",",0,0
102951,placebo-controlled,0,0
102952,clinical,0,0
102953,trial,0,1
102954,of,0,0
102955,hookworm,1,1
102956,infection,1,1
102957,.,1,1
102958,Data,0,0
102959,from,0,1
102960,epidemiologic,0,1
102961,studies,0,0
102962,suggest,0,0
102963,that,0,0
102964,hookworm,0,1
102965,infections,0,1
102966,",",0,1
102967,in,0,0
102968,establishing,0,0
102969,an,0,1
102970,immunologic,0,0
102971,phenotype,0,1
102972,conducive,0,0
102973,to,0,0
102974,parasite,0,0
102975,survival,0,0
102976,",",0,0
102977,may,0,0
102978,protect,0,0
102979,against,0,0
102980,the,0,0
102981,development,0,0
102982,of,0,0
102983,allergic,0,1
102984,disease,0,1
102985,.,0,1
102986,We,0,0
102987,describe,0,0
102988,immunologic,0,0
102989,findings,0,0
102990,from,0,1
102991,a,0,1
102992,clinical,0,0
102993,study,0,1
102994,designed,0,0
102995,to,0,0
102996,investigate,0,0
102997,the,0,0
102998,safety,0,0
102999,of,0,0
103000,iatrogenic,0,1
103001,hookworm,0,1
103002,infection,0,1
103003,in,0,0
103004,participants,1,1
103005,with,1,1
103006,allergic,1,1
103007,rhinitis,1,1
103008,.,1,1
103009,The,0,0
103010,low,0,0
103011,",",0,0
103012,relatively,0,0
103013,safe,0,0
103014,level,0,0
103015,of,0,0
103016,hookworm,0,1
103017,infection,0,1
103018,used,0,0
103019,in,0,0
103020,this,0,0
103021,study,0,0
103022,was,0,0
103023,immunogenic,0,1
103024,",",0,1
103025,inducing,0,0
103026,eosinophilia,0,1
103027,and,0,1
103028,a,0,1
103029,significant,0,0
103030,specific,0,0
103031,IgG,0,0
103032,response,0,0
103033,.,0,1
103034,Importantly,0,0
103035,",",0,0
103036,no,0,0
103037,potentiation,0,0
103038,of,0,0
103039,IgE,0,1
103040,responses,0,0
103041,to,0,1
103042,the,0,1
103043,environmental,0,1
103044,allergens,0,1
103045,to,0,1
103046,which,0,1
103047,the,0,0
103048,participants,1,1
103049,were,1,1
103050,sensitized,1,1
103051,was,0,0
103052,seen,0,0
103053,.,0,1
103054,However,0,0
103055,",",0,0
103056,no,0,0
103057,evidence,0,0
103058,of,0,0
103059,systemic,0,0
103060,immune,0,0
103061,regulation,0,0
103062,was,0,0
103063,seen,0,0
103064,in,0,1
103065,infected,0,1
103066,participants,0,1
103067,.,0,1
103068,This,0,0
103069,finding,0,0
103070,may,0,0
103071,indicate,0,0
103072,that,0,0
103073,the,0,0
103074,level,0,0
103075,of,0,0
103076,infection,0,1
103077,or,0,1
103078,the,0,0
103079,frequency,0,0
103080,of,0,0
103081,infection,0,1
103082,may,0,0
103083,have,0,0
103084,to,0,0
103085,be,0,0
103086,altered,0,1
103087,in,0,0
103088,future,0,0
103089,trials,0,1
103090,to,0,1
103091,induce,0,0
103092,a,0,0
103093,therapeutically,0,0
103094,conducive,0,0
103095,immunologic,0,0
103096,phenotype,0,1
103097,.,0,1
103098,Intranasal,0,1
103099,oxytocin,0,0
103100,improves,0,0
103101,emotion,0,0
103102,recognition,0,0
103103,for,0,0
103104,youth,1,1
103105,with,1,1
103106,autism,1,1
103107,spectrum,1,1
103108,disorders,1,1
103109,.,1,1
103110,BACKGROUND,0,0
103111,A,0,0
103112,diagnostic,0,0
103113,hallmark,0,0
103114,of,0,0
103115,autism,0,1
103116,spectrum,0,1
103117,disorders,0,1
103118,is,0,0
103119,a,0,0
103120,qualitative,0,0
103121,impairment,0,1
103122,in,0,1
103123,social,0,1
103124,communication,0,0
103125,and,0,1
103126,interaction,0,0
103127,.,0,1
103128,Deficits,0,0
103129,in,0,0
103130,the,0,0
103131,ability,0,0
103132,to,0,0
103133,recognize,0,1
103134,the,0,0
103135,emotions,0,0
103136,of,0,0
103137,others,0,1
103138,are,0,0
103139,believed,0,0
103140,to,0,0
103141,contribute,0,0
103142,to,0,0
103143,this,0,0
103144,.,0,0
103145,There,0,0
103146,is,0,0
103147,currently,0,0
103148,no,0,0
103149,effective,0,0
103150,treatment,0,0
103151,for,0,0
103152,these,0,0
103153,problems,0,1
103154,.,0,1
103155,METHODS,0,0
103156,In,0,0
103157,a,0,0
103158,double-blind,0,0
103159,",",0,0
103160,randomized,0,0
103161,",",0,0
103162,placebo-controlled,0,0
103163,",",0,0
103164,crossover,0,0
103165,design,0,1
103166,",",0,0
103167,we,0,0
103168,administered,0,0
103169,oxytocin,0,0
103170,nasal,0,1
103171,spray,0,1
103172,(,0,1
103173,18,0,1
103174,or,0,1
103175,24,0,1
103176,IU,0,0
103177,),0,1
103178,or,0,1
103179,a,0,1
103180,placebo,0,0
103181,to,0,0
103182,16,1,1
103183,male,1,1
103184,youth,1,1
103185,aged,1,1
103186,12,1,1
103187,to,1,1
103188,19,1,1
103189,who,1,1
103190,were,1,1
103191,diagnosed,1,1
103192,with,1,1
103193,Autistic,1,1
103194,or,1,1
103195,Asperger,1,1
103196,'s,1,1
103197,Disorder,1,1
103198,.,1,1
103199,Participants,1,1
103200,then,0,0
103201,completed,0,1
103202,the,0,0
103203,Reading,0,0
103204,the,0,0
103205,Mind,0,0
103206,in,0,0
103207,the,0,0
103208,Eyes,0,1
103209,Task,0,0
103210,",",0,0
103211,a,0,0
103212,widely,0,0
103213,used,0,0
103214,and,0,0
103215,reliable,0,0
103216,test,0,0
103217,of,0,0
103218,emotion,0,0
103219,recognition,0,0
103220,.,0,1
103221,RESULTS,0,0
103222,In,0,0
103223,comparison,0,0
103224,with,0,1
103225,placebo,0,0
103226,",",0,0
103227,oxytocin,0,0
103228,administration,0,0
103229,improved,0,0
103230,performance,0,0
103231,on,0,0
103232,the,0,0
103233,Reading,0,0
103234,the,0,0
103235,Mind,0,0
103236,in,0,0
103237,the,0,0
103238,Eyes,0,1
103239,Task,0,0
103240,.,0,1
103241,This,0,0
103242,effect,0,0
103243,was,0,0
103244,also,0,0
103245,shown,0,0
103246,when,0,0
103247,analysis,0,0
103248,was,0,0
103249,restricted,0,1
103250,to,0,0
103251,the,0,0
103252,younger,1,1
103253,participants,1,1
103254,aged,1,1
103255,12,1,1
103256,to,1,1
103257,15,1,1
103258,who,0,1
103259,received,0,1
103260,the,0,1
103261,lower,0,0
103262,dose,0,0
103263,.,0,0
103264,CONCLUSIONS,0,0
103265,This,0,0
103266,study,0,0
103267,provides,0,0
103268,the,0,0
103269,first,0,0
103270,evidence,0,0
103271,that,0,0
103272,oxytocin,0,0
103273,nasal,0,1
103274,spray,0,0
103275,improves,0,0
103276,emotion,0,0
103277,recognition,0,0
103278,in,0,1
103279,young,1,1
103280,people,1,1
103281,diagnosed,1,1
103282,with,1,1
103283,autism,1,1
103284,spectrum,1,1
103285,disorders,1,1
103286,.,1,1
103287,Findings,0,0
103288,suggest,0,0
103289,the,0,0
103290,potential,0,0
103291,of,0,0
103292,earlier,0,1
103293,intervention,0,1
103294,and,0,0
103295,further,0,0
103296,evaluation,0,0
103297,of,0,0
103298,oxytocin,0,0
103299,nasal,0,1
103300,spray,0,1
103301,as,0,0
103302,a,0,1
103303,treatment,0,0
103304,to,0,0
103305,improve,0,0
103306,social,0,0
103307,communication,0,0
103308,and,0,0
103309,interaction,0,0
103310,in,0,1
103311,young,1,1
103312,people,1,1
103313,with,1,1
103314,autism,1,1
103315,spectrum,1,1
103316,disorders,1,1
103317,.,1,1
103318,Chemoradiotherapy,0,1
103319,with,0,1
103320,concurrent,0,1
103321,gemcitabine,0,0
103322,and,0,0
103323,cisplatin,0,0
103324,with,0,1
103325,or,0,1
103326,without,0,1
103327,sequential,0,0
103328,chemotherapy,0,1
103329,with,0,1
103330,gemcitabine/cisplatin,0,0
103331,vs,0,0
103332,chemoradiotherapy,0,1
103333,with,0,1
103334,concurrent,0,1
103335,5-fluorouracil,0,0
103336,in,0,1
103337,patients,1,1
103338,with,1,1
103339,locally,1,1
103340,advanced,1,1
103341,pancreatic,1,1
103342,cancer,1,1
103343,--,1,1
103344,a,1,1
103345,multi-centre,1,0
103346,randomised,0,1
103347,phase,0,1
103348,II,0,1
103349,study,0,1
103350,.,0,1
103351,BACKGROUND,0,0
103352,No,0,0
103353,standard,0,1
103354,treatment,0,0
103355,for,0,0
103356,locally,1,1
103357,advanced,1,1
103358,pancreatic,1,1
103359,cancer,1,1
103360,(,1,1
103361,LAPC,1,0
103362,),1,1
103363,is,0,0
103364,defined,0,0
103365,.,0,0
103366,PATIENTS,0,0
103367,AND,0,0
103368,METHODS,0,0
103369,Within,0,1
103370,a,0,1
103371,multi-centre,0,0
103372,",",0,0
103373,randomised,0,1
103374,phase,0,1
103375,II,0,1
103376,trial,0,0
103377,",",0,1
103378,95,1,0
103379,patients,1,1
103380,with,1,1
103381,LAPC,1,1
103382,were,0,1
103383,assigned,0,1
103384,to,0,1
103385,three,0,0
103386,different,0,0
103387,chemoradiotherapy,0,1
103388,(,0,1
103389,CRT,0,1
103390,),0,1
103391,regimens,0,0
103392,:,0,1
103393,patients,0,1
103394,received,0,1
103395,conventionally,0,1
103396,fractionated,0,0
103397,radiotherapy,0,1
103398,of,0,0
103399,50,0,1
103400,Gy,0,1
103401,and,0,1
103402,were,0,1
103403,randomised,0,0
103404,to,0,0
103405,concurrent,0,1
103406,5-fluorouracil,0,0
103407,(,0,1
103408,350,0,1
103409,mg,0,1
103410,m,0,1
103411,(,0,1
103412,-2,0,1
103413,),0,1
103414,per,0,0
103415,day,0,0
103416,on,0,0
103417,each,0,0
103418,day,0,0
103419,of,0,0
103420,radiotherapy,0,1
103421,",",0,1
103422,RT-5-FU,0,0
103423,arm,0,1
103424,),0,1
103425,",",0,0
103426,concurrent,0,0
103427,gemcitabine,0,0
103428,(,0,1
103429,300,0,1
103430,mg,0,1
103431,m,0,1
103432,(,0,1
103433,-2,0,1
103434,),0,1
103435,),0,1
103436,",",0,0
103437,and,0,0
103438,cisplatin,0,0
103439,(,0,1
103440,30,0,1
103441,mg,0,1
103442,m,0,1
103443,(,0,1
103444,-2,0,1
103445,),0,1
103446,),0,1
103447,on,0,1
103448,days,0,0
103449,1,0,1
103450,",",0,1
103451,8,0,0
103452,",",0,0
103453,22,0,1
103454,",",0,0
103455,and,0,1
103456,29,0,1
103457,(,0,1
103458,RT-GC,0,0
103459,arm,0,1
103460,),0,1
103461,",",0,0
103462,or,0,1
103463,the,0,0
103464,same,0,0
103465,concurrent,0,0
103466,treatment,0,0
103467,followed,0,0
103468,by,0,0
103469,sequential,0,0
103470,full-dose,0,1
103471,gemcitabine,0,0
103472,(,0,1
103473,1000,0,0
103474,mg,0,1
103475,m,0,1
103476,(,0,1
103477,-2,0,1
103478,),0,1
103479,),0,1
103480,and,0,1
103481,cisplatin,0,0
103482,(,0,1
103483,50,0,1
103484,mg,0,1
103485,m,0,1
103486,(,0,1
103487,-2,0,1
103488,),0,1
103489,),0,1
103490,every,0,0
103491,2,0,1
103492,weeks,0,0
103493,(,0,1
103494,RT-GC+GC,0,1
103495,arm,0,1
103496,),0,1
103497,.,0,1
103498,Primary,0,0
103499,end,0,0
103500,point,0,0
103501,was,0,0
103502,the,0,0
103503,overall,0,0
103504,survival,0,0
103505,(,0,1
103506,OS,0,0
103507,),0,1
103508,rate,0,0
103509,after,0,1
103510,9,0,1
103511,months,0,1
103512,.,0,1
103513,RESULTS,0,0
103514,The,0,0
103515,9-month,0,0
103516,OS,0,0
103517,rate,0,0
103518,was,0,0
103519,58,0,1
103520,%,0,0
103521,in,0,0
103522,the,0,0
103523,RT-5-FU,0,0
103524,arm,0,0
103525,",",0,1
103526,52,0,1
103527,%,0,0
103528,in,0,0
103529,the,0,0
103530,RT-GC,0,0
103531,arm,0,0
103532,",",0,0
103533,and,0,0
103534,45,0,1
103535,%,0,0
103536,in,0,0
103537,the,0,0
103538,RT-GC+GC,0,0
103539,arm,0,1
103540,.,0,1
103541,Corresponding,0,0
103542,median,0,0
103543,survival,0,0
103544,times,0,0
103545,were,0,1
103546,9.6,0,0
103547,",",0,1
103548,9.3,0,0
103549,",",0,0
103550,and,0,1
103551,7.3,0,0
103552,months,0,0
103553,(,0,1
103554,P=0.61,0,0
103555,),0,1
103556,respectively,0,0
103557,.,0,1
103558,The,0,0
103559,intent-to-treat,0,0
103560,response,0,0
103561,rate,0,0
103562,was,0,0
103563,19,0,1
103564,",",0,1
103565,22,0,1
103566,",",0,0
103567,and,0,0
103568,13,0,1
103569,%,0,0
103570,respectively,0,0
103571,.,0,1
103572,Median,0,0
103573,progression-free,0,0
103574,survival,0,0
103575,was,0,0
103576,estimated,0,0
103577,with,0,1
103578,4.0,0,0
103579,",",0,1
103580,5.6,0,0
103581,",",0,0
103582,and,0,1
103583,6.0,0,1
103584,months,0,0
103585,(,0,1
103586,P=0.21,0,0
103587,),0,1
103588,.,0,1
103589,Grade,0,0
103590,3/4,0,1
103591,haematological,0,1
103592,toxicities,0,0
103593,were,0,0
103594,more,0,0
103595,frequent,0,0
103596,in,0,0
103597,the,0,1
103598,two,0,0
103599,GC-containing,0,1
103600,arms,0,1
103601,",",0,1
103602,no,0,0
103603,grade,0,1
103604,3/4,0,0
103605,febrile,0,1
103606,neutropaenia,0,1
103607,was,0,0
103608,observed,0,0
103609,.,0,1
103610,CONCLUSION,0,0
103611,None,0,0
103612,of,0,0
103613,the,0,0
103614,three,0,0
103615,CRT,0,1
103616,regimens,0,0
103617,tested,0,0
103618,met,0,1
103619,the,0,0
103620,investigators,0,0
103621,',0,1
103622,definition,0,1
103623,for,0,1
103624,efficacy,0,0
103625,;,0,1
103626,the,0,0
103627,median,0,0
103628,OS,0,0
103629,was,0,0
103630,similar,0,0
103631,to,0,0
103632,those,0,0
103633,previously,0,1
103634,reported,0,0
103635,with,0,1
103636,gemcitabine,0,0
103637,alone,0,0
103638,in,0,0
103639,LAPC,0,1
103640,.,0,1
103641,First-line,0,0
103642,cisplatin,0,0
103643,with,0,1
103644,docetaxel,0,0
103645,or,0,1
103646,vinorelbine,0,0
103647,in,0,0
103648,patients,1,1
103649,with,1,1
103650,advanced,1,1
103651,non-small-cell,1,1
103652,lung,1,1
103653,cancer,1,1
103654,:,1,1
103655,a,0,0
103656,quality,1,0
103657,of,1,0
103658,life,1,1
103659,directed,1,0
103660,phase,1,1
103661,II,1,1
103662,randomized,1,1
103663,trial,1,0
103664,of,1,0
103665,Gruppo,1,1
103666,Oncologico,1,1
103667,Italia,1,1
103668,Meridionale,1,1
103669,.,1,1
103670,BACKGROUND,0,0
103671,Quality,0,0
103672,of,0,0
103673,life,0,1
103674,(,0,1
103675,QoL,0,0
103676,),0,1
103677,has,0,0
103678,gained,0,0
103679,greater,0,0
103680,importance,0,0
103681,in,0,0
103682,the,0,0
103683,management,0,0
103684,of,0,0
103685,metastatic,1,1
103686,non-small-cell,1,1
103687,lung,1,1
103688,cancer,1,1
103689,due,0,0
103690,to,0,1
103691,the,0,0
103692,palliative,0,1
103693,nature,0,1
103694,of,0,0
103695,treatment,0,1
103696,.,0,1
103697,Docetaxel,0,0
103698,(,0,0
103699,DCT,0,1
103700,),0,1
103701,and,0,0
103702,cisplatin,0,0
103703,(,0,1
103704,CDDP,0,1
103705,),0,0
103706,doublet,0,0
103707,has,0,0
103708,been,0,0
103709,reported,0,0
103710,to,0,0
103711,be,0,0
103712,associated,0,0
103713,to,0,0
103714,a,0,0
103715,better,0,0
103716,QoL,0,0
103717,than,0,0
103718,the,0,0
103719,weekly,0,0
103720,vinorelbine,0,0
103721,(,0,1
103722,VNR,0,1
103723,),0,1
103724,and,0,1
103725,CDDP,0,1
103726,regimen,0,0
103727,.,0,1
103728,Recently,0,1
103729,a,0,0
103730,newer,0,0
103731,more,0,0
103732,tolerated,0,0
103733,schedule,0,0
103734,of,0,0
103735,the,0,0
103736,VNR/CDDP,0,0
103737,regimen,0,0
103738,has,0,0
103739,been,0,0
103740,published,0,0
103741,and,0,0
103742,is,0,0
103743,widely,0,0
103744,employed,0,0
103745,in,0,0
103746,medical,0,1
103747,practice,0,0
103748,.,0,1
103749,The,0,0
103750,impact,0,0
103751,of,0,0
103752,these,0,0
103753,regimens,0,0
103754,on,0,0
103755,patients,0,1
103756,',0,1
103757,QoL,0,0
103758,as,0,0
103759,well,0,0
103760,as,0,0
103761,symptoms,0,0
103762,control,0,1
103763,and,0,1
103764,type,0,1
103765,and,0,0
103766,grading,0,1
103767,chemo-related,0,1
103768,side-effects,0,0
103769,has,0,0
103770,been,0,0
103771,compared,0,0
103772,prospectically,0,1
103773,.,0,1
103774,METHODS,0,0
103775,Patients,1,1
103776,received,0,1
103777,CDDP,0,1
103778,75,0,1
103779,mg/m,0,1
103780,(,0,1
103781,2,0,1
103782,),0,1
103783,plus,0,0
103784,DCT,0,1
103785,75,0,1
103786,mg/m,0,1
103787,(,0,1
103788,2,0,1
103789,),0,1
103790,on,0,0
103791,day,0,0
103792,1,0,1
103793,every,0,0
103794,weeks,0,0
103795,(,0,1
103796,arm,0,1
103797,A,0,1
103798,),0,1
103799,or,0,1
103800,CDDP,0,1
103801,80,0,1
103802,mg/m,0,0
103803,(,0,1
103804,2,0,1
103805,),0,1
103806,on,0,0
103807,day,0,1
103808,1,0,1
103809,plus,0,0
103810,VNR,0,1
103811,30,0,1
103812,mg/m,0,1
103813,(,0,1
103814,2,0,1
103815,),0,1
103816,day,0,0
103817,1,0,1
103818,and,0,1
103819,8,0,1
103820,every,0,0
103821,3,0,1
103822,weeks,0,0
103823,(,0,1
103824,arm,0,1
103825,B,0,1
103826,),0,1
103827,.,0,1
103828,G-CSF,0,1
103829,and/or,0,0
103830,EPO,0,1
103831,were,0,1
103832,employed,0,0
103833,as,0,0
103834,needed,0,1
103835,.,0,1
103836,Health-related,0,0
103837,QoL,0,0
103838,was,0,0
103839,assessed,0,0
103840,at,0,0
103841,entry,0,1
103842,and,0,0
103843,after,0,0
103844,every,0,0
103845,cycle,0,0
103846,by,0,0
103847,the,0,0
103848,EORTC-QLQ-C30,0,0
103849,and,0,1
103850,LC13,0,1
103851,questionnaires,0,0
103852,",",0,1
103853,toxicity,0,0
103854,by,0,0
103855,the,0,0
103856,NCI-NCCN,0,0
103857,CTC,0,0
103858,vs,0,0
103859,2,0,1
103860,",",0,0
103861,and,0,0
103862,intent-to-treat,0,0
103863,objective,0,0
103864,response,0,0
103865,by,0,0
103866,the,0,0
103867,Recist,0,1
103868,criteria,0,1
103869,.,0,1
103870,RESULTS,0,0
103871,The,0,0
103872,QoL,0,0
103873,questionnaires,0,0
103874,were,0,1
103875,completed,0,1
103876,by,0,0
103877,37,1,1
103878,pts,1,1
103879,(,1,1
103880,88,1,1
103881,%,1,0
103882,),1,1
103883,in,1,0
103884,the,1,0
103885,DCT/CDDP,1,1
103886,arm,1,1
103887,and,0,1
103888,39,1,1
103889,pts,1,1
103890,(,1,1
103891,87,1,1
103892,%,1,0
103893,),1,1
103894,in,1,0
103895,the,1,0
103896,VNR/CDDP,1,1
103897,one,1,1
103898,.,1,1
103899,Baseline,0,0
103900,mean,0,1
103901,scores,0,0
103902,and,0,1
103903,rates,0,0
103904,at,0,1
103905,which,0,1
103906,pts,0,1
103907,failed,0,1
103908,to,0,1
103909,complete,0,1
103910,QoL,0,0
103911,assessment,0,0
103912,were,0,1
103913,similar,0,0
103914,in,0,0
103915,the,0,1
103916,two,0,1
103917,arms,0,1
103918,.,0,1
103919,Global,0,0
103920,health,0,0
103921,status,0,1
103922,of,0,0
103923,the,0,0
103924,EORTC,0,1
103925,QLQ-C30,0,0
103926,scale,0,0
103927,and,0,1
103928,specific,0,0
103929,symptoms,0,1
103930,control,0,1
103931,(,0,1
103932,LC13,0,0
103933,module,0,1
103934,),0,1
103935,improved,0,0
103936,during,0,0
103937,treatment,0,0
103938,without,0,1
103939,any,0,0
103940,statistically,0,0
103941,significant,0,0
103942,difference,0,0
103943,between,0,0
103944,the,0,1
103945,two,0,1
103946,arms,0,1
103947,.,0,1
103948,Emotional,0,0
103949,functioning,0,1
103950,remained,0,0
103951,stable,0,1
103952,in,0,1
103953,both,0,0
103954,groups,0,0
103955,during,0,0
103956,treatment,0,1
103957,",",0,1
103958,whereas,0,0
103959,physical,0,1
103960,and,0,1
103961,role,0,0
103962,improved,0,0
103963,slightly,0,0
103964,.,0,1
103965,In,0,0
103966,the,0,0
103967,DCT/CDDP,0,1
103968,arm,0,1
103969,14,0,1
103970,pts,0,1
103971,(,0,1
103972,33,0,1
103973,%,0,0
103974,;,0,1
103975,95,0,0
103976,%,0,0
103977,CL,0,1
103978,24-40,0,1
103979,%,0,0
103980,),0,1
103981,had,0,1
103982,PR,0,0
103983,",",0,1
103984,and,0,0
103985,10,0,1
103986,(,0,1
103987,24,0,1
103988,%,0,0
103989,),0,1
103990,SD,0,1
103991,for,0,1
103992,a,0,1
103993,57,0,1
103994,%,0,0
103995,TGCR,0,1
103996,.,0,1
103997,In,0,0
103998,the,0,0
103999,VNR/CDDP,0,1
104000,arm,0,1
104001,12,0,1
104002,pts,0,1
104003,(,0,1
104004,27,0,1
104005,%,0,0
104006,),0,1
104007,achieved,0,0
104008,PR,0,0
104009,",",0,1
104010,18,0,1
104011,(,0,1
104012,41,0,1
104013,%,0,0
104014,),0,0
104015,SD,0,0
104016,a,0,0
104017,68,0,0
104018,%,0,0
104019,TGCR,0,1
104020,.,0,1
104021,Differences,0,0
104022,were,0,0
104023,not,0,0
104024,statistically,0,0
104025,significant,0,0
104026,.,0,1
104027,Median,0,0
104028,time-to-progression,0,0
104029,was,0,0
104030,4.2,0,0
104031,months,0,0
104032,in,0,1
104033,the,0,1
104034,DCT/CDDP,0,1
104035,arm,0,1
104036,and,0,1
104037,4.5,0,1
104038,months,0,0
104039,in,0,1
104040,the,0,1
104041,VNR/CDDP,0,1
104042,one,0,1
104043,",",0,0
104044,and,0,0
104045,median,0,0
104046,overall,0,0
104047,survival,0,0
104048,was,0,0
104049,12.1,0,0
104050,(,0,1
104051,range,0,1
104052,1-26+,0,1
104053,months,0,0
104054,),0,1
104055,and,0,1
104056,12.5,0,0
104057,months,0,0
104058,(,0,1
104059,range,0,1
104060,1-28+,0,1
104061,months,0,0
104062,),0,1
104063,for,0,1
104064,DCT/CDDP,0,1
104065,and,0,1
104066,VNR/CDDP,0,1
104067,arms,0,0
104068,",",0,1
104069,respectively,0,0
104070,.,0,1
104071,Febrile,0,0
104072,neutropenia,0,0
104073,rate,0,0
104074,was,0,0
104075,higher,0,0
104076,in,0,0
104077,the,0,0
104078,VNR/CDDP,0,1
104079,arm,0,0
104080,(,0,1
104081,p=0.02,0,0
104082,),0,0
104083,as,0,0
104084,well,0,0
104085,as,0,0
104086,G3-4,0,0
104087,anemia,0,1
104088,(,0,1
104089,p=0.005,0,0
104090,),0,1
104091,and,0,0
104092,G-CSF/EPO,0,0
104093,use,0,0
104094,(,0,1
104095,p=0.019,0,0
104096,),0,1
104097,.,0,1
104098,CONCLUSIONS,0,0
104099,Global,0,0
104100,and,0,1
104101,specific,0,0
104102,health-related,0,0
104103,QoL,0,1
104104,data,0,0
104105,similar,0,0
104106,in,0,1
104107,both,0,0
104108,treatment,0,0
104109,groups,0,0
104110,with,0,1
104111,no,0,0
104112,statistically,0,0
104113,significant,0,0
104114,difference,0,0
104115,.,0,1
104116,Efficacy,0,0
104117,measures,0,0
104118,",",0,1
104119,overall,0,0
104120,response,0,0
104121,rate,0,0
104122,",",0,0
104123,time-to-progression,0,0
104124,and,0,0
104125,overall,0,0
104126,survival,0,0
104127,were,0,1
104128,equivalent,0,0
104129,in,0,1
104130,both,0,0
104131,arms,0,0
104132,.,0,1
104133,However,0,0
104134,",",0,0
104135,severe,0,1
104136,anemia,0,1
104137,and,0,1
104138,febrile,0,1
104139,neutropenia,0,0
104140,are,0,0
104141,statistically,0,0
104142,more,0,0
104143,frequent,0,0
104144,in,0,0
104145,the,0,0
104146,VNR/CDDP,0,1
104147,arm,0,0
104148,than,0,0
104149,in,0,0
104150,the,0,0
104151,DCT/CDDP,0,1
104152,one,0,1
104153,.,0,1
104154,These,0,0
104155,data,0,0
104156,should,0,0
104157,be,0,0
104158,considered,0,0
104159,in,0,0
104160,treatment,0,0
104161,decision-making,0,0
104162,for,0,0
104163,pts,1,1
104164,with,1,1
104165,advanced,1,1
104166,non-small-cell,1,1
104167,lung,1,1
104168,cancer,1,1
104169,and,0,0
104170,for,0,0
104171,the,0,0
104172,design,0,1
104173,of,0,0
104174,future,0,0
104175,trials,0,1
104176,with,0,1
104177,chemotherapy,0,1
104178,plus,0,0
104179,biologics,0,1
104180,.,0,1
104181,Bipolar,0,1
104182,transurethral,0,1
104183,resection,0,1
104184,of,0,0
104185,the,0,0
104186,prostate,0,0
104187,causes,0,0
104188,less,0,0
104189,bleeding,0,0
104190,than,0,0
104191,the,0,0
104192,monopolar,0,0
104193,technique,0,0
104194,:,0,1
104195,a,1,1
104196,single-centre,1,1
104197,randomized,1,1
104198,trial,1,1
104199,of,1,1
104200,202,1,1
104201,patients,1,1
104202,.,1,1
104203,OBJECTIVE,0,0
104204,To,0,0
104205,compare,0,0
104206,bipolar,0,1
104207,with,0,1
104208,the,0,0
104209,conventional,0,1
104210,monopolar,0,0
104211,transurethral,1,1
104212,resection,1,1
104213,of,1,0
104214,the,1,0
104215,prostate,1,1
104216,(,1,0
104217,TURP,1,1
104218,),1,1
104219,for,0,0
104220,blood,0,0
104221,loss,0,0
104222,and,0,0
104223,speed,0,0
104224,of,0,0
104225,resection,0,1
104226,.,0,1
104227,PATIENTS,0,0
104228,AND,0,0
104229,METHODS,0,0
104230,In,0,0
104231,all,0,0
104232,",",0,0
104233,202,1,1
104234,consecutive,1,1
104235,patients,1,1
104236,from,1,1
104237,the,1,0
104238,hospital,1,1
104239,waiting,1,1
104240,list,1,1
104241,were,0,1
104242,randomized,0,1
104243,to,0,0
104244,undergo,0,1
104245,TURP,0,1
104246,using,0,0
104247,either,0,0
104248,a,0,1
104249,bipolar,0,1
104250,system,0,0
104251,(,0,1
104252,Surgmaster,0,0
104253,TURis,0,1
104254,",",0,0
104255,Olympus,0,0
104256,",",0,0
104257,Tokyo,0,1
104258,",",0,0
104259,Japan,0,1
104260,),0,0
104261,or,0,1
104262,a,0,1
104263,monopolar,0,0
104264,system,0,1
104265,(,0,1
104266,24,0,1
104267,F,0,1
104268,",",0,1
104269,Storz,0,0
104270,",",0,0
104271,T?bingen,0,1
104272,",",0,0
104273,Germany,0,1
104274,),0,1
104275,.,0,1
104276,The,0,0
104277,blood,0,0
104278,loss,0,0
104279,during,0,0
104280,and,0,0
104281,after,0,1
104282,surgery,0,1
104283,was,0,0
104284,measured,0,0
104285,using,0,0
104286,a,0,1
104287,photometer,0,0
104288,.,0,1
104289,Other,0,0
104290,variables,0,0
104291,compared,0,0
104292,included,0,1
104293,indices,0,0
104294,of,0,1
104295,resection,0,1
104296,speed,0,0
104297,and,0,0
104298,transfusion,0,0
104299,rate,0,0
104300,.,0,0
104301,RESULTS,0,0
104302,There,0,0
104303,were,0,0
104304,no,0,0
104305,statistically,0,0
104306,significant,0,0
104307,differences,0,0
104308,in,0,1
104309,operative,0,1
104310,duration,0,0
104311,",",0,0
104312,resection,0,1
104313,weight,0,0
104314,",",0,0
104315,resection,0,1
104316,speed,0,0
104317,or,0,1
104318,radicality,0,0
104319,of,0,0
104320,resection,0,1
104321,.,0,1
104322,However,0,0
104323,",",0,0
104324,the,0,0
104325,median,0,0
104326,blood,0,0
104327,loss,0,0
104328,was,0,0
104329,235,0,1
104330,mL,0,0
104331,for,0,0
104332,the,0,0
104333,bipolar,0,1
104334,and,0,0
104335,350,0,1
104336,mL,0,0
104337,for,0,1
104338,monopolar,0,0
104339,TURP,0,1
104340,(,0,1
104341,P,0,0
104342,<,0,0
104343,0.001,0,0
104344,),0,1
104345,.,0,1
104346,The,0,0
104347,decrease,0,0
104348,in,0,0
104349,blood,0,0
104350,haemoglobin,0,0
104351,concentration,0,0
104352,during,0,0
104353,the,0,0
104354,day,0,0
104355,of,0,0
104356,surgery,0,1
104357,was,0,0
104358,smaller,0,0
104359,in,0,0
104360,the,0,0
104361,bipolar,0,1
104362,group,0,1
104363,(,0,1
104364,5.5,0,1
104365,%,0,0
104366,vs,0,0
104367,9.6,0,0
104368,%,0,0
104369,P,0,0
104370,<,0,0
104371,0.001,0,0
104372,),0,1
104373,.,0,1
104374,Fewer,0,0
104375,patients,0,1
104376,were,0,1
104377,transfused,0,1
104378,with,0,1
104379,erythrocytes,0,0
104380,(,0,1
104381,4,0,1
104382,%,0,0
104383,vs,0,0
104384,11,0,1
104385,%,0,0
104386,",",0,1
104387,P,0,0
104388,<,0,0
104389,0.01,0,0
104390,),0,1
104391,",",0,0
104392,which,0,0
104393,can,0,0
104394,be,0,0
104395,explained,0,0
104396,by,0,0
104397,the,0,0
104398,much,0,0
104399,lower,0,0
104400,75th,0,0
104401,percentile,0,0
104402,for,0,0
104403,blood,0,0
104404,loss,0,0
104405,in,0,0
104406,the,0,0
104407,bipolar,0,1
104408,group,0,0
104409,(,0,1
104410,at,0,1
104411,472,0,1
104412,vs,0,0
104413,855,0,1
104414,mL,0,0
104415,",",0,0
104416,respectively,0,0
104417,),0,1
104418,.,0,1
104419,CONCLUSIONS,0,0
104420,Bipolar,0,1
104421,TURP,0,1
104422,using,0,0
104423,the,0,0
104424,TURis,0,1
104425,system,0,0
104426,was,0,0
104427,performed,0,0
104428,with,0,1
104429,the,0,0
104430,same,0,0
104431,speed,0,0
104432,as,0,0
104433,monopolar,0,0
104434,TURP,0,1
104435,but,0,0
104436,caused,0,0
104437,34,0,1
104438,%,0,0
104439,less,0,0
104440,bleeding,0,0
104441,",",0,0
104442,the,0,0
104443,difference,0,0
104444,being,0,1
104445,greatest,0,0
104446,(,0,1
104447,81,0,1
104448,%,0,0
104449,),0,1
104450,for,0,0
104451,the,0,0
104452,largest,0,1
104453,blood,0,0
104454,losses,0,0
104455,.,0,1
104456,Bipolar,0,0
104457,TURP,0,1
104458,also,0,0
104459,required,0,0
104460,fewer,0,0
104461,erythrocyte,0,0
104462,transfusions,0,0
104463,than,0,0
104464,the,0,1
104465,conventional,0,1
104466,monopolar,0,0
104467,technique,0,0
104468,.,0,1
104469,Different,0,1
104470,therapeutic,0,0
104471,modalities,0,0
104472,for,0,1
104473,treatment,0,1
104474,of,0,0
104475,melasma,0,1
104476,.,0,1
104477,BACKGROUND,0,0
104478,Chemical,0,1
104479,peels,0,1
104480,and,0,1
104481,topical,0,0
104482,depigmenting,0,1
104483,agents,0,1
104484,have,0,0
104485,become,0,0
104486,a,0,0
104487,popular,0,0
104488,modality,0,0
104489,in,0,0
104490,the,0,0
104491,treatment,0,0
104492,of,0,0
104493,melasma,0,1
104494,.,0,1
104495,AIMS,0,0
104496,To,0,0
104497,compare,0,0
104498,the,0,0
104499,clinical,0,0
104500,efficacy,0,0
104501,of,0,0
104502,trichloroacetic,0,1
104503,acid,0,0
104504,peel,0,1
104505,20,0,1
104506,%,0,0
104507,vs,0,0
104508,.,0,1
104509,Jessner,0,0
104510,'s,0,1
104511,solution,0,0
104512,peel,0,1
104513,vs.,0,0
104514,the,0,0
104515,topical,0,0
104516,mixture,0,0
104517,of,0,0
104518,hydroquinone,0,0
104519,2,0,1
104520,%,0,0
104521,and,0,0
104522,kojic,0,1
104523,acid,0,0
104524,.,0,1
104525,PATIENTS,0,0
104526,AND,0,0
104527,METHODS,0,0
104528,Forty,1,1
104529,five,1,1
104530,patients,1,1
104531,with,1,1
104532,melasma,1,1
104533,were,1,1
104534,randomly,1,1
104535,assigned,1,1
104536,into,1,1
104537,three,1,1
104538,groups,1,1
104539,of,1,1
104540,fifteen,1,1
104541,patients,1,1
104542,each,1,1
104543,.,1,1
104544,Group,0,0
104545,A,0,1
104546,received,0,1
104547,Jessner,0,1
104548,'s,0,1
104549,solution,0,0
104550,peel,0,1
104551,",",0,0
104552,group,0,1
104553,B,0,1
104554,received,0,1
104555,trichloroacetic,0,1
104556,acid,0,0
104557,peel,0,1
104558,20,0,1
104559,%,0,0
104560,",",0,0
104561,and,0,0
104562,group,0,1
104563,C,0,1
104564,received,0,1
104565,topical,0,0
104566,hydroquinone,0,0
104567,2,0,1
104568,%,0,0
104569,and,0,0
104570,kojic,0,1
104571,acid,0,0
104572,.,0,1
104573,All,0,1
104574,patients,0,1
104575,were,0,1
104576,seen,0,1
104577,in,0,0
104578,follow-up,0,0
104579,period,0,1
104580,after,0,1
104581,16,0,1
104582,weeks,0,1
104583,;,0,1
104584,clinical,0,0
104585,evaluation,0,0
104586,using,0,0
104587,Melasma,0,1
104588,Area,0,0
104589,and,0,1
104590,Severity,0,0
104591,Index,0,0
104592,(,0,1
104593,MASI,0,0
104594,),0,1
104595,score,0,0
104596,and,0,1
104597,photography,0,0
104598,were,0,0
104599,recorded,0,0
104600,before,0,0
104601,and,0,0
104602,after,0,1
104603,treatment,0,0
104604,and,0,1
104605,after,0,1
104606,16,0,1
104607,weeks,0,1
104608,.,0,1
104609,RESULTS,0,0
104610,There,0,0
104611,was,0,0
104612,a,0,0
104613,decrease,0,0
104614,in,0,0
104615,MASI,0,0
104616,score,0,0
104617,in,0,0
104618,all,0,1
104619,three,0,0
104620,groups,0,0
104621,after,0,1
104622,treatment,0,1
104623,and,0,1
104624,after,0,0
104625,follow-up,0,0
104626,period,0,1
104627,but,0,0
104628,after,0,0
104629,treatment,0,0
104630,MASI,0,0
104631,score,0,0
104632,was,0,0
104633,statistically,0,0
104634,significantly,0,0
104635,lower,0,0
104636,in,0,0
104637,group,0,0
104638,A,0,1
104639,than,0,0
104640,group,0,1
104641,C,0,1
104642,(,0,1
104643,P,0,0
104644,=,0,1
104645,0.01,0,0
104646,),0,1
104647,",",0,0
104648,and,0,0
104649,it,0,0
104650,was,0,0
104651,also,0,0
104652,statistically,0,0
104653,significantly,0,0
104654,lower,0,0
104655,in,0,0
104656,group,0,0
104657,B,0,1
104658,than,0,0
104659,group,0,1
104660,C,0,1
104661,(,0,1
104662,P,0,0
104663,<,0,0
104664,0.001,0,0
104665,),0,0
104666,but,0,0
104667,there,0,0
104668,was,0,0
104669,no,0,0
104670,statistically,0,0
104671,significant,0,0
104672,difference,0,0
104673,between,0,0
104674,groups,0,1
104675,A,0,1
104676,and,0,1
104677,B,0,1
104678,.,0,1
104679,After,0,0
104680,the,0,0
104681,follow-up,0,0
104682,period,0,0
104683,",",0,0
104684,MASI,0,0
104685,score,0,0
104686,was,0,0
104687,statistically,0,0
104688,significantly,0,0
104689,lower,0,0
104690,in,0,0
104691,group,0,0
104692,A,0,1
104693,than,0,0
104694,group,0,1
104695,C,0,1
104696,(,0,1
104697,P,0,0
104698,<,0,0
104699,0.001,0,0
104700,),0,0
104701,",",0,0
104702,statistically,0,0
104703,significantly,0,0
104704,lower,0,0
104705,in,0,0
104706,group,0,0
104707,B,0,1
104708,than,0,0
104709,group,0,1
104710,C,0,1
104711,(,0,1
104712,P,0,0
104713,<,0,0
104714,0.001,0,0
104715,),0,1
104716,",",0,0
104717,and,0,0
104718,statistically,0,0
104719,significantly,0,0
104720,lower,0,0
104721,in,0,0
104722,group,0,0
104723,B,0,1
104724,than,0,0
104725,group,0,1
104726,A,0,1
104727,(,0,1
104728,P,0,0
104729,=,0,1
104730,0.035,0,0
104731,),0,1
104732,.,0,1
104733,The,0,0
104734,statistical,0,0
104735,analysis,0,0
104736,was,0,0
104737,done,0,0
104738,through,0,1
104739,one-way,0,1
104740,anova,0,0
104741,followed,0,1
104742,by,0,0
104743,least,0,1
104744,significant,0,0
104745,difference,0,0
104746,(,0,1
104747,LSD,0,1
104748,),0,1
104749,.,0,1
104750,CONCLUSION,0,0
104751,Trichloroacetic,0,0
104752,acid,0,0
104753,20,0,1
104754,%,0,0
104755,showed,0,0
104756,better,0,0
104757,results,0,0
104758,than,0,0
104759,Jessner,0,1
104760,'s,0,1
104761,solution,0,0
104762,as,0,0
104763,peeling,0,0
104764,agent,0,0
104765,and,0,0
104766,hydroquinone,0,0
104767,2,0,0
104768,%,0,0
104769,with,0,1
104770,kojic,0,1
104771,acid,0,0
104772,as,0,0
104773,a,0,1
104774,topical,0,0
104775,agent,0,0
104776,in,0,0
104777,the,0,0
104778,treatment,0,0
104779,of,0,0
104780,melasma,1,1
104781,.,1,1
104782,Sinemet,1,1
104783,CR,1,1
104784,in,1,1
104785,Parkinson,1,1
104786,'s,1,1
104787,disease,1,1
104788,.,1,1
104789,Sinemet,0,0
104790,CR,0,0
104791,",",0,0
104792,a,0,0
104793,controlled,0,0
104794,release,0,0
104795,carbidopa/levodopa,0,1
104796,preparation,0,0
104797,",",0,0
104798,was,0,0
104799,compared,0,0
104800,to,0,1
104801,conventional,0,1
104802,carbidopa/levodopa,0,1
104803,in,0,0
104804,a,0,1
104805,double,0,0
104806,blind,0,1
104807,",",0,0
104808,placebo-controlled,0,0
104809,trial,0,1
104810,.,0,1
104811,Comparable,0,0
104812,clinical,0,0
104813,benefits,0,0
104814,and,0,1
104815,adverse,0,0
104816,effects,0,0
104817,were,0,1
104818,noted,0,0
104819,with,0,1
104820,the,0,1
104821,two,0,1
104822,medications,0,0
104823,.,0,1
104824,However,0,0
104825,significantly,0,0
104826,less,0,0
104827,frequent,0,0
104828,dosing,0,0
104829,was,0,0
104830,necessary,0,0
104831,with,0,1
104832,Sinemet,0,1
104833,CR,0,1
104834,.,0,1
104835,The,0,0
104836,6,0,0
104837,minute,0,0
104838,walk,0,1
104839,in,0,0
104840,idiopathic,0,1
104841,pulmonary,0,1
104842,fibrosis,0,1
104843,:,0,1
104844,longitudinal,0,1
104845,changes,0,0
104846,and,0,1
104847,minimum,0,1
104848,important,0,0
104849,difference,0,0
104850,.,0,1
104851,RATIONALE,0,0
104852,The,0,0
104853,response,0,0
104854,characteristics,0,0
104855,of,0,1
104856,the,0,1
104857,6,0,0
104858,minute,0,0
104859,walk,0,1
104860,test,0,0
104861,(,0,1
104862,6MWT,0,0
104863,),0,1
104864,in,0,1
104865,studies,0,0
104866,of,0,1
104867,idiopathic,1,1
104868,pulmonary,1,1
104869,fibrosis,1,1
104870,(,1,1
104871,IPF,1,0
104872,),1,1
104873,are,0,0
104874,only,0,0
104875,poorly,0,0
104876,understood,0,0
104877,",",0,0
104878,and,0,0
104879,the,0,0
104880,change,0,0
104881,in,0,0
104882,walk,0,1
104883,distance,0,0
104884,that,0,0
104885,constitutes,0,0
104886,the,0,0
104887,minimum,0,0
104888,important,0,0
104889,difference,0,0
104890,(,0,1
104891,MID,0,1
104892,),0,1
104893,over,0,0
104894,time,0,0
104895,is,0,0
104896,unknown,0,0
104897,.,0,1
104898,OBJECTIVES,0,0
104899,To,0,0
104900,examine,0,0
104901,changes,0,0
104902,over,0,0
104903,time,0,0
104904,in,0,0
104905,distance,0,0
104906,walked,0,1
104907,(,0,0
104908,ie,0,1
104909,",",0,1
104910,6MWD,0,0
104911,),0,1
104912,during,0,0
104913,the,0,0
104914,6MWT,0,0
104915,and,0,0
104916,to,0,0
104917,estimate,0,0
104918,the,0,0
104919,change,0,0
104920,in,0,0
104921,distance,0,0
104922,that,0,0
104923,constitutes,0,0
104924,the,0,0
104925,MID,0,0
104926,in,0,0
104927,patients,1,1
104928,with,1,1
104929,IPF,1,1
104930,.,1,1
104931,METHODS,0,0
104932,Data,0,1
104933,from,0,1
104934,a,0,0
104935,recently,0,1
104936,completed,0,1
104937,trial,0,0
104938,that,0,0
104939,included,0,1
104940,subjects,1,1
104941,with,1,1
104942,IPF,1,1
104943,who,1,1
104944,completed,1,1
104945,the,1,1
104946,6MWT,1,0
104947,",",1,0
104948,Saint,1,1
104949,George,1,1
104950,'s,1,1
104951,Respiratory,1,1
104952,Questionnaire,1,1
104953,(,1,1
104954,SGRQ,1,1
104955,),1,1
104956,and,1,0
104957,forced,1,0
104958,vital,1,0
104959,capacity,1,0
104960,(,1,1
104961,FVC,1,0
104962,),1,1
104963,at,0,1
104964,6,0,1
104965,and,0,1
104966,12,0,1
104967,months,0,0
104968,were,0,1
104969,used,0,0
104970,to,0,0
104971,examine,0,0
104972,longitudinal,0,1
104973,changes,0,0
104974,in,0,1
104975,6MWD,0,0
104976,.,0,1
104977,Both,0,0
104978,anchor-,0,0
104979,and,0,1
104980,distribution-based,0,0
104981,approaches,0,0
104982,as,0,0
104983,well,0,0
104984,as,0,0
104985,linear,0,0
104986,regression,0,0
104987,analyses,0,0
104988,were,0,1
104989,used,0,0
104990,to,0,0
104991,determine,0,0
104992,the,0,0
104993,MID,0,1
104994,for,0,1
104995,6MWD,0,0
104996,.,0,1
104997,The,0,0
104998,SGRQ,0,0
104999,Total,0,1
105000,score,0,0
105001,and,0,1
105002,FVC,0,0
105003,were,0,1
105004,used,0,0
105005,as,0,0
105006,clinical,0,1
105007,anchors,0,1
105008,.,0,1
105009,MAIN,0,0
105010,RESULTS,0,0
105011,Among,0,1
105012,123,1,1
105013,subjects,1,1
105014,alive,1,1
105015,and,1,1
105016,able,1,0
105017,to,1,0
105018,complete,1,1
105019,the,1,0
105020,6MWT,1,0
105021,at,1,0
105022,both,1,0
105023,follow-up,1,0
105024,time,1,0
105025,points,1,0
105026,",",0,1
105027,6MWD,0,0
105028,did,0,0
105029,not,0,0
105030,change,0,0
105031,significantly,0,0
105032,over,0,0
105033,time,0,0
105034,(,0,1
105035,378.1,0,0
105036,m,0,1
105037,at,0,0
105038,baseline,0,0
105039,vs,0,0
105040,376.8,0,0
105041,m,0,1
105042,at,0,1
105043,6,0,1
105044,months,0,1
105045,vs,0,0
105046,361.3,0,0
105047,m,0,1
105048,at,0,1
105049,12,0,1
105050,months,0,0
105051,",",0,1
105052,p=0.5,0,0
105053,),0,1
105054,.,0,1
105055,The,0,0
105056,point,0,0
105057,estimate,0,0
105058,for,0,0
105059,the,0,0
105060,6MWD,0,0
105061,MID,0,1
105062,was,0,0
105063,28,0,1
105064,m,0,1
105065,with,0,1
105066,a,0,0
105067,range,0,1
105068,of,0,0
105069,10.8-58.5,0,0
105070,m.,0,1
105071,CONCLUSION,0,0
105072,In,0,1
105073,a,0,0
105074,group,0,1
105075,of,0,0
105076,patients,1,1
105077,with,1,1
105078,IPF,1,1
105079,with,1,1
105080,moderate,1,1
105081,physiological,1,0
105082,impairment,1,1
105083,",",0,0
105084,for,0,0
105085,those,0,1
105086,alive,0,1
105087,and,0,0
105088,able,0,0
105089,to,0,0
105090,complete,0,1
105091,a,0,0
105092,6MWT,0,0
105093,",",0,0
105094,6MWD,0,0
105095,does,0,0
105096,not,0,0
105097,change,0,0
105098,over,0,0
105099,12,0,1
105100,months,0,1
105101,.,0,1
105102,At,0,0
105103,the,0,0
105104,population,0,1
105105,level,0,0
105106,",",0,0
105107,the,0,0
105108,MID,0,1
105109,for,0,0
105110,6MWD,0,0
105111,appears,0,0
105112,to,0,0
105113,be,0,0
105114,approximately,0,1
105115,28,0,1
105116,m.,0,1
105117,Further,0,1
105118,investigation,0,1
105119,using,0,0
105120,other,0,1
105121,anchors,0,1
105122,and,0,1
105123,derivation,0,1
105124,methods,0,1
105125,is,0,0
105126,required,0,0
105127,to,0,0
105128,refine,0,0
105129,estimates,0,0
105130,of,0,0
105131,the,0,0
105132,MID,0,1
105133,for,0,0
105134,6MWD,0,0
105135,in,0,1
105136,this,0,0
105137,patient,1,1
105138,population,1,1
105139,.,1,1
105140,Divalproex,0,0
105141,sodium,0,0
105142,vs,0,0
105143,placebo,0,0
105144,for,0,0
105145,the,0,0
105146,treatment,0,0
105147,of,0,0
105148,irritability,0,0
105149,in,0,1
105150,children,1,1
105151,and,1,1
105152,adolescents,1,1
105153,with,1,1
105154,autism,1,1
105155,spectrum,1,1
105156,disorders,1,1
105157,.,1,1
105158,Autism,0,1
105159,spectrum,0,1
105160,disorders,0,1
105161,(,0,1
105162,ASDs,0,1
105163,),0,1
105164,are,0,0
105165,neurodevelopmental,0,1
105166,disorders,0,1
105167,characterized,0,1
105168,by,0,1
105169,social,0,0
105170,and,0,1
105171,language,0,1
105172,deficits,0,0
105173,and,0,1
105174,by,0,1
105175,repetitive,0,0
105176,behaviors,0,1
105177,and,0,1
105178,interests,0,0
105179,.,0,1
105180,Irritability/aggression,0,0
105181,is,0,0
105182,a,0,0
105183,significant,0,0
105184,comorbid,0,1
105185,symptom,0,0
105186,in,0,0
105187,this,0,0
105188,population,0,1
105189,",",0,0
105190,which,0,0
105191,greatly,0,0
105192,impacts,0,0
105193,burden,0,0
105194,of,0,0
105195,care,0,1
105196,.,0,1
105197,This,0,0
105198,study,0,0
105199,examined,0,0
105200,the,0,0
105201,effect,0,0
105202,of,0,0
105203,divalproex,0,0
105204,sodium,0,0
105205,for,0,0
105206,irritability/aggression,0,1
105207,in,0,1
105208,children,1,1
105209,and,1,1
105210,adolescents,1,1
105211,with,1,1
105212,ASD,1,1
105213,.,1,1
105214,This,0,0
105215,was,0,0
105216,a,0,0
105217,12-week,0,0
105218,randomized,0,1
105219,",",0,0
105220,double-blind,0,0
105221,",",0,0
105222,placebo-controlled,0,0
105223,trial,0,0
105224,.,0,1
105225,All,0,1
105226,efficacy,0,0
105227,measures,0,0
105228,were,0,1
105229,obtained,0,0
105230,by,0,0
105231,an,0,0
105232,independent,0,0
105233,evaluator,0,0
105234,blinded,0,0
105235,to,0,0
105236,randomization,0,0
105237,condition,0,0
105238,and,0,0
105239,side,0,0
105240,effects,0,0
105241,.,0,1
105242,A,0,0
105243,total,1,1
105244,of,1,0
105245,55,1,1
105246,subjects,1,1
105247,gavetheir,1,1
105248,consent,1,1
105249,and,1,1
105250,27,1,1
105251,were,1,1
105252,randomized,1,1
105253,in,1,0
105254,a,1,1
105255,1,1,1
105256,:,1,1
105257,1,1,1
105258,manner,1,0
105259,(,1,1
105260,mean,1,1
105261,age,1,1
105262,9.46+/-2.46,1,0
105263,",",1,0
105264,mean,1,1
105265,nonverbal,1,1
105266,IQ,1,1
105267,63.3+/-23.9,1,1
105268,),1,1
105269,.,1,1
105270,Two,0,1
105271,subjects,0,1
105272,from,0,1
105273,the,0,1
105274,active,0,1
105275,group,0,1
105276,and,0,1
105277,one,0,1
105278,subject,0,1
105279,from,0,1
105280,the,0,0
105281,placebo,0,0
105282,group,0,0
105283,discontinued,0,0
105284,the,0,0
105285,study,0,0
105286,because,0,0
105287,of,0,0
105288,either,0,1
105289,a,0,0
105290,lack,0,0
105291,of,0,0
105292,efficacy,0,0
105293,or,0,1
105294,side,0,0
105295,effects,0,0
105296,(,0,1
105297,increased,0,0
105298,irritability,0,0
105299,),0,1
105300,.,0,1
105301,Primary,0,1
105302,outcome,0,0
105303,measures,0,0
105304,were,0,1
105305,Aberrant,0,1
105306,Behavior,0,1
105307,Checklist-Irritability,0,0
105308,subscale,0,0
105309,and,0,1
105310,Clinical,0,0
105311,Global,0,1
105312,Impression-Improvement,0,0
105313,",",0,0
105314,which,0,0
105315,focused,0,0
105316,on,0,0
105317,irritability,0,0
105318,.,0,1
105319,Overall,0,0
105320,",",0,0
105321,62.5,0,0
105322,%,0,0
105323,of,0,1
105324,divalproex,0,0
105325,subjects,0,1
105326,vs,0,0
105327,9,0,0
105328,%,0,0
105329,of,0,1
105330,placebo,0,1
105331,subjects,0,1
105332,were,0,1
105333,responders,0,0
105334,(,0,1
105335,CGI-irritability,0,0
105336,OR,0,0
105337,:,0,1
105338,16.7,0,1
105339,",",0,1
105340,Fisher,0,0
105341,'s,0,1
105342,exact,0,0
105343,p=0.008,0,0
105344,),0,1
105345,.,0,0
105346,A,0,0
105347,statistically,0,0
105348,significant,0,0
105349,improvement,0,0
105350,was,0,0
105351,also,0,0
105352,noted,0,0
105353,on,0,0
105354,the,0,0
105355,ABC-Irritability,0,1
105356,subscale,0,0
105357,(,0,1
105358,p=0.048,0,0
105359,),0,0
105360,.,0,0
105361,There,0,0
105362,was,0,0
105363,a,0,0
105364,trend,0,0
105365,for,0,0
105366,responders,0,0
105367,to,0,1
105368,have,0,0
105369,higher,0,0
105370,valproate,0,1
105371,blood,0,0
105372,levels,0,0
105373,compared,0,0
105374,with,0,1
105375,nonresponders,0,0
105376,.,0,1
105377,This,0,0
105378,study,0,0
105379,suggests,0,0
105380,the,0,0
105381,efficacy,0,0
105382,of,0,0
105383,divalproex,0,0
105384,for,0,0
105385,the,0,0
105386,treatment,0,0
105387,of,0,0
105388,irritability,0,0
105389,in,0,1
105390,children,0,1
105391,and,0,1
105392,adolescents,0,1
105393,with,0,1
105394,ASD,0,1
105395,.,0,1
105396,Larger,0,0
105397,sample,0,1
105398,follow-up,0,0
105399,studies,0,0
105400,are,0,0
105401,warranted,0,0
105402,.,0,1
105403,Effect,0,0
105404,of,0,0
105405,pravastatin,0,0
105406,on,0,0
105407,kidney,0,1
105408,function,0,0
105409,and,0,0
105410,urinary,0,0
105411,protein,0,0
105412,excretion,0,0
105413,in,0,0
105414,autosomal,1,1
105415,dominant,1,1
105416,polycystic,1,1
105417,kidney,1,1
105418,disease,1,1
105419,.,1,1
105420,OBJECTIVE,0,0
105421,Autosomal,1,1
105422,dominant,1,1
105423,polycystic,1,1
105424,kidney,1,1
105425,disease,1,1
105426,(,1,1
105427,ADPKD,1,1
105428,),1,1
105429,is,0,0
105430,progressive,0,0
105431,",",0,0
105432,resulting,0,0
105433,in,0,0
105434,end-stage,1,1
105435,kidney,1,1
105436,failure,1,1
105437,in,1,0
105438,most,1,1
105439,patients,1,1
105440,.,1,1
105441,Experimental,0,0
105442,and,0,0
105443,clinical,0,0
105444,studies,0,0
105445,have,0,0
105446,suggested,0,0
105447,that,0,0
105448,statins,0,0
105449,may,0,0
105450,slow,0,0
105451,the,0,0
105452,progression,0,0
105453,of,0,0
105454,chronic,0,1
105455,kidney,0,1
105456,disease,0,1
105457,in,0,0
105458,general,0,1
105459,and,0,1
105460,ADPKD,0,1
105461,specifically,0,0
105462,.,0,1
105463,MATERIAL,0,0
105464,AND,0,0
105465,METHODS,0,0
105466,This,0,0
105467,randomized,0,1
105468,open-label,0,1
105469,clinical,0,0
105470,trial,0,1
105471,was,0,0
105472,conducted,0,0
105473,to,0,0
105474,assess,0,0
105475,the,0,0
105476,effect,0,0
105477,of,0,0
105478,pravastatin,0,0
105479,20,0,1
105480,mg,0,0
105481,on,0,0
105482,kidney,0,1
105483,function,0,0
105484,and,0,0
105485,urinary,0,0
105486,protein,0,0
105487,excretion,0,0
105488,in,0,0
105489,patients,1,1
105490,with,1,1
105491,ADPKD,1,1
105492,.,1,1
105493,Sixty,1,1
105494,patients,1,1
105495,were,1,1
105496,initially,1,1
105497,recruited,1,1
105498,but,1,0
105499,49,1,1
105500,of,1,0
105501,these,1,0
105502,received,1,0
105503,either,1,0
105504,pravastatin,1,0
105505,20,1,1
105506,mg,1,0
105507,or,1,1
105508,no,1,0
105509,treatment,1,0
105510,for,1,0
105511,2,1,1
105512,years,1,1
105513,.,1,1
105514,Trial,0,1
105515,visits,0,0
105516,were,0,1
105517,conducted,0,1
105518,every,0,0
105519,3,0,0
105520,months,0,0
105521,",",0,1
105522,assessing,0,0
105523,kidney,0,1
105524,function,0,0
105525,by,0,0
105526,estimated,0,0
105527,glomerular,0,1
105528,filtration,0,0
105529,rate,0,0
105530,and,0,1
105531,24,0,1
105532,h,0,0
105533,urine,0,1
105534,creatinine,0,0
105535,clearance,0,0
105536,and,0,0
105537,urinary,0,0
105538,protein,0,0
105539,excretion,0,0
105540,.,0,0
105541,RESULTS,0,0
105542,There,0,0
105543,were,0,0
105544,no,0,0
105545,significant,0,0
105546,(,0,1
105547,p,0,0
105548,>,0,1
105549,0.05,0,0
105550,),0,1
105551,changes,0,0
105552,in,0,1
105553,markers,0,0
105554,of,0,1
105555,kidney,0,1
105556,function,0,0
105557,or,0,1
105558,urinary,0,0
105559,protein,0,0
105560,excretion,0,0
105561,between,0,0
105562,groups,0,0
105563,over,0,0
105564,the,0,1
105565,2,0,1
105566,years,0,1
105567,despite,0,1
105568,a,0,1
105569,significant,0,0
105570,fall,0,0
105571,in,0,1
105572,total,0,1
105573,serum,0,0
105574,cholesterol,0,0
105575,in,0,1
105576,pravastatin-treated,0,1
105577,patients,0,1
105578,(,0,1
105579,p,0,0
105580,=,0,1
105581,0.029,0,0
105582,),0,1
105583,.,0,1
105584,CONCLUSION,0,0
105585,This,0,0
105586,trial,0,0
105587,found,0,0
105588,that,0,0
105589,taking,0,1
105590,20,0,1
105591,mg,0,0
105592,pravastatin,0,0
105593,for,0,1
105594,2,0,1
105595,years,0,1
105596,had,0,1
105597,no,0,0
105598,significant,0,0
105599,effect,0,0
105600,on,0,0
105601,kidney,0,1
105602,function,0,0
105603,or,0,1
105604,urinary,0,0
105605,protein,0,0
105606,excretion,0,0
105607,in,0,0
105608,patients,0,1
105609,with,0,1
105610,ADPKD,0,1
105611,.,0,1
105612,The,0,0
105613,lack,0,0
105614,of,0,0
105615,statistical,0,0
105616,power,0,0
105617,limits,0,0
105618,the,0,0
105619,external,0,0
105620,validity,0,0
105621,of,0,0
105622,these,0,0
105623,findings,0,0
105624,.,0,1
105625,A,0,0
105626,larger,0,0
105627,",",0,0
105628,longer,0,0
105629,duration,0,0
105630,study,0,0
105631,using,0,0
105632,a,0,0
105633,higher,0,0
105634,dose,0,0
105635,of,0,0
105636,a,0,0
105637,more,0,0
105638,potent,0,0
105639,statin,0,0
105640,is,0,0
105641,required,0,0
105642,.,0,0
105643,Evaluation,0,0
105644,of,0,0
105645,a,0,1
105646,new,0,1
105647,wound,0,0
105648,closure,0,1
105649,device,0,0
105650,for,0,0
105651,linear,1,0
105652,surgical,1,1
105653,incisions,1,1
105654,:,1,1
105655,3M,0,0
105656,Steri-Strip,0,1
105657,S,0,1
105658,Surgical,0,1
105659,Skin,0,1
105660,Closure,0,1
105661,versus,0,0
105662,subcuticular,0,0
105663,closure,0,1
105664,.,0,1
105665,BACKGROUND,0,0
105666,Technological,0,0
105667,innovations,0,0
105668,are,0,0
105669,often,0,0
105670,adopted,0,0
105671,before,0,0
105672,scientific,0,0
105673,comparison,0,0
105674,to,0,1
105675,an,0,0
105676,accepted,0,1
105677,standard,0,1
105678,.,0,1
105679,The,0,0
105680,authors,0,0
105681,',0,1
105682,study,0,1
105683,compared,0,0
105684,suture,0,0
105685,with,0,1
105686,a,0,1
105687,new,0,1
105688,coaptive,0,0
105689,film,0,0
105690,device,0,0
105691,",",0,1
105692,3M,0,0
105693,Steri-Strip,0,1
105694,S,0,1
105695,Surgical,0,1
105696,Skin,0,1
105697,Closure,0,1
105698,",",0,0
105699,on,0,0
105700,linear,0,0
105701,incisions,0,1
105702,.,0,1
105703,METHODS,0,0
105704,Patients,1,1
105705,undergoing,1,1
105706,Wise-pattern,1,1
105707,breast,1,1
105708,reduction,1,0
105709,or,1,1
105710,abdominal,1,1
105711,procedures,1,1
105712,had,0,1
105713,paired,0,1
105714,incisions,0,1
105715,randomly,0,1
105716,assigned,0,1
105717,to,0,0
105718,Steri-Strip,0,1
105719,S,0,1
105720,or,0,1
105721,suture,0,0
105722,closure,0,1
105723,.,0,1
105724,Key,0,1
105725,outcome,0,0
105726,measures,0,0
105727,were,0,1
105728,closure,0,1
105729,time,0,0
105730,",",0,0
105731,patient,0,0
105732,comfort,0,0
105733,",",0,0
105734,and,0,0
105735,scar,0,0
105736,quality,0,0
105737,at,0,1
105738,6,0,1
105739,months,0,1
105740,by,0,1
105741,patients,0,1
105742,and,0,1
105743,surgeons,0,1
105744,using,0,0
105745,a,0,1
105746,new,0,1
105747,scar,0,0
105748,evaluation,0,0
105749,tool,0,0
105750,",",0,0
105751,visual,0,0
105752,assessment,0,0
105753,of,0,1
105754,linear,0,0
105755,scars,0,1
105756,.,0,1
105757,Statistical,0,0
105758,differences,0,0
105759,between,0,0
105760,the,0,1
105761,two,0,0
105762,closure,0,1
105763,techniques,0,0
105764,were,0,1
105765,assessed,0,0
105766,by,0,0
105767,Wilcoxon,0,0
105768,signed,0,1
105769,rank,0,0
105770,test,0,0
105771,.,0,1
105772,RESULTS,0,0
105773,Of,1,1
105774,59,1,1
105775,patients,1,1
105776,",",1,1
105777,eight,1,1
105778,were,1,0
105779,excluded,1,1
105780,from,1,1
105781,randomization,1,0
105782,(,0,1
105783,a,0,0
105784,surgeon,0,1
105785,judged,0,0
105786,Steri-Strip,0,1
105787,S,0,0
105788,to,0,0
105789,be,0,0
105790,a,0,0
105791,nonviable,0,0
105792,closure,0,0
105793,technique,0,0
105794,for,0,0
105795,mismatched,0,1
105796,wound,0,1
105797,edges,0,0
105798,),0,1
105799,.,0,1
105800,Fifty-one,1,1
105801,patients,1,1
105802,(,1,1
105803,breast,1,1
105804,",",1,0
105805,n,1,1
105806,=,1,1
105807,24,1,1
105808,;,1,1
105809,abdomen,1,0
105810,",",1,1
105811,n,1,1
105812,=,1,1
105813,27,1,1
105814,),1,1
105815,were,0,1
105816,randomized,0,1
105817,.,0,1
105818,Operative,0,0
105819,time,0,0
105820,with,0,1
105821,Steri-Strip,0,1
105822,S,0,1
105823,for,0,0
105824,breast,0,1
105825,was,0,0
105826,2.0,0,0
105827,minutes,0,0
105828,(,0,1
105829,SD,0,1
105830,=,0,1
105831,1.1,0,0
105832,),0,1
105833,versus,0,0
105834,suture,0,0
105835,closure,0,1
105836,at,0,1
105837,4.6,0,1
105838,minutes,0,0
105839,(,0,1
105840,SD,0,1
105841,=,0,1
105842,1.5,0,1
105843,;,0,0
105844,p,0,0
105845,<,0,0
105846,0.001,0,0
105847,),0,0
105848,.,0,1
105849,Similarly,0,0
105850,",",0,0
105851,Steri-Strip,0,0
105852,S,0,0
105853,versus,0,0
105854,suture,0,0
105855,for,0,0
105856,the,0,0
105857,abdomen,0,0
105858,was,0,0
105859,faster,0,0
105860,(,0,0
105861,p,0,0
105862,<,0,0
105863,0.001,0,0
105864,;,0,0
105865,4.9,0,1
105866,minutes,0,0
105867,",",0,1
105868,SD,0,1
105869,=,0,0
105870,2.3,0,0
105871,versus,0,0
105872,10.1,0,1
105873,minutes,0,0
105874,",",0,1
105875,SD,0,1
105876,=,0,1
105877,3.4,0,1
105878,),0,1
105879,.,0,1
105880,Comfort,0,0
105881,scores,0,0
105882,did,0,0
105883,not,0,0
105884,differ,0,0
105885,between,0,0
105886,closures,0,1
105887,[,0,1
105888,5.8,0,0
105889,(,0,1
105890,SD,0,1
105891,=,0,1
105892,2.7,0,1
105893,),0,1
105894,versus,0,0
105895,6.9,0,0
105896,(,0,1
105897,SD,0,1
105898,=,0,1
105899,2.0,0,0
105900,),0,0
105901,",",0,0
105902,respectively,0,0
105903,",",0,0
105904,on,0,0
105905,breast,0,1
105906,(,0,1
105907,p,0,0
105908,=,0,1
105909,0.142,0,0
105910,),0,1
105911,and,0,1
105912,7.7,0,0
105913,(,0,1
105914,SD,0,1
105915,=,0,1
105916,1.8,0,1
105917,),0,1
105918,versus,0,0
105919,7.7,0,0
105920,(,0,1
105921,SD,0,1
105922,=,0,1
105923,2.3,0,1
105924,),0,1
105925,on,0,1
105926,abdomen,0,1
105927,(,0,1
105928,p,0,0
105929,=,0,1
105930,0.903,0,0
105931,),0,1
105932,],0,1
105933,.,0,1
105934,Complication,0,0
105935,rates,0,0
105936,did,0,0
105937,not,0,0
105938,differ,0,0
105939,between,0,0
105940,closure,0,1
105941,types,0,1
105942,.,0,1
105943,Patients,0,1
105944,',0,1
105945,visual,0,0
105946,assessment,0,0
105947,of,0,1
105948,linear,0,0
105949,scars,0,1
105950,rating,0,0
105951,of,0,1
105952,breasts,0,1
105953,was,0,0
105954,3.8,0,1
105955,(,0,1
105956,SD,0,1
105957,=,0,1
105958,2.9,0,0
105959,),0,1
105960,for,0,1
105961,Steri-Strip,0,1
105962,S,0,1
105963,and,0,0
105964,better,0,0
105965,at,0,1
105966,2.6,0,0
105967,(,0,1
105968,SD,0,1
105969,=,0,1
105970,2.9,0,0
105971,),0,1
105972,for,0,0
105973,suture,0,0
105974,(,0,1
105975,p,0,0
105976,=,0,1
105977,0.008,0,0
105978,),0,1
105979,.,0,1
105980,One,0,1
105981,surgeon,0,1
105982,rated,0,0
105983,breast,0,1
105984,Steri-Strip,0,0
105985,S,0,0
105986,scars,0,1
105987,worse,0,0
105988,than,0,0
105989,suture,0,0
105990,scars,0,1
105991,(,0,1
105992,4.3,0,1
105993,versus,0,0
105994,3.7,0,1
105995,;,0,0
105996,p,0,0
105997,=,0,0
105998,0.014,0,0
105999,),0,0
106000,.,0,1
106001,For,0,1
106002,abdominal,0,1
106003,scars,0,1
106004,",",0,0
106005,there,0,0
106006,was,0,0
106007,no,0,0
106008,difference,0,0
106009,in,0,0
106010,the,0,0
106011,patient,0,1
106012,or,0,1
106013,surgeon,0,1
106014,ratings,0,0
106015,.,0,1
106016,CONCLUSIONS,0,0
106017,Steri-Strip,0,0
106018,S,0,0
106019,permits,0,0
106020,faster,0,0
106021,wound,0,0
106022,closure,0,0
106023,than,0,0
106024,suture,0,0
106025,.,0,1
106026,On,0,0
106027,the,0,0
106028,basis,0,0
106029,of,0,0
106030,patient,0,1
106031,reports,0,1
106032,of,0,1
106033,comfort,0,0
106034,and,0,1
106035,scar,0,0
106036,quality,0,0
106037,",",0,0
106038,surgeons,0,1
106039,increase,0,0
106040,efficiency,0,0
106041,and,0,0
106042,maintain,0,0
106043,quality,0,0
106044,with,0,1
106045,the,0,0
106046,use,0,0
106047,of,0,0
106048,Steri-Strip,0,1
106049,S,0,1
106050,on,0,1
106051,abdominal,0,1
106052,wounds,0,1
106053,but,0,0
106054,not,0,0
106055,on,0,0
106056,breast,0,1
106057,wounds,0,1
106058,.,0,1
106059,Prospective,0,1
106060,study,0,1
106061,of,0,1
106062,Clostridium,0,0
106063,difficile,0,1
106064,intestinal,0,1
106065,colonization,0,0
106066,and,0,1
106067,disease,0,1
106068,following,0,0
106069,single-dose,0,0
106070,antibiotic,0,0
106071,prophylaxis,0,1
106072,in,0,1
106073,surgery,0,1
106074,.,0,1
106075,A,0,0
106076,total,0,1
106077,of,0,0
106078,108,1,1
106079,volunteers,1,1
106080,undergoing,1,1
106081,an,1,1
106082,elective,1,1
106083,surgical,1,1
106084,procedure,1,0
106085,were,0,1
106086,randomly,0,1
106087,given,0,0
106088,a,0,0
106089,single,0,0
106090,2-g,0,0
106091,intravenous,0,1
106092,prophylactic,0,1
106093,dose,0,0
106094,of,0,0
106095,either,0,0
106096,a,0,1
106097,cephalosporin,0,0
106098,or,0,1
106099,mezlocillin,0,1
106100,.,0,1
106101,Stool,0,0
106102,samples,0,1
106103,were,0,1
106104,cultured,0,1
106105,for,0,0
106106,Clostridium,0,0
106107,difficile,0,1
106108,the,0,0
106109,day,0,0
106110,before,0,0
106111,the,0,0
106112,operation,0,1
106113,and,0,0
106114,later,0,1
106115,on,0,0
106116,postoperative,0,1
106117,days,0,1
106118,4,0,1
106119,",",0,1
106120,7,0,1
106121,",",0,0
106122,and,0,1
106123,14,0,1
106124,.,0,1
106125,C.,0,0
106126,difficile,0,1
106127,was,0,0
106128,detected,0,0
106129,in,0,1
106130,23.0,0,1
106131,%,0,0
106132,of,0,1
106133,patients,1,1
106134,who,0,1
106135,received,0,1
106136,a,0,1
106137,cephalosporin,0,0
106138,(,0,0
106139,cefoxitin,0,0
106140,",",0,1
106141,8.3,0,0
106142,%,0,0
106143,;,0,1
106144,cefazolin,0,0
106145,",",0,0
106146,14.3,0,0
106147,%,0,0
106148,;,0,1
106149,cefotetan,0,0
106150,",",0,0
106151,20.0,0,1
106152,%,0,0
106153,;,0,1
106154,ceftriaxone,0,0
106155,",",0,0
106156,25.0,0,0
106157,%,0,0
106158,;,0,1
106159,cefoperazone,0,0
106160,",",0,0
106161,43.7,0,0
106162,%,0,0
106163,),0,0
106164,",",0,0
106165,in,0,0
106166,3.3,0,0
106167,%,0,0
106168,of,0,1
106169,patients,1,1
106170,given,0,1
106171,mezlocillin,0,1
106172,",",0,0
106173,and,0,0
106174,in,0,0
106175,none,0,1
106176,of,0,1
106177,15,1,1
106178,control,1,1
106179,volunteers,1,1
106180,given,0,0
106181,no,0,0
106182,antimicrobial,0,0
106183,agent,0,0
106184,.,0,1
106185,No,0,0
106186,patient,0,0
106187,experienced,0,1
106188,diarrhea,0,1
106189,.,0,1
106190,Helping,0,0
106191,women,0,1
106192,make,0,1
106193,choices,0,0
106194,about,0,0
106195,mammography,0,1
106196,screening,0,1
106197,:,0,1
106198,an,0,0
106199,online,0,0
106200,randomized,0,1
106201,trial,0,0
106202,of,0,0
106203,a,0,0
106204,decision,0,0
106205,aid,0,0
106206,for,0,1
106207,40-year-old,1,1
106208,women,1,1
106209,.,1,1
106210,OBJECTIVE,0,0
106211,To,0,0
106212,evaluate,0,0
106213,the,0,0
106214,effect,0,0
106215,of,0,0
106216,a,0,0
106217,decision,0,0
106218,aid,0,0
106219,(,0,1
106220,DA,0,1
106221,),0,1
106222,on,0,0
106223,women,0,1
106224,'s,0,1
106225,knowledge,0,0
106226,of,0,1
106227,the,0,0
106228,benefits,0,0
106229,and,0,1
106230,harms,0,0
106231,of,0,1
106232,screening,0,1
106233,and,0,1
106234,on,0,0
106235,their,0,1
106236,ability,0,0
106237,to,0,0
106238,make,0,0
106239,an,0,0
106240,informed,0,0
106241,decision,0,0
106242,.,0,1
106243,METHODS,0,0
106244,An,0,0
106245,online,0,0
106246,randomized,0,1
106247,controlled,0,0
106248,trial,0,1
106249,among,0,1
106250,321,1,1
106251,women,1,1
106252,aged,1,1
106253,38-45,1,1
106254,years,1,1
106255,was,1,0
106256,conducted,1,1
106257,.,1,1
106258,Participants,0,1
106259,were,0,1
106260,randomized,0,1
106261,to,0,0
106262,either,0,1
106263,immediate,0,0
106264,or,0,1
106265,delayed,0,1
106266,access,0,0
106267,to,0,0
106268,the,0,0
106269,online,0,0
106270,DA,0,0
106271,which,0,0
106272,(,0,1
106273,i,0,1
106274,),0,1
106275,explained,0,0
106276,the,0,0
106277,benefits,0,0
106278,and,0,1
106279,harms,0,0
106280,",",0,1
106281,(,0,1
106282,ii,0,1
106283,),0,1
106284,included,0,1
106285,a,0,1
106286,values,0,0
106287,clarification,0,0
106288,exercise,0,1
106289,and,0,0
106290,a,0,0
106291,worksheet,0,0
106292,to,0,0
106293,support,0,0
106294,decision,0,0
106295,making,0,0
106296,.,0,1
106297,The,0,0
106298,primary,0,0
106299,outcome,0,0
106300,",",0,0
106301,knowledge,0,0
106302,of,0,0
106303,benefits,0,0
106304,and,0,1
106305,harms,0,0
106306,of,0,0
106307,screening,0,1
106308,",",0,0
106309,and,0,0
106310,secondary,0,1
106311,outcomes,0,0
106312,",",0,1
106313,informed,0,0
106314,choice,0,0
106315,(,0,0
106316,composite,0,0
106317,of,0,0
106318,knowledge,0,0
106319,",",0,1
106320,values,0,0
106321,and,0,1
106322,intention,0,1
106323,),0,0
106324,",",0,0
106325,anxiety,0,1
106326,and,0,0
106327,acceptability,0,0
106328,of,0,0
106329,the,0,0
106330,DA,0,0
106331,were,0,1
106332,measured,0,0
106333,using,0,0
106334,online,0,1
106335,questionnaires,0,1
106336,.,0,1
106337,RESULTS,0,0
106338,Women,1,1
106339,in,1,0
106340,the,1,0
106341,intervention,1,0
106342,group,1,0
106343,were,0,0
106344,more,0,0
106345,knowledgeable,0,0
106346,(,0,0
106347,mean,0,1
106348,score,0,0
106349,out,0,1
106350,of,0,0
106351,10,0,1
106352,",",0,1
106353,7.35,0,0
106354,vs,0,0
106355,6.27,0,0
106356,",",0,0
106357,p,0,0
106358,<,0,0
106359,0.001,0,0
106360,),0,1
106361,and,0,0
106362,were,0,0
106363,more,0,0
106364,likely,0,0
106365,to,0,0
106366,have,0,0
106367,made,0,0
106368,a,0,0
106369,decision,0,0
106370,(,0,0
106371,82,0,1
106372,%,0,0
106373,vs,0,0
106374,61,0,1
106375,%,0,0
106376,p,0,0
106377,<,0,0
106378,0.001,0,0
106379,),0,1
106380,.,0,1
106381,Of,0,1
106382,those,0,1
106383,who,0,1
106384,made,0,1
106385,a,0,1
106386,decision,0,0
106387,",",0,0
106388,women,0,1
106389,in,0,0
106390,the,0,0
106391,intervention,0,0
106392,group,0,0
106393,were,0,0
106394,less,0,0
106395,likely,0,0
106396,to,0,0
106397,start,0,1
106398,screening,0,1
106399,now,0,0
106400,(,0,1
106401,52,0,1
106402,%,0,0
106403,vs,0,0
106404,65,0,1
106405,%,0,0
106406,p=0.05,0,0
106407,),0,0
106408,.,0,0
106409,There,0,0
106410,was,0,0
106411,no,0,0
106412,significant,0,0
106413,difference,0,0
106414,in,0,0
106415,the,0,0
106416,proportion,0,1
106417,of,0,1
106418,women,0,1
106419,who,0,1
106420,made,0,1
106421,an,0,1
106422,informed,0,0
106423,choice,0,0
106424,(,0,1
106425,71,0,1
106426,%,0,0
106427,intervention,0,0
106428,group,0,1
106429,vs,0,0
106430,64,0,1
106431,%,0,0
106432,control,0,1
106433,group,0,0
106434,",",0,0
106435,p=0.24,0,0
106436,),0,1
106437,.,0,1
106438,The,0,0
106439,DA,0,0
106440,was,0,0
106441,helpful,0,0
106442,",",0,1
106443,balanced,0,0
106444,and,0,0
106445,clear,0,0
106446,",",0,0
106447,and,0,0
106448,did,0,0
106449,not,0,0
106450,make,0,0
106451,women,0,1
106452,anxious,0,1
106453,.,0,1
106454,CONCLUSIONS,0,0
106455,The,0,0
106456,DA,0,0
106457,increased,0,0
106458,knowledge,0,0
106459,and,0,0
106460,reduced,0,0
106461,indecision,0,0
106462,",",0,0
106463,without,0,1
106464,increasing,0,0
106465,feelings,0,0
106466,of,0,1
106467,anxiety,0,1
106468,.,0,1
106469,PRACTICE,0,0
106470,IMPLICATIONS,0,0
106471,This,0,0
106472,decision,0,0
106473,aid,0,0
106474,is,0,0
106475,easy,0,0
106476,to,0,0
106477,access,0,1
106478,online,0,0
106479,and,0,0
106480,could,0,0
106481,be,0,0
106482,an,0,0
106483,inexpensive,0,0
106484,way,0,0
106485,of,0,1
106486,supporting,0,0
106487,women,0,1
106488,aged,0,1
106489,40,0,1
106490,who,0,1
106491,are,0,1
106492,considering,0,1
106493,whether,0,0
106494,to,0,1
106495,start,0,1
106496,screening,0,0
106497,now,0,0
106498,",",0,0
106499,or,0,0
106500,wait,0,0
106501,until,0,0
106502,they,0,1
106503,are,0,0
106504,50,0,1
106505,.,0,1
106506,The,0,0
106507,results,0,0
106508,of,0,0
106509,this,0,0
106510,study,0,0
106511,demonstrate,0,0
106512,the,0,0
106513,potential,0,0
106514,of,0,0
106515,DAs,0,1
106516,to,0,0
106517,help,0,0
106518,inform,0,0
106519,women,0,1
106520,about,0,0
106521,both,0,0
106522,the,0,0
106523,benefits,0,0
106524,and,0,1
106525,risks,0,0
106526,of,0,0
106527,screening,0,1
106528,at,0,0
106529,this,0,0
106530,age,0,1
106531,and,0,0
106532,to,0,0
106533,support,0,0
106534,women,0,1
106535,and,0,1
106536,clinicians,0,1
106537,in,0,0
106538,this,0,0
106539,decision,0,0
106540,making,0,0
106541,process,0,0
106542,.,0,1
106543,Relief,0,0
106544,of,0,0
106545,periorbital,0,1
106546,pain,0,1
106547,after,0,1
106548,acute,0,1
106549,angle,0,0
106550,closure,0,1
106551,glaucoma,0,1
106552,attack,0,1
106553,by,0,0
106554,botulinum,0,0
106555,toxin,0,0
106556,type,0,1
106557,A,0,1
106558,.,0,1
106559,PURPOSE,0,0
106560,To,0,0
106561,assess,0,0
106562,the,0,0
106563,efficacy,0,0
106564,and,0,0
106565,safety,0,0
106566,of,0,0
106567,botulinum,0,0
106568,toxin,0,0
106569,type,0,1
106570,A,0,1
106571,(,0,1
106572,BoNT-A,0,1
106573,),0,1
106574,injection,0,0
106575,in,0,1
106576,patients,1,1
106577,suffering,1,1
106578,from,1,1
106579,intractable,1,1
106580,periorbital,1,1
106581,pain,1,1
106582,after,1,0
106583,acute,1,1
106584,angle,1,0
106585,closure,1,1
106586,glaucoma,1,1
106587,(,1,1
106588,AACG,1,1
106589,),1,1
106590,.,1,1
106591,PATIENTS,0,0
106592,AND,0,0
106593,METHODS,0,0
106594,In,0,1
106595,this,0,0
106596,prospective,0,1
106597,randomized,0,1
106598,intervention,0,0
106599,study,0,1
106600,",",0,1
106601,19,1,1
106602,patients,1,1
106603,suffering,1,1
106604,from,1,1
106605,periorbital,1,1
106606,pain,1,1
106607,after,1,0
106608,an,1,1
106609,AACG,1,0
106610,attack,1,1
106611,were,0,0
106612,injected,0,0
106613,with,0,1
106614,BoNT-A,0,1
106615,or,0,1
106616,placebo,0,0
106617,for,0,0
106618,pain,0,1
106619,relief,0,0
106620,.,0,1
106621,Patients,0,1
106622,were,0,0
106623,assessed,0,0
106624,on,0,0
106625,days,0,0
106626,1,0,1
106627,",",0,1
106628,2,0,1
106629,",",0,0
106630,7,0,1
106631,",",0,0
106632,14,0,1
106633,",",0,0
106634,30,0,1
106635,",",0,0
106636,60,0,1
106637,",",0,0
106638,and,0,1
106639,90,0,1
106640,.,0,1
106641,The,0,0
106642,main,0,0
106643,outcomes,0,0
106644,were,0,1
106645,mean,0,1
106646,change,0,0
106647,of,0,0
106648,visual,0,0
106649,analog,0,0
106650,rating,0,0
106651,scale,0,0
106652,(,0,1
106653,VARS,0,0
106654,),0,1
106655,and,0,1
106656,index,0,1
106657,scores,0,0
106658,measured,0,0
106659,through,0,1
106660,a,0,1
106661,quality-of-life,0,0
106662,questionnaire,0,0
106663,(,0,1
106664,EQ-5D,0,1
106665,),0,1
106666,",",0,0
106667,and,0,0
106668,changes,0,0
106669,in,0,1
106670,the,0,1
106671,visual,0,0
106672,analog,0,0
106673,scale,0,0
106674,(,0,1
106675,VAS,0,0
106676,),0,1
106677,",",0,0
106678,all,0,0
106679,of,0,0
106680,which,0,0
106681,were,0,1
106682,assessed,0,0
106683,at,0,0
106684,each,0,0
106685,visit,0,0
106686,.,0,0
106687,A,0,0
106688,secondary,0,0
106689,outcome,0,0
106690,was,0,0
106691,the,0,0
106692,frequency,0,0
106693,and,0,0
106694,nature,0,1
106695,of,0,1
106696,adverse,0,0
106697,events,0,0
106698,and,0,1
106699,the,0,0
106700,number,0,0
106701,of,0,1
106702,patients,0,1
106703,who,0,1
106704,withdrew,0,1
106705,from,0,1
106706,the,0,0
106707,study,0,0
106708,as,0,0
106709,a,0,1
106710,result,0,0
106711,.,0,0
106712,RESULTS,0,0
106713,In,0,0
106714,the,0,0
106715,treatment,0,0
106716,group,0,0
106717,(,0,1
106718,n=10,0,1
106719,),0,0
106720,",",0,0
106721,the,0,0
106722,mean,0,0
106723,index,0,0
106724,score,0,0
106725,of,0,0
106726,EQ-5D,0,1
106727,and,0,1
106728,VAS,0,0
106729,changed,0,0
106730,significantly,0,0
106731,from,0,0
106732,the,0,0
106733,placebo,0,0
106734,group,0,0
106735,(,0,1
106736,by,0,0
106737,0.299,0,0
106738,and,0,1
106739,2.61,0,0
106740,",",0,0
106741,respectively,0,0
106742,),0,0
106743,from,0,1
106744,day,0,1
106745,2,0,1
106746,(,0,1
106747,P,0,0
106748,<,0,0
106749,0.01,0,0
106750,),0,1
106751,.,0,1
106752,The,0,0
106753,VARS,0,0
106754,of,0,0
106755,EQ-5D,0,0
106756,also,0,0
106757,disclosed,0,1
106758,significant,0,0
106759,changes,0,0
106760,from,0,1
106761,day,0,1
106762,2,0,1
106763,(,0,1
106764,17,0,1
106765,",",0,1
106766,P,0,0
106767,<,0,0
106768,0.01,0,0
106769,),0,1
106770,.,0,1
106771,In,0,0
106772,addition,0,0
106773,",",0,0
106774,efficacy,0,0
106775,was,0,0
106776,maintained,0,0
106777,mainly,0,0
106778,between,0,0
106779,days,0,0
106780,2,0,1
106781,and,0,1
106782,60,0,1
106783,but,0,0
106784,declined,0,0
106785,slightly,0,0
106786,by,0,0
106787,day,0,0
106788,90,0,1
106789,.,0,1
106790,The,0,0
106791,most,0,0
106792,frequently,0,0
106793,reported,0,0
106794,treatment-related,0,0
106795,adverse,0,0
106796,events,0,0
106797,in,0,1
106798,the,0,0
106799,treatment,0,0
106800,and,0,0
106801,placebo,0,1
106802,groups,0,0
106803,were,0,1
106804,local,0,0
106805,tenderness,0,1
106806,(,0,1
106807,21,0,1
106808,%,0,0
106809,),0,1
106810,",",0,0
106811,subcutaneous,0,1
106812,hemorrhage,0,1
106813,(,0,1
106814,10.5,0,0
106815,%,0,0
106816,),0,1
106817,",",0,0
106818,and,0,0
106819,conjunctivitis,0,0
106820,(,0,1
106821,10.5,0,0
106822,%,0,0
106823,),0,1
106824,.,0,1
106825,No,0,0
106826,severe,0,1
106827,adverse,0,0
106828,events,0,0
106829,were,0,1
106830,reported,0,1
106831,during,0,0
106832,the,0,0
106833,study,0,0
106834,or,0,1
106835,follow-up,0,0
106836,period,0,1
106837,.,0,1
106838,CONCLUSIONS,0,0
106839,BoNT-A,0,1
106840,is,0,0
106841,effective,0,0
106842,and,0,0
106843,well,0,0
106844,tolerated,0,0
106845,for,0,0
106846,the,0,0
106847,treatment,0,0
106848,of,0,0
106849,periorbital,0,1
106850,pain,0,1
106851,after,0,0
106852,an,0,1
106853,AACG,0,0
106854,attack,0,1
106855,.,0,1
106856,Its,0,0
106857,effects,0,0
106858,may,0,0
106859,be,0,0
106860,maintained,0,0
106861,for,0,0
106862,3,0,1
106863,months,0,1
106864,.,0,1
106865,Attenuation,0,0
106866,of,0,1
106867,hemodynamic,0,0
106868,responses,0,0
106869,to,0,1
106870,laryngoscopy,0,1
106871,and,0,0
106872,tracheal,0,1
106873,intubation,0,1
106874,during,0,0
106875,rapid,0,0
106876,sequence,0,0
106877,induction,0,1
106878,:,0,1
106879,remifentanil,0,0
106880,vs.,0,0
106881,lidocaine,0,0
106882,with,0,1
106883,esmolol,0,0
106884,.,0,1
106885,AIM,0,0
106886,This,0,0
106887,study,0,0
106888,was,0,0
106889,designed,0,0
106890,to,0,0
106891,compare,0,0
106892,the,0,0
106893,effectiveness,0,0
106894,of,0,0
106895,remifentanil,0,0
106896,vs.,0,0
106897,a,0,0
106898,lidocaine-esmolol,0,0
106899,combination,0,0
106900,in,0,0
106901,blunting,0,0
106902,the,0,0
106903,hemodynamic,0,0
106904,response,0,0
106905,to,0,0
106906,laryngoscopy,0,1
106907,and,0,0
106908,intubation,0,1
106909,during,0,0
106910,rapid,0,0
106911,sequence,0,0
106912,induction,0,1
106913,using,0,0
106914,thiopental,0,0
106915,and,0,1
106916,rocuronium,0,0
106917,in,0,1
106918,normotensive,1,1
106919,patients,1,1
106920,.,1,1
106921,METHODS,0,0
106922,Sixty-six,1,1
106923,patients,1,1
106924,with,1,1
106925,American,1,1
106926,Society,1,1
106927,of,1,1
106928,Anesthesiologists,1,1
106929,(,1,1
106930,ASA,1,1
106931,),1,1
106932,physical,1,1
106933,status,1,1
106934,class,1,1
106935,I,1,1
106936,who,1,1
106937,required,1,1
106938,tracheal,1,1
106939,intubation,1,1
106940,for,1,0
106941,elective,1,1
106942,surgery,1,1
106943,were,0,1
106944,randomly,0,1
106945,assigned,0,1
106946,to,0,0
106947,one,0,1
106948,of,0,1
106949,two,0,1
106950,groups,0,1
106951,.,0,1
106952,Group,0,1
106953,R,0,1
106954,received,0,1
106955,0.9,0,0
106956,%,0,0
106957,saline,0,0
106958,10,0,1
106959,ml,0,0
106960,and,0,0
106961,remifentanil,0,0
106962,1,0,0
106963,microg/kg,0,0
106964,.,0,1
106965,Group,0,1
106966,LE,0,0
106967,received,0,1
106968,lidocaine,0,0
106969,1.5,0,0
106970,mg/kg,0,0
106971,and,0,1
106972,esmolol,0,0
106973,1.0,0,0
106974,mg/kg,0,0
106975,.,0,1
106976,Anesthesia,0,0
106977,was,0,0
106978,induced,0,0
106979,with,0,1
106980,thiopental,0,0
106981,sodium,0,0
106982,5,0,0
106983,mg/kg,0,0
106984,",",0,0
106985,followed,0,0
106986,by,0,0
106987,rocuronium,0,1
106988,1.0,0,0
106989,mg/kg,0,0
106990,.,0,1
106991,Mean,0,1
106992,arterial,0,1
106993,pressure,0,0
106994,and,0,0
106995,heart,0,1
106996,rate,0,0
106997,were,0,0
106998,recorded,0,0
106999,at,0,0
107000,baseline,0,0
107001,",",0,0
107002,after,0,0
107003,induction,0,0
107004,",",0,0
107005,immediately,0,0
107006,after,0,0
107007,intubation,0,0
107008,and,0,0
107009,every,0,0
107010,minute,0,0
107011,for,0,0
107012,five,0,1
107013,minutes,0,0
107014,after,0,1
107015,intubation,0,1
107016,.,0,1
107017,RESULTS,0,0
107018,Changes,0,0
107019,in,0,1
107020,mean,0,1
107021,arterial,0,1
107022,pressure,0,0
107023,over,0,0
107024,time,0,0
107025,between,0,0
107026,the,0,1
107027,two,0,1
107028,groups,0,0
107029,were,0,1
107030,significantly,0,0
107031,different,0,0
107032,(,0,1
107033,P,0,0
107034,<,0,0
107035,0.0001,0,0
107036,),0,1
107037,.,0,1
107038,The,0,0
107039,maximum,0,0
107040,pressor,0,0
107041,response,0,0
107042,was,0,0
107043,observed,0,0
107044,immediately,0,0
107045,after,0,0
107046,intubation,0,0
107047,",",0,0
107048,at,0,0
107049,which,0,0
107050,time,0,0
107051,the,0,0
107052,mean,0,1
107053,arterial,0,1
107054,pressure,0,0
107055,change,0,0
107056,from,0,1
107057,baseline,0,0
107058,in,0,0
107059,group,0,1
107060,LE,0,0
107061,(,0,1
107062,29.7,0,1
107063,%,0,0
107064,),0,1
107065,(,0,1
107066,95,0,0
107067,%,0,0
107068,confidence,0,0
107069,interval,0,0
107070,[,0,0
107071,CI,0,0
107072,],0,1
107073,:,0,1
107074,116.1,0,0
107075,",",0,1
107076,121.9,0,0
107077,),0,0
107078,was,0,0
107079,higher,0,0
107080,than,0,0
107081,that,0,0
107082,in,0,0
107083,group,0,1
107084,R,0,1
107085,(,0,1
107086,4.4,0,0
107087,%,0,0
107088,),0,1
107089,(,0,1
107090,95,0,0
107091,%,0,0
107092,CI,0,0
107093,:,0,1
107094,92.9,0,0
107095,",",0,1
107096,98.5,0,0
107097,),0,1
107098,(,0,1
107099,P,0,0
107100,<,0,0
107101,0.0001,0,0
107102,),0,1
107103,.,0,1
107104,Two,0,1
107105,patients,0,1
107106,in,0,1
107107,group,0,1
107108,R,0,1
107109,and,0,1
107110,15,0,1
107111,patients,0,1
107112,in,0,1
107113,group,0,1
107114,LE,0,0
107115,developed,0,1
107116,hypertension,0,1
107117,(,0,1
107118,odds,0,0
107119,ratio,0,1
107120,[,0,0
107121,OR,0,0
107122,],0,1
107123,:,0,1
107124,0.064,0,0
107125,),0,1
107126,(,0,1
107127,P,0,0
107128,<,0,0
107129,0.001,0,0
107130,),0,1
107131,.,0,1
107132,Changes,0,0
107133,in,0,0
107134,heart,0,1
107135,rate,0,0
107136,over,0,0
107137,time,0,0
107138,between,0,0
107139,the,0,1
107140,two,0,1
107141,groups,0,0
107142,were,0,1
107143,not,0,0
107144,significantly,0,0
107145,different,0,0
107146,(,0,1
107147,P=0.465,0,0
107148,),0,1
107149,.,0,1
107150,CONCLUSION,0,0
107151,The,0,0
107152,results,0,0
107153,of,0,0
107154,this,0,0
107155,study,0,0
107156,show,0,0
107157,that,0,0
107158,remifentanil,0,0
107159,1,0,0
107160,mg/kg,0,0
107161,is,0,0
107162,more,0,0
107163,effective,0,0
107164,than,0,0
107165,the,0,0
107166,combination,0,0
107167,of,0,0
107168,lidocaine,0,0
107169,1.5,0,1
107170,mg/kg,0,0
107171,and,0,1
107172,esmolol,0,0
107173,1,0,0
107174,mg/kg,0,0
107175,for,0,0
107176,attenuating,0,0
107177,the,0,0
107178,hemodynamic,0,0
107179,responses,0,0
107180,to,0,1
107181,rapid,0,1
107182,sequence,0,0
107183,intubation,0,1
107184,.,0,1
107185,A,0,0
107186,prospective,0,0
107187,multicenter,0,0
107188,randomized,0,1
107189,comparative,0,0
107190,study,0,1
107191,between,0,0
107192,the,0,0
107193,U-,0,0
107194,and,0,1
107195,H-type,0,1
107196,methods,0,1
107197,of,0,1
107198,the,0,1
107199,TVT,0,1
107200,SECUR,0,1
107201,procedure,0,0
107202,for,0,0
107203,the,0,0
107204,treatment,0,0
107205,of,0,0
107206,female,1,1
107207,stress,1,1
107208,urinary,1,1
107209,incontinence,1,1
107210,:,1,1
107211,1-year,0,0
107212,follow-up,0,1
107213,.,0,1
107214,BACKGROUND,0,0
107215,No,0,0
107216,studies,0,0
107217,have,0,1
107218,been,0,0
107219,published,0,0
107220,comparing,0,0
107221,the,0,0
107222,U-,0,0
107223,and,0,1
107224,H-type,0,1
107225,methods,0,1
107226,of,0,1
107227,the,0,1
107228,TVT,0,1
107229,SECUR,0,1
107230,(,0,1
107231,TVT-S,0,1
107232,),0,1
107233,procedure,0,0
107234,.,0,1
107235,OBJECTIVE,0,0
107236,Our,0,0
107237,aim,0,0
107238,was,0,0
107239,to,0,0
107240,compare,0,0
107241,the,0,0
107242,efficacy,0,0
107243,and,0,0
107244,safety,0,0
107245,of,0,0
107246,the,0,1
107247,two,0,0
107248,types,0,1
107249,of,0,1
107250,TVT-S,0,1
107251,for,0,1
107252,female,1,1
107253,stress,1,1
107254,urinary,1,1
107255,incontinence,1,0
107256,(,1,1
107257,SUI,1,1
107258,),1,1
107259,.,1,1
107260,DESIGN,0,0
107261,",",0,0
107262,SETTING,0,1
107263,",",0,0
107264,AND,0,0
107265,PARTICIPANTS,0,1
107266,Women,1,1
107267,with,1,1
107268,urodynamic,1,1
107269,SUI,1,1
107270,were,1,1
107271,enrolled,1,1
107272,in,0,0
107273,this,0,0
107274,12-mo,0,1
107275,multicenter,0,0
107276,randomized,0,1
107277,study,0,1
107278,.,0,1
107279,INTERVENTION,0,0
107280,Subjects,1,1
107281,were,0,1
107282,randomly,0,1
107283,allocated,0,1
107284,to,0,0
107285,either,0,0
107286,the,0,0
107287,U-,0,0
107288,or,0,1
107289,H-type,0,1
107290,method,0,0
107291,of,0,0
107292,TVT-S.,0,1
107293,MEASUREMENTS,0,1
107294,Pre-,0,1
107295,and,0,1
107296,postoperative,0,1
107297,evaluations,0,0
107298,included,0,1
107299,a,0,1
107300,standing,0,0
107301,stress,0,0
107302,test,0,0
107303,",",0,0
107304,the,0,0
107305,Sandvik,0,0
107306,questionnaire,0,0
107307,",",0,0
107308,the,0,0
107309,Incontinence,0,0
107310,Quality,0,0
107311,of,0,1
107312,Life,0,0
107313,(,0,1
107314,I-QOL,0,1
107315,),0,1
107316,questionnaire,0,0
107317,",",0,0
107318,and,0,0
107319,the,0,0
107320,International,0,1
107321,Consultation,0,0
107322,on,0,0
107323,Incontinence,0,1
107324,Questionnaire-Female,0,1
107325,Lower,0,1
107326,Urinary,0,1
107327,Tract,0,1
107328,Symptoms,0,1
107329,(,0,1
107330,ICIQ-FLUTS,0,1
107331,),0,1
107332,.,0,1
107333,Patients,0,1
107334,',0,1
107335,satisfaction,0,0
107336,and,0,1
107337,complications,0,0
107338,were,0,1
107339,evaluated,0,0
107340,.,0,1
107341,Objective,0,0
107342,and,0,0
107343,subjective,0,0
107344,cures,0,1
107345,were,0,1
107346,defined,0,1
107347,as,0,0
107348,no,0,0
107349,leakage,0,0
107350,on,0,0
107351,the,0,0
107352,stress,0,0
107353,test,0,0
107354,and,0,1
107355,responses,0,0
107356,on,0,0
107357,the,0,1
107358,Sandvik,0,0
107359,questionnaire,0,0
107360,",",0,0
107361,respectively,0,0
107362,.,0,1
107363,We,0,0
107364,compared,0,0
107365,the,0,0
107366,surgical,0,1
107367,outcomes,0,0
107368,between,0,0
107369,the,0,1
107370,two,0,1
107371,methods,0,1
107372,.,0,1
107373,RESULTS,0,0
107374,AND,0,0
107375,LIMITATIONS,0,1
107376,Of,1,1
107377,285,1,1
107378,women,1,1
107379,",",1,1
107380,144,1,1
107381,had,1,1
107382,the,1,0
107383,U-type,1,0
107384,method,1,0
107385,and,1,1
107386,141,1,1
107387,had,1,1
107388,the,1,0
107389,H-type,1,1
107390,method,1,0
107391,.,1,1
107392,Objective,0,0
107393,cure,0,0
107394,rates,0,0
107395,were,0,1
107396,87.5,0,0
107397,%,0,0
107398,for,0,0
107399,the,0,0
107400,U-type,0,0
107401,method,0,0
107402,and,0,1
107403,80.1,0,0
107404,%,0,0
107405,for,0,0
107406,the,0,0
107407,H-type,0,1
107408,method,0,0
107409,(,0,1
107410,p=0.091,0,0
107411,),0,1
107412,.,0,1
107413,Subjective,0,0
107414,cure,0,0
107415,rates,0,0
107416,were,0,1
107417,77.1,0,0
107418,%,0,0
107419,for,0,0
107420,the,0,0
107421,U-type,0,0
107422,method,0,0
107423,and,0,1
107424,75.7,0,0
107425,%,0,0
107426,for,0,0
107427,the,0,0
107428,H-type,0,1
107429,method,0,0
107430,(,0,1
107431,p=0.786,0,0
107432,),0,1
107433,.,0,1
107434,Improvement,0,0
107435,in,0,0
107436,I-QOL,0,0
107437,and,0,1
107438,domain,0,0
107439,scores,0,0
107440,of,0,0
107441,the,0,1
107442,ICIQ-FLUTS,0,0
107443,(,0,0
107444,filling,0,0
107445,and,0,0
107446,incontinence,0,0
107447,sum,0,0
107448,",",0,0
107449,QOL,0,0
107450,score,0,0
107451,),0,1
107452,",",0,0
107453,and,0,1
107454,patients,0,1
107455,',0,1
107456,satisfaction,0,0
107457,favored,0,0
107458,the,0,0
107459,U-type,0,0
107460,method,0,0
107461,.,0,0
107462,There,0,0
107463,were,0,0
107464,three,0,0
107465,cases,0,1
107466,of,0,1
107467,intraoperative,0,1
107468,vaginal,0,1
107469,wall,0,1
107470,perforation,0,1
107471,",",0,0
107472,one,0,1
107473,case,0,0
107474,of,0,0
107475,increased,0,0
107476,bleeding,0,1
107477,",",0,0
107478,and,0,1
107479,three,0,0
107480,cases,0,1
107481,of,0,1
107482,temporary,0,1
107483,postoperative,0,1
107484,retention,0,0
107485,.,0,1
107486,A,0,0
107487,power,0,0
107488,calculation,0,0
107489,was,0,0
107490,not,0,0
107491,performed,0,0
107492,",",0,0
107493,and,0,0
107494,some,0,0
107495,baseline,0,0
107496,characteristics,0,0
107497,were,0,1
107498,not,0,0
107499,balanced,0,0
107500,between,0,0
107501,the,0,1
107502,two,0,1
107503,methods,0,1
107504,.,0,1
107505,CONCLUSIONS,0,0
107506,Both,0,0
107507,methods,0,1
107508,of,0,1
107509,TVT-S,0,1
107510,provided,0,0
107511,comparable,0,0
107512,cure,0,0
107513,rates,0,0
107514,for,0,1
107515,female,1,1
107516,SUI,1,1
107517,.,1,1
107518,However,0,0
107519,",",0,0
107520,QOL,0,0
107521,and,0,0
107522,treatment,0,0
107523,satisfaction,0,0
107524,favored,0,0
107525,the,0,0
107526,U-type,0,0
107527,method,0,0
107528,.,0,1
107529,TRIAL,0,0
107530,REGISTRATION,0,0
107531,The,0,0
107532,protocol,0,0
107533,of,0,0
107534,this,0,0
107535,study,0,0
107536,was,0,0
107537,not,0,0
107538,registered,0,1
107539,.,0,1
107540,Comparison,0,0
107541,of,0,0
107542,the,0,0
107543,in,0,0
107544,vitro,0,0
107545,and,0,1
107546,in,0,0
107547,vivo,0,0
107548,release,0,0
107549,of,0,0
107550,digoxin,0,0
107551,from,0,1
107552,four,0,1
107553,different,0,1
107554,soft,0,1
107555,gelatin,0,0
107556,capsule,0,1
107557,formulations,0,0
107558,.,0,1
107559,A,0,0
107560,blinded,0,0
107561,",",0,0
107562,four-treatment,0,0
107563,crossover,0,0
107564,study,0,1
107565,in,0,1
107566,16,1,1
107567,normal,1,1
107568,adult,1,1
107569,male,1,1
107570,volunteers,1,1
107571,compared,0,0
107572,plasma,0,0
107573,concentrations,0,0
107574,and,0,1
107575,urinary,0,1
107576,excretion,0,0
107577,of,0,0
107578,digoxin,0,0
107579,",",0,0
107580,measured,0,0
107581,by,0,0
107582,radioimmunoassay,0,0
107583,",",0,0
107584,after,0,0
107585,oral,0,0
107586,administration,0,0
107587,of,0,0
107588,soft,0,1
107589,gelatin,0,0
107590,capsule,0,1
107591,formulations,0,0
107592,of,0,1
107593,digoxin,1,1
107594,.,1,1
107595,Four,0,0
107596,0.4-mg,0,0
107597,formulations,0,0
107598,with,0,1
107599,different,0,1
107600,in,0,1
107601,vitro,0,0
107602,burst,0,1
107603,times,0,0
107604,and,0,1
107605,dissolution,0,0
107606,rates,0,0
107607,were,0,1
107608,administered,0,0
107609,",",0,0
107610,with,0,1
107611,2-week,0,0
107612,intervals,0,0
107613,between,0,1
107614,treatments,0,0
107615,.,0,1
107616,The,0,0
107617,two,0,0
107618,capsules,0,0
107619,with,0,1
107620,lowest,0,0
107621,in,0,0
107622,vitro,0,0
107623,burst,0,1
107624,times,0,0
107625,(,0,1
107626,2.9,0,1
107627,and,0,1
107628,16,0,1
107629,min,0,0
107630,),0,1
107631,gave,0,0
107632,comparable,0,0
107633,in,0,1
107634,vivo,0,1
107635,results,0,0
107636,.,0,1
107637,The,0,0
107638,other,0,0
107639,two,0,0
107640,capsules,0,0
107641,",",0,1
107642,with,0,1
107643,in,0,0
107644,vitro,0,0
107645,burst,0,1
107646,times,0,0
107647,of,0,1
107648,62,0,1
107649,and,0,1
107650,229,0,1
107651,min,0,0
107652,",",0,0
107653,produced,0,0
107654,significant,0,0
107655,delays,0,0
107656,in,0,1
107657,digoxin,0,1
107658,absorption,0,0
107659,.,0,1
107660,In,0,0
107661,vitro-in,0,0
107662,vivo,0,0
107663,correlations,0,0
107664,were,0,1
107665,obtained,0,0
107666,by,0,0
107667,comparing,0,0
107668,the,0,0
107669,logarithm,0,0
107670,of,0,0
107671,the,0,0
107672,in,0,0
107673,vitro,0,0
107674,burst,0,0
107675,time,0,0
107676,with,0,1
107677,time,0,0
107678,to,0,0
107679,peak,0,0
107680,plasma,0,0
107681,level,0,0
107682,and,0,0
107683,the,0,0
107684,time,0,0
107685,to,0,0
107686,the,0,0
107687,first,0,0
107688,measurable,0,0
107689,plasma,0,0
107690,level,0,0
107691,(,0,1
107692,>,0,1
107693,or,0,1
107694,=,0,1
107695,0,0,0
107696,.,0,1
107697,05,0,0
107698,ng/ml,0,0
107699,),0,1
107700,.,0,1
107701,Also,0,0
107702,",",0,0
107703,the,0,0
107704,mean,0,0
107705,time,0,0
107706,to,0,0
107707,peak,0,0
107708,plasma,0,0
107709,level,0,0
107710,correlated,0,0
107711,with,0,1
107712,the,0,0
107713,logarithm,0,0
107714,of,0,0
107715,the,0,0
107716,time,0,0
107717,required,0,0
107718,to,0,0
107719,release,0,0
107720,either,0,1
107721,50,0,1
107722,%,0,0
107723,or,0,1
107724,85,0,1
107725,%,0,0
107726,of,0,0
107727,the,0,0
107728,digoxin,0,0
107729,in,0,0
107730,vitro,0,0
107731,.,0,1
107732,No,0,0
107733,significant,0,0
107734,changes,0,0
107735,were,0,1
107736,found,0,0
107737,in,0,0
107738,the,0,0
107739,amount,0,0
107740,of,0,0
107741,digoxin,0,0
107742,absorbed,0,0
107743,from,0,1
107744,each,0,0
107745,capsule,0,0
107746,as,0,0
107747,determined,0,0
107748,by,0,0
107749,urinary,0,1
107750,excretion,0,0
107751,or,0,1
107752,AUC0-infinity,0,0
107753,.,0,1
107754,The,0,0
107755,limit,0,0
107756,to,0,0
107757,exercise,0,0
107758,tolerance,0,1
107759,in,0,1
107760,humans,1,1
107761,:,1,1
107762,mind,0,1
107763,over,0,0
107764,muscle,0,0
107765,?,0,1
107766,In,0,0
107767,exercise,0,0
107768,physiology,0,0
107769,",",0,0
107770,it,0,0
107771,has,0,0
107772,been,0,0
107773,traditionally,0,0
107774,assumed,0,0
107775,that,0,0
107776,high-intensity,0,1
107777,aerobic,0,1
107778,exercise,0,1
107779,stops,0,1
107780,at,0,1
107781,the,0,0
107782,point,0,0
107783,commonly,0,0
107784,called,0,0
107785,exhaustion,0,0
107786,because,0,1
107787,fatigued,0,1
107788,subjects,0,1
107789,are,0,0
107790,no,0,0
107791,longer,0,0
107792,able,0,0
107793,to,0,0
107794,generate,0,0
107795,the,0,0
107796,power,0,0
107797,output,0,0
107798,required,0,0
107799,by,0,0
107800,the,0,0
107801,task,0,1
107802,despite,0,0
107803,their,0,1
107804,maximal,0,0
107805,voluntary,0,1
107806,effort,0,1
107807,.,0,1
107808,We,0,0
107809,tested,0,0
107810,the,0,0
107811,validity,0,0
107812,of,0,0
107813,this,0,0
107814,assumption,0,0
107815,by,0,0
107816,measuring,0,0
107817,maximal,0,0
107818,voluntary,0,1
107819,cycling,0,0
107820,power,0,0
107821,before,0,1
107822,(,0,1
107823,mean,0,1
107824,+/-,0,0
107825,SD,0,1
107826,",",0,1
107827,"1,075",0,1
107828,+/-,0,0
107829,214,0,1
107830,W,0,1
107831,),0,1
107832,and,0,0
107833,immediately,0,0
107834,after,0,0
107835,(,0,1
107836,731,0,1
107837,+/-,0,1
107838,206,0,1
107839,W,0,1
107840,),0,1
107841,(,0,1
107842,P,0,0
107843,<,0,0
107844,0.001,0,0
107845,),0,1
107846,exhaustive,1,0
107847,cycling,1,0
107848,exercise,1,0
107849,at,0,1
107850,242,0,1
107851,+/-,0,1
107852,24,0,1
107853,W,0,1
107854,(,0,1
107855,80,0,1
107856,%,0,0
107857,of,0,0
107858,peak,0,0
107859,aerobic,0,0
107860,power,0,0
107861,measured,0,0
107862,during,0,0
107863,a,0,1
107864,preliminary,0,0
107865,incremental,0,0
107866,exercise,0,0
107867,test,0,0
107868,),0,1
107869,in,0,0
107870,ten,1,1
107871,fit,1,0
107872,male,1,1
107873,human,1,1
107874,subjects,1,1
107875,.,1,1
107876,Perceived,0,0
107877,exertion,0,0
107878,during,0,0
107879,exhaustive,0,0
107880,cycling,0,1
107881,exercise,0,0
107882,was,0,0
107883,strongly,0,0
107884,correlated,0,0
107885,(,0,0
107886,r,0,0
107887,=,0,1
107888,-0.82,0,0
107889,",",0,1
107890,P,0,0
107891,=,0,1
107892,0.003,0,0
107893,),0,1
107894,with,0,1
107895,time,0,0
107896,to,0,1
107897,exhaustion,0,0
107898,(,0,1
107899,10.5,0,0
107900,+/-,0,1
107901,2.1,0,1
107902,min,0,0
107903,),0,1
107904,.,0,1
107905,These,0,0
107906,results,0,0
107907,challenge,0,0
107908,the,0,0
107909,long-standing,0,1
107910,assumption,0,0
107911,that,0,0
107912,muscle,0,0
107913,fatigue,0,0
107914,causes,0,0
107915,exhaustion,0,0
107916,during,0,0
107917,high-intensity,0,1
107918,aerobic,0,0
107919,exercise,0,0
107920,",",0,0
107921,and,0,0
107922,suggest,0,0
107923,that,0,0
107924,exercise,0,0
107925,tolerance,0,1
107926,in,0,0
107927,highly,0,1
107928,motivated,0,1
107929,subjects,0,1
107930,is,0,0
107931,ultimately,0,0
107932,limited,0,0
107933,by,0,0
107934,perception,0,0
107935,of,0,0
107936,effort,0,1
107937,.,0,1
107938,PSK,0,1
107939,may,0,0
107940,suppress,0,1
107941,CD57,0,0
107942,(,0,1
107943,+,0,0
107944,),0,1
107945,T,0,1
107946,cells,0,0
107947,to,0,1
107948,improve,0,0
107949,survival,0,0
107950,of,0,0
107951,advanced,1,1
107952,gastric,1,1
107953,cancer,1,1
107954,patients,1,1
107955,.,1,1
107956,BACKGROUND,0,0
107957,A,0,1
107958,recent,0,1
107959,report,0,0
107960,showed,0,0
107961,that,0,0
107962,oral,0,1
107963,adjuvant,0,1
107964,immunochemotherapy,0,1
107965,with,0,1
107966,protein-bound,0,0
107967,polysaccharide,0,0
107968,K,0,0
107969,(,0,1
107970,PSK,0,1
107971,),0,1
107972,and,0,0
107973,tegafur/uracil,0,0
107974,(,0,1
107975,UFT,0,1
107976,),0,1
107977,for,0,0
107978,stage,0,1
107979,II,0,1
107980,and,0,1
107981,III,0,1
107982,colorectal,0,1
107983,cancer,0,1
107984,improves,0,0
107985,overall,0,0
107986,survival,0,0
107987,compared,0,0
107988,with,0,1
107989,UFT,0,1
107990,alone,0,1
107991,.,0,0
107992,PSK,0,0
107993,has,0,0
107994,been,0,0
107995,supposed,0,0
107996,to,0,0
107997,improve,0,0
107998,survival,0,0
107999,through,0,1
108000,immunological,0,0
108001,mechanisms,0,0
108002,such,0,0
108003,as,0,0
108004,induction,0,1
108005,of,0,1
108006,cytokines,0,0
108007,",",0,1
108008,regulation,0,0
108009,of,0,0
108010,Th1/Th2,0,0
108011,balance,0,0
108012,",",0,0
108013,and,0,0
108014,inhibition,0,0
108015,of,0,1
108016,immunosuppressive,0,1
108017,molecules,0,1
108018,.,0,1
108019,METHODS,0,0
108020,We,0,0
108021,investigated,0,0
108022,the,0,0
108023,mechanisms,0,0
108024,by,0,0
108025,which,0,0
108026,PSK,0,1
108027,influences,0,0
108028,immunological,0,0
108029,parameters,0,0
108030,such,0,0
108031,as,0,1
108032,Th1,0,1
108033,cells,0,0
108034,(,0,1
108035,IFN-gamma-positive,0,1
108036,CD4,0,1
108037,(,0,1
108038,+,0,0
108039,),0,1
108040,T,0,1
108041,cells,0,0
108042,),0,1
108043,",",0,1
108044,Th2,0,1
108045,cells,0,0
108046,(,0,1
108047,IL-4-positive,0,1
108048,CD4,0,1
108049,(,0,1
108050,+,0,0
108051,),0,1
108052,T,0,1
108053,cells,0,0
108054,),0,1
108055,",",0,1
108056,Th1/Th2,0,0
108057,ratio,0,0
108058,",",0,1
108059,NKT,0,1
108060,cells,0,0
108061,(,0,1
108062,CD56,0,1
108063,(,0,1
108064,+,0,0
108065,),0,1
108066,T,0,1
108067,cells,0,0
108068,and,0,1
108069,CD57,0,1
108070,(,0,1
108071,+,0,0
108072,),0,1
108073,T,0,1
108074,cells,0,0
108075,),0,1
108076,",",0,1
108077,NK,0,0
108078,cells,0,0
108079,",",0,1
108080,and,0,1
108081,CD25,0,0
108082,(,0,1
108083,+,0,0
108084,),0,1
108085,CD4,0,1
108086,(,0,1
108087,+,0,0
108088,),0,1
108089,T,0,1
108090,cells,0,0
108091,in,0,1
108092,stage,1,1
108093,III,1,1
108094,gastric,1,1
108095,cancer,1,1
108096,patients,1,1
108097,.,1,1
108098,Patients,0,1
108099,were,0,0
108100,randomly,0,1
108101,assigned,0,1
108102,to,0,0
108103,receive,0,1
108104,either,0,1
108105,3,0,0
108106,g,0,1
108107,PSK,0,1
108108,plus,0,0
108109,300,0,1
108110,mg,0,1
108111,UFT,0,1
108112,(,0,1
108113,PSK,0,1
108114,group,0,1
108115,),0,1
108116,or,0,1
108117,300,0,1
108118,mg,0,0
108119,UFT,0,1
108120,alone,0,1
108121,(,0,0
108122,control,0,1
108123,),0,0
108124,orally,0,0
108125,each,0,0
108126,day,0,0
108127,for,0,0
108128,at,0,1
108129,least,0,1
108130,1,0,1
108131,year,0,1
108132,following,0,0
108133,their,0,1
108134,operation,0,1
108135,.,0,1
108136,RESULTS,0,0
108137,Twenty-one,1,1
108138,registered,1,1
108139,patients,1,1
108140,with,1,1
108141,stage,1,1
108142,III,1,1
108143,gastric,1,1
108144,cancer,1,1
108145,were,0,1
108146,analyzed,0,0
108147,.,0,1
108148,The,0,0
108149,3-year,0,0
108150,overall,0,0
108151,survival,0,0
108152,was,0,0
108153,62.2,0,1
108154,%,0,0
108155,in,0,0
108156,the,0,0
108157,PSK,0,1
108158,group,0,1
108159,(,0,1
108160,n,0,1
108161,=,0,1
108162,10,0,1
108163,),0,1
108164,and,0,1
108165,12.5,0,0
108166,%,0,0
108167,in,0,0
108168,the,0,0
108169,control,0,1
108170,group,0,0
108171,(,0,1
108172,n,0,1
108173,=,0,1
108174,11,0,1
108175,),0,1
108176,(,0,1
108177,P,0,0
108178,=,0,1
108179,0.038,0,0
108180,),0,1
108181,.,0,1
108182,Before,0,0
108183,operation,0,0
108184,",",0,0
108185,there,0,0
108186,were,0,0
108187,no,0,0
108188,significant,0,0
108189,differences,0,0
108190,in,0,1
108191,the,0,1
108192,proportions,0,0
108193,of,0,1
108194,Th1,0,1
108195,cells,0,0
108196,",",0,1
108197,Th2,0,1
108198,cells,0,0
108199,",",0,1
108200,Th1/Th2,0,0
108201,ratio,0,0
108202,",",0,0
108203,CD56,0,1
108204,(,0,1
108205,+,0,0
108206,),0,1
108207,T,0,1
108208,cells,0,0
108209,",",0,1
108210,CD57,0,1
108211,(,0,1
108212,+,0,0
108213,),0,1
108214,T,0,1
108215,cells,0,0
108216,",",0,1
108217,NK,0,1
108218,cells,0,0
108219,",",0,1
108220,and,0,1
108221,CD4,0,1
108222,(,0,1
108223,+,0,0
108224,),0,1
108225,CD25,0,1
108226,(,0,1
108227,+,0,0
108228,),0,1
108229,T,0,1
108230,cells,0,0
108231,between,0,0
108232,PSK,0,1
108233,and,0,1
108234,control,0,1
108235,groups,0,0
108236,.,0,1
108237,However,0,0
108238,",",0,0
108239,after,0,0
108240,operation,0,1
108241,",",0,1
108242,CD57,0,1
108243,(,0,1
108244,+,0,0
108245,),0,1
108246,T,0,1
108247,cells,0,0
108248,decreased,0,0
108249,significantly,0,0
108250,in,0,0
108251,the,0,0
108252,PSK,0,1
108253,group,0,1
108254,compared,0,0
108255,to,0,0
108256,the,0,0
108257,control,0,0
108258,(,0,0
108259,P,0,0
108260,=,0,1
108261,0.0486,0,0
108262,),0,0
108263,.,0,0
108264,When,0,0
108265,all,0,0
108266,patients,0,1
108267,were,0,1
108268,analyzed,0,0
108269,",",0,0
108270,patients,0,1
108271,with,0,1
108272,increased,0,0
108273,proportion,0,1
108274,(,0,1
108275,>,0,1
108276,18,0,1
108277,%,0,0
108278,),0,1
108279,of,0,0
108280,CD57,0,1
108281,(,0,1
108282,+,0,0
108283,),0,1
108284,T,0,1
108285,cells,0,0
108286,showed,0,0
108287,worse,0,0
108288,survival,0,0
108289,than,0,0
108290,those,0,0
108291,with,0,1
108292,lower,0,0
108293,(,0,1
108294,<,0,0
108295,or,0,1
108296,=,0,1
108297,18,0,1
108298,%,0,0
108299,),0,1
108300,CD57,0,1
108301,(,0,1
108302,+,0,0
108303,),0,1
108304,T,0,1
108305,cells,0,0
108306,(,0,1
108307,3-year,0,1
108308,survival,0,0
108309,",",0,1
108310,25.0,0,0
108311,and,0,1
108312,45.7,0,0
108313,%,0,0
108314,",",0,0
108315,respectively,0,0
108316,;,0,0
108317,P,0,0
108318,=,0,1
108319,0.046,0,0
108320,),0,1
108321,",",0,0
108322,consistent,0,0
108323,with,0,1
108324,our,0,1
108325,previous,0,1
108326,report,0,0
108327,that,0,0
108328,high,0,1
108329,CD57,0,1
108330,(,0,1
108331,+,0,0
108332,),0,0
108333,is,0,0
108334,an,0,0
108335,indicator,0,0
108336,of,0,0
108337,poor,0,1
108338,prognosis,0,1
108339,in,0,1
108340,patients,0,1
108341,with,0,1
108342,advanced,0,1
108343,gastric,0,1
108344,cancer,0,1
108345,.,0,1
108346,However,0,0
108347,",",0,0
108348,in,0,0
108349,the,0,0
108350,group,0,0
108351,treated,0,1
108352,with,0,1
108353,PSK,0,1
108354,+,0,0
108355,UFT,0,1
108356,",",0,0
108357,3-year,0,1
108358,survival,0,0
108359,of,0,1
108360,CD57-high,0,1
108361,patients,0,1
108362,was,0,0
108363,as,0,0
108364,great,0,0
108365,as,0,0
108366,that,0,0
108367,of,0,0
108368,CD57-low,0,1
108369,patients,0,1
108370,(,0,1
108371,66.7,0,1
108372,and,0,1
108373,51.4,0,1
108374,%,0,0
108375,",",0,0
108376,respectively,0,0
108377,;,0,0
108378,P,0,0
108379,=,0,1
108380,0.67,0,0
108381,),0,1
108382,.,0,1
108383,CONCLUSION,0,0
108384,The,0,0
108385,present,0,0
108386,findings,0,0
108387,suggest,0,0
108388,that,0,0
108389,PSK,0,1
108390,improves,0,0
108391,overall,0,0
108392,survival,0,0
108393,of,0,0
108394,stage,1,1
108395,III,1,1
108396,gastric,1,1
108397,cancer,1,1
108398,patients,1,1
108399,partly,0,0
108400,by,0,0
108401,inhibiting,0,0
108402,CD57,0,1
108403,(,0,1
108404,+,0,0
108405,),0,1
108406,T,0,1
108407,cells,0,0
108408,",",0,1
108409,a,0,1
108410,proven,0,0
108411,poor,0,1
108412,prognostic,0,0
108413,factor,0,0
108414,in,0,1
108415,advanced,0,1
108416,gastric,0,1
108417,cancer,0,1
108418,.,0,1
108419,Efficacy,0,0
108420,and,0,0
108421,safety,0,0
108422,of,0,0
108423,a,0,1
108424,high,0,1
108425,protein,0,0
108426,",",0,0
108427,low,0,0
108428,carbohydrate,0,0
108429,diet,0,1
108430,for,0,0
108431,weight,0,1
108432,loss,0,0
108433,in,0,1
108434,severely,1,1
108435,obese,1,1
108436,adolescents,1,1
108437,.,1,1
108438,OBJECTIVE,0,0
108439,To,0,0
108440,evaluate,0,0
108441,the,0,0
108442,efficacy,0,0
108443,and,0,0
108444,safety,0,0
108445,of,0,0
108446,a,0,1
108447,carbohydrate,0,0
108448,restricted,0,1
108449,versus,0,0
108450,a,0,1
108451,low,0,1
108452,fat,0,0
108453,diet,0,1
108454,on,0,0
108455,weight,0,1
108456,loss,0,0
108457,",",0,1
108458,metabolic,0,1
108459,markers,0,0
108460,",",0,1
108461,body,0,1
108462,composition,0,0
108463,",",0,0
108464,and,0,0
108465,cardiac,0,1
108466,function,0,0
108467,tests,0,0
108468,in,0,1
108469,severely,1,1
108470,obese,1,1
108471,adolescents,1,1
108472,.,1,1
108473,STUDY,0,0
108474,DESIGN,0,1
108475,Subjects,0,1
108476,were,0,1
108477,randomly,0,1
108478,assigned,0,1
108479,to,0,0
108480,1,0,1
108481,of,0,1
108482,2,0,1
108483,diets,0,1
108484,:,0,1
108485,a,0,1
108486,high,0,0
108487,protein,0,0
108488,",",0,0
108489,low,0,0
108490,carbohydrate,0,0
108491,(,0,1
108492,20,0,1
108493,g/d,0,0
108494,),0,1
108495,diet,0,0
108496,(,0,1
108497,high,0,1
108498,protein,0,0
108499,",",0,0
108500,low,0,0
108501,carbohydrate,0,0
108502,",",0,1
108503,HPLC,0,1
108504,),0,1
108505,or,0,1
108506,low,0,1
108507,fat,0,1
108508,(,0,1
108509,30,0,1
108510,%,0,0
108511,of,0,1
108512,calories,0,1
108513,),0,1
108514,regimen,0,1
108515,for,0,0
108516,13,0,1
108517,weeks,0,1
108518,;,0,1
108519,close,0,0
108520,monitoring,0,0
108521,was,0,0
108522,maintained,0,0
108523,to,0,0
108524,evaluate,0,0
108525,safety,0,0
108526,.,0,0
108527,After,0,0
108528,the,0,0
108529,intervention,0,0
108530,",",0,0
108531,no,0,0
108532,clinical,0,0
108533,contact,0,0
108534,was,0,0
108535,made,0,0
108536,until,0,1
108537,follow-up,0,1
108538,measurements,0,0
108539,were,0,1
108540,obtained,0,0
108541,at,0,1
108542,24,0,1
108543,and,0,1
108544,36,0,1
108545,weeks,0,0
108546,from,0,1
108547,baseline,0,1
108548,.,0,1
108549,The,0,0
108550,primary,0,1
108551,outcome,0,0
108552,was,0,0
108553,change,0,0
108554,in,0,0
108555,body,0,1
108556,mass,0,1
108557,index,0,1
108558,Z-score,0,0
108559,for,0,0
108560,age,0,1
108561,and,0,1
108562,sex,0,0
108563,(,0,1
108564,BMI-Z,0,1
108565,),0,1
108566,at,0,1
108567,13,0,1
108568,",",0,1
108569,24,0,0
108570,",",0,0
108571,and,0,1
108572,36,0,1
108573,weeks,0,1
108574,.,0,1
108575,RESULTS,0,0
108576,Forty-six,1,1
108577,subjects,1,1
108578,(,1,1
108579,24,1,1
108580,HPLC,1,1
108581,",",1,1
108582,22,1,1
108583,in,1,0
108584,low,1,1
108585,fat,1,1
108586,),1,1
108587,initiated,1,0
108588,and,1,1
108589,33,1,1
108590,subjects,1,1
108591,completed,1,1
108592,the,1,0
108593,intervention,1,0
108594,;,1,1
108595,follow-up,0,1
108596,data,0,0
108597,were,0,1
108598,available,0,0
108599,on,0,0
108600,approximately,0,1
108601,half,0,1
108602,of,0,0
108603,the,0,0
108604,subjects,0,1
108605,.,0,1
108606,Significant,0,0
108607,reduction,0,0
108608,in,0,0
108609,(,0,1
108610,BMI-Z,0,1
108611,),0,1
108612,was,0,0
108613,achieved,0,0
108614,in,0,0
108615,both,0,0
108616,groups,0,0
108617,during,0,0
108618,intervention,0,1
108619,and,0,0
108620,was,0,0
108621,significantly,0,0
108622,greater,0,0
108623,for,0,0
108624,the,0,0
108625,HPLC,0,1
108626,group,0,1
108627,(,0,1
108628,P,0,0
108629,=,0,1
108630,.03,0,0
108631,),0,1
108632,.,0,1
108633,Both,0,0
108634,groups,0,0
108635,maintained,0,0
108636,significant,0,0
108637,BMI-Z,0,1
108638,reduction,0,0
108639,at,0,1
108640,follow-up,0,1
108641,;,0,1
108642,changes,0,0
108643,were,0,1
108644,not,0,0
108645,significantly,0,0
108646,different,0,0
108647,between,0,0
108648,groups,0,1
108649,.,0,1
108650,Loss,0,0
108651,of,0,0
108652,lean,0,1
108653,body,0,1
108654,mass,0,1
108655,was,0,0
108656,not,0,0
108657,spared,0,0
108658,in,0,0
108659,the,0,0
108660,HPLC,0,1
108661,group,0,1
108662,.,0,1
108663,No,0,0
108664,serious,0,0
108665,adverse,0,0
108666,effects,0,0
108667,were,0,1
108668,observed,0,0
108669,related,0,0
108670,to,0,1
108671,metabolic,0,1
108672,profiles,0,0
108673,",",0,1
108674,cardiac,0,1
108675,function,0,0
108676,",",0,0
108677,or,0,1
108678,subjective,0,0
108679,complaints,0,1
108680,.,0,1
108681,CONCLUSIONS,0,0
108682,The,0,0
108683,HPLC,0,0
108684,diet,0,0
108685,is,0,0
108686,a,0,0
108687,safe,0,0
108688,and,0,0
108689,effective,0,0
108690,option,0,0
108691,for,0,0
108692,medically,0,1
108693,supervised,0,1
108694,weight,0,0
108695,loss,0,0
108696,in,0,1
108697,severely,1,1
108698,obese,1,1
108699,adolescents,1,1
108700,.,1,1
108701,Short-term,0,1
108702,effects,0,0
108703,of,0,1
108704,systemic,0,1
108705,antibiotics,0,0
108706,during,0,1
108707,periodontal,1,1
108708,healing,1,0
108709,.,1,1
108710,OBJECTIVES,0,0
108711,To,0,0
108712,investigate,0,0
108713,the,0,0
108714,short-term,0,0
108715,effects,0,0
108716,of,0,1
108717,nonsurgical,1,1
108718,therapy,1,1
108719,(,1,1
108720,scaling,1,0
108721,and,1,0
108722,root,1,1
108723,planing,1,0
108724,",",1,0
108725,SRP,1,0
108726,),1,0
108727,on,1,0
108728,the,1,0
108729,subgingival,1,0
108730,microbiota,1,0
108731,in,1,0
108732,chronic,1,1
108733,(,1,1
108734,CP,1,1
108735,),1,1
108736,and,1,1
108737,aggressive,1,1
108738,(,1,1
108739,AP,1,1
108740,),1,1
108741,periodontal,1,1
108742,disease,1,1
108743,.,1,1
108744,METHOD,0,0
108745,AND,0,0
108746,MATERIALS,0,1
108747,Ninety-seven,1,1
108748,CP,1,1
108749,and,1,1
108750,AP,1,1
108751,subjects,1,1
108752,underwent,1,1
108753,full-mouth,1,1
108754,SRP,1,1
108755,on,1,1
108756,2,1,1
108757,consecutive,1,1
108758,days,1,1
108759,.,1,1
108760,AP,0,1
108761,patients,0,1
108762,were,0,1
108763,randomly,0,1
108764,assigned,0,1
108765,to,0,0
108766,either,0,1
108767,receive,0,1
108768,systemic,0,0
108769,metronidazole,0,0
108770,plus,0,0
108771,amoxicillin,0,0
108772,(,0,1
108773,AP+AB,0,1
108774,),0,1
108775,or,0,1
108776,were,0,0
108777,treated,0,1
108778,mechanically,0,1
108779,alone,0,0
108780,(,0,0
108781,AP,0,1
108782,),0,1
108783,.,0,1
108784,Pathogens,0,0
108785,were,0,0
108786,identified,0,1
108787,with,0,1
108788,16S,0,1
108789,rRNA,0,1
108790,oligodeoxynucleotide,0,0
108791,probes,0,1
108792,and,0,1
108793,dot-blot,0,0
108794,hybridization,0,0
108795,before,0,0
108796,and,0,1
108797,at,0,1
108798,days,0,0
108799,2,0,1
108800,",",0,1
108801,3,0,0
108802,",",0,0
108803,4,0,0
108804,",",0,0
108805,7,0,1
108806,",",0,0
108807,10,0,1
108808,",",0,0
108809,and,0,0
108810,21,0,1
108811,of,0,0
108812,healing,0,0
108813,.,0,1
108814,CP,0,0
108815,subjects,0,1
108816,were,0,1
108817,treated,0,1
108818,by,0,0
108819,scaling,0,0
108820,and,0,1
108821,root,0,1
108822,planing,0,0
108823,along,0,0
108824,with,0,1
108825,placebo,0,1
108826,tablets,0,1
108827,.,0,1
108828,RESULTS,0,0
108829,Initially,0,1
108830,",",0,1
108831,AP,0,1
108832,cell,0,1
108833,counts,0,0
108834,were,0,1
108835,69.9-,0,1
108836,(,0,1
108837,Porphyromonas,0,0
108838,gingivalis,0,0
108839,),0,1
108840,",",0,0
108841,10.2-,0,0
108842,(,0,1
108843,Aggregatibacter,0,1
108844,actinomycetemcomitans,0,1
108845,),0,1
108846,",",0,1
108847,5.7-,0,1
108848,(,0,1
108849,Tannerella,0,1
108850,forsythia,0,1
108851,),0,1
108852,",",0,0
108853,and,0,0
108854,3.3-fold,0,0
108855,(,0,1
108856,Prevotella,0,0
108857,intermedia,0,1
108858,),0,1
108859,enhanced,0,0
108860,compared,0,0
108861,to,0,1
108862,CP,0,0
108863,cell,0,1
108864,counts,0,0
108865,.,0,1
108866,Following,0,0
108867,SRP,0,0
108868,",",0,1
108869,immediate,0,0
108870,elimination,0,0
108871,occurred,0,0
108872,in,0,0
108873,single,0,0
108874,individuals,0,1
108875,of,0,1
108876,all,0,1
108877,three,0,0
108878,treatment,0,0
108879,groups,0,1
108880,at,0,1
108881,day,0,1
108882,2,0,1
108883,.,0,1
108884,After,0,0
108885,SRP,0,0
108886,plus,0,0
108887,antibiotic,0,0
108888,therapy,0,0
108889,(,0,1
108890,AP+AB,0,1
108891,),0,1
108892,",",0,0
108893,the,0,0
108894,prevalence,0,0
108895,scores,0,0
108896,dropped,0,0
108897,beyond,0,1
108898,the,0,0
108899,levels,0,0
108900,of,0,1
108901,AP,0,1
108902,and,0,1
108903,CP,0,0
108904,",",0,0
108905,beginning,0,0
108906,at,0,0
108907,day,0,0
108908,7,0,1
108909,",",0,0
108910,and,0,0
108911,remained,0,0
108912,low,0,1
108913,until,0,1
108914,day,0,1
108915,21,0,1
108916,(,0,1
108917,P,0,0
108918,=or,0,1
108919,<,0,0
108920,.05,0,0
108921,),0,1
108922,.,0,1
108923,Clinical,0,0
108924,healing,0,0
108925,statistically,0,0
108926,benefited,0,1
108927,from,0,0
108928,SRP,0,0
108929,with,0,1
108930,no,0,0
108931,differences,0,0
108932,among,0,1
108933,the,0,1
108934,three,0,0
108935,treatment,0,1
108936,groups,0,1
108937,.,0,1
108938,CONCLUSION,0,0
108939,Nonsurgical,0,1
108940,therapy,0,0
108941,resulted,0,0
108942,in,0,0
108943,both,0,0
108944,a,0,0
108945,suppression,0,0
108946,and,0,0
108947,early,0,1
108948,elimination,0,0
108949,of,0,0
108950,single,0,0
108951,taxa,0,1
108952,immediately,0,0
108953,after,0,0
108954,completion,0,0
108955,of,0,0
108956,active,0,1
108957,treatment,0,1
108958,.,0,1
108959,Systemic,0,0
108960,antibiotics,0,0
108961,significantly,0,0
108962,accelerate,0,0
108963,the,0,0
108964,suppression,0,0
108965,of,0,0
108966,the,0,0
108967,periodontal,0,1
108968,microflora,0,0
108969,",",0,0
108970,but,0,0
108971,have,0,0
108972,limited,0,0
108973,effect,0,0
108974,on,0,0
108975,the,0,0
108976,elimination,0,0
108977,of,0,0
108978,target,0,0
108979,isolates,0,1
108980,during,0,1
108981,healing,0,0
108982,.,0,1
108983,The,0,0
108984,ScanBrit,0,0
108985,randomised,0,0
108986,",",0,0
108987,controlled,0,0
108988,",",0,0
108989,single-blind,0,0
108990,study,0,0
108991,of,0,0
108992,a,0,1
108993,gluten-,0,1
108994,and,0,0
108995,casein-free,0,1
108996,dietary,0,0
108997,intervention,0,1
108998,for,0,1
108999,children,1,1
109000,with,1,1
109001,autism,1,1
109002,spectrum,1,1
109003,disorders,1,1
109004,.,1,0
109005,There,0,0
109006,is,0,0
109007,increasing,0,0
109008,interest,0,0
109009,in,0,0
109010,the,0,0
109011,use,0,0
109012,of,0,0
109013,gluten-,0,1
109014,and,0,1
109015,casein-free,0,1
109016,diets,0,0
109017,for,0,1
109018,children,1,1
109019,with,1,1
109020,autism,1,1
109021,spectrum,1,1
109022,disorders,1,1
109023,(,1,1
109024,ASDs,1,1
109025,),1,1
109026,.,1,1
109027,We,0,0
109028,report,0,0
109029,results,0,0
109030,from,0,1
109031,a,0,1
109032,two-stage,0,0
109033,",",0,0
109034,24-month,0,0
109035,",",0,0
109036,randomised,0,0
109037,",",0,0
109038,controlled,0,0
109039,trial,0,0
109040,incorporating,0,0
109041,an,0,0
109042,adaptive,0,0
109043,'catch-up,0,1
109044,',0,1
109045,design,0,1
109046,and,0,1
109047,interim,0,0
109048,analysis,0,0
109049,.,0,1
109050,Stage,0,0
109051,1,0,0
109052,of,0,0
109053,the,0,0
109054,trial,0,0
109055,saw,0,0
109056,72,1,1
109057,Danish,1,1
109058,children,1,1
109059,(,1,1
109060,aged,1,1
109061,4,1,1
109062,years,1,1
109063,to,1,1
109064,10,1,1
109065,years,1,1
109066,11,1,1
109067,months,1,1
109068,),1,1
109069,assigned,1,1
109070,to,1,0
109071,diet,1,0
109072,(,1,0
109073,A,1,1
109074,),1,0
109075,or,1,1
109076,non-diet,1,1
109077,(,1,1
109078,B,1,1
109079,),1,1
109080,groups,1,0
109081,by,1,1
109082,stratified,1,1
109083,randomisation,1,1
109084,.,1,1
109085,Autism,0,1
109086,Diagnostic,0,1
109087,Observation,0,1
109088,Schedule,0,0
109089,(,0,1
109090,ADOS,0,0
109091,),0,1
109092,and,0,0
109093,the,0,0
109094,Gilliam,0,1
109095,Autism,0,1
109096,Rating,0,0
109097,Scale,0,1
109098,(,0,1
109099,GARS,0,1
109100,),0,1
109101,were,0,1
109102,used,0,0
109103,to,0,0
109104,assess,0,0
109105,core,0,1
109106,autism,0,1
109107,behaviours,0,0
109108,",",0,1
109109,Vineland,0,1
109110,Adaptive,0,0
109111,Behaviour,0,1
109112,Scales,0,0
109113,(,0,1
109114,VABS,0,0
109115,),0,1
109116,to,0,0
109117,ascertain,0,0
109118,developmental,0,1
109119,level,0,0
109120,",",0,0
109121,and,0,0
109122,Attention-Deficit,0,1
109123,Hyperactivity,0,1
109124,Disorder,0,1
109125,-,0,1
109126,IV,0,1
109127,scale,0,0
109128,(,0,1
109129,ADHD-IV,0,1
109130,),0,1
109131,to,0,0
109132,determine,0,0
109133,inattention,0,0
109134,and,0,0
109135,hyperactivity,0,1
109136,.,0,1
109137,Participants,0,1
109138,were,0,0
109139,tested,0,0
109140,at,0,0
109141,baseline,0,0
109142,",",0,1
109143,8,0,0
109144,",",0,0
109145,and,0,1
109146,12,0,1
109147,months,0,1
109148,.,0,1
109149,Based,0,0
109150,on,0,0
109151,per,0,1
109152,protocol,0,1
109153,repeated,0,0
109154,measures,0,0
109155,analysis,0,0
109156,",",0,1
109157,data,0,0
109158,for,0,1
109159,26,1,1
109160,diet,1,1
109161,children,1,1
109162,and,1,1
109163,29,1,1
109164,controls,1,1
109165,were,0,1
109166,available,0,1
109167,at,0,1
109168,12,0,1
109169,months,0,1
109170,.,0,1
109171,At,0,0
109172,this,0,0
109173,point,0,0
109174,",",0,0
109175,there,0,0
109176,was,0,0
109177,a,0,0
109178,significant,0,0
109179,improvement,0,0
109180,to,0,0
109181,mean,0,1
109182,diet,0,1
109183,group,0,1
109184,scores,0,0
109185,(,0,1
109186,time*treatment,0,0
109187,interaction,0,0
109188,),0,1
109189,on,0,0
109190,sub-domains,0,0
109191,of,0,1
109192,ADOS,0,0
109193,",",0,1
109194,GARS,0,0
109195,and,0,1
109196,ADHD-IV,0,1
109197,measures,0,0
109198,.,0,1
109199,Surpassing,0,0
109200,of,0,0
109201,predefined,0,1
109202,statistical,0,0
109203,thresholds,0,0
109204,as,0,0
109205,evidence,0,0
109206,of,0,0
109207,improvement,0,0
109208,in,0,0
109209,group,0,1
109210,A,0,1
109211,at,0,1
109212,12,0,1
109213,months,0,1
109214,sanctioned,0,1
109215,the,0,0
109216,re-assignment,0,0
109217,of,0,0
109218,group,0,1
109219,B,0,1
109220,participants,0,1
109221,to,0,1
109222,active,0,1
109223,dietary,0,0
109224,treatment,0,1
109225,.,0,1
109226,Stage,0,1
109227,2,0,1
109228,data,0,0
109229,for,0,1
109230,18,0,1
109231,group,0,1
109232,A,0,1
109233,and,0,1
109234,17,0,1
109235,group,0,1
109236,B,0,1
109237,participants,0,1
109238,were,0,1
109239,available,0,1
109240,at,0,1
109241,24,0,1
109242,months,0,1
109243,.,0,1
109244,Multiple,0,0
109245,scenario,0,0
109246,analysis,0,0
109247,based,0,1
109248,on,0,0
109249,inter-,0,0
109250,and,0,1
109251,intra-group,0,0
109252,comparisons,0,0
109253,showed,0,0
109254,some,0,0
109255,evidence,0,0
109256,of,0,0
109257,sustained,0,1
109258,clinical,0,1
109259,group,0,1
109260,improvements,0,0
109261,although,0,0
109262,possibly,0,0
109263,indicative,0,0
109264,of,0,0
109265,a,0,1
109266,plateau,0,0
109267,effect,0,0
109268,for,0,0
109269,intervention,0,1
109270,.,0,1
109271,Our,0,0
109272,results,0,0
109273,suggest,0,0
109274,that,0,0
109275,dietary,0,0
109276,intervention,0,0
109277,may,0,0
109278,positively,0,0
109279,affect,0,0
109280,developmental,0,1
109281,outcome,0,0
109282,for,0,0
109283,some,0,1
109284,children,1,1
109285,diagnosed,1,1
109286,with,1,1
109287,ASD,1,1
109288,.,1,1
109289,In,0,0
109290,the,0,0
109291,absence,0,0
109292,of,0,0
109293,a,0,0
109294,placebo,0,0
109295,condition,0,0
109296,to,0,0
109297,the,0,0
109298,current,0,0
109299,investigation,0,0
109300,",",0,0
109301,we,0,0
109302,are,0,0
109303,",",0,0
109304,however,0,0
109305,",",0,0
109306,unable,0,0
109307,to,0,0
109308,disqualify,0,1
109309,potential,0,0
109310,effects,0,0
109311,derived,0,1
109312,from,0,1
109313,intervention,0,0
109314,outside,0,1
109315,of,0,1
109316,dietary,0,1
109317,changes,0,0
109318,.,0,1
109319,Further,0,0
109320,studies,0,0
109321,are,0,0
109322,required,0,0
109323,to,0,0
109324,ascertain,0,0
109325,potential,0,0
109326,best-,0,0
109327,and,0,1
109328,non-responders,0,0
109329,to,0,1
109330,intervention,0,1
109331,.,0,1
109332,The,0,0
109333,study,0,0
109334,was,0,0
109335,registered,0,1
109336,with,0,1
109337,ClincialTrials.gov,0,1
109338,",",0,1
109339,number,0,0
109340,NCT00614198,0,1
109341,.,0,1
109342,Beneficial,0,0
109343,effect,0,0
109344,of,0,0
109345,etidronate,0,0
109346,therapy,0,0
109347,in,0,0
109348,chronically,1,1
109349,hospitalized,1,1
109350,",",1,0
109351,disabled,1,1
109352,patients,1,1
109353,with,1,1
109354,stroke,1,1
109355,.,1,1
109356,Incidence,0,0
109357,of,0,0
109358,hip,0,1
109359,fractures,0,1
109360,is,0,0
109361,high,0,0
109362,in,0,0
109363,chronically,1,1
109364,hospitalized,1,1
109365,",",1,0
109366,disabled,1,1
109367,",",1,0
109368,elderly,1,1
109369,patients,1,1
109370,after,1,1
109371,stroke,1,1
109372,.,1,1
109373,Duration,1,0
109374,of,1,0
109375,hospitalization,1,1
109376,was,1,0
109377,more,1,0
109378,than,1,0
109379,1,1,0
109380,year,1,1
109381,because,1,0
109382,of,1,0
109383,insufficiency,1,1
109384,of,1,1
109385,nursing,1,1
109386,homes,1,1
109387,.,1,1
109388,Our,0,0
109389,study,0,0
109390,showed,0,0
109391,that,0,0
109392,immobilization-induced,0,0
109393,hypercalcemia,0,1
109394,and,0,1
109395,25-hydroxyvitamin,0,1
109396,D,0,1
109397,deficiency,0,1
109398,contribute,0,0
109399,to,0,0
109400,reduced,0,0
109401,bone,0,0
109402,mineral,0,0
109403,density,0,0
109404,(,0,1
109405,BMD,0,1
109406,),0,1
109407,.,0,1
109408,This,0,0
109409,study,0,0
109410,was,0,0
109411,designed,0,0
109412,to,0,0
109413,address,0,0
109414,the,0,0
109415,possibility,0,0
109416,that,0,0
109417,treatment,0,0
109418,with,0,1
109419,etidronate,0,0
109420,may,0,0
109421,reduce,0,0
109422,the,0,0
109423,bone,0,0
109424,resorption,0,0
109425,and,0,0
109426,lower,0,0
109427,the,0,0
109428,incidence,0,0
109429,of,0,0
109430,fractures,0,1
109431,in,0,1
109432,elderly,1,1
109433,patients,1,1
109434,who,1,1
109435,are,1,1
109436,chronically,1,1
109437,hospitalized,1,1
109438,and,1,0
109439,disabled,1,1
109440,as,1,0
109441,a,1,0
109442,result,1,0
109443,of,1,0
109444,hemiparesis,1,1
109445,after,1,1
109446,stroke,1,1
109447,.,1,1
109448,Patients,1,1
109449,with,1,1
109450,stroke,1,1
109451,were,0,1
109452,randomly,0,1
109453,assigned,0,1
109454,to,0,0
109455,daily,0,0
109456,treatment,0,0
109457,with,0,1
109458,400,0,0
109459,mg,0,1
109460,of,0,1
109461,etidronate,0,0
109462,(,0,1
109463,n,0,1
109464,=,0,1
109465,40,0,1
109466,),0,1
109467,or,0,1
109468,a,0,1
109469,placebo,0,0
109470,(,0,0
109471,n,0,1
109472,=,0,1
109473,40,0,1
109474,),0,1
109475,",",0,0
109476,and,0,0
109477,followed,0,0
109478,up,0,1
109479,for,0,1
109480,2,0,1
109481,years,0,1
109482,.,0,1
109483,At,0,0
109484,baseline,0,0
109485,",",0,0
109486,both,0,0
109487,groups,0,0
109488,had,0,1
109489,low,0,1
109490,BMD,0,1
109491,with,0,1
109492,high,0,1
109493,levels,0,0
109494,of,0,1
109495,serum,0,0
109496,ionized,0,0
109497,calcium,0,0
109498,and,0,0
109499,urinary,0,1
109500,deoxypyridinoline,0,0
109501,.,0,1
109502,In,0,0
109503,the,0,0
109504,etidronate,0,0
109505,group,0,0
109506,",",0,0
109507,serum,0,0
109508,calcium,0,0
109509,and,0,0
109510,urinary,0,1
109511,deoxypyridinoline,0,0
109512,levels,0,0
109513,decreased,0,0
109514,significantly,0,0
109515,during,0,0
109516,the,0,0
109517,study,0,0
109518,period,0,0
109519,",",0,0
109520,whereas,0,0
109521,the,0,0
109522,levels,0,0
109523,in,0,0
109524,the,0,0
109525,placebo,0,0
109526,group,0,0
109527,were,0,1
109528,increased,0,0
109529,.,0,1
109530,BMD,0,0
109531,on,0,0
109532,the,0,0
109533,hemiplegic,0,1
109534,side,0,0
109535,increased,0,0
109536,by,0,0
109537,1.4,0,0
109538,%,0,0
109539,in,0,0
109540,the,0,0
109541,etidronate,0,0
109542,group,0,0
109543,and,0,0
109544,decreased,0,0
109545,by,0,0
109546,2.2,0,0
109547,%,0,0
109548,in,0,0
109549,the,0,0
109550,placebo,0,0
109551,group,0,0
109552,(,0,1
109553,P,0,0
109554,<,0,0
109555,.001,0,0
109556,),0,1
109557,.,0,1
109558,Two,0,1
109559,patients,0,1
109560,sustained,0,1
109561,hip,0,1
109562,fractures,0,1
109563,in,0,1
109564,the,0,0
109565,placebo,0,0
109566,group,0,0
109567,",",0,0
109568,and,0,0
109569,no,0,0
109570,hip,0,1
109571,fracture,0,1
109572,occurred,0,0
109573,in,0,0
109574,the,0,0
109575,etidronate,0,0
109576,group,0,1
109577,.,0,1
109578,Treatment,0,0
109579,with,0,1
109580,etidronate,0,0
109581,increases,0,0
109582,BMD,0,1
109583,in,0,1
109584,chronically,1,1
109585,hospitalized,1,1
109586,patients,1,1
109587,poststroke,1,1
109588,",",0,0
109589,and,0,0
109590,may,0,0
109591,prevent,0,0
109592,hip,0,1
109593,fracture,0,1
109594,.,0,1
109595,Capsaicin,0,0
109596,jelly,0,0
109597,against,0,0
109598,migraine,1,1
109599,pain,1,1
109600,.,1,1
109601,OBJECTIVE,0,0
109602,Recent,0,1
109603,studies,0,0
109604,support,0,0
109605,the,0,0
109606,role,0,0
109607,of,0,0
109608,extracranial,0,1
109609,perivascular,0,1
109610,afferents,0,1
109611,in,0,1
109612,a,0,1
109613,substantial,0,0
109614,percentage,0,0
109615,of,0,1
109616,migraineurs,1,1
109617,.,1,1
109618,Perivascular,0,1
109619,afferent,0,1
109620,fibres,0,0
109621,of,0,1
109622,the,0,1
109623,superficial,0,1
109624,temporal,0,0
109625,artery,0,1
109626,contain,0,0
109627,peptides,0,0
109628,",",0,1
109629,like,0,0
109630,calcitonin,0,0
109631,gene-related,0,0
109632,peptide,0,0
109633,(,0,1
109634,CGRP,0,1
109635,),0,1
109636,and,0,0
109637,substance,0,1
109638,P,0,0
109639,(,0,1
109640,SP,0,1
109641,),0,1
109642,.,0,1
109643,CGRP,0,0
109644,and,0,0
109645,SP,0,1
109646,are,0,0
109647,considered,0,0
109648,relevant,0,0
109649,in,0,0
109650,the,0,0
109651,genesis,0,0
109652,of,0,0
109653,migraine,0,1
109654,pain,0,1
109655,.,0,1
109656,Capsaicin,0,0
109657,is,0,0
109658,an,0,0
109659,agonist,0,0
109660,of,0,0
109661,the,0,0
109662,transient,0,0
109663,receptor,0,0
109664,potential,0,0
109665,vanilloid,0,0
109666,type,0,1
109667,1,0,1
109668,.,0,1
109669,It,0,0
109670,causes,0,0
109671,membrane,0,0
109672,depolarisation,0,0
109673,of,0,1
109674,sensory,0,1
109675,neurons,0,1
109676,",",0,0
109677,which,0,0
109678,release,0,0
109679,CGRP,0,0
109680,",",0,1
109681,SP,0,1
109682,and,0,0
109683,other,0,1
109684,pain,0,1
109685,peptides,0,0
109686,;,0,1
109687,excitation,0,0
109688,is,0,0
109689,followed,0,0
109690,by,0,0
109691,a,0,0
109692,refractory,0,1
109693,state,0,1
109694,",",0,0
109695,causing,0,0
109696,inactivation,0,0
109697,.,0,1
109698,Topical,0,0
109699,capsaicin,0,0
109700,has,0,0
109701,been,0,0
109702,found,0,0
109703,to,0,0
109704,be,0,0
109705,efficacious,0,0
109706,in,0,1
109707,several,0,1
109708,types,0,1
109709,of,0,1
109710,neuropathic,0,1
109711,pain,0,1
109712,.,0,1
109713,We,0,0
109714,attempted,0,0
109715,to,0,0
109716,verify,0,0
109717,whether,0,0
109718,topical,0,0
109719,periarterial,0,0
109720,capsaicin,0,0
109721,could,0,0
109722,ameliorate,0,0
109723,pain,0,0
109724,in,0,0
109725,absence,0,0
109726,of,0,0
109727,and,0,0
109728,during,0,0
109729,a,0,1
109730,migraine,0,1
109731,attack,0,1
109732,.,0,1
109733,METHODS,0,0
109734,On,0,1
109735,23,1,1
109736,migraineurs,1,1
109737,showing,1,0
109738,pain,1,1
109739,at,1,0
109740,pressure,1,0
109741,on,1,0
109742,scalp,1,1
109743,arteries,1,1
109744,",",0,1
109745,we,0,0
109746,administered,0,0
109747,topical,0,0
109748,capsaicin,0,0
109749,0.1,0,0
109750,%,0,0
109751,or,0,1
109752,vaseline,0,0
109753,jelly,0,0
109754,on,0,0
109755,painful,0,1
109756,arteries,0,1
109757,in,0,1
109758,absence,0,0
109759,of,0,0
109760,migraine,0,1
109761,attack,0,1
109762,.,0,1
109763,In,0,0
109764,those,0,0
109765,having,0,1
109766,pain,0,1
109767,reduction,0,0
109768,>,0,1
109769,50,0,1
109770,%,0,0
109771,",",0,0
109772,we,0,0
109773,made,0,0
109774,the,0,0
109775,same,0,0
109776,comparison,0,0
109777,during,0,0
109778,a,0,1
109779,migraine,0,1
109780,attack,0,1
109781,.,0,1
109782,RESULTS,0,0
109783,Topical,0,1
109784,capsaicin,0,0
109785,caused,0,0
109786,>,0,1
109787,50,0,1
109788,%,0,0
109789,reduction,0,0
109790,of,0,0
109791,arterial,0,1
109792,pain,0,1
109793,in,0,0
109794,absence,0,0
109795,of,0,0
109796,attack,0,1
109797,in,0,1
109798,17/23,0,1
109799,patients,0,1
109800,",",0,1
109801,as,0,0
109802,opposed,0,0
109803,to,0,1
109804,two,0,0
109805,with,0,1
109806,vaseline,0,0
109807,.,0,1
109808,During,0,0
109809,attacks,0,0
109810,of,0,1
109811,mild-,0,1
109812,to,0,0
109813,moderate-intensity,0,0
109814,",",0,0
109815,>,0,1
109816,50,0,1
109817,%,0,0
109818,improvement,0,0
109819,was,0,0
109820,obtained,0,0
109821,in,0,0
109822,11/17,0,1
109823,with,0,1
109824,capsaicin,0,0
109825,and,0,1
109826,in,0,0
109827,one,0,1
109828,with,0,1
109829,vaseline,0,0
109830,.,0,1
109831,CONCLUSIONS,0,0
109832,Although,0,0
109833,referring,0,1
109834,to,0,1
109835,a,0,1
109836,small,0,0
109837,number,0,0
109838,of,0,1
109839,patients,0,1
109840,",",0,1
109841,our,0,0
109842,data,0,0
109843,show,0,0
109844,that,0,0
109845,topical,0,0
109846,capsaicin,0,0
109847,may,0,0
109848,relieve,0,0
109849,arterial,0,0
109850,pain,0,1
109851,in,0,0
109852,absence,0,0
109853,of,0,0
109854,and,0,0
109855,during,0,0
109856,a,0,1
109857,migraine,0,1
109858,attack,0,1
109859,in,0,0
109860,a,0,1
109861,substantial,0,0
109862,number,0,0
109863,of,0,1
109864,patients,1,1
109865,experiencing,1,1
109866,scalp,1,1
109867,arterial,1,1
109868,tenderness,1,0
109869,.,1,0
109870,More,0,1
109871,active,0,0
109872,capsacinoids,0,0
109873,might,0,0
109874,be,0,0
109875,tried,0,0
109876,in,0,0
109877,the,0,0
109878,future,0,0
109879,and,0,0
109880,could,0,0
109881,provide,0,0
109882,a,0,0
109883,new,0,0
109884,method,0,0
109885,for,0,0
109886,treating,0,0
109887,migraine,0,1
109888,attacks,0,1
109889,.,0,1
109890,Clonidine,0,0
109891,clearance,0,0
109892,matures,0,0
109893,rapidly,0,1
109894,during,0,0
109895,the,0,0
109896,early,0,1
109897,postnatal,0,1
109898,period,0,1
109899,:,0,1
109900,a,0,0
109901,population,0,1
109902,pharmacokinetic,0,0
109903,analysis,0,0
109904,in,0,1
109905,newborns,1,1
109906,with,1,1
109907,neonatal,1,1
109908,abstinence,1,1
109909,syndrome,1,1
109910,.,1,1
109911,The,0,0
109912,population,0,1
109913,pharmacokinetic,0,0
109914,(,0,1
109915,PK,0,0
109916,),0,1
109917,profile,0,0
109918,of,0,0
109919,oral,0,1
109920,clonidine,0,0
109921,was,0,0
109922,characterized,0,0
109923,in,0,0
109924,newborns,1,1
109925,with,1,1
109926,neonatal,1,1
109927,abstinence,1,0
109928,syndrome,1,1
109929,",",0,0
109930,and,0,0
109931,significant,0,0
109932,covariates,0,0
109933,affecting,0,1
109934,its,0,0
109935,PK,0,1
109936,parameters,0,0
109937,were,0,1
109938,identified,0,1
109939,.,0,1
109940,Plasma,0,0
109941,clonidine,0,0
109942,concentration,0,0
109943,data,0,0
109944,were,0,1
109945,obtained,0,0
109946,from,0,1
109947,a,0,1
109948,clinical,0,0
109949,trial,0,0
109950,in,0,1
109951,which,0,1
109952,36,1,1
109953,newborns,1,1
109954,",",1,1
109955,aged,1,1
109956,1,1,0
109957,to,1,1
109958,25,1,1
109959,days,1,0
109960,(,1,1
109961,postnatal,1,1
109962,age,1,1
109963,",",1,1
109964,PNA,1,1
109965,),1,1
109966,and,1,1
109967,weighing,1,1
109968,2.1,1,0
109969,to,1,1
109970,3.9,1,0
109971,kg,1,1
109972,",",0,1
109973,were,0,1
109974,enrolled,0,1
109975,to,0,0
109976,take,0,0
109977,multiple,0,1
109978,oral,0,1
109979,doses,0,0
109980,of,0,1
109981,clonidine,0,0
109982,.,0,1
109983,The,0,0
109984,population,0,1
109985,PK,0,0
109986,model,0,0
109987,of,0,0
109988,clonidine,0,0
109989,was,0,0
109990,developed,0,1
109991,by,0,0
109992,NONMEM,0,0
109993,",",0,1
109994,and,0,0
109995,significant,0,0
109996,covariates,0,0
109997,were,0,1
109998,identified,0,1
109999,",",0,0
110000,followed,0,0
110001,by,0,0
110002,nonparametric,0,0
110003,bootstraps,0,0
110004,(,0,1
110005,2000,0,1
110006,replicates,0,1
110007,),0,1
110008,and,0,1
110009,simulation,0,0
110010,experiments,0,0
110011,.,0,1
110012,A,0,1
110013,1-compartment,0,0
110014,open,0,1
110015,linear,0,0
110016,PK,0,0
110017,model,0,0
110018,was,0,0
110019,chosen,0,0
110020,to,0,0
110021,describe,0,1
110022,plasma,0,0
110023,concentrations,0,0
110024,of,0,1
110025,clonidine,0,0
110026,",",0,0
110027,and,0,0
110028,body,0,1
110029,weight,0,1
110030,and,0,1
110031,PNA,0,1
110032,were,0,1
110033,significant,0,0
110034,covariates,0,0
110035,for,0,1
110036,apparent,0,1
110037,clearance,0,0
110038,(,0,1
110039,CL/F,0,0
110040,),0,0
110041,as,0,0
110042,follows,0,0
110043,:,0,1
110044,CL/F,0,0
110045,(,0,1
110046,L/h,0,1
110047,),0,1
110048,=,0,1
110049,15.2,0,0
110050,?,0,1
110051,[,0,0
110052,body,0,1
110053,weight,0,0
110054,(,0,1
110055,kg,0,1
110056,),0,1
110057,/70,0,0
110058,],0,1
110059,(,0,1
110060,0.75,0,0
110061,),0,1
110062,?,0,1
110063,[,0,0
110064,PNA,0,1
110065,(,0,1
110066,day,0,0
110067,),0,1
110068,(,0,1
110069,0.441,0,0
110070,),0,1
110071,/,0,1
110072,(,0,1
110073,4.06,0,0
110074,(,0,1
110075,0.441,0,0
110076,),0,1
110077,+,0,0
110078,PNA,0,1
110079,(,0,1
110080,day,0,0
110081,),0,1
110082,(,0,1
110083,0.441,0,0
110084,),0,1
110085,),0,1
110086,],0,1
110087,.,0,1
110088,Furthermore,0,0
110089,",",0,0
110090,CL/F,0,0
110091,of,0,0
110092,clonidine,0,0
110093,increased,0,0
110094,rapidly,0,0
110095,with,0,1
110096,PNA,0,0
110097,during,0,0
110098,the,0,0
110099,first,0,0
110100,month,0,0
110101,of,0,0
110102,life,0,1
110103,after,0,0
110104,body,0,1
110105,weight,0,1
110106,was,0,0
110107,adjusted,0,0
110108,.,0,1
110109,Any,0,0
110110,optimal,0,0
110111,dosage,0,0
110112,regimen,0,0
110113,for,0,0
110114,clonidine,0,0
110115,in,0,1
110116,term,0,1
110117,neonates,0,1
110118,should,0,0
110119,be,0,0
110120,based,0,0
110121,on,0,0
110122,infant,0,1
110123,'s,0,1
110124,age,0,1
110125,and,0,1
110126,body,0,1
110127,weight,0,1
110128,",",0,0
110129,and,0,0
110130,1.5,0,0
110131,?g/kg,0,0
110132,every,0,0
110133,4,0,0
110134,hours,0,0
110135,is,0,0
110136,proposed,0,0
110137,starting,0,0
110138,the,0,0
110139,second,0,1
110140,week,0,0
110141,of,0,0
110142,life,0,1
110143,based,0,1
110144,on,0,0
110145,the,0,0
110146,simulation,0,0
110147,results,0,0
110148,.,0,1
110149,Influence,0,0
110150,of,0,0
110151,bony,1,1
110152,defects,1,1
110153,on,0,0
110154,implant,0,1
110155,stability,0,0
110156,.,0,1
110157,INTRODUCTION,0,0
110158,The,0,0
110159,purpose,0,0
110160,of,0,0
110161,this,0,0
110162,study,0,0
110163,was,0,0
110164,to,0,0
110165,analyze,0,0
110166,the,0,0
110167,evolution,0,0
110168,of,0,0
110169,implant,0,1
110170,mechanical,0,1
110171,stability,0,0
110172,in,0,1
110173,different,0,1
110174,types/sizes,0,0
110175,of,0,1
110176,bony,1,1
110177,defects,1,1
110178,using,0,0
110179,both,0,0
110180,Periotest,0,0
110181,and,0,1
110182,Osstell,0,0
110183,devices,0,0
110184,as,0,1
110185,objective,0,1
110186,tools,0,0
110187,.,0,1
110188,MATERIALS,0,0
110189,AND,0,0
110190,METHODS,0,0
110191,Thirty-two,1,1
110192,implants,1,1
110193,were,1,1
110194,randomly,1,1
110195,allocated,1,1
110196,to,0,0
110197,one,0,1
110198,of,0,0
110199,the,0,1
110200,four,1,1
110201,types,1,1
110202,of,1,1
110203,bone,1,1
110204,defects,1,1
110205,:,1,1
110206,marginal,1,1
110207,bone,1,1
110208,loss,1,0
110209,",",1,0
110210,peri-apical,1,0
110211,bone,1,0
110212,defect,1,1
110213,",",1,0
110214,constant,1,0
110215,width,1,0
110216,dehiscence,1,1
110217,and,1,0
110218,constant,1,0
110219,length,1,0
110220,dehiscences,1,1
110221,.,1,1
110222,Periotest/Osstell,0,0
110223,measurements,0,0
110224,were,0,1
110225,completed,0,1
110226,before,0,0
110227,and,0,1
110228,during,0,0
110229,staged,0,1
110230,bone,0,1
110231,removal,0,0
110232,(,0,0
110233,to,0,0
110234,enlarge,0,1
110235,defect,0,1
110236,size,0,0
110237,),0,1
110238,.,0,1
110239,RESULTS,0,0
110240,Significant,0,0
110241,differences,0,0
110242,(,0,1
110243,P,0,0
110244,<,0,0
110245,0.05,0,0
110246,),0,1
110247,with,0,1
110248,initial,0,1
110249,values,0,0
110250,were,0,1
110251,found,0,0
110252,after,0,0
110253,a,0,1
110254,2,0,1
110255,mm,0,1
110256,marginal,0,1
110257,bone,0,1
110258,removal,0,0
110259,(,0,1
110260,Osstell/Periotest,0,0
110261,),0,1
110262,;,0,0
110263,for,0,0
110264,a,0,1
110265,peri-apical,0,0
110266,bone,0,0
110267,lesion,0,0
110268,",",0,0
110269,after,0,0
110270,removal,0,0
110271,of,0,1
110272,5,0,1
110273,mm,0,1
110274,(,0,1
110275,Osstell,0,0
110276,),0,1
110277,or,0,1
110278,8,0,1
110279,mm,0,1
110280,(,0,1
110281,Periotest,0,0
110282,),0,1
110283,;,0,0
110284,for,0,0
110285,a,0,1
110286,6-mm-long,0,0
110287,dehiscence,0,0
110288,",",0,0
110289,after,0,0
110290,removal,0,0
110291,up,0,1
110292,to,0,1
110293,180,0,1
110294,degrees,0,0
110295,of,0,1
110296,the,0,1
110297,implant,0,0
110298,perimeter,0,1
110299,(,0,1
110300,Osstell/Periotest,0,0
110301,),0,1
110302,;,0,0
110303,for,0,0
110304,a,0,1
110305,3-mm-wide,0,0
110306,dehiscence,0,0
110307,",",0,0
110308,after,0,0
110309,removal,0,0
110310,of,0,1
110311,10,0,1
110312,mm,0,1
110313,(,0,1
110314,Osstell,0,0
110315,),0,1
110316,or,0,1
110317,6,0,0
110318,mm,0,1
110319,(,0,1
110320,Periotest,0,0
110321,),0,1
110322,.,0,1
110323,CONCLUSION,0,0
110324,Periotest,0,0
110325,and,0,0
110326,Osstell,0,0
110327,are,0,0
110328,in,0,0
110329,general,0,1
110330,not,0,0
110331,very,0,0
110332,sensitive,0,0
110333,in,0,0
110334,the,0,0
110335,identification,0,1
110336,of,0,0
110337,peri-implant,0,1
110338,bone,0,1
110339,destruction,0,0
110340,",",0,0
110341,except,0,0
110342,for,0,0
110343,marginal,0,1
110344,bone,0,1
110345,loss,0,0
110346,.,0,1
110347,Ventilator-delivered,0,1
110348,mask,0,1
110349,ventilation,0,0
110350,compared,0,0
110351,with,0,1
110352,three,0,1
110353,standard,0,1
110354,methods,0,1
110355,of,0,1
110356,mask,0,1
110357,ventilation,0,1
110358,in,0,0
110359,a,0,1
110360,manikin,1,1
110361,model,1,0
110362,.,1,1
110363,BACKGROUND,0,0
110364,Little,0,0
110365,is,0,0
110366,known,0,0
110367,regarding,0,0
110368,the,0,0
110369,variations,0,0
110370,in,0,0
110371,effective,0,0
110372,ventilation,0,1
110373,during,0,0
110374,bag,0,0
110375,and,0,1
110376,mask,0,0
110377,resuscitation,0,1
110378,with,0,1
110379,standard,0,1
110380,methods,0,1
110381,compared,0,0
110382,with,0,1
110383,that,0,0
110384,delivered,0,0
110385,by,0,0
110386,ventilator-delivered,0,1
110387,mask,0,1
110388,ventilation,0,1
110389,(,0,1
110390,VDMV,0,1
110391,),0,1
110392,.,0,1
110393,AIM,0,0
110394,To,0,0
110395,measure,0,0
110396,the,0,0
110397,variations,0,0
110398,in,0,0
110399,delivered,0,1
110400,airway,0,1
110401,pressure,0,0
110402,",",0,0
110403,tidal,0,0
110404,volume,0,0
110405,(,0,1
110406,TV,0,1
110407,),0,1
110408,",",0,0
110409,minute,0,0
110410,ventilation,0,1
110411,(,0,1
110412,MV,0,1
110413,),0,1
110414,and,0,1
110415,inspiratory,0,1
110416,time,0,0
110417,during,0,0
110418,a,0,1
110419,3-min,0,0
110420,period,0,0
110421,of,0,0
110422,mask,0,1
110423,ventilation,0,1
110424,comparing,0,0
110425,VDMV,0,1
110426,with,0,1
110427,three,0,1
110428,commonly,0,1
110429,used,0,0
110430,hand-delivered,0,0
110431,methods,0,1
110432,of,0,1
110433,bag,0,1
110434,and,0,1
110435,mask,0,1
110436,ventilation,0,1
110437,:,0,1
110438,Laerdal,0,1
110439,self-inflating,0,1
110440,bag,0,0
110441,(,0,1
110442,SIB,0,1
110443,),0,1
110444,;,0,1
110445,anaesthetic,0,0
110446,bag,0,0
110447,and,0,1
110448,T-piece,0,1
110449,Neopuff,0,1
110450,.,0,1
110451,METHODS,0,0
110452,A,0,1
110453,modified,1,0
110454,resuscitation,1,1
110455,manikin,1,1
110456,was,0,0
110457,used,0,0
110458,to,0,0
110459,measure,0,0
110460,variation,0,0
110461,in,0,0
110462,mechanical,0,1
110463,ventilation,0,1
110464,during,0,1
110465,3-min,0,0
110466,periods,0,0
110467,of,0,1
110468,mask,0,1
110469,ventilation,0,1
110470,.,0,1
110471,Thirty-six,1,1
110472,experienced,1,1
110473,practitioners,1,1
110474,gave,0,0
110475,positive,0,1
110476,pressure,0,0
110477,mask,0,1
110478,ventilation,0,1
110479,targeting,0,0
110480,acceptable,0,0
110481,chest,0,1
110482,wall,0,1
110483,movement,0,0
110484,with,0,1
110485,a,0,0
110486,rate,0,0
110487,of,0,0
110488,60,0,1
110489,inflations/min,0,0
110490,and,0,0
110491,when,0,0
110492,pressures,0,0
110493,could,0,0
110494,be,0,0
110495,targeted,0,0
110496,or,0,1
110497,set,0,0
110498,",",0,0
110499,a,0,0
110500,peak,0,0
110501,inspiratory,0,1
110502,pressure,0,0
110503,(,0,1
110504,PIP,0,0
110505,),0,1
110506,of,0,1
110507,18,0,1
110508,cm,0,1
110509,water,0,0
110510,",",0,1
110511,positive,0,1
110512,end-expiratory,0,0
110513,pressure,0,0
110514,(,0,1
110515,PEEP,0,0
110516,),0,1
110517,of,0,1
110518,5,0,1
110519,cm,0,1
110520,water,0,0
110521,",",0,1
110522,for,0,0
110523,3,0,1
110524,min,0,0
110525,with,0,1
110526,each,0,1
110527,of,0,0
110528,the,0,0
110529,four,0,0
110530,mask,0,1
110531,ventilation,0,1
110532,methods,0,1
110533,.,0,1
110534,Each,0,0
110535,mode,0,0
110536,was,0,0
110537,randomly,0,1
110538,sequenced,0,0
110539,.,0,0
110540,RESULTS,0,0
110541,A,0,0
110542,total,0,1
110543,of,0,0
110544,21,0,1
110545,136,0,1
110546,inflations,0,0
110547,were,0,1
110548,recorded,0,0
110549,and,0,0
110550,analysed,0,1
110551,.,0,1
110552,VDMV,0,0
110553,achieved,0,0
110554,PIP,0,0
110555,and,0,0
110556,PEEP,0,0
110557,closest,0,0
110558,to,0,0
110559,that,0,0
110560,targeted,0,0
110561,and,0,0
110562,significantly,0,0
110563,lower,0,0
110564,variation,0,0
110565,in,0,0
110566,all,0,1
110567,measured,0,0
110568,parameters,0,0
110569,(,0,1
110570,p,0,0
110571,<,0,0
110572,0.001,0,0
110573,),0,1
110574,other,0,0
110575,than,0,0
110576,with,0,1
110577,PIP,0,1
110578,.,0,1
110579,SIB,0,0
110580,delivered,0,0
110581,TV,0,1
110582,and,0,0
110583,MV,0,0
110584,over,0,0
110585,twice,0,0
110586,that,0,0
110587,delivered,0,0
110588,by,0,0
110589,VDMV,0,1
110590,and,0,1
110591,Neopuff,0,1
110592,.,0,1
110593,CONCLUSION,0,0
110594,During,0,0
110595,3-min,0,0
110596,periods,0,0
110597,of,0,1
110598,mask,0,1
110599,ventilation,0,1
110600,on,0,0
110601,a,0,0
110602,manikin,0,0
110603,",",0,0
110604,VDMV,0,0
110605,produced,0,0
110606,the,0,0
110607,least,0,0
110608,variation,0,0
110609,in,0,0
110610,delivered,0,1
110611,ventilation,0,1
110612,.,0,1
110613,SIB,0,0
110614,produced,0,0
110615,wide,0,1
110616,variation,0,0
110617,and,0,0
110618,unacceptably,0,0
110619,high,0,1
110620,TV,0,1
110621,and,0,1
110622,MV,0,0
110623,in,0,1
110624,experienced,0,1
110625,hands,0,1
110626,.,0,1
110627,Comparing,0,0
110628,the,0,0
110629,effectiveness,0,0
110630,of,0,0
110631,peer,0,1
110632,mentoring,0,0
110633,and,0,0
110634,student,0,0
110635,mentoring,0,0
110636,in,0,0
110637,a,0,1
110638,35-week,0,1
110639,fitness,0,0
110640,program,0,1
110641,for,0,0
110642,older,1,1
110643,adults,1,1
110644,.,1,1
110645,To,0,0
110646,investigate,0,0
110647,the,0,0
110648,applicability,0,0
110649,and,0,0
110650,effectiveness,0,0
110651,of,0,0
110652,a,0,1
110653,peer-mentored,0,1
110654,exercise,0,0
110655,program,0,1
110656,",",0,0
110657,this,0,0
110658,study,0,0
110659,compared,0,0
110660,the,0,0
110661,retention,0,0
110662,and,0,0
110663,participation,0,1
110664,rates,0,0
110665,",",0,1
110666,and,0,1
110667,physical,0,1
110668,improvements,0,0
110669,of,0,1
110670,older,1,1
110671,adults,1,1
110672,trained,0,1
110673,by,0,1
110674,peer,0,1
110675,mentors,0,1
110676,(,0,1
110677,PM,0,1
110678,),0,1
110679,to,0,0
110680,a,0,1
110681,group,0,0
110682,trained,0,1
110683,by,0,0
110684,young,0,1
110685,qualified,0,1
110686,student,0,0
110687,mentors,0,1
110688,(,0,1
110689,SM,0,1
110690,),0,1
110691,.,0,1
110692,A,0,0
110693,group,0,0
110694,of,0,0
110695,older,1,1
110696,adults,1,1
110697,were,0,1
110698,prepared,0,0
110699,as,0,0
110700,peer,0,1
110701,mentors,0,1
110702,through,0,1
110703,a,0,1
110704,30-week,0,1
110705,preparation,0,0
110706,program,0,1
110707,.,0,1
110708,Later,0,0
110709,",",0,0
110710,60,1,1
110711,older,1,1
110712,adults,1,1
110713,(,1,0
110714,mean,1,1
110715,?,1,1
110716,SD,1,0
110717,age,1,1
110718,:,1,1
110719,68.7,1,1
110720,?,1,1
110721,6.1,1,0
110722,years,1,1
110723,),1,1
110724,were,1,1
110725,recruited,0,1
110726,and,0,0
110727,randomly,0,1
110728,assigned,0,1
110729,to,0,0
110730,either,0,0
110731,the,0,0
110732,PM,0,1
110733,or,0,1
110734,SM,0,1
110735,group,0,1
110736,.,0,1
110737,Both,0,0
110738,groups,0,0
110739,completed,0,1
110740,an,0,1
110741,identical,0,0
110742,35-week,0,1
110743,fitness,0,1
110744,program,0,1
110745,.,0,1
110746,Pre-,0,0
110747,",",0,0
110748,midterm-,0,1
110749,and,0,1
110750,post-training,0,0
110751,assessments,0,0
110752,of,0,1
110753,fitness,0,1
110754,were,0,1
110755,completed,0,1
110756,and,0,1
110757,rates,0,0
110758,of,0,1
110759,participation,0,1
110760,and,0,1
110761,retention,0,0
110762,were,0,1
110763,documented,0,0
110764,.,0,1
110765,The,0,0
110766,same,0,0
110767,retention,0,0
110768,rates,0,0
110769,were,0,1
110770,observed,0,0
110771,in,0,0
110772,the,0,1
110773,two,0,0
110774,groups,0,0
110775,",",0,1
110776,but,0,0
110777,SM,0,1
110778,group,0,1
110779,had,0,1
110780,higher,0,0
110781,participation,0,0
110782,.,0,1
110783,Both,0,0
110784,groups,0,0
110785,improved,0,0
110786,significantly,0,0
110787,in,0,0
110788,all,0,0
110789,measures,0,0
110790,of,0,0
110791,fitness,0,0
110792,and,0,0
110793,there,0,0
110794,were,0,0
110795,no,0,0
110796,significant,0,0
110797,post-test,0,0
110798,differences,0,0
110799,between,0,0
110800,the,0,1
110801,groups,0,0
110802,in,0,0
110803,the,0,1
110804,fitness,0,1
110805,measures,0,0
110806,.,0,1
110807,Findings,0,0
110808,suggest,0,0
110809,that,0,0
110810,the,0,0
110811,peer,0,1
110812,mentor,0,0
110813,model,0,0
110814,is,0,0
110815,applicable,0,0
110816,in,0,0
110817,an,0,1
110818,older,1,1
110819,adult,1,1
110820,exercise,1,0
110821,program,1,0
110822,and,1,0
110823,may,0,0
110824,be,0,0
110825,as,0,0
110826,effective,0,0
110827,as,0,0
110828,a,0,1
110829,program,0,1
110830,mentored,0,0
110831,by,0,0
110832,young,0,1
110833,professionals,0,1
110834,.,0,1
110835,A,0,0
110836,first-in-man,0,0
110837,",",0,0
110838,randomized,0,1
110839,",",0,0
110840,placebo-controlled,0,0
110841,study,0,0
110842,to,0,0
110843,evaluate,0,0
110844,the,0,0
110845,safety,0,0
110846,and,0,0
110847,feasibility,0,0
110848,of,0,0
110849,autologous,0,1
110850,delipidated,0,1
110851,high-density,0,1
110852,lipoprotein,0,0
110853,plasma,0,0
110854,infusions,0,0
110855,in,0,1
110856,patients,1,1
110857,with,1,1
110858,acute,1,1
110859,coronary,1,1
110860,syndrome,1,1
110861,.,1,1
110862,OBJECTIVES,0,0
110863,This,0,0
110864,study,0,0
110865,aimed,0,0
110866,to,0,0
110867,determine,0,0
110868,whether,0,0
110869,serial,0,1
110870,autologous,0,1
110871,infusions,0,1
110872,of,0,1
110873,selective,0,1
110874,high-density,0,1
110875,lipoprotein,0,0
110876,(,0,1
110877,HDL,0,1
110878,),0,1
110879,delipidated,0,1
110880,plasma,0,0
110881,are,0,0
110882,feasible,0,0
110883,and,0,0
110884,well,0,0
110885,tolerated,0,0
110886,in,0,0
110887,patients,1,1
110888,with,1,1
110889,acute,1,1
110890,coronary,1,1
110891,syndrome,1,1
110892,(,1,1
110893,ACS,1,1
110894,),1,1
110895,.,1,1
110896,BACKGROUND,0,0
110897,Low,0,1
110898,HDL,0,0
110899,is,0,0
110900,associated,0,0
110901,with,0,1
110902,increased,0,0
110903,risk,0,1
110904,of,0,0
110905,cardiovascular,0,1
110906,disease,0,1
110907,.,0,1
110908,Plasma,0,0
110909,selective,0,1
110910,delipidation,0,1
110911,converts,0,1
110912,alphaHDL,0,0
110913,to,0,1
110914,prebeta-like,0,0
110915,HDL,0,0
110916,",",0,0
110917,the,0,0
110918,most,0,0
110919,effective,0,0
110920,form,0,1
110921,of,0,0
110922,HDL,0,0
110923,for,0,1
110924,lipid,0,0
110925,removal,0,1
110926,from,0,1
110927,arterial,0,1
110928,plaques,0,1
110929,.,0,1
110930,METHODS,0,0
110931,ACS,1,1
110932,patients,1,1
110933,undergoing,1,1
110934,cardiac,1,1
110935,catheterization,1,1
110936,with,1,1
110937,>,1,1
110938,or=1,1,1
110939,nonobstructive,1,1
110940,native,1,1
110941,coronary,1,1
110942,artery,1,1
110943,atheroma,1,1
110944,were,0,1
110945,randomized,0,1
110946,to,0,0
110947,either,0,1
110948,7,0,1
110949,weekly,0,0
110950,HDL,0,1
110951,selective,0,1
110952,delipidated,0,1
110953,or,0,1
110954,control,0,1
110955,plasma,0,0
110956,apheresis/reinfusions,0,0
110957,.,0,1
110958,Patients,0,1
110959,underwent,0,1
110960,intravascular,0,1
110961,ultrasound,0,1
110962,(,0,1
110963,IVUS,0,1
110964,),0,1
110965,evaluation,0,0
110966,of,0,0
110967,the,0,0
110968,target,0,0
110969,vessel,0,1
110970,during,0,0
110971,the,0,0
110972,catheterization,0,1
110973,for,0,0
110974,ACS,0,0
110975,and,0,1
110976,up,0,1
110977,to,0,1
110978,14,0,1
110979,days,0,0
110980,following,0,0
110981,the,0,0
110982,final,0,0
110983,apheresis/reinfusion,0,0
110984,session,0,0
110985,.,0,1
110986,2-D,0,0
110987,gel,0,0
110988,electrophoresis,0,0
110989,of,0,0
110990,delipidated,0,1
110991,plasmas,0,1
110992,established,0,1
110993,successful,0,1
110994,conversion,0,0
110995,of,0,0
110996,alphaHDL,0,0
110997,to,0,1
110998,prebeta-like,0,0
110999,HDL,0,1
111000,.,0,1
111001,The,0,0
111002,trial,0,0
111003,was,0,0
111004,complete,0,1
111005,with,0,1
111006,28,1,1
111007,patients,1,1
111008,randomized,0,1
111009,.,0,1
111010,RESULTS,0,0
111011,All,0,1
111012,reinfusion,0,0
111013,sessions,0,0
111014,were,0,1
111015,tolerated,0,0
111016,well,0,0
111017,by,0,0
111018,all,0,1
111019,patients,0,1
111020,.,0,1
111021,The,0,0
111022,levels,0,0
111023,of,0,0
111024,prebeta-like,0,1
111025,HDL,0,1
111026,and,0,1
111027,alphaHDL,0,0
111028,in,0,0
111029,the,0,0
111030,delipidated,0,1
111031,plasma,0,0
111032,converted,0,0
111033,from,0,1
111034,5.6,0,0
111035,%,0,0
111036,to,0,1
111037,79.1,0,0
111038,%,0,0
111039,and,0,1
111040,92.8,0,0
111041,%,0,0
111042,to,0,1
111043,20.9,0,0
111044,%,0,0
111045,",",0,0
111046,respectively,0,0
111047,.,0,0
111048,The,0,0
111049,IVUS,0,0
111050,data,0,0
111051,demonstrated,0,0
111052,a,0,1
111053,numeric,0,0
111054,trend,0,0
111055,toward,0,0
111056,regression,0,0
111057,in,0,0
111058,the,0,0
111059,total,0,1
111060,atheroma,0,1
111061,volume,0,0
111062,of,0,0
111063,-12.18,0,0
111064,+/-,0,1
111065,36.75,0,0
111066,mm,0,1
111067,(,0,1
111068,3,0,1
111069,),0,1
111070,in,0,0
111071,the,0,0
111072,delipidated,0,1
111073,group,0,0
111074,versus,0,0
111075,an,0,0
111076,increase,0,0
111077,of,0,0
111078,total,0,1
111079,atheroma,0,1
111080,volume,0,1
111081,of,0,1
111082,2.80,0,0
111083,+/-,0,1
111084,21.25,0,0
111085,mm,0,1
111086,(,0,1
111087,3,0,1
111088,),0,1
111089,in,0,0
111090,the,0,0
111091,control,0,1
111092,group,0,0
111093,(,0,1
111094,p,0,0
111095,=,0,1
111096,0.268,0,0
111097,),0,1
111098,.,0,1
111099,CONCLUSIONS,0,0
111100,In,1,1
111101,ACS,1,1
111102,patients,1,1
111103,",",0,1
111104,serial,0,1
111105,autologous,0,1
111106,infusions,0,1
111107,of,0,1
111108,selective,0,1
111109,HDL,0,1
111110,delipidated,0,1
111111,plasma,0,0
111112,are,0,0
111113,clinically,0,1
111114,feasible,0,0
111115,and,0,0
111116,well,0,0
111117,tolerated,0,0
111118,.,0,0
111119,This,0,0
111120,therapy,0,0
111121,may,0,0
111122,offer,0,0
111123,a,0,0
111124,novel,0,0
111125,adjunct,0,0
111126,treatment,0,1
111127,for,0,1
111128,patients,1,1
111129,presenting,1,1
111130,with,1,1
111131,ACS,1,1
111132,.,1,1
111133,Further,0,0
111134,study,0,0
111135,will,0,0
111136,be,0,0
111137,needed,0,0
111138,to,0,0
111139,determine,0,0
111140,its,0,0
111141,ability,0,0
111142,to,0,0
111143,reduce,0,0
111144,clinical,0,0
111145,cardiovascular,0,1
111146,events,0,0
111147,.,0,1
111148,Physician-pharmacist,0,0
111149,cooperation,0,1
111150,program,0,1
111151,for,0,0
111152,blood,0,0
111153,pressure,0,0
111154,control,0,1
111155,in,0,0
111156,patients,1,1
111157,with,1,1
111158,hypertension,1,1
111159,:,1,1
111160,a,0,0
111161,randomized-controlled,0,1
111162,trial,0,0
111163,.,0,1
111164,BACKGROUND,0,0
111165,The,0,0
111166,aim,0,0
111167,of,0,0
111168,the,0,0
111169,trial,0,0
111170,was,0,0
111171,to,0,0
111172,evaluate,0,0
111173,the,0,0
111174,effectiveness,0,0
111175,of,0,0
111176,a,0,0
111177,program,0,1
111178,of,0,0
111179,cooperation,0,1
111180,between,0,0
111181,physician,0,1
111182,and,0,1
111183,pharmacist,0,0
111184,to,0,0
111185,reduce,0,0
111186,cardiovascular,1,1
111187,risk,1,1
111188,factors,1,0
111189,in,1,1
111190,patients,1,1
111191,with,1,1
111192,mild,1,1
111193,to,1,1
111194,moderate,1,1
111195,hypertension,1,1
111196,by,0,0
111197,promoting,0,0
111198,better,0,0
111199,blood,0,0
111200,pressure,0,0
111201,(,0,1
111202,BP,0,1
111203,),0,1
111204,control,0,1
111205,",",0,1
111206,appropriate,0,0
111207,changes,0,0
111208,in,0,1
111209,antihypertensive,0,1
111210,medications,0,1
111211,",",0,1
111212,and,0,1
111213,beneficial,0,0
111214,changes,0,0
111215,in,0,1
111216,lifestyle,0,1
111217,.,0,1
111218,METHODS,0,0
111219,The,1,0
111220,132,1,1
111221,subjects,1,1
111222,in,1,1
111223,this,1,0
111224,randomized,1,1
111225,",",1,0
111226,controlled,1,0
111227,trial,1,0
111228,were,1,0
111229,in,1,0
111230,the,1,0
111231,age,1,1
111232,range,1,1
111233,of,1,1
111234,40-79,1,1
111235,years,1,1
111236,.,1,1
111237,The,1,0
111238,inclusion,1,0
111239,criteria,1,1
111240,were,1,1
111241,:,1,1
111242,systolic,1,1
111243,BP,1,1
111244,(,1,1
111245,SBP,1,1
111246,),1,1
111247,ranging,1,1
111248,from,1,1
111249,140-179,1,1
111250,mm,1,1
111251,Hg,1,0
111252,and/or,1,0
111253,diastolic,1,0
111254,BP,1,1
111255,(,1,1
111256,DBP,1,1
111257,),1,1
111258,ranging,1,1
111259,from,1,1
111260,90-99,1,1
111261,mm,1,1
111262,Hg,1,1
111263,and,1,1
111264,treatment-naive,1,1
111265,(,1,1
111266,untreated,1,1
111267,for,1,1
111268,hypertension,1,1
111269,),1,1
111270,;,1,0
111271,or,1,1
111272,on,1,0
111273,a,1,0
111274,regimen,1,0
111275,of,1,0
111276,medication,1,1
111277,for,1,1
111278,hypertension,1,1
111279,.,1,1
111280,Of,1,0
111281,these,1,0
111282,132,1,1
111283,subjects,1,1
111284,",",1,1
111285,124,1,1
111286,(,1,1
111287,94,1,1
111288,%,1,0
111289,),1,1
111290,were,1,0
111291,already,1,1
111292,receiving,1,1
111293,treatment,1,0
111294,with,1,1
111295,antihypertensive,1,1
111296,medications,1,1
111297,.,1,1
111298,Equal,0,0
111299,numbers,0,0
111300,of,0,1
111301,subjects,0,1
111302,were,0,1
111303,randomly,0,1
111304,assigned,0,1
111305,to,0,0
111306,one,0,1
111307,of,0,1
111308,two,0,1
111309,groups,0,1
111310,:,0,1
111311,a,0,1
111312,physician-pharmacist,0,0
111313,intervention,0,0
111314,group,0,1
111315,(,0,1
111316,n,0,1
111317,=,0,1
111318,66,0,1
111319,),0,1
111320,and,0,0
111321,a,0,0
111322,control,0,0
111323,group,0,0
111324,(,0,1
111325,n,0,1
111326,=,0,1
111327,66,0,1
111328,),0,1
111329,.,0,1
111330,RESULTS,0,0
111331,The,0,0
111332,6-month,0,0
111333,follow-up,0,0
111334,rate,0,0
111335,was,0,0
111336,97,0,1
111337,%,0,0
111338,in,0,0
111339,both,0,0
111340,groups,0,0
111341,.,0,1
111342,At,0,0
111343,6,0,0
111344,months,0,0
111345,",",0,1
111346,the,0,0
111347,mean,0,0
111348,decrease,0,0
111349,in,0,0
111350,SBP/DBP,0,1
111351,",",0,1
111352,as,0,0
111353,measured,0,0
111354,at,0,0
111355,home,0,1
111356,in,0,0
111357,the,0,0
111358,morning,0,0
111359,",",0,0
111360,was,0,0
111361,2.9/3.3,0,0
111362,mm,0,1
111363,Hg,0,0
111364,in,0,0
111365,the,0,0
111366,intervention,0,0
111367,group,0,0
111368,relative,0,0
111369,to,0,0
111370,baseline,0,0
111371,(,0,1
111372,P,0,0
111373,=,0,1
111374,0.02,0,0
111375,and,0,1
111376,P,0,0
111377,<,0,0
111378,0.0001,0,0
111379,for,0,1
111380,SBP,0,1
111381,and,0,1
111382,DBP,0,1
111383,",",0,0
111384,respectively,0,0
111385,),0,0
111386,.,0,0
111387,The,0,0
111388,mean,0,0
111389,decrease,0,0
111390,in,0,0
111391,home,0,1
111392,morning,0,0
111393,SBP,0,1
111394,in,0,0
111395,the,0,0
111396,intervention,0,0
111397,group,0,0
111398,was,0,0
111399,not,0,0
111400,significantly,0,0
111401,greater,0,0
111402,than,0,0
111403,in,0,0
111404,the,0,0
111405,control,0,1
111406,group,0,0
111407,.,0,1
111408,However,0,0
111409,",",0,0
111410,the,0,0
111411,DBP,0,1
111412,decline,0,0
111413,was,0,0
111414,significantly,0,0
111415,greater,0,0
111416,in,0,0
111417,the,0,0
111418,intervention,0,0
111419,than,0,0
111420,control,0,1
111421,groups,0,0
111422,",",0,1
111423,which,0,0
111424,showed,0,0
111425,a,0,0
111426,mean,0,0
111427,decrease,0,0
111428,of,0,1
111429,2.8,0,0
111430,mm,0,1
111431,Hg,0,1
111432,(,0,1
111433,confidence,0,0
111434,interval,0,0
111435,:,0,1
111436,-5.5,0,0
111437,to,0,0
111438,-0.1,0,0
111439,;,0,1
111440,P,0,0
111441,=,0,1
111442,0.04,0,0
111443,),0,1
111444,.,0,1
111445,The,0,0
111446,percentage,0,0
111447,of,0,0
111448,patients,0,1
111449,in,0,1
111450,whom,0,1
111451,control,0,1
111452,of,0,1
111453,home,0,1
111454,morning,0,0
111455,BP,0,1
111456,was,0,0
111457,achieved,0,0
111458,was,0,0
111459,53,0,1
111460,%,0,0
111461,in,0,0
111462,the,0,0
111463,intervention,0,0
111464,group,0,1
111465,and,0,1
111466,47,0,1
111467,%,0,0
111468,in,0,0
111469,the,0,0
111470,control,0,1
111471,group,0,0
111472,(,0,1
111473,P,0,0
111474,=,0,1
111475,0.40,0,0
111476,),0,1
111477,.,0,1
111478,A,0,0
111479,higher,0,0
111480,percentage,0,0
111481,of,0,0
111482,patients,0,1
111483,in,0,1
111484,the,0,0
111485,intervention,0,0
111486,group,0,0
111487,",",0,0
111488,relative,0,0
111489,to,0,0
111490,the,0,0
111491,control,0,0
111492,group,0,0
111493,",",0,0
111494,were,0,0
111495,able,0,0
111496,to,0,0
111497,reduce,0,0
111498,the,0,0
111499,use,0,0
111500,of,0,0
111501,antihypertensive,0,1
111502,medications,0,1
111503,(,0,1
111504,31,0,1
111505,vs.,0,0
111506,8,0,1
111507,%,0,0
111508,",",0,1
111509,P,0,0
111510,<,0,0
111511,0.0001,0,0
111512,),0,1
111513,",",0,0
111514,and,0,0
111515,fewer,0,0
111516,patients,0,1
111517,in,0,0
111518,this,0,0
111519,group,0,1
111520,required,0,0
111521,additional,0,0
111522,medications,0,1
111523,or,0,1
111524,increases,0,0
111525,in,0,1
111526,dosage,0,0
111527,relative,0,0
111528,to,0,1
111529,the,0,0
111530,controls,0,1
111531,(,0,0
111532,11,0,1
111533,vs.,0,0
111534,28,0,1
111535,%,0,0
111536,",",0,1
111537,P,0,0
111538,=,0,1
111539,0.03,0,0
111540,),0,1
111541,.,0,1
111542,Patients,0,1
111543,of,0,0
111544,the,0,0
111545,intervention,0,0
111546,group,0,0
111547,were,0,0
111548,more,0,0
111549,likely,0,0
111550,to,0,0
111551,show,0,0
111552,reduction,0,0
111553,in,0,0
111554,body,0,1
111555,mass,0,1
111556,index,0,0
111557,and,0,0
111558,sodium,0,0
111559,intake,0,0
111560,and,0,0
111561,to,0,0
111562,stop,0,0
111563,smoking,0,1
111564,",",0,0
111565,as,0,0
111566,compared,0,0
111567,with,0,1
111568,the,0,0
111569,control,0,1
111570,group,0,0
111571,.,0,0
111572,CONCLUSIONS,0,0
111573,A,0,0
111574,program,0,0
111575,of,0,0
111576,cooperation,0,1
111577,between,0,0
111578,physician,0,1
111579,and,0,1
111580,pharmacist,0,0
111581,was,0,0
111582,successful,0,1
111583,in,0,0
111584,reducing,0,0
111585,cardiovascular,0,1
111586,risk,0,1
111587,factors,0,0
111588,in,0,1
111589,patients,1,1
111590,with,1,1
111591,mild,1,1
111592,to,1,1
111593,moderate,1,1
111594,hypertension,1,1
111595,by,0,0
111596,promoting,0,0
111597,better,0,0
111598,blood,0,0
111599,pressure,0,0
111600,(,0,1
111601,BP,0,1
111602,),0,1
111603,control,0,1
111604,",",0,1
111605,appropriate,0,0
111606,changes,0,0
111607,in,0,1
111608,antihypertensive,0,1
111609,medications,0,1
111610,",",0,1
111611,and,0,1
111612,beneficial,0,0
111613,changes,0,0
111614,in,0,1
111615,lifestyle,0,1
111616,.,0,1
111617,Effects,0,1
111618,of,0,1
111619,intravenous,0,1
111620,iron,0,0
111621,combined,0,0
111622,with,0,1
111623,low-dose,0,0
111624,recombinant,0,0
111625,human,0,1
111626,erythropoietin,0,0
111627,on,0,0
111628,transfusion,0,0
111629,requirements,0,1
111630,in,0,1
111631,iron-deficient,1,1
111632,patients,1,1
111633,undergoing,1,1
111634,bilateral,1,1
111635,total,1,1
111636,knee,1,1
111637,replacement,1,1
111638,arthroplasty,1,1
111639,.,1,1
111640,BACKGROUND,0,0
111641,The,0,0
111642,authors,0,0
111643,examined,0,0
111644,the,0,0
111645,impact,0,0
111646,of,0,0
111647,parenteral,0,1
111648,iron,0,0
111649,and,0,1
111650,recombinant,0,0
111651,human,0,1
111652,erythropoietin-?,0,0
111653,(,0,1
111654,rHuEPO-?,0,1
111655,),0,1
111656,administered,0,0
111657,in,0,0
111658,the,0,0
111659,bilateral,0,1
111660,total,0,1
111661,knee,0,1
111662,replacement,0,1
111663,arthroplasty,0,1
111664,(,0,1
111665,TKRA,0,0
111666,),0,1
111667,",",0,0
111668,on,0,0
111669,postoperative,0,0
111670,anemia,0,1
111671,and,0,1
111672,transfusion,0,0
111673,requirements,0,1
111674,in,0,1
111675,iron-deficient,1,1
111676,patients,1,1
111677,.,1,1
111678,STUDY,0,0
111679,DESIGN,0,1
111680,AND,0,0
111681,METHODS,1,0
111682,A,1,1
111683,total,1,1
111684,of,1,1
111685,108,1,1
111686,iron-deficient,1,1
111687,patients,1,1
111688,were,1,1
111689,randomly,0,1
111690,assigned,0,1
111691,to,0,1
111692,two,0,1
111693,groups,0,1
111694,:,0,1
111695,Group,0,1
111696,C,0,1
111697,(,0,1
111698,control,0,1
111699,),0,1
111700,or,0,1
111701,Group,0,1
111702,IE,0,1
111703,(,0,1
111704,200,0,1
111705,mg,0,0
111706,of,0,0
111707,iron,0,0
111708,sucrose,0,0
111709,intravenously,0,1
111710,over,0,0
111711,1,0,1
111712,hr,0,1
111713,and,0,1
111714,3000,0,1
111715,IU,0,0
111716,of,0,1
111717,rHuEPO-?,0,0
111718,subcutaneously,0,1
111719,during,0,0
111720,the,0,0
111721,operation,0,1
111722,and,0,0
111723,during,0,0
111724,the,0,0
111725,postoperative,0,0
111726,period,0,0
111727,if,0,0
111728,the,0,0
111729,hemoglobin,0,0
111730,[,0,0
111731,Hb,0,0
111732,],0,1
111733,level,0,0
111734,was,0,0
111735,70-80,0,0
111736,g/L,0,1
111737,),0,1
111738,.,0,1
111739,One,0,1
111740,or,0,1
111741,2,0,1
111742,units,0,1
111743,of,0,1
111744,blood,0,0
111745,were,0,1
111746,transfused,0,0
111747,to,0,1
111748,patients,0,1
111749,in,0,1
111750,both,0,0
111751,groups,0,0
111752,according,0,1
111753,to,0,1
111754,postoperative,0,1
111755,Hb,0,0
111756,level,0,0
111757,(,0,1
111758,between,0,0
111759,60,0,1
111760,and,0,1
111761,70,0,1
111762,g/L,0,1
111763,or,0,1
111764,betweeen,0,0
111765,50,0,1
111766,and,0,1
111767,60,0,1
111768,g/L,0,1
111769,",",0,0
111770,respectively,0,0
111771,),0,1
111772,.,0,1
111773,Perioperative,0,0
111774,laboratory,0,0
111775,and,0,1
111776,clinical,0,0
111777,outcomes,0,0
111778,(,0,1
111779,Hb,0,0
111780,",",0,1
111781,iron,0,0
111782,variables,0,0
111783,",",0,1
111784,postoperative,0,0
111785,bleeding,0,1
111786,amount,0,0
111787,",",0,0
111788,and,0,0
111789,number,0,0
111790,of,0,0
111791,units,0,1
111792,of,0,1
111793,RBCs,0,0
111794,transfused,0,1
111795,and,0,1
111796,incidences,0,0
111797,),0,1
111798,were,0,1
111799,documented,0,1
111800,.,0,1
111801,RESULTS,0,0
111802,Although,0,0
111803,preoperative,0,1
111804,Hb,0,0
111805,and,0,0
111806,the,0,0
111807,amount,0,0
111808,of,0,0
111809,postoperative,0,0
111810,bleeding,0,1
111811,were,0,1
111812,comparable,0,0
111813,in,0,0
111814,the,0,1
111815,two,0,0
111816,groups,0,0
111817,",",0,1
111818,Hb,0,0
111819,levels,0,0
111820,at,0,1
111821,1,0,1
111822,",",0,1
111823,2,0,0
111824,",",0,0
111825,and,0,1
111826,3,0,1
111827,days,0,0
111828,and,0,1
111829,at,0,1
111830,2,0,1
111831,and,0,1
111832,6,0,1
111833,weeks,0,0
111834,postoperation,0,0
111835,were,0,1
111836,significantly,0,0
111837,higher,0,0
111838,in,0,0
111839,Group,0,1
111840,IE,0,1
111841,.,0,1
111842,Furthermore,0,0
111843,",",0,0
111844,the,0,0
111845,transfusion,0,0
111846,rate,0,0
111847,was,0,0
111848,significantly,0,0
111849,lower,0,0
111850,in,0,0
111851,Group,0,1
111852,IE,0,1
111853,(,0,1
111854,20.4,0,0
111855,%,0,0
111856,vs.,0,0
111857,53.7,0,0
111858,%,0,0
111859,",",0,0
111860,p=0.011,0,0
111861,),0,0
111862,and,0,0
111863,the,0,0
111864,mean,0,0
111865,number,0,0
111866,of,0,0
111867,red,0,1
111868,blood,0,1
111869,cell,0,1
111870,units,0,1
111871,transfused,0,1
111872,was,0,0
111873,markedly,0,0
111874,lower,0,0
111875,in,0,0
111876,Group,0,1
111877,IE,0,1
111878,(,0,0
111879,0.2?0.5,0,0
111880,vs.,0,0
111881,0.8?0.8,0,0
111882,",",0,0
111883,p=0.005,0,0
111884,),0,1
111885,.,0,1
111886,Postoperative,0,0
111887,iron,0,0
111888,",",0,0
111889,ferritin,0,0
111890,",",0,0
111891,and,0,0
111892,transferrin,0,0
111893,saturation,0,1
111894,levels,0,0
111895,were,0,1
111896,significantly,0,0
111897,higher,0,0
111898,in,0,0
111899,Group,0,1
111900,IE,0,1
111901,.,0,1
111902,CONCLUSIONS,0,0
111903,Treatment,0,0
111904,with,0,1
111905,parenteral,0,1
111906,iron,0,0
111907,and,0,1
111908,low-dose,0,0
111909,rHuEPO-?,0,1
111910,in,0,1
111911,bilateral,0,1
111912,TKRA,0,0
111913,effectively,0,0
111914,attenuated,0,0
111915,anemia,0,1
111916,and,0,0
111917,decreased,0,0
111918,transfusion,0,0
111919,requirements,1,1
111920,in,1,1
111921,iron-deficient,1,1
111922,patients,1,1
111923,.,1,1
111924,Prospective,0,1
111925,randomized,0,1
111926,trial,0,1
111927,of,0,0
111928,short-term,0,0
111929,neoadjuvant,0,1
111930,chemotherapy,0,1
111931,for,0,1
111932,advanced,1,1
111933,gastric,1,1
111934,cancer,1,1
111935,.,1,1
111936,BACKGROUND,0,0
111937,We,0,0
111938,performed,0,0
111939,short-term,0,0
111940,neoadjuvant,0,1
111941,chemotherapy,0,1
111942,(,0,1
111943,s-NAC,0,0
111944,),0,1
111945,to,0,0
111946,examine,0,0
111947,whether,0,0
111948,anticancer,0,0
111949,drugs,0,0
111950,can,0,0
111951,change,0,0
111952,the,0,0
111953,proliferative,0,1
111954,ability,0,0
111955,of,0,1
111956,cancer,0,1
111957,cells,0,0
111958,in,0,1
111959,gastric,1,1
111960,cancer,1,1
111961,patients,1,1
111962,.,1,1
111963,METHODS,0,0
111964,Chemotherapy,0,1
111965,was,0,0
111966,performed,0,0
111967,for,0,0
111968,72,0,1
111969,h,0,0
111970,before,0,0
111971,gastrectomy,0,1
111972,in,0,1
111973,63,1,1
111974,gastric,1,1
111975,cancer,1,1
111976,patients,1,1
111977,.,1,1
111978,Patients,0,1
111979,were,0,0
111980,classed,0,1
111981,into,0,1
111982,four,0,1
111983,groups,0,1
111984,:,0,1
111985,Group,1,1
111986,F,1,1
111987,",",1,1
111988,16,1,1
111989,cases,1,1
111990,who,1,1
111991,received,1,1
111992,a,1,1
111993,single,1,0
111994,administration,1,0
111995,of,1,0
111996,5-fluorouracil,1,0
111997,(,1,1
111998,5-FU,1,1
111999,),1,1
112000,;,1,1
112001,Group,1,1
112002,C,1,1
112003,",",1,1
112004,15,1,1
112005,cases,1,1
112006,who,1,1
112007,received,1,1
112008,a,1,1
112009,single,1,0
112010,administration,1,0
112011,of,1,0
112012,cis-diamminedichloroplatinum,1,1
112013,(,1,1
112014,CDDP,1,1
112015,;,1,1
112016,cisplatin,1,0
112017,),1,1
112018,;,1,1
112019,Group,1,1
112020,FC,1,1
112021,",",1,1
112022,16,1,1
112023,cases,1,1
112024,who,1,1
112025,received,1,1
112026,both,1,1
112027,5-FU+CDDP,1,0
112028,;,1,0
112029,and,0,0
112030,a,1,1
112031,Control,1,1
112032,group,1,0
112033,",",1,1
112034,16,1,1
112035,cases,1,1
112036,who,1,1
112037,did,1,1
112038,not,1,1
112039,receive,1,1
112040,chemotherapy,1,1
112041,.,1,1
112042,We,0,0
112043,reviewed,0,1
112044,neoadjuvant,0,1
112045,biopsy,0,1
112046,tissue,0,1
112047,and,0,0
112048,gastric,0,1
112049,cancer,0,1
112050,tissue,0,1
112051,delivered,0,0
112052,by,0,0
112053,operation,0,1
112054,in,0,1
112055,these,0,0
112056,cases,0,1
112057,.,0,1
112058,The,0,0
112059,TUNEL,0,0
112060,method,0,0
112061,and,0,0
112062,immunohistochemistry,0,1
112063,with,0,1
112064,an,0,0
112065,anti-MIB-1,0,1
112066,antibody,0,0
112067,were,0,1
112068,used,0,0
112069,to,0,0
112070,evaluate,0,0
112071,cellular,0,0
112072,apoptosis,0,0
112073,and,0,1
112074,proliferative,0,1
112075,ability,0,0
112076,",",0,0
112077,respectively,0,0
112078,.,0,0
112079,The,0,0
112080,apoptotic,0,0
112081,index,0,0
112082,(,0,1
112083,AI,0,0
112084,),0,1
112085,and,0,0
112086,an,0,0
112087,MIB-1,0,1
112088,index,0,0
112089,(,0,1
112090,MI,0,1
112091,),0,1
112092,were,0,0
112093,also,0,0
112094,calculated,0,0
112095,.,0,0
112096,RESULTS,0,0
112097,There,0,0
112098,were,0,0
112099,no,0,0
112100,differences,0,0
112101,in,0,1
112102,AI,0,0
112103,or,0,1
112104,MI,0,1
112105,in,0,0
112106,biopsy,0,1
112107,tissue,0,1
112108,between,0,0
112109,the,0,0
112110,groups,0,0
112111,.,0,1
112112,The,0,0
112113,AI,0,0
112114,of,0,0
112115,gastric,0,1
112116,cancer,0,1
112117,tissue,0,1
112118,in,0,0
112119,Group,0,1
112120,FC,0,1
112121,was,0,0
112122,significantly,0,0
112123,higher,0,0
112124,than,0,0
112125,in,0,0
112126,the,0,1
112127,other,0,1
112128,groups,0,0
112129,(,0,1
112130,P,0,0
112131,<,0,0
112132,0.01,0,0
112133,),0,1
112134,.,0,1
112135,The,0,0
112136,MI,0,0
112137,of,0,0
112138,Group,0,1
112139,FC,0,1
112140,was,0,0
112141,significantly,0,0
112142,lower,0,0
112143,than,0,0
112144,in,0,0
112145,the,0,1
112146,other,0,1
112147,groups,0,0
112148,(,0,1
112149,P,0,0
112150,<,0,0
112151,0.05,0,0
112152,),0,1
112153,.,0,1
112154,In,0,0
112155,addition,0,0
112156,",",0,0
112157,after,0,0
112158,s-NAC,0,0
112159,operation,0,1
112160,there,0,0
112161,was,0,0
112162,a,0,0
112163,significant,0,0
112164,inhibition,0,0
112165,of,0,0
112166,proliferative,0,1
112167,potency,0,0
112168,and,0,0
112169,an,0,0
112170,induction,0,0
112171,of,0,0
112172,apoptosis,0,0
112173,in,0,1
112174,Group,0,1
112175,FC,0,1
112176,.,0,1
112177,CONCLUSION,0,0
112178,Combination,0,0
112179,of,0,1
112180,CDDP,0,1
112181,and,0,1
112182,5-FU,0,1
112183,reduced,0,0
112184,proliferative,0,1
112185,potency,0,0
112186,and,0,1
112187,increased,0,0
112188,cellular,0,0
112189,apoptosis,0,0
112190,in,0,1
112191,gastric,1,1
112192,cancer,1,1
112193,cells,0,1
112194,.,0,1
112195,Niacin,0,0
112196,revisited,0,0
112197,.,0,1
112198,A,0,0
112199,randomized,0,0
112200,",",0,0
112201,controlled,0,0
112202,trial,0,0
112203,of,0,0
112204,wax-matrix,0,0
112205,sustained-release,0,0
112206,niacin,0,0
112207,in,0,1
112208,hypercholesterolemia,1,1
112209,.,1,1
112210,Two,1,1
112211,hundred,1,1
112212,one,1,1
112213,male,1,1
112214,and,1,1
112215,female,1,1
112216,subjects,1,1
112217,",",1,1
112218,aged,1,1
112219,20,1,1
112220,to,1,1
112221,70,1,1
112222,years,1,1
112223,",",1,1
112224,with,1,1
112225,elevated,1,1
112226,low-density,1,1
112227,lipoprotein,1,0
112228,cholesterol,1,0
112229,values,1,0
112230,(,1,1
112231,in,1,1
112232,the,1,0
112233,75th,1,0
112234,to,1,1
112235,95th,1,1
112236,percentiles,1,1
112237,),1,1
112238,",",1,0
112239,participated,1,1
112240,in,0,0
112241,a,0,0
112242,randomized,0,1
112243,",",0,0
112244,controlled,0,0
112245,",",0,0
112246,double-blind,0,0
112247,study,0,0
112248,using,0,0
112249,a,0,0
112250,new,0,1
112251,form,0,0
112252,of,0,0
112253,niacin,0,0
112254,(,0,1
112255,Enduracin,0,0
112256,),0,1
112257,",",0,0
112258,which,0,0
112259,employs,0,0
112260,a,0,0
112261,wax-matrix,0,0
112262,vehicle,0,0
112263,for,0,0
112264,sustained,0,1
112265,release,0,0
112266,.,0,1
112267,Four,0,0
112268,niacin,0,0
112269,treatment,0,1
112270,groups,0,1
112271,(,0,1
112272,daily,0,0
112273,doses,0,0
112274,of,0,1
112275,2000,0,1
112276,",",0,1
112277,1500,0,1
112278,",",0,0
112279,1250,0,0
112280,",",0,0
112281,and,0,0
112282,1000,0,0
112283,mg,0,1
112284,),0,1
112285,were,0,0
112286,compared,0,0
112287,with,0,1
112288,placebo-,0,0
112289,and,0,1
112290,diet-treated,0,1
112291,controls,0,1
112292,to,0,1
112293,determine,0,0
112294,side-effect,0,0
112295,profile,0,0
112296,and,0,1
112297,optimal,0,0
112298,range,0,1
112299,of,0,0
112300,efficacy,0,0
112301,.,0,1
112302,The,0,0
112303,groups,0,0
112304,given,0,1
112305,2000,0,1
112306,and,0,1
112307,1500,0,1
112308,mg,0,0
112309,demonstrated,0,0
112310,significant,0,0
112311,reductions,0,0
112312,in,0,1
112313,values,0,0
112314,of,0,1
112315,low-density,0,1
112316,lipoprotein,0,0
112317,cholesterol,0,0
112318,(,0,1
112319,-26,0,0
112320,%,0,0
112321,and,0,1
112322,-19.3,0,0
112323,%,0,0
112324,",",0,0
112325,respectively,0,0
112326,),0,0
112327,",",0,0
112328,total,0,1
112329,cholesterol,0,0
112330,(,0,1
112331,-18.4,0,0
112332,%,0,0
112333,and,0,1
112334,-13.3,0,0
112335,%,0,0
112336,),0,1
112337,",",0,0
112338,and,0,0
112339,total,0,1
112340,cholesterol-high-density,0,0
112341,lipoprotein,0,0
112342,cholesterol,0,0
112343,ratio,0,0
112344,(,0,1
112345,-20.4,0,0
112346,%,0,0
112347,and,0,1
112348,-19.4,0,0
112349,%,0,0
112350,),0,0
112351,when,0,0
112352,compared,0,0
112353,with,0,1
112354,diet-,0,1
112355,and,0,1
112356,placebo-treated,0,1
112357,controls,0,1
112358,.,0,1
112359,Smaller,0,1
112360,improvements,0,0
112361,were,0,1
112362,seen,0,0
112363,in,0,0
112364,high-density,0,1
112365,lipoprotein,0,0
112366,cholesterol,0,0
112367,and,0,1
112368,triglyceride,0,0
112369,levels,0,0
112370,.,0,1
112371,Blood,0,0
112372,chemistry,0,0
112373,monitoring,0,0
112374,indicated,0,0
112375,that,0,0
112376,reduction,0,0
112377,in,0,0
112378,low-density,0,1
112379,lipoprotein,0,0
112380,cholesterol,0,0
112381,level,0,0
112382,strongly,0,0
112383,correlated,0,0
112384,with,0,1
112385,an,0,0
112386,increase,0,0
112387,in,0,0
112388,baseline,0,0
112389,levels,0,0
112390,of,0,1
112391,some,0,1
112392,enzymes,0,0
112393,for,0,1
112394,niacin-treated,0,1
112395,subjects,0,1
112396,.,0,1
112397,The,0,0
112398,improved,0,0
112399,side-effect,0,0
112400,profile,0,0
112401,of,0,0
112402,the,0,0
112403,wax-matrix,0,0
112404,form,0,0
112405,of,0,0
112406,niacin,0,0
112407,was,0,0
112408,particularly,0,0
112409,notable,0,0
112410,.,0,1
112411,The,0,0
112412,dropout,0,0
112413,rate,0,0
112414,due,0,0
112415,to,0,1
112416,side,0,0
112417,effects,0,0
112418,was,0,0
112419,only,0,0
112420,3.4,0,0
112421,%,0,0
112422,and,0,1
112423,was,0,0
112424,coupled,0,0
112425,with,0,1
112426,good,0,0
112427,medication,0,1
112428,compliance,0,0
112429,.,0,1
112430,A,0,0
112431,comparison,0,0
112432,of,0,0
112433,the,0,0
112434,effect,0,0
112435,of,0,0
112436,short-term,0,0
112437,aromatase,0,1
112438,inhibitor,0,0
112439,(,0,1
112440,letrozole,0,1
112441,),0,1
112442,and,0,1
112443,GnRH,0,0
112444,agonist,0,1
112445,(,0,1
112446,triptorelin,0,0
112447,),0,1
112448,versus,0,0
112449,case,0,0
112450,control,0,1
112451,on,0,0
112452,pregnancy,0,1
112453,rate,0,0
112454,and,0,0
112455,symptom,0,0
112456,and,0,0
112457,sign,0,0
112458,recurrence,0,0
112459,after,0,0
112460,laparoscopic,0,1
112461,treatment,0,1
112462,of,0,0
112463,endometriosis,0,1
112464,.,0,1
112465,PURPOSE,0,0
112466,To,0,0
112467,compare,0,0
112468,the,0,0
112469,role,0,0
112470,of,0,0
112471,an,0,0
112472,aromatase,0,0
112473,inhibitor,0,0
112474,(,0,1
112475,letrozole,0,0
112476,),0,1
112477,with,0,1
112478,a,0,1
112479,GnRH,0,0
112480,agonist,0,0
112481,(,0,1
112482,triptorelin,0,0
112483,),0,1
112484,versus,0,0
112485,case,0,0
112486,control,0,1
112487,on,0,0
112488,the,0,0
112489,pregnancy,0,1
112490,rate,0,0
112491,and,0,0
112492,recurrence,0,0
112493,of,0,1
112494,symptoms,0,1
112495,and,0,1
112496,signs,0,1
112497,in,0,1
112498,patients,1,1
112499,with,1,1
112500,endometriosis,1,1
112501,.,1,1
112502,METHODS,0,0
112503,In,0,0
112504,a,0,1
112505,prospective,0,1
112506,randomized,0,1
112507,clinical,0,0
112508,trial,0,0
112509,",",0,0
112510,after,1,0
112511,treatment,1,0
112512,of,1,1
112513,144,1,1
112514,infertile,1,1
112515,women,1,1
112516,in,1,1
112517,their,1,1
112518,reproductive,1,1
112519,age,1,1
112520,by,1,0
112521,laparoscopy,1,1
112522,(,1,1
112523,whose,1,1
112524,endometriosis,1,1
112525,was,1,1
112526,confirmed,1,0
112527,by,1,0
112528,prior,1,1
112529,laparoscopy,1,1
112530,),1,1
112531,",",0,0
112532,they,0,0
112533,were,0,0
112534,divided,0,1
112535,into,0,1
112536,3,0,1
112537,groups,0,1
112538,:,0,1
112539,group,0,1
112540,1,0,1
112541,(,1,1
112542,47,1,1
112543,cases,1,1
112544,),1,1
112545,who,1,1
112546,received,1,1
112547,letrozole,1,1
112548,for,1,1
112549,2,1,1
112550,months,1,0
112551,",",1,1
112552,group,1,1
112553,2,1,1
112554,(,1,1
112555,40,1,1
112556,patients,1,1
112557,),1,1
112558,who,1,1
112559,were,1,1
112560,prescribed,1,1
112561,triptorelin,1,0
112562,for,1,1
112563,2,1,1
112564,months,1,1
112565,and,1,1
112566,group,1,1
112567,3,1,1
112568,who,1,1
112569,were,1,1
112570,57,1,1
112571,patients,1,1
112572,in,1,1
112573,the,1,0
112574,control,1,1
112575,group,1,0
112576,and,1,0
112577,did,1,0
112578,not,1,0
112579,receive,1,0
112580,any,1,0
112581,medication,1,0
112582,.,1,1
112583,We,0,0
112584,followed,0,0
112585,up,0,0
112586,each,0,0
112587,group,0,0
112588,at,0,0
112589,least,0,1
112590,for,0,1
112591,12,0,1
112592,months,0,1
112593,after,0,1
112594,their,0,1
112595,restoration,0,0
112596,of,0,0
112597,regular,0,1
112598,cycle,0,0
112599,.,0,1
112600,RESULTS,0,0
112601,Pregnancy,0,1
112602,rate,0,0
112603,was,0,0
112604,23.4,0,0
112605,%,0,0
112606,in,0,1
112607,group,0,1
112608,1,0,1
112609,",",0,1
112610,27.5,0,0
112611,%,0,0
112612,in,0,1
112613,group,0,1
112614,2,0,1
112615,",",0,1
112616,and,0,0
112617,28.1,0,0
112618,%,0,0
112619,in,0,1
112620,group,0,1
112621,3,0,1
112622,.,0,1
112623,The,0,0
112624,results,0,0
112625,did,0,0
112626,not,0,0
112627,show,0,0
112628,significant,0,0
112629,differences,0,0
112630,among,0,1
112631,the,0,1
112632,3,0,1
112633,groups,0,1
112634,.,0,1
112635,Recurrence,0,0
112636,rate,0,0
112637,of,0,0
112638,endometriosis,0,1
112639,was,0,0
112640,6.4,0,0
112641,%,0,0
112642,in,0,1
112643,group,0,1
112644,1,0,1
112645,",",0,1
112646,5,0,0
112647,%,0,0
112648,group,0,1
112649,2,0,1
112650,and,0,1
112651,5.3,0,0
112652,%,0,0
112653,in,0,1
112654,group,0,1
112655,3,0,1
112656,",",0,0
112657,which,0,0
112658,was,0,0
112659,not,0,0
112660,statistically,0,0
112661,significantly,0,0
112662,different,0,0
112663,as,0,0
112664,well,0,0
112665,.,0,1
112666,CONCLUSION,0,0
112667,Pregnancy,0,1
112668,rate,0,0
112669,and,0,0
112670,endometriosis,0,1
112671,recurrence,0,0
112672,rate,0,0
112673,are,0,0
112674,comparable,0,0
112675,among,0,1
112676,the,0,1
112677,3,0,1
112678,groups,0,1
112679,.,0,1
112680,Double-blind,0,0
112681,",",0,0
112682,placebo-controlled,0,0
112683,study,0,1
112684,of,0,0
112685,azelastine,0,1
112686,and,0,0
112687,fluticasone,0,0
112688,in,0,0
112689,a,0,1
112690,single,0,0
112691,nasal,0,1
112692,spray,0,1
112693,delivery,0,0
112694,device,0,0
112695,.,0,0
112696,BACKGROUND,0,0
112697,A,0,0
112698,proof-of-concept,0,0
112699,study,0,0
112700,suggested,0,0
112701,that,0,0
112702,combination,0,0
112703,therapy,0,0
112704,with,0,1
112705,commercial,0,0
112706,azelastine,0,1
112707,hydrochloride,0,0
112708,nasal,0,1
112709,spray,0,0
112710,and,0,0
112711,fluticasone,0,0
112712,propionate,0,0
112713,nasal,0,1
112714,spray,0,0
112715,significantly,0,0
112716,improved,0,0
112717,nasal,0,1
112718,symptoms,0,1
112719,of,0,1
112720,seasonal,0,1
112721,allergic,1,1
112722,rhinitis,1,1
112723,compared,0,0
112724,with,0,1
112725,either,0,0
112726,agent,0,0
112727,alone,0,0
112728,.,0,1
112729,OBJECTIVE,0,0
112730,To,0,0
112731,compare,0,0
112732,an,0,0
112733,azelastine-fluticasone,0,0
112734,combination,0,0
112735,nasal,0,1
112736,spray,0,0
112737,administered,0,0
112738,in,0,0
112739,a,0,1
112740,single-delivery,0,0
112741,device,0,0
112742,with,0,1
112743,a,0,0
112744,commercially,0,0
112745,available,0,0
112746,azelastine,0,0
112747,nasal,0,1
112748,spray,0,0
112749,and,0,0
112750,fluticasone,0,0
112751,nasal,0,1
112752,spray,0,1
112753,.,0,1
112754,METHODS,0,0
112755,This,0,0
112756,14-day,0,0
112757,",",0,0
112758,multicenter,0,0
112759,",",0,0
112760,randomized,0,0
112761,",",0,0
112762,double-blind,0,0
112763,study,0,1
112764,was,0,0
112765,conducted,0,0
112766,during,0,0
112767,the,0,0
112768,Texas,0,1
112769,mountain,0,1
112770,cedar,0,1
112771,season,0,1
112772,.,0,1
112773,After,0,0
112774,a,0,0
112775,5-day,0,0
112776,placebo,0,0
112777,lead-in,0,0
112778,",",0,1
112779,610,1,1
112780,patients,1,1
112781,with,1,1
112782,moderate-to-severe,1,1
112783,nasal,1,1
112784,symptoms,1,1
112785,were,0,1
112786,randomized,0,1
112787,to,0,0
112788,treatment,0,0
112789,with,0,1
112790,(,0,1
112791,1,0,1
112792,),0,1
112793,azelastine,0,1
112794,nasal,0,1
112795,spray,0,0
112796,",",0,0
112797,(,0,1
112798,2,0,1
112799,),0,1
112800,fluticasone,0,0
112801,nasal,0,1
112802,spray,0,0
112803,",",0,0
112804,(,0,1
112805,3,0,1
112806,),0,1
112807,combination,0,0
112808,azelastine,0,1
112809,and,0,0
112810,fluticasone,0,0
112811,nasal,0,1
112812,spray,0,0
112813,",",0,0
112814,or,0,1
112815,(,0,1
112816,4,0,0
112817,),0,1
112818,placebo,0,0
112819,nasal,0,1
112820,spray,0,1
112821,.,0,1
112822,All,0,1
112823,treatments,0,0
112824,were,0,1
112825,given,0,1
112826,as,0,0
112827,1,0,0
112828,spray,0,1
112829,per,0,1
112830,nostril,0,0
112831,twice,0,1
112832,daily,0,0
112833,.,0,1
112834,The,0,0
112835,primary,0,0
112836,efficacy,0,0
112837,variable,0,0
112838,was,0,0
112839,the,0,0
112840,change,0,0
112841,from,0,0
112842,baseline,0,0
112843,in,0,0
112844,the,0,0
112845,total,0,1
112846,nasal,0,1
112847,symptom,0,1
112848,score,0,0
112849,(,0,1
112850,TNSS,0,1
112851,),0,1
112852,",",0,0
112853,consisting,0,1
112854,of,0,0
112855,nasal,0,1
112856,congestion,0,1
112857,",",0,0
112858,runny,0,0
112859,nose,0,0
112860,",",0,0
112861,itchy,0,0
112862,nose,0,0
112863,",",0,0
112864,and,0,0
112865,sneezing,0,0
112866,.,0,1
112867,RESULTS,0,0
112868,All,0,1
112869,3,0,1
112870,active,0,1
112871,groups,0,1
112872,were,0,1
112873,statistically,0,0
112874,superior,0,0
112875,(,0,1
112876,P,0,0
112877,<,0,0
112878,or=,0,1
112879,.02,0,0
112880,),0,1
112881,to,0,0
112882,placebo,0,0
112883,",",0,0
112884,and,0,0
112885,the,0,0
112886,combination,0,0
112887,was,0,0
112888,statistically,0,0
112889,superior,0,0
112890,(,0,1
112891,P,0,0
112892,<,0,0
112893,or=,0,1
112894,.003,0,0
112895,),0,1
112896,to,0,0
112897,either,0,0
112898,agent,0,0
112899,alone,0,0
112900,.,0,1
112901,The,0,0
112902,TNSS,0,1
112903,improved,0,0
112904,by,0,0
112905,28.4,0,1
112906,%,0,0
112907,with,0,1
112908,combination,0,0
112909,azelastine-fluticasone,0,0
112910,",",0,0
112911,20.4,0,0
112912,%,0,0
112913,with,0,1
112914,fluticasone,0,0
112915,",",0,1
112916,16.4,0,0
112917,%,0,0
112918,with,0,1
112919,azelastine,0,0
112920,",",0,1
112921,and,0,0
112922,11.2,0,0
112923,%,0,0
112924,with,0,1
112925,placebo,0,0
112926,.,0,1
112927,All,0,1
112928,3,0,0
112929,treatments,0,0
112930,were,0,1
112931,well,0,0
112932,tolerated,0,0
112933,.,0,0
112934,CONCLUSIONS,0,0
112935,The,0,0
112936,combination,0,0
112937,azelastine-fluticasone,0,0
112938,nasal,0,1
112939,spray,0,0
112940,provided,0,0
112941,statistically,0,0
112942,significant,0,0
112943,improvement,0,0
112944,in,0,0
112945,the,0,0
112946,TNSS,0,1
112947,and,0,0
112948,additive,0,0
112949,clinical,0,0
112950,benefit,0,0
112951,compared,0,0
112952,with,0,1
112953,either,0,0
112954,agent,0,0
112955,alone,0,0
112956,in,0,0
112957,patients,1,1
112958,with,1,1
112959,moderate-to-severe,1,1
112960,seasonal,1,1
112961,allergic,1,1
112962,rhinitis,1,1
112963,.,1,1
112964,TRIAL,0,0
112965,REGISTRATION,0,0
112966,clinicaltrials.gov,0,1
112967,Identifier,0,1
112968,:,0,1
112969,NCT00660517,0,1
112970,.,0,1
112971,Tracheal,0,1
112972,soiling,0,0
112973,with,0,1
112974,blood,0,0
112975,during,0,0
112976,intranasal,0,0
112977,surgery,0,1
112978,--,0,1
112979,comparison,0,0
112980,of,0,0
112981,two,0,1
112982,endotracheal,0,1
112983,tubes,0,1
112984,.,0,1
112985,Sixty,1,1
112986,adult,1,1
112987,patients,1,1
112988,",",1,1
112989,ASA,1,1
112990,Classes,1,1
112991,I,1,1
112992,&,1,1
112993,II,1,1
112994,",",0,0
112995,were,0,0
112996,involved,0,0
112997,in,0,0
112998,a,0,1
112999,study,0,0
113000,to,0,0
113001,compare,0,0
113002,the,0,0
113003,effectiveness,0,0
113004,of,0,0
113005,Mallinckrodt,0,1
113006,Hi-Lo-Evac,0,1
113007,tube,0,1
113008,and,0,1
113009,Portex,0,0
113010,blue,0,1
113011,line,0,0
113012,tube,0,1
113013,in,0,0
113014,preventing,0,0
113015,soiling,0,0
113016,of,0,0
113017,the,0,0
113018,lower,0,0
113019,airways,0,1
113020,during,0,0
113021,intranasal,0,0
113022,surgery,0,1
113023,.,0,1
113024,The,0,0
113025,Hi-Lo-Evac,0,0
113026,tube,0,1
113027,with,0,1
113028,and,0,0
113029,without,0,1
113030,pack,0,0
113031,was,0,0
113032,significantly,0,0
113033,more,0,0
113034,effective,0,0
113035,than,0,0
113036,the,0,0
113037,Portex,0,0
113038,tube,0,1
113039,with,0,1
113040,pharyngeal,0,1
113041,pack,0,0
113042,(,0,1
113043,P,0,0
113044,less,0,0
113045,than,0,0
113046,0.002,0,0
113047,),0,1
113048,and,0,1
113049,(,0,1
113050,P,0,0
113051,less,0,0
113052,than,0,0
113053,0.01,0,0
113054,respectively,0,1
113055,),0,0
113056,.,0,0
113057,There,0,0
113058,was,0,0
113059,no,0,0
113060,significant,0,0
113061,difference,0,0
113062,when,0,0
113063,the,0,0
113064,Hi-Lo-Evac,0,0
113065,tube,0,1
113066,was,0,0
113067,used,0,0
113068,with,0,1
113069,or,0,1
113070,without,0,1
113071,a,0,1
113072,pack,0,0
113073,(,0,0
113074,P,0,0
113075,greater,0,0
113076,than,0,0
113077,0.2,0,0
113078,),0,1
113079,.,0,0
113080,The,0,0
113081,more,0,0
113082,effective,0,0
113083,protection,0,0
113084,of,0,0
113085,the,0,0
113086,lower,0,0
113087,airways,0,1
113088,by,0,0
113089,the,0,1
113090,Hi-Lo-Evac,0,0
113091,tube,0,0
113092,is,0,0
113093,attributed,0,0
113094,to,0,0
113095,the,0,0
113096,facility,0,1
113097,of,0,0
113098,subglottic,0,1
113099,aspiration,0,1
113100,during,0,1
113101,surgery,0,1
113102,.,0,1
113103,It,0,0
113104,is,0,0
113105,suggested,0,0
113106,that,0,0
113107,the,0,0
113108,Hi-Lo-Evac,0,0
113109,tube,0,1
113110,could,0,0
113111,be,0,0
113112,used,0,0
113113,with,0,1
113114,safety,0,0
113115,during,0,1
113116,intranasal,0,0
113117,surgery,0,1
113118,in,0,0
113119,order,0,0
113120,to,0,0
113121,reduce,0,0
113122,postoperative,0,0
113123,morbidity,0,0
113124,associated,0,0
113125,with,0,1
113126,the,0,0
113127,use,0,0
113128,of,0,0
113129,pharyngeal,0,1
113130,pack,0,0
113131,.,0,1
113132,Sunlight,0,1
113133,exposure,0,0
113134,or,0,1
113135,vitamin,0,0
113136,D,0,0
113137,supplementation,0,0
113138,for,0,0
113139,vitamin,1,0
113140,D-deficient,1,1
113141,non-western,1,1
113142,immigrants,1,1
113143,:,1,1
113144,a,0,1
113145,randomized,0,1
113146,clinical,0,0
113147,trial,0,1
113148,.,0,1
113149,UNLABELLED,0,0
113150,Vitamin,0,0
113151,D,0,0
113152,deficiency,0,1
113153,is,0,0
113154,very,0,0
113155,common,0,0
113156,in,0,1
113157,non-western,1,1
113158,immigrants,1,1
113159,.,1,1
113160,In,0,0
113161,this,0,0
113162,randomized,0,1
113163,clinical,0,0
113164,trial,0,0
113165,",",0,0
113166,vitamin,0,0
113167,D,0,1
113168,800,0,0
113169,IU/day,0,1
113170,or,0,1
113171,"100,000",0,1
113172,IU/3,0,1
113173,months,0,1
113174,were,0,1
113175,compared,0,0
113176,with,0,1
113177,advised,0,1
113178,sunlight,0,1
113179,exposure,0,1
113180,.,0,1
113181,Vitamin,0,0
113182,D,0,0
113183,supplementation,0,0
113184,was,0,0
113185,more,0,0
113186,effective,0,0
113187,than,0,0
113188,advised,0,1
113189,sunlight,0,0
113190,exposure,0,1
113191,in,0,0
113192,improving,0,0
113193,vitamin,0,0
113194,D,0,1
113195,status,0,1
113196,and,0,0
113197,lowering,0,0
113198,parathyroid,0,1
113199,hormone,0,1
113200,levels,0,1
113201,.,0,1
113202,INTRODUCTION,0,0
113203,Vitamin,0,0
113204,D,0,1
113205,deficiency,0,1
113206,(,0,1
113207,25-hydroxyvitamin,0,1
113208,D,0,1
113209,[,0,1
113210,25,0,1
113211,(,0,1
113212,OH,0,1
113213,),0,1
113214,D,0,1
113215,],0,1
113216,<,0,0
113217,25,0,1
113218,nmol/l,0,1
113219,),0,0
113220,is,0,0
113221,common,0,0
113222,among,0,0
113223,non-western,0,1
113224,immigrants,0,1
113225,.,0,1
113226,It,0,0
113227,can,0,0
113228,be,0,0
113229,treated,0,0
113230,with,0,1
113231,vitamin,0,0
113232,D,0,1
113233,supplementation,0,0
113234,or,0,1
113235,sunlight,0,0
113236,exposure,0,1
113237,.,0,1
113238,METHODS,0,0
113239,To,0,0
113240,determine,0,0
113241,whether,0,0
113242,the,0,0
113243,effect,0,0
113244,of,0,0
113245,vitamin,0,0
113246,D,0,1
113247,(,0,1
113248,3,0,1
113249,),0,1
113250,supplementation,0,0
113251,(,0,1
113252,daily,0,0
113253,800,0,0
113254,IU,0,0
113255,or,0,1
113256,"100,000",0,1
113257,IU/3,0,1
113258,months,0,1
113259,),0,1
113260,or,0,1
113261,sunlight,0,0
113262,exposure,0,0
113263,advice,0,0
113264,is,0,0
113265,similar,0,0
113266,with,0,1
113267,regard,0,0
113268,to,0,1
113269,serum,0,0
113270,25,0,1
113271,(,0,1
113272,OH,0,1
113273,),0,1
113274,D,0,0
113275,and,0,0
113276,parathyroid,0,1
113277,hormone,0,0
113278,(,0,0
113279,PTH,0,1
113280,),0,1
113281,concentrations,0,0
113282,.,0,1
113283,Randomized,0,0
113284,clinical,0,0
113285,trial,1,1
113286,in,1,1
113287,11,1,1
113288,general,1,1
113289,practices,1,1
113290,in,1,1
113291,The,1,1
113292,Netherlands,1,1
113293,.,1,1
113294,Non-western,1,1
113295,immigrants,1,1
113296,",",1,1
113297,aged,1,1
113298,18-65,1,1
113299,years,1,1
113300,(,1,1
113301,n,1,1
113302,=,1,1
113303,232,1,1
113304,),1,1
113305,and,1,1
113306,serum,1,0
113307,25,1,1
113308,(,1,1
113309,OH,1,1
113310,),1,1
113311,D,1,1
113312,<,1,0
113313,25,1,1
113314,nmol/l,1,1
113315,were,1,1
113316,randomly,0,1
113317,assigned,0,1
113318,to,0,0
113319,supplementation,0,0
113320,(,0,1
113321,daily,0,0
113322,800,0,0
113323,IU,0,0
113324,or,0,1
113325,"100,000",0,1
113326,IU/3,0,1
113327,months,0,1
113328,),0,1
113329,or,0,1
113330,advice,0,0
113331,for,0,0
113332,sunlight,0,0
113333,exposure,0,1
113334,for,0,1
113335,6,0,1
113336,months,0,1
113337,(,0,1
113338,March-September,0,1
113339,),0,1
113340,.,0,1
113341,Blood,0,0
113342,samples,0,0
113343,were,0,1
113344,collected,0,1
113345,at,0,0
113346,baseline,0,0
113347,",",0,0
113348,during,0,0
113349,treatment,0,0
113350,(,0,1
113351,3,0,1
113352,months,0,1
113353,",",0,1
113354,6,0,1
113355,months,0,0
113356,),0,1
113357,",",0,0
113358,and,0,0
113359,at,0,0
113360,follow-up,0,0
113361,(,0,1
113362,12,0,1
113363,months,0,1
113364,),0,1
113365,.,0,1
113366,Statistical,0,0
113367,analysis,0,0
113368,was,0,0
113369,performed,0,0
113370,with,0,1
113371,multilevel,0,1
113372,regression,0,0
113373,modelling,0,0
113374,.,0,0
113375,RESULTS,0,0
113376,The,0,0
113377,intention-to-treat,0,0
113378,analysis,0,0
113379,included,1,1
113380,211,1,1
113381,persons,1,1
113382,.,0,1
113383,Baseline,0,0
113384,serum,0,0
113385,25,0,1
113386,(,0,1
113387,OH,0,1
113388,),0,1
113389,D,0,1
113390,was,0,0
113391,22.5,0,0
113392,?,0,1
113393,11.1,0,0
113394,nmol/l,0,1
113395,.,0,1
113396,After,0,0
113397,6,0,0
113398,months,0,0
113399,",",0,1
113400,mean,0,1
113401,serum,0,0
113402,25,0,1
113403,(,0,1
113404,OH,0,1
113405,),0,1
113406,D,0,0
113407,increased,0,0
113408,to,0,1
113409,53,0,1
113410,nmol/l,0,1
113411,with,0,1
113412,800,0,1
113413,IU/day,0,1
113414,",",0,1
113415,to,0,1
113416,50.5,0,0
113417,nmol/l,0,1
113418,with,0,1
113419,"100,000",0,1
113420,IU/3,0,1
113421,months,0,0
113422,",",0,1
113423,and,0,1
113424,to,0,1
113425,29.1,0,1
113426,nmol/l,0,1
113427,with,0,1
113428,advised,0,1
113429,sunlight,0,1
113430,exposure,0,0
113431,(,0,0
113432,supplementation,0,0
113433,vs,0,0
113434,sunshine,0,0
113435,p,0,0
113436,<,0,0
113437,0.001,0,0
113438,),0,1
113439,.,0,1
113440,Serum,0,1
113441,PTH,0,0
113442,decreased,0,0
113443,significantly,0,0
113444,in,0,0
113445,all,0,0
113446,groups,0,0
113447,after,0,1
113448,3,0,1
113449,months,0,0
113450,",",0,0
113451,more,0,0
113452,in,0,0
113453,the,0,0
113454,supplementation,0,0
113455,groups,0,0
113456,than,0,0
113457,in,0,1
113458,the,0,0
113459,advised,0,1
113460,sunlight,0,0
113461,group,0,1
113462,(,0,1
113463,p,0,0
113464,<,0,0
113465,0.05,0,0
113466,),0,0
113467,.,0,0
113468,There,0,0
113469,was,0,0
113470,no,0,0
113471,significant,0,0
113472,effect,0,0
113473,on,0,0
113474,physical,0,1
113475,performance,0,0
113476,and,0,1
113477,functional,0,1
113478,limitations,0,0
113479,.,0,1
113480,CONCLUSION,0,0
113481,Vitamin,0,0
113482,D,0,0
113483,supplementation,0,0
113484,is,0,0
113485,more,0,0
113486,effective,0,0
113487,than,0,0
113488,advised,0,1
113489,sunlight,0,0
113490,exposure,0,1
113491,for,0,0
113492,treating,0,0
113493,vitamin,0,0
113494,D,0,0
113495,deficiency,1,1
113496,in,1,1
113497,non-western,1,1
113498,immigrants,1,1
113499,.,1,1
113500,Randomized,0,1
113501,controlled,0,0
113502,trial,0,0
113503,of,0,0
113504,electro-acupuncture,0,0
113505,for,0,0
113506,autism,1,1
113507,spectrum,1,1
113508,disorder,1,1
113509,.,1,1
113510,OBJECTIVE,0,0
113511,To,0,0
113512,study,0,0
113513,the,0,0
113514,efficacy,0,0
113515,",",0,0
113516,safety,0,0
113517,",",0,0
113518,and,0,0
113519,compliance,0,0
113520,of,0,0
113521,short-term,0,0
113522,electro-acupuncture,0,1
113523,for,0,1
113524,children,1,1
113525,with,1,1
113526,autism,1,1
113527,spectrum,1,1
113528,disorder,1,1
113529,(,1,1
113530,ASD,1,1
113531,),1,1
113532,.,1,1
113533,DESIGN,0,0
113534,Randomized,0,0
113535,",",0,0
113536,double-blind,0,0
113537,",",0,0
113538,sham-controlled,0,0
113539,",",0,0
113540,clinical,0,0
113541,trial,0,1
113542,.,0,1
113543,SUBJECTS,0,0
113544,AND,0,0
113545,METHODS,0,0
113546,Children,1,1
113547,with,1,1
113548,ASD,1,1
113549,were,0,1
113550,randomly,0,1
113551,assigned,0,1
113552,to,0,0
113553,an,0,0
113554,electro-acupuncture,1,0
113555,(,1,0
113556,EA,1,1
113557,),1,1
113558,group,1,1
113559,(,1,1
113560,n=30,1,1
113561,),1,1
113562,or,1,1
113563,a,1,1
113564,sham,1,0
113565,electro-acupuncture,1,0
113566,(,1,1
113567,SEA,1,1
113568,),1,1
113569,group,1,0
113570,(,1,0
113571,n=25,1,1
113572,),1,0
113573,matched,1,1
113574,by,1,0
113575,age,1,1
113576,and,1,0
113577,severity,1,0
113578,of,1,0
113579,autism,1,1
113580,.,1,1
113581,The,0,0
113582,EA,0,0
113583,group,0,0
113584,received,0,0
113585,electro-acupuncture,0,0
113586,for,0,0
113587,selected,0,1
113588,acupoints,0,0
113589,while,0,0
113590,the,0,1
113591,SEA,0,1
113592,group,0,1
113593,received,0,1
113594,sham,0,0
113595,electro-acupuncture,0,0
113596,to,0,1
113597,sham,0,0
113598,acupoints,0,0
113599,.,0,1
113600,A,0,0
113601,total,0,1
113602,of,0,0
113603,12,0,1
113604,EA,0,1
113605,and,0,1
113606,SEA,0,1
113607,sessions,0,0
113608,over,0,1
113609,four,0,1
113610,weeks,0,1
113611,were,0,1
113612,given,0,1
113613,.,0,1
113614,Primary,0,0
113615,outcome,0,0
113616,measures,0,0
113617,included,0,1
113618,Functional,0,1
113619,Independence,0,0
113620,Measure,0,0
113621,for,0,0
113622,Children,0,1
113623,(,0,1
113624,WeeFIM,0,1
113625,),0,1
113626,",",0,0
113627,Pediatric,0,1
113628,Evaluation,0,0
113629,of,0,1
113630,Disability,0,0
113631,Inventory,0,1
113632,(,0,1
113633,PEDI,0,0
113634,),0,1
113635,",",0,0
113636,Leiter,0,1
113637,International,0,1
113638,Performance,0,1
113639,Scale-Revised,0,1
113640,(,0,1
113641,Leiter-R,0,1
113642,),0,1
113643,",",0,0
113644,and,0,0
113645,Clinical,0,0
113646,Global,0,1
113647,Impression-Improvement,0,0
113648,(,0,1
113649,CGI-I,0,1
113650,),0,1
113651,scale,0,0
113652,.,0,1
113653,Secondary,0,0
113654,outcome,0,0
113655,measures,0,0
113656,consisted,0,1
113657,of,0,1
113658,Aberrant,0,1
113659,Behavior,0,1
113660,Checklist,0,0
113661,(,0,1
113662,ABC,0,1
113663,),0,1
113664,",",0,0
113665,Ritvo-Freeman,0,0
113666,Real,0,1
113667,Life,0,1
113668,Scale,0,1
113669,(,0,1
113670,RFRLS,0,0
113671,),0,1
113672,",",0,0
113673,Reynell,0,1
113674,Developmental,0,1
113675,Language,0,1
113676,Scale,0,1
113677,(,0,1
113678,RDLS,0,1
113679,),0,1
113680,",",0,0
113681,and,0,0
113682,a,0,0
113683,standardized,0,0
113684,parental,0,1
113685,report,0,1
113686,.,0,1
113687,Data,0,0
113688,were,0,0
113689,analyzed,0,0
113690,by,0,0
113691,the,0,0
113692,Mann-Whitney,0,0
113693,test,0,0
113694,.,0,0
113695,RESULTS,0,0
113696,There,0,0
113697,were,0,0
113698,significant,0,0
113699,improvements,0,0
113700,in,0,1
113701,the,0,0
113702,language,0,0
113703,comprehension,0,0
113704,domain,0,0
113705,of,0,0
113706,WeeFIM,0,1
113707,(,0,1
113708,p=0.02,0,0
113709,),0,1
113710,",",0,0
113711,self-care,0,0
113712,caregiver,0,0
113713,assistant,0,0
113714,domain,0,0
113715,of,0,0
113716,PEDI,0,0
113717,(,0,1
113718,p=0.028,0,0
113719,),0,1
113720,",",0,0
113721,and,0,0
113722,CGI-I,0,1
113723,(,0,1
113724,p=0.003,0,0
113725,),0,1
113726,in,0,0
113727,the,0,0
113728,EA,0,1
113729,group,0,1
113730,compared,0,0
113731,to,0,0
113732,the,0,0
113733,SEA,0,1
113734,group,0,1
113735,.,0,1
113736,As,0,0
113737,for,0,0
113738,the,0,0
113739,parental,0,0
113740,report,0,0
113741,",",0,0
113742,the,0,0
113743,EA,0,0
113744,group,0,0
113745,also,0,0
113746,showed,0,0
113747,significantly,0,0
113748,better,0,0
113749,social,0,0
113750,initiation,0,0
113751,(,0,1
113752,p=0.01,0,0
113753,),0,1
113754,",",0,0
113755,receptive,0,1
113756,language,0,0
113757,(,0,1
113758,p=0.006,0,0
113759,),0,0
113760,",",0,0
113761,motor,0,0
113762,skills,0,0
113763,(,0,1
113764,p=0.034,0,0
113765,),0,0
113766,",",0,0
113767,coordination,0,0
113768,(,0,0
113769,p=0.07,0,0
113770,),0,1
113771,",",0,0
113772,and,0,0
113773,attention,0,0
113774,span,0,1
113775,(,0,1
113776,p=0.003,0,0
113777,),0,1
113778,.,0,1
113779,More,0,1
113780,than,0,0
113781,70,0,1
113782,percent,0,1
113783,of,0,1
113784,children,1,1
113785,with,1,1
113786,ASD,1,1
113787,adapted,0,0
113788,to,0,0
113789,acupuncture,0,0
113790,easily,0,0
113791,",",0,0
113792,while,0,0
113793,eight,0,1
113794,percent,0,1
113795,had,0,1
113796,poor,0,1
113797,acupuncture,0,1
113798,compliance,0,0
113799,.,0,1
113800,Mild,0,0
113801,side,0,0
113802,effects,0,0
113803,of,0,1
113804,minor,0,0
113805,superficial,0,1
113806,bleeding,0,1
113807,or,0,1
113808,irritability,0,0
113809,during,0,0
113810,acupuncture,0,1
113811,were,0,1
113812,observed,0,0
113813,.,0,0
113814,CONCLUSION,0,0
113815,A,0,0
113816,short,0,0
113817,",",0,0
113818,four-week,0,0
113819,(,0,1
113820,12,0,1
113821,sessions,0,0
113822,),0,1
113823,course,0,1
113824,of,0,0
113825,electro-acupuncture,0,0
113826,is,0,0
113827,useful,0,0
113828,to,0,0
113829,improve,0,0
113830,specific,0,0
113831,functions,0,0
113832,in,0,1
113833,children,1,1
113834,with,1,1
113835,ASD,1,1
113836,",",0,0
113837,especially,0,0
113838,for,0,0
113839,language,0,0
113840,comprehension,0,0
113841,and,0,0
113842,self-care,0,0
113843,ability,0,0
113844,.,0,1
113845,Green,0,1
113846,banana-supplemented,0,0
113847,diet,0,1
113848,in,0,0
113849,the,0,0
113850,home,0,1
113851,management,0,0
113852,of,0,0
113853,acute,1,1
113854,and,1,1
113855,prolonged,1,0
113856,diarrhoea,1,1
113857,in,1,1
113858,children,1,1
113859,:,1,1
113860,a,1,1
113861,community-based,1,1
113862,trial,1,0
113863,in,1,1
113864,rural,1,1
113865,Bangladesh,1,1
113866,.,1,1
113867,SUMMARY,0,0
113868,OBJECTIVE,0,0
113869,To,0,0
113870,determine,0,0
113871,the,0,0
113872,effectiveness,0,0
113873,of,0,0
113874,green,0,1
113875,banana,0,1
113876,in,0,0
113877,the,0,0
113878,home,0,1
113879,management,0,0
113880,of,0,0
113881,acute,1,1
113882,(,1,1
113883,<,1,0
113884,7,1,1
113885,days,1,1
113886,),1,1
113887,or,1,1
113888,prolonged,1,0
113889,(,1,1
113890,?,1,1
113891,7,1,0
113892,days,1,0
113893,),1,1
113894,diarrhoea,1,1
113895,at,1,0
113896,the,0,0
113897,community,0,1
113898,level,0,0
113899,.,0,1
113900,METHODS,0,0
113901,A,0,1
113902,cluster,0,1
113903,randomized,0,1
113904,field,0,0
113905,trial,0,0
113906,was,0,0
113907,conducted,0,1
113908,among,1,1
113909,2968,1,1
113910,Bangladeshi,1,1
113911,rural,1,1
113912,children,1,1
113913,6-36,1,1
113914,months,1,1
113915,old,1,1
113916,.,1,1
113917,Wards,0,1
113918,(,0,1
113919,villages,0,1
113920,),0,1
113921,were,0,1
113922,randomly,0,1
113923,assigned,0,1
113924,to,0,0
113925,either,0,0
113926,a,0,0
113927,standard,0,0
113928,care,0,1
113929,group,0,1
113930,or,0,1
113931,a,0,0
113932,standard,0,0
113933,care,0,1
113934,plus,0,0
113935,green,0,1
113936,banana,0,0
113937,group,0,0
113938,where,0,0
113939,mothers,0,1
113940,were,0,0
113941,instructed,0,1
113942,to,0,0
113943,add,0,0
113944,cooked,0,0
113945,green,0,1
113946,banana,0,1
113947,to,0,1
113948,the,0,0
113949,diets,0,0
113950,of,0,1
113951,diarrhoeal,1,1
113952,children,1,1
113953,.,1,1
113954,Through,0,0
113955,a,0,0
113956,village-based,0,1
113957,surveillance,0,1
113958,system,0,0
113959,",",0,0
113960,diarrhoeal,0,1
113961,morbidity,0,0
113962,data,0,0
113963,(,0,1
113964,severity,0,0
113965,",",0,0
113966,duration,0,0
113967,",",0,0
113968,compliance,0,0
113969,),0,1
113970,were,0,0
113971,collected,0,1
113972,for,0,1
113973,14,0,1
113974,days,0,1
113975,.,0,1
113976,Treatment,0,0
113977,effects,0,0
113978,were,0,1
113979,determined,0,0
113980,by,0,0
113981,analysing,0,0
113982,cumulative,0,0
113983,probability,0,0
113984,of,0,0
113985,cure,0,0
113986,by,0,0
113987,testing,0,0
113988,Cox,0,0
113989,proportional,0,0
113990,hazards,0,0
113991,models,0,1
113992,and,0,1
113993,relative,0,0
113994,risk,0,1
113995,(,0,1
113996,RR,0,1
113997,),0,1
113998,.,0,1
113999,RESULTS,0,0
114000,The,0,0
114001,cumulative,0,0
114002,probability,0,0
114003,of,0,0
114004,cure,0,0
114005,was,0,0
114006,significantly,0,0
114007,(,0,1
114008,P,0,0
114009,<,0,0
114010,0.001,0,0
114011,),0,1
114012,different,0,1
114013,in,0,1
114014,children,0,1
114015,receiving,0,1
114016,GB,0,0
114017,for,0,0
114018,both,0,0
114019,acute,0,1
114020,[,0,0
114021,hazard,0,0
114022,ratio,0,0
114023,(,0,1
114024,HR,0,0
114025,),0,1
114026,=,0,0
114027,0.63,0,0
114028,(,0,0
114029,95,0,0
114030,%,0,0
114031,CI,0,0
114032,:,0,1
114033,0.56-0.67,0,0
114034,),0,1
114035,],0,1
114036,and,0,1
114037,prolonged,0,0
114038,diarrhoea,0,1
114039,[,0,0
114040,HR,0,0
114041,=,0,1
114042,0.38,0,0
114043,(,0,0
114044,95,0,0
114045,%,0,0
114046,CI,0,0
114047,:,0,1
114048,0.26-0.59,0,0
114049,),0,1
114050,],0,1
114051,.,0,1
114052,The,0,0
114053,recovery,0,0
114054,rates,0,0
114055,of,0,1
114056,children,0,1
114057,with,0,1
114058,acute,0,1
114059,diarrhoea,0,1
114060,receiving,0,1
114061,GB,0,0
114062,(,0,1
114063,vs.,0,0
114064,control,0,1
114065,),0,0
114066,were,0,0
114067,significantly,0,0
114068,more,0,0
114069,by,0,0
114070,day,0,0
114071,3,0,1
114072,:,0,1
114073,79.9,0,1
114074,%,0,0
114075,vs,0,0
114076,.,0,1
114077,53.3,0,0
114078,%,0,0
114079,[,0,0
114080,(,0,1
114081,RR,0,1
114082,),0,1
114083,=,0,1
114084,0.47,0,0
114085,",",0,1
114086,95,0,0
114087,%,0,0
114088,CI,0,0
114089,:,0,1
114090,0.41-0.55,0,0
114091,],0,1
114092,",",0,0
114093,(,0,0
114094,P,0,0
114095,<,0,0
114096,0.001,0,0
114097,),0,1
114098,and,0,1
114099,day,0,1
114100,7,0,1
114101,:,0,1
114102,96.6,0,1
114103,%,0,0
114104,vs,0,0
114105,.,0,1
114106,89.1,0,0
114107,%,0,0
114108,(,0,1
114109,RR,0,1
114110,=,0,1
114111,0.32,0,0
114112,;,0,1
114113,0.22-0.46,0,0
114114,),0,1
114115,",",0,0
114116,(,0,1
114117,P,0,0
114118,<,0,0
114119,0.001,0,0
114120,),0,1
114121,.,0,1
114122,Children,0,1
114123,with,0,1
114124,prolonged,0,0
114125,diarrhoea,0,1
114126,receiving,0,1
114127,green,0,1
114128,banana,0,1
114129,had,0,1
114130,significantly,0,0
114131,higher,0,0
114132,recovery,0,0
114133,rates,0,0
114134,by,0,1
114135,day,0,1
114136,10,0,1
114137,:,0,1
114138,79.8,0,0
114139,%,0,0
114140,vs,0,0
114141,.,0,1
114142,51.9,0,0
114143,%,0,0
114144,(,0,1
114145,RR,0,1
114146,=,0,1
114147,0.42,0,0
114148,;,0,1
114149,0.23-0.73,0,0
114150,),0,1
114151,",",0,0
114152,(,0,1
114153,P,0,0
114154,<,0,0
114155,0.001,0,0
114156,),0,1
114157,and,0,1
114158,day,0,1
114159,14,0,1
114160,:,0,1
114161,93.6,0,0
114162,%,0,0
114163,vs,0,0
114164,.,0,1
114165,67.2,0,0
114166,%,0,0
114167,(,0,1
114168,RR,0,1
114169,=,0,1
114170,0.22,0,0
114171,;,0,1
114172,0.08-0.54,0,0
114173,),0,1
114174,",",0,0
114175,(,0,1
114176,P,0,0
114177,<,0,0
114178,0.001,0,0
114179,),0,1
114180,.,0,1
114181,CONCLUSION,0,0
114182,A,0,0
114183,green,0,0
114184,banana-supplemented,0,0
114185,diet,0,1
114186,hastened,0,0
114187,recovery,0,0
114188,of,0,0
114189,acute,1,1
114190,and,1,1
114191,prolonged,1,0
114192,childhood,1,1
114193,diarrhoea,1,1
114194,managed,1,1
114195,at,0,0
114196,home,0,1
114197,in,0,1
114198,rural,0,1
114199,Bangladesh,0,1
114200,.,0,1
114201,Early,0,1
114202,treatment,0,1
114203,of,0,1
114204,cold,0,1
114205,sores,0,1
114206,with,0,1
114207,topical,0,0
114208,ME-609,0,1
114209,decreases,0,0
114210,the,0,0
114211,frequency,0,0
114212,of,0,0
114213,ulcerative,0,1
114214,lesions,0,1
114215,:,0,1
114216,a,0,1
114217,randomized,0,1
114218,",",0,0
114219,double-blind,0,0
114220,",",0,0
114221,placebo-controlled,0,0
114222,",",0,0
114223,patient-initiated,0,0
114224,clinical,0,0
114225,trial,0,1
114226,.,0,1
114227,BACKGROUND,0,0
114228,Prior,0,1
114229,pilot,0,1
114230,studies,0,0
114231,support,0,0
114232,the,0,0
114233,use,0,0
114234,of,0,0
114235,antiviral,0,1
114236,medications,0,1
114237,with,0,1
114238,topical,0,0
114239,corticosteroids,0,1
114240,for,0,1
114241,herpes,1,1
114242,simplex,1,1
114243,labialis,1,1
114244,(,1,1
114245,HSL,1,1
114246,),1,1
114247,.,1,1
114248,ME-609,0,0
114249,(,0,0
114250,Xerese,0,1
114251,",",0,1
114252,Xerclear,0,0
114253,),0,0
114254,is,0,0
114255,a,0,0
114256,combination,0,0
114257,of,0,0
114258,5,0,0
114259,%,0,0
114260,acyclovir,0,0
114261,and,0,1
114262,1,0,0
114263,%,0,0
114264,hydrocortisone,0,0
114265,developed,0,1
114266,for,0,0
114267,the,0,0
114268,topical,0,0
114269,treatment,0,0
114270,of,0,1
114271,HSL,0,1
114272,.,0,1
114273,OBJECTIVES,0,0
114274,The,0,0
114275,primary,0,1
114276,study,0,0
114277,end,0,0
114278,point,0,0
114279,was,0,0
114280,the,0,0
114281,prevention,0,1
114282,of,0,0
114283,ulcerative,0,1
114284,HSL,0,1
114285,lesions,0,1
114286,.,0,1
114287,METHODS,0,0
114288,In,0,0
114289,all,0,0
114290,",",0,1
114291,2437,1,1
114292,patients,1,1
114293,with,1,1
114294,a,1,1
114295,history,1,1
114296,of,1,0
114297,HSL,1,1
114298,were,0,1
114299,randomized,0,1
114300,to,0,1
114301,self-initiate,0,0
114302,treatment,0,0
114303,with,0,1
114304,ME-609,0,1
114305,",",0,1
114306,5,0,0
114307,%,0,0
114308,acyclovir,0,0
114309,in,0,0
114310,ME-609,0,1
114311,vehicle,0,1
114312,",",0,0
114313,or,0,1
114314,ME-609,0,1
114315,vehicle,0,0
114316,(,0,1
114317,placebo,0,0
114318,),0,1
114319,at,0,0
114320,the,0,0
114321,earliest,0,0
114322,sign,0,0
114323,of,0,0
114324,a,0,1
114325,cold,0,1
114326,sore,0,1
114327,recurrence,0,0
114328,.,0,1
114329,Cream,0,0
114330,was,0,0
114331,applied,0,0
114332,5,0,0
114333,times/d,0,0
114334,for,0,1
114335,5,0,1
114336,days,0,0
114337,.,0,1
114338,A,0,0
114339,total,0,1
114340,of,0,0
114341,1443,1,1
114342,patients,1,1
114343,experienced,1,1
114344,a,1,1
114345,recurrence,1,0
114346,and,0,0
114347,initiated,0,0
114348,treatment,0,0
114349,with,0,1
114350,ME-609,0,1
114351,(,0,1
114352,n,0,1
114353,=,0,1
114354,601,0,1
114355,),0,0
114356,",",0,0
114357,acyclovir,0,0
114358,(,0,1
114359,n,0,1
114360,=,0,1
114361,610,0,1
114362,),0,1
114363,",",0,0
114364,or,0,1
114365,placebo,0,0
114366,(,0,1
114367,n,0,1
114368,=,0,1
114369,232,0,1
114370,),0,1
114371,.,0,1
114372,RESULTS,0,0
114373,Of,0,1
114374,patients,0,1
114375,receiving,0,1
114376,ME-609,0,1
114377,",",0,1
114378,42,0,1
114379,%,0,0
114380,did,0,0
114381,not,0,0
114382,develop,0,0
114383,an,0,0
114384,ulcerative,0,1
114385,lesion,0,0
114386,compared,0,0
114387,with,0,1
114388,35,1,1
114389,%,1,0
114390,of,1,1
114391,patients,1,1
114392,receiving,0,1
114393,acyclovir,0,1
114394,in,0,1
114395,ME-609,0,1
114396,vehicle,0,1
114397,(,0,1
114398,P,0,0
114399,=,0,1
114400,.014,0,0
114401,),0,1
114402,and,0,1
114403,26,0,1
114404,%,0,0
114405,of,0,1
114406,patients,0,1
114407,receiving,0,1
114408,placebo,0,1
114409,(,0,1
114410,P,0,0
114411,<,0,0
114412,.0001,0,0
114413,),0,1
114414,.,0,1
114415,In,0,0
114416,patients,0,1
114417,with,0,1
114418,ulcerative,0,1
114419,lesions,0,1
114420,",",0,1
114421,healing,0,0
114422,times,0,0
114423,were,0,1
114424,reduced,0,0
114425,in,0,0
114426,the,0,0
114427,ME-609,0,1
114428,and,0,0
114429,acyclovir,0,1
114430,groups,0,0
114431,compared,0,0
114432,with,0,1
114433,placebo,0,0
114434,(,0,1
114435,P,0,0
114436,<,0,0
114437,.01,0,0
114438,for,0,0
114439,both,0,0
114440,),0,1
114441,.,0,0
114442,The,0,0
114443,cumulative,0,0
114444,lesion,0,0
114445,area,0,0
114446,for,0,0
114447,all,0,1
114448,lesions,0,1
114449,was,0,0
114450,reduced,0,0
114451,50,0,1
114452,%,0,0
114453,in,0,1
114454,patients,0,1
114455,receiving,0,1
114456,ME-609,0,1
114457,compared,0,0
114458,with,0,1
114459,the,0,0
114460,placebo,0,0
114461,group,0,0
114462,(,0,1
114463,P,0,0
114464,<,0,0
114465,.0001,0,0
114466,),0,0
114467,.,0,0
114468,There,0,0
114469,were,0,0
114470,no,0,0
114471,differences,0,0
114472,among,0,1
114473,groups,0,1
114474,in,0,1
114475,the,0,0
114476,number,0,0
114477,of,0,0
114478,patients,0,1
114479,with,0,1
114480,positive,0,1
114481,herpes,0,1
114482,simplex,0,1
114483,virus,0,1
114484,cultures,0,0
114485,.,0,1
114486,The,0,0
114487,side-effect,0,0
114488,profile,0,0
114489,was,0,0
114490,similar,0,0
114491,among,0,1
114492,treatments,0,0
114493,.,0,1
114494,LIMITATIONS,0,0
114495,The,0,0
114496,study,0,0
114497,did,0,0
114498,not,0,0
114499,contain,0,0
114500,a,0,0
114501,group,0,0
114502,treated,0,1
114503,with,0,1
114504,a,0,1
114505,topical,0,0
114506,corticosteroid,0,0
114507,alone,0,1
114508,.,0,1
114509,CONCLUSIONS,0,0
114510,ME-609,0,0
114511,prevented,0,0
114512,progression,0,0
114513,of,0,1
114514,cold,0,1
114515,sores,0,1
114516,to,0,1
114517,ulcerative,0,1
114518,lesions,0,1
114519,and,0,1
114520,significantly,0,0
114521,reduced,0,0
114522,the,0,0
114523,cumulative,0,0
114524,lesion,0,0
114525,area,0,0
114526,compared,0,0
114527,with,0,1
114528,acyclovir,0,0
114529,and,0,1
114530,placebo,0,0
114531,.,0,1
114532,ME-609,0,0
114533,treatment,0,0
114534,offers,0,0
114535,additional,0,1
114536,therapeutic,0,1
114537,benefit,0,0
114538,compared,0,0
114539,with,0,1
114540,therapy,0,0
114541,with,0,1
114542,topical,0,0
114543,acyclovir,0,0
114544,alone,0,1
114545,.,0,1
114546,A,0,0
114547,phase,0,0
114548,II,0,1
114549,randomized,0,1
114550,trial,0,0
114551,comparing,0,0
114552,radiotherapy,0,1
114553,with,0,1
114554,concurrent,0,1
114555,weekly,0,1
114556,cisplatin,0,0
114557,or,0,1
114558,weekly,0,0
114559,paclitaxel,0,1
114560,in,0,1
114561,patients,1,1
114562,with,1,1
114563,advanced,1,1
114564,cervical,1,1
114565,cancer,1,1
114566,.,1,1
114567,PURPOSE/OBJECTIVE,0,0
114568,This,0,0
114569,is,0,0
114570,a,0,0
114571,prospective,0,0
114572,comparison,0,0
114573,of,0,0
114574,weekly,0,1
114575,cisplatin,0,0
114576,to,0,0
114577,weekly,0,0
114578,paclitaxel,0,0
114579,as,0,0
114580,concurrent,0,0
114581,chemotherapy,0,1
114582,with,0,1
114583,standard,0,1
114584,radiotherapy,0,1
114585,for,0,0
114586,locally,0,1
114587,advanced,1,1
114588,cervical,1,1
114589,carcinoma,1,1
114590,.,1,1
114591,MATERIALS/METHODS,0,0
114592,Between,1,1
114593,May,1,0
114594,2000,1,1
114595,and,1,1
114596,May,1,0
114597,2004,1,1
114598,",",1,1
114599,31,1,1
114600,women,1,1
114601,with,1,1
114602,FIGO,1,1
114603,stage,1,1
114604,IB2-IVA,1,0
114605,cervical,1,1
114606,cancer,1,1
114607,or,1,1
114608,with,1,1
114609,postsurgical,1,1
114610,pelvic,1,1
114611,recurrence,1,0
114612,were,1,1
114613,enrolled,1,1
114614,into,1,0
114615,this,1,0
114616,phase,1,1
114617,II,1,1
114618,study,1,1
114619,and,0,0
114620,randomized,0,1
114621,to,0,0
114622,receive,0,1
114623,on,0,0
114624,a,0,0
114625,weekly,0,0
114626,basis,0,0
114627,either,0,1
114628,40,0,1
114629,mg/m?,0,0
114630,Cisplatin,0,1
114631,(,0,1
114632,group,0,1
114633,I,0,1
114634,;,0,1
114635,16,0,1
114636,patients,0,1
114637,),0,1
114638,or,0,1
114639,50,0,1
114640,mg/m?,0,0
114641,paclitaxel,0,1
114642,(,0,1
114643,group,0,1
114644,II,0,1
114645,;,0,1
114646,15,0,1
114647,patients,0,1
114648,),0,1
114649,concurrently,0,1
114650,with,0,1
114651,radiotherapy,0,1
114652,.,0,1
114653,Median,0,0
114654,total,0,1
114655,dose,0,0
114656,to,0,0
114657,point,0,0
114658,A,0,1
114659,was,0,0
114660,74,0,1
114661,Gy,0,1
114662,(,0,1
114663,range,0,1
114664,:,0,1
114665,66-92,0,1
114666,Gy,0,1
114667,),0,1
114668,for,0,0
114669,group,0,1
114670,I,0,1
114671,and,0,1
114672,66,0,1
114673,Gy,0,1
114674,(,0,1
114675,range,0,1
114676,:,0,1
114677,40-98,0,1
114678,Gy,0,1
114679,),0,1
114680,for,0,0
114681,group,0,1
114682,II,0,1
114683,.,0,1
114684,Median,0,0
114685,follow-up,0,0
114686,time,0,0
114687,was,0,0
114688,46,0,1
114689,months,0,1
114690,.,0,1
114691,RESULTS,1,0
114692,Patient,1,0
114693,and,1,1
114694,tumor,1,1
114695,characteristics,1,1
114696,were,1,1
114697,similar,0,0
114698,in,0,1
114699,both,0,0
114700,groups,0,0
114701,.,0,1
114702,The,0,0
114703,mean,0,0
114704,number,0,0
114705,of,0,1
114706,chemotherapy,0,1
114707,cycles,0,0
114708,was,0,0
114709,also,0,0
114710,comparable,0,0
114711,with,0,1
114712,87,0,1
114713,%,0,0
114714,and,0,1
114715,80,0,1
114716,%,0,0
114717,of,0,1
114718,patients,0,1
114719,receiving,0,1
114720,at,0,1
114721,least,0,1
114722,4,0,1
114723,doses,0,0
114724,in,0,1
114725,groups,0,1
114726,I,0,1
114727,and,0,1
114728,II,0,1
114729,",",0,0
114730,respectively,0,0
114731,.,0,1
114732,Seven,0,0
114733,patients,0,1
114734,(,0,1
114735,44,0,1
114736,%,0,0
114737,),0,1
114738,of,0,0
114739,group,0,1
114740,I,0,1
114741,and,0,1
114742,8,0,1
114743,patients,0,1
114744,(,0,1
114745,53,0,1
114746,%,0,0
114747,),0,1
114748,of,0,0
114749,group,0,1
114750,II,0,1
114751,developed,0,1
114752,tumor,0,1
114753,recurrence,0,0
114754,.,0,1
114755,The,0,0
114756,Median,0,1
114757,Survival,0,0
114758,time,0,0
114759,was,0,0
114760,not,0,0
114761,reached,0,0
114762,for,0,0
114763,Group,0,1
114764,I,0,1
114765,and,0,1
114766,53,0,1
114767,months,0,0
114768,for,0,1
114769,group,0,1
114770,II,0,1
114771,.,0,1
114772,The,0,0
114773,proportion,0,0
114774,of,0,0
114775,patients,0,1
114776,surviving,0,1
114777,at,0,1
114778,2,0,1
114779,and,0,1
114780,5,0,1
114781,years,0,1
114782,was,0,0
114783,78,0,1
114784,%,0,0
114785,and,0,1
114786,54,0,1
114787,%,0,0
114788,for,0,0
114789,group,0,1
114790,I,0,1
114791,and,0,1
114792,73,0,1
114793,%,0,0
114794,and,0,1
114795,43,0,1
114796,%,0,0
114797,for,0,0
114798,group,0,1
114799,II,0,1
114800,respectively,0,0
114801,.,0,0
114802,CONCLUSIONS,0,0
114803,This,0,0
114804,small,0,0
114805,prospective,0,1
114806,study,0,1
114807,shows,0,0
114808,that,0,0
114809,weekly,0,0
114810,paclitaxel,0,0
114811,does,0,0
114812,not,0,0
114813,provide,0,0
114814,any,0,0
114815,clinical,0,0
114816,advantage,0,0
114817,over,0,0
114818,weekly,0,0
114819,cisplatin,0,0
114820,for,0,0
114821,concurrent,0,0
114822,chemoradiation,0,1
114823,for,1,0
114824,advanced,1,1
114825,carcinoma,1,1
114826,of,1,0
114827,the,1,0
114828,cervix,1,1
114829,.,1,1
114830,Action,0,1
114831,observation,0,0
114832,treatment,0,0
114833,improves,0,0
114834,recovery,0,0
114835,of,0,0
114836,postsurgical,1,1
114837,orthopedic,1,1
114838,patients,1,1
114839,:,1,1
114840,evidence,0,0
114841,for,0,0
114842,a,0,1
114843,top-down,0,0
114844,effect,0,0
114845,?,0,1
114846,OBJECTIVE,0,0
114847,To,0,0
114848,assess,0,0
114849,whether,0,0
114850,action,0,0
114851,observation,0,0
114852,treatment,0,0
114853,(,0,1
114854,AOT,0,1
114855,),0,1
114856,may,0,0
114857,also,0,0
114858,improve,0,0
114859,motor,0,0
114860,recovery,0,0
114861,in,0,0
114862,postsurgical,1,1
114863,orthopedic,1,1
114864,patients,1,1
114865,",",0,1
114866,in,0,0
114867,addition,0,0
114868,to,0,1
114869,conventional,0,1
114870,physiotherapy,0,1
114871,.,0,1
114872,DESIGN,0,0
114873,Randomized,0,0
114874,controlled,0,0
114875,trial,0,1
114876,.,0,1
114877,SETTING,0,1
114878,Department,0,1
114879,of,0,0
114880,rehabilitation,0,1
114881,.,0,1
114882,PARTICIPANTS,0,0
114883,Patients,1,1
114884,(,1,1
114885,N=60,1,1
114886,),1,1
114887,admitted,1,1
114888,to,1,0
114889,our,1,0
114890,department,1,1
114891,postorthopedic,1,1
114892,surgery,1,1
114893,were,0,0
114894,randomly,0,1
114895,assigned,0,1
114896,to,0,0
114897,either,0,0
114898,a,0,0
114899,case,0,0
114900,(,0,0
114901,n=30,0,1
114902,),0,1
114903,or,0,1
114904,control,0,1
114905,(,0,1
114906,n=30,0,1
114907,),0,1
114908,group,0,1
114909,.,0,1
114910,Exclusion,1,0
114911,criteria,1,1
114912,were,1,1
114913,age,1,1
114914,18,1,1
114915,years,1,1
114916,or,1,1
114917,younger,1,1
114918,and,1,1
114919,90,1,1
114920,years,1,1
114921,or,1,1
114922,older,1,1
114923,",",1,0
114924,Mini-Mental,1,0
114925,State,1,0
114926,Examination,1,1
114927,score,1,1
114928,of,1,0
114929,21,1,1
114930,of,1,1
114931,30,1,1
114932,or,1,1
114933,lower,1,0
114934,",",1,0
114935,no,1,0
114936,ambulating,1,0
114937,order,1,0
114938,",",1,0
114939,advanced,1,1
114940,vision,1,0
114941,impairment,1,1
114942,",",1,0
114943,malignancy,1,1
114944,",",1,0
114945,pneumonia,1,0
114946,",",1,0
114947,or,1,1
114948,heart,1,1
114949,failure,1,1
114950,.,1,1
114951,INTERVENTIONS,0,0
114952,All,0,1
114953,participants,0,1
114954,underwent,0,1
114955,conventional,1,1
114956,physiotherapy,1,1
114957,.,1,1
114958,In,0,0
114959,addition,0,0
114960,",",0,1
114961,patients,0,1
114962,in,0,0
114963,the,0,0
114964,case,0,0
114965,group,0,0
114966,were,0,1
114967,asked,0,0
114968,to,0,0
114969,observe,0,0
114970,video,0,0
114971,clips,0,1
114972,showing,0,1
114973,daily,0,0
114974,actions,0,0
114975,and,0,1
114976,to,0,1
114977,imitate,0,0
114978,them,0,0
114979,afterward,0,1
114980,.,0,1
114981,Patients,0,1
114982,in,0,0
114983,the,0,0
114984,control,0,1
114985,group,0,0
114986,were,0,1
114987,asked,0,0
114988,to,0,0
114989,observe,0,0
114990,video,0,0
114991,clips,0,1
114992,with,0,1
114993,no,0,0
114994,motor,0,0
114995,content,0,0
114996,and,0,0
114997,to,0,0
114998,execute,0,0
114999,the,0,0
115000,same,0,0
115001,actions,0,0
115002,as,0,1
115003,patients,0,1
115004,in,0,1
115005,the,0,0
115006,case,0,0
115007,group,0,0
115008,afterward,0,1
115009,.,0,1
115010,Participants,0,1
115011,were,0,0
115012,scored,0,1
115013,on,0,0
115014,functional,0,1
115015,scales,0,0
115016,at,0,1
115017,baseline,0,0
115018,and,0,1
115019,after,0,0
115020,treatment,0,0
115021,by,0,0
115022,a,0,1
115023,physician,0,1
115024,blinded,0,0
115025,to,0,0
115026,group,0,1
115027,assignment,0,1
115028,.,0,1
115029,MAIN,0,0
115030,OUTCOMES,0,0
115031,MEASURES,0,0
115032,Changes,0,0
115033,in,0,1
115034,FIM,0,1
115035,and,0,1
115036,Tinetti,0,1
115037,scale,0,1
115038,scores,0,0
115039,",",0,1
115040,and,0,0
115041,dependence,0,0
115042,on,0,0
115043,walking,0,0
115044,aids,0,1
115045,.,0,1
115046,RESULTS,0,0
115047,At,0,0
115048,baseline,0,0
115049,",",0,1
115050,groups,0,0
115051,did,0,0
115052,not,0,0
115053,differ,0,0
115054,in,0,0
115055,clinical,0,0
115056,and,0,1
115057,functional,0,1
115058,scale,0,1
115059,scores,0,0
115060,.,0,1
115061,After,0,0
115062,treatment,0,0
115063,",",0,1
115064,patients,0,1
115065,in,0,0
115066,the,0,0
115067,case,0,0
115068,group,0,0
115069,scored,0,0
115070,better,0,0
115071,than,0,0
115072,patients,0,1
115073,in,0,1
115074,the,0,0
115075,control,0,1
115076,group,0,0
115077,(,0,1
115078,FIM,0,1
115079,total,0,1
115080,score,0,0
115081,",",0,1
115082,P=.02,0,0
115083,;,0,1
115084,FIM,0,1
115085,motor,0,0
115086,subscore,0,0
115087,",",0,1
115088,P=.001,0,0
115089,;,0,1
115090,Tinetti,0,1
115091,scale,0,0
115092,score,0,0
115093,",",0,0
115094,P=.04,0,1
115095,),0,1
115096,;,0,1
115097,patients,0,1
115098,in,0,0
115099,the,0,0
115100,case,0,0
115101,group,0,0
115102,were,0,0
115103,assigned,0,0
115104,more,0,0
115105,frequently,0,0
115106,to,0,0
115107,1,0,0
115108,crutch,0,1
115109,(,0,1
115110,P=.01,0,0
115111,),0,1
115112,.,0,1
115113,CONCLUSIONS,0,0
115114,In,0,0
115115,addition,0,0
115116,to,0,1
115117,conventional,0,1
115118,physiotherapy,0,1
115119,",",0,0
115120,AOT,0,1
115121,is,0,0
115122,effective,0,0
115123,in,0,0
115124,the,0,0
115125,rehabilitation,0,1
115126,of,0,0
115127,postsurgical,1,1
115128,orthopedic,1,1
115129,patients,1,1
115130,.,1,1
115131,The,0,0
115132,present,0,0
115133,results,0,0
115134,strongly,0,0
115135,support,0,0
115136,top-down,0,0
115137,effects,0,0
115138,of,0,1
115139,this,0,0
115140,treatment,0,0
115141,in,0,0
115142,motor,0,0
115143,recovery,0,0
115144,",",0,0
115145,even,0,0
115146,in,0,0
115147,nonneurologic,1,1
115148,patients,1,1
115149,.,1,1
115150,The,0,0
115151,effect,0,0
115152,of,0,0
115153,educational,0,1
115154,intervention,0,1
115155,on,0,0
115156,pain,0,1
115157,beliefs,0,0
115158,and,0,1
115159,postoperative,0,1
115160,pain,0,1
115161,relief,0,0
115162,among,0,1
115163,Chinese,1,1
115164,patients,1,1
115165,with,1,1
115166,fractured,1,1
115167,limbs,1,1
115168,.,1,1
115169,Cardiovascular,0,1
115170,safety,0,0
115171,of,0,1
115172,degarelix,0,1
115173,:,0,1
115174,results,0,0
115175,from,0,1
115176,a,0,1
115177,12-month,0,0
115178,",",0,0
115179,comparative,0,0
115180,",",0,0
115181,randomized,0,1
115182,",",0,0
115183,open,0,1
115184,label,0,0
115185,",",0,0
115186,parallel,0,0
115187,group,0,1
115188,phase,0,1
115189,III,0,1
115190,trial,0,1
115191,in,0,1
115192,patients,1,1
115193,with,1,1
115194,prostate,1,1
115195,cancer,1,1
115196,.,1,1
115197,PURPOSE,0,0
115198,We,0,0
115199,assessed,0,0
115200,the,0,0
115201,cardiovascular,0,1
115202,safety,0,0
115203,profile,0,0
115204,of,0,0
115205,degarelix,0,0
115206,",",0,0
115207,a,0,0
115208,new,0,1
115209,gonadotropin-releasing,0,0
115210,hormone,0,1
115211,antagonist,0,0
115212,.,0,1
115213,MATERIALS,0,0
115214,AND,0,0
115215,METHODS,0,0
115216,This,0,0
115217,is,0,0
115218,the,0,0
115219,first,0,0
115220,report,0,0
115221,to,0,1
115222,our,0,0
115223,knowledge,0,0
115224,on,0,0
115225,cardiovascular,0,1
115226,safety,0,0
115227,data,0,0
115228,from,0,1
115229,a,0,1
115230,completed,0,1
115231,1-year,0,0
115232,randomized,0,1
115233,controlled,0,0
115234,trial,0,1
115235,of,0,0
115236,leuprolide,0,0
115237,acetate,0,0
115238,vs,0,0
115239,degarelix,0,1
115240,.,0,1
115241,Outcomes,0,0
115242,considered,0,0
115243,in,0,0
115244,these,0,0
115245,analyses,0,0
115246,included,0,1
115247,the,0,0
115248,QT,0,0
115249,interval,0,0
115250,by,0,0
115251,central,0,0
115252,reading,0,1
115253,and,0,0
115254,analysis,0,0
115255,",",0,0
115256,and,0,0
115257,cardiovascular,0,1
115258,adverse,0,0
115259,events,0,0
115260,.,0,1
115261,On,0,0
115262,multivariate,0,0
115263,analyses,0,0
115264,relationships,0,0
115265,between,0,0
115266,selected,0,1
115267,baseline,0,1
115268,factors,0,0
115269,and,0,1
115270,cardiovascular,0,1
115271,events,0,0
115272,were,0,1
115273,evaluated,0,0
115274,.,0,0
115275,RESULTS,0,0
115276,There,0,0
115277,were,0,0
115278,no,0,0
115279,significant,0,0
115280,differences,0,0
115281,between,0,1
115282,treatment,0,1
115283,groups,0,1
115284,for,0,1
115285,mean,0,1
115286,change,0,0
115287,in,0,1
115288,Fridericia,0,1
115289,'s,0,1
115290,correction,0,1
115291,of,0,1
115292,QT,0,0
115293,during,0,0
115294,the,0,0
115295,trial,0,0
115296,.,0,0
115297,Markedly,0,0
115298,abnormal,0,1
115299,Fridericia,0,1
115300,'s,0,1
115301,correction,0,1
115302,of,0,1
115303,QT,0,0
115304,values,0,0
115305,(,0,1
115306,500,0,1
115307,milliseconds,0,0
115308,or,0,1
115309,greater,0,0
115310,),0,1
115311,were,0,0
115312,observed,0,0
115313,in,0,0
115314,only,0,0
115315,a,0,0
115316,small,0,0
115317,number,0,0
115318,of,0,1
115319,subjects,0,1
115320,by,0,1
115321,treatment,0,1
115322,group,0,1
115323,",",0,0
115324,that,0,0
115325,is,0,0
115326,2,0,0
115327,(,0,0
115328,less,0,0
115329,than,0,0
115330,1,0,0
115331,%,0,0
115332,),0,1
115333,in,0,0
115334,the,0,0
115335,pooled,0,0
115336,degarelix,0,1
115337,group,0,1
115338,and,0,1
115339,2,0,1
115340,(,0,1
115341,1,0,1
115342,%,0,0
115343,),0,1
115344,in,0,0
115345,the,0,0
115346,leuprolide,0,0
115347,group,0,1
115348,.,0,1
115349,Supraventricular,0,0
115350,arrhythmias,0,0
115351,were,0,1
115352,the,0,0
115353,most,0,0
115354,common,0,0
115355,type,0,1
115356,of,0,0
115357,arrhythmias,0,1
115358,",",0,1
115359,affecting,0,0
115360,2,0,0
115361,%,0,0
115362,of,0,1
115363,subjects,0,1
115364,in,0,1
115365,the,0,1
115366,pooled,0,0
115367,degarelix,0,1
115368,group,0,1
115369,and,0,1
115370,4,0,0
115371,%,0,0
115372,in,0,0
115373,the,0,0
115374,leuprolide,0,0
115375,group,0,1
115376,.,0,1
115377,Other,0,0
115378,arrhythmias,0,1
115379,occurred,0,0
115380,in,0,1
115381,1,0,1
115382,%,0,0
115383,or,0,1
115384,less,0,0
115385,of,0,0
115386,subjects,0,1
115387,by,0,1
115388,treatment,0,1
115389,group,0,1
115390,.,0,1
115391,The,0,0
115392,most,0,0
115393,frequently,0,0
115394,reported,0,0
115395,cardiac,0,1
115396,disorder,0,1
115397,was,0,0
115398,ischemic,0,1
115399,heart,0,1
115400,disease,0,1
115401,",",0,0
115402,which,0,0
115403,occurred,0,0
115404,in,0,0
115405,4,0,0
115406,%,0,0
115407,of,0,1
115408,subjects,0,1
115409,treated,0,1
115410,with,0,1
115411,degarelix,0,1
115412,and,0,1
115413,10,0,1
115414,%,0,0
115415,of,0,0
115416,those,0,1
115417,on,0,0
115418,leuprolide,0,0
115419,.,0,1
115420,Cox,0,0
115421,proportional,0,0
115422,hazard,0,0
115423,ratio,0,0
115424,estimates,0,0
115425,for,0,1
115426,selected,0,1
115427,baseline,0,1
115428,covariates,0,0
115429,showed,0,0
115430,a,0,1
115431,significantly,0,0
115432,increased,0,0
115433,risk,0,0
115434,of,0,1
115435,cardiovascular,0,1
115436,events,0,0
115437,by,0,1
115438,age,0,1
115439,(,0,1
115440,p=0.0459,0,0
115441,),0,1
115442,and,0,0
115443,systolic,0,1
115444,blood,0,0
115445,pressure,0,0
115446,(,0,1
115447,p=0.0061,0,0
115448,),0,1
115449,.,0,1
115450,CONCLUSIONS,0,0
115451,In,0,1
115452,men,1,1
115453,with,1,1
115454,prostate,1,1
115455,cancer,1,1
115456,degarelix,0,0
115457,and,0,0
115458,leuprolide,0,0
115459,have,0,0
115460,similar,0,0
115461,cardiovascular,0,1
115462,safety,0,0
115463,profiles,0,0
115464,.,0,1
115465,These,0,1
115466,observations,0,0
115467,suggest,0,0
115468,that,0,0
115469,the,0,0
115470,cardiovascular,0,1
115471,events,0,0
115472,associated,0,0
115473,with,0,1
115474,both,0,0
115475,agents,0,0
115476,result,0,0
115477,from,0,0
115478,hypogonadism,0,1
115479,rather,0,0
115480,than,0,0
115481,a,0,0
115482,direct,0,0
115483,drug,0,0
115484,effect,0,0
115485,.,0,1
115486,A,0,0
115487,comparison,0,0
115488,of,0,0
115489,human,0,1
115490,papillomavirus,0,1
115491,testing,0,0
115492,of,0,0
115493,clinician-collected,0,0
115494,and,0,1
115495,self-collected,0,0
115496,samples,0,1
115497,during,0,1
115498,follow-up,0,1
115499,after,0,1
115500,screen-and-treat,0,1
115501,.,0,1
115502,Screen-and-treat,0,0
115503,cervical,0,1
115504,cancer,0,1
115505,prevention,0,1
115506,programs,0,1
115507,based,0,1
115508,on,0,1
115509,high-risk,0,1
115510,human,0,1
115511,papillomavirus,0,1
115512,(,0,1
115513,HPV,0,1
115514,),0,1
115515,testing,0,0
115516,and,0,0
115517,cryotherapy,0,0
115518,have,0,0
115519,been,0,0
115520,shown,0,0
115521,to,0,0
115522,be,0,0
115523,effective,0,0
115524,in,0,1
115525,resource-limited,0,1
115526,settings,0,1
115527,.,0,1
115528,However,0,0
115529,",",0,0
115530,because,0,0
115531,cryotherapy,0,0
115532,is,0,0
115533,not,0,0
115534,100,0,0
115535,%,0,0
115536,effective,0,0
115537,",",0,0
115538,follow-up,0,0
115539,is,0,0
115540,needed,0,0
115541,after,0,0
115542,treatment,0,0
115543,to,0,0
115544,detect,0,0
115545,post-treatment,0,0
115546,failures,0,1
115547,.,0,1
115548,We,0,0
115549,compared,0,0
115550,the,0,0
115551,test,0,0
115552,performances,0,0
115553,of,0,1
115554,high-risk,0,1
115555,HPV,0,1
115556,testing,0,1
115557,(,0,1
115558,Hybrid,0,1
115559,Capture,0,1
115560,2,0,1
115561,),0,1
115562,using,0,0
115563,self-collected,0,0
115564,and,0,1
115565,clinician-collected,0,0
115566,samples,0,1
115567,as,0,0
115568,well,0,0
115569,as,0,0
115570,cervical,0,1
115571,cytology,0,1
115572,for,0,0
115573,identifying,0,0
115574,cervical,0,1
115575,intraepithelial,0,1
115576,neoplasia,0,1
115577,grades,0,1
115578,2,0,1
115579,or,0,1
115580,3,0,1
115581,or,0,1
115582,invasive,0,1
115583,cervical,0,1
115584,cancer,0,1
115585,(,0,1
115586,CIN2+,0,0
115587,),0,1
115588,among,1,1
115589,women,1,1
115590,who,1,1
115591,did,1,1
115592,(,1,1
115593,n=812,1,1
115594,),1,1
115595,and,1,0
115596,did,1,0
115597,not,1,0
115598,(,1,0
115599,n=1858,1,1
115600,),1,1
115601,undergo,1,1
115602,cryotherapy,1,0
115603,in,1,0
115604,a,1,1
115605,South,1,1
115606,African,1,1
115607,screen-and-treat,1,1
115608,trial,1,1
115609,.,1,1
115610,At,0,0
115611,6,0,0
115612,months,0,1
115613,after,0,1
115614,enrolment,0,1
115615,(,0,1
115616,and,0,0
115617,after,0,0
115618,cryotherapy,0,0
115619,",",0,0
115620,if,0,0
115621,performed,0,0
115622,),0,1
115623,",",0,1
115624,women,0,1
115625,were,0,1
115626,tested,0,0
115627,using,0,0
115628,all,0,1
115629,three,0,0
115630,screening,0,1
115631,methods,0,1
115632,and,0,1
115633,then,0,1
115634,underwent,0,1
115635,colposcopy/biopsy,0,1
115636,.,0,1
115637,A,0,0
115638,predefined,0,0
115639,subset,0,1
115640,of,0,1
115641,women,0,1
115642,(,0,1
115643,"n=1,455",0,1
115644,),0,1
115645,had,0,1
115646,extended,0,1
115647,follow-up,0,0
115648,with,0,1
115649,colposcopy/biopsy,0,1
115650,at,0,1
115651,12,0,1
115652,months,0,1
115653,.,0,1
115654,A,0,0
115655,total,0,1
115656,of,0,0
115657,33,0,1
115658,and,0,1
115659,91,0,1
115660,cases,0,1
115661,of,0,1
115662,CIN2+,0,0
115663,were,0,1
115664,detected,0,0
115665,among,0,1
115666,treated,0,1
115667,and,0,1
115668,untreated,0,1
115669,women,0,1
115670,",",0,1
115671,respectively,0,0
115672,.,0,0
115673,The,0,0
115674,sensitivity,0,0
115675,of,0,0
115676,HPV,0,1
115677,testing,0,1
115678,using,0,0
115679,clinician-collected,0,0
115680,samples,0,1
115681,and,0,1
115682,cervical,0,1
115683,cytology,0,1
115684,did,0,0
115685,not,0,0
115686,differ,0,0
115687,by,0,0
115688,treatment,0,0
115689,status,0,1
115690,.,0,1
115691,HPV,0,0
115692,testing,0,0
115693,of,0,1
115694,clinician-collected,0,0
115695,samples,0,1
115696,detected,0,0
115697,the,0,1
115698,most,0,0
115699,cases,0,1
115700,of,0,1
115701,CIN2+,0,0
115702,among,0,1
115703,both,0,0
115704,treated,0,1
115705,(,0,0
115706,85,0,1
115707,%,0,0
115708,),0,1
115709,and,0,1
115710,untreated,0,1
115711,(,0,1
115712,91,0,1
115713,%,0,0
115714,),0,1
115715,women,0,1
115716,(,0,1
115717,p=0.31,0,0
115718,),0,1
115719,.,0,1
115720,Cytology,0,0
115721,(,0,0
115722,at,0,0
115723,a,0,0
115724,cutoff,0,0
115725,of,0,0
115726,atypical,0,1
115727,squamous,0,1
115728,cells,0,0
115729,of,0,1
115730,undetermined,0,1
115731,significance,0,0
115732,or,0,1
115733,greater,0,0
115734,),0,1
115735,detected,0,0
115736,76,0,1
115737,%,0,0
115738,of,0,1
115739,cases,0,1
115740,among,0,1
115741,both,0,0
115742,treated,0,1
115743,and,0,0
115744,untreated,0,1
115745,women,0,1
115746,.,0,1
115747,However,0,0
115748,",",0,0
115749,the,0,0
115750,sensitivity,0,0
115751,of,0,0
115752,HPV,0,1
115753,testing,0,1
115754,using,0,0
115755,self-collected,0,0
115756,samples,0,1
115757,was,0,0
115758,significantly,0,0
115759,lower,0,0
115760,among,0,0
115761,treated,0,1
115762,versus,0,0
115763,untreated,0,1
115764,women,0,1
115765,(,0,1
115766,55,0,1
115767,%,0,0
115768,vs.,0,0
115769,78,0,1
115770,%,0,0
115771,",",0,0
115772,p=0.01,0,0
115773,),0,1
115774,.,0,1
115775,HPV,0,0
115776,testing,0,0
115777,using,0,0
115778,self-collected,0,0
115779,vaginal,0,1
115780,specimens,0,1
115781,may,0,0
115782,be,0,0
115783,useful,0,0
115784,in,0,0
115785,primary,0,1
115786,screening,0,1
115787,but,0,0
115788,performs,0,0
115789,poorly,0,1
115790,for,0,0
115791,detecting,0,0
115792,post-treatment,0,0
115793,failures,0,1
115794,.,0,1
115795,High-calcium,0,0
115796,milk,0,1
115797,prevents,0,0
115798,overweight,0,1
115799,and,0,1
115800,obesity,0,1
115801,among,0,1
115802,postmenopausal,1,1
115803,women,1,1
115804,.,1,1
115805,BACKGROUND,0,0
115806,The,0,0
115807,Sixth,0,1
115808,National,0,1
115809,Nutrition,0,1
115810,Survey,0,1
115811,2003,0,1
115812,revealed,0,0
115813,that,0,0
115814,the,0,0
115815,highest,0,0
115816,prevalence,0,0
115817,of,0,0
115818,overweight,0,1
115819,and,0,0
115820,obesity,0,1
115821,among,0,1
115822,Filipino,1,1
115823,female,1,1
115824,adults,1,1
115825,(,1,1
115826,30.8,1,1
115827,%,1,0
115828,),1,1
115829,was,1,0
115830,found,1,0
115831,in,1,0
115832,the,1,0
115833,age,1,1
115834,group,1,1
115835,from,1,1
115836,40,1,1
115837,to,1,1
115838,59,1,1
115839,years,1,1
115840,.,1,1
115841,Obesity,0,0
115842,is,0,0
115843,associated,0,0
115844,with,0,0
115845,a,0,0
115846,number,0,0
115847,of,0,0
115848,chronic,0,1
115849,diseases,0,1
115850,",",0,1
115851,including,0,1
115852,cardiovascular,0,1
115853,disease,0,1
115854,",",0,0
115855,hypertension,0,1
115856,",",0,0
115857,and,0,1
115858,diabetes,0,1
115859,.,0,1
115860,Low,0,1
115861,calcium,0,0
115862,intake,0,0
115863,has,0,0
115864,been,0,0
115865,identified,0,0
115866,as,0,0
115867,a,0,1
115868,potential,0,0
115869,contributing,0,0
115870,factor,0,0
115871,to,0,0
115872,overweight,0,1
115873,and,0,0
115874,obesity,0,1
115875,.,0,1
115876,OBJECTIVE,0,0
115877,To,0,0
115878,assess,0,0
115879,the,0,0
115880,effect,0,0
115881,of,0,0
115882,a,0,0
115883,high-calcium,0,0
115884,",",0,0
115885,fortified,0,0
115886,",",0,0
115887,low-fat,0,0
115888,milk,0,0
115889,drink,0,1
115890,with,0,1
115891,added,0,0
115892,vitamin,0,0
115893,D,0,0
115894,versus,0,0
115895,a,0,0
115896,low-calcium,0,0
115897,placebo,0,0
115898,drink,0,1
115899,on,0,0
115900,anthropometric,0,1
115901,measurements,0,0
115902,of,0,1
115903,postmenopausal,1,1
115904,women,1,1
115905,.,1,1
115906,METHODS,0,0
115907,Women,1,1
115908,who,1,1
115909,were,1,1
115910,at,1,1
115911,least,1,1
115912,5,1,1
115913,years,1,1
115914,postmenopausal,1,1
115915,were,1,1
115916,invited,1,1
115917,to,1,0
115918,participate,1,1
115919,in,0,0
115920,the,0,0
115921,study,0,1
115922,.,0,1
115923,Potential,0,0
115924,participants,0,1
115925,underwent,0,1
115926,three,0,1
115927,stages,0,1
115928,of,0,1
115929,screening,0,1
115930,:,0,1
115931,initial,0,0
115932,interview,0,1
115933,",",0,1
115934,dual-energy,0,0
115935,x-ray,0,1
115936,absorptiometry,0,1
115937,",",0,0
115938,and,0,0
115939,blood,0,0
115940,testing,0,0
115941,for,0,0
115942,biochemical,0,0
115943,screening,0,1
115944,.,0,1
115945,Anthropometric,0,0
115946,indices,0,0
115947,were,0,1
115948,measured,0,0
115949,at,0,0
115950,baseline,0,0
115951,and,0,0
115952,the,0,0
115953,end,0,0
115954,of,0,0
115955,the,0,0
115956,study,0,1
115957,.,0,1
115958,Sixty,1,1
115959,women,1,1
115960,were,1,1
115961,qualified,1,1
115962,to,1,0
115963,participate,1,1
115964,in,0,0
115965,the,0,0
115966,study,0,0
115967,.,0,1
115968,The,0,0
115969,women,0,1
115970,were,0,1
115971,randomly,0,1
115972,assigned,0,1
115973,to,0,1
115974,two,0,0
115975,groups,0,1
115976,",",0,1
115977,one,0,1
115978,of,0,0
115979,which,0,1
115980,received,0,1
115981,400,0,0
115982,ml,0,0
115983,of,0,0
115984,the,0,0
115985,high-calcium,0,0
115986,milk,0,0
115987,daily,0,0
115988,for,0,1
115989,16,0,1
115990,weeks,0,0
115991,while,0,0
115992,the,0,1
115993,other,0,0
115994,received,0,0
115995,the,0,0
115996,placebo,0,0
115997,drink,0,0
115998,.,0,1
115999,RESULTS,0,0
116000,No,0,0
116001,significant,0,0
116002,increases,0,0
116003,were,0,1
116004,observed,0,0
116005,in,0,0
116006,the,0,0
116007,anthropometric,0,1
116008,indices,0,0
116009,of,0,1
116010,the,0,1
116011,subjects,0,1
116012,receiving,0,1
116013,the,0,0
116014,high-calcium,0,0
116015,fortified,0,0
116016,milk,0,0
116017,at,0,0
116018,the,0,0
116019,end,0,0
116020,of,0,0
116021,the,0,0
116022,study,0,0
116023,.,0,0
116024,However,0,0
116025,",",0,0
116026,there,0,0
116027,were,0,0
116028,significant,0,0
116029,increases,0,0
116030,in,0,1
116031,the,0,0
116032,weight,0,1
116033,(,0,0
116034,p,0,0
116035,=,0,1
116036,.008,0,0
116037,),0,1
116038,",",0,0
116039,body,0,1
116040,mass,0,1
116041,index,0,1
116042,(,0,1
116043,p,0,0
116044,=,0,1
116045,.007,0,0
116046,),0,1
116047,",",0,0
116048,and,0,0
116049,waist,0,1
116050,(,0,1
116051,p,0,0
116052,=,0,1
116053,.018,0,0
116054,),0,1
116055,and,0,0
116056,hip,0,1
116057,(,0,1
116058,p,0,0
116059,=,0,1
116060,.003,0,0
116061,),0,1
116062,circumferences,0,1
116063,of,0,1
116064,the,0,1
116065,subjects,0,1
116066,receiving,0,1
116067,the,0,0
116068,placebo,0,0
116069,drink,0,0
116070,.,0,0
116071,CONCLUSIONS,0,0
116072,A,0,0
116073,change,0,0
116074,in,0,0
116075,dietary,0,0
116076,calcium,0,0
116077,intake,0,0
116078,may,0,0
116079,be,0,0
116080,a,0,0
116081,useful,0,0
116082,measure,0,0
116083,as,0,0
116084,part,0,0
116085,of,0,0
116086,an,0,0
116087,overall,0,0
116088,approach,0,0
116089,to,0,0
116090,prevent,0,0
116091,the,0,0
116092,occurrence,0,0
116093,of,0,0
116094,overweight,0,1
116095,and,0,0
116096,obesity,0,1
116097,among,0,1
116098,postmenopausal,1,1
116099,women,1,1
116100,.,1,1
116101,PDE5,0,0
116102,inhibition,0,0
116103,with,0,1
116104,sildenafil,0,1
116105,improves,0,0
116106,left,0,1
116107,ventricular,0,1
116108,diastolic,0,1
116109,function,0,0
116110,",",0,0
116111,cardiac,0,1
116112,geometry,0,0
116113,",",0,0
116114,and,0,0
116115,clinical,0,0
116116,status,0,1
116117,in,0,1
116118,patients,1,1
116119,with,1,1
116120,stable,1,1
116121,systolic,1,1
116122,heart,1,1
116123,failure,1,1
116124,:,1,1
116125,results,0,0
116126,of,0,0
116127,a,0,1
116128,1-year,0,0
116129,",",0,0
116130,prospective,0,1
116131,",",0,0
116132,randomized,0,1
116133,",",0,0
116134,placebo-controlled,0,0
116135,study,0,1
116136,.,0,1
116137,BACKGROUND,0,0
116138,In,0,0
116139,heart,0,1
116140,failure,0,1
116141,(,0,1
116142,HF,0,1
116143,),0,1
116144,",",0,0
116145,a,0,0
116146,defective,0,0
116147,nitric,0,0
116148,oxide,0,0
116149,signaling,0,0
116150,is,0,0
116151,involved,0,0
116152,in,0,0
116153,left,0,1
116154,ventricular,0,1
116155,(,0,1
116156,LV,0,1
116157,),0,1
116158,diastolic,0,1
116159,abnormalities,0,1
116160,and,0,1
116161,remodeling,0,1
116162,.,0,1
116163,PDE5,0,0
116164,inhibition,0,0
116165,",",0,0
116166,by,0,0
116167,blocking,0,0
116168,degradation,0,0
116169,of,0,0
116170,nitric,0,0
116171,oxide,0,1
116172,second-messenger,0,0
116173,cyclic,0,0
116174,guanosine,0,0
116175,monophosphate,0,0
116176,",",0,0
116177,might,0,0
116178,be,0,0
116179,beneficial,0,0
116180,.,0,1
116181,In,0,0
116182,a,0,0
116183,cohort,0,1
116184,of,0,0
116185,systolic,1,1
116186,HF,1,1
116187,patients,1,1
116188,",",0,1
116189,we,0,0
116190,tested,0,0
116191,the,0,0
116192,effects,0,0
116193,of,0,0
116194,PDE5,0,1
116195,inhibition,0,0
116196,(,0,1
116197,sildenafil,0,0
116198,),0,1
116199,on,0,0
116200,LV,0,1
116201,ejection,0,1
116202,fraction,0,1
116203,",",0,0
116204,diastolic,0,0
116205,function,0,0
116206,",",0,0
116207,cardiac,0,1
116208,geometry,0,0
116209,",",0,0
116210,and,0,0
116211,clinical,0,0
116212,status,0,1
116213,.,0,1
116214,METHODS,0,0
116215,AND,0,0
116216,RESULTS,0,1
116217,Forty-five,1,1
116218,HF,1,1
116219,patients,1,1
116220,(,1,1
116221,New,1,1
116222,York,1,1
116223,Heart,1,1
116224,Association,1,1
116225,class,1,1
116226,II-III,1,1
116227,),1,1
116228,were,0,0
116229,randomly,0,1
116230,assigned,0,1
116231,to,0,0
116232,placebo,0,0
116233,or,0,1
116234,sildenafil,0,0
116235,(,0,1
116236,50,0,1
116237,mg,0,1
116238,three,0,1
116239,times,0,0
116240,per,0,1
116241,day,0,1
116242,),0,1
116243,for,0,0
116244,1,0,1
116245,year,0,1
116246,",",0,0
116247,with,0,1
116248,assessment,0,0
116249,(,0,1
116250,6,0,1
116251,months,0,1
116252,and,0,1
116253,1,0,1
116254,year,0,1
116255,),0,1
116256,of,0,0
116257,LV,0,1
116258,ejection,0,1
116259,fraction,0,1
116260,",",0,0
116261,diastolic,0,0
116262,function,0,0
116263,",",0,0
116264,geometry,0,0
116265,",",0,0
116266,cardiopulmonary,0,1
116267,exercise,0,0
116268,performance,0,0
116269,",",0,0
116270,and,0,0
116271,quality,0,0
116272,of,0,0
116273,life,0,1
116274,.,0,1
116275,In,0,0
116276,the,0,0
116277,sildenafil,0,0
116278,group,0,0
116279,only,0,0
116280,",",0,0
116281,at,0,0
116282,6,0,1
116283,months,0,1
116284,and,0,1
116285,1,0,1
116286,year,0,1
116287,",",0,0
116288,LV,0,0
116289,ejection,0,1
116290,fraction,0,1
116291,",",0,0
116292,early,0,1
116293,diastolic,0,1
116294,tissue,0,1
116295,Doppler,0,1
116296,velocities,0,0
116297,(,0,1
116298,E,0,1
116299,',0,1
116300,),0,1
116301,at,0,1
116302,the,0,0
116303,mitral,0,1
116304,lateral,0,1
116305,(,0,1
116306,from,0,1
116307,4.62,0,0
116308,to,0,1
116309,5.20,0,0
116310,and,0,1
116311,5.19,0,0
116312,m/s,0,1
116313,),0,1
116314,and,0,1
116315,septal,0,1
116316,(,0,1
116317,from,0,1
116318,4.71,0,0
116319,to,0,1
116320,5.23,0,0
116321,and,0,1
116322,5.24,0,0
116323,m/s,0,0
116324,),0,0
116325,annuli,0,1
116326,significantly,0,0
116327,increased,0,0
116328,",",0,0
116329,whereas,0,0
116330,the,0,0
116331,ratio,0,0
116332,of,0,0
116333,early,0,1
116334,transmitral,0,1
116335,(,0,1
116336,E,0,1
116337,),0,1
116338,to,0,1
116339,E,0,1
116340,',0,1
116341,lateral,0,1
116342,decreased,0,0
116343,(,0,1
116344,from,0,1
116345,13.1,0,0
116346,to,0,1
116347,9.8,0,0
116348,to,0,1
116349,9.4,0,1
116350,),0,1
116351,(,0,1
116352,P,0,0
116353,<,0,0
116354,0.01,0,0
116355,),0,1
116356,.,0,1
116357,Changes,0,0
116358,were,0,0
116359,accompanied,0,0
116360,by,0,0
116361,a,0,0
116362,reverse,0,1
116363,remodeling,0,0
116364,of,0,0
116365,left,0,1
116366,atrial,0,1
116367,volume,0,0
116368,index,0,1
116369,(,0,1
116370,from,0,1
116371,32.0,0,1
116372,to,0,1
116373,29.0,0,1
116374,and,0,1
116375,29.1,0,1
116376,mL/m,0,0
116377,(,0,1
116378,2,0,1
116379,),0,1
116380,;,0,1
116381,P,0,0
116382,<,0,0
116383,0.01,0,0
116384,),0,1
116385,and,0,1
116386,LV,0,1
116387,mass,0,1
116388,index,0,1
116389,(,0,1
116390,from,0,1
116391,148.0,0,0
116392,to,0,1
116393,130.0,0,1
116394,and,0,1
116395,128.0,0,1
116396,g/m,0,1
116397,(,0,1
116398,2,0,1
116399,),0,1
116400,;,0,1
116401,P,0,0
116402,<,0,0
116403,0.01,0,0
116404,),0,1
116405,.,0,1
116406,Furthermore,0,0
116407,",",0,0
116408,sildenafil,0,0
116409,improved,0,0
116410,exercise,0,0
116411,performance,0,0
116412,(,0,1
116413,peak,0,0
116414,Vo,0,1
116415,(,0,1
116416,2,0,1
116417,),0,1
116418,),0,1
116419,",",0,0
116420,ventilation,0,0
116421,efficiency,0,0
116422,(,0,1
116423,ventilation,0,1
116424,to,0,1
116425,CO,0,1
116426,(,0,1
116427,2,0,1
116428,),0,1
116429,production,0,0
116430,slope,0,0
116431,),0,0
116432,",",0,0
116433,and,0,0
116434,quality,0,0
116435,of,0,0
116436,life,0,1
116437,(,0,1
116438,P,0,0
116439,<,0,0
116440,0.01,0,0
116441,),0,1
116442,.,0,1
116443,Minor,0,0
116444,adverse,0,0
116445,effects,0,0
116446,were,0,1
116447,noted,0,0
116448,:,0,1
116449,flushing,0,0
116450,in,0,1
116451,4,0,0
116452,and,0,1
116453,headache,0,1
116454,in,0,1
116455,2,0,1
116456,treated,0,1
116457,patients,0,1
116458,.,0,1
116459,CONCLUSIONS,0,0
116460,Findings,0,0
116461,confirm,0,0
116462,that,0,0
116463,in,0,0
116464,HF,0,1
116465,",",0,0
116466,sildenafil,0,0
116467,improves,0,0
116468,functional,0,0
116469,capacity,0,0
116470,and,0,1
116471,clinical,0,0
116472,status,0,1
116473,and,0,0
116474,provide,0,0
116475,the,0,0
116476,first,0,0
116477,human,0,1
116478,evidence,0,0
116479,that,0,0
116480,LV,0,1
116481,diastolic,0,1
116482,function,0,0
116483,and,0,1
116484,cardiac,0,1
116485,geometry,0,0
116486,are,0,0
116487,additional,0,0
116488,targets,0,1
116489,of,0,1
116490,benefits,0,0
116491,related,0,0
116492,to,0,1
116493,chronic,0,1
116494,PDE5,0,1
116495,inhibition,0,0
116496,.,0,1
116497,Detection,0,1
116498,rates,0,0
116499,of,0,0
116500,cancer,0,1
116501,",",0,0
116502,high,0,1
116503,grade,0,1
116504,PIN,0,0
116505,and,0,1
116506,atypical,0,1
116507,lesions,0,1
116508,suspicious,0,1
116509,for,0,1
116510,cancer,0,1
116511,in,0,0
116512,the,0,0
116513,European,1,1
116514,Randomized,1,0
116515,Study,1,1
116516,of,1,0
116517,Screening,1,1
116518,for,1,1
116519,Prostate,1,1
116520,Cancer,1,1
116521,.,1,1
116522,THE,0,0
116523,AIM,0,0
116524,OF,0,1
116525,THE,0,1
116526,STUDY,0,0
116527,This,0,0
116528,article,0,0
116529,presents,0,0
116530,the,0,0
116531,incidence,0,0
116532,of,0,0
116533,prostate,0,1
116534,cancer,0,1
116535,",",0,0
116536,isolated,0,1
116537,high,0,1
116538,grade,0,1
116539,prostatic,0,1
116540,intraepithelial,0,1
116541,neoplasia,0,1
116542,(,0,1
116543,PIN,0,0
116544,),0,1
116545,and,0,1
116546,atypical,0,1
116547,lesions,0,1
116548,suspicious,0,1
116549,for,0,1
116550,prostate,0,1
116551,cancer,0,1
116552,(,0,1
116553,LSPC,0,0
116554,),0,1
116555,during,0,0
116556,subsequent,0,0
116557,screening,0,1
116558,rounds,0,0
116559,in,0,1
116560,the,0,1
116561,centres,0,1
116562,of,0,0
116563,five,0,1
116564,of,0,1
116565,the,0,1
116566,countries,0,1
116567,participating,1,1
116568,in,1,1
116569,the,1,0
116570,European,1,1
116571,Randomized,1,0
116572,Study,1,1
116573,of,1,0
116574,Screening,1,1
116575,for,1,1
116576,Prostate,1,1
116577,Cancer,1,1
116578,(,1,1
116579,ERSPC,1,0
116580,),1,1
116581,.,1,1
116582,The,0,0
116583,incidence,0,0
116584,and,0,0
116585,predictive,0,0
116586,value,0,0
116587,of,0,0
116588,high,0,1
116589,grade,0,1
116590,PIN,0,0
116591,and,0,1
116592,LSPC,0,0
116593,for,0,0
116594,prostate,0,1
116595,cancer,0,1
116596,in,0,0
116597,subsequent,0,0
116598,biopsy,0,1
116599,following,0,0
116600,these,0,0
116601,diagnoses,0,1
116602,were,0,1
116603,evaluated,0,0
116604,.,0,1
116605,PATIENTS,0,0
116606,AND,0,0
116607,METHODS,0,0
116608,Study,0,1
116609,group,0,1
116610,consisted,0,1
116611,of,0,0
116612,"56,653",1,1
116613,screened,1,1
116614,men,1,1
116615,in,1,1
116616,the,1,1
116617,ERSPC,1,0
116618,centres,1,1
116619,of,1,1
116620,Finland,1,1
116621,",",1,1
116622,Italy,1,1
116623,",",1,0
116624,Netherlands,1,1
116625,",",1,0
116626,Sweden,1,1
116627,and,1,0
116628,Switzerland,1,1
116629,",",1,1
116630,who,1,1
116631,underwent,1,1
116632,3-7,1,1
116633,screening,1,1
116634,rounds,1,0
116635,at,1,1
116636,2-4,1,1
116637,year,1,1
116638,interval,1,0
116639,.,1,1
116640,Data,1,0
116641,for,1,0
116642,prostate,1,1
116643,cancer,1,1
116644,were,1,0
116645,obtained,1,0
116646,from,1,1
116647,the,1,0
116648,ERSPC,1,0
116649,central,1,0
116650,database,1,1
116651,.,1,1
116652,Data,1,0
116653,for,1,0
116654,high,1,1
116655,grade,1,1
116656,PIN,1,0
116657,and,1,1
116658,LSPC,1,0
116659,were,1,1
116660,gathered,1,1
116661,from,1,1
116662,each,1,0
116663,ERSPC,1,0
116664,centre,1,1
116665,.,1,1
116666,Detection,0,0
116667,rates,0,0
116668,of,0,1
116669,subsequent,0,0
116670,prostate,0,1
116671,cancer,0,1
116672,in,0,0
116673,the,0,0
116674,first,0,0
116675,re-biopsy,0,0
116676,after,0,1
116677,these,0,0
116678,diagnoses,0,1
116679,were,0,1
116680,determined,0,0
116681,.,0,0
116682,RESULTS,0,0
116683,The,0,0
116684,average,0,0
116685,cancer,0,1
116686,detection,0,1
116687,rate,0,0
116688,was,0,0
116689,3.5,0,0
116690,%,0,0
116691,",",0,1
116692,3.2,0,0
116693,%,0,0
116694,and,0,1
116695,3.5,0,0
116696,%,0,0
116697,for,0,0
116698,the,0,0
116699,completed,0,1
116700,rounds,0,0
116701,1,0,1
116702,",",0,1
116703,2,0,1
116704,and,0,1
116705,3,0,0
116706,",",0,0
116707,respectively,0,0
116708,",",0,0
116709,in,0,0
116710,all,0,1
116711,five,0,1
116712,centres,0,1
116713,.,0,1
116714,Incidence,0,0
116715,of,0,0
116716,high,0,1
116717,grade,0,1
116718,PIN,0,0
116719,increased,0,0
116720,from,0,1
116721,1.5,0,0
116722,%,0,0
116723,in,0,0
116724,the,0,0
116725,first,0,0
116726,round,0,1
116727,to,0,1
116728,5.0,0,0
116729,%,0,0
116730,in,0,0
116731,the,0,0
116732,third,0,1
116733,round,0,0
116734,",",0,0
116735,varying,0,0
116736,among,0,0
116737,centres,0,1
116738,in,0,1
116739,the,0,1
116740,first,0,0
116741,round,0,1
116742,between,0,0
116743,0.8,0,1
116744,%,0,0
116745,and,0,1
116746,7.6,0,0
116747,%,0,0
116748,.,0,1
116749,The,0,0
116750,cancer,0,1
116751,detection,0,0
116752,rate,0,0
116753,in,0,0
116754,the,0,0
116755,first,0,0
116756,re-biopsy,0,0
116757,after,0,0
116758,the,0,0
116759,diagnosis,0,1
116760,of,0,0
116761,high,0,1
116762,grade,0,1
116763,PIN,0,0
116764,was,0,0
116765,12.9,0,0
116766,%,0,0
116767,.,0,1
116768,Incidence,0,0
116769,of,0,0
116770,LSPC,0,1
116771,was,0,0
116772,2.4,0,0
116773,%,0,0
116774,",",0,1
116775,2.7,0,0
116776,%,0,0
116777,",",0,1
116778,2.2,0,0
116779,%,0,0
116780,and,0,1
116781,2.6,0,0
116782,%,0,0
116783,in,0,0
116784,the,0,0
116785,first,0,0
116786,",",0,0
116787,second,0,0
116788,",",0,0
116789,third,0,1
116790,and,0,0
116791,fourth,0,1
116792,round,0,0
116793,",",0,0
116794,respectively,0,0
116795,.,0,0
116796,The,0,0
116797,cancer,0,1
116798,detection,0,0
116799,rate,0,0
116800,at,0,0
116801,the,0,0
116802,first,0,0
116803,re-biopsy,0,0
116804,after,0,0
116805,the,0,0
116806,diagnosis,0,1
116807,of,0,0
116808,LSPC,0,0
116809,was,0,0
116810,in,0,1
116811,average,0,1
116812,33.8,0,1
116813,%,0,0
116814,.,0,1
116815,CONCLUSIONS,0,0
116816,Cancer,0,1
116817,detection,0,1
116818,rate,0,0
116819,was,0,0
116820,stable,0,1
116821,during,0,0
116822,the,0,1
116823,three,0,0
116824,screening,0,1
116825,rounds,0,0
116826,.,0,1
116827,The,0,0
116828,wide,0,0
116829,variation,0,0
116830,in,0,0
116831,frequency,0,0
116832,in,0,0
116833,particular,0,0
116834,of,0,1
116835,high,0,1
116836,grade,0,1
116837,PIN,0,0
116838,among,0,0
116839,the,0,0
116840,ERSPC,0,0
116841,centres,0,1
116842,suggests,0,0
116843,a,0,0
116844,considerable,0,0
116845,inter-observer,0,0
116846,variation,0,0
116847,.,0,1
116848,The,0,0
116849,average,0,0
116850,comparatively,0,0
116851,low,0,1
116852,detection,0,0
116853,rate,0,0
116854,of,0,0
116855,isolated,0,1
116856,high,0,1
116857,grade,0,1
116858,PIN,0,0
116859,in,0,0
116860,the,0,0
116861,first,0,0
116862,screening,0,0
116863,round,0,1
116864,may,0,0
116865,be,0,0
116866,screening-related,0,0
116867,",",0,0
116868,while,0,0
116869,its,0,0
116870,consistent,0,0
116871,increase,0,0
116872,during,0,1
116873,three,0,1
116874,screening,0,1
116875,rounds,0,0
116876,could,0,0
116877,be,0,0
116878,the,0,0
116879,consequence,0,0
116880,of,0,0
116881,a.o,0,1
116882,.,0,1
116883,previous,0,0
116884,screening,0,1
116885,and,0,0
116886,ageing,0,1
116887,of,0,0
116888,the,0,0
116889,population,0,1
116890,.,0,0
116891,The,0,0
116892,observed,0,0
116893,low,0,0
116894,risk,0,1
116895,of,0,0
116896,prostate,0,1
116897,cancer,0,1
116898,after,0,0
116899,isolated,0,1
116900,high,0,1
116901,grade,0,1
116902,PIN,0,0
116903,in,0,0
116904,this,0,0
116905,screening,0,0
116906,setting,0,1
116907,is,0,0
116908,in,0,0
116909,line,0,0
116910,with,0,1
116911,the,0,0
116912,current,0,0
116913,recommendation,0,0
116914,to,0,0
116915,abstain,0,1
116916,from,0,1
116917,early,0,1
116918,repeat,0,1
116919,biopsies,0,1
116920,after,0,1
116921,this,0,0
116922,diagnosis,0,1
116923,.,0,0
116924,The,0,0
116925,association,0,0
116926,of,0,0
116927,LSPC,0,0
116928,with,0,1
116929,high,0,1
116930,incidence,0,0
116931,of,0,0
116932,prostate,0,1
116933,cancer,0,1
116934,in,0,1
116935,re-biopsies,0,1
116936,confirms,0,0
116937,the,0,1
116938,need,0,0
116939,for,0,0
116940,early,0,1
116941,repeat,0,1
116942,biopsies,0,1
116943,and,0,1
116944,follow-up,0,0
116945,of,0,0
116946,these,0,0
116947,men,1,1
116948,.,1,1
116949,The,0,0
116950,low,0,0
116951,percentage,0,0
116952,of,0,1
116953,LSPC,0,0
116954,(,0,1
116955,<,0,0
116956,3,0,0
116957,%,0,0
116958,of,0,1
116959,biopsies,0,1
116960,),0,1
116961,throughout,0,0
116962,all,0,0
116963,rounds,0,0
116964,is,0,0
116965,reassuring,0,0
116966,as,0,0
116967,it,0,0
116968,limits,0,0
116969,the,0,0
116970,biopsy,0,1
116971,burden,0,0
116972,in,0,0
116973,a,0,0
116974,screening,0,1
116975,setting,0,1
116976,.,0,1
116977,Antimigraine,0,0
116978,efficacy,0,0
116979,of,0,0
116980,telcagepant,0,0
116981,based,0,1
116982,on,0,0
116983,patient,1,1
116984,'s,1,1
116985,historical,1,1
116986,triptan,1,1
116987,response,1,0
116988,.,1,1
116989,OBJECTIVE,0,0
116990,To,0,0
116991,evaluate,0,0
116992,whether,0,0
116993,the,0,0
116994,same,0,0
116995,or,0,1
116996,different,0,1
116997,patients,1,1
116998,respond,1,1
116999,to,1,1
117000,triptans,1,1
117001,and,1,1
117002,telcagepant,1,0
117003,.,1,1
117004,BACKGROUND,0,0
117005,Telcagepant,0,0
117006,is,0,0
117007,an,0,0
117008,oral,0,0
117009,calcitonin,0,0
117010,gene-related,0,0
117011,peptide,0,0
117012,receptor,0,0
117013,antagonist,0,0
117014,with,0,1
117015,acute,0,1
117016,antimigraine,0,0
117017,efficacy,0,0
117018,comparable,0,0
117019,to,0,1
117020,oral,0,1
117021,triptans,0,1
117022,.,0,1
117023,It,0,0
117024,is,0,0
117025,currently,0,0
117026,unknown,0,0
117027,whether,0,0
117028,migraine,1,1
117029,patients,1,1
117030,who,1,1
117031,can,1,0
117032,not,1,1
117033,be,1,0
117034,adequately,1,0
117035,helped,1,0
117036,with,1,1
117037,triptans,1,1
117038,might,0,0
117039,benefit,0,0
117040,from,0,0
117041,treatment,0,0
117042,with,0,1
117043,telcagepant,0,0
117044,.,0,1
117045,METHODS,0,0
117046,Post-hoc,0,0
117047,analysis,0,0
117048,of,0,1
117049,data,0,0
117050,from,0,1
117051,a,0,1
117052,randomized,0,1
117053,",",0,0
117054,controlled,0,0
117055,trial,0,0
117056,of,0,0
117057,telcagepant,0,0
117058,(,0,1
117059,150,0,1
117060,mg,0,0
117061,",",0,1
117062,300,0,1
117063,mg,0,0
117064,),0,1
117065,zolmitriptan,0,0
117066,5,0,0
117067,mg,0,0
117068,",",0,0
117069,or,0,0
117070,placebo,0,0
117071,for,0,0
117072,a,0,1
117073,moderate/severe,0,1
117074,migraine,0,1
117075,.,0,1
117076,Responder,0,0
117077,rates,0,0
117078,were,0,1
117079,analyzed,0,0
117080,according,0,1
117081,to,0,1
117082,patients,1,1
117083,',1,1
117084,self-reported,1,1
117085,historical,1,1
117086,triptan,1,0
117087,response,1,0
117088,(,1,1
117089,HTR,1,1
117090,),1,1
117091,:,1,1
117092,(,1,1
117093,1,1,1
117094,),1,1
117095,good,1,0
117096,HTR,1,1
117097,(,1,1
117098,N,1,1
117099,=,1,1
117100,660,1,1
117101,),1,1
117102,:,1,1
117103,response,1,0
117104,in,1,1
117105,75-100,1,0
117106,%,1,0
117107,of,1,1
117108,attacks,1,1
117109,;,1,1
117110,(,1,1
117111,2,1,1
117112,),1,1
117113,intermediate,1,1
117114,HTR,1,0
117115,(,1,1
117116,N,1,1
117117,=,1,1
117118,248,1,1
117119,),1,1
117120,:,1,1
117121,response,1,0
117122,in,1,0
117123,25-74,1,1
117124,%,1,0
117125,of,1,1
117126,attacks,1,1
117127,;,1,1
117128,(,1,1
117129,3,1,1
117130,),1,1
117131,poor,1,1
117132,HTR/no,1,0
117133,use,1,0
117134,(,1,1
117135,N,1,1
117136,=,1,1
117137,407,1,1
117138,),1,1
117139,:,1,1
117140,response,1,0
117141,in,1,1
117142,<,1,0
117143,25,1,1
117144,%,1,0
117145,of,1,1
117146,attacks,1,1
117147,",",1,1
117148,or,1,1
117149,patient,1,0
117150,did,1,0
117151,not,1,0
117152,take,1,1
117153,triptans,1,0
117154,.,1,1
117155,A,0,0
117156,limitation,0,0
117157,of,0,0
117158,the,0,0
117159,analysis,0,0
117160,is,0,0
117161,that,0,0
117162,the,1,0
117163,last,1,0
117164,subgroup,1,0
117165,comprised,1,1
117166,mainly,1,0
117167,(,1,1
117168,91,1,1
117169,%,1,0
117170,),1,1
117171,patients,1,1
117172,who,1,1
117173,reported,1,1
117174,that,1,1
117175,they,1,0
117176,did,1,0
117177,not,1,0
117178,take,1,0
117179,triptans,1,0
117180,",",1,0
117181,but,1,0
117182,it,1,0
117183,was,1,0
117184,not,1,0
117185,known,1,0
117186,whether,1,0
117187,these,1,0
117188,patients,1,1
117189,were,1,1
117190,triptan-na?ve,1,0
117191,or,1,1
117192,had,1,1
117193,previously,1,1
117194,used,1,0
117195,triptans,1,1
117196,and,1,1
117197,stopped,1,1
117198,taking,1,1
117199,them,1,0
117200,.,1,1
117201,RESULTS,0,0
117202,For,0,0
117203,zolmitriptan,0,0
117204,",",0,1
117205,2-hour,0,0
117206,pain,0,1
117207,relief,0,0
117208,rates,0,0
117209,were,0,1
117210,higher,0,0
117211,in,0,0
117212,the,0,0
117213,good,0,0
117214,HTR,0,0
117215,subgroup,0,1
117216,(,0,1
117217,116/162,0,1
117218,",",0,1
117219,72,0,1
117220,%,0,0
117221,),0,1
117222,than,0,0
117223,in,0,0
117224,the,0,0
117225,intermediate,0,1
117226,(,0,0
117227,29/62,0,0
117228,",",0,1
117229,47,0,1
117230,%,0,0
117231,),0,1
117232,and,0,0
117233,poor/no,0,1
117234,use,0,0
117235,(,0,1
117236,44/111,0,1
117237,",",0,1
117238,40,0,1
117239,%,0,0
117240,),0,1
117241,HTR,0,1
117242,subgroups,0,0
117243,.,0,1
117244,The,0,0
117245,2-hour,0,0
117246,pain,0,1
117247,relief,0,0
117248,rates,0,0
117249,were,0,1
117250,similar,0,0
117251,across,0,1
117252,HTR,0,1
117253,subgroups,0,0
117254,for,0,1
117255,telcagepant,0,0
117256,150,0,1
117257,mg,0,1
117258,(,0,1
117259,48-58,0,1
117260,%,0,0
117261,),0,1
117262,",",0,0
117263,300,0,1
117264,mg,0,0
117265,(,0,1
117266,52-58,0,1
117267,%,0,0
117268,),0,1
117269,",",0,0
117270,and,0,0
117271,placebo,0,0
117272,(,0,1
117273,26-31,0,1
117274,%,0,0
117275,),0,1
117276,.,0,1
117277,In,0,0
117278,the,0,0
117279,poor/no,0,1
117280,use,0,0
117281,HTR,0,0
117282,subgroup,0,0
117283,",",0,0
117284,more,0,0
117285,patients,0,1
117286,receiving,0,1
117287,telcagepant,0,0
117288,300,0,1
117289,mg,0,1
117290,(,0,1
117291,56/98,0,1
117292,",",0,1
117293,57.1,0,0
117294,%,0,0
117295,),0,1
117296,had,0,1
117297,2-hour,0,0
117298,pain,0,1
117299,relief,0,0
117300,than,0,0
117301,those,0,1
117302,receiving,0,1
117303,zolmitriptan,0,0
117304,(,0,1
117305,44/111,0,1
117306,",",0,1
117307,39.6,0,0
117308,%,0,0
117309,;,0,1
117310,odds,0,0
117311,ratio,0,0
117312,=,0,1
117313,2.11,0,0
117314,[,0,1
117315,95,0,0
117316,%,0,1
117317,CI,0,0
117318,:,0,1
117319,"1.20,3.71",0,0
117320,],0,1
117321,",",0,1
117322,P,0,0
117323,=,0,1
117324,.009,0,0
117325,),0,1
117326,;,0,0
117327,the,0,0
117328,percentage,0,0
117329,for,0,0
117330,telcagepant,0,0
117331,150,0,1
117332,mg,0,1
117333,(,0,1
117334,57/119,0,1
117335,",",0,1
117336,47.9,0,0
117337,%,0,0
117338,),0,1
117339,was,0,0
117340,not,0,0
117341,significantly,0,0
117342,different,0,0
117343,from,0,1
117344,zolmitriptan,0,0
117345,(,0,1
117346,odds,0,0
117347,ratio,0,0
117348,=,0,1
117349,1.41,0,0
117350,[,0,1
117351,95,0,0
117352,%,0,1
117353,CI,0,0
117354,:,0,1
117355,0.82,0,0
117356,",",0,1
117357,2.40,0,0
117358,],0,1
117359,",",0,1
117360,P,0,0
117361,=,0,1
117362,.211,0,0
117363,),0,1
117364,.,0,1
117365,CONCLUSIONS,0,0
117366,This,0,0
117367,suggests,0,0
117368,that,0,0
117369,different,0,0
117370,patients,0,1
117371,may,0,0
117372,respond,0,1
117373,to,0,0
117374,triptans,0,1
117375,or,0,1
117376,telcagepant,0,0
117377,300,0,1
117378,mg,0,1
117379,.,0,0
117380,Caution,0,0
117381,should,0,0
117382,be,0,0
117383,exercised,0,0
117384,in,0,0
117385,interpreting,0,0
117386,the,0,0
117387,results,0,0
117388,because,0,0
117389,of,0,1
117390,the,0,0
117391,post-hoc,0,0
117392,nature,0,1
117393,of,0,0
117394,the,0,0
117395,analysis,0,0
117396,(,0,0
117397,clinical,0,0
117398,trial,0,1
117399,registry,0,1
117400,:,0,1
117401,NCT00442936,0,1
117402,),0,1
117403,.,0,1
117404,Blockade,0,1
117405,of,0,1
117406,cytotoxic,0,1
117407,T-lymphocyte,0,0
117408,antigen-4,0,0
117409,by,0,0
117410,ipilimumab,0,1
117411,results,0,0
117412,in,0,1
117413,dysregulation,0,0
117414,of,0,0
117415,gastrointestinal,0,1
117416,immunity,0,1
117417,in,0,1
117418,patients,1,1
117419,with,1,1
117420,advanced,1,1
117421,melanoma,1,1
117422,.,1,1
117423,Blockade,0,0
117424,of,0,0
117425,cytotoxic,0,1
117426,T-lymphocyte,0,0
117427,antigen-4,0,0
117428,(,0,1
117429,CTLA-4,0,1
117430,),0,1
117431,by,0,0
117432,ipilimumab,0,1
117433,leads,0,0
117434,to,0,1
117435,immune-mediated,0,1
117436,tumor,0,1
117437,regression,0,0
117438,and,0,1
117439,immune-related,0,0
117440,adverse,0,0
117441,events,0,0
117442,(,0,1
117443,irAEs,0,1
117444,),0,1
117445,",",0,0
117446,including,0,0
117447,diarrhea,0,1
117448,and,0,1
117449,colitis,0,1
117450,.,0,1
117451,The,0,0
117452,current,0,0
117453,analyses,0,0
117454,were,0,1
117455,undertaken,0,1
117456,to,0,0
117457,promote,0,0
117458,an,0,0
117459,understanding,0,0
117460,of,0,0
117461,the,0,0
117462,underlying,0,0
117463,mechanism,0,0
117464,of,0,0
117465,action,0,0
117466,and,0,0
117467,to,0,0
117468,identify,0,0
117469,potential,0,0
117470,biomarkers,0,0
117471,that,0,0
117472,could,0,0
117473,help,0,0
117474,in,0,0
117475,the,0,0
117476,prediction,0,0
117477,and,0,0
117478,management,0,1
117479,of,0,0
117480,ipilimumab-induced,0,1
117481,gastrointestinal,0,1
117482,irAEs,0,1
117483,.,0,1
117484,Treatment-na?ve,1,0
117485,or,1,1
117486,previously,1,1
117487,treated,1,1
117488,patients,1,1
117489,with,1,1
117490,unresectable,1,1
117491,stage,1,1
117492,III/IV,1,0
117493,melanoma,1,1
117494,(,1,1
117495,n,1,1
117496,=,1,1
117497,115,1,1
117498,),1,1
117499,received,1,1
117500,open-label,1,1
117501,ipilimumab,1,1
117502,(,1,1
117503,10,1,1
117504,mg/kg,1,0
117505,every,1,0
117506,3,1,0
117507,weeks,1,0
117508,for,1,1
117509,four,1,1
117510,doses,1,1
117511,),1,1
117512,and,1,1
117513,were,0,1
117514,randomized,0,1
117515,to,0,0
117516,receive,0,1
117517,concomitant,0,0
117518,blinded,0,0
117519,prophylactic,0,1
117520,oral,0,1
117521,budesonide,0,0
117522,(,0,1
117523,9,0,0
117524,mg/d,0,0
117525,with,0,1
117526,gradual,0,0
117527,taper,0,0
117528,through,0,1
117529,week,0,0
117530,16,0,1
117531,),0,1
117532,or,0,1
117533,placebo,0,1
117534,.,0,1
117535,Outcome,0,0
117536,measures,0,0
117537,included,0,1
117538,histologic,0,0
117539,assessment,0,0
117540,of,0,1
117541,bowel,0,1
117542,biopsies,0,1
117543,and,0,1
117544,assessment,0,0
117545,of,0,1
117546,serologic,0,1
117547,markers,0,0
117548,of,0,1
117549,inflammatory,0,1
117550,bowel,0,1
117551,disease,0,1
117552,(,0,1
117553,IBD,0,1
117554,),0,1
117555,",",0,0
117556,fecal,0,1
117557,calprotectin,0,0
117558,levels,0,0
117559,",",0,1
117560,and,0,1
117561,polymorphisms,0,0
117562,in,0,1
117563,immune-related,0,1
117564,genes,0,0
117565,.,0,1
117566,Ipilimumab,0,0
117567,resulted,0,0
117568,in,0,0
117569,dysregulation,0,0
117570,of,0,0
117571,gastrointestinal,0,1
117572,mucosal,0,1
117573,immunity,0,0
117574,as,0,0
117575,evidenced,0,0
117576,by,0,0
117577,altered,0,1
117578,antibody,0,0
117579,levels,0,0
117580,to,0,1
117581,enteric,0,1
117582,flora,0,1
117583,",",0,0
117584,inflammatory,0,0
117585,cell,0,1
117586,infiltration,0,0
117587,into,0,1
117588,gastrointestinal,0,1
117589,mucosa,0,1
117590,",",0,0
117591,and,0,0
117592,increased,0,0
117593,fecal,0,1
117594,calprotectin,0,0
117595,associated,0,0
117596,with,0,1
117597,diarrhea,0,1
117598,and,0,1
117599,clinical,0,0
117600,evidence,0,0
117601,of,0,0
117602,colitis,0,1
117603,.,0,1
117604,The,0,0
117605,pattern,0,0
117606,of,0,0
117607,ipilimumab-induced,0,1
117608,antibody,0,0
117609,titers,0,0
117610,to,0,1
117611,microbial,0,0
117612,flora,0,1
117613,and,0,0
117614,the,0,0
117615,histologic,0,0
117616,features,0,1
117617,and,0,1
117618,location,0,1
117619,of,0,0
117620,the,0,0
117621,inflammation,0,0
117622,were,0,0
117623,distinct,0,0
117624,from,0,1
117625,classic,0,1
117626,IBD,0,1
117627,.,0,1
117628,Prophylactic,0,0
117629,budesonide,0,0
117630,did,0,0
117631,not,0,0
117632,prevent,0,0
117633,ipilimumab-induced,0,0
117634,bowel,0,1
117635,inflammation,0,1
117636,.,0,1
117637,Despite,0,0
117638,an,0,0
117639,observed,0,0
117640,association,0,0
117641,between,0,0
117642,colonic,0,1
117643,inflammation,0,1
117644,and,0,0
117645,grade,0,1
117646,2,0,0
117647,or,0,1
117648,higher,0,0
117649,diarrhea,0,1
117650,",",0,0
117651,no,0,0
117652,baseline,0,0
117653,biomarkers,0,0
117654,could,0,0
117655,reliably,0,0
117656,predict,0,0
117657,development,0,0
117658,of,0,0
117659,gastrointestinal,0,1
117660,toxicity,0,0
117661,.,0,1
117662,Although,0,0
117663,classic,0,1
117664,IBD,0,1
117665,and,0,1
117666,ipilimumab-related,0,1
117667,gastrointestinal,0,1
117668,toxicity,0,0
117669,are,0,0
117670,both,0,0
117671,immune,0,0
117672,mediated,0,0
117673,",",0,0
117674,the,0,0
117675,observed,0,0
117676,pattern,0,1
117677,of,0,0
117678,biomarkers,0,1
117679,suggests,0,0
117680,ipilimumab-related,0,0
117681,gastrointestinal,0,0
117682,toxicity,0,0
117683,may,0,0
117684,be,0,0
117685,a,0,0
117686,distinct,0,0
117687,clinicopathologic,0,1
117688,entity,0,1
117689,.,0,1
117690,[,0,1
117691,GISSI-2,0,1
117692,;,0,1
117693,the,0,0
117694,beginning,0,0
117695,of,0,0
117696,the,0,0
117697,end,0,0
117698,or,0,0
117699,the,0,0
117700,end,0,0
117701,of,0,0
117702,the,0,0
117703,beginning,0,0
117704,for,0,0
117705,tissue,0,1
117706,plasminogen,0,1
117707,activator,0,0
117708,in,0,0
117709,acute,1,1
117710,myocardial,1,1
117711,infarct,1,1
117712,?,0,1
117713,],0,0
117714,.,0,1
117715,Intervention,0,1
117716,targeting,0,0
117717,development,0,0
117718,of,0,0
117719,socially,0,1
117720,synchronous,0,1
117721,engagement,0,0
117722,in,0,1
117723,toddlers,1,1
117724,with,1,1
117725,autism,1,1
117726,spectrum,1,1
117727,disorder,1,1
117728,:,1,1
117729,a,0,0
117730,randomized,0,1
117731,controlled,0,0
117732,trial,0,1
117733,.,0,1
117734,BACKGROUND,0,0
117735,Social,0,0
117736,and,0,1
117737,communication,0,0
117738,impairments,0,1
117739,are,0,0
117740,core,0,1
117741,deficits,0,1
117742,and,0,1
117743,prognostic,0,0
117744,indicators,0,0
117745,of,0,1
117746,autism,0,1
117747,.,0,1
117748,We,0,0
117749,evaluated,0,0
117750,the,0,0
117751,impact,0,0
117752,of,0,0
117753,supplementing,0,0
117754,a,0,1
117755,comprehensive,0,0
117756,intervention,0,0
117757,with,0,1
117758,a,0,1
117759,curriculum,0,0
117760,targeting,0,0
117761,socially,0,1
117762,synchronous,0,1
117763,behavior,0,0
117764,on,0,0
117765,social,0,1
117766,outcomes,0,0
117767,of,0,1
117768,toddlers,1,1
117769,with,1,1
117770,autism,1,1
117771,spectrum,1,1
117772,disorders,1,1
117773,(,1,1
117774,ASD,1,1
117775,),1,1
117776,.,1,1
117777,METHODS,0,0
117778,Fifty,1,1
117779,toddlers,1,1
117780,with,1,1
117781,ASD,1,1
117782,",",1,0
117783,ages,1,1
117784,21,1,0
117785,to,1,0
117786,33,1,1
117787,months,1,0
117788,",",0,1
117789,were,0,1
117790,randomized,0,1
117791,to,0,1
117792,one,0,1
117793,of,0,1
117794,two,0,1
117795,six-month,0,1
117796,interventions,0,1
117797,:,0,1
117798,Interpersonal,0,1
117799,Synchrony,0,1
117800,or,0,1
117801,Non-Interpersonal,0,1
117802,Synchrony,0,1
117803,.,0,1
117804,The,0,0
117805,interventions,0,0
117806,provided,0,0
117807,identical,0,1
117808,intensity,0,0
117809,(,0,1
117810,10,0,1
117811,hours,0,0
117812,per,0,1
117813,week,0,0
117814,in,0,0
117815,classroom,0,1
117816,),0,1
117817,",",0,0
117818,student-to-teacher,0,0
117819,ratio,0,0
117820,",",0,0
117821,schedule,0,0
117822,",",0,0
117823,home-based,0,0
117824,parent,0,1
117825,training,0,0
117826,(,0,1
117827,1.5,0,0
117828,hours,0,0
117829,per,0,1
117830,month,0,1
117831,),0,1
117832,",",0,0
117833,parent,0,1
117834,education,0,1
117835,(,0,1
117836,38,0,1
117837,hours,0,0
117838,),0,1
117839,",",0,1
117840,and,0,1
117841,instructional,0,0
117842,strategies,0,0
117843,",",0,1
117844,except,0,0
117845,the,0,0
117846,Interpersonal,0,1
117847,Synchrony,0,0
117848,condition,0,0
117849,provided,0,0
117850,a,0,0
117851,supplementary,0,0
117852,curriculum,0,0
117853,targeting,0,0
117854,socially,0,1
117855,engaged,0,1
117856,imitation,0,0
117857,",",0,0
117858,joint,0,0
117859,attention,0,0
117860,",",0,0
117861,and,0,0
117862,affect,0,0
117863,sharing,0,1
117864,;,0,1
117865,measures,0,0
117866,of,0,0
117867,these,0,0
117868,were,0,1
117869,primary,0,1
117870,outcomes,0,0
117871,.,0,1
117872,Assessments,0,0
117873,were,0,1
117874,conducted,0,1
117875,pre-intervention,0,0
117876,",",0,0
117877,immediately,0,0
117878,post-intervention,0,0
117879,",",0,0
117880,and,0,0
117881,",",0,0
117882,to,0,0
117883,assess,0,0
117884,maintenance,0,0
117885,",",0,0
117886,at,0,0
117887,six-month,0,0
117888,follow-up,0,1
117889,.,0,1
117890,Random,0,1
117891,effects,0,0
117892,models,0,1
117893,were,0,1
117894,used,0,0
117895,to,0,0
117896,examine,0,0
117897,differences,0,0
117898,between,0,0
117899,groups,0,1
117900,over,0,1
117901,time,0,0
117902,.,0,1
117903,Secondary,0,0
117904,analyses,0,0
117905,examined,0,1
117906,gains,0,0
117907,in,0,1
117908,expressive,0,1
117909,language,0,1
117910,and,0,1
117911,nonverbal,0,1
117912,cognition,0,0
117913,",",0,0
117914,and,0,0
117915,time,0,0
117916,effects,0,0
117917,during,0,0
117918,the,0,0
117919,intervention,0,0
117920,and,0,0
117921,follow-up,0,1
117922,periods,0,0
117923,.,0,1
117924,RESULTS,0,0
117925,A,0,0
117926,significant,0,0
117927,treatment,0,0
117928,effect,0,0
117929,was,0,0
117930,found,0,0
117931,for,0,0
117932,socially,0,1
117933,engaged,0,1
117934,imitation,0,0
117935,(,0,1
117936,p,0,0
117937,=,0,1
117938,.02,0,0
117939,),0,0
117940,",",0,0
117941,with,0,1
117942,more,0,0
117943,than,0,0
117944,doubling,0,0
117945,(,0,1
117946,17,0,1
117947,%,0,0
117948,to,0,1
117949,42,0,1
117950,%,0,0
117951,),0,1
117952,of,0,1
117953,imitated,0,1
117954,acts,0,0
117955,paired,0,1
117956,with,0,1
117957,eye,0,1
117958,contact,0,0
117959,in,0,0
117960,the,0,0
117961,Interpersonal,0,1
117962,Synchrony,0,0
117963,group,0,1
117964,after,0,0
117965,the,0,0
117966,intervention,0,0
117967,.,0,0
117968,This,0,0
117969,skill,0,0
117970,was,0,0
117971,generalized,0,1
117972,to,0,0
117973,unfamiliar,0,1
117974,contexts,0,0
117975,and,0,0
117976,maintained,0,0
117977,through,0,0
117978,follow-up,0,0
117979,.,0,1
117980,Similar,0,0
117981,gains,0,0
117982,were,0,1
117983,observed,0,0
117984,for,0,0
117985,initiation,0,0
117986,of,0,0
117987,joint,0,1
117988,attention,0,0
117989,and,0,1
117990,shared,0,0
117991,positive,0,1
117992,affect,0,0
117993,",",0,0
117994,but,0,0
117995,between-group,0,0
117996,differences,0,0
117997,did,0,0
117998,not,0,0
117999,reach,0,0
118000,statistical,0,0
118001,significance,0,0
118002,.,0,1
118003,A,0,0
118004,significant,0,0
118005,time,0,0
118006,effect,0,0
118007,was,0,0
118008,found,0,0
118009,for,0,0
118010,all,0,1
118011,outcomes,0,0
118012,(,0,1
118013,p,0,0
118014,<,0,0
118015,.001,0,0
118016,),0,1
118017,;,0,1
118018,greatest,0,0
118019,change,0,0
118020,occurred,0,0
118021,during,0,0
118022,the,0,0
118023,intervention,0,0
118024,period,0,0
118025,",",0,0
118026,particularly,0,0
118027,in,0,0
118028,the,0,0
118029,Interpersonal,0,1
118030,Synchrony,0,0
118031,group,0,1
118032,.,0,1
118033,CONCLUSIONS,0,0
118034,This,0,0
118035,is,0,0
118036,the,0,0
118037,first,0,0
118038,ASD,0,1
118039,randomized,0,1
118040,trial,0,1
118041,involving,0,1
118042,toddlers,1,1
118043,to,0,1
118044,identify,0,0
118045,an,0,0
118046,active,0,0
118047,ingredient,0,0
118048,for,0,0
118049,enhancing,0,0
118050,socially,0,1
118051,engaged,0,1
118052,imitation,0,1
118053,.,0,1
118054,Adding,0,0
118055,social,0,0
118056,engagement,0,1
118057,targets,0,0
118058,to,0,1
118059,intervention,0,1
118060,improves,0,0
118061,short-term,0,0
118062,outcome,0,0
118063,at,0,0
118064,no,0,0
118065,additional,0,0
118066,cost,0,0
118067,to,0,0
118068,the,0,0
118069,intervention,0,0
118070,.,0,0
118071,The,0,0
118072,social,0,0
118073,",",0,0
118074,language,0,0
118075,",",0,0
118076,and,0,0
118077,cognitive,0,0
118078,gains,0,0
118079,in,0,1
118080,our,0,1
118081,participants,0,1
118082,provide,0,0
118083,evidence,0,0
118084,for,0,0
118085,plasticity,0,0
118086,of,0,0
118087,these,0,0
118088,developmental,0,1
118089,systems,0,0
118090,in,0,1
118091,toddlers,1,1
118092,with,1,1
118093,ASD,1,1
118094,.,1,1
118095,http,0,0
118096,:,0,1
118097,//www.clinicaltrials.gov/ct2/show/NCT00106210,0,0
118098,?,0,1
118099,term,0,0
118100,=,0,0
118101,landa,0,1
118102,&,0,1
118103,rank,0,0
118104,=,0,1
118105,3,0,1
118106,.,0,1
118107,Cost-effectiveness,0,0
118108,of,0,0
118109,ablation,0,1
118110,surgery,0,1
118111,in,0,0
118112,patients,1,1
118113,with,1,1
118114,atrial,1,1
118115,fibrillation,1,1
118116,undergoing,1,1
118117,cardiac,1,1
118118,surgery,1,1
118119,.,1,1
118120,This,0,0
118121,study,0,0
118122,was,0,0
118123,performed,0,0
118124,to,0,0
118125,assess,0,0
118126,the,0,0
118127,cost-effectiveness,0,0
118128,of,0,0
118129,concomitant,0,0
118130,ablation,0,1
118131,surgery,0,1
118132,(,0,1
118133,AS,0,1
118134,),0,1
118135,compared,0,0
118136,to,0,0
118137,regular,0,1
118138,cardiac,0,1
118139,surgery,0,1
118140,in,0,1
118141,atrial,1,1
118142,fibrillation,1,1
118143,(,1,1
118144,AF,1,1
118145,),1,1
118146,patients,1,1
118147,over,0,0
118148,a,0,1
118149,one-year,0,0
118150,follow-up,0,0
118151,.,0,1
118152,Cost,0,0
118153,analysis,0,0
118154,was,0,0
118155,performed,0,0
118156,from,0,1
118157,a,0,1
118158,societal,0,0
118159,perspective,0,0
118160,alongside,0,0
118161,a,0,0
118162,prospective,0,1
118163,",",0,0
118164,randomised,0,0
118165,",",0,0
118166,double-blinded,0,0
118167,",",0,0
118168,multicentre,0,1
118169,trial,0,1
118170,.,0,1
118171,One,1,1
118172,hundred,1,1
118173,and,1,1
118174,fifty,1,1
118175,patients,1,1
118176,with,1,1
118177,documented,1,1
118178,AF,1,1
118179,were,0,1
118180,randomly,0,1
118181,assigned,0,1
118182,to,0,0
118183,undergo,0,1
118184,cardiac,0,1
118185,surgery,0,1
118186,with,0,1
118187,or,0,1
118188,without,0,1
118189,AS,0,1
118190,.,0,1
118191,One,1,1
118192,hundred,1,1
118193,and,1,1
118194,thirty-two,1,1
118195,patients,1,1
118196,were,1,1
118197,included,1,1
118198,in,1,0
118199,the,1,0
118200,cost-effectiveness,1,0
118201,study,1,0
118202,.,1,1
118203,All,0,1
118204,costs,0,0
118205,(,0,1
118206,medical,0,1
118207,and,0,1
118208,non-medical,0,1
118209,),0,1
118210,were,0,1
118211,measured,0,0
118212,during,0,0
118213,follow-up,0,1
118214,.,0,1
118215,Costs,0,0
118216,data,0,0
118217,were,0,1
118218,combined,0,0
118219,with,0,1
118220,quality,0,0
118221,adjusted,0,0
118222,life,0,1
118223,years,0,1
118224,(,0,1
118225,QALYs,0,1
118226,),0,1
118227,to,0,0
118228,obtain,0,0
118229,the,0,0
118230,incremental,0,0
118231,costs,0,1
118232,per,0,1
118233,QALY,0,1
118234,.,0,1
118235,Total,0,0
118236,costs,0,0
118237,of,0,1
118238,the,0,1
118239,AS,0,1
118240,group,0,0
118241,were,0,0
118242,significantly,0,0
118243,higher,0,0
118244,compared,0,0
118245,to,0,0
118246,the,0,0
118247,regular,0,0
118248,cardiac,0,1
118249,surgery,0,1
118250,group,0,0
118251,[,0,0
118252,cost,0,0
118253,difference,0,0
118254,bootstrap,0,0
118255,:,0,1
118256,"?4,724",0,1
118257,;,0,1
118258,95,0,0
118259,%,0,0
118260,uncertainty,0,0
118261,interval,0,0
118262,(,0,1
118263,UI,0,1
118264,),0,1
118265,",",0,0
118266,"?2,770-?6,678",0,1
118267,],0,1
118268,.,0,1
118269,The,0,0
118270,bootstrapped,0,0
118271,difference,0,0
118272,in,0,1
118273,QALYs,0,1
118274,was,0,0
118275,not,0,0
118276,statistically,0,0
118277,significant,0,0
118278,(,0,1
118279,0.06,0,0
118280,;,0,1
118281,95,0,0
118282,%,0,0
118283,UI,0,1
118284,:,0,1
118285,-0.024,0,0
118286,to,0,1
118287,0.14,0,0
118288,),0,1
118289,.,0,1
118290,The,0,0
118291,incremental,0,0
118292,cost-effectiveness,0,0
118293,ratio,0,0
118294,is,0,0
118295,"?73,359",0,1
118296,per,0,0
118297,QALY,0,1
118298,.,0,1
118299,The,0,0
118300,acceptability,0,0
118301,curve,0,0
118302,showed,0,0
118303,that,0,0
118304,",",0,0
118305,even,0,0
118306,in,0,0
118307,the,0,0
118308,case,0,0
118309,of,0,0
118310,a,0,1
118311,maximum,0,0
118312,threshold,0,0
118313,value,0,0
118314,of,0,0
118315,"?80,000",0,1
118316,per,0,1
118317,QALY,0,1
118318,gained,0,0
118319,",",0,0
118320,the,0,0
118321,probability,0,0
118322,of,0,0
118323,AS,0,0
118324,being,0,0
118325,more,0,0
118326,cost-effective,0,0
118327,than,0,0
118328,regular,0,1
118329,cardiac,0,1
118330,surgery,0,1
118331,did,0,0
118332,not,0,0
118333,reach,0,0
118334,beyond,0,1
118335,50,0,1
118336,%,0,0
118337,.,0,1
118338,Concluding,0,0
118339,that,0,0
118340,concomitant,0,0
118341,AS,0,1
118342,in,0,0
118343,AF,0,0
118344,is,0,0
118345,not,0,0
118346,cost-effective,0,0
118347,after,0,0
118348,a,0,1
118349,one-year,0,0
118350,follow-up,0,0
118351,compared,0,0
118352,to,0,0
118353,regular,0,1
118354,cardiac,0,1
118355,surgery,0,1
118356,.,0,1
118357,Effect,0,0
118358,of,0,0
118359,L-arginine,0,1
118360,or,0,1
118361,L-citrulline,0,0
118362,oral,0,0
118363,supplementation,0,0
118364,on,0,0
118365,blood,0,0
118366,pressure,0,0
118367,and,0,0
118368,right,0,1
118369,ventricular,0,1
118370,function,0,0
118371,in,0,0
118372,heart,1,1
118373,failure,1,1
118374,patients,1,1
118375,with,1,1
118376,preserved,1,1
118377,ejection,1,1
118378,fraction,1,1
118379,.,1,1
118380,BACKGROUND,0,0
118381,The,0,0
118382,effect,0,0
118383,of,0,0
118384,L-arginine,0,1
118385,and,0,1
118386,L-citrulline,0,0
118387,on,0,0
118388,blood,0,0
118389,pressure,0,0
118390,and,0,0
118391,right,0,1
118392,ventricular,0,1
118393,function,0,0
118394,in,0,0
118395,heart,1,1
118396,failure,1,1
118397,patients,1,1
118398,with,1,1
118399,preserved,1,1
118400,ejection,1,1
118401,fraction,1,1
118402,(,1,1
118403,HFpEF,1,0
118404,),1,1
118405,is,0,0
118406,unknown,0,0
118407,.,0,0
118408,We,0,0
118409,have,0,0
118410,therefore,0,0
118411,evaluated,0,0
118412,",",0,0
118413,in,0,0
118414,a,0,1
118415,randomized,0,1
118416,clinical,0,0
118417,trial,0,0
118418,",",0,0
118419,the,0,0
118420,effect,0,0
118421,of,0,0
118422,these,0,0
118423,aminoacids,0,0
118424,in,0,1
118425,chronic,1,1
118426,outstanding,1,1
118427,and,1,1
118428,stable,1,1
118429,patients,1,1
118430,with,1,1
118431,HFpEF,1,1
118432,.,1,1
118433,METHODS,0,0
118434,AND,0,0
118435,RESULTS,0,1
118436,All,1,1
118437,patients,1,1
118438,underwent,1,1
118439,an,1,1
118440,echocardiogram,1,0
118441,and,1,0
118442,radioisotopic,1,0
118443,ventriculography,1,0
118444,rest/exercise,1,0
118445,",",0,0
118446,and,0,0
118447,were,0,0
118448,randomized,0,1
118449,in,0,0
118450,a,0,1
118451,consecutive,0,1
118452,manner,0,0
118453,to,0,1
118454,the,0,0
118455,L-arginine,1,0
118456,group,1,1
118457,(,1,0
118458,n,1,1
118459,=,1,1
118460,15,1,1
118461,;,1,0
118462,8,1,1
118463,g/day,1,0
118464,),1,1
118465,;,1,0
118466,and,1,0
118467,the,1,0
118468,citrulline,1,0
118469,malate,1,0
118470,group,1,1
118471,(,1,0
118472,n,1,1
118473,=,1,1
118474,15,1,1
118475,;,1,0
118476,3,0,1
118477,g/day,0,0
118478,),0,1
118479,.,0,1
118480,The,0,0
118481,duration,0,0
118482,of,0,0
118483,follow-up,0,0
118484,was,0,0
118485,two,0,1
118486,months,0,0
118487,.,0,1
118488,The,0,0
118489,principal,0,0
118490,echocardiographic,0,1
118491,finding,0,0
118492,was,0,0
118493,a,0,0
118494,statistically,0,0
118495,significant,0,0
118496,decrease,0,0
118497,in,0,1
118498,pulmonary,0,1
118499,artery,0,1
118500,pressure,0,0
118501,in,0,0
118502,the,0,0
118503,L-arginine,0,1
118504,(,0,1
118505,56.3,0,1
118506,?,0,1
118507,10,0,0
118508,vs,0,0
118509,44,0,1
118510,?,0,1
118511,16.5,0,0
118512,mm,0,0
118513,Hg,0,0
118514,",",0,0
118515,p,0,0
118516,<,0,0
118517,0.05,0,0
118518,),0,1
118519,and,0,0
118520,the,0,0
118521,citrulline,0,0
118522,(,0,1
118523,56.67,0,0
118524,?,0,1
118525,7.96,0,0
118526,vs,0,0
118527,47.67,0,1
118528,?,0,1
118529,8.59,0,0
118530,mm,0,0
118531,Hg,0,0
118532,",",0,0
118533,p,0,0
118534,<,0,0
118535,0.05,0,0
118536,),0,1
118537,groups,0,1
118538,.,0,1
118539,Duration,0,0
118540,on,0,0
118541,treadmill,0,0
118542,and,0,1
118543,right,0,1
118544,ventricular,0,1
118545,ejection,0,1
118546,fraction,0,1
118547,post,0,1
118548,exercise,0,0
118549,increased,0,0
118550,",",0,0
118551,while,0,0
118552,diastolic,0,1
118553,and,0,1
118554,systolic,0,1
118555,artery,0,1
118556,pressure,0,0
118557,decreased,0,0
118558,significantly,0,0
118559,in,0,0
118560,both,0,0
118561,groups,0,0
118562,.,0,0
118563,There,0,0
118564,were,0,0
118565,no,0,0
118566,other,0,0
118567,statistically,0,0
118568,significant,0,0
118569,differences,0,0
118570,between,0,0
118571,the,0,1
118572,groups,0,0
118573,.,0,1
118574,CONCLUSIONS,0,0
118575,Administration,0,0
118576,of,0,1
118577,L-arginine,0,1
118578,and,0,1
118579,citrulline,1,0
118580,to,1,1
118581,patients,1,1
118582,with,1,1
118583,HFpEF,1,1
118584,improved,1,0
118585,right,0,1
118586,ventricular,0,1
118587,function,0,0
118588,by,0,0
118589,increasing,0,0
118590,right,0,1
118591,ventricular,0,1
118592,ejection,0,1
118593,fraction,0,1
118594,",",0,0
118595,and,0,0
118596,probably,0,0
118597,decreasing,0,0
118598,systolic,0,1
118599,pulmonary,0,1
118600,artery,0,1
118601,pressure,0,1
118602,.,0,1
118603,In,0,1
118604,vitro,0,0
118605,determination,0,0
118606,of,0,0
118607,the,0,0
118608,chromatic,0,0
118609,effect,0,0
118610,of,0,0
118611,a,0,0
118612,silver,0,0
118613,nanoparticles,0,0
118614,solution,0,0
118615,linked,0,0
118616,to,0,0
118617,the,0,0
118618,gantrez,0,0
118619,S-97,0,0
118620,copolymer,0,0
118621,on,0,0
118622,tooth,1,1
118623,enamel,1,1
118624,.,1,1
118625,Silver,0,0
118626,nanoparticles,0,0
118627,(,0,1
118628,NNPs,0,0
118629,),0,0
118630,",",0,0
118631,alone,0,0
118632,or,0,0
118633,in,0,0
118634,combination,0,0
118635,with,0,1
118636,the,0,0
118637,bioadhesive,0,0
118638,Gantrez,0,1
118639,S-97,0,0
118640,",",0,0
118641,have,0,0
118642,demonstrated,0,0
118643,their,0,0
118644,efficacy,0,0
118645,against,0,1
118646,Streptococcus,0,1
118647,mutans,0,1
118648,;,0,1
118649,however,0,0
118650,",",0,0
118651,it,0,0
118652,is,0,0
118653,not,0,0
118654,known,0,0
118655,if,0,0
118656,this,0,0
118657,combination,0,0
118658,changes,0,0
118659,the,0,0
118660,color,0,0
118661,of,0,0
118662,teeth,0,1
118663,.,0,1
118664,The,0,0
118665,aim,0,0
118666,of,0,0
118667,this,0,0
118668,work,0,0
118669,was,0,0
118670,to,0,0
118671,measure,0,0
118672,the,0,0
118673,color,0,1
118674,changes,0,0
118675,occurring,0,1
118676,after,0,0
118677,the,0,0
118678,use,0,0
118679,of,0,0
118680,a,0,1
118681,Gantrez-NNP,0,0
118682,combination,0,0
118683,on,0,0
118684,enamel,0,1
118685,tooth,0,1
118686,blocks,0,1
118687,.,0,1
118688,Two,1,1
118689,study,1,1
118690,groups,1,0
118691,were,1,1
118692,randomly,1,1
118693,formed,1,1
118694,:,1,1
118695,enamel,1,1
118696,blocks,1,0
118697,brushed,1,0
118698,with,1,1
118699,(,1,1
118700,a,1,1
118701,),1,0
118702,the,1,0
118703,Gantrez-NNP,1,0
118704,combination,1,0
118705,and,1,0
118706,(,1,1
118707,b,1,1
118708,),1,1
118709,conventional,1,1
118710,toothpaste,1,0
118711,",",1,1
118712,for,1,0
118713,1,1,0
118714,minute,1,0
118715,once,1,0
118716,daily,1,0
118717,for,1,1
118718,4,1,1
118719,weeks,1,0
118720,",",1,1
118721,then,1,0
118722,rinsed,1,0
118723,with,1,1
118724,distilled,1,0
118725,water,1,0
118726,and,1,0
118727,placed,1,0
118728,in,1,0
118729,thymol,1,0
118730,solution,1,0
118731,.,1,1
118732,Color,0,1
118733,changes,0,0
118734,in,0,0
118735,the,0,1
118736,enamel,0,1
118737,blocks,0,0
118738,were,0,1
118739,measured,0,0
118740,using,0,0
118741,a,0,1
118742,Minolta,0,0
118743,colorimeter,0,0
118744,CR300,0,1
118745,.,0,1
118746,Analysis,0,0
118747,of,0,0
118748,mixed,0,1
118749,models,0,1
118750,was,0,0
118751,performed,0,0
118752,with,0,1
118753,R,0,1
118754,2.10.1,0,1
118755,at,0,1
118756,a,0,1
118757,95,0,0
118758,%,0,0
118759,confidence,0,0
118760,level,0,0
118761,",",0,0
118762,using,0,0
118763,the,0,0
118764,nonlinear,0,0
118765,mixed,0,1
118766,effects,0,0
118767,(,0,1
118768,NLME,0,0
118769,),0,1
118770,package,0,0
118771,.,0,1
118772,The,0,0
118773,results,0,0
118774,showed,0,0
118775,that,0,0
118776,there,0,0
118777,were,0,0
118778,no,0,0
118779,color,0,0
118780,changes,0,0
118781,over,0,0
118782,time,0,0
118783,",",0,0
118784,only,0,0
118785,a,0,0
118786,high,0,0
118787,luminosity,0,1
118788,equal,0,0
118789,in,0,1
118790,both,0,0
118791,groups,0,0
118792,.,0,1
118793,Our,0,0
118794,study,0,0
118795,showed,0,0
118796,that,0,0
118797,the,0,0
118798,use,0,0
118799,of,0,0
118800,the,0,0
118801,Gantrez-NNP,0,0
118802,combination,0,0
118803,is,0,0
118804,safe,0,0
118805,with,0,1
118806,respect,0,0
118807,to,0,1
118808,dental,1,1
118809,esthetics,1,0
118810,in,0,1
118811,the,0,0
118812,control,0,1
118813,of,0,0
118814,S.,0,1
118815,mutans,0,1
118816,.,0,1
118817,Comparison,0,0
118818,of,0,1
118819,different,0,1
118820,approaches,0,0
118821,for,0,1
118822,assessment,0,0
118823,of,0,0
118824,HER2,0,1
118825,expression,0,0
118826,on,0,0
118827,protein,0,0
118828,and,0,1
118829,mRNA,0,1
118830,level,0,0
118831,:,0,1
118832,prediction,0,0
118833,of,0,0
118834,chemotherapy,0,1
118835,response,0,0
118836,in,0,0
118837,the,0,0
118838,neoadjuvant,0,1
118839,GeparTrio,0,1
118840,trial,0,1
118841,(,0,1
118842,NCT00544765,0,1
118843,),0,1
118844,.,0,1
118845,Human,0,1
118846,epidermal,0,0
118847,growth,0,0
118848,factor,0,0
118849,receptor,0,0
118850,2,0,1
118851,(,0,1
118852,HER2,0,1
118853,),0,0
118854,testing,0,0
118855,is,0,0
118856,an,0,0
118857,essential,0,0
118858,part,0,0
118859,of,0,0
118860,pathological,0,1
118861,assessment,0,0
118862,in,0,0
118863,breast,1,1
118864,cancer,1,1
118865,patients,1,1
118866,",",0,1
118867,as,0,0
118868,HER2,0,0
118869,provides,0,0
118870,not,0,0
118871,only,0,0
118872,prognostic,0,0
118873,but,0,0
118874,also,0,0
118875,predictive,0,0
118876,information,0,0
118877,on,0,0
118878,response,0,0
118879,to,0,1
118880,targeted,0,1
118881,therapy,0,0
118882,.,0,0
118883,So,0,0
118884,far,0,0
118885,",",0,0
118886,HER2,0,0
118887,test,0,0
118888,accuracy,0,0
118889,of,0,0
118890,immunohistochemistry/in,0,1
118891,situ-hybridization,0,0
118892,techniques,0,0
118893,is,0,0
118894,still,0,0
118895,under,0,0
118896,debate,0,0
118897,",",0,0
118898,and,0,0
118899,more,0,0
118900,reliable,0,0
118901,and,0,0
118902,robust,0,0
118903,technologies,0,0
118904,are,0,0
118905,needed,0,0
118906,.,0,1
118907,To,0,0
118908,address,0,0
118909,this,0,0
118910,issue,0,0
118911,and,0,0
118912,to,0,0
118913,evaluate,0,0
118914,the,0,0
118915,predictive,0,0
118916,value,0,0
118917,of,0,0
118918,HER2,0,1
118919,on,0,0
118920,chemotherapy,0,1
118921,",",0,0
118922,we,0,0
118923,investigated,1,0
118924,a,1,0
118925,cohort,1,1
118926,of,1,0
118927,278,1,1
118928,patients,1,1
118929,from,1,1
118930,the,1,1
118931,GeparTrio,1,1
118932,trial,1,0
118933,",",0,0
118934,a,0,0
118935,prospective,0,1
118936,neoadjuvant,0,1
118937,anthracycline/taxane-based,0,1
118938,multicenter,0,1
118939,study,0,1
118940,.,0,1
118941,In,0,0
118942,the,0,0
118943,GeparTrio,0,1
118944,trial,0,0
118945,",",0,1
118946,patients,0,1
118947,were,0,1
118948,not,0,0
118949,treated,0,1
118950,with,0,1
118951,any,0,0
118952,anti-HER2,0,0
118953,therapy,0,0
118954,",",0,0
118955,as,0,0
118956,this,0,0
118957,was,0,0
118958,not,0,0
118959,standard,0,0
118960,therapy,0,0
118961,at,0,0
118962,this,0,0
118963,time,0,0
118964,.,0,0
118965,The,0,0
118966,HER2,0,0
118967,status,0,1
118968,was,0,0
118969,analyzed,0,0
118970,by,0,0
118971,three,0,1
118972,different,0,1
118973,approaches,0,0
118974,:,0,1
118975,local,0,0
118976,and,0,1
118977,central,0,0
118978,evaluation,0,0
118979,using,0,0
118980,immunohistochemistry,0,1
118981,combined,0,0
118982,with,0,1
118983,in,0,0
118984,situ-hybridization,0,0
118985,as,0,0
118986,well,0,0
118987,as,0,0
118988,evaluation,0,0
118989,of,0,0
118990,HER2,0,1
118991,mRNA,0,1
118992,expression,0,0
118993,using,0,0
118994,kinetic,0,0
118995,RT-PCR,0,1
118996,from,0,1
118997,formalin-fixed,0,1
118998,",",0,1
118999,paraffin-embedded,0,1
119000,(,0,1
119001,FFPE,0,1
119002,),0,1
119003,tissue,0,1
119004,samples,0,1
119005,using,0,0
119006,a,0,1
119007,predefined,0,0
119008,cutoff,0,0
119009,.,0,1
119010,HER2,0,0
119011,overexpression/amplification,0,0
119012,was,0,0
119013,observed,0,0
119014,in,0,1
119015,37.3,0,0
119016,%,0,0
119017,(,0,1
119018,91/244,0,1
119019,),0,1
119020,and,0,1
119021,17.9,0,1
119022,%,0,0
119023,(,0,1
119024,41/229,0,1
119025,),0,1
119026,of,0,0
119027,the,0,0
119028,informative,0,0
119029,samples,0,1
119030,in,0,1
119031,the,0,1
119032,local,0,0
119033,and,0,1
119034,central,0,1
119035,evaluations,0,0
119036,",",0,1
119037,respectively,0,0
119038,.,0,1
119039,Positive,0,1
119040,HER2,0,1
119041,mRNA,0,1
119042,levels,0,0
119043,were,0,1
119044,found,0,0
119045,in,0,1
119046,19.8,0,0
119047,%,0,0
119048,(,0,1
119049,55/278,0,1
119050,),0,1
119051,.,0,1
119052,We,0,0
119053,observed,0,0
119054,a,0,0
119055,highly,0,0
119056,significant,0,0
119057,correlation,0,0
119058,between,0,0
119059,central,0,1
119060,HER2,0,1
119061,expression,0,0
119062,and,0,1
119063,HER2,0,1
119064,status,0,1
119065,measured,0,0
119066,by,0,0
119067,kinetic,0,0
119068,RT-PCR,0,0
119069,(,0,0
119070,r,0,0
119071,=,0,0
119072,0.856,0,0
119073,",",0,0
119074,P,0,0
119075,<,0,0
119076,0.0001,0,0
119077,),0,1
119078,and,0,0
119079,an,0,0
119080,overall,0,0
119081,agreement,0,0
119082,of,0,1
119083,95.6,0,1
119084,%,0,0
119085,(,0,1
119086,?,0,1
119087,statistic,0,0
119088,",",0,0
119089,0.862,0,0
119090,",",0,0
119091,CI,0,0
119092,0.77-0.94,0,0
119093,),0,1
119094,.,0,1
119095,Further,0,0
119096,",",0,0
119097,central,0,0
119098,HER2,0,0
119099,as,0,0
119100,well,0,0
119101,as,0,0
119102,HER2,0,0
119103,mRNA,0,1
119104,expression,0,0
119105,were,0,1
119106,predictors,0,0
119107,for,0,1
119108,a,0,1
119109,pathological,0,1
119110,complete,0,1
119111,response,0,0
119112,after,0,1
119113,neoadjuvant,0,1
119114,anthracycline/taxane-based,0,1
119115,primary,0,1
119116,chemotherapy,0,1
119117,in,0,0
119118,a,0,1
119119,univariate,0,0
119120,binary,0,0
119121,logistic,0,0
119122,regression,0,0
119123,analysis,0,0
119124,(,0,1
119125,OR,0,0
119126,3.29,0,0
119127,",",0,1
119128,P,0,0
119129,=,0,1
119130,0.002,0,0
119131,;,0,1
119132,OR,0,0
119133,2.65,0,0
119134,",",0,1
119135,P,0,0
119136,=,0,1
119137,0.004,0,0
119138,),0,1
119139,.,0,1
119140,The,0,0
119141,predictive,0,0
119142,value,0,0
119143,could,0,0
119144,be,0,0
119145,confirmed,0,0
119146,for,0,0
119147,the,0,0
119148,central,0,0
119149,HER2,0,0
119150,status,0,1
119151,by,0,0
119152,multivariate,0,0
119153,analysis,0,0
119154,(,0,1
119155,OR,0,0
119156,3.04,0,0
119157,",",0,1
119158,P,0,0
119159,=,0,1
119160,0.027,0,0
119161,),0,1
119162,.,0,1
119163,The,0,0
119164,locally,0,0
119165,assessed,0,0
119166,HER2,0,0
119167,status,0,1
119168,was,0,0
119169,not,0,0
119170,predictive,0,0
119171,of,0,0
119172,response,0,0
119173,to,0,1
119174,chemotherapy,0,1
119175,.,0,1
119176,Our,0,0
119177,results,0,0
119178,suggest,0,0
119179,that,0,0
119180,standardized,0,0
119181,methods,0,1
119182,are,0,0
119183,preferable,0,0
119184,for,0,0
119185,evaluation,0,0
119186,of,0,0
119187,HER2,0,1
119188,status,0,1
119189,.,0,1
119190,The,0,0
119191,kinetic,0,0
119192,RT-PCR,0,0
119193,from,0,1
119194,FFPE,0,0
119195,tissue,0,1
119196,might,0,0
119197,be,0,0
119198,an,0,0
119199,additional,0,0
119200,approach,0,0
119201,for,0,0
119202,assessment,0,0
119203,of,0,0
119204,this,0,0
119205,important,0,0
119206,prognostic,0,0
119207,and,0,1
119208,predictive,0,0
119209,parameter,0,0
119210,but,0,0
119211,has,0,0
119212,to,0,0
119213,be,0,0
119214,confirmed,0,0
119215,by,0,0
119216,other,0,1
119217,studies,0,0
119218,.,0,1
119219,The,0,0
119220,nightly,0,0
119221,use,0,0
119222,of,0,0
119223,sodium,0,0
119224,oxybate,0,0
119225,is,0,0
119226,associated,0,0
119227,with,0,0
119228,a,0,0
119229,reduction,0,0
119230,in,0,0
119231,nocturnal,1,1
119232,sleep,1,1
119233,disruption,1,0
119234,:,1,1
119235,a,0,0
119236,double-blind,0,0
119237,",",0,0
119238,placebo-controlled,0,0
119239,study,0,1
119240,in,0,1
119241,patients,1,1
119242,with,1,1
119243,narcolepsy,1,1
119244,.,1,1
119245,OBJECTIVE,0,0
119246,To,0,0
119247,further,0,0
119248,explore,0,0
119249,the,0,0
119250,effects,0,0
119251,of,0,0
119252,sodium,0,0
119253,oxybate,0,0
119254,(,0,1
119255,SXB,0,0
119256,),0,1
119257,administration,0,0
119258,on,0,0
119259,nocturnal,0,1
119260,sleep,0,1
119261,in,0,1
119262,narcolepsy,1,1
119263,patients,1,1
119264,during,0,1
119265,a,0,1
119266,double-blind,0,0
119267,",",0,0
119268,placebo-controlled,0,0
119269,",",0,0
119270,parallel,0,0
119271,group,0,1
119272,study,0,1
119273,conducted,0,1
119274,with,0,1
119275,228,1,1
119276,adult,1,1
119277,patients,1,1
119278,with,1,1
119279,narcolepsy/cataplexy,1,1
119280,in,1,1
119281,the,1,1
119282,United,1,1
119283,States,1,1
119284,",",1,1
119285,Canada,1,1
119286,",",1,0
119287,and,1,0
119288,Europe,1,0
119289,.,1,1
119290,METHOD,0,0
119291,Patients,0,1
119292,were,0,1
119293,withdrawn,0,1
119294,from,0,1
119295,antidepressants,0,0
119296,and,0,1
119297,sedative/hypnotics,0,0
119298,",",0,0
119299,and,0,0
119300,then,0,0
119301,randomized,0,1
119302,to,0,0
119303,receive,0,1
119304,4.5,0,0
119305,",",0,0
119306,6,0,0
119307,",",0,0
119308,or,0,1
119309,9,0,0
119310,g,0,1
119311,SXB,0,0
119312,or,0,1
119313,placebo,0,0
119314,nightly,0,0
119315,for,0,0
119316,8,0,1
119317,weeks,0,1
119318,.,0,1
119319,Patients,0,1
119320,receiving,1,1
119321,6,1,1
119322,and,1,1
119323,9,1,1
119324,g/night,1,1
119325,doses,1,0
119326,were,0,1
119327,titrated,0,0
119328,to,0,0
119329,their,0,1
119330,final,0,0
119331,dose,0,0
119332,in,0,1
119333,weekly,0,1
119334,1.5,0,1
119335,g,0,1
119336,increments,0,0
119337,",",0,1
119338,while,0,0
119339,patients,0,1
119340,receiving,0,1
119341,placebo,0,1
119342,were,0,1
119343,randomized,0,1
119344,to,0,0
119345,undergo,0,1
119346,a,0,0
119347,similar,0,0
119348,mock,0,1
119349,dose,0,0
119350,titration,0,0
119351,.,0,1
119352,The,0,0
119353,use,0,0
119354,of,0,0
119355,stimulant,0,1
119356,therapy,0,1
119357,continued,0,0
119358,unchanged,0,0
119359,.,0,1
119360,Changes,0,0
119361,in,0,0
119362,sleep,0,1
119363,architecture,0,1
119364,were,0,1
119365,measured,0,0
119366,using,0,0
119367,centrally,0,0
119368,scored,0,1
119369,nocturnal,0,1
119370,polysomnograms,0,1
119371,.,0,1
119372,Daily,0,1
119373,diaries,0,0
119374,were,0,1
119375,used,0,0
119376,to,0,0
119377,record,0,1
119378,changes,0,0
119379,in,0,1
119380,narcolepsy,0,1
119381,symptoms,0,1
119382,and,0,1
119383,adverse,0,0
119384,events,0,0
119385,.,0,1
119386,RESULTS,0,0
119387,Following,0,1
119388,8,0,1
119389,weeks,0,1
119390,of,0,1
119391,SXB,0,0
119392,treatment,0,0
119393,",",0,0
119394,study,0,1
119395,patients,0,1
119396,demonstrated,0,0
119397,significant,0,0
119398,dose-related,0,0
119399,increases,0,0
119400,in,0,1
119401,the,0,0
119402,duration,0,0
119403,of,0,0
119404,stage,0,1
119405,3,0,1
119406,and,0,1
119407,4,0,0
119408,sleep,0,1
119409,",",0,0
119410,reaching,0,0
119411,a,0,0
119412,median,0,0
119413,increase,0,0
119414,of,0,1
119415,52.5,0,1
119416,minutes,0,0
119417,in,0,1
119418,patients,0,1
119419,receiving,0,1
119420,9,0,0
119421,g,0,1
119422,nightly,0,0
119423,.,0,1
119424,Compared,0,0
119425,to,0,0
119426,placebo-treated,0,0
119427,patients,0,1
119428,",",0,1
119429,delta,0,0
119430,power,0,0
119431,was,0,0
119432,significantly,0,0
119433,increased,0,0
119434,in,0,0
119435,all,0,1
119436,dose,0,0
119437,groups,0,0
119438,.,0,1
119439,Stage,0,1
119440,1,0,0
119441,sleep,0,1
119442,and,0,0
119443,the,0,0
119444,frequency,0,0
119445,of,0,0
119446,nocturnal,0,1
119447,awakenings,0,1
119448,were,0,1
119449,each,0,0
119450,significantly,0,0
119451,decreased,0,0
119452,at,0,0
119453,the,0,0
119454,6,0,0
119455,and,0,1
119456,9,0,1
119457,g/night,0,1
119458,doses,0,0
119459,.,0,1
119460,The,0,0
119461,changes,0,0
119462,in,0,0
119463,nocturnal,0,1
119464,sleep,0,1
119465,coincided,0,0
119466,with,0,1
119467,significant,0,0
119468,decreases,0,0
119469,in,0,1
119470,the,0,0
119471,severity,0,0
119472,and,0,0
119473,frequency,0,0
119474,of,0,0
119475,narcolepsy,0,1
119476,symptoms,0,1
119477,.,0,1
119478,CONCLUSIONS,0,0
119479,The,0,0
119480,nightly,0,0
119481,administration,0,0
119482,of,0,1
119483,SXB,0,0
119484,to,0,1
119485,narcolepsy,0,1
119486,patients,0,1
119487,significantly,0,0
119488,impacts,0,0
119489,measures,0,0
119490,of,0,0
119491,slow,0,1
119492,wave,0,0
119493,sleep,0,1
119494,",",0,0
119495,wake,0,1
119496,after,0,0
119497,sleep,0,1
119498,onset,0,1
119499,",",0,1
119500,awakenings,0,0
119501,",",0,1
119502,total,0,1
119503,sleep,0,1
119504,time,0,0
119505,",",0,0
119506,and,0,0
119507,stage,0,1
119508,1,0,0
119509,sleep,0,1
119510,in,0,0
119511,a,0,1
119512,dose-related,0,0
119513,manner,0,0
119514,.,0,1
119515,The,0,0
119516,frequency,0,0
119517,and,0,0
119518,severity,0,0
119519,of,0,0
119520,narcolepsy,0,1
119521,symptoms,0,1
119522,decreased,0,0
119523,with,0,1
119524,treatment,0,1
119525,.,0,1
119526,Using,0,1
119527,personalized,0,0
119528,feedback,0,0
119529,to,0,0
119530,reduce,0,0
119531,alcohol,0,0
119532,use,0,0
119533,among,0,1
119534,hazardous,1,1
119535,drinking,1,1
119536,college,1,1
119537,students,1,1
119538,:,1,1
119539,the,0,0
119540,moderating,0,0
119541,effect,0,0
119542,of,0,1
119543,alcohol-related,0,1
119544,negative,0,1
119545,consequences,0,0
119546,.,0,1
119547,UNLABELLED,0,0
119548,Web-based,0,0
119549,screening,0,1
119550,and,0,1
119551,brief,0,1
119552,interventions,0,0
119553,that,0,0
119554,include,0,0
119555,personalized,0,0
119556,feedback,0,0
119557,about,0,0
119558,their,0,1
119559,alcohol,0,1
119560,use,0,0
119561,have,0,0
119562,proven,0,0
119563,to,0,0
119564,be,0,0
119565,particularly,0,0
119566,promising,0,0
119567,for,0,0
119568,reducing,0,0
119569,hazardous,1,1
119570,drinking,1,0
119571,among,1,1
119572,university,1,1
119573,students,1,1
119574,.,1,1
119575,Despite,0,0
119576,the,0,0
119577,increasing,0,0
119578,use,0,0
119579,of,0,0
119580,these,0,0
119581,approaches,0,0
119582,",",0,0
119583,there,0,0
119584,is,0,0
119585,still,0,0
119586,relatively,0,0
119587,little,0,0
119588,known,0,0
119589,about,0,0
119590,how,0,0
119591,the,0,0
119592,content,0,0
119593,of,0,0
119594,these,0,0
119595,interventions,0,0
119596,may,0,0
119597,influence,0,0
119598,outcomes,0,0
119599,and,0,1
119600,who,0,1
119601,may,0,0
119602,benefit,0,1
119603,most,0,0
119604,from,0,1
119605,these,0,0
119606,approaches,0,0
119607,.,0,1
119608,The,0,0
119609,current,0,0
119610,study,0,1
119611,sought,0,0
119612,to,0,0
119613,address,0,0
119614,these,0,0
119615,issues,0,0
119616,by,0,0
119617,examining,0,0
119618,how,0,0
119619,individual,0,0
119620,differences,0,0
119621,in,0,1
119622,alcohol,0,1
119623,consequences,0,0
119624,influence,0,0
119625,outcomes,0,0
119626,of,0,0
119627,a,0,1
119628,laboratory-based,0,0
119629,computerized,0,1
119630,intervention,0,1
119631,.,0,1
119632,METHODS,0,0
119633,One-hundred,1,1
119634,and,1,1
119635,nineteen,1,1
119636,introductory,1,1
119637,psychology,1,1
119638,students,1,1
119639,who,1,1
119640,either,1,1
119641,had,1,1
119642,two,1,0
119643,episodes,1,1
119644,of,1,1
119645,heavy,1,1
119646,episodic,1,1
119647,drinking,1,0
119648,in,1,0
119649,the,1,0
119650,past,1,1
119651,month,1,0
119652,or,1,1
119653,scored,1,0
119654,?8,1,0
119655,on,1,0
119656,the,1,1
119657,AUDIT,1,0
119658,participated,1,1
119659,in,1,0
119660,this,1,0
119661,randomized,1,1
119662,controlled,1,0
119663,trial,1,0
119664,for,1,0
119665,course,1,0
119666,credit,1,0
119667,.,1,1
119668,Participants,0,1
119669,were,0,1
119670,assigned,0,1
119671,to,0,1
119672,1,0,1
119673,of,0,1
119674,4,0,1
119675,conditions,0,1
119676,in,0,1
119677,this,0,1
119678,2,0,1
119679,Intervention,0,1
119680,(,0,1
119681,Alcohol,0,0
119682,Feedback,0,0
119683,vs.,0,0
119684,Control,0,1
119685,),0,1
119686,?2,0,0
119687,Assessment,0,0
119688,(,0,1
119689,Motivational,0,0
119690,Assessment,0,0
119691,vs.,0,0
119692,No,0,0
119693,Motivational,0,1
119694,Assessment,0,0
119695,),0,1
119696,between-subjects,0,0
119697,design,0,1
119698,.,0,1
119699,Quantity,0,0
119700,of,0,0
119701,alcohol,0,1
119702,consumed,0,1
119703,per,0,0
119704,week,0,0
119705,and,0,1
119706,heavy,0,1
119707,episodic,0,1
119708,drinking,0,1
119709,one,0,0
119710,month,0,0
119711,later,0,0
119712,were,0,0
119713,the,0,0
119714,primary,0,1
119715,dependent,0,1
119716,variables,0,0
119717,.,0,1
119718,RESULTS,0,0
119719,Controlling,0,0
119720,for,0,0
119721,corresponding,0,1
119722,baseline,0,0
119723,alcohol,0,1
119724,measures,0,0
119725,",",0,1
119726,hierarchical,0,1
119727,linear,0,0
119728,regression,0,0
119729,analyses,0,0
119730,showed,0,0
119731,a,0,1
119732,significant,0,0
119733,interaction,0,0
119734,between,0,0
119735,intervention,0,0
119736,condition,0,0
119737,and,0,0
119738,baseline,0,0
119739,alcohol-related,0,1
119740,consequences,0,0
119741,.,0,1
119742,For,0,1
119743,those,0,1
119744,who,0,1
119745,reported,0,1
119746,more,0,1
119747,alcohol,0,1
119748,consequences,0,0
119749,at,0,1
119750,baseline,0,0
119751,",",0,0
119752,the,0,0
119753,alcohol,0,0
119754,intervention,0,0
119755,resulted,0,0
119756,in,0,0
119757,significantly,0,0
119758,less,0,0
119759,alcohol,0,1
119760,use,0,0
119761,and,0,0
119762,fewer,0,0
119763,heavy,0,1
119764,drinking,0,0
119765,episodes,0,1
119766,at,0,1
119767,follow-up,0,0
119768,",",0,0
119769,while,0,0
119770,no,0,0
119771,difference,0,0
119772,was,0,0
119773,observed,0,0
119774,between,0,0
119775,intervention,0,1
119776,conditions,0,1
119777,for,0,0
119778,those,0,1
119779,with,0,1
119780,few,0,0
119781,baseline,0,1
119782,consequences,0,0
119783,.,0,1
119784,Assessment,0,0
119785,did,0,0
119786,not,0,0
119787,moderate,0,1
119788,intervention,0,0
119789,effects,0,0
119790,.,0,1
119791,DISCUSSION,0,0
119792,These,0,1
119793,findings,0,0
119794,suggest,0,0
119795,that,0,0
119796,a,0,1
119797,feedback-based,0,0
119798,computerized,0,1
119799,intervention,0,0
119800,that,0,0
119801,includes,0,0
119802,normative,0,0
119803,information,0,0
119804,about,0,0
119805,alcohol,0,1
119806,use,0,0
119807,and,0,0
119808,consequences,0,0
119809,may,0,0
119810,be,0,0
119811,more,0,0
119812,effective,0,0
119813,for,0,0
119814,hazardous,1,1
119815,drinking,1,1
119816,students,1,1
119817,who,1,1
119818,are,1,1
119819,experiencing,1,1
119820,higher,1,0
119821,levels,1,0
119822,of,1,1
119823,alcohol-related,1,1
119824,consequences,1,0
119825,.,1,1
119826,Intermittent,0,1
119827,theta-burst,0,0
119828,transcranial,0,0
119829,magnetic,0,0
119830,stimulation,0,0
119831,for,0,0
119832,treatment,0,0
119833,of,0,0
119834,Parkinson,1,1
119835,disease,1,1
119836,.,1,1
119837,OBJECTIVE,0,0
119838,To,0,0
119839,investigate,0,0
119840,the,0,0
119841,safety,0,0
119842,and,0,0
119843,efficacy,0,0
119844,of,0,0
119845,intermittent,0,1
119846,theta-burst,0,0
119847,stimulation,0,0
119848,(,0,1
119849,iTBS,0,1
119850,),0,1
119851,in,0,0
119852,the,0,0
119853,treatment,0,0
119854,of,0,0
119855,motor,0,0
119856,symptoms,0,1
119857,in,0,1
119858,Parkinson,0,1
119859,disease,0,1
119860,(,0,1
119861,PD,0,1
119862,),0,1
119863,.,0,1
119864,BACKGROUND,0,0
119865,Progression,0,1
119866,of,0,0
119867,PD,0,1
119868,is,0,0
119869,characterized,0,0
119870,by,0,0
119871,the,0,0
119872,emergence,0,1
119873,of,0,0
119874,motor,0,0
119875,deficits,0,0
119876,",",0,0
119877,which,0,0
119878,eventually,0,0
119879,respond,0,0
119880,less,0,0
119881,to,0,0
119882,dopaminergic,0,0
119883,therapy,0,0
119884,and,0,0
119885,pose,0,0
119886,a,0,0
119887,therapeutic,0,0
119888,challenge,0,0
119889,.,0,1
119890,Repetitive,0,0
119891,transcranial,0,0
119892,magnetic,0,1
119893,stimulation,0,0
119894,(,0,1
119895,rTMS,0,0
119896,),0,0
119897,has,0,0
119898,shown,0,0
119899,promising,0,0
119900,results,0,0
119901,in,0,1
119902,improving,0,0
119903,gait,0,0
119904,",",0,0
119905,a,0,0
119906,major,0,0
119907,cause,0,0
119908,of,0,0
119909,disability,0,1
119910,",",0,0
119911,and,0,0
119912,may,0,0
119913,provide,0,0
119914,a,0,0
119915,therapeutic,0,0
119916,alternative,0,0
119917,.,0,1
119918,iTBS,0,0
119919,is,0,0
119920,a,0,0
119921,novel,0,0
119922,type,0,1
119923,of,0,0
119924,rTMS,0,0
119925,that,0,0
119926,may,0,0
119927,be,0,0
119928,more,0,0
119929,efficacious,0,0
119930,than,0,0
119931,conventional,0,1
119932,rTMS,0,1
119933,.,0,1
119934,METHODS,0,0
119935,In,0,0
119936,this,0,0
119937,randomized,0,1
119938,",",0,0
119939,double-blind,0,0
119940,",",0,0
119941,sham-controlled,0,0
119942,study,0,0
119943,",",0,0
119944,we,0,0
119945,investigated,0,0
119946,safety,0,0
119947,and,0,0
119948,efficacy,0,0
119949,of,0,0
119950,iTBS,0,1
119951,of,0,0
119952,the,0,0
119953,motor,0,0
119954,and,0,0
119955,dorsolateral,0,0
119956,prefrontal,0,1
119957,cortices,0,1
119958,in,0,1
119959,8,0,1
119960,sessions,0,0
119961,over,0,1
119962,2,0,1
119963,weeks,0,1
119964,(,0,1
119965,evidence,0,0
119966,Class,0,1
119967,I,0,1
119968,),0,1
119969,.,0,1
119970,Assessment,0,0
119971,of,0,0
119972,safety,0,0
119973,and,0,1
119974,clinical,0,0
119975,efficacy,0,0
119976,over,0,0
119977,a,0,1
119978,1-month,0,0
119979,period,0,0
119980,included,0,1
119981,timed,0,0
119982,tests,0,0
119983,of,0,1
119984,gait,0,1
119985,and,0,0
119986,bradykinesia,0,0
119987,",",0,0
119988,Unified,0,0
119989,Parkinson,0,1
119990,'s,0,1
119991,Disease,0,1
119992,Rating,0,0
119993,Scale,0,1
119994,(,0,1
119995,UPDRS,0,1
119996,),0,1
119997,",",0,0
119998,and,0,0
119999,additional,0,0
120000,clinical,0,0
120001,",",0,0
120002,neuropsychological,0,0
120003,",",0,0
120004,and,0,1
120005,neurophysiologic,0,0
120006,measures,0,0
120007,.,0,1
120008,RESULTS,0,0
120009,We,0,0
120010,investigated,0,0
120011,26,1,1
120012,patients,1,1
120013,with,1,1
120014,mild,1,1
120015,to,1,1
120016,moderate,1,1
120017,PD,1,1
120018,:,1,1
120019,13,0,1
120020,received,0,1
120021,iTBS,0,1
120022,and,0,1
120023,13,0,1
120024,sham,0,0
120025,stimulation,0,0
120026,.,0,1
120027,We,0,0
120028,found,0,0
120029,beneficial,0,0
120030,effects,0,0
120031,of,0,1
120032,iTBS,0,1
120033,on,0,0
120034,mood,0,0
120035,",",0,0
120036,but,0,0
120037,no,0,0
120038,improvement,0,0
120039,of,0,0
120040,gait,0,0
120041,",",0,0
120042,bradykinesia,0,0
120043,",",0,0
120044,UPDRS,0,0
120045,",",0,0
120046,and,0,0
120047,other,0,1
120048,measures,0,0
120049,.,0,1
120050,EEG/EMG,0,1
120051,monitoring,0,0
120052,recorded,0,0
120053,no,0,0
120054,pathologic,0,0
120055,increase,0,0
120056,of,0,0
120057,cortical,0,1
120058,excitability,0,0
120059,or,0,1
120060,epileptic,0,1
120061,activity,0,0
120062,.,0,1
120063,Few,0,0
120064,reported,0,0
120065,discomfort,0,0
120066,or,0,1
120067,pain,0,1
120068,and,0,1
120069,one,0,1
120070,experienced,0,1
120071,tinnitus,0,1
120072,during,0,0
120073,real,0,0
120074,stimulation,0,0
120075,.,0,1
120076,CONCLUSION,0,0
120077,iTBS,0,1
120078,of,0,0
120079,the,0,0
120080,motor,0,0
120081,and,0,0
120082,prefrontal,0,0
120083,cortices,0,0
120084,appears,0,0
120085,safe,0,0
120086,and,0,0
120087,improves,0,0
120088,mood,0,0
120089,",",0,0
120090,but,0,0
120091,failed,0,0
120092,to,0,0
120093,improve,0,0
120094,motor,0,0
120095,performance,0,0
120096,and,0,0
120097,functional,0,0
120098,status,0,1
120099,in,0,1
120100,PD,0,1
120101,.,0,1
120102,CLASSIFICATION,0,0
120103,OF,0,1
120104,EVIDENCE,0,1
120105,This,0,0
120106,study,0,0
120107,provides,0,0
120108,Class,0,0
120109,I,0,0
120110,evidence,0,0
120111,that,0,0
120112,iTBS,0,1
120113,was,0,0
120114,not,0,0
120115,effective,0,0
120116,for,0,0
120117,gait,0,0
120118,",",0,0
120119,upper,0,1
120120,extremity,0,1
120121,bradykinesia,0,0
120122,",",0,0
120123,or,0,1
120124,other,0,0
120125,motor,0,0
120126,symptoms,0,1
120127,in,0,1
120128,PD,1,1
120129,.,1,1
120130,Effects,0,1
120131,of,0,1
120132,weight,0,1
120133,loss,0,0
120134,and,0,0
120135,exercise,0,0
120136,on,0,0
120137,insulin,1,0
120138,resistance,1,0
120139,",",0,0
120140,and,0,0
120141,intramyocellular,0,0
120142,triacylglycerol,0,0
120143,",",0,0
120144,diacylglycerol,0,0
120145,and,0,0
120146,ceramide,0,0
120147,.,0,1
120148,AIMS/HYPOTHESIS,0,0
120149,Intramyocellular,0,0
120150,lipids,0,0
120151,",",0,1
120152,including,0,0
120153,diacylglycerol,0,0
120154,(,0,1
120155,DAG,0,1
120156,),0,1
120157,and,0,1
120158,ceramides,0,0
120159,",",0,1
120160,have,0,0
120161,been,0,0
120162,linked,0,0
120163,to,0,0
120164,insulin,0,0
120165,resistance,0,0
120166,.,0,1
120167,This,0,0
120168,randomised,0,0
120169,repeated-measures,0,0
120170,study,0,1
120171,examined,0,0
120172,the,0,0
120173,effects,0,0
120174,of,0,0
120175,diet-induced,0,1
120176,weight,0,1
120177,loss,0,0
120178,(,0,1
120179,DIWL,0,1
120180,),0,1
120181,and,0,1
120182,aerobic,0,0
120183,exercise,0,1
120184,(,0,1
120185,EX,0,1
120186,),0,1
120187,on,0,0
120188,insulin,0,1
120189,sensitivity,0,0
120190,and,0,0
120191,intramyocellular,0,0
120192,triacylglycerol,0,0
120193,(,0,1
120194,IMTG,0,1
120195,),0,1
120196,",",0,0
120197,DAG,0,0
120198,and,0,0
120199,ceramide,0,0
120200,.,0,1
120201,METHODS,0,0
120202,Sixteen,1,1
120203,overweight,1,1
120204,to,1,0
120205,obese,1,1
120206,adults,1,1
120207,(,1,1
120208,BMI,1,1
120209,30.6,1,1
120210,?,1,1
120211,0.8,1,0
120212,;,1,1
120213,67.2,1,1
120214,?,1,1
120215,4.0,1,0
120216,years,1,1
120217,of,1,1
120218,age,1,1
120219,),1,1
120220,with,1,1
120221,either,1,1
120222,impaired,1,1
120223,fasting,1,0
120224,glucose,1,0
120225,",",1,0
120226,or,1,1
120227,impaired,1,1
120228,glucose,1,0
120229,tolerance,1,1
120230,completed,1,1
120231,one,1,1
120232,of,1,1
120233,two,1,1
120234,lifestyle,1,1
120235,interventions,1,1
120236,:,1,1
120237,DIWL,1,1
120238,(,1,1
120239,n,1,1
120240,=,1,1
120241,8,1,1
120242,),1,1
120243,or,1,1
120244,EX,1,1
120245,(,1,1
120246,n,1,1
120247,=,1,1
120248,8,1,1
120249,),1,1
120250,.,0,1
120251,Insulin,0,0
120252,sensitivity,0,0
120253,was,0,0
120254,determined,0,0
120255,using,0,0
120256,hyperinsulinaemic-euglycaemic,0,1
120257,clamps,0,1
120258,.,0,1
120259,Intramyocellular,0,0
120260,lipids,0,0
120261,were,0,1
120262,measured,0,0
120263,in,0,0
120264,muscle,0,1
120265,biopsies,0,1
120266,using,0,1
120267,histochemistry,0,1
120268,and,0,1
120269,tandem,0,0
120270,mass,0,1
120271,spectrometry,0,1
120272,.,0,1
120273,RESULTS,0,0
120274,Insulin,0,0
120275,sensitivity,0,0
120276,was,0,0
120277,improved,0,0
120278,with,0,1
120279,DIWL,0,1
120280,(,0,1
120281,20.6,0,1
120282,?,0,1
120283,4.7,0,0
120284,%,0,0
120285,),0,1
120286,and,0,1
120287,EX,0,1
120288,(,0,1
120289,19.2,0,0
120290,?,0,1
120291,12.9,0,0
120292,%,0,0
120293,),0,1
120294,.,0,1
120295,Body,0,1
120296,weight,0,0
120297,and,0,1
120298,body,0,1
120299,fat,0,0
120300,were,0,1
120301,decreased,0,0
120302,by,0,0
120303,both,0,0
120304,interventions,0,0
120305,",",0,0
120306,with,0,1
120307,greater,0,0
120308,decreases,0,0
120309,in,0,1
120310,DIWL,0,1
120311,compared,0,0
120312,with,0,1
120313,EX,0,1
120314,.,0,1
120315,Muscle,0,0
120316,glycogen,0,0
120317,",",0,0
120318,IMTG,0,1
120319,content,0,0
120320,and,0,1
120321,oxidative,0,0
120322,capacity,0,0
120323,were,0,0
120324,all,0,0
120325,significantly,0,0
120326,(,0,0
120327,p,0,0
120328,<,0,0
120329,0.05,0,0
120330,),0,1
120331,decreased,0,0
120332,with,0,1
120333,DIWL,0,1
120334,and,0,1
120335,increased,0,0
120336,with,0,1
120337,EX,0,0
120338,.,0,1
120339,There,0,0
120340,were,0,0
120341,decreases,0,0
120342,in,0,1
120343,DAG,0,1
120344,with,0,1
120345,DIWL,0,1
120346,(,0,1
120347,-12.4,0,0
120348,?,0,1
120349,14.6,0,0
120350,%,0,0
120351,),0,1
120352,and,0,1
120353,EX,0,1
120354,(,0,1
120355,-40.9,0,0
120356,?,0,1
120357,12.0,0,0
120358,%,0,0
120359,),0,1
120360,.,0,1
120361,Ceramide,0,0
120362,decreased,0,0
120363,with,0,1
120364,EX,0,1
120365,(,0,1
120366,-33.7,0,0
120367,?,0,1
120368,11.2,0,0
120369,%,0,0
120370,),0,1
120371,",",0,0
120372,but,0,0
120373,not,0,0
120374,with,0,1
120375,DIWL,0,0
120376,.,0,1
120377,Dihydroceramide,0,0
120378,was,0,0
120379,decreased,0,0
120380,with,0,1
120381,both,0,0
120382,interventions,0,0
120383,.,0,1
120384,Sphingosine,0,0
120385,was,0,0
120386,decreased,0,0
120387,only,0,0
120388,with,0,1
120389,EX,0,1
120390,.,0,1
120391,Changes,0,0
120392,in,0,0
120393,total,0,1
120394,DAG,0,1
120395,",",0,1
120396,total,0,1
120397,ceramides,0,0
120398,and,0,1
120399,other,0,1
120400,sphingolipids,0,0
120401,did,0,0
120402,not,0,0
120403,correlate,0,0
120404,with,0,1
120405,changes,0,0
120406,in,0,1
120407,glucose,0,1
120408,disposal,0,1
120409,.,0,0
120410,Stearoyl-coenzyme,0,0
120411,A,0,0
120412,desaturase,0,0
120413,1,0,0
120414,(,0,1
120415,SCD1,0,1
120416,),0,1
120417,content,0,0
120418,was,0,0
120419,decreased,0,0
120420,with,0,1
120421,DIWL,0,1
120422,(,0,1
120423,-19.5,0,0
120424,?,0,1
120425,8.5,0,0
120426,%,0,0
120427,",",0,0
120428,p,0,0
120429,<,0,0
120430,0.05,0,0
120431,),0,1
120432,",",0,0
120433,but,0,0
120434,increased,0,0
120435,with,0,1
120436,EX,0,1
120437,(,0,1
120438,19.6,0,1
120439,?,0,1
120440,7.4,0,0
120441,%,0,0
120442,",",0,0
120443,p,0,0
120444,<,0,0
120445,0.05,0,0
120446,),0,1
120447,.,0,1
120448,Diacylglycerol,0,0
120449,acyltransferase,0,0
120450,1,0,1
120451,(,0,1
120452,DGAT1,0,1
120453,),0,1
120454,was,0,0
120455,unchanged,0,0
120456,with,0,1
120457,the,0,1
120458,interventions,0,0
120459,.,0,1
120460,CONCLUSIONS/INTERPRETATION,0,0
120461,Diet-induced,0,0
120462,weight,0,1
120463,loss,0,0
120464,and,0,0
120465,exercise,0,0
120466,training,0,0
120467,both,0,0
120468,improved,0,0
120469,insulin,0,0
120470,resistance,0,0
120471,and,0,0
120472,decreased,0,0
120473,DAG,0,0
120474,",",0,0
120475,while,0,0
120476,only,0,0
120477,exercise,0,1
120478,decreased,0,0
120479,ceramides,0,0
120480,",",0,0
120481,despite,0,0
120482,the,0,0
120483,interventions,0,0
120484,having,0,1
120485,different,0,1
120486,effects,0,0
120487,on,0,1
120488,IMTG,0,1
120489,.,0,1
120490,These,0,0
120491,alterations,0,0
120492,may,0,0
120493,be,0,0
120494,mediated,0,0
120495,through,0,1
120496,differential,0,1
120497,changes,0,0
120498,in,0,1
120499,skeletal,0,1
120500,muscle,0,0
120501,capacity,0,0
120502,for,0,0
120503,oxidation,0,0
120504,and,0,1
120505,triacylglycerol,0,0
120506,synthesis,0,0
120507,.,0,1
120508,TRIAL,0,0
120509,REGISTRATION,0,0
120510,ClinicalTrials.gov,0,1
120511,NCT00766298,0,1
120512,.,0,1
120513,Quitting,0,1
120514,a,0,1
120515,weight,0,1
120516,loss,0,0
120517,program,0,1
120518,is,0,0
120519,associated,0,0
120520,with,0,1
120521,anhedonia,1,1
120522,:,1,1
120523,preliminary,1,0
120524,findings,1,0
120525,of,1,1
120526,the,1,1
120527,Lifestyle,1,1
120528,Intervention,1,1
120529,Treatment,1,0
120530,Evaluation,1,0
120531,Study,1,1
120532,in,1,1
120533,northern,1,1
120534,Finland,1,1
120535,.,1,1
120536,OBJECTIVES,0,0
120537,To,0,0
120538,examine,0,0
120539,whether,0,0
120540,a,0,0
120541,diagnosis,0,1
120542,for,0,0
120543,major,1,1
120544,depression,1,1
120545,",",1,0
120546,chronic,1,1
120547,depression,1,1
120548,or,1,1
120549,specific,1,0
120550,symptoms,1,1
120551,of,1,0
120552,depression,1,1
120553,is,0,0
120554,associated,0,0
120555,with,0,0
120556,the,0,0
120557,risk,0,0
120558,of,0,0
120559,quitting,0,1
120560,a,0,1
120561,weight,0,1
120562,loss,0,0
120563,program,0,1
120564,.,0,1
120565,STUDY,0,0
120566,DESIGN,0,0
120567,The,0,0
120568,study,0,0
120569,involved,0,0
120570,82,1,1
120571,overweight,1,1
120572,adults,1,1
120573,participating,1,1
120574,in,1,1
120575,the,1,0
120576,Lifestyle,1,1
120577,Intervention,1,1
120578,Treatment,1,0
120579,Evaluation,1,0
120580,(,1,1
120581,LITE,1,0
120582,),1,1
120583,follow-up,1,0
120584,study,1,1
120585,at,1,1
120586,Oulu,1,1
120587,University,1,1
120588,Hospital,1,1
120589,in,1,1
120590,northern,1,1
120591,Finland,1,1
120592,.,1,1
120593,METHODS,0,0
120594,Psychiatric,0,1
120595,diagnostic,0,1
120596,assessments,0,0
120597,were,0,1
120598,based,0,1
120599,on,0,0
120600,the,0,0
120601,Structured,0,0
120602,Clinical,0,0
120603,Interview,0,1
120604,for,0,1
120605,DSMIV,0,1
120606,disorders,0,1
120607,(,0,1
120608,SCID-I,0,1
120609,),0,1
120610,conducted,0,1
120611,by,0,0
120612,a,0,1
120613,clinical,0,0
120614,psychiatrist,0,1
120615,.,0,1
120616,Anhedonia,0,0
120617,(,0,0
120618,lack,0,0
120619,of,0,0
120620,pleasure,0,0
120621,),0,1
120622,was,0,0
120623,assessed,0,0
120624,as,0,0
120625,one,0,1
120626,of,0,0
120627,the,0,0
120628,core,0,1
120629,symptoms,0,0
120630,of,0,1
120631,major,0,1
120632,depression,0,1
120633,and,0,1
120634,chronic,0,1
120635,depression,0,1
120636,(,0,1
120637,dysthymia,0,1
120638,),0,1
120639,.,0,1
120640,Anhedonia,0,0
120641,was,0,0
120642,defined,0,0
120643,to,0,0
120644,be,0,0
120645,present,0,0
120646,if,0,0
120647,the,0,1
120648,participants,0,1
120649,reported,0,1
120650,having,0,1
120651,suffered,0,1
120652,a,0,1
120653,major,0,0
120654,loss,0,0
120655,of,0,0
120656,interest,0,0
120657,during,0,0
120658,the,0,0
120659,previous,0,1
120660,month,0,0
120661,.,0,1
120662,RESULTS,0,0
120663,Twenty,0,1
120664,participants,0,1
120665,(,0,1
120666,24.4,0,1
120667,%,0,0
120668,),0,1
120669,quit,0,1
120670,during,0,0
120671,the,0,0
120672,6-month,0,0
120673,intervention,0,0
120674,period,0,1
120675,.,0,1
120676,Anhedonia,0,0
120677,put,0,0
120678,individuals,0,1
120679,at,0,1
120680,risk,0,1
120681,of,0,0
120682,quitting,0,1
120683,the,0,0
120684,weight,0,1
120685,loss,0,0
120686,program,0,1
120687,(,0,1
120688,bivariate,0,0
120689,analysis,0,0
120690,OR,0,0
120691,3.1,0,0
120692,",",0,1
120693,95,0,0
120694,%,0,0
120695,CI,0,0
120696,0.8-11.6,0,0
120697,",",0,0
120698,p=0.091,0,0
120699,",",0,0
120700,multivariate,0,0
120701,analysis,0,0
120702,OR,0,0
120703,6.5,0,0
120704,",",0,1
120705,95,0,0
120706,%,0,0
120707,CI,0,0
120708,1.1-38.2,0,0
120709,",",0,0
120710,p=0.038,0,0
120711,),0,0
120712,.,0,1
120713,However,0,0
120714,",",0,0
120715,a,0,0
120716,diagnosis,0,1
120717,for,0,0
120718,major,0,1
120719,depression,0,1
120720,or,0,1
120721,chronic,0,1
120722,depression,0,1
120723,did,0,0
120724,not,0,0
120725,predict,0,0
120726,quitting,0,1
120727,.,0,1
120728,CONCLUSIONS,0,0
120729,Individual,0,0
120730,assessments,0,0
120731,of,0,1
120732,obesity,0,1
120733,and,0,0
120734,overweight,0,1
120735,should,0,0
120736,also,0,0
120737,include,0,0
120738,an,0,0
120739,assessment,0,0
120740,for,0,0
120741,subthreshold,0,0
120742,depression,0,1
120743,",",0,0
120744,mainly,0,0
120745,anhedonia,0,1
120746,.,0,1
120747,Distinct,0,1
120748,fast,0,0
120749,and,0,0
120750,slow,0,0
120751,processes,0,0
120752,contribute,0,0
120753,to,0,0
120754,the,0,0
120755,selection,0,0
120756,of,0,0
120757,preferred,1,0
120758,step,1,0
120759,frequency,1,0
120760,during,1,0
120761,human,1,1
120762,walking,1,0
120763,.,1,1
120764,Humans,0,0
120765,spontaneously,0,1
120766,select,0,1
120767,a,0,0
120768,step,0,0
120769,frequency,0,0
120770,that,0,0
120771,minimizes,0,0
120772,the,0,0
120773,energy,0,0
120774,expenditure,0,0
120775,of,0,0
120776,walking,0,0
120777,.,0,1
120778,This,0,0
120779,selection,0,0
120780,might,0,0
120781,be,0,0
120782,embedded,0,0
120783,within,0,0
120784,the,0,0
120785,neural,0,0
120786,circuits,0,0
120787,that,0,0
120788,generate,0,0
120789,gait,0,0
120790,so,0,0
120791,that,0,0
120792,the,0,0
120793,optimum,0,0
120794,is,0,0
120795,pre-programmed,0,0
120796,for,0,0
120797,a,0,1
120798,given,0,0
120799,walking,0,0
120800,speed,0,0
120801,.,0,1
120802,Or,0,0
120803,perhaps,0,0
120804,step,0,0
120805,frequency,0,0
120806,is,0,0
120807,directly,0,0
120808,optimized,0,0
120809,",",0,0
120810,based,0,1
120811,on,0,0
120812,sensed,0,0
120813,feedback,0,0
120814,of,0,0
120815,energy,0,0
120816,expenditure,0,0
120817,.,0,1
120818,Direct,0,0
120819,optimization,0,0
120820,is,0,0
120821,expected,0,0
120822,to,0,0
120823,be,0,0
120824,slow,0,0
120825,due,0,0
120826,to,0,1
120827,the,0,0
120828,compounded,0,0
120829,effect,0,0
120830,of,0,1
120831,delays,0,0
120832,and,0,1
120833,iteration,0,0
120834,",",0,0
120835,whereas,0,0
120836,a,0,0
120837,pre-programmed,0,0
120838,mechanism,0,0
120839,presumably,0,0
120840,allows,0,0
120841,for,0,0
120842,faster,0,0
120843,step,0,0
120844,frequency,0,0
120845,selection,0,0
120846,",",0,0
120847,albeit,0,0
120848,dependent,0,0
120849,on,0,0
120850,prior,0,1
120851,experience,0,1
120852,.,0,1
120853,To,0,0
120854,test,0,0
120855,for,0,0
120856,both,0,0
120857,pre-programmed,0,0
120858,selection,0,0
120859,and,0,1
120860,direct,0,0
120861,optimization,0,0
120862,",",0,0
120863,we,0,0
120864,applied,0,0
120865,perturbations,0,0
120866,to,0,1
120867,treadmill,1,0
120868,walking,1,0
120869,to,0,0
120870,elicit,0,0
120871,transient,0,0
120872,changes,0,0
120873,in,0,1
120874,step,0,0
120875,frequency,0,0
120876,.,0,1
120877,We,0,0
120878,found,0,0
120879,that,0,0
120880,human,1,1
120881,step,1,0
120882,frequency,1,0
120883,adjustments,1,0
120884,(,1,1
120885,n,1,1
120886,=,1,1
120887,7,1,1
120888,),1,1
120889,occurred,0,0
120890,with,0,1
120891,two,0,1
120892,components,0,0
120893,",",0,1
120894,the,0,0
120895,first,0,0
120896,dominating,0,0
120897,the,0,0
120898,response,0,0
120899,(,0,1
120900,66,0,1
120901,?,0,1
120902,10,0,0
120903,%,0,0
120904,of,0,1
120905,total,0,1
120906,amplitude,0,0
120907,change,0,0
120908,;,0,1
120909,mean,0,1
120910,?,0,1
120911,SD,0,0
120912,),0,0
120913,and,0,0
120914,occurring,0,0
120915,quite,0,0
120916,quickly,0,0
120917,(,0,0
120918,1.44,0,0
120919,?,0,1
120920,1.14,0,0
120921,s,0,0
120922,to,0,1
120923,complete,0,1
120924,95,0,0
120925,%,0,0
120926,of,0,0
120927,total,0,1
120928,change,0,0
120929,),0,1
120930,.,0,1
120931,The,0,0
120932,other,0,0
120933,component,0,0
120934,was,0,0
120935,of,0,0
120936,smaller,0,0
120937,amplitude,0,0
120938,(,0,1
120939,35,0,1
120940,?,0,1
120941,10,0,0
120942,%,0,0
120943,of,0,0
120944,total,0,1
120945,change,0,0
120946,),0,1
120947,and,0,1
120948,took,0,1
120949,tens,0,0
120950,of,0,1
120951,seconds,0,1
120952,(,0,1
120953,27.56,0,1
120954,?,0,1
120955,16.18,0,0
120956,s,0,0
120957,for,0,1
120958,95,0,0
120959,%,0,0
120960,completion,0,0
120961,),0,1
120962,.,0,1
120963,The,0,0
120964,fast,0,0
120965,process,0,0
120966,appeared,0,0
120967,to,0,0
120968,be,0,0
120969,too,0,0
120970,fast,0,0
120971,for,0,0
120972,direct,0,1
120973,optimization,0,0
120974,and,0,0
120975,more,0,0
120976,indicative,0,0
120977,of,0,0
120978,a,0,1
120979,pre-programmed,0,0
120980,response,0,0
120981,.,0,1
120982,It,0,0
120983,also,0,0
120984,persisted,0,0
120985,even,0,0
120986,with,0,1
120987,unusual,0,0
120988,closed-loop,0,1
120989,perturbations,0,1
120990,that,0,0
120991,conflicted,0,0
120992,with,0,1
120993,prior,0,1
120994,experience,0,1
120995,and,0,0
120996,rendered,0,1
120997,the,0,0
120998,response,0,0
120999,energetically,0,0
121000,suboptimal,0,0
121001,.,0,1
121002,The,0,0
121003,slow,0,0
121004,process,0,0
121005,was,0,0
121006,more,0,0
121007,consistent,0,0
121008,with,0,0
121009,the,0,0
121010,timing,0,0
121011,expected,0,0
121012,for,0,0
121013,direct,0,1
121014,optimization,0,0
121015,.,0,1
121016,Our,0,0
121017,interpretation,0,0
121018,of,0,0
121019,these,0,0
121020,results,0,0
121021,is,0,0
121022,that,0,0
121023,humans,1,0
121024,may,1,0
121025,rely,0,0
121026,heavily,0,0
121027,on,0,0
121028,pre-programmed,0,0
121029,gaits,0,1
121030,to,0,1
121031,rapidly,0,1
121032,select,0,0
121033,their,0,0
121034,preferred,0,0
121035,step,0,0
121036,frequency,0,0
121037,and,0,0
121038,then,0,0
121039,gradually,0,0
121040,fine-tune,0,0
121041,that,0,0
121042,selection,0,1
121043,with,0,1
121044,direct,0,1
121045,optimization,0,0
121046,.,0,1
121047,Sequential,0,1
121048,alternate,0,0
121049,administration,0,0
121050,of,0,0
121051,tamoxifen,0,1
121052,and,0,1
121053,medroxyprogesterone,0,0
121054,acetate,0,0
121055,in,0,0
121056,advanced,1,1
121057,breast,1,1
121058,cancer,1,1
121059,:,1,1
121060,clinical-biological,0,1
121061,randomized,0,1
121062,study,0,1
121063,.,0,1
121064,From,1,1
121065,January,1,1
121066,1985,1,1
121067,to,1,1
121068,September,1,1
121069,1988,1,1
121070,",",1,1
121071,60,1,1
121072,women,1,1
121073,with,1,1
121074,advanced,1,1
121075,breast,1,1
121076,cancer,1,1
121077,were,1,0
121078,randomized,1,1
121079,in,1,1
121080,two,1,1
121081,arms,1,1
121082,to,0,1
121083,receive,0,1
121084,:,0,1
121085,A,0,1
121086,),0,0
121087,tamoxifen,0,1
121088,(,0,1
121089,TAM,0,1
121090,),0,1
121091,(,0,1
121092,20,0,1
121093,mg/die,0,0
121094,),0,1
121095,until,0,1
121096,progression,0,0
121097,or,0,1
121098,B,0,1
121099,),0,1
121100,TAM,0,1
121101,(,0,1
121102,20,0,1
121103,mg/die,0,0
121104,for,0,1
121105,14,0,1
121106,days,0,0
121107,),0,1
121108,then,0,0
121109,medroxyprogesterone,0,0
121110,acetate,0,0
121111,(,0,1
121112,MPA,0,1
121113,),0,1
121114,(,0,1
121115,1500,0,1
121116,mg/die,0,0
121117,p.o,0,1
121118,.,0,1
121119,for,0,0
121120,14,0,1
121121,days,0,1
121122,),0,1
121123,followed,0,1
121124,by,0,1
121125,7,0,1
121126,days,0,0
121127,of,0,1
121128,wash-out,0,0
121129,before,0,0
121130,repeating,0,0
121131,the,0,0
121132,TAM/MPA,0,1
121133,treatment,0,0
121134,.,0,1
121135,All,1,1
121136,patients,1,1
121137,were,1,1
121138,post-menopausal,1,1
121139,",",1,0
121140,previously,1,1
121141,untreated,1,1
121142,with,1,1
121143,hormone,1,1
121144,therapy,1,0
121145,",",1,0
121146,and,1,0
121147,with,1,1
121148,tumor,1,1
121149,receptor,1,0
121150,status,1,1
121151,determined,1,0
121152,immediately,1,0
121153,before,1,0
121154,randomization,1,0
121155,;,1,1
121156,all,1,0
121157,had,1,0
121158,objectively,1,0
121159,evaluable,1,1
121160,lesions,1,1
121161,.,1,1
121162,In,0,0
121163,order,0,0
121164,to,0,0
121165,verify,0,0
121166,hormone,0,1
121167,receptor,0,0
121168,variations,0,0
121169,due,0,1
121170,to,0,1
121171,the,0,0
121172,antiestrogen,0,0
121173,",",0,0
121174,when,0,0
121175,possible,0,0
121176,a,0,0
121177,second,0,1
121178,biopsy,0,1
121179,was,0,0
121180,performed,0,0
121181,after,0,0
121182,the,0,0
121183,initial,0,1
121184,14,0,1
121185,day,0,0
121186,cycle,0,0
121187,of,0,0
121188,TAM,0,1
121189,.,0,1
121190,Thirty-one,1,1
121191,and,1,0
121192,29,1,1
121193,patients,1,1
121194,were,1,1
121195,included,1,1
121196,respectively,1,0
121197,in,1,0
121198,arms,1,1
121199,A,1,1
121200,and,1,1
121201,B,1,1
121202,.,1,1
121203,Objective,0,0
121204,regression,0,0
121205,(,0,1
121206,CR,0,1
121207,+,0,0
121208,PR,0,0
121209,),0,1
121210,was,0,0
121211,observed,0,0
121212,in,0,1
121213,58,0,1
121214,%,0,0
121215,of,0,0
121216,group,0,1
121217,A,0,1
121218,and,0,1
121219,75,0,1
121220,%,0,0
121221,of,0,0
121222,group,0,1
121223,B,0,1
121224,",",0,0
121225,with,0,1
121226,CR,0,1
121227,in,0,1
121228,11,0,1
121229,%,0,0
121230,and,0,1
121231,23,0,1
121232,%,0,0
121233,",",0,0
121234,respectively,0,0
121235,.,0,1
121236,Differences,0,0
121237,were,0,0
121238,not,0,0
121239,statistically,0,0
121240,significant,0,0
121241,.,0,1
121242,Median,0,0
121243,time,0,0
121244,to,0,1
121245,progression,0,0
121246,was,0,0
121247,12,0,1
121248,months,0,0
121249,for,0,1
121250,group,0,1
121251,A,0,1
121252,and,0,1
121253,9,0,0
121254,for,0,0
121255,group,0,1
121256,B,0,1
121257,.,0,1
121258,Overall,0,0
121259,survival,0,0
121260,has,0,0
121261,not,0,0
121262,yet,0,0
121263,been,0,0
121264,reached,0,0
121265,in,0,0
121266,group,0,1
121267,A,0,1
121268,while,0,0
121269,it,0,0
121270,was,0,0
121271,34,0,1
121272,months,0,1
121273,for,0,1
121274,patients,0,1
121275,of,0,1
121276,group,0,1
121277,B.,0,1
121278,Metrorrhagia,0,1
121279,was,0,0
121280,observed,0,0
121281,in,0,1
121282,two,0,1
121283,cases,0,1
121284,of,0,1
121285,group,0,1
121286,A,0,1
121287,and,0,1
121288,in,0,0
121289,6,0,0
121290,of,0,1
121291,group,0,1
121292,B,0,1
121293,",",0,0
121294,and,0,0
121295,thrombophlebitis,0,1
121296,in,0,1
121297,1,0,1
121298,and,0,1
121299,3,0,1
121300,cases,0,1
121301,",",0,1
121302,respectively,0,0
121303,.,0,0
121304,The,0,0
121305,second,0,0
121306,biopsy,0,1
121307,confirmed,0,0
121308,a,0,0
121309,clear,0,0
121310,increase,0,0
121311,of,0,0
121312,PgR,0,1
121313,content,0,0
121314,in,0,1
121315,8/11,0,1
121316,cases,0,1
121317,(,0,1
121318,75,0,1
121319,%,0,0
121320,),0,1
121321,.,0,1
121322,Plasma,0,1
121323,level,0,0
121324,variations,0,0
121325,of,0,1
121326,TAM,0,1
121327,",",0,1
121328,N-desmethyl,0,0
121329,TAM,0,1
121330,and,0,1
121331,MPA,0,1
121332,were,0,1
121333,checked,0,0
121334,at,0,1
121335,various,0,0
121336,intervals,0,0
121337,on,0,1
121338,3,0,1
121339,patients,0,1
121340,of,0,1
121341,group,0,1
121342,B,0,1
121343,",",0,0
121344,and,0,0
121345,confirmed,0,0
121346,that,0,0
121347,our,0,0
121348,schedule,0,0
121349,is,0,0
121350,able,0,0
121351,to,0,0
121352,produce,0,0
121353,a,0,0
121354,drug,0,0
121355,wash-out,0,0
121356,period,0,0
121357,for,0,0
121358,tumor,0,1
121359,cells,0,0
121360,.,0,1
121361,In,0,0
121362,conclusion,0,0
121363,",",0,0
121364,our,0,0
121365,study,0,0
121366,demonstrated,0,0
121367,that,0,0
121368,while,0,0
121369,the,0,0
121370,manipulation,0,0
121371,of,0,0
121372,hormone,0,1
121373,receptors,0,0
121374,seems,0,0
121375,possible,0,0
121376,",",0,0
121377,results,0,0
121378,indicating,0,0
121379,better,0,0
121380,overall,0,0
121381,survival,0,0
121382,and,0,1
121383,time,0,0
121384,to,0,0
121385,progression,0,0
121386,were,0,0
121387,not,0,0
121388,obtained,0,0
121389,with,0,1
121390,alternate,0,0
121391,sequential,0,0
121392,TAM-MPA,0,1
121393,therapy,0,1
121394,.,0,1
121395,An,0,0
121396,interactive,1,0
121397,computer,1,0
121398,program,1,1
121399,can,0,0
121400,effectively,0,0
121401,educate,0,0
121402,potential,1,0
121403,users,1,1
121404,of,1,1
121405,cystic,1,1
121406,fibrosis,1,1
121407,carrier,1,1
121408,tests,1,0
121409,.,1,1
121410,The,0,0
121411,demand,0,0
121412,for,0,0
121413,cystic,0,1
121414,fibrosis,0,1
121415,(,0,1
121416,CF,0,1
121417,),0,1
121418,carrier,0,0
121419,testing,0,0
121420,is,0,0
121421,steadily,0,0
121422,growing,0,0
121423,",",0,0
121424,not,0,0
121425,only,0,0
121426,from,0,0
121427,individuals,1,1
121428,with,1,1
121429,raised,1,0
121430,a,1,1
121431,priori,1,0
121432,carrier,1,0
121433,risk,1,0
121434,",",0,0
121435,but,0,0
121436,also,0,0
121437,from,0,0
121438,the,0,0
121439,general,0,1
121440,population,0,1
121441,.,0,1
121442,This,0,0
121443,trend,0,0
121444,will,0,0
121445,likely,0,0
121446,exceed,0,0
121447,the,0,0
121448,availability,0,0
121449,of,0,0
121450,genetic,0,1
121451,counselors,0,1
121452,",",0,1
121453,making,0,0
121454,it,0,0
121455,impossible,0,0
121456,to,0,0
121457,provide,0,0
121458,standard,0,1
121459,face-to-face,0,0
121460,genetic,0,1
121461,counseling,0,1
121462,to,0,0
121463,all,0,0
121464,those,0,0
121465,asking,0,0
121466,for,0,0
121467,the,0,0
121468,test,0,0
121469,.,0,1
121470,In,0,0
121471,order,0,0
121472,to,0,0
121473,reduce,0,0
121474,the,0,0
121475,time,0,0
121476,needed,0,0
121477,to,0,0
121478,educate,0,0
121479,individuals,0,1
121480,on,0,0
121481,the,0,1
121482,basics,0,0
121483,of,0,0
121484,the,0,0
121485,disease,0,1
121486,",",0,0
121487,its,0,0
121488,genetic,0,0
121489,transmission,0,1
121490,",",0,0
121491,and,0,0
121492,carrier,0,0
121493,testing,0,0
121494,peculiarities,0,1
121495,",",0,1
121496,we,0,0
121497,developed,0,0
121498,an,0,0
121499,educational,0,1
121500,method,0,0
121501,based,0,1
121502,on,0,0
121503,an,0,0
121504,interactive,0,0
121505,computer,0,0
121506,program,0,1
121507,(,0,1
121508,IC,0,1
121509,),0,1
121510,.,0,1
121511,To,0,0
121512,assess,0,0
121513,the,0,0
121514,effectiveness,0,0
121515,of,0,0
121516,this,0,0
121517,program,0,1
121518,and,0,0
121519,to,0,0
121520,compare,0,0
121521,it,0,0
121522,to,0,0
121523,a,0,1
121524,classical,0,1
121525,genetic,0,0
121526,counseling,0,1
121527,session,0,0
121528,",",0,0
121529,we,0,0
121530,conducted,0,0
121531,a,0,0
121532,comparative,0,0
121533,trial,0,0
121534,.,0,1
121535,In,0,0
121536,a,0,0
121537,population,0,1
121538,setting,0,1
121539,of,0,1
121540,people,0,1
121541,undergoing,0,1
121542,assisted,0,1
121543,reproduction,0,1
121544,",",0,1
121545,44,1,1
121546,individuals,1,1
121547,were,0,1
121548,randomly,0,1
121549,assigned,0,1
121550,to,0,0
121551,either,0,0
121552,receiving,0,1
121553,standard,0,1
121554,one-on-one,0,1
121555,genetic,0,1
121556,counseling,0,1
121557,or,0,1
121558,education,0,0
121559,by,0,0
121560,the,0,0
121561,IC,0,0
121562,program,0,1
121563,.,0,1
121564,We,0,0
121565,measured,0,0
121566,pre-,0,0
121567,and,0,0
121568,post-intervention,0,0
121569,knowledge,0,0
121570,about,0,0
121571,CF,0,1
121572,genetic,0,1
121573,transmission,0,1
121574,and,0,0
121575,carrier,0,0
121576,testing,0,0
121577,.,0,1
121578,Starting,0,0
121579,from,0,0
121580,an,0,1
121581,equivalent,0,0
121582,baseline,0,0
121583,of,0,1
121584,correct,0,0
121585,answers,0,0
121586,to,0,1
121587,a,0,1
121588,specially,0,0
121589,designed,0,0
121590,multiple-choice,0,0
121591,questionnaire,0,0
121592,(,0,1
121593,47,0,1
121594,%,0,0
121595,in,0,0
121596,the,0,0
121597,counselor,0,1
121598,group,0,1
121599,and,0,1
121600,45,0,1
121601,%,0,0
121602,in,0,0
121603,the,0,0
121604,computer,0,0
121605,group,0,0
121606,),0,1
121607,both,0,0
121608,groups,0,0
121609,showed,0,0
121610,a,0,1
121611,highly,0,0
121612,significant,0,0
121613,and,0,0
121614,similar,0,0
121615,increase,0,0
121616,(,0,1
121617,reaching,0,0
121618,84,0,1
121619,%,0,0
121620,in,0,0
121621,the,0,0
121622,counselor,0,1
121623,group,0,1
121624,and,0,1
121625,85,0,1
121626,%,0,0
121627,in,0,0
121628,the,0,0
121629,computer,0,0
121630,group,0,1
121631,),0,1
121632,.,0,1
121633,The,0,0
121634,computer,0,0
121635,program,0,0
121636,under,0,0
121637,evaluation,0,0
121638,can,0,0
121639,successfully,0,0
121640,educate,0,0
121641,individuals,0,1
121642,considering,0,0
121643,genetic,0,1
121644,testing,0,1
121645,for,0,1
121646,CF,0,1
121647,.,0,1
121648,A,0,1
121649,randomized,0,1
121650,controlled,0,0
121651,trial,0,1
121652,of,0,1
121653,Hanen,0,0
121654,'s,0,1
121655,'More,0,1
121656,Than,0,1
121657,Words,0,0
121658,',0,1
121659,in,0,1
121660,toddlers,1,1
121661,with,1,1
121662,early,1,1
121663,autism,1,1
121664,symptoms,1,1
121665,.,1,1
121666,BACKGROUND,0,0
121667,This,0,0
121668,randomized,0,1
121669,controlled,0,0
121670,trial,0,1
121671,compared,0,0
121672,Hanen,0,0
121673,'s,0,1
121674,'More,0,1
121675,than,0,1
121676,Words,0,1
121677,',0,1
121678,(,0,1
121679,HMTW,0,0
121680,),0,1
121681,",",0,0
121682,a,0,0
121683,parent-implemented,0,0
121684,intervention,0,0
121685,",",0,0
121686,to,0,0
121687,a,0,0
121688,'business,0,0
121689,as,0,0
121690,usual,0,1
121691,',0,1
121692,control,0,1
121693,group,0,1
121694,.,0,1
121695,METHODS,0,0
121696,Sixty-two,1,1
121697,children,1,1
121698,(,1,1
121699,51,1,1
121700,boys,1,1
121701,and,1,1
121702,11,1,1
121703,girls,1,1
121704,;,1,1
121705,M,1,1
121706,age,1,1
121707,=,1,1
121708,20,1,1
121709,months,1,1
121710,;,1,1
121711,SD,1,1
121712,=,1,1
121713,2.6,1,1
121714,),1,1
121715,who,1,1
121716,met,1,1
121717,criteria,1,1
121718,for,1,1
121719,autism,1,1
121720,spectrum,1,1
121721,disorders,1,1
121722,(,1,1
121723,ASD,1,1
121724,),1,1
121725,and,1,1
121726,their,1,1
121727,parents,1,1
121728,participated,1,1
121729,in,1,0
121730,the,1,0
121731,study,1,0
121732,.,1,0
121733,The,0,0
121734,HMTW,0,0
121735,intervention,0,0
121736,was,0,0
121737,provided,0,0
121738,over,0,0
121739,3.5,0,1
121740,months,0,0
121741,.,0,1
121742,There,0,0
121743,were,0,0
121744,three,0,0
121745,measurement,0,0
121746,periods,0,0
121747,:,0,1
121748,prior,0,1
121749,to,0,0
121750,randomization,0,0
121751,(,0,1
121752,Time,0,1
121753,1,0,1
121754,),0,1
121755,and,0,1
121756,at,0,1
121757,5,0,1
121758,and,0,1
121759,9,0,1
121760,months,0,0
121761,post,0,1
121762,enrollment,0,1
121763,(,0,1
121764,Times,0,0
121765,2,0,1
121766,and,0,1
121767,3,0,1
121768,),0,1
121769,.,0,1
121770,Children,0,1
121771,'s,0,1
121772,communication,0,0
121773,and,0,1
121774,parental,0,1
121775,responsivity,0,0
121776,were,0,1
121777,measured,0,0
121778,at,0,0
121779,each,0,0
121780,time,0,0
121781,point,0,0
121782,.,0,1
121783,Children,0,1
121784,'s,0,1
121785,object,0,0
121786,interest,0,0
121787,",",0,0
121788,a,0,0
121789,putative,0,0
121790,moderator,0,0
121791,",",0,0
121792,was,0,0
121793,measured,0,0
121794,at,0,1
121795,Time,0,1
121796,1,0,1
121797,.,0,0
121798,RESULTS,0,0
121799,There,0,0
121800,were,0,0
121801,no,0,0
121802,main,0,0
121803,effects,0,0
121804,of,0,1
121805,the,0,1
121806,HMTW,0,0
121807,intervention,0,0
121808,on,0,0
121809,either,0,1
121810,parental,0,0
121811,responsivity,0,0
121812,or,0,1
121813,children,0,1
121814,'s,0,1
121815,communication,0,0
121816,.,0,1
121817,However,0,0
121818,",",0,0
121819,the,0,0
121820,effects,0,0
121821,on,0,0
121822,residualized,0,1
121823,gains,0,1
121824,in,0,1
121825,parental,0,1
121826,responsivity,0,0
121827,from,0,1
121828,Time,0,1
121829,1,0,1
121830,to,0,1
121831,both,0,0
121832,Times,0,0
121833,2,0,1
121834,and,0,1
121835,3,0,1
121836,yielded,0,0
121837,noteworthy,0,0
121838,effect,0,0
121839,sizes,0,0
121840,(,0,1
121841,Glass,0,1
121842,'s,0,1
121843,?,0,1
121844,=,0,0
121845,.71,0,0
121846,",",0,0
121847,.50,0,0
121848,respectively,0,0
121849,),0,1
121850,.,0,1
121851,In,0,0
121852,contrast,0,0
121853,",",0,0
121854,there,0,0
121855,were,0,0
121856,treatment,0,0
121857,effects,0,0
121858,on,0,0
121859,child,0,1
121860,communication,0,0
121861,gains,0,0
121862,to,0,1
121863,Time,0,1
121864,3,0,0
121865,that,0,0
121866,were,0,1
121867,moderated,0,0
121868,by,0,0
121869,children,0,1
121870,'s,0,1
121871,Time,0,1
121872,1,0,1
121873,object,0,1
121874,interest,0,0
121875,.,0,1
121876,Children,0,1
121877,with,0,1
121878,lower,0,0
121879,levels,0,0
121880,of,0,1
121881,Time,0,1
121882,1,0,1
121883,object,0,1
121884,interest,0,0
121885,exhibited,0,0
121886,facilitated,0,0
121887,growth,0,0
121888,in,0,1
121889,communication,0,0
121890,;,0,1
121891,children,0,1
121892,with,0,1
121893,higher,0,0
121894,levels,0,0
121895,of,0,0
121896,object,0,1
121897,interest,0,0
121898,exhibited,0,0
121899,growth,0,0
121900,attenuation,0,0
121901,.,0,0
121902,CONCLUSIONS,0,0
121903,The,0,0
121904,HMTW,0,0
121905,intervention,0,0
121906,showed,0,0
121907,differential,0,0
121908,effects,0,0
121909,on,0,0
121910,child,0,1
121911,communication,0,0
121912,depending,0,0
121913,on,0,0
121914,a,0,1
121915,baseline,0,0
121916,child,0,1
121917,factor,0,0
121918,.,0,1
121919,HMTW,0,0
121920,facilitated,0,0
121921,communication,0,0
121922,in,0,0
121923,children,0,1
121924,with,0,1
121925,lower,0,1
121926,levels,0,0
121927,of,0,1
121928,Time,0,1
121929,1,0,1
121930,object,0,1
121931,interest,0,1
121932,.,0,1
121933,Parents,1,0
121934,of,1,1
121935,children,1,1
121936,who,1,1
121937,evidence,1,1
121938,higher,1,1
121939,object,1,0
121940,interest,1,0
121941,may,0,0
121942,require,0,0
121943,greater,0,0
121944,support,0,0
121945,to,0,0
121946,implement,0,0
121947,the,0,0
121948,HMTW,0,0
121949,strategies,0,0
121950,",",0,0
121951,or,0,1
121952,may,0,0
121953,require,0,0
121954,different,0,0
121955,strategies,0,0
121956,than,0,1
121957,those,0,1
121958,provided,0,0
121959,by,0,0
121960,the,0,0
121961,HMTW,0,0
121962,curriculum,0,1
121963,.,0,1
121964,The,0,0
121965,effect,0,0
121966,of,0,0
121967,pain-free,0,1
121968,treadmill,0,0
121969,training,0,0
121970,on,0,0
121971,fibrinogen,0,0
121972,",",0,0
121973,haematocrit,0,0
121974,",",0,0
121975,and,0,0
121976,lipid,0,0
121977,profile,0,0
121978,in,0,1
121979,patients,1,1
121980,with,1,1
121981,claudication,1,1
121982,.,1,1
121983,OBJECTIVE,0,0
121984,To,0,0
121985,assess,0,0
121986,the,0,0
121987,effect,0,0
121988,of,0,0
121989,pain-free,0,1
121990,treadmill,0,0
121991,training,0,1
121992,on,0,0
121993,changes,0,0
121994,of,0,1
121995,plasma,0,0
121996,fibrinogen,0,0
121997,",",0,0
121998,haematocrit,0,0
121999,",",0,0
122000,lipid,0,0
122001,profile,0,0
122002,",",0,0
122003,and,0,0
122004,walking,0,0
122005,ability,0,0
122006,in,0,1
122007,patients,1,1
122008,with,1,1
122009,claudication,1,1
122010,.,1,1
122011,DESIGN,0,0
122012,Randomized,0,0
122013,control,0,1
122014,trial,0,1
122015,.,0,1
122016,METHODS,0,0
122017,Sixty-eight,1,1
122018,patients,1,1
122019,with,1,1
122020,peripheral,1,1
122021,obstructive,1,1
122022,arterial,1,1
122023,disease,1,1
122024,and,1,1
122025,intermittent,1,1
122026,claudication,1,1
122027,(,1,1
122028,Fontaine,1,1
122029,stage,1,1
122030,II,1,1
122031,),1,1
122032,were,0,0
122033,randomly,0,1
122034,assigned,0,1
122035,into,0,0
122036,the,0,0
122037,treadmill,0,0
122038,training,0,0
122039,(,0,1
122040,repetitive,0,0
122041,intervals,0,0
122042,to,0,1
122043,onset,0,1
122044,of,0,0
122045,claudication,0,1
122046,pain,0,1
122047,",",0,1
122048,three,0,0
122049,times,0,0
122050,a,0,1
122051,week,0,0
122052,),0,0
122053,or,0,1
122054,a,0,0
122055,control,0,0
122056,group,0,0
122057,(,0,0
122058,no,0,0
122059,change,0,0
122060,in,0,0
122061,physical,0,1
122062,activity,0,0
122063,),0,1
122064,over,0,0
122065,3,0,1
122066,months,0,1
122067,.,0,1
122068,Both,0,0
122069,groups,0,0
122070,performed,0,0
122071,treadmill,0,0
122072,test,0,0
122073,to,0,0
122074,assess,0,0
122075,pain-free,0,0
122076,walking,0,0
122077,time,0,0
122078,(,0,1
122079,PFWT,0,1
122080,),0,1
122081,and,0,1
122082,maximal,0,0
122083,walking,0,0
122084,time,0,0
122085,(,0,1
122086,MWT,0,1
122087,),0,1
122088,and,0,0
122089,had,0,1
122090,blood,0,0
122091,analyses,0,0
122092,[,0,0
122093,for,0,0
122094,haematocrit,0,0
122095,",",0,0
122096,fibrinogen,0,0
122097,",",0,0
122098,triglycerides,0,0
122099,",",0,0
122100,and,0,1
122101,cholesterol,0,0
122102,:,0,1
122103,total,0,1
122104,",",0,0
122105,high-density,0,1
122106,lipoprotein,0,0
122107,(,0,1
122108,HDL,0,1
122109,),0,1
122110,and,0,1
122111,low-density,0,1
122112,lipoprotein,0,0
122113,(,0,1
122114,LDL,0,1
122115,),0,1
122116,],0,1
122117,done,0,0
122118,at,0,0
122119,baseline,0,0
122120,and,0,1
122121,after,0,1
122122,6,0,1
122123,and,0,1
122124,12,0,1
122125,weeks,0,0
122126,of,0,1
122127,the,0,1
122128,study,0,1
122129,.,0,1
122130,RESULTS,0,0
122131,Total,0,0
122132,and,0,1
122133,LDL,0,1
122134,cholesterol,0,0
122135,levels,0,0
122136,in,0,0
122137,the,0,0
122138,training,0,0
122139,group,0,0
122140,decreased,0,0
122141,(,0,1
122142,p,0,0
122143,<,0,0
122144,0.05,0,0
122145,),0,1
122146,by,0,0
122147,14.8,0,0
122148,%,0,0
122149,and,0,1
122150,"20,5",0,1
122151,%,0,0
122152,",",0,0
122153,respectively,0,0
122154,.,0,1
122155,Significant,0,0
122156,(,0,0
122157,p,0,0
122158,<,0,0
122159,0.05,0,0
122160,),0,1
122161,HDL,0,0
122162,cholesterol,0,0
122163,increased,0,0
122164,(,0,1
122165,14.6,0,1
122166,%,0,0
122167,),0,1
122168,and,0,1
122169,triglycerides,0,0
122170,decreased,0,0
122171,(,0,1
122172,19,0,1
122173,%,0,0
122174,),0,1
122175,in,0,0
122176,the,0,0
122177,training,0,0
122178,group,0,1
122179,but,0,0
122180,changes,0,0
122181,of,0,0
122182,all,0,1
122183,these,0,0
122184,lipids,0,0
122185,were,0,1
122186,insignificant,0,0
122187,in,0,0
122188,the,0,0
122189,control,0,0
122190,group,0,0
122191,over,0,0
122192,the,0,1
122193,3,0,1
122194,months,0,0
122195,.,0,1
122196,Haematocrit,0,0
122197,and,0,0
122198,fibrinogen,0,0
122199,changes,0,0
122200,were,0,1
122201,insignificant,0,0
122202,in,0,1
122203,both,0,0
122204,groups,0,0
122205,.,0,1
122206,PFWT,0,0
122207,was,0,0
122208,prolonged,0,0
122209,by,0,0
122210,109,0,1
122211,%,0,0
122212,and,0,1
122213,MWT,0,1
122214,increased,0,0
122215,by,0,0
122216,54,0,1
122217,%,0,0
122218,in,0,0
122219,the,0,0
122220,training,0,0
122221,group,0,0
122222,(,0,1
122223,p,0,0
122224,<,0,0
122225,0.01,0,0
122226,),0,1
122227,",",0,0
122228,but,0,0
122229,not,0,0
122230,in,0,0
122231,the,0,0
122232,control,0,1
122233,group,0,1
122234,.,0,1
122235,CONCLUSION,0,0
122236,The,0,0
122237,improvement,0,0
122238,in,0,0
122239,walking,0,0
122240,time,0,0
122241,over,0,1
122242,3,0,1
122243,months,0,1
122244,of,0,1
122245,pain-free,0,1
122246,treadmill,0,1
122247,training,0,1
122248,parallels,0,0
122249,with,0,1
122250,progressive,0,1
122251,normalization,0,0
122252,of,0,1
122253,lipid,0,0
122254,profiles,0,0
122255,in,0,1
122256,patients,1,1
122257,with,1,1
122258,claudication,1,1
122259,.,1,1
122260,Influence,0,0
122261,of,0,0
122262,two,0,1
122263,different,0,1
122264,flap,0,1
122265,designs,0,1
122266,on,0,1
122267,the,0,0
122268,sequelae,0,0
122269,of,0,0
122270,mandibular,1,1
122271,third,1,1
122272,molar,1,1
122273,surgery,1,1
122274,.,1,1
122275,PURPOSE,0,0
122276,The,0,0
122277,aim,0,0
122278,of,0,0
122279,this,0,0
122280,study,0,0
122281,was,0,0
122282,to,0,0
122283,compare,0,0
122284,the,0,0
122285,influence,0,0
122286,of,0,0
122287,triangular,0,0
122288,and,0,1
122289,envelope,0,0
122290,flaps,0,1
122291,on,0,0
122292,trismus,0,0
122293,",",0,0
122294,pain,0,1
122295,",",0,0
122296,and,0,0
122297,facial,0,1
122298,swelling,0,1
122299,after,0,1
122300,mandibular,1,1
122301,third,1,1
122302,molar,1,1
122303,surgery,1,1
122304,.,1,1
122305,METHODS,0,0
122306,Twenty,1,1
122307,healthy,1,1
122308,patients,1,1
122309,with,1,1
122310,bilateral,1,1
122311,",",1,0
122312,symmetrically,1,0
122313,impacted,1,0
122314,mandibular,1,1
122315,third,1,1
122316,molars,1,1
122317,were,0,1
122318,included,0,1
122319,in,0,0
122320,this,0,0
122321,double-blinded,0,0
122322,",",0,0
122323,prospective,0,1
122324,",",0,0
122325,cross-over,0,0
122326,",",0,0
122327,randomized,0,1
122328,study,0,0
122329,.,0,1
122330,The,0,0
122331,patients,0,1
122332,were,0,1
122333,operated,0,1
122334,with,0,1
122335,envelope,0,0
122336,flap,0,1
122337,on,0,0
122338,one,0,1
122339,side,0,0
122340,and,0,1
122341,triangular,0,0
122342,flap,0,1
122343,on,0,0
122344,the,0,0
122345,other,0,0
122346,side,0,0
122347,.,0,1
122348,Trismus,0,0
122349,was,0,0
122350,determined,0,0
122351,by,0,0
122352,measuring,0,0
122353,maximum,0,0
122354,interincisal,0,0
122355,opening,0,1
122356,",",0,0
122357,and,0,0
122358,facial,0,1
122359,swelling,0,1
122360,was,0,0
122361,evaluated,0,0
122362,using,0,0
122363,a,0,0
122364,tape,0,0
122365,measuring,0,0
122366,method,0,0
122367,.,0,1
122368,Pain,0,0
122369,was,0,0
122370,determined,0,0
122371,using,0,0
122372,visual,0,0
122373,analog,0,0
122374,scale,0,0
122375,(,0,1
122376,VAS,0,1
122377,),0,1
122378,and,0,0
122379,recording,0,0
122380,the,0,0
122381,number,0,0
122382,of,0,0
122383,pain,0,1
122384,pills,0,0
122385,taken,0,0
122386,.,0,1
122387,RESULTS,0,0
122388,The,0,0
122389,facial,0,1
122390,swelling,0,1
122391,measurements,0,0
122392,and,0,1
122393,VAS,0,1
122394,scores,0,0
122395,were,0,1
122396,lower,0,0
122397,in,0,0
122398,the,0,0
122399,envelope,0,0
122400,flap,0,1
122401,group,0,1
122402,compared,0,0
122403,to,0,0
122404,the,0,0
122405,triangular,0,0
122406,flap,0,1
122407,group,0,0
122408,.,0,0
122409,There,0,0
122410,was,0,0
122411,no,0,0
122412,significant,0,0
122413,difference,0,0
122414,between,0,0
122415,the,0,0
122416,two,0,0
122417,flap,0,1
122418,designs,0,0
122419,in,0,1
122420,operation,0,1
122421,time,0,0
122422,",",0,0
122423,maximum,0,0
122424,interincisal,0,0
122425,opening,0,0
122426,",",0,0
122427,and,0,0
122428,the,0,0
122429,number,0,0
122430,of,0,0
122431,analgesics,0,0
122432,taken,0,1
122433,.,0,1
122434,CONCLUSION,0,0
122435,Envelope,0,0
122436,flap,0,1
122437,yields,0,0
122438,to,0,1
122439,less,0,0
122440,facial,0,1
122441,swelling,0,0
122442,and,0,1
122443,reduced,0,0
122444,VAS,0,1
122445,scores,0,0
122446,in,0,1
122447,comparison,0,0
122448,to,0,0
122449,triangular,0,0
122450,flap,0,0
122451,.,0,0
122452,There,0,0
122453,is,0,0
122454,no,0,0
122455,clinical,0,0
122456,difference,0,0
122457,in,0,0
122458,trismus,0,0
122459,between,0,0
122460,the,0,0
122461,two,0,0
122462,flap,0,1
122463,designs,0,0
122464,.,0,1
122465,Despite,0,0
122466,the,0,0
122467,higher,0,0
122468,VAS,0,0
122469,scores,0,0
122470,with,0,1
122471,triangular,0,0
122472,flap,0,1
122473,",",0,0
122474,no,0,0
122475,additional,0,0
122476,doses,0,0
122477,of,0,1
122478,analgesics,0,1
122479,were,0,1
122480,required,0,0
122481,in,0,0
122482,triangular,0,0
122483,flap,0,1
122484,.,0,1
122485,A,0,0
122486,randomized,0,0
122487,study,0,1
122488,on,0,0
122489,hormone-resistant,1,1
122490,prostatic,1,1
122491,cancer,1,1
122492,:,1,1
122493,estramustine,0,1
122494,phosphate,0,0
122495,versus,0,0
122496,low,0,1
122497,dose,0,0
122498,epirubicin,0,1
122499,with,0,1
122500,or,0,1
122501,without,0,1
122502,medroxyprogesterone,0,0
122503,acetate,0,0
122504,.,0,1
122505,A,0,0
122506,Norwegian,0,1
122507,multicenter,0,1
122508,study,0,1
122509,.,0,1
122510,A,0,0
122511,prospective,0,0
122512,randomized,0,0
122513,study,0,0
122514,has,0,0
122515,been,0,0
122516,carried,0,0
122517,out,0,1
122518,in,0,0
122519,order,0,0
122520,to,0,1
122521,compare,0,0
122522,three,0,0
122523,different,0,0
122524,treatment,0,1
122525,modalities,0,0
122526,for,0,1
122527,symptomatic,1,1
122528,metastatic,1,1
122529,hormone-resistant,1,1
122530,prostatic,1,1
122531,cancer,1,1
122532,.,1,1
122533,A,0,0
122534,total,1,1
122535,of,1,0
122536,79,1,1
122537,patients,1,1
122538,were,1,1
122539,included,1,1
122540,.,1,1
122541,One,0,1
122542,group,0,0
122543,was,0,0
122544,treated,0,1
122545,with,0,1
122546,estramustine,0,1
122547,phosphate,0,0
122548,",",0,0
122549,another,0,1
122550,with,0,1
122551,Epirubicin,0,0
122552,plus,0,0
122553,Medroxyprogesterone,0,0
122554,acetate,0,0
122555,(,0,1
122556,MPA,0,1
122557,),0,1
122558,",",0,0
122559,while,0,0
122560,the,0,0
122561,third,0,1
122562,arm,0,0
122563,consisted,0,1
122564,of,0,0
122565,Epirubicin,0,0
122566,plus,0,0
122567,placebo,0,0
122568,.,0,1
122569,Best,0,0
122570,palliation,0,1
122571,was,0,0
122572,obtained,0,0
122573,by,0,0
122574,the,0,0
122575,combination,0,0
122576,of,0,0
122577,Epirubicin,0,0
122578,and,0,1
122579,MPA,0,1
122580,.,0,1
122581,This,0,0
122582,combination,0,0
122583,also,0,0
122584,seemed,0,0
122585,to,0,0
122586,be,0,0
122587,associated,0,0
122588,with,0,1
122589,the,0,0
122590,longest,0,0
122591,response,0,0
122592,duration,0,0
122593,.,0,1
122594,Immediate,0,1
122595,effects,0,0
122596,of,0,1
122597,a,0,1
122598,tibiofibular,0,1
122599,joint,0,0
122600,manipulation,0,0
122601,on,0,0
122602,lower,0,0
122603,extremity,0,1
122604,H-reflex,0,0
122605,measurements,0,0
122606,in,0,1
122607,individuals,1,1
122608,with,1,1
122609,chronic,1,1
122610,ankle,1,1
122611,instability,1,0
122612,.,1,1
122613,Persistent,0,0
122614,muscle,0,0
122615,inhibition,0,0
122616,of,0,0
122617,the,0,0
122618,fibularis,0,0
122619,longus,0,1
122620,and,0,1
122621,soleus,0,1
122622,muscles,0,1
122623,and,0,1
122624,altered,0,1
122625,joint,0,0
122626,arthrokinematics,0,0
122627,may,0,0
122628,play,0,0
122629,a,0,0
122630,role,0,0
122631,in,0,0
122632,chronic,1,1
122633,ankle,1,1
122634,instability,1,0
122635,(,1,1
122636,CAI,1,0
122637,),1,1
122638,.,1,1
122639,Joint,0,0
122640,mobilization,0,0
122641,has,0,0
122642,been,0,0
122643,shown,0,0
122644,to,0,0
122645,improve,0,0
122646,ankle,0,1
122647,joint,0,0
122648,motion,0,0
122649,",",0,1
122650,but,0,0
122651,effects,0,0
122652,on,0,0
122653,surrounding,0,0
122654,musculature,0,0
122655,is,0,0
122656,unknown,0,0
122657,.,0,0
122658,The,0,0
122659,purpose,0,0
122660,of,0,0
122661,this,0,0
122662,study,0,0
122663,was,0,0
122664,to,0,0
122665,determine,0,0
122666,the,0,0
122667,change,0,0
122668,in,0,0
122669,fibularis,0,0
122670,longus,0,1
122671,and,0,1
122672,soleus,0,1
122673,activation,0,0
122674,following,0,0
122675,tibiofibular,0,1
122676,joint,0,1
122677,manipulation,0,1
122678,in,0,1
122679,individuals,1,1
122680,with,1,1
122681,CAI,1,1
122682,.,1,1
122683,Forty-three,1,1
122684,subjects,1,1
122685,were,0,1
122686,randomized,0,1
122687,to,0,1
122688,one,0,1
122689,of,0,1
122690,three,0,1
122691,groups,0,1
122692,(,0,1
122693,proximal,0,1
122694,tibiofibular,0,1
122695,manipulation,0,0
122696,",",0,0
122697,distal,0,1
122698,tibiofibular,0,1
122699,manipulation,0,0
122700,",",0,0
122701,or,0,1
122702,control,0,1
122703,),0,1
122704,.,0,1
122705,A,0,0
122706,two-way,0,0
122707,mixed,0,1
122708,model,0,1
122709,ANOVA,0,1
122710,was,0,0
122711,used,0,0
122712,to,0,0
122713,compare,0,0
122714,changes,0,0
122715,in,0,0
122716,the,0,0
122717,ratio,0,0
122718,of,0,0
122719,the,0,0
122720,maximum,0,0
122721,H-reflex,0,0
122722,and,0,1
122723,maximum,0,0
122724,M-wave,0,1
122725,measurements,0,0
122726,(,0,1
122727,H/M,0,1
122728,ratio,0,0
122729,),0,1
122730,of,0,0
122731,the,0,0
122732,fibularis,0,0
122733,longus,0,1
122734,and,0,0
122735,soleus,0,1
122736,between,0,0
122737,groups,0,0
122738,over,0,0
122739,time,0,0
122740,(,0,1
122741,pre,0,0
122742,",",0,0
122743,post,0,0
122744,0,0,0
122745,",",0,1
122746,10,0,1
122747,",",0,0
122748,20,0,1
122749,",",0,0
122750,30,0,1
122751,min,0,0
122752,),0,1
122753,.,0,1
122754,The,0,0
122755,distal,0,0
122756,tibiofibular,0,1
122757,joint,0,1
122758,manipulation,0,0
122759,group,0,1
122760,demonstrated,0,0
122761,a,0,0
122762,significant,0,0
122763,increase,0,0
122764,(,0,1
122765,P,0,0
122766,<,0,0
122767,.05,0,0
122768,),0,1
122769,in,0,0
122770,soleus,0,1
122771,H/M,0,1
122772,ratio,0,0
122773,at,0,0
122774,all,0,0
122775,post-intervention,0,0
122776,time,0,0
122777,periods,0,0
122778,except,0,1
122779,20,0,1
122780,min,0,0
122781,post-intervention,0,0
122782,(,0,1
122783,P=.48,0,0
122784,),0,1
122785,.,0,1
122786,The,0,0
122787,proximal,0,1
122788,tibiofibular,0,1
122789,joint,0,1
122790,manipulation,0,0
122791,and,0,1
122792,control,0,1
122793,groups,0,0
122794,did,0,0
122795,not,0,0
122796,demonstrate,0,0
122797,a,0,0
122798,change,0,0
122799,in,0,0
122800,soleus,0,1
122801,H/M,0,1
122802,ratios,0,0
122803,.,0,1
122804,All,0,1
122805,groups,0,0
122806,demonstrated,0,0
122807,a,0,1
122808,decrease,0,0
122809,(,0,0
122810,P,0,0
122811,<,0,0
122812,.05,0,0
122813,),0,1
122814,from,0,1
122815,baseline,0,0
122816,values,0,0
122817,in,0,1
122818,fibularis,0,1
122819,longus,0,1
122820,(,0,1
122821,10-30,0,1
122822,min,0,0
122823,post-intervention,0,0
122824,),0,1
122825,and,0,0
122826,soleus,0,1
122827,(,0,1
122828,30,0,1
122829,min,0,0
122830,post-intervention,0,0
122831,),0,1
122832,H/M,0,1
122833,ratios,0,0
122834,.,0,1
122835,Interventions,0,0
122836,directed,0,0
122837,at,0,1
122838,the,0,0
122839,distal,0,1
122840,tibiofibular,0,1
122841,joint,0,1
122842,acutely,0,1
122843,increase,0,0
122844,soleus,0,1
122845,muscle,0,0
122846,activation,0,0
122847,.,0,1
122848,The,0,0
122849,effects,0,0
122850,of,0,0
122851,encoding,0,1
122852,in,0,0
122853,hypnosis,0,1
122854,and,0,1
122855,post-hypnotic,0,0
122856,suggestion,0,0
122857,on,0,0
122858,academic,0,1
122859,performance,0,0
122860,.,0,1
122861,This,0,0
122862,study,0,0
122863,examined,0,0
122864,the,0,0
122865,relationship,0,0
122866,between,0,0
122867,proactive,1,0
122868,learning,1,0
122869,in,1,0
122870,hypnosis,1,0
122871,",",1,0
122872,post-hypnotic,1,0
122873,suggestion,1,0
122874,",",1,0
122875,and,1,0
122876,academic,1,1
122877,performance,1,0
122878,.,1,1
122879,Participants,1,1
122880,(,1,1
122881,N,1,1
122882,=,1,1
122883,56,1,1
122884,),1,1
122885,were,0,1
122886,randomly,0,1
122887,assigned,0,1
122888,to,0,0
122889,a,0,0
122890,control,1,0
122891,group,1,0
122892,or,0,1
122893,a,0,0
122894,treatment,1,0
122895,group,1,0
122896,.,1,1
122897,The,0,0
122898,treatment,0,0
122899,group,0,0
122900,was,0,0
122901,hypnotized,0,0
122902,and,0,0
122903,read,0,0
122904,a,0,0
122905,passage,0,0
122906,while,0,0
122907,in,0,0
122908,hypnosis,0,1
122909,.,0,1
122910,Concurrently,0,0
122911,",",0,0
122912,they,0,0
122913,were,0,0
122914,given,0,0
122915,a,0,0
122916,post-hypnotic,0,0
122917,suggestion,0,0
122918,",",0,0
122919,which,0,0
122920,attempted,0,0
122921,to,0,0
122922,aid,0,0
122923,recognition,0,0
122924,and,0,0
122925,performance,0,0
122926,on,0,0
122927,a,0,0
122928,test,0,0
122929,immediately,0,0
122930,following,0,0
122931,the,0,0
122932,hypnosis,0,0
122933,session,0,0
122934,.,0,1
122935,Both,0,0
122936,groups,0,0
122937,completed,0,1
122938,a,0,1
122939,multiple-choice,0,0
122940,test,0,0
122941,based,0,1
122942,on,0,0
122943,the,0,0
122944,aforementioned,0,0
122945,passage,0,0
122946,.,0,1
122947,An,0,0
122948,analysis,0,0
122949,of,0,0
122950,covariance,0,0
122951,discerned,0,0
122952,the,0,0
122953,effect,0,0
122954,of,0,0
122955,proactive,0,1
122956,learning,0,0
122957,and,0,1
122958,post-hypnotic,0,0
122959,suggestion,0,0
122960,on,0,0
122961,test,0,0
122962,performance,0,0
122963,",",0,0
122964,while,0,0
122965,controlling,0,0
122966,for,0,0
122967,the,0,0
122968,variance,0,0
122969,introduced,0,0
122970,by,0,0
122971,scholastic,0,1
122972,aptitude,0,0
122973,as,0,0
122974,measured,0,0
122975,by,0,0
122976,the,0,0
122977,ACT,0,0
122978,.,0,1
122979,Results,0,0
122980,indicated,0,0
122981,that,0,0
122982,the,0,0
122983,hypnosis,0,1
122984,sessions,0,0
122985,predicted,0,0
122986,significantly,0,0
122987,impaired,0,1
122988,test,0,0
122989,performance,0,0
122990,.,0,1
122991,Do,0,1
122992,sheltered,0,1
122993,workshops,0,0
122994,enhance,0,0
122995,employment,0,1
122996,outcomes,0,0
122997,for,0,1
122998,adults,1,1
122999,with,1,1
123000,autism,1,1
123001,spectrum,1,1
123002,disorder,1,1
123003,?,0,1
123004,This,0,0
123005,study,0,0
123006,investigated,0,0
123007,whether,0,0
123008,sheltered,0,1
123009,workshops,0,0
123010,help,0,0
123011,prepare,0,0
123012,individuals,1,1
123013,with,1,1
123014,autism,1,1
123015,spectrum,1,1
123016,disorder,1,1
123017,(,1,1
123018,ASD,1,1
123019,),1,1
123020,for,0,0
123021,competitive,0,0
123022,employment,0,1
123023,within,0,0
123024,the,0,0
123025,community,0,1
123026,.,0,1
123027,Two,0,1
123028,groups,0,0
123029,of,0,1
123030,individuals,0,1
123031,were,0,1
123032,compared,0,0
123033,:,0,1
123034,(,1,0
123035,a,1,1
123036,),1,1
123037,215,1,1
123038,supported,1,1
123039,employees,1,1
123040,who,1,1
123041,were,1,1
123042,in,1,1
123043,sheltered,1,1
123044,workshops,1,0
123045,prior,1,1
123046,to,1,1
123047,entering,1,1
123048,supported,1,0
123049,employment,1,1
123050,and,1,0
123051,(,1,1
123052,b,1,1
123053,),1,1
123054,215,1,1
123055,supported,1,1
123056,employees,1,1
123057,who,1,1
123058,were,1,1
123059,not,1,1
123060,in,1,0
123061,sheltered,1,1
123062,workshops,1,1
123063,.,1,1
123064,Individuals,0,1
123065,from,0,1
123066,both,0,0
123067,groups,0,0
123068,were,0,1
123069,matched,0,1
123070,based,0,1
123071,on,0,0
123072,their,0,1
123073,primary,0,1
123074,diagnosis,0,1
123075,",",0,0
123076,secondary,0,0
123077,diagnosis,0,1
123078,(,0,1
123079,if,0,0
123080,present,0,0
123081,),0,1
123082,",",0,0
123083,and,0,0
123084,gender,0,1
123085,.,0,1
123086,Results,0,0
123087,showed,0,0
123088,that,0,0
123089,there,0,0
123090,were,0,0
123091,no,0,0
123092,differences,0,0
123093,in,0,1
123094,rates,0,0
123095,of,0,1
123096,employment,0,1
123097,between,0,0
123098,these,0,0
123099,two,0,1
123100,groups,0,0
123101,.,0,1
123102,However,0,0
123103,",",0,1
123104,individuals,0,1
123105,who,0,1
123106,participated,0,1
123107,in,0,1
123108,sheltered,0,1
123109,workshops,0,0
123110,earned,0,0
123111,significantly,0,0
123112,less,0,0
123113,(,0,0
123114,US,0,0
123115,$,0,1
123116,129.36,0,0
123117,versus,0,0
123118,US,0,1
123119,$,0,1
123120,191.42,0,0
123121,per,0,1
123122,week,0,0
123123,),0,1
123124,",",0,0
123125,and,0,0
123126,cost,0,0
123127,significantly,0,0
123128,more,0,0
123129,to,0,0
123130,serve,0,0
123131,(,0,1
123132,US,0,0
123133,$,0,1
123134,"6,065.08",0,0
123135,versus,0,0
123136,US,0,1
123137,$,0,1
123138,"2,440.60",0,1
123139,),0,0
123140,",",0,0
123141,than,0,0
123142,their,0,1
123143,non-sheltered,0,1
123144,workshop,0,1
123145,peers,0,1
123146,.,0,1
123147,Results,0,0
123148,presented,0,1
123149,here,0,0
123150,suggest,0,0
123151,that,0,0
123152,individuals,1,1
123153,with,1,1
123154,ASD,1,1
123155,achieve,0,0
123156,better,0,0
123157,vocational,0,0
123158,outcomes,0,0
123159,if,0,0
123160,they,0,1
123161,do,0,0
123162,not,0,0
123163,participate,0,1
123164,in,0,0
123165,sheltered,0,1
123166,workshops,0,0
123167,prior,0,1
123168,to,0,0
123169,enrolling,0,1
123170,in,0,0
123171,supported,0,0
123172,employment,0,1
123173,.,0,1
123174,Enalapril,0,0
123175,and,0,0
123176,lisinopril,0,1
123177,in,0,0
123178,the,0,0
123179,treatment,0,0
123180,of,0,0
123181,mild,1,1
123182,to,1,0
123183,moderate,1,1
123184,essential,1,1
123185,hypertension,1,1
123186,.,1,1
123187,Hypertensive,1,1
123188,patients,1,1
123189,were,0,1
123190,randomly,0,1
123191,assigned,0,1
123192,to,0,0
123193,receive,0,1
123194,5,1,0
123195,mg,1,0
123196,of,1,0
123197,enalapril,1,1
123198,(,1,1
123199,n,1,1
123200,=,1,1
123201,50,1,1
123202,),1,1
123203,or,1,1
123204,10,1,1
123205,mg,1,0
123206,of,1,0
123207,lisinopril,1,1
123208,(,1,1
123209,n,1,1
123210,=,1,1
123211,47,1,1
123212,),1,1
123213,daily,1,0
123214,.,1,1
123215,During,0,0
123216,a,0,0
123217,four-week,0,0
123218,titration,0,0
123219,period,0,0
123220,",",0,0
123221,the,0,0
123222,doses,0,0
123223,were,0,1
123224,increased,0,0
123225,weekly,0,0
123226,to,0,0
123227,a,0,0
123228,maximum,0,0
123229,of,0,0
123230,40,0,1
123231,mg,0,0
123232,once,0,0
123233,daily,0,0
123234,until,0,0
123235,the,0,0
123236,treatment,0,0
123237,goal,0,0
123238,of,0,0
123239,diastolic,0,1
123240,blood,0,0
123241,pressure,0,0
123242,(,0,1
123243,BP,0,1
123244,),0,1
123245,of,0,0
123246,less,0,0
123247,than,0,1
123248,90,0,1
123249,mmHg,0,0
123250,was,0,0
123251,reached,0,0
123252,;,0,1
123253,treatment,0,0
123254,was,0,0
123255,then,0,0
123256,continued,0,0
123257,for,0,0
123258,four,0,1
123259,weeks,0,1
123260,.,0,1
123261,Systolic,0,1
123262,and,0,0
123263,diastolic,0,1
123264,BP,0,1
123265,declined,0,0
123266,significantly,0,0
123267,in,0,0
123268,the,0,0
123269,two,1,0
123270,treatment,1,0
123271,groups,1,0
123272,",",0,1
123273,from,0,1
123274,147/98,0,1
123275,mmHg,0,0
123276,in,0,0
123277,both,0,0
123278,the,0,0
123279,enalapril,0,0
123280,and,0,0
123281,lisinopril,0,1
123282,groups,0,1
123283,to,0,1
123284,126/82,0,1
123285,and,0,1
123286,122/81,0,1
123287,mmHg,0,0
123288,",",0,0
123289,respectively,0,0
123290,",",0,0
123291,at,0,0
123292,the,0,0
123293,end,0,0
123294,of,0,0
123295,treatment,0,0
123296,.,0,1
123297,During,0,0
123298,the,0,0
123299,first,0,0
123300,week,0,0
123301,of,0,0
123302,treatment,0,0
123303,",",0,0
123304,the,0,0
123305,goal,0,0
123306,of,0,0
123307,diastolic,0,1
123308,BP,0,1
123309,of,0,0
123310,less,0,0
123311,than,0,1
123312,90,0,1
123313,mmHg,0,0
123314,was,0,0
123315,reached,0,0
123316,by,0,0
123317,40,0,1
123318,%,0,0
123319,of,0,0
123320,the,0,0
123321,enalapril,0,0
123322,group,0,1
123323,and,0,1
123324,62,0,1
123325,%,0,0
123326,of,0,0
123327,the,0,0
123328,lisinopril,0,1
123329,group,0,0
123330,;,0,0
123331,by,0,0
123332,the,0,0
123333,end,0,0
123334,of,0,0
123335,the,0,0
123336,titration,0,0
123337,period,0,0
123338,",",0,0
123339,98,0,1
123340,%,0,0
123341,and,0,1
123342,96,0,1
123343,%,0,0
123344,",",0,0
123345,respectively,0,0
123346,",",0,0
123347,had,0,0
123348,achieved,0,0
123349,the,0,0
123350,BP,0,1
123351,goal,0,0
123352,.,0,1
123353,Few,0,0
123354,side,0,0
123355,effects,0,0
123356,were,0,1
123357,reported,0,0
123358,and,0,0
123359,there,0,0
123360,were,0,0
123361,no,0,0
123362,abnormal,0,1
123363,laboratory,0,0
123364,findings,0,0
123365,during,0,1
123366,treatment,0,1
123367,.,0,1
123368,It,0,0
123369,is,0,0
123370,concluded,0,0
123371,that,0,0
123372,once-daily,0,0
123373,administration,0,0
123374,of,0,0
123375,enalapril,0,0
123376,or,0,1
123377,lisinopril,0,0
123378,was,0,0
123379,generally,0,0
123380,effective,0,0
123381,and,0,0
123382,well-tolerated,0,0
123383,in,0,0
123384,the,0,0
123385,management,0,0
123386,of,0,0
123387,mild,1,1
123388,to,1,0
123389,moderate,1,1
123390,uncomplicated,1,1
123391,essential,1,1
123392,hypertension,1,1
123393,.,1,1
123394,?-Blockers,0,1
123395,in,1,1
123396,patients,1,1
123397,with,1,1
123398,intermittent,1,1
123399,claudication,1,1
123400,and,1,1
123401,arterial,1,1
123402,hypertension,1,1
123403,:,1,1
123404,results,0,0
123405,from,0,1
123406,the,0,0
123407,nebivolol,0,0
123408,or,0,0
123409,metoprolol,0,0
123410,in,0,0
123411,arterial,0,1
123412,occlusive,0,1
123413,disease,0,1
123414,trial,0,1
123415,.,0,1
123416,The,0,0
123417,use,0,0
123418,of,0,0
123419,?-receptor,0,0
123420,blockers,0,0
123421,in,0,1
123422,peripheral,0,1
123423,arterial,0,1
123424,disease,0,1
123425,is,0,0
123426,controversial,0,0
123427,for,0,0
123428,their,0,1
123429,impact,0,0
123430,on,0,0
123431,vasomotor,0,0
123432,tone,0,0
123433,.,0,1
123434,The,0,0
123435,?-blocker,0,0
123436,nebivolol,0,0
123437,possesses,0,0
123438,vasodilating,0,0
123439,",",0,0
123440,endothelium-dependent,0,0
123441,",",0,1
123442,NO-releasing,0,0
123443,properties,0,0
123444,that,0,0
123445,might,0,0
123446,be,0,0
123447,beneficial,0,0
123448,in,0,0
123449,peripheral,0,1
123450,arterial,0,1
123451,disease,0,1
123452,.,0,1
123453,The,0,0
123454,aim,0,0
123455,of,0,0
123456,the,0,0
123457,study,0,0
123458,was,0,0
123459,to,0,0
123460,evaluate,0,0
123461,the,0,0
123462,effects,0,0
123463,and,0,0
123464,tolerability,0,0
123465,of,0,0
123466,nebivolol,0,0
123467,in,0,0
123468,comparison,0,0
123469,with,0,1
123470,metoprolol,0,0
123471,in,0,1
123472,these,0,0
123473,patients,1,1
123474,.,1,1
123475,A,1,0
123476,total,1,1
123477,of,1,0
123478,128,1,1
123479,patients,1,1
123480,with,1,1
123481,intermittent,1,1
123482,claudication,1,1
123483,and,1,1
123484,essential,1,1
123485,hypertension,1,1
123486,were,1,1
123487,included,0,1
123488,and,0,1
123489,double-blind,0,1
123490,randomized,0,1
123491,to,0,1
123492,receive,0,1
123493,5,0,0
123494,mg,0,0
123495,of,0,0
123496,nebivolol,0,0
123497,(,0,1
123498,N=65,0,1
123499,),0,1
123500,or,0,1
123501,95,0,0
123502,mg,0,0
123503,of,0,0
123504,metoprolol,0,0
123505,(,0,1
123506,N=63,0,1
123507,),0,1
123508,once,0,0
123509,daily,0,0
123510,.,0,1
123511,End,0,1
123512,points,0,0
123513,were,0,1
123514,changes,0,0
123515,in,0,1
123516,ankle-brachial,0,0
123517,index,0,1
123518,",",0,1
123519,initial,0,0
123520,and,0,0
123521,absolute,0,0
123522,claudication,0,1
123523,distance,0,0
123524,",",0,0
123525,endothelial,0,0
123526,function,0,0
123527,assessed,0,0
123528,by,0,0
123529,flow-mediated,0,1
123530,dilatation,0,1
123531,of,0,0
123532,the,0,0
123533,brachial,0,1
123534,artery,0,1
123535,",",0,0
123536,blood,0,0
123537,pressure,0,0
123538,",",0,0
123539,and,0,0
123540,quality,0,0
123541,of,0,0
123542,life,0,1
123543,using,0,0
123544,the,0,0
123545,claudication,0,1
123546,scale,0,0
123547,questionnaire,0,0
123548,.,0,1
123549,End,0,0
123550,point,0,0
123551,analysis,0,0
123552,was,0,0
123553,possible,0,0
123554,in,0,1
123555,109,0,1
123556,patients,0,1
123557,(,0,1
123558,85.2,0,1
123559,%,0,0
123560,),0,1
123561,.,0,1
123562,After,0,0
123563,the,0,0
123564,48-week,0,0
123565,treatment,0,0
123566,period,0,0
123567,",",0,0
123568,ankle-brachial,0,0
123569,index,0,1
123570,and,0,1
123571,absolute,0,0
123572,claudication,0,1
123573,distance,0,0
123574,improved,0,0
123575,significantly,0,0
123576,in,0,0
123577,both,0,0
123578,patient,0,1
123579,groups,0,0
123580,(,0,1
123581,P,0,0
123582,<,0,0
123583,0.05,0,0
123584,for,0,0
123585,both,0,0
123586,),0,0
123587,",",0,0
123588,with,0,1
123589,no,0,0
123590,difference,0,0
123591,across,0,0
123592,treatments,0,0
123593,.,0,1
123594,A,0,0
123595,significant,0,0
123596,increase,0,0
123597,of,0,0
123598,initial,0,1
123599,claudication,0,1
123600,distance,0,0
123601,was,0,0
123602,found,0,0
123603,in,0,0
123604,the,0,0
123605,nebivolol,0,0
123606,group,0,1
123607,.,0,1
123608,Adjusted,0,0
123609,mean,0,0
123610,change,0,0
123611,of,0,0
123612,initial,0,1
123613,claudication,0,1
123614,distance,0,0
123615,was,0,0
123616,33.9,0,0
123617,%,0,0
123618,after,0,0
123619,nebivolol,0,0
123620,(,0,1
123621,P=0.003,0,0
123622,),0,1
123623,and,0,1
123624,16.6,0,0
123625,%,0,0
123626,after,0,0
123627,metoprolol,0,0
123628,(,0,1
123629,P=0.12,0,0
123630,),0,1
123631,treatment,0,0
123632,.,0,1
123633,Quality,0,0
123634,of,0,0
123635,life,0,0
123636,was,0,0
123637,not,0,0
123638,influenced,0,0
123639,by,0,0
123640,either,0,0
123641,treatment,0,0
123642,",",0,0
123643,and,0,0
123644,there,0,0
123645,was,0,0
123646,no,0,0
123647,relevant,0,0
123648,change,0,0
123649,in,0,1
123650,flow-mediated,0,1
123651,dilatation,0,1
123652,in,0,1
123653,patients,0,1
123654,treated,0,1
123655,with,0,1
123656,nebivolol,0,0
123657,or,0,1
123658,metoprolol,0,0
123659,(,0,1
123660,P=0.16,0,0
123661,),0,1
123662,.,0,1
123663,Both,0,0
123664,drugs,0,0
123665,were,0,1
123666,equally,0,1
123667,effective,0,0
123668,in,0,0
123669,lowering,0,0
123670,blood,0,0
123671,pressure,0,0
123672,.,0,1
123673,In,0,0
123674,conclusion,0,0
123675,",",0,0
123676,?-blocker,0,0
123677,therapy,0,0
123678,was,0,0
123679,well,0,0
123680,tolerated,1,0
123681,in,1,0
123682,patients,1,1
123683,with,1,1
123684,intermittent,1,1
123685,claudication,1,1
123686,and,1,1
123687,arterial,1,1
123688,hypertension,1,1
123689,during,1,0
123690,a,0,0
123691,treatment,0,0
123692,period,0,0
123693,of,0,0
123694,?1,0,0
123695,year,0,1
123696,.,0,1
123697,In,0,0
123698,the,0,0
123699,direct,0,0
123700,comparison,0,0
123701,",",0,0
123702,there,0,0
123703,was,0,0
123704,no,0,0
123705,significant,0,0
123706,difference,0,0
123707,between,0,0
123708,nebivolol,0,0
123709,and,0,1
123710,metoprolol,0,0
123711,.,0,1
123712,[,1,0
123713,Diabetic,1,1
123714,retinopathy,1,1
123715,candesartan,0,1
123716,trial,0,1
123717,],0,1
123718,.,0,1
123719,The,0,0
123720,benefits,0,0
123721,of,0,0
123722,including,0,1
123723,clinical,0,0
123724,factors,0,0
123725,in,0,1
123726,rectal,0,1
123727,normal,0,1
123728,tissue,0,1
123729,complication,0,0
123730,probability,0,0
123731,modeling,0,0
123732,after,1,0
123733,radiotherapy,1,1
123734,for,1,0
123735,prostate,1,1
123736,cancer,1,1
123737,.,1,1
123738,PURPOSE,0,0
123739,To,0,0
123740,study,0,0
123741,the,0,0
123742,impact,0,0
123743,of,0,0
123744,clinical,0,0
123745,predisposing,0,1
123746,factors,0,0
123747,on,0,1
123748,rectal,0,1
123749,normal,0,1
123750,tissue,0,1
123751,complication,0,0
123752,probability,0,0
123753,modeling,0,0
123754,using,0,0
123755,the,0,0
123756,updated,0,0
123757,results,0,0
123758,of,0,1
123759,the,0,1
123760,Dutch,0,1
123761,prostate,0,1
123762,dose-escalation,0,1
123763,trial,0,1
123764,.,0,1
123765,METHODS,0,0
123766,AND,0,0
123767,MATERIALS,0,1
123768,Toxicity,0,0
123769,data,0,0
123770,of,0,1
123771,512,1,1
123772,patients,1,1
123773,(,1,1
123774,conformally,1,1
123775,treated,1,1
123776,to,1,1
123777,68,1,1
123778,Gy,1,1
123779,[,1,0
123780,n,1,1
123781,=,1,1
123782,284,1,1
123783,],1,1
123784,and,1,1
123785,78,1,1
123786,Gy,1,1
123787,[,1,0
123788,n,1,1
123789,=,1,1
123790,228,1,1
123791,],1,1
123792,),1,1
123793,with,1,1
123794,complete,1,1
123795,follow-up,1,1
123796,at,1,1
123797,3,1,1
123798,years,1,1
123799,after,1,1
123800,radiotherapy,1,1
123801,were,1,1
123802,studied,1,1
123803,.,1,1
123804,Scored,0,0
123805,end,0,0
123806,points,0,0
123807,were,0,1
123808,rectal,0,1
123809,bleeding,0,1
123810,",",0,0
123811,high,0,1
123812,stool,0,0
123813,frequency,0,0
123814,",",0,0
123815,and,0,0
123816,fecal,0,1
123817,incontinence,0,1
123818,.,0,1
123819,Two,0,1
123820,traditional,0,1
123821,dose-based,0,0
123822,models,0,1
123823,(,0,1
123824,Lyman-Kutcher-Burman,0,1
123825,(,0,1
123826,LKB,0,1
123827,),0,1
123828,and,0,1
123829,Relative,0,1
123830,Seriality,0,0
123831,(,0,1
123832,RS,0,0
123833,),0,1
123834,and,0,0
123835,a,0,1
123836,logistic,0,0
123837,model,0,0
123838,were,0,1
123839,fitted,0,0
123840,using,0,0
123841,a,0,0
123842,maximum,0,0
123843,likelihood,0,0
123844,approach,0,1
123845,.,0,1
123846,Furthermore,0,0
123847,",",0,0
123848,these,0,0
123849,model,0,0
123850,fits,0,0
123851,were,0,1
123852,improved,0,0
123853,by,0,0
123854,including,0,0
123855,the,0,0
123856,most,0,0
123857,significant,0,0
123858,clinical,0,1
123859,factors,0,0
123860,.,0,1
123861,The,0,0
123862,area,0,0
123863,under,0,0
123864,the,0,0
123865,receiver,0,0
123866,operating,0,0
123867,characteristic,0,0
123868,curve,0,0
123869,(,0,1
123870,AUC,0,0
123871,),0,1
123872,was,0,0
123873,used,0,0
123874,to,0,0
123875,compare,0,0
123876,the,0,0
123877,discriminating,0,0
123878,ability,0,0
123879,of,0,0
123880,all,0,1
123881,fits,0,0
123882,.,0,1
123883,RESULTS,0,0
123884,Including,0,0
123885,clinical,0,0
123886,factors,0,0
123887,significantly,0,0
123888,increased,0,0
123889,the,0,0
123890,predictive,0,0
123891,power,0,0
123892,of,0,0
123893,the,0,0
123894,models,0,0
123895,for,0,0
123896,all,0,1
123897,end,0,0
123898,points,0,0
123899,.,0,1
123900,In,0,0
123901,the,0,0
123902,optimal,0,0
123903,LKB,0,1
123904,",",0,1
123905,RS,0,0
123906,",",0,0
123907,and,0,0
123908,logistic,0,0
123909,models,0,1
123910,for,0,1
123911,rectal,0,1
123912,bleeding,0,1
123913,and,0,1
123914,fecal,0,1
123915,incontinence,0,0
123916,",",0,0
123917,the,0,0
123918,first,0,0
123919,significant,0,0
123920,(,0,1
123921,p,0,0
123922,=,0,1
123923,0.011-0.013,0,0
123924,),0,1
123925,clinical,0,0
123926,factor,0,0
123927,was,0,0
123928,previous,0,1
123929,abdominal,0,1
123930,surgery,0,1
123931,.,0,1
123932,As,0,0
123933,second,0,1
123934,significant,0,0
123935,(,0,1
123936,p,0,0
123937,=,0,1
123938,0.012-0.016,0,0
123939,),0,1
123940,factor,0,0
123941,",",0,0
123942,cardiac,0,1
123943,history,0,1
123944,was,0,0
123945,included,0,1
123946,in,0,0
123947,all,0,1
123948,three,0,0
123949,rectal,0,1
123950,bleeding,0,1
123951,fits,0,0
123952,",",0,1
123953,whereas,0,0
123954,including,0,1
123955,diabetes,0,1
123956,was,0,0
123957,significant,0,0
123958,(,0,1
123959,p,0,0
123960,=,0,1
123961,0.039-0.048,0,0
123962,),0,1
123963,in,0,0
123964,fecal,0,1
123965,incontinence,0,1
123966,modeling,0,0
123967,but,0,0
123968,only,0,0
123969,in,0,0
123970,the,0,0
123971,LKB,0,1
123972,and,0,1
123973,logistic,0,0
123974,models,0,1
123975,.,0,1
123976,High,0,0
123977,stool,0,0
123978,frequency,0,0
123979,fits,0,0
123980,only,0,0
123981,benefitted,0,0
123982,significantly,0,0
123983,(,0,0
123984,p,0,0
123985,=,0,1
123986,0.003-0.006,0,0
123987,),0,1
123988,from,0,1
123989,the,0,0
123990,inclusion,0,0
123991,of,0,0
123992,the,0,0
123993,baseline,0,0
123994,toxicity,0,0
123995,score,0,0
123996,.,0,1
123997,For,0,0
123998,all,0,0
123999,models,0,0
124000,rectal,0,1
124001,bleeding,0,1
124002,fits,0,0
124003,had,0,1
124004,the,0,0
124005,highest,0,0
124006,AUC,0,0
124007,(,0,1
124008,0.77,0,0
124009,),0,0
124010,where,0,0
124011,it,0,0
124012,was,0,0
124013,0.63,0,0
124014,and,0,1
124015,0.68,0,0
124016,for,0,0
124017,high,0,1
124018,stool,0,1
124019,frequency,0,0
124020,and,0,0
124021,fecal,0,1
124022,incontinence,0,0
124023,",",0,0
124024,respectively,0,0
124025,.,0,1
124026,LKB,0,0
124027,and,0,0
124028,logistic,0,0
124029,model,0,1
124030,fits,0,0
124031,resulted,0,0
124032,in,0,1
124033,similar,0,0
124034,values,0,0
124035,for,0,1
124036,the,0,0
124037,volume,0,0
124038,parameter,0,0
124039,.,0,1
124040,The,0,0
124041,steepness,0,0
124042,parameter,0,0
124043,was,0,0
124044,somewhat,0,0
124045,higher,0,0
124046,in,0,0
124047,the,0,0
124048,logistic,0,0
124049,model,0,0
124050,",",0,0
124051,also,0,0
124052,resulting,0,0
124053,in,0,0
124054,a,0,0
124055,slightly,0,0
124056,lower,0,0
124057,D,0,0
124058,(,0,1
124059,50,0,1
124060,),0,1
124061,.,0,1
124062,Anal,0,0
124063,wall,0,1
124064,DVHs,0,1
124065,were,0,1
124066,used,0,0
124067,for,0,0
124068,fecal,0,1
124069,incontinence,0,0
124070,",",0,0
124071,whereas,0,0
124072,anorectal,0,1
124073,wall,0,1
124074,dose,0,0
124075,best,0,0
124076,described,0,0
124077,the,0,0
124078,other,0,0
124079,two,0,1
124080,endpoints,0,0
124081,.,0,1
124082,CONCLUSIONS,0,0
124083,Comparable,0,0
124084,prediction,0,1
124085,models,0,1
124086,were,0,1
124087,obtained,0,0
124088,with,0,1
124089,LKB,0,1
124090,",",0,1
124091,RS,0,0
124092,",",0,0
124093,and,0,0
124094,logistic,0,0
124095,NTCP,0,1
124096,models,0,1
124097,.,0,1
124098,Including,0,0
124099,clinical,0,0
124100,factors,0,0
124101,improved,0,0
124102,the,0,0
124103,predictive,0,0
124104,power,0,0
124105,of,0,0
124106,all,0,0
124107,models,0,0
124108,significantly,0,0
124109,.,0,1
124110,Positive,0,1
124111,impact,0,0
124112,of,0,0
124113,crisis,0,1
124114,resource,0,0
124115,management,0,0
124116,training,0,0
124117,on,0,0
124118,no-flow,0,0
124119,time,0,0
124120,and,0,0
124121,team,0,1
124122,member,0,1
124123,verbalisations,0,0
124124,during,0,1
124125,simulated,0,0
124126,cardiopulmonary,0,1
124127,resuscitation,0,1
124128,:,0,1
124129,a,0,1
124130,randomised,0,0
124131,controlled,0,0
124132,trial,0,1
124133,.,0,1
124134,OBJECTIVES,0,0
124135,To,0,0
124136,evaluate,0,0
124137,the,0,0
124138,impact,0,0
124139,of,0,0
124140,video-based,0,0
124141,interactive,0,0
124142,crisis,0,1
124143,resource,0,0
124144,management,0,1
124145,(,0,1
124146,CRM,0,0
124147,),0,1
124148,training,0,0
124149,on,0,0
124150,no-flow,0,0
124151,time,0,0
124152,(,0,1
124153,NFT,0,1
124154,),0,1
124155,and,0,1
124156,on,0,0
124157,proportions,0,0
124158,of,0,1
124159,team,0,1
124160,member,0,1
124161,verbalisations,0,0
124162,(,0,1
124163,TMV,0,0
124164,),0,1
124165,during,0,0
124166,simulated,0,0
124167,cardiopulmonary,0,1
124168,resuscitation,0,1
124169,(,0,1
124170,CPR,0,0
124171,),0,1
124172,.,0,1
124173,Further,0,0
124174,",",0,0
124175,to,0,0
124176,investigate,0,0
124177,the,0,0
124178,link,0,0
124179,between,0,0
124180,team,0,1
124181,leader,0,1
124182,verbalisation,0,0
124183,accuracy,0,0
124184,and,0,1
124185,NFT,0,1
124186,.,0,1
124187,METHODS,0,0
124188,The,0,0
124189,randomised,0,0
124190,controlled,0,0
124191,study,0,0
124192,was,0,0
124193,embedded,0,0
124194,in,0,0
124195,the,0,0
124196,obligatory,0,0
124197,advanced,0,1
124198,life,0,0
124199,support,0,0
124200,(,0,1
124201,ALS,0,1
124202,),0,1
124203,course,0,0
124204,for,0,1
124205,final-year,1,1
124206,medical,1,1
124207,students,1,1
124208,.,1,1
124209,Students,1,1
124210,(,1,1
124211,176,1,1
124212,;,1,1
124213,25.35?1.03,1,0
124214,years,1,1
124215,",",1,1
124216,63,1,1
124217,%,1,0
124218,female,1,1
124219,),1,0
124220,were,0,0
124221,alphabetically,0,1
124222,assigned,0,1
124223,to,1,1
124224,44,1,1
124225,four-person,1,1
124226,teams,1,1
124227,that,0,0
124228,were,0,1
124229,then,0,0
124230,randomly,0,1
124231,(,0,0
124232,computer-generated,0,0
124233,),0,1
124234,assigned,0,1
124235,to,0,0
124236,either,0,1
124237,CRM,0,0
124238,intervention,0,0
124239,(,0,1
124240,n=26,0,1
124241,),0,1
124242,",",0,0
124243,receiving,0,1
124244,interactive,0,0
124245,video-based,0,0
124246,CRM-training,0,0
124247,",",0,0
124248,or,0,0
124249,to,0,0
124250,control,0,1
124251,intervention,0,0
124252,(,0,0
124253,n=18,0,1
124254,),0,1
124255,",",0,0
124256,receiving,0,1
124257,an,0,0
124258,additional,0,0
124259,ALS-training,0,0
124260,.,0,1
124261,Primary,0,1
124262,outcomes,0,0
124263,were,0,1
124264,NFT,0,1
124265,and,0,1
124266,proportions,0,0
124267,of,0,1
124268,TMV,0,0
124269,",",0,1
124270,which,0,0
124271,were,0,0
124272,subdivided,0,1
124273,into,0,1
124274,eight,0,1
124275,categories,0,1
124276,:,0,1
124277,four,0,1
124278,team,0,1
124279,leader,0,1
124280,verbalisations,0,0
124281,(,0,1
124282,TLV,0,1
124283,),0,1
124284,with,0,1
124285,different,0,1
124286,accuracy,0,0
124287,levels,0,0
124288,and,0,1
124289,four,0,1
124290,follower,0,0
124291,verbalisation,0,1
124292,categories,0,0
124293,(,0,1
124294,FV,0,1
124295,),0,1
124296,.,0,1
124297,Measurements,0,0
124298,were,0,0
124299,made,0,0
124300,of,1,0
124301,all,1,1
124302,groups,1,0
124303,administering,1,0
124304,simulated,1,0
124305,adult,1,1
124306,CPR,1,0
124307,.,1,1
124308,RESULTS,0,0
124309,NFT,0,1
124310,rates,0,0
124311,were,0,1
124312,significantly,0,0
124313,lower,0,0
124314,in,0,0
124315,the,0,0
124316,CRM-training,0,0
124317,group,0,1
124318,(,0,1
124319,31.4?6.1,0,0
124320,%,0,0
124321,vs.,0,0
124322,36.3?6.6,0,1
124323,%,0,0
124324,",",0,0
124325,p=0.014,0,0
124326,),0,1
124327,.,0,1
124328,Proportions,0,0
124329,of,0,0
124330,all,0,1
124331,TLV,0,1
124332,categories,0,0
124333,were,0,1
124334,higher,0,0
124335,in,0,0
124336,the,0,0
124337,CRM-training,0,0
124338,group,0,1
124339,(,0,1
124340,p,0,0
124341,<,0,0
124342,0.001,0,0
124343,),0,1
124344,.,0,1
124345,Differences,0,0
124346,in,0,0
124347,FV,0,1
124348,were,0,1
124349,only,0,0
124350,found,0,0
124351,for,0,0
124352,one,0,1
124353,category,0,1
124354,(,0,1
124355,unsolicited,0,0
124356,information,0,1
124357,),0,1
124358,(,0,1
124359,p=0.012,0,0
124360,),0,1
124361,.,0,1
124362,The,0,0
124363,highest,0,0
124364,correlation,0,0
124365,with,0,1
124366,NFT,0,1
124367,was,0,0
124368,found,0,0
124369,for,0,0
124370,high,0,1
124371,accuracy,0,0
124372,TLV,0,1
124373,(,0,1
124374,direct,0,1
124375,orders,0,0
124376,),0,1
124377,(,0,1
124378,p=0.06,0,0
124379,),0,1
124380,.,0,0
124381,CONCLUSIONS,0,0
124382,The,0,0
124383,inclusion,0,0
124384,of,0,0
124385,CRM,0,0
124386,training,0,1
124387,in,0,0
124388,undergraduate,0,1
124389,medical,0,1
124390,education,0,1
124391,reduces,0,0
124392,NFT,0,1
124393,in,0,1
124394,simulated,0,0
124395,CPR,0,0
124396,and,0,0
124397,improves,0,0
124398,TLV,0,0
124399,proportions,0,0
124400,during,0,1
124401,simulated,0,0
124402,CPR,0,0
124403,.,0,1
124404,Further,0,0
124405,research,0,0
124406,will,0,0
124407,test,0,0
124408,how,0,0
124409,these,0,0
124410,results,0,0
124411,translate,0,0
124412,into,0,1
124413,clinical,0,0
124414,performance,0,0
124415,and,0,1
124416,patient,0,1
124417,outcome,0,0
124418,.,0,1
124419,Intervention,0,1
124420,to,0,0
124421,lower,0,0
124422,household,0,1
124423,wood,0,1
124424,smoke,0,1
124425,exposure,0,0
124426,in,0,1
124427,Guatemala,0,1
124428,reduces,0,0
124429,ST-segment,0,1
124430,depression,0,1
124431,on,0,0
124432,electrocardiograms,0,1
124433,.,0,1
124434,BACKGROUND,0,0
124435,A,0,0
124436,large,0,1
124437,body,0,1
124438,of,0,0
124439,evidence,0,0
124440,suggests,0,0
124441,that,0,0
124442,fine,0,0
124443,particulate,0,1
124444,matter,0,0
124445,(,0,1
124446,PM,0,1
124447,),0,1
124448,air,0,0
124449,pollution,0,0
124450,is,0,0
124451,a,0,0
124452,cause,0,0
124453,of,0,0
124454,cardiovascular,0,1
124455,disease,0,1
124456,",",0,0
124457,but,0,0
124458,little,0,0
124459,is,0,0
124460,known,0,0
124461,in,0,0
124462,particular,0,0
124463,about,0,0
124464,the,0,1
124465,cardiovascular,0,1
124466,effects,0,0
124467,of,0,1
124468,indoor,0,1
124469,air,0,1
124470,pollution,0,0
124471,from,0,1
124472,household,0,1
124473,use,0,0
124474,of,0,1
124475,solid,0,1
124476,fuels,0,0
124477,in,0,1
124478,developing,0,1
124479,countries,0,1
124480,.,0,1
124481,RESPIRE,0,0
124482,(,0,0
124483,Randomized,0,1
124484,Exposure,0,0
124485,Study,0,1
124486,of,0,1
124487,Pollution,0,1
124488,Indoors,0,1
124489,and,0,1
124490,Respiratory,0,1
124491,Effects,0,0
124492,),0,1
124493,was,0,0
124494,a,0,0
124495,randomized,0,1
124496,trial,0,0
124497,of,0,0
124498,a,0,0
124499,chimney,0,1
124500,woodstove,0,0
124501,that,0,0
124502,reduces,0,0
124503,wood,0,0
124504,smoke,0,0
124505,exposure,0,0
124506,.,0,1
124507,OBJECTIVES,0,0
124508,We,0,0
124509,tested,0,0
124510,the,0,0
124511,hypotheses,0,0
124512,that,0,0
124513,the,0,0
124514,stove,0,0
124515,intervention,0,0
124516,",",0,0
124517,compared,0,0
124518,with,0,1
124519,open,0,1
124520,fire,0,1
124521,use,0,0
124522,",",0,0
124523,would,0,0
124524,reduce,0,0
124525,ST-segment,0,0
124526,depression,0,1
124527,and,0,0
124528,increase,0,0
124529,heart,0,1
124530,rate,0,0
124531,variability,0,0
124532,(,0,1
124533,HRV,0,1
124534,),0,1
124535,.,0,1
124536,METHODS,0,0
124537,We,0,0
124538,used,0,0
124539,two,0,0
124540,complementary,0,1
124541,study,0,1
124542,designs,0,0
124543,:,0,1
124544,a,0,1
124545,),0,0
124546,between-groups,0,0
124547,comparisons,0,0
124548,based,0,1
124549,on,0,0
124550,randomized,0,1
124551,stove,0,1
124552,assignment,0,0
124553,",",0,0
124554,and,0,0
124555,b,0,1
124556,),0,1
124557,before-and-after,0,1
124558,comparisons,0,0
124559,within,0,1
124560,control,1,1
124561,subjects,1,1
124562,who,1,1
124563,used,1,1
124564,open,1,1
124565,fires,1,1
124566,during,1,1
124567,the,1,0
124568,trial,1,0
124569,and,1,0
124570,received,1,1
124571,chimney,1,1
124572,stoves,1,0
124573,after,1,1
124574,the,1,1
124575,trial,1,0
124576,.,1,1
124577,Electrocardiogram,0,0
124578,sessions,0,0
124579,that,0,0
124580,lasted,0,1
124581,20,0,1
124582,hr,0,0
124583,were,0,1
124584,repeated,0,0
124585,up,0,1
124586,to,0,1
124587,three,0,0
124588,times,0,0
124589,among,0,1
124590,49,1,1
124591,intervention,1,1
124592,and,1,1
124593,70,1,1
124594,control,1,1
124595,women,1,1
124596,38-84,1,1
124597,years,1,1
124598,of,1,1
124599,age,1,1
124600,",",1,1
124601,and,1,0
124602,55,1,1
124603,control,1,1
124604,subjects,1,1
124605,were,0,1
124606,also,0,0
124607,assessed,0,0
124608,after,0,0
124609,receiving,0,1
124610,stoves,0,1
124611,.,0,1
124612,HRV,0,0
124613,and,0,0
124614,ST-segment,0,1
124615,values,0,0
124616,were,0,1
124617,assessed,0,0
124618,for,0,0
124619,each,0,0
124620,30-min,0,0
124621,period,0,0
124622,.,0,1
124623,ST-segment,0,0
124624,depression,0,1
124625,was,0,0
124626,defined,0,0
124627,as,0,0
124628,an,0,0
124629,average,0,0
124630,value,0,0
124631,below,0,1
124632,-1.00,0,0
124633,mm,0,1
124634,.,0,1
124635,Personal,0,0
124636,fine,0,1
124637,PM,0,1
124638,[,0,0
124639,aerodynamic,0,1
124640,diameter,0,1
124641,?,0,1
124642,2.5,0,0
124643,?m,0,1
124644,(,0,1
124645,PM?.?,0,0
124646,],0,1
124647,exposures,0,1
124648,were,0,1
124649,measured,0,0
124650,for,0,0
124651,24,0,1
124652,hr,0,0
124653,before,0,0
124654,each,0,0
124655,electrocardiogram,0,0
124656,.,0,1
124657,RESULTS,0,0
124658,PM?.?,0,0
124659,exposure,0,1
124660,means,0,0
124661,were,0,1
124662,266,0,1
124663,and,0,1
124664,102,0,1
124665,?g/m?,0,1
124666,during,0,0
124667,the,0,0
124668,trial,0,0
124669,period,0,0
124670,in,0,0
124671,the,0,0
124672,control,0,1
124673,and,0,0
124674,intervention,0,0
124675,groups,0,0
124676,",",0,1
124677,respectively,0,0
124678,.,0,0
124679,During,0,0
124680,the,0,0
124681,trial,0,0
124682,",",0,0
124683,the,0,0
124684,stove,0,0
124685,intervention,0,0
124686,was,0,0
124687,associated,0,0
124688,with,0,1
124689,an,0,1
124690,odds,0,0
124691,ratio,0,0
124692,of,0,1
124693,0.26,0,0
124694,(,0,1
124695,95,0,0
124696,%,0,0
124697,confidence,0,0
124698,interval,0,0
124699,",",0,0
124700,0.08-0.90,0,0
124701,),0,1
124702,for,0,0
124703,ST-segment,0,1
124704,depression,0,1
124705,.,0,1
124706,We,0,0
124707,found,0,0
124708,similar,0,0
124709,associations,0,0
124710,with,0,1
124711,the,0,1
124712,before-and-after,0,1
124713,comparison,0,0
124714,.,0,1
124715,The,0,0
124716,intervention,0,0
124717,was,0,0
124718,not,0,0
124719,significantly,0,0
124720,associated,0,0
124721,with,0,1
124722,HRV,0,1
124723,.,0,1
124724,CONCLUSIONS,0,0
124725,The,0,0
124726,stove,0,0
124727,intervention,0,0
124728,was,0,0
124729,associated,0,0
124730,with,0,1
124731,reduced,0,0
124732,occurrence,0,0
124733,of,0,0
124734,nonspecific,0,1
124735,ST-segment,0,1
124736,depression,0,1
124737,",",0,0
124738,suggesting,0,0
124739,that,0,0
124740,household,0,1
124741,wood,0,1
124742,smoke,0,1
124743,exposures,0,0
124744,affect,0,0
124745,ventricular,0,1
124746,repolarization,0,0
124747,and,0,0
124748,potentially,0,0
124749,cardiovascular,0,1
124750,health,0,1
124751,.,0,1
124752,Preoperative,0,1
124753,beta-blocker,0,1
124754,usage,0,0
124755,:,0,1
124756,is,0,0
124757,it,0,0
124758,really,0,0
124759,worthy,0,0
124760,of,0,0
124761,being,0,1
124762,a,0,1
124763,quality,0,0
124764,indicator,0,0
124765,?,0,1
124766,BACKGROUND,0,0
124767,Since,0,1
124768,2007,0,1
124769,",",0,0
124770,the,0,0
124771,use,0,0
124772,of,0,0
124773,preoperative,0,1
124774,?-blockers,0,1
124775,has,0,0
124776,been,0,0
124777,used,0,0
124778,as,0,0
124779,a,0,0
124780,quality,0,0
124781,standard,0,1
124782,for,1,1
124783,patients,1,1
124784,undergoing,1,1
124785,coronary,1,1
124786,artery,1,1
124787,bypass,1,1
124788,graft,1,1
124789,surgery,1,1
124790,.,1,1
124791,Recent,0,0
124792,studies,0,0
124793,have,0,0
124794,called,0,1
124795,into,0,0
124796,question,0,0
124797,of,0,0
124798,the,0,0
124799,benefit,0,0
124800,of,0,0
124801,empiric,0,0
124802,preoperative,0,1
124803,?-blocker,0,1
124804,use,0,0
124805,.,0,1
124806,METHODS,0,0
124807,Data,0,1
124808,were,0,1
124809,extracted,0,1
124810,from,0,1
124811,our,0,0
124812,Society,0,1
124813,of,0,0
124814,Thoracic,0,1
124815,Surgeons,0,1
124816,certified,0,1
124817,database,0,1
124818,for,1,1
124819,patients,1,1
124820,undergoing,1,1
124821,isolated,1,1
124822,coronary,1,1
124823,artery,1,1
124824,bypass,1,1
124825,graft,1,1
124826,surgery,1,1
124827,from,1,1
124828,2000,1,1
124829,to,1,1
124830,2008,1,1
124831,.,1,1
124832,We,0,0
124833,compared,0,0
124834,the,0,0
124835,outcomes,0,0
124836,for,1,1
124837,patients,1,1
124838,who,1,1
124839,received,1,1
124840,preoperative,1,1
124841,?-blockers,1,1
124842,with,1,1
124843,those,1,1
124844,of,1,1
124845,patients,1,1
124846,who,1,1
124847,did,1,1
124848,not,1,1
124849,.,1,0
124850,RESULTS,1,0
124851,The,0,0
124852,study,0,0
124853,group,0,1
124854,had,0,1
124855,"12,855",1,1
124856,patients,1,1
124857,",",1,1
124858,of,1,1
124859,whom,1,1
124860,"7,967",1,1
124861,(,1,1
124862,62.0,1,1
124863,%,1,0
124864,),1,1
124865,were,1,0
124866,treated,1,1
124867,preoperatively,1,1
124868,with,1,1
124869,?-blockers,1,1
124870,.,1,1
124871,Using,1,0
124872,propensity,0,0
124873,matching,0,1
124874,",",0,0
124875,we,0,0
124876,selected,0,1
124877,two,0,1
124878,matched,0,1
124879,groups,0,1
124880,of,0,1
124881,"4,474",0,1
124882,patients,0,1
124883,with,0,1
124884,preoperative,0,1
124885,?-blocker,0,1
124886,use,0,0
124887,and,0,0
124888,"4,474",0,1
124889,not,0,0
124890,using,0,0
124891,preoperative,0,1
124892,?-blockers,0,1
124893,.,0,1
124894,In,0,0
124895,the,0,0
124896,unmatched,0,1
124897,cohort,0,1
124898,",",0,0
124899,only,0,0
124900,deep,0,0
124901,sternal,0,1
124902,infection,0,1
124903,(,0,1
124904,0.3,0,0
124905,%,0,0
124906,versus,0,0
124907,0.5,0,0
124908,%,0,0
124909,without,0,1
124910,?-blockers,0,1
124911,;,0,1
124912,p=0.032,0,0
124913,),0,0
124914,",",0,0
124915,pneumonia,0,1
124916,(,0,1
124917,1.9,0,0
124918,%,0,0
124919,versus,0,0
124920,2.4,0,0
124921,%,0,0
124922,without,0,1
124923,?-blockers,0,1
124924,;,0,1
124925,p=0.039,0,0
124926,),0,0
124927,",",0,0
124928,and,0,0
124929,intraoperative,0,0
124930,blood,0,0
124931,usage,0,0
124932,(,0,1
124933,37.2,0,0
124934,%,0,0
124935,versus,0,0
124936,34.1,0,0
124937,%,0,0
124938,without,0,1
124939,?-blockers,0,1
124940,;,0,1
124941,p,0,0
124942,<,0,0
124943,0.001,0,0
124944,),0,1
124945,reached,0,0
124946,statistically,0,0
124947,significant,0,0
124948,difference,0,0
124949,.,0,1
124950,In,0,0
124951,the,0,0
124952,matched,0,1
124953,groups,0,0
124954,",",0,0
124955,there,0,0
124956,was,0,0
124957,no,0,0
124958,difference,0,0
124959,between,0,0
124960,adverse,0,0
124961,event,0,0
124962,rates,0,0
124963,in,0,1
124964,patients,0,1
124965,treated,0,1
124966,with,0,1
124967,?-blockers,0,1
124968,and,0,1
124969,those,0,1
124970,who,0,1
124971,were,0,1
124972,not,0,1
124973,.,0,0
124974,The,0,0
124975,number,0,0
124976,of,0,0
124977,patients,0,1
124978,requiring,0,1
124979,intraoperative,0,0
124980,blood,0,0
124981,product,0,0
124982,use,0,0
124983,was,0,0
124984,significantly,0,0
124985,higher,0,0
124986,among,0,1
124987,?-blocker-treated,0,1
124988,patients,0,1
124989,(,0,1
124990,p=0.004,0,0
124991,),0,1
124992,.,0,1
124993,Calculating,0,0
124994,the,0,0
124995,adjusted,0,0
124996,odds,0,0
124997,ratios,0,0
124998,showed,0,0
124999,that,0,0
125000,in,0,0
125001,the,0,1
125002,matched,0,1
125003,groups,0,0
125004,",",0,1
125005,the,0,0
125006,preoperative,0,0
125007,use,0,0
125008,of,0,1
125009,?-blockers,0,1
125010,was,0,0
125011,not,0,0
125012,an,0,0
125013,independent,0,0
125014,predictor,0,0
125015,of,0,0
125016,mortality,0,0
125017,.,0,1
125018,CONCLUSIONS,0,0
125019,A,0,0
125020,rational,0,0
125021,for,0,0
125022,preoperative,0,1
125023,?-blockade,0,1
125024,exists,0,0
125025,.,0,1
125026,However,0,0
125027,",",0,0
125028,as,0,0
125029,with,0,1
125030,any,0,1
125031,medical,0,1
125032,intervention,0,0
125033,",",0,0
125034,its,0,0
125035,application,0,0
125036,should,0,0
125037,be,0,0
125038,tailored,0,0
125039,to,0,0
125040,specific,0,0
125041,clinical,0,1
125042,scenarios,0,0
125043,.,0,1
125044,With,0,1
125045,no,0,0
125046,differences,0,0
125047,in,0,0
125048,mortality,0,0
125049,or,0,1
125050,morbidity,0,0
125051,",",0,0
125052,our,0,0
125053,findings,0,0
125054,do,0,0
125055,not,0,0
125056,support,0,0
125057,preoperative,0,0
125058,?-blockade,0,0
125059,as,0,0
125060,a,0,1
125061,useful,0,0
125062,quality,0,0
125063,indicator,0,0
125064,for,0,0
125065,coronary,0,1
125066,artery,0,1
125067,bypass,0,1
125068,graft,0,1
125069,surgery,0,1
125070,.,0,1
125071,Nepafenac,0,0
125072,for,0,1
125073,epiretinal,1,1
125074,membrane,1,0
125075,surgery,1,1
125076,.,1,1
125077,Behavioral,0,1
125078,effects,0,0
125079,of,0,1
125080,Org,0,1
125081,2766,0,1
125082,",",0,0
125083,a,0,0
125084,synthetic,0,0
125085,analog,0,0
125086,of,0,0
125087,the,0,0
125088,adrenocorticotrophic,0,0
125089,hormone,0,1
125090,(,0,1
125091,4-9,0,1
125092,),0,1
125093,",",0,1
125094,in,0,0
125095,14,1,1
125096,outpatient,1,1
125097,autistic,1,1
125098,children,1,1
125099,.,1,1
125100,Fourteen,1,1
125101,children,1,1
125102,(,1,1
125103,12,1,1
125104,infantile,1,1
125105,autism,1,1
125106,full,1,1
125107,syndrome,1,1
125108,present,1,0
125109,",",1,1
125110,2,1,1
125111,atypical,1,1
125112,pervasive,1,1
125113,developmental,1,1
125114,disorder,1,1
125115,),1,1
125116,between,1,0
125117,5,1,1
125118,and,1,1
125119,13,1,1
125120,years,1,1
125121,of,1,1
125122,age,1,1
125123,participated,0,1
125124,in,0,0
125125,a,0,1
125126,double-blind,0,0
125127,placebo-controlled,0,0
125128,cross-over,0,1
125129,trial,0,1
125130,.,0,1
125131,Each,0,0
125132,child,0,1
125133,received,0,1
125134,20,0,1
125135,mg,0,1
125136,Org,0,1
125137,2766,0,1
125138,(,0,1
125139,synthetic,0,0
125140,analog,0,0
125141,of,0,1
125142,ACTH,0,1
125143,4-9,0,1
125144,),0,1
125145,/day,0,0
125146,during,0,1
125147,4,0,0
125148,weeks,0,0
125149,",",0,1
125150,or,0,1
125151,placebo,0,0
125152,in,0,0
125153,a,0,1
125154,randomly,0,1
125155,assigned,0,1
125156,sequence,0,0
125157,.,0,1
125158,Drug,0,0
125159,effects,0,0
125160,were,0,1
125161,monitored,0,0
125162,by,0,0
125163,ethological,0,1
125164,playroom,0,1
125165,observation,0,0
125166,and,0,0
125167,by,0,0
125168,Aberrant,0,1
125169,Behavior,0,1
125170,Checklist,0,0
125171,ratings,0,0
125172,by,0,1
125173,parents,0,1
125174,and,0,1
125175,teachers,0,1
125176,.,0,1
125177,Data,0,0
125178,of,0,0
125179,the,0,0
125180,playroom,0,0
125181,observation,0,0
125182,pointed,0,0
125183,to,0,0
125184,an,0,0
125185,activating,0,0
125186,influence,0,0
125187,of,0,1
125188,Org,0,1
125189,2766,0,1
125190,",",0,0
125191,as,0,0
125192,revealed,0,0
125193,by,0,0
125194,a,0,1
125195,significant,0,0
125196,decrease,0,0
125197,of,0,0
125198,stereotypic,0,1
125199,behavior,0,0
125200,and,0,1
125201,significant,0,0
125202,increases,0,0
125203,in,0,1
125204,change,0,0
125205,toys,0,0
125206,",",0,0
125207,locomote,0,1
125208,",",0,0
125209,and,0,0
125210,talk,0,0
125211,.,0,1
125212,Checklist,0,0
125213,ratings,0,0
125214,did,0,0
125215,not,0,0
125216,show,0,0
125217,significant,0,0
125218,changes,0,0
125219,.,0,1
125220,The,0,0
125221,clinical,0,0
125222,implications,0,0
125223,of,0,1
125224,these,0,0
125225,findings,0,0
125226,are,0,0
125227,discussed,0,0
125228,.,0,1
125229,Low-dose,0,0
125230,magnesium,0,0
125231,sulfate,0,0
125232,versus,0,0
125233,Pritchard,0,1
125234,regimen,0,0
125235,for,0,0
125236,the,0,0
125237,treatment,0,0
125238,of,0,0
125239,eclampsia,1,1
125240,imminent,1,1
125241,eclampsia,1,1
125242,.,1,1
125243,Predictors,0,0
125244,and,0,1
125245,moderators,0,0
125246,of,0,1
125247,parent,0,1
125248,training,0,0
125249,efficacy,0,0
125250,in,0,0
125251,a,0,0
125252,sample,1,1
125253,of,1,0
125254,children,1,1
125255,with,1,1
125256,autism,1,1
125257,spectrum,1,1
125258,disorders,1,1
125259,and,1,1
125260,serious,1,1
125261,behavioral,1,1
125262,problems,1,1
125263,.,1,1
125264,The,0,0
125265,Research,0,1
125266,Units,0,0
125267,on,0,0
125268,Pediatric,0,1
125269,Psychopharmacology,0,1
125270,--,0,1
125271,Autism,0,1
125272,Network,0,1
125273,reported,0,1
125274,additional,0,0
125275,benefit,0,0
125276,when,0,0
125277,adding,0,0
125278,parent,0,0
125279,training,0,0
125280,(,0,1
125281,PT,0,1
125282,),0,1
125283,to,0,1
125284,antipsychotic,0,1
125285,medication,0,1
125286,in,0,1
125287,children,1,1
125288,with,1,1
125289,autism,1,1
125290,spectrum,1,1
125291,disorders,1,1
125292,and,1,1
125293,serious,1,1
125294,behavior,1,1
125295,problems,1,1
125296,.,1,1
125297,The,0,0
125298,intent-to-treat,0,0
125299,analyses,0,0
125300,were,0,1
125301,rerun,0,0
125302,with,0,1
125303,putative,0,1
125304,predictors,0,0
125305,and,0,1
125306,moderators,0,0
125307,.,0,1
125308,The,0,0
125309,Home,0,0
125310,Situations,0,0
125311,Questionnaire,0,0
125312,(,0,1
125313,HSQ,0,1
125314,),0,1
125315,and,0,0
125316,the,0,0
125317,Hyperactivity/Noncompliance,0,0
125318,subscale,0,0
125319,of,0,0
125320,the,0,0
125321,Aberrant,0,1
125322,Behavior,0,1
125323,Checklist,0,0
125324,were,0,1
125325,used,0,0
125326,as,0,0
125327,outcome,0,0
125328,measures,0,0
125329,.,0,1
125330,Candidate,0,1
125331,predictors,0,0
125332,and,0,1
125333,moderators,0,0
125334,included,0,1
125335,21,0,1
125336,demographics,0,0
125337,and,0,1
125338,baseline,0,1
125339,measures,0,0
125340,of,0,1
125341,behavior,0,1
125342,.,0,1
125343,Higher,0,0
125344,baseline,0,0
125345,HSQ,0,1
125346,scores,0,0
125347,predicted,0,0
125348,greater,0,0
125349,improvement,0,0
125350,on,0,0
125351,the,0,0
125352,HSQ,0,1
125353,regardless,0,0
125354,of,0,0
125355,treatment,0,0
125356,assignment,0,0
125357,",",0,0
125358,but,0,0
125359,no,0,0
125360,other,0,0
125361,predictors,0,0
125362,of,0,1
125363,outcome,0,0
125364,were,0,1
125365,observed,0,0
125366,.,0,1
125367,None,0,0
125368,of,0,0
125369,the,0,0
125370,variables,0,0
125371,measured,0,0
125372,in,0,0
125373,this,0,0
125374,study,0,0
125375,moderated,0,0
125376,response,0,0
125377,to,0,1
125378,PT,0,1
125379,.,0,1
125380,Antipsychotic,0,0
125381,medication,0,0
125382,plus,0,0
125383,PT,0,0
125384,appears,0,0
125385,to,0,0
125386,be,0,0
125387,equally,0,0
125388,effective,0,0
125389,for,0,0
125390,children,1,1
125391,with,1,1
125392,a,1,1
125393,wide,1,0
125394,range,1,1
125395,of,1,0
125396,demographic,1,0
125397,and,1,1
125398,behavioral,1,1
125399,characteristics,1,1
125400,.,1,1
125401,Using,0,1
125402,the,0,1
125403,transporters,0,0
125404,DVD,0,1
125405,as,0,0
125406,a,0,1
125407,learning,0,0
125408,tool,0,0
125409,for,0,0
125410,children,1,1
125411,with,1,1
125412,Autism,1,1
125413,Spectrum,1,1
125414,Disorders,1,1
125415,(,1,1
125416,ASD,1,1
125417,),1,1
125418,.,1,1
125419,Data,0,0
125420,from,0,1
125421,two,1,1
125422,groups,1,1
125423,of,1,1
125424,children,1,1
125425,who,0,1
125426,were,0,1
125427,randomly,0,1
125428,allocated,0,1
125429,to,0,0
125430,those,0,1
125431,groups,0,0
125432,showed,0,0
125433,that,0,0
125434,the,0,0
125435,ability,0,0
125436,of,0,0
125437,children,1,1
125438,with,1,1
125439,ASD,1,1
125440,to,0,1
125441,identify,0,0
125442,and,0,0
125443,label,0,0
125444,basic,0,0
125445,and,0,0
125446,complex,0,1
125447,facial,0,1
125448,expressions,0,0
125449,following,0,0
125450,a,0,1
125451,3-week,0,0
125452,home,0,1
125453,based,0,1
125454,DVD,0,0
125455,intervention,0,0
125456,significantly,0,0
125457,improved,0,0
125458,when,0,0
125459,viewing,0,0
125460,The,0,0
125461,Transporters,0,0
125462,DVD,0,1
125463,.,0,1
125464,Improvements,0,0
125465,in,0,0
125466,emotion,0,0
125467,recognition,0,0
125468,appear,0,0
125469,related,0,0
125470,to,0,0
125471,the,0,0
125472,content,0,0
125473,of,0,0
125474,the,0,0
125475,DVD,0,1
125476,as,0,0
125477,participants,0,1
125478,in,0,1
125479,a,0,1
125480,control,0,1
125481,group,0,1
125482,who,0,1
125483,observed,0,0
125484,an,0,1
125485,alternate,0,0
125486,DVD,0,0
125487,showed,0,0
125488,no,0,0
125489,such,0,0
125490,improvement,0,0
125491,.,0,1
125492,Although,0,0
125493,social,0,0
125494,behaviour,0,0
125495,improved,0,0
125496,significantly,0,0
125497,as,0,0
125498,a,0,0
125499,result,0,0
125500,of,0,0
125501,watching,0,1
125502,The,0,0
125503,Transporters,0,0
125504,",",0,1
125505,a,0,1
125506,significant,0,0
125507,improvement,0,0
125508,in,0,1
125509,social,0,1
125510,behaviour,0,0
125511,was,0,0
125512,however,0,0
125513,",",0,0
125514,also,0,0
125515,observed,0,0
125516,in,0,0
125517,the,0,0
125518,Thomas,0,1
125519,the,0,0
125520,Tank,0,0
125521,Engine,0,0
125522,condition,0,0
125523,suggesting,0,0
125524,the,0,0
125525,unique,0,1
125526,content,0,0
125527,of,0,0
125528,The,0,0
125529,Transporters,0,0
125530,DVD,0,0
125531,was,0,0
125532,not,0,0
125533,pivotal,0,0
125534,to,0,0
125535,the,0,0
125536,improvement,0,0
125537,of,0,0
125538,social,0,0
125539,behaviour,0,0
125540,in,0,1
125541,general,0,1
125542,.,0,1
125543,Comparative,0,0
125544,effectiveness,0,0
125545,of,0,0
125546,exercise,0,0
125547,electrocardiography,0,1
125548,with,0,1
125549,or,0,1
125550,without,0,1
125551,myocardial,0,1
125552,perfusion,0,0
125553,single,0,0
125554,photon,0,0
125555,emission,0,1
125556,computed,0,0
125557,tomography,0,1
125558,in,0,0
125559,women,1,1
125560,with,1,1
125561,suspected,1,1
125562,coronary,1,1
125563,artery,1,1
125564,disease,1,1
125565,:,1,1
125566,results,0,0
125567,from,0,1
125568,the,0,1
125569,What,0,1
125570,Is,0,0
125571,the,0,1
125572,Optimal,0,0
125573,Method,0,0
125574,for,0,1
125575,Ischemia,0,1
125576,Evaluation,0,0
125577,in,0,1
125578,Women,0,1
125579,(,0,1
125580,WOMEN,0,1
125581,),0,1
125582,trial,0,1
125583,.,0,1
125584,BACKGROUND,0,0
125585,There,0,0
125586,is,0,0
125587,a,0,0
125588,paucity,0,0
125589,of,0,0
125590,randomized,0,1
125591,trials,0,1
125592,regarding,0,0
125593,diagnostic,0,1
125594,testing,0,1
125595,in,0,1
125596,women,1,1
125597,with,1,1
125598,suspected,1,1
125599,coronary,1,1
125600,artery,1,1
125601,disease,1,1
125602,(,1,1
125603,CAD,1,0
125604,),1,1
125605,.,1,1
125606,It,0,0
125607,remains,0,0
125608,unclear,0,0
125609,whether,0,0
125610,the,0,0
125611,addition,0,0
125612,of,0,0
125613,myocardial,0,1
125614,perfusion,0,0
125615,imaging,0,0
125616,(,0,1
125617,MPI,0,1
125618,),0,1
125619,to,0,0
125620,the,0,0
125621,standard,0,1
125622,ECG,0,0
125623,exercise,0,1
125624,treadmill,0,0
125625,test,0,0
125626,(,0,1
125627,ETT,0,1
125628,),0,1
125629,provides,0,0
125630,incremental,0,0
125631,information,0,0
125632,to,0,0
125633,improve,0,0
125634,clinical,0,0
125635,decision,0,0
125636,making,0,0
125637,in,0,0
125638,women,1,1
125639,with,1,1
125640,suspected,1,1
125641,CAD,1,1
125642,.,1,1
125643,METHODS,0,0
125644,AND,0,0
125645,RESULTS,0,1
125646,We,0,0
125647,randomized,0,1
125648,symptomatic,1,1
125649,women,1,1
125650,with,1,1
125651,suspected,1,1
125652,CAD,1,0
125653,",",1,0
125654,an,1,0
125655,interpretable,1,0
125656,ECG,1,0
125657,",",1,1
125658,and,1,0
125659,?5,1,0
125660,metabolic,1,1
125661,equivalents,1,0
125662,on,1,0
125663,the,1,1
125664,Duke,1,1
125665,Activity,1,0
125666,Status,1,0
125667,Index,1,1
125668,to,1,1
125669,1,0,1
125670,of,0,1
125671,2,0,1
125672,diagnostic,0,1
125673,strategies,0,0
125674,:,0,1
125675,ETT,0,1
125676,or,0,1
125677,exercise,0,1
125678,MPI,0,1
125679,.,0,1
125680,The,0,0
125681,primary,0,0
125682,end,0,0
125683,point,0,0
125684,was,0,0
125685,2-year,0,0
125686,incidence,0,0
125687,of,0,0
125688,major,0,1
125689,adverse,0,0
125690,cardiac,0,1
125691,events,0,0
125692,",",0,0
125693,defined,0,1
125694,as,0,0
125695,CAD,0,0
125696,death,0,0
125697,or,0,1
125698,hospitalization,0,1
125699,for,0,0
125700,an,0,1
125701,acute,0,1
125702,coronary,0,1
125703,syndrome,0,1
125704,or,0,1
125705,heart,0,1
125706,failure,0,1
125707,.,0,1
125708,A,0,0
125709,total,1,1
125710,of,1,0
125711,824,1,1
125712,women,1,1
125713,were,1,1
125714,randomized,0,1
125715,to,0,1
125716,ETT,0,1
125717,or,0,1
125718,exercise,0,1
125719,MPI,0,1
125720,.,0,1
125721,For,0,1
125722,women,0,1
125723,randomized,0,1
125724,to,0,1
125725,ETT,0,1
125726,",",0,1
125727,ECG,0,1
125728,results,0,0
125729,were,0,1
125730,normal,0,1
125731,in,0,1
125732,64,0,1
125733,%,0,0
125734,",",0,0
125735,indeterminate,0,1
125736,in,0,0
125737,16,0,1
125738,%,0,0
125739,",",0,0
125740,and,0,0
125741,abnormal,0,1
125742,in,0,1
125743,20,0,1
125744,%,0,0
125745,.,0,1
125746,By,0,0
125747,comparison,0,0
125748,",",0,0
125749,the,0,0
125750,exercise,0,0
125751,MPI,0,1
125752,results,0,0
125753,were,0,1
125754,normal,0,1
125755,in,0,1
125756,91,0,1
125757,%,0,0
125758,",",0,0
125759,mildly,0,1
125760,abnormal,0,1
125761,in,0,0
125762,3,0,1
125763,%,0,0
125764,",",0,0
125765,and,0,0
125766,moderate,0,1
125767,to,0,0
125768,severely,0,1
125769,abnormal,0,1
125770,in,0,0
125771,6,0,1
125772,%,0,0
125773,.,0,1
125774,At,0,0
125775,2,0,1
125776,years,0,1
125777,",",0,0
125778,there,0,0
125779,was,0,0
125780,no,0,0
125781,difference,0,0
125782,in,0,0
125783,major,0,1
125784,adverse,0,0
125785,cardiac,0,1
125786,events,0,0
125787,(,0,1
125788,98.0,0,0
125789,%,0,0
125790,for,0,1
125791,ETT,0,1
125792,and,0,1
125793,97.7,0,0
125794,%,0,0
125795,for,0,1
125796,MPI,0,1
125797,;,0,1
125798,P=0.59,0,0
125799,),0,1
125800,.,0,1
125801,Compared,0,0
125802,with,0,1
125803,ETT,0,1
125804,",",0,1
125805,index,0,0
125806,testing,0,0
125807,costs,0,0
125808,were,0,1
125809,higher,0,0
125810,for,0,0
125811,exercise,0,0
125812,MPI,0,1
125813,(,0,1
125814,P,0,0
125815,<,0,0
125816,0.001,0,0
125817,),0,1
125818,",",0,0
125819,whereas,0,0
125820,downstream,0,0
125821,procedural,0,1
125822,costs,0,0
125823,were,0,1
125824,slightly,0,0
125825,lower,0,0
125826,(,0,0
125827,P=0.0008,0,0
125828,),0,1
125829,.,0,1
125830,Overall,0,0
125831,",",0,0
125832,the,0,0
125833,cumulative,0,0
125834,diagnostic,0,1
125835,cost,0,0
125836,savings,0,0
125837,was,0,0
125838,48,0,1
125839,%,0,0
125840,for,0,1
125841,ETT,0,1
125842,compared,0,0
125843,with,0,1
125844,exercise,0,1
125845,MPI,0,1
125846,(,0,1
125847,P,0,0
125848,<,0,0
125849,0.001,0,0
125850,),0,1
125851,.,0,1
125852,CONCLUSIONS,0,0
125853,In,0,0
125854,low-risk,0,1
125855,",",0,1
125856,exercising,0,1
125857,women,0,1
125858,",",0,1
125859,a,0,1
125860,diagnostic,0,0
125861,strategy,0,0
125862,that,0,0
125863,uses,0,0
125864,ETT,0,0
125865,versus,0,0
125866,exercise,0,1
125867,MPI,0,1
125868,yields,0,0
125869,similar,0,0
125870,2-year,0,1
125871,posttest,0,0
125872,outcomes,0,0
125873,while,0,0
125874,providing,0,0
125875,significant,0,0
125876,diagnostic,0,1
125877,cost,0,0
125878,savings,0,0
125879,.,0,1
125880,The,0,0
125881,ETT,0,0
125882,with,0,1
125883,selective,0,1
125884,follow-up,0,0
125885,testing,0,0
125886,should,0,0
125887,be,0,0
125888,considered,0,0
125889,as,0,0
125890,the,0,0
125891,initial,0,0
125892,diagnostic,0,0
125893,strategy,0,0
125894,in,0,1
125895,symptomatic,1,1
125896,women,1,1
125897,with,1,1
125898,suspected,1,1
125899,CAD,1,1
125900,.,1,1
125901,CLINICAL,0,1
125902,TRIAL,0,0
125903,REGISTRATION,0,1
125904,http,0,0
125905,:,0,1
125906,//www.clinicaltrials.gov,0,0
125907,.,0,1
125908,Unique,0,0
125909,identifier,0,1
125910,:,0,1
125911,NCT00282711,0,0
125912,.,0,1
125913,Increasing,0,0
125914,verbal,0,0
125915,responsiveness,0,0
125916,in,0,1
125917,parents,1,1
125918,of,1,1
125919,children,1,1
125920,with,1,1
125921,autism,1,1
125922,:,1,1
125923,a,1,0
125924,pilot,0,0
125925,study,0,1
125926,.,0,1
125927,Correlational,0,0
125928,studies,0,0
125929,have,0,0
125930,revealed,0,0
125931,a,0,0
125932,positive,0,0
125933,relationship,0,0
125934,between,0,0
125935,parent,1,1
125936,verbal,0,0
125937,responsiveness,0,0
125938,and,0,1
125939,language,0,1
125940,outcomes,0,0
125941,in,0,1
125942,children,1,1
125943,with,1,1
125944,autism,1,1
125945,.,1,1
125946,We,0,0
125947,investigated,0,0
125948,whether,0,0
125949,parents,1,1
125950,of,1,1
125951,young,1,1
125952,children,1,1
125953,on,1,0
125954,the,1,0
125955,autism,1,1
125956,spectrum,1,1
125957,could,0,0
125958,learn,0,0
125959,and,0,0
125960,implement,0,0
125961,the,0,0
125962,specific,0,0
125963,categories,0,1
125964,of,0,1
125965,verbal,0,1
125966,responsiveness,0,0
125967,that,0,0
125968,have,0,0
125969,been,0,0
125970,suggested,0,0
125971,to,0,0
125972,facilitate,0,0
125973,language,0,0
125974,development,0,0
125975,.,0,1
125976,Parents,1,0
125977,were,0,1
125978,taught,0,1
125979,to,0,0
125980,increase,0,0
125981,their,0,1
125982,verbal,0,0
125983,responsiveness,0,0
125984,in,0,0
125985,the,0,0
125986,context,0,0
125987,of,0,0
125988,a,0,1
125989,short-term,0,0
125990,language,0,0
125991,intervention,0,0
125992,that,0,0
125993,included,0,1
125994,group,0,0
125995,parent,0,1
125996,education,0,1
125997,sessions,0,0
125998,",",0,0
125999,as,0,0
126000,well,0,0
126001,as,0,0
126002,individual,0,0
126003,and,0,1
126004,small-group,0,1
126005,coaching,0,0
126006,sessions,0,0
126007,of,0,1
126008,parent-child,0,1
126009,play,0,0
126010,interactions,0,1
126011,.,0,1
126012,Parents,1,0
126013,in,0,0
126014,the,0,0
126015,treatment,0,0
126016,group,0,0
126017,increased,0,0
126018,their,0,0
126019,use,0,0
126020,of,0,1
126021,comments,0,0
126022,that,0,0
126023,:,0,1
126024,described,0,0
126025,their,0,1
126026,child,0,1
126027,'s,0,1
126028,focus,0,1
126029,of,0,1
126030,attention,0,0
126031,;,0,1
126032,interpreted,0,0
126033,or,0,1
126034,expanded,0,0
126035,child,0,1
126036,communication,0,0
126037,acts,0,0
126038,;,0,1
126039,and,0,1
126040,prompted,0,1
126041,child,0,1
126042,communication,0,0
126043,.,0,1
126044,Preliminary,0,0
126045,treatment,0,0
126046,effects,0,0
126047,were,0,1
126048,also,0,0
126049,noted,0,0
126050,in,0,0
126051,children,0,1
126052,'s,0,1
126053,prompted,0,1
126054,and,0,1
126055,spontaneous,0,1
126056,communication,0,0
126057,.,0,1
126058,These,0,0
126059,results,0,0
126060,support,0,0
126061,the,0,0
126062,use,0,0
126063,of,0,0
126064,parent-mediated,0,1
126065,interventions,0,1
126066,targeting,0,1
126067,verbal,0,0
126068,responsiveness,0,0
126069,to,0,0
126070,facilitate,0,0
126071,language,0,0
126072,development,0,0
126073,and,0,0
126074,communication,0,0
126075,in,0,1
126076,young,1,1
126077,children,1,1
126078,with,1,1
126079,autism,1,1
126080,.,1,1
126081,Ameliorating,0,1
126082,intrusive,1,1
126083,memories,1,1
126084,of,1,1
126085,distressing,1,1
126086,experiences,1,0
126087,using,0,1
126088,computerized,0,1
126089,reappraisal,0,1
126090,training,0,0
126091,.,0,1
126092,The,0,0
126093,types,0,0
126094,of,0,1
126095,appraisals,0,0
126096,that,0,0
126097,follow,1,0
126098,traumatic,1,1
126099,experiences,1,0
126100,have,0,1
126101,been,0,0
126102,linked,0,0
126103,to,0,0
126104,the,0,0
126105,emergence,0,1
126106,of,0,0
126107,posttraumatic,0,0
126108,stress,0,1
126109,disorder,0,1
126110,(,0,1
126111,PTSD,0,1
126112,),0,1
126113,.,0,1
126114,Could,0,0
126115,changing,0,0
126116,reappraisals,0,0
126117,following,0,0
126118,a,0,1
126119,stressful,0,0
126120,event,0,0
126121,reduce,0,0
126122,the,0,0
126123,emergence,0,0
126124,of,0,0
126125,PTSD,0,1
126126,symptoms,0,1
126127,?,0,1
126128,The,0,0
126129,present,0,0
126130,proof-of-principle,0,0
126131,study,0,1
126132,examined,0,0
126133,whether,0,0
126134,a,0,0
126135,nonexplicit,0,0
126136,",",0,0
126137,systematic,0,0
126138,computerized,0,0
126139,training,0,0
126140,in,0,0
126141,reappraisal,0,0
126142,style,0,0
126143,following,1,0
126144,a,1,0
126145,stressful,1,0
126146,event,1,0
126147,(,1,0
126148,a,1,0
126149,highly,1,0
126150,distressing,1,0
126151,film,1,0
126152,),1,1
126153,could,0,0
126154,reduce,0,0
126155,intrusive,0,0
126156,memories,0,0
126157,of,0,1
126158,the,0,0
126159,film,0,0
126160,",",0,0
126161,and,0,0
126162,symptoms,0,0
126163,associated,0,0
126164,with,0,1
126165,posttraumatic,0,0
126166,distress,0,0
126167,over,0,0
126168,the,0,0
126169,subsequent,0,0
126170,week,0,0
126171,.,0,1
126172,Participants,1,1
126173,were,0,1
126174,trained,0,1
126175,to,0,0
126176,adopt,0,0
126177,a,0,0
126178,generally,0,0
126179,positive,0,0
126180,or,0,1
126181,negative,0,1
126182,poststressor,0,0
126183,appraisal,0,0
126184,style,0,0
126185,using,0,0
126186,a,0,0
126187,series,0,1
126188,of,0,0
126189,scripted,0,1
126190,vignettes,0,1
126191,after,0,1
126192,having,0,1
126193,been,0,1
126194,exposed,0,1
126195,to,0,0
126196,highly,0,0
126197,distressing,0,0
126198,film,0,0
126199,clips,0,1
126200,.,0,1
126201,The,0,0
126202,training,0,0
126203,targeted,0,1
126204,self-efficacy,0,0
126205,beliefs,0,0
126206,and,0,1
126207,reappraisals,0,1
126208,of,0,1
126209,secondary,0,1
126210,emotions,0,0
126211,(,0,1
126212,emotions,0,0
126213,in,0,1
126214,response,0,0
126215,to,0,1
126216,the,0,0
126217,emotional,0,0
126218,reactions,0,0
126219,elicited,0,0
126220,by,0,0
126221,the,0,0
126222,film,0,0
126223,),0,1
126224,.,0,1
126225,Successful,0,0
126226,appraisal,0,0
126227,induction,0,1
126228,was,0,0
126229,verified,0,0
126230,using,0,0
126231,novel,0,1
126232,vignettes,0,1
126233,and,0,1
126234,via,0,1
126235,change,0,0
126236,scores,0,0
126237,on,0,0
126238,the,0,0
126239,post,0,1
126240,traumatic,0,1
126241,cognitions,0,0
126242,inventory,0,1
126243,.,0,1
126244,Compared,0,0
126245,with,0,1
126246,those,0,1
126247,trained,0,1
126248,negatively,0,0
126249,",",0,0
126250,those,0,0
126251,trained,0,1
126252,positively,0,0
126253,reported,0,0
126254,in,0,0
126255,a,0,0
126256,diary,0,0
126257,fewer,0,0
126258,intrusive,0,1
126259,memories,0,0
126260,of,0,1
126261,the,0,0
126262,film,0,0
126263,during,0,0
126264,the,0,0
126265,subsequent,0,0
126266,week,0,0
126267,",",0,0
126268,and,0,0
126269,lower,0,0
126270,scores,0,0
126271,on,0,0
126272,the,0,0
126273,Impact,0,0
126274,of,0,0
126275,Event,0,0
126276,Scale,0,1
126277,(,0,0
126278,a,0,0
126279,widely,0,0
126280,used,0,0
126281,measure,0,0
126282,of,0,0
126283,posttraumatic,0,1
126284,stress,0,1
126285,symptoms,0,1
126286,),0,1
126287,.,0,1
126288,Results,0,0
126289,support,0,0
126290,the,0,0
126291,use,0,0
126292,of,0,0
126293,computerized,0,1
126294,",",0,1
126295,nonexplicit,0,0
126296,",",0,0
126297,reappraisal,0,0
126298,training,0,0
126299,after,1,0
126300,a,1,1
126301,stressful,1,0
126302,event,1,0
126303,has,0,0
126304,occurred,0,0
126305,and,0,0
126306,provide,0,0
126307,a,0,0
126308,platform,0,0
126309,for,0,0
126310,future,0,0
126311,translational,0,1
126312,studies,0,0
126313,with,0,1
126314,clinical,0,1
126315,populations,0,1
126316,that,0,0
126317,have,0,0
126318,experienced,0,0
126319,significant,0,0
126320,real-world,0,1
126321,stress,0,0
126322,or,0,1
126323,trauma,0,1
126324,.,0,1
126325,Effect,0,0
126326,of,0,0
126327,ozone,0,0
126328,application,0,0
126329,on,0,0
126330,the,0,0
126331,resin-dentin,0,0
126332,microtensile,0,0
126333,bond,0,0
126334,strength,0,0
126335,.,0,0
126336,When,0,0
126337,ozone,0,0
126338,is,0,0
126339,used,0,0
126340,during,0,0
126341,caries,0,1
126342,treatment,0,1
126343,",",0,1
126344,bond,0,0
126345,strength,0,0
126346,can,0,0
126347,be,0,0
126348,compromised,0,0
126349,by,0,0
126350,the,0,0
126351,release,0,0
126352,of,0,0
126353,oxygen,0,0
126354,.,0,1
126355,The,0,0
126356,use,0,0
126357,of,0,0
126358,antioxidant,0,0
126359,agents,0,0
126360,neutralizes,0,0
126361,the,0,0
126362,free,0,0
126363,oxygen,0,0
126364,.,0,1
126365,The,0,0
126366,aim,0,0
126367,of,0,0
126368,this,0,0
126369,study,0,0
126370,was,0,0
126371,to,0,0
126372,evaluate,0,0
126373,the,0,0
126374,effects,0,0
126375,of,0,0
126376,ozone,0,0
126377,and,0,1
126378,sodium,0,0
126379,ascorbate,0,0
126380,on,0,0
126381,resin-dentin,0,0
126382,microtensile,0,0
126383,bond,0,0
126384,strength,0,0
126385,(,0,1
126386,?TBS,0,1
126387,),0,1
126388,.,0,1
126389,Forty,1,1
126390,human,1,1
126391,third,1,1
126392,molars,1,1
126393,were,0,1
126394,divided,0,1
126395,into,0,1
126396,four,0,1
126397,groups,0,1
126398,:,0,1
126399,Group,0,1
126400,1,0,0
126401,",",0,0
126402,not,0,0
126403,treated,0,1
126404,with,0,1
126405,ozone,0,0
126406,;,0,1
126407,Group,0,1
126408,2,0,1
126409,",",0,0
126410,ozone,0,0
126411,application,0,0
126412,followed,0,0
126413,by,0,0
126414,acid,0,0
126415,etching,0,0
126416,;,0,1
126417,Group,0,1
126418,3,0,0
126419,",",0,0
126420,acid,0,0
126421,etching,0,0
126422,followed,0,0
126423,by,0,0
126424,ozone,0,0
126425,application,0,0
126426,;,0,1
126427,and,0,1
126428,Group,0,1
126429,4,0,0
126430,",",0,0
126431,ozone,0,0
126432,and,0,0
126433,application,0,0
126434,of,0,0
126435,sodium,0,0
126436,ascorbate,0,0
126437,.,0,1
126438,Bonded,0,0
126439,beams,0,0
126440,(,0,1
126441,1.0,0,0
126442,mm,0,1
126443,(,0,1
126444,2,0,1
126445,),0,1
126446,),0,1
126447,were,0,1
126448,tested,0,0
126449,under,0,1
126450,tension,0,1
126451,(,0,1
126452,0.5,0,0
126453,mm,0,1
126454,min,0,0
126455,(,0,1
126456,-1,0,0
126457,),0,1
126458,),0,1
126459,.,0,1
126460,The,0,0
126461,?TBS,0,1
126462,values,0,0
126463,were,0,1
126464,analyzed,0,0
126465,using,0,0
126466,one-way,0,0
126467,analysis,0,0
126468,of,0,0
126469,variance,0,0
126470,(,0,1
126471,ANOVA,0,1
126472,),0,1
126473,and,0,0
126474,the,0,0
126475,Tukey,0,0
126476,test,0,0
126477,(,0,1
126478,p=0.05,0,0
126479,),0,1
126480,.,0,1
126481,All,0,1
126482,beams,0,0
126483,that,0,0
126484,fractured,0,1
126485,were,0,0
126486,analyzed,0,0
126487,under,0,1
126488,stereomicroscopy,0,0
126489,(,0,1
126490,40?,0,1
126491,),0,1
126492,.,0,1
126493,Group,0,1
126494,1,0,0
126495,had,0,1
126496,significantly,0,0
126497,higher,0,0
126498,?TBS,0,1
126499,values,0,0
126500,than,0,1
126501,Group,0,1
126502,2,0,1
126503,or,0,1
126504,3,0,1
126505,.,0,1
126506,The,0,0
126507,?TBS,0,1
126508,values,0,0
126509,of,0,1
126510,Groups,0,1
126511,1,0,1
126512,and,0,1
126513,4,0,0
126514,were,0,1
126515,similar,0,0
126516,and,0,0
126517,higher,0,0
126518,than,0,0
126519,those,0,0
126520,of,0,0
126521,Group,0,1
126522,2,0,1
126523,.,0,1
126524,The,0,0
126525,use,0,0
126526,of,0,0
126527,ozone,0,0
126528,in,0,1
126529,Group,0,1
126530,2,0,1
126531,resulted,0,0
126532,in,0,1
126533,lower,0,0
126534,values,0,0
126535,of,0,0
126536,?TBS,0,1
126537,in,0,1
126538,all,0,1
126539,conditions,0,1
126540,evaluated,0,0
126541,.,0,1
126542,The,0,0
126543,predominant,0,0
126544,failure,0,1
126545,mode,0,0
126546,was,0,0
126547,adhesive,0,0
126548,.,0,1
126549,The,0,0
126550,application,0,0
126551,of,0,0
126552,ozone,0,0
126553,decreased,0,0
126554,the,0,0
126555,?TBS,0,1
126556,of,0,0
126557,the,0,0
126558,dentin-composite,0,0
126559,resin,0,1
126560,interface,0,0
126561,.,0,1
126562,These,0,0
126563,values,0,0
126564,were,0,0
126565,reversed,0,0
126566,when,0,0
126567,compared,0,0
126568,with,0,1
126569,Groups,0,1
126570,1,0,1
126571,and,0,0
126572,2,0,0
126573,when,0,0
126574,sodium,0,0
126575,ascorbate,0,0
126576,was,0,0
126577,used,0,0
126578,.,0,1
126579,The,0,0
126580,relationship,0,0
126581,between,0,0
126582,physical,0,1
126583,activity,0,0
126584,level,0,0
126585,",",0,0
126586,anxiety,0,0
126587,",",0,0
126588,depression,0,1
126589,",",0,0
126590,and,0,0
126591,functional,0,0
126592,ability,0,0
126593,in,0,1
126594,children,1,1
126595,and,1,1
126596,adolescents,1,1
126597,with,1,1
126598,juvenile,1,1
126599,idiopathic,1,1
126600,arthritis,1,1
126601,.,1,1
126602,The,0,0
126603,aim,0,0
126604,of,0,0
126605,this,0,0
126606,study,0,0
126607,was,0,0
126608,to,0,0
126609,assess,0,0
126610,the,0,0
126611,relationships,0,0
126612,between,0,0
126613,physical,0,1
126614,activity,0,0
126615,level,0,0
126616,and,0,0
126617,anxiety,0,1
126618,",",0,0
126619,depression,0,1
126620,",",0,0
126621,and,0,0
126622,functional,0,0
126623,ability,0,0
126624,in,0,1
126625,children,1,1
126626,and,1,1
126627,adolescents,1,1
126628,with,1,1
126629,juvenile,1,1
126630,idiopathic,1,1
126631,arthritis,1,1
126632,(,1,1
126633,JIA,1,1
126634,),1,1
126635,.,1,1
126636,Cross-sectional,0,1
126637,study,0,0
126638,design,0,1
126639,including,0,1
126640,patients,1,1
126641,with,1,1
126642,JIA,1,1
126643,aged,1,1
126644,between,1,0
126645,8,1,1
126646,and,1,1
126647,17,1,1
126648,years,1,1
126649,and,1,1
126650,healthy,1,1
126651,controls,1,1
126652,was,1,0
126653,used,1,0
126654,.,1,1
126655,Sociodemographic,0,0
126656,data,0,0
126657,and,0,1
126658,clinical,0,1
126659,features,0,1
126660,were,0,1
126661,assessed,0,0
126662,.,0,1
126663,Physical,0,0
126664,activity,0,0
126665,level,0,0
126666,and,0,0
126667,energy,0,0
126668,expenditure,0,0
126669,were,0,0
126670,assessed,0,0
126671,with,0,1
126672,a,0,1
126673,1-day,0,0
126674,activity,0,0
126675,diary,0,0
126676,.,0,1
126677,Anxiety,0,0
126678,was,0,0
126679,screened,0,1
126680,by,0,0
126681,The,0,0
126682,Screen,0,1
126683,for,0,0
126684,Child,0,1
126685,Anxiety,0,1
126686,Related,0,0
126687,Emotional,0,0
126688,Disorders,0,1
126689,(,0,1
126690,SCARED,0,1
126691,),0,1
126692,questionnaire,0,1
126693,.,0,1
126694,Depressive,0,0
126695,symptoms,0,0
126696,were,0,1
126697,assessed,0,0
126698,by,0,0
126699,the,0,0
126700,Children,0,1
126701,'s,0,1
126702,Depression,0,0
126703,Inventory,0,1
126704,(,0,1
126705,CDI,0,1
126706,),0,1
126707,.,0,1
126708,Functional,0,0
126709,ability,0,0
126710,was,0,0
126711,assessed,0,0
126712,with,0,1
126713,the,0,0
126714,Childhood,0,1
126715,Health,0,0
126716,Assessment,0,0
126717,Questionnaire,0,0
126718,(,0,1
126719,CHAQ,0,1
126720,),0,1
126721,.,0,1
126722,Pain,0,0
126723,and,0,0
126724,overall,0,0
126725,well-being,0,0
126726,were,0,1
126727,measured,0,0
126728,using,0,0
126729,a,0,0
126730,visual,0,0
126731,analog,0,0
126732,scale,0,0
126733,(,0,1
126734,VAS,0,1
126735,),0,1
126736,.,0,1
126737,Fifty-two,1,1
126738,patients,1,1
126739,and,1,1
126740,48,1,1
126741,controls,1,1
126742,were,1,1
126743,included,1,1
126744,with,1,1
126745,a,1,1
126746,mean,1,1
126747,age,1,1
126748,of,1,1
126749,12.13,1,0
126750,?,1,1
126751,2.92,1,0
126752,and,1,1
126753,11.27,1,0
126754,?,1,1
126755,1.59,1,0
126756,years,1,1
126757,",",1,1
126758,respectively,1,0
126759,.,1,0
126760,The,1,0
126761,mean,1,0
126762,disease,1,1
126763,duration,1,0
126764,was,1,0
126765,64,1,1
126766,months,1,0
126767,.,1,1
126768,The,0,0
126769,JIA,0,0
126770,group,0,0
126771,had,0,1
126772,significantly,0,0
126773,less,0,0
126774,time,0,0
126775,in,0,0
126776,physical,0,1
126777,activity,0,0
126778,(,0,1
126779,p,0,0
126780,=,0,1
126781,0.000,0,0
126782,),0,1
126783,",",0,0
126784,decrease,0,0
126785,in,0,0
126786,energy,0,0
126787,expenditure,0,0
126788,(,0,1
126789,p,0,0
126790,=,0,1
126791,0.04,0,0
126792,),0,1
126793,",",0,0
126794,and,0,0
126795,higher,0,0
126796,CHAQ,0,1
126797,scores,0,0
126798,(,0,1
126799,p,0,0
126800,=,0,1
126801,0.000,0,0
126802,),0,0
126803,compared,0,0
126804,with,0,1
126805,the,0,0
126806,control,0,1
126807,group,0,0
126808,.,0,1
126809,In,0,0
126810,the,0,0
126811,JIA,0,0
126812,group,0,0
126813,",",0,1
126814,significant,0,0
126815,relationships,0,0
126816,were,0,1
126817,found,0,0
126818,between,0,0
126819,the,0,0
126820,number,0,0
126821,of,0,0
126822,active,0,1
126823,joint,0,1
126824,and,0,0
126825,disease,0,1
126826,duration,0,0
126827,(,0,1
126828,r,0,0
126829,=,0,1
126830,0.44,0,0
126831,",",0,0
126832,p,0,0
126833,=,0,1
126834,0.000,0,0
126835,),0,1
126836,and,0,1
126837,VAS,0,0
126838,pain,0,1
126839,(,0,0
126840,r,0,0
126841,=,0,0
126842,0.30,0,0
126843,",",0,0
126844,p,0,0
126845,=,0,1
126846,0.02,0,0
126847,),0,1
126848,",",0,0
126849,between,0,0
126850,SCARED,0,0
126851,and,0,1
126852,CDI,0,1
126853,(,0,0
126854,r,0,0
126855,=,0,0
126856,0.54,0,0
126857,",",0,0
126858,p,0,0
126859,=,0,1
126860,0.000,0,0
126861,),0,1
126862,.,0,1
126863,Significant,0,0
126864,relationships,0,0
126865,were,0,1
126866,found,0,0
126867,between,0,0
126868,VAS,0,0
126869,overall,0,0
126870,well-being,0,0
126871,and,0,1
126872,CDI,0,1
126873,(,0,0
126874,r,0,0
126875,=,0,0
126876,0.29,0,0
126877,",",0,0
126878,p,0,0
126879,=,0,1
126880,0.03,0,0
126881,),0,1
126882,",",0,1
126883,CHAQ,0,0
126884,(,0,0
126885,r,0,0
126886,=,0,0
126887,0.37,0,0
126888,",",0,0
126889,p,0,0
126890,=,0,1
126891,0.000,0,0
126892,),0,1
126893,",",0,0
126894,and,0,0
126895,VAS,0,0
126896,pain,0,1
126897,(,0,0
126898,r,0,0
126899,=,0,0
126900,0.41,0,0
126901,",",0,0
126902,p,0,0
126903,=,0,1
126904,0.000,0,0
126905,),0,1
126906,.,0,1
126907,Correlation,0,0
126908,between,0,0
126909,CHAQ,0,1
126910,and,0,1
126911,CDI,0,1
126912,(,0,0
126913,r,0,0
126914,=,0,0
126915,0.34,0,0
126916,",",0,0
126917,p,0,0
126918,=,0,1
126919,0.01,0,0
126920,),0,1
126921,was,0,0
126922,significant,0,0
126923,.,0,1
126924,The,0,0
126925,result,0,0
126926,of,0,0
126927,our,0,0
126928,study,0,1
126929,suggested,0,0
126930,that,0,0
126931,only,0,0
126932,depression,0,1
126933,was,0,0
126934,related,0,0
126935,to,0,0
126936,anxiety,0,1
126937,",",0,0
126938,functional,0,0
126939,ability,0,0
126940,",",0,0
126941,and,0,0
126942,well-being,0,0
126943,in,1,1
126944,children,1,1
126945,and,1,1
126946,adolescents,1,1
126947,with,1,1
126948,JIA,1,1
126949,.,0,1
126950,Chronic,0,1
126951,vasodilator,0,0
126952,therapy,0,0
126953,with,0,1
126954,flosequinan,0,0
126955,in,0,1
126956,congestive,1,1
126957,heart,1,1
126958,failure,1,1
126959,.,1,1
126960,This,0,0
126961,study,0,0
126962,was,0,0
126963,conducted,0,0
126964,to,0,0
126965,determine,0,0
126966,the,0,0
126967,long-term,0,0
126968,effect,0,0
126969,of,0,0
126970,flosequinan,0,0
126971,",",0,0
126972,a,0,0
126973,new,0,0
126974,orally,0,0
126975,administered,0,0
126976,arterial,0,1
126977,and,0,1
126978,venous,0,1
126979,dilator,0,0
126980,",",0,0
126981,on,0,0
126982,the,0,0
126983,clinical,0,0
126984,course,0,0
126985,of,0,1
126986,patients,1,1
126987,with,1,1
126988,moderate,1,1
126989,to,1,1
126990,severe,1,1
126991,congestive,1,1
126992,heart,1,1
126993,failure,1,1
126994,.,1,1
126995,Seventeen,1,1
126996,patients,1,1
126997,on,1,1
126998,chronic,1,1
126999,digitalis,1,1
127000,and,1,1
127001,diuretic,1,0
127002,therapy,1,0
127003,were,0,1
127004,randomized,0,1
127005,to,0,0
127006,receive,0,0
127007,either,0,0
127008,flosequinan,0,0
127009,(,0,0
127010,n,0,1
127011,=,0,1
127012,9,0,1
127013,),0,1
127014,or,0,1
127015,placebo,0,0
127016,(,0,1
127017,n,0,1
127018,=,0,1
127019,8,0,1
127020,),0,1
127021,in,0,0
127022,a,0,1
127023,double-blind,0,0
127024,fashion,0,0
127025,.,0,1
127026,Changes,0,0
127027,in,0,0
127028,symptomatology,0,1
127029,",",0,0
127030,exercise,0,0
127031,performance,0,0
127032,",",0,0
127033,and,0,0
127034,left,0,1
127035,ventricular,0,1
127036,function,0,0
127037,were,0,1
127038,assessed,0,0
127039,serially,0,0
127040,during,0,0
127041,the,0,0
127042,two-month,0,0
127043,treatment,0,0
127044,period,0,0
127045,.,0,1
127046,During,0,0
127047,the,0,0
127048,course,0,0
127049,of,0,0
127050,therapy,0,0
127051,",",0,0
127052,a,0,0
127053,modest,0,0
127054,improvement,0,0
127055,in,0,0
127056,the,0,0
127057,symptom,0,1
127058,scores,0,0
127059,and,0,1
127060,functional,0,1
127061,classification,0,1
127062,of,0,0
127063,the,0,0
127064,flosequinan-treated,1,0
127065,patients,1,1
127066,was,0,0
127067,observed,0,0
127068,.,0,1
127069,Flosequinan,0,0
127070,evoked,0,0
127071,a,0,0
127072,significant,0,0
127073,increase,0,0
127074,in,0,1
127075,maximal,0,0
127076,exercise,0,1
127077,capacity,0,0
127078,.,0,1
127079,While,0,1
127080,long-term,0,0
127081,flosequinan,0,0
127082,administration,0,0
127083,also,0,0
127084,effected,0,0
127085,a,0,0
127086,progressive,0,0
127087,increase,0,0
127088,in,0,0
127089,resting,0,0
127090,heart,0,1
127091,rate,0,0
127092,",",0,0
127093,it,0,0
127094,did,0,0
127095,not,0,0
127096,consistently,0,0
127097,improve,0,0
127098,indices,0,0
127099,of,0,1
127100,left,0,1
127101,ventricular,0,1
127102,systolic,0,1
127103,function,0,0
127104,.,0,1
127105,The,0,0
127106,addition,0,0
127107,of,0,0
127108,chronic,0,1
127109,vasodilator,0,1
127110,therapy,0,0
127111,with,0,1
127112,flosequinan,0,0
127113,to,0,0
127114,standard,0,1
127115,digitalis-diuretic,0,0
127116,regimens,0,0
127117,is,0,0
127118,capable,0,0
127119,of,0,0
127120,inducing,0,0
127121,clinical,0,0
127122,improvement,0,0
127123,in,0,1
127124,patients,1,1
127125,with,1,1
127126,moderate,1,1
127127,to,1,1
127128,severe,1,1
127129,chronic,1,1
127130,heart,1,1
127131,failure,1,1
127132,.,1,1
127133,Trials,0,0
127134,involving,0,1
127135,larger,0,1
127136,patient,0,1
127137,populations,0,1
127138,will,0,0
127139,be,0,0
127140,necessary,0,0
127141,to,0,0
127142,confirm,0,0
127143,the,0,0
127144,results,0,0
127145,of,0,0
127146,this,0,0
127147,preliminary,0,0
127148,study,0,1
127149,and,0,0
127150,to,0,0
127151,determine,0,0
127152,the,0,0
127153,extent,0,0
127154,of,0,0
127155,clinical,0,0
127156,improvement,0,0
127157,",",0,1
127158,subpopulations,0,0
127159,benefited,0,1
127160,",",0,0
127161,role,0,0
127162,in,0,0
127163,heart,0,1
127164,failure,0,1
127165,therapeutics,0,0
127166,",",0,0
127167,and,0,0
127168,so,0,0
127169,forth,0,0
127170,.,0,1
127171,Cancer,1,1
127172,information,1,0
127173,and,1,1
127174,anxiety,1,1
127175,:,1,1
127176,applying,0,0
127177,the,0,0
127178,extended,0,1
127179,parallel,0,0
127180,process,0,0
127181,model,0,0
127182,.,0,0
127183,There,0,0
127184,is,0,0
127185,concern,0,0
127186,that,0,0
127187,public,0,1
127188,education,0,1
127189,about,0,0
127190,testicular,0,1
127191,cancer,0,1
127192,(,0,1
127193,TC,0,0
127194,),0,1
127195,may,0,0
127196,cause,0,0
127197,unnecessary,0,0
127198,anxiety,0,1
127199,.,0,1
127200,Psychological,0,0
127201,theory,0,0
127202,suggests,0,0
127203,that,0,0
127204,if,0,0
127205,threat,0,0
127206,(,0,1
127207,eg,0,0
127208,",",0,1
127209,TC,0,0
127210,),0,0
127211,information,0,0
127212,is,0,0
127213,accompanied,0,0
127214,with,0,1
127215,threat,0,0
127216,control,0,1
127217,strategies,0,0
127218,(,0,1
127219,eg,0,1
127220,",",0,0
127221,testicular,0,1
127222,self-examination,0,1
127223,;,0,1
127224,TSE,0,1
127225,),0,0
127226,anxiety,0,0
127227,is,0,0
127228,less,0,0
127229,likely,0,0
127230,.,0,0
127231,Male,1,0
127232,students,1,1
127233,(,1,1
127234,N=443,1,1
127235,),1,1
127236,were,0,1
127237,randomized,0,1
127238,to,0,0
127239,either,0,0
127240,a,0,0
127241,TC,0,0
127242,or,0,1
127243,TC,0,0
127244,+TSE,0,1
127245,information,0,0
127246,group,0,1
127247,or,0,1
127248,a,0,0
127249,no,0,0
127250,information,0,0
127251,control,0,0
127252,group,0,0
127253,",",0,0
127254,and,0,0
127255,assessed,0,0
127256,at,0,0
127257,three,0,1
127258,time,0,0
127259,points,0,0
127260,.,0,1
127261,Anxiety,0,0
127262,levels,0,0
127263,did,0,0
127264,not,0,0
127265,differ,0,0
127266,between,0,0
127267,the,0,0
127268,groups,0,0
127269,and,0,1
127270,exposure,0,1
127271,to,0,1
127272,TC+TSE,0,0
127273,resulted,0,0
127274,in,0,0
127275,greater,0,0
127276,perceived,0,0
127277,message,0,0
127278,benefit,0,0
127279,",",0,0
127280,increased,0,0
127281,intention,0,0
127282,to,0,0
127283,self-examine,0,1
127284,and,0,0
127285,lower,0,0
127286,message,0,0
127287,denigration,0,0
127288,.,0,0
127289,This,0,0
127290,suggests,0,0
127291,TC,0,0
127292,information,0,0
127293,is,0,0
127294,not,0,0
127295,anxiogenic,0,0
127296,",",0,0
127297,but,0,0
127298,inclusion,0,1
127299,of,0,0
127300,TSE,0,0
127301,information,0,0
127302,may,0,0
127303,improve,0,0
127304,acceptance,0,0
127305,of,0,0
127306,disease,0,1
127307,awareness,0,0
127308,information,0,0
127309,.,0,1
127310,Quality,0,0
127311,of,0,0
127312,individual,0,0
127313,INR,0,1
127314,control,0,1
127315,and,0,0
127316,the,0,0
127317,risk,0,0
127318,of,0,0
127319,stroke,0,1
127320,and,0,1
127321,bleeding,0,1
127322,events,0,0
127323,in,0,1
127324,atrial,1,1
127325,fibrillation,1,1
127326,patients,1,1
127327,:,1,1
127328,a,0,1
127329,nested,0,0
127330,case,0,0
127331,control,0,1
127332,analysis,0,0
127333,of,0,0
127334,the,0,0
127335,ACTIVE,0,1
127336,W,0,0
127337,study,0,1
127338,.,0,1
127339,INTRODUCTION,0,0
127340,Time,0,0
127341,in,0,1
127342,therapeutic,0,0
127343,range,0,1
127344,(,0,1
127345,TTR,0,1
127346,),0,1
127347,for,0,0
127348,international,0,1
127349,normalized,0,0
127350,ratio,0,0
127351,(,0,1
127352,INR,0,1
127353,),0,0
127354,is,0,0
127355,an,0,0
127356,accepted,0,0
127357,quality,0,0
127358,measure,0,0
127359,of,0,0
127360,anticoagulation,0,0
127361,control,0,1
127362,in,0,1
127363,patient,0,1
127364,populations,0,1
127365,",",0,1
127366,but,0,0
127367,its,0,0
127368,usefulness,0,0
127369,for,0,0
127370,predicting,0,0
127371,stroke,0,1
127372,and,0,0
127373,bleeding,0,1
127374,in,0,0
127375,individuals,0,1
127376,is,0,0
127377,not,0,0
127378,well,0,0
127379,understood,0,0
127380,.,0,1
127381,MATERIALS,0,0
127382,AND,0,0
127383,METHODS,0,0
127384,In,0,1
127385,a,0,1
127386,nested,0,0
127387,case,0,0
127388,control,0,1
127389,analysis,0,0
127390,among,0,1
127391,ACTIVE,1,1
127392,W,1,1
127393,study,1,1
127394,patients,1,1
127395,",",1,1
127396,cases,1,1
127397,with,1,1
127398,stroke,1,1
127399,and,1,1
127400,cases,1,1
127401,with,1,1
127402,bleeding,1,1
127403,were,1,1
127404,separately,1,0
127405,matched,1,1
127406,with,1,1
127407,controls,1,1
127408,.,1,1
127409,Several,0,0
127410,anticoagulation,0,0
127411,quality,0,0
127412,measures,0,0
127413,were,0,1
127414,compared,0,0
127415,",",0,0
127416,overall,0,0
127417,and,0,0
127418,in,0,0
127419,a,0,1
127420,time-dependent,0,0
127421,manner,0,0
127422,.,0,1
127423,RESULTS,0,0
127424,32,1,1
127425,cases,1,1
127426,with,1,1
127427,ischemic,1,1
127428,stroke,1,1
127429,and,1,1
127430,234,1,1
127431,cases,1,1
127432,with,1,1
127433,bleeding,1,1
127434,in,1,0
127435,the,1,0
127436,analysis,1,0
127437,were,0,0
127438,matched,0,1
127439,in,0,0
127440,a,0,1
127441,4:1,0,0
127442,ratio,0,0
127443,to,0,1
127444,122,0,1
127445,and,0,1
127446,865,0,1
127447,controls,0,1
127448,",",0,1
127449,respectively,0,0
127450,.,0,1
127451,Follow-up,0,0
127452,duration,0,0
127453,was,0,0
127454,257?154days,0,1
127455,for,0,0
127456,the,0,0
127457,stroke,0,1
127458,analysis,0,0
127459,and,0,1
127460,222?146days,0,1
127461,for,0,0
127462,the,0,0
127463,bleeding,0,1
127464,analysis,0,0
127465,.,0,1
127466,Compared,0,0
127467,with,0,1
127468,their,0,1
127469,respective,0,1
127470,controls,0,1
127471,",",0,0
127472,the,0,0
127473,study,0,0
127474,mean,0,1
127475,TTR,0,1
127476,of,0,0
127477,both,0,0
127478,stroke,0,1
127479,cases,0,1
127480,(,0,1
127481,53.9,0,1
127482,%,0,0
127483,?25.1,0,0
127484,vs,0,0
127485,63.4,0,0
127486,%,0,0
127487,?24.8,0,0
127488,;,0,1
127489,p=0.055,0,0
127490,),0,1
127491,and,0,1
127492,bleeding,0,1
127493,cases,0,1
127494,(,0,1
127495,56.2,0,1
127496,%,0,0
127497,?25.4,0,0
127498,vs,0,0
127499,63.4,0,0
127500,%,0,0
127501,?26.8,0,0
127502,;,0,0
127503,p,0,0
127504,<,0,0
127505,0.001,0,0
127506,),0,0
127507,was,0,0
127508,lower,0,0
127509,.,0,1
127510,Time,0,0
127511,below,0,0
127512,range,0,1
127513,for,0,0
127514,stroke,0,1
127515,and,0,0
127516,time,0,0
127517,above,0,0
127518,range,0,1
127519,for,0,0
127520,bleeding,0,1
127521,were,0,0
127522,only,0,0
127523,greater,0,0
127524,in,0,0
127525,the,0,0
127526,last,0,0
127527,month,0,0
127528,leading,0,0
127529,up,0,0
127530,to,0,0
127531,the,0,0
127532,event,0,0
127533,",",0,0
127534,not,0,0
127535,over,0,0
127536,the,0,0
127537,entire,0,0
127538,study,0,1
127539,period,0,1
127540,.,0,1
127541,Rather,0,0
127542,",",0,0
127543,over,0,0
127544,the,0,0
127545,entire,0,0
127546,study,0,1
127547,period,0,1
127548,bleeding,0,1
127549,cases,0,1
127550,spent,0,0
127551,more,0,0
127552,time,0,0
127553,below,0,0
127554,range,0,1
127555,than,0,1
127556,controls,0,1
127557,(,0,1
127558,26.8,0,1
127559,%,0,0
127560,?25.9,0,0
127561,vs,0,0
127562,20.8,0,0
127563,%,0,0
127564,?24.0,0,0
127565,;,0,1
127566,p=0.001,0,0
127567,),0,1
127568,.,0,1
127569,CONCLUSIONS,0,0
127570,TTR,0,1
127571,was,0,0
127572,lower,0,0
127573,in,0,0
127574,individual,1,0
127575,AF,1,1
127576,patients,1,1
127577,with,1,1
127578,stroke,1,1
127579,or,1,1
127580,bleeding,1,1
127581,compared,1,0
127582,with,0,1
127583,matched,0,1
127584,controls,0,1
127585,in,0,1
127586,ACTIVE,0,1
127587,W.,0,1
127588,Maintaining,0,0
127589,a,0,1
127590,high,0,1
127591,TTR,0,1
127592,",",0,1
127593,with,0,1
127594,equal,0,0
127595,importance,0,0
127596,to,0,0
127597,avoid,0,0
127598,low,0,1
127599,and,0,0
127600,high,0,1
127601,INRs,0,1
127602,",",0,0
127603,is,0,0
127604,a,0,0
127605,relevant,0,0
127606,goal,0,0
127607,of,0,0
127608,individual,0,0
127609,patient,0,1
127610,treatment,0,0
127611,to,0,0
127612,prevent,0,0
127613,stroke,0,1
127614,and,0,0
127615,bleeding,0,1
127616,.,0,1
127617,Use,0,1
127618,of,0,1
127619,hormonal,0,1
127620,contraceptives,0,1
127621,and,0,1
127622,risk,0,1
127623,of,0,0
127624,HIV-1,1,1
127625,transmission,0,1
127626,:,0,1
127627,a,0,0
127628,prospective,0,1
127629,cohort,0,1
127630,study,0,1
127631,.,0,1
127632,BACKGROUND,0,0
127633,Hormonal,0,1
127634,contraceptives,0,1
127635,are,0,0
127636,used,0,0
127637,widely,0,0
127638,but,0,0
127639,their,0,1
127640,effects,0,0
127641,on,0,0
127642,HIV-1,0,1
127643,risk,0,1
127644,are,0,0
127645,unclear,0,0
127646,.,0,1
127647,We,0,0
127648,aimed,0,0
127649,to,0,0
127650,assess,0,0
127651,the,0,0
127652,association,0,0
127653,between,0,0
127654,hormonal,0,0
127655,contraceptive,0,1
127656,use,0,0
127657,and,0,0
127658,risk,0,1
127659,of,0,0
127660,HIV-1,1,1
127661,acquisition,1,0
127662,by,1,0
127663,women,1,1
127664,and,1,1
127665,HIV-1,1,1
127666,transmission,1,1
127667,from,1,1
127668,HIV-1-infected,1,1
127669,women,1,1
127670,to,1,1
127671,their,1,1
127672,male,1,1
127673,partners,1,1
127674,.,1,1
127675,METHODS,0,0
127676,In,0,0
127677,this,0,0
127678,prospective,0,1
127679,study,0,0
127680,",",0,0
127681,we,0,0
127682,followed,0,0
127683,up,0,1
127684,3790,1,1
127685,heterosexual,1,1
127686,HIV-1-serodiscordant,1,1
127687,couples,1,1
127688,participating,1,1
127689,in,1,1
127690,two,1,1
127691,longitudinal,1,1
127692,studies,1,0
127693,of,1,1
127694,HIV-1,1,1
127695,incidence,1,0
127696,in,1,1
127697,seven,1,1
127698,African,1,1
127699,countries,1,1
127700,.,1,1
127701,Among,0,1
127702,injectable,0,0
127703,and,0,1
127704,oral,0,1
127705,hormonal,0,1
127706,contraceptive,0,1
127707,users,0,1
127708,and,0,1
127709,non-users,0,1
127710,",",0,1
127711,we,0,0
127712,compared,0,0
127713,rates,0,0
127714,of,0,1
127715,HIV-1,0,1
127716,acquisition,0,0
127717,by,0,0
127718,women,0,1
127719,and,0,1
127720,HIV-1,0,1
127721,transmission,0,1
127722,from,0,1
127723,women,0,1
127724,to,0,1
127725,men,0,1
127726,.,0,1
127727,The,0,0
127728,primary,0,0
127729,outcome,0,0
127730,measure,0,0
127731,was,0,0
127732,HIV-1,0,1
127733,seroconversion,0,1
127734,.,0,1
127735,We,0,0
127736,used,0,0
127737,Cox,0,0
127738,proportional,0,0
127739,hazards,0,0
127740,regression,0,0
127741,and,0,1
127742,marginal,0,1
127743,structural,0,0
127744,modelling,0,0
127745,to,0,0
127746,assess,0,0
127747,the,0,0
127748,effect,0,0
127749,of,0,0
127750,contraceptive,0,1
127751,use,0,0
127752,on,0,0
127753,HIV-1,0,1
127754,risk,0,1
127755,.,0,1
127756,FINDINGS,0,0
127757,Among,0,1
127758,1314,1,1
127759,couples,1,1
127760,in,1,1
127761,which,1,1
127762,the,1,0
127763,HIV-1-seronegative,1,1
127764,partner,1,1
127765,was,1,0
127766,female,1,1
127767,(,1,1
127768,median,1,1
127769,follow-up,1,1
127770,18?0,1,1
127771,[,1,1
127772,IQR,1,1
127773,12?6-24?2,1,1
127774,],1,1
127775,months,1,1
127776,),1,1
127777,",",1,1
127778,rates,1,0
127779,of,0,1
127780,HIV-1,0,1
127781,acquisition,0,0
127782,were,0,1
127783,6?61,0,1
127784,per,0,1
127785,100,0,1
127786,person-years,0,0
127787,in,0,1
127788,women,0,1
127789,who,0,1
127790,used,0,1
127791,hormonal,0,1
127792,contraception,0,1
127793,and,0,1
127794,3?78,0,1
127795,per,0,1
127796,100,0,1
127797,person-years,0,0
127798,in,0,1
127799,those,0,1
127800,who,0,1
127801,did,0,1
127802,not,0,1
127803,(,0,0
127804,adjusted,0,0
127805,hazard,0,0
127806,ratio,0,0
127807,1?98,0,1
127808,",",0,1
127809,95,0,0
127810,%,0,0
127811,CI,0,0
127812,1?06-3?68,0,1
127813,",",0,0
127814,p=0?03,0,0
127815,),0,1
127816,.,0,1
127817,Among,1,1
127818,2476,1,1
127819,couples,1,1
127820,in,1,1
127821,which,1,1
127822,the,1,0
127823,HIV-1-seronegative,1,1
127824,partner,1,1
127825,was,1,0
127826,male,1,1
127827,(,0,1
127828,median,0,1
127829,follow-up,0,1
127830,18?7,0,1
127831,[,0,1
127832,IQR,0,1
127833,12?8-24?2,0,1
127834,],0,1
127835,months,0,1
127836,),0,1
127837,",",0,1
127838,rates,0,0
127839,of,0,1
127840,HIV-1,0,1
127841,transmission,0,1
127842,from,0,1
127843,women,0,1
127844,to,0,1
127845,men,0,1
127846,were,0,1
127847,2?61,0,1
127848,per,0,1
127849,100,0,1
127850,person-years,0,0
127851,in,0,1
127852,couples,0,1
127853,in,0,1
127854,which,0,1
127855,women,0,1
127856,used,0,0
127857,hormonal,0,1
127858,contraception,0,1
127859,and,0,1
127860,1?51,0,1
127861,per,0,1
127862,100,0,1
127863,person-years,0,0
127864,in,0,1
127865,couples,0,1
127866,in,0,1
127867,which,0,1
127868,women,0,1
127869,did,0,0
127870,not,0,0
127871,use,0,0
127872,hormonal,0,0
127873,contraception,0,1
127874,(,0,0
127875,adjusted,0,0
127876,hazard,0,0
127877,ratio,0,0
127878,1?97,0,1
127879,",",0,1
127880,95,0,0
127881,%,0,0
127882,CI,0,0
127883,1?12-3?45,0,1
127884,",",0,0
127885,p=0?02,0,0
127886,),0,1
127887,.,0,1
127888,Marginal,0,0
127889,structural,0,0
127890,model,0,1
127891,analyses,0,0
127892,generated,0,0
127893,much,0,0
127894,the,0,0
127895,same,0,0
127896,results,0,0
127897,to,0,1
127898,the,0,1
127899,Cox,0,0
127900,proportional,0,0
127901,hazards,0,0
127902,regression,0,0
127903,.,0,1
127904,INTERPRETATION,0,0
127905,Women,0,1
127906,should,0,0
127907,be,0,0
127908,counselled,0,0
127909,about,0,0
127910,potentially,0,0
127911,increased,0,0
127912,risk,0,0
127913,of,0,0
127914,HIV-1,0,1
127915,acquisition,0,0
127916,and,0,0
127917,transmission,0,1
127918,with,0,1
127919,hormonal,0,0
127920,contraception,0,1
127921,",",0,0
127922,especially,0,0
127923,injectable,0,0
127924,methods,0,1
127925,",",0,1
127926,and,0,0
127927,about,0,0
127928,the,0,0
127929,importance,0,0
127930,of,0,0
127931,dual,0,0
127932,protection,0,0
127933,with,0,1
127934,condoms,0,0
127935,to,0,1
127936,decrease,0,0
127937,HIV-1,0,1
127938,risk,0,1
127939,.,0,1
127940,Non-hormonal,0,0
127941,or,0,1
127942,low-dose,0,0
127943,hormonal,0,1
127944,contraceptive,0,1
127945,methods,0,1
127946,should,0,0
127947,be,0,0
127948,considered,0,0
127949,for,0,0
127950,women,0,1
127951,with,0,1
127952,or,0,1
127953,at-risk,0,1
127954,for,0,1
127955,HIV-1,0,1
127956,.,0,1
127957,FUNDING,0,0
127958,US,0,0
127959,National,0,1
127960,Institutes,0,1
127961,of,0,1
127962,Health,0,0
127963,and,0,1
127964,the,0,0
127965,Bill,0,0
127966,&,0,1
127967,Melinda,0,1
127968,Gates,0,0
127969,Foundation,0,1
127970,.,0,1
127971,A,0,0
127972,double-blind,0,0
127973,",",0,0
127974,randomized,0,0
127975,",",0,0
127976,controlled,0,0
127977,",",0,0
127978,multicenter,0,0
127979,study,0,0
127980,to,0,0
127981,assess,0,0
127982,the,0,0
127983,safety,0,0
127984,and,0,0
127985,cardiovascular,0,1
127986,effects,0,0
127987,of,0,1
127988,skeletal,0,1
127989,myoblast,0,0
127990,implantation,0,1
127991,by,0,0
127992,catheter,0,0
127993,delivery,0,1
127994,in,0,0
127995,patients,1,1
127996,with,1,1
127997,chronic,1,1
127998,heart,1,1
127999,failure,1,1
128000,after,1,0
128001,myocardial,1,1
128002,infarction,1,1
128003,.,1,1
128004,BACKGROUND,0,0
128005,We,0,0
128006,sought,0,0
128007,to,0,0
128008,determine,0,0
128009,the,0,0
128010,safety,0,0
128011,and,0,0
128012,preliminary,0,0
128013,efficacy,0,0
128014,of,0,0
128015,transcatheter,0,1
128016,intramyocardial,0,0
128017,administration,0,0
128018,of,0,1
128019,myoblasts,0,1
128020,in,0,1
128021,patients,1,1
128022,with,1,1
128023,heart,1,1
128024,failure,1,1
128025,(,1,1
128026,HF,1,1
128027,),1,1
128028,.,1,1
128029,METHODS,0,0
128030,MARVEL,0,0
128031,is,0,0
128032,a,0,0
128033,randomized,0,0
128034,placebo-controlled,0,0
128035,trial,0,1
128036,of,0,0
128037,image-guided,0,1
128038,",",0,1
128039,catheter-based,0,1
128040,intramyocardial,0,0
128041,injection,0,0
128042,of,0,0
128043,placebo,0,0
128044,or,0,1
128045,myoblasts,0,1
128046,(,0,1
128047,400,0,1
128048,or,0,1
128049,800,0,1
128050,million,0,1
128051,),0,1
128052,in,0,1
128053,patients,1,1
128054,with,1,1
128055,class,1,1
128056,II,1,1
128057,to,1,1
128058,IV,1,1
128059,HF,1,1
128060,and,1,1
128061,ejection,1,1
128062,fraction,1,1
128063,<,1,0
128064,35,1,1
128065,%,1,0
128066,.,1,1
128067,Primary,0,0
128068,end,0,0
128069,points,0,0
128070,were,0,1
128071,frequency,0,0
128072,of,0,0
128073,serious,0,1
128074,adverse,0,0
128075,events,0,0
128076,(,0,1
128077,safety,0,0
128078,),0,1
128079,and,0,1
128080,changes,0,0
128081,in,0,1
128082,6-minute,0,0
128083,walk,0,1
128084,test,0,0
128085,and,0,1
128086,Minnesota,0,1
128087,Living,0,1
128088,With,0,1
128089,HF,0,1
128090,score,0,0
128091,(,0,1
128092,efficacy,0,0
128093,),0,1
128094,.,0,1
128095,Of,1,1
128096,330,1,1
128097,patients,1,1
128098,intended,1,0
128099,for,1,0
128100,enrollment,1,1
128101,",",1,1
128102,23,1,1
128103,were,1,1
128104,randomized,1,1
128105,(,1,1
128106,MARVEL-1,1,0
128107,),1,1
128108,before,1,0
128109,stopping,1,0
128110,the,1,0
128111,study,1,0
128112,for,1,0
128113,financial,1,1
128114,reasons,1,0
128115,.,1,1
128116,RESULTS,0,0
128117,At,0,1
128118,6,0,1
128119,months,0,0
128120,",",0,1
128121,similar,0,0
128122,numbers,0,0
128123,of,0,1
128124,events,0,0
128125,occurred,0,0
128126,in,0,0
128127,each,0,1
128128,group,0,1
128129,:,0,1
128130,8,0,1
128131,(,0,1
128132,placebo,0,0
128133,),0,1
128134,",",0,1
128135,7,0,1
128136,(,0,1
128137,low,0,1
128138,dose,0,0
128139,),0,1
128140,",",0,0
128141,and,0,1
128142,8,0,1
128143,(,0,1
128144,high,0,1
128145,dose,0,0
128146,),0,0
128147,",",0,0
128148,without,0,1
128149,deaths,0,0
128150,.,0,1
128151,Ventricular,0,1
128152,tachycardia,0,1
128153,responsive,0,1
128154,to,0,0
128155,amiodarone,0,0
128156,was,0,0
128157,more,0,0
128158,frequent,0,0
128159,in,0,0
128160,myoblast-treated,0,1
128161,patients,0,1
128162,:,0,1
128163,1,0,1
128164,(,0,1
128165,placebo,0,0
128166,),0,1
128167,",",0,1
128168,3,0,0
128169,(,0,1
128170,low,0,1
128171,dose,0,0
128172,),0,1
128173,",",0,0
128174,and,0,1
128175,4,0,0
128176,(,0,1
128177,high,0,1
128178,dose,0,0
128179,),0,1
128180,.,0,1
128181,A,0,0
128182,trend,0,0
128183,toward,0,0
128184,improvement,0,0
128185,in,0,1
128186,functional,0,1
128187,capacity,0,1
128188,was,0,0
128189,noted,0,0
128190,in,0,1
128191,myoblast-treated,0,1
128192,groups,0,1
128193,(,0,1
128194,?6-minute,0,0
128195,walk,0,1
128196,test,0,0
128197,of,0,0
128198,-3.6,0,0
128199,vs,0,0
128200,+95.6,0,0
128201,vs,0,0
128202,+85.5,0,0
128203,m,0,1
128204,[,0,0
128205,placebo,0,0
128206,vs,0,0
128207,low,0,1
128208,dose,0,0
128209,vs,0,0
128210,high,0,1
128211,dose,0,0
128212,;,0,1
128213,P,0,0
128214,=,0,1
128215,.50,0,0
128216,],0,1
128217,),0,1
128218,without,0,1
128219,significant,0,0
128220,changes,0,0
128221,in,0,1
128222,Minnesota,0,1
128223,Living,0,1
128224,With,0,1
128225,HF,0,1
128226,scores,0,0
128227,.,0,1
128228,CONCLUSIONS,0,0
128229,In,1,1
128230,HF,1,1
128231,patients,1,1
128232,with,1,1
128233,chronic,1,1
128234,postinfarction,1,1
128235,cardiomyopathy,1,1
128236,",",1,0
128237,transcatheter,0,1
128238,administration,0,0
128239,of,0,1
128240,myoblasts,0,1
128241,in,0,1
128242,doses,0,1
128243,of,0,1
128244,400,0,1
128245,to,0,1
128246,800,0,1
128247,million,0,1
128248,cells,0,0
128249,is,0,0
128250,feasible,0,0
128251,and,0,0
128252,may,0,0
128253,lead,0,0
128254,to,0,0
128255,important,0,0
128256,clinical,0,1
128257,benefits,0,0
128258,.,0,1
128259,Ventricular,0,0
128260,tachycardia,0,0
128261,may,0,0
128262,be,0,0
128263,provoked,0,0
128264,by,0,0
128265,myoblast,0,0
128266,injection,0,0
128267,but,0,0
128268,appears,0,0
128269,to,0,0
128270,be,0,0
128271,a,0,0
128272,transient,0,0
128273,and,0,0
128274,treatable,0,1
128275,problem,0,1
128276,.,0,1
128277,A,0,0
128278,large-scale,0,0
128279,outcome,0,0
128280,trial,0,1
128281,of,0,0
128282,myoblast,0,0
128283,administration,0,0
128284,in,1,1
128285,HF,1,1
128286,patients,1,1
128287,with,1,1
128288,postinfarction,1,1
128289,cardiomyopathy,1,1
128290,is,0,0
128291,feasible,0,0
128292,and,0,0
128293,warranted,0,0
128294,.,0,1
128295,Epicutaneous,0,1
128296,allergen-specific,0,0
128297,immunotherapy,0,0
128298,ameliorates,0,0
128299,grass,0,1
128300,pollen-induced,0,1
128301,rhinoconjunctivitis,0,1
128302,:,0,1
128303,A,0,1
128304,double-blind,0,0
128305,",",0,0
128306,placebo-controlled,0,0
128307,dose,0,0
128308,escalation,0,1
128309,study,0,1
128310,.,0,1
128311,BACKGROUND,0,0
128312,Epicutaneous,0,1
128313,allergen,0,0
128314,administration,0,0
128315,using,0,0
128316,a,0,0
128317,patch,0,0
128318,may,0,0
128319,be,0,0
128320,an,0,0
128321,alternative,0,0
128322,to,0,1
128323,subcutaneous,0,1
128324,or,0,1
128325,sublingual,0,1
128326,immunotherapy,0,0
128327,.,0,1
128328,OBJECTIVE,0,0
128329,To,0,0
128330,optimize,0,0
128331,treatment,0,0
128332,dose,0,0
128333,and,0,0
128334,to,0,0
128335,demonstrate,0,0
128336,the,0,0
128337,efficacy,0,0
128338,and,0,0
128339,safety,0,0
128340,of,0,0
128341,epicutaneous,0,0
128342,immunotherapy,0,1
128343,.,0,1
128344,METHODS,0,0
128345,This,0,0
128346,monocentric,0,1
128347,",",0,0
128348,placebo-controlled,0,0
128349,",",0,0
128350,double-blind,0,0
128351,trial,0,1
128352,included,1,1
128353,132,1,1
128354,patients,1,1
128355,with,1,1
128356,grass,1,1
128357,pollen-induced,1,1
128358,rhinoconjunctivitis,1,1
128359,.,1,1
128360,In,0,0
128361,February,0,1
128362,2008,0,1
128363,",",0,1
128364,patients,0,1
128365,were,0,1
128366,randomly,0,1
128367,allocated,0,1
128368,to,0,0
128369,receive,0,1
128370,placebo,0,0
128371,or,0,1
128372,3,0,1
128373,different,0,1
128374,doses,0,0
128375,of,0,1
128376,allergen,0,0
128377,.,0,1
128378,Before,0,0
128379,and,0,0
128380,during,0,0
128381,the,0,0
128382,pollen,0,0
128383,season,0,1
128384,2008,0,1
128385,",",0,1
128386,patients,1,1
128387,received,1,1
128388,6,1,1
128389,weekly,1,1
128390,patches,1,1
128391,.,1,1
128392,Efficacy,0,0
128393,was,0,0
128394,assessed,0,0
128395,4,0,0
128396,to,0,1
128397,5,0,1
128398,months,0,0
128399,later,0,1
128400,(,0,1
128401,n,0,1
128402,=,0,1
128403,110,0,1
128404,),0,1
128405,and,0,0
128406,during,0,0
128407,the,0,0
128408,pollen,0,0
128409,season,0,0
128410,of,0,0
128411,the,0,0
128412,treatment-free,0,0
128413,follow-up,0,0
128414,year,0,1
128415,in,0,1
128416,2009,0,1
128417,(,0,1
128418,n,0,1
128419,=,0,1
128420,93,0,1
128421,),0,1
128422,.,0,1
128423,The,0,0
128424,primary,0,1
128425,outcome,0,0
128426,was,0,0
128427,patient-reported,0,0
128428,changes,0,0
128429,in,0,1
128430,hay,0,1
128431,fever,0,1
128432,symptoms,0,0
128433,assessed,0,0
128434,by,0,0
128435,a,0,1
128436,visual,0,0
128437,analog,0,0
128438,scale,0,1
128439,.,0,1
128440,Secondary,0,0
128441,outcome,0,0
128442,measures,0,0
128443,were,0,1
128444,weekly,0,1
128445,visual,0,0
128446,analog,0,0
128447,scale,0,1
128448,symptom,0,1
128449,scores,0,0
128450,during,0,1
128451,pollen,0,0
128452,season,0,1
128453,",",0,0
128454,use,0,0
128455,of,0,0
128456,rescue,0,0
128457,medication,0,1
128458,",",0,0
128459,changes,0,0
128460,in,0,1
128461,conjunctival,0,1
128462,and,0,1
128463,skin,0,1
128464,reactivity,0,0
128465,",",0,0
128466,as,0,0
128467,well,0,0
128468,as,0,0
128469,safety,0,0
128470,.,0,1
128471,RESULTS,0,0
128472,Hay,0,0
128473,fever,0,1
128474,symptoms,0,0
128475,during,0,0
128476,the,0,0
128477,pollen,0,0
128478,season,0,1
128479,were,0,0
128480,reduced,0,0
128481,by,0,0
128482,more,0,0
128483,than,0,1
128484,30,0,1
128485,%,0,0
128486,in,0,1
128487,2008,0,1
128488,and,0,1
128489,by,0,0
128490,24,0,1
128491,%,0,0
128492,in,0,1
128493,2009,0,1
128494,in,0,1
128495,the,0,0
128496,high-dose,0,0
128497,group,0,1
128498,as,0,0
128499,compared,0,0
128500,with,0,1
128501,that,0,0
128502,in,0,0
128503,the,0,0
128504,placebo,0,0
128505,group,0,0
128506,",",0,0
128507,and,0,0
128508,the,0,0
128509,alleviation,0,0
128510,of,0,0
128511,symptoms,0,0
128512,in,0,1
128513,the,0,1
128514,follow-up,0,0
128515,year,0,1
128516,was,0,0
128517,dependent,0,0
128518,on,0,0
128519,the,0,0
128520,treatment,0,0
128521,dose,0,0
128522,.,0,1
128523,Higher,0,0
128524,allergen,0,0
128525,doses,0,0
128526,were,0,1
128527,associated,0,0
128528,with,0,1
128529,drug-related,0,1
128530,adverse,0,0
128531,events,0,0
128532,(,0,1
128533,AEs,0,0
128534,),0,0
128535,",",0,0
128536,predominantly,0,1
128537,manifested,0,0
128538,by,0,0
128539,pruritus,0,0
128540,",",0,0
128541,erythema,0,0
128542,",",0,0
128543,wheal,0,0
128544,",",0,0
128545,or,0,1
128546,eczema,0,1
128547,.,0,1
128548,Eleven,0,1
128549,systemic,0,0
128550,AEs,0,0
128551,of,0,1
128552,grades,0,1
128553,1,0,1
128554,to,0,1
128555,2,0,1
128556,required,0,0
128557,treatment,0,0
128558,and,0,0
128559,led,0,0
128560,to,0,0
128561,study,0,1
128562,exclusion,0,0
128563,.,0,0
128564,The,0,0
128565,dropout,0,0
128566,rate,0,0
128567,due,0,0
128568,to,0,1
128569,AEs,0,0
128570,was,0,0
128571,8.3,0,0
128572,%,0,0
128573,.,0,1
128574,No,0,0
128575,drug-related,0,0
128576,serious,0,0
128577,AE,0,0
128578,was,0,0
128579,recorded,0,0
128580,.,0,1
128581,CONCLUSION,0,0
128582,Epicutaneous,0,0
128583,immunotherapy,0,0
128584,is,0,0
128585,safe,0,0
128586,and,0,0
128587,efficacious,0,0
128588,in,0,0
128589,a,0,1
128590,dose-dependent,0,0
128591,manner,0,0
128592,after,0,1
128593,6,0,1
128594,patches,0,1
128595,only,0,1
128596,.,0,1
128597,Changes,0,1
128598,in,0,1
128599,H,0,1
128600,reflex,0,0
128601,and,0,0
128602,V,0,0
128603,wave,0,0
128604,following,0,0
128605,short-term,0,0
128606,endurance,0,1
128607,and,0,0
128608,strength,0,0
128609,training,0,0
128610,.,0,1
128611,This,0,0
128612,study,0,0
128613,examined,0,0
128614,the,0,0
128615,effects,0,0
128616,of,0,1
128617,3,0,1
128618,wk,0,1
128619,of,0,0
128620,either,0,1
128621,endurance,0,0
128622,or,0,1
128623,strength,0,0
128624,training,0,0
128625,on,0,0
128626,plasticity,0,0
128627,of,0,0
128628,the,0,0
128629,neural,0,0
128630,mechanisms,0,0
128631,involved,0,1
128632,in,0,0
128633,the,0,0
128634,soleus,0,1
128635,H,0,1
128636,reflex,0,0
128637,and,0,0
128638,V,0,0
128639,wave,0,1
128640,.,0,1
128641,Twenty-five,1,1
128642,sedentary,1,1
128643,healthy,1,1
128644,subjects,1,1
128645,were,0,1
128646,randomized,0,1
128647,into,0,0
128648,an,0,0
128649,endurance,0,0
128650,group,0,0
128651,(,0,1
128652,n,0,1
128653,=,0,1
128654,13,0,1
128655,),0,1
128656,or,0,1
128657,strength,0,0
128658,group,0,1
128659,(,0,1
128660,n,0,1
128661,=,0,1
128662,12,0,1
128663,),0,1
128664,.,0,1
128665,Evoked,0,0
128666,V-wave,0,0
128667,",",0,0
128668,H-reflex,0,0
128669,",",0,0
128670,and,0,0
128671,M-wave,0,0
128672,recruitment,0,0
128673,curves,0,0
128674,",",0,1
128675,maximal,0,0
128676,voluntary,0,1
128677,contraction,0,1
128678,(,0,1
128679,MVC,0,1
128680,),0,1
128681,",",0,0
128682,and,0,0
128683,time-to-task-failure,0,0
128684,(,0,1
128685,isometric,0,0
128686,contraction,0,1
128687,at,0,1
128688,40,0,1
128689,%,0,0
128690,MVC,0,1
128691,),0,1
128692,of,0,0
128693,the,0,0
128694,plantar,0,1
128695,flexors,0,0
128696,were,0,1
128697,recorded,0,0
128698,before,0,0
128699,and,0,1
128700,after,0,1
128701,training,0,1
128702,.,0,1
128703,Following,0,0
128704,strength,0,0
128705,training,0,0
128706,",",0,0
128707,MVC,0,1
128708,of,0,0
128709,the,0,0
128710,plantar,0,1
128711,flexors,0,0
128712,increased,0,0
128713,by,0,1
128714,14.4,0,0
128715,?,0,1
128716,5.2,0,0
128717,%,0,0
128718,in,0,0
128719,the,0,0
128720,strength,0,0
128721,group,0,0
128722,(,0,1
128723,P,0,0
128724,<,0,0
128725,0.001,0,0
128726,),0,1
128727,",",0,0
128728,whereas,0,0
128729,time-to-task-failure,0,0
128730,was,0,0
128731,prolonged,0,0
128732,in,0,0
128733,the,0,0
128734,endurance,0,0
128735,group,0,1
128736,(,0,1
128737,22.7,0,1
128738,?,0,1
128739,17.1,0,0
128740,%,0,0
128741,;,0,1
128742,P,0,0
128743,<,0,0
128744,0.05,0,0
128745,),0,1
128746,.,0,1
128747,The,0,0
128748,V,0,0
128749,wave-to-maximal,0,0
128750,M,0,1
128751,wave,0,1
128752,(,0,1
128753,V/M,0,0
128754,(,0,1
128755,max,0,1
128756,),0,1
128757,),0,1
128758,ratio,0,0
128759,increased,0,0
128760,significantly,0,0
128761,(,0,1
128762,55.1,0,1
128763,?,0,1
128764,28.3,0,0
128765,%,0,0
128766,;,0,1
128767,P,0,0
128768,<,0,0
128769,0.001,0,0
128770,),0,1
128771,following,0,0
128772,strength,0,0
128773,training,0,0
128774,",",0,0
128775,but,0,0
128776,the,0,0
128777,maximal,0,0
128778,H,0,1
128779,wave-to-maximal,0,1
128780,M,0,1
128781,wave,0,1
128782,(,0,1
128783,H,0,1
128784,(,0,1
128785,max,0,1
128786,),0,1
128787,/M,0,0
128788,(,0,1
128789,max,0,1
128790,),0,1
128791,),0,1
128792,ratio,0,0
128793,remained,0,0
128794,unchanged,0,0
128795,.,0,1
128796,Conversely,0,0
128797,",",0,0
128798,in,0,0
128799,the,0,0
128800,endurance,0,0
128801,group,0,0
128802,the,0,0
128803,V/M,0,0
128804,(,0,0
128805,max,0,1
128806,),0,1
128807,ratio,0,0
128808,was,0,0
128809,not,0,0
128810,altered,0,1
128811,",",0,0
128812,whereas,0,0
128813,the,0,0
128814,H,0,1
128815,(,0,0
128816,max,0,1
128817,),0,1
128818,/M,0,0
128819,(,0,1
128820,max,0,1
128821,),0,1
128822,ratio,0,0
128823,increased,0,0
128824,by,0,0
128825,30.8,0,1
128826,?,0,1
128827,21.7,0,0
128828,%,0,0
128829,(,0,1
128830,P,0,0
128831,<,0,0
128832,0.05,0,0
128833,),0,1
128834,.,0,1
128835,The,0,0
128836,endurance,0,0
128837,training,0,0
128838,group,0,1
128839,also,0,0
128840,displayed,0,0
128841,a,0,0
128842,reduction,0,0
128843,in,0,0
128844,the,0,0
128845,H-reflex,0,0
128846,excitability,0,0
128847,threshold,0,0
128848,while,0,0
128849,the,0,0
128850,H-reflex,0,0
128851,amplitude,0,0
128852,on,0,0
128853,the,0,0
128854,ascending,0,1
128855,limb,0,0
128856,of,0,0
128857,the,0,0
128858,recruitment,0,0
128859,curve,0,0
128860,increased,0,0
128861,.,0,1
128862,Strength,0,0
128863,training,0,0
128864,only,0,0
128865,elicited,0,0
128866,a,0,0
128867,significant,0,0
128868,decrease,0,0
128869,in,0,1
128870,H-reflex,0,0
128871,excitability,0,0
128872,threshold,0,0
128873,",",0,0
128874,while,0,0
128875,H-reflex,0,0
128876,amplitudes,0,0
128877,over,0,0
128878,the,0,0
128879,ascending,0,1
128880,limb,0,0
128881,remained,0,0
128882,unchanged,0,0
128883,.,0,1
128884,These,0,0
128885,observations,0,0
128886,indicate,0,0
128887,that,0,0
128888,the,0,0
128889,H-reflex,0,0
128890,pathway,0,0
128891,is,0,0
128892,strongly,0,0
128893,involved,0,0
128894,in,0,0
128895,the,0,0
128896,enhanced,0,0
128897,endurance,0,0
128898,resistance,0,0
128899,that,0,0
128900,occurs,0,0
128901,following,0,0
128902,endurance,0,0
128903,training,0,0
128904,.,0,1
128905,On,0,0
128906,the,0,0
128907,contrary,0,0
128908,",",0,0
128909,the,0,0
128910,improvements,0,0
128911,in,0,1
128912,MVC,0,1
128913,following,0,0
128914,strength,0,0
128915,training,0,0
128916,are,0,0
128917,likely,0,0
128918,attributed,0,0
128919,to,0,1
128920,increased,0,0
128921,descending,0,1
128922,drive,0,0
128923,and/or,0,0
128924,modulation,0,0
128925,in,0,1
128926,afferents,0,1
128927,other,0,1
128928,than,0,1
128929,Ia,0,1
128930,afferents,0,1
128931,.,0,1
128932,[,0,0
128933,Prophylactic,0,1
128934,intraaortic,0,1
128935,balloon,0,1
128936,pumping,0,0
128937,in,0,0
128938,high-risk,1,1
128939,cardiac,1,1
128940,surgery,1,1
128941,patients,1,1
128942,],1,1
128943,.,0,1
128944,BACKGROUND,0,0
128945,We,0,0
128946,examined,0,0
128947,the,0,0
128948,impact,0,0
128949,of,0,0
128950,prophylactic,0,1
128951,IABP,0,1
128952,insertion,0,1
128953,in,0,0
128954,EuroSCORE-stratified,1,1
128955,high-risk,1,1
128956,cardiac,1,1
128957,surgery,1,1
128958,patients,1,1
128959,with,1,1
128960,a,1,1
128961,score,1,0
128962,?8,1,0
128963,.,1,1
128964,MATERIAL,0,0
128965,AND,0,0
128966,METHODS,0,0
128967,A,0,1
128968,randomized,0,1
128969,trial,0,1
128970,with,1,1
128971,104,1,1
128972,patients,1,1
128973,either,1,1
128974,without,1,1
128975,prophylactic,1,1
128976,IABP,1,1
128977,insertion,1,1
128978,(,1,1
128979,group,1,1
128980,A,1,1
128981,",",1,0
128982,n=52,1,1
128983,),1,0
128984,or,1,1
128985,with,1,1
128986,IABP,1,1
128987,(,1,1
128988,group,1,1
128989,B,1,1
128990,",",1,0
128991,n=52,1,1
128992,),1,1
128993,was,1,0
128994,conducted,0,1
128995,.,0,1
128996,The,0,0
128997,primary,0,1
128998,endpoint,0,0
128999,was,0,0
129000,30-day,0,0
129001,mortality,0,0
129002,.,0,1
129003,RESULTS,1,0
129004,The,1,0
129005,median,1,0
129006,age,1,1
129007,of,1,0
129008,the,1,0
129009,patients,1,1
129010,was,1,0
129011,74,1,1
129012,years,1,1
129013,and,1,1
129014,43,1,1
129015,%,1,0
129016,of,1,1
129017,participants,1,1
129018,were,1,1
129019,females,1,1
129020,.,1,1
129021,The,1,0
129022,30-day,0,0
129023,mortality,0,0
129024,did,0,0
129025,not,0,0
129026,differ,0,0
129027,between,0,0
129028,group,0,1
129029,A,0,1
129030,(,0,1
129031,17.3,0,0
129032,%,0,0
129033,),0,1
129034,and,0,0
129035,group,0,1
129036,B,0,1
129037,(,0,1
129038,13.4,0,0
129039,%,0,0
129040,;,0,1
129041,p=0.78,0,0
129042,),0,1
129043,.,0,1
129044,The,0,0
129045,median,0,0
129046,hospital,0,1
129047,stay,0,0
129048,was,0,0
129049,14,0,1
129050,days,0,0
129051,in,0,1
129052,both,0,1
129053,groups,0,0
129054,.,0,1
129055,Intra-,0,1
129056,and,0,0
129057,postoperative,0,0
129058,IABP,0,1
129059,support,0,0
129060,was,0,0
129061,required,0,0
129062,by,0,0
129063,13,0,1
129064,patients,0,1
129065,(,0,1
129066,21,0,1
129067,%,0,0
129068,),0,1
129069,in,0,0
129070,group,0,1
129071,A,0,1
129072,.,0,1
129073,The,0,0
129074,median,0,0
129075,ventilation,0,0
129076,time,0,0
129077,(,0,1
129078,14,0,1
129079,hours,0,1
129080,versus,0,0
129081,13,0,1
129082,hours,0,0
129083,),0,1
129084,",",0,1
129085,median,0,0
129086,catecholamine,0,0
129087,dose,0,0
129088,",",0,0
129089,frequency,0,0
129090,of,0,0
129091,dialysis-dependent,0,1
129092,acute,0,1
129093,renal,0,1
129094,failure,0,1
129095,(,0,1
129096,28,0,1
129097,%,0,0
129098,versus,0,0
129099,18,0,1
129100,%,0,0
129101,),0,1
129102,",",0,1
129103,cardiac,0,1
129104,indices,0,0
129105,",",0,1
129106,and,0,0
129107,frequency,0,0
129108,of,0,0
129109,a,0,1
129110,low,0,1
129111,cardiac,0,1
129112,output,0,0
129113,syndrome,0,1
129114,(,0,1
129115,26,0,1
129116,%,0,0
129117,versus,0,0
129118,25,0,1
129119,%,0,0
129120,),0,1
129121,did,0,0
129122,not,0,0
129123,significantly,0,0
129124,differ,0,0
129125,between,0,0
129126,groups,0,1
129127,.,0,1
129128,CONCLUSION,0,0
129129,Prophylactic,0,1
129130,preoperative,0,1
129131,IABP,0,1
129132,insertion,0,1
129133,in,0,0
129134,EuroSCORE-stratified,1,1
129135,high-risk,1,1
129136,patients,1,1
129137,is,1,0
129138,not,0,0
129139,associated,0,0
129140,with,0,1
129141,decreased,0,0
129142,30-day,0,0
129143,mortality,0,1
129144,.,0,1
129145,[,0,0
129146,Clinical,0,0
129147,observations,0,0
129148,on,0,0
129149,the,0,0
129150,treatment,0,0
129151,of,0,0
129152,hookworm,1,1
129153,",",1,1
129154,Ascaris,1,1
129155,and,1,0
129156,Trichuris,1,0
129157,infection,1,1
129158,with,0,1
129159,oxibendazole,0,1
129160,],0,1
129161,.,0,1
129162,340,1,1
129163,cases,1,1
129164,of,1,1
129165,hookworm,1,1
129166,infection,1,1
129167,",",1,1
129168,196,1,1
129169,cases,1,1
129170,of,1,1
129171,ascariasis,1,1
129172,and,1,1
129173,178,1,1
129174,cases,1,1
129175,of,1,1
129176,trichuriasis,1,1
129177,were,1,1
129178,treated,1,1
129179,with,1,1
129180,an,1,0
129181,anthelmintic,1,0
129182,",",1,0
129183,oxibendazole,1,0
129184,",",1,1
129185,15mg/kg.d,1,1
129186,x,1,1
129187,3d,1,1
129188,;,1,1
129189,102,1,1
129190,",",1,1
129191,70,1,1
129192,and,1,1
129193,66,1,1
129194,cases,1,1
129195,of,1,1
129196,respective,1,1
129197,infections,1,1
129198,were,1,1
129199,treated,1,1
129200,with,1,1
129201,pyrantel,1,1
129202,10mg/kg.d,1,0
129203,x,1,1
129204,3d,1,1
129205,and,1,1
129206,108,1,1
129207,",",1,1
129208,74,1,1
129209,and,1,1
129210,63,1,1
129211,cases,1,1
129212,took,1,1
129213,placebo,1,0
129214,for,0,0
129215,comparison,0,0
129216,and,0,1
129217,as,0,0
129218,control,0,1
129219,under,0,1
129220,double-blind,0,1
129221,observations,0,1
129222,.,0,1
129223,Re-examinations,0,0
129224,of,0,0
129225,the,0,0
129226,stool,0,0
129227,were,0,0
129228,performed,0,0
129229,after,0,0
129230,the,0,0
129231,treatment,0,0
129232,.,0,0
129233,Among,0,1
129234,the,0,0
129235,cases,0,1
129236,treated,0,1
129237,with,0,1
129238,oxibendazole,0,0
129239,",",0,0
129240,the,0,0
129241,egg,0,0
129242,negative,0,0
129243,conversion,0,1
129244,rates,0,0
129245,of,0,0
129246,hookworm,0,1
129247,",",0,1
129248,Ascaris,0,1
129249,and,0,1
129250,Trichuris,0,1
129251,were,0,1
129252,70.3-80.6,0,0
129253,%,0,0
129254,",",0,1
129255,92.5-97.8,0,0
129256,and,0,1
129257,67.0-71.0,0,0
129258,%,0,0
129259,respectively,0,0
129260,.,0,0
129261,The,0,0
129262,egg,0,0
129263,reduction,0,0
129264,rates,0,0
129265,of,0,1
129266,hookworm,0,1
129267,were,0,1
129268,98.1-98.6,0,0
129269,%,0,0
129270,.,0,1
129271,The,0,0
129272,larval,0,1
129273,negative,0,1
129274,conversion,0,1
129275,rates,0,0
129276,of,0,1
129277,Ancylostoma,0,1
129278,duodenale,0,1
129279,and,0,0
129280,Necator,0,1
129281,americanus,0,1
129282,were,0,1
129283,77.7,0,1
129284,and,0,1
129285,83.2,0,0
129286,%,0,0
129287,respectively,0,0
129288,.,0,1
129289,Among,0,0
129290,the,0,0
129291,cases,0,1
129292,treated,0,1
129293,with,0,1
129294,pyrantel,0,0
129295,",",0,0
129296,the,0,0
129297,egg,0,0
129298,negative,0,0
129299,conversion,0,1
129300,rates,0,0
129301,of,0,1
129302,the,0,1
129303,three,0,0
129304,above,0,0
129305,mentioned,0,1
129306,parasites,0,1
129307,were,0,1
129308,73.5,0,0
129309,",",0,1
129310,90.0,0,0
129311,and,0,1
129312,28.8,0,1
129313,%,0,0
129314,respectively,0,0
129315,.,0,0
129316,The,0,0
129317,egg,0,0
129318,reduction,0,0
129319,rate,0,0
129320,of,0,0
129321,hookworm,0,1
129322,was,0,0
129323,98.8,0,0
129324,%,0,0
129325,.,0,1
129326,Among,0,1
129327,the,0,0
129328,cases,0,1
129329,treated,0,1
129330,with,0,1
129331,placebo,0,0
129332,",",0,0
129333,the,0,0
129334,egg,0,0
129335,negative,0,0
129336,conversion,0,1
129337,rates,0,0
129338,of,0,1
129339,the,0,1
129340,three,0,0
129341,above,0,0
129342,mentioned,0,1
129343,parasites,0,1
129344,were,0,1
129345,6.5,0,0
129346,",",0,1
129347,29.7,0,1
129348,and,0,1
129349,7.9,0,0
129350,%,0,0
129351,.,0,1
129352,No,0,0
129353,marked,0,0
129354,adverse,0,0
129355,reactions,0,0
129356,were,0,1
129357,observed,0,0
129358,by,0,0
129359,clinical,0,0
129360,and,0,1
129361,laboratory,0,1
129362,examinations,0,1
129363,.,0,1
129364,Challenges,0,1
129365,and,0,1
129366,potential,0,1
129367,solutions,0,0
129368,to,0,1
129369,meeting,0,1
129370,accrual,0,1
129371,goals,0,1
129372,in,0,1
129373,a,0,1
129374,Phase,0,1
129375,II,0,1
129376,chemoprevention,0,1
129377,trial,0,0
129378,for,0,0
129379,prostate,1,1
129380,cancer,1,1
129381,.,1,1
129382,OBJECTIVE,0,0
129383,The,0,0
129384,goal,0,0
129385,of,0,0
129386,this,0,0
129387,report,0,0
129388,is,0,0
129389,to,0,0
129390,describe,0,0
129391,the,0,0
129392,on,0,0
129393,going,0,0
129394,strategies,0,0
129395,",",0,1
129396,successes,0,0
129397,",",0,1
129398,challenges,0,0
129399,and,0,1
129400,solutions,0,0
129401,for,0,0
129402,recruitment,0,0
129403,in,0,0
129404,this,0,0
129405,multi-center,0,0
129406,",",0,0
129407,phase,0,1
129408,II,0,1
129409,chemoprevention,0,1
129410,trial,0,1
129411,targeting,0,0
129412,men,1,1
129413,at,1,1
129414,high,1,1
129415,risk,1,1
129416,for,1,0
129417,prostate,1,1
129418,cancer,1,1
129419,.,1,1
129420,METHODS,0,0
129421,We,0,0
129422,developed,0,1
129423,and,0,0
129424,implemented,0,0
129425,a,0,0
129426,multi-center,0,1
129427,clinical,0,0
129428,trial,0,1
129429,in,0,1
129430,institutions,0,1
129431,with,0,1
129432,supportive,0,1
129433,infrastructure,0,0
129434,",",0,0
129435,lead,0,0
129436,by,0,0
129437,a,0,0
129438,recruitment,0,0
129439,team,0,0
129440,of,0,0
129441,experienced,0,1
129442,and,0,1
129443,committed,0,1
129444,physicians,0,1
129445,and,0,1
129446,clinical,0,0
129447,trial,0,0
129448,staff,0,1
129449,",",0,0
129450,implementing,0,0
129451,multi-media,0,0
129452,and,0,0
129453,community,0,1
129454,outreach,0,1
129455,strategies,0,0
129456,to,0,1
129457,meet,0,1
129458,recruitment,0,0
129459,goals,0,1
129460,.,0,1
129461,Screening,0,1
129462,logs,0,0
129463,were,0,1
129464,reviewed,0,1
129465,to,0,0
129466,identify,0,0
129467,trends,0,0
129468,as,0,0
129469,well,0,0
129470,as,0,0
129471,patient,0,0
129472,",",0,0
129473,protocol,0,0
129474,and,0,0
129475,infrastructure,0,0
129476,-related,0,1
129477,barriers,0,0
129478,impacting,0,1
129479,accrual,0,1
129480,and,0,1
129481,revisions,0,0
129482,to,0,1
129483,protocol,0,1
129484,implemented,0,0
129485,.,0,1
129486,RESULTS,0,0
129487,Between,1,1
129488,January,1,1
129489,2008,1,1
129490,and,1,1
129491,February,1,1
129492,2011,1,1
129493,a,1,0
129494,total,1,1
129495,of,1,0
129496,3547,1,1
129497,individuals,1,1
129498,were,1,1
129499,prescreened,1,1
129500,with,1,1
129501,94,1,1
129502,%,1,0
129503,(,1,1
129504,n=3092,1,1
129505,),1,1
129506,determined,1,0
129507,to,1,0
129508,be,1,0
129509,ineligible,1,1
129510,based,1,1
129511,on,1,0
129512,diagnosis,1,1
129513,of,1,0
129514,cancer,1,1
129515,or,1,1
129516,benign,1,1
129517,biopsy,1,1
129518,results,1,0
129519,.,1,1
129520,Of,0,0
129521,these,0,0
129522,",",0,0
129523,216,1,1
129524,were,1,1
129525,considered,1,0
129526,eligible,1,1
129527,for,1,1
129528,further,1,0
129529,screening,1,1
129530,with,1,1
129531,52,1,1
129532,%,1,0
129533,(,1,1
129534,n=113,1,1
129535,),1,1
129536,declining,1,0
129537,to,1,0
129538,participate,1,1
129539,due,1,0
129540,to,1,0
129541,patient,1,1
129542,related,1,0
129543,factors,1,0
129544,and,1,1
129545,14,1,1
129546,%,1,0
129547,(,1,1
129548,n=29,1,1
129549,),1,1
129550,eliminated,1,0
129551,due,1,0
129552,to,1,1
129553,protocol-related,1,1
129554,criteria,1,1
129555,for,1,1
129556,exclusion,1,1
129557,.,1,1
129558,Ninety-four,1,1
129559,(,1,1
129560,94,1,1
129561,),1,1
129562,subjects,1,1
129563,consented,1,1
129564,to,1,0
129565,participate,1,1
129566,with,1,1
129567,34,1,1
129568,%,1,0
129569,of,1,0
129570,these,1,0
129571,subjects,1,1
129572,(,1,1
129573,n=74,1,1
129574,),1,1
129575,meeting,1,1
129576,all,1,1
129577,eligibility,1,1
129578,criteria,1,1
129579,to,0,1
129580,be,0,0
129581,randomized,0,1
129582,to,0,0
129583,receive,0,1
129584,study,0,0
129585,agent,0,0
129586,or,0,1
129587,placebo,0,0
129588,.,0,1
129589,Across,0,0
129590,all,0,0
129591,sites,0,0
129592,",",0,1
129593,99,0,1
129594,%,0,0
129595,of,0,0
129596,the,0,0
129597,recruitment,0,0
129598,of,0,0
129599,subjects,0,1
129600,in,0,1
129601,this,0,0
129602,clinical,0,0
129603,trial,0,0
129604,is,0,0
129605,via,0,0
129606,physician,0,1
129607,recruitment,0,1
129608,and,0,0
129609,referral,0,1
129610,with,0,1
129611,less,0,0
129612,than,0,1
129613,1,0,0
129614,%,0,0
129615,responding,0,1
129616,to,0,1
129617,other,0,1
129618,recruitment,0,1
129619,strategies,0,0
129620,.,0,1
129621,CONCLUSION,0,0
129622,A,0,0
129623,contemporary,0,0
129624,approach,0,0
129625,to,0,0
129626,subject,0,1
129627,recruitment,0,0
129628,and,0,0
129629,frequent,0,0
129630,evaluation,0,0
129631,is,0,0
129632,needed,0,0
129633,to,0,0
129634,assure,0,0
129635,responsiveness,0,0
129636,to,0,0
129637,emerging,0,0
129638,challenges,0,0
129639,to,0,1
129640,accrual,0,1
129641,and,0,0
129642,the,0,0
129643,evolving,0,0
129644,scientific,0,0
129645,literature,0,0
129646,.,0,1
129647,A,0,0
129648,focus,0,0
129649,on,0,0
129650,investing,0,0
129651,on,0,0
129652,improving,0,0
129653,systems,0,0
129654,for,0,1
129655,physician,0,1
129656,recruitment,0,0
129657,may,0,0
129658,be,0,0
129659,key,0,0
129660,to,0,0
129661,meeting,0,1
129662,recruitment,0,0
129663,target,0,1
129664,in,0,1
129665,chemoprevention,0,1
129666,trials,0,1
129667,.,0,1
129668,A,0,0
129669,randomized,0,0
129670,",",0,0
129671,dose-escalation,0,1
129672,study,0,1
129673,of,0,0
129674,subconjunctival,0,1
129675,and,0,1
129676,intravitreal,0,0
129677,injections,0,0
129678,of,0,1
129679,sirolimus,0,1
129680,in,0,1
129681,patients,1,1
129682,with,1,1
129683,diabetic,1,1
129684,macular,1,1
129685,edema,1,1
129686,.,1,1
129687,OBJECTIVE,0,0
129688,To,0,0
129689,evaluate,0,0
129690,the,0,0
129691,safety,0,0
129692,and,0,0
129693,tolerability,0,0
129694,of,0,0
129695,a,0,1
129696,single,0,0
129697,subconjunctival,0,0
129698,(,0,1
129699,SCJ,0,1
129700,),0,1
129701,or,0,1
129702,intravitreal,0,0
129703,(,0,1
129704,IVT,0,1
129705,),0,1
129706,injection,0,0
129707,of,0,0
129708,an,0,0
129709,ophthalmic,0,1
129710,sirolimus,0,1
129711,formulation,0,0
129712,in,0,0
129713,eyes,0,1
129714,with,0,1
129715,diabetic,0,1
129716,macular,0,1
129717,edema,0,1
129718,(,0,1
129719,DME,0,1
129720,),0,1
129721,.,0,1
129722,DESIGN,0,0
129723,Randomized,0,0
129724,",",0,0
129725,open-label,0,0
129726,",",0,0
129727,dose-escalating,0,1
129728,phase,0,0
129729,I,0,1
129730,study,0,1
129731,.,0,1
129732,PARTICIPANTS,0,0
129733,Fifty,1,1
129734,eyes,1,1
129735,among,1,1
129736,50,1,1
129737,patients,1,1
129738,with,1,1
129739,DME,1,1
129740,",",1,1
129741,retinal,1,1
129742,thickness,1,1
129743,?,1,1
129744,300,1,0
129745,microns,1,0
129746,and,1,1
129747,best-corrected,1,0
129748,visual,1,0
129749,acuity,1,0
129750,(,1,1
129751,BCVA,1,0
129752,),1,1
129753,20/40,1,1
129754,to,1,1
129755,20/200,1,1
129756,.,1,1
129757,METHODS,0,0
129758,A,0,0
129759,single,0,0
129760,dose,0,0
129761,of,0,0
129762,sirolimus,0,1
129763,administered,0,0
129764,SCJ,0,1
129765,(,0,1
129766,220,0,1
129767,",",0,1
129768,440,0,1
129769,",",0,0
129770,880,0,1
129771,",",0,0
129772,1320,0,1
129773,",",0,0
129774,or,0,1
129775,1760,0,1
129776,?g,0,0
129777,),0,1
129778,or,0,1
129779,IVT,0,1
129780,(,0,1
129781,44,0,1
129782,",",0,1
129783,110,0,1
129784,",",0,0
129785,176,0,1
129786,",",0,0
129787,264,0,1
129788,",",0,0
129789,or,0,1
129790,352,0,1
129791,?g,0,0
129792,),0,1
129793,on,0,1
129794,day,0,1
129795,0,0,0
129796,;,0,1
129797,observation,0,0
129798,through,0,1
129799,day,0,0
129800,90,0,1
129801,.,0,1
129802,MAIN,0,0
129803,OUTCOME,0,1
129804,MEASURES,0,0
129805,Primary,0,1
129806,end,0,0
129807,points,0,0
129808,were,0,1
129809,the,0,0
129810,frequency,0,0
129811,and,0,0
129812,severity,0,0
129813,of,0,0
129814,ocular,0,1
129815,and,0,1
129816,systemic,0,1
129817,adverse,0,0
129818,events,0,0
129819,.,0,1
129820,Secondary,0,0
129821,end,0,0
129822,points,0,0
129823,were,0,1
129824,changes,0,0
129825,in,0,1
129826,BCVA,0,0
129827,and,0,1
129828,retinal,0,1
129829,thickness,0,1
129830,.,0,1
129831,RESULTS,0,0
129832,No,0,0
129833,dose-limiting,0,0
129834,toxicities,0,0
129835,were,0,1
129836,observed,0,0
129837,and,0,1
129838,ocular,0,1
129839,adverse,0,0
129840,events,0,0
129841,were,0,1
129842,mostly,0,1
129843,mild,0,1
129844,and,0,0
129845,transient,0,1
129846,.,0,1
129847,Conjunctival,0,0
129848,hyperemia,0,0
129849,",",0,0
129850,hemorrhage,0,0
129851,",",0,0
129852,and,0,0
129853,edema,0,1
129854,were,0,1
129855,common,0,0
129856,after,0,0
129857,the,0,0
129858,SCJ,0,1
129859,injection,0,0
129860,procedure,0,0
129861,and,0,0
129862,conjunctival,0,1
129863,hemorrhage,0,1
129864,was,0,0
129865,common,0,0
129866,after,0,0
129867,the,0,0
129868,IVT,0,0
129869,injection,0,0
129870,procedure,0,0
129871,.,0,1
129872,Three,0,1
129873,patients,0,1
129874,experienced,0,1
129875,ocular,0,1
129876,adverse,0,0
129877,events,0,0
129878,considered,0,1
129879,possibly,0,0
129880,related,0,0
129881,to,0,0
129882,study,0,1
129883,drug,0,0
129884,:,0,1
129885,Conjunctival,0,1
129886,edema,0,1
129887,and,0,1
129888,reduced,0,0
129889,visual,0,0
129890,acuity,0,0
129891,were,0,1
129892,reported,0,0
129893,in,0,1
129894,1,0,1
129895,SCJ,0,1
129896,patient,0,1
129897,each,0,0
129898,and,0,0
129899,iritis,0,1
129900,was,0,0
129901,reported,0,0
129902,in,0,1
129903,1,0,1
129904,IVT,0,1
129905,patient,0,1
129906,.,0,1
129907,No,0,0
129908,serious,0,0
129909,ocular,0,1
129910,adverse,0,0
129911,events,0,0
129912,were,0,1
129913,reported,0,1
129914,.,0,1
129915,No,0,0
129916,nonocular,0,1
129917,adverse,0,0
129918,events,0,0
129919,were,0,1
129920,considered,0,0
129921,related,0,0
129922,to,0,0
129923,study,0,1
129924,drug,0,0
129925,.,0,1
129926,Systemic,0,0
129927,exposure,0,0
129928,to,0,0
129929,sirolimus,0,1
129930,was,0,0
129931,low,0,0
129932,",",0,0
129933,with,0,1
129934,blood,0,0
129935,concentrations,0,0
129936,below,0,1
129937,levels,0,1
129938,necessary,0,0
129939,for,0,1
129940,systemic,0,1
129941,immunosuppression,0,1
129942,.,0,1
129943,For,0,0
129944,the,0,0
129945,SCJ,0,1
129946,group,0,1
129947,(,0,1
129948,n,0,1
129949,=,0,1
129950,25,0,1
129951,),0,1
129952,",",0,0
129953,a,0,0
129954,median,0,0
129955,increase,0,0
129956,in,0,1
129957,BCVA,0,0
129958,started,0,1
129959,at,0,0
129960,day,0,0
129961,7,0,1
129962,(,0,1
129963,5.0,0,0
129964,letters,0,1
129965,),0,1
129966,and,0,1
129967,was,0,0
129968,3.0,0,0
129969,",",0,1
129970,4.0,0,0
129971,",",0,0
129972,and,0,1
129973,4.0,0,0
129974,letters,0,0
129975,at,0,1
129976,days,0,1
129977,14,0,1
129978,",",0,1
129979,45,0,1
129980,and,0,1
129981,90,0,1
129982,",",0,0
129983,respectively,0,0
129984,.,0,0
129985,At,0,0
129986,day,0,0
129987,45,0,1
129988,",",0,0
129989,median,0,0
129990,decrease,0,0
129991,in,0,1
129992,retinal,0,1
129993,thickness,0,1
129994,was,0,0
129995,-23.7,0,0
129996,?m,0,1
129997,.,0,1
129998,For,0,0
129999,the,0,0
130000,IVT,0,0
130001,group,0,1
130002,(,0,1
130003,n,0,1
130004,=,0,1
130005,25,0,1
130006,),0,1
130007,",",0,0
130008,the,0,0
130009,median,0,0
130010,increase,0,0
130011,in,0,1
130012,BCVA,0,0
130013,was,0,0
130014,2.0,0,0
130015,letters,0,0
130016,at,0,1
130017,day,0,1
130018,7,0,1
130019,;,0,1
130020,at,0,1
130021,days,0,0
130022,14,0,1
130023,",",0,1
130024,45,0,1
130025,",",0,0
130026,and,0,0
130027,90,0,0
130028,",",0,0
130029,the,0,0
130030,median,0,0
130031,increase,0,0
130032,was,0,0
130033,maintained,0,0
130034,(,0,1
130035,4.0,0,1
130036,letters,0,1
130037,),0,1
130038,;,0,1
130039,the,0,0
130040,median,0,0
130041,decrease,0,0
130042,in,0,1
130043,retinal,0,1
130044,thickness,0,1
130045,was,0,0
130046,-52.0,0,0
130047,?m,0,1
130048,at,0,1
130049,day,0,0
130050,45,0,1
130051,.,0,1
130052,CONCLUSIONS,0,0
130053,Locally,0,1
130054,administered,0,0
130055,sirolimus,0,1
130056,was,0,0
130057,well-tolerated,0,0
130058,with,0,1
130059,minimal,0,1
130060,systemic,0,0
130061,exposure,0,0
130062,at,0,1
130063,all,0,1
130064,doses,0,0
130065,tested,0,0
130066,in,0,1
130067,this,0,0
130068,small,0,1
130069,phase,0,0
130070,I,0,1
130071,population,0,1
130072,.,0,0
130073,These,0,0
130074,findings,0,0
130075,support,0,0
130076,advancing,0,0
130077,the,0,0
130078,present,0,0
130079,sirolimus,0,1
130080,formulation,0,0
130081,into,0,1
130082,phase,0,1
130083,II,0,1
130084,studies,0,0
130085,.,0,1
130086,FINANCIAL,0,0
130087,DISCLOSURE,0,0
130088,(,0,1
130089,S,0,1
130090,),0,1
130091,Proprietary,0,0
130092,or,0,1
130093,commercial,0,0
130094,disclosure,0,0
130095,may,0,0
130096,be,0,0
130097,found,0,0
130098,after,0,0
130099,the,0,0
130100,references,0,1
130101,.,0,1
130102,Safety,0,0
130103,",",0,0
130104,tolerability,0,0
130105,",",0,0
130106,and,0,0
130107,immunogenicity,0,0
130108,after,0,1
130109,1,0,1
130110,and,0,1
130111,2,0,1
130112,doses,0,0
130113,of,0,1
130114,zoster,0,1
130115,vaccine,0,1
130116,in,0,1
130117,healthy,1,1
130118,adults,1,1
130119,?60,1,1
130120,years,1,1
130121,of,1,1
130122,age,1,1
130123,.,1,1
130124,BACKGROUND,0,0
130125,Incidence,0,0
130126,and,0,0
130127,severity,0,0
130128,of,0,1
130129,herpes,0,1
130130,zoster,0,1
130131,(,0,1
130132,HZ,0,0
130133,),0,1
130134,and,0,1
130135,postherpetic,0,1
130136,neuralgia,0,1
130137,increase,0,0
130138,with,0,1
130139,age,0,1
130140,",",0,0
130141,associated,0,0
130142,with,0,1
130143,age-related,0,0
130144,decrease,0,0
130145,in,0,0
130146,immunity,0,0
130147,to,0,1
130148,varicella-zoster,0,1
130149,virus,0,1
130150,(,0,1
130151,VZV,0,1
130152,),0,1
130153,.,0,1
130154,One,0,1
130155,dose,0,0
130156,of,0,0
130157,zoster,0,1
130158,vaccine,0,1
130159,(,0,1
130160,ZV,0,0
130161,),0,1
130162,has,0,0
130163,demonstrated,0,0
130164,substantial,0,0
130165,protection,0,0
130166,against,0,1
130167,HZ,0,0
130168,;,0,1
130169,this,0,0
130170,study,0,0
130171,examined,0,0
130172,impact,0,0
130173,of,0,0
130174,a,0,1
130175,second,0,0
130176,dose,0,0
130177,of,0,1
130178,ZV,0,0
130179,.,0,1
130180,METHODS,0,0
130181,Randomized,0,0
130182,",",0,0
130183,double-blind,1,0
130184,",",1,0
130185,multicenter,1,0
130186,study,1,1
130187,with,1,1
130188,210,1,1
130189,subjects,1,1
130190,?60,1,1
130191,years,1,1
130192,old,1,1
130193,compared,0,0
130194,immunity,0,0
130195,and,0,1
130196,safety,0,0
130197,profiles,0,0
130198,after,0,1
130199,one,0,1
130200,and,0,1
130201,two,0,1
130202,doses,0,0
130203,of,0,1
130204,ZV,0,0
130205,",",0,0
130206,separated,0,0
130207,by,0,0
130208,6,0,1
130209,weeks,0,0
130210,",",0,1
130211,vs.,0,0
130212,placebo,0,0
130213,.,0,1
130214,Immunogenicity,0,0
130215,was,0,0
130216,evaluated,0,0
130217,using,0,0
130218,VZV,0,1
130219,interferon-gamma,0,0
130220,(,0,1
130221,IFN-?,0,1
130222,),0,1
130223,enzyme-linked,0,1
130224,immunospot,0,1
130225,(,0,1
130226,ELISPOT,0,1
130227,),0,1
130228,assay,0,0
130229,and,0,1
130230,VZV,0,1
130231,glycoprotein,0,0
130232,enzyme-linked,0,1
130233,immunosorbent,0,0
130234,antibody,0,0
130235,(,0,1
130236,gpELISA,0,1
130237,),0,1
130238,assay,0,0
130239,.,0,1
130240,Adverse,0,0
130241,experiences,0,0
130242,(,0,1
130243,AEs,0,1
130244,),0,1
130245,were,0,0
130246,recorded,0,0
130247,on,0,0
130248,a,0,1
130249,standardized,0,0
130250,Vaccination,0,1
130251,Report,0,1
130252,Card,0,0
130253,.,0,1
130254,RESULTS,0,0
130255,No,0,0
130256,serious,0,0
130257,vaccine-related,0,1
130258,AEs,0,0
130259,occurred,0,0
130260,.,0,1
130261,VZV,0,0
130262,IFN-?,0,1
130263,ELISPOT,0,1
130264,geometric,0,1
130265,mean,0,1
130266,count,0,0
130267,(,0,1
130268,GMC,0,1
130269,),0,1
130270,of,0,1
130271,spot-forming,0,1
130272,cells,0,1
130273,per,0,1
130274,10,0,1
130275,(,0,1
130276,6,0,1
130277,),0,1
130278,peripheral,0,1
130279,blood,0,1
130280,mononuclear,0,1
130281,cells,0,0
130282,increased,0,0
130283,in,0,1
130284,the,0,0
130285,ZV,0,0
130286,group,0,1
130287,from,0,1
130288,16.9,0,0
130289,prevaccination,0,1
130290,to,0,1
130291,49.5,0,1
130292,and,0,1
130293,32.8,0,0
130294,at,0,1
130295,2,0,1
130296,and,0,1
130297,6,0,1
130298,weeks,0,0
130299,postdose,0,0
130300,1,0,0
130301,",",0,0
130302,respectively,0,0
130303,.,0,1
130304,Two,0,1
130305,weeks,0,0
130306,",",0,1
130307,6,0,1
130308,weeks,0,0
130309,and,0,1
130310,6,0,1
130311,months,0,0
130312,postdose,0,0
130313,2,0,1
130314,",",0,0
130315,GMC,0,0
130316,was,0,0
130317,44.3,0,1
130318,",",0,1
130319,42.9,0,0
130320,",",0,0
130321,and,0,0
130322,36.5,0,0
130323,",",0,0
130324,respectively,0,0
130325,.,0,1
130326,GMC,0,0
130327,in,0,0
130328,the,0,0
130329,placebo,0,0
130330,group,0,0
130331,did,0,0
130332,not,0,0
130333,change,0,0
130334,during,0,0
130335,the,0,0
130336,study,0,0
130337,.,0,0
130338,The,0,0
130339,peak,0,0
130340,ELISPOT,0,1
130341,response,0,0
130342,occurred,0,0
130343,?2,0,0
130344,weeks,0,0
130345,after,0,1
130346,each,0,1
130347,ZV,0,0
130348,dose,0,0
130349,.,0,1
130350,The,0,0
130351,gpELISA,0,0
130352,geometric,0,0
130353,mean,0,1
130354,titers,0,0
130355,(,0,1
130356,GMTs,0,1
130357,),0,1
130358,in,0,0
130359,the,0,0
130360,ZV,0,0
130361,group,0,0
130362,were,0,0
130363,higher,0,0
130364,than,0,0
130365,in,0,0
130366,the,0,0
130367,placebo,0,0
130368,group,0,1
130369,at,0,1
130370,6,0,1
130371,weeks,0,0
130372,after,0,1
130373,each,0,1
130374,dose,0,0
130375,.,0,0
130376,Correlation,0,0
130377,between,0,0
130378,the,0,0
130379,IFN-?,0,1
130380,ELISPOT,0,0
130381,and,0,1
130382,gpELISA,0,1
130383,assays,0,0
130384,was,0,0
130385,poor,0,1
130386,.,0,1
130387,CONCLUSIONS,0,0
130388,ZV,0,0
130389,was,0,0
130390,generally,0,0
130391,well-tolerated,0,0
130392,and,0,0
130393,immunogenic,0,1
130394,in,0,1
130395,adults,0,1
130396,?60,0,1
130397,years,0,1
130398,old,0,1
130399,.,0,1
130400,A,0,0
130401,second,0,0
130402,dose,0,0
130403,of,0,1
130404,ZV,0,0
130405,was,0,0
130406,generally,0,0
130407,safe,0,0
130408,",",0,0
130409,but,0,0
130410,did,0,0
130411,not,0,0
130412,boost,0,1
130413,VZV-specific,0,0
130414,immunity,0,0
130415,beyond,0,1
130416,levels,0,0
130417,achieved,0,0
130418,postdose,0,0
130419,1,0,1
130420,.,0,1
130421,Dopamine,0,0
130422,transporter,0,0
130423,gene,0,0
130424,moderates,0,0
130425,response,0,0
130426,to,0,0
130427,behavioral,1,0
130428,parent,1,1
130429,training,1,1
130430,in,1,0
130431,children,1,1
130432,with,1,1
130433,ADHD,1,1
130434,:,1,1
130435,a,0,0
130436,pilot,0,0
130437,study,0,0
130438,.,0,0
130439,There,0,0
130440,is,0,0
130441,great,0,0
130442,variability,0,0
130443,in,0,0
130444,the,0,0
130445,degree,0,1
130446,to,0,0
130447,which,0,0
130448,children,1,1
130449,with,1,1
130450,attention,1,0
130451,deficit/hyperactivity,1,1
130452,disorder,1,1
130453,(,1,1
130454,ADHD,1,0
130455,),1,1
130456,improve,0,0
130457,through,0,0
130458,behavioral,0,1
130459,treatments,0,0
130460,.,0,1
130461,This,0,0
130462,study,0,0
130463,investigates,0,0
130464,the,0,0
130465,influence,0,0
130466,of,0,0
130467,the,0,0
130468,dopamine,0,0
130469,transporter,0,0
130470,gene,0,0
130471,(,0,1
130472,SCL6A3/DAT1,0,1
130473,),0,1
130474,on,0,0
130475,outcome,0,0
130476,of,0,0
130477,behavioral,0,1
130478,parent,0,1
130479,training,0,0
130480,(,0,1
130481,BPT,0,1
130482,),0,1
130483,.,0,1
130484,Study,1,0
130485,subjects,1,1
130486,were,1,1
130487,a,1,1
130488,subsample,1,1
130489,(,1,0
130490,n,1,1
130491,=,1,1
130492,50,1,1
130493,",",1,1
130494,for,1,1
130495,whom,1,1
130496,DAT1,1,1
130497,genotypes,1,1
130498,were,1,1
130499,available,1,1
130500,),1,1
130501,of,1,0
130502,a,1,1
130503,randomized,1,1
130504,controlled,1,0
130505,BPT,1,1
130506,effectiveness,1,0
130507,study,1,1
130508,(,1,1
130509,N,1,1
130510,=,1,1
130511,94,1,1
130512,),1,1
130513,comparing,1,0
130514,BPT,1,1
130515,plus,1,0
130516,ongoing,1,1
130517,routine,1,1
130518,clinical,1,0
130519,care,1,1
130520,(,1,1
130521,RCC,1,0
130522,),1,1
130523,versus,1,0
130524,RCC,1,0
130525,alone,1,0
130526,in,1,0
130527,referred,1,1
130528,children,1,1
130529,(,1,1
130530,4-12,1,1
130531,years,1,1
130532,old,1,1
130533,),1,1
130534,with,1,1
130535,ADHD,1,1
130536,.,1,1
130537,Treatment,0,0
130538,outcome,0,0
130539,was,0,0
130540,based,0,1
130541,on,0,0
130542,parent-reported,0,1
130543,ADHD,0,1
130544,symptoms,0,1
130545,and,0,1
130546,behavioral,0,1
130547,problems,0,1
130548,.,0,1
130549,Presence,0,0
130550,of,0,0
130551,2,0,1
130552,versus,0,0
130553,no,0,0
130554,or,0,1
130555,1,0,0
130556,DAT1,0,1
130557,10-repeat,0,1
130558,allele,0,0
130559,served,0,1
130560,as,0,0
130561,moderator,0,0
130562,variable,0,1
130563,.,0,1
130564,Time,0,0
130565,?,0,1
130566,Treatment,0,0
130567,?,0,1
130568,Genotype,0,1
130569,effect,0,0
130570,was,0,0
130571,analyzed,0,0
130572,with,0,1
130573,repeated-measures,0,0
130574,analysis,0,0
130575,of,0,0
130576,variance,0,0
130577,",",0,0
130578,controlling,0,0
130579,for,0,0
130580,baseline,0,0
130581,medication,0,1
130582,status,0,1
130583,.,0,1
130584,Results,0,0
130585,indicate,0,0
130586,that,0,0
130587,DAT1,0,1
130588,moderated,0,0
130589,treatment,0,0
130590,response,0,0
130591,(,0,1
130592,p,0,0
130593,=,0,1
130594,.009,0,0
130595,),0,1
130596,.,0,1
130597,In,0,0
130598,children,0,1
130599,with,0,1
130600,no,0,1
130601,or,0,1
130602,1,0,0
130603,DAT1,0,1
130604,10-repeat,0,1
130605,allele,0,0
130606,",",0,0
130607,superior,0,0
130608,treatment,0,0
130609,effects,0,0
130610,of,0,1
130611,BPT,0,1
130612,+,0,0
130613,RCC,0,0
130614,compared,0,0
130615,with,0,1
130616,RCC,0,0
130617,alone,0,1
130618,were,0,1
130619,present,0,0
130620,(,0,1
130621,p,0,0
130622,=,0,1
130623,.005,0,0
130624,),0,1
130625,",",0,0
130626,which,0,0
130627,was,0,0
130628,not,0,0
130629,the,0,0
130630,case,0,0
130631,in,0,0
130632,children,0,1
130633,with,0,1
130634,2,0,1
130635,DAT1,0,1
130636,10-repeat,0,1
130637,alleles,0,1
130638,(,0,1
130639,p,0,0
130640,=,0,1
130641,.57,0,0
130642,),0,1
130643,.,0,1
130644,Our,0,0
130645,findings,0,0
130646,suggest,0,0
130647,that,0,0
130648,genetic,0,1
130649,differences,0,0
130650,in,0,1
130651,DAT1,0,1
130652,in,0,1
130653,children,0,1
130654,with,0,1
130655,ADHD,0,1
130656,influence,0,0
130657,their,0,0
130658,susceptibility,0,0
130659,to,0,0
130660,a,0,0
130661,behavioral,0,0
130662,intervention,0,0
130663,directed,0,0
130664,at,0,0
130665,shaping,0,0
130666,their,0,1
130667,environment,0,0
130668,through,0,1
130669,their,0,1
130670,parents,0,1
130671,.,0,1
130672,The,0,0
130673,role,0,0
130674,of,0,0
130675,the,0,0
130676,dopamine,0,0
130677,system,0,0
130678,in,0,0
130679,motivation,0,0
130680,and,0,1
130681,learning,0,0
130682,and,0,0
130683,in,0,0
130684,the,0,0
130685,aberrant,0,1
130686,sensitivity,0,0
130687,to,0,0
130688,reinforcement,0,0
130689,in,0,0
130690,children,0,1
130691,with,0,1
130692,ADHD,0,1
130693,may,0,0
130694,explain,0,0
130695,this,0,0
130696,moderating,0,0
130697,effect,0,0
130698,",",0,0
130699,given,0,0
130700,that,0,0
130701,the,0,0
130702,management,0,1
130703,of,0,0
130704,contingencies,0,0
130705,is,0,0
130706,typically,0,1
130707,addressed,0,0
130708,in,0,0
130709,BPT,0,1
130710,.,0,1
130711,Randomised,0,0
130712,controlled,0,0
130713,trial,0,1
130714,of,0,0
130715,improvisational,0,0
130716,music,0,1
130717,therapy,0,0
130718,'s,0,1
130719,effectiveness,0,0
130720,for,0,1
130721,children,1,1
130722,with,1,1
130723,autism,1,1
130724,spectrum,1,1
130725,disorders,1,1
130726,(,0,1
130727,TIME-A,0,1
130728,),0,1
130729,:,0,1
130730,study,0,1
130731,protocol,0,1
130732,.,0,1
130733,BACKGROUND,0,0
130734,Previous,0,0
130735,research,0,0
130736,has,0,0
130737,suggested,0,0
130738,that,0,0
130739,music,0,0
130740,therapy,0,0
130741,may,0,0
130742,facilitate,0,0
130743,skills,0,0
130744,in,0,1
130745,areas,0,0
130746,typically,0,1
130747,affected,0,0
130748,by,0,0
130749,autism,1,1
130750,spectrum,1,1
130751,disorders,1,1
130752,such,0,0
130753,as,0,1
130754,social,0,1
130755,interaction,0,0
130756,and,0,1
130757,communication,0,0
130758,.,0,1
130759,However,0,0
130760,",",0,0
130761,generalisability,0,0
130762,of,0,0
130763,previous,0,1
130764,findings,0,0
130765,has,0,0
130766,been,0,0
130767,restricted,0,0
130768,",",0,0
130769,as,0,0
130770,studies,0,0
130771,were,0,1
130772,limited,0,0
130773,in,0,0
130774,either,0,1
130775,methodological,0,0
130776,accuracy,0,0
130777,or,0,1
130778,the,0,0
130779,clinical,0,0
130780,relevance,0,0
130781,of,0,0
130782,their,0,1
130783,approach,0,1
130784,.,0,1
130785,The,0,0
130786,aim,0,0
130787,of,0,0
130788,this,0,0
130789,study,0,0
130790,is,0,0
130791,to,0,0
130792,determine,0,0
130793,effects,0,0
130794,of,0,0
130795,improvisational,0,1
130796,music,0,0
130797,therapy,0,0
130798,on,0,0
130799,social,0,1
130800,communication,0,0
130801,skills,0,0
130802,of,0,1
130803,children,1,1
130804,with,1,1
130805,autism,1,1
130806,spectrum,1,1
130807,disorders,1,1
130808,.,1,1
130809,An,0,0
130810,additional,0,0
130811,aim,0,0
130812,of,0,0
130813,the,0,0
130814,study,0,0
130815,is,0,0
130816,to,0,0
130817,examine,0,0
130818,if,0,0
130819,variation,0,0
130820,in,0,0
130821,dose,0,0
130822,of,0,0
130823,treatment,0,0
130824,(,0,1
130825,i.e.,0,0
130826,",",0,0
130827,number,0,0
130828,of,0,0
130829,music,0,0
130830,therapy,0,1
130831,sessions,0,0
130832,per,0,1
130833,week,0,0
130834,),0,0
130835,affects,0,0
130836,outcome,0,0
130837,of,0,0
130838,therapy,0,0
130839,",",0,0
130840,and,0,0
130841,to,0,0
130842,determine,0,0
130843,cost-effectiveness,0,0
130844,.,0,1
130845,METHODS/DESIGN,0,0
130846,Children,1,1
130847,aged,1,1
130848,between,1,0
130849,4,1,1
130850,;,1,1
130851,0,1,0
130852,and,1,1
130853,6,1,1
130854,;,1,1
130855,11,1,1
130856,years,1,1
130857,who,1,1
130858,are,1,1
130859,diagnosed,1,1
130860,with,1,1
130861,autism,1,1
130862,spectrum,1,1
130863,disorder,1,1
130864,will,0,0
130865,be,0,0
130866,randomly,0,1
130867,assigned,0,1
130868,to,0,0
130869,one,0,1
130870,of,0,1
130871,three,0,1
130872,conditions,0,1
130873,.,0,1
130874,Parents,1,0
130875,of,1,0
130876,all,1,1
130877,participants,1,1
130878,will,0,0
130879,receive,0,1
130880,three,0,0
130881,sessions,0,0
130882,of,0,1
130883,parent,0,1
130884,counselling,0,0
130885,(,0,1
130886,at,0,0
130887,0,0,0
130888,",",0,1
130889,2,0,0
130890,",",0,0
130891,and,0,1
130892,5,0,1
130893,months,0,1
130894,),0,1
130895,.,0,1
130896,In,0,0
130897,addition,0,0
130898,",",0,1
130899,children,0,1
130900,randomised,0,1
130901,to,0,1
130902,the,0,0
130903,two,0,0
130904,intervention,0,0
130905,groups,0,0
130906,will,0,0
130907,be,0,0
130908,offered,0,0
130909,individual,0,0
130910,",",0,0
130911,improvisational,0,0
130912,music,0,0
130913,therapy,0,0
130914,over,0,0
130915,a,0,0
130916,period,0,0
130917,of,0,0
130918,five,0,1
130919,months,0,0
130920,",",0,1
130921,either,0,1
130922,one,0,1
130923,session,0,0
130924,(,0,1
130925,low-intensity,0,1
130926,),0,1
130927,or,0,1
130928,three,0,1
130929,sessions,0,0
130930,(,0,1
130931,high-intensity,0,1
130932,),0,1
130933,per,0,1
130934,week,0,0
130935,.,0,1
130936,Generalised,0,1
130937,effects,0,0
130938,of,0,1
130939,music,0,0
130940,therapy,0,0
130941,will,0,0
130942,be,0,0
130943,measured,0,0
130944,using,0,0
130945,standardised,0,0
130946,scales,0,0
130947,completed,0,1
130948,by,0,1
130949,blinded,0,1
130950,assessors,0,1
130951,(,0,1
130952,Autism,0,1
130953,Diagnostic,0,1
130954,Observation,0,0
130955,Schedule,0,0
130956,",",0,1
130957,ADOS,0,0
130958,),0,1
130959,and,0,1
130960,parents,0,1
130961,(,0,1
130962,Social,0,1
130963,Responsiveness,0,1
130964,Scale,0,1
130965,",",0,1
130966,SRS,0,0
130967,),0,1
130968,before,0,0
130969,and,0,1
130970,2,0,1
130971,",",0,1
130972,5,0,0
130973,",",0,0
130974,and,0,1
130975,12,0,1
130976,months,0,0
130977,after,0,1
130978,randomisation,0,1
130979,.,0,1
130980,Cost,0,0
130981,effectiveness,0,0
130982,will,0,0
130983,be,0,0
130984,calculated,0,0
130985,as,0,0
130986,man,0,1
130987,years,0,1
130988,.,0,1
130989,A,0,0
130990,group,0,0
130991,sequential,0,0
130992,design,0,1
130993,with,0,1
130994,first,0,0
130995,interim,0,0
130996,look,0,0
130997,at,0,1
130998,N,0,1
130999,=,0,0
131000,235,0,1
131001,will,0,0
131002,ensure,0,0
131003,both,0,0
131004,power,0,0
131005,and,0,0
131006,efficiency,0,0
131007,.,0,1
131008,DISCUSSION,0,0
131009,Responding,0,0
131010,to,0,0
131011,the,0,0
131012,need,0,0
131013,for,0,0
131014,more,0,0
131015,rigorously,0,0
131016,designed,0,0
131017,trials,0,0
131018,examining,0,0
131019,the,0,0
131020,effectiveness,0,0
131021,of,0,0
131022,music,0,0
131023,therapy,0,0
131024,in,0,0
131025,autism,1,1
131026,spectrum,1,1
131027,disorders,1,1
131028,",",0,0
131029,this,0,0
131030,pragmatic,0,0
131031,trial,0,1
131032,sets,0,1
131033,out,0,1
131034,to,0,1
131035,generate,0,0
131036,findings,0,0
131037,that,0,0
131038,will,0,0
131039,be,0,0
131040,well,0,0
131041,generalisable,0,0
131042,to,0,0
131043,clinical,0,0
131044,practice,0,0
131045,.,0,1
131046,Addressing,0,0
131047,the,0,0
131048,issue,0,1
131049,of,0,0
131050,dose,0,0
131051,variation,0,0
131052,",",0,0
131053,this,0,0
131054,study,0,0
131055,'s,0,1
131056,results,0,0
131057,will,0,0
131058,also,0,0
131059,provide,0,0
131060,information,0,0
131061,on,0,0
131062,the,0,0
131063,relevance,0,0
131064,of,0,0
131065,session,0,0
131066,frequency,0,0
131067,for,0,0
131068,therapy,0,0
131069,outcome,0,0
131070,.,0,1
131071,TRIAL,0,0
131072,REGISTRATION,0,0
131073,Current,0,1
131074,Controlled,0,1
131075,Trials,0,1
131076,ISRCTN78923965,0,1
131077,.,0,1
131078,The,0,0
131079,relationship,0,0
131080,of,0,0
131081,alexithymia,0,1
131082,to,0,1
131083,emotional,0,0
131084,dysregulation,0,0
131085,within,0,0
131086,an,0,0
131087,alcohol,1,1
131088,dependent,1,0
131089,treatment,1,1
131090,sample,1,1
131091,.,1,1
131092,Difficulties,0,0
131093,regulating,0,0
131094,emotions,0,0
131095,have,0,1
131096,implications,0,0
131097,for,0,0
131098,the,0,0
131099,development,0,0
131100,",",0,0
131101,maintenance,0,0
131102,",",0,0
131103,and,0,0
131104,recovery,0,0
131105,from,0,1
131106,alcohol,1,1
131107,problems,1,1
131108,.,1,1
131109,One,0,1
131110,construct,0,0
131111,thought,0,0
131112,to,0,0
131113,impede,0,0
131114,the,0,0
131115,regulation,0,0
131116,of,0,0
131117,emotion,0,0
131118,is,0,0
131119,alexithymia,0,0
131120,.,0,0
131121,Alexithymia,0,0
131122,is,0,0
131123,characterized,0,0
131124,by,0,0
131125,difficulties,0,0
131126,identifying,0,0
131127,",",0,1
131128,differentiating,0,0
131129,and,0,0
131130,expressing,0,1
131131,feelings,0,0
131132,",",0,1
131133,a,0,1
131134,limited,0,0
131135,imagination,0,1
131136,and,0,1
131137,fantasy,0,1
131138,life,0,1
131139,",",0,0
131140,and,0,0
131141,an,0,0
131142,externally-oriented,0,0
131143,thinking,0,0
131144,style,0,0
131145,(,0,0
131146,e.g.,0,0
131147,",",0,0
131148,prefer,0,0
131149,talking,0,0
131150,about,0,0
131151,daily,0,0
131152,activities,0,0
131153,rather,0,1
131154,than,0,1
131155,feelings,0,0
131156,),0,1
131157,.,0,1
131158,Given,0,0
131159,that,0,0
131160,poor,0,1
131161,emotion,0,0
131162,regulation,0,0
131163,skills,0,0
131164,have,0,1
131165,been,0,0
131166,found,0,0
131167,to,0,0
131168,predict,0,0
131169,posttreatment,1,0
131170,levels,1,0
131171,of,1,1
131172,alcohol,1,1
131173,use,1,0
131174,",",0,0
131175,and,0,0
131176,that,0,0
131177,several,0,1
131178,defining,0,0
131179,characteristics,0,1
131180,of,0,1
131181,alexithymia,0,1
131182,bear,0,0
131183,similarity,0,0
131184,to,0,1
131185,deficits,0,0
131186,in,0,1
131187,emotion,0,0
131188,regulation,0,0
131189,skills,0,0
131190,",",0,0
131191,it,0,0
131192,is,0,0
131193,possible,0,0
131194,that,0,0
131195,alexithymia,0,1
131196,may,0,0
131197,predict,0,0
131198,poorer,0,0
131199,alcohol,0,1
131200,treatment,0,0
131201,outcomes,0,0
131202,.,0,1
131203,Thus,0,1
131204,",",0,0
131205,the,0,0
131206,present,0,0
131207,study,0,0
131208,first,0,0
131209,examined,0,0
131210,the,0,0
131211,relationship,0,0
131212,of,0,0
131213,alexithymia,0,1
131214,to,0,1
131215,several,0,0
131216,other,0,0
131217,emotion,0,0
131218,regulation,0,0
131219,measures,0,0
131220,and,0,1
131221,then,0,0
131222,investigated,0,0
131223,the,0,0
131224,impact,0,0
131225,of,0,0
131226,alexithymia,0,1
131227,on,0,0
131228,attrition,0,1
131229,and,0,1
131230,alcohol,0,1
131231,treatment,0,0
131232,outcomes,0,0
131233,in,0,1
131234,men,1,1
131235,and,1,1
131236,women,1,1
131237,(,1,1
131238,N=77,1,1
131239,),1,1
131240,enrolled,1,1
131241,in,1,0
131242,a,1,1
131243,12-week,1,0
131244,cognitive-behavioral,1,1
131245,intervention,1,1
131246,for,1,0
131247,alcohol,1,1
131248,dependence,1,0
131249,.,1,1
131250,At,0,0
131251,baseline,0,0
131252,",",0,1
131253,higher,0,0
131254,scores,0,0
131255,on,0,0
131256,alexithymia,0,1
131257,were,0,1
131258,associated,0,0
131259,poorer,0,0
131260,emotion,0,0
131261,regulation,0,0
131262,skills,0,0
131263,",",0,1
131264,fewer,0,0
131265,percent,0,1
131266,days,0,0
131267,abstinent,0,1
131268,",",0,1
131269,greater,0,0
131270,alcohol,0,1
131271,dependence,0,0
131272,severity,0,0
131273,",",0,0
131274,and,0,0
131275,several,0,0
131276,high-risk,0,1
131277,drinking,0,1
131278,situations,0,0
131279,.,0,1
131280,Alexithymia,0,0
131281,was,0,0
131282,unrelated,0,1
131283,to,0,1
131284,attrition,0,1
131285,and,0,0
131286,to,0,0
131287,level,0,0
131288,of,0,0
131289,alcohol,0,1
131290,consumption,0,0
131291,at,0,0
131292,posttreatment,0,0
131293,.,0,1
131294,Overall,0,0
131295,",",0,0
131296,the,0,0
131297,construct,0,0
131298,of,0,0
131299,alexithymia,0,1
131300,is,0,0
131301,shown,0,0
131302,to,0,0
131303,be,0,0
131304,related,0,0
131305,to,0,0
131306,several,0,1
131307,theoretically-related,0,1
131308,constructs,0,0
131309,(,0,1
131310,e.g.,0,0
131311,",",0,0
131312,emotion,0,0
131313,regulation,0,0
131314,",",0,0
131315,mindfulness,0,0
131316,),0,1
131317,but,0,0
131318,demonstrated,0,0
131319,a,0,0
131320,limited,0,0
131321,relationship,0,0
131322,to,0,1
131323,drinking,0,0
131324,outcomes,0,0
131325,in,0,1
131326,those,1,1
131327,seeking,1,1
131328,treatment,1,0
131329,for,1,0
131330,alcohol,1,1
131331,dependence,1,1
131332,.,1,1
131333,Predictors,0,0
131334,of,0,1
131335,response,0,0
131336,to,0,1
131337,ziprasidone,0,1
131338,:,0,1
131339,results,0,0
131340,from,0,1
131341,a,0,1
131342,6-week,0,0
131343,randomized,0,1
131344,double-blind,0,1
131345,",",0,0
131346,placebo-controlled,0,0
131347,trial,0,0
131348,for,0,1
131349,acute,1,1
131350,depressive,1,1
131351,mixed,1,1
131352,state,1,1
131353,.,1,1
131354,INTRODUCTION,0,0
131355,The,0,0
131356,present,0,0
131357,study,0,0
131358,is,0,0
131359,aimed,0,0
131360,at,0,0
131361,investigating,0,0
131362,possible,0,0
131363,predictors,0,0
131364,of,0,1
131365,response,0,0
131366,to,0,0
131367,ziprasidone,0,1
131368,in,0,0
131369,a,0,0
131370,sample,0,1
131371,of,0,0
131372,patients,1,1
131373,with,1,1
131374,mixed,1,1
131375,depressive,1,1
131376,state,1,1
131377,.,1,1
131378,METHODS,0,0
131379,72,1,1
131380,patients,1,1
131381,were,1,1
131382,randomized,1,1
131383,to,0,0
131384,either,0,0
131385,ziprasidone,0,0
131386,or,0,1
131387,placebo,0,0
131388,and,0,0
131389,treated,0,1
131390,prospectively,0,1
131391,for,0,1
131392,6,0,1
131393,weeks,0,1
131394,.,0,1
131395,The,0,0
131396,clinical,0,0
131397,response,0,0
131398,and,0,1
131399,remission,0,1
131400,were,0,0
131401,defined,0,0
131402,with,0,1
131403,various,0,0
131404,clinical,0,1
131405,variables,0,0
131406,including,0,1
131407,Montgomery,0,1
131408,Asberg,0,1
131409,Depression,0,1
131410,Rating,0,0
131411,Scale,0,1
131412,.,0,1
131413,Further,0,0
131414,outcome,0,0
131415,measures,0,0
131416,included,0,1
131417,predictors,0,0
131418,of,0,1
131419,remission,0,1
131420,and,0,1
131421,other,0,1
131422,clinical,0,0
131423,variables,0,0
131424,over,0,0
131425,time,0,0
131426,.,0,1
131427,RESULTS,0,0
131428,None,0,0
131429,of,0,0
131430,the,0,0
131431,variables,0,0
131432,under,0,1
131433,investigation,0,1
131434,were,0,1
131435,significantly,0,0
131436,associated,0,0
131437,with,0,1
131438,response,0,0
131439,or,0,1
131440,remission,0,1
131441,at,0,1
131442,6,0,1
131443,weeks,0,0
131444,(,0,1
131445,all,0,1
131446,p-values,0,0
131447,>,0,1
131448,0.003,0,0
131449,",",0,0
131450,respectively,0,0
131451,),0,1
131452,.,0,1
131453,CONCLUSIONS,0,0
131454,Further,0,0
131455,investigations,0,0
131456,are,0,0
131457,warranted,0,0
131458,due,0,0
131459,to,0,1
131460,clear,0,1
131461,limitations,0,0
131462,",",0,1
131463,mostly,0,1
131464,small,0,0
131465,sample,0,1
131466,size,0,0
131467,and,0,0
131468,use,0,0
131469,of,0,1
131470,concomitant,0,0
131471,medications,0,1
131472,.,0,1
131473,Comparison,0,0
131474,of,0,1
131475,sedative,0,1
131476,drugs,0,0
131477,under,0,1
131478,peribulbar,0,1
131479,or,0,1
131480,topical,0,0
131481,anesthesia,0,1
131482,during,0,1
131483,phacoemulsification,1,1
131484,.,1,1
131485,BACKGROUND,0,0
131486,AND,0,0
131487,OBJECTIVE,0,0
131488,To,0,0
131489,compare,0,0
131490,dexmedetomidine,0,0
131491,and,0,0
131492,midazolam+fentanyl,0,1
131493,sedation,0,1
131494,primarily,0,0
131495,based,0,1
131496,on,0,0
131497,patient,0,1
131498,satisfaction,0,0
131499,during,0,0
131500,phacoemulsification,0,1
131501,under,0,1
131502,topical,0,0
131503,and,0,1
131504,peribulbar,0,0
131505,anesthesia,0,1
131506,.,0,1
131507,PATIENTS,0,0
131508,AND,0,0
131509,METHODS,0,0
131510,Prospective,0,1
131511,",",0,0
131512,randomized,0,1
131513,",",0,0
131514,and,0,0
131515,double-blind,0,0
131516,study,0,1
131517,of,0,0
131518,80,1,1
131519,American,1,1
131520,Society,1,1
131521,of,1,1
131522,Anesthesiology,1,1
131523,grade,1,1
131524,I-II,1,1
131525,patients,1,1
131526,who,1,1
131527,underwent,1,1
131528,phacoemulsification,1,1
131529,with,1,1
131530,local,1,0
131531,anesthesia,1,1
131532,under,1,1
131533,sedation,1,1
131534,.,1,1
131535,Patients,0,1
131536,were,0,0
131537,divided,0,1
131538,into,0,1
131539,four,1,1
131540,groups,1,1
131541,(,1,1
131542,20,1,1
131543,patients,1,1
131544,for,1,1
131545,each,1,1
131546,),1,1
131547,:,1,1
131548,dexmedetomidine,0,0
131549,and,0,0
131550,topical,0,0
131551,anesthesia,0,1
131552,",",0,0
131553,dexmedetomidine,0,0
131554,and,0,0
131555,peribulbar,0,0
131556,anesthesia,0,0
131557,",",0,0
131558,midazolam+fentanyl,0,1
131559,and,0,0
131560,topical,0,0
131561,anesthesia,0,1
131562,",",0,0
131563,and,0,0
131564,midazolam+fentanyl,0,1
131565,and,0,0
131566,peribulbar,0,0
131567,anesthesia,0,1
131568,.,0,1
131569,Patient,0,0
131570,and,0,0
131571,surgeon,0,1
131572,satisfaction,0,0
131573,were,0,1
131574,determined,0,0
131575,on,0,0
131576,a,0,1
131577,5-point,0,0
131578,scale,0,0
131579,.,0,1
131580,The,0,0
131581,pain,0,0
131582,was,0,0
131583,determined,0,0
131584,by,0,0
131585,verbal,0,0
131586,pain,0,1
131587,scale,0,0
131588,intraoperatively,0,0
131589,and,0,0
131590,postoperatively,0,0
131591,.,0,1
131592,Drugs,0,0
131593,were,0,1
131594,given,0,0
131595,to,0,0
131596,a,0,1
131597,Ramsay,0,0
131598,sedation,0,0
131599,scale,0,0
131600,of,0,1
131601,3,0,1
131602,.,0,1
131603,Topical,0,1
131604,and,0,0
131605,peribulbar,0,0
131606,anesthesia,0,1
131607,were,0,1
131608,performed,0,0
131609,by,0,0
131610,an,0,1
131611,ophthalmologist,0,1
131612,.,0,1
131613,Hemodynamic,0,0
131614,",",0,0
131615,respiratory,0,1
131616,",",0,0
131617,and,0,0
131618,intraocular,0,1
131619,pressure,0,0
131620,monitoring,0,0
131621,was,0,0
131622,done,0,1
131623,.,0,1
131624,Operative,0,0
131625,and,0,0
131626,recovery,0,0
131627,times,0,0
131628,were,0,1
131629,recorded,0,0
131630,.,0,1
131631,RESULTS,0,0
131632,In,0,0
131633,the,0,0
131634,midazolam+fentanyl,0,1
131635,groups,0,0
131636,",",0,1
131637,better,0,0
131638,patient,0,1
131639,and,0,0
131640,surgeon,0,1
131641,satisfaction,0,0
131642,scores,0,0
131643,were,0,1
131644,obtained,0,0
131645,(,0,1
131646,P,0,0
131647,<,0,0
131648,.005,0,0
131649,),0,1
131650,",",0,0
131651,verbal,0,0
131652,pain,0,1
131653,scale,0,1
131654,scores,0,0
131655,were,0,1
131656,significantly,0,0
131657,lower,0,0
131658,(,0,0
131659,P,0,0
131660,<,0,0
131661,.001,0,0
131662,),0,1
131663,",",0,0
131664,and,0,1
131665,patients,0,1
131666,needed,0,0
131667,less,0,0
131668,postoperative,0,0
131669,analgesia,0,0
131670,.,0,1
131671,Ramsay,0,0
131672,sedation,0,1
131673,scale,0,1
131674,scores,0,0
131675,were,0,1
131676,between,0,0
131677,3,0,1
131678,and,0,1
131679,4,0,0
131680,in,0,1
131681,all,0,1
131682,patients,0,1
131683,and,0,0
131684,there,0,0
131685,were,0,0
131686,no,0,0
131687,significant,0,0
131688,differences,0,0
131689,.,0,1
131690,Intraocular,0,1
131691,pressure,0,0
131692,alterations,0,0
131693,were,0,1
131694,similar,0,0
131695,between,0,0
131696,groups,0,1
131697,.,0,1
131698,Recovery,0,0
131699,time,0,0
131700,was,0,0
131701,longer,0,0
131702,in,0,0
131703,the,0,0
131704,dexmedetomidine,0,0
131705,groups,0,0
131706,(,0,1
131707,P,0,0
131708,<,0,0
131709,.05,0,0
131710,),0,1
131711,.,0,1
131712,CONCLUSION,0,0
131713,The,0,0
131714,study,0,0
131715,demonstrated,0,0
131716,that,0,0
131717,the,0,0
131718,midazolam+fentanyl,0,1
131719,combination,0,0
131720,provided,0,0
131721,high-level,0,1
131722,patient,0,1
131723,satisfaction,0,0
131724,scores,0,0
131725,",",0,1
131726,low-level,0,1
131727,pain,0,1
131728,scores,0,0
131729,",",0,0
131730,and,0,0
131731,shorter,0,0
131732,recovery,0,0
131733,time,0,0
131734,.,0,1
131735,Also,0,0
131736,",",0,0
131737,both,0,0
131738,of,0,0
131739,the,0,0
131740,peribulbar,0,0
131741,and,0,0
131742,topical,0,0
131743,anesthesia,0,1
131744,procedures,0,1
131745,showed,0,0
131746,similar,0,0
131747,efficiency,0,0
131748,.,0,1
131749,Randomised,0,0
131750,clinical,0,0
131751,trial,0,1
131752,:,0,1
131753,efficacy,0,0
131754,of,0,0
131755,a,0,1
131756,new,0,1
131757,synbiotic,0,0
131758,formulation,0,0
131759,containing,0,0
131760,Lactobacillus,0,0
131761,paracasei,0,0
131762,B21060,0,1
131763,plus,0,0
131764,arabinogalactan,0,0
131765,and,0,1
131766,xilooligosaccharides,0,0
131767,in,0,1
131768,children,1,1
131769,with,1,1
131770,acute,1,1
131771,diarrhoea,1,1
131772,.,1,1
131773,BACKGROUND,0,0
131774,Acute,0,0
131775,diarrhoea,0,1
131776,is,0,0
131777,a,0,0
131778,frequent,0,0
131779,problem,0,1
131780,in,0,1
131781,children,1,1
131782,with,1,1
131783,heavy,1,1
131784,economic,1,0
131785,burden,1,1
131786,for,1,1
131787,families,1,1
131788,and,1,1
131789,society,1,1
131790,.,1,1
131791,AIM,0,0
131792,To,0,0
131793,test,0,0
131794,the,0,0
131795,efficacy,0,0
131796,of,0,0
131797,a,0,1
131798,new,0,1
131799,synbiotic,0,0
131800,formulation,0,0
131801,containing,0,0
131802,Lactobacillus,0,0
131803,paracasei,0,0
131804,B21060,0,1
131805,",",0,0
131806,arabinogalactan,0,0
131807,and,0,0
131808,xilooligosaccharides,0,0
131809,in,0,1
131810,children,1,1
131811,with,1,1
131812,acute,1,1
131813,diarrhoea,1,1
131814,.,1,1
131815,METHODS,0,0
131816,Double-blind,0,0
131817,",",0,0
131818,randomised,0,0
131819,",",0,0
131820,placebo-controlled,0,0
131821,trial,0,0
131822,",",0,1
131823,including,0,0
131824,children,1,1
131825,(,1,1
131826,age,1,1
131827,3-36,1,1
131828,m,1,1
131829,),1,1
131830,with,1,1
131831,acute,1,1
131832,diarrhoea,1,1
131833,who,0,1
131834,were,0,1
131835,allocated,0,1
131836,to,0,0
131837,placebo,0,0
131838,or,0,1
131839,synbiotic,0,0
131840,group,0,1
131841,.,0,1
131842,Major,0,0
131843,outcome,0,0
131844,was,0,0
131845,resolution,0,0
131846,rate,0,0
131847,of,0,0
131848,diarrhoea,0,1
131849,at,0,1
131850,72,0,1
131851,h.,0,1
131852,Total,0,1
131853,duration,0,0
131854,of,0,0
131855,diarrhoea,0,1
131856,",",0,0
131857,daily,0,0
131858,stool,0,0
131859,outputs,0,0
131860,",",0,1
131861,stool,0,0
131862,consistency,0,0
131863,",",0,0
131864,working,0,1
131865,days,0,0
131866,lost,0,1
131867,by,0,1
131868,parents,0,1
131869,",",0,1
131870,adjunctive,0,1
131871,medications,0,0
131872,",",0,1
131873,and,0,0
131874,hospitalisation,0,0
131875,were,0,0
131876,also,0,0
131877,assessed,0,0
131878,.,0,1
131879,RESULTS,0,0
131880,We,0,0
131881,enrolled,0,1
131882,55,1,1
131883,children,1,1
131884,in,1,1
131885,placebo,1,1
131886,group,1,1
131887,and,1,1
131888,52,1,1
131889,in,1,1
131890,synbiotic,1,0
131891,group,1,1
131892,.,1,1
131893,The,1,0
131894,two,1,0
131895,groups,1,0
131896,were,1,1
131897,similar,1,0
131898,for,1,1
131899,demographic,1,0
131900,and,1,1
131901,clinical,1,1
131902,characteristics,1,1
131903,.,1,1
131904,Resolution,0,0
131905,rate,0,0
131906,of,0,0
131907,diarrhoea,0,1
131908,at,0,1
131909,72,0,1
131910,h,0,0
131911,was,0,0
131912,significantly,0,0
131913,higher,0,0
131914,in,0,0
131915,synbiotic,0,0
131916,group,0,1
131917,(,0,1
131918,67,0,1
131919,%,0,0
131920,),0,1
131921,compared,0,0
131922,to,0,0
131923,placebo,0,0
131924,group,0,1
131925,(,0,1
131926,40,0,1
131927,%,0,0
131928,",",0,1
131929,P,0,0
131930,=,0,1
131931,0.005,0,0
131932,),0,1
131933,.,0,1
131934,Children,0,1
131935,in,0,0
131936,synbiotic,0,0
131937,group,0,1
131938,showed,0,0
131939,a,0,0
131940,significant,0,0
131941,reduction,0,0
131942,in,0,0
131943,the,0,0
131944,duration,0,0
131945,of,0,0
131946,diarrhoea,0,1
131947,(,0,1
131948,90.5,0,0
131949,h,0,0
131950,",",0,0
131951,78.1-102.9,0,0
131952,vs.,0,0
131953,109.8,0,0
131954,h,0,0
131955,",",0,1
131956,96.0-123.5,0,0
131957,",",0,0
131958,P,0,0
131959,=,0,1
131960,0.040,0,0
131961,),0,1
131962,",",0,0
131963,daily,0,0
131964,stool,0,1
131965,outputs,0,0
131966,(,0,1
131967,3.3,0,1
131968,",",0,0
131969,2.8-3.8,0,1
131970,vs.,0,0
131971,2.4,0,0
131972,",",0,1
131973,1.9-2.8,0,0
131974,",",0,0
131975,P,0,0
131976,=,0,1
131977,0.005,0,0
131978,),0,1
131979,and,0,1
131980,stool,0,0
131981,consistency,0,0
131982,(,0,1
131983,1.3,0,0
131984,",",0,0
131985,0.9-1.6,0,0
131986,vs.,0,0
131987,0.6,0,0
131988,",",0,1
131989,0.4-0.9,0,0
131990,",",0,0
131991,P,0,0
131992,=,0,1
131993,0.002,0,0
131994,),0,1
131995,compared,0,0
131996,to,0,0
131997,placebo,0,0
131998,group,0,1
131999,(,0,1
132000,data,0,0
132001,expressed,0,0
132002,as,0,0
132003,mean,0,1
132004,",",0,1
132005,95,0,0
132006,%,0,0
132007,CI,0,0
132008,),0,1
132009,.,0,1
132010,Rate,0,0
132011,of,0,0
132012,parents,0,1
132013,that,0,0
132014,missed,0,1
132015,at,0,0
132016,least,0,1
132017,one,0,1
132018,working,0,1
132019,day,0,0
132020,(,0,1
132021,41.8,0,0
132022,%,0,0
132023,vs.,0,0
132024,15.4,0,0
132025,%,0,0
132026,",",0,1
132027,P,0,0
132028,=,0,1
132029,0.003,0,0
132030,),0,1
132031,",",0,0
132032,rate,0,0
132033,of,0,0
132034,children,0,1
132035,that,0,0
132036,needed,0,1
132037,adjunctive,0,1
132038,medications,0,1
132039,(,0,1
132040,25.5,0,0
132041,%,0,0
132042,vs.,0,0
132043,5.8,0,0
132044,%,0,0
132045,",",0,1
132046,P,0,0
132047,=,0,1
132048,0.005,0,0
132049,),0,1
132050,or,0,1
132051,hospitalisation,0,1
132052,(,0,1
132053,10.9,0,0
132054,%,0,0
132055,vs.,0,0
132056,0,0,0
132057,%,0,0
132058,",",0,1
132059,P,0,0
132060,=,0,1
132061,0.014,0,0
132062,),0,1
132063,after,0,0
132064,the,0,0
132065,first,0,0
132066,72,0,1
132067,h,0,0
132068,of,0,0
132069,treatment,0,0
132070,",",0,0
132071,were,0,0
132072,reduced,0,0
132073,in,0,0
132074,synbiotic,0,0
132075,group,0,1
132076,.,0,1
132077,CONCLUSION,0,0
132078,The,0,0
132079,synbiotic,0,0
132080,formulation,0,0
132081,studied,0,1
132082,is,0,0
132083,effective,0,0
132084,in,0,0
132085,children,0,1
132086,with,0,1
132087,acute,0,1
132088,diarrhoea,0,1
132089,.,0,1
132090,Australian,0,1
132091,New,0,1
132092,Zealand,0,1
132093,Clinical,0,0
132094,Trials,0,1
132095,Registry,0,1
132096,(,0,1
132097,ACTRN12611000641998,0,1
132098,),0,1
132099,.,0,1
132100,Evaluation,0,0
132101,of,0,0
132102,masking,0,1
132103,study,0,1
132104,participants,1,1
132105,to,0,1
132106,intravitreal,0,1
132107,injections,0,0
132108,in,0,0
132109,a,0,1
132110,randomized,0,1
132111,clinical,0,0
132112,trial,0,1
132113,.,0,1
132114,OBJECTIVE,0,0
132115,To,0,0
132116,evaluate,0,0
132117,the,0,0
132118,success,0,0
132119,of,0,0
132120,masking,0,1
132121,study,0,1
132122,participants,1,1
132123,to,0,1
132124,treatment,0,1
132125,allocation,0,0
132126,using,0,0
132127,sham,0,0
132128,intravitreal,0,1
132129,injections,0,0
132130,.,0,1
132131,METHODS,0,0
132132,Eyes,1,1
132133,were,0,1
132134,randomized,0,1
132135,to,0,0
132136,receive,0,1
132137,sham,0,0
132138,injections,0,0
132139,plus,0,0
132140,prompt,0,0
132141,laser,0,0
132142,",",0,0
132143,intravitreal,0,0
132144,ranibizumab,0,1
132145,injections,0,0
132146,plus,0,0
132147,prompt,0,0
132148,laser,0,0
132149,",",0,0
132150,intravitreal,0,0
132151,ranibizumab,0,1
132152,injections,0,0
132153,plus,0,0
132154,deferred,0,1
132155,laser,0,0
132156,",",0,0
132157,or,0,0
132158,intravitreal,0,0
132159,triamcinolone,0,0
132160,acetonide,0,0
132161,injections,0,0
132162,plus,0,0
132163,prompt,0,0
132164,laser,0,0
132165,up,0,0
132166,to,0,0
132167,every,0,0
132168,16,0,1
132169,weeks,0,0
132170,with,0,1
132171,sham,0,1
132172,injections,0,0
132173,intermittently,0,1
132174,.,0,1
132175,All,1,0
132176,eyes,1,0
132177,could,0,0
132178,receive,0,1
132179,treatment,0,0
132180,or,0,0
132181,sham,0,0
132182,as,0,0
132183,often,0,0
132184,as,0,0
132185,every,0,0
132186,4,0,0
132187,weeks,0,1
132188,.,0,1
132189,Participants,1,1
132190,with,1,1
132191,2,1,1
132192,study,1,1
132193,eyes,1,1
132194,had,0,1
132195,1,0,1
132196,eye,0,1
132197,randomized,0,1
132198,to,0,0
132199,sham,0,0
132200,plus,0,0
132201,prompt,0,0
132202,laser,0,0
132203,and,0,1
132204,1,0,1
132205,eye,0,1
132206,randomized,0,1
132207,to,0,0
132208,a,0,0
132209,real,0,0
132210,injection,0,0
132211,group,0,1
132212,.,0,1
132213,Sham,0,0
132214,injections,0,0
132215,were,0,1
132216,performed,0,0
132217,by,0,0
132218,pressing,0,0
132219,the,0,0
132220,syringe,0,0
132221,hub,0,0
132222,against,0,0
132223,the,0,0
132224,conjunctiva,0,1
132225,to,0,0
132226,mimic,0,0
132227,a,0,0
132228,real,0,0
132229,injection,0,0
132230,.,0,1
132231,Laser,0,0
132232,treatment,0,0
132233,was,0,0
132234,not,0,0
132235,masked,0,0
132236,.,0,0
132237,At,0,0
132238,the,0,0
132239,1-year,0,0
132240,visit,0,0
132241,",",0,1
132242,participants,0,1
132243,were,0,1
132244,asked,0,1
132245,if,0,0
132246,they,0,0
132247,believed,0,0
132248,that,0,0
132249,the,0,0
132250,injections,0,0
132251,received,0,1
132252,during,0,0
132253,the,0,0
132254,study,0,0
132255,were,0,0
132256,real,0,0
132257,",",0,0
132258,sham,0,0
132259,",",0,0
132260,or,0,0
132261,sometimes,0,0
132262,real,0,0
132263,and,0,0
132264,sometimes,0,0
132265,sham,0,0
132266,.,0,1
132267,RESULTS,0,0
132268,Among,0,1
132269,423,1,1
132270,participants,1,1
132271,with,1,1
132272,1,1,1
132273,study,1,1
132274,eye,1,1
132275,",",0,0
132276,the,0,0
132277,correct,0,0
132278,assignment,0,0
132279,was,0,0
132280,stated,0,1
132281,by,0,0
132282,9.9,0,0
132283,%,0,0
132284,of,0,0
132285,the,0,0
132286,sham,0,0
132287,plus,0,0
132288,prompt,0,0
132289,laser,0,0
132290,group,0,1
132291,",",0,0
132292,88.0,0,0
132293,%,0,0
132294,of,0,0
132295,the,0,0
132296,ranibizumab,0,0
132297,plus,0,0
132298,prompt,0,0
132299,laser,0,0
132300,group,0,1
132301,",",0,0
132302,89.6,0,0
132303,%,0,0
132304,of,0,0
132305,the,0,0
132306,unmasked,0,0
132307,ranibizumab,0,1
132308,plus,0,0
132309,deferred,0,1
132310,laser,0,0
132311,group,0,1
132312,",",0,0
132313,and,0,0
132314,44.0,0,0
132315,%,0,0
132316,of,0,0
132317,the,0,0
132318,triamcinolone,0,0
132319,plus,0,0
132320,prompt,0,0
132321,laser,0,0
132322,group,0,1
132323,.,0,1
132324,Among,0,1
132325,112,1,1
132326,participants,1,1
132327,with,1,1
132328,2,1,1
132329,study,1,1
132330,eyes,1,1
132331,",",0,0
132332,the,0,0
132333,correct,0,0
132334,assignment,0,0
132335,was,0,0
132336,stated,0,1
132337,for,0,0
132338,24.1,0,1
132339,%,0,0
132340,of,0,0
132341,the,0,0
132342,sham,0,0
132343,plus,0,0
132344,prompt,0,0
132345,laser,0,1
132346,eyes,0,1
132347,.,0,1
132348,CONCLUSIONS,0,0
132349,Successful,0,0
132350,masking,0,0
132351,of,0,0
132352,an,0,0
132353,intravitreal,0,0
132354,injection,0,0
132355,can,0,0
132356,be,0,0
132357,accomplished,0,0
132358,when,0,0
132359,a,0,0
132360,sham,0,0
132361,injection,0,0
132362,procedure,0,0
132363,carefully,0,0
132364,mimics,0,0
132365,a,0,0
132366,real,0,0
132367,injection,0,0
132368,procedure,0,0
132369,.,0,0
132370,Masking,0,0
132371,seems,0,0
132372,less,0,0
132373,successful,0,0
132374,when,0,0
132375,one,0,1
132376,eye,0,0
132377,is,0,0
132378,receiving,0,0
132379,a,0,0
132380,real,0,0
132381,injection,0,0
132382,and,0,0
132383,the,0,0
132384,other,0,0
132385,eye,0,1
132386,is,0,0
132387,receiving,0,0
132388,a,0,0
132389,sham,0,0
132390,injection,0,0
132391,or,0,0
132392,when,0,0
132393,an,0,0
132394,individual,0,0
132395,eye,0,0
132396,receives,0,0
132397,both,0,0
132398,real,0,0
132399,and,0,1
132400,sham,0,1
132401,injections,0,0
132402,.,0,1
132403,Efficacy,0,0
132404,and,0,0
132405,safety,0,0
132406,of,0,0
132407,leuprolide,0,0
132408,acetate,0,0
132409,3-month,0,1
132410,depot,0,1
132411,11.25,0,0
132412,milligrams,0,0
132413,or,0,1
132414,30,0,1
132415,milligrams,0,0
132416,for,0,1
132417,the,0,0
132418,treatment,0,0
132419,of,0,0
132420,central,1,0
132421,precocious,1,1
132422,puberty,1,1
132423,.,1,1
132424,CONTEXT,0,0
132425,GnRH,0,0
132426,agonist,0,1
132427,(,0,1
132428,GnRHa,0,1
132429,),0,1
132430,monthly,0,0
132431,injections,0,0
132432,are,0,0
132433,frequently,0,0
132434,used,0,0
132435,in,0,0
132436,the,0,0
132437,treatment,0,0
132438,of,0,0
132439,central,1,0
132440,precocious,1,1
132441,puberty,1,1
132442,(,1,1
132443,CPP,1,1
132444,),1,1
132445,.,1,1
132446,The,0,0
132447,3-month,0,0
132448,leuprolide,0,0
132449,depot,0,0
132450,11.25-,0,0
132451,and,0,1
132452,30-mg,0,0
132453,formulations,0,0
132454,are,0,0
132455,newly,0,1
132456,approved,0,1
132457,treatment,0,0
132458,options,0,0
132459,.,0,1
132460,OBJECTIVE,0,0
132461,The,0,0
132462,aim,0,0
132463,of,0,0
132464,the,0,0
132465,study,0,0
132466,was,0,0
132467,to,0,0
132468,investigate,0,0
132469,the,0,0
132470,safety,0,0
132471,and,0,0
132472,efficacy,0,0
132473,of,0,0
132474,leuprolide,0,0
132475,acetate,0,0
132476,3-month,0,1
132477,depot,0,1
132478,formulations,0,0
132479,for,0,0
132480,the,0,0
132481,treatment,0,0
132482,of,0,0
132483,CPP,1,1
132484,in,1,1
132485,children,1,1
132486,.,1,1
132487,DESIGN,0,0
132488,This,0,0
132489,was,0,0
132490,a,0,0
132491,phase,0,0
132492,III,0,0
132493,",",0,0
132494,randomized,0,1
132495,",",0,0
132496,open-label,0,0
132497,",",0,0
132498,dose-ranging,0,0
132499,6-month,0,1
132500,study,0,1
132501,.,0,1
132502,SETTING,0,1
132503,Twenty-two,1,1
132504,U.S.,1,1
132505,medical,1,1
132506,centers,1,1
132507,(,1,1
132508,including,1,1
132509,Puerto,1,1
132510,Rico,1,1
132511,),1,1
132512,participated,1,1
132513,.,1,1
132514,PATIENTS,0,0
132515,Children,1,1
132516,diagnosed,1,1
132517,with,1,1
132518,CPP,1,1
132519,(,1,1
132520,n,1,1
132521,=,1,1
132522,84,1,1
132523,),1,1
132524,",",1,1
132525,who,1,1
132526,were,1,1
132527,either,1,1
132528,treatment,1,0
132529,naive,1,1
132530,or,1,1
132531,previously,1,1
132532,treated,1,1
132533,with,1,1
132534,GnRHa,1,1
132535,",",1,1
132536,were,1,0
132537,recruited,1,1
132538,.,1,1
132539,Chronological,1,0
132540,age,1,1
132541,at,1,0
132542,onset,1,1
132543,of,1,1
132544,pubertal,1,1
132545,signs,1,1
132546,was,1,0
132547,less,1,0
132548,than,1,0
132549,8,1,0
132550,yr,1,1
132551,in,1,1
132552,girls,1,1
132553,and,1,1
132554,less,1,1
132555,than,1,0
132556,9,1,0
132557,yr,1,1
132558,in,1,1
132559,boys,1,1
132560,",",1,1
132561,and,1,0
132562,bone,1,0
132563,age,1,1
132564,was,1,0
132565,advanced,1,1
132566,over,1,0
132567,chronological,1,1
132568,age,1,1
132569,at,1,1
132570,least,1,1
132571,1,1,1
132572,yr,1,1
132573,.,1,1
132574,INTERVENTION,0,0
132575,Leuprolide,0,0
132576,acetate,0,0
132577,depot,0,0
132578,(,0,1
132579,11.25,0,0
132580,or,0,1
132581,30,0,1
132582,mg,0,1
132583,),0,1
132584,was,0,0
132585,administered,0,0
132586,im,0,1
132587,every,0,0
132588,3,0,1
132589,months,0,0
132590,.,0,1
132591,MAIN,0,0
132592,OUTCOME,0,1
132593,MEASURES,0,1
132594,Biochemical,0,0
132595,[,0,0
132596,peak-stimulated,0,0
132597,LH,0,1
132598,",",0,1
132599,estradiol,0,0
132600,(,0,1
132601,girls,0,1
132602,),0,1
132603,",",0,1
132604,and,0,0
132605,testosterone,0,0
132606,(,0,1
132607,boys,0,1
132608,),0,1
132609,],0,1
132610,and,0,1
132611,anthropometric,0,1
132612,(,0,1
132613,growth,0,0
132614,rate,0,0
132615,",",0,0
132616,bone,0,0
132617,age,0,1
132618,acceleration,0,0
132619,",",0,0
132620,pubertal,0,1
132621,progression,0,1
132622,),0,1
132623,parameters,0,0
132624,and,0,1
132625,safety,0,0
132626,were,0,1
132627,assessed,0,0
132628,.,0,1
132629,RESULTS,0,0
132630,Peak-stimulated,0,0
132631,LH,0,1
132632,was,0,0
132633,suppressed,0,0
132634,in,0,0
132635,the,0,0
132636,11.25-,0,0
132637,and,0,0
132638,30-mg,0,0
132639,dose,0,0
132640,groups,0,1
132641,in,0,1
132642,78.4,0,1
132643,and,0,1
132644,95.2,0,1
132645,%,0,0
132646,",",0,0
132647,respectively,0,0
132648,",",0,0
132649,of,0,0
132650,children,0,1
132651,from,0,1
132652,months,0,1
132653,2,0,1
132654,through,0,1
132655,6,0,0
132656,.,0,1
132657,There,0,0
132658,were,0,0
132659,nine,0,1
132660,treatment,0,1
132661,failures,0,1
132662,(,0,1
132663,peak-stimulated,0,0
132664,LH,0,1
132665,>,0,1
132666,4,0,1
132667,IU/liter,0,1
132668,),0,1
132669,in,0,0
132670,the,0,0
132671,11.25-mg,0,0
132672,group,0,1
132673,and,0,1
132674,two,0,0
132675,in,0,0
132676,the,0,0
132677,30-mg,0,0
132678,group,0,1
132679,.,0,1
132680,Basal,0,0
132681,sex,0,0
132682,steroid,0,0
132683,suppression,0,0
132684,",",0,0
132685,growth,0,0
132686,rates,0,0
132687,",",0,1
132688,pubertal,0,1
132689,progression,0,0
132690,",",0,0
132691,bone,0,0
132692,age,0,1
132693,advancement,0,0
132694,",",0,0
132695,and,0,0
132696,adverse,0,0
132697,events,0,0
132698,were,0,1
132699,similar,0,0
132700,with,0,1
132701,either,0,1
132702,dose,0,0
132703,.,0,1
132704,CONCLUSIONS,0,0
132705,Treatment,0,0
132706,with,0,1
132707,leuprolide,0,0
132708,acetate,0,0
132709,3-month,0,1
132710,depot,0,1
132711,formulations,0,0
132712,(,0,1
132713,11.25,0,0
132714,and,0,1
132715,30,0,1
132716,mg,0,0
132717,),0,1
132718,effectively,0,0
132719,suppressed,0,0
132720,the,0,0
132721,GnRH,0,0
132722,axis,0,0
132723,",",0,0
132724,was,0,0
132725,well,0,0
132726,tolerated,0,0
132727,",",0,0
132728,and,0,0
132729,may,0,0
132730,positively,0,0
132731,impact,0,0
132732,patient,0,0
132733,convenience,0,1
132734,and,0,1
132735,compliance,0,0
132736,.,0,1
132737,Virtual,0,1
132738,reality,0,0
132739,for,0,0
132740,acute,0,1
132741,pain,0,1
132742,reduction,0,0
132743,in,0,1
132744,adolescents,1,1
132745,undergoing,1,1
132746,burn,1,1
132747,wound,1,1
132748,care,1,1
132749,:,1,1
132750,a,0,0
132751,prospective,0,1
132752,randomized,0,1
132753,controlled,0,0
132754,trial,0,0
132755,.,0,1
132756,BACKGROUND,0,0
132757,Effective,0,0
132758,pain,0,1
132759,management,0,0
132760,remains,0,0
132761,a,0,0
132762,challenge,0,0
132763,for,0,0
132764,adolescents,1,1
132765,during,1,1
132766,conscious,1,1
132767,burn,1,1
132768,wound,1,1
132769,care,1,1
132770,procedures,1,1
132771,.,1,1
132772,Virtual,0,0
132773,reality,0,0
132774,(,0,1
132775,VR,0,0
132776,),0,0
132777,shows,0,0
132778,promise,0,0
132779,as,0,0
132780,a,0,1
132781,non-pharmacological,0,1
132782,adjunct,0,0
132783,in,0,0
132784,reducing,0,0
132785,pain,0,1
132786,.,0,1
132787,AIMS,0,0
132788,This,0,0
132789,study,0,0
132790,assessed,0,0
132791,off-the-shelf,0,0
132792,VR,0,1
132793,for,0,1
132794,(,0,1
132795,1,0,1
132796,),0,1
132797,its,0,0
132798,effect,0,0
132799,on,0,0
132800,reducing,0,0
132801,acute,0,1
132802,pain,0,1
132803,intensity,0,0
132804,during,0,0
132805,adolescent,0,1
132806,burn,0,1
132807,wound,0,0
132808,care,0,1
132809,",",0,0
132810,and,0,0
132811,(,0,1
132812,2,0,1
132813,),0,1
132814,its,0,0
132815,clinical,0,0
132816,utility,0,0
132817,in,0,0
132818,a,0,1
132819,busy,0,1
132820,hospital,0,1
132821,setting,0,1
132822,.,0,1
132823,METHODS,0,0
132824,Forty-one,1,1
132825,adolescents,1,1
132826,(,1,1
132827,11-17,1,1
132828,years,1,1
132829,),1,1
132830,participated,0,1
132831,in,0,0
132832,this,0,0
132833,prospective,0,1
132834,randomized,0,1
132835,controlled,0,0
132836,trial,0,0
132837,.,0,1
132838,Acute,0,0
132839,pain,0,1
132840,outcomes,0,0
132841,including,0,1
132842,adolescent,0,1
132843,self-report,0,1
132844,",",0,0
132845,nursing,0,1
132846,staff,0,1
132847,behavioral,0,1
132848,observation,0,0
132849,",",0,0
132850,caregiver,0,0
132851,observation,0,0
132852,and,0,1
132853,physiological,0,0
132854,measures,0,0
132855,were,0,1
132856,collected,0,1
132857,.,0,1
132858,Length,0,0
132859,of,0,0
132860,procedure,0,0
132861,times,0,0
132862,and,0,1
132863,adolescent,0,1
132864,reactions,0,0
132865,were,0,1
132866,also,0,0
132867,recorded,0,0
132868,to,0,0
132869,inform,0,0
132870,clinical,0,0
132871,utility,0,0
132872,.,0,1
132873,RESULTS,0,0
132874,Nursing,0,0
132875,staff,0,1
132876,reported,0,0
132877,a,0,0
132878,statistically,0,0
132879,significant,0,0
132880,reduction,0,0
132881,in,0,1
132882,pain,0,1
132883,scores,0,0
132884,during,0,1
132885,dressing,0,0
132886,removal,0,0
132887,",",0,0
132888,and,0,0
132889,significantly,0,0
132890,less,0,0
132891,rescue,0,0
132892,doses,0,0
132893,of,0,1
132894,Entonox,0,1
132895,given,0,0
132896,to,0,0
132897,those,0,1
132898,receiving,0,1
132899,VR,0,0
132900,",",0,1
132901,compared,0,0
132902,to,0,0
132903,those,0,1
132904,receiving,0,1
132905,standard,0,1
132906,distraction,0,1
132907,.,0,1
132908,For,0,0
132909,all,0,0
132910,other,0,0
132911,pain,0,1
132912,outcomes,0,0
132913,and,0,1
132914,length,0,0
132915,of,0,0
132916,treatment,0,0
132917,",",0,0
132918,there,0,0
132919,was,0,0
132920,a,0,0
132921,trend,0,0
132922,for,0,0
132923,lower,0,0
132924,pain,0,1
132925,scores,0,0
132926,and,0,1
132927,treatment,0,1
132928,times,0,0
132929,for,0,1
132930,those,0,1
132931,receiving,0,1
132932,VR,0,0
132933,",",0,0
132934,but,0,0
132935,these,0,0
132936,differences,0,0
132937,were,0,0
132938,not,0,0
132939,statistically,0,0
132940,significant,0,0
132941,.,0,1
132942,CONCLUSION,0,0
132943,Despite,0,0
132944,only,0,0
132945,minimal,0,0
132946,pain,0,1
132947,reduction,0,0
132948,achieved,0,0
132949,using,0,0
132950,off-the-shelf,0,0
132951,VR,0,1
132952,",",0,1
132953,other,0,0
132954,results,0,0
132955,from,0,1
132956,this,0,0
132957,trial,0,0
132958,and,0,0
132959,previous,0,1
132960,research,0,1
132961,on,0,0
132962,younger,0,1
132963,children,0,1
132964,with,0,1
132965,burns,0,1
132966,suggest,0,0
132967,a,0,0
132968,customized,0,0
132969,",",0,0
132970,adolescent,0,1
132971,and,0,1
132972,hospital,0,1
132973,friendly,0,0
132974,device,0,0
132975,may,0,0
132976,be,0,0
132977,more,0,0
132978,effective,0,0
132979,in,0,0
132980,pain,0,1
132981,reduction,0,0
132982,.,0,1
132983,Infrared,0,0
132984,LED,0,0
132985,irradiation,0,0
132986,applied,0,0
132987,during,0,0
132988,high-intensity,0,1
132989,treadmill,0,0
132990,training,0,1
132991,improves,0,0
132992,maximal,0,1
132993,exercise,0,1
132994,tolerance,0,1
132995,in,0,1
132996,postmenopausal,1,1
132997,women,1,1
132998,:,1,1
132999,a,0,1
133000,6-month,0,0
133001,longitudinal,0,1
133002,study,0,1
133003,.,0,1
133004,Reduced,0,0
133005,aerobic,0,0
133006,fitness,0,0
133007,is,0,0
133008,associated,0,0
133009,with,0,1
133010,an,0,0
133011,increased,0,0
133012,risk,0,0
133013,of,0,1
133014,cardiovascular,0,1
133015,diseases,0,1
133016,among,0,1
133017,the,0,0
133018,older,1,1
133019,population,1,1
133020,.,1,0
133021,The,0,0
133022,aim,0,0
133023,of,0,0
133024,this,0,0
133025,study,0,0
133026,was,0,0
133027,to,0,0
133028,investigate,0,0
133029,the,0,0
133030,effects,0,0
133031,of,0,0
133032,LED,0,0
133033,irradiation,0,1
133034,(,0,1
133035,850,0,1
133036,nm,0,1
133037,),0,0
133038,applied,0,0
133039,during,0,0
133040,treadmill,0,0
133041,training,0,0
133042,on,0,0
133043,the,0,0
133044,maximal,0,0
133045,exercise,0,0
133046,tolerance,0,1
133047,in,0,1
133048,postmenopausal,1,1
133049,women,1,1
133050,.,1,1
133051,At,0,0
133052,the,0,0
133053,beginning,0,0
133054,of,0,0
133055,the,0,0
133056,study,0,0
133057,",",0,0
133058,45,1,1
133059,postmenopausal,1,1
133060,women,1,1
133061,were,0,1
133062,assigned,0,1
133063,randomly,0,1
133064,to,0,1
133065,three,0,0
133066,groups,0,0
133067,",",0,1
133068,and,0,1
133069,30,0,1
133070,women,0,1
133071,completed,0,1
133072,the,0,0
133073,entire,0,1
133074,6,0,0
133075,months,0,0
133076,of,0,1
133077,the,0,1
133078,study,0,0
133079,.,0,1
133080,The,0,0
133081,groups,0,0
133082,were,0,1
133083,:,0,1
133084,(,0,1
133085,1,0,1
133086,),0,1
133087,the,0,0
133088,LED,0,0
133089,group,0,0
133090,(,0,1
133091,treadmill,0,0
133092,training,0,0
133093,associated,0,0
133094,with,0,1
133095,phototherapy,0,1
133096,",",0,1
133097,n,0,1
133098,=,0,1
133099,10,0,1
133100,),0,1
133101,",",0,1
133102,(,0,1
133103,2,0,1
133104,),0,1
133105,the,0,0
133106,exercise,0,0
133107,group,0,0
133108,(,0,0
133109,treadmill,0,0
133110,training,0,0
133111,",",0,1
133112,n,0,1
133113,=,0,1
133114,10,0,1
133115,),0,1
133116,",",0,0
133117,and,0,0
133118,(,0,1
133119,3,0,1
133120,),0,1
133121,the,0,0
133122,sedentary,0,1
133123,group,0,0
133124,(,0,1
133125,neither,0,0
133126,physical,0,0
133127,training,0,0
133128,nor,0,0
133129,phototherapy,0,1
133130,",",0,0
133131,n,0,1
133132,=,0,1
133133,10,0,1
133134,),0,1
133135,.,0,1
133136,The,0,0
133137,training,0,0
133138,was,0,0
133139,performed,0,0
133140,for,0,0
133141,45,0,1
133142,min,0,0
133143,twice,0,0
133144,a,0,0
133145,week,0,0
133146,for,0,0
133147,6,0,1
133148,months,0,1
133149,at,0,1
133150,intensities,0,1
133151,between,0,1
133152,85,0,1
133153,%,0,0
133154,and,0,1
133155,90,0,1
133156,%,0,0
133157,maximal,0,0
133158,heart,0,1
133159,rate,0,0
133160,(,0,1
133161,HRmax,0,0
133162,),0,1
133163,.,0,1
133164,The,0,0
133165,irradiation,0,0
133166,parameters,0,0
133167,were,0,1
133168,39,0,1
133169,mW/cm,0,0
133170,(,0,1
133171,2,0,1
133172,),0,1
133173,",",0,1
133174,45,0,1
133175,min,0,0
133176,and,0,1
133177,108,0,1
133178,J/cm,0,1
133179,(,0,1
133180,2,0,1
133181,),0,1
133182,.,0,1
133183,The,0,0
133184,cardiovascular,0,1
133185,parameters,0,0
133186,were,0,1
133187,measured,0,0
133188,at,0,0
133189,baseline,0,0
133190,and,0,1
133191,after,0,1
133192,6,0,1
133193,months,0,1
133194,.,0,1
133195,As,0,0
133196,expected,0,0
133197,",",0,0
133198,no,0,0
133199,significant,0,0
133200,differences,0,0
133201,were,0,1
133202,found,0,0
133203,in,0,0
133204,the,0,0
133205,sedentary,0,1
133206,group,0,0
133207,(,0,1
133208,p,0,0
133209,?,0,1
133210,0.05,0,0
133211,),0,0
133212,.,0,1
133213,The,0,0
133214,maximal,0,0
133215,time,0,0
133216,of,0,0
133217,tolerance,0,1
133218,(,0,1
133219,Tlim,0,1
133220,),0,1
133221,",",0,1
133222,metabolic,0,1
133223,equivalents,0,0
133224,(,0,1
133225,METs,0,1
133226,),0,1
133227,and,0,1
133228,Bruce,0,1
133229,stage,0,1
133230,reached,0,0
133231,significantly,0,0
133232,higher,0,0
133233,values,0,0
133234,in,0,0
133235,the,0,1
133236,LED,0,0
133237,group,0,0
133238,and,0,0
133239,the,0,0
133240,exercise,0,0
133241,group,0,0
133242,(,0,1
133243,p,0,0
133244,<,0,0
133245,0.01,0,0
133246,),0,1
133247,.,0,1
133248,Furthermore,0,0
133249,",",0,0
133250,the,0,0
133251,HR,0,0
133252,",",0,0
133253,double,0,0
133254,product,0,0
133255,and,0,1
133256,Borg,0,0
133257,score,0,0
133258,at,0,0
133259,isotime,0,0
133260,were,0,0
133261,significantly,0,0
133262,lower,0,0
133263,in,0,0
133264,the,0,0
133265,LED,0,0
133266,group,0,0
133267,and,0,0
133268,in,0,0
133269,the,0,0
133270,exercise,0,0
133271,group,0,0
133272,(,0,1
133273,p,0,0
133274,<,0,0
133275,0.05,0,0
133276,),0,1
133277,.,0,1
133278,However,0,0
133279,",",0,0
133280,the,0,0
133281,time,0,0
133282,of,0,0
133283,recovery,0,0
133284,showed,0,0
133285,a,0,0
133286,significant,0,0
133287,decrease,0,0
133288,only,0,0
133289,in,0,0
133290,the,0,0
133291,LED,0,0
133292,group,0,1
133293,(,0,1
133294,p,0,0
133295,=,0,1
133296,0.003,0,0
133297,),0,1
133298,.,0,1
133299,Moreover,0,0
133300,",",0,0
133301,the,0,0
133302,differences,0,0
133303,between,0,0
133304,before,0,1
133305,and,0,1
133306,after,0,1
133307,training,0,0
133308,(,0,1
133309,delta,0,0
133310,values,0,0
133311,),0,1
133312,for,0,1
133313,the,0,0
133314,Tlim,0,0
133315,",",0,0
133316,METs,0,0
133317,and,0,0
133318,HR,0,0
133319,at,0,1
133320,isotime,0,0
133321,were,0,1
133322,greater,0,0
133323,in,0,0
133324,the,0,0
133325,LED,0,0
133326,group,0,0
133327,than,0,0
133328,in,0,0
133329,the,0,0
133330,exercise,0,0
133331,group,0,0
133332,with,0,1
133333,a,0,1
133334,significant,0,0
133335,intergroup,0,0
133336,difference,0,0
133337,(,0,1
133338,p,0,0
133339,<,0,0
133340,0.05,0,0
133341,),0,1
133342,.,0,1
133343,Therefore,0,0
133344,",",0,0
133345,the,0,0
133346,infrared,0,0
133347,LED,0,0
133348,irradiation,0,1
133349,during,0,0
133350,treadmill,0,0
133351,training,0,0
133352,can,0,0
133353,improve,0,0
133354,maximal,0,0
133355,performance,0,0
133356,and,0,1
133357,post-exercise,0,0
133358,recovery,1,0
133359,in,1,1
133360,postmenopausal,1,1
133361,women,1,1
133362,.,1,1
133363,Randomized,0,0
133364,crossover,0,0
133365,study,0,1
133366,comparing,0,0
133367,efficacy,0,0
133368,of,0,0
133369,transnasal,0,1
133370,endoscopy,0,1
133371,with,0,1
133372,that,0,0
133373,of,0,0
133374,standard,0,1
133375,endoscopy,0,1
133376,to,0,0
133377,detect,0,0
133378,Barrett,0,1
133379,'s,0,1
133380,esophagus,0,1
133381,.,0,1
133382,BACKGROUND,0,0
133383,Unsedated,0,1
133384,transnasal,0,1
133385,endoscopy,0,1
133386,(,0,1
133387,TNE,0,1
133388,),0,1
133389,may,0,0
133390,be,0,0
133391,safer,0,0
133392,and,0,0
133393,less,0,0
133394,expensive,0,0
133395,than,0,0
133396,standard,0,1
133397,endoscopy,0,1
133398,(,0,1
133399,SE,0,1
133400,),0,1
133401,for,0,0
133402,detecting,0,0
133403,Barrett,1,1
133404,'s,1,1
133405,esophagus,1,1
133406,(,1,1
133407,BE,1,1
133408,),1,1
133409,.,1,1
133410,Emerging,0,0
133411,technologies,0,0
133412,require,0,1
133413,robust,0,0
133414,evaluation,0,0
133415,before,0,1
133416,routine,0,1
133417,use,0,0
133418,.,0,1
133419,OBJECTIVE,0,0
133420,To,0,0
133421,evaluate,0,0
133422,the,0,0
133423,sensitivity,0,0
133424,",",0,0
133425,specificity,0,0
133426,",",0,0
133427,and,0,0
133428,acceptability,0,0
133429,of,0,0
133430,TNE,0,1
133431,in,0,1
133432,diagnosing,0,1
133433,BE,0,1
133434,compared,0,0
133435,with,0,1
133436,those,0,1
133437,of,0,0
133438,SE,0,1
133439,.,0,1
133440,DESIGN,0,0
133441,Prospective,0,0
133442,",",0,0
133443,randomized,0,0
133444,",",0,0
133445,crossover,0,0
133446,study,0,1
133447,.,0,1
133448,SETTING,0,1
133449,Single,0,0
133450,",",0,1
133451,tertiary-care,0,1
133452,referral,0,1
133453,center,0,1
133454,.,0,1
133455,PATIENTS,0,0
133456,This,0,0
133457,study,0,0
133458,enrolled,0,1
133459,consecutive,1,1
133460,patients,1,1
133461,with,1,1
133462,BE,1,1
133463,or,1,1
133464,those,1,0
133465,referred,1,1
133466,for,1,0
133467,diagnostic,1,1
133468,assessment,1,0
133469,.,1,1
133470,INTERVENTION,0,0
133471,All,0,1
133472,patients,0,1
133473,underwent,0,1
133474,TNE,0,1
133475,followed,0,1
133476,by,0,0
133477,SE,0,1
133478,or,0,1
133479,the,0,0
133480,reverse,0,1
133481,.,0,1
133482,Spielberger,0,0
133483,State-Trait,0,0
133484,Anxiety,0,1
133485,Inventory,0,1
133486,short-form,0,1
133487,questionnaires,0,0
133488,",",0,1
133489,a,0,1
133490,visual,0,0
133491,analogue,0,0
133492,scale,0,0
133493,",",0,0
133494,and,0,0
133495,a,0,0
133496,single,0,0
133497,question,0,0
133498,addressing,0,0
133499,preference,0,0
133500,for,0,0
133501,endoscopy,0,1
133502,type,0,1
133503,were,0,1
133504,administered,0,0
133505,.,0,1
133506,MAIN,0,0
133507,OUTCOME,0,1
133508,MEASUREMENTS,0,1
133509,Diagnostic,0,1
133510,accuracy,0,0
133511,and,0,0
133512,tolerability,0,0
133513,of,0,0
133514,TNE,0,1
133515,were,0,1
133516,compared,0,0
133517,with,0,1
133518,those,0,1
133519,of,0,0
133520,SE,0,1
133521,.,0,1
133522,RESULTS,0,0
133523,Of,0,1
133524,95,1,0
133525,patients,1,1
133526,randomized,1,1
133527,",",1,1
133528,82,1,1
133529,completed,1,1
133530,the,1,0
133531,study,1,0
133532,.,1,0
133533,We,0,0
133534,correctly,0,1
133535,diagnosed,0,1
133536,48,0,1
133537,of,0,1
133538,49,0,1
133539,BE,0,1
133540,cases,0,1
133541,by,0,0
133542,TNE,0,1
133543,for,0,1
133544,endoscopic,0,1
133545,findings,0,0
133546,of,0,1
133547,columnar,0,1
133548,lined,0,1
133549,esophagus,0,1
133550,compared,0,0
133551,with,0,1
133552,the,0,0
133553,criterion,0,1
133554,standard,0,0
133555,",",0,0
133556,SE,0,1
133557,",",0,0
133558,giving,0,0
133559,a,0,0
133560,sensitivity,0,0
133561,and,0,0
133562,specificity,0,0
133563,of,0,0
133564,0.98,0,0
133565,and,0,1
133566,1.00,0,0
133567,",",0,0
133568,respectively,0,0
133569,.,0,0
133570,The,0,0
133571,BE,0,0
133572,median,0,0
133573,length,0,0
133574,was,0,0
133575,3,0,0
133576,cm,0,1
133577,(,0,1
133578,interquartile,0,0
133579,range,0,1
133580,[,0,0
133581,IQR,0,1
133582,],0,1
133583,1-5,0,0
133584,cm,0,1
133585,),0,1
133586,with,0,1
133587,SE,0,1
133588,and,0,1
133589,3,0,1
133590,cm,0,1
133591,(,0,1
133592,IQR,0,1
133593,2-4,0,1
133594,cm,0,1
133595,),0,1
133596,with,0,1
133597,TNE,0,1
133598,",",0,1
133599,giving,0,0
133600,high,0,1
133601,correlations,0,0
133602,between,0,0
133603,the,0,1
133604,two,0,1
133605,modalities,0,0
133606,(,0,1
133607,R,0,1
133608,(,0,1
133609,2,0,1
133610,),0,1
133611,=,0,1
133612,0.97,0,0
133613,;,0,1
133614,P,0,0
133615,<,0,0
133616,.001,0,0
133617,),0,1
133618,.,0,1
133619,The,0,0
133620,sensitivity,0,0
133621,and,0,0
133622,specificity,0,0
133623,for,0,0
133624,detecting,0,0
133625,intestinal,0,1
133626,metaplasia,0,1
133627,by,0,0
133628,TNE,0,1
133629,compared,0,0
133630,with,0,1
133631,those,0,1
133632,by,0,0
133633,SE,0,1
133634,was,0,0
133635,0.91,0,0
133636,and,0,1
133637,1.00,0,0
133638,",",0,0
133639,respectively,0,0
133640,.,0,0
133641,The,0,0
133642,mean,0,0
133643,(,0,0
133644,?,0,1
133645,standard,0,0
133646,deviation,0,1
133647,),0,1
133648,post-endoscopy,0,0
133649,Spielberger,0,1
133650,State-Trait,0,0
133651,Anxiety,0,1
133652,Inventory,0,1
133653,short-form,0,0
133654,score,0,0
133655,for,0,1
133656,TNE,0,1
133657,(,0,1
133658,30.0,0,1
133659,?,0,1
133660,1.10,0,0
133661,standard,0,0
133662,error,0,0
133663,of,0,0
133664,the,0,0
133665,mean,0,1
133666,[,0,0
133667,SEM,0,1
133668,],0,1
133669,),0,1
133670,was,0,0
133671,lower,0,0
133672,than,0,0
133673,that,0,0
133674,for,0,0
133675,SE,0,1
133676,(,0,1
133677,30.7,0,1
133678,?,0,1
133679,1.29,0,0
133680,SEM,0,0
133681,),0,1
133682,",",0,0
133683,(,0,1
133684,P,0,0
133685,=,0,1
133686,.054,0,0
133687,),0,1
133688,.,0,1
133689,The,0,0
133690,visual,0,0
133691,analogue,0,0
133692,scale,0,1
133693,scores,0,0
133694,were,0,1
133695,no,0,0
133696,different,0,0
133697,(,0,1
133698,P,0,0
133699,=,0,1
133700,.07,0,0
133701,),0,1
133702,.,0,1
133703,The,0,0
133704,majority,0,0
133705,of,0,0
133706,patients,0,1
133707,(,0,1
133708,59,0,1
133709,%,0,0
133710,),0,1
133711,expressed,0,0
133712,a,0,0
133713,preference,0,0
133714,for,0,0
133715,TNE,0,1
133716,.,0,1
133717,LIMITATIONS,0,0
133718,This,0,0
133719,is,0,0
133720,a,0,0
133721,small,0,0
133722,study,0,0
133723,",",0,0
133724,with,0,1
133725,limited,0,0
133726,generalizability,0,0
133727,",",0,0
133728,a,0,0
133729,high,0,0
133730,prevalence,0,1
133731,of,0,1
133732,patients,1,1
133733,with,1,1
133734,BE,1,1
133735,",",0,1
133736,differential,0,0
133737,drop-out,0,0
133738,between,0,0
133739,the,0,1
133740,two,0,0
133741,procedures,0,0
133742,",",0,1
133743,and,0,0
133744,use,0,0
133745,of,0,0
133746,sedation,0,1
133747,.,0,1
133748,CONCLUSION,0,0
133749,TNE,0,0
133750,is,0,0
133751,an,0,0
133752,accurate,0,0
133753,and,0,0
133754,well-tolerated,0,0
133755,method,0,0
133756,for,0,0
133757,diagnosing,0,0
133758,BE,0,1
133759,compared,0,0
133760,with,0,1
133761,SE,0,1
133762,.,0,1
133763,TNE,0,1
133764,warrants,0,0
133765,further,0,1
133766,evaluation,0,0
133767,as,0,0
133768,a,0,0
133769,screening,0,1
133770,tool,0,0
133771,for,0,1
133772,BE,0,1
133773,.,0,1
133774,Pemetrexed,0,0
133775,in,0,0
133776,combination,0,0
133777,with,0,1
133778,cisplatin,0,0
133779,versus,0,0
133780,cisplatin,0,0
133781,monotherapy,0,1
133782,in,0,0
133783,patients,1,1
133784,with,1,1
133785,recurrent,1,1
133786,or,1,1
133787,metastatic,1,1
133788,head,1,1
133789,and,1,0
133790,neck,1,1
133791,cancer,1,1
133792,:,1,1
133793,final,0,0
133794,results,0,0
133795,of,0,1
133796,a,0,1
133797,randomized,0,1
133798,",",0,0
133799,double-blind,0,0
133800,",",0,0
133801,placebo-controlled,0,0
133802,",",0,0
133803,phase,0,1
133804,3,0,0
133805,study,0,1
133806,.,0,1
133807,BACKGROUND,0,0
133808,Recurrent,1,1
133809,or,1,1
133810,metastatic,1,1
133811,squamous,1,1
133812,cell,1,1
133813,carcinoma,1,1
133814,of,1,0
133815,the,1,0
133816,head,1,1
133817,and,1,0
133818,neck,1,1
133819,(,1,1
133820,SCCHN,1,0
133821,),1,1
133822,is,0,0
133823,associated,0,0
133824,with,0,1
133825,poor,0,1
133826,survival,0,0
133827,.,0,1
133828,Platinum-based,0,0
133829,chemotherapy,0,0
133830,is,0,0
133831,often,0,0
133832,a,0,0
133833,first-line,0,0
133834,treatment,0,0
133835,.,0,1
133836,Pemetrexed,0,0
133837,has,0,0
133838,shown,0,0
133839,single-agent,0,0
133840,activity,0,0
133841,in,0,1
133842,SCCHN,0,1
133843,and,0,1
133844,in,0,0
133845,combination,0,0
133846,with,0,1
133847,cisplatin,0,0
133848,for,0,1
133849,other,0,1
133850,tumors,0,1
133851,.,0,1
133852,This,0,0
133853,trial,0,0
133854,examined,0,0
133855,the,0,0
133856,efficacy,0,0
133857,of,0,0
133858,pemetrexed-cisplatin,0,0
133859,for,0,1
133860,SCCHN,0,1
133861,.,0,1
133862,METHODS,0,0
133863,In,0,0
133864,a,0,1
133865,double-blind,0,0
133866,phase,0,1
133867,3,0,1
133868,trial,0,1
133869,",",0,1
133870,patients,1,1
133871,with,1,1
133872,recurrent,1,1
133873,or,1,1
133874,metastatic,1,1
133875,SCCHN,1,1
133876,and,1,1
133877,no,1,0
133878,prior,1,1
133879,systemic,1,0
133880,therapy,1,1
133881,for,1,0
133882,metastatic,1,1
133883,disease,1,1
133884,were,1,1
133885,randomized,1,1
133886,to,1,0
133887,pemetrexed,1,0
133888,(,1,1
133889,500,1,1
133890,mg/m,1,1
133891,(,1,1
133892,2,1,1
133893,),1,1
133894,),1,1
133895,plus,1,0
133896,cisplatin,1,0
133897,(,1,1
133898,75,1,1
133899,mg/m,1,1
133900,(,1,1
133901,2,1,1
133902,),1,1
133903,;,1,0
133904,n,1,1
133905,=,1,1
133906,398,1,1
133907,),1,1
133908,or,1,1
133909,placebo,1,0
133910,plus,1,0
133911,cisplatin,1,0
133912,(,1,1
133913,75,1,1
133914,mg/m,1,1
133915,(,1,1
133916,2,1,1
133917,),1,1
133918,;,1,0
133919,n,1,1
133920,=,1,1
133921,397,1,1
133922,),1,0
133923,to,0,0
133924,assess,0,0
133925,overall,0,0
133926,survival,0,0
133927,(,0,1
133928,OS,0,0
133929,),0,1
133930,and,0,1
133931,secondary,0,1
133932,endpoints,0,0
133933,.,0,1
133934,RESULTS,0,0
133935,Median,0,1
133936,OS,0,0
133937,was,0,0
133938,7.3,0,0
133939,months,0,0
133940,in,0,1
133941,the,0,1
133942,pemetrexed-cisplatin,0,0
133943,arm,0,1
133944,and,0,1
133945,6.3,0,0
133946,months,0,0
133947,in,0,1
133948,the,0,1
133949,placebo-cisplatin,0,0
133950,arm,0,1
133951,(,0,1
133952,hazard,0,0
133953,ratio,0,0
133954,[,0,0
133955,HR,0,0
133956,],0,1
133957,",",0,1
133958,0.87,0,0
133959,;,0,1
133960,95,0,0
133961,%,0,0
133962,confidence,0,0
133963,interval,0,0
133964,[,0,0
133965,CI,0,0
133966,],0,1
133967,",",0,1
133968,0.75-1.02,0,0
133969,;,0,1
133970,P,0,0
133971,=,0,1
133972,.082,0,0
133973,),0,1
133974,.,0,1
133975,Median,0,0
133976,progression-free,0,0
133977,survival,0,0
133978,(,0,1
133979,PFS,0,1
133980,",",0,1
133981,months,0,0
133982,),0,1
133983,was,0,0
133984,similar,0,0
133985,in,0,0
133986,both,0,0
133987,treatment,0,0
133988,arms,0,0
133989,(,0,1
133990,pemetrexed-cisplatin,0,0
133991,",",0,1
133992,3.6,0,0
133993,;,0,0
133994,placebo-cisplatin,0,0
133995,",",0,1
133996,2.8,0,0
133997,;,0,1
133998,HR,0,0
133999,",",0,1
134000,0.88,0,0
134001,;,0,1
134002,95,0,0
134003,%,0,0
134004,CI,0,0
134005,",",0,1
134006,0.76-1.03,0,0
134007,;,0,1
134008,P,0,0
134009,=,0,1
134010,.166,0,0
134011,),0,1
134012,.,0,1
134013,Among,0,1
134014,patients,0,1
134015,with,0,1
134016,performance,0,0
134017,status,0,1
134018,0,0,0
134019,or,0,1
134020,1,0,0
134021,",",0,0
134022,pemetrexed-cisplatin,0,0
134023,(,0,1
134024,n,0,1
134025,=,0,1
134026,347,0,1
134027,),0,1
134028,led,0,0
134029,to,0,0
134030,longer,0,0
134031,OS,0,0
134032,and,0,0
134033,PFS,0,1
134034,than,0,0
134035,placebo-cisplatin,0,0
134036,(,0,0
134037,n,0,1
134038,=,0,1
134039,343,0,1
134040,;,0,0
134041,8.4,0,0
134042,vs,0,0
134043,6.7,0,0
134044,months,0,1
134045,;,0,1
134046,HR,0,0
134047,",",0,1
134048,0.83,0,0
134049,;,0,1
134050,P,0,0
134051,=,0,1
134052,.026,0,0
134053,;,0,1
134054,4.0,0,0
134055,vs,0,0
134056,3.0,0,1
134057,months,0,1
134058,;,0,1
134059,HR,0,0
134060,",",0,1
134061,0.84,0,0
134062,;,0,1
134063,P,0,0
134064,=,0,1
134065,.044,0,0
134066,",",0,0
134067,respectively,0,0
134068,),0,0
134069,.,0,1
134070,Among,0,1
134071,patients,1,1
134072,with,1,1
134073,oropharyngeal,1,1
134074,cancers,1,1
134075,",",0,1
134076,pemetrexed-cisplatin,0,0
134077,(,0,1
134078,n,0,1
134079,=,0,1
134080,86,0,1
134081,),0,1
134082,resulted,0,0
134083,in,0,0
134084,longer,0,0
134085,OS,0,0
134086,and,0,0
134087,PFS,0,1
134088,than,0,0
134089,placebo-cisplatin,0,0
134090,(,0,0
134091,n,0,1
134092,=,0,1
134093,106,0,1
134094,;,0,0
134095,9.9,0,1
134096,vs,0,0
134097,6.1,0,1
134098,months,0,1
134099,;,0,1
134100,HR,0,0
134101,",",0,1
134102,0.59,0,0
134103,;,0,1
134104,P,0,0
134105,=,0,1
134106,.002,0,0
134107,;,0,1
134108,4.0,0,0
134109,vs,0,0
134110,3.4,0,1
134111,months,0,1
134112,;,0,1
134113,HR,0,0
134114,",",0,1
134115,0.73,0,0
134116,;,0,1
134117,P,0,0
134118,=,0,1
134119,.047,0,0
134120,",",0,0
134121,respectively,0,0
134122,),0,1
134123,.,0,1
134124,Pemetrexed-cisplatin,0,0
134125,toxicity,0,0
134126,was,0,0
134127,consistent,0,0
134128,with,0,1
134129,studies,0,0
134130,in,0,1
134131,other,0,1
134132,tumors,0,1
134133,.,0,1
134134,CONCLUSIONS,0,0
134135,Pemetrexed-cisplatin,0,0
134136,compared,0,0
134137,with,0,1
134138,placebo-cisplatin,0,0
134139,did,0,0
134140,not,0,0
134141,significantly,0,0
134142,improve,0,0
134143,survival,0,0
134144,for,0,0
134145,the,0,0
134146,intent-to-treat,0,0
134147,population,0,1
134148,.,0,1
134149,However,0,0
134150,",",0,0
134151,in,0,0
134152,a,0,0
134153,prespecified,0,0
134154,subgroup,0,0
134155,analysis,0,0
134156,",",0,0
134157,pemetrexed-cisplatin,0,0
134158,showed,0,0
134159,OS,0,0
134160,and,0,1
134161,PFS,0,0
134162,advantage,0,0
134163,for,0,0
134164,patients,0,1
134165,with,0,1
134166,performance,0,0
134167,status,0,1
134168,0,0,0
134169,or,0,1
134170,1,0,1
134171,or,0,1
134172,oropharyngeal,0,1
134173,cancers,0,1
134174,.,0,1
134175,Group,0,1
134176,cognitive,0,1
134177,behavior,0,0
134178,therapy,0,1
134179,for,0,0
134180,children,1,1
134181,with,1,1
134182,high-functioning,1,1
134183,autism,1,1
134184,spectrum,1,1
134185,disorders,1,1
134186,and,1,1
134187,anxiety,1,1
134188,:,1,1
134189,a,0,0
134190,randomized,0,1
134191,trial,0,1
134192,.,0,1
134193,BACKGROUND,0,0
134194,Children,1,1
134195,with,1,1
134196,high-functioning,1,1
134197,autism,1,1
134198,spectrum,1,1
134199,disorders,1,1
134200,(,1,1
134201,ASD,1,1
134202,),1,1
134203,are,0,0
134204,at,0,0
134205,high,0,1
134206,risk,0,1
134207,for,0,0
134208,developing,0,1
134209,significant,0,0
134210,anxiety,0,1
134211,.,0,0
134212,Anxiety,0,0
134213,can,0,0
134214,adversely,0,0
134215,impact,0,0
134216,functioning,0,0
134217,across,0,0
134218,school,0,1
134219,",",0,0
134220,home,0,1
134221,and,0,0
134222,community,0,1
134223,environments,0,0
134224,.,0,1
134225,Cognitive,0,0
134226,behavioral,0,1
134227,therapies,0,0
134228,(,0,1
134229,CBT,0,1
134230,),0,1
134231,are,0,0
134232,frequently,0,0
134233,used,0,0
134234,with,0,1
134235,success,0,0
134236,for,0,1
134237,children,0,1
134238,with,0,1
134239,anxiety,0,1
134240,symptoms,0,1
134241,.,0,1
134242,Modified,0,0
134243,CBT,0,0
134244,interventions,0,0
134245,for,0,1
134246,anxiety,1,1
134247,in,1,1
134248,children,1,1
134249,with,1,1
134250,ASD,1,1
134251,have,0,0
134252,also,0,0
134253,yielded,0,0
134254,promising,0,0
134255,results,0,0
134256,.,0,1
134257,METHODS,0,0
134258,Fifty,1,1
134259,children,1,1
134260,with,1,1
134261,high-functioning,1,1
134262,ASD,1,1
134263,and,1,1
134264,anxiety,1,1
134265,were,0,1
134266,randomizedto,0,1
134267,group,0,1
134268,CBT,0,1
134269,or,0,1
134270,treatment-as-usual,0,1
134271,(,0,1
134272,TAU,0,0
134273,),0,1
134274,for,0,1
134275,12,0,1
134276,weeks,0,1
134277,.,0,1
134278,Independent,0,1
134279,clinical,0,0
134280,evaluators,0,0
134281,",",0,1
134282,blind,0,1
134283,to,0,0
134284,condition,0,0
134285,",",0,0
134286,completed,0,1
134287,structured,0,1
134288,interviews,0,1
134289,(,0,1
134290,Anxiety,0,1
134291,Disorders,0,1
134292,Interview,0,1
134293,Schedule,0,1
134294,?,0,1
134295,Parent,0,1
134296,Version,0,1
134297,;,0,1
134298,ADIS-P,0,1
134299,),0,1
134300,pre-,0,0
134301,and,0,0
134302,post-intervention,0,0
134303,condition,0,0
134304,.,0,1
134305,RESULTS,1,0
134306,Forty-seven,1,1
134307,children,1,1
134308,completed,1,1
134309,either,0,1
134310,the,0,0
134311,CBT,0,0
134312,or,0,1
134313,TAU,0,0
134314,condition,0,1
134315,.,0,1
134316,Results,0,0
134317,indicated,0,0
134318,markedly,0,0
134319,better,0,0
134320,outcomes,0,0
134321,for,0,0
134322,the,0,1
134323,CBT,0,0
134324,group,0,1
134325,.,0,1
134326,Significant,0,0
134327,differences,0,0
134328,by,0,1
134329,group,0,1
134330,were,0,1
134331,noted,0,0
134332,in,0,0
134333,Clinician,0,0
134334,Severity,0,0
134335,Ratings,0,0
134336,",",0,0
134337,diagnostic,0,0
134338,status,0,1
134339,",",0,0
134340,and,0,0
134341,clinician,0,0
134342,ratings,0,0
134343,of,0,1
134344,global,0,0
134345,improvement,0,0
134346,.,0,1
134347,In,0,0
134348,the,0,0
134349,intent-to-treat,0,0
134350,sample,0,1
134351,",",0,0
134352,10,0,1
134353,of,0,1
134354,20,0,1
134355,children,0,1
134356,(,0,1
134357,50,0,1
134358,%,0,0
134359,),0,1
134360,in,0,0
134361,the,0,0
134362,CBT,0,0
134363,group,0,0
134364,had,0,1
134365,a,0,0
134366,clinically,0,1
134367,meaningful,0,0
134368,positive,0,1
134369,treatment,0,0
134370,response,0,0
134371,",",0,0
134372,compared,0,0
134373,to,0,0
134374,2,0,1
134375,of,0,1
134376,23,0,1
134377,children,0,1
134378,(,0,1
134379,8.7,0,0
134380,%,0,0
134381,),0,1
134382,in,0,0
134383,the,0,0
134384,TAU,0,0
134385,group,0,1
134386,.,0,1
134387,CONCLUSIONS,0,0
134388,Initial,0,0
134389,results,0,0
134390,from,0,1
134391,this,0,0
134392,randomized,0,1
134393,",",0,0
134394,designed,0,0
134395,treatment,0,0
134396,study,0,0
134397,suggest,0,0
134398,that,0,0
134399,agroup,0,0
134400,CBT,0,0
134401,intervention,0,0
134402,specifically,0,0
134403,developed,0,1
134404,for,0,0
134405,children,0,1
134406,with,0,1
134407,ASD,0,1
134408,may,0,0
134409,be,0,0
134410,effective,0,0
134411,in,0,0
134412,decreasing,0,0
134413,anxiety,0,1
134414,.,0,1
134415,Limitations,0,0
134416,of,0,0
134417,this,0,0
134418,study,0,0
134419,include,0,0
134420,small,0,0
134421,sample,0,1
134422,size,0,0
134423,",",0,0
134424,lack,0,0
134425,of,0,0
134426,an,0,0
134427,attention,0,0
134428,control,0,0
134429,group,0,0
134430,",",0,0
134431,and,0,0
134432,use,0,0
134433,of,0,0
134434,outcome,0,0
134435,measures,0,0
134436,normed,0,0
134437,with,0,1
134438,typically,0,1
134439,developing,0,1
134440,children,0,1
134441,Comparison,0,0
134442,of,0,1
134443,active-learning,0,1
134444,strategies,0,0
134445,for,0,1
134446,motivational,0,1
134447,interviewing,0,1
134448,skills,0,0
134449,",",0,0
134450,knowledge,0,0
134451,",",0,0
134452,and,0,0
134453,confidence,0,0
134454,in,0,0
134455,first-year,1,1
134456,pharmacy,1,1
134457,students,1,1
134458,.,1,1
134459,OBJECTIVE,0,0
134460,To,0,0
134461,compare,0,0
134462,3,0,1
134463,strategies,0,0
134464,for,0,1
134465,pharmacy,1,1
134466,student,1,0
134467,learning,0,0
134468,of,0,0
134469,motivational,0,0
134470,interviewing,0,1
134471,skills,0,0
134472,",",0,0
134473,knowledge,0,0
134474,of,0,0
134475,motivational,0,0
134476,interviewing,0,1
134477,principles,0,0
134478,",",0,1
134479,and,0,0
134480,confidence,0,0
134481,in,0,0
134482,and,0,1
134483,attitudes,0,0
134484,toward,0,0
134485,their,0,1
134486,application,0,0
134487,.,0,1
134488,DESIGN,0,0
134489,Following,0,0
134490,a,0,1
134491,motivational,0,0
134492,interviewing,0,0
134493,lecture,0,1
134494,",",0,1
134495,first-year,1,1
134496,students,1,1
134497,were,0,1
134498,randomized,0,1
134499,to,0,0
134500,perform,0,0
134501,practice,0,0
134502,activities,0,0
134503,(,0,1
134504,written,0,1
134505,dialogue,0,0
134506,",",0,0
134507,peer,0,0
134508,role-play,0,0
134509,",",0,0
134510,or,0,1
134511,mock-patient,0,1
134512,counseling,0,1
134513,activities,0,0
134514,),0,1
134515,.,0,1
134516,Motivational,0,0
134517,interviewing,0,0
134518,skills,0,0
134519,",",0,0
134520,knowledge,0,0
134521,",",0,0
134522,confidence,0,0
134523,",",0,0
134524,and,0,0
134525,attitudes,0,0
134526,were,0,1
134527,measured,0,0
134528,.,0,1
134529,ASSESSMENT,0,0
134530,All,0,1
134531,students,0,1
134532,demonstrated,0,0
134533,improvement,0,0
134534,in,0,0
134535,skills,0,0
134536,",",0,1
134537,knowledge,0,0
134538,",",0,0
134539,and,0,0
134540,confidence,0,0
134541,.,0,1
134542,Students,1,0
134543,in,0,0
134544,the,0,1
134545,mock-patient,0,1
134546,counseling,0,0
134547,group,0,1
134548,demonstrated,0,0
134549,significantly,0,0
134550,better,0,0
134551,motivational,0,0
134552,interviewing,0,0
134553,skills,0,0
134554,during,0,1
134555,practice,0,1
134556,and,0,0
134557,trended,0,0
134558,toward,0,0
134559,higher,0,0
134560,scores,0,0
134561,on,0,0
134562,the,0,1
134563,summative,0,0
134564,evaluation,0,0
134565,.,0,1
134566,They,0,0
134567,also,0,0
134568,demonstrated,0,0
134569,a,0,0
134570,significant,0,0
134571,improvement,0,0
134572,in,0,0
134573,knowledge,0,0
134574,compared,0,0
134575,with,0,1
134576,that,0,0
134577,of,0,0
134578,the,0,0
134579,written,0,0
134580,dialogue,0,0
134581,group,0,1
134582,during,0,0
134583,practice,0,0
134584,.,0,1
134585,Feedback,0,0
134586,at,0,0
134587,the,0,0
134588,end,0,0
134589,was,0,0
134590,generally,0,0
134591,positive,0,0
134592,",",0,0
134593,with,0,1
134594,students,1,1
134595,expressing,0,1
134596,recognition,0,0
134597,for,0,0
134598,the,0,0
134599,value,0,0
134600,of,0,0
134601,motivational,0,0
134602,interviewing,0,1
134603,.,0,1
134604,CONCLUSIONS,0,0
134605,Students,0,1
134606,demonstrated,0,0
134607,their,0,1
134608,best,0,0
134609,performance,0,0
134610,of,0,0
134611,motivational,0,0
134612,interviewing,0,1
134613,during,0,1
134614,assessments,0,0
134615,using,0,1
134616,interactions,0,0
134617,with,0,1
134618,mock,0,1
134619,or,0,1
134620,standardized,0,1
134621,patients,0,1
134622,.,0,1
134623,Impact,0,0
134624,of,0,0
134625,the,0,0
134626,quantity,0,0
134627,and,0,0
134628,flavonoid,0,1
134629,content,0,0
134630,of,0,1
134631,fruits,0,1
134632,and,0,1
134633,vegetables,0,1
134634,on,0,1
134635,markers,0,0
134636,of,0,1
134637,intake,0,1
134638,in,0,1
134639,adults,1,1
134640,with,1,1
134641,an,1,1
134642,increased,1,0
134643,risk,1,0
134644,of,1,0
134645,cardiovascular,1,1
134646,disease,1,1
134647,:,1,1
134648,the,0,0
134649,FLAVURS,0,0
134650,trial,0,0
134651,.,0,1
134652,PURPOSE,0,0
134653,Limited,0,1
134654,robust,0,0
134655,randomised,0,1
134656,controlled,0,0
134657,trials,0,0
134658,investigating,0,0
134659,fruit,0,1
134660,and,0,1
134661,vegetable,0,1
134662,(,0,1
134663,F,0,1
134664,&,0,1
134665,V,0,0
134666,),0,1
134667,intake,0,0
134668,in,0,0
134669,people,1,1
134670,at,1,1
134671,risk,1,1
134672,of,1,0
134673,cardiovascular,1,1
134674,disease,1,1
134675,(,1,1
134676,CVD,1,1
134677,),1,1
134678,exist,0,0
134679,.,0,1
134680,We,0,0
134681,aimed,0,0
134682,to,0,0
134683,design,0,1
134684,and,0,0
134685,validate,0,0
134686,a,0,0
134687,dietary,0,0
134688,strategy,0,0
134689,of,0,0
134690,increasing,0,0
134691,flavonoid-rich,0,1
134692,versus,0,0
134693,flavonoid-poor,0,1
134694,F,0,1
134695,&,0,1
134696,V,0,0
134697,consumption,0,0
134698,on,0,0
134699,nutrient,0,1
134700,biomarker,0,1
134701,profile,0,0
134702,.,0,1
134703,METHODS,0,0
134704,A,0,0
134705,parallel,0,0
134706,",",0,0
134707,randomised,0,0
134708,",",0,0
134709,controlled,0,0
134710,",",0,0
134711,dose-response,0,0
134712,dietary,0,0
134713,intervention,0,1
134714,study,0,1
134715,.,0,1
134716,Participants,1,1
134717,with,1,1
134718,a,1,1
134719,CVD,1,1
134720,relative,1,0
134721,risk,1,1
134722,of,1,1
134723,1.5,1,0
134724,assessed,1,0
134725,by,1,0
134726,risk,1,1
134727,scores,1,0
134728,were,0,1
134729,randomly,0,1
134730,assigned,0,1
134731,to,0,0
134732,one,0,1
134733,of,0,0
134734,the,0,1
134735,3,0,1
134736,groups,0,1
134737,:,0,1
134738,habitual,0,1
134739,(,0,1
134740,control,0,1
134741,",",0,0
134742,CT,0,0
134743,),0,0
134744,",",0,0
134745,high-flavonoid,0,0
134746,(,0,1
134747,HF,0,1
134748,),0,1
134749,or,0,1
134750,low-flavonoid,0,1
134751,(,0,1
134752,LF,0,0
134753,),0,1
134754,diets,0,0
134755,.,0,1
134756,While,0,1
134757,the,0,0
134758,CT,0,0
134759,group,0,1
134760,(,0,1
134761,n,0,1
134762,=,0,1
134763,57,0,1
134764,),0,1
134765,consumed,0,1
134766,their,0,1
134767,habitual,0,1
134768,diet,0,0
134769,throughout,0,0
134770,",",0,0
134771,the,0,0
134772,HF,0,0
134773,(,0,1
134774,n,0,1
134775,=,0,1
134776,58,0,1
134777,),0,1
134778,and,0,1
134779,LF,0,0
134780,(,0,1
134781,n,0,1
134782,=,0,1
134783,59,0,1
134784,),0,1
134785,groups,0,0
134786,sequentially,0,1
134787,increased,0,0
134788,their,0,0
134789,daily,0,0
134790,F,0,1
134791,&,0,1
134792,V,0,0
134793,intake,0,0
134794,by,0,0
134795,an,0,1
134796,additional,0,0
134797,2,0,1
134798,",",0,1
134799,4,0,0
134800,and,0,1
134801,6,0,1
134802,portions,0,0
134803,for,0,1
134804,6-week,0,1
134805,periods,0,0
134806,during,0,1
134807,the,0,1
134808,18-week,0,0
134809,study,0,1
134810,.,0,1
134811,RESULTS,0,0
134812,Compliance,0,0
134813,to,0,1
134814,target,0,1
134815,numbers,0,0
134816,and,0,1
134817,types,0,1
134818,of,0,1
134819,F,0,1
134820,&,0,1
134821,V,0,0
134822,was,0,0
134823,broadly,0,0
134824,met,0,1
134825,and,0,0
134826,verified,0,0
134827,by,0,0
134828,dietary,0,0
134829,records,0,1
134830,",",0,1
134831,and,0,0
134832,plasma,0,0
134833,and,0,1
134834,urinary,0,1
134835,biomarkers,0,1
134836,.,0,1
134837,Mean,0,1
134838,(,0,1
134839,?,0,1
134840,SEM,0,0
134841,),0,0
134842,number,0,0
134843,of,0,0
134844,F,0,1
134845,&,0,1
134846,V,0,0
134847,portions/day,0,0
134848,consumed,0,1
134849,by,0,0
134850,the,0,0
134851,HF,0,1
134852,and,0,1
134853,LF,0,0
134854,groups,0,0
134855,at,0,1
134856,baseline,0,1
134857,(,0,1
134858,3.8,0,1
134859,?,0,1
134860,0.3,0,0
134861,and,0,1
134862,3.4,0,1
134863,?,0,1
134864,0.3,0,0
134865,),0,0
134866,",",0,1
134867,6,0,1
134868,weeks,0,0
134869,(,0,1
134870,6.3,0,0
134871,?,0,1
134872,0.4,0,0
134873,and,0,1
134874,5.8,0,0
134875,?,0,1
134876,0.3,0,0
134877,),0,0
134878,",",0,1
134879,12,0,1
134880,weeks,0,0
134881,(,0,1
134882,7.0,0,1
134883,?,0,1
134884,0.3,0,0
134885,and,0,1
134886,6.8,0,0
134887,?,0,1
134888,0.3,0,0
134889,),0,1
134890,and,0,1
134891,18,0,1
134892,weeks,0,1
134893,(,0,1
134894,7.6,0,1
134895,?,0,1
134896,0.4,0,0
134897,and,0,1
134898,8.1,0,1
134899,?,0,1
134900,0.4,0,0
134901,),0,0
134902,",",0,0
134903,respectively,0,0
134904,",",0,0
134905,was,0,0
134906,similar,0,0
134907,at,0,0
134908,baseline,0,0
134909,yet,0,0
134910,higher,0,0
134911,than,0,0
134912,the,0,0
134913,CT,0,0
134914,group,0,1
134915,(,0,1
134916,3.9,0,0
134917,?,0,1
134918,0.3,0,0
134919,",",0,0
134920,4.3,0,0
134921,?,0,1
134922,0.3,0,0
134923,",",0,0
134924,4.6,0,1
134925,?,0,1
134926,0.4,0,0
134927,",",0,0
134928,4.5,0,1
134929,?,0,1
134930,0.3,0,0
134931,),0,0
134932,(,0,1
134933,P,0,0
134934,=,0,1
134935,0.015,0,0
134936,),0,0
134937,.,0,0
134938,There,0,0
134939,was,0,0
134940,a,0,0
134941,dose-dependent,0,0
134942,increase,0,0
134943,in,0,1
134944,dietary,0,0
134945,and,0,1
134946,urinary,0,1
134947,flavonoids,0,0
134948,in,0,1
134949,the,0,1
134950,HF,0,0
134951,group,0,0
134952,",",0,0
134953,with,0,1
134954,no,0,0
134955,change,0,0
134956,in,0,0
134957,other,0,1
134958,groups,0,1
134959,(,0,1
134960,P,0,0
134961,=,0,1
134962,0.0001,0,0
134963,),0,1
134964,.,0,1
134965,Significantly,0,0
134966,higher,0,0
134967,dietary,0,0
134968,intakes,0,0
134969,of,0,1
134970,folate,0,0
134971,(,0,1
134972,P,0,0
134973,=,0,1
134974,0.035,0,0
134975,),0,1
134976,",",0,1
134977,non-starch,0,1
134978,polysaccharides,0,0
134979,(,0,1
134980,P,0,0
134981,=,0,1
134982,0.001,0,0
134983,),0,0
134984,",",0,0
134985,vitamin,0,0
134986,C,0,0
134987,(,0,1
134988,P,0,0
134989,=,0,1
134990,0.0001,0,0
134991,),0,1
134992,and,0,1
134993,carotenoids,0,0
134994,(,0,1
134995,P,0,0
134996,=,0,1
134997,0.0001,0,0
134998,),0,1
134999,were,0,1
135000,observed,0,0
135001,in,0,0
135002,both,0,0
135003,intervention,0,1
135004,groups,0,0
135005,compared,0,0
135006,with,0,1
135007,CT,0,0
135008,",",0,1
135009,which,0,0
135010,were,0,0
135011,broadly,0,0
135012,supported,0,0
135013,by,0,0
135014,nutrient,0,1
135015,biomarker,0,1
135016,analysis,0,0
135017,.,0,0
135018,CONCLUSIONS,0,0
135019,The,0,0
135020,success,0,0
135021,of,0,0
135022,improving,0,0
135023,nutrient,0,1
135024,profile,0,0
135025,by,0,0
135026,active,0,1
135027,encouragement,0,0
135028,of,0,1
135029,F,0,1
135030,&,0,1
135031,V,0,0
135032,intake,0,0
135033,in,0,0
135034,an,0,0
135035,intervention,0,0
135036,study,0,0
135037,implies,0,0
135038,the,0,0
135039,need,0,0
135040,for,0,0
135041,a,0,0
135042,more,0,0
135043,hands-on,0,0
135044,public,0,1
135045,health,0,1
135046,approach,0,1
135047,.,0,1
135048,Effect,0,0
135049,of,0,0
135050,sulfasalazine,0,0
135051,on,0,0
135052,inflammation,0,1
135053,and,0,1
135054,endothelial,0,0
135055,function,0,0
135056,in,0,1
135057,patients,1,1
135058,with,1,1
135059,established,1,1
135060,coronary,1,1
135061,artery,1,1
135062,disease,1,1
135063,.,1,1
135064,Inflammation,0,0
135065,is,0,0
135066,critical,0,0
135067,for,0,0
135068,atherosclerosis,0,1
135069,development,0,0
135070,and,0,0
135071,may,0,0
135072,be,0,0
135073,a,0,0
135074,target,0,0
135075,for,0,0
135076,risk-reduction,0,0
135077,therapy,0,0
135078,.,0,1
135079,In,0,0
135080,experimental,0,0
135081,studies,0,0
135082,",",0,1
135083,activation,0,0
135084,of,0,0
135085,the,0,0
135086,inflammatory,0,0
135087,regulator,0,0
135088,",",0,0
135089,nuclear,0,0
135090,factor,0,0
135091,kappa,0,0
135092,B,0,1
135093,(,0,1
135094,NFlB,0,1
135095,),0,0
135096,",",0,0
135097,contributes,0,0
135098,to,0,0
135099,endothelial,0,0
135100,activation,0,0
135101,and,0,1
135102,reduced,0,0
135103,nitric,0,0
135104,oxide,0,0
135105,production,0,0
135106,.,0,1
135107,We,0,0
135108,treated,0,1
135109,patients,1,1
135110,with,1,1
135111,coronary,1,1
135112,artery,1,1
135113,disease,1,1
135114,with,0,1
135115,sulfasalazine,0,0
135116,",",0,0
135117,an,0,0
135118,inhibitor,0,0
135119,of,0,0
135120,NF?B,0,0
135121,",",0,0
135122,and,0,0
135123,placebo,0,0
135124,in,0,0
135125,a,0,0
135126,randomized,0,1
135127,",",0,0
135128,double-blind,0,0
135129,",",0,0
135130,crossover,0,0
135131,study,0,1
135132,design,0,1
135133,.,0,1
135134,Brachial,0,0
135135,artery,0,1
135136,flow-mediated,0,1
135137,dilation,0,1
135138,(,0,1
135139,FMD,0,1
135140,),0,1
135141,and,0,1
135142,digital,0,0
135143,vascular,0,0
135144,function,0,0
135145,were,0,1
135146,measured,0,0
135147,at,0,0
135148,baseline,0,0
135149,and,0,0
135150,after,0,0
135151,each,0,0
135152,6-week,0,0
135153,treatment,0,0
135154,period,0,0
135155,.,0,1
135156,Of,0,0
135157,the,1,0
135158,53,1,1
135159,patients,1,1
135160,enrolled,1,1
135161,in,1,0
135162,the,1,0
135163,crossover,1,0
135164,study,1,0
135165,",",1,1
135166,32,1,1
135167,(,1,1
135168,age,1,1
135169,60,1,1
135170,?,1,1
135171,10,1,0
135172,",",1,0
135173,22,1,1
135174,%,1,0
135175,female,1,1
135176,),1,1
135177,completed,1,1
135178,all,0,0
135179,the,0,0
135180,visits,0,0
135181,",",0,0
135182,with,0,1
135183,a,0,0
135184,high,0,1
135185,rate,0,0
135186,of,0,0
135187,study,0,1
135188,withdrawal,0,0
135189,due,0,0
135190,to,0,1
135191,gastrointestinal,0,1
135192,side,0,0
135193,effects,0,0
135194,.,0,1
135195,In,0,0
135196,a,0,0
135197,subset,0,1
135198,of,0,0
135199,10,1,1
135200,participants,1,1
135201,",",1,1
135202,we,0,0
135203,compared,0,0
135204,the,0,0
135205,effects,0,0
135206,of,0,1
135207,4,0,1
135208,days,0,0
135209,of,0,1
135210,sulfasalazine,0,1
135211,treatment,0,1
135212,(,0,1
135213,n,0,1
135214,=,0,1
135215,5,0,1
135216,),0,1
135217,to,0,0
135218,no,0,0
135219,treatment,0,0
135220,(,0,0
135221,n,0,1
135222,=,0,1
135223,5,0,1
135224,),0,1
135225,on,0,0
135226,NF?B-regulated,0,1
135227,gene,0,0
135228,expression,0,0
135229,in,0,0
135230,peripheral,0,1
135231,blood,0,1
135232,mononuclear,0,1
135233,cells,0,0
135234,.,0,1
135235,Tumor,0,1
135236,necrosis,0,0
135237,factor,0,0
135238,?-stimulated,0,0
135239,expression,0,0
135240,of,0,1
135241,CD69,0,0
135242,and,0,1
135243,NFlB,0,1
135244,subunit,0,0
135245,p50,0,0
135246,was,0,0
135247,significantly,0,0
135248,blunted,0,0
135249,after,0,1
135250,4,0,0
135251,days,0,0
135252,of,0,1
135253,sulfasalazine,0,1
135254,treatment,0,0
135255,but,0,0
135256,not,0,0
135257,after,0,0
135258,no,0,0
135259,treatment,0,0
135260,.,0,0
135261,However,0,0
135262,",",0,0
135263,FMD,0,0
135264,and,0,0
135265,digital,0,0
135266,vasodilator,0,1
135267,response,0,0
135268,did,0,0
135269,not,0,0
135270,significantly,0,0
135271,change,0,0
135272,from,0,0
135273,baseline,0,0
135274,with,0,1
135275,long-term,0,0
135276,sulfasalazine,0,1
135277,treatment,0,1
135278,.,0,1
135279,Short-term,0,0
135280,sulfasalazine,0,0
135281,inhibited,0,0
135282,NFlB,0,1
135283,activity,0,0
135284,;,0,0
135285,however,0,0
135286,",",0,0
135287,long-term,0,0
135288,treatment,0,0
135289,was,0,0
135290,poorly,0,1
135291,tolerated,0,0
135292,and,0,0
135293,did,0,0
135294,not,0,0
135295,improve,0,0
135296,endothelial,0,0
135297,function,0,0
135298,.,0,1
135299,Our,0,0
135300,findings,0,0
135301,suggest,0,0
135302,that,0,0
135303,sulfasalazine,0,0
135304,therapy,0,0
135305,is,0,0
135306,not,0,0
135307,the,0,0
135308,optimal,0,0
135309,anti-inflammatory,0,0
135310,treatment,0,1
135311,for,0,0
135312,reversing,0,0
135313,endothelial,0,0
135314,dysfunction,0,1
135315,in,0,1
135316,cardiovascular,0,1
135317,disease,0,1
135318,.,0,1
135319,Further,0,0
135320,studies,0,0
135321,are,0,0
135322,warranted,0,0
135323,to,0,0
135324,investigate,0,0
135325,the,0,0
135326,potential,0,0
135327,for,0,0
135328,NFlB,0,1
135329,inhibition,0,0
135330,to,0,0
135331,reduce,0,0
135332,cardiovascular,0,1
135333,risk,0,1
135334,.,0,1
135335,Longitudinal,0,1
135336,follow-up,0,1
135337,of,0,1
135338,children,1,1
135339,with,1,1
135340,autism,1,1
135341,receiving,1,1
135342,targeted,1,1
135343,interventions,1,0
135344,on,1,0
135345,joint,1,1
135346,attention,1,0
135347,and,1,1
135348,play,1,0
135349,.,1,1
135350,OBJECTIVE,0,0
135351,This,0,0
135352,study,0,0
135353,examines,0,0
135354,the,0,0
135355,cognitive,0,0
135356,and,0,0
135357,language,0,1
135358,outcomes,0,0
135359,of,0,1
135360,children,1,1
135361,with,1,1
135362,an,1,1
135363,autism,1,1
135364,spectrum,1,1
135365,disorder,1,1
135366,(,1,1
135367,ASD,1,1
135368,),1,1
135369,over,1,0
135370,a,1,1
135371,5-year,1,1
135372,period,1,0
135373,after,1,0
135374,receiving,1,1
135375,targeted,1,1
135376,early,1,1
135377,interventions,1,0
135378,that,1,0
135379,focused,1,1
135380,on,1,0
135381,joint,1,1
135382,attention,1,0
135383,and,1,1
135384,play,1,0
135385,skills,1,0
135386,.,1,1
135387,METHOD,0,0
135388,Forty,1,1
135389,children,1,1
135390,from,1,1
135391,the,1,1
135392,original,1,1
135393,study,1,1
135394,(,1,1
135395,n,1,1
135396,=,1,1
135397,58,1,1
135398,),1,1
135399,had,1,1
135400,complete,1,1
135401,data,1,0
135402,at,1,1
135403,the,1,1
135404,5-year,1,1
135405,follow-up,1,0
135406,.,1,1
135407,RESULTS,0,0
135408,In,0,0
135409,all,0,0
135410,",",0,0
135411,80,0,0
135412,%,0,0
135413,of,0,1
135414,children,0,1
135415,had,0,1
135416,achieved,0,0
135417,functional,0,0
135418,use,0,0
135419,of,0,0
135420,spoken,0,0
135421,language,0,1
135422,with,0,1
135423,baseline,0,0
135424,play,0,0
135425,level,0,0
135426,predicting,0,0
135427,spoken,0,0
135428,language,0,1
135429,at,0,0
135430,the,0,0
135431,5-year,0,1
135432,follow-up,0,0
135433,.,0,1
135434,Of,0,1
135435,children,0,1
135436,who,0,1
135437,were,0,1
135438,using,0,1
135439,spoken,0,0
135440,language,0,1
135441,at,0,1
135442,age,0,1
135443,8,0,1
135444,years,0,1
135445,",",0,1
135446,several,0,1
135447,baseline,0,0
135448,behaviors,0,0
135449,predicted,0,0
135450,their,0,1
135451,later,0,1
135452,ability,0,0
135453,",",0,0
135454,including,0,0
135455,earlier,0,0
135456,age,0,1
135457,of,0,0
135458,entry,0,1
135459,into,0,1
135460,the,0,0
135461,study,0,0
135462,",",0,0
135463,initiating,0,0
135464,joint,0,1
135465,attention,0,0
135466,skill,0,0
135467,",",0,0
135468,play,0,0
135469,level,0,0
135470,",",0,0
135471,and,0,0
135472,assignment,0,0
135473,to,0,0
135474,either,0,0
135475,the,0,0
135476,joint,0,0
135477,attention,0,0
135478,or,0,1
135479,symbolic,0,0
135480,play,0,0
135481,intervention,0,1
135482,group,0,1
135483,.,0,1
135484,Only,0,0
135485,baseline,0,0
135486,play,0,0
135487,diversity,0,1
135488,predicted,0,0
135489,cognitive,0,1
135490,scores,0,0
135491,at,0,1
135492,age,0,1
135493,8,0,1
135494,years,0,1
135495,.,0,1
135496,CONCLUSIONS,0,0
135497,This,0,0
135498,study,0,0
135499,is,0,0
135500,one,0,0
135501,of,0,0
135502,the,0,0
135503,only,0,0
135504,long-term,0,0
135505,follow-up,0,1
135506,studies,0,0
135507,of,0,1
135508,children,1,1
135509,who,1,1
135510,participated,1,1
135511,in,1,1
135512,preschool,1,1
135513,early,1,1
135514,interventions,1,0
135515,aimed,1,0
135516,at,1,1
135517,targeting,1,0
135518,core,1,1
135519,developmental,1,1
135520,difficulties,1,1
135521,.,1,1
135522,The,0,0
135523,study,0,0
135524,findings,0,0
135525,suggest,0,0
135526,that,0,0
135527,focusing,0,0
135528,on,0,0
135529,joint,0,1
135530,attention,0,0
135531,and,0,1
135532,play,0,0
135533,skills,0,0
135534,in,0,1
135535,comprehensive,0,1
135536,treatment,0,1
135537,models,0,0
135538,is,0,0
135539,important,0,0
135540,for,0,0
135541,long-term,0,0
135542,spoken,0,0
135543,language,0,1
135544,outcomes,0,0
135545,.,0,1
135546,Spotty,0,1
135547,calcification,0,1
135548,as,0,0
135549,a,0,0
135550,marker,0,0
135551,of,0,0
135552,accelerated,0,0
135553,progression,0,1
135554,of,0,0
135555,coronary,0,1
135556,atherosclerosis,0,1
135557,:,0,1
135558,insights,0,0
135559,from,0,1
135560,serial,0,1
135561,intravascular,0,1
135562,ultrasound,0,1
135563,.,0,1
135564,OBJECTIVES,0,0
135565,The,0,0
135566,purpose,0,0
135567,of,0,0
135568,this,0,0
135569,study,0,0
135570,was,0,0
135571,to,0,0
135572,determine,0,0
135573,atheroma,1,1
135574,progression,1,0
135575,in,1,1
135576,patients,1,1
135577,with,1,1
135578,spotty,1,1
135579,calcification,1,1
135580,.,1,1
135581,BACKGROUND,0,0
135582,Although,0,0
135583,extensively,0,0
135584,calcified,0,1
135585,atherosclerotic,0,1
135586,lesions,0,1
135587,have,0,1
135588,been,0,0
135589,proposed,0,0
135590,to,0,0
135591,be,0,0
135592,clinically,0,1
135593,quiescent,0,1
135594,",",0,0
135595,the,0,0
135596,presence,0,0
135597,of,0,0
135598,spotty,0,1
135599,calcification,0,1
135600,within,0,0
135601,plaque,0,0
135602,has,0,0
135603,been,0,0
135604,reported,0,0
135605,to,0,0
135606,be,0,0
135607,associated,0,0
135608,with,0,1
135609,an,0,0
135610,increased,0,0
135611,incidence,0,0
135612,of,0,0
135613,ischemic,0,1
135614,cardiovascular,0,1
135615,events,0,0
135616,.,0,1
135617,The,0,0
135618,relationship,0,0
135619,between,0,0
135620,spotty,0,1
135621,calcification,0,1
135622,and,0,0
135623,disease,0,1
135624,progression,0,0
135625,has,0,0
135626,not,0,0
135627,been,0,0
135628,investigated,0,0
135629,.,0,1
135630,METHODS,0,0
135631,A,0,0
135632,total,1,1
135633,of,1,1
135634,"1,347",1,1
135635,stable,1,1
135636,patients,1,1
135637,with,1,1
135638,angiographic,1,1
135639,coronary,1,1
135640,artery,1,1
135641,disease,1,1
135642,underwent,1,1
135643,serial,1,1
135644,evaluation,1,0
135645,of,1,0
135646,atheroma,1,1
135647,burden,1,1
135648,with,1,1
135649,intravascular,1,1
135650,ultrasound,1,1
135651,imaging,1,0
135652,.,1,1
135653,Patients,1,1
135654,with,1,1
135655,spotty,1,1
135656,calcification,1,1
135657,were,1,1
135658,identified,1,0
135659,based,1,1
135660,on,1,0
135661,the,1,0
135662,presence,1,0
135663,of,1,0
135664,lesions,1,1
135665,(,1,1
135666,1,1,1
135667,to,1,1
135668,4,1,1
135669,mm,1,1
135670,in,1,1
135671,length,1,0
135672,),1,1
135673,containing,1,0
135674,an,1,0
135675,arc,1,1
135676,of,1,0
135677,calcification,1,1
135678,of,1,1
135679,<,1,0
135680,90?,1,1
135681,.,1,1
135682,Clinical,0,0
135683,characteristics,0,0
135684,and,0,1
135685,disease,0,1
135686,progression,0,0
135687,were,0,0
135688,compared,0,0
135689,between,1,0
135690,patients,1,1
135691,with,1,1
135692,spotty,1,1
135693,calcification,1,1
135694,(,1,1
135695,n,1,1
135696,=,1,1
135697,922,1,1
135698,),1,1
135699,and,1,0
135700,those,1,0
135701,with,1,1
135702,no,1,0
135703,calcification,1,1
135704,(,1,0
135705,n,1,1
135706,=,1,1
135707,425,1,1
135708,),1,1
135709,.,1,1
135710,RESULTS,1,0
135711,Patients,1,1
135712,with,1,1
135713,spotty,1,1
135714,calcification,1,1
135715,were,1,1
135716,older,1,1
135717,(,1,1
135718,age,1,1
135719,56,1,1
135720,years,1,1
135721,vs.,1,0
135722,54,1,1
135723,years,1,1
135724,;,1,1
135725,p,1,0
135726,=,1,0
135727,0.001,1,0
135728,),1,0
135729,",",1,0
135730,more,1,0
135731,likely,1,0
135732,to,1,0
135733,be,1,0
135734,male,1,1
135735,(,1,1
135736,68,1,1
135737,%,1,0
135738,vs.,1,0
135739,54,1,1
135740,%,1,0
135741,;,1,0
135742,p,1,0
135743,=,1,1
135744,0.01,1,0
135745,),1,0
135746,",",1,0
135747,and,1,0
135748,have,1,0
135749,a,1,0
135750,history,1,1
135751,of,1,0
135752,diabetes,1,1
135753,mellitus,1,1
135754,(,1,1
135755,30,1,1
135756,%,1,0
135757,vs.,1,0
135758,24,1,1
135759,%,1,0
135760,;,1,0
135761,p,1,0
135762,=,1,1
135763,0.01,1,0
135764,),1,1
135765,and,1,1
135766,myocardial,1,1
135767,infarction,1,1
135768,(,1,1
135769,28,1,1
135770,%,1,0
135771,vs.,1,0
135772,20,1,1
135773,%,1,0
135774,;,1,0
135775,p,1,0
135776,=,1,1
135777,0.004,1,0
135778,),1,0
135779,",",1,0
135780,and,1,0
135781,have,1,0
135782,lower,1,0
135783,on-treatment,1,0
135784,high-density,1,0
135785,lipoprotein,1,1
135786,cholesterol,1,0
135787,levels,1,0
135788,(,1,1
135789,48,1,1
135790,?,1,1
135791,16,1,0
135792,mg/dl,1,0
135793,vs.,1,0
135794,51,1,1
135795,?,1,1
135796,17,1,1
135797,mg/dl,1,0
135798,;,1,0
135799,p,1,0
135800,=,1,1
135801,0.001,1,0
135802,),1,1
135803,.,1,1
135804,Patients,1,1
135805,with,1,1
135806,spotty,1,1
135807,calcification,1,1
135808,demonstrated,1,0
135809,a,0,0
135810,greater,0,0
135811,percent,0,0
135812,atheroma,0,1
135813,volume,0,0
135814,(,0,1
135815,PAV,0,1
135816,),0,1
135817,(,0,1
135818,36.0,0,1
135819,?,0,1
135820,7.6,0,0
135821,%,0,0
135822,vs.,0,0
135823,29.0,0,1
135824,?,0,1
135825,8.5,0,0
135826,%,0,0
135827,;,0,0
135828,p,0,0
135829,<,0,0
135830,0.001,0,0
135831,),0,1
135832,and,0,1
135833,total,0,1
135834,atheroma,0,1
135835,volume,0,0
135836,(,0,1
135837,174.6,0,0
135838,?,0,1
135839,71.9,0,0
135840,mm,0,1
135841,(,0,1
135842,3,0,0
135843,),0,1
135844,vs.,0,0
135845,133.9,0,0
135846,?,0,1
135847,64.9,0,0
135848,mm,0,1
135849,(,0,1
135850,3,0,1
135851,),0,1
135852,;,0,0
135853,p,0,0
135854,<,0,0
135855,0.001,0,0
135856,),0,1
135857,.,0,1
135858,On,0,0
135859,serial,0,0
135860,evaluation,0,0
135861,",",0,0
135862,spotty,0,1
135863,calcification,0,1
135864,was,0,0
135865,associated,0,0
135866,with,0,1
135867,greater,0,0
135868,progression,0,0
135869,of,0,0
135870,PAV,0,1
135871,(,0,1
135872,+0.43,0,0
135873,?,0,1
135874,0.07,0,0
135875,%,0,0
135876,vs.,0,0
135877,+0.02,0,0
135878,?,0,1
135879,0.11,0,0
135880,%,0,0
135881,;,0,0
135882,p,0,0
135883,=,0,1
135884,0.002,0,0
135885,),0,1
135886,.,0,1
135887,Although,0,0
135888,intensive,0,1
135889,low-density,0,1
135890,lipoprotein,0,0
135891,cholesterol,0,0
135892,and,0,0
135893,blood,0,0
135894,pressure,0,0
135895,lowering,0,0
135896,therapy,0,0
135897,slowed,0,0
135898,disease,0,1
135899,progression,0,0
135900,",",0,0
135901,these,0,0
135902,efficacies,0,0
135903,were,0,1
135904,attenuated,1,0
135905,in,1,0
135906,patients,1,1
135907,with,1,1
135908,spotty,1,1
135909,calcification,1,1
135910,.,1,1
135911,CONCLUSIONS,1,0
135912,The,0,0
135913,presence,0,0
135914,of,0,0
135915,spotty,0,1
135916,calcification,0,1
135917,is,0,0
135918,associated,0,0
135919,with,0,0
135920,more,0,0
135921,extensive,0,0
135922,and,0,0
135923,diffuse,0,1
135924,coronary,0,1
135925,atherosclerosis,0,1
135926,and,0,1
135927,accelerated,0,0
135928,disease,0,1
135929,progression,0,0
135930,despite,0,0
135931,use,0,0
135932,of,0,1
135933,medical,0,1
135934,therapies,0,1
135935,.,0,1
135936,Teacher-implemented,0,1
135937,joint,0,1
135938,attention,0,0
135939,intervention,0,1
135940,:,0,1
135941,pilot,0,0
135942,randomized,0,1
135943,controlled,0,0
135944,study,0,1
135945,for,0,0
135946,preschoolers,1,1
135947,with,1,1
135948,autism,1,1
135949,.,1,1
135950,OBJECTIVE,0,0
135951,The,0,0
135952,vast,0,0
135953,majority,0,1
135954,of,0,1
135955,children,1,1
135956,with,1,1
135957,an,1,1
135958,autism,1,1
135959,spectrum,1,1
135960,disorder,1,1
135961,(,1,1
135962,ASD,1,1
135963,),1,1
135964,attend,1,1
135965,public,1,1
135966,preschools,1,1
135967,at,0,1
135968,some,0,0
135969,point,0,0
135970,in,0,0
135971,their,0,1
135972,childhood,0,1
135973,.,0,1
135974,Community,0,0
135975,preschool,0,1
135976,practices,0,1
135977,often,0,1
135978,are,0,0
135979,not,0,0
135980,evidence,0,0
135981,based,0,1
135982,",",0,0
135983,and,0,0
135984,almost,0,0
135985,none,0,0
135986,target,0,0
135987,the,0,0
135988,prelinguistic,0,1
135989,core,0,1
135990,deficits,0,1
135991,of,0,1
135992,ASD,0,1
135993,.,0,1
135994,This,0,0
135995,study,0,0
135996,investigated,0,0
135997,the,0,0
135998,effectiveness,0,0
135999,of,0,0
136000,public,1,1
136001,preschool,1,1
136002,teachers,1,1
136003,implementing,0,0
136004,a,0,1
136005,validated,0,0
136006,intervention,0,0
136007,(,0,0
136008,the,0,0
136009,Joint,0,0
136010,Attention,0,0
136011,and,0,1
136012,Symbolic,0,1
136013,Play/Engagement,0,0
136014,and,0,1
136015,Regulation,0,0
136016,intervention,0,1
136017,;,0,1
136018,JASP/ER,0,0
136019,),0,1
136020,on,0,0
136021,a,0,1
136022,core,0,0
136023,deficit,0,1
136024,of,0,0
136025,autism,0,1
136026,",",0,0
136027,initiating,0,0
136028,joint,0,1
136029,attention,0,0
136030,.,0,1
136031,METHOD,0,0
136032,Sixteen,1,1
136033,dyads,1,1
136034,(,1,1
136035,preschoolers,1,1
136036,with,1,1
136037,ASD,1,1
136038,and,1,1
136039,the,1,0
136040,public,1,1
136041,school,1,1
136042,teachers,1,1
136043,who,1,1
136044,worked,1,1
136045,in,1,1
136046,the,1,0
136047,child,1,1
136048,'s,1,1
136049,classroom,1,1
136050,),1,1
136051,were,0,0
136052,randomly,0,1
136053,assigned,0,1
136054,to,0,0
136055,the,0,0
136056,6-week,0,0
136057,JASP/ER,0,0
136058,intervention,0,0
136059,or,0,1
136060,a,0,0
136061,control,0,1
136062,group,0,1
136063,.,0,1
136064,RESULTS,0,0
136065,At,0,0
136066,the,0,0
136067,end,0,0
136068,of,0,0
136069,the,0,0
136070,intervention,0,0
136071,",",0,0
136072,JASP/ER,0,0
136073,teachers,0,1
136074,used,0,0
136075,more,0,0
136076,JASP/ER,0,0
136077,strategies,0,0
136078,than,0,0
136079,the,0,1
136080,control,0,1
136081,teachers,0,1
136082,",",0,1
136083,and,0,1
136084,JASP/ER,0,0
136085,preschoolers,0,1
136086,used,0,0
136087,more,0,0
136088,joint,0,0
136089,attention,0,0
136090,in,0,0
136091,their,0,1
136092,classroom,0,0
136093,than,0,0
136094,control,0,1
136095,children,0,1
136096,.,0,1
136097,Additionally,0,0
136098,",",0,0
136099,JASP/ER,0,0
136100,children,0,1
136101,spent,0,0
136102,more,0,0
136103,time,0,0
136104,in,0,0
136105,supported,0,0
136106,engagement,0,0
136107,and,0,0
136108,less,0,0
136109,time,0,0
136110,in,0,0
136111,object,0,1
136112,engagement,0,1
136113,than,0,0
136114,control,0,1
136115,preschoolers,0,1
136116,on,0,0
136117,a,0,1
136118,taped,0,0
136119,play,0,0
136120,interaction,0,0
136121,.,0,1
136122,CONCLUSIONS,0,0
136123,Findings,0,0
136124,suggest,0,0
136125,that,0,0
136126,teachers,1,1
136127,were,0,1
136128,able,0,0
136129,to,0,0
136130,improve,0,0
136131,a,0,0
136132,core,0,0
136133,deficit,0,1
136134,of,0,0
136135,children,1,1
136136,with,1,1
136137,ASD,1,1
136138,in,1,1
136139,a,1,1
136140,public,1,1
136141,preschool,1,1
136142,context,0,0
136143,.,0,1
136144,Long-term,0,1
136145,decrease,0,0
136146,in,0,0
136147,bladder,0,1
136148,cancer,0,1
136149,recurrence,0,0
136150,with,0,1
136151,hexaminolevulinate,0,1
136152,enabled,0,0
136153,fluorescence,0,0
136154,cystoscopy,0,0
136155,.,0,1
136156,PURPOSE,0,0
136157,We,0,0
136158,assessed,0,0
136159,the,0,0
136160,impact,0,0
136161,of,0,0
136162,hexaminolevulinate,0,1
136163,fluorescence,0,0
136164,cystoscopic,0,0
136165,detection,0,0
136166,of,0,0
136167,papillary,0,1
136168,",",0,1
136169,nonmuscle,0,1
136170,invasive,0,1
136171,bladder,0,1
136172,cancer,0,1
136173,on,0,0
136174,the,0,0
136175,long-term,0,0
136176,recurrence,0,0
136177,rate,0,0
136178,.,0,1
136179,MATERIALS,0,0
136180,AND,0,0
136181,METHODS,0,0
136182,Long-term,1,1
136183,followup,1,1
136184,was,1,0
136185,assessed,1,0
136186,in,1,1
136187,551,1,1
136188,participants,1,1
136189,enrolled,1,1
136190,in,1,1
136191,a,1,0
136192,prospective,1,1
136193,",",1,0
136194,randomized,1,1
136195,study,1,1
136196,of,1,0
136197,fluorescence,1,0
136198,cystoscopy,1,0
136199,for,1,0
136200,Ta,1,1
136201,or,1,1
136202,T1,1,0
136203,urothelial,1,1
136204,bladder,1,1
136205,cancer,1,1
136206,.,1,1
136207,In,0,0
136208,the,0,0
136209,original,0,1
136210,study,0,1
136211,280,1,1
136212,patients,1,1
136213,in,1,1
136214,the,1,1
136215,white,1,1
136216,light,1,0
136217,cystoscopy,1,0
136218,group,1,1
136219,and,0,1
136220,271,1,1
136221,in,1,0
136222,the,1,0
136223,fluorescence,1,0
136224,cystoscopy,1,0
136225,group,1,1
136226,were,1,0
136227,followed,1,0
136228,with,1,1
136229,cystoscopy,1,0
136230,for,0,1
136231,3,0,1
136232,",",0,1
136233,6,0,0
136234,and,0,1
136235,9,0,1
136236,months,0,0
136237,after,0,1
136238,initial,0,1
136239,resection,0,1
136240,or,0,1
136241,until,0,1
136242,recurrence,0,0
136243,.,0,1
136244,A,0,0
136245,study,0,0
136246,extension,0,0
136247,protocol,0,0
136248,was,0,0
136249,done,0,0
136250,for,0,0
136251,long-term,0,0
136252,followup,0,0
136253,of,0,0
136254,these,0,0
136255,patients,0,1
136256,.,0,1
136257,RESULTS,0,0
136258,Followup,0,1
136259,information,1,0
136260,was,1,0
136261,obtained,1,0
136262,for,1,0
136263,261,1,1
136264,of,1,1
136265,the,1,1
136266,280,1,1
136267,patients,1,1
136268,(,1,1
136269,93,1,1
136270,%,1,0
136271,),1,1
136272,in,1,0
136273,the,1,0
136274,white,1,1
136275,light,1,0
136276,group,1,1
136277,and,0,1
136278,255,1,1
136279,of,1,0
136280,the,1,1
136281,271,1,1
136282,(,1,1
136283,94,1,1
136284,%,1,0
136285,),1,1
136286,in,1,0
136287,the,1,0
136288,fluorescence,1,0
136289,group,1,1
136290,.,1,1
136291,Median,0,0
136292,followup,0,0
136293,in,0,0
136294,the,0,0
136295,white,0,1
136296,light,0,0
136297,and,0,1
136298,fluorescence,0,0
136299,groups,0,1
136300,was,0,0
136301,53.0,0,1
136302,and,0,1
136303,55.1,0,1
136304,months,0,0
136305,",",0,1
136306,and,0,1
136307,83,0,1
136308,(,0,1
136309,31.8,0,1
136310,%,0,0
136311,),0,1
136312,and,0,1
136313,97,0,1
136314,patients,0,1
136315,(,0,1
136316,38,0,1
136317,%,0,0
136318,),0,1
136319,remained,0,0
136320,tumor,0,1
136321,free,0,1
136322,",",0,0
136323,respectively,0,0
136324,.,0,1
136325,Median,0,0
136326,time,0,0
136327,to,0,0
136328,recurrence,0,0
136329,was,0,0
136330,9.4,0,0
136331,months,0,0
136332,in,0,1
136333,the,0,1
136334,white,0,1
136335,light,0,0
136336,group,0,1
136337,and,0,1
136338,16.4,0,1
136339,months,0,0
136340,in,0,1
136341,the,0,0
136342,fluorescence,0,0
136343,group,0,0
136344,(,0,1
136345,p,0,0
136346,=,0,1
136347,0.04,0,0
136348,),0,1
136349,.,0,1
136350,The,0,0
136351,intravesical,0,0
136352,therapy,0,0
136353,rate,0,0
136354,was,0,0
136355,similar,0,0
136356,in,0,0
136357,the,0,1
136358,2,0,1
136359,groups,0,0
136360,(,0,1
136361,46,0,1
136362,%,0,0
136363,and,0,1
136364,45,0,1
136365,%,0,0
136366,",",0,0
136367,respectively,0,0
136368,),0,1
136369,.,0,1
136370,Cystectomy,0,1
136371,was,0,0
136372,done,0,1
136373,in,0,0
136374,22,0,1
136375,of,0,1
136376,280,0,1
136377,cases,0,1
136378,(,0,1
136379,7.9,0,1
136380,%,0,0
136381,),0,1
136382,in,0,0
136383,the,0,0
136384,white,0,1
136385,light,0,0
136386,group,0,1
136387,and,0,1
136388,in,0,0
136389,13,0,1
136390,of,0,1
136391,the,0,1
136392,271,0,1
136393,(,0,1
136394,4.8,0,0
136395,%,0,0
136396,),0,1
136397,in,0,0
136398,the,0,0
136399,fluorescence,0,0
136400,group,0,0
136401,(,0,1
136402,p,0,0
136403,=,0,1
136404,0.16,0,0
136405,),0,1
136406,.,0,1
136407,CONCLUSIONS,0,0
136408,Hexaminolevulinate,0,1
136409,fluorescence,0,0
136410,cystoscopy,0,0
136411,significantly,0,0
136412,improves,0,0
136413,long-term,0,0
136414,bladder,0,1
136415,cancer,0,1
136416,time,0,0
136417,to,0,0
136418,recurrence,0,0
136419,with,0,1
136420,a,0,0
136421,trend,0,0
136422,toward,0,0
136423,improved,0,0
136424,bladder,0,1
136425,preservation,0,0
136426,.,0,1
136427,The,0,0
136428,effect,0,0
136429,of,0,0
136430,the,0,0
136431,PostureJac,0,1
136432,on,0,0
136433,deep,0,1
136434,cervical,0,1
136435,flexor,0,1
136436,endurance,0,1
136437,:,0,1
136438,implications,0,0
136439,in,0,0
136440,the,0,0
136441,management,0,0
136442,of,0,0
136443,cervicogenic,0,1
136444,headache,0,1
136445,and,0,1
136446,mechanical,0,1
136447,neck,0,1
136448,pain,0,1
136449,.,0,1
136450,The,0,0
136451,convergence,0,0
136452,of,0,0
136453,cervical,0,1
136454,and,0,1
136455,trigeminal,0,1
136456,afferents,0,1
136457,on,0,1
136458,second-order,0,1
136459,neurons,0,1
136460,in,0,1
136461,the,0,1
136462,trigeminocervical,0,0
136463,nucleus,0,0
136464,may,0,0
136465,refer,0,0
136466,pain,0,0
136467,from,0,0
136468,the,0,0
136469,upper,0,1
136470,cervical,0,1
136471,spine,0,1
136472,into,0,1
136473,the,0,0
136474,head,0,1
136475,and,0,0
136476,face,0,0
136477,.,0,1
136478,Furthermore,0,0
136479,",",0,0
136480,bi-directional,0,0
136481,interactions,0,0
136482,between,0,1
136483,trigeminal,0,1
136484,and,0,1
136485,upper,0,1
136486,cervical,0,1
136487,afferents,0,1
136488,may,0,0
136489,also,0,0
136490,explain,0,0
136491,neck,0,1
136492,symptoms,0,0
136493,of,0,1
136494,trigeminal,0,1
136495,origin,0,1
136496,(,0,1
136497,e.g.,0,0
136498,",",0,1
136499,migraine,0,1
136500,),0,1
136501,.,0,0
136502,It,0,0
136503,is,0,0
136504,known,0,0
136505,that,0,0
136506,cervicogenic,0,1
136507,headache,0,1
136508,sufferers,0,1
136509,present,0,1
136510,with,0,1
136511,several,0,1
136512,musculoskeletal,0,1
136513,changes,0,0
136514,including,0,1
136515,poor,0,1
136516,endurance,0,0
136517,of,0,0
136518,the,0,0
136519,deep,0,1
136520,cervical,0,1
136521,flexor,0,1
136522,muscles,0,1
136523,.,0,1
136524,These,0,1
136525,intrinsic,0,0
136526,muscles,0,1
136527,of,0,1
136528,the,0,0
136529,neck,0,1
136530,contribute,0,0
136531,to,0,0
136532,stabilization,0,0
136533,and,0,0
136534,protection,0,0
136535,of,0,0
136536,the,0,0
136537,cervical,0,1
136538,spine,0,1
136539,and,0,1
136540,are,0,0
136541,critical,0,0
136542,for,0,0
136543,the,0,0
136544,control,0,0
136545,of,0,0
136546,both,0,0
136547,intervertebral,0,1
136548,motion,0,0
136549,and,0,0
136550,the,0,0
136551,cervical,0,1
136552,lordosis,0,0
136553,.,0,1
136554,The,0,0
136555,purpose,0,0
136556,of,0,0
136557,this,0,0
136558,study,0,0
136559,was,0,0
136560,to,0,0
136561,determine,0,0
136562,whether,0,0
136563,the,0,0
136564,use,0,0
136565,of,0,0
136566,the,0,0
136567,PostureJac,0,1
136568,(,0,1
136569,SomatoCentric,0,1
136570,Systems,0,1
136571,",",0,0
136572,Inc.,0,0
136573,",",0,0
136574,Toronto,0,1
136575,",",0,0
136576,Ontario,0,1
136577,",",0,0
136578,Canada,0,1
136579,),0,0
136580,",",0,0
136581,a,0,0
136582,posture,0,0
136583,support,0,0
136584,and,0,0
136585,exercise,0,0
136586,jacket,0,0
136587,",",0,0
136588,was,0,0
136589,effective,0,0
136590,in,0,0
136591,enhancing,0,0
136592,deep,0,1
136593,cervical,0,1
136594,muscle,0,0
136595,endurance,0,1
136596,.,0,1
136597,Forty-five,1,1
136598,(,1,1
136599,45,1,1
136600,),1,1
136601,female,1,1
136602,subjects,1,1
136603,",",1,0
136604,between,1,0
136605,the,1,0
136606,ages,1,1
136607,of,1,1
136608,18,1,1
136609,and,1,1
136610,40,1,1
136611,years,1,1
136612,",",0,1
136613,were,0,1
136614,randomly,0,1
136615,assigned,0,1
136616,to,0,1
136617,three,0,1
136618,groups,0,0
136619,consisting,0,1
136620,of,0,0
136621,the,0,0
136622,no-treatment,1,0
136623,control,1,0
136624,",",1,0
136625,the,1,0
136626,treatment-control,1,1
136627,(,1,0
136628,table,1,0
136629,stabilization,1,0
136630,),1,1
136631,",",1,0
136632,and,1,0
136633,the,1,0
136634,experimental,1,0
136635,(,1,1
136636,PostureJac,1,1
136637,),1,1
136638,group,1,1
136639,.,1,1
136640,The,0,0
136641,outcome,0,0
136642,measure,0,0
136643,of,0,0
136644,deep,0,1
136645,cervical,0,1
136646,flexor,0,1
136647,muscle,0,0
136648,endurance,0,0
136649,was,0,0
136650,based,0,1
136651,on,0,0
136652,the,0,0
136653,Flexor,0,0
136654,Endurance,0,1
136655,Test,0,0
136656,and,0,1
136657,was,0,0
136658,recorded,0,0
136659,in,0,1
136660,seconds,0,0
136661,.,0,1
136662,The,0,0
136663,results,0,0
136664,indicated,0,0
136665,that,0,0
136666,the,0,0
136667,PostureJac,1,1
136668,group,1,1
136669,was,0,0
136670,superior,0,0
136671,to,0,1
136672,the,0,0
136673,no-treatment,1,0
136674,control,1,1
136675,(,1,1
136676,p=.001,1,0
136677,),1,1
136678,and,1,0
136679,the,1,0
136680,treatment-control,1,1
136681,(,1,0
136682,p=.004,1,0
136683,),1,1
136684,groups,1,1
136685,in,0,1
136686,terms,0,0
136687,of,0,1
136688,increasing,0,0
136689,endurance,0,0
136690,of,0,0
136691,the,0,0
136692,deep,0,1
136693,cervical,0,1
136694,flexors,0,1
136695,.,0,1
136696,Consequently,0,0
136697,",",0,0
136698,the,0,0
136699,PostureJac,0,0
136700,may,0,0
136701,be,0,0
136702,a,0,0
136703,useful,0,0
136704,therapeutic,0,0
136705,tool,0,0
136706,in,0,0
136707,the,0,0
136708,management,0,0
136709,of,0,0
136710,cervicogenic,0,1
136711,headache,0,1
136712,and,0,1
136713,mechanical,0,1
136714,neck,0,1
136715,pain,0,1
136716,.,0,1
136717,Healthcare,0,1
136718,costs,0,0
136719,around,0,0
136720,the,0,0
136721,time,0,0
136722,of,0,0
136723,smoking,0,1
136724,cessation,0,0
136725,.,0,1
136726,BACKGROUND,0,0
136727,The,0,0
136728,Affordable,0,1
136729,Care,0,0
136730,Act,0,0
136731,mandates,0,1
136732,that,0,0
136733,new,0,1
136734,insurance,0,1
136735,plans,0,1
136736,cover,0,1
136737,smoking-cessation,0,1
136738,therapy,0,0
136739,without,0,1
136740,cost-sharing,0,1
136741,.,0,1
136742,Previous,0,0
136743,cost,0,0
136744,difference,0,0
136745,estimates,0,0
136746,",",0,0
136747,which,0,0
136748,show,0,0
136749,a,0,0
136750,spike,0,0
136751,around,0,0
136752,the,0,0
136753,time,0,0
136754,of,0,0
136755,cessation,0,0
136756,",",0,1
136757,suggest,0,0
136758,premiums,0,0
136759,might,0,0
136760,rise,0,0
136761,as,0,0
136762,a,0,0
136763,result,0,0
136764,of,0,0
136765,covering,0,1
136766,these,0,0
136767,services,0,1
136768,.,0,1
136769,PURPOSE,0,0
136770,The,0,0
136771,goal,0,0
136772,of,0,0
136773,the,0,0
136774,study,0,0
136775,was,0,0
136776,to,0,0
136777,test,0,0
136778,(,0,1
136779,1,0,0
136780,),0,1
136781,whether,0,0
136782,individuals,1,1
136783,in,1,1
136784,an,1,1
136785,RCT,1,0
136786,of,1,0
136787,pharmacotherapy,1,1
136788,and,1,0
136789,counseling,1,0
136790,for,1,0
136791,smoking,1,1
136792,cessation,1,0
136793,differed,0,0
136794,in,0,0
136795,their,0,0
136796,healthcare,0,0
136797,costs,0,0
136798,around,0,0
136799,the,0,0
136800,cessation,0,0
136801,period,0,0
136802,",",0,0
136803,and,0,0
136804,(,0,1
136805,2,0,1
136806,),0,1
136807,whether,0,0
136808,the,0,0
136809,healthcare,0,1
136810,costs,0,0
136811,of,0,0
136812,those,0,1
136813,in,0,0
136814,the,0,1
136815,trial,0,1
136816,who,0,1
136817,successfully,0,1
136818,quit,0,1
136819,were,0,0
136820,different,0,0
136821,from,0,1
136822,a,0,1
136823,matched,0,1
136824,sample,0,1
136825,of,0,1
136826,smokers,0,1
136827,in,0,1
136828,the,0,1
136829,community,0,1
136830,.,0,1
136831,METHODS,0,0
136832,Generalized,0,1
136833,linear,0,0
136834,regression,0,0
136835,models,0,1
136836,were,0,1
136837,used,0,0
136838,to,0,0
136839,analyze,0,0
136840,healthcare,0,1
136841,cost,0,0
136842,data,0,0
136843,on,0,1
136844,individuals,1,1
136845,enrolled,1,1
136846,in,1,1
136847,a,1,1
136848,comparative,1,0
136849,effectiveness,1,0
136850,trial,1,0
136851,of,1,0
136852,cessation,1,1
136853,therapies,1,0
136854,between,1,1
136855,October,1,1
136856,2005,1,1
136857,and,1,1
136858,May,1,0
136859,2007,1,1
136860,(,1,1
136861,1346,1,1
136862,total,1,1
136863,participants,1,1
136864,;,1,1
136865,1338,1,1
136866,with,1,1
136867,requisite,1,1
136868,data,1,0
136869,for,1,1
136870,further,1,1
136871,analysis,1,1
136872,),1,1
136873,.,1,1
136874,Cost,0,0
136875,differences,0,0
136876,for,0,0
136877,the,0,0
136878,period,0,0
136879,preceding,0,0
136880,and,0,1
136881,subsequent,0,0
136882,to,0,0
136883,the,0,0
136884,cessation,0,0
136885,attempt,0,0
136886,were,0,0
136887,assessed,0,0
136888,by,0,0
136889,trial,0,1
136890,participants,0,1
136891,',0,1
136892,12-month,0,1
136893,sustained,0,1
136894,quit,0,1
136895,status,0,1
136896,.,0,1
136897,Healthcare,0,0
136898,cost,0,0
136899,differences,0,0
136900,between,0,0
136901,sustained,0,1
136902,quitters,0,1
136903,and,0,1
136904,a,0,1
136905,sample,0,1
136906,of,0,0
136907,community-dwelling,0,1
136908,smokers,0,1
136909,",",0,1
136910,matched,0,1
136911,to,0,0
136912,these,0,0
136913,quitters,0,0
136914,on,0,0
136915,the,0,0
136916,basis,0,0
136917,of,0,0
136918,health,0,1
136919,services,0,1
136920,use,0,0
136921,around,0,0
136922,the,0,0
136923,time,0,0
136924,trial,0,0
136925,participant,0,0
136926,enrolled,0,1
136927,and,0,1
136928,by,0,0
136929,demographics,0,0
136930,",",0,1
136931,were,0,1
136932,also,0,0
136933,examined,0,0
136934,.,0,1
136935,Data,0,0
136936,were,0,0
136937,analyzed,0,0
136938,in,0,1
136939,2011,0,1
136940,.,0,1
136941,RESULTS,0,0
136942,All,0,1
136943,three,0,0
136944,groups,0,0
136945,had,0,1
136946,a,0,1
136947,spike,0,0
136948,in,0,0
136949,cost,0,0
136950,associated,0,0
136951,with,0,1
136952,the,0,0
136953,index,0,0
136954,clinic,0,1
136955,visit,0,1
136956,.,0,1
136957,Regression,0,0
136958,results,0,0
136959,revealed,0,0
136960,little,0,0
136961,difference,0,0
136962,in,0,1
136963,healthcare,0,1
136964,costs,0,1
136965,by,0,0
136966,quit,0,1
136967,status,0,1
136968,for,0,0
136969,trial,0,1
136970,participants,0,1
136971,until,0,1
136972,the,0,1
136973,sixth,0,0
136974,quarter,0,1
136975,post-quit,0,0
136976,.,0,1
136977,By,0,0
136978,that,0,0
136979,quarter,0,1
136980,",",0,0
136981,continuous,0,0
136982,sustained,0,1
136983,quitters,0,1
136984,cost,0,0
136985,$,0,1
136986,541,0,1
136987,(,0,0
136988,p,0,0
136989,<,0,0
136990,0.001,0,0
136991,),0,0
136992,less,0,0
136993,than,0,0
136994,continuing,0,0
136995,smokers,0,1
136996,.,0,1
136997,Continuous,0,0
136998,sustained,0,1
136999,quitters,0,0
137000,cost,0,0
137001,less,0,0
137002,than,0,0
137003,their,0,1
137004,matched,0,1
137005,community-,0,1
137006,dwelling,0,1
137007,smokers,0,1
137008,in,0,1
137009,almost,0,1
137010,every,0,0
137011,quarter,0,1
137012,observed,0,0
137013,.,0,1
137014,The,0,0
137015,cost,0,0
137016,difference,0,0
137017,ranged,0,0
137018,from,0,1
137019,$,0,1
137020,270,0,1
137021,(,0,1
137022,p=0.01,0,0
137023,),0,1
137024,during,0,0
137025,the,0,0
137026,quarter,0,1
137027,of,0,0
137028,quit,0,1
137029,",",0,0
137030,to,0,0
137031,$,0,0
137032,490,0,1
137033,(,0,0
137034,p,0,0
137035,<,0,0
137036,0.01,0,0
137037,),0,0
137038,in,0,0
137039,the,0,0
137040,6th,0,0
137041,quarter,0,1
137042,after,0,1
137043,quitting,0,1
137044,.,0,1
137045,CONCLUSIONS,0,0
137046,The,0,0
137047,inclusion,0,0
137048,of,0,0
137049,smoking-cessation,0,1
137050,therapy,0,0
137051,does,0,0
137052,not,0,0
137053,appear,0,0
137054,to,0,0
137055,raise,0,0
137056,short-term,0,0
137057,healthcare,0,1
137058,costs,0,1
137059,.,0,1
137060,By,0,0
137061,the,0,0
137062,sixth,0,0
137063,quarter,0,1
137064,post-quit,0,0
137065,",",0,0
137066,sustained,0,1
137067,quitters,0,0
137068,were,0,0
137069,less,0,0
137070,costly,0,0
137071,than,0,0
137072,trial,0,1
137073,participants,0,1
137074,who,0,1
137075,continued,0,1
137076,smoking,0,1
137077,.,0,1
137078,Phase,0,1
137079,II,0,1
137080,multi-institutional,0,1
137081,prospective,0,1
137082,randomised,0,1
137083,trial,0,0
137084,comparing,0,0
137085,S-1+paclitaxel,0,1
137086,with,0,1
137087,S-1+cisplatin,0,0
137088,in,0,1
137089,patients,1,1
137090,with,1,1
137091,unresectable,1,1
137092,and/or,1,1
137093,recurrent,1,1
137094,advanced,1,1
137095,gastric,1,1
137096,cancer,1,1
137097,.,1,1
137098,BACKGROUND,0,0
137099,A,0,0
137100,combination,0,0
137101,of,0,0
137102,S-1,0,0
137103,and,0,0
137104,cisplatin,0,0
137105,has,0,0
137106,been,0,0
137107,shown,0,0
137108,to,0,0
137109,be,0,0
137110,effective,0,0
137111,with,0,1
137112,acceptable,0,0
137113,safety,0,0
137114,for,0,0
137115,the,0,0
137116,first-line,0,0
137117,treatment,0,0
137118,of,0,0
137119,far-advanced,0,1
137120,gastric,0,1
137121,cancer,0,1
137122,in,0,1
137123,Japan,0,1
137124,.,0,1
137125,This,0,0
137126,is,0,0
137127,the,0,0
137128,first,0,0
137129,randomised,0,1
137130,phase,0,1
137131,II,0,1
137132,trial,0,0
137133,to,0,0
137134,compare,0,0
137135,S-1+paclitaxel,0,0
137136,with,0,1
137137,S-1+cisplatin,0,0
137138,in,0,0
137139,this,0,0
137140,setting,0,1
137141,.,0,1
137142,METHODS,0,0
137143,Patients,1,1
137144,with,1,1
137145,unresectable,1,1
137146,and/or,1,1
137147,recurrent,1,1
137148,advanced,1,1
137149,gastric,1,1
137150,cancer,1,1
137151,were,1,1
137152,randomly,1,1
137153,assigned,1,1
137154,to,1,0
137155,receive,1,1
137156,one,1,1
137157,of,1,0
137158,the,1,1
137159,two,1,1
137160,regimens,1,0
137161,:,1,1
137162,S-1,1,0
137163,(,1,1
137164,40,1,1
137165,mg,1,1
137166,m,1,1
137167,(,1,1
137168,-2,1,0
137169,),1,0
137170,twice,1,0
137171,daily,1,0
137172,),1,0
137173,on,1,0
137174,days,1,0
137175,1-14,1,1
137176,plus,1,0
137177,paclitaxel,1,1
137178,(,1,1
137179,60,1,1
137180,mg,1,1
137181,m,1,1
137182,(,1,1
137183,-2,1,1
137184,),1,1
137185,),1,1
137186,on,1,1
137187,days,1,0
137188,1,1,1
137189,",",1,1
137190,8,1,0
137191,",",1,0
137192,and,1,0
137193,15,1,1
137194,of,1,0
137195,a,1,1
137196,4-week,1,0
137197,cycle,1,0
137198,(,1,1
137199,S-1+paclitaxel,1,1
137200,),1,1
137201,or,1,1
137202,S-1,1,0
137203,(,1,1
137204,40,1,1
137205,mg,1,1
137206,m,1,1
137207,(,1,1
137208,-2,1,0
137209,),1,0
137210,twice,1,0
137211,daily,1,0
137212,),1,0
137213,on,1,0
137214,days,1,0
137215,1-21,1,1
137216,plus,1,0
137217,cisplatin,1,0
137218,(,1,1
137219,60,1,1
137220,mg,1,1
137221,m,1,1
137222,(,1,1
137223,-2,1,1
137224,),1,1
137225,),1,1
137226,on,1,0
137227,day,1,0
137228,8,1,1
137229,of,1,0
137230,a,1,1
137231,5-week,1,0
137232,cycle,1,0
137233,(,1,1
137234,S-1+cisplatin,1,0
137235,),1,1
137236,.,1,1
137237,The,0,0
137238,primary,0,0
137239,end,0,0
137240,point,0,0
137241,was,0,0
137242,the,0,0
137243,response,0,0
137244,rate,0,0
137245,(,0,1
137246,RR,0,1
137247,),0,1
137248,.,0,1
137249,Secondary,0,0
137250,end,0,0
137251,points,0,0
137252,included,0,1
137253,progression-free,0,0
137254,survival,0,0
137255,(,0,1
137256,PFS,0,1
137257,),0,1
137258,",",0,0
137259,overall,0,0
137260,survival,0,0
137261,(,0,1
137262,OS,0,0
137263,),0,1
137264,",",0,0
137265,and,0,0
137266,safety,0,0
137267,.,0,0
137268,RESULTS,0,0
137269,A,0,0
137270,total,0,1
137271,of,0,0
137272,83,1,1
137273,patients,1,1
137274,were,0,1
137275,eligible,0,1
137276,for,0,0
137277,safety,0,0
137278,and,0,1
137279,efficacy,0,0
137280,analyses,0,0
137281,.,0,1
137282,In,0,0
137283,the,0,0
137284,S-1+paclitaxel,0,0
137285,and,0,1
137286,S-1+cisplatin,0,0
137287,groups,0,0
137288,",",0,1
137289,RRs,0,1
137290,(,0,1
137291,52.3,0,1
137292,%,0,0
137293,vs,0,0
137294,48.7,0,1
137295,%,0,0
137296,;,0,1
137297,P=0.74,0,0
137298,),0,1
137299,and,0,1
137300,median,0,1
137301,PFS,0,1
137302,(,0,1
137303,9,0,0
137304,vs,0,0
137305,6,0,1
137306,months,0,0
137307,;,0,1
137308,P=0.50,0,0
137309,),0,1
137310,were,0,1
137311,similar,0,0
137312,.,0,1
137313,The,0,0
137314,median,0,0
137315,OS,0,0
137316,was,0,0
137317,similar,0,0
137318,in,0,0
137319,the,0,0
137320,S-1+paclitaxel,0,0
137321,and,0,1
137322,S-1+cisplatin,0,0
137323,groups,0,1
137324,(,0,1
137325,16,0,1
137326,vs,0,0
137327,17,0,1
137328,months,0,0
137329,;,0,1
137330,P=0.84,0,0
137331,),0,1
137332,.,0,1
137333,The,0,0
137334,incidence,0,0
137335,of,0,0
137336,grade,0,1
137337,3,0,0
137338,or,0,1
137339,higher,0,0
137340,haematological,0,1
137341,toxicity,0,0
137342,was,0,0
137343,19.0,0,0
137344,%,0,0
137345,with,0,1
137346,S-1+paclitaxel,0,1
137347,and,0,1
137348,19.5,0,0
137349,%,0,0
137350,with,0,1
137351,S-1+cisplatin,0,0
137352,.,0,1
137353,The,0,0
137354,incidence,0,0
137355,of,0,0
137356,grade,0,1
137357,3,0,0
137358,or,0,1
137359,higher,0,0
137360,non-haematological,0,1
137361,toxicity,0,0
137362,was,0,0
137363,14.2,0,0
137364,%,0,0
137365,with,0,1
137366,S-1+paclitaxel,0,1
137367,and,0,1
137368,17.1,0,0
137369,%,0,0
137370,with,0,1
137371,S-1+cisplatin,0,0
137372,.,0,1
137373,CONCLUSION,0,0
137374,S-1+paclitaxel,0,0
137375,was,0,0
137376,suggested,0,0
137377,to,0,0
137378,be,0,0
137379,a,0,0
137380,feasible,0,0
137381,and,0,0
137382,effective,0,0
137383,non-platinum-based,0,1
137384,regimen,0,1
137385,for,0,1
137386,chemotherapy,0,1
137387,in,0,1
137388,patients,1,1
137389,with,1,1
137390,advanced,1,1
137391,gastric,1,1
137392,cancer,1,1
137393,.,1,1
137394,Our,0,0
137395,results,0,0
137396,should,0,0
137397,be,0,0
137398,confirmed,0,0
137399,in,0,0
137400,multicenter,0,0
137401,",",0,0
137402,phase,0,1
137403,III-controlled,0,0
137404,clinical,0,0
137405,trials,0,1
137406,.,0,1
137407,[,0,1
137408,Effect,0,0
137409,of,0,0
137410,probucol,0,1
137411,on,0,0
137412,serum,0,0
137413,malondialdehyde,0,0
137414,and,0,0
137415,superoxide,0,0
137416,dismutase,0,0
137417,in,0,1
137418,patients,1,1
137419,with,1,1
137420,primary,1,1
137421,hypertension,1,1
137422,],1,1
137423,.,0,1
137424,OBJECTIVE,0,0
137425,To,0,0
137426,observe,0,0
137427,the,0,0
137428,therapeutic,0,0
137429,effect,0,0
137430,of,0,0
137431,probucol,0,1
137432,on,0,0
137433,serum,0,0
137434,malondialdehyde,0,0
137435,(,0,1
137436,MDA,0,1
137437,),0,1
137438,and,0,1
137439,superoxide,0,0
137440,dismutase,0,0
137441,(,0,1
137442,SOD,0,1
137443,),0,1
137444,in,0,1
137445,patients,1,1
137446,with,1,1
137447,primary,1,1
137448,hypertension,1,1
137449,.,1,1
137450,METHODS,0,0
137451,A,0,1
137452,randomized,0,1
137453,study,0,1
137454,was,0,0
137455,performed,0,0
137456,on,0,0
137457,40,1,1
137458,patients,1,1
137459,with,1,1
137460,hypertension,1,1
137461,.,1,1
137462,The,0,0
137463,patients,0,1
137464,were,0,1
137465,randomly,0,1
137466,assigned,0,1
137467,to,0,0
137468,the,0,0
137469,control,0,0
137470,(,0,0
137471,levamlodipine,0,0
137472,besylate,0,1
137473,2.5,0,0
137474,mg/d,0,0
137475,plus,0,0
137476,benazepril,0,1
137477,10,0,1
137478,mg/d,0,0
137479,",",0,0
137480,n=20,0,1
137481,),0,1
137482,or,0,1
137483,probucol,0,1
137484,group,0,1
137485,(,0,1
137486,levamlodipine,0,0
137487,besylate,0,1
137488,2.5,0,0
137489,mg/d,0,0
137490,plus,0,0
137491,benazepril,0,1
137492,10,0,1
137493,mg/d,0,0
137494,plus,0,0
137495,probucol,0,1
137496,500,0,1
137497,mg/d,0,0
137498,",",0,0
137499,n=20,0,1
137500,),0,1
137501,.,0,1
137502,An,1,0
137503,additional,1,0
137504,twenty,1,1
137505,healthy,1,1
137506,people,1,1
137507,were,1,1
137508,enrolled,1,1
137509,in,1,0
137510,the,1,0
137511,study,1,0
137512,(,1,0
137513,normal,1,1
137514,group,1,1
137515,),1,1
137516,.,1,1
137517,All,0,1
137518,subjects,0,1
137519,were,0,1
137520,followed,0,1
137521,up,0,0
137522,for,0,0
137523,a,0,0
137524,period,0,0
137525,of,0,0
137526,four,0,1
137527,weeks,0,1
137528,.,0,1
137529,Lipids,0,0
137530,and,0,0
137531,hepatic/renal,0,1
137532,function,0,0
137533,were,0,1
137534,measured,0,0
137535,at,0,0
137536,baseline,0,0
137537,and,0,1
137538,after,0,1
137539,4,0,1
137540,weeks,0,1
137541,.,0,1
137542,The,0,0
137543,levels,0,0
137544,of,0,0
137545,serum,0,1
137546,MDA,0,1
137547,and,0,1
137548,SOD,0,1
137549,activity,0,0
137550,were,0,0
137551,assayed,0,0
137552,by,0,0
137553,chemical,0,1
137554,colorimetry,0,0
137555,",",0,0
137556,and,0,0
137557,other,0,0
137558,indices,0,0
137559,",",0,1
137560,including,0,0
137561,blood,0,0
137562,pressure,0,0
137563,",",0,1
137564,lipids,0,0
137565,and,0,1
137566,hepatic/renal,0,1
137567,function,0,0
137568,",",0,0
137569,were,0,0
137570,measured,0,0
137571,at,0,0
137572,baseline,0,0
137573,and,0,1
137574,after,0,1
137575,4,0,1
137576,weeks,0,1
137577,.,0,1
137578,RESULTS,0,0
137579,Compared,0,0
137580,to,0,0
137581,the,0,0
137582,normal,0,1
137583,group,0,0
137584,",",0,0
137585,the,0,0
137586,levels,0,0
137587,of,0,0
137588,MDA,0,1
137589,in,0,0
137590,all,0,0
137591,of,0,0
137592,the,0,0
137593,hypertension,1,1
137594,patient,1,1
137595,groups,0,0
137596,were,0,1
137597,higher,0,0
137598,",",0,0
137599,SOD,0,0
137600,was,0,0
137601,lower,0,0
137602,.,0,1
137603,The,0,0
137604,antihypertensive,0,0
137605,treatment,0,0
137606,decreased,0,0
137607,serum,0,0
137608,MDA,0,1
137609,levels,0,0
137610,but,0,0
137611,increased,0,0
137612,SOD,0,0
137613,content,0,0
137614,",",0,0
137615,and,0,0
137616,probucol,0,0
137617,treatment,0,0
137618,exaggerated,0,0
137619,these,0,0
137620,effects,0,0
137621,",",0,0
137622,with,0,1
137623,greater,0,0
137624,reduction,0,0
137625,of,0,0
137626,serum,0,0
137627,MDA,0,1
137628,levels,0,0
137629,and,0,1
137630,greater,0,0
137631,increase,0,0
137632,of,0,0
137633,SOD,0,1
137634,content,0,0
137635,.,0,1
137636,CONCLUSION,0,0
137637,The,0,0
137638,treatment,0,0
137639,with,0,1
137640,probucol,0,0
137641,can,0,0
137642,improve,0,0
137643,oxidative,0,0
137644,stress,0,0
137645,in,0,1
137646,hypertension,1,1
137647,patients,1,1
137648,",",0,0
137649,resulting,0,0
137650,in,0,0
137651,reduced,0,0
137652,serum,0,0
137653,MDA,0,1
137654,levels,0,0
137655,and,0,1
137656,improved,0,0
137657,SOD,0,0
137658,activity,0,0
137659,",",0,0
137660,thus,0,0
137661,contributing,0,0
137662,agreater,0,0
137663,antihypertensive,0,0
137664,effect,0,0
137665,.,0,1
137666,Impact,0,0
137667,of,0,0
137668,an,0,1
137669,Asha,0,0
137670,intervention,0,0
137671,on,0,0
137672,depressive,0,1
137673,symptoms,0,1
137674,among,0,1
137675,rural,1,1
137676,women,1,1
137677,living,1,1
137678,with,1,1
137679,AIDS,1,1
137680,in,1,1
137681,India,1,1
137682,:,1,1
137683,comparison,0,0
137684,of,0,0
137685,the,0,0
137686,Asha-Life,0,0
137687,and,0,0
137688,Usual,0,0
137689,Care,0,1
137690,program,0,1
137691,.,0,1
137692,The,0,0
137693,purpose,0,0
137694,of,0,0
137695,this,0,0
137696,randomized,0,1
137697,pilot,0,0
137698,study,0,0
137699,is,0,0
137700,to,0,0
137701,conduct,0,0
137702,an,0,0
137703,intervention,0,0
137704,with,0,1
137705,68,1,1
137706,rural,1,1
137707,women,1,1
137708,living,1,1
137709,with,1,1
137710,AIDS,1,1
137711,to,0,0
137712,compare,0,0
137713,the,0,0
137714,effectiveness,0,0
137715,of,0,0
137716,two,0,1
137717,different,0,1
137718,programs,0,1
137719,on,0,1
137720,depressive,0,1
137721,symptoms,0,1
137722,.,0,1
137723,The,0,0
137724,trial,0,0
137725,was,0,0
137726,designed,0,0
137727,to,0,0
137728,assess,0,0
137729,the,0,0
137730,impact,0,0
137731,of,0,0
137732,the,0,0
137733,Asha-Life,0,0
137734,intervention,0,0
137735,engaging,0,1
137736,with,0,1
137737,an,0,1
137738,HIV-trained,0,1
137739,village,0,1
137740,woman,0,1
137741,",",0,0
137742,Asha,0,0
137743,(,0,1
137744,Accredited,0,1
137745,Social,0,1
137746,Health,0,0
137747,Activist,0,1
137748,),0,1
137749,",",0,0
137750,to,0,0
137751,participate,0,1
137752,in,0,0
137753,the,0,0
137754,care,0,1
137755,of,0,0
137756,women,0,1
137757,living,0,1
137758,with,0,1
137759,AIDS,0,1
137760,(,0,1
137761,WLA,0,0
137762,),0,1
137763,",",0,0
137764,along,0,0
137765,with,0,1
137766,other,0,1
137767,health,0,1
137768,care,0,1
137769,providers,0,1
137770,compared,0,0
137771,to,0,1
137772,a,0,1
137773,Usual,0,0
137774,Care,0,1
137775,group,0,1
137776,.,0,1
137777,Two,1,1
137778,high,1,1
137779,prevalence,1,1
137780,HIV/AIDS,1,1
137781,villages,1,1
137782,in,1,1
137783,rural,1,1
137784,Andhra,1,1
137785,Pradesh,1,1
137786,",",1,0
137787,which,1,0
137788,were,1,0
137789,demographically,1,1
137790,alike,1,0
137791,and,1,0
137792,served,1,1
137793,by,1,0
137794,distinct,1,0
137795,Public,1,1
137796,Health,1,0
137797,Centers,1,1
137798,",",1,0
137799,were,1,0
137800,selected,1,1
137801,randomly,1,1
137802,from,1,0
137803,a,1,0
137804,total,1,1
137805,of,1,0
137806,16,1,1
137807,villages,1,1
137808,.,1,1
137809,The,0,0
137810,findings,0,0
137811,of,0,0
137812,this,0,0
137813,study,0,0
137814,demonstrated,0,0
137815,that,0,0
137816,the,0,0
137817,Asha-Life,0,0
137818,participants,0,1
137819,significantly,0,0
137820,reduced,0,0
137821,their,0,0
137822,depressive,0,1
137823,symptom,0,1
137824,scores,0,0
137825,compared,0,0
137826,to,0,1
137827,the,0,0
137828,Usual,0,0
137829,Care,0,1
137830,participants,0,1
137831,.,0,1
137832,Moreover,0,0
137833,",",0,0
137834,women,1,1
137835,living,1,1
137836,with,1,1
137837,AIDS,1,1
137838,who,0,1
137839,demonstrated,0,1
137840,higher,0,1
137841,depressive,0,1
137842,symptom,0,0
137843,scores,0,0
137844,at,0,1
137845,baseline,0,0
137846,had,0,1
137847,greater,0,0
137848,reduction,0,0
137849,in,0,0
137850,their,0,1
137851,depressive,0,1
137852,symptoms,0,1
137853,than,0,1
137854,women,0,1
137855,with,0,1
137856,lower,0,1
137857,scores,0,0
137858,.,0,1
137859,Effect,0,0
137860,of,0,0
137861,whole,0,0
137862,body,0,1
137863,vibration,0,0
137864,on,0,0
137865,stereotypy,0,1
137866,of,0,1
137867,young,1,1
137868,children,1,1
137869,with,1,1
137870,autism,1,1
137871,.,1,1
137872,The,0,0
137873,objective,0,0
137874,of,0,0
137875,this,0,0
137876,case,0,0
137877,was,0,0
137878,report,0,0
137879,on,0,0
137880,the,0,0
137881,effects,0,0
137882,of,0,0
137883,acute,0,1
137884,whole,0,0
137885,body,0,1
137886,vibration,0,0
137887,exposure,0,0
137888,on,0,0
137889,stereotyped,0,1
137890,behaviour,0,0
137891,of,0,1
137892,young,1,1
137893,children,1,1
137894,with,1,1
137895,autism,1,1
137896,.,1,1
137897,Four,1,0
137898,young,1,1
137899,boys,1,1
137900,(,1,1
137901,ages,1,1
137902,4-5,1,1
137903,years,1,1
137904,),1,1
137905,diagnosed,1,1
137906,with,1,1
137907,autism,1,1
137908,participated,1,1
137909,.,1,1
137910,The,1,0
137911,children,1,1
137912,were,1,1
137913,participants,1,1
137914,in,1,1
137915,an,1,1
137916,early,1,1
137917,intensive,1,1
137918,behavioural,1,0
137919,intervention,1,1
137920,clinic,1,1
137921,and,0,1
137922,during,0,1
137923,downtimes,0,0
137924,stood,0,1
137925,on,0,0
137926,a,0,1
137927,whole,0,0
137928,body,0,1
137929,vibration,0,0
137930,platform,0,0
137931,with,0,1
137932,the,0,0
137933,machine,0,0
137934,turned,0,0
137935,off,0,0
137936,(,0,0
137937,control,0,1
137938,condition,0,0
137939,),0,0
137940,and,0,0
137941,on,0,0
137942,(,0,1
137943,treatment,0,0
137944,condition,0,0
137945,),0,1
137946,for,0,1
137947,three,0,1
137948,to,0,1
137949,four,0,1
137950,",",0,1
137951,30,0,1
137952,s,0,1
137953,periods,0,0
137954,(,0,1
137955,frequency=28,0,1
137956,Hz,0,1
137957,;,0,1
137958,amplitude,0,0
137959,0.97,0,0
137960,mm,0,0
137961,),0,1
137962,.,0,1
137963,The,0,0
137964,outcome,0,0
137965,measure,0,0
137966,was,0,0
137967,frequency,0,0
137968,of,0,0
137969,stereotypic,0,1
137970,behaviour,0,0
137971,",",0,0
137972,which,0,0
137973,was,0,0
137974,evaluated,0,0
137975,for,0,0
137976,5,0,0
137977,min,0,0
137978,before,0,0
137979,and,0,1
137980,after,0,0
137981,standing,0,0
137982,on,0,0
137983,the,0,0
137984,vibration,0,0
137985,platform,0,0
137986,.,0,1
137987,The,0,0
137988,results,0,0
137989,revealed,0,0
137990,that,0,0
137991,whole,0,0
137992,body,0,1
137993,vibration,0,0
137994,was,0,0
137995,not,0,0
137996,able,0,0
137997,to,0,0
137998,uniformly,0,0
137999,decrease,0,0
138000,the,0,0
138001,rates,0,0
138002,of,0,0
138003,all,0,1
138004,types,0,1
138005,of,0,1
138006,stereotypy,0,1
138007,;,0,0
138008,that,0,0
138009,is,0,0
138010,",",0,0
138011,some,0,0
138012,stereotypy,0,0
138013,decreased,0,0
138014,while,0,0
138015,others,0,1
138016,were,0,1
138017,unchanged,0,0
138018,.,0,1
138019,Subjectively,0,0
138020,",",0,0
138021,the,0,0
138022,children,1,1
138023,enjoyed,0,0
138024,whole,0,0
138025,body,0,1
138026,vibration,0,0
138027,which,0,0
138028,was,0,0
138029,easy,0,0
138030,to,0,0
138031,integrate,0,0
138032,into,0,0
138033,the,0,0
138034,behavioural,0,0
138035,programme,0,1
138036,.,0,1
138037,Comparing,0,0
138038,microvascular,0,1
138039,alterations,0,0
138040,during,0,1
138041,minimal,0,1
138042,extracorporeal,0,1
138043,circulation,0,0
138044,and,0,1
138045,conventional,0,1
138046,cardiopulmonary,0,1
138047,bypass,0,1
138048,in,0,1
138049,coronary,1,1
138050,artery,1,1
138051,bypass,1,1
138052,graft,1,1
138053,surgery,1,1
138054,:,1,1
138055,a,0,0
138056,prospective,0,0
138057,",",0,0
138058,randomized,0,1
138059,study,0,1
138060,.,0,1
138061,OBJECTIVES,0,0
138062,Minimal,0,0
138063,extracorporeal,0,0
138064,circulation,0,0
138065,(,0,1
138066,MECC,0,1
138067,),0,1
138068,has,0,0
138069,been,0,0
138070,introduced,0,0
138071,in,0,0
138072,coronary,0,1
138073,artery,0,1
138074,bypass,0,1
138075,graft,0,1
138076,(,0,1
138077,CABG,0,1
138078,),0,1
138079,surgery,0,1
138080,",",0,0
138081,offering,0,0
138082,clinical,0,0
138083,benefits,0,0
138084,owing,0,1
138085,to,0,1
138086,reduced,0,0
138087,hemodilution,0,0
138088,and,0,0
138089,no,0,0
138090,blood-air,0,0
138091,interface,0,0
138092,.,0,1
138093,Yet,0,0
138094,",",0,0
138095,the,0,0
138096,effects,0,0
138097,of,0,0
138098,MECC,0,1
138099,on,0,0
138100,the,0,0
138101,intraoperative,0,0
138102,microvascular,0,1
138103,perfusion,0,0
138104,in,0,0
138105,comparison,0,0
138106,with,0,1
138107,conventional,0,1
138108,extracorporeal,0,1
138109,circulation,0,0
138110,(,0,1
138111,CECC,0,1
138112,),0,1
138113,have,0,0
138114,not,0,0
138115,been,0,0
138116,studied,0,0
138117,so,0,0
138118,far,0,1
138119,.,0,0
138120,METHODS,0,0
138121,The,0,0
138122,current,0,0
138123,study,0,1
138124,aimed,0,0
138125,to,0,0
138126,analyze,0,0
138127,alterations,0,0
138128,in,0,1
138129,microvascular,0,1
138130,perfusion,0,1
138131,at,0,1
138132,4,0,0
138133,predefined,0,1
138134,time,0,0
138135,points,0,0
138136,(,0,1
138137,T1-T4,0,1
138138,),0,1
138139,during,0,0
138140,on-pump,0,1
138141,CABG,0,1
138142,using,0,0
138143,orthogonal,0,0
138144,polarization,0,1
138145,spectral,0,1
138146,imaging,0,0
138147,.,0,1
138148,Forty,1,1
138149,patients,1,1
138150,were,1,1
138151,randomized,1,1
138152,for,0,0
138153,being,0,1
138154,operated,0,1
138155,on,0,0
138156,with,0,1
138157,either,0,1
138158,MECC,0,1
138159,or,0,1
138160,CECC,0,1
138161,.,0,1
138162,Changes,0,0
138163,in,0,0
138164,functional,0,1
138165,capillary,0,1
138166,density,0,0
138167,(,0,1
138168,FCD,0,1
138169,),0,1
138170,",",0,0
138171,blood,0,0
138172,flow,0,0
138173,velocity,0,0
138174,",",0,0
138175,and,0,0
138176,vessel,0,1
138177,diameter,0,0
138178,were,0,0
138179,analyzed,0,0
138180,by,0,0
138181,a,0,1
138182,blinded,0,0
138183,investigator,0,0
138184,.,0,1
138185,RESULTS,0,0
138186,After,0,0
138187,start,0,1
138188,of,0,0
138189,extracorporeal,0,0
138190,circulation,0,0
138191,(,0,1
138192,ECC,0,1
138193,),0,1
138194,and,0,1
138195,aortic,0,1
138196,crossclamping,0,1
138197,(,0,1
138198,T2,0,1
138199,),0,1
138200,",",0,0
138201,both,0,0
138202,groups,0,0
138203,showed,0,0
138204,a,0,1
138205,significant,0,0
138206,drop,0,0
138207,of,0,0
138208,FCD,0,1
138209,",",0,0
138210,with,0,1
138211,a,0,0
138212,significantly,0,0
138213,higher,0,0
138214,FCD,0,1
138215,in,0,0
138216,the,0,0
138217,MECC,0,1
138218,group,0,1
138219,(,0,1
138220,206.8,0,1
138221,?,0,1
138222,33.6,0,0
138223,cm/cm?,0,0
138224,in,0,1
138225,CECC,0,1
138226,group,0,1
138227,versus,0,0
138228,217.8,0,0
138229,?,0,1
138230,35.3,0,0
138231,cm/cm?,0,0
138232,in,0,1
138233,MECC,0,1
138234,group,0,1
138235,;,0,1
138236,P,0,0
138237,=,0,1
138238,.034,0,0
138239,),0,1
138240,.,0,1
138241,In,0,0
138242,the,0,0
138243,late,0,1
138244,phase,0,1
138245,of,0,0
138246,the,0,0
138247,ECC,0,0
138248,(,0,1
138249,T3,0,1
138250,),0,1
138251,",",0,0
138252,FCD,0,1
138253,in,0,0
138254,the,0,0
138255,MECC,0,1
138256,group,0,0
138257,was,0,0
138258,already,0,0
138259,recovered,0,0
138260,",",0,0
138261,whereas,0,0
138262,FCD,0,1
138263,in,0,0
138264,the,0,0
138265,CECC,0,1
138266,group,0,0
138267,was,0,0
138268,still,0,0
138269,significantly,0,0
138270,depressed,0,1
138271,(,0,1
138272,223.1,0,1
138273,?,0,1
138274,35.6,0,0
138275,cm/cm?,0,0
138276,in,0,1
138277,MECC,0,1
138278,group,0,1
138279,;,0,1
138280,P,0,0
138281,=,0,1
138282,.100,0,0
138283,vs,0,0
138284,T1,0,0
138285,;,0,1
138286,211.1,0,0
138287,?,0,1
138288,36.9,0,0
138289,cm/cm?,0,0
138290,in,0,1
138291,CECC,0,1
138292,group,0,1
138293,;,0,1
138294,P,0,0
138295,=,0,1
138296,.017,0,0
138297,vs,0,0
138298,T1,0,0
138299,),0,1
138300,.,0,1
138301,After,0,0
138302,termination,0,0
138303,of,0,1
138304,ECC,0,1
138305,(,0,1
138306,T4,0,1
138307,),0,1
138308,",",0,0
138309,FCD,0,1
138310,recovered,0,0
138311,in,0,0
138312,both,0,0
138313,groups,0,0
138314,to,0,0
138315,baseline,0,1
138316,.,0,1
138317,Blood,0,0
138318,flow,0,0
138319,velocity,0,0
138320,tended,0,0
138321,to,0,0
138322,be,0,0
138323,higher,0,0
138324,in,0,0
138325,the,0,0
138326,MECC,0,1
138327,group,0,0
138328,",",0,0
138329,with,0,1
138330,a,0,0
138331,significant,0,0
138332,intergroup,0,0
138333,difference,0,0
138334,after,0,0
138335,aortic,0,1
138336,crossclamping,0,1
138337,(,0,1
138338,T2,0,1
138339,),0,1
138340,.,0,1
138341,CONCLUSIONS,0,0
138342,Orthogonal,0,0
138343,polarization,0,1
138344,spectral,0,1
138345,imaging,0,0
138346,data,0,0
138347,reveal,0,0
138348,an,0,0
138349,impairment,0,1
138350,of,0,0
138351,microvascular,0,1
138352,perfusion,0,0
138353,during,0,1
138354,on-pump,0,1
138355,CABG,0,1
138356,.,0,1
138357,Changes,0,0
138358,in,0,0
138359,FCD,0,1
138360,indicate,0,0
138361,a,0,0
138362,faster,0,0
138363,recovery,0,0
138364,of,0,0
138365,the,0,0
138366,microvascular,0,1
138367,perfusion,0,0
138368,in,0,0
138369,MECC,0,1
138370,during,0,0
138371,the,0,0
138372,reperfusion,0,0
138373,period,0,0
138374,.,0,1
138375,Beneficial,0,0
138376,recovery,0,0
138377,of,0,0
138378,microvascular,0,1
138379,organ,0,1
138380,perfusion,0,0
138381,could,0,0
138382,partly,0,0
138383,explain,0,0
138384,the,0,0
138385,perioperative,0,0
138386,advantages,0,0
138387,reported,0,1
138388,for,0,1
138389,MECC,0,1
138390,.,0,1
138391,Nutritional,0,0
138392,orientation,0,0
138393,",",0,0
138394,knowledge,0,0
138395,and,0,0
138396,quality,0,0
138397,of,0,0
138398,diet,0,1
138399,in,0,0
138400,heart,1,1
138401,failure,1,1
138402,:,1,1
138403,randomized,0,1
138404,clinical,0,0
138405,trial,0,1
138406,.,0,1
138407,BACKGROUND,0,0
138408,Non-pharmacological,0,0
138409,measures,0,0
138410,are,0,0
138411,recommended,0,0
138412,for,0,0
138413,heart,1,1
138414,failure,1,1
138415,patients,1,1
138416,.,1,1
138417,However,0,0
138418,",",0,0
138419,most,0,0
138420,studies,0,0
138421,evaluate,0,0
138422,low,0,1
138423,sodium,0,0
138424,diet,0,0
138425,",",0,0
138426,while,0,0
138427,little,0,0
138428,is,0,0
138429,known,0,0
138430,about,0,0
138431,the,0,0
138432,effects,0,0
138433,of,0,1
138434,interventions,0,0
138435,to,0,1
138436,improve,0,0
138437,adherence,0,0
138438,and,0,0
138439,knowledge,0,0
138440,of,0,0
138441,patients,0,1
138442,about,0,0
138443,diet,0,1
138444,content,0,0
138445,.,0,1
138446,OBJECTIVE,0,0
138447,To,0,0
138448,evaluate,0,0
138449,if,0,0
138450,a,0,0
138451,global,0,0
138452,nutritional,0,0
138453,orientation,0,0
138454,could,0,0
138455,affect,0,0
138456,nutritional,0,0
138457,knowledge,0,0
138458,",",0,0
138459,adherence,0,0
138460,to,0,1
138461,food,0,0
138462,guidelines,0,1
138463,",",0,1
138464,anthropometrics,0,1
138465,and,0,0
138466,quality,0,0
138467,of,0,0
138468,life,0,1
138469,in,0,0
138470,heart,1,1
138471,failure,1,1
138472,patients,1,1
138473,.,1,1
138474,METHODS,0,0
138475,Forty,1,1
138476,six,1,1
138477,patients,1,1
138478,were,0,1
138479,randomized,0,1
138480,to,0,0
138481,intervention,0,0
138482,or,0,0
138483,control,0,1
138484,group,0,1
138485,.,0,1
138486,Both,0,0
138487,groups,0,0
138488,received,0,1
138489,usual,0,1
138490,care,0,1
138491,with,0,1
138492,medical,0,1
138493,and,0,1
138494,nursing,0,1
138495,staff,0,1
138496,;,0,0
138497,the,0,0
138498,intervention,0,0
138499,group,0,0
138500,received,0,1
138501,additional,0,0
138502,nutritional,0,0
138503,guidance,0,0
138504,about,0,0
138505,diet,0,1
138506,and,0,1
138507,its,0,0
138508,relationship,0,0
138509,with,0,1
138510,disease,0,1
138511,",",0,1
138512,sources,0,0
138513,of,0,1
138514,nutrients,0,1
138515,",",0,1
138516,and,0,0
138517,reduction,0,0
138518,of,0,0
138519,dietary,0,0
138520,sodium,0,0
138521,and,0,1
138522,fats,0,0
138523,.,0,1
138524,Enforcement,0,0
138525,of,0,0
138526,the,0,0
138527,nutritional,0,0
138528,guidance,0,0
138529,was,0,0
138530,performed,0,0
138531,after,0,1
138532,4,0,1
138533,weeks,0,1
138534,.,0,1
138535,Both,0,0
138536,groups,0,0
138537,were,0,1
138538,evaluated,0,0
138539,at,0,0
138540,baseline,0,0
138541,",",0,0
138542,and,0,0
138543,after,0,1
138544,6,0,1
138545,weeks,0,1
138546,and,0,1
138547,6,0,1
138548,months,0,1
138549,.,0,1
138550,Evaluations,0,0
138551,included,0,1
138552,anthropometric,0,1
138553,parameters,0,0
138554,",",0,1
138555,sodium,0,0
138556,excretion,0,0
138557,in,0,0
138558,24-hour,0,0
138559,urine,0,1
138560,",",0,0
138561,dietary,0,0
138562,recall,0,0
138563,",",0,0
138564,nutrition,0,0
138565,knowledge,0,0
138566,and,0,0
138567,quality,0,0
138568,of,0,0
138569,life,0,1
138570,questionnaires,0,0
138571,.,0,1
138572,RESULTS,0,0
138573,Mean,1,1
138574,age,1,1
138575,of,1,1
138576,included,1,1
138577,patients,1,1
138578,was,1,1
138579,58,1,1
138580,?,1,1
138581,10,1,1
138582,years,1,1
138583,and,1,1
138584,70,1,1
138585,%,1,0
138586,were,1,1
138587,male,1,1
138588,.,1,1
138589,After,0,1
138590,6,0,0
138591,months,0,1
138592,of,0,1
138593,follow-up,0,0
138594,",",0,0
138595,the,0,0
138596,nutritional,0,0
138597,knowledge,0,0
138598,of,0,0
138599,intervention,0,0
138600,group,0,1
138601,increased,0,0
138602,compared,0,0
138603,to,0,0
138604,control,0,1
138605,(,0,1
138606,p,0,0
138607,<,0,0
138608,0.05,0,0
138609,),0,1
138610,.,0,1
138611,Caloric,0,0
138612,",",0,0
138613,fat,0,0
138614,and,0,0
138615,sodium,0,0
138616,intake,0,0
138617,decreased,0,0
138618,in,0,0
138619,the,0,0
138620,intervention,0,0
138621,group,0,0
138622,compared,0,0
138623,to,0,0
138624,control,0,1
138625,(,0,1
138626,p,0,0
138627,<,0,0
138628,0.05,0,0
138629,),0,1
138630,.,0,1
138631,No,0,0
138632,significant,0,0
138633,differences,0,0
138634,were,0,1
138635,seen,0,0
138636,in,0,0
138637,quality,0,0
138638,of,0,0
138639,life,0,1
138640,or,0,1
138641,anthropometric,0,1
138642,parameters,0,0
138643,.,0,1
138644,CONCLUSIONS,0,0
138645,Nutritional,0,0
138646,orientation,0,0
138647,was,0,0
138648,effective,0,0
138649,to,0,1
138650,modify,0,0
138651,1,0,1
138652,),0,0
138653,knowledge,0,0
138654,about,0,0
138655,food,0,0
138656,and,0,0
138657,nutrition,0,1
138658,",",0,0
138659,and,0,0
138660,2,0,1
138661,),0,1
138662,quality,0,0
138663,of,0,0
138664,diet,0,1
138665,in,1,1
138666,outpatients,1,1
138667,with,1,1
138668,heart,1,1
138669,failure,1,1
138670,.,1,1
138671,Further,0,0
138672,studies,0,0
138673,are,0,0
138674,necessary,0,0
138675,to,0,0
138676,evaluate,0,0
138677,the,0,0
138678,benefits,0,0
138679,on,0,0
138680,quality,0,0
138681,of,0,0
138682,life,0,1
138683,and,0,1
138684,prognosis,0,0
138685,.,0,1
138686,Randomized,0,1
138687,controlled,0,0
138688,trial,0,1
138689,:,0,1
138690,Multimodal,0,0
138691,Anxiety,0,1
138692,and,0,1
138693,Social,0,1
138694,Skill,0,0
138695,Intervention,0,1
138696,for,0,1
138697,adolescents,1,1
138698,with,1,1
138699,autism,1,1
138700,spectrum,1,1
138701,disorder,1,1
138702,.,1,0
138703,Anxiety,1,0
138704,is,1,0
138705,common,1,0
138706,among,1,0
138707,adolescents,1,1
138708,with,1,1
138709,autism,1,1
138710,spectrum,1,1
138711,disorders,1,1
138712,(,1,1
138713,ASD,1,1
138714,),1,0
138715,and,0,0
138716,may,0,0
138717,amplify,0,0
138718,the,0,0
138719,core,0,0
138720,social,0,0
138721,disability,0,1
138722,",",0,0
138723,thus,0,0
138724,necessitating,0,1
138725,combined,0,0
138726,treatment,0,1
138727,approaches,0,0
138728,.,0,1
138729,This,0,0
138730,pilot,0,0
138731,",",0,0
138732,randomized,0,1
138733,controlled,0,0
138734,trial,0,0
138735,evaluated,0,0
138736,the,0,0
138737,feasibility,0,0
138738,and,0,0
138739,preliminary,0,0
138740,outcomes,0,0
138741,of,0,1
138742,the,0,1
138743,Multimodal,0,0
138744,Anxiety,0,0
138745,and,0,1
138746,Social,0,1
138747,Skills,0,0
138748,Intervention,0,1
138749,(,0,1
138750,MASSI,0,1
138751,),0,1
138752,program,0,1
138753,in,1,0
138754,a,1,0
138755,sample,1,1
138756,of,1,0
138757,30,1,1
138758,adolescents,1,1
138759,with,1,1
138760,ASD,1,1
138761,and,1,1
138762,anxiety,1,1
138763,symptoms,1,1
138764,of,1,1
138765,moderate,1,1
138766,or,1,1
138767,greater,1,0
138768,severity,1,0
138769,.,1,0
138770,The,0,0
138771,treatment,0,0
138772,was,0,0
138773,acceptable,0,0
138774,to,0,1
138775,families,0,1
138776,",",0,1
138777,subject,0,1
138778,adherence,0,0
138779,was,0,0
138780,high,0,1
138781,",",0,0
138782,and,0,0
138783,therapist,0,0
138784,fidelity,0,0
138785,was,0,0
138786,high,0,1
138787,.,0,1
138788,A,0,0
138789,16,0,1
138790,%,0,0
138791,improvement,0,0
138792,in,0,0
138793,ASD,0,1
138794,social,0,1
138795,impairment,0,1
138796,(,0,1
138797,within-group,0,0
138798,effect,0,0
138799,size,0,1
138800,=,0,1
138801,1.18,0,0
138802,),0,1
138803,was,0,0
138804,observed,0,0
138805,on,0,0
138806,a,0,1
138807,parent-reported,0,0
138808,scale,0,0
138809,.,0,1
138810,Although,0,0
138811,anxiety,0,1
138812,symptoms,0,1
138813,declined,0,0
138814,by,0,0
138815,26,0,1
138816,%,0,0
138817,",",0,0
138818,the,0,0
138819,change,0,0
138820,was,0,0
138821,not,0,0
138822,statistically,0,0
138823,significant,0,0
138824,.,0,1
138825,These,0,0
138826,findings,0,0
138827,suggest,0,0
138828,MASSI,0,0
138829,is,0,0
138830,a,0,0
138831,feasible,0,0
138832,treatment,0,0
138833,program,0,1
138834,and,0,0
138835,further,0,0
138836,evaluation,0,0
138837,is,0,0
138838,warranted,0,0
138839,.,0,0
138840,Parent-implemented,0,1
138841,enhanced,0,0
138842,milieu,0,1
138843,teaching,0,1
138844,with,0,1
138845,preschool,1,1
138846,children,1,1
138847,who,1,1
138848,have,1,1
138849,intellectual,1,1
138850,disabilities,1,1
138851,.,1,1
138852,PURPOSE,0,0
138853,The,0,0
138854,purpose,0,0
138855,of,0,0
138856,this,0,0
138857,study,0,0
138858,was,0,0
138859,to,0,0
138860,compare,0,0
138861,the,0,0
138862,effects,0,0
138863,of,0,0
138864,enhanced,0,0
138865,milieu,0,1
138866,teaching,0,1
138867,(,0,1
138868,EMT,0,0
138869,),0,1
138870,implemented,0,0
138871,by,0,0
138872,parents,0,1
138873,and,0,1
138874,therapists,0,0
138875,versus,0,0
138876,therapists,0,0
138877,only,0,0
138878,on,0,0
138879,the,0,0
138880,language,1,0
138881,skills,1,0
138882,of,1,1
138883,preschool,1,1
138884,children,1,1
138885,with,1,1
138886,intellectual,1,1
138887,disabilities,1,1
138888,(,1,1
138889,IDs,1,1
138890,),1,1
138891,",",1,0
138892,including,1,0
138893,children,1,1
138894,with,1,1
138895,Down,1,1
138896,syndrome,1,1
138897,and,1,1
138898,children,1,1
138899,with,1,1
138900,autism,1,1
138901,spectrum,1,1
138902,disorders,1,1
138903,.,1,1
138904,METHOD,0,0
138905,Seventy-seven,1,1
138906,children,1,1
138907,were,1,1
138908,randomly,1,1
138909,assigned,1,1
138910,to,0,1
138911,2,0,1
138912,treatments,0,0
138913,(,0,1
138914,parent,0,1
138915,+,0,0
138916,therapist,0,0
138917,EMT,0,0
138918,or,0,1
138919,therapist-only,0,0
138920,EMT,0,0
138921,),0,1
138922,and,0,1
138923,received,0,1
138924,36,0,1
138925,intervention,0,1
138926,sessions,0,0
138927,.,0,1
138928,Children,0,1
138929,were,0,0
138930,assessed,0,0
138931,before,0,0
138932,",",0,0
138933,immediately,0,0
138934,after,0,0
138935,",",0,1
138936,6,0,0
138937,months,0,0
138938,after,0,1
138939,",",0,1
138940,and,0,1
138941,12,0,1
138942,months,0,0
138943,after,0,1
138944,intervention,0,1
138945,.,0,1
138946,Separate,0,0
138947,linear,0,0
138948,regressions,0,0
138949,were,0,1
138950,conducted,0,1
138951,for,0,0
138952,each,0,1
138953,standardized,0,0
138954,and,0,0
138955,observational,0,1
138956,measure,0,0
138957,at,0,0
138958,each,0,0
138959,time,0,0
138960,point,0,0
138961,.,0,1
138962,RESULTS,0,0
138963,Parents,1,0
138964,in,1,1
138965,the,1,0
138966,parent,1,1
138967,+,1,0
138968,therapist,1,0
138969,group,1,0
138970,demonstrated,0,0
138971,greater,0,0
138972,use,0,0
138973,of,0,0
138974,EMT,0,0
138975,strategies,0,0
138976,at,0,1
138977,home,0,1
138978,than,0,1
138979,untrained,0,1
138980,parents,0,1
138981,in,0,1
138982,the,0,1
138983,therapist-only,0,0
138984,group,0,0
138985,",",0,0
138986,and,0,0
138987,these,0,0
138988,effects,0,0
138989,maintained,0,0
138990,over,0,0
138991,time,0,0
138992,.,0,1
138993,Effect,0,0
138994,sizes,0,0
138995,for,0,1
138996,observational,0,1
138997,measures,0,0
138998,ranged,0,1
138999,from,0,1
139000,d,0,1
139001,=,0,1
139002,0.10,0,0
139003,to,0,0
139004,d,0,1
139005,=,0,1
139006,1.32,0,0
139007,favoring,0,0
139008,the,0,0
139009,parent,0,1
139010,+,0,0
139011,therapist,0,0
139012,group,0,0
139013,",",0,0
139014,with,0,1
139015,the,0,0
139016,largest,0,0
139017,effect,0,0
139018,sizes,0,0
139019,found,0,0
139020,12,0,0
139021,months,0,0
139022,after,0,1
139023,intervention,0,1
139024,.,0,1
139025,CONCLUSION,0,0
139026,Findings,0,0
139027,from,0,1
139028,this,0,0
139029,study,0,0
139030,indicate,0,0
139031,generally,0,0
139032,that,0,0
139033,there,0,0
139034,are,0,0
139035,benefits,0,0
139036,to,0,1
139037,training,0,1
139038,parents,0,1
139039,to,0,1
139040,implement,0,0
139041,naturalistic,0,0
139042,language,0,1
139043,intervention,0,1
139044,strategies,0,0
139045,with,0,1
139046,preschool,1,1
139047,children,1,1
139048,who,1,1
139049,have,1,1
139050,ID,1,1
139051,and,1,1
139052,significant,1,0
139053,language,1,1
139054,impairments,1,1
139055,.,1,1
139056,The,0,0
139057,impact,0,0
139058,of,0,0
139059,patient,0,1
139060,and,0,1
139061,physician,0,1
139062,computer,0,0
139063,mediated,0,0
139064,communication,0,0
139065,skill,0,0
139066,training,0,0
139067,on,0,0
139068,reported,0,1
139069,communication,0,0
139070,and,0,0
139071,patient,0,1
139072,satisfaction,0,0
139073,.,0,1
139074,OBJECTIVE,0,0
139075,The,0,0
139076,objective,0,0
139077,was,0,0
139078,to,0,0
139079,evaluate,0,0
139080,parallel,0,0
139081,patient,0,1
139082,and,0,1
139083,physician,0,1
139084,computer-mediated,0,0
139085,communication,0,0
139086,skill,0,0
139087,training,0,0
139088,on,0,0
139089,participants,0,1
139090,',0,1
139091,report,0,0
139092,of,0,1
139093,skill,0,0
139094,use,0,0
139095,and,0,0
139096,patient,0,1
139097,satisfaction,0,0
139098,.,0,1
139099,METHODS,0,0
139100,Separate,0,0
139101,patient,0,1
139102,and,0,1
139103,clinician,0,1
139104,web-tools,0,0
139105,comprised,0,1
139106,of,0,1
139107,over,0,0
139108,500,0,1
139109,",",0,1
139110,10-s,0,0
139111,video,0,0
139112,clips,0,1
139113,demonstrating,0,0
139114,patient-centered,0,1
139115,skills,0,0
139116,in,0,1
139117,various,0,1
139118,ways,0,1
139119,.,0,1
139120,Four,1,1
139121,clinician,1,0
139122,members,1,1
139123,of,1,1
139124,the,1,1
139125,American,1,1
139126,Academy,1,1
139127,of,1,1
139128,Family,1,1
139129,Physicians,1,1
139130,National,1,1
139131,Research,1,1
139132,Network,1,0
139133,participated,1,1
139134,by,1,0
139135,enrolling,1,1
139136,194,1,1
139137,patients,1,1
139138,into,1,1
139139,a,1,1
139140,randomized,1,1
139141,patient,1,1
139142,trial,1,1
139143,and,1,1
139144,29,1,1
139145,physicians,1,1
139146,into,1,1
139147,a,1,1
139148,non-randomized,1,1
139149,clinician,1,0
139150,trial,1,1
139151,of,1,1
139152,respective,1,1
139153,interventions,1,1
139154,.,1,1
139155,All,0,1
139156,participants,0,1
139157,completed,0,1
139158,baseline,0,0
139159,and,0,1
139160,follow-up,0,1
139161,self-report,0,1
139162,measures,0,0
139163,of,0,1
139164,visit,0,1
139165,communication,0,0
139166,and,0,0
139167,satisfaction,0,0
139168,.,0,1
139169,RESULTS,0,0
139170,Intervention,0,1
139171,patients,0,1
139172,reported,0,1
139173,using,0,1
139174,more,0,0
139175,skills,0,0
139176,than,0,0
139177,controls,0,1
139178,in,0,1
139179,five,0,1
139180,of,0,1
139181,six,0,1
139182,skill,0,0
139183,areas,0,0
139184,",",0,1
139185,including,0,0
139186,identification,0,1
139187,of,0,1
139188,problems/concerns,0,1
139189,",",0,1
139190,information,0,0
139191,exchange,0,0
139192,",",0,0
139193,treatment,0,0
139194,adherence,0,0
139195,",",0,0
139196,shared,0,0
139197,decision-making,0,0
139198,and,0,0
139199,interpersonal,0,0
139200,rapport,0,0
139201,(,0,0
139202,all,0,0
139203,p,0,0
139204,<,0,0
139205,.05,0,0
139206,),0,1
139207,;,0,1
139208,post,0,1
139209,intervention,0,0
139210,",",0,1
139211,physicians,0,1
139212,reported,0,0
139213,using,0,1
139214,more,0,0
139215,skills,0,0
139216,in,0,0
139217,the,0,1
139218,same,0,1
139219,5,0,1
139220,areas,0,0
139221,(,0,1
139222,all,0,1
139223,p,0,0
139224,<,0,0
139225,.01,0,0
139226,),0,1
139227,.,0,1
139228,Intervention,0,1
139229,group,0,1
139230,patients,0,1
139231,reported,0,1
139232,higher,0,0
139233,levels,0,0
139234,of,0,0
139235,satisfaction,0,0
139236,than,0,0
139237,controls,0,1
139238,in,0,1
139239,five,0,1
139240,of,0,1
139241,six,0,1
139242,domains,0,0
139243,(,0,1
139244,all,0,1
139245,p,0,0
139246,<,0,0
139247,.05,0,0
139248,),0,1
139249,.,0,1
139250,CONCLUSION,0,0
139251,Communication,0,0
139252,skill,0,0
139253,training,0,0
139254,delivered,0,0
139255,in,0,0
139256,a,0,1
139257,computer,0,0
139258,mediated,0,0
139259,format,0,0
139260,had,0,1
139261,a,0,0
139262,positive,0,1
139263,and,0,0
139264,parallel,0,0
139265,impact,0,0
139266,on,0,0
139267,both,0,0
139268,patient,0,1
139269,and,0,0
139270,clinician,0,0
139271,reported,0,0
139272,use,0,0
139273,of,0,0
139274,patient-centered,0,0
139275,communication,0,0
139276,and,0,1
139277,in,0,0
139278,patient,0,1
139279,satisfaction,0,0
139280,.,0,1
139281,PRACTICE,0,0
139282,IMPLICATIONS,0,1
139283,Computer-mediated,0,0
139284,interventions,0,0
139285,are,0,0
139286,cost,0,0
139287,and,0,0
139288,time,0,0
139289,effective,0,0
139290,thereby,0,0
139291,increasing,0,0
139292,patient,0,0
139293,and,0,1
139294,clinician,0,0
139295,willingness,0,0
139296,to,0,0
139297,undertake,0,0
139298,training,0,0
139299,.,0,1
139300,Promoting,0,0
139301,physical,0,1
139302,activity,0,0
139303,in,0,1
139304,patients,1,1
139305,with,1,1
139306,colon,1,1
139307,adenomas,1,1
139308,:,1,1
139309,a,0,0
139310,randomized,0,1
139311,pilot,0,0
139312,intervention,0,1
139313,trial,0,1
139314,.,0,1
139315,BACKGROUND,0,0
139316,Physical,0,0
139317,activity,0,0
139318,decreases,0,0
139319,risk,0,0
139320,of,0,0
139321,colon,0,1
139322,polyps,0,1
139323,and,0,1
139324,colon,0,1
139325,cancer,0,1
139326,and,0,0
139327,might,0,0
139328,reduce,0,0
139329,risk,0,0
139330,of,0,0
139331,colon,0,1
139332,cancer,0,1
139333,recurrence,0,0
139334,.,0,1
139335,Focusing,0,0
139336,on,0,0
139337,recent,0,1
139338,calls,0,1
139339,for,0,1
139340,translation,0,0
139341,of,0,0
139342,epidemiologic,0,1
139343,evidence,0,0
139344,into,0,1
139345,clinical,0,0
139346,care,0,1
139347,",",0,0
139348,our,0,0
139349,pilot,0,0
139350,study,0,0
139351,delivered,0,0
139352,an,0,0
139353,evidence-based,0,0
139354,physical,0,1
139355,activity,0,0
139356,intervention,0,1
139357,in,0,0
139358,adults,1,1
139359,with,1,1
139360,polyps,1,1
139361,",",0,1
139362,who,0,1
139363,are,0,0
139364,thus,0,1
139365,at,0,0
139366,elevated,0,0
139367,risk,0,1
139368,of,0,0
139369,developing,0,1
139370,colon,0,1
139371,cancer,0,1
139372,.,0,1
139373,The,0,0
139374,objective,0,0
139375,was,0,0
139376,to,0,0
139377,evaluate,0,0
139378,change,0,0
139379,in,0,0
139380,physical,0,1
139381,activity,0,0
139382,",",0,0
139383,measured,0,0
139384,by,0,0
139385,steps,0,1
139386,per,0,1
139387,day,0,1
139388,and,0,1
139389,minutes,0,0
139390,of,0,1
139391,moderate/vigorous,0,1
139392,physical,0,1
139393,activity,0,0
139394,.,0,1
139395,METHODS,0,0
139396,Sixteen,1,1
139397,adults,1,1
139398,with,1,1
139399,adenomas,1,1
139400,detected,1,0
139401,and,1,0
139402,removed,1,0
139403,at,1,0
139404,screening,1,1
139405,colonoscopy,1,1
139406,were,0,1
139407,recruited,0,1
139408,to,0,0
139409,a,0,1
139410,12-week,0,0
139411,physical,0,1
139412,activity,0,0
139413,intervention,0,1
139414,.,0,1
139415,Participants,0,1
139416,were,0,1
139417,randomized,0,1
139418,to,0,0
139419,receive,0,0
139420,a,0,0
139421,standard,0,0
139422,(,0,0
139423,30,0,1
139424,minutes/day,0,1
139425,),0,1
139426,or,0,1
139427,high,0,1
139428,(,0,1
139429,60,0,1
139430,minutes/day,0,1
139431,),0,1
139432,walking,0,0
139433,program,0,1
139434,.,0,1
139435,Physical,0,0
139436,activity,0,0
139437,was,0,0
139438,measured,0,0
139439,via,0,0
139440,blinded,0,0
139441,pedometer,0,0
139442,and,0,0
139443,accelerometer,0,0
139444,at,0,0
139445,baseline,0,0
139446,and,0,1
139447,follow-up,0,0
139448,.,0,1
139449,Intervention,0,1
139450,messages,0,0
139451,focused,0,1
139452,on,0,0
139453,self-monitoring,0,0
139454,using,0,1
139455,pedometers,0,1
139456,and,0,1
139457,overcoming,0,0
139458,barriers,0,0
139459,to,0,1
139460,engaging,0,1
139461,in,0,0
139462,physical,0,1
139463,activity,0,0
139464,.,0,1
139465,RESULTS,0,0
139466,Participants,0,1
139467,in,0,1
139468,both,0,0
139469,arms,0,0
139470,significantly,0,0
139471,increased,0,0
139472,objectively,0,0
139473,measured,0,0
139474,minutes,0,0
139475,of,0,1
139476,moderate/vigorous,0,1
139477,physical,0,1
139478,activity,0,0
139479,over,0,0
139480,the,0,0
139481,course,0,0
139482,of,0,0
139483,the,0,0
139484,intervention,0,0
139485,.,0,1
139486,Both,0,0
139487,arms,0,0
139488,exceeded,0,0
139489,the,0,0
139490,intervention,0,0
139491,goal,0,0
139492,",",0,0
139493,but,0,0
139494,there,0,0
139495,was,0,0
139496,not,0,0
139497,a,0,0
139498,significant,0,0
139499,difference,0,0
139500,between,0,0
139501,arms,0,1
139502,at,0,1
139503,follow-up,0,1
139504,.,0,1
139505,Results,0,0
139506,were,0,1
139507,similar,0,0
139508,for,0,0
139509,pedometer,0,0
139510,measured,0,0
139511,physical,0,1
139512,activity,0,0
139513,",",0,0
139514,with,0,1
139515,a,0,1
139516,significant,0,0
139517,overall,0,0
139518,increase,0,0
139519,in,0,0
139520,steps/day,0,1
139521,from,0,1
139522,baseline,0,0
139523,to,0,0
139524,follow-up,0,0
139525,",",0,0
139526,but,0,0
139527,no,0,0
139528,between,0,0
139529,arm,0,0
139530,difference,0,0
139531,in,0,0
139532,change,0,0
139533,.,0,1
139534,CONCLUSION,0,0
139535,Simple,0,0
139536,interventions,0,0
139537,of,0,1
139538,minimal,0,1
139539,contact,0,0
139540,time,0,0
139541,focusing,0,0
139542,on,0,0
139543,walking,0,0
139544,can,0,0
139545,significantly,0,0
139546,increase,0,0
139547,physical,0,0
139548,activity,0,0
139549,in,0,1
139550,individuals,0,1
139551,at,0,1
139552,increased,0,0
139553,risk,0,1
139554,of,0,0
139555,developing,0,1
139556,colon,0,1
139557,cancer,0,1
139558,.,0,1
139559,TRIAL,0,0
139560,REGISTRATION,0,0
139561,ClinicalTrials.gov,0,1
139562,NCT01476631,0,1
139563,.,0,1
139564,Direct,0,1
139565,renin,0,0
139566,inhibition,0,0
139567,improves,0,0
139568,parasympathetic,0,0
139569,function,0,0
139570,in,0,1
139571,diabetes,1,1
139572,.,1,1
139573,AIM,0,0
139574,The,0,0
139575,renin-angiotensin-aldosterone,0,0
139576,system,0,0
139577,(,0,1
139578,RAAS,0,1
139579,),0,1
139580,and,0,1
139581,autonomic,0,0
139582,nervous,0,1
139583,system,0,0
139584,regulate,0,0
139585,the,0,0
139586,cardiovascular,0,1
139587,system,0,1
139588,.,0,1
139589,Blockade,0,0
139590,of,0,0
139591,the,0,0
139592,RAAS,0,1
139593,may,0,0
139594,slow,0,0
139595,the,0,0
139596,progression,0,0
139597,of,0,0
139598,end-organ,0,1
139599,damage,0,1
139600,.,0,1
139601,Direct,0,0
139602,renin,0,0
139603,inhibition,0,0
139604,offers,0,0
139605,a,0,0
139606,means,0,0
139607,for,0,0
139608,blocking,0,0
139609,the,0,0
139610,RAAS,0,1
139611,.,0,1
139612,The,0,0
139613,objective,0,0
139614,of,0,0
139615,this,0,0
139616,study,0,0
139617,was,0,0
139618,to,0,0
139619,examine,0,0
139620,the,0,0
139621,effect,0,0
139622,of,0,0
139623,direct,0,0
139624,renin,0,0
139625,inhibition,0,0
139626,on,0,0
139627,cardiovascular,0,1
139628,autonomic,0,1
139629,function,0,0
139630,.,0,1
139631,METHODS,0,0
139632,In,0,0
139633,this,0,0
139634,double-blind,0,0
139635,",",0,0
139636,placebo-controlled,0,0
139637,trial,0,0
139638,",",0,1
139639,60,1,1
139640,individuals,1,1
139641,with,1,1
139642,diabetes,1,1
139643,were,0,1
139644,randomly,0,1
139645,assigned,0,1
139646,to,0,0
139647,300,0,1
139648,mg,0,0
139649,of,0,0
139650,aliskiren,0,0
139651,or,0,1
139652,placebo,0,0
139653,once,0,0
139654,daily,0,0
139655,for,0,1
139656,6,0,1
139657,weeks,0,1
139658,.,0,1
139659,The,0,0
139660,primary,0,0
139661,end,0,0
139662,point,0,0
139663,was,0,0
139664,a,0,0
139665,change,0,0
139666,in,0,0
139667,tests,0,0
139668,of,0,1
139669,cardiovascular,0,1
139670,autonomic,0,1
139671,function,0,0
139672,.,0,1
139673,Autonomic,0,0
139674,function,0,0
139675,was,0,0
139676,assessed,0,0
139677,by,0,0
139678,power,0,0
139679,spectral,0,1
139680,analysis,0,0
139681,and,0,1
139682,RR-variation,0,0
139683,during,0,0
139684,deep,0,1
139685,breathing,0,1
139686,[,0,0
139687,i.e,0,1
139688,.,0,1
139689,mean,0,0
139690,circular,0,1
139691,resultant,0,0
139692,(,0,1
139693,MCR,0,1
139694,),0,1
139695,",",0,0
139696,expiration/inspiration,0,0
139697,(,0,1
139698,E/I,0,1
139699,),0,1
139700,ratio,0,0
139701,],0,1
139702,.,0,1
139703,The,0,0
139704,MCR,0,1
139705,and,0,0
139706,E/I,0,1
139707,ratio,0,0
139708,assess,0,0
139709,parasympathetic,0,0
139710,function,0,0
139711,.,0,1
139712,Secondary,0,0
139713,measures,0,0
139714,included,0,1
139715,change,0,0
139716,in,0,1
139717,biochemical,0,0
139718,parameters,0,0
139719,[,0,1
139720,e.g,0,0
139721,.,0,1
139722,plasma,0,0
139723,renin,0,0
139724,activity,0,0
139725,",",0,0
139726,leptin,0,0
139727,and,0,0
139728,interleukin-6,0,0
139729,],0,1
139730,.,0,1
139731,Change,0,0
139732,in,0,0
139733,cardiovascular,0,1
139734,autonomic,0,1
139735,function,0,0
139736,and,0,1
139737,blood,0,0
139738,analytes,0,0
139739,were,0,1
139740,analysed,0,1
139741,by,0,0
139742,a,0,1
139743,mixed,0,1
139744,effects,0,0
139745,model,0,1
139746,for,0,1
139747,repeated,0,0
139748,measures,0,0
139749,.,0,1
139750,RESULTS,0,0
139751,Baseline,0,0
139752,characteristics,0,1
139753,were,0,1
139754,similar,0,0
139755,between,0,0
139756,treatment,0,1
139757,groups,0,1
139758,.,0,1
139759,In,0,0
139760,response,0,0
139761,to,0,1
139762,aliskiren,0,0
139763,compared,0,0
139764,with,0,1
139765,placebo,0,0
139766,",",0,0
139767,blood,0,0
139768,pressure,0,0
139769,was,0,0
139770,reduced,0,0
139771,as,0,0
139772,well,0,0
139773,as,0,0
139774,plasma,0,0
139775,renin,0,0
139776,activity,0,0
139777,[,0,0
139778,from,0,1
139779,2.4,0,1
139780,?,0,1
139781,3.8,0,0
139782,(,0,0
139783,mean,0,1
139784,?,0,1
139785,standard,0,0
139786,deviation,0,1
139787,),0,1
139788,to,0,1
139789,0.5,0,0
139790,?,0,1
139791,0.4,0,0
139792,?g/l/h,0,0
139793,",",0,0
139794,p,0,0
139795,<,0,0
139796,0.001,0,0
139797,],0,1
139798,.,0,0
139799,There,0,0
139800,was,0,0
139801,a,0,0
139802,significant,0,0
139803,interaction,0,0
139804,(,0,1
139805,aliskiren,0,0
139806,?,0,1
139807,visit,0,0
139808,),0,0
139809,for,0,0
139810,MCR,0,1
139811,(,0,1
139812,p,0,0
139813,=,0,1
139814,0.003,0,0
139815,),0,1
139816,and,0,1
139817,E/I,0,1
139818,ratio,0,0
139819,(,0,1
139820,p,0,0
139821,=,0,1
139822,0.003,0,0
139823,),0,1
139824,indicating,0,0
139825,improvement,0,0
139826,in,0,1
139827,MCR,0,1
139828,and,0,1
139829,E/I,0,1
139830,ratio,0,0
139831,for,0,0
139832,those,0,1
139833,on,0,0
139834,aliskiren,0,0
139835,.,0,1
139836,MCR,0,1
139837,means,0,0
139838,",",0,0
139839,baseline,0,0
139840,vs.,0,0
139841,follow-up,0,0
139842,",",0,1
139843,were,0,1
139844,41.8,0,1
139845,?,0,1
139846,19.7,0,0
139847,vs.,0,0
139848,50.8,0,1
139849,?,0,1
139850,26.1,0,0
139851,(,0,0
139852,aliskiren,0,0
139853,),0,1
139854,and,0,1
139855,38.2,0,1
139856,?,0,1
139857,23.6,0,0
139858,vs.,0,0
139859,37.5,0,1
139860,?,0,1
139861,24.1,0,0
139862,(,0,0
139863,placebo,0,1
139864,),0,1
139865,.,0,1
139866,CONCLUSIONS,0,0
139867,Parasympathetic,0,0
139868,function,0,0
139869,(,0,1
139870,i.e,0,1
139871,.,0,1
139872,MCR,0,1
139873,and,0,0
139874,E/I,0,1
139875,ratio,0,0
139876,),0,1
139877,was,0,0
139878,enhanced,0,0
139879,by,0,0
139880,downregulation,0,0
139881,of,0,0
139882,the,0,0
139883,RAAS,0,1
139884,.,0,1
139885,[,0,0
139886,Does,0,0
139887,urapidil,0,0
139888,attenuate,0,0
139889,the,0,0
139890,hypertensive,1,1
139891,response,1,0
139892,to,1,0
139893,tracheal,1,1
139894,intubation,1,0
139895,at,1,0
139896,the,1,0
139897,time,1,0
139898,of,1,0
139899,general,1,1
139900,anesthesia,1,1
139901,?,0,1
139902,],0,0
139903,.,0,1
139904,RESPECT-PTSD,0,1
139905,:,0,1
139906,re-engineering,0,0
139907,systems,0,0
139908,for,0,1
139909,the,0,1
139910,primary,0,1
139911,care,0,1
139912,treatment,0,0
139913,of,0,0
139914,PTSD,1,0
139915,",",0,0
139916,a,0,0
139917,randomized,0,0
139918,controlled,0,0
139919,trial,0,1
139920,.,0,1
139921,BACKGROUND,0,0
139922,Although,0,0
139923,collaborative,0,0
139924,care,0,1
139925,is,0,0
139926,effective,0,0
139927,for,0,0
139928,treating,0,0
139929,depression,0,1
139930,and,0,1
139931,other,0,1
139932,mental,0,1
139933,disorders,0,1
139934,in,0,1
139935,primary,0,1
139936,care,0,1
139937,",",0,0
139938,there,0,0
139939,have,0,0
139940,been,0,0
139941,no,0,0
139942,randomized,0,1
139943,trials,0,0
139944,of,0,1
139945,collaborative,0,1
139946,care,0,1
139947,specifically,0,0
139948,for,0,0
139949,patients,1,1
139950,with,1,1
139951,Posttraumatic,1,1
139952,stress,1,1
139953,disorder,1,1
139954,(,1,1
139955,PTSD,1,1
139956,),1,1
139957,.,1,1
139958,OBJECTIVE,0,0
139959,To,0,0
139960,compare,0,0
139961,a,0,0
139962,collaborative,0,0
139963,approach,0,0
139964,",",0,0
139965,the,0,0
139966,Three,0,1
139967,Component,0,1
139968,Model,0,1
139969,(,0,1
139970,3CM,0,1
139971,),0,1
139972,",",0,0
139973,with,0,1
139974,usual,0,1
139975,care,0,1
139976,for,0,0
139977,treating,0,0
139978,PTSD,0,1
139979,in,0,1
139980,primary,0,1
139981,care,0,1
139982,.,0,1
139983,DESIGN,0,0
139984,The,0,0
139985,study,0,0
139986,was,0,0
139987,a,0,0
139988,two-arm,0,0
139989,",",0,0
139990,parallel,0,0
139991,randomized,0,1
139992,clinical,0,0
139993,trial,0,1
139994,.,0,1
139995,PTSD,1,0
139996,patients,1,1
139997,were,1,1
139998,recruited,1,1
139999,from,1,1
140000,five,1,1
140001,primary,1,1
140002,care,1,1
140003,clinics,1,1
140004,at,1,1
140005,four,1,1
140006,Veterans,1,1
140007,Affairs,1,1
140008,healthcare,1,1
140009,facilities,1,1
140010,and,0,1
140011,randomized,0,1
140012,to,0,0
140013,receive,0,1
140014,usual,0,1
140015,care,0,1
140016,or,0,1
140017,usual,0,1
140018,care,0,1
140019,plus,0,0
140020,3CM,0,1
140021,.,0,1
140022,Blinded,0,0
140023,assessors,0,0
140024,collected,0,1
140025,data,0,0
140026,at,0,1
140027,baseline,0,1
140028,and,0,1
140029,3-month,0,0
140030,and,0,1
140031,6-month,0,1
140032,follow-up,0,1
140033,.,0,1
140034,PARTICIPANTS,0,0
140035,Participants,1,1
140036,were,1,1
140037,195,1,1
140038,Veterans,1,1
140039,.,1,1
140040,Their,1,1
140041,average,1,0
140042,age,1,1
140043,was,1,0
140044,45,1,1
140045,years,1,1
140046,",",1,1
140047,91,1,1
140048,%,1,0
140049,were,1,1
140050,male,1,1
140051,",",1,1
140052,58,1,1
140053,%,1,0
140054,were,1,1
140055,white,1,1
140056,",",1,1
140057,40,1,1
140058,%,1,0
140059,served,1,1
140060,in,1,0
140061,Iraq,1,1
140062,or,1,1
140063,Afghanistan,1,1
140064,",",1,1
140065,and,1,0
140066,42,1,1
140067,%,1,0
140068,served,1,1
140069,in,1,0
140070,Vietnam,1,1
140071,.,1,1
140072,INTERVENTION,0,0
140073,All,0,1
140074,participants,0,1
140075,received,0,1
140076,usual,0,1
140077,care,0,1
140078,.,0,1
140079,Participants,0,1
140080,assigned,0,1
140081,to,0,1
140082,3CM,0,1
140083,also,0,0
140084,received,0,0
140085,telephone,0,0
140086,care,0,1
140087,management,0,1
140088,.,0,1
140089,Care,0,0
140090,managers,0,1
140091,received,0,1
140092,supervision,0,0
140093,from,0,1
140094,a,0,1
140095,psychiatrist,0,1
140096,.,0,1
140097,MAIN,0,0
140098,MEASURES,0,0
140099,PTSD,0,1
140100,symptom,0,1
140101,severity,0,0
140102,was,0,0
140103,the,0,0
140104,primary,0,1
140105,outcome,0,0
140106,.,0,1
140107,Depression,0,0
140108,",",0,0
140109,functioning,0,0
140110,",",0,0
140111,perceived,0,0
140112,quality,0,0
140113,of,0,0
140114,care,0,1
140115,",",0,0
140116,utilization,0,0
140117,",",0,0
140118,and,0,0
140119,costs,0,1
140120,were,0,1
140121,secondary,0,1
140122,outcomes,0,0
140123,.,0,1
140124,KEY,0,0
140125,RESULTS,0,0
140126,There,0,0
140127,were,0,0
140128,no,0,0
140129,differences,0,0
140130,between,0,0
140131,3CM,0,1
140132,and,0,1
140133,usual,0,1
140134,care,0,1
140135,in,0,1
140136,symptoms,0,1
140137,or,0,1
140138,functioning,0,1
140139,.,0,1
140140,Participants,0,1
140141,assigned,0,1
140142,to,0,1
140143,3CM,0,1
140144,were,0,0
140145,more,0,0
140146,likely,0,0
140147,to,0,0
140148,have,0,0
140149,a,0,0
140150,mental,0,1
140151,health,0,0
140152,visit,0,0
140153,",",0,0
140154,fill,0,0
140155,an,0,0
140156,antidepressant,0,0
140157,prescription,0,0
140158,",",0,0
140159,and,0,0
140160,have,0,0
140161,adequate,0,0
140162,antidepressant,0,1
140163,refills,0,0
140164,.,0,1
140165,3CM,0,1
140166,participants,0,1
140167,also,0,0
140168,had,0,0
140169,more,0,0
140170,mental,0,0
140171,health,0,0
140172,visits,0,0
140173,and,0,1
140174,higher,0,0
140175,outpatient,0,1
140176,pharmacy,0,1
140177,costs,0,1
140178,.,0,1
140179,CONCLUSIONS,0,0
140180,Results,0,0
140181,suggest,0,0
140182,the,0,0
140183,need,0,0
140184,for,0,0
140185,careful,0,0
140186,examination,0,1
140187,of,0,0
140188,the,0,0
140189,way,0,0
140190,that,0,0
140191,collaborative,0,1
140192,care,0,1
140193,models,0,1
140194,are,0,0
140195,implemented,0,0
140196,for,0,0
140197,treating,0,0
140198,PTSD,0,1
140199,",",0,0
140200,and,0,0
140201,for,0,0
140202,additional,0,1
140203,supports,0,0
140204,to,0,1
140205,encourage,0,0
140206,primary,0,1
140207,care,0,1
140208,providers,0,1
140209,to,0,1
140210,manage,0,1
140211,PTSD,0,1
140212,.,0,1
140213,Teaching,0,0
140214,emotion,0,0
140215,recognition,0,1
140216,skills,0,0
140217,to,0,1
140218,young,1,1
140219,children,1,1
140220,with,1,1
140221,autism,1,1
140222,:,1,1
140223,a,0,1
140224,randomised,0,0
140225,controlled,0,0
140226,trial,0,1
140227,of,0,0
140228,an,0,0
140229,emotion,0,0
140230,training,0,0
140231,programme,0,1
140232,.,0,1
140233,BACKGROUND,0,0
140234,Children,1,1
140235,with,1,1
140236,autism,1,1
140237,have,0,0
140238,difficulties,0,0
140239,in,0,1
140240,emotion,0,0
140241,recognition,0,0
140242,and,0,0
140243,a,0,0
140244,number,0,0
140245,of,0,0
140246,interventions,0,0
140247,have,0,1
140248,been,0,0
140249,designed,0,0
140250,to,0,0
140251,target,0,0
140252,these,0,0
140253,problems,0,0
140254,.,0,1
140255,However,0,0
140256,",",0,0
140257,few,0,0
140258,emotion,0,0
140259,training,0,0
140260,interventions,0,0
140261,have,0,1
140262,been,0,0
140263,trialled,0,1
140264,with,0,1
140265,young,1,1
140266,children,1,1
140267,with,1,1
140268,autism,1,1
140269,and,1,1
140270,co-morbid,1,1
140271,ID,1,1
140272,.,1,1
140273,This,0,0
140274,study,0,0
140275,aimed,0,0
140276,to,0,0
140277,evaluate,0,0
140278,the,0,0
140279,efficacy,0,0
140280,of,0,0
140281,an,0,0
140282,emotion,0,0
140283,training,0,0
140284,programme,0,1
140285,for,0,0
140286,a,0,0
140287,group,1,1
140288,of,1,0
140289,young,1,1
140290,children,1,1
140291,with,1,1
140292,autism,1,1
140293,with,1,1
140294,a,1,0
140295,range,1,1
140296,of,1,0
140297,intellectual,1,1
140298,ability,1,0
140299,.,1,1
140300,METHODS,0,0
140301,Participants,1,1
140302,were,1,1
140303,55,1,1
140304,children,1,1
140305,with,1,1
140306,autistic,1,1
140307,disorder,1,1
140308,",",1,1
140309,aged,1,1
140310,4-7,1,1
140311,years,1,1
140312,(,1,1
140313,FSIQ,1,1
140314,42-107,1,1
140315,),1,1
140316,.,1,1
140317,Children,0,1
140318,were,0,0
140319,randomly,0,1
140320,assigned,0,1
140321,to,0,0
140322,an,0,0
140323,intervention,0,0
140324,(,0,0
140325,n,0,1
140326,=,0,1
140327,28,0,1
140328,),0,1
140329,or,0,1
140330,control,0,1
140331,group,0,1
140332,(,0,0
140333,n,0,1
140334,=,0,1
140335,27,0,1
140336,),0,1
140337,.,0,1
140338,Participants,0,1
140339,in,0,0
140340,the,0,0
140341,intervention,0,0
140342,group,0,0
140343,watched,0,1
140344,a,0,0
140345,DVD,0,0
140346,designed,0,0
140347,to,0,0
140348,teach,0,0
140349,emotion,0,0
140350,recognition,0,0
140351,skills,0,0
140352,to,0,1
140353,children,0,1
140354,with,0,1
140355,autism,0,1
140356,(,0,1
140357,the,0,0
140358,Transporters,0,0
140359,),0,1
140360,",",0,1
140361,whereas,0,0
140362,the,0,0
140363,control,0,1
140364,group,0,0
140365,watched,0,1
140366,a,0,0
140367,DVD,0,0
140368,of,0,0
140369,Thomas,0,1
140370,the,0,0
140371,Tank,0,1
140372,Engine,0,0
140373,.,0,1
140374,Participants,0,1
140375,were,0,0
140376,assessed,0,0
140377,on,0,0
140378,their,0,1
140379,ability,0,0
140380,to,0,0
140381,complete,0,1
140382,basic,0,0
140383,emotion,0,0
140384,recognition,0,0
140385,tasks,0,0
140386,",",0,1
140387,mindreading,0,1
140388,and,0,0
140389,theory,0,0
140390,of,0,0
140391,mind,0,1
140392,(,0,1
140393,TOM,0,1
140394,),0,1
140395,tasks,0,0
140396,before,0,1
140397,and,0,1
140398,after,0,0
140399,the,0,0
140400,4-week,0,0
140401,intervention,0,0
140402,period,0,0
140403,",",0,0
140404,and,0,0
140405,at,0,0
140406,3-month,0,0
140407,follow-up,0,1
140408,.,0,1
140409,RESULTS,0,0
140410,Analyses,0,0
140411,controlled,0,0
140412,for,0,0
140413,the,0,0
140414,effect,0,0
140415,of,0,0
140416,chronological,0,1
140417,age,0,1
140418,",",0,0
140419,verbal,0,0
140420,intelligence,0,1
140421,",",0,0
140422,gender,0,0
140423,and,0,0
140424,DVD,0,1
140425,viewing,0,0
140426,time,0,0
140427,on,0,1
140428,outcomes,0,0
140429,.,0,1
140430,Children,0,1
140431,in,0,0
140432,the,0,0
140433,intervention,0,0
140434,group,0,0
140435,showed,0,0
140436,improved,0,0
140437,performance,0,0
140438,in,0,0
140439,the,0,0
140440,recognition,0,0
140441,of,0,0
140442,anger,0,0
140443,compared,0,0
140444,with,0,1
140445,the,0,0
140446,control,0,0
140447,group,0,0
140448,",",0,0
140449,with,0,1
140450,few,0,0
140451,improvements,0,0
140452,maintained,0,1
140453,at,0,1
140454,3-month,0,0
140455,follow-up,0,0
140456,.,0,0
140457,There,0,0
140458,was,0,0
140459,no,0,0
140460,generalisation,0,0
140461,of,0,0
140462,skills,0,0
140463,to,0,1
140464,TOM,0,1
140465,or,0,1
140466,social,0,1
140467,skills,0,0
140468,.,0,1
140469,CONCLUSIONS,0,0
140470,The,0,0
140471,Transporters,0,0
140472,programme,0,1
140473,showed,0,0
140474,limited,0,0
140475,efficacy,0,0
140476,in,0,0
140477,teaching,0,1
140478,basic,0,0
140479,emotion,0,0
140480,recognition,0,0
140481,skills,0,0
140482,to,0,1
140483,young,1,1
140484,children,1,1
140485,with,1,1
140486,autism,1,1
140487,with,0,1
140488,a,0,0
140489,lower,0,0
140490,range,0,1
140491,of,0,0
140492,cognitive,0,1
140493,ability,0,0
140494,.,0,1
140495,Improvements,0,0
140496,were,0,1
140497,limited,0,0
140498,to,0,0
140499,the,0,0
140500,recognition,0,0
140501,of,0,0
140502,expressions,0,0
140503,of,0,1
140504,anger,0,0
140505,",",0,0
140506,with,0,1
140507,poor,0,1
140508,maintenance,0,1
140509,of,0,0
140510,these,0,0
140511,skills,0,0
140512,at,0,1
140513,follow-up,0,1
140514,.,0,1
140515,These,0,0
140516,findings,0,0
140517,provide,0,0
140518,limited,0,0
140519,support,0,0
140520,for,0,0
140521,the,0,0
140522,efficacy,0,0
140523,of,0,0
140524,the,0,0
140525,Transporters,0,0
140526,programme,0,1
140527,for,0,1
140528,young,1,1
140529,children,1,1
140530,with,1,1
140531,autism,1,1
140532,of,0,0
140533,a,0,1
140534,lower,0,0
140535,cognitive,0,0
140536,range,0,1
140537,.,0,1
140538,Who,0,1
140539,is,0,1
140540,at,0,1
140541,low,0,0
140542,risk,0,1
140543,for,0,0
140544,cardiovascular,0,1
140545,disease,0,1
140546,?,0,1
140547,An,0,0
140548,assessment,0,0
140549,of,0,0
140550,different,0,1
140551,definitions,0,1
140552,.,0,1
140553,BACKGROUND,0,0
140554,There,0,0
140555,is,0,0
140556,little,0,0
140557,information,0,0
140558,regarding,0,0
140559,the,0,0
140560,determinants,0,0
140561,and,0,1
140562,trends,0,0
140563,of,0,0
140564,the,0,0
140565,prevalence,0,0
140566,of,0,0
140567,low,0,1
140568,cardiovascular,0,1
140569,risk,0,1
140570,factor,0,0
140571,(,0,1
140572,RF,0,0
140573,),0,1
140574,profile,0,0
140575,in,0,0
140576,the,0,0
140577,general,1,1
140578,population,1,1
140579,.,1,1
140580,The,0,0
140581,aim,0,0
140582,of,0,0
140583,this,0,0
140584,study,0,0
140585,was,0,0
140586,to,0,0
140587,assess,0,0
140588,the,0,0
140589,prevalence,0,0
140590,and,0,0
140591,trends,0,0
140592,of,0,1
140593,low,0,1
140594,RF,0,0
140595,profile,0,0
140596,in,0,0
140597,the,0,0
140598,Swiss,1,1
140599,population,1,1
140600,according,0,1
140601,to,0,1
140602,different,0,1
140603,definitions,0,1
140604,.,0,1
140605,METHODS,0,0
140606,Population-based,1,0
140607,cross-sectional,1,1
140608,studies,1,0
140609,conducted,1,1
140610,in,1,1
140611,1984-1986,1,1
140612,(,1,1
140613,N=3300,1,1
140614,),1,1
140615,",",1,0
140616,1988-1989,1,1
140617,(,1,1
140618,N=3331,1,1
140619,),1,1
140620,",",1,0
140621,1992-1993,1,1
140622,(,1,1
140623,N=3133,1,1
140624,),1,1
140625,and,1,1
140626,2003-2006,1,1
140627,(,1,1
140628,N=6170,1,1
140629,),1,1
140630,and,1,0
140631,restricted,1,1
140632,to,1,0
140633,age,1,1
140634,group,1,1
140635,35-75,1,1
140636,years,1,1
140637,.,1,1
140638,Seven,0,0
140639,different,0,0
140640,definitions,0,0
140641,of,0,1
140642,low,0,1
140643,RF,0,0
140644,profile,0,0
140645,were,0,1
140646,used,0,0
140647,to,0,0
140648,assess,0,0
140649,determinants,0,0
140650,",",0,1
140651,while,0,0
140652,two,0,1
140653,definitions,0,1
140654,were,0,1
140655,used,0,0
140656,to,0,0
140657,assess,0,0
140658,trends,0,0
140659,.,0,1
140660,RESULTS,0,0
140661,Prevalence,0,1
140662,of,0,1
140663,low,0,1
140664,RF,0,0
140665,profile,0,0
140666,varied,0,0
140667,between,0,0
140668,6.5,0,0
140669,%,0,0
140670,(,0,1
140671,95,0,0
140672,%,0,0
140673,confidence,0,0
140674,interval,0,0
140675,:,0,1
140676,5.9-7.1,0,0
140677,),0,1
140678,and,0,1
140679,9.7,0,0
140680,%,0,0
140681,(,0,1
140682,9.0-10.5,0,1
140683,),0,1
140684,depending,0,1
140685,on,0,0
140686,the,0,0
140687,definition,0,1
140688,used,0,0
140689,.,0,1
140690,This,0,0
140691,prevalence,0,0
140692,was,0,0
140693,higher,0,0
140694,than,0,0
140695,in,0,0
140696,other,0,1
140697,countries,0,1
140698,.,0,1
140699,Irrespective,0,0
140700,of,0,0
140701,the,0,0
140702,definition,0,0
140703,used,0,0
140704,",",0,0
140705,the,0,0
140706,prevalence,0,0
140707,of,0,0
140708,low,0,1
140709,RF,0,0
140710,profile,0,0
140711,was,0,0
140712,higher,0,0
140713,in,0,0
140714,women,0,1
140715,and,0,1
140716,in,0,1
140717,physically,0,1
140718,active,0,1
140719,participants,0,1
140720,",",0,1
140721,and,0,0
140722,decreased,0,0
140723,with,0,1
140724,increasing,0,0
140725,age,0,1
140726,or,0,1
140727,in,0,0
140728,the,0,0
140729,presence,0,0
140730,of,0,0
140731,a,0,0
140732,family,0,1
140733,history,0,1
140734,of,0,0
140735,cardiovascular,0,1
140736,disease,0,1
140737,.,0,1
140738,Using,0,0
140739,one,0,0
140740,definition,0,1
140741,",",0,0
140742,the,0,0
140743,prevalence,0,0
140744,of,0,0
140745,low,0,1
140746,RF,0,0
140747,profile,0,0
140748,increased,0,0
140749,from,0,1
140750,3.8,0,0
140751,%,0,0
140752,(,0,1
140753,3.1-4.5,0,0
140754,),0,1
140755,in,0,1
140756,1984-1986,0,1
140757,to,0,1
140758,6.7,0,0
140759,%,0,0
140760,(,0,1
140761,6.1-7.3,0,0
140762,),0,1
140763,in,0,1
140764,2003-2006,0,1
140765,;,0,1
140766,using,0,0
140767,another,0,1
140768,definition,0,0
140769,",",0,0
140770,the,0,0
140771,results,0,0
140772,were,0,1
140773,5.9,0,0
140774,%,0,0
140775,(,0,1
140776,5.1-6.8,0,0
140777,),0,1
140778,and,0,1
140779,9.7,0,0
140780,%,0,0
140781,(,0,1
140782,9.0-10.5,0,1
140783,),0,0
140784,",",0,0
140785,respectively,0,0
140786,.,0,1
140787,CONCLUSION,0,0
140788,Switzerland,0,1
140789,is,0,0
140790,characterized,0,0
140791,by,0,0
140792,a,0,1
140793,high,0,1
140794,and,0,0
140795,increasing,0,0
140796,prevalence,0,0
140797,of,0,1
140798,low,0,1
140799,RF,0,0
140800,profile,0,0
140801,within,0,0
140802,the,0,0
140803,age,1,1
140804,group,1,1
140805,35,1,1
140806,to,1,1
140807,75,1,1
140808,",",0,0
140809,irrespective,0,0
140810,of,0,0
140811,the,0,0
140812,criteria,0,1
140813,used,0,0
140814,.,0,1
140815,This,0,0
140816,high,0,0
140817,prevalence,0,0
140818,might,0,0
140819,partly,0,0
140820,explain,0,0
140821,the,0,0
140822,low,0,0
140823,and,0,0
140824,decreasing,0,0
140825,trend,0,0
140826,in,0,1
140827,cardiovascular,0,1
140828,mortality,0,1
140829,rates,0,0
140830,.,0,1
140831,A,0,0
140832,comparison,0,0
140833,between,0,0
140834,oral,0,1
140835,ciprofloxacin,0,1
140836,and,0,1
140837,intra-peritoneal,0,0
140838,vancomycin,0,0
140839,and,0,0
140840,gentamicin,0,0
140841,in,0,0
140842,the,0,0
140843,treatment,0,0
140844,of,0,0
140845,CAPD,1,0
140846,peritonitis,1,1
140847,.,1,1
140848,Fifty-one,1,1
140849,patients,1,1
140850,were,1,1
140851,included,1,1
140852,in,0,0
140853,a,0,0
140854,prospective,0,1
140855,",",0,0
140856,randomized,0,1
140857,comparison,0,0
140858,of,0,0
140859,oral,0,1
140860,ciprofloxacin,0,1
140861,and,0,1
140862,intraperitoneal,0,0
140863,vancomycin/gentamicin,0,0
140864,in,0,0
140865,the,0,0
140866,treatment,0,0
140867,of,0,0
140868,CAPD,1,0
140869,peritonitis,1,1
140870,.,1,1
140871,Staphylococcal,0,0
140872,species,0,0
140873,accounted,0,0
140874,for,0,1
140875,40,0,1
140876,%,0,0
140877,of,0,0
140878,the,0,0
140879,isolates,0,1
140880,with,0,1
140881,an,0,1
140882,equal,0,0
140883,incidence,0,0
140884,of,0,0
140885,Staphylococcus,0,1
140886,aureus,0,1
140887,and,0,0
140888,coagulase,0,1
140889,negative,0,1
140890,staphylococci,0,1
140891,.,0,1
140892,Although,0,0
140893,",",0,0
140894,overall,0,0
140895,",",0,0
140896,there,0,0
140897,was,0,0
140898,no,0,0
140899,significant,0,0
140900,difference,0,0
140901,between,0,0
140902,the,0,0
140903,regimens,0,0
140904,in,0,0
140905,outcome,0,0
140906,",",0,0
140907,ciprofloxacin,0,0
140908,was,0,0
140909,significantly,0,0
140910,less,0,0
140911,effective,0,0
140912,when,0,0
140913,peritonitis,0,1
140914,was,0,0
140915,due,0,0
140916,to,0,0
140917,coagulase,0,1
140918,negative,0,0
140919,staphylococci,0,1
140920,.,0,1
140921,Psychological,0,1
140922,adjustment,0,0
140923,and,0,1
140924,levels,0,0
140925,of,0,1
140926,self,0,1
140927,esteem,0,0
140928,in,0,0
140929,children,1,1
140930,with,1,1
140931,visual-motor,1,1
140932,integration,1,0
140933,difficulties,1,0
140934,influences,0,0
140935,the,0,0
140936,results,0,0
140937,of,0,0
140938,a,0,1
140939,randomized,0,1
140940,intervention,0,0
140941,trial,0,0
140942,.,0,1
140943,This,0,0
140944,study,0,0
140945,evaluates,0,0
140946,how,0,0
140947,much,0,0
140948,the,0,0
140949,effects,0,0
140950,of,0,1
140951,intervention,0,1
140952,programs,0,1
140953,are,0,0
140954,influenced,0,0
140955,by,0,0
140956,pre-existing,1,1
140957,psychological,1,1
140958,adjustment,1,0
140959,and,1,1
140960,self-esteem,1,0
140961,levels,1,0
140962,in,1,1
140963,kindergarten,1,1
140964,and,1,1
140965,first,1,0
140966,grade,1,1
140967,children,1,1
140968,with,1,1
140969,poor,1,1
140970,visual-motor,1,1
140971,integration,1,1
140972,skills,1,0
140973,",",1,1
140974,from,1,1
140975,low,1,1
140976,socioeconomic,1,1
140977,backgrounds,1,1
140978,.,1,1
140979,One,1,1
140980,hundred,1,1
140981,and,1,1
140982,sixteen,1,1
140983,mainstream,1,1
140984,kindergarten,1,1
140985,and,1,1
140986,first-grade,1,1
140987,children,1,1
140988,",",1,1
140989,from,1,1
140990,low,1,1
140991,socioeconomic,1,1
140992,backgrounds,1,1
140993,",",1,1
140994,scoring,1,1
140995,below,1,1
140996,the,1,0
140997,25th,1,0
140998,percentile,1,0
140999,on,1,0
141000,a,1,0
141001,measure,1,0
141002,of,1,0
141003,visual-motor,1,0
141004,integration,1,0
141005,(,1,1
141006,VMI,1,1
141007,),1,1
141008,were,1,1
141009,recruited,1,1
141010,and,0,0
141011,randomly,0,1
141012,divided,0,1
141013,into,0,1
141014,two,0,0
141015,parallel,0,0
141016,intervention,0,1
141017,groups,0,1
141018,.,0,1
141019,One,0,1
141020,intervention,0,0
141021,group,0,1
141022,received,0,1
141023,directive,0,0
141024,visual-motor,0,0
141025,intervention,0,0
141026,(,0,1
141027,DVMI,0,1
141028,),0,1
141029,",",0,0
141030,while,0,0
141031,the,0,0
141032,second,0,1
141033,intervention,0,0
141034,group,0,1
141035,received,0,0
141036,a,0,0
141037,non-directive,0,1
141038,supportive,0,0
141039,intervention,0,1
141040,(,0,1
141041,NDSI,0,1
141042,),0,1
141043,.,0,1
141044,Tests,0,0
141045,were,0,1
141046,administered,0,0
141047,to,0,0
141048,evaluate,0,0
141049,visual-motor,0,0
141050,integration,0,0
141051,skills,0,0
141052,outcome,0,0
141053,.,0,0
141054,Children,0,1
141055,with,0,1
141056,higher,0,0
141057,baseline,0,0
141058,measures,0,0
141059,of,0,1
141060,psychological,0,1
141061,adjustment,0,0
141062,and,0,1
141063,self-esteem,0,0
141064,responded,0,0
141065,better,0,0
141066,in,0,0
141067,NDSI,0,0
141068,while,0,0
141069,children,0,1
141070,with,0,1
141071,lower,0,0
141072,baseline,0,0
141073,performance,0,0
141074,on,0,0
141075,psychological,0,1
141076,adjustment,0,0
141077,and,0,1
141078,self-esteem,0,0
141079,responded,0,0
141080,better,0,0
141081,in,0,0
141082,DVMI,0,0
141083,.,0,1
141084,This,0,0
141085,study,0,0
141086,suggests,0,0
141087,that,0,0
141088,children,0,1
141089,from,0,1
141090,low,0,1
141091,socioeconomic,0,1
141092,backgrounds,0,1
141093,with,0,1
141094,low,0,1
141095,VMI,0,1
141096,performance,0,0
141097,scores,0,0
141098,will,0,0
141099,benefit,0,0
141100,more,0,0
141101,from,0,0
141102,intervention,0,0
141103,programs,0,1
141104,if,0,0
141105,clinicians,0,1
141106,choose,0,1
141107,the,0,0
141108,type,0,1
141109,of,0,0
141110,intervention,0,0
141111,according,0,1
141112,to,0,0
141113,baseline,0,0
141114,psychological,0,0
141115,adjustment,0,0
141116,and,0,1
141117,self-esteem,0,0
141118,measures,0,0
141119,.,0,1
141120,[,0,0
141121,Clinical,0,0
141122,efficiency,0,0
141123,of,0,1
141124,cytokines,0,0
141125,in,0,1
141126,prophylactics,0,1
141127,and,0,1
141128,treatment,0,1
141129,of,0,0
141130,infectious,1,1
141131,and,1,1
141132,inflammatory,1,0
141133,complications,1,1
141134,after,1,1
141135,oral,1,1
141136,surgery,1,1
141137,procedures,1,1
141138,],1,1
141139,.,0,1
141140,The,0,0
141141,study,0,0
141142,presents,0,0
141143,the,0,0
141144,results,0,0
141145,of,0,0
141146,prevention,1,1
141147,and,1,0
141148,treatment,1,0
141149,of,1,0
141150,infectious,1,1
141151,and,1,1
141152,inflammatory,1,0
141153,complications,1,1
141154,after,1,1
141155,oral,1,1
141156,surgery,1,1
141157,procedures,1,1
141158,.,1,1
141159,Combined,0,0
141160,therapy,0,0
141161,with,0,1
141162,antibiotics,0,0
141163,and,0,1
141164,superlimf,0,1
141165,promotes,0,0
141166,a,0,0
141167,more,0,0
141168,rapid,0,0
141169,reduction,0,0
141170,in,0,0
141171,the,0,0
141172,duration,0,0
141173,of,0,0
141174,clinical,0,1
141175,symptoms,0,1
141176,and,0,1
141177,duration,0,0
141178,of,0,0
141179,treatment,0,0
141180,than,0,0
141181,monotherapy,0,1
141182,with,0,1
141183,antibiotics,0,0
141184,.,0,1
141185,Results,0,0
141186,of,0,0
141187,the,0,0
141188,study,0,0
141189,substantiate,0,0
141190,the,0,0
141191,feasibility,0,0
141192,of,0,0
141193,using,0,0
141194,superlimf,0,1
141195,in,0,1
141196,outpatient,1,1
141197,oral,0,1
141198,surgical,0,1
141199,procedures,0,1
141200,for,0,1
141201,infectious,0,1
141202,and,0,1
141203,inflammatory,0,0
141204,complications,0,1
141205,treatment,0,1
141206,.,0,1
141207,Manuka,0,1
141208,honey-impregnated,0,0
141209,dressings,0,0
141210,in,0,1
141211,the,0,0
141212,treatment,0,0
141213,of,0,0
141214,neuropathic,1,1
141215,diabetic,1,1
141216,foot,1,1
141217,ulcers,1,1
141218,.,1,1
141219,In,0,0
141220,this,0,0
141221,study,0,0
141222,",",0,0
141223,we,0,0
141224,investigate,0,0
141225,the,0,0
141226,effect,0,0
141227,of,0,0
141228,manuka,0,0
141229,honey-impregnated,0,1
141230,dressings,0,0
141231,(,0,1
141232,MHID,0,0
141233,),0,1
141234,on,0,0
141235,the,0,0
141236,healing,1,0
141237,of,1,0
141238,neuropathic,1,1
141239,diabetic,1,1
141240,foot,1,1
141241,ulcers,1,1
141242,(,1,1
141243,NDFU,1,1
141244,),1,1
141245,.,0,1
141246,A,0,0
141247,total,0,1
141248,of,0,1
141249,63,1,1
141250,Caucasians,1,1
141251,",",1,1
141252,type,1,1
141253,2,1,1
141254,diabetic,1,1
141255,patients,1,1
141256,followed,1,1
141257,up,1,1
141258,in,1,0
141259,the,1,0
141260,diabetic,1,1
141261,foot,1,0
141262,outpatient,1,1
141263,clinic,1,1
141264,comprised,0,1
141265,the,0,0
141266,study,0,0
141267,population,0,1
141268,.,0,1
141269,Patients,0,1
141270,were,0,0
141271,randomised,0,1
141272,in,0,1
141273,two,0,1
141274,groups,0,0
141275,as,0,0
141276,follows,0,0
141277,:,0,1
141278,group,0,0
141279,I,0,1
141280,patients,0,1
141281,were,0,1
141282,treated,0,1
141283,with,0,1
141284,MHID,0,0
141285,and,0,1
141286,group,0,1
141287,II,0,1
141288,patients,0,1
141289,were,0,1
141290,treated,0,1
141291,with,0,1
141292,conventional,0,1
141293,dressings,0,0
141294,(,0,1
141295,CD,0,1
141296,),0,1
141297,.,0,1
141298,The,0,0
141299,patients,0,1
141300,were,0,1
141301,followed,0,1
141302,up,0,0
141303,on,0,0
141304,a,0,1
141305,weekly,0,0
141306,basis,0,0
141307,for,0,1
141308,16,0,1
141309,weeks,0,1
141310,.,0,1
141311,Mean,0,1
141312,healing,0,0
141313,time,0,0
141314,was,0,0
141315,31,0,1
141316,?,0,1
141317,4,0,0
141318,days,0,0
141319,in,0,1
141320,group,0,1
141321,I,0,1
141322,versus,0,0
141323,43,0,1
141324,?,0,1
141325,3,0,0
141326,days,0,0
141327,in,0,1
141328,group,0,1
141329,II,0,1
141330,(,0,1
141331,P,0,0
141332,<,0,0
141333,0?05,0,1
141334,),0,1
141335,.,0,1
141336,In,0,0
141337,group,0,1
141338,I,0,1
141339,patients,0,1
141340,78?13,0,1
141341,%,0,1
141342,of,0,1
141343,ulcers,0,1
141344,became,0,1
141345,sterile,0,0
141346,during,0,0
141347,the,0,0
141348,first,0,0
141349,week,0,0
141350,versus,0,0
141351,35?5,0,1
141352,%,0,0
141353,in,0,0
141354,group,0,1
141355,II,0,1
141356,patients,0,1
141357,;,0,1
141358,the,0,1
141359,corresponding,0,0
141360,percentages,0,0
141361,for,0,1
141362,weeks,0,1
141363,2,0,1
141364,",",0,1
141365,4,0,0
141366,and,0,1
141367,6,0,1
141368,were,0,1
141369,15?62,0,1
141370,%,0,0
141371,versus,0,0
141372,38?7,0,1
141373,%,0,0
141374,",",0,1
141375,6?25,0,0
141376,%,0,0
141377,versus,0,0
141378,12?9,0,1
141379,%,0,0
141380,and,0,1
141381,0,0,0
141382,%,0,0
141383,versus,0,0
141384,12?9,0,1
141385,%,0,0
141386,respectively,0,0
141387,.,0,0
141388,The,0,0
141389,percent,0,0
141390,of,0,0
141391,ulcers,0,1
141392,healed,0,1
141393,did,0,0
141394,not,0,0
141395,differ,0,0
141396,significantly,0,0
141397,between,0,0
141398,groups,0,0
141399,(,0,1
141400,97,0,1
141401,%,0,0
141402,for,0,1
141403,MHID,0,0
141404,and,0,1
141405,90,0,1
141406,%,0,0
141407,for,0,0
141408,CD,0,1
141409,),0,1
141410,.,0,1
141411,MHID,0,0
141412,represent,0,0
141413,an,0,0
141414,effective,0,0
141415,treatment,0,0
141416,for,1,1
141417,NDFU,1,1
141418,leading,0,0
141419,to,0,0
141420,a,0,1
141421,significant,0,0
141422,reduction,0,0
141423,in,0,0
141424,the,0,0
141425,time,0,0
141426,of,0,0
141427,healing,0,0
141428,and,0,1
141429,rapid,0,0
141430,disinfection,0,0
141431,of,0,1
141432,ulcers,0,1
141433,.,0,1
141434,Airway,0,1
141435,responses,0,0
141436,and,0,1
141437,inflammation,0,1
141438,in,0,0
141439,subjects,1,1
141440,with,1,1
141441,asthma,1,1
141442,after,0,1
141443,four,0,1
141444,days,0,0
141445,of,0,1
141446,repeated,0,0
141447,high-single-dose,0,1
141448,allergen,0,0
141449,challenge,0,0
141450,.,0,1
141451,BACKGROUND,0,0
141452,Both,0,0
141453,standard,0,1
141454,and,0,1
141455,low-dose,0,0
141456,allergen,0,0
141457,provocations,0,0
141458,are,0,0
141459,an,0,0
141460,established,0,0
141461,tool,0,0
141462,in,0,1
141463,asthma,0,1
141464,research,0,1
141465,to,0,0
141466,improve,0,0
141467,our,0,0
141468,understanding,0,0
141469,of,0,0
141470,the,0,0
141471,pathophysiological,0,0
141472,mechanism,0,0
141473,of,0,0
141474,allergic,1,1
141475,asthma,1,1
141476,.,1,1
141477,However,0,0
141478,",",0,0
141479,clinical,0,0
141480,symptoms,0,0
141481,are,0,0
141482,less,0,0
141483,likely,0,0
141484,to,0,0
141485,be,0,0
141486,induced,0,0
141487,.,0,0
141488,Therefore,0,0
141489,",",0,0
141490,we,0,0
141491,designed,0,0
141492,a,0,0
141493,protocol,0,0
141494,for,0,0
141495,repetitive,0,0
141496,high-dose,0,1
141497,bronchial,0,1
141498,allergen,0,1
141499,challenges,0,0
141500,to,0,1
141501,generate,0,1
141502,clinical,0,0
141503,symptoms,0,0
141504,and,0,1
141505,airway,0,1
141506,inflammation,0,1
141507,.,0,1
141508,METHODS,0,0
141509,A,0,0
141510,total,0,1
141511,of,0,1
141512,27,1,1
141513,patients,1,1
141514,aged,1,1
141515,18,1,1
141516,to,1,1
141517,40,1,1
141518,years,1,1
141519,with,1,1
141520,positive,1,1
141521,skin-prick,1,1
141522,tests,1,0
141523,and,1,1
141524,mild,1,1
141525,asthma,1,1
141526,underwent,0,1
141527,repetitive,0,0
141528,high-dose,0,1
141529,allergen,0,0
141530,challenges,0,0
141531,with,0,1
141532,household,0,1
141533,dust,0,1
141534,mites,0,1
141535,for,0,1
141536,four,0,1
141537,consecutive,0,1
141538,days,0,1
141539,.,0,1
141540,Pulmonary,0,1
141541,function,0,0
141542,and,0,1
141543,exhaled,0,0
141544,NO,0,0
141545,were,0,1
141546,measured,0,0
141547,at,0,0
141548,every,0,0
141549,visit,0,0
141550,.,0,1
141551,Induced,0,0
141552,sputum,0,1
141553,was,0,0
141554,analysed,0,1
141555,before,0,0
141556,and,0,0
141557,after,0,0
141558,the,0,0
141559,allergen,0,0
141560,challenges,0,0
141561,for,0,0
141562,cell,0,1
141563,counts,0,0
141564,",",0,1
141565,ECP,0,0
141566,",",0,0
141567,IL-5,0,0
141568,",",0,0
141569,INF-?,0,1
141570,",",0,0
141571,IL-8,0,0
141572,",",0,0
141573,and,0,0
141574,the,0,0
141575,transcription,0,0
141576,factor,0,0
141577,Foxp3,0,1
141578,.,0,1
141579,RESULTS,0,0
141580,We,0,0
141581,found,0,0
141582,a,0,0
141583,significant,0,0
141584,decrease,0,0
141585,in,0,1
141586,pulmonary,0,1
141587,function,0,0
141588,",",0,0
141589,an,0,0
141590,increased,0,0
141591,use,0,0
141592,of,0,0
141593,salbutamol,0,0
141594,and,0,0
141595,the,0,0
141596,development,0,0
141597,of,0,0
141598,a,0,1
141599,late,0,1
141600,asthmatic,0,1
141601,response,0,0
141602,and,0,1
141603,bronchial,0,1
141604,hyperresponsiveness,0,0
141605,",",0,0
141606,as,0,0
141607,well,0,0
141608,as,0,0
141609,a,0,0
141610,significant,0,0
141611,induction,0,0
141612,of,0,0
141613,eNO,0,1
141614,",",0,1
141615,eosinophils,0,0
141616,",",0,0
141617,and,0,1
141618,Th-2,0,0
141619,cytokines,0,0
141620,.,0,1
141621,Repeated,0,0
141622,provocation,0,0
141623,was,0,0
141624,feasible,0,0
141625,in,0,0
141626,the,0,0
141627,majority,0,1
141628,of,0,0
141629,patients,0,1
141630,.,0,1
141631,Two,0,1
141632,subjects,0,1
141633,had,0,1
141634,severe,0,1
141635,adverse,0,0
141636,events,0,0
141637,requiring,0,1
141638,prednisolone,0,0
141639,to,0,0
141640,cope,0,1
141641,with,0,1
141642,nocturnal,0,1
141643,asthma,0,1
141644,symptoms,0,1
141645,.,0,1
141646,CONCLUSIONS,0,0
141647,Repeated,0,0
141648,high-dose,0,0
141649,bronchial,0,1
141650,allergen,0,1
141651,challenges,0,0
141652,resulted,0,0
141653,in,0,1
141654,severe,0,1
141655,asthma,0,1
141656,symptoms,0,1
141657,and,0,1
141658,marked,0,1
141659,Th-2-mediated,0,0
141660,allergic,0,1
141661,airway,0,1
141662,inflammation,0,1
141663,.,0,1
141664,The,0,0
141665,high-dose,0,0
141666,challenge,0,0
141667,model,0,0
141668,is,0,0
141669,suitable,0,0
141670,only,0,0
141671,in,0,0
141672,an,0,0
141673,attenuated,0,0
141674,form,0,0
141675,in,1,1
141676,diseased,1,1
141677,volunteers,1,1
141678,for,0,1
141679,proof-of-concept,0,1
141680,studies,0,0
141681,and,0,1
141682,in,0,1
141683,clinical,0,1
141684,settings,0,1
141685,to,0,1
141686,reduce,0,0
141687,the,0,0
141688,risk,0,0
141689,of,0,0
141690,severe,0,1
141691,asthma,0,1
141692,exacerbations,0,1
141693,.,0,1
141694,TRIAL,0,0
141695,REGISTRATION,0,0
141696,ClinicalTrials.govNCT00677209,0,1
141697,.,0,1
141698,Improving,0,0
141699,RBC,0,1
141700,K,0,0
141701,transport,0,0
141702,and,0,1
141703,hemoglobin-O2,0,0
141704,binding,0,0
141705,by,0,0
141706,amiloride,0,0
141707,:,0,1
141708,A,0,1
141709,novel,0,0
141710,therapeutic,0,0
141711,approach,0,1
141712,for,0,0
141713,reversion,0,0
141714,of,0,0
141715,angina,0,1
141716,and,0,1
141717,myocardial,0,1
141718,ischemia,0,1
141719,in,0,1
141720,coronary,1,1
141721,heart,1,1
141722,diseases,1,1
141723,.,1,1
141724,UNLABELLED,0,0
141725,Coronary,0,1
141726,heart,0,1
141727,disease,0,1
141728,(,0,1
141729,CHD,0,0
141730,),0,0
141731,is,0,0
141732,the,0,0
141733,leading,0,0
141734,cause,0,0
141735,of,0,0
141736,morbidity,0,0
141737,and,0,0
141738,mortality,0,0
141739,across,0,0
141740,the,0,0
141741,entire,0,0
141742,world,0,0
141743,",",0,0
141744,in,0,0
141745,which,0,0
141746,reversion,0,0
141747,of,0,0
141748,angina,0,1
141749,or,0,1
141750,improvement,0,0
141751,of,0,0
141752,ECG,0,0
141753,remains,0,0
141754,an,0,0
141755,unrealistic,0,0
141756,therapeutic,0,0
141757,option,0,0
141758,for,0,1
141759,most,0,0
141760,patients,0,1
141761,",",0,0
141762,suggesting,0,0
141763,that,0,0
141764,microvascular,0,1
141765,dysfunction,0,1
141766,or,0,1
141767,impaired,0,1
141768,oxygen,0,0
141769,delivery,0,0
141770,might,0,0
141771,be,0,0
141772,critical,0,0
141773,factors,0,0
141774,in,0,1
141775,CHD,0,1
141776,.,0,1
141777,This,0,0
141778,research,0,0
141779,article,0,0
141780,",",0,0
141781,thus,0,0
141782,presents,0,0
141783,the,0,0
141784,rationale,0,0
141785,basis,0,0
141786,",",0,1
141787,clinical,0,0
141788,and,0,0
141789,experimental,0,0
141790,",",0,0
141791,for,0,0
141792,the,0,0
141793,first,0,0
141794,therapeutic,0,0
141795,innovation,0,0
141796,addressing,0,0
141797,the,0,0
141798,role,0,0
141799,of,0,0
141800,red,0,1
141801,blood,0,0
141802,cell,0,1
141803,(,0,1
141804,RBC,0,1
141805,),0,1
141806,H/K,0,0
141807,and,0,1
141808,O2/CO2,0,1
141809,exchanges,0,0
141810,in,0,1
141811,CHD,0,1
141812,.,0,1
141813,It,0,0
141814,is,0,0
141815,followed,0,0
141816,by,0,0
141817,a,0,1
141818,randomized,0,1
141819,single-blind,0,0
141820,trial,0,1
141821,of,0,1
141822,Amiloride,1,0
141823,and,1,1
141824,Optimal,1,0
141825,Medical,1,1
141826,Therapy,1,1
141827,(,1,1
141828,OMT,1,1
141829,",",1,1
141830,n=35,1,1
141831,cases,1,1
141832,),1,1
141833,vs,1,0
141834,OMT,1,0
141835,alone,1,0
141836,(,1,1
141837,n=35,1,1
141838,cases,1,1
141839,),1,1
141840,in,1,1
141841,patients,1,1
141842,having,1,1
141843,angina,1,1
141844,",",1,0
141845,ST-T,1,1
141846,alteration,1,0
141847,and,1,0
141848,a,1,1
141849,defective,1,0
141850,RBC-K,1,1
141851,transport,1,0
141852,.,1,1
141853,All,1,1
141854,patients,1,1
141855,had,1,1
141856,serial,1,1
141857,clinical,1,0
141858,evaluation,1,0
141859,",",1,1
141860,Ion,1,0
141861,Transport,1,1
141862,Studies,1,1
141863,",",1,1
141864,ECGs,1,0
141865,and,1,1
141866,non-invasive,1,0
141867,aortic,1,1
141868,waveform,1,0
141869,and,1,1
141870,cardiovascular,1,1
141871,hemodynamic,1,0
141872,recordings,1,1
141873,.,1,1
141874,Statistical,0,0
141875,analysis,0,0
141876,was,0,0
141877,performed,0,0
141878,by,0,0
141879,SAS,0,0
141880,.,0,1
141881,RESULTS,0,0
141882,Amiloride,0,0
141883,rapidly,0,1
141884,improved,0,0
141885,RBC-K,0,1
141886,(,0,1
141887,93.5,0,0
141888,?4,0,0
141889,vs,0,0
141890,84.5,0,0
141891,?4,0,0
141892,mmol/lc,0,0
141893,",",0,0
141894,p=,0,0
141895,<,0,0
141896,0.001,0,0
141897,),0,0
141898,",",0,0
141899,angina,0,1
141900,(,0,0
141901,80,0,1
141902,%,0,0
141903,of,0,1
141904,cases,0,1
141905,",",0,1
141906,1.5,0,1
141907,?0.3,0,0
141908,weeks,0,0
141909,",",0,1
141910,CI:1.72,0,0
141911,to,0,1
141912,1.45,0,0
141913,),0,1
141914,",",0,1
141915,CCS,0,0
141916,Class,0,1
141917,(,0,1
141918,1.3,0,0
141919,?0.5,0,0
141920,vs,0,0
141921,3.1,0,0
141922,?0.8,0,0
141923,",",0,0
141924,p,0,0
141925,<,0,0
141926,0.001,0,0
141927,),0,1
141928,vs,0,0
141929,patients,0,1
141930,with,0,1
141931,OMT,0,1
141932,alone,0,1
141933,CCS,0,0
141934,Class,0,1
141935,(,0,1
141936,3.2,0,1
141937,?,0,1
141938,0.4,0,0
141939,vs,0,0
141940,3.3,0,1
141941,?,0,1
141942,0.5,0,0
141943,",",0,0
141944,p,0,0
141945,=0.21,0,0
141946,),0,1
141947,.,0,1
141948,Reversion,0,0
141949,of,0,0
141950,angina,0,1
141951,was,0,0
141952,sustained,0,0
141953,through,0,0
141954,the,0,0
141955,next,0,1
141956,6-months,0,0
141957,(,0,1
141958,87,0,1
141959,%,0,0
141960,vs,0,0
141961,26,0,1
141962,%,0,0
141963,in,0,0
141964,OMT,0,1
141965,",",0,1
141966,RR,0,1
141967,2.1,0,0
141968,",",0,0
141969,odds,0,0
141970,ratio,0,0
141971,6.31,0,0
141972,",",0,1
141973,Pearson,0,0
141974,x2,0,0
141975,34.6,0,0
141976,",",0,0
141977,p,0,0
141978,<,0,0
141979,0.0001,0,0
141980,at,0,1
141981,95,0,0
141982,%,0,0
141983,CI,0,0
141984,),0,1
141985,and,0,1
141986,1-year,0,0
141987,(,0,1
141988,85,0,1
141989,%,0,0
141990,vs,0,0
141991,37,0,1
141992,%,0,0
141993,OMT,0,1
141994,),0,1
141995,.,0,1
141996,At,0,0
141997,6-months,0,0
141998,of,0,0
141999,amiloride,0,0
142000,",",0,1
142001,ECG,0,0
142002,became,0,1
142003,normal,0,1
142004,(,0,1
142005,29,0,1
142006,%,0,0
142007,vs,0,0
142008,0,0,0
142009,%,0,0
142010,",",0,1
142011,RR,0,1
142012,?,0,1
142013,uncalculated-time,0,0
142014,",",0,0
142015,odds,0,0
142016,ratio,0,0
142017,?,0,1
142018,",",0,0
142019,Pearson,0,0
142020,x2,0,0
142021,42.4,0,1
142022,at,0,1
142023,95,0,0
142024,%,0,0
142025,CI,0,0
142026,",",0,0
142027,p,0,0
142028,<,0,0
142029,0.0001,0,0
142030,),0,1
142031,",",0,0
142032,improved,0,0
142033,(,0,1
142034,55,0,1
142035,%,0,0
142036,vs,0,0
142037,29,0,1
142038,%,0,0
142039,;,0,1
142040,RR2.1,0,0
142041,",",0,0
142042,odds,0,0
142043,ratio,0,0
142044,3.16,0,0
142045,",",0,1
142046,95,0,0
142047,%,0,0
142048,CI,0,0
142049,",",0,0
142050,p,0,0
142051,<,0,0
142052,0.0001,0,0
142053,),0,1
142054,or,0,1
142055,unchanged,0,0
142056,(,0,1
142057,15,0,1
142058,%,0,0
142059,vs,0,0
142060,67,0,1
142061,%,0,0
142062,OMT,0,1
142063,),0,1
142064,.,0,1
142065,At,0,0
142066,1-year,0,0
142067,",",0,1
142068,seven,0,1
142069,patients,0,1
142070,on,0,1
142071,amiloride,0,0
142072,(,0,1
142073,18,0,1
142074,%,0,0
142075,),0,1
142076,exhibited,0,0
142077,evidence,0,0
142078,of,0,0
142079,electrical,0,0
142080,regeneration,0,1
142081,of,0,0
142082,the,0,0
142083,heart,0,1
142084,",",0,0
142085,not,0,0
142086,observed,0,0
142087,with,0,1
142088,placebo,0,1
142089,.,0,1
142090,IN,0,1
142091,CONCLUSION,0,0
142092,This,0,0
142093,therapeutical,0,0
142094,innovation,0,0
142095,of,0,1
142096,amiloride,0,0
142097,improves,0,0
142098,RBC,0,1
142099,H/K,0,1
142100,and,0,1
142101,O2/CO2,0,0
142102,function,0,0
142103,",",0,0
142104,and,0,0
142105,reverses,0,0
142106,angina,0,1
142107,",",0,0
142108,ST-T,0,1
142109,alterations,0,0
142110,while,0,0
142111,inducing,0,1
142112,electrical,0,0
142113,regeneration,0,1
142114,of,0,0
142115,the,0,0
142116,heart,0,1
142117,",",0,0
142118,in,1,0
142119,patients,1,1
142120,receiving,1,1
142121,optimal,1,0
142122,medical,1,1
142123,treatment,1,1
142124,for,1,1
142125,angina,1,1
142126,.,0,1
142127,The,0,0
142128,article,0,0
142129,has,0,0
142130,short,0,0
142131,discussion,0,0
142132,on,0,0
142133,the,0,0
142134,relevant,0,1
142135,patents,0,1
142136,to,0,1
142137,the,0,0
142138,topic,0,0
142139,.,0,1
142140,The,0,0
142141,effects,0,0
142142,of,0,0
142143,moderate,0,1
142144,to,0,1
142145,vigorous,0,1
142146,aerobic,0,0
142147,exercise,0,0
142148,on,0,0
142149,the,0,0
142150,sleep,1,1
142151,need,1,0
142152,of,1,0
142153,sedentary,1,1
142154,young,1,1
142155,adults,1,1
142156,.,1,1
142157,Exercise,0,0
142158,has,0,0
142159,been,0,0
142160,recommended,0,0
142161,for,0,0
142162,enhancing,0,0
142163,sleep,0,1
142164,;,0,1
142165,a,0,0
142166,claim,0,1
142167,linked,0,0
142168,to,0,0
142169,the,0,0
142170,belief,0,0
142171,that,0,0
142172,sleep,0,1
142173,need,0,0
142174,-,0,0
142175,defined,0,0
142176,by,0,0
142177,sleep,0,1
142178,duration,0,0
142179,and,0,1
142180,depth,0,0
142181,-,0,0
142182,is,0,0
142183,increased,0,0
142184,post-exercise,0,0
142185,to,0,0
142186,allow,0,0
142187,tissue,0,1
142188,recovery,0,0
142189,.,0,1
142190,Objective,0,0
142191,studies,0,0
142192,investigating,0,0
142193,exercise-sleep,0,1
142194,responses,0,0
142195,have,0,1
142196,produced,0,0
142197,mixed,0,1
142198,outcomes,0,0
142199,",",0,1
142200,and,0,0
142201,the,0,0
142202,disparity,0,0
142203,in,0,0
142204,results,0,0
142205,between,0,0
142206,studies,0,0
142207,may,0,0
142208,be,0,0
142209,due,0,0
142210,to,0,1
142211,differences,0,0
142212,in,0,1
142213,individual,0,0
142214,characteristics,0,1
142215,and/or,0,1
142216,exercise,0,0
142217,protocol,0,0
142218,",",0,0
142219,emphasising,0,0
142220,the,0,0
142221,importance,0,0
142222,of,0,0
142223,carefully,0,1
142224,controlled,0,1
142225,trials,0,0
142226,.,0,1
142227,We,0,0
142228,investigated,0,0
142229,the,0,0
142230,role,0,0
142231,of,0,0
142232,exercise,0,0
142233,on,0,0
142234,the,0,0
142235,sleep,0,1
142236,need,0,0
142237,of,0,1
142238,sedentary,1,1
142239,adults,1,1
142240,",",0,1
142241,after,0,0
142242,controlling,0,0
142243,for,0,0
142244,exercise,0,0
142245,mode,0,0
142246,",",0,0
142247,timing,0,0
142248,and,0,0
142249,duration,0,0
142250,.,0,1
142251,Twelve,1,1
142252,healthy,1,1
142253,volunteers,1,1
142254,(,1,1
142255,25.2,1,1
142256,?,1,1
142257,4.0,1,0
142258,years,1,1
142259,",",1,1
142260,9,1,0
142261,females,1,1
142262,",",1,1
142263,[,1,0
142264,Vdot,1,1
142265,],1,1
142266,O,1,0
142267,(,1,1
142268,2,1,1
142269,),1,1
142270,max,1,1
142271,35.4,1,1
142272,?,1,1
142273,8.8,1,0
142274,ml?,1,0
142275,kg,1,1
142276,(,1,1
142277,-1,1,0
142278,),1,1
142279,?,1,1
142280,min,1,0
142281,(,1,0
142282,-1,1,0
142283,),1,1
142284,),1,1
142285,were,1,1
142286,randomised,0,0
142287,to,0,0
142288,no-exercise,0,0
142289,or,0,1
142290,to,0,0
142291,a,0,0
142292,bout,0,0
142293,of,0,0
142294,treadmill,0,0
142295,exercise,0,1
142296,at,0,1
142297,45,0,1
142298,%,0,0
142299,",",0,1
142300,55,0,1
142301,%,0,0
142302,",",0,1
142303,65,0,1
142304,%,0,0
142305,or,0,1
142306,75,0,1
142307,%,0,0
142308,[,0,1
142309,Vdot,0,1
142310,],0,1
142311,O,0,0
142312,(,0,1
142313,2,0,1
142314,),0,1
142315,max,0,0
142316,in,0,0
142317,a,0,0
142318,crossover,0,0
142319,design,0,1
142320,.,0,0
142321,Sleep,0,0
142322,on,0,0
142323,no-exercise,0,0
142324,and,0,1
142325,exercise,0,1
142326,nights,0,1
142327,were,0,1
142328,assessed,0,0
142329,by,0,0
142330,polysomnography,0,1
142331,.,0,1
142332,Participants,0,1
142333,spent,0,0
142334,a,0,1
142335,greater,0,0
142336,proportion,0,0
142337,of,0,0
142338,sleep,0,1
142339,in,0,1
142340,light,0,0
142341,sleep,0,1
142342,(,0,1
142343,stage,0,1
142344,1,0,1
142345,+,0,0
142346,stage,0,1
142347,2,0,1
142348,),0,1
142349,after,0,0
142350,exercise,0,0
142351,at,0,1
142352,both,0,0
142353,65,0,1
142354,%,0,0
142355,and,0,1
142356,75,0,1
142357,%,0,0
142358,[,0,1
142359,Vdot,0,1
142360,],0,1
142361,O,0,0
142362,(,0,1
142363,2,0,1
142364,),0,1
142365,max,0,1
142366,(,0,1
142367,P,0,0
142368,<,0,0
142369,0.05,0,0
142370,),0,1
142371,than,0,0
142372,the,0,0
142373,no-exercise,0,0
142374,condition,0,0
142375,.,0,0
142376,There,0,0
142377,was,0,0
142378,a,0,0
142379,trend,0,0
142380,of,0,0
142381,a,0,1
142382,reduced,0,0
142383,proportion,0,1
142384,of,0,0
142385,rapid,0,0
142386,eye,0,1
142387,movement,0,0
142388,sleep,0,1
142389,with,0,1
142390,increased,0,0
142391,exercise,0,1
142392,intensity,0,0
142393,(,0,1
142394,P,0,0
142395,=,0,1
142396,0.067,0,0
142397,),0,1
142398,.,0,1
142399,No,0,0
142400,other,0,0
142401,changes,0,0
142402,were,0,1
142403,observed,0,0
142404,in,0,0
142405,any,0,0
142406,other,0,1
142407,sleep,0,1
142408,variables,0,0
142409,.,0,1
142410,Two,0,1
142411,findings,0,0
142412,emerged,0,1
142413,:,0,1
142414,vigorous,0,1
142415,exercise,0,0
142416,did,0,0
142417,not,0,0
142418,increase,0,0
142419,sleep,0,1
142420,need,0,0
142421,;,0,0
142422,however,0,0
142423,",",0,0
142424,this,0,0
142425,level,0,0
142426,of,0,0
142427,exercise,0,0
142428,increased,0,0
142429,light,0,0
142430,sleep,0,1
142431,.,0,1
142432,Research,1,1
142433,Units,1,1
142434,of,1,1
142435,Pediatric,1,1
142436,Psychopharmacology,1,1
142437,(,1,1
142438,RUPP,1,1
142439,),1,1
142440,autism,1,1
142441,network,1,1
142442,randomized,0,1
142443,clinical,0,0
142444,trial,0,0
142445,of,0,0
142446,parent,0,1
142447,training,0,0
142448,and,0,1
142449,medication,0,1
142450,:,0,1
142451,one-year,0,1
142452,follow-up,0,1
142453,.,0,1
142454,OBJECTIVE,0,0
142455,To,0,0
142456,follow,0,0
142457,up,0,0
142458,on,0,0
142459,a,0,0
142460,three-site,1,0
142461,",",0,0
142462,24-week,0,0
142463,randomized,0,1
142464,clinical,0,0
142465,trial,0,1
142466,(,1,1
142467,N,1,1
142468,=,1,1
142469,124,1,1
142470,),1,1
142471,comparing,0,0
142472,antipsychotic,0,1
142473,medication,0,1
142474,alone,0,0
142475,(,0,1
142476,MED,0,0
142477,),0,1
142478,with,0,1
142479,antipsychotic,0,1
142480,medication,0,1
142481,plus,0,0
142482,parent,0,1
142483,training,0,0
142484,in,0,0
142485,the,0,0
142486,behavior,0,0
142487,management,0,1
142488,(,0,1
142489,COMB,0,0
142490,),0,1
142491,of,0,0
142492,children,1,1
142493,with,1,1
142494,autism,1,1
142495,spectrum,1,1
142496,disorders,1,1
142497,and,1,1
142498,severe,1,1
142499,behavior,1,1
142500,problems,1,1
142501,.,1,1
142502,The,0,0
142503,COMB,0,0
142504,treatment,0,0
142505,had,0,1
142506,shown,0,0
142507,a,0,0
142508,significant,0,0
142509,advantage,0,0
142510,for,0,1
142511,child,1,1
142512,behavioral,0,1
142513,noncompliance,0,1
142514,(,0,1
142515,p,0,0
142516,=,0,1
142517,.006,0,0
142518,",",0,0
142519,d,0,0
142520,=,0,1
142521,0.34,0,0
142522,),0,1
142523,",",0,0
142524,irritability,0,0
142525,(,0,1
142526,p,0,0
142527,=,0,1
142528,.01,0,0
142529,",",0,0
142530,d,0,0
142531,=,0,1
142532,0.48,0,0
142533,),0,1
142534,",",0,0
142535,and,0,0
142536,hyperactivity/noncompliance,0,1
142537,(,0,1
142538,p,0,0
142539,=,0,1
142540,.04,0,0
142541,",",0,0
142542,d,0,0
142543,=,0,1
142544,0.55,0,0
142545,),0,1
142546,with,0,1
142547,a,0,1
142548,lower,0,0
142549,medication,0,0
142550,dose,0,0
142551,.,0,1
142552,METHOD,0,0
142553,One,0,1
142554,year,0,1
142555,after,0,0
142556,each,0,0
142557,participant,0,0
142558,'s,0,1
142559,termination,0,0
142560,",",0,1
142561,the,0,0
142562,authors,0,0
142563,mailed,0,1
142564,an,0,1
142565,assessment,0,0
142566,packet,0,0
142567,with,0,1
142568,a,0,1
142569,return-addressed,0,0
142570,envelope,0,0
142571,;,0,0
142572,a,0,0
142573,telephone,0,0
142574,call,0,0
142575,alerted,0,0
142576,the,0,0
142577,family,0,1
142578,.,0,1
142579,Failure,0,0
142580,to,0,0
142581,return,0,0
142582,packets,0,0
142583,within,0,1
142584,1,0,1
142585,month,0,0
142586,elicited,0,0
142587,another,0,1
142588,contact,0,0
142589,and,0,0
142590,offers,0,0
142591,to,0,0
142592,resend,0,1
142593,.,0,1
142594,RESULTS,0,0
142595,Eighty-seven,0,1
142596,of,0,1
142597,124,0,1
142598,families,0,1
142599,(,0,1
142600,70.2,0,1
142601,%,0,0
142602,),0,1
142603,participated,0,1
142604,in,0,0
142605,the,0,0
142606,follow-up,0,0
142607,.,0,0
142608,The,0,0
142609,improvement,0,0
142610,difference,0,0
142611,between,0,0
142612,treatments,0,0
142613,attenuated,0,0
142614,from,0,1
142615,after,0,0
142616,treatment,0,0
142617,to,0,0
142618,follow-up,0,0
142619,for,0,0
142620,noncompliance,0,1
142621,(,0,1
142622,d,0,0
142623,=,0,1
142624,0.32,0,0
142625,to,0,1
142626,0.12,0,0
142627,),0,1
142628,and,0,1
142629,irritability,0,0
142630,(,0,0
142631,d,0,0
142632,=,0,1
142633,0.46,0,0
142634,to,0,1
142635,0.03,0,0
142636,),0,1
142637,.,0,1
142638,The,0,0
142639,follow-up,0,0
142640,differences,0,0
142641,were,0,1
142642,nonsignificant,0,0
142643,(,0,1
142644,the,0,0
142645,noncompliance,0,0
142646,difference,0,0
142647,also,0,0
142648,was,0,0
142649,nonsignificant,0,0
142650,after,0,0
142651,treatment,0,0
142652,for,0,0
142653,these,0,0
142654,87,0,1
142655,families,0,1
142656,),0,1
142657,.,0,1
142658,Sixty-seven,0,1
142659,percent,0,0
142660,of,0,0
142661,the,0,0
142662,COMB,0,0
142663,group,0,1
142664,and,0,1
142665,53,0,1
142666,%,0,0
142667,of,0,0
142668,the,0,0
142669,MED,0,0
142670,group,0,0
142671,were,0,0
142672,still,0,0
142673,taking,0,1
142674,risperidone,0,0
142675,",",0,0
142676,the,0,0
142677,original,0,0
142678,study,0,1
142679,medication,0,1
142680,.,0,1
142681,Most,0,0
142682,needed,0,0
142683,dose,0,0
142684,adjustments,0,0
142685,or,0,1
142686,additional,0,0
142687,medication,0,1
142688,",",0,0
142689,and,0,0
142690,the,0,0
142691,COMB,0,0
142692,group,0,0
142693,no,0,0
142694,longer,0,0
142695,had,0,0
142696,a,0,0
142697,significantly,0,0
142698,lower,0,0
142699,dose,0,0
142700,.,0,0
142701,All,0,1
142702,COMB,0,0
142703,families,0,1
142704,but,0,0
142705,only,0,0
142706,39,0,1
142707,%,0,0
142708,of,0,1
142709,MED,0,0
142710,families,0,1
142711,reported,0,1
142712,seeking,0,1
142713,parent,0,1
142714,training,0,0
142715,after,0,0
142716,treatment,0,1
142717,.,0,1
142718,Improvements,0,0
142719,in,0,0
142720,daily,0,0
142721,living,0,1
142722,skills,0,0
142723,during,0,1
142724,treatment,0,1
142725,predicted,0,0
142726,noncompliance,0,1
142727,improvement,0,0
142728,at,0,0
142729,follow-up,0,0
142730,for,0,0
142731,the,0,0
142732,COMB,0,0
142733,children,0,1
142734,",",0,1
142735,but,0,0
142736,noncompliance,0,1
142737,deterioration,0,0
142738,and,0,0
142739,especially,0,0
142740,hyperactivity/noncompliance,0,1
142741,deterioration,0,0
142742,for,0,0
142743,the,0,0
142744,MED,0,0
142745,children,0,1
142746,.,0,1
142747,CONCLUSIONS,0,0
142748,The,0,0
142749,study,0,0
142750,treatment,0,0
142751,experience/familiarity,0,0
142752,greatly,0,0
142753,influenced,0,0
142754,the,0,0
142755,follow-up,0,0
142756,treatment,0,0
142757,:,0,1
142758,those,0,1
142759,who,0,1
142760,had,0,1
142761,received,0,1
142762,parent,0,1
142763,training,0,0
142764,reported,0,0
142765,seeking,0,1
142766,it,0,0
142767,",",0,0
142768,whereas,0,0
142769,those,0,1
142770,who,0,1
142771,had,0,1
142772,not,0,1
142773,received,0,0
142774,it,0,0
142775,tended,0,0
142776,not,0,0
142777,to,0,0
142778,seek,0,0
142779,it,0,0
142780,.,0,0
142781,The,0,0
142782,superiority,0,0
142783,of,0,0
142784,COMB,0,1
142785,over,0,0
142786,MED,0,0
142787,after,0,1
142788,treatment,0,0
142789,attenuated,0,0
142790,by,0,0
142791,more,0,0
142792,than,0,0
142793,half,0,1
142794,at,0,1
142795,follow-up,0,1
142796,.,0,1
142797,Role,0,1
142798,of,0,1
142799,posterior,0,1
142800,tibial,0,1
142801,nerve,0,0
142802,stimulation,0,0
142803,in,0,0
142804,the,0,0
142805,treatment,0,0
142806,of,0,0
142807,refractory,0,1
142808,monosymptomatic,0,1
142809,nocturnal,0,1
142810,enuresis,0,1
142811,:,0,1
142812,a,0,0
142813,pilot,0,0
142814,study,0,1
142815,.,0,1
142816,PURPOSE,0,0
142817,We,0,0
142818,evaluated,0,0
142819,the,0,0
142820,early,0,1
142821,clinical,0,0
142822,and,0,1
142823,urodynamic,0,1
142824,results,0,0
142825,of,0,1
142826,posterior,0,1
142827,tibial,0,1
142828,nerve,0,0
142829,stimulation,0,0
142830,in,0,0
142831,patients,1,1
142832,with,1,1
142833,refractory,1,1
142834,monosymptomatic,1,1
142835,nocturnal,1,1
142836,enuresis,1,1
142837,.,1,1
142838,MATERIALS,0,0
142839,AND,0,0
142840,METHODS,0,0
142841,We,0,0
142842,randomly,0,1
142843,assigned,0,1
142844,28,1,1
142845,patients,1,1
142846,with,1,1
142847,refractory,1,1
142848,monosymptomatic,1,1
142849,nocturnal,1,1
142850,enuresis,1,1
142851,to,1,1
142852,2,1,1
142853,equal,1,1
142854,groups,1,1
142855,.,1,1
142856,Group,0,1
142857,1,0,0
142858,received,0,1
142859,a,0,1
142860,weekly,0,0
142861,session,0,0
142862,of,0,0
142863,posterior,0,1
142864,tibial,0,1
142865,nerve,0,0
142866,stimulation,0,0
142867,for,0,1
142868,12,0,1
142869,weeks,0,1
142870,and,0,1
142871,group,0,1
142872,2,0,1
142873,was,0,0
142874,the,0,0
142875,placebo,0,0
142876,group,0,1
142877,.,0,1
142878,Evaluation,0,0
142879,was,0,0
142880,performed,0,0
142881,in,0,0
142882,each,0,0
142883,group,0,0
142884,at,0,0
142885,baseline,0,0
142886,and,0,1
142887,after,0,0
142888,posterior,0,1
142889,tibial,0,1
142890,nerve,0,1
142891,stimulation,0,0
142892,to,0,0
142893,compare,0,0
142894,clinical,0,0
142895,and,0,1
142896,urodynamic,0,1
142897,findings,0,0
142898,.,0,1
142899,Another,0,1
142900,clinical,0,0
142901,assessment,0,0
142902,was,0,0
142903,done,0,1
142904,3,0,1
142905,months,0,0
142906,after,0,1
142907,the,0,1
142908,first,0,0
142909,followup,0,0
142910,.,0,1
142911,RESULTS,0,0
142912,The,0,0
142913,2,0,1
142914,groups,0,0
142915,were,0,1
142916,comparable,0,0
142917,in,0,1
142918,baseline,0,1
142919,clinical,0,0
142920,and,0,1
142921,urodynamic,0,1
142922,data,0,0
142923,.,0,1
142924,Overall,0,0
142925,",",0,0
142926,13,1,1
142927,patients,1,1
142928,(,1,1
142929,46.4,1,1
142930,%,1,0
142931,),1,1
142932,had,1,1
142933,detrusor,1,1
142934,overactivity,1,1
142935,and,1,1
142936,14,1,1
142937,(,1,1
142938,50,1,1
142939,%,1,0
142940,),1,1
142941,had,1,1
142942,decreased,1,0
142943,bladder,1,1
142944,capacity,1,0
142945,.,1,1
142946,After,0,0
142947,treatment,0,0
142948,11,0,1
142949,group,0,1
142950,1,0,1
142951,patients,0,1
142952,(,0,1
142953,78.6,0,1
142954,%,0,0
142955,),0,1
142956,had,0,1
142957,a,0,1
142958,partial,0,1
142959,or,0,1
142960,full,0,1
142961,response,0,0
142962,to,0,0
142963,posterior,0,1
142964,tibial,0,1
142965,nerve,0,0
142966,stimulation,0,0
142967,but,0,0
142968,only,0,0
142969,2,0,1
142970,(,0,1
142971,14.3,0,0
142972,%,0,0
142973,),0,1
142974,in,0,0
142975,group,0,1
142976,2,0,1
142977,had,0,1
142978,a,0,1
142979,partial,0,1
142980,response,0,0
142981,(,0,1
142982,p,0,0
142983,=,0,1
142984,0.002,0,0
142985,),0,1
142986,.,0,1
142987,Also,0,0
142988,",",0,0
142989,the,0,0
142990,average,0,0
142991,number,0,0
142992,of,0,1
142993,wet,0,1
142994,nights,0,1
142995,in,0,1
142996,group,0,1
142997,1,0,1
142998,was,0,0
142999,significantly,0,0
143000,lower,0,0
143001,than,0,0
143002,at,0,0
143003,baseline,0,0
143004,(,0,1
143005,p,0,0
143006,=,0,1
143007,0.002,0,0
143008,),0,1
143009,.,0,1
143010,All,0,1
143011,urodynamic,0,0
143012,parameters,0,0
143013,significantly,0,0
143014,improved,0,0
143015,in,0,0
143016,group,0,1
143017,1,0,1
143018,.,0,1
143019,In,0,0
143020,contrast,0,0
143021,",",0,0
143022,the,0,0
143023,number,0,0
143024,of,0,0
143025,wet,0,1
143026,nights,0,1
143027,and,0,1
143028,urodynamic,0,1
143029,parameters,0,0
143030,did,0,0
143031,not,0,0
143032,change,0,0
143033,significantly,0,0
143034,in,0,0
143035,group,0,1
143036,2,0,1
143037,.,0,1
143038,At,0,0
143039,3-month,0,0
143040,followup,0,0
143041,the,0,0
143042,number,0,0
143043,of,0,0
143044,patients,0,1
143045,with,0,1
143046,a,0,1
143047,partial,0,1
143048,or,0,1
143049,full,0,1
143050,response,0,0
143051,in,0,1
143052,group,0,1
143053,1,0,1
143054,had,0,1
143055,decreased,0,0
143056,from,0,1
143057,11,0,1
143058,(,0,1
143059,78.6,0,1
143060,%,0,0
143061,),0,1
143062,to,0,1
143063,6,0,1
143064,(,0,1
143065,42.9,0,1
143066,%,0,0
143067,),0,1
143068,.,0,1
143069,No,0,0
143070,change,0,0
143071,was,0,0
143072,evident,0,0
143073,in,0,1
143074,group,0,1
143075,2,0,1
143076,.,0,1
143077,CONCLUSIONS,0,0
143078,Posterior,0,1
143079,tibial,0,1
143080,nerve,0,0
143081,stimulation,0,0
143082,can,0,0
143083,be,0,0
143084,a,0,0
143085,viable,0,0
143086,treatment,0,0
143087,option,0,0
143088,in,0,0
143089,some,0,0
143090,patients,1,1
143091,with,1,1
143092,refractory,1,1
143093,monosymptomatic,1,1
143094,nocturnal,1,1
143095,enuresis,1,1
143096,.,1,1
143097,However,0,0
143098,",",0,0
143099,deterioration,0,0
143100,in,0,0
143101,some,0,0
143102,responders,0,0
143103,with,0,1
143104,time,0,0
143105,suggests,0,0
143106,the,0,0
143107,need,0,0
143108,for,0,0
143109,maintenance,0,1
143110,protocols,0,0
143111,.,0,1
143112,Acceleration,0,0
143113,of,0,0
143114,insulin,0,0
143115,pharmacodynamic,0,0
143116,profile,0,0
143117,by,0,0
143118,a,0,1
143119,novel,0,0
143120,insulin,0,0
143121,infusion,0,0
143122,site,0,0
143123,warming,0,0
143124,device,0,0
143125,.,0,1
143126,BACKGROUND,0,0
143127,AND,0,0
143128,OBJECTIVE,0,1
143129,Subcutaneously,0,1
143130,injected,0,0
143131,rapid-acting,0,0
143132,insulin,0,1
143133,analogs,0,0
143134,do,0,0
143135,not,0,0
143136,replicate,0,1
143137,physiologic,0,0
143138,insulin,0,0
143139,action,0,0
143140,due,0,1
143141,to,0,1
143142,delays,0,0
143143,in,0,1
143144,their,0,1
143145,onset,0,1
143146,and,0,0
143147,peak,0,0
143148,action,0,0
143149,resulting,0,0
143150,in,0,0
143151,postprandial,0,1
143152,glucose,0,1
143153,excursions,0,1
143154,.,0,1
143155,The,0,0
143156,InsuPatch,0,0
143157,(,0,1
143158,IP,0,0
143159,),0,0
143160,is,0,0
143161,a,0,0
143162,novel,0,0
143163,insulin,0,0
143164,infusion,0,0
143165,site,0,0
143166,warming,0,0
143167,device,0,0
143168,developed,0,1
143169,to,0,0
143170,accelerate,0,0
143171,insulin,0,0
143172,action,0,0
143173,by,0,0
143174,increasing,0,0
143175,blood,0,0
143176,flow,0,0
143177,to,0,0
143178,the,0,0
143179,area,0,0
143180,of,0,0
143181,insulin,0,1
143182,absorption,0,0
143183,.,0,1
143184,Thirteen,1,1
143185,adolescents,1,1
143186,with,1,1
143187,type,1,1
143188,1,1,1
143189,diabetes,1,1
143190,(,1,1
143191,T1D,1,0
143192,",",1,1
143193,mean,1,1
143194,age,1,1
143195,14,1,1
143196,?,1,1
143197,4,1,0
143198,yr,1,1
143199,),1,1
143200,were,1,0
143201,enrolled,1,1
143202,in,0,0
143203,this,0,0
143204,study,0,0
143205,to,0,0
143206,investigate,0,0
143207,the,0,0
143208,effect,0,0
143209,of,0,0
143210,the,0,0
143211,IP,0,0
143212,on,0,0
143213,the,0,0
143214,pharmacodynamics,0,0
143215,and,0,1
143216,pharmacokinetics,0,0
143217,of,0,1
143218,a,0,1
143219,0.2,0,0
143220,unit/kg,0,1
143221,bolus,0,0
143222,dose,0,0
143223,of,0,0
143224,aspart,0,1
143225,insulin,0,1
143226,using,0,0
143227,the,0,0
143228,euglycemic,0,0
143229,clamp,0,0
143230,technique,0,0
143231,.,0,1
143232,RESEARCH,0,1
143233,DESIGN,0,1
143234,AND,0,0
143235,METHODS,0,0
143236,Each,0,1
143237,subject,0,1
143238,underwent,0,1
143239,two,0,1
143240,euglycemic,0,1
143241,clamp,0,0
143242,procedures,0,1
143243,on,0,1
143244,separate,0,1
143245,occasions,0,1
143246,:,0,1
143247,one,0,1
143248,with,0,1
143249,IP,0,1
143250,and,0,1
143251,one,0,1
143252,without,0,1
143253,IP,0,0
143254,activation,0,0
143255,in,0,0
143256,random,0,1
143257,order,0,0
143258,.,0,0
143259,RESULTS,0,0
143260,When,0,0
143261,the,0,0
143262,insulin,0,0
143263,bolus,0,0
143264,was,0,0
143265,given,0,0
143266,with,0,1
143267,IP,0,0
143268,activation,0,0
143269,as,0,0
143270,compared,0,0
143271,to,0,1
143272,without,0,1
143273,IP,0,0
143274,activation,0,0
143275,",",0,0
143276,time,0,0
143277,to,0,0
143278,reach,0,0
143279,maximum,0,0
143280,insulin,0,0
143281,action,0,0
143282,(,0,1
143283,T,0,1
143284,(,0,1
143285,GIRmax,0,0
143286,),0,1
143287,),0,1
143288,and,0,0
143289,to,0,1
143290,reach,0,0
143291,50,0,1
143292,%,0,0
143293,maximum,0,0
143294,action,0,0
143295,(,0,1
143296,T,0,1
143297,(,0,1
143298,50,0,1
143299,%,0,0
143300,GIRmax,0,0
143301,),0,1
143302,),0,1
143303,were,0,1
143304,35,0,1
143305,and,0,1
143306,18,0,1
143307,min,0,0
143308,earlier,0,1
143309,(,0,1
143310,125,0,1
143311,?,0,1
143312,8,0,0
143313,min,0,0
143314,vs.,0,0
143315,90,0,1
143316,?,0,1
143317,6,0,0
143318,min,0,0
143319,",",0,0
143320,p,0,0
143321,=,0,1
143322,0.002,0,0
143323,and,0,1
143324,58,0,1
143325,?,0,1
143326,5,0,0
143327,min,0,0
143328,.,0,1
143329,vs.,0,0
143330,40,0,1
143331,?,0,1
143332,3,0,0
143333,min,0,0
143334,",",0,0
143335,p,0,0
143336,=,0,0
143337,0.01,0,0
143338,",",0,0
143339,respectively,0,0
143340,),0,0
143341,",",0,0
143342,and,0,0
143343,the,0,0
143344,area,0,0
143345,under,0,0
143346,curve,0,0
143347,",",0,1
143348,AUC,0,0
143349,(,0,1
143350,GIR,0,1
143351,0-90,0,0
143352,min,0,0
143353,),0,1
143354,",",0,0
143355,reflecting,0,0
143356,early,0,1
143357,glucodynamic,0,0
143358,action,0,0
143359,",",0,0
143360,was,0,0
143361,significantly,0,0
143362,greater,0,0
143363,(,0,0
143364,p,0,0
143365,=,0,1
143366,0.001,0,0
143367,),0,1
143368,.,0,1
143369,IP,0,0
143370,activation,0,0
143371,also,0,0
143372,accelerated,0,0
143373,the,0,0
143374,rise,0,0
143375,in,0,0
143376,plasma,0,0
143377,insulin,0,1
143378,levels,0,0
143379,after,0,1
143380,the,0,0
143381,bolus,0,0
143382,(,0,0
143383,p,0,0
143384,=,0,1
143385,0.03,0,0
143386,),0,1
143387,and,0,0
143388,resulted,0,0
143389,in,0,0
143390,a,0,0
143391,higher,0,0
143392,peak,0,0
143393,(,0,0
143394,p,0,0
143395,=,0,1
143396,0.04,0,0
143397,),0,1
143398,and,0,1
143399,greater,0,0
143400,overall,0,0
143401,increase,0,0
143402,(,0,1
143403,p,0,0
143404,=,0,1
143405,0.02,0,0
143406,),0,1
143407,in,0,1
143408,plasma,0,0
143409,insulin,0,1
143410,levels,0,1
143411,.,0,1
143412,CONCLUSIONS,0,0
143413,Our,0,0
143414,results,0,0
143415,show,0,0
143416,that,0,0
143417,insulin,0,0
143418,infusion,0,0
143419,site,0,0
143420,warming,0,0
143421,with,0,1
143422,IP,0,0
143423,activation,0,0
143424,accelerates,0,0
143425,the,0,0
143426,time,0,0
143427,action,0,0
143428,profile,0,0
143429,of,0,0
143430,aspart,0,0
143431,insulin,0,0
143432,which,0,0
143433,may,0,0
143434,be,0,0
143435,of,0,0
143436,benefit,0,0
143437,to,0,1
143438,current,0,1
143439,open-loop,0,0
143440,and,0,1
143441,future,0,0
143442,closed-loop,0,0
143443,insulin,0,0
143444,delivery,0,1
143445,in,0,0
143446,patients,1,1
143447,with,1,1
143448,T1D,1,1
143449,.,1,1
143450,Custom-fit,0,0
143451,minimally,0,1
143452,invasive,0,1
143453,total,0,1
143454,knee,0,1
143455,arthroplasty,0,1
143456,:,0,1
143457,effect,0,0
143458,on,0,0
143459,blood,0,0
143460,loss,0,0
143461,and,0,1
143462,early,0,1
143463,clinical,0,1
143464,outcomes,0,0
143465,.,0,1
143466,PURPOSE,0,0
143467,Recently,0,1
143468,",",0,1
143469,new,0,1
143470,custom-fit,0,0
143471,pin,0,1
143472,guides,0,0
143473,in,0,1
143474,total,1,1
143475,knee,1,1
143476,arthroplasty,1,1
143477,(,1,1
143478,TKA,1,1
143479,),1,1
143480,have,0,0
143481,been,0,0
143482,introduced,0,0
143483,.,0,1
143484,Use,0,0
143485,of,0,0
143486,these,0,0
143487,guides,0,0
143488,may,0,0
143489,reduce,0,0
143490,operating,0,0
143491,time,0,0
143492,.,0,1
143493,Use,0,0
143494,of,0,0
143495,the,0,0
143496,guides,0,0
143497,combined,0,0
143498,with,0,1
143499,the,0,0
143500,absence,0,0
143501,of,0,0
143502,intramedullary,0,1
143503,alignment,0,0
143504,jigs,0,1
143505,may,0,0
143506,lead,0,0
143507,to,0,0
143508,reduced,0,0
143509,blood,0,0
143510,loss,0,0
143511,and,0,0
143512,improved,0,0
143513,early,0,1
143514,outcomes,0,0
143515,.,0,1
143516,Our,0,0
143517,aim,0,0
143518,was,0,0
143519,to,0,0
143520,evaluate,0,0
143521,blood,0,0
143522,loss,0,0
143523,and,0,1
143524,early,0,1
143525,clinical,0,0
143526,outcomes,0,0
143527,in,0,1
143528,patients,1,1
143529,undergoing,1,1
143530,minimally,1,1
143531,invasive,1,1
143532,TKA,1,1
143533,using,1,1
143534,custom-fit,1,0
143535,magnetic,1,1
143536,resonance,1,1
143537,imaging,1,0
143538,(,1,1
143539,MRI,1,1
143540,),1,1
143541,-based,1,0
143542,pin,1,1
143543,guides,1,0
143544,.,1,1
143545,METHODS,0,0
143546,A,0,1
143547,prospective,0,1
143548,study,0,1
143549,in,0,1
143550,80,1,1
143551,patients,1,1
143552,was,0,0
143553,carried,0,0
143554,out,0,1
143555,.,0,1
143556,Patients,0,1
143557,were,0,0
143558,divided,0,1
143559,randomly,0,1
143560,into,0,1
143561,2,0,1
143562,equal,0,1
143563,groups,0,1
143564,.,0,1
143565,In,0,0
143566,one,0,1
143567,group,0,1
143568,",",0,0
143569,intramedullary,0,1
143570,alignment,0,0
143571,jigs,0,1
143572,were,0,1
143573,used,0,0
143574,.,0,1
143575,In,0,0
143576,the,0,0
143577,second,0,0
143578,group,0,0
143579,",",0,1
143580,custom-fit,0,0
143581,MRI-based,0,0
143582,pin,0,1
143583,guides,0,0
143584,were,0,1
143585,used,0,0
143586,.,0,1
143587,All,0,1
143588,patients,0,1
143589,received,0,1
143590,the,0,0
143591,same,0,0
143592,cemented,0,1
143593,posterior-stabilized,0,1
143594,implant,0,1
143595,through,0,1
143596,a,0,1
143597,mini-midvastus,0,1
143598,approach,0,0
143599,.,0,1
143600,The,0,0
143601,volume,0,0
143602,in,0,0
143603,the,0,0
143604,drain,0,1
143605,bottles,0,0
143606,was,0,0
143607,recorded,0,0
143608,after,0,1
143609,48,0,1
143610,h.,0,1
143611,Hb,0,1
143612,loss,0,0
143613,was,0,0
143614,estimated,0,0
143615,by,0,0
143616,subtracting,0,0
143617,the,0,0
143618,postoperative,0,0
143619,from,0,0
143620,the,0,0
143621,preoperative,0,1
143622,Hb,0,0
143623,level,0,0
143624,.,0,1
143625,Transfusion,0,0
143626,requirements,0,0
143627,and,0,1
143628,surgical,0,1
143629,time,0,0
143630,were,0,1
143631,recorded,0,0
143632,.,0,1
143633,Outcome,0,0
143634,measures,0,0
143635,were,0,1
143636,Knee,0,1
143637,Society,0,1
143638,Scores,0,1
143639,(,0,1
143640,KSS,0,1
143641,),0,1
143642,",",0,0
143643,knee,0,1
143644,flexion,0,1
143645,",",0,0
143646,knee,0,1
143647,swelling,0,0
143648,and,0,0
143649,pain,0,1
143650,.,0,0
143651,RESULTS,0,0
143652,There,0,0
143653,was,0,0
143654,lower,0,0
143655,mean,0,1
143656,drainage,0,1
143657,of,0,0
143658,blood,0,0
143659,in,0,0
143660,the,0,0
143661,custom-fit,0,0
143662,group,0,1
143663,(,0,1
143664,391,0,1
143665,ml,0,0
143666,vs.,0,0
143667,603,0,1
143668,ml,0,0
143669,;,0,0
143670,p,0,0
143671,<,0,0
143672,0.0001,0,0
143673,),0,0
143674,.,0,0
143675,There,0,0
143676,was,0,0
143677,no,0,0
143678,difference,0,0
143679,in,0,0
143680,estimated,0,0
143681,loss,0,0
143682,of,0,0
143683,Hb,0,0
143684,(,0,1
143685,3.6,0,0
143686,g/dl,0,1
143687,vs.,0,0
143688,4.1,0,1
143689,g/dl,0,1
143690,;,0,1
143691,n.s,0,1
143692,.,0,1
143693,),0,0
143694,and,0,0
143695,in,0,1
143696,transfusion,0,0
143697,requirements,0,1
143698,(,0,1
143699,7.5,0,0
143700,%,0,0
143701,vs.,0,0
143702,10,0,1
143703,%,0,0
143704,;,0,1
143705,n.s.,0,0
143706,),0,1
143707,.,0,1
143708,Surgical,0,1
143709,time,0,0
143710,was,0,0
143711,reduced,0,0
143712,in,0,0
143713,the,0,0
143714,custom-fit,0,0
143715,group,0,1
143716,(,0,1
143717,12,0,0
143718,min,0,0
143719,less,0,0
143720,;,0,0
143721,p,0,0
143722,=,0,0
143723,0.001,0,0
143724,),0,0
143725,.,0,1
143726,KSS,0,0
143727,measured,0,0
143728,at,0,0
143729,week,0,0
143730,2,0,1
143731,",",0,1
143732,6,0,0
143733,and,0,1
143734,12,0,1
143735,showed,0,0
143736,no,0,0
143737,significant,0,0
143738,difference,0,0
143739,between,0,0
143740,groups,0,1
143741,.,0,1
143742,Knee,0,1
143743,flexion,0,1
143744,measured,0,0
143745,on,0,0
143746,days,0,0
143747,7,0,1
143748,",",0,1
143749,10,0,1
143750,and,0,0
143751,at,0,1
143752,week,0,0
143753,6,0,0
143754,",",0,1
143755,12,0,0
143756,and,0,0
143757,knee,0,1
143758,swelling,0,0
143759,and,0,0
143760,pain,0,1
143761,measured,0,0
143762,on,0,0
143763,days,0,0
143764,1,0,1
143765,",",0,1
143766,3,0,0
143767,",",0,1
143768,10,0,1
143769,and,0,0
143770,at,0,1
143771,week,0,0
143772,6,0,0
143773,",",0,1
143774,12,0,0
143775,showed,0,0
143776,no,0,0
143777,significant,0,0
143778,difference,0,0
143779,between,0,0
143780,groups,0,1
143781,.,0,1
143782,CONCLUSIONS,0,0
143783,Using,0,0
143784,custom-fit,0,0
143785,pin,0,1
143786,guides,0,0
143787,reduces,0,0
143788,blood,0,1
143789,drainage,0,1
143790,",",0,0
143791,but,0,0
143792,not,0,0
143793,the,0,0
143794,estimated,0,0
143795,Hb,0,0
143796,loss,0,0
143797,in,0,0
143798,minimally,0,1
143799,invasive,0,1
143800,TKA,0,0
143801,and,0,0
143802,does,0,0
143803,not,0,0
143804,affect,0,0
143805,transfusion,0,0
143806,rate,0,0
143807,.,0,1
143808,Surgical,0,0
143809,time,0,0
143810,is,0,0
143811,reduced,0,0
143812,.,0,0
143813,There,0,0
143814,is,0,0
143815,no,0,0
143816,effect,0,0
143817,on,0,0
143818,the,0,0
143819,early,0,1
143820,clinical,0,0
143821,outcomes,0,0
143822,.,0,1
143823,LEVEL,0,0
143824,OF,0,1
143825,EVIDENCE,0,1
143826,Therapeutic,0,1
143827,study,0,1
143828,",",0,0
143829,Level,0,0
143830,I,0,1
143831,.,0,1
143832,[,0,1
143833,Effects,0,0
143834,of,0,1
143835,transcutaneous,0,1
143836,electrical,0,0
143837,stimulation,0,0
143838,of,0,0
143839,auricular,0,1
143840,Shenmen,0,1
143841,point,0,0
143842,on,0,0
143843,postoperative,0,0
143844,nausea,0,0
143845,and,0,1
143846,vomiting,0,0
143847,and,0,1
143848,patient-controlled,0,0
143849,epidural,0,1
143850,analgesia,0,0
143851,in,0,1
143852,cesarean,1,1
143853,section,1,1
143854,],1,1
143855,.,0,1
143856,OBJECTIVE,0,0
143857,To,0,0
143858,investigate,0,0
143859,the,0,0
143860,effects,0,0
143861,of,0,0
143862,transcutaneous,0,1
143863,electrical,0,0
143864,stimulation,0,0
143865,of,0,0
143866,auricular,0,1
143867,Shenmen,0,1
143868,point,0,0
143869,on,0,0
143870,postoperative,0,0
143871,nausea,0,0
143872,and,0,1
143873,vomiting,0,0
143874,and,0,1
143875,patient-controlled,0,0
143876,epidural,0,1
143877,analgesia,0,0
143878,in,0,1
143879,cesarean,0,1
143880,section,0,1
143881,.,0,1
143882,METHODS,0,0
143883,After,0,1
143884,IRB,0,1
143885,approval,0,1
143886,and,0,1
143887,informed,0,0
143888,consent,0,1
143889,",",0,1
143890,one,1,1
143891,hundred,1,1
143892,and,1,0
143893,eighty,1,1
143894,singleton,1,1
143895,primiparas,1,1
143896,undergoing,1,1
143897,elective,1,1
143898,cesarean,1,1
143899,section,1,1
143900,",",1,0
143901,in,1,0
143902,Qingdao,1,1
143903,Municipal,1,1
143904,Hospital,1,1
143905,",",1,0
143906,and,1,0
143907,Qingdao,1,1
143908,Hiser,1,1
143909,Medical,1,1
143910,Center,1,1
143911,",",1,0
143912,from,1,1
143913,November,1,1
143914,2011,1,1
143915,to,1,1
143916,March,1,1
143917,2012,1,1
143918,",",1,0
143919,were,1,0
143920,randomly,1,1
143921,assigned,1,1
143922,to,0,1
143923,three,0,1
143924,groups,0,1
143925,:,0,1
143926,transcutaneous,0,1
143927,electrical,0,0
143928,stimulation,0,0
143929,of,0,0
143930,auricular,0,1
143931,Shenmen,0,1
143932,point,0,0
143933,group,0,1
143934,(,0,1
143935,group,0,1
143936,A,0,1
143937,",",0,1
143938,n,0,1
143939,=,0,1
143940,60,0,1
143941,),0,1
143942,",",0,1
143943,transcutaneous,0,0
143944,electrical,0,0
143945,stimulation,0,0
143946,of,0,0
143947,auricular,0,1
143948,Eye,0,1
143949,point,0,0
143950,group,0,1
143951,(,0,1
143952,group,0,1
143953,B,0,1
143954,",",0,1
143955,n,0,1
143956,=,0,1
143957,60,0,1
143958,),0,1
143959,and,0,0
143960,control,0,1
143961,group,0,1
143962,(,0,1
143963,group,0,1
143964,C,0,0
143965,",",0,1
143966,n,0,1
143967,=,0,1
143968,60,0,1
143969,),0,1
143970,.,0,1
143971,Women,0,1
143972,of,0,0
143973,group,0,1
143974,A,0,1
143975,received,0,1
143976,transcutaneous,0,0
143977,electrical,0,0
143978,stimulation,0,0
143979,of,0,0
143980,auricular,0,1
143981,Shenmen,0,1
143982,point,0,0
143983,(,0,1
143984,frequency,0,0
143985,1.5,0,1
143986,HZ,0,0
143987,),0,1
143988,at,0,0
143989,the,0,0
143990,time,0,0
143991,of,0,0
143992,preoperation,0,0
143993,",",0,1
143994,4,0,0
143995,",",0,1
143996,10,0,1
143997,and,0,1
143998,22,0,1
143999,hours,0,0
144000,of,0,1
144001,postoperation,0,1
144002,for,0,1
144003,30,0,1
144004,minutes,0,0
144005,.,0,1
144006,The,0,0
144007,strength,0,0
144008,was,0,0
144009,controlled,0,0
144010,by,0,0
144011,themselves,0,0
144012,.,0,1
144013,Women,0,1
144014,of,0,0
144015,group,0,1
144016,B,0,1
144017,received,0,1
144018,stimulation,0,0
144019,of,0,0
144020,auricular,0,1
144021,Eye,0,1
144022,point,0,0
144023,as,0,0
144024,group,0,1
144025,A,0,1
144026,.,0,1
144027,Women,0,1
144028,of,0,0
144029,group,0,1
144030,C,0,1
144031,received,0,1
144032,pressurization,0,1
144033,and,0,0
144034,connected,0,0
144035,line,0,0
144036,were,0,0
144037,the,0,0
144038,same,0,0
144039,with,0,1
144040,group,0,1
144041,A,0,1
144042,",",0,0
144043,but,0,0
144044,without,0,1
144045,electrical,0,0
144046,stimulation,0,0
144047,.,0,1
144048,The,0,0
144049,following,0,0
144050,indexes,0,0
144051,was,0,0
144052,observed,0,0
144053,:,0,1
144054,the,0,0
144055,incidence,0,0
144056,of,0,0
144057,postoperative,0,0
144058,nausea,0,0
144059,and,0,1
144060,vomiting,0,0
144061,(,0,1
144062,PONV,0,0
144063,),0,1
144064,for,0,1
144065,48,0,1
144066,hours,0,1
144067,;,0,1
144068,the,0,0
144069,rate,0,0
144070,of,0,0
144071,metoclopramide,0,0
144072,;,0,1
144073,the,0,0
144074,visual,0,0
144075,analogue,0,0
144076,scale,0,0
144077,(,0,1
144078,VAS,0,0
144079,),0,1
144080,score,0,0
144081,of,0,0
144082,rest,0,0
144083,pain,0,1
144084,",",0,0
144085,uterine,0,1
144086,contration,0,0
144087,pain,0,1
144088,and,0,0
144089,dynamic,0,0
144090,pain,0,1
144091,at,0,0
144092,the,0,0
144093,time,0,0
144094,of,0,0
144095,postoperation,0,0
144096,for,0,1
144097,6,0,0
144098,",",0,1
144099,12,0,1
144100,",",0,1
144101,24,0,1
144102,and,0,1
144103,48,0,1
144104,hours,0,0
144105,(,0,1
144106,T,0,1
144107,(,0,1
144108,1,0,1
144109,),0,1
144110,-T,0,1
144111,(,0,1
144112,4,0,0
144113,),0,1
144114,),0,1
144115,;,0,1
144116,the,0,0
144117,total,0,1
144118,number,0,0
144119,and,0,1
144120,effective,0,0
144121,compressions,0,0
144122,number,0,0
144123,of,0,1
144124,patient-controlled,0,0
144125,epidural,0,1
144126,analgesia,0,0
144127,(,0,1
144128,PCEA,0,1
144129,),0,1
144130,;,0,0
144131,the,0,0
144132,dose,0,0
144133,of,0,0
144134,analgesia,0,0
144135,mixture,0,0
144136,;,0,1
144137,the,0,0
144138,anal,0,1
144139,exhaust,0,1
144140,time,0,0
144141,;,0,0
144142,the,0,0
144143,volume,0,0
144144,of,0,0
144145,postoperative,0,0
144146,bleeding,0,1
144147,for,0,1
144148,6,0,1
144149,hours,0,0
144150,of,0,1
144151,postoperation,0,0
144152,and,0,0
144153,the,0,0
144154,other,0,0
144155,side,0,0
144156,effects,0,0
144157,.,0,1
144158,RESULTS,0,0
144159,Compared,0,0
144160,with,0,1
144161,group,0,1
144162,B,0,1
144163,and,0,1
144164,group,0,1
144165,C,0,0
144166,",",0,0
144167,the,0,0
144168,incidence,0,0
144169,of,0,0
144170,PONV,0,0
144171,",",0,0
144172,the,0,0
144173,rate,0,0
144174,of,0,0
144175,metoclopramide,0,0
144176,",",0,0
144177,the,0,0
144178,VAS,0,0
144179,score,0,0
144180,at,0,0
144181,the,0,0
144182,time,0,0
144183,T,0,1
144184,(,0,1
144185,1,0,1
144186,),0,1
144187,-T,0,1
144188,(,0,1
144189,4,0,0
144190,),0,1
144191,",",0,0
144192,the,0,0
144193,total,0,1
144194,number,0,0
144195,and,0,1
144196,effective,0,0
144197,compressions,0,0
144198,number,0,0
144199,of,0,1
144200,PCEA,0,0
144201,",",0,0
144202,the,0,0
144203,ratio,0,0
144204,of,0,0
144205,the,0,0
144206,total,0,1
144207,number,0,0
144208,with,0,1
144209,effective,0,0
144210,compressions,0,1
144211,number,0,0
144212,and,0,1
144213,the,0,0
144214,dose,0,0
144215,of,0,0
144216,analgesia,0,0
144217,mixture,0,0
144218,were,0,1
144219,decreased,0,0
144220,in,0,0
144221,group,0,1
144222,A,0,1
144223,(,0,1
144224,P,0,0
144225,<,0,0
144226,0.05,0,0
144227,),0,1
144228,",",0,0
144229,but,0,0
144230,no,0,0
144231,difference,0,0
144232,compared,0,0
144233,group,0,1
144234,B,0,1
144235,with,0,1
144236,group,0,1
144237,C,0,1
144238,(,0,1
144239,P,0,0
144240,>,0,1
144241,0.05,0,0
144242,),0,1
144243,.,0,1
144244,The,0,0
144245,anal,0,0
144246,exhaust,0,0
144247,time,0,0
144248,and,0,0
144249,the,0,0
144250,volume,0,0
144251,of,0,0
144252,postoperative,0,0
144253,bleeding,0,1
144254,for,0,1
144255,6,0,1
144256,hours,0,0
144257,of,0,1
144258,postoperation,0,0
144259,were,0,1
144260,no,0,0
144261,difference,0,0
144262,in,0,0
144263,the,0,1
144264,three,0,0
144265,groups,0,0
144266,(,0,1
144267,P,0,0
144268,>,0,1
144269,0.05,0,0
144270,),0,1
144271,.,0,1
144272,No,0,0
144273,other,0,0
144274,side,0,0
144275,effects,0,0
144276,were,0,1
144277,observed,0,0
144278,.,0,1
144279,CONCLUSION,0,0
144280,Transcutaneous,0,0
144281,electrical,0,0
144282,stimulation,0,0
144283,of,0,1
144284,auricular,0,1
144285,Shenmen,0,1
144286,point,0,0
144287,can,0,0
144288,reduce,0,0
144289,the,0,0
144290,incidence,0,0
144291,of,0,0
144292,PONV,0,0
144293,and,0,0
144294,improves,0,0
144295,analgesia,0,0
144296,effect,0,0
144297,of,0,0
144298,PCEA,0,1
144299,in,0,0
144300,postoperation,0,0
144301,of,0,0
144302,cesarean,0,1
144303,section,0,1
144304,.,0,1
144305,Randomized,0,0
144306,trial,0,0
144307,of,0,0
144308,early,0,1
144309,developmental,0,1
144310,intervention,0,1
144311,on,0,0
144312,outcomes,0,0
144313,in,0,1
144314,children,1,1
144315,after,1,1
144316,birth,1,1
144317,asphyxia,1,1
144318,in,0,0
144319,developing,0,1
144320,countries,0,1
144321,.,0,1
144322,OBJECTIVE,0,0
144323,To,0,0
144324,determine,0,0
144325,if,0,0
144326,early,0,1
144327,developmental,0,1
144328,intervention,0,0
144329,(,0,1
144330,EDI,0,1
144331,),0,1
144332,improves,0,0
144333,developmental,0,1
144334,abilities,0,0
144335,in,0,1
144336,resuscitated,1,1
144337,children,1,1
144338,.,1,1
144339,STUDY,0,0
144340,DESIGN,0,0
144341,This,0,0
144342,was,0,0
144343,a,0,0
144344,parallel,1,0
144345,group,1,0
144346,",",0,0
144347,randomized,0,1
144348,controlled,0,0
144349,trial,0,1
144350,of,0,1
144351,infants,1,1
144352,unresponsive,1,1
144353,to,1,1
144354,stimulation,1,1
144355,who,1,1
144356,received,1,1
144357,bag,1,1
144358,and,1,0
144359,mask,1,0
144360,ventilation,1,0
144361,as,1,0
144362,part,1,1
144363,of,1,0
144364,their,1,1
144365,resuscitation,1,1
144366,at,1,0
144367,birth,1,1
144368,and,1,1
144369,infants,1,1
144370,who,1,1
144371,did,1,1
144372,not,1,1
144373,require,1,0
144374,any,1,0
144375,resuscitation,1,0
144376,born,1,1
144377,in,1,1
144378,rural,1,1
144379,communities,1,1
144380,in,1,1
144381,India,1,1
144382,",",1,1
144383,Pakistan,1,1
144384,",",1,0
144385,and,1,0
144386,Zambia,1,1
144387,.,1,1
144388,Intervention,1,1
144389,infants,1,1
144390,received,0,1
144391,a,0,1
144392,parent-implemented,0,0
144393,EDI,0,0
144394,delivered,0,1
144395,with,0,1
144396,home,0,1
144397,visits,0,1
144398,by,0,1
144399,parent,0,1
144400,trainers,0,1
144401,every,0,0
144402,other,0,0
144403,week,0,0
144404,for,0,1
144405,3,0,1
144406,years,0,1
144407,starting,0,1
144408,the,0,0
144409,first,0,0
144410,month,0,0
144411,after,0,1
144412,birth,0,1
144413,.,0,1
144414,Parents,0,0
144415,in,0,0
144416,both,0,0
144417,intervention,0,0
144418,and,0,0
144419,control,0,1
144420,groups,0,0
144421,received,0,1
144422,health,0,1
144423,and,0,0
144424,safety,0,0
144425,counseling,0,0
144426,during,0,0
144427,home,0,1
144428,visits,0,1
144429,on,0,0
144430,the,0,1
144431,same,0,0
144432,schedule,0,0
144433,.,0,1
144434,The,0,0
144435,main,0,0
144436,outcome,0,0
144437,measure,0,0
144438,was,0,0
144439,the,0,0
144440,Mental,0,1
144441,Development,0,0
144442,Index,0,0
144443,(,0,1
144444,MDI,0,1
144445,),0,1
144446,of,0,0
144447,the,0,0
144448,Bayley,0,1
144449,Scales,0,0
144450,of,0,1
144451,Infant,0,1
144452,Development,0,0
144453,",",0,1
144454,2nd,0,1
144455,edition,0,1
144456,",",0,0
144457,assessed,0,0
144458,at,0,1
144459,36,0,1
144460,months,0,1
144461,by,0,1
144462,evaluators,0,1
144463,unaware,0,1
144464,of,0,1
144465,treatment,0,1
144466,group,0,1
144467,and,0,0
144468,resuscitation,0,1
144469,history,0,1
144470,.,0,1
144471,RESULTS,0,0
144472,MDI,0,0
144473,was,0,0
144474,higher,0,0
144475,in,0,0
144476,the,0,0
144477,EDI,0,1
144478,(,0,1
144479,102.6,0,1
144480,?,0,1
144481,9.8,0,0
144482,),0,0
144483,compared,0,0
144484,with,0,1
144485,the,0,0
144486,control,0,1
144487,resuscitated,0,1
144488,children,0,1
144489,(,0,1
144490,98.0,0,1
144491,?,0,1
144492,14.6,0,0
144493,",",0,0
144494,1-sided,0,0
144495,P,0,0
144496,=,0,1
144497,.0202,0,0
144498,),0,1
144499,",",0,0
144500,but,0,0
144501,there,0,0
144502,was,0,0
144503,no,0,0
144504,difference,0,0
144505,between,0,0
144506,groups,0,0
144507,in,0,1
144508,the,0,1
144509,nonresuscitated,0,1
144510,children,0,1
144511,(,0,1
144512,100.1,0,1
144513,?,0,1
144514,10.7,0,0
144515,vs,0,0
144516,97.7,0,0
144517,?,0,1
144518,10.4,0,0
144519,",",0,0
144520,P,0,0
144521,=,0,1
144522,.1392,0,0
144523,),0,1
144524,.,0,1
144525,The,0,0
144526,Psychomotor,0,0
144527,Development,0,0
144528,Index,0,0
144529,was,0,0
144530,higher,0,0
144531,in,0,0
144532,the,0,0
144533,EDI,0,0
144534,group,0,0
144535,for,0,0
144536,both,0,0
144537,the,0,0
144538,resuscitated,0,1
144539,(,0,0
144540,P,0,0
144541,=,0,1
144542,.0430,0,0
144543,),0,1
144544,and,0,1
144545,nonresuscitated,0,1
144546,children,0,1
144547,(,0,1
144548,P,0,0
144549,=,0,1
144550,.0164,0,0
144551,),0,1
144552,.,0,1
144553,CONCLUSIONS,0,0
144554,This,0,0
144555,trial,0,0
144556,of,0,0
144557,home-based,0,1
144558,",",0,1
144559,parent,0,1
144560,provided,0,0
144561,EDI,0,1
144562,in,1,1
144563,children,1,1
144564,resuscitated,1,1
144565,at,1,0
144566,birth,1,1
144567,provides,1,0
144568,evidence,1,0
144569,of,0,0
144570,treatment,0,1
144571,benefits,0,0
144572,on,0,0
144573,cognitive,0,1
144574,and,0,1
144575,psychomotor,0,1
144576,outcomes,0,0
144577,.,0,1
144578,MDI,0,0
144579,and,0,0
144580,Psychomotor,0,1
144581,Development,0,0
144582,Index,0,1
144583,scores,0,0
144584,of,0,1
144585,both,0,0
144586,nonresuscitated,0,0
144587,and,1,1
144588,resuscitated,1,1
144589,infants,1,1
144590,were,0,1
144591,within,0,1
144592,normal,0,1
144593,range,0,1
144594,",",0,0
144595,independent,0,0
144596,of,0,0
144597,early,0,1
144598,intervention,0,1
144599,.,0,1
144600,[,0,0
144601,Therapeutic,0,1
144602,efficacy,0,0
144603,of,0,0
144604,youdujing,0,1
144605,preparation,0,1
144606,in,0,1
144607,treating,0,0
144608,cervical,1,1
144609,high-risk,1,1
144610,human,1,1
144611,papilloma,1,1
144612,virus,1,1
144613,infection,1,1
144614,patients,1,1
144615,],1,1
144616,.,0,1
144617,OBJECTIVE,0,0
144618,To,0,0
144619,study,0,1
144620,the,0,0
144621,clinical,0,0
144622,efficacy,0,0
144623,and,0,0
144624,mechanisms,0,0
144625,of,0,0
144626,Youdujing,0,1
144627,(,0,1
144628,YDJ,0,1
144629,),0,1
144630,preparation,0,0
144631,in,0,0
144632,treating,0,0
144633,the,0,0
144634,cervical,1,1
144635,high-risk,1,1
144636,human,1,1
144637,papilloma,1,1
144638,virus,1,1
144639,(,1,1
144640,HR-HPV,1,1
144641,),1,1
144642,infection,1,1
144643,.,1,1
144644,METHODS,0,0
144645,Totally,1,1
144646,HR-HPV,1,1
144647,infection,1,1
144648,70,1,1
144649,patients,1,1
144650,were,0,1
144651,assigned,0,1
144652,to,0,0
144653,the,0,0
144654,treatment,0,0
144655,group,0,0
144656,and,0,0
144657,the,0,0
144658,control,0,0
144659,group,0,0
144660,using,0,0
144661,random,0,1
144662,single,0,1
144663,blind,0,1
144664,method,0,0
144665,",",0,1
144666,35,0,1
144667,cases,0,1
144668,in,0,1
144669,each,0,1
144670,group,0,1
144671,.,0,1
144672,YDJ,0,1
144673,external,0,0
144674,lotion,0,1
144675,and,0,1
144676,YDJ,0,1
144677,cream,0,0
144678,were,0,1
144679,applied,0,0
144680,to,0,1
144681,patients,0,1
144682,in,0,0
144683,the,0,0
144684,treatment,0,0
144685,group,0,0
144686,",",0,0
144687,while,0,0
144688,normal,0,1
144689,saline,0,0
144690,was,0,0
144691,applied,0,0
144692,for,0,0
144693,those,0,0
144694,in,0,0
144695,the,0,0
144696,control,0,1
144697,group,0,1
144698,.,0,1
144699,HR-HPV,0,0
144700,DNA,0,0
144701,detection,0,1
144702,was,0,0
144703,performed,0,0
144704,by,0,0
144705,the,0,0
144706,end,0,0
144707,of,0,0
144708,the,0,0
144709,1st,0,1
144710,menstruation,0,1
144711,after,0,1
144712,3,0,1
144713,menstrual,0,1
144714,cycles,0,0
144715,.,0,1
144716,The,0,0
144717,cervical,0,1
144718,biopsy,0,1
144719,and,0,1
144720,cervical,0,1
144721,smear,0,1
144722,were,0,1
144723,performed,0,0
144724,using,0,0
144725,vaginoscope,0,1
144726,before,0,0
144727,and,0,0
144728,after,0,1
144729,treatment,0,0
144730,.,0,1
144731,The,0,0
144732,mRNA,0,0
144733,expression,0,0
144734,of,0,0
144735,human,0,1
144736,telomerase,0,0
144737,reverse,0,1
144738,transcriptase,0,1
144739,(,0,1
144740,hTERT,0,1
144741,),0,1
144742,was,0,0
144743,detected,0,0
144744,from,0,1
144745,fresh,0,1
144746,tissues,0,1
144747,of,0,1
144748,the,0,1
144749,cervical,0,1
144750,lesion,0,0
144751,.,0,1
144752,RESULTS,0,0
144753,The,0,0
144754,total,0,1
144755,effective,0,0
144756,rate,0,0
144757,was,0,0
144758,96.6,0,0
144759,%,0,0
144760,in,0,0
144761,the,0,0
144762,treatment,0,0
144763,group,0,0
144764,",",0,0
144765,higher,0,0
144766,than,0,0
144767,that,0,0
144768,of,0,0
144769,the,0,0
144770,control,0,1
144771,group,0,1
144772,(,0,1
144773,70.00,0,0
144774,%,0,0
144775,",",0,1
144776,P,0,0
144777,<,0,0
144778,0.01,0,0
144779,),0,1
144780,.,0,1
144781,Before,0,0
144782,treatment,0,0
144783,there,0,0
144784,was,0,0
144785,no,0,0
144786,statistical,0,0
144787,difference,0,0
144788,in,0,0
144789,the,0,0
144790,pathological,0,1
144791,results,0,0
144792,of,0,1
144793,the,0,0
144794,cervix,0,1
144795,and,0,0
144796,the,0,0
144797,mRNA,0,0
144798,expression,0,0
144799,of,0,0
144800,hTERT,0,1
144801,between,0,0
144802,the,0,1
144803,two,0,1
144804,groups,0,0
144805,(,0,1
144806,P,0,0
144807,>,0,1
144808,0.05,0,0
144809,),0,1
144810,.,0,1
144811,The,0,0
144812,mRNA,0,0
144813,expression,0,0
144814,of,0,0
144815,hTERT,0,1
144816,decreased,0,0
144817,in,0,0
144818,the,0,1
144819,two,0,0
144820,groups,0,0
144821,after,0,1
144822,treatment,0,1
144823,",",0,0
144824,showing,0,0
144825,statistical,0,0
144826,difference,0,0
144827,(,0,1
144828,P,0,0
144829,<,0,0
144830,0.01,0,0
144831,),0,1
144832,.,0,1
144833,Better,0,1
144834,effects,0,0
144835,on,0,0
144836,the,0,1
144837,pathological,0,1
144838,results,0,0
144839,of,0,1
144840,the,0,0
144841,cervix,0,1
144842,and,0,0
144843,the,0,0
144844,mRNA,0,0
144845,expression,0,0
144846,of,0,0
144847,hTERT,0,1
144848,were,0,1
144849,obtained,0,0
144850,in,0,0
144851,the,0,0
144852,treatment,0,0
144853,group,0,0
144854,after,0,0
144855,treatment,0,0
144856,(,0,1
144857,P,0,0
144858,<,0,0
144859,0.05,0,0
144860,),0,1
144861,.,0,1
144862,CONCLUSION,0,0
144863,YDJ,0,1
144864,played,0,0
144865,a,0,0
144866,role,0,0
144867,in,0,0
144868,clearing,0,1
144869,HR-HPV,0,1
144870,infection,0,1
144871,and,0,0
144872,reversing,0,0
144873,the,0,0
144874,cervical,0,1
144875,precancerous,0,1
144876,changes,0,0
144877,possibly,0,0
144878,through,0,1
144879,down-regulating,0,0
144880,the,0,0
144881,mRNA,0,0
144882,expression,0,0
144883,of,0,0
144884,hTERT,0,1
144885,and,0,0
144886,lowering,0,0
144887,the,0,0
144888,telomerase,0,0
144889,activation,0,0
144890,.,0,1
144891,Exposure,0,0
144892,to,0,0
144893,the,0,0
144894,self-face,0,0
144895,facilitates,0,0
144896,identification,0,0
144897,of,0,0
144898,dynamic,0,0
144899,facial,0,1
144900,expressions,0,1
144901,:,0,1
144902,influences,0,0
144903,on,0,1
144904,individual,0,1
144905,differences,0,0
144906,.,0,1
144907,A,0,0
144908,growing,0,0
144909,literature,0,0
144910,suggests,0,0
144911,that,0,0
144912,the,0,0
144913,self-face,0,0
144914,is,0,0
144915,involved,0,0
144916,in,0,0
144917,processing,0,0
144918,the,0,0
144919,facial,0,1
144920,expressions,0,0
144921,of,0,1
144922,others,0,1
144923,.,0,1
144924,The,0,0
144925,authors,0,0
144926,experimentally,0,1
144927,activated,0,0
144928,self-face,1,0
144929,representations,1,0
144930,to,0,1
144931,assess,0,0
144932,its,0,0
144933,effects,0,0
144934,on,0,0
144935,the,0,0
144936,recognition,0,0
144937,of,0,0
144938,dynamically,0,0
144939,emerging,0,0
144940,facial,0,1
144941,expressions,0,1
144942,of,0,1
144943,others,0,1
144944,.,0,1
144945,They,0,0
144946,exposed,0,1
144947,participants,1,1
144948,to,0,1
144949,videos,0,0
144950,of,0,0
144951,either,0,1
144952,their,0,0
144953,own,0,1
144954,faces,0,0
144955,(,0,0
144956,self-face,0,0
144957,prime,0,1
144958,),0,0
144959,or,0,0
144960,faces,0,0
144961,of,0,0
144962,others,0,0
144963,(,0,1
144964,nonself-face,0,1
144965,prime,0,1
144966,),0,1
144967,prior,0,1
144968,to,0,0
144969,a,0,0
144970,facial,0,1
144971,expression,0,0
144972,judgment,0,0
144973,task,0,1
144974,.,0,1
144975,Their,0,1
144976,results,0,0
144977,show,0,0
144978,that,0,0
144979,experimentally,0,1
144980,activating,0,1
144981,self-face,0,0
144982,representations,0,1
144983,results,0,0
144984,in,0,1
144985,earlier,0,1
144986,recognition,0,0
144987,of,0,0
144988,dynamically,0,0
144989,emerging,0,0
144990,facial,0,1
144991,expression,0,0
144992,.,0,1
144993,As,0,0
144994,a,0,0
144995,group,0,1
144996,",",0,0
144997,participants,1,1
144998,in,1,0
144999,the,1,1
145000,self-face,1,0
145001,prime,1,0
145002,condition,1,1
145003,recognized,0,1
145004,expressions,0,0
145005,earlier,0,0
145006,(,0,0
145007,when,0,0
145008,less,0,0
145009,affective,0,0
145010,perceptual,0,0
145011,information,0,0
145012,was,0,0
145013,available,0,1
145014,),0,1
145015,compared,0,0
145016,to,0,1
145017,participants,0,1
145018,in,0,1
145019,the,0,1
145020,nonself-face,0,0
145021,prime,0,1
145022,condition,0,0
145023,.,0,0
145024,There,0,0
145025,were,0,0
145026,individual,0,0
145027,differences,0,0
145028,in,0,1
145029,performance,0,0
145030,",",0,0
145031,such,0,0
145032,that,0,0
145033,poorer,0,0
145034,expression,0,0
145035,identification,0,0
145036,was,0,0
145037,associated,0,0
145038,with,0,1
145039,higher,1,0
145040,autism,1,1
145041,traits,1,0
145042,(,0,1
145043,in,0,0
145044,this,0,0
145045,neurocognitively,1,1
145046,healthy,1,1
145047,sample,1,1
145048,),1,1
145049,.,0,1
145050,However,0,0
145051,",",0,0
145052,when,0,0
145053,randomized,0,1
145054,into,0,0
145055,the,0,0
145056,self-face,0,0
145057,prime,0,0
145058,condition,0,1
145059,",",0,1
145060,participants,1,1
145061,with,1,1
145062,high,1,1
145063,autism,1,1
145064,traits,1,0
145065,performed,1,0
145066,as,1,0
145067,well,1,0
145068,as,1,0
145069,those,1,0
145070,with,1,1
145071,low,1,1
145072,autism,1,1
145073,traits,1,1
145074,.,1,1
145075,Taken,0,0
145076,together,0,0
145077,",",0,0
145078,these,0,0
145079,data,0,0
145080,suggest,0,0
145081,that,0,0
145082,the,0,0
145083,ability,0,0
145084,to,0,0
145085,recognize,0,1
145086,facial,0,1
145087,expressions,0,0
145088,in,0,1
145089,others,0,1
145090,is,0,0
145091,linked,0,0
145092,with,0,1
145093,the,0,0
145094,internal,0,1
145095,representations,0,0
145096,of,0,1
145097,our,0,1
145098,own,0,1
145099,faces,0,1
145100,.,0,1
145101,An,0,0
145102,internet-based,0,1
145103,cognitive-behavioural,0,1
145104,training,0,1
145105,for,0,0
145106,acute,1,1
145107,tinnitus,1,1
145108,:,1,1
145109,secondary,0,0
145110,analysis,0,0
145111,of,0,0
145112,acceptance,0,1
145113,in,0,1
145114,terms,0,0
145115,of,0,1
145116,satisfaction,0,0
145117,",",0,0
145118,trial,0,0
145119,attrition,0,1
145120,and,0,0
145121,non-usage,0,1
145122,attrition,0,1
145123,.,0,1
145124,OBJECTIVES,0,0
145125,Recent,0,1
145126,studies,0,0
145127,on,0,0
145128,tinnitus,0,1
145129,have,0,0
145130,focused,0,0
145131,on,0,0
145132,the,0,0
145133,efficacy,0,0
145134,of,0,0
145135,Internet-based,0,1
145136,interventions,0,1
145137,.,0,1
145138,Other,0,0
145139,core,0,1
145140,features,0,1
145141,of,0,0
145142,the,0,0
145143,quality,0,0
145144,of,0,0
145145,service,0,1
145146,",",0,1
145147,e.g,0,0
145148,.,0,1
145149,acceptance,0,0
145150,and,0,0
145151,attrition,0,0
145152,",",0,0
145153,have,0,0
145154,often,0,0
145155,been,0,0
145156,overlooked,0,0
145157,.,0,1
145158,This,0,0
145159,study,0,0
145160,analyses,0,0
145161,Internet-based,0,0
145162,training,0,0
145163,regarding,0,0
145164,acceptance,0,0
145165,and,0,0
145166,attrition,0,1
145167,in,0,0
145168,a,0,0
145169,trial,0,0
145170,on,0,0
145171,minimal-contact,1,1
145172,interventions,1,1
145173,for,1,1
145174,acute,1,1
145175,tinnitus,1,1
145176,.,1,1
145177,Whenever,0,0
145178,possible,0,0
145179,",",0,0
145180,we,0,0
145181,give,0,0
145182,information,0,0
145183,on,0,0
145184,other,0,1
145185,forms,0,1
145186,of,0,1
145187,training,0,1
145188,for,0,1
145189,comparison,0,0
145190,.,0,1
145191,METHODS,0,0
145192,In,0,0
145193,a,0,1
145194,randomised,0,0
145195,controlled,0,0
145196,trial,0,1
145197,with,0,1
145198,337,1,1
145199,participants,1,1
145200,",",1,1
145201,87,1,1
145202,persons,1,1
145203,took,1,1
145204,part,1,1
145205,in,1,0
145206,the,1,0
145207,Internet,1,1
145208,training,1,0
145209,.,1,1
145210,RESULTS,0,0
145211,The,1,0
145212,participants,1,1
145213,were,1,1
145214,as,1,0
145215,satisfied,1,1
145216,with,1,1
145217,the,1,0
145218,Internet-based,1,1
145219,training,1,0
145220,as,1,0
145221,with,1,1
145222,a,1,1
145223,face-to-face,1,0
145224,group,1,1
145225,training,1,0
145226,.,1,0
145227,There,0,0
145228,was,0,0
145229,a,0,0
145230,34.48,0,0
145231,%,0,0
145232,dropout,0,0
145233,from,0,1
145234,the,0,0
145235,Internet-based,0,1
145236,training,0,0
145237,(,0,1
145238,dropout,0,0
145239,attrition,0,1
145240,),0,1
145241,.,0,1
145242,The,0,0
145243,training,0,0
145244,attrition,0,1
145245,from,0,1
145246,the,0,0
145247,Internet-based,0,1
145248,training,0,0
145249,was,0,0
145250,even,0,0
145251,higher,0,0
145252,at,0,0
145253,64.4,0,0
145254,%,0,0
145255,.,0,1
145256,CONCLUSIONS,0,0
145257,Two,0,1
145258,out,0,1
145259,of,0,1
145260,three,0,1
145261,indicators,0,0
145262,for,0,1
145263,acceptance-satisfaction,0,0
145264,and,0,1
145265,dropout,0,0
145266,attrition-provide,0,1
145267,comparable,0,0
145268,results,0,0
145269,between,0,0
145270,the,0,1
145271,Internet-based,0,1
145272,training,0,0
145273,and,0,0
145274,a,0,0
145275,face-to-face,0,0
145276,group,0,1
145277,training,0,0
145278,.,0,1
145279,The,0,0
145280,third,0,0
145281,indicator,0,0
145282,",",0,0
145283,training,0,0
145284,attrition,0,0
145285,",",0,0
145286,shows,0,0
145287,a,0,0
145288,better,0,0
145289,result,0,0
145290,for,0,0
145291,the,0,0
145292,group,0,1
145293,training,0,0
145294,.,0,1
145295,Future,0,0
145296,research,0,0
145297,should,0,0
145298,focus,0,1
145299,on,0,0
145300,attrition,0,1
145301,in,0,0
145302,order,0,0
145303,to,0,0
145304,enhance,0,0
145305,the,0,0
145306,overall,0,0
145307,effectiveness,0,0
145308,of,0,0
145309,training,0,1
145310,.,0,1
145311,Does,0,0
145312,single,0,0
145313,use,0,0
145314,of,0,0
145315,an,0,0
145316,autologous,0,1
145317,transfusion,0,0
145318,system,0,1
145319,in,0,0
145320,TKA,1,1
145321,reduce,0,0
145322,the,0,0
145323,need,0,0
145324,for,0,0
145325,allogenic,0,1
145326,blood,0,1
145327,?,0,1
145328,:,0,0
145329,a,0,0
145330,prospective,0,1
145331,randomized,0,1
145332,trial,0,1
145333,.,0,1
145334,BACKGROUND,0,0
145335,Mechanical,0,0
145336,autotransfusion,0,0
145337,systems,0,0
145338,for,0,1
145339,washed,0,0
145340,shed,0,0
145341,blood,0,0
145342,(,0,1
145343,WSB,0,1
145344,),0,1
145345,were,0,1
145346,introduced,0,0
145347,to,0,0
145348,reduce,0,0
145349,the,0,0
145350,need,0,0
145351,for,0,0
145352,postoperative,0,1
145353,allogenic,0,1
145354,blood,0,1
145355,transfusions,0,0
145356,(,0,1
145357,ABTs,0,1
145358,),0,1
145359,.,0,1
145360,Although,0,0
145361,some,0,0
145362,authors,0,0
145363,have,0,0
145364,postulated,0,0
145365,decreased,0,0
145366,requirements,0,1
145367,for,0,1
145368,ABT,0,1
145369,by,0,0
145370,using,0,0
145371,autologous,0,1
145372,retransfusion,0,1
145373,devices,0,0
145374,",",0,1
145375,other,0,1
145376,trials,0,0
145377,",",0,1
145378,mostly,0,1
145379,evaluating,0,0
145380,retransfusion,0,0
145381,devices,0,0
145382,for,0,1
145383,unwashed,0,1
145384,shed,0,0
145385,blood,0,0
145386,(,0,1
145387,USB,0,1
145388,),0,1
145389,",",0,0
145390,verified,0,0
145391,a,0,0
145392,small,0,0
145393,or,0,1
145394,no,0,0
145395,benefit,0,0
145396,in,0,0
145397,reducing,0,0
145398,the,0,0
145399,need,0,0
145400,for,0,0
145401,postoperative,0,1
145402,ABT,0,1
145403,.,0,1
145404,Because,0,0
145405,of,0,0
145406,these,0,0
145407,contradictory,0,0
145408,findings,0,0
145409,it,0,0
145410,is,0,0
145411,still,0,0
145412,unclear,0,0
145413,whether,0,0
145414,autologous,0,1
145415,retransfusion,0,1
145416,systems,0,0
145417,for,0,0
145418,WSB,0,1
145419,can,0,0
145420,reduce,0,0
145421,transfusion,0,0
145422,requirements,0,1
145423,.,0,1
145424,QUESTIONS/PURPOSES,0,0
145425,We,0,0
145426,therefore,0,0
145427,asked,0,0
145428,whether,0,0
145429,one,0,1
145430,such,0,0
145431,autologous,0,1
145432,transfusion,0,0
145433,system,0,1
145434,for,0,0
145435,WSB,0,0
145436,can,0,0
145437,reduce,0,0
145438,the,0,0
145439,requirements,0,0
145440,for,0,1
145441,postoperative,0,1
145442,ABT,0,1
145443,.,0,1
145444,METHODS,0,0
145445,In,0,0
145446,a,0,1
145447,prospective,0,1
145448,",",0,0
145449,randomized,0,1
145450,",",0,0
145451,controlled,0,0
145452,study,0,0
145453,",",0,0
145454,we,1,0
145455,enrolled,1,1
145456,151,1,1
145457,patients,1,1
145458,undergoing,1,1
145459,TKA,1,1
145460,.,1,1
145461,In,0,0
145462,Group,1,1
145463,A,1,1
145464,(,1,1
145465,n=76,1,1
145466,patients,1,1
145467,),1,1
145468,",",0,0
145469,the,0,0
145470,autotransfusion,0,0
145471,system,0,0
145472,was,0,0
145473,used,0,0
145474,for,0,0
145475,a,0,0
145476,total,0,1
145477,of,0,0
145478,6,0,1
145479,hours,0,0
145480,(,0,1
145481,intraoperatively,0,1
145482,and,0,0
145483,postoperatively,0,0
145484,),0,0
145485,and,0,0
145486,the,0,0
145487,WSB,0,0
145488,was,0,0
145489,retransfused,0,1
145490,after,0,0
145491,processing,0,0
145492,.,0,1
145493,In,0,0
145494,Control,1,1
145495,Group,1,1
145496,B,1,1
145497,(,1,1
145498,n=75,1,1
145499,patients,1,1
145500,),1,1
145501,",",0,0
145502,a,0,0
145503,regular,0,0
145504,drain,0,0
145505,without,0,1
145506,suction,0,1
145507,was,0,0
145508,used,0,0
145509,.,0,1
145510,We,0,0
145511,used,0,0
145512,signs,0,1
145513,of,0,0
145514,anemia,0,1
145515,and/or,0,0
145516,a,0,0
145517,hemoglobin,0,0
145518,value,0,0
145519,less,0,0
145520,than,0,0
145521,8,0,0
145522,g/dL,0,1
145523,as,0,0
145524,indications,0,0
145525,for,0,1
145526,transfusion,0,0
145527,.,0,1
145528,If,0,0
145529,necessary,0,0
145530,",",0,1
145531,we,0,0
145532,administered,0,0
145533,one,0,1
145534,or,0,1
145535,two,0,1
145536,units,0,1
145537,of,0,1
145538,allogenic,0,1
145539,blood,0,1
145540,.,0,1
145541,RESULTS,0,0
145542,Twenty-three,0,1
145543,patients,0,1
145544,(,0,1
145545,33,0,1
145546,%,0,0
145547,),0,1
145548,in,0,0
145549,Group,0,1
145550,A,0,1
145551,",",0,1
145552,who,0,1
145553,received,0,1
145554,an,0,1
145555,average,0,0
145556,of,0,0
145557,283,0,1
145558,mL,0,0
145559,(,0,1
145560,range,0,1
145561,",",0,0
145562,160-406,0,1
145563,mL,0,0
145564,),0,1
145565,of,0,0
145566,salvaged,0,1
145567,blood,0,0
145568,",",0,0
145569,needed,0,0
145570,a,0,0
145571,mean,0,1
145572,of,0,0
145573,2.1,0,0
145574,units,0,1
145575,of,0,1
145576,allogenic,0,1
145577,blood,0,0
145578,",",0,0
145579,compared,0,0
145580,with,0,1
145581,23,0,1
145582,patients,0,1
145583,(,0,1
145584,33,0,1
145585,%,0,0
145586,),0,1
145587,in,0,0
145588,Control,0,1
145589,Group,0,1
145590,B,0,1
145591,who,0,1
145592,needed,0,1
145593,a,0,1
145594,mean,0,1
145595,of,0,0
145596,2.1,0,0
145597,units,0,1
145598,of,0,1
145599,allogenic,0,1
145600,blood,0,1
145601,.,0,1
145602,CONCLUSIONS,0,0
145603,We,0,0
145604,found,0,0
145605,the,0,0
145606,use,0,0
145607,of,0,0
145608,an,0,0
145609,autotransfusion,0,0
145610,system,0,0
145611,did,0,0
145612,not,0,0
145613,reduce,0,0
145614,the,0,0
145615,rate,0,0
145616,of,0,0
145617,postoperative,0,1
145618,ABTs,0,1
145619,.,0,1
145620,LEVEL,0,0
145621,OF,0,1
145622,EVIDENCE,0,1
145623,Level,0,1
145624,II,0,1
145625,",",0,0
145626,therapeutic,0,0
145627,study,0,1
145628,.,0,1
145629,See,0,0
145630,the,0,0
145631,Guidelines,0,1
145632,for,0,0
145633,Authors,0,0
145634,for,0,0
145635,a,0,1
145636,complete,0,1
145637,description,0,0
145638,of,0,1
145639,levels,0,0
145640,of,0,1
145641,evidence,0,0
145642,.,0,1
145643,A,0,0
145644,randomised,0,0
145645,controlled,0,0
145646,trial,0,1
145647,of,0,0
145648,bumetanide,0,0
145649,in,0,0
145650,the,0,0
145651,treatment,0,0
145652,of,0,0
145653,autism,1,1
145654,in,1,1
145655,children,1,1
145656,.,1,1
145657,Gamma,0,1
145658,aminobutyric,0,0
145659,acid,0,0
145660,(,0,1
145661,GABA,0,0
145662,),0,1
145663,-mediated,0,0
145664,synapses,0,0
145665,and,0,1
145666,the,0,1
145667,oscillations,0,0
145668,they,0,0
145669,orchestrate,0,0
145670,are,0,0
145671,altered,0,1
145672,in,0,0
145673,autism,0,1
145674,.,0,1
145675,GABA-acting,0,0
145676,benzodiazepines,0,0
145677,exert,0,0
145678,in,0,1
145679,some,0,0
145680,patients,0,1
145681,with,0,1
145682,autism,0,1
145683,paradoxical,0,1
145684,effects,0,0
145685,",",0,1
145686,raising,0,0
145687,the,0,0
145688,possibility,0,0
145689,that,0,0
145690,like,0,0
145691,in,0,1
145692,epilepsies,0,1
145693,",",0,1
145694,GABA,0,0
145695,excites,0,0
145696,neurons,0,0
145697,because,0,0
145698,of,0,1
145699,elevated,0,1
145700,intracellular,0,1
145701,concentrations,0,0
145702,of,0,1
145703,chloride,0,0
145704,.,0,1
145705,Following,0,0
145706,a,0,0
145707,successful,0,1
145708,pilot,0,0
145709,study,0,1
145710,",",0,0
145711,(,0,1
145712,1,0,1
145713,),0,1
145714,we,0,0
145715,have,0,0
145716,now,0,0
145717,performed,0,0
145718,a,0,0
145719,double-blind,0,0
145720,clinical,0,0
145721,trial,0,1
145722,using,0,0
145723,the,0,0
145724,diuretic,0,0
145725,",",0,0
145726,chloride-importer,0,0
145727,antagonist,0,0
145728,bumetanide,0,0
145729,that,0,0
145730,reduces,0,0
145731,intracellular,0,0
145732,chloride,0,0
145733,reinforcing,0,0
145734,GABAergic,0,1
145735,inhibition,0,0
145736,.,0,1
145737,Sixty,1,1
145738,children,1,1
145739,with,1,1
145740,autism,1,1
145741,or,1,1
145742,Asperger,1,1
145743,syndrome,1,1
145744,(,1,1
145745,3-11,1,1
145746,years,1,1
145747,old,1,1
145748,),1,1
145749,received,0,1
145750,for,0,1
145751,3,0,1
145752,months,0,1
145753,placebo,0,1
145754,or,0,1
145755,bumetanide,0,0
145756,(,0,1
145757,1,0,1
145758,mg,0,0
145759,daily,0,0
145760,),0,1
145761,",",0,0
145762,followed,0,0
145763,by,0,0
145764,1-month,0,0
145765,wash,0,0
145766,out,0,1
145767,.,0,1
145768,Determination,0,0
145769,of,0,0
145770,the,0,0
145771,severity,0,0
145772,of,0,0
145773,autism,0,1
145774,was,0,0
145775,made,0,0
145776,with,0,1
145777,video,0,0
145778,films,0,1
145779,at,0,1
145780,day,0,1
145781,0,0,0
145782,(,0,1
145783,D0,0,1
145784,),0,1
145785,and,0,0
145786,D90,0,1
145787,by,0,0
145788,blind,0,1
145789,",",0,1
145790,independent,0,0
145791,evaluators,0,1
145792,.,0,1
145793,Bumetanide,0,0
145794,reduced,0,0
145795,significantly,0,0
145796,the,0,0
145797,Childhood,0,1
145798,Autism,0,1
145799,Rating,0,0
145800,Scale,0,1
145801,(,0,1
145802,CARS,0,1
145803,),0,1
145804,(,0,1
145805,D90-D0,0,1
145806,;,0,1
145807,P,0,0
145808,<,0,0
145809,0.004,0,0
145810,treated,0,1
145811,vs,0,0
145812,placebo,0,0
145813,),0,0
145814,",",0,0
145815,Clinical,0,0
145816,Global,0,1
145817,Impressions,0,0
145818,(,0,1
145819,P,0,0
145820,<,0,0
145821,0.017,0,0
145822,treated,0,1
145823,vs,0,0
145824,placebo,0,1
145825,),0,1
145826,and,0,1
145827,Autism,0,1
145828,Diagnostic,0,1
145829,Observation,0,1
145830,Schedule,0,0
145831,values,0,0
145832,when,0,0
145833,the,0,0
145834,most,0,0
145835,severe,0,1
145836,cases,0,1
145837,(,0,1
145838,CARS,0,1
145839,values,0,0
145840,above,0,1
145841,the,0,1
145842,mean,0,1
145843,?,0,1
145844,s.d,0,1
145845,.,0,1
145846,;,0,0
145847,n=9,0,1
145848,),0,1
145849,were,0,1
145850,removed,0,0
145851,(,0,1
145852,Wilcoxon,0,0
145853,test,0,0
145854,:,0,1
145855,P-value=0.031,0,0
145856,;,0,1
145857,Student,0,0
145858,'s,0,1
145859,t-test,0,0
145860,:,0,1
145861,P-value=0.017,0,0
145862,),0,1
145863,.,0,1
145864,Side,0,0
145865,effects,0,0
145866,were,0,1
145867,restricted,0,1
145868,to,0,0
145869,an,0,0
145870,occasional,0,0
145871,mild,0,1
145872,hypokalaemia,0,0
145873,(,0,1
145874,3.0-3.5,0,1
145875,mM,0,0
145876,l,0,0
145877,(,0,1
145878,-1,0,0
145879,),0,1
145880,K,0,0
145881,(,0,1
145882,+,0,0
145883,),0,1
145884,),0,1
145885,that,0,0
145886,was,0,0
145887,treated,0,1
145888,with,0,1
145889,supplemental,0,1
145890,potassium,0,0
145891,.,0,1
145892,In,0,0
145893,a,0,0
145894,companion,0,0
145895,study,0,0
145896,",",0,0
145897,chronic,0,1
145898,bumetanide,0,0
145899,treatment,0,0
145900,significantly,0,0
145901,improved,0,0
145902,accuracy,0,0
145903,in,0,0
145904,facial,0,1
145905,emotional,0,0
145906,labelling,0,0
145907,",",0,0
145908,and,0,0
145909,increased,0,0
145910,brain,0,0
145911,activation,0,0
145912,in,0,1
145913,areas,0,0
145914,involved,0,1
145915,in,0,1
145916,social,0,1
145917,and,0,1
145918,emotional,0,0
145919,perception,0,0
145920,(,0,1
145921,Hadjikhani,0,1
145922,et,0,1
145923,al.,0,0
145924,",",0,0
145925,submitted,0,0
145926,),0,0
145927,.,0,1
145928,Therefore,0,0
145929,",",0,0
145930,bumetanide,0,0
145931,is,0,0
145932,a,0,0
145933,promising,0,0
145934,novel,0,0
145935,therapeutic,0,0
145936,agent,0,0
145937,to,0,0
145938,treat,0,1
145939,autism,0,1
145940,.,0,1
145941,Larger,0,0
145942,trials,0,0
145943,are,0,0
145944,warranted,0,0
145945,to,0,0
145946,better,0,0
145947,determine,0,0
145948,the,0,0
145949,population,0,1
145950,best,0,0
145951,suited,0,0
145952,for,0,0
145953,this,0,0
145954,treatment,0,0
145955,.,0,1
145956,Differences,0,0
145957,in,0,1
145958,reach,0,0
145959,and,0,0
145960,attrition,0,1
145961,between,0,0
145962,Web-based,0,0
145963,and,0,1
145964,print-delivered,0,1
145965,tailored,0,0
145966,interventions,0,1
145967,among,0,1
145968,adults,1,1
145969,over,1,1
145970,50,1,1
145971,years,1,1
145972,of,1,1
145973,age,1,1
145974,:,1,1
145975,clustered,0,1
145976,randomized,0,1
145977,trial,0,1
145978,.,0,1
145979,BACKGROUND,0,0
145980,The,0,0
145981,Internet,0,0
145982,has,0,0
145983,the,0,0
145984,potential,0,0
145985,to,0,0
145986,provide,0,0
145987,large,0,1
145988,populations,0,1
145989,with,0,1
145990,individual,0,0
145991,health,0,1
145992,promotion,0,0
145993,advice,0,0
145994,at,0,0
145995,a,0,0
145996,relatively,0,0
145997,low,0,0
145998,cost,0,0
145999,.,0,1
146000,Despite,0,0
146001,the,0,0
146002,high,0,1
146003,rates,0,0
146004,of,0,1
146005,Internet,0,1
146006,access,0,0
146007,",",0,0
146008,actual,0,0
146009,reach,0,0
146010,by,0,0
146011,Web-based,0,0
146012,interventions,0,0
146013,is,0,0
146014,often,0,0
146015,disappointingly,0,0
146016,low,0,0
146017,",",0,0
146018,and,0,0
146019,differences,0,0
146020,in,0,1
146021,use,0,0
146022,between,0,0
146023,demographic,0,0
146024,subgroups,0,0
146025,are,0,0
146026,present,0,0
146027,.,0,1
146028,Furthermore,0,0
146029,",",0,0
146030,Web-based,0,0
146031,interventions,0,0
146032,often,0,1
146033,have,0,0
146034,to,0,0
146035,deal,0,0
146036,with,0,1
146037,high,0,1
146038,rates,0,0
146039,of,0,1
146040,attrition,0,1
146041,.,0,1
146042,OBJECTIVE,0,0
146043,This,0,0
146044,study,0,0
146045,aims,0,0
146046,to,0,0
146047,assess,0,0
146048,user,0,0
146049,characteristics,0,0
146050,related,0,0
146051,to,0,1
146052,participation,0,0
146053,and,0,0
146054,attrition,0,0
146055,when,0,0
146056,comparing,0,0
146057,Web-based,0,0
146058,and,0,1
146059,print-delivered,0,1
146060,tailored,0,0
146061,interventions,0,0
146062,containing,0,1
146063,similar,0,0
146064,content,0,0
146065,and,0,0
146066,thereby,0,0
146067,to,0,0
146068,provide,0,0
146069,recommendations,0,0
146070,in,0,0
146071,choosing,0,0
146072,the,0,0
146073,appropriate,0,0
146074,delivery,0,0
146075,mode,0,0
146076,for,0,0
146077,a,0,1
146078,particular,0,0
146079,target,0,0
146080,audience,0,0
146081,.,0,1
146082,METHODS,0,0
146083,We,0,0
146084,studied,0,1
146085,the,0,0
146086,distribution,0,0
146087,of,0,0
146088,a,0,1
146089,Web-based,0,0
146090,and,0,0
146091,a,0,1
146092,print-delivered,0,0
146093,version,0,0
146094,of,0,0
146095,the,0,0
146096,Active,0,0
146097,Plus,0,1
146098,intervention,0,0
146099,in,0,0
146100,a,0,1
146101,clustered,0,1
146102,randomized,0,1
146103,controlled,0,0
146104,trial,0,0
146105,(,0,1
146106,RCT,0,1
146107,),0,1
146108,.,0,1
146109,Participants,1,1
146110,were,1,0
146111,recruited,1,1
146112,via,1,1
146113,direct,1,0
146114,mailing,1,1
146115,within,1,1
146116,the,1,0
146117,participating,1,1
146118,Municipal,1,1
146119,Health,1,1
146120,Council,1,1
146121,regions,1,1
146122,and,1,1
146123,randomized,1,1
146124,to,1,0
146125,the,1,0
146126,printed,1,0
146127,or,1,1
146128,Web-based,1,0
146129,intervention,1,0
146130,by,1,0
146131,their,1,1
146132,region,1,1
146133,.,1,1
146134,Based,0,0
146135,on,0,0
146136,the,0,0
146137,answers,0,0
146138,given,0,0
146139,in,0,1
146140,a,0,1
146141,prior,0,1
146142,assessment,0,0
146143,",",0,1
146144,participants,0,1
146145,received,0,1
146146,tailored,0,0
146147,advice,0,0
146148,on,0,1
146149,3,0,1
146150,occasions,0,1
146151,:,0,1
146152,(,0,1
146153,1,0,1
146154,),0,1
146155,within,0,1
146156,2,0,1
146157,weeks,0,0
146158,after,0,1
146159,the,0,0
146160,baseline,0,0
146161,",",0,0
146162,(,0,1
146163,2,0,1
146164,),0,1
146165,2,0,1
146166,months,0,0
146167,after,0,1
146168,the,0,0
146169,baseline,0,0
146170,",",0,0
146171,and,0,0
146172,(,0,1
146173,3,0,1
146174,),0,1
146175,within,0,1
146176,4,0,1
146177,months,0,1
146178,after,0,1
146179,the,0,0
146180,baseline,0,0
146181,(,0,0
146182,based,0,1
146183,on,0,0
146184,a,0,1
146185,second,0,0
146186,assessment,0,0
146187,at,0,1
146188,3,0,1
146189,months,0,1
146190,),0,1
146191,.,0,1
146192,The,0,0
146193,baseline,0,0
146194,(,0,0
146195,printed,0,0
146196,or,0,1
146197,Web-based,0,1
146198,),0,1
146199,results,0,0
146200,were,0,1
146201,analyzed,0,0
146202,using,0,0
146203,ANOVA,0,1
146204,and,0,1
146205,chi-square,0,0
146206,tests,0,0
146207,to,0,1
146208,establish,0,0
146209,the,0,0
146210,differences,0,0
146211,in,0,1
146212,user,0,1
146213,characteristics,0,1
146214,between,0,0
146215,both,0,0
146216,intervention,0,1
146217,groups,0,0
146218,.,0,1
146219,We,0,0
146220,used,0,0
146221,logistic,0,0
146222,regression,0,0
146223,analyses,0,0
146224,to,0,0
146225,study,0,1
146226,the,0,0
146227,interaction,0,0
146228,between,0,0
146229,the,0,0
146230,user,0,0
146231,characteristics,0,0
146232,and,0,1
146233,the,0,0
146234,delivery,0,0
146235,mode,0,0
146236,in,0,0
146237,the,0,0
146238,prediction,0,0
146239,of,0,0
146240,dropout,0,0
146241,rate,0,0
146242,within,0,0
146243,the,0,0
146244,intervention,0,0
146245,period,0,0
146246,.,0,0
146247,RESULTS,0,0
146248,The,0,0
146249,printed,0,0
146250,intervention,0,0
146251,resulted,0,0
146252,in,0,0
146253,a,0,0
146254,higher,0,0
146255,participation,0,0
146256,rate,0,0
146257,(,0,1
146258,19,0,1
146259,%,0,0
146260,),0,1
146261,than,0,0
146262,the,0,0
146263,Web-based,0,0
146264,intervention,0,0
146265,(,0,1
146266,12,0,1
146267,%,0,0
146268,),0,1
146269,.,0,1
146270,Participants,0,1
146271,of,0,0
146272,the,0,1
146273,Web-based,0,0
146274,intervention,0,0
146275,were,0,0
146276,significantly,0,0
146277,younger,0,1
146278,(,0,0
146279,P,0,0
146280,<,0,0
146281,.001,0,0
146282,),0,0
146283,",",0,0
146284,more,0,0
146285,often,0,0
146286,men,0,1
146287,(,0,1
146288,P=.01,0,1
146289,),0,1
146290,",",0,0
146291,had,0,0
146292,a,0,0
146293,higher,0,0
146294,body,0,1
146295,mass,0,1
146296,index,0,1
146297,(,0,1
146298,BMI,0,1
146299,),0,1
146300,(,0,1
146301,P=.001,0,0
146302,),0,1
146303,and,0,0
146304,a,0,0
146305,lower,0,0
146306,intention,0,0
146307,to,0,0
146308,be,0,0
146309,physically,0,1
146310,active,0,0
146311,(,0,1
146312,P=.03,0,0
146313,),0,1
146314,than,0,0
146315,participants,0,1
146316,of,0,1
146317,the,0,0
146318,printed,0,0
146319,intervention,0,0
146320,.,0,1
146321,The,0,0
146322,dropout,0,0
146323,rate,0,0
146324,was,0,0
146325,significantly,0,0
146326,higher,0,0
146327,in,0,0
146328,the,0,0
146329,Web-based,0,0
146330,intervention,0,0
146331,group,0,1
146332,(,0,1
146333,53,0,1
146334,%,0,0
146335,),0,1
146336,compared,0,0
146337,to,0,0
146338,the,0,0
146339,print-delivered,0,0
146340,intervention,0,0
146341,(,0,1
146342,39,0,1
146343,%,0,0
146344,",",0,1
146345,P,0,0
146346,<,0,0
146347,.001,0,0
146348,),0,1
146349,.,0,1
146350,A,0,0
146351,low,0,0
146352,intention,0,0
146353,to,0,0
146354,be,0,0
146355,physically,0,1
146356,active,0,0
146357,was,0,0
146358,a,0,1
146359,strong,0,0
146360,predictor,0,0
146361,for,0,0
146362,dropout,0,0
146363,within,0,0
146364,both,0,0
146365,delivery,0,0
146366,modes,0,0
146367,(,0,1
146368,P,0,0
146369,<,0,0
146370,.001,0,0
146371,),0,1
146372,.,0,1
146373,The,0,0
146374,difference,0,0
146375,in,0,0
146376,dropout,0,0
146377,rate,0,0
146378,between,0,0
146379,the,0,0
146380,Web-based,0,0
146381,and,0,0
146382,the,0,0
146383,printed,0,0
146384,intervention,0,0
146385,was,0,0
146386,not,0,0
146387,explained,0,0
146388,by,0,0
146389,user,0,1
146390,characteristics,0,1
146391,.,0,1
146392,CONCLUSIONS,0,0
146393,The,0,0
146394,reach,0,0
146395,of,0,0
146396,the,0,0
146397,same,0,0
146398,tailored,0,0
146399,physical,0,1
146400,activity,0,0
146401,(,0,1
146402,PA,0,1
146403,),0,1
146404,intervention,0,0
146405,in,0,0
146406,a,0,1
146407,printed,0,0
146408,or,0,1
146409,Web-based,0,0
146410,delivery,0,0
146411,mode,0,0
146412,differed,0,0
146413,between,0,0
146414,sociodemographic,0,1
146415,subgroups,0,1
146416,of,0,1
146417,participants,0,1
146418,over,0,1
146419,50,0,1
146420,years,0,1
146421,of,0,1
146422,age,0,1
146423,.,0,1
146424,Although,0,0
146425,the,0,0
146426,reach,0,0
146427,of,0,0
146428,the,0,0
146429,Web-based,0,0
146430,intervention,0,0
146431,is,0,0
146432,lower,0,0
146433,",",0,0
146434,Web-based,0,0
146435,interventions,0,0
146436,can,0,0
146437,be,0,0
146438,a,0,0
146439,good,0,0
146440,channel,0,0
146441,to,0,0
146442,reach,0,0
146443,high-risk,0,1
146444,populations,0,1
146445,(,0,1
146446,lower,0,0
146447,PA,0,1
146448,intention,0,0
146449,and,0,0
146450,higher,0,0
146451,BMI,0,1
146452,),0,0
146453,.,0,1
146454,While,0,0
146455,the,0,0
146456,dropout,0,0
146457,rate,0,0
146458,was,0,0
146459,significantly,0,0
146460,higher,0,0
146461,in,0,0
146462,the,0,0
146463,Web-based,0,0
146464,intervention,0,0
146465,group,0,0
146466,",",0,0
146467,no,0,0
146468,specific,0,0
146469,user,0,0
146470,characteristics,0,1
146471,explained,0,0
146472,the,0,0
146473,difference,0,0
146474,in,0,0
146475,dropout,0,0
146476,rates,0,0
146477,between,0,0
146478,the,0,0
146479,delivery,0,0
146480,modes,0,0
146481,.,0,1
146482,More,0,1
146483,research,0,0
146484,is,0,0
146485,needed,0,0
146486,to,0,0
146487,determine,0,0
146488,what,0,0
146489,caused,0,0
146490,the,0,1
146491,high,0,0
146492,rate,0,0
146493,of,0,0
146494,dropout,0,0
146495,in,0,0
146496,the,0,0
146497,Web-based,0,0
146498,intervention,0,0
146499,.,0,1
146500,TRIAL,0,0
146501,REGISTRATION,0,0
146502,Dutch,0,1
146503,Trial,0,1
146504,Register,0,1
146505,(,0,1
146506,NTR,0,1
146507,),0,1
146508,:,0,1
146509,2297,0,1
146510,:,0,1
146511,http,0,0
146512,:,0,1
146513,//www.trialregister.nl/trialreg/admin/rctview.asp,0,1
146514,?,0,1
146515,TC=2297,0,0
146516,(,0,0
146517,Archived,0,1
146518,by,0,0
146519,WebCite,0,0
146520,at,0,1
146521,http,0,0
146522,:,0,1
146523,//www.webcitation.org/65TkwoESp,0,0
146524,),0,1
146525,.,0,1
146526,HOXB13,0,1
146527,G84E,0,0
146528,mutation,0,1
146529,in,0,1
146530,Finland,1,1
146531,:,1,1
146532,population-based,0,1
146533,analysis,0,0
146534,of,0,0
146535,prostate,1,1
146536,",",1,0
146537,breast,1,1
146538,",",1,0
146539,and,1,0
146540,colorectal,1,1
146541,cancer,1,1
146542,risk,1,1
146543,.,1,0
146544,BACKGROUND,0,0
146545,A,0,0
146546,recently,0,1
146547,identified,0,0
146548,germline,0,1
146549,mutation,0,1
146550,G84E,0,0
146551,in,0,1
146552,HOXB13,0,1
146553,was,0,0
146554,shown,0,0
146555,to,0,0
146556,increase,0,0
146557,the,0,0
146558,risk,0,0
146559,of,0,0
146560,prostate,0,1
146561,cancer,0,1
146562,.,0,1
146563,In,0,0
146564,a,0,0
146565,family-based,0,1
146566,analysis,0,0
146567,by,0,0
146568,The,0,0
146569,International,0,1
146570,Consortium,0,1
146571,for,0,1
146572,Prostate,0,1
146573,Cancer,0,1
146574,Genetics,0,1
146575,(,0,1
146576,ICPCG,0,1
146577,),0,1
146578,",",0,0
146579,the,0,0
146580,G84E,0,0
146581,mutation,0,1
146582,was,0,0
146583,most,0,0
146584,prevalent,0,1
146585,in,0,1
146586,families,0,1
146587,from,0,1
146588,the,0,1
146589,Nordic,0,1
146590,countries,0,1
146591,of,0,1
146592,Finland,0,1
146593,(,0,1
146594,22.4,0,1
146595,%,0,0
146596,),0,1
146597,and,0,1
146598,Sweden,0,1
146599,(,0,1
146600,8.2,0,0
146601,%,0,0
146602,),0,1
146603,.,0,1
146604,METHODS,0,0
146605,To,0,0
146606,further,0,0
146607,investigate,0,0
146608,the,0,0
146609,importance,0,0
146610,of,0,0
146611,G84E,0,0
146612,in,0,1
146613,the,0,0
146614,Finns,1,1
146615,",",0,0
146616,we,0,0
146617,determined,0,0
146618,its,0,0
146619,frequency,0,0
146620,in,0,0
146621,more,1,0
146622,than,1,1
146623,"4,000",1,1
146624,prostate,1,1
146625,cancer,1,1
146626,cases,1,1
146627,and,1,1
146628,"5,000",1,1
146629,controls,1,1
146630,.,1,1
146631,In,1,0
146632,addition,1,0
146633,",",1,1
146634,986,1,1
146635,breast,1,1
146636,cancer,1,1
146637,and,1,1
146638,442,1,1
146639,colorectal,1,1
146640,cancer,1,1
146641,(,1,1
146642,CRC,1,1
146643,),1,1
146644,cases,1,1
146645,were,1,1
146646,studied,1,1
146647,.,1,1
146648,Genotyping,0,0
146649,was,0,0
146650,conducted,0,1
146651,using,0,0
146652,TaqMan,0,1
146653,",",0,1
146654,MassARRAY,0,1
146655,iPLEX,0,0
146656,",",0,0
146657,and,0,0
146658,sequencing,0,1
146659,.,0,1
146660,Statistical,0,0
146661,analyses,0,0
146662,were,0,1
146663,conducted,0,1
146664,using,0,0
146665,Fisher,0,0
146666,exact,0,0
146667,test,0,0
146668,",",0,0
146669,and,0,0
146670,overall,0,0
146671,survival,0,0
146672,was,0,0
146673,analyzed,0,0
146674,using,0,0
146675,Cox,0,0
146676,modeling,0,1
146677,.,0,1
146678,RESULTS,0,0
146679,The,0,0
146680,frequency,0,0
146681,of,0,0
146682,the,0,0
146683,G84E,0,0
146684,mutation,0,1
146685,was,0,0
146686,significantly,0,0
146687,higher,0,0
146688,among,0,0
146689,patients,0,1
146690,with,0,1
146691,prostate,0,1
146692,cancer,0,1
146693,and,0,0
146694,highest,0,0
146695,among,0,1
146696,patients,0,1
146697,with,0,1
146698,a,0,1
146699,family,0,1
146700,history,0,1
146701,of,0,0
146702,the,0,0
146703,disease,0,1
146704,",",0,0
146705,hereditary,0,1
146706,prostate,0,1
146707,cancer,0,1
146708,[,0,0
146709,8.4,0,0
146710,%,0,0
146711,vs.,0,0
146712,1.0,0,0
146713,%,0,0
146714,in,0,1
146715,controls,0,1
146716,;,0,1
146717,OR,0,0
146718,8.8,0,0
146719,;,0,1
146720,95,0,0
146721,%,0,0
146722,confidence,0,0
146723,interval,0,0
146724,(,0,1
146725,CI,0,0
146726,),0,1
146727,",",0,0
146728,4.9-15.7,0,0
146729,],0,1
146730,.,0,1
146731,The,0,0
146732,mutation,0,0
146733,contributed,0,0
146734,significantly,0,0
146735,to,0,0
146736,younger,0,1
146737,age,0,1
146738,(,0,1
146739,?55,0,1
146740,years,0,1
146741,),0,1
146742,at,0,1
146743,onset,0,1
146744,and,0,1
146745,high,0,1
146746,prostate-specific,0,1
146747,antigen,0,0
146748,(,0,1
146749,PSA,0,1
146750,;,0,1
146751,?20,0,1
146752,ng/mL,0,1
146753,),0,1
146754,at,0,0
146755,diagnosis,0,1
146756,.,0,1
146757,An,0,0
146758,association,0,0
146759,with,0,1
146760,increased,0,0
146761,prostate,0,1
146762,cancer,0,1
146763,risk,0,1
146764,in,0,0
146765,patients,0,1
146766,with,0,1
146767,prior,0,1
146768,benign,0,1
146769,prostate,0,1
146770,hyperplasia,0,1
146771,(,0,1
146772,BPH,0,0
146773,),0,1
146774,diagnosis,0,1
146775,was,0,0
146776,also,0,0
146777,revealed,0,0
146778,.,0,0
146779,No,0,0
146780,statistically,0,0
146781,significant,0,0
146782,evidence,0,0
146783,for,0,0
146784,a,0,0
146785,contribution,0,0
146786,in,0,0
146787,CRC,0,1
146788,risk,0,1
146789,was,0,0
146790,detected,0,0
146791,",",0,0
146792,but,0,0
146793,a,0,0
146794,suggestive,0,0
146795,role,0,0
146796,for,0,0
146797,the,0,0
146798,mutation,0,1
146799,was,0,0
146800,observed,0,0
146801,in,0,0
146802,familial,0,1
146803,BRCA1/2-negative,0,1
146804,breast,0,1
146805,cancer,0,1
146806,.,0,1
146807,CONCLUSIONS,0,0
146808,These,0,1
146809,findings,0,0
146810,confirm,0,0
146811,an,0,0
146812,increased,0,0
146813,cancer,0,1
146814,risk,0,0
146815,associated,0,0
146816,with,0,1
146817,the,0,0
146818,G84E,0,0
146819,mutation,0,1
146820,in,0,0
146821,the,0,0
146822,Finnish,1,1
146823,population,1,1
146824,",",1,0
146825,particularly,1,0
146826,for,0,0
146827,early-onset,0,1
146828,prostate,0,1
146829,cancer,0,1
146830,and,0,1
146831,cases,1,1
146832,with,1,1
146833,substantially,0,0
146834,elevated,0,1
146835,PSA,0,1
146836,.,0,1
146837,IMPACT,0,0
146838,This,0,0
146839,study,0,0
146840,confirms,0,0
146841,the,0,0
146842,overall,0,0
146843,importance,0,0
146844,of,0,0
146845,the,0,0
146846,HOXB13,0,1
146847,G84E,0,0
146848,mutation,1,1
146849,in,1,0
146850,prostate,1,1
146851,cancer,1,1
146852,susceptibility,1,0
146853,.,0,1
146854,Divergence,0,0
146855,in,0,0
146856,student,1,0
146857,and,1,1
146858,educator,1,1
146859,conceptual,1,0
146860,structures,1,0
146861,during,0,1
146862,auscultation,1,1
146863,training,1,1
146864,.,1,1
146865,CONTEXT,0,0
146866,Simulation-based,0,0
146867,medical,0,1
146868,education,0,1
146869,allows,0,0
146870,trainees,0,0
146871,to,0,0
146872,engage,0,1
146873,in,0,0
146874,self-regulated,0,1
146875,learning,0,0
146876,(,0,1
146877,SRL,0,1
146878,),0,0
146879,",",0,0
146880,yet,0,0
146881,research,0,0
146882,aimed,0,0
146883,at,0,0
146884,elucidating,0,0
146885,the,0,0
146886,mechanisms,0,0
146887,of,0,0
146888,SRL,0,1
146889,in,0,0
146890,this,0,0
146891,context,0,0
146892,is,0,0
146893,relatively,0,0
146894,absent,0,0
146895,.,0,1
146896,We,0,0
146897,compared,0,0
146898,'unguided,0,1
146899,',0,1
146900,SRL,0,1
146901,with,0,1
146902,'directed,0,1
146903,',0,1
146904,SRL,0,1
146905,(,0,1
146906,DSRL,0,1
146907,),0,1
146908,",",0,1
146909,wherein,0,1
146910,learners,0,1
146911,followed,0,1
146912,an,0,1
146913,expert-designed,0,1
146914,booklet,0,1
146915,.,0,1
146916,METHODS,0,0
146917,Year,1,1
146918,1,1,1
146919,medical,1,1
146920,students,1,1
146921,(,1,1
146922,n,1,1
146923,=,1,1
146924,37,1,1
146925,),1,1
146926,were,1,1
146927,randomly,1,1
146928,assigned,1,1
146929,to,1,0
146930,practise,1,0
146931,identifying,1,0
146932,seven,1,1
146933,cardiac,1,1
146934,murmurs,1,1
146935,using,1,0
146936,a,1,1
146937,simulator,1,0
146938,and,1,0
146939,video,1,0
146940,only,1,0
146941,(,1,0
146942,SRL,1,1
146943,group,1,1
146944,),1,1
146945,or,1,1
146946,a,1,1
146947,simulator,1,0
146948,and,1,0
146949,video,1,0
146950,plus,1,0
146951,the,1,0
146952,booklet,1,0
146953,(,1,0
146954,DSRL,1,1
146955,group,1,1
146956,),1,1
146957,.,0,1
146958,All,0,1
146959,participants,0,1
146960,completed,0,1
146961,a,0,1
146962,22-item,0,0
146963,test,0,0
146964,3,0,1
146965,weeks,0,0
146966,later,0,1
146967,.,0,1
146968,To,0,0
146969,compare,0,0
146970,interventions,0,0
146971,",",0,0
146972,we,0,0
146973,analysed,0,1
146974,students,0,1
146975,',0,1
146976,diagnostic,0,1
146977,accuracy,0,0
146978,.,0,1
146979,As,0,0
146980,a,0,0
146981,novel,0,0
146982,source,0,0
146983,of,0,0
146984,evidence,0,0
146985,",",0,0
146986,we,0,0
146987,documented,0,0
146988,how,0,0
146989,participants,0,1
146990,autonomously,0,0
146991,sequenced,0,1
146992,the,0,0
146993,seven,0,1
146994,murmurs,0,1
146995,during,0,1
146996,initial,0,1
146997,and,0,1
146998,delayed,0,1
146999,practice,0,1
147000,sessions,0,0
147001,.,0,1
147002,In,0,0
147003,addition,0,0
147004,",",0,0
147005,we,1,0
147006,surveyed,1,1
147007,clinical,1,0
147008,educators,1,1
147009,(,1,1
147010,n,1,1
147011,=,1,1
147012,17,1,1
147013,),1,1
147014,to,0,0
147015,find,0,0
147016,out,0,0
147017,how,0,0
147018,they,0,0
147019,would,0,0
147020,sequence,0,0
147021,their,0,0
147022,teaching,0,1
147023,of,0,0
147024,these,0,0
147025,murmurs,0,1
147026,.,0,1
147027,RESULTS,0,0
147028,The,0,0
147029,DSRL,0,0
147030,group,0,1
147031,used,0,0
147032,50,0,1
147033,%,0,0
147034,more,0,0
147035,training,0,0
147036,time,0,0
147037,than,0,0
147038,the,0,0
147039,SRL,0,1
147040,group,0,1
147041,(,0,1
147042,p,0,0
147043,<,0,0
147044,0.001,0,0
147045,),0,1
147046,.,0,1
147047,The,0,0
147048,groups,0,0
147049,',0,1
147050,diagnostic,0,1
147051,accuracy,0,0
147052,",",0,0
147053,however,0,0
147054,",",0,0
147055,did,0,0
147056,not,0,0
147057,differ,0,0
147058,significantly,0,0
147059,on,0,0
147060,the,0,0
147061,post-test,0,0
147062,",",0,0
147063,retention,0,0
147064,test,0,0
147065,or,0,1
147066,transfer,0,1
147067,test,0,0
147068,items,0,0
147069,(,0,0
147070,p,0,0
147071,>,0,1
147072,0.12,0,0
147073,),0,1
147074,.,0,1
147075,Despite,0,0
147076,practising,0,1
147077,with,0,1
147078,the,0,0
147079,expert-defined,0,1
147080,'timing-based,0,0
147081,',0,1
147082,approach,0,0
147083,to,0,1
147084,murmur,0,1
147085,diagnosis,0,1
147086,(,0,1
147087,i.e,0,1
147088,.,0,1
147089,systolic,0,0
147090,versus,0,0
147091,diastolic,0,1
147092,),0,1
147093,",",0,0
147094,84,0,1
147095,%,0,0
147096,of,0,1
147097,DSRL,0,1
147098,participants,0,1
147099,implemented,0,0
147100,a,0,1
147101,location-based,0,0
147102,approach,0,0
147103,(,0,1
147104,i.e,0,1
147105,.,0,1
147106,practising,0,1
147107,aortic,0,1
147108,murmurs,0,1
147109,separately,0,1
147110,from,0,1
147111,mitral,0,1
147112,murmurs,0,1
147113,),0,1
147114,during,0,1
147115,a,0,1
147116,second,0,0
147117,",",0,0
147118,unguided,0,0
147119,practice,0,0
147120,session,0,0
147121,.,0,1
147122,Notably,0,0
147123,",",0,0
147124,most,0,0
147125,SRL,0,1
147126,participants,0,1
147127,used,0,0
147128,that,0,0
147129,same,0,0
147130,approach,0,1
147131,spontaneously,0,1
147132,.,0,1
147133,By,0,0
147134,contrast,0,0
147135,",",0,1
147136,clinical,0,0
147137,educators,0,1
147138,were,0,1
147139,split,0,1
147140,in,0,0
147141,their,0,1
147142,use,0,0
147143,of,0,0
147144,the,0,0
147145,timing-based,0,0
147146,(,0,1
147147,n,0,1
147148,=,0,1
147149,10,0,1
147150,),0,1
147151,and,0,0
147152,the,0,0
147153,location-based,0,0
147154,(,0,1
147155,n,0,1
147156,=,0,1
147157,6,0,1
147158,),0,1
147159,approaches,0,0
147160,.,0,1
147161,Chi-squared,0,0
147162,analyses,0,0
147163,suggested,0,0
147164,educators,0,1
147165,',0,1
147166,conceptions,0,1
147167,for,0,1
147168,organising,0,1
147169,murmurs,0,1
147170,differed,0,0
147171,significantly,0,0
147172,from,0,1
147173,students,0,1
147174,',0,1
147175,conceptions,0,1
147176,.,0,1
147177,CONCLUSIONS,0,0
147178,Contrary,0,0
147179,to,0,1
147180,our,0,1
147181,predictions,0,0
147182,",",0,1
147183,directing,0,1
147184,students,0,1
147185,',0,1
147186,SRL,0,1
147187,produced,0,0
147188,no,0,0
147189,additional,0,0
147190,benefit,0,0
147191,and,0,1
147192,increased,0,0
147193,their,0,0
147194,practice,0,0
147195,time,0,0
147196,.,0,1
147197,Our,0,0
147198,findings,0,0
147199,suggest,0,0
147200,one,0,1
147201,potential,0,0
147202,source,0,1
147203,of,0,0
147204,these,0,0
147205,results,0,0
147206,was,0,0
147207,a,0,1
147208,divergence,0,0
147209,between,0,0
147210,student,0,0
147211,and,0,1
147212,educator,0,0
147213,conceptions,0,1
147214,for,0,0
147215,structuring,0,0
147216,the,0,0
147217,practice,0,0
147218,of,0,0
147219,cardiac,0,1
147220,auscultation,0,1
147221,skills,0,0
147222,.,0,1
147223,This,0,0
147224,phenomenon,0,0
147225,has,0,0
147226,not,0,0
147227,been,0,0
147228,well,0,0
147229,articulated,0,0
147230,in,0,0
147231,the,0,0
147232,medical,0,1
147233,education,0,0
147234,literature,0,0
147235,",",0,0
147236,and,0,0
147237,may,0,0
147238,have,0,0
147239,important,0,0
147240,implications,0,0
147241,in,0,1
147242,many,0,1
147243,(,0,1
147244,especially,0,0
147245,technology-mediated,0,0
147246,),0,0
147247,educational,0,1
147248,contexts,0,1
147249,.,0,1
147250,Influence,0,0
147251,of,0,0
147252,SNPs,0,1
147253,in,0,1
147254,nutrient-sensitive,0,1
147255,candidate,0,1
147256,genes,0,0
147257,and,0,1
147258,gene-diet,0,1
147259,interactions,0,0
147260,on,0,1
147261,blood,0,1
147262,lipids,0,0
147263,:,0,1
147264,the,0,0
147265,DiOGenes,1,0
147266,study,1,1
147267,.,1,1
147268,Blood,0,0
147269,lipid,0,0
147270,response,0,0
147271,to,0,1
147272,a,0,0
147273,given,0,0
147274,dietary,0,0
147275,intervention,0,0
147276,could,0,0
147277,be,0,0
147278,determined,0,0
147279,by,0,0
147280,the,0,0
147281,effect,0,0
147282,of,0,0
147283,diet,0,0
147284,",",0,1
147285,gene,0,0
147286,variants,0,1
147287,or,0,1
147288,gene-diet,0,1
147289,interactions,0,0
147290,.,0,1
147291,The,0,0
147292,objective,0,0
147293,of,0,0
147294,the,0,0
147295,present,0,0
147296,study,0,1
147297,was,0,0
147298,to,0,0
147299,investigate,0,0
147300,whether,0,0
147301,variants,0,1
147302,in,0,1
147303,presumed,0,1
147304,nutrient-sensitive,0,1
147305,genes,0,0
147306,involved,0,1
147307,in,0,1
147308,lipid,0,0
147309,metabolism,0,0
147310,modified,0,0
147311,lipid,0,0
147312,profile,0,0
147313,after,0,1
147314,weight,0,1
147315,loss,0,0
147316,and,0,0
147317,in,0,0
147318,response,0,0
147319,to,0,1
147320,a,0,0
147321,given,0,0
147322,diet,0,0
147323,",",0,0
147324,among,0,0
147325,overweight,1,1
147326,European,1,1
147327,adults,1,1
147328,participating,1,1
147329,in,1,1
147330,the,1,0
147331,Diet,1,0
147332,Obesity,1,1
147333,and,1,1
147334,Genes,1,1
147335,study,1,1
147336,.,1,1
147337,By,0,0
147338,multiple,0,1
147339,linear,0,0
147340,regressions,0,0
147341,",",0,1
147342,240,0,1
147343,SNPs,0,0
147344,in,0,1
147345,twenty-four,1,1
147346,candidate,1,1
147347,genes,1,0
147348,were,1,1
147349,investigated,1,0
147350,for,0,0
147351,SNP,0,1
147352,main,0,0
147353,and,0,1
147354,SNP-diet,0,1
147355,interaction,0,0
147356,effects,0,0
147357,on,0,0
147358,total,0,1
147359,cholesterol,0,0
147360,",",0,0
147361,LDL-cholesterol,0,0
147362,",",0,0
147363,HDL-cholesterol,0,0
147364,and,0,0
147365,TAG,0,1
147366,after,0,0
147367,an,0,1
147368,8-week,0,0
147369,low-energy,0,1
147370,diet,0,1
147371,(,0,1
147372,only,0,0
147373,main,0,0
147374,effect,0,0
147375,),0,1
147376,",",0,0
147377,and,0,0
147378,a,0,0
147379,6-month,0,0
147380,ad,0,1
147381,libitum,0,1
147382,weight,0,1
147383,maintenance,0,0
147384,diet,0,0
147385,",",0,0
147386,with,0,1
147387,different,0,0
147388,contents,0,1
147389,of,0,1
147390,dietary,0,0
147391,protein,0,0
147392,or,0,1
147393,glycaemic,0,0
147394,index,0,1
147395,.,0,1
147396,After,0,0
147397,adjusting,0,0
147398,for,0,1
147399,multiple,0,1
147400,testing,0,0
147401,",",0,0
147402,a,0,0
147403,SNP-dietary,0,1
147404,protein,0,0
147405,interaction,0,0
147406,effect,0,0
147407,on,0,0
147408,TAG,0,1
147409,was,0,0
147410,identified,0,1
147411,for,0,0
147412,lipin,0,0
147413,1,0,1
147414,(,0,1
147415,LPIN1,0,1
147416,),0,1
147417,rs4315495,0,0
147418,",",0,0
147419,with,0,1
147420,a,0,0
147421,decrease,0,0
147422,in,0,0
147423,TAG,0,1
147424,of,0,1
147425,20.26,0,0
147426,mmol/l,0,0
147427,per,0,1
147428,A-allele/protein,0,0
147429,unit,0,1
147430,(,0,1
147431,95,0,0
147432,%,0,0
147433,CI,0,0
147434,20.38,0,0
147435,",",0,1
147436,20.14,0,0
147437,",",0,0
147438,P=0.000043,0,0
147439,),0,1
147440,.,0,1
147441,In,0,0
147442,conclusion,0,0
147443,",",0,0
147444,we,0,0
147445,investigated,0,0
147446,SNP-diet,0,1
147447,interactions,0,0
147448,for,0,1
147449,blood,0,1
147450,lipid,0,0
147451,profiles,0,0
147452,for,0,1
147453,240,0,1
147454,SNPs,0,1
147455,in,0,1
147456,twenty-four,0,1
147457,candidate,0,1
147458,genes,0,0
147459,",",0,0
147460,selected,0,1
147461,for,0,0
147462,their,0,1
147463,involvement,0,1
147464,in,0,0
147465,lipid,0,0
147466,metabolism,0,0
147467,pathways,0,0
147468,",",0,1
147469,and,0,1
147470,identified,0,1
147471,one,0,1
147472,significant,0,0
147473,interaction,0,0
147474,between,0,0
147475,LPIN1,0,1
147476,rs4315495,0,0
147477,and,0,1
147478,dietary,0,0
147479,protein,0,0
147480,for,0,1
147481,TAG,0,1
147482,concentration,0,0
147483,.,0,1
147484,Design,0,1
147485,and,0,0
147486,development,0,0
147487,of,0,0
147488,a,0,1
147489,Virtual,0,0
147490,Dolphinarium,0,1
147491,for,0,1
147492,children,1,1
147493,with,1,1
147494,autism,1,1
147495,.,1,1
147496,The,0,0
147497,recent,0,0
147498,proliferation,0,0
147499,of,0,0
147500,virtual,0,0
147501,reality,0,0
147502,(,0,1
147503,VR,0,1
147504,),0,1
147505,technology,0,0
147506,applications,0,0
147507,in,0,0
147508,the,0,0
147509,autism,0,1
147510,therapy,0,0
147511,to,0,0
147512,promote,0,0
147513,learning,0,0
147514,and,0,0
147515,positive,0,1
147516,behavior,0,0
147517,among,0,1
147518,such,0,0
147519,children,0,1
147520,has,0,0
147521,produced,0,0
147522,optimistic,0,0
147523,results,0,0
147524,in,0,1
147525,developing,0,1
147526,a,0,0
147527,variety,0,0
147528,of,0,0
147529,skills,0,0
147530,and,0,1
147531,abilities,0,0
147532,in,0,1
147533,them,0,1
147534,.,0,1
147535,Dolphin-assisted,0,0
147536,therapy,0,0
147537,has,0,0
147538,also,0,0
147539,become,0,0
147540,a,0,0
147541,topic,0,0
147542,of,0,0
147543,public,0,1
147544,and,0,1
147545,research,0,1
147546,interest,0,0
147547,for,0,0
147548,autism,0,1
147549,intervention,0,0
147550,and,0,0
147551,treatment,0,0
147552,.,0,1
147553,This,0,0
147554,paper,0,0
147555,will,0,0
147556,present,0,0
147557,an,0,0
147558,innovative,0,0
147559,design,0,1
147560,and,0,0
147561,development,0,0
147562,of,0,0
147563,a,0,1
147564,Virtual,0,0
147565,Dolphinarium,0,1
147566,for,0,1
147567,potential,0,0
147568,autism,0,1
147569,intervention,0,0
147570,.,0,1
147571,Instead,0,0
147572,of,0,0
147573,emulating,0,0
147574,the,0,0
147575,swimming,0,0
147576,with,0,1
147577,dolphins,0,1
147578,",",0,1
147579,our,0,1
147580,virtual,0,0
147581,dolphin,0,1
147582,interaction,0,0
147583,program,0,1
147584,will,0,0
147585,allow,0,0
147586,children,1,1
147587,with,1,1
147588,autism,1,1
147589,to,1,0
147590,act,1,0
147591,as,1,0
147592,dolphin,1,1
147593,trainers,1,1
147594,at,1,1
147595,the,1,0
147596,poolside,1,0
147597,and,1,0
147598,to,1,0
147599,learn,1,0
147600,(,1,1
147601,nonverbal,1,1
147602,),1,1
147603,communication,1,0
147604,through,1,1
147605,hand,1,1
147606,gestures,1,0
147607,with,1,1
147608,the,1,1
147609,virtual,1,1
147610,dolphins,1,1
147611,.,1,1
147612,Immersive,0,0
147613,visualization,0,0
147614,and,0,1
147615,gesture-based,0,0
147616,interaction,0,0
147617,are,0,0
147618,implemented,0,0
147619,to,0,0
147620,engage,0,1
147621,children,1,1
147622,with,1,1
147623,autism,1,1
147624,within,0,1
147625,an,0,0
147626,immersive,0,0
147627,room,0,1
147628,equipped,0,1
147629,with,0,1
147630,a,0,1
147631,curved,0,0
147632,screen,0,1
147633,spanning,0,1
147634,a,0,1
147635,320,0,1
147636,(,0,1
147637,?,0,1
147638,),0,0
147639,and,0,0
147640,a,0,1
147641,high-end,0,0
147642,five-panel,0,0
147643,projection,0,0
147644,system,0,1
147645,.,0,1
147646,This,0,0
147647,paper,0,0
147648,will,0,0
147649,also,0,0
147650,report,0,0
147651,a,0,0
147652,pilot,0,0
147653,study,0,0
147654,to,0,0
147655,establish,0,0
147656,trial,0,0
147657,protocol,0,0
147658,of,0,0
147659,autism,0,1
147660,screening,0,1
147661,to,0,0
147662,explore,0,0
147663,the,0,0
147664,participants,0,1
147665,',0,1
147666,readiness,0,0
147667,for,0,1
147668,the,0,0
147669,virtual,0,0
147670,dolphin,0,1
147671,interaction,0,0
147672,.,0,1
147673,This,0,0
147674,research,0,0
147675,will,0,0
147676,have,0,0
147677,two,0,0
147678,potential,0,0
147679,benefits,0,0
147680,in,0,1
147681,the,0,0
147682,sense,0,0
147683,of,0,0
147684,helping,1,1
147685,children,1,1
147686,with,1,1
147687,autism,1,1
147688,and,0,0
147689,protecting,0,0
147690,the,0,0
147691,endangered,0,1
147692,species,0,0
147693,.,0,1
147694,Pretreatment,0,0
147695,and,0,0
147696,co-administration,0,0
147697,of,0,0
147698,oral,0,1
147699,anti-diabetic,0,1
147700,agent,0,1
147701,with,0,1
147702,clomiphene,0,1
147703,citrate,0,0
147704,or,0,1
147705,rFSH,0,1
147706,for,0,0
147707,ovulation,0,1
147708,induction,0,1
147709,in,0,0
147710,clomiphene-citrate-resistant,1,1
147711,polycystic,1,1
147712,ovary,1,1
147713,syndrome,1,1
147714,.,1,1
147715,AIM,0,0
147716,The,0,0
147717,objective,0,0
147718,of,0,0
147719,this,0,0
147720,study,0,0
147721,was,0,0
147722,to,0,0
147723,explore,0,0
147724,the,0,0
147725,result,0,0
147726,of,0,0
147727,pretreatment,0,0
147728,and,0,1
147729,concomitant,0,0
147730,use,0,0
147731,of,0,0
147732,metformin,0,0
147733,with,0,1
147734,clomiphene,0,1
147735,citrate,0,0
147736,(,0,1
147737,CC,0,1
147738,),0,1
147739,and,0,0
147740,rFSH,0,1
147741,for,0,0
147742,ovulation,0,1
147743,induction,0,1
147744,in,0,0
147745,clomiphene-citrate-resistant,1,1
147746,polycystic,1,1
147747,ovary,1,1
147748,syndrome,1,1
147749,(,1,1
147750,PCOS,1,1
147751,),1,1
147752,.,1,1
147753,MATERIAL,0,0
147754,AND,0,0
147755,METHODS,0,0
147756,This,0,0
147757,randomized,0,1
147758,controlled,0,0
147759,trial,0,1
147760,was,0,0
147761,done,0,0
147762,in,0,0
147763,the,0,0
147764,Dhaka,1,1
147765,Medical,1,1
147766,College,1,1
147767,and,1,1
147768,Hospital,1,1
147769,and,1,0
147770,the,1,0
147771,Infertility,1,1
147772,Care,1,0
147773,and,1,1
147774,Research,1,1
147775,Centre,1,1
147776,",",1,0
147777,Dhaka,1,1
147778,",",1,0
147779,Bangladesh,1,1
147780,.,1,1
147781,A,0,0
147782,total,0,1
147783,of,0,1
147784,165,1,1
147785,infertile,1,1
147786,patients,1,1
147787,with,1,1
147788,CC-resistant,1,1
147789,PCOS,1,1
147790,who,1,1
147791,attended,1,1
147792,for,1,1
147793,treatment,1,0
147794,were,1,1
147795,the,1,0
147796,target,1,0
147797,population,1,1
147798,for,1,0
147799,this,1,0
147800,study,1,1
147801,.,1,1
147802,Patients,0,1
147803,were,0,0
147804,divided,0,1
147805,into,0,1
147806,three,0,1
147807,groups,0,1
147808,:,0,1
147809,groups,0,1
147810,A,0,1
147811,and,0,1
147812,B,0,1
147813,were,0,1
147814,given,0,0
147815,metformin,0,0
147816,and,0,1
147817,group,0,1
147818,C,0,0
147819,was,0,0
147820,the,0,0
147821,control,0,0
147822,.,0,0
147823,Along,0,0
147824,with,0,1
147825,metformin,0,0
147826,",",0,0
147827,group,0,1
147828,A,0,1
147829,received,0,1
147830,CC,0,1
147831,and,0,1
147832,group,0,1
147833,B,0,1
147834,received,0,1
147835,rFSH,0,1
147836,.,0,1
147837,Group,0,1
147838,C,0,0
147839,was,0,0
147840,treated,0,1
147841,with,0,1
147842,only,0,0
147843,rFSH,0,1
147844,.,0,1
147845,Metformin,0,0
147846,was,0,0
147847,given,0,0
147848,1500,0,1
147849,mg,0,0
147850,daily,0,0
147851,for,0,1
147852,4,0,1
147853,weeks,0,1
147854,.,0,1
147855,Afterwards,0,1
147856,CC,0,1
147857,or,0,1
147858,rFSH,0,1
147859,were,0,0
147860,added,0,0
147861,for,0,0
147862,induction,0,0
147863,of,0,0
147864,ovulation,0,1
147865,along,0,0
147866,with,0,1
147867,metformin,0,1
147868,.,0,1
147869,Six,0,0
147870,ovulatory,0,1
147871,cycles,0,0
147872,were,0,1
147873,assessed,0,0
147874,.,0,1
147875,Treatment,0,0
147876,was,0,0
147877,terminated,0,0
147878,when,0,0
147879,there,0,0
147880,was,0,0
147881,no,0,0
147882,response,0,0
147883,with,0,1
147884,maximum,0,0
147885,dose,0,0
147886,of,0,1
147887,CC,0,1
147888,and,0,1
147889,rFSH,0,1
147890,or,0,1
147891,after,0,1
147892,six,0,1
147893,ovulatory,0,1
147894,cycles,0,0
147895,without,0,1
147896,pregnancy,0,1
147897,or,0,1
147898,after,0,0
147899,achieving,0,0
147900,pregnancy,0,1
147901,.,0,1
147902,A,0,0
147903,P-value,0,0
147904,of,0,0
147905,<,0,0
147906,0.5,0,0
147907,was,0,0
147908,considered,0,0
147909,as,0,0
147910,significant,0,0
147911,.,0,1
147912,RESULTS,0,0
147913,Ovulation,0,0
147914,(,0,1
147915,89.09,0,0
147916,%,0,0
147917,),0,1
147918,and,0,0
147919,pregnancy,0,1
147920,(,0,1
147921,54.55,0,1
147922,%,0,0
147923,),0,1
147924,rates,0,0
147925,were,0,1
147926,higher,0,0
147927,in,0,0
147928,group,0,1
147929,B.,0,1
147930,Ovulation,0,0
147931,(,0,1
147932,74.55,0,0
147933,%,0,0
147934,),0,1
147935,and,0,0
147936,pregnancy,0,1
147937,(,0,1
147938,29.09,0,0
147939,%,0,0
147940,),0,1
147941,rates,0,0
147942,were,0,1
147943,also,0,0
147944,satisfactory,0,0
147945,in,0,0
147946,group,0,1
147947,C,0,1
147948,but,0,0
147949,a,0,0
147950,dose,0,0
147951,of,0,0
147952,rFSH,0,1
147953,requirement,0,1
147954,was,0,0
147955,significantly,0,0
147956,higher,0,0
147957,(,0,0
147958,P,0,0
147959,=,0,1
147960,0.000,0,0
147961,),0,1
147962,.,0,1
147963,In,0,0
147964,group,0,0
147965,A,0,1
147966,",",0,0
147967,both,0,0
147968,ovulation,0,0
147969,and,0,0
147970,pregnancy,0,1
147971,rate,0,0
147972,were,0,0
147973,much,0,0
147974,lower,0,0
147975,than,0,0
147976,the,0,0
147977,other,0,1
147978,two,0,1
147979,groups,0,1
147980,(,0,1
147981,27.27,0,0
147982,%,0,0
147983,and,0,1
147984,12.73,0,0
147985,%,0,0
147986,",",0,0
147987,respectively,0,0
147988,),0,1
147989,.,0,1
147990,CONCLUSIONS,0,0
147991,Use,0,0
147992,of,0,0
147993,metformin,0,0
147994,increases,0,0
147995,the,0,0
147996,response,0,0
147997,of,0,0
147998,ovulation-inducing,0,1
147999,agents,0,0
148000,and,0,1
148001,can,0,0
148002,be,0,0
148003,used,0,0
148004,safely,0,0
148005,in,1,0
148006,PCOS,1,1
148007,.,1,1
148008,Family,0,1
148009,economic,0,0
148010,empowerment,0,1
148011,and,0,1
148012,mental,0,1
148013,health,0,1
148014,among,0,1
148015,AIDS-affected,1,1
148016,children,1,1
148017,living,1,1
148018,in,1,1
148019,AIDS-impacted,1,1
148020,communities,1,1
148021,:,1,1
148022,evidence,0,0
148023,from,0,1
148024,a,0,1
148025,randomised,0,0
148026,evaluation,0,0
148027,in,0,1
148028,southwestern,1,1
148029,Uganda,1,1
148030,.,1,1
148031,OBJECTIVE,0,0
148032,The,0,0
148033,authors,0,0
148034,examine,0,0
148035,whether,0,0
148036,an,0,0
148037,innovative,0,0
148038,family,0,1
148039,economic,0,0
148040,empowerment,0,0
148041,intervention,0,0
148042,addresses,0,0
148043,mental,0,0
148044,health,0,0
148045,functioning,0,1
148046,of,0,1
148047,AIDS-affected,1,1
148048,children,1,1
148049,in,1,1
148050,communities,1,1
148051,heavily,1,1
148052,impacted,1,0
148053,by,1,0
148054,HIV/AIDS,1,1
148055,in,1,1
148056,Uganda,1,1
148057,.,1,1
148058,METHODS,0,0
148059,A,0,1
148060,cluster,0,1
148061,randomised,0,1
148062,controlled,0,0
148063,trial,0,0
148064,consisting,0,1
148065,of,0,0
148066,two,0,1
148067,study,0,1
148068,arms,0,0
148069,",",0,0
148070,a,1,0
148071,treatment,1,0
148072,condition,1,0
148073,(,1,1
148074,n=179,1,1
148075,),1,1
148076,and,1,0
148077,a,1,0
148078,control,1,0
148079,condition,1,0
148080,(,1,1
148081,n=118,1,1
148082,),1,1
148083,",",0,0
148084,was,0,0
148085,used,0,0
148086,to,0,0
148087,examine,0,0
148088,the,0,0
148089,impact,0,0
148090,of,0,0
148091,the,0,0
148092,family,0,1
148093,economic,0,0
148094,empowerment,0,0
148095,intervention,0,1
148096,on,0,0
148097,children,0,1
148098,'s,0,1
148099,levels,0,0
148100,of,0,1
148101,hopelessness,0,1
148102,and,0,1
148103,depression,0,1
148104,.,0,1
148105,The,0,0
148106,intervention,0,0
148107,comprised,0,1
148108,matched,0,1
148109,children,0,1
148110,savings,0,0
148111,accounts,0,1
148112,",",0,1
148113,financial,0,1
148114,management,0,1
148115,workshops,0,0
148116,and,0,1
148117,mentorship,0,1
148118,.,0,1
148119,Data,0,0
148120,were,0,0
148121,collected,0,1
148122,at,0,0
148123,baseline,0,0
148124,and,0,1
148125,12,0,1
148126,months,0,1
148127,post-intervention,0,0
148128,.,0,1
148129,RESULTS,0,0
148130,Using,0,0
148131,multivariate,0,0
148132,analysis,0,0
148133,with,0,1
148134,several,0,1
148135,socioeconomic,0,1
148136,controls,0,1
148137,",",0,1
148138,the,0,0
148139,authors,0,0
148140,find,0,0
148141,that,0,0
148142,children,0,1
148143,in,0,1
148144,the,0,0
148145,treatment,0,0
148146,condition,0,0
148147,(,0,0
148148,receiving,0,1
148149,the,0,0
148150,intervention,0,0
148151,),0,0
148152,report,0,0
148153,significant,0,0
148154,improvement,0,0
148155,in,0,0
148156,their,0,1
148157,mental,0,1
148158,health,0,1
148159,functioning,0,1
148160,.,0,1
148161,Specifically,0,0
148162,",",0,0
148163,the,0,0
148164,intervention,0,0
148165,reduces,0,0
148166,hopelessness,0,0
148167,and,0,0
148168,depression,0,1
148169,levels,0,0
148170,.,0,1
148171,On,0,0
148172,the,0,0
148173,other,0,0
148174,hand,0,1
148175,",",0,1
148176,children,0,1
148177,in,0,0
148178,the,0,0
148179,control,0,1
148180,condition,0,0
148181,(,0,0
148182,not,0,0
148183,receiving,0,1
148184,the,0,0
148185,intervention,0,0
148186,),0,0
148187,report,0,0
148188,no,0,0
148189,changes,0,0
148190,on,0,0
148191,both,0,1
148192,measures,0,0
148193,.,0,1
148194,CONCLUSIONS,0,0
148195,The,0,0
148196,findings,0,0
148197,indicate,0,0
148198,that,0,0
148199,children,1,1
148200,with,1,1
148201,poor,1,1
148202,mental,1,1
148203,health,1,1
148204,functioning,1,1
148205,living,1,1
148206,in,1,1
148207,communities,1,1
148208,affected,1,1
148209,by,1,0
148210,HIV/AIDS,1,1
148211,may,0,0
148212,benefit,0,0
148213,from,0,0
148214,innovative,0,0
148215,family,0,1
148216,economic,0,0
148217,empowerment,0,1
148218,interventions,0,0
148219,.,0,1
148220,As,0,0
148221,measures,0,0
148222,of,0,1
148223,mental,0,1
148224,health,0,1
148225,functioning,0,1
148226,",",0,0
148227,both,0,0
148228,hopelessness,0,0
148229,and,0,0
148230,depression,0,1
148231,have,0,0
148232,long-term,0,0
148233,negative,0,1
148234,psychosocial,0,1
148235,and,0,1
148236,developmental,0,1
148237,impacts,0,0
148238,on,0,1
148239,children,0,1
148240,.,0,1
148241,These,0,1
148242,findings,0,0
148243,have,0,0
148244,implications,0,0
148245,for,0,1
148246,public,0,1
148247,health,0,1
148248,programmes,0,1
148249,intended,0,0
148250,for,0,1
148251,long-term,0,0
148252,care,0,1
148253,and,0,0
148254,support,0,0
148255,of,0,1
148256,children,1,1
148257,living,1,1
148258,in,1,1
148259,resource,1,1
148260,poor,1,1
148261,AIDS-impacted,1,1
148262,communities,1,1
148263,.,1,1
148264,Social,0,1
148265,skills,0,0
148266,improvement,0,0
148267,in,0,1
148268,children,1,1
148269,with,1,1
148270,high-functioning,1,1
148271,autism,1,1
148272,:,1,1
148273,a,0,0
148274,pilot,0,0
148275,randomized,0,1
148276,controlled,0,0
148277,trial,0,1
148278,.,0,1
148279,High-functioning,0,1
148280,autism,0,1
148281,(,0,1
148282,HFA,0,1
148283,),0,1
148284,is,0,0
148285,characterized,0,0
148286,by,0,0
148287,persistent,0,1
148288,impairment,0,1
148289,in,0,1
148290,social,0,0
148291,interaction,0,0
148292,despite,0,0
148293,the,0,0
148294,absence,0,0
148295,of,0,0
148296,mental,0,1
148297,retardation,0,1
148298,.,0,1
148299,Although,0,0
148300,an,0,0
148301,increasing,0,0
148302,number,0,0
148303,of,0,1
148304,group-based,0,1
148305,programs,0,1
148306,for,0,1
148307,the,0,0
148308,improvement,0,0
148309,of,0,0
148310,social,0,1
148311,skills,0,0
148312,have,0,1
148313,been,0,0
148314,described,0,0
148315,",",0,0
148316,randomized,0,1
148317,controlled,0,0
148318,trials,0,0
148319,are,0,0
148320,needed,0,0
148321,to,0,0
148322,evaluate,0,0
148323,their,0,1
148324,efficacy,0,0
148325,.,0,1
148326,To,0,0
148327,compare,0,0
148328,the,0,0
148329,effect,0,0
148330,of,0,0
148331,a,0,1
148332,Social,0,0
148333,Skills,0,0
148334,Training,0,1
148335,Group-based,0,1
148336,Program,0,1
148337,(,0,1
148338,SST-GP,0,1
148339,),0,1
148340,and,0,0
148341,a,0,0
148342,Leisure,0,0
148343,Activities,0,0
148344,Group-based,0,0
148345,Program,0,0
148346,(,0,1
148347,LA-GP,0,0
148348,),0,1
148349,on,0,0
148350,the,0,0
148351,perception,0,0
148352,of,0,0
148353,facial,0,1
148354,emotions,0,0
148355,and,0,1
148356,quality,0,0
148357,of,0,0
148358,life,0,1
148359,(,0,1
148360,QoL,0,0
148361,),0,1
148362,in,0,1
148363,young,0,1
148364,people,0,1
148365,with,0,1
148366,HFA,0,1
148367,.,0,1
148368,Eligible,0,0
148369,patients,0,1
148370,were,0,1
148371,children,1,1
148372,and,1,1
148373,adolescents,1,1
148374,with,1,1
148375,HFA,1,1
148376,.,1,1
148377,Participants,0,1
148378,were,0,1
148379,randomized,0,1
148380,to,0,0
148381,the,0,0
148382,SST,0,0
148383,or,0,1
148384,LA,0,0
148385,group,0,1
148386,.,0,1
148387,The,0,0
148388,primary,0,1
148389,outcome,0,0
148390,was,0,0
148391,defined,0,0
148392,as,0,0
148393,an,0,0
148394,improvement,0,0
148395,of,0,0
148396,2,0,1
148397,points,0,0
148398,in,0,1
148399,error,0,0
148400,rates,0,0
148401,for,0,1
148402,facial,0,1
148403,emotion,0,0
148404,labeling,0,0
148405,(,0,1
148406,DANVA2,0,0
148407,),0,1
148408,from,0,1
148409,baseline,0,0
148410,.,0,1
148411,After,0,0
148412,the,0,0
148413,6-month,0,0
148414,training,0,0
148415,period,0,0
148416,",",0,0
148417,the,0,0
148418,SST,0,0
148419,Group,0,1
148420,made,0,1
148421,fewer,0,0
148422,errors,0,0
148423,in,0,0
148424,labeling,0,0
148425,anger,0,0
148426,on,0,0
148427,adult,0,1
148428,faces,0,0
148429,",",0,0
148430,whereas,0,0
148431,error,0,0
148432,rates,0,0
148433,in,0,1
148434,the,0,1
148435,LA,0,0
148436,Group,0,1
148437,remained,0,0
148438,stable,0,1
148439,.,0,1
148440,Progress,0,0
148441,in,0,0
148442,the,0,0
148443,ability,0,0
148444,to,0,0
148445,recognize,0,1
148446,anger,0,0
148447,in,0,0
148448,the,0,0
148449,SST,0,0
148450,Group,0,1
148451,was,0,0
148452,due,0,0
148453,to,0,1
148454,better,0,0
148455,recognition,0,0
148456,of,0,0
148457,low,0,1
148458,intensity,0,0
148459,stimuli,0,0
148460,on,0,0
148461,adult,0,1
148462,faces,0,1
148463,.,0,0
148464,QoL,0,0
148465,increased,0,0
148466,in,0,0
148467,the,0,0
148468,SST,0,0
148469,Group,0,1
148470,in,0,0
148471,the,0,0
148472,dimension,0,0
148473,of,0,0
148474,school,0,1
148475,environment,0,0
148476,",",0,0
148477,as,0,0
148478,a,0,0
148479,marker,0,0
148480,of,0,0
148481,the,0,0
148482,transfer,0,1
148483,of,0,0
148484,skills,0,0
148485,acquired,0,1
148486,in,0,0
148487,the,0,0
148488,treatment,0,0
148489,setting,0,1
148490,to,0,0
148491,their,0,1
148492,use,0,0
148493,in,0,0
148494,the,0,0
148495,community,0,1
148496,.,0,0
148497,The,0,0
148498,SST-GP,0,0
148499,had,0,1
148500,higher,0,0
148501,efficacy,0,0
148502,than,0,0
148503,the,0,0
148504,LA-GP,0,0
148505,.,0,1
148506,Data,0,0
148507,justify,0,0
148508,replication,0,1
148509,using,0,0
148510,larger,0,1
148511,samples,0,1
148512,.,0,1
148513,A,0,1
148514,randomized,0,1
148515,controlled,0,0
148516,trial,0,1
148517,of,0,1
148518,COMPASS,0,1
148519,web-based,0,1
148520,and,0,1
148521,face-to-face,0,0
148522,teacher,0,1
148523,coaching,0,0
148524,in,0,0
148525,autism,1,1
148526,.,1,1
148527,OBJECTIVE,0,0
148528,Most,0,0
148529,children,1,1
148530,with,1,1
148531,autism,1,1
148532,rely,0,0
148533,on,0,0
148534,schools,0,1
148535,as,0,1
148536,their,0,1
148537,primary,0,1
148538,source,0,1
148539,of,0,0
148540,intervention,0,0
148541,",",0,0
148542,yet,0,0
148543,research,0,0
148544,has,0,0
148545,suggested,0,0
148546,that,0,0
148547,teachers,0,1
148548,rarely,0,1
148549,use,0,0
148550,evidence-based,0,0
148551,practices,0,1
148552,.,0,1
148553,To,0,0
148554,address,0,0
148555,the,0,0
148556,need,0,0
148557,for,0,0
148558,improved,0,0
148559,educational,0,1
148560,outcomes,0,0
148561,",",0,0
148562,a,0,0
148563,previously,0,1
148564,tested,0,0
148565,consultation,0,0
148566,intervention,0,0
148567,called,0,1
148568,the,0,0
148569,Collaborative,0,0
148570,Model,0,1
148571,for,0,0
148572,Promoting,0,0
148573,Competence,0,1
148574,and,0,1
148575,Success,0,1
148576,(,0,1
148577,COMPASS,0,1
148578,;,0,1
148579,Ruble,0,1
148580,",",0,0
148581,Dalrymple,0,1
148582,",",0,0
148583,&,0,1
148584,McGrew,0,0
148585,",",0,1
148586,2010,0,1
148587,;,0,1
148588,Ruble,0,1
148589,",",0,0
148590,Dalrymple,0,1
148591,",",0,0
148592,&,0,1
148593,McGrew,0,0
148594,",",0,1
148595,2012,0,1
148596,),0,1
148597,was,0,0
148598,evaluated,0,0
148599,in,0,0
148600,a,0,1
148601,2nd,0,1
148602,randomized,0,1
148603,controlled,0,0
148604,trial,0,0
148605,",",0,0
148606,with,0,1
148607,the,0,0
148608,addition,1,0
148609,of,1,0
148610,a,1,1
148611,web-based,1,1
148612,group,1,1
148613,.,1,1
148614,METHOD,0,0
148615,Forty-nine,1,1
148616,teacher-child,1,1
148617,dyads,1,1
148618,were,0,1
148619,randomized,0,1
148620,into,0,1
148621,1,0,1
148622,of,0,1
148623,3,0,1
148624,groups,0,1
148625,:,0,1
148626,(,0,1
148627,1,0,1
148628,),0,1
148629,a,0,1
148630,placebo,0,0
148631,control,0,1
148632,(,0,1
148633,PBO,0,0
148634,),0,1
148635,group,0,1
148636,",",0,0
148637,(,0,1
148638,2,0,1
148639,),0,1
148640,COMPASS,0,1
148641,followed,0,0
148642,by,0,0
148643,face-to-face,0,0
148644,(,0,1
148645,FF,0,1
148646,),0,1
148647,coaching,0,0
148648,sessions,0,0
148649,",",0,1
148650,and,0,1
148651,(,0,1
148652,3,0,1
148653,),0,1
148654,COMPASS,0,1
148655,followed,0,1
148656,by,0,0
148657,web-based,0,1
148658,(,0,1
148659,WEB,0,1
148660,),0,1
148661,coaching,0,1
148662,sessions,0,0
148663,.,0,1
148664,Three,0,1
148665,individualized,0,0
148666,goals,0,1
148667,(,0,1
148668,social,0,1
148669,",",0,0
148670,communication,0,0
148671,",",0,0
148672,and,0,0
148673,independence,0,0
148674,skills,0,0
148675,),0,1
148676,were,0,1
148677,selected,0,1
148678,for,0,0
148679,intervention,0,0
148680,for,0,0
148681,each,0,0
148682,child,1,1
148683,.,1,0
148684,The,0,0
148685,primary,0,0
148686,outcome,0,0
148687,of,0,1
148688,independent,0,1
148689,ratings,0,0
148690,of,0,1
148691,child,0,1
148692,goal,0,0
148693,attainment,0,1
148694,and,0,0
148695,several,0,1
148696,process,0,0
148697,measures,0,0
148698,(,0,1
148699,e.g.,0,0
148700,",",0,0
148701,consultant,0,1
148702,and,0,0
148703,teacher,0,1
148704,fidelity,0,0
148705,),0,1
148706,were,0,1
148707,evaluated,0,0
148708,.,0,1
148709,RESULTS,0,0
148710,Using,0,0
148711,an,0,0
148712,intent-to-treat,0,0
148713,approach,0,0
148714,",",0,1
148715,findings,0,0
148716,replicated,0,0
148717,earlier,0,1
148718,results,0,0
148719,with,0,0
148720,a,0,1
148721,very,0,0
148722,large,0,1
148723,effect,0,0
148724,size,0,0
148725,(,0,1
148726,d,0,1
148727,=,0,1
148728,1.41,0,0
148729,),0,1
148730,for,0,0
148731,the,0,0
148732,FF,0,1
148733,group,0,0
148734,and,0,0
148735,a,0,0
148736,large,0,1
148737,effect,0,0
148738,size,0,0
148739,(,0,1
148740,d,0,1
148741,=,0,1
148742,1.12,0,0
148743,),0,1
148744,for,0,0
148745,the,0,0
148746,WEB,0,1
148747,group,0,1
148748,relative,0,0
148749,to,0,0
148750,the,0,0
148751,PBO,0,0
148752,group,0,0
148753,.,0,0
148754,There,0,0
148755,were,0,0
148756,no,0,0
148757,differences,0,0
148758,in,0,0
148759,overall,0,0
148760,change,0,0
148761,across,0,0
148762,goal,0,1
148763,domains,0,0
148764,between,0,0
148765,the,0,1
148766,FF,0,1
148767,and,0,1
148768,WEB,0,1
148769,groups,0,0
148770,",",0,1
148771,suggesting,0,0
148772,the,0,0
148773,efficacy,0,0
148774,of,0,0
148775,videoconferencing,0,0
148776,technology,0,0
148777,.,0,1
148778,CONCLUSIONS,0,0
148779,COMPASS,0,0
148780,is,0,0
148781,effective,0,0
148782,and,0,0
148783,results,0,0
148784,in,0,1
148785,improved,0,0
148786,educational,0,1
148787,outcomes,0,0
148788,for,0,1
148789,young,1,1
148790,children,1,1
148791,with,1,1
148792,autism,1,1
148793,.,1,1
148794,Videoconferencing,0,0
148795,technology,0,0
148796,",",0,0
148797,as,0,0
148798,a,0,0
148799,scalable,0,0
148800,tool,0,0
148801,",",0,0
148802,has,0,0
148803,promise,0,0
148804,for,0,0
148805,facilitating,0,0
148806,access,0,0
148807,to,0,1
148808,autism,0,1
148809,specialists,0,1
148810,and,0,1
148811,bridging,0,0
148812,the,0,0
148813,research-to-practice,0,1
148814,gap,0,0
148815,.,0,1
148816,[,0,1
148817,Effects,0,0
148818,of,0,1
148819,dujieqing,0,1
148820,oral,0,0
148821,liquid,0,1
148822,on,0,0
148823,the,0,0
148824,promoter,0,0
148825,methylation,0,0
148826,of,0,0
148827,the,0,0
148828,MGMT,0,0
148829,gene,0,0
148830,in,0,0
148831,middle-and-late,1,1
148832,stage,1,1
148833,tumor,1,1
148834,patients,1,1
148835,receiving,1,1
148836,chemotherapy,1,1
148837,],1,1
148838,.,0,1
148839,OBJECTIVE,0,0
148840,To,0,0
148841,observe,0,0
148842,the,0,0
148843,effects,0,0
148844,of,0,0
148845,Dujieqing,0,1
148846,Oral,0,1
148847,Liquid,0,1
148848,(,0,1
148849,DJQ,0,1
148850,),0,1
148851,on,0,0
148852,the,0,0
148853,promoter,0,0
148854,methylation,0,0
148855,of,0,0
148856,the,0,0
148857,O6-methylguanine-DNA,0,1
148858,methyltransferase,0,0
148859,(,0,1
148860,MGMT,0,0
148861,),0,1
148862,gene,0,0
148863,in,0,0
148864,the,0,0
148865,plasma,0,0
148866,DNA,0,0
148867,samples,0,1
148868,from,0,1
148869,middle-and-late,1,1
148870,stage,1,1
148871,tumor,1,1
148872,patients,1,1
148873,receiving,1,1
148874,chemotherapy,1,1
148875,.,1,1
148876,METHODS,0,0
148877,Recruited,1,1
148878,60,1,1
148879,patients,1,1
148880,were,1,1
148881,randomly,1,1
148882,assigned,1,1
148883,to,0,0
148884,the,0,0
148885,treatment,0,0
148886,group,0,0
148887,(,0,0
148888,treated,0,1
148889,by,0,0
148890,conventional,0,1
148891,chemotherapy,0,1
148892,combined,0,0
148893,DJQ,0,1
148894,",",0,1
148895,20,0,1
148896,mL,0,0
148897,each,0,0
148898,time,0,0
148899,",",0,0
148900,three,0,0
148901,times,0,0
148902,daily,0,0
148903,),0,1
148904,and,0,0
148905,the,0,0
148906,control,0,0
148907,group,0,0
148908,(,0,0
148909,treated,0,1
148910,by,0,0
148911,chemotherapy,0,1
148912,alone,0,1
148913,),0,0
148914,",",0,0
148915,30,0,1
148916,in,0,0
148917,each,0,1
148918,group,0,1
148919,.,0,0
148920,The,0,0
148921,therapeutic,0,0
148922,course,0,0
148923,was,0,0
148924,8,0,1
148925,weeks,0,0
148926,.,0,1
148927,The,0,0
148928,promoter,0,0
148929,methylation,0,0
148930,of,0,0
148931,the,0,0
148932,MGMT,0,0
148933,gene,0,0
148934,in,0,0
148935,the,0,0
148936,plasma,0,0
148937,DNA,0,0
148938,samples,0,0
148939,form,0,0
148940,middle-and-late,1,0
148941,stage,1,1
148942,tumor,1,1
148943,patients,1,1
148944,receiving,1,1
148945,chemotherapy,1,1
148946,was,0,0
148947,detected,0,0
148948,before,0,0
148949,and,0,0
148950,after,0,1
148951,treatment,0,0
148952,using,0,0
148953,nested,0,1
148954,methylation-specific,0,1
148955,polymerase,0,0
148956,chain,0,0
148957,reaction,0,0
148958,(,0,1
148959,MSP,0,1
148960,),0,1
148961,.,0,1
148962,Meanwhile,0,0
148963,",",0,0
148964,the,0,0
148965,peripheral,0,1
148966,hemogram,0,0
148967,was,0,0
148968,detected,0,0
148969,.,0,1
148970,The,0,0
148971,clinical,0,0
148972,efficacy,0,0
148973,and,0,1
148974,toxic/adverse,0,1
148975,reactions,0,0
148976,were,0,1
148977,assessed,0,0
148978,using,0,0
148979,Karnofsky,0,1
148980,performance,0,0
148981,scale,0,0
148982,(,0,1
148983,KPS,0,1
148984,),0,1
148985,.,0,1
148986,RESULTS,0,0
148987,Results,0,0
148988,of,0,0
148989,the,0,0
148990,promoter,0,0
148991,methylation,0,0
148992,of,0,1
148993,MGMT,0,0
148994,genes,0,0
148995,showed,0,0
148996,that,0,0
148997,methylation,0,0
148998,rate,0,0
148999,was,0,0
149000,20.00,0,0
149001,%,0,0
149002,in,0,0
149003,the,0,0
149004,treatment,0,0
149005,group,0,1
149006,and,0,1
149007,46.67,0,0
149008,%,0,0
149009,in,0,0
149010,the,0,0
149011,control,0,1
149012,group,0,0
149013,(,0,1
149014,P,0,0
149015,<,0,0
149016,0.05,0,0
149017,),0,1
149018,.,0,1
149019,Compared,0,0
149020,with,0,1
149021,before,0,0
149022,treatment,0,0
149023,",",0,0
149024,the,0,0
149025,KPS,0,0
149026,was,0,0
149027,significantly,0,0
149028,improved,0,0
149029,in,0,0
149030,the,0,0
149031,treatment,0,0
149032,group,0,0
149033,after,0,0
149034,treatment,0,0
149035,",",0,0
149036,while,0,0
149037,it,0,0
149038,significantly,0,0
149039,decreased,0,0
149040,in,0,0
149041,the,0,0
149042,control,0,0
149043,group,0,0
149044,after,0,0
149045,treatment,0,0
149046,(,0,1
149047,both,0,0
149048,P,0,0
149049,<,0,0
149050,0.05,0,0
149051,),0,0
149052,.,0,0
149053,There,0,0
149054,was,0,0
149055,statistical,0,0
149056,difference,0,0
149057,in,0,0
149058,the,0,0
149059,KPS,0,0
149060,between,0,0
149061,the,0,1
149062,two,0,0
149063,groups,0,0
149064,after,0,1
149065,treatment,0,1
149066,(,0,1
149067,P,0,0
149068,<,0,0
149069,0.01,0,0
149070,),0,1
149071,.,0,1
149072,The,0,0
149073,toxic/adverse,0,0
149074,reactions,0,0
149075,were,0,1
149076,milder,0,0
149077,in,0,0
149078,the,0,0
149079,treatment,0,0
149080,group,0,0
149081,than,0,0
149082,in,0,0
149083,the,0,0
149084,control,0,1
149085,group,0,0
149086,(,0,1
149087,P,0,0
149088,<,0,0
149089,0.01,0,0
149090,),0,1
149091,.,0,1
149092,CONCLUSIONS,0,0
149093,DJQ,0,0
149094,showed,0,0
149095,efficiency,0,0
149096,synergism,0,0
149097,and,0,0
149098,toxicity,0,0
149099,reducing,0,0
149100,effects,0,0
149101,",",0,0
149102,but,0,0
149103,with,0,1
149104,no,0,0
149105,effect,0,0
149106,on,0,0
149107,the,0,0
149108,hematopoietic,0,1
149109,function,0,0
149110,of,0,0
149111,the,0,0
149112,bone,0,0
149113,marrow,0,1
149114,.,0,1
149115,MGMT,0,0
149116,gene,0,0
149117,was,0,0
149118,indicated,0,0
149119,as,0,0
149120,DJQ,0,1
149121,'s,0,1
149122,target,0,0
149123,point,0,0
149124,for,0,0
149125,efficiency,0,0
149126,synergism,0,0
149127,and,0,0
149128,toxicity,0,0
149129,reducing,0,0
149130,.,0,1
149131,The,0,0
149132,efficiency,0,0
149133,synergism,0,0
149134,and,0,0
149135,toxicity,0,0
149136,reducing,0,0
149137,effects,0,0
149138,were,0,1
149139,achieved,0,0
149140,by,0,0
149141,regulating,0,0
149142,the,0,0
149143,activities,0,0
149144,of,0,0
149145,MGMT,0,0
149146,gene,0,1
149147,.,0,1
149148,The,0,0
149149,addition,0,0
149150,of,0,0
149151,amifostine,0,0
149152,to,0,0
149153,carboplatin,0,0
149154,and,0,0
149155,paclitaxel,0,0
149156,based,0,1
149157,chemoradiation,0,0
149158,in,0,0
149159,locally,1,1
149160,advanced,1,1
149161,non-small,1,1
149162,cell,1,1
149163,lung,1,1
149164,cancer,1,1
149165,:,1,1
149166,long-term,0,0
149167,follow-up,0,0
149168,of,0,1
149169,Radiation,0,0
149170,Therapy,0,1
149171,Oncology,0,1
149172,Group,0,1
149173,(,0,1
149174,RTOG,0,1
149175,),0,1
149176,randomized,0,1
149177,trial,0,1
149178,9801,0,1
149179,.,0,1
149180,INTRODUCTION,0,0
149181,We,0,0
149182,report,0,0
149183,the,0,0
149184,long-term,0,0
149185,results,0,0
149186,of,0,1
149187,RTOG,0,1
149188,9801,0,1
149189,",",0,0
149190,a,0,0
149191,randomized,0,1
149192,trial,0,0
149193,investigating,0,0
149194,the,0,0
149195,ability,0,0
149196,of,0,0
149197,amifostine,0,0
149198,",",0,0
149199,a,0,0
149200,radioprotector,0,0
149201,",",0,0
149202,to,0,0
149203,reduce,0,0
149204,chemoradiation-induced,0,0
149205,esophagitis,0,1
149206,.,0,1
149207,METHODS,0,0
149208,Patients,1,1
149209,with,1,1
149210,stages,1,1
149211,II,1,1
149212,and,1,1
149213,IIIA/B,1,0
149214,non-small-cell,1,1
149215,lung,1,1
149216,cancer,1,1
149217,received,0,0
149218,induction,0,0
149219,paclitaxel,0,0
149220,225,0,1
149221,mg/m2,0,0
149222,intravenously,0,1
149223,(,0,1
149224,IV,0,1
149225,),0,1
149226,and,0,1
149227,carboplatin,0,0
149228,area,0,0
149229,under,0,0
149230,the,0,0
149231,curve,0,0
149232,(,0,0
149233,AUC,0,0
149234,),0,1
149235,6,0,0
149236,both,0,0
149237,days,0,0
149238,1,0,1
149239,and,0,1
149240,22,0,1
149241,",",0,0
149242,followed,0,0
149243,by,0,0
149244,concurrent,0,1
149245,weekly,0,1
149246,paclitaxel,0,1
149247,(,0,1
149248,50,0,1
149249,mg/m2,0,1
149250,),0,1
149251,and,0,0
149252,carboplatin,0,0
149253,(,0,1
149254,AUC,0,0
149255,2,0,1
149256,),0,1
149257,",",0,0
149258,with,0,1
149259,hyperfractionated,0,1
149260,radiation,0,1
149261,therapy,0,0
149262,(,0,1
149263,69.6,0,1
149264,Gy,0,1
149265,at,0,1
149266,1.2,0,1
149267,Gy,0,1
149268,BID,0,1
149269,),0,1
149270,.,0,1
149271,Patients,0,1
149272,were,0,0
149273,randomly,0,1
149274,assigned,0,1
149275,to,0,0
149276,amifostine,0,0
149277,(,0,1
149278,AM,0,1
149279,),0,1
149280,500,0,1
149281,mg,0,1
149282,IV,0,1
149283,four,0,1
149284,times,0,0
149285,per,0,1
149286,week,0,0
149287,or,0,1
149288,no-AM,0,0
149289,during,0,1
149290,chemoradiotherapy,0,1
149291,.,0,1
149292,Stratification,0,0
149293,factors,0,0
149294,included,0,1
149295,age,0,1
149296,(,0,1
149297,<,0,0
149298,70,0,1
149299,vs.,0,0
149300,?70,0,1
149301,years,0,1
149302,),0,1
149303,",",0,1
149304,stage,0,1
149305,and,0,0
149306,performance,0,0
149307,status,0,1
149308,.,0,1
149309,RESULTS,1,0
149310,243,1,1
149311,patients,1,1
149312,(,1,1
149313,pts,1,1
149314,),1,1
149315,were,1,1
149316,enrolled,1,1
149317,;,1,1
149318,120,1,1
149319,received,1,1
149320,AM,1,1
149321,",",1,1
149322,123,1,1
149323,received,1,1
149324,no-AM,1,1
149325,.,1,1
149326,Two,1,1
149327,pts,1,0
149328,on,1,0
149329,each,1,1
149330,arm,1,1
149331,were,1,0
149332,found,1,0
149333,ineligible,1,1
149334,.,1,1
149335,Overall,1,0
149336,",",1,0
149337,85,1,1
149338,%,1,0
149339,of,1,1
149340,patients,1,1
149341,were,1,1
149342,?70,1,1
149343,years,1,1
149344,;,1,1
149345,75,1,1
149346,%,1,0
149347,had,1,1
149348,a,1,0
149349,KPS,1,1
149350,?90,1,1
149351,.,1,1
149352,34,1,0
149353,%,1,0
149354,had,1,1
149355,squamous,1,1
149356,histology,1,1
149357,.,1,1
149358,With,1,0
149359,median,0,0
149360,follow-up,0,1
149361,of,0,1
149362,96.3,0,1
149363,months,0,1
149364,(,0,1
149365,for,0,1
149366,patients,0,1
149367,still,0,1
149368,alive,0,1
149369,),0,0
149370,",",0,0
149371,overall,0,0
149372,survival,0,0
149373,was,0,0
149374,identical,0,0
149375,(,0,1
149376,hazard,0,0
149377,ratio,0,0
149378,1.03,0,0
149379,(,0,1
149380,0.79-1.34,0,0
149381,),0,1
149382,",",0,0
149383,NS,0,0
149384,),0,1
149385,:,0,1
149386,five-year,0,1
149387,survival,0,0
149388,17,0,1
149389,%,0,0
149390,in,0,0
149391,both,0,0
149392,arms,0,0
149393,.,0,1
149394,The,0,0
149395,incidence,0,0
149396,of,0,0
149397,late,0,1
149398,grade,0,1
149399,3-5,0,1
149400,toxicities,0,0
149401,was,0,0
149402,16,0,1
149403,%,0,0
149404,in,0,0
149405,the,0,0
149406,AM,0,1
149407,arm,0,1
149408,and,0,1
149409,19,0,1
149410,%,0,0
149411,in,0,0
149412,the,0,0
149413,control,0,1
149414,arm,0,0
149415,(,0,1
149416,hazard,0,0
149417,ratio,0,0
149418,1.24,0,0
149419,(,0,1
149420,0.66-2.32,0,0
149421,),0,1
149422,",",0,0
149423,NS,0,0
149424,),0,0
149425,.,0,0
149426,There,0,0
149427,was,0,0
149428,no,0,0
149429,significant,0,0
149430,difference,0,0
149431,between,0,0
149432,the,0,0
149433,arms,0,0
149434,regarding,0,0
149435,overall,0,0
149436,survival,0,0
149437,",",0,0
149438,disease-free,0,0
149439,survival,0,0
149440,or,0,1
149441,long-term,0,0
149442,toxicity,0,0
149443,.,0,1
149444,CONCLUSION,0,0
149445,The,0,0
149446,chemoradiation,0,0
149447,regimen,0,0
149448,of,0,1
149449,carboplatin,0,0
149450,and,0,1
149451,paclitaxel,0,0
149452,produced,0,0
149453,long-term,0,0
149454,results,0,0
149455,in,0,1
149456,the,0,1
149457,multi-institutional,0,1
149458,setting,0,1
149459,comparable,0,0
149460,to,0,1
149461,other,0,1
149462,regimens,0,0
149463,.,0,1
149464,Amifostine,0,0
149465,did,0,0
149466,not,0,0
149467,appear,0,0
149468,to,0,0
149469,compromise,0,0
149470,survival,0,0
149471,.,0,1
149472,As,0,0
149473,done,0,0
149474,in,0,1
149475,RTOG,0,1
149476,9801,0,0
149477,",",0,0
149478,more,0,0
149479,consistent,0,0
149480,reporting,0,0
149481,of,0,0
149482,long,0,1
149483,term,0,1
149484,toxicity,0,0
149485,is,0,0
149486,needed,0,0
149487,for,0,0
149488,comparison,0,0
149489,of,0,0
149490,different,0,1
149491,chemoradiation,0,1
149492,regimens,0,0
149493,.,0,1
149494,Development,0,0
149495,of,0,0
149496,the,0,0
149497,Therapist,1,1
149498,Empathy,0,1
149499,Scale,0,1
149500,.,0,1
149501,BACKGROUND,0,0
149502,Few,0,1
149503,measures,0,0
149504,exist,0,0
149505,to,0,0
149506,examine,0,0
149507,therapist,1,0
149508,empathy,0,0
149509,as,0,0
149510,it,0,0
149511,occurs,0,0
149512,in,0,0
149513,session,0,0
149514,.,0,1
149515,AIMS,0,0
149516,A,0,0
149517,9-item,0,0
149518,observer,0,0
149519,rating,0,0
149520,scale,0,0
149521,",",0,0
149522,called,0,0
149523,the,0,0
149524,Therapist,0,1
149525,Empathy,0,1
149526,Scale,0,1
149527,(,0,1
149528,TES,0,0
149529,),0,1
149530,",",0,0
149531,was,0,0
149532,developed,0,0
149533,based,0,1
149534,on,0,0
149535,Watson,0,0
149536,'s,0,1
149537,(,0,1
149538,1999,0,1
149539,),0,1
149540,work,0,0
149541,to,0,0
149542,assess,0,0
149543,affective,0,1
149544,",",0,0
149545,cognitive,0,0
149546,",",0,0
149547,attitudinal,0,0
149548,",",0,0
149549,and,0,1
149550,attunement,0,0
149551,aspects,0,0
149552,of,0,1
149553,therapist,0,1
149554,empathy,0,0
149555,.,0,1
149556,The,0,0
149557,aim,0,0
149558,of,0,0
149559,this,0,0
149560,study,0,0
149561,was,0,0
149562,to,0,0
149563,evaluate,0,0
149564,the,0,0
149565,inter-rater,0,0
149566,reliability,0,0
149567,",",0,0
149568,internal,0,0
149569,consistency,0,0
149570,",",0,0
149571,and,0,0
149572,construct,0,0
149573,and,0,0
149574,criterion,0,1
149575,validity,0,0
149576,of,0,0
149577,the,0,0
149578,TES,0,0
149579,.,0,1
149580,METHOD,0,0
149581,Raters,0,0
149582,evaluated,0,1
149583,therapist,1,1
149584,empathy,0,0
149585,in,0,1
149586,315,1,1
149587,client,1,1
149588,sessions,1,0
149589,conducted,1,1
149590,by,1,1
149591,91,1,1
149592,therapists,1,0
149593,",",1,1
149594,using,1,0
149595,data,1,0
149596,from,1,1
149597,a,1,1
149598,multi-site,1,1
149599,therapist,1,0
149600,training,1,0
149601,trial,1,0
149602,(,1,0
149603,Martino,1,1
149604,et,1,1
149605,al.,1,1
149606,",",0,0
149607,2010,1,1
149608,),1,1
149609,in,1,1
149610,Motivational,1,1
149611,Interviewing,1,1
149612,(,1,1
149613,MI,1,1
149614,),1,1
149615,.,1,1
149616,RESULTS,0,0
149617,Inter-rater,0,0
149618,reliability,0,0
149619,(,0,1
149620,ICC,0,1
149621,=,0,1
149622,.87,0,0
149623,to,0,0
149624,.91,0,0
149625,),0,0
149626,and,0,0
149627,internal,0,1
149628,consistency,0,0
149629,(,0,1
149630,Cronbach,0,0
149631,'s,0,1
149632,alpha,0,0
149633,=,0,1
149634,.94,0,0
149635,),0,1
149636,were,0,1
149637,high,0,1
149638,.,0,1
149639,Confirmatory,0,0
149640,factor,0,0
149641,analyses,0,0
149642,indicated,0,0
149643,some,0,0
149644,support,0,0
149645,for,0,0
149646,single-factor,0,0
149647,fit,0,0
149648,.,0,1
149649,Convergent,0,0
149650,validity,0,0
149651,was,0,0
149652,supported,0,0
149653,by,0,0
149654,correlations,0,0
149655,between,0,1
149656,TES,0,1
149657,scores,0,0
149658,and,0,1
149659,MI,0,1
149660,fundamental,0,0
149661,adherence,0,0
149662,(,0,1
149663,r,0,0
149664,range,0,1
149665,.50,0,0
149666,to,0,0
149667,.67,0,0
149668,),0,0
149669,and,0,0
149670,competence,0,1
149671,scores,0,0
149672,(,0,1
149673,r,0,0
149674,range,0,1
149675,.56,0,0
149676,to,0,0
149677,.69,0,0
149678,),0,1
149679,.,0,1
149680,Discriminant,0,0
149681,validity,0,0
149682,was,0,0
149683,indicated,0,0
149684,by,0,0
149685,negative,0,1
149686,or,0,1
149687,nonsignificant,0,0
149688,correlations,0,0
149689,between,0,1
149690,TES,0,1
149691,and,0,1
149692,MI-inconsistent,0,0
149693,behavior,0,0
149694,(,0,1
149695,r,0,0
149696,range,0,1
149697,.05,0,0
149698,to,0,0
149699,-.33,0,0
149700,),0,0
149701,.,0,0
149702,CONCLUSIONS,0,0
149703,The,0,0
149704,TES,0,0
149705,demonstrates,0,0
149706,excellent,0,0
149707,inter-rater,0,0
149708,reliability,0,0
149709,and,0,1
149710,internal,0,1
149711,consistency,0,0
149712,.,0,1
149713,RESULTS,0,0
149714,indicate,0,0
149715,some,0,0
149716,support,0,0
149717,for,0,0
149718,a,0,1
149719,single-factor,0,0
149720,solution,0,0
149721,and,0,1
149722,convergent,0,0
149723,and,0,0
149724,discriminant,0,0
149725,validity,0,0
149726,.,0,1
149727,Future,0,0
149728,studies,0,0
149729,should,0,0
149730,examine,0,0
149731,the,0,0
149732,use,0,0
149733,of,0,0
149734,the,0,0
149735,TES,0,0
149736,to,0,0
149737,evaluate,0,0
149738,therapist,1,0
149739,empathy,0,0
149740,in,0,0
149741,different,0,1
149742,psychotherapy,0,1
149743,approaches,0,0
149744,and,0,1
149745,to,0,0
149746,determine,0,0
149747,the,0,0
149748,impact,0,0
149749,of,0,0
149750,therapist,0,0
149751,empathy,0,0
149752,on,0,0
149753,client,0,1
149754,outcome,0,0
149755,.,0,1
149756,Effects,0,1
149757,of,0,1
149758,low,0,1
149759,and,0,1
149760,high,0,1
149761,protein,0,0
149762,:,0,1
149763,carbohydrate,0,1
149764,ratios,0,0
149765,in,0,1
149766,the,0,0
149767,diet,0,0
149768,of,0,0
149769,pregnant,1,1
149770,gilts,1,1
149771,on,0,1
149772,maternal,0,1
149773,cortisol,0,0
149774,concentrations,0,0
149775,and,0,1
149776,the,0,0
149777,adrenocortical,0,1
149778,and,0,0
149779,sympathoadrenal,0,0
149780,reactivity,0,0
149781,in,1,0
149782,their,1,1
149783,offspring,1,1
149784,.,1,1
149785,Inadequate,0,0
149786,maternal,0,1
149787,nutrition,0,1
149788,during,0,0
149789,gestation,0,1
149790,may,0,0
149791,cause,0,0
149792,an,0,0
149793,adverse,0,0
149794,environment,0,0
149795,for,0,0
149796,the,0,0
149797,fetus,0,1
149798,leading,0,0
149799,to,0,1
149800,alterations,0,0
149801,of,0,0
149802,the,0,1
149803,hypothalamic-pituitary-adrenal,0,0
149804,(,0,1
149805,HPA,0,1
149806,),0,1
149807,and,0,1
149808,sympatho-adrenomedullary,0,0
149809,(,0,1
149810,SAM,0,0
149811,),0,0
149812,systems,0,0
149813,later,0,1
149814,in,0,0
149815,life,0,0
149816,.,0,1
149817,In,0,0
149818,the,0,0
149819,present,0,0
149820,study,0,0
149821,",",0,0
149822,we,0,0
149823,investigated,0,0
149824,the,0,0
149825,effects,0,0
149826,of,0,1
149827,diets,0,1
149828,with,0,1
149829,low,0,1
149830,and,0,1
149831,high,0,1
149832,protein,0,0
149833,:,0,1
149834,carbohydrate,0,1
149835,ratios,0,0
149836,on,0,1
149837,cortisol,0,0
149838,concentrations,0,0
149839,of,0,1
149840,pregnant,1,1
149841,gilts,1,1
149842,as,0,0
149843,well,0,0
149844,as,0,0
149845,the,0,0
149846,long-term,0,0
149847,effects,0,0
149848,on,0,0
149849,the,0,0
149850,function,0,0
149851,of,0,0
149852,the,0,0
149853,HPA,0,1
149854,and,0,1
149855,SAM,0,0
149856,axes,0,0
149857,in,1,1
149858,their,1,1
149859,offspring,1,1
149860,.,1,1
149861,Throughout,0,0
149862,gestation,0,1
149863,",",0,1
149864,33,1,1
149865,German,1,1
149866,Landrace,1,1
149867,gilts,1,1
149868,were,0,1
149869,fed,0,1
149870,high,0,1
149871,(,0,1
149872,HP,0,1
149873,",",0,1
149874,30,0,1
149875,%,0,0
149876,),0,1
149877,",",0,0
149878,low,0,1
149879,(,0,1
149880,LP,0,1
149881,",",0,1
149882,6.5,0,0
149883,%,0,0
149884,),0,1
149885,",",0,0
149886,or,0,1
149887,adequate,0,0
149888,(,0,1
149889,AP,0,1
149890,",",0,1
149891,12.1,0,0
149892,%,0,0
149893,),0,1
149894,protein,0,0
149895,diets,0,0
149896,",",0,1
149897,which,0,0
149898,were,0,0
149899,made,0,0
149900,isocaloric,0,0
149901,by,0,0
149902,adjusting,0,0
149903,the,0,0
149904,carbohydrate,0,0
149905,content,0,0
149906,.,0,1
149907,The,0,0
149908,salivary,0,1
149909,cortisol,0,0
149910,concentrations,0,0
149911,of,1,1
149912,the,1,1
149913,sows,1,1
149914,were,0,1
149915,measured,0,0
149916,in,0,0
149917,the,0,0
149918,course,0,0
149919,of,0,0
149920,the,0,0
149921,gestation,0,1
149922,period,0,0
149923,.,0,1
149924,The,1,0
149925,offspring,1,0
149926,were,1,0
149927,cross-fostered,1,1
149928,",",0,0
149929,and,0,0
149930,the,0,0
149931,plasma,0,0
149932,cortisol,0,0
149933,and,0,1
149934,catecholamine,0,0
149935,concentrations,0,0
149936,of,0,1
149937,the,0,0
149938,offspring,1,1
149939,were,0,0
149940,determined,0,0
149941,on,0,0
149942,postnatal,0,1
149943,d,0,1
149944,(,0,1
149945,PND,0,1
149946,),0,1
149947,1,0,1
149948,and,0,1
149949,27,0,1
149950,and,0,1
149951,under,0,1
149952,specific,0,0
149953,challenging,0,1
149954,conditions,0,1
149955,:,0,1
149956,after,0,1
149957,weaning,0,1
149958,(,0,1
149959,PND,0,1
149960,29,0,1
149961,),0,1
149962,and,0,1
149963,after,0,1
149964,ACTH,0,1
149965,and,0,1
149966,insulin,0,1
149967,challenges,0,0
149968,(,0,1
149969,PND,0,1
149970,68,0,1
149971,and,0,1
149972,70,0,1
149973,",",0,0
149974,respectively,0,0
149975,),0,1
149976,.,0,1
149977,Glucocorticoid,0,0
149978,receptor,0,0
149979,(,0,1
149980,GR,0,0
149981,),0,1
149982,binding,0,0
149983,and,0,1
149984,neurotransmitter,0,0
149985,concentrations,0,0
149986,were,0,1
149987,measured,0,0
149988,in,0,0
149989,stress-related,0,0
149990,brain,0,1
149991,regions,0,1
149992,",",0,1
149993,and,0,1
149994,histological,0,0
149995,analyses,0,0
149996,of,0,1
149997,the,0,1
149998,adrenal,0,1
149999,were,0,1
150000,performed,0,0
150001,.,0,1
150002,Maternal,0,0
150003,salivary,0,1
150004,cortisol,0,0
150005,concentrations,0,0
150006,increased,0,0
150007,throughout,0,0
150008,gestation,0,1
150009,(,0,1
150010,P,0,0
150011,<,0,0
150012,0.001,0,0
150013,),0,1
150014,and,0,0
150015,the,0,0
150016,LP,0,1
150017,gilts,0,1
150018,had,0,1
150019,greater,0,0
150020,salivary,0,1
150021,cortisol,0,0
150022,compared,0,0
150023,with,0,1
150024,the,0,0
150025,AP,0,1
150026,and,0,1
150027,HP,0,1
150028,gilts,0,1
150029,(,0,1
150030,P,0,0
150031,<,0,0
150032,0.05,0,0
150033,),0,1
150034,.,0,1
150035,No,0,0
150036,differences,0,0
150037,between,0,1
150038,diets,0,1
150039,were,0,1
150040,found,0,0
150041,for,0,0
150042,cortisol,0,0
150043,",",0,0
150044,corticosteroid-binding,0,0
150045,globulin,0,0
150046,",",0,0
150047,and,0,0
150048,catecholamine,0,0
150049,concentrations,0,0
150050,in,0,1
150051,plasma,0,0
150052,and,0,1
150053,for,0,0
150054,GR,0,0
150055,binding,0,0
150056,in,0,0
150057,hippocampus,0,0
150058,and,0,0
150059,hypothalamus,0,0
150060,in,0,0
150061,piglets,1,1
150062,at,0,1
150063,PND,0,1
150064,1,0,1
150065,and,0,1
150066,27,0,1
150067,.,0,1
150068,However,0,0
150069,",",0,0
150070,the,0,0
150071,cortisol,0,0
150072,response,0,0
150073,to,0,0
150074,weaning,0,1
150075,was,0,0
150076,increased,0,0
150077,in,0,1
150078,LP,0,1
150079,piglets,0,1
150080,(,0,1
150081,P,0,0
150082,<,0,0
150083,0.05,0,0
150084,),0,1
150085,",",0,0
150086,and,0,0
150087,in,0,0
150088,HP,0,1
150089,offspring,0,1
150090,the,0,0
150091,basal,0,0
150092,plasma,0,0
150093,noradrenaline,0,0
150094,concentrations,0,0
150095,were,0,1
150096,increased,0,0
150097,(,0,1
150098,P,0,0
150099,<,0,0
150100,0.05,0,0
150101,),0,1
150102,.,0,1
150103,The,0,0
150104,cortisol,0,0
150105,response,0,0
150106,to,0,0
150107,the,0,0
150108,ACTH,0,1
150109,and,0,0
150110,the,0,0
150111,insulin,0,0
150112,challenge,0,0
150113,did,0,0
150114,not,0,0
150115,differ,0,0
150116,between,0,0
150117,diets,0,0
150118,.,0,1
150119,On,0,1
150120,PND,0,1
150121,81,0,1
150122,",",0,0
150123,an,0,0
150124,increased,0,0
150125,adrenal,0,1
150126,medulla,0,1
150127,area,0,0
150128,was,0,0
150129,observed,0,0
150130,in,0,0
150131,LP,0,1
150132,offspring,0,1
150133,compared,0,0
150134,with,0,1
150135,the,0,0
150136,AP,0,1
150137,offspring,0,1
150138,(,0,1
150139,P,0,0
150140,<,0,0
150141,0.05,0,0
150142,),0,1
150143,.,0,1
150144,Our,0,0
150145,results,0,0
150146,show,0,0
150147,that,0,0
150148,maternal,0,1
150149,diets,0,0
150150,with,0,1
150151,aberrant,0,1
150152,protein,0,0
150153,:,0,1
150154,carbohydrate,0,1
150155,ratios,0,0
150156,during,0,1
150157,gestation,0,1
150158,have,0,0
150159,moderate,0,1
150160,long-term,0,0
150161,effects,0,0
150162,on,0,0
150163,the,0,0
150164,function,0,0
150165,of,0,0
150166,the,0,0
150167,HPA,0,1
150168,and,0,0
150169,SAM,0,0
150170,system,0,0
150171,in,0,0
150172,the,0,0
150173,offspring,0,0
150174,",",0,0
150175,which,0,0
150176,indicates,0,0
150177,that,0,0
150178,pigs,1,1
150179,show,0,0
150180,a,0,0
150181,considerable,0,0
150182,plasticity,0,0
150183,to,0,0
150184,cope,0,1
150185,with,0,1
150186,maternal,0,1
150187,malnutrition,0,1
150188,.,0,1
150189,JobTIPS,0,0
150190,:,0,1
150191,a,0,0
150192,transition,0,1
150193,to,0,0
150194,employment,0,1
150195,program,0,1
150196,for,0,0
150197,individuals,1,1
150198,with,1,1
150199,autism,1,1
150200,spectrum,1,1
150201,disorders,1,1
150202,.,1,1
150203,This,0,0
150204,study,0,0
150205,evaluated,0,0
150206,the,0,0
150207,effectiveness,0,0
150208,of,0,0
150209,an,0,0
150210,internet,0,0
150211,accessed,0,0
150212,training,0,0
150213,program,0,1
150214,that,0,0
150215,included,0,1
150216,Theory,0,1
150217,of,0,0
150218,Mind-based,0,0
150219,guidance,0,0
150220,",",0,1
150221,video,0,0
150222,models,0,0
150223,",",0,1
150224,visual,0,0
150225,supports,0,0
150226,",",0,1
150227,and,0,1
150228,virtual,0,0
150229,reality,0,0
150230,practice,0,0
150231,sessions,0,0
150232,in,0,1
150233,teaching,0,1
150234,appropriate,0,0
150235,job,0,1
150236,interview,0,1
150237,skills,0,0
150238,to,0,1
150239,individuals,1,1
150240,with,1,1
150241,high,1,1
150242,functioning,1,1
150243,Autism,1,1
150244,Spectrum,1,1
150245,Disorders,1,1
150246,.,1,1
150247,In,0,0
150248,a,0,0
150249,randomized,0,1
150250,study,0,0
150251,",",0,0
150252,twenty-two,1,1
150253,youth,1,1
150254,",",1,0
150255,ages,1,1
150256,16-19,1,0
150257,",",1,0
150258,were,1,0
150259,evaluated,1,0
150260,during,1,0
150261,two,1,1
150262,employment,1,1
150263,interviews,1,1
150264,.,1,1
150265,Half,0,0
150266,received,0,0
150267,a,0,0
150268,training,0,0
150269,intervention,0,0
150270,following,0,0
150271,the,0,0
150272,initial,0,0
150273,interview,0,0
150274,and,0,0
150275,the,0,1
150276,half,0,1
150277,who,0,1
150278,served,0,1
150279,as,0,1
150280,a,0,0
150281,contrast,0,1
150282,group,0,0
150283,did,0,0
150284,not,0,0
150285,.,0,1
150286,Their,0,1
150287,performance,0,0
150288,pre,0,0
150289,and,0,0
150290,post,0,1
150291,intervention,0,0
150292,was,0,0
150293,assessed,0,0
150294,by,0,0
150295,four,0,1
150296,independent,0,1
150297,raters,0,1
150298,using,0,0
150299,a,0,1
150300,scale,0,0
150301,that,0,0
150302,included,0,1
150303,evaluation,0,0
150304,of,0,0
150305,both,0,0
150306,Content,0,0
150307,and,0,1
150308,Delivery,0,1
150309,.,0,1
150310,Results,0,0
150311,suggest,0,0
150312,that,0,0
150313,youth,0,1
150314,who,0,1
150315,completed,0,1
150316,the,0,1
150317,JobTIPS,0,0
150318,employment,0,1
150319,program,0,1
150320,demonstrated,0,0
150321,significantly,0,0
150322,more,0,0
150323,effective,0,0
150324,verbal,0,0
150325,content,0,0
150326,skills,0,0
150327,than,0,1
150328,those,0,1
150329,who,0,1
150330,did,0,1
150331,not,0,1
150332,.,0,1
150333,MEG,0,1
150334,premotor,0,0
150335,abnormalities,0,1
150336,in,0,1
150337,children,1,1
150338,with,1,1
150339,Asperger,1,1
150340,'s,1,1
150341,syndrome,1,1
150342,:,1,1
150343,determinants,0,0
150344,of,0,1
150345,social,0,1
150346,behavior,0,1
150347,?,0,1
150348,Children,0,1
150349,with,0,1
150350,Asperger,0,1
150351,'s,0,1
150352,syndrome,0,1
150353,show,0,0
150354,deficits,0,0
150355,in,0,1
150356,social,0,1
150357,functioning,0,1
150358,while,0,0
150359,their,0,1
150360,intellectual,0,1
150361,and,0,0
150362,language,0,0
150363,development,0,0
150364,is,0,0
150365,intact,0,0
150366,suggesting,0,0
150367,a,0,1
150368,specific,0,0
150369,dysfunction,0,1
150370,in,0,1
150371,mechanisms,0,0
150372,mediating,0,0
150373,social,0,1
150374,cognition,0,0
150375,.,0,1
150376,An,0,0
150377,action,0,0
150378,observation/execution,0,0
150379,matching,0,0
150380,system,0,0
150381,might,0,0
150382,be,0,0
150383,one,0,0
150384,such,0,0
150385,mechanism,0,0
150386,.,0,1
150387,Recent,0,0
150388,studies,0,0
150389,indeed,0,0
150390,showed,0,0
150391,that,0,0
150392,electrophysiological,0,0
150393,modulation,0,0
150394,of,0,0
150395,the,0,0
150396,Mu-rhythm,0,1
150397,in,0,0
150398,the,0,0
150399,10-12Hz,0,1
150400,range,0,1
150401,is,0,0
150402,weaker,0,0
150403,when,0,0
150404,individuals,0,1
150405,with,0,1
150406,Asperger,0,1
150407,'s,0,1
150408,syndrome,0,1
150409,observe,0,0
150410,actions,0,0
150411,performed,0,0
150412,by,0,1
150413,others,0,1
150414,compared,0,0
150415,to,0,1
150416,controls,0,1
150417,.,0,1
150418,However,0,0
150419,",",0,0
150420,electrophysiological,0,0
150421,studies,0,0
150422,typically,0,1
150423,fall,0,0
150424,short,0,0
150425,in,0,0
150426,revealing,0,0
150427,the,0,0
150428,neural,0,0
150429,generators,0,0
150430,of,0,1
150431,this,0,0
150432,activity,0,0
150433,.,0,0
150434,To,0,0
150435,fill,0,0
150436,this,0,0
150437,gap,0,0
150438,we,0,0
150439,assessed,0,0
150440,magnetoencephalographic,0,1
150441,Mu-modulations,0,1
150442,in,0,1
150443,Asperger,1,1
150444,'s,1,1
150445,and,1,0
150446,typically,1,1
150447,developed,1,1
150448,children,1,1
150449,",",0,1
150450,while,0,0
150451,observing,0,0
150452,grasping,0,1
150453,movements,0,1
150454,.,0,1
150455,Mu-power,0,0
150456,increased,0,0
150457,at,0,0
150458,frontal,0,1
150459,and,0,1
150460,central,0,1
150461,sensors,0,1
150462,during,0,1
150463,movement,0,1
150464,observation,0,0
150465,.,0,1
150466,This,0,0
150467,modulation,0,0
150468,was,0,0
150469,stronger,0,0
150470,in,0,0
150471,typical,0,1
150472,than,0,1
150473,in,0,1
150474,Asperger,0,1
150475,children,0,1
150476,.,0,1
150477,Source,0,0
150478,localization,0,0
150479,revealed,0,0
150480,stronger,0,0
150481,sources,0,0
150482,in,0,0
150483,premotor,0,0
150484,cortex,0,0
150485,",",0,0
150486,the,0,0
150487,intraparietal,0,0
150488,lobule,0,0
150489,(,0,1
150490,IPL,0,1
150491,),0,1
150492,and,0,0
150493,the,0,0
150494,mid-occipito-temporal,0,1
150495,gyrus,0,0
150496,(,0,1
150497,MOTG,0,0
150498,),0,1
150499,and,0,1
150500,weaker,0,0
150501,sources,0,0
150502,in,0,0
150503,prefrontal,0,1
150504,cortex,0,0
150505,in,0,1
150506,typical,0,1
150507,participants,0,1
150508,compared,0,0
150509,to,0,1
150510,Asperger,0,1
150511,.,0,1
150512,Activity,0,0
150513,in,0,0
150514,premotor,0,0
150515,regions,0,1
150516,",",0,1
150517,IPL,0,1
150518,and,0,1
150519,MOTG,0,0
150520,correlated,0,0
150521,positively,0,0
150522,with,0,1
150523,social,0,0
150524,competence,0,1
150525,",",0,1
150526,whereas,0,0
150527,prefrontal,0,1
150528,Mu-sources,0,0
150529,correlated,0,0
150530,negatively,0,0
150531,with,0,1
150532,social,0,0
150533,competence,0,1
150534,.,0,1
150535,No,0,0
150536,correlation,0,0
150537,with,0,1
150538,intellectual,0,1
150539,ability,0,0
150540,was,0,0
150541,found,0,0
150542,at,0,0
150543,any,0,0
150544,of,0,0
150545,these,0,0
150546,sites,0,1
150547,.,0,1
150548,These,0,1
150549,findings,0,0
150550,localize,0,1
150551,abnormal,0,1
150552,Mu-activity,0,1
150553,in,0,0
150554,the,0,0
150555,brain,0,0
150556,of,0,0
150557,Asperger,1,1
150558,children,1,1
150559,providing,0,0
150560,evidence,0,0
150561,which,0,0
150562,associates,0,0
150563,motor-system,0,0
150564,abnormalities,0,0
150565,with,0,1
150566,social-function,0,1
150567,deficits,0,1
150568,.,0,1
150569,Effect,0,0
150570,of,0,0
150571,phenylephrine,0,0
150572,on,0,0
150573,the,0,0
150574,haemodynamic,0,0
150575,state,0,1
150576,and,0,1
150577,cerebral,0,1
150578,oxygen,0,0
150579,saturation,0,0
150580,during,0,0
150581,anaesthesia,0,1
150582,in,0,0
150583,the,0,0
150584,upright,0,1
150585,position,0,0
150586,.,0,1
150587,BACKGROUND,0,0
150588,The,0,0
150589,upright,0,1
150590,sitting,0,0
150591,or,0,1
150592,beachchair,0,0
150593,position,0,0
150594,is,0,0
150595,associated,0,0
150596,with,0,0
150597,hypotension,0,0
150598,",",0,0
150599,risk,0,0
150600,of,0,0
150601,cerebral,0,1
150602,hypoperfusion,0,0
150603,",",0,0
150604,and,0,0
150605,cerebral,0,1
150606,injury,0,1
150607,.,0,1
150608,We,0,0
150609,hypothesized,0,0
150610,that,0,0
150611,by,0,0
150612,increasing,0,0
150613,arterial,0,1
150614,pressure,0,1
150615,with,0,1
150616,phenylephrine,0,0
150617,administration,0,0
150618,",",0,0
150619,cerebral,0,1
150620,perfusion,0,0
150621,",",0,0
150622,and,0,0
150623,postoperative,0,0
150624,recovery,0,0
150625,would,0,0
150626,be,0,0
150627,improved,0,0
150628,.,0,1
150629,METHODS,0,0
150630,Thirty-four,1,1
150631,patients,1,1
150632,undergoing,1,1
150633,elective,1,1
150634,shoulder,1,1
150635,surgery,1,1
150636,were,1,1
150637,randomized,1,1
150638,to,0,0
150639,receive,0,0
150640,either,0,0
150641,saline,0,0
150642,or,0,1
150643,phenylephrine,0,0
150644,infusion,0,0
150645,(,0,1
150646,PE,0,1
150647,),0,1
150648,5,0,0
150649,min,0,0
150650,before,0,0
150651,being,0,1
150652,placed,0,0
150653,in,0,0
150654,the,0,0
150655,upright,0,1
150656,position,0,1
150657,.,0,1
150658,Simultaneous,0,0
150659,measurements,0,0
150660,of,0,1
150661,mean,0,1
150662,arterial,0,1
150663,pressure,0,0
150664,",",0,0
150665,cerebral,0,1
150666,oxygen,0,0
150667,saturation,0,0
150668,",",0,0
150669,middle,0,1
150670,cerebral,0,1
150671,artery,0,1
150672,velocity,0,0
150673,",",0,0
150674,and,0,0
150675,cardiac,0,1
150676,function,0,0
150677,using,0,0
150678,transthoracic,0,1
150679,echocardiography,0,1
150680,were,0,1
150681,made,0,0
150682,.,0,1
150683,Postoperative,0,0
150684,neurocognitive,0,0
150685,function,0,0
150686,was,0,0
150687,assessed,0,0
150688,.,0,1
150689,RESULTS,0,0
150690,At,0,0
150691,the,0,0
150692,commencement,0,0
150693,of,0,0
150694,PE,0,1
150695,",",0,1
150696,mean,0,1
150697,(,0,1
150698,SD,0,1
150699,),0,1
150700,cerebral,0,1
150701,oxygen,0,0
150702,saturation,0,0
150703,significantly,0,0
150704,decreased,0,0
150705,from,0,1
150706,77,0,1
150707,(,0,1
150708,10,0,1
150709,),0,1
150710,to,0,1
150711,67,0,1
150712,(,0,1
150713,13,0,1
150714,),0,1
150715,%,0,0
150716,(,0,1
150717,P=0.02,0,0
150718,),0,1
150719,",",0,0
150720,and,0,0
150721,further,0,0
150722,to,0,1
150723,59,0,1
150724,(,0,1
150725,11,0,1
150726,),0,1
150727,%,0,0
150728,on,0,0
150729,upright,0,1
150730,positioning,0,0
150731,.,0,1
150732,The,0,0
150733,level,0,0
150734,of,0,0
150735,cerebral,0,1
150736,saturation,0,1
150737,upright,0,1
150738,was,0,0
150739,not,0,0
150740,significantly,0,0
150741,different,0,0
150742,to,0,1
150743,patients,0,1
150744,receiving,0,1
150745,saline,0,0
150746,(,0,1
150747,P=0.07,0,0
150748,),0,1
150749,",",0,0
150750,with,0,1
150751,values,0,0
150752,remaining,0,1
150753,at,0,1
150754,room-air,0,1
150755,levels,0,1
150756,.,0,1
150757,Middle,0,1
150758,cerebral,0,1
150759,artery,0,1
150760,blood,0,0
150761,velocity,0,0
150762,increased,0,0
150763,by,0,0
150764,20,0,1
150765,%,0,0
150766,(,0,1
150767,P=0.04,0,0
150768,),0,1
150769,.,0,1
150770,Phenylephrine,0,0
150771,prevented,0,0
150772,hypotension,0,0
150773,in,0,0
150774,the,0,0
150775,upright,0,1
150776,position,0,0
150777,primarily,0,1
150778,by,0,0
150779,maintaining,0,0
150780,preload,0,0
150781,and,0,1
150782,increasing,0,0
150783,systemic,0,0
150784,vascular,0,1
150785,resistance,0,0
150786,(,0,1
150787,P=0.01,0,0
150788,),0,1
150789,",",0,0
150790,and,0,0
150791,was,0,0
150792,associated,0,0
150793,with,0,1
150794,a,0,0
150795,decrease,0,0
150796,in,0,0
150797,cardiac,0,1
150798,output,0,0
150799,.,0,1
150800,No,0,0
150801,postoperative,0,0
150802,neurocognitive,0,0
150803,dysfunction,0,1
150804,was,0,0
150805,identified,0,1
150806,.,0,1
150807,CONCLUSIONS,0,0
150808,Despite,0,0
150809,maintaining,0,0
150810,arterial,0,1
150811,pressure,0,0
150812,with,0,1
150813,phenylephrine,0,0
150814,",",0,0
150815,cerebral,0,1
150816,desaturation,0,0
150817,occurred,0,0
150818,with,0,1
150819,upright,0,1
150820,positioning,0,0
150821,.,0,1
150822,Cerebral,0,1
150823,oxygen,0,0
150824,saturation,0,0
150825,can,0,0
150826,provide,0,0
150827,a,0,0
150828,valuable,0,0
150829,endpoint,0,0
150830,when,0,0
150831,evaluating,0,0
150832,the,0,0
150833,effect,0,0
150834,of,0,0
150835,vasopressor,0,0
150836,therapy,0,0
150837,on,0,0
150838,cerebral,0,1
150839,perfusion,0,1
150840,.,0,1
150841,Daclizumab,0,1
150842,high-yield,0,0
150843,process,0,0
150844,in,0,1
150845,relapsing-remitting,1,1
150846,multiple,1,1
150847,sclerosis,1,1
150848,(,1,1
150849,SELECT,1,0
150850,),1,1
150851,:,1,1
150852,a,0,0
150853,randomised,0,0
150854,",",0,0
150855,double-blind,0,0
150856,",",0,0
150857,placebo-controlled,0,0
150858,trial,0,1
150859,.,0,1
150860,BACKGROUND,0,0
150861,Daclizumab,0,0
150862,",",0,0
150863,a,0,0
150864,humanised,0,0
150865,monoclonal,0,0
150866,antibody,0,0
150867,",",0,0
150868,modulates,0,0
150869,interleukin-2,0,0
150870,signalling,0,0
150871,by,0,0
150872,blocking,0,0
150873,the,0,0
150874,?,0,1
150875,subunit,0,0
150876,(,0,0
150877,CD25,0,1
150878,),0,1
150879,of,0,0
150880,the,0,0
150881,interleukin-2,0,0
150882,receptor,0,0
150883,.,0,1
150884,We,0,0
150885,assessed,0,0
150886,whether,0,0
150887,daclizumab,0,1
150888,high-yield,0,1
150889,process,0,0
150890,(,0,1
150891,HYP,0,1
150892,),0,1
150893,would,0,0
150894,be,0,0
150895,effective,0,0
150896,when,0,0
150897,given,0,0
150898,as,0,0
150899,monotherapy,0,1
150900,for,0,0
150901,a,0,1
150902,1,0,0
150903,year,0,1
150904,treatment,0,0
150905,period,0,0
150906,in,1,0
150907,patients,1,1
150908,with,1,1
150909,relapsing-remitting,1,1
150910,multiple,1,1
150911,sclerosis,1,1
150912,.,1,1
150913,METHODS,0,0
150914,We,0,0
150915,did,0,0
150916,a,0,0
150917,randomised,0,0
150918,",",0,0
150919,double-blind,0,0
150920,",",0,0
150921,placebo-controlled,0,0
150922,trial,0,1
150923,at,1,1
150924,76,1,1
150925,centres,1,1
150926,in,1,1
150927,the,1,1
150928,Czech,1,1
150929,Republic,1,1
150930,",",1,0
150931,Germany,1,1
150932,",",1,0
150933,Hungary,1,1
150934,",",1,0
150935,India,1,1
150936,",",1,0
150937,Poland,1,1
150938,",",1,0
150939,Russia,1,1
150940,",",1,0
150941,Ukraine,1,1
150942,",",1,0
150943,Turkey,1,0
150944,",",1,0
150945,and,1,0
150946,the,1,0
150947,UK,1,1
150948,between,1,0
150949,Feb,1,1
150950,15,1,1
150951,",",1,1
150952,2008,1,1
150953,",",1,0
150954,and,1,1
150955,May,1,0
150956,14,1,1
150957,",",1,1
150958,2010,1,1
150959,.,1,1
150960,Patients,1,1
150961,aged,1,1
150962,18-55,1,1
150963,years,1,1
150964,with,1,1
150965,relapsing-remitting,1,1
150966,multiple,1,1
150967,sclerosis,1,1
150968,were,0,1
150969,randomly,0,1
150970,assigned,0,1
150971,(,0,1
150972,1:1:1,0,0
150973,),0,1
150974,",",0,0
150975,via,0,0
150976,a,0,1
150977,central,0,0
150978,interactive,0,0
150979,voice,0,0
150980,response,0,0
150981,system,0,0
150982,",",0,0
150983,to,0,0
150984,subcutaneous,0,1
150985,injections,0,0
150986,of,0,1
150987,daclizumab,0,1
150988,HYP,0,1
150989,150,0,1
150990,mg,0,1
150991,or,0,1
150992,300,0,1
150993,mg,0,0
150994,",",0,0
150995,or,0,0
150996,placebo,0,0
150997,",",0,0
150998,every,0,0
150999,4,0,0
151000,weeks,0,0
151001,for,0,1
151002,52,0,1
151003,weeks,0,1
151004,.,0,1
151005,Patients,0,1
151006,and,0,1
151007,study,0,1
151008,personnel,0,1
151009,were,0,1
151010,masked,0,1
151011,to,0,0
151012,treatment,0,0
151013,assignment,0,0
151014,",",0,0
151015,except,0,0
151016,for,0,0
151017,the,0,0
151018,site,0,1
151019,pharmacist,0,1
151020,who,0,1
151021,prepared,0,1
151022,the,0,1
151023,study,0,0
151024,drug,0,0
151025,for,0,0
151026,injection,0,0
151027,",",0,0
151028,but,0,0
151029,had,0,1
151030,no,0,0
151031,interaction,0,0
151032,with,0,1
151033,the,0,0
151034,patient,0,1
151035,.,0,0
151036,The,0,0
151037,primary,0,1
151038,endpoint,0,0
151039,was,0,0
151040,annualised,0,0
151041,relapse,0,0
151042,rate,0,0
151043,.,0,1
151044,Analysis,0,0
151045,was,0,0
151046,by,0,0
151047,intention,0,0
151048,to,0,1
151049,treat,0,1
151050,.,0,0
151051,The,0,0
151052,trial,0,0
151053,is,0,0
151054,registered,0,0
151055,with,0,1
151056,ClinicalTrials.gov,0,0
151057,",",0,1
151058,number,0,0
151059,NCT00390221,0,0
151060,.,0,1
151061,FINDINGS,1,0
151062,204,1,1
151063,patients,1,1
151064,were,1,1
151065,assigned,1,1
151066,to,1,0
151067,receive,1,1
151068,placebo,1,0
151069,",",1,0
151070,208,1,1
151071,to,1,0
151072,daclizumab,1,1
151073,HYP,1,1
151074,150,1,1
151075,mg,1,0
151076,",",1,1
151077,and,1,0
151078,209,1,1
151079,to,1,0
151080,daclizumab,1,1
151081,HYP,0,1
151082,300,0,1
151083,mg,0,0
151084,",",0,1
151085,of,0,1
151086,whom,0,1
151087,188,0,1
151088,(,0,1
151089,92,0,1
151090,%,0,0
151091,),0,1
151092,",",0,1
151093,192,0,1
151094,(,0,1
151095,92,0,1
151096,%,0,0
151097,),0,1
151098,",",0,0
151099,and,0,1
151100,197,0,1
151101,(,0,1
151102,94,0,1
151103,%,0,0
151104,),0,0
151105,",",0,0
151106,respectively,0,0
151107,",",0,0
151108,completed,0,1
151109,follow-up,0,0
151110,to,0,1
151111,week,0,0
151112,52,0,1
151113,.,0,1
151114,The,0,0
151115,annualised,0,0
151116,relapse,0,0
151117,rate,0,0
151118,was,0,0
151119,lower,0,0
151120,for,0,1
151121,patients,0,1
151122,given,0,1
151123,daclizumab,0,1
151124,HYP,0,1
151125,150,0,1
151126,mg,0,1
151127,(,0,1
151128,0?21,0,1
151129,",",0,1
151130,95,0,0
151131,%,0,0
151132,CI,0,0
151133,0?16-0?29,0,1
151134,;,0,1
151135,54,0,1
151136,%,0,0
151137,reduction,0,0
151138,",",0,0
151139,95,0,0
151140,%,0,0
151141,CI,0,0
151142,33-68,0,1
151143,%,0,0
151144,;,0,0
151145,p,0,0
151146,<,0,0
151147,0?0001,0,1
151148,),0,1
151149,or,0,1
151150,300,0,1
151151,mg,0,1
151152,(,0,1
151153,0?23,0,1
151154,",",0,1
151155,0?17-0?31,0,1
151156,",",0,0
151157,50,0,1
151158,%,0,0
151159,reduction,0,0
151160,",",0,0
151161,28-65,0,1
151162,%,0,0
151163,;,0,1
151164,p=0?00015,0,0
151165,),0,0
151166,than,0,0
151167,for,0,0
151168,those,0,1
151169,given,0,0
151170,placebo,0,0
151171,(,0,1
151172,0?46,0,1
151173,",",0,1
151174,0?37-0?57,0,1
151175,),0,0
151176,.,0,1
151177,More,0,1
151178,patients,0,1
151179,were,0,1
151180,relapse,0,1
151181,free,0,1
151182,in,0,0
151183,the,0,0
151184,daclizumab,0,0
151185,HYP,0,1
151186,150,0,1
151187,mg,0,1
151188,(,0,1
151189,81,0,1
151190,%,0,0
151191,),0,1
151192,and,0,1
151193,300,0,1
151194,mg,0,1
151195,(,0,1
151196,80,0,1
151197,%,0,0
151198,),0,1
151199,groups,0,0
151200,than,0,0
151201,in,0,1
151202,the,0,0
151203,placebo,0,0
151204,group,0,1
151205,(,0,1
151206,64,0,1
151207,%,0,0
151208,;,0,1
151209,p,0,0
151210,<,0,0
151211,0?0001,0,0
151212,in,0,0
151213,the,0,0
151214,150,0,1
151215,mg,0,0
151216,group,0,1
151217,and,0,0
151218,p=0?0003,0,0
151219,in,0,0
151220,the,0,1
151221,300,0,1
151222,mg,0,0
151223,group,0,1
151224,),0,1
151225,.,0,1
151226,12,0,0
151227,(,0,1
151228,6,0,1
151229,%,0,0
151230,),0,1
151231,patients,0,1
151232,in,0,1
151233,the,0,0
151234,placebo,0,0
151235,group,0,0
151236,",",0,1
151237,15,0,1
151238,(,0,1
151239,7,0,1
151240,%,0,0
151241,),0,1
151242,of,0,0
151243,those,0,1
151244,in,0,0
151245,the,0,0
151246,daclizumab,0,0
151247,150,0,1
151248,mg,0,0
151249,group,0,1
151250,",",0,0
151251,and,0,0
151252,19,0,1
151253,(,0,1
151254,9,0,0
151255,%,0,0
151256,),0,1
151257,in,0,0
151258,the,0,0
151259,300,0,1
151260,mg,0,0
151261,group,0,1
151262,had,0,1
151263,serious,0,0
151264,adverse,0,0
151265,events,0,0
151266,excluding,0,1
151267,multiple,0,1
151268,sclerosis,0,1
151269,relapse,0,1
151270,.,0,1
151271,One,0,1
151272,patient,0,1
151273,given,0,0
151274,daclizumab,0,1
151275,HYP,0,1
151276,150,0,1
151277,mg,0,1
151278,who,0,1
151279,was,0,1
151280,recovering,0,1
151281,from,0,1
151282,a,0,1
151283,serious,0,0
151284,rash,0,0
151285,died,0,1
151286,because,0,0
151287,of,0,0
151288,local,0,0
151289,complication,0,0
151290,of,0,0
151291,a,0,0
151292,psoas,0,0
151293,abscess,0,0
151294,.,0,1
151295,INTERPRETATION,0,0
151296,Subcutaneous,0,1
151297,daclizumab,0,1
151298,HYP,0,1
151299,administered,0,0
151300,every,0,0
151301,4,0,0
151302,weeks,0,0
151303,led,0,0
151304,to,0,1
151305,clinically,0,1
151306,important,0,0
151307,effects,0,0
151308,on,0,1
151309,multiple,0,1
151310,sclerosis,0,1
151311,disease,0,1
151312,activity,0,0
151313,during,0,0
151314,1,0,0
151315,year,0,1
151316,of,0,0
151317,treatment,0,1
151318,.,0,1
151319,Our,0,0
151320,findings,0,0
151321,support,0,0
151322,the,0,0
151323,potential,0,0
151324,for,0,0
151325,daclizumab,0,1
151326,HYP,0,1
151327,to,0,0
151328,offer,0,0
151329,an,0,0
151330,additional,0,0
151331,treatment,0,0
151332,option,1,0
151333,for,1,0
151334,relapsing-remitting,1,1
151335,disease,1,1
151336,.,1,1
151337,FUNDING,1,0
151338,Biogen,0,0
151339,Idec,0,0
151340,and,0,1
151341,AbbVie,0,0
151342,Biotherapeutics,0,1
151343,Inc,0,0
151344,.,0,1
151345,Effects,0,0
151346,of,0,1
151347,parecoxib,0,0
151348,on,0,0
151349,morphine,0,0
151350,analgesia,0,0
151351,after,0,0
151352,gynecology,0,1
151353,tumor,0,1
151354,operation,0,1
151355,:,0,1
151356,a,0,0
151357,randomized,0,1
151358,trial,0,0
151359,of,0,0
151360,parecoxib,0,0
151361,used,0,0
151362,in,0,0
151363,postsurgical,0,1
151364,pain,0,1
151365,management,0,1
151366,.,0,0
151367,BACKGROUND,0,0
151368,The,0,0
151369,analgesic,0,0
151370,efficacy,0,0
151371,of,0,0
151372,parecoxib,0,0
151373,in,0,1
151374,postsurgical,0,1
151375,pain,0,1
151376,management,0,0
151377,has,0,0
151378,been,0,0
151379,confirmed,0,0
151380,in,0,0
151381,minimally,0,1
151382,invasive,0,1
151383,surgery,0,1
151384,.,0,1
151385,However,0,0
151386,",",0,0
151387,little,0,0
151388,is,0,0
151389,known,0,0
151390,about,0,0
151391,its,0,0
151392,effects,0,0
151393,used,0,0
151394,in,0,1
151395,combination,0,0
151396,with,0,1
151397,opioids,0,0
151398,and,0,1
151399,about,0,0
151400,its,0,0
151401,potential,0,0
151402,for,0,1
151403,opioid-sparing,0,1
151404,effects,0,0
151405,in,0,1
151406,complex,0,1
151407,operations,0,1
151408,.,0,1
151409,This,0,0
151410,study,0,0
151411,was,0,0
151412,performed,0,0
151413,to,0,0
151414,investigate,0,0
151415,the,0,0
151416,influence,0,0
151417,of,0,0
151418,parecoxib,0,0
151419,on,0,0
151420,morphine,0,0
151421,analgesia,0,0
151422,after,0,0
151423,gynecological,0,1
151424,tumor,0,1
151425,surgery,0,1
151426,.,0,1
151427,METHODS,0,0
151428,Eighty,1,1
151429,patients,1,1
151430,undergoing,1,1
151431,gynecological,1,1
151432,tumor,1,1
151433,resection,1,1
151434,were,0,1
151435,randomized,0,1
151436,to,0,0
151437,receive,0,1
151438,either,0,0
151439,intravenous,0,0
151440,parecoxib,0,0
151441,at,0,0
151442,a,0,0
151443,dose,0,0
151444,of,0,0
151445,40,0,1
151446,mg,0,1
151447,(,0,1
151448,Group,0,1
151449,P,0,0
151450,",",0,1
151451,n,0,1
151452,=,0,1
151453,40,0,1
151454,),0,1
151455,followed,0,1
151456,by,0,1
151457,40,0,1
151458,mg,0,1
151459,every,0,1
151460,12,0,1
151461,h,0,0
151462,for,0,1
151463,48,0,1
151464,h,0,0
151465,or,0,1
151466,saline,0,0
151467,as,0,0
151468,a,0,1
151469,control,0,1
151470,(,0,0
151471,Group,0,1
151472,C,0,1
151473,",",0,1
151474,n,0,1
151475,=,0,1
151476,40,0,1
151477,),0,1
151478,30,0,1
151479,min,0,0
151480,before,0,0
151481,induction,0,0
151482,of,0,0
151483,anesthesia,0,1
151484,",",0,0
151485,followed,0,0
151486,by,0,0
151487,saline,0,0
151488,at,0,0
151489,the,0,0
151490,same,0,0
151491,time,0,0
151492,points,0,0
151493,after,0,1
151494,the,0,1
151495,operation,0,1
151496,.,0,1
151497,All,0,1
151498,patients,0,1
151499,had,0,1
151500,access,0,1
151501,to,0,1
151502,patient-controlled,0,0
151503,analgesia,0,0
151504,with,0,1
151505,intravenous,0,1
151506,morphine,0,1
151507,.,0,1
151508,Patients,0,1
151509,were,0,0
151510,assessed,0,0
151511,with,0,1
151512,respect,0,0
151513,to,0,0
151514,pain,0,1
151515,score,0,0
151516,(,0,0
151517,visual,0,0
151518,analog,0,0
151519,scale,0,0
151520,from,0,1
151521,0-10,0,0
151522,),0,1
151523,",",0,0
151524,cumulative,0,0
151525,morphine,0,0
151526,requirement,0,1
151527,",",0,0
151528,satisfaction,0,0
151529,score,0,0
151530,",",0,0
151531,and,0,0
151532,side,0,0
151533,effects,0,0
151534,at,0,1
151535,2,0,1
151536,",",0,1
151537,6,0,0
151538,",",0,0
151539,12,0,1
151540,",",0,0
151541,24,0,0
151542,",",0,0
151543,and,0,0
151544,48,0,1
151545,h,0,0
151546,after,0,1
151547,surgery,0,1
151548,.,0,1
151549,RESULTS,1,0
151550,A,1,0
151551,total,1,1
151552,of,1,0
151553,79,1,1
151554,patients,1,1
151555,were,1,1
151556,evaluated,1,0
151557,.,1,1
151558,The,1,0
151559,cumulative,0,0
151560,dose,0,0
151561,of,0,0
151562,morphine,0,0
151563,administered,0,0
151564,at,0,0
151565,each,0,0
151566,time,0,0
151567,point,0,0
151568,was,0,0
151569,lower,0,0
151570,in,0,0
151571,Group,0,1
151572,P,0,0
151573,than,0,0
151574,in,0,1
151575,Group,0,1
151576,C,0,1
151577,(,0,1
151578,P,0,0
151579,<,0,0
151580,0.05,0,0
151581,),0,1
151582,",",0,1
151583,at,0,0
151584,2,0,1
151585,h,0,0
151586,(,0,1
151587,3.81,0,0
151588,?,0,1
151589,0.35,0,0
151590,versus,0,0
151591,4.13,0,0
151592,?,0,1
151593,0.45,0,0
151594,;,0,0
151595,P,0,0
151596,=,0,1
151597,0.01,0,0
151598,),0,1
151599,",",0,1
151600,6,0,0
151601,h,0,0
151602,(,0,1
151603,16.20,0,0
151604,?,0,1
151605,1.49,0,0
151606,versus,0,0
151607,19.60,0,0
151608,?,0,1
151609,0.35,0,0
151610,;,0,0
151611,P,0,0
151612,<,0,0
151613,0.001,0,0
151614,),0,1
151615,",",0,1
151616,12,0,1
151617,h,0,0
151618,(,0,1
151619,26.29,0,1
151620,?,0,1
151621,2.75,0,0
151622,versus,0,0
151623,32.49,0,1
151624,?,0,1
151625,2.42,0,0
151626,;,0,0
151627,P,0,0
151628,<,0,0
151629,0.001,0,0
151630,),0,1
151631,",",0,1
151632,24,0,1
151633,h,0,0
151634,(,0,1
151635,41.72,0,1
151636,?,0,1
151637,2.70,0,0
151638,versus,0,0
151639,49.97,0,1
151640,?,0,1
151641,4.53,0,0
151642,;,0,0
151643,P,0,0
151644,<,0,0
151645,0.001,0,0
151646,),0,1
151647,",",0,1
151648,and,0,0
151649,48,0,1
151650,h,0,0
151651,(,0,1
151652,60.06,0,1
151653,?,0,1
151654,4.00,0,0
151655,versus,0,0
151656,65.68,0,1
151657,?,0,1
151658,3.23,0,0
151659,;,0,0
151660,P,0,0
151661,<,0,0
151662,0.001,0,0
151663,),0,1
151664,.,0,1
151665,Compared,0,0
151666,with,0,1
151667,Group,0,1
151668,C,0,1
151669,",",0,1
151670,Group,0,1
151671,P,0,0
151672,had,0,1
151673,significantly,0,0
151674,lower,0,0
151675,visual,0,0
151676,analog,0,0
151677,scale,0,1
151678,scores,0,0
151679,at,0,1
151680,rest,0,0
151681,and,0,1
151682,with,0,1
151683,movement,0,0
151684,",",0,0
151685,respectively,0,0
151686,",",0,0
151687,at,0,0
151688,2,0,1
151689,h,0,0
151690,(,0,1
151691,4.2,0,0
151692,",",0,1
151693,P,0,0
151694,<,0,0
151695,0.001,0,0
151696,and,0,1
151697,5.0,0,0
151698,",",0,1
151699,P,0,0
151700,<,0,0
151701,0.001,0,0
151702,),0,1
151703,",",0,1
151704,6,0,0
151705,h,0,0
151706,(,0,1
151707,3.6,0,0
151708,",",0,1
151709,P,0,0
151710,<,0,0
151711,0.001,0,0
151712,and,0,1
151713,4.5,0,0
151714,",",0,1
151715,P,0,0
151716,<,0,0
151717,0.001,0,0
151718,),0,1
151719,",",0,1
151720,12,0,1
151721,h,0,0
151722,(,0,1
151723,3.0,0,0
151724,",",0,1
151725,P,0,0
151726,=,0,1
151727,0.017,0,0
151728,and,0,1
151729,4.0,0,0
151730,",",0,1
151731,P,0,0
151732,<,0,0
151733,0.001,0,0
151734,),0,1
151735,",",0,1
151736,24,0,1
151737,h,0,0
151738,(,0,1
151739,2.1,0,0
151740,",",0,1
151741,P,0,0
151742,<,0,0
151743,0.001,0,0
151744,and,0,1
151745,3.4,0,0
151746,",",0,1
151747,P,0,0
151748,<,0,0
151749,0.001,0,0
151750,),0,1
151751,",",0,1
151752,and,0,0
151753,48,0,1
151754,h,0,0
151755,(,0,1
151756,1.8,0,0
151757,",",0,1
151758,P,0,0
151759,<,0,0
151760,0.001,0,0
151761,and,0,1
151762,2.6,0,0
151763,",",0,1
151764,P,0,0
151765,<,0,0
151766,0.001,0,0
151767,),0,1
151768,.,0,1
151769,The,0,0
151770,satisfaction,0,0
151771,score,0,0
151772,was,0,0
151773,higher,0,0
151774,in,0,0
151775,Group,0,0
151776,P,0,0
151777,than,0,0
151778,in,0,1
151779,Group,0,1
151780,C,0,1
151781,(,0,1
151782,8.6,0,0
151783,?,0,1
151784,0.3,0,0
151785,versus,0,0
151786,6.8,0,0
151787,?,0,1
151788,0.7,0,0
151789,",",0,0
151790,P,0,0
151791,<,0,0
151792,0.001,0,0
151793,),0,0
151794,.,0,0
151795,There,0,0
151796,were,0,0
151797,no,0,0
151798,significant,0,0
151799,differences,0,0
151800,in,0,1
151801,side,0,0
151802,effects,0,0
151803,between,0,0
151804,the,0,1
151805,two,0,1
151806,groups,0,0
151807,(,0,1
151808,P,0,0
151809,>,0,1
151810,0.05,0,0
151811,),0,1
151812,.,0,1
151813,CONCLUSIONS,0,0
151814,The,0,0
151815,use,0,0
151816,of,0,0
151817,parecoxib,0,0
151818,with,0,1
151819,patient-controlled,0,0
151820,analgesic,0,0
151821,morphine,0,0
151822,in,0,1
151823,postoperative,0,0
151824,analgesia,0,0
151825,resulted,0,0
151826,in,0,0
151827,comprehensive,0,0
151828,enhancement,0,0
151829,of,0,0
151830,the,0,0
151831,analgesic,0,0
151832,efficacy,0,0
151833,",",0,0
151834,reducing,0,0
151835,the,0,0
151836,opioid,0,0
151837,requirement,0,1
151838,and,0,1
151839,increasing,0,0
151840,patient,0,1
151841,satisfaction,0,0
151842,after,0,1
151843,gynecological,0,1
151844,tumor,0,1
151845,surgery,0,1
151846,.,0,1
151847,The,0,0
151848,role,0,0
151849,of,0,0
151850,treatment,0,0
151851,fidelity,0,0
151852,on,0,0
151853,outcomes,0,0
151854,during,0,1
151855,a,0,1
151856,randomized,0,1
151857,field,0,0
151858,trial,0,0
151859,of,0,0
151860,an,0,0
151861,autism,1,1
151862,intervention,0,0
151863,.,0,1
151864,This,0,0
151865,randomized,0,0
151866,field,0,0
151867,trial,0,1
151868,comparing,0,0
151869,Strategies,0,0
151870,for,0,1
151871,Teaching,0,1
151872,based,0,1
151873,on,0,0
151874,Autism,0,1
151875,Research,0,1
151876,and,0,1
151877,Structured,0,0
151878,Teaching,0,1
151879,enrolled,0,1
151880,educators,0,1
151881,in,0,1
151882,33,1,1
151883,kindergarten-through-second-grade,1,1
151884,autism,1,1
151885,support,1,0
151886,classrooms,1,1
151887,and,1,1
151888,119,1,1
151889,students,1,1
151890,",",1,1
151891,aged,1,1
151892,5-8,1,1
151893,years,1,1
151894,in,1,1
151895,the,1,1
151896,School,1,1
151897,District,1,1
151898,of,1,1
151899,Philadelphia,1,1
151900,.,1,1
151901,Students,1,0
151902,were,0,0
151903,assessed,0,0
151904,at,0,0
151905,the,0,0
151906,beginning,0,0
151907,and,0,0
151908,end,0,0
151909,of,0,0
151910,the,0,0
151911,academic,0,1
151912,year,0,0
151913,using,0,0
151914,the,0,0
151915,Differential,0,1
151916,Ability,0,0
151917,Scales,0,1
151918,.,0,1
151919,Program,0,0
151920,fidelity,0,0
151921,was,0,0
151922,measured,0,0
151923,through,0,0
151924,video,0,0
151925,coding,0,1
151926,and,0,0
151927,use,0,0
151928,of,0,0
151929,a,0,1
151930,checklist,0,0
151931,.,0,1
151932,Outcomes,0,0
151933,were,0,0
151934,assessed,0,0
151935,using,0,0
151936,linear,0,0
151937,regression,0,0
151938,with,0,1
151939,random,0,1
151940,effects,0,0
151941,for,0,1
151942,classroom,0,1
151943,and,0,1
151944,student,1,0
151945,.,1,1
151946,Average,0,0
151947,fidelity,0,0
151948,was,0,0
151949,57,0,1
151950,%,0,0
151951,in,0,0
151952,Strategies,0,0
151953,for,0,1
151954,Teaching,0,0
151955,based,0,1
151956,on,0,0
151957,Autism,0,1
151958,Research,0,1
151959,classrooms,0,1
151960,and,0,1
151961,48,0,1
151962,%,0,0
151963,in,0,1
151964,Structured,0,1
151965,Teaching,0,1
151966,classrooms,0,1
151967,.,0,1
151968,There,0,0
151969,was,0,0
151970,a,0,0
151971,9.2-point,0,0
151972,(,0,1
151973,standard,0,1
151974,deviation,0,1
151975,=,0,1
151976,9.6,0,0
151977,),0,1
151978,increase,0,0
151979,in,0,1
151980,Differential,0,1
151981,Ability,0,0
151982,Scales,0,0
151983,score,0,0
151984,over,0,0
151985,the,0,0
151986,8-month,0,1
151987,study,0,0
151988,period,0,0
151989,",",0,0
151990,but,0,0
151991,no,0,0
151992,main,0,0
151993,effect,0,0
151994,of,0,0
151995,program,0,1
151996,.,0,0
151997,There,0,0
151998,was,0,0
151999,a,0,0
152000,significant,0,0
152001,interaction,0,0
152002,between,0,0
152003,fidelity,0,0
152004,and,0,1
152005,group,0,1
152006,.,0,1
152007,In,0,0
152008,classrooms,0,1
152009,with,0,1
152010,either,0,1
152011,low,0,1
152012,or,0,1
152013,high,0,1
152014,program,0,1
152015,fidelity,0,0
152016,",",0,0
152017,students,1,1
152018,in,1,1
152019,Strategies,1,0
152020,for,1,1
152021,Teaching,1,0
152022,based,1,1
152023,on,1,0
152024,Autism,1,1
152025,Research,1,1
152026,experienced,0,1
152027,a,0,0
152028,greater,0,0
152029,gain,0,0
152030,in,0,0
152031,Differential,0,1
152032,Ability,0,0
152033,Scales,0,0
152034,score,0,1
152035,than,0,0
152036,students,1,1
152037,in,1,1
152038,Structured,1,1
152039,Teaching,1,1
152040,(,0,1
152041,11.2,0,0
152042,vs.,0,0
152043,5.5,0,1
152044,points,0,0
152045,and,0,1
152046,11.3,0,0
152047,vs.,0,0
152048,8.9,0,0
152049,points,0,0
152050,",",0,1
152051,respectively,0,0
152052,),0,0
152053,.,0,1
152054,In,0,0
152055,classrooms,0,1
152056,with,0,1
152057,moderate,0,1
152058,fidelity,0,0
152059,",",0,1
152060,students,1,1
152061,in,1,1
152062,Structured,1,1
152063,Teaching,1,0
152064,experienced,0,1
152065,a,0,0
152066,greater,0,0
152067,gain,0,0
152068,than,0,0
152069,students,1,1
152070,in,1,1
152071,Strategies,1,0
152072,for,1,1
152073,Teaching,1,0
152074,based,1,1
152075,on,1,0
152076,Autism,1,1
152077,Research,1,1
152078,(,0,1
152079,10.1,0,0
152080,vs.,0,0
152081,4.4,0,1
152082,points,0,0
152083,),0,1
152084,.,0,1
152085,The,0,0
152086,results,0,0
152087,suggest,0,0
152088,significant,0,0
152089,variability,0,0
152090,in,0,0
152091,implementation,0,0
152092,of,0,1
152093,evidence-based,0,0
152094,practices,0,1
152095,",",0,0
152096,even,0,0
152097,with,0,1
152098,supports,0,0
152099,",",0,1
152100,and,0,0
152101,also,0,0
152102,suggest,0,0
152103,the,0,0
152104,need,0,0
152105,to,0,0
152106,address,0,0
152107,challenging,0,0
152108,issues,0,0
152109,related,0,0
152110,to,0,1
152111,implementation,0,0
152112,measurement,0,0
152113,in,0,0
152114,community,0,1
152115,settings,0,1
152116,.,0,1
152117,Evaluation,0,0
152118,of,0,0
152119,the,0,0
152120,effect,0,0
152121,of,0,0
152122,low,0,1
152123,level,0,0
152124,laser,0,0
152125,on,0,0
152126,prevention,0,1
152127,of,0,0
152128,chemotherapy-induced,1,1
152129,mucositis,1,0
152130,.,1,1
152131,Radiotherapy,0,0
152132,in,0,0
152133,the,0,0
152134,head,0,1
152135,and,0,0
152136,neck,0,1
152137,region,0,1
152138,and,0,0
152139,chemotherapy,0,1
152140,might,0,0
152141,give,0,0
152142,rise,0,0
152143,to,0,0
152144,oral,0,0
152145,mucositis,0,0
152146,which,0,0
152147,is,0,0
152148,a,0,0
152149,severe,0,1
152150,and,0,0
152151,painful,0,1
152152,inflammation,0,0
152153,.,0,0
152154,There,0,0
152155,is,0,0
152156,no,0,0
152157,known,0,0
152158,definite,0,1
152159,cure,0,0
152160,for,0,1
152161,mucositis,0,0
152162,.,0,1
152163,A,0,0
152164,number,0,0
152165,of,0,0
152166,studies,0,0
152167,have,0,1
152168,attempted,0,0
152169,to,0,0
152170,evaluate,0,0
152171,the,0,0
152172,effect,0,0
152173,of,0,0
152174,low-power,0,0
152175,laser,0,0
152176,on,0,0
152177,radiotherapy-,0,1
152178,and,0,1
152179,chemotherapy-induced,0,1
152180,mucositis,0,0
152181,.,0,1
152182,The,0,0
152183,present,0,0
152184,study,0,1
152185,was,0,0
152186,undertaken,0,0
152187,to,0,0
152188,evaluate,0,0
152189,the,0,0
152190,effect,0,0
152191,of,0,0
152192,low-power,0,0
152193,laser,0,0
152194,on,0,0
152195,the,0,0
152196,prevention,0,1
152197,of,0,0
152198,mucositis,0,0
152199,",",0,0
152200,xerostomia,0,0
152201,and,0,0
152202,pain,0,1
152203,as,0,0
152204,a,0,0
152205,result,0,0
152206,of,0,0
152207,chemotherapy,0,1
152208,.,0,1
152209,The,0,0
152210,subjects,0,1
152211,in,0,0
152212,this,0,0
152213,double-blind,0,0
152214,randomized,0,1
152215,controlled,0,0
152216,study,0,1
152217,were,0,1
152218,24,1,1
152219,adult,1,1
152220,patients,1,1
152221,who,1,1
152222,underwent,1,1
152223,chemotherapy,1,1
152224,during,1,1
152225,2009-2010,1,1
152226,.,1,1
152227,The,0,0
152228,results,0,0
152229,showed,0,0
152230,that,0,0
152231,low-power,0,0
152232,laser,0,0
152233,was,0,0
152234,able,0,0
152235,to,0,0
152236,decrease,0,0
152237,the,0,0
152238,effect,0,0
152239,of,0,0
152240,chemotherapy,0,1
152241,on,0,0
152242,oral,0,0
152243,mucositis,0,0
152244,",",0,0
152245,xerostomia,0,0
152246,and,0,0
152247,pain,0,1
152248,in,0,0
152249,a,0,0
152250,variety,0,0
152251,of,0,0
152252,malignancies,0,1
152253,(,0,1
152254,P,0,0
152255,&,0,1
152256,lt,0,1
152257,;,0,1
152258,0.05,0,0
152259,),0,1
152260,.,0,0
152261,It,0,0
152262,can,0,0
152263,be,0,0
152264,concluded,0,0
152265,that,0,0
152266,low-power,0,0
152267,laser,0,0
152268,might,0,0
152269,decrease,0,0
152270,the,0,0
152271,intensity,0,0
152272,of,0,0
152273,mucositis,0,0
152274,.,0,1
152275,The,0,0
152276,effects,0,0
152277,of,0,0
152278,a,0,1
152279,multi-component,0,0
152280,higher-functioning,1,1
152281,autism,1,1
152282,anti-stigma,0,0
152283,program,0,1
152284,on,0,0
152285,adolescent,1,1
152286,boys,1,1
152287,.,1,1
152288,A,0,1
152289,six-session,0,0
152290,higher-functioning,1,1
152291,autism,1,1
152292,anti-stigma,0,0
152293,program,0,1
152294,incorporating,0,0
152295,descriptive,0,0
152296,",",0,0
152297,explanatory,0,0
152298,and,0,0
152299,directive,0,1
152300,information,0,0
152301,was,0,0
152302,delivered,0,0
152303,to,0,0
152304,adolescent,1,1
152305,boys,1,1
152306,and,0,0
152307,the,0,0
152308,impact,0,0
152309,upon,0,0
152310,knowledge,0,0
152311,",",0,1
152312,attitudes,0,0
152313,and,0,1
152314,behavioural,0,1
152315,intentions,0,1
152316,towards,0,0
152317,peers,0,1
152318,with,0,1
152319,autism,0,1
152320,was,0,0
152321,evaluated,0,0
152322,.,0,1
152323,Participants,1,1
152324,were,1,1
152325,seventh-,1,1
152326,",",1,1
152327,eighth-,1,1
152328,and,1,1
152329,ninth-grade,1,1
152330,students,1,1
152331,(,1,1
152332,N,1,1
152333,=,1,1
152334,395,1,1
152335,),1,1
152336,from,1,1
152337,regular,1,1
152338,classes,1,1
152339,in,1,1
152340,a,1,1
152341,mainstream,1,1
152342,school,1,1
152343,.,1,1
152344,Two-eighth-grade,1,1
152345,classes,1,1
152346,were,1,1
152347,randomly,0,1
152348,allocated,0,1
152349,to,0,0
152350,the,0,0
152351,intervention,0,0
152352,condition,0,0
152353,and,0,0
152354,all,0,0
152355,remaining,0,1
152356,students,0,1
152357,were,0,1
152358,either,0,1
152359,allocated,0,1
152360,to,0,0
152361,the,0,0
152362,no-intervention,0,0
152363,peer,0,1
152364,or,0,1
152365,no-intervention,0,0
152366,non-peer,0,1
152367,condition,0,1
152368,.,0,1
152369,The,0,0
152370,anti-stigma,0,0
152371,program,0,1
152372,improved,0,0
152373,the,0,0
152374,knowledge,0,0
152375,and,0,0
152376,attitudes,0,0
152377,",",0,0
152378,but,0,0
152379,not,0,0
152380,the,0,0
152381,behavioural,0,0
152382,intentions,0,0
152383,of,0,1
152384,participants,0,1
152385,towards,0,0
152386,their,0,1
152387,peers,0,1
152388,with,0,1
152389,autism,0,1
152390,.,0,1
152391,Knowledge,0,0
152392,and,0,0
152393,attitudinal,0,1
152394,changes,0,0
152395,were,0,1
152396,maintained,0,0
152397,at,0,0
152398,follow-up,0,0
152399,.,0,0
152400,There,0,0
152401,were,0,0
152402,no,0,0
152403,spill-over,0,0
152404,effects,0,0
152405,of,0,1
152406,the,0,0
152407,program,0,1
152408,to,0,1
152409,non-targeted,0,1
152410,students,0,1
152411,.,0,1
152412,These,0,1
152413,results,0,0
152414,provide,0,0
152415,some,0,0
152416,preliminary,0,0
152417,evidence,0,0
152418,for,0,0
152419,the,0,0
152420,effectiveness,0,0
152421,of,0,0
152422,multi-session,0,0
152423,anti-stigma,0,1
152424,programs,0,1
152425,incorporating,0,0
152426,combined,0,0
152427,information,0,0
152428,for,1,0
152429,adolescent,1,1
152430,students,1,1
152431,in,1,1
152432,inclusive,1,1
152433,educational,1,1
152434,environments,1,1
152435,.,1,1
152436,Are,0,1
152437,postural,0,0
152438,responses,0,0
152439,to,0,1
152440,backward,0,1
152441,and,0,0
152442,forward,0,0
152443,perturbations,0,0
152444,processed,0,0
152445,by,0,1
152446,different,0,1
152447,neural,0,1
152448,circuits,0,0
152449,?,0,1
152450,Startle,0,0
152451,pathways,0,0
152452,may,0,0
152453,contribute,0,0
152454,to,0,0
152455,rapid,0,0
152456,accomplishment,0,0
152457,of,0,0
152458,postural,0,0
152459,stability,0,0
152460,.,0,1
152461,Here,0,0
152462,we,0,0
152463,investigate,0,0
152464,the,0,0
152465,possible,0,0
152466,influence,0,0
152467,of,0,0
152468,a,0,1
152469,startling,0,0
152470,auditory,0,1
152471,stimulus,0,0
152472,(,0,1
152473,SAS,0,0
152474,),0,1
152475,on,0,0
152476,postural,0,0
152477,responses,0,1
152478,.,0,1
152479,We,0,0
152480,formulated,0,0
152481,four,0,1
152482,specific,0,1
152483,questions,0,1
152484,:,0,1
152485,(,0,1
152486,1,0,0
152487,),0,1
152488,can,0,0
152489,a,0,1
152490,concurrent,0,0
152491,SAS,0,0
152492,shorten,0,0
152493,the,0,0
152494,onset,0,1
152495,of,0,0
152496,automatic,0,1
152497,postural,0,0
152498,responses,0,1
152499,?,0,1
152500,;,0,0
152501,and,0,0
152502,if,0,0
152503,so,0,0
152504,(,0,1
152505,2,0,0
152506,),0,0
152507,is,0,0
152508,this,0,0
152509,effect,0,0
152510,different,0,0
152511,for,0,0
152512,forward,0,0
152513,versus,0,0
152514,backward,0,1
152515,perturbations,0,1
152516,?,0,1
152517,;,0,0
152518,(,0,0
152519,3,0,0
152520,),0,0
152521,does,0,0
152522,this,0,0
152523,effect,0,0
152524,depend,0,0
152525,on,0,0
152526,prior,0,1
152527,knowledge,0,0
152528,of,0,0
152529,the,0,0
152530,perturbation,0,0
152531,direction,0,0
152532,?,0,1
152533,;,0,0
152534,and,0,0
152535,(,0,1
152536,4,0,0
152537,),0,0
152538,is,0,0
152539,this,0,0
152540,effect,0,0
152541,different,0,0
152542,for,0,1
152543,low-,0,1
152544,and,0,1
152545,high-magnitude,0,1
152546,perturbations,0,1
152547,?,0,1
152548,Balance,0,0
152549,was,0,0
152550,perturbed,0,0
152551,in,0,1
152552,11,1,1
152553,healthy,1,1
152554,participants,1,1
152555,by,1,0
152556,a,1,1
152557,movable,1,1
152558,platform,1,0
152559,that,1,0
152560,suddenly,1,1
152561,translated,1,0
152562,forward,1,0
152563,or,1,1
152564,backward,1,0
152565,.,1,0
152566,Each,0,0
152567,participant,0,0
152568,received,0,1
152569,160,0,1
152570,perturbations,0,1
152571,",",0,1
152572,25,0,1
152573,%,0,0
152574,of,0,0
152575,which,0,0
152576,were,0,1
152577,combined,0,0
152578,with,0,1
152579,a,0,1
152580,SAS,0,0
152581,.,0,1
152582,We,0,0
152583,varied,0,0
152584,the,0,0
152585,direction,0,0
152586,and,0,0
152587,magnitude,0,0
152588,of,0,0
152589,the,0,0
152590,perturbations,0,0
152591,",",0,0
152592,as,0,0
152593,well,0,0
152594,as,0,0
152595,the,0,0
152596,prior,0,1
152597,knowledge,0,0
152598,of,0,0
152599,perturbation,0,1
152600,direction,0,0
152601,.,0,1
152602,Perturbation,0,0
152603,trials,0,0
152604,were,0,1
152605,interspersed,0,1
152606,with,0,1
152607,SAS-only,0,1
152608,trials,0,1
152609,.,0,1
152610,The,0,0
152611,SAS,0,0
152612,accelerated,0,0
152613,and,0,0
152614,strengthened,0,0
152615,postural,0,0
152616,responses,0,0
152617,with,0,1
152618,clear,0,1
152619,functional,0,1
152620,benefits,0,0
152621,(,0,1
152622,better,0,0
152623,balance,0,0
152624,control,0,1
152625,),0,0
152626,",",0,0
152627,but,0,0
152628,this,0,0
152629,was,0,0
152630,only,0,0
152631,true,0,0
152632,for,0,1
152633,responses,0,0
152634,that,0,0
152635,protected,0,0
152636,against,0,0
152637,falling,0,1
152638,backwards,0,1
152639,(,0,1
152640,i.e,0,1
152641,.,0,1
152642,in,0,0
152643,tibialis,0,0
152644,anterior,0,1
152645,and,0,1
152646,rectus,0,1
152647,femoris,0,1
152648,),0,1
152649,.,0,1
152650,These,0,0
152651,muscles,0,0
152652,also,0,0
152653,demonstrated,0,0
152654,the,0,0
152655,most,0,0
152656,common,0,1
152657,SAS-triggered,0,0
152658,responses,0,0
152659,without,0,1
152660,perturbation,0,1
152661,.,0,1
152662,Increasing,0,0
152663,the,0,0
152664,perturbation,0,0
152665,magnitude,0,0
152666,accelerated,0,0
152667,postural,0,0
152668,responses,0,0
152669,",",0,1
152670,but,0,0
152671,again,0,0
152672,with,0,1
152673,a,0,0
152674,larger,0,0
152675,acceleration,0,0
152676,for,0,0
152677,backward,0,1
152678,perturbations,0,1
152679,.,0,1
152680,We,0,0
152681,conclude,0,0
152682,that,0,0
152683,postural,0,0
152684,responses,0,0
152685,to,0,1
152686,backward,0,1
152687,and,0,0
152688,forward,0,0
152689,perturbations,0,0
152690,may,0,0
152691,be,0,0
152692,processed,0,0
152693,by,0,0
152694,different,0,1
152695,neural,0,0
152696,circuits,0,0
152697,",",0,1
152698,with,0,1
152699,influence,0,0
152700,of,0,1
152701,startle,0,1
152702,pathways,0,0
152703,on,0,1
152704,postural,0,0
152705,responses,0,0
152706,to,0,1
152707,backward,0,1
152708,perturbations,0,0
152709,.,0,1
152710,These,0,1
152711,findings,0,0
152712,give,0,0
152713,directions,0,0
152714,for,0,1
152715,future,0,1
152716,studies,0,0
152717,investigating,0,0
152718,whether,0,0
152719,deficits,0,1
152720,in,0,1
152721,startle,0,1
152722,pathways,0,0
152723,may,0,0
152724,explain,0,0
152725,the,0,0
152726,prominent,0,0
152727,backward,0,0
152728,instability,0,0
152729,seen,0,0
152730,in,0,0
152731,patients,1,1
152732,with,1,1
152733,Parkinson,1,1
152734,'s,1,1
152735,disease,1,1
152736,and,1,1
152737,progressive,1,1
152738,supranuclear,1,1
152739,palsy,1,1
152740,.,1,1
152741,Palliative,0,1
152742,brachytherapy,0,1
152743,with,0,1
152744,or,0,1
152745,without,0,1
152746,primary,0,1
152747,stent,0,1
152748,placement,0,1
152749,in,0,1
152750,patients,1,1
152751,with,1,1
152752,oesophageal,1,1
152753,cancer,1,1
152754,",",0,0
152755,a,0,0
152756,randomised,0,0
152757,phase,0,1
152758,III,0,1
152759,trial,0,1
152760,.,0,1
152761,PURPOSE,0,0
152762,To,0,0
152763,investigate,0,0
152764,whether,0,0
152765,a,0,0
152766,combination,0,0
152767,of,0,0
152768,self-expanding,0,1
152769,metal,0,1
152770,stent,0,1
152771,(,0,1
152772,SEMS,0,1
152773,),0,1
152774,and,0,0
152775,brachytherapy,0,0
152776,provided,0,0
152777,more,0,0
152778,rapid,0,0
152779,and,0,0
152780,prolonged,0,0
152781,effect,0,0
152782,on,0,0
152783,dysphagia,0,1
152784,without,0,1
152785,increased,0,0
152786,pain,0,1
152787,compared,0,0
152788,to,0,0
152789,brachytherapy,0,1
152790,alone,0,0
152791,in,0,0
152792,patients,1,1
152793,with,1,1
152794,incurable,1,1
152795,oesophageal,1,1
152796,cancer,1,1
152797,.,1,1
152798,METHODS,0,0
152799,41,1,1
152800,Patients,1,1
152801,were,0,1
152802,randomised,0,1
152803,to,0,1
152804,SEMS,0,1
152805,followed,0,1
152806,by,0,0
152807,brachytherapy,0,1
152808,",",0,1
152809,8,0,1
152810,Gy?3,0,1
152811,(,0,1
152812,n=21,0,1
152813,),0,0
152814,or,0,0
152815,brachytherapy,0,1
152816,alone,0,0
152817,",",0,0
152818,8,0,0
152819,Gy?3,0,1
152820,(,0,1
152821,n=20,0,1
152822,),0,1
152823,.,0,1
152824,Change,0,0
152825,in,0,0
152826,dysphagia,0,1
152827,and,0,1
152828,pain,0,1
152829,three,0,0
152830,and,0,1
152831,seven,0,1
152832,weeks,0,0
152833,after,0,1
152834,randomisation,0,0
152835,(,0,1
152836,FU1,0,0
152837,and,0,1
152838,FU2,0,1
152839,),0,1
152840,was,0,0
152841,assessed,0,0
152842,by,0,0
152843,patient-reported,0,0
152844,outcome,0,0
152845,.,0,1
152846,Dysphagia,0,1
152847,",",0,0
152848,other,0,0
152849,symptoms,0,1
152850,and,0,1
152851,health-related,0,0
152852,quality,0,0
152853,of,0,0
152854,life,0,1
152855,were,0,1
152856,assessed,0,0
152857,every,0,0
152858,four,0,0
152859,weeks,0,0
152860,thereafter,0,0
152861,.,0,1
152862,The,0,0
152863,study,0,0
152864,was,0,0
152865,closed,0,0
152866,before,0,0
152867,the,0,0
152868,estimated,0,0
152869,patient-number,0,0
152870,was,0,0
152871,reached,0,0
152872,due,0,0
152873,to,0,0
152874,slow,0,1
152875,recruitment,0,0
152876,.,0,1
152877,RESULTS,0,0
152878,Patients,0,1
152879,receiving,0,1
152880,SEMS,0,1
152881,followed,0,1
152882,by,0,0
152883,brachytherapy,0,1
152884,had,0,1
152885,significantly,0,0
152886,improved,0,0
152887,dysphagia,0,1
152888,at,0,1
152889,FU1,0,0
152890,compared,0,0
152891,to,0,1
152892,patients,0,1
152893,receiving,0,1
152894,brachytherapy,0,1
152895,alone,0,0
152896,(,0,0
152897,n=35,0,1
152898,),0,1
152899,.,0,1
152900,Difference,0,0
152901,in,0,0
152902,pain,0,1
152903,was,0,0
152904,not,0,0
152905,observed,0,0
152906,.,0,1
152907,At,0,0
152908,FU2,0,0
152909,",",0,1
152910,patients,0,1
152911,in,0,1
152912,both,0,0
152913,arms,0,0
152914,(,0,1
152915,n=21,0,1
152916,),0,0
152917,had,0,1
152918,less,0,0
152919,dysphagia,0,1
152920,.,0,1
152921,Four,0,0
152922,patients,0,1
152923,in,0,1
152924,the,0,1
152925,combined,0,0
152926,treatment,0,0
152927,arm,0,1
152928,experienced,0,1
152929,manageable,0,0
152930,complications,0,0
152931,",",0,1
152932,no,0,0
152933,complications,0,0
152934,occurred,0,0
152935,after,0,0
152936,brachytherapy,0,1
152937,alone,0,1
152938,.,0,1
152939,CONCLUSION,0,0
152940,For,0,1
152941,the,0,0
152942,relief,0,0
152943,of,0,0
152944,dysphagia,0,1
152945,",",0,1
152946,SEMS,0,0
152947,followed,0,0
152948,by,0,0
152949,brachytherapy,0,1
152950,is,0,0
152951,preferable,0,0
152952,and,0,0
152953,safe,0,0
152954,for,0,1
152955,patients,0,1
152956,in,0,1
152957,need,0,1
152958,of,0,0
152959,immediate,0,0
152960,alleviation,0,0
152961,",",0,0
152962,while,0,0
152963,brachytherapy,0,1
152964,with,0,1
152965,or,0,1
152966,without,0,1
152967,preceding,0,0
152968,SEMS,0,1
152969,provides,0,0
152970,relief,0,0
152971,within,0,0
152972,a,0,1
152973,few,0,0
152974,weeks,0,0
152975,after,0,1
152976,treatment,0,1
152977,.,0,1
152978,Environmental,0,0
152979,enrichment,0,0
152980,as,0,0
152981,an,0,0
152982,effective,0,0
152983,treatment,0,0
152984,for,0,1
152985,autism,0,1
152986,:,0,1
152987,a,0,0
152988,randomized,0,1
152989,controlled,0,0
152990,trial,0,1
152991,.,0,1
152992,Enriched,0,0
152993,sensorimotor,0,0
152994,environments,0,0
152995,enable,0,0
152996,rodents,0,1
152997,to,0,1
152998,compensate,0,0
152999,for,0,0
153000,a,0,0
153001,wide,0,0
153002,range,0,1
153003,of,0,1
153004,neurological,0,1
153005,challenges,0,0
153006,",",0,1
153007,including,0,0
153008,those,0,0
153009,induced,0,0
153010,in,0,0
153011,animal,0,1
153012,models,0,1
153013,of,0,1
153014,autism,0,1
153015,.,0,1
153016,Given,0,0
153017,the,0,0
153018,sensorimotor,0,0
153019,deficits,0,0
153020,in,0,1
153021,most,0,1
153022,children,1,1
153023,with,1,1
153024,autism,1,1
153025,",",0,0
153026,we,0,0
153027,attempted,0,0
153028,to,0,0
153029,translate,0,0
153030,that,0,0
153031,approach,0,0
153032,to,0,0
153033,their,0,1
153034,treatment,0,0
153035,.,0,1
153036,In,0,0
153037,a,0,0
153038,randomized,0,1
153039,controlled,0,0
153040,trial,0,0
153041,",",0,0
153042,3-12,1,1
153043,year-old,1,1
153044,children,1,1
153045,with,1,1
153046,autism,1,1
153047,were,0,1
153048,assigned,0,1
153049,to,0,0
153050,either,0,0
153051,a,0,0
153052,sensorimotor,0,0
153053,enrichment,0,0
153054,group,0,0
153055,",",0,0
153056,which,0,0
153057,received,0,0
153058,daily,0,0
153059,olfactory/tactile,0,1
153060,stimulation,0,0
153061,along,0,0
153062,with,0,1
153063,exercises,0,1
153064,that,0,0
153065,stimulated,0,1
153066,other,0,0
153067,paired,0,1
153068,sensory,0,1
153069,modalities,0,0
153070,",",0,1
153071,or,0,1
153072,to,0,0
153073,a,0,0
153074,control,0,1
153075,group,0,1
153076,.,0,1
153077,We,0,0
153078,administered,0,0
153079,tests,0,0
153080,of,0,1
153081,cognitive,0,1
153082,performance,0,0
153083,and,0,0
153084,autism,0,1
153085,severity,0,0
153086,to,0,1
153087,both,0,0
153088,groups,0,0
153089,at,0,0
153090,the,0,0
153091,initiation,0,0
153092,of,0,0
153093,the,0,0
153094,study,0,0
153095,and,0,0
153096,after,0,1
153097,6,0,1
153098,months,0,1
153099,.,0,1
153100,Severity,0,0
153101,of,0,0
153102,autism,0,1
153103,",",0,0
153104,as,0,0
153105,assessed,0,0
153106,with,0,1
153107,the,0,0
153108,Childhood,0,1
153109,Autism,0,1
153110,Rating,0,0
153111,Scale,0,1
153112,",",0,0
153113,improved,0,0
153114,significantly,0,0
153115,in,0,0
153116,the,0,0
153117,enriched,0,0
153118,group,0,1
153119,compared,0,0
153120,to,0,1
153121,controls,0,1
153122,.,0,1
153123,Indeed,0,0
153124,",",0,0
153125,42,0,0
153126,%,0,0
153127,of,0,0
153128,the,0,0
153129,enriched,0,0
153130,group,0,0
153131,and,0,0
153132,only,0,0
153133,7,0,1
153134,%,0,0
153135,of,0,0
153136,the,0,0
153137,control,0,1
153138,group,0,1
153139,had,0,1
153140,what,0,0
153141,we,0,1
153142,considered,0,1
153143,to,0,0
153144,be,0,0
153145,a,0,0
153146,clinically,0,0
153147,significant,0,0
153148,improvement,0,0
153149,of,0,1
153150,5,0,1
153151,points,0,0
153152,on,0,0
153153,that,0,0
153154,scale,0,0
153155,.,0,1
153156,Sensorimotor,0,0
153157,enrichment,0,0
153158,also,0,0
153159,produced,0,0
153160,a,0,0
153161,clear,0,0
153162,improvement,0,0
153163,in,0,0
153164,cognition,0,0
153165,",",0,0
153166,as,0,0
153167,determined,0,0
153168,by,0,0
153169,their,0,1
153170,Leiter-R,0,1
153171,Visualization,0,0
153172,and,0,1
153173,Reasoning,0,1
153174,scores,0,0
153175,.,0,1
153176,At,0,0
153177,6,0,0
153178,months,0,0
153179,",",0,1
153180,the,0,0
153181,change,0,0
153182,in,0,0
153183,average,0,1
153184,scores,0,0
153185,for,0,1
153186,the,0,1
153187,enriched,0,0
153188,group,0,1
153189,was,0,0
153190,11.3,0,0
153191,points,0,0
153192,higher,0,0
153193,than,0,0
153194,that,0,0
153195,for,0,0
153196,the,0,0
153197,control,0,1
153198,group,0,0
153199,.,0,1
153200,Finally,0,0
153201,",",0,0
153202,69,0,1
153203,%,0,0
153204,of,0,1
153205,parents,0,1
153206,in,0,1
153207,the,0,1
153208,enriched,0,0
153209,group,0,1
153210,and,0,1
153211,31,0,1
153212,%,0,0
153213,of,0,1
153214,parents,0,1
153215,in,0,1
153216,the,0,0
153217,control,0,1
153218,group,0,0
153219,reported,0,0
153220,improvement,0,0
153221,in,0,0
153222,their,0,1
153223,child,0,1
153224,over,0,0
153225,the,0,0
153226,6-month,0,0
153227,study,0,1
153228,.,0,1
153229,Environmental,0,0
153230,enrichment,0,0
153231,therefore,0,0
153232,appears,0,0
153233,to,0,0
153234,be,0,0
153235,effective,0,0
153236,in,0,0
153237,ameliorating,0,0
153238,some,0,0
153239,of,0,0
153240,the,0,0
153241,symptoms,0,0
153242,of,0,0
153243,autism,0,1
153244,in,0,1
153245,children,0,1
153246,.,0,1
153247,Concomitant,0,0
153248,",",0,0
153249,sequential,0,0
153250,",",0,0
153251,and,0,0
153252,hybrid,0,0
153253,therapy,0,0
153254,for,0,1
153255,H.,0,1
153256,pylori,0,1
153257,eradication,0,1
153258,:,0,1
153259,a,0,0
153260,pilot,0,0
153261,study,0,1
153262,.,0,1
153263,BACKGROUND,0,0
153264,AND,0,0
153265,OBJECTIVE,0,0
153266,Since,0,1
153267,the,0,0
153268,efficacy,0,0
153269,of,0,0
153270,the,0,0
153271,standard,0,1
153272,triple,0,0
153273,therapies,0,0
153274,for,0,1
153275,Helicobacter,0,1
153276,pylori,0,1
153277,eradication,0,0
153278,has,0,0
153279,decreased,0,0
153280,",",0,0
153281,novel,0,1
153282,antibiotic,0,0
153283,regimens,0,0
153284,have,0,1
153285,been,0,0
153286,introduced,0,0
153287,",",0,0
153288,including,0,0
153289,concomitant,0,0
153290,",",0,0
153291,sequential,0,0
153292,",",0,0
153293,and,0,1
153294,hybrid,0,1
153295,therapies,0,0
153296,.,0,1
153297,We,0,0
153298,aimed,0,0
153299,to,0,0
153300,compare,0,0
153301,the,0,0
153302,cure,0,0
153303,rates,0,0
153304,achieved,0,0
153305,by,0,0
153306,these,0,0
153307,new,0,1
153308,therapy,0,1
153309,regimens,0,0
153310,.,0,1
153311,METHODS,0,0
153312,This,0,0
153313,was,0,0
153314,a,0,0
153315,multicenter,1,0
153316,",",1,0
153317,open-label,1,0
153318,",",1,0
153319,pilot,1,0
153320,study,1,0
153321,enrolling,1,1
153322,consecutive,1,1
153323,non-ulcer,1,1
153324,dyspepsia,1,1
153325,patients,1,1
153326,with,1,1
153327,H.,1,1
153328,pylori,1,1
153329,infection,1,1
153330,never,1,1
153331,previously,1,1
153332,treated,1,1
153333,for,1,0
153334,the,1,0
153335,infection,1,1
153336,.,1,1
153337,Patients,0,1
153338,were,0,1
153339,randomized,0,1
153340,to,0,0
153341,receive,0,1
153342,one,0,1
153343,of,0,0
153344,the,0,1
153345,following,0,0
153346,treatments,0,0
153347,:,0,1
153348,(,0,1
153349,a,0,1
153350,),0,0
153351,concomitant,0,0
153352,therapy,0,1
153353,:,0,1
153354,omeprazole,0,0
153355,20mg,0,0
153356,",",0,1
153357,amoxicillin,0,0
153358,1g,0,1
153359,",",0,0
153360,clarithromycin,0,0
153361,500,0,0
153362,mg,0,0
153363,",",0,0
153364,and,0,0
153365,tinidazole,0,0
153366,500,0,1
153367,mg,0,1
153368,for,0,1
153369,5,0,1
153370,days,0,1
153371,;,0,1
153372,(,0,1
153373,b,0,1
153374,),0,1
153375,sequential,0,0
153376,therapy,0,1
153377,:,0,1
153378,omeprazole,0,0
153379,20mg,0,1
153380,and,0,1
153381,amoxicillin,0,0
153382,1g,0,1
153383,for,0,1
153384,5,0,1
153385,days,0,0
153386,followed,0,1
153387,by,0,1
153388,omeprazole,0,0
153389,20mg,0,1
153390,",",0,1
153391,clarithromycin,0,0
153392,500,0,0
153393,mg,0,0
153394,",",0,0
153395,and,0,0
153396,tinidazole,0,0
153397,500,0,1
153398,mg,0,1
153399,for,0,1
153400,5,0,1
153401,days,0,1
153402,;,0,1
153403,(,0,1
153404,c,0,1
153405,),0,1
153406,hybrid,0,1
153407,therapy,0,1
153408,:,0,1
153409,omeprazole,0,0
153410,20mg,0,1
153411,",",0,0
153412,and,0,0
153413,amoxicillin,0,0
153414,1g,0,1
153415,for,0,0
153416,7,0,1
153417,days,0,0
153418,followed,0,1
153419,by,0,1
153420,omeprazole,0,0
153421,20mg,0,0
153422,",",0,1
153423,amoxicillin,0,0
153424,1g,0,1
153425,",",0,0
153426,clarithromycin,0,0
153427,500,0,0
153428,mg,0,0
153429,",",0,0
153430,and,0,0
153431,tinidazole,0,0
153432,500,0,1
153433,mg,0,0
153434,",",0,1
153435,for,0,0
153436,7,0,1
153437,days,0,0
153438,.,0,1
153439,All,0,1
153440,drugs,0,0
153441,were,0,1
153442,administered,0,0
153443,twice,0,0
153444,daily,0,0
153445,.,0,0
153446,Bacterial,0,0
153447,eradication,0,0
153448,was,0,0
153449,checked,0,1
153450,6,0,1
153451,weeks,0,0
153452,after,0,1
153453,treatment,0,1
153454,by,0,0
153455,using,0,0
153456,a,0,1
153457,(,0,1
153458,13,0,1
153459,),0,1
153460,C-urea,0,0
153461,breath,0,0
153462,test,0,0
153463,.,0,1
153464,A,0,0
153465,10-day,0,0
153466,",",0,0
153467,second-line,0,0
153468,therapy,0,0
153469,with,0,1
153470,omeprazole,0,0
153471,20mg,0,1
153472,",",0,1
153473,levofloxacin,0,0
153474,250,0,0
153475,mg,0,0
153476,",",0,0
153477,and,0,0
153478,amoxicillin,0,0
153479,1g,0,1
153480,",",0,0
153481,all,0,0
153482,given,0,0
153483,twice,0,0
153484,daily,0,0
153485,",",0,0
153486,was,0,0
153487,offered,0,0
153488,to,0,0
153489,the,0,0
153490,eradication,0,0
153491,failure,0,1
153492,patients,0,1
153493,.,0,1
153494,RESULTS,0,0
153495,Overall,0,0
153496,",",0,1
153497,270,1,1
153498,patients,1,1
153499,were,1,1
153500,enrolled,1,1
153501,",",1,0
153502,but,1,0
153503,13,1,1
153504,patients,1,1
153505,early,1,1
153506,interrupted,1,1
153507,treatment,1,0
153508,due,0,0
153509,to,0,1
153510,side,0,0
153511,effects,0,0
153512,.,0,1
153513,At,0,0
153514,intention-to-treat,0,0
153515,(,0,1
153516,ITT,0,1
153517,),0,1
153518,and,0,1
153519,per-protocol,0,0
153520,analysis,0,0
153521,(,0,1
153522,PP,0,1
153523,),0,1
153524,",",0,0
153525,the,0,0
153526,eradication,0,0
153527,rates,0,0
153528,were,0,1
153529,85.5,0,0
153530,%,0,0
153531,and,0,1
153532,91.6,0,0
153533,%,0,0
153534,with,0,1
153535,the,0,0
153536,concomitant,0,0
153537,regimen,0,0
153538,",",0,1
153539,91.1,0,0
153540,%,0,0
153541,and,0,1
153542,92.1,0,0
153543,%,0,0
153544,with,0,1
153545,the,0,0
153546,sequential,0,0
153547,therapy,0,0
153548,",",0,1
153549,and,0,0
153550,80,0,1
153551,%,0,0
153552,and,0,1
153553,85.7,0,0
153554,%,0,0
153555,with,0,1
153556,the,0,0
153557,hybrid,0,1
153558,regimen,0,1
153559,.,0,1
153560,Differences,0,0
153561,were,0,0
153562,not,0,0
153563,statistically,0,0
153564,significant,0,0
153565,.,0,1
153566,H.,0,0
153567,pylori,0,1
153568,infection,0,1
153569,was,0,0
153570,cured,0,0
153571,in,0,1
153572,10,0,1
153573,(,0,1
153574,55.6,0,1
153575,%,0,0
153576,),0,1
153577,patients,0,1
153578,with,0,1
153579,the,0,1
153580,second-line,0,1
153581,regimen,0,0
153582,.,0,1
153583,CONCLUSION,0,0
153584,In,0,0
153585,our,0,0
153586,study,0,0
153587,",",0,0
153588,both,0,0
153589,concomitant,0,0
153590,and,0,0
153591,sequential,0,0
153592,therapy,0,0
153593,",",0,0
153594,but,0,0
153595,not,0,0
153596,hybrid,0,0
153597,therapy,0,0
153598,",",0,0
153599,reached,0,0
153600,high,0,1
153601,eradication,0,1
153602,rates,0,0
153603,.,0,1
153604,The,0,0
153605,success,0,0
153606,rate,0,0
153607,of,0,0
153608,second-line,0,1
153609,levofloxacin-based,0,0
153610,triple,0,0
153611,therapy,0,0
153612,is,0,0
153613,decreasing,0,0
153614,.,0,0
153615,[,0,0
153616,Closure,0,1
153617,of,0,1
153618,persistent,1,1
153619,foramen,1,1
153620,ovale,1,1
153621,-,0,1
153622,the,0,0
153623,last,0,0
153624,closure,0,1
153625,?,0,1
153626,],0,0
153627,.,0,1
153628,Effects,0,1
153629,of,0,1
153630,extended,0,1
153631,release,0,0
153632,methylphenidate,0,0
153633,treatment,0,0
153634,on,0,0
153635,ratings,0,0
153636,of,0,1
153637,attention-deficit/hyperactivity,0,1
153638,disorder,0,1
153639,(,0,1
153640,ADHD,0,1
153641,),0,1
153642,and,0,0
153643,associated,0,0
153644,behavior,0,0
153645,in,0,0
153646,children,1,1
153647,with,1,1
153648,autism,1,1
153649,spectrum,1,1
153650,disorders,1,1
153651,and,1,1
153652,ADHD,1,1
153653,symptoms,1,1
153654,.,1,1
153655,OBJECTIVE,0,0
153656,The,0,0
153657,purpose,0,0
153658,of,0,0
153659,this,0,0
153660,study,0,0
153661,was,0,0
153662,to,0,0
153663,examine,0,0
153664,the,0,0
153665,behavioral,0,0
153666,effects,0,0
153667,of,0,1
153668,four,0,1
153669,doses,0,0
153670,of,0,1
153671,psychostimulant,0,1
153672,medication,0,1
153673,",",0,0
153674,combining,0,0
153675,extended-release,0,0
153676,methylphenidate,0,1
153677,(,0,1
153678,MPH,0,1
153679,),0,1
153680,in,0,0
153681,the,0,0
153682,morning,0,0
153683,with,0,1
153684,immediate-release,0,0
153685,MPH,0,1
153686,in,0,0
153687,the,0,0
153688,afternoon,0,1
153689,.,0,1
153690,METHOD,0,0
153691,The,0,0
153692,sample,0,1
153693,comprised,0,1
153694,24,1,1
153695,children,1,1
153696,(,1,1
153697,19,1,1
153698,boys,1,1
153699,;,1,1
153700,5,1,1
153701,girls,1,1
153702,),1,1
153703,who,1,1
153704,met,1,1
153705,American,1,1
153706,Psychiatric,1,1
153707,Association,1,1
153708,",",1,1
153709,Diagnostic,1,0
153710,and,1,1
153711,Statistical,1,0
153712,Manual,1,1
153713,of,1,1
153714,Mental,1,1
153715,Disorders,1,1
153716,",",1,1
153717,4th,1,1
153718,ed,1,1
153719,.,1,1
153720,(,0,0
153721,DSM-IV-TR,0,0
153722,),0,1
153723,criteria,0,1
153724,for,0,0
153725,an,0,0
153726,autism,0,1
153727,spectrum,0,1
153728,disorder,0,1
153729,(,0,1
153730,ASD,0,1
153731,),0,1
153732,on,0,0
153733,the,0,0
153734,Autism,0,1
153735,Diagnostic,0,1
153736,Interview-Revised,0,1
153737,(,0,1
153738,ADI-R,0,1
153739,),0,1
153740,and,0,0
153741,the,0,0
153742,Autism,0,1
153743,Diagnostic,0,1
153744,Observation,0,1
153745,Schedule,0,0
153746,(,0,1
153747,ADOS,0,0
153748,),0,1
153749,",",0,0
153750,and,0,0
153751,had,0,1
153752,significant,0,0
153753,symptoms,0,1
153754,of,0,1
153755,attention-deficit/hyperactivity,0,1
153756,disorder,0,1
153757,(,0,1
153758,ADHD,0,1
153759,),0,1
153760,.,0,1
153761,This,0,0
153762,sample,0,1
153763,consisted,0,1
153764,of,0,0
153765,elementary,1,1
153766,school-age,1,1
153767,",",1,1
153768,community-based,1,1
153769,children,1,1
153770,(,1,1
153771,mean,1,1
153772,chronological,1,1
153773,age=8.8,1,1
153774,years,1,1
153775,",",1,1
153776,SD=1.7,1,1
153777,;,1,1
153778,mean,1,1
153779,intelligence,1,1
153780,quotient,1,0
153781,[,1,0
153782,IQ,1,1
153783,],1,1
153784,=85,1,1
153785,;,1,1
153786,SD=16.8,1,1
153787,),1,1
153788,.,1,1
153789,Effects,0,0
153790,of,0,0
153791,four,0,1
153792,dose,0,0
153793,levels,0,0
153794,of,0,1
153795,MPH,0,1
153796,on,0,0
153797,parent,0,1
153798,and,0,0
153799,teacher,0,1
153800,behavioral,0,1
153801,ratings,0,0
153802,were,0,1
153803,investigated,0,0
153804,using,0,0
153805,a,0,0
153806,within-subject,0,0
153807,",",0,0
153808,crossover,0,0
153809,",",0,0
153810,placebo-controlled,0,0
153811,design,0,1
153812,.,0,1
153813,RESULTS,0,0
153814,MPH,0,0
153815,treatment,0,0
153816,was,0,0
153817,associated,0,0
153818,with,0,1
153819,significant,0,0
153820,declines,0,0
153821,in,0,1
153822,hyperactive,0,1
153823,and,0,1
153824,impulsive,0,0
153825,behavior,0,0
153826,at,0,0
153827,both,0,0
153828,home,0,1
153829,and,0,0
153830,school,0,1
153831,.,0,1
153832,Parents,0,0
153833,noted,0,0
153834,significant,0,0
153835,declines,0,0
153836,in,0,1
153837,inattentive,0,1
153838,and,0,1
153839,oppositional,0,1
153840,behavior,0,0
153841,",",0,1
153842,and,0,0
153843,improvements,0,0
153844,in,0,1
153845,social,0,1
153846,skills,0,0
153847,.,0,1
153848,No,0,0
153849,exacerbation,0,0
153850,of,0,0
153851,stereotypies,0,1
153852,was,0,0
153853,noted,0,0
153854,",",0,0
153855,and,0,0
153856,side,0,0
153857,effects,0,0
153858,were,0,1
153859,similar,0,0
153860,to,0,1
153861,those,0,0
153862,seen,0,0
153863,in,0,0
153864,typically,0,1
153865,developing,0,1
153866,children,0,1
153867,with,0,1
153868,ADHD,0,1
153869,.,0,1
153870,Dose,0,0
153871,response,0,0
153872,was,0,0
153873,primarily,0,0
153874,linear,0,0
153875,in,0,0
153876,the,0,0
153877,dose,0,0
153878,range,0,1
153879,studied,0,1
153880,.,0,0
153881,CONCLUSIONS,0,0
153882,The,0,0
153883,results,0,0
153884,of,0,0
153885,this,0,0
153886,study,0,0
153887,suggest,0,0
153888,that,0,0
153889,MPH,0,1
153890,formulations,0,0
153891,are,0,0
153892,efficacious,0,0
153893,and,0,1
153894,well-tolerated,0,0
153895,for,0,1
153896,children,1,1
153897,with,1,1
153898,ASD,1,1
153899,and,1,1
153900,significant,1,0
153901,ADHD,1,1
153902,symptoms,1,1
153903,.,1,1
153904,Perceptual,0,0
153905,learning,0,0
153906,of,0,0
153907,speech,1,1
153908,under,0,1
153909,optimal,0,0
153910,and,0,1
153911,adverse,0,0
153912,conditions,0,1
153913,.,0,1
153914,Humans,1,1
153915,have,0,0
153916,a,0,0
153917,remarkable,0,0
153918,ability,0,0
153919,to,0,0
153920,understand,0,0
153921,spoken,0,0
153922,language,0,0
153923,despite,0,0
153924,the,0,0
153925,large,0,1
153926,amount,0,0
153927,of,0,0
153928,variability,0,0
153929,in,0,1
153930,speech,0,1
153931,.,0,1
153932,Previous,0,0
153933,research,0,0
153934,has,0,0
153935,shown,0,0
153936,that,0,0
153937,listeners,0,1
153938,can,0,0
153939,use,0,0
153940,lexical,0,0
153941,information,0,0
153942,to,0,0
153943,guide,0,0
153944,their,0,0
153945,interpretation,0,0
153946,of,0,1
153947,atypical,0,1
153948,sounds,0,0
153949,in,0,1
153950,speech,0,1
153951,(,0,1
153952,Norris,0,1
153953,",",0,0
153954,McQueen,0,1
153955,",",0,0
153956,&,0,1
153957,Cutler,0,1
153958,",",0,1
153959,2003,0,1
153960,),0,1
153961,.,0,1
153962,This,0,0
153963,kind,0,0
153964,of,0,0
153965,lexically,0,0
153966,induced,0,0
153967,perceptual,0,0
153968,learning,0,0
153969,enables,0,0
153970,people,1,1
153971,to,0,1
153972,adjust,0,0
153973,to,0,0
153974,the,0,0
153975,variations,0,0
153976,in,0,1
153977,utterances,0,1
153978,due,0,1
153979,to,0,1
153980,talker-specific,0,1
153981,characteristics,0,1
153982,",",0,1
153983,such,0,0
153984,as,0,0
153985,individual,0,0
153986,identity,0,1
153987,and,0,1
153988,dialect,0,1
153989,.,0,1
153990,The,0,0
153991,current,0,0
153992,study,0,1
153993,investigated,0,0
153994,perceptual,0,0
153995,learning,0,0
153996,in,0,1
153997,two,0,1
153998,optimal,0,0
153999,conditions,0,1
154000,:,0,1
154001,conversational,0,1
154002,speech,0,1
154003,(,0,1
154004,Experiment,0,1
154005,1,0,1
154006,),0,1
154007,versus,0,0
154008,clear,0,0
154009,speech,0,1
154010,(,0,1
154011,Experiment,0,1
154012,2,0,1
154013,),0,1
154014,",",0,1
154015,and,0,1
154016,three,0,0
154017,adverse,0,0
154018,conditions,0,1
154019,:,0,1
154020,noise,0,1
154021,(,0,1
154022,Experiment,0,1
154023,3a,0,1
154024,),0,1
154025,versus,0,0
154026,two,0,1
154027,cognitive,0,1
154028,loads,0,0
154029,(,0,1
154030,Experiments,0,0
154031,4a,0,1
154032,and,0,1
154033,4b,0,0
154034,),0,1
154035,.,0,1
154036,Perceptual,0,0
154037,learning,0,0
154038,occurred,0,0
154039,in,0,0
154040,the,0,0
154041,two,0,0
154042,optimal,0,0
154043,conditions,0,1
154044,and,0,1
154045,in,0,1
154046,the,0,0
154047,two,0,0
154048,cognitive,0,1
154049,load,0,0
154050,conditions,0,1
154051,",",0,0
154052,but,0,0
154053,not,0,0
154054,in,0,0
154055,the,0,0
154056,noise,0,0
154057,condition,0,0
154058,.,0,1
154059,Furthermore,0,0
154060,",",0,0
154061,perceptual,0,0
154062,learning,0,0
154063,occurred,0,0
154064,only,0,0
154065,in,0,0
154066,the,0,0
154067,first,0,0
154068,of,0,1
154069,two,0,1
154070,sessions,0,0
154071,for,0,1
154072,each,0,1
154073,participant,0,0
154074,",",0,0
154075,and,0,0
154076,only,0,0
154077,for,0,0
154078,atypical,0,1
154079,/s/,0,1
154080,sounds,0,0
154081,and,0,0
154082,not,0,0
154083,for,0,0
154084,atypical,0,1
154085,/f/,0,0
154086,sounds,0,0
154087,.,0,0
154088,This,0,0
154089,pattern,0,0
154090,of,0,0
154091,learning,0,0
154092,and,0,0
154093,nonlearning,0,0
154094,reflects,0,0
154095,a,0,0
154096,balance,0,0
154097,between,0,0
154098,flexibility,0,0
154099,and,0,0
154100,stability,0,0
154101,that,0,0
154102,the,0,0
154103,speech,0,0
154104,system,0,0
154105,must,0,0
154106,have,0,0
154107,to,0,0
154108,deal,0,0
154109,with,0,1
154110,speech,0,1
154111,variability,0,0
154112,in,0,0
154113,the,0,0
154114,diverse,0,1
154115,conditions,0,1
154116,that,0,0
154117,speech,0,1
154118,is,0,0
154119,encountered,0,0
154120,.,0,0
154121,Teacher,0,1
154122,and,0,1
154123,child,0,1
154124,predictors,0,0
154125,of,0,1
154126,achieving,0,0
154127,IEP,0,1
154128,goals,0,1
154129,of,0,1
154130,children,1,1
154131,with,1,1
154132,autism,1,1
154133,.,1,1
154134,It,0,0
154135,is,0,0
154136,encouraging,0,0
154137,that,0,0
154138,children,1,1
154139,with,1,1
154140,autism,1,1
154141,show,0,0
154142,a,0,0
154143,strong,0,0
154144,response,0,0
154145,to,0,1
154146,early,0,1
154147,intervention,0,0
154148,",",0,0
154149,yet,0,0
154150,more,0,0
154151,research,0,0
154152,is,0,0
154153,needed,0,0
154154,for,0,0
154155,understanding,0,0
154156,the,0,0
154157,variability,0,0
154158,in,0,0
154159,responsiveness,0,0
154160,to,0,1
154161,specialized,0,1
154162,programs,0,1
154163,.,0,1
154164,Treatment,0,0
154165,predictor,0,0
154166,variables,0,0
154167,from,0,1
154168,47,1,1
154169,teachers,1,1
154170,and,1,1
154171,children,1,1
154172,who,1,1
154173,were,1,1
154174,randomized,1,1
154175,to,1,0
154176,receive,1,1
154177,the,1,0
154178,COMPASS,1,1
154179,intervention,1,0
154180,(,0,1
154181,Ruble,0,1
154182,et,0,1
154183,al,0,1
154184,.,0,1
154185,in,0,0
154186,The,0,0
154187,collaborative,0,0
154188,model,0,0
154189,for,0,0
154190,promoting,0,0
154191,competence,0,0
154192,and,0,0
154193,success,0,0
154194,for,0,0
154195,students,0,1
154196,with,0,1
154197,ASD,0,1
154198,.,0,1
154199,Springer,0,0
154200,",",0,0
154201,New,0,1
154202,York,0,1
154203,",",0,1
154204,2012a,0,1
154205,),0,1
154206,were,0,1
154207,analyzed,0,0
154208,.,0,1
154209,Predictors,0,0
154210,evaluated,0,0
154211,against,0,1
154212,child,0,1
154213,IEP,0,0
154214,goal,0,0
154215,attainment,0,1
154216,included,0,1
154217,child,0,1
154218,",",0,0
154219,teacher,0,0
154220,",",0,0
154221,intervention,0,0
154222,practice,0,0
154223,",",0,0
154224,and,0,0
154225,implementation,0,0
154226,practice,0,0
154227,variables,0,0
154228,based,0,1
154229,on,0,0
154230,an,0,0
154231,implementation,0,0
154232,science,0,0
154233,framework,0,1
154234,(,0,1
154235,Dunst,0,0
154236,and,0,1
154237,Trivette,0,0
154238,in,0,1
154239,J,0,0
154240,Soc,0,1
154241,Sci,0,0
154242,8:143-148,0,1
154243,",",0,1
154244,2012,0,1
154245,),0,1
154246,.,0,1
154247,Findings,0,0
154248,revealed,0,0
154249,one,0,1
154250,child,0,1
154251,(,0,1
154252,engagement,0,0
154253,),0,1
154254,",",0,0
154255,one,0,1
154256,teacher,0,1
154257,(,0,1
154258,exhaustion,0,0
154259,),0,1
154260,",",0,0
154261,two,0,0
154262,intervention,0,0
154263,quality,0,0
154264,(,0,1
154265,IEP,0,0
154266,quality,0,0
154267,for,0,0
154268,targeted,0,1
154269,and,0,0
154270,not,0,0
154271,targeted,0,1
154272,elements,0,1
154273,),0,1
154274,",",0,0
154275,and,0,0
154276,no,0,0
154277,implementation,0,0
154278,quality,0,0
154279,variables,0,0
154280,accounted,0,0
154281,for,0,0
154282,variance,0,0
154283,in,0,1
154284,child,0,1
154285,outcomes,0,0
154286,when,0,0
154287,analyzed,0,0
154288,separately,0,0
154289,.,0,0
154290,When,0,0
154291,the,0,0
154292,four,0,0
154293,significant,0,0
154294,variables,0,0
154295,were,0,1
154296,compared,0,0
154297,against,0,0
154298,each,0,0
154299,other,0,0
154300,in,0,0
154301,a,0,1
154302,single,0,0
154303,regression,0,0
154304,analysis,0,0
154305,",",0,0
154306,IEP,0,0
154307,quality,0,0
154308,accounted,0,0
154309,for,0,0
154310,one,0,1
154311,quarter,0,1
154312,of,0,0
154313,the,0,0
154314,variance,0,0
154315,in,0,0
154316,child,0,1
154317,outcomes,0,0
154318,.,0,1
154319,Singing,0,1
154320,can,0,0
154321,facilitate,0,0
154322,foreign,1,1
154323,language,1,0
154324,learning,1,0
154325,.,1,1
154326,This,0,0
154327,study,0,0
154328,presents,0,0
154329,the,0,0
154330,first,0,0
154331,experimental,0,0
154332,evidence,0,0
154333,that,0,0
154334,singing,0,1
154335,can,0,0
154336,facilitate,0,0
154337,short-term,0,0
154338,paired-associate,0,1
154339,phrase,0,1
154340,learning,0,0
154341,in,0,0
154342,an,0,0
154343,unfamiliar,1,1
154344,language,1,0
154345,(,1,1
154346,Hungarian,1,1
154347,),1,1
154348,.,1,1
154349,Sixty,1,1
154350,adult,1,1
154351,participants,1,1
154352,were,0,1
154353,randomly,0,1
154354,assigned,0,1
154355,to,0,0
154356,one,0,1
154357,of,0,1
154358,three,0,1
154359,listen-and-repeat,0,1
154360,learning,0,0
154361,conditions,0,1
154362,:,0,1
154363,speaking,0,1
154364,",",0,0
154365,rhythmic,0,0
154366,speaking,0,1
154367,",",0,0
154368,or,0,1
154369,singing,0,1
154370,.,0,1
154371,Participants,0,1
154372,in,0,0
154373,the,0,0
154374,singing,0,1
154375,condition,0,0
154376,showed,0,0
154377,superior,0,0
154378,overall,0,0
154379,performance,0,0
154380,on,0,0
154381,a,0,0
154382,collection,0,1
154383,of,0,0
154384,Hungarian,0,1
154385,language,0,1
154386,tests,0,0
154387,after,0,1
154388,a,0,1
154389,15-min,0,0
154390,learning,0,0
154391,period,0,0
154392,",",0,0
154393,as,0,0
154394,compared,0,0
154395,with,0,1
154396,participants,0,1
154397,in,0,1
154398,the,0,0
154399,speaking,0,1
154400,and,0,0
154401,rhythmic,0,0
154402,speaking,0,1
154403,conditions,0,1
154404,.,0,1
154405,This,0,0
154406,superior,0,0
154407,performance,0,0
154408,was,0,0
154409,statistically,0,0
154410,significant,0,0
154411,(,0,1
154412,p,0,0
154413,<,0,0
154414,.05,0,0
154415,),0,1
154416,for,0,0
154417,the,0,1
154418,two,0,1
154419,tests,0,0
154420,that,0,0
154421,required,0,1
154422,participants,0,1
154423,to,0,1
154424,recall,0,0
154425,and,0,0
154426,produce,0,0
154427,spoken,0,0
154428,Hungarian,0,1
154429,phrases,0,1
154430,.,0,1
154431,The,0,0
154432,differences,0,0
154433,in,0,0
154434,performance,0,0
154435,were,0,1
154436,not,0,0
154437,explained,0,0
154438,by,0,0
154439,potentially,0,0
154440,influencing,0,0
154441,factors,0,0
154442,such,0,0
154443,as,0,0
154444,age,1,1
154445,",",1,0
154446,gender,1,0
154447,",",1,0
154448,mood,1,0
154449,",",1,0
154450,phonological,1,1
154451,working,1,1
154452,memory,1,0
154453,ability,1,0
154454,",",1,0
154455,or,1,1
154456,musical,1,0
154457,ability,1,0
154458,and,1,1
154459,training,1,0
154460,.,1,1
154461,These,0,0
154462,results,0,0
154463,suggest,0,0
154464,that,0,0
154465,a,0,1
154466,listen-and-sing,0,1
154467,learning,0,0
154468,method,0,0
154469,can,0,0
154470,facilitate,0,0
154471,verbatim,0,0
154472,memory,0,0
154473,for,0,1
154474,spoken,0,0
154475,foreign,0,1
154476,language,0,1
154477,phrases,0,1
154478,.,0,1
154479,A,0,0
154480,chinese,0,1
154481,mind-body,0,0
154482,exercise,0,0
154483,improves,0,0
154484,self-control,0,0
154485,of,0,0
154486,children,1,1
154487,with,1,1
154488,autism,1,1
154489,:,1,1
154490,a,0,0
154491,randomized,0,1
154492,controlled,0,0
154493,trial,0,1
154494,.,0,1
154495,Self-control,0,0
154496,problems,0,0
154497,commonly,0,1
154498,manifest,0,1
154499,as,0,0
154500,temper,0,0
154501,outbursts,0,1
154502,and,0,1
154503,repetitive/rigid/impulsive,0,1
154504,behaviors,0,0
154505,",",0,1
154506,in,0,1
154507,children,1,1
154508,with,1,1
154509,autism,1,1
154510,spectrum,1,1
154511,disorders,1,1
154512,(,1,1
154513,ASD,1,1
154514,),1,1
154515,",",0,0
154516,which,0,0
154517,often,0,0
154518,contributes,0,0
154519,to,0,0
154520,learning,0,0
154521,difficulties,0,0
154522,and,0,1
154523,caregiver,0,1
154524,burden,0,1
154525,.,0,1
154526,The,0,0
154527,present,0,0
154528,study,0,1
154529,aims,0,0
154530,to,0,0
154531,compare,0,0
154532,the,0,0
154533,effect,0,0
154534,of,0,0
154535,a,0,1
154536,traditional,0,0
154537,Chinese,0,1
154538,Chan-based,0,0
154539,mind-body,0,0
154540,exercise,0,0
154541,",",0,0
154542,Nei,0,1
154543,Yang,0,1
154544,Gong,0,1
154545,",",0,0
154546,with,0,1
154547,that,0,0
154548,of,0,0
154549,the,0,0
154550,conventional,0,1
154551,Progressive,0,1
154552,Muscle,0,1
154553,Relaxation,0,0
154554,(,0,1
154555,PMR,0,1
154556,),0,1
154557,technique,0,0
154558,in,0,0
154559,enhancing,0,0
154560,the,0,0
154561,self-control,0,0
154562,of,0,0
154563,children,1,1
154564,with,1,1
154565,ASD,1,1
154566,.,1,1
154567,Forty-six,1,1
154568,age-,1,1
154569,and,1,1
154570,IQ-matched,1,1
154571,ASD,1,1
154572,children,1,1
154573,were,0,1
154574,randomly,0,1
154575,assigned,0,1
154576,to,0,0
154577,receive,0,1
154578,group,0,0
154579,training,0,0
154580,in,0,0
154581,Nei,0,1
154582,Yang,0,1
154583,Gong,0,1
154584,(,0,1
154585,experimental,0,1
154586,group,0,1
154587,),0,1
154588,or,0,1
154589,PMR,0,0
154590,(,0,0
154591,control,0,1
154592,group,0,1
154593,),0,0
154594,twice,0,0
154595,per,0,0
154596,week,0,0
154597,for,0,1
154598,four,0,1
154599,weeks,0,1
154600,.,0,1
154601,The,0,0
154602,participants,0,1
154603,',0,1
154604,self-control,0,0
154605,was,0,0
154606,measured,0,0
154607,by,0,0
154608,three,0,1
154609,neuropsychological,0,1
154610,tests,0,0
154611,and,0,1
154612,parental,0,1
154613,rating,0,0
154614,on,0,0
154615,standardized,0,1
154616,questionnaires,0,0
154617,",",0,1
154618,and,0,0
154619,the,0,0
154620,underlying,0,0
154621,neural,0,0
154622,mechanism,0,0
154623,was,0,0
154624,assessed,0,0
154625,by,0,0
154626,the,0,0
154627,participants,0,1
154628,',0,1
154629,brain,0,1
154630,EEG,0,1
154631,activity,0,0
154632,during,0,0
154633,an,0,0
154634,inhibitory-control,0,1
154635,task,0,1
154636,before,0,0
154637,and,0,0
154638,after,0,1
154639,intervention,0,0
154640,.,0,1
154641,The,0,0
154642,results,0,0
154643,show,0,0
154644,that,0,0
154645,the,0,0
154646,experimental,0,0
154647,group,0,0
154648,demonstrated,0,0
154649,significantly,0,0
154650,greater,0,0
154651,improvement,0,0
154652,in,0,0
154653,self-control,0,0
154654,than,0,0
154655,the,0,0
154656,control,0,0
154657,group,0,0
154658,",",0,0
154659,which,0,0
154660,concurs,0,0
154661,with,0,0
154662,the,0,0
154663,parental,0,1
154664,reports,0,1
154665,of,0,1
154666,reduced,0,0
154667,autistic,0,1
154668,symptoms,0,1
154669,and,0,1
154670,increased,0,0
154671,control,0,1
154672,of,0,0
154673,temper,0,0
154674,and,0,1
154675,behaviors,0,0
154676,.,0,1
154677,In,0,0
154678,addition,0,0
154679,",",0,0
154680,the,0,0
154681,experimental,0,0
154682,group,0,1
154683,showed,0,0
154684,enhanced,0,0
154685,EEG,0,1
154686,activity,0,0
154687,in,0,0
154688,the,0,0
154689,anterior,0,1
154690,cingulate,0,0
154691,cortex,0,0
154692,",",0,0
154693,a,0,0
154694,region,0,0
154695,that,0,0
154696,mediates,0,0
154697,self-control,0,0
154698,",",0,0
154699,whereas,0,0
154700,the,0,0
154701,PMR,0,0
154702,group,0,0
154703,did,0,0
154704,not,0,0
154705,.,0,1
154706,The,0,0
154707,present,0,0
154708,findings,0,0
154709,support,0,0
154710,the,0,0
154711,potential,0,0
154712,application,0,0
154713,of,0,0
154714,Chinese,0,1
154715,Chan-based,0,1
154716,mind-body,0,1
154717,exercises,0,0
154718,as,0,0
154719,a,0,1
154720,form,0,0
154721,of,0,0
154722,neuropsychological,0,1
154723,rehabilitation,0,1
154724,for,0,1
154725,patients,1,1
154726,with,1,1
154727,self-control,1,1
154728,problems,1,1
154729,.,1,1
154730,Chinese,0,1
154731,Clinical,0,0
154732,Trial,0,1
154733,Registry,0,1
154734,;,0,1
154735,Registration,0,0
154736,No,0,0
154737,.,0,1
154738,:,0,1
154739,ChiCTR-TRC-12002561,0,0
154740,;,0,1
154741,URL,0,1
154742,:,0,1
154743,www.chictr.org,0,1
154744,.,0,1
154745,Bedside,0,0
154746,ultrasound-guided,0,1
154747,celiac,0,1
154748,plexus,0,1
154749,neurolysis,0,1
154750,in,0,0
154751,upper,1,1
154752,abdominal,1,1
154753,cancer,1,1
154754,patients,1,1
154755,:,1,1
154756,a,0,1
154757,randomized,0,1
154758,",",0,0
154759,prospective,0,1
154760,study,0,1
154761,for,0,0
154762,comparison,0,0
154763,of,0,1
154764,percutaneous,0,1
154765,bilateral,0,1
154766,paramedian,0,1
154767,vs.,0,0
154768,unilateral,0,1
154769,paramedian,0,0
154770,needle-insertion,0,1
154771,technique,0,0
154772,.,0,1
154773,INTRODUCTION,0,0
154774,Percutaneous,0,1
154775,anterior,0,1
154776,abdominal,0,1
154777,ultrasound,0,1
154778,guidance,0,0
154779,for,0,0
154780,performing,0,0
154781,celiac,0,1
154782,plexus,0,1
154783,neurolysis,0,1
154784,is,0,0
154785,a,0,0
154786,relatively,0,0
154787,new,0,0
154788,but,0,0
154789,more,0,0
154790,economical,0,0
154791,",",0,0
154792,less,0,0
154793,time-consuming,0,0
154794,",",0,0
154795,more,0,0
154796,comfortable,0,0
154797,bedside,0,0
154798,technique,0,0
154799,for,0,0
154800,interventional,0,1
154801,pain,0,1
154802,management,0,1
154803,.,0,1
154804,Paucity,0,0
154805,of,0,0
154806,studies,0,0
154807,evaluating,0,0
154808,the,0,0
154809,efficacy,0,0
154810,of,0,0
154811,single-site,0,1
154812,vs.,0,0
154813,double-site,0,0
154814,injections,0,0
154815,at,0,1
154816,celiac,0,1
154817,trunk,0,1
154818,for,0,0
154819,ultrasound-guided,0,1
154820,celiac,0,1
154821,plexus,0,1
154822,neurolysis,0,1
154823,(,0,1
154824,USCPN,0,1
154825,),0,1
154826,prompted,0,1
154827,us,0,1
154828,to,0,0
154829,conduct,0,0
154830,a,0,0
154831,prospective,0,0
154832,",",0,0
154833,randomized,0,1
154834,",",0,0
154835,single-blind,0,0
154836,clinical,0,0
154837,trial,0,0
154838,to,0,0
154839,compare,0,0
154840,USCPN,0,1
154841,using,0,0
154842,bilateral,0,1
154843,paramedian,0,1
154844,(,0,1
154845,double,0,0
154846,needle,0,1
154847,),0,1
154848,technique,0,0
154849,with,0,1
154850,unilateral,0,1
154851,paramedian,0,1
154852,(,0,1
154853,single,0,0
154854,needle,0,1
154855,),0,1
154856,technique,0,0
154857,.,0,1
154858,METHODS,0,0
154859,Sixty,1,1
154860,patients,1,1
154861,aged,1,1
154862,18,1,1
154863,years,1,1
154864,or,1,1
154865,older,1,1
154866,with,1,1
154867,unresectable,1,1
154868,upper,1,1
154869,abdominal,1,1
154870,cancers,1,1
154871,were,0,1
154872,randomized,0,1
154873,into,0,1
154874,two,0,1
154875,groups,0,1
154876,to,0,1
154877,receive,0,1
154878,USCPN,0,1
154879,.,0,1
154880,A,0,0
154881,20-mL,0,0
154882,mixture,0,0
154883,of,0,1
154884,50,0,1
154885,%,0,0
154886,ethanol,0,0
154887,with,0,1
154888,0.25,0,0
154889,%,0,0
154890,bupivacaine,0,0
154891,was,0,0
154892,injected,0,0
154893,either,0,0
154894,unilaterally,0,1
154895,(,0,0
154896,20,0,1
154897,mL?1,0,1
154898,site,0,0
154899,),0,0
154900,or,0,1
154901,bilaterally,0,0
154902,(,0,1
154903,10,0,1
154904,mL?2,0,1
154905,sites,0,1
154906,),0,1
154907,depending,0,1
154908,on,0,0
154909,the,0,0
154910,randomization,0,0
154911,group,0,1
154912,.,0,1
154913,Subjects,0,1
154914,were,0,0
154915,assessed,0,0
154916,for,0,0
154917,the,0,0
154918,pain,0,1
154919,relief,0,0
154920,using,0,0
154921,Numerical,0,0
154922,rating,0,0
154923,scale,0,0
154924,(,0,1
154925,NRS,0,0
154926,),0,1
154927,to,0,0
154928,assess,0,0
154929,their,0,0
154930,pain,0,1
154931,relief,0,0
154932,.,0,1
154933,RESULTS,0,0
154934,Baseline,0,0
154935,parameters,0,0
154936,being,0,1
154937,comparable,0,0
154938,(,0,1
154939,P,0,0
154940,>,0,1
154941,0.05,0,0
154942,),0,1
154943,",",0,0
154944,the,0,0
154945,site,0,0
154946,of,0,0
154947,drug,0,1
154948,injections,0,0
154949,(,0,1
154950,single,0,1
154951,or,0,1
154952,double,0,0
154953,needle,0,1
154954,),0,1
154955,had,0,1
154956,no,0,0
154957,bearing,0,1
154958,on,0,0
154959,the,0,0
154960,onset,0,1
154961,of,0,0
154962,pain,0,1
154963,relief,0,0
154964,and,0,0
154965,patient,0,1
154966,satisfaction,0,0
154967,scores,0,0
154968,(,0,1
154969,P,0,0
154970,>,0,1
154971,0.05,0,0
154972,),0,1
154973,.,0,1
154974,Pain,0,0
154975,relief,0,0
154976,during,0,0
154977,follow-up,0,1
154978,visits,0,1
154979,was,0,0
154980,comparable,0,0
154981,between,0,0
154982,the,0,1
154983,two,0,1
154984,groups,0,0
154985,(,0,1
154986,P,0,0
154987,>,0,1
154988,0.05,0,0
154989,),0,1
154990,.,0,1
154991,The,0,0
154992,discomfort,0,0
154993,score,0,0
154994,correlated,0,0
154995,well,0,0
154996,with,0,1
154997,the,0,0
154998,pain,0,1
154999,relief,0,0
155000,scoring,0,0
155001,without,0,1
155002,any,0,1
155003,significant,0,0
155004,difference,0,0
155005,between,0,0
155006,the,0,1
155007,two,0,0
155008,groups,0,0
155009,except,0,0
155010,in,0,1
155011,the,0,0
155012,last,0,0
155013,visit,0,0
155014,(,0,1
155015,at,0,1
155016,3,0,1
155017,month,0,1
155018,),0,1
155019,.,0,1
155020,Incidences,0,0
155021,of,0,0
155022,the,0,1
155023,complications,0,0
155024,were,0,1
155025,comparable,0,0
155026,in,0,0
155027,the,0,1
155028,two,0,1
155029,groups,0,0
155030,(,0,1
155031,P,0,0
155032,>,0,1
155033,0.05,0,0
155034,),0,1
155035,.,0,1
155036,CONCLUSION,0,0
155037,Ultrasound-guided,0,1
155038,celiac,0,1
155039,plexus,0,1
155040,neurolysis,0,1
155041,using,0,0
155042,unilateral,0,1
155043,paramedian,0,1
155044,(,0,1
155045,single,0,0
155046,needle,0,1
155047,),0,1
155048,needle-insertion,0,0
155049,technique,0,0
155050,is,0,0
155051,comparable,0,0
155052,with,0,1
155053,bilateral,0,1
155054,paramedian,0,1
155055,(,0,1
155056,double,0,0
155057,needle,0,1
155058,),0,1
155059,needle-insertion,0,0
155060,technique,0,0
155061,with,0,1
155062,regard,0,0
155063,to,0,0
155064,pain,0,1
155065,relief,0,0
155066,and,0,0
155067,side,0,0
155068,effects,0,0
155069,.,0,1
155070,Community-based,0,1
155071,treatment,0,1
155072,for,0,1
155073,opioid,1,1
155074,dependent,1,1
155075,offenders,1,1
155076,:,1,1
155077,a,0,1
155078,pilot,0,0
155079,study,0,1
155080,.,0,1
155081,BACKGROUND,0,0
155082,Primary,0,1
155083,care,0,1
155084,opioid,0,1
155085,substitution,0,0
155086,treatment,0,0
155087,(,0,1
155088,OST,0,0
155089,),0,0
155090,has,0,0
155091,not,0,0
155092,been,0,0
155093,compared,0,0
155094,to,0,1
155095,program-based,0,0
155096,OST,0,1
155097,for,0,1
155098,community-supervised,1,1
155099,offenders,1,1
155100,.,1,1
155101,OBJECTIVE,0,0
155102,The,0,0
155103,purpose,0,0
155104,of,0,0
155105,this,0,0
155106,project,0,1
155107,was,0,0
155108,to,0,0
155109,compare,0,0
155110,primary,0,1
155111,care,0,1
155112,to,0,0
155113,specialist,0,1
155114,supervised,0,1
155115,OST,0,0
155116,for,0,1
155117,opioid,0,1
155118,dependent,0,1
155119,offenders,0,1
155120,in,0,1
155121,terms,0,0
155122,of,0,1
155123,substance,0,1
155124,use,0,0
155125,and,0,0
155126,HIV,0,1
155127,risk,0,1
155128,outcomes,0,0
155129,.,0,1
155130,METHODS,0,0
155131,This,0,0
155132,project,0,0
155133,randomly,0,1
155134,assigned,0,1
155135,15,1,0
155136,jail,1,1
155137,diversion,1,1
155138,participants,1,1
155139,to,0,1
155140,either,0,1
155141,:,0,1
155142,(,0,0
155143,i,0,1
155144,),0,1
155145,primary,0,1
155146,care,0,1
155147,buprenorphine,0,1
155148,OST,0,0
155149,",",0,0
155150,(,0,0
155151,ii,0,0
155152,),0,1
155153,specialist,0,1
155154,facility,0,1
155155,buprenorphine,0,1
155156,OST,0,0
155157,",",0,0
155158,or,0,1
155159,(,0,1
155160,iii,0,1
155161,),0,1
155162,specialist,0,1
155163,facility,0,1
155164,methadone,0,1
155165,OST,0,1
155166,.,0,1
155167,Participation,0,1
155168,lasted,0,0
155169,13.5,0,0
155170,months,0,0
155171,(,0,1
155172,12-month,0,1
155173,active,0,1
155174,treatment,0,0
155175,plus,0,0
155176,a,0,0
155177,post-participation,0,0
155178,visit,0,1
155179,),0,1
155180,.,0,1
155181,RESULTS,0,0
155182,All,0,1
155183,subjects,0,1
155184,endorsed,0,1
155185,0,0,0
155186,days,0,0
155187,of,0,1
155188,opioid,0,1
155189,use,0,0
155190,in,0,0
155191,the,0,0
155192,previous,0,1
155193,14,0,1
155194,at,0,1
155195,follow-up,0,1
155196,.,0,1
155197,Specialty,0,1
155198,care,0,1
155199,reduced,0,0
155200,HIV,0,1
155201,risk,0,1
155202,(,0,1
155203,Risk,0,1
155204,Assessment,0,0
155205,Battery,0,1
155206,composite,0,0
155207,score,0,1
155208,),0,1
155209,over,0,0
155210,6,0,1
155211,months,0,0
155212,(,0,1
155213,-.24,0,0
155214,?,0,1
155215,.17,0,0
155216,),0,0
155217,compared,0,0
155218,to,0,0
155219,primary,0,1
155220,care,0,1
155221,(,0,0
155222,.02,0,0
155223,?,0,1
155224,.14,0,0
155225,;,0,0
155226,p,0,0
155227,=,0,1
155228,.032,0,0
155229,),0,1
155230,.,0,1
155231,CONCLUSION,0,0
155232,Findings,0,0
155233,support,0,0
155234,primary,0,1
155235,care,0,1
155236,OST,0,0
155237,feasibility,0,0
155238,for,0,0
155239,a,0,1
155240,community-supervised,0,1
155241,offender,0,1
155242,sample,0,1
155243,.,0,1
155244,Specialist,0,1
155245,care,0,1
155246,may,0,0
155247,facilitate,0,0
155248,improvements,0,0
155249,in,0,1
155250,secondary,0,1
155251,outcomes,0,0
155252,",",0,1
155253,such,0,0
155254,as,0,0
155255,HIV,0,1
155256,risk,0,1
155257,behaviors,0,0
155258,.,0,1
155259,SCIENTIFIC,0,0
155260,SIGNIFICANCE,0,1
155261,Further,0,0
155262,research,0,0
155263,is,0,0
155264,needed,0,0
155265,to,0,0
155266,clarify,0,0
155267,(,0,0
155268,i,0,0
155269,),0,1
155270,the,0,0
155271,role,0,0
155272,of,0,0
155273,primary,0,1
155274,care,0,1
155275,in,0,0
155276,addicted,0,1
155277,offender,0,1
155278,management,0,0
155279,",",0,0
155280,and,0,0
155281,(,0,0
155282,ii,0,1
155283,),0,1
155284,the,0,0
155285,matching,0,1
155286,of,0,0
155287,offenders,0,1
155288,",",0,1
155289,based,0,1
155290,upon,0,0
155291,history,0,1
155292,and,0,0
155293,co-morbidity,0,0
155294,",",0,0
155295,to,0,0
155296,care,0,1
155297,coordination,0,0
155298,conditions,0,1
155299,.,0,1
155300,Infant,0,1
155301,distress,0,0
155302,and,0,0
155303,development,0,0
155304,of,0,0
155305,functional,0,1
155306,gastrointestinal,0,1
155307,disorders,0,1
155308,in,0,1
155309,childhood,0,1
155310,:,0,1
155311,is,0,0
155312,there,0,0
155313,a,0,0
155314,connection,0,0
155315,?,0,1
155316,Assessment,0,0
155317,of,0,0
155318,global,0,0
155319,functioning,0,1
155320,in,0,1
155321,adolescents,1,1
155322,with,1,1
155323,autism,1,1
155324,spectrum,1,1
155325,disorders,1,1
155326,:,1,1
155327,utility,0,0
155328,of,0,0
155329,the,0,0
155330,Developmental,0,1
155331,Disability-Child,0,0
155332,Global,0,1
155333,Assessment,0,0
155334,Scale,0,1
155335,.,0,1
155336,Assessment,0,0
155337,of,0,0
155338,global,0,0
155339,functioning,0,1
155340,is,0,0
155341,an,0,0
155342,important,0,0
155343,consideration,0,0
155344,in,0,0
155345,treatment,0,0
155346,outcome,0,0
155347,research,0,1
155348,;,0,0
155349,yet,0,0
155350,",",0,0
155351,there,0,0
155352,is,0,0
155353,little,0,0
155354,guidance,0,0
155355,on,0,0
155356,its,0,0
155357,evidence-based,0,0
155358,assessment,0,0
155359,for,0,1
155360,children,1,1
155361,with,1,1
155362,autism,1,1
155363,spectrum,1,1
155364,disorders,1,1
155365,.,1,1
155366,This,0,0
155367,study,0,0
155368,investigated,0,0
155369,the,0,0
155370,utility,0,0
155371,and,0,0
155372,validity,0,0
155373,of,0,0
155374,clinician-rated,0,0
155375,global,0,0
155376,functioning,0,1
155377,using,0,0
155378,the,0,0
155379,Developmental,0,1
155380,Disability-Child,0,0
155381,Global,0,1
155382,Assessment,0,0
155383,Scale,0,1
155384,in,0,0
155385,a,0,0
155386,sample,1,1
155387,of,1,0
155388,higher,1,0
155389,functioning,1,1
155390,adolescents,1,1
155391,with,1,1
155392,autism,1,1
155393,spectrum,1,1
155394,disorders,1,1
155395,and,1,1
155396,comorbid,1,1
155397,anxiety,1,1
155398,disorders,1,1
155399,enrolled,1,1
155400,in,1,0
155401,a,1,1
155402,randomized,1,1
155403,controlled,1,0
155404,trial,1,0
155405,(,1,1
155406,n,1,1
155407,=,1,1
155408,30,1,1
155409,),1,1
155410,.,1,1
155411,Pretreatment,0,0
155412,Developmental,0,1
155413,Disability-Child,0,1
155414,Global,0,1
155415,Assessment,0,0
155416,Scale,0,1
155417,scores,0,0
155418,correlated,0,0
155419,with,0,1
155420,severity,0,0
155421,of,0,0
155422,autism,0,1
155423,spectrum,0,1
155424,disorders,0,1
155425,core,0,1
155426,symptoms,0,0
155427,(,0,1
155428,r,0,0
155429,=,0,0
155430,-.388,0,0
155431,",",0,0
155432,p,0,0
155433,=,0,0
155434,.034,0,0
155435,),0,1
155436,",",0,0
155437,pragmatic,0,1
155438,communication,0,0
155439,(,0,1
155440,r,0,0
155441,=,0,1
155442,.407,0,0
155443,",",0,0
155444,p,0,0
155445,=,0,0
155446,.032,0,0
155447,),0,1
155448,",",0,0
155449,and,0,0
155450,verbal,0,0
155451,ability,0,0
155452,(,0,1
155453,r,0,0
155454,=,0,1
155455,.449,0,0
155456,",",0,0
155457,p,0,0
155458,=,0,0
155459,.013,0,0
155460,),0,1
155461,and,0,0
155462,did,0,0
155463,not,0,0
155464,correlate,0,0
155465,with,0,1
155466,severity,0,0
155467,of,0,1
155468,anxiety,0,1
155469,symptoms,0,1
155470,or,0,1
155471,with,0,1
155472,parent-reported,0,0
155473,adaptive,0,0
155474,behavior,0,1
155475,.,0,1
155476,Change,0,0
155477,in,0,0
155478,Developmental,0,1
155479,Disability-Child,0,1
155480,Global,0,1
155481,Assessment,0,0
155482,Scale,0,1
155483,scores,0,0
155484,during,0,0
155485,treatment,0,0
155486,was,0,0
155487,associated,0,0
155488,with,0,1
155489,autism,0,1
155490,spectrum,0,1
155491,disorders,0,1
155492,symptomatic,0,1
155493,improvement,0,0
155494,(,0,1
155495,r,0,0
155496,=,0,1
155497,.414,0,0
155498,",",0,0
155499,p,0,0
155500,=,0,0
155501,.040,0,0
155502,),0,1
155503,and,0,0
155504,with,0,1
155505,improved,0,0
155506,general,0,1
155507,communication,0,0
155508,(,0,1
155509,r,0,0
155510,=,0,1
155511,.499,0,0
155512,",",0,0
155513,p,0,0
155514,=,0,0
155515,.013,0,0
155516,),0,1
155517,.,0,1
155518,Results,0,0
155519,support,0,0
155520,the,0,0
155521,importance,0,0
155522,of,0,0
155523,assessing,0,0
155524,global,0,0
155525,functioning,0,1
155526,in,0,0
155527,addition,0,0
155528,to,0,0
155529,symptom,0,0
155530,change,0,0
155531,and,0,0
155532,treatment,0,0
155533,response,0,0
155534,in,0,1
155535,clinical,0,1
155536,trials,0,1
155537,.,0,1
155538,Use,0,1
155539,of,0,0
155540,EORTC,0,1
155541,target,0,1
155542,definition,0,1
155543,guidelines,0,1
155544,for,0,1
155545,dose-intensified,0,1
155546,salvage,0,1
155547,radiation,0,1
155548,therapy,0,0
155549,for,0,0
155550,recurrent,0,1
155551,prostate,0,1
155552,cancer,0,1
155553,:,0,1
155554,results,0,0
155555,of,0,0
155556,the,0,0
155557,quality,0,0
155558,assurance,0,0
155559,program,0,1
155560,of,0,0
155561,the,0,0
155562,randomized,0,1
155563,trial,0,1
155564,SAKK,0,1
155565,09/10,0,1
155566,.,0,1
155567,PURPOSE,0,0
155568,Different,0,0
155569,international,0,1
155570,target,0,0
155571,volume,0,0
155572,delineation,0,0
155573,guidelines,0,1
155574,exist,0,0
155575,and,0,0
155576,different,0,0
155577,treatment,0,0
155578,techniques,0,0
155579,are,0,0
155580,available,0,0
155581,for,0,0
155582,salvage,0,1
155583,radiation,0,1
155584,therapy,0,0
155585,(,0,1
155586,RT,0,1
155587,),0,1
155588,for,0,0
155589,recurrent,0,1
155590,prostate,0,1
155591,cancer,0,1
155592,",",0,0
155593,but,0,0
155594,less,0,0
155595,is,0,0
155596,known,0,0
155597,regarding,0,0
155598,their,0,1
155599,respective,0,1
155600,applicability,0,0
155601,in,0,1
155602,clinical,0,0
155603,practice,0,1
155604,.,0,1
155605,METHODS,0,0
155606,AND,0,0
155607,MATERIALS,0,1
155608,A,0,1
155609,randomized,0,1
155610,phase,0,1
155611,III,0,1
155612,trial,0,1
155613,testing,0,1
155614,64,1,1
155615,Gy,1,1
155616,vs,1,0
155617,70,1,1
155618,Gy,1,1
155619,salvage,1,1
155620,RT,1,1
155621,was,0,0
155622,accompanied,0,0
155623,by,0,0
155624,an,0,0
155625,intense,0,0
155626,quality,0,0
155627,assurance,0,0
155628,program,0,1
155629,including,0,0
155630,a,0,1
155631,site-specific,0,0
155632,and,0,0
155633,study-specific,0,0
155634,questionnaire,0,0
155635,and,0,0
155636,a,0,0
155637,dummy,0,1
155638,run,0,0
155639,(,0,1
155640,DR,0,0
155641,),0,1
155642,.,0,1
155643,Target,0,0
155644,volume,0,0
155645,delineation,0,0
155646,was,0,0
155647,performed,0,0
155648,according,0,1
155649,to,0,0
155650,the,0,0
155651,European,0,1
155652,Organisation,0,1
155653,for,0,0
155654,the,0,0
155655,Research,0,1
155656,and,0,0
155657,Treatment,0,0
155658,of,0,1
155659,Cancer,0,1
155660,guidelines,0,1
155661,",",0,1
155662,and,0,0
155663,a,0,0
155664,DR-based,0,0
155665,treatment,0,0
155666,plan,0,1
155667,was,0,0
155668,established,0,0
155669,for,0,1
155670,70,0,1
155671,Gy,0,1
155672,.,0,1
155673,Major,0,0
155674,and,0,0
155675,minor,0,0
155676,protocol,0,1
155677,deviations,0,0
155678,were,0,1
155679,noted,0,0
155680,",",0,0
155681,interobserver,0,0
155682,agreement,0,0
155683,of,0,0
155684,delineated,0,0
155685,target,0,1
155686,contours,0,1
155687,was,0,0
155688,assessed,0,0
155689,",",0,0
155690,and,0,0
155691,dose-volume,0,0
155692,histogram,0,0
155693,(,0,1
155694,DVH,0,1
155695,),0,1
155696,parameters,0,0
155697,of,0,1
155698,different,0,1
155699,treatment,0,1
155700,techniques,0,0
155701,were,0,1
155702,compared,0,0
155703,.,0,1
155704,RESULTS,0,0
155705,Thirty,1,1
155706,European,1,1
155707,centers,1,1
155708,participated,1,1
155709,",",1,1
155710,43,1,1
155711,%,1,0
155712,of,1,0
155713,which,1,0
155714,were,1,1
155715,using,1,0
155716,3-dimensional,1,1
155717,conformal,1,1
155718,RT,1,1
155719,(,1,1
155720,3D-CRT,1,1
155721,),1,1
155722,",",1,0
155723,with,1,1
155724,the,1,0
155725,remaining,1,1
155726,centers,1,1
155727,using,1,1
155728,intensity,1,0
155729,modulated,1,0
155730,RT,1,1
155731,(,1,1
155732,IMRT,1,1
155733,),1,1
155734,or,1,1
155735,volumetric,1,0
155736,modulated,1,0
155737,arc,1,1
155738,technique,1,0
155739,(,1,1
155740,VMAT,1,0
155741,),1,1
155742,.,1,1
155743,The,0,0
155744,first,0,0
155745,submitted,0,0
155746,version,0,0
155747,of,0,0
155748,the,0,0
155749,DR,0,0
155750,contained,0,0
155751,major,0,1
155752,deviations,0,1
155753,in,0,1
155754,21,0,1
155755,of,0,1
155756,30,0,1
155757,(,0,1
155758,70,0,1
155759,%,0,0
155760,),0,1
155761,centers,0,1
155762,",",0,1
155763,mostly,0,1
155764,caused,0,0
155765,by,0,0
155766,inappropriately,0,1
155767,defined,0,0
155768,or,0,0
155769,lack,0,0
155770,of,0,0
155771,prostate,0,1
155772,bed,0,0
155773,(,0,1
155774,PB,0,0
155775,),0,1
155776,.,0,1
155777,All,0,1
155778,but,0,0
155779,5,1,1
155780,centers,1,1
155781,completed,1,1
155782,the,1,0
155783,DR,1,0
155784,successfully,1,0
155785,with,0,1
155786,their,0,1
155787,second,0,1
155788,submitted,0,1
155789,version,0,1
155790,.,0,1
155791,The,0,0
155792,interobserver,0,0
155793,agreement,0,0
155794,of,0,0
155795,the,0,0
155796,PB,0,0
155797,was,0,0
155798,moderate,0,1
155799,and,0,1
155800,was,0,0
155801,improved,0,0
155802,by,0,0
155803,the,0,0
155804,DR,0,0
155805,review,0,0
155806,",",0,0
155807,as,0,0
155808,indicated,0,0
155809,by,0,0
155810,an,0,1
155811,increased,0,0
155812,?,0,1
155813,value,0,0
155814,(,0,0
155815,0.59,0,0
155816,vs,0,0
155817,0.55,0,0
155818,),0,0
155819,",",0,0
155820,mean,0,1
155821,sensitivity,0,0
155822,(,0,1
155823,0.64,0,0
155824,vs,0,0
155825,0.58,0,0
155826,),0,0
155827,",",0,0
155828,volume,0,0
155829,of,0,0
155830,total,0,1
155831,agreement,0,1
155832,(,0,1
155833,3.9,0,0
155834,vs,0,0
155835,3.3,0,1
155836,cm,0,1
155837,(,0,1
155838,3,0,1
155839,),0,1
155840,),0,1
155841,",",0,0
155842,and,0,0
155843,decrease,0,0
155844,in,0,0
155845,the,0,0
155846,union,0,1
155847,volume,0,0
155848,(,0,1
155849,79.3,0,0
155850,vs,0,0
155851,84.2,0,0
155852,cm,0,1
155853,(,0,1
155854,3,0,1
155855,),0,1
155856,),0,1
155857,.,0,1
155858,Rectal,0,1
155859,and,0,0
155860,bladder,0,1
155861,wall,0,1
155862,DVH,0,1
155863,parameters,0,0
155864,of,0,1
155865,IMRT,0,1
155866,and,0,1
155867,VMAT,0,0
155868,vs,0,0
155869,3D-CRT,0,1
155870,plans,0,1
155871,were,0,1
155872,not,0,0
155873,significantly,0,0
155874,different,0,0
155875,.,0,0
155876,CONCLUSIONS,0,0
155877,The,0,0
155878,interobserver,0,0
155879,agreement,0,0
155880,of,0,0
155881,PB,0,0
155882,delineation,0,0
155883,was,0,0
155884,moderate,0,1
155885,but,0,0
155886,was,0,0
155887,improved,0,0
155888,by,0,0
155889,the,0,0
155890,DR.,0,1
155891,Major,0,1
155892,deviations,0,0
155893,could,0,0
155894,be,0,0
155895,identified,0,0
155896,for,0,0
155897,the,0,0
155898,majority,0,1
155899,of,0,0
155900,centers,0,1
155901,.,0,1
155902,The,0,0
155903,DR,0,0
155904,has,0,0
155905,improved,0,0
155906,the,0,0
155907,acquaintance,0,0
155908,of,0,0
155909,the,0,0
155910,participating,0,1
155911,centers,0,1
155912,with,0,1
155913,the,0,0
155914,trial,0,0
155915,protocol,0,0
155916,.,0,1
155917,Effectiveness,0,0
155918,of,0,0
155919,a,0,1
155920,theory-based,0,0
155921,intervention,0,0
155922,to,0,0
155923,increase,0,0
155924,colorectal,1,1
155925,cancer,1,1
155926,screening,1,1
155927,among,1,1
155928,Iranian,1,1
155929,health,1,1
155930,club,1,1
155931,members,1,1
155932,:,1,1
155933,a,0,1
155934,randomized,0,1
155935,trial,0,1
155936,.,0,1
155937,Colorectal,0,0
155938,cancer,0,1
155939,is,0,0
155940,the,0,0
155941,third,0,0
155942,most,0,0
155943,commonly,0,1
155944,diagnosed,0,1
155945,cancer,0,1
155946,and,0,0
155947,the,0,0
155948,fourth,0,0
155949,leading,0,0
155950,cause,0,0
155951,of,0,0
155952,death,0,0
155953,in,0,0
155954,the,0,0
155955,world,0,0
155956,.,0,0
155957,There,0,0
155958,are,0,0
155959,few,0,0
155960,published,0,1
155961,studies,0,0
155962,that,0,0
155963,have,0,0
155964,used,0,0
155965,theory-based,0,1
155966,interventions,0,0
155967,designed,0,0
155968,to,0,1
155969,increase,0,0
155970,colorectal,0,1
155971,cancer,0,1
155972,screening,0,1
155973,in,0,0
155974,community,0,1
155975,lay,0,1
155976,health,0,1
155977,organizations,0,1
155978,.,0,1
155979,The,0,0
155980,present,0,0
155981,study,0,1
155982,was,0,0
155983,guided,0,1
155984,by,0,0
155985,the,0,0
155986,theoretical,0,0
155987,concepts,0,0
155988,of,0,1
155989,the,0,1
155990,preventive,0,1
155991,health,0,1
155992,model,0,0
155993,.,0,1
155994,Twelve,1,1
155995,health,1,1
155996,clubs,1,1
155997,of,1,0
155998,a,1,1
155999,municipal,1,1
156000,district,1,1
156001,in,1,1
156002,Tehran,1,1
156003,were,1,1
156004,randomized,1,1
156005,to,0,1
156006,two,0,1
156007,study,0,1
156008,groups,0,1
156009,with,0,1
156010,equal,0,1
156011,ratio,0,0
156012,.,0,1
156013,The,0,0
156014,control,0,0
156015,group,0,0
156016,received,0,1
156017,usual,0,1
156018,services,0,1
156019,throughout,0,0
156020,the,0,0
156021,study,0,0
156022,while,0,0
156023,the,0,0
156024,intervention,0,0
156025,group,0,0
156026,also,0,0
156027,received,0,0
156028,a,0,0
156029,theory-based,0,0
156030,educational,0,1
156031,program,0,1
156032,on,0,0
156033,colorectal,0,1
156034,cancer,0,1
156035,screening,0,1
156036,plus,0,0
156037,a,0,1
156038,reminder,0,0
156039,call,0,0
156040,.,0,1
156041,Screening,0,1
156042,behavior,0,0
156043,",",0,0
156044,the,0,0
156045,main,0,0
156046,outcome,0,0
156047,",",0,0
156048,was,0,0
156049,assessed,0,0
156050,4,0,0
156051,months,0,0
156052,after,0,1
156053,randomization,0,1
156054,.,0,1
156055,A,1,0
156056,total,1,1
156057,of,1,0
156058,360,1,1
156059,members,1,1
156060,aged,1,1
156061,50,1,1
156062,and,1,0
156063,older,1,1
156064,from,1,1
156065,12,1,1
156066,health,1,1
156067,clubs,1,1
156068,completed,1,1
156069,a,1,1
156070,baseline,1,0
156071,survey,1,1
156072,.,1,1
156073,Participants,0,1
156074,in,0,0
156075,the,0,0
156076,intervention,0,0
156077,group,0,0
156078,reported,0,1
156079,increased,0,0
156080,knowledge,0,0
156081,of,0,0
156082,colorectal,0,1
156083,cancer,0,1
156084,and,0,1
156085,screening,0,1
156086,tests,0,0
156087,at,0,1
156088,4,0,1
156089,months,0,1
156090,follow-up,0,1
156091,(,0,1
156092,p,0,0
156093,'s,0,1
156094,<,0,0
156095,.001,0,0
156096,),0,1
156097,.,0,1
156098,Moreover,0,0
156099,",",0,0
156100,exposure,0,0
156101,to,0,0
156102,the,0,0
156103,theory-based,0,0
156104,intervention,0,0
156105,significantly,0,0
156106,improved,0,0
156107,self-efficacy,0,0
156108,",",0,0
156109,perceived,0,0
156110,susceptibility,0,0
156111,",",0,0
156112,efficacy,0,0
156113,of,0,0
156114,screening,0,1
156115,",",0,0
156116,social,0,0
156117,support,0,0
156118,",",0,0
156119,and,0,0
156120,intention,0,0
156121,to,0,0
156122,be,0,0
156123,screened,0,1
156124,for,0,0
156125,colorectal,0,1
156126,cancer,0,1
156127,",",0,0
156128,from,0,0
156129,baseline,0,0
156130,to,0,1
156131,4,0,1
156132,months,0,1
156133,follow-up,0,1
156134,(,0,1
156135,p,0,0
156136,'s,0,1
156137,<,0,0
156138,.001,0,0
156139,),0,1
156140,.,0,1
156141,The,0,0
156142,screening,0,0
156143,rate,0,0
156144,for,0,0
156145,colorectal,0,1
156146,cancer,0,1
156147,was,0,0
156148,significantly,0,0
156149,higher,0,0
156150,in,0,0
156151,the,0,0
156152,intervention,0,0
156153,group,0,0
156154,compared,0,0
156155,to,0,0
156156,the,0,0
156157,control,0,0
156158,group,0,1
156159,(,0,1
156160,odds,0,0
156161,ratio,0,0
156162,=,0,1
156163,15.93,0,0
156164,",",0,1
156165,95,0,0
156166,%,0,0
156167,CI,0,0
156168,=,0,1
156169,5.57,0,0
156170,",",0,1
156171,45.53,0,0
156172,),0,1
156173,.,0,1
156174,Our,0,0
156175,theory-based,0,0
156176,intervention,0,1
156177,was,0,0
156178,found,0,0
156179,to,0,0
156180,have,0,0
156181,a,0,0
156182,significant,0,0
156183,effect,0,0
156184,on,0,0
156185,colorectal,0,1
156186,cancer,0,1
156187,screening,0,1
156188,use,0,0
156189,as,0,0
156190,measured,0,0
156191,by,0,0
156192,self-report,0,1
156193,.,0,1
156194,The,0,0
156195,findings,0,0
156196,could,0,0
156197,have,0,1
156198,implications,0,0
156199,for,0,0
156200,colorectal,0,1
156201,cancer,0,1
156202,screening,0,1
156203,program,0,1
156204,development,0,0
156205,and,0,0
156206,implementation,0,0
156207,in,0,0
156208,primary,0,1
156209,health,0,1
156210,care,0,1
156211,settings,0,1
156212,and,0,1
156213,through,0,1
156214,other,0,1
156215,community,0,1
156216,organizations,0,1
156217,.,0,1
156218,[,0,1
156219,Treatment,0,0
156220,of,0,1
156221,autism,1,1
156222,children,1,1
156223,:,1,1
156224,observation,0,1
156225,on,0,0
156226,efficacy,0,0
156227,of,0,0
156228,behavior,0,0
156229,training,0,1
156230,with,0,1
156231,retention,0,0
156232,of,0,1
156233,needles,0,0
156234,on,0,1
156235,head,0,1
156236,],0,1
156237,.,0,1
156238,OBJECTIVE,0,0
156239,To,0,0
156240,observe,0,0
156241,the,0,0
156242,effect,0,0
156243,difference,0,0
156244,of,0,0
156245,behavior,0,0
156246,training,0,1
156247,with,0,1
156248,head,0,1
156249,needling,0,0
156250,retention,0,0
156251,and,0,1
156252,behavior,0,0
156253,training,0,0
156254,after,0,0
156255,acupuncture,0,0
156256,for,0,1
156257,autism,1,1
156258,children,1,1
156259,.,1,1
156260,METHODS,0,0
156261,Sixty,1,1
156262,qualified,1,1
156263,autism,1,1
156264,children,1,1
156265,were,0,1
156266,divided,0,1
156267,randomly,0,1
156268,into,0,1
156269,simultaneous,0,0
156270,head,0,1
156271,needling,0,0
156272,retention,0,0
156273,and,0,1
156274,behavior,0,0
156275,training,0,0
156276,group,0,1
156277,(,0,0
156278,trial,0,0
156279,group,0,1
156280,),0,1
156281,and,0,0
156282,behavior,0,0
156283,training,0,0
156284,after,0,0
156285,acupuncture,0,0
156286,treatment,0,0
156287,group,0,0
156288,(,0,0
156289,control,0,1
156290,group,0,1
156291,),0,1
156292,with,0,1
156293,30,0,1
156294,case,0,1
156295,in,0,0
156296,each,0,0
156297,group,0,1
156298,.,0,1
156299,Retention,0,0
156300,needles,0,0
156301,on,0,0
156302,the,0,0
156303,head,0,1
156304,with,0,1
156305,simultaneous,0,0
156306,behavior,0,1
156307,training,0,0
156308,was,0,0
156309,applied,0,0
156310,for,0,0
156311,the,0,0
156312,trial,0,0
156313,group,0,0
156314,.,0,1
156315,The,0,0
156316,main,0,0
156317,acupoints,0,0
156318,included,0,1
156319,Sishen,0,0
156320,Xue,0,0
156321,",",0,1
156322,Dingshen,0,0
156323,Sanxue,0,0
156324,(,0,1
156325,3,0,1
156326,points,0,0
156327,for,0,1
156328,mental,0,1
156329,tranquilization,0,1
156330,),0,1
156331,",",0,0
156332,Nao,0,1
156333,Sanxue,0,0
156334,(,0,1
156335,3,0,1
156336,points,0,0
156337,for,0,1
156338,the,0,0
156339,function,0,0
156340,of,0,0
156341,brain,0,1
156342,),0,1
156343,",",0,0
156344,Shou,0,1
156345,Zhisanxue,0,0
156346,(,0,1
156347,3,0,1
156348,points,0,0
156349,for,0,1
156350,mental,0,1
156351,activities,0,0
156352,on,0,1
156353,hand,0,1
156354,),0,1
156355,and,0,1
156356,Zozhi,0,1
156357,Sonxue,0,0
156358,(,0,1
156359,3,0,1
156360,points,0,0
156361,for,0,1
156362,mental,0,1
156363,activities,0,0
156364,on,0,1
156365,foot,0,1
156366,),0,1
156367,.,0,1
156368,Other,0,0
156369,points,0,0
156370,were,0,1
156371,combined,0,0
156372,according,0,1
156373,to,0,1
156374,conditions,0,1
156375,of,0,1
156376,patients,0,1
156377,.,0,1
156378,Needles,0,0
156379,on,0,0
156380,the,0,1
156381,4,0,0
156382,extremities,0,1
156383,were,0,1
156384,withdrawn,0,0
156385,first,0,0
156386,after,0,1
156387,30,0,1
156388,minutes,0,0
156389,",",0,1
156390,needles,0,0
156391,on,0,0
156392,head,0,1
156393,were,0,1
156394,remained,0,0
156395,during,0,0
156396,behavior,0,0
156397,training,0,1
156398,.,0,1
156399,While,0,1
156400,behavior,0,0
156401,training,0,1
156402,was,0,0
156403,applied,0,0
156404,to,0,0
156405,the,0,0
156406,control,0,0
156407,group,0,0
156408,when,0,0
156409,acupuncture,0,0
156410,treatment,0,0
156411,was,0,0
156412,completely,0,0
156413,accomplished,0,0
156414,.,0,1
156415,Treatments,0,0
156416,were,0,0
156417,applied,0,0
156418,once,0,0
156419,a,0,0
156420,day,0,0
156421,to,0,0
156422,both,0,0
156423,groups,0,0
156424,.,0,1
156425,And,0,1
156426,3,0,1
156427,months,0,0
156428,was,0,0
156429,taken,0,0
156430,as,0,0
156431,one,0,1
156432,observation,0,1
156433,cycle,0,0
156434,.,0,1
156435,Estimation,0,0
156436,was,0,0
156437,made,0,0
156438,on,0,0
156439,therapeutic,0,0
156440,effect,0,0
156441,and,0,0
156442,developing,0,0
156443,level,0,0
156444,of,0,1
156445,autism,1,1
156446,children,1,1
156447,with,0,1
156448,CARS,0,1
156449,and,0,1
156450,PEP,0,1
156451,.,0,1
156452,RESULTS,0,0
156453,The,0,0
156454,total,0,1
156455,effective,0,0
156456,rate,0,0
156457,of,0,0
156458,the,0,0
156459,trial,0,0
156460,group,0,1
156461,was,0,0
156462,83.3,0,0
156463,%,0,0
156464,(,0,1
156465,25/30,0,0
156466,),0,0
156467,",",0,0
156468,better,0,0
156469,than,0,0
156470,66.7,0,0
156471,%,0,0
156472,(,0,1
156473,20/30,0,0
156474,),0,1
156475,of,0,0
156476,the,0,0
156477,control,0,1
156478,group,0,0
156479,(,0,1
156480,P,0,0
156481,<,0,0
156482,0.05,0,0
156483,),0,1
156484,.,0,1
156485,The,0,0
156486,CARS,0,0
156487,scores,0,0
156488,of,0,1
156489,both,0,0
156490,groups,0,0
156491,declined,0,0
156492,after,0,0
156493,the,0,0
156494,treatment,0,0
156495,.,0,0
156496,And,0,0
156497,the,0,0
156498,score,0,0
156499,of,0,0
156500,trail,0,1
156501,group,0,1
156502,was,0,0
156503,lower,0,0
156504,than,0,0
156505,the,0,0
156506,control,0,1
156507,group,0,0
156508,(,0,0
156509,all,0,0
156510,P,0,0
156511,<,0,0
156512,0.05,0,0
156513,),0,1
156514,.,0,1
156515,While,0,1
156516,the,0,0
156517,PEP,0,1
156518,scores,0,0
156519,of,0,1
156520,both,0,0
156521,groups,0,0
156522,increased,0,0
156523,",",0,0
156524,and,0,0
156525,the,0,0
156526,score,0,0
156527,of,0,0
156528,trail,0,1
156529,group,0,1
156530,was,0,0
156531,higher,0,0
156532,than,0,0
156533,the,0,0
156534,control,0,1
156535,group,0,0
156536,(,0,0
156537,all,0,0
156538,P,0,0
156539,<,0,0
156540,0.05,0,0
156541,),0,1
156542,.,0,1
156543,The,0,0
156544,increasing,0,0
156545,level,0,0
156546,of,0,1
156547,scores,0,0
156548,of,0,1
156549,cognitive,0,1
156550,understanding,0,0
156551,and,0,1
156552,cognitive,0,0
156553,expression,0,0
156554,were,0,0
156555,all,0,0
156556,better,0,0
156557,than,0,0
156558,the,0,0
156559,control,0,1
156560,group,0,0
156561,(,0,0
156562,all,0,0
156563,P,0,0
156564,<,0,0
156565,0.05,0,0
156566,),0,1
156567,.,0,1
156568,CONCLUSION,0,0
156569,The,0,0
156570,effect,0,0
156571,of,0,0
156572,behavior,0,0
156573,training,0,1
156574,with,0,1
156575,head,0,1
156576,needle,0,1
156577,retention,0,0
156578,on,0,0
156579,autism,1,1
156580,children,1,1
156581,is,0,0
156582,better,0,0
156583,than,0,0
156584,behavior,0,0
156585,training,0,1
156586,after,0,0
156587,acupuncture,0,0
156588,treatment,0,0
156589,",",0,0
156590,especially,0,0
156591,in,0,0
156592,enhancing,0,0
156593,cognition,0,0
156594,understanding,0,0
156595,and,0,0
156596,cognition,0,0
156597,expression,0,0
156598,.,0,1
156599,Possible,0,1
156600,etiology,0,1
156601,of,0,1
156602,improvements,0,0
156603,in,0,1
156604,both,0,0
156605,quality,0,0
156606,of,0,0
156607,life,0,1
156608,and,0,1
156609,overlapping,0,1
156610,gastroesophageal,0,1
156611,reflux,0,1
156612,disease,0,1
156613,by,0,0
156614,proton,0,0
156615,pump,0,1
156616,inhibitor,0,0
156617,treatment,0,0
156618,in,0,0
156619,a,0,1
156620,prospective,0,1
156621,randomized,0,1
156622,controlled,0,0
156623,trial,0,0
156624,.,0,1
156625,BACKGROUND,0,0
156626,Symptoms,0,0
156627,suggestive,0,0
156628,of,0,0
156629,functional,0,1
156630,dyspepsia,0,1
156631,(,0,1
156632,FD,0,0
156633,),0,1
156634,and,0,1
156635,irritable,0,1
156636,bowel,0,1
156637,syndrome,0,1
156638,(,0,1
156639,IBS,0,0
156640,),0,0
156641,frequently,0,1
156642,overlap,0,0
156643,with,0,0
156644,those,0,1
156645,of,0,0
156646,gastroesophageal,0,1
156647,reflux,0,1
156648,disease,0,1
156649,.,0,1
156650,Despite,0,0
156651,the,0,0
156652,high,0,1
156653,prevalence,0,0
156654,of,0,0
156655,symptomatic,0,1
156656,overlap,0,0
156657,",",0,0
156658,the,0,0
156659,underlying,0,0
156660,etiology,0,0
156661,remains,0,0
156662,poorly,0,0
156663,defined,0,0
156664,.,0,1
156665,We,0,0
156666,assessed,0,0
156667,the,0,0
156668,correlation,0,0
156669,of,0,0
156670,symptomatic,0,1
156671,relief,0,0
156672,and,0,1
156673,health-related,0,0
156674,quality,0,0
156675,of,0,0
156676,life,0,1
156677,(,0,1
156678,HRQoL,0,0
156679,),0,1
156680,with,0,1
156681,healing,0,0
156682,of,0,0
156683,reflux,0,1
156684,esophagitis,0,1
156685,to,0,0
156686,further,0,0
156687,derive,0,0
156688,insights,0,0
156689,into,0,1
156690,the,0,1
156691,underlying,0,1
156692,etiology,0,1
156693,.,0,1
156694,METHODS,0,0
156695,626,1,1
156696,patients,1,1
156697,with,1,1
156698,reflux,1,1
156699,esophagitis,1,1
156700,were,0,1
156701,enrolled,0,1
156702,into,0,1
156703,one,0,1
156704,of,0,1
156705,two,0,1
156706,treatment,0,1
156707,groups,0,1
156708,(,0,1
156709,classical,0,1
156710,healing,0,0
156711,concept,0,0
156712,or,0,1
156713,the,0,0
156714,complete,0,0
156715,remission,0,1
156716,concept,0,0
156717,),0,0
156718,to,0,0
156719,investigate,0,0
156720,differences,0,0
156721,in,0,0
156722,treatment,0,1
156723,intensity,0,0
156724,.,0,1
156725,Patients,0,1
156726,were,0,0
156727,treated,0,1
156728,with,0,1
156729,pantoprazole,0,0
156730,until,0,1
156731,esophageal,0,1
156732,mucosal,0,1
156733,healing,0,0
156734,.,0,1
156735,Remission,0,0
156736,was,0,0
156737,followed,0,0
156738,for,0,0
156739,up,0,1
156740,to,0,1
156741,6,0,0
156742,months,0,0
156743,without,0,1
156744,treatment,0,1
156745,.,0,1
156746,Gastro-intestinal,0,1
156747,symptoms,0,0
156748,and,0,1
156749,HRQoL,0,0
156750,were,0,1
156751,analyzed,0,0
156752,using,0,0
156753,disease-specific,0,0
156754,",",0,0
156755,psychometrically,0,1
156756,validated,0,0
156757,patient-reported,0,0
156758,outcome,0,0
156759,instruments,0,0
156760,(,0,1
156761,ReQuest?,0,1
156762,",",0,1
156763,GERDyzer?,0,0
156764,),0,1
156765,.,0,1
156766,RESULTS,0,0
156767,Symptomatic,0,1
156768,burden,0,1
156769,reflected,0,0
156770,by,0,0
156771,ReQuest?,0,0
156772,substantially,0,0
156773,decreased,0,0
156774,from,0,0
156775,baseline,0,0
156776,to,0,0
156777,end,0,0
156778,of,0,0
156779,treatment,0,0
156780,by,0,0
156781,83,0,1
156782,%,0,0
156783,and,0,1
156784,88,0,0
156785,%,0,0
156786,in,0,0
156787,either,0,0
156788,treatment,0,0
156789,group,0,0
156790,",",0,0
156791,respectively,0,0
156792,.,0,0
156793,ReQuest?,0,0
156794,scores,0,0
156795,significantly,0,0
156796,decreased,0,0
156797,in,0,0
156798,patients,0,1
156799,with,0,1
156800,or,0,1
156801,without,0,1
156802,heartburn,0,1
156803,and,0,0
156804,in,0,0
156805,those,0,1
156806,with,0,1
156807,symptoms,0,0
156808,suggestive,0,1
156809,of,0,1
156810,FD,0,0
156811,and,0,1
156812,IBS,0,0
156813,",",0,0
156814,indicating,0,0
156815,response,0,0
156816,of,0,0
156817,all,0,1
156818,symptom,0,1
156819,categories,0,1
156820,to,0,1
156821,treatment,0,1
156822,(,0,1
156823,p,0,0
156824,<,0,0
156825,0.005,0,0
156826,),0,1
156827,.,0,1
156828,Therapy-associated,0,0
156829,relief,0,0
156830,of,0,1
156831,symptoms,0,1
156832,was,0,0
156833,paralleled,0,0
156834,by,0,0
156835,substantial,0,0
156836,gains,0,1
156837,in,0,1
156838,HRQoL,0,0
156839,",",0,1
156840,which,0,0
156841,continued,0,0
156842,to,0,0
156843,stabilize,0,0
156844,post-treatment,0,0
156845,.,0,1
156846,CONCLUSIONS,0,0
156847,Pantoprazole,0,0
156848,is,0,0
156849,effective,0,0
156850,in,0,0
156851,relieving,0,0
156852,upper,0,1
156853,and,0,1
156854,lower,0,0
156855,gastro-intestinal,0,1
156856,symptoms,0,0
156857,overlapping,0,1
156858,with,0,1
156859,erosive,0,1
156860,esophagitis,0,1
156861,",",0,0
156862,and,0,0
156863,provides,0,0
156864,sustained,0,0
156865,improvement,0,0
156866,in,0,1
156867,HRQoL,0,0
156868,post-treatment,0,0
156869,.,0,1
156870,Our,0,0
156871,results,0,0
156872,propose,0,0
156873,a,0,0
156874,link,0,0
156875,between,0,0
156876,both,0,0
156877,healing,0,0
156878,of,0,0
156879,erosive,0,1
156880,esophagitis,0,1
156881,and,0,0
156882,the,0,0
156883,slower,0,0
156884,remission,0,1
156885,of,0,0
156886,upper,0,1
156887,and,0,1
156888,lower,0,0
156889,gastro-intestinal,0,1
156890,symptoms,0,0
156891,.,0,1
156892,Since,0,1
156893,the,0,0
156894,improvement,0,0
156895,observed,0,0
156896,is,0,0
156897,likely,0,0
156898,to,0,0
156899,be,0,0
156900,multifactorial,0,0
156901,",",0,0
156902,the,0,0
156903,possibility,0,0
156904,for,0,0
156905,an,0,0
156906,immune-mediated,0,1
156907,etiology,0,1
156908,and,0,0
156909,identification,0,1
156910,of,0,0
156911,putative,0,1
156912,susceptibility,0,0
156913,factors,0,0
156914,by,0,0
156915,genome-wide,0,1
156916,association,0,0
156917,study,0,0
156918,may,0,0
156919,provide,0,0
156920,focus,0,0
156921,for,0,0
156922,future,0,0
156923,research,0,1
156924,.,0,1
156925,TRIAL,0,0
156926,REGISTRATION,0,0
156927,ClinicalTrials.gov,0,1
156928,identifier,0,1
156929,:,0,1
156930,NCT00325676,0,1
156931,.,0,1
156932,Pimecrolimus,0,0
156933,cream,0,0
156934,and,0,1
156935,Tacrolimus,0,0
156936,ointment,0,0
156937,in,0,0
156938,the,0,0
156939,treatment,0,0
156940,of,0,0
156941,atopic,1,1
156942,dermatitis,1,1
156943,:,1,1
156944,a,0,0
156945,pilot,0,0
156946,study,0,0
156947,on,0,0
156948,patient,0,1
156949,preference,0,1
156950,.,0,1
156951,BACKGROUND,0,0
156952,Pimecrolimus,0,0
156953,cream,0,0
156954,1,0,0
156955,%,0,0
156956,is,0,0
156957,approved,0,1
156958,for,0,0
156959,mild,1,1
156960,to,1,0
156961,moderate,1,1
156962,atopic,1,1
156963,dermatitis,1,1
156964,in,1,0
156965,children,1,1
156966,older,1,1
156967,than,1,1
156968,two,1,0
156969,years,1,1
156970,of,1,1
156971,age,1,1
156972,and,1,1
156973,adults,1,1
156974,.,1,1
156975,Tacrolimus,0,0
156976,ointment,0,0
156977,0.03,0,0
156978,%,0,0
156979,is,0,0
156980,approved,0,1
156981,for,0,0
156982,moderate,1,1
156983,to,1,1
156984,severe,1,1
156985,atopic,1,1
156986,dermatitis,1,1
156987,in,1,0
156988,the,1,0
156989,patient,1,1
156990,population,1,1
156991,between,1,0
156992,two,1,0
156993,to,1,1
156994,seventeen,1,1
156995,years,1,1
156996,of,1,0
156997,age,1,1
156998,and,0,1
156999,Tacrolimus,0,0
157000,0.1,0,0
157001,%,0,0
157002,ointment,0,1
157003,for,0,0
157004,moderate,1,1
157005,to,1,1
157006,severe,1,1
157007,atopic,1,1
157008,dermatitis,1,1
157009,in,1,1
157010,patients,1,1
157011,18,1,1
157012,years,1,1
157013,of,1,1
157014,age,1,1
157015,and,1,1
157016,older,1,1
157017,.,1,1
157018,However,0,0
157019,",",0,0
157020,beyond,0,0
157021,safety,0,0
157022,and,0,0
157023,efficacy,0,0
157024,",",0,0
157025,the,0,0
157026,delivery,0,0
157027,system,0,0
157028,or,0,1
157029,vehicle,0,0
157030,used,0,0
157031,in,0,0
157032,topical,0,0
157033,treatment,0,1
157034,formulations,0,0
157035,is,0,0
157036,equally,0,0
157037,important,0,0
157038,in,0,0
157039,affecting,0,0
157040,patient,0,1
157041,satisfaction,0,0
157042,",",0,0
157043,tolerability,0,0
157044,",",0,0
157045,and,0,0
157046,subsequent,0,0
157047,treatment,0,0
157048,compliance,0,0
157049,and,0,0
157050,hence,0,0
157051,clinical,0,0
157052,resolution,0,0
157053,of,0,0
157054,active,0,1
157055,disease,0,1
157056,.,0,1
157057,The,0,0
157058,Autism,0,1
157059,MEAL,0,0
157060,Plan,0,1
157061,:,0,1
157062,a,0,0
157063,parent-training,0,0
157064,curriculum,0,0
157065,to,0,0
157066,manage,0,1
157067,eating,0,1
157068,aversions,0,0
157069,and,0,1
157070,low,0,1
157071,intake,0,0
157072,among,0,1
157073,children,1,1
157074,with,1,1
157075,autism,1,1
157076,.,1,1
157077,Feeding,0,0
157078,problems,0,0
157079,represent,0,0
157080,a,0,0
157081,frequent,0,0
157082,concern,0,0
157083,reported,0,1
157084,by,0,0
157085,caregivers,1,1
157086,of,1,1
157087,children,1,1
157088,with,1,1
157089,autism,1,1
157090,spectrum,1,1
157091,disorders,1,1
157092,",",0,1
157093,and,0,0
157094,growing,0,0
157095,evidence,0,0
157096,suggests,0,0
157097,atypical,0,1
157098,patterns,0,0
157099,of,0,0
157100,intake,0,0
157101,may,0,0
157102,place,0,0
157103,this,0,0
157104,population,0,1
157105,at,0,0
157106,risk,0,1
157107,of,0,0
157108,nutritional,0,1
157109,and/or,0,1
157110,related,0,0
157111,medical,0,1
157112,issues,0,0
157113,",",0,1
157114,including,0,1
157115,chronic,0,1
157116,vitamin,0,1
157117,and,0,1
157118,mineral,0,1
157119,deficiencies,0,1
157120,",",0,1
157121,poor,0,1
157122,bone,0,0
157123,growth,0,0
157124,",",0,0
157125,and,0,0
157126,obesity,0,1
157127,.,0,1
157128,This,0,0
157129,combination,0,0
157130,of,0,0
157131,factors,0,0
157132,emphasizes,0,0
157133,a,0,0
157134,clear,0,0
157135,need,0,0
157136,to,0,0
157137,identify,0,0
157138,and,0,0
157139,disseminate,0,0
157140,evidence-based,0,0
157141,treatment,0,0
157142,of,0,1
157143,feeding,0,1
157144,problems,0,1
157145,associated,0,0
157146,with,0,1
157147,autism,0,1
157148,spectrum,0,1
157149,disorders,0,1
157150,.,0,1
157151,Behavioral,0,0
157152,intervention,0,0
157153,represents,0,0
157154,an,0,0
157155,effective,0,0
157156,treatment,0,0
157157,for,0,0
157158,chronic,0,1
157159,feeding,0,1
157160,concerns,0,0
157161,in,0,0
157162,this,0,0
157163,population,0,1
157164,;,0,0
157165,however,0,0
157166,",",0,0
157167,evidence,0,0
157168,has,0,0
157169,largely,0,0
157170,been,0,0
157171,established,0,0
157172,with,0,1
157173,trained,0,1
157174,therapists,0,0
157175,working,0,1
157176,in,0,1
157177,highly,0,1
157178,structured,0,1
157179,settings,0,1
157180,.,0,1
157181,This,0,0
157182,pilot,0,0
157183,study,0,0
157184,seeks,0,0
157185,to,0,0
157186,fill,0,0
157187,this,0,0
157188,gap,0,0
157189,in,0,0
157190,the,0,0
157191,literature,0,0
157192,by,0,0
157193,describing,0,0
157194,and,0,0
157195,evaluating,0,0
157196,the,0,0
157197,Autism,0,1
157198,MEAL,0,0
157199,Plan,0,1
157200,",",0,0
157201,a,0,0
157202,behaviorally,0,1
157203,based,0,1
157204,parent-training,0,0
157205,curriculum,0,0
157206,to,0,0
157207,address,0,0
157208,feeding,0,1
157209,problems,0,1
157210,associated,0,0
157211,with,0,1
157212,autism,0,1
157213,spectrum,0,1
157214,disorders,0,1
157215,.,0,1
157216,We,0,0
157217,assessed,0,0
157218,the,0,0
157219,feasibility,0,0
157220,of,0,0
157221,the,0,0
157222,intervention,0,0
157223,in,0,0
157224,terms,0,0
157225,of,0,1
157226,program,0,1
157227,content,0,0
157228,and,0,0
157229,study,0,1
157230,protocol,0,0
157231,(,0,1
157232,e.g,0,0
157233,.,0,1
157234,recruitment,0,0
157235,and,0,0
157236,retention,0,0
157237,of,0,0
157238,participants,0,1
157239,",",0,1
157240,assessment,0,0
157241,procedures,0,1
157242,),0,1
157243,",",0,0
157244,as,0,0
157245,well,0,0
157246,as,0,0
157247,efficacy,0,0
157248,in,0,1
157249,terms,0,0
157250,of,0,1
157251,changes,0,0
157252,in,0,1
157253,feeding,0,1
157254,behaviors,0,0
157255,.,0,1
157256,A,0,0
157257,total,0,1
157258,of,0,0
157259,10,1,1
157260,families,1,1
157261,participated,1,1
157262,in,1,0
157263,the,1,0
157264,treatment,1,0
157265,condition,1,0
157266,",",0,0
157267,and,0,0
157268,the,0,0
157269,program,0,0
157270,was,0,0
157271,evaluated,0,0
157272,using,0,0
157273,a,0,0
157274,waitlist,0,1
157275,control,0,1
157276,design,0,1
157277,(,0,1
157278,n,0,1
157279,=,0,1
157280,9,0,1
157281,),0,1
157282,",",0,0
157283,representing,0,1
157284,the,0,0
157285,first,0,0
157286,randomized-control,0,1
157287,study,0,1
157288,of,0,0
157289,a,0,0
157290,feeding,0,0
157291,intervention,0,0
157292,in,0,0
157293,autism,0,1
157294,spectrum,0,1
157295,disorders,0,1
157296,.,0,1
157297,Results,0,0
157298,provide,0,0
157299,provisional,0,0
157300,support,0,0
157301,regarding,0,0
157302,the,0,0
157303,utility,0,0
157304,of,0,0
157305,the,0,0
157306,program,0,0
157307,",",0,0
157308,including,0,0
157309,high,0,1
157310,social,0,1
157311,validity,0,0
157312,",",0,0
157313,parent,0,1
157314,perception,0,0
157315,of,0,0
157316,effectiveness,0,0
157317,",",0,0
157318,and,0,0
157319,reduced,0,0
157320,levels,0,0
157321,of,0,1
157322,caregiver,0,1
157323,stress,0,0
157324,following,0,0
157325,intervention,0,1
157326,.,0,1
157327,Implications,0,0
157328,",",0,0
157329,limitations,0,0
157330,",",0,0
157331,and,0,1
157332,future,0,0
157333,directions,0,0
157334,for,0,1
157335,this,0,0
157336,line,0,0
157337,of,0,0
157338,research,0,1
157339,are,0,0
157340,discussed,0,0
157341,.,0,1
157342,Entomological,0,1
157343,determinants,0,0
157344,of,0,1
157345,insecticide-treated,0,1
157346,bed,0,1
157347,net,0,0
157348,effectiveness,0,0
157349,in,0,1
157350,Western,1,1
157351,Myanmar,1,1
157352,.,1,1
157353,BACKGROUND,0,0
157354,In,0,0
157355,a,0,1
157356,large,0,1
157357,cluster,0,1
157358,randomized,0,1
157359,control,0,1
157360,trial,0,1
157361,of,0,0
157362,insecticide-treated,0,1
157363,bed,0,1
157364,nets,0,1
157365,(,0,1
157366,ITN,0,1
157367,),0,1
157368,in,0,0
157369,Western,1,1
157370,Myanmar,1,1
157371,the,0,0
157372,malaria,0,1
157373,protective,0,0
157374,effect,0,0
157375,of,0,1
157376,ITN,0,1
157377,was,0,0
157378,found,0,0
157379,to,0,0
157380,be,0,0
157381,highly,0,0
157382,variable,0,0
157383,and,0,0
157384,",",0,0
157385,in,0,0
157386,aggregate,0,0
157387,",",0,0
157388,the,0,0
157389,effect,0,0
157390,was,0,0
157391,not,0,0
157392,statistically,0,0
157393,significant,0,0
157394,.,0,1
157395,A,0,0
157396,coincident,0,0
157397,entomological,0,1
157398,investigation,0,1
157399,measured,0,0
157400,malaria,0,1
157401,vector,0,1
157402,abundance,0,1
157403,and,0,0
157404,biting,0,1
157405,behaviour,0,0
157406,and,0,0
157407,the,0,0
157408,human,1,1
157409,population,1,1
157410,sleeping,0,1
157411,habits,0,0
157412,",",0,1
157413,factors,0,0
157414,relevant,0,1
157415,to,0,0
157416,ITN,0,1
157417,effectiveness,0,0
157418,.,0,1
157419,METHODS,0,0
157420,Entomological,0,1
157421,surveys,0,1
157422,were,0,1
157423,carried,0,0
157424,out,0,1
157425,using,0,0
157426,different,0,0
157427,catching,0,1
157428,methods,0,1
157429,to,0,1
157430,identify,0,1
157431,potential,0,0
157432,malaria,0,1
157433,vector,0,1
157434,species,0,1
157435,and,0,1
157436,characterise,0,0
157437,their,0,1
157438,biting,0,1
157439,habits,0,0
157440,.,0,1
157441,The,0,0
157442,salivary,0,1
157443,glands,0,1
157444,were,0,1
157445,dissected,0,1
157446,from,0,1
157447,all,0,1
157448,female,0,1
157449,anophelines,0,1
157450,caught,0,1
157451,to,0,1
157452,identify,0,0
157453,sporozoites,0,0
157454,by,0,0
157455,microscopy,0,1
157456,.,0,1
157457,FINDINGS,0,0
157458,Between,0,1
157459,1995,0,1
157460,and,0,1
157461,2000,0,1
157462,a,0,0
157463,total,0,1
157464,of,0,0
157465,"4,824",1,1
157466,female,1,1
157467,anopheline,1,1
157468,mosquitoes,1,1
157469,were,0,1
157470,caught,0,1
157471,with,0,1
157472,various,0,0
157473,catching,0,1
157474,methods,0,1
157475,.,0,1
157476,A,0,0
157477,total,0,1
157478,of,0,0
157479,916,1,1
157480,person,1,1
157481,nights,1,1
157482,yielded,1,0
157483,"3,009",1,1
157484,female,1,1
157485,anopheline,1,1
157486,mosquitoes,1,1
157487,between,1,1
157488,6,1,1
157489,pm,1,1
157490,and,1,1
157491,6,1,1
157492,am,1,1
157493,.,1,0
157494,Except,0,0
157495,for,0,0
157496,Anopheles,0,1
157497,annularis,0,1
157498,",",0,0
157499,which,0,0
157500,showed,0,0
157501,no,0,0
157502,apparent,0,0
157503,preference,0,0
157504,(,0,1
157505,51,0,1
157506,%,0,0
157507,outdoor,0,1
157508,biting,0,1
157509,),0,0
157510,",",0,0
157511,all,0,0
157512,major,0,1
157513,species,0,0
157514,showed,0,0
157515,a,0,1
157516,strong,0,0
157517,preference,0,0
157518,for,0,0
157519,outdoor,0,1
157520,biting,0,1
157521,;,0,0
157522,Anopheles,0,1
157523,epiroticus,0,1
157524,(,0,1
157525,79,0,1
157526,%,0,0
157527,),0,1
157528,",",0,0
157529,Anopheles,0,1
157530,subpictus,0,1
157531,(,0,1
157532,72,0,1
157533,%,0,0
157534,),0,1
157535,",",0,0
157536,Anopheles,0,1
157537,maculatus,0,1
157538,(,0,1
157539,92,0,1
157540,%,0,0
157541,),0,1
157542,",",0,0
157543,Anopheles,0,1
157544,aconitus,0,1
157545,(,0,1
157546,85,0,1
157547,%,0,0
157548,),0,1
157549,and,0,1
157550,Anopheles,0,1
157551,vagus,0,0
157552,(,0,1
157553,72,0,1
157554,%,0,0
157555,),0,1
157556,.,0,1
157557,Most,0,0
157558,human,0,1
157559,biting,0,1
157560,occurred,0,0
157561,in,0,0
157562,the,0,0
157563,early,0,1
157564,evening,0,0
157565,with,0,1
157566,the,0,0
157567,peak,0,0
157568,biting,0,1
157569,time,0,0
157570,between,0,1
157571,6,0,1
157572,pm,0,1
157573,and,0,1
157574,7,0,1
157575,pm,0,1
157576,(,0,1
157577,35,0,1
157578,%,0,0
157579,),0,1
157580,.,0,1
157581,Overall,0,0
157582,51,0,1
157583,%,0,0
157584,(,0,1
157585,1447/2837,0,1
157586,),0,1
157587,of,0,0
157588,all,0,1
157589,bites,0,1
157590,recorded,0,0
157591,were,0,1
157592,between,0,0
157593,6,0,1
157594,pm,0,1
157595,and,0,1
157596,8,0,1
157597,pm,0,1
157598,.,0,1
157599,A,1,0
157600,large,1,0
157601,proportion,1,1
157602,of,1,1
157603,children,1,1
157604,were,0,1
157605,not,0,0
157606,sleeping,0,0
157607,under,0,0
157608,an,0,1
157609,ITN,0,1
157610,during,0,0
157611,peak,0,0
157612,biting,0,1
157613,times,0,0
157614,.,0,1
157615,Only,0,0
157616,one,0,0
157617,An,0,0
157618,.,0,1
157619,annularis,0,0
157620,mosquito,0,1
157621,(,0,1
157622,0.02,0,0
157623,%,0,0
157624,),0,1
157625,had,0,1
157626,malaria,0,1
157627,sporozoites,0,0
157628,identified,0,1
157629,in,0,1
157630,the,0,0
157631,salivary,0,1
157632,glands,0,1
157633,.,0,1
157634,CONCLUSIONS,0,0
157635,Peak,0,0
157636,vector,0,1
157637,biting,0,1
157638,occurred,0,0
157639,early,0,1
157640,in,0,0
157641,the,0,0
157642,evening,0,0
157643,and,0,0
157644,mainly,0,0
157645,occurred,0,0
157646,outdoors,0,0
157647,.,0,1
157648,The,0,0
157649,limited,0,0
157650,efficacy,0,0
157651,of,0,0
157652,ITN,0,1
157653,in,0,0
157654,this,0,0
157655,area,0,0
157656,of,0,0
157657,Western,1,1
157658,Myanmar,1,1
157659,may,0,0
157660,be,0,0
157661,explained,0,0
157662,by,0,0
157663,the,0,0
157664,biting,0,1
157665,behaviour,0,0
157666,of,0,0
157667,the,0,0
157668,prevalent,0,1
157669,Anopheles,0,1
157670,mosquito,0,1
157671,vectors,0,0
157672,in,0,0
157673,this,0,0
157674,area,0,0
157675,.,0,1
157676,Comparison,0,0
157677,of,0,0
157678,meloxicam,0,0
157679,and,0,0
157680,a,0,0
157681,glucosamine-chondroitin,0,0
157682,supplement,0,0
157683,in,0,0
157684,management,0,1
157685,of,0,0
157686,feline,1,1
157687,osteoarthritis,1,1
157688,.,1,1
157689,A,0,0
157690,double-blind,0,0
157691,randomised,0,0
157692,",",0,0
157693,placebo-controlled,0,0
157694,",",0,0
157695,prospective,0,1
157696,trial,0,1
157697,.,0,1
157698,OBJECTIVE,0,0
157699,To,0,0
157700,compare,0,0
157701,the,0,0
157702,efficacy,0,0
157703,of,0,0
157704,meloxicam,0,0
157705,and,0,0
157706,a,0,1
157707,glucosamine-chondroitin,0,0
157708,(,0,1
157709,Glu-Ch,0,1
157710,),0,1
157711,supplement,0,0
157712,in,0,0
157713,the,0,0
157714,management,0,0
157715,of,0,0
157716,feline,1,1
157717,osteoarthritis,1,1
157718,(,1,1
157719,OA,1,1
157720,),1,1
157721,.,0,1
157722,METHODS,0,0
157723,Prospective,0,0
157724,",",0,0
157725,blinded,0,0
157726,",",0,0
157727,randomized,0,1
157728,clinical,0,0
157729,trial,0,1
157730,.,0,1
157731,Cats,1,0
157732,over,1,1
157733,eight,1,1
157734,years,1,1
157735,of,1,1
157736,age,1,1
157737,with,1,1
157738,clinical,1,0
157739,signs,1,1
157740,of,1,1
157741,chronic,1,1
157742,OA,1,1
157743,were,1,1
157744,assigned,1,1
157745,to,1,1
157746,one,1,1
157747,of,1,1
157748,two,1,1
157749,groups,1,1
157750,and,0,1
157751,Glu-Ch,0,1
157752,or,0,1
157753,meloxicam,0,0
157754,was,0,0
157755,administered,0,0
157756,orally,0,1
157757,for,0,1
157758,70,0,1
157759,days,0,0
157760,",",0,1
157761,followed,0,0
157762,by,0,0
157763,a,0,0
157764,placebo,0,0
157765,until,0,0
157766,day,0,0
157767,98,0,1
157768,.,0,1
157769,Cats,1,0
157770,were,0,1
157771,assessed,0,0
157772,by,0,0
157773,a,0,0
157774,veterinarian,0,1
157775,on,0,0
157776,five,0,1
157777,occasions,0,1
157778,and,0,1
157779,the,0,0
157780,owner,0,0
157781,completed,0,1
157782,an,0,0
157783,assessment,0,0
157784,form,0,0
157785,at,0,0
157786,the,0,0
157787,same,0,0
157788,time,0,0
157789,.,0,1
157790,RESULTS,0,0
157791,Data,0,1
157792,were,0,1
157793,collected,0,1
157794,from,0,1
157795,thirty,0,1
157796,cats,0,1
157797,.,0,1
157798,Pre-treatment,0,0
157799,disease,0,1
157800,scores,0,0
157801,were,0,1
157802,significantly,0,0
157803,higher,0,0
157804,in,0,0
157805,the,0,0
157806,meloxicam,0,0
157807,group,0,0
157808,for,0,0
157809,owner,0,1
157810,mobility,0,0
157811,(,0,1
157812,p=0.01,0,0
157813,),0,1
157814,and,0,0
157815,veterinary,0,1
157816,lameness,0,1
157817,(,0,1
157818,p=0.02,0,0
157819,),0,1
157820,.,0,1
157821,Owner,0,0
157822,mobility,0,0
157823,scores,0,0
157824,at,0,1
157825,day,0,1
157826,14,0,1
157827,(,0,1
157828,p=0.01,0,0
157829,),0,1
157830,and,0,1
157831,day,0,0
157832,42,0,1
157833,(,0,1
157834,p=0.002,0,0
157835,),0,1
157836,were,0,0
157837,significantly,0,0
157838,improved,0,0
157839,compared,0,0
157840,to,0,1
157841,pre-treatment,0,0
157842,scores,0,0
157843,for,0,1
157844,the,0,0
157845,meloxicam,0,0
157846,group,0,0
157847,.,0,0
157848,When,0,0
157849,meloxicam,0,0
157850,and,0,0
157851,Glu-Ch,0,0
157852,were,0,1
157853,discontinued,0,0
157854,and,0,0
157855,the,0,0
157856,placebo,0,0
157857,commenced,0,1
157858,",",0,0
157859,a,0,0
157860,significant,0,0
157861,proportion,0,0
157862,of,0,0
157863,the,0,0
157864,meloxicam,0,0
157865,group,0,0
157866,showed,0,0
157867,worsening,0,0
157868,of,0,0
157869,all,0,0
157870,the,0,0
157871,owner-assessed,0,0
157872,scores,0,0
157873,between,0,1
157874,day,0,1
157875,70,0,1
157876,and,0,1
157877,day,0,0
157878,98,0,0
157879,",",0,0
157880,when,0,0
157881,compared,0,0
157882,to,0,0
157883,the,0,0
157884,Glu-Ch,0,0
157885,group,0,0
157886,(,0,1
157887,mobility,0,0
157888,p=0.01,0,0
157889,;,0,0
157890,activity,0,0
157891,p=0.02,0,0
157892,;,0,1
157893,temperament,0,1
157894,p=0.04,0,0
157895,;,0,1
157896,lifestyle,0,1
157897,p=0.01,0,0
157898,),0,1
157899,.,0,1
157900,CONCLUSIONS,0,0
157901,Treatment,0,0
157902,with,0,1
157903,meloxicam,0,0
157904,resulted,0,0
157905,in,0,0
157906,a,0,1
157907,significant,0,0
157908,improvement,0,0
157909,in,0,0
157910,mobility,0,0
157911,and,0,1
157912,activity,0,0
157913,levels,0,0
157914,of,0,1
157915,cats,1,1
157916,with,0,1
157917,OA,0,1
157918,until,0,1
157919,the,0,0
157920,placebo,0,0
157921,was,0,0
157922,introduced,0,0
157923,.,0,0
157924,A,0,0
157925,greater,0,0
157926,proportion,0,1
157927,of,0,0
157928,cats,0,1
157929,receiving,0,1
157930,meloxicam,0,0
157931,medication,0,1
157932,showed,0,0
157933,a,0,0
157934,significant,0,0
157935,worsening,0,0
157936,of,0,0
157937,owner,0,0
157938,assessment,0,0
157939,scores,0,0
157940,once,0,0
157941,the,0,0
157942,placed,0,0
157943,was,0,0
157944,introduced,0,0
157945,",",0,0
157946,when,0,0
157947,compared,0,0
157948,to,0,0
157949,the,0,0
157950,Glu-Ch,0,0
157951,group,0,1
157952,.,0,1
157953,Therapeutic,0,1
157954,effect,0,0
157955,of,0,0
157956,inhaled,0,0
157957,budesonide,0,0
157958,(,0,1
157959,Pulmicort?,0,1
157960,Turbuhaler,0,1
157961,),0,1
157962,on,0,0
157963,the,0,0
157964,inflammatory,0,0
157965,response,0,0
157966,to,0,1
157967,one-lung,0,1
157968,ventilation,0,1
157969,.,0,1
157970,This,0,0
157971,prospective,0,0
157972,",",0,0
157973,double-blind,0,0
157974,trial,0,0
157975,was,0,0
157976,designed,0,0
157977,to,0,0
157978,evaluate,0,0
157979,the,0,0
157980,effect,0,0
157981,of,0,0
157982,inhaled,0,0
157983,budesonide,0,0
157984,on,0,0
157985,lung,0,1
157986,function,0,0
157987,and,0,0
157988,the,0,0
157989,inflammatory,0,0
157990,response,0,0
157991,to,0,1
157992,one-lung,0,1
157993,ventilation,0,1
157994,.,0,1
157995,One,1,1
157996,hundred,1,1
157997,patients,1,1
157998,scheduled,1,1
157999,for,1,1
158000,lobectomy,1,1
158001,were,0,1
158002,allocated,0,1
158003,randomly,0,1
158004,to,0,0
158005,pre-operative,0,0
158006,nebulised,0,0
158007,budesonide,0,0
158008,or,0,1
158009,saline,0,0
158010,.,0,1
158011,Bronchoalveolar,0,1
158012,lavage,0,1
158013,fluid,0,1
158014,samples,0,1
158015,were,0,1
158016,collected,0,1
158017,from,0,1
158018,either,0,0
158019,the,0,0
158020,collapsed,0,0
158021,or,0,1
158022,the,0,0
158023,ventilated,0,0
158024,lung,0,1
158025,both,0,0
158026,before,0,0
158027,one-lung,0,0
158028,ventilation,0,1
158029,and,0,1
158030,30,0,1
158031,min,0,0
158032,after,0,0
158033,re-expansion,0,0
158034,of,0,0
158035,the,0,0
158036,lung,0,1
158037,.,0,1
158038,The,0,0
158039,concentrations,0,0
158040,of,0,0
158041,serum,0,0
158042,and,0,1
158043,bronchoalveolar,0,1
158044,lavage,0,1
158045,fluid,0,1
158046,cytokines,0,0
158047,were,0,1
158048,determined,0,0
158049,.,0,1
158050,Budesonide,0,0
158051,treatment,0,0
158052,",",0,0
158053,compared,0,0
158054,with,0,1
158055,saline,0,0
158056,",",0,0
158057,reduced,0,0
158058,both,0,0
158059,peak,0,0
158060,(,0,0
158061,mean,0,1
158062,(,0,1
158063,SD,0,1
158064,),0,1
158065,3.7,0,1
158066,(,0,1
158067,0.4,0,1
158068,),0,1
158069,vs,0,0
158070,2.5,0,0
158071,(,0,1
158072,0.2,0,1
158073,),0,1
158074,kPa,0,1
158075,),0,1
158076,and,0,0
158077,plateau,0,1
158078,(,0,1
158079,mean,0,1
158080,(,0,1
158081,SD,0,1
158082,),0,1
158083,3.1,0,0
158084,(,0,1
158085,0.2,0,1
158086,),0,1
158087,vs,0,0
158088,2.2,0,0
158089,(,0,1
158090,0.1,0,1
158091,),0,1
158092,kPa,0,0
158093,",",0,0
158094,respectively,0,0
158095,",",0,0
158096,p,0,0
158097,<,0,0
158098,0.001,0,0
158099,for,0,0
158100,both,0,0
158101,),0,1
158102,ventilatory,0,1
158103,pressures,0,0
158104,.,0,1
158105,Thirty,0,1
158106,minutes,0,0
158107,after,0,1
158108,re-expansion,0,0
158109,",",0,0
158110,lung,0,1
158111,compliance,0,0
158112,increased,0,0
158113,in,0,0
158114,the,0,0
158115,budesonide,0,0
158116,group,0,0
158117,compared,0,0
158118,with,0,1
158119,saline,0,0
158120,(,0,1
158121,57.5,0,0
158122,(,0,1
158123,4.1,0,1
158124,),0,1
158125,vs,0,0
158126,40.1,0,0
158127,(,0,1
158128,3.5,0,0
158129,),0,1
158130,ml.cmH,0,0
158131,(,0,1
158132,2,0,1
158133,),0,1
158134,O,0,0
158135,(,0,1
158136,-1,0,0
158137,),0,0
158138,",",0,0
158139,respectively,0,0
158140,p,0,0
158141,<,0,0
158142,0.001,0,0
158143,),0,1
158144,.,0,1
158145,Budesonide,0,0
158146,also,0,0
158147,reduced,0,0
158148,the,0,0
158149,concentrations,0,0
158150,of,0,0
158151,tumour,0,1
158152,necrosis,0,1
158153,factor-?,0,0
158154,",",0,0
158155,interleukin-1?,0,0
158156,",",0,0
158157,interleukin-6,0,0
158158,and,0,0
158159,interleukin-8,0,0
158160,in,0,1
158161,bronchoalveolar,0,1
158162,lavage,0,1
158163,fluid,0,1
158164,",",0,0
158165,but,0,0
158166,increased,0,0
158167,interleukin-10,0,0
158168,30,0,1
158169,min,0,0
158170,after,0,0
158171,re-expansion,0,0
158172,(,0,1
158173,p,0,0
158174,<,0,0
158175,0.05,0,0
158176,for,0,0
158177,all,0,1
158178,measures,0,0
158179,),0,1
158180,.,0,1
158181,Pre-operative,0,0
158182,nebulisation,0,0
158183,of,0,0
158184,budesonide,0,0
158185,may,0,0
158186,be,0,0
158187,effective,0,0
158188,in,0,0
158189,improving,0,0
158190,ventilatory,0,1
158191,mechanics,0,1
158192,and,0,1
158193,reducing,0,0
158194,the,0,0
158195,inflammatory,0,0
158196,response,0,0
158197,to,0,1
158198,one-lung,0,0
158199,ventilation,0,1
158200,during,0,0
158201,thoracic,0,1
158202,surgery,0,1
158203,.,0,1
158204,Central,0,0
158205,5-HT4,0,1
158206,receptor,0,0
158207,binding,0,0
158208,as,0,0
158209,biomarker,0,0
158210,of,0,0
158211,serotonergic,0,0
158212,tonus,0,1
158213,in,0,1
158214,humans,1,1
158215,:,1,1
158216,a,0,1
158217,[,0,0
158218,11C,0,1
158219,],0,1
158220,SB207145,0,1
158221,PET,0,0
158222,study,0,1
158223,.,0,1
158224,Identification,0,0
158225,of,0,0
158226,a,0,1
158227,biomarker,0,0
158228,that,0,0
158229,can,0,0
158230,inform,0,0
158231,on,0,0
158232,extracellular,0,0
158233,serotonin,0,0
158234,(,0,1
158235,5-HT,0,1
158236,),0,1
158237,levels,0,0
158238,in,0,1
158239,the,0,1
158240,brains,0,1
158241,of,0,1
158242,living,1,1
158243,humans,1,1
158244,would,0,0
158245,enable,0,0
158246,greater,0,0
158247,understanding,0,0
158248,of,0,0
158249,the,0,0
158250,way,0,0
158251,brain,0,0
158252,circuits,0,0
158253,are,0,0
158254,modulated,0,0
158255,by,0,0
158256,serotonergic,0,0
158257,neurotransmission,0,0
158258,.,0,1
158259,Substantial,0,0
158260,evidence,0,0
158261,from,0,1
158262,studies,0,0
158263,in,0,1
158264,animals,0,1
158265,and,0,1
158266,humans,0,1
158267,indicates,0,0
158268,an,0,0
158269,inverse,0,0
158270,relationship,0,0
158271,between,0,0
158272,central,0,0
158273,5-HT,0,1
158274,tonus,0,0
158275,and,0,1
158276,5-HT,0,0
158277,type,0,1
158278,4,0,0
158279,receptor,0,0
158280,(,0,1
158281,5-HT4R,0,0
158282,),0,1
158283,density,0,0
158284,",",0,0
158285,suggesting,0,0
158286,that,0,0
158287,5-HT4R,0,0
158288,receptor,0,0
158289,density,0,0
158290,may,0,0
158291,be,0,0
158292,a,0,0
158293,biomarker,0,0
158294,marker,0,0
158295,for,0,0
158296,5-HT,0,1
158297,tonus,0,0
158298,.,0,1
158299,Here,0,0
158300,",",0,0
158301,we,0,0
158302,investigated,0,0
158303,whether,0,0
158304,a,0,1
158305,3-week,0,0
158306,administration,0,0
158307,of,0,0
158308,a,0,1
158309,selective,0,1
158310,serotonin,0,0
158311,reuptake,0,0
158312,inhibitor,0,0
158313,",",0,0
158314,expected,0,0
158315,to,0,0
158316,increase,0,0
158317,brain,0,1
158318,5-HT,0,0
158319,levels,0,0
158320,",",0,0
158321,is,0,0
158322,associated,0,0
158323,with,0,0
158324,a,0,0
158325,decline,0,0
158326,in,0,0
158327,brain,0,1
158328,5-HT4R,0,0
158329,binding,0,0
158330,.,0,1
158331,A,1,0
158332,total,1,1
158333,of,1,0
158334,35,1,1
158335,healthy,1,1
158336,men,1,1
158337,were,1,1
158338,studied,1,1
158339,in,0,0
158340,a,0,0
158341,placebo-controlled,0,0
158342,",",0,0
158343,randomized,0,1
158344,",",0,0
158345,double-blind,0,0
158346,study,0,1
158347,.,0,1
158348,Participants,0,1
158349,were,0,1
158350,assigned,0,1
158351,to,0,0
158352,receive,0,1
158353,3,0,1
158354,weeks,0,0
158355,of,0,1
158356,oral,0,1
158357,dosing,0,0
158358,with,0,1
158359,placebo,0,0
158360,or,0,1
158361,fluoxetine,0,0
158362,",",0,1
158363,40,0,1
158364,mg,0,0
158365,per,0,1
158366,day,0,0
158367,.,0,1
158368,Brain,0,0
158369,5-HT4R,0,0
158370,binding,0,0
158371,was,0,0
158372,quantified,0,0
158373,at,0,0
158374,baseline,0,0
158375,and,0,1
158376,at,0,0
158377,follow-up,0,0
158378,with,0,1
158379,[,0,0
158380,(,0,1
158381,11,0,1
158382,),0,1
158383,C,0,1
158384,],0,1
158385,SB207145,0,1
158386,positron,0,1
158387,emission,0,1
158388,tomography,0,0
158389,(,0,1
158390,PET,0,0
158391,),0,1
158392,.,0,1
158393,Three,0,1
158394,weeks,0,0
158395,of,0,1
158396,intervention,0,1
158397,with,0,1
158398,fluoxetine,0,1
158399,was,0,0
158400,associated,0,0
158401,with,0,1
158402,a,0,1
158403,5.2,0,0
158404,%,0,0
158405,reduction,0,0
158406,in,0,0
158407,brain,0,1
158408,5-HT4R,0,0
158409,binding,0,0
158410,(,0,1
158411,P=0.017,0,0
158412,),0,1
158413,",",0,0
158414,whereas,0,0
158415,placebo,0,0
158416,intervention,0,0
158417,did,0,0
158418,not,0,0
158419,change,0,0
158420,5-HT4R,0,0
158421,binding,0,0
158422,(,0,1
158423,P=0.52,0,0
158424,),0,1
158425,.,0,1
158426,Our,0,0
158427,findings,0,0
158428,are,0,0
158429,consistent,0,0
158430,with,0,1
158431,a,0,1
158432,model,0,0
158433,",",0,0
158434,wherein,0,0
158435,the,0,0
158436,5-HT4R,0,0
158437,density,0,0
158438,adjusts,0,0
158439,to,0,0
158440,changes,0,0
158441,in,0,1
158442,the,0,1
158443,extracellular,0,0
158444,5-HT,0,0
158445,tonus,0,1
158446,.,0,1
158447,Our,0,0
158448,data,0,0
158449,demonstrate,0,0
158450,for,0,1
158451,the,0,0
158452,first,0,0
158453,time,0,0
158454,in,0,1
158455,humans,1,1
158456,that,0,0
158457,the,0,0
158458,imaging,0,0
158459,of,0,0
158460,central,0,0
158461,5-HT4R,0,0
158462,binding,0,0
158463,may,0,0
158464,be,0,0
158465,used,0,0
158466,as,0,0
158467,an,0,0
158468,in,0,0
158469,vivo,0,0
158470,biomarker,0,0
158471,of,0,0
158472,the,0,0
158473,central,0,0
158474,5-HT,0,0
158475,tonus,0,1
158476,.,0,1
158477,Improving,0,0
158478,maternal,1,1
158479,mental,1,1
158480,health,1,1
158481,after,1,0
158482,a,1,1
158483,child,1,1
158484,'s,1,1
158485,diagnosis,1,1
158486,of,1,1
158487,autism,1,1
158488,spectrum,1,1
158489,disorder,1,1
158490,:,1,1
158491,results,0,0
158492,from,0,1
158493,a,0,1
158494,randomized,0,1
158495,clinical,0,0
158496,trial,0,1
158497,.,0,0
158498,IMPORTANCE,0,0
158499,The,0,0
158500,prevalence,0,0
158501,of,0,0
158502,psychological,0,0
158503,distress,0,1
158504,among,0,1
158505,mothers,1,1
158506,of,1,1
158507,children,1,1
158508,with,1,1
158509,autism,1,1
158510,spectrum,1,1
158511,disorder,1,1
158512,(,1,1
158513,ASD,1,1
158514,),1,0
158515,suggests,0,0
158516,a,0,0
158517,need,0,0
158518,for,0,0
158519,interventions,0,0
158520,that,0,0
158521,address,0,0
158522,parental,0,0
158523,mental,0,1
158524,health,0,1
158525,during,0,0
158526,the,0,0
158527,critical,0,0
158528,period,0,0
158529,after,0,0
158530,the,0,0
158531,child,0,1
158532,'s,0,1
158533,autism,0,1
158534,diagnosis,0,1
158535,when,0,0
158536,parents,0,1
158537,are,0,0
158538,learning,0,0
158539,to,0,0
158540,navigate,0,0
158541,the,0,0
158542,complex,0,0
158543,system,0,0
158544,of,0,1
158545,autism,0,1
158546,services,0,1
158547,.,0,1
158548,OBJECTIVE,0,0
158549,To,0,0
158550,investigate,0,0
158551,whether,0,0
158552,a,0,0
158553,brief,0,0
158554,cognitive,0,0
158555,behavioral,0,1
158556,intervention,0,0
158557,",",0,0
158558,problem-solving,0,0
158559,education,0,1
158560,(,0,1
158561,PSE,0,1
158562,),0,0
158563,",",0,0
158564,decreases,0,0
158565,parenting,0,0
158566,stress,0,0
158567,and,0,1
158568,maternal,0,1
158569,depressive,0,1
158570,symptoms,0,1
158571,during,0,0
158572,the,0,0
158573,period,0,0
158574,immediately,0,0
158575,following,0,0
158576,a,0,0
158577,child,0,1
158578,'s,0,1
158579,diagnosis,0,1
158580,of,0,1
158581,ASD,0,1
158582,.,0,1
158583,DESIGN,0,0
158584,",",0,0
158585,SETTING,0,1
158586,",",0,0
158587,AND,0,0
158588,PARTICIPANTS,0,1
158589,A,0,1
158590,randomized,0,1
158591,clinical,0,0
158592,trial,0,1
158593,compared,0,0
158594,6,0,1
158595,sessions,0,0
158596,of,0,1
158597,PSE,0,1
158598,with,0,1
158599,usual,0,1
158600,care,0,1
158601,.,0,1
158602,Settings,0,0
158603,included,0,1
158604,an,0,0
158605,autism,1,1
158606,clinic,1,1
158607,and,1,1
158608,6,1,1
158609,community-based,1,1
158610,early,1,1
158611,intervention,1,1
158612,programs,1,1
158613,that,1,0
158614,primarily,1,1
158615,serve,1,0
158616,low-income,1,1
158617,families,1,1
158618,.,1,1
158619,Participants,1,1
158620,were,1,1
158621,mothers,1,1
158622,of,1,1
158623,122,1,1
158624,young,1,1
158625,children,1,1
158626,(,1,1
158627,mean,1,1
158628,age,1,1
158629,",",1,1
158630,34,1,1
158631,months,1,1
158632,),1,1
158633,who,1,1
158634,recently,1,1
158635,received,1,1
158636,a,1,0
158637,diagnosis,1,1
158638,of,1,0
158639,ASD,1,1
158640,.,1,1
158641,Among,0,1
158642,mothers,0,1
158643,assessed,0,0
158644,for,0,0
158645,eligibility,0,1
158646,",",0,1
158647,17.0,0,0
158648,%,0,0
158649,declined,0,0
158650,participation,0,0
158651,.,0,1
158652,We,0,0
158653,report,0,0
158654,outcomes,0,0
158655,after,0,1
158656,3,0,1
158657,months,0,1
158658,of,0,1
158659,follow-up,0,1
158660,(,0,1
158661,immediate,0,0
158662,postdiagnosis,0,1
158663,period,0,1
158664,),0,1
158665,.,0,1
158666,INTERVENTIONS,0,0
158667,Problem-solving,0,0
158668,education,0,0
158669,is,0,0
158670,a,0,0
158671,brief,0,0
158672,",",0,0
158673,cognitive,0,0
158674,intervention,0,0
158675,delivered,0,1
158676,in,0,1
158677,six,0,1
158678,30-minute,0,0
158679,individualized,0,0
158680,sessions,0,0
158681,by,0,0
158682,existing,0,1
158683,staff,0,1
158684,(,0,1
158685,early,0,1
158686,intervention,0,1
158687,programs,0,1
158688,),0,1
158689,or,0,1
158690,research,0,1
158691,staff,0,1
158692,without,0,1
158693,formal,0,1
158694,mental,0,1
158695,health,0,1
158696,training,0,0
158697,(,0,0
158698,autism,0,1
158699,clinic,0,1
158700,),0,1
158701,.,0,1
158702,MAIN,0,0
158703,OUTCOMES,0,0
158704,AND,0,0
158705,MEASURES,0,1
158706,Primary,0,1
158707,outcomes,0,0
158708,were,0,1
158709,parental,0,1
158710,stress,0,0
158711,and,0,1
158712,maternal,0,1
158713,depressive,0,1
158714,symptoms,0,1
158715,.,0,1
158716,RESULTS,0,0
158717,Fifty-nine,1,1
158718,mothers,1,1
158719,were,0,1
158720,randomized,0,1
158721,to,0,0
158722,receive,0,1
158723,PSE,0,1
158724,and,0,1
158725,63,0,1
158726,to,0,0
158727,receive,0,1
158728,usual,0,1
158729,care,0,1
158730,.,0,1
158731,The,0,0
158732,follow-up,0,0
158733,rate,0,0
158734,was,0,0
158735,91.0,0,0
158736,%,0,0
158737,.,0,1
158738,Most,0,0
158739,intervention,0,0
158740,mothers,0,1
158741,(,0,1
158742,78.0,0,1
158743,%,0,0
158744,),0,1
158745,received,0,0
158746,the,0,0
158747,full,0,1
158748,PSE,0,1
158749,course,0,1
158750,.,0,1
158751,At,0,0
158752,the,0,0
158753,3-month,0,0
158754,follow-up,0,0
158755,assessment,0,0
158756,",",0,1
158757,PSE,0,1
158758,mothers,0,1
158759,were,0,0
158760,significantly,0,0
158761,less,0,0
158762,likely,0,0
158763,than,0,0
158764,those,0,1
158765,serving,0,1
158766,as,0,0
158767,controls,0,1
158768,to,0,0
158769,have,0,0
158770,clinically,0,1
158771,significant,0,0
158772,parental,0,1
158773,stress,0,1
158774,(,0,1
158775,3.8,0,0
158776,%,0,0
158777,vs,0,0
158778,29.3,0,1
158779,%,0,0
158780,;,0,1
158781,adjusted,0,0
158782,relative,0,0
158783,risk,0,1
158784,[,0,0
158785,aRR,0,0
158786,],0,1
158787,",",0,1
158788,0.17,0,0
158789,;,0,1
158790,95,0,0
158791,%,0,0
158792,CI,0,0
158793,",",0,1
158794,0.04,0,0
158795,to,0,1
158796,0.65,0,0
158797,),0,1
158798,.,0,1
158799,For,0,1
158800,depressive,0,1
158801,symptoms,0,1
158802,",",0,1
158803,the,0,0
158804,risk,0,0
158805,reduction,0,0
158806,in,0,0
158807,clinically,0,1
158808,significant,0,0
158809,symptoms,0,0
158810,did,0,0
158811,not,0,0
158812,reach,0,0
158813,statistical,0,0
158814,significance,0,0
158815,(,0,1
158816,5.7,0,0
158817,%,0,0
158818,vs,0,0
158819,22.4,0,1
158820,%,0,0
158821,;,0,1
158822,aRR,0,0
158823,",",0,1
158824,0.33,0,0
158825,;,0,1
158826,95,0,0
158827,%,0,0
158828,CI,0,0
158829,",",0,1
158830,0.10,0,0
158831,to,0,1
158832,1.08,0,0
158833,),0,1
158834,;,0,0
158835,however,0,0
158836,",",0,0
158837,the,0,0
158838,reduction,0,0
158839,in,0,0
158840,mean,0,1
158841,depressive,0,1
158842,symptoms,0,0
158843,was,0,0
158844,statistically,0,0
158845,significant,0,0
158846,(,0,1
158847,Quick,0,1
158848,Inventory,0,1
158849,of,0,1
158850,Depressive,0,1
158851,Symptomatology,0,1
158852,score,0,0
158853,",",0,0
158854,4.6,0,0
158855,with,0,1
158856,PSE,0,1
158857,vs,0,0
158858,6.9,0,0
158859,with,0,1
158860,usual,0,1
158861,care,0,1
158862,;,0,1
158863,adjusted,0,0
158864,mean,0,1
158865,difference,0,0
158866,",",0,1
158867,-1.67,0,0
158868,;,0,1
158869,95,0,0
158870,%,0,0
158871,CI,0,0
158872,",",0,1
158873,-3.17,0,0
158874,to,0,0
158875,-0.18,0,0
158876,),0,1
158877,.,0,1
158878,CONCLUSIONS,0,0
158879,AND,0,0
158880,RELEVANCE,0,1
158881,The,0,1
158882,positive,0,1
158883,effects,0,0
158884,of,0,1
158885,PSE,0,1
158886,in,0,1
158887,reducing,0,0
158888,parenting,0,1
158889,stress,0,0
158890,and,0,1
158891,depressive,0,1
158892,symptoms,0,1
158893,during,0,1
158894,the,0,1
158895,critical,0,0
158896,postdiagnosis,0,0
158897,period,0,0
158898,",",0,0
158899,when,0,0
158900,parents,0,1
158901,are,0,0
158902,asked,0,0
158903,to,0,0
158904,navigate,0,0
158905,a,0,0
158906,complex,0,0
158907,service,0,1
158908,delivery,0,0
158909,system,0,0
158910,",",0,0
158911,suggest,0,0
158912,that,0,0
158913,it,0,0
158914,may,0,0
158915,have,0,0
158916,a,0,0
158917,place,0,0
158918,in,0,0
158919,clinical,0,0
158920,practice,0,1
158921,.,0,1
158922,Further,0,0
158923,work,0,0
158924,will,0,0
158925,monitor,0,0
158926,these,0,0
158927,families,0,1
158928,for,0,0
158929,a,0,1
158930,total,0,1
158931,of,0,0
158932,9,0,1
158933,months,0,0
158934,to,0,1
158935,determine,0,0
158936,the,0,0
158937,trajectory,0,0
158938,of,0,0
158939,outcomes,0,0
158940,.,0,1
158941,TRIAL,0,0
158942,REGISTRATION,0,0
158943,clinicaltrials.gov,0,1
158944,Identifier,0,1
158945,:,0,1
158946,NCT01021384,0,1
158947,.,0,1
158948,Study,0,1
158949,protocol,0,1
158950,:,0,1
158951,Rehabilitation,0,1
158952,including,0,1
158953,Social,0,0
158954,and,0,1
158955,Physical,0,0
158956,activity,0,0
158957,and,0,0
158958,Education,0,1
158959,in,0,0
158960,Children,1,1
158961,and,1,1
158962,Teenagers,1,1
158963,with,1,1
158964,Cancer,1,1
158965,(,0,1
158966,RESPECT,0,1
158967,),0,1
158968,.,0,1
158969,BACKGROUND,0,0
158970,During,0,0
158971,cancer,0,1
158972,treatment,0,0
158973,children,1,1
158974,have,1,0
158975,reduced,1,0
158976,contact,1,0
158977,with,1,1
158978,their,1,1
158979,social,1,0
158980,network,1,1
158981,of,1,1
158982,friends,1,0
158983,",",1,0
158984,and,1,0
158985,have,1,0
158986,limited,1,0
158987,participation,1,0
158988,in,1,0
158989,education,1,1
158990,",",1,1
158991,sports,1,1
158992,",",1,0
158993,and,1,1
158994,leisure,1,1
158995,activities,1,0
158996,.,1,1
158997,During,0,0
158998,and,0,0
158999,following,0,0
159000,cancer,0,1
159001,treatment,0,0
159002,",",0,0
159003,children,1,1
159004,describe,0,1
159005,school,0,1
159006,related,0,0
159007,problems,0,1
159008,",",0,1
159009,reduced,0,0
159010,physical,0,0
159011,fitness,0,0
159012,",",0,1
159013,and,0,0
159014,problems,0,1
159015,related,0,0
159016,to,0,1
159017,interaction,0,0
159018,with,0,1
159019,peers,0,1
159020,.,0,1
159021,METHODS/DESIGN,0,0
159022,The,0,0
159023,RESPECT,0,0
159024,study,0,0
159025,is,0,0
159026,a,0,0
159027,nationwide,1,0
159028,population-based,0,1
159029,prospective,0,1
159030,",",0,0
159031,controlled,0,0
159032,",",0,0
159033,mixed-methods,0,1
159034,intervention,0,1
159035,study,0,1
159036,looking,0,1
159037,at,0,1
159038,children,1,1
159039,aged,1,1
159040,6-18,1,1
159041,years,1,1
159042,newly,1,1
159043,diagnosed,1,1
159044,with,1,1
159045,cancer,1,1
159046,in,1,1
159047,eastern,1,1
159048,Denmark,1,1
159049,(,1,1
159050,n=120,1,1
159051,),1,1
159052,and,1,0
159053,a,1,1
159054,matched,1,1
159055,control,1,1
159056,group,1,1
159057,in,1,0
159058,western,1,1
159059,Denmark,1,1
159060,(,1,1
159061,n=120,1,1
159062,),1,1
159063,.,1,1
159064,RESPECT,0,0
159065,includes,1,0
159066,Danish-speaking,1,1
159067,children,1,1
159068,diagnosed,1,1
159069,with,1,1
159070,cancer,1,1
159071,and,1,0
159072,treated,1,1
159073,at,1,0
159074,pediatric,1,1
159075,oncology,1,1
159076,units,1,1
159077,in,1,1
159078,Denmark,1,1
159079,.,1,1
159080,Primary,0,0
159081,endpoints,0,0
159082,are,0,0
159083,the,0,0
159084,level,0,0
159085,of,0,0
159086,educational,0,1
159087,achievement,0,1
159088,one,0,1
159089,year,0,1
159090,after,0,0
159091,the,0,0
159092,cessation,0,0
159093,of,0,0
159094,first-line,0,1
159095,cancer,0,1
159096,therapy,0,0
159097,",",0,0
159098,and,0,0
159099,the,0,0
159100,value,0,0
159101,of,0,0
159102,VO2max,0,1
159103,one,0,1
159104,year,0,1
159105,after,0,0
159106,the,0,0
159107,cessation,0,0
159108,of,0,0
159109,first-line,0,1
159110,cancer,0,1
159111,therapy,0,1
159112,.,0,1
159113,Secondary,0,0
159114,endpoints,0,0
159115,are,0,0
159116,quality,0,0
159117,of,0,0
159118,life,0,1
159119,measured,0,0
159120,by,0,0
159121,validated,0,1
159122,questionnaires,0,1
159123,and,0,1
159124,interviews,0,1
159125,",",0,1
159126,and,0,1
159127,physical,0,1
159128,performance,0,0
159129,.,0,1
159130,RESPECT,0,0
159131,includes,0,0
159132,a,0,0
159133,multimodal,0,0
159134,intervention,0,0
159135,program,0,1
159136,",",0,0
159137,including,0,0
159138,ambassador-facilitated,0,0
159139,educational,0,1
159140,",",0,1
159141,physical,0,0
159142,",",0,0
159143,and,0,1
159144,social,0,1
159145,interventions,0,0
159146,.,0,1
159147,The,0,0
159148,educational,0,0
159149,intervention,0,0
159150,includes,0,0
159151,an,0,0
159152,educational,0,0
159153,program,0,1
159154,aimed,0,0
159155,at,0,0
159156,the,0,0
159157,child,1,1
159158,with,1,1
159159,cancer,1,1
159160,",",0,0
159161,the,0,0
159162,child,0,1
159163,'s,0,1
159164,schoolteachers,0,1
159165,and,0,1
159166,classmates,0,1
159167,",",0,0
159168,and,0,0
159169,the,0,0
159170,child,0,1
159171,'s,0,1
159172,parents,0,1
159173,.,0,1
159174,Children,1,1
159175,with,1,1
159176,cancer,1,1
159177,will,0,0
159178,each,0,0
159179,have,0,0
159180,two,0,0
159181,ambassadors,0,1
159182,assigned,0,1
159183,from,0,1
159184,their,0,1
159185,class,0,1
159186,.,0,1
159187,The,0,0
159188,ambassadors,0,0
159189,visit,0,0
159190,the,0,0
159191,child,1,1
159192,with,1,1
159193,cancer,1,1
159194,at,0,0
159195,the,0,0
159196,hospital,0,1
159197,at,0,0
159198,alternating,0,1
159199,2-week,0,0
159200,intervals,0,0
159201,and,0,1
159202,participate,0,1
159203,in,0,0
159204,the,0,0
159205,intervention,0,0
159206,program,0,1
159207,.,0,1
159208,The,0,0
159209,physical,0,0
159210,and,0,0
159211,social,0,0
159212,intervention,0,0
159213,examines,0,0
159214,the,0,0
159215,effect,0,0
159216,of,0,0
159217,early,0,1
159218,",",0,0
159219,structured,0,1
159220,",",0,0
159221,individualized,0,0
159222,",",0,0
159223,and,0,0
159224,continuous,0,0
159225,physical,0,1
159226,activity,0,0
159227,from,0,1
159228,diagnosis,0,1
159229,throughout,0,0
159230,the,0,0
159231,treatment,0,0
159232,period,0,0
159233,.,0,1
159234,The,0,0
159235,patients,1,1
159236,are,0,0
159237,tested,0,0
159238,at,0,0
159239,diagnosis,0,1
159240,",",0,1
159241,at,0,0
159242,3,0,1
159243,and,0,1
159244,6,0,1
159245,months,0,0
159246,after,0,1
159247,diagnosis,0,1
159248,",",0,1
159249,and,0,0
159250,one,0,1
159251,year,0,1
159252,after,0,0
159253,the,0,0
159254,cessation,0,0
159255,of,0,0
159256,treatment,0,0
159257,.,0,1
159258,The,0,0
159259,study,0,0
159260,is,0,0
159261,powered,0,0
159262,to,0,0
159263,quantify,0,0
159264,the,0,0
159265,impact,0,0
159266,of,0,0
159267,the,0,0
159268,combined,0,0
159269,educational,0,1
159270,",",0,1
159271,physical,0,0
159272,",",0,0
159273,and,0,0
159274,social,0,0
159275,intervention,0,1
159276,programs,0,1
159277,.,0,1
159278,DISCUSSION,0,0
159279,RESPECT,0,0
159280,is,0,0
159281,the,0,0
159282,first,0,0
159283,population-based,0,1
159284,study,0,1
159285,to,0,0
159286,examine,0,0
159287,the,0,0
159288,effect,0,0
159289,of,0,0
159290,early,0,1
159291,rehabilitation,0,1
159292,for,0,1
159293,children,0,1
159294,with,0,1
159295,cancer,0,1
159296,",",0,0
159297,and,0,0
159298,to,0,0
159299,use,0,0
159300,healthy,0,1
159301,classmates,0,1
159302,as,0,1
159303,ambassadors,0,1
159304,to,0,1
159305,facilitate,0,0
159306,the,0,0
159307,normalization,0,0
159308,of,0,0
159309,social,0,0
159310,life,0,1
159311,in,0,0
159312,the,0,0
159313,hospital,0,1
159314,.,0,1
159315,For,0,0
159316,children,1,1
159317,with,1,1
159318,cancer,1,1
159319,",",0,0
159320,RESPECT,0,0
159321,contributes,0,0
159322,to,0,0
159323,expanding,0,0
159324,knowledge,0,0
159325,on,0,0
159326,rehabilitation,0,1
159327,that,0,0
159328,can,0,0
159329,also,0,0
159330,facilitate,0,0
159331,rehabilitation,0,1
159332,of,0,0
159333,other,0,1
159334,children,0,1
159335,undergoing,0,1
159336,hospitalization,0,1
159337,for,0,1
159338,long-term,0,0
159339,illness,0,1
159340,.,0,1
159341,TRIAL,0,0
159342,REGISTRATION,0,0
159343,Clinical,0,0
159344,Trials.gov,0,1
159345,:,0,1
159346,file,0,0
159347,.,0,1
159348,NCT01772849,0,0
159349,and,0,0
159350,NCT01772862,0,0
159351,.,0,1
159352,Differences,0,0
159353,in,0,1
159354,vision,0,1
159355,between,0,0
159356,clinic,0,1
159357,and,0,1
159358,home,0,1
159359,and,0,0
159360,the,0,0
159361,effect,0,0
159362,of,0,0
159363,lighting,0,0
159364,in,0,1
159365,older,1,1
159366,adults,1,1
159367,with,1,1
159368,and,1,1
159369,without,1,1
159370,glaucoma,1,1
159371,.,1,1
159372,IMPORTANCE,0,0
159373,Patients,0,1
159374,often,0,1
159375,report,0,0
159376,greater,0,0
159377,visual,0,0
159378,difficulties,0,0
159379,at,0,1
159380,home,0,1
159381,than,0,0
159382,expected,0,0
159383,from,0,1
159384,vision,0,0
159385,testing,0,0
159386,in,0,0
159387,the,0,0
159388,clinic,0,1
159389,.,0,1
159390,Such,0,0
159391,discordance,0,0
159392,may,0,0
159393,be,0,0
159394,owing,0,0
159395,to,0,0
159396,worse,0,0
159397,vision,0,0
159398,in,0,0
159399,the,0,0
159400,home,0,1
159401,than,0,0
159402,measured,0,0
159403,in,0,1
159404,clinic,0,1
159405,.,0,1
159406,OBJECTIVE,0,0
159407,To,0,0
159408,compare,0,0
159409,vision,0,0
159410,measured,0,0
159411,between,0,0
159412,the,0,0
159413,clinic,0,1
159414,and,0,0
159415,home,0,1
159416,and,0,1
159417,evaluate,0,0
159418,factors,0,0
159419,",",0,1
159420,including,0,0
159421,lighting,0,0
159422,",",0,0
159423,associated,0,0
159424,with,0,1
159425,these,0,0
159426,differences,0,0
159427,.,0,1
159428,DESIGN,0,0
159429,",",0,0
159430,SETTING,0,1
159431,",",0,0
159432,AND,0,0
159433,PARTICIPANTS,0,1
159434,This,0,0
159435,cross-sectional,0,1
159436,study,0,0
159437,conducted,1,1
159438,from,1,1
159439,2005-2009,1,1
159440,involved,1,1
159441,126,1,1
159442,patients,1,1
159443,with,1,1
159444,glaucoma,1,1
159445,and,1,1
159446,49,1,1
159447,without,1,1
159448,glaucoma,1,1
159449,recruited,1,1
159450,from,1,1
159451,the,1,0
159452,Glaucoma,1,1
159453,and,1,0
159454,Comprehensive,1,0
159455,Eye,1,1
159456,Clinics,1,1
159457,at,1,1
159458,Washington,1,1
159459,University,1,1
159460,",",1,1
159461,St,1,0
159462,Louis,1,1
159463,",",1,1
159464,Missouri,1,1
159465,.,1,1
159466,Patients,0,1
159467,underwent,0,1
159468,clinic,0,1
159469,and,0,1
159470,home,0,1
159471,visits,0,0
159472,",",0,1
159473,were,0,1
159474,aged,1,1
159475,55,1,1
159476,to,1,1
159477,90,1,1
159478,years,1,1
159479,",",0,1
159480,were,0,1
159481,consecutively,0,1
159482,recruited,0,1
159483,",",0,0
159484,and,0,0
159485,met,0,1
159486,inclusion,0,1
159487,criteria,0,1
159488,for,0,0
159489,this,0,0
159490,study,0,0
159491,.,0,0
159492,A,1,0
159493,total,1,1
159494,of,1,0
159495,166,1,1
159496,eligible,1,1
159497,patients,1,1
159498,refused,1,1
159499,participation,1,1
159500,.,1,1
159501,EXPOSURE,0,0
159502,Participants,0,1
159503,underwent,0,1
159504,clinic,0,1
159505,and,0,1
159506,home,0,1
159507,visits,0,1
159508,randomized,0,1
159509,to,0,1
159510,order,0,0
159511,of,0,0
159512,completion,0,0
159513,.,0,1
159514,At,0,0
159515,each,0,0
159516,visit,0,0
159517,",",0,0
159518,masked,0,0
159519,and,0,0
159520,certified,0,1
159521,examiners,0,1
159522,measured,0,0
159523,binocular,0,1
159524,distance,0,0
159525,visual,0,0
159526,acuity,0,0
159527,(,0,1
159528,DVA,0,1
159529,),0,1
159530,with,0,1
159531,a,0,1
159532,nonbacklit,0,0
159533,chart,0,0
159534,",",0,0
159535,near,0,0
159536,visual,0,0
159537,acuity,0,0
159538,(,0,1
159539,NVA,0,1
159540,),0,1
159541,",",0,0
159542,contrast,0,1
159543,sensitivity,0,0
159544,(,0,1
159545,CS,0,0
159546,),0,1
159547,",",0,0
159548,CS,0,0
159549,with,0,1
159550,glare,0,0
159551,",",0,0
159552,and,0,0
159553,lighting,0,1
159554,.,0,1
159555,MAIN,0,0
159556,OUTCOMES,0,0
159557,AND,0,0
159558,MEASURES,0,0
159559,Differences,0,0
159560,in,0,0
159561,vision,0,0
159562,between,0,0
159563,the,0,0
159564,clinic,0,1
159565,and,0,0
159566,home,0,1
159567,.,0,0
159568,RESULTS,0,0
159569,The,0,0
159570,mean,0,1
159571,scores,0,0
159572,for,0,1
159573,all,0,1
159574,vision,0,0
159575,tests,0,0
159576,were,0,0
159577,significantly,0,0
159578,better,0,0
159579,in,0,0
159580,the,0,0
159581,clinic,0,1
159582,than,0,0
159583,home,0,1
159584,for,0,1
159585,participants,0,1
159586,with,0,1
159587,and,0,1
159588,without,0,1
159589,glaucoma,0,1
159590,(,0,1
159591,P,0,0
159592,<,0,0
159593,.05,0,0
159594,",",0,0
159595,matched-pair,0,1
159596,t,0,0
159597,tests,0,0
159598,),0,1
159599,.,0,1
159600,For,0,0
159601,DVA,0,1
159602,",",0,1
159603,29,0,1
159604,%,0,0
159605,of,0,1
159606,participants,0,1
159607,with,0,1
159608,glaucoma,0,1
159609,read,0,1
159610,2,0,0
159611,or,0,1
159612,more,0,0
159613,lines,0,0
159614,better,0,0
159615,in,0,0
159616,the,0,0
159617,clinic,0,1
159618,than,0,0
159619,home,0,1
159620,and,0,1
159621,39,0,1
159622,%,0,0
159623,with,0,1
159624,advanced,0,1
159625,glaucoma,0,1
159626,read,0,1
159627,3,0,0
159628,or,0,1
159629,more,0,0
159630,lines,0,0
159631,better,0,0
159632,.,0,0
159633,For,0,0
159634,the,0,0
159635,entire,0,0
159636,sample,0,1
159637,",",0,1
159638,21,0,1
159639,%,0,0
159640,of,0,0
159641,participants,0,1
159642,read,0,1
159643,2,0,0
159644,or,0,1
159645,more,0,0
159646,lines,0,0
159647,better,0,0
159648,in,0,0
159649,the,0,0
159650,clinic,0,1
159651,than,0,0
159652,home,0,1
159653,for,0,1
159654,NVA,0,1
159655,and,0,1
159656,49,0,1
159657,%,0,0
159658,read,0,1
159659,2,0,1
159660,or,0,1
159661,more,0,0
159662,triplets,0,0
159663,better,0,0
159664,in,0,0
159665,the,0,0
159666,clinic,0,1
159667,for,0,0
159668,CS,0,0
159669,with,0,1
159670,glare,0,1
159671,.,0,1
159672,Lighting,0,0
159673,was,0,0
159674,the,0,0
159675,most,0,0
159676,significant,0,0
159677,factor,0,0
159678,associated,0,0
159679,with,0,1
159680,differences,0,0
159681,in,0,1
159682,vision,0,0
159683,between,0,0
159684,the,0,0
159685,clinic,0,1
159686,and,0,0
159687,home,0,1
159688,for,0,0
159689,DVA,0,1
159690,",",0,1
159691,NVA,0,1
159692,",",0,0
159693,and,0,0
159694,CS,0,0
159695,with,0,1
159696,glare,0,0
159697,testing,0,0
159698,(,0,1
159699,P,0,0
159700,<,0,0
159701,.05,0,0
159702,",",0,0
159703,multiple,0,1
159704,regression,0,0
159705,model,0,1
159706,),0,1
159707,.,0,1
159708,Median,0,0
159709,home,0,1
159710,lighting,0,1
159711,was,0,0
159712,4.3,0,0
159713,times,0,0
159714,and,0,1
159715,2.8,0,0
159716,times,0,0
159717,lower,0,1
159718,than,0,1
159719,clinic,0,1
159720,lighting,0,1
159721,in,0,1
159722,areas,0,0
159723,tested,0,0
159724,for,0,1
159725,DVA,0,1
159726,and,0,1
159727,NVA,0,1
159728,",",0,0
159729,respectively,0,0
159730,.,0,1
159731,Home,0,0
159732,lighting,0,0
159733,was,0,0
159734,below,0,1
159735,that,0,0
159736,recommended,0,0
159737,in,0,0
159738,85,0,1
159739,%,0,0
159740,or,0,1
159741,greater,0,0
159742,of,0,1
159743,participants,0,1
159744,.,0,1
159745,CONCLUSIONS,0,0
159746,AND,0,0
159747,RELEVANCE,0,1
159748,Vision,0,1
159749,measured,0,0
159750,in,0,0
159751,the,0,0
159752,clinic,0,1
159753,is,0,0
159754,generally,0,0
159755,better,0,0
159756,than,0,0
159757,vision,0,0
159758,measured,0,0
159759,at,0,0
159760,home,0,1
159761,",",0,1
159762,with,0,1
159763,differences,0,0
159764,mainly,0,1
159765,owing,0,0
159766,to,0,0
159767,poor,0,1
159768,home,0,1
159769,lighting,0,1
159770,.,0,1
159771,Knowledge,0,0
159772,that,0,0
159773,vision,0,0
159774,discrepancies,0,0
159775,between,0,0
159776,patient,0,1
159777,report,0,1
159778,and,0,1
159779,clinical,0,0
159780,testing,0,0
159781,may,0,0
159782,be,0,0
159783,owing,0,0
159784,to,0,0
159785,home,0,1
159786,lighting,0,0
159787,may,0,0
159788,initiate,0,0
159789,clinician-patient,0,0
159790,discussions,0,0
159791,to,0,1
159792,optimize,0,0
159793,home,0,1
159794,lighting,0,0
159795,and,0,0
159796,improve,0,0
159797,the,0,0
159798,vision,0,0
159799,of,0,0
159800,older,1,1
159801,adults,1,1
159802,in,0,1
159803,their,0,1
159804,homes,0,1
159805,.,0,1
159806,The,0,0
159807,efficacy,0,0
159808,and,0,0
159809,safety,0,0
159810,of,0,0
159811,cyclosporine,0,1
159812,reduction,0,0
159813,in,0,0
159814,de,0,1
159815,novo,0,1
159816,renal,0,1
159817,allograft,0,1
159818,patients,1,1
159819,receiving,1,1
159820,sirolimus,1,1
159821,and,1,1
159822,corticosteroids,1,1
159823,:,1,1
159824,results,0,0
159825,from,0,1
159826,an,0,1
159827,open-label,0,1
159828,comparative,0,0
159829,study,0,1
159830,.,0,1
159831,This,0,0
159832,study,0,0
159833,evaluated,0,0
159834,the,0,0
159835,safety,0,0
159836,and,0,0
159837,efficacy,0,0
159838,of,0,0
159839,a,0,0
159840,sirolimus,0,1
159841,",",0,0
159842,corticosteroid,0,0
159843,",",0,0
159844,and,0,0
159845,cyclosporine,0,1
159846,reduction,0,0
159847,regimen,0,0
159848,in,0,1
159849,an,0,1
159850,open-label,0,1
159851,",",0,0
159852,12-month,0,0
159853,trial,0,1
159854,of,0,0
159855,420,1,1
159856,de,1,1
159857,novo,1,1
159858,renal,1,1
159859,allograft,1,1
159860,recipients,1,1
159861,at,1,1
159862,49,1,1
159863,European,1,1
159864,transplant,1,1
159865,centers,1,1
159866,.,1,1
159867,One,0,1
159868,month,0,0
159869,post-transplantation,0,0
159870,",",0,1
159871,357,1,1
159872,patients,1,1
159873,were,0,1
159874,randomized,0,1
159875,to,0,0
159876,receive,0,1
159877,standard-dose,0,0
159878,cyclosporine,0,1
159879,(,0,1
159880,sCsA,0,1
159881,",",0,0
159882,n,0,1
159883,=,0,1
159884,179,0,1
159885,),0,1
159886,or,0,1
159887,reduced-dose,0,1
159888,cyclosporine,0,1
159889,(,0,1
159890,rCsA,0,0
159891,",",0,0
159892,n,0,1
159893,=,0,1
159894,178,0,1
159895,),0,1
159896,.,0,1
159897,All,0,1
159898,patients,0,1
159899,also,0,0
159900,received,0,1
159901,sirolimus,0,1
159902,and,0,1
159903,corticosteroids,0,0
159904,.,0,1
159905,The,0,0
159906,primary,0,1
159907,end,0,0
159908,points,0,0
159909,were,0,1
159910,the,0,0
159911,rate,0,0
159912,of,0,0
159913,biopsy-confirmed,0,1
159914,acute,0,1
159915,rejection,0,1
159916,(,0,1
159917,BCAR,0,1
159918,),0,1
159919,and,0,1
159920,renal,0,1
159921,function,0,0
159922,",",0,0
159923,as,0,0
159924,measured,0,0
159925,by,0,0
159926,serum,0,0
159927,creatinine,0,0
159928,.,0,1
159929,Baseline,0,0
159930,demographic,0,0
159931,and,0,1
159932,donor,0,1
159933,characteristics,0,1
159934,were,0,1
159935,similar,0,0
159936,between,0,0
159937,groups,0,1
159938,.,0,1
159939,BCAR,0,0
159940,rates,0,0
159941,at,0,1
159942,12,0,1
159943,months,0,0
159944,were,0,1
159945,not,0,0
159946,significantly,0,0
159947,different,0,0
159948,:,0,1
159949,11.2,0,0
159950,%,0,0
159951,for,0,1
159952,rCsA,0,1
159953,patients,0,1
159954,and,0,1
159955,16.2,0,1
159956,%,0,0
159957,for,0,1
159958,sCsA,0,1
159959,patients,0,1
159960,.,0,1
159961,Mean,0,1
159962,serum,0,0
159963,creatinine,0,0
159964,(,0,1
159965,?SEM,0,0
159966,),0,1
159967,was,0,0
159968,significantly,0,0
159969,lower,0,0
159970,(,0,1
159971,1.75,0,0
159972,?,0,1
159973,0.10,0,0
159974,vs.,0,0
159975,1.97,0,0
159976,?,0,1
159977,0.07,0,0
159978,mg/dl,0,0
159979,",",0,1
159980,P,0,0
159981,<,0,0
159982,0.001,0,0
159983,),0,1
159984,",",0,0
159985,and,0,0
159986,creatinine,0,0
159987,clearance,0,0
159988,(,0,1
159989,?SEM,0,0
159990,;,0,1
159991,Nankivell,0,0
159992,method,0,0
159993,),0,0
159994,was,0,0
159995,significantly,0,0
159996,higher,0,0
159997,(,0,1
159998,57.8,0,1
159999,?,0,1
160000,1.78,0,0
160001,vs.,0,0
160002,49.5,0,1
160003,?,0,1
160004,2.46,0,0
160005,ml/min,0,0
160006,",",0,1
160007,P,0,0
160008,<,0,0
160009,0.001,0,0
160010,),0,1
160011,in,0,1
160012,patients,0,1
160013,receiving,0,1
160014,rCsA,0,1
160015,versus,0,0
160016,sCsA,0,1
160017,at,0,1
160018,1,0,0
160019,year,0,1
160020,",",0,0
160021,respectively,0,0
160022,.,0,1
160023,Patient,0,0
160024,and,0,0
160025,graft,0,1
160026,survival,0,0
160027,exceeded,0,1
160028,98,0,1
160029,%,0,0
160030,in,0,0
160031,both,0,0
160032,groups,0,0
160033,.,0,1
160034,No,0,0
160035,significant,0,0
160036,differences,0,0
160037,in,0,1
160038,infection,0,1
160039,or,0,1
160040,malignancy,0,1
160041,were,0,0
160042,noted,0,0
160043,between,0,0
160044,groups,0,1
160045,.,0,1
160046,The,0,0
160047,rCsA,0,0
160048,with,0,1
160049,sirolimus,0,1
160050,and,0,1
160051,corticosteroid,0,0
160052,regimen,0,0
160053,resulted,0,0
160054,in,0,1
160055,excellent,0,0
160056,12-month,0,1
160057,patient,0,1
160058,and,0,0
160059,graft,0,1
160060,survival,0,0
160061,",",0,0
160062,a,0,0
160063,low,0,0
160064,incidence,0,0
160065,of,0,0
160066,BCAR,0,1
160067,",",0,1
160068,and,0,0
160069,improved,0,0
160070,renal,0,1
160071,function,0,0
160072,in,0,1
160073,renal,0,1
160074,allograft,0,1
160075,recipients,0,1
160076,.,0,1
160077,Sirolimus,0,1
160078,administered,0,0
160079,with,0,1
160080,rCsA,0,1
160081,and,0,1
160082,corticosteroids,0,0
160083,provided,0,0
160084,adequate,0,0
160085,immunosuppression,0,1
160086,while,0,0
160087,reducing,0,0
160088,the,0,0
160089,potential,0,0
160090,for,0,0
160091,the,0,0
160092,nephrotoxic,0,0
160093,effects,0,0
160094,of,0,1
160095,cyclosporine,0,1
160096,.,0,1
160097,These,0,0
160098,findings,0,0
160099,may,0,0
160100,help,0,0
160101,to,0,0
160102,improve,0,0
160103,long-term,0,0
160104,renal,0,1
160105,allograft,0,1
160106,outcomes,0,0
160107,.,0,1
160108,Low-fluence,0,0
160109,photodynamic,0,1
160110,therapy,0,1
160111,versus,0,0
160112,ranibizumab,0,1
160113,for,0,0
160114,chronic,1,1
160115,central,1,1
160116,serous,1,1
160117,chorioretinopathy,1,1
160118,:,1,1
160119,one-year,0,1
160120,results,0,0
160121,of,0,1
160122,a,0,1
160123,randomized,0,1
160124,trial,0,1
160125,.,0,1
160126,PURPOSE,0,0
160127,To,0,0
160128,compare,0,0
160129,the,0,0
160130,efficacy,0,0
160131,and,0,0
160132,safety,0,0
160133,between,0,0
160134,low-fluence,0,0
160135,photodynamic,0,1
160136,therapy,0,1
160137,(,0,1
160138,PDT,0,1
160139,),0,1
160140,and,0,0
160141,the,0,0
160142,intravitreal,0,0
160143,ranibizumab,0,0
160144,in,0,0
160145,the,0,0
160146,treatment,0,0
160147,of,0,0
160148,chronic,0,1
160149,central,0,1
160150,serous,0,1
160151,chorioretinopathy,0,1
160152,(,0,1
160153,CSC,0,1
160154,),0,1
160155,.,0,1
160156,DESIGN,0,0
160157,Prospective,0,0
160158,",",0,0
160159,randomized,0,1
160160,",",0,0
160161,single-center,0,1
160162,",",0,0
160163,parallel-arm,0,0
160164,",",0,0
160165,controlled,0,0
160166,trial,0,1
160167,.,0,1
160168,PARTICIPANTS,0,0
160169,Thirty-four,1,1
160170,eyes,1,1
160171,of,1,1
160172,32,1,1
160173,patients,1,1
160174,with,1,1
160175,chronic,1,1
160176,CSC,1,1
160177,with,1,1
160178,>,1,1
160179,6,1,1
160180,months,1,0
160181,',1,1
160182,duration,1,1
160183,of,1,1
160184,symptoms,1,1
160185,or,1,1
160186,recurrent,1,1
160187,CSC,1,1
160188,were,1,1
160189,randomly,1,1
160190,placed,1,0
160191,into,1,0
160192,the,1,0
160193,low-fluence,1,0
160194,PDT,1,1
160195,group,1,1
160196,(,1,1
160197,n,1,1
160198,=,1,1
160199,18,1,1
160200,),1,1
160201,or,1,1
160202,the,1,0
160203,ranibizumab,1,0
160204,group,1,0
160205,(,1,1
160206,n,1,1
160207,=,1,1
160208,16,1,1
160209,),1,1
160210,.,1,1
160211,INTERVENTION,0,0
160212,The,0,0
160213,patients,0,1
160214,underwent,0,1
160215,a,0,0
160216,single,0,0
160217,session,0,0
160218,of,0,0
160219,low-fluence,0,0
160220,PDT,0,1
160221,or,0,1
160222,3,0,1
160223,consecutive,0,1
160224,monthly,0,1
160225,injections,0,0
160226,of,0,1
160227,ranibizumab,0,1
160228,.,0,1
160229,Rescue,0,0
160230,treatment,0,0
160231,was,0,0
160232,available,0,0
160233,from,0,1
160234,month,0,0
160235,3,0,1
160236,if,0,0
160237,the,0,0
160238,subretinal,0,1
160239,fluid,0,0
160240,(,0,1
160241,SRF,0,1
160242,),0,1
160243,persisted,0,0
160244,or,0,1
160245,recurred,0,0
160246,after,0,0
160247,primary,0,1
160248,treatment,0,1
160249,;,0,1
160250,low-fluence,0,0
160251,PDT,0,1
160252,was,0,0
160253,given,0,0
160254,to,0,0
160255,the,0,0
160256,ranibizumab,0,0
160257,group,0,0
160258,and,0,0
160259,intravitreal,0,0
160260,ranibizumab,0,0
160261,to,0,0
160262,the,0,0
160263,low-fluence,0,0
160264,PDT,0,1
160265,group,0,1
160266,.,0,1
160267,MAIN,0,0
160268,OUTCOME,0,1
160269,MEASURES,0,0
160270,The,0,0
160271,primary,0,1
160272,outcome,0,0
160273,was,0,0
160274,the,0,0
160275,proportion,0,0
160276,of,0,0
160277,eyes,0,1
160278,with,0,1
160279,complete,0,1
160280,resolution,0,0
160281,of,0,0
160282,SRF,0,0
160283,without,0,1
160284,rescue,0,1
160285,treatment,0,1
160286,.,0,1
160287,Secondary,0,0
160288,outcomes,0,0
160289,included,0,1
160290,the,0,0
160291,mean,0,1
160292,changes,0,0
160293,in,0,1
160294,logarithm,0,0
160295,of,0,0
160296,the,0,0
160297,minimum,0,0
160298,angle,0,0
160299,of,0,0
160300,resolution,0,0
160301,best-corrected,0,0
160302,visual,0,0
160303,acuity,0,0
160304,(,0,1
160305,BCVA,0,0
160306,),0,1
160307,",",0,0
160308,central,0,0
160309,retinal,0,1
160310,thickness,0,1
160311,(,0,1
160312,CRT,0,1
160313,),0,1
160314,",",0,0
160315,and,0,1
160316,angiographic,0,0
160317,findings,0,0
160318,from,0,1
160319,baseline,0,1
160320,to,0,1
160321,12,0,1
160322,months,0,1
160323,.,0,1
160324,RESULTS,0,0
160325,At,0,0
160326,month,0,0
160327,12,0,1
160328,",",0,1
160329,16,1,1
160330,eyes,1,1
160331,(,0,1
160332,88.9,0,0
160333,%,0,0
160334,),0,1
160335,of,0,0
160336,the,0,0
160337,low-fluence,0,0
160338,PDT,0,1
160339,group,0,1
160340,maintained,0,0
160341,complete,0,1
160342,resolution,0,0
160343,of,0,0
160344,SRF,0,0
160345,without,0,1
160346,rescue,0,0
160347,treatment,0,1
160348,versus,0,0
160349,2,1,1
160350,eyes,1,1
160351,(,0,1
160352,12.5,0,0
160353,%,0,0
160354,),0,1
160355,in,0,0
160356,the,0,0
160357,ranibizumab,0,0
160358,group,0,0
160359,(,0,1
160360,P,0,0
160361,<,0,0
160362,0.001,0,0
160363,),0,1
160364,.,0,1
160365,Two,0,1
160366,eyes,0,1
160367,(,0,1
160368,11.1,0,1
160369,%,0,0
160370,),0,1
160371,in,0,0
160372,the,0,0
160373,low-fluence,0,0
160374,PDT,0,1
160375,group,0,1
160376,and,0,1
160377,11,0,1
160378,eyes,0,1
160379,(,0,1
160380,68.8,0,1
160381,%,0,0
160382,),0,1
160383,in,0,0
160384,the,0,0
160385,ranibizumab,0,0
160386,group,0,0
160387,met,0,1
160388,the,0,0
160389,criteria,0,1
160390,for,0,0
160391,rescue,0,1
160392,treatment,0,0
160393,(,0,1
160394,P,0,0
160395,=,0,1
160396,0.001,0,0
160397,),0,1
160398,.,0,1
160399,In,0,0
160400,the,0,0
160401,low-fluence,0,0
160402,PDT,0,1
160403,group,0,0
160404,",",0,0
160405,the,0,0
160406,mean,0,0
160407,decrease,0,0
160408,in,0,0
160409,CRT,0,1
160410,from,0,1
160411,baseline,0,0
160412,was,0,0
160413,significantly,0,0
160414,greater,0,0
160415,than,0,0
160416,that,0,0
160417,in,0,0
160418,the,0,0
160419,ranibizumab,0,0
160420,group,0,0
160421,until,0,1
160422,month,0,1
160423,6,0,1
160424,(,0,1
160425,P,0,0
160426,<,0,0
160427,0.05,0,0
160428,),0,1
160429,",",0,0
160430,but,0,0
160431,the,0,0
160432,differences,0,0
160433,became,0,1
160434,insignificant,0,0
160435,thereafter,0,0
160436,.,0,1
160437,The,0,0
160438,improvement,0,0
160439,in,0,0
160440,BCVA,0,0
160441,from,0,1
160442,baseline,0,0
160443,was,0,0
160444,superior,0,0
160445,in,0,0
160446,the,0,0
160447,low-fluence,0,0
160448,PDT,0,1
160449,group,0,1
160450,to,0,0
160451,that,0,0
160452,in,0,0
160453,the,0,0
160454,ranibizumab,0,0
160455,group,0,0
160456,",",0,0
160457,but,0,0
160458,the,0,0
160459,differences,0,0
160460,were,0,0
160461,not,0,0
160462,statistically,0,0
160463,significant,0,0
160464,except,0,0
160465,at,0,1
160466,month,0,1
160467,3,0,1
160468,(,0,1
160469,P,0,0
160470,=,0,1
160471,0.025,0,0
160472,),0,1
160473,.,0,1
160474,On,0,0
160475,indocyanine,0,0
160476,green,0,1
160477,angiography,0,0
160478,",",0,0
160479,a,0,0
160480,significantly,0,0
160481,greater,0,0
160482,proportion,0,0
160483,of,0,0
160484,the,0,0
160485,low-fluence,0,0
160486,PDT,0,1
160487,group,0,1
160488,(,0,1
160489,16,0,1
160490,eyes,0,1
160491,;,0,1
160492,88.9,0,0
160493,%,0,0
160494,),0,1
160495,showed,0,0
160496,a,0,0
160497,marked,0,0
160498,reduction,0,0
160499,in,0,1
160500,choroidal,0,1
160501,hyperpermeability,0,0
160502,after,0,1
160503,primary,0,1
160504,treatment,0,0
160505,than,0,0
160506,that,0,0
160507,of,0,0
160508,the,0,0
160509,ranibizumab,0,0
160510,group,0,1
160511,(,0,1
160512,0,0,0
160513,eyes,0,1
160514,;,0,1
160515,P,0,0
160516,<,0,0
160517,0.001,0,0
160518,),0,1
160519,.,0,1
160520,No,0,0
160521,serious,0,0
160522,adverse,0,0
160523,events,0,0
160524,related,0,0
160525,to,0,1
160526,the,0,0
160527,drugs,0,0
160528,or,0,1
160529,procedures,0,1
160530,were,0,1
160531,observed,0,0
160532,.,0,0
160533,CONCLUSIONS,0,0
160534,This,0,0
160535,study,0,0
160536,represents,0,0
160537,the,0,0
160538,overall,0,0
160539,superiority,0,0
160540,of,0,0
160541,low-fluence,0,0
160542,PDT,0,1
160543,compared,0,0
160544,with,0,1
160545,intravitreal,0,0
160546,ranibizumab,0,1
160547,in,0,0
160548,the,0,0
160549,treatment,0,0
160550,of,0,0
160551,chronic,0,1
160552,CSC,0,1
160553,.,0,1
160554,Exercise,0,0
160555,for,0,0
160556,methamphetamine,1,1
160557,dependence,1,1
160558,:,1,1
160559,rationale,0,0
160560,",",0,0
160561,design,0,1
160562,",",0,0
160563,and,0,0
160564,methodology,0,0
160565,.,0,1
160566,BACKGROUND,0,0
160567,Effective,0,1
160568,pharmacotherapies,0,1
160569,to,0,1
160570,treat,0,1
160571,methamphetamine,0,1
160572,(,0,0
160573,MA,0,0
160574,),0,1
160575,dependence,0,0
160576,have,0,0
160577,not,0,0
160578,been,0,0
160579,identified,0,0
160580,",",0,0
160581,and,0,0
160582,behavioral,0,0
160583,therapies,0,0
160584,are,0,0
160585,marginally,0,0
160586,effective,0,0
160587,.,0,1
160588,Based,0,0
160589,on,0,0
160590,behavioral,0,1
160591,studies,0,0
160592,demonstrating,0,0
160593,the,0,0
160594,potential,0,0
160595,efficacy,0,0
160596,of,0,0
160597,aerobic,0,0
160598,exercise,0,1
160599,for,0,0
160600,improving,0,0
160601,depressive,0,1
160602,symptoms,0,1
160603,",",0,1
160604,anxiety,0,1
160605,",",0,0
160606,cognitive,0,0
160607,deficits,0,0
160608,",",0,1
160609,and,0,0
160610,substance,0,1
160611,use,0,0
160612,outcomes,0,0
160613,",",0,0
160614,the,0,0
160615,study,0,0
160616,described,0,0
160617,here,0,0
160618,is,0,0
160619,examining,0,0
160620,exercise,0,0
160621,as,0,0
160622,a,0,1
160623,potential,0,0
160624,treatment,0,0
160625,for,0,1
160626,MA-dependent,1,1
160627,individuals,1,1
160628,.,1,1
160629,METHODS,0,0
160630,This,0,0
160631,study,0,0
160632,is,0,0
160633,randomizing,0,0
160634,150,1,0
160635,participants,1,1
160636,with,1,1
160637,MA,1,0
160638,dependence,1,0
160639,at,1,0
160640,a,1,1
160641,residential,1,1
160642,treatment,1,0
160643,facility,1,1
160644,for,1,1
160645,addictive,1,1
160646,disorders,1,1
160647,to,1,1
160648,receive,1,1
160649,either,1,0
160650,a,1,0
160651,thrice-weekly,1,0
160652,structured,1,1
160653,aerobic,1,0
160654,and,1,0
160655,resistance,1,0
160656,exercise,1,0
160657,intervention,1,0
160658,or,1,1
160659,a,1,0
160660,health,1,0
160661,education,1,0
160662,condition,1,0
160663,.,1,1
160664,Recruitment,0,0
160665,commenced,0,1
160666,in,0,0
160667,March,0,1
160668,",",0,1
160669,2010,0,1
160670,.,0,1
160671,Enrollment,0,0
160672,and,0,0
160673,follow-up,0,0
160674,phases,0,1
160675,are,0,0
160676,ongoing,0,0
160677,",",0,0
160678,and,0,0
160679,recruitment,0,0
160680,is,0,0
160681,exceeding,0,0
160682,targeted,0,1
160683,enrollment,0,1
160684,rates,0,0
160685,.,0,1
160686,CONCLUSIONS,0,0
160687,Seeking,0,1
160688,evidence,0,0
160689,for,0,0
160690,a,0,0
160691,possibly,0,0
160692,effective,0,0
160693,adjunct,0,0
160694,to,0,1
160695,traditional,0,1
160696,behavioral,0,1
160697,approaches,0,0
160698,for,0,1
160699,treatment,0,1
160700,of,0,0
160701,MA,0,0
160702,dependence,0,0
160703,",",0,0
160704,this,0,0
160705,study,0,0
160706,is,0,0
160707,assessing,0,0
160708,the,0,0
160709,ability,0,0
160710,of,0,0
160711,an,0,0
160712,8-week,0,0
160713,aerobic,0,0
160714,and,0,0
160715,resistance,0,0
160716,exercise,0,0
160717,protocol,0,0
160718,to,0,0
160719,reduce,0,0
160720,relapse,0,0
160721,to,0,0
160722,MA,0,0
160723,use,0,0
160724,during,0,0
160725,a,0,1
160726,12-week,0,0
160727,follow-up,0,0
160728,period,0,1
160729,after,0,0
160730,discharge,0,1
160731,from,0,1
160732,residential-based,0,1
160733,treatment,0,1
160734,.,0,1
160735,The,0,0
160736,study,0,0
160737,also,0,0
160738,is,0,0
160739,evaluating,0,0
160740,improvements,0,0
160741,in,0,1
160742,health,0,1
160743,and,0,1
160744,functional,0,1
160745,outcomes,0,0
160746,during,0,1
160747,and,0,1
160748,after,0,0
160749,the,0,0
160750,protocol,0,0
160751,.,0,0
160752,This,0,0
160753,paper,0,0
160754,describes,0,0
160755,the,0,0
160756,design,0,0
160757,and,0,0
160758,methods,0,1
160759,of,0,0
160760,the,0,1
160761,study,0,1
160762,.,0,1
160763,Intraluminal,0,1
160764,exfoliated,0,1
160765,cancer,0,1
160766,cells,0,0
160767,and,0,1
160768,effectiveness,0,0
160769,of,0,0
160770,bowel,0,1
160771,ligatures,0,1
160772,during,1,0
160773,sigmoidectomy,1,1
160774,for,1,1
160775,sigmoid,1,1
160776,colon,1,1
160777,cancer,1,1
160778,.,1,1
160779,PURPOSES,0,0
160780,To,0,0
160781,establish,0,0
160782,the,0,0
160783,efficiency,0,0
160784,of,0,0
160785,bowel,0,1
160786,ligatures,0,1
160787,in,0,1
160788,colon,1,1
160789,cancer,1,1
160790,surgery,1,1
160791,",",0,0
160792,focusing,0,0
160793,on,0,0
160794,the,0,0
160795,extent,0,0
160796,to,0,0
160797,which,0,0
160798,exfoliated,0,1
160799,cancer,0,1
160800,cells,0,0
160801,are,0,0
160802,shed,0,0
160803,in,0,0
160804,the,0,0
160805,colonic,0,1
160806,lumen,0,0
160807,during,0,1
160808,sigmoidectomy,0,1
160809,.,0,1
160810,METHODS,0,0
160811,Twenty,1,1
160812,consecutive,1,1
160813,patients,1,1
160814,who,1,1
160815,underwent,1,1
160816,sigmoidectomy,1,1
160817,for,1,0
160818,sigmoid,1,1
160819,colon,1,1
160820,cancer,1,1
160821,were,0,0
160822,prospectively,0,1
160823,randomized,0,1
160824,into,0,1
160825,two,0,1
160826,groups,0,1
160827,:,0,1
160828,the,0,1
160829,ligatures,0,0
160830,group,0,0
160831,",",0,1
160832,in,0,0
160833,which,0,0
160834,bowel,0,1
160835,ligatures,0,0
160836,were,0,1
160837,placed,0,0
160838,",",0,0
160839,3,0,0
160840,",",0,0
160841,5,0,0
160842,",",0,0
160843,10,0,1
160844,cm,0,1
160845,from,0,1
160846,the,0,0
160847,tumor,0,1
160848,proximally,0,0
160849,and,0,0
160850,distally,0,0
160851,before,0,0
160852,dissection,0,1
160853,;,0,1
160854,and,0,0
160855,the,0,0
160856,no,0,0
160857,ligatures,0,0
160858,group,0,0
160859,",",0,1
160860,in,0,0
160861,which,0,0
160862,the,0,0
160863,corresponding,0,0
160864,sites,0,0
160865,were,0,1
160866,ligated,0,0
160867,only,0,0
160868,immediately,0,0
160869,before,0,0
160870,taking,0,1
160871,the,0,0
160872,specimen,0,1
160873,out,0,1
160874,.,0,1
160875,Each,0,0
160876,colonic,0,1
160877,segment,0,0
160878,ligated,0,0
160879,was,0,0
160880,irrigated,0,0
160881,with,0,1
160882,saline,0,0
160883,and,0,1
160884,samples,0,1
160885,were,0,1
160886,sent,0,1
160887,for,0,0
160888,blind,0,1
160889,cytological,0,1
160890,examination,0,1
160891,.,0,1
160892,RESULTS,0,0
160893,Cancer,0,1
160894,cells,0,0
160895,were,0,1
160896,found,0,0
160897,in,0,0
160898,the,0,0
160899,colonic,0,1
160900,segment,0,0
160901,where,0,0
160902,the,0,0
160903,tumor,0,0
160904,was,0,0
160905,located,0,0
160906,",",0,0
160907,in,0,0
160908,18,0,1
160909,of,0,1
160910,20,0,1
160911,samples,0,1
160912,.,0,1
160913,The,0,0
160914,frequency,0,0
160915,of,0,0
160916,free,0,1
160917,cancer,0,1
160918,cells,0,0
160919,decreased,0,0
160920,from,0,1
160921,50,0,1
160922,to,0,1
160923,0,0,0
160924,%,0,0
160925,(,0,1
160926,p,0,0
160927,<,0,0
160928,0.04,0,0
160929,),0,1
160930,in,0,0
160931,the,0,0
160932,distal,0,1
160933,3-5,0,1
160934,cm,0,1
160935,colonic,0,1
160936,segment,0,1
160937,and,0,1
160938,from,0,1
160939,80,0,1
160940,to,0,1
160941,20,0,1
160942,%,0,0
160943,(,0,1
160944,p,0,0
160945,<,0,0
160946,0.03,0,0
160947,),0,1
160948,in,0,0
160949,the,0,0
160950,proximal,0,1
160951,colonic,0,1
160952,segment,0,1
160953,after,0,0
160954,performing,0,1
160955,bowel,0,1
160956,ligatures,0,1
160957,.,0,1
160958,Free,0,1
160959,cancer,0,1
160960,cells,0,0
160961,were,0,1
160962,confirmed,0,1
160963,in,0,0
160964,1,0,1
160965,of,0,1
160966,10,0,1
160967,samples,0,1
160968,at,0,1
160969,both,0,0
160970,colonic,0,1
160971,segments,0,1
160972,5-10,0,1
160973,cm,0,1
160974,from,0,1
160975,the,0,0
160976,tumor,0,1
160977,",",0,0
160978,even,0,0
160979,after,0,0
160980,bowel,0,1
160981,ligatures,0,1
160982,.,0,1
160983,CONCLUSIONS,0,0
160984,Intraluminal,0,1
160985,exfoliated,0,1
160986,cancer,0,1
160987,cells,0,0
160988,could,0,0
160989,be,0,0
160990,eliminated,0,0
160991,by,0,0
160992,placing,0,0
160993,bowel,0,1
160994,ligatures,0,1
160995,during,0,1
160996,sigmoidectomy,0,1
160997,.,0,1
160998,Measures,0,0
160999,should,0,0
161000,be,0,0
161001,considered,0,0
161002,to,0,0
161003,eliminate,0,0
161004,exfoliated,0,1
161005,cancer,0,1
161006,cells,0,0
161007,during,1,0
161008,colectomy,1,1
161009,",",0,0
161010,even,0,0
161011,after,0,0
161012,placing,0,0
161013,bowel,0,1
161014,ligatures,0,1
161015,.,0,1
161016,Using,0,1
161017,the,0,0
161018,virtual,0,0
161019,reality-cognitive,0,0
161020,rehabilitation,0,1
161021,approach,0,0
161022,to,0,0
161023,improve,0,0
161024,contextual,0,0
161025,processing,0,0
161026,in,0,1
161027,children,1,1
161028,with,1,1
161029,autism,1,1
161030,.,1,1
161031,BACKGROUND,0,0
161032,This,0,0
161033,pilot,0,0
161034,study,0,0
161035,investigated,0,0
161036,the,0,0
161037,efficacy,0,0
161038,of,0,0
161039,a,0,1
161040,novel,0,1
161041,virtual,0,0
161042,reality-cognitive,0,1
161043,rehabilitation,0,1
161044,(,0,1
161045,VR-CR,0,0
161046,),0,1
161047,intervention,0,0
161048,to,0,0
161049,improve,0,0
161050,contextual,0,0
161051,processing,0,0
161052,of,0,1
161053,objects,0,1
161054,in,0,1
161055,children,1,1
161056,with,1,1
161057,autism,1,1
161058,.,1,1
161059,Previous,0,0
161060,research,0,0
161061,supports,0,0
161062,that,0,0
161063,children,1,1
161064,with,1,1
161065,autism,1,1
161066,show,0,0
161067,deficits,0,0
161068,in,0,1
161069,contextual,0,0
161070,processing,0,0
161071,",",0,0
161072,as,0,0
161073,well,0,0
161074,as,0,0
161075,deficits,0,0
161076,in,0,1
161077,its,0,0
161078,elementary,0,1
161079,components,0,0
161080,:,0,1
161081,abstraction,0,0
161082,and,0,0
161083,cognitive,0,1
161084,flexibility,0,0
161085,.,0,1
161086,METHODS,0,0
161087,Four,1,1
161088,children,1,1
161089,with,1,1
161090,autism,1,1
161091,participated,0,1
161092,in,0,0
161093,a,0,0
161094,multiple-baseline,0,0
161095,",",0,0
161096,single-subject,0,1
161097,study,0,1
161098,.,0,1
161099,The,0,0
161100,children,1,1
161101,were,0,0
161102,taught,0,0
161103,how,0,0
161104,to,0,1
161105,see,0,0
161106,objects,0,1
161107,in,0,0
161108,context,0,0
161109,by,0,0
161110,reinforcing,0,0
161111,attention,0,0
161112,to,0,1
161113,pivotal,0,0
161114,contextual,0,0
161115,information,0,1
161116,.,0,1
161117,RESULTS,0,0
161118,All,0,1
161119,children,1,1
161120,demonstrated,0,0
161121,statistically,0,0
161122,significant,0,0
161123,improvements,0,0
161124,in,0,1
161125,contextual,0,0
161126,processing,0,0
161127,and,0,1
161128,cognitive,0,1
161129,flexibility,0,0
161130,.,0,1
161131,Mixed,0,1
161132,results,0,0
161133,were,0,1
161134,found,0,0
161135,on,0,0
161136,the,0,0
161137,control,0,1
161138,test,0,0
161139,and,0,1
161140,changes,0,0
161141,in,0,1
161142,context-related,0,0
161143,behaviours,0,1
161144,.,0,1
161145,CONCLUSIONS,0,0
161146,Larger-scale,0,0
161147,studies,0,0
161148,are,0,0
161149,warranted,0,0
161150,to,0,0
161151,determine,0,0
161152,the,0,0
161153,effectiveness,0,0
161154,and,0,0
161155,usability,0,0
161156,in,0,0
161157,comprehensive,0,1
161158,educational,0,1
161159,programs,0,1
161160,.,0,1
161161,Impact,0,0
161162,of,0,0
161163,vitamin,0,0
161164,D,0,0
161165,supplementation,0,0
161166,on,0,0
161167,inflammatory,0,0
161168,markers,0,0
161169,in,0,1
161170,African,1,1
161171,Americans,1,1
161172,:,1,1
161173,results,0,0
161174,of,0,0
161175,a,0,1
161176,four-arm,0,0
161177,",",0,0
161178,randomized,0,1
161179,",",0,0
161180,placebo-controlled,0,0
161181,trial,0,1
161182,.,0,1
161183,African,1,1
161184,Americans,1,1
161185,have,1,1
161186,a,1,1
161187,disproportionate,1,0
161188,burden,1,1
161189,of,1,0
161190,inflammation-associated,1,0
161191,chronic,1,1
161192,diseases,1,1
161193,such,0,0
161194,as,0,1
161195,cancer,0,1
161196,and,0,1
161197,lower,0,0
161198,circulating,0,0
161199,levels,0,0
161200,of,0,1
161201,25-hydroxyvitamin,0,1
161202,D,0,1
161203,[,0,1
161204,25,0,1
161205,(,0,1
161206,OH,0,1
161207,),0,1
161208,D,0,1
161209,],0,1
161210,.,0,1
161211,The,0,0
161212,effect,0,0
161213,of,0,0
161214,vitamin,0,0
161215,D3,0,0
161216,(,0,1
161217,cholecalciferol,0,0
161218,),0,1
161219,supplementation,0,0
161220,on,0,0
161221,inflammatory,0,0
161222,markers,0,0
161223,is,0,0
161224,uncertain,0,0
161225,.,0,0
161226,We,0,0
161227,conducted,0,0
161228,a,0,0
161229,randomized,0,0
161230,",",0,0
161231,double-blind,0,0
161232,",",0,0
161233,placebo-controlled,0,0
161234,trial,0,0
161235,of,0,0
161236,supplemental,0,1
161237,oral,0,1
161238,vitamin,0,1
161239,D,0,0
161240,(,0,1
161241,placebo,0,0
161242,",",0,0
161243,"1,000",0,0
161244,",",0,0
161245,"2,000",0,0
161246,",",0,0
161247,or,0,1
161248,"4,000",0,1
161249,IU/day,0,0
161250,of,0,0
161251,vitamin,0,0
161252,D3,0,0
161253,orally,0,1
161254,for,0,1
161255,3,0,1
161256,months,0,1
161257,),0,1
161258,in,0,1
161259,328,1,1
161260,African,1,1
161261,Americans,1,1
161262,(,1,1
161263,median,1,1
161264,age,1,1
161265,",",1,1
161266,51,1,1
161267,years,1,1
161268,),1,1
161269,of,1,1
161270,public,1,1
161271,housing,1,1
161272,communities,1,1
161273,in,1,1
161274,Boston,1,1
161275,",",1,1
161276,MA,1,0
161277,",",1,1
161278,who,1,1
161279,were,1,1
161280,enrolled,1,1
161281,over,1,0
161282,three,1,0
161283,consecutive,1,1
161284,winter,1,1
161285,periods,1,0
161286,(,1,1
161287,2007-2010,1,1
161288,),1,1
161289,.,1,1
161290,Change,0,0
161291,from,0,1
161292,0,0,0
161293,to,0,1
161294,3,0,1
161295,months,0,0
161296,of,0,1
161297,plasma,0,0
161298,levels,0,1
161299,of,0,1
161300,25,0,1
161301,(,0,1
161302,OH,0,1
161303,),0,1
161304,D,0,0
161305,",",0,1
161306,high-sensitivity,0,0
161307,C-reactive,0,1
161308,protein,0,0
161309,(,0,1
161310,CRP,0,1
161311,),0,0
161312,",",0,0
161313,interleukin,0,0
161314,(,0,1
161315,IL,0,1
161316,),0,1
161317,-6,0,0
161318,",",0,0
161319,IL-10,0,0
161320,",",0,0
161321,and,0,0
161322,soluble,0,0
161323,TNF-?,0,1
161324,receptor,0,0
161325,type,0,1
161326,2,0,1
161327,(,0,1
161328,sTNF-R2,0,1
161329,),0,1
161330,in,0,1
161331,292,0,1
161332,(,0,1
161333,89,0,1
161334,%,0,0
161335,),0,1
161336,participants,0,1
161337,were,0,1
161338,measured,0,0
161339,.,0,1
161340,Overall,0,0
161341,",",0,0
161342,no,0,0
161343,statistically,0,0
161344,significant,0,0
161345,changes,0,0
161346,in,0,1
161347,CRP,0,1
161348,",",0,1
161349,IL-6,0,0
161350,",",0,0
161351,IL-10,0,0
161352,",",0,0
161353,and,0,0
161354,sTNF-R2,0,1
161355,were,0,1
161356,observed,0,0
161357,after,0,0
161358,the,0,0
161359,vitamin,0,0
161360,D,0,0
161361,supplementation,0,0
161362,period,0,1
161363,.,0,1
161364,Baseline,0,0
161365,CRP,0,0
161366,was,0,0
161367,significantly,0,0
161368,inversely,0,0
161369,associated,0,0
161370,with,0,1
161371,the,0,0
161372,baseline,0,0
161373,25,0,1
161374,(,0,1
161375,OH,0,1
161376,),0,1
161377,D,0,0
161378,level,0,0
161379,(,0,1
161380,P,0,0
161381,<,0,0
161382,0.001,0,0
161383,),0,1
161384,in,0,1
161385,unadjusted,0,0
161386,and,0,1
161387,adjusted,0,0
161388,models,0,1
161389,.,0,1
161390,An,0,0
161391,interaction,0,0
161392,between,0,0
161393,baseline,0,0
161394,25,0,1
161395,(,0,1
161396,OH,0,1
161397,),0,1
161398,D,0,0
161399,and,0,1
161400,vitamin,0,0
161401,D,0,1
161402,supplementation,0,0
161403,was,0,0
161404,observed,0,0
161405,for,0,0
161406,outcome,0,0
161407,change,0,0
161408,in,0,0
161409,log,0,0
161410,CRP,0,1
161411,(,0,0
161412,month,0,0
161413,3-month,0,1
161414,0,0,0
161415,;,0,0
161416,P,0,0
161417,for,0,0
161418,interaction,0,0
161419,=,0,1
161420,0.04,0,0
161421,),0,1
161422,.,0,1
161423,Within,0,0
161424,an,0,0
161425,unselected,0,1
161426,population,0,1
161427,of,0,1
161428,African,0,1
161429,Americans,0,1
161430,",",0,1
161431,short-term,0,0
161432,exposure,0,0
161433,to,0,0
161434,vitamin,0,0
161435,D,0,0
161436,supplementation,0,0
161437,produced,0,0
161438,no,0,0
161439,change,0,0
161440,in,0,0
161441,circulating,0,0
161442,inflammatory,0,1
161443,markers,0,0
161444,.,0,1
161445,This,0,0
161446,study,0,0
161447,confirms,0,0
161448,the,0,0
161449,strong,0,0
161450,independent,0,0
161451,association,0,0
161452,of,0,0
161453,CRP,0,1
161454,with,0,1
161455,25,0,1
161456,(,0,1
161457,OH,0,1
161458,),0,1
161459,D,0,0
161460,status,0,1
161461,even,0,0
161462,after,0,0
161463,adjusting,0,0
161464,for,0,0
161465,body,0,1
161466,mass,0,1
161467,index,0,1
161468,.,0,1
161469,Future,0,0
161470,studies,0,0
161471,of,0,1
161472,longer,0,0
161473,supplemental,0,1
161474,vitamin,0,0
161475,D3,0,0
161476,duration,0,0
161477,are,0,0
161478,necessary,0,0
161479,to,0,0
161480,examine,0,0
161481,the,0,0
161482,complex,0,0
161483,influence,0,0
161484,of,0,0
161485,vitamin,0,0
161486,D3,0,0
161487,on,0,0
161488,CRP,0,1
161489,and,0,1
161490,other,0,0
161491,chronic,0,1
161492,inflammatory,0,0
161493,cytokines,0,0
161494,for,0,1
161495,possible,0,0
161496,reduction,0,0
161497,of,1,0
161498,cancer,1,1
161499,health,1,1
161500,disparities,1,0
161501,in,1,1
161502,African,1,1
161503,Americans,1,1
161504,.,1,1
161505,An,0,0
161506,open-label,0,0
161507,extension,0,0
161508,study,0,1
161509,of,0,0
161510,the,0,0
161511,safety,0,0
161512,and,0,0
161513,efficacy,0,0
161514,of,0,0
161515,risperidone,0,0
161516,in,0,1
161517,children,1,1
161518,and,1,1
161519,adolescents,1,1
161520,with,1,1
161521,autistic,1,1
161522,disorder,1,1
161523,.,1,1
161524,OBJECTIVE,0,0
161525,The,0,0
161526,purpose,0,0
161527,of,0,0
161528,this,0,0
161529,study,0,0
161530,was,0,0
161531,to,0,0
161532,evaluate,0,0
161533,the,0,0
161534,long-term,0,0
161535,safety,0,0
161536,and,0,0
161537,efficacy,0,0
161538,of,0,0
161539,risperidone,0,0
161540,in,0,0
161541,treating,0,0
161542,irritability,0,0
161543,and,0,1
161544,related,0,0
161545,behaviors,0,0
161546,in,0,1
161547,children,1,1
161548,and,1,1
161549,adolescents,1,1
161550,with,1,1
161551,autistic,1,1
161552,disorders,1,1
161553,.,1,1
161554,METHODS,0,0
161555,In,0,0
161556,this,0,0
161557,6,0,0
161558,month,0,0
161559,(,0,1
161560,26,0,1
161561,week,0,0
161562,),0,1
161563,open-label,0,1
161564,extension,0,0
161565,(,0,1
161566,OLE,0,1
161567,),0,1
161568,study,0,1
161569,",",0,1
161570,patients,1,1
161571,(,1,1
161572,5-17,1,1
161573,years,1,1
161574,of,1,1
161575,age,1,1
161576,",",1,1
161577,who,1,1
161578,completed,1,1
161579,the,1,1
161580,previous,1,0
161581,fixed-dose,1,0
161582,",",1,1
161583,6,1,0
161584,week,1,0
161585,",",1,1
161586,double-blind,1,0
161587,[,1,0
161588,DB,1,1
161589,],1,1
161590,phase,1,1
161591,),1,0
161592,were,0,0
161593,flexibly,0,0
161594,dosed,0,0
161595,with,0,1
161596,risperidone,0,0
161597,based,0,1
161598,on,0,0
161599,body,0,1
161600,weight,0,1
161601,.,0,1
161602,The,0,0
161603,maximum,0,0
161604,allowed,0,0
161605,dose,0,0
161606,was,0,0
161607,1.25,0,0
161608,mg/day,0,0
161609,for,0,0
161610,those,0,1
161611,weighing,0,1
161612,20,0,1
161613,to,0,1
161614,<,0,0
161615,45,0,1
161616,kg,0,1
161617,",",0,1
161618,and,0,0
161619,1.75,0,0
161620,mg/day,0,0
161621,for,0,0
161622,those,0,1
161623,weighing,0,1
161624,?,0,1
161625,45,0,1
161626,kg,0,1
161627,.,0,1
161628,The,0,0
161629,study,0,0
161630,primarily,0,0
161631,assessed,0,0
161632,risperidone,0,0
161633,'s,0,1
161634,safety,0,0
161635,;,0,1
161636,efficacy,0,0
161637,was,0,0
161638,assessed,0,0
161639,as,0,0
161640,a,0,1
161641,secondary,0,0
161642,end-point,0,0
161643,.,0,1
161644,RESULTS,1,0
161645,Fifty-six,1,1
161646,(,1,1
161647,71,1,1
161648,%,1,0
161649,),1,1
161650,out,1,1
161651,of,1,1
161652,79,1,1
161653,enrolled,1,1
161654,patients,1,1
161655,completed,1,1
161656,the,1,1
161657,OLE,1,1
161658,;,1,0
161659,the,1,0
161660,most,0,0
161661,common,0,1
161662,discontinuations,0,0
161663,were,0,1
161664,for,0,1
161665,insufficient,0,0
161666,response,0,0
161667,(,0,1
161668,7,0,1
161669,[,0,1
161670,9,0,0
161671,%,0,0
161672,],0,1
161673,),0,1
161674,or,0,1
161675,adverse,0,0
161676,events,0,0
161677,(,0,1
161678,AE,0,0
161679,),0,1
161680,(,0,1
161681,5,0,1
161682,[,0,1
161683,6,0,0
161684,%,0,0
161685,],0,1
161686,),0,1
161687,.,0,1
161688,The,0,0
161689,most,0,0
161690,common,0,0
161691,(,0,1
161692,?,0,1
161693,5,0,0
161694,%,0,0
161695,frequency,0,0
161696,in,0,0
161697,the,0,0
161698,total,0,1
161699,group,0,1
161700,),0,1
161701,AEs,0,0
161702,were,0,1
161703,increased,0,0
161704,appetite,0,0
161705,(,0,1
161706,11,0,1
161707,%,0,0
161708,[,0,0
161709,n=9,0,1
161710,],0,1
161711,),0,1
161712,;,0,0
161713,increased,0,0
161714,weight,0,1
161715,and,0,0
161716,vomiting,0,0
161717,(,0,1
161718,9,0,0
161719,%,0,0
161720,[,0,0
161721,n=7,0,1
161722,],0,1
161723,each,0,1
161724,),0,1
161725,;,0,0
161726,sedation,0,1
161727,",",0,0
161728,pyrexia,0,1
161729,",",0,0
161730,and,0,0
161731,upper,0,1
161732,respiratory,0,1
161733,tract,0,1
161734,infection,0,1
161735,(,0,1
161736,8,0,1
161737,%,0,0
161738,[,0,0
161739,n=6,0,1
161740,],0,1
161741,each,0,1
161742,),0,1
161743,;,0,0
161744,nasopharyngitis,0,1
161745,(,0,1
161746,6,0,0
161747,%,0,0
161748,[,0,0
161749,n=5,0,1
161750,],0,1
161751,),0,1
161752,;,0,0
161753,and,0,1
161754,somnolence,0,1
161755,and,0,0
161756,fatigue,0,0
161757,(,0,1
161758,5,0,0
161759,%,0,0
161760,[,0,0
161761,n=4,0,1
161762,],0,1
161763,each,0,1
161764,),0,1
161765,.,0,1
161766,Extrapyramidal,0,0
161767,AEs,0,0
161768,were,0,1
161769,reported,0,1
161770,in,0,1
161771,6,0,1
161772,(,0,1
161773,8,0,1
161774,%,0,0
161775,),0,1
161776,patients,0,1
161777,.,0,1
161778,Increase,0,0
161779,in,0,0
161780,mean,0,1
161781,weight,0,1
161782,(,0,1
161783,11-15,0,1
161784,%,0,0
161785,),0,1
161786,and,0,0
161787,body,0,1
161788,mass,0,1
161789,index,0,1
161790,(,0,1
161791,5-10,0,1
161792,%,0,0
161793,),0,1
161794,occurred,0,0
161795,;,0,1
161796,one,0,1
161797,patient,0,1
161798,discontinued,0,0
161799,because,0,0
161800,of,0,0
161801,weight,0,1
161802,increase,0,0
161803,.,0,1
161804,One,0,1
161805,potentially,0,0
161806,prolactin-related,0,0
161807,AE,0,0
161808,(,0,1
161809,irregular,0,1
161810,menstruation,0,1
161811,),0,1
161812,was,0,0
161813,reported,0,0
161814,.,0,1
161815,The,0,0
161816,risperidone,0,0
161817,high-dose,0,0
161818,group,0,1
161819,had,0,1
161820,the,0,0
161821,greatest,0,0
161822,mean,0,0
161823,improvement,0,0
161824,in,0,1
161825,sleep,0,1
161826,visual,0,0
161827,analog,0,0
161828,scale,0,1
161829,(,0,1
161830,24.6,0,1
161831,),0,1
161832,.,0,1
161833,All,0,1
161834,groups,0,0
161835,showed,0,0
161836,additional,0,0
161837,improvement,0,0
161838,in,0,0
161839,efficacy,0,0
161840,scale,0,1
161841,scores,0,0
161842,during,0,1
161843,the,0,1
161844,OLE,0,1
161845,.,0,1
161846,CONCLUSIONS,0,0
161847,During,0,0
161848,this,0,0
161849,OLE,0,1
161850,",",0,0
161851,safety,0,0
161852,findings,0,0
161853,with,0,1
161854,risperidone,0,1
161855,treatment,0,0
161856,(,0,1
161857,maximum,0,0
161858,weight-based,0,0
161859,dose,0,0
161860,of,0,1
161861,1.25,0,0
161862,mg/day,0,1
161863,or,0,1
161864,1.75,0,0
161865,mg/day,0,1
161866,),0,1
161867,were,0,1
161868,consistent,0,0
161869,with,0,1
161870,those,0,1
161871,observed,0,0
161872,in,0,0
161873,the,0,0
161874,DB,0,1
161875,phase,0,0
161876,",",0,0
161877,and,0,0
161878,with,0,1
161879,the,0,0
161880,current,0,0
161881,safety,0,0
161882,information,0,0
161883,for,0,0
161884,risperidone,0,0
161885,in,0,0
161886,autistic,0,1
161887,",",0,1
161888,psychiatric,0,1
161889,",",0,0
161890,and,0,1
161891,behavioral,0,1
161892,disorders,0,1
161893,.,0,1
161894,Patients,0,1
161895,experienced,0,1
161896,some,0,0
161897,additional,0,0
161898,improvement,0,0
161899,in,0,0
161900,irritability,0,0
161901,and,0,1
161902,related,0,0
161903,behaviors,0,0
161904,.,0,1
161905,CLINICAL,0,1
161906,TRIALS,0,0
161907,REGISTRY,0,1
161908,This,0,0
161909,phase-4,0,0
161910,study,0,0
161911,is,0,0
161912,registered,0,0
161913,at,0,0
161914,ClinicalTrials.gov,0,1
161915,(,0,1
161916,NCT00576732,0,1
161917,),0,1
161918,.,0,1
161919,Whole-body,0,1
161920,CT,0,1
161921,screening,0,1
161922,:,0,1
161923,scan,0,0
161924,delay,0,1
161925,and,0,0
161926,contrast,0,1
161927,injection,0,0
161928,duration,0,0
161929,for,0,0
161930,optimal,0,0
161931,enhancement,0,0
161932,of,0,1
161933,abdominal,0,1
161934,organs,0,1
161935,and,0,1
161936,deep,0,1
161937,vessels,0,1
161938,.,0,1
161939,PURPOSE,0,0
161940,To,0,0
161941,assess,0,0
161942,the,0,0
161943,optimal,0,0
161944,scan,0,0
161945,delays,0,0
161946,and,0,1
161947,contrast,0,1
161948,injection,0,0
161949,durations,0,0
161950,for,0,1
161951,contrast-enhanced,0,1
161952,whole-body,0,1
161953,computed,0,0
161954,tomography,0,0
161955,(,0,1
161956,CT,0,1
161957,),0,1
161958,.,0,1
161959,MATERIALS,0,0
161960,AND,0,0
161961,METHODS,0,0
161962,One,1,1
161963,hundred,1,1
161964,forty-two,1,1
161965,patients,1,1
161966,were,0,1
161967,randomized,0,1
161968,into,0,1
161969,three,0,1
161970,groups,0,1
161971,:,0,1
161972,protocol,0,1
161973,A-scan,0,0
161974,delay,0,1
161975,of,0,1
161976,65,0,1
161977,s,0,1
161978,after,0,1
161979,starting,0,1
161980,contrast,0,1
161981,injection,0,0
161982,over,0,0
161983,30,0,1
161984,s,0,1
161985,;,0,1
161986,protocol,0,1
161987,B-105,0,1
161988,and,0,1
161989,70,0,1
161990,s,0,1
161991,;,0,0
161992,and,0,0
161993,protocol,0,1
161994,C-145,0,0
161995,and,0,1
161996,110,0,1
161997,s,0,0
161998,",",0,0
161999,respectively,0,0
162000,.,0,1
162001,Contrast,0,0
162002,enhancement,0,0
162003,and,0,1
162004,diagnostic,0,0
162005,acceptability,0,0
162006,were,0,1
162007,assessed,0,0
162008,.,0,1
162009,RESULTS,0,0
162010,Qualitative,0,0
162011,assessment,0,0
162012,was,0,0
162013,subtle,0,0
162014,among,0,1
162015,the,0,1
162016,three,0,1
162017,protocols,0,0
162018,.,0,1
162019,Homogenous,0,0
162020,enhancement,0,0
162021,of,0,1
162022,deep,0,1
162023,veins,0,1
162024,was,0,0
162025,more,0,0
162026,assuredly,0,0
162027,achieved,0,0
162028,with,0,1
162029,protocol,0,1
162030,C.,0,0
162031,CONCLUSION,0,0
162032,With,0,1
162033,protocol,0,1
162034,C,0,0
162035,",",0,0
162036,qualitatively,0,0
162037,acceptable,0,0
162038,enhancement,0,0
162039,can,0,0
162040,be,0,0
162041,obtained,0,0
162042,in,0,0
162043,whole-body,0,1
162044,CT,0,1
162045,.,0,1
162046,A,0,0
162047,randomized,0,0
162048,controlled,0,0
162049,trial,0,1
162050,of,0,0
162051,the,0,0
162052,Korean,0,1
162053,version,0,0
162054,of,0,0
162055,the,0,0
162056,PEERS,0,0
162057,(,0,1
162058,?,0,1
162059,),0,0
162060,parent-assisted,0,1
162061,social,0,1
162062,skills,0,0
162063,training,0,1
162064,program,0,1
162065,for,1,1
162066,teens,1,1
162067,with,1,1
162068,ASD,1,1
162069,.,1,1
162070,Impaired,0,1
162071,social,0,0
162072,functioning,0,1
162073,is,0,0
162074,a,0,0
162075,hallmark,0,0
162076,feature,0,0
162077,of,0,0
162078,autism,0,1
162079,spectrum,0,1
162080,disorder,0,1
162081,(,0,1
162082,ASD,0,1
162083,),0,0
162084,",",0,0
162085,often,0,0
162086,requiring,0,1
162087,treatment,0,0
162088,throughout,0,0
162089,the,0,0
162090,life,0,1
162091,span,0,1
162092,.,0,1
162093,PEERS,0,0
162094,(,0,1
162095,?,0,1
162096,),0,0
162097,(,0,0
162098,Program,0,0
162099,for,0,0
162100,the,0,0
162101,Education,0,1
162102,and,0,0
162103,Enrichment,0,0
162104,of,0,1
162105,Relational,0,0
162106,Skills,0,0
162107,),0,0
162108,is,0,0
162109,a,0,0
162110,parent-assisted,1,0
162111,social,1,1
162112,skills,1,0
162113,training,1,1
162114,for,1,1
162115,teens,1,1
162116,with,1,1
162117,ASD,1,1
162118,.,1,1
162119,Although,0,0
162120,PEERS,0,0
162121,(,0,1
162122,?,0,1
162123,),0,0
162124,has,0,0
162125,an,0,0
162126,established,0,0
162127,evidence,0,0
162128,base,0,0
162129,in,0,0
162130,improving,0,0
162131,the,0,0
162132,social,0,0
162133,skills,0,0
162134,of,0,1
162135,adolescents,0,1
162136,and,0,1
162137,young,0,1
162138,adults,0,1
162139,with,0,1
162140,ASD,0,1
162141,in,0,1
162142,North,0,1
162143,America,0,1
162144,",",0,0
162145,the,0,0
162146,efficacy,0,0
162147,of,0,0
162148,this,0,0
162149,treatment,0,0
162150,has,0,0
162151,yet,0,0
162152,to,0,0
162153,be,0,0
162154,established,0,0
162155,in,0,0
162156,cross-cultural,0,0
162157,validation,0,1
162158,trials,0,1
162159,.,0,1
162160,The,0,0
162161,objective,0,0
162162,of,0,0
162163,this,0,0
162164,study,0,0
162165,is,0,0
162166,to,0,0
162167,examine,0,0
162168,the,0,0
162169,feasibility,0,0
162170,and,0,0
162171,treatment,0,0
162172,efficacy,0,0
162173,of,0,0
162174,a,0,1
162175,Korean,0,1
162176,version,0,0
162177,of,0,1
162178,PEERS,0,1
162179,(,0,1
162180,?,0,1
162181,),0,0
162182,for,0,0
162183,enhancing,0,0
162184,social,0,1
162185,skills,0,0
162186,through,0,1
162187,a,0,1
162188,randomized,0,1
162189,controlled,0,0
162190,trial,0,0
162191,(,0,1
162192,RCT,0,1
162193,),0,1
162194,.The,0,0
162195,English,0,1
162196,version,0,0
162197,of,0,0
162198,the,0,0
162199,PEERS,0,0
162200,(,0,1
162201,?,0,1
162202,),0,0
162203,Treatment,0,0
162204,Manual,0,1
162205,(,0,1
162206,Laugeson,0,0
162207,&,0,1
162208,Frankel,0,1
162209,",",0,1
162210,2010,0,1
162211,),0,1
162212,was,0,0
162213,translated,0,0
162214,into,0,1
162215,Korean,1,1
162216,and,1,1
162217,reviewed,1,1
162218,by,1,0
162219,21,1,1
162220,child,1,1
162221,mental,1,1
162222,health,1,1
162223,professionals,1,1
162224,.,1,1
162225,Items,1,0
162226,identified,0,0
162227,as,0,0
162228,culturally,0,1
162229,sensitive,0,0
162230,were,0,0
162231,surveyed,1,1
162232,by,1,0
162233,447,1,1
162234,middle,1,1
162235,school,1,1
162236,students,1,1
162237,",",1,1
162238,and,1,0
162239,material,0,1
162240,was,0,0
162241,modified,0,0
162242,accordingly,1,1
162243,.,1,1
162244,Participants,1,1
162245,included,1,1
162246,47,1,1
162247,teens,1,1
162248,between,1,1
162249,12,1,1
162250,and,1,1
162251,18,1,1
162252,years,1,1
162253,of,1,1
162254,age,1,1
162255,with,1,1
162256,a,1,0
162257,diagnosis,1,1
162258,of,1,0
162259,ASD,1,1
162260,and,1,1
162261,a,1,1
162262,verbal,1,0
162263,intelligence,1,1
162264,quotient,1,0
162265,(,1,1
162266,IQ,1,1
162267,),1,1
162268,?,1,1
162269,65,1,1
162270,.,0,1
162271,Eligible,0,0
162272,teens,0,1
162273,were,0,1
162274,randomly,0,1
162275,assigned,0,1
162276,to,0,0
162277,a,0,0
162278,treatment,0,0
162279,group,0,0
162280,(,0,1
162281,TG,0,0
162282,),0,1
162283,or,0,1
162284,delayed,0,1
162285,treatment,0,0
162286,control,0,1
162287,group,0,1
162288,(,0,1
162289,CG,0,1
162290,),0,1
162291,.,0,1
162292,Primary,0,1
162293,outcome,0,0
162294,measures,0,0
162295,included,0,1
162296,questionnaires,0,0
162297,and,0,1
162298,direct,0,1
162299,observations,0,0
162300,quantifying,0,0
162301,social,0,1
162302,ability,0,0
162303,and,0,1
162304,problems,0,1
162305,directly,0,0
162306,related,0,0
162307,to,0,0
162308,ASD,0,1
162309,.,0,1
162310,Secondary,0,0
162311,outcome,0,0
162312,measures,0,0
162313,included,0,1
162314,scales,0,0
162315,for,0,1
162316,depressive,0,1
162317,symptoms,0,0
162318,",",0,0
162319,anxiety,0,1
162320,",",0,0
162321,and,0,0
162322,other,0,0
162323,behavioral,0,1
162324,problems,0,1
162325,.,0,1
162326,Rating,0,0
162327,scales,0,0
162328,for,0,1
162329,parental,0,1
162330,depressive,0,1
162331,symptoms,0,1
162332,and,0,1
162333,anxiety,0,1
162334,were,0,1
162335,examined,0,0
162336,to,0,0
162337,detect,0,0
162338,changes,0,0
162339,in,0,1
162340,parental,0,1
162341,psychosocial,0,1
162342,functioning,0,1
162343,throughout,0,0
162344,the,0,0
162345,PEERS,0,0
162346,(,0,1
162347,?,0,1
162348,),0,0
162349,treatment,0,0
162350,.,0,1
162351,Independent,0,1
162352,samples,0,1
162353,t-tests,0,0
162354,revealed,0,1
162355,no,0,1
162356,significant,0,0
162357,differences,0,0
162358,at,0,1
162359,baseline,0,0
162360,across,0,0
162361,the,0,0
162362,TG,0,0
162363,and,0,1
162364,CG,0,1
162365,conditions,0,1
162366,with,0,1
162367,regard,0,0
162368,to,0,1
162369,age,0,1
162370,(,0,1
162371,14.04,0,0
162372,?,0,1
162373,1.64,0,0
162374,and,0,1
162375,13.54,0,0
162376,?,0,1
162377,1.50,0,0
162378,years,0,1
162379,),0,1
162380,",",0,1
162381,IQ,0,1
162382,(,0,1
162383,99.39,0,0
162384,?,0,1
162385,18.09,0,0
162386,&,0,1
162387,100.67,0,1
162388,?,0,1
162389,16.97,0,0
162390,),0,0
162391,",",0,0
162392,parental,0,0
162393,education,0,0
162394,",",0,0
162395,socioeconomic,0,1
162396,status,0,1
162397,",",0,0
162398,or,0,1
162399,ASD,0,1
162400,symptoms,0,1
162401,(,0,1
162402,p,0,0
162403,<,0,0
162404,0.05,0,0
162405,),0,0
162406,",",0,0
162407,respectively,0,0
162408,.,0,1
162409,Results,0,0
162410,for,0,0
162411,treatment,0,0
162412,outcome,0,0
162413,suggest,0,0
162414,that,0,0
162415,the,0,0
162416,TG,0,0
162417,showed,0,0
162418,significant,0,0
162419,improvement,0,0
162420,in,0,0
162421,communication,0,0
162422,and,0,1
162423,social,0,0
162424,interaction,0,0
162425,domain,0,1
162426,scores,0,0
162427,on,0,0
162428,the,0,1
162429,Autism,0,1
162430,Diagnostic,0,1
162431,Observation,0,0
162432,Schedule,0,0
162433,",",0,0
162434,interpersonal,0,0
162435,relationship,0,0
162436,and,0,0
162437,play/leisure,0,1
162438,time,0,0
162439,on,0,0
162440,the,0,0
162441,subdomain,0,1
162442,scores,0,0
162443,of,0,0
162444,the,0,1
162445,Korean,0,1
162446,version,0,0
162447,of,0,0
162448,the,0,0
162449,Vineland,0,1
162450,Adaptive,0,0
162451,Behavior,0,1
162452,Scale,0,1
162453,(,0,1
162454,p,0,0
162455,'s,0,1
162456,<,0,0
162457,0.01,0,0
162458,),0,1
162459,",",0,1
162460,social,0,0
162461,skills,0,0
162462,knowledge,0,0
162463,total,0,1
162464,scores,0,0
162465,on,0,0
162466,the,0,0
162467,Test,0,0
162468,of,0,0
162469,Adolescent,0,1
162470,Social,0,1
162471,Skills,0,0
162472,Knowledge-Revised,0,0
162473,(,0,1
162474,p,0,0
162475,<,0,0
162476,0.01,0,0
162477,),0,1
162478,",",0,0
162479,and,0,0
162480,decreased,0,0
162481,depressive,0,1
162482,symptoms,0,1
162483,on,0,0
162484,the,0,1
162485,Child,0,1
162486,Depression,0,0
162487,Inventory,0,1
162488,following,0,0
162489,treatment,0,0
162490,(,0,1
162491,p,0,0
162492,<,0,0
162493,0.05,0,0
162494,),0,1
162495,.,0,1
162496,Analyses,0,0
162497,of,0,0
162498,parental,0,1
162499,outcome,0,0
162500,reveal,0,0
162501,a,0,0
162502,significant,0,0
162503,decrease,0,0
162504,in,0,1
162505,maternal,0,1
162506,state,0,1
162507,anxiety,0,1
162508,in,0,0
162509,the,0,0
162510,TG,0,0
162511,after,0,0
162512,controlling,0,0
162513,for,0,1
162514,potential,0,0
162515,confounding,0,0
162516,variables,0,0
162517,(,0,1
162518,p,0,0
162519,<,0,0
162520,0.05,0,0
162521,),0,1
162522,.,0,1
162523,Despite,0,0
162524,cultural,0,0
162525,and,0,1
162526,linguistic,0,1
162527,differences,0,0
162528,",",0,1
162529,the,0,0
162530,PEERS,0,0
162531,(,0,1
162532,?,0,1
162533,),0,0
162534,social,0,0
162535,skills,0,0
162536,intervention,0,1
162537,appears,0,0
162538,to,0,0
162539,be,0,0
162540,efficacious,1,0
162541,for,1,0
162542,teens,1,1
162543,with,1,1
162544,ASD,1,1
162545,in,1,1
162546,Korea,1,1
162547,with,0,1
162548,modest,0,0
162549,cultural,0,0
162550,adjustment,0,0
162551,.,0,1
162552,In,0,0
162553,an,0,0
162554,RCT,0,1
162555,",",0,0
162556,participants,0,1
162557,receiving,0,1
162558,the,0,1
162559,PEERS,0,0
162560,(,0,1
162561,?,0,1
162562,),0,0
162563,treatment,0,0
162564,showed,0,0
162565,significant,0,0
162566,improvement,0,0
162567,in,0,1
162568,social,0,1
162569,skills,0,0
162570,knowledge,0,0
162571,",",0,1
162572,interpersonal,0,0
162573,skills,0,0
162574,",",0,1
162575,and,0,1
162576,play/leisure,0,1
162577,skills,0,0
162578,",",0,0
162579,as,0,0
162580,well,0,0
162581,as,0,0
162582,a,0,0
162583,decrease,0,0
162584,in,0,0
162585,depressive,0,1
162586,symptoms,0,1
162587,and,0,1
162588,ASD,0,1
162589,symptoms,0,1
162590,.,0,1
162591,This,0,0
162592,study,0,0
162593,represents,0,0
162594,one,0,0
162595,of,0,0
162596,only,0,0
162597,a,0,1
162598,few,0,0
162599,cross-cultural,0,0
162600,validation,0,1
162601,trials,0,0
162602,of,0,0
162603,an,0,1
162604,established,0,0
162605,evidence-based,0,0
162606,treatment,0,1
162607,for,0,1
162608,adolescents,1,1
162609,with,1,1
162610,ASD,1,1
162611,.,1,1
162612,Evaluating,0,0
162613,intervention,0,0
162614,using,0,0
162615,time,0,0
162616,aids,0,1
162617,in,0,1
162618,children,1,1
162619,with,1,1
162620,disabilities,1,1
162621,.,1,1
162622,OBJECTIVE,0,0
162623,The,0,0
162624,aim,0,0
162625,of,0,0
162626,this,0,0
162627,study,0,0
162628,was,0,0
162629,to,0,0
162630,evaluate,0,0
162631,complex,0,0
162632,intervention,0,0
162633,using,0,0
162634,time,0,0
162635,aids,0,1
162636,for,0,1
162637,children,1,1
162638,with,1,1
162639,intellectual,1,1
162640,and,1,1
162641,developmental,1,1
162642,disabilities,1,1
162643,who,1,1
162644,exhibit,1,1
162645,limitations,1,1
162646,in,1,1
162647,daily,1,0
162648,time,1,0
162649,management,1,1
162650,.,1,1
162651,METHODS,0,0
162652,Participating,1,1
162653,children,1,1
162654,(,1,1
162655,n,1,1
162656,=,1,1
162657,47,1,1
162658,),1,1
162659,(,1,1
162660,F17/M30,1,1
162661,),1,1
162662,were,1,1
162663,aged,1,1
162664,6-11,1,1
162665,with,1,1
162666,ADHD,1,0
162667,",",1,0
162668,autism,1,1
162669,spectrum,1,1
162670,disorders,1,1
162671,",",1,1
162672,mild,1,1
162673,or,1,1
162674,moderate,1,1
162675,intellectual,1,1
162676,disability,1,1
162677,",",1,0
162678,spina,1,1
162679,bifida,1,1
162680,",",1,0
162681,and,1,0
162682,cerebral,1,1
162683,palsy,1,1
162684,.,1,1
162685,This,0,0
162686,study,0,0
162687,used,0,0
162688,a,0,0
162689,Randomized,0,0
162690,Block,0,0
162691,and,0,1
162692,Waiting,0,1
162693,List,0,1
162694,control,0,1
162695,group,0,1
162696,design,0,1
162697,",",0,0
162698,with,0,1
162699,25,0,1
162700,children,0,1
162701,allocated,0,1
162702,to,0,1
162703,control,0,1
162704,and,0,1
162705,22,0,1
162706,to,0,1
162707,intervention,0,1
162708,group,0,1
162709,.,0,1
162710,In,1,0
162711,total,1,1
162712,10,1,1
162713,children,1,1
162714,(,1,1
162715,21.3,1,0
162716,%,1,0
162717,),1,1
162718,",",1,0
162719,five,1,1
162720,from,1,1
162721,each,1,0
162722,group,1,0
162723,",",1,0
162724,dropped,1,0
162725,out,1,0
162726,",",1,0
162727,leaving,1,1
162728,37,1,1
162729,children,1,1
162730,in,1,1
162731,the,1,0
162732,data,1,0
162733,analysis,1,0
162734,.,1,1
162735,RESULTS,0,0
162736,Children,0,1
162737,in,0,1
162738,both,0,0
162739,groups,0,0
162740,gained,0,0
162741,significantly,0,0
162742,in,0,0
162743,time-processing,0,0
162744,ability,0,0
162745,between,0,0
162746,the,0,0
162747,first,0,0
162748,and,0,1
162749,second,0,1
162750,data,0,0
162751,collection,0,1
162752,",",0,0
162753,but,0,0
162754,the,0,0
162755,children,0,1
162756,in,0,0
162757,the,0,0
162758,intervention,0,0
162759,group,0,0
162760,improved,0,0
162761,time-processing,0,0
162762,ability,0,0
162763,significantly,0,0
162764,more,0,0
162765,than,0,0
162766,controls,0,1
162767,.,0,1
162768,The,0,0
162769,control,0,0
162770,group,0,0
162771,also,0,0
162772,displayed,0,0
162773,significant,0,0
162774,changes,0,0
162775,after,0,1
162776,receiving,0,1
162777,intervention,0,0
162778,between,0,0
162779,the,0,0
162780,second,0,1
162781,and,0,1
162782,third,0,1
162783,data,0,0
162784,collection,0,1
162785,.,0,1
162786,The,0,0
162787,intervention,0,0
162788,had,0,1
162789,a,0,0
162790,large,0,1
162791,effect,0,0
162792,(,0,1
162793,ES,0,1
162794,Cohen,0,1
162795,'s,0,1
162796,d,0,0
162797,=,0,1
162798,0.81,0,0
162799,),0,0
162800,on,0,0
162801,time-processing,0,0
162802,ability,0,0
162803,and,0,0
162804,a,0,0
162805,medium,0,0
162806,effect,0,0
162807,(,0,1
162808,ES,0,1
162809,Cohen,0,1
162810,'s,0,1
162811,d,0,0
162812,=,0,1
162813,0.68,0,0
162814,),0,0
162815,on,0,0
162816,managing,0,1
162817,one,0,1
162818,'s,0,1
162819,time,0,0
162820,.,0,1
162821,CONCLUSIONS,0,0
162822,This,0,0
162823,study,0,0
162824,provides,0,0
162825,preliminary,0,0
162826,evidence,0,0
162827,that,0,0
162828,time-processing,0,0
162829,ability,0,0
162830,and,0,1
162831,managing,0,0
162832,one,0,1
162833,'s,0,1
162834,time,0,0
162835,can,0,0
162836,be,0,0
162837,improved,0,0
162838,by,0,0
162839,intervention,0,0
162840,using,0,0
162841,time,0,0
162842,aids,0,1
162843,in,0,1
162844,children,1,1
162845,with,1,1
162846,intellectual,1,1
162847,and,1,1
162848,developmental,1,1
162849,disabilities,1,1
162850,",",0,1
162851,supporting,0,0
162852,the,0,0
162853,need,0,0
162854,to,0,0
162855,consider,0,0
162856,time,0,0
162857,aids,0,1
162858,in,0,1
162859,intervention,0,1
162860,in,0,1
162861,these,0,0
162862,children,0,1
162863,.,0,1
162864,Early,0,1
162865,psychosocial,0,1
162866,intervention,0,1
162867,in,0,1
162868,Alzheimer,1,1
162869,'s,1,1
162870,disease,1,1
162871,:,1,1
162872,cost,0,0
162873,utility,0,0
162874,evaluation,0,0
162875,alongside,0,0
162876,the,0,0
162877,Danish,1,1
162878,Alzheimer,0,1
162879,'s,0,1
162880,Intervention,0,1
162881,Study,0,1
162882,(,0,1
162883,DAISY,0,1
162884,),0,1
162885,.,0,1
162886,OBJECTIVE,0,0
162887,To,0,0
162888,assess,0,0
162889,the,0,0
162890,cost,0,0
162891,utility,0,0
162892,of,0,0
162893,early,0,1
162894,psychosocial,0,1
162895,intervention,0,1
162896,for,0,1
162897,patients,1,1
162898,with,1,1
162899,Alzheimer,1,1
162900,'s,1,1
162901,disease,1,1
162902,and,1,1
162903,their,1,1
162904,primary,1,1
162905,caregivers,1,1
162906,.,1,1
162907,DESIGN,0,0
162908,Cost,0,0
162909,utility,0,0
162910,evaluation,0,0
162911,alongside,0,0
162912,a,0,0
162913,multicentre,0,0
162914,",",0,0
162915,randomised,0,0
162916,controlled,0,0
162917,trial,0,1
162918,with,0,1
162919,3,0,1
162920,years,0,1
162921,of,0,1
162922,follow-up,0,1
162923,.,0,1
162924,SETTING,0,1
162925,Primary,1,1
162926,care,1,1
162927,and,1,1
162928,memory,1,1
162929,clinics,1,1
162930,in,1,1
162931,five,1,1
162932,Danish,1,1
162933,districts,1,1
162934,.,1,1
162935,PARTICIPANTS,0,1
162936,330,1,1
162937,community-dwelling,1,1
162938,patients,1,1
162939,and,1,1
162940,their,1,1
162941,primary,1,1
162942,caregivers,1,1
162943,.,1,1
162944,INTERVENTION,0,0
162945,Psychosocial,0,1
162946,counselling,0,0
162947,and,0,0
162948,support,0,0
162949,lasting,0,0
162950,8-12,0,1
162951,months,0,1
162952,after,0,1
162953,diagnosis,0,1
162954,and,0,0
162955,follow-up,0,0
162956,at,0,0
162957,3,0,1
162958,",",0,1
162959,6,0,0
162960,",",0,1
162961,12,0,1
162962,and,0,1
162963,36,0,1
162964,months,0,0
162965,in,0,1
162966,the,0,0
162967,intervention,0,0
162968,group,0,0
162969,or,0,1
162970,follow-up,0,0
162971,only,0,0
162972,in,0,0
162973,the,0,0
162974,control,0,1
162975,group,0,1
162976,.,0,1
162977,MAIN,0,0
162978,OUTCOME,0,1
162979,MEASURES,0,0
162980,The,0,0
162981,primary,0,1
162982,outcome,0,0
162983,measure,0,0
162984,was,0,0
162985,the,0,0
162986,cost,0,0
162987,of,0,0
162988,additional,0,0
162989,quality-adjusted,0,0
162990,life,0,1
162991,years,0,1
162992,(,0,1
162993,QALYs,0,1
162994,),0,1
162995,.,0,1
162996,Costs,0,0
162997,were,0,0
162998,measured,0,0
162999,from,0,1
163000,a,0,1
163001,societal,0,0
163002,perspective,0,0
163003,",",0,0
163004,including,0,0
163005,the,0,0
163006,costs,0,0
163007,of,0,0
163008,healthcare,0,1
163009,",",0,0
163010,social,0,0
163011,care,0,1
163012,",",0,0
163013,informal,0,0
163014,care,0,1
163015,and,0,0
163016,production,0,0
163017,loss,0,0
163018,.,0,1
163019,QALYs,0,0
163020,were,0,0
163021,estimated,0,0
163022,separately,0,0
163023,for,0,0
163024,the,0,0
163025,patient,0,0
163026,and,0,0
163027,the,0,0
163028,caregiver,0,0
163029,before,0,0
163030,aggregation,0,0
163031,for,0,0
163032,the,0,0
163033,main,0,0
163034,analysis,0,0
163035,.,0,1
163036,RESULTS,0,0
163037,None,0,0
163038,of,0,0
163039,the,0,0
163040,observed,0,0
163041,cost,0,0
163042,and,0,1
163043,QALY,0,1
163044,measures,0,0
163045,were,0,1
163046,significantly,0,0
163047,different,0,0
163048,between,0,0
163049,the,0,0
163050,intervention,0,0
163051,and,0,0
163052,control,0,1
163053,groups,0,0
163054,",",0,0
163055,although,0,0
163056,a,0,0
163057,tendency,0,0
163058,was,0,0
163059,noted,0,0
163060,for,0,0
163061,psychosocial,0,1
163062,care,0,1
163063,leading,0,0
163064,to,0,1
163065,cost,0,0
163066,increases,0,0
163067,with,0,1
163068,informal,0,1
163069,care,0,1
163070,that,0,0
163071,was,0,0
163072,not,0,0
163073,outweighed,0,0
163074,by,0,0
163075,the,0,0
163076,tendency,0,0
163077,for,0,0
163078,cost,0,0
163079,savings,0,0
163080,with,0,1
163081,formal,0,1
163082,care,0,1
163083,.,0,1
163084,The,0,0
163085,probability,0,0
163086,of,0,0
163087,psychosocial,0,1
163088,intervention,0,1
163089,being,0,1
163090,cost-effective,0,0
163091,did,0,0
163092,not,0,0
163093,exceed,0,0
163094,36,0,1
163095,%,0,0
163096,for,0,0
163097,any,0,0
163098,threshold,0,0
163099,value,0,0
163100,.,0,1
163101,The,0,0
163102,alternative,0,0
163103,scenario,0,0
163104,analysis,0,0
163105,showed,0,0
163106,that,0,0
163107,the,0,0
163108,probability,0,0
163109,of,0,0
163110,cost-effectiveness,0,0
163111,increased,0,0
163112,over,0,0
163113,the,0,0
163114,range,0,1
163115,of,0,0
163116,threshold,0,0
163117,values,0,0
163118,used,0,0
163119,if,0,0
163120,the,0,0
163121,cost,0,0
163122,perspective,0,0
163123,was,0,0
163124,restricted,0,1
163125,to,0,1
163126,formal,0,1
163127,healthcare,0,1
163128,.,0,1
163129,CONCLUSIONS,0,0
163130,A,0,0
163131,multifaceted,0,0
163132,",",0,1
163133,psychosocial,0,1
163134,intervention,0,0
163135,programme,0,1
163136,was,0,0
163137,found,0,0
163138,unlikely,0,0
163139,to,0,0
163140,be,0,0
163141,cost-effective,0,0
163142,from,0,1
163143,a,0,1
163144,societal,0,0
163145,perspective,0,0
163146,.,0,1
163147,The,0,0
163148,recommendation,0,0
163149,for,0,0
163150,practice,0,0
163151,in,0,1
163152,settings,0,1
163153,that,0,0
163154,are,0,0
163155,similar,0,0
163156,to,0,1
163157,the,0,0
163158,Danish,0,0
163159,setting,0,1
163160,is,0,0
163161,to,0,0
163162,provide,0,0
163163,follow-up,0,0
163164,with,0,1
163165,referral,0,1
163166,to,0,1
163167,available,0,1
163168,local,0,0
163169,support,0,0
163170,programmes,0,1
163171,when,0,0
163172,needed,0,0
163173,",",0,0
163174,and,0,0
163175,to,0,0
163176,restrict,0,0
163177,large,0,1
163178,multifaceted,0,0
163179,intervention,0,1
163180,programmes,0,1
163181,to,0,1
163182,patients,1,1
163183,and,1,1
163184,caregivers,1,1
163185,with,1,1
163186,special,1,1
163187,needs,1,1
163188,until,0,1
163189,further,0,1
163190,evidence,0,0
163191,for,0,1
163192,cost-effectiveness,0,0
163193,emerges,0,1
163194,.,0,1
163195,TRIAL,0,0
163196,REGISTRATION,0,0
163197,The,0,0
163198,study,0,0
163199,was,0,0
163200,registered,0,1
163201,in,0,0
163202,the,0,0
163203,Clinical,0,0
163204,Trial,0,1
163205,Database,0,1
163206,as,0,0
163207,ISRCTN74848736,0,1
163208,.,0,1
163209,[,0,0
163210,Rehabilitation,0,1
163211,of,0,0
163212,the,0,0
163213,patients,1,1
163214,presenting,1,1
163215,with,1,1
163216,combined,1,1
163217,pathology,1,1
163218,:,1,1
163219,dyscirculatory,1,1
163220,encephalopathy,1,1
163221,and,1,0
163222,climacteric,1,1
163223,syndrome,1,1
163224,],1,1
163225,.,1,1
163226,The,0,0
163227,present,0,0
163228,paper,0,0
163229,reports,0,0
163230,the,0,0
163231,data,0,0
163232,on,0,0
163233,rehabilitation,1,1
163234,of,1,1
163235,women,1,1
163236,presenting,1,1
163237,with,1,1
163238,combined,1,1
163239,pathology,1,1
163240,:,1,1
163241,dyscirculatory,1,1
163242,encephalopathy,1,1
163243,and,1,0
163244,climacteric,1,1
163245,syndrome,1,1
163246,.,1,1
163247,It,0,0
163248,is,0,0
163249,shown,0,0
163250,that,0,0
163251,the,0,0
163252,introduction,0,0
163253,of,0,0
163254,ozonotherapy,0,0
163255,and,0,0
163256,klimadynon,0,0
163257,",",0,0
163258,a,0,0
163259,herbal,0,0
163260,medicine,0,1
163261,possessed,0,0
163262,of,0,0
163263,the,0,0
163264,estrogen-like,0,0
163265,action,0,0
163266,",",0,0
163267,into,0,0
163268,combined,0,0
163269,rehabilitative,0,1
163270,treatment,0,0
163271,ensures,0,0
163272,the,0,0
163273,significant,0,0
163274,improvement,0,0
163275,of,0,0
163276,the,0,0
163277,parameters,0,0
163278,of,0,0
163279,interest,0,0
163280,",",0,0
163281,such,0,0
163282,as,0,0
163283,climacteric,0,1
163284,symptoms,0,1
163285,",",0,1
163286,short-term,0,0
163287,memory,0,0
163288,",",0,0
163289,lipid,0,0
163290,profile,0,0
163291,",",0,0
163292,endothelial,0,0
163293,function,0,0
163294,",",0,0
163295,cerebral,0,1
163296,circulation,0,0
163297,",",0,0
163298,and,0,0
163299,quality,0,0
163300,of,0,0
163301,life,0,1
163302,.,0,1
163303,Preschool-based,0,1
163304,social,0,1
163305,communication,0,0
163306,treatment,0,1
163307,for,0,0
163308,children,1,1
163309,with,1,1
163310,autism,1,1
163311,:,1,1
163312,12-month,0,0
163313,follow-up,0,0
163314,of,0,0
163315,a,0,1
163316,randomized,0,1
163317,trial,0,0
163318,.,0,1
163319,OBJECTIVE,0,0
163320,This,0,0
163321,study,0,0
163322,reports,0,0
163323,12-month,0,0
163324,follow-up,0,0
163325,data,0,0
163326,from,0,1
163327,a,0,1
163328,randomized,0,1
163329,controlled,0,0
163330,trial,0,1
163331,of,0,0
163332,preschool-based,0,1
163333,social,0,1
163334,communication,0,0
163335,treatment,0,0
163336,for,0,1
163337,young,1,1
163338,children,1,1
163339,with,1,1
163340,autism,1,1
163341,.,1,1
163342,METHOD,0,0
163343,A,1,0
163344,total,1,1
163345,of,1,1
163346,61,1,1
163347,children,1,1
163348,(,1,1
163349,48,1,1
163350,males,1,1
163351,),1,1
163352,with,1,1
163353,autism,1,1
163354,",",1,1
163355,29,1,1
163356,to,1,1
163357,60,1,1
163358,months,1,0
163359,of,1,1
163360,age,1,1
163361,",",1,0
163362,had,1,0
163363,earlier,1,0
163364,been,1,0
163365,randomized,1,0
163366,either,1,1
163367,to,1,1
163368,8,1,1
163369,weeks,1,0
163370,of,1,1
163371,preschool-based,1,1
163372,social,1,1
163373,communication,1,0
163374,treatment,1,0
163375,in,1,0
163376,addition,1,0
163377,to,1,1
163378,standard,1,1
163379,preschool,1,1
163380,program,1,1
163381,(,1,1
163382,n,1,1
163383,=,1,1
163384,34,1,1
163385,),1,1
163386,or,1,1
163387,to,1,1
163388,standard,1,1
163389,preschool,1,1
163390,program,1,1
163391,only,1,0
163392,(,1,0
163393,n,1,1
163394,=,1,1
163395,27,1,1
163396,),1,1
163397,.,1,1
163398,Significant,0,0
163399,short-term,0,0
163400,effects,0,0
163401,on,0,1
163402,targeted,0,1
163403,social,0,1
163404,communication,0,0
163405,skills,0,0
163406,have,0,0
163407,previously,0,1
163408,been,0,0
163409,published,0,0
163410,.,0,1
163411,Long-term,0,0
163412,gains,0,0
163413,in,0,1
163414,social,0,1
163415,communication,0,0
163416,",",0,0
163417,language,0,0
163418,and,0,0
163419,global,0,0
163420,social,0,1
163421,functioning,0,1
163422,and,0,1
163423,communication,0,0
163424,were,0,0
163425,assessed,0,0
163426,from,0,1
163427,video-taped,0,0
163428,preschool,0,1
163429,teacher-child,0,1
163430,and,0,1
163431,mother-child,0,1
163432,interactions,0,0
163433,",",0,1
163434,Early,0,1
163435,Social,0,1
163436,Communication,0,1
163437,Scales,0,0
163438,",",0,1
163439,Reynell,0,1
163440,Developmental,0,1
163441,Language,0,0
163442,Scale,0,1
163443,",",0,0
163444,and,0,0
163445,Social,0,0
163446,Communication,0,1
163447,Questionnaire,0,0
163448,.,0,1
163449,RESULTS,0,0
163450,Compared,0,0
163451,with,0,1
163452,those,0,0
163453,in,0,0
163454,the,0,0
163455,control,0,0
163456,group,0,0
163457,",",0,0
163458,the,0,0
163459,treated,0,1
163460,children,0,1
163461,achieved,0,0
163462,significantly,0,0
163463,larger,0,0
163464,improvements,0,0
163465,in,0,0
163466,joint,0,1
163467,attention,0,0
163468,and,0,1
163469,joint,0,1
163470,engagement,0,0
163471,from,0,1
163472,baseline,0,0
163473,to,0,1
163474,12-month,0,0
163475,follow-up,0,0
163476,.,0,1
163477,However,0,0
163478,",",0,0
163479,no,0,0
163480,effects,0,0
163481,were,0,1
163482,detected,0,0
163483,on,0,0
163484,language,0,0
163485,and,0,1
163486,global,0,0
163487,ratings,0,0
163488,of,0,1
163489,social,0,1
163490,functioning,0,1
163491,and,0,1
163492,communication,0,0
163493,.,0,1
163494,The,0,0
163495,treatment,0,0
163496,effect,0,0
163497,on,0,0
163498,child,0,1
163499,initiation,0,0
163500,of,0,0
163501,joint,0,1
163502,attention,0,0
163503,increased,0,0
163504,with,0,1
163505,increasing,0,0
163506,level,0,0
163507,of,0,0
163508,sociability,0,1
163509,at,0,0
163510,baseline,0,1
163511,",",0,1
163512,whereas,0,0
163513,nonverbal,0,1
163514,IQ,0,1
163515,and,0,1
163516,expressive,0,1
163517,language,0,0
163518,had,0,1
163519,no,0,0
163520,moderating,0,0
163521,effect,0,0
163522,.,0,1
163523,CONCLUSIONS,0,0
163524,This,0,0
163525,study,0,0
163526,is,0,0
163527,the,0,0
163528,first,0,0
163529,to,0,0
163530,show,0,0
163531,that,0,0
163532,",",0,0
163533,similar,0,0
163534,to,0,1
163535,specialist-delivered,0,1
163536,treatment,0,0
163537,",",0,0
163538,preschool-based,0,1
163539,treatment,0,0
163540,may,0,0
163541,produce,0,0
163542,small,0,0
163543,but,0,0
163544,possibly,0,0
163545,clinically,0,1
163546,important,0,0
163547,long-term,0,0
163548,changes,0,0
163549,in,0,1
163550,social,0,1
163551,communication,0,0
163552,in,0,1
163553,young,0,1
163554,children,0,1
163555,with,0,1
163556,autism,0,1
163557,.,0,1
163558,The,0,0
163559,treatment,0,0
163560,did,0,0
163561,not,0,0
163562,affect,0,0
163563,language,0,0
163564,and,0,1
163565,global,0,0
163566,ratings,0,0
163567,of,0,1
163568,social,0,1
163569,functioning,0,1
163570,and,0,1
163571,communication,0,0
163572,.,0,1
163573,More,0,1
163574,studies,0,0
163575,are,0,0
163576,needed,0,0
163577,to,0,0
163578,better,0,0
163579,understand,0,0
163580,whether,0,0
163581,treatment,0,0
163582,effects,0,0
163583,may,0,0
163584,be,0,0
163585,improved,0,0
163586,by,0,0
163587,increasing,0,0
163588,the,0,0
163589,intensity,0,0
163590,and,0,0
163591,duration,0,0
163592,of,0,0
163593,the,0,0
163594,treatment,0,0
163595,.,0,1
163596,Clinical,0,0
163597,trial,0,0
163598,registration,0,0
163599,information,0,0
163600,--,0,1
163601,Joint,0,0
163602,Attention,0,0
163603,Intervention,0,1
163604,and,0,1
163605,Young,0,1
163606,Children,0,1
163607,With,0,1
163608,Autism,0,1
163609,;,0,1
163610,http,0,0
163611,:,0,1
163612,//clinicaltrials.gov/,0,0
163613,;,0,1
163614,NCT00378157,0,1
163615,.,0,1
163616,Participant,0,1
163617,characteristics,0,1
163618,and,0,1
163619,intervention,0,1
163620,processes,0,0
163621,associated,0,0
163622,with,0,1
163623,reductions,0,0
163624,in,0,1
163625,television,0,1
163626,viewing,0,0
163627,in,0,0
163628,the,0,0
163629,High,0,0
163630,Five,0,1
163631,for,0,1
163632,Kids,1,1
163633,study,0,1
163634,.,0,1
163635,OBJECTIVE,0,0
163636,To,0,0
163637,evaluate,0,0
163638,the,0,0
163639,High,0,0
163640,Five,0,1
163641,for,0,1
163642,Kids,1,1
163643,intervention,0,0
163644,effect,0,0
163645,on,0,0
163646,television,0,1
163647,within,0,1
163648,subgroups,0,0
163649,",",0,1
163650,examine,0,0
163651,participant,0,0
163652,characteristics,0,0
163653,associated,0,0
163654,with,0,1
163655,process,0,0
163656,measures,0,0
163657,and,0,1
163658,assess,0,0
163659,perceived,0,0
163660,helpfulness,0,0
163661,of,0,0
163662,television,0,1
163663,intervention,0,1
163664,components,0,0
163665,.,0,1
163666,METHOD,0,0
163667,High,1,1
163668,Five,1,1
163669,(,1,1
163670,randomized,1,1
163671,controlled,1,0
163672,trial,1,1
163673,of,1,0
163674,445,1,1
163675,overweight/obese,1,1
163676,2-7,1,1
163677,year-olds,1,1
163678,in,1,1
163679,Massachusetts,1,1
163680,[,1,0
163681,2006-2008,1,1
163682,],1,1
163683,),1,1
163684,reduced,1,0
163685,television,1,0
163686,by,1,0
163687,0.36,1,0
163688,h/day,1,1
163689,.,1,1
163690,1-year,0,0
163691,effects,0,0
163692,on,0,0
163693,television,0,1
163694,viewing,0,0
163695,",",0,0
163696,stratified,0,1
163697,by,0,0
163698,subgroup,0,1
163699,",",0,0
163700,were,0,0
163701,assessed,0,0
163702,using,0,0
163703,linear,0,0
163704,regression,0,0
163705,.,0,1
163706,Among,1,1
163707,intervention,1,0
163708,participants,1,1
163709,(,1,1
163710,n=253,1,1
163711,),1,1
163712,",",0,0
163713,associations,0,0
163714,of,0,0
163715,intervention,0,1
163716,component,0,0
163717,helpfulness,0,0
163718,with,0,1
163719,television,0,0
163720,reduction,0,0
163721,were,0,1
163722,examined,0,0
163723,using,0,0
163724,linear,0,0
163725,regression,0,0
163726,and,0,1
163727,associations,0,0
163728,of,0,1
163729,participant,0,1
163730,characteristics,0,1
163731,with,0,1
163732,processes,0,0
163733,linked,0,0
163734,to,0,1
163735,television,0,0
163736,reduction,0,0
163737,(,0,0
163738,choosing,0,0
163739,television,0,0
163740,and,0,1
163741,completing,0,0
163742,intervention,0,1
163743,visits,0,1
163744,),0,1
163745,were,0,1
163746,examined,0,0
163747,using,0,0
163748,logistic,0,0
163749,regression,0,0
163750,.,0,1
163751,RESULTS,0,0
163752,High,0,1
163753,Five,0,1
163754,reduced,0,0
163755,television,0,0
163756,across,0,1
163757,subgroups,0,0
163758,.,0,1
163759,Parents,1,0
163760,of,1,0
163761,Latino,1,1
163762,(,1,1
163763,versus,1,0
163764,white,1,1
163765,),1,1
163766,children,1,1
163767,had,0,1
163768,lower,0,0
163769,odds,0,0
163770,of,0,0
163771,completing,0,1
163772,?2,0,0
163773,study,0,1
163774,visits,0,1
163775,(,0,1
163776,Odds,0,1
163777,Ratio,0,1
163778,:,0,1
163779,0.39,0,0
163780,[,0,0
163781,95,0,0
163782,%,0,0
163783,Confidence,0,0
163784,Interval,0,0
163785,:,0,1
163786,0.18,0,0
163787,",",0,1
163788,0.84,1,0
163789,],1,1
163790,),1,1
163791,.,1,1
163792,Parents,1,0
163793,of,1,0
163794,black,1,1
163795,(,1,1
163796,versus,1,0
163797,white,1,1
163798,),1,1
163799,children,1,1
163800,had,1,1
163801,higher,0,0
163802,odds,0,0
163803,of,0,0
163804,choosing,0,0
163805,television,0,1
163806,(,0,1
163807,Odds,0,1
163808,Ratio,0,1
163809,:,0,1
163810,2.23,0,0
163811,[,0,0
163812,95,0,0
163813,%,0,0
163814,Confidence,0,0
163815,Interval,0,0
163816,:,0,1
163817,1.08,0,0
163818,",",0,1
163819,4.59,0,0
163820,],0,1
163821,),0,0
163822,",",0,0
163823,as,0,0
163824,did,1,0
163825,parents,1,1
163826,of,1,1
163827,obese,1,1
163828,(,1,1
163829,versus,1,0
163830,overweight,1,1
163831,),1,1
163832,children,1,1
163833,and,1,1
163834,children,1,1
163835,watching,1,1
163836,?2,1,0
163837,h/day,1,1
163838,(,1,1
163839,versus,1,0
163840,<,1,0
163841,2,1,1
163842,),1,1
163843,at,1,1
163844,baseline,1,0
163845,.,1,1
163846,Greater,1,0
163847,perceived,0,0
163848,helpfulness,0,0
163849,was,0,0
163850,associated,0,0
163851,with,0,1
163852,greater,0,0
163853,television,0,1
163854,reduction,0,0
163855,.,0,1
163856,CONCLUSION,0,0
163857,Clinic-based,0,0
163858,motivational,0,1
163859,interviewing,0,1
163860,reduces,0,0
163861,television,0,1
163862,viewing,1,0
163863,in,1,1
163864,children,1,1
163865,.,1,1
163866,Low,1,1
163867,cost,0,0
163868,education,0,1
163869,approaches,0,0
163870,(,0,1
163871,e.g.,0,0
163872,",",0,1
163873,printed,0,0
163874,materials,0,1
163875,),0,1
163876,may,0,0
163877,be,0,0
163878,well-received,0,0
163879,.,0,1
163880,Parents,1,0
163881,of,1,0
163882,children,1,1
163883,at,1,1
163884,higher,1,0
163885,obesity,1,1
163886,risk,1,0
163887,could,1,0
163888,be,0,0
163889,more,0,0
163890,motivated,0,0
163891,to,0,0
163892,reduce,0,0
163893,television,0,0
163894,.,0,1
163895,Non-contrast-enhanced,0,1
163896,4D,0,1
163897,MR,0,1
163898,angiography,0,1
163899,with,0,1
163900,STAR,0,0
163901,spin,0,0
163902,labeling,0,0
163903,and,0,0
163904,variable,0,0
163905,flip,0,0
163906,angle,0,0
163907,sampling,0,1
163908,:,0,1
163909,a,0,0
163910,feasibility,0,0
163911,study,0,0
163912,for,0,0
163913,the,0,0
163914,assessment,0,0
163915,of,0,0
163916,Dural,1,1
163917,Arteriovenous,1,1
163918,Fistula,1,1
163919,.,1,1
163920,INTRODUCTION,0,0
163921,This,0,0
163922,study,0,0
163923,aimed,0,0
163924,to,0,0
163925,evaluate,0,0
163926,the,0,0
163927,feasibility,0,0
163928,of,0,0
163929,non-contrast-enhanced,0,1
163930,4D,0,1
163931,magnetic,0,1
163932,resonance,0,1
163933,angiography,0,1
163934,(,0,1
163935,NCE,0,1
163936,4D,0,1
163937,MRA,0,1
163938,),0,1
163939,with,0,1
163940,signal,0,1
163941,targeting,0,0
163942,with,0,1
163943,alternative,0,0
163944,radiofrequency,0,1
163945,(,0,1
163946,STAR,0,0
163947,),0,1
163948,spin,0,0
163949,labeling,0,0
163950,and,0,0
163951,variable,0,0
163952,flip,0,0
163953,angle,0,0
163954,(,0,1
163955,VFA,0,1
163956,),0,1
163957,sampling,0,0
163958,in,0,0
163959,the,0,0
163960,assessment,0,0
163961,of,0,0
163962,dural,1,1
163963,arteriovenous,1,1
163964,fistula,1,0
163965,(,1,1
163966,DAVF,1,0
163967,),1,1
163968,in,1,0
163969,the,1,0
163970,transverse,1,0
163971,sinus,1,1
163972,.,1,1
163973,METHODS,0,0
163974,Nine,1,1
163975,patients,1,1
163976,underwent,1,1
163977,NCE,1,1
163978,4D,1,1
163979,MRA,1,1
163980,for,0,0
163981,the,0,0
163982,evaluation,0,0
163983,of,0,0
163984,DAVF,0,0
163985,in,0,0
163986,the,0,0
163987,transverse,0,0
163988,sinus,0,1
163989,at,0,1
163990,3,0,1
163991,T.,0,1
163992,One,0,1
163993,patient,0,1
163994,was,0,0
163995,examined,0,0
163996,twice,0,0
163997,",",0,0
163998,once,0,0
163999,before,0,0
164000,and,0,0
164001,once,0,0
164002,after,0,0
164003,the,0,0
164004,interventional,0,1
164005,treatment,0,0
164006,.,0,1
164007,All,1,1
164008,patients,1,1
164009,also,1,0
164010,underwent,1,1
164011,digital,1,0
164012,subtraction,1,0
164013,angiography,1,1
164014,(,1,1
164015,DSA,1,1
164016,),1,1
164017,and/or,0,1
164018,contrast-enhanced,0,0
164019,magnetic,0,0
164020,resonance,0,1
164021,angiography,0,1
164022,(,0,1
164023,CEMRA,0,0
164024,),0,1
164025,.,0,1
164026,For,0,0
164027,the,0,0
164028,acquisition,0,0
164029,of,0,0
164030,NCE,0,1
164031,4D,0,1
164032,MRA,0,1
164033,",",0,0
164034,a,0,0
164035,STAR,0,0
164036,spin,0,0
164037,tagging,0,1
164038,method,0,0
164039,was,0,0
164040,used,0,0
164041,",",0,0
164042,and,0,0
164043,a,0,0
164044,VFA,0,1
164045,sampling,0,0
164046,was,0,0
164047,applied,0,0
164048,in,0,0
164049,the,0,0
164050,data,0,0
164051,readout,0,0
164052,module,0,1
164053,instead,0,0
164054,of,0,0
164055,a,0,0
164056,constant,0,0
164057,flip,0,0
164058,angle,0,0
164059,.,0,1
164060,Two,0,1
164061,readers,0,1
164062,evaluated,0,0
164063,the,0,1
164064,NCE,0,1
164065,4D,0,1
164066,MRA,0,1
164067,data,0,0
164068,for,0,1
164069,the,0,0
164070,diagnosis,0,1
164071,of,0,0
164072,DAVF,0,0
164073,and,0,1
164074,its,0,0
164075,type,0,1
164076,with,0,1
164077,consensus,0,1
164078,.,0,1
164079,The,0,0
164080,results,0,0
164081,were,0,1
164082,compared,0,0
164083,with,0,1
164084,those,0,1
164085,from,0,1
164086,DSA,0,1
164087,and/or,0,1
164088,CEMRA,0,0
164089,.,0,1
164090,RESULTS,0,0
164091,All,0,1
164092,patients,0,1
164093,underwent,0,1
164094,NCE,0,1
164095,4D,0,1
164096,MRA,0,1
164097,without,0,1
164098,any,0,0
164099,difficulty,0,0
164100,.,0,1
164101,Among,1,1
164102,seven,1,1
164103,patients,1,1
164104,with,1,1
164105,patent,1,1
164106,DAVFs,1,0
164107,",",1,0
164108,all,0,0
164109,cases,0,1
164110,showed,0,0
164111,an,0,1
164112,early,0,1
164113,visualization,0,0
164114,of,0,0
164115,the,0,0
164116,transverse,0,0
164117,sinus,0,1
164118,on,0,0
164119,NCE,0,1
164120,4D,0,1
164121,MRA,0,1
164122,.,0,1
164123,Except,0,0
164124,for,0,0
164125,one,0,1
164126,case,0,0
164127,",",0,0
164128,the,0,0
164129,type,0,1
164130,of,0,0
164131,DAVF,0,0
164132,of,0,1
164133,NCE,0,1
164134,4D,0,1
164135,MRA,0,1
164136,was,0,0
164137,agreed,0,1
164138,with,0,1
164139,that,0,0
164140,of,0,0
164141,reference,0,0
164142,standard,0,1
164143,study,0,1
164144,.,0,1
164145,Cortical,0,0
164146,venous,0,1
164147,reflux,0,1
164148,(,0,1
164149,CVR,0,1
164150,),0,1
164151,was,0,0
164152,demonstrated,0,0
164153,in,0,1
164154,two,0,1
164155,cases,0,1
164156,out,0,1
164157,of,1,1
164158,three,1,1
164159,patients,1,1
164160,with,1,1
164161,CVR,1,1
164162,.,1,1
164163,CONCLUSION,0,0
164164,NCE,0,1
164165,4D,0,1
164166,MRA,0,1
164167,with,0,1
164168,STAR,0,0
164169,tagging,0,1
164170,and,0,1
164171,VFA,0,1
164172,sampling,0,0
164173,is,0,0
164174,technically,0,0
164175,and,0,0
164176,clinically,0,1
164177,feasible,0,0
164178,and,0,0
164179,represents,0,0
164180,a,0,0
164181,promising,0,0
164182,technique,0,0
164183,for,0,0
164184,assessment,0,0
164185,of,0,0
164186,DAVF,0,0
164187,in,0,0
164188,the,0,0
164189,transverse,0,0
164190,sinus,0,1
164191,.,0,1
164192,Further,0,0
164193,technical,0,0
164194,developments,0,0
164195,should,0,0
164196,aim,0,0
164197,at,0,0
164198,improvements,0,0
164199,of,0,1
164200,spatial,0,1
164201,and,0,1
164202,temporal,0,0
164203,coverage,0,1
164204,.,0,1
164205,Accumulated,0,0
164206,brisk,0,1
164207,walking,0,0
164208,reduces,0,0
164209,arterial,0,1
164210,stiffness,0,1
164211,in,1,1
164212,overweight,1,1
164213,adults,1,1
164214,:,1,1
164215,evidence,0,0
164216,from,0,1
164217,a,0,0
164218,randomized,0,1
164219,control,0,1
164220,trial,0,1
164221,.,0,1
164222,Arterial,0,0
164223,stiffness,0,0
164224,is,0,0
164225,a,0,0
164226,major,0,0
164227,contributor,0,0
164228,to,0,0
164229,the,0,0
164230,development,0,0
164231,of,0,0
164232,atherosclerosis,0,1
164233,and,0,0
164234,consequently,0,0
164235,cardiovascular,0,1
164236,disease,0,1
164237,.,0,1
164238,This,0,0
164239,study,0,0
164240,aimed,0,0
164241,to,0,0
164242,examine,0,0
164243,whether,0,0
164244,6,0,0
164245,months,0,1
164246,of,0,1
164247,accumulated,0,0
164248,(,0,1
164249,3,0,1
164250,?,0,1
164251,10,0,0
164252,minutes,0,0
164253,",",0,1
164254,5,0,1
164255,days/week,0,1
164256,),0,1
164257,brisk,0,0
164258,walking,0,0
164259,was,0,0
164260,sufficient,0,0
164261,to,0,0
164262,reduce,0,0
164263,arterial,0,1
164264,stiffness,1,0
164265,in,1,0
164266,sedentary,1,1
164267,",",1,1
164268,overweight,1,1
164269,individuals,1,1
164270,.,1,1
164271,Seventy-seven,1,1
164272,individuals,1,1
164273,(,1,1
164274,19,1,1
164275,men,1,1
164276,",",1,1
164277,58,1,1
164278,women,1,1
164279,;,1,1
164280,age,1,1
164281,",",1,1
164282,30-55,1,1
164283,years,1,1
164284,),1,1
164285,were,0,1
164286,randomly,0,1
164287,allocated,0,1
164288,to,0,0
164289,one,0,1
164290,of,0,1
164291,three,0,1
164292,groups,1,1
164293,;,1,1
164294,two,1,1
164295,groups,1,1
164296,completed,1,1
164297,30,1,1
164298,minutes,1,0
164299,of,1,1
164300,accumulated,1,0
164301,walking,1,0
164302,with,1,1
164303,either,1,1
164304,monthly,1,0
164305,or,1,1
164306,weekly,1,1
164307,telephone,1,1
164308,support,1,0
164309,;,1,0
164310,the,1,0
164311,third,1,1
164312,group,1,1
164313,(,1,1
164314,control,1,1
164315,),1,1
164316,performed,1,0
164317,stretching,1,0
164318,exercises,1,0
164319,.,1,1
164320,The,1,0
164321,walking,1,0
164322,groups,1,0
164323,were,0,1
164324,combined,0,0
164325,and,0,0
164326,telephone,0,1
164327,support,0,0
164328,included,0,1
164329,as,0,0
164330,a,0,1
164331,covariate,0,0
164332,.,0,1
164333,Anthropometry,0,0
164334,",",0,0
164335,blood,0,0
164336,pressure,0,0
164337,(,0,1
164338,BP,0,1
164339,),0,1
164340,",",0,0
164341,blood,0,0
164342,lipids,0,0
164343,",",0,0
164344,pulse,0,0
164345,wave,0,0
164346,velocity,0,0
164347,(,0,1
164348,PWV,0,0
164349,),0,1
164350,",",0,0
164351,and,0,0
164352,NOx,0,0
164353,(,0,1
164354,surrogate,0,0
164355,marker,0,0
164356,for,0,0
164357,nitric,0,0
164358,oxide,0,1
164359,),0,1
164360,were,0,0
164361,measured,0,0
164362,at,0,0
164363,baseline,0,0
164364,",",0,0
164365,post-intervention,0,0
164366,and,0,1
164367,4,0,0
164368,months,0,1
164369,post-intervention,0,0
164370,.,0,1
164371,No,0,0
164372,changes,0,0
164373,were,0,1
164374,observed,0,0
164375,for,0,0
164376,anthropometry,0,1
164377,",",0,0
164378,BP,0,1
164379,",",0,0
164380,or,0,1
164381,lipids,0,0
164382,.,0,1
164383,However,0,0
164384,",",0,0
164385,at,0,0
164386,the,0,0
164387,end,0,0
164388,of,0,0
164389,the,0,0
164390,intervention,0,0
164391,",",0,0
164392,there,0,0
164393,was,0,0
164394,a,0,0
164395,decrease,0,0
164396,in,0,0
164397,PWV,0,0
164398,(,0,1
164399,P,0,0
164400,<,0,0
164401,.001,0,0
164402,),0,1
164403,accompanied,0,0
164404,by,0,0
164405,an,0,0
164406,increase,0,0
164407,in,0,0
164408,NOx,0,0
164409,(,0,1
164410,P,0,0
164411,<,0,0
164412,.001,0,0
164413,),0,0
164414,",",0,0
164415,with,0,1
164416,changes,0,0
164417,maintained,0,1
164418,4,0,1
164419,months,0,1
164420,post-intervention,0,0
164421,.,0,1
164422,A,0,0
164423,strong,0,0
164424,negative,0,1
164425,correlation,0,0
164426,between,0,0
164427,PWV,0,0
164428,and,0,1
164429,NOx,0,0
164430,was,0,0
164431,also,0,0
164432,observed,0,0
164433,(,0,0
164434,P,0,0
164435,<,0,0
164436,.001,0,0
164437,;,0,1
164438,r,0,0
164439,=,0,1
164440,-0.65,0,0
164441,),0,1
164442,.,0,1
164443,A,0,0
164444,lifestyle,0,0
164445,approach,0,0
164446,to,0,1
164447,meeting,0,1
164448,current,0,1
164449,physical,0,1
164450,activity,0,0
164451,guidelines,0,1
164452,results,0,0
164453,in,0,1
164454,favorable,0,0
164455,alterations,0,0
164456,in,0,1
164457,arterial,0,1
164458,function,0,0
164459,in,1,1
164460,overweight,1,1
164461,individuals,1,1
164462,.,1,1
164463,Decreased,0,0
164464,expression,0,0
164465,of,0,0
164466,Yes-associated,0,0
164467,protein,0,0
164468,is,0,0
164469,associated,0,0
164470,with,0,0
164471,outcome,0,0
164472,in,0,0
164473,the,0,0
164474,luminal,1,1
164475,A,1,1
164476,breast,1,1
164477,cancer,1,1
164478,subgroup,1,1
164479,and,0,0
164480,with,0,1
164481,an,0,0
164482,impaired,0,1
164483,tamoxifen,0,1
164484,response,0,0
164485,.,0,1
164486,BACKGROUND,0,0
164487,Yes-associated,0,0
164488,protein,0,0
164489,(,0,1
164490,YAP1,0,1
164491,),0,0
164492,is,0,0
164493,frequently,0,0
164494,reported,0,0
164495,to,0,0
164496,function,0,0
164497,as,0,0
164498,an,0,0
164499,oncogene,0,0
164500,in,0,0
164501,many,0,1
164502,types,0,1
164503,of,0,1
164504,cancer,0,1
164505,",",0,0
164506,but,0,0
164507,in,0,0
164508,breast,0,1
164509,cancer,0,1
164510,results,0,0
164511,remain,0,1
164512,controversial,0,0
164513,.,0,1
164514,We,0,0
164515,set,0,0
164516,out,0,0
164517,to,0,0
164518,clarify,0,0
164519,the,0,0
164520,role,0,0
164521,of,0,0
164522,YAP1,0,1
164523,in,0,1
164524,breast,0,1
164525,cancer,0,1
164526,by,0,0
164527,examining,0,0
164528,gene,0,0
164529,and,0,1
164530,protein,0,0
164531,expression,0,0
164532,in,0,1
164533,subgroups,0,0
164534,of,0,1
164535,patient,0,1
164536,material,0,1
164537,and,0,1
164538,by,0,0
164539,downregulating,0,0
164540,YAP1,0,1
164541,in,0,1
164542,vitro,0,0
164543,and,0,1
164544,studying,0,0
164545,its,0,0
164546,role,0,0
164547,in,0,0
164548,response,0,0
164549,to,0,0
164550,the,0,0
164551,widely,0,0
164552,used,0,0
164553,anti-estrogen,0,0
164554,tamoxifen,0,1
164555,.,0,1
164556,METHODS,0,0
164557,YAP1,0,1
164558,protein,0,0
164559,intensity,0,0
164560,was,0,0
164561,scored,0,0
164562,as,0,0
164563,absent,0,1
164564,",",0,0
164565,weak,0,0
164566,",",0,0
164567,intermediate,0,1
164568,or,0,1
164569,strong,0,0
164570,in,0,1
164571,two,1,1
164572,primary,1,1
164573,breast,1,1
164574,cancer,1,1
164575,cohorts,1,1
164576,(,1,1
164577,n,1,1
164578,=,1,1
164579,144,1,1
164580,and,1,1
164581,n,1,1
164582,=,1,1
164583,564,1,1
164584,),1,1
164585,and,1,1
164586,mRNA,1,0
164587,expression,1,0
164588,of,1,1
164589,YAP1,1,1
164590,was,1,0
164591,evaluated,1,0
164592,in,1,0
164593,a,1,0
164594,gene,1,0
164595,expression,1,0
164596,dataset,1,1
164597,(,1,1
164598,n,1,1
164599,=,1,1
164600,1107,1,1
164601,),1,1
164602,.,0,1
164603,Recurrence-free,0,0
164604,survival,0,0
164605,was,0,0
164606,analysed,0,0
164607,using,0,0
164608,the,0,0
164609,log-rank,0,0
164610,test,0,0
164611,and,0,0
164612,Cox,0,0
164613,multivariate,0,0
164614,analysis,0,0
164615,was,0,0
164616,used,0,0
164617,to,0,0
164618,test,0,0
164619,for,0,0
164620,independence,0,0
164621,.,0,1
164622,WST-1,0,0
164623,assay,0,0
164624,was,0,0
164625,employed,0,0
164626,to,0,0
164627,measure,0,0
164628,cell,0,1
164629,viability,0,0
164630,and,0,0
164631,a,0,0
164632,luciferase,0,0
164633,ERE,0,0
164634,(,0,1
164635,estrogen,0,0
164636,responsive,0,1
164637,element,0,1
164638,),0,1
164639,construct,0,0
164640,was,0,0
164641,used,0,0
164642,to,0,0
164643,study,0,0
164644,the,0,0
164645,effect,0,0
164646,of,0,0
164647,tamoxifen,0,1
164648,",",0,0
164649,following,0,0
164650,downregulation,0,0
164651,of,0,1
164652,YAP1,0,1
164653,using,0,1
164654,siRNAs,0,1
164655,.,0,1
164656,RESULTS,0,0
164657,In,0,0
164658,the,0,0
164659,ER+,1,0
164660,(,1,1
164661,Estrogen,1,0
164662,Receptor,1,0
164663,?,1,1
164664,positive,1,0
164665,),1,0
164666,subgroup,1,1
164667,of,0,0
164668,the,0,0
164669,randomised,0,0
164670,cohort,0,1
164671,",",0,0
164672,YAP1,0,1
164673,expression,0,0
164674,was,0,0
164675,inversely,0,0
164676,correlated,0,0
164677,to,0,0
164678,histological,0,0
164679,grade,0,1
164680,and,0,1
164681,proliferation,0,0
164682,(,0,1
164683,p,0,0
164684,=,0,1
164685,0.001,0,0
164686,and,0,0
164687,p,0,0
164688,=,0,0
164689,0.016,0,0
164690,",",0,0
164691,respectively,0,0
164692,),0,0
164693,whereas,0,0
164694,in,0,1
164695,the,1,1
164696,ER-,1,1
164697,(,1,1
164698,Estrogen,1,0
164699,Receptor,1,0
164700,?,1,1
164701,negative,1,0
164702,),1,0
164703,subgroup,1,1
164704,YAP1,1,1
164705,expression,0,0
164706,correlated,0,0
164707,positively,0,0
164708,to,0,0
164709,proliferation,0,0
164710,(,0,1
164711,p,0,0
164712,=,0,1
164713,0.005,0,0
164714,),0,1
164715,.,0,1
164716,Notably,0,0
164717,",",0,0
164718,low,0,0
164719,YAP1,0,1
164720,mRNA,0,0
164721,was,0,0
164722,independently,0,0
164723,associated,0,0
164724,with,0,1
164725,decreased,0,0
164726,recurrence-free,0,0
164727,survival,0,0
164728,in,0,0
164729,the,0,0
164730,gene,0,0
164731,expression,0,0
164732,dataset,0,0
164733,",",0,0
164734,specifically,0,0
164735,for,0,0
164736,the,0,0
164737,luminal,0,1
164738,A,0,1
164739,subgroup,0,1
164740,(,0,1
164741,p,0,0
164742,<,0,0
164743,0.001,0,0
164744,),0,0
164745,which,0,0
164746,includes,0,0
164747,low,0,0
164748,proliferating,0,0
164749,tumours,0,1
164750,of,0,0
164751,lower,0,0
164752,grade,0,1
164753,",",0,0
164754,usually,0,0
164755,associated,0,0
164756,with,0,1
164757,a,0,1
164758,good,0,0
164759,prognosis,0,0
164760,.,0,1
164761,This,0,0
164762,subgroup,0,0
164763,specificity,0,0
164764,led,0,0
164765,us,0,1
164766,to,0,0
164767,hypothesize,0,0
164768,that,0,0
164769,YAP1,0,1
164770,may,0,0
164771,be,0,0
164772,important,0,0
164773,for,0,0
164774,response,0,0
164775,to,0,1
164776,endocrine,0,1
164777,therapies,0,0
164778,",",0,0
164779,such,0,0
164780,as,0,0
164781,tamoxifen,0,1
164782,",",0,0
164783,extensively,0,0
164784,used,0,0
164785,for,0,0
164786,luminal,0,1
164787,A,0,1
164788,breast,0,1
164789,cancers,0,1
164790,.,0,1
164791,In,0,0
164792,a,0,0
164793,tamoxifen,0,1
164794,randomised,0,0
164795,patient,0,1
164796,material,0,1
164797,",",0,1
164798,absent,0,1
164799,YAP1,0,1
164800,protein,0,0
164801,expression,0,0
164802,was,0,0
164803,associated,0,0
164804,with,0,1
164805,impaired,0,1
164806,tamoxifen,0,1
164807,response,0,0
164808,which,0,0
164809,was,0,0
164810,significant,0,0
164811,upon,0,0
164812,interaction,0,0
164813,analysis,0,0
164814,(,0,1
164815,p,0,0
164816,=,0,1
164817,0.042,0,0
164818,),0,1
164819,.,0,1
164820,YAP1,0,1
164821,downregulation,0,0
164822,resulted,0,0
164823,in,0,0
164824,increased,0,0
164825,progesterone,0,0
164826,receptor,0,0
164827,(,0,1
164828,PgR,0,1
164829,),0,1
164830,expression,0,0
164831,and,0,0
164832,a,0,0
164833,delayed,0,0
164834,and,0,0
164835,weaker,0,0
164836,tamoxifen,0,1
164837,in,0,0
164838,support,0,0
164839,of,0,0
164840,the,0,0
164841,clinical,0,0
164842,data,0,0
164843,.,0,1
164844,CONCLUSIONS,0,0
164845,Decreased,0,0
164846,YAP1,0,1
164847,expression,0,0
164848,is,0,0
164849,an,0,0
164850,independent,0,0
164851,prognostic,0,0
164852,factor,0,0
164853,for,0,0
164854,recurrence,0,0
164855,in,0,0
164856,the,0,0
164857,less,0,0
164858,aggressive,1,1
164859,luminal,1,0
164860,A,1,1
164861,breast,1,1
164862,cancer,1,1
164863,subgroup,1,0
164864,",",1,0
164865,likely,0,0
164866,due,0,0
164867,to,0,0
164868,the,0,0
164869,decreased,0,0
164870,tamoxifen,0,1
164871,sensitivity,0,0
164872,conferred,0,0
164873,by,0,0
164874,YAP1,0,1
164875,downregulation,0,0
164876,.,0,1
164877,Effects,0,1
164878,of,0,1
164879,phosphorus-restricted,0,1
164880,diet,0,1
164881,and,0,1
164882,phosphate-binding,0,0
164883,therapy,0,1
164884,on,0,0
164885,outcomes,0,0
164886,in,0,1
164887,patients,1,1
164888,with,1,1
164889,chronic,1,1
164890,kidney,1,1
164891,disease,1,1
164892,.,1,1
164893,BACKGROUND,0,0
164894,Phosphorus,0,0
164895,is,0,0
164896,associated,0,0
164897,with,0,0
164898,mortality,0,0
164899,in,0,1
164900,patients,1,1
164901,with,1,1
164902,chronic,1,1
164903,kidney,1,1
164904,disease,1,1
164905,(,1,1
164906,CKD,1,1
164907,),1,1
164908,not,1,0
164909,on,1,0
164910,dialysis,1,1
164911,",",0,0
164912,possibly,0,0
164913,through,0,0
164914,phosphorus-dependent,0,0
164915,vascular,0,1
164916,calcification,0,1
164917,.,0,1
164918,Although,0,0
164919,a,0,0
164920,phosphorus-restricted,0,1
164921,diet,0,1
164922,reduces,0,0
164923,serum,0,0
164924,phosphorus,0,0
164925,",",0,0
164926,it,0,0
164927,is,0,0
164928,unlikely,0,0
164929,that,0,0
164930,it,0,0
164931,reduces,0,0
164932,vascular,0,0
164933,calcification,0,0
164934,progression,0,0
164935,in,0,1
164936,CKD,0,1
164937,.,0,1
164938,This,0,0
164939,study,0,0
164940,evaluated,0,0
164941,whether,0,0
164942,a,0,1
164943,combined,0,0
164944,strategy,0,0
164945,of,0,0
164946,phosphorus-restricted,0,1
164947,diet,0,1
164948,and,0,1
164949,phosphate-binding,0,0
164950,therapy,0,0
164951,can,0,0
164952,reduce,0,0
164953,the,0,0
164954,risk,0,0
164955,of,0,0
164956,all-cause,0,0
164957,mortality,0,0
164958,and/or,0,1
164959,dialysis,0,1
164960,initiation,0,0
164961,by,0,0
164962,attenuating,0,0
164963,coronary,0,1
164964,artery,0,1
164965,calcification,0,1
164966,(,0,1
164967,CAC,0,1
164968,),0,1
164969,progression,0,0
164970,in,0,1
164971,non-dialysis,1,1
164972,CKD,1,1
164973,patients,1,1
164974,.,1,1
164975,METHODS,0,0
164976,This,0,0
164977,was,0,0
164978,a,0,0
164979,post,0,0
164980,hoc,0,0
164981,analysis,0,0
164982,of,0,0
164983,a,0,0
164984,subgroup,1,1
164985,of,1,0
164986,patients,1,1
164987,from,1,1
164988,a,1,1
164989,study,1,0
164990,that,1,0
164991,evaluated,1,0
164992,the,1,0
164993,impact,1,0
164994,of,1,0
164995,two,1,0
164996,phosphorus,1,1
164997,binder,1,1
164998,regimens,1,0
164999,on,1,1
165000,hard,1,1
165001,outcomes,1,0
165002,in,1,1
165003,CKD,1,1
165004,.,1,1
165005,Patients,1,1
165006,(,1,1
165007,n,1,1
165008,=,1,1
165009,113,1,1
165010,),1,1
165011,with,1,1
165012,stage,1,1
165013,3-4,1,1
165014,CKD,1,1
165015,and,1,1
165016,evidence,1,0
165017,of,1,0
165018,CAC,1,0
165019,on,1,0
165020,a,1,1
165021,phosphorus-restricted,1,1
165022,diet,1,0
165023,were,1,1
165024,randomized,0,1
165025,to,0,0
165026,receive,0,0
165027,either,0,0
165028,calcium,0,0
165029,carbonate,0,0
165030,or,0,1
165031,sevelamer,0,0
165032,added,0,0
165033,to,0,0
165034,their,0,1
165035,phosphorus-restricted,0,1
165036,diet,0,1
165037,.,0,1
165038,End-points,0,0
165039,were,0,0
165040,death,0,0
165041,for,0,0
165042,any,0,0
165043,cause,0,0
165044,and,0,0
165045,initiation,0,0
165046,of,0,0
165047,dialysis,0,1
165048,.,0,1
165049,Patients,0,1
165050,were,0,1
165051,monitored,0,0
165052,to,0,0
165053,the,0,0
165054,first,0,0
165055,event,0,0
165056,or,0,1
165057,to,0,0
165058,conclusion,0,0
165059,of,0,0
165060,the,0,0
165061,36-month,0,0
165062,follow-up,0,0
165063,.,0,1
165064,RESULTS,0,0
165065,Overall,0,0
165066,",",0,0
165067,treatment,0,0
165068,with,0,1
165069,calcium,0,0
165070,carbonate,0,0
165071,was,0,0
165072,associated,0,0
165073,with,0,1
165074,increased,0,0
165075,CAC,0,1
165076,progression,0,0
165077,and,0,0
165078,occurrence,0,0
165079,of,0,0
165080,all-cause,0,0
165081,mortality,0,0
165082,",",0,0
165083,dialysis,0,1
165084,initiation,0,0
165085,",",0,0
165086,and,0,0
165087,the,0,0
165088,composite,0,0
165089,end-point,0,0
165090,.,0,1
165091,After,0,0
165092,adjustment,0,0
165093,for,0,1
165094,confounders,0,0
165095,",",0,1
165096,sevelamer,0,0
165097,use,0,0
165098,was,0,0
165099,the,0,0
165100,only,0,0
165101,independent,0,0
165102,predictive,0,0
165103,factor,0,0
165104,of,0,0
165105,reduced,0,0
165106,risk,0,1
165107,of,0,0
165108,each,0,0
165109,endpoint,0,0
165110,but,0,0
165111,only,0,0
165112,if,0,0
165113,CAC,0,0
165114,progression,0,1
165115,was,0,0
165116,either,0,0
165117,absent,0,1
165118,or,0,1
165119,moderate,0,1
165120,.,0,1
165121,Accelerated,0,0
165122,progression,0,0
165123,(,0,1
165124,annual,0,1
165125,CAC,0,1
165126,increase,0,0
165127,>,0,1
165128,75th,0,0
165129,percentile,0,1
165130,of,0,0
165131,the,0,0
165132,study,0,0
165133,cohort,0,1
165134,),0,0
165135,increased,0,0
165136,the,0,0
165137,risk,0,0
165138,of,0,0
165139,all-cause,0,0
165140,mortality,0,0
165141,and,0,1
165142,composite,0,0
165143,end-point,0,0
165144,(,0,1
165145,p,0,0
165146,=,0,1
165147,0.01,0,0
165148,),0,1
165149,independently,0,0
165150,of,0,0
165151,the,0,0
165152,use,0,0
165153,of,0,0
165154,sevelamer,0,0
165155,.,0,1
165156,CONCLUSIONS,0,0
165157,A,0,0
165158,significant,0,0
165159,reduction,0,0
165160,in,0,1
165161,all-cause,0,0
165162,mortality,0,0
165163,",",0,0
165164,dialysis,0,1
165165,initiation,0,0
165166,",",0,0
165167,and,0,0
165168,composite,0,0
165169,end-point,0,0
165170,risk,0,1
165171,was,0,0
165172,achieved,0,0
165173,by,0,0
165174,combining,0,0
165175,phosphorus-restricted,0,1
165176,diet,0,1
165177,and,0,1
165178,sevelamer,0,0
165179,in,0,1
165180,non-dialysis,0,1
165181,CKD,0,1
165182,patients,1,1
165183,with,1,1
165184,absent,0,1
165185,or,0,1
165186,moderate,0,1
165187,but,0,0
165188,not,0,0
165189,accelerated,0,0
165190,CAC,0,0
165191,progression,0,1
165192,.,0,1
165193,Future,0,0
165194,studies,0,0
165195,should,0,0
165196,investigate,0,0
165197,the,0,0
165198,role,0,0
165199,of,0,0
165200,serum,0,0
165201,phosphorus,0,0
165202,",",0,0
165203,the,0,0
165204,usefulness,0,0
165205,of,0,0
165206,a,0,1
165207,phosphorus-restricted,0,1
165208,diet,0,0
165209,",",0,0
165210,and,0,0
165211,the,0,0
165212,appropriateness,0,0
165213,of,0,0
165214,current,0,1
165215,normal,0,1
165216,ranges,0,1
165217,of,0,1
165218,serum,0,0
165219,phosphorus,0,1
165220,concentration,0,0
165221,in,0,0
165222,relation,0,0
165223,to,0,1
165224,events,0,0
165225,in,0,1
165226,non-dialyzed,0,1
165227,CKD,0,1
165228,patients,0,1
165229,.,0,1
165230,Postoperative,0,1
165231,sleep,1,1
165232,disturbances,1,0
165233,after,0,1
165234,zolpidem,0,1
165235,treatment,0,0
165236,in,0,0
165237,fast-track,0,1
165238,hip,0,1
165239,and,0,0
165240,knee,0,1
165241,replacement,0,1
165242,.,0,1
165243,STUDY,0,0
165244,OBJECTIVES,0,0
165245,Previous,0,1
165246,studies,0,0
165247,have,0,1
165248,demonstrated,0,0
165249,pronounced,0,0
165250,reduction,0,0
165251,of,0,0
165252,REM,0,0
165253,sleep,0,1
165254,on,0,0
165255,the,0,0
165256,first,0,0
165257,nights,0,1
165258,following,0,1
165259,major,0,1
165260,surgery,0,1
165261,which,0,0
165262,may,0,0
165263,influence,0,0
165264,pain,0,0
165265,",",0,0
165266,analgesic,0,0
165267,use,0,0
165268,",",0,0
165269,and,0,0
165270,recovery,0,0
165271,.,0,1
165272,This,0,0
165273,placebo-controlled,0,0
165274,",",0,0
165275,randomized,0,1
165276,",",0,0
165277,double-blind,0,0
165278,study,0,1
165279,set,0,0
165280,out,0,0
165281,to,0,0
165282,evaluate,0,0
165283,the,0,0
165284,effect,0,0
165285,of,0,0
165286,zolpidem,0,1
165287,on,0,0
165288,sleep,0,1
165289,architecture,0,1
165290,in,0,0
165291,an,0,0
165292,elderly,1,1
165293,population,1,1
165294,undergoing,1,1
165295,fast-track,1,1
165296,total,1,1
165297,hip,1,1
165298,and,1,0
165299,knee,1,1
165300,arthroplasty,1,1
165301,(,1,1
165302,THA/TKA,1,1
165303,),1,1
165304,with,1,1
165305,length,1,0
165306,of,1,0
165307,stay,1,0
165308,<,1,0
165309,3,1,1
165310,days,1,1
165311,.,1,1
165312,METHODS,0,0
165313,Twenty,1,1
165314,patients,1,1
165315,(,1,1
165316,?,1,1
165317,60,1,1
165318,years,1,1
165319,),1,1
165320,undergoing,1,1
165321,THA,1,1
165322,or,1,1
165323,TKA,1,1
165324,in,1,0
165325,a,1,1
165326,standardized,1,0
165327,setup,1,0
165328,with,1,1
165329,spinal,1,1
165330,anesthesia,1,1
165331,and,1,1
165332,multimodal,1,1
165333,opioid-sparing,1,1
165334,postoperative,1,1
165335,analgesia,1,0
165336,were,1,1
165337,included,1,1
165338,.,1,1
165339,Polysomnography,0,1
165340,measures,0,0
165341,were,0,1
165342,performed,0,0
165343,for,0,1
165344,2,0,1
165345,nights,0,1
165346,",",0,1
165347,1,0,0
165348,night,0,0
165349,at,0,0
165350,home,0,1
165351,prior,0,1
165352,to,0,0
165353,surgery,0,1
165354,and,0,0
165355,on,0,0
165356,the,0,0
165357,first,0,0
165358,night,0,0
165359,after,0,0
165360,surgery,0,1
165361,",",0,0
165362,when,0,0
165363,the,0,0
165364,patient,0,0
165365,received,0,0
165366,placebo,0,0
165367,or,0,1
165368,zolpidem,0,1
165369,10,0,1
165370,mg.,0,1
165371,Analgesic,0,0
165372,use,0,0
165373,",",0,0
165374,pain,0,1
165375,levels,0,0
165376,",",0,1
165377,and,0,1
165378,subjective,0,0
165379,measures,0,0
165380,of,0,1
165381,fatigue,0,0
165382,and,0,1
165383,sleep,0,1
165384,quality,0,0
165385,were,0,1
165386,recorded,0,0
165387,.,0,1
165388,Analysis,0,0
165389,of,0,0
165390,sleep,0,1
165391,data,0,0
165392,was,0,0
165393,performed,0,0
165394,according,0,1
165395,to,0,0
165396,the,0,0
165397,American,0,1
165398,Academy,0,1
165399,of,0,1
165400,Sleep,0,0
165401,Medicine,0,1
165402,manual,0,1
165403,.,0,1
165404,RESULTS,0,0
165405,Objective,0,0
165406,sleep,0,1
165407,data,0,0
165408,did,0,0
165409,not,0,0
165410,show,0,0
165411,a,0,0
165412,significant,0,0
165413,difference,0,0
165414,between,0,0
165415,groups,0,0
165416,in,0,1
165417,any,0,1
165418,of,0,0
165419,the,0,0
165420,sleep,0,1
165421,stages,0,1
165422,.,0,1
165423,However,0,0
165424,",",0,0
165425,subjective,0,0
165426,data,0,0
165427,on,0,1
165428,sleep,0,1
165429,quality,0,0
165430,and,0,1
165431,fatigue,0,0
165432,showed,0,0
165433,significantly,0,0
165434,less,0,0
165435,fatigue,0,0
165436,and,0,0
165437,better,0,0
165438,sleep,0,1
165439,quality,0,0
165440,in,0,0
165441,the,0,0
165442,zolpidem,0,1
165443,group,0,0
165444,(,0,1
165445,p,0,0
165446,<,0,0
165447,0.05,0,0
165448,),0,1
165449,",",0,0
165450,and,0,0
165451,reduced,0,0
165452,objectively,0,0
165453,recorded,0,0
165454,number,0,0
165455,of,0,1
165456,arousals,0,0
165457,(,0,1
165458,p,0,0
165459,=,0,1
165460,0.004,0,0
165461,),0,1
165462,.,0,1
165463,Levels,0,0
165464,of,0,0
165465,pain,0,1
165466,and,0,1
165467,opioid,0,0
165468,use,0,0
165469,were,0,1
165470,similar,0,0
165471,in,0,0
165472,the,0,1
165473,2,0,1
165474,groups,0,1
165475,.,0,1
165476,CONCLUSIONS,0,0
165477,Our,0,1
165478,objective,0,1
165479,data,0,0
165480,did,0,0
165481,not,0,0
165482,support,0,0
165483,the,0,0
165484,primary,0,1
165485,hypothesis,0,0
165486,that,0,0
165487,one,0,1
165488,night,0,0
165489,'s,0,1
165490,treatment,0,0
165491,with,0,1
165492,zolpidem,0,1
165493,would,0,0
165494,significantly,0,0
165495,improve,0,0
165496,sleep,0,1
165497,architecture,0,0
165498,following,0,0
165499,major,0,1
165500,surgery,0,1
165501,",",0,0
165502,although,0,0
165503,there,0,0
165504,was,0,0
165505,improved,0,0
165506,feeling,0,0
165507,of,0,0
165508,sleep,0,1
165509,quality,0,0
165510,and,0,1
165511,fatigue,0,0
165512,associated,0,0
165513,with,0,1
165514,fewer,0,0
165515,postoperative,0,1
165516,arousals,0,0
165517,.,0,1
165518,CITATION,0,0
165519,Krenk,0,0
165520,L,0,0
165521,;,0,1
165522,Jennum,0,1
165523,P,0,0
165524,;,0,1
165525,Kehlet,0,0
165526,H.,0,1
165527,Postoperative,0,1
165528,sleep,0,1
165529,disturbances,0,0
165530,after,0,1
165531,zolpidem,0,1
165532,treatment,0,0
165533,in,0,0
165534,fast-track,0,1
165535,hip,0,1
165536,and,0,0
165537,knee,0,1
165538,replacement,0,1
165539,.,0,1
165540,Omitting,0,0
165541,radiotherapy,0,1
165542,in,0,1
165543,early,0,1
165544,positron,1,1
165545,emission,1,1
165546,tomography-negative,1,1
165547,stage,1,1
165548,I/II,1,1
165549,Hodgkin,1,1
165550,lymphoma,1,1
165551,is,0,0
165552,associated,0,0
165553,with,0,1
165554,an,0,0
165555,increased,0,0
165556,risk,0,0
165557,of,0,0
165558,early,0,1
165559,relapse,0,1
165560,:,0,1
165561,Clinical,0,0
165562,results,0,0
165563,of,0,1
165564,the,0,1
165565,preplanned,0,0
165566,interim,0,0
165567,analysis,0,0
165568,of,0,0
165569,the,0,0
165570,randomized,0,1
165571,EORTC/LYSA/FIL,0,0
165572,H10,0,0
165573,trial,0,1
165574,.,0,1
165575,PURPOSE,0,0
165576,Combined-modality,0,0
165577,treatment,0,0
165578,is,0,0
165579,standard,0,0
165580,treatment,0,0
165581,for,0,1
165582,patients,1,1
165583,with,1,1
165584,clinical,1,1
165585,stage,1,1
165586,I/II,1,1
165587,Hodgkin,1,1
165588,lymphoma,1,1
165589,(,1,1
165590,HL,1,1
165591,),1,1
165592,.,1,1
165593,We,0,0
165594,hypothesized,0,0
165595,that,0,0
165596,an,0,0
165597,early,0,1
165598,positron,0,1
165599,emission,0,1
165600,tomography,0,0
165601,(,0,1
165602,PET,0,0
165603,),0,0
165604,scan,0,0
165605,could,0,0
165606,be,0,0
165607,used,0,0
165608,to,0,0
165609,adapt,0,0
165610,treatment,0,0
165611,.,0,0
165612,Therefore,0,0
165613,",",0,0
165614,we,0,0
165615,started,0,0
165616,the,0,0
165617,randomized,0,1
165618,EORTC/LYSA/FIL,0,0
165619,Intergroup,0,1
165620,H10,0,0
165621,trial,0,0
165622,evaluating,0,0
165623,whether,0,0
165624,involved-node,0,1
165625,radiotherapy,0,1
165626,(,0,1
165627,IN-RT,0,0
165628,),0,1
165629,could,0,0
165630,be,0,0
165631,omitted,0,0
165632,without,0,1
165633,compromising,0,0
165634,progression-free,0,0
165635,survival,0,0
165636,in,0,1
165637,patients,1,1
165638,attaining,1,1
165639,a,1,1
165640,negative,1,0
165641,early,1,1
165642,PET,1,0
165643,scan,1,1
165644,after,1,1
165645,two,1,1
165646,cycles,1,0
165647,of,1,1
165648,ABVD,1,1
165649,(,0,1
165650,doxorubicin,0,0
165651,",",0,0
165652,bleomycin,0,0
165653,",",0,0
165654,vinblastine,0,0
165655,",",0,0
165656,and,0,0
165657,dacarbazine,0,0
165658,),0,1
165659,as,0,0
165660,compared,0,0
165661,with,0,1
165662,standard,0,1
165663,combined-modality,0,0
165664,treatment,0,1
165665,.,0,1
165666,PATIENTS,0,0
165667,AND,0,0
165668,METHODS,0,0
165669,Patients,1,1
165670,age,1,1
165671,15,1,1
165672,to,1,1
165673,70,1,1
165674,years,1,1
165675,with,1,1
165676,untreated,1,1
165677,clinical,1,0
165678,stage,1,1
165679,I/II,1,1
165680,HL,1,1
165681,were,1,1
165682,eligible,1,1
165683,.,1,1
165684,Here,0,0
165685,we,0,0
165686,report,0,0
165687,the,0,0
165688,clinical,0,0
165689,outcome,0,0
165690,of,0,0
165691,the,0,0
165692,preplanned,0,0
165693,interim,0,0
165694,futility,0,0
165695,analysis,0,0
165696,scheduled,0,1
165697,to,0,0
165698,occur,0,0
165699,after,0,0
165700,documentation,0,0
165701,of,0,1
165702,34,0,1
165703,events,0,0
165704,in,0,1
165705,the,0,1
165706,early,0,1
165707,PET-negative,0,1
165708,group,0,1
165709,.,0,1
165710,Because,0,0
165711,testing,0,0
165712,for,0,0
165713,futility,0,0
165714,in,0,0
165715,this,0,0
165716,noninferiority,0,0
165717,trial,0,0
165718,corresponds,0,0
165719,to,0,1
165720,testing,0,0
165721,the,0,0
165722,hypothesis,0,0
165723,of,0,0
165724,no,0,0
165725,difference,0,0
165726,",",0,0
165727,a,0,0
165728,one-sided,0,0
165729,superiority,0,0
165730,test,0,0
165731,was,0,0
165732,conducted,0,1
165733,.,0,0
165734,RESULTS,0,0
165735,The,1,0
165736,analysis,1,0
165737,included,1,1
165738,"1,137",1,1
165739,patients,1,1
165740,.,1,1
165741,In,0,0
165742,the,0,0
165743,favorable,1,0
165744,subgroup,1,1
165745,",",0,1
165746,85.8,0,0
165747,%,0,0
165748,had,0,1
165749,a,0,0
165750,negative,0,0
165751,early,0,1
165752,PET,0,1
165753,scan,0,1
165754,(,0,1
165755,standard,0,1
165756,arm,0,1
165757,",",0,1
165758,one,0,1
165759,event,0,0
165760,v,0,0
165761,experimental,0,0
165762,arm,0,1
165763,",",0,1
165764,nine,0,1
165765,events,0,0
165766,),0,1
165767,.,0,1
165768,In,0,0
165769,the,0,0
165770,unfavorable,1,0
165771,subgroup,1,1
165772,",",0,1
165773,74.8,0,0
165774,%,0,0
165775,had,0,1
165776,a,0,0
165777,negative,0,0
165778,early,0,1
165779,PET,0,1
165780,scan,0,1
165781,(,0,1
165782,standard,0,1
165783,arm,0,1
165784,",",0,1
165785,seven,0,1
165786,events,0,0
165787,v,0,1
165788,experimental,0,1
165789,arm,0,1
165790,",",0,1
165791,16,0,1
165792,events,0,0
165793,),0,1
165794,.,0,1
165795,The,0,0
165796,independent,0,0
165797,data,0,0
165798,monitoring,0,0
165799,committee,0,0
165800,concluded,0,0
165801,it,0,0
165802,was,0,0
165803,unlikely,0,0
165804,that,0,0
165805,we,0,0
165806,would,0,0
165807,show,0,0
165808,noninferiority,0,0
165809,in,0,0
165810,the,0,0
165811,final,0,0
165812,results,0,0
165813,for,0,1
165814,the,0,1
165815,experimental,0,0
165816,arm,0,1
165817,and,0,1
165818,advised,0,1
165819,stopping,0,0
165820,random,0,1
165821,assignment,0,1
165822,for,0,1
165823,early,0,1
165824,PET-negative,0,1
165825,patients,0,1
165826,.,0,1
165827,CONCLUSION,0,0
165828,On,0,0
165829,the,0,0
165830,basis,0,0
165831,of,0,0
165832,this,0,0
165833,analysis,0,0
165834,",",0,0
165835,combined-modality,0,0
165836,treatment,0,0
165837,resulted,0,0
165838,in,0,0
165839,fewer,0,0
165840,early,0,1
165841,progressions,0,0
165842,in,0,1
165843,clinical,0,1
165844,stage,0,1
165845,I/II,0,1
165846,HL,0,1
165847,",",0,0
165848,although,0,0
165849,early,0,1
165850,outcome,0,0
165851,was,0,0
165852,excellent,0,0
165853,in,0,1
165854,both,0,0
165855,arms,0,0
165856,.,0,1
165857,The,0,0
165858,final,0,0
165859,analysis,0,0
165860,will,0,0
165861,reveal,0,0
165862,whether,0,0
165863,this,0,0
165864,finding,0,0
165865,is,0,0
165866,maintained,0,0
165867,over,0,0
165868,time,0,0
165869,.,0,1
165870,Pegylated,0,0
165871,feline,0,1
165872,granulocyte,0,0
165873,colony-stimulating,0,1
165874,factor,0,0
165875,increases,0,0
165876,neutrophil,0,0
165877,levels,0,1
165878,in,0,1
165879,cats,1,1
165880,.,1,1
165881,Neutropenia,0,1
165882,can,0,0
165883,often,0,0
165884,be,0,0
165885,corrected,0,0
165886,by,0,0
165887,treatment,0,0
165888,with,0,1
165889,granulocyte-colony,0,0
165890,stimulating,0,0
165891,factor,0,0
165892,(,0,1
165893,G-CSF,0,1
165894,),0,1
165895,and,0,1
165896,off-label,0,1
165897,use,0,0
165898,of,0,0
165899,commercial,0,1
165900,human,0,1
165901,G-CSF,0,1
165902,(,0,1
165903,HuG-CSF,0,1
165904,),0,0
165905,is,0,0
165906,a,0,0
165907,commonly,0,0
165908,used,0,0
165909,treatment,0,0
165910,for,0,1
165911,neutropenic,1,1
165912,animals,1,1
165913,.,1,1
165914,However,0,0
165915,",",0,0
165916,long-term,0,0
165917,HuG-CSF,0,1
165918,treatment,0,0
165919,can,0,0
165920,be,0,0
165921,associated,0,0
165922,with,0,1
165923,adverse,0,0
165924,effects,0,0
165925,",",0,1
165926,including,0,1
165927,neutropenia,0,0
165928,.,0,1
165929,Here,0,0
165930,",",0,0
165931,feline,0,1
165932,(,0,1
165933,Fe,0,1
165934,),0,1
165935,G-CSF,0,1
165936,was,0,0
165937,produced,0,0
165938,in,0,0
165939,Pichia,0,1
165940,pastoris,0,0
165941,",",0,0
165942,pegylated,0,0
165943,(,0,1
165944,Peg,0,0
165945,),0,1
165946,FeG-CSF,0,1
165947,and,0,0
165948,tested,0,0
165949,in,0,1
165950,cats,0,1
165951,.,0,1
165952,A,0,1
165953,randomized,0,0
165954,controlled,0,0
165955,clinical,0,0
165956,trial,0,1
165957,was,0,0
165958,conducted,0,0
165959,to,0,0
165960,evaluate,0,0
165961,the,0,0
165962,efficacy,0,0
165963,of,0,0
165964,PegFeG-CSF,0,1
165965,compared,0,0
165966,to,0,1
165967,FeG-CSF,0,1
165968,or,0,1
165969,HuG-CSF,0,1
165970,in,0,1
165971,FIV-infected,1,1
165972,(,1,1
165973,n=14,1,1
165974,),1,1
165975,",",1,0
165976,FIV-uninfected,1,1
165977,healthy,1,1
165978,cats,1,1
165979,(,1,1
165980,n=19,1,1
165981,),1,1
165982,",",1,0
165983,and,1,0
165984,in,1,0
165985,HuG-CSF-induced,1,0
165986,neutropenic,1,1
165987,cats,1,1
165988,(,1,1
165989,n=4,1,1
165990,),1,1
165991,.,1,1
165992,Daily,0,1
165993,FeG-CSF,0,1
165994,doses,0,0
165995,induced,0,1
165996,higher,0,0
165997,neutrophil,0,0
165998,production,0,0
165999,than,0,0
166000,HuG-CSF,0,1
166001,after,0,1
166002,the,0,0
166003,second,0,0
166004,week,0,0
166005,of,0,0
166006,treatment,0,0
166007,(,0,1
166008,P,0,0
166009,?,0,1
166010,0.002,0,0
166011,),0,1
166012,.,0,1
166013,Weekly,0,0
166014,doses,0,0
166015,of,0,1
166016,PegFeG-CSF,0,1
166017,induced,0,0
166018,higher,0,0
166019,neutrophil,0,0
166020,counts,0,0
166021,and,0,1
166022,showed,0,0
166023,greater,0,0
166024,sustained,0,0
166025,activity,0,0
166026,than,0,0
166027,weekly,0,1
166028,doses,0,0
166029,of,0,1
166030,FeG-CSF,0,1
166031,.,0,1
166032,PegFeG-CSF,0,0
166033,provided,0,0
166034,the,0,0
166035,most,0,0
166036,therapeutic,0,0
166037,and,0,1
166038,sustainable,0,0
166039,neutrophil,0,0
166040,production,0,0
166041,(,0,1
166042,P,0,0
166043,<,0,0
166044,0.001,0,0
166045,),0,1
166046,in,0,0
166047,both,1,0
166048,FIV-uninfected,1,1
166049,and,1,1
166050,FIV-infected,1,1
166051,cats,1,1
166052,",",1,1
166053,without,0,1
166054,the,0,0
166055,development,0,0
166056,of,0,0
166057,neutralizing,0,1
166058,antibodies,0,0
166059,.,0,1
166060,Conversely,0,0
166061,",",0,0
166062,all,1,0
166063,HuG-CSF-treated,1,1
166064,cats,1,1
166065,developed,1,1
166066,neutralizing,0,1
166067,antibodies,0,0
166068,",",0,1
166069,suggesting,0,0
166070,cross-reactive,0,1
166071,antibodies,0,1
166072,to,0,1
166073,endogenous,0,1
166074,G-CSF,0,1
166075,in,0,0
166076,a,0,0
166077,majority,0,1
166078,of,0,0
166079,the,0,0
166080,cases,0,1
166081,with,0,1
166082,severe,0,1
166083,neutropenia,0,0
166084,.,0,1
166085,Strikingly,0,0
166086,",",0,0
166087,when,0,0
166088,PegFeG-CSF,0,0
166089,was,0,0
166090,used,0,0
166091,to,0,0
166092,rescue,0,0
166093,cats,0,1
166094,with,0,1
166095,HuG-CSF-induced,0,0
166096,neutropenia,0,0
166097,",",0,0
166098,clinically,0,1
166099,normal,0,1
166100,neutrophil,0,0
166101,numbers,0,0
166102,returned,0,1
166103,.,0,1
166104,Thus,0,0
166105,",",0,0
166106,PegFeG-CSF,0,0
166107,appears,0,0
166108,to,0,0
166109,be,0,0
166110,a,0,0
166111,superior,0,0
166112,treatment,0,0
166113,for,0,0
166114,neutropenia,0,0
166115,in,0,1
166116,feline,1,1
166117,patients,1,1
166118,.,1,1
166119,Multicenter,0,1
166120,randomized,0,1
166121,phase,0,1
166122,2,0,1
166123,clinical,0,0
166124,trial,0,1
166125,of,0,0
166126,a,0,1
166127,recombinant,0,0
166128,human,0,1
166129,endostatin,0,0
166130,adenovirus,0,1
166131,in,0,0
166132,patients,1,1
166133,with,1,1
166134,advanced,1,1
166135,head,1,1
166136,and,1,0
166137,neck,1,1
166138,carcinoma,1,1
166139,.,1,1
166140,A,0,0
166141,randomized,0,0
166142,",",0,0
166143,open-label,0,1
166144,",",0,1
166145,phase,0,1
166146,2,0,0
166147,",",0,0
166148,multicenter,0,0
166149,clinical,0,0
166150,trial,0,0
166151,was,0,0
166152,conducted,0,0
166153,to,0,0
166154,evaluate,0,0
166155,the,0,0
166156,efficacy,0,0
166157,and,0,0
166158,safety,0,0
166159,of,0,0
166160,the,0,0
166161,addition,0,0
166162,of,0,0
166163,a,0,1
166164,recombinant,0,0
166165,human,0,1
166166,endostatin,0,0
166167,adenovirus,0,1
166168,(,0,1
166169,E10A,0,1
166170,),0,1
166171,to,0,0
166172,cisplatin,0,0
166173,and,0,0
166174,paclitaxel,0,0
166175,in,0,0
166176,patients,1,1
166177,with,1,1
166178,advanced,1,1
166179,head,1,1
166180,and,1,1
166181,neck,1,1
166182,squamous,1,1
166183,cell,1,1
166184,carcinoma,1,1
166185,or,1,1
166186,nasopharyngeal,1,1
166187,carcinoma,1,1
166188,.,1,1
166189,Patients,1,1
166190,with,1,1
166191,locally,1,1
166192,advanced,1,1
166193,or,1,1
166194,metastatic,1,1
166195,head,1,1
166196,and,1,1
166197,neck,1,1
166198,squamous,1,1
166199,cell,1,1
166200,carcinoma,1,1
166201,or,1,1
166202,nasopharyngeal,1,1
166203,carcinoma,1,1
166204,not,1,0
166205,suitable,1,0
166206,for,1,0
166207,operation,1,1
166208,or,1,1
166209,radiotherapy,1,1
166210,were,0,0
166211,randomly,0,1
166212,assigned,0,1
166213,to,0,0
166214,receive,0,1
166215,E10A,0,0
166216,plus,0,0
166217,chemotherapy,0,1
166218,every,0,0
166219,3,0,0
166220,weeks,0,0
166221,for,0,1
166222,a,0,1
166223,maximum,0,0
166224,of,0,0
166225,six,0,1
166226,cycles,0,0
166227,or,0,1
166228,to,0,1
166229,receive,0,0
166230,chemotherapy,0,1
166231,only,0,0
166232,.,0,1
166233,One,1,1
166234,hundred,1,1
166235,and,1,1
166236,thirty-six,1,1
166237,eligible,1,1
166238,patients,1,1
166239,were,1,1
166240,randomly,1,1
166241,assigned,1,1
166242,.,1,0
166243,The,0,0
166244,addition,0,0
166245,of,0,0
166246,E10A,0,0
166247,did,0,0
166248,not,0,0
166249,significantly,0,0
166250,improve,0,0
166251,the,0,0
166252,objective,0,0
166253,response,0,0
166254,rate,0,0
166255,(,0,1
166256,29.9,0,1
166257,versus,0,0
166258,39.7,0,0
166259,%,0,0
166260,",",0,1
166261,P,0,0
166262,=,0,1
166263,0.154,0,0
166264,),0,1
166265,.,0,1
166266,However,0,0
166267,",",0,1
166268,patients,0,1
166269,who,0,1
166270,received,0,1
166271,endostatin,0,0
166272,had,0,0
166273,longer,0,0
166274,progression-free,0,0
166275,survival,0,0
166276,(,0,1
166277,7.03,0,0
166278,versus,0,0
166279,3.60,0,0
166280,months,0,0
166281,",",0,1
166282,P,0,0
166283,=,0,1
166284,0.006,0,0
166285,;,0,1
166286,hazard,0,0
166287,ratio,0,0
166288,:,0,1
166289,0.55,0,0
166290,),0,1
166291,.,0,1
166292,The,0,0
166293,combination,0,0
166294,of,0,0
166295,E10A,0,1
166296,with,0,1
166297,chemotherapy,0,1
166298,benefited,0,1
166299,prior,0,1
166300,chemotherapy-treated,0,1
166301,patients,0,1
166302,and,0,1
166303,those,0,1
166304,who,0,1
166305,received,0,1
166306,three,0,1
166307,to,0,1
166308,four,0,1
166309,treatment,0,1
166310,cycles,0,0
166311,(,0,1
166312,6.50,0,0
166313,versus,0,0
166314,3.43,0,0
166315,months,0,0
166316,",",0,1
166317,P,0,0
166318,=,0,1
166319,0.003,0,0
166320,;,0,1
166321,8.27,0,0
166322,versus,0,0
166323,4.27,0,0
166324,months,0,0
166325,",",0,1
166326,P,0,0
166327,=,0,1
166328,0.018,0,0
166329,;,0,1
166330,respectively,0,0
166331,),0,0
166332,.,0,0
166333,The,0,0
166334,overall,0,0
166335,disease,0,1
166336,control,0,1
166337,rate,0,0
166338,significantly,0,0
166339,increased,0,0
166340,from,0,1
166341,80.6,0,0
166342,%,0,0
166343,in,0,0
166344,the,0,0
166345,control,0,1
166346,group,0,1
166347,to,0,1
166348,92.6,0,0
166349,%,0,0
166350,in,0,0
166351,the,0,0
166352,test,0,0
166353,group,0,0
166354,(,0,1
166355,P,0,0
166356,=,0,1
166357,0.034,0,0
166358,),0,1
166359,.,0,1
166360,Except,0,0
166361,for,0,0
166362,fever,0,1
166363,",",0,0
166364,no,0,0
166365,adverse,0,0
166366,events,0,0
166367,were,0,1
166368,associated,0,0
166369,with,0,1
166370,the,0,0
166371,E10A,0,0
166372,treatment,0,0
166373,.,0,1
166374,In,0,0
166375,summary,0,0
166376,",",0,1
166377,E10A,0,0
166378,plus,0,0
166379,chemotherapy,0,1
166380,is,0,0
166381,a,0,0
166382,safe,0,0
166383,and,0,0
166384,effective,0,0
166385,therapeutic,0,0
166386,approach,0,1
166387,in,0,1
166388,patients,1,1
166389,with,1,1
166390,advanced,1,1
166391,head,1,1
166392,and,1,1
166393,neck,1,1
166394,squamous,1,1
166395,cell,1,1
166396,carcinoma,1,1
166397,or,1,1
166398,nasopharyngeal,1,1
166399,carcinoma,1,1
166400,.,1,1
166401,Clonidine,0,0
166402,in,0,1
166403,patients,1,1
166404,undergoing,1,1
166405,noncardiac,1,1
166406,surgery,1,1
166407,.,1,1
166408,BACKGROUND,0,0
166409,Marked,0,0
166410,activation,0,0
166411,of,0,0
166412,the,0,0
166413,sympathetic,0,0
166414,nervous,0,0
166415,system,0,0
166416,occurs,0,0
166417,during,0,0
166418,and,0,0
166419,after,0,1
166420,noncardiac,1,1
166421,surgery,1,1
166422,.,1,1
166423,Low-dose,0,0
166424,clonidine,0,0
166425,",",0,0
166426,which,0,0
166427,blunts,0,0
166428,central,0,0
166429,sympathetic,0,0
166430,outflow,0,0
166431,",",0,0
166432,may,0,0
166433,prevent,0,0
166434,perioperative,0,0
166435,myocardial,0,1
166436,infarction,0,1
166437,and,0,0
166438,death,0,0
166439,without,0,1
166440,inducing,0,0
166441,hemodynamic,0,0
166442,instability,0,1
166443,.,0,1
166444,METHODS,0,0
166445,We,0,0
166446,performed,0,0
166447,a,0,0
166448,blinded,0,0
166449,",",0,0
166450,randomized,0,0
166451,trial,0,0
166452,with,0,1
166453,a,0,1
166454,2-by-2,0,0
166455,factorial,0,0
166456,design,0,1
166457,to,0,0
166458,allow,0,0
166459,separate,0,0
166460,evaluation,0,0
166461,of,0,0
166462,low-dose,0,0
166463,clonidine,0,0
166464,versus,0,0
166465,placebo,0,0
166466,and,0,0
166467,low-dose,0,0
166468,aspirin,0,0
166469,versus,0,0
166470,placebo,0,0
166471,in,0,0
166472,patients,1,1
166473,with,1,1
166474,",",1,1
166475,or,1,1
166476,at,1,0
166477,risk,1,0
166478,for,1,0
166479,",",1,0
166480,atherosclerotic,1,1
166481,disease,1,1
166482,who,1,1
166483,were,1,1
166484,undergoing,1,1
166485,noncardiac,1,1
166486,surgery,1,1
166487,.,1,1
166488,A,0,0
166489,total,0,1
166490,of,0,0
166491,"10,010",1,1
166492,patients,1,1
166493,at,1,1
166494,135,1,1
166495,centers,1,1
166496,in,1,1
166497,23,1,1
166498,countries,1,1
166499,were,1,1
166500,enrolled,1,1
166501,.,1,1
166502,For,0,0
166503,the,0,0
166504,comparison,0,0
166505,of,0,0
166506,clonidine,0,0
166507,with,0,1
166508,placebo,0,0
166509,",",0,1
166510,patients,0,1
166511,were,0,1
166512,randomly,0,1
166513,assigned,0,1
166514,to,0,0
166515,receive,0,1
166516,clonidine,0,0
166517,(,0,1
166518,0.2,0,0
166519,mg,0,0
166520,per,0,1
166521,day,0,1
166522,),0,1
166523,or,0,0
166524,placebo,0,0
166525,just,0,0
166526,before,0,0
166527,surgery,0,1
166528,",",0,0
166529,with,0,1
166530,the,0,0
166531,study,0,0
166532,drug,0,0
166533,continued,0,0
166534,until,0,1
166535,72,0,1
166536,hours,0,0
166537,after,0,1
166538,surgery,0,1
166539,.,0,1
166540,The,0,0
166541,primary,0,1
166542,outcome,0,0
166543,was,0,0
166544,a,0,0
166545,composite,0,0
166546,of,0,0
166547,death,0,0
166548,or,0,1
166549,nonfatal,0,0
166550,myocardial,0,1
166551,infarction,0,1
166552,at,0,1
166553,30,0,1
166554,days,0,1
166555,.,0,1
166556,RESULTS,0,0
166557,Clonidine,0,0
166558,",",0,0
166559,as,0,0
166560,compared,0,0
166561,with,0,1
166562,placebo,0,0
166563,",",0,0
166564,did,0,0
166565,not,0,0
166566,reduce,0,0
166567,the,0,0
166568,number,0,0
166569,of,0,0
166570,primary-outcome,0,1
166571,events,0,0
166572,(,0,1
166573,367,0,1
166574,and,0,1
166575,339,0,1
166576,",",0,0
166577,respectively,0,0
166578,;,0,0
166579,hazard,0,0
166580,ratio,0,0
166581,with,0,1
166582,clonidine,0,0
166583,",",0,1
166584,1.08,0,0
166585,;,0,1
166586,95,0,0
166587,%,0,0
166588,confidence,0,0
166589,interval,0,0
166590,[,0,0
166591,CI,0,0
166592,],0,1
166593,",",0,1
166594,0.93,0,0
166595,to,0,1
166596,1.26,0,0
166597,;,0,1
166598,P=0.29,0,0
166599,),0,1
166600,.,0,1
166601,Myocardial,0,0
166602,infarction,0,1
166603,occurred,0,0
166604,in,0,1
166605,329,1,1
166606,patients,1,1
166607,(,0,1
166608,6.6,0,0
166609,%,0,0
166610,),0,1
166611,assigned,0,1
166612,to,0,0
166613,clonidine,0,0
166614,and,0,0
166615,in,0,1
166616,295,0,1
166617,patients,0,1
166618,(,0,1
166619,5.9,0,1
166620,%,0,0
166621,),0,1
166622,assigned,0,1
166623,to,0,0
166624,placebo,0,0
166625,(,0,0
166626,hazard,0,0
166627,ratio,0,0
166628,",",0,1
166629,1.11,0,0
166630,;,0,1
166631,95,0,0
166632,%,0,0
166633,CI,0,0
166634,",",0,1
166635,0.95,0,0
166636,to,0,1
166637,1.30,0,0
166638,;,0,1
166639,P=0.18,0,0
166640,),0,1
166641,.,0,0
166642,Significantly,0,0
166643,more,0,0
166644,patients,0,1
166645,in,0,0
166646,the,0,0
166647,clonidine,0,0
166648,group,0,0
166649,than,0,0
166650,in,0,0
166651,the,0,0
166652,placebo,0,0
166653,group,0,0
166654,had,0,1
166655,clinically,0,1
166656,important,0,0
166657,hypotension,0,0
166658,(,0,1
166659,2385,0,1
166660,patients,0,1
166661,[,0,1
166662,47.6,0,1
166663,%,0,0
166664,],0,1
166665,vs.,0,0
166666,1854,0,1
166667,patients,0,1
166668,[,0,1
166669,37.1,0,1
166670,%,0,0
166671,],0,1
166672,;,0,0
166673,hazard,0,0
166674,ratio,0,0
166675,1.32,0,0
166676,;,0,1
166677,95,0,0
166678,%,0,0
166679,CI,0,0
166680,",",0,1
166681,1.24,0,0
166682,to,0,1
166683,1.40,0,0
166684,;,0,1
166685,P,0,0
166686,<,0,0
166687,0.001,0,0
166688,),0,1
166689,.,0,1
166690,Clonidine,0,0
166691,",",0,0
166692,as,0,0
166693,compared,0,0
166694,with,0,1
166695,placebo,0,0
166696,",",0,0
166697,was,0,0
166698,associated,0,0
166699,with,0,1
166700,an,0,0
166701,increased,0,0
166702,rate,0,0
166703,of,0,0
166704,nonfatal,0,0
166705,cardiac,0,1
166706,arrest,0,1
166707,(,0,1
166708,0.3,0,0
166709,%,0,0
166710,[,0,1
166711,16,0,1
166712,patients,0,1
166713,],0,1
166714,vs.,0,0
166715,0.1,0,0
166716,%,0,0
166717,[,0,1
166718,5,0,1
166719,patients,0,1
166720,],0,1
166721,;,0,0
166722,hazard,0,0
166723,ratio,0,0
166724,",",0,1
166725,3.20,0,0
166726,;,0,1
166727,95,0,0
166728,%,0,0
166729,CI,0,0
166730,",",0,1
166731,1.17,0,0
166732,to,0,1
166733,8.73,0,1
166734,;,0,1
166735,P=0.02,0,0
166736,),0,1
166737,.,0,1
166738,CONCLUSIONS,0,0
166739,Administration,0,0
166740,of,0,0
166741,low-dose,0,0
166742,clonidine,0,0
166743,in,0,1
166744,patients,1,1
166745,undergoing,1,1
166746,noncardiac,1,1
166747,surgery,1,1
166748,did,0,0
166749,not,0,0
166750,reduce,0,0
166751,the,0,0
166752,rate,0,0
166753,of,0,0
166754,the,0,0
166755,composite,0,0
166756,outcome,0,0
166757,of,0,0
166758,death,0,0
166759,or,0,1
166760,nonfatal,0,0
166761,myocardial,0,1
166762,infarction,0,1
166763,;,0,1
166764,it,0,0
166765,did,0,0
166766,",",0,0
166767,however,0,0
166768,",",0,0
166769,increase,0,0
166770,the,0,0
166771,risk,0,0
166772,of,0,0
166773,clinically,0,1
166774,important,0,0
166775,hypotension,0,0
166776,and,0,1
166777,nonfatal,0,0
166778,cardiac,0,1
166779,arrest,0,1
166780,.,0,1
166781,(,0,0
166782,Funded,0,1
166783,by,0,0
166784,the,0,1
166785,Canadian,0,1
166786,Institutes,0,1
166787,of,0,1
166788,Health,0,1
166789,Research,0,1
166790,and,0,1
166791,others,0,1
166792,;,0,1
166793,POISE-2,0,1
166794,ClinicalTrials.gov,0,1
166795,number,0,0
166796,",",0,1
166797,NCT01082874,0,0
166798,.,0,1
166799,),0,0
166800,.,0,1
166801,Cobedding,0,1
166802,of,0,0
166803,twin,1,1
166804,premature,1,1
166805,infants,1,1
166806,:,1,1
166807,calming,0,0
166808,effects,0,0
166809,on,0,1
166810,pain,0,1
166811,responses,0,0
166812,.,0,1
166813,BACKGROUND,0,0
166814,The,0,0
166815,purpose,0,0
166816,of,0,0
166817,this,0,0
166818,trial,0,0
166819,was,0,0
166820,to,0,0
166821,determine,0,0
166822,whether,0,0
166823,cobedding,0,1
166824,of,0,1
166825,preterm,1,1
166826,twins,1,1
166827,has,0,1
166828,analgesic,0,0
166829,effects,0,0
166830,during,0,1
166831,heel,0,1
166832,lancing,0,1
166833,or,0,1
166834,not,0,1
166835,.,0,1
166836,METHODS,0,0
166837,One,1,1
166838,hundred,1,1
166839,premature,1,1
166840,twins,1,1
166841,(,1,1
166842,50,1,1
166843,sets,1,1
166844,),1,1
166845,born,1,1
166846,between,1,0
166847,26,1,1
166848,weeks,1,1
166849,',1,1
166850,and,1,1
166851,34,1,1
166852,weeks,1,0
166853,',1,1
166854,gestation,1,1
166855,undergoing,1,1
166856,heel,1,1
166857,blood,1,0
166858,sampling,1,0
166859,were,0,0
166860,randomly,0,1
166861,assigned,0,1
166862,into,0,1
166863,two,0,1
166864,groups,0,1
166865,:,0,1
166866,the,0,0
166867,cobedding,0,1
166868,group,0,0
166869,(,0,1
166870,receiving,0,1
166871,care,0,1
166872,in,0,0
166873,the,0,0
166874,same,0,0
166875,incubator,0,0
166876,),0,1
166877,and,0,0
166878,the,0,0
166879,standard,0,0
166880,care,0,1
166881,group,0,1
166882,(,0,0
166883,receiving,0,1
166884,care,0,1
166885,in,0,1
166886,separate,0,1
166887,incubators,0,1
166888,),0,1
166889,.,0,1
166890,Pain,0,0
166891,was,0,0
166892,assessed,0,0
166893,using,0,0
166894,the,0,0
166895,premature,0,1
166896,infant,0,1
166897,pain,0,1
166898,profile,0,0
166899,score,0,0
166900,.,0,1
166901,Duration,0,0
166902,of,0,0
166903,crying,0,0
166904,was,0,0
166905,measured,0,0
166906,after,0,0
166907,heel,0,1
166908,blood,0,0
166909,sampling,0,0
166910,",",0,0
166911,and,0,0
166912,salivary,0,1
166913,cortisol,0,0
166914,was,0,0
166915,measured,0,0
166916,prior,0,1
166917,to,0,0
166918,and,0,0
166919,after,0,0
166920,heel,0,1
166921,blood,0,0
166922,sampling,0,1
166923,.,0,1
166924,RESULTS,0,0
166925,Infants,0,1
166926,in,0,1
166927,the,0,0
166928,standard,0,0
166929,care,0,1
166930,group,0,1
166931,cried,0,1
166932,for,0,0
166933,a,0,0
166934,longer,0,0
166935,time,0,0
166936,during,0,0
166937,heel,0,1
166938,lancing,0,1
166939,than,0,0
166940,those,0,1
166941,in,0,0
166942,the,0,0
166943,cobedding,0,1
166944,group,0,1
166945,(,0,1
166946,42.6,0,1
166947,?,0,1
166948,19.8,0,0
166949,seconds,0,0
166950,vs.,0,0
166951,36.4,0,1
166952,?,0,1
166953,21.7,0,0
166954,seconds,0,0
166955,",",0,1
166956,p,0,0
166957,=,0,1
166958,0.03,0,0
166959,),0,1
166960,.,0,1
166961,The,0,0
166962,mean,0,0
166963,premature,0,1
166964,infant,0,1
166965,pain,0,1
166966,profile,0,0
166967,score,0,0
166968,after,0,0
166969,heel,0,1
166970,lancing,0,1
166971,was,0,0
166972,significantly,0,0
166973,higher,0,0
166974,in,0,0
166975,the,0,0
166976,standard,0,0
166977,care,0,1
166978,group,0,1
166979,(,0,1
166980,9.8,0,0
166981,?,0,1
166982,2.6,0,0
166983,vs.,0,0
166984,8.06,0,0
166985,?,0,1
166986,2.8,0,0
166987,",",0,0
166988,p,0,0
166989,=,0,1
166990,0.002,0,0
166991,),0,1
166992,.,0,1
166993,The,0,0
166994,mean,0,0
166995,salivary,0,1
166996,cortisol,0,0
166997,after,0,0
166998,heel,0,1
166999,lancing,0,1
167000,was,0,0
167001,also,0,0
167002,significantly,0,0
167003,higher,0,0
167004,in,0,0
167005,the,0,0
167006,standard,0,0
167007,care,0,1
167008,group,0,1
167009,(,0,1
167010,24.3,0,1
167011,?,0,1
167012,7.4,0,0
167013,nmol/L,0,0
167014,vs.,0,0
167015,20.8,0,1
167016,?,0,1
167017,7.4,0,0
167018,nmol/L,0,0
167019,",",0,0
167020,p,0,0
167021,=,0,1
167022,0.02,0,0
167023,),0,1
167024,.,0,1
167025,No,0,0
167026,significant,0,0
167027,adverse,0,0
167028,effects,0,0
167029,were,0,1
167030,seen,0,1
167031,with,0,1
167032,cobedding,0,1
167033,.,0,1
167034,CONCLUSION,0,0
167035,Cobedding,0,0
167036,is,0,0
167037,a,0,0
167038,comforting,0,0
167039,measure,1,0
167040,for,1,0
167041,twin,1,1
167042,premature,1,1
167043,infants,1,1
167044,during,1,1
167045,heel,0,1
167046,lancing,0,1
167047,",",0,0
167048,which,0,0
167049,can,0,0
167050,be,0,0
167051,performed,0,0
167052,without,0,0
167053,any,0,0
167054,significant,0,0
167055,adverse,0,0
167056,effects,0,0
167057,.,0,1
167058,Cytokine,0,0
167059,and,0,1
167060,clinical,0,0
167061,response,0,0
167062,to,0,1
167063,Saccharomyces,0,0
167064,boulardii,0,0
167065,therapy,0,0
167066,in,0,0
167067,diarrhea-dominant,0,1
167068,irritable,0,1
167069,bowel,0,1
167070,syndrome,0,1
167071,:,0,1
167072,a,0,0
167073,randomized,0,1
167074,trial,0,1
167075,.,0,1
167076,INTRODUCTION,0,0
167077,This,0,0
167078,preliminary,0,0
167079,study,0,1
167080,aimed,0,0
167081,to,0,0
167082,investigate,0,0
167083,the,0,0
167084,effects,0,0
167085,of,0,0
167086,the,0,1
167087,probiotic,0,0
167088,Saccharomyces,0,0
167089,boulardii,0,0
167090,on,0,0
167091,proinflammatory,0,0
167092,and,0,1
167093,anti-inflammatory,0,0
167094,cytokines,0,0
167095,in,0,1
167096,patients,1,1
167097,with,1,1
167098,diarrhea-dominant,1,1
167099,irritable,1,1
167100,bowel,1,1
167101,syndrome,1,1
167102,(,1,1
167103,IBS-D,1,0
167104,),1,1
167105,.,1,1
167106,The,0,0
167107,other,0,0
167108,objectives,0,0
167109,were,0,1
167110,to,0,0
167111,document,0,0
167112,any,0,0
167113,clinical,0,0
167114,improvement,0,0
167115,as,0,0
167116,judged,0,0
167117,by,0,0
167118,symptoms,0,0
167119,",",0,1
167120,quality,0,0
167121,of,0,0
167122,life,0,0
167123,",",0,0
167124,and,0,0
167125,histology,0,0
167126,.,0,1
167127,PATIENTS,0,0
167128,AND,0,0
167129,METHODS,0,0
167130,This,0,0
167131,was,0,0
167132,a,0,0
167133,randomized,0,1
167134,",",0,0
167135,double,0,0
167136,blind,0,1
167137,",",0,0
167138,placebo-controlled,0,0
167139,trial,0,0
167140,in,0,0
167141,which,0,0
167142,S.,0,1
167143,boulardii,0,0
167144,",",0,1
167145,750,0,0
167146,mg/day,0,0
167147,",",0,0
167148,or,0,1
167149,placebo,0,0
167150,was,0,0
167151,administered,0,0
167152,for,0,1
167153,6,0,1
167154,weeks,0,1
167155,in,0,1
167156,IBS-D,1,1
167157,patients,1,1
167158,",",0,1
167159,in,0,0
167160,addition,0,0
167161,to,0,0
167162,ispaghula,0,0
167163,husk,0,0
167164,standard,0,1
167165,treatment,0,1
167166,.,0,1
167167,RESULTS,0,0
167168,Thirty-seven,1,1
167169,patients,1,1
167170,received,1,1
167171,S.,1,1
167172,boulardii,1,0
167173,and,1,1
167174,35,1,1
167175,patients,1,1
167176,received,1,1
167177,the,1,0
167178,placebo,1,0
167179,.,1,1
167180,As,0,0
167181,compared,0,0
167182,with,0,1
167183,placebo,0,0
167184,",",0,0
167185,the,0,0
167186,S.,0,0
167187,boulardii,0,0
167188,group,0,1
167189,showed,0,0
167190,a,0,0
167191,significant,0,0
167192,decrease,0,0
167193,in,0,0
167194,blood,0,0
167195,and,0,1
167196,tissue,0,1
167197,levels,0,0
167198,of,0,1
167199,proinflammatory,0,0
167200,cytokines,0,0
167201,interleukin-8,0,0
167202,(,0,1
167203,IL-8,0,1
167204,),0,1
167205,and,0,1
167206,tumor,0,1
167207,necrosis,0,1
167208,factor-?,0,0
167209,(,0,1
167210,P,0,0
167211,<,0,0
167212,0.001,0,0
167213,),0,1
167214,and,0,0
167215,an,0,0
167216,increase,0,0
167217,in,0,0
167218,anti-inflammatory,0,1
167219,IL-10,0,1
167220,levels,0,0
167221,",",0,0
167222,as,0,0
167223,well,0,0
167224,as,0,0
167225,an,0,0
167226,increase,0,0
167227,in,0,0
167228,the,0,0
167229,tissue,0,1
167230,IL-10/IL-12,0,0
167231,ratio,0,0
167232,(,0,1
167233,P,0,0
167234,<,0,0
167235,0.001,0,0
167236,),0,1
167237,.,0,1
167238,No,0,0
167239,significant,0,0
167240,change,0,0
167241,in,0,0
167242,the,0,0
167243,blood,0,0
167244,and,0,0
167245,tissue,0,1
167246,levels,0,0
167247,of,0,1
167248,cytokines,0,0
167249,was,0,0
167250,found,0,0
167251,in,0,0
167252,the,0,0
167253,placebo,0,0
167254,group,0,1
167255,.,0,1
167256,Bowel-related,0,0
167257,IBS-D,0,0
167258,symptoms,0,1
167259,reported,0,1
167260,in,0,1
167261,the,0,0
167262,patients,0,1
167263,',0,1
167264,daily,0,0
167265,diary,0,0
167266,improved,0,0
167267,in,0,1
167268,both,0,0
167269,groups,0,0
167270,.,0,1
167271,However,0,0
167272,",",0,0
167273,overall,0,0
167274,improvement,0,0
167275,in,0,0
167276,the,0,0
167277,quality,0,0
167278,of,0,0
167279,life,0,0
167280,was,0,0
167281,more,0,0
167282,marked,0,0
167283,in,0,0
167284,the,0,0
167285,S.,0,1
167286,boulardii,0,0
167287,group,0,1
167288,.,0,1
167289,Although,0,0
167290,baseline,0,0
167291,histological,0,1
167292,findings,0,0
167293,were,0,1
167294,mild,0,1
167295,",",0,0
167296,an,0,0
167297,improvement,0,0
167298,was,0,0
167299,observed,0,0
167300,in,0,0
167301,the,0,0
167302,probiotic,0,0
167303,group,0,0
167304,in,0,0
167305,the,0,0
167306,lymphocyte,0,0
167307,and,0,0
167308,neutrophil,0,0
167309,infiltrates,0,1
167310,(,0,1
167311,P=0.017,0,0
167312,and,0,1
167313,0.018,0,0
167314,),0,1
167315,",",0,0
167316,epithelial,0,1
167317,mitosis,0,1
167318,(,0,1
167319,P=0.003,0,0
167320,),0,1
167321,",",0,0
167322,and,0,1
167323,intraepithelial,0,1
167324,lymphocytes,0,0
167325,(,0,1
167326,P=0.024,0,0
167327,),0,1
167328,.,0,1
167329,No,0,0
167330,serious,0,0
167331,adverse,0,0
167332,events,0,0
167333,were,0,1
167334,found,0,0
167335,in,0,0
167336,either,0,1
167337,group,0,1
167338,.,0,1
167339,CONCLUSION,0,0
167340,S.,0,0
167341,boulardii,0,0
167342,with,0,1
167343,ispaghula,0,0
167344,husk,0,1
167345,was,0,0
167346,superior,0,0
167347,to,0,0
167348,placebo,0,0
167349,with,0,1
167350,ispaghula,0,0
167351,husk,0,1
167352,in,0,0
167353,improving,0,0
167354,the,0,0
167355,cytokine,0,0
167356,profile,0,0
167357,",",0,0
167358,histology,0,0
167359,",",0,0
167360,and,0,0
167361,quality,0,0
167362,of,0,0
167363,life,0,1
167364,of,1,1
167365,patients,1,1
167366,with,1,1
167367,IBS-D,1,0
167368,.,1,1
167369,These,0,0
167370,preliminary,0,0
167371,results,0,0
167372,need,0,0
167373,to,0,0
167374,be,0,0
167375,confirmed,0,0
167376,in,0,0
167377,a,0,1
167378,well-powered,0,0
167379,trial,0,1
167380,.,0,1
167381,Effect,0,0
167382,of,0,0
167383,a,0,1
167384,mixed,0,1
167385,kinesio,0,0
167386,taping-compression,0,0
167387,technique,0,0
167388,on,0,0
167389,quality,0,0
167390,of,0,0
167391,life,0,1
167392,and,0,1
167393,clinical,0,0
167394,and,0,1
167395,gait,0,1
167396,parameters,0,0
167397,in,0,1
167398,postmenopausal,1,1
167399,women,1,1
167400,with,1,1
167401,chronic,1,1
167402,venous,1,1
167403,insufficiency,1,1
167404,:,1,1
167405,double-blinded,0,0
167406,",",0,0
167407,randomized,0,1
167408,controlled,0,0
167409,trial,0,1
167410,.,0,1
167411,OBJECTIVE,0,0
167412,To,0,0
167413,investigate,0,0
167414,the,0,0
167415,short-term,0,0
167416,effect,0,0
167417,of,0,0
167418,a,0,1
167419,mixed,0,1
167420,Kinesio,0,0
167421,taping,0,0
167422,(,0,1
167423,KT,0,1
167424,),0,1
167425,model,0,0
167426,on,0,0
167427,range,0,1
167428,of,0,0
167429,ankle,0,1
167430,motion,0,1
167431,(,0,1
167432,ROAM,0,0
167433,),0,1
167434,",",0,0
167435,gait,0,0
167436,",",0,0
167437,pain,0,0
167438,",",0,0
167439,perimeter,0,0
167440,of,0,0
167441,lower,0,0
167442,limbs,0,1
167443,",",0,0
167444,and,0,0
167445,quality,0,0
167446,of,0,0
167447,life,0,1
167448,in,0,1
167449,postmenopausal,1,1
167450,women,1,1
167451,with,1,1
167452,chronic,1,1
167453,venous,1,1
167454,insufficiency,1,1
167455,(,1,1
167456,CVI,1,1
167457,),1,1
167458,.,1,1
167459,DESIGN,0,0
167460,Double-blinded,0,0
167461,",",0,0
167462,randomized,0,1
167463,controlled,0,0
167464,trial,0,1
167465,.,0,1
167466,SETTING,0,1
167467,Clinical,0,0
167468,setting,0,1
167469,.,0,1
167470,PARTICIPANTS,0,0
167471,Consecutive,1,1
167472,postmenopausal,1,1
167473,women,1,1
167474,(,1,1
167475,N=130,1,1
167476,;,1,1
167477,mean,1,1
167478,age,1,1
167479,?,1,1
167480,SD,1,0
167481,",",1,0
167482,65.44?14.7y,1,0
167483,),1,1
167484,with,1,1
167485,mild,1,1
167486,CVI,1,1
167487,.,1,1
167488,No,0,0
167489,participant,0,0
167490,withdrew,0,0
167491,because,0,0
167492,of,0,1
167493,adverse,0,0
167494,effects,0,0
167495,.,0,1
167496,INTERVENTION,0,0
167497,Participants,0,1
167498,were,0,1
167499,randomly,0,1
167500,assigned,0,1
167501,to,0,0
167502,either,0,1
167503,(,0,1
167504,1,0,0
167505,),0,1
167506,an,0,1
167507,experimental,0,0
167508,group,0,0
167509,to,0,0
167510,receive,0,1
167511,a,0,0
167512,mixed,0,0
167513,KT-compression,0,0
167514,treatment,0,1
167515,following,0,0
167516,KT,0,1
167517,recommendations,0,1
167518,for,0,1
167519,gastrocnemius,0,1
167520,muscle,0,0
167521,enhancement,0,0
167522,and,0,0
167523,functional,0,0
167524,correction,0,1
167525,of,0,0
167526,the,0,0
167527,ankle,0,1
167528,",",0,0
167529,and,0,0
167530,adding,0,0
167531,2,0,1
167532,tapes,0,0
167533,to,0,1
167534,simulate,0,1
167535,traditional,0,0
167536,compression,0,0
167537,bandages,0,0
167538,(,0,1
167539,no,0,1
167540,KT,0,1
167541,guidelines,0,1
167542,),0,1
167543,;,0,1
167544,or,0,1
167545,(,0,1
167546,2,0,1
167547,),0,1
167548,a,0,1
167549,placebo,0,0
167550,control,0,0
167551,group,0,1
167552,for,0,0
167553,sham,0,0
167554,KT,0,1
167555,.,0,1
167556,Both,0,0
167557,interventions,0,0
167558,were,0,1
167559,performed,0,1
167560,3,0,1
167561,times,0,0
167562,a,0,1
167563,week,0,0
167564,during,0,0
167565,a,0,1
167566,4-week,0,0
167567,period,0,0
167568,.,0,1
167569,MAIN,0,0
167570,OUTCOME,0,1
167571,MEASURES,0,0
167572,ROAM,0,0
167573,",",0,0
167574,gait,0,0
167575,",",0,0
167576,pain,0,0
167577,",",0,0
167578,perimeter,0,0
167579,of,0,0
167580,right,0,1
167581,and,0,0
167582,left,0,1
167583,lower,0,0
167584,limb,0,0
167585,",",0,0
167586,and,0,0
167587,quality,0,0
167588,of,0,0
167589,life,0,1
167590,were,0,1
167591,assessed,0,0
167592,at,0,0
167593,baseline,0,0
167594,and,0,1
167595,48,0,1
167596,hours,0,0
167597,posttreatment,0,1
167598,.,0,1
167599,RESULTS,0,0
167600,Quality,0,0
167601,of,0,0
167602,life,0,0
167603,was,0,0
167604,better,0,0
167605,in,0,0
167606,the,0,0
167607,intervention,0,0
167608,group,0,0
167609,by,0,0
167610,a,0,0
167611,mean,0,1
167612,of,0,0
167613,8.76,0,0
167614,points,0,0
167615,(,0,1
167616,95,0,0
167617,%,0,0
167618,confidence,0,0
167619,interval,0,0
167620,[,0,0
167621,CI,0,0
167622,],0,1
167623,",",0,1
167624,4.96-12.55,0,0
167625,),0,1
167626,.,0,1
167627,The,0,0
167628,experimental,0,0
167629,group,0,0
167630,also,0,0
167631,showed,0,0
167632,significant,0,0
167633,pre-/posttreatment,0,0
167634,improvements,0,0
167635,in,0,0
167636,both,0,0
167637,lower,0,0
167638,limbs,0,1
167639,in,0,0
167640,gait,0,1
167641,dorsiflexion,0,1
167642,ROAM,0,0
167643,(,0,1
167644,95,0,0
167645,%,0,0
167646,CI,0,0
167647,",",0,1
167648,1.02-2.49,0,0
167649,),0,0
167650,",",0,0
167651,cadence,0,0
167652,(,0,1
167653,95,0,0
167654,%,0,0
167655,CI,0,0
167656,",",0,1
167657,3.45-1.47,0,0
167658,),0,0
167659,",",0,0
167660,stride,0,0
167661,length,0,0
167662,(,0,1
167663,95,0,0
167664,%,0,0
167665,CI,0,0
167666,",",0,1
167667,21.48-10.83,0,0
167668,),0,0
167669,",",0,0
167670,step,0,0
167671,length,0,0
167672,(,0,1
167673,95,0,0
167674,%,0,0
167675,CI,0,0
167676,",",0,1
167677,1.68-6.61,0,0
167678,),0,0
167679,",",0,0
167680,stance,0,0
167681,phase,0,1
167682,(,0,1
167683,95,0,0
167684,%,0,0
167685,CI,0,0
167686,",",0,1
167687,61-107,0,1
167688,),0,0
167689,",",0,0
167690,and,0,0
167691,foot,0,1
167692,(,0,1
167693,95,0,0
167694,%,0,0
167695,CI,0,0
167696,",",0,1
167697,.56-.92,0,0
167698,),0,1
167699,and,0,0
167700,malleolus,0,1
167701,(,0,1
167702,95,0,0
167703,%,0,0
167704,CI,0,0
167705,",",0,1
167706,1.15-1.63,0,0
167707,),0,1
167708,circumference,0,0
167709,.,0,1
167710,None,0,0
167711,of,0,0
167712,these,0,0
167713,variables,0,0
167714,were,0,1
167715,significantly,0,0
167716,modified,0,0
167717,in,0,0
167718,the,0,0
167719,placebo,0,0
167720,group,0,0
167721,.,0,1
167722,Both,0,0
167723,groups,0,0
167724,reported,0,0
167725,a,0,1
167726,significant,0,0
167727,reduction,0,0
167728,in,0,1
167729,pain,0,1
167730,.,0,1
167731,CONCLUSIONS,0,0
167732,Ankle,0,1
167733,dorsiflexion,0,0
167734,during,0,0
167735,gait,0,0
167736,",",0,1
167737,walking,0,0
167738,parameters,0,0
167739,",",0,1
167740,peripheral,0,1
167741,edema,0,1
167742,",",0,0
167743,venous,0,1
167744,pain,0,1
167745,",",0,0
167746,and,0,0
167747,quality,0,0
167748,of,0,0
167749,life,0,1
167750,remain,0,0
167751,improved,0,0
167752,in,0,0
167753,patients,0,1
167754,with,0,1
167755,CVI,0,1
167756,at,0,1
167757,1,0,1
167758,month,0,0
167759,after,0,1
167760,mixed,0,1
167761,KT-compression,0,0
167762,therapy,0,1
167763,.,0,1
167764,KT,0,0
167765,may,0,0
167766,have,0,0
167767,a,0,0
167768,placebo,0,0
167769,effect,0,0
167770,on,0,0
167771,pain,0,1
167772,perception,0,0
167773,.,0,1
167774,The,0,0
167775,KRAS-variant,0,0
167776,and,0,0
167777,miRNA,0,1
167778,expression,0,0
167779,in,0,1
167780,RTOG,0,1
167781,endometrial,1,1
167782,cancer,1,1
167783,clinical,0,1
167784,trials,0,1
167785,9708,0,1
167786,and,0,1
167787,9905,0,1
167788,.,0,1
167789,OBJECTIVE,0,0
167790,To,0,0
167791,explore,0,0
167792,the,0,0
167793,association,0,0
167794,of,0,0
167795,a,0,1
167796,functional,0,0
167797,germline,0,1
167798,variant,0,1
167799,in,0,0
167800,the,0,0
167801,3'-UTR,0,0
167802,of,0,0
167803,KRAS,0,1
167804,with,0,1
167805,endometrial,0,1
167806,cancer,0,1
167807,risk,0,0
167808,",",0,0
167809,as,0,0
167810,well,0,0
167811,as,0,0
167812,the,0,0
167813,association,0,0
167814,of,0,0
167815,microRNA,0,0
167816,(,0,1
167817,miRNA,0,1
167818,),0,1
167819,signatures,0,1
167820,and,0,1
167821,the,0,0
167822,KRAS-variant,0,1
167823,with,0,1
167824,clinical,0,1
167825,characteristics,0,1
167826,and,0,1
167827,survival,0,0
167828,outcomes,0,0
167829,in,0,1
167830,two,0,1
167831,prospective,0,1
167832,RTOG,0,1
167833,endometrial,0,1
167834,cancer,0,1
167835,trials,0,1
167836,.,0,1
167837,METHODS/MATERIALS,0,0
167838,The,0,0
167839,association,0,0
167840,of,0,0
167841,the,0,0
167842,KRAS-variant,0,1
167843,with,0,1
167844,endometrial,0,1
167845,cancer,0,1
167846,risk,0,1
167847,was,0,0
167848,evaluated,0,0
167849,by,0,0
167850,case-control,0,1
167851,analysis,0,0
167852,of,0,1
167853,467,1,1
167854,women,1,1
167855,with,1,1
167856,type,1,1
167857,1,1,1
167858,or,1,1
167859,2,1,1
167860,endometrial,1,1
167861,cancer,1,1
167862,and,1,1
167863,582,1,1
167864,age-matched,1,1
167865,controls,1,1
167866,.,1,1
167867,miRNA,0,1
167868,and,0,0
167869,DNA,0,1
167870,were,0,1
167871,isolated,0,1
167872,for,0,0
167873,expression,0,0
167874,profiling,0,1
167875,and,0,0
167876,genotyping,0,0
167877,from,0,1
167878,tumor,1,1
167879,specimens,1,1
167880,of,1,1
167881,46,1,1
167882,women,1,1
167883,with,1,1
167884,type,1,1
167885,1,1,1
167886,endometrial,1,1
167887,cancer,1,1
167888,enrolled,1,1
167889,in,1,1
167890,RTOG,1,1
167891,trials,1,1
167892,9708,1,1
167893,and,1,1
167894,9905.,1,1
167895,miRNA,0,1
167896,expression,0,1
167897,levels,0,0
167898,and,0,1
167899,KRAS-variant,0,1
167900,genotype,0,1
167901,were,0,0
167902,correlated,0,0
167903,with,0,1
167904,patient,0,1
167905,and,0,1
167906,tumor,0,1
167907,characteristics,0,0
167908,",",0,1
167909,and,0,1
167910,survival,0,0
167911,outcomes,0,0
167912,were,0,1
167913,evaluated,0,0
167914,by,0,0
167915,variant,0,1
167916,allele,0,0
167917,type,0,1
167918,.,0,1
167919,RESULTS,0,0
167920,The,0,0
167921,KRAS-variant,0,0
167922,was,0,0
167923,not,0,0
167924,significantly,0,0
167925,associated,0,0
167926,with,0,1
167927,overall,0,0
167928,endometrial,0,1
167929,cancer,0,1
167930,risk,0,1
167931,(,0,1
167932,14,0,1
167933,%,0,0
167934,controls,0,1
167935,and,0,1
167936,17,0,1
167937,%,0,0
167938,type,0,1
167939,1,0,1
167940,cancers,0,1
167941,),0,1
167942,",",0,1
167943,although,0,0
167944,was,0,0
167945,enriched,0,0
167946,in,0,0
167947,type,0,1
167948,2,0,1
167949,endometrial,0,1
167950,cancers,0,1
167951,(,0,1
167952,24,0,1
167953,%,0,0
167954,",",0,0
167955,p,0,0
167956,=,0,1
167957,0.2,0,1
167958,),0,1
167959,.,0,1
167960,In,0,0
167961,the,0,0
167962,combined,0,0
167963,analysis,0,0
167964,of,0,1
167965,RTOG,0,1
167966,9708/9905,0,1
167967,",",0,0
167968,miRNA,0,1
167969,expression,0,0
167970,differed,0,0
167971,by,0,0
167972,age,0,1
167973,",",0,0
167974,presence,0,0
167975,of,0,0
167976,lymphovascular,0,1
167977,invasion,0,0
167978,and,0,1
167979,KRAS-variant,0,1
167980,status,0,1
167981,.,0,1
167982,Overall,0,0
167983,survival,0,0
167984,rates,0,0
167985,at,0,1
167986,3,0,1
167987,years,0,1
167988,for,0,1
167989,patients,1,1
167990,with,1,1
167991,the,1,0
167992,variant,1,1
167993,and,1,0
167994,wild-type,1,1
167995,alleles,1,1
167996,were,1,1
167997,100,0,1
167998,%,0,0
167999,and,0,1
168000,77,0,1
168001,%,0,0
168002,(,0,1
168003,HR,0,0
168004,0.3,0,0
168005,",",0,0
168006,p,0,0
168007,=,0,1
168008,0.24,0,0
168009,),0,0
168010,",",0,0
168011,respectively,0,0
168012,",",0,0
168013,favoring,0,0
168014,the,0,0
168015,variant,0,1
168016,.,0,0
168017,CONCLUSIONS,0,0
168018,The,0,0
168019,KRAS-variant,0,0
168020,may,0,0
168021,be,0,0
168022,a,0,0
168023,genetic,0,0
168024,marker,0,0
168025,of,0,0
168026,risk,0,1
168027,for,0,1
168028,type,0,1
168029,2,0,1
168030,endometrial,0,1
168031,cancers,0,1
168032,.,0,1
168033,In,0,0
168034,addition,0,0
168035,",",0,0
168036,tumor,0,1
168037,miRNA,0,1
168038,expression,0,0
168039,appears,0,0
168040,to,0,0
168041,be,0,0
168042,associated,0,0
168043,with,0,1
168044,patient,0,1
168045,age,0,1
168046,",",0,0
168047,lymphovascular,0,0
168048,invasion,0,0
168049,and,0,0
168050,the,0,0
168051,KRAS-variant,0,0
168052,",",0,0
168053,supporting,0,0
168054,the,0,0
168055,hypothesis,0,0
168056,that,0,0
168057,altered,0,1
168058,tumor,0,0
168059,biology,0,0
168060,can,0,0
168061,be,0,0
168062,measured,0,0
168063,by,0,0
168064,miRNA,0,1
168065,expression,0,0
168066,",",0,0
168067,and,0,0
168068,that,0,0
168069,the,0,0
168070,KRAS-variant,0,1
168071,likely,0,0
168072,impacts,0,0
168073,endometrial,0,1
168074,tumor,0,1
168075,biology,0,0
168076,.,0,1
168077,Classification,0,1
168078,of,0,0
168079,motor,0,0
168080,imagery,0,0
168081,performance,0,0
168082,in,0,0
168083,acute,1,1
168084,stroke,1,1
168085,.,1,1
168086,OBJECTIVE,0,0
168087,Effective,0,0
168088,motor,0,0
168089,imagery,0,0
168090,performance,0,0
168091,",",0,0
168092,seen,0,0
168093,as,0,0
168094,strong,0,0
168095,suppression,0,0
168096,of,0,0
168097,the,0,0
168098,sensorimotor,0,0
168099,rhythm,0,1
168100,",",0,0
168101,is,0,0
168102,the,0,0
168103,key,0,0
168104,element,0,0
168105,in,0,0
168106,motor,0,0
168107,imagery,0,0
168108,therapy,0,0
168109,.,0,1
168110,Therefore,0,0
168111,",",0,0
168112,optimization,0,0
168113,of,0,0
168114,methods,0,1
168115,to,0,1
168116,classify,0,1
168117,whether,0,0
168118,the,0,0
168119,subject,0,0
168120,is,0,0
168121,performing,0,0
168122,the,0,0
168123,imagery,0,0
168124,task,0,0
168125,is,0,0
168126,a,0,0
168127,prerequisite,0,0
168128,.,0,0
168129,An,0,0
168130,optimal,0,0
168131,classification,0,1
168132,method,0,0
168133,should,0,0
168134,have,0,0
168135,high,0,0
168136,performance,0,0
168137,accuracy,0,0
168138,and,0,0
168139,use,0,0
168140,a,0,0
168141,small,0,0
168142,number,0,0
168143,of,0,1
168144,channels,0,0
168145,.,0,1
168146,We,0,0
168147,investigated,0,0
168148,the,0,0
168149,additional,0,0
168150,benefit,0,0
168151,of,0,0
168152,the,0,0
168153,common,0,0
168154,spatial,0,0
168155,pattern,0,1
168156,filtering,0,1
168157,(,0,1
168158,CSP,0,1
168159,),0,1
168160,to,0,0
168161,a,0,1
168162,linear,0,0
168163,discriminant,0,0
168164,analysis,0,0
168165,(,0,1
168166,LDA,0,1
168167,),0,1
168168,classifier,0,1
168169,",",0,0
168170,for,0,0
168171,different,0,0
168172,channel,0,1
168173,configurations,0,0
168174,.,0,1
168175,METHODS,0,0
168176,Ten,1,1
168177,hemispheric,1,1
168178,acute,1,1
168179,stroke,1,1
168180,patients,1,1
168181,and,1,1
168182,11,1,1
168183,healthy,1,1
168184,subjects,1,1
168185,were,1,1
168186,included,1,1
168187,.,1,1
168188,EEGs,0,0
168189,were,0,0
168190,recorded,0,0
168191,using,0,1
168192,60,0,1
168193,channels,0,0
168194,.,0,1
168195,The,0,0
168196,classifier,0,0
168197,was,0,0
168198,trained,0,1
168199,with,0,1
168200,a,0,0
168201,motor,0,0
168202,execution,0,0
168203,task,0,1
168204,.,0,1
168205,For,0,0
168206,both,0,0
168207,healthy,0,1
168208,controls,0,1
168209,and,0,1
168210,patients,0,1
168211,",",0,0
168212,analysis,0,0
168213,of,0,0
168214,recordings,0,0
168215,was,0,0
168216,initially,0,1
168217,limited,0,0
168218,to,0,1
168219,3,0,1
168220,and,0,1
168221,11,0,1
168222,electrodes,0,0
168223,recording,0,1
168224,from,0,1
168225,the,0,0
168226,motor,0,0
168227,cortex,0,0
168228,area,0,0
168229,",",0,0
168230,and,0,0
168231,later,0,1
168232,repeated,0,0
168233,using,0,0
168234,45,0,1
168235,electrodes,0,1
168236,.,0,1
168237,RESULTS,0,0
168238,No,0,0
168239,significant,0,0
168240,improvement,0,0
168241,on,0,0
168242,the,0,0
168243,addition,0,0
168244,of,0,0
168245,CSP,0,0
168246,to,0,1
168247,LDA,0,1
168248,was,0,0
168249,found,0,0
168250,(,0,0
168251,in,0,0
168252,both,0,0
168253,cases,0,1
168254,",",0,0
168255,the,0,0
168256,area,0,0
168257,under,0,0
168258,the,0,0
168259,receiving,0,1
168260,operating,0,0
168261,characteristic,0,0
168262,(,0,1
168263,AU-ROC,0,1
168264,),0,1
168265,?,0,1
168266,0.70,0,0
168267,(,0,0
168268,acceptable,0,0
168269,),0,1
168270,),0,1
168271,.,0,1
168272,We,0,0
168273,then,0,0
168274,repeated,0,0
168275,the,0,0
168276,LDA+CSP,0,1
168277,method,0,0
168278,on,0,0
168279,recordings,0,0
168280,of,0,1
168281,45,0,1
168282,electrodes,0,0
168283,",",0,1
168284,since,0,0
168285,the,0,0
168286,use,0,0
168287,of,0,0
168288,imagery,0,0
168289,neuronal,0,1
168290,circuits,0,0
168291,may,0,0
168292,well,0,0
168293,extend,0,0
168294,beyond,0,0
168295,the,0,0
168296,motor,0,0
168297,area,0,0
168298,.,0,1
168299,AU-ROC,0,0
168300,rose,0,0
168301,to,0,1
168302,0.90,0,0
168303,",",0,0
168304,but,0,0
168305,no,0,0
168306,virtual,0,0
168307,'most,0,1
168308,responsible,0,0
168309,',0,1
168310,electrode,0,0
168311,was,0,0
168312,observed,0,0
168313,.,0,1
168314,Finally,0,0
168315,",",0,0
168316,in,0,0
168317,mild-to-moderate,1,1
168318,stroke,1,1
168319,patients,1,1
168320,we,1,0
168321,could,0,0
168322,successfully,0,0
168323,use,0,0
168324,the,0,0
168325,EEG,0,1
168326,data,0,0
168327,recorded,0,0
168328,from,0,1
168329,the,0,0
168330,healthy,0,1
168331,hemisphere,0,0
168332,to,0,0
168333,train,0,0
168334,the,0,0
168335,classifier,0,1
168336,(,0,1
168337,AU-ROC,0,1
168338,?,0,1
168339,0.70,0,0
168340,),0,1
168341,.,0,1
168342,SIGNIFICANCE,0,0
168343,Including,0,0
168344,only,0,0
168345,the,0,0
168346,channels,0,0
168347,on,0,0
168348,the,0,1
168349,unaffected,0,0
168350,motor,0,0
168351,cortex,0,0
168352,is,0,0
168353,sufficient,0,0
168354,to,0,0
168355,train,0,0
168356,a,0,0
168357,classifier,0,1
168358,.,0,1
168359,[,0,0
168360,The,0,0
168361,effects,0,0
168362,of,0,0
168363,tirofiban,0,1
168364,on,0,0
168365,acute,0,1
168366,non-ST,0,1
168367,segment,0,1
168368,elevation,0,1
168369,myocardial,1,1
168370,infarction,1,1
168371,patients,1,1
168372,not,1,1
168373,receiving,1,1
168374,early,1,1
168375,reperfusion,1,0
168376,intervention,1,1
168377,],1,1
168378,.,0,1
168379,OBJECTIVE,0,0
168380,To,0,0
168381,study,0,0
168382,the,0,0
168383,efficacy,0,0
168384,and,0,0
168385,safety,0,0
168386,of,0,0
168387,tirofiban,0,0
168388,in,0,1
168389,patients,1,1
168390,with,1,1
168391,acute,1,1
168392,non-ST-,1,1
168393,segment,1,1
168394,elevation,1,1
168395,myocardial,1,1
168396,infarction,1,1
168397,(,1,1
168398,NSTEMI,1,0
168399,),1,1
168400,without,1,1
168401,early,1,1
168402,reperfusion,1,0
168403,intervention,1,1
168404,.,1,1
168405,METHODS,0,0
168406,A,0,0
168407,total,1,1
168408,of,1,1
168409,151,1,1
168410,NSTEMI,1,1
168411,patients,1,1
168412,without,1,1
168413,early,1,1
168414,reperfusion,1,0
168415,intervention,1,0
168416,were,0,0
168417,enrolled,0,1
168418,in,0,0
168419,the,0,0
168420,study,0,0
168421,and,0,0
168422,randomized,0,1
168423,to,0,0
168424,the,0,0
168425,tirofiban,0,0
168426,group,0,0
168427,(,0,1
168428,n,0,1
168429,=,0,1
168430,76,0,1
168431,),0,1
168432,and,0,0
168433,the,0,0
168434,control,0,0
168435,group,0,0
168436,(,0,1
168437,n,0,1
168438,=,0,1
168439,75,0,1
168440,),0,1
168441,.,0,1
168442,Coronary,0,1
168443,angiography,0,0
168444,was,0,0
168445,performed,0,0
168446,at,0,1
168447,day,0,0
168448,3,0,1
168449,and,0,1
168450,day,0,0
168451,7,0,1
168452,",",0,0
168453,while,0,0
168454,percutaneous,0,1
168455,coronary,0,1
168456,intervention,0,1
168457,(,0,1
168458,PCI,0,1
168459,),0,1
168460,was,0,0
168461,performed,0,0
168462,when,0,0
168463,necessary,0,0
168464,.,0,1
168465,Parameters,0,0
168466,including,0,0
168467,thrombolysis,0,1
168468,in,0,1
168469,myocardial,0,1
168470,infarction,0,1
168471,(,0,1
168472,TIMI,0,1
168473,),0,1
168474,flow,0,0
168475,",",0,1
168476,bleeding,0,1
168477,complications,0,0
168478,and,0,1
168479,clinic,0,1
168480,events,0,0
168481,within,0,1
168482,30,0,1
168483,days,0,0
168484,were,0,1
168485,compared,0,0
168486,between,0,0
168487,the,0,1
168488,two,0,1
168489,groups,0,1
168490,.,0,1
168491,RESULTS,0,0
168492,Before,0,0
168493,PCI,0,0
168494,",",0,0
168495,no,0,0
168496,increase,0,0
168497,in,0,0
168498,the,0,0
168499,percentage,0,0
168500,of,0,0
168501,patient,0,1
168502,with,0,1
168503,TIMI,0,1
168504,flow,0,0
168505,better,0,0
168506,than,0,0
168507,TIMI-2,0,1
168508,was,0,0
168509,observed,0,0
168510,by,0,0
168511,the,0,0
168512,treatment,0,0
168513,of,0,0
168514,tirofiban,0,0
168515,(,0,1
168516,69.3,0,0
168517,%,0,0
168518,vs,0,0
168519,78.9,0,1
168520,%,0,0
168521,",",0,1
168522,P,0,0
168523,=,0,1
168524,0.10,0,0
168525,),0,1
168526,.,0,1
168527,While,0,1
168528,after,0,0
168529,PCI,0,1
168530,",",0,1
168531,significant,0,0
168532,increase,0,0
168533,in,0,0
168534,the,0,0
168535,percentage,0,0
168536,of,0,0
168537,patient,0,1
168538,with,0,1
168539,TIMI,0,1
168540,flow,0,0
168541,better,0,0
168542,than,0,0
168543,TIMI-2,0,1
168544,was,0,0
168545,manifested,0,0
168546,in,0,0
168547,the,0,0
168548,tirofiban,0,0
168549,group,0,1
168550,(,0,1
168551,96.0,0,0
168552,%,0,0
168553,vs,0,0
168554,100.0,0,1
168555,%,0,0
168556,",",0,1
168557,P,0,0
168558,=,0,1
168559,0.04,0,0
168560,),0,1
168561,.,0,1
168562,Tirofiban,0,0
168563,treatment,0,0
168564,also,0,0
168565,significantly,0,0
168566,decreased,0,0
168567,the,0,0
168568,rate,0,0
168569,of,0,0
168570,poor,0,1
168571,myocardial,0,1
168572,perfusion,0,0
168573,after,0,1
168574,PCI,0,1
168575,(,0,1
168576,19.7,0,1
168577,%,0,0
168578,vs,0,0
168579,34.7,0,0
168580,%,0,0
168581,",",0,1
168582,P,0,0
168583,=,0,1
168584,0.04,0,0
168585,),0,0
168586,.,0,0
168587,There,0,0
168588,were,0,0
168589,0,0,0
168590,and,0,1
168591,4,0,1
168592,major,0,1
168593,adverse,0,0
168594,cardiovascular,0,1
168595,events,0,0
168596,(,0,1
168597,MACE,0,0
168598,),0,1
168599,within,0,1
168600,30,0,1
168601,days,0,0
168602,observed,0,0
168603,in,0,0
168604,the,0,0
168605,tirofiban,0,0
168606,group,0,0
168607,and,0,0
168608,the,0,0
168609,control,0,0
168610,group,0,1
168611,(,0,1
168612,0.0,0,0
168613,%,0,0
168614,vs,0,0
168615,5.3,0,0
168616,%,0,0
168617,",",0,1
168618,P,0,0
168619,=,0,1
168620,0.05,0,0
168621,),0,1
168622,.,0,1
168623,No,0,0
168624,difference,0,0
168625,between,0,0
168626,the,0,1
168627,two,0,1
168628,groups,0,0
168629,was,0,0
168630,found,0,0
168631,in,0,0
168632,the,0,0
168633,bleeding,0,1
168634,complications,0,0
168635,within,0,1
168636,30,0,1
168637,days,0,0
168638,including,0,1
168639,the,0,0
168640,mild,0,1
168641,hemorrhage,0,1
168642,(,0,1
168643,5,0,0
168644,vs,0,0
168645,4,0,0
168646,cases,0,1
168647,",",0,1
168648,P,0,0
168649,=,0,1
168650,0.75,0,0
168651,),0,1
168652,",",0,0
168653,severe,0,1
168654,hemorrhage,0,1
168655,(,0,1
168656,2,0,1
168657,vs,0,0
168658,1,0,1
168659,cases,0,1
168660,",",0,1
168661,P,0,0
168662,=,0,1
168663,0.56,0,0
168664,),0,1
168665,or,0,1
168666,severe,0,1
168667,thrombocytopenia,0,1
168668,(,0,1
168669,2,0,1
168670,vs,0,0
168671,0,0,0
168672,cases,0,1
168673,",",0,1
168674,P,0,0
168675,=,0,1
168676,0.49,0,0
168677,),0,1
168678,.,0,1
168679,CONCLUSIONS,0,0
168680,Tirofiban,0,0
168681,treatment,0,0
168682,does,0,0
168683,not,0,0
168684,increase,0,0
168685,the,0,0
168686,bleeding,0,0
168687,complications,0,0
168688,in,0,1
168689,NSTEMI,1,1
168690,patients,1,1
168691,without,1,1
168692,early,1,1
168693,PCI,1,1
168694,.,1,1
168695,Tirofiban,0,0
168696,can,0,0
168697,improve,0,0
168698,the,0,0
168699,TIMI,0,0
168700,flow,0,0
168701,and,0,0
168702,the,0,0
168703,myocardial,0,1
168704,perfusion,0,0
168705,after,0,0
168706,PCI,0,0
168707,with,0,1
168708,less,0,0
168709,MACE,0,0
168710,within,0,1
168711,30,0,1
168712,days,0,1
168713,.,0,1
168714,A,0,0
168715,trial,0,0
168716,of,0,0
168717,D-cycloserine,0,1
168718,to,0,1
168719,treat,0,1
168720,stereotypies,0,0
168721,in,0,1
168722,older,1,1
168723,adolescents,1,1
168724,and,1,1
168725,young,1,1
168726,adults,1,1
168727,with,1,1
168728,autism,1,1
168729,spectrum,1,1
168730,disorder,1,1
168731,.,1,1
168732,OBJECTIVES,0,0
168733,Autism,0,1
168734,spectrum,0,1
168735,disorders,0,1
168736,(,0,1
168737,ASDs,0,1
168738,),0,1
168739,have,0,0
168740,core,0,1
168741,impairments,0,1
168742,in,0,1
168743,social,0,1
168744,communication,0,0
168745,as,0,0
168746,well,0,0
168747,as,0,0
168748,the,0,0
168749,presence,0,0
168750,of,0,0
168751,repetitive,0,0
168752,",",0,1
168753,stereotypic,0,1
168754,behaviors,0,0
168755,and,0,1
168756,restricted,0,1
168757,interests,0,0
168758,.,0,1
168759,Older,0,1
168760,adolescents,0,1
168761,and,0,1
168762,young,0,1
168763,adults,0,1
168764,are,0,0
168765,particularly,0,0
168766,impacted,0,0
168767,by,0,0
168768,these,0,0
168769,deficits,0,1
168770,.,0,1
168771,Preclinical,0,1
168772,data,0,0
168773,implicate,0,0
168774,glutamatergic,0,0
168775,dysfunction,0,1
168776,in,0,0
168777,the,0,0
168778,pathophysiology,0,0
168779,of,0,0
168780,ASDs,0,1
168781,.,0,1
168782,D-Cycloserine,0,0
168783,(,0,0
168784,DCS,0,1
168785,),0,1
168786,",",0,0
168787,a,0,0
168788,partial,0,0
168789,glycineB,0,0
168790,agonist,0,1
168791,at,0,0
168792,the,0,0
168793,N-methyl-D-aspartic,0,0
168794,acid,0,0
168795,receptor,0,0
168796,site,0,0
168797,",",0,0
168798,has,0,0
168799,been,0,0
168800,shown,0,0
168801,to,0,0
168802,improve,0,0
168803,sociability,0,0
168804,in,0,0
168805,mouse,0,1
168806,models,0,1
168807,and,0,1
168808,a,0,1
168809,small,0,0
168810,human,0,1
168811,study,0,1
168812,.,0,1
168813,The,0,0
168814,sensitivity,0,0
168815,of,0,0
168816,the,0,0
168817,obligatory,0,0
168818,glycineB,0,0
168819,co-agonist,0,1
168820,binding,0,0
168821,site,0,0
168822,may,0,0
168823,change,0,0
168824,with,0,1
168825,daily,0,0
168826,administration,0,0
168827,of,0,0
168828,DCS,0,0
168829,as,0,0
168830,a,0,0
168831,result,0,0
168832,of,0,0
168833,agonist-induced,0,0
168834,desensitization,0,1
168835,.,0,1
168836,The,0,0
168837,efficacy,0,0
168838,of,0,0
168839,a,0,1
168840,pulsed,0,0
168841,once-weekly,0,0
168842,administration,0,0
168843,versus,0,0
168844,daily,0,0
168845,administration,0,0
168846,of,0,1
168847,DCS,0,1
168848,was,0,0
168849,compared,0,0
168850,.,0,1
168851,METHODS,0,0
168852,Males,1,1
168853,and,1,1
168854,females,1,1
168855,",",1,0
168856,ages,1,1
168857,14,1,0
168858,to,1,0
168859,25,1,1
168860,years,1,1
168861,",",1,1
168862,with,1,1
168863,a,1,1
168864,Diagnostic,1,1
168865,and,1,0
168866,Statistical,1,0
168867,Manual,1,1
168868,of,1,1
168869,Mental,1,1
168870,Disorders,1,1
168871,",",1,1
168872,Fourth,1,1
168873,Edition,1,0
168874,Text,1,1
168875,Revision,1,0
168876,diagnosis,1,1
168877,of,1,0
168878,an,1,1
168879,ASD,1,1
168880,were,1,0
168881,enrolled,1,1
168882,in,0,0
168883,a,0,0
168884,double-blind,0,0
168885,",",0,0
168886,randomized,0,1
168887,10-week,0,1
168888,trial,0,0
168889,consisting,0,1
168890,of,0,1
168891,8,0,1
168892,weeks,0,1
168893,of,0,1
168894,active,0,1
168895,drug,0,1
168896,with,0,1
168897,either,0,1
168898,weekly,0,0
168899,or,0,1
168900,daily,0,0
168901,administration,0,0
168902,of,0,1
168903,50,0,1
168904,mg,0,1
168905,of,0,1
168906,DCS,0,0
168907,followed,0,1
168908,by,0,0
168909,a,0,1
168910,2-week,0,0
168911,follow-up,0,0
168912,visit,0,1
168913,.,0,1
168914,RESULTS,0,0
168915,For,0,1
168916,the,0,0
168917,purposes,0,0
168918,of,0,0
168919,this,0,0
168920,study,0,0
168921,",",0,0
168922,no,0,0
168923,statistical,0,0
168924,or,0,1
168925,clinical,0,1
168926,differences,0,0
168927,existed,0,0
168928,between,0,0
168929,the,0,0
168930,2,0,1
168931,dosage,0,0
168932,groups,0,0
168933,on,0,0
168934,the,0,1
168935,Aberrant,0,1
168936,Behavior,0,1
168937,Checklist,0,0
168938,subscale,0,0
168939,3,0,0
168940,",",0,0
168941,which,0,0
168942,measures,0,0
168943,stereotypies/repetitive,0,0
168944,movements,0,0
168945,.,0,1
168946,When,0,1
168947,combining,0,0
168948,groups,0,0
168949,",",0,0
168950,a,0,0
168951,statistically,0,0
168952,significant,0,0
168953,decrease,0,0
168954,of,0,1
168955,37,0,1
168956,%,0,0
168957,was,0,0
168958,found,0,0
168959,from,0,1
168960,baseline,0,0
168961,to,0,1
168962,week,0,0
168963,8,0,0
168964,when,0,0
168965,study,0,1
168966,drug,0,0
168967,was,0,0
168968,completed,0,1
168969,using,0,0
168970,a,0,1
168971,linear,0,0
168972,mixed,0,0
168973,effects,0,0
168974,model,0,1
168975,(,0,1
168976,P,0,0
168977,=,0,1
168978,0.003,0,0
168979,),0,1
168980,.,0,1
168981,CONCLUSIONS,0,0
168982,D-Cycloserine,0,0
168983,was,0,0
168984,shown,0,0
168985,to,0,0
168986,be,0,0
168987,effective,0,0
168988,in,0,0
168989,improving,0,0
168990,stereotypic,0,1
168991,symptoms,0,0
168992,in,0,1
168993,older,0,1
168994,adolescents,0,1
168995,and,0,1
168996,young,0,1
168997,adults,0,1
168998,with,0,1
168999,ASDs,0,1
169000,measured,0,0
169001,by,0,0
169002,the,0,0
169003,Aberrant,0,1
169004,Behavior,0,1
169005,Checklist,0,0
169006,subscale,0,0
169007,3,0,1
169008,.,0,1
169009,In,0,0
169010,addition,0,0
169011,",",0,1
169012,DCS,0,0
169013,was,0,0
169014,safe,0,0
169015,and,0,0
169016,well,0,0
169017,tolerated,0,0
169018,.,0,1
169019,A,0,1
169020,randomized,0,1
169021,clinical,0,0
169022,trial,0,1
169023,comparison,0,0
169024,between,0,0
169025,pivotal,0,0
169026,response,0,0
169027,treatment,0,0
169028,(,0,1
169029,PRT,0,1
169030,),0,1
169031,and,0,0
169032,structured,0,1
169033,applied,0,0
169034,behavior,0,0
169035,analysis,0,0
169036,(,0,1
169037,ABA,0,0
169038,),0,1
169039,intervention,0,1
169040,for,0,1
169041,children,1,1
169042,with,1,1
169043,autism,1,1
169044,.,1,1
169045,Accumulating,0,0
169046,studies,0,0
169047,are,0,0
169048,documenting,0,0
169049,specific,0,0
169050,motivational,0,1
169051,variables,0,0
169052,that,0,0
169053,",",0,0
169054,when,0,0
169055,combined,0,0
169056,into,0,0
169057,a,0,1
169058,naturalistic,0,0
169059,teaching,0,1
169060,paradigm,0,0
169061,",",0,0
169062,can,0,0
169063,positively,0,0
169064,influence,0,0
169065,the,0,0
169066,effectiveness,0,0
169067,of,0,0
169068,interventions,0,0
169069,for,0,1
169070,children,1,1
169071,with,1,1
169072,autism,1,1
169073,spectrum,1,1
169074,disorder,1,1
169075,(,1,1
169076,ASD,1,1
169077,),1,1
169078,.,1,1
169079,The,0,0
169080,purpose,0,0
169081,of,0,0
169082,this,0,0
169083,study,0,0
169084,was,0,0
169085,to,0,0
169086,compare,0,0
169087,two,0,0
169088,applied,0,0
169089,behavior,0,1
169090,analysis,0,0
169091,(,0,1
169092,ABA,0,0
169093,),0,1
169094,intervention,0,1
169095,procedures,0,0
169096,",",0,0
169097,a,0,1
169098,naturalistic,0,0
169099,approach,0,0
169100,",",0,0
169101,pivotal,0,0
169102,response,0,0
169103,treatment,0,0
169104,(,0,1
169105,PRT,0,1
169106,),0,1
169107,with,0,1
169108,a,0,1
169109,structured,0,1
169110,ABA,0,0
169111,approach,0,1
169112,in,0,0
169113,a,0,0
169114,school,0,1
169115,setting,0,1
169116,.,0,1
169117,A,0,0
169118,randomized,0,0
169119,clinical,0,0
169120,trial,0,1
169121,design,0,1
169122,using,0,1
169123,two,1,0
169124,groups,1,1
169125,of,1,1
169126,children,1,1
169127,",",1,1
169128,matched,1,1
169129,according,1,0
169130,to,1,0
169131,age,1,1
169132,",",1,0
169133,sex,1,0
169134,and,1,0
169135,mean,1,1
169136,length,1,0
169137,of,1,0
169138,utterance,1,0
169139,was,0,0
169140,used,0,0
169141,to,0,0
169142,compare,0,0
169143,the,0,0
169144,interventions,0,0
169145,.,0,1
169146,The,0,0
169147,data,0,0
169148,showed,0,0
169149,that,0,0
169150,the,0,0
169151,PRT,0,1
169152,approach,0,0
169153,was,0,0
169154,significantly,0,0
169155,more,0,0
169156,effective,0,0
169157,in,0,0
169158,improving,0,0
169159,targeted,0,1
169160,and,0,1
169161,untargeted,0,0
169162,areas,0,0
169163,after,0,1
169164,3,0,1
169165,months,0,1
169166,of,0,1
169167,intervention,0,1
169168,.,0,1
169169,The,0,0
169170,results,0,0
169171,are,0,0
169172,discussed,0,0
169173,in,0,0
169174,terms,0,0
169175,of,0,1
169176,variables,0,0
169177,that,0,0
169178,produce,0,0
169179,more,0,0
169180,rapid,0,1
169181,improvements,0,0
169182,in,0,1
169183,communication,0,0
169184,for,0,1
169185,children,0,1
169186,with,0,1
169187,ASD,0,1
169188,.,0,1
169189,Efficacy,0,0
169190,and,0,0
169191,cost-effectiveness,0,0
169192,of,0,0
169193,an,0,1
169194,experimental,0,1
169195,short-term,0,0
169196,inpatient,0,1
169197,Dialectical,0,1
169198,Behavior,0,1
169199,Therapy,0,1
169200,(,0,1
169201,DBT,0,1
169202,),0,1
169203,program,0,1
169204,:,0,1
169205,study,0,0
169206,protocol,0,0
169207,for,0,0
169208,a,0,1
169209,randomized,0,1
169210,controlled,0,0
169211,trial,0,1
169212,.,0,1
169213,BACKGROUND,0,0
169214,Borderline,1,1
169215,Personality,1,1
169216,Disorder,1,1
169217,(,1,1
169218,BPD,1,0
169219,),1,0
169220,is,0,0
169221,a,0,0
169222,serious,0,0
169223,psychiatric,0,1
169224,condition,0,0
169225,associated,0,0
169226,with,0,1
169227,substantial,0,0
169228,mortality,0,0
169229,",",0,0
169230,burden,0,1
169231,and,0,0
169232,public,0,1
169233,health,0,1
169234,costs,0,1
169235,.,0,1
169236,DBT,0,1
169237,is,0,0
169238,the,0,0
169239,treatment,0,0
169240,model,0,0
169241,with,0,1
169242,the,0,0
169243,largest,0,0
169244,number,0,0
169245,of,0,0
169246,published,0,0
169247,research,0,0
169248,articles,0,0
169249,showing,0,0
169250,effectiveness,0,0
169251,.,0,1
169252,However,0,0
169253,",",0,0
169254,some,0,0
169255,patients,0,1
169256,are,0,0
169257,not,0,0
169258,sufficiently,0,0
169259,engaged,0,0
169260,in,0,0
169261,outpatient,0,1
169262,treatment,0,1
169263,while,0,0
169264,presenting,0,1
169265,severe,0,1
169266,parasuicidal,0,1
169267,behavior,0,0
169268,",",0,0
169269,making,0,0
169270,hospitalization,0,1
169271,necessary,0,0
169272,.,0,1
169273,The,0,0
169274,Center,0,0
169275,for,0,0
169276,Personality,0,1
169277,Disorders,0,1
169278,Jelgersma,0,1
169279,developed,0,1
169280,an,0,0
169281,intensive,0,1
169282,12-week,0,0
169283,inpatient,0,1
169284,DBT,0,1
169285,program,0,1
169286,that,0,0
169287,(,0,1
169288,i,0,1
169289,),0,0
169290,rapidly,0,0
169291,reduces,0,0
169292,core,0,0
169293,borderline,0,1
169294,symptoms,0,1
169295,like,0,0
169296,suicidal,0,1
169297,behavior,0,0
169298,",",0,0
169299,(,0,0
169300,ii,0,0
169301,),0,0
169302,minimizes,0,0
169303,the,0,0
169304,negative,0,0
169305,effects,0,0
169306,of,0,1
169307,an,0,1
169308,inpatient,0,1
169309,setting,0,1
169310,",",0,0
169311,and,0,0
169312,(,0,0
169313,iii,0,1
169314,),0,0
169315,enhances,0,0
169316,compliance,0,0
169317,with,0,1
169318,outpatient,0,1
169319,treatment,0,1
169320,.,0,1
169321,We,0,0
169322,evaluate,0,0
169323,the,0,0
169324,(,0,0
169325,cost-,0,0
169326,),0,1
169327,effectiveness,0,0
169328,of,0,0
169329,this,0,0
169330,experimental,0,0
169331,program,0,1
169332,.,0,1
169333,METHODS/DESIGN,0,0
169334,Seventy,1,1
169335,patients,1,1
169336,",",1,1
169337,aged,1,1
169338,18,1,1
169339,to,1,1
169340,45,1,1
169341,years,1,1
169342,with,1,1
169343,a,1,1
169344,primary,1,1
169345,diagnosis,1,1
169346,of,1,0
169347,BPD,1,0
169348,",",1,0
169349,showing,1,0
169350,a,1,0
169351,chronic,1,1
169352,pattern,1,1
169353,of,1,1
169354,parasuicidal,1,1
169355,gestures,1,1
169356,and/or,1,1
169357,reporting,1,1
169358,high,1,1
169359,degrees,1,1
169360,of,1,1
169361,severity,1,0
169362,of,1,0
169363,other,1,1
169364,borderline,1,1
169365,symptoms,1,0
169366,",",1,0
169367,are,1,0
169368,randomly,1,1
169369,allocated,1,1
169370,to,1,0
169371,the,1,0
169372,control,1,0
169373,and,1,0
169374,intervention,1,1
169375,groups,1,1
169376,.,1,1
169377,Subjects,1,1
169378,in,1,0
169379,the,1,0
169380,control,1,0
169381,group,1,0
169382,receive,1,1
169383,standard,1,0
169384,outpatient,1,1
169385,DBT,1,1
169386,",",1,0
169387,provided,1,0
169388,in,1,0
169389,one,1,1
169390,of,1,1
169391,three,1,1
169392,regular,1,1
169393,mental,1,1
169394,health,1,1
169395,settings,1,1
169396,in,1,1
169397,GGZ,1,1
169398,Rivierduinen,1,1
169399,.,1,1
169400,Subjects,1,1
169401,in,1,0
169402,the,1,0
169403,intervention,1,0
169404,group,1,1
169405,receive,1,1
169406,12,1,0
169407,weeks,1,0
169408,of,1,1
169409,intensified,1,1
169410,inpatient,1,1
169411,DBT,1,1
169412,plus,1,0
169413,six,1,1
169414,months,1,0
169415,of,1,1
169416,standard,1,1
169417,DBT,1,1
169418,",",1,0
169419,provided,1,0
169420,in,1,0
169421,the,1,0
169422,Center,1,1
169423,for,1,0
169424,Personality,1,1
169425,Disorders,1,1
169426,Jelgersma,1,1
169427,.,1,1
169428,The,0,0
169429,primary,0,0
169430,outcome,0,0
169431,is,0,0
169432,the,0,0
169433,number,0,0
169434,of,0,0
169435,suicide,0,1
169436,attempts/self-harming,0,1
169437,acts,0,0
169438,.,0,1
169439,Secondary,0,0
169440,outcomes,0,0
169441,are,0,0
169442,severity,0,0
169443,of,0,0
169444,other,0,1
169445,borderline,0,1
169446,complaints,0,1
169447,",",0,0
169448,quality,0,0
169449,of,0,0
169450,life,0,0
169451,",",0,0
169452,general,0,1
169453,psychopathological,0,1
169454,symptoms,0,1
169455,and,0,1
169456,health,0,1
169457,care,0,1
169458,utilization,0,0
169459,and,0,1
169460,productivity,0,0
169461,costs,0,1
169462,.,0,1
169463,Data,0,1
169464,are,0,0
169465,gathered,0,1
169466,using,0,0
169467,a,0,0
169468,prospective,0,1
169469,",",0,0
169470,two,0,0
169471,(,0,1
169472,group,0,1
169473,:,0,1
169474,intervention,0,0
169475,and,0,0
169476,control,0,1
169477,),0,1
169478,by,0,0
169479,five,0,1
169480,(,0,1
169481,time,0,0
169482,of,0,0
169483,measurement,0,0
169484,),0,1
169485,repeated,0,0
169486,measures,0,0
169487,factorial,0,0
169488,design.Participants,0,1
169489,will,0,0
169490,complete,0,1
169491,three-monthly,0,0
169492,outcome,0,0
169493,assessments,0,0
169494,in,0,0
169495,the,0,0
169496,course,0,0
169497,of,0,0
169498,therapy,0,0
169499,:,0,1
169500,at,0,0
169501,baseline,0,0
169502,",",0,1
169503,and,0,0
169504,12,0,1
169505,",",0,1
169506,24,0,1
169507,",",0,1
169508,36,0,1
169509,and,0,1
169510,52,0,1
169511,weeks,0,0
169512,after,0,1
169513,the,0,0
169514,start,0,1
169515,of,0,0
169516,the,0,0
169517,treatment,0,0
169518,.,0,0
169519,The,0,0
169520,period,0,0
169521,of,0,0
169522,recruitment,0,0
169523,started,0,0
169524,in,0,1
169525,March,0,1
169526,2012,0,1
169527,and,0,0
169528,the,0,0
169529,study,0,0
169530,will,0,0
169531,end,0,0
169532,in,0,0
169533,December,0,1
169534,2014,0,1
169535,.,0,1
169536,DISCUSSION,1,0
169537,Highly,1,1
169538,suicidal,1,1
169539,outpatient,1,1
169540,patients,1,1
169541,can,1,0
169542,pose,0,0
169543,a,0,0
169544,dilemma,0,0
169545,for,0,0
169546,mental,0,1
169547,health,0,1
169548,care,0,1
169549,professionals,0,1
169550,.,0,1
169551,Although,0,0
169552,hospitalization,0,0
169553,seems,0,0
169554,inevitable,0,0
169555,under,0,0
169556,some,0,0
169557,circumstances,0,0
169558,",",0,0
169559,it,0,0
169560,has,0,0
169561,proven,0,0
169562,to,0,0
169563,be,0,0
169564,harmful,0,0
169565,in,0,0
169566,its,0,0
169567,own,0,1
169568,right,0,1
169569,.,0,1
169570,This,0,0
169571,paper,0,0
169572,outlines,0,0
169573,the,0,0
169574,background,0,0
169575,and,0,0
169576,methods,0,1
169577,of,0,0
169578,a,0,1
169579,randomized,0,1
169580,trial,0,0
169581,evaluating,0,0
169582,the,0,0
169583,possible,0,0
169584,surplus,0,0
169585,value,0,0
169586,of,0,0
169587,a,0,1
169588,short-term,0,0
169589,inpatient,0,1
169590,DBT,0,1
169591,program,0,1
169592,.,0,1
169593,The,0,0
169594,effect,0,0
169595,of,0,0
169596,the,0,0
169597,use,0,0
169598,of,0,0
169599,oxytocin,0,0
169600,on,0,0
169601,blood,0,0
169602,loss,0,0
169603,during,0,0
169604,different,0,1
169605,postpartum,0,1
169606,periods,0,0
169607,.,0,1
169608,OBJECTIVE,0,0
169609,Postpartum,1,1
169610,hemorrhage,1,1
169611,is,0,0
169612,the,0,0
169613,most,0,0
169614,important,0,0
169615,reason,0,0
169616,for,0,0
169617,maternal,0,1
169618,mortality,0,0
169619,.,0,1
169620,In,0,0
169621,developed,0,1
169622,countries,0,1
169623,",",0,1
169624,the,0,0
169625,reason,0,0
169626,of,0,0
169627,13,0,1
169628,%,0,0
169629,of,0,1
169630,maternal,0,1
169631,deaths,0,0
169632,is,0,0
169633,postpartum,0,1
169634,hemorrhage,0,0
169635,while,0,0
169636,this,0,0
169637,percentage,0,0
169638,reaches,0,0
169639,more,0,0
169640,than,0,0
169641,30,0,1
169642,%,0,0
169643,in,0,1
169644,other,0,1
169645,countries,0,1
169646,.,0,1
169647,In,0,0
169648,this,0,0
169649,study,0,0
169650,",",0,0
169651,the,0,0
169652,effect,0,0
169653,of,0,0
169654,oxytocin,0,0
169655,use,0,0
169656,in,0,1
169657,different,0,1
169658,times,0,0
169659,at,0,1
169660,the,0,1
169661,3rd,0,1
169662,stage,0,1
169663,of,0,0
169664,delivery,0,1
169665,on,0,0
169666,changes,0,0
169667,in,0,1
169668,the,0,0
169669,postpartum,0,1
169670,hemoglobin,0,0
169671,levels,0,0
169672,was,0,0
169673,compared,0,0
169674,.,0,1
169675,DESIGN,0,0
169676,AND,0,0
169677,SETTING,0,1
169678,In,0,1
169679,the,0,0
169680,study,0,0
169681,",",0,0
169682,89,1,1
169683,pregnant,1,1
169684,women,1,1
169685,to,1,1
169686,whom,1,1
169687,oxytocin,1,1
169688,was,1,1
169689,administered,1,0
169690,after,1,0
169691,placenta,1,1
169692,separation,1,0
169693,were,1,1
169694,studied,1,1
169695,in,1,1
169696,Group,1,1
169697,1,1,1
169698,",",1,1
169699,89,1,1
169700,pregnant,1,1
169701,women,1,1
169702,were,1,1
169703,included,1,1
169704,in,1,1
169705,Group,1,1
169706,2,1,1
169707,",",1,0
169708,and,1,0
169709,oxytocin,1,0
169710,was,1,0
169711,administered,1,0
169712,after,1,0
169713,delivery,1,0
169714,of,1,0
169715,the,1,0
169716,shoulder,1,1
169717,.,1,1
169718,The,0,0
169719,levels,0,0
169720,of,0,0
169721,hemoglobin,0,1
169722,and,0,0
169723,hematocrit,0,0
169724,before,0,0
169725,and,0,0
169726,after,0,1
169727,delivery,0,0
169728,were,0,1
169729,quantified,0,0
169730,.,0,0
169731,RESULTS,0,0
169732,The,0,0
169733,biochemical,0,0
169734,parameters,0,0
169735,were,0,1
169736,examined,0,0
169737,",",0,0
169738,there,0,0
169739,was,0,0
169740,no,0,0
169741,significant,0,0
169742,statistical,0,0
169743,differences,0,0
169744,in,0,1
169745,the,0,1
169746,levels,0,0
169747,of,0,0
169748,hemoglobin,0,1
169749,and,0,0
169750,hemotocrit,0,0
169751,before,0,0
169752,delivery,0,0
169753,between,0,0
169754,the,0,1
169755,two,0,1
169756,groups,0,0
169757,.,0,1
169758,When,0,1
169759,compared,0,0
169760,to,0,0
169761,Group,0,1
169762,1,0,0
169763,",",0,1
169764,?-hemoglobin,0,0
169765,(,0,1
169766,P=,0,1
169767,>,0,1
169768,0.001,0,0
169769,),0,1
169770,",",0,1
169771,?-hematocrit,0,0
169772,(,0,1
169773,P=,0,1
169774,>,0,1
169775,0.001,0,0
169776,),0,1
169777,",",0,0
169778,the,0,0
169779,change,0,0
169780,between,0,0
169781,the,0,0
169782,prepartum,0,0
169783,and,0,0
169784,postpartum,0,1
169785,hemoglobin,0,0
169786,percentage,0,0
169787,(,0,1
169788,P,0,0
169789,<,0,0
169790,=0.001,0,0
169791,),0,1
169792,",",0,0
169793,and,0,0
169794,change,0,0
169795,between,0,0
169796,the,0,0
169797,prepartum,0,0
169798,and,0,0
169799,postpartum,0,1
169800,hemotocrit,0,0
169801,percentage,0,0
169802,(,0,1
169803,P,0,0
169804,<,0,0
169805,=0.001,0,0
169806,),0,1
169807,were,0,0
169808,statistically,0,0
169809,lower,0,0
169810,in,0,0
169811,Group,0,1
169812,2,0,1
169813,.,0,1
169814,CONCLUSIONS,0,0
169815,It,0,0
169816,was,0,0
169817,determined,0,0
169818,that,0,0
169819,the,0,0
169820,use,0,0
169821,of,0,0
169822,oxytocin,0,0
169823,after,0,0
169824,shoulder,0,1
169825,delivery,0,0
169826,has,0,0
169827,more,0,0
169828,effects,0,0
169829,on,0,0
169830,decreasing,0,0
169831,the,0,0
169832,amount,0,0
169833,of,0,0
169834,postpartum,0,1
169835,hemorrhage,0,1
169836,.,0,1
169837,Improving,0,0
169838,adolescent,1,1
169839,social,1,1
169840,competence,1,1
169841,and,1,1
169842,behavior,1,0
169843,:,1,1
169844,a,0,0
169845,randomized,0,1
169846,trial,0,0
169847,of,0,0
169848,an,0,0
169849,11-week,0,1
169850,equine,0,1
169851,facilitated,0,0
169852,learning,0,0
169853,prevention,0,1
169854,program,0,1
169855,.,0,0
169856,There,0,0
169857,is,0,0
169858,growing,0,0
169859,evidence,0,0
169860,that,0,0
169861,promoting,0,0
169862,social,0,0
169863,competence,0,1
169864,in,0,0
169865,youth,1,1
169866,is,0,0
169867,an,0,0
169868,effective,0,0
169869,strategy,0,0
169870,to,0,0
169871,prevent,0,0
169872,mental,0,1
169873,",",0,0
169874,emotional,0,0
169875,",",0,0
169876,and,0,1
169877,behavioral,0,1
169878,disorders,0,1
169879,in,0,1
169880,adulthood,0,1
169881,.,0,1
169882,Research,0,0
169883,suggests,0,0
169884,that,0,0
169885,programs,0,0
169886,delivered,0,1
169887,in,0,1
169888,collaboration,0,1
169889,with,0,1
169890,schools,0,1
169891,are,0,0
169892,particularly,0,0
169893,effective,0,0
169894,when,0,0
169895,they,0,1
169896,target,0,0
169897,social,0,0
169898,and,0,1
169899,emotional,0,0
169900,skill,0,0
169901,building,0,0
169902,",",0,0
169903,utilize,0,0
169904,an,0,0
169905,interactive,0,0
169906,instructional,0,0
169907,style,0,0
169908,",",0,0
169909,provide,0,0
169910,opportunities,0,0
169911,for,0,0
169912,youth,0,1
169913,participation,0,0
169914,and,0,0
169915,self-direction,0,0
169916,",",0,0
169917,and,0,0
169918,include,0,0
169919,explicit,0,0
169920,attempts,0,1
169921,to,0,1
169922,enhance,0,0
169923,youth,0,1
169924,social,0,0
169925,competence,0,0
169926,.,0,1
169927,A,0,0
169928,relatively,0,0
169929,new,0,1
169930,but,0,0
169931,popular,0,0
169932,approach,0,0
169933,that,0,0
169934,incorporates,0,0
169935,these,0,0
169936,characteristics,0,0
169937,is,0,0
169938,human,0,1
169939,animal,0,0
169940,interaction,0,0
169941,",",0,0
169942,which,0,0
169943,can,0,0
169944,be,0,0
169945,implemented,0,0
169946,in,0,0
169947,educational,0,1
169948,settings,0,1
169949,.,0,1
169950,We,0,0
169951,report,0,0
169952,the,0,0
169953,results,0,0
169954,from,0,1
169955,a,0,1
169956,randomized,0,1
169957,clinical,0,0
169958,trial,0,1
169959,examining,0,0
169960,the,0,0
169961,effects,0,0
169962,of,0,0
169963,an,0,1
169964,11-week,0,1
169965,equine,0,1
169966,facilitated,0,0
169967,learning,0,0
169968,(,0,1
169969,EFL,0,1
169970,),0,1
169971,program,0,1
169972,on,0,0
169973,the,0,0
169974,social,0,0
169975,competence,0,0
169976,and,0,0
169977,behavior,0,0
169978,of,0,0
169979,5th-8th,1,1
169980,grade,1,1
169981,children,1,1
169982,.,1,1
169983,Children,1,1
169984,(,1,0
169985,N,1,1
169986,=,1,1
169987,131,1,1
169988,),1,1
169989,were,1,1
169990,recruited,1,1
169991,through,1,0
169992,referral,1,1
169993,by,1,1
169994,school,1,1
169995,counselors,1,1
169996,and,1,1
169997,school-based,1,1
169998,recruitment,1,0
169999,and,1,0
170000,then,1,0
170001,screened,1,1
170002,for,1,0
170003,low,1,1
170004,social,1,1
170005,competence,1,1
170006,.,1,1
170007,Researchers,0,0
170008,randomly,0,1
170009,assigned,0,1
170010,children,0,1
170011,to,0,1
170012,an,0,1
170013,experimental,0,0
170014,(,0,1
170015,n,0,1
170016,=,0,1
170017,53,0,1
170018,),0,1
170019,or,0,1
170020,waitlisted,0,1
170021,control,0,1
170022,group,0,1
170023,(,0,1
170024,n,0,1
170025,=,0,1
170026,60,0,1
170027,),0,1
170028,.,0,1
170029,Children,0,1
170030,in,0,0
170031,the,0,0
170032,experimental,0,0
170033,group,0,0
170034,participated,0,1
170035,in,0,0
170036,an,0,1
170037,11-week,0,1
170038,EFL,0,1
170039,program,0,1
170040,consisting,0,1
170041,of,0,0
170042,once-weekly,0,0
170043,",",0,1
170044,90-min,0,0
170045,sessions,0,0
170046,of,0,1
170047,individual,0,0
170048,and,0,1
170049,team-focused,0,0
170050,activities,0,0
170051,",",0,1
170052,whereas,0,0
170053,children,0,1
170054,in,0,1
170055,the,0,0
170056,control,0,1
170057,group,0,0
170058,served,0,1
170059,as,0,0
170060,a,0,1
170061,wait-listed,0,1
170062,control,0,1
170063,and,0,1
170064,participated,0,1
170065,16,0,1
170066,weeks,0,0
170067,later,0,1
170068,.,0,1
170069,Parents,0,0
170070,of,0,0
170071,children,0,1
170072,in,0,1
170073,both,0,0
170074,groups,0,0
170075,rated,0,1
170076,child,0,1
170077,social,0,0
170078,competence,0,1
170079,at,0,1
170080,pretest,0,0
170081,and,0,1
170082,posttest,0,0
170083,.,0,1
170084,Three,0,1
170085,independent,0,0
170086,raters,0,1
170087,observed,0,0
170088,and,0,1
170089,reported,0,1
170090,children,0,1
170091,'s,0,1
170092,positive,0,1
170093,and,0,1
170094,negative,0,1
170095,behavior,0,0
170096,using,0,0
170097,a,0,0
170098,validated,0,0
170099,checklist,0,0
170100,during,0,0
170101,each,0,0
170102,weekly,0,0
170103,session,0,0
170104,.,0,1
170105,Results,0,0
170106,indicated,0,0
170107,that,0,0
170108,program,0,1
170109,participation,0,0
170110,had,0,1
170111,a,0,0
170112,moderate,0,1
170113,treatment,0,0
170114,effect,0,0
170115,(,0,1
170116,d,0,1
170117,=,0,1
170118,.55,0,0
170119,),0,1
170120,on,0,0
170121,social,0,1
170122,competence,0,1
170123,(,0,1
170124,p,0,0
170125,=,0,1
170126,.02,0,0
170127,),0,1
170128,that,0,0
170129,was,0,0
170130,independent,0,0
170131,of,0,1
170132,pretest,0,1
170133,levels,0,0
170134,",",0,0
170135,age,0,1
170136,",",0,0
170137,gender,0,0
170138,",",0,0
170139,and,0,0
170140,referral,0,1
170141,status,0,1
170142,.,0,1
170143,Results,0,0
170144,showed,0,0
170145,that,0,0
170146,higher,0,0
170147,levels,0,0
170148,of,0,0
170149,program,0,1
170150,attendance,0,0
170151,predicted,0,0
170152,children,0,1
170153,'s,0,1
170154,trajectories,0,1
170155,of,0,1
170156,observed,0,0
170157,positive,0,1
170158,(,0,1
170159,?,0,1
170160,=,0,0
170161,.500,0,0
170162,;,0,1
170163,p,0,0
170164,=,0,1
170165,.003,0,0
170166,),0,1
170167,and,0,1
170168,negative,0,1
170169,behavior,0,0
170170,(,0,1
170171,?,0,1
170172,=,0,0
170173,-.062,0,0
170174,;,0,1
170175,p,0,0
170176,<,0,0
170177,.001,0,0
170178,),0,1
170179,over,0,0
170180,the,0,0
170181,11-week,0,1
170182,program,0,1
170183,.,0,1
170184,Balance,0,0
170185,training,0,0
170186,in,0,1
170187,elderly,1,1
170188,women,1,1
170189,using,1,1
170190,public,1,1
170191,parks,1,1
170192,.,1,1
170193,This,0,0
170194,study,0,0
170195,evaluates,0,0
170196,the,0,0
170197,effects,0,0
170198,of,0,0
170199,a,0,1
170200,balance,0,0
170201,training,0,0
170202,program,0,1
170203,developed,1,1
170204,in,1,1
170205,public,1,1
170206,parks,1,1
170207,on,0,1
170208,functionality,0,0
170209,and,0,1
170210,general,0,1
170211,state,0,1
170212,of,0,0
170213,health,0,1
170214,in,0,1
170215,elderly,1,1
170216,women,1,1
170217,.,1,1
170218,It,0,0
170219,was,0,0
170220,a,0,0
170221,randomized,0,1
170222,controlled,0,0
170223,trial,0,1
170224,.,0,1
170225,Women,1,1
170226,older,1,1
170227,than,1,1
170228,65,1,1
170229,years,1,1
170230,(,1,1
170231,n,1,1
170232,=,1,1
170233,28,1,1
170234,;,1,0
170235,68.5,1,1
170236,?,1,1
170237,2.9,1,0
170238,),1,0
170239,participated,0,1
170240,in,0,0
170241,a,0,0
170242,balance,0,0
170243,training,0,0
170244,program,0,1
170245,that,0,0
170246,lasted,0,1
170247,6,0,0
170248,weeks,0,0
170249,",",0,1
170250,with,0,1
170251,sessions,0,0
170252,taking,0,1
170253,place,0,0
170254,twice,0,0
170255,a,0,0
170256,week,0,0
170257,(,0,0
170258,12,0,1
170259,exercises/session,0,0
170260,",",0,1
170261,50,0,1
170262,min,0,0
170263,),0,1
170264,.,0,1
170265,Balance,0,0
170266,was,0,0
170267,analyzed,0,0
170268,by,0,0
170269,the,0,0
170270,Berg,0,1
170271,Balance,0,0
170272,Scale,0,1
170273,and,0,1
170274,Timed,0,1
170275,Up,0,0
170276,&,0,1
170277,Go,0,1
170278,Test,0,0
170279,.,0,1
170280,The,0,0
170281,generic,0,0
170282,health,0,1
170283,status,0,1
170284,was,0,0
170285,measured,0,0
170286,by,0,0
170287,the,0,0
170288,SF-12,0,0
170289,Health,0,0
170290,Survey,0,1
170291,.,0,1
170292,These,0,1
170293,tests,0,0
170294,showed,0,0
170295,statistically,0,0
170296,significant,0,0
170297,differences,0,0
170298,in,0,1
170299,the,0,1
170300,experimental,0,0
170301,group,0,1
170302,(,0,1
170303,p,0,0
170304,<,0,0
170305,.05,0,0
170306,),0,1
170307,.,0,1
170308,Public,1,1
170309,parks,1,1
170310,are,0,0
170311,adequate,0,0
170312,installations,0,0
170313,for,0,1
170314,developing,0,1
170315,balance,0,0
170316,.,0,1
170317,Video-feedback,0,0
170318,Intervention,0,1
170319,to,0,0
170320,promote,0,0
170321,Positive,0,1
170322,Parenting,0,0
170323,adapted,0,0
170324,to,0,1
170325,Autism,0,1
170326,(,0,1
170327,VIPP-AUTI,0,1
170328,),0,1
170329,:,0,1
170330,A,0,1
170331,randomized,0,1
170332,controlled,0,0
170333,trial,0,0
170334,.,0,1
170335,In,0,0
170336,a,0,0
170337,randomized,0,1
170338,controlled,0,0
170339,trial,0,0
170340,",",0,0
170341,we,0,0
170342,evaluated,0,0
170343,the,0,0
170344,early,0,1
170345,intervention,0,0
170346,program,0,1
170347,Video-feedback,0,0
170348,Intervention,0,1
170349,to,0,0
170350,promote,0,0
170351,Positive,1,1
170352,Parenting,1,0
170353,adapted,1,0
170354,to,1,1
170355,Autism,1,1
170356,(,1,1
170357,VIPP-AUTI,1,1
170358,),1,1
170359,with,1,1
170360,78,1,1
170361,primary,1,1
170362,caregivers,1,1
170363,and,1,1
170364,their,1,1
170365,child,1,1
170366,(,1,1
170367,16-61,1,1
170368,months,1,1
170369,),1,1
170370,with,1,1
170371,Autism,1,1
170372,Spectrum,1,1
170373,Disorder,1,1
170374,.,1,1
170375,VIPP-AUTI,0,0
170376,is,0,0
170377,a,0,0
170378,brief,0,0
170379,attachment-based,0,0
170380,intervention,0,0
170381,program,0,1
170382,",",0,0
170383,focusing,0,0
170384,on,0,0
170385,improving,0,0
170386,parent-child,0,1
170387,interaction,0,0
170388,and,0,0
170389,reducing,0,0
170390,the,0,0
170391,child,0,1
170392,'s,0,1
170393,individual,0,0
170394,Autism,0,1
170395,Spectrum,0,1
170396,Disorder-related,0,0
170397,symptomatology,0,1
170398,in,0,1
170399,five,0,1
170400,home,0,1
170401,visits,0,1
170402,.,0,1
170403,VIPP-AUTI,0,0
170404,",",0,0
170405,as,0,0
170406,compared,0,0
170407,with,0,1
170408,usual,0,1
170409,care,0,1
170410,",",0,0
170411,demonstrated,0,0
170412,efficacy,0,0
170413,in,0,0
170414,reducing,0,0
170415,parental,0,1
170416,intrusiveness,0,0
170417,.,0,1
170418,Moreover,0,0
170419,",",0,1
170420,parents,0,1
170421,who,0,1
170422,received,0,1
170423,VIPP-AUTI,0,1
170424,showed,0,0
170425,increased,0,0
170426,feelings,0,0
170427,of,0,1
170428,self-efficacy,0,0
170429,in,0,0
170430,child,0,1
170431,rearing,0,1
170432,.,0,1
170433,No,0,0
170434,significant,0,0
170435,group,0,1
170436,differences,0,0
170437,were,0,1
170438,found,0,0
170439,on,0,0
170440,other,0,1
170441,aspects,0,0
170442,of,0,1
170443,parent-child,0,1
170444,interaction,0,0
170445,or,0,1
170446,on,0,0
170447,child,0,1
170448,play,0,0
170449,behavior,0,0
170450,.,0,1
170451,At,0,0
170452,3-months,0,0
170453,follow-up,0,0
170454,",",0,1
170455,intervention,0,0
170456,effects,0,0
170457,were,0,1
170458,found,0,0
170459,on,0,0
170460,child-initiated,0,0
170461,joint,0,1
170462,attention,0,0
170463,skills,0,0
170464,",",0,0
170465,not,0,0
170466,mediated,0,0
170467,by,0,0
170468,intervention,0,1
170469,effects,0,0
170470,on,0,0
170471,parenting,0,1
170472,.,0,1
170473,Implementation,0,0
170474,of,0,0
170475,VIPP-AUTI,0,1
170476,in,0,1
170477,clinical,0,0
170478,practice,0,0
170479,is,0,0
170480,facilitated,0,0
170481,by,0,0
170482,the,0,0
170483,use,0,0
170484,of,0,0
170485,a,0,1
170486,detailed,0,1
170487,manual,0,0
170488,and,0,0
170489,a,0,0
170490,relatively,0,0
170491,brief,0,0
170492,training,0,0
170493,of,0,1
170494,interveners,0,1
170495,.,0,1
170496,36-month,0,1
170497,treatment,0,0
170498,experience,0,1
170499,of,0,1
170500,two,0,1
170501,doses,0,0
170502,of,0,1
170503,leuprolide,0,1
170504,acetate,0,0
170505,3-month,0,0
170506,depot,0,1
170507,for,0,1
170508,children,1,1
170509,with,1,1
170510,central,1,1
170511,precocious,1,1
170512,puberty,1,1
170513,.,1,1
170514,CONTEXT,0,0
170515,We,0,0
170516,have,0,0
170517,recently,0,1
170518,demonstrated,0,0
170519,short-term,0,0
170520,(,0,1
170521,6-month,0,1
170522,),0,1
170523,efficacy,0,0
170524,and,0,0
170525,safety,0,0
170526,of,0,0
170527,leuprolide,0,0
170528,acetate,0,0
170529,3-month,0,1
170530,depot,0,1
170531,11.25,0,0
170532,and,0,1
170533,30,0,1
170534,mg,0,1
170535,in,0,1
170536,children,1,1
170537,with,1,1
170538,central,1,1
170539,precocious,1,1
170540,puberty,1,1
170541,(,1,1
170542,CPP,1,1
170543,),1,1
170544,.,1,1
170545,OBJECTIVE,0,0
170546,To,0,0
170547,assess,0,0
170548,long-term,0,0
170549,(,0,1
170550,36-month,0,1
170551,),0,1
170552,hypothalamic-pituitary-gonadal,0,1
170553,axis,0,0
170554,suppression,0,0
170555,and,0,0
170556,safety,0,0
170557,of,0,0
170558,leuprolide,0,0
170559,acetate,0,0
170560,3-month,0,1
170561,depot,0,1
170562,11.25,0,0
170563,and,0,1
170564,30,0,1
170565,mg,0,1
170566,in,0,1
170567,children,1,1
170568,with,1,1
170569,CPP,1,1
170570,.,1,1
170571,DESIGN,0,0
170572,Open-label,0,0
170573,",",0,0
170574,36-month,0,0
170575,extension,0,0
170576,.,0,1
170577,SETTING,0,1
170578,Twenty,1,1
170579,pediatric,1,1
170580,endocrine,1,1
170581,centers,1,1
170582,.,1,1
170583,PATIENTS,0,0
170584,Seventy-two,1,1
170585,children,1,1
170586,(,1,1
170587,mean,1,1
170588,age,1,1
170589,",",1,1
170590,8.5,1,0
170591,?,1,1
170592,1.6,1,0
170593,y,1,1
170594,;,1,1
170595,65,1,1
170596,females,1,1
170597,),1,1
170598,with,1,1
170599,CPP,1,1
170600,completed,1,1
170601,and,1,0
170602,showed,1,0
170603,maintenance,1,0
170604,of,1,0
170605,LH,1,1
170606,suppression,1,0
170607,after,1,0
170608,a,1,1
170609,6-month,1,0
170610,lead-in,1,0
170611,study,1,1
170612,.,1,1
170613,INTERVENTION,0,0
170614,Leuprolide,0,0
170615,acetate,0,0
170616,depot,0,0
170617,(,0,1
170618,11.25,0,0
170619,or,0,1
170620,30,0,1
170621,mg,0,1
170622,),0,1
170623,administered,0,0
170624,im,0,1
170625,every,0,0
170626,3,0,1
170627,months,0,0
170628,.,0,1
170629,MAIN,0,0
170630,OUTCOME,0,1
170631,MEASURES,0,1
170632,Peak-stimulated,0,0
170633,LH,0,1
170634,",",0,0
170635,estradiol,0,0
170636,",",0,0
170637,T,0,1
170638,",",0,0
170639,growth,0,0
170640,rate,0,0
170641,",",0,0
170642,pubertal,0,1
170643,progression,0,0
170644,",",0,0
170645,and,0,0
170646,adverse,0,0
170647,events,0,0
170648,(,0,1
170649,AEs,0,1
170650,),0,1
170651,.,0,1
170652,RESULTS,0,0
170653,Twenty-nine,0,1
170654,of,0,1
170655,34,0,1
170656,subjects,0,1
170657,in,0,1
170658,the,0,1
170659,11.25-mg,0,0
170660,group,0,1
170661,and,0,1
170662,36,0,1
170663,of,0,1
170664,38,0,1
170665,subjects,0,1
170666,in,0,1
170667,the,0,1
170668,30-mg,0,0
170669,group,0,1
170670,had,0,1
170671,LH,0,1
170672,values,0,0
170673,<,0,0
170674,4,0,0
170675,mIU/mL,0,1
170676,after,0,1
170677,day,0,1
170678,1,0,1
170679,at,0,0
170680,all,0,1
170681,time,0,0
170682,points,0,0
170683,.,0,1
170684,All,0,1
170685,seven,0,1
170686,subjects,0,1
170687,who,0,1
170688,escaped,0,1
170689,LH,0,1
170690,suppression,0,0
170691,at,0,0
170692,any,0,0
170693,time,0,0
170694,still,0,0
170695,maintained,0,0
170696,sex,0,0
170697,steroid,0,0
170698,concentrations,0,0
170699,at,0,1
170700,prepubertal,0,1
170701,levels,0,1
170702,and,0,1
170703,showed,0,0
170704,no,0,0
170705,signs,0,0
170706,of,0,0
170707,pubertal,0,1
170708,progression,0,1
170709,.,0,1
170710,AEs,0,0
170711,were,0,0
170712,comparable,0,0
170713,between,0,0
170714,groups,0,0
170715,",",0,1
170716,with,0,1
170717,injection,0,0
170718,site,0,0
170719,pain,0,1
170720,being,0,1
170721,the,0,0
170722,most,0,0
170723,common,0,0
170724,(,0,1
170725,26.4,0,1
170726,%,0,0
170727,overall,0,0
170728,),0,1
170729,.,0,1
170730,No,0,0
170731,AE,0,0
170732,led,0,0
170733,to,0,0
170734,discontinuation,0,0
170735,of,0,0
170736,study,0,1
170737,drug,0,1
170738,.,0,1
170739,The,0,0
170740,safety,0,0
170741,profile,0,0
170742,over,0,0
170743,36,0,1
170744,months,0,1
170745,was,0,0
170746,comparable,0,0
170747,to,0,1
170748,that,0,0
170749,observed,0,0
170750,during,0,0
170751,the,0,0
170752,6-month,0,0
170753,pivotal,0,0
170754,study,0,1
170755,.,0,0
170756,CONCLUSIONS,0,0
170757,The,0,0
170758,two,0,0
170759,doses,0,0
170760,of,0,1
170761,leuprolide,0,1
170762,acetate,0,0
170763,3-month,0,1
170764,depot,0,0
170765,were,0,1
170766,associated,0,0
170767,with,0,1
170768,an,0,0
170769,acceptable,0,0
170770,safety,0,0
170771,profile,0,0
170772,and,0,0
170773,provided,0,0
170774,maintenance,0,0
170775,of,0,0
170776,LH,0,1
170777,suppression,0,0
170778,in,0,0
170779,the,0,0
170780,majority,0,1
170781,of,0,0
170782,children,0,1
170783,with,0,1
170784,CPP,0,1
170785,during,0,1
170786,the,0,1
170787,36,0,1
170788,months,0,0
170789,of,0,1
170790,the,0,0
170791,study,0,0
170792,or,0,1
170793,until,0,0
170794,readiness,0,0
170795,for,0,1
170796,puberty,0,1
170797,.,0,1
170798,A,0,0
170799,randomized,0,0
170800,",",0,0
170801,phase,0,1
170802,II,0,1
170803,study,0,1
170804,of,0,0
170805,afatinib,0,0
170806,versus,0,0
170807,cetuximab,0,0
170808,in,0,0
170809,metastatic,1,1
170810,or,1,1
170811,recurrent,1,1
170812,squamous,1,1
170813,cell,1,1
170814,carcinoma,1,1
170815,of,1,0
170816,the,1,0
170817,head,1,1
170818,and,1,0
170819,neck,1,1
170820,.,1,1
170821,BACKGROUND,0,0
170822,Afatinib,0,0
170823,is,0,0
170824,an,0,0
170825,oral,0,0
170826,",",0,0
170827,irreversible,0,0
170828,ErbB,0,0
170829,family,0,1
170830,blocker,0,0
170831,that,0,0
170832,has,0,0
170833,shown,0,0
170834,activity,0,0
170835,in,0,0
170836,epidermal,0,1
170837,growth,0,0
170838,factor,0,0
170839,receptor,0,0
170840,(,0,1
170841,EGFR,0,0
170842,),0,1
170843,-mutated,0,1
170844,lung,0,1
170845,cancer,0,1
170846,.,0,1
170847,We,0,0
170848,hypothesized,0,0
170849,that,0,0
170850,the,0,0
170851,agent,0,0
170852,would,0,0
170853,have,0,0
170854,greater,0,0
170855,antitumor,0,0
170856,activity,0,0
170857,compared,0,0
170858,with,0,1
170859,cetuximab,0,0
170860,in,0,0
170861,recurrent,1,1
170862,or,1,1
170863,metastatic,1,1
170864,(,1,1
170865,R/M,1,1
170866,),1,1
170867,head,1,1
170868,and,1,1
170869,neck,1,1
170870,squamous,1,1
170871,cell,1,1
170872,carcinoma,1,1
170873,(,1,1
170874,HNSCC,1,1
170875,),1,1
170876,patients,1,1
170877,",",1,1
170878,whose,1,1
170879,disease,1,1
170880,has,1,1
170881,progressed,1,1
170882,after,1,0
170883,platinum-containing,1,1
170884,therapy,1,1
170885,.,1,1
170886,PATIENTS,0,0
170887,AND,0,0
170888,METHODS,0,0
170889,An,0,0
170890,open-label,0,0
170891,",",0,0
170892,randomized,0,0
170893,",",0,0
170894,phase,0,1
170895,II,0,1
170896,trial,0,0
170897,was,0,0
170898,conducted,0,1
170899,in,0,1
170900,43,1,1
170901,centers,1,1
170902,;,1,1
170903,124,1,1
170904,patients,1,1
170905,were,0,1
170906,randomized,0,1
170907,(,0,1
170908,1,0,1
170909,:,0,1
170910,1,0,1
170911,),0,1
170912,to,0,0
170913,either,0,1
170914,afatinib,0,0
170915,(,0,0
170916,50,0,1
170917,mg/day,0,1
170918,),0,1
170919,or,0,1
170920,cetuximab,0,0
170921,(,0,1
170922,250,0,0
170923,mg/m,0,1
170924,(,0,1
170925,2,0,1
170926,),0,1
170927,/week,0,0
170928,),0,1
170929,until,0,1
170930,disease,0,1
170931,progression,0,1
170932,or,0,1
170933,intolerable,0,1
170934,adverse,0,0
170935,events,0,0
170936,(,0,1
170937,AEs,0,1
170938,),0,1
170939,(,0,1
170940,stage,0,1
170941,I,0,1
170942,),0,0
170943,",",0,0
170944,with,0,1
170945,optional,0,0
170946,crossover,0,1
170947,(,0,1
170948,stage,0,1
170949,II,0,1
170950,),0,1
170951,.,0,1
170952,The,0,0
170953,primary,0,0
170954,end,0,0
170955,point,0,0
170956,was,0,0
170957,tumor,0,1
170958,shrinkage,0,0
170959,before,0,0
170960,crossover,0,0
170961,assessed,0,0
170962,by,0,0
170963,investigator,0,0
170964,(,0,1
170965,IR,0,1
170966,),0,1
170967,and,0,1
170968,independent,0,0
170969,central,0,1
170970,review,0,1
170971,(,0,1
170972,ICR,0,1
170973,),0,1
170974,.,0,1
170975,RESULTS,0,0
170976,A,1,0
170977,total,1,1
170978,of,1,0
170979,121,1,1
170980,patients,1,1
170981,were,1,1
170982,treated,1,1
170983,(,1,1
170984,61,1,1
170985,afatinib,1,0
170986,",",1,1
170987,60,1,1
170988,cetuximab,1,0
170989,),1,1
170990,and,1,1
170991,68,1,1
170992,crossed,1,0
170993,over,1,0
170994,to,1,0
170995,stage,1,1
170996,II,1,1
170997,(,1,1
170998,32,1,1
170999,and,1,1
171000,36,1,1
171001,respectively,1,0
171002,),1,1
171003,.,1,1
171004,In,0,0
171005,stage,0,1
171006,I,0,1
171007,",",0,0
171008,mean,0,1
171009,tumor,0,1
171010,shrinkage,0,0
171011,by,0,0
171012,IR/ICR,0,1
171013,was,0,0
171014,10.4,0,0
171015,%,0,0
171016,/16.6,0,0
171017,%,0,0
171018,with,0,1
171019,afatinib,0,0
171020,and,0,1
171021,5.4,0,0
171022,%,0,0
171023,/10.1,0,1
171024,%,0,0
171025,with,0,1
171026,cetuximab,0,0
171027,(,0,1
171028,P,0,0
171029,=,0,1
171030,0.46/0.30,0,0
171031,),0,1
171032,.,0,1
171033,Objective,0,0
171034,response,0,0
171035,rate,0,0
171036,was,0,0
171037,16.1,0,0
171038,%,0,0
171039,/8.1,0,0
171040,%,0,0
171041,with,0,1
171042,afatinib,0,0
171043,and,0,1
171044,6.5,0,0
171045,%,0,0
171046,/9.7,0,0
171047,%,0,0
171048,with,0,1
171049,cetuximab,0,0
171050,(,0,1
171051,IR/ICR,0,1
171052,),0,1
171053,.,0,1
171054,Comparable,0,0
171055,disease,0,1
171056,control,0,1
171057,rates,0,0
171058,were,0,1
171059,observed,0,0
171060,with,0,1
171061,afatinib,0,0
171062,(,0,1
171063,50,0,1
171064,%,0,0
171065,),0,1
171066,and,0,0
171067,cetuximab,0,0
171068,(,0,1
171069,56.5,0,1
171070,%,0,0
171071,),0,1
171072,by,0,0
171073,IR,0,1
171074,;,0,1
171075,similar,0,0
171076,results,0,0
171077,were,0,1
171078,seen,0,1
171079,by,0,0
171080,ICR,0,1
171081,.,0,1
171082,Most,0,0
171083,common,0,0
171084,grade,0,1
171085,?3,0,1
171086,drug-related,0,1
171087,AEs,0,0
171088,(,0,1
171089,DRAEs,0,1
171090,),0,1
171091,were,0,1
171092,rash/acne,0,1
171093,(,0,1
171094,18,0,1
171095,%,0,0
171096,versus,0,0
171097,8.3,0,0
171098,%,0,0
171099,),0,1
171100,",",0,0
171101,diarrhea,0,1
171102,(,0,1
171103,14.8,0,0
171104,%,0,0
171105,versus,0,0
171106,0,0,0
171107,%,0,0
171108,),0,1
171109,",",0,0
171110,and,0,0
171111,stomatitis/mucositis,0,1
171112,(,0,1
171113,11.5,0,0
171114,%,0,0
171115,versus,0,0
171116,0,0,0
171117,%,0,0
171118,),0,1
171119,with,0,1
171120,afatinib,0,0
171121,and,0,0
171122,cetuximab,0,0
171123,",",0,0
171124,respectively,0,0
171125,.,0,1
171126,Patients,0,1
171127,with,0,1
171128,DRAEs,0,1
171129,leading,0,0
171130,to,0,0
171131,treatment,0,0
171132,discontinuation,0,0
171133,were,0,1
171134,23,0,1
171135,%,0,0
171136,with,0,1
171137,afatinib,0,0
171138,and,0,1
171139,5,0,0
171140,%,0,0
171141,with,0,1
171142,cetuximab,0,0
171143,.,0,1
171144,In,0,0
171145,stage,0,1
171146,II,0,1
171147,",",0,0
171148,disease,0,1
171149,control,0,0
171150,rate,0,0
171151,(,0,1
171152,IR/ICR,0,1
171153,),0,1
171154,was,0,0
171155,38.9,0,0
171156,%,0,0
171157,/33.3,0,0
171158,%,0,0
171159,with,0,1
171160,afatinib,0,0
171161,and,0,1
171162,18.8,0,1
171163,%,0,0
171164,/18.8,0,0
171165,%,0,0
171166,with,0,1
171167,cetuximab,0,0
171168,.,0,1
171169,CONCLUSION,0,0
171170,Afatinib,0,0
171171,showed,0,0
171172,antitumor,0,0
171173,activity,0,0
171174,comparable,0,0
171175,to,0,0
171176,cetuximab,0,0
171177,in,0,0
171178,R/M,1,1
171179,HNSCC,1,1
171180,in,1,0
171181,this,0,0
171182,exploratory,0,1
171183,phase,0,1
171184,II,0,1
171185,trial,0,0
171186,",",0,0
171187,although,0,0
171188,more,0,0
171189,patients,0,1
171190,on,0,0
171191,afatinib,0,1
171192,discontinued,0,0
171193,treatment,0,1
171194,due,0,0
171195,to,0,1
171196,AEs,0,0
171197,.,0,1
171198,Sequential,0,0
171199,EGFR/ErbB,0,0
171200,treatment,0,0
171201,with,0,1
171202,afatinib,0,0
171203,and,0,1
171204,cetuximab,0,0
171205,provided,0,0
171206,sustained,0,1
171207,clinical,0,0
171208,benefit,0,0
171209,in,0,1
171210,patients,0,1
171211,after,0,1
171212,crossover,0,1
171213,",",0,0
171214,suggesting,0,0
171215,a,0,0
171216,lack,0,0
171217,of,0,0
171218,cross-resistance,0,0
171219,.,0,1
171220,[,0,1
171221,Mitomycin,0,0
171222,C,0,1
171223,plus,0,0
171224,HCFU,0,1
171225,adjuvant,0,1
171226,chemotherapy,0,0
171227,for,0,0
171228,noncuratively,0,1
171229,resected,0,1
171230,cases,0,1
171231,of,0,1
171232,colorectal,0,1
171233,carcinoma,0,1
171234,.,0,1
171235,(,0,0
171236,Second,0,0
171237,report,0,1
171238,),0,1
171239,:,0,1
171240,5-year,0,1
171241,survival,0,0
171242,rate,0,0
171243,.,0,1
171244,Cooperative,0,1
171245,Study,0,0
171246,Group,0,1
171247,of,0,1
171248,Kyushu,0,1
171249,and,0,1
171250,Chugoku,0,1
171251,for,0,1
171252,HCFU,0,1
171253,Adjuvant,0,1
171254,Chemotherapy,0,1
171255,],0,1
171256,.,0,1
171257,In,0,0
171258,order,0,0
171259,to,0,0
171260,examine,0,0
171261,the,0,0
171262,efficacy,0,0
171263,of,0,0
171264,adjuvant,0,1
171265,chemotherapy,0,1
171266,employing,0,0
171267,mitomycin,0,0
171268,C,0,1
171269,(,0,1
171270,MMC,0,1
171271,),0,1
171272,and,0,0
171273,carmofur,0,1
171274,(,0,1
171275,HCFU,0,1
171276,),0,1
171277,for,1,0
171278,patients,1,1
171279,with,1,1
171280,noncuratively,1,1
171281,resected,1,1
171282,colorectal,1,1
171283,carcinoma,1,1
171284,",",0,0
171285,a,0,0
171286,cooperative,0,1
171287,study,0,1
171288,was,0,0
171289,performed,0,0
171290,by,0,0
171291,54,1,1
171292,institutions,1,1
171293,in,1,1
171294,the,1,1
171295,Kyushu,1,1
171296,and,1,1
171297,Chugoku,1,1
171298,areas,1,0
171299,of,1,1
171300,Japan,1,1
171301,.,1,1
171302,The,1,0
171303,criteria,1,1
171304,for,1,0
171305,patient,1,1
171306,selection,1,1
171307,were,1,0
171308,as,1,0
171309,follows,1,0
171310,:,1,1
171311,1,1,0
171312,),1,1
171313,Age,1,0
171314,of,1,1
171315,75,1,1
171316,years,1,1
171317,or,1,1
171318,less,1,0
171319,and,1,0
171320,not,1,0
171321,accompanied,1,0
171322,by,1,0
171323,any,1,0
171324,serious,1,0
171325,disease,1,1
171326,.,1,1
171327,2,1,0
171328,),1,1
171329,Macroscopic,1,0
171330,diagnosis,1,1
171331,as,1,0
171332,being,1,1
171333,noncuratively,1,1
171334,resected,1,1
171335,on,1,0
171336,completion,1,0
171337,of,1,0
171338,the,1,0
171339,surgical,1,1
171340,procedure,1,0
171341,.,1,1
171342,3,1,0
171343,),1,0
171344,Definitive,1,0
171345,diagnosis,1,1
171346,of,1,0
171347,colorectal,1,1
171348,carcinomas,1,1
171349,",",1,0
171350,histologically,1,1
171351,.,1,1
171352,4,1,0
171353,),1,0
171354,No,1,0
171355,synchronous,1,1
171356,or,1,1
171357,metachronous,1,1
171358,double,1,0
171359,cancer,1,1
171360,.,1,1
171361,The,0,0
171362,prospective,0,0
171363,randomized,0,1
171364,controlled,0,0
171365,study,0,0
171366,consisted,0,1
171367,of,0,1
171368,two,0,1
171369,groups,0,1
171370,.,0,1
171371,In,0,0
171372,Group,0,1
171373,A,0,1
171374,",",0,0
171375,the,0,0
171376,MMC,1,0
171377,group,1,0
171378,received,0,0
171379,bolus,0,0
171380,intravenous,0,1
171381,injections,0,0
171382,of,0,1
171383,20,0,1
171384,mg,0,1
171385,MMC,0,1
171386,on,0,0
171387,the,0,0
171388,day,0,0
171389,of,0,0
171390,operation,0,1
171391,and,0,1
171392,10,0,1
171393,mg,0,0
171394,the,0,0
171395,next,0,0
171396,day,0,0
171397,",",0,0
171398,followed,0,0
171399,by,0,0
171400,10,0,1
171401,mg,0,1
171402,every,0,1
171403,4,0,0
171404,weeks,0,0
171405,until,0,1
171406,a,0,1
171407,total,0,1
171408,of,0,0
171409,100,0,1
171410,mg,0,1
171411,had,0,1
171412,been,0,1
171413,administered,0,0
171414,.,0,1
171415,In,0,0
171416,Group,0,1
171417,B,0,1
171418,",",0,0
171419,the,0,0
171420,MMC,0,0
171421,+,0,0
171422,HCFU,0,1
171423,group,0,1
171424,received,0,1
171425,the,0,0
171426,same,0,0
171427,treatment,0,0
171428,in,0,1
171429,Group,0,1
171430,A,0,1
171431,",",0,0
171432,but,0,0
171433,with,0,1
171434,the,0,0
171435,addition,0,0
171436,of,0,0
171437,600,0,1
171438,mg/day,0,0
171439,of,0,0
171440,HCFU,0,1
171441,from,0,1
171442,the,0,0
171443,second,0,0
171444,week,0,0
171445,",",0,0
171446,orally,0,0
171447,for,0,0
171448,at,0,0
171449,least,0,1
171450,one,0,1
171451,year,0,1
171452,.,0,1
171453,Concerning,0,0
171454,the,0,0
171455,69-month,0,1
171456,survival,0,0
171457,rate,0,0
171458,",",0,0
171459,a,0,0
171460,better,0,0
171461,result,0,0
171462,was,0,0
171463,observed,0,0
171464,in,0,0
171465,the,0,0
171466,MMC,0,0
171467,+,0,0
171468,HCFU,0,1
171469,group,0,1
171470,than,0,0
171471,in,0,0
171472,the,0,0
171473,MMC,0,0
171474,only,0,0
171475,group,0,1
171476,(,0,0
171477,generalized,0,1
171478,Wilcoxon,0,0
171479,test,0,0
171480,:,0,1
171481,p,0,0
171482,less,0,0
171483,than,0,0
171484,0.05,0,0
171485,),0,1
171486,.,0,1
171487,Significantly,0,0
171488,better,0,0
171489,survival,0,0
171490,rates,0,0
171491,were,0,1
171492,obtained,0,0
171493,in,0,0
171494,those,0,1
171495,cases,0,1
171496,with,0,1
171497,disseminating,0,1
171498,peritoneal,0,1
171499,metastasis,0,1
171500,",",0,0
171501,hepatic,0,0
171502,metastasis,0,1
171503,and,0,1
171504,stage,0,1
171505,V,0,0
171506,cancer,0,1
171507,in,0,0
171508,the,0,0
171509,MMC,0,0
171510,+,0,0
171511,HCFU,0,1
171512,group,0,0
171513,as,0,0
171514,when,0,0
171515,compared,0,0
171516,with,0,0
171517,the,0,0
171518,MMC,0,0
171519,only,0,0
171520,group,0,1
171521,.,0,0
171522,No,0,0
171523,significant,0,0
171524,side,0,0
171525,effects,0,0
171526,due,0,1
171527,to,0,1
171528,the,0,0
171529,combined,0,0
171530,administration,0,0
171531,of,0,1
171532,HCFU,0,1
171533,were,0,1
171534,recognized,0,1
171535,.,0,1
171536,The,0,0
171537,combined,0,0
171538,administration,0,0
171539,of,0,1
171540,MMC,0,1
171541,and,0,1
171542,HCFU,0,1
171543,was,0,0
171544,suggested,0,0
171545,to,0,0
171546,be,0,0
171547,a,0,0
171548,safe,0,0
171549,and,0,0
171550,effective,0,0
171551,adjuvant,0,1
171552,chemotherapy,0,1
171553,for,0,0
171554,noncuratively,0,1
171555,resected,0,1
171556,cases,0,1
171557,of,0,1
171558,colorectal,0,1
171559,carcinoma,0,1
171560,.,0,1
171561,Self-management,0,0
171562,improvement,0,0
171563,program,0,1
171564,combined,0,0
171565,with,0,1
171566,community,0,1
171567,involvement,0,1
171568,in,0,0
171569,Thai,1,1
171570,hypertensive,1,1
171571,population,1,1
171572,:,1,1
171573,an,0,0
171574,action,0,0
171575,research,0,1
171576,.,0,1
171577,OBJECTIVE,0,0
171578,To,0,0
171579,investigate,0,0
171580,the,0,0
171581,effectiveness,0,0
171582,of,0,0
171583,a,0,1
171584,program,0,0
171585,that,0,0
171586,utilizes,0,0
171587,community,0,0
171588,involvement,0,0
171589,to,0,0
171590,improve,0,0
171591,the,0,0
171592,self-management,0,0
171593,strategies,0,0
171594,among,0,1
171595,people,1,1
171596,living,1,1
171597,with,1,1
171598,hypertension,1,1
171599,.,1,1
171600,MATERIAL,0,0
171601,AND,0,0
171602,METHOD,0,1
171603,Forty-four,1,1
171604,subjects,1,1
171605,",",1,1
171606,aged,1,1
171607,35,1,1
171608,to,1,1
171609,59-year-old,1,1
171610,",",1,0
171611,with,1,1
171612,hypertension,1,1
171613,in,1,1
171614,Nakhon,1,1
171615,Pathom,1,1
171616,Province,1,1
171617,",",1,0
171618,Thailand,1,1
171619,",",0,0
171620,were,0,0
171621,randomly,0,1
171622,allocated,0,1
171623,to,0,0
171624,either,0,0
171625,an,0,0
171626,experimental,0,0
171627,group,0,1
171628,(,0,1
171629,n,0,1
171630,=,0,1
171631,22,0,1
171632,),0,1
171633,or,0,1
171634,a,0,0
171635,control,0,0
171636,group,0,0
171637,(,0,1
171638,n,0,1
171639,=,0,1
171640,20,0,1
171641,),0,1
171642,.,0,1
171643,The,0,0
171644,experimental,0,0
171645,group,0,0
171646,attended,0,1
171647,a,0,0
171648,program,0,0
171649,to,0,0
171650,improve,0,0
171651,self-management,0,1
171652,methods,0,1
171653,based,0,1
171654,on,0,1
171655,social,0,1
171656,cognitive,0,1
171657,theory,0,1
171658,(,0,1
171659,SCT,0,1
171660,),0,1
171661,.,0,1
171662,The,0,0
171663,program,0,0
171664,lasted,0,0
171665,12,0,1
171666,weeks,0,0
171667,",",0,1
171668,consisted,0,1
171669,of,0,0
171670,1,0,1
171671,1/2,0,1
171672,hours,0,0
171673,meeting,0,1
171674,once,0,0
171675,a,0,0
171676,week,0,0
171677,",",0,0
171678,including,0,0
171679,group,0,1
171680,meetings,0,1
171681,and,0,1
171682,home,0,1
171683,visit,0,0
171684,monitoring,0,0
171685,.,0,1
171686,Mann-Whitney,0,0
171687,U,0,0
171688,test,0,0
171689,and,0,1
171690,Friedman,0,0
171691,test,0,0
171692,were,0,1
171693,employed,0,0
171694,to,0,0
171695,analyze,0,0
171696,the,0,0
171697,program,0,0
171698,'s,0,1
171699,effectiveness,0,0
171700,.,0,1
171701,RESULTS,0,0
171702,After,0,0
171703,the,0,0
171704,program,0,0
171705,",",0,0
171706,the,0,0
171707,mean,0,0
171708,rank,0,0
171709,of,0,0
171710,the,0,0
171711,perceived,0,0
171712,self-efficacy,0,0
171713,for,0,0
171714,the,0,0
171715,self-management,0,1
171716,strategies,0,0
171717,was,0,0
171718,statistically,0,0
171719,different,0,0
171720,between,0,0
171721,the,0,1
171722,two,0,1
171723,groups,0,0
171724,(,0,1
171725,p,0,0
171726,=,0,1
171727,0.023,0,0
171728,),0,1
171729,.,0,1
171730,In,0,0
171731,the,0,0
171732,experimental,0,0
171733,group,0,0
171734,",",0,0
171735,after,0,0
171736,the,0,0
171737,twelve,0,1
171738,week,0,0
171739,",",0,0
171740,the,0,0
171741,mean,0,0
171742,rank,0,0
171743,of,0,0
171744,perceived,0,0
171745,self-efficacy,0,0
171746,and,0,0
171747,outcome,0,0
171748,expectancy,0,1
171749,increased,0,0
171750,and,0,0
171751,diastolic,0,1
171752,blood,0,0
171753,pressure,0,0
171754,decreased,0,0
171755,after,0,0
171756,the,0,0
171757,eight,0,1
171758,week,0,0
171759,.,0,1
171760,CONCLUSION,0,0
171761,The,0,0
171762,program,0,0
171763,applied,0,0
171764,social,0,0
171765,cognitive,0,1
171766,theory,0,1
171767,(,0,1
171768,SCT,0,1
171769,),0,1
171770,to,0,0
171771,promote,0,0
171772,self-management,0,1
171773,techniques,0,0
171774,",",0,1
171775,increased,0,0
171776,the,0,0
171777,health,0,0
171778,promoting,0,0
171779,behavior,0,0
171780,among,0,1
171781,hypertensive,0,1
171782,people,0,1
171783,.,0,1
171784,The,0,0
171785,effects,0,0
171786,of,0,1
171787,two,0,1
171788,Chinese,0,1
171789,herbal,0,1
171790,medicinal,0,1
171791,formulae,0,0
171792,vs.,0,0
171793,placebo,0,0
171794,controls,0,1
171795,for,0,0
171796,treatment,0,1
171797,of,0,0
171798,allergic,1,1
171799,rhinitis,1,1
171800,:,1,1
171801,a,0,1
171802,randomised,0,0
171803,controlled,0,0
171804,trial,0,1
171805,.,0,1
171806,BACKGROUND,0,0
171807,Allergic,1,1
171808,rhinitis,1,1
171809,is,0,0
171810,a,0,0
171811,chronic,0,1
171812,illness,0,1
171813,",",0,1
171814,affecting,0,0
171815,10,0,1
171816,to,0,1
171817,40,0,1
171818,%,0,0
171819,of,0,0
171820,the,0,0
171821,worldwide,0,1
171822,population,0,1
171823,.,0,1
171824,Chinese,0,1
171825,herbal,0,1
171826,medicines,0,1
171827,",",0,1
171828,the,0,0
171829,treatment,0,0
171830,of,0,0
171831,allergic,0,1
171832,rhinitis,0,1
171833,",",0,1
171834,adopted,0,0
171835,thousands,0,1
171836,of,0,1
171837,years,0,1
171838,in,0,1
171839,ancient,0,1
171840,China,0,1
171841,",",0,0
171842,has,0,0
171843,recently,0,0
171844,raised,0,0
171845,much,0,0
171846,attention,0,0
171847,among,0,1
171848,researchers,0,1
171849,globally,0,1
171850,.,0,1
171851,This,0,0
171852,study,0,0
171853,evaluates,0,0
171854,the,0,0
171855,effects,0,0
171856,of,0,1
171857,two,0,1
171858,Chinese,0,1
171859,herbal,0,1
171860,formulae,0,1
171861,[,0,1
171862,Cure-allergic-rhinitis,0,1
171863,Syrup,0,1
171864,(,0,1
171865,CS,0,1
171866,),0,1
171867,and,0,1
171868,Yu-ping-feng,0,1
171869,San,0,1
171870,(,0,1
171871,YS,0,0
171872,),0,1
171873,],0,1
171874,in,0,0
171875,treating,0,0
171876,undergraduate,1,1
171877,nursing,1,1
171878,students,1,1
171879,with,1,1
171880,allergic,1,1
171881,rhinitis,1,1
171882,over,1,0
171883,a,1,1
171884,3-month,1,0
171885,follow-up,1,0
171886,",",0,0
171887,when,0,0
171888,compared,0,0
171889,to,0,0
171890,a,0,0
171891,placebo,0,0
171892,control,0,1
171893,group,0,1
171894,.,0,1
171895,METHODS,0,0
171896,A,0,0
171897,double-blind,0,0
171898,",",0,0
171899,randomised,0,0
171900,controlled,0,0
171901,trial,0,1
171902,with,0,1
171903,repeated-measures,0,0
171904,",",0,1
171905,three-parallel-groups,0,0
171906,design,0,1
171907,was,0,0
171908,conducted,0,0
171909,in,0,0
171910,a,0,1
171911,random,0,1
171912,sample,0,1
171913,of,0,1
171914,249,1,1
171915,participants,1,1
171916,recruited,1,1
171917,from,1,1
171918,one,1,1
171919,university,1,1
171920,in,1,1
171921,Hong,1,1
171922,Kong,1,1
171923,.,1,1
171924,After,0,0
171925,baseline,0,0
171926,measurements,0,0
171927,",",0,1
171928,participants,0,1
171929,were,0,1
171930,randomly,0,1
171931,assigned,0,1
171932,to,0,0
171933,CS,0,0
171934,",",0,0
171935,YS,0,0
171936,",",0,0
171937,or,0,1
171938,placebo,0,0
171939,groups,0,0
171940,(,0,1
171941,n=83,0,1
171942,per,0,1
171943,group,0,1
171944,),0,1
171945,.,0,1
171946,The,0,0
171947,main,0,0
171948,outcomes,0,0
171949,",",0,1
171950,including,0,1
171951,symptom,0,0
171952,severity,0,0
171953,",",0,0
171954,quality,0,0
171955,of,0,0
171956,life,0,0
171957,",",0,0
171958,and,0,0
171959,body,0,1
171960,constitution,0,0
171961,",",0,0
171962,were,0,0
171963,measured,0,0
171964,with,0,1
171965,self-administered,0,1
171966,questionnaires,0,0
171967,at,0,1
171968,baseline,0,0
171969,and,0,0
171970,immediately,0,0
171971,",",0,0
171972,1,0,0
171973,and,0,1
171974,3,0,1
171975,months,0,0
171976,after,0,1
171977,the,0,1
171978,4-week,0,0
171979,interventions,0,0
171980,.,0,1
171981,RESULTS,0,0
171982,240,1,1
171983,participants,1,1
171984,completed,1,1
171985,the,1,0
171986,trial,1,0
171987,",",1,0
171988,with,1,1
171989,9,1,0
171990,(,1,1
171991,3.6,1,1
171992,%,1,0
171993,),1,1
171994,drop-outs,1,0
171995,.,1,1
171996,The,0,0
171997,results,0,0
171998,of,0,0
171999,Generalised,0,1
172000,Estimating,0,0
172001,Equations,0,1
172002,test,0,0
172003,followed,0,0
172004,by,0,0
172005,pairwise,0,1
172006,contrasts,0,1
172007,tests,0,0
172008,indicated,0,0
172009,that,0,0
172010,the,0,1
172011,participants,0,1
172012,who,0,1
172013,received,0,1
172014,CS,0,1
172015,showed,0,0
172016,significantly,0,0
172017,greater,0,0
172018,reduction,0,0
172019,of,0,0
172020,symptoms,0,1
172021,(,0,1
172022,mean,0,1
172023,difference,0,0
172024,of,0,0
172025,CS,0,0
172026,vs.,0,0
172027,placebo=26.13-34.55,0,0
172028,",",0,1
172029,P,0,0
172030,<,0,0
172031,0.0005,0,0
172032,),0,1
172033,and,0,1
172034,improvements,0,0
172035,in,0,1
172036,quality,0,0
172037,of,0,0
172038,life,0,1
172039,(,0,1
172040,mean,0,1
172041,difference,0,0
172042,of,0,0
172043,CS,0,0
172044,vs.,0,0
172045,placebo=12.81-16.76,0,0
172046,",",0,1
172047,P,0,0
172048,<,0,0
172049,0.001,0,0
172050,),0,1
172051,",",0,0
172052,and,0,0
172053,body,0,1
172054,constitution,0,0
172055,in,0,0
172056,'Qi-deficiency,0,1
172057,',0,1
172058,",",0,0
172059,'Yang-deficiency,0,1
172060,',0,1
172061,",",0,0
172062,and,0,0
172063,'Inherited,0,1
172064,Special,0,1
172065,',0,1
172066,(,0,1
172067,mean,0,1
172068,difference,0,0
172069,of,0,0
172070,CS,0,0
172071,vs.,0,0
172072,placebo=7.05-8.12,0,0
172073,",",0,1
172074,7.56-8.92,0,0
172075,",",0,0
172076,and,0,0
172077,4.48-8.10,0,0
172078,",",0,1
172079,P=0.01-,0,0
172080,<,0,0
172081,0.0005,0,0
172082,",",0,1
172083,0.001-0.004,0,0
172084,",",0,0
172085,and,0,0
172086,0.01-,0,0
172087,<,0,0
172088,0.0005,0,0
172089,",",0,0
172090,accordingly,0,0
172091,",",0,0
172092,at,0,0
172093,three,0,1
172094,post-tests,0,0
172095,),0,1
172096,.,0,1
172097,The,0,0
172098,participants,0,1
172099,who,0,1
172100,received,0,1
172101,YS,0,1
172102,also,0,0
172103,indicated,0,0
172104,significant,0,0
172105,greater,0,0
172106,improvements,0,0
172107,in,0,0
172108,symptom,0,1
172109,severity,0,0
172110,",",0,0
172111,quality,0,0
172112,of,0,0
172113,life,0,0
172114,",",0,0
172115,and,0,0
172116,a,0,1
172117,few,0,0
172118,patterns,0,1
172119,of,0,1
172120,body,0,1
172121,constitution,0,0
172122,when,0,0
172123,compared,0,0
172124,to,0,0
172125,the,0,0
172126,placebo,0,0
172127,group,0,0
172128,.,0,1
172129,However,0,0
172130,",",0,0
172131,its,0,0
172132,effects,0,0
172133,were,0,1
172134,lesser,0,0
172135,in,0,0
172136,strength,0,0
172137,(,0,1
172138,i.e.,0,0
172139,",",0,0
172140,smaller,0,0
172141,effect,0,0
172142,sizes,0,0
172143,),0,1
172144,",",0,1
172145,varieties,0,1
172146,of,0,1
172147,symptoms,0,1
172148,",",0,1
172149,and,0,0
172150,body,0,1
172151,constitution,0,0
172152,and,0,0
172153,sustainability,0,0
172154,over,0,0
172155,the,0,1
172156,3,0,1
172157,months,0,0
172158,.,0,1
172159,CONCLUSIONS,0,0
172160,The,0,0
172161,herbal,0,0
172162,formula,0,0
172163,CS,0,0
172164,was,0,0
172165,found,0,0
172166,effective,0,0
172167,to,0,1
172168,reduce,0,0
172169,symptoms,0,0
172170,and,0,1
172171,enhance,0,0
172172,quality,0,0
172173,of,0,0
172174,life,0,1
172175,in,0,1
172176,young,0,1
172177,adults,0,1
172178,(,0,1
172179,nursing,0,1
172180,students,0,1
172181,),0,1
172182,with,0,1
172183,allergic,0,1
172184,rhinitis,0,1
172185,in,0,1
172186,'Yang-,0,1
172187,and/or,0,1
172188,Qi-deficiency,0,1
172189,',0,1
172190,body,0,1
172191,constitution,0,0
172192,.,0,1
172193,Further,0,0
172194,controlled,0,0
172195,trials,0,0
172196,of,0,1
172197,its,0,0
172198,effects,0,0
172199,in,0,1
172200,Chinese,0,1
172201,and/or,0,1
172202,Asians,0,1
172203,with,0,1
172204,allergic,0,1
172205,rhinitis,0,1
172206,in,0,1
172207,terms,0,0
172208,of,0,1
172209,socio-demographic,0,1
172210,",",0,1
172211,ethnic,0,1
172212,and,0,1
172213,illness,0,1
172214,characteristics,0,1
172215,and,0,1
172216,a,0,1
172217,longer-term,0,0
172218,follow-up,0,0
172219,are,0,0
172220,recommended,0,0
172221,.,0,1
172222,TRIAL,0,0
172223,REGISTRATION,0,0
172224,The,0,0
172225,trial,0,0
172226,has,0,0
172227,registered,0,0
172228,at,0,0
172229,ClinicalTrials.gov,0,0
172230,with,0,1
172231,an,0,1
172232,ID,0,1
172233,:,0,1
172234,NCT02027194,0,0
172235,(,0,1
172236,3,0,1
172237,January,0,1
172238,2014,0,1
172239,),0,1
172240,.,0,1
172241,Neck,1,1
172242,circumference,1,0
172243,and,1,1
172244,early,1,1
172245,stage,1,1
172246,atherosclerosis,1,1
172247,:,1,1
172248,the,0,0
172249,cardiometabolic,0,0
172250,risk,0,0
172251,in,0,0
172252,Chinese,0,1
172253,(,0,1
172254,CRC,0,1
172255,),0,1
172256,study,0,1
172257,.,0,1
172258,BACKGROUND,0,0
172259,Neck,0,1
172260,circumference,0,0
172261,(,0,1
172262,NC,0,0
172263,),0,1
172264,has,0,0
172265,been,0,0
172266,previously,0,0
172267,related,0,0
172268,to,0,0
172269,cardiometabolic,0,1
172270,risk,0,1
172271,factors,0,0
172272,.,0,1
172273,In,0,0
172274,this,0,0
172275,study,0,0
172276,we,0,0
172277,examined,0,0
172278,the,0,0
172279,association,0,0
172280,between,0,0
172281,NC,1,1
172282,and,1,1
172283,early,1,1
172284,stage,1,1
172285,atherosclerosis,1,1
172286,in,1,1
172287,Chinese,1,1
172288,adults,1,1
172289,.,1,1
172290,METHODS,0,0
172291,The,0,0
172292,study,0,1
172293,samples,0,0
172294,were,0,1
172295,from,0,1
172296,a,0,1
172297,community-based,0,1
172298,health,0,1
172299,examination,0,0
172300,survey,0,1
172301,in,0,0
172302,central,1,1
172303,China,1,1
172304,.,1,1
172305,In,1,0
172306,total,1,1
172307,"2,318",1,1
172308,men,1,1
172309,and,1,1
172310,women,1,1
172311,(,1,1
172312,18-64,1,1
172313,y,1,1
172314,),1,1
172315,were,1,0
172316,included,1,1
172317,in,1,0
172318,the,1,0
172319,final,1,1
172320,analyses,1,0
172321,.,1,1
172322,Carotid,0,0
172323,radial,0,1
172324,pulse,0,0
172325,wave,0,0
172326,velocity,0,0
172327,(,0,1
172328,crPWV,0,0
172329,),0,1
172330,",",0,0
172331,carotid,0,1
172332,femoral,0,1
172333,PWV,0,0
172334,(,0,1
172335,cfPWV,0,0
172336,),0,1
172337,",",0,0
172338,carotid,0,1
172339,artery,0,1
172340,dorsalis,0,0
172341,pedis,0,1
172342,PWV,0,0
172343,(,0,1
172344,cdPWV,0,0
172345,),0,1
172346,and,0,1
172347,NC,0,1
172348,were,0,1
172349,measured,0,0
172350,.,0,1
172351,RESULTS,0,0
172352,After,0,0
172353,adjustment,0,0
172354,for,0,0
172355,age,0,1
172356,",",0,0
172357,sex,0,0
172358,",",0,0
172359,lipids,0,0
172360,",",0,0
172361,glucose,0,0
172362,",",0,0
172363,blood,0,0
172364,pressure,0,0
172365,",",0,0
172366,heart,0,1
172367,rate,0,0
172368,",",0,0
172369,body,0,1
172370,mass,0,1
172371,index,0,1
172372,(,0,1
172373,BMI,0,1
172374,),0,1
172375,",",0,0
172376,high,0,1
172377,NC,0,0
172378,was,0,0
172379,significantly,0,0
172380,associated,0,0
172381,with,0,1
172382,an,0,0
172383,increasing,0,0
172384,trend,0,0
172385,of,0,0
172386,cfPWV,0,0
172387,",",0,0
172388,cdPWV,0,0
172389,and,0,0
172390,crPWV,0,0
172391,(,0,1
172392,P,0,0
172393,=,0,1
172394,0.001,0,0
172395,",",0,1
172396,0.049,0,0
172397,",",0,0
172398,and,0,1
172399,0.038,0,0
172400,;,0,1
172401,respectively,0,0
172402,),0,0
172403,.,0,1
172404,In,0,0
172405,addition,0,0
172406,",",0,0
172407,we,0,0
172408,found,0,0
172409,significant,0,0
172410,interaction,0,0
172411,between,0,0
172412,hypertension,0,1
172413,status,0,1
172414,and,0,0
172415,NC,0,0
172416,level,0,0
172417,in,0,0
172418,relation,0,0
172419,to,0,0
172420,cfPWV,0,0
172421,",",0,0
172422,adjusted,0,0
172423,for,0,0
172424,age,0,1
172425,",",0,0
172426,sex,0,0
172427,",",0,0
172428,BMI,0,0
172429,",",0,0
172430,fasting,0,0
172431,glucose,0,0
172432,",",0,1
172433,lipids,0,0
172434,and,0,1
172435,heart,0,1
172436,rate,0,0
172437,(,0,1
172438,P,0,0
172439,for,0,1
172440,interaction,0,0
172441,=,0,1
172442,0.034,0,0
172443,),0,1
172444,.,0,1
172445,The,0,0
172446,associations,0,0
172447,between,0,0
172448,NC,0,1
172449,and,0,1
172450,cfPWV,0,0
172451,were,0,1
172452,significant,0,0
172453,(,0,1
172454,P,0,0
172455,=,0,1
172456,0.02,0,0
172457,),0,1
172458,among,0,0
172459,those,0,1
172460,with,0,1
172461,hypertension,0,1
172462,",",0,0
172463,but,0,0
172464,not,0,0
172465,significant,0,0
172466,among,0,0
172467,those,0,1
172468,without,0,1
172469,hypertension,0,1
172470,.,0,1
172471,CONCLUSIONS,0,0
172472,Our,0,0
172473,data,0,0
172474,showed,0,0
172475,that,0,0
172476,high,0,1
172477,NC,0,1
172478,was,0,0
172479,associated,0,0
172480,with,0,1
172481,an,0,0
172482,increased,0,0
172483,risk,0,0
172484,of,0,0
172485,early,1,1
172486,stage,1,1
172487,atherosclerosis,1,1
172488,in,1,1
172489,Chinese,1,1
172490,adults,1,1
172491,",",1,1
172492,independent,0,0
172493,of,0,0
172494,other,0,1
172495,metabolic,0,1
172496,risk,0,1
172497,factors,0,0
172498,.,0,1
172499,Hypertension,0,0
172500,might,0,0
172501,modify,0,0
172502,the,0,0
172503,association,0,0
172504,between,0,0
172505,NC,0,1
172506,and,0,1
172507,cfPWV,0,1
172508,.,0,1
172509,A,0,0
172510,further,0,0
172511,investigation,0,0
172512,of,0,0
172513,goal-directed,0,0
172514,intention,0,0
172515,understanding,0,0
172516,in,0,1
172517,young,1,1
172518,children,1,1
172519,with,1,1
172520,autism,1,1
172521,spectrum,1,1
172522,disorders,1,1
172523,.,1,1
172524,Findings,0,0
172525,from,0,1
172526,research,0,1
172527,investigating,0,0
172528,goal-directed,0,0
172529,intention,0,0
172530,understanding,0,0
172531,in,0,0
172532,children,1,1
172533,with,1,1
172534,autism,1,1
172535,spectrum,1,1
172536,disorders,1,1
172537,(,1,1
172538,ASD,1,1
172539,),1,1
172540,have,0,0
172541,been,0,0
172542,equivocal,0,0
172543,",",0,0
172544,in,0,0
172545,part,0,0
172546,because,0,0
172547,of,0,0
172548,the,0,0
172549,varying,0,0
172550,methodologies,0,0
172551,used,0,0
172552,across,0,1
172553,studies,0,0
172554,.,0,1
172555,This,0,0
172556,study,0,0
172557,compares,0,0
172558,both,0,0
172559,object-oriented,0,0
172560,and,0,0
172561,social-communicatively,0,1
172562,cued,0,0
172563,goal-directed,0,0
172564,intention,0,0
172565,understanding,0,0
172566,in,0,0
172567,children,1,1
172568,with,1,1
172569,ASD,1,1
172570,and,1,1
172571,typically-developing,1,1
172572,children,1,1
172573,.,1,1
172574,Relative,0,0
172575,to,0,0
172576,matched,0,1
172577,controls,0,1
172578,",",0,1
172579,children,0,1
172580,with,0,1
172581,ASD,0,1
172582,did,0,0
172583,not,0,0
172584,exhibit,0,0
172585,deficits,0,0
172586,in,0,1
172587,object-oriented,0,1
172588,intention,0,1
172589,understanding,0,0
172590,.,0,1
172591,While,0,1
172592,children,1,1
172593,with,1,1
172594,ASD,1,1
172595,also,0,0
172596,demonstrated,0,0
172597,the,0,0
172598,ability,0,0
172599,to,0,0
172600,understand,0,0
172601,intention,0,0
172602,when,0,0
172603,cued,0,0
172604,by,0,0
172605,social-communication,0,1
172606,indicators,0,0
172607,",",0,1
172608,typically-developing,0,1
172609,children,0,1
172610,differentiated,0,1
172611,between,0,0
172612,intentional,0,1
172613,and,0,1
172614,unintentional,0,1
172615,acts,0,0
172616,at,0,1
172617,a,0,0
172618,significantly,0,0
172619,greater,0,0
172620,level,0,0
172621,.,0,0
172622,Group,0,0
172623,differences,0,0
172624,in,0,0
172625,performance,0,0
172626,were,0,1
172627,eliminated,0,0
172628,if,0,0
172629,only,0,0
172630,trials,0,1
172631,in,0,1
172632,which,0,1
172633,children,0,1
172634,attended,0,1
172635,to,0,1
172636,the,0,0
172637,experimenter,0,0
172638,'s,0,1
172639,face,0,0
172640,were,0,1
172641,considered,0,0
172642,.,0,1
172643,Results,0,0
172644,suggest,0,0
172645,that,0,0
172646,children,1,1
172647,with,1,1
172648,ASD,1,1
172649,have,0,1
172650,intact,0,0
172651,object-oriented,0,0
172652,intention,0,1
172653,understanding,0,0
172654,abilities,0,0
172655,",",0,1
172656,and,0,0
172657,are,0,0
172658,able,0,0
172659,to,0,0
172660,use,0,0
172661,social-communicative,0,1
172662,cues,0,0
172663,to,0,1
172664,understand,0,0
172665,intention,0,0
172666,.,0,0
172667,However,0,0
172668,",",0,0
172669,their,0,0
172670,ability,0,0
172671,to,0,0
172672,demonstrate,0,0
172673,social-communicatively,0,1
172674,cued,0,0
172675,intention,0,0
172676,understanding,0,0
172677,is,0,0
172678,limited,0,0
172679,by,0,0
172680,a,0,0
172681,lack,0,0
172682,of,0,0
172683,attention,0,0
172684,to,0,0
172685,relevant,0,0
172686,social-communicative,0,1
172687,information,0,0
172688,.,0,1
172689,Examining,0,0
172690,the,0,0
172691,temperature,0,0
172692,of,0,0
172693,embryo,0,0
172694,culture,0,0
172695,in,0,0
172696,in,1,0
172697,vitro,1,0
172698,fertilization,1,1
172699,:,1,1
172700,a,0,0
172701,randomized,0,1
172702,controlled,0,0
172703,trial,0,0
172704,comparing,0,0
172705,traditional,0,0
172706,core,0,1
172707,temperature,0,1
172708,(,0,1
172709,37?C,0,1
172710,),0,1
172711,to,0,0
172712,a,0,0
172713,more,0,0
172714,physiologic,0,0
172715,",",0,0
172716,cooler,0,1
172717,temperature,0,1
172718,(,0,1
172719,36?C,0,1
172720,),0,1
172721,.,0,1
172722,OBJECTIVE,0,0
172723,To,0,0
172724,determine,0,0
172725,whether,0,0
172726,culture,0,0
172727,at,0,0
172728,a,0,0
172729,more,0,0
172730,physiologically,0,0
172731,cooler,0,0
172732,temperature,0,0
172733,",",0,0
172734,as,0,0
172735,suggested,0,0
172736,by,0,0
172737,limited,0,0
172738,human,0,1
172739,and,0,1
172740,animal,0,1
172741,data,0,0
172742,",",0,0
172743,would,0,0
172744,improve,0,0
172745,blastulation,0,0
172746,and,0,0
172747,pregnancy,0,1
172748,rates,0,0
172749,in,0,1
172750,human,1,1
172751,clinical,1,1
172752,IVF,1,1
172753,.,1,1
172754,DESIGN,0,0
172755,Paired,0,1
172756,randomized,0,1
172757,controlled,0,0
172758,trial,0,1
172759,.,0,1
172760,SETTING,0,1
172761,Academic,0,1
172762,.,0,1
172763,PATIENT,1,0
172764,(,1,0
172765,S,1,1
172766,),1,1
172767,Infertile,1,1
172768,couples,1,1
172769,(,1,1
172770,n=52,1,1
172771,),1,1
172772,with,1,1
172773,a,1,1
172774,female,1,1
172775,partner,1,0
172776,less,1,0
172777,than,1,1
172778,42,1,1
172779,years,1,1
172780,old,1,1
172781,with,1,1
172782,eight,1,1
172783,or,1,1
172784,more,1,0
172785,mature,1,1
172786,oocytes,1,1
172787,retrieved,1,0
172788,.,1,0
172789,INTERVENTION,0,0
172790,(,0,0
172791,S,0,1
172792,),0,1
172793,Mature,0,0
172794,oocytes,0,1
172795,obtained,0,0
172796,from,0,0
172797,a,0,1
172798,single,0,0
172799,cohort,0,1
172800,of,0,1
172801,oocytes,0,1
172802,were,0,1
172803,randomly,0,1
172804,divided,0,1
172805,into,0,1
172806,two,0,1
172807,groups,0,1
172808,;,0,1
172809,one,0,1
172810,was,0,0
172811,cultured,0,1
172812,at,0,1
172813,37?C,0,1
172814,and,0,1
172815,the,0,0
172816,other,0,0
172817,at,0,0
172818,36?C,0,1
172819,from,0,1
172820,the,0,0
172821,time,0,0
172822,of,0,0
172823,ICSI,0,0
172824,to,0,1
172825,the,0,0
172826,time,0,0
172827,of,0,0
172828,embryo,0,0
172829,transfer,0,1
172830,or,0,1
172831,vitrification,0,0
172832,.,0,1
172833,Paired,0,1
172834,embryo,0,0
172835,transfers,0,1
172836,were,0,1
172837,accomplished,0,0
172838,by,0,0
172839,transferring,0,1
172840,one,0,1
172841,euploid,0,1
172842,embryo,0,0
172843,from,0,1
172844,each,0,0
172845,group,0,1
172846,.,0,1
172847,DNA,0,0
172848,fingerprinting,0,0
172849,was,0,0
172850,used,0,0
172851,as,0,0
172852,needed,0,0
172853,to,0,0
172854,determine,0,0
172855,the,0,0
172856,outcome,0,0
172857,for,0,0
172858,each,0,0
172859,embryo,0,0
172860,.,0,1
172861,MAIN,0,0
172862,OUTCOME,0,1
172863,MEASURE,0,0
172864,(,0,1
172865,S,0,1
172866,),0,1
172867,Rate,0,0
172868,of,0,0
172869,development,0,0
172870,of,0,1
172871,expanded,0,1
172872,blastocysts,0,1
172873,suitable,0,0
172874,for,0,1
172875,transfer,0,1
172876,or,0,1
172877,vitrification,0,0
172878,(,0,1
172879,primary,0,1
172880,outcome,0,0
172881,),0,1
172882,",",0,0
172883,fertilization,0,0
172884,",",0,0
172885,aneuploidy,0,0
172886,",",0,0
172887,and,0,0
172888,sustained,0,0
172889,implantation,0,1
172890,.,0,1
172891,RESULT,0,0
172892,(,0,0
172893,S,0,1
172894,),0,1
172895,A,0,1
172896,total,1,1
172897,of,1,0
172898,805,1,1
172899,mature,1,1
172900,oocytes,1,1
172901,were,1,1
172902,cultured,0,1
172903,;,0,1
172904,399,0,1
172905,at,0,1
172906,36?C,0,1
172907,and,0,1
172908,406,0,1
172909,at,0,1
172910,37?C,0,1
172911,.,0,1
172912,Paired,0,1
172913,analysis,0,0
172914,demonstrated,0,0
172915,a,0,0
172916,higher,0,0
172917,rate,0,0
172918,of,0,0
172919,usable,0,1
172920,blastocyst,0,1
172921,formation,0,0
172922,per,0,0
172923,zygote,0,0
172924,at,0,1
172925,37?C,0,1
172926,(,0,1
172927,48.4,0,0
172928,%,0,0
172929,),0,1
172930,vs.,0,0
172931,at,0,1
172932,36?C,0,1
172933,(,0,1
172934,41.2,0,1
172935,%,0,0
172936,),0,1
172937,.,0,1
172938,Rates,0,0
172939,of,0,0
172940,fertilization,0,1
172941,",",0,0
172942,aneuploidy,0,0
172943,",",0,0
172944,and,0,0
172945,sustained,0,0
172946,implantation,0,1
172947,were,0,1
172948,equivalent,0,0
172949,.,0,1
172950,CONCLUSION,0,0
172951,(,0,0
172952,S,0,1
172953,),0,1
172954,IVF,0,1
172955,culture,0,0
172956,at,0,0
172957,36?C,0,1
172958,does,0,0
172959,not,0,0
172960,improve,0,0
172961,clinically,0,1
172962,relevant,0,0
172963,parameters,0,0
172964,of,0,1
172965,embryo,0,1
172966,development,0,0
172967,or,0,1
172968,sustained,0,1
172969,implantation,0,1
172970,rates,0,0
172971,.,0,1
172972,CLINICAL,0,1
172973,TRIAL,0,0
172974,REGISTRATION,0,1
172975,NUMBER,0,1
172976,NCT01506089,0,1
172977,.,0,1
172978,Reducing,0,1
172979,the,0,0
172980,psychological,0,0
172981,distress,0,0
172982,of,0,1
172983,family,1,1
172984,caregivers,1,1
172985,of,1,1
172986,home,1,1
172987,based,1,1
172988,palliative,1,1
172989,care,1,1
172990,patients,1,1
172991,:,1,1
172992,longer,0,0
172993,term,0,1
172994,effects,0,0
172995,from,0,1
172996,a,0,1
172997,randomised,0,0
172998,controlled,0,0
172999,trial,0,1
173000,.,0,1
173001,BACKGROUND,0,0
173002,Palliative,0,1
173003,care,0,1
173004,incorporates,0,0
173005,comprehensive,0,0
173006,support,0,0
173007,of,0,1
173008,family,1,1
173009,caregivers,1,1
173010,because,0,1
173011,many,0,1
173012,of,0,0
173013,them,0,0
173014,experience,0,1
173015,burden,0,1
173016,and,0,0
173017,distress,0,0
173018,.,0,1
173019,However,0,0
173020,",",0,0
173021,evidence-based,0,0
173022,support,0,0
173023,initiatives,0,1
173024,are,0,0
173025,few,0,0
173026,.,0,1
173027,PURPOSE,0,0
173028,We,0,0
173029,evaluated,0,0
173030,a,0,0
173031,one-to-one,0,1
173032,psychoeducational,0,1
173033,intervention,0,0
173034,aimed,0,0
173035,at,0,0
173036,mitigating,0,0
173037,the,0,0
173038,distress,0,0
173039,of,0,0
173040,caregivers,1,1
173041,of,1,1
173042,patients,1,1
173043,with,1,1
173044,advanced,1,1
173045,cancer,1,1
173046,receiving,1,1
173047,home-based,1,1
173048,palliative,1,1
173049,care,1,1
173050,.,1,1
173051,We,0,0
173052,hypothesised,0,0
173053,that,0,0
173054,caregivers,1,1
173055,would,0,0
173056,report,0,1
173057,decreased,0,0
173058,distress,0,0
173059,as,0,0
173060,assessed,0,0
173061,by,0,0
173062,the,0,0
173063,General,0,1
173064,Health,0,0
173065,Questionnaire,0,0
173066,(,0,1
173067,GHQ,0,1
173068,),0,1
173069,.,0,1
173070,METHOD,0,0
173071,A,0,0
173072,randomised,0,0
173073,controlled,0,0
173074,trial,0,1
173075,comparing,0,0
173076,two,0,0
173077,versions,0,0
173078,of,0,1
173079,the,0,0
173080,delivery,0,0
173081,of,0,0
173082,the,0,0
173083,intervention,0,0
173084,(,0,0
173085,one,0,1
173086,face-to-face,0,0
173087,home,0,1
173088,visit,0,0
173089,plus,0,0
173090,telephone,0,0
173091,calls,0,0
173092,versus,0,0
173093,two,0,0
173094,visits,0,1
173095,),0,1
173096,plus,0,0
173097,standard,0,1
173098,care,0,1
173099,to,0,0
173100,a,0,0
173101,control,0,0
173102,group,0,0
173103,(,0,1
173104,standard,0,1
173105,care,0,1
173106,only,0,0
173107,),0,1
173108,across,0,0
173109,four,1,1
173110,sites,1,1
173111,in,1,1
173112,Australia,1,1
173113,.,1,1
173114,RESULTS,0,0
173115,Recruitment,1,0
173116,to,1,1
173117,the,1,0
173118,one,1,1
173119,visit,1,0
173120,condition,1,1
173121,was,1,0
173122,57,1,1
173123,",",1,0
173124,the,1,0
173125,two,1,0
173126,visit,1,0
173127,condition,1,1
173128,93,1,1
173129,",",1,0
173130,and,1,0
173131,the,1,0
173132,control,1,1
173133,148,1,1
173134,.,1,1
173135,We,0,0
173136,previously,0,1
173137,reported,0,1
173138,non-significant,0,0
173139,changes,0,0
173140,in,0,1
173141,distress,0,1
173142,between,0,1
173143,times,0,0
173144,1,0,1
173145,(,0,1
173146,baseline,0,0
173147,),0,1
173148,and,0,1
173149,2,0,1
173150,(,0,1
173151,1-week,0,0
173152,post-intervention,0,0
173153,),0,1
173154,but,0,0
173155,significant,0,0
173156,gains,0,0
173157,in,0,1
173158,competence,0,1
173159,and,0,1
173160,preparedness,0,1
173161,.,0,1
173162,We,0,0
173163,report,0,0
173164,here,0,0
173165,changes,0,0
173166,in,0,0
173167,distress,0,1
173168,between,0,1
173169,times,0,0
173170,1,0,1
173171,and,0,1
173172,3,0,1
173173,(,0,1
173174,8-week,0,0
173175,post-death,0,1
173176,),0,0
173177,.,0,0
173178,There,0,0
173179,was,0,0
173180,significantly,0,0
173181,less,0,0
173182,worsening,0,0
173183,in,0,0
173184,distress,0,1
173185,between,0,1
173186,times,0,0
173187,1,0,1
173188,and,0,1
173189,3,0,1
173190,in,0,0
173191,the,0,0
173192,one,0,1
173193,visit,0,0
173194,intervention,0,0
173195,group,0,1
173196,than,0,0
173197,in,0,0
173198,the,0,0
173199,control,0,1
173200,group,0,0
173201,;,0,0
173202,however,0,0
173203,",",0,0
173204,no,0,0
173205,significant,0,0
173206,difference,0,0
173207,was,0,0
173208,found,0,0
173209,between,0,0
173210,the,0,0
173211,two,0,0
173212,visit,0,0
173213,intervention,0,0
173214,and,0,0
173215,the,0,0
173216,control,0,1
173217,group,0,1
173218,.,0,1
173219,CONCLUSIONS,0,0
173220,These,0,1
173221,results,0,0
173222,are,0,0
173223,consistent,0,0
173224,with,0,1
173225,the,0,0
173226,aim,0,0
173227,of,0,0
173228,the,0,0
173229,intervention,0,0
173230,",",0,0
173231,and,0,0
173232,they,0,0
173233,support,0,0
173234,existing,0,0
173235,evidence,0,0
173236,demonstrating,0,0
173237,that,0,0
173238,relatively,0,1
173239,short,0,1
173240,psychoeducational,0,0
173241,interventions,0,0
173242,can,0,0
173243,help,0,0
173244,family,1,1
173245,caregivers,1,1
173246,who,1,1
173247,are,1,1
173248,supporting,1,1
173249,a,1,0
173250,dying,1,1
173251,relative,1,0
173252,.,1,1
173253,The,0,0
173254,sustained,0,0
173255,benefit,0,0
173256,during,0,0
173257,the,0,0
173258,bereavement,0,0
173259,period,0,0
173260,may,0,0
173261,also,0,0
173262,have,0,0
173263,positive,0,1
173264,resource,0,0
173265,implications,0,0
173266,",",0,0
173267,which,0,0
173268,should,0,0
173269,be,0,0
173270,the,0,0
173271,subject,0,0
173272,of,0,0
173273,future,0,0
173274,inquiry,0,1
173275,.,0,1
173276,Egg,0,1
173277,intake,0,0
173278,during,0,0
173279,carbohydrate,0,1
173280,restriction,0,1
173281,alters,0,0
173282,peripheral,0,1
173283,blood,0,0
173284,mononuclear,0,1
173285,cell,0,1
173286,inflammation,0,0
173287,and,0,0
173288,cholesterol,0,0
173289,homeostasis,0,0
173290,in,0,0
173291,metabolic,0,1
173292,syndrome,0,1
173293,.,0,1
173294,Egg,0,1
173295,yolk,0,1
173296,contains,0,1
173297,bioactive,0,0
173298,components,0,0
173299,that,0,0
173300,improve,0,0
173301,plasma,0,0
173302,inflammatory,0,0
173303,markers,0,0
173304,and,0,1
173305,HDL,0,1
173306,profiles,0,0
173307,in,0,1
173308,metabolic,0,1
173309,syndrome,0,1
173310,(,0,1
173311,MetS,0,0
173312,),0,1
173313,under,0,0
173314,carbohydrate,0,1
173315,restriction,0,1
173316,.,0,1
173317,We,0,0
173318,further,0,0
173319,sought,0,0
173320,to,0,0
173321,determine,0,0
173322,whether,0,0
173323,egg,0,0
173324,yolk,0,1
173325,intake,0,1
173326,affects,0,0
173327,peripheral,0,1
173328,blood,0,0
173329,mononuclear,0,1
173330,cell,0,1
173331,(,0,1
173332,PBMC,0,0
173333,),0,1
173334,inflammation,0,1
173335,and,0,0
173336,cholesterol,0,0
173337,homeostasis,0,0
173338,in,0,0
173339,MetS,0,0
173340,",",0,1
173341,as,0,0
173342,HDL,0,0
173343,and,0,1
173344,its,0,0
173345,associated,0,0
173346,lipid,0,0
173347,transporter,0,0
173348,ATP-binding,0,1
173349,cassette,0,0
173350,transporter,0,0
173351,A1,0,0
173352,(,0,1
173353,ABCA1,0,1
173354,),0,0
173355,reduce,0,0
173356,the,0,0
173357,inflammatory,0,0
173358,potential,0,0
173359,of,0,1
173360,leukocytes,0,0
173361,through,0,1
173362,modulation,0,0
173363,of,0,0
173364,cellular,0,0
173365,cholesterol,0,0
173366,content,0,0
173367,and,0,0
173368,distribution,0,1
173369,.,0,1
173370,Thirty-seven,1,1
173371,men,1,1
173372,and,1,1
173373,women,1,1
173374,classified,1,1
173375,with,1,1
173376,MetS,1,0
173377,consumed,0,1
173378,a,0,1
173379,moderate,0,1
173380,carbohydrate-restricted,0,1
173381,diet,0,1
173382,(,0,1
173383,25,0,1
173384,%,0,0
173385,-30,0,0
173386,%,0,0
173387,of,0,0
173388,energy,0,0
173389,),0,1
173390,for,0,1
173391,12,0,1
173392,weeks,0,0
173393,",",0,1
173394,in,0,0
173395,addition,0,0
173396,to,0,0
173397,consuming,0,1
173398,either,0,1
173399,three,0,0
173400,whole,0,0
173401,eggs,0,1
173402,per,0,1
173403,day,0,1
173404,(,0,1
173405,EGG,0,1
173406,),0,1
173407,or,0,1
173408,the,0,0
173409,equivalent,0,0
173410,amount,0,0
173411,of,0,0
173412,yolk-free,0,0
173413,egg,0,0
173414,substitute,0,0
173415,(,0,1
173416,SUB,0,0
173417,),0,1
173418,.,0,1
173419,Interestingly,0,0
173420,",",0,0
173421,lipopolysaccharide-induced,0,0
173422,PBMC,0,0
173423,IL-1?,0,1
173424,and,0,1
173425,TNF?,0,1
173426,secretion,0,0
173427,increased,0,0
173428,from,0,1
173429,baseline,0,0
173430,to,0,1
173431,week,0,0
173432,12,0,1
173433,in,0,0
173434,the,0,0
173435,SUB,0,0
173436,group,0,0
173437,only,0,0
173438,",",0,0
173439,despite,0,0
173440,increases,0,0
173441,in,0,1
173442,PBMC,0,1
173443,toll-like,0,1
173444,receptor,0,1
173445,4,0,0
173446,(,0,1
173447,TLR4,0,1
173448,),0,1
173449,mRNA,0,0
173450,expression,0,0
173451,in,0,0
173452,the,0,0
173453,EGG,0,0
173454,group,0,1
173455,.,0,1
173456,Compared,0,0
173457,to,0,0
173458,baseline,0,0
173459,",",0,0
173460,ABCA1,0,1
173461,and,0,1
173462,3-hydroxy-3-methyl-glutaryl,0,0
173463,(,0,1
173464,HMG,0,0
173465,),0,1
173466,-CoA,0,1
173467,reductase,0,0
173468,mRNA,0,0
173469,expression,0,0
173470,increased,0,0
173471,by,0,0
173472,week,0,0
173473,12,0,1
173474,in,0,0
173475,the,0,0
173476,EGG,0,0
173477,group,0,0
173478,only,0,0
173479,",",0,1
173480,whereas,0,0
173481,changes,0,0
173482,in,0,1
173483,PBMC,0,1
173484,total,0,1
173485,cholesterol,0,0
173486,positively,0,0
173487,correlated,0,0
173488,with,0,1
173489,changes,0,0
173490,in,0,1
173491,lipid,0,0
173492,raft,0,0
173493,content,0,0
173494,.,0,1
173495,Together,0,0
173496,",",0,0
173497,these,0,0
173498,findings,0,0
173499,suggest,0,0
173500,that,0,0
173501,intake,0,0
173502,of,0,1
173503,whole,0,0
173504,eggs,0,1
173505,during,0,1
173506,carbohydrate,0,1
173507,restriction,0,1
173508,alters,0,0
173509,PBMC,0,1
173510,inflammation,0,1
173511,and,0,0
173512,cholesterol,0,0
173513,homeostasis,0,0
173514,in,0,1
173515,MetS,0,1
173516,.,0,1
173517,Randomized,0,1
173518,open-label,0,1
173519,non-comparative,0,1
173520,multicenter,0,1
173521,phase,0,1
173522,II,0,1
173523,trial,0,1
173524,of,0,0
173525,sequential,0,0
173526,erlotinib,0,0
173527,and,0,0
173528,docetaxel,0,0
173529,versus,0,0
173530,docetaxel,0,0
173531,alone,0,0
173532,in,0,0
173533,patients,1,1
173534,with,1,1
173535,non-small-cell,1,1
173536,lung,1,1
173537,cancer,1,1
173538,after,1,0
173539,failure,1,1
173540,of,1,0
173541,first-line,1,1
173542,chemotherapy,1,1
173543,:,1,1
173544,GFPC,0,0
173545,10.02,0,0
173546,study,0,1
173547,.,0,1
173548,BACKGROUND,0,0
173549,Concomitant,0,0
173550,administration,0,0
173551,of,0,0
173552,erlotinib,0,0
173553,with,0,1
173554,standard,0,1
173555,chemotherapy,0,1
173556,does,0,0
173557,not,0,0
173558,appear,0,0
173559,to,0,0
173560,improve,0,0
173561,survival,0,0
173562,among,0,0
173563,patients,1,1
173564,with,1,1
173565,non-small-cell,1,1
173566,lung,1,1
173567,cancer,1,1
173568,(,1,1
173569,NSCLC,1,1
173570,),1,1
173571,",",0,0
173572,but,0,0
173573,preliminary,0,0
173574,studies,0,0
173575,suggest,0,0
173576,that,0,0
173577,sequential,0,0
173578,administration,0,0
173579,might,0,0
173580,be,0,0
173581,effective,0,0
173582,.,0,1
173583,OBJECTIVE,0,0
173584,To,0,0
173585,assess,0,0
173586,the,0,0
173587,efficacy,0,0
173588,and,0,0
173589,tolerability,0,0
173590,of,0,0
173591,second-line,0,1
173592,sequential,0,0
173593,administration,0,0
173594,of,0,0
173595,erlotinib,0,0
173596,and,0,0
173597,docetaxel,0,0
173598,in,0,0
173599,advanced,0,1
173600,NSCLC,0,1
173601,.,0,1
173602,METHODS,0,0
173603,In,0,0
173604,an,0,1
173605,open-label,0,1
173606,phase,0,1
173607,II,0,1
173608,trial,0,1
173609,",",0,0
173610,patients,1,1
173611,with,1,1
173612,advanced,1,1
173613,NSCLC,1,1
173614,",",1,1
173615,EGFR,1,0
173616,wild-type,1,1
173617,or,1,1
173618,unknown,1,0
173619,",",1,1
173620,PS,1,1
173621,0-2,1,1
173622,",",1,1
173623,in,1,1
173624,whom,1,1
173625,initial,1,1
173626,cisplatin-based,1,1
173627,chemotherapy,1,1
173628,had,1,1
173629,failed,1,0
173630,were,0,1
173631,randomized,0,1
173632,to,0,1
173633,sequential,0,0
173634,erlotinib,0,0
173635,150,0,1
173636,mg/d,0,0
173637,(,0,1
173638,day,0,0
173639,2-16,0,1
173640,),0,1
173641,+docetaxel,0,0
173642,(,0,1
173643,75,0,1
173644,mg/m,0,1
173645,(,0,1
173646,2,0,1
173647,),0,1
173648,d1,0,0
173649,),0,1
173650,(,0,1
173651,arm,0,1
173652,ED,0,1
173653,),0,1
173654,or,0,1
173655,docetaxel,0,0
173656,(,0,1
173657,75,0,1
173658,mg/m,0,1
173659,(,0,1
173660,2,0,1
173661,),0,1
173662,d1,0,0
173663,),0,1
173664,alone,0,0
173665,(,0,1
173666,arm,0,1
173667,D,0,1
173668,),0,1
173669,(,0,1
173670,21-day,0,0
173671,cycle,0,0
173672,),0,1
173673,.,0,1
173674,The,0,0
173675,primary,0,1
173676,endpoint,0,0
173677,was,0,0
173678,the,0,0
173679,progression-free,0,0
173680,survival,0,0
173681,rate,0,0
173682,at,0,1
173683,15,0,1
173684,weeks,0,1
173685,(,0,1
173686,PFS,0,1
173687,15,0,1
173688,),0,1
173689,.,0,1
173690,Secondary,0,0
173691,endpoints,0,0
173692,included,0,1
173693,PFS,0,1
173694,",",0,0
173695,overall,0,0
173696,survival,0,0
173697,(,0,1
173698,OS,0,0
173699,),0,1
173700,",",0,0
173701,the,0,0
173702,overall,0,0
173703,response,0,0
173704,rate,0,0
173705,(,0,1
173706,ORR,0,1
173707,),0,1
173708,and,0,1
173709,tolerability,0,0
173710,.,0,1
173711,Based,0,0
173712,on,0,0
173713,a,0,1
173714,Simon,0,0
173715,optimal,0,0
173716,two-stage,0,1
173717,design,0,1
173718,",",0,0
173719,the,0,0
173720,ED,0,0
173721,strategy,0,0
173722,was,0,0
173723,rejected,0,1
173724,if,0,0
173725,the,0,0
173726,primary,0,1
173727,endpoint,0,0
173728,was,0,0
173729,below,0,1
173730,33/66,0,1
173731,patients,0,1
173732,at,0,1
173733,the,0,0
173734,end,0,0
173735,of,0,0
173736,the,0,0
173737,two,0,1
173738,Simon,0,1
173739,stages,0,1
173740,.,0,1
173741,RESULTS,0,0
173742,147,1,1
173743,patients,1,1
173744,were,1,1
173745,randomized,1,1
173746,(,1,1
173747,median,1,1
173748,age,1,1
173749,:,1,1
173750,60?8,1,0
173751,years,1,1
173752,",",1,1
173753,PS,1,1
173754,0/1/2,1,1
173755,:,1,1
173756,44/83/20,1,1
173757,patients,1,1
173758,;,1,1
173759,males,1,1
173760,:,1,1
173761,78,1,1
173762,%,1,0
173763,),1,1
173764,.,1,1
173765,The,0,0
173766,ED,0,0
173767,strategy,0,0
173768,was,0,0
173769,rejected,0,0
173770,",",0,0
173771,with,0,1
173772,only,0,0
173773,18,0,1
173774,of,0,1
173775,73,0,1
173776,patients,0,1
173777,achieving,0,0
173778,PFS15,0,1
173779,in,0,1
173780,arm,0,1
173781,ED,0,0
173782,at,0,0
173783,the,0,0
173784,end,0,0
173785,of,0,0
173786,stage,0,1
173787,2,0,1
173788,and,0,1
173789,17,0,1
173790,of,0,1
173791,74,0,1
173792,patients,0,1
173793,in,0,1
173794,arm,0,1
173795,D.,0,1
173796,In,0,1
173797,arms,0,1
173798,ED,0,1
173799,and,0,1
173800,D,0,0
173801,",",0,0
173802,respectively,0,0
173803,",",0,0
173804,median,0,0
173805,PFS,0,1
173806,was,0,0
173807,2.2,0,0
173808,and,0,1
173809,2.5,0,1
173810,months,0,0
173811,and,0,1
173812,median,0,1
173813,OS,0,0
173814,was,0,0
173815,6.5,0,0
173816,and,0,1
173817,8.3,0,0
173818,months,0,1
173819,.,0,1
173820,CONCLUSION,0,0
173821,Sequential,0,0
173822,erlotinib,0,0
173823,and,0,0
173824,docetaxel,0,0
173825,was,0,0
173826,not,0,0
173827,more,0,0
173828,effective,0,0
173829,than,0,0
173830,docetaxel,0,0
173831,alone,0,0
173832,as,0,0
173833,second-line,0,1
173834,treatment,0,1
173835,for,0,1
173836,advanced,0,1
173837,NSCLC,0,1
173838,with,0,1
173839,wild-type,0,1
173840,or,0,1
173841,unknown,0,1
173842,EGFR,0,0
173843,status,0,1
173844,.,0,1
173845,The,0,0
173846,Impact,0,0
173847,of,0,0
173848,Pupillary,0,1
173849,Dilation,0,1
173850,on,0,0
173851,Intraocular,0,1
173852,Pressure,0,0
173853,and,0,1
173854,Anterior,0,0
173855,Segment,0,0
173856,Morphology,0,1
173857,in,0,0
173858,Subjects,1,1
173859,with,1,1
173860,and,1,1
173861,without,1,1
173862,Pseudoexfoliation,1,1
173863,.,1,1
173864,PURPOSE,0,0
173865,To,0,0
173866,investigate,0,0
173867,the,0,0
173868,change,0,0
173869,in,0,0
173870,pre-,0,0
173871,and,0,1
173872,post-dilation,0,0
173873,anterior,0,1
173874,segment,0,1
173875,parameters,0,0
173876,and,0,1
173877,intraocular,0,1
173878,pressure,0,0
173879,(,0,1
173880,IOP,0,1
173881,),0,1
173882,of,0,0
173883,patients,1,1
173884,with,1,1
173885,and,1,1
173886,without,1,1
173887,pseudoexfoliation,1,1
173888,",",0,0
173889,after,0,0
173890,topical,0,0
173891,application,0,0
173892,of,0,0
173893,phenylephrine,0,0
173894,HCl,0,0
173895,10,0,1
173896,%,0,0
173897,and,0,0
173898,tropicamide,0,0
173899,1,0,0
173900,%,0,0
173901,.,0,1
173902,MATERIALS,0,0
173903,AND,0,0
173904,METHODS,0,0
173905,Totally,1,1
173906,129,1,1
173907,eyes,1,1
173908,of,1,1
173909,129,1,1
173910,patients,1,1
173911,were,1,1
173912,included,1,1
173913,in,1,0
173914,the,1,0
173915,study,1,0
173916,.,1,0
173917,Of,1,0
173918,the,1,0
173919,129,1,1
173920,eyes,1,1
173921,;,1,1
173922,31,1,1
173923,had,1,1
173924,pseudoexfoliation,1,1
173925,syndrome,1,1
173926,(,1,1
173927,PXS,1,1
173928,),1,1
173929,",",1,1
173930,37,1,1
173931,had,1,1
173932,pseudoexfoliation,1,1
173933,glaucoma,1,1
173934,(,1,1
173935,PXG,1,1
173936,),1,1
173937,",",1,1
173938,31,1,1
173939,eyes,1,1
173940,were,1,1
173941,the,1,1
173942,fellow,1,1
173943,eyes,1,1
173944,of,1,1
173945,subjects,1,1
173946,with,1,1
173947,unilateral,1,1
173948,pseudoexfoliation,1,1
173949,syndrome,1,1
173950,(,1,1
173951,subclinical,1,1
173952,PXS,1,1
173953,),1,1
173954,and,1,1
173955,30,1,1
173956,eyes,1,1
173957,were,1,1
173958,the,1,0
173959,eyes,1,1
173960,of,1,1
173961,subjects,1,1
173962,without,1,1
173963,PXS,1,1
173964,(,1,1
173965,controls,1,1
173966,),1,1
173967,.,1,1
173968,Patients,1,1
173969,underwent,0,1
173970,Pentacam,0,1
173971,analysis,0,0
173972,and,0,1
173973,IOP,0,1
173974,measurement,0,0
173975,before,0,0
173976,and,0,0
173977,after,0,1
173978,dilation,0,1
173979,.,0,1
173980,The,0,0
173981,changes,0,0
173982,in,0,0
173983,IOP,0,1
173984,",",0,1
173985,anterior,0,1
173986,chamber,0,0
173987,depth,0,0
173988,(,0,1
173989,ACD,0,0
173990,),0,1
173991,",",0,0
173992,anterior,0,1
173993,chamber,0,0
173994,volume,0,0
173995,(,0,1
173996,ACV,0,1
173997,),0,1
173998,",",0,0
173999,anterior,0,1
174000,chamber,0,0
174001,angle,0,0
174002,(,0,1
174003,ACA,0,0
174004,),0,1
174005,",",0,0
174006,central,0,0
174007,corneal,0,1
174008,thickness,0,0
174009,(,0,1
174010,CCT,0,1
174011,),0,1
174012,and,0,1
174013,pupillary,0,1
174014,diameter,0,1
174015,(,0,1
174016,PD,0,1
174017,),0,1
174018,were,0,1
174019,investigated,0,0
174020,30,0,1
174021,min,0,0
174022,after,0,0
174023,the,0,0
174024,application,0,0
174025,of,0,0
174026,mydriatic,0,1
174027,agents,0,1
174028,.,0,1
174029,RESULTS,0,0
174030,The,0,0
174031,mean,0,0
174032,change,0,0
174033,of,0,0
174034,IOP,0,1
174035,in,0,1
174036,eyes,0,1
174037,with,0,1
174038,PXS,0,1
174039,",",0,1
174040,in,0,0
174041,eyes,0,1
174042,with,0,1
174043,PXG,0,1
174044,",",0,1
174045,in,0,0
174046,eyes,0,1
174047,with,0,1
174048,subclinical,0,1
174049,PXS,0,1
174050,and,0,1
174051,eyes,0,1
174052,of,0,1
174053,control,0,1
174054,subjects,0,1
174055,were,0,1
174056,1.45,0,1
174057,?,0,1
174058,2.03,0,0
174059,mmhg,0,0
174060,",",0,1
174061,0.27,0,0
174062,?,0,1
174063,2.25,0,0
174064,mmhg,0,0
174065,",",0,1
174066,-0.35,0,0
174067,?,0,1
174068,1.58,0,0
174069,mmHg,0,0
174070,and,0,0
174071,-1.06,0,0
174072,?,0,1
174073,1.59mmHg,0,0
174074,",",0,0
174075,respectively,0,0
174076,.,0,1
174077,Post-dilation,0,0
174078,IOP,0,1
174079,values,0,0
174080,were,0,1
174081,lower,0,0
174082,(,0,1
174083,p,0,0
174084,=,0,1
174085,0.001,0,0
174086,),0,1
174087,in,0,1
174088,eyes,0,1
174089,of,0,1
174090,controls,0,1
174091,but,0,0
174092,higher,0,0
174093,(,0,1
174094,p,0,0
174095,<,0,0
174096,0.001,0,0
174097,),0,1
174098,in,0,1
174099,eyes,0,1
174100,of,0,1
174101,PXS,0,1
174102,than,0,0
174103,the,0,0
174104,pre-dilation,0,1
174105,levels,0,0
174106,.,0,1
174107,All,0,1
174108,patients,0,1
174109,exhibited,0,0
174110,statistically,0,0
174111,significant,0,0
174112,increase,0,0
174113,in,0,0
174114,ACD,0,0
174115,",",0,1
174116,ACV,0,1
174117,and,0,0
174118,PD,0,1
174119,after,0,0
174120,the,0,0
174121,dilation,0,1
174122,procedure,0,0
174123,(,0,1
174124,p,0,0
174125,<,0,0
174126,0.001,0,0
174127,),0,1
174128,.,0,1
174129,Additionally,0,0
174130,",",0,0
174131,post,0,0
174132,dilation,0,1
174133,CCT,0,1
174134,values,0,0
174135,were,0,1
174136,significantly,0,0
174137,lower,0,0
174138,than,0,0
174139,pre-dilation,0,1
174140,values,0,0
174141,in,0,1
174142,all,0,1
174143,groups,0,0
174144,;,0,0
174145,the,0,0
174146,difference,0,0
174147,was,0,0
174148,statistically,0,0
174149,significant,0,0
174150,only,0,0
174151,for,0,0
174152,eyes,0,1
174153,with,0,1
174154,PXG,0,1
174155,",",0,1
174156,eyes,0,1
174157,with,0,1
174158,subclinical,0,1
174159,PXS,0,1
174160,and,0,1
174161,eyes,0,1
174162,of,0,1
174163,controls,0,1
174164,.,0,1
174165,CONCLUSION,0,0
174166,Eyes,0,1
174167,with,0,1
174168,PXS,0,1
174169,had,0,1
174170,a,0,0
174171,higher,0,0
174172,tendency,0,0
174173,of,0,0
174174,IOP,0,1
174175,elevation,0,1
174176,after,0,0
174177,pupillary,0,1
174178,dilation,0,1
174179,.,0,1
174180,Eyes,0,1
174181,with,0,1
174182,subclinical,0,1
174183,PXS,0,1
174184,",",0,0
174185,however,0,0
174186,",",0,0
174187,exhibited,0,0
174188,a,0,0
174189,minor,0,0
174190,increase,0,0
174191,in,0,0
174192,IOP,0,1
174193,",",0,0
174194,reflecting,0,0
174195,the,0,0
174196,asymmetrical,0,0
174197,character,0,1
174198,of,0,0
174199,the,0,0
174200,disease,0,1
174201,.,0,1
174202,Anti-glaucoma,0,0
174203,medications,0,0
174204,may,0,0
174205,have,0,0
174206,blunted,0,0
174207,any,0,0
174208,IOP,0,1
174209,elevation,0,0
174210,induced,0,0
174211,by,0,0
174212,pupillary,0,1
174213,dilation,0,1
174214,in,0,1
174215,eyes,0,1
174216,with,0,1
174217,PXG,0,1
174218,.,0,1
174219,Caphosol,0,0
174220,(,0,1
174221,?,0,1
174222,),0,0
174223,mouthwash,0,0
174224,gives,0,0
174225,no,0,0
174226,additional,0,0
174227,protection,0,0
174228,against,0,0
174229,oral,0,1
174230,mucositis,0,0
174231,compared,0,0
174232,to,0,0
174233,cryotherapy,0,0
174234,alone,0,0
174235,in,1,0
174236,stem,1,1
174237,cell,1,1
174238,transplantation,1,1
174239,.,1,1
174240,A,0,0
174241,pilot,0,0
174242,study,0,1
174243,.,0,1
174244,PURPOSE,0,0
174245,To,0,0
174246,investigate,0,0
174247,if,0,0
174248,adding,0,0
174249,Caphosol,0,0
174250,(,0,1
174251,?,0,1
174252,),0,0
174253,",",0,0
174254,a,0,0
174255,mouthwash,0,0
174256,solution,0,0
174257,",",0,0
174258,to,0,0
174259,oral,0,0
174260,cryotherapy,0,1
174261,(,0,1
174262,OC,0,0
174263,),0,0
174264,further,0,0
174265,protects,0,0
174266,against,0,0
174267,oral,0,1
174268,mucositis,0,0
174269,(,0,1
174270,OM,0,0
174271,),0,1
174272,",",0,0
174273,a,0,0
174274,toxic,0,0
174275,painful,0,1
174276,complication,0,0
174277,to,0,0
174278,high,0,1
174279,dose,0,0
174280,chemotherapy,0,1
174281,.,0,1
174282,METHOD,0,0
174283,The,0,0
174284,study,0,0
174285,was,0,0
174286,a,0,0
174287,randomised,0,0
174288,",",0,0
174289,controlled,0,0
174290,",",0,0
174291,study,0,0
174292,design,1,1
174293,.,1,1
174294,Patients,1,1
174295,?16,1,1
174296,years,1,1
174297,scheduled,1,1
174298,for,1,1
174299,allogeneic,1,1
174300,stem,1,1
174301,cell,1,1
174302,transplantation,1,1
174303,were,1,0
174304,included,1,1
174305,consecutively,1,1
174306,and,0,0
174307,randomised,0,0
174308,to,0,0
174309,experimental,0,0
174310,group,0,1
174311,receiving,0,1
174312,OC,0,1
174313,combined,0,0
174314,with,0,1
174315,Caphosol,0,0
174316,(,0,1
174317,?,0,1
174318,),0,0
174319,(,0,0
174320,n,0,1
174321,=,0,1
174322,20,0,1
174323,),0,1
174324,or,1,1
174325,control,1,1
174326,group,1,1
174327,receiving,1,1
174328,OC,0,1
174329,only,0,0
174330,(,0,1
174331,n,0,1
174332,=,0,1
174333,20,0,1
174334,),0,1
174335,.,0,1
174336,OC,0,0
174337,was,0,0
174338,given,0,0
174339,from,0,1
174340,start,0,1
174341,to,0,0
174342,end,0,0
174343,of,0,0
174344,HDCT,0,1
174345,.,0,1
174346,Caphosol,0,0
174347,(,0,1
174348,?,0,1
174349,),0,0
174350,",",0,0
174351,from,0,1
174352,day,0,0
174353,0,0,0
174354,to,0,1
174355,day,0,1
174356,21,0,1
174357,.,0,0
174358,RESULT,0,0
174359,There,0,0
174360,were,0,0
174361,no,0,0
174362,significant,0,0
174363,differences,0,0
174364,regarding,0,0
174365,age,0,1
174366,or,0,1
174367,gender,0,0
174368,between,0,0
174369,the,0,0
174370,groups,0,0
174371,.,0,1
174372,Mucositis,0,1
174373,was,0,0
174374,assessed,0,0
174375,with,0,1
174376,the,0,0
174377,World,0,1
174378,Health,0,0
174379,Organisation,0,1
174380,(,0,1
174381,WHO,0,1
174382,),0,1
174383,grading,0,1
174384,scale,0,0
174385,.,0,1
174386,Pain,0,0
174387,was,0,0
174388,assessed,0,0
174389,with,0,1
174390,a,0,1
174391,10,0,1
174392,cm,0,1
174393,visual,0,0
174394,analogue,0,0
174395,scale,0,0
174396,(,0,1
174397,VAS,0,0
174398,),0,1
174399,from,0,1
174400,0,0,0
174401,=,0,1
174402,no,0,0
174403,pain,0,1
174404,to,0,1
174405,10,0,0
174406,=,0,0
174407,worst,0,0
174408,imaginable,0,0
174409,pain,0,0
174410,.,0,1
174411,Start,0,0
174412,and,0,0
174413,duration,0,0
174414,of,0,0
174415,therapy,0,0
174416,with,0,1
174417,pain,0,1
174418,relieving,0,0
174419,drugs,0,0
174420,",",0,1
174421,serum,0,0
174422,C-reactive,0,1
174423,protein,0,0
174424,values,0,0
174425,",",0,1
174426,and,0,0
174427,number,0,0
174428,of,0,0
174429,days,0,0
174430,of,0,1
174431,hospitalisation,0,1
174432,were,0,1
174433,collected,0,0
174434,from,0,1
174435,the,0,0
174436,medical,0,1
174437,records,0,1
174438,.,0,1
174439,Data,0,1
174440,on,0,0
174441,OM,0,1
174442,",",0,1
174443,oral,0,0
174444,pain,0,1
174445,",",0,0
174446,use,0,0
174447,of,0,0
174448,i.v,0,0
174449,.,0,1
174450,opioids,0,0
174451,and,0,1
174452,total,0,1
174453,parenteral,0,1
174454,nutrition,0,1
174455,were,0,1
174456,collected,0,1
174457,during,0,1
174458,22,0,1
174459,days,0,0
174460,.,0,1
174461,There,0,0
174462,was,0,0
174463,no,0,0
174464,significant,0,0
174465,difference,0,0
174466,between,0,0
174467,the,0,0
174468,groups,0,0
174469,on,0,0
174470,OM,0,1
174471,",",0,1
174472,oral,0,0
174473,pain,0,1
174474,",",0,0
174475,use,0,0
174476,of,0,0
174477,i.v,0,0
174478,.,0,1
174479,opioids,0,0
174480,or,0,1
174481,TPN,0,0
174482,between,0,0
174483,the,0,1
174484,groups,0,0
174485,.,0,1
174486,CONCLUSION,0,0
174487,The,0,0
174488,study,0,0
174489,showed,0,0
174490,no,0,0
174491,additional,0,0
174492,effect,0,0
174493,of,0,0
174494,combining,0,0
174495,Caphosol,0,0
174496,(,0,1
174497,?,0,1
174498,),0,0
174499,with,0,1
174500,OC,0,1
174501,.,0,1
174502,A,0,0
174503,neuropsychological,0,0
174504,rehabilitation,0,1
174505,program,0,1
174506,for,0,0
174507,patients,1,1
174508,with,1,1
174509,Multiple,1,1
174510,Sclerosis,1,1
174511,based,1,1
174512,on,1,0
174513,the,1,0
174514,model,1,0
174515,of,1,0
174516,the,1,0
174517,ICF,1,1
174518,.,1,1
174519,BACKGROUND,0,0
174520,Forty,0,1
174521,to,0,0
174522,sixty,0,1
174523,percent,0,1
174524,of,0,0
174525,MS,0,1
174526,patients,0,1
174527,suffer,0,1
174528,from,0,1
174529,cognitive,0,1
174530,impairments,0,1
174531,.,0,1
174532,Cognitive,0,0
174533,deficits,0,0
174534,are,0,0
174535,a,0,0
174536,great,0,0
174537,burden,0,1
174538,for,0,1
174539,patients,0,1
174540,affected,0,1
174541,.,0,1
174542,In,0,0
174543,particular,0,0
174544,they,0,1
174545,may,0,0
174546,lead,0,0
174547,to,0,0
174548,a,0,0
174549,reduced,0,0
174550,quality,0,0
174551,of,0,0
174552,life,0,0
174553,",",0,0
174554,loss,0,0
174555,of,0,0
174556,work,0,0
174557,and,0,1
174558,problems,0,1
174559,with,0,1
174560,the,0,1
174561,social,0,0
174562,environment,0,0
174563,.,0,1
174564,OBJECTIVE,0,0
174565,The,0,0
174566,aim,0,0
174567,of,0,0
174568,this,0,0
174569,study,0,0
174570,was,0,0
174571,to,0,0
174572,evaluate,0,0
174573,a,0,0
174574,specific,0,0
174575,neuropsychological,0,1
174576,rehabilitation,0,1
174577,program,0,1
174578,for,0,1
174579,MS,1,1
174580,patients,1,1
174581,according,1,1
174582,to,1,1
174583,the,1,0
174584,ICF,1,0
174585,to,0,0
174586,be,0,0
174587,able,0,0
174588,to,0,0
174589,meet,0,1
174590,more,0,0
174591,properly,0,0
174592,individual,0,0
174593,requirements,0,0
174594,on,0,0
174595,the,0,0
174596,therapy,0,0
174597,level,0,0
174598,of,0,0
174599,function,0,0
174600,as,0,0
174601,well,0,0
174602,as,0,0
174603,of,0,0
174604,activities,0,0
174605,and,0,1
174606,participation,0,1
174607,.,0,1
174608,METHODS,0,0
174609,Forty,1,1
174610,patients,1,1
174611,with,1,1
174612,MS,1,1
174613,were,1,1
174614,randomised,1,0
174615,in,1,0
174616,an,1,0
174617,intervention,1,0
174618,(,1,0
174619,IG,1,1
174620,),1,1
174621,-,1,0
174622,and,1,0
174623,a,1,0
174624,control,1,0
174625,group,1,0
174626,(,1,1
174627,CG,1,1
174628,),1,1
174629,.,1,1
174630,The,0,0
174631,outcome,0,0
174632,measure,0,0
174633,of,0,0
174634,the,0,0
174635,IG,0,1
174636,",",0,1
174637,who,0,1
174638,started,0,1
174639,an,0,1
174640,intensive,0,1
174641,computer,0,0
174642,based,0,1
174643,home,0,1
174644,training,0,0
174645,of,0,0
174646,attention,0,0
174647,and,0,1
174648,attended,0,1
174649,psychological,0,0
174650,counselling,0,0
174651,was,0,0
174652,compared,0,0
174653,to,0,0
174654,the,0,0
174655,untrained,0,1
174656,CG,0,1
174657,.,0,1
174658,RESULTS,0,0
174659,In,0,1
174660,specific,0,0
174661,domains,0,0
174662,of,0,1
174663,attention,0,0
174664,(,0,1
174665,simple,0,0
174666,and,0,1
174667,cued,0,0
174668,alertness,0,0
174669,and,0,1
174670,divided,0,1
174671,attention,0,0
174672,),0,1
174673,significant,0,0
174674,group,0,1
174675,differences,0,0
174676,between,0,0
174677,CG,0,1
174678,and,0,0
174679,IG,0,1
174680,could,0,0
174681,be,0,0
174682,found,0,0
174683,.,0,1
174684,The,0,0
174685,IG,0,0
174686,reported,0,0
174687,an,0,0
174688,improvement,0,0
174689,of,0,0
174690,mental,0,1
174691,fatigue,0,0
174692,and,0,1
174693,retardation,0,1
174694,.,0,1
174695,CONCLUSION,0,0
174696,These,0,1
174697,findings,0,0
174698,support,0,0
174699,the,0,0
174700,idea,0,0
174701,that,0,0
174702,a,0,1
174703,neuropsychological,0,0
174704,rehabilitation,0,1
174705,program,0,1
174706,",",0,0
174707,which,0,0
174708,based,0,1
174709,on,0,0
174710,the,0,0
174711,model,0,0
174712,of,0,0
174713,ICF,0,0
174714,",",0,0
174715,could,0,0
174716,improve,0,0
174717,cognitive,0,0
174718,impairment,0,0
174719,and,0,0
174720,could,0,0
174721,also,0,0
174722,have,0,0
174723,a,0,0
174724,positive,0,0
174725,influence,0,0
174726,of,0,1
174727,activities,0,0
174728,and,0,1
174729,participation,0,1
174730,.,0,1
174731,Efficacy,0,0
174732,of,0,0
174733,artemisinin-based,0,1
174734,combination,0,0
174735,treatments,0,0
174736,of,0,1
174737,uncomplicated,0,1
174738,falciparum,0,1
174739,malaria,0,1
174740,in,0,1
174741,under-five-year-old,1,1
174742,Nigerian,1,1
174743,children,1,1
174744,.,1,1
174745,The,0,0
174746,efficacy,0,0
174747,of,0,0
174748,3-day,0,1
174749,regimens,0,0
174750,of,0,1
174751,artemether-lumefantrine,0,1
174752,and,0,1
174753,artesunate-amodiaquine,0,0
174754,were,0,1
174755,evaluated,0,0
174756,in,0,1
174757,747,1,1
174758,children,1,1
174759,<,1,1
174760,5,1,1
174761,years,1,1
174762,of,1,1
174763,age,1,1
174764,with,1,1
174765,uncomplicated,1,1
174766,malaria,1,1
174767,from,1,1
174768,six,1,1
174769,geographical,1,1
174770,areas,1,0
174771,of,1,1
174772,Nigeria,1,1
174773,.,1,1
174774,Fever,0,1
174775,clearance,0,0
174776,was,0,0
174777,significantly,0,0
174778,faster,0,0
174779,(,0,0
174780,P,0,0
174781,=,0,1
174782,0.006,0,0
174783,),0,1
174784,and,0,0
174785,the,0,0
174786,proportion,0,0
174787,of,0,0
174788,children,0,1
174789,with,0,1
174790,parasitemia,0,1
174791,1,0,1
174792,day,0,0
174793,after,0,0
174794,treatment,0,0
174795,began,0,1
174796,was,0,0
174797,significantly,0,0
174798,lower,0,0
174799,(,0,0
174800,P,0,0
174801,=,0,1
174802,0.016,0,0
174803,),0,1
174804,in,0,0
174805,artesunate-amodiaquine-compared,0,1
174806,with,0,1
174807,artemether-lumefantrine-treated,0,1
174808,children,0,1
174809,.,0,1
174810,Parasite,0,1
174811,clearance,0,0
174812,times,0,0
174813,were,0,1
174814,similar,0,0
174815,with,0,1
174816,both,0,0
174817,treatments,0,0
174818,.,0,1
174819,Overall,0,0
174820,efficacy,0,0
174821,was,0,0
174822,96.3,0,1
174823,%,0,0
174824,(,0,1
174825,95,0,0
174826,%,0,0
174827,confidence,0,0
174828,interval,0,0
174829,[,0,0
174830,CI,0,0
174831,],0,1
174832,94.5-97.6,0,0
174833,%,0,0
174834,),0,1
174835,",",0,0
174836,and,0,0
174837,was,0,0
174838,similar,0,0
174839,for,0,0
174840,both,0,0
174841,regimens,0,0
174842,.,0,1
174843,Polymerase,0,0
174844,chain,0,0
174845,reaction-corrected,0,0
174846,parasitologic,0,1
174847,cure,0,0
174848,rates,0,0
174849,on,0,1
174850,Day,0,1
174851,28,0,1
174852,were,0,1
174853,96.9,0,1
174854,%,0,0
174855,(,0,1
174856,95,0,0
174857,%,0,0
174858,CI,0,0
174859,93.9-98.2,0,0
174860,%,0,0
174861,),0,1
174862,and,0,1
174863,98.3,0,0
174864,%,0,0
174865,(,0,1
174866,95,0,0
174867,%,0,0
174868,CI,0,0
174869,96.1-99.3,0,0
174870,%,0,0
174871,),0,1
174872,for,0,0
174873,artemether-lumefantrine,0,1
174874,and,0,1
174875,artesunate-amodiaquine,0,0
174876,",",0,0
174877,respectively,0,0
174878,.,0,1
174879,Gametocyte,0,0
174880,carriage,0,0
174881,post,0,1
174882,treatment,0,0
174883,was,0,0
174884,significantly,0,0
174885,lower,0,0
174886,than,0,0
174887,pretreatment,0,0
174888,(,0,1
174889,P,0,0
174890,<,0,0
174891,0.0001,0,0
174892,),0,1
174893,.,0,1
174894,In,0,0
174895,anemic,1,1
174896,children,1,1
174897,",",0,1
174898,mean,0,1
174899,time,0,0
174900,to,0,0
174901,recovery,0,0
174902,from,0,1
174903,anemia,0,1
174904,was,0,0
174905,10,0,1
174906,days,0,0
174907,(,0,1
174908,95,0,0
174909,%,0,0
174910,CI,0,0
174911,9.04-10.9,0,0
174912,),0,1
174913,and,0,1
174914,was,0,0
174915,similar,0,0
174916,for,0,0
174917,both,0,0
174918,regimens,0,0
174919,.,0,1
174920,Both,0,0
174921,treatments,0,0
174922,were,0,1
174923,well,0,0
174924,tolerated,0,0
174925,and,0,0
174926,are,0,0
174927,safe,0,0
174928,and,0,1
174929,efficacious,0,0
174930,treatments,0,0
174931,of,0,1
174932,uncomplicated,0,1
174933,falciparum,0,1
174934,malaria,0,1
174935,in,0,0
174936,young,1,1
174937,Nigerian,1,1
174938,children,1,1
174939,.,1,1
174940,Working,0,1
174941,memory,0,1
174942,and,0,1
174943,cognitive,0,0
174944,flexibility-training,0,0
174945,for,0,1
174946,children,1,1
174947,with,1,1
174948,an,1,1
174949,autism,1,1
174950,spectrum,1,1
174951,disorder,1,1
174952,:,1,1
174953,a,0,0
174954,randomized,0,1
174955,controlled,0,0
174956,trial,0,1
174957,.,0,1
174958,BACKGROUND,0,0
174959,People,1,1
174960,with,1,1
174961,autism,1,1
174962,spectrum,1,1
174963,disorders,1,1
174964,(,1,1
174965,ASDs,1,1
174966,),1,1
174967,experience,0,1
174968,executive,0,0
174969,function,0,0
174970,(,0,1
174971,EF,0,1
174972,),0,1
174973,deficits,0,0
174974,.,0,0
174975,There,0,0
174976,is,0,0
174977,an,0,0
174978,urgent,0,1
174979,need,0,0
174980,for,0,1
174981,effective,0,0
174982,interventions,0,0
174983,",",0,1
174984,but,0,0
174985,in,0,0
174986,spite,0,0
174987,of,0,0
174988,the,0,0
174989,increasing,0,0
174990,research,0,0
174991,focus,0,1
174992,on,0,0
174993,computerized,0,1
174994,cognitive,0,1
174995,training,0,0
174996,",",0,0
174997,this,0,0
174998,has,0,0
174999,not,0,0
175000,been,0,0
175001,studied,0,1
175002,in,0,1
175003,ASD,0,1
175004,.,0,1
175005,Hence,0,0
175006,",",0,0
175007,we,0,0
175008,investigated,0,0
175009,two,0,0
175010,EF,0,1
175011,training,0,1
175012,conditions,0,1
175013,in,0,1
175014,children,1,1
175015,with,1,1
175016,ASD,1,1
175017,.,1,1
175018,METHODS,0,0
175019,In,0,0
175020,a,0,1
175021,randomized,0,1
175022,controlled,0,0
175023,trial,0,0
175024,",",0,0
175025,children,1,1
175026,with,1,1
175027,ASD,1,1
175028,(,1,1
175029,n,1,1
175030,=,1,1
175031,121,1,1
175032,",",1,1
175033,8-12,1,1
175034,years,1,1
175035,",",1,1
175036,IQ,1,1
175037,>,1,1
175038,80,1,1
175039,),1,1
175040,were,0,1
175041,randomly,0,1
175042,assigned,0,1
175043,to,0,0
175044,an,0,0
175045,adaptive,0,0
175046,working,0,1
175047,memory,0,1
175048,(,0,1
175049,WM,0,1
175050,),0,1
175051,training,0,0
175052,",",0,0
175053,an,0,0
175054,adaptive,0,0
175055,cognitive,0,0
175056,flexibility-training,0,0
175057,",",0,0
175058,or,0,0
175059,a,0,0
175060,non-adaptive,0,0
175061,control,0,1
175062,training,0,0
175063,(,0,1
175064,mock-training,0,1
175065,),0,1
175066,.,0,1
175067,Braingame,0,0
175068,Brian,0,1
175069,",",0,0
175070,a,0,0
175071,computerized,0,0
175072,EF-training,0,0
175073,with,0,1
175074,game-elements,0,0
175075,",",0,1
175076,was,0,0
175077,used,0,0
175078,.,0,1
175079,Outcome,0,0
175080,measures,0,0
175081,(,0,1
175082,pretraining,0,0
175083,",",0,0
175084,post-training,0,0
175085,",",0,0
175086,and,0,0
175087,6-week-follow-up,0,1
175088,),0,1
175089,were,0,1
175090,near-transfer,0,1
175091,to,0,1
175092,trained,0,1
175093,EFs,0,1
175094,",",0,1
175095,far-transfer,0,0
175096,to,0,0
175097,other,0,1
175098,EFs,0,1
175099,(,0,1
175100,sustained,0,1
175101,attention,0,0
175102,and,0,0
175103,inhibition,0,0
175104,),0,0
175105,",",0,0
175106,and,0,0
175107,parent,0,1
175108,'s,0,1
175109,ratings,0,0
175110,of,0,1
175111,daily,0,0
175112,life,0,1
175113,EFs,0,1
175114,",",0,0
175115,social,0,0
175116,behavior,0,0
175117,",",0,0
175118,attention,0,0
175119,deficit,0,1
175120,hyperactivity,0,1
175121,disorder,0,1
175122,(,0,1
175123,ADHD,0,1
175124,),0,1
175125,-behavior,0,0
175126,",",0,0
175127,and,0,0
175128,quality,0,0
175129,of,0,0
175130,life,0,1
175131,.,0,1
175132,RESULTS,0,0
175133,Attrition-rate,0,0
175134,was,0,0
175135,26,0,1
175136,%,0,0
175137,.,0,1
175138,Children,0,1
175139,in,0,0
175140,all,0,1
175141,conditions,0,1
175142,who,0,1
175143,completed,0,1
175144,the,0,1
175145,training,0,0
175146,improved,0,0
175147,in,0,0
175148,WM,0,1
175149,",",0,1
175150,cognitive,0,0
175151,flexibility,0,0
175152,",",0,0
175153,attention,0,0
175154,",",0,0
175155,and,0,0
175156,on,0,0
175157,parent,0,1
175158,'s,0,1
175159,ratings,0,0
175160,",",0,1
175161,but,0,0
175162,not,0,0
175163,in,0,0
175164,inhibition,0,0
175165,.,0,0
175166,There,0,0
175167,were,0,0
175168,no,0,0
175169,significant,0,0
175170,differential,0,1
175171,intervention,0,1
175172,effects,0,0
175173,",",0,1
175174,although,0,0
175175,children,0,1
175176,in,0,1
175177,the,0,1
175178,WM,0,1
175179,condition,0,0
175180,showed,0,0
175181,a,0,0
175182,trend,0,0
175183,toward,0,0
175184,improvement,0,0
175185,on,0,0
175186,near-transfer,0,1
175187,WM,0,1
175188,and,0,1
175189,ADHD-behavior,0,0
175190,",",0,1
175191,and,0,0
175192,children,0,1
175193,in,0,1
175194,the,0,1
175195,cognitive,0,0
175196,flexibility,0,0
175197,condition,0,0
175198,showed,0,0
175199,a,0,0
175200,trend,0,0
175201,toward,0,0
175202,improvement,0,0
175203,on,0,0
175204,near-transfer,0,1
175205,flexibility,0,0
175206,.,0,1
175207,CONCLUSION,0,0
175208,Although,0,0
175209,children,0,1
175210,in,0,1
175211,the,0,1
175212,WM,0,1
175213,condition,0,0
175214,tended,0,0
175215,to,0,0
175216,improve,0,0
175217,more,0,0
175218,in,0,0
175219,WM,0,0
175220,and,0,1
175221,ADHD-behavior,0,0
175222,",",0,0
175223,the,0,0
175224,lack,0,0
175225,of,0,0
175226,differential,0,0
175227,improvement,0,0
175228,on,0,0
175229,most,0,1
175230,outcome,0,0
175231,measures,0,0
175232,",",0,1
175233,the,0,0
175234,absence,0,0
175235,of,0,0
175236,a,0,1
175237,clear,0,0
175238,effect,0,0
175239,of,0,0
175240,the,0,0
175241,adaptive,0,0
175242,training,0,0
175243,compared,0,0
175244,to,0,0
175245,the,0,0
175246,mock-training,0,0
175247,",",0,0
175248,and,0,0
175249,the,0,0
175250,high,0,0
175251,attrition,0,1
175252,rate,0,0
175253,suggest,0,0
175254,that,0,0
175255,the,0,0
175256,training,0,0
175257,in,0,0
175258,its,0,0
175259,present,0,0
175260,form,0,0
175261,is,0,0
175262,probably,0,0
175263,not,0,0
175264,suitable,0,0
175265,for,0,0
175266,children,1,1
175267,with,1,1
175268,ASD,1,1
175269,.,1,1
175270,Inhibition,0,0
175271,of,0,0
175272,PCSK9,0,1
175273,with,0,1
175274,evolocumab,0,1
175275,in,0,1
175276,homozygous,1,1
175277,familial,1,1
175278,hypercholesterolaemia,1,1
175279,(,0,1
175280,TESLA,0,0
175281,Part,0,1
175282,B,0,1
175283,),0,1
175284,:,0,1
175285,a,0,0
175286,randomised,0,0
175287,",",0,0
175288,double-blind,0,0
175289,",",0,0
175290,placebo-controlled,0,0
175291,trial,0,1
175292,.,0,1
175293,BACKGROUND,0,0
175294,Homozygous,1,1
175295,familial,1,1
175296,hypercholesterolaemia,1,1
175297,is,0,0
175298,a,0,0
175299,rare,0,0
175300,",",0,0
175301,serious,0,0
175302,disorder,0,1
175303,caused,0,0
175304,by,0,0
175305,very,0,0
175306,low,0,1
175307,or,0,1
175308,absent,0,1
175309,plasma,0,0
175310,clearance,0,0
175311,of,0,0
175312,LDL,0,0
175313,",",0,0
175314,substantially,0,0
175315,raised,0,0
175316,LDL,0,0
175317,cholesterol,0,0
175318,",",0,0
175319,and,0,0
175320,accelerated,0,0
175321,development,0,0
175322,of,0,0
175323,cardiovascular,0,1
175324,disease,0,1
175325,.,0,1
175326,Conventional,0,1
175327,lipid-lowering,0,1
175328,treatments,0,0
175329,are,0,0
175330,modestly,0,0
175331,effective,0,0
175332,.,0,1
175333,Evolocumab,0,0
175334,",",0,0
175335,a,0,0
175336,monoclonal,0,0
175337,antibody,0,0
175338,to,0,0
175339,proprotein,0,0
175340,convertase,0,0
175341,subtilisin/kexin,0,0
175342,type,0,1
175343,9,0,0
175344,(,0,1
175345,PCSK9,0,1
175346,),0,1
175347,",",0,0
175348,reduced,0,0
175349,LDL,0,0
175350,cholesterol,0,0
175351,by,0,0
175352,16,0,1
175353,%,0,0
175354,in,0,0
175355,a,0,0
175356,pilot,0,0
175357,study,0,1
175358,.,0,1
175359,We,0,0
175360,now,0,0
175361,report,0,0
175362,results,0,0
175363,with,0,1
175364,evolocumab,0,1
175365,in,0,0
175366,a,0,0
175367,randomised,0,0
175368,",",0,0
175369,double-blind,0,0
175370,",",0,0
175371,placebo-controlled,0,0
175372,phase,0,1
175373,3,0,1
175374,trial,0,1
175375,.,0,1
175376,METHODS,0,0
175377,This,0,0
175378,randomised,0,0
175379,",",0,0
175380,double-blind,0,0
175381,",",0,0
175382,placebo-controlled,0,0
175383,phase,0,1
175384,3,0,1
175385,trial,0,1
175386,was,0,0
175387,undertaken,0,1
175388,at,0,1
175389,17,0,1
175390,sites,0,1
175391,in,0,1
175392,ten,1,1
175393,countries,1,1
175394,in,1,1
175395,North,1,1
175396,America,1,1
175397,",",1,0
175398,Europe,1,0
175399,",",1,0
175400,the,1,0
175401,Middle,1,1
175402,East,1,0
175403,",",1,0
175404,and,1,0
175405,South,1,1
175406,Africa,1,1
175407,.,1,1
175408,50,1,1
175409,eligible,1,1
175410,patients,1,1
175411,(,1,1
175412,aged,1,1
175413,?12,1,1
175414,years,1,1
175415,),1,1
175416,with,1,1
175417,homozygous,1,1
175418,familial,1,1
175419,hypercholesterolaemia,1,1
175420,",",1,0
175421,on,1,0
175422,stable,1,1
175423,lipid-regulating,1,1
175424,therapy,1,0
175425,for,1,0
175426,at,1,1
175427,least,1,1
175428,4,1,1
175429,weeks,1,0
175430,",",1,1
175431,and,1,0
175432,not,1,0
175433,receiving,1,1
175434,lipoprotein,1,0
175435,apheresis,1,0
175436,",",1,0
175437,were,1,0
175438,randomly,1,1
175439,allocated,1,1
175440,by,1,0
175441,a,1,1
175442,computer-generated,1,0
175443,randomisation,1,0
175444,sequence,1,0
175445,in,1,0
175446,a,1,1
175447,2:1,1,1
175448,ratio,1,0
175449,to,1,0
175450,receive,1,1
175451,subcutaneous,1,1
175452,evolocumab,1,1
175453,420,1,1
175454,mg,1,1
175455,or,1,1
175456,placebo,1,0
175457,every,1,0
175458,4,1,0
175459,weeks,1,0
175460,for,1,1
175461,12,1,1
175462,weeks,1,1
175463,.,1,1
175464,Randomisation,0,0
175465,was,0,0
175466,stratified,0,1
175467,by,0,0
175468,LDL,0,1
175469,cholesterol,0,0
175470,at,0,0
175471,screening,0,1
175472,(,0,1
175473,<,0,0
175474,11,0,1
175475,mmol/L,0,0
175476,or,0,1
175477,?11,0,0
175478,mmol/L,0,0
175479,),0,0
175480,and,0,0
175481,implemented,0,0
175482,by,0,0
175483,a,0,1
175484,computerised,0,0
175485,interactive,0,0
175486,voice-response,0,0
175487,system,1,1
175488,.,1,1
175489,Patients,1,1
175490,",",1,0
175491,study,1,1
175492,personnel,1,1
175493,",",1,0
175494,and,1,0
175495,the,1,0
175496,funder,1,1
175497,were,1,0
175498,masked,1,0
175499,to,1,0
175500,treatment,1,0
175501,and,1,0
175502,to,1,0
175503,the,1,0
175504,efficacy,1,0
175505,results,1,0
175506,by,1,0
175507,the,1,1
175508,central,1,0
175509,laboratory,1,0
175510,not,1,0
175511,returning,1,1
175512,LDL,1,0
175513,cholesterol,1,0
175514,or,1,1
175515,any,1,1
175516,lipid,1,0
175517,results,1,0
175518,to,1,1
175519,the,1,1
175520,clinical,1,0
175521,sites,1,0
175522,after,1,1
175523,the,1,0
175524,baseline,1,0
175525,visit,1,0
175526,.,1,1
175527,The,1,0
175528,primary,0,1
175529,endpoint,0,0
175530,was,0,0
175531,percentage,0,0
175532,change,0,0
175533,in,0,0
175534,ultracentrifugation,0,0
175535,LDL,0,1
175536,cholesterol,0,0
175537,from,0,1
175538,baseline,0,0
175539,at,0,1
175540,week,0,0
175541,12,0,1
175542,compared,0,0
175543,with,0,1
175544,placebo,0,0
175545,",",0,0
175546,analysed,0,0
175547,by,0,0
175548,intention-to-treat,0,0
175549,.,0,1
175550,This,0,0
175551,trial,0,0
175552,is,0,0
175553,registered,0,0
175554,with,0,1
175555,ClinicalTrials.gov,0,0
175556,",",0,1
175557,number,0,0
175558,NCT01588496,0,0
175559,.,0,1
175560,FINDINGS,0,0
175561,Of,0,1
175562,the,0,0
175563,50,1,1
175564,eligible,1,1
175565,patients,1,1
175566,randomly,1,1
175567,assigned,1,1
175568,to,1,0
175569,the,1,0
175570,two,1,0
175571,treatment,1,0
175572,groups,1,1
175573,",",1,1
175574,49,1,1
175575,actually,1,0
175576,received,1,0
175577,the,1,0
175578,study,1,0
175579,drug,1,0
175580,and,1,0
175581,completed,1,1
175582,the,1,0
175583,study,1,0
175584,(,1,0
175585,16,1,1
175586,in,1,0
175587,the,1,0
175588,placebo,1,0
175589,group,1,1
175590,and,1,1
175591,33,1,1
175592,in,1,0
175593,the,1,0
175594,evolocumab,1,1
175595,group,1,1
175596,),1,1
175597,.,1,1
175598,Compared,1,0
175599,with,0,1
175600,placebo,0,0
175601,",",0,0
175602,evolocumab,0,1
175603,significantly,0,0
175604,reduced,0,0
175605,ultracentrifugation,0,0
175606,LDL,0,0
175607,cholesterol,0,0
175608,at,0,1
175609,12,0,1
175610,weeks,0,1
175611,by,0,1
175612,30?9,0,1
175613,%,0,0
175614,(,0,1
175615,95,0,0
175616,%,0,0
175617,CI,0,0
175618,-43?9,0,0
175619,%,0,0
175620,to,0,1
175621,-18?0,0,1
175622,%,0,0
175623,;,0,0
175624,p,0,0
175625,<,0,0
175626,0?0001,0,1
175627,),0,1
175628,.,0,1
175629,Treatment-emergent,0,0
175630,adverse,0,0
175631,events,0,0
175632,occurred,0,0
175633,in,0,1
175634,ten,0,1
175635,(,0,1
175636,63,0,1
175637,%,0,0
175638,),0,1
175639,of,0,1
175640,16,0,1
175641,patients,0,1
175642,in,0,1
175643,the,0,0
175644,placebo,0,0
175645,group,0,1
175646,and,0,1
175647,12,0,1
175648,(,0,1
175649,36,0,1
175650,%,0,0
175651,),0,1
175652,of,0,0
175653,33,0,1
175654,in,0,0
175655,the,0,0
175656,evolocumab,0,1
175657,group,0,0
175658,.,0,1
175659,No,0,0
175660,serious,0,0
175661,clinical,0,0
175662,or,0,1
175663,laboratory,0,1
175664,adverse,0,0
175665,events,0,0
175666,occurred,0,0
175667,",",0,0
175668,and,0,0
175669,no,0,0
175670,anti-evolocumab,0,0
175671,antibody,0,0
175672,development,0,0
175673,was,0,0
175674,detected,0,0
175675,during,0,0
175676,the,0,0
175677,study,0,1
175678,.,0,1
175679,INTERPRETATION,1,0
175680,In,1,1
175681,patients,1,1
175682,with,1,1
175683,homozygous,1,1
175684,familial,1,1
175685,hypercholesterolaemia,1,1
175686,receiving,1,1
175687,stable,0,1
175688,background,0,0
175689,lipid-lowering,0,1
175690,treatment,0,0
175691,and,0,0
175692,not,0,0
175693,on,0,0
175694,apheresis,0,0
175695,",",0,0
175696,evolocumab,0,1
175697,420,0,0
175698,mg,0,0
175699,administered,0,0
175700,every,0,0
175701,4,0,0
175702,weeks,0,0
175703,was,0,0
175704,well,0,0
175705,tolerated,0,0
175706,and,0,0
175707,significantly,0,0
175708,reduced,0,0
175709,LDL,0,0
175710,cholesterol,0,0
175711,compared,0,0
175712,with,0,1
175713,placebo,0,1
175714,.,0,1
175715,FUNDING,0,0
175716,Amgen,0,1
175717,Inc,0,0
175718,.,0,1
175719,Pharmacodynamic,0,0
175720,analysis,0,0
175721,of,0,0
175722,intravenous,0,1
175723,recombinant,0,0
175724,urate,0,0
175725,oxidase,0,0
175726,using,0,0
175727,an,0,0
175728,indirect,1,0
175729,pharmacological,1,0
175730,response,1,0
175731,model,1,0
175732,in,1,1
175733,healthy,1,1
175734,subjects,1,1
175735,.,1,1
175736,AIM,0,0
175737,Pharmacodynamic,0,0
175738,analysis,0,0
175739,of,0,0
175740,intravenous,0,1
175741,recombinant,0,0
175742,urate,0,0
175743,oxidase,0,0
175744,produced,0,0
175745,by,0,0
175746,Escherichia,0,0
175747,coli,0,0
175748,was,0,0
175749,performed,0,0
175750,in,1,1
175751,healthy,1,1
175752,subjects,1,1
175753,using,1,1
175754,a,1,1
175755,pharmacokinetic/pharmacodynamic,1,0
175756,(,1,1
175757,PK/PD,1,0
175758,),1,1
175759,model,1,0
175760,.,1,1
175761,METHODS,0,0
175762,A,0,0
175763,randomized,0,1
175764,",",0,0
175765,single-blind,0,0
175766,",",0,0
175767,placebo-controlled,0,0
175768,study,0,1
175769,was,0,0
175770,performed,0,0
175771,in,1,1
175772,40,1,1
175773,healthy,1,1
175774,Chinese,1,1
175775,subjects,1,1
175776,(,1,1
175777,4,1,1
175778,groups,1,1
175779,of,1,1
175780,10,1,1
175781,subjects,1,1
175782,each,1,0
175783,",",1,0
175784,placebo,1,0
175785,4:1,1,0
175786,ratio,1,0
175787,),1,1
175788,who,1,1
175789,received,1,1
175790,infusions,1,1
175791,of,1,1
175792,uricase,1,1
175793,(,1,1
175794,single,1,0
175795,doses,1,0
175796,of,1,1
175797,0.1,1,1
175798,",",1,1
175799,0.2,1,0
175800,",",1,0
175801,and,1,0
175802,0.3,1,0
175803,mg/kg,1,0
175804,;,1,1
175805,multiple,1,1
175806,doses,1,0
175807,of,1,1
175808,0.2,1,1
175809,mg?kg,1,1
175810,(,1,1
175811,-1,1,0
175812,),1,1
175813,?d,1,1
175814,(,1,1
175815,-1,1,0
175816,),1,1
175817,for,1,1
175818,7,1,1
175819,d,1,1
175820,),1,1
175821,.,1,1
175822,PK,0,0
175823,profiles,0,0
175824,were,0,1
175825,determined,0,0
175826,through,0,1
175827,plasma,0,0
175828,uricase,0,0
175829,activity,0,0
175830,",",0,0
175831,and,0,0
175832,PD,0,1
175833,profiles,0,0
175834,were,0,1
175835,established,0,1
175836,using,0,0
175837,uric,0,0
175838,acid,0,0
175839,levels,0,0
175840,in,0,1
175841,plasma,0,0
175842,and,0,1
175843,urine,0,1
175844,.,0,1
175845,The,0,0
175846,plasma,0,0
175847,PD,0,1
175848,parameter,0,0
175849,was,0,0
175850,estimated,0,0
175851,as,0,0
175852,changes,0,0
175853,in,0,1
175854,plasma,0,0
175855,uric,0,0
175856,acid,0,0
175857,levels,0,0
175858,as,0,0
175859,the,0,0
175860,effect,0,0
175861,in,0,0
175862,the,0,0
175863,indirect,0,0
175864,response,0,0
175865,model,0,0
175866,.,0,1
175867,Adverse,0,0
175868,events,0,0
175869,were,0,1
175870,also,0,0
175871,monitored,0,0
175872,.,0,0
175873,RESULTS,0,0
175874,A,0,0
175875,two-compartment,0,0
175876,PK,0,0
175877,model,0,0
175878,with,0,1
175879,constant,0,0
175880,iv,0,1
175881,input,0,1
175882,and,0,0
175883,first-order,0,0
175884,output,0,0
175885,was,0,0
175886,used,0,0
175887,to,0,0
175888,describe,0,0
175889,the,0,0
175890,kinetic,0,0
175891,process,0,0
175892,of,0,0
175893,plasma,0,0
175894,uricase,0,0
175895,.,0,1
175896,The,0,0
175897,low,0,0
175898,value,0,0
175899,(,0,1
175900,2.8,0,0
175901,U/L,0,1
175902,),0,1
175903,of,0,0
175904,drug,0,1
175905,concentration,0,0
175906,that,0,0
175907,achieved,0,0
175908,50,0,1
175909,%,0,0
175910,of,0,0
175911,maximum,0,0
175912,effect,0,0
175913,(,0,1
175914,EC50,0,0
175915,),0,1
175916,indicated,0,0
175917,that,0,0
175918,low,0,1
175919,plasma,0,0
175920,uricase,0,1
175921,concentrations,0,0
175922,were,0,1
175923,sufficient,0,0
175924,to,0,0
175925,produce,0,0
175926,pharmacological,0,0
175927,effects,0,0
175928,.,0,1
175929,A,0,0
175930,strong,0,0
175931,relationship,0,0
175932,(,0,1
175933,r,0,0
175934,(,0,1
175935,2,0,1
175936,),0,1
175937,=0.9991,0,0
175938,),0,1
175939,between,0,0
175940,the,0,0
175941,mean,0,1
175942,uric,0,0
175943,acid,0,0
175944,concentration,0,0
175945,in,0,0
175946,blood,0,0
175947,and,0,0
175948,the,0,0
175949,mean,0,1
175950,uric,0,0
175951,acid,0,0
175952,excretion,0,0
175953,rate,0,0
175954,in,0,0
175955,urine,0,1
175956,in,0,0
175957,the,0,0
175958,range,0,1
175959,of,0,0
175960,11,0,1
175961,to,0,1
175962,30,0,1
175963,h,0,0
175964,after,0,1
175965,single,0,0
175966,dosing,0,0
175967,was,0,0
175968,found,0,0
175969,.,0,1
175970,Infusions,1,0
175971,of,1,0
175972,uricase,1,0
175973,were,1,1
175974,well,1,0
175975,tolerated,1,0
175976,in,1,0
175977,all,1,1
175978,subjects,1,1
175979,.,1,1
175980,CONCLUSION,0,0
175981,The,0,0
175982,PK/PD,0,0
175983,model,0,0
175984,predicted,0,0
175985,the,1,0
175986,effective,1,0
175987,dose,1,0
175988,to,1,1
175989,be,1,0
175990,0.1,1,0
175991,mg/kg,1,0
175992,in,1,1
175993,healthy,1,1
175994,subjects,1,1
175995,.,1,1
175996,The,0,0
175997,excretion,0,0
175998,rate,0,0
175999,of,0,0
176000,uric,0,0
176001,acid,0,0
176002,in,0,0
176003,urine,0,0
176004,may,0,0
176005,be,0,0
176006,used,0,0
176007,as,0,0
176008,a,0,1
176009,new,0,1
176010,index,0,0
176011,for,0,1
176012,pharmacological,0,0
176013,effects,0,0
176014,in,0,1
176015,further,0,1
176016,clinical,0,1
176017,trials,0,1
176018,.,0,1
176019,Selenium,0,1
176020,Treatment,0,0
176021,and,0,1
176022,Chagasic,0,1
176023,Cardiopathy,0,1
176024,(,0,1
176025,STCC,0,1
176026,),0,1
176027,:,0,1
176028,study,0,1
176029,protocol,0,0
176030,for,0,0
176031,a,0,1
176032,double-blind,0,0
176033,randomized,0,1
176034,controlled,0,0
176035,trial,0,0
176036,.,0,1
176037,BACKGROUND,0,0
176038,Heart,0,1
176039,disease,0,1
176040,progression,0,0
176041,occurs,0,0
176042,in,0,0
176043,30,0,0
176044,%,0,0
176045,of,0,1
176046,patients,0,1
176047,with,0,1
176048,chronic,0,1
176049,Trypanosoma,0,1
176050,cruzi,0,1
176051,infection,0,1
176052,.,0,1
176053,Supplementation,0,0
176054,with,0,1
176055,selenium,0,1
176056,(,0,1
176057,Se,0,0
176058,),0,1
176059,in,0,0
176060,animal,0,1
176061,model,0,0
176062,of,0,0
176063,T.,0,1
176064,cruzi,0,1
176065,infection,0,1
176066,produced,0,0
176067,promising,0,0
176068,results,0,0
176069,.,0,0
176070,There,0,0
176071,is,0,0
176072,evidence,0,0
176073,that,0,0
176074,patients,1,1
176075,with,1,1
176076,Chagas,1,1
176077,heart,1,1
176078,disease,1,1
176079,have,0,0
176080,lower,0,0
176081,Se,0,0
176082,levels,0,0
176083,than,0,1
176084,healthy,0,1
176085,individuals,0,1
176086,and,0,1
176087,patients,0,1
176088,with,0,1
176089,T.,0,1
176090,cruzi,0,1
176091,infection,0,1
176092,without,0,1
176093,of,0,0
176094,cardiac,0,1
176095,disease,0,1
176096,.,0,1
176097,The,0,0
176098,aim,0,0
176099,of,0,0
176100,this,0,0
176101,investigation,0,0
176102,is,0,0
176103,to,0,0
176104,estimate,0,0
176105,the,0,0
176106,effect,0,0
176107,of,0,0
176108,Se,0,0
176109,treatment,0,1
176110,on,0,0
176111,prevention,0,1
176112,of,0,0
176113,heart,0,1
176114,disease,0,1
176115,progression,0,0
176116,in,0,0
176117,patients,1,1
176118,with,1,1
176119,chagasic,1,1
176120,cardiopathy,1,1
176121,.,1,1
176122,METHODS,0,0
176123,The,0,0
176124,Selenium,0,1
176125,Treatment,0,0
176126,and,0,1
176127,Chagasic,0,1
176128,Cardiopathy,0,1
176129,trial,0,0
176130,is,0,0
176131,a,0,0
176132,superiority,0,0
176133,",",0,0
176134,double-blind,0,0
176135,",",0,0
176136,placebo-controlled,0,0
176137,",",0,0
176138,randomized,0,1
176139,clinical,0,0
176140,trial,0,1
176141,.,0,1
176142,The,0,0
176143,eligibility,0,1
176144,criteria,0,1
176145,are,0,0
176146,as,0,0
176147,follows,0,0
176148,:,0,1
176149,(,1,0
176150,1,1,1
176151,),1,1
176152,a,1,1
176153,Chagas,1,1
176154,disease,1,1
176155,diagnosis,1,1
176156,confirmed,1,0
176157,by,1,0
176158,serology,1,1
176159,;,1,1
176160,(,1,1
176161,2,1,1
176162,),1,1
176163,segmental,1,0
176164,",",1,0
176165,mild,1,1
176166,or,1,1
176167,moderate,1,1
176168,global,1,0
176169,left,1,1
176170,ventricular,1,1
176171,systolic,1,1
176172,dysfunction,1,1
176173,;,1,1
176174,and,1,1
176175,(,1,1
176176,3,1,1
176177,),1,1
176178,age,1,1
176179,between,1,0
176180,18,1,1
176181,and,1,1
176182,65,1,1
176183,years,1,1
176184,.,1,1
176185,The,0,0
176186,exclusion,1,0
176187,criteria,1,1
176188,are,1,0
176189,as,1,0
176190,follows,1,0
176191,:,1,1
176192,(,1,0
176193,1,1,1
176194,),1,1
176195,pregnancy,1,1
176196,",",1,0
176197,(,1,1
176198,2,1,0
176199,),1,0
176200,diabetes,1,1
176201,mellitus,1,1
176202,",",1,0
176203,(,1,1
176204,3,1,1
176205,),1,1
176206,tobacco,1,1
176207,use,1,0
176208,",",1,0
176209,(,1,1
176210,4,1,0
176211,),1,1
176212,alcohol,1,1
176213,abuse,1,1
176214,",",1,0
176215,(,1,1
176216,5,1,0
176217,),1,1
176218,evidence,1,0
176219,of,1,0
176220,nonchagasic,1,1
176221,heart,1,1
176222,disease,1,1
176223,",",1,0
176224,(,1,1
176225,6,1,0
176226,),1,1
176227,depression,1,1
176228,",",1,0
176229,(,1,1
176230,7,1,1
176231,),1,1
176232,dysphagia,1,1
176233,with,1,1
176234,evidence,1,0
176235,of,1,1
176236,food,1,0
176237,residues,1,1
176238,in,1,0
176239,the,1,0
176240,esophagus,1,1
176241,",",1,0
176242,(,1,1
176243,8,1,1
176244,),1,1
176245,dysphagia,1,1
176246,with,1,1
176247,weight,1,1
176248,loss,1,0
176249,higher,1,0
176250,than,1,0
176251,15,1,1
176252,%,1,0
176253,of,1,0
176254,usual,1,1
176255,weight,1,1
176256,in,1,0
176257,the,1,0
176258,last,1,1
176259,four,1,1
176260,months,1,0
176261,and/or,1,1
176262,(,1,1
176263,9,1,0
176264,),1,1
176265,conditions,1,0
176266,that,1,0
176267,may,1,0
176268,result,1,0
176269,in,1,0
176270,low,1,1
176271,protocol,1,1
176272,adherence,1,0
176273,.,1,1
176274,The,0,0
176275,intervention,0,0
176276,will,0,0
176277,be,0,0
176278,100,0,0
176279,?g,0,0
176280,of,0,0
176281,sodium,0,0
176282,selenite,0,0
176283,once,0,0
176284,daily,0,0
176285,for,0,0
176286,365,0,1
176287,consecutive,0,1
176288,days,0,0
176289,compared,0,0
176290,to,0,1
176291,placebo,0,0
176292,.,0,1
176293,The,0,0
176294,following,0,0
176295,are,0,0
176296,the,0,0
176297,primary,0,1
176298,outcomes,0,0
176299,to,0,1
176300,be,0,0
176301,measured,0,0
176302,:,0,1
176303,(,0,1
176304,1,0,1
176305,),0,1
176306,the,0,0
176307,trajectories,0,0
176308,of,0,0
176309,the,0,0
176310,left,0,1
176311,ventricular,0,0
176312,ejection,0,1
176313,fraction,0,1
176314,in,0,0
176315,the,0,0
176316,follow-up,0,0
176317,period,0,0
176318,;,0,1
176319,(,0,1
176320,2,0,1
176321,),0,1
176322,reduction,0,0
176323,of,0,0
176324,heart,0,1
176325,disease,0,1
176326,progression,0,0
176327,rates,0,0
176328,",",0,1
176329,with,0,1
176330,progression,0,0
176331,defined,0,1
176332,as,0,0
176333,a,0,1
176334,10,0,1
176335,%,0,0
176336,decrease,0,0
176337,in,0,0
176338,left,0,1
176339,ventricular,0,1
176340,ejection,0,1
176341,fraction,0,1
176342,;,0,1
176343,and,0,1
176344,(,0,1
176345,3,0,1
176346,),0,1
176347,rate,0,0
176348,of,0,0
176349,hospital,0,1
176350,admissions,0,1
176351,attributable,0,0
176352,to,0,1
176353,dysrhythmia,0,1
176354,",",0,0
176355,heart,0,1
176356,failure,0,1
176357,or,0,1
176358,stroke,0,1
176359,due,0,0
176360,to,0,1
176361,Chagas,0,1
176362,disease,0,1
176363,.,0,1
176364,One,0,1
176365,hundred,0,1
176366,thirty,0,1
176367,patients,0,1
176368,will,0,0
176369,be,0,0
176370,randomly,0,0
176371,allocated,0,1
176372,into,0,0
176373,either,0,0
176374,the,0,0
176375,intervention,0,0
176376,or,0,1
176377,placebo,0,0
176378,group,0,1
176379,at,0,0
176380,a,0,0
176381,ratio,0,0
176382,of,0,0
176383,1:1,0,1
176384,.,0,1
176385,The,0,0
176386,sequence,0,0
176387,allocation,0,0
176388,concealment,0,0
176389,and,0,0
176390,blinding,0,0
176391,were,0,1
176392,planned,0,0
176393,to,0,0
176394,be,0,0
176395,conducted,0,0
176396,with,0,1
176397,the,0,0
176398,strategy,0,0
176399,of,0,0
176400,numbered,0,1
176401,boxes,0,0
176402,.,0,1
176403,Both,0,0
176404,patients,0,1
176405,and,0,1
176406,health-care,0,1
176407,providers,0,1
176408,will,0,0
176409,remain,0,1
176410,blinded,0,0
176411,to,0,0
176412,the,0,0
176413,intervention,0,0
176414,groups,0,0
176415,during,0,1
176416,the,0,1
176417,5,0,0
176418,years,0,1
176419,of,0,1
176420,follow-up,0,1
176421,.,0,1
176422,DISCUSSION,0,0
176423,If,0,0
176424,Se,0,0
176425,treatment,0,0
176426,reduces,0,0
176427,the,0,0
176428,progression,0,0
176429,of,0,0
176430,Chagas,0,1
176431,cardiopathy,0,1
176432,",",0,0
176433,the,0,0
176434,inclusion,0,0
176435,of,0,0
176436,this,0,0
176437,micronutrient,0,0
176438,in,0,0
176439,the,0,0
176440,daily,0,0
176441,diet,0,0
176442,can,0,0
176443,improve,0,0
176444,the,0,0
176445,therapeutic,0,0
176446,regimen,0,0
176447,for,0,1
176448,this,0,0
176449,neglected,0,1
176450,tropical,0,1
176451,disease,0,1
176452,at,0,1
176453,low,0,1
176454,cost,0,0
176455,.,0,1
176456,TRIAL,0,0
176457,REGISTRATION,0,0
176458,Clinical,0,0
176459,Trials.gov,0,1
176460,ID,0,1
176461,:,0,1
176462,NCT00875173,0,0
176463,(,0,1
176464,registered,0,1
176465,20,0,1
176466,October,0,1
176467,20,0,1
176468,2008,0,1
176469,),0,1
176470,.,0,1
176471,A,0,0
176472,randomized,0,0
176473,controlled,0,0
176474,trial,0,1
176475,of,0,1
176476,Pivotal,0,1
176477,Response,0,0
176478,Treatment,0,0
176479,Group,0,1
176480,for,0,1
176481,parents,1,1
176482,of,1,1
176483,children,1,1
176484,with,1,1
176485,autism,1,1
176486,.,1,1
176487,BACKGROUND,0,0
176488,With,0,1
176489,rates,0,0
176490,of,0,1
176491,autism,0,1
176492,diagnosis,0,1
176493,continuing,0,0
176494,to,0,0
176495,rise,0,0
176496,",",0,0
176497,there,0,0
176498,is,0,0
176499,an,0,0
176500,urgent,0,1
176501,need,0,0
176502,for,0,1
176503,effective,0,0
176504,and,0,1
176505,efficient,0,0
176506,service,0,1
176507,delivery,0,1
176508,models,0,1
176509,.,0,1
176510,Pivotal,0,0
176511,Response,0,0
176512,Treatment,0,0
176513,(,0,1
176514,PRT,0,1
176515,),0,1
176516,is,0,0
176517,considered,0,0
176518,an,0,0
176519,established,0,0
176520,treatment,0,0
176521,for,0,0
176522,autism,0,1
176523,spectrum,0,1
176524,disorder,0,1
176525,(,0,1
176526,ASD,0,1
176527,),0,1
176528,;,0,0
176529,however,0,0
176530,",",0,0
176531,there,0,0
176532,have,0,0
176533,been,0,0
176534,few,0,0
176535,well-controlled,0,1
176536,studies,0,0
176537,with,0,1
176538,adequate,0,1
176539,sample,0,1
176540,size,0,0
176541,.,0,1
176542,The,0,0
176543,aim,0,0
176544,of,0,0
176545,this,0,0
176546,study,0,0
176547,was,0,0
176548,to,0,0
176549,conduct,0,0
176550,a,0,0
176551,randomized,0,0
176552,controlled,0,0
176553,trial,0,0
176554,to,0,0
176555,evaluate,0,0
176556,PRT,0,1
176557,parent,0,1
176558,training,0,0
176559,group,0,1
176560,(,0,1
176561,PRTG,0,1
176562,),0,1
176563,for,0,0
176564,targeting,0,0
176565,language,0,1
176566,deficits,0,1
176567,in,0,1
176568,young,1,1
176569,children,1,1
176570,with,1,1
176571,ASD,1,1
176572,.,1,1
176573,METHODS,0,0
176574,Fifty-three,1,1
176575,children,1,1
176576,with,1,1
176577,autism,1,1
176578,and,1,1
176579,significant,1,0
176580,language,1,0
176581,delay,1,1
176582,between,1,0
176583,2,1,1
176584,and,1,1
176585,6,1,1
176586,years,1,1
176587,old,1,1
176588,were,1,1
176589,randomized,1,1
176590,to,1,1
176591,PRTG,1,1
176592,(,1,1
176593,N,1,1
176594,=,1,1
176595,27,1,1
176596,),1,1
176597,or,1,1
176598,psychoeducation,1,1
176599,group,1,1
176600,(,1,1
176601,PEG,1,1
176602,;,1,1
176603,N,1,1
176604,=,1,1
176605,26,1,1
176606,),1,1
176607,for,1,1
176608,12,1,1
176609,weeks,1,1
176610,.,1,1
176611,The,1,0
176612,PRTG,0,0
176613,taught,0,1
176614,parents,0,1
176615,behavioral,0,1
176616,techniques,0,0
176617,to,0,1
176618,facilitate,0,0
176619,language,0,0
176620,development,0,0
176621,.,0,1
176622,The,0,0
176623,PEG,0,1
176624,taught,0,1
176625,general,0,1
176626,information,0,0
176627,about,0,0
176628,ASD,0,1
176629,(,0,1
176630,clinical,0,0
176631,trial,0,1
176632,NCT01881750,0,1
176633,;,0,1
176634,http,0,0
176635,:,0,1
176636,//www.clinicaltrials.gov,0,0
176637,),0,1
176638,.,0,1
176639,RESULTS,0,0
176640,Analysis,0,0
176641,of,0,1
176642,child,0,1
176643,utterances,0,1
176644,during,0,1
176645,the,0,1
176646,structured,0,1
176647,laboratory,0,0
176648,observation,0,0
176649,(,0,1
176650,primary,0,1
176651,outcome,0,0
176652,),0,1
176653,indicated,0,0
176654,that,0,0
176655,",",0,0
176656,compared,0,0
176657,with,0,1
176658,children,0,1
176659,in,0,1
176660,the,0,0
176661,PEG,0,1
176662,",",0,0
176663,children,0,1
176664,in,0,0
176665,the,0,1
176666,PRTG,0,0
176667,demonstrated,0,0
176668,greater,0,0
176669,improvement,0,0
176670,in,0,0
176671,frequency,0,0
176672,of,0,1
176673,utterances,0,1
176674,(,0,1
176675,F,0,1
176676,(,0,1
176677,2,0,1
176678,",",0,1
176679,43,0,1
176680,),0,1
176681,=,0,1
176682,3.53,0,0
176683,",",0,0
176684,p,0,0
176685,=,0,0
176686,.038,0,0
176687,",",0,0
176688,d,0,0
176689,=,0,1
176690,0.42,0,0
176691,),0,1
176692,.,0,1
176693,Results,0,0
176694,indicated,0,0
176695,that,0,0
176696,parents,0,1
176697,were,0,1
176698,able,0,0
176699,to,0,0
176700,learn,0,1
176701,PRT,0,1
176702,in,0,0
176703,a,0,1
176704,group,0,0
176705,format,0,0
176706,",",0,0
176707,as,0,0
176708,the,0,0
176709,majority,0,1
176710,of,0,0
176711,parents,0,1
176712,in,0,1
176713,the,0,1
176714,PRTG,0,1
176715,(,0,1
176716,84,0,1
176717,%,0,0
176718,),0,1
176719,met,0,1
176720,fidelity,0,0
176721,of,0,0
176722,implementation,0,0
176723,criteria,0,1
176724,after,0,1
176725,12,0,1
176726,weeks,0,1
176727,.,0,1
176728,Children,0,1
176729,also,0,0
176730,demonstrated,0,0
176731,greater,0,0
176732,improvement,0,0
176733,in,0,0
176734,adaptive,0,0
176735,communication,0,0
176736,skills,0,0
176737,(,0,1
176738,Vineland-II,0,1
176739,),0,1
176740,following,0,0
176741,PRTG,0,1
176742,and,0,1
176743,baseline,0,0
176744,Mullen,0,1
176745,visual,0,0
176746,reception,0,1
176747,scores,0,0
176748,predicted,0,0
176749,treatment,0,1
176750,response,0,0
176751,to,0,1
176752,PRTG,0,1
176753,.,0,1
176754,CONCLUSIONS,0,0
176755,This,0,0
176756,is,0,0
176757,the,0,0
176758,first,0,0
176759,randomized,0,1
176760,controlled,0,0
176761,trial,0,1
176762,of,0,0
176763,group-delivered,0,1
176764,PRT,0,1
176765,and,0,1
176766,one,0,1
176767,of,0,0
176768,the,0,0
176769,largest,0,1
176770,experimental,0,0
176771,investigations,0,0
176772,of,0,1
176773,the,0,1
176774,PRT,0,1
176775,model,0,0
176776,to,0,1
176777,date,0,0
176778,.,0,1
176779,The,0,0
176780,findings,0,0
176781,suggest,0,0
176782,that,0,0
176783,specific,0,0
176784,instruction,0,0
176785,in,0,1
176786,PRT,0,1
176787,results,0,0
176788,in,0,1
176789,greater,0,0
176790,skill,0,0
176791,acquisition,0,0
176792,for,0,0
176793,both,0,0
176794,parents,0,1
176795,and,0,1
176796,children,0,1
176797,",",0,0
176798,especially,0,0
176799,in,0,0
176800,functional,0,0
176801,and,0,1
176802,adaptive,0,0
176803,communication,0,0
176804,skills,0,0
176805,.,0,1
176806,Further,0,0
176807,research,0,0
176808,in,0,0
176809,PRT,0,1
176810,is,0,0
176811,warranted,0,0
176812,to,0,0
176813,replicate,0,1
176814,the,0,0
176815,observed,0,0
176816,results,0,0
176817,and,0,1
176818,address,0,0
176819,other,0,1
176820,core,0,1
176821,ASD,0,1
176822,symptoms,0,1
176823,.,0,1
176824,Anthropometric,0,1
176825,indices,0,0
176826,of,0,1
176827,Gambian,1,1
176828,children,1,1
176829,after,0,1
176830,one,0,1
176831,or,0,1
176832,three,0,1
176833,annual,0,1
176834,rounds,0,0
176835,of,0,1
176836,mass,0,1
176837,drug,0,1
176838,administration,0,0
176839,with,0,1
176840,azithromycin,0,0
176841,for,0,0
176842,trachoma,1,1
176843,control,0,1
176844,.,0,1
176845,BACKGROUND,0,0
176846,Mass,0,1
176847,drug,0,1
176848,administration,0,0
176849,(,0,1
176850,MDA,0,1
176851,),0,1
176852,with,0,1
176853,azithromycin,0,0
176854,",",0,0
176855,carried,0,0
176856,out,0,0
176857,for,0,0
176858,the,0,0
176859,control,0,1
176860,of,0,0
176861,blinding,0,0
176862,trachoma,0,1
176863,",",0,0
176864,has,0,0
176865,been,0,0
176866,linked,0,0
176867,to,0,0
176868,reduced,0,0
176869,mortality,0,0
176870,in,0,1
176871,children,1,1
176872,.,1,1
176873,While,0,1
176874,the,0,0
176875,mechanism,0,0
176876,behind,0,0
176877,this,0,0
176878,reduction,0,0
176879,is,0,0
176880,unclear,0,0
176881,",",0,0
176882,it,0,0
176883,may,0,0
176884,be,0,0
176885,due,0,0
176886,",",0,0
176887,in,0,0
176888,part,0,0
176889,",",0,0
176890,to,0,0
176891,improved,0,0
176892,nutritional,0,0
176893,status,0,1
176894,via,0,1
176895,a,0,1
176896,potential,0,0
176897,reduction,0,0
176898,in,0,0
176899,the,0,0
176900,community,0,1
176901,burden,0,1
176902,of,0,0
176903,infectious,0,1
176904,disease,0,1
176905,.,0,1
176906,To,0,0
176907,determine,0,0
176908,whether,0,0
176909,MDA,0,0
176910,with,0,1
176911,azithromycin,0,1
176912,improves,0,0
176913,anthropometric,0,1
176914,indices,0,0
176915,at,0,1
176916,the,0,0
176917,community,0,1
176918,level,0,0
176919,",",0,0
176920,we,0,0
176921,measured,0,0
176922,the,0,0
176923,heights,0,0
176924,and,0,1
176925,weights,0,1
176926,of,0,1
176927,children,1,1
176928,aged,1,1
176929,1,1,1
176930,to,1,1
176931,4,1,1
176932,years,1,1
176933,in,1,1
176934,communities,1,1
176935,where,1,1
176936,one,1,1
176937,(,1,0
176938,single,1,0
176939,MDA,1,1
176940,arm,1,1
176941,),1,1
176942,or,1,1
176943,three,1,1
176944,annual,1,1
176945,rounds,1,0
176946,(,1,1
176947,annual,1,1
176948,MDA,1,1
176949,arm,1,1
176950,),1,1
176951,of,1,0
176952,azithromycin,1,1
176953,had,0,1
176954,been,0,1
176955,distributed,0,1
176956,.,0,1
176957,METHODS,0,0
176958,Data,0,1
176959,collection,0,1
176960,took,0,1
176961,place,0,1
176962,three,0,0
176963,years,0,1
176964,after,0,1
176965,treatment,0,1
176966,in,0,0
176967,the,0,0
176968,single,0,0
176969,MDA,0,0
176970,arm,0,1
176971,and,0,1
176972,one,0,1
176973,year,0,1
176974,after,0,0
176975,the,0,0
176976,final,0,0
176977,round,0,1
176978,of,0,0
176979,treatment,0,0
176980,in,0,0
176981,the,0,0
176982,annual,0,0
176983,MDA,0,0
176984,arm,0,1
176985,.,0,1
176986,Mean,0,1
176987,height-for-age,0,0
176988,",",0,0
176989,weight-for-age,0,0
176990,and,0,0
176991,weight-for-height,0,1
176992,z,0,0
176993,scores,0,0
176994,were,0,1
176995,compared,0,0
176996,between,0,0
176997,treatment,0,1
176998,arms,0,1
176999,.,0,1
177000,RESULTS,0,0
177001,No,0,0
177002,significant,0,0
177003,differences,0,0
177004,in,0,1
177005,mean,0,1
177006,height-for-age,0,1
177007,",",0,0
177008,weight-for-age,0,0
177009,or,0,1
177010,weight-for-height,0,1
177011,z,0,0
177012,scores,0,0
177013,were,0,1
177014,found,0,0
177015,between,0,0
177016,the,0,0
177017,annual,0,1
177018,MDA,0,0
177019,and,0,1
177020,single,0,1
177021,MDA,0,1
177022,arms,0,1
177023,",",0,1
177024,nor,0,0
177025,was,0,0
177026,there,0,0
177027,a,0,0
177028,significant,0,0
177029,reduction,0,0
177030,in,0,0
177031,prevalence,0,0
177032,of,0,0
177033,stunting,0,0
177034,",",0,0
177035,wasting,0,1
177036,or,0,1
177037,underweight,0,1
177038,between,0,0
177039,arms,0,1
177040,.,0,1
177041,CONCLUSIONS,0,0
177042,Our,0,0
177043,data,0,0
177044,do,0,0
177045,not,0,0
177046,provide,0,0
177047,evidence,0,0
177048,that,0,0
177049,community,0,1
177050,MDA,0,1
177051,with,0,1
177052,azithromycin,0,0
177053,improved,0,0
177054,anthropometric,0,1
177055,outcomes,0,0
177056,of,0,1
177057,children,1,1
177058,in,1,1
177059,The,1,1
177060,Gambia,1,1
177061,.,1,0
177062,This,0,0
177063,may,0,0
177064,suggest,0,0
177065,reductions,0,0
177066,in,0,0
177067,mortality,0,0
177068,associated,0,0
177069,with,0,1
177070,azithromycin,0,0
177071,MDA,0,1
177072,are,0,0
177073,due,0,0
177074,to,0,0
177075,a,0,1
177076,mechanism,0,0
177077,other,0,0
177078,than,0,0
177079,improved,0,0
177080,nutritional,0,1
177081,status,0,1
177082,.,0,1
177083,A,0,0
177084,randomized,0,0
177085,controlled,0,0
177086,trial,0,1
177087,of,0,0
177088,cognitive-behavioral,0,1
177089,therapy,0,1
177090,versus,0,0
177091,treatment,0,0
177092,as,0,0
177093,usual,0,1
177094,for,0,1
177095,adolescents,1,1
177096,with,1,1
177097,autism,1,1
177098,spectrum,1,1
177099,disorders,1,1
177100,and,1,1
177101,comorbid,1,1
177102,anxiety,1,1
177103,.,1,1
177104,OBJECTIVE,0,0
177105,Examine,0,0
177106,the,0,0
177107,efficacy,0,0
177108,of,0,0
177109,a,0,0
177110,personalized,0,0
177111,",",0,0
177112,modular,0,0
177113,cognitive-behavioral,0,1
177114,therapy,0,1
177115,(,0,1
177116,CBT,0,1
177117,),0,1
177118,protocol,0,1
177119,among,0,1
177120,early,1,1
177121,adolescents,1,1
177122,with,1,1
177123,high-functioning,1,1
177124,autism,1,1
177125,spectrum,1,1
177126,disorders,1,1
177127,(,1,1
177128,ASDs,1,1
177129,),1,1
177130,and,1,1
177131,co-occurring,1,1
177132,anxiety,1,1
177133,relative,0,0
177134,to,0,0
177135,treatment,0,0
177136,as,0,0
177137,usual,0,1
177138,(,0,1
177139,TAU,0,0
177140,),0,1
177141,.,0,1
177142,METHOD,0,0
177143,Thirty-one,1,1
177144,children,1,1
177145,(,1,1
177146,11-16,1,1
177147,years,1,1
177148,),1,1
177149,with,1,1
177150,ASD,1,1
177151,and,1,1
177152,clinically,1,1
177153,significant,1,0
177154,anxiety,1,1
177155,were,0,1
177156,randomly,0,1
177157,assigned,0,1
177158,to,0,0
177159,receive,0,1
177160,16,0,1
177161,weekly,0,1
177162,CBT,0,1
177163,sessions,0,0
177164,or,0,1
177165,an,0,1
177166,equivalent,0,0
177167,duration,0,0
177168,of,0,1
177169,TAU,0,0
177170,.,0,1
177171,Participants,0,1
177172,were,0,0
177173,assessed,0,0
177174,by,0,0
177175,blinded,0,1
177176,raters,0,1
177177,at,0,1
177178,screening,0,1
177179,",",0,0
177180,posttreatment,0,0
177181,",",0,0
177182,and,0,0
177183,1-month,0,0
177184,follow-up,0,1
177185,.,0,1
177186,RESULTS,0,0
177187,Youth,0,1
177188,randomized,0,1
177189,to,0,1
177190,CBT,0,0
177191,demonstrated,0,0
177192,superior,0,0
177193,improvement,0,0
177194,across,0,1
177195,primary,0,1
177196,outcomes,0,0
177197,relative,0,0
177198,to,0,0
177199,those,0,1
177200,receiving,0,1
177201,TAU,0,0
177202,.,0,1
177203,Eleven,0,1
177204,of,0,0
177205,16,0,1
177206,adolescents,0,1
177207,randomized,0,1
177208,to,0,1
177209,CBT,0,0
177210,were,0,1
177211,treatment,0,0
177212,responders,0,0
177213,",",0,1
177214,versus,0,0
177215,4,0,0
177216,of,0,0
177217,15,0,1
177218,in,0,1
177219,the,0,0
177220,TAU,0,0
177221,condition,0,1
177222,.,0,1
177223,Gains,0,0
177224,were,0,0
177225,maintained,0,0
177226,at,0,0
177227,1-month,0,0
177228,follow-up,0,1
177229,for,0,1
177230,CBT,0,1
177231,responders,0,0
177232,.,0,1
177233,CONCLUSIONS,0,0
177234,These,0,1
177235,data,0,0
177236,extend,0,1
177237,findings,0,0
177238,of,0,0
177239,the,0,1
177240,promising,0,0
177241,effects,0,0
177242,of,0,1
177243,CBT,0,1
177244,in,0,1
177245,anxious,1,1
177246,youth,1,1
177247,with,1,1
177248,ASD,1,1
177249,to,1,1
177250,early,1,1
177251,adolescents,1,1
177252,.,1,1
177253,Absence,0,0
177254,of,0,0
177255,analgesic,0,0
177256,effect,0,0
177257,of,0,0
177258,intravenous,0,1
177259,melatonin,0,0
177260,administration,0,0
177261,during,0,0
177262,daytime,0,0
177263,after,0,1
177264,laparoscopic,0,1
177265,cholecystectomy,0,1
177266,:,0,1
177267,a,0,0
177268,randomized,0,1
177269,trial,0,1
177270,.,0,1
177271,STUDY,0,0
177272,OBJECTIVE,0,0
177273,To,0,0
177274,investigate,0,0
177275,whether,0,0
177276,melatonin,0,0
177277,administered,0,0
177278,intraoperatively,0,0
177279,reduced,0,0
177280,pain,1,1
177281,following,1,0
177282,laparoscopic,1,1
177283,cholecystectomy,1,1
177284,.,1,1
177285,DESIGN,0,0
177286,Randomized,0,0
177287,",",0,0
177288,placebo-controlled,0,0
177289,",",0,0
177290,double-blinded,0,0
177291,study,0,1
177292,.,0,1
177293,SETTING,0,1
177294,Two,1,1
177295,surgical,1,1
177296,departments,1,1
177297,in,1,1
177298,Copenhagen,1,1
177299,.,1,1
177300,PATIENTS,0,0
177301,44,1,1
177302,women,1,1
177303,between,1,1
177304,18,1,1
177305,and,1,1
177306,70,1,1
177307,years,1,1
177308,of,1,1
177309,age,1,1
177310,",",1,1
177311,who,1,1
177312,were,1,1
177313,surgical,1,1
177314,candidates,1,1
177315,for,1,1
177316,laparoscopic,1,1
177317,cholecystectomy,1,1
177318,.,1,1
177319,INTERVENTIONS,0,0
177320,Patients,0,1
177321,were,0,1
177322,anesthetized,0,1
177323,by,0,0
177324,a,0,1
177325,standard,0,1
177326,protocol,0,0
177327,and,0,0
177328,received,0,0
177329,a,0,0
177330,standard,0,0
177331,multimodal,0,0
177332,postoperative,0,1
177333,analgesic,0,0
177334,regimen,0,1
177335,.,0,1
177336,Patients,1,1
177337,undergoing,1,1
177338,surgery,1,1
177339,were,1,1
177340,admitted,1,1
177341,on,1,0
177342,the,1,0
177343,day,1,0
177344,of,1,0
177345,surgery,1,1
177346,and,1,1
177347,were,1,0
177348,discharged,1,1
177349,the,1,0
177350,day,1,0
177351,after,1,0
177352,surgery,1,1
177353,.,1,1
177354,Ten,0,1
177355,mg,0,0
177356,of,0,1
177357,intravenous,0,1
177358,(,0,1
177359,IV,0,1
177360,),0,1
177361,melatonin,0,0
177362,or,0,1
177363,placebo,0,0
177364,were,0,0
177365,administered,0,0
177366,at,0,0
177367,the,0,0
177368,time,0,0
177369,of,0,0
177370,surgical,0,1
177371,incision,0,1
177372,.,0,1
177373,MEASUREMENTS,0,0
177374,Pain,0,0
177375,was,0,0
177376,assessed,0,0
177377,by,0,0
177378,a,0,0
177379,set,0,0
177380,of,0,0
177381,questionnaires,0,0
177382,documenting,0,0
177383,pain,0,1
177384,at,0,1
177385,rest,0,0
177386,using,0,0
177387,a,0,0
177388,visual,0,0
177389,analog,0,0
177390,scale,0,0
177391,(,0,1
177392,VAS,0,1
177393,),0,1
177394,.,0,1
177395,The,0,0
177396,use,0,0
177397,of,0,0
177398,rescue,0,0
177399,medication,0,1
177400,was,0,0
177401,recorded,0,0
177402,.,0,1
177403,Sleep,0,0
177404,quality,0,0
177405,and,0,1
177406,general,0,1
177407,well-being,0,0
177408,were,0,1
177409,measured,0,0
177410,on,0,0
177411,separate,0,1
177412,VAS,0,1
177413,scales,0,0
177414,.,0,1
177415,Sleepiness,0,0
177416,was,0,0
177417,assessed,0,0
177418,by,0,0
177419,the,0,0
177420,Karolinska,0,1
177421,Sleepiness,0,1
177422,Scale,0,1
177423,.,0,1
177424,MAIN,0,0
177425,RESULTS,0,1
177426,Forty-four,1,1
177427,patients,1,1
177428,were,1,1
177429,included,1,1
177430,and,1,0
177431,randomized,1,1
177432,to,1,0
177433,the,1,0
177434,study,1,1
177435,.,1,1
177436,Three,1,1
177437,patients,1,1
177438,did,1,0
177439,not,1,0
177440,complete,1,0
177441,the,1,0
177442,study,1,0
177443,.,1,1
177444,No,0,0
177445,differences,0,0
177446,in,0,1
177447,VAS,0,1
177448,pain,0,1
177449,scores,0,0
177450,",",0,1
177451,sleep,0,1
177452,quality,0,0
177453,",",0,0
177454,general,0,1
177455,well-being,0,0
177456,",",0,0
177457,or,0,1
177458,sleepiness,0,0
177459,were,0,0
177460,found,0,0
177461,between,0,0
177462,the,0,1
177463,two,0,0
177464,groups,0,0
177465,in,0,1
177466,the,0,1
177467,postoperative,0,0
177468,period,0,0
177469,.,0,1
177470,The,0,0
177471,use,0,0
177472,of,0,0
177473,postoperative,0,0
177474,rescue,0,1
177475,medication,0,1
177476,did,0,0
177477,not,0,0
177478,differ,0,0
177479,between,0,0
177480,the,0,0
177481,groups,0,0
177482,.,0,1
177483,CONCLUSIONS,0,0
177484,The,0,0
177485,use,0,0
177486,of,0,0
177487,10mg,0,0
177488,of,0,1
177489,IV,0,1
177490,melatonin,0,0
177491,administered,0,0
177492,during,0,0
177493,laparoscopic,0,1
177494,cholecystectomy,0,1
177495,did,0,0
177496,not,0,0
177497,affect,0,0
177498,postoperative,0,0
177499,pain,0,1
177500,or,0,1
177501,use,0,0
177502,of,0,0
177503,analgesic,0,0
177504,medication,0,1
177505,.,0,1
177506,The,0,0
177507,durability,0,0
177508,of,0,0
177509,endovascular,0,1
177510,coiling,0,1
177511,versus,0,0
177512,neurosurgical,0,1
177513,clipping,0,1
177514,of,0,0
177515,ruptured,1,1
177516,cerebral,1,1
177517,aneurysms,1,1
177518,:,1,1
177519,18,0,1
177520,year,0,1
177521,follow-up,0,0
177522,of,0,0
177523,the,0,0
177524,UK,1,1
177525,cohort,1,1
177526,of,1,0
177527,the,1,0
177528,International,1,1
177529,Subarachnoid,1,1
177530,Aneurysm,1,1
177531,Trial,1,1
177532,(,1,1
177533,ISAT,1,1
177534,),1,1
177535,.,1,1
177536,BACKGROUND,0,0
177537,Previous,0,1
177538,analyses,0,0
177539,of,0,1
177540,the,0,1
177541,International,1,1
177542,Subarachnoid,1,1
177543,Aneurysm,1,1
177544,Trial,1,1
177545,(,1,1
177546,ISAT,1,1
177547,),1,1
177548,cohort,1,1
177549,have,0,0
177550,reported,0,0
177551,on,0,0
177552,the,0,0
177553,risks,0,0
177554,of,0,0
177555,recurrent,0,1
177556,subarachnoid,0,1
177557,haemorrhage,0,1
177558,and,0,1
177559,death,0,0
177560,or,0,1
177561,dependency,0,0
177562,for,0,0
177563,a,0,0
177564,minimum,0,0
177565,of,0,0
177566,5,0,1
177567,years,0,1
177568,and,0,1
177569,up,0,1
177570,to,0,0
177571,a,0,0
177572,maximum,0,0
177573,of,0,0
177574,14,0,1
177575,years,0,1
177576,after,0,1
177577,treatment,0,1
177578,of,0,0
177579,a,0,1
177580,ruptured,0,1
177581,intracranial,0,1
177582,aneurysm,0,1
177583,with,0,1
177584,either,0,1
177585,neurosurgical,0,1
177586,clipping,0,1
177587,or,0,1
177588,endovascular,0,1
177589,coiling,0,1
177590,.,0,1
177591,At,0,0
177592,1,0,0
177593,year,0,1
177594,there,0,0
177595,was,0,0
177596,a,0,0
177597,7,0,0
177598,%,0,0
177599,absolute,0,0
177600,and,0,0
177601,a,0,1
177602,24,0,0
177603,%,0,0
177604,relative,0,0
177605,risk,0,1
177606,reduction,0,0
177607,of,0,0
177608,death,0,0
177609,and,0,0
177610,dependency,0,0
177611,in,0,0
177612,the,0,0
177613,coiling,0,0
177614,group,0,0
177615,compared,0,0
177616,with,0,1
177617,the,0,0
177618,clipping,0,1
177619,group,0,0
177620,",",0,0
177621,but,0,0
177622,the,0,0
177623,medium-term,0,0
177624,results,0,0
177625,showed,0,0
177626,the,0,0
177627,increased,0,0
177628,need,0,0
177629,for,0,0
177630,re-treatment,0,0
177631,of,0,0
177632,the,0,0
177633,target,0,0
177634,aneurysm,0,1
177635,in,0,0
177636,the,0,0
177637,patients,0,1
177638,given,0,0
177639,coiling,0,1
177640,.,0,1
177641,We,0,0
177642,report,0,0
177643,the,0,0
177644,long-term,0,0
177645,follow-up,0,0
177646,of,0,1
177647,patients,0,1
177648,in,0,1
177649,this,0,0
177650,UK,0,1
177651,cohort,0,1
177652,.,0,1
177653,METHODS,0,0
177654,In,0,0
177655,ISAT,0,1
177656,",",0,1
177657,patients,1,1
177658,were,1,1
177659,randomly,1,1
177660,allocated,1,1
177661,to,1,0
177662,either,1,1
177663,neurosurgical,1,1
177664,clipping,1,1
177665,or,1,1
177666,endovascular,1,1
177667,coiling,1,1
177668,after,1,0
177669,a,1,1
177670,subarachnoid,1,1
177671,haemorrhage,1,1
177672,",",1,0
177673,assuming,1,0
177674,treatment,1,0
177675,equipoise,1,0
177676,",",1,0
177677,between,1,0
177678,Sept,1,0
177679,12,1,1
177680,",",1,1
177681,1994,1,1
177682,",",1,0
177683,and,1,1
177684,May,1,0
177685,1,1,1
177686,",",1,1
177687,2002,1,1
177688,.,1,1
177689,We,0,0
177690,followed,0,0
177691,up,0,1
177692,1644,1,1
177693,patients,1,1
177694,in,1,1
177695,22,1,1
177696,UK,1,1
177697,neurosurgical,1,1
177698,centres,1,1
177699,for,1,1
177700,death,1,1
177701,and,1,1
177702,clinical,1,0
177703,outcomes,1,0
177704,for,1,1
177705,10?0-18?5,1,1
177706,years,1,1
177707,.,1,1
177708,We,0,0
177709,assessed,0,0
177710,dependency,0,0
177711,as,0,0
177712,self-reported,0,1
177713,modified,0,1
177714,Rankin,0,0
177715,scale,0,1
177716,score,0,0
177717,obtained,0,0
177718,through,0,0
177719,yearly,0,1
177720,questionnaires,0,0
177721,.,0,1
177722,Data,0,0
177723,for,0,0
177724,recurrent,0,1
177725,aneurysms,0,1
177726,and,0,1
177727,rebleeding,0,0
177728,events,0,0
177729,were,0,1
177730,collected,0,1
177731,from,0,1
177732,questionnaires,0,0
177733,and,0,1
177734,from,0,1
177735,hospital,0,1
177736,and,0,1
177737,general,0,1
177738,practitioner,0,1
177739,records,0,1
177740,.,0,1
177741,The,0,0
177742,Office,0,0
177743,for,0,1
177744,National,0,1
177745,Statistics,0,1
177746,supplied,0,0
177747,data,0,1
177748,on,0,1
177749,deaths,0,0
177750,.,0,1
177751,This,0,0
177752,study,0,0
177753,is,0,0
177754,registered,0,0
177755,",",0,0
177756,number,0,0
177757,ISRCTN49866681,0,1
177758,.,0,1
177759,FINDINGS,0,0
177760,At,0,1
177761,10,0,1
177762,years,0,1
177763,",",0,1
177764,674,0,1
177765,(,0,1
177766,83,0,1
177767,%,0,0
177768,),0,1
177769,of,0,1
177770,809,0,1
177771,patients,0,1
177772,allocated,0,1
177773,endovascular,0,1
177774,coiling,0,1
177775,and,0,1
177776,657,0,1
177777,(,0,1
177778,79,0,1
177779,%,0,0
177780,),0,1
177781,of,0,1
177782,835,0,1
177783,patients,0,1
177784,allocated,0,1
177785,neurosurgical,0,1
177786,clipping,0,1
177787,were,0,1
177788,alive,0,1
177789,(,0,1
177790,odds,0,0
177791,ratio,0,1
177792,[,0,0
177793,OR,0,0
177794,],0,1
177795,1?35,0,1
177796,",",0,1
177797,95,0,0
177798,%,0,0
177799,CI,0,0
177800,1?06-1?73,0,1
177801,),0,1
177802,.,0,1
177803,Of,0,1
177804,1003,0,1
177805,individuals,0,1
177806,who,0,1
177807,returned,0,1
177808,a,0,1
177809,questionnaire,0,0
177810,at,0,1
177811,10,0,1
177812,years,0,1
177813,",",0,1
177814,435,0,1
177815,(,0,1
177816,82,0,1
177817,%,0,0
177818,),0,1
177819,patients,0,1
177820,treated,0,1
177821,with,0,1
177822,endovascular,0,1
177823,coiling,0,1
177824,and,0,1
177825,370,0,1
177826,(,0,1
177827,78,0,1
177828,%,0,0
177829,),0,1
177830,patients,0,1
177831,treated,0,1
177832,with,0,1
177833,neurosurgical,0,1
177834,clipping,0,1
177835,were,0,1
177836,independent,0,0
177837,(,0,1
177838,modified,0,1
177839,Rankin,0,0
177840,scale,0,1
177841,score,0,1
177842,0-2,0,1
177843,;,0,1
177844,OR,0,0
177845,1?25,0,1
177846,;,0,1
177847,95,0,0
177848,%,0,0
177849,CI,0,0
177850,0?92-1?71,0,1
177851,),0,1
177852,.,0,1
177853,Patients,0,1
177854,in,0,0
177855,the,0,1
177856,endovascular,0,1
177857,treatment,0,0
177858,group,0,0
177859,were,0,0
177860,more,0,0
177861,likely,0,0
177862,to,0,0
177863,be,0,0
177864,alive,0,1
177865,and,0,0
177866,independent,0,1
177867,at,0,1
177868,10,0,1
177869,years,0,1
177870,than,0,1
177871,were,0,1
177872,patients,0,1
177873,in,0,0
177874,the,0,0
177875,neurosurgery,0,1
177876,group,0,0
177877,(,0,1
177878,OR,0,0
177879,1?34,0,1
177880,",",0,1
177881,95,0,0
177882,%,0,0
177883,CI,0,0
177884,1?07-1?67,0,1
177885,),0,1
177886,.,0,1
177887,33,0,1
177888,patients,0,1
177889,had,0,1
177890,a,0,1
177891,recurrent,0,1
177892,subarachnoid,0,1
177893,haemorrhage,0,1
177894,more,0,0
177895,than,0,0
177896,1,0,0
177897,year,0,1
177898,after,0,0
177899,their,0,1
177900,initial,0,1
177901,haemorrhage,0,1
177902,(,0,1
177903,17,0,1
177904,from,0,1
177905,the,0,0
177906,target,0,0
177907,aneurysm,0,1
177908,),0,1
177909,.,0,1
177910,INTERPRETATION,0,0
177911,Although,0,0
177912,rates,0,0
177913,of,0,1
177914,increased,0,0
177915,dependency,0,0
177916,alone,0,0
177917,did,0,0
177918,not,0,0
177919,differ,0,0
177920,between,0,0
177921,groups,0,0
177922,",",0,1
177923,the,0,0
177924,probability,0,0
177925,of,0,0
177926,death,0,0
177927,or,0,1
177928,dependency,0,0
177929,was,0,0
177930,significantly,0,0
177931,greater,0,0
177932,in,0,0
177933,the,0,0
177934,neurosurgical,0,1
177935,group,0,0
177936,than,0,0
177937,in,0,0
177938,the,0,0
177939,endovascular,0,1
177940,group,0,1
177941,.,0,1
177942,Rebleeding,0,0
177943,was,0,0
177944,more,0,0
177945,likely,0,0
177946,after,0,0
177947,endovascular,0,1
177948,coiling,0,1
177949,than,0,0
177950,after,0,0
177951,neurosurgical,0,1
177952,clipping,0,1
177953,",",0,0
177954,but,0,0
177955,the,0,0
177956,risk,0,0
177957,was,0,0
177958,small,0,0
177959,and,0,0
177960,the,0,0
177961,probability,0,0
177962,of,0,0
177963,disability-free,0,1
177964,survival,0,0
177965,was,0,0
177966,significantly,0,0
177967,greater,0,0
177968,in,0,0
177969,the,0,0
177970,endovascular,0,1
177971,group,0,0
177972,than,0,0
177973,in,0,0
177974,the,0,0
177975,neurosurgical,0,1
177976,group,0,1
177977,at,0,1
177978,10,0,1
177979,years,0,1
177980,.,0,1
177981,FUNDING,0,0
177982,UK,0,1
177983,Medical,0,1
177984,Research,0,1
177985,Council,0,1
177986,.,0,1
177987,Parents,0,1
177988,',0,1
177989,Adoption,0,1
177990,of,0,1
177991,Social,0,1
177992,Communication,0,1
177993,Intervention,0,1
177994,Strategies,0,0
177995,:,0,1
177996,Families,0,1
177997,Including,0,1
177998,Children,1,1
177999,with,1,1
178000,Autism,1,1
178001,Spectrum,1,1
178002,Disorder,1,1
178003,Who,1,1
178004,are,1,0
178005,Minimally,1,1
178006,Verbal,1,1
178007,.,1,1
178008,Notably,0,0
178009,absent,0,0
178010,from,0,0
178011,the,0,0
178012,intervention,0,0
178013,literature,0,0
178014,are,0,0
178015,parent,0,1
178016,training,0,1
178017,programs,0,1
178018,targeting,0,1
178019,school-aged,1,1
178020,children,1,1
178021,with,1,1
178022,autism,1,1
178023,who,1,1
178024,have,1,1
178025,limited,1,1
178026,communication,1,0
178027,skills,1,0
178028,(,0,1
178029,Tager-Flusberg,0,1
178030,and,0,1
178031,Kasari,0,1
178032,in,0,1
178033,Autism,0,1
178034,Res,0,1
178035,6:468-478,0,1
178036,",",0,1
178037,2013,0,1
178038,),0,1
178039,.,0,1
178040,Sixty-one,1,1
178041,children,1,1
178042,with,1,1
178043,autism,1,1
178044,age,1,1
178045,5-8,1,1
178046,with,1,1
178047,minimal,1,1
178048,spontaneous,1,1
178049,communication,1,0
178050,received,1,1
178051,a,1,0
178052,6-month,1,0
178053,social,1,0
178054,communication,1,0
178055,intervention,1,0
178056,including,1,0
178057,parent,1,1
178058,training,1,1
178059,.,1,1
178060,Parent-child,1,1
178061,play,1,0
178062,interactions,1,0
178063,were,0,1
178064,coded,0,1
178065,for,0,1
178066,parents,0,1
178067,',0,1
178068,strategy,0,0
178069,implementation,0,0
178070,and,0,1
178071,children,0,1
178072,'s,0,1
178073,time,0,0
178074,jointly,0,1
178075,engaged,0,1
178076,(,0,0
178077,Adamson,0,1
178078,et,0,1
178079,al,0,0
178080,.,0,0
178081,in,0,0
178082,J,0,0
178083,Autism,0,1
178084,Dev,0,1
178085,Disord,0,1
178086,39:84-96,0,1
178087,",",0,1
178088,2009,0,1
178089,),0,1
178090,.,0,1
178091,Parents,1,0
178092,mastered,0,0
178093,an,0,0
178094,average,0,0
178095,of,0,0
178096,70,0,1
178097,%,0,0
178098,of,0,0
178099,the,0,0
178100,strategies,0,0
178101,.,0,1
178102,Further,0,0
178103,analyses,0,0
178104,indicated,0,0
178105,some,0,0
178106,gains,0,0
178107,in,0,0
178108,implementation,0,0
178109,occurred,0,0
178110,from,0,1
178111,mere,0,0
178112,observation,0,1
178113,of,0,1
178114,sessions,0,0
178115,",",0,1
178116,while,0,0
178117,the,0,0
178118,greatest,0,0
178119,gains,0,0
178120,occurred,0,0
178121,in,0,0
178122,the,0,0
178123,first,0,0
178124,month,0,0
178125,of,0,0
178126,active,0,1
178127,coaching,0,1
178128,and,0,1
178129,workshops,0,0
178130,.,0,1
178131,Children,1,1
178132,'s,1,1
178133,joint,0,1
178134,engagement,0,1
178135,was,0,0
178136,associated,0,0
178137,with,0,1
178138,parents,0,1
178139,',0,1
178140,implementation,0,0
178141,success,0,0
178142,across,0,0
178143,time,0,0
178144,demonstrating,0,0
178145,parents,1,1
178146,',1,1
178147,implementation,1,0
178148,was,0,0
178149,relevant,0,0
178150,to,0,1
178151,children,1,1
178152,'s,1,1
178153,social,1,1
178154,engagement,1,1
178155,.,1,1
178156,Institutional,0,1
178157,clinical,0,0
178158,trial,0,1
178159,accrual,0,1
178160,volume,0,0
178161,and,0,0
178162,survival,0,0
178163,of,0,0
178164,patients,1,1
178165,with,1,1
178166,head,1,1
178167,and,1,1
178168,neck,1,1
178169,cancer,1,1
178170,.,1,1
178171,PURPOSE,0,0
178172,National,0,0
178173,Comprehensive,0,1
178174,Cancer,0,1
178175,Network,0,1
178176,guidelines,0,1
178177,recommend,0,1
178178,patients,1,1
178179,with,1,1
178180,head,1,1
178181,and,1,1
178182,neck,1,1
178183,cancer,1,1
178184,(,1,1
178185,HNC,1,1
178186,),1,1
178187,receive,0,1
178188,treatment,0,0
178189,at,0,1
178190,centers,0,1
178191,with,0,1
178192,expertise,0,0
178193,",",0,0
178194,but,0,0
178195,whether,0,0
178196,provider,0,1
178197,experience,0,1
178198,affects,0,0
178199,survival,0,0
178200,is,0,0
178201,unknown,0,0
178202,.,0,1
178203,PATIENTS,0,0
178204,AND,0,0
178205,METHODS,0,0
178206,The,0,0
178207,effect,0,0
178208,of,0,0
178209,institutional,0,1
178210,experience,0,1
178211,on,0,0
178212,overall,0,0
178213,survival,0,0
178214,(,0,1
178215,OS,0,0
178216,),0,1
178217,in,0,1
178218,patients,1,1
178219,with,1,1
178220,stage,1,1
178221,III,1,1
178222,or,1,1
178223,IV,1,1
178224,HNC,1,1
178225,was,0,0
178226,investigated,0,0
178227,within,0,0
178228,a,0,1
178229,randomized,0,1
178230,trial,0,0
178231,of,0,0
178232,the,0,0
178233,Radiation,0,0
178234,Therapy,0,1
178235,Oncology,0,1
178236,Group,0,1
178237,(,0,1
178238,RTOG,0,1
178239,0129,0,1
178240,),0,1
178241,",",0,0
178242,which,0,0
178243,compared,0,0
178244,cisplatin,0,0
178245,concurrent,0,0
178246,with,0,1
178247,standard,0,1
178248,versus,0,0
178249,accelerated,0,0
178250,fractionation,0,1
178251,radiotherapy,0,1
178252,.,0,1
178253,As,0,0
178254,a,0,0
178255,surrogate,0,0
178256,for,0,0
178257,experience,0,1
178258,",",0,1
178259,institutions,0,1
178260,were,0,1
178261,classified,0,1
178262,as,0,0
178263,historically,0,1
178264,low-,0,1
178265,(,0,1
178266,HLACs,0,1
178267,),0,1
178268,or,0,1
178269,high-accruing,0,1
178270,centers,0,1
178271,(,0,1
178272,HHACs,0,1
178273,),0,1
178274,based,0,1
178275,on,0,0
178276,accrual,0,1
178277,to,0,1
178278,21,1,1
178279,RTOG,1,1
178280,HNC,1,1
178281,trials,1,1
178282,(,1,1
178283,1997,1,1
178284,to,1,1
178285,2002,1,1
178286,),1,1
178287,.,1,1
178288,The,0,0
178289,effect,0,0
178290,of,0,0
178291,accrual,0,1
178292,volume,0,1
178293,on,0,0
178294,OS,0,0
178295,was,0,0
178296,estimated,0,0
178297,by,0,0
178298,Cox,0,0
178299,proportional,0,0
178300,hazards,0,0
178301,models,0,1
178302,.,0,1
178303,RESULTS,0,0
178304,Median,0,1
178305,RTOG,0,1
178306,accrual,0,1
178307,(,0,1
178308,1997,0,1
178309,to,0,1
178310,2002,0,1
178311,),0,1
178312,at,0,1
178313,HLACs,0,1
178314,was,0,0
178315,four,0,1
178316,versus,0,0
178317,65,0,1
178318,patients,0,1
178319,at,0,1
178320,HHACs,0,1
178321,.,0,1
178322,Analysis,0,0
178323,included,0,1
178324,471,1,1
178325,patients,1,1
178326,in,1,1
178327,RTOG,1,1
178328,0129,1,1
178329,(,1,1
178330,2002,1,1
178331,to,1,1
178332,2005,1,1
178333,),1,1
178334,with,1,1
178335,known,1,1
178336,human,1,1
178337,papillomavirus,1,1
178338,and,1,0
178339,smoking,1,1
178340,status,1,1
178341,.,1,1
178342,Patients,0,1
178343,at,0,0
178344,HLACs,0,1
178345,versus,0,0
178346,HHACs,0,0
178347,had,0,1
178348,better,0,0
178349,performance,0,0
178350,status,0,1
178351,(,0,1
178352,0,0,0
178353,:,0,1
178354,62,0,1
178355,%,0,0
178356,v,0,0
178357,52,0,1
178358,%,0,0
178359,;,0,1
178360,P,0,0
178361,=,0,1
178362,.04,0,0
178363,),0,1
178364,and,0,0
178365,lower,0,0
178366,T,0,1
178367,stage,0,1
178368,(,0,1
178369,T4,0,1
178370,:,0,1
178371,26.5,0,1
178372,%,0,0
178373,v,0,0
178374,35.3,0,1
178375,%,0,0
178376,;,0,1
178377,P,0,0
178378,=,0,1
178379,.002,0,0
178380,),0,1
178381,but,0,0
178382,were,0,1
178383,otherwise,0,1
178384,similar,0,0
178385,.,0,1
178386,Radiotherapy,0,0
178387,protocol,0,1
178388,deviations,0,0
178389,were,0,1
178390,higher,0,0
178391,at,0,0
178392,HLACs,0,0
178393,versus,0,0
178394,HHACs,0,1
178395,(,0,1
178396,18,0,1
178397,%,0,0
178398,v,0,0
178399,6,0,1
178400,%,0,0
178401,;,0,1
178402,P,0,0
178403,<,0,0
178404,.001,0,0
178405,),0,0
178406,.,0,0
178407,When,0,0
178408,compared,0,0
178409,with,0,1
178410,HHACs,0,1
178411,",",0,1
178412,patients,0,1
178413,at,0,1
178414,HLACs,0,1
178415,had,0,1
178416,worse,0,0
178417,OS,0,0
178418,(,0,1
178419,5,0,1
178420,years,0,1
178421,:,0,1
178422,51.0,0,1
178423,%,0,0
178424,v,0,0
178425,69.1,0,1
178426,%,0,0
178427,;,0,1
178428,P,0,0
178429,=,0,1
178430,.002,0,0
178431,),0,1
178432,.,0,1
178433,Treatment,0,0
178434,at,0,0
178435,HLACs,0,1
178436,was,0,0
178437,associated,0,0
178438,with,0,1
178439,increased,0,0
178440,death,0,0
178441,risk,0,1
178442,of,0,0
178443,91,0,1
178444,%,0,0
178445,(,0,1
178446,hazard,0,0
178447,ratio,0,0
178448,[,0,0
178449,HR,0,0
178450,],0,1
178451,",",0,1
178452,1.91,0,0
178453,;,0,1
178454,95,0,0
178455,%,0,0
178456,CI,0,0
178457,",",0,1
178458,1.37,0,0
178459,to,0,1
178460,2.65,0,0
178461,),0,1
178462,after,0,0
178463,adjustment,0,0
178464,for,0,1
178465,prognostic,0,0
178466,factors,0,0
178467,and,0,1
178468,72,0,1
178469,%,0,0
178470,(,0,1
178471,HR,0,0
178472,",",0,1
178473,1.72,0,0
178474,;,0,1
178475,95,0,0
178476,%,0,0
178477,CI,0,0
178478,",",0,1
178479,1.23,0,0
178480,to,0,1
178481,2.40,0,0
178482,),0,1
178483,after,0,0
178484,radiotherapy,0,1
178485,compliance,0,0
178486,adjustment,0,0
178487,.,0,1
178488,CONCLUSION,0,0
178489,OS,0,0
178490,is,0,0
178491,worse,0,0
178492,for,0,0
178493,patients,0,1
178494,with,0,1
178495,HNC,0,1
178496,treated,0,1
178497,at,0,0
178498,HLACs,0,1
178499,versus,0,0
178500,HHACs,0,0
178501,to,0,0
178502,cooperative,0,1
178503,group,0,1
178504,trials,0,0
178505,after,0,1
178506,accounting,0,0
178507,for,0,0
178508,radiotherapy,0,1
178509,protocol,0,1
178510,deviations,0,0
178511,.,0,1
178512,Institutional,0,1
178513,experience,0,0
178514,substantially,0,0
178515,influences,0,0
178516,survival,0,0
178517,in,0,0
178518,locally,0,1
178519,advanced,0,1
178520,HNC,0,1
178521,.,0,1
178522,Comparison,0,0
178523,on,0,0
178524,therapeutic,0,0
178525,effect,0,0
178526,of,0,0
178527,plasma,0,0
178528,exchange,0,0
178529,and,0,1
178530,intravenous,0,1
178531,immunoglobulin,0,0
178532,for,0,1
178533,Guillian-Barre,1,1
178534,syndrome,1,1
178535,.,1,1
178536,OBJECTIVES,0,0
178537,To,0,0
178538,observe,0,0
178539,and,0,0
178540,compare,0,0
178541,the,0,0
178542,clinical,0,0
178543,curative,0,1
178544,effect,0,0
178545,of,0,0
178546,the,0,0
178547,plasma,1,0
178548,exchange,1,0
178549,(,1,1
178550,PE,1,1
178551,),1,1
178552,and,1,1
178553,intravenous,1,1
178554,immunoglobulin,1,0
178555,(,1,1
178556,IVIg,1,1
178557,),1,1
178558,for,1,0
178559,Guillian-Barre,1,1
178560,Syndrome,1,1
178561,(,1,1
178562,GBS,1,1
178563,),1,1
178564,.,1,1
178565,METHODS,0,0
178566,Overall,0,0
178567,",",0,1
178568,64,1,1
178569,adult,1,1
178570,patients,1,1
178571,with,1,1
178572,GBS,1,1
178573,for,1,1
178574,PE,1,1
178575,and,1,1
178576,IVIg,1,1
178577,treatment,1,0
178578,",",1,0
178579,respectively,1,0
178580,",",1,0
178581,and,1,0
178582,nerve,1,0
178583,function,1,0
178584,were,0,1
178585,observed,0,0
178586,pre-treatment,0,0
178587,and,0,1
178588,at,0,1
178589,1,0,1
178590,week/2,0,0
178591,weeks,0,0
178592,after,0,1
178593,completion,0,0
178594,of,0,1
178595,treatment,0,0
178596,;,0,1
178597,the,0,0
178598,blood,0,0
178599,immunoglobulin,0,0
178600,",",0,0
178601,complement,0,0
178602,",",0,0
178603,fibrinogen,0,0
178604,(,0,1
178605,Fib,0,0
178606,),0,1
178607,and,0,1
178608,monocyte,0,0
178609,percentage,0,0
178610,(,0,1
178611,MON,0,1
178612,%,0,0
178613,),0,1
178614,were,0,0
178615,detected,0,0
178616,simultaneously,0,0
178617,.,0,1
178618,RESULTS,0,0
178619,After,0,1
178620,PE,0,1
178621,treatment,0,0
178622,",",0,0
178623,nerve,0,0
178624,function,0,0
178625,defect,0,1
178626,appeared,0,0
178627,to,0,0
178628,improve,0,0
178629,better,0,0
178630,than,0,0
178631,the,0,0
178632,IVIg,0,1
178633,group,0,1
178634,and,0,1
178635,clinical,0,0
178636,effect,0,0
178637,was,0,0
178638,better,0,0
178639,than,0,0
178640,the,0,0
178641,IVIg,0,1
178642,group,0,1
178643,.,0,1
178644,Treatment,0,0
178645,effective,0,0
178646,rates,0,0
178647,of,0,1
178648,the,0,1
178649,two,0,0
178650,groups,0,0
178651,after,0,1
178652,2,0,1
178653,weeks,0,0
178654,",",0,0
178655,respectively,0,0
178656,",",0,0
178657,are,0,0
178658,96,0,1
178659,and,0,1
178660,79,0,1
178661,%,0,0
178662,.,0,1
178663,PE,0,1
178664,and,0,0
178665,IVIg,0,1
178666,can,0,0
178667,significantly,0,0
178668,reduce,0,0
178669,the,1,0
178670,GBS,1,0
178671,patients,1,1
178672,',1,1
178673,blood,1,0
178674,immunoglobulin,0,1
178675,IgG,0,0
178676,",",0,0
178677,IgA,0,1
178678,",",0,0
178679,IgM,0,0
178680,",",0,0
178681,C3,0,1
178682,and,0,0
178683,C4,0,1
178684,",",0,0
178685,but,0,0
178686,these,0,0
178687,were,0,0
178688,significantly,0,0
178689,lower,0,0
178690,in,0,0
178691,the,0,0
178692,PE,0,1
178693,group,0,0
178694,than,0,0
178695,in,0,0
178696,the,0,0
178697,IVIg,0,1
178698,group,0,1
178699,.,0,1
178700,Fib,0,0
178701,and,0,0
178702,MON,0,1
178703,%,0,0
178704,were,0,0
178705,significantly,0,0
178706,lower,0,0
178707,in,0,0
178708,the,0,0
178709,PE,0,1
178710,group,0,0
178711,than,0,0
178712,in,0,0
178713,the,0,0
178714,IVIg,0,1
178715,group,0,1
178716,.,0,1
178717,CONCLUSION,0,0
178718,Both,0,0
178719,PE,0,1
178720,and,0,0
178721,IVIg,0,1
178722,have,0,0
178723,a,0,0
178724,high,0,0
178725,response,0,0
178726,as,0,0
178727,therapy,0,0
178728,and,0,1
178729,are,0,0
178730,reasonable,0,0
178731,therapeutic,0,0
178732,options,0,1
178733,for,0,1
178734,GBS,0,1
178735,.,0,1
178736,However,0,0
178737,",",0,0
178738,PE,0,1
178739,treatment,0,0
178740,has,0,0
178741,a,0,0
178742,more,0,0
178743,significantly,0,0
178744,curative,0,0
178745,effect,0,0
178746,",",0,0
178747,as,0,0
178748,it,0,0
178749,can,0,0
178750,effectively,0,0
178751,improve,0,0
178752,symptoms,0,0
178753,and,0,0
178754,be,0,0
178755,helpful,0,0
178756,in,0,0
178757,the,0,0
178758,early,0,1
178759,rehabilitation,1,1
178760,of,1,1
178761,patients,1,1
178762,.,1,1
178763,Exploratory,0,1
178764,Subset,0,1
178765,Analysis,0,1
178766,of,0,1
178767,African,1,1
178768,Americans,1,1
178769,From,1,1
178770,the,1,1
178771,PointBreak,1,1
178772,Study,1,1
178773,:,1,1
178774,Pemetrexed-Carboplatin-Bevacizumab,0,0
178775,Followed,0,1
178776,by,0,0
178777,Maintenance,0,1
178778,Pemetrexed-Bevacizumab,0,1
178779,Versus,0,1
178780,Paclitaxel-Carboplatin-Bevacizumab,0,0
178781,Followed,0,1
178782,by,0,0
178783,Maintenance,0,1
178784,Bevacizumab,0,1
178785,in,1,0
178786,Patients,1,1
178787,With,1,1
178788,Stage,1,1
178789,IIIB/IV,1,1
178790,Nonsquamous,1,1
178791,Non-Small-Cell,1,1
178792,Lung,1,1
178793,Cancer,1,1
178794,.,1,1
178795,INTRODUCTION,1,0
178796,African,1,1
178797,Americans,1,1
178798,have,1,1
178799,a,1,1
178800,greater,1,0
178801,incidence,1,0
178802,of,1,0
178803,lung,1,1
178804,cancer,1,1
178805,than,1,0
178806,whites,1,1
178807,and,0,1
178808,have,0,0
178809,been,0,0
178810,underrepresented,0,1
178811,in,0,1
178812,clinical,0,1
178813,trials,0,1
178814,.,0,1
178815,In,0,0
178816,the,0,0
178817,PointBreak,0,1
178818,trial,0,0
178819,(,0,1
178820,pemetrexed-carboplatin-bevacizumab,0,0
178821,and,0,1
178822,maintenance,0,1
178823,pemetrexed-bevacizumab,0,0
178824,[,0,1
178825,PemCBev,0,1
178826,],0,1
178827,vs.,0,0
178828,paclitaxel-carboplatin-bevacizumab,0,0
178829,and,0,1
178830,maintenance,0,0
178831,bevacizumab,0,0
178832,[,0,0
178833,PacCBev,0,1
178834,],0,1
178835,),0,1
178836,",",0,1
178837,10,1,1
178838,%,1,0
178839,of,1,0
178840,the,1,0
178841,patients,1,1
178842,were,1,1
178843,African,1,1
178844,American,1,1
178845,.,1,1
178846,PointBreak,0,0
178847,had,0,1
178848,negative,0,1
178849,findings,0,0
178850,;,0,1
178851,PemCBev,0,1
178852,did,0,0
178853,not,0,0
178854,demonstrate,0,0
178855,superior,0,0
178856,overall,0,0
178857,survival,0,0
178858,(,0,1
178859,OS,0,0
178860,),0,1
178861,.,0,1
178862,MATERIALS,0,0
178863,AND,0,0
178864,METHODS,0,0
178865,PointBreak,0,1
178866,subgroup,0,1
178867,efficacy,0,0
178868,and,0,1
178869,safety,0,0
178870,data,0,0
178871,were,0,1
178872,retrospectively,0,1
178873,analyzed,1,0
178874,:,1,1
178875,African,1,1
178876,Americans,1,1
178877,versus,1,1
178878,whites,1,1
178879,for,1,1
178880,PemCBev,1,1
178881,;,1,1
178882,PemCBev,1,1
178883,versus,1,0
178884,PacCBev,1,1
178885,in,1,1
178886,African,1,1
178887,Americans,1,1
178888,;,1,1
178889,and,1,1
178890,academic,1,1
178891,versus,1,0
178892,community,1,1
178893,settings,1,1
178894,for,1,1
178895,African,1,1
178896,Americans,1,1
178897,.,1,1
178898,Hazard,0,0
178899,ratios,0,0
178900,(,0,1
178901,HRs,0,1
178902,),0,1
178903,and,0,1
178904,P,0,0
178905,values,0,0
178906,were,0,1
178907,derived,0,1
178908,from,0,1
178909,a,0,1
178910,multivariate,0,0
178911,Cox,0,0
178912,proportional,0,0
178913,hazards,0,0
178914,model,0,1
178915,after,0,1
178916,adjusting,0,0
178917,for,0,1
178918,covariates,0,0
178919,.,0,1
178920,RESULTS,1,0
178921,Of,1,1
178922,939,1,1
178923,intent-to-treat,1,0
178924,(,1,1
178925,ITT,1,1
178926,),1,1
178927,patients,1,1
178928,",",1,1
178929,94,1,1
178930,were,1,1
178931,African,1,1
178932,American,1,1
178933,and,1,1
178934,805,1,1
178935,were,1,1
178936,white,1,1
178937,.,1,1
178938,African-American,1,1
178939,enrollment,0,1
178940,was,0,0
178941,uniform,0,0
178942,across,0,0
178943,the,0,0
178944,study,0,1
178945,sites,0,0
178946,(,0,1
178947,median,0,1
178948,",",0,1
178949,1,0,1
178950,African,0,1
178951,American,0,1
178952,per,0,1
178953,site,0,0
178954,),0,1
178955,.,0,1
178956,In,0,0
178957,the,0,0
178958,PemCBev,0,1
178959,arm,0,0
178960,",",0,0
178961,OS,0,0
178962,(,0,1
178963,HR,0,0
178964,",",0,1
178965,1.125,0,0
178966,;,0,1
178967,P,0,0
178968,=,0,1
178969,.525,0,0
178970,),0,1
178971,",",0,0
178972,progression-free,0,0
178973,survival,0,0
178974,(,0,1
178975,PFS,0,1
178976,),0,1
178977,(,0,1
178978,HR,0,0
178979,",",0,1
178980,1.229,0,0
178981,;,0,1
178982,P,0,0
178983,=,0,1
178984,.251,0,0
178985,),0,1
178986,",",0,0
178987,response,0,0
178988,(,0,1
178989,P,0,0
178990,=,0,1
178991,.607,0,0
178992,),0,1
178993,",",0,0
178994,and,0,0
178995,toxicity,0,0
178996,profiles,0,0
178997,were,0,1
178998,similar,0,0
178999,in,0,1
179000,African,0,1
179001,Americans,0,1
179002,versus,0,1
179003,whites,0,1
179004,.,0,1
179005,For,0,1
179006,African,0,1
179007,Americans,0,1
179008,",",0,1
179009,OS,0,0
179010,(,0,1
179011,HR,0,0
179012,",",0,1
179013,1.375,0,0
179014,;,0,1
179015,P,0,0
179016,=,0,1
179017,.209,0,0
179018,),0,1
179019,",",0,0
179020,PFS,0,0
179021,(,0,1
179022,HR,0,0
179023,",",0,1
179024,0.902,0,0
179025,;,0,1
179026,P,0,0
179027,=,0,1
179028,.670,0,0
179029,),0,1
179030,",",0,0
179031,response,0,0
179032,(,0,1
179033,P,0,0
179034,=,0,1
179035,1.000,0,0
179036,),0,1
179037,",",0,0
179038,and,0,0
179039,toxicity,0,0
179040,profiles,0,0
179041,were,0,1
179042,similar,0,0
179043,in,0,0
179044,the,0,0
179045,PemCBev,0,1
179046,versus,0,0
179047,PacCBev,0,1
179048,arm,0,1
179049,.,0,1
179050,For,0,1
179051,African,0,1
179052,Americans,0,1
179053,",",0,1
179054,no,0,1
179055,significant,0,0
179056,differences,0,0
179057,were,0,1
179058,seen,0,1
179059,in,0,0
179060,OS,0,0
179061,(,0,1
179062,HR,0,0
179063,",",0,1
179064,0.661,0,0
179065,;,0,1
179066,P,0,0
179067,=,0,1
179068,.191,0,0
179069,),0,1
179070,or,0,1
179071,PFS,0,1
179072,(,0,1
179073,HR,0,0
179074,",",0,1
179075,0.969,0,0
179076,;,0,1
179077,P,0,0
179078,=,0,1
179079,.915,0,0
179080,),0,1
179081,in,0,0
179082,academic,0,1
179083,versus,0,0
179084,community,0,1
179085,practice,0,1
179086,settings,0,1
179087,.,0,1
179088,CONCLUSION,0,0
179089,In,0,0
179090,the,0,0
179091,PemCBev,0,1
179092,arm,0,0
179093,",",0,0
179094,this,0,0
179095,exploratory,0,0
179096,analysis,0,0
179097,showed,0,0
179098,no,0,0
179099,significant,0,0
179100,differences,1,0
179101,between,1,1
179102,African,1,1
179103,Americans,1,1
179104,and,1,1
179105,whites,1,1
179106,for,1,0
179107,the,0,0
179108,efficacy,0,0
179109,outcomes,0,0
179110,or,0,0
179111,toxicity,0,0
179112,profiles,0,0
179113,.,0,1
179114,Consistent,0,0
179115,with,0,1
179116,the,0,0
179117,ITT,0,1
179118,population,0,1
179119,negative,0,0
179120,trial,0,0
179121,result,0,0
179122,",",0,0
179123,for,1,1
179124,African,1,1
179125,Americans,1,1
179126,",",1,1
179127,the,1,1
179128,median,1,0
179129,OS,0,0
179130,was,0,0
179131,not,0,0
179132,superior,0,0
179133,for,0,0
179134,either,0,1
179135,arm,0,1
179136,.,0,1
179137,For,0,1
179138,African,1,1
179139,Americans,1,1
179140,",",1,1
179141,PFS,1,1
179142,and,1,1
179143,OS,0,0
179144,were,0,1
179145,similar,0,0
179146,in,0,0
179147,the,0,0
179148,academic,0,1
179149,and,0,0
179150,community,0,1
179151,settings,0,1
179152,.,0,1
179153,Additional,0,0
179154,outcomes,0,0
179155,data,1,1
179156,for,1,1
179157,African,1,1
179158,Americans,1,1
179159,should,0,0
179160,be,0,0
179161,collected,0,0
179162,in,0,0
179163,lung,0,1
179164,cancer,0,1
179165,studies,0,0
179166,.,0,1
179167,Sustaining,0,1
179168,control,0,1
179169,of,0,0
179170,schistosomiasis,0,1
179171,mansoni,0,1
179172,in,0,0
179173,moderate,1,1
179174,endemicity,1,1
179175,areas,1,0
179176,in,1,1
179177,western,1,1
179178,C?te,1,1
179179,d'Ivoire,1,1
179180,:,1,1
179181,a,0,1
179182,SCORE,0,0
179183,study,0,1
179184,protocol,0,1
179185,.,0,1
179186,BACKGROUND,0,0
179187,Schistosomiasis,0,1
179188,is,0,0
179189,a,0,0
179190,parasitic,0,0
179191,disease,0,1
179192,that,0,0
179193,occurs,0,0
179194,in,0,0
179195,the,1,0
179196,tropics,1,1
179197,and,1,1
179198,subtropics,1,1
179199,.,1,1
179200,The,0,0
179201,mainstay,0,0
179202,of,0,0
179203,control,0,1
179204,is,0,0
179205,preventive,0,0
179206,chemotherapy,0,1
179207,with,0,1
179208,praziquantel,0,0
179209,.,0,1
179210,In,0,0
179211,Africa,0,0
179212,",",0,0
179213,an,0,0
179214,estimated,0,0
179215,230,0,1
179216,million,0,1
179217,people,0,1
179218,require,0,1
179219,preventive,0,1
179220,chemotherapy,0,1
179221,.,0,1
179222,In,0,0
179223,western,0,1
179224,C?te,0,1
179225,d'Ivoire,0,1
179226,",",0,0
179227,infections,0,0
179228,with,0,1
179229,Schistosoma,0,1
179230,mansoni,0,1
179231,are,0,0
179232,widespread,0,0
179233,.,0,1
179234,To,0,0
179235,provide,0,0
179236,an,0,0
179237,evidence-base,0,0
179238,for,0,0
179239,programme,0,1
179240,decisions,0,0
179241,about,0,0
179242,preventive,0,1
179243,chemotherapy,0,1
179244,to,0,0
179245,sustain,0,0
179246,control,0,1
179247,of,0,0
179248,schistosomiasis,0,1
179249,",",0,0
179250,a,0,0
179251,5-year,0,1
179252,multi-country,0,1
179253,study,0,1
179254,with,0,1
179255,different,0,1
179256,treatment,0,1
179257,arms,0,0
179258,has,0,0
179259,been,0,0
179260,designed,0,0
179261,by,0,0
179262,the,0,0
179263,Schistosomiasis,0,1
179264,Consortium,0,1
179265,for,0,1
179266,Operational,0,1
179267,Research,0,1
179268,and,0,1
179269,Evaluation,0,0
179270,(,0,1
179271,SCORE,0,1
179272,),0,0
179273,and,0,0
179274,is,0,0
179275,currently,0,0
179276,being,0,0
179277,implemented,0,0
179278,in,0,1
179279,various,0,0
179280,African,0,1
179281,settings,0,1
179282,",",0,1
179283,including,0,1
179284,C?te,0,0
179285,d'Ivoire,0,1
179286,.,0,1
179287,METHODS/DESIGN,0,0
179288,We,0,0
179289,report,0,0
179290,the,0,0
179291,study,0,0
179292,protocol,0,0
179293,",",0,0
179294,including,0,0
179295,ethics,0,1
179296,statement,0,1
179297,and,0,1
179298,insight,0,0
179299,from,0,1
179300,a,0,1
179301,large-scale,0,0
179302,eligibility,0,1
179303,survey,0,1
179304,carried,0,0
179305,out,0,1
179306,in,0,1
179307,four,1,1
179308,provinces,1,1
179309,in,1,1
179310,western,1,1
179311,C?te,1,1
179312,d'Ivoire,1,1
179313,.,1,1
179314,The,1,0
179315,study,0,0
179316,protocol,0,0
179317,has,0,0
179318,been,0,0
179319,approved,0,1
179320,by,0,0
179321,the,0,1
179322,ethics,0,1
179323,committees,0,1
179324,of,0,1
179325,Basel,0,1
179326,and,0,1
179327,C?te,0,1
179328,d'Ivoire,1,1
179329,.,1,1
179330,A,1,0
179331,total,1,1
179332,of,1,0
179333,"12,110",1,1
179334,children,1,1
179335,",",1,1
179336,aged,1,1
179337,13-14,1,1
179338,years,1,1
179339,",",1,1
179340,from,1,1
179341,264,1,1
179342,villages,1,1
179343,were,1,1
179344,screened,1,1
179345,for,1,0
179346,S.,1,1
179347,mansoni,1,1
179348,using,1,0
179349,duplicate,1,1
179350,Kato-Katz,1,1
179351,thick,1,1
179352,smears,1,1
179353,from,1,1
179354,single,1,1
179355,stool,1,1
179356,samples,1,1
179357,.,1,1
179358,Among,1,1
179359,the,1,0
179360,schools,1,1
179361,with,1,1
179362,a,1,1
179363,S.,1,1
179364,mansoni,1,1
179365,prevalence,1,1
179366,of,1,0
179367,10-24,1,1
179368,%,1,0
179369,",",1,1
179370,75,1,1
179371,schools,1,1
179372,were,1,1
179373,selected,1,1
179374,and,1,0
179375,randomly,1,1
179376,assigned,1,1
179377,to,1,0
179378,one,1,1
179379,of,1,1
179380,three,1,1
179381,treatment,1,1
179382,arms,1,1
179383,.,1,1
179384,In,1,0
179385,each,1,0
179386,school,1,1
179387,",",1,0
179388,three,1,0
179389,stool,1,0
179390,samples,1,1
179391,are,1,0
179392,being,1,1
179393,collected,1,1
179394,from,1,1
179395,100,1,1
179396,children,1,1
179397,aged,1,1
179398,9-12,1,1
179399,years,1,1
179400,annually,1,1
179401,and,1,1
179402,one,1,1
179403,stool,1,0
179404,sample,1,1
179405,from,1,1
179406,100,1,1
179407,first-year,1,1
179408,students,1,1
179409,at,1,1
179410,baseline,1,0
179411,and,1,0
179412,in,1,0
179413,the,1,0
179414,final,1,0
179415,year,1,1
179416,and,1,1
179417,subjected,1,1
179418,to,1,0
179419,duplicate,1,1
179420,Kato-Katz,1,1
179421,thick,1,1
179422,smears,1,1
179423,.,1,1
179424,Cost,1,0
179425,and,0,0
179426,coverage,0,0
179427,data,0,0
179428,for,0,1
179429,the,0,1
179430,different,0,0
179431,intervention,0,0
179432,arms,0,0
179433,",",0,0
179434,along,0,0
179435,with,0,1
179436,environmental,0,1
179437,",",0,1
179438,political,0,0
179439,and,0,1
179440,other,0,1
179441,characteristics,0,0
179442,that,0,0
179443,might,0,0
179444,impact,0,0
179445,on,0,0
179446,the,0,0
179447,infection,0,1
179448,prevalence,0,0
179449,and,0,0
179450,intensity,0,0
179451,will,0,0
179452,be,0,0
179453,recorded,0,0
179454,in,0,0
179455,each,0,0
179456,study,0,0
179457,year,0,0
179458,",",0,0
179459,using,0,0
179460,a,0,0
179461,pretested,0,1
179462,village,0,1
179463,inventory,0,1
179464,form,0,0
179465,.,0,0
179466,DISCUSSION,0,0
179467,The,0,0
179468,study,0,0
179469,will,0,0
179470,document,0,0
179471,changes,0,0
179472,in,0,1
179473,S.,0,1
179474,mansoni,0,1
179475,infection,0,1
179476,prevalence,0,0
179477,and,0,0
179478,intensity,0,0
179479,according,0,1
179480,to,0,1
179481,different,0,1
179482,treatment,0,1
179483,schemes,0,0
179484,.,0,1
179485,Moreover,0,0
179486,",",0,0
179487,factors,0,0
179488,that,0,0
179489,determine,0,0
179490,the,0,0
179491,effectiveness,0,0
179492,of,0,0
179493,preventive,0,1
179494,chemotherapy,0,1
179495,will,0,0
179496,be,0,0
179497,identified,0,0
179498,.,0,1
179499,These,0,0
179500,factors,0,0
179501,will,0,0
179502,help,0,0
179503,to,0,0
179504,develop,0,0
179505,reasonable,0,0
179506,measures,0,0
179507,of,0,1
179508,force,0,1
179509,of,0,0
179510,transmission,0,0
179511,that,0,0
179512,can,0,0
179513,be,0,0
179514,used,0,0
179515,to,0,0
179516,make,0,0
179517,decisions,0,0
179518,about,0,0
179519,the,0,0
179520,most,0,0
179521,cost-effective,0,0
179522,means,0,0
179523,of,0,1
179524,lowering,0,0
179525,prevalence,0,0
179526,",",0,0
179527,intensity,0,0
179528,and,0,0
179529,transmission,0,0
179530,in,0,0
179531,a,0,0
179532,given,0,0
179533,setting,0,1
179534,.,0,1
179535,The,0,0
179536,gathered,0,1
179537,information,0,0
179538,and,0,0
179539,results,0,0
179540,will,0,0
179541,inform,0,0
179542,how,0,0
179543,to,0,0
179544,effectively,0,0
179545,sustain,0,0
179546,control,0,0
179547,of,0,0
179548,schistosomiasis,0,1
179549,at,0,0
179550,a,0,1
179551,low,0,0
179552,level,0,0
179553,in,0,1
179554,different,0,0
179555,social-ecological,0,1
179556,contexts,0,1
179557,.,0,1
179558,TRIAL,0,0
179559,REGISTRATION,0,0
179560,ISRCTN99401114,0,1
179561,(,0,1
179562,date,0,0
179563,assigned,0,1
179564,:,0,1
179565,12,0,1
179566,November,0,1
179567,2014,0,1
179568,),0,1
179569,.,0,1
179570,TRANSCONJUNCTIVAL,0,1
179571,NONVITRECTOMIZING,0,1
179572,VITREOUS,0,1
179573,SURGERY,0,1
179574,VERSUS,0,1
179575,25-GAUGE,0,1
179576,VITRECTOMY,0,1
179577,IN,0,1
179578,PATIENTS,1,1
179579,WITH,1,1
179580,EPIRETINAL,1,1
179581,MEMBRANE,1,1
179582,:,1,1
179583,A,0,1
179584,Prospective,0,1
179585,Randomized,0,1
179586,Study,0,1
179587,.,0,1
179588,PURPOSE,0,0
179589,To,0,0
179590,compare,0,0
179591,the,0,0
179592,clinical,0,0
179593,outcomes,0,0
179594,and,0,1
179595,the,0,0
179596,rate,0,0
179597,of,0,0
179598,complications,0,1
179599,of,0,1
179600,27-gauge,0,0
179601,transconjunctival,0,1
179602,nonvitrectomizing,0,1
179603,vitreous,0,1
179604,surgery,0,1
179605,(,0,1
179606,NVS,0,1
179607,),0,1
179608,and,0,0
179609,of,0,0
179610,25-gauge,0,0
179611,transconjunctival,0,1
179612,sutureless,0,1
179613,vitrectomy,0,1
179614,surgery,1,1
179615,for,1,0
179616,idiopathic,1,1
179617,epiretinal,1,1
179618,membrane,1,0
179619,removal,1,1
179620,.,1,1
179621,METHODS,0,0
179622,In,0,0
179623,this,0,0
179624,prospective,0,1
179625,randomized,0,1
179626,study,0,1
179627,",",0,1
179628,83,1,1
179629,phakic,1,1
179630,eyes,1,1
179631,of,1,1
179632,83,1,1
179633,consecutive,1,1
179634,patients,1,1
179635,with,1,1
179636,an,1,1
179637,idiopathic,1,1
179638,epiretinal,1,1
179639,membrane,1,0
179640,were,1,1
179641,randomized,1,1
179642,to,1,0
179643,receive,1,1
179644,27-gauge,1,0
179645,NVS,1,1
179646,(,1,1
179647,NVS-group,1,1
179648,),1,1
179649,or,1,1
179650,25-gauge,1,0
179651,vitrectomy,1,1
179652,(,1,1
179653,Standard-group,1,1
179654,),1,1
179655,.,0,1
179656,Main,0,0
179657,outcome,0,0
179658,measures,0,0
179659,were,0,1
179660,best-corrected,0,0
179661,visual,0,0
179662,acuity,0,0
179663,",",0,1
179664,central,0,0
179665,retinal,0,1
179666,thickness,0,0
179667,",",0,0
179668,nuclear,0,1
179669,density,0,0
179670,units,0,1
179671,',0,1
179672,changes,0,0
179673,",",0,1
179674,and,0,0
179675,rate,0,0
179676,of,0,1
179677,complications,0,1
179678,.,0,1
179679,RESULTS,0,0
179680,Thirty-nine,1,1
179681,eyes,1,1
179682,of,1,1
179683,the,1,1
179684,Standard-group,1,1
179685,and,1,0
179686,40,1,1
179687,of,1,0
179688,the,1,0
179689,NVS-group,1,1
179690,were,1,0
179691,considered,1,0
179692,in,1,0
179693,final,1,0
179694,analysis,1,0
179695,.,1,1
179696,Mean,0,1
179697,best-corrected,0,0
179698,visual,0,0
179699,acuity,0,0
179700,improved,0,0
179701,significantly,0,0
179702,in,0,0
179703,both,0,0
179704,groups,0,0
179705,",",0,0
179706,with,0,1
179707,a,0,0
179708,significant,0,0
179709,better,0,0
179710,result,0,0
179711,at,0,0
179712,12,0,1
179713,months,0,1
179714,in,0,1
179715,NVS-group,0,1
179716,(,0,1
179717,P,0,0
179718,=,0,1
179719,0.039,0,0
179720,;,0,1
179721,t-test,0,0
179722,),0,1
179723,.,0,1
179724,Central,0,0
179725,retinal,0,1
179726,thickness,0,0
179727,decreased,0,0
179728,significantly,0,0
179729,in,0,0
179730,both,0,0
179731,groups,0,0
179732,(,0,1
179733,P,0,0
179734,<,0,0
179735,0.001,0,0
179736,",",0,1
179737,Tukey,0,0
179738,test,0,0
179739,),0,0
179740,",",0,0
179741,without,0,1
179742,significant,0,0
179743,difference,0,0
179744,between,0,0
179745,the,0,1
179746,two,0,0
179747,groups,0,0
179748,at,0,1
179749,any,0,1
179750,time,0,0
179751,point,0,0
179752,.,0,1
179753,At,0,0
179754,12,0,1
179755,months,0,0
179756,",",0,1
179757,nuclear,0,1
179758,density,0,0
179759,increased,0,0
179760,significantly,0,0
179761,in,0,0
179762,the,0,0
179763,Standard-group,0,0
179764,(,0,0
179765,analysis,0,0
179766,of,0,0
179767,variance,0,0
179768,",",0,1
179769,P,0,0
179770,<,0,0
179771,0.001,0,0
179772,),0,1
179773,",",0,0
179774,and,0,0
179775,it,0,0
179776,did,0,0
179777,not,0,0
179778,change,0,0
179779,in,0,0
179780,the,0,0
179781,NVS-group,0,1
179782,(,0,0
179783,analysis,0,0
179784,of,0,0
179785,variance,0,0
179786,",",0,1
179787,P,0,0
179788,=,0,1
179789,0.537,0,0
179790,),0,1
179791,.,0,1
179792,Epiretinal,0,1
179793,membrane,0,0
179794,recurred,0,1
179795,in,0,0
179796,5.1,0,0
179797,%,0,0
179798,of,0,1
179799,eyes,0,1
179800,in,0,1
179801,the,0,1
179802,Standard-group,0,0
179803,and,0,0
179804,in,0,1
179805,7.5,0,0
179806,%,0,0
179807,of,0,1
179808,eyes,0,1
179809,in,0,1
179810,the,0,1
179811,NVS-group,0,1
179812,(,0,1
179813,Fisher,0,0
179814,'s,0,1
179815,exact,0,0
179816,test,0,0
179817,",",0,1
179818,P,0,0
179819,=,0,1
179820,1.000,0,0
179821,),0,1
179822,.,0,1
179823,CONCLUSION,0,0
179824,The,0,0
179825,27-gauge,0,0
179826,NVS,0,1
179827,is,0,0
179828,an,0,0
179829,effective,0,0
179830,surgical,0,1
179831,procedure,0,0
179832,in,0,1
179833,eyes,0,1
179834,with,0,1
179835,epiretinal,0,1
179836,membrane,0,0
179837,and,0,0
179838,it,0,0
179839,induces,0,0
179840,less,0,0
179841,progression,0,0
179842,of,0,0
179843,nuclear,0,1
179844,sclerosis,0,1
179845,than,0,0
179846,25-gauge,0,0
179847,vitrectomy,0,1
179848,.,0,1
179849,Improving,0,0
179850,peer,1,1
179851,engagement,1,1
179852,of,0,1
179853,children,1,1
179854,with,1,1
179855,autism,1,1
179856,on,1,0
179857,the,1,0
179858,school,1,1
179859,playground,1,1
179860,:,1,1
179861,a,0,0
179862,randomized,0,1
179863,controlled,0,0
179864,trial,0,0
179865,.,0,1
179866,This,0,0
179867,study,0,0
179868,aimed,0,0
179869,to,0,0
179870,test,0,0
179871,the,0,0
179872,effects,0,0
179873,of,0,0
179874,a,0,1
179875,psychosocial,0,1
179876,intervention,0,0
179877,",",0,0
179878,Remaking,0,0
179879,Recess,0,1
179880,",",0,1
179881,on,0,0
179882,peer,0,1
179883,engagement,0,1
179884,for,0,0
179885,children,1,1
179886,with,1,1
179887,autism,1,1
179888,spectrum,1,1
179889,disorder,1,1
179890,(,1,1
179891,ASD,1,1
179892,),1,1
179893,.,1,1
179894,Using,0,0
179895,a,0,0
179896,randomized,0,1
179897,",",0,0
179898,wait-list-controlled,0,1
179899,design,0,1
179900,",",0,0
179901,the,0,0
179902,intervention,0,0
179903,was,0,0
179904,implemented,0,0
179905,during,0,0
179906,recess,0,0
179907,at,0,1
179908,four,1,1
179909,elementary,1,1
179910,schools,1,1
179911,.,1,1
179912,The,0,0
179913,immediate,1,0
179914,treatment,1,0
179915,(,1,1
179916,IT,1,1
179917,),1,1
179918,group,1,1
179919,consisted,1,1
179920,of,1,0
179921,13,1,1
179922,(,1,1
179923,2,1,1
179924,female,1,1
179925,),1,1
179926,elementary,1,1
179927,school,1,1
179928,students,1,1
179929,with,1,1
179930,ASD,1,1
179931,and,1,1
179932,the,1,0
179933,wait-list,1,0
179934,(,1,0
179935,WL,1,0
179936,),1,1
179937,group,1,1
179938,contained,1,0
179939,11,1,1
179940,(,1,1
179941,4,1,0
179942,female,1,1
179943,),1,1
179944,students,1,1
179945,with,1,1
179946,ASD,1,1
179947,.,1,1
179948,All,1,0
179949,of,1,0
179950,the,1,0
179951,children,1,1
179952,with,1,1
179953,ASD,1,1
179954,were,0,1
179955,fully,0,0
179956,included,0,1
179957,in,0,0
179958,the,0,0
179959,general,0,1
179960,education,0,1
179961,program,0,1
179962,.,0,1
179963,Analyses,0,0
179964,revealed,0,0
179965,that,0,0
179966,time,0,0
179967,spent,0,0
179968,engaged,0,1
179969,with,0,1
179970,peers,0,1
179971,was,0,0
179972,significantly,0,0
179973,increased,0,0
179974,for,0,0
179975,the,0,0
179976,IT,0,1
179977,group,0,1
179978,and,0,0
179979,maintained,0,0
179980,over,0,0
179981,the,0,0
179982,follow-up,0,0
179983,.,0,1
179984,School,0,0
179985,playground,0,1
179986,staff,0,1
179987,in,0,0
179988,the,0,0
179989,IT,0,1
179990,group,0,1
179991,showed,0,0
179992,increased,0,0
179993,behaviors,0,0
179994,aimed,0,0
179995,at,0,1
179996,improving,0,0
179997,peer,0,1
179998,engagement,0,1
179999,for,0,0
180000,children,1,1
180001,with,1,1
180002,ASD,1,1
180003,compared,0,0
180004,to,0,0
180005,playground,0,1
180006,staff,0,0
180007,at,0,0
180008,the,0,0
180009,WL,0,0
180010,sites,0,1
180011,.,0,1
180012,These,0,1
180013,improvements,0,0
180014,did,0,0
180015,not,0,0
180016,maintain,0,0
180017,to,0,0
180018,follow-up,0,0
180019,.,0,1
180020,These,0,0
180021,results,0,0
180022,suggest,0,0
180023,that,0,0
180024,a,0,1
180025,low,0,0
180026,dose,0,0
180027,",",0,0
180028,brief,0,0
180029,intervention,0,0
180030,can,0,0
180031,be,0,0
180032,beneficial,0,0
180033,in,0,0
180034,increasing,0,0
180035,peer,0,1
180036,engagement,0,1
180037,for,0,0
180038,children,0,1
180039,with,0,1
180040,autism,0,1
180041,in,0,1
180042,inclusive,0,1
180043,settings,0,1
180044,",",0,1
180045,but,0,0
180046,continued,0,0
180047,support,0,0
180048,of,0,0
180049,playground,0,1
180050,staff,0,1
180051,is,0,0
180052,likely,0,0
180053,needed,0,0
180054,.,0,1
180055,Diet-Related,0,1
180056,Colorectal,0,1
180057,Cancer,0,1
180058,Prevention,0,1
180059,Beliefs,0,0
180060,and,0,1
180061,Dietary,0,1
180062,Intakes,0,0
180063,in,0,0
180064,an,0,1
180065,Urban,1,1
180066,Minority,1,1
180067,Population,1,1
180068,.,1,1
180069,In,0,0
180070,the,0,0
180071,United,1,1
180072,States,1,1
180073,",",0,1
180074,colorectal,0,1
180075,cancer,0,1
180076,(,0,1
180077,CRC,0,1
180078,),0,0
180079,is,0,0
180080,the,0,0
180081,third,0,0
180082,leading,0,0
180083,cause,0,0
180084,of,0,0
180085,cancer-related,0,1
180086,death,0,0
180087,and,0,1
180088,third,0,1
180089,most,0,0
180090,commonly,0,1
180091,diagnosed,0,1
180092,cancer,0,1
180093,among,0,1
180094,adults,0,1
180095,.,0,1
180096,This,0,0
180097,study,0,0
180098,is,0,0
180099,the,0,0
180100,first,0,0
180101,to,0,0
180102,examine,0,0
180103,the,0,0
180104,relationship,0,0
180105,between,0,0
180106,diet-related,0,1
180107,beliefs,0,0
180108,for,0,1
180109,colorectal,0,1
180110,cancer,0,1
180111,prevention,0,1
180112,and,0,0
180113,dietary,0,0
180114,intake,0,0
180115,among,0,0
180116,an,0,0
180117,urban,1,1
180118,",",1,0
180119,predominantly,1,1
180120,Black,1,0
180121,population,1,1
180122,(,1,1
180123,n,1,1
180124,=,1,1
180125,169,1,1
180126,),1,1
180127,.,1,1
180128,More,0,1
180129,than,0,0
180130,two-thirds,0,0
180131,reported,0,1
180132,diet-related,0,1
180133,CRC,0,1
180134,prevention,0,1
180135,beliefs,0,0
180136,.,0,1
180137,Those,0,0
180138,with,0,1
180139,diet-related,0,1
180140,CRC,0,1
180141,prevention,0,1
180142,beliefs,0,0
180143,had,0,1
180144,healthier,0,1
180145,intakes,0,1
180146,for,0,0
180147,dietary,0,0
180148,fiber,0,0
180149,(,0,1
180150,p,0,0
180151,=,0,1
180152,.005,0,0
180153,),0,1
180154,",",0,0
180155,fruit,0,1
180156,",",0,0
180157,vegetable,0,0
180158,",",0,0
180159,bean,0,0
180160,(,0,1
180161,p,0,0
180162,=,0,1
180163,.027,0,0
180164,),0,1
180165,",",0,0
180166,red,0,1
180167,meat,0,1
180168,(,0,1
180169,p,0,0
180170,=,0,1
180171,.032,0,0
180172,),0,0
180173,",",0,0
180174,vitamin,0,0
180175,C,0,0
180176,(,0,1
180177,p,0,0
180178,=,0,1
180179,.039,0,0
180180,),0,1
180181,",",0,0
180182,and,0,0
180183,cholesterol,0,0
180184,(,0,1
180185,p,0,0
180186,=,0,1
180187,.045,0,0
180188,),0,1
180189,.,0,1
180190,Most,0,0
180191,people,0,1
180192,may,0,0
180193,already,0,1
180194,have,0,0
180195,diet-related,0,1
180196,CRC,0,1
180197,prevention,0,1
180198,beliefs,0,0
180199,and,0,0
180200,having,0,1
180201,them,0,0
180202,is,0,0
180203,associated,0,0
180204,with,0,0
180205,a,0,0
180206,more,0,0
180207,healthful,0,0
180208,dietary,0,0
180209,intake,0,1
180210,.,0,1
180211,Inverse,0,1
180212,fluoxetine,0,1
180213,effects,0,0
180214,on,0,0
180215,inhibitory,0,0
180216,brain,0,0
180217,activation,0,0
180218,in,0,1
180219,non-comorbid,1,1
180220,boys,1,1
180221,with,1,1
180222,ADHD,1,1
180223,and,1,1
180224,with,1,1
180225,ASD,1,1
180226,.,1,1
180227,RATIONALE,0,0
180228,Attention,0,0
180229,deficit,0,1
180230,hyperactivity,0,1
180231,disorder,0,1
180232,(,0,1
180233,ADHD,0,1
180234,),0,1
180235,and,0,0
180236,autism,0,1
180237,spectrum,0,1
180238,disorder,0,1
180239,(,0,1
180240,ASD,0,1
180241,),0,1
180242,are,0,0
180243,often,0,0
180244,comorbid,0,1
180245,and,0,0
180246,have,0,0
180247,both,0,0
180248,performance,0,0
180249,and,0,0
180250,brain,0,1
180251,dysfunctions,0,1
180252,during,0,1
180253,motor,0,0
180254,response,0,0
180255,inhibition,0,0
180256,.,0,1
180257,Serotonin,0,0
180258,agonists,0,0
180259,modulate,0,0
180260,motor,0,0
180261,response,0,0
180262,inhibition,0,0
180263,and,0,0
180264,have,0,0
180265,shown,0,0
180266,positive,0,1
180267,behavioural,0,0
180268,effects,0,0
180269,in,0,1
180270,both,0,1
180271,disorders,0,1
180272,.,0,1
180273,AIMS,0,0
180274,We,0,0
180275,therefore,0,0
180276,used,0,0
180277,functional,0,1
180278,magnetic,0,1
180279,resonance,0,1
180280,imaging,0,0
180281,(,0,1
180282,fMRI,0,0
180283,),0,0
180284,to,0,0
180285,investigate,0,0
180286,the,0,0
180287,so,0,0
180288,far,0,1
180289,unknown,0,0
180290,shared,0,0
180291,and,0,1
180292,disorder-specific,0,0
180293,inhibitory,0,0
180294,brain,0,1
180295,dysfunctions,0,1
180296,in,0,1
180297,these,0,1
180298,two,0,0
180299,disorders,0,1
180300,",",0,0
180301,as,0,0
180302,well,0,0
180303,as,0,0
180304,the,0,0
180305,effects,0,0
180306,of,0,0
180307,a,0,1
180308,single,0,0
180309,dose,0,0
180310,of,0,0
180311,the,0,0
180312,selective,0,1
180313,serotonin,0,0
180314,reuptake,0,0
180315,inhibitor,0,0
180316,fluoxetine,0,1
180317,.,0,1
180318,METHODS,0,0
180319,Age-matched,1,1
180320,boys,1,1
180321,with,1,1
180322,ADHD,1,1
180323,(,1,1
180324,18,1,1
180325,),1,1
180326,",",1,1
180327,ASD,1,1
180328,(,1,1
180329,19,1,1
180330,),1,1
180331,and,1,1
180332,healthy,1,1
180333,controls,1,1
180334,(,1,1
180335,25,1,1
180336,),1,1
180337,were,0,1
180338,compared,0,0
180339,with,0,1
180340,fMRI,0,0
180341,during,0,0
180342,a,0,1
180343,stop,0,1
180344,task,0,1
180345,measuring,0,0
180346,motor,0,0
180347,inhibition,0,0
180348,.,0,1
180349,Patients,0,1
180350,were,0,0
180351,scanned,0,1
180352,twice,0,0
180353,",",0,0
180354,under,0,0
180355,either,0,0
180356,an,0,0
180357,acute,0,1
180358,dose,0,0
180359,of,0,0
180360,fluoxetine,0,1
180361,or,0,1
180362,placebo,0,0
180363,in,0,0
180364,a,0,0
180365,double-blind,0,0
180366,",",0,0
180367,placebo-controlled,0,0
180368,randomised,0,1
180369,design,0,1
180370,.,0,1
180371,Repeated,0,0
180372,measures,0,0
180373,analyses,0,0
180374,within,0,1
180375,patients,0,1
180376,assessed,0,1
180377,drug,0,1
180378,effects,0,0
180379,.,0,1
180380,To,0,0
180381,test,0,0
180382,for,0,0
180383,potential,0,0
180384,normalisation,0,1
180385,effects,0,0
180386,of,0,1
180387,brain,0,1
180388,dysfunctions,0,1
180389,",",0,1
180390,patients,0,1
180391,under,0,1
180392,each,0,1
180393,drug,0,0
180394,condition,0,0
180395,were,0,1
180396,compared,0,0
180397,to,0,1
180398,controls,0,1
180399,.,0,1
180400,RESULTS,0,0
180401,Under,0,1
180402,placebo,0,0
180403,",",0,1
180404,relative,0,0
180405,to,0,1
180406,controls,0,1
180407,",",0,0
180408,ASD,1,1
180409,boys,1,1
180410,showed,0,0
180411,overactivation,0,0
180412,in,0,0
180413,left,0,1
180414,and,0,1
180415,right,0,1
180416,inferior,0,0
180417,frontal,0,1
180418,cortex,0,0
180419,(,0,1
180420,IFC,0,1
180421,),0,1
180422,",",0,0
180423,while,0,0
180424,ADHD,1,0
180425,boys,1,1
180426,showed,0,0
180427,disorder-specific,0,0
180428,underactivation,0,0
180429,in,0,1
180430,orbitofrontal,0,0
180431,cortex,0,0
180432,(,0,1
180433,OFC,0,1
180434,),0,1
180435,and,0,1
180436,basal,0,1
180437,ganglia,0,1
180438,.,0,1
180439,Under,0,1
180440,fluoxetine,0,0
180441,",",0,0
180442,the,0,0
180443,prefrontal,0,0
180444,dysfunctions,0,1
180445,were,0,1
180446,no,0,0
180447,longer,0,0
180448,observed,0,0
180449,",",0,0
180450,due,0,0
180451,to,0,1
180452,inverse,0,0
180453,effects,0,0
180454,of,0,1
180455,fluoxetine,0,1
180456,on,0,0
180457,these,0,0
180458,activations,0,0
180459,:,0,1
180460,fluoxetine,0,1
180461,downregulated,0,1
180462,IFC,0,1
180463,and,0,1
180464,OFC,0,1
180465,activation,0,0
180466,in,0,1
180467,ASD,0,1
180468,but,0,0
180469,upregulated,0,1
180470,them,0,0
180471,in,0,1
180472,ADHD,0,1
180473,.,0,1
180474,CONCLUSIONS,0,0
180475,The,0,0
180476,findings,0,0
180477,show,0,0
180478,that,0,0
180479,fluoxetine,0,1
180480,normalises,0,0
180481,frontal,0,1
180482,lobe,0,1
180483,dysfunctions,0,1
180484,in,0,1
180485,both,0,0
180486,disorders,0,1
180487,via,0,1
180488,inverse,0,1
180489,effects,0,0
180490,",",0,1
180491,downregulating,0,0
180492,abnormally,0,0
180493,increased,0,0
180494,frontal,0,0
180495,activation,0,0
180496,in,0,1
180497,ASD,0,1
180498,and,0,0
180499,upregulating,0,0
180500,abnormally,0,1
180501,decreased,0,0
180502,frontal,0,0
180503,activation,0,0
180504,in,0,0
180505,ADHD,0,0
180506,",",0,0
180507,potentially,0,0
180508,reflecting,0,0
180509,inverse,0,0
180510,baseline,0,1
180511,serotonin,0,0
180512,levels,0,0
180513,in,0,1
180514,both,0,1
180515,disorders,0,1
180516,.,0,1
180517,Carboplatin,0,1
180518,and,0,1
180519,pegylated,0,0
180520,liposomal,0,0
180521,doxorubicin,0,0
180522,versus,0,0
180523,carboplatin,0,0
180524,and,0,0
180525,paclitaxel,0,0
180526,in,0,0
180527,very,1,0
180528,platinum-sensitive,1,1
180529,ovarian,1,1
180530,cancer,1,1
180531,patients,1,1
180532,:,1,1
180533,results,0,0
180534,from,0,1
180535,a,0,1
180536,subset,1,1
180537,analysis,1,0
180538,of,1,0
180539,the,1,0
180540,CALYPSO,1,0
180541,phase,1,1
180542,III,1,1
180543,trial,1,1
180544,.,1,1
180545,AIM,0,0
180546,To,0,0
180547,perform,0,0
180548,a,0,0
180549,subset,0,1
180550,analysis,0,0
180551,of,0,1
180552,patients,1,1
180553,with,1,1
180554,very,1,0
180555,platinum-sensitive,1,1
180556,recurrent,1,1
180557,ovarian,1,1
180558,cancer,1,1
180559,(,1,1
180560,ROC,1,1
180561,),1,1
180562,enrolled,1,1
180563,in,1,0
180564,the,1,0
180565,phase,1,1
180566,III,1,1
180567,CALYPSO,1,0
180568,trial,1,1
180569,.,1,1
180570,PATIENTS,0,0
180571,AND,0,0
180572,METHODS,0,0
180573,The,1,0
180574,international,1,1
180575,non-inferiority,1,0
180576,trial,1,1
180577,enrolled,1,1
180578,women,1,1
180579,with,1,1
180580,ROC,1,1
180581,that,1,0
180582,relapsed,1,1
180583,>,1,1
180584,6,1,1
180585,months,1,0
180586,following,1,1
180587,first-,1,1
180588,or,1,1
180589,second-line,1,1
180590,platinum-,1,1
180591,and,1,1
180592,paclitaxel-based,1,1
180593,therapies,1,0
180594,.,1,1
180595,Patients,0,1
180596,were,0,1
180597,randomised,0,1
180598,to,0,0
180599,CD,0,1
180600,[,0,0
180601,carboplatin-pegylated,0,0
180602,liposomal,0,0
180603,doxorubicin,0,1
180604,(,0,1
180605,PLD,0,0
180606,),0,1
180607,],0,1
180608,or,0,1
180609,CP,0,0
180610,(,0,1
180611,carboplatin-paclitaxel,0,0
180612,),0,1
180613,and,0,0
180614,stratified,0,1
180615,by,0,0
180616,treatment-free,0,0
180617,interval,0,0
180618,(,0,1
180619,TFI,0,1
180620,),0,1
180621,.,0,1
180622,In,0,0
180623,this,0,0
180624,analysis,0,0
180625,",",0,0
180626,patients,1,1
180627,with,1,1
180628,a,1,1
180629,TFI,1,1
180630,>,1,1
180631,24,1,1
180632,months,1,1
180633,were,0,1
180634,analysed,0,1
180635,separately,0,0
180636,for,0,0
180637,progression,0,0
180638,free,0,1
180639,survival,0,0
180640,(,0,1
180641,PFS,0,1
180642,),0,1
180643,",",0,0
180644,the,0,0
180645,primary,0,1
180646,endpoint,0,0
180647,of,0,0
180648,CALYPSO,0,0
180649,",",0,1
180650,overall,0,0
180651,survival,0,0
180652,(,0,1
180653,OS,0,0
180654,),0,1
180655,and,0,1
180656,safety,0,0
180657,.,0,0
180658,RESULTS,0,0
180659,A,1,0
180660,total,1,1
180661,of,1,0
180662,259,1,1
180663,very,1,0
180664,platinum-sensitive,1,1
180665,patients,1,1
180666,were,1,1
180667,included,1,1
180668,(,1,0
180669,n=131,1,1
180670,",",1,1
180671,CD,1,1
180672,;,1,0
180673,n=128,1,1
180674,",",1,0
180675,CP,1,0
180676,),1,1
180677,.,1,1
180678,Median,0,1
180679,PFS,0,1
180680,was,0,0
180681,12.0,0,0
180682,months,0,0
180683,for,0,1
180684,the,0,0
180685,CD,0,1
180686,arm,0,1
180687,and,0,1
180688,12.3,0,1
180689,months,0,0
180690,for,0,1
180691,CP,0,1
180692,[,0,1
180693,HR=1.05,0,0
180694,(,0,1
180695,95,0,0
180696,%,0,0
180697,CI,0,0
180698,",",0,1
180699,0.79-1.40,0,0
180700,),0,1
180701,;,0,1
180702,P=0.73,0,0
180703,for,0,0
180704,superiority,0,0
180705,],0,1
180706,and,0,1
180707,median,0,1
180708,OS,0,0
180709,was,0,0
180710,40.2,0,1
180711,months,0,0
180712,for,0,1
180713,CD,0,1
180714,and,0,1
180715,43.9,0,1
180716,for,0,1
180717,CP,0,1
180718,[,0,1
180719,HR=1.18,0,0
180720,(,0,1
180721,95,0,0
180722,%,0,0
180723,CI,0,0
180724,0.85-1.63,0,0
180725,),0,1
180726,;,0,1
180727,P=0.33,0,0
180728,for,0,0
180729,superiority,0,0
180730,],0,1
180731,.,0,1
180732,Overall,0,0
180733,response,0,0
180734,rates,0,0
180735,were,0,1
180736,42,0,1
180737,%,0,0
180738,and,0,1
180739,38,0,1
180740,%,0,0
180741,",",0,0
180742,respectively,0,0
180743,(,0,0
180744,P=0.46,0,0
180745,),0,1
180746,.,0,1
180747,Toxicities,0,0
180748,were,0,0
180749,more,0,0
180750,common,0,0
180751,with,0,1
180752,CP,0,0
180753,versus,0,0
180754,CD,0,1
180755,",",0,0
180756,including,0,0
180757,grade,0,1
180758,3/4,0,1
180759,neutropenia,0,0
180760,(,0,1
180761,40.8,0,0
180762,%,0,0
180763,versus,0,0
180764,27.5,0,1
180765,%,0,0
180766,;,0,1
180767,P=0.025,0,0
180768,),0,1
180769,",",0,0
180770,nausea,0,0
180771,(,0,1
180772,4.8,0,0
180773,%,0,0
180774,versus,0,0
180775,3.1,0,0
180776,%,0,0
180777,;,0,1
180778,P=0.47,0,0
180779,),0,1
180780,",",0,0
180781,allergic,0,1
180782,reaction,0,0
180783,(,0,1
180784,8,0,0
180785,%,0,0
180786,versus,0,0
180787,3.1,0,0
180788,%,0,0
180789,;,0,1
180790,P=0.082,0,0
180791,),0,1
180792,sensory,0,1
180793,neuropathy,0,1
180794,(,0,1
180795,4.8,0,0
180796,%,0,0
180797,versus,0,0
180798,2.3,0,1
180799,%,0,0
180800,;,0,1
180801,P=0.27,0,0
180802,),0,1
180803,and,0,1
180804,grade,0,1
180805,2,0,1
180806,alopecia,0,1
180807,(,0,1
180808,88,0,0
180809,%,0,0
180810,versus,0,0
180811,9.2,0,0
180812,%,0,0
180813,;,0,1
180814,P,0,0
180815,<,0,0
180816,0.001,0,0
180817,),0,1
180818,.,0,1
180819,Grade,0,0
180820,3/4,0,0
180821,thrombocytopenia,0,1
180822,(,0,1
180823,12.2,0,0
180824,%,0,0
180825,versus,0,0
180826,3.2,0,1
180827,%,0,0
180828,;,0,1
180829,P=0.007,0,0
180830,),0,1
180831,and,0,0
180832,mucositis,0,0
180833,(,0,1
180834,2.3,0,0
180835,%,0,0
180836,versus,0,0
180837,0,0,0
180838,%,0,0
180839,;,0,1
180840,P=0.089,0,0
180841,),0,0
180842,were,0,0
180843,more,0,0
180844,common,0,0
180845,with,0,1
180846,CD,0,1
180847,.,0,1
180848,Grade,0,0
180849,3/4,0,0
180850,hand-foot,0,0
180851,syndrome,0,1
180852,occurred,0,0
180853,rarely,0,0
180854,with,0,1
180855,CD,0,1
180856,(,0,1
180857,3,0,1
180858,patients,0,1
180859,versus,0,0
180860,0,0,0
180861,in,0,1
180862,CP,0,1
180863,arm,0,1
180864,;,0,1
180865,P=0.089,0,0
180866,),0,1
180867,.,0,1
180868,CONCLUSION,0,0
180869,CP,0,0
180870,and,0,1
180871,CD,0,1
180872,were,0,1
180873,equally,0,0
180874,effective,0,0
180875,treatment,0,0
180876,regimens,0,0
180877,for,0,1
180878,patients,1,1
180879,with,1,1
180880,very,1,0
180881,platinum-sensitive,1,1
180882,ROC,1,1
180883,.,1,1
180884,The,0,0
180885,favourable,0,0
180886,risk-benefit,0,0
180887,profile,0,0
180888,suggests,0,0
180889,carboplatin-PLD,0,0
180890,as,0,0
180891,treatment,0,0
180892,of,0,0
180893,choice,0,0
180894,for,0,0
180895,these,0,0
180896,patients,0,1
180897,.,0,1
180898,Efficacy,0,0
180899,and,0,0
180900,safety,0,0
180901,of,0,0
180902,repeated,0,0
180903,use,0,0
180904,of,0,0
180905,ulipristal,0,0
180906,acetate,0,0
180907,in,0,1
180908,uterine,1,1
180909,fibroids,1,1
180910,.,1,1
180911,OBJECTIVE,0,0
180912,To,0,0
180913,investigate,0,0
180914,the,0,0
180915,efficacy,0,0
180916,and,0,0
180917,safety,0,0
180918,of,0,0
180919,repeated,0,0
180920,12-week,0,0
180921,courses,0,0
180922,of,0,1
180923,5,0,1
180924,or,0,1
180925,10,0,1
180926,mg,0,0
180927,daily,0,0
180928,of,0,0
180929,ulipristal,0,0
180930,acetate,0,0
180931,for,0,0
180932,intermittent,0,1
180933,treatment,0,1
180934,of,0,0
180935,symptomatic,1,1
180936,uterine,1,1
180937,fibroids,1,1
180938,.,1,1
180939,DESIGN,0,0
180940,Double-blind,0,0
180941,",",0,0
180942,randomized,0,1
180943,administration,0,0
180944,of,0,1
180945,two,0,1
180946,12-week,0,1
180947,courses,0,0
180948,of,0,1
180949,ulipristal,0,1
180950,acetate,0,0
180951,.,0,1
180952,SETTING,0,1
180953,Gynecology,1,1
180954,centers,1,1
180955,.,1,1
180956,PATIENT,0,1
180957,(,0,0
180958,S,0,1
180959,),0,1
180960,A,0,1
180961,total,1,1
180962,of,1,1
180963,451,1,1
180964,patients,1,1
180965,with,1,1
180966,symptomatic,1,1
180967,uterine,1,1
180968,fibroid,1,1
180969,(,1,1
180970,s,1,1
180971,),1,1
180972,and,1,0
180973,heavy,1,1
180974,bleeding,1,1
180975,.,1,1
180976,INTERVENTION,0,0
180977,(,0,0
180978,S,0,1
180979,),0,1
180980,Two,0,1
180981,repeated,0,0
180982,12-week,0,0
180983,treatment,0,1
180984,courses,0,0
180985,of,0,1
180986,daily,0,0
180987,5,0,1
180988,or,0,1
180989,10,0,1
180990,mg,0,0
180991,of,0,0
180992,ulipristal,0,0
180993,acetate,0,0
180994,.,0,1
180995,MAIN,0,0
180996,OUTCOME,0,1
180997,MEASURE,0,0
180998,(,0,1
180999,S,0,1
181000,),0,1
181001,Amenorrhea,0,1
181002,",",0,0
181003,controlled,0,0
181004,bleeding,0,0
181005,",",0,0
181006,fibroid,0,1
181007,volume,0,0
181008,",",0,0
181009,quality,0,0
181010,of,0,0
181011,life,0,1
181012,(,0,1
181013,QoL,0,0
181014,),0,1
181015,",",0,0
181016,pain,0,1
181017,.,0,1
181018,RESULT,0,0
181019,(,0,0
181020,S,0,1
181021,),0,1
181022,In,0,1
181023,the,0,0
181024,5-,0,1
181025,and,0,0
181026,10-mg,0,0
181027,treatment,0,1
181028,groups,0,1
181029,(,0,1
181030,62,0,1
181031,%,0,0
181032,and,0,1
181033,73,0,1
181034,%,0,0
181035,of,0,1
181036,patients,0,1
181037,",",0,1
181038,respectively,0,0
181039,),0,0
181040,achieved,0,0
181041,amenorrhea,0,1
181042,during,0,0
181043,both,0,0
181044,treatment,0,1
181045,courses,0,0
181046,.,0,1
181047,Proportions,0,0
181048,of,0,1
181049,patients,0,1
181050,achieving,0,0
181051,controlled,0,0
181052,bleeding,0,1
181053,during,0,0
181054,two,0,1
181055,treatment,0,1
181056,courses,0,0
181057,were,0,1
181058,>,0,1
181059,80,0,1
181060,%,0,0
181061,.,0,1
181062,Menstruation,0,0
181063,resumed,0,0
181064,after,0,0
181065,each,0,0
181066,treatment,0,0
181067,course,0,0
181068,and,0,0
181069,was,0,0
181070,diminished,0,0
181071,compared,0,0
181072,with,0,1
181073,baseline,0,0
181074,.,0,1
181075,After,0,0
181076,the,0,0
181077,second,0,1
181078,treatment,0,0
181079,course,0,0
181080,",",0,1
181081,median,0,0
181082,reductions,0,0
181083,from,0,1
181084,baseline,0,1
181085,in,0,1
181086,fibroid,0,1
181087,volume,0,1
181088,were,0,1
181089,54,0,1
181090,%,0,0
181091,and,0,1
181092,58,0,1
181093,%,0,0
181094,for,0,0
181095,the,0,0
181096,patients,0,1
181097,receiving,0,1
181098,5,0,1
181099,and,0,1
181100,10,0,1
181101,mg,0,0
181102,of,0,0
181103,ulipristal,0,0
181104,acetate,0,0
181105,",",0,0
181106,respectively,0,0
181107,.,0,1
181108,Pain,0,0
181109,and,0,0
181110,QoL,0,0
181111,improved,0,0
181112,in,0,0
181113,both,0,0
181114,groups,0,0
181115,.,0,1
181116,Ulipristal,0,0
181117,acetate,0,0
181118,was,0,0
181119,well,0,0
181120,tolerated,0,0
181121,with,0,1
181122,less,0,0
181123,than,0,1
181124,5,0,0
181125,%,0,0
181126,of,0,1
181127,patients,0,1
181128,discontinuing,0,1
181129,treatment,0,1
181130,due,0,1
181131,to,0,1
181132,adverse,0,0
181133,events,0,0
181134,.,0,1
181135,CONCLUSION,0,0
181136,(,0,0
181137,S,0,1
181138,),0,1
181139,Repeated,0,0
181140,12-week,0,0
181141,courses,0,0
181142,of,0,1
181143,daily,0,0
181144,oral,0,1
181145,ulipristal,0,0
181146,acetate,0,0
181147,(,0,1
181148,5,0,1
181149,and,0,1
181150,10,0,1
181151,mg,0,0
181152,),0,0
181153,effectively,0,0
181154,control,0,1
181155,bleeding,0,0
181156,and,0,0
181157,pain,0,1
181158,",",0,0
181159,reduce,0,0
181160,fibroid,0,1
181161,volume,0,0
181162,",",0,0
181163,and,0,0
181164,restore,0,0
181165,QoL,0,0
181166,in,0,0
181167,patients,0,1
181168,with,0,1
181169,symptomatic,0,1
181170,fibroids,0,1
181171,.,0,1
181172,CLINICAL,0,1
181173,TRIAL,0,0
181174,REGISTRATION,0,1
181175,NUMBER,0,1
181176,NCT01629563,0,1
181177,(,0,1
181178,PEARL,0,1
181179,IV,0,1
181180,),0,1
181181,.,0,1
181182,Effects,0,0
181183,of,0,1
181184,stellate,0,0
181185,ganglionic,0,1
181186,block,0,1
181187,on,0,0
181188,hemodynamic,0,0
181189,changes,0,0
181190,and,0,1
181191,intrapulmonary,0,1
181192,shunt,0,1
181193,in,0,1
181194,perioperative,1,0
181195,patients,1,1
181196,with,1,1
181197,esophageal,1,1
181198,cancer,1,1
181199,.,1,1
181200,OBJECTIVE,0,0
181201,The,0,0
181202,aim,0,0
181203,of,0,0
181204,this,0,0
181205,study,0,0
181206,was,0,0
181207,to,0,0
181208,observe,0,0
181209,the,0,0
181210,effects,0,0
181211,of,0,0
181212,stellate,0,0
181213,ganglion,0,1
181214,block,0,1
181215,(,0,1
181216,SGB,0,1
181217,),0,1
181218,on,0,0
181219,hemodynamic,0,0
181220,changes,0,0
181221,and,0,1
181222,intrapulmonary,0,1
181223,shunt,0,1
181224,during,0,0
181225,one-lung,0,1
181226,ventilation,0,1
181227,(,0,1
181228,OLV,0,1
181229,),0,1
181230,.,0,1
181231,PATIENTS,0,0
181232,AND,0,0
181233,METHODS,1,0
181234,Thirty,1,1
181235,ASA,1,1
181236,class,1,1
181237,I-II,1,1
181238,patients,1,1
181239,undergoing,1,1
181240,elective,1,1
181241,esophageal,1,1
181242,surgery,1,1
181243,were,0,0
181244,randomly,0,1
181245,divided,0,1
181246,into,0,1
181247,two,0,1
181248,groups,0,1
181249,:,0,1
181250,general,0,1
181251,anesthesia,0,1
181252,group,0,1
181253,(,0,1
181254,group,0,1
181255,N,0,1
181256,",",0,0
181257,n=15,0,1
181258,),0,1
181259,and,0,0
181260,general,0,1
181261,anesthesia,0,1
181262,combined,0,0
181263,SGB,0,1
181264,group,0,1
181265,(,0,1
181266,group,0,1
181267,S,0,0
181268,",",0,0
181269,n=15,0,1
181270,),0,0
181271,",",0,0
181272,patients,0,1
181273,in,0,1
181274,group,0,1
181275,S,0,1
181276,were,0,1
181277,received,0,1
181278,left,0,1
181279,SGB,0,1
181280,before,0,1
181281,induction,0,1
181282,.,0,1
181283,Radial,0,0
181284,artery,0,1
181285,was,0,0
181286,cannulated,0,1
181287,for,0,0
181288,arterial,0,1
181289,blood,0,0
181290,pressure,0,0
181291,(,0,1
181292,ABP,0,1
181293,),0,1
181294,monitoring,0,0
181295,and,0,0
181296,blood,0,0
181297,sampling,0,0
181298,and,0,0
181299,Swan-Ganz,0,1
181300,catheter,0,0
181301,was,0,0
181302,position,0,0
181303,in,0,0
181304,the,0,0
181305,pulmonary,0,1
181306,artery,0,1
181307,via,0,1
181308,right,0,1
181309,internal,0,1
181310,jugular,0,1
181311,vein,0,1
181312,under,0,1
181313,local,0,0
181314,anesthesia,0,1
181315,.,0,1
181316,ECG,0,0
181317,",",0,0
181318,MAP,0,0
181319,",",0,0
181320,HR,0,0
181321,",",0,0
181322,CVP,0,0
181323,",",0,0
181324,continuous,0,0
181325,cardiac,0,1
181326,output,0,0
181327,(,0,1
181328,CCO,0,1
181329,),0,1
181330,index,0,1
181331,and,0,1
181332,BIS,0,0
181333,were,0,1
181334,continuously,0,0
181335,monitored,0,0
181336,during,0,0
181337,anesthesia,0,1
181338,.,0,1
181339,General,0,0
181340,anesthesia,0,0
181341,was,0,0
181342,induced,0,0
181343,with,0,1
181344,propofol,0,0
181345,1.5-2.0,0,0
181346,mg/kg,0,0
181347,",",0,1
181348,sufentanil,0,0
181349,0.4,0,0
181350,?g/kg,0,0
181351,",",0,0
181352,and,0,0
181353,Rocuronium,0,0
181354,0.6-0.9,0,0
181355,mg/kg,0,0
181356,.,0,1
181357,Endobronchial,0,1
181358,occluder,0,1
181359,was,0,0
181360,placed,0,0
181361,blindly,0,1
181362,after,0,0
181363,tracheal,0,1
181364,indubation,0,1
181365,and,0,0
181366,the,0,0
181367,correct,0,0
181368,position,0,0
181369,was,0,0
181370,verified,0,0
181371,by,0,0
181372,auscultation,0,1
181373,and,0,1
181374,fiberoptic,0,1
181375,bronchoscopy,0,1
181376,.,0,1
181377,The,0,0
181378,patients,0,1
181379,were,0,1
181380,mechanically,0,1
181381,ventilated,0,1
181382,.,0,0
181383,The,0,0
181384,ventilation,0,0
181385,conditions,0,1
181386,were,0,1
181387,Fio2=100,0,0
181388,%,0,0
181389,",",0,0
181390,VT,0,0
181391,=,0,0
181392,8-10,0,1
181393,ml/kg,0,0
181394,",",0,1
181395,I,0,1
181396,:,0,1
181397,E,0,0
181398,=,0,0
181399,1:2,0,1
181400,and,0,0
181401,respiratory,0,1
181402,rate,0,0
181403,was,0,0
181404,adjusted,0,0
181405,to,0,0
181406,maintained,0,0
181407,PETCO2,0,1
181408,at,0,1
181409,35-45,0,1
181410,mmHg,0,0
181411,during,0,0
181412,both,0,0
181413,two-lung,0,0
181414,ventilation,0,0
181415,(,0,1
181416,TLV,0,1
181417,),0,1
181418,and,0,1
181419,OLV,0,1
181420,.,0,1
181421,Anesthesia,0,0
181422,was,0,0
181423,maintained,0,0
181424,with,0,1
181425,continuous,0,0
181426,infusion,0,0
181427,of,0,0
181428,propofol,0,0
181429,4-10,0,1
181430,mg/kg?h,0,0
181431,",",0,1
181432,sufentanil,0,0
181433,0.2,0,0
181434,?g/kg?h,0,0
181435,",",0,0
181436,vecuronium,0,0
181437,o.1,0,0
181438,mg/kg?h,0,0
181439,",",0,0
181440,BIS,0,0
181441,was,0,0
181442,maintained,0,0
181443,at,0,1
181444,45-55,0,1
181445,.,0,1
181446,Blood,0,0
181447,samples,0,0
181448,were,0,1
181449,taken,0,0
181450,from,0,1
181451,radial,0,1
181452,artery,0,1
181453,and,0,1
181454,S-G,0,0
181455,catheter,0,0
181456,for,0,0
181457,blood,0,0
181458,gas,0,1
181459,analysis,0,0
181460,at,0,1
181461,following,0,1
181462,intervals,0,0
181463,:,0,1
181464,during,0,1
181465,spontaneous,0,0
181466,breathing,0,0
181467,when,0,0
181468,the,0,0
181469,patient,0,0
181470,was,0,0
181471,awake,0,1
181472,(,0,1
181473,T0,0,1
181474,),0,1
181475,",",0,1
181476,1,0,0
181477,min,0,0
181478,after,0,1
181479,tracheal,0,1
181480,indubation,0,1
181481,(,0,1
181482,T1,0,0
181483,),0,1
181484,",",0,1
181485,1,0,0
181486,min,0,0
181487,after,0,0
181488,patient,0,1
181489,was,0,0
181490,placed,0,0
181491,in,0,0
181492,lateral,0,1
181493,position,0,1
181494,(,0,1
181495,T2,0,1
181496,),0,1
181497,and,0,1
181498,15,0,1
181499,min,0,0
181500,after,0,0
181501,it,0,0
181502,(,0,1
181503,T3,0,1
181504,),0,1
181505,",",0,1
181506,1,0,0
181507,min,0,0
181508,after,0,0
181509,ribs,0,1
181510,was,0,0
181511,braced,0,1
181512,(,0,1
181513,T4,0,1
181514,),0,1
181515,",",0,0
181516,30,0,1
181517,",",0,0
181518,60,0,1
181519,",",0,0
181520,120,0,1
181521,min,0,0
181522,during,0,0
181523,the,0,0
181524,course,0,0
181525,of,0,0
181526,OLV,0,1
181527,(,0,1
181528,T5,0,1
181529,",",0,0
181530,T6,0,0
181531,",",0,0
181532,T7,0,0
181533,),0,0
181534,",",0,0
181535,the,0,0
181536,two,0,0
181537,lungs,0,0
181538,were,0,1
181539,ventilated,0,1
181540,again,0,0
181541,for,0,0
181542,30,0,1
181543,min,0,0
181544,(,0,1
181545,T8,0,1
181546,),0,1
181547,and,0,1
181548,Qs/Qt,0,1
181549,was,0,0
181550,calculated,0,0
181551,.,0,1
181552,RESULTS,0,0
181553,SVRI,0,0
181554,",",0,0
181555,MAP,0,0
181556,",",0,0
181557,HR,0,0
181558,in,0,0
181559,group,0,1
181560,N,0,1
181561,increased,0,0
181562,significantly,0,0
181563,at,0,0
181564,T1,0,0
181565,",",0,1
181566,T2,0,1
181567,",",0,0
181568,T4,0,0
181569,compared,0,0
181570,with,0,1
181571,group,0,1
181572,S,0,1
181573,(,0,1
181574,p,0,0
181575,<,0,0
181576,0.05,0,0
181577,),0,1
181578,.,0,1
181579,Qs/Qt,0,0
181580,was,0,0
181581,significantly,0,0
181582,increased,0,0
181583,after,0,0
181584,patient,0,1
181585,was,0,0
181586,placed,0,0
181587,in,0,0
181588,lateral,0,1
181589,position,0,1
181590,and,0,0
181591,increased,0,0
181592,further,0,0
181593,during,0,0
181594,OLV,0,1
181595,;,0,1
181596,the,0,0
181597,calculated,0,0
181598,Qs/Qt,0,1
181599,values,0,0
181600,were,0,1
181601,highest,0,0
181602,at,0,1
181603,T5?,0,1
181604,PaO2,0,1
181605,was,0,0
181606,significantly,0,0
181607,lower,0,0
181608,after,0,0
181609,OLV,0,1
181610,was,0,0
181611,started,0,0
181612,and,0,0
181613,reached,0,0
181614,the,0,0
181615,lowest,0,0
181616,level,0,0
181617,at,0,0
181618,T6,0,1
181619,then,0,0
181620,was,0,0
181621,gradually,0,0
181622,increasing,0,0
181623,.,0,0
181624,There,0,0
181625,was,0,0
181626,no,0,0
181627,significant,0,0
181628,difference,0,0
181629,in,0,1
181630,Qs/Qt,0,1
181631,and,0,1
181632,PaO2,0,1
181633,at,0,0
181634,all,0,1
181635,time,0,0
181636,points,0,0
181637,between,0,1
181638,two,0,1
181639,groups,0,1
181640,.,0,1
181641,CONCLUSIONS,0,0
181642,SGB,0,1
181643,before,0,0
181644,induction,0,0
181645,effectively,0,0
181646,suppress,0,0
181647,the,0,0
181648,stress,0,0
181649,response,0,0
181650,work,0,0
181651,as,0,0
181652,stable,0,1
181653,blood,0,1
181654,dynamics,0,0
181655,and,0,0
181656,does,0,0
181657,not,0,0
181658,affect,0,0
181659,Qs/Qt,0,0
181660,and,0,0
181661,arterial,0,1
181662,oxygenation,0,0
181663,during,0,0
181664,OLV,0,1
181665,",",0,0
181666,SGB,0,0
181667,is,0,0
181668,a,0,0
181669,safe,0,0
181670,technique,0,0
181671,of,0,0
181672,anesthesia,0,1
181673,for,0,1
181674,general,0,1
181675,thoracic,0,1
181676,surgery,0,1
181677,.,0,1
181678,Inclusion,0,0
181679,of,0,0
181680,anti-phospholipase,1,1
181681,A2,1,1
181682,antibody,1,0
181683,to,0,1
181684,backgrounding,0,1
181685,diets,0,0
181686,on,0,0
181687,performance,0,0
181688,",",0,0
181689,feed,0,0
181690,efficiency,0,0
181691,",",0,0
181692,in,0,0
181693,vitro,0,0
181694,fermentation,0,0
181695,",",0,0
181696,and,0,0
181697,the,0,0
181698,acute-phase,0,0
181699,response,0,0
181700,of,0,0
181701,growing,1,0
181702,beef,1,1
181703,calves,1,1
181704,.,1,1
181705,In,0,0
181706,Exp,0,0
181707,.,0,1
181708,1,0,0
181709,",",0,0
181710,individual,0,0
181711,performance,0,0
181712,and,0,1
181713,daily,0,0
181714,DMI,0,1
181715,was,0,0
181716,measured,0,0
181717,on,0,0
181718,70,1,1
181719,crossbred,1,1
181720,weaned,1,1
181721,calves,1,1
181722,during,1,1
181723,a,1,1
181724,70-d,1,0
181725,period,1,0
181726,using,1,0
181727,a,1,1
181728,GrowSafe,1,0
181729,system,1,0
181730,(,1,1
181731,GrowSafe,1,0
181732,Systems,1,1
181733,Ltd.,1,1
181734,",",0,1
181735,Airdrie,1,1
181736,",",1,0
181737,AB,1,1
181738,",",1,0
181739,Canada,1,1
181740,),1,0
181741,at,1,0
181742,the,1,0
181743,University,1,1
181744,of,1,0
181745,Florida,1,1
181746,North,1,1
181747,Florida,1,1
181748,Research,1,1
181749,and,1,1
181750,Education,1,1
181751,Center,1,1
181752,Feed,1,1
181753,Efficiency,1,1
181754,Facility,1,1
181755,(,1,1
181756,FEF,1,1
181757,),1,1
181758,.,1,1
181759,Calves,1,1
181760,were,0,0
181761,fed,0,1
181762,a,0,0
181763,low-concentrate,0,0
181764,(,0,0
181765,LC,0,0
181766,),0,1
181767,growing,0,0
181768,diet,0,0
181769,",",0,0
181770,blocked,0,0
181771,by,0,0
181772,weight,0,1
181773,and,0,0
181774,sex,0,0
181775,",",0,0
181776,and,0,0
181777,then,0,0
181778,randomly,0,1
181779,assigned,0,1
181780,to,0,1
181781,pens,0,0
181782,to,0,0
181783,receive,0,1
181784,either,0,0
181785,no,0,0
181786,additional,0,0
181787,supplement,0,0
181788,(,0,1
181789,CON,0,1
181790,;,0,1
181791,n,0,1
181792,=,0,1
181793,35,0,1
181794,),0,0
181795,or,0,1
181796,receive,0,1
181797,a,0,0
181798,supplement,0,0
181799,of,0,0
181800,anti-phospholipase,0,1
181801,A2,0,1
181802,antibody,0,0
181803,(,0,1
181804,aPLA2,0,1
181805,),0,1
181806,at,0,0
181807,an,0,0
181808,inclusion,0,0
181809,rate,0,0
181810,of,0,0
181811,0.6,0,0
181812,%,0,0
181813,of,0,0
181814,the,0,0
181815,diet,0,1
181816,DM,0,0
181817,(,0,1
181818,n,0,1
181819,=,0,1
181820,35,0,1
181821,),0,1
181822,.,0,1
181823,After,0,0
181824,the,0,0
181825,70-d,0,0
181826,feed,0,1
181827,efficiency,0,0
181828,(,0,1
181829,FE,0,0
181830,),0,1
181831,trial,0,0
181832,(,0,1
181833,Phase,0,1
181834,1,0,1
181835,),0,1
181836,",",0,1
181837,calves,0,1
181838,were,0,1
181839,loaded,0,0
181840,into,0,1
181841,a,0,1
181842,commercial,0,0
181843,livestock,0,1
181844,trailer,0,1
181845,and,0,0
181846,were,0,0
181847,driven,0,0
181848,for,0,0
181849,approximately,0,1
181850,"1,600",0,1
181851,km,0,1
181852,during,0,1
181853,24,0,1
181854,h.,0,1
181855,Upon,0,1
181856,return,0,1
181857,to,0,0
181858,the,0,0
181859,FEF,0,1
181860,(,0,1
181861,Phase,0,1
181862,2,0,1
181863,),0,1
181864,",",0,1
181865,calves,0,1
181866,were,0,1
181867,relocated,0,1
181868,to,0,0
181869,the,0,0
181870,same,0,0
181871,pens,0,1
181872,and,0,1
181873,groups,0,1
181874,and,0,1
181875,received,0,1
181876,the,0,0
181877,same,0,0
181878,diets,0,0
181879,and,0,1
181880,treatments,0,0
181881,for,0,1
181882,28,0,1
181883,d.,0,1
181884,Blood,0,1
181885,samples,0,1
181886,from,0,1
181887,each,0,1
181888,calf,0,1
181889,were,0,0
181890,collected,0,0
181891,on,0,0
181892,d,0,1
181893,0,0,0
181894,",",0,1
181895,1,0,0
181896,",",0,0
181897,3,0,0
181898,",",0,0
181899,5,0,0
181900,",",0,0
181901,7,0,1
181902,",",0,0
181903,14,0,1
181904,",",0,0
181905,21,0,1
181906,",",0,0
181907,and,0,0
181908,28,0,1
181909,relative,0,0
181910,to,0,0
181911,initiation,0,0
181912,of,0,0
181913,transportation,0,1
181914,and,0,1
181915,were,0,0
181916,analyzed,0,0
181917,for,0,0
181918,determination,0,0
181919,of,0,1
181920,concentrations,0,0
181921,of,0,1
181922,plasma,0,0
181923,ceruloplasmin,0,0
181924,and,0,0
181925,haptoglobin,0,0
181926,.,0,1
181927,In,0,0
181928,Phase,0,1
181929,1,0,1
181930,",",0,1
181931,initial,0,1
181932,BW,0,1
181933,(,0,1
181934,242.0,0,1
181935,?,0,1
181936,3.7,0,0
181937,kg,0,1
181938,;,0,1
181939,P,0,0
181940,=,0,1
181941,0.92,0,0
181942,),0,1
181943,",",0,0
181944,BW,0,1
181945,at,0,1
181946,d,0,1
181947,70,0,1
181948,(,0,1
181949,313.0,0,1
181950,?,0,1
181951,4.1,0,0
181952,kg,0,1
181953,;,0,1
181954,P,0,0
181955,=,0,1
181956,0.79,0,0
181957,),0,1
181958,",",0,0
181959,and,0,0
181960,ADG,0,1
181961,(,0,1
181962,1.01,0,0
181963,?,0,1
181964,0.02,0,0
181965,kg,0,1
181966,;,0,1
181967,P,0,0
181968,=,0,1
181969,0.95,0,0
181970,),0,1
181971,were,0,1
181972,similar,0,0
181973,between,0,0
181974,treatments,0,0
181975,.,0,1
181976,However,0,0
181977,",",0,0
181978,daily,0,0
181979,DMI,0,1
181980,was,0,0
181981,greater,0,0
181982,(,0,1
181983,P,0,0
181984,=,0,1
181985,0.01,0,0
181986,),0,1
181987,for,0,1
181988,CON,0,1
181989,(,0,1
181990,9.18,0,0
181991,?,0,1
181992,0.15,0,0
181993,kg,0,1
181994,),0,1
181995,than,0,0
181996,aPLA2,0,1
181997,(,0,1
181998,8.53,0,0
181999,?,0,1
182000,0.15,0,0
182001,kg,0,1
182002,),0,1
182003,.,0,1
182004,In,0,0
182005,addition,0,0
182006,",",0,0
182007,residual,0,0
182008,feed,0,1
182009,intake,0,0
182010,was,0,0
182011,greater,0,0
182012,(,0,1
182013,P,0,0
182014,=,0,1
182015,0.002,0,0
182016,),0,1
182017,for,0,1
182018,CON,0,1
182019,(,0,1
182020,0.389,0,0
182021,?,0,1
182022,0.110,0,0
182023,kg/d,0,0
182024,),0,1
182025,than,0,0
182026,aPLA2,0,1
182027,calves,0,1
182028,(,0,1
182029,-0.272,0,0
182030,?,0,1
182031,0.110,0,0
182032,kg/d,0,0
182033,),0,1
182034,.,0,1
182035,In,0,0
182036,Phase,0,1
182037,2,0,1
182038,",",0,0
182039,after,0,0
182040,transportation,0,0
182041,",",0,0
182042,there,0,0
182043,were,0,0
182044,no,0,0
182045,differences,0,0
182046,between,0,0
182047,treatments,0,0
182048,on,0,1
182049,BW,0,1
182050,loss,0,0
182051,due,0,0
182052,to,0,0
182053,transportation,0,1
182054,shrink,0,0
182055,(,0,1
182056,26.0,0,1
182057,?,0,1
182058,0.6,0,0
182059,kg,0,1
182060,;,0,1
182061,P,0,0
182062,=,0,1
182063,0.86,0,0
182064,),0,1
182065,",",0,0
182066,BW,0,1
182067,at,0,1
182068,d,0,1
182069,28,0,1
182070,(,0,1
182071,339.0,0,0
182072,?,0,1
182073,4.1,0,0
182074,kg,0,1
182075,;,0,1
182076,P,0,0
182077,=,0,1
182078,0.72,0,0
182079,),0,1
182080,",",0,1
182081,ADG,0,1
182082,(,0,1
182083,1.28,0,0
182084,?,0,1
182085,0.03,0,0
182086,kg/d,0,0
182087,;,0,1
182088,P,0,0
182089,=,0,1
182090,0.72,0,0
182091,),0,1
182092,",",0,1
182093,G,0,1
182094,:,0,1
182095,F,0,1
182096,(,0,1
182097,0.164,0,0
182098,?,0,1
182099,0.004,0,0
182100,;,0,0
182101,P,0,0
182102,=,0,1
182103,0.83,0,0
182104,),0,1
182105,",",0,1
182106,and,0,0
182107,concentrations,0,0
182108,of,0,1
182109,plasma,0,0
182110,haptoglobin,0,0
182111,(,0,1
182112,0.08,0,0
182113,?,0,1
182114,0.02,0,0
182115,mg/mL,0,0
182116,;,0,1
182117,P,0,0
182118,=,0,1
182119,0.41,0,0
182120,),0,1
182121,.,0,1
182122,However,0,0
182123,",",0,0
182124,concentrations,0,0
182125,of,0,0
182126,plasma,0,0
182127,ceruloplasmin,0,0
182128,were,0,1
182129,greater,0,0
182130,(,0,1
182131,P,0,0
182132,<,0,0
182133,0.001,0,0
182134,),0,1
182135,for,0,1
182136,CON,0,1
182137,calves,0,1
182138,(,0,1
182139,14.3,0,1
182140,?,0,1
182141,0.3,0,0
182142,mg/dL,0,0
182143,),0,1
182144,compared,0,0
182145,to,0,1
182146,aPLA2,0,1
182147,calves,0,1
182148,(,0,1
182149,13.0,0,1
182150,?,0,1
182151,0.3,0,0
182152,mg/dL,0,0
182153,),0,1
182154,.,0,1
182155,In,0,0
182156,Exp,0,0
182157,.,0,1
182158,2,0,0
182159,",",0,0
182160,the,0,0
182161,effects,0,0
182162,of,0,0
182163,aPLA2,0,1
182164,inclusion,0,1
182165,on,0,0
182166,LC,0,0
182167,and,0,1
182168,high-concentrate,0,1
182169,(,0,1
182170,HC,0,1
182171,),0,0
182172,substrates,0,0
182173,on,0,0
182174,in,0,0
182175,vitro,0,0
182176,fermentation,0,0
182177,parameters,0,0
182178,were,0,1
182179,assessed,0,0
182180,.,0,1
182181,Addition,0,0
182182,of,0,0
182183,aPLA2,0,1
182184,had,0,1
182185,no,0,0
182186,effects,0,0
182187,on,0,0
182188,in,0,1
182189,vitro,0,0
182190,fermentation,0,0
182191,parameters,0,0
182192,of,0,1
182193,LC,0,0
182194,and,0,1
182195,HC,0,1
182196,substrates,0,1
182197,.,0,1
182198,In,0,0
182199,conclusion,0,0
182200,",",0,0
182201,supplementation,0,0
182202,of,0,0
182203,aPLA2,0,1
182204,improved,0,0
182205,FE,0,0
182206,of,0,0
182207,growing,0,1
182208,beef,0,1
182209,calves,0,1
182210,when,0,0
182211,fed,0,1
182212,LC,0,0
182213,diets,0,0
182214,in,0,1
182215,Phase,0,1
182216,1,0,1
182217,and,0,0
182218,addition,0,0
182219,of,0,0
182220,aPLA2,0,1
182221,had,0,1
182222,no,0,0
182223,effect,0,0
182224,on,0,0
182225,fermentation,0,0
182226,parameters,0,0
182227,of,0,1
182228,LC,0,0
182229,and,0,1
182230,HC,0,1
182231,substrates,0,1
182232,.,0,1
182233,In,0,0
182234,addition,0,0
182235,",",0,1
182236,calves,0,1
182237,supplemented,0,0
182238,with,0,1
182239,aPLA2,0,1
182240,had,0,1
182241,reduced,0,0
182242,concentrations,0,0
182243,of,0,1
182244,plasma,0,0
182245,ceruloplasmin,0,0
182246,after,0,1
182247,24,0,1
182248,h,0,0
182249,of,0,0
182250,transportation,0,1
182251,.,0,1
182252,N-acetylcysteine,0,0
182253,as,0,0
182254,an,0,1
182255,adjunctive,0,1
182256,therapy,0,0
182257,to,0,0
182258,risperidone,0,0
182259,for,0,0
182260,treatment,0,0
182261,of,0,0
182262,irritability,0,0
182263,in,1,1
182264,autism,1,1
182265,:,1,1
182266,a,0,0
182267,randomized,0,1
182268,",",0,0
182269,double-blind,0,0
182270,",",0,0
182271,placebo-controlled,0,0
182272,clinical,0,0
182273,trial,0,1
182274,of,0,0
182275,efficacy,0,0
182276,and,0,1
182277,safety,0,0
182278,.,0,1
182279,OBJECTIVES,0,0
182280,According,0,1
182281,to,0,0
182282,the,0,0
182283,proposed,0,0
182284,interference,0,0
182285,of,0,0
182286,N-acetylcysteine,0,0
182287,(,0,1
182288,NAC,0,1
182289,),0,1
182290,with,0,1
182291,pathophysiologic,0,0
182292,processes,0,0
182293,of,0,1
182294,autistic,0,1
182295,disorders,0,1
182296,(,0,1
182297,ADs,0,1
182298,),0,1
182299,",",0,0
182300,we,0,0
182301,aimed,0,0
182302,to,0,0
182303,assess,0,0
182304,the,0,0
182305,effectiveness,0,0
182306,and,0,0
182307,safety,0,0
182308,of,0,0
182309,NAC,0,0
182310,as,0,0
182311,an,0,1
182312,adjunct,0,0
182313,to,0,0
182314,risperidone,0,0
182315,in,0,0
182316,the,0,0
182317,treatment,0,0
182318,of,0,0
182319,ADs,0,1
182320,in,0,1
182321,a,0,1
182322,randomized,0,1
182323,",",0,0
182324,double-blind,0,0
182325,",",0,0
182326,clinical,0,0
182327,trial,0,1
182328,.,0,1
182329,METHODS,0,0
182330,The,0,0
182331,participants,1,1
182332,were,1,1
182333,referred,1,1
182334,outpatients,1,1
182335,between,1,1
182336,4,1,1
182337,and,1,1
182338,12,1,1
182339,years,1,1
182340,of,1,1
182341,age,1,1
182342,with,1,1
182343,the,1,0
182344,diagnosis,1,1
182345,of,1,0
182346,ADs,1,1
182347,and,1,1
182348,a,1,0
182349,score,1,0
182350,of,1,0
182351,more,1,0
182352,than,1,0
182353,12,1,1
182354,on,1,1
182355,Aberrant,1,1
182356,Behavior,1,1
182357,Checklist-Community,1,1
182358,(,1,1
182359,ABC-C,1,1
182360,),1,1
182361,Irritability,1,0
182362,subscale,1,0
182363,score,1,0
182364,.,1,1
182365,The,0,0
182366,participants,0,1
182367,were,0,1
182368,randomized,0,1
182369,into,0,1
182370,2,0,1
182371,groups,0,1
182372,.,0,1
182373,One,0,1
182374,group,0,0
182375,received,0,1
182376,risperidone,0,0
182377,plus,0,0
182378,NAC,0,0
182379,",",0,0
182380,and,0,0
182381,the,0,0
182382,other,0,0
182383,group,0,1
182384,received,0,1
182385,risperidone,0,0
182386,plus,0,0
182387,placebo,0,0
182388,.,0,1
182389,The,0,0
182390,dose,0,0
182391,of,0,0
182392,risperidone,0,0
182393,was,0,0
182394,titrated,0,0
182395,between,0,0
182396,1,0,1
182397,and,0,1
182398,2.0,0,0
182399,mg/d,0,0
182400,",",0,0
182401,and,0,0
182402,the,0,0
182403,dose,0,0
182404,of,0,0
182405,NAC,0,1
182406,was,0,0
182407,600,0,1
182408,to,0,1
182409,900,0,1
182410,mg/d,0,0
182411,.,0,1
182412,The,0,0
182413,main,0,0
182414,outcome,0,0
182415,was,0,0
182416,mean,0,1
182417,decrease,0,0
182418,in,0,0
182419,the,0,0
182420,ABC-C,0,1
182421,irritability,0,0
182422,subscale,0,0
182423,score,0,0
182424,from,0,1
182425,baseline,0,0
182426,at,0,1
182427,5,0,1
182428,and,0,1
182429,10,0,1
182430,weeks,0,1
182431,.,0,1
182432,Changes,0,0
182433,in,0,1
182434,other,0,1
182435,subscales,0,0
182436,were,0,1
182437,considered,0,0
182438,as,0,0
182439,secondary,0,1
182440,outcome,0,0
182441,measures,0,0
182442,.,0,1
182443,RESULTS,0,0
182444,Forty,1,1
182445,patients,1,1
182446,completed,1,1
182447,the,1,0
182448,10-week,1,1
182449,trial,1,1
182450,.,1,1
182451,Baseline,0,0
182452,characteristics,0,0
182453,including,0,1
182454,age,0,1
182455,",",0,0
182456,sex,0,0
182457,and,0,0
182458,body,0,1
182459,weight,0,0
182460,",",0,0
182461,as,0,0
182462,well,0,0
182463,as,0,0
182464,baseline,0,0
182465,scores,0,0
182466,in,0,1
182467,5,0,1
182468,subscales,0,0
182469,did,0,0
182470,not,0,0
182471,demonstrate,0,0
182472,statistically,0,0
182473,significant,0,0
182474,difference,0,0
182475,between,0,0
182476,the,0,1
182477,2,0,1
182478,groups,0,1
182479,.,0,1
182480,Repeated-measures,0,0
182481,analysis,0,0
182482,showed,0,0
182483,significant,0,0
182484,effect,0,0
182485,for,0,1
182486,time,0,0
182487,?,0,1
182488,treatment,0,0
182489,interaction,0,0
182490,in,0,0
182491,irritability,0,0
182492,(,0,1
182493,P,0,0
182494,=,0,1
182495,0.01,0,0
182496,),0,1
182497,and,0,1
182498,hyperactivity/noncompliance,0,1
182499,(,0,1
182500,P,0,0
182501,=,0,1
182502,0.02,0,0
182503,),0,1
182504,subscales,0,0
182505,.,0,1
182506,By,0,0
182507,week,0,0
182508,10,0,1
182509,",",0,0
182510,the,0,0
182511,NAC,0,0
182512,group,0,0
182513,showed,0,0
182514,significantly,0,0
182515,more,0,0
182516,reduction,0,0
182517,in,0,0
182518,irritability,0,0
182519,(,0,1
182520,P,0,0
182521,=,0,1
182522,0.02,0,0
182523,),0,1
182524,and,0,1
182525,hyperactivity/noncompliance,0,1
182526,(,0,1
182527,P,0,0
182528,=,0,1
182529,0.01,0,0
182530,),0,1
182531,subscales,0,0
182532,scores,0,0
182533,.,0,1
182534,CONCLUSIONS,0,0
182535,N-acetylcysteine,0,0
182536,can,0,0
182537,be,0,0
182538,considered,0,0
182539,as,0,0
182540,an,0,0
182541,adjuvant,0,1
182542,therapy,0,0
182543,for,0,0
182544,ADs,0,1
182545,with,0,1
182546,beneficial,0,0
182547,therapeutic,0,1
182548,outcomes,0,0
182549,.,0,1
182550,Hepatic,0,1
182551,cytoprotective,0,0
182552,effect,0,0
182553,of,0,0
182554,ischemic,0,1
182555,and,0,1
182556,anesthetic,0,0
182557,preconditioning,0,0
182558,before,0,1
182559,liver,0,1
182560,resection,0,1
182561,when,0,0
182562,using,0,0
182563,intermittent,0,0
182564,vascular,0,1
182565,inflow,0,1
182566,occlusion,0,1
182567,:,0,1
182568,a,0,1
182569,randomized,0,1
182570,clinical,0,0
182571,trial,0,1
182572,.,0,1
182573,BACKGROUND,0,0
182574,Ischemic,0,1
182575,preconditioning,0,0
182576,(,0,1
182577,IPC,0,0
182578,),0,1
182579,and,0,1
182580,anesthetic,0,0
182581,preconditioning,0,0
182582,(,0,1
182583,APC,0,0
182584,),0,1
182585,have,0,0
182586,been,0,0
182587,reported,0,0
182588,to,0,0
182589,attenuate,0,0
182590,ischemia-reperfusion,0,0
182591,(,0,0
182592,IR,0,1
182593,),0,1
182594,injury,0,1
182595,after,0,0
182596,liver,0,1
182597,resection,0,1
182598,under,0,1
182599,continuous,0,0
182600,inflow,0,1
182601,occlusion,0,1
182602,.,0,1
182603,This,0,0
182604,study,0,0
182605,evaluates,0,0
182606,whether,0,0
182607,these,0,0
182608,strategies,0,0
182609,enhance,0,0
182610,hepatic,0,0
182611,protection,0,0
182612,of,0,0
182613,remnant,0,1
182614,liver,0,1
182615,against,0,0
182616,IR,0,1
182617,after,0,1
182618,liver,1,1
182619,resection,1,1
182620,with,1,1
182621,intermittent,1,1
182622,clamping,1,1
182623,(,1,1
182624,INT,1,1
182625,),1,1
182626,.,1,1
182627,METHODS,0,0
182628,A,1,0
182629,total,1,1
182630,of,1,0
182631,106,1,1
182632,patients,1,1
182633,without,1,1
182634,underlying,1,1
182635,liver,1,1
182636,disease,1,1
182637,and,1,0
182638,submitted,1,0
182639,to,1,0
182640,liver,1,1
182641,resection,1,1
182642,using,1,0
182643,INT,1,1
182644,were,0,1
182645,randomized,0,1
182646,into,0,1
182647,3,0,1
182648,groups,0,1
182649,:,0,1
182650,IPC,0,1
182651,(,0,1
182652,10,0,1
182653,minutes,0,0
182654,of,0,1
182655,inflow,0,1
182656,occlusion,0,1
182657,followed,0,1
182658,by,0,0
182659,10,0,1
182660,minutes,0,0
182661,of,0,1
182662,reperfusion,0,0
182663,before,0,1
182664,liver,0,1
182665,transection,0,1
182666,),0,1
182667,",",0,0
182668,APC,0,0
182669,(,0,1
182670,sevoflurane,0,0
182671,administration,0,0
182672,for,0,1
182673,20,0,1
182674,minutes,0,0
182675,before,0,1
182676,liver,0,1
182677,transection,0,1
182678,),0,1
182679,",",0,0
182680,and,0,0
182681,INT,0,0
182682,(,0,0
182683,no,0,0
182684,preconditioning,0,0
182685,),0,1
182686,.,0,1
182687,Patients,0,1
182688,were,0,0
182689,also,0,0
182690,stratified,0,1
182691,according,0,0
182692,to,0,0
182693,the,0,0
182694,extent,0,0
182695,of,0,0
182696,the,0,0
182697,hepatectomy,0,0
182698,.,0,1
182699,Cytoprotection,0,0
182700,was,0,0
182701,evaluated,0,0
182702,by,0,0
182703,comparing,0,0
182704,hepatocyte,0,0
182705,and,0,1
182706,endothelial,0,0
182707,dysfunction,0,1
182708,markers,0,0
182709,",",0,0
182710,apoptosis,0,0
182711,",",0,0
182712,histologic,0,0
182713,lesions,0,1
182714,",",0,1
182715,and,0,1
182716,postoperative,0,0
182717,outcome,0,0
182718,.,0,1
182719,RESULTS,0,0
182720,No,0,0
182721,differences,0,0
182722,were,0,1
182723,observed,0,0
182724,in,0,0
182725,preoperative,0,1
182726,chemotherapy,0,1
182727,and,0,0
182728,steatosis,0,1
182729,",",0,0
182730,total,0,1
182731,warm,0,1
182732,ischemia,0,1
182733,time,0,0
182734,",",0,0
182735,operative,0,0
182736,time,0,0
182737,",",0,0
182738,or,0,1
182739,blood,0,0
182740,loss,0,0
182741,.,0,1
182742,Kinetics,0,0
182743,of,0,1
182744,transaminases,0,0
182745,(,0,1
182746,aspartate,0,0
182747,aminotransferase,0,0
182748,",",0,1
182749,P,0,0
182750,=,0,1
182751,.137,0,0
182752,;,0,1
182753,alanine,0,1
182754,aminotransferase,0,0
182755,",",0,1
182756,P,0,0
182757,=,0,1
182758,.616,0,0
182759,),0,0
182760,",",0,0
182761,bilirubin,0,0
182762,(,0,1
182763,P,0,0
182764,=,0,1
182765,.980,0,0
182766,),0,1
182767,",",0,0
182768,and,0,0
182769,hyaluronic,0,0
182770,acid,0,0
182771,increase,0,0
182772,(,0,1
182773,P,0,0
182774,=,0,1
182775,.514,0,0
182776,),0,1
182777,revealed,0,0
182778,no,0,0
182779,differences,0,0
182780,.,0,1
182781,Significant,0,0
182782,apoptosis,0,0
182783,was,0,0
182784,present,0,0
182785,in,0,1
182786,40,0,1
182787,%,0,0
182788,of,0,1
182789,patients,0,1
182790,",",0,1
182791,mild-to-moderate,0,1
182792,leukocyte,0,0
182793,infiltration,0,0
182794,and,0,0
182795,steatosis,0,1
182796,in,0,1
182797,45,0,1
182798,%,0,0
182799,and,0,1
182800,55,0,1
182801,%,0,0
182802,",",0,0
182803,respectively,0,0
182804,",",0,0
182805,and,0,0
182806,mild,0,1
182807,sinusoidal,0,0
182808,congestion,0,1
182809,in,0,1
182810,65,0,1
182811,%,0,0
182812,",",0,0
182813,with,0,1
182814,a,0,0
182815,similar,0,0
182816,distribution,0,0
182817,in,0,0
182818,the,0,1
182819,3,0,1
182820,groups,0,0
182821,.,0,1
182822,When,0,1
182823,patients,0,1
182824,were,0,0
182825,stratified,0,1
182826,by,0,0
182827,major,0,1
182828,versus,0,0
182829,minor,0,0
182830,resections,0,1
182831,",",0,1
182832,no,0,0
182833,differences,0,0
182834,were,0,1
182835,observed,0,0
182836,in,0,0
182837,any,0,0
182838,of,0,0
182839,the,0,0
182840,variables,0,0
182841,studied,0,1
182842,.,0,1
182843,Postoperative,0,0
182844,clinical,0,0
182845,outcomes,0,0
182846,were,0,1
182847,also,0,0
182848,similar,0,0
182849,.,0,1
182850,CONCLUSION,0,0
182851,These,0,1
182852,results,0,0
182853,suggest,0,0
182854,that,0,0
182855,these,0,0
182856,protocols,0,0
182857,of,0,1
182858,IPC,0,1
182859,and,0,1
182860,APC,0,0
182861,used,0,0
182862,in,0,0
182863,this,0,0
182864,study,0,0
182865,do,0,0
182866,not,0,0
182867,provide,0,0
182868,better,0,0
182869,cytoprotection,0,0
182870,from,0,0
182871,IR,0,0
182872,when,0,0
182873,INT,0,0
182874,is,0,0
182875,used,0,0
182876,.,0,0
182877,Randomized,0,1
182878,Controlled,0,1
182879,Trial,0,1
182880,of,0,1
182881,Mind,0,1
182882,Reading,0,0
182883,and,0,1
182884,In,0,1
182885,Vivo,0,1
182886,Rehearsal,0,1
182887,for,0,1
182888,High-Functioning,1,1
182889,Children,1,1
182890,with,1,1
182891,ASD,1,1
182892,.,1,1
182893,This,0,0
182894,randomized,0,0
182895,controlled,0,0
182896,trial,0,0
182897,evaluated,0,0
182898,the,0,0
182899,efficacy,0,0
182900,of,0,0
182901,a,0,0
182902,computer,0,0
182903,software,0,0
182904,(,0,0
182905,i.e.,0,0
182906,",",0,0
182907,Mind,0,0
182908,Reading,0,1
182909,),0,1
182910,and,0,0
182911,in,0,0
182912,vivo,0,0
182913,rehearsal,0,0
182914,treatment,0,0
182915,on,0,0
182916,the,0,0
182917,emotion,0,0
182918,decoding,0,1
182919,and,0,1
182920,encoding,0,0
182921,skills,0,0
182922,",",0,1
182923,autism,0,1
182924,symptoms,0,0
182925,",",0,1
182926,and,0,1
182927,social,0,0
182928,skills,0,0
182929,of,0,1
182930,43,1,1
182931,children,1,1
182932,",",1,1
182933,ages,1,1
182934,7-12,1,1
182935,years,1,1
182936,with,1,1
182937,high-functioning,1,1
182938,autism,1,1
182939,spectrum,1,1
182940,disorder,1,1
182941,(,1,1
182942,HFASD,1,1
182943,),1,1
182944,.,1,1
182945,Children,0,1
182946,in,0,0
182947,treatment,0,0
182948,(,0,1
182949,n,0,1
182950,=,0,1
182951,22,0,1
182952,),0,1
182953,received,0,1
182954,the,0,0
182955,manualized,0,0
182956,protocol,0,0
182957,over,0,0
182958,12,0,1
182959,weeks,0,1
182960,.,0,1
182961,Primary,0,1
182962,analyses,0,0
182963,indicated,0,0
182964,significantly,0,0
182965,better,0,0
182966,posttest,0,0
182967,performance,0,0
182968,for,0,0
182969,the,0,0
182970,treatment,0,0
182971,group,0,0
182972,(,0,1
182973,compared,0,0
182974,to,0,1
182975,controls,0,1
182976,),0,1
182977,on,0,0
182978,3,0,1
182979,of,0,1
182980,the,0,1
182981,4,0,0
182982,measures,0,0
182983,of,0,1
182984,emotion,0,0
182985,decoding,0,1
182986,and,0,0
182987,encoding,0,0
182988,and,0,0
182989,these,0,0
182990,were,0,0
182991,maintained,0,0
182992,at,0,0
182993,5-week,0,1
182994,follow-up,0,1
182995,.,0,1
182996,Analyses,0,0
182997,of,0,1
182998,secondary,0,1
182999,measures,0,0
183000,favored,0,0
183001,the,0,0
183002,treatment,0,0
183003,group,0,1
183004,for,0,0
183005,1,0,0
183006,of,0,1
183007,the,0,1
183008,2,0,1
183009,measures,0,0
183010,;,0,1
183011,specifically,0,0
183012,",",0,0
183013,ASD,0,1
183014,symptoms,0,0
183015,were,0,1
183016,significantly,0,0
183017,lower,0,0
183018,at,0,0
183019,posttest,0,0
183020,and,0,1
183021,follow-up,0,0
183022,.,0,1
183023,Baseline,0,0
183024,distribution,0,1
183025,of,0,0
183026,participants,1,1
183027,with,1,1
183028,depression,1,1
183029,and,1,1
183030,impaired,1,1
183031,quality,1,0
183032,of,1,0
183033,life,1,1
183034,in,0,0
183035,the,0,0
183036,Treatment,0,0
183037,of,0,0
183038,Preserved,0,1
183039,Cardiac,0,1
183040,Function,0,1
183041,Heart,0,1
183042,Failure,0,1
183043,with,0,1
183044,an,0,1
183045,Aldosterone,0,0
183046,Antagonist,0,1
183047,Trial,0,1
183048,.,0,1
183049,BACKGROUND,0,0
183050,Previous,0,1
183051,studies,0,0
183052,have,0,0
183053,demonstrated,0,0
183054,the,0,0
183055,psychosocial,0,1
183056,effect,0,0
183057,of,0,0
183058,heart,0,1
183059,failure,0,1
183060,in,0,0
183061,patients,1,1
183062,with,1,1
183063,reduced,1,0
183064,ejection,1,1
183065,fraction,1,1
183066,.,1,1
183067,However,0,0
183068,",",0,0
183069,the,0,0
183070,effects,0,0
183071,on,0,0
183072,patients,0,1
183073,with,0,1
183074,preserved,0,1
183075,ejection,0,1
183076,fraction,0,1
183077,have,0,0
183078,not,0,0
183079,yet,0,0
183080,been,0,0
183081,elucidated,0,0
183082,.,0,1
183083,This,0,0
183084,study,0,0
183085,aimed,0,0
183086,to,0,0
183087,determine,0,0
183088,the,0,0
183089,baseline,0,0
183090,characteristics,0,0
183091,of,0,1
183092,participants,1,1
183093,with,1,1
183094,heart,1,1
183095,failure,1,1
183096,with,1,1
183097,preserved,1,1
183098,ejection,1,1
183099,fraction,1,1
183100,as,0,0
183101,it,0,0
183102,relates,0,0
183103,to,0,0
183104,impaired,0,0
183105,quality,0,0
183106,of,0,0
183107,life,0,1
183108,(,0,1
183109,QOL,0,1
183110,),0,1
183111,and,0,0
183112,depression,0,1
183113,",",0,1
183114,identify,0,0
183115,predictors,0,0
183116,of,0,1
183117,poor,0,1
183118,QOL,0,1
183119,and,0,1
183120,depression,0,1
183121,",",0,0
183122,and,0,0
183123,determine,0,0
183124,the,0,0
183125,correlation,0,0
183126,between,0,0
183127,QOL,0,0
183128,and,0,1
183129,depression,0,1
183130,.,0,1
183131,METHODS,0,0
183132,AND,0,0
183133,RESULTS,0,1
183134,Among,0,1
183135,patients,1,1
183136,enrolled,1,1
183137,in,1,1
183138,the,1,0
183139,Treatment,1,0
183140,of,1,0
183141,Preserved,1,1
183142,Cardiac,1,1
183143,Function,1,1
183144,Heart,1,1
183145,Failure,1,1
183146,With,1,1
183147,an,1,1
183148,Aldosterone,1,0
183149,Antagonist,1,1
183150,Trial,1,1
183151,(,1,1
183152,TOPCAT,1,1
183153,),1,1
183154,",",1,1
183155,3400,1,1
183156,patients,1,1
183157,completed,1,1
183158,the,1,0
183159,Kansas,1,1
183160,City,1,1
183161,Cardiomyopathy,1,1
183162,Questionnaire,1,0
183163,",",1,1
183164,3395,1,1
183165,patients,1,1
183166,completed,1,1
183167,European,1,1
183168,QOL,1,1
183169,5D,1,0
183170,Visual,1,1
183171,Analog,1,0
183172,Scale,1,1
183173,",",1,1
183174,and,1,1
183175,1431,1,1
183176,patients,1,1
183177,in,1,1
183178,United,1,1
183179,States,1,1
183180,and,1,1
183181,Canada,1,1
183182,completed,1,1
183183,the,1,0
183184,Patient,1,0
183185,Health,1,0
183186,Questionnaire-9,1,0
183187,.,1,1
183188,The,0,0
183189,mean,0,0
183190,summary,0,0
183191,score,0,0
183192,on,0,0
183193,the,0,0
183194,Kansas,0,1
183195,City,0,1
183196,Cardiomyopathy,0,1
183197,Questionnaire,0,0
183198,was,0,0
183199,54.8,0,1
183200,",",0,0
183201,and,0,0
183202,on,0,0
183203,European,0,1
183204,QOL,0,1
183205,5D,0,0
183206,Visual,0,1
183207,Analog,0,0
183208,Scale,0,1
183209,",",0,0
183210,it,0,0
183211,was,0,0
183212,60.3,0,1
183213,;,0,1
183214,27,0,1
183215,%,0,0
183216,of,0,1
183217,patients,0,1
183218,had,0,1
183219,moderate,0,1
183220,to,0,1
183221,severe,0,1
183222,depression,0,1
183223,.,0,1
183224,Factors,0,0
183225,associated,0,0
183226,with,0,1
183227,better,0,0
183228,Kansas,0,1
183229,City,0,1
183230,Cardiomyopathy,0,1
183231,Questionnaire,0,0
183232,and,0,1
183233,European,0,1
183234,QOL,0,1
183235,5D,0,0
183236,Visual,0,1
183237,Analog,0,0
183238,Scale,0,1
183239,via,0,1
183240,multiple,0,1
183241,logistic,0,0
183242,regression,0,0
183243,analysis,0,0
183244,were,0,1
183245,American,0,1
183246,region,0,1
183247,",",0,0
183248,older,0,1
183249,age,0,1
183250,",",0,0
183251,no,0,0
183252,history,0,1
183253,of,0,0
183254,angina,0,1
183255,pectoris,0,1
183256,or,0,1
183257,asthma,0,1
183258,",",0,0
183259,no,0,0
183260,use,0,0
183261,of,0,0
183262,hypoglycemic,0,1
183263,agent,0,0
183264,",",0,0
183265,more,0,0
183266,activity,0,0
183267,level,0,0
183268,",",0,0
183269,and,0,0
183270,lower,0,0
183271,New,0,1
183272,York,0,1
183273,Heart,0,1
183274,Association,0,1
183275,class,0,1
183276,.,0,1
183277,Factors,0,0
183278,associated,0,0
183279,with,0,1
183280,depression,0,1
183281,via,0,1
183282,multiple,0,1
183283,logistic,0,0
183284,regression,0,0
183285,analysis,0,0
183286,included,0,1
183287,younger,0,1
183288,age,0,1
183289,",",0,0
183290,female,0,1
183291,sex,0,0
183292,",",0,0
183293,comorbid,0,1
183294,angina,0,1
183295,",",0,0
183296,chronic,0,1
183297,obstructive,0,1
183298,pulmonary,0,1
183299,disease,0,1
183300,",",0,0
183301,use,0,0
183302,of,0,0
183303,a,0,1
183304,hypoglycemic,0,1
183305,agent,0,0
183306,",",0,0
183307,lower,0,0
183308,activity,0,0
183309,level,0,0
183310,",",0,0
183311,higher,0,0
183312,New,0,1
183313,York,0,1
183314,Heart,0,1
183315,Association,0,1
183316,class,0,1
183317,",",0,0
183318,and,0,0
183319,selective,0,1
183320,serotonin,0,0
183321,reuptake,0,0
183322,inhibitor,0,0
183323,use,0,0
183324,.,0,0
183325,There,0,0
183326,were,0,0
183327,significant,0,0
183328,correlations,0,0
183329,between,0,0
183330,each,0,1
183331,of,0,0
183332,the,0,0
183333,QOL,0,1
183334,scores,0,0
183335,and,0,1
183336,depression,0,1
183337,.,0,1
183338,CONCLUSIONS,0,0
183339,Patients,1,1
183340,with,1,1
183341,heart,1,1
183342,failure,1,1
183343,with,1,1
183344,preserved,1,1
183345,ejection,1,1
183346,fraction,1,1
183347,",",1,1
183348,who,1,1
183349,were,1,1
183350,younger,1,1
183351,had,1,1
183352,higher,1,0
183353,New,1,1
183354,York,1,1
183355,Heart,1,1
183356,Association,1,1
183357,class,1,1
183358,or,1,1
183359,comorbid,1,1
183360,angina,1,1
183361,pectoris,1,1
183362,",",1,0
183363,had,1,1
183364,lower,1,0
183365,activity,1,0
183366,levels,1,0
183367,",",1,0
183368,lived,1,1
183369,in,1,0
183370,Eastern,1,1
183371,Europe,1,1
183372,or,1,1
183373,were,1,1
183374,taking,1,1
183375,hypoglycemic,1,1
183376,agents,1,1
183377,",",0,0
183378,were,0,0
183379,more,0,0
183380,likely,0,0
183381,to,0,0
183382,have,0,0
183383,impaired,1,1
183384,QOL,1,0
183385,and,1,1
183386,depression,1,1
183387,.,1,1
183388,CLINICAL,0,1
183389,TRIAL,0,0
183390,REGISTRATION,0,1
183391,URL,0,1
183392,:,0,1
183393,http,0,0
183394,:,0,1
183395,//www.clinicaltrials.gov,0,0
183396,.,0,1
183397,Unique,0,0
183398,identifier,0,1
183399,:,0,1
183400,NCT00094302,0,1
183401,.,0,1
183402,The,0,0
183403,nature,0,0
183404,of,0,0
183405,placebo,0,0
183406,response,0,0
183407,in,0,1
183408,clinical,0,0
183409,studies,0,0
183410,of,0,1
183411,major,1,1
183412,depressive,1,1
183413,disorder,1,1
183414,.,1,1
183415,OBJECTIVE,0,0
183416,To,0,0
183417,review,0,1
183418,factors,0,0
183419,influencing,0,0
183420,placebo,0,1
183421,response,0,0
183422,and,0,0
183423,clinical,0,0
183424,trial,0,0
183425,outcome,0,0
183426,in,0,0
183427,depression,1,1
183428,",",0,0
183429,and,0,0
183430,suggest,0,0
183431,ways,0,0
183432,to,0,1
183433,optimize,0,0
183434,trial,0,0
183435,success,0,0
183436,in,0,0
183437,mood,0,1
183438,disorders,0,1
183439,.,0,1
183440,DATA,0,1
183441,SOURCES,0,1
183442,PubMed,0,1
183443,searches,0,1
183444,were,0,1
183445,conducted,0,1
183446,by,0,0
183447,cross-referencing,0,0
183448,the,0,0
183449,terms,0,0
183450,depression,0,1
183451,",",0,1
183452,depressive,0,1
183453,with,0,1
183454,placebo,0,0
183455,",",0,0
183456,clinical,0,0
183457,trial,0,0
183458,",",0,0
183459,and,0,0
183460,clinical,0,0
183461,trials,0,1
183462,for,0,1
183463,studies,1,0
183464,published,1,1
183465,in,1,1
183466,English,1,1
183467,between,1,0
183468,1970,1,1
183469,and,1,1
183470,September,1,1
183471,2013,1,1
183472,.,1,1
183473,STUDY,0,0
183474,SELECTION,0,0
183475,Relevant,0,1
183476,abstracts,0,1
183477,were,0,1
183478,identified,0,1
183479,in,0,0
183480,PubMed,0,1
183481,",",0,1
183482,including,0,0
183483,clinical,0,0
183484,trials,0,1
183485,",",0,1
183486,quantitative,0,0
183487,studies,0,0
183488,",",0,1
183489,and,0,1
183490,qualitative,0,0
183491,research,0,1
183492,.,0,1
183493,We,0,0
183494,obtained,0,0
183495,and,0,0
183496,reviewed,0,1
183497,relevant,0,1
183498,articles,0,1
183499,and,0,1
183500,utilized,0,0
183501,their,0,1
183502,information,0,0
183503,to,0,0
183504,synthesize,0,0
183505,the,0,0
183506,present,0,0
183507,review,0,1
183508,.,0,1
183509,DATA,0,0
183510,EXTRACTION,0,0
183511,Included,0,1
183512,articles,0,1
183513,were,0,1
183514,grouped,0,1
183515,in,0,0
183516,the,0,0
183517,following,0,0
183518,areas,0,0
183519,of,0,1
183520,relevance,0,0
183521,:,0,1
183522,(,0,1
183523,1,0,1
183524,),0,1
183525,biological,0,0
183526,validity,0,0
183527,of,0,0
183528,illness,0,1
183529,",",0,1
183530,(,0,1
183531,2,0,1
183532,),0,1
183533,baseline,0,0
183534,severity,0,0
183535,of,0,0
183536,illness,0,1
183537,",",0,1
183538,(,0,1
183539,3,0,1
183540,),0,1
183541,chronicity,0,0
183542,of,0,0
183543,the,0,0
183544,index,0,0
183545,episode,0,1
183546,of,0,0
183547,depression,0,1
183548,",",0,1
183549,(,0,1
183550,4,0,0
183551,),0,1
183552,age,0,1
183553,of,0,0
183554,participants,0,1
183555,",",0,1
183556,(,0,1
183557,5,0,1
183558,),0,1
183559,medical,0,1
183560,and,0,1
183561,psychiatric,0,1
183562,comorbidity,0,1
183563,",",0,1
183564,(,0,1
183565,6,0,0
183566,),0,1
183567,probability,0,0
183568,of,0,0
183569,receiving,0,1
183570,placebo,0,0
183571,",",0,1
183572,(,0,1
183573,7,0,1
183574,),0,1
183575,use,0,0
183576,of,0,0
183577,prospective,0,1
183578,treatment,0,1
183579,phases,0,1
183580,(,0,1
183581,lead-in,0,0
183582,),0,1
183583,(,0,1
183584,8,0,1
183585,),0,1
183586,dosing,0,0
183587,schedule,0,0
183588,",",0,0
183589,(,0,1
183590,9,0,0
183591,),0,1
183592,trial,0,0
183593,duration,0,0
183594,",",0,0
183595,(,0,1
183596,10,0,1
183597,),0,1
183598,frequency,0,0
183599,of,0,1
183600,follow-up,0,1
183601,assessments,0,0
183602,",",0,1
183603,and,0,1
183604,(,0,1
183605,11,0,1
183606,),0,1
183607,study,0,1
183608,outcome,0,0
183609,measure,0,0
183610,.,0,1
183611,RESULTS,0,0
183612,Several,0,0
183613,key,0,0
183614,elements,0,1
183615,emerge,0,1
183616,as,0,0
183617,critical,0,0
183618,to,0,0
183619,the,0,0
183620,ultimate,0,0
183621,success,0,0
183622,of,0,0
183623,a,0,1
183624,clinical,0,0
183625,trial,0,0
183626,",",0,0
183627,including,0,0
183628,the,0,0
183629,probability,0,0
183630,of,0,0
183631,receiving,0,1
183632,placebo,0,0
183633,",",0,0
183634,study,0,0
183635,duration,0,0
183636,",",0,0
183637,dosing,0,0
183638,schedule,0,0
183639,",",0,0
183640,visit,0,0
183641,frequency,0,0
183642,",",0,0
183643,the,0,0
183644,use,0,0
183645,of,0,0
183646,blinded,0,1
183647,lead-in,0,0
183648,phases,0,0
183649,",",0,1
183650,the,0,0
183651,use,0,0
183652,of,0,0
183653,centralized,0,1
183654,raters,0,1
183655,",",0,1
183656,illness,0,1
183657,severity,0,0
183658,and,0,0
183659,duration,0,0
183660,",",0,0
183661,and,0,0
183662,comorbid,0,1
183663,anxiety,0,1
183664,.,0,1
183665,CONCLUSIONS,0,0
183666,Our,0,0
183667,increasing,0,0
183668,understanding,0,0
183669,of,0,0
183670,the,0,0
183671,placebo,1,0
183672,response,1,0
183673,in,1,1
183674,clinical,1,0
183675,trials,1,1
183676,of,0,1
183677,major,1,1
183678,depressive,1,1
183679,disorder,1,1
183680,lends,0,0
183681,to,0,0
183682,a,0,0
183683,",",0,0
183684,gradually,0,0
183685,",",0,0
183686,more,0,0
183687,predictable,0,0
183688,phenomenon,0,0
183689,and,0,0
183690,",",0,0
183691,hopefully,0,0
183692,",",0,0
183693,to,0,0
183694,one,0,0
183695,that,0,0
183696,becomes,0,0
183697,lesser,0,0
183698,in,0,0
183699,magnitude,0,0
183700,and,0,1
183701,variability,0,0
183702,.,0,1
183703,Several,0,0
183704,elements,0,1
183705,have,0,1
183706,emerged,0,0
183707,that,0,0
183708,seem,0,0
183709,to,0,0
183710,play,0,0
183711,a,0,0
183712,critical,0,0
183713,role,0,0
183714,in,0,0
183715,trial,0,0
183716,success,0,0
183717,",",0,0
183718,gradually,0,0
183719,reshaping,0,0
183720,the,0,0
183721,design,0,1
183722,of,0,0
183723,clinical,0,0
183724,",",0,1
183725,translational,0,0
183726,",",0,0
183727,as,0,0
183728,well,0,0
183729,as,0,0
183730,mechanistic,0,0
183731,studies,0,0
183732,in,0,1
183733,depression,0,1
183734,.,0,1
183735,A,0,0
183736,randomised,0,0
183737,controlled,0,0
183738,comparison,0,0
183739,between,0,0
183740,stimulating,0,0
183741,and,0,1
183742,standard,0,1
183743,catheters,0,1
183744,for,0,1
183745,lumbar,0,1
183746,plexus,0,1
183747,block,0,1
183748,.,0,1
183749,The,0,0
183750,aim,0,0
183751,of,0,0
183752,this,0,0
183753,randomised,0,0
183754,",",0,0
183755,prospective,0,0
183756,",",0,0
183757,blinded,0,0
183758,study,0,0
183759,was,0,0
183760,to,0,0
183761,evaluate,0,0
183762,if,0,0
183763,stimulating,0,0
183764,catheters,0,1
183765,can,0,0
183766,decrease,0,0
183767,the,0,0
183768,minimum,0,0
183769,effective,0,0
183770,anaesthetic,0,1
183771,volume,0,1
183772,in,0,1
183773,50,0,1
183774,%,0,0
183775,of,0,1
183776,patients,1,1
183777,during,1,1
183778,lumbar,1,1
183779,plexus,1,1
183780,block,1,1
183781,using,0,0
183782,mepivacaine,0,0
183783,1.5,0,1
183784,%,0,0
183785,compared,0,0
183786,with,0,1
183787,standard,0,1
183788,catheters,0,1
183789,.,0,1
183790,Fifty-eight,1,1
183791,patients,1,1
183792,of,1,1
183793,ASA,1,1
183794,physical,1,1
183795,status,1,1
183796,1-3,1,1
183797,were,1,1
183798,randomly,1,1
183799,allocated,1,1
183800,to,1,0
183801,receive,1,0
183802,a,1,0
183803,lumbar,1,0
183804,plexus,1,1
183805,block,1,0
183806,via,1,0
183807,a,1,1
183808,stimulating,1,0
183809,or,1,1
183810,standard,1,1
183811,catheter,1,0
183812,",",1,1
183813,with,1,1
183814,29,1,1
183815,in,1,0
183816,each,1,1
183817,group,1,1
183818,.,1,0
183819,The,0,0
183820,first,0,0
183821,dose,0,0
183822,was,0,0
183823,30,0,1
183824,ml,0,0
183825,and,0,1
183826,subsequent,0,0
183827,doses,0,0
183828,were,0,1
183829,determined,0,0
183830,using,0,0
183831,the,0,0
183832,up-and-down,0,0
183833,staircase,0,0
183834,method,0,0
183835,.,0,1
183836,The,0,0
183837,minimum,0,0
183838,effective,0,0
183839,anaesthetic,0,1
183840,volume50,0,1
183841,was,0,0
183842,12.2,0,0
183843,ml,0,0
183844,(,0,1
183845,95,0,0
183846,%,0,0
183847,CI,0,0
183848,7.3-17.1,0,0
183849,ml,0,0
183850,),0,1
183851,using,0,0
183852,the,0,0
183853,stimulating,0,0
183854,catheter,0,0
183855,and,0,1
183856,24.8,0,0
183857,ml,0,0
183858,(,0,1
183859,95,0,0
183860,%,0,0
183861,CI,0,0
183862,23.2-27.5,0,1
183863,ml,0,0
183864,),0,1
183865,with,0,1
183866,the,0,0
183867,standard,0,1
183868,catheter,0,0
183869,(,0,1
183870,p,0,0
183871,<,0,0
183872,0.0001,0,0
183873,),0,1
183874,.,0,1
183875,Complete,0,0
183876,lumbar,0,1
183877,plexus,0,1
183878,block,0,1
183879,was,0,0
183880,achieved,0,0
183881,with,0,1
183882,the,0,0
183883,initial,0,0
183884,dose,0,0
183885,of,0,0
183886,mepivacaine,0,0
183887,in,0,1
183888,29,0,1
183889,(,0,1
183890,100,0,1
183891,%,0,0
183892,),0,1
183893,patients,0,1
183894,in,0,1
183895,the,0,1
183896,stimulating,0,0
183897,catheter,0,0
183898,group,0,1
183899,and,0,1
183900,20,0,1
183901,(,0,1
183902,69,0,1
183903,%,0,0
183904,),0,1
183905,patients,0,1
183906,in,0,1
183907,the,0,1
183908,standard,0,1
183909,catheter,0,0
183910,group,0,1
183911,(,0,1
183912,p,0,0
183913,=,0,1
183914,0.002,0,0
183915,),0,1
183916,.,0,1
183917,This,0,0
183918,study,0,0
183919,showed,0,0
183920,that,0,0
183921,use,0,0
183922,of,0,0
183923,a,0,1
183924,stimulating,0,0
183925,catheter,0,0
183926,halves,0,0
183927,the,0,0
183928,minimum,0,0
183929,effective,0,0
183930,anaesthetic,0,1
183931,volume50,0,0
183932,of,0,1
183933,mepivacaine,0,0
183934,1.5,0,0
183935,%,0,0
183936,while,0,0
183937,increasing,0,0
183938,the,0,0
183939,success,0,0
183940,rate,0,0
183941,in,0,1
183942,patients,0,1
183943,receiving,0,1
183944,continuous,0,0
183945,lumbar,0,1
183946,plexus,0,1
183947,block,0,1
183948,.,0,1
183949,Serotonergic,0,0
183950,psychedelics,0,1
183951,temporarily,0,0
183952,modify,0,0
183953,information,0,0
183954,transfer,0,1
183955,in,0,1
183956,humans,1,1
183957,.,1,1
183958,BACKGROUND,0,0
183959,Psychedelics,0,1
183960,induce,0,1
183961,intense,0,1
183962,modifications,0,0
183963,in,0,1
183964,the,0,0
183965,sensorium,0,1
183966,",",0,0
183967,the,0,0
183968,sense,0,0
183969,of,0,0
183970,self,0,1
183971,",",0,0
183972,and,0,0
183973,the,0,0
183974,experience,0,0
183975,of,0,0
183976,reality,0,0
183977,.,0,1
183978,Despite,0,0
183979,advances,0,0
183980,in,0,1
183981,our,0,1
183982,understanding,0,0
183983,of,0,0
183984,the,0,0
183985,molecular,0,0
183986,and,0,0
183987,cellular,0,1
183988,level,0,0
183989,mechanisms,0,0
183990,of,0,1
183991,these,0,0
183992,drugs,0,0
183993,",",0,0
183994,knowledge,0,0
183995,of,0,0
183996,their,0,1
183997,actions,0,0
183998,on,0,0
183999,global,0,0
184000,brain,0,1
184001,dynamics,0,0
184002,is,0,0
184003,still,0,0
184004,incomplete,0,0
184005,.,0,1
184006,Recent,0,1
184007,imaging,0,0
184008,studies,0,0
184009,have,0,1
184010,found,0,0
184011,changes,0,0
184012,in,0,1
184013,functional,0,1
184014,coupling,0,0
184015,between,0,0
184016,frontal,0,1
184017,and,0,1
184018,parietal,0,1
184019,brain,0,1
184020,structures,0,0
184021,",",0,0
184022,suggesting,0,0
184023,a,0,0
184024,modification,0,0
184025,in,0,0
184026,information,0,0
184027,flow,0,0
184028,between,0,0
184029,brain,0,1
184030,regions,0,1
184031,during,0,1
184032,acute,0,1
184033,effects,0,0
184034,.,0,1
184035,METHODS,0,0
184036,Here,0,0
184037,we,0,0
184038,assessed,0,0
184039,the,0,0
184040,psychedelic-induced,0,1
184041,changes,0,0
184042,in,0,1
184043,directionality,0,0
184044,of,0,0
184045,information,0,0
184046,flow,0,0
184047,during,0,0
184048,the,0,0
184049,acute,0,1
184050,effects,0,0
184051,of,0,1
184052,a,0,1
184053,psychedelic,0,0
184054,in,0,0
184055,humans,1,1
184056,.,1,1
184057,We,0,0
184058,measured,0,0
184059,modifications,0,0
184060,in,0,1
184061,connectivity,0,0
184062,of,0,1
184063,brain,0,1
184064,oscillations,0,0
184065,using,0,0
184066,transfer,0,1
184067,entropy,0,0
184068,",",0,0
184069,a,0,0
184070,nonlinear,0,0
184071,measure,0,0
184072,of,0,0
184073,directed,0,0
184074,functional,0,1
184075,connectivity,0,0
184076,based,0,1
184077,on,0,0
184078,information,0,0
184079,theory,0,1
184080,.,0,1
184081,Ten,1,1
184082,healthy,1,1
184083,male,1,1
184084,volunteers,1,1
184085,with,1,1
184086,prior,1,1
184087,experience,1,1
184088,with,1,1
184089,psychedelics,1,1
184090,participated,0,1
184091,in,0,1
184092,2,0,1
184093,experimental,0,1
184094,sessions,0,0
184095,.,0,1
184096,They,0,0
184097,received,0,0
184098,a,0,0
184099,placebo,0,0
184100,or,0,0
184101,a,0,0
184102,dose,0,0
184103,of,0,0
184104,ayahuasca,0,0
184105,",",0,0
184106,a,0,0
184107,psychedelic,0,0
184108,preparation,0,0
184109,containing,0,0
184110,the,0,0
184111,serotonergic,0,0
184112,5-HT2A,0,1
184113,agonist,0,1
184114,N,0,1
184115,",",0,1
184116,N-dimethyltryptamine,0,1
184117,.,0,0
184118,RESULTS,0,0
184119,The,0,0
184120,analysis,0,0
184121,showed,0,0
184122,significant,0,0
184123,changes,0,0
184124,in,0,1
184125,the,0,0
184126,coupling,0,0
184127,of,0,0
184128,brain,0,1
184129,oscillations,0,0
184130,between,0,0
184131,anterior,0,1
184132,and,0,1
184133,posterior,0,1
184134,recording,0,1
184135,sites,0,1
184136,.,0,1
184137,Transfer,0,1
184138,entropy,0,0
184139,analysis,0,0
184140,showed,0,0
184141,that,0,0
184142,frontal,0,1
184143,sources,0,0
184144,decreased,0,0
184145,their,0,1
184146,influence,0,0
184147,over,0,0
184148,central,0,0
184149,",",0,1
184150,parietal,0,0
184151,",",0,0
184152,and,0,1
184153,occipital,0,1
184154,sites,0,1
184155,.,0,1
184156,Conversely,0,0
184157,",",0,0
184158,sources,0,0
184159,in,0,1
184160,posterior,0,1
184161,locations,0,1
184162,increased,0,0
184163,their,0,1
184164,influence,0,0
184165,over,0,0
184166,signals,0,0
184167,measured,0,0
184168,at,0,1
184169,anterior,0,1
184170,locations,0,1
184171,.,0,1
184172,Exploratory,0,1
184173,correlations,0,0
184174,found,0,0
184175,that,0,0
184176,anterior-to-posterior,0,0
184177,transfer,0,1
184178,entropy,0,0
184179,decreases,0,0
184180,were,0,1
184181,correlated,0,0
184182,with,0,1
184183,the,0,0
184184,intensity,0,0
184185,of,0,0
184186,subjective,0,0
184187,effects,0,0
184188,",",0,1
184189,while,0,0
184190,the,0,0
184191,imbalance,0,0
184192,between,0,0
184193,anterior-to-posterior,0,0
184194,and,0,1
184195,posterior-to-anterior,0,0
184196,transfer,0,1
184197,entropy,0,0
184198,correlated,0,0
184199,with,0,1
184200,the,0,0
184201,degree,0,1
184202,of,0,0
184203,incapacitation,0,0
184204,experienced,0,1
184205,.,0,1
184206,CONCLUSIONS,0,0
184207,These,0,1
184208,results,0,0
184209,suggest,0,0
184210,that,0,0
184211,psychedelics,0,1
184212,induce,0,0
184213,a,0,0
184214,temporary,0,0
184215,disruption,0,0
184216,of,0,1
184217,neural,0,0
184218,hierarchies,0,1
184219,by,0,1
184220,reducing,0,0
184221,top-down,0,0
184222,control,0,1
184223,and,0,1
184224,increasing,0,0
184225,bottom-up,0,0
184226,information,0,0
184227,transfer,0,1
184228,in,0,0
184229,the,0,0
184230,human,1,1
184231,brain,0,1
184232,.,0,1
184233,Subcutaneous,0,1
184234,versus,0,0
184235,intravenous,0,1
184236,bortezomib,0,1
184237,in,0,1
184238,two,0,1
184239,different,0,1
184240,induction,0,1
184241,therapies,0,0
184242,for,0,0
184243,newly,0,1
184244,diagnosed,0,1
184245,multiple,0,1
184246,myeloma,0,1
184247,:,0,1
184248,an,0,0
184249,interim,0,0
184250,analysis,0,0
184251,from,0,1
184252,the,0,0
184253,prospective,0,1
184254,GMMG-MM5,0,0
184255,trial,0,1
184256,.,0,1
184257,We,0,0
184258,investigated,0,0
184259,the,0,0
184260,impact,0,0
184261,of,0,0
184262,subcutaneous,0,1
184263,versus,0,0
184264,intravenous,0,1
184265,bortezomib,0,0
184266,in,0,0
184267,the,0,0
184268,MM5,0,1
184269,trial,0,0
184270,of,0,0
184271,the,0,0
184272,German-Speaking,0,1
184273,Myeloma,0,1
184274,Multicenter,0,1
184275,Group,0,1
184276,which,0,0
184277,compared,0,0
184278,bortezomib,0,0
184279,",",0,0
184280,doxorubicin,0,0
184281,",",0,0
184282,and,0,0
184283,dexamethasone,0,0
184284,with,0,1
184285,bortezomib,0,0
184286,",",0,0
184287,cyclophosphamide,0,1
184288,",",0,0
184289,and,0,0
184290,dexamethasone,0,0
184291,induction,0,0
184292,therapy,0,0
184293,in,0,0
184294,newly,1,1
184295,diagnosed,1,1
184296,multiple,1,1
184297,myeloma,1,1
184298,.,1,1
184299,Based,0,0
184300,on,0,0
184301,data,0,0
184302,from,0,1
184303,relapsed,0,1
184304,myeloma,0,1
184305,",",0,0
184306,the,0,0
184307,route,0,0
184308,of,0,0
184309,administration,0,0
184310,for,0,0
184311,bortezomib,0,0
184312,was,0,0
184313,changed,0,0
184314,from,0,1
184315,intravenous,0,1
184316,to,0,1
184317,subcutaneous,0,1
184318,after,0,1
184319,314,1,1
184320,of,1,1
184321,604,1,1
184322,patients,1,1
184323,had,1,1
184324,been,1,1
184325,enrolled,1,1
184326,.,1,1
184327,We,0,0
184328,analyzed,0,0
184329,598,1,1
184330,patients,1,1
184331,who,1,1
184332,received,1,1
184333,at,1,1
184334,least,1,1
184335,one,1,1
184336,dose,1,0
184337,of,1,0
184338,trial,1,1
184339,medication,1,1
184340,.,1,1
184341,Adverse,0,0
184342,events,0,0
184343,were,0,0
184344,reported,0,0
184345,more,0,0
184346,frequently,0,0
184347,in,0,0
184348,patients,1,1
184349,treated,1,1
184350,with,1,1
184351,intravenous,1,1
184352,bortezomib,1,1
184353,(,0,1
184354,intravenous=65,0,1
184355,%,0,0
184356,;,0,1
184357,subcutaneous=56,0,1
184358,%,0,0
184359,",",0,0
184360,P=0.02,0,0
184361,),0,1
184362,.,0,1
184363,Rates,0,0
184364,of,0,0
184365,grade,0,1
184366,2,0,1
184367,or,0,1
184368,more,0,0
184369,peripheral,0,1
184370,neuropathy,0,1
184371,were,0,1
184372,higher,0,0
184373,in,0,1
184374,patients,1,1
184375,treated,1,1
184376,with,1,1
184377,intravenous,1,1
184378,bortezomib,1,0
184379,during,0,0
184380,the,0,0
184381,third,0,1
184382,cycle,0,0
184383,(,0,1
184384,intravenous=8,0,0
184385,%,0,0
184386,;,0,1
184387,subcutaneous=2,0,0
184388,%,0,0
184389,",",0,0
184390,P=0.001,0,0
184391,),0,1
184392,.,0,1
184393,Overall,0,0
184394,response,0,0
184395,rates,0,0
184396,were,0,1
184397,similar,0,0
184398,in,0,1
184399,patients,0,1
184400,treated,0,1
184401,intravenously,0,1
184402,or,0,1
184403,subcutaneously,0,1
184404,.,0,0
184405,The,0,0
184406,presence,0,0
184407,of,0,0
184408,International,0,1
184409,Staging,0,1
184410,System,0,1
184411,stage,0,1
184412,III,0,1
184413,disease,0,1
184414,",",0,0
184415,renal,0,1
184416,impairment,0,1
184417,or,0,1
184418,adverse,0,0
184419,cytogenetic,0,1
184420,abnormalities,0,1
184421,did,0,0
184422,not,0,0
184423,have,0,0
184424,a,0,0
184425,negative,0,0
184426,impact,0,0
184427,on,0,0
184428,overall,0,0
184429,response,0,0
184430,rates,0,0
184431,in,0,0
184432,either,0,1
184433,group,0,1
184434,.,0,1
184435,To,0,0
184436,our,0,0
184437,knowledge,0,0
184438,this,0,0
184439,is,0,0
184440,the,0,0
184441,largest,0,0
184442,study,0,0
184443,to,0,0
184444,present,0,0
184445,data,0,0
184446,comparing,0,0
184447,subcutaneous,0,1
184448,with,0,1
184449,intravenous,0,1
184450,bortezomib,0,0
184451,in,0,1
184452,newly,0,1
184453,diagnosed,0,1
184454,myeloma,0,1
184455,.,0,1
184456,We,0,0
184457,show,0,0
184458,better,0,0
184459,tolerance,0,1
184460,and,0,0
184461,similar,0,0
184462,overall,0,0
184463,response,0,0
184464,rates,0,0
184465,for,0,1
184466,subcutaneous,0,1
184467,compared,0,0
184468,to,0,1
184469,intravenous,0,1
184470,bortezomib,0,0
184471,.,0,1
184472,The,0,0
184473,clinical,0,0
184474,trial,0,0
184475,is,0,0
184476,registered,0,0
184477,at,0,0
184478,eudract.ema.europa.eu,0,1
184479,as,0,0
184480,n.,0,1
184481,2010-019173-16,0,1
184482,.,0,1
184483,A,0,1
184484,Randomized,0,1
184485,Double,0,1
184486,Blind,0,1
184487,Clinical,0,0
184488,Trial,0,1
184489,on,0,0
184490,a,0,1
184491,Sabgh,0,1
184492,Formulation,0,0
184493,for,0,0
184494,Patients,1,1
184495,With,1,1
184496,Vitiligo,1,1
184497,.,1,1
184498,BACKGROUND,0,0
184499,The,0,0
184500,cosmetic,0,0
184501,problem,0,0
184502,that,0,0
184503,vitiligo,0,1
184504,produces,0,0
184505,affects,1,0
184506,patients,1,1
184507,psychologically,1,1
184508,.,1,1
184509,Many,0,0
184510,patients,1,1
184511,with,1,1
184512,vitiligo,1,1
184513,are,0,0
184514,suggested,0,0
184515,to,0,0
184516,cover,0,0
184517,their,0,1
184518,white,0,1
184519,skin,0,1
184520,patches,0,0
184521,with,0,1
184522,cosmetic,0,1
184523,products,0,0
184524,.,0,0
184525,There,0,0
184526,are,0,0
184527,formulations,0,0
184528,in,0,1
184529,traditional,0,1
184530,Iranian,0,1
184531,pharmacy,0,1
184532,to,0,0
184533,color,0,1
184534,these,0,0
184535,white,0,1
184536,skin,0,1
184537,patches,0,0
184538,.,0,1
184539,In,0,0
184540,this,0,0
184541,study,0,0
184542,",",0,0
184543,one,0,1
184544,of,0,0
184545,these,0,0
184546,formulations,0,0
184547,was,0,0
184548,compared,0,0
184549,with,0,1
184550,a,0,1
184551,cosmetic,0,0
184552,formulation,0,0
184553,.,0,1
184554,METHODS,0,0
184555,Two,1,1
184556,groups,1,1
184557,of,1,1
184558,patients,1,1
184559,were,1,1
184560,selected,1,1
184561,.,1,1
184562,One,0,1
184563,group,0,0
184564,used,0,0
184565,a,0,0
184566,marketed,0,0
184567,formulation,0,0
184568,and,0,1
184569,other,0,0
184570,group,0,1
184571,used,0,0
184572,a,0,0
184573,traditional,0,0
184574,Iranian,0,1
184575,Pharmacy,0,1
184576,formulation,0,0
184577,.,0,1
184578,The,0,0
184579,quality,0,0
184580,of,0,0
184581,life,0,1
184582,of,0,0
184583,the,0,0
184584,patients,0,1
184585,was,0,0
184586,compared,0,0
184587,based,0,1
184588,on,0,0
184589,the,0,0
184590,Dermatology,0,1
184591,Life,0,0
184592,Quality,0,0
184593,Index,0,1
184594,Questionnaire,0,0
184595,.,0,1
184596,RESULTS,0,0
184597,Both,0,0
184598,interventions,0,0
184599,were,0,1
184600,associated,0,0
184601,with,0,1
184602,statistically,0,0
184603,improved,0,0
184604,Dermatology,0,1
184605,Life,0,1
184606,Quality,0,0
184607,Index,0,0
184608,scores,0,0
184609,over,0,0
184610,the,0,0
184611,8-week,0,0
184612,intervention,0,0
184613,(,0,1
184614,P,0,0
184615,<,0,0
184616,.05,0,0
184617,),0,0
184618,",",0,0
184619,although,0,0
184620,the,0,0
184621,difference,0,0
184622,between,0,0
184623,the,0,0
184624,2,0,0
184625,was,0,0
184626,not,0,0
184627,statistically,0,0
184628,significant,0,0
184629,(,0,1
184630,P,0,0
184631,=,0,1
184632,.436,0,0
184633,),0,1
184634,.,0,1
184635,CONCLUSION,0,0
184636,Traditional,0,1
184637,Iranian,0,1
184638,Pharmacy,0,0
184639,formulation,0,0
184640,is,0,0
184641,effective,0,0
184642,in,0,0
184643,increasing,0,0
184644,the,0,0
184645,quality,0,0
184646,of,0,0
184647,life,0,1
184648,in,0,1
184649,vitiligo,0,1
184650,patients,0,1
184651,.,0,1
184652,Effect,0,0
184653,of,0,0
184654,parent,0,1
184655,training,0,0
184656,vs,0,0
184657,parent,0,1
184658,education,0,1
184659,on,0,0
184660,behavioral,1,1
184661,problems,1,1
184662,in,1,1
184663,children,1,1
184664,with,1,1
184665,autism,1,1
184666,spectrum,1,1
184667,disorder,1,1
184668,:,1,1
184669,a,0,1
184670,randomized,0,1
184671,clinical,0,0
184672,trial,0,1
184673,.,0,1
184674,IMPORTANCE,0,0
184675,Disruptive,0,0
184676,behavior,0,0
184677,is,0,0
184678,common,0,0
184679,in,0,0
184680,children,1,1
184681,with,1,1
184682,autism,1,1
184683,spectrum,1,1
184684,disorder,1,1
184685,.,1,1
184686,Behavioral,0,0
184687,interventions,0,0
184688,are,0,0
184689,used,0,0
184690,to,0,0
184691,treat,0,1
184692,disruptive,0,1
184693,behavior,0,0
184694,but,0,0
184695,have,0,0
184696,not,0,0
184697,been,0,0
184698,evaluated,0,0
184699,in,0,0
184700,large-scale,0,1
184701,randomized,0,1
184702,trials,0,1
184703,.,0,1
184704,OBJECTIVE,0,0
184705,To,0,0
184706,evaluate,0,0
184707,the,0,0
184708,efficacy,0,0
184709,of,0,0
184710,parent,0,1
184711,training,0,1
184712,for,0,0
184713,children,1,1
184714,with,1,1
184715,autism,1,1
184716,spectrum,1,1
184717,disorder,1,1
184718,and,1,0
184719,disruptive,1,1
184720,behavior,1,1
184721,.,1,1
184722,DESIGN,0,0
184723,",",0,0
184724,SETTING,0,1
184725,",",0,0
184726,AND,0,0
184727,PARTICIPANTS,0,1
184728,This,0,0
184729,24-week,0,0
184730,randomized,0,1
184731,trial,0,1
184732,compared,0,0
184733,parent,1,1
184734,training,1,0
184735,(,1,1
184736,n,1,1
184737,=,1,1
184738,89,1,1
184739,),1,1
184740,to,1,0
184741,parent,1,1
184742,education,1,0
184743,(,1,0
184744,n,1,1
184745,=,1,1
184746,91,1,1
184747,),1,1
184748,at,1,1
184749,6,1,1
184750,centers,1,1
184751,(,1,1
184752,Emory,1,1
184753,University,1,1
184754,",",1,1
184755,Indiana,1,1
184756,University,1,1
184757,",",1,1
184758,Ohio,1,1
184759,State,1,0
184760,University,1,1
184761,",",1,0
184762,University,1,1
184763,of,1,0
184764,Pittsburgh,1,1
184765,",",1,1
184766,University,1,1
184767,of,1,0
184768,Rochester,1,1
184769,",",1,1
184770,Yale,1,1
184771,University,1,1
184772,),1,1
184773,.,1,1
184774,We,1,0
184775,screened,1,1
184776,267,1,1
184777,children,1,1
184778,;,1,1
184779,180,1,1
184780,children,1,1
184781,(,1,1
184782,aged,1,1
184783,3-7,1,1
184784,years,1,1
184785,),1,1
184786,with,1,1
184787,autism,1,1
184788,spectrum,1,1
184789,disorder,1,1
184790,and,1,1
184791,disruptive,1,1
184792,behaviors,1,0
184793,were,1,1
184794,randomly,1,1
184795,assigned,1,1
184796,(,1,0
184797,86,1,1
184798,%,1,0
184799,white,1,1
184800,",",1,1
184801,88,1,0
184802,%,1,0
184803,male,1,1
184804,),1,1
184805,between,1,0
184806,September,1,1
184807,2010,1,1
184808,and,1,1
184809,February,1,1
184810,2014,1,1
184811,.,1,1
184812,INTERVENTIONS,1,0
184813,Parent,0,1
184814,training,0,1
184815,(,0,1
184816,11,0,1
184817,core,0,1
184818,",",0,1
184819,2,0,1
184820,optional,0,1
184821,sessions,0,0
184822,;,0,1
184823,2,0,1
184824,telephone,0,1
184825,boosters,0,1
184826,;,0,1
184827,2,0,1
184828,home,0,1
184829,visits,0,1
184830,),0,1
184831,provided,0,0
184832,specific,0,0
184833,strategies,0,0
184834,to,0,1
184835,manage,0,1
184836,disruptive,0,1
184837,behavior,0,0
184838,.,0,1
184839,Parent,0,0
184840,education,0,0
184841,(,0,1
184842,12,0,1
184843,core,0,1
184844,sessions,0,0
184845,",",0,1
184846,1,0,1
184847,home,0,1
184848,visit,0,1
184849,),0,1
184850,provided,0,0
184851,information,0,0
184852,about,0,0
184853,autism,0,1
184854,but,0,0
184855,no,0,0
184856,behavior,0,0
184857,management,0,1
184858,strategies,0,0
184859,.,0,1
184860,MAIN,0,0
184861,OUTCOMES,0,0
184862,AND,0,0
184863,MEASURES,0,1
184864,Parents,0,1
184865,rated,0,1
184866,disruptive,0,1
184867,behavior,0,0
184868,and,0,0
184869,noncompliance,0,1
184870,on,0,0
184871,co-primary,0,0
184872,outcomes,0,0
184873,:,0,1
184874,the,0,1
184875,Aberrant,0,1
184876,Behavior,0,1
184877,Checklist-Irritability,0,0
184878,subscale,0,0
184879,(,0,0
184880,range,0,1
184881,",",0,0
184882,0-45,0,0
184883,),0,0
184884,and,0,0
184885,the,0,0
184886,Home,0,1
184887,Situations,0,0
184888,Questionnaire-Autism,0,1
184889,Spectrum,0,1
184890,Disorder,0,1
184891,(,0,1
184892,range,0,1
184893,",",0,0
184894,0-9,0,1
184895,),0,1
184896,.,0,1
184897,On,0,0
184898,both,0,0
184899,measures,0,0
184900,",",0,1
184901,higher,0,0
184902,scores,0,0
184903,indicate,0,0
184904,greater,0,0
184905,severity,0,0
184906,and,0,0
184907,a,0,1
184908,25,0,1
184909,%,0,0
184910,reduction,0,0
184911,indicates,0,0
184912,clinical,0,0
184913,improvement,0,0
184914,.,0,1
184915,A,0,0
184916,clinician,0,0
184917,blind,0,1
184918,to,0,1
184919,treatment,0,0
184920,assignment,0,0
184921,rated,0,0
184922,the,0,0
184923,Improvement,0,0
184924,scale,0,0
184925,of,0,0
184926,the,0,0
184927,Clinical,0,0
184928,Global,0,1
184929,Impression,0,0
184930,(,0,1
184931,range,0,1
184932,",",0,0
184933,1-7,0,0
184934,),0,0
184935,",",0,0
184936,a,0,0
184937,secondary,0,0
184938,outcome,0,0
184939,",",0,0
184940,with,0,1
184941,a,0,0
184942,positive,0,0
184943,response,0,0
184944,less,0,0
184945,than,0,1
184946,3,0,0
184947,.,0,1
184948,RESULTS,0,0
184949,At,0,0
184950,week,0,0
184951,24,0,1
184952,",",0,0
184953,the,0,0
184954,Aberrant,0,1
184955,Behavior,0,1
184956,Checklist-Irritability,0,0
184957,subscale,0,0
184958,declined,0,0
184959,47.7,0,1
184960,%,0,0
184961,in,0,0
184962,parent,0,1
184963,training,0,0
184964,(,0,1
184965,from,0,1
184966,23.7,0,1
184967,to,0,1
184968,12.4,0,0
184969,),0,1
184970,compared,0,0
184971,with,0,1
184972,31.8,0,1
184973,%,0,0
184974,for,0,0
184975,parent,0,1
184976,education,0,1
184977,(,0,1
184978,23.9,0,1
184979,to,0,1
184980,16.3,0,0
184981,),0,1
184982,(,0,1
184983,treatment,0,0
184984,effect,0,0
184985,",",0,1
184986,-3.9,0,0
184987,;,0,1
184988,95,0,0
184989,%,0,0
184990,CI,0,0
184991,",",0,1
184992,-6.2,0,0
184993,to,0,0
184994,-1.7,0,0
184995,;,0,1
184996,P,0,0
184997,<,0,0
184998,.001,0,0
184999,",",0,0
185000,standardized,0,0
185001,effect,0,0
185002,size,0,0
185003,=,0,1
185004,0.62,0,0
185005,),0,1
185006,.,0,1
185007,The,0,0
185008,Home,0,0
185009,Situations,0,0
185010,Questionnaire-Autism,0,1
185011,Spectrum,0,1
185012,Disorder,0,1
185013,declined,0,0
185014,55,0,1
185015,%,0,0
185016,(,0,1
185017,from,0,1
185018,4.0,0,1
185019,to,0,1
185020,1.8,0,1
185021,),0,1
185022,compared,0,0
185023,with,0,1
185024,34.2,0,0
185025,%,0,0
185026,in,0,0
185027,parent,0,1
185028,education,0,1
185029,(,0,1
185030,3.8,0,0
185031,to,0,1
185032,2.5,0,0
185033,),0,1
185034,(,0,1
185035,treatment,0,0
185036,effect,0,0
185037,",",0,1
185038,-0.7,0,0
185039,;,0,1
185040,95,0,0
185041,%,0,0
185042,CI,0,0
185043,",",0,1
185044,-1.1,0,0
185045,to,0,0
185046,-0.3,0,0
185047,;,0,1
185048,P,0,0
185049,<,0,0
185050,.001,0,0
185051,",",0,0
185052,standardized,0,0
185053,effect,0,0
185054,size,0,0
185055,=,0,1
185056,0.45,0,0
185057,),0,1
185058,.,0,1
185059,Neither,0,0
185060,measure,0,0
185061,met,0,1
185062,the,0,0
185063,prespecified,0,0
185064,minimal,0,0
185065,clinically,0,1
185066,important,0,0
185067,difference,0,0
185068,.,0,1
185069,The,0,0
185070,proportions,0,0
185071,with,0,1
185072,a,0,1
185073,positive,0,1
185074,response,0,0
185075,on,0,0
185076,the,0,0
185077,Clinical,0,0
185078,Global,0,1
185079,Impression-Improvement,0,0
185080,scale,0,1
185081,were,0,1
185082,68.5,0,0
185083,%,0,0
185084,for,0,0
185085,parent,0,1
185086,training,0,1
185087,vs,0,0
185088,39.6,0,0
185089,%,0,0
185090,for,0,0
185091,parent,0,1
185092,education,0,1
185093,(,0,1
185094,P,0,0
185095,<,0,0
185096,.001,0,0
185097,),0,1
185098,.,0,1
185099,CONCLUSIONS,0,0
185100,AND,0,0
185101,RELEVANCE,0,1
185102,For,1,1
185103,children,1,1
185104,with,1,1
185105,autism,1,1
185106,spectrum,1,1
185107,disorder,1,1
185108,",",1,0
185109,a,1,0
185110,24-week,0,0
185111,parent,0,1
185112,training,0,0
185113,program,0,1
185114,was,0,0
185115,superior,0,0
185116,to,0,0
185117,parent,0,1
185118,education,0,0
185119,for,0,0
185120,reducing,0,0
185121,disruptive,0,1
185122,behavior,0,1
185123,on,0,0
185124,parent-reported,0,1
185125,outcomes,0,0
185126,",",0,1
185127,although,0,0
185128,the,0,0
185129,clinical,0,0
185130,significance,0,0
185131,of,0,0
185132,the,0,0
185133,improvement,0,0
185134,is,0,0
185135,unclear,0,0
185136,.,0,0
185137,The,0,0
185138,rate,0,0
185139,of,0,0
185140,positive,0,1
185141,response,0,0
185142,judged,0,0
185143,by,0,0
185144,a,0,1
185145,blinded,0,0
185146,clinician,0,0
185147,was,0,0
185148,greater,0,0
185149,for,0,0
185150,parent,0,1
185151,training,0,0
185152,vs,0,0
185153,parent,0,1
185154,education,0,1
185155,.,0,1
185156,TRIAL,0,0
185157,REGISTRATION,0,0
185158,clinicaltrials.gov,0,1
185159,Identifier,0,1
185160,:,0,1
185161,NCT01233414,0,1
185162,.,0,1
185163,Investigating,0,1
185164,a,0,1
185165,Multimodal,0,0
185166,Intervention,0,1
185167,for,0,0
185168,Children,1,1
185169,With,1,1
185170,Limited,1,1
185171,Expressive,1,1
185172,Vocabularies,1,1
185173,Associated,1,0
185174,With,1,1
185175,Autism,1,1
185176,.,1,1
185177,PURPOSE,0,0
185178,This,0,0
185179,study,0,0
185180,investigated,0,0
185181,a,0,0
185182,new,0,1
185183,intervention,0,0
185184,package,0,0
185185,aimed,0,0
185186,at,0,0
185187,increasing,0,0
185188,expressive,0,1
185189,word,0,0
185190,learning,0,0
185191,by,0,0
185192,school-age,1,1
185193,children,1,1
185194,with,1,1
185195,autism,1,1
185196,who,1,1
185197,have,1,1
185198,limited,1,1
185199,expressive,1,1
185200,vocabularies,1,1
185201,.,1,1
185202,This,0,0
185203,pilot,0,0
185204,investigation,0,0
185205,was,0,0
185206,intended,0,0
185207,to,0,0
185208,show,0,0
185209,proof,0,0
185210,of,0,0
185211,concept,0,0
185212,.,0,1
185213,METHOD,0,0
185214,Ten,1,1
185215,children,1,1
185216,between,1,0
185217,the,1,1
185218,ages,1,1
185219,of,1,1
185220,6,1,1
185221,and,1,1
185222,10,1,1
185223,years,1,1
185224,participated,1,1
185225,",",1,1
185226,with,1,1
185227,educational,1,1
185228,diagnoses,1,1
185229,of,1,1
185230,autism,1,1
185231,and,1,1
185232,limited,1,0
185233,expressive,1,1
185234,vocabularies,1,1
185235,at,1,1
185236,the,1,0
185237,outset,1,1
185238,of,1,0
185239,the,1,0
185240,study,1,0
185241,.,1,0
185242,A,0,0
185243,multimodal,0,0
185244,intervention,0,0
185245,composed,0,1
185246,of,0,0
185247,speech,0,1
185248,sound,0,1
185249,practice,0,0
185250,and,0,1
185251,augmentative,0,1
185252,and,0,1
185253,alternative,0,0
185254,communication,0,0
185255,was,0,0
185256,used,0,0
185257,to,0,0
185258,teach,0,0
185259,individualized,0,0
185260,vocabulary,0,1
185261,words,0,0
185262,that,0,0
185263,were,0,1
185264,selected,0,1
185265,on,0,0
185266,the,0,0
185267,basis,0,0
185268,of,0,0
185269,initial,0,1
185270,speech,0,1
185271,sound,0,1
185272,repertoires,0,1
185273,and,0,1
185274,principles,0,0
185275,of,0,1
185276,phonotactic,0,1
185277,probability,0,0
185278,and,0,0
185279,neighborhood,0,1
185280,density,0,0
185281,.,0,1
185282,A,0,0
185283,multiple-probe,0,0
185284,design,0,1
185285,was,0,0
185286,used,0,0
185287,to,0,0
185288,evaluate,0,0
185289,learning,0,0
185290,outcomes,0,0
185291,.,0,1
185292,RESULTS,0,0
185293,Five,0,1
185294,children,1,1
185295,showed,0,0
185296,gains,0,0
185297,in,0,1
185298,spoken-word,0,0
185299,learning,0,0
185300,across,0,0
185301,successive,0,1
185302,word,0,1
185303,sets,0,1
185304,(,0,1
185305,high,0,1
185306,responders,0,0
185307,),0,1
185308,.,0,1
185309,Five,0,1
185310,children,1,1
185311,did,0,0
185312,not,0,0
185313,meet,0,1
185314,learning,0,0
185315,criteria,0,1
185316,(,0,1
185317,low,0,1
185318,responders,0,0
185319,),0,1
185320,.,0,1
185321,Comparisons,0,0
185322,of,0,1
185323,behaviors,0,0
185324,measured,0,0
185325,prior,0,1
185326,to,0,0
185327,intervention,0,0
185328,indicated,0,0
185329,that,0,0
185330,high,0,1
185331,responders,0,0
185332,had,0,1
185333,relatively,0,1
185334,higher,0,0
185335,skills,0,0
185336,in,0,0
185337,receptive,0,1
185338,language,0,1
185339,",",0,0
185340,prelinguistic,0,1
185341,communication,0,0
185342,",",0,0
185343,vocal/verbal,0,1
185344,imitation,0,1
185345,",",0,0
185346,adaptive,0,0
185347,behavior,0,0
185348,",",0,0
185349,and,0,0
185350,consonant,0,1
185351,productions,0,0
185352,.,0,1
185353,CONCLUSIONS,0,0
185354,The,0,0
185355,intervention,0,0
185356,package,0,0
185357,holds,0,0
185358,promise,0,0
185359,for,0,0
185360,improving,0,0
185361,spoken,0,0
185362,word,0,1
185363,productions,0,0
185364,for,0,1
185365,some,0,1
185366,children,1,1
185367,with,1,1
185368,autism,1,1
185369,who,1,1
185370,have,1,1
185371,limited,1,1
185372,expressive,1,1
185373,vocabularies,1,1
185374,.,1,1
185375,Further,0,0
185376,research,0,0
185377,is,0,0
185378,needed,0,0
185379,to,0,0
185380,better,0,0
185381,describe,0,0
185382,who,0,1
185383,may,0,0
185384,most,0,1
185385,benefit,0,0
185386,from,0,0
185387,this,0,0
185388,approach,0,0
185389,as,0,0
185390,well,0,0
185391,as,0,0
185392,investigate,0,0
185393,generalized,0,1
185394,benefits,0,0
185395,to,0,1
185396,untaught,0,1
185397,contexts,0,1
185398,and,0,1
185399,targets,0,0
185400,.,0,1
185401,Indicators,0,1
185402,for,0,1
185403,Cervical,0,1
185404,Length,0,1
185405,in,0,1
185406,Twin,1,1
185407,Pregnancies,1,1
185408,.,1,1
185409,OBJECTIVE,0,0
185410,Cervical,0,1
185411,length,0,0
185412,(,0,1
185413,CL,0,0
185414,),0,1
185415,is,0,0
185416,associated,0,0
185417,with,0,0
185418,the,0,0
185419,risk,0,0
185420,of,0,0
185421,preterm,0,1
185422,birth,0,1
185423,(,0,1
185424,PTB,0,1
185425,),0,1
185426,in,0,1
185427,multiple,0,1
185428,pregnancies,0,1
185429,.,0,1
185430,However,0,0
185431,",",0,0
185432,the,0,0
185433,position,0,0
185434,of,0,0
185435,CL,0,1
185436,within,0,1
185437,the,0,0
185438,pathophysiological,0,0
185439,pathway,0,0
185440,of,0,0
185441,PTB,0,1
185442,is,0,0
185443,unclear,0,0
185444,",",0,0
185445,and,0,0
185446,it,0,0
185447,is,0,0
185448,unknown,0,0
185449,which,0,0
185450,factors,0,0
185451,are,0,0
185452,predictive,0,0
185453,for,0,1
185454,CL,0,1
185455,.,0,1
185456,This,0,0
185457,study,0,0
185458,aims,0,0
185459,to,0,0
185460,investigate,0,0
185461,whether,0,0
185462,in,0,0
185463,twin,0,1
185464,pregnancies,0,1
185465,baseline,0,1
185466,maternal,0,1
185467,and,0,1
185468,obstetrical,0,1
185469,characteristics,0,1
185470,are,0,0
185471,potential,0,0
185472,indicators,0,0
185473,for,0,1
185474,CL,0,1
185475,",",0,0
185476,to,0,0
185477,improve,0,0
185478,insight,0,0
185479,in,0,0
185480,the,0,0
185481,pathophysiological,0,0
185482,pathway,0,0
185483,of,0,1
185484,PTB,0,1
185485,.,0,1
185486,STUDY,0,0
185487,DESIGN,0,1
185488,Secondary,0,1
185489,analysis,0,0
185490,of,0,0
185491,data,0,0
185492,on,0,1
185493,twin,1,1
185494,pregnancies,1,1
185495,and,1,1
185496,CL,1,1
185497,measurement,1,0
185498,between,1,0
185499,16,1,1
185500,and,1,1
185501,22,1,1
185502,weeks,1,0
185503,.,1,1
185504,A,0,0
185505,set,0,0
185506,of,0,0
185507,10,0,1
185508,potential,0,0
185509,indicators,0,0
185510,",",0,1
185511,known,0,1
185512,to,0,0
185513,be,0,0
185514,associated,0,0
185515,with,0,1
185516,an,0,0
185517,increased,0,0
185518,risk,0,0
185519,of,0,0
185520,PTB,0,1
185521,and/or,0,0
185522,which,0,0
185523,have,0,0
185524,a,0,0
185525,plausible,0,0
185526,mechanism,0,0
185527,resulting,0,0
185528,in,0,0
185529,a,0,1
185530,change,0,0
185531,of,0,0
185532,CL,0,1
185533,were,0,1
185534,selected,0,1
185535,.,0,1
185536,We,0,0
185537,used,0,0
185538,multivariable,0,0
185539,linear,0,0
185540,regression,0,0
185541,with,0,1
185542,backward,0,1
185543,selection,0,0
185544,to,0,0
185545,identify,0,0
185546,independent,0,0
185547,indicators,0,0
185548,for,0,1
185549,CL,0,1
185550,.,0,1
185551,RESULTS,0,0
185552,A,1,0
185553,total,1,1
185554,of,1,0
185555,"1,447",1,1
185556,women,1,1
185557,with,1,1
185558,twin,1,1
185559,pregnancies,1,1
185560,were,1,1
185561,included,1,1
185562,.,1,1
185563,Mean,0,1
185564,CL,0,1
185565,was,0,0
185566,43.7,0,0
185567,(,0,1
185568,?8.9,0,1
185569,),0,1
185570,mm,0,1
185571,.,0,1
185572,In,0,0
185573,multivariable,0,0
185574,analysis,0,0
185575,",",0,0
185576,age,0,1
185577,(,0,1
185578,0.27,0,0
185579,mm/y,0,1
185580,;,0,1
185581,95,0,0
185582,%,0,0
185583,confidence,0,0
185584,interval,0,0
185585,[,0,0
185586,CI,0,0
185587,],0,1
185588,0.16,0,0
185589,to,0,1
185590,0.39,0,0
185591,),0,1
185592,",",0,0
185593,use,0,0
185594,of,0,0
185595,assisted,0,1
185596,reproductive,0,1
185597,technologies,0,0
185598,(,0,1
185599,ART,0,1
185600,),0,1
185601,(,0,1
185602,-1.42,0,0
185603,mm,0,1
185604,",",0,1
185605,95,0,0
185606,%,0,0
185607,CI,0,0
185608,-2.6,0,0
185609,to,0,0
185610,-0.25,0,0
185611,),0,0
185612,",",0,0
185613,and,0,0
185614,having,0,1
185615,delivered,0,0
185616,at,0,0
185617,term,0,1
185618,in,0,0
185619,a,0,1
185620,previous,0,1
185621,pregnancy,0,1
185622,(,0,1
185623,1.32,0,0
185624,mm,0,1
185625,",",0,1
185626,95,0,0
185627,%,0,0
185628,CI,0,0
185629,0.25,0,0
185630,to,0,1
185631,2.39,0,0
185632,),0,1
185633,were,0,1
185634,significantly,0,0
185635,associated,0,0
185636,with,0,1
185637,CL,0,1
185638,.,0,1
185639,CONCLUSION,0,0
185640,This,0,0
185641,study,0,0
185642,shows,0,0
185643,that,0,0
185644,in,1,0
185645,twin,1,1
185646,pregnancies,1,1
185647,",",1,0
185648,age,1,1
185649,",",0,0
185650,use,0,0
185651,of,0,0
185652,ART,0,1
185653,and,0,1
185654,having,0,1
185655,delivered,0,0
185656,term,0,1
185657,in,0,0
185658,a,0,1
185659,previous,0,0
185660,pregnancy,0,0
185661,has,0,0
185662,an,0,0
185663,association,0,0
185664,with,0,1
185665,CL,0,1
185666,.,0,1
185667,The,0,0
185668,effects,0,0
185669,of,0,0
185670,preoperative,0,1
185671,oral,0,1
185672,pregabalin,0,0
185673,and,0,1
185674,perioperative,0,0
185675,intravenous,0,1
185676,lidocaine,0,0
185677,infusion,0,0
185678,on,0,0
185679,postoperative,0,0
185680,morphine,0,0
185681,requirement,0,1
185682,in,0,1
185683,patients,1,1
185684,undergoing,1,1
185685,laparatomy,1,1
185686,.,1,1
185687,OBJECTIVES,0,0
185688,To,0,0
185689,evaluate,0,0
185690,and,0,0
185691,compare,0,0
185692,the,0,0
185693,effects,0,0
185694,of,0,0
185695,preoperative,0,1
185696,oral,0,1
185697,pregabalin,0,0
185698,and,0,1
185699,perioperative,0,0
185700,intravenous,0,1
185701,lidocaine,0,0
185702,infusion,0,0
185703,on,0,0
185704,postoperative,0,0
185705,morphine,0,0
185706,requirement,0,1
185707,",",0,1
185708,adverse,0,0
185709,effects,0,0
185710,",",0,1
185711,patients,0,1
185712,',0,1
185713,satisfaction,0,0
185714,",",0,1
185715,mobilization,0,0
185716,",",0,0
185717,time,0,0
185718,to,0,0
185719,first,0,0
185720,defecation,0,1
185721,and,0,1
185722,time,0,0
185723,to,0,0
185724,discharge,0,1
185725,in,0,0
185726,patients,0,1
185727,undergoing,0,1
185728,laparotomy,0,1
185729,.,0,1
185730,METHODS,0,0
185731,Eighty,1,1
185732,patients,1,1
185733,(,1,1
185734,18,1,1
185735,to,1,1
185736,65,1,1
185737,years,1,1
185738,of,1,1
185739,age,1,1
185740,),1,1
185741,undergoing,1,1
185742,elective,1,1
185743,laparotomy,1,1
185744,were,0,1
185745,randomly,0,1
185746,divided,0,1
185747,into,0,1
185748,four,0,1
185749,groups,0,1
185750,(,0,1
185751,n=20,0,1
185752,in,0,0
185753,each,0,1
185754,group,0,1
185755,),0,1
185756,:,0,1
185757,group,0,1
185758,C,0,0
185759,",",0,1
185760,placebo,0,0
185761,capsules,0,0
185762,and,0,1
185763,normal,0,1
185764,saline,0,0
185765,infusion,0,0
185766,perioperatively,0,0
185767,(,0,0
185768,control,0,1
185769,),0,1
185770,;,0,1
185771,group,0,1
185772,L,0,0
185773,",",0,1
185774,placebo,0,0
185775,capsules,0,0
185776,and,0,1
185777,lidocaine,0,0
185778,1,0,1
185779,mg?kg,0,1
185780,intravenous,0,1
185781,bolus,0,0
185782,dose,0,0
185783,followed,0,1
185784,by,0,0
185785,2,0,1
185786,mg?kg?h,0,1
185787,infusion,0,0
185788,until,0,1
185789,skin,0,1
185790,closure,0,1
185791,;,0,1
185792,group,0,1
185793,P,0,0
185794,",",0,1
185795,150,0,1
185796,mg,0,0
185797,oral,0,1
185798,pregabalin,0,0
185799,and,0,1
185800,normal,0,1
185801,saline,0,0
185802,infusion,0,0
185803,perioperatively,0,0
185804,;,0,0
185805,and,0,0
185806,group,0,1
185807,PL,0,1
185808,",",0,1
185809,150,0,1
185810,&,0,1
185811,nbsp,0,1
185812,;,0,1
185813,mg,0,0
185814,oral,0,0
185815,pregabalin,0,0
185816,and,0,1
185817,lidocaine,0,0
185818,2,0,1
185819,mg?kg?h,0,1
185820,infusion,0,0
185821,until,0,1
185822,skin,0,1
185823,closure,0,1
185824,.,0,1
185825,Hemodynamic,0,0
185826,parameters,0,0
185827,",",0,1
185828,visual,0,0
185829,analogue,0,0
185830,scale,0,0
185831,(,0,1
185832,VAS,0,0
185833,),0,0
185834,scores,0,0
185835,",",0,0
185836,analgesic,0,0
185837,consumption,0,0
185838,",",0,1
185839,side,0,0
185840,effects,0,0
185841,",",0,1
185842,time,0,0
185843,to,0,0
185844,mobilization,0,0
185845,",",0,0
185846,time,0,0
185847,to,0,0
185848,first,0,0
185849,defecation,0,1
185850,",",0,0
185851,time,0,0
185852,to,0,0
185853,discharge,0,1
185854,and,0,1
185855,patients,0,1
185856,',0,1
185857,satisfaction,0,0
185858,were,0,1
185859,recorded,0,0
185860,.,0,1
185861,RESULTS,0,0
185862,VAS,0,0
185863,scores,0,0
185864,of,0,1
185865,group,0,1
185866,L,0,0
185867,",",0,0
185868,group,0,1
185869,P,0,0
185870,and,0,1
185871,group,0,1
185872,PL,0,1
185873,were,0,1
185874,lower,0,0
185875,than,0,0
185876,group,0,1
185877,C,0,1
185878,(,0,1
185879,P,0,0
185880,<,0,0
185881,0.05,0,0
185882,),0,1
185883,.,0,1
185884,Morphine,0,0
185885,consumption,0,0
185886,of,0,0
185887,group,0,1
185888,P,0,0
185889,and,0,1
185890,group,0,1
185891,PL,0,1
185892,was,0,0
185893,lower,0,0
185894,than,0,0
185895,group,0,1
185896,C,0,1
185897,(,0,1
185898,P,0,0
185899,<,0,0
185900,0.05,0,0
185901,),0,1
185902,.,0,1
185903,Incidence,0,0
185904,of,0,0
185905,nausea,0,0
185906,in,0,0
185907,group,0,1
185908,C,0,0
185909,was,0,0
185910,higher,0,0
185911,than,0,0
185912,group,0,1
185913,L,0,0
185914,and,0,1
185915,group,0,1
185916,PL,0,1
185917,.,0,1
185918,Time,0,0
185919,to,0,0
185920,first,0,0
185921,defecation,0,1
185922,and,0,0
185923,mobilization,0,0
185924,were,0,0
185925,shorter,0,0
185926,in,0,0
185927,group,0,1
185928,L,0,0
185929,and,0,1
185930,group,0,1
185931,PL,0,1
185932,compared,0,0
185933,with,0,1
185934,group,0,1
185935,C,0,1
185936,(,0,1
185937,P,0,0
185938,<,0,0
185939,0.05,0,0
185940,),0,1
185941,.,0,1
185942,CONCLUSION,0,0
185943,Preoperative,0,1
185944,oral,0,1
185945,pregabalin,0,0
185946,and,0,1
185947,perioperative,0,0
185948,intravenous,0,1
185949,lidocaine,0,0
185950,infusion,0,0
185951,decreased,0,0
185952,postoperative,0,1
185953,VAS,0,1
185954,scores,0,0
185955,.,0,1
185956,Preoperative,0,1
185957,oral,0,0
185958,pregabalin,0,0
185959,decreased,0,0
185960,morphine,0,0
185961,requirement,0,1
185962,and,0,1
185963,perioperative,0,0
185964,intravenous,0,1
185965,lidocaine,0,0
185966,infusion,0,0
185967,hastened,0,0
185968,gastrointestinal,0,1
185969,motility,0,0
185970,and,0,0
185971,mobilization,0,0
185972,",",0,0
185973,and,0,0
185974,decreased,0,0
185975,the,0,0
185976,incidence,0,0
185977,of,0,0
185978,nausea,0,0
185979,in,0,1
185980,patients,0,1
185981,undergoing,0,1
185982,laparotomy,0,1
185983,.,0,1
185984,Therefore,0,0
185985,",",0,0
185986,preoperative,0,0
185987,pregabalin,0,0
185988,with,0,1
185989,or,0,1
185990,without,0,1
185991,lidocaine,0,0
185992,provides,0,0
185993,superior,0,0
185994,pain,0,0
185995,relief,0,0
185996,in,0,1
185997,patients,0,1
185998,undergoing,0,1
185999,laparatomy,0,1
186000,.,0,1
186001,Intradermal,0,1
186002,insulin,0,0
186003,infusion,0,0
186004,achieves,0,0
186005,faster,0,0
186006,insulin,0,0
186007,action,0,0
186008,than,0,0
186009,subcutaneous,0,1
186010,infusion,0,0
186011,for,0,0
186012,3-day,0,1
186013,wear,0,1
186014,.,0,1
186015,Rapid,0,0
186016,uptake,0,0
186017,previously,0,1
186018,demonstrated,0,0
186019,by,0,0
186020,intradermal,0,0
186021,(,0,1
186022,ID,0,1
186023,),0,1
186024,drug,0,0
186025,administration,0,0
186026,indicates,0,0
186027,compound,0,0
186028,delivery,0,0
186029,within,0,0
186030,the,0,0
186031,dermis,0,1
186032,may,0,0
186033,have,0,0
186034,clinical,0,0
186035,and,0,1
186036,pharmacological,0,0
186037,advantages,0,0
186038,for,0,1
186039,certain,0,1
186040,drug,0,1
186041,therapies,0,0
186042,.,0,1
186043,This,0,0
186044,study,0,0
186045,is,0,0
186046,the,0,0
186047,first,0,0
186048,clinical,0,0
186049,trial,0,0
186050,to,0,0
186051,evaluate,0,0
186052,continuous,0,0
186053,microneedle-based,0,0
186054,drug,0,1
186055,infusion,0,0
186056,",",0,0
186057,device,0,0
186058,wearability,0,0
186059,",",0,0
186060,and,0,0
186061,intradermal,0,0
186062,microneedle,0,0
186063,insulin,0,1
186064,kinetics,0,0
186065,over,0,0
186066,a,0,1
186067,multi-day,0,1
186068,(,0,1
186069,72,0,1
186070,h,0,0
186071,),0,1
186072,wear,0,0
186073,period,0,0
186074,.,0,1
186075,This,0,0
186076,was,0,0
186077,a,0,0
186078,single,0,0
186079,center,0,1
186080,",",0,0
186081,open-label,0,0
186082,",",0,0
186083,two-period,0,0
186084,crossover,0,0
186085,study,0,1
186086,in,1,1
186087,T1DM,1,1
186088,patients,1,1
186089,on,1,1
186090,continuous,1,1
186091,subcutaneous,1,1
186092,insulin,1,1
186093,infusion,1,0
186094,(,1,1
186095,CSII,1,1
186096,),1,1
186097,.,1,1
186098,Patients,0,1
186099,received,0,1
186100,treatment,0,1
186101,during,0,1
186102,interventional,0,1
186103,visits,0,1
186104,:,0,1
186105,one,0,1
186106,SC,0,1
186107,and,0,1
186108,one,0,1
186109,ID,0,1
186110,basal/bolus,0,0
186111,infusion,0,0
186112,of,0,0
186113,insulin,0,1
186114,aspart,0,1
186115,(,0,1
186116,NovoRapid?,0,0
186117,U-100,0,0
186118,),0,1
186119,administered,0,0
186120,over,0,0
186121,3,0,1
186122,days,0,0
186123,in,0,1
186124,a,0,1
186125,randomized,0,1
186126,order,1,0
186127,.,1,1
186128,Twenty-eight,1,1
186129,patients,1,1
186130,were,1,1
186131,randomized,1,1
186132,and,1,0
186133,exposed,0,1
186134,to,0,0
186135,trial,0,0
186136,product,0,0
186137,",",0,0
186138,and,0,0
186139,23,1,1
186140,completed,1,1
186141,the,1,0
186142,study,1,0
186143,.,1,1
186144,Bolus,1,1
186145,insulin,0,1
186146,infusions,0,0
186147,were,0,1
186148,given,0,0
186149,prior,0,1
186150,to,0,0
186151,standardized,0,0
186152,breakfast,0,0
186153,and,0,0
186154,lunch,0,1
186155,test,0,0
186156,meals,0,1
186157,on,0,0
186158,each,0,1
186159,of,0,0
186160,the,0,0
186161,three,0,0
186162,treatment,0,1
186163,days,0,0
186164,.,0,1
186165,Blood,0,0
186166,samples,0,0
186167,were,0,1
186168,drawn,0,0
186169,at,0,0
186170,predefined,0,1
186171,time,0,0
186172,points,0,0
186173,for,0,1
186174,measurements,0,0
186175,of,0,1
186176,insulin,0,1
186177,aspart,0,1
186178,and,0,0
186179,blood,0,0
186180,glucose,0,0
186181,in,0,0
186182,serum,0,0
186183,.,0,1
186184,The,0,0
186185,primary,0,0
186186,endpoint,0,0
186187,insulin,0,1
186188,Tmax,0,0
186189,demonstrated,0,0
186190,that,0,0
186191,ID,0,1
186192,bolus,0,0
186193,infusion,0,0
186194,was,0,0
186195,associated,0,0
186196,with,0,1
186197,a,0,0
186198,significantly,0,0
186199,shorter,0,0
186200,Tmax,0,0
186201,with,0,1
186202,statistically,0,0
186203,significantly,0,0
186204,smaller,0,0
186205,intra-subject,0,0
186206,variability,0,0
186207,",",0,0
186208,compared,0,0
186209,to,0,0
186210,SC,0,1
186211,infusion,0,0
186212,",",0,0
186213,and,0,0
186214,this,0,0
186215,difference,0,0
186216,was,0,0
186217,maintained,0,0
186218,over,0,0
186219,three,0,1
186220,treatment,0,1
186221,days,0,1
186222,.,0,1
186223,Analyses,0,0
186224,of,0,0
186225,secondary,0,1
186226,PK,0,1
186227,endpoints,0,0
186228,corresponded,0,1
186229,with,0,1
186230,the,0,0
186231,primary,0,1
186232,endpoint,0,0
186233,findings,0,0
186234,.,0,1
186235,Postprandial,0,0
186236,glycemic,0,0
186237,response,0,0
186238,was,0,0
186239,significantly,0,0
186240,less,0,0
186241,pronounced,0,0
186242,after,0,0
186243,ID,0,1
186244,bolus,0,0
186245,:,0,1
186246,For,0,1
186247,most,0,1
186248,endpoints,0,0
186249,ID,0,1
186250,vs.,0,0
186251,SC,0,1
186252,",",0,1
186253,differences,0,0
186254,were,0,1
186255,statistically,0,0
186256,significant,0,0
186257,within,0,0
186258,the,0,0
186259,0-1.5,0,0
186260,or,0,1
186261,0-2,0,1
186262,h,0,0
186263,time,0,0
186264,period,0,1
186265,.,0,1
186266,Intradermal,0,0
186267,delivery,0,0
186268,of,0,0
186269,insulin,0,0
186270,is,0,0
186271,a,0,0
186272,viable,0,0
186273,delivery,0,0
186274,route,0,0
186275,alternative,0,0
186276,providing,0,0
186277,reduced,0,0
186278,time,0,0
186279,for,0,0
186280,insulin,0,0
186281,absorption,0,0
186282,with,0,1
186283,less,0,0
186284,intra-subject,0,0
186285,variability,0,0
186286,and,0,1
186287,lower,0,0
186288,glycemic,0,0
186289,response,0,0
186290,.,0,1
186291,Erlotinib,0,1
186292,is,0,0
186293,effective,0,0
186294,in,0,0
186295,pancreatic,1,1
186296,cancer,1,1
186297,with,1,1
186298,epidermal,1,1
186299,growth,1,0
186300,factor,1,0
186301,receptor,1,0
186302,mutations,1,1
186303,:,1,1
186304,a,0,1
186305,randomized,0,1
186306,",",0,0
186307,open-label,0,1
186308,",",0,0
186309,prospective,0,1
186310,trial,0,1
186311,.,0,1
186312,OBJECTIVE,0,0
186313,To,0,0
186314,analyze,0,0
186315,the,0,0
186316,efficacy,0,0
186317,of,0,0
186318,gemcitabine,0,0
186319,with,0,1
186320,or,0,1
186321,without,0,1
186322,erlotinib,0,0
186323,for,0,1
186324,pancreatic,0,1
186325,cancer,0,1
186326,",",0,0
186327,and,0,0
186328,to,0,0
186329,determine,0,0
186330,the,0,0
186331,predictive,0,0
186332,role,0,0
186333,of,0,0
186334,epidermal,0,1
186335,growth,0,0
186336,factor,0,0
186337,receptor,0,0
186338,(,0,1
186339,EGFR,0,0
186340,),0,1
186341,and,0,1
186342,KRAS,0,1
186343,mutations,0,1
186344,in,0,1
186345,these,0,1
186346,patients,0,1
186347,.,0,1
186348,METHODS,0,0
186349,This,0,0
186350,was,0,0
186351,a,0,0
186352,single-center,0,1
186353,",",0,0
186354,randomized,0,1
186355,",",0,0
186356,open-label,0,0
186357,",",0,0
186358,prospective,0,1
186359,trial,0,1
186360,.,0,1
186361,Eighty-eight,1,1
186362,chemotherapy-na?ve,1,1
186363,metastatic,1,1
186364,pancreatic,1,1
186365,cancer,1,1
186366,patients,1,1
186367,were,1,1
186368,randomized,1,1
186369,for,1,0
186370,treatment,1,0
186371,with,1,1
186372,gemcitabine,1,0
186373,or,1,1
186374,gemcitabine,1,0
186375,plus,1,0
186376,erlotinib,1,0
186377,.,1,1
186378,EGFR,0,0
186379,and,0,0
186380,KRAS,0,1
186381,mutations,0,1
186382,were,0,1
186383,analyzed,0,0
186384,",",0,0
186385,respectively,0,0
186386,.,0,0
186387,The,0,0
186388,primary,0,1
186389,endpoint,0,0
186390,was,0,0
186391,the,0,0
186392,disease,0,1
186393,control,0,1
186394,rate,0,0
186395,.,0,1
186396,RESULTS,0,0
186397,Disease,0,1
186398,control,0,1
186399,rate,0,0
186400,(,0,1
186401,64,0,1
186402,%,0,0
186403,vs.,0,0
186404,25,0,1
186405,%,0,0
186406,;,0,1
186407,P,0,0
186408,<,0,0
186409,0.001,0,0
186410,),0,1
186411,",",0,0
186412,progression-free,0,0
186413,survival,0,0
186414,(,0,1
186415,median,0,0
186416,3.8,0,1
186417,vs.,0,0
186418,2.4,0,1
186419,months,0,1
186420,;,0,1
186421,P,0,0
186422,<,0,0
186423,0.001,0,0
186424,),0,1
186425,",",0,0
186426,and,0,0
186427,overall,0,0
186428,survival,0,0
186429,(,0,1
186430,median,0,0
186431,7.2,0,1
186432,vs.,0,0
186433,4.4,0,1
186434,months,0,1
186435,;,0,1
186436,P,0,0
186437,<,0,0
186438,0.001,0,0
186439,),0,0
186440,were,0,0
186441,better,0,0
186442,in,0,0
186443,the,0,0
186444,gemcitabine,0,0
186445,plus,0,0
186446,erlotinib,0,0
186447,group,0,1
186448,than,0,0
186449,in,0,0
186450,the,0,0
186451,gemcitabine,0,0
186452,alone,0,0
186453,group,0,1
186454,.,0,0
186455,In,0,0
186456,the,0,0
186457,gemcitabine,0,0
186458,plus,0,0
186459,erlotinib,0,0
186460,group,0,1
186461,",",0,0
186462,disease,0,1
186463,control,0,1
186464,(,0,1
186465,85,0,1
186466,%,0,0
186467,vs.,0,0
186468,33,0,1
186469,%,0,0
186470,;,0,1
186471,P,0,0
186472,=,0,1
186473,0.001,0,0
186474,),0,1
186475,",",0,0
186476,progression-free,0,0
186477,survival,0,0
186478,(,0,1
186479,median,0,0
186480,5.9,0,1
186481,vs.,0,0
186482,2.4,0,1
186483,months,0,1
186484,;,0,1
186485,P,0,0
186486,=,0,1
186487,0.004,0,0
186488,),0,1
186489,",",0,0
186490,and,0,0
186491,overall,0,0
186492,survival,0,0
186493,(,0,1
186494,median,0,0
186495,8.7,0,0
186496,vs.,0,0
186497,6.0,0,1
186498,months,0,1
186499,;,0,1
186500,P,0,0
186501,=,0,1
186502,0.044,0,0
186503,),0,0
186504,were,0,0
186505,better,0,0
186506,in,1,0
186507,patients,1,1
186508,with,1,1
186509,EGFR,1,1
186510,mutations,1,1
186511,than,1,0
186512,in,1,0
186513,those,1,1
186514,without,1,1
186515,EGFR,1,1
186516,mutations,1,1
186517,.,1,1
186518,KRAS,0,0
186519,mutation,0,0
186520,was,0,0
186521,not,0,0
186522,associated,0,0
186523,with,0,1
186524,treatment,0,0
186525,response,0,0
186526,or,0,1
186527,survival,0,0
186528,.,0,1
186529,CONCLUSIONS,0,0
186530,Gemcitabine,0,0
186531,plus,0,0
186532,erlotinib,0,0
186533,is,0,0
186534,more,0,0
186535,effective,0,0
186536,than,0,0
186537,gemcitabine,0,0
186538,alone,0,0
186539,for,0,0
186540,treating,1,1
186541,metastatic,1,1
186542,pancreatic,1,1
186543,cancer,1,1
186544,patients,1,1
186545,",",1,0
186546,especially,1,0
186547,those,1,0
186548,with,1,1
186549,EGFR,1,1
186550,mutations,1,1
186551,.,1,1
186552,ClinicalTrials.gov,0,0
186553,number,0,0
186554,",",0,1
186555,NCT01608841,0,1
186556,.,0,1
186557,Improvement,0,0
186558,in,0,0
186559,Patient-Reported,1,0
186560,Visual,1,1
186561,Function,1,0
186562,After,1,1
186563,Ocriplasmin,1,0
186564,for,1,1
186565,Vitreomacular,1,1
186566,Adhesion,1,1
186567,:,1,1
186568,Results,0,0
186569,of,0,0
186570,the,0,0
186571,Microplasmin,0,0
186572,for,0,0
186573,Intravitreous,0,1
186574,Injection-Traction,0,1
186575,Release,0,1
186576,Without,0,1
186577,Surgical,0,1
186578,Treatment,0,0
186579,(,0,1
186580,MIVI-TRUST,0,1
186581,),0,1
186582,Trials,0,1
186583,.,0,1
186584,IMPORTANCE,0,1
186585,The,0,0
186586,impact,0,0
186587,of,0,0
186588,vitreomacular,0,1
186589,adhesion,0,0
186590,(,0,1
186591,VMA,0,1
186592,),0,1
186593,resolution,0,0
186594,on,0,0
186595,patient-reported,1,0
186596,visual,1,0
186597,function,1,0
186598,in,1,1
186599,symptomatic,1,1
186600,VMA/vitreomacular,1,1
186601,traction,1,1
186602,(,1,1
186603,VMT,1,0
186604,),1,0
186605,has,0,0
186606,not,0,0
186607,yet,0,0
186608,been,0,0
186609,documented,0,0
186610,",",0,0
186611,to,0,0
186612,our,0,0
186613,knowledge,0,0
186614,.,0,1
186615,OBJECTIVE,0,0
186616,To,0,0
186617,determine,0,0
186618,the,0,0
186619,impact,0,0
186620,of,0,0
186621,intravitreal,0,0
186622,ocriplasmin,0,0
186623,on,0,1
186624,patient-reported,0,1
186625,visual,0,0
186626,function,0,0
186627,using,0,0
186628,the,0,0
186629,25-item,0,0
186630,National,0,1
186631,Eye,0,1
186632,Institute,0,1
186633,Visual,0,1
186634,Function,0,1
186635,Questionnaire,0,0
186636,(,0,1
186637,NEI,0,1
186638,VFQ-25,0,0
186639,),0,1
186640,during,0,0
186641,a,0,1
186642,6-month,0,0
186643,follow-up,0,0
186644,in,0,1
186645,patients,1,1
186646,with,1,1
186647,symptomatic,1,1
186648,VMA,1,1
186649,.,1,1
186650,DESIGN,0,0
186651,",",0,0
186652,SETTING,0,1
186653,",",0,0
186654,AND,0,0
186655,PARTICIPANTS,0,1
186656,Two,0,1
186657,multicenter,0,1
186658,",",0,0
186659,randomized,0,0
186660,",",0,0
186661,masked,0,0
186662,",",0,0
186663,phase,0,1
186664,3,0,1
186665,clinical,0,0
186666,trials,0,1
186667,(,0,1
186668,studies,0,0
186669,TG-MV-006,0,0
186670,[,0,1
186671,between,0,0
186672,December,0,1
186673,2008,0,1
186674,and,0,1
186675,April,0,1
186676,2010,0,1
186677,],0,1
186678,and,0,1
186679,TG-MV-007,0,1
186680,[,0,0
186681,between,0,0
186682,December,0,1
186683,2008,0,1
186684,and,0,1
186685,July,0,1
186686,2010,0,1
186687,],0,1
186688,),0,1
186689,at,0,1
186690,clinic-based,0,1
186691,centers,0,1
186692,in,0,1
186693,the,0,1
186694,United,0,1
186695,States,0,1
186696,and,0,1
186697,Europe,0,1
186698,.,0,1
186699,A,1,0
186700,total,1,1
186701,of,1,1
186702,652,1,1
186703,patients,1,1
186704,with,1,1
186705,symptomatic,1,1
186706,VMA/VMT,1,0
186707,",",1,0
186708,including,1,0
186709,when,1,0
186710,associated,1,0
186711,with,1,0
186712,a,1,1
186713,macular,1,1
186714,hole,1,1
186715,400,1,0
186716,?m,1,1
186717,or,1,1
186718,smaller,1,0
186719,",",1,0
186720,were,0,0
186721,studied,0,1
186722,.,0,1
186723,Analysis,0,0
186724,was,0,0
186725,by,0,0
186726,intent-to-treat,0,0
186727,population,0,1
186728,and,0,0
186729,performed,0,0
186730,in,0,1
186731,May,0,0
186732,2013,0,1
186733,.,0,1
186734,INTERVENTIONS,1,0
186735,Patients,1,1
186736,with,1,1
186737,symptomatic,1,1
186738,VMA/VMT,1,0
186739,were,0,1
186740,randomly,0,1
186741,assigned,0,1
186742,(,0,1
186743,2:1,0,1
186744,or,0,1
186745,3:1,0,1
186746,in,0,0
186747,study,0,1
186748,TG-MV-006,0,0
186749,and,0,0
186750,study,0,1
186751,TG-MV-007,0,0
186752,",",0,0
186753,respectively,0,0
186754,),0,0
186755,to,0,0
186756,receive,0,1
186757,a,0,0
186758,single,0,0
186759,intravitreal,0,0
186760,injection,0,0
186761,of,0,0
186762,ocriplasmin,0,0
186763,",",0,1
186764,125,0,1
186765,?g,0,0
186766,",",0,0
186767,or,0,1
186768,placebo-injected,0,0
186769,vehicle,0,0
186770,(,0,1
186771,placebo,0,1
186772,),0,1
186773,.,0,1
186774,The,0,0
186775,NEI,0,0
186776,VFQ-25,0,0
186777,was,0,0
186778,administered,0,0
186779,at,0,0
186780,baseline,0,0
186781,and,0,1
186782,6,0,1
186783,months,0,0
186784,following,0,1
186785,ocriplasmin,0,0
186786,injection,0,0
186787,.,0,1
186788,MAIN,0,0
186789,OUTCOMES,0,0
186790,AND,0,0
186791,MEASURES,0,1
186792,Mean,0,1
186793,changes,0,0
186794,between,0,0
186795,baseline,0,1
186796,and,0,1
186797,6-month,0,1
186798,follow-up,0,1
186799,NEI,0,1
186800,VFQ-25,0,0
186801,composite,0,0
186802,and,0,1
186803,subscale,0,0
186804,scores,0,0
186805,and,0,1
186806,the,0,0
186807,proportion,0,0
186808,of,0,0
186809,patients,0,1
186810,with,0,1
186811,a,0,1
186812,clinically,0,1
186813,meaningful,0,0
186814,change,0,0
186815,(,0,1
186816,?5,0,0
186817,points,0,0
186818,),0,1
186819,in,0,1
186820,scores,0,0
186821,.,0,1
186822,RESULTS,0,0
186823,Across,0,1
186824,the,0,1
186825,2,0,1
186826,studies,1,0
186827,",",1,1
186828,464,1,1
186829,patients,1,1
186830,received,1,1
186831,ocriplasmin,1,0
186832,and,1,1
186833,188,1,1
186834,received,1,1
186835,placebo,1,0
186836,.,1,1
186837,At,1,0
186838,6,0,0
186839,months,0,0
186840,",",0,1
186841,the,0,0
186842,ocriplasmin,0,0
186843,group,0,0
186844,reported,0,0
186845,greater,0,0
186846,mean,0,1
186847,improvements,0,0
186848,from,0,1
186849,baseline,0,0
186850,in,0,0
186851,the,0,0
186852,NEI,0,0
186853,VFQ-25,0,0
186854,composite,0,0
186855,score,0,0
186856,than,0,0
186857,the,0,0
186858,placebo,0,0
186859,group,0,0
186860,(,0,1
186861,mean,0,1
186862,change,0,0
186863,",",0,1
186864,3.4,0,0
186865,vs,0,0
186866,0.7,0,0
186867,",",0,0
186868,respectively,0,0
186869,;,0,0
186870,P,0,0
186871,=,0,1
186872,.005,0,0
186873,),0,1
186874,.,0,1
186875,Improvements,0,0
186876,were,0,0
186877,also,0,0
186878,noted,0,0
186879,in,0,0
186880,subscale,0,0
186881,scores,0,0
186882,",",0,1
186883,with,0,1
186884,the,0,0
186885,following,0,0
186886,respective,0,1
186887,mean,0,1
186888,changes,0,0
186889,for,0,1
186890,the,0,0
186891,ocriplasmin,0,0
186892,vs,0,0
186893,placebo,0,1
186894,groups,0,1
186895,:,0,1
186896,vision-related,0,0
186897,dependency,0,0
186898,",",0,1
186899,1.7,0,0
186900,vs,0,0
186901,-2.1,0,0
186902,(,0,1
186903,P,0,0
186904,=,0,1
186905,.009,0,0
186906,),0,1
186907,;,0,1
186908,driving,0,1
186909,difficulty,0,0
186910,",",0,1
186911,2.7,0,0
186912,vs,0,0
186913,-1.5,0,0
186914,(,0,1
186915,P,0,0
186916,=,0,1
186917,.03,0,0
186918,),0,1
186919,;,0,1
186920,distance,0,0
186921,vision,0,0
186922,activities,0,0
186923,",",0,1
186924,4.1,0,1
186925,vs,0,0
186926,0.8,0,1
186927,(,0,1
186928,P,0,0
186929,=,0,1
186930,.03,0,0
186931,),0,1
186932,;,0,1
186933,and,0,1
186934,general,0,1
186935,vision,0,0
186936,",",0,1
186937,6.1,0,0
186938,vs,0,0
186939,2.1,0,0
186940,(,0,1
186941,P,0,0
186942,=,0,1
186943,.003,0,0
186944,),0,1
186945,.,0,1
186946,A,0,0
186947,higher,0,0
186948,proportion,0,0
186949,of,0,0
186950,the,0,0
186951,ocriplasmin,0,0
186952,group,0,0
186953,had,0,1
186954,a,0,0
186955,clinically,0,1
186956,meaningful,0,0
186957,(,0,1
186958,?5-point,0,0
186959,),0,1
186960,improvement,0,0
186961,in,0,1
186962,NEI,0,1
186963,VFQ-25,0,0
186964,composite,0,0
186965,score,0,0
186966,from,0,1
186967,baseline,0,0
186968,than,0,0
186969,the,0,0
186970,placebo,0,0
186971,group,0,1
186972,(,0,1
186973,36.0,0,0
186974,%,0,0
186975,vs,0,0
186976,27.2,0,1
186977,%,0,0
186978,",",0,0
186979,respectively,0,0
186980,;,0,0
186981,P,0,0
186982,=,0,1
186983,.03,0,0
186984,),0,1
186985,.,0,1
186986,Fewer,0,0
186987,ocriplasmin-treated,0,0
186988,patients,0,1
186989,had,0,1
186990,a,0,1
186991,clinically,0,1
186992,meaningful,0,0
186993,worsening,0,0
186994,in,0,0
186995,their,0,1
186996,visual,0,0
186997,function,0,0
186998,than,0,0
186999,the,0,0
187000,placebo,0,0
187001,group,0,1
187002,(,0,1
187003,15.0,0,0
187004,%,0,0
187005,vs,0,0
187006,24.3,0,0
187007,%,0,0
187008,",",0,0
187009,respectively,0,0
187010,;,0,0
187011,P,0,0
187012,=,0,1
187013,.005,0,0
187014,),0,1
187015,.,0,1
187016,Changes,0,0
187017,in,0,0
187018,NEI,0,1
187019,VFQ-25,0,0
187020,composite,0,0
187021,score,0,0
187022,and,0,1
187023,various,0,0
187024,subscale,0,0
187025,scores,0,0
187026,were,0,1
187027,observed,0,0
187028,in,0,1
187029,ocriplasmin-treated,0,1
187030,patients,0,1
187031,who,0,1
187032,achieved,0,1
187033,VMA,0,1
187034,resolution,0,0
187035,at,0,1
187036,day,0,0
187037,28,0,1
187038,.,0,1
187039,CONCLUSIONS,0,0
187040,AND,0,0
187041,RELEVANCE,0,1
187042,Ocriplasmin,0,0
187043,produces,0,0
187044,clinically,0,0
187045,meaningful,0,0
187046,improvement,0,0
187047,in,0,1
187048,patient-reported,0,0
187049,visual,0,0
187050,function,0,0
187051,in,1,1
187052,symptomatic,1,1
187053,VMA/VMT,1,1
187054,.,1,1
187055,TRIAL,0,0
187056,REGISTRATION,0,0
187057,clinicaltrials.gov,0,1
187058,Identifiers,0,1
187059,:,0,1
187060,NCT00781859,0,0
187061,and,0,1
187062,NCT00798317,0,1
187063,.,0,1
187064,A,0,0
187065,Randomized,0,0
187066,Controlled,0,0
187067,Trial,0,1
187068,to,0,0
187069,Improve,0,0
187070,Social,0,0
187071,Skills,0,0
187072,in,0,1
187073,Young,1,1
187074,Adults,1,1
187075,with,1,1
187076,Autism,1,1
187077,Spectrum,1,1
187078,Disorder,1,1
187079,:,1,1
187080,The,0,0
187081,UCLA,0,0
187082,PEERS,0,0
187083,(,0,1
187084,?,0,1
187085,),0,0
187086,Program,0,0
187087,.,0,1
187088,Research,0,0
187089,suggests,0,0
187090,that,0,0
187091,impaired,0,1
187092,social,0,1
187093,skills,0,0
187094,are,0,0
187095,often,0,0
187096,the,0,0
187097,most,0,0
187098,significant,0,0
187099,challenge,0,0
187100,for,0,0
187101,those,0,1
187102,with,0,1
187103,autism,0,1
187104,spectrum,0,1
187105,disorder,0,1
187106,(,0,1
187107,ASD,0,1
187108,),0,0
187109,",",0,0
187110,yet,0,0
187111,few,0,0
187112,evidence-based,0,0
187113,social,0,1
187114,skills,0,0
187115,interventions,0,0
187116,exist,0,0
187117,for,1,0
187118,adults,1,1
187119,on,1,0
187120,the,1,1
187121,spectrum,1,1
187122,.,1,0
187123,This,0,0
187124,replication,0,0
187125,trial,0,0
187126,tested,0,0
187127,the,0,0
187128,effectiveness,0,0
187129,of,0,0
187130,PEERS,0,0
187131,",",0,0
187132,a,0,0
187133,caregiver-assisted,0,0
187134,social,0,1
187135,skills,0,0
187136,program,0,1
187137,for,1,1
187138,high-functioning,1,1
187139,young,1,1
187140,adults,1,1
187141,with,1,1
187142,ASD,1,1
187143,.,1,1
187144,Using,0,0
187145,a,0,0
187146,randomized,1,1
187147,controlled,1,0
187148,design,1,1
187149,",",1,1
187150,22,1,1
187151,young,1,1
187152,adults,1,1
187153,18-24,1,1
187154,years,1,1
187155,of,1,1
187156,age,1,1
187157,were,1,1
187158,randomly,1,1
187159,assigned,1,1
187160,to,0,0
187161,a,0,0
187162,treatment,0,0
187163,(,0,0
187164,n,0,1
187165,=,0,1
187166,12,0,1
187167,),0,1
187168,or,0,1
187169,delayed,0,1
187170,treatment,0,0
187171,control,0,1
187172,(,0,1
187173,n,0,1
187174,=,0,1
187175,10,0,1
187176,),0,1
187177,group,0,1
187178,.,0,1
187179,Results,0,0
187180,revealed,0,0
187181,that,0,0
187182,the,0,0
187183,treatment,0,0
187184,group,0,0
187185,improved,0,0
187186,significantly,0,0
187187,in,0,0
187188,overall,0,0
187189,social,0,1
187190,skills,0,0
187191,",",0,1
187192,frequency,0,0
187193,of,0,0
187194,social,0,0
187195,engagement,0,0
187196,",",0,0
187197,and,0,0
187198,social,0,1
187199,skills,0,0
187200,knowledge,0,0
187201,",",0,0
187202,and,0,0
187203,significantly,0,0
187204,reduced,0,0
187205,ASD,0,1
187206,symptoms,0,1
187207,related,0,0
187208,to,0,1
187209,social,0,0
187210,responsiveness,0,0
187211,following,0,0
187212,PEERS,0,1
187213,.,0,1
187214,Most,0,0
187215,treatment,0,0
187216,gains,0,0
187217,were,0,1
187218,maintained,0,0
187219,at,0,0
187220,a,0,1
187221,16-week,0,1
187222,follow-up,0,0
187223,assessment,0,0
187224,with,0,1
187225,new,0,1
187226,improvements,0,0
187227,observed,0,0
187228,.,0,1
187229,Risk,0,1
187230,of,0,0
187231,anterior,1,1
187232,cruciate,1,1
187233,ligament,1,1
187234,fatigue,1,0
187235,failure,1,1
187236,is,1,0
187237,increased,0,0
187238,by,0,0
187239,limited,0,0
187240,internal,0,1
187241,femoral,0,1
187242,rotation,0,0
187243,during,0,0
187244,in,0,0
187245,vitro,0,0
187246,repeated,0,0
187247,pivot,0,1
187248,landings,0,1
187249,.,0,1
187250,BACKGROUND,0,0
187251,A,0,0
187252,reduced,0,0
187253,range,0,1
187254,of,0,0
187255,hip,0,1
187256,internal,0,0
187257,rotation,0,0
187258,is,0,0
187259,associated,0,0
187260,with,0,1
187261,increased,0,0
187262,peak,0,0
187263,anterior,0,1
187264,cruciate,0,1
187265,ligament,0,1
187266,(,0,1
187267,ACL,0,1
187268,),0,1
187269,strain,0,0
187270,and,0,0
187271,risk,0,0
187272,for,0,0
187273,injury,0,1
187274,.,0,1
187275,It,0,0
187276,is,0,0
187277,unknown,0,0
187278,",",0,0
187279,however,0,0
187280,",",0,0
187281,whether,0,0
187282,limiting,0,0
187283,the,0,0
187284,available,0,0
187285,range,0,1
187286,of,0,0
187287,internal,0,1
187288,femoral,0,1
187289,rotation,0,0
187290,increases,0,0
187291,the,0,0
187292,susceptibility,0,0
187293,of,0,0
187294,the,0,0
187295,ACL,0,1
187296,to,0,0
187297,fatigue,0,0
187298,failure,0,1
187299,.,0,1
187300,HYPOTHESIS,0,0
187301,Risk,0,1
187302,of,0,0
187303,ACL,0,1
187304,failure,0,1
187305,is,0,0
187306,significantly,0,0
187307,greater,0,0
187308,in,0,0
187309,female,1,1
187310,knee,1,1
187311,specimens,1,1
187312,with,0,1
187313,a,0,1
187314,limited,0,0
187315,range,0,1
187316,of,0,0
187317,internal,0,1
187318,femoral,0,1
187319,rotation,0,0
187320,",",0,0
187321,smaller,0,0
187322,femoral-ACL,0,1
187323,attachment,0,0
187324,angle,0,0
187325,",",0,0
187326,and,0,0
187327,smaller,0,0
187328,tibial,0,1
187329,eminence,0,0
187330,volume,0,0
187331,during,0,0
187332,repeated,0,0
187333,in,0,0
187334,vitro,0,0
187335,simulated,0,0
187336,single-leg,0,1
187337,pivot,0,1
187338,landings,0,1
187339,.,0,1
187340,STUDY,0,0
187341,DESIGN,0,1
187342,Controlled,0,1
187343,laboratory,0,1
187344,study,0,1
187345,.,0,0
187346,METHODS,0,0
187347,A,0,0
187348,custom-built,0,0
187349,testing,0,0
187350,apparatus,0,1
187351,was,0,0
187352,used,0,0
187353,to,0,0
187354,simulate,0,0
187355,repeated,0,0
187356,single-leg,0,0
187357,pivot,0,1
187358,landings,0,1
187359,with,0,1
187360,a,0,1
187361,4?-body,0,0
187362,weight,0,1
187363,impulsive,0,0
187364,load,0,0
187365,that,0,0
187366,induces,0,0
187367,knee,0,1
187368,compression,0,0
187369,",",0,0
187370,knee,0,1
187371,flexion,0,1
187372,",",0,0
187373,and,1,0
187374,internal,1,0
187375,tibial,1,1
187376,torque,1,0
187377,in,1,1
187378,32,1,1
187379,paired,1,1
187380,human,1,1
187381,knee,1,1
187382,specimens,1,1
187383,from,1,1
187384,8,1,1
187385,male,1,1
187386,and,1,1
187387,8,1,1
187388,female,1,1
187389,donors,1,1
187390,.,1,1
187391,These,0,1
187392,test,0,0
187393,loads,0,0
187394,were,0,1
187395,applied,0,0
187396,to,0,0
187397,each,0,0
187398,pair,0,1
187399,of,0,0
187400,specimens,0,1
187401,",",0,1
187402,in,0,1
187403,one,0,1
187404,knee,0,1
187405,with,0,1
187406,limited,0,0
187407,internal,0,1
187408,femoral,0,1
187409,rotation,0,0
187410,and,0,0
187411,in,0,0
187412,the,0,0
187413,contralateral,0,1
187414,knee,0,1
187415,with,0,1
187416,femoral,0,1
187417,rotation,0,0
187418,resisted,0,1
187419,by,0,0
187420,2,0,1
187421,springs,0,1
187422,to,0,1
187423,simulate,0,1
187424,the,0,0
187425,active,0,0
187426,hip,0,1
187427,rotator,0,1
187428,muscles,0,1
187429,',0,1
187430,resistance,0,0
187431,to,0,1
187432,stretch,0,0
187433,.,0,1
187434,The,0,0
187435,landings,0,0
187436,were,0,1
187437,repeated,0,0
187438,until,0,1
187439,ACL,0,1
187440,failure,0,1
187441,occurred,0,0
187442,or,0,1
187443,until,0,0
187444,a,0,0
187445,minimum,0,0
187446,of,0,0
187447,100,0,1
187448,trials,0,1
187449,were,0,1
187450,executed,0,1
187451,.,0,1
187452,The,0,0
187453,angle,0,0
187454,at,0,0
187455,which,0,0
187456,the,0,0
187457,ACL,0,0
187458,originates,0,0
187459,from,0,0
187460,the,0,0
187461,femur,0,1
187462,and,0,0
187463,the,0,0
187464,tibial,0,1
187465,eminence,0,0
187466,volume,0,0
187467,were,0,0
187468,measured,0,0
187469,on,0,0
187470,magnetic,0,1
187471,resonance,0,1
187472,images,0,1
187473,.,0,1
187474,RESULTS,0,0
187475,The,0,0
187476,final,0,0
187477,Cox,0,0
187478,regression,0,0
187479,model,0,0
187480,(,0,1
187481,P,0,0
187482,=,0,1
187483,.024,0,0
187484,),0,1
187485,revealed,0,0
187486,that,0,0
187487,range,0,1
187488,of,0,1
187489,internal,0,1
187490,femoral,0,1
187491,rotation,0,0
187492,and,0,0
187493,sex,0,0
187494,of,0,0
187495,donor,0,1
187496,were,0,1
187497,significant,0,0
187498,factors,0,0
187499,in,0,1
187500,determining,0,0
187501,risk,0,1
187502,of,0,1
187503,ACL,0,1
187504,fatigue,0,0
187505,failure,0,1
187506,.,0,1
187507,The,0,0
187508,specimens,0,1
187509,with,0,1
187510,limited,0,0
187511,range,0,1
187512,of,0,0
187513,internal,0,1
187514,femoral,0,1
187515,rotation,0,0
187516,had,0,1
187517,a,0,0
187518,failure,0,1
187519,risk,0,1
187520,17.1,0,0
187521,times,0,0
187522,higher,0,0
187523,than,0,0
187524,did,0,0
187525,the,0,0
187526,specimens,0,1
187527,with,0,1
187528,free,0,1
187529,rotation,0,0
187530,(,0,1
187531,P,0,0
187532,=,0,1
187533,.016,0,0
187534,),0,1
187535,.,0,1
187536,The,0,0
187537,female,0,1
187538,knee,0,1
187539,specimens,0,1
187540,had,0,1
187541,a,0,1
187542,risk,0,0
187543,of,0,0
187544,ACL,0,1
187545,failure,0,1
187546,26.9,0,1
187547,times,0,0
187548,higher,0,0
187549,than,0,0
187550,the,0,0
187551,male,0,1
187552,specimens,0,1
187553,(,0,1
187554,P,0,0
187555,=,0,1
187556,.055,0,0
187557,),0,1
187558,.,0,1
187559,CONCLUSION,0,0
187560,Limiting,0,1
187561,the,0,0
187562,range,0,1
187563,of,0,0
187564,internal,0,1
187565,femoral,0,1
187566,rotation,0,0
187567,during,0,1
187568,repetitive,0,0
187569,pivot,0,1
187570,landings,0,0
187571,increases,0,0
187572,the,0,0
187573,risk,0,0
187574,of,0,0
187575,an,0,1
187576,ACL,0,1
187577,fatigue,0,0
187578,failure,0,1
187579,in,0,0
187580,comparison,0,0
187581,with,0,1
187582,free,0,1
187583,rotation,0,0
187584,in,0,0
187585,a,0,1
187586,cadaveric,0,1
187587,model,0,0
187588,.,0,1
187589,CLINICAL,0,1
187590,RELEVANCE,0,1
187591,Screening,0,1
187592,for,0,0
187593,restricted,0,1
187594,internal,0,1
187595,rotation,0,0
187596,at,0,0
187597,the,0,0
187598,hip,0,1
187599,in,0,0
187600,ACL,0,1
187601,injury,0,1
187602,prevention,0,1
187603,programs,0,1
187604,as,0,0
187605,well,0,0
187606,as,0,0
187607,in,0,0
187608,individuals,0,1
187609,with,0,1
187610,ACL,0,1
187611,injuries,0,1
187612,and/or,0,1
187613,reconstructions,0,0
187614,is,0,0
187615,warranted,0,0
187616,.,0,0
187617,Replacing,0,0
187618,Non-Active,0,1
187619,Video,0,0
187620,Gaming,0,0
187621,by,0,0
187622,Active,0,1
187623,Video,0,0
187624,Gaming,0,0
187625,to,0,1
187626,Prevent,0,0
187627,Excessive,1,0
187628,Weight,1,1
187629,Gain,1,1
187630,in,1,1
187631,Adolescents,1,1
187632,.,1,1
187633,OBJECTIVE,0,0
187634,The,0,0
187635,aim,0,0
187636,of,0,0
187637,the,0,0
187638,current,0,0
187639,study,0,1
187640,was,0,0
187641,to,0,0
187642,evaluate,0,0
187643,the,0,0
187644,effects,0,0
187645,of,0,0
187646,and,0,1
187647,adherence,0,0
187648,to,0,0
187649,an,0,0
187650,active,0,0
187651,video,0,0
187652,game,0,0
187653,promotion,0,0
187654,intervention,0,0
187655,on,0,0
187656,anthropometrics,0,1
187657,",",0,1
187658,sedentary,0,1
187659,screen,0,1
187660,time,0,0
187661,and,0,0
187662,consumption,0,0
187663,of,0,1
187664,sugar-sweetened,0,1
187665,beverages,0,1
187666,and,0,1
187667,snacks,0,0
187668,among,0,1
187669,non-active,1,1
187670,video,1,0
187671,gaming,1,1
187672,adolescents,1,1
187673,who,1,1
187674,primarily,1,1
187675,were,1,1
187676,of,1,0
187677,healthy,1,1
187678,weight,1,1
187679,.,1,1
187680,METHODS,0,0
187681,We,0,0
187682,assigned,0,1
187683,270,1,1
187684,gaming,1,1
187685,(,1,1
187686,i.e,1,1
187687,.,1,1
187688,?,1,0
187689,2,1,0
187690,hours/week,1,1
187691,non-active,1,1
187692,video,1,0
187693,game,1,0
187694,time,1,0
187695,),1,1
187696,adolescents,1,1
187697,randomly,1,1
187698,to,1,0
187699,an,1,0
187700,intervention,1,0
187701,group,1,0
187702,(,1,1
187703,n,1,1
187704,=,1,1
187705,140,1,1
187706,),1,1
187707,(,1,1
187708,receiving,1,1
187709,active,1,1
187710,video,1,0
187711,games,1,0
187712,and,1,1
187713,encouragement,1,0
187714,to,1,0
187715,play,1,0
187716,),1,0
187717,or,1,1
187718,a,1,1
187719,waiting-list,1,0
187720,control,1,1
187721,group,1,1
187722,(,1,1
187723,n,1,1
187724,=,1,1
187725,130,1,1
187726,),1,1
187727,.,1,1
187728,BMI-SDS,0,0
187729,(,0,0
187730,SDS,0,1
187731,=,0,0
187732,adjusted,0,0
187733,for,0,0
187734,mean,0,1
187735,standard,0,1
187736,deviation,0,1
187737,score,0,0
187738,),0,0
187739,",",0,0
187740,waist,0,1
187741,circumference-SDS,0,0
187742,",",0,0
187743,hip,0,1
187744,circumference,0,0
187745,and,0,0
187746,sum,0,0
187747,of,0,1
187748,skinfolds,0,1
187749,were,0,1
187750,measured,0,0
187751,at,0,0
187752,baseline,0,0
187753,",",0,1
187754,at,0,0
187755,four,0,1
187756,and,0,1
187757,ten,0,1
187758,months,0,0
187759,follow-up,0,1
187760,(,0,1
187761,primary,0,1
187762,outcomes,0,0
187763,),0,1
187764,.,0,1
187765,Sedentary,0,1
187766,screen,0,1
187767,time,0,0
187768,",",0,0
187769,physical,0,0
187770,activity,0,0
187771,",",0,0
187772,consumption,0,0
187773,of,0,0
187774,sugar-sweetened,0,1
187775,beverages,0,1
187776,and,0,1
187777,snacks,0,0
187778,",",0,1
187779,and,0,1
187780,process,0,0
187781,measures,0,0
187782,(,0,1
187783,not,0,0
187784,at,0,0
187785,baseline,0,0
187786,),0,1
187787,were,0,0
187788,assessed,0,0
187789,with,0,1
187790,self-reports,0,0
187791,at,0,1
187792,baseline,0,0
187793,",",0,1
187794,one,0,1
187795,",",0,1
187796,four,0,1
187797,and,0,1
187798,ten,0,1
187799,months,0,0
187800,follow-up,0,1
187801,.,0,1
187802,Multi-level-intention,0,0
187803,to,0,0
187804,treat-regression,0,1
187805,analyses,0,0
187806,were,0,1
187807,conducted,0,1
187808,.,0,0
187809,RESULTS,0,0
187810,The,1,0
187811,control,1,0
187812,group,1,0
187813,decreased,1,0
187814,significantly,0,0
187815,more,0,0
187816,than,0,0
187817,the,0,0
187818,intervention,0,0
187819,group,0,0
187820,on,0,0
187821,BMI-SDS,0,1
187822,(,0,1
187823,?,0,1
187824,=,0,0
187825,0.074,0,0
187826,",",0,0
187827,95,0,0
187828,%,0,0
187829,CI,0,0
187830,:,0,1
187831,0.008,0,0
187832,;,0,1
187833,0.14,0,0
187834,),0,1
187835,",",0,0
187836,and,0,0
187837,sum,0,0
187838,of,0,1
187839,skinfolds,0,1
187840,(,0,1
187841,?,0,1
187842,=,0,0
187843,3.22,0,0
187844,",",0,0
187845,95,0,0
187846,%,0,0
187847,CI,0,0
187848,:,0,1
187849,0.27,0,0
187850,;,0,1
187851,6.17,0,0
187852,),0,1
187853,(,0,1
187854,overall,0,0
187855,effects,0,0
187856,),0,1
187857,.,0,1
187858,The,0,0
187859,intervention,1,0
187860,group,1,0
187861,had,1,1
187862,a,0,0
187863,significantly,0,0
187864,higher,0,0
187865,decrease,0,0
187866,in,0,0
187867,self-reported,0,1
187868,non-active,0,1
187869,video,0,0
187870,game,0,0
187871,time,0,0
187872,(,0,1
187873,?,0,1
187874,=,0,0
187875,-1.76,0,0
187876,",",0,0
187877,95,0,0
187878,%,0,0
187879,CI,0,0
187880,:,0,1
187881,-3.20,0,0
187882,;,0,1
187883,-0.32,0,0
187884,),0,1
187885,and,0,1
187886,total,0,1
187887,sedentary,0,1
187888,screen,0,1
187889,time,0,0
187890,(,0,1
187891,Exp,0,0
187892,(,0,1
187893,?,0,1
187894,=,0,0
187895,0.81,0,0
187896,",",0,0
187897,95,0,0
187898,%,0,0
187899,CI,0,0
187900,:,0,1
187901,0.74,0,0
187902,;,0,1
187903,0.88,0,0
187904,),0,1
187905,than,0,0
187906,the,0,0
187907,control,0,1
187908,group,0,0
187909,(,0,1
187910,overall,0,0
187911,effects,0,0
187912,),0,1
187913,.,0,1
187914,The,0,0
187915,process,0,0
187916,evaluation,0,0
187917,showed,0,0
187918,that,1,0
187919,14,1,1
187920,%,1,0
187921,of,1,0
187922,the,1,0
187923,adolescents,1,1
187924,played,1,0
187925,the,0,0
187926,Move,0,1
187927,video,0,0
187928,games,0,0
187929,every,0,0
187930,week,0,0
187931,?,0,1
187932,1,0,0
187933,hour/week,0,0
187934,during,0,0
187935,the,0,0
187936,whole,0,0
187937,intervention,0,0
187938,period,0,0
187939,.,0,0
187940,CONCLUSIONS,0,0
187941,The,0,0
187942,active,0,0
187943,video,0,0
187944,game,0,0
187945,intervention,0,0
187946,did,0,0
187947,not,0,0
187948,result,0,0
187949,in,0,0
187950,lower,0,0
187951,values,0,0
187952,on,0,0
187953,anthropometrics,1,1
187954,in,1,1
187955,a,1,1
187956,group,1,1
187957,of,1,0
187958,'excessive,1,1
187959,',1,1
187960,non-active,1,1
187961,video,1,1
187962,gamers,1,1
187963,(,1,1
187964,mean,1,1
187965,~,1,1
187966,14,1,1
187967,hours/week,1,1
187968,),1,1
187969,who,1,1
187970,primarily,1,1
187971,were,1,1
187972,of,1,0
187973,healthy,1,1
187974,weight,1,1
187975,compared,0,0
187976,to,0,0
187977,a,0,0
187978,control,0,0
187979,group,0,0
187980,throughout,0,0
187981,a,0,1
187982,ten-month-period,0,1
187983,.,0,0
187984,Even,0,0
187985,some,0,0
187986,effects,0,0
187987,in,0,0
187988,the,0,1
187989,unexpected,0,0
187990,direction,0,0
187991,were,0,1
187992,found,0,0
187993,",",0,0
187994,with,0,1
187995,the,0,0
187996,control,0,1
187997,group,0,0
187998,showing,0,0
187999,lower,0,0
188000,BMI-SDS,0,1
188001,and,0,0
188002,skin,0,1
188003,folds,0,1
188004,than,0,0
188005,the,0,0
188006,intervention,0,0
188007,group,0,0
188008,.,0,1
188009,The,0,0
188010,intervention,0,0
188011,did,0,0
188012,result,0,0
188013,in,0,0
188014,less,0,0
188015,self-reported,0,1
188016,sedentary,0,1
188017,screen,0,1
188018,time,0,0
188019,",",0,0
188020,although,0,0
188021,these,0,0
188022,results,0,0
188023,are,0,0
188024,likely,0,0
188025,biased,0,0
188026,by,0,0
188027,social,0,1
188028,desirability,0,0
188029,.,0,1
188030,TRIAL,0,0
188031,REGISTRATION,0,0
188032,Dutch,0,1
188033,Trial,0,1
188034,Register,0,1
188035,NTR3228,0,1
188036,.,0,1
188037,Transcranial,0,0
188038,Magnetic,0,1
188039,Stimulation,0,0
188040,to,0,1
188041,Address,0,1
188042,Mild,1,1
188043,Cognitive,1,1
188044,Impairment,1,1
188045,in,1,0
188046,the,1,0
188047,Elderly,1,1
188048,:,1,1
188049,A,0,1
188050,Randomized,0,0
188051,Controlled,0,1
188052,Study,0,1
188053,.,0,1
188054,Transcranial,0,0
188055,magnetic,0,0
188056,stimulation,0,0
188057,(,0,1
188058,TMS,0,1
188059,),0,0
188060,is,0,0
188061,a,0,0
188062,noninvasive,0,0
188063,brain,0,0
188064,stimulation,0,0
188065,technique,0,0
188066,with,0,1
188067,potential,0,0
188068,to,0,1
188069,improve,0,0
188070,memory,0,0
188071,.,0,1
188072,Mild,1,0
188073,cognitive,1,0
188074,impairment,1,1
188075,(,1,1
188076,MCI,1,1
188077,),1,1
188078,",",0,0
188079,which,0,0
188080,still,0,0
188081,lacks,0,0
188082,a,0,0
188083,specific,0,0
188084,therapy,0,0
188085,",",0,0
188086,is,0,0
188087,a,0,0
188088,clinical,0,0
188089,syndrome,0,1
188090,associated,0,0
188091,with,0,1
188092,increased,0,0
188093,risk,0,1
188094,of,0,0
188095,dementia,0,1
188096,.,0,1
188097,This,0,0
188098,study,0,0
188099,aims,0,0
188100,to,0,0
188101,assess,0,0
188102,the,0,0
188103,effects,0,0
188104,of,0,0
188105,high-frequency,0,0
188106,repetitive,0,0
188107,TMS,0,1
188108,(,0,1
188109,HF,0,1
188110,rTMS,0,1
188111,),0,1
188112,on,0,0
188113,everyday,0,0
188114,memory,0,1
188115,of,0,0
188116,the,1,0
188117,elderly,1,1
188118,with,1,1
188119,MCI,1,1
188120,.,1,1
188121,We,0,0
188122,conducted,0,0
188123,a,0,0
188124,double-blinded,0,0
188125,randomized,0,1
188126,sham-controlled,0,1
188127,trial,0,1
188128,using,0,0
188129,rTMS,0,0
188130,over,0,0
188131,the,0,0
188132,left,0,1
188133,dorsolateral,0,0
188134,prefrontal,0,1
188135,cortex,0,0
188136,(,0,1
188137,DLPFC,0,1
188138,),0,1
188139,.,0,1
188140,Thirty-four,1,1
188141,elderly,1,1
188142,outpatients,1,1
188143,meeting,1,1
188144,Petersen,1,1
188145,'s,1,1
188146,MCI,1,1
188147,criteria,1,1
188148,were,0,1
188149,randomly,0,1
188150,assigned,0,1
188151,to,0,0
188152,receive,0,1
188153,10,0,1
188154,sessions,0,0
188155,of,0,1
188156,either,0,1
188157,active,0,1
188158,TMS,0,1
188159,or,0,1
188160,sham,0,0
188161,",",0,1
188162,10,0,1
188163,Hz,0,0
188164,rTMS,0,1
188165,at,0,1
188166,110,0,1
188167,%,0,0
188168,of,0,0
188169,motor,0,0
188170,threshold,0,0
188171,",",0,1
188172,"2,000",0,0
188173,pulses,0,0
188174,per,0,1
188175,session,0,0
188176,.,0,1
188177,Neuropsychological,0,0
188178,assessment,0,0
188179,at,0,0
188180,baseline,0,0
188181,",",0,0
188182,after,0,0
188183,the,0,0
188184,last,0,0
188185,session,0,0
188186,(,0,1
188187,10th,0,1
188188,),0,1
188189,and,0,1
188190,at,0,1
188191,one-month,0,0
188192,follow-up,0,0
188193,",",0,0
188194,was,0,0
188195,applied,0,0
188196,.,0,1
188197,ANOVA,0,0
188198,on,0,0
188199,the,0,0
188200,primary,0,1
188201,efficacy,0,0
188202,measure,0,0
188203,",",0,0
188204,the,0,0
188205,Rivermead,0,0
188206,Behavioural,0,0
188207,Memory,0,1
188208,Test,0,0
188209,",",0,0
188210,revealed,0,0
188211,a,0,0
188212,significant,0,0
188213,group-by-time,0,0
188214,interaction,0,0
188215,(,0,1
188216,p,0,0
188217,=,0,1
188218,0.05,0,0
188219,),0,1
188220,",",0,0
188221,favoring,0,0
188222,the,0,0
188223,active,0,1
188224,group,0,1
188225,.,0,1
188226,The,0,0
188227,improvement,0,0
188228,was,0,0
188229,kept,0,0
188230,after,0,1
188231,one,0,1
188232,month,0,1
188233,.,0,1
188234,Other,0,0
188235,neuropsychological,0,1
188236,tests,0,0
188237,were,0,1
188238,heterogeneous,0,1
188239,.,0,1
188240,rTMS,0,0
188241,at,0,0
188242,10,0,1
188243,Hz,0,1
188244,enhanced,0,0
188245,everyday,0,0
188246,memory,1,1
188247,in,1,0
188248,elderly,1,1
188249,with,1,1
188250,MCI,1,1
188251,after,0,1
188252,10,0,1
188253,sessions,0,0
188254,.,0,1
188255,These,0,1
188256,findings,0,0
188257,suggest,0,0
188258,that,0,0
188259,rTMS,0,0
188260,might,0,0
188261,be,0,0
188262,effective,0,0
188263,as,0,0
188264,a,0,1
188265,therapy,0,0
188266,for,0,0
188267,MCI,0,1
188268,and,0,0
188269,probably,0,0
188270,a,0,0
188271,tool,0,0
188272,to,0,0
188273,delay,0,1
188274,deterioration,0,0
188275,.,0,1
188276,Brief,0,1
188277,Report,0,1
188278,:,0,1
188279,Cobicistat,0,0
188280,Compared,0,0
188281,With,0,1
188282,Ritonavir,0,0
188283,as,0,0
188284,a,0,1
188285,Pharmacoenhancer,0,1
188286,for,0,0
188287,Atazanavir,0,1
188288,in,0,1
188289,Combination,0,0
188290,With,0,1
188291,Emtricitabine/Tenofovir,0,1
188292,Disoproxil,0,1
188293,Fumarate,0,1
188294,:,0,1
188295,Week,0,1
188296,144,0,1
188297,Results,0,0
188298,.,0,1
188299,BACKGROUND,0,0
188300,Cobicistat,0,0
188301,(,0,1
188302,COBI,0,0
188303,),0,0
188304,is,0,0
188305,a,0,0
188306,pharmacoenhancer,0,0
188307,with,0,1
188308,no,0,0
188309,antiretroviral,0,1
188310,activity,0,0
188311,.,0,1
188312,METHODS,0,0
188313,International,0,1
188314,",",0,0
188315,randomized,0,1
188316,double-blind,0,0
188317,active-controlled,0,1
188318,trial,0,0
188319,to,0,0
188320,evaluate,0,0
188321,the,0,0
188322,efficacy,0,0
188323,and,0,0
188324,safety,0,0
188325,of,0,0
188326,COBI,0,0
188327,vs,0,0
188328,ritonavir,0,1
188329,(,0,1
188330,RTV,0,1
188331,),0,1
188332,as,0,0
188333,a,0,0
188334,pharmacoenhancer,0,1
188335,of,0,0
188336,atazanavir,0,0
188337,in,0,0
188338,combination,0,0
188339,with,0,1
188340,emtricitabine/tenofovir,0,0
188341,disoproxil,0,0
188342,fumarate,0,0
188343,in,0,0
188344,HIV,1,1
188345,treatment-naive,1,1
188346,patients,1,1
188347,followed,0,1
188348,through,0,1
188349,week,0,0
188350,144,0,1
188351,.,0,1
188352,RESULTS,0,0
188353,At,0,0
188354,Week,0,1
188355,144,0,1
188356,",",0,1
188357,virologic,0,0
188358,suppression,0,0
188359,was,0,0
188360,achieved,0,0
188361,in,0,1
188362,72,0,1
188363,%,0,0
188364,(,0,1
188365,COBI,0,1
188366,),0,1
188367,and,0,1
188368,74,0,1
188369,%,0,0
188370,(,0,1
188371,RTV,0,1
188372,),0,1
188373,of,0,1
188374,patients,0,1
188375,.,0,1
188376,Adverse,0,0
188377,events,0,0
188378,leading,0,0
188379,to,0,1
188380,study,0,1
188381,drug,0,0
188382,discontinuation,0,0
188383,occurred,0,0
188384,in,0,0
188385,11,0,1
188386,%,0,0
188387,of,0,1
188388,patients,0,1
188389,in,0,1
188390,each,0,1
188391,group,0,1
188392,.,0,1
188393,Median,0,0
188394,changes,0,0
188395,in,0,1
188396,serum,0,0
188397,creatinine,0,0
188398,(,0,1
188399,mg/dL,0,0
188400,),0,1
188401,were,0,1
188402,+0.13,0,0
188403,(,0,1
188404,COBI,0,1
188405,),0,1
188406,and,0,1
188407,+0.07,0,0
188408,(,0,1
188409,RTV,0,1
188410,),0,1
188411,and,0,0
188412,were,0,1
188413,unchanged,0,0
188414,from,0,1
188415,week,0,0
188416,48,0,1
188417,.,0,1
188418,CONCLUSIONS,0,0
188419,Once-daily,0,0
188420,COBI,0,0
188421,is,0,0
188422,a,0,0
188423,safe,0,0
188424,and,0,0
188425,effective,0,0
188426,pharmacoenhancer,0,1
188427,of,0,0
188428,the,0,0
188429,protease,0,0
188430,inhibitor,0,0
188431,atazanavir,0,0
188432,.,0,1
188433,A,0,0
188434,New,0,1
188435,Interactive,0,1
188436,Screening,0,1
188437,Test,0,0
188438,for,0,1
188439,Autism,1,1
188440,Spectrum,1,1
188441,Disorders,1,1
188442,in,1,1
188443,Toddlers,1,1
188444,.,1,1
188445,OBJECTIVE,0,0
188446,To,0,0
188447,develop,0,0
188448,a,0,0
188449,clinically,0,0
188450,valid,0,0
188451,interactive,0,0
188452,level,0,0
188453,2,0,1
188454,screening,0,1
188455,assessment,0,0
188456,for,0,0
188457,autism,1,1
188458,spectrum,1,1
188459,disorders,1,1
188460,(,1,1
188461,ASD,1,1
188462,),1,1
188463,in,1,1
188464,toddlers,1,1
188465,that,0,0
188466,is,0,0
188467,brief,0,0
188468,",",0,0
188469,easily,0,0
188470,administered,0,0
188471,",",0,0
188472,and,0,0
188473,scored,0,0
188474,by,0,0
188475,clinicians,0,1
188476,.,0,1
188477,STUDY,0,0
188478,DESIGN,0,0
188479,We,0,0
188480,describe,0,0
188481,the,0,0
188482,development,0,0
188483,",",0,0
188484,training,0,0
188485,",",0,0
188486,standardization,0,0
188487,",",0,0
188488,and,0,0
188489,validation,0,0
188490,of,0,0
188491,the,0,0
188492,Rapid,0,0
188493,Interactive,0,1
188494,Screening,0,1
188495,Test,0,0
188496,for,0,0
188497,Autism,1,1
188498,in,1,1
188499,Toddlers,1,1
188500,(,1,1
188501,RITA-T,1,1
188502,),1,1
188503,with,1,1
188504,ASD-specific,1,0
188505,diagnostic,1,1
188506,instruments,1,0
188507,.,1,1
188508,The,0,0
188509,RITA-T,0,0
188510,can,0,0
188511,be,0,0
188512,administered,0,0
188513,and,0,0
188514,scored,0,0
188515,in,0,1
188516,10,0,1
188517,minutes,0,0
188518,.,0,1
188519,We,0,0
188520,studied,0,0
188521,the,0,0
188522,validity,0,0
188523,of,0,0
188524,the,0,0
188525,RITA-T,0,1
188526,to,0,0
188527,distinguish,0,1
188528,between,0,0
188529,toddlers,1,1
188530,with,1,1
188531,ASD,1,1
188532,from,1,1
188533,toddlers,1,1
188534,with,1,1
188535,developmental,1,1
188536,delay,1,1
188537,(,1,1
188538,DD,1,1
188539,),1,1
188540,/non-ASD,1,0
188541,in,1,0
188542,an,1,0
188543,early,1,1
188544,childhood,1,1
188545,clinic,1,1
188546,.,1,1
188547,We,0,0
188548,also,0,0
188549,evaluated,0,0
188550,the,0,0
188551,test,0,0
188552,'s,0,1
188553,performance,0,0
188554,in,0,1
188555,toddlers,1,1
188556,with,1,1
188557,no,1,1
188558,developmental,1,1
188559,concerns,1,0
188560,.,1,1
188561,We,0,0
188562,identified,0,0
188563,a,0,0
188564,cutoff,0,0
188565,score,0,0
188566,based,0,1
188567,on,0,0
188568,sensitivity,0,0
188569,",",0,0
188570,specificity,0,0
188571,",",0,0
188572,and,0,0
188573,positive,0,1
188574,predictive,0,0
188575,value,0,0
188576,of,0,0
188577,the,0,0
188578,RITA-T,0,1
188579,that,0,0
188580,best,0,0
188581,differentiates,0,0
188582,between,0,0
188583,ASD,1,1
188584,and,1,1
188585,DD/non-ASD,1,1
188586,.,1,1
188587,RESULTS,0,0
188588,A,1,0
188589,total,1,1
188590,of,1,0
188591,61,1,1
188592,toddlers,1,1
188593,were,0,1
188594,enrolled,0,1
188595,.,0,1
188596,RITA-T,0,1
188597,scores,0,0
188598,were,0,1
188599,correlated,0,0
188600,with,0,1
188601,ASD-specific,0,0
188602,diagnostic,0,1
188603,tools,0,0
188604,(,0,1
188605,r,0,0
188606,=,0,1
188607,0.79,0,0
188608,;,0,1
188609,P,0,0
188610,<,0,0
188611,.01,0,0
188612,),0,1
188613,and,0,1
188614,ASD,0,1
188615,clinical,0,1
188616,diagnoses,0,1
188617,(,0,1
188618,r,0,0
188619,=,0,1
188620,0.77,0,0
188621,;,0,1
188622,P,0,0
188623,<,0,0
188624,.01,0,0
188625,),0,1
188626,.,0,1
188627,Mean,0,1
188628,scores,0,0
188629,were,0,1
188630,significantly,0,0
188631,different,0,0
188632,in,0,0
188633,subjects,1,1
188634,with,1,1
188635,ASD,1,1
188636,",",1,0
188637,those,1,0
188638,with,1,1
188639,DD/non-ASD,1,1
188640,",",1,0
188641,and,1,0
188642,those,1,0
188643,with,1,1
188644,no,1,0
188645,developmental,1,1
188646,concerns,1,0
188647,(,0,1
188648,20.8,0,1
188649,vs,0,0
188650,13,0,1
188651,vs,0,0
188652,10.6,0,0
188653,",",0,0
188654,respectively,0,0
188655,;,0,0
188656,P,0,0
188657,<,0,0
188658,.0001,0,0
188659,),0,1
188660,.,0,1
188661,At,0,0
188662,a,0,0
188663,cutoff,0,0
188664,score,0,0
188665,of,0,0
188666,>,0,1
188667,14,0,1
188668,",",0,0
188669,the,0,0
188670,RITA-T,0,0
188671,had,0,1
188672,a,0,0
188673,sensitivity,0,0
188674,of,0,0
188675,1.00,0,0
188676,",",0,0
188677,specificity,0,0
188678,of,0,0
188679,0.84,0,0
188680,",",0,1
188681,and,0,0
188682,positive,0,1
188683,predictive,0,0
188684,value,0,0
188685,of,0,0
188686,0.88,0,0
188687,for,0,1
188688,identifying,0,0
188689,ASD,1,1
188690,risk,1,1
188691,in,1,0
188692,a,1,1
188693,high-risk,1,1
188694,group,1,1
188695,.,1,1
188696,CONCLUSION,0,0
188697,The,0,0
188698,RITA-T,0,0
188699,is,0,0
188700,a,0,0
188701,promising,0,0
188702,new,0,1
188703,level,0,1
188704,2,0,1
188705,interactive,0,0
188706,screening,0,1
188707,tool,0,0
188708,for,0,0
188709,improving,0,0
188710,the,0,0
188711,early,0,1
188712,identification,0,1
188713,of,0,0
188714,ASD,1,1
188715,in,1,1
188716,toddlers,1,1
188717,in,0,1
188718,general,0,1
188719,pediatric,0,1
188720,and,0,1
188721,early,0,1
188722,intervention,0,1
188723,settings,0,1
188724,and,0,1
188725,allowing,0,0
188726,access,0,0
188727,to,0,1
188728,treatment,0,1
188729,.,0,1
188730,Total,1,1
188731,and,1,1
188732,Partial,1,1
188733,Prevalence,1,1
188734,of,1,1
188735,Cancer,1,1
188736,Across,1,1
188737,Kerman,1,1
188738,Province,1,1
188739,",",1,0
188740,Iran,1,0
188741,",",1,0
188742,in,1,0
188743,2014,1,1
188744,",",0,0
188745,Using,0,0
188746,an,0,0
188747,Adapted,0,0
188748,Generalized,0,1
188749,Network,0,1
188750,Scale-Up,0,1
188751,Method,0,1
188752,.,0,1
188753,Due,0,0
188754,to,0,0
188755,the,0,0
188756,lack,0,0
188757,of,0,0
188758,nationwide,0,1
188759,population-based,0,1
188760,cancer,0,1
188761,registration,0,0
188762,",",0,0
188763,the,0,0
188764,total,0,1
188765,cancer,0,1
188766,prevalence,0,1
188767,in,0,0
188768,Iran,1,0
188769,is,0,0
188770,unknown,0,0
188771,.,0,0
188772,Our,0,0
188773,previous,0,0
188774,work,0,0
188775,in,0,0
188776,which,0,0
188777,we,0,0
188778,used,0,0
188779,a,0,0
188780,basic,0,0
188781,network,0,0
188782,scale-up,0,0
188783,(,0,1
188784,NSU,0,1
188785,),0,1
188786,method,0,0
188787,",",0,0
188788,failed,0,0
188789,to,0,0
188790,provide,0,0
188791,plausible,0,0
188792,estimates,0,0
188793,of,0,1
188794,total,1,1
188795,cancer,1,1
188796,prevalence,1,1
188797,in,1,1
188798,Kerman,1,1
188799,.,1,1
188800,The,0,0
188801,aim,0,0
188802,of,0,0
188803,the,0,0
188804,present,0,0
188805,study,0,1
188806,was,0,0
188807,to,0,0
188808,estimate,0,0
188809,total,0,1
188810,and,0,0
188811,partial,0,1
188812,prevalence,0,1
188813,of,0,0
188814,cancer,0,1
188815,in,0,1
188816,southeastern,0,1
188817,Iran,0,1
188818,using,0,0
188819,an,0,0
188820,adapted,0,0
188821,version,0,0
188822,of,0,0
188823,the,0,0
188824,generalized,0,1
188825,network,0,0
188826,scale-up,0,0
188827,method,0,0
188828,.,0,1
188829,A,0,0
188830,survey,0,0
188831,was,0,0
188832,conducted,0,1
188833,in,0,1
188834,2014,1,1
188835,using,0,1
188836,multi-stage,0,1
188837,cluster,0,1
188838,sampling,0,1
188839,.,0,1
188840,A,0,0
188841,total,1,1
188842,of,1,0
188843,1995,1,1
188844,face-to-face,1,0
188845,gender-matched,1,1
188846,interviews,1,1
188847,were,0,1
188848,performed,0,0
188849,based,0,1
188850,on,0,0
188851,an,0,0
188852,adapted,0,0
188853,version,0,0
188854,of,0,0
188855,the,0,0
188856,NSU,0,0
188857,questionnaire,0,1
188858,.,0,1
188859,Interviewees,0,1
188860,were,0,0
188861,asked,0,1
188862,about,0,0
188863,their,0,1
188864,family,0,1
188865,cancer,0,1
188866,history,0,1
188867,.,0,1
188868,Total,0,0
188869,and,0,0
188870,partial,0,1
188871,prevalence,0,1
188872,were,0,1
188873,estimated,0,0
188874,using,0,0
188875,a,0,1
188876,generalized,0,1
188877,NSU,0,0
188878,estimator,0,0
188879,.,0,1
188880,The,0,0
188881,Monte,0,0
188882,Carlo,0,0
188883,method,0,0
188884,was,0,0
188885,adopted,0,0
188886,for,0,0
188887,the,0,0
188888,estimation,0,0
188889,of,0,0
188890,upper/lower,0,1
188891,bounds,0,0
188892,of,0,1
188893,the,0,0
188894,uncertainty,0,0
188895,range,0,1
188896,of,0,0
188897,point,0,0
188898,estimates,0,0
188899,.,0,1
188900,One-yr,0,0
188901,",",0,0
188902,2-3,0,0
188903,yr,0,1
188904,",",0,0
188905,and,0,0
188906,4-5,0,0
188907,yr,0,1
188908,prevalence,0,0
188909,(,0,1
188910,per,0,1
188911,"100,000",0,1
188912,people,0,1
188913,),0,1
188914,was,0,0
188915,respectively,0,0
188916,estimated,0,0
188917,at,0,0
188918,78,0,1
188919,(,0,1
188920,95,0,0
188921,%,0,0
188922,CI,0,0
188923,",",0,0
188924,66,0,1
188925,",",0,1
188926,90,0,1
188927,),0,1
188928,",",0,1
188929,128,0,1
188930,(,0,1
188931,95,0,0
188932,%,0,0
188933,CI,0,0
188934,",",0,0
188935,118,0,1
188936,",",0,1
188937,147,0,1
188938,),0,0
188939,",",0,1
188940,and,0,1
188941,59,0,1
188942,(,0,1
188943,95,0,0
188944,%,0,0
188945,CI,0,0
188946,",",0,0
188947,49,0,1
188948,",",0,1
188949,70,0,1
188950,),0,1
188951,for,0,1
188952,women,0,1
188953,",",0,1
188954,and,0,1
188955,48,0,1
188956,(,0,1
188957,95,0,0
188958,%,0,0
188959,CI,0,0
188960,",",0,0
188961,38,0,1
188962,",",0,1
188963,58,0,1
188964,),0,1
188965,",",0,1
188966,78,0,1
188967,(,0,1
188968,95,0,0
188969,%,0,0
188970,CI,0,0
188971,",",0,0
188972,66,0,1
188973,",",0,1
188974,91,0,1
188975,),0,0
188976,",",0,1
188977,and,0,1
188978,42,0,1
188979,(,0,1
188980,95,0,0
188981,%,0,0
188982,CI,0,0
188983,",",0,0
188984,32,0,1
188985,",",0,1
188986,52,0,1
188987,),0,1
188988,for,0,1
188989,men,0,1
188990,.,0,1
188991,The,0,0
188992,5-yr,0,0
188993,prevalence,0,0
188994,of,0,0
188995,all,0,1
188996,cancers,0,1
188997,was,0,0
188998,estimated,0,0
188999,at,0,1
189000,0.18,0,0
189001,percent,0,1
189002,for,0,1
189003,men,0,1
189004,",",0,1
189005,and,0,1
189006,0.27,0,0
189007,percent,0,1
189008,for,0,1
189009,women,0,1
189010,.,0,1
189011,This,0,0
189012,study,0,0
189013,showed,0,0
189014,that,0,0
189015,the,0,0
189016,generalized,0,1
189017,familial,0,1
189018,network,0,1
189019,scale-up,0,0
189020,method,0,0
189021,is,0,0
189022,capable,0,0
189023,of,0,0
189024,estimating,0,0
189025,cancer,0,1
189026,prevalence,0,0
189027,",",0,0
189028,with,0,1
189029,acceptable,0,0
189030,precision,0,0
189031,.,0,1
189032,Homocysteine,0,1
189033,Metabolism,0,0
189034,Gene,0,0
189035,Polymorphisms,0,0
189036,(,0,1
189037,MTHFR,0,1
189038,C677T,0,0
189039,",",0,1
189040,MTHFR,0,1
189041,A1298C,0,0
189042,",",0,1
189043,MTR,0,0
189044,A2756G,0,1
189045,and,0,1
189046,MTRR,0,0
189047,A66G,0,1
189048,),0,0
189049,Jointly,0,0
189050,Elevate,0,0
189051,the,0,0
189052,Risk,0,1
189053,of,0,0
189054,Folate,0,0
189055,Deficiency,0,1
189056,.,0,1
189057,Folate,0,0
189058,deficiency,0,1
189059,is,0,0
189060,strongly,0,0
189061,associated,0,0
189062,with,0,1
189063,cardiovascular,0,1
189064,disease,0,1
189065,.,0,1
189066,We,0,0
189067,aimed,0,0
189068,to,0,0
189069,explore,0,0
189070,the,0,0
189071,joint,0,0
189072,effect,0,0
189073,of,0,0
189074,the,0,0
189075,methylenetetrahydrofolate,0,0
189076,reductase,0,0
189077,(,0,1
189078,MTHFR,0,1
189079,),0,1
189080,C677T,0,0
189081,and,0,1
189082,A1298C,0,0
189083,",",0,0
189084,methionine,0,0
189085,synthase,0,0
189086,(,0,1
189087,MTR,0,0
189088,),0,1
189089,A2756G,0,0
189090,",",0,0
189091,and,0,0
189092,methionine,0,0
189093,synthase,0,0
189094,reductase,0,0
189095,(,0,1
189096,MTRR,0,0
189097,),0,1
189098,A66G,0,1
189099,polymorphisms,0,0
189100,on,0,0
189101,folate,0,0
189102,deficiency,0,1
189103,in,0,0
189104,a,1,1
189105,Chinese,1,1
189106,hypertensive,1,1
189107,population,1,1
189108,.,1,1
189109,A,1,0
189110,total,1,1
189111,of,1,0
189112,480,1,1
189113,subjects,1,1
189114,aged,1,1
189115,28-75,1,1
189116,were,1,1
189117,enrolled,1,1
189118,in,1,0
189119,this,1,0
189120,study,1,0
189121,from,1,1
189122,September,1,1
189123,2005-December,1,1
189124,2005,1,1
189125,from,1,1
189126,six,1,1
189127,hospitals,1,1
189128,in,1,1
189129,different,1,1
189130,Chinese,1,1
189131,regions,1,1
189132,.,1,1
189133,Known,0,1
189134,genotypes,0,0
189135,were,0,1
189136,detected,0,0
189137,by,0,0
189138,PCR-RFLP,0,1
189139,methods,0,1
189140,and,0,1
189141,serum,0,0
189142,folate,0,0
189143,was,0,0
189144,measured,0,0
189145,by,0,0
189146,chemiluminescence,0,0
189147,immunoassay,0,1
189148,.,0,1
189149,Our,0,0
189150,results,0,0
189151,showed,0,0
189152,that,0,0
189153,MTHFR,0,1
189154,677TT,0,1
189155,and,0,1
189156,MTR,0,0
189157,2756AG,0,1
189158,+,0,0
189159,GG,0,0
189160,were,0,1
189161,independently,0,0
189162,associated,0,0
189163,with,0,1
189164,a,0,0
189165,higher,0,0
189166,risk,0,0
189167,of,0,0
189168,folate,0,0
189169,deficiency,0,1
189170,(,0,0
189171,TT,0,1
189172,vs.,0,0
189173,CC,0,1
189174,+,0,0
189175,CT,0,0
189176,",",0,0
189177,p,0,0
189178,<,0,0
189179,0.001,0,0
189180,and,0,1
189181,AG,0,1
189182,+,0,0
189183,GG,0,0
189184,vs.,0,0
189185,AA,0,1
189186,p,0,0
189187,=,0,1
189188,0.030,0,0
189189,",",0,0
189190,respectively,0,0
189191,),0,0
189192,.,0,0
189193,However,0,0
189194,",",0,0
189195,the,0,0
189196,MTHFR,0,0
189197,A1298C,0,0
189198,mutation,0,1
189199,may,0,0
189200,confer,0,0
189201,protection,0,0
189202,by,0,0
189203,elevating,0,0
189204,the,0,0
189205,serum,0,0
189206,folate,0,0
189207,level,0,0
189208,(,0,1
189209,p,0,0
189210,=,0,1
189211,0.025,0,0
189212,),0,1
189213,.,0,1
189214,Furthermore,0,0
189215,",",0,0
189216,patients,0,1
189217,carrying,0,1
189218,two,0,0
189219,or,0,1
189220,more,0,0
189221,risk,0,1
189222,genotypes,0,0
189223,showed,0,0
189224,higher,0,0
189225,odds,0,0
189226,of,0,0
189227,folate,0,0
189228,deficiency,0,1
189229,than,0,0
189230,null,0,0
189231,risk,0,1
189232,genotype,0,1
189233,carriers,0,0
189234,",",0,0
189235,especially,0,0
189236,those,0,0
189237,carrying,0,0
189238,four,0,1
189239,risk,0,1
189240,genotypes,0,0
189241,.,0,1
189242,These,0,1
189243,findings,0,0
189244,were,0,1
189245,verified,0,0
189246,by,0,0
189247,generalized,0,1
189248,multifactor,0,0
189249,dimensionality,0,0
189250,reduction,0,0
189251,(,0,1
189252,p,0,0
189253,=,0,1
189254,0.0107,0,0
189255,),0,1
189256,and,0,0
189257,a,0,1
189258,cumulative,0,0
189259,effects,0,0
189260,model,0,1
189261,(,0,1
189262,p,0,0
189263,=,0,1
189264,0.001,0,0
189265,),0,1
189266,.,0,1
189267,The,0,0
189268,results,0,0
189269,of,0,0
189270,this,0,0
189271,study,0,0
189272,have,0,0
189273,shown,0,0
189274,that,0,0
189275,interactions,0,0
189276,among,0,1
189277,homocysteine,0,1
189278,metabolism,0,0
189279,gene,0,0
189280,polymorphisms,0,0
189281,lead,0,0
189282,to,0,1
189283,dramatic,0,0
189284,elevations,0,0
189285,in,0,1
189286,the,0,0
189287,folate,0,0
189288,deficiency,0,1
189289,risk,0,1
189290,.,0,1
189291,Recruitment,0,0
189292,and,0,0
189293,Reasons,0,1
189294,for,0,0
189295,Non-Participation,0,1
189296,in,0,1
189297,a,0,1
189298,Family-Coping-Orientated,0,1
189299,Palliative,0,1
189300,Home,0,1
189301,Care,0,1
189302,Trial,0,1
189303,(,0,1
189304,FamCope,0,1
189305,),0,1
189306,.,0,1
189307,Cancer,1,1
189308,patients,1,1
189309,and,1,1
189310,their,1,1
189311,family,1,1
189312,caregivers,1,1
189313,need,0,1
189314,support,0,0
189315,to,0,0
189316,cope,0,1
189317,with,0,1
189318,physical,0,0
189319,",",0,1
189320,psychosocial,0,1
189321,",",0,0
189322,and,0,1
189323,existential,0,1
189324,problems,0,1
189325,early,0,1
189326,in,0,0
189327,the,0,0
189328,palliative,0,1
189329,care,0,1
189330,trajectory,0,0
189331,.,0,1
189332,Many,0,0
189333,interventions,0,0
189334,target,0,1
189335,patient,0,1
189336,symptomatology,0,0
189337,",",0,0
189338,with,0,1
189339,health,0,1
189340,care,0,1
189341,professionals,0,1
189342,acting,0,0
189343,as,0,1
189344,problem-solvers,0,1
189345,.,0,1
189346,Family,0,0
189347,coping,0,0
189348,",",0,0
189349,however,0,0
189350,",",0,0
189351,is,0,0
189352,a,0,0
189353,new,0,0
189354,research,0,0
189355,area,0,0
189356,within,0,1
189357,palliative,0,1
189358,care,0,1
189359,.,0,1
189360,The,0,0
189361,FamCope,0,0
189362,intervention,0,0
189363,was,0,0
189364,developed,0,0
189365,to,0,0
189366,test,0,0
189367,if,0,0
189368,a,0,0
189369,nurse-led,0,1
189370,family-coping-orientated,0,1
189371,palliative,0,1
189372,home,0,1
189373,care,0,1
189374,intervention,0,0
189375,would,0,0
189376,help,0,0
189377,families,0,1
189378,cope,0,1
189379,with,0,1
189380,physical,0,1
189381,and,0,1
189382,psychosocial,0,1
189383,problems,0,1
189384,at,0,1
189385,home,0,1
189386,--,0,1
189387,together,0,0
189388,as,0,0
189389,a,0,0
189390,family,0,1
189391,and,0,0
189392,in,0,0
189393,interaction,0,0
189394,with,0,1
189395,health,0,1
189396,care,0,1
189397,professionals,0,1
189398,.,0,1
189399,However,0,0
189400,",",0,0
189401,an,0,0
189402,unexpectedly,0,0
189403,high,0,0
189404,number,0,0
189405,of,0,1
189406,families,0,1
189407,declined,0,0
189408,participation,0,0
189409,in,0,0
189410,the,0,0
189411,trial,0,0
189412,.,0,0
189413,We,0,0
189414,describe,0,0
189415,and,0,0
189416,discuss,0,0
189417,the,0,0
189418,recruitment,0,0
189419,strategy,0,0
189420,and,0,0
189421,patient,0,1
189422,reported,0,1
189423,reasons,0,0
189424,for,0,1
189425,non-participation,0,1
189426,to,0,0
189427,add,0,0
189428,to,0,0
189429,the,0,0
189430,knowledge,0,0
189431,about,0,0
189432,what,0,0
189433,impedes,0,1
189434,recruitment,0,1
189435,and,0,0
189436,to,0,0
189437,identify,0,0
189438,the,0,0
189439,factors,0,0
189440,that,0,0
189441,influence,0,0
189442,willingness,0,0
189443,to,0,0
189444,participate,0,1
189445,in,0,0
189446,research,0,0
189447,aimed,0,0
189448,at,0,0
189449,family,0,1
189450,coping,0,0
189451,early,0,1
189452,in,0,0
189453,the,0,0
189454,palliative,0,1
189455,care,0,1
189456,trajectory,0,0
189457,.,0,1
189458,Patients,1,1
189459,with,1,1
189460,advanced,1,1
189461,cancer,1,1
189462,and,1,1
189463,their,1,1
189464,closest,1,1
189465,relative,1,0
189466,were,1,0
189467,recruited,1,1
189468,from,1,1
189469,medical,1,1
189470,",",1,1
189471,surgical,1,1
189472,",",1,0
189473,and,1,1
189474,oncological,1,1
189475,departments,1,1
189476,.,1,1
189477,Reasons,0,1
189478,for,0,0
189479,non-participation,0,1
189480,were,0,1
189481,registered,0,1
189482,and,0,1
189483,characteristics,0,1
189484,of,0,1
189485,participants,0,1
189486,and,0,1
189487,non-participants,0,1
189488,were,0,1
189489,compared,0,0
189490,to,0,0
189491,evaluate,0,0
189492,differences,0,0
189493,between,0,0
189494,subgroups,0,1
189495,of,0,1
189496,non-participants,0,1
189497,based,0,1
189498,on,0,0
189499,reasons,0,0
189500,not,0,0
189501,to,0,0
189502,participate,0,1
189503,and,0,1
189504,reasons,0,0
189505,to,0,0
189506,participate,0,1
189507,in,0,0
189508,the,0,0
189509,trial,0,0
189510,.,0,0
189511,A,0,0
189512,total,0,1
189513,of,0,0
189514,65.9,0,0
189515,%,0,0
189516,of,0,0
189517,the,0,0
189518,families,0,1
189519,declined,0,0
189520,participation,0,1
189521,.,0,1
189522,Two,0,1
189523,main,0,0
189524,categories,0,1
189525,for,0,1
189526,declining,0,1
189527,participation,0,1
189528,emerged,0,0
189529,:,0,1
189530,first,0,0
189531,",",0,0
189532,that,0,0
189533,the,0,0
189534,burden,0,1
189535,of,0,0
189536,illness,0,1
189537,is,0,0
189538,too,0,0
189539,great,0,0
189540,and,0,0
189541,",",0,0
189542,second,0,0
189543,",",0,0
189544,that,0,0
189545,it,0,0
189546,was,0,0
189547,too,0,0
189548,soon,0,0
189549,to,0,0
189550,receive,0,0
189551,this,0,0
189552,kind,0,0
189553,of,0,0
189554,support,0,0
189555,.,0,1
189556,Men,1,1
189557,were,0,0
189558,more,0,0
189559,likely,0,0
189560,to,0,0
189561,participate,0,1
189562,than,0,0
189563,women,1,1
189564,.,1,1
189565,Patients,0,1
189566,in,0,0
189567,the,0,0
189568,too,0,0
189569,soon,0,0
189570,group,0,0
189571,had,0,1
189572,similar,0,0
189573,characteristics,0,1
189574,to,0,1
189575,participants,0,1
189576,in,0,0
189577,the,0,1
189578,trial,0,0
189579,.,0,0
189580,Timing,0,0
189581,of,0,0
189582,interventions,0,0
189583,and,0,1
189584,readiness,0,1
189585,of,0,1
189586,patients,0,1
189587,and,0,1
189588,their,0,1
189589,relatives,0,1
189590,seems,0,0
189591,to,0,0
189592,affect,0,0
189593,willingness,0,0
189594,to,0,0
189595,receive,0,1
189596,a,0,0
189597,family-coping-orientated,0,1
189598,care,0,1
189599,approach,0,1
189600,and,0,0
189601,impeded,0,0
189602,recruitment,0,0
189603,to,0,0
189604,this,0,0
189605,trial,0,0
189606,.,0,1
189607,Our,0,0
189608,findings,0,0
189609,can,0,0
189610,be,0,0
189611,used,0,0
189612,in,0,0
189613,further,0,0
189614,research,0,1
189615,and,0,1
189616,in,0,0
189617,clinical,0,0
189618,practice,0,0
189619,in,0,0
189620,order,0,0
189621,to,0,1
189622,construct,0,0
189623,interventions,0,0
189624,and,0,1
189625,target,0,1
189626,relevant,0,1
189627,populations,0,1
189628,for,0,1
189629,early,0,1
189630,family-coping-orientated,0,1
189631,palliative,0,1
189632,care,0,1
189633,.,0,1
189634,Adequacy,0,0
189635,of,0,0
189636,hot,0,0
189637,biopsy,0,1
189638,for,0,0
189639,the,0,0
189640,treatment,0,0
189641,of,0,0
189642,diminutive,0,1
189643,polyps,0,1
189644,:,0,1
189645,a,0,1
189646,prospective,0,1
189647,randomized,0,1
189648,trial,0,1
189649,.,0,1
189650,Patients,1,1
189651,with,1,1
189652,diminutive,1,1
189653,polyps,1,1
189654,in,1,1
189655,the,1,0
189656,rectum,1,1
189657,or,1,1
189658,sigmoid,1,1
189659,colon,1,1
189660,were,0,1
189661,randomized,0,1
189662,to,0,1
189663,hot,0,0
189664,biopsy,0,1
189665,treatment,0,0
189666,for,0,0
189667,either,0,1
189668,1,0,1
189669,),0,0
189670,electrocautery,0,0
189671,for,0,1
189672,2,0,1
189673,s,0,1
189674,(,0,1
189675,fixed,0,0
189676,duration,0,0
189677,cautery,0,0
189678,),0,1
189679,or,0,1
189680,2,0,1
189681,),0,1
189682,cautery,0,0
189683,until,0,1
189684,visible,0,0
189685,necrosis,0,1
189686,of,0,0
189687,the,0,0
189688,polyp,0,0
189689,base,0,0
189690,was,0,0
189691,evident,0,0
189692,(,0,1
189693,variable,0,1
189694,duration,0,0
189695,cautery,0,0
189696,),0,1
189697,.,0,1
189698,Sigmoidoscopy,0,0
189699,was,0,0
189700,performed,0,0
189701,4,0,0
189702,wk,0,1
189703,after,0,0
189704,treatment,0,0
189705,to,0,0
189706,determine,0,0
189707,the,0,0
189708,adequacy,0,0
189709,of,0,0
189710,polyp,0,1
189711,eradication,0,1
189712,.,0,1
189713,In,0,0
189714,the,0,0
189715,fixed,0,0
189716,duration,0,0
189717,cautery,0,0
189718,group,0,1
189719,",",0,0
189720,11,0,1
189721,of,0,1
189722,21,0,1
189723,polyps,0,1
189724,(,0,1
189725,52,0,1
189726,%,0,0
189727,),0,1
189728,were,0,0
189729,eradicated,0,0
189730,",",0,0
189731,compared,0,0
189732,with,0,1
189733,12,0,1
189734,of,0,1
189735,14,0,1
189736,polyps,0,1
189737,(,0,1
189738,86,0,1
189739,%,0,0
189740,),0,1
189741,in,0,0
189742,the,0,0
189743,variable,0,0
189744,duration,0,0
189745,cautery,0,0
189746,group,0,1
189747,(,0,1
189748,p,0,0
189749,=,0,1
189750,0.04,0,0
189751,),0,0
189752,.,0,0
189753,When,0,0
189754,analyzed,0,0
189755,according,0,0
189756,to,0,1
189757,whether,0,0
189758,or,0,1
189759,not,0,0
189760,visible,0,0
189761,necrosis,0,1
189762,was,0,0
189763,achieved,0,0
189764,(,0,0
189765,some,0,0
189766,of,0,0
189767,the,0,0
189768,polyps,0,1
189769,in,0,0
189770,the,0,1
189771,fixed,0,0
189772,duration,0,0
189773,cautery,0,0
189774,group,0,1
189775,showed,0,0
189776,necrosis,0,1
189777,with,0,1
189778,2,0,1
189779,s,0,1
189780,cautery,0,0
189781,),0,1
189782,",",0,0
189783,19,0,1
189784,of,0,1
189785,23,0,1
189786,polyps,0,1
189787,(,0,1
189788,83,0,1
189789,%,0,0
189790,),0,1
189791,were,0,0
189792,eradicated,0,0
189793,when,0,0
189794,necrosis,0,1
189795,was,0,0
189796,evident,0,0
189797,",",0,0
189798,compared,0,0
189799,to,0,0
189800,5,0,1
189801,of,0,1
189802,12,0,1
189803,(,0,1
189804,42,0,1
189805,%,0,0
189806,),0,1
189807,without,0,1
189808,necrosis,0,1
189809,(,0,1
189810,p,0,0
189811,=,0,1
189812,0.004,0,0
189813,),0,1
189814,.,0,1
189815,We,0,0
189816,conclude,0,0
189817,that,0,0
189818,hot,0,0
189819,biopsy,0,1
189820,treatment,0,0
189821,for,0,1
189822,diminutive,0,1
189823,polyps,0,1
189824,is,0,0
189825,significantly,0,0
189826,more,0,0
189827,effective,0,0
189828,when,0,0
189829,visible,0,0
189830,necrosis,0,0
189831,is,0,0
189832,achieved,0,0
189833,during,0,0
189834,cautery,0,0
189835,.,0,1
189836,Furthermore,0,0
189837,",",0,0
189838,even,0,0
189839,with,0,1
189840,visible,0,0
189841,necrosis,0,0
189842,",",0,0
189843,there,0,0
189844,is,0,0
189845,a,0,0
189846,17,0,0
189847,%,0,0
189848,failure,0,1
189849,rate,0,0
189850,of,0,0
189851,polyp,0,1
189852,eradication,0,1
189853,.,0,1
189854,Effects,0,0
189855,of,0,1
189856,propofol,0,0
189857,and,0,0
189858,isoflurane,0,0
189859,on,0,0
189860,haemodynamics,0,0
189861,and,0,1
189862,the,0,0
189863,inflammatory,0,0
189864,response,0,0
189865,in,0,1
189866,cardiopulmonary,0,1
189867,bypass,0,1
189868,surgery,0,1
189869,.,0,1
189870,Cardiopulmonary,1,0
189871,bypass,1,1
189872,(,1,1
189873,CPB,1,0
189874,),1,1
189875,causes,0,0
189876,reperfusion,0,0
189877,injury,0,0
189878,that,0,0
189879,when,0,0
189880,most,0,0
189881,severe,0,0
189882,is,0,0
189883,clinically,0,0
189884,manifested,0,0
189885,as,0,0
189886,a,0,1
189887,systemic,0,0
189888,inflammatory,0,0
189889,response,0,0
189890,syndrome,0,1
189891,.,0,1
189892,The,0,0
189893,anaesthetic,0,0
189894,propofol,0,0
189895,may,0,0
189896,have,0,0
189897,anti-inflammatory,0,0
189898,properties,0,0
189899,that,0,0
189900,may,0,0
189901,reduce,0,0
189902,such,0,0
189903,a,0,0
189904,response,0,0
189905,.,0,1
189906,We,0,0
189907,hypothesised,0,0
189908,differing,0,0
189909,effects,0,0
189910,of,0,1
189911,propofol,0,0
189912,and,0,0
189913,isoflurane,0,0
189914,on,0,0
189915,inflammatory,0,0
189916,markers,0,0
189917,in,0,1
189918,patients,1,1
189919,having,1,1
189920,CBR,1,1
189921,Forty,1,1
189922,patients,1,1
189923,undergoing,1,1
189924,elective,1,1
189925,CPB,1,0
189926,were,1,1
189927,randomised,1,0
189928,to,1,0
189929,receive,1,0
189930,either,1,0
189931,propofol,1,0
189932,or,1,0
189933,isoflurane,1,0
189934,for,1,0
189935,maintenance,1,0
189936,of,1,0
189937,anaesthesia,1,1
189938,.,1,1
189939,CRP,0,0
189940,",",0,0
189941,IL-6,0,0
189942,",",0,0
189943,IL-8,0,0
189944,",",0,0
189945,HIF-1?,0,0
189946,(,0,1
189947,ELISA,0,1
189948,),0,1
189949,",",0,0
189950,CD11,0,0
189951,and,0,0
189952,CD18,0,0
189953,expression,0,0
189954,(,0,1
189955,flow,0,0
189956,cytometry,0,0
189957,),0,1
189958,",",0,0
189959,and,0,0
189960,haemoxygenase,0,0
189961,(,0,1
189962,HO-1,0,0
189963,),0,1
189964,promoter,0,1
189965,polymorphisms,0,0
189966,(,0,1
189967,PCR/electrophoresis,0,0
189968,),0,1
189969,were,0,0
189970,measured,0,0
189971,before,0,0
189972,anaesthetic,0,0
189973,induction,0,1
189974,",",0,1
189975,4,0,0
189976,hours,0,0
189977,post-CPB,0,0
189978,",",0,1
189979,and,0,1
189980,24,0,1
189981,hours,0,0
189982,later,0,1
189983,.,0,0
189984,There,0,0
189985,were,0,0
189986,no,0,0
189987,differences,0,0
189988,in,0,0
189989,the,0,1
189990,4,0,1
189991,hours,0,0
189992,changes,0,0
189993,in,0,1
189994,CRP,0,1
189995,",",0,1
189996,IL-6,0,0
189997,",",0,0
189998,IL-8,0,0
189999,or,0,1
190000,CD18,0,0
190001,between,0,0
190002,the,0,1
190003,two,0,0
190004,groups,0,0
190005,",",0,1
190006,but,0,0
190007,those,0,0
190008,in,0,0
190009,the,1,0
190010,propofol,1,0
190011,group,1,0
190012,had,0,1
190013,higher,0,0
190014,HIF-1?,0,1
190015,(,0,1
190016,P,0,0
190017,=,0,1
190018,0.016,0,0
190019,),0,1
190020,and,0,1
190021,lower,0,0
190022,CD11,0,0
190023,expression,0,0
190024,(,0,1
190025,P,0,0
190026,=,0,1
190027,0.026,0,0
190028,),0,1
190029,.,0,1
190030,After,0,0
190031,24,0,1
190032,hours,0,0
190033,",",0,1
190034,compared,0,0
190035,to,0,0
190036,the,1,0
190037,isoflurane,1,0
190038,group,1,0
190039,",",1,0
190040,the,1,0
190041,propofol,1,0
190042,group,1,0
190043,had,1,1
190044,significantly,0,0
190045,lower,0,0
190046,levels,0,0
190047,of,0,0
190048,CRP,0,1
190049,(,0,1
190050,P,0,0
190051,<,0,0
190052,0.001,0,0
190053,),0,1
190054,",",0,1
190055,IL-6,0,0
190056,(,0,1
190057,P,0,0
190058,<,0,0
190059,0.001,0,0
190060,),0,1
190061,and,0,1
190062,IL-8,0,1
190063,(,0,1
190064,P,0,0
190065,<,0,0
190066,0.001,0,0
190067,),0,1
190068,",",0,0
190069,with,0,1
190070,higher,0,0
190071,levels,0,1
190072,CD11,0,0
190073,(,0,1
190074,P,0,0
190075,=,0,1
190076,0.009,0,0
190077,),0,1
190078,and,0,1
190079,CD18,0,0
190080,(,0,1
190081,P,0,0
190082,=,0,1
190083,0.002,0,0
190084,),0,1
190085,expression,0,0
190086,.,0,1
190087,After,0,0
190088,24,0,1
190089,hours,1,0
190090,",",1,1
190091,patients,1,1
190092,on,1,0
190093,propofol,1,0
190094,had,1,1
190095,increased,0,0
190096,expression,0,0
190097,of,0,0
190098,shorter,0,0
190099,HO-1,0,0
190100,GT,0,0
190101,(,0,1
190102,n,0,1
190103,),0,1
190104,repeats,0,1
190105,than,1,1
190106,patients,1,1
190107,on,1,1
190108,isoflurane,1,0
190109,(,1,1
190110,P,0,0
190111,=,0,1
190112,0.001,0,0
190113,),0,1
190114,.,0,1
190115,Use,0,0
190116,of,0,0
190117,propofol,0,0
190118,in,0,0
190119,CPB,0,0
190120,is,0,0
190121,associated,0,0
190122,with,0,0
190123,a,0,1
190124,less,0,0
190125,adverse,0,0
190126,inflammatory,0,0
190127,profile,0,0
190128,than,0,0
190129,is,0,0
190130,isofluorane,0,0
190131,",",0,0
190132,and,0,0
190133,an,0,0
190134,increased,0,0
190135,up-regulation,0,0
190136,of,0,0
190137,HO-1,0,0
190138,.,0,1
190139,This,0,0
190140,supports,0,0
190141,the,0,0
190142,hypothesis,0,0
190143,that,0,0
190144,propofol,0,0
190145,has,0,0
190146,anti-inflammatory,0,0
190147,activity,0,0
190148,.,0,1
190149,Effectiveness,0,0
190150,of,0,0
190151,Neuromuscular,0,1
190152,Electrical,0,0
190153,Stimulation,0,1
190154,on,0,0
190155,Patients,1,1
190156,With,1,1
190157,Dysphagia,1,1
190158,With,1,1
190159,Medullary,1,1
190160,Infarction,1,1
190161,.,1,1
190162,OBJECTIVE,0,0
190163,To,0,0
190164,evaluate,0,0
190165,and,0,0
190166,compare,0,0
190167,the,0,0
190168,effects,0,0
190169,of,0,0
190170,neuromuscular,0,1
190171,electrical,0,0
190172,stimulation,0,0
190173,(,0,1
190174,NMES,0,1
190175,),0,1
190176,acting,0,0
190177,on,0,0
190178,the,0,0
190179,sensory,0,0
190180,input,0,0
190181,or,0,1
190182,motor,0,0
190183,muscle,0,0
190184,in,0,0
190185,treating,0,0
190186,patients,1,1
190187,with,1,1
190188,dysphagia,1,1
190189,with,1,1
190190,medullary,1,1
190191,infarction,1,1
190192,.,1,1
190193,DESIGN,0,0
190194,Prospective,0,1
190195,randomized,0,1
190196,controlled,0,0
190197,study,0,1
190198,.,0,1
190199,SETTING,0,1
190200,Department,0,1
190201,of,0,0
190202,physical,0,1
190203,medicine,0,1
190204,and,0,1
190205,rehabilitation,0,1
190206,.,0,1
190207,PARTICIPANTS,0,0
190208,Patients,1,1
190209,with,1,1
190210,dysphagia,1,1
190211,with,1,1
190212,medullary,1,1
190213,infarction,1,1
190214,(,1,1
190215,N=82,1,0
190216,),1,1
190217,.,1,1
190218,INTERVENTIONS,0,0
190219,Participants,0,1
190220,were,0,1
190221,randomized,0,1
190222,over,0,0
190223,3,0,1
190224,intervention,0,1
190225,groups,0,1
190226,:,0,1
190227,traditional,0,1
190228,swallowing,0,0
190229,therapy,0,0
190230,",",0,0
190231,sensory,0,0
190232,approach,0,0
190233,combined,0,0
190234,with,0,1
190235,traditional,0,0
190236,swallowing,0,0
190237,therapy,0,0
190238,",",0,0
190239,and,0,0
190240,motor,0,0
190241,approach,0,0
190242,combined,0,0
190243,with,0,1
190244,traditional,0,0
190245,swallowing,0,1
190246,therapy,0,1
190247,.,0,1
190248,Electrical,0,0
190249,stimulation,0,0
190250,sessions,0,0
190251,were,0,1
190252,for,0,1
190253,20,0,1
190254,minutes,0,0
190255,",",0,0
190256,twice,0,0
190257,a,0,0
190258,day,0,0
190259,",",0,0
190260,for,0,0
190261,5d/wk,0,0
190262,",",0,0
190263,over,0,0
190264,a,0,0
190265,4-week,0,0
190266,period,0,0
190267,.,0,1
190268,MAIN,0,0
190269,OUTCOME,0,1
190270,MEASURES,0,0
190271,Swallowing,0,1
190272,function,0,0
190273,was,0,0
190274,evaluated,0,0
190275,by,0,0
190276,the,0,0
190277,water,0,0
190278,swallow,0,0
190279,test,0,0
190280,and,0,1
190281,Standardized,0,0
190282,Swallowing,0,1
190283,Assessment,0,0
190284,",",0,0
190285,oral,0,0
190286,intake,0,0
190287,was,0,0
190288,evaluated,0,0
190289,by,0,0
190290,the,0,0
190291,Functional,0,0
190292,Oral,0,1
190293,Intake,0,1
190294,Scale,0,1
190295,",",0,0
190296,quality,0,0
190297,of,0,0
190298,life,0,1
190299,was,0,0
190300,evaluated,0,0
190301,by,0,0
190302,the,0,0
190303,Swallowing-Related,0,1
190304,Quality,0,0
190305,of,0,1
190306,Life,0,0
190307,(,0,1
190308,SWAL-QOL,0,1
190309,),0,1
190310,Scale,0,1
190311,",",0,0
190312,and,0,0
190313,cognition,0,0
190314,was,0,0
190315,evaluated,0,0
190316,by,0,0
190317,the,0,0
190318,Mini-Mental,0,1
190319,State,0,0
190320,Examination,0,1
190321,(,0,1
190322,MMSE,0,1
190323,),0,1
190324,.,0,0
190325,RESULTS,0,0
190326,There,0,0
190327,were,0,0
190328,no,0,0
190329,statistically,0,0
190330,significant,0,0
190331,differences,0,0
190332,between,0,0
190333,the,0,1
190334,groups,0,0
190335,in,0,0
190336,age,0,1
190337,",",0,0
190338,sex,0,0
190339,",",0,0
190340,duration,0,0
190341,",",0,0
190342,MMSE,0,0
190343,score,0,0
190344,",",0,0
190345,or,0,0
190346,severity,0,0
190347,of,0,0
190348,the,0,0
190349,swallowing,0,0
190350,disorder,0,1
190351,(,0,1
190352,P,0,0
190353,>,0,1
190354,.05,0,0
190355,),0,1
190356,.,0,1
190357,All,0,1
190358,groups,0,0
190359,showed,0,0
190360,improved,0,0
190361,swallowing,0,0
190362,function,0,0
190363,(,0,1
190364,P?.01,0,1
190365,),0,1
190366,;,0,0
190367,the,0,0
190368,sensory,0,0
190369,approach,0,0
190370,combined,0,0
190371,with,0,1
190372,traditional,0,0
190373,swallowing,0,1
190374,therapy,0,0
190375,group,0,1
190376,showed,0,0
190377,significantly,0,0
190378,greater,0,0
190379,improvement,0,0
190380,than,0,0
190381,the,0,0
190382,other,0,1
190383,2,0,1
190384,groups,0,1
190385,",",0,1
190386,and,0,0
190387,the,0,0
190388,motor,0,0
190389,approach,0,0
190390,combined,0,0
190391,with,0,1
190392,traditional,0,0
190393,swallowing,0,1
190394,therapy,0,0
190395,group,0,1
190396,showed,0,0
190397,greater,0,0
190398,improvement,0,0
190399,than,0,0
190400,the,0,0
190401,traditional,0,0
190402,swallowing,0,0
190403,therapy,0,0
190404,group,0,1
190405,(,0,1
190406,P,0,0
190407,<,0,0
190408,.05,0,0
190409,),0,1
190410,.,0,1
190411,SWAL-QOL,0,0
190412,Scale,0,1
190413,scores,0,0
190414,increased,0,0
190415,more,0,0
190416,significantly,0,0
190417,in,0,0
190418,the,0,0
190419,sensory,0,0
190420,approach,0,0
190421,combined,0,0
190422,with,0,1
190423,traditional,0,0
190424,swallowing,0,1
190425,therapy,0,0
190426,and,0,1
190427,motor,0,0
190428,approach,0,0
190429,combined,0,0
190430,with,0,1
190431,traditional,0,0
190432,swallowing,0,1
190433,therapy,0,1
190434,groups,0,0
190435,than,0,0
190436,in,0,1
190437,the,0,0
190438,traditional,0,0
190439,swallowing,0,0
190440,therapy,0,0
190441,group,0,0
190442,",",0,0
190443,and,0,0
190444,the,0,0
190445,sensory,0,0
190446,approach,0,0
190447,combined,0,0
190448,with,0,1
190449,traditional,0,0
190450,swallowing,0,1
190451,therapy,0,0
190452,and,0,1
190453,motor,0,0
190454,approach,0,0
190455,combined,0,0
190456,with,0,1
190457,traditional,0,0
190458,swallowing,0,1
190459,therapy,0,1
190460,groups,0,0
190461,showed,0,0
190462,statistically,0,0
190463,significant,0,0
190464,differences,0,0
190465,(,0,1
190466,P=.04,0,1
190467,),0,1
190468,.,0,1
190469,CONCLUSIONS,0,0
190470,NMES,0,0
190471,that,0,0
190472,targets,0,0
190473,either,0,0
190474,sensory,0,0
190475,input,0,1
190476,or,0,1
190477,motor,0,0
190478,muscle,0,0
190479,coupled,0,0
190480,with,0,1
190481,traditional,0,0
190482,therapy,0,0
190483,is,0,0
190484,conducive,0,0
190485,to,0,0
190486,recovery,0,0
190487,from,0,1
190488,dysphagia,0,1
190489,and,0,0
190490,improves,0,0
190491,quality,0,0
190492,of,0,0
190493,life,0,1
190494,for,1,1
190495,patients,1,1
190496,with,1,1
190497,dysphagia,1,1
190498,with,1,1
190499,medullary,1,1
190500,infarction,1,1
190501,.,1,1
190502,A,0,0
190503,sensory,0,0
190504,approach,0,0
190505,appears,0,0
190506,to,0,0
190507,be,0,0
190508,better,0,0
190509,than,0,0
190510,a,0,0
190511,motor,0,0
190512,approach,0,0
190513,.,0,1
190514,The,0,0
190515,effects,0,0
190516,of,0,0
190517,haloperidol,0,0
190518,on,0,0
190519,discrimination,0,0
190520,learning,0,0
190521,and,0,1
190522,behavioral,0,1
190523,symptoms,0,1
190524,in,0,1
190525,autistic,1,1
190526,children,1,1
190527,.,1,1
190528,This,0,0
190529,double-blind,0,0
190530,and,0,0
190531,placebo-controlled,0,1
190532,clinical,0,0
190533,trial,0,1
190534,in,0,1
190535,autistic,1,1
190536,children,1,1
190537,had,0,1
190538,three,0,1
190539,objectives,0,0
190540,:,0,1
190541,(,0,1
190542,a,0,1
190543,),0,0
190544,to,0,0
190545,replicate,0,1
190546,earlier,0,1
190547,findings,0,0
190548,that,0,0
190549,haloperidol,0,0
190550,administration,0,0
190551,is,0,0
190552,associated,0,0
190553,with,0,1
190554,a,0,1
190555,significant,0,0
190556,reduction,0,0
190557,of,0,1
190558,behavioral,0,1
190559,symptoms,0,1
190560,;,0,1
190561,(,0,1
190562,b,0,1
190563,),0,1
190564,to,0,1
190565,further,0,0
190566,assess,0,0
190567,its,0,0
190568,safety,0,0
190569,when,0,0
190570,given,0,0
190571,on,0,0
190572,a,0,1
190573,short-term,0,0
190574,basis,0,0
190575,;,0,1
190576,and,0,0
190577,(,0,1
190578,c,0,1
190579,),0,0
190580,to,0,0
190581,assess,0,0
190582,whether,0,0
190583,it,0,0
190584,has,0,0
190585,an,0,0
190586,effect,0,0
190587,on,0,0
190588,discrimination,0,0
190589,learning,0,0
190590,.,0,1
190591,Forty-five,1,1
190592,children,1,1
190593,",",1,1
190594,2.02,1,0
190595,to,1,1
190596,7.58,1,0
190597,years,1,1
190598,old,1,1
190599,(,1,1
190600,M,1,1
190601,=,1,1
190602,4.49,1,0
190603,),1,1
190604,",",0,0
190605,completed,0,1
190606,this,0,0
190607,crossover,0,0
190608,design,0,0
190609,",",0,0
190610,with,0,1
190611,random,0,1
190612,assignment,0,1
190613,to,0,1
190614,treatment,0,1
190615,sequences,0,1
190616,.,0,1
190617,Haloperidol,0,0
190618,was,0,0
190619,shown,0,0
190620,to,0,0
190621,be,0,0
190622,a,0,0
190623,powerful,0,0
190624,therapeutic,0,0
190625,agent,0,0
190626,when,0,0
190627,administered,0,0
190628,for,0,0
190629,4,0,1
190630,weeks,0,1
190631,and,0,1
190632,free,0,1
190633,of,0,1
190634,side,0,0
190635,effects,0,0
190636,;,0,1
190637,at,0,1
190638,doses,0,0
190639,ranging,0,1
190640,from,0,1
190641,0.25,0,0
190642,to,0,1
190643,4.0,0,0
190644,mg/day,0,0
190645,(,0,1
190646,M,0,1
190647,=,0,1
190648,0.844,0,0
190649,),0,0
190650,",",0,0
190651,there,0,0
190652,was,0,0
190653,a,0,0
190654,clinically,0,0
190655,and,0,0
190656,statistically,0,0
190657,significant,0,0
190658,reduction,0,0
190659,of,0,0
190660,a,0,0
190661,variety,0,0
190662,of,0,0
190663,symptoms,0,1
190664,.,0,1
190665,Under,0,1
190666,the,0,0
190667,given,0,0
190668,conditions,0,0
190669,",",0,1
190670,the,0,0
190671,children,0,1
190672,failed,0,0
190673,to,0,0
190674,learn,0,0
190675,on,0,0
190676,either,0,0
190677,haloperidol,0,0
190678,or,0,1
190679,placebo,0,0
190680,.,0,1
190681,Efficacy,0,0
190682,of,0,0
190683,colchicine,0,0
190684,versus,0,0
190685,placebo,0,0
190686,for,0,0
190687,the,0,0
190688,treatment,0,0
190689,of,0,0
190690,pericardial,1,1
190691,effusion,1,1
190692,after,1,1
190693,open-heart,1,1
190694,surgery,1,1
190695,:,1,1
190696,A,0,1
190697,randomized,0,1
190698,",",0,0
190699,placebo-controlled,0,0
190700,trial,0,1
190701,.,0,1
190702,BACKGROUND,0,0
190703,Pericardial,1,1
190704,effusion,1,1
190705,(,1,1
190706,PE,1,1
190707,),1,1
190708,",",0,0
190709,a,0,0
190710,common,0,0
190711,complication,0,0
190712,after,0,1
190713,open-heart,0,1
190714,surgery,0,1
190715,",",0,1
190716,accounts,0,0
190717,for,0,1
190718,50,0,1
190719,%,0,0
190720,to,0,1
190721,85,0,1
190722,%,0,0
190723,of,0,1
190724,patients,0,1
190725,.,0,1
190726,Although,0,0
190727,reversible,0,0
190728,in,0,0
190729,most,0,0
190730,of,0,0
190731,the,0,0
190732,cases,0,1
190733,",",0,0
190734,it,0,0
190735,could,0,0
190736,be,0,0
190737,life,0,0
190738,threatening,0,0
190739,in,0,0
190740,the,0,0
190741,occurrence,0,0
190742,of,0,0
190743,tamponade,0,1
190744,in,0,1
190745,large,0,1
190746,effusions,0,1
190747,.,0,1
190748,We,0,0
190749,aimed,0,0
190750,to,0,0
190751,determine,0,0
190752,the,0,0
190753,therapeutic,0,0
190754,efficacy,0,0
190755,of,0,0
190756,colchicine,0,0
190757,on,0,0
190758,PE,1,1
190759,after,1,1
190760,open-heart,1,1
190761,surgery,1,1
190762,.,1,1
190763,METHODS,0,0
190764,The,0,0
190765,study,0,0
190766,is,0,0
190767,a,0,0
190768,prospective,0,0
190769,",",0,0
190770,randomized,0,1
190771,",",0,0
190772,triple-blind,0,0
190773,",",0,0
190774,placebo-controlled,0,0
190775,single-center,1,1
190776,trial,1,1
190777,at,1,1
190778,Tehran,1,1
190779,Heart,1,1
190780,Center,1,1
190781,.,1,1
190782,A,1,0
190783,total,1,1
190784,of,1,1
190785,149,1,1
190786,patients,1,1
190787,with,1,1
190788,mild,1,1
190789,or,1,1
190790,moderate,1,1
190791,PE,1,1
190792,in,1,1
190793,transthoracic,1,1
190794,echocardiography,1,0
190795,were,0,0
190796,randomly,0,1
190797,assigned,0,1
190798,to,0,0
190799,receive,0,1
190800,1,0,1
190801,mg/d,0,0
190802,colchicine,0,0
190803,(,0,1
190804,n,0,1
190805,=,0,1
190806,74,0,1
190807,),0,1
190808,or,0,1
190809,1,0,0
190810,tablet,0,0
190811,of,0,0
190812,placebo,0,0
190813,(,0,1
190814,n,0,1
190815,=,0,1
190816,75,0,1
190817,),0,1
190818,for,0,1
190819,2,0,1
190820,weeks,0,0
190821,and,0,1
190822,then,0,1
190823,underwent,0,1
190824,follow-up,0,0
190825,echocardiography,0,1
190826,.,0,1
190827,RESULTS,0,0
190828,Baseline,0,0
190829,and,0,1
190830,clinical,0,0
190831,characteristics,0,0
190832,were,0,1
190833,not,0,0
190834,significantly,0,0
190835,different,0,0
190836,between,0,0
190837,the,0,0
190838,2,0,1
190839,study,0,1
190840,groups,0,0
190841,except,0,0
190842,for,0,1
190843,age,0,1
190844,(,0,1
190845,P,0,0
190846,=,0,1
190847,.02,0,0
190848,),0,1
190849,and,0,1
190850,graft,0,1
190851,numbers,0,0
190852,(,0,1
190853,P,0,0
190854,=,0,1
190855,.005,0,0
190856,),0,0
190857,.,0,0
190858,There,0,0
190859,was,0,0
190860,no,0,0
190861,significant,0,0
190862,difference,0,0
190863,in,0,0
190864,pretreatment,0,0
190865,and,0,1
190866,posttreatment,0,0
190867,PE,0,1
190868,sizes,0,0
190869,between,0,0
190870,the,0,0
190871,2,0,1
190872,study,0,1
190873,groups,0,1
190874,(,0,1
190875,P,0,0
190876,=,0,1
190877,.440,0,0
190878,and,0,1
190879,.844,0,0
190880,",",0,0
190881,respectively,0,0
190882,),0,1
190883,.,0,1
190884,Median,0,0
190885,(,0,1
190886,25th-75th,0,1
190887,percentiles,0,1
190888,),0,1
190889,of,0,1
190890,effusion,0,1
190891,changes,0,0
190892,was,0,0
190893,5,0,1
190894,mm,0,1
190895,(,0,1
190896,1-7.6,0,0
190897,mm,0,1
190898,),0,1
190899,in,0,0
190900,the,0,0
190901,colchicine,0,0
190902,group,0,1
190903,and,0,1
190904,5,0,0
190905,mm,0,1
190906,(,0,1
190907,1-6.6,0,0
190908,mm,0,1
190909,),0,1
190910,in,0,0
190911,the,0,0
190912,placebo,0,0
190913,group,0,0
190914,(,0,1
190915,P,0,0
190916,=,0,1
190917,.932,0,0
190918,),0,1
190919,.,0,1
190920,Intervention,0,0
190921,had,0,1
190922,no,0,0
190923,significant,0,0
190924,impact,0,0
190925,on,0,0
190926,pretreatment,0,0
190927,and,0,1
190928,posttreatment,0,0
190929,effusion,0,1
190930,values,0,0
190931,and,0,1
190932,changes,0,0
190933,in,0,1
190934,isolated,0,1
190935,coronary,1,1
190936,artery,1,1
190937,bypass,1,1
190938,graft,1,1
190939,surgery,1,1
190940,patients,1,1
190941,(,0,1
190942,P,0,0
190943,=,0,1
190944,.607,0,0
190945,",",0,0
190946,.539,0,0
190947,",",0,0
190948,and,0,0
190949,.628,0,0
190950,",",0,0
190951,respectively,0,0
190952,),0,0
190953,.,0,1
190954,After,0,0
190955,adjustment,0,0
190956,for,0,1
190957,possible,0,0
190958,confounders,0,0
190959,",",0,0
190960,there,0,0
190961,was,0,0
190962,still,0,0
190963,no,0,0
190964,significant,0,0
190965,difference,0,0
190966,in,0,1
190967,postoperative,0,0
190968,PE,0,1
190969,between,0,0
190970,the,0,0
190971,2,0,1
190972,study,0,1
190973,groups,0,1
190974,(,0,1
190975,t,0,0
190976,=,0,1
190977,-0.285,0,0
190978,",",0,1
190979,P,0,0
190980,=,0,1
190981,.776,0,0
190982,),0,1
190983,.,0,1
190984,CONCLUSION,0,0
190985,We,0,0
190986,concluded,0,0
190987,that,0,0
190988,prescription,0,1
190989,of,0,0
190990,colchicine,0,0
190991,does,0,0
190992,not,0,0
190993,seem,0,0
190994,to,0,0
190995,be,0,0
190996,effective,0,0
190997,in,0,0
190998,treatment,0,1
190999,of,0,1
191000,asymptomatic,0,1
191001,postoperative,0,1
191002,PE,1,1
191003,.,1,0
191004,This,0,0
191005,could,0,0
191006,be,0,0
191007,justified,0,0
191008,in,0,0
191009,case,0,0
191010,that,0,0
191011,the,0,0
191012,etiology,0,1
191013,of,0,0
191014,most,0,0
191015,of,0,0
191016,the,0,0
191017,PEs,1,0
191018,might,0,0
191019,be,0,0
191020,contribution,0,0
191021,of,0,0
191022,noninflammatory,0,1
191023,factors,0,0
191024,which,0,0
191025,are,0,0
191026,better,0,0
191027,to,0,0
191028,be,0,0
191029,dealt,0,0
191030,with,0,1
191031,observational,0,1
191032,approaches,0,0
191033,.,0,1
191034,Amiprilose,0,0
191035,hydrochloride,0,0
191036,for,0,0
191037,rheumatoid,1,1
191038,arthritis,1,1
191039,.,1,1
191040,STUDY,0,0
191041,OBJECTIVE,0,0
191042,To,0,0
191043,assess,0,0
191044,the,0,0
191045,safety,0,0
191046,and,0,0
191047,efficacy,0,0
191048,of,0,0
191049,amiprilose,0,0
191050,hydrochloride,0,0
191051,(,0,1
191052,HCl,0,0
191053,),0,1
191054,",",0,0
191055,a,0,0
191056,novel,0,0
191057,synthetic,0,0
191058,carbohydrate,0,1
191059,with,0,1
191060,anti-inflammatory,0,0
191061,and,0,1
191062,immunomodulatory,0,0
191063,properties,0,0
191064,",",0,1
191065,in,0,1
191066,patients,1,1
191067,with,1,1
191068,rheumatoid,1,1
191069,arthritis,1,1
191070,.,1,1
191071,DESIGN,0,0
191072,Prospective,0,0
191073,",",0,0
191074,multicenter,0,0
191075,",",0,0
191076,randomized,0,0
191077,",",0,0
191078,parallel,0,0
191079,group,0,1
191080,",",0,1
191081,double-blind,0,0
191082,placebo-controlled,0,0
191083,12-week,0,0
191084,trial,0,1
191085,.,0,1
191086,PATIENTS,0,0
191087,Two,1,1
191088,hundred,1,1
191089,and,1,1
191090,one,1,1
191091,functional,1,1
191092,class,1,1
191093,I,1,1
191094,and,1,1
191095,II,1,1
191096,patients,1,1
191097,with,1,1
191098,definite,1,1
191099,or,1,1
191100,classic,1,1
191101,rheumatoid,1,1
191102,arthritis,1,1
191103,",",1,0
191104,previously,1,1
191105,untreated,1,1
191106,with,1,1
191107,disease,1,1
191108,modifying,1,0
191109,antirheumatic,1,1
191110,drugs,1,0
191111,.,1,1
191112,INTERVENTIONS,0,0
191113,Patients,0,1
191114,were,0,1
191115,withdrawn,0,1
191116,from,0,1
191117,nonsteroidal,0,1
191118,anti-inflammatory,0,0
191119,drug,0,1
191120,therapy,0,0
191121,.,0,1
191122,Those,0,1
191123,who,0,1
191124,flared,0,1
191125,were,0,1
191126,randomly,0,1
191127,assigned,0,1
191128,to,0,0
191129,amiprilose,0,0
191130,HCl,0,0
191131,",",0,0
191132,6,0,0
191133,g/d,0,0
191134,",",0,0
191135,or,0,0
191136,placebo,0,0
191137,for,0,1
191138,12,0,1
191139,weeks,0,1
191140,.,0,1
191141,No,0,0
191142,concomitant,0,0
191143,anti-inflammatory,0,0
191144,or,0,1
191145,antirheumatic,0,0
191146,drug,0,1
191147,therapy,0,0
191148,was,0,0
191149,permitted,0,0
191150,during,0,0
191151,the,0,0
191152,study,0,1
191153,.,0,1
191154,Combination,0,0
191155,acetaminophen,0,0
191156,and,0,0
191157,propoxyphene,0,0
191158,napsylate,0,1
191159,was,0,0
191160,the,0,0
191161,only,0,0
191162,supplemental,0,1
191163,analgesic,0,0
191164,medication,0,1
191165,allowed,0,0
191166,.,0,1
191167,MEASUREMENTS,0,0
191168,AND,0,0
191169,MAIN,0,0
191170,RESULTS,0,0
191171,The,0,0
191172,number,0,0
191173,of,0,0
191174,painful,0,1
191175,joints,0,1
191176,and,0,1
191177,swollen,0,1
191178,joints,0,1
191179,",",0,1
191180,joint,0,1
191181,pain,0,1
191182,and,0,1
191183,joint,0,1
191184,swelling,0,1
191185,indices,0,0
191186,",",0,1
191187,left,0,1
191188,and,0,0
191189,right,0,1
191190,grip,0,0
191191,strength,0,0
191192,",",0,0
191193,investigator,0,0
191194,global,0,0
191195,assessment,0,0
191196,",",0,0
191197,and,0,0
191198,patient,0,1
191199,global,0,0
191200,assessment,0,0
191201,returned,0,1
191202,to,0,0
191203,baseline,0,0
191204,for,0,0
191205,the,0,0
191206,amiprilose,0,0
191207,group,0,1
191208,and,0,0
191209,showed,0,0
191210,statistically,0,0
191211,significant,0,0
191212,(,0,0
191213,P,0,0
191214,less,0,0
191215,than,0,0
191216,0.05,0,0
191217,),0,1
191218,differences,0,0
191219,from,0,1
191220,the,0,0
191221,placebo,0,0
191222,group,0,1
191223,within,0,1
191224,4,0,0
191225,to,0,1
191226,6,0,1
191227,weeks,0,0
191228,.,0,1
191229,The,0,0
191230,protocol,0,0
191231,criteria,0,1
191232,for,0,1
191233,overall,0,0
191234,therapeutic,0,0
191235,response,0,0
191236,were,0,1
191237,satisfied,0,1
191238,by,0,0
191239,41,0,1
191240,%,0,0
191241,of,0,0
191242,the,0,0
191243,amiprilose,0,0
191244,patients,0,1
191245,",",0,1
191246,compared,0,0
191247,with,0,1
191248,21,0,1
191249,%,0,0
191250,of,0,0
191251,the,0,0
191252,placebo,0,0
191253,group,0,0
191254,(,0,1
191255,P,0,0
191256,=,0,1
191257,0.003,0,0
191258,),0,1
191259,.,0,1
191260,Approximately,0,0
191261,0.5,0,0
191262,tablet,0,0
191263,per,0,1
191264,day,0,1
191265,less,0,0
191266,analgesic,0,0
191267,medication,0,1
191268,was,0,0
191269,taken,0,0
191270,by,0,0
191271,the,0,0
191272,amiprilose,0,0
191273,group,0,1
191274,(,0,1
191275,P,0,0
191276,less,0,0
191277,than,0,0
191278,0.05,0,0
191279,at,0,1
191280,weeks,0,1
191281,6,0,1
191282,and,0,1
191283,12,0,1
191284,),0,0
191285,.,0,0
191286,There,0,0
191287,were,0,0
191288,no,0,0
191289,statistically,0,0
191290,significant,0,0
191291,differences,0,0
191292,in,0,1
191293,morning,0,0
191294,stiffness,0,0
191295,",",0,0
191296,walking,0,0
191297,time,0,0
191298,",",0,0
191299,erythrocyte,0,0
191300,sedimentation,0,0
191301,rate,0,0
191302,",",0,0
191303,C-reactive,0,1
191304,protein,0,0
191305,",",0,0
191306,or,0,0
191307,rheumatoid,0,1
191308,factor,0,0
191309,between,0,0
191310,the,0,0
191311,groups,0,0
191312,.,0,1
191313,A,0,0
191314,similar,0,0
191315,number,0,0
191316,of,0,1
191317,adverse,0,0
191318,experiences,0,1
191319,were,0,1
191320,reported,0,1
191321,by,0,0
191322,the,0,0
191323,patients,0,1
191324,on,0,0
191325,amiprilose,0,0
191326,(,0,1
191327,67,0,1
191328,%,0,0
191329,),0,1
191330,and,0,0
191331,on,0,0
191332,placebo,0,0
191333,(,0,1
191334,63,0,1
191335,%,0,0
191336,),0,1
191337,.,0,1
191338,One,0,1
191339,patient,0,0
191340,on,0,0
191341,amiprilose,0,0
191342,developed,0,1
191343,thrombocytopenia,0,1
191344,of,0,0
191345,unknown,0,1
191346,cause,0,0
191347,;,0,1
191348,no,0,0
191349,other,0,0
191350,reported,0,1
191351,adverse,0,0
191352,effects,0,0
191353,were,0,1
191354,serious,0,1
191355,.,0,1
191356,CONCLUSIONS,0,0
191357,Amiprilose,0,0
191358,HCl,0,0
191359,has,0,0
191360,significant,0,0
191361,anti-inflammatory,0,0
191362,activity,0,0
191363,and,0,0
191364,a,0,0
191365,favorable,0,0
191366,safety,0,0
191367,profile,0,0
191368,when,0,0
191369,used,0,0
191370,as,0,0
191371,the,0,0
191372,sole,0,0
191373,antirheumatic,0,0
191374,therapy,0,1
191375,in,0,1
191376,patients,1,1
191377,with,1,1
191378,active,1,1
191379,rheumatoid,1,1
191380,arthritis,1,1
191381,.,1,1
191382,Synthetic,0,0
191383,carbohydrates,0,0
191384,may,0,0
191385,represent,0,0
191386,an,0,0
191387,important,0,0
191388,new,0,1
191389,class,0,1
191390,of,0,1
191391,drugs,0,0
191392,for,0,1
191393,the,0,0
191394,treatment,0,0
191395,of,0,0
191396,inflammatory,0,0
191397,",",0,1
191398,autoimmune,0,1
191399,diseases,0,1
191400,.,0,1
191401,Efficacy,0,0
191402,of,0,0
191403,Low-Dose,0,0
191404,Buspirone,0,1
191405,for,0,1
191406,Restricted,0,1
191407,and,0,1
191408,Repetitive,0,1
191409,Behavior,0,1
191410,in,0,1
191411,Young,1,1
191412,Children,1,1
191413,with,1,1
191414,Autism,1,1
191415,Spectrum,1,1
191416,Disorder,1,1
191417,:,1,1
191418,A,0,1
191419,Randomized,0,0
191420,Trial,0,1
191421,.,0,1
191422,OBJECTIVES,0,0
191423,To,0,0
191424,determine,0,0
191425,safety,0,0
191426,and,0,0
191427,efficacy,0,0
191428,of,0,0
191429,the,0,0
191430,5HT1A,0,1
191431,serotonin,0,0
191432,partial,0,1
191433,agonist,0,1
191434,buspirone,0,0
191435,on,0,0
191436,core,0,1
191437,autism,0,1
191438,and,0,1
191439,associated,0,0
191440,features,0,1
191441,in,0,1
191442,children,1,1
191443,with,1,1
191444,autism,1,1
191445,spectrum,1,1
191446,disorder,1,1
191447,(,1,1
191448,ASD,1,1
191449,),1,1
191450,.,1,1
191451,STUDY,0,0
191452,DESIGN,0,1
191453,Children,1,1
191454,2-6,1,1
191455,years,1,1
191456,of,1,1
191457,age,1,1
191458,with,1,1
191459,ASD,1,1
191460,(,1,1
191461,N,1,1
191462,=,1,1
191463,166,1,1
191464,),1,1
191465,were,0,1
191466,randomized,0,1
191467,to,0,0
191468,receive,0,1
191469,placebo,0,0
191470,or,0,1
191471,2.5,0,0
191472,or,0,1
191473,5.0,0,0
191474,mg,0,0
191475,of,0,0
191476,buspirone,0,0
191477,twice,0,0
191478,daily,0,0
191479,.,0,1
191480,The,0,0
191481,primary,0,1
191482,objective,0,0
191483,was,0,0
191484,to,0,0
191485,evaluate,0,0
191486,the,0,0
191487,effects,0,0
191488,of,0,1
191489,24,0,1
191490,weeks,0,1
191491,of,0,1
191492,buspirone,0,1
191493,on,0,0
191494,the,0,0
191495,Autism,0,1
191496,Diagnostic,0,1
191497,Observation,0,1
191498,Schedule,0,0
191499,(,0,1
191500,ADOS,0,0
191501,),0,1
191502,Composite,0,0
191503,Total,0,1
191504,Score,0,1
191505,.,0,1
191506,Secondary,0,0
191507,objectives,0,0
191508,included,0,1
191509,evaluating,0,0
191510,the,0,0
191511,effects,0,0
191512,of,0,0
191513,buspirone,0,1
191514,on,0,0
191515,social,0,0
191516,competence,0,1
191517,",",0,1
191518,repetitive,0,0
191519,behaviors,0,0
191520,",",0,1
191521,language,0,0
191522,",",0,0
191523,sensory,0,0
191524,dysfunction,0,1
191525,",",0,0
191526,and,0,0
191527,anxiety,0,1
191528,and,0,0
191529,to,0,0
191530,assess,0,0
191531,side,0,0
191532,effects,0,0
191533,.,0,1
191534,Positron,0,1
191535,emission,0,1
191536,tomography,0,1
191537,measures,0,0
191538,of,0,1
191539,tryptophan,0,0
191540,metabolism,0,0
191541,and,0,0
191542,blood,0,0
191543,serotonin,0,0
191544,concentrations,0,0
191545,were,0,1
191546,assessed,0,0
191547,as,0,0
191548,predictors,0,0
191549,of,0,1
191550,buspirone,0,1
191551,efficacy,0,0
191552,.,0,0
191553,RESULTS,0,0
191554,There,0,0
191555,was,0,0
191556,no,0,0
191557,difference,0,0
191558,in,0,0
191559,the,0,0
191560,ADOS,0,0
191561,Composite,0,0
191562,Total,0,1
191563,Score,0,1
191564,between,0,0
191565,baseline,0,0
191566,and,0,1
191567,24,0,1
191568,weeks,0,0
191569,among,0,1
191570,the,0,1
191571,3,0,1
191572,treatment,0,1
191573,groups,0,1
191574,(,0,1
191575,P,0,0
191576,=,0,1
191577,.400,0,0
191578,),0,1
191579,;,0,0
191580,however,0,0
191581,",",0,0
191582,the,0,0
191583,ADOS,0,0
191584,Restricted,0,1
191585,and,0,1
191586,Repetitive,0,1
191587,Behavior,0,1
191588,score,0,0
191589,showed,0,0
191590,a,0,0
191591,time-by-treatment,0,0
191592,effect,0,0
191593,(,0,1
191594,P,0,0
191595,=,0,1
191596,.006,0,0
191597,),0,1
191598,;,0,0
191599,the,0,0
191600,2.5-mg,0,0
191601,buspirone,0,0
191602,group,0,1
191603,showed,0,0
191604,significant,0,0
191605,improvement,0,0
191606,(,0,1
191607,P,0,0
191608,=,0,1
191609,.003,0,0
191610,),0,1
191611,",",0,0
191612,whereas,0,0
191613,placebo,0,0
191614,and,0,1
191615,5.0-mg,0,0
191616,buspirone,0,1
191617,groups,0,0
191618,showed,0,0
191619,no,0,0
191620,change,0,0
191621,.,0,1
191622,Children,0,1
191623,in,0,0
191624,the,0,0
191625,2.5-mg,0,0
191626,buspirone,0,0
191627,group,0,0
191628,were,0,0
191629,more,0,0
191630,likely,0,0
191631,to,0,0
191632,improve,0,0
191633,if,0,0
191634,they,0,0
191635,had,0,1
191636,fewer,0,0
191637,foci,0,1
191638,of,0,0
191639,increased,0,0
191640,brain,0,1
191641,tryptophan,0,0
191642,metabolism,0,0
191643,on,0,0
191644,positron,0,1
191645,emission,0,1
191646,tomography,0,0
191647,(,0,1
191648,P,0,0
191649,=,0,1
191650,.018,0,0
191651,),0,1
191652,or,0,1
191653,if,0,0
191654,they,0,0
191655,showed,0,0
191656,normal,0,1
191657,levels,0,0
191658,of,0,1
191659,blood,0,0
191660,serotonin,0,0
191661,(,0,1
191662,P,0,0
191663,=,0,1
191664,.044,0,0
191665,),0,1
191666,.,0,1
191667,Adverse,0,0
191668,events,0,0
191669,did,0,0
191670,not,0,0
191671,differ,0,0
191672,significantly,0,0
191673,among,0,0
191674,treatment,0,1
191675,groups,0,1
191676,.,0,1
191677,CONCLUSIONS,0,0
191678,Treatment,0,0
191679,with,0,1
191680,2.5,0,0
191681,mg,0,1
191682,of,0,1
191683,buspirone,0,1
191684,in,0,1
191685,young,1,1
191686,children,1,1
191687,with,1,1
191688,ASD,1,1
191689,might,0,0
191690,be,0,0
191691,a,0,0
191692,useful,0,0
191693,adjunct,0,0
191694,therapy,0,0
191695,to,0,0
191696,target,0,0
191697,restrictive,0,1
191698,and,0,1
191699,repetitive,0,0
191700,behaviors,0,0
191701,in,0,1
191702,conjunction,0,0
191703,with,0,1
191704,behavioral,0,1
191705,interventions,0,1
191706,.,0,1
191707,TRIAL,0,0
191708,REGISTRATION,0,0
191709,ClinicalTrials.gov,0,1
191710,:,0,1
191711,NCT00873509,0,1
191712,.,0,1
191713,[,0,0
191714,The,0,0
191715,effect,0,0
191716,of,0,0
191717,ionic,0,0
191718,and,0,1
191719,nonionic,0,0
191720,x-ray,0,1
191721,contrast,0,1
191722,media,0,1
191723,on,0,0
191724,myocardial,0,1
191725,perfusion,0,0
191726,and,0,1
191727,myocardial,0,1
191728,function,0,0
191729,],0,1
191730,.,0,1
191731,The,0,0
191732,influence,0,0
191733,of,0,0
191734,injections,0,0
191735,of,0,1
191736,Amidotrizoate,0,0
191737,and,0,1
191738,Iopromide,0,0
191739,into,0,1
191740,the,0,0
191741,left,0,1
191742,coronary,0,1
191743,artery,0,1
191744,on,0,0
191745,global,0,0
191746,myocardial,0,1
191747,perfusion,0,0
191748,and,0,1
191749,function,0,0
191750,(,0,1
191751,pressures,0,0
191752,in,0,1
191753,the,0,1
191754,left,0,1
191755,ventricle,0,0
191756,",",0,0
191757,heart,0,1
191758,rate,0,0
191759,),0,0
191760,as,0,0
191761,well,0,0
191762,as,0,0
191763,excitation,0,0
191764,formation,0,0
191765,and,0,0
191766,transmission,0,1
191767,was,0,0
191768,studied,0,1
191769,in,0,1
191770,16,1,1
191771,patients,1,1
191772,with,1,1
191773,ischaemic,1,1
191774,heart,1,1
191775,disease,1,1
191776,.,1,0
191777,No,0,0
191778,statistically,0,0
191779,significant,0,0
191780,differences,0,0
191781,in,0,1
191782,myocardial,0,1
191783,perfusion,0,0
191784,measured,0,0
191785,were,0,0
191786,found,0,0
191787,with,0,1
191788,xenon-133,0,0
191789,in,0,1
191790,this,0,0
191791,small,0,0
191792,group,0,1
191793,between,0,0
191794,rest,0,0
191795,and,0,1
191796,dipyridamole,0,0
191797,load,0,0
191798,for,0,1
191799,ionic,0,0
191800,and,0,1
191801,non-ionic,0,1
191802,contrast,0,1
191803,media,0,1
191804,.,0,1
191805,Oxidized,0,0
191806,Regenerated,0,1
191807,Cellulose,0,0
191808,Reduces,0,1
191809,the,0,1
191810,Amount,0,1
191811,of,0,0
191812,Fluid,0,1
191813,Drainage,0,1
191814,after,0,1
191815,Liver,0,1
191816,Resection,0,1
191817,:,0,1
191818,A,0,1
191819,Randomized,0,0
191820,Prospective,0,1
191821,Clinical,0,0
191822,Trial,0,1
191823,.,0,1
191824,BACKGROUND/AIMS,0,0
191825,Oxidized,0,0
191826,regenerated,0,1
191827,cellulose,0,0
191828,(,0,1
191829,ORC,0,0
191830,),0,1
191831,has,0,0
191832,been,0,0
191833,registered,0,0
191834,as,0,0
191835,adjuncts,0,0
191836,to,0,1
191837,stimulate,0,0
191838,hemostasis,0,0
191839,in,0,0
191840,liver,0,1
191841,surgery,0,1
191842,.,0,1
191843,However,0,0
191844,",",0,0
191845,most,0,0
191846,previous,0,1
191847,studies,0,0
191848,were,0,1
191849,primarily,0,1
191850,designed,0,0
191851,to,0,0
191852,study,0,0
191853,the,0,0
191854,intra-operative,0,0
191855,hemostatic,0,0
191856,efficacy,0,0
191857,",",0,0
191858,and,0,0
191859,the,0,0
191860,effect,0,0
191861,on,0,0
191862,prophylactic,0,1
191863,application,0,0
191864,was,0,0
191865,never,0,1
191866,studied,0,0
191867,as,0,0
191868,a,0,1
191869,primary,0,1
191870,endpoint,0,0
191871,.,0,1
191872,This,0,0
191873,randomized,0,0
191874,prospective,0,1
191875,clinical,0,0
191876,trial,0,1
191877,was,0,0
191878,undertaken,0,0
191879,to,0,0
191880,evaluate,0,0
191881,whether,0,0
191882,ORC,0,0
191883,is,0,0
191884,safe,0,0
191885,and,0,0
191886,effective,0,0
191887,when,0,0
191888,used,0,0
191889,as,0,0
191890,a,0,1
191891,prophylactic,0,1
191892,agent,0,0
191893,covering,0,1
191894,the,0,0
191895,raw,0,0
191896,cut,0,0
191897,surface,0,0
191898,during,1,0
191899,the,1,0
191900,hepatectomy,1,0
191901,to,0,0
191902,reduce,0,0
191903,the,0,0
191904,volume,0,0
191905,and,0,0
191906,duration,0,0
191907,of,0,0
191908,drainage,0,1
191909,.,0,1
191910,METHODOLOGY,0,0
191911,Between,1,1
191912,June,1,1
191913,2011,1,1
191914,and,1,1
191915,August,1,1
191916,2012,1,1
191917,",",1,0
191918,a,1,0
191919,total,1,1
191920,of,1,0
191921,40,1,1
191922,patients,1,1
191923,undergoing,1,1
191924,major,1,1
191925,hepatectomy,1,1
191926,were,0,1
191927,randomly,0,1
191928,assigned,0,1
191929,to,0,0
191930,ORC,0,0
191931,or,0,1
191932,control,0,1
191933,groups,0,1
191934,(,0,1
191935,20,0,1
191936,in,0,0
191937,each,0,1
191938,group,0,1
191939,),0,1
191940,.,0,1
191941,Patient,0,0
191942,characteristics,0,0
191943,",",0,1
191944,resection-related,0,1
191945,factors,0,0
191946,",",0,1
191947,debit,0,0
191948,of,0,0
191949,drainage,0,1
191950,and,0,1
191951,postoperative,0,1
191952,complications,0,1
191953,were,0,1
191954,compared,0,0
191955,between,0,0
191956,the,0,1
191957,two,0,1
191958,groups,0,0
191959,.,0,1
191960,RESULTS,0,0
191961,The,1,0
191962,two,1,0
191963,groups,1,0
191964,were,1,1
191965,comparable,1,0
191966,in,1,1
191967,terms,1,0
191968,of,1,1
191969,demographics,1,0
191970,",",1,1
191971,indications,1,0
191972,for,1,0
191973,surgery,1,1
191974,",",1,0
191975,extent,1,0
191976,of,1,0
191977,hepatectomy,1,0
191978,",",1,0
191979,and,1,0
191980,intraoperative,1,0
191981,blood,1,0
191982,loss,1,0
191983,.,1,1
191984,The,0,0
191985,amount,0,0
191986,of,0,0
191987,drainage,0,1
191988,after,0,1
191989,operation,0,1
191990,was,0,0
191991,significantly,0,0
191992,less,0,0
191993,in,0,0
191994,the,0,0
191995,ORC,0,0
191996,group,0,0
191997,compared,0,0
191998,with,0,1
191999,the,0,0
192000,control,0,1
192001,group,0,1
192002,(,0,1
192003,406.9,0,1
192004,?,0,1
192005,308.1,0,0
192006,vs.,0,0
192007,627.0,0,1
192008,?,0,1
192009,301.6,0,0
192010,ml,0,0
192011,",",0,1
192012,P,0,0
192013,=,0,1
192014,0.028,0,0
192015,),0,1
192016,.,0,1
192017,CONCLUSIONS,0,0
192018,Application,0,0
192019,of,0,1
192020,ORC,0,0
192021,covering,0,1
192022,the,0,0
192023,raw,0,0
192024,cut,0,0
192025,surface,0,0
192026,during,0,0
192027,the,0,0
192028,hepatectomy,0,0
192029,can,0,0
192030,significantly,0,0
192031,decrease,0,0
192032,the,0,0
192033,amount,0,0
192034,of,0,0
192035,drainage,0,1
192036,.,0,1
192037,Low,0,1
192038,power,0,0
192039,laser,0,0
192040,therapy,0,0
192041,of,0,0
192042,shoulder,1,1
192043,tendonitis,1,1
192044,.,1,1
192045,30,1,0
192046,patients,1,1
192047,with,1,1
192048,supraspinatus,1,1
192049,or,1,1
192050,bicipital,1,1
192051,tendonitis,1,1
192052,were,1,1
192053,randomly,1,1
192054,allocated,1,1
192055,to,0,0
192056,active,0,1
192057,infrared,0,0
192058,laser,0,0
192059,therapy,0,0
192060,at,0,1
192061,904,0,1
192062,nm,0,1
192063,three,0,1
192064,times,0,0
192065,weekly,0,1
192066,for,0,1
192067,2,0,1
192068,weeks,0,0
192069,",",0,1
192070,dummy,0,1
192071,laser,0,0
192072,or,0,1
192073,drug,0,0
192074,treatment,0,0
192075,for,0,1
192076,2,0,1
192077,weeks,0,1
192078,.,0,1
192079,Objectively,0,0
192080,maximum,0,0
192081,active,0,1
192082,extension,0,0
192083,",",0,0
192084,flexion,0,1
192085,and,0,0
192086,abduction,0,1
192087,of,0,0
192088,the,0,0
192089,shoulder,0,1
192090,",",0,0
192091,and,0,0
192092,subjectively,0,0
192093,pain,0,1
192094,stiffness,0,0
192095,movement,0,0
192096,and,0,1
192097,function,0,0
192098,were,0,0
192099,measured,0,0
192100,at,0,1
192101,0,0,0
192102,and,0,1
192103,2,0,1
192104,weeks,0,1
192105,.,0,1
192106,Significant,0,0
192107,improvement,0,0
192108,of,0,0
192109,active,0,1
192110,over,0,0
192111,dummy,0,1
192112,laser,0,0
192113,was,0,0
192114,noted,0,0
192115,for,0,0
192116,all,0,1
192117,seven,0,1
192118,assessments,0,0
192119,.,0,1
192120,Active,0,0
192121,laser,0,0
192122,therapy,0,0
192123,produced,0,0
192124,significant,0,0
192125,improvement,0,0
192126,over,0,0
192127,drug,0,0
192128,therapy,0,0
192129,for,0,0
192130,all,0,1
192131,three,0,0
192132,objective,0,0
192133,measures,0,0
192134,and,0,1
192135,pain,0,1
192136,.,0,1
192137,Naproxen,0,0
192138,sodium,0,0
192139,significantly,0,0
192140,improved,0,0
192141,only,0,0
192142,movement,0,0
192143,and,0,0
192144,function,0,0
192145,compared,0,0
192146,to,0,0
192147,dummy,0,1
192148,laser,0,0
192149,.,0,1
192150,These,0,0
192151,results,0,0
192152,demonstrate,0,0
192153,the,0,0
192154,effectiveness,0,0
192155,of,0,0
192156,laser,0,0
192157,therapy,0,0
192158,in,0,0
192159,tendonitis,0,1
192160,of,0,0
192161,the,0,0
192162,shoulder,0,1
192163,.,0,1
192164,[,1,0
192165,Diabetic,1,1
192166,constipation,1,1
192167,treated,0,1
192168,with,0,1
192169,acupoint,0,0
192170,embedding,0,0
192171,therapy,0,0
192172,and,0,1
192173,forlax,0,1
192174,:,0,1
192175,a,0,0
192176,randomized,0,1
192177,controlled,0,0
192178,trial,0,0
192179,],0,1
192180,.,0,1
192181,OBJECTIVE,0,0
192182,To,0,0
192183,compare,0,0
192184,the,0,0
192185,difference,0,0
192186,among,0,0
192187,the,0,0
192188,combined,0,0
192189,method,0,0
192190,of,0,0
192191,oral,0,0
192192,administration,0,0
192193,of,0,0
192194,forlaxand,0,1
192195,acupoint,0,0
192196,embedding,0,0
192197,therapy,0,0
192198,",",0,0
192199,the,0,0
192200,simple,0,0
192201,acupoint,0,0
192202,embedding,0,0
192203,therapy,0,0
192204,and,0,0
192205,the,0,0
192206,simple,0,0
192207,oral,0,0
192208,administration,0,0
192209,of,0,0
192210,for-lax,0,1
192211,in,0,1
192212,the,0,0
192213,clinical,0,0
192214,efficacy,0,0
192215,on,0,0
192216,diabetic,1,1
192217,constipation,1,1
192218,.,1,1
192219,METHODS,0,0
192220,One,1,1
192221,hundred,1,1
192222,and,1,1
192223,fifty,1,1
192224,patients,1,1
192225,were,1,1
192226,randomized,1,1
192227,intoa,1,1
192228,comprehensive,1,0
192229,group,1,0
192230,",",0,0
192231,an,0,0
192232,acupoint,0,0
192233,embedding,0,0
192234,group,0,1
192235,and,0,0
192236,a,0,0
192237,forlax,0,1
192238,group,0,1
192239,",",0,1
192240,50,0,1
192241,cases,0,1
192242,in,0,1
192243,each,0,1
192244,one,0,1
192245,.,0,1
192246,In,0,0
192247,the,0,0
192248,acupointembedding,0,0
192249,group,0,0
192250,",",0,0
192251,the,0,0
192252,embedding,0,0
192253,therapy,0,0
192254,was,0,0
192255,applied,0,0
192256,to,0,1
192257,bilateral,0,1
192258,Tianshu,0,1
192259,(,0,1
192260,ST,0,1
192261,25,0,1
192262,),0,1
192263,",",0,1
192264,Daheng,0,1
192265,(,0,1
192266,SP,0,1
192267,15,0,1
192268,),0,1
192269,",",0,1
192270,Shangjuxu,0,0
192271,(,0,1
192272,ST,0,1
192273,37,0,1
192274,),0,1
192275,and,0,1
192276,Dachangshu,0,1
192277,(,0,1
192278,BL,0,1
192279,25,0,1
192280,),0,0
192281,",",0,0
192282,once,0,0
192283,a,0,0
192284,week,0,0
192285,.,0,0
192286,In,0,0
192287,the,0,0
192288,forlax,0,1
192289,group,0,0
192290,",",0,0
192291,forlax,0,1
192292,(,0,0
192293,polyethylene,0,0
192294,glycol,0,0
192295,),0,1
192296,was,0,0
192297,prescribedfor,0,0
192298,oral,0,0
192299,administration,0,0
192300,",",0,0
192301,once,0,0
192302,a,0,0
192303,day,0,0
192304,",",0,0
192305,10,0,1
192306,g,0,1
192307,each,0,1
192308,time,0,0
192309,.,0,0
192310,In,0,0
192311,the,0,0
192312,comprehensive,0,0
192313,group,0,0
192314,",",0,0
192315,the,0,0
192316,acupoint,0,0
192317,embedding,0,0
192318,therapyand,0,1
192319,forlax,0,1
192320,were,0,1
192321,combined,0,0
192322,and,0,0
192323,the,0,0
192324,methods,0,1
192325,were,0,1
192326,the,0,0
192327,same,0,0
192328,as,0,0
192329,the,0,0
192330,first,0,1
192331,two,0,1
192332,groups,0,1
192333,.,0,1
192334,The,0,0
192335,treatment,0,0
192336,for,0,0
192337,4,0,0
192338,weeks,0,1
192339,wasas,0,1
192340,one,0,1
192341,session,0,0
192342,",",0,1
192343,and,0,1
192344,2,0,1
192345,sessions,0,0
192346,were,0,1
192347,required,0,0
192348,in,0,0
192349,the,0,1
192350,three,0,1
192351,groups,0,0
192352,.,0,1
192353,Separately,0,0
192354,",",0,0
192355,in,0,0
192356,4,0,0
192357,weeks,0,1
192358,",",0,1
192359,8,0,1
192360,weeks,0,0
192361,of,0,1
192362,treatment,0,1
192363,and2,0,0
192364,months,0,0
192365,after,0,1
192366,treatment,0,0
192367,",",0,0
192368,the,0,0
192369,constipation,0,1
192370,symptom,0,0
192371,scores,0,0
192372,were,0,1
192373,compared,0,0
192374,among,0,0
192375,the,0,1
192376,three,0,1
192377,groups,0,0
192378,.,0,1
192379,At,0,0
192380,the,0,0
192381,end,0,0
192382,of2,0,1
192383,sessions,0,0
192384,of,0,0
192385,treatment,0,0
192386,",",0,0
192387,the,0,0
192388,clinical,0,0
192389,efficacy,0,0
192390,and,0,1
192391,adverse,0,0
192392,reactions,0,0
192393,were,0,1
192394,compared,0,0
192395,among,0,0
192396,the,0,1
192397,three,0,1
192398,groups,0,1
192399,.,0,1
192400,In2,0,0
192401,months,0,0
192402,after,0,1
192403,treatment,0,0
192404,",",0,0
192405,the,0,0
192406,recurrence,0,0
192407,rate,0,0
192408,was,0,0
192409,compared,0,0
192410,among,0,0
192411,the,0,1
192412,three,0,1
192413,groups,0,0
192414,.,0,1
192415,RESULTS,0,0
192416,The,0,0
192417,total,0,1
192418,effectiverate,0,0
192419,was,0,0
192420,98,0,1
192421,.,0,1
192422,0,0,0
192423,%,0,0
192424,(,0,1
192425,49/50,0,1
192426,),0,1
192427,in,0,0
192428,the,0,0
192429,comprehensive,0,0
192430,group,0,0
192431,",",0,0
192432,better,0,0
192433,than,0,0
192434,86,0,1
192435,.,0,1
192436,0,0,0
192437,%,0,0
192438,(,0,1
192439,43/50,0,0
192440,),0,1
192441,in,0,0
192442,the,0,0
192443,acupoint,0,0
192444,embeddinggroup,0,0
192445,and,0,1
192446,78,0,1
192447,.,0,1
192448,0,0,0
192449,%,0,0
192450,(,0,1
192451,11/50,0,1
192452,),0,1
192453,in,0,0
192454,the,0,0
192455,forlax,0,1
192456,group,0,0
192457,(,0,0
192458,both,0,0
192459,P,0,0
192460,<,0,0
192461,0,0,0
192462,.,0,1
192463,01,0,1
192464,),0,0
192465,.,0,1
192466,In,0,0
192467,the,0,0
192468,4,0,0
192469,weeks,0,0
192470,and,0,1
192471,8,0,1
192472,weeks,0,0
192473,of,0,1
192474,treatment,0,0
192475,",",0,0
192476,the,0,0
192477,con-stipation,0,0
192478,symptom,0,0
192479,scores,0,0
192480,were,0,1
192481,reduced,0,0
192482,significantly,0,0
192483,as,0,0
192484,compared,0,0
192485,with,0,1
192486,those,0,1
192487,before,0,0
192488,treatment,0,0
192489,in,0,0
192490,the,0,1
192491,three,0,0
192492,groups,0,0
192493,(,0,1
192494,all,0,1
192495,P,0,0
192496,<,0,0
192497,0,0,0
192498,.,0,1
192499,05,0,0
192500,),0,0
192501,.,0,1
192502,The,0,0
192503,results,0,0
192504,in,0,0
192505,the,0,1
192506,comprehensive,0,0
192507,group,0,0
192508,were,0,1
192509,lower,0,0
192510,than,0,0
192511,those,0,0
192512,in,0,0
192513,the,0,0
192514,other,0,1
192515,two,0,1
192516,groups,0,1
192517,(,0,1
192518,all,0,1
192519,P,0,0
192520,<,0,0
192521,0,0,0
192522,.,0,1
192523,05,0,0
192524,),0,0
192525,.,0,1
192526,In,0,0
192527,the,0,0
192528,4,0,0
192529,weeks,0,0
192530,of,0,1
192531,treatment,0,0
192532,",",0,0
192533,the,0,0
192534,scores,0,0
192535,were,0,1
192536,not,0,0
192537,different,0,0
192538,significantly,0,0
192539,between,0,0
192540,the,0,0
192541,acupoint,0,0
192542,embedding,0,0
192543,group,0,1
192544,and,0,0
192545,the,0,0
192546,forlax,0,1
192547,group,0,0
192548,(,0,1
192549,P,0,0
192550,>,0,1
192551,0.05,0,0
192552,),0,1
192553,.,0,1
192554,In,0,0
192555,8,0,1
192556,weeks,0,1
192557,of,0,1
192558,treatment,0,1
192559,and,0,1
192560,2,0,1
192561,months,0,0
192562,after,0,1
192563,treatment,0,0
192564,",",0,0
192565,the,0,0
192566,scores,0,0
192567,in,0,0
192568,the,0,0
192569,acupoint,0,0
192570,embedding,0,0
192571,group,0,0
192572,were,0,1
192573,better,0,0
192574,tan,0,0
192575,those,0,0
192576,in,0,0
192577,the,0,0
192578,forlax,0,1
192579,group,0,0
192580,(,0,0
192581,all,0,0
192582,p,0,0
192583,<,0,0
192584,0.05,0,0
192585,),0,0
192586,.,0,0
192587,There,0,0
192588,were,0,0
192589,2,0,0
192590,cases,0,1
192591,of,0,1
192592,drug,0,1
192593,adverse,0,0
192594,reaction,0,0
192595,in,0,0
192596,the,0,0
192597,comprehensive,0,0
192598,group,0,1
192599,",",0,1
192600,6,0,0
192601,cases,0,1
192602,in,0,1
192603,the,0,0
192604,forlax,0,1
192605,group,0,1
192606,and,0,1
192607,0,0,0
192608,case,0,0
192609,in,0,0
192610,the,0,0
192611,acupoint,0,0
192612,embedding,0,0
192613,group,0,1
192614,.,0,1
192615,The,0,0
192616,recurrence,0,0
192617,rate,0,0
192618,was,0,0
192619,8.1,0,0
192620,%,0,0
192621,(,0,1
192622,4/49,0,0
192623,),0,1
192624,in,0,0
192625,the,0,0
192626,comprehensive,0,0
192627,group,0,0
192628,",",0,0
192629,lower,0,0
192630,than,0,0
192631,32.6,0,1
192632,%,0,0
192633,(,0,1
192634,14/43,0,1
192635,),0,1
192636,in,0,0
192637,the,0,0
192638,acupoint,0,0
192639,embedding,0,0
192640,group,0,1
192641,and,0,1
192642,59.0,0,0
192643,%,0,0
192644,(,0,1
192645,23/39,0,0
192646,),0,1
192647,in,0,0
192648,the,0,0
192649,forlax,0,1
192650,group,0,0
192651,(,0,0
192652,both,0,0
192653,P,0,0
192654,<,0,0
192655,0.01,0,0
192656,),0,1
192657,.,0,1
192658,CONCLUSION,0,0
192659,the,0,0
192660,combined,0,0
192661,therapy,0,0
192662,of,0,0
192663,acupoint,0,0
192664,embedding,0,0
192665,and,0,0
192666,forlax,0,1
192667,achieves,0,0
192668,the,0,0
192669,better,0,0
192670,clinical,0,0
192671,efficacy,0,0
192672,on,0,0
192673,diabetic,1,1
192674,constipation,1,1
192675,and,0,0
192676,constipation,0,1
192677,symptom,0,0
192678,scores,0,0
192679,as,0,0
192680,compared,0,0
192681,with,0,1
192682,the,0,0
192683,simple,0,0
192684,acupoint,0,0
192685,embedding,0,0
192686,therapy,0,0
192687,and,0,0
192688,the,0,0
192689,oral,0,0
192690,administration,0,0
192691,of,0,0
192692,forlax,0,1
192693,the,0,0
192694,short-term,0,0
192695,efficacy,0,0
192696,of,0,0
192697,the,0,0
192698,simple,0,0
192699,acupoint,0,0
192700,embedding,0,0
192701,therapy,0,0
192702,is,0,0
192703,not,0,0
192704,different,0,0
192705,significantly,0,0
192706,from,0,1
192707,the,0,0
192708,simple,0,0
192709,forlax,0,1
192710,medication,0,1
192711,",",0,0
192712,but,0,0
192713,the,0,0
192714,long-term,0,0
192715,efficacy,0,0
192716,and,0,0
192717,safety,0,0
192718,are,0,0
192719,better,0,0
192720,than,0,0
192721,those,0,0
192722,of,0,0
192723,simple,0,0
192724,forlax,0,1
192725,medicaiton,0,1
192726,.,0,1
192727,A,0,0
192728,comparison,0,0
192729,of,0,0
192730,high,0,1
192731,and,0,1
192732,low,0,1
192733,fat,0,1
192734,meals,0,1
192735,on,0,1
192736,postprandial,1,1
192737,esophageal,1,1
192738,acid,1,0
192739,exposure,1,1
192740,.,1,1
192741,Fatty,0,0
192742,foods,0,1
192743,have,0,1
192744,been,0,0
192745,identified,0,1
192746,as,0,0
192747,precipitating,0,1
192748,factors,0,0
192749,in,0,1
192750,symptomatic,0,1
192751,gastroesophageal,1,1
192752,reflux,1,1
192753,(,1,1
192754,GER,1,1
192755,),1,1
192756,.,1,1
192757,A,0,0
192758,fat,0,0
192759,meal,0,0
192760,has,0,0
192761,also,0,0
192762,been,0,0
192763,found,0,0
192764,to,0,0
192765,decrease,0,0
192766,lower,0,0
192767,esophageal,0,1
192768,sphincter,0,0
192769,pressure,0,0
192770,(,0,1
192771,LESP,0,1
192772,),0,1
192773,in,0,1
192774,normal,0,1
192775,subjects,0,1
192776,.,0,1
192777,We,0,0
192778,used,0,0
192779,the,0,0
192780,ambulatory,0,1
192781,24-h,0,0
192782,pH,0,1
192783,monitor,0,0
192784,to,0,0
192785,assess,0,0
192786,esophageal,0,1
192787,acid,0,0
192788,exposure,0,1
192789,in,0,1
192790,10,1,1
192791,normal,1,1
192792,subjects,1,1
192793,and,1,1
192794,10,1,1
192795,GER,1,1
192796,patients,1,1
192797,following,1,1
192798,low,1,1
192799,and,1,1
192800,high,1,1
192801,fat,1,0
192802,meals,1,1
192803,eaten,1,1
192804,in,1,0
192805,two,1,1
192806,body,1,1
192807,positions,1,0
192808,.,1,1
192809,The,0,0
192810,meals,0,0
192811,had,0,1
192812,nearly,0,1
192813,identical,0,0
192814,protein,0,0
192815,content,0,0
192816,",",0,0
192817,volumes,0,0
192818,",",0,1
192819,and,0,1
192820,calories,0,1
192821,.,0,1
192822,On,0,1
192823,successive,0,1
192824,days,0,0
192825,",",0,1
192826,patients,0,1
192827,ingested,0,1
192828,one,0,1
192829,of,0,0
192830,the,0,0
192831,meals,0,1
192832,twice,0,0
192833,",",0,0
192834,followed,0,0
192835,by,0,0
192836,random,0,1
192837,assignment,0,1
192838,to,0,1
192839,3,0,1
192840,h,0,0
192841,upright,0,1
192842,and,0,1
192843,3,0,1
192844,h,0,0
192845,recumbent,0,1
192846,position,0,1
192847,.,0,1
192848,Acid,0,0
192849,exposure,0,0
192850,for,0,0
192851,each,0,0
192852,hour,0,0
192853,over,0,0
192854,a,0,1
192855,3-h,0,0
192856,postprandial,0,0
192857,(,0,1
192858,PP,0,1
192859,),0,1
192860,period,0,0
192861,was,0,0
192862,assessed,0,0
192863,as,0,0
192864,the,0,0
192865,percent,0,0
192866,time,0,0
192867,pH,0,0
192868,less,0,0
192869,than,0,1
192870,4.0,0,0
192871,.,0,1
192872,Increased,0,0
192873,upright,0,1
192874,acid,0,0
192875,exposure,0,0
192876,occurred,0,0
192877,in,0,0
192878,normals,0,1
192879,after,0,1
192880,the,0,1
192881,high,0,1
192882,fat,0,0
192883,(,0,1
192884,6.2,0,0
192885,+/-,0,1
192886,2.1,0,1
192887,%,0,0
192888,;,0,1
192889,mean,0,1
192890,+/-,0,0
192891,SE,0,1
192892,),0,1
192893,compared,0,0
192894,with,0,1
192895,the,0,0
192896,low,0,1
192897,fat,0,0
192898,meal,0,1
192899,(,0,1
192900,1.5,0,1
192901,+/-,0,1
192902,0.5,0,0
192903,%,0,0
192904,;,0,0
192905,p,0,0
192906,less,0,0
192907,than,0,0
192908,0.05,0,0
192909,),0,1
192910,.,0,1
192911,GER,0,0
192912,patients,0,1
192913,had,0,1
192914,greater,0,0
192915,(,0,0
192916,p,0,0
192917,less,0,0
192918,than,0,0
192919,0.05,0,0
192920,),0,1
192921,acid,0,0
192922,exposure,0,1
192923,than,0,0
192924,normals,0,1
192925,in,0,1
192926,all,0,1
192927,study,0,1
192928,periods,0,0
192929,",",0,0
192930,but,0,0
192931,no,0,0
192932,differences,0,0
192933,were,0,1
192934,found,0,0
192935,between,0,0
192936,low,0,1
192937,and,0,1
192938,high,0,1
192939,fat,0,1
192940,meals,0,1
192941,in,0,0
192942,either,0,1
192943,study,0,1
192944,position,0,0
192945,.,0,1
192946,High,0,0
192947,fat,0,0
192948,meals,0,1
192949,induce,0,0
192950,upright,0,1
192951,GER,0,1
192952,in,0,1
192953,normals,0,1
192954,",",0,0
192955,but,0,0
192956,do,0,0
192957,not,0,0
192958,significantly,0,0
192959,affect,0,0
192960,the,0,0
192961,abnormal,0,0
192962,amount,0,0
192963,of,0,0
192964,GER,0,1
192965,in,0,1
192966,patients,0,1
192967,.,0,1
192968,In,0,0
192969,addition,0,0
192970,",",0,1
192971,progressive,0,1
192972,increases,0,0
192973,in,0,1
192974,acid,0,0
192975,exposure,0,1
192976,were,0,1
192977,found,0,0
192978,over,0,0
192979,the,0,0
192980,3,0,1
192981,postprandial,0,1
192982,hours,0,0
192983,in,0,1
192984,GER,0,1
192985,patients,0,1
192986,in,0,1
192987,a,0,1
192988,recumbent,0,0
192989,position,0,0
192990,.,0,1
192991,The,0,0
192992,findings,0,0
192993,are,0,0
192994,consistent,0,0
192995,with,0,1
192996,prior,0,1
192997,data,0,0
192998,showing,0,1
192999,decreased,0,0
193000,LESP,0,1
193001,with,0,1
193002,a,0,1
193003,fat,0,0
193004,meal,0,0
193005,in,0,1
193006,normals,0,1
193007,.,0,1
193008,An,0,0
193009,evaluation,0,0
193010,of,0,0
193011,sealing,0,0
193012,ability,0,0
193013,of,0,0
193014,calcium,0,0
193015,hydroxide,0,1
193016,sealers,0,0
193017,.,0,1
193018,Solid,0,0
193019,core,0,0
193020,filling,0,0
193021,material,0,1
193022,such,0,0
193023,as,0,0
193024,gutta-percha,0,0
193025,has,0,0
193026,been,0,0
193027,used,0,0
193028,to,0,0
193029,fill,0,0
193030,the,0,0
193031,root,0,0
193032,canal,0,0
193033,in,0,0
193034,conjunction,0,0
193035,with,0,1
193036,a,0,1
193037,sealer,0,0
193038,to,0,0
193039,prevent,0,0
193040,apical,0,0
193041,leakage,0,0
193042,.,0,1
193043,The,0,0
193044,purpose,0,0
193045,of,0,0
193046,this,0,0
193047,study,0,0
193048,was,0,0
193049,to,0,0
193050,compare,0,0
193051,apical,0,0
193052,seal,0,1
193053,of,0,1
193054,five,0,1
193055,different,0,1
193056,root,0,1
193057,canal,0,1
193058,sealers,0,0
193059,.,0,1
193060,Sixty,1,1
193061,roots,1,1
193062,of,1,1
193063,maxillary,1,1
193064,central,1,1
193065,incisors,1,1
193066,were,0,1
193067,cleansed,0,0
193068,and,0,0
193069,shaped,0,0
193070,and,0,0
193071,randomly,0,1
193072,assigned,0,1
193073,to,0,0
193074,one,0,1
193075,of,0,1
193076,six,0,1
193077,groups,0,1
193078,of,0,1
193079,ten,0,1
193080,roots,0,1
193081,each,0,1
193082,.,0,1
193083,The,0,0
193084,root,0,0
193085,canals,0,1
193086,were,0,1
193087,obturated,0,1
193088,with,0,1
193089,gutta-percha,0,0
193090,and,0,1
193091,one,0,1
193092,of,0,0
193093,the,0,0
193094,sealers,0,0
193095,by,0,0
193096,the,0,1
193097,lateral-vertical,0,0
193098,condensation,0,1
193099,technique,0,0
193100,.,0,1
193101,Groups,0,0
193102,I,0,0
193103,",",0,0
193104,II,0,1
193105,",",0,0
193106,III,0,1
193107,",",0,0
193108,IV,0,0
193109,",",0,0
193110,and,0,0
193111,V,0,0
193112,consisted,0,1
193113,of,0,0
193114,roots,0,1
193115,in,0,1
193116,which,0,0
193117,the,0,0
193118,canal,0,0
193119,was,0,0
193120,filled,0,0
193121,with,0,1
193122,gutta-percha,0,0
193123,along,0,0
193124,with,0,1
193125,either,0,1
193126,Roth,0,0
193127,'s,0,1
193128,sealer,0,0
193129,",",0,1
193130,AH26,0,1
193131,",",0,0
193132,Sealapex,0,0
193133,",",0,0
193134,CRCS,0,1
193135,",",0,0
193136,or,0,1
193137,Nogenol,0,0
193138,sealer,0,0
193139,",",0,0
193140,respectively,0,0
193141,.,0,1
193142,Group,0,0
193143,VI,0,0
193144,was,0,0
193145,filled,0,0
193146,with,0,1
193147,gutta-percha,0,0
193148,and,0,1
193149,without,0,1
193150,sealer,0,0
193151,to,0,0
193152,serve,0,0
193153,as,0,0
193154,a,0,0
193155,control,0,1
193156,.,0,0
193157,The,0,0
193158,access,0,0
193159,opening,0,0
193160,was,0,0
193161,filled,0,0
193162,with,0,1
193163,amalgam,0,1
193164,.,0,1
193165,Each,1,0
193166,tooth,1,0
193167,was,0,0
193168,then,0,0
193169,placed,0,0
193170,in,0,0
193171,a,0,1
193172,capped,0,0
193173,vial,0,0
193174,containing,0,0
193175,2,0,1
193176,X,0,1
193177,2,0,1
193178,inch,0,1
193179,gauze,0,0
193180,pads,0,0
193181,saturated,0,0
193182,with,0,1
193183,distilled,0,0
193184,water,0,0
193185,",",0,0
193186,and,0,0
193187,the,0,0
193188,sealer,0,0
193189,was,0,0
193190,allowed,0,0
193191,to,0,0
193192,set,0,0
193193,at,0,1
193194,37,0,1
193195,degrees,0,1
193196,C,0,1
193197,in,0,1
193198,the,0,0
193199,humidor,0,1
193200,for,0,0
193201,48,0,1
193202,hours,0,1
193203,.,0,1
193204,The,0,0
193205,roots,0,0
193206,",",0,0
193207,except,0,0
193208,for,0,0
193209,the,0,1
193210,apical,0,0
193211,2,0,1
193212,mm,0,1
193213,",",0,0
193214,were,0,0
193215,coated,0,0
193216,with,0,1
193217,two,0,1
193218,layers,0,0
193219,of,0,1
193220,nail,0,1
193221,polish,0,1
193222,.,0,1
193223,The,0,0
193224,roots,0,1
193225,were,0,1
193226,stained,0,0
193227,with,0,1
193228,india,0,1
193229,ink,0,1
193230,",",0,0
193231,decalcified,0,1
193232,",",0,0
193233,dehydrated,0,0
193234,",",0,0
193235,and,0,0
193236,then,0,0
193237,placed,0,0
193238,in,0,0
193239,methylsalicylate,0,0
193240,to,0,0
193241,make,0,0
193242,them,0,0
193243,transparent,0,0
193244,.,0,1
193245,The,0,0
193246,leakage,0,0
193247,was,0,0
193248,measured,0,0
193249,with,0,1
193250,a,0,1
193251,filar,0,1
193252,micrometer,0,0
193253,eyepiece,0,0
193254,under,0,0
193255,a,0,0
193256,dissecting,0,1
193257,microscope,0,0
193258,.,0,1
193259,The,0,0
193260,mean,0,0
193261,apical,0,0
193262,leakage,0,1
193263,of,0,1
193264,six,0,1
193265,groups,0,1
193266,was,0,0
193267,as,0,0
193268,follows,0,0
193269,:,0,0
193270,I,0,0
193271,=,0,1
193272,0.45,0,0
193273,mm,0,1
193274,",",0,0
193275,II,0,1
193276,=,0,0
193277,0.277,0,0
193278,mm,0,0
193279,",",0,0
193280,III,0,0
193281,=,0,0
193282,0.343,0,0
193283,mm,0,0
193284,",",0,0
193285,IV,0,0
193286,=,0,0
193287,0.263,0,0
193288,mm,0,0
193289,",",0,0
193290,V,0,0
193291,=,0,0
193292,0.336,0,0
193293,mm,0,0
193294,",",0,0
193295,and,0,0
193296,VI,0,1
193297,=,0,1
193298,2.310,0,0
193299,mm,0,1
193300,.,0,1
193301,Results,0,0
193302,showed,0,0
193303,no,0,0
193304,significant,0,0
193305,difference,0,0
193306,in,0,0
193307,the,0,0
193308,apical,0,0
193309,seal,0,0
193310,produced,0,0
193311,by,0,0
193312,gutta-percha,0,0
193313,and,0,0
193314,the,0,0
193315,tested,0,0
193316,root,0,1
193317,canal,0,1
193318,sealers,0,0
193319,.,0,1
193320,(,0,0
193321,ABSTRACT,0,0
193322,TRUNCATED,0,1
193323,AT,0,1
193324,250,0,1
193325,WORDS,0,1
193326,),0,1
193327,Rate-modulated,0,1
193328,cardiac,0,1
193329,pacing,0,0
193330,based,0,1
193331,on,0,0
193332,transthoracic,0,1
193333,impedance,0,0
193334,measurements,0,0
193335,of,0,1
193336,minute,0,1
193337,ventilation,0,1
193338,:,0,1
193339,correlation,0,0
193340,with,0,1
193341,exercise,0,0
193342,gas,0,1
193343,exchange,0,0
193344,.,0,1
193345,The,0,0
193346,relation,0,0
193347,of,0,0
193348,pacing,0,0
193349,rate,0,0
193350,to,0,1
193351,physiologic,0,0
193352,variables,0,0
193353,of,0,0
193354,metabolic,0,1
193355,demand,0,0
193356,was,0,0
193357,examined,0,0
193358,in,0,1
193359,10,1,1
193360,consecutive,1,1
193361,patients,1,1
193362,with,1,1
193363,a,1,1
193364,minute,1,0
193365,ventilation-sensing,1,0
193366,",",1,0
193367,rate-modulating,1,0
193368,ventricular,1,1
193369,pacemaker,1,1
193370,implanted,1,1
193371,for,1,0
193372,complete,1,1
193373,heart,1,1
193374,block,1,1
193375,.,1,1
193376,All,1,1
193377,patients,1,1
193378,had,1,1
193379,paroxysmal,1,1
193380,(,1,1
193381,seven,1,1
193382,patients,1,1
193383,),1,1
193384,or,1,1
193385,chronic,1,1
193386,(,1,1
193387,three,1,1
193388,patients,1,1
193389,),1,1
193390,atrial,1,1
193391,fibrillation,1,1
193392,and,1,1
193393,were,1,0
193394,referred,1,1
193395,for,1,0
193396,catheter,1,0
193397,ablation,1,1
193398,of,1,0
193399,the,1,0
193400,atrioventricular,1,1
193401,junction,1,1
193402,.,1,1
193403,Treadmill,0,0
193404,exercise,0,0
193405,testing,0,0
193406,with,0,1
193407,measurement,0,0
193408,of,0,0
193409,expired,0,0
193410,gas,0,1
193411,exchange,0,0
193412,and,0,0
193413,respiratory,0,1
193414,flow,0,0
193415,was,0,0
193416,performed,0,0
193417,before,0,0
193418,ablation,0,1
193419,and,0,1
193420,4,0,0
193421,weeks,0,0
193422,after,0,1
193423,pacemaker,0,1
193424,implantation,0,1
193425,",",0,0
193426,with,0,1
193427,the,0,0
193428,pacemaker,0,1
193429,programmed,0,0
193430,to,0,0
193431,both,0,0
193432,the,0,0
193433,fixed-rate,0,0
193434,VVI,0,1
193435,and,0,1
193436,rate-modulating,0,0
193437,minute,0,0
193438,ventilation,0,1
193439,VVIR,0,1
193440,pacing,0,0
193441,modes,0,0
193442,in,0,1
193443,random,0,1
193444,sequence,0,0
193445,.,0,1
193446,The,0,0
193447,relation,0,0
193448,of,0,0
193449,pacing,0,0
193450,rate,0,0
193451,to,0,0
193452,oxygen,0,0
193453,consumption,0,0
193454,(,0,0
193455,VO2,0,1
193456,),0,1
193457,",",0,0
193458,expired,0,0
193459,carbon,0,0
193460,dioxide,0,0
193461,concentration,0,0
193462,(,0,1
193463,VCO2,0,1
193464,),0,1
193465,",",0,0
193466,respiratory,0,1
193467,quotient,0,0
193468,",",0,0
193469,tidal,0,0
193470,volume,0,0
193471,",",0,0
193472,respiratory,0,1
193473,rate,0,0
193474,and,0,0
193475,minute,0,0
193476,ventilation,0,1
193477,was,0,0
193478,determined,0,0
193479,during,0,0
193480,exercise,0,0
193481,in,0,0
193482,the,0,0
193483,rate-modulating,0,0
193484,minute,0,0
193485,ventilation,0,1
193486,pacing,0,0
193487,mode,0,0
193488,.,0,1
193489,Pacing,0,0
193490,rate,0,0
193491,was,0,0
193492,highly,0,0
193493,correlated,0,0
193494,with,0,1
193495,minute,0,0
193496,ventilation,0,1
193497,(,0,1
193498,r,0,0
193499,=,0,1
193500,0.89,0,0
193501,),0,1
193502,",",0,0
193503,respiratory,0,1
193504,quotient,0,0
193505,(,0,1
193506,r,0,0
193507,=,0,1
193508,0.89,0,0
193509,),0,1
193510,",",0,1
193511,VCO2,0,0
193512,(,0,0
193513,r,0,0
193514,=,0,1
193515,0.87,0,0
193516,),0,0
193517,",",0,0
193518,tidal,0,0
193519,volume,0,0
193520,(,0,1
193521,r,0,0
193522,=,0,1
193523,0.87,0,0
193524,),0,1
193525,",",0,1
193526,VO2,0,1
193527,(,0,0
193528,r,0,0
193529,=,0,1
193530,0.84,0,0
193531,),0,1
193532,and,0,1
193533,respiratory,0,1
193534,rate,0,0
193535,(,0,0
193536,r,0,0
193537,=,0,1
193538,0.84,0,0
193539,),0,1
193540,.,0,1
193541,The,0,0
193542,mean,0,0
193543,exercise,0,0
193544,duration,0,0
193545,increased,0,0
193546,from,0,1
193547,8.3,0,0
193548,+/-,0,1
193549,2.8,0,0
193550,min,0,0
193551,in,0,0
193552,the,0,0
193553,fixed,0,0
193554,rate,0,0
193555,pacing,0,0
193556,mode,0,0
193557,to,0,1
193558,10.2,0,0
193559,+/-,0,0
193560,3.4,0,0
193561,min,0,0
193562,in,0,0
193563,the,0,0
193564,rate-modulating,0,0
193565,",",0,0
193566,minute,0,0
193567,ventilation,0,0
193568,mode,0,0
193569,(,0,1
193570,p,0,0
193571,=,0,1
193572,0.0001,0,0
193573,),0,1
193574,.,0,1
193575,The,0,0
193576,maximal,0,0
193577,VO2,0,1
193578,increased,0,0
193579,from,0,1
193580,13.4,0,0
193581,+/-,0,1
193582,3.4,0,1
193583,to,0,1
193584,16.3,0,1
193585,+/-,0,0
193586,4.1,0,1
193587,cc/kg,0,1
193588,per,0,1
193589,min,0,0
193590,(,0,1
193591,p,0,0
193592,=,0,1
193593,0.0004,0,0
193594,),0,1
193595,.,0,1
193596,The,0,0
193597,maximal,0,0
193598,heart,0,1
193599,rate,0,0
193600,achieved,0,0
193601,in,0,0
193602,the,0,0
193603,minute,0,0
193604,ventilation,0,0
193605,pacing,0,0
193606,mode,0,0
193607,was,0,0
193608,136,0,1
193609,+/-,0,0
193610,9.7,0,0
193611,beats/min,0,0
193612,",",0,1
193613,similar,0,0
193614,to,0,0
193615,that,0,0
193616,observed,0,0
193617,in,0,0
193618,the,0,0
193619,patient,0,1
193620,'s,0,1
193621,intrinsic,0,0
193622,cardiac,0,1
193623,rhythm,0,1
193624,before,0,0
193625,ablation,0,1
193626,(,0,1
193627,134.9,0,0
193628,+/-,0,1
193629,30.1,0,1
193630,beats/min,0,0
193631,",",0,0
193632,p,0,0
193633,=,0,0
193634,NS,0,0
193635,),0,1
193636,.,0,1
193637,(,0,0
193638,ABSTRACT,0,0
193639,TRUNCATED,0,1
193640,AT,0,1
193641,250,0,1
193642,WORDS,0,1
193643,),0,1
193644,Use,0,1
193645,of,0,0
193646,transdermal,0,0
193647,glyceryl,0,0
193648,trinitrate,0,0
193649,to,0,0
193650,reduce,0,0
193651,failure,0,1
193652,of,0,0
193653,intravenous,1,1
193654,infusion,1,0
193655,due,1,0
193656,to,1,0
193657,phlebitis,1,1
193658,and,1,0
193659,extravasation,1,1
193660,.,1,1
193661,Self-adhesive,0,0
193662,patches,0,0
193663,which,0,1
193664,release,0,0
193665,glyceryl,0,0
193666,trinitrate,0,0
193667,at,0,0
193668,a,0,1
193669,slow,0,0
193670,continuous,0,0
193671,rate,0,0
193672,or,0,1
193673,placebo,0,1
193674,patches,0,0
193675,were,0,1
193676,applied,0,0
193677,to,0,0
193678,the,0,0
193679,skin,1,1
193680,of,1,0
193681,patients,1,1
193682,distal,0,1
193683,to,0,1
193684,intravenous,0,1
193685,infusion,0,0
193686,sites,0,1
193687,in,0,1
193688,a,0,1
193689,double-blind,0,0
193690,manner,0,0
193691,.,0,1
193692,The,0,0
193693,frequency,0,0
193694,of,0,0
193695,infusion,0,0
193696,failure,0,1
193697,was,0,0
193698,three,0,0
193699,times,0,0
193700,lower,0,0
193701,with,0,1
193702,the,0,0
193703,glyceryl,0,0
193704,trinitrate,0,0
193705,than,0,0
193706,with,0,1
193707,placebo,0,1
193708,patches,0,1
193709,.,0,1
193710,The,0,0
193711,decrease,0,0
193712,was,0,0
193713,of,0,0
193714,similar,0,0
193715,magnitude,0,0
193716,whether,0,0
193717,failure,0,1
193718,was,0,0
193719,due,0,0
193720,to,0,1
193721,extravasation,0,1
193722,or,0,1
193723,phlebitis,0,1
193724,.,0,1
193725,Headaches,0,1
193726,were,0,1
193727,more,0,0
193728,common,0,1
193729,in,0,0
193730,patients,1,1
193731,with,1,1
193732,active,1,1
193733,patches,1,1
193734,but,0,0
193735,were,0,1
193736,relieved,0,0
193737,by,0,0
193738,simple,0,0
193739,analgesics,0,1
193740,.,0,1
193741,Low,0,1
193742,doses,0,0
193743,of,0,0
193744,ketazolam,0,1
193745,in,0,1
193746,anxiety,1,1
193747,:,1,1
193748,a,0,0
193749,double-blind,0,0
193750,",",0,0
193751,placebo-controlled,0,0
193752,study,0,1
193753,.,0,1
193754,A,0,0
193755,multicenter,0,0
193756,",",0,0
193757,double-blind,0,0
193758,",",0,0
193759,between-patient,0,0
193760,trial,0,1
193761,comparing,0,0
193762,two,0,0
193763,doses,0,0
193764,of,0,1
193765,ketazolam,0,1
193766,(,0,1
193767,15,0,1
193768,and,0,1
193769,30,0,1
193770,mg,0,0
193771,),0,1
193772,with,0,1
193773,placebo,0,0
193774,",",0,0
193775,each,0,0
193776,given,0,0
193777,once,0,0
193778,daily,0,0
193779,",",0,0
193780,in,0,0
193781,the,0,0
193782,evening,0,0
193783,",",0,0
193784,to,0,1
193785,92,1,1
193786,outpatients,1,1
193787,affected,1,1
193788,by,1,0
193789,generalized,1,1
193790,anxiety,1,1
193791,disorders,1,1
193792,for,1,1
193793,at,1,1
193794,least,1,1
193795,1,1,1
193796,month,1,0
193797,",",0,0
193798,was,0,0
193799,carried,0,0
193800,out,0,1
193801,.,0,1
193802,After,0,0
193803,1-week,0,0
193804,washout,0,1
193805,period,0,1
193806,47,1,1
193807,patients,1,1
193808,were,0,1
193809,randomized,0,1
193810,to,0,0
193811,ketazolam,0,1
193812,15,0,1
193813,mg,0,0
193814,",",0,1
193815,and,0,0
193816,45,0,1
193817,to,0,0
193818,placebo,0,1
193819,for,0,1
193820,15,0,1
193821,days,0,0
193822,(,0,1
193823,first,0,1
193824,period,0,1
193825,),0,1
193826,.,0,1
193827,At,0,0
193828,the,0,0
193829,end,0,0
193830,of,0,0
193831,this,0,0
193832,period,0,0
193833,",",0,0
193834,if,0,0
193835,the,0,0
193836,patient,0,0
193837,experienced,0,0
193838,a,0,0
193839,decrease,0,0
193840,on,0,0
193841,the,0,0
193842,total,0,1
193843,Hamilton,0,1
193844,Anxiety,0,1
193845,Rating,0,0
193846,Scale,0,1
193847,(,0,1
193848,HAM-A,0,1
193849,),0,1
193850,of,0,0
193851,at,0,1
193852,least,0,1
193853,25,0,1
193854,%,0,0
193855,of,0,0
193856,basal,0,0
193857,value,0,0
193858,",",0,0
193859,the,0,0
193860,treatment,0,0
193861,was,0,0
193862,kept,0,0
193863,unchanged,0,0
193864,for,0,0
193865,a,0,1
193866,further,0,1
193867,15,0,1
193868,days,0,0
193869,",",0,1
193870,otherwise,0,1
193871,15,0,0
193872,mg,0,0
193873,of,0,1
193874,ketazolam,0,1
193875,were,0,1
193876,added,0,0
193877,to,0,0
193878,the,0,0
193879,previous,0,0
193880,treatment,0,0
193881,(,0,1
193882,second,0,1
193883,period,0,1
193884,),0,1
193885,.,0,1
193886,Anxiety,0,0
193887,was,0,0
193888,rated,0,0
193889,after,0,1
193890,2,0,1
193891,and,0,1
193892,4,0,1
193893,weeks,0,0
193894,with,0,1
193895,the,0,1
193896,Italian,0,1
193897,HAM-A,0,1
193898,scale,0,0
193899,and,0,0
193900,with,0,1
193901,a,0,1
193902,4-point,0,0
193903,scale,0,0
193904,(,0,1
193905,patient,0,1
193906,'s,0,1
193907,assessment,0,0
193908,),0,1
193909,.,0,1
193910,Seventy-eight,1,1
193911,patients,1,1
193912,completed,1,1
193913,the,1,0
193914,first,1,0
193915,period,1,0
193916,and,1,1
193917,75,1,1
193918,the,1,0
193919,whole,1,0
193920,study,1,0
193921,.,1,1
193922,During,0,0
193923,the,0,0
193924,first,0,0
193925,period,0,0
193926,the,0,0
193927,percentage,0,0
193928,of,0,0
193929,responders,0,0
193930,was,0,0
193931,almost,0,1
193932,identical,0,0
193933,in,0,0
193934,both,0,0
193935,treatment,0,0
193936,groups,0,0
193937,",",0,0
193938,but,0,0
193939,during,0,0
193940,the,0,0
193941,second,0,0
193942,period,0,0
193943,a,0,1
193944,further,0,0
193945,slight,0,0
193946,improvement,0,0
193947,was,0,0
193948,observed,0,0
193949,in,0,0
193950,the,0,0
193951,early,0,1
193952,placebo,0,0
193953,responders,0,0
193954,",",0,0
193955,while,0,0
193956,the,0,0
193957,HAM-A,0,0
193958,score,0,0
193959,of,0,0
193960,patients,0,1
193961,on,0,1
193962,ketazolam,0,1
193963,continued,0,0
193964,to,0,0
193965,improve,0,0
193966,significantly,0,0
193967,(,0,0
193968,p,0,0
193969,less,0,0
193970,than,0,0
193971,0.01,0,0
193972,),0,1
193973,throughout,0,0
193974,the,0,0
193975,study,0,0
193976,.,0,0
193977,Likewise,0,0
193978,a,0,0
193979,significant,0,0
193980,(,0,0
193981,p,0,0
193982,less,0,0
193983,than,0,0
193984,0.001,0,0
193985,),0,1
193986,difference,0,0
193987,between,0,0
193988,treatments,0,0
193989,was,0,0
193990,observed,0,0
193991,",",0,0
193992,on,0,0
193993,the,0,0
193994,4-point,0,0
193995,scale,0,0
193996,",",0,0
193997,in,0,0
193998,the,0,0
193999,population,0,1
194000,as,0,0
194001,a,0,1
194002,whole,0,0
194003,(,0,0
194004,end,0,0
194005,of,0,0
194006,first,0,0
194007,period,0,1
194008,),0,0
194009,as,0,0
194010,well,0,0
194011,as,0,0
194012,in,0,0
194013,responder,0,0
194014,patients,0,1
194015,(,0,1
194016,end,0,0
194017,second,0,1
194018,period,0,1
194019,),0,1
194020,.,0,1
194021,Tolerability,0,0
194022,was,0,0
194023,good,0,0
194024,",",0,0
194025,except,0,0
194026,in,0,0
194027,1,0,1
194028,patient,0,1
194029,on,0,0
194030,placebo,0,1
194031,",",0,1
194032,who,0,1
194033,was,0,1
194034,withdrawn,0,1
194035,from,0,1
194036,the,0,0
194037,study,0,0
194038,because,0,0
194039,of,0,0
194040,severe,0,1
194041,headache,0,1
194042,.,0,1
194043,Motion,0,0
194044,aftereffects,0,0
194045,with,0,0
194046,horizontally,0,0
194047,moving,0,0
194048,sound,0,1
194049,sources,0,0
194050,in,0,1
194051,the,0,1
194052,free,0,1
194053,field,0,0
194054,.,0,1
194055,A,0,0
194056,horizontally,0,0
194057,moving,0,0
194058,sound,0,0
194059,was,0,0
194060,presented,0,1
194061,to,0,0
194062,an,1,0
194063,observer,1,0
194064,seated,1,0
194065,in,1,0
194066,the,1,0
194067,center,1,1
194068,of,1,0
194069,an,1,0
194070,anechoic,1,1
194071,chamber,1,0
194072,.,1,1
194073,The,0,0
194074,sound,0,0
194075,",",0,0
194076,either,0,0
194077,a,0,0
194078,500-Hz,0,0
194079,low-pass,0,0
194080,noise,0,1
194081,or,0,1
194082,a,0,0
194083,6300-Hz,0,1
194084,high-pass,0,1
194085,noise,0,0
194086,",",0,0
194087,repeatedly,0,0
194088,traversed,0,0
194089,a,0,0
194090,semicircular,0,0
194091,arc,0,1
194092,in,0,0
194093,the,0,0
194094,observer,1,0
194095,'s,1,1
194096,front,1,1
194097,hemifield,1,1
194098,at,1,1
194099,ear,1,1
194100,level,1,0
194101,(,0,1
194102,distance,0,0
194103,:,0,1
194104,1.5,0,0
194105,m,0,1
194106,),0,1
194107,.,0,1
194108,At,0,0
194109,10-sec,0,0
194110,intervals,0,0
194111,this,0,0
194112,adaptor,0,0
194113,was,0,0
194114,interrupted,0,0
194115,",",0,0
194116,and,0,0
194117,a,0,0
194118,750-msec,0,0
194119,moving,0,0
194120,probe,0,0
194121,(,0,0
194122,a,0,1
194123,500-Hz,0,0
194124,low-pass,0,0
194125,noise,0,1
194126,),0,1
194127,was,0,0
194128,presented,0,1
194129,from,0,1
194130,a,0,1
194131,horizontal,0,0
194132,arc,0,1
194133,1.6,0,0
194134,m,0,1
194135,in,0,0
194136,front,0,1
194137,of,0,0
194138,the,0,0
194139,observer,0,0
194140,.,0,0
194141,During,0,0
194142,a,0,0
194143,run,0,0
194144,",",0,0
194145,the,0,0
194146,adaptor,0,0
194147,was,0,0
194148,presented,0,1
194149,at,0,0
194150,a,0,1
194151,constant,0,0
194152,velocity,0,0
194153,(,0,1
194154,-200,0,1
194155,degrees,0,0
194156,to,0,1
194157,+200,0,1
194158,degrees/sec,0,1
194159,),0,0
194160,",",0,0
194161,while,0,0
194162,probes,0,1
194163,with,0,1
194164,velocities,0,1
194165,varying,0,1
194166,from,0,1
194167,-10,0,0
194168,degrees,0,0
194169,to,0,1
194170,+10,0,0
194171,degrees/sec,0,1
194172,were,0,0
194173,presented,0,1
194174,in,0,0
194175,a,0,1
194176,random,0,1
194177,order,0,0
194178,.,0,1
194179,Observers,1,0
194180,judged,1,0
194181,the,1,0
194182,direction,1,0
194183,of,1,0
194184,motion,1,1
194185,(,1,1
194186,left,1,1
194187,or,1,1
194188,right,1,1
194189,),1,1
194190,of,1,0
194191,each,1,1
194192,probe,1,0
194193,.,1,0
194194,As,0,0
194195,in,0,0
194196,the,0,0
194197,case,0,0
194198,of,0,0
194199,stimuli,0,0
194200,presented,0,1
194201,over,0,1
194202,headphones,0,1
194203,(,0,1
194204,Grantham,0,1
194205,&,0,1
194206,Wightman,0,1
194207,",",0,1
194208,1979,0,1
194209,),0,0
194210,",",0,0
194211,an,0,0
194212,auditory,0,0
194213,motion,0,0
194214,aftereffect,0,0
194215,(,0,1
194216,MAE,0,1
194217,),0,1
194218,occurred,0,0
194219,:,0,1
194220,subjects,0,1
194221,responded,0,1
194222,left,0,1
194223,to,0,0
194224,probes,0,0
194225,more,0,0
194226,often,0,0
194227,when,0,0
194228,the,0,0
194229,adaptor,0,0
194230,moved,0,0
194231,right,0,0
194232,than,0,0
194233,when,0,0
194234,it,0,0
194235,moved,0,0
194236,left,0,1
194237,.,0,0
194238,When,0,0
194239,the,0,0
194240,adaptor,0,0
194241,and,0,0
194242,probe,0,0
194243,were,0,0
194244,spectrally,0,0
194245,the,0,0
194246,same,0,0
194247,",",0,0
194248,the,0,0
194249,MAE,0,0
194250,was,0,0
194251,greater,0,0
194252,than,0,0
194253,when,0,0
194254,they,0,0
194255,were,0,0
194256,from,0,1
194257,different,0,1
194258,spectral,0,1
194259,regions,0,1
194260,;,0,1
194261,the,0,0
194262,magnitude,0,0
194263,of,0,0
194264,this,0,0
194265,difference,0,0
194266,depended,0,0
194267,on,0,0
194268,adaptor,0,0
194269,speed,0,0
194270,and,0,0
194271,was,0,0
194272,subject-dependent,0,0
194273,.,0,0
194274,It,0,0
194275,is,0,0
194276,proposed,0,0
194277,that,0,0
194278,there,0,0
194279,are,0,0
194280,two,0,0
194281,components,0,0
194282,underlying,0,1
194283,the,0,0
194284,auditory,0,1
194285,MAE,0,1
194286,:,0,1
194287,(,0,1
194288,1,0,1
194289,),0,1
194290,a,0,1
194291,generalized,0,1
194292,bias,0,0
194293,to,0,0
194294,respond,0,0
194295,that,0,0
194296,probes,0,0
194297,move,0,0
194298,in,0,0
194299,the,0,0
194300,direction,0,0
194301,opposite,0,0
194302,to,0,0
194303,that,0,0
194304,of,0,0
194305,the,0,0
194306,adaptor,0,0
194307,",",0,0
194308,independent,0,0
194309,of,0,0
194310,their,0,1
194311,spectra,0,1
194312,;,0,1
194313,and,0,1
194314,(,0,1
194315,2,0,1
194316,),0,1
194317,a,0,0
194318,loss,0,0
194319,of,0,0
194320,sensitivity,0,0
194321,to,0,0
194322,the,0,0
194323,velocity,0,0
194324,of,0,0
194325,moving,0,0
194326,sounds,0,0
194327,after,0,1
194328,prolonged,0,0
194329,exposure,0,1
194330,to,0,1
194331,moving,0,0
194332,sounds,0,0
194333,having,0,1
194334,the,0,0
194335,same,0,0
194336,spectral,0,1
194337,content,0,0
194338,.,0,1
194339,Lack,0,1
194340,of,0,0
194341,effect,0,0
194342,of,0,0
194343,warfarin,0,0
194344,on,0,0
194345,the,0,0
194346,restenosis,0,1
194347,rate,0,0
194348,or,0,1
194349,on,1,0
194350,clinical,1,0
194351,outcome,1,0
194352,after,1,0
194353,balloon,1,0
194354,coronary,1,1
194355,angioplasty,1,1
194356,.,1,1
194357,Between,1,0
194358,September,1,1
194359,1985,1,1
194360,and,1,1
194361,April,1,1
194362,1987,1,1
194363,",",1,1
194364,110,1,1
194365,consecutive,1,1
194366,patients,1,1
194367,who,1,1
194368,had,1,1
194369,successful,1,1
194370,coronary,1,1
194371,angioplasty,1,1
194372,were,0,1
194373,included,0,1
194374,in,0,0
194375,a,0,1
194376,randomised,0,1
194377,prospective,0,1
194378,controlled,0,0
194379,evaluation,0,0
194380,of,0,0
194381,the,0,0
194382,effects,0,0
194383,of,0,0
194384,warfarin,0,0
194385,on,0,0
194386,restenosis,0,1
194387,.,0,1
194388,The,0,0
194389,warfarin,0,0
194390,(,0,0
194391,n,0,1
194392,=,0,1
194393,56,0,1
194394,),0,1
194395,and,0,0
194396,the,0,0
194397,control,0,0
194398,(,0,0
194399,n,0,1
194400,=,0,1
194401,54,0,1
194402,),0,1
194403,groups,0,0
194404,were,0,1
194405,not,0,0
194406,different,0,0
194407,in,0,0
194408,terms,0,0
194409,of,0,1
194410,age,0,1
194411,",",0,0
194412,sex,0,0
194413,",",0,0
194414,previous,0,1
194415,coronary,0,1
194416,bypass,0,1
194417,surgery,0,1
194418,or,0,1
194419,coronary,0,1
194420,balloon,0,0
194421,angioplasty,0,1
194422,",",0,0
194423,severity,0,0
194424,of,0,0
194425,symptoms,0,0
194426,",",0,1
194427,and,0,0
194428,frequency,0,0
194429,of,0,0
194430,multivessel,0,1
194431,disease,0,1
194432,or,0,1
194433,of,0,0
194434,total,0,1
194435,coronary,0,1
194436,occlusions,0,1
194437,.,0,1
194438,Warfarin,0,0
194439,was,0,0
194440,started,0,0
194441,on,0,0
194442,the,0,0
194443,day,0,0
194444,of,0,0
194445,the,0,0
194446,procedure,0,0
194447,and,0,0
194448,the,0,0
194449,dosage,0,0
194450,was,0,0
194451,adjusted,0,0
194452,to,0,0
194453,maintain,0,0
194454,the,0,0
194455,thromboplastin,0,0
194456,international,0,1
194457,normalised,0,0
194458,ratio,0,0
194459,greater,0,0
194460,than,0,0
194461,or,0,1
194462,equal,0,1
194463,to,0,1
194464,2.5,0,0
194465,.,0,1
194466,One,0,1
194467,hundred,0,1
194468,and,0,1
194469,five,0,1
194470,(,0,1
194471,96,0,1
194472,%,0,0
194473,),0,1
194474,of,0,0
194475,the,0,1
194476,patients,0,1
194477,were,0,1
194478,given,0,1
194479,verapamil,0,1
194480,and,0,1
194481,other,0,1
194482,antianginal,0,1
194483,drugs,0,0
194484,were,0,1
194485,prescribed,0,1
194486,as,0,0
194487,needed,0,1
194488,.,0,1
194489,Low,0,1
194490,molecular,0,0
194491,weight,0,1
194492,dextran,0,1
194493,and,0,0
194494,heparin,0,0
194495,were,0,0
194496,given,0,0
194497,during,0,0
194498,the,0,0
194499,procedure,0,0
194500,and,0,0
194501,heparin,0,0
194502,was,0,0
194503,continued,0,0
194504,for,0,1
194505,24,0,1
194506,hours,0,0
194507,in,0,1
194508,all,0,1
194509,patients,0,1
194510,.,0,1
194511,One,1,1
194512,hundred,1,1
194513,and,1,1
194514,eight,1,1
194515,(,1,1
194516,98,1,1
194517,%,1,0
194518,),1,1
194519,of,1,1
194520,patients,1,1
194521,were,1,1
194522,followed,1,0
194523,up,1,0
194524,clinically,1,1
194525,after,1,0
194526,a,1,0
194527,median,1,0
194528,of,1,0
194529,five,1,1
194530,months,1,0
194531,(,1,1
194532,range,1,1
194533,1-20,1,1
194534,),1,1
194535,.,1,1
194536,Eighty,1,1
194537,five,1,1
194538,(,1,1
194539,77,1,1
194540,%,1,0
194541,),1,1
194542,had,1,1
194543,follow,1,0
194544,up,1,0
194545,angiography,1,1
194546,at,1,1
194547,five,1,1
194548,months,1,1
194549,.,1,1
194550,In,0,0
194551,the,0,0
194552,warfarin,0,0
194553,group,0,1
194554,symptoms,0,0
194555,improved,0,0
194556,in,0,1
194557,46,0,1
194558,(,0,1
194559,85,0,1
194560,%,0,0
194561,),0,1
194562,patients,0,1
194563,by,0,1
194564,at,0,1
194565,least,0,1
194566,1,0,1
194567,angina,0,1
194568,class,0,1
194569,and,0,1
194570,31,0,1
194571,(,0,1
194572,57,0,1
194573,%,0,0
194574,),0,1
194575,were,0,1
194576,symptom,0,1
194577,free,0,1
194578,;,0,1
194579,the,0,0
194580,exercise,0,0
194581,test,0,0
194582,remained,0,0
194583,positive,0,1
194584,in,0,1
194585,20,0,1
194586,(,0,1
194587,36,0,1
194588,%,0,0
194589,),0,1
194590,patients,0,1
194591,and,0,1
194592,the,0,0
194593,angiographic,0,0
194594,restenosis,0,1
194595,rate,0,0
194596,was,0,0
194597,25,0,1
194598,%,0,0
194599,per,0,1
194600,lesion,0,1
194601,and,0,1
194602,29,0,1
194603,%,0,0
194604,per,0,1
194605,patient,0,0
194606,.,0,0
194607,There,0,0
194608,were,0,0
194609,no,0,0
194610,major,0,1
194611,bleeding,0,1
194612,complications,0,1
194613,.,0,1
194614,In,0,0
194615,the,0,0
194616,control,0,1
194617,group,0,1
194618,46,0,1
194619,(,0,1
194620,85,0,1
194621,%,0,0
194622,),0,1
194623,patients,0,1
194624,were,0,1
194625,improved,0,0
194626,by,0,0
194627,at,0,1
194628,least,0,1
194629,1,0,1
194630,angina,0,1
194631,class,0,1
194632,and,0,1
194633,31,0,1
194634,(,0,1
194635,57,0,1
194636,%,0,0
194637,),0,1
194638,were,0,1
194639,symptom,0,1
194640,free,0,1
194641,;,0,1
194642,the,0,0
194643,exercise,0,0
194644,test,0,0
194645,was,0,0
194646,positive,0,1
194647,in,0,1
194648,11,0,1
194649,(,0,1
194650,21,0,1
194651,%,0,0
194652,),0,1
194653,patients,0,1
194654,and,0,1
194655,the,0,0
194656,angiographic,0,0
194657,restenosis,0,1
194658,rate,0,0
194659,was,0,0
194660,33,0,1
194661,%,0,0
194662,per,0,1
194663,lesion,0,1
194664,and,0,1
194665,37,0,1
194666,%,0,0
194667,per,0,1
194668,patient,0,1
194669,.,0,1
194670,Although,0,0
194671,the,0,0
194672,incidence,0,0
194673,of,0,0
194674,angiographic,0,0
194675,restenosis,0,1
194676,tended,0,0
194677,to,0,0
194678,be,0,0
194679,lower,0,0
194680,with,0,1
194681,warfarin,0,0
194682,",",0,0
194683,none,0,0
194684,of,0,0
194685,these,0,0
194686,differences,0,0
194687,was,0,0
194688,significant,0,0
194689,.,0,1
194690,These,0,0
194691,data,0,0
194692,suggest,0,0
194693,that,0,0
194694,the,0,0
194695,combination,0,0
194696,of,0,0
194697,verapamil,0,1
194698,and,0,0
194699,warfarin,0,0
194700,",",0,0
194701,in,0,0
194702,the,0,0
194703,absence,0,0
194704,of,0,0
194705,aspirin,0,0
194706,",",0,0
194707,is,0,0
194708,not,0,0
194709,significantly,0,0
194710,better,0,0
194711,than,0,0
194712,verapamil,0,0
194713,alone,0,0
194714,in,0,0
194715,preventing,0,0
194716,symptom,0,1
194717,recurrence,0,0
194718,or,0,1
194719,angiographic,0,0
194720,restenosis,0,1
194721,after,0,1
194722,coronary,0,1
194723,angioplasty,0,1
194724,.,0,1
194725,Intensive,0,1
194726,induction,0,1
194727,chemotherapy,0,1
194728,for,0,0
194729,small,0,1
194730,cell,0,1
194731,anaplastic,0,1
194732,carcinoma,0,1
194733,of,0,0
194734,the,0,0
194735,lung,0,1
194736,.,0,0
194737,The,0,0
194738,role,0,0
194739,of,0,0
194740,intensive,0,1
194741,induction,0,1
194742,chemotherapy,0,1
194743,in,0,0
194744,small,0,1
194745,cell,0,1
194746,cancer,0,1
194747,of,0,0
194748,the,0,0
194749,lung,0,1
194750,remains,0,0
194751,unclear,0,0
194752,.,0,0
194753,Twenty-eight,1,1
194754,newly,1,1
194755,diagnosed,1,1
194756,patients,1,1
194757,with,1,1
194758,small,1,1
194759,cell,1,1
194760,lung,1,1
194761,cancer,1,1
194762,were,0,1
194763,randomized,0,1
194764,to,0,0
194765,receive,0,1
194766,either,0,0
194767,high-dose,0,0
194768,or,0,1
194769,standard-dose,0,0
194770,cyclophosphamide,0,1
194771,",",0,0
194772,vincristine,0,0
194773,",",0,0
194774,and,0,0
194775,semustine,0,0
194776,in,0,0
194777,a,0,0
194778,trial,0,0
194779,where,0,0
194780,the,0,0
194781,dose,0,0
194782,of,0,0
194783,induction,0,1
194784,chemotherapy,0,1
194785,was,0,0
194786,the,0,0
194787,sole,0,0
194788,treatment,0,0
194789,variable,0,1
194790,.,0,1
194791,Complete,0,0
194792,responses,0,0
194793,(,0,1
194794,CR,0,1
194795,),0,1
194796,were,0,0
194797,achieved,0,0
194798,in,0,1
194799,57,0,1
194800,%,0,0
194801,of,0,1
194802,patients,0,1
194803,receiving,0,1
194804,high-dose,0,1
194805,therapy,0,1
194806,as,0,0
194807,compared,0,0
194808,to,0,1
194809,21,0,1
194810,%,0,0
194811,of,0,1
194812,patients,0,1
194813,receiving,0,1
194814,standard-dose,0,1
194815,therapy,0,1
194816,(,0,1
194817,P,0,0
194818,less,0,0
194819,than,0,0
194820,0.05,0,0
194821,),0,1
194822,.,0,0
194823,There,0,0
194824,was,0,0
194825,a,0,0
194826,higher,0,0
194827,rate,0,0
194828,of,0,0
194829,severe,0,1
194830,toxicity,0,0
194831,in,0,0
194832,the,0,0
194833,high-dose,0,0
194834,group,0,1
194835,(,0,1
194836,P,0,0
194837,less,0,0
194838,than,0,0
194839,0.01,0,0
194840,),0,1
194841,.,0,1
194842,The,0,0
194843,overall,0,0
194844,median,0,0
194845,survival,0,0
194846,was,0,0
194847,not,0,0
194848,improved,0,0
194849,(,0,1
194850,36,0,1
194851,weeks,0,0
194852,for,0,1
194853,the,0,1
194854,high-dose,0,0
194855,group,0,1
194856,vs,0,0
194857,43,0,1
194858,weeks,0,0
194859,for,0,1
194860,the,0,1
194861,standard-dose,0,0
194862,group,0,1
194863,),0,1
194864,;,0,0
194865,however,0,0
194866,",",0,0
194867,the,0,0
194868,median,0,0
194869,survival,0,0
194870,in,0,1
194871,patients,0,1
194872,achieving,0,0
194873,CR,0,1
194874,was,0,0
194875,prolonged,0,0
194876,(,0,1
194877,92,0,1
194878,weeks,0,0
194879,for,0,1
194880,the,0,1
194881,high-dose,0,0
194882,group,0,1
194883,vs,0,0
194884,50,0,1
194885,weeks,0,0
194886,for,0,1
194887,the,0,1
194888,standard-dose,0,0
194889,group,0,1
194890,),0,1
194891,.,0,1
194892,These,0,1
194893,effects,0,0
194894,were,0,1
194895,most,0,0
194896,pronounced,0,0
194897,in,0,0
194898,patients,1,1
194899,with,1,1
194900,extensive,1,1
194901,disease,1,1
194902,;,1,1
194903,a,0,0
194904,CR,0,0
194905,after,0,0
194906,induction,0,1
194907,was,0,0
194908,achieved,0,0
194909,in,0,0
194910,five,0,1
194911,of,0,1
194912,nine,0,1
194913,patients,0,1
194914,treated,0,1
194915,with,0,1
194916,high,0,1
194917,doses,0,0
194918,but,0,0
194919,not,0,0
194920,in,0,0
194921,any,0,0
194922,of,0,0
194923,those,0,0
194924,treated,0,1
194925,with,0,1
194926,standard,0,1
194927,doses,0,0
194928,(,0,1
194929,P,0,0
194930,less,0,0
194931,than,0,0
194932,0.05,0,0
194933,),0,1
194934,.,0,1
194935,A,0,0
194936,small,0,0
194937,group,0,1
194938,of,0,0
194939,patients,0,1
194940,appear,0,0
194941,to,0,0
194942,benefit,0,0
194943,by,0,0
194944,achieving,0,0
194945,a,0,1
194946,long-term,0,0
194947,remission,0,1
194948,with,0,1
194949,intensive,0,1
194950,induction,0,1
194951,chemotherapy,0,1
194952,",",0,0
194953,but,0,0
194954,this,0,0
194955,effect,0,0
194956,may,0,0
194957,be,0,0
194958,offset,0,0
194959,by,0,0
194960,increased,0,0
194961,morbidity,0,0
194962,.,0,1
194963,Treatment,0,0
194964,of,0,0
194965,varicella-zoster,0,1
194966,virus,0,1
194967,infection,0,1
194968,in,0,0
194969,severely,1,1
194970,immunocompromised,1,1
194971,patients,1,1
194972,.,1,1
194973,A,0,0
194974,randomized,0,0
194975,comparison,0,0
194976,of,0,0
194977,acyclovir,0,0
194978,and,0,1
194979,vidarabine,0,0
194980,.,0,1
194981,In,0,0
194982,a,0,0
194983,prospective,0,1
194984,",",0,0
194985,randomized,0,1
194986,trial,0,0
194987,",",0,0
194988,we,0,0
194989,compared,0,0
194990,intravenous,0,1
194991,acyclovir,0,0
194992,and,0,1
194993,vidarabine,0,1
194994,in,0,0
194995,the,0,0
194996,treatment,0,0
194997,of,0,0
194998,varicella-zoster,1,1
194999,virus,1,1
195000,infection,1,1
195001,in,1,0
195002,severely,1,1
195003,immunocompromised,1,1
195004,patients,1,1
195005,who,1,1
195006,presented,1,1
195007,within,1,1
195008,72,1,1
195009,hours,1,0
195010,of,1,1
195011,onset,1,1
195012,of,1,0
195013,the,1,0
195014,infection,1,1
195015,.,1,1
195016,Eleven,1,1
195017,patients,1,1
195018,were,1,1
195019,treated,1,1
195020,in,1,0
195021,each,1,0
195022,group,1,1
195023,.,1,1
195024,Cutaneous,0,0
195025,dissemination,0,0
195026,of,0,0
195027,infection,0,1
195028,occurred,0,0
195029,in,0,0
195030,none,0,0
195031,of,0,0
195032,the,0,0
195033,10,0,1
195034,acyclovir,0,0
195035,recipients,0,1
195036,and,0,1
195037,in,0,1
195038,5,0,0
195039,of,0,1
195040,the,0,0
195041,10,0,1
195042,vidarabine,0,1
195043,recipients,0,1
195044,who,0,1
195045,had,0,1
195046,presented,0,1
195047,with,0,1
195048,localized,0,1
195049,dermatomal,0,0
195050,disease,0,1
195051,(,0,1
195052,P,0,0
195053,=,0,1
195054,0.016,0,0
195055,),0,1
195056,.,0,1
195057,As,0,0
195058,compared,0,0
195059,with,0,1
195060,vidarabine,0,0
195061,",",0,0
195062,acyclovir,0,0
195063,treatment,0,0
195064,shortened,0,0
195065,the,0,0
195066,median,0,0
195067,periods,0,0
195068,during,0,1
195069,which,0,1
195070,cultures,0,0
195071,were,0,1
195072,positive,0,1
195073,for,0,0
195074,the,0,0
195075,virus,0,1
195076,(,0,0
195077,four,0,1
195078,vs.,0,0
195079,seven,0,1
195080,days,0,0
195081,",",0,1
195082,P,0,0
195083,=,0,1
195084,0.004,0,0
195085,),0,1
195086,and,0,1
195087,new,0,1
195088,lesions,0,1
195089,formed,0,1
195090,(,0,1
195091,three,0,0
195092,vs.,0,0
195093,six,0,1
195094,days,0,0
195095,",",0,1
195096,P,0,0
195097,=,0,1
195098,0.03,0,0
195099,),0,1
195100,.,0,1
195101,Acyclovir,0,0
195102,also,0,0
195103,shortened,0,0
195104,the,0,0
195105,median,0,0
195106,interval,0,0
195107,until,0,1
195108,the,0,0
195109,first,0,0
195110,decrease,0,0
195111,in,0,0
195112,pain,0,1
195113,(,0,0
195114,4,0,0
195115,vs.,0,0
195116,7,0,1
195117,days,0,0
195118,",",0,1
195119,P,0,0
195120,=,0,1
195121,0.005,0,0
195122,),0,1
195123,",",0,0
195124,the,0,0
195125,pustulation,0,0
195126,of,0,0
195127,all,0,1
195128,lesions,0,1
195129,(,0,0
195130,4,0,1
195131,vs.,0,0
195132,7,0,1
195133,days,0,0
195134,",",0,1
195135,P,0,0
195136,=,0,1
195137,0.0004,0,0
195138,),0,1
195139,",",0,0
195140,the,0,0
195141,crusting,0,0
195142,of,0,0
195143,all,0,1
195144,lesions,0,1
195145,(,0,0
195146,7,0,1
195147,vs.,0,0
195148,17,0,1
195149,days,0,0
195150,",",0,1
195151,P,0,0
195152,=,0,1
195153,0.0003,0,0
195154,),0,1
195155,",",0,0
195156,and,0,0
195157,the,0,0
195158,complete,0,0
195159,healing,0,0
195160,of,0,1
195161,lesions,0,1
195162,(,0,1
195163,17,0,1
195164,vs.,0,0
195165,28,0,1
195166,days,0,0
195167,",",0,1
195168,P,0,0
195169,=,0,1
195170,0.003,0,0
195171,),0,1
195172,.,0,1
195173,In,0,0
195174,addition,0,0
195175,",",0,0
195176,acyclovir,0,0
195177,reduced,0,0
195178,the,0,0
195179,incidence,0,0
195180,of,0,0
195181,fever,0,1
195182,(,0,0
195183,two,0,0
195184,vs.,0,0
195185,eight,0,1
195186,patients,0,1
195187,",",0,1
195188,P,0,0
195189,=,0,1
195190,0.015,0,0
195191,),0,1
195192,.,0,1
195193,We,0,0
195194,conclude,0,0
195195,that,0,0
195196,acyclovir,0,0
195197,is,0,0
195198,better,0,0
195199,than,0,0
195200,vidarabine,0,0
195201,for,0,0
195202,the,0,0
195203,treatment,0,0
195204,of,0,0
195205,varicella-zoster,0,1
195206,infection,0,1
195207,in,0,1
195208,immunocompromised,1,1
195209,patients,1,1
195210,.,1,1
195211,Intravenous,0,1
195212,hyperimmune,0,1
195213,globulin,0,0
195214,prophylaxis,0,1
195215,against,0,0
195216,cytomegalovirus,0,1
195217,interstitial,0,1
195218,pneumonitis,0,1
195219,after,0,1
195220,allogenic,1,1
195221,bone,1,1
195222,marrow,1,1
195223,transplantation,1,1
195224,.,1,1
195225,In,0,0
195226,an,0,0
195227,attempt,0,0
195228,to,0,0
195229,reduce,0,0
195230,the,0,0
195231,incidence,0,0
195232,of,0,0
195233,lethal,0,0
195234,cytomegalovirus,0,1
195235,(,0,1
195236,CMV,0,1
195237,),0,1
195238,interstitial,0,1
195239,pneumonitis,0,1
195240,after,1,0
195241,allogenic,1,1
195242,bone,1,1
195243,marrow,1,1
195244,transplantation,1,1
195245,49,1,1
195246,patients,1,1
195247,were,1,1
195248,randomized,1,1
195249,in,1,0
195250,a,1,1
195251,multicenter,1,0
195252,controlled,1,0
195253,study,1,0
195254,to,0,0
195255,receive,0,1
195256,either,0,0
195257,CMV-hyperimmune,0,1
195258,globulin,0,0
195259,or,0,1
195260,a,0,0
195261,control,0,1
195262,immune,0,0
195263,globulin,0,0
195264,with,0,1
195265,low,0,1
195266,anticytomegalovirus,0,1
195267,titer,0,0
195268,.,0,1
195269,Immune,0,0
195270,globulin,0,0
195271,was,0,0
195272,administered,0,0
195273,intravenously,0,1
195274,6,0,0
195275,times,0,0
195276,with,0,1
195277,20,0,1
195278,days,0,0
195279,interval,0,0
195280,",",0,0
195281,starting,0,0
195282,on,0,0
195283,day,0,0
195284,7,0,1
195285,before,0,1
195286,transplantation,0,1
195287,.,0,1
195288,Patients,0,1
195289,receiving,0,1
195290,CMV,0,1
195291,hyperimmune,0,1
195292,globulin,0,0
195293,or,0,1
195294,control,0,1
195295,immune,0,0
195296,globulin,0,0
195297,were,0,1
195298,comparable,0,0
195299,with,0,1
195300,regard,0,0
195301,to,0,0
195302,age,0,1
195303,",",0,0
195304,diagnosis,0,1
195305,",",0,0
195306,pretransplant,0,1
195307,anti-CMV,0,0
195308,titer,0,0
195309,",",0,0
195310,incidence,0,0
195311,of,0,0
195312,graft-versus-host,0,1
195313,disease,0,1
195314,and,0,1
195315,transfusions,0,0
195316,.,0,1
195317,In,0,0
195318,each,0,0
195319,group,0,0
195320,",",0,0
195321,the,0,0
195322,incidence,0,0
195323,of,0,0
195324,histologically,0,1
195325,proven,0,1
195326,CMV,0,1
195327,interstitial,0,1
195328,pneumonitis,0,1
195329,during,0,0
195330,the,0,0
195331,first,0,1
195332,110,0,1
195333,days,0,0
195334,post,0,1
195335,BMT,0,0
195336,was,0,0
195337,recorded,0,0
195338,.,0,1
195339,Six,1,0
195340,of,1,0
195341,23,1,1
195342,patients,1,1
195343,in,0,1
195344,the,0,0
195345,control,0,1
195346,group,0,1
195347,versus,0,0
195348,1,0,1
195349,of,0,0
195350,26,0,1
195351,in,0,1
195352,the,0,0
195353,CMV,0,1
195354,hyperimmune,0,1
195355,globulin,0,0
195356,group,0,1
195357,died,0,1
195358,of,0,0
195359,CMV,0,1
195360,interstitial,0,1
195361,pneumonitis,0,1
195362,(,0,0
195363,p,0,0
195364,less,0,0
195365,than,0,0
195366,0.05,0,0
195367,),0,1
195368,.,0,1
195369,No,0,0
195370,significant,0,0
195371,effect,0,0
195372,on,0,0
195373,idiopathic,0,1
195374,pneumonitis,0,1
195375,or,0,1
195376,survival,0,0
195377,was,0,0
195378,observed,0,0
195379,.,0,1
195380,Plasma,0,1
195381,"3,4-dihydroxyphenylethyleneglycol",0,0
195382,and,0,1
195383,3-methoxy-4-hydroxyphenylethyleneglycol,0,0
195384,as,0,0
195385,indicators,0,0
195386,of,0,1
195387,central,0,1
195388,noradrenergic,0,0
195389,activity,0,0
195390,.,0,1
195391,A,0,0
195392,comparative,0,0
195393,study,0,0
195394,on,0,0
195395,control,1,1
195396,subjects,1,1
195397,and,1,1
195398,depressed,1,1
195399,patients,1,1
195400,.,1,1
195401,Animal,0,0
195402,studies,0,0
195403,have,0,1
195404,suggested,0,0
195405,interspecies,0,0
195406,differences,0,0
195407,in,0,1
195408,brain,0,1
195409,norepinephrine,0,0
195410,(,0,1
195411,NE,0,0
195412,),0,1
195413,metabolism,0,0
195414,",",0,0
195415,especially,0,0
195416,with,0,1
195417,regard,0,0
195418,to,0,1
195419,the,0,0
195420,relative,0,0
195421,proportions,0,0
195422,of,0,1
195423,"3,4-dihydroxyphenylethyleneglycol",0,0
195424,(,0,1
195425,DOPEG,0,1
195426,),0,1
195427,compared,0,0
195428,to,0,1
195429,3-methoxy-4-hydroxyphenylethyleneglycol,0,0
195430,(,0,1
195431,MOPEG,0,1
195432,),0,1
195433,.,0,1
195434,In,0,0
195435,order,0,0
195436,to,0,0
195437,question,0,0
195438,the,0,0
195439,value,0,0
195440,of,0,0
195441,both,0,0
195442,glycol,0,0
195443,metabolites,0,0
195444,as,0,1
195445,peripheral,0,1
195446,indices,0,0
195447,of,0,1
195448,central,0,1
195449,noradrenergic,0,0
195450,activity,0,0
195451,",",0,0
195452,a,0,0
195453,comparative,0,0
195454,study,0,0
195455,of,0,0
195456,plasma,0,0
195457,DOPEG,0,0
195458,and,0,1
195459,MOPEG,0,1
195460,(,0,1
195461,measured,0,0
195462,by,0,0
195463,HPLC,0,1
195464,),0,1
195465,related,0,0
195466,to,0,0
195467,depression,0,1
195468,",",0,0
195469,sex,0,0
195470,",",0,0
195471,age,0,1
195472,and,0,1
195473,diagnostic,0,1
195474,categories,0,1
195475,(,0,1
195476,DSM-III,0,1
195477,),0,1
195478,was,0,0
195479,carried,0,0
195480,out,0,1
195481,on,0,0
195482,depressed,1,1
195483,and,1,1
195484,control,1,1
195485,subjects,1,1
195486,.,1,1
195487,In,0,0
195488,addition,0,0
195489,",",0,1
195490,two,1,0
195491,groups,1,1
195492,of,1,1
195493,8,1,1
195494,patients,1,1
195495,were,0,1
195496,randomly,0,1
195497,submitted,0,0
195498,to,0,0
195499,a,0,1
195500,desipramine,0,0
195501,150,0,0
195502,mg/day,0,0
195503,",",0,0
195504,or,0,0
195505,a,0,1
195506,metapramine,0,1
195507,450,0,1
195508,mg/day,0,1
195509,antidepressant,0,1
195510,treatment,0,0
195511,influencing,0,0
195512,the,0,0
195513,formation,0,0
195514,of,0,0
195515,DOPEG,0,0
195516,and,0,1
195517,MOPEG,0,1
195518,in,0,0
195519,a,0,1
195520,different,0,0
195521,way,0,0
195522,.,0,1
195523,The,0,0
195524,study,0,0
195525,did,0,0
195526,not,0,0
195527,demonstrate,0,0
195528,any,0,0
195529,difference,0,0
195530,between,0,0
195531,DOPEG,0,0
195532,and,0,1
195533,MOPEG,0,1
195534,for,0,0
195535,most,0,0
195536,of,0,0
195537,the,0,0
195538,experimental,0,1
195539,factors,0,0
195540,.,0,1
195541,We,0,0
195542,found,0,0
195543,also,0,0
195544,a,0,0
195545,significant,0,0
195546,positive,0,1
195547,correlation,0,0
195548,between,0,0
195549,plasma,0,0
195550,levels,0,0
195551,of,0,1
195552,DOPEG,0,1
195553,and,0,1
195554,MOPEG,0,1
195555,.,0,1
195556,Our,0,0
195557,results,0,0
195558,support,0,0
195559,the,0,0
195560,idea,0,0
195561,that,0,0
195562,each,0,0
195563,of,0,0
195564,these,0,0
195565,two,0,0
195566,biological,0,0
195567,indices,0,0
195568,can,0,0
195569,be,0,0
195570,used,0,0
195571,in,0,0
195572,the,0,0
195573,assessment,0,0
195574,of,0,0
195575,central,0,0
195576,noradrenergic,0,0
195577,activity,0,0
195578,.,0,1
195579,Dose,0,0
195580,dependent,0,1
195581,response,0,0
195582,of,0,1
195583,symptoms,0,0
195584,",",0,1
195585,pituitary,0,1
195586,",",0,0
195587,and,0,0
195588,bone,0,0
195589,to,0,0
195590,transdermal,0,0
195591,oestrogen,0,0
195592,in,0,0
195593,postmenopausal,1,1
195594,women,1,1
195595,.,1,1
195596,The,0,0
195597,effect,0,0
195598,of,0,0
195599,the,0,0
195600,plasma,0,0
195601,oestradiol,0,0
195602,concentration,0,0
195603,on,0,0
195604,climacteric,0,1
195605,symptoms,0,1
195606,",",0,1
195607,gonadotrophin,0,0
195608,release,0,0
195609,",",0,0
195610,and,0,0
195611,bone,0,0
195612,resorption,0,0
195613,was,0,0
195614,studied,0,1
195615,in,0,1
195616,three,1,1
195617,groups,1,1
195618,of,1,1
195619,postmenopausal,1,1
195620,women,1,1
195621,given,1,1
195622,0.025,1,0
195623,mg,1,0
195624,",",1,1
195625,0.05,1,0
195626,mg,1,0
195627,",",1,1
195628,or,1,1
195629,0.1,1,0
195630,mg,1,1
195631,transdermal,1,1
195632,oestradiol,1,1
195633,daily,1,0
195634,.,1,0
195635,There,0,0
195636,was,0,0
195637,a,0,0
195638,dose,0,0
195639,related,0,0
195640,reduction,0,0
195641,in,0,1
195642,symptoms,0,0
195643,",",0,1
195644,plasma,0,0
195645,follicle,0,1
195646,stimulating,0,0
195647,hormone,0,0
195648,concentration,0,0
195649,",",0,0
195650,and,0,0
195651,urinary,0,0
195652,calcium,0,0
195653,and,0,1
195654,hydroxyproline,0,0
195655,excretion,0,0
195656,.,0,1
195657,The,0,0
195658,relation,0,0
195659,of,0,0
195660,the,0,0
195661,response,0,0
195662,to,0,0
195663,plasma,0,0
195664,oestradiol,0,0
195665,values,0,0
195666,was,0,0
195667,similar,0,0
195668,for,0,0
195669,each,0,0
195670,variable,0,0
195671,with,0,1
195672,an,0,1
195673,initial,0,0
195674,large,0,1
195675,reduction,0,0
195676,and,0,1
195677,little,0,0
195678,change,0,0
195679,in,0,0
195680,response,0,0
195681,to,0,1
195682,increases,0,0
195683,in,0,0
195684,the,0,0
195685,plasma,0,0
195686,oestradiol,0,0
195687,concentration,0,0
195688,above,0,1
195689,150,0,1
195690,pmol/l,0,1
195691,(,0,1
195692,41,0,1
195693,pg/ml,0,1
195694,),0,1
195695,.,0,1
195696,Hormone,0,0
195697,replacement,0,0
195698,therapy,0,0
195699,producing,0,0
195700,an,0,0
195701,effect,0,0
195702,equivalent,0,0
195703,to,0,0
195704,higher,0,0
195705,oestradiol,0,0
195706,concentrations,0,0
195707,is,0,0
195708,likely,0,0
195709,to,0,0
195710,increase,0,0
195711,the,0,0
195712,risk,0,0
195713,of,0,0
195714,side,0,0
195715,effects,0,0
195716,without,0,1
195717,conferring,0,0
195718,any,0,0
195719,additional,0,0
195720,benefit,0,0
195721,.,0,1
195722,Chemotherapy,0,1
195723,of,0,1
195724,advanced,1,1
195725,gastric,1,1
195726,carcinoma,1,1
195727,(,1,1
195728,stage,1,1
195729,IV,1,1
195730,),1,1
195731,:,1,1
195732,a,0,1
195733,randomized,0,1
195734,study,0,1
195735,of,0,0
195736,FAM,0,0
195737,versus,0,0
195738,5-FU,0,1
195739,plus,0,0
195740,BCNU,0,1
195741,.,0,1
195742,Forty-six,1,1
195743,patients,1,1
195744,with,1,1
195745,advanced,1,1
195746,gastric,1,1
195747,carcinoma,1,1
195748,(,1,1
195749,Stage,1,1
195750,IV,1,1
195751,),1,1
195752,were,1,0
195753,evaluated,1,0
195754,in,0,0
195755,a,0,1
195756,prospective,0,1
195757,randomized,0,1
195758,comparison,0,0
195759,of,0,0
195760,two,0,1
195761,chemotherapy,0,1
195762,regimens,0,0
195763,(,0,1
195764,FAM,0,0
195765,versus,0,0
195766,5-FU,0,1
195767,plus,0,0
195768,BCNU,0,1
195769,),0,1
195770,to,0,0
195771,identify,0,0
195772,therapeutic,0,0
195773,activity,0,0
195774,.,0,1
195775,Treatment,0,0
195776,groups,0,0
195777,were,0,1
195778,well,0,0
195779,balanced,0,0
195780,with,0,1
195781,respect,0,0
195782,to,0,1
195783,known,0,1
195784,prognostic,0,0
195785,factors,0,0
195786,.,0,1
195787,Thirty-three,1,1
195788,patients,1,1
195789,had,1,1
195790,measurable,1,0
195791,disease,1,1
195792,and,1,1
195793,thirteen,1,1
195794,had,1,1
195795,only,1,0
195796,microscopic,1,0
195797,residual,1,0
195798,disease,1,1
195799,in,1,0
195800,the,1,0
195801,resection,1,1
195802,margins,1,1
195803,.,1,1
195804,The,0,0
195805,overall,0,0
195806,median,0,0
195807,survival,0,0
195808,of,0,0
195809,the,0,0
195810,entire,0,1
195811,group,0,1
195812,was,0,0
195813,13.2,0,1
195814,months,0,1
195815,.,0,1
195816,Two,0,1
195817,(,0,1
195818,6,0,1
195819,%,0,0
195820,),0,1
195821,patients,0,1
195822,with,0,1
195823,measurable,0,0
195824,disease,0,1
195825,reached,0,0
195826,complete,0,1
195827,response,0,0
195828,(,0,1
195829,CR,0,1
195830,),0,1
195831,",",0,1
195832,1,0,1
195833,(,0,1
195834,3,0,1
195835,%,0,0
195836,),0,1
195837,partial,0,1
195838,response,0,0
195839,(,0,1
195840,PR,0,0
195841,),0,1
195842,",",0,1
195843,12,0,1
195844,(,0,1
195845,36,0,1
195846,%,0,0
195847,),0,1
195848,had,0,1
195849,stable,0,1
195850,disease,0,1
195851,(,0,1
195852,SD,0,1
195853,),0,1
195854,and,0,1
195855,18,0,1
195856,(,0,1
195857,56,0,1
195858,%,0,0
195859,),0,1
195860,had,0,1
195861,progressive,0,1
195862,disease,0,1
195863,(,0,1
195864,PD,0,1
195865,),0,1
195866,.,0,1
195867,The,0,0
195868,responders,0,0
195869,had,0,1
195870,not,0,0
195871,reached,0,0
195872,the,0,0
195873,median,0,0
195874,survival,0,0
195875,yet,0,0
195876,",",0,0
195877,the,0,0
195878,patients,0,1
195879,with,0,1
195880,SD,0,1
195881,had,0,1
195882,a,0,0
195883,median,0,0
195884,survival,0,0
195885,of,0,1
195886,14.7,0,1
195887,months,0,1
195888,and,0,1
195889,the,0,1
195890,PD,0,1
195891,9.5,0,0
195892,months,0,1
195893,.,0,1
195894,In,0,0
195895,the,0,0
195896,FAM,0,0
195897,arm,0,0
195898,there,0,0
195899,were,0,0
195900,3,0,0
195901,(,0,1
195902,18,0,1
195903,%,0,0
195904,),0,1
195905,responders,0,0
195906,(,0,1
195907,2,0,1
195908,CR,0,1
195909,and,0,1
195910,1,0,1
195911,PR,0,0
195912,),0,1
195913,",",0,1
195914,7,0,1
195915,(,0,1
195916,41,0,1
195917,%,0,0
195918,),0,1
195919,SD,0,1
195920,and,0,1
195921,7,0,1
195922,(,0,1
195923,41,0,1
195924,%,0,0
195925,),0,1
195926,PD,0,1
195927,",",0,0
195928,versus,0,0
195929,O,0,0
195930,responders,0,0
195931,",",0,1
195932,5,0,1
195933,(,0,1
195934,31,0,1
195935,%,0,0
195936,),0,1
195937,SD,0,1
195938,and,0,1
195939,11,0,1
195940,(,0,1
195941,69,0,1
195942,%,0,0
195943,),0,1
195944,PD,0,1
195945,in,0,0
195946,the,0,0
195947,5-FU,0,1
195948,plus,0,0
195949,BCNU,0,1
195950,arm,0,1
195951,.,0,1
195952,In,0,0
195953,the,0,0
195954,FAM,0,0
195955,arm,0,0
195956,the,0,0
195957,median,0,0
195958,survival,0,0
195959,was,0,0
195960,15.7,0,0
195961,months,0,1
195962,versus,0,0
195963,9.9,0,1
195964,months,0,1
195965,in,0,1
195966,the,0,1
195967,other,0,0
195968,therapeutic,0,0
195969,arm,0,1
195970,.,0,1
195971,The,0,0
195972,statistical,0,0
195973,analysis,0,0
195974,indicated,0,0
195975,that,0,0
195976,survival,0,0
195977,associated,0,0
195978,with,0,1
195979,FAM,0,0
195980,regimen,0,1
195981,was,0,0
195982,superior,0,0
195983,to,0,1
195984,that,0,0
195985,reached,0,0
195986,with,0,1
195987,the,0,0
195988,5-FU,0,1
195989,plus,0,0
195990,BCNU,0,1
195991,regimen,0,1
195992,.,0,1
195993,Thirteen,1,1
195994,patients,1,1
195995,with,0,1
195996,unmeasurable,0,1
195997,disease,0,1
195998,had,0,1
195999,a,0,0
196000,median,0,0
196001,survival,0,0
196002,of,0,1
196003,15.9,0,1
196004,months,0,1
196005,.,0,1
196006,Psoriasis,1,1
196007,of,1,0
196008,the,1,0
196009,scalp,1,0
196010,treated,0,1
196011,with,0,1
196012,Grenz,0,1
196013,rays,0,1
196014,or,0,1
196015,topical,0,0
196016,corticosteroid,0,0
196017,combined,0,0
196018,with,0,1
196019,Grenz,0,1
196020,rays,0,1
196021,.,0,1
196022,A,0,1
196023,comparative,0,0
196024,randomized,0,1
196025,trial,0,1
196026,.,0,1
196027,To,0,0
196028,investigate,0,0
196029,the,0,0
196030,effect,0,0
196031,of,0,0
196032,Grenz,0,1
196033,ray,0,0
196034,therapy,0,0
196035,alone,0,0
196036,compared,0,0
196037,with,0,1
196038,Grenz,0,1
196039,rays,0,0
196040,combined,0,0
196041,with,0,1
196042,a,0,1
196043,topical,0,0
196044,corticosteroid,0,0
196045,(,0,1
196046,betamethasone,0,0
196047,dipropionate,0,0
196048,),0,1
196049,in,0,0
196050,psoriasis,0,1
196051,of,0,0
196052,the,0,0
196053,scalp,0,0
196054,",",0,0
196055,40,1,1
196056,patients,1,1
196057,were,0,1
196058,randomized,0,1
196059,into,0,1
196060,two,0,1
196061,groups,0,1
196062,.,0,1
196063,One,0,1
196064,group,0,1
196065,received,0,1
196066,4,0,0
196067,Gy,1,1
196068,of,1,1
196069,Grenz,1,1
196070,rays,1,0
196071,administered,0,0
196072,on,0,1
196073,six,0,1
196074,occasions,0,1
196075,at,0,1
196076,intervals,0,0
196077,of,0,1
196078,1,0,1
196079,week,0,0
196080,and,0,0
196081,the,0,0
196082,other,0,0
196083,group,0,1
196084,was,0,0
196085,given,0,0
196086,the,0,0
196087,same,0,0
196088,Grenz,0,1
196089,ray,0,0
196090,treatment,0,0
196091,plus,0,0
196092,topical,0,0
196093,corticosteroid,0,0
196094,.,0,1
196095,The,0,0
196096,patients,0,1
196097,were,0,1
196098,assessed,0,0
196099,before,0,0
196100,and,0,1
196101,after,0,1
196102,Grenz,0,1
196103,ray,0,0
196104,therapy,0,0
196105,and,0,1
196106,were,0,1
196107,followed-up,0,1
196108,for,0,1
196109,6,0,1
196110,months,0,1
196111,.,0,1
196112,Of,0,1
196113,the,0,0
196114,37,1,1
196115,patients,1,1
196116,who,1,1
196117,completed,1,1
196118,the,1,1
196119,trial,1,0
196120,16,0,1
196121,out,0,1
196122,of,0,1
196123,19,0,1
196124,(,0,1
196125,84,0,1
196126,%,0,0
196127,),0,1
196128,of,0,0
196129,the,0,0
196130,patients,0,1
196131,in,0,0
196132,the,0,1
196133,Grenz,0,0
196134,ray,0,0
196135,group,0,1
196136,",",0,0
196137,and,0,0
196138,13,0,1
196139,out,0,1
196140,of,0,1
196141,18,0,1
196142,(,0,1
196143,72,0,1
196144,%,0,0
196145,),0,1
196146,of,0,0
196147,the,0,0
196148,patients,0,1
196149,in,0,0
196150,the,0,0
196151,combination,0,0
196152,group,0,1
196153,healed,0,1
196154,.,0,1
196155,The,0,0
196156,remission,0,0
196157,time,0,0
196158,did,0,0
196159,not,0,0
196160,differ,0,0
196161,significantly,0,0
196162,between,0,0
196163,the,0,0
196164,two,0,1
196165,groups,0,0
196166,.,0,1
196167,Of,0,1
196168,the,0,1
196169,patients,1,1
196170,who,1,1
196171,healed,1,1
196172,",",0,1
196173,5,0,0
196174,of,0,1
196175,16,0,1
196176,patients,0,1
196177,in,0,1
196178,the,0,1
196179,Grenz,0,0
196180,ray,0,0
196181,only,0,0
196182,group,0,1
196183,and,0,0
196184,4,0,0
196185,of,0,1
196186,13,0,1
196187,patients,0,1
196188,in,0,1
196189,the,0,0
196190,combination,0,0
196191,group,0,0
196192,remained,0,0
196193,healed,0,1
196194,at,0,1
196195,6,0,1
196196,months,0,1
196197,.,0,1
196198,We,0,0
196199,conclude,0,0
196200,that,0,0
196201,Grenz,0,1
196202,ray,0,0
196203,therapy,0,0
196204,is,0,0
196205,a,0,0
196206,useful,0,0
196207,treatment,0,0
196208,modality,0,0
196209,for,0,0
196210,scalp,0,1
196211,psoriasis,0,1
196212,",",0,0
196213,but,0,0
196214,that,0,0
196215,the,0,0
196216,addition,0,0
196217,of,0,0
196218,a,0,1
196219,topical,0,0
196220,corticosteroid,0,0
196221,has,0,0
196222,only,0,0
196223,a,0,0
196224,minor,0,0
196225,effect,0,0
196226,.,0,1
196227,Educational,0,0
196228,intervention,0,1
196229,for,0,0
196230,altering,0,0
196231,water-sanitation,0,0
196232,behavior,0,0
196233,to,0,0
196234,reduce,0,0
196235,childhood,1,1
196236,diarrhea,1,1
196237,in,1,0
196238,urban,1,1
196239,Bangladesh,1,1
196240,:,1,1
196241,impact,0,0
196242,on,0,0
196243,nutritional,0,1
196244,status,0,1
196245,.,0,1
196246,We,0,0
196247,evaluated,0,0
196248,whether,0,0
196249,an,0,0
196250,educational,0,1
196251,intervention,0,0
196252,that,0,0
196253,was,0,0
196254,effective,0,0
196255,in,0,0
196256,reducing,0,0
196257,childhood,1,1
196258,diarrhea,1,1
196259,also,0,0
196260,improved,0,0
196261,childhood,0,1
196262,nutritional,0,1
196263,status,0,1
196264,.,0,1
196265,Fifty-one,1,1
196266,communities,1,1
196267,of,1,1
196268,38,1,1
196269,families,1,1
196270,each,1,1
196271,were,0,1
196272,randomized,0,0
196273,to,0,0
196274,receive,0,0
196275,the,0,0
196276,intervention,0,0
196277,or,0,0
196278,no,0,0
196279,intervention,0,0
196280,.,0,1
196281,During,0,0
196282,1,0,0
196283,y,0,1
196284,of,0,1
196285,follow-up,0,1
196286,the,0,0
196287,rate,0,0
196288,of,0,0
196289,diarrhea,0,1
196290,(,0,1
196291,per,0,1
196292,100,0,1
196293,wk,0,1
196294,),0,1
196295,in,0,0
196296,children,1,1
196297,less,1,1
196298,than,1,1
196299,6,1,0
196300,y,1,1
196301,in,0,0
196302,the,0,0
196303,intervention,0,0
196304,group,0,1
196305,was,0,0
196306,5.89,0,0
196307,episodes,0,1
196308,whereas,0,0
196309,that,0,0
196310,in,0,0
196311,the,0,0
196312,nonintervention,0,1
196313,group,0,1
196314,was,0,0
196315,7.55,0,0
196316,episodes,0,1
196317,(,0,1
196318,protective,0,0
196319,efficacy,0,0
196320,22,0,1
196321,%,0,0
196322,;,0,0
196323,p,0,0
196324,less,0,0
196325,than,0,0
196326,0.0001,0,0
196327,),0,1
196328,.,0,1
196329,During,0,0
196330,the,0,0
196331,same,0,0
196332,follow-up,0,0
196333,period,0,1
196334,children,0,1
196335,in,0,1
196336,both,0,0
196337,groups,0,0
196338,exhibited,0,0
196339,comparable,0,0
196340,patterns,0,1
196341,of,0,1
196342,weight,0,1
196343,gain,0,1
196344,;,0,1
196345,1,0,0
196346,y,0,1
196347,after,0,0
196348,the,0,0
196349,intervention,0,0
196350,the,0,0
196351,mean,0,0
196352,weight,0,1
196353,for,0,0
196354,age,0,1
196355,of,0,1
196356,children,0,1
196357,in,0,1
196358,both,0,0
196359,groups,0,0
196360,was,0,0
196361,76,0,1
196362,%,0,0
196363,of,0,0
196364,the,0,0
196365,NCHS,0,1
196366,standard,0,1
196367,.,0,1
196368,No,0,0
196369,significant,0,0
196370,differences,0,0
196371,were,0,1
196372,observed,0,0
196373,in,0,0
196374,the,0,0
196375,proportion,0,0
196376,of,0,0
196377,each,0,0
196378,group,0,1
196379,that,0,0
196380,experienced,0,1
196381,a,0,0
196382,major,0,0
196383,deterioration,0,0
196384,or,0,1
196385,improvement,0,0
196386,of,0,0
196387,nutritional,0,1
196388,status,0,1
196389,.,0,1
196390,We,0,0
196391,conclude,0,0
196392,that,0,0
196393,an,0,0
196394,intervention,0,0
196395,that,0,0
196396,reduces,0,0
196397,rates,0,0
196398,of,0,0
196399,childhood,1,1
196400,diarrhea,1,1
196401,may,0,0
196402,not,0,0
196403,necessarily,0,0
196404,also,0,0
196405,improve,0,0
196406,nutritional,0,0
196407,status,0,1
196408,.,0,1
196409,Surgery,0,1
196410,of,0,0
196411,aphakic,1,1
196412,retinal,1,1
196413,detachment,1,1
196414,.,1,1
196415,In,0,0
196416,a,0,0
196417,prospective,0,1
196418,study,0,1
196419,84,1,1
196420,patients,1,1
196421,with,1,1
196422,aphakic,1,1
196423,retinal,1,1
196424,detachment,1,1
196425,were,1,1
196426,treated,1,1
196427,either,1,0
196428,by,1,0
196429,local,1,0
196430,scleral,1,1
196431,buckling,1,1
196432,alone,1,0
196433,or,1,1
196434,combined,1,0
196435,with,1,1
196436,an,1,1
196437,encirclement,1,0
196438,.,1,0
196439,The,0,0
196440,rate,0,0
196441,of,0,0
196442,surgical,0,1
196443,reattachment,0,0
196444,of,0,0
196445,the,0,0
196446,retina,0,0
196447,was,0,0
196448,found,0,0
196449,to,0,0
196450,be,0,0
196451,similar,0,0
196452,with,0,1
196453,either,0,1
196454,technique,0,0
196455,over,0,0
196456,a,0,1
196457,minimum,0,0
196458,follow-up,0,0
196459,period,0,1
196460,of,0,1
196461,one,0,1
196462,year,0,1
196463,.,0,1
196464,Simplicity,0,0
196465,and,0,0
196466,a,0,1
196467,low,0,0
196468,incidence,0,0
196469,of,0,1
196470,serious,0,0
196471,complications,0,1
196472,of,0,1
196473,the,0,1
196474,local,0,0
196475,procedure,0,0
196476,merit,0,0
196477,its,0,0
196478,application,0,0
196479,as,0,0
196480,the,0,0
196481,initial,0,0
196482,method,0,0
196483,of,0,0
196484,repairing,0,0
196485,aphakic,0,1
196486,detachments,0,1
196487,.,0,1
196488,[,0,0
196489,Propofol,0,0
196490,infusion,0,0
196491,for,0,0
196492,the,0,0
196493,maintenance,0,0
196494,of,0,0
196495,short-term,1,0
196496,anesthesia,1,1
196497,],1,1
196498,.,0,1
196499,The,0,0
196500,administration,0,0
196501,of,0,0
196502,propofol,0,0
196503,by,0,0
196504,infusion,0,0
196505,for,0,0
196506,maintenance,0,0
196507,of,0,0
196508,anesthesia,0,0
196509,has,0,0
196510,attracted,0,0
196511,much,0,0
196512,attention,0,0
196513,recently,0,1
196514,.,0,1
196515,We,0,0
196516,investigated,0,0
196517,the,0,0
196518,necessary,0,0
196519,infusion,0,0
196520,rate,0,0
196521,of,0,0
196522,propofol,0,0
196523,to,0,0
196524,maintain,0,0
196525,anesthesia,0,1
196526,for,0,0
196527,short,0,1
196528,surgical,0,1
196529,procedures,0,1
196530,without,0,1
196531,loss,0,0
196532,of,0,0
196533,the,0,0
196534,evident,0,0
196535,advantages,0,0
196536,of,0,1
196537,this,0,0
196538,substance,0,1
196539,.,0,1
196540,Forty,1,1
196541,unpremedicated,1,1
196542,female,1,1
196543,patients,1,1
196544,aged,1,1
196545,18-59,1,1
196546,",",1,0
196547,scheduled,1,1
196548,for,1,0
196549,minor,1,0
196550,gynecological,1,1
196551,procedures,1,1
196552,",",0,1
196553,were,0,1
196554,randomly,0,1
196555,assigned,0,1
196556,to,0,1
196557,four,0,1
196558,groups,0,1
196559,.,0,1
196560,Anesthesia,0,0
196561,was,0,0
196562,induced,0,0
196563,with,0,1
196564,2.0,0,0
196565,mg/kg,0,0
196566,propofol,0,0
196567,i.v,0,1
196568,.,0,1
196569,and,0,0
196570,simultaneously,0,0
196571,an,0,0
196572,infusion,0,0
196573,of,0,0
196574,0.05,0,0
196575,",",0,1
196576,0.10,0,0
196577,",",0,0
196578,0.15,0,0
196579,",",0,0
196580,or,0,1
196581,0.20,0,0
196582,mg,0,0
196583,propofol/kg,0,1
196584,per,0,1
196585,minute,0,0
196586,was,0,0
196587,started,0,0
196588,.,0,1
196589,The,0,0
196590,patients,1,1
196591,were,0,1
196592,breathing,0,1
196593,N2O/O2,0,1
196594,with,0,1
196595,FIO2,0,1
196596,33,0,1
196597,%,0,0
196598,.,0,1
196599,Additional,0,0
196600,propofol,0,0
196601,was,0,0
196602,administered,0,0
196603,as,0,0
196604,a,0,0
196605,bolus,0,0
196606,of,0,0
196607,10,0,1
196608,to,0,1
196609,20,0,1
196610,mg,0,0
196611,when,0,0
196612,the,0,0
196613,patients,0,1
196614,moved,0,1
196615,.,0,1
196616,With,0,1
196617,0.05,0,0
196618,mg,0,1
196619,propofol/kg,0,1
196620,per,0,1
196621,minute,0,0
196622,all,0,1
196623,patients,0,1
196624,required,0,0
196625,additional,0,1
196626,bolus,0,0
196627,injections,0,0
196628,of,0,1
196629,propofol,0,0
196630,;,0,1
196631,with,0,1
196632,0.10,0,0
196633,mg,0,1
196634,8,0,1
196635,patients,0,1
196636,",",0,1
196637,with,0,1
196638,0.15,0,0
196639,mg,0,1
196640,5,0,1
196641,patients,0,1
196642,",",0,1
196643,and,0,1
196644,with,0,1
196645,0.20,0,0
196646,mg,0,1
196647,1,0,1
196648,patient,0,1
196649,required,0,0
196650,bolus,0,0
196651,injection,0,0
196652,.,0,1
196653,Therefore,0,0
196654,",",0,0
196655,0.15,0,0
196656,mg/kg,0,0
196657,per,0,0
196658,minute,0,0
196659,can,0,0
196660,be,0,0
196661,considered,0,0
196662,as,0,0
196663,an,0,1
196664,approximate,0,0
196665,ED50,0,0
196666,value,0,0
196667,.,0,1
196668,The,0,0
196669,total,0,1
196670,propofol,0,0
196671,consumption,0,0
196672,(,0,1
196673,infusion,0,0
196674,+,0,0
196675,bolus,0,0
196676,),0,1
196677,increased,0,0
196678,from,0,1
196679,0.102,0,0
196680,+/-,0,1
196681,0.028,0,0
196682,(,0,1
196683,+/-,0,0
196684,SD,0,1
196685,),0,1
196686,with,0,1
196687,the,0,0
196688,lowest,0,0
196689,infusion,0,0
196690,rate,0,0
196691,to,0,1
196692,0.202,0,0
196693,+/-,0,1
196694,0.006,0,0
196695,mg/kg,0,0
196696,per,0,1
196697,minute,0,0
196698,with,0,1
196699,the,0,0
196700,highest,0,0
196701,infusion,0,0
196702,rate,0,0
196703,and,0,0
196704,recovery,0,0
196705,time,0,0
196706,from,0,1
196707,5.2,0,0
196708,+/-,0,1
196709,1.4,0,0
196710,to,0,1
196711,9.9,0,1
196712,+/-,0,0
196713,2.6,0,1
196714,min,0,0
196715,.,0,0
196716,There,0,0
196717,was,0,0
196718,a,0,0
196719,significant,0,0
196720,correlation,0,0
196721,between,0,0
196722,propofol,0,0
196723,consumption,0,0
196724,and,0,0
196725,recovery,0,0
196726,time,0,0
196727,.,0,1
196728,After,0,0
196729,induction,0,0
196730,",",0,0
196731,arterial,0,1
196732,blood,0,0
196733,pressure,0,0
196734,decreased,0,0
196735,by,0,0
196736,systolic/diastolic,0,0
196737,20/10-15,0,0
196738,mmHg,0,0
196739,.,0,1
196740,With,0,0
196741,the,0,0
196742,low,0,1
196743,infusion,0,0
196744,rate,0,0
196745,",",0,0
196746,arterial,0,1
196747,pressure,0,0
196748,increased,0,0
196749,to,0,0
196750,its,0,0
196751,control,0,1
196752,value,0,0
196753,during,0,0
196754,operation,0,1
196755,;,0,1
196756,it,0,0
196757,remained,0,0
196758,at,0,0
196759,the,0,0
196760,postinduction,0,0
196761,value,0,0
196762,with,0,1
196763,high,0,1
196764,infusion,0,0
196765,rates,0,0
196766,.,0,1
196767,Side-effects,0,0
196768,:,0,1
196769,10,0,1
196770,patients,0,1
196771,had,0,1
196772,salivation,0,0
196773,that,0,0
196774,in,0,0
196775,some,0,0
196776,instances,0,0
196777,lead,0,0
196778,to,0,0
196779,coughing,0,1
196780,",",0,1
196781,9,0,0
196782,reported,0,0
196783,pain,0,1
196784,at,0,0
196785,the,0,0
196786,injection,0,0
196787,site,0,0
196788,during,0,0
196789,induction,0,0
196790,",",0,1
196791,and,0,0
196792,9,0,0
196793,reported,0,1
196794,dreams,0,1
196795,of,0,0
196796,a,0,1
196797,pleasant,0,0
196798,nature,0,1
196799,.,0,1
196800,(,0,0
196801,ABSTRACT,0,0
196802,TRUNCATED,0,1
196803,AT,0,1
196804,250,0,1
196805,WORDS,0,1
196806,),0,1
196807,Randomized,0,1
196808,study,0,1
196809,of,0,0
196810,13-cis,0,0
196811,retinoic,0,0
196812,acid,0,0
196813,v,0,0
196814,placebo,0,0
196815,in,0,0
196816,the,0,0
196817,myelodysplastic,1,1
196818,disorders,1,1
196819,.,1,1
196820,A,0,0
196821,double-blind,0,0
196822,",",0,0
196823,placebo-controlled,0,0
196824,randomized,0,1
196825,trial,0,1
196826,of,0,0
196827,13-cis,0,0
196828,retinoic,0,0
196829,acid,0,0
196830,was,0,0
196831,performed,0,0
196832,to,0,0
196833,determine,0,0
196834,if,0,0
196835,the,0,0
196836,drug,0,0
196837,has,0,0
196838,a,0,0
196839,therapeutic,0,0
196840,effect,0,0
196841,in,0,1
196842,patients,1,1
196843,with,1,1
196844,myelodysplastic,1,1
196845,syndromes,1,1
196846,(,1,1
196847,MDS,1,1
196848,),1,1
196849,.,1,1
196850,Sixty-eight,1,1
196851,evaluable,1,1
196852,patients,1,1
196853,with,1,1
196854,MDS,1,1
196855,were,1,1
196856,randomized,1,1
196857,to,0,0
196858,receive,0,1
196859,a,0,0
196860,single,0,0
196861,",",0,0
196862,daily,0,0
196863,oral,0,0
196864,dose,0,0
196865,of,0,0
196866,either,0,1
196867,13-cis,0,0
196868,retinoic,0,0
196869,acid,0,0
196870,(,0,0
196871,13-CRA,0,1
196872,",",0,1
196873,100,0,1
196874,mg/m2,0,0
196875,),0,1
196876,or,0,1
196877,matching,0,1
196878,placebo,0,0
196879,.,0,1
196880,Treatment,0,0
196881,was,0,0
196882,continued,0,0
196883,",",0,0
196884,when,0,0
196885,possible,0,0
196886,",",0,0
196887,for,0,0
196888,a,0,0
196889,period,0,0
196890,of,0,0
196891,6,0,1
196892,months,0,1
196893,.,0,1
196894,Determination,0,0
196895,of,0,0
196896,response,0,0
196897,to,0,1
196898,treatment,0,0
196899,was,0,0
196900,based,0,1
196901,on,0,0
196902,clinical,0,0
196903,course,0,0
196904,",",0,0
196905,repeat,0,0
196906,bone,0,1
196907,marrow,0,1
196908,biopsies,0,1
196909,",",0,1
196910,and,0,1
196911,aspirates,0,1
196912,and,0,1
196913,blood,0,1
196914,counts,0,0
196915,(,0,1
196916,CBC,0,1
196917,),0,1
196918,with,0,1
196919,WBC,0,1
196920,differential,0,0
196921,",",0,0
196922,platelet,0,0
196923,",",0,0
196924,and,0,0
196925,reticulocyte,0,1
196926,numbers,0,0
196927,at,0,1
196928,specified,0,1
196929,intervals,0,0
196930,.,0,1
196931,No,0,0
196932,significant,0,0
196933,difference,0,0
196934,was,0,0
196935,noted,0,0
196936,between,0,0
196937,the,0,0
196938,two,0,0
196939,treatment,0,0
196940,groups,0,1
196941,in,0,1
196942,response,0,0
196943,to,0,0
196944,test,0,0
196945,drug,0,0
196946,(,0,0
196947,P,0,0
196948,=,0,1
196949,.66,0,0
196950,),0,1
196951,.,0,1
196952,One,0,1
196953,patient,0,1
196954,(,0,1
196955,3,0,1
196956,%,0,0
196957,),0,1
196958,in,0,0
196959,the,0,0
196960,13-CRA,0,1
196961,group,0,1
196962,and,0,1
196963,two,0,1
196964,patients,0,1
196965,(,0,1
196966,6,0,1
196967,%,0,0
196968,),0,1
196969,in,0,0
196970,the,0,0
196971,placebo,0,0
196972,group,0,0
196973,had,0,1
196974,a,0,0
196975,minor,0,0
196976,response,0,0
196977,.,0,1
196978,Approximately,0,0
196979,30,0,0
196980,%,0,0
196981,of,0,1
196982,patients,0,1
196983,in,0,1
196984,both,0,0
196985,groups,0,0
196986,had,0,1
196987,progression,0,1
196988,of,0,0
196989,their,0,1
196990,disease,0,1
196991,",",0,0
196992,and,0,0
196993,progression-free,0,0
196994,survival,0,0
196995,was,0,0
196996,nearly,0,1
196997,identical,0,0
196998,.,0,1
196999,Greater,0,0
197000,than,0,0
197001,90,0,1
197002,%,0,0
197003,of,0,0
197004,the,0,0
197005,patients,0,1
197006,receiving,0,1
197007,13-CRA,0,1
197008,developed,0,1
197009,mild,0,1
197010,or,0,1
197011,moderate,0,1
197012,skin,0,1
197013,toxicity,0,0
197014,that,0,0
197015,was,0,0
197016,reversible,0,0
197017,with,0,1
197018,decreasing,0,0
197019,or,0,1
197020,discontinuing,0,0
197021,the,0,0
197022,drug,0,0
197023,.,0,1
197024,Our,0,0
197025,study,0,0
197026,did,0,0
197027,not,0,0
197028,find,0,0
197029,that,0,0
197030,13-CRA,0,1
197031,exerts,0,0
197032,a,0,1
197033,beneficial,0,0
197034,therapeutic,0,0
197035,effect,0,0
197036,in,0,1
197037,patients,1,1
197038,with,1,1
197039,MDS,1,1
197040,.,1,1
197041,BCG,0,1
197042,(,0,1
197043,RIVM,0,1
197044,),0,1
197045,versus,0,0
197046,mitomycin,0,0
197047,intravesical,0,1
197048,therapy,0,1
197049,in,0,1
197050,superficial,1,1
197051,bladder,1,1
197052,cancer,1,1
197053,.,1,1
197054,First,0,0
197055,results,0,0
197056,of,0,1
197057,randomized,0,1
197058,prospective,0,1
197059,trial,0,1
197060,.,0,1
197061,This,0,0
197062,study,0,0
197063,presents,0,0
197064,the,0,0
197065,preliminary,0,0
197066,results,0,0
197067,of,0,1
197068,a,0,1
197069,randomized,0,1
197070,prospective,0,1
197071,two-arm,0,0
197072,study,0,1
197073,in,0,0
197074,which,0,0
197075,bacillus,0,1
197076,Calmette-Gu?rin,0,1
197077,(,0,1
197078,BCG,0,1
197079,),0,1
197080,RIVM,0,0
197081,",",0,0
197082,a,0,0
197083,Dutch,0,1
197084,BCG,0,1
197085,preparation,0,0
197086,",",0,0
197087,is,0,0
197088,compared,0,0
197089,with,0,1
197090,mitomycin,0,0
197091,C,0,1
197092,(,0,1
197093,MMC,0,1
197094,),0,1
197095,in,1,1
197096,patients,1,1
197097,with,1,1
197098,primary,1,1
197099,or,1,1
197100,recurrent,1,1
197101,superficial,1,1
197102,bladder,1,1
197103,tumors,1,1
197104,",",1,1
197105,including,1,0
197106,carcinoma,1,1
197107,in,1,1
197108,situ,1,0
197109,(,1,1
197110,CIS,1,0
197111,),1,1
197112,.,1,1
197113,Therapeutic,0,0
197114,regimens,0,0
197115,were,0,1
197116,as,0,0
197117,follows,0,0
197118,:,0,1
197119,after,0,0
197120,complete,0,1
197121,transurethral,0,1
197122,resection,0,1
197123,of,0,0
197124,all,0,1
197125,visible,0,0
197126,tumors,0,1
197127,",",0,1
197128,BCG,0,1
197129,RIVM,0,1
197130,(,0,1
197131,1,0,1
197132,x,0,1
197133,10,0,1
197134,(,0,1
197135,9,0,1
197136,),0,1
197137,bacilli,0,1
197138,in,0,1
197139,50,0,1
197140,mL,0,0
197141,saline,0,0
197142,),0,1
197143,was,0,0
197144,instilled,0,0
197145,once,0,0
197146,a,0,0
197147,week,0,0
197148,for,0,0
197149,six,0,1
197150,consecutive,0,1
197151,weeks,0,0
197152,",",0,1
197153,and,0,0
197154,mitomycin,0,0
197155,C,0,0
197156,(,0,1
197157,30,0,1
197158,mg,0,1
197159,in,0,1
197160,50,0,1
197161,mL,0,0
197162,saline,0,0
197163,),0,1
197164,was,0,0
197165,administered,0,0
197166,once,0,0
197167,a,0,0
197168,week,0,0
197169,for,0,0
197170,one,0,1
197171,month,0,1
197172,(,0,1
197173,weeks,0,1
197174,1,0,1
197175,to,0,1
197176,4,0,1
197177,),0,1
197178,and,0,0
197179,thereafter,0,0
197180,once,0,0
197181,a,0,0
197182,month,0,0
197183,for,0,0
197184,a,0,0
197185,total,0,1
197186,of,0,0
197187,six,0,1
197188,months,0,1
197189,.,0,1
197190,Reported,1,0
197191,are,1,0
197192,the,1,0
197193,incidence,1,0
197194,of,1,0
197195,side,1,0
197196,effects,1,0
197197,in,1,1
197198,165,1,1
197199,patients,1,1
197200,and,1,1
197201,the,1,0
197202,recurrence,1,0
197203,rate,1,0
197204,of,1,0
197205,tumors,1,1
197206,in,1,1
197207,308,1,1
197208,patients,1,1
197209,after,1,1
197210,a,1,1
197211,follow-up,1,0
197212,period,1,0
197213,of,1,1
197214,twelve,1,1
197215,months,1,1
197216,.,1,1
197217,Drug-induced,0,0
197218,",",0,0
197219,or,0,1
197220,chemical,0,1
197221,cystitis,0,1
197222,was,0,0
197223,observed,0,0
197224,in,0,1
197225,13,0,1
197226,(,0,1
197227,16.7,0,1
197228,%,0,0
197229,),0,1
197230,of,0,0
197231,78,0,1
197232,BCG-treated,0,1
197233,patients,0,1
197234,and,0,1
197235,in,0,1
197236,12,0,1
197237,(,0,1
197238,13.8,0,1
197239,%,0,0
197240,),0,1
197241,of,0,0
197242,87,0,1
197243,MMC-treated,0,1
197244,patients,0,1
197245,.,0,1
197246,In,0,0
197247,the,0,0
197248,same,0,0
197249,groups,0,0
197250,bacterial,0,0
197251,cystitis,0,1
197252,occurred,0,0
197253,in,0,0
197254,17,0,1
197255,(,0,1
197256,21.8,0,1
197257,%,0,0
197258,),0,1
197259,patients,0,1
197260,and,0,1
197261,in,0,1
197262,16,0,1
197263,(,0,1
197264,18.4,0,0
197265,%,0,0
197266,),0,1
197267,patients,0,1
197268,",",0,1
197269,respectively,0,0
197270,.,0,0
197271,In,0,0
197272,the,0,0
197273,BCG-treated,0,0
197274,group,0,1
197275,(,0,1
197276,N,0,1
197277,=,0,1
197278,148,0,1
197279,),0,1
197280,",",0,1
197281,44,0,1
197282,(,0,1
197283,29.8,0,1
197284,%,0,0
197285,),0,1
197286,had,0,1
197287,recurrent,0,1
197288,tumors,0,1
197289,",",0,1
197290,while,0,0
197291,in,0,0
197292,the,0,0
197293,MMC-treated,0,1
197294,group,0,1
197295,(,0,1
197296,N,0,1
197297,=,0,1
197298,160,0,1
197299,),0,1
197300,",",0,1
197301,40,0,1
197302,(,0,1
197303,25.0,0,0
197304,%,0,0
197305,),0,1
197306,had,0,1
197307,a,0,1
197308,recurrence,0,0
197309,.,0,0
197310,The,0,0
197311,recurrence,0,0
197312,rate,0,0
197313,for,0,1
197314,BCG-treated,0,1
197315,patients,0,1
197316,was,0,1
197317,0.33,0,0
197318,;,0,0
197319,the,0,0
197320,recurrence,0,0
197321,rate,0,0
197322,for,0,1
197323,MMC-treated,0,1
197324,patients,0,1
197325,was,0,0
197326,0.29,0,0
197327,(,0,1
197328,P,0,0
197329,=,0,1
197330,0.560,0,0
197331,",",0,0
197332,not,0,0
197333,significant,0,0
197334,),0,1
197335,.,0,1
197336,These,0,1
197337,preliminary,0,0
197338,data,0,0
197339,demonstrated,0,0
197340,no,0,0
197341,statistically,0,0
197342,significant,0,0
197343,difference,0,0
197344,between,0,0
197345,the,0,1
197346,two,0,0
197347,arms,0,0
197348,with,0,1
197349,regard,0,0
197350,to,0,1
197351,toxicity,0,0
197352,and,0,0
197353,recurrence,0,0
197354,of,0,1
197355,tumors,0,1
197356,.,0,1
197357,Pulsatile,0,1
197358,insulin,0,0
197359,delivery,0,0
197360,is,0,0
197361,more,0,0
197362,efficient,0,0
197363,than,0,0
197364,continuous,0,0
197365,infusion,0,0
197366,in,0,0
197367,modulating,0,0
197368,islet,0,1
197369,cell,0,1
197370,function,0,0
197371,in,0,1
197372,normal,1,1
197373,subjects,1,1
197374,and,1,1
197375,patients,1,1
197376,with,1,1
197377,type,1,1
197378,1,1,1
197379,diabetes,1,1
197380,.,1,1
197381,The,0,0
197382,respective,0,1
197383,modulating,0,0
197384,effects,0,0
197385,of,0,1
197386,continuous,0,0
197387,and,0,1
197388,intermittent,0,1
197389,insulin,0,0
197390,delivery,0,0
197391,on,0,0
197392,pancreatic,0,1
197393,islet,0,1
197394,cell,0,1
197395,function,0,0
197396,were,0,0
197397,studied,0,1
197398,in,0,1
197399,seven,1,1
197400,normal,1,1
197401,men,1,1
197402,and,1,1
197403,nine,1,1
197404,insulin-dependent,1,1
197405,(,1,1
197406,type,1,1
197407,1,1,1
197408,),1,1
197409,diabetic,1,1
197410,patients,1,1
197411,.,1,1
197412,In,0,0
197413,the,0,0
197414,normal,1,1
197415,men,1,1
197416,",",0,1
197417,saline,0,0
197418,or,0,1
197419,continuous,0,0
197420,(,0,1
197421,0.8,0,0
197422,mU,0,0
197423,kg-1,0,0
197424,min-1,0,0
197425,),0,1
197426,or,0,1
197427,pulsatile,0,0
197428,(,0,1
197429,5.2,0,0
197430,mU,0,0
197431,kg-1,0,0
197432,min-1,0,0
197433,",",0,1
197434,with,0,1
197435,a,0,0
197436,switching,0,0
197437,on/off,0,0
197438,length,0,0
197439,of,0,0
197440,2/11,0,1
197441,min,0,0
197442,),0,1
197443,human,0,1
197444,insulin,0,1
197445,were,0,1
197446,delivered,0,0
197447,on,0,0
197448,different,0,1
197449,days,0,0
197450,and,0,1
197451,in,0,1
197452,random,0,1
197453,order,0,0
197454,.,0,1
197455,Despite,0,0
197456,hyperinsulinemia,0,1
197457,",",0,0
197458,blood,0,0
197459,glucose,0,0
197460,was,0,0
197461,kept,0,0
197462,close,0,0
197463,to,0,0
197464,its,0,0
197465,basal,0,0
197466,value,0,0
197467,by,0,0
197468,the,0,0
197469,glucose,0,0
197470,clamp,0,0
197471,technique,0,0
197472,.,0,1
197473,The,0,0
197474,diabetic,1,1
197475,patients,1,1
197476,also,0,0
197477,were,0,1
197478,infused,0,0
197479,in,0,0
197480,random,0,1
197481,order,0,0
197482,and,0,1
197483,on,0,0
197484,different,0,1
197485,days,0,0
197486,with,0,1
197487,either,0,1
197488,saline,0,0
197489,or,0,0
197490,a,0,0
197491,smaller,0,0
197492,amount,0,0
197493,of,0,0
197494,insulin,0,0
197495,delivered,0,1
197496,continuously,0,0
197497,(,0,0
197498,0.15,0,0
197499,mU,0,0
197500,kg-1,0,0
197501,min-1,0,0
197502,),0,1
197503,or,0,1
197504,in,0,0
197505,a,0,1
197506,pulsatile,0,0
197507,manner,0,0
197508,(,0,1
197509,0.97,0,0
197510,mU,0,0
197511,kg-1,0,0
197512,min-1,0,0
197513,for,0,1
197514,2,0,1
197515,min,0,0
197516,",",0,0
197517,followed,0,0
197518,by,0,0
197519,11,0,1
197520,min,0,0
197521,during,0,1
197522,which,0,0
197523,no,0,0
197524,insulin,0,0
197525,was,0,0
197526,infused,0,0
197527,),0,1
197528,.,0,1
197529,In,0,0
197530,all,0,0
197531,experiments,0,0
197532,",",0,1
197533,5,0,0
197534,g,0,1
197535,arginine,0,0
197536,were,0,1
197537,given,0,0
197538,iv,0,1
197539,as,0,0
197540,a,0,1
197541,bolus,0,0
197542,dose,0,0
197543,30,0,1
197544,min,0,0
197545,before,0,0
197546,the,0,0
197547,end,0,0
197548,of,0,0
197549,the,0,0
197550,study,0,0
197551,",",0,0
197552,and,0,0
197553,plasma,0,0
197554,C-peptide,0,0
197555,and,0,0
197556,glucagon,0,0
197557,levels,0,0
197558,were,0,1
197559,determined,0,0
197560,to,0,0
197561,assess,0,0
197562,islet,0,1
197563,cell,0,1
197564,function,0,0
197565,.,0,1
197566,In,0,0
197567,the,0,0
197568,normal,1,1
197569,men,1,1
197570,",",0,1
197571,insulin,0,0
197572,administration,0,0
197573,resulted,0,0
197574,in,0,0
197575,a,0,1
197576,significant,0,0
197577,decline,0,0
197578,of,0,0
197579,basal,0,0
197580,plasma,0,0
197581,glucagon,0,0
197582,and,0,1
197583,C-peptide,0,0
197584,levels,0,0
197585,and,0,1
197586,in,0,1
197587,a,0,1
197588,clear-cut,0,0
197589,decrease,0,0
197590,in,0,0
197591,the,0,0
197592,arginine-induced,0,0
197593,glucagon,0,0
197594,response,0,0
197595,.,0,1
197596,These,0,0
197597,effects,0,0
197598,of,0,0
197599,insulin,0,1
197600,were,0,0
197601,significantly,0,0
197602,more,0,0
197603,marked,0,0
197604,when,0,0
197605,insulin,0,0
197606,was,0,0
197607,delivered,0,0
197608,in,0,0
197609,a,0,0
197610,pulsatile,0,0
197611,rather,0,0
197612,than,0,0
197613,a,0,0
197614,continuous,0,0
197615,manner,0,0
197616,.,0,1
197617,In,0,0
197618,the,0,0
197619,insulin-dependent,1,1
197620,diabetic,1,1
197621,patients,1,1
197622,",",0,0
197623,the,0,0
197624,lower,0,0
197625,dose,0,0
197626,of,0,0
197627,insulin,0,0
197628,infused,0,0
197629,continuously,0,0
197630,did,0,0
197631,not,0,0
197632,alter,0,0
197633,the,0,0
197634,basal,0,0
197635,or,0,1
197636,arginine-stimulated,0,0
197637,glucagon,0,0
197638,response,0,0
197639,.,0,1
197640,In,0,0
197641,contrast,0,0
197642,",",0,0
197643,when,0,0
197644,the,0,0
197645,same,0,0
197646,amount,0,0
197647,of,0,0
197648,insulin,0,0
197649,was,0,0
197650,delivered,0,0
197651,intermittently,0,1
197652,",",0,0
197653,arginine-induced,0,0
197654,glucagon,0,0
197655,release,0,0
197656,was,0,0
197657,greatly,0,0
197658,reduced,0,0
197659,.,0,0
197660,Thus,0,0
197661,",",0,0
197662,these,0,0
197663,data,0,0
197664,support,0,0
197665,the,0,0
197666,concept,0,0
197667,that,0,0
197668,insulin,0,0
197669,per,0,0
197670,se,0,0
197671,is,0,0
197672,a,0,0
197673,potent,0,0
197674,physiological,0,0
197675,modulator,0,1
197676,of,0,0
197677,islet,0,1
197678,A-,0,1
197679,and,0,1
197680,B-cell,0,0
197681,function,0,0
197682,.,0,1
197683,Furthermore,0,0
197684,",",0,0
197685,they,0,0
197686,suggest,0,0
197687,that,0,0
197688,these,0,0
197689,effects,0,0
197690,of,0,0
197691,insulin,0,1
197692,are,0,0
197693,reinforced,0,0
197694,when,0,0
197695,the,0,0
197696,hormone,0,0
197697,is,0,0
197698,administered,0,0
197699,in,0,0
197700,an,0,0
197701,intermittent,0,0
197702,manner,0,0
197703,in,0,0
197704,an,0,0
197705,attempt,0,0
197706,to,0,0
197707,reproduce,0,0
197708,the,0,0
197709,pulsatile,0,0
197710,physiological,0,0
197711,release,0,0
197712,of,0,0
197713,insulin,0,1
197714,.,0,1
197715,[,0,0
197716,Prevention,0,1
197717,of,0,0
197718,thromboembolism,0,1
197719,in,0,1
197720,patients,1,1
197721,operated,1,1
197722,on,1,0
197723,for,1,0
197724,hip,1,1
197725,prosthesis,1,1
197726,],1,1
197727,.,0,1
197728,The,0,0
197729,latest,0,0
197730,research,0,0
197731,into,0,0
197732,the,0,0
197733,prevention,0,1
197734,of,0,0
197735,peri-,0,0
197736,and,0,1
197737,postoperative,0,0
197738,thromboembolic,0,0
197739,disease,0,1
197740,has,0,0
197741,found,0,0
197742,orthopaedic,0,1
197743,surgery,0,1
197744,patients,0,1
197745,to,0,1
197746,be,0,0
197747,most,0,0
197748,at,0,0
197749,risk,0,1
197750,.,0,1
197751,As,0,0
197752,the,0,0
197753,genesis,0,0
197754,of,0,0
197755,deep,0,1
197756,venous,0,1
197757,thrombosis,0,1
197758,(,0,1
197759,DVT,0,1
197760,),0,1
197761,is,0,0
197762,due,0,0
197763,to,0,0
197764,haemodynamic,0,0
197765,",",0,0
197766,hemorheologic,0,0
197767,and,0,1
197768,parietal,0,1
197769,factors,0,0
197770,",",0,1
197771,various,0,0
197772,prophylactic,0,1
197773,measures,0,0
197774,have,0,1
197775,been,0,0
197776,considered,0,0
197777,in,0,0
197778,the,0,0
197779,past,0,1
197780,",",0,0
197781,measures,0,0
197782,which,0,0
197783,have,0,0
197784,not,0,0
197785,proved,0,0
197786,able,0,0
197787,to,0,0
197788,provide,0,0
197789,satisfactory,0,0
197790,protection,0,0
197791,in,0,1
197792,orthopaedics,0,1
197793,.,0,1
197794,The,0,0
197795,results,0,0
197796,obtained,0,0
197797,with,0,1
197798,Defibrotide,0,0
197799,in,0,0
197800,a,0,1
197801,random,0,1
197802,and,0,0
197803,controlled,0,0
197804,clinical,0,0
197805,study,0,1
197806,versus,0,0
197807,calcium,0,0
197808,heparin,0,0
197809,involving,0,1
197810,211,1,1
197811,patients,1,1
197812,of,1,1
197813,both,1,1
197814,sexes,1,1
197815,candidates,1,1
197816,to,1,1
197817,receive,1,1
197818,total,1,1
197819,hip,1,1
197820,arthroplasty,1,1
197821,and,1,0
197822,presenting,1,1
197823,at,1,1
197824,least,1,1
197825,one,1,1
197826,major,1,1
197827,thromboembolic,1,1
197828,risk,1,0
197829,factor,1,0
197830,are,0,0
197831,reported,0,0
197832,.,0,1
197833,The,0,0
197834,patients,0,1
197835,were,0,1
197836,assigned,0,1
197837,at,0,0
197838,random,0,1
197839,to,0,1
197840,one,0,1
197841,of,0,0
197842,the,0,1
197843,following,0,0
197844,treatments,0,0
197845,:,0,1
197846,1,0,1
197847,),0,1
197848,Defibrotide,0,0
197849,at,0,0
197850,a,0,0
197851,dose,0,0
197852,of,0,0
197853,400,0,0
197854,mg,0,1
197855,b.i.d,0,1
197856,.,0,1
197857,i.v,0,0
197858,.,0,1
197859,in,0,0
197860,50,0,1
197861,ml,0,0
197862,phleboclysis,0,1
197863,in,0,1
197864,5,0,1
197865,minutes,0,0
197866,(,0,1
197867,n,0,1
197868,=,0,1
197869,108,0,1
197870,),0,1
197871,;,0,1
197872,2,0,1
197873,),0,1
197874,calcium,0,0
197875,heparin,0,0
197876,at,0,0
197877,a,0,0
197878,dose,0,0
197879,of,0,0
197880,5000,0,1
197881,IU,0,0
197882,t.i.d,0,1
197883,.,0,1
197884,subcutaneously,0,0
197885,(,0,0
197886,n,0,1
197887,=,0,1
197888,103,0,1
197889,),0,1
197890,.,0,1
197891,The,0,0
197892,treatment,0,0
197893,began,0,1
197894,the,0,0
197895,day,0,0
197896,before,0,0
197897,operation,0,1
197898,and,0,0
197899,continued,0,0
197900,on,0,0
197901,average,0,1
197902,up,0,1
197903,to,0,0
197904,the,0,0
197905,eighth,0,0
197906,day,0,0
197907,for,0,0
197908,the,0,0
197909,Defibrotide,0,0
197910,group,0,1
197911,.,0,1
197912,With,0,0
197913,the,0,0
197914,control,0,1
197915,group,0,0
197916,it,0,0
197917,continued,0,0
197918,until,0,0
197919,discharge,0,0
197920,(,0,0
197921,usually,0,0
197922,on,0,0
197923,the,0,0
197924,15th,0,0
197925,day,0,0
197926,),0,1
197927,and,0,0
197928,at,0,0
197929,home,0,1
197930,for,0,0
197931,about,0,0
197932,three,0,0
197933,weeks,0,0
197934,until,0,1
197935,the,0,0
197936,completion,0,0
197937,of,0,0
197938,the,0,0
197939,physiotherapy,0,1
197940,cycle,0,0
197941,.,0,1
197942,In,0,0
197943,the,0,0
197944,108,0,1
197945,patients,0,1
197946,treated,0,1
197947,with,0,1
197948,Defibrotide,0,0
197949,only,0,0
197950,one,0,1
197951,case,0,0
197952,of,0,1
197953,DVT,0,1
197954,was,0,0
197955,reported,0,0
197956,and,0,0
197957,in,0,0
197958,none,0,0
197959,of,0,0
197960,these,0,0
197961,patients,0,1
197962,were,0,1
197963,symptoms,0,1
197964,or,0,1
197965,signs,0,1
197966,of,0,1
197967,pulmonary,0,1
197968,embolism,0,1
197969,encountered,0,1
197970,.,0,1
197971,In,0,0
197972,the,0,0
197973,group,0,0
197974,treated,0,1
197975,with,0,1
197976,calcium,0,0
197977,heparin,0,1
197978,2,0,1
197979,cases,0,1
197980,of,0,1
197981,clinically,0,1
197982,and,0,0
197983,radiologically,0,1
197984,diagnosed,0,1
197985,pulmonary,0,1
197986,embolism,0,1
197987,and,0,1
197988,4,0,0
197989,cases,0,1
197990,of,0,1
197991,DVT,0,1
197992,were,0,1
197993,observed,0,0
197994,.,0,1
197995,Although,0,0
197996,the,0,0
197997,differences,0,0
197998,were,0,0
197999,not,0,0
198000,statistically,0,0
198001,significant,0,0
198002,",",0,0
198003,the,0,0
198004,tendency,0,0
198005,favours,0,0
198006,Defibrotide,0,0
198007,.,0,0
198008,Statistically,0,0
198009,significant,0,0
198010,(,0,1
198011,p,0,0
198012,less,0,0
198013,than,0,0
198014,0.01,0,0
198015,),0,1
198016,was,0,0
198017,the,0,0
198018,difference,0,0
198019,in,0,0
198020,postoperative,0,0
198021,bleeding,0,1
198022,evaluated,0,0
198023,with,0,1
198024,particular,0,0
198025,attention,0,0
198026,in,0,1
198027,patients,0,1
198028,of,0,1
198029,advanced,0,1
198030,age,0,1
198031,.,0,1
198032,Further,0,0
198033,",",0,0
198034,in,0,0
198035,the,0,0
198036,Defibrotide,0,0
198037,group,0,0
198038,",",0,0
198039,scarring,0,0
198040,was,0,0
198041,considered,0,0
198042,excellent,0,0
198043,in,0,1
198044,96,0,1
198045,%,0,0
198046,of,0,1
198047,cases,0,1
198048,while,0,0
198049,in,0,1
198050,the,0,0
198051,heparin,0,0
198052,group,0,0
198053,scarring,0,0
198054,was,0,0
198055,excellent,0,0
198056,in,0,1
198057,85,0,1
198058,%,0,0
198059,(,0,0
198060,p,0,0
198061,less,0,0
198062,than,0,0
198063,0.05,0,0
198064,),0,1
198065,.,0,1
198066,To,0,0
198067,conclude,0,0
198068,",",0,0
198069,the,0,0
198070,sure,0,0
198071,clinical,0,0
198072,effectiveness,0,0
198073,",",0,0
198074,tolerance,0,0
198075,",",0,0
198076,handiness,0,0
198077,and,0,0
198078,lack,0,0
198079,of,0,0
198080,interference,0,0
198081,with,0,1
198082,clotting,0,0
198083,functions,0,0
198084,make,0,0
198085,Defibrotide,0,0
198086,a,0,0
198087,really,0,0
198088,useful,0,0
198089,drug,0,0
198090,for,0,0
198091,the,0,0
198092,prevention,0,1
198093,of,0,0
198094,thromboembolic,0,1
198095,episodes,0,1
198096,in,0,1
198097,patients,1,1
198098,undergoing,1,1
198099,major,1,1
198100,orthopaedic,1,1
198101,surgery,1,1
198102,.,1,1
198103,Need,0,1
198104,for,0,0
198105,insulin,0,0
198106,therapy,0,0
198107,in,0,0
198108,type,1,1
198109,II,1,1
198110,diabetes,1,1
198111,mellitus,1,1
198112,.,1,0
198113,A,0,0
198114,randomized,0,0
198115,trial,0,1
198116,.,0,1
198117,To,1,0
198118,identify,1,0
198119,patients,1,1
198120,with,1,1
198121,type,1,1
198122,II,1,1
198123,diabetes,1,1
198124,mellitus,1,1
198125,for,1,0
198126,whom,1,1
198127,insulin,1,1
198128,therapy,1,1
198129,is,1,0
198130,most,1,0
198131,beneficial,1,0
198132,",",1,0
198133,we,1,0
198134,conducted,1,0
198135,a,1,0
198136,randomized,1,1
198137,controlled,1,0
198138,trial,1,0
198139,in,1,0
198140,the,1,0
198141,general,1,1
198142,medicine,1,1
198143,clinic,1,1
198144,of,1,0
198145,a,1,0
198146,university,1,1
198147,hospital,1,1
198148,.,1,1
198149,Asymptomatic,1,0
198150,",",1,0
198151,obese,1,1
198152,",",1,1
198153,insulin-treated,1,1
198154,patients,1,1
198155,were,0,1
198156,given,0,1
198157,diet,0,0
198158,and,0,0
198159,diabetes,0,1
198160,education,0,0
198161,and,0,0
198162,",",0,0
198163,in,0,0
198164,half,0,1
198165,of,0,0
198166,these,0,0
198167,patients,0,1
198168,",",0,0
198169,insulin,0,1
198170,therapy,0,0
198171,was,0,0
198172,withdrawn,0,0
198173,.,0,1
198174,Over,0,0
198175,six,0,1
198176,months,0,1
198177,",",0,1
198178,patients,0,1
198179,developing,0,1
198180,hyperglycemic,0,1
198181,symptoms,0,1
198182,or,0,1
198183,acetonemia,0,1
198184,were,0,0
198185,counted,0,0
198186,as,0,0
198187,study,0,1
198188,failures,0,1
198189,.,0,1
198190,Failure,0,1
198191,criteria,0,1
198192,developed,0,1
198193,in,0,1
198194,13,0,1
198195,of,0,1
198196,25,1,1
198197,insulin-withdrawal,1,1
198198,patients,1,1
198199,",",0,1
198200,at,0,0
198201,a,0,0
198202,median,0,0
198203,of,0,0
198204,four,0,1
198205,weeks,0,1
198206,after,0,1
198207,withdrawal,0,0
198208,",",0,0
198209,compared,0,0
198210,with,0,1
198211,two,0,1
198212,of,0,1
198213,24,1,1
198214,control,1,1
198215,subjects,1,1
198216,.,1,1
198217,Elevated,0,1
198218,stimulated,0,0
198219,glucose,0,0
198220,levels,0,0
198221,predicted,0,0
198222,the,0,0
198223,need,0,0
198224,for,0,0
198225,insulin,0,1
198226,therapy,0,1
198227,.,0,1
198228,Hyperglycemia,0,0
198229,worsened,0,0
198230,in,0,1
198231,insulin-withdrawal,0,1
198232,patients,0,1
198233,who,0,1
198234,did,0,1
198235,not,0,1
198236,meet,0,1
198237,study,0,0
198238,failure,0,1
198239,criteria,0,1
198240,",",0,1
198241,but,0,0
198242,it,0,0
198243,improved,0,0
198244,in,0,0
198245,control,0,1
198246,patients,0,1
198247,.,0,1
198248,Study,0,0
198249,patients,0,1
198250,were,0,1
198251,insulin,0,1
198252,deficient,0,1
198253,as,0,0
198254,shown,0,0
198255,by,0,0
198256,low,0,1
198257,baseline,0,0
198258,C,0,1
198259,peptide,0,0
198260,values,0,0
198261,(,0,1
198262,0.43,0,0
198263,+/-,0,1
198264,0.05,0,0
198265,nmol/L,0,0
198266,),0,1
198267,.,0,1
198268,The,0,0
198269,prompt,0,0
198270,metabolic,0,1
198271,decompensation,0,1
198272,precipitated,0,1
198273,by,0,0
198274,insulin,0,0
198275,withdrawal,0,0
198276,suggests,0,0
198277,that,0,0
198278,insulin-deficient,0,1
198279,patients,0,1
198280,may,0,0
198281,benefit,0,0
198282,from,0,0
198283,insulin,0,0
198284,therapy,0,0
198285,and,0,0
198286,may,0,0
198287,need,0,0
198288,it,0,0
198289,to,0,0
198290,prevent,0,0
198291,symptomatic,0,1
198292,hyperglycemia,0,1
198293,.,0,1
198294,Nitrous,0,1
198295,oxide,0,0
198296,does,0,0
198297,not,0,0
198298,increase,0,0
198299,the,0,0
198300,incidence,0,0
198301,of,0,0
198302,nausea,1,0
198303,and,1,0
198304,vomiting,1,0
198305,after,1,0
198306,isoflurane,1,0
198307,anesthesia,1,1
198308,.,1,1
198309,A,0,0
198310,total,0,1
198311,of,0,0
198312,110,1,1
198313,patients,1,1
198314,undergoing,1,1
198315,elective,1,1
198316,abdominal,1,1
198317,hysterectomy,1,1
198318,were,1,1
198319,anesthetized,1,1
198320,in,1,0
198321,random,1,1
198322,order,1,0
198323,with,0,1
198324,either,0,0
198325,isoflurane,0,0
198326,in,0,0
198327,nitrous,0,1
198328,oxide,0,0
198329,and,0,1
198330,oxygen,0,0
198331,or,0,1
198332,isoflurane,0,0
198333,in,0,0
198334,air,0,1
198335,and,0,1
198336,oxygen,0,0
198337,.,0,1
198338,Fentanyl,0,0
198339,was,0,0
198340,used,0,0
198341,as,0,0
198342,an,0,0
198343,adjunct,0,0
198344,to,0,0
198345,isoflurane,0,0
198346,in,0,0
198347,all,1,0
198348,patients,1,1
198349,",",0,1
198350,0.05,0,0
198351,mg,0,0
198352,every,0,0
198353,45,0,1
198354,min,0,0
198355,.,0,1
198356,No,0,0
198357,difference,0,0
198358,was,0,0
198359,found,0,0
198360,between,0,0
198361,the,0,0
198362,two,0,0
198363,anesthetic,0,0
198364,techniques,0,0
198365,in,0,1
198366,the,0,0
198367,incidence,0,0
198368,of,0,0
198369,nausea,0,0
198370,",",0,0
198371,vomiting,0,0
198372,",",0,0
198373,or,0,1
198374,both,0,0
198375,during,0,0
198376,the,0,0
198377,first,0,0
198378,24,0,1
198379,hr,0,1
198380,after,0,1
198381,operation,0,1
198382,.,0,1
198383,The,0,0
198384,overall,0,0
198385,incidence,0,0
198386,was,0,0
198387,62,0,1
198388,and,0,1
198389,67,0,1
198390,%,0,0
198391,for,0,1
198392,air-O2,0,1
198393,and,0,1
198394,N2O-O2,0,1
198395,groups,0,0
198396,",",0,1
198397,respectively,0,0
198398,.,0,1
198399,Patients,0,1
198400,who,0,1
198401,had,0,1
198402,had,0,1
198403,nausea,0,0
198404,or,0,1
198405,vomiting,0,0
198406,after,0,1
198407,previous,0,1
198408,anesthetics,0,0
198409,had,0,1
198410,nausea,0,0
198411,or,0,1
198412,vomiting,0,0
198413,significantly,0,0
198414,more,0,0
198415,frequently,0,0
198416,than,0,0
198417,patients,0,1
198418,who,0,1
198419,did,0,1
198420,not,0,1
198421,.,0,0
198422,It,0,0
198423,is,0,0
198424,concluded,0,0
198425,that,0,0
198426,nitrous,0,0
198427,oxide,0,0
198428,does,0,0
198429,not,0,0
198430,contribute,0,0
198431,to,0,0
198432,the,0,0
198433,occurrence,0,0
198434,of,0,0
198435,nausea,0,0
198436,or,0,1
198437,vomiting,0,0
198438,after,0,0
198439,isoflurane,0,0
198440,anesthesia,0,1
198441,for,0,1
198442,gynecologic,0,1
198443,laparotomies,0,1
198444,.,0,1
198445,Therapeutic,0,1
198446,strategies,0,0
198447,in,0,1
198448,acute,1,1
198449,myelocytic,1,1
198450,leukemia,1,1
198451,:,1,1
198452,a,0,0
198453,status,0,0
198454,report,0,0
198455,of,0,0
198456,the,0,0
198457,experience,0,1
198458,of,0,0
198459,CALGB,0,1
198460,.,0,1
198461,Cancer,1,0
198462,and,1,0
198463,Leukemia,1,1
198464,Group,0,1
198465,B,0,1
198466,.,0,1
198467,Oral,0,1
198468,ribavirin,0,1
198469,treatment,0,1
198470,of,0,0
198471,influenza,0,1
198472,A,0,1
198473,and,0,1
198474,B,0,1
198475,.,0,1
198476,A,0,0
198477,loading,0,0
198478,dose,0,0
198479,and,0,1
198480,short-term,0,0
198481,administration,0,0
198482,of,0,0
198483,oral,0,0
198484,ribavirin,0,1
198485,significantly,0,0
198486,improved,0,0
198487,symptoms,0,0
198488,and,0,1
198489,signs,0,1
198490,of,0,1
198491,influenza,1,1
198492,type,1,1
198493,A,1,1
198494,or,1,1
198495,B,1,1
198496,infection,1,1
198497,in,1,1
198498,25,1,1
198499,patients,1,1
198500,.,1,1
198501,The,0,0
198502,antiviral,0,0
198503,effect,0,0
198504,was,0,0
198505,not,0,0
198506,significant,0,0
198507,.,0,1
198508,No,0,0
198509,adverse,0,0
198510,clinical,0,0
198511,effects,0,0
198512,or,0,1
198513,significant,0,0
198514,laboratory,0,1
198515,values,0,0
198516,were,0,1
198517,observed,0,0
198518,.,0,1
198519,Oral,0,0
198520,treatment,0,0
198521,of,0,1
198522,patients,1,1
198523,with,1,1
198524,influenza,1,1
198525,A,1,1
198526,or,1,1
198527,B,1,0
198528,infection,1,1
198529,might,0,0
198530,be,0,0
198531,possible,0,0
198532,with,0,1
198533,ribavirin,0,1
198534,.,0,1
198535,[,0,0
198536,Prevention,0,1
198537,of,0,0
198538,migraine,1,1
198539,with,0,1
198540,flunarizine,0,0
198541,and,0,1
198542,acetylsalicylic,0,0
198543,acid,0,0
198544,.,0,1
198545,A,0,0
198546,double-blind,0,0
198547,study,0,1
198548,],0,1
198549,.,0,1
198550,UNLABELLED,0,0
198551,30,1,1
198552,children,1,1
198553,between,1,1
198554,7,1,1
198555,and,1,1
198556,17,1,1
198557,years,1,1
198558,suffering,1,1
198559,from,1,1
198560,at,1,1
198561,least,1,1
198562,2,1,1
198563,attacks/month,1,1
198564,of,1,1
198565,common,1,1
198566,or,1,1
198567,classical,1,1
198568,migraine,1,1
198569,since,1,0
198570,more,1,0
198571,than,1,1
198572,1,1,0
198573,year,1,1
198574,were,0,1
198575,studied,0,1
198576,.,0,1
198577,After,0,0
198578,clinical,0,0
198579,exclusion,0,1
198580,of,0,0
198581,symptomatic,0,1
198582,headache,0,1
198583,4,0,1
198584,weeks,0,0
198585,were,0,1
198586,documented,0,1
198587,by,0,0
198588,means,0,0
198589,of,0,1
198590,a,0,1
198591,migraine,0,1
198592,diary,0,0
198593,.,0,1
198594,Prophylaxis,0,0
198595,with,0,1
198596,Calcium,0,0
198597,entry,0,1
198598,blocker,0,1
198599,Flunarizine,0,0
198600,(,0,1
198601,Sibelium,0,1
198602,),0,1
198603,or,0,1
198604,Thromboxane,0,0
198605,A,0,1
198606,inhibitor,0,0
198607,Acetylsalicylic,0,0
198608,acid,0,0
198609,(,0,1
198610,ASS,0,1
198611,),0,1
198612,was,0,0
198613,carried,0,0
198614,out,0,1
198615,in,0,0
198616,a,0,1
198617,double,0,0
198618,blind,0,1
198619,design,0,1
198620,for,0,1
198621,3,0,1
198622,months,0,1
198623,.,0,1
198624,Medication,0,0
198625,was,0,0
198626,given,0,0
198627,as,0,0
198628,one,0,1
198629,dosage,0,0
198630,in,0,0
198631,the,0,0
198632,evening,0,0
198633,:,0,1
198634,2-5,0,1
198635,mg/kg,0,0
198636,KG,0,0
198637,ASS,0,1
198638,or,0,1
198639,5-10,0,1
198640,mg,0,1
198641,Flunarizine,0,1
198642,.,0,1
198643,Documented,0,0
198644,attack,0,1
198645,frequency,0,0
198646,and,0,0
198647,duration,0,0
198648,were,0,0
198649,controlled,0,0
198650,at,0,1
198651,monthly,0,0
198652,physical,0,1
198653,examinations,0,1
198654,.,0,1
198655,Final,0,1
198656,results,0,0
198657,showed,0,0
198658,no,0,0
198659,differences,0,0
198660,in,0,0
198661,significant,0,0
198662,reduction,0,0
198663,of,0,0
198664,attack,0,1
198665,frequency,0,0
198666,or,0,1
198667,symptoms,0,0
198668,between,0,0
198669,both,0,0
198670,different,0,0
198671,therapeutic,0,0
198672,principals,0,1
198673,.,0,1
198674,72.4,0,0
198675,%,0,0
198676,(,0,1
198677,ASS,0,1
198678,73.3,0,1
198679,%,0,0
198680,;,0,1
198681,Flunarizine,0,0
198682,71.4,0,1
198683,%,0,0
198684,),0,1
198685,of,0,1
198686,patients,0,1
198687,were,0,1
198688,attack-free,0,1
198689,or,0,1
198690,had,0,1
198691,at,0,0
198692,least,0,1
198693,a,0,1
198694,50,0,1
198695,%,0,0
198696,reduction,0,0
198697,.,0,1
198698,Migraine,0,0
198699,frequency,0,0
198700,of,0,0
198701,initially,0,1
198702,7-8,0,1
198703,was,0,0
198704,reduced,0,0
198705,to,0,1
198706,1-2,0,1
198707,attacks/month,0,1
198708,.,0,1
198709,Duration,0,0
198710,remained,0,0
198711,constant,0,0
198712,in,0,1
198713,both,0,0
198714,groups,0,0
198715,(,0,1
198716,1-3,0,1
198717,h,0,0
198718,),0,1
198719,.,0,1
198720,Side,0,0
198721,effects,0,0
198722,were,0,1
198723,slight,0,0
198724,body,0,1
198725,weight,0,1
198726,gain,0,0
198727,or,0,1
198728,abdominal,0,1
198729,pain,0,1
198730,after,0,0
198731,intake,0,0
198732,",",0,0
198733,prophylaxis,0,0
198734,had,0,1
198735,not,0,0
198736,to,0,0
198737,be,0,0
198738,interrupted,0,0
198739,therefore,0,0
198740,.,0,1
198741,Longtime,0,0
198742,prognosis,0,0
198743,is,0,0
198744,not,0,0
198745,yet,0,0
198746,possible,0,0
198747,because,0,0
198748,the,0,0
198749,time,0,0
198750,of,0,0
198751,observation,0,0
198752,is,0,0
198753,too,0,0
198754,short,0,0
198755,so,0,0
198756,far,0,1
198757,.,0,1
198758,CONCLUSION,0,0
198759,Both,0,0
198760,substances,0,1
198761,are,0,0
198762,definitely,0,0
198763,useful,0,0
198764,and,0,0
198765,have,0,0
198766,few,0,0
198767,side,0,0
198768,effects,0,0
198769,in,0,1
198770,childhood,1,1
198771,migraine,1,1
198772,.,1,1
198773,If,0,0
198774,the,0,0
198775,response,0,0
198776,to,0,0
198777,one,0,1
198778,is,0,0
198779,insufficient,0,0
198780,the,0,0
198781,other,0,0
198782,substance,0,1
198783,should,0,0
198784,be,0,0
198785,tried,0,0
198786,.,0,1
198787,Effects,0,1
198788,of,0,1
198789,maternal,0,1
198790,glucose,0,0
198791,infusion,0,0
198792,on,0,0
198793,fetal,0,1
198794,acid-base,0,0
198795,status,0,1
198796,in,0,1
198797,human,1,1
198798,pregnancy,1,1
198799,.,1,1
198800,The,0,0
198801,maternal,0,0
198802,and,0,0
198803,fetal,0,1
198804,metabolic,0,1
198805,effects,0,0
198806,of,0,1
198807,three,0,1
198808,commonly,0,1
198809,used,0,0
198810,intravenous,0,1
198811,fluids,0,1
198812,administered,0,0
198813,before,0,1
198814,regional,0,1
198815,anesthesia,0,1
198816,were,0,1
198817,studied,0,1
198818,in,0,1
198819,32,1,1
198820,gravid,1,1
198821,women,1,1
198822,undergoing,1,1
198823,elective,1,1
198824,cesarean,1,1
198825,section,1,1
198826,at,1,1
198827,term,1,1
198828,.,1,1
198829,Patients,0,1
198830,were,0,0
198831,randomized,0,1
198832,into,0,1
198833,one,0,1
198834,of,0,1
198835,three,0,1
198836,groups,0,1
198837,to,0,1
198838,receive,0,1
198839,1,0,0
198840,L,0,0
198841,of,0,0
198842,either,0,1
198843,5,0,0
198844,%,0,0
198845,dextrose,0,0
198846,(,0,1
198847,50,0,1
198848,gm,0,1
198849,of,0,0
198850,glucose,0,0
198851,),0,1
198852,or,0,1
198853,Ringer,0,1
198854,'s,0,1
198855,lactate,0,0
198856,or,0,1
198857,isotonic,0,0
198858,saline,0,0
198859,solution,0,0
198860,before,0,1
198861,epidural,0,1
198862,anesthesia,0,1
198863,.,0,1
198864,Acute,0,0
198865,glucose,0,0
198866,infusion,0,0
198867,resulted,0,0
198868,in,0,0
198869,maternal,0,1
198870,hyperglycemia,0,1
198871,",",0,0
198872,hyperinsulinemia,0,1
198873,",",0,0
198874,and,0,0
198875,an,0,0
198876,increase,0,0
198877,in,0,0
198878,the,0,0
198879,blood,0,0
198880,lactate,0,0
198881,level,0,0
198882,.,0,1
198883,Cord,0,0
198884,blood,0,0
198885,glucose,0,0
198886,",",0,0
198887,insulin,0,0
198888,",",0,0
198889,and,0,0
198890,lactate,0,0
198891,levels,0,0
198892,were,0,1
198893,also,0,0
198894,increased,0,0
198895,in,0,0
198896,this,0,0
198897,group,0,1
198898,.,0,0
198899,The,0,0
198900,key,0,0
198901,finding,0,0
198902,of,0,0
198903,this,0,0
198904,study,0,0
198905,was,0,0
198906,the,0,0
198907,significant,0,0
198908,lowering,0,0
198909,of,0,0
198910,pH,0,0
198911,in,0,0
198912,the,0,0
198913,umbilical,0,0
198914,cord,0,1
198915,vein,0,1
198916,(,0,1
198917,7.31,0,0
198918,+/-,0,1
198919,0.04,0,0
198920,),0,1
198921,and,0,1
198922,artery,0,1
198923,(,0,1
198924,7.21,0,0
198925,+/-,0,1
198926,0.06,0,0
198927,),0,1
198928,in,0,0
198929,the,0,0
198930,glucose-infused,0,0
198931,group,0,0
198932,when,0,0
198933,compared,0,0
198934,with,0,0
198935,the,0,0
198936,non-glucose,0,0
198937,infusion,0,0
198938,groups,0,0
198939,(,0,1
198940,p,0,0
198941,less,0,0
198942,than,0,0
198943,0.05,0,0
198944,),0,1
198945,.,0,1
198946,Confounding,0,0
198947,perinatal,0,1
198948,factors,0,0
198949,such,0,0
198950,as,0,1
198951,maternal,0,1
198952,position,0,1
198953,",",0,0
198954,maternal,0,1
198955,hypotension,0,0
198956,",",0,0
198957,and,0,0
198958,prolonged,0,0
198959,time,0,0
198960,of,0,0
198961,surgery,0,1
198962,did,0,0
198963,not,0,0
198964,influence,0,0
198965,the,0,0
198966,fetal,0,0
198967,acid-base,0,0
198968,status,0,1
198969,.,0,1
198970,Thus,0,1
198971,acute,0,1
198972,maternal,0,1
198973,glucose,0,0
198974,infusion,0,0
198975,in,0,1
198976,normal,0,1
198977,patients,0,1
198978,can,0,0
198979,cause,0,0
198980,fetal,0,0
198981,hyperglycemia,0,1
198982,",",0,0
198983,metabolic,0,0
198984,acidosis,0,0
198985,",",0,0
198986,and,0,0
198987,neonatal,0,1
198988,hypoglycemia,0,1
198989,.,0,1
198990,These,0,0
198991,findings,0,0
198992,may,0,0
198993,be,0,0
198994,of,0,0
198995,particular,0,0
198996,clinical,0,0
198997,importance,0,0
198998,when,0,0
198999,fetal,0,1
199000,distress,0,0
199001,or,0,1
199002,fetal,0,0
199003,hypoxemia,0,1
199004,is,0,0
199005,due,0,0
199006,to,0,0
199007,other,0,1
199008,perinatal,0,1
199009,events,0,0
199010,.,0,1
199011,Under,0,1
199012,these,0,0
199013,circumstances,0,0
199014,",",0,1
199015,acute,0,1
199016,maternal,0,1
199017,glucose,0,0
199018,infusion,0,0
199019,may,0,0
199020,further,0,0
199021,contribute,0,0
199022,to,0,0
199023,fetal,0,0
199024,metabolic,0,1
199025,acidosis,0,1
199026,.,0,1
199027,Levamisole,0,0
199028,versus,0,0
199029,placebo,0,0
199030,as,0,0
199031,an,0,0
199032,adjunct,0,0
199033,to,0,0
199034,primary,0,1
199035,therapy,0,0
199036,of,0,0
199037,laryngopharyngeal,1,1
199038,epidermoid,1,1
199039,carcinoma,1,1
199040,.,1,1
199041,Evaluation,0,0
199042,of,0,0
199043,the,0,0
199044,immune,0,0
199045,status,0,1
199046,.,0,1
199047,Twenty-four,1,1
199048,patients,1,1
199049,",",1,1
199050,with,1,1
199051,a,1,0
199052,biopsy-proven,1,1
199053,laryngeal,1,1
199054,or,1,1
199055,hypopharyngeal,1,1
199056,carcinoma,1,1
199057,",",0,0
199058,received,0,0
199059,as,0,0
199060,an,0,0
199061,adjunct,0,0
199062,to,0,0
199063,their,0,1
199064,primary,0,1
199065,treatment,0,0
199066,(,0,1
199067,surgery,0,1
199068,and/or,0,1
199069,radiotherapy,0,1
199070,),0,0
199071,",",0,0
199072,levamisole,0,0
199073,(,0,1
199074,150,0,1
199075,mg,0,0
199076,daily,0,0
199077,during,0,1
199078,three,0,0
199079,consecutive,0,1
199080,days,0,0
199081,",",0,1
199082,every,0,0
199083,fortnight,0,0
199084,),0,0
199085,or,0,1
199086,placebo,0,0
199087,",",0,0
199088,following,0,0
199089,a,0,0
199090,single-blind,0,0
199091,",",0,0
199092,but,0,0
199093,randomized,0,1
199094,method,0,0
199095,.,0,1
199096,At,0,0
199097,the,0,0
199098,end,0,0
199099,of,0,0
199100,the,0,0
199101,follow-up,0,0
199102,",",0,0
199103,an,0,0
199104,investigation,0,0
199105,of,0,0
199106,the,0,0
199107,immune,0,0
199108,status,0,1
199109,was,0,0
199110,done,0,0
199111,",",0,0
199112,and,0,0
199113,compared,0,0
199114,with,0,1
199115,that,0,0
199116,of,0,0
199117,a,0,0
199118,healthy,1,1
199119,control-group,1,1
199120,.,1,1
199121,It,0,0
199122,is,0,0
199123,concluded,0,0
199124,that,0,0
199125,the,0,0
199126,immunity,0,0
199127,is,0,0
199128,disturbed,0,0
199129,in,0,0
199130,patients,1,1
199131,with,1,1
199132,laryngo-pharyngeal,1,1
199133,cancer,1,1
199134,",",0,0
199135,but,0,0
199136,that,0,0
199137,this,0,0
199138,disturbance,0,0
199139,does,0,0
199140,not,0,0
199141,clearly,0,0
199142,correlate,0,0
199143,with,0,1
199144,the,0,0
199145,clinical,0,0
199146,state,0,1
199147,of,0,0
199148,the,0,0
199149,disease,0,1
199150,.,0,0
199151,Also,0,0
199152,",",0,0
199153,the,0,0
199154,immunological,0,0
199155,measures,0,0
199156,did,0,0
199157,not,0,0
199158,appear,0,0
199159,relevant,0,0
199160,to,0,0
199161,the,0,0
199162,significantly,0,0
199163,favourable,0,0
199164,effect,0,0
199165,of,0,0
199166,levamisole,0,0
199167,on,0,0
199168,the,0,0
199169,prognosis,0,0
199170,.,0,1
199171,Hepatorenal,0,1
199172,syndrome,0,1
199173,.,0,1
199174,Studies,0,0
199175,of,0,0
199176,the,0,0
199177,effect,0,0
199178,of,0,0
199179,vascular,0,0
199180,volume,0,1
199181,and,0,1
199182,intraperitoneal,0,0
199183,pressure,0,0
199184,on,0,0
199185,renal,0,1
199186,and,0,1
199187,hepatic,0,1
199188,function,0,0
199189,.,0,1
199190,Eleven,1,1
199191,patients,1,1
199192,with,1,1
199193,well-documented,1,1
199194,hepatorenal,1,1
199195,syndrome,1,1
199196,were,0,1
199197,studied,0,1
199198,by,0,0
199199,measurement,0,0
199200,of,0,0
199201,blood,0,0
199202,volume,0,0
199203,",",0,0
199204,glomerular,0,0
199205,filtration,0,0
199206,rate,0,0
199207,",",0,0
199208,renal,0,1
199209,plasma,0,0
199210,flow,0,0
199211,",",0,0
199212,plasma,0,0
199213,aldosterone,0,0
199214,concentration,0,0
199215,",",0,0
199216,renin,0,0
199217,substrate,0,0
199218,concentration,0,0
199219,",",0,0
199220,and,0,0
199221,plasma,0,0
199222,renin,0,0
199223,activity,0,0
199224,.,0,1
199225,They,0,0
199226,were,0,0
199227,then,0,0
199228,given,0,0
199229,750,0,0
199230,ml,0,0
199231,of,0,0
199232,stored,0,0
199233,plasma,0,0
199234,",",0,1
199235,750,0,0
199236,ml,0,0
199237,of,0,1
199238,fresh,0,1
199239,frozen,0,1
199240,plasma,0,0
199241,",",0,0
199242,and,0,0
199243,then,0,0
199244,an,0,0
199245,infusion,0,0
199246,of,0,0
199247,angiotensin,0,0
199248,II,0,1
199249,",",0,0
199250,in,0,0
199251,random,0,1
199252,order,0,0
199253,on,0,0
199254,successive,0,1
199255,days,0,1
199256,.,0,1
199257,Infusion,0,0
199258,of,0,0
199259,fresh,0,1
199260,frozen,0,1
199261,plasma,0,0
199262,improved,0,0
199263,function,0,0
199264,more,0,0
199265,than,0,0
199266,did,0,0
199267,stored,0,0
199268,plasma,0,0
199269,and,0,0
199270,in,0,0
199271,addition,0,0
199272,returned,0,1
199273,a,0,0
199274,very,0,0
199275,low,0,0
199276,filtration,0,0
199277,fraction,0,1
199278,toward,0,0
199279,normal,0,1
199280,.,0,1
199281,Angiotensin,0,0
199282,II,0,1
199283,infusion,0,0
199284,increased,0,0
199285,filtration,0,0
199286,fraction,0,1
199287,",",0,0
199288,but,0,0
199289,decreased,0,0
199290,glomerular,0,0
199291,filtration,0,0
199292,rate,0,0
199293,",",0,0
199294,renal,0,1
199295,plasma,0,0
199296,flow,0,0
199297,",",0,0
199298,and,0,0
199299,urine,0,0
199300,flow,0,0
199301,sharply,0,0
199302,.,0,1
199303,Patients,0,1
199304,were,0,0
199305,then,0,0
199306,given,0,0
199307,a,0,0
199308,daily,0,0
199309,infusion,0,0
199310,of,0,1
199311,"1,000",0,1
199312,ml,0,0
199313,of,0,1
199314,fresh,0,1
199315,frozen,0,1
199316,plasma,0,0
199317,for,0,1
199318,seven,0,1
199319,to,0,1
199320,18,0,1
199321,days,0,0
199322,to,0,1
199323,expand,0,0
199324,the,0,0
199325,blood,0,0
199326,volume,0,0
199327,to,0,1
199328,supranormal,0,1
199329,levels,0,0
199330,as,0,0
199331,assayed,0,1
199332,by,0,0
199333,serial,0,1
199334,measurement,0,0
199335,of,0,0
199336,blood,0,0
199337,volume,0,1
199338,.,0,1
199339,Plasma,0,0
199340,aldosterone,0,0
199341,levels,0,0
199342,decreased,0,0
199343,to,0,1
199344,a,0,0
199345,normal,0,1
199346,range,0,1
199347,",",0,0
199348,glomerular,0,0
199349,filtration,0,0
199350,rate,0,0
199351,and,0,0
199352,renal,0,1
199353,plasma,0,0
199354,flow,0,0
199355,both,0,0
199356,increased,0,0
199357,",",0,0
199358,and,0,0
199359,urinary,0,0
199360,excretion,0,0
199361,of,0,0
199362,sodium,0,0
199363,and,0,0
199364,potassium,0,0
199365,both,0,0
199366,returned,0,1
199367,toward,0,0
199368,normal,0,1
199369,.,0,1
199370,The,0,0
199371,effect,0,0
199372,of,0,0
199373,intraperitoneal,0,0
199374,pressure,0,0
199375,was,0,0
199376,then,0,0
199377,studied,0,1
199378,by,0,0
199379,measuring,0,0
199380,glomerular,0,1
199381,filtration,0,0
199382,rate,0,0
199383,",",0,0
199384,renal,0,1
199385,plasma,0,0
199386,flow,0,0
199387,",",0,0
199388,pressure,0,0
199389,in,0,0
199390,the,0,0
199391,vena,0,0
199392,cava,0,0
199393,",",0,0
199394,hepatic,0,0
199395,vein,0,1
199396,free,0,1
199397,flow,0,0
199398,",",0,0
199399,and,0,0
199400,hepatic,0,1
199401,vein,0,1
199402,wedged,0,1
199403,pressure,0,0
199404,before,0,0
199405,",",0,0
199406,during,0,0
199407,",",0,0
199408,and,0,0
199409,after,0,0
199410,paracentesis,0,1
199411,to,0,0
199412,reduce,0,0
199413,the,0,0
199414,intraperitoneal,0,0
199415,pressure,0,0
199416,from,0,1
199417,30,0,1
199418,to,0,1
199419,40,0,1
199420,cm,0,1
199421,H2O,0,0
199422,to,0,1
199423,12,0,1
199424,to,0,1
199425,17,0,1
199426,cm,0,1
199427,H2O,0,0
199428,.,0,1
199429,Venous,0,1
199430,pressures,0,0
199431,moved,0,1
199432,parallel,0,0
199433,to,0,0
199434,ascitic,0,1
199435,fluid,0,1
199436,pressures,0,0
199437,",",0,1
199438,and,0,1
199439,glomerular,0,0
199440,filtration,0,0
199441,rate,0,0
199442,",",0,0
199443,renal,0,1
199444,plasma,0,0
199445,flow,0,0
199446,",",0,0
199447,and,0,0
199448,urine,0,0
199449,flow,0,0
199450,all,0,0
199451,improved,0,0
199452,sharply,0,0
199453,;,0,0
199454,then,0,0
199455,",",0,0
199456,as,0,0
199457,ascitic,0,1
199458,fluid,0,1
199459,continued,0,0
199460,to,0,0
199461,form,0,0
199462,",",0,0
199463,reducing,0,0
199464,vascular,0,0
199465,volume,0,0
199466,",",0,0
199467,urine,0,0
199468,flow,0,0
199469,",",0,0
199470,glomerular,0,0
199471,filtration,0,0
199472,rate,0,0
199473,",",0,0
199474,and,0,0
199475,renal,0,1
199476,plasma,0,0
199477,flow,0,0
199478,all,0,0
199479,decreased,0,0
199480,slowly,0,0
199481,.,0,1
199482,Six,0,0
199483,patients,0,1
199484,then,0,1
199485,underwent,0,1
199486,placement,0,0
199487,of,0,0
199488,a,0,1
199489,LeVeen,0,1
199490,shunt,0,1
199491,.,0,1
199492,Improvement,0,0
199493,in,0,0
199494,glomerular,0,0
199495,filtration,0,0
199496,rate,0,0
199497,and,0,0
199498,renal,0,1
199499,plasma,0,0
199500,flow,0,0
199501,and,0,0
199502,clinical,0,0
199503,condition,0,0
199504,was,0,0
199505,dramatic,0,0
199506,.,0,1
199507,During,0,0
199508,postoperative,0,0
199509,observation,0,0
199510,of,0,0
199511,up,0,1
199512,to,0,1
199513,two,0,1
199514,years,0,1
199515,",",0,1
199516,progressive,0,1
199517,improvement,0,0
199518,in,0,1
199519,hepatic,0,0
199520,function,0,0
199521,has,0,0
199522,occurred,0,0
199523,.,0,0
199524,Clofibrate,0,1
199525,and,0,0
199526,diabetes,0,1
199527,control,0,0
199528,in,0,0
199529,patients,1,1
199530,treated,1,1
199531,with,1,1
199532,oral,1,1
199533,hypoglycaemic,1,1
199534,agents,1,1
199535,.,1,1
199536,1,0,0
199537,.,0,1
199538,Twenty-two,1,1
199539,maturity-onset,1,1
199540,type,1,1
199541,diabetics,1,1
199542,treated,1,1
199543,with,1,1
199544,oral,1,1
199545,hypoglycaemic,1,1
199546,agents,1,1
199547,entered,0,1
199548,a,0,1
199549,single-blind,0,0
199550,crossover,0,0
199551,study,0,1
199552,using,0,0
199553,placebo,0,0
199554,(,0,0
199555,periods,0,0
199556,A,0,1
199557,and,0,0
199558,C,0,0
199559,",",0,1
199560,2,0,1
199561,months,0,0
199562,each,0,1
199563,),0,1
199564,and,0,0
199565,clofibrate,0,1
199566,(,0,1
199567,2,0,1
199568,g/day,0,0
199569,;,0,1
199570,period,0,1
199571,B,0,1
199572,;,0,1
199573,2,0,1
199574,months,0,1
199575,),0,1
199576,.,0,1
199577,2,0,0
199578,.,0,1
199579,In,0,0
199580,thirteen,1,1
199581,patients,1,1
199582,",",1,1
199583,under,1,0
199584,reasonably,1,0
199585,good,1,0
199586,control,1,0
199587,",",0,0
199588,clofibrate,0,0
199589,did,0,0
199590,not,0,0
199591,reduce,0,0
199592,fasting,0,0
199593,or,0,1
199594,post-prandial,0,0
199595,blood,0,0
199596,glucose,0,0
199597,",",0,0
199598,nor,0,0
199599,24,0,1
199600,h,0,0
199601,glycosuria,0,1
199602,;,0,0
199603,no,0,0
199604,improvement,0,0
199605,was,0,0
199606,noted,0,0
199607,in,0,0
199608,the,0,0
199609,M-value,0,0
199610,",",0,0
199611,an,0,0
199612,index,0,0
199613,of,0,0
199614,diabetes,0,1
199615,control,0,1
199616,.,0,1
199617,3,0,0
199618,.,0,1
199619,In,0,0
199620,contrast,0,0
199621,",",0,1
199622,in,0,0
199623,nine,0,1
199624,patients,0,1
199625,",",0,1
199626,with,0,1
199627,poor,0,1
199628,diabetes,0,1
199629,control,0,1
199630,",",0,1
199631,clofibrate,0,1
199632,reduced,0,0
199633,24,0,1
199634,h,0,0
199635,glycosuria,0,1
199636,and,0,0
199637,significantly,0,0
199638,improved,0,0
199639,the,0,0
199640,M-value,0,0
199641,.,0,1
199642,4,0,0
199643,.,0,0
199644,In,0,0
199645,all,0,0
199646,patients,0,1
199647,",",0,0
199648,clofibrate,0,1
199649,therapy,0,0
199650,was,0,0
199651,associated,0,0
199652,with,0,1
199653,a,0,1
199654,significant,0,0
199655,19-23,0,1
199656,%,0,0
199657,reduction,0,0
199658,in,0,0
199659,plasma,0,0
199660,fibrinogen,0,0
199661,.,0,1
199662,5,0,0
199663,.,0,0
199664,It,0,0
199665,is,0,0
199666,suggested,0,0
199667,that,0,0
199668,addition,0,0
199669,of,0,0
199670,clofibrate,0,1
199671,may,0,0
199672,be,0,0
199673,useful,0,0
199674,in,0,1
199675,maturity-onset,1,1
199676,diabetics,1,1
199677,not,1,0
199678,adequately,1,1
199679,controlled,1,0
199680,by,1,0
199681,diet,1,0
199682,combined,1,0
199683,with,1,1
199684,oral,1,1
199685,hypoglycaemic,1,1
199686,agents,1,1
199687,.,1,1
199688,Ascaris,0,1
199689,and,0,1
199690,growth,0,1
199691,rates,0,0
199692,:,0,1
199693,a,0,1
199694,randomized,0,1
199695,trial,0,0
199696,of,0,0
199697,treatment,0,1
199698,.,0,1
199699,Three,1,1
199700,hundred,1,1
199701,forty-one,1,1
199702,Tanzanian,1,1
199703,preschool,1,1
199704,children,1,1
199705,were,0,1
199706,randomly,0,1
199707,assigned,0,1
199708,to,0,0
199709,levamisole,0,0
199710,or,0,0
199711,placebo,0,0
199712,treatment,0,0
199713,given,0,0
199714,at,0,1
199715,three-month,0,1
199716,intervals,0,0
199717,.,0,1
199718,Weights,0,1
199719,and,0,1
199720,heights,0,1
199721,were,0,1
199722,measured,0,0
199723,at,0,0
199724,the,0,0
199725,tri-monthly,0,0
199726,treatment,0,0
199727,visits,0,1
199728,for,0,0
199729,a,0,1
199730,period,0,0
199731,of,0,0
199732,one,0,1
199733,year,0,1
199734,.,0,1
199735,Among,0,1
199736,the,0,0
199737,273,1,1
199738,children,1,1
199739,who,1,1
199740,were,1,1
199741,seen,1,1
199742,and,1,0
199743,weighed,1,1
199744,at,1,0
199745,the,1,0
199746,one-year,1,0
199747,follow-up,1,0
199748,visit,1,0
199749,",",0,0
199750,the,0,0
199751,rate,0,0
199752,of,0,0
199753,weight,0,1
199754,gain,0,0
199755,was,0,0
199756,8,0,0
199757,per,0,0
199758,cent,0,1
199759,greater,0,0
199760,for,0,0
199761,those,0,0
199762,receiving,0,1
199763,levamisole,0,0
199764,than,0,0
199765,for,0,0
199766,placebo-treated,0,1
199767,controls,0,1
199768,(,0,1
199769,p,0,0
199770,=,0,1
199771,.06,0,1
199772,),0,1
199773,.,0,1
199774,In,0,0
199775,78,1,1
199776,children,1,1
199777,known,0,1
199778,to,0,1
199779,be,0,0
199780,infected,0,1
199781,with,0,1
199782,Ascaris,0,1
199783,at,0,1
199784,baseline,0,0
199785,",",0,0
199786,the,0,0
199787,rate,0,0
199788,of,0,0
199789,weight,0,1
199790,gain,0,0
199791,was,0,0
199792,21,0,1
199793,per,0,0
199794,cent,0,1
199795,greater,0,0
199796,in,0,1
199797,children,1,1
199798,treated,0,1
199799,with,0,1
199800,levamisole,0,0
199801,than,0,0
199802,in,0,0
199803,those,0,1
199804,receiving,0,1
199805,placebo,0,0
199806,(,0,1
199807,p,0,0
199808,=,0,1
199809,.03,0,0
199810,),0,1
199811,.,0,1
199812,The,0,0
199813,rate,0,0
199814,of,0,0
199815,height,0,1
199816,gain,0,0
199817,was,0,0
199818,no,0,0
199819,different,0,0
199820,for,0,0
199821,treatment,0,0
199822,and,0,1
199823,placebo,0,1
199824,groups,0,1
199825,.,0,1
199826,The,0,0
199827,treatment,0,0
199828,of,0,0
199829,senile,0,1
199830,dementia,0,1
199831,associated,0,0
199832,with,0,1
199833,cerebrovascular,0,1
199834,insufficiency,0,1
199835,:,0,1
199836,a,0,0
199837,comparative,0,0
199838,study,0,0
199839,of,0,0
199840,buflomedil,0,0
199841,and,0,1
199842,dihydrogenated,0,0
199843,ergot,0,0
199844,alkaloids,0,1
199845,.,0,1
199846,Seventy-six,1,1
199847,patients,1,1
199848,took,1,1
199849,part,1,1
199850,in,1,0
199851,a,1,0
199852,randomized,1,1
199853,",",1,0
199854,comparative,1,0
199855,study,1,0
199856,of,1,0
199857,the,1,0
199858,efficacy,1,0
199859,of,1,0
199860,buflomedil,1,0
199861,hydrochloride,1,0
199862,and,1,0
199863,dihydrogenated,1,0
199864,ergot,1,0
199865,alkaloids,1,0
199866,in,1,1
199867,the,1,0
199868,treatment,1,0
199869,of,1,0
199870,senile,1,1
199871,dementia,1,1
199872,associated,1,0
199873,with,1,1
199874,cerebrovascular,1,1
199875,insufficiency,1,1
199876,.,1,1
199877,Efficacy,0,0
199878,was,0,0
199879,assessed,0,0
199880,by,0,0
199881,the,0,0
199882,patients,0,1
199883,',0,1
199884,performance,0,0
199885,in,0,1
199886,four,0,1
199887,psychometric,0,1
199888,tests,0,0
199889,.,0,1
199890,The,0,0
199891,results,0,0
199892,showed,0,0
199893,that,0,0
199894,a,0,0
199895,trend,0,0
199896,in,0,0
199897,favour,0,0
199898,of,0,0
199899,the,0,0
199900,buflomedil,0,0
199901,group,0,1
199902,in,0,0
199903,three,0,0
199904,of,0,1
199905,the,0,1
199906,tests,0,0
199907,became,0,1
199908,statistically,0,0
199909,significant,0,0
199910,in,0,0
199911,the,0,0
199912,fourth,0,1
199913,.,0,1
199914,Both,0,0
199915,drugs,0,0
199916,appeared,0,0
199917,to,0,1
199918,be,0,0
199919,safe,0,0
199920,",",0,0
199921,causing,0,0
199922,no,0,0
199923,marked,0,1
199924,adverse,0,0
199925,reactions,0,0
199926,.,0,1
199927,In,0,0
199928,conclusion,0,0
199929,",",0,0
199930,buflomedil,0,0
199931,is,0,0
199932,as,0,0
199933,effective,0,0
199934,or,0,0
199935,more,0,0
199936,effective,0,0
199937,than,0,0
199938,dihydrogenated,0,0
199939,ergot,0,0
199940,alkaloids,0,0
199941,in,0,1
199942,the,0,0
199943,treatment,0,0
199944,of,0,0
199945,senile,1,1
199946,dementia,1,1
199947,associated,1,0
199948,with,1,1
199949,cerebrovascular,1,1
199950,insufficiency,1,1
199951,and,0,0
199952,could,0,0
199953,prove,0,0
199954,a,0,0
199955,valuable,0,0
199956,addition,0,0
199957,to,0,1
199958,long-term,0,0
199959,therapy,0,0
199960,if,0,0
199961,further,0,0
199962,studies,0,0
199963,support,0,0
199964,the,0,0
199965,trend,0,0
199966,shown,0,0
199967,in,0,0
199968,this,0,0
199969,study,0,1
199970,.,0,1
199971,Chemotherapy,0,1
199972,with,0,1
199973,cyclophosphamide,0,1
199974,",",0,0
199975,doxorubicin,0,0
199976,",",0,0
199977,vincristine,0,0
199978,",",0,0
199979,and,0,0
199980,prednisone,0,0
199981,alone,0,0
199982,or,0,1
199983,with,0,1
199984,levamisole,0,0
199985,or,0,1
199986,with,0,1
199987,levamisole,0,1
199988,plus,0,0
199989,BCG,0,1
199990,for,0,0
199991,malignant,0,1
199992,lymphoma,0,1
199993,:,0,1
199994,a,0,1
199995,Southwest,0,1
199996,Oncology,0,1
199997,Group,0,1
199998,Study,0,1
199999,.,0,1
200000,Between,0,1
200001,1977,0,1
200002,and,0,1
200003,1983,0,1
200004,the,0,0
200005,Southwest,0,1
200006,Oncology,0,1
200007,Group,0,1
200008,(,0,1
200009,SWOG,0,1
200010,),0,1
200011,evaluated,0,0
200012,chemotherapy,0,1
200013,alone,0,0
200014,(,0,0
200015,cyclophosphamide,0,1
200016,",",0,0
200017,doxorubicin,0,0
200018,",",0,0
200019,vincristine,0,0
200020,",",0,0
200021,prednisone,0,1
200022,;,0,1
200023,CHOP,0,1
200024,),0,1
200025,or,0,1
200026,chemoimmunotherapy,0,0
200027,(,0,1
200028,CHOP-levamisole,0,0
200029,or,0,1
200030,CHOP-levamisole-BCG,0,1
200031,),0,1
200032,in,0,0
200033,a,0,1
200034,randomized,0,1
200035,prospective,0,1
200036,clinical,0,0
200037,trial,0,1
200038,involving,0,1
200039,715,1,1
200040,eligible,1,1
200041,patients,1,1
200042,with,1,1
200043,all,1,1
200044,types,1,1
200045,of,1,0
200046,malignant,1,1
200047,lymphoma,1,1
200048,(,1,1
200049,ML,1,0
200050,),1,1
200051,.,1,1
200052,Of,0,1
200053,281,1,1
200054,evaluable,1,1
200055,patients,1,1
200056,with,1,1
200057,favorable,1,0
200058,histologic,1,0
200059,types,1,1
200060,of,1,1
200061,ML,1,0
200062,",",0,1
200063,171,0,1
200064,(,0,1
200065,61,0,1
200066,%,0,0
200067,),0,1
200068,achieved,0,0
200069,complete,0,1
200070,remission,0,1
200071,(,0,1
200072,CR,0,1
200073,),0,0
200074,and,0,0
200075,there,0,0
200076,was,0,0
200077,no,0,0
200078,difference,0,0
200079,in,0,0
200080,CR,0,0
200081,rate,0,0
200082,",",0,0
200083,CR,0,0
200084,duration,0,0
200085,",",0,0
200086,or,0,1
200087,survival,0,0
200088,according,0,1
200089,to,0,0
200090,the,0,0
200091,type,0,1
200092,of,0,0
200093,initial,0,1
200094,treatment,0,1
200095,.,0,1
200096,Of,0,1
200097,388,1,1
200098,evaluable,1,1
200099,patients,1,1
200100,with,1,1
200101,unfavorable,1,1
200102,histologic,1,0
200103,types,1,1
200104,of,1,1
200105,ML,1,0
200106,",",0,1
200107,194,0,1
200108,(,0,1
200109,50,0,1
200110,%,0,0
200111,),0,1
200112,achieved,0,0
200113,CR,0,1
200114,.,0,1
200115,Levamisole,0,0
200116,appeared,0,0
200117,to,0,0
200118,adversely,0,0
200119,affect,0,0
200120,CR,0,0
200121,rates,0,0
200122,in,0,1
200123,nodular,0,1
200124,mixed,0,1
200125,and,0,1
200126,nodular,0,1
200127,large-cell,0,1
200128,lymphoma,0,1
200129,and,0,0
200130,CR,0,0
200131,duration,0,0
200132,in,0,1
200133,patients,0,1
200134,with,0,1
200135,unfavorable,0,0
200136,histology,0,1
200137,ML,0,0
200138,.,0,1
200139,Chemoimmunotherapy,0,0
200140,with,0,1
200141,levamisole,0,1
200142,or,0,1
200143,levamisole-BCG,0,1
200144,offers,0,0
200145,no,0,0
200146,advantage,0,0
200147,in,0,0
200148,terms,0,0
200149,of,0,1
200150,CR,0,1
200151,rates,0,0
200152,",",0,1
200153,CR,0,0
200154,duration,0,0
200155,",",0,0
200156,or,0,1
200157,survival,0,0
200158,compared,0,0
200159,to,0,1
200160,CHOP,0,0
200161,chemotherapy,0,1
200162,alone,0,0
200163,",",0,0
200164,and,0,0
200165,levamisole,0,0
200166,may,0,0
200167,have,0,0
200168,had,0,0
200169,an,0,0
200170,adverse,0,0
200171,impact,0,0
200172,on,0,0
200173,outcome,0,0
200174,in,0,1
200175,certain,0,0
200176,subtypes,0,1
200177,of,0,1
200178,ML,0,1
200179,.,0,1
200180,Effect,0,0
200181,of,0,0
200182,increasing,0,0
200183,doses,0,0
200184,of,0,1
200185,labetalol,0,1
200186,on,0,0
200187,blood,0,0
200188,pressure,0,0
200189,",",0,0
200190,plasma,0,0
200191,renin,0,0
200192,activity,0,0
200193,and,0,0
200194,aldosterone,0,0
200195,in,0,1
200196,hypertensive,1,1
200197,patients,1,1
200198,.,1,1
200199,1,0,0
200200,.,0,1
200201,Four,0,1
200202,different,0,0
200203,doses,0,0
200204,of,0,1
200205,labetalol,0,1
200206,(,0,1
200207,150,0,1
200208,",",0,1
200209,300,0,1
200210,",",0,1
200211,600,0,1
200212,and,0,1
200213,900,0,1
200214,mg/day,0,1
200215,),0,1
200216,were,0,0
200217,given,0,0
200218,for,0,0
200219,1,0,1
200220,week,0,0
200221,to,0,0
200222,each,0,0
200223,of,0,0
200224,four,1,1
200225,groups,1,1
200226,of,1,1
200227,patients,1,1
200228,with,1,1
200229,essential,1,1
200230,hypertension,1,1
200231,(,1,1
200232,six,1,1
200233,patients,1,1
200234,for,1,1
200235,each,1,1
200236,group,1,1
200237,),1,1
200238,.,1,1
200239,2,0,0
200240,.,0,1
200241,Labetalol,0,0
200242,decreased,0,0
200243,mean,0,1
200244,blood,0,0
200245,pressure,0,0
200246,and,0,0
200247,heart,0,1
200248,rate,0,0
200249,to,0,0
200250,the,0,0
200251,same,0,0
200252,extent,0,0
200253,on,0,0
200254,the,0,0
200255,first,0,0
200256,and,0,0
200257,the,0,0
200258,seventh,0,0
200259,days,0,0
200260,of,0,1
200261,treatment,0,1
200262,.,0,1
200263,Only,0,0
200264,standing,0,0
200265,blood,0,0
200266,pressure,0,0
200267,showed,0,0
200268,a,0,0
200269,dose-dependent,0,0
200270,inhibition,0,0
200271,both,0,0
200272,in,0,0
200273,the,0,0
200274,supine,0,0
200275,and,0,0
200276,upright,0,1
200277,position,0,1
200278,.,0,1
200279,3,0,0
200280,.,0,1
200281,Labetalol,0,0
200282,exerted,0,0
200283,a,0,0
200284,net,0,0
200285,inhibitory,0,0
200286,effect,0,0
200287,on,0,0
200288,plasma,0,0
200289,renin,0,0
200290,activity,0,0
200291,",",0,0
200292,which,0,0
200293,was,0,0
200294,related,0,0
200295,to,0,0
200296,basal,0,0
200297,renin,0,0
200298,values,0,0
200299,and,0,1
200300,was,0,0
200301,already,0,1
200302,maximal,0,0
200303,at,0,0
200304,the,0,0
200305,lowest,0,0
200306,doses,0,0
200307,.,0,1
200308,This,0,0
200309,effect,0,0
200310,was,0,0
200311,well,0,0
200312,maintained,0,0
200313,in,0,0
200314,the,0,0
200315,supine,0,0
200316,position,0,0
200317,.,0,1
200318,This,0,0
200319,effect,0,0
200320,was,0,0
200321,well,0,0
200322,maintained,0,0
200323,in,0,0
200324,the,0,0
200325,supine,0,0
200326,position,0,0
200327,",",0,0
200328,although,0,0
200329,during,0,0
200330,standing,0,0
200331,it,0,0
200332,tended,0,0
200333,to,0,0
200334,be,0,0
200335,less,0,0
200336,evident,0,0
200337,with,0,1
200338,increasing,0,0
200339,doses,0,1
200340,.,0,1
200341,4,0,0
200342,.,0,1
200343,Urinary,0,0
200344,aldosterone,0,0
200345,was,0,0
200346,decreased,0,0
200347,in,0,0
200348,a,0,1
200349,dose-dependent,0,0
200350,fashion,0,0
200351,and,0,1
200352,its,0,0
200353,changes,0,0
200354,were,0,1
200355,largely,0,0
200356,independent,0,0
200357,fashion,0,0
200358,and,0,1
200359,its,0,0
200360,changes,0,0
200361,were,0,1
200362,largely,0,0
200363,independent,0,0
200364,of,0,0
200365,plasma,0,0
200366,renin,0,0
200367,activity,0,0
200368,.,0,1
200369,5,0,0
200370,.,0,1
200371,Neither,0,0
200372,basal,0,0
200373,values,0,0
200374,nor,0,0
200375,changes,0,0
200376,of,0,1
200377,renin,0,0
200378,and,0,1
200379,aldosterone,0,0
200380,were,0,1
200381,related,0,0
200382,to,0,0
200383,the,0,0
200384,hypotensive,0,0
200385,effect,0,0
200386,of,0,0
200387,labetalol,0,1
200388,.,0,1
200389,6,0,0
200390,.,0,1
200391,During,0,0
200392,labetalol,0,0
200393,treatment,0,1
200394,urinary,0,1
200395,sodium,0,0
200396,excretion,0,0
200397,fell,0,0
200398,for,0,0
200399,2-3,0,1
200400,days,0,0
200401,and,0,1
200402,then,0,1
200403,returned,0,0
200404,to,0,0
200405,basal,0,1
200406,values,0,0
200407,.,0,1
200408,The,0,0
200409,retentive,0,0
200410,effect,0,0
200411,of,0,0
200412,labetalol,0,0
200413,on,0,0
200414,sodium,0,0
200415,was,0,0
200416,directly,0,0
200417,related,0,0
200418,to,0,0
200419,the,0,0
200420,decrease,0,0
200421,of,0,0
200422,blood,0,0
200423,pressure,0,0
200424,",",0,0
200425,and,0,0
200426,the,0,0
200427,successive,0,0
200428,sodium,0,0
200429,escape,0,0
200430,might,0,0
200431,be,0,0
200432,explained,0,0
200433,either,0,0
200434,by,0,0
200435,the,0,0
200436,observed,0,0
200437,increase,0,0
200438,of,0,0
200439,plasma,0,0
200440,volume,0,0
200441,(,0,1
200442,indirectly,0,0
200443,measured,0,0
200444,by,0,0
200445,packed,0,0
200446,cell,0,1
200447,volume,0,1
200448,),0,0
200449,or,0,1
200450,by,0,0
200451,aldosterone,0,0
200452,inhibition,0,0
200453,.,0,1
200454,Therapist,1,1
200455,success,0,0
200456,and,0,1
200457,its,0,0
200458,determinants,0,0
200459,.,0,1
200460,This,0,0
200461,study,0,0
200462,examined,0,0
200463,the,0,0
200464,relatively,0,0
200465,unexplored,0,0
200466,contribution,0,0
200467,of,0,0
200468,the,0,0
200469,therapist,0,0
200470,'s,0,1
200471,performance,0,0
200472,in,0,1
200473,determining,0,0
200474,outcomes,0,0
200475,of,0,1
200476,treatment,0,1
200477,.,0,1
200478,Nine,1,1
200479,therapists,1,0
200480,were,1,1
200481,studied,1,1
200482,:,1,1
200483,three,0,0
200484,performed,0,0
200485,supportive-expressive,0,1
200486,psychotherapy,0,1
200487,;,0,1
200488,three,0,0
200489,",",0,0
200490,cognitive-behavioral,0,1
200491,psychotherapy,0,1
200492,;,0,1
200493,and,0,1
200494,three,0,0
200495,",",0,0
200496,drug,0,0
200497,counseling,0,0
200498,.,0,1
200499,Profound,0,1
200500,differences,0,0
200501,were,0,1
200502,discovered,0,1
200503,in,0,0
200504,the,0,0
200505,therapists,0,0
200506,',0,1
200507,success,0,0
200508,with,0,1
200509,the,0,0
200510,patients,0,1
200511,in,0,0
200512,their,0,1
200513,case,0,0
200514,loads,0,0
200515,.,0,0
200516,Four,0,0
200517,potential,0,0
200518,determinants,0,0
200519,of,0,1
200520,these,0,1
200521,differences,0,0
200522,were,0,1
200523,explored,0,0
200524,:,0,1
200525,patient,0,1
200526,factors,0,0
200527,;,0,1
200528,therapist,0,1
200529,factors,0,0
200530,;,0,1
200531,patient-therapist,0,1
200532,relationship,0,0
200533,factors,0,0
200534,;,0,1
200535,and,0,1
200536,therapy,0,1
200537,factors,0,0
200538,.,0,1
200539,Results,0,0
200540,showed,0,0
200541,that,0,0
200542,patient,0,1
200543,characteristics,0,1
200544,within,0,1
200545,each,0,1
200546,case,0,0
200547,load,0,0
200548,(,0,0
200549,after,0,0
200550,random,0,1
200551,assignments,0,1
200552,),0,1
200553,were,0,1
200554,similar,0,0
200555,and,0,0
200556,disclosed,0,1
200557,no,0,0
200558,differences,0,0
200559,that,0,0
200560,would,0,0
200561,have,0,0
200562,explained,0,0
200563,the,0,0
200564,differences,0,0
200565,in,0,1
200566,success,0,0
200567,;,0,1
200568,therapist,0,0
200569,'s,0,1
200570,personal,0,1
200571,qualities,0,0
200572,were,0,1
200573,correlated,0,0
200574,with,0,1
200575,outcomes,0,0
200576,but,0,0
200577,not,0,0
200578,significantly,0,0
200579,(,0,0
200580,mean,0,1
200581,r,0,0
200582,=,0,1
200583,.32,0,0
200584,),0,1
200585,;,0,0
200586,an,0,0
200587,early-in-treatment,0,1
200588,measure,0,0
200589,of,0,0
200590,the,0,0
200591,patient-therapist,0,0
200592,relationship,0,0
200593,",",0,0
200594,the,0,0
200595,Helping,0,0
200596,Alliance,0,0
200597,Questionnaire,0,0
200598,",",0,0
200599,yielded,0,0
200600,significant,0,0
200601,correlations,0,0
200602,with,0,1
200603,outcomes,0,0
200604,(,0,1
200605,mean,0,1
200606,r,0,0
200607,=,0,1
200608,.65,0,0
200609,),0,1
200610,;,0,0
200611,among,0,0
200612,the,0,0
200613,therapy,0,0
200614,techniques,0,0
200615,",",0,1
200616,purity,0,0
200617,provided,0,0
200618,significant,0,0
200619,correlations,0,0
200620,with,0,1
200621,outcomes,0,0
200622,(,0,1
200623,mean,0,1
200624,r,0,0
200625,=,0,1
200626,.44,0,0
200627,),0,0
200628,",",0,0
200629,both,0,0
200630,across,0,0
200631,therapists,0,0
200632,and,0,1
200633,within,0,1
200634,each,0,0
200635,therapist,0,0
200636,'s,0,1
200637,case,0,1
200638,load,0,0
200639,.,0,1
200640,The,0,0
200641,three,0,0
200642,therapist-related,0,0
200643,factors,0,0
200644,were,0,1
200645,moderately,0,1
200646,associated,0,0
200647,with,0,1
200648,each,0,1
200649,other,0,0
200650,.,0,1
200651,A,0,0
200652,study,0,0
200653,of,0,0
200654,a,0,1
200655,Self-Care,0,0
200656,Rehabilitation,0,1
200657,Program,0,1
200658,in,0,1
200659,pediatric,1,1
200660,asthma,1,1
200661,.,1,1
200662,The,0,0
200663,Self-Care,0,0
200664,Rehabilitation,0,1
200665,in,0,1
200666,Pediatric,0,1
200667,Asthma,0,1
200668,(,0,1
200669,SCRPA,0,1
200670,),0,1
200671,project,0,1
200672,was,0,0
200673,designed,0,0
200674,to,0,0
200675,ascertain,0,0
200676,the,0,0
200677,level,0,0
200678,to,0,0
200679,which,0,0
200680,children,1,1
200681,with,1,1
200682,asthma,1,1
200683,are,1,0
200684,able,1,0
200685,to,1,0
200686,acquire,1,0
200687,the,1,0
200688,asthma,1,1
200689,knowledge,1,0
200690,and,1,1
200691,skills,1,0
200692,presented,1,1
200693,in,1,1
200694,a,1,1
200695,self-management,1,0
200696,training,1,0
200697,program,1,1
200698,conducted,1,1
200699,by,1,0
200700,the,1,0
200701,American,1,1
200702,Lung,1,1
200703,Association,1,1
200704,of,1,1
200705,Utah,1,1
200706,and,0,1
200707,the,0,0
200708,effect,0,0
200709,of,0,0
200710,such,0,0
200711,training,0,0
200712,on,0,0
200713,the,0,0
200714,asthma,0,1
200715,experience,0,1
200716,.,0,1
200717,The,0,0
200718,preschool,1,1
200719,SCRPA,0,1
200720,Curriculum,0,1
200721,(,1,1
200722,ages,1,1
200723,2-5,1,0
200724,),1,0
200725,consisted,0,1
200726,of,0,1
200727,six,0,1
200728,1-hour,0,0
200729,classes,0,1
200730,scheduled,0,1
200731,twice,0,0
200732,a,0,0
200733,week,0,0
200734,for,0,0
200735,3,0,1
200736,weeks,0,1
200737,.,0,1
200738,The,0,0
200739,first,0,0
200740,and,0,1
200741,last,0,1
200742,classes,0,1
200743,were,0,1
200744,for,0,1
200745,one,1,1
200746,or,1,1
200747,both,1,0
200748,parents,1,1
200749,only,0,0
200750,",",0,0
200751,and,0,0
200752,the,0,0
200753,middle,0,1
200754,four,0,1
200755,sessions,0,0
200756,were,0,1
200757,for,0,0
200758,the,0,0
200759,child,1,1
200760,and,1,0
200761,parent,1,1
200762,(,1,1
200763,s,1,1
200764,),1,1
200765,.,1,1
200766,The,0,0
200767,school-age,0,1
200768,SCRPA,0,1
200769,curriculum,0,1
200770,(,1,1
200771,ages,1,1
200772,6-14,1,1
200773,),1,1
200774,consisted,0,1
200775,of,0,0
200776,eight,0,1
200777,90-minute,0,1
200778,classes,0,1
200779,for,0,1
200780,both,0,0
200781,child,1,1
200782,and,1,0
200783,parent,1,1
200784,(,1,1
200785,s,1,1
200786,),1,1
200787,scheduled,0,1
200788,twice,0,0
200789,a,0,0
200790,week,0,0
200791,for,0,0
200792,4,0,1
200793,weeks,0,1
200794,.,0,1
200795,Private,1,1
200796,physicians,1,1
200797,referred,1,1
200798,21,1,1
200799,preschool,1,1
200800,children,1,1
200801,and,1,1
200802,38,1,1
200803,school-age,1,1
200804,children,1,1
200805,into,1,1
200806,the,1,1
200807,program,1,1
200808,.,1,0
200809,The,0,0
200810,school-age,1,1
200811,children,1,1
200812,were,0,1
200813,randomly,0,1
200814,assigned,0,1
200815,to,0,0
200816,a,0,0
200817,study,0,0
200818,or,0,1
200819,control,0,1
200820,group,0,0
200821,",",0,0
200822,and,0,0
200823,the,0,0
200824,preschool,1,1
200825,children,1,1
200826,served,0,1
200827,as,0,0
200828,their,0,1
200829,own,0,1
200830,controls,0,1
200831,.,0,1
200832,A,0,0
200833,comparison,0,0
200834,of,0,0
200835,asthma,0,1
200836,episodes,0,1
200837,during,0,1
200838,the,0,1
200839,3,0,1
200840,months,0,0
200841,before,0,1
200842,and,0,1
200843,after,0,1
200844,training,0,0
200845,showed,0,0
200846,a,0,0
200847,statistically,0,0
200848,significant,0,0
200849,decrease,0,0
200850,in,0,0
200851,the,0,0
200852,number,0,0
200853,of,0,0
200854,episodes,0,1
200855,but,0,0
200856,no,0,0
200857,change,0,0
200858,in,0,0
200859,severity,0,0
200860,in,0,0
200861,the,0,0
200862,preschool,0,1
200863,",",0,0
200864,school,0,1
200865,study,0,0
200866,",",0,0
200867,and,0,0
200868,school,0,1
200869,control,0,1
200870,groups,0,0
200871,.,0,1
200872,The,0,0
200873,decrease,0,0
200874,in,0,0
200875,episodes,0,1
200876,for,0,1
200877,the,0,1
200878,control,0,1
200879,groups,0,0
200880,suggest,0,0
200881,that,0,0
200882,the,0,0
200883,family,0,1
200884,record,0,0
200885,keeping,0,0
200886,required,0,0
200887,of,0,0
200888,all,0,0
200889,subjects,0,1
200890,may,0,0
200891,have,0,0
200892,a,0,0
200893,beneficial,0,0
200894,effect,0,0
200895,",",0,0
200896,a,0,0
200897,phenomenon,0,0
200898,worth,0,0
200899,further,0,1
200900,investigation,0,1
200901,.,0,1
200902,Also,0,0
200903,",",0,0
200904,the,0,0
200905,school-age,0,1
200906,group,0,0
200907,",",0,0
200908,in,0,0
200909,pre-,0,0
200910,and,0,1
200911,posttesting,0,0
200912,",",0,0
200913,demonstrated,0,0
200914,that,0,0
200915,the,0,0
200916,SCRPA,0,1
200917,curriculum,0,1
200918,increased,0,0
200919,knowledge,0,0
200920,and,0,1
200921,skills,0,0
200922,in,0,0
200923,the,0,0
200924,study,0,0
200925,group,0,0
200926,",",0,0
200927,changes,0,0
200928,not,0,0
200929,found,0,0
200930,in,0,0
200931,the,0,0
200932,control,0,1
200933,group,0,1
200934,.,0,1
200935,Chronic,1,1
200936,lateral,1,1
200937,humeral,1,1
200938,epicondylitis,1,1
200939,--,1,1
200940,a,1,0
200941,double-blind,0,0
200942,controlled,0,0
200943,assessment,0,0
200944,of,0,0
200945,pulsed,0,1
200946,electromagnetic,0,1
200947,field,0,1
200948,therapy,0,1
200949,.,0,1
200950,Pulsed,0,0
200951,electromagnetic,0,0
200952,fields,0,1
200953,(,0,1
200954,PEMF,0,1
200955,),0,1
200956,have,0,0
200957,been,0,0
200958,shown,0,0
200959,to,0,0
200960,be,0,0
200961,beneficial,0,0
200962,in,0,0
200963,the,0,0
200964,treatment,0,0
200965,of,0,0
200966,rotator,0,1
200967,cuff,0,1
200968,tendinitis,0,1
200969,.,0,1
200970,As,0,0
200971,lateral,1,1
200972,humeral,1,1
200973,epicondylitis,1,1
200974,(,1,1
200975,tennis,1,1
200976,elbow,1,1
200977,),1,0
200978,is,0,0
200979,a,0,0
200980,similar,0,0
200981,chronic,0,1
200982,tendon,0,1
200983,lesion,0,0
200984,",",0,1
200985,30,1,1
200986,patients,1,1
200987,with,1,1
200988,both,1,0
200989,clinical,1,0
200990,and,1,0
200991,thermographic,1,0
200992,evidence,1,0
200993,of,1,0
200994,tennis,1,1
200995,elbow,1,1
200996,were,0,0
200997,randomly,0,1
200998,allocated,0,1
200999,to,0,0
201000,receive,0,1
201001,either,0,0
201002,active,0,0
201003,or,0,1
201004,inactive,0,1
201005,PEMF,0,1
201006,therapy,0,1
201007,.,0,1
201008,Treatment,0,0
201009,was,0,0
201010,continued,0,0
201011,for,0,0
201012,a,0,1
201013,minimum,0,0
201014,period,0,0
201015,of,0,1
201016,eight,0,1
201017,weeks,0,1
201018,.,0,1
201019,At,0,0
201020,this,0,0
201021,time,0,0
201022,there,0,0
201023,was,0,0
201024,no,0,0
201025,statistical,0,0
201026,difference,0,0
201027,between,0,0
201028,the,0,1
201029,two,0,1
201030,groups,0,1
201031,.,0,1
201032,Fluorouracil,0,0
201033,as,0,0
201034,an,0,1
201035,adjuvant,0,1
201036,to,0,0
201037,surgery,0,1
201038,in,0,0
201039,carcinoma,1,1
201040,of,1,0
201041,the,1,0
201042,colon,1,1
201043,.,1,1
201044,Comparison,0,0
201045,of,0,0
201046,the,0,0
201047,potassium-,0,0
201048,retaining,0,0
201049,effects,0,0
201050,of,0,1
201051,amiloride,0,0
201052,and,0,0
201053,spironolactone,0,0
201054,in,0,1
201055,hypertensive,1,1
201056,patients,1,1
201057,with,1,1
201058,thiazide-induced,1,0
201059,hypokalaemia,1,1
201060,.,1,1
201061,Bites,0,1
201062,by,0,1
201063,the,0,1
201064,saw-scaled,0,0
201065,or,0,1
201066,carpet,0,1
201067,viper,0,0
201068,(,0,1
201069,Echis,0,0
201070,carinatus,0,1
201071,),0,1
201072,:,0,1
201073,trial,0,1
201074,of,0,0
201075,two,0,1
201076,specific,0,1
201077,antivenoms,0,1
201078,.,0,1
201079,Echis,0,0
201080,carinatus,0,0
201081,is,0,0
201082,the,0,0
201083,most,0,0
201084,important,0,0
201085,cause,0,0
201086,of,0,0
201087,morbidity,0,0
201088,and,0,0
201089,mortality,0,0
201090,from,0,1
201091,snake,0,0
201092,bite,0,1
201093,in,0,1
201094,Nigeria,0,1
201095,and,0,1
201096,in,0,0
201097,many,0,1
201098,other,0,1
201099,parts,0,1
201100,of,0,1
201101,the,0,1
201102,world,0,0
201103,.,0,1
201104,Forty-six,1,1
201105,patients,1,1
201106,with,1,1
201107,systemic,1,1
201108,poisoning,1,1
201109,by,1,0
201110,this,1,0
201111,snake,1,0
201112,were,0,0
201113,given,0,0
201114,echis,0,0
201115,antivenom,0,0
201116,made,0,0
201117,either,0,0
201118,by,0,0
201119,the,0,0
201120,South,0,1
201121,African,0,1
201122,Institute,0,1
201123,for,0,1
201124,Medical,0,1
201125,Research,0,1
201126,(,0,1
201127,S.A.I.M.R,0,1
201128,.,0,1
201129,),0,0
201130,or,0,1
201131,by,0,0
201132,Behringwerke,0,1
201133,(,0,1
201134,North,0,1
201135,and,0,1
201136,West,0,1
201137,African,0,1
201138,polyvalent,0,1
201139,antivenom,0,0
201140,),0,1
201141,.,0,1
201142,A,0,0
201143,simple,0,0
201144,test,0,0
201145,of,0,0
201146,blood,0,0
201147,coagulability,0,0
201148,was,0,0
201149,used,0,0
201150,to,0,0
201151,assess,0,0
201152,whether,0,0
201153,an,0,0
201154,adequate,0,0
201155,neutralizing,0,0
201156,dose,0,0
201157,of,0,0
201158,antivenom,0,0
201159,had,0,1
201160,been,0,1
201161,given,0,0
201162,.,0,1
201163,An,0,0
201164,average,0,0
201165,of,0,0
201166,15.2,0,0
201167,ml,0,0
201168,S.A.I.M.R,0,1
201169,.,0,1
201170,antivenom,0,0
201171,restored,0,0
201172,normal,0,1
201173,coagulability,0,0
201174,permanently,0,1
201175,in,0,0
201176,all,0,1
201177,23,1,1
201178,patients,1,1
201179,in,1,1
201180,one,1,1
201181,group,1,1
201182,",",0,0
201183,but,0,0
201184,in,0,0
201185,the,0,0
201186,other,0,0
201187,group,0,0
201188,receiving,0,1
201189,an,0,0
201190,average,0,0
201191,dose,0,0
201192,of,0,1
201193,37.9,0,1
201194,ml,0,0
201195,Behringwerke,0,1
201196,antivenom,0,0
201197,normal,0,1
201198,clotting,0,0
201199,resulted,0,0
201200,in,0,0
201201,only,0,0
201202,18,0,1
201203,out,0,1
201204,of,0,1
201205,23,0,1
201206,patients,0,1
201207,.,0,1
201208,Local,0,1
201209,tissue,0,1
201210,swelling,0,1
201211,was,0,0
201212,similar,0,0
201213,in,0,1
201214,both,0,0
201215,groups,0,0
201216,",",0,0
201217,but,0,0
201218,local,0,0
201219,necrosis,0,1
201220,occurred,0,0
201221,in,0,1
201222,three,0,1
201223,patients,0,1
201224,treated,0,1
201225,with,0,1
201226,Behringwerke,0,1
201227,antivenom,0,0
201228,and,0,0
201229,in,0,0
201230,none,0,1
201231,given,0,1
201232,S.A.I.M.R,0,1
201233,.,0,1
201234,antivenom,0,0
201235,.,0,1
201236,Potassium,0,0
201237,",",0,0
201238,glucose,0,0
201239,",",0,0
201240,and,0,0
201241,insulin,0,0
201242,in,0,0
201243,treatment,0,0
201244,of,0,0
201245,myocardial,1,1
201246,infarction,1,1
201247,.,1,1
201248,Mebendazole,0,0
201249,in,0,1
201250,enterobiasis,1,1
201251,:,1,1
201252,a,0,1
201253,placebo,0,0
201254,--,0,1
201255,controlled,0,0
201256,trial,0,0
201257,in,0,0
201258,a,0,1
201259,paediatric,1,1
201260,community,1,1
201261,.,1,1
201262,The,0,0
201263,gastric,0,1
201264,emptying,0,0
201265,and,0,1
201266,small,0,1
201267,intestinal,0,1
201268,transit,0,0
201269,after,0,0
201270,highly,1,0
201271,selective,1,1
201272,vagotomy,1,1
201273,without,1,1
201274,drainage,1,1
201275,and,1,1
201276,selective,1,1
201277,vagotomy,1,1
201278,with,1,1
201279,pyloroplasty,1,1
201280,.,1,1
201281,Miotics,1,1
201282,in,1,1
201283,cataract,1,1
201284,surgery,1,1
201285,.,1,1
201286,Comparison,1,0
201287,of,1,0
201288,some,1,1
201289,pharmacokinetic,1,0
201290,parameters,1,0
201291,of,1,1
201292,(,1,1
201293,+,1,0
201294,),1,1
201295,-cyanidanol-3,1,0
201296,obtained,1,0
201297,with,1,1
201298,specific,1,0
201299,and,1,1
201300,non-specific,1,1
201301,analytical,1,0
201302,methods,1,1
201303,.,1,1
201304,Propranolol,0,0
201305,vs,0,0
201306,acetazolamide,0,0
201307,.,0,1
201308,A,1,0
201309,long-term,1,0
201310,double-masked,1,1
201311,study,1,1
201312,of,1,0
201313,the,1,0
201314,effect,1,0
201315,on,1,0
201316,intraocular,1,1
201317,pressure,1,0
201318,and,1,0
201319,blood,1,0
201320,pressure,1,0
201321,.,1,1
201322,One-trial,1,0
201323,learning,1,0
201324,with,1,1
201325,control,1,1
201326,of,1,0
201327,item-difficulty,1,1
201328,.,1,1
201329,A,0,0
201330,double-blind,0,0
201331,comparison,0,0
201332,of,0,0
201333,bromperidol,0,1
201334,and,0,0
201335,haloperidol,0,0
201336,in,0,0
201337,newly,1,1
201338,admitted,1,1
201339,schizophrenic,1,1
201340,patients,1,1
201341,.,1,1
201342,Acute,0,1
201343,intervention,0,1
201344,studies,0,0
201345,in,0,1
201346,patients,1,1
201347,with,1,1
201348,myocardial,1,1
201349,infarction,1,1
201350,using,0,0
201351,atenolol,0,0
201352,",",0,0
201353,propranolol,0,0
201354,",",0,0
201355,oxprenolol,0,0
201356,and,0,0
201357,disopyramide,0,0
201358,phosphate,0,0
201359,.,0,1
201360,The,0,0
201361,value,0,0
201362,of,0,0
201363,beta-blockade,0,0
201364,and,0,1
201365,of,0,0
201366,disopyramide,0,0
201367,phosphate,0,0
201368,in,0,0
201369,the,0,0
201370,immediate,0,0
201371,treatment,0,0
201372,of,0,1
201373,patients,1,1
201374,with,1,1
201375,suspected,1,1
201376,acute,1,1
201377,myocardial,1,1
201378,infarction,1,1
201379,was,0,0
201380,assessed,0,0
201381,in,0,1
201382,two,0,0
201383,placebo,0,1
201384,controlled,0,1
201385,trials,0,0
201386,.,0,1
201387,In,1,0
201388,the,1,0
201389,first,1,0
201390,study,1,1
201391,388,1,1
201392,patients,1,1
201393,with,1,1
201394,suspected,1,1
201395,acute,1,1
201396,myocardial,1,1
201397,infarction,1,1
201398,were,0,1
201399,randomly,0,1
201400,allocated,0,1
201401,to,0,0
201402,treatment,0,0
201403,with,0,1
201404,propranolol,0,0
201405,",",0,0
201406,atenolol,0,0
201407,",",0,0
201408,or,0,0
201409,placebo,0,0
201410,",",0,0
201411,and,0,0
201412,when,0,0
201413,analysed,0,0
201414,on,0,0
201415,an,0,0
201416,initial,0,0
201417,intention,0,0
201418,to,0,0
201419,treat,0,0
201420,basis,0,0
201421,there,0,0
201422,was,0,0
201423,no,0,0
201424,significant,0,0
201425,difference,0,0
201426,between,0,0
201427,the,0,1
201428,three,0,0
201429,groups,0,0
201430,in,0,1
201431,respect,0,0
201432,of,0,0
201433,the,0,0
201434,mortality,0,0
201435,at,0,0
201436,one,0,1
201437,year,0,1
201438,.,0,1
201439,In,0,0
201440,addition,0,0
201441,",",0,0
201442,there,0,0
201443,was,0,0
201444,no,0,0
201445,evidence,0,0
201446,to,0,0
201447,suggest,0,0
201448,that,0,0
201449,either,0,0
201450,atenolol,0,0
201451,",",0,0
201452,or,0,1
201453,propranolol,0,0
201454,reduced,0,0
201455,the,0,0
201456,incidence,0,0
201457,of,0,0
201458,'serious,0,0
201459,',0,1
201460,ventricular,0,1
201461,arrhythmias,0,1
201462,in,0,1
201463,the,0,1
201464,coronary,0,1
201465,care,0,1
201466,unit,0,1
201467,.,0,1
201468,In,0,0
201469,the,0,0
201470,second,0,1
201471,study,0,1
201472,473,1,1
201473,patients,1,1
201474,with,1,1
201475,suspected,1,1
201476,acute,1,1
201477,myocardial,1,1
201478,infarction,1,1
201479,were,0,1
201480,randomly,0,1
201481,allocated,0,1
201482,to,0,0
201483,treatment,0,0
201484,with,0,1
201485,oxprenolol,0,0
201486,",",0,0
201487,disopyramide,0,0
201488,phosphate,0,0
201489,",",0,0
201490,or,0,1
201491,placebo,0,0
201492,.,0,1
201493,Again,0,0
201494,no,0,0
201495,significant,0,0
201496,differences,0,0
201497,were,0,1
201498,seen,0,0
201499,with,0,1
201500,respect,0,0
201501,to,0,0
201502,the,0,0
201503,mortality,0,0
201504,at,0,1
201505,six,0,1
201506,weeks,0,0
201507,.,0,1
201508,There,0,0
201509,was,0,0
201510,",",0,0
201511,however,0,0
201512,",",0,0
201513,a,0,0
201514,significantly,0,0
201515,increased,0,0
201516,incidence,0,0
201517,of,0,0
201518,heart,0,1
201519,failure,0,1
201520,in,0,0
201521,the,0,0
201522,group,0,1
201523,which,0,0
201524,received,0,1
201525,disopyramide,0,0
201526,phosphate,0,1
201527,.,0,1
201528,Patients,1,1
201529,who,0,1
201530,received,0,1
201531,this,0,1
201532,drug,0,0
201533,also,0,0
201534,showed,0,0
201535,a,0,0
201536,reduced,0,0
201537,number,0,0
201538,of,0,1
201539,dysrhythmic,0,1
201540,episodes,0,1
201541,on,0,1
201542,24-hour,0,1
201543,ECG,0,1
201544,recordings,0,0
201545,",",0,1
201546,but,0,0
201547,this,0,0
201548,trend,0,0
201549,did,0,0
201550,not,0,0
201551,achieve,0,0
201552,statistical,0,0
201553,significance,0,0
201554,.,0,1
201555,These,0,0
201556,results,0,0
201557,suggest,0,0
201558,that,0,0
201559,none,0,0
201560,of,0,0
201561,the,0,1
201562,three,0,0
201563,beta-blockers,0,0
201564,tested,0,0
201565,nor,0,0
201566,disopyramide,0,0
201567,phosphate,0,0
201568,is,0,0
201569,likely,0,0
201570,to,0,0
201571,reduce,0,0
201572,the,0,0
201573,mortality,0,0
201574,from,0,1
201575,acute,0,1
201576,myocardial,0,1
201577,infarction,0,1
201578,when,0,0
201579,given,0,0
201580,prophylactically,0,0
201581,",",0,0
201582,although,0,0
201583,disopyramide,0,0
201584,phosphate,0,0
201585,does,0,0
201586,reduce,0,0
201587,the,0,0
201588,incidence,0,0
201589,of,0,0
201590,'serious,0,0
201591,',0,1
201592,ventriicular,0,1
201593,arrhythmias,0,1
201594,.,0,1
201595,Comparison,0,0
201596,of,0,0
201597,the,0,0
201598,antihypertensive,0,0
201599,effect,0,0
201600,of,0,0
201601,metipranolol,0,0
201602,",",0,0
201603,butizide,0,0
201604,and,0,0
201605,torrat,0,1
201606,in,0,0
201607,Kenyan,1,1
201608,Africans,1,1
201609,.,1,1
201610,The,0,0
201611,effect,0,0
201612,of,0,0
201613,Naftidrofuryl,0,0
201614,on,0,0
201615,ethanol-induced,0,1
201616,liver,0,1
201617,damage,0,0
201618,in,0,0
201619,chronic,1,1
201620,alcoholic,1,1
201621,patients,1,1
201622,.,1,1
201623,A,0,1
201624,prospective,0,0
201625,double-blind,0,0
201626,placebo-controlled,0,0
201627,trial,0,1
201628,of,0,0
201629,intramuscular,0,1
201630,Naftidrofuryl,0,0
201631,was,0,0
201632,carried,0,0
201633,out,0,1
201634,on,0,0
201635,32,1,1
201636,randomly,1,1
201637,selected,1,1
201638,hospitalized,1,1
201639,male,1,1
201640,alcoholic,1,1
201641,patients,1,1
201642,with,1,1
201643,clinical,1,0
201644,",",1,1
201645,biochemical,1,0
201646,and,1,0
201647,histological,1,0
201648,evidence,1,0
201649,of,1,0
201650,hepatic,1,1
201651,damage,1,1
201652,.,1,1
201653,Seventeen,0,1
201654,patients,0,1
201655,received,0,1
201656,the,0,0
201657,drug,0,0
201658,(,0,0
201659,40,0,1
201660,mg,0,1
201661,in,0,1
201662,5,0,0
201663,ml,0,0
201664,i.m,0,1
201665,.,0,1
201666,three,0,0
201667,times,0,0
201668,daily,0,0
201669,for,0,1
201670,6,0,1
201671,days,0,1
201672,),0,1
201673,and,0,1
201674,15,0,1
201675,patients,0,1
201676,received,0,1
201677,a,0,1
201678,placebo,0,0
201679,(,0,0
201680,5,0,0
201681,ml,0,0
201682,in,0,1
201683,normal,0,1
201684,saline,0,0
201685,i.m,0,1
201686,.,0,1
201687,three,0,0
201688,times,0,0
201689,daily,0,0
201690,for,0,1
201691,6,0,1
201692,days,0,1
201693,),0,1
201694,.,0,1
201695,The,0,0
201696,drug,0,0
201697,was,0,0
201698,well,0,0
201699,tolerated,0,0
201700,and,0,0
201701,there,0,0
201702,were,0,0
201703,no,0,0
201704,adverse,0,0
201705,side-effects,0,0
201706,.,0,1
201707,Naftidrofuryl,0,0
201708,significantly,0,0
201709,improved,0,0
201710,the,0,0
201711,physiological,0,0
201712,function,0,0
201713,of,0,0
201714,the,0,0
201715,liver,0,1
201716,cells,0,0
201717,as,0,0
201718,reflected,0,0
201719,by,0,0
201720,indocyanine,0,0
201721,green,0,1
201722,(,0,1
201723,ICG,0,1
201724,),0,1
201725,clearance,0,0
201726,by,0,0
201727,the,0,0
201728,liver,0,1
201729,(,0,0
201730,t,0,0
201731,=,0,1
201732,2.61,0,0
201733,;,0,0
201734,p,0,0
201735,less,0,0
201736,than,0,0
201737,or,0,1
201738,equal,0,1
201739,to,0,1
201740,0.02,0,0
201741,),0,1
201742,and,0,0
201743,also,0,0
201744,caused,0,0
201745,a,0,0
201746,larger,0,0
201747,fall,0,0
201748,in,0,0
201749,raised,0,0
201750,serum,0,0
201751,levels,0,0
201752,of,0,1
201753,gamma,0,0
201754,glutamyl,0,0
201755,transpeptidase,0,0
201756,(,0,1
201757,GGT,0,0
201758,),0,1
201759,than,0,0
201760,did,0,0
201761,the,0,0
201762,placebo,0,0
201763,injections,0,0
201764,.,0,1
201765,Overall,0,0
201766,clinical,0,0
201767,improvement,0,0
201768,(,0,1
201769,e.g,0,0
201770,.,0,1
201771,appetite,0,0
201772,",",0,0
201773,body,0,1
201774,weight,0,0
201775,",",0,0
201776,reduced,0,0
201777,liver,0,1
201778,size,0,0
201779,",",0,0
201780,general,0,1
201781,sense,0,0
201782,of,0,0
201783,well-being,0,0
201784,),0,0
201785,was,0,0
201786,more,0,0
201787,clearly,0,0
201788,evident,0,0
201789,in,0,0
201790,patients,0,1
201791,of,0,1
201792,the,0,0
201793,treated,0,1
201794,group,0,0
201795,than,0,0
201796,in,0,0
201797,those,0,1
201798,of,0,0
201799,the,0,0
201800,placebo,0,0
201801,group,0,1
201802,.,0,1
201803,Naftidrofuryl,0,0
201804,",",0,0
201805,therefore,0,0
201806,",",0,0
201807,appears,0,0
201808,to,0,0
201809,be,0,0
201810,of,0,0
201811,benefit,0,0
201812,in,0,1
201813,ethanol-induced,1,1
201814,liver,1,1
201815,damage,1,0
201816,and,0,0
201817,more,0,0
201818,extensive,0,0
201819,long-term,0,0
201820,trials,0,1
201821,are,0,0
201822,suggested,0,0
201823,in,0,0
201824,patients,1,1
201825,with,1,1
201826,alcoholic,1,1
201827,liver,1,1
201828,disease,1,1
201829,(,1,1
201830,ALD,1,1
201831,),1,1
201832,.,1,1
201833,[,0,0
201834,The,0,0
201835,somatostatin,0,0
201836,infusion,0,0
201837,test,0,0
201838,for,0,0
201839,the,0,0
201840,evaluation,0,0
201841,of,0,0
201842,glucose,0,0
201843,utilization,0,0
201844,in,0,1
201845,bezafibrate,0,0
201846,medication,0,1
201847,],0,1
201848,.,0,1
201849,The,0,0
201850,utilisation,0,0
201851,of,0,0
201852,blood,0,0
201853,glucose,0,0
201854,may,0,0
201855,be,0,0
201856,used,0,0
201857,for,0,0
201858,definition,0,1
201859,of,0,0
201860,insulin,0,0
201861,resistance,0,0
201862,in,0,0
201863,type,1,1
201864,II,1,1
201865,diabetes,1,1
201866,mellitus,1,1
201867,.,1,0
201868,To,0,0
201869,evaluate,0,0
201870,this,0,0
201871,possibility,0,0
201872,we,0,0
201873,adapted,0,0
201874,an,0,0
201875,infusion,0,0
201876,test,0,0
201877,of,0,0
201878,somatostatin,1,0
201879,in,1,1
201880,10,1,1
201881,normal,1,1
201882,persons,1,1
201883,(,1,1
201884,age,1,1
201885,26,1,1
201886,+/-,1,1
201887,3,1,1
201888,years,1,1
201889,",",1,1
201890,relative,1,0
201891,body,1,1
201892,weight,1,1
201893,26,1,1
201894,+/-,1,0
201895,10,1,1
201896,%,1,0
201897,according,1,1
201898,to,1,1
201899,Broca,1,1
201900,),1,1
201901,in,0,0
201902,a,0,1
201903,randomized,0,1
201904,cross-over,0,0
201905,therapy,0,0
201906,with,0,1
201907,bezafibrate,0,1
201908,(,0,1
201909,3,0,1
201910,X,0,1
201911,200,0,1
201912,mg/die,0,0
201913,),0,1
201914,.,0,1
201915,As,0,0
201916,the,0,0
201917,coefficient,0,0
201918,of,0,0
201919,variation,0,0
201920,(,0,1
201921,VC,0,0
201922,),0,1
201923,of,0,0
201924,measured,0,0
201925,blood,0,0
201926,glucose,0,0
201927,continuously,0,0
201928,increased,0,0
201929,the,0,0
201930,best,0,0
201931,time,0,0
201932,of,0,0
201933,a,0,1
201934,steady,0,0
201935,state,0,1
201936,was,0,0
201937,between,0,0
201938,90,0,1
201939,and,0,1
201940,130,0,1
201941,min,0,0
201942,after,0,0
201943,beginning,0,1
201944,the,0,0
201945,infusion,0,0
201946,(,0,0
201947,mean,0,1
201948,VC,0,0
201949,8.9,0,0
201950,%,0,0
201951,),0,1
201952,.,0,1
201953,While,0,1
201954,insulin,0,0
201955,remained,0,0
201956,nearly,0,0
201957,constant,0,0
201958,(,0,1
201959,41,0,1
201960,(,0,1
201961,45,0,1
201962,;,0,1
201963,38,0,1
201964,),0,1
201965,microU/ml,0,0
201966,),0,1
201967,blood,0,0
201968,glucose,0,0
201969,dropped,0,0
201970,by,0,0
201971,about,0,0
201972,14,0,1
201973,%,0,0
201974,and,0,0
201975,reached,0,0
201976,a,0,0
201977,steady,0,0
201978,state,0,1
201979,of,0,1
201980,89,0,1
201981,(,0,1
201982,134,0,1
201983,;,0,1
201984,45,0,1
201985,),0,1
201986,mg/dl,0,0
201987,.,0,1
201988,During,0,0
201989,the,0,0
201990,therapy,0,0
201991,of,0,0
201992,bezafibrate,0,0
201993,blood,0,0
201994,glucose,0,0
201995,was,0,0
201996,significantly,0,0
201997,decreased,0,0
201998,by,0,0
201999,36,0,1
202000,%,0,0
202001,130,0,1
202002,min,0,0
202003,after,0,0
202004,beginning,0,1
202005,the,0,0
202006,infusion,0,0
202007,.,0,0
202008,Although,0,0
202009,the,0,0
202010,effect,0,0
202011,was,0,0
202012,not,0,0
202013,significant,0,0
202014,during,0,0
202015,the,0,0
202016,whole,0,0
202017,time,0,0
202018,of,0,0
202019,the,0,0
202020,steady,0,0
202021,state,0,1
202022,it,0,0
202023,became,0,1
202024,evident,0,0
202025,by,0,0
202026,a,0,1
202027,negative,0,0
202028,correlation,0,0
202029,with,0,1
202030,lactate,0,0
202031,(,0,1
202032,r,0,0
202033,=,0,1
202034,-0.687,0,0
202035,),0,1
202036,and,0,0
202037,pyruvate,0,0
202038,(,0,1
202039,r,0,0
202040,=,0,1
202041,-0.843,0,0
202042,),0,1
202043,.,0,1
202044,A,0,0
202045,correlation,0,0
202046,with,0,1
202047,a,0,1
202048,concomitant,0,0
202049,decrease,0,0
202050,of,0,0
202051,triglyceride,0,0
202052,and,0,0
202053,cholesterol,0,0
202054,also,0,0
202055,induced,0,0
202056,by,0,0
202057,bezafibrate,0,0
202058,could,0,0
202059,not,0,0
202060,be,0,0
202061,proven,0,0
202062,.,0,0
202063,The,0,0
202064,results,0,0
202065,show,0,0
202066,that,0,0
202067,the,0,0
202068,infusion,0,0
202069,test,0,0
202070,of,0,0
202071,somatostatin,0,0
202072,is,0,0
202073,fitted,0,0
202074,to,0,0
202075,measure,0,0
202076,a,0,0
202077,steady,0,0
202078,state,0,1
202079,of,0,0
202080,blood,0,0
202081,glucose,0,0
202082,and,0,0
202083,insulin,0,0
202084,and,0,0
202085,that,0,0
202086,it,0,0
202087,is,0,0
202088,possible,0,0
202089,by,0,0
202090,this,0,0
202091,technique,0,0
202092,to,0,0
202093,quantify,0,0
202094,a,0,0
202095,changed,0,0
202096,utilisation,0,0
202097,of,0,0
202098,blood,0,0
202099,glucose,0,0
202100,induced,0,0
202101,by,0,0
202102,specific,0,0
202103,therapy,0,1
202104,.,0,1
202105,Statistical,0,0
202106,aspects,0,0
202107,of,0,1
202108,early,0,1
202109,termination,0,0
202110,in,0,0
202111,the,0,0
202112,beta-blocker,0,0
202113,heart,0,1
202114,attack,0,1
202115,trial,0,0
202116,.,0,1
202117,The,0,0
202118,Beta-Blocker,0,0
202119,Heart,0,1
202120,Attack,0,1
202121,Trial,0,1
202122,was,0,0
202123,a,0,1
202124,randomized,0,1
202125,double,0,0
202126,blind,0,1
202127,controlled,0,0
202128,trial,0,0
202129,comparing,0,0
202130,propranolol,0,0
202131,with,0,1
202132,placebo,0,0
202133,in,0,1
202134,3837,1,1
202135,patients,1,1
202136,with,1,1
202137,a,1,1
202138,recent,1,1
202139,myocardial,1,1
202140,infarction,1,1
202141,.,1,1
202142,The,0,0
202143,trial,0,0
202144,was,0,0
202145,terminated,0,0
202146,on,0,0
202147,recommendation,0,0
202148,of,0,0
202149,the,0,0
202150,Policy,0,0
202151,and,0,0
202152,Data,0,1
202153,Monitoring,0,0
202154,Board,0,1
202155,9,0,1
202156,months,0,0
202157,before,0,1
202158,the,0,1
202159,scheduled,0,1
202160,closing,0,0
202161,date,0,0
202162,.,0,1
202163,The,0,0
202164,propranolol,0,0
202165,group,0,0
202166,",",0,0
202167,at,0,0
202168,the,0,0
202169,time,0,0
202170,of,0,0
202171,the,0,0
202172,decision,0,0
202173,",",0,0
202174,had,0,1
202175,a,0,0
202176,26,0,1
202177,%,0,0
202178,lower,0,0
202179,mortality,0,0
202180,(,0,0
202181,z,0,0
202182,=,0,1
202183,2.82,0,0
202184,),0,1
202185,.,0,1
202186,Many,0,1
202187,issues,0,0
202188,were,0,1
202189,considered,0,0
202190,in,0,0
202191,this,0,0
202192,decision,0,0
202193,.,0,0
202194,These,0,0
202195,included,0,0
202196,the,0,0
202197,magnitude,0,0
202198,of,0,0
202199,the,0,0
202200,overall,0,0
202201,results,0,0
202202,;,0,1
202203,consistency,0,0
202204,of,0,0
202205,results,0,0
202206,across,0,1
202207,subgroups,0,0
202208,",",0,1
202209,clinical,0,0
202210,centers,0,1
202211,",",0,1
202212,and,0,0
202213,cause,0,0
202214,of,0,0
202215,death,0,0
202216,;,0,1
202217,and,0,0
202218,completeness,0,0
202219,of,0,0
202220,follow-up,0,1
202221,.,0,1
202222,Two,0,1
202223,basic,0,0
202224,statistical,0,0
202225,methods,0,1
202226,were,0,1
202227,used,0,0
202228,in,0,0
202229,declaring,0,0
202230,the,0,0
202231,overall,0,0
202232,mortality,0,0
202233,results,0,0
202234,significant,0,0
202235,.,0,1
202236,The,0,0
202237,first,0,0
202238,method,0,0
202239,evaluated,0,0
202240,the,0,0
202241,current,0,0
202242,survival,0,0
202243,data,0,0
202244,taking,0,1
202245,into,0,1
202246,account,0,0
202247,the,0,0
202248,issue,0,0
202249,of,0,0
202250,repeated,0,0
202251,significance,0,0
202252,testing,0,0
202253,.,0,1
202254,The,0,0
202255,second,0,0
202256,method,0,0
202257,evaluated,0,0
202258,whether,0,0
202259,the,0,0
202260,observed,0,0
202261,trend,0,0
202262,was,0,0
202263,so,0,0
202264,impressive,0,0
202265,that,0,0
202266,the,0,0
202267,conclusion,0,0
202268,was,0,0
202269,unlikely,0,0
202270,to,0,0
202271,change,0,0
202272,even,0,0
202273,if,0,0
202274,the,0,0
202275,trial,0,0
202276,should,0,0
202277,continue,0,0
202278,to,0,0
202279,the,0,0
202280,scheduled,0,1
202281,end,0,0
202282,.,0,1
202283,These,0,1
202284,two,0,0
202285,methods,0,1
202286,",",0,0
202287,as,0,0
202288,well,0,0
202289,as,0,0
202290,other,0,1
202291,considerations,0,0
202292,led,0,0
202293,to,0,1
202294,the,0,0
202295,recommendation,0,0
202296,to,0,0
202297,discontinue,0,0
202298,the,0,0
202299,trial,0,0
202300,.,0,1
202301,Comparison,0,0
202302,of,0,0
202303,hypnotherapy,0,0
202304,with,0,1
202305,systematic,0,1
202306,relaxation,0,0
202307,in,0,0
202308,the,0,0
202309,treatment,0,0
202310,of,0,0
202311,cigarette,0,1
202312,habituation,0,0
202313,.,0,1
202314,Because,0,0
202315,of,0,0
202316,the,0,1
202317,methodological,0,0
202318,deficiencies,0,0
202319,in,0,1
202320,this,0,0
202321,area,0,0
202322,of,0,0
202323,research,0,1
202324,",",0,0
202325,it,0,0
202326,is,0,0
202327,impossible,0,0
202328,to,0,0
202329,make,0,0
202330,any,0,0
202331,valid,0,0
202332,conclusions,0,0
202333,about,0,0
202334,whether,0,0
202335,hypnosis,0,0
202336,itself,0,0
202337,is,0,0
202338,effective,0,0
202339,in,0,0
202340,the,0,0
202341,treatment,0,0
202342,of,0,0
202343,cigarette,0,1
202344,habituation,0,0
202345,.,0,1
202346,In,0,0
202347,this,0,0
202348,study,0,0
202349,",",0,0
202350,87,1,1
202351,volunteers,1,1
202352,who,1,1
202353,wanted,1,1
202354,to,1,1
202355,quit,1,1
202356,cigarette,1,0
202357,smoking,1,1
202358,were,0,0
202359,assigned,0,1
202360,randomly,0,1
202361,to,0,0
202362,the,0,0
202363,experimental,0,0
202364,hypnosis,0,0
202365,group,0,0
202366,",",0,0
202367,the,0,0
202368,comparison,0,0
202369,relaxation,0,0
202370,group,0,0
202371,",",0,0
202372,and,0,0
202373,the,0,0
202374,waiting,0,0
202375,list,0,0
202376,control,0,1
202377,group,0,1
202378,.,0,1
202379,Ss,0,0
202380,in,0,0
202381,the,0,0
202382,treatment,0,0
202383,groups,0,0
202384,had,0,1
202385,four,0,1
202386,weekly,0,0
202387,50-minute,0,0
202388,",",0,1
202389,individual,0,0
202390,sessions,0,0
202391,.,0,1
202392,Four,0,1
202393,months,0,0
202394,after,0,1
202395,the,0,0
202396,completion,0,0
202397,of,0,0
202398,treatment,0,0
202399,",",0,1
202400,Ss,0,0
202401,were,0,0
202402,administered,0,0
202403,a,0,0
202404,questionnaire,0,0
202405,and,0,0
202406,a,0,0
202407,hypnotic,0,0
202408,susceptibility,0,0
202409,scale,0,1
202410,.,0,1
202411,Ss,0,0
202412,in,0,0
202413,the,0,0
202414,hypnosis,0,1
202415,group,0,1
202416,who,0,1
202417,were,0,1
202418,in,0,1
202419,the,0,0
202420,upper,0,1
202421,two-thirds,0,0
202422,of,0,1
202423,the,0,0
202424,group,0,1
202425,in,0,0
202426,terms,0,0
202427,of,0,1
202428,hypnotic,0,1
202429,susceptibility,0,0
202430,reduced,0,0
202431,their,0,0
202432,cigarette,0,0
202433,consumption,0,0
202434,substantially,0,0
202435,more,0,0
202436,than,0,0
202437,Ss,0,0
202438,in,0,0
202439,the,0,0
202440,relaxation,0,0
202441,group,0,1
202442,who,0,1
202443,were,0,1
202444,in,0,1
202445,the,0,0
202446,upper,0,1
202447,two-thirds,0,0
202448,of,0,1
202449,the,0,0
202450,group,0,1
202451,in,0,0
202452,terms,0,0
202453,of,0,1
202454,hypnotic,0,1
202455,susceptibility,0,0
202456,.,0,1
202457,Therefore,0,0
202458,",",0,0
202459,the,0,0
202460,hypnotic,0,0
202461,state,0,1
202462,appears,0,0
202463,to,0,0
202464,be,0,0
202465,therapeutic,0,0
202466,for,0,1
202467,individuals,1,1
202468,who,0,1
202469,can,0,1
202470,enter,0,1
202471,medium,0,0
202472,or,0,1
202473,deep,0,1
202474,states,0,1
202475,of,0,1
202476,hypnosis,0,1
202477,.,0,1
202478,Caries,0,1
202479,preventive,0,1
202480,effects,0,0
202481,of,0,1
202482,toothpastes,0,0
202483,containing,0,1
202484,monofluorophosphate,0,0
202485,and,0,1
202486,trimetaphosphate,0,0
202487,:,0,1
202488,a,0,1
202489,3-year,0,1
202490,clinical,0,0
202491,trial,0,1
202492,.,0,1
202493,The,0,0
202494,caries-preventive,0,0
202495,effects,0,0
202496,of,0,1
202497,two,0,1
202498,toothpastes,0,0
202499,were,0,1
202500,tested,0,0
202501,in,0,0
202502,a,0,1
202503,3-year,0,1
202504,clinical,0,0
202505,trial,0,1
202506,involving,0,1
202507,1319,1,1
202508,children,1,1
202509,aged,1,1
202510,11-13,1,1
202511,years,1,1
202512,.,1,1
202513,The,0,0
202514,test,0,0
202515,toothpastes,0,0
202516,were,0,1
202517,:,0,1
202518,1,0,1
202519,),0,1
202520,a,0,1
202521,low,0,0
202522,abrasion,0,0
202523,paste,0,0
202524,containing,0,0
202525,0.8,0,0
202526,%,0,0
202527,sodium,0,0
202528,monofluorophosphate,0,0
202529,(,0,1
202530,MFP,0,1
202531,),0,1
202532,",",0,0
202533,and,0,1
202534,2,0,1
202535,),0,1
202536,a,0,1
202537,paste,0,0
202538,containing,0,0
202539,3,0,1
202540,%,0,0
202541,sodium,0,0
202542,trimetaphosphate,0,0
202543,(,0,1
202544,TMP,0,1
202545,),0,1
202546,.,0,1
202547,The,0,0
202548,control,0,0
202549,toothpaste,0,0
202550,was,0,0
202551,a,0,0
202552,conventional,0,0
202553,",",0,0
202554,moderately,0,1
202555,abrasive,0,0
202556,paste,0,0
202557,containing,0,0
202558,0.8,0,0
202559,%,0,0
202560,sodium,0,0
202561,monofluorophosphate,0,0
202562,.,0,1
202563,The,0,0
202564,children,1,1
202565,were,0,1
202566,examined,0,0
202567,clinically,0,1
202568,and,0,0
202569,radiologically,0,1
202570,each,0,0
202571,year,0,0
202572,.,0,1
202573,Toothpaste,0,0
202574,was,0,0
202575,supplied,0,0
202576,to,0,1
202577,the,0,0
202578,children,0,1
202579,'s,0,1
202580,homes,0,1
202581,",",0,1
202582,and,0,0
202583,its,0,0
202584,use,0,0
202585,was,0,0
202586,unsupervised,0,1
202587,.,0,1
202588,Caries,0,0
202589,increments,0,0
202590,after,0,1
202591,3,0,1
202592,years,0,1
202593,",",0,1
202594,in,0,1
202595,terms,0,0
202596,of,0,1
202597,DMF,0,1
202598,teeth,0,1
202599,and,0,1
202600,DMF,0,1
202601,surfaces,0,0
202602,",",0,1
202603,showed,0,0
202604,no,0,0
202605,significant,0,0
202606,differences,0,0
202607,between,0,0
202608,the,1,1
202609,MFP,1,1
202610,test,1,0
202611,group,1,1
202612,(,1,1
202613,444,1,1
202614,children,1,1
202615,),1,1
202616,and,1,1
202617,the,1,0
202618,MFP,1,1
202619,control,1,1
202620,group,1,1
202621,(,1,1
202622,450,1,1
202623,children,1,1
202624,),1,1
202625,.,0,1
202626,However,0,0
202627,",",0,0
202628,the,0,0
202629,TMP,1,0
202630,test,1,0
202631,group,1,1
202632,(,1,1
202633,425,1,1
202634,children,1,1
202635,),1,1
202636,had,0,1
202637,significantly,0,0
202638,higher,0,0
202639,caries,0,1
202640,increments,0,0
202641,than,0,1
202642,the,0,1
202643,MFP,0,1
202644,control,0,1
202645,group,0,1
202646,.,0,1
202647,All,0,1
202648,three,1,0
202649,groups,1,1
202650,of,1,1
202651,children,1,1
202652,showed,0,0
202653,some,0,0
202654,improvement,0,0
202655,in,0,0
202656,oral,0,1
202657,hygiene,0,1
202658,and,0,1
202659,in,0,0
202660,gingival,0,1
202661,health,0,1
202662,",",0,0
202663,but,0,0
202664,there,0,0
202665,were,0,0
202666,no,0,0
202667,significant,0,0
202668,differences,0,0
202669,between,0,0
202670,the,0,1
202671,groups,0,1
202672,.,0,1
202673,Treatment,0,0
202674,of,0,0
202675,adult,1,1
202676,asthma,1,1
202677,:,1,1
202678,controlled,0,0
202679,double-blind,0,1
202680,clinical,0,0
202681,trial,0,1
202682,of,0,0
202683,oxitropium,0,0
202684,bromide,0,0
202685,.,0,1
202686,Sixteen,1,1
202687,young,1,1
202688,adult,1,1
202689,sufferers,1,1
202690,from,1,1
202691,extrinsic,1,1
202692,paroxysmal,1,1
202693,asthma,1,1
202694,with,1,1
202695,pollen,1,0
202696,hypersensitivity,1,1
202697,took,1,1
202698,part,1,0
202699,in,1,0
202700,a,1,1
202701,therapeutic,1,0
202702,trial,1,0
202703,of,1,0
202704,the,1,0
202705,synthetic,1,0
202706,anticholinergic,1,0
202707,agent,1,0
202708,oxitropium,1,0
202709,bromide,1,0
202710,administered,1,0
202711,by,1,0
202712,a,1,0
202713,metered,1,0
202714,dose,1,0
202715,inhaler,1,0
202716,.,1,1
202717,The,0,0
202718,study,0,0
202719,comprised,0,1
202720,three,0,0
202721,3-week,0,1
202722,periods,0,0
202723,.,0,1
202724,The,0,0
202725,first,0,0
202726,",",0,0
202727,run-in,0,1
202728,period,0,0
202729,was,0,0
202730,carried,0,0
202731,out,0,0
202732,to,0,0
202733,confirm,0,0
202734,the,0,0
202735,ability,0,0
202736,of,0,0
202737,the,0,0
202738,patients,0,1
202739,to,0,0
202740,maintain,0,1
202741,a,0,0
202742,daily,0,0
202743,record,0,1
202744,of,0,1
202745,symptoms,0,1
202746,.,0,1
202747,During,0,0
202748,the,0,0
202749,second,0,1
202750,and,0,1
202751,third,0,1
202752,periods,0,0
202753,",",0,1
202754,the,0,0
202755,patient,0,0
202756,received,0,1
202757,3,0,1
202758,X,0,1
202759,2,0,1
202760,inhalations,0,0
202761,of,0,1
202762,drug,0,1
202763,or,0,1
202764,placebo,0,0
202765,in,0,0
202766,a,0,1
202767,cross-over,0,0
202768,design,0,1
202769,.,0,1
202770,The,0,0
202771,medical,0,1
202772,staff,0,1
202773,was,0,0
202774,blind,0,1
202775,to,0,0
202776,the,0,0
202777,nature,0,0
202778,of,0,0
202779,the,0,0
202780,aerosol,0,0
202781,(,0,0
202782,drug,0,0
202783,or,0,1
202784,placebo,0,0
202785,),0,0
202786,",",0,0
202787,which,0,0
202788,was,0,0
202789,given,0,0
202790,in,0,0
202791,random,0,1
202792,order,0,0
202793,.,0,1
202794,The,0,0
202795,run-in,0,0
202796,clinical,0,0
202797,score,0,1
202798,was,0,0
202799,high,0,1
202800,.,0,1
202801,Asymptomatic,0,1
202802,days,0,0
202803,were,0,1
202804,relatively,0,1
202805,infrequent,0,1
202806,and,0,0
202807,daily,0,0
202808,drug,0,1
202809,consumption,0,0
202810,was,0,0
202811,high,0,1
202812,.,0,1
202813,Functional,0,0
202814,studies,0,0
202815,between,0,0
202816,the,0,1
202817,cross-over,0,1
202818,periods,0,0
202819,showed,0,0
202820,flow-rate,0,0
202821,values,0,0
202822,close,0,0
202823,to,0,1
202824,normal,0,1
202825,",",0,0
202826,with,0,1
202827,an,0,0
202828,increase,0,0
202829,in,0,0
202830,residual,0,0
202831,volume,0,1
202832,and,0,1
202833,functional,0,0
202834,residual,0,1
202835,capacity,0,1
202836,.,0,1
202837,During,0,0
202838,treatment,0,0
202839,either,0,1
202840,with,0,1
202841,placebo,0,0
202842,or,0,1
202843,oxitropium,0,0
202844,",",0,0
202845,there,0,0
202846,was,0,0
202847,a,0,0
202848,statistically,0,0
202849,significant,0,0
202850,decrease,0,0
202851,in,0,1
202852,clinical,0,1
202853,scores,0,0
202854,.,0,1
202855,Results,0,0
202856,for,0,0
202857,oxitropium,0,1
202858,bromide,0,0
202859,treatment,0,0
202860,were,0,0
202861,significantly,0,0
202862,better,0,0
202863,than,0,0
202864,the,0,0
202865,run-in,0,1
202866,values,0,0
202867,(,0,1
202868,p,0,0
202869,less,0,0
202870,than,0,0
202871,0.005,0,0
202872,),0,1
202873,and,0,0
202874,the,0,0
202875,placebo,0,0
202876,period,0,0
202877,(,0,0
202878,p,0,0
202879,less,0,0
202880,than,0,0
202881,0.02,0,0
202882,),0,1
202883,.,0,0
202884,There,0,0
202885,was,0,0
202886,no,0,0
202887,significant,0,0
202888,change,0,0
202889,in,0,1
202890,non-trial,0,1
202891,drug,0,1
202892,consumption,0,0
202893,.,0,1
202894,Functional,0,0
202895,values,0,0
202896,showed,0,0
202897,no,0,0
202898,difference,0,0
202899,in,0,0
202900,terms,0,0
202901,of,0,1
202902,flow,0,0
202903,rate,0,0
202904,",",0,0
202905,although,0,0
202906,oxitropium,0,0
202907,did,0,0
202908,cause,0,0
202909,a,0,0
202910,significant,0,0
202911,improvement,0,0
202912,in,0,0
202913,the,0,0
202914,RV/TLC,0,0
202915,ratio,0,0
202916,(,0,0
202917,p,0,0
202918,less,0,0
202919,than,0,0
202920,0.05,0,0
202921,),0,1
202922,.,0,1
202923,No,0,0
202924,adverse,0,0
202925,reactions,0,0
202926,were,0,1
202927,reported,0,1
202928,.,0,1
202929,Fentanyl,0,0
202930,supplementation,0,0
202931,to,0,0
202932,inhalation,1,1
202933,anaesthesia,1,1
202934,.,1,1
202935,In,0,0
202936,eight,1,1
202937,out,1,1
202938,of,1,1
202939,15,1,1
202940,healthy,1,1
202941,patients,1,1
202942,undergoing,1,1
202943,body,1,1
202944,surface,1,0
202945,surgery,1,1
202946,",",0,0
202947,the,0,0
202948,effect,0,0
202949,of,0,0
202950,a,0,1
202951,fentanyl,0,0
202952,infusion,0,0
202953,on,0,0
202954,a,0,1
202955,conventional,0,0
202956,thiopentone,0,0
202957,",",0,0
202958,nitrous,0,0
202959,oxide,0,0
202960,",",0,0
202961,oxygen,0,0
202962,and,0,0
202963,halothane,0,0
202964,anaesthetic,0,0
202965,was,0,0
202966,studied,0,1
202967,.,0,1
202968,The,0,0
202969,fentanyl,0,0
202970,infusion,0,0
202971,(,0,1
202972,2,0,1
202973,micrograms/kg/hour,0,0
202974,),0,1
202975,reduced,0,0
202976,the,0,0
202977,induction,0,0
202978,dose,0,0
202979,of,0,0
202980,thiopentone,0,1
202981,and,0,1
202982,caused,0,0
202983,marked,0,0
202984,respiratory,0,1
202985,depression,0,1
202986,with,0,1
202987,a,0,0
202988,reduction,0,0
202989,in,0,0
202990,the,0,0
202991,patients,0,1
202992,',0,1
202993,response,0,0
202994,to,0,1
202995,surgery,0,1
202996,.,0,1
202997,The,0,0
202998,mean,0,0
202999,arterial,0,1
203000,pressures,0,0
203001,and,0,1
203002,pulse,0,1
203003,rates,0,0
203004,were,0,1
203005,not,0,0
203006,significantly,0,0
203007,different,0,0
203008,in,0,0
203009,each,0,0
203010,group,0,0
203011,throughout,0,0
203012,the,0,0
203013,course,0,0
203014,of,0,0
203015,the,0,0
203016,operation,0,1
203017,.,0,0
203018,The,0,0
203019,fentanyl,0,0
203020,made,0,0
203021,no,0,0
203022,difference,0,0
203023,to,0,0
203024,the,0,0
203025,patients,0,1
203026,',0,1
203027,postoperative,0,1
203028,analgesic,0,1
203029,requirements,0,1
203030,or,0,1
203031,to,0,1
203032,their,0,0
203033,recovery,0,0
203034,in,0,0
203035,the,0,0
203036,first,0,1
203037,24,0,1
203038,hours,0,1
203039,.,0,1
203040,[,0,1
203041,Treatment,0,0
203042,of,0,1
203043,essential,0,1
203044,headache,0,1
203045,in,0,1
203046,developmental,1,1
203047,age,1,1
203048,with,0,1
203049,L-5-HTP,0,1
203050,(,0,1
203051,cross,0,1
203052,over,0,0
203053,double-blind,0,0
203054,study,0,1
203055,versus,0,0
203056,placebo,0,0
203057,),0,1
203058,],0,1
203059,.,0,1
203060,Thirty,1,1
203061,patients,1,1
203062,(,1,1
203063,mean,1,1
203064,age,1,1
203065,:,1,1
203066,10.38,1,0
203067,years,1,1
203068,),1,1
203069,affected,1,0
203070,by,1,0
203071,primary,1,1
203072,headache,1,1
203073,were,1,1
203074,selected,1,1
203075,for,0,0
203076,a,0,1
203077,double-blind,0,0
203078,cross-over,0,1
203079,clinical,0,0
203080,trial,0,1
203081,.,0,1
203082,The,0,0
203083,patients,0,1
203084,were,0,1
203085,randomized,0,1
203086,into,0,1
203087,2,0,1
203088,homogeneous,0,1
203089,groups,0,1
203090,of,0,1
203091,15,0,1
203092,and,0,1
203093,treated,0,1
203094,for,0,1
203095,12,0,1
203096,weeks,0,1
203097,with,0,1
203098,L-5-HTP,0,1
203099,(,0,1
203100,100,0,1
203101,mg/day,0,1
203102,),0,1
203103,and,0,0
203104,placebo,0,0
203105,as,0,0
203106,per,0,0
203107,the,0,0
203108,following,0,0
203109,design,0,1
203110,:,0,1
203111,placebo,0,0
203112,-,0,0
203113,L-5-HTP,0,1
203114,(,0,1
203115,group,0,1
203116,A,0,1
203117,),0,1
203118,and,0,1
203119,L-5-HTP,0,1
203120,-,0,0
203121,placebo,0,0
203122,(,0,1
203123,group,0,1
203124,B,0,1
203125,),0,1
203126,.,0,1
203127,Evaluation,0,0
203128,was,0,0
203129,carried,0,0
203130,out,0,1
203131,every,0,0
203132,3,0,1
203133,weeks,0,0
203134,by,0,0
203135,the,0,1
203136,Migraine,0,1
203137,Index,0,0
203138,supplying,0,0
203139,a,0,1
203140,general,0,1
203141,assessment,0,0
203142,of,0,0
203143,the,0,0
203144,attacks,0,0
203145,",",0,0
203146,i.e,0,1
203147,.,0,1
203148,severity,0,0
203149,",",0,0
203150,duration,0,0
203151,and,0,0
203152,frequency,0,0
203153,.,0,1
203154,The,0,0
203155,decrease,0,0
203156,in,0,0
203157,mean,0,1
203158,score,0,1
203159,values,0,0
203160,was,0,0
203161,directly,0,0
203162,proportional,0,0
203163,to,0,0
203164,L-5-HTP,0,1
203165,treatment,0,0
203166,",",0,0
203167,and,0,0
203168,statistical,0,0
203169,significance,0,0
203170,(,0,1
203171,Wilcoxon,0,0
203172,'s,0,1
203173,test,0,0
203174,),0,1
203175,was,0,0
203176,observed,0,0
203177,only,0,0
203178,for,0,0
203179,L-5-HTP,0,1
203180,in,0,1
203181,both,0,0
203182,groups,0,0
203183,",",0,0
203184,from,0,1
203185,0.05,0,0
203186,to,0,1
203187,0.01,0,0
203188,.,0,1
203189,Improvement,0,0
203190,",",0,0
203191,as,0,0
203192,evaluated,0,0
203193,by,0,0
203194,CGI,0,1
203195,on,0,0
203196,percentage,0,0
203197,distribution,0,0
203198,of,0,0
203199,the,0,0
203200,patients,0,1
203201,",",0,0
203202,was,0,0
203203,homogeneous,0,1
203204,in,0,1
203205,both,0,0
203206,groups,0,1
203207,.,0,1
203208,Endotracheal,1,1
203209,cuff,1,1
203210,pressure,1,0
203211,and,1,0
203212,tracheal,1,1
203213,mucosal,1,1
203214,blood,1,0
203215,flow,1,0
203216,:,1,1
203217,endoscopic,0,0
203218,study,0,1
203219,of,0,0
203220,effects,0,0
203221,of,0,1
203222,four,1,1
203223,large,1,1
203224,volume,1,1
203225,cuffs,1,1
203226,.,1,1
203227,Large,0,0
203228,volume,0,0
203229,",",0,0
203230,low,0,0
203231,pressure,0,0
203232,endotracheal,0,1
203233,tube,0,1
203234,cuffs,0,1
203235,are,0,0
203236,claimed,0,0
203237,to,0,0
203238,have,0,0
203239,less,0,0
203240,deleterious,0,0
203241,effect,0,0
203242,on,0,0
203243,tracheal,0,1
203244,mucosa,0,1
203245,than,0,0
203246,high,0,1
203247,pressure,0,0
203248,",",0,0
203249,low,0,1
203250,volume,0,1
203251,cuffs,0,1
203252,.,0,1
203253,Low,1,1
203254,pressure,1,0
203255,cuffs,1,0
203256,",",0,0
203257,however,0,0
203258,",",0,0
203259,may,0,0
203260,easily,0,0
203261,be,0,0
203262,overinflated,0,0
203263,to,0,0
203264,yield,0,0
203265,pressures,0,0
203266,that,0,0
203267,will,0,0
203268,exceed,0,0
203269,capillary,0,0
203270,perfusion,0,0
203271,pressure,0,0
203272,.,0,1
203273,Various,0,0
203274,large,0,1
203275,volume,0,0
203276,cuffed,0,1
203277,endotracheal,0,1
203278,tubes,0,1
203279,were,0,1
203280,studied,0,1
203281,",",0,0
203282,including,0,0
203283,Portex,0,0
203284,Profile,0,0
203285,",",0,1
203286,Searle,0,1
203287,Sensiv,0,1
203288,",",0,1
203289,Mallinkrodt,0,0
203290,Hi-Lo,0,0
203291,",",0,0
203292,and,0,0
203293,Lanz,0,1
203294,.,0,1
203295,Tracheal,0,1
203296,mucosal,0,0
203297,blood,0,0
203298,flow,0,0
203299,in,0,1
203300,40,1,1
203301,patients,1,1
203302,undergoing,1,1
203303,surgery,1,1
203304,was,0,0
203305,assessed,0,0
203306,using,0,0
203307,an,0,0
203308,endoscopic,0,1
203309,photographic,0,0
203310,technique,0,0
203311,while,0,0
203312,varying,0,0
203313,the,0,0
203314,cuff,0,1
203315,inflation,0,0
203316,pressure,0,0
203317,.,0,1
203318,It,0,0
203319,was,0,0
203320,found,0,0
203321,that,0,0
203322,these,0,0
203323,cuffs,0,0
203324,when,0,0
203325,overpressurised,0,0
203326,impaired,0,0
203327,mucosal,0,1
203328,blood,0,0
203329,flow,0,0
203330,.,0,1
203331,This,0,0
203332,impairment,0,0
203333,of,0,0
203334,tracheal,0,1
203335,mucosal,0,1
203336,blood,0,0
203337,flow,0,0
203338,is,0,0
203339,an,0,0
203340,important,0,0
203341,factor,0,0
203342,in,0,1
203343,tracheal,0,1
203344,morbidity,0,0
203345,associated,0,0
203346,with,0,1
203347,intubation,0,1
203348,.,0,1
203349,Hence,0,0
203350,it,0,0
203351,is,0,0
203352,recommended,0,0
203353,that,0,0
203354,a,0,0
203355,cuff,0,1
203356,inflation,0,0
203357,pressure,0,0
203358,of,0,1
203359,30,0,1
203360,cm,0,1
203361,H2O,0,0
203362,(,0,1
203363,22,0,1
203364,mm,0,1
203365,Hg,0,0
203366,),0,0
203367,should,0,0
203368,not,0,0
203369,be,0,0
203370,exceeded,0,0
203371,.,0,1
203372,Cognitive,0,1
203373,effects,0,0
203374,of,0,1
203375,lithium,0,0
203376,carbonate,0,0
203377,and,0,0
203378,haloperidol,0,0
203379,in,0,0
203380,treatment-resistant,1,1
203381,aggressive,1,1
203382,children,1,1
203383,.,1,1
203384,The,0,0
203385,effects,0,0
203386,of,0,0
203387,lithium,0,0
203388,carbonate,0,0
203389,and,0,0
203390,haloperidol,0,0
203391,on,0,0
203392,cognition,0,0
203393,were,0,1
203394,examined,0,0
203395,in,0,0
203396,a,0,0
203397,placebo-controlled,0,0
203398,",",0,0
203399,double-blind,0,0
203400,study,0,1
203401,of,0,1
203402,61,1,1
203403,treatment-resistant,1,1
203404,",",1,1
203405,hospitalized,1,1
203406,school-aged,1,1
203407,children,1,1
203408,.,1,1
203409,They,0,0
203410,all,0,0
203411,had,0,1
203412,a,0,0
203413,DSM-III,0,0
203414,diagnosis,0,1
203415,of,0,0
203416,conduct,0,0
203417,disorder,0,1
203418,--,0,1
203419,undersocialized,1,1
203420,",",1,0
203421,aggressive,1,1
203422,",",1,0
203423,with,1,1
203424,a,1,0
203425,profile,1,0
203426,of,1,0
203427,highly,1,0
203428,explosive,1,1
203429,and,1,0
203430,aggressive,1,1
203431,behavior,1,1
203432,.,1,1
203433,Children,1,1
203434,were,1,0
203435,assessed,1,0
203436,at,1,0
203437,the,1,0
203438,end,1,0
203439,of,1,0
203440,a,1,1
203441,two-week,1,0
203442,placebo-baseline,1,0
203443,period,1,0
203444,and,1,0
203445,again,1,0
203446,after,1,1
203447,four,1,1
203448,weeks,1,1
203449,of,1,1
203450,treatment,1,1
203451,.,1,1
203452,Drug,0,0
203453,effects,0,0
203454,on,0,0
203455,cognition,0,0
203456,were,0,1
203457,mild,0,1
203458,.,0,1
203459,Haloperidol,0,0
203460,(,0,0
203461,mean,0,1
203462,dose,0,0
203463,",",0,1
203464,2.95,0,0
203465,mg/day,0,0
203466,),0,1
203467,caused,0,0
203468,significant,0,0
203469,decreases,0,0
203470,in,0,1
203471,Porteus,0,1
203472,Maze,0,1
203473,test,0,0
203474,quotient,0,0
203475,scores,0,0
203476,and,0,1
203477,a,0,1
203478,slowing,0,0
203479,of,0,0
203480,reaction,0,0
203481,time,0,0
203482,(,0,1
203483,RT,0,1
203484,),0,1
203485,on,0,0
203486,a,0,1
203487,simple,0,0
203488,RT,0,1
203489,task,0,1
203490,.,0,1
203491,Lithium,0,0
203492,carbonate,0,0
203493,(,0,1
203494,mean,0,1
203495,dose,0,0
203496,",",0,1
203497,"1,166",0,1
203498,mg/day,0,0
203499,),0,1
203500,adversely,0,0
203501,affected,0,0
203502,qualitative,0,0
203503,scores,0,0
203504,on,0,0
203505,the,0,1
203506,Porteus,0,1
203507,Maze,0,1
203508,test,0,0
203509,.,0,1
203510,No,0,0
203511,significant,0,0
203512,treatment,0,1
203513,effects,0,0
203514,were,0,1
203515,found,0,0
203516,for,0,0
203517,the,0,0
203518,Matching,0,0
203519,Familiar,0,1
203520,Figures,0,0
203521,Test,0,0
203522,",",0,0
203523,short-term,0,0
203524,recognition,0,0
203525,memory,0,0
203526,and,0,0
203527,concept,0,0
203528,attainment,0,1
203529,tasks,0,0
203530,",",0,0
203531,or,0,1
203532,the,0,0
203533,Stroop,0,1
203534,Test,0,0
203535,.,0,1
203536,Ascorbic,0,0
203537,acid,0,0
203538,and,0,0
203539,performance,0,0
203540,in,0,0
203541,man,0,1
203542,.,0,1
203543,Effects,0,0
203544,on,0,0
203545,performance,0,0
203546,of,0,1
203547,1,0,1
203548,",",0,1
203549,2,0,1
203550,and,0,1
203551,4,0,0
203552,g,0,1
203553,ascorbic,0,0
203554,acid,0,0
203555,were,0,1
203556,studied,0,1
203557,from,0,1
203558,0.5-5.5,0,0
203559,h,0,0
203560,after,0,0
203561,ingestion,0,0
203562,in,0,1
203563,six,1,1
203564,healthy,1,1
203565,females,1,1
203566,.,1,1
203567,Diazepam,0,0
203568,(,0,1
203569,5,0,1
203570,mg,0,1
203571,),0,1
203572,was,0,0
203573,included,0,1
203574,as,0,0
203575,an,0,0
203576,active,0,1
203577,control,0,1
203578,",",0,0
203579,and,0,0
203580,it,0,0
203581,impaired,0,1
203582,digit,0,0
203583,symbol,0,0
203584,substitution,0,0
203585,",",0,0
203586,visuomotor,0,0
203587,coordination,0,0
203588,and,0,0
203589,complex,0,0
203590,reaction,0,0
203591,time,0,0
203592,.,0,0
203593,There,0,0
203594,were,0,0
203595,no,0,0
203596,effects,0,0
203597,of,0,0
203598,any,0,1
203599,dose,0,0
203600,of,0,0
203601,ascorbic,0,0
203602,acid,0,0
203603,on,0,0
203604,performance,0,0
203605,.,0,1
203606,Risk,0,1
203607,of,0,0
203608,infection,0,1
203609,after,0,1
203610,penetrating,0,1
203611,abdominal,0,1
203612,trauma,0,1
203613,.,0,1
203614,To,0,0
203615,identify,0,0
203616,the,0,0
203617,risk,0,0
203618,factors,0,0
203619,for,0,0
203620,the,0,0
203621,development,0,0
203622,of,0,0
203623,postoperative,0,1
203624,septic,0,1
203625,complications,0,1
203626,in,0,1
203627,patients,1,1
203628,with,1,1
203629,intestinal,1,1
203630,perforation,1,1
203631,after,1,1
203632,abdominal,1,1
203633,trauma,1,1
203634,",",0,0
203635,and,0,0
203636,to,0,0
203637,compare,0,0
203638,the,0,0
203639,efficacies,0,0
203640,of,0,0
203641,single-drug,0,1
203642,and,0,1
203643,dual-drug,0,1
203644,prophylactic,0,1
203645,antibiotic,0,0
203646,therapy,0,0
203647,",",0,0
203648,we,0,0
203649,studied,0,1
203650,145,1,1
203651,patients,1,1
203652,who,1,1
203653,presented,1,1
203654,with,1,1
203655,abdominal,1,1
203656,trauma,1,1
203657,and,1,1
203658,intestinal,1,1
203659,perforation,1,1
203660,at,1,1
203661,two,1,1
203662,hospitals,1,1
203663,between,1,1
203664,July,1,1
203665,1979,1,1
203666,and,1,1
203667,June,1,1
203668,1982,1,1
203669,.,1,1
203670,Logistic-regression,0,0
203671,analysis,0,0
203672,showed,0,0
203673,that,0,0
203674,a,0,0
203675,higher,0,0
203676,risk,0,0
203677,of,0,0
203678,infection,0,1
203679,(,0,1
203680,P,0,0
203681,less,0,0
203682,than,0,0
203683,0.05,0,0
203684,),0,1
203685,was,0,0
203686,associated,0,0
203687,with,0,1
203688,increased,0,0
203689,age,0,1
203690,",",0,0
203691,injury,0,1
203692,to,0,0
203693,the,0,0
203694,left,0,1
203695,colon,0,1
203696,necessitating,0,1
203697,colostomy,0,1
203698,",",0,0
203699,a,0,0
203700,larger,0,0
203701,number,0,0
203702,of,0,0
203703,units,0,1
203704,of,0,1
203705,blood,0,0
203706,or,0,1
203707,blood,0,0
203708,products,0,0
203709,administered,0,0
203710,at,0,1
203711,surgery,0,1
203712,",",0,0
203713,and,0,0
203714,a,0,0
203715,larger,0,0
203716,number,0,0
203717,of,0,0
203718,injured,0,1
203719,organs,0,1
203720,.,0,1
203721,The,0,0
203722,presence,0,0
203723,of,0,0
203724,shock,0,1
203725,on,0,0
203726,arrival,0,1
203727,",",0,0
203728,which,0,0
203729,was,0,0
203730,found,0,0
203731,to,0,0
203732,increase,0,0
203733,the,0,0
203734,risk,0,0
203735,of,0,0
203736,infection,0,0
203737,when,0,0
203738,this,0,0
203739,factor,0,0
203740,was,0,0
203741,analyzed,0,0
203742,individually,0,0
203743,",",0,0
203744,did,0,0
203745,not,0,0
203746,add,0,0
203747,predictive,0,0
203748,power,0,0
203749,.,0,1
203750,Patients,1,1
203751,with,1,1
203752,postoperative,1,1
203753,sepsis,1,1
203754,were,0,1
203755,hospitalized,0,1
203756,significantly,0,0
203757,longer,0,0
203758,than,0,0
203759,were,0,0
203760,patients,0,1
203761,without,0,1
203762,infection,0,1
203763,(,0,0
203764,13.8,0,1
203765,vs.,0,0
203766,7.7,0,0
203767,days,0,0
203768,",",0,1
203769,P,0,0
203770,less,0,0
203771,than,0,0
203772,0.0001,0,0
203773,),0,1
203774,.,0,1
203775,Both,0,0
203776,treatment,0,0
203777,regimens,0,0
203778,--,0,0
203779,cefoxitin,0,0
203780,given,0,0
203781,alone,0,0
203782,and,0,0
203783,clindamycin,0,0
203784,and,0,1
203785,gentamicin,0,0
203786,given,0,0
203787,together,0,0
203788,--,0,1
203789,resulted,0,0
203790,in,0,0
203791,similar,0,0
203792,infection,0,1
203793,rates,0,0
203794,",",0,1
203795,drug,0,0
203796,toxicity,0,0
203797,",",0,0
203798,duration,0,0
203799,of,0,0
203800,hospitalization,0,1
203801,",",0,1
203802,and,0,1
203803,costs,0,1
203804,.,0,1
203805,Immunogenicity,0,0
203806,and,0,0
203807,safety,0,0
203808,of,0,0
203809,a,0,1
203810,plasma-derived,0,0
203811,heat-inactivated,0,1
203812,hepatitis,0,1
203813,B,0,1
203814,vaccine,0,1
203815,(,0,1
203816,CLB,0,1
203817,),0,1
203818,.,0,1
203819,Studies,0,0
203820,in,0,1
203821,volunteers,1,1
203822,at,1,1
203823,a,1,1
203824,low,1,0
203825,risk,1,0
203826,of,1,0
203827,infection,1,1
203828,with,1,1
203829,hepatitis,1,1
203830,B,1,1
203831,virus,1,1
203832,.,1,1
203833,The,0,0
203834,safety,0,0
203835,and,0,0
203836,immunogenicity,0,0
203837,of,0,0
203838,a,0,1
203839,plasma-derived,0,0
203840,heat-inactivated,0,1
203841,hepatitis,0,1
203842,B,0,1
203843,vaccine,0,1
203844,(,0,1
203845,CLB,0,1
203846,),0,1
203847,were,0,0
203848,evaluated,0,0
203849,in,0,1
203850,471,1,1
203851,healthy,1,1
203852,human,1,1
203853,volunteers,1,1
203854,",",1,1
203855,who,1,1
203856,",",1,1
203857,both,1,1
203858,in,1,0
203859,their,1,1
203860,occupations,1,1
203861,and,1,1
203862,in,1,1
203863,their,1,1
203864,private,1,1
203865,lives,1,1
203866,",",1,1
203867,had,1,1
203868,been,1,0
203869,at,1,0
203870,minimal,1,0
203871,risk,1,1
203872,of,1,0
203873,being,1,1
203874,infected,1,1
203875,with,1,1
203876,hepatitis,1,1
203877,B,1,1
203878,virus,1,1
203879,.,1,1
203880,The,0,0
203881,first,0,0
203882,202,0,1
203883,individuals,0,1
203884,received,0,1
203885,three,0,1
203886,3-micrograms,0,1
203887,doses,0,0
203888,of,0,1
203889,heat-inactivated,0,1
203890,hepatitis,0,1
203891,B,0,1
203892,surface,0,0
203893,antigen,0,0
203894,(,0,1
203895,HBsAg,0,1
203896,),0,1
203897,at,0,1
203898,one-month,0,0
203899,intervals,0,0
203900,(,0,1
203901,trial,0,1
203902,A,0,1
203903,),0,0
203904,.,0,0
203905,A,0,0
203906,total,0,1
203907,of,0,0
203908,42,0,1
203909,%,0,0
203910,one,0,1
203911,month,0,0
203912,after,0,0
203913,the,0,0
203914,first,0,0
203915,injection,0,0
203916,",",0,1
203917,84,0,1
203918,%,0,0
203919,after,0,1
203920,two,0,1
203921,months,0,0
203922,",",0,1
203923,and,0,1
203924,93,0,1
203925,%,0,0
203926,after,0,1
203927,five,0,1
203928,months,0,1
203929,had,0,1
203930,become,0,0
203931,anti-HBs,0,1
203932,(,0,1
203933,antibody,0,0
203934,to,0,0
203935,hepatitis,0,1
203936,B,0,1
203937,surface,0,0
203938,antigen,0,0
203939,),0,1
203940,positive,0,1
203941,.,0,1
203942,In,0,0
203943,a,0,0
203944,second,0,1
203945,randomized,0,1
203946,study,0,1
203947,(,0,1
203948,trial,0,1
203949,B,0,1
203950,),0,0
203951,",",0,0
203952,the,0,0
203953,immunogenicity,0,0
203954,of,0,0
203955,five,0,1
203956,different,0,1
203957,dosages,0,0
203958,of,0,1
203959,the,0,0
203960,vaccine,0,0
203961,was,0,0
203962,compared,0,0
203963,in,0,1
203964,269,0,1
203965,volunteers,0,1
203966,.,0,0
203967,When,0,0
203968,the,0,0
203969,dose,0,0
203970,of,0,0
203971,HBsAg,0,1
203972,was,0,0
203973,diminished,0,0
203974,from,0,1
203975,3,0,1
203976,micrograms,0,1
203977,to,0,1
203978,1.5,0,1
203979,",",0,1
203980,0.6,0,0
203981,",",0,0
203982,and,0,0
203983,0.25,0,0
203984,microgram,0,0
203985,",",0,0
203986,no,0,0
203987,decrease,0,0
203988,of,0,0
203989,the,0,0
203990,anti-HBs,0,0
203991,response,0,0
203992,was,0,0
203993,observed,0,0
203994,.,0,1
203995,However,0,0
203996,",",0,0
203997,when,0,0
203998,the,0,0
203999,dose,0,0
204000,was,0,0
204001,diminished,0,0
204002,to,0,1
204003,0.1,0,0
204004,microgram,0,0
204005,of,0,0
204006,HBsAg,0,0
204007,",",0,0
204008,the,0,0
204009,anti-HBs,0,0
204010,response,0,0
204011,dropped,0,0
204012,significantly,0,0
204013,to,0,0
204014,63,0,1
204015,%,0,0
204016,(,0,0
204017,p,0,0
204018,less,0,0
204019,than,0,0
204020,0.001,0,0
204021,),0,1
204022,.,0,1
204023,In,0,0
204024,the,0,0
204025,recipients,0,1
204026,of,0,0
204027,all,0,1
204028,five,0,1
204029,vaccine,0,1
204030,dosages,0,0
204031,",",0,0
204032,no,0,0
204033,influence,0,0
204034,of,0,0
204035,sex,0,0
204036,and,0,1
204037,age,0,1
204038,was,0,0
204039,found,0,0
204040,on,0,0
204041,the,0,0
204042,anti-HBs,0,1
204043,conversion,0,1
204044,rates,0,0
204045,.,0,1
204046,During,0,0
204047,the,0,0
204048,eight-month,0,1
204049,observation,0,0
204050,period,0,0
204051,",",0,0
204052,none,0,0
204053,of,0,0
204054,the,0,0
204055,vaccinees,0,1
204056,became,0,1
204057,HBsAg,0,1
204058,and/or,0,1
204059,anti-HBc,0,1
204060,(,0,1
204061,antibody,0,0
204062,to,0,0
204063,hepatitis,0,1
204064,B,0,1
204065,core,0,1
204066,antigen,0,0
204067,),0,1
204068,positive,0,1
204069,",",0,0
204070,and,0,0
204071,none,0,1
204072,developed,0,1
204073,antibodies,0,0
204074,associated,0,0
204075,with,0,1
204076,autoimmune,0,1
204077,liver,0,1
204078,disease,0,1
204079,.,0,1
204080,No,0,0
204081,serious,0,0
204082,side,0,0
204083,effects,0,0
204084,were,0,1
204085,observed,0,0
204086,.,0,1
204087,Rational-emotive,0,0
204088,therapy,0,0
204089,and,0,0
204090,the,0,0
204091,reduction,0,0
204092,of,0,0
204093,interpersonal,0,0
204094,anxiety,0,1
204095,in,0,1
204096,junior,1,1
204097,high,1,1
204098,school,1,1
204099,students,1,1
204100,.,1,1
204101,This,0,0
204102,study,0,0
204103,evaluated,0,0
204104,the,0,0
204105,effectiveness,0,0
204106,of,0,0
204107,rational-emotive,0,1
204108,therapy,0,1
204109,and,0,1
204110,rational-emotive,0,0
204111,imagery,0,0
204112,.,0,1
204113,Fifty-nine,1,1
204114,junior,1,1
204115,high,1,1
204116,school,1,1
204117,students,1,1
204118,who,1,1
204119,volunteered,1,1
204120,to,1,1
204121,participate,1,1
204122,in,1,0
204123,treatment,1,0
204124,for,1,1
204125,interpersonal,1,0
204126,anxiety,1,1
204127,were,0,1
204128,randomly,0,1
204129,assigned,0,1
204130,to,0,0
204131,rational-emotive,0,0
204132,therapy,0,0
204133,without,0,1
204134,imagery,0,0
204135,(,1,1
204136,RET,1,0
204137,),1,1
204138,",",1,0
204139,rational-emotive,1,0
204140,therapy,1,0
204141,with,1,1
204142,imagery,1,0
204143,(,1,1
204144,REI,1,0
204145,),1,1
204146,",",1,0
204147,relationship-oriented,1,0
204148,counseling,1,0
204149,(,1,1
204150,ROC,1,1
204151,),1,1
204152,",",1,0
204153,and,1,0
204154,waiting-list,1,0
204155,control,1,1
204156,(,1,1
204157,WLC,1,1
204158,),1,1
204159,groups,1,1
204160,.,1,1
204161,Groups,0,0
204162,met,0,1
204163,for,0,1
204164,seven,0,1
204165,50-minute,0,0
204166,treatment,0,1
204167,sessions,0,0
204168,during,0,1
204169,a,0,1
204170,three-week,0,1
204171,period,0,1
204172,.,0,1
204173,Assessments,0,0
204174,were,0,0
204175,conducted,0,1
204176,at,0,0
204177,pretreatment,0,0
204178,",",0,0
204179,posttreatment,0,0
204180,",",0,0
204181,and,0,0
204182,three-week,0,1
204183,follow-up,0,0
204184,.,0,1
204185,Both,0,0
204186,self-report,0,0
204187,and,0,1
204188,sociometric,0,1
204189,measures,0,0
204190,were,0,1
204191,used,0,0
204192,to,0,0
204193,evaluate,0,0
204194,treatment,0,0
204195,outcome,0,0
204196,.,0,1
204197,At,0,0
204198,postassessment,0,0
204199,",",0,0
204200,both,0,0
204201,the,0,0
204202,RET,0,0
204203,and,0,1
204204,REI,0,0
204205,groups,0,1
204206,were,0,1
204207,rated,0,1
204208,on,0,0
204209,sociometric,0,1
204210,measures,0,0
204211,as,0,0
204212,significantly,0,0
204213,less,0,0
204214,interpersonally,0,0
204215,anxious,0,0
204216,than,0,0
204217,the,0,0
204218,WLC,0,1
204219,group,0,1
204220,.,0,1
204221,Mean,0,1
204222,scores,0,0
204223,favored,0,0
204224,the,0,0
204225,RET,0,0
204226,and,0,1
204227,REI,0,0
204228,groups,0,0
204229,",",0,1
204230,but,0,0
204231,no,0,0
204232,significant,0,0
204233,differences,0,0
204234,between,0,0
204235,these,0,1
204236,groups,0,0
204237,and,0,0
204238,the,0,0
204239,ROC,0,1
204240,group,0,1
204241,were,0,1
204242,obtained,0,0
204243,.,0,1
204244,The,0,0
204245,self-report,0,0
204246,measure,0,0
204247,did,0,0
204248,not,0,0
204249,significantly,0,0
204250,differentiate,0,0
204251,between,0,0
204252,groups,0,0
204253,",",0,1
204254,but,0,0
204255,the,0,0
204256,REI,0,0
204257,group,0,1
204258,demonstrated,0,0
204259,significant,0,0
204260,pre-,0,0
204261,to,0,1
204262,follow-up,0,1
204263,changes,0,0
204264,.,0,1
204265,Both,0,0
204266,the,0,0
204267,RET,0,0
204268,and,0,1
204269,REI,0,0
204270,groups,0,0
204271,yielded,0,0
204272,greater,0,0
204273,reductions,0,0
204274,in,0,0
204275,irrational,0,1
204276,thinking,0,0
204277,than,0,0
204278,did,0,0
204279,the,0,0
204280,ROC,0,1
204281,and,0,1
204282,WLC,0,1
204283,groups,0,1
204284,.,0,1
204285,In,0,0
204286,addition,0,0
204287,",",0,0
204288,the,0,0
204289,pattern,0,1
204290,of,0,0
204291,the,0,0
204292,results,0,0
204293,supported,0,0
204294,the,0,0
204295,use,0,0
204296,of,0,0
204297,rational-emotive,0,0
204298,imagery,0,0
204299,as,0,0
204300,a,0,0
204301,component,0,0
204302,of,0,0
204303,rational-emotive,0,1
204304,therapy,0,1
204305,.,0,1
204306,The,0,0
204307,practical,0,0
204308,implications,0,0
204309,of,0,1
204310,these,0,0
204311,findings,0,0
204312,are,0,0
204313,discussed,0,0
204314,.,0,1
204315,High-dose,0,1
204316,weekly,0,1
204317,fractionation,0,1
204318,radiotherapy,0,1
204319,in,0,0
204320,advanced,1,1
204321,cancer,1,1
204322,of,1,0
204323,the,1,0
204324,uterine,1,1
204325,cervix,1,1
204326,.,1,1
204327,A,0,0
204328,trial,0,0
204329,comparing,0,0
204330,two,1,0
204331,different,1,1
204332,radiotherapy,1,1
204333,techniques,1,0
204334,and,0,1
204335,schedules,0,0
204336,in,0,0
204337,the,0,0
204338,treatment,0,0
204339,of,0,0
204340,83,1,1
204341,patients,1,1
204342,with,1,1
204343,advanced,1,1
204344,cancer,1,1
204345,of,1,0
204346,the,1,0
204347,uterine,1,1
204348,cervix,1,1
204349,(,1,1
204350,stage,1,1
204351,IIIB,1,1
204352,),1,1
204353,employing,1,0
204354,external,1,0
204355,irradiation,1,0
204356,alone,1,0
204357,is,0,0
204358,described,0,0
204359,.,0,0
204360,The,0,0
204361,one,0,0
204362,technique,0,0
204363,",",0,0
204364,used,0,0
204365,routinely,0,0
204366,in,0,0
204367,this,0,0
204368,department,0,1
204369,",",0,0
204370,employed,0,0
204371,a,0,0
204372,conventional,0,0
204373,daily,0,0
204374,fractionation,0,1
204375,schedule,0,0
204376,while,0,0
204377,the,0,0
204378,other,0,0
204379,used,0,0
204380,a,0,1
204381,high-dose,0,0
204382,weekly,0,1
204383,fractionation,0,1
204384,regimen,0,1
204385,.,0,1
204386,The,0,0
204387,techniques,0,0
204388,are,0,0
204389,described,0,0
204390,.,0,1
204391,The,0,0
204392,aim,0,0
204393,of,0,0
204394,the,0,0
204395,trial,0,0
204396,was,0,0
204397,to,0,0
204398,compare,0,0
204399,the,0,0
204400,efficacy,0,0
204401,and,0,0
204402,morbidity,0,0
204403,of,0,0
204404,these,0,0
204405,two,0,0
204406,methods,0,1
204407,of,0,1
204408,treatment,0,1
204409,.,0,1
204410,Dose,0,0
204411,distribution,0,0
204412,curves,0,0
204413,in,0,1
204414,cross-section,0,1
204415,and,0,1
204416,midsagittal,0,1
204417,planes,0,0
204418,are,0,0
204419,shown,0,0
204420,and,0,1
204421,calculations,0,0
204422,or,0,1
204423,equivalent,0,0
204424,doses,0,0
204425,at,0,1
204426,various,0,1
204427,selected,0,1
204428,points,0,0
204429,using,0,1
204430,Ellis,0,1
204431,'s,0,1
204432,nominal,0,0
204433,single-dose,0,0
204434,formula,0,0
204435,are,0,0
204436,tabulated,0,0
204437,.,0,1
204438,The,0,0
204439,2-year,0,0
204440,survival,0,0
204441,figures,0,0
204442,were,0,1
204443,33,0,1
204444,%,0,0
204445,for,0,0
204446,the,0,0
204447,daily,0,0
204448,fractionation,0,0
204449,technique,0,0
204450,and,0,1
204451,22,0,1
204452,%,0,0
204453,for,0,0
204454,the,0,0
204455,weekly,0,0
204456,regimen,0,0
204457,.,0,1
204458,Serious,0,0
204459,late,0,1
204460,complication,0,1
204461,rates,0,0
204462,were,0,1
204463,6,0,0
204464,%,0,0
204465,for,0,0
204466,the,0,0
204467,daily,0,0
204468,regimen,0,0
204469,and,0,1
204470,22,0,1
204471,%,0,0
204472,for,0,0
204473,the,0,0
204474,weekly,0,0
204475,schedule,0,0
204476,.,0,1
204477,These,0,0
204478,differences,0,0
204479,are,0,0
204480,not,0,0
204481,statistically,0,0
204482,significant,0,0
204483,.,0,1
204484,Late,0,0
204485,complication,0,0
204486,rates,0,0
204487,in,0,1
204488,the,0,1
204489,weekly,0,0
204490,fractionation,0,1
204491,regimen,0,1
204492,appeared,0,0
204493,to,0,0
204494,be,0,0
204495,lower,0,0
204496,than,0,0
204497,figures,0,0
204498,quoted,0,1
204499,by,0,1
204500,other,0,1
204501,authors,0,1
204502,.,0,1
204503,Local,0,1
204504,control,0,0
204505,within,0,1
204506,the,0,0
204507,irradiated,0,0
204508,volume,0,0
204509,was,0,0
204510,better,0,0
204511,in,0,0
204512,the,0,0
204513,group,0,0
204514,treated,0,1
204515,by,0,0
204516,the,0,0
204517,daily,0,0
204518,fractionation,0,0
204519,method,0,0
204520,.,0,1
204521,[,0,0
204522,Treatment,0,0
204523,of,0,0
204524,the,0,0
204525,hyperkinetic,0,1
204526,response,0,0
204527,to,0,0
204528,exercise,1,0
204529,after,1,0
204530,myocardial,1,1
204531,infarct,1,1
204532,.,1,1
204533,Results,0,0
204534,of,0,0
204535,a,0,1
204536,randomized,0,1
204537,ergometric,0,0
204538,study,0,1
204539,],0,1
204540,.,0,1
204541,Modifying,0,0
204542,the,0,0
204543,Type,1,1
204544,A,1,1
204545,coronary-prone,1,1
204546,behavior,1,0
204547,pattern,0,1
204548,.,0,1
204549,Breathlessness,0,1
204550,and,0,1
204551,psychiatric,0,1
204552,morbidity,0,0
204553,in,0,1
204554,chronic,1,1
204555,bronchitis,1,1
204556,and,1,1
204557,emphysema,1,1
204558,:,1,1
204559,a,0,0
204560,study,0,0
204561,of,0,0
204562,psychotherapeutic,0,1
204563,management,0,1
204564,.,0,1
204565,This,0,0
204566,paper,0,0
204567,describes,0,0
204568,a,0,0
204569,study,0,0
204570,of,0,0
204571,the,0,0
204572,outcome,0,0
204573,of,0,0
204574,psychotherapy,0,1
204575,with,0,1
204576,patients,1,1
204577,disabled,1,1
204578,by,1,1
204579,chronic,1,1
204580,obstructive,1,1
204581,airways,1,1
204582,disease,1,1
204583,giving,1,0
204584,rise,1,0
204585,to,1,1
204586,dyspnoea,1,1
204587,.,1,1
204588,Forty-three,1,1
204589,men,1,1
204590,and,1,1
204591,22,1,1
204592,women,1,1
204593,with,1,1
204594,severe,1,1
204595,COAD,1,1
204596,were,0,1
204597,randomly,0,1
204598,allocated,0,1
204599,for,0,0
204600,8,0,1
204601,weeks,0,1
204602,to,0,1
204603,one,0,1
204604,of,0,1
204605,three,0,1
204606,types,0,1
204607,of,0,1
204608,psychotherapy,0,1
204609,or,0,1
204610,to,0,0
204611,an,0,0
204612,untreated,0,1
204613,control,0,1
204614,group,0,1
204615,",",0,0
204616,and,0,0
204617,were,0,0
204618,followed,0,0
204619,up,0,1
204620,six,0,1
204621,months,0,0
204622,later,0,1
204623,.,0,1
204624,The,0,0
204625,group,0,0
204626,treated,0,1
204627,by,0,0
204628,a,0,1
204629,medical,0,1
204630,nurse,0,1
204631,without,0,1
204632,training,0,0
204633,in,0,0
204634,psychotherapy,0,1
204635,experienced,0,1
204636,sustained,0,0
204637,relief,0,0
204638,of,0,0
204639,dyspnoea,0,1
204640,but,0,0
204641,tended,0,0
204642,to,0,0
204643,undergo,0,1
204644,less,0,0
204645,psychodynamic,0,0
204646,change,0,0
204647,;,0,1
204648,psychiatric,0,1
204649,symptoms,0,1
204650,were,0,1
204651,reduced,0,0
204652,in,0,0
204653,those,0,1
204654,receiving,0,1
204655,supportive,0,0
204656,",",0,0
204657,but,0,0
204658,not,0,0
204659,analytical,0,0
204660,",",0,0
204661,psychotherapy,0,1
204662,.,0,1
204663,The,0,0
204664,psychosomatic,0,1
204665,mechanisms,0,0
204666,involved,0,1
204667,and,0,1
204668,the,0,0
204669,implications,0,0
204670,for,0,1
204671,medical,0,1
204672,and,0,1
204673,nursing,0,1
204674,practice,0,0
204675,and,0,1
204676,for,0,0
204677,liaison,0,1
204678,psychotherapy,0,1
204679,are,0,0
204680,discussed,0,0
204681,.,0,1
204682,Postoperative,0,1
204683,dreaming,0,1
204684,.,0,1
204685,A,0,0
204686,comparison,0,0
204687,of,0,0
204688,the,0,0
204689,incidence,0,0
204690,following,0,0
204691,pentazocine,0,0
204692,and,0,1
204693,morphine,0,0
204694,premedication,0,1
204695,.,0,1
204696,The,0,0
204697,incidence,0,0
204698,of,0,0
204699,postoperative,0,0
204700,dreaming,0,1
204701,following,0,0
204702,the,0,0
204703,use,0,0
204704,of,0,0
204705,morphine,0,0
204706,and,0,0
204707,pentazocine,0,0
204708,as,0,0
204709,premedicants,0,1
204710,in,0,1
204711,an,0,1
204712,otherwise,0,1
204713,standard,0,0
204714,anaesthetic,0,0
204715,sequence,0,0
204716,is,0,0
204717,compared,0,0
204718,in,0,0
204719,healthy,1,1
204720,volunteers,1,1
204721,.,1,1
204722,No,0,0
204723,statistically,0,0
204724,significant,0,0
204725,difference,0,0
204726,was,0,0
204727,demonstrated,0,0
204728,between,0,0
204729,the,0,1
204730,two,0,1
204731,drugs,0,0
204732,.,0,1
204733,The,0,0
204734,causes,0,0
204735,of,0,1
204736,psychotomimetic,0,1
204737,problems,0,1
204738,in,0,1
204739,the,0,1
204740,postoperative,0,0
204741,period,0,0
204742,and,0,0
204743,the,0,0
204744,difficulty,0,0
204745,of,0,0
204746,precise,0,0
204747,definition,0,1
204748,of,0,0
204749,hallucinations,0,0
204750,are,0,0
204751,discussed,0,0
204752,.,0,1
204753,Adriamycin,0,1
204754,and,0,0
204755,chlorambucil,0,1
204756,versus,0,0
204757,adriamycin,0,0
204758,and,0,0
204759,thiabendazole,0,0
204760,in,0,0
204761,the,0,0
204762,treatment,0,0
204763,of,0,0
204764,extensive,1,1
204765,",",1,1
204766,non-small,1,1
204767,cell,1,1
204768,carcinoma,1,1
204769,of,1,0
204770,the,1,0
204771,lung,1,1
204772,:,1,1
204773,a,1,1
204774,Southwest,1,1
204775,Oncology,1,1
204776,Group,1,1
204777,pilot,0,1
204778,study,0,1
204779,.,0,1
204780,EORTC,0,0
204781,protocols,0,0
204782,in,0,0
204783,prostatic,1,1
204784,cancer,1,1
204785,.,1,1
204786,An,0,0
204787,interim,0,0
204788,report,0,0
204789,.,0,1
204790,Two,0,1
204791,parallel,0,0
204792,prospective,0,1
204793,randomized,0,1
204794,studies,0,0
204795,have,0,1
204796,been,0,0
204797,undertaken,0,0
204798,by,0,0
204799,the,0,0
204800,EORTC,0,1
204801,Urological,0,0
204802,Group,0,1
204803,in,0,0
204804,previously,1,1
204805,untreated,1,1
204806,patients,1,1
204807,with,1,1
204808,prostatic,1,1
204809,cancer,1,1
204810,in,0,0
204811,order,0,0
204812,to,0,0
204813,compare,0,0
204814,low,0,1
204815,dose,0,0
204816,Stilboestrol,0,1
204817,versus,0,0
204818,Cyproterone,0,0
204819,acetate,0,0
204820,versus,0,0
204821,Medroxyprogesterone,0,0
204822,acetate,0,0
204823,in,0,0
204824,the,0,0
204825,first,0,0
204826,trial,0,0
204827,",",0,0
204828,and,0,0
204829,Stilboestrol,0,1
204830,versus,0,0
204831,Estracyt,0,1
204832,in,0,0
204833,the,0,0
204834,second,0,1
204835,trial,0,0
204836,.,0,1
204837,Although,0,0
204838,the,0,0
204839,follow,0,0
204840,up,0,0
204841,is,0,0
204842,still,0,0
204843,short,0,0
204844,",",0,0
204845,no,0,0
204846,superiority,0,0
204847,of,0,0
204848,the,0,0
204849,other,0,0
204850,drugs,0,0
204851,over,0,1
204852,Stilboestrol,0,1
204853,had,0,1
204854,appeared,0,0
204855,so,0,0
204856,far,0,1
204857,with,0,1
204858,regard,0,0
204859,to,0,1
204860,either,0,1
204861,objective,0,0
204862,response,0,0
204863,or,0,1
204864,significant,0,0
204865,side,0,0
204866,effects,0,0
204867,apart,0,1
204868,from,0,1
204869,gynaecomastia,0,1
204870,.,0,1
204871,In,0,0
204872,the,0,0
204873,third,0,1
204874,trial,0,0
204875,",",0,1
204876,patients,1,1
204877,with,1,1
204878,advanced,1,1
204879,disease,1,1
204880,no,1,0
204881,longer,1,0
204882,responsive,1,0
204883,to,1,0
204884,hormonal,1,0
204885,treatment,1,0
204886,were,0,1
204887,randomized,0,1
204888,to,0,0
204889,either,0,1
204890,Adriamycin,0,1
204891,or,0,1
204892,Procarbazine,0,1
204893,.,0,1
204894,Toxicity,0,0
204895,and,0,0
204896,early,0,1
204897,death,0,0
204898,were,0,1
204899,particularly,0,0
204900,frequent,0,0
204901,in,0,0
204902,Procarbazine,1,1
204903,treated,1,1
204904,patients,1,1
204905,",",0,1
204906,whereas,0,0
204907,most,0,1
204908,patients,0,1
204909,progressed,0,1
204910,in,0,0
204911,both,0,0
204912,treatment,0,1
204913,groups,0,0
204914,.,0,1
204915,Carbenicillin-trimethoprim/sulfamethoxazole,0,1
204916,versus,0,0
204917,carbenicillin-gentamicin,0,0
204918,as,0,0
204919,empiric,0,0
204920,therapy,0,1
204921,of,0,0
204922,infection,0,1
204923,in,0,1
204924,granulocytopenic,1,1
204925,patients,1,1
204926,.,1,1
204927,A,0,0
204928,prospective,0,0
204929,",",0,0
204930,randomized,0,1
204931,",",0,0
204932,double-blind,0,0
204933,study,0,1
204934,.,0,1
204935,The,0,0
204936,results,0,0
204937,of,0,0
204938,therapy,0,1
204939,with,0,1
204940,carbenicillin,0,0
204941,plus,0,0
204942,trimethoprim-sulfamethoxazole,0,1
204943,(,0,1
204944,C-T/S,0,1
204945,),0,1
204946,were,0,1
204947,compared,0,0
204948,to,0,0
204949,those,0,0
204950,obtained,0,0
204951,with,0,1
204952,carbenicillin,0,0
204953,plus,0,0
204954,gentamicin,0,0
204955,(,0,1
204956,C-G,0,0
204957,),0,1
204958,in,0,0
204959,a,0,1
204960,prospective,0,1
204961,double-blind,0,0
204962,study,0,1
204963,of,0,0
204964,empiric,0,0
204965,antibiotic,0,0
204966,therapy,0,1
204967,in,0,1
204968,granulocytopenic,1,1
204969,patients,1,1
204970,.,1,1
204971,Patients,1,1
204972,were,1,0
204973,stratified,1,1
204974,into,1,1
204975,two,1,1
204976,groups,1,1
204977,:,1,1
204978,favorable-prognosis,1,1
204979,",",1,0
204980,group,1,1
204981,1,1,0
204982,(,1,1
204983,carcinoma,1,1
204984,",",1,0
204985,lymphoma,1,1
204986,",",1,0
204987,multiple,1,1
204988,myeloma,1,1
204989,),1,1
204990,",",1,0
204991,or,1,1
204992,unfavorable-prognosis,1,0
204993,",",1,0
204994,group,1,1
204995,2,1,1
204996,(,1,1
204997,acute,1,1
204998,leukemia,1,1
204999,",",1,0
205000,bone,1,0
205001,marrow,1,1
205002,transplantation,1,1
205003,),1,0
205004,",",1,0
205005,based,1,1
205006,on,1,0
205007,anticipated,1,0
205008,duration,1,0
205009,of,1,0
205010,granulocytopenia,1,0
205011,.,1,1
205012,Over-all,0,0
205013,",",0,0
205014,empiric,0,0
205015,antibiotic,0,0
205016,trials,0,0
205017,were,0,0
205018,more,0,0
205019,often,0,0
205020,successful,0,0
205021,(,0,1
205022,P,0,0
205023,=,0,1
205024,0.004,0,0
205025,),0,1
205026,in,0,1
205027,group,0,1
205028,1,0,1
205029,(,0,1
205030,55,0,1
205031,of,0,1
205032,62,0,1
205033,patients,0,1
205034,or,0,1
205035,89,0,1
205036,per,0,1
205037,cent,0,1
205038,),0,1
205039,than,0,0
205040,in,0,1
205041,group,0,1
205042,2,0,1
205043,(,0,1
205044,42,0,1
205045,of,0,1
205046,64,0,1
205047,patients,0,1
205048,",",0,1
205049,66,0,1
205050,per,0,1
205051,cent,0,1
205052,),0,1
205053,mwithin,0,1
205054,group,0,1
205055,1,0,0
205056,",",0,0
205057,there,0,0
205058,was,0,0
205059,a,0,0
205060,favorable,0,0
205061,outcome,0,0
205062,in,0,1
205063,30,0,1
205064,of,0,1
205065,32,0,1
205066,(,0,1
205067,94,0,1
205068,per,0,1
205069,cent,0,1
205070,),0,1
205071,C-T/S,0,1
205072,trials,0,0
205073,and,0,1
205074,in,0,1
205075,25,0,1
205076,of,0,1
205077,30,0,1
205078,(,0,1
205079,83,0,1
205080,per,0,1
205081,cent,0,1
205082,),0,1
205083,C-G,0,1
205084,trials,0,1
205085,(,0,1
205086,P,0,0
205087,=,0,1
205088,0.25,0,0
205089,),0,1
205090,;,0,1
205091,within,0,1
205092,group,0,1
205093,2,0,0
205094,",",0,0
205095,there,0,0
205096,was,0,0
205097,a,0,0
205098,favorable,0,0
205099,outcome,0,0
205100,in,0,1
205101,23,0,1
205102,of,0,1
205103,30,0,1
205104,(,0,1
205105,77,0,1
205106,per,0,1
205107,cent,0,1
205108,),0,1
205109,C-T/S,0,1
205110,trials,0,0
205111,and,0,1
205112,in,0,1
205113,19,0,1
205114,of,0,1
205115,34,0,1
205116,(,0,1
205117,56,0,1
205118,per,0,1
205119,cent,0,1
205120,),0,1
205121,C-G,0,1
205122,trials,0,1
205123,(,0,1
205124,P,0,0
205125,=,0,1
205126,0.14,0,0
205127,),0,1
205128,",",0,1
205129,Combined,0,0
205130,results,0,0
205131,in,0,1
205132,both,0,0
205133,groups,0,0
205134,indicated,0,0
205135,a,0,1
205136,higher,0,0
205137,proportion,0,0
205138,of,0,0
205139,favorable,0,0
205140,outcome,0,0
205141,in,0,1
205142,C-T/S,0,1
205143,trials,0,1
205144,(,0,1
205145,53,0,1
205146,of,0,1
205147,62,0,1
205148,",",0,1
205149,85,0,1
205150,per,0,1
205151,cent,0,1
205152,),0,1
205153,than,0,0
205154,in,0,1
205155,C-G,0,1
205156,trials,0,1
205157,(,0,1
205158,44,0,1
205159,of,0,1
205160,64,0,1
205161,",",0,1
205162,69,0,1
205163,per,0,1
205164,cent,0,1
205165,),0,1
205166,.,0,1
205167,Further,0,0
205168,analysis,0,0
205169,(,0,1
205170,Manetl-Naenszel,0,0
205171,test,0,0
205172,),0,1
205173,showed,0,0
205174,the,0,0
205175,over-all,0,0
205176,difference,0,0
205177,in,0,0
205178,outcome,0,0
205179,to,0,0
205180,be,0,0
205181,significant,0,0
205182,(,0,1
205183,P,0,0
205184,=,0,1
205185,0.049,0,0
205186,),0,1
205187,",",0,0
205188,but,0,0
205189,the,0,0
205190,general,0,1
205191,applicability,0,0
205192,of,0,0
205193,this,0,0
205194,result,0,0
205195,may,0,0
205196,be,0,0
205197,limited,0,0
205198,by,0,0
205199,the,0,0
205200,rather,0,0
205201,low,0,0
205202,incidence,0,0
205203,of,0,0
205204,gram-negative,0,1
205205,bacterial,0,0
205206,infections,0,1
205207,in,0,1
205208,this,0,0
205209,study,0,0
205210,.,0,0
205211,There,0,0
205212,was,0,0
205213,no,0,0
205214,difference,0,0
205215,between,0,0
205216,the,0,0
205217,treatment,0,0
205218,regimens,0,0
205219,in,0,0
205220,antibiotic,0,0
205221,toxicity,0,0
205222,",",0,0
205223,and,0,0
205224,serious,0,0
205225,superinfection,0,0
205226,occurred,0,0
205227,only,0,0
205228,in,0,0
205229,group,0,1
205230,2,0,1
205231,patients,0,1
205232,(,0,1
205233,21,0,1
205234,per,0,1
205235,cent,0,1
205236,of,0,1
205237,trials,0,1
205238,),0,1
205239,",",0,0
205240,equally,0,0
205241,divided,0,0
205242,between,0,0
205243,treatment,0,1
205244,arms,0,1
205245,.,0,1
205246,Initial,0,0
205247,protocol,0,0
205248,dosing,0,0
205249,achieved,0,0
205250,target,0,1
205251,plasma,0,0
205252,levels,0,0
205253,of,0,1
205254,trimethoprim,0,1
205255,(,0,1
205256,3,0,1
205257,to,0,1
205258,8,0,1
205259,micrograms/ml,0,0
205260,),0,1
205261,or,0,1
205262,gentamicin,0,0
205263,(,0,1
205264,4,0,0
205265,to,0,1
205266,10,0,1
205267,micrograms/ml,0,0
205268,),0,1
205269,in,0,0
205270,57,0,1
205271,of,0,1
205272,68,0,1
205273,(,0,1
205274,84,0,1
205275,per,0,1
205276,cent,0,1
205277,),0,1
205278,C-T/S,0,1
205279,trials,0,1
205280,compared,0,0
205281,to,0,1
205282,21,0,1
205283,of,0,1
205284,60,0,1
205285,(,0,1
205286,35,0,1
205287,per,0,1
205288,cent,0,1
205289,),0,1
205290,C-G,0,1
205291,trials,0,1
205292,.,0,1
205293,[,1,0
205294,Median,1,1
205295,and,1,1
205296,mediolateral,1,0
205297,episiotomy,1,1
205298,],1,1
205299,.,1,1
205300,Report,0,1
205301,on,0,0
205302,the,0,0
205303,second,0,1
205304,myelomatosis,0,1
205305,trial,0,1
205306,after,0,1
205307,five,0,1
205308,years,0,1
205309,of,0,1
205310,follow-up,0,1
205311,.,0,1
205312,Medical,0,0
205313,Research,0,1
205314,Council,0,1
205315,'s,0,1
205316,Working,0,1
205317,Party,0,1
205318,on,0,0
205319,Leukaemia,1,1
205320,in,1,1
205321,Adults,1,1
205322,.,1,1
205323,Three,1,1
205324,hundred,1,1
205325,and,1,1
205326,seventy-two,1,1
205327,patients,1,1
205328,were,0,1
205329,randomized,0,1
205330,between,0,0
205331,3,0,1
205332,regimens,0,0
205333,of,0,1
205334,chemotherapy,0,1
205335,:,0,1
205336,cyclophosphamide,0,1
205337,",",0,0
205338,intermittent,0,0
205339,melphalan,0,1
205340,",",0,0
205341,and,0,0
205342,melphalan,0,1
205343,with,0,1
205344,prednisone,0,1
205345,",",0,0
205346,and,0,0
205347,were,0,0
205348,followed,0,0
205349,up,0,1
205350,to,0,0
205351,death,0,0
205352,or,0,1
205353,for,0,0
205354,at,0,1
205355,least,0,1
205356,5,0,1
205357,years,0,1
205358,.,0,1
205359,There,0,0
205360,was,0,0
205361,no,0,0
205362,difference,0,0
205363,in,0,0
205364,survival,0,0
205365,between,0,0
205366,the,0,0
205367,treatments,0,0
205368,",",0,0
205369,either,0,1
205370,overall,0,0
205371,or,0,1
205372,in,0,0
205373,any,0,0
205374,subgroup,0,1
205375,of,0,0
205376,patients,0,1
205377,.,0,1
205378,Therefore,0,0
205379,",",0,0
205380,the,0,0
205381,choice,0,0
205382,among,0,0
205383,these,0,0
205384,3,0,0
205385,treatments,0,0
205386,should,0,0
205387,be,0,0
205388,guided,0,0
205389,by,0,0
205390,the,0,0
205391,patient,0,1
205392,'s,0,1
205393,comfort,0,0
205394,and,0,1
205395,convenience,0,1
205396,.,0,1
205397,The,0,0
205398,most,0,0
205399,important,0,0
205400,prognostic,0,0
205401,feature,0,1
205402,at,0,1
205403,presentation,0,1
205404,was,0,0
205405,the,0,0
205406,quality,0,0
205407,of,0,0
205408,renal,0,1
205409,function,0,0
205410,.,0,1
205411,It,0,0
205412,was,0,0
205413,possible,0,0
205414,to,0,0
205415,define,0,0
205416,good,1,0
205417,",",1,0
205418,intermediate,1,1
205419,and,1,0
205420,poor,1,1
205421,renal-function,1,1
205422,groups,1,1
205423,which,0,0
205424,were,0,1
205425,highly,0,0
205426,correlated,0,0
205427,with,0,1
205428,prognosis,0,0
205429,(,0,1
205430,X2,0,1
205431,for,0,1
205432,trend,0,0
205433,=,0,1
205434,62.6,0,1
205435,),0,1
205436,.,0,1
205437,The,0,0
205438,haemoglobin,0,0
205439,level,0,0
205440,at,0,1
205441,presentation,0,1
205442,was,0,0
205443,strongly,0,0
205444,correlated,0,0
205445,with,0,1
205446,prognosis,0,0
205447,among,0,1
205448,patients,1,1
205449,in,1,1
205450,the,1,1
205451,good,1,0
205452,renal-function,1,0
205453,group,1,1
205454,.,1,1
205455,Among,0,1
205456,107,1,1
205457,patients,1,1
205458,who,1,1
205459,presented,1,1
205460,with,1,1
205461,good,1,0
205462,renal,1,1
205463,function,1,0
205464,and,1,1
205465,with,1,1
205466,haemoglobin,1,1
205467,above,1,1
205468,100,1,1
205469,g/l,1,0
205470,",",0,0
205471,the,0,0
205472,5-year,0,1
205473,survival,0,0
205474,was,0,0
205475,43,0,1
205476,%,0,0
205477,.,0,1
205478,Other,0,0
205479,prognostic,0,0
205480,features,0,1
205481,were,0,0
205482,much,0,0
205483,less,0,0
205484,important,0,0
205485,when,0,0
205486,account,0,0
205487,was,0,0
205488,taken,0,0
205489,of,0,0
205490,renal,0,1
205491,function,0,0
205492,and,0,1
205493,haemoglobin,0,1
205494,level,0,0
205495,.,0,1
205496,Clinical,0,0
205497,evaluation,0,0
205498,of,0,0
205499,the,0,0
205500,antihypertensive,0,0
205501,effect,0,0
205502,of,0,0
205503,metoprolol,0,0
205504,in,0,0
205505,combination,0,0
205506,with,0,1
205507,hydrochlorothiazide,0,0
205508,and,0,0
205509,hydralazine,0,0
205510,in,0,0
205511,an,0,1
205512,unselected,1,1
205513,hypertensive,1,1
205514,population,1,1
205515,.,1,1
205516,One,1,1
205517,hundred,1,1
205518,nineteen,1,1
205519,patients,1,1
205520,with,1,1
205521,essential,1,1
205522,hypertension,1,1
205523,(,1,1
205524,96,1,1
205525,completing,1,1
205526,six,1,1
205527,months,1,1
205528,and,1,1
205529,92,1,1
205530,a,1,1
205531,one,1,1
205532,year,1,1
205533,study,1,1
205534,period,1,1
205535,),1,1
205536,were,0,0
205537,randomized,0,1
205538,into,0,1
205539,four,0,1
205540,parallel,0,0
205541,groups,0,1
205542,and,0,1
205543,treated,0,1
205544,with,0,1
205545,one,0,1
205546,of,0,1
205547,four,0,1
205548,programs,0,1
205549,:,0,1
205550,200,0,1
205551,mg,0,0
205552,of,0,1
205553,metoprolol,0,0
205554,plus,0,0
205555,placebo,0,1
205556,;,0,1
205557,200,0,1
205558,mg,0,0
205559,of,0,0
205560,metoprolol,0,0
205561,plus,0,0
205562,25,0,1
205563,mg,0,0
205564,of,0,1
205565,hydrochlorothiazide,0,0
205566,;,0,1
205567,200,0,1
205568,mg,0,0
205569,of,0,0
205570,metoprolol,0,0
205571,plus,0,0
205572,50,0,1
205573,mg,0,0
205574,hydrochlorothiazide,0,0
205575,",",0,0
205576,or,0,1
205577,;,0,1
205578,200,0,1
205579,mg,0,0
205580,metoprolol,0,0
205581,plus,0,0
205582,50,0,1
205583,mg,0,0
205584,of,0,0
205585,hydralazine,0,1
205586,.,0,1
205587,Blood,0,0
205588,pressure,0,0
205589,reduction,0,0
205590,was,0,0
205591,significant,0,0
205592,in,0,0
205593,these,0,0
205594,all,1,0
205595,groups,1,0
205596,and,0,1
205597,no,0,1
205598,differences,0,0
205599,were,0,1
205600,observed,0,0
205601,in,0,0
205602,blood,0,0
205603,pressure,0,0
205604,reduction,0,0
205605,among,0,1
205606,the,0,0
205607,groups,0,0
205608,.,0,1
205609,During,0,0
205610,the,0,0
205611,one,0,1
205612,year,0,0
205613,therapy,0,0
205614,the,0,0
205615,levels,0,0
205616,of,0,0
205617,serum,0,0
205618,bilirubin,0,0
205619,",",0,0
205620,uric,0,0
205621,acid,0,0
205622,and,0,1
205623,triglycerides,0,0
205624,were,0,1
205625,significantly,0,0
205626,increased,0,0
205627,in,0,0
205628,all,0,1
205629,groups,0,0
205630,but,0,0
205631,the,0,0
205632,group,0,0
205633,treated,0,1
205634,with,0,1
205635,metoprolol,0,0
205636,and,0,1
205637,hydralazine,0,1
205638,.,0,1
205639,Serum,0,0
205640,cholesterol,0,0
205641,level,0,0
205642,did,0,0
205643,not,0,0
205644,increase,0,0
205645,in,0,0
205646,any,0,0
205647,group,0,0
205648,during,0,0
205649,the,0,0
205650,one,0,1
205651,year,0,1
205652,therapy,0,0
205653,.,0,1
205654,The,0,0
205655,results,0,0
205656,indicate,0,0
205657,that,0,0
205658,the,0,0
205659,combination,0,0
205660,therapy,0,0
205661,in,0,0
205662,mild,0,1
205663,to,0,0
205664,moderate,0,1
205665,hypertension,0,1
205666,should,0,0
205667,not,0,0
205668,be,0,0
205669,initiated,0,0
205670,before,0,0
205671,individual,0,0
205672,response,0,0
205673,to,0,1
205674,single,0,0
205675,drug,0,0
205676,therapy,0,0
205677,is,0,0
205678,evaluated,0,0
205679,.,0,0
205680,Antihypertensive,0,1
205681,drug,0,0
205682,treatment,0,0
205683,may,0,0
205684,cause,0,0
205685,some,0,0
205686,biochemical,0,0
205687,changes,0,0
205688,and,0,1
205689,those,0,1
205690,changes,0,0
205691,seem,0,0
205692,to,0,0
205693,be,0,0
205694,smallest,1,0
205695,patients,1,1
205696,treated,0,1
205697,with,0,1
205698,combination,0,0
205699,of,0,0
205700,beta-blocker,0,0
205701,and,0,1
205702,hydralazine,0,1
205703,.,0,1
205704,[,0,0
205705,Prevention,0,1
205706,of,0,1
205707,stress,1,0
205708,ulcers,1,1
205709,with,0,1
205710,synthetic,0,1
205711,depot,0,0
205712,secretin,0,0
205713,],0,1
205714,.,0,1
205715,The,0,0
205716,pathogenesis,0,0
205717,of,0,0
205718,stress,1,0
205719,ulcers,1,1
205720,is,0,0
205721,still,0,0
205722,far,0,0
205723,from,0,0
205724,being,0,1
205725,understood,0,0
205726,.,0,1
205727,It,0,0
205728,is,0,0
205729,reported,0,0
205730,about,0,0
205731,a,0,1
205732,synthetic,0,0
205733,secretin,0,0
205734,(,0,1
205735,Hoe,0,1
205736,069,0,1
205737,+,0,0
205738,depot,0,0
205739,component,0,0
205740,),0,0
205741,given,0,0
205742,prophylactically,0,1
205743,to,0,1
205744,100,1,1
205745,patients,1,1
205746,postoperatively,1,0
205747,.,1,1
205748,It,0,0
205749,eliminated,0,0
205750,or,0,1
205751,ameliorated,0,0
205752,stress,0,1
205753,ulcers,0,1
205754,.,0,1
205755,The,0,0
205756,result,0,0
205757,",",0,0
205758,confirmed,0,0
205759,by,0,0
205760,gastroscopy,0,1
205761,",",0,0
205762,demonstrates,0,0
205763,the,0,0
205764,treatment,0,0
205765,with,0,1
205766,secretin,0,0
205767,plus,0,0
205768,depot,0,0
205769,component,0,0
205770,as,0,0
205771,a,0,0
205772,highly,0,0
205773,recommendable,0,0
205774,prophylaxis,0,1
205775,in,0,0
205776,the,0,0
205777,postsurgical,0,1
205778,intensive,0,1
205779,care,0,1
205780,treatment,0,1
205781,.,0,1
205782,Bacteremia,0,1
205783,due,0,1
205784,to,0,1
205785,Bacteroides,0,1
205786,fragilis,0,1
205787,after,0,0
205788,elective,1,1
205789,appendectomy,1,1
205790,in,1,1
205791,renal,1,1
205792,transplant,1,1
205793,recipients,1,1
205794,.,1,1
205795,Bacteremia,0,0
205796,caused,0,0
205797,by,0,0
205798,Bacteroides,0,1
205799,fragilis,0,1
205800,occurred,0,0
205801,in,0,0
205802,four,1,1
205803,of,1,1
205804,75,1,1
205805,children,1,1
205806,after,1,1
205807,renal,1,1
205808,transplantation,1,1
205809,",",0,0
205810,and,0,0
205811,B.,0,1
205812,fragilis,0,1
205813,was,0,0
205814,the,0,0
205815,most,0,0
205816,common,0,0
205817,cause,0,0
205818,of,0,0
205819,postoperative,0,1
205820,bacteremia,0,1
205821,.,0,1
205822,Bacteroides,0,0
205823,bacteremia,0,1
205824,was,0,0
205825,significantly,0,0
205826,associated,0,0
205827,with,0,1
205828,performance,0,0
205829,of,0,0
205830,elective,0,1
205831,appendectomy,0,1
205832,at,0,0
205833,the,0,0
205834,time,0,0
205835,of,0,0
205836,transplantation,0,1
205837,(,0,1
205838,P,0,0
205839,less,0,0
205840,than,0,0
205841,0.01,0,0
205842,),0,1
205843,and,0,1
205844,with,0,1
205845,profound,0,1
205846,lymphocytopenia,0,1
205847,(,0,1
205848,P,0,0
205849,=,0,1
205850,0.01,0,0
205851,),0,1
205852,.,0,1
205853,No,0,0
205854,patient,0,0
205855,received,0,0
205856,antibiotics,0,0
205857,at,0,1
205858,the,0,0
205859,time,0,0
205860,of,0,0
205861,surgery,0,1
205862,or,0,1
205863,prior,0,1
205864,to,0,0
205865,the,0,0
205866,first,0,0
205867,positive,0,1
205868,blood,0,0
205869,culture,0,0
205870,",",0,0
205871,yet,0,0
205872,B.,0,1
205873,fragilis,0,1
205874,was,0,0
205875,the,0,0
205876,single,0,0
205877,organism,0,0
205878,isolated,0,1
205879,from,0,1
205880,blood,0,0
205881,and,0,1
205882,abscesses,0,1
205883,in,0,1
205884,these,0,1
205885,patients,0,1
205886,.,0,1
205887,A,0,0
205888,role,0,0
205889,for,0,0
205890,lymphocytes,0,0
205891,in,0,1
205892,containment,0,1
205893,of,0,0
205894,B.,0,1
205895,fragilis,0,1
205896,has,0,0
205897,not,0,0
205898,been,0,0
205899,suggested,0,0
205900,previously,0,1
205901,",",0,0
205902,although,0,0
205903,unexplained,0,1
205904,occurrence,0,0
205905,of,0,0
205906,bacteroides,0,0
205907,bacteremia,0,1
205908,in,0,1
205909,immunocompromised,1,1
205910,patients,1,1
205911,has,0,0
205912,occasionally,0,0
205913,been,0,0
205914,reported,0,0
205915,.,0,1
205916,Lymphocytes,0,0
205917,themselves,0,0
205918,may,0,0
205919,be,0,0
205920,important,0,0
205921,in,0,0
205922,this,0,0
205923,host-bacterium,0,0
205924,interaction,0,0
205925,",",0,0
205926,or,0,0
205927,lymphocytopenia,0,0
205928,may,0,0
205929,be,0,0
205930,the,0,0
205931,marker,0,0
205932,for,0,0
205933,a,0,0
205934,more,0,0
205935,generalized,0,0
205936,deficiency,0,0
205937,in,0,1
205938,host,0,1
205939,defenses,0,1
205940,.,0,1
205941,Lidocaine,0,1
205942,and,0,1
205943,bupivacaine,0,0
205944,mixtures,0,0
205945,for,0,1
205946,epidural,0,1
205947,blockade,0,0
205948,.,0,1
205949,In,0,0
205950,a,0,0
205951,prospective,0,1
205952,double-blind,0,0
205953,clinical,0,0
205954,study,0,1
205955,",",0,0
205956,single-dose,0,0
205957,lumbar,0,1
205958,epidural,0,1
205959,blockade,0,0
205960,was,0,0
205961,instituted,0,1
205962,in,0,1
205963,60,1,1
205964,healthy,1,1
205965,patients,1,1
205966,undergoing,1,1
205967,lower,1,0
205968,abdominal,1,1
205969,surgery,1,1
205970,.,1,1
205971,Patients,0,1
205972,were,0,0
205973,randomly,0,1
205974,assigned,0,1
205975,to,0,0
205976,one,0,1
205977,of,0,1
205978,five,0,1
205979,groups,0,1
205980,.,0,1
205981,Each,0,0
205982,group,0,0
205983,received,0,0
205984,treatment,0,0
205985,with,0,1
205986,a,0,1
205987,different,0,0
205988,local,0,0
205989,anesthetic,0,1
205990,solution,0,0
205991,containing,0,0
205992,"1:200,000",0,1
205993,epinephrine,0,0
205994,.,0,1
205995,Local,0,1
205996,anesthetic,0,0
205997,solutions,0,0
205998,used,0,0
205999,were,0,1
206000,0.5,0,0
206001,per,0,1
206002,cent,0,1
206003,bupivacaine,0,0
206004,HCl,0,0
206005,",",0,0
206006,2,0,0
206007,per,0,0
206008,cent,0,1
206009,lidocaine,0,0
206010,HCl,0,0
206011,",",0,0
206012,and,0,0
206013,lidocaine-bupivacaine,0,0
206014,mixtures,0,0
206015,in,0,1
206016,the,0,1
206017,ratios,0,0
206018,of,0,0
206019,1:3,0,1
206020,",",0,1
206021,1:1,0,1
206022,or,0,1
206023,3:1,0,1
206024,by,0,0
206025,volume,0,1
206026,.,0,1
206027,Onset,0,0
206028,and,0,0
206029,complete,0,1
206030,spread,0,0
206031,of,0,0
206032,sensory,0,1
206033,blockade,0,0
206034,were,0,1
206035,similar,0,0
206036,in,0,0
206037,all,0,1
206038,five,0,1
206039,groups,0,1
206040,.,0,1
206041,Time,0,0
206042,to,0,0
206043,regression,0,0
206044,to,0,1
206045,two,0,0
206046,segments,0,1
206047,of,0,1
206048,partial,0,1
206049,and,0,1
206050,complete,0,1
206051,sensory,0,1
206052,blockade,0,0
206053,was,0,0
206054,positively,0,0
206055,correlated,0,0
206056,(,0,0
206057,P,0,0
206058,less,0,0
206059,than,0,0
206060,0.05,0,0
206061,),0,1
206062,with,0,1
206063,increasing,0,0
206064,dose,0,0
206065,of,0,0
206066,bupivacaine,0,0
206067,in,0,1
206068,the,0,0
206069,solutions,0,0
206070,and,0,0
206071,ranged,0,1
206072,from,0,1
206073,84,0,1
206074,min,0,0
206075,(,0,1
206076,partial,0,1
206077,),0,1
206078,and,0,1
206079,70,0,1
206080,min,0,0
206081,(,0,1
206082,complete,0,1
206083,),0,1
206084,for,0,0
206085,lidocaine,0,0
206086,",",0,1
206087,to,0,0
206088,128,0,1
206089,min,0,0
206090,(,0,1
206091,partial,0,1
206092,),0,1
206093,and,0,1
206094,101,0,1
206095,min,0,0
206096,(,0,1
206097,complete,0,1
206098,),0,1
206099,for,0,1
206100,bupivacaine,0,0
206101,.,0,1
206102,Using,0,0
206103,skin,0,1
206104,temperature,0,1
206105,as,0,0
206106,a,0,0
206107,criterion,0,1
206108,of,0,0
206109,sympathetic,0,0
206110,blockade,0,0
206111,",",0,0
206112,all,0,0
206113,three,0,0
206114,mixtures,0,0
206115,demonstrated,0,0
206116,a,0,1
206117,duration,0,0
206118,of,0,0
206119,action,0,0
206120,intermediate,0,1
206121,between,0,0
206122,the,0,0
206123,two,0,0
206124,single,0,0
206125,drugs,0,0
206126,",",0,1
206127,lidocaine,0,0
206128,(,0,1
206129,124,0,1
206130,+/-,0,1
206131,13,0,1
206132,min,0,0
206133,),0,1
206134,and,0,0
206135,bupivacaine,0,0
206136,(,0,1
206137,286,0,1
206138,+/-,0,1
206139,32,0,1
206140,min,0,0
206141,),0,1
206142,.,0,1
206143,Onset,0,0
206144,of,0,0
206145,complete,0,1
206146,motor,0,0
206147,blockade,0,0
206148,was,0,0
206149,fastest,0,0
206150,and,0,0
206151,the,0,0
206152,degree,0,0
206153,of,0,0
206154,motor,0,0
206155,blockade,0,0
206156,was,0,0
206157,most,0,0
206158,profound,0,1
206159,with,0,1
206160,the,0,0
206161,mixture,0,0
206162,containing,0,0
206163,equal,0,1
206164,proportions,0,0
206165,of,0,1
206166,lidocaine,0,0
206167,and,0,1
206168,bupivacaine,0,0
206169,.,0,1
206170,Pharmacokinetics,0,0
206171,of,0,1
206172,individual,0,0
206173,drugs,0,0
206174,were,0,1
206175,unaltered,0,0
206176,in,0,0
206177,any,0,0
206178,of,0,0
206179,the,0,0
206180,mixtures,0,0
206181,.,0,1
206182,Non-Hodgkin,0,1
206183,'s,0,1
206184,malignant,0,1
206185,lymphomas,0,1
206186,:,0,1
206187,treatment,0,0
206188,of,0,1
206189,localized,0,1
206190,relapses,0,1
206191,with,0,1
206192,chemo,0,1
206193,+,0,0
206194,radio,0,0
206195,+,0,0
206196,BCG-therapy,0,1
206197,.,0,1
206198,16,1,1
206199,patients,1,1
206200,with,1,1
206201,relapsing,1,1
206202,non-Hodgkin,1,1
206203,'s,1,1
206204,malignant,1,1
206205,lymphomas,1,1
206206,considered,1,0
206207,as,1,0
206208,clinical,1,0
206209,stage,1,1
206210,I,1,1
206211,or,1,1
206212,II,1,1
206213,were,0,1
206214,treated,0,1
206215,by,0,0
206216,an,0,0
206217,association,0,0
206218,of,0,0
206219,chemo,0,1
206220,+,0,0
206221,radiotherapy,0,1
206222,and,0,0
206223,thereafter,0,0
206224,by,0,0
206225,maintenance,0,0
206226,BCG,0,1
206227,therapy,0,1
206228,.,0,1
206229,5,1,0
206230,of,1,0
206231,them,1,1
206232,were,1,1
206233,included,1,1
206234,in,1,0
206235,a,1,1
206236,randomized,1,1
206237,trial,1,0
206238,and,0,0
206239,have,0,0
206240,a,0,0
206241,significantly,0,0
206242,different,0,0
206243,disease-free,0,0
206244,survival,0,0
206245,from,0,1
206246,patients,0,1
206247,receiving,0,1
206248,the,0,0
206249,same,0,0
206250,treatment,0,0
206251,but,0,0
206252,without,0,1
206253,BCG,0,1
206254,.,0,1
206255,11,1,0
206256,were,1,0
206257,systematically,1,0
206258,treated,1,1
206259,by,1,0
206260,BCG,1,1
206261,and,0,0
206262,they,0,0
206263,also,0,0
206264,have,0,0
206265,a,0,0
206266,fairly,0,0
206267,good,0,0
206268,disease-free,0,1
206269,survival,0,0
206270,.,0,1
206271,Such,0,0
206272,a,0,0
206273,treatment,0,0
206274,appears,0,0
206275,to,0,0
206276,be,0,0
206277,of,0,0
206278,value,0,0
206279,in,0,0
206280,treating,0,0
206281,these,0,0
206282,patients,0,1
206283,and,0,0
206284,even,0,0
206285,probably,0,0
206286,of,0,0
206287,curing,0,0
206288,some,0,0
206289,of,0,0
206290,them,0,1
206291,.,0,1
206292,[,0,0
206293,Comparative,0,0
206294,study,0,1
206295,of,0,0
206296,cinoxacin,0,1
206297,(,0,1
206298,Cinobac,0,1
206299,),0,0
206300,",",0,0
206301,nitrofurantoin,0,1
206302,(,0,1
206303,Furadantine,0,1
206304,MC,0,1
206305,),0,1
206306,and,0,1
206307,oxolinic,0,0
206308,acid,0,0
206309,(,0,1
206310,Uritrate,0,0
206311,),0,1
206312,in,0,0
206313,urinary,0,1
206314,tract,0,1
206315,infections,0,1
206316,.,0,1
206317,Results,0,0
206318,of,0,0
206319,a,0,1
206320,random,0,1
206321,study,0,0
206322,of,0,1
206323,three,1,1
206324,groups,1,1
206325,of,1,1
206326,30,1,1
206327,patients,1,1
206328,with,1,1
206329,uncomplicated,1,1
206330,urinary,1,1
206331,infections,1,1
206332,],1,1
206333,.,1,1
206334,Antibiotic,0,0
206335,therapy,0,1
206336,of,0,1
206337,acute,0,1
206338,exacerbations,0,1
206339,of,0,1
206340,chronic,0,1
206341,bronchitis,0,1
206342,.,0,1
206343,A,0,0
206344,controlled,0,0
206345,study,0,0
206346,using,0,0
206347,tetracycline,0,0
206348,.,0,1
206349,We,0,0
206350,conducted,0,0
206351,a,0,0
206352,double-blind,0,0
206353,",",0,0
206354,randomized,0,0
206355,",",0,0
206356,placebo-controlled,0,0
206357,trial,0,1
206358,in,0,1
206359,40,1,1
206360,patients,1,1
206361,to,1,1
206362,evaluate,1,0
206363,the,1,0
206364,need,1,0
206365,for,1,0
206366,antibiotics,1,0
206367,in,1,1
206368,acute,1,1
206369,exacerbations,1,1
206370,of,1,1
206371,chronic,1,1
206372,bronchitis,1,1
206373,.,1,1
206374,All,1,1
206375,patients,1,1
206376,were,1,1
206377,sufficiently,1,0
206378,ill,1,1
206379,to,1,0
206380,require,1,0
206381,hospitalization,1,1
206382,although,1,0
206383,none,1,1
206384,needed,1,1
206385,ventilatory,1,1
206386,support,1,0
206387,;,1,0
206388,the,1,0
206389,presence,1,0
206390,of,1,0
206391,pneumonia,1,1
206392,was,1,0
206393,excluded,1,1
206394,.,1,1
206395,Treatment,0,0
206396,consisted,0,1
206397,of,0,0
206398,bronchodilators,0,1
206399,",",0,1
206400,corticosteroids,0,0
206401,",",0,0
206402,and,0,0
206403,either,0,0
206404,tetracycline,0,0
206405,",",0,0
206406,500,0,0
206407,mg,0,0
206408,",",0,0
206409,or,0,0
206410,placebo,0,0
206411,by,0,0
206412,mouth,0,1
206413,every,0,0
206414,6,0,0
206415,hours,0,0
206416,for,0,1
206417,1,0,1
206418,week,0,0
206419,.,0,1
206420,Arterial,0,0
206421,blood,0,0
206422,gases,0,0
206423,",",0,1
206424,spirometric,0,1
206425,tests,0,0
206426,",",0,1
206427,bacteriologic,0,0
206428,evaluation,0,0
206429,of,0,0
206430,sputum,0,1
206431,",",0,0
206432,and,0,0
206433,patient,0,1
206434,and,0,0
206435,physician,0,1
206436,evaluation,0,0
206437,of,0,0
206438,the,0,0
206439,severity,0,0
206440,of,0,0
206441,illness,0,1
206442,were,0,1
206443,assessed,0,0
206444,at,0,0
206445,the,0,0
206446,beginning,0,0
206447,and,0,0
206448,end,0,0
206449,of,0,0
206450,the,0,0
206451,study,0,0
206452,.,0,1
206453,All,0,1
206454,patients,0,1
206455,improved,0,0
206456,both,0,0
206457,symptomatically,0,1
206458,and,0,0
206459,by,0,0
206460,objective,0,0
206461,measures,0,0
206462,of,0,1
206463,lung,0,1
206464,function,0,0
206465,.,0,1
206466,At,0,0
206467,the,0,0
206468,end,0,0
206469,of,0,0
206470,the,0,0
206471,study,0,0
206472,period,0,0
206473,there,0,0
206474,were,0,0
206475,no,0,0
206476,differences,0,0
206477,between,0,0
206478,those,0,1
206479,patients,0,1
206480,receiving,0,1
206481,tetracycline,0,0
206482,and,0,0
206483,those,0,0
206484,receiving,0,1
206485,placebo,0,0
206486,.,0,1
206487,We,0,0
206488,conclude,0,0
206489,that,0,0
206490,antibiotic,0,0
206491,therapy,0,0
206492,is,0,0
206493,not,0,0
206494,needed,0,0
206495,in,0,0
206496,moderately,1,1
206497,ill,1,1
206498,patients,1,1
206499,with,1,1
206500,exacerbations,1,1
206501,of,1,1
206502,chronic,1,1
206503,bronchitis,1,1
206504,.,1,1
206505,A,0,0
206506,comparison,0,0
206507,of,0,0
206508,dorsal,0,0
206509,and,0,1
206510,volar,0,1
206511,resting,0,0
206512,hand,0,1
206513,splints,0,1
206514,in,0,0
206515,the,0,0
206516,reduction,0,0
206517,of,0,0
206518,hypertonus,1,1
206519,.,1,1
206520,Ten,1,1
206521,adults,1,1
206522,with,1,1
206523,hypertonic,1,1
206524,wrist,1,1
206525,flexors,1,0
206526,volunteered,1,1
206527,as,1,0
206528,subjects,1,1
206529,in,0,1
206530,an,0,1
206531,experiment,0,0
206532,comparing,0,0
206533,the,0,0
206534,effectiveness,0,0
206535,of,0,0
206536,dorsal,0,0
206537,and,0,1
206538,volar,0,1
206539,resting,0,0
206540,hand,0,1
206541,splints,0,1
206542,in,0,0
206543,the,0,0
206544,reduction,0,0
206545,of,0,0
206546,abnormal,0,1
206547,muscle,0,1
206548,tone,0,0
206549,.,0,1
206550,Subjects,0,1
206551,were,0,0
206552,randomly,0,1
206553,assigned,0,1
206554,to,0,1
206555,two,0,0
206556,groups,0,1
206557,of,0,1
206558,five,0,1
206559,each,0,1
206560,.,0,1
206561,Individuals,0,0
206562,in,0,1
206563,one,0,1
206564,group,0,1
206565,were,0,1
206566,fitted,0,0
206567,with,0,1
206568,dorsal,0,1
206569,splints,0,1
206570,",",0,1
206571,and,0,1
206572,individuals,0,1
206573,in,0,1
206574,a,0,1
206575,second,0,0
206576,group,0,1
206577,with,0,1
206578,volar,0,1
206579,splints,0,1
206580,.,0,1
206581,Measurements,0,0
206582,by,0,0
206583,spring-weighted,0,1
206584,scales,0,0
206585,were,0,1
206586,taken,0,0
206587,to,0,0
206588,assess,0,0
206589,the,0,0
206590,efficiency,0,0
206591,of,0,0
206592,each,0,0
206593,splint,0,1
206594,design,0,1
206595,in,0,0
206596,the,0,0
206597,reduction,0,0
206598,of,0,0
206599,hypertonus,0,1
206600,.,0,1
206601,Results,0,0
206602,demonstrated,0,0
206603,no,0,0
206604,significant,0,0
206605,differences,0,0
206606,between,0,0
206607,the,0,0
206608,volar,0,0
206609,and,0,0
206610,dorsal,0,1
206611,splints,0,1
206612,in,0,1
206613,reducing,0,0
206614,hypertonus,1,1
206615,.,1,1
206616,However,0,0
206617,",",0,0
206618,the,0,0
206619,age,0,1
206620,of,0,0
206621,the,0,0
206622,subjects,0,1
206623,was,0,0
206624,found,0,0
206625,to,0,0
206626,be,0,0
206627,an,0,0
206628,intervening,0,0
206629,variable,0,0
206630,:,0,1
206631,The,0,0
206632,older,1,1
206633,subjects,1,1
206634,of,0,0
206635,both,0,0
206636,groups,0,0
206637,demonstrated,0,0
206638,a,0,1
206639,gradual,0,0
206640,but,0,0
206641,not,0,0
206642,significant,0,0
206643,decline,0,0
206644,in,0,0
206645,hypertonus,0,0
206646,",",0,0
206647,whereas,0,0
206648,the,0,0
206649,younger,1,1
206650,adults,1,1
206651,demonstrated,0,0
206652,a,0,1
206653,significant,0,0
206654,decline,0,0
206655,in,0,0
206656,hypertonus,0,1
206657,over,0,0
206658,a,0,1
206659,6-week,0,0
206660,period,0,1
206661,.,0,1
206662,Treatment,0,0
206663,of,0,0
206664,familial,0,1
206665,hypercholesterolemia,0,1
206666,with,0,1
206667,a,0,0
206668,combination,0,0
206669,of,0,0
206670,bezafibrate,0,0
206671,and,0,1
206672,guar,0,0
206673,.,0,1
206674,The,0,0
206675,effect,0,0
206676,of,0,0
206677,guar,0,0
206678,(,0,1
206679,15.6,0,0
206680,g/day,0,0
206681,),0,0
206682,",",0,0
206683,a,0,0
206684,dietary,0,0
206685,fibre,0,0
206686,",",0,0
206687,and,0,0
206688,simultaneous,0,0
206689,administration,0,0
206690,of,0,0
206691,bezafibrate,0,1
206692,(,0,1
206693,600,0,1
206694,mg/day,0,0
206695,),0,1
206696,during,0,0
206697,dietetic,0,1
206698,treatment,0,0
206699,on,0,0
206700,the,0,0
206701,plasma,0,0
206702,lipoproteins,0,0
206703,and,0,1
206704,apolipoproteins,0,1
206705,was,0,0
206706,investigated,0,0
206707,in,0,1
206708,12,1,1
206709,patients,1,1
206710,with,1,1
206711,familial,1,1
206712,hypercholesterolemia,1,1
206713,(,1,1
206714,corresponding,1,0
206715,to,1,0
206716,the,1,0
206717,HLP,1,0
206718,type,1,1
206719,IIa,1,1
206720,pattern,1,1
206721,),1,1
206722,.,1,1
206723,Either,0,0
206724,bezafibrate,0,0
206725,alone,0,0
206726,or,0,0
206727,bezafibrate,0,0
206728,in,0,0
206729,combination,0,0
206730,with,0,1
206731,guar,0,0
206732,was,0,0
206733,administered,0,0
206734,in,0,0
206735,a,0,0
206736,cross-over,0,0
206737,study,0,0
206738,for,0,1
206739,3,0,1
206740,months,0,1
206741,.,0,1
206742,Guar,0,1
206743,led,0,0
206744,to,0,0
206745,an,0,0
206746,additional,0,0
206747,lowering,0,0
206748,of,0,0
206749,the,0,0
206750,total,0,1
206751,cholesterol,0,0
206752,in,0,0
206753,the,0,0
206754,plasma,0,0
206755,by,0,0
206756,7,0,1
206757,%,0,0
206758,(,0,1
206759,P,0,0
206760,less,0,0
206761,than,0,0
206762,or,0,1
206763,equal,0,1
206764,to,0,1
206765,0.05,0,0
206766,),0,1
206767,associated,0,0
206768,with,0,1
206769,a,0,0
206770,fall,0,0
206771,of,0,0
206772,the,0,0
206773,low,0,1
206774,density,0,0
206775,lipoprotein,0,0
206776,cholesterol,0,0
206777,(,0,1
206778,LDL-cholesterol,0,0
206779,(,0,1
206780,LDL-cholesterol,0,0
206781,),0,1
206782,by,0,0
206783,13,0,1
206784,%,0,0
206785,(,0,1
206786,P,0,0
206787,less,0,0
206788,than,0,0
206789,or,0,1
206790,equal,0,1
206791,to,0,1
206792,0.01,0,0
206793,),0,1
206794,without,0,1
206795,any,0,1
206796,changes,0,0
206797,in,0,0
206798,the,0,0
206799,very,0,0
206800,low,0,0
206801,density,0,0
206802,lipoprotein,0,0
206803,(,0,1
206804,VLDL,0,1
206805,),0,1
206806,and,0,1
206807,high,0,1
206808,density,0,0
206809,lipoprotein,0,0
206810,(,0,1
206811,HDL,0,1
206812,),0,1
206813,cholesterols,0,0
206814,.,0,1
206815,In,0,0
206816,parallel,0,0
206817,with,0,1
206818,the,0,0
206819,decrease,0,0
206820,in,0,0
206821,LDL-cholesterol,0,0
206822,",",0,0
206823,the,0,0
206824,apoprotein,0,0
206825,B,0,1
206826,also,0,0
206827,was,0,0
206828,diminished,0,0
206829,by,0,0
206830,20,0,1
206831,%,0,0
206832,(,0,1
206833,P,0,0
206834,less,0,0
206835,than,0,0
206836,or,0,1
206837,equal,0,1
206838,to,0,1
206839,0.05,0,0
206840,),0,1
206841,.,0,1
206842,The,0,0
206843,plasma,0,0
206844,triglyceride,0,0
206845,level,0,0
206846,and,0,0
206847,the,0,0
206848,triglyceride,0,0
206849,distribution,0,0
206850,within,0,1
206851,the,0,0
206852,individual,0,0
206853,lipoprotein,0,0
206854,fractions,0,1
206855,were,0,1
206856,not,0,0
206857,altered,0,1
206858,in,0,0
206859,any,0,0
206860,consistent,0,0
206861,manner,0,0
206862,by,0,0
206863,the,0,0
206864,addition,0,0
206865,of,0,0
206866,guar,0,0
206867,.,0,1
206868,Neither,0,0
206869,the,0,0
206870,fasting,0,0
206871,plasma,0,0
206872,glucose,0,0
206873,level,0,0
206874,nor,0,0
206875,the,0,0
206876,body,0,1
206877,weight,0,0
206878,were,0,1
206879,affected,0,0
206880,.,0,1
206881,The,0,0
206882,side-effects,0,0
206883,due,0,0
206884,to,0,1
206885,guar,0,0
206886,treatment,0,0
206887,consisted,0,1
206888,of,0,0
206889,slight,0,0
206890,nausea,0,0
206891,",",0,0
206892,meteorism,0,0
206893,and,0,0
206894,constipation,0,1
206895,",",0,0
206896,but,0,0
206897,this,0,0
206898,did,0,0
206899,not,0,0
206900,in,0,0
206901,any,0,0
206902,of,0,0
206903,the,0,0
206904,cases,0,1
206905,lead,0,0
206906,to,0,0
206907,early,0,1
206908,termination,0,0
206909,of,0,0
206910,the,0,0
206911,study,0,0
206912,.,0,1
206913,These,0,0
206914,results,0,0
206915,demonstrate,0,0
206916,that,0,0
206917,guar,0,0
206918,exerts,0,0
206919,its,0,0
206920,cholesterol-lowering,0,0
206921,effect,0,0
206922,in,0,0
206923,addition,0,0
206924,to,0,0
206925,that,0,0
206926,of,0,0
206927,bezafibrate,0,0
206928,.,0,1
206929,The,0,0
206930,effects,0,0
206931,of,0,0
206932,haloperidol,0,0
206933,on,0,0
206934,learning,0,0
206935,and,0,0
206936,behavior,0,0
206937,in,0,1
206938,autistic,1,1
206939,children,1,1
206940,.,1,1
206941,The,0,0
206942,effects,0,0
206943,of,0,0
206944,haloperidol,0,0
206945,on,0,0
206946,behavioral,0,1
206947,symptoms,0,1
206948,and,0,1
206949,learning,0,0
206950,were,0,0
206951,critically,0,1
206952,assessed,0,0
206953,in,0,0
206954,autistic,1,1
206955,children,1,1
206956,in,0,1
206957,an,0,1
206958,ongoing,0,1
206959,double-blind,0,1
206960,placebo-controlled,0,1
206961,clinical,0,0
206962,trial,0,1
206963,.,0,1
206964,Children,0,1
206965,were,0,0
206966,randomly,0,1
206967,assigned,0,1
206968,to,0,0
206969,haloperidol-placebo-haloperidol,0,0
206970,or,0,1
206971,placebo-haloperidol-placebo,0,0
206972,treatment,0,1
206973,sequences,0,1
206974,.,0,1
206975,Statistically,0,0
206976,",",0,0
206977,haloperidol,0,0
206978,was,0,0
206979,significantly,0,0
206980,superior,0,0
206981,to,0,0
206982,placebo,0,0
206983,in,0,0
206984,reducing,0,0
206985,behavioral,0,1
206986,symptoms,0,1
206987,.,0,1
206988,In,0,0
206989,discrimination,0,0
206990,learning,0,0
206991,paradigm,0,1
206992,",",0,1
206993,children,0,1
206994,receiving,0,1
206995,haloperidol,0,0
206996,learned,0,0
206997,the,0,0
206998,discrimination,0,0
206999,while,0,0
207000,those,0,1
207001,on,0,0
207002,placebo,0,0
207003,did,0,1
207004,not,0,1
207005,.,0,1
207006,Discrimination,0,0
207007,attained,0,0
207008,on,0,0
207009,haloperidol,0,0
207010,was,0,0
207011,retained,0,0
207012,when,0,0
207013,the,0,0
207014,children,0,1
207015,were,0,1
207016,switched,0,0
207017,to,0,0
207018,placebo,0,0
207019,.,0,1
207020,The,0,0
207021,effects,0,0
207022,of,0,0
207023,prophylactic,0,1
207024,management,0,1
207025,and,0,1
207026,therapeutics,0,0
207027,on,0,0
207028,hypertensive,1,1
207029,disease,1,1
207030,in,1,1
207031,pregnancy,1,1
207032,:,1,1
207033,preliminary,0,0
207034,studies,0,0
207035,.,0,1
207036,A,0,1
207037,controlled,0,0
207038,prospective,0,1
207039,evaluation,0,0
207040,of,0,0
207041,pregnancy,0,1
207042,complicated,0,1
207043,by,0,0
207044,chronic,0,1
207045,hypertension,0,1
207046,is,0,0
207047,proposed,0,0
207048,and,0,0
207049,preliminary,0,0
207050,data,0,0
207051,on,0,0
207052,population,0,1
207053,selection,0,0
207054,and,0,0
207055,pregnancy,0,0
207056,outcome,0,0
207057,are,0,0
207058,presented,0,1
207059,.,0,1
207060,Sixty-three,1,1
207061,women,1,1
207062,with,1,1
207063,evidence,1,0
207064,of,1,0
207065,underlying,1,1
207066,hypertensive,1,1
207067,disease,1,1
207068,were,1,1
207069,followed,1,0
207070,prospectively,0,1
207071,throughout,0,0
207072,pregnancy,0,1
207073,.,0,1
207074,Twenty-three,0,1
207075,patients,0,1
207076,were,0,1
207077,followed,0,1
207078,in,0,0
207079,a,0,0
207080,protocol,0,0
207081,of,0,0
207082,intensified,0,1
207083,prenatal,0,1
207084,care,0,1
207085,and,0,1
207086,randomized,0,1
207087,assignment,0,1
207088,of,0,1
207089,antihypertensive,0,1
207090,agents,0,1
207091,:,0,1
207092,placebo,0,0
207093,",",0,0
207094,hydralazine,0,0
207095,",",0,0
207096,or,0,1
207097,methyldopa,0,0
207098,.,0,1
207099,Forty,1,1
207100,patients,1,1
207101,were,1,1
207102,followed,1,1
207103,in,1,0
207104,the,1,0
207105,high-risk,1,1
207106,pregnancy,1,1
207107,clinics,1,1
207108,at,1,1
207109,Duke,1,1
207110,University,1,1
207111,.,1,1
207112,The,0,0
207113,incidence,0,0
207114,of,0,0
207115,preeclampsia,0,1
207116,in,0,0
207117,the,0,0
207118,randomized,0,1
207119,prophylactic,0,1
207120,antihypertensive,0,1
207121,group,0,1
207122,was,0,0
207123,statistically,0,0
207124,lower,0,0
207125,than,0,0
207126,that,0,0
207127,in,0,0
207128,the,0,0
207129,nonrandomized,0,0
207130,group,0,1
207131,(,0,1
207132,8.7,0,0
207133,versus,0,0
207134,32.5,0,1
207135,%,0,0
207136,;,0,1
207137,P,0,0
207138,less,0,0
207139,than,0,0
207140,.01,0,0
207141,),0,0
207142,.,0,0
207143,There,0,0
207144,were,0,0
207145,no,0,0
207146,other,0,0
207147,statistically,0,0
207148,significant,0,0
207149,differences,0,0
207150,between,0,0
207151,the,0,1
207152,groups,0,0
207153,.,0,1
207154,The,0,0
207155,63,1,1
207156,hypertensive,1,1
207157,women,1,1
207158,had,0,1
207159,a,0,1
207160,high,0,0
207161,incidence,0,0
207162,of,0,1
207163,diabetes,0,1
207164,mellitus,0,1
207165,diagnosed,0,1
207166,during,0,1
207167,pregnancy,0,1
207168,(,0,1
207169,49.2,0,1
207170,%,0,0
207171,),0,1
207172,as,0,0
207173,compared,0,0
207174,to,0,1
207175,the,0,0
207176,authors,0,0
207177,',0,1
207178,general,0,1
207179,obstetric,0,1
207180,population,0,1
207181,(,0,1
207182,8.1,0,0
207183,%,0,0
207184,),0,1
207185,.,0,1
207186,Vaginal,0,1
207187,pH,0,0
207188,and,0,0
207189,microflora,0,1
207190,related,0,0
207191,to,0,0
207192,yeast,1,0
207193,infections,1,1
207194,and,1,1
207195,treatment,1,1
207196,.,1,1
207197,The,0,0
207198,relationship,0,0
207199,between,0,0
207200,vaginal,0,1
207201,pH,0,0
207202,",",0,0
207203,microflora,0,0
207204,",",0,0
207205,and,0,0
207206,yeast,1,0
207207,infection,1,1
207208,was,1,0
207209,investigated,1,0
207210,in,1,1
207211,93,1,1
207212,women,1,1
207213,randomly,1,1
207214,treated,1,1
207215,with,1,1
207216,either,1,1
207217,nystatin,1,0
207218,or,1,1
207219,miconazole,1,1
207220,pessaries,1,0
207221,and,1,1
207222,cream,1,1
207223,for,1,1
207224,two,1,1
207225,weeks,1,1
207226,.,1,1
207227,The,0,0
207228,vaginal,0,0
207229,pH,0,0
207230,was,0,0
207231,measured,0,0
207232,in,0,0
207233,a,0,0
207234,control,1,0
207235,group,1,1
207236,of,1,1
207237,48,1,1
207238,women,1,1
207239,.,1,1
207240,In,0,0
207241,the,0,0
207242,study,0,0
207243,group,0,0
207244,",",0,1
207245,37,0,1
207246,patients,0,1
207247,defaulted,0,1
207248,",",0,1
207249,39,0,1
207250,were,0,0
207251,cured,0,0
207252,",",0,0
207253,and,0,0
207254,17,0,1
207255,required,0,0
207256,treatment,0,0
207257,during,0,0
207258,the,0,0
207259,six-month,0,0
207260,follow-up,0,0
207261,period,0,1
207262,.,0,1
207263,In,0,0
207264,both,0,0
207265,study,0,0
207266,and,0,0
207267,control,0,1
207268,groups,0,0
207269,before,0,1
207270,and,0,1
207271,after,0,0
207272,treatment,0,0
207273,the,0,0
207274,mean,0,1
207275,vaginal,0,1
207276,pH,0,0
207277,was,0,0
207278,in,0,0
207279,the,0,0
207280,range,0,1
207281,of,0,0
207282,4.3-4.6,0,0
207283,.,0,1
207284,Lactobacilli,0,0
207285,were,0,0
207286,plentiful,0,1
207287,in,0,1
207288,78,0,1
207289,(,0,1
207290,91,0,1
207291,%,0,0
207292,),0,1
207293,out,0,1
207294,of,0,1
207295,86,0,1
207296,patients,0,1
207297,and,0,0
207298,shows,0,0
207299,that,0,0
207300,lactobacilli,0,0
207301,and,0,1
207302,yeasts,0,0
207303,commonly,0,1
207304,coexist,0,0
207305,.,0,0
207306,The,0,0
207307,influence,0,0
207308,of,0,0
207309,other,0,1
207310,organisms,0,1
207311,appeared,0,0
207312,to,0,1
207313,be,0,0
207314,negligible,0,0
207315,.,0,1
207316,The,0,0
207317,trial,0,0
207318,showed,0,0
207319,that,0,0
207320,nystatin,0,0
207321,and,0,1
207322,micromazole,0,1
207323,were,0,0
207324,equallly,0,0
207325,effective,0,0
207326,in,0,0
207327,the,0,0
207328,treatment,0,0
207329,of,0,0
207330,vaginal,1,1
207331,yeast,1,0
207332,infection,1,1
207333,and,0,0
207334,that,0,0
207335,the,0,0
207336,broad-spectrum,0,0
207337,activity,0,0
207338,of,0,0
207339,micronazole,0,0
207340,offered,0,0
207341,no,0,0
207342,advantage,0,0
207343,in,0,0
207344,this,0,0
207345,condition,0,0
207346,.,0,1
207347,[,0,0
207348,Erythropoietin,0,0
207349,therapy,0,0
207350,during,0,0
207351,frequent,0,1
207352,autologous,1,1
207353,blood,1,1
207354,donations,1,1
207355,.,1,1
207356,Dose-finding,0,0
207357,study,0,0
207358,],0,1
207359,.,0,1
207360,Avoidance,0,0
207361,of,0,0
207362,homologous,0,0
207363,blood,0,1
207364,products,0,0
207365,and,0,1
207366,patients,0,1
207367,',0,1
207368,demand,0,0
207369,for,0,1
207370,preoperative,0,1
207371,autologous,0,1
207372,blood,0,1
207373,donation,0,0
207374,programs,0,1
207375,are,0,0
207376,increasing,0,0
207377,.,0,1
207378,As,0,0
207379,many,0,0
207380,of,0,1
207381,these,0,0
207382,patients,1,1
207383,are,1,0
207384,older,1,1
207385,",",1,0
207386,with,1,1
207387,a,1,0
207388,compromised,1,0
207389,cardiovascular,1,1
207390,system,1,0
207391,and,0,0
207392,a,0,0
207393,slow,0,0
207394,response,0,0
207395,of,0,0
207396,the,0,0
207397,erythropoietic,0,0
207398,system,0,0
207399,when,0,0
207400,anemia,0,1
207401,occurs,0,0
207402,",",0,0
207403,the,0,0
207404,feasibility,0,0
207405,and,0,0
207406,benefit,0,0
207407,of,0,0
207408,autologous,0,1
207409,blood,0,0
207410,donation,0,0
207411,is,0,0
207412,often,0,0
207413,limited,0,0
207414,.,0,1
207415,Augmentation,0,0
207416,of,0,0
207417,preoperative,0,1
207418,blood,0,0
207419,donation,0,0
207420,by,0,0
207421,therapy,0,0
207422,with,0,1
207423,recombinant,0,0
207424,human,0,1
207425,erythropoietin,0,0
207426,(,0,1
207427,rHuEPO,0,0
207428,),0,0
207429,has,0,0
207430,been,0,0
207431,described,0,0
207432,in,0,1
207433,animal,0,1
207434,models,0,1
207435,and,0,1
207436,in,0,1
207437,patients,0,1
207438,.,0,1
207439,METHODS,0,0
207440,.,0,0
207441,In,0,0
207442,a,0,0
207443,multicenter,0,0
207444,",",0,0
207445,controlled,0,0
207446,",",0,0
207447,randomized,0,0
207448,trial,0,0
207449,",",0,1
207450,49,1,1
207451,patients,1,1
207452,scheduled,1,1
207453,for,1,1
207454,orthopaedic,1,1
207455,or,1,1
207456,vascular,1,0
207457,surgery,1,1
207458,received,0,1
207459,0,0,0
207460,(,0,1
207461,control,0,1
207462,group,0,0
207463,",",0,0
207464,n,0,1
207465,=,0,0
207466,9,0,0
207467,),0,0
207468,",",0,1
207469,200,0,1
207470,(,0,1
207471,n,0,1
207472,=,0,1
207473,10,0,1
207474,),0,1
207475,",",0,1
207476,300,0,1
207477,(,0,1
207478,n,0,1
207479,=,0,1
207480,11,0,1
207481,),0,1
207482,",",0,1
207483,400,0,0
207484,(,0,1
207485,n,0,1
207486,=,0,1
207487,10,0,1
207488,),0,1
207489,or,0,1
207490,500,0,1
207491,(,0,1
207492,n,0,1
207493,=,0,1
207494,9,0,1
207495,),0,1
207496,U/kg,0,1
207497,rHuEPO,0,1
207498,(,0,1
207499,Erypo,0,1
207500,",",0,0
207501,Cilag,0,0
207502,",",0,0
207503,Sulzbach,0,1
207504,",",0,0
207505,distributor,0,0
207506,Fresenius,0,1
207507,",",0,0
207508,Oberursel,0,1
207509,",",0,0
207510,Germany,0,1
207511,),0,0
207512,subcutaneously,0,1
207513,twice,0,0
207514,a,0,0
207515,week,0,0
207516,for,0,0
207517,3,0,1
207518,weeks,0,0
207519,while,0,0
207520,every,0,0
207521,week,0,0
207522,450,0,0
207523,ml,0,0
207524,blood,0,0
207525,was,0,0
207526,collected,0,1
207527,.,0,1
207528,Iron,0,0
207529,sulphate,0,0
207530,100,0,1
207531,mg,0,0
207532,was,0,0
207533,prescribed,0,0
207534,orally,0,0
207535,twice,0,0
207536,a,0,0
207537,day,0,0
207538,.,0,1
207539,Patients,1,1
207540,were,1,1
207541,ineligible,1,1
207542,if,1,0
207543,they,1,1
207544,had,1,1
207545,uncontrolled,1,1
207546,hypertension,1,1
207547,",",1,0
207548,recent,1,1
207549,myocardial,1,1
207550,infarction,1,1
207551,",",1,1
207552,haematological,1,1
207553,disorders,1,1
207554,or,1,1
207555,a,1,1
207556,history,1,1
207557,of,1,0
207558,seizures,1,1
207559,.,1,1
207560,Blood,0,0
207561,donation,0,0
207562,had,0,1
207563,to,0,0
207564,be,0,0
207565,cancelled,0,1
207566,if,0,0
207567,the,0,0
207568,haematocrit,1,0
207569,was,1,0
207570,below,1,1
207571,30,1,1
207572,%,1,0
207573,.,1,1
207574,RESULTS,0,0
207575,.,0,0
207576,There,0,0
207577,was,0,0
207578,a,0,0
207579,significant,0,0
207580,(,0,1
207581,ANOVA,0,1
207582,),0,1
207583,drop,0,0
207584,of,0,0
207585,the,0,0
207586,haematocrit,0,0
207587,value,0,0
207588,only,0,0
207589,in,0,0
207590,the,0,0
207591,control,0,0
207592,group,0,0
207593,",",0,0
207594,and,0,0
207595,end-point,0,0
207596,values,0,0
207597,for,0,1
207598,haematocrit,0,0
207599,and,0,1
207600,haemoglobin,0,0
207601,were,0,0
207602,significantly,0,0
207603,elevated,0,0
207604,in,0,0
207605,the,0,0
207606,400,0,0
207607,and,0,1
207608,500,0,1
207609,U/kg,0,1
207610,groups,0,1
207611,compared,0,0
207612,with,0,1
207613,the,0,0
207614,control,0,1
207615,group,0,0
207616,(,0,1
207617,Table,0,1
207618,9,0,1
207619,),0,1
207620,.,0,1
207621,DISCUSSION,0,0
207622,.,0,0
207623,The,0,0
207624,erythropoietic,0,0
207625,stimulus,0,0
207626,of,0,0
207627,phlebotomy,0,0
207628,for,0,1
207629,autologous,0,1
207630,blood,0,0
207631,donations,0,0
207632,is,0,0
207633,often,0,0
207634,not,0,0
207635,efficient,0,0
207636,enough,0,0
207637,to,0,0
207638,guarantee,0,0
207639,a,0,0
207640,constant,0,0
207641,haematocrit,0,0
207642,.,0,1
207643,Lowering,0,0
207644,of,0,0
207645,the,0,0
207646,preoperative,0,0
207647,haematocrit,0,0
207648,jeopardizes,0,0
207649,the,0,0
207650,aim,0,0
207651,of,0,0
207652,avoidance,0,0
207653,of,0,0
207654,homologous,0,0
207655,blood,0,1
207656,transfusions,0,0
207657,.,0,1
207658,rHuEPO,0,0
207659,increased,0,0
207660,the,0,0
207661,efficiency,0,0
207662,of,0,0
207663,autologous,0,1
207664,blood,0,1
207665,collections,0,0
207666,",",0,1
207667,as,0,0
207668,predonation,0,0
207669,haematocrit,0,0
207670,values,0,0
207671,could,0,0
207672,be,0,0
207673,preserved,0,0
207674,in,0,0
207675,the,0,0
207676,high-dosage,0,1
207677,groups,0,0
207678,.,0,1
207679,As,0,0
207680,a,0,0
207681,consequence,0,0
207682,",",0,0
207683,homologous,0,0
207684,transfusions,0,0
207685,could,0,0
207686,be,0,0
207687,avoided,0,0
207688,.,0,0
207689,However,0,0
207690,",",0,0
207691,there,0,0
207692,were,0,0
207693,broad,0,0
207694,interindividual,0,0
207695,differences,0,0
207696,in,0,1
207697,the,0,1
207698,erythropoietic,0,0
207699,response,0,0
207700,",",0,0
207701,possibly,0,0
207702,due,0,0
207703,to,0,1
207704,limitations,0,0
207705,in,0,1
207706,iron,0,1
207707,availability,0,0
207708,.,0,1
207709,Adverse,0,0
207710,effects,0,0
207711,of,0,1
207712,rHuEPO,0,1
207713,therapy,0,0
207714,",",0,0
207715,such,0,0
207716,as,0,0
207717,hypertension,0,1
207718,",",0,0
207719,thrombosis,0,1
207720,or,0,1
207721,neurologic,0,1
207722,disorders,0,1
207723,",",0,1
207724,are,0,0
207725,mostly,0,0
207726,reported,0,0
207727,in,0,0
207728,patients,1,1
207729,with,1,1
207730,terminal,1,1
207731,kidney,1,1
207732,failure,1,1
207733,.,1,1
207734,No,0,0
207735,such,0,0
207736,disturbances,0,0
207737,were,0,1
207738,observed,0,0
207739,in,0,0
207740,the,0,0
207741,present,0,0
207742,study,0,1
207743,.,0,1
207744,CONCLUSION,0,0
207745,.,0,0
207746,rHuEPO,0,0
207747,ameliorates,0,0
207748,the,0,0
207749,preoperative,0,0
207750,decrease,0,0
207751,of,0,0
207752,haemoglobin,0,0
207753,and,0,1
207754,haematocrit,0,0
207755,values,0,0
207756,due,0,1
207757,to,0,1
207758,autologous,1,1
207759,blood,1,0
207760,donations,1,1
207761,in,0,1
207762,a,0,1
207763,dose-related,0,0
207764,fashion,0,0
207765,.,0,1
207766,The,0,0
207767,individually,0,0
207768,adjusted,0,0
207769,dosage,0,0
207770,of,0,0
207771,rHuEPO,0,0
207772,and,0,1
207773,iron,0,0
207774,supplementation,0,0
207775,merits,0,0
207776,further,0,1
207777,investigation,0,1
207778,.,0,1
207779,Double-blind,0,0
207780,comparison,0,0
207781,of,0,0
207782,the,0,0
207783,efficacy,0,0
207784,and,0,0
207785,safety,0,0
207786,of,0,0
207787,trandolapril,0,1
207788,2,0,1
207789,mg,0,0
207790,and,0,0
207791,hydrochlorothiazide,0,0
207792,25,0,1
207793,mg,0,0
207794,in,0,1
207795,patients,1,1
207796,with,1,1
207797,mild-to-moderate,1,1
207798,essential,1,1
207799,hypertension,1,1
207800,.,1,1
207801,Investigator,0,0
207802,Study,0,0
207803,Group,0,1
207804,.,0,1
207805,This,0,0
207806,multicenter,0,0
207807,international,0,1
207808,trial,0,1
207809,recruited,0,1
207810,205,1,1
207811,patients,1,1
207812,from,1,1
207813,16,1,1
207814,investigators,1,1
207815,.,1,1
207816,After,0,0
207817,a,0,0
207818,4-week,0,0
207819,",",0,0
207820,single-blind,0,0
207821,placebo,0,0
207822,run-in,0,1
207823,",",0,1
207824,patients,0,1
207825,were,0,1
207826,randomized,0,1
207827,to,0,0
207828,receive,0,1
207829,16,0,1
207830,weeks,0,0
207831,of,0,1
207832,trandolapril,0,1
207833,2,0,1
207834,mg/day,0,1
207835,(,0,1
207836,68,0,1
207837,patients,0,1
207838,),0,1
207839,",",0,0
207840,hydrochlorothiazide,0,0
207841,(,0,0
207842,HCTZ,0,0
207843,),0,1
207844,25,0,1
207845,mg/day,0,1
207846,(,0,1
207847,68,0,1
207848,patients,0,1
207849,),0,1
207850,",",0,0
207851,or,0,1
207852,the,0,0
207853,combination,0,0
207854,(,0,1
207855,69,0,1
207856,patients,0,1
207857,),0,1
207858,.,0,1
207859,Morning,0,0
207860,predosing,0,0
207861,supine,0,1
207862,diastolic,0,1
207863,blood,0,0
207864,pressure,0,0
207865,(,0,1
207866,DBP,0,1
207867,),0,1
207868,was,0,0
207869,the,0,0
207870,primary,0,1
207871,efficacy,0,0
207872,measurement,0,0
207873,.,0,1
207874,Intention-to-treat,0,0
207875,analysis,0,0
207876,showed,0,0
207877,significant,0,0
207878,decreases,0,0
207879,in,0,1
207880,all,0,1
207881,three,0,0
207882,groups,0,0
207883,in,0,1
207884,mean,0,1
207885,(,0,1
207886,+/-,0,0
207887,SEM,0,1
207888,),0,1
207889,supine,0,0
207890,DBP,0,1
207891,throughout,0,0
207892,the,0,0
207893,study,0,0
207894,",",0,0
207895,with,0,1
207896,no,0,0
207897,significant,0,0
207898,differences,0,0
207899,at,0,1
207900,week,0,0
207901,16,0,1
207902,between,0,0
207903,trandolapril,0,1
207904,(,0,1
207905,-10.6,0,0
207906,+/-,0,1
207907,1.3,0,0
207908,mm,0,1
207909,Hg,0,1
207910,),0,1
207911,and,0,1
207912,HCTZ,0,1
207913,(,0,1
207914,-10.9,0,0
207915,+/-,0,1
207916,1.3,0,0
207917,mm,0,1
207918,Hg,0,1
207919,),0,1
207920,.,0,1
207921,The,0,0
207922,combination,0,0
207923,gave,0,0
207924,a,0,0
207925,significantly,0,0
207926,greater,0,0
207927,reduction,0,0
207928,than,0,0
207929,either,0,0
207930,drug,0,0
207931,alone,0,0
207932,(,0,0
207933,-15.1,0,0
207934,+/-,0,1
207935,1.13,0,0
207936,mm,0,1
207937,Hg,0,1
207938,),0,1
207939,.,0,1
207940,Blood,0,0
207941,pressure,0,0
207942,was,0,0
207943,normalized,0,0
207944,in,0,0
207945,the,0,0
207946,combination,0,0
207947,group,0,1
207948,in,0,1
207949,67,0,1
207950,%,0,0
207951,of,0,1
207952,patients,0,1
207953,",",0,0
207954,a,0,0
207955,significantly,0,0
207956,higher,0,0
207957,proportion,0,0
207958,than,0,0
207959,either,0,1
207960,trandolapril,0,0
207961,(,0,0
207962,63,0,1
207963,%,0,0
207964,),0,1
207965,or,0,1
207966,HCTZ,0,1
207967,(,0,1
207968,60,0,1
207969,%,0,0
207970,;,0,0
207971,p,0,0
207972,=,0,1
207973,0.04,0,0
207974,),0,1
207975,.,0,1
207976,Each,0,0
207977,treatment,0,0
207978,was,0,0
207979,well,0,0
207980,tolerated,0,0
207981,.,0,0
207982,The,0,0
207983,incidence,0,0
207984,of,0,0
207985,adverse,0,0
207986,events,0,0
207987,was,0,0
207988,similar,0,0
207989,in,0,0
207990,all,0,1
207991,three,0,1
207992,groups,0,1
207993,.,0,1
207994,Trandolapril,0,0
207995,2,0,0
207996,mg,0,0
207997,once,0,0
207998,daily,0,0
207999,is,0,0
208000,an,0,0
208001,effective,0,0
208002,antihypertensive,0,1
208003,agent,0,0
208004,",",0,1
208005,comparable,0,0
208006,to,0,1
208007,HCTZ,0,1
208008,.,0,1
208009,Furthermore,0,0
208010,",",0,0
208011,the,0,0
208012,combination,0,0
208013,of,0,0
208014,the,0,1
208015,two,0,1
208016,drugs,0,0
208017,was,0,0
208018,shown,0,0
208019,to,0,0
208020,enhance,0,0
208021,the,0,0
208022,antihypertensive,0,0
208023,effect,0,0
208024,of,0,0
208025,the,0,1
208026,two,0,0
208027,compounds,0,1
208028,alone,0,1
208029,.,0,1
208030,Multicyclic,0,0
208031,",",0,0
208032,dose-intensive,0,0
208033,chemotherapy,0,1
208034,supported,0,0
208035,by,0,0
208036,sequential,0,0
208037,reinfusion,0,0
208038,of,0,1
208039,hematopoietic,0,1
208040,progenitors,0,1
208041,in,0,1
208042,whole,0,1
208043,blood,0,0
208044,.,0,1
208045,PURPOSE,0,0
208046,To,0,0
208047,support,0,0
208048,multicyclic,0,0
208049,",",0,0
208050,dose-intensive,0,0
208051,chemotherapy,0,1
208052,",",0,0
208053,we,0,0
208054,assessed,0,0
208055,the,0,0
208056,effects,0,0
208057,of,0,0
208058,reinfusing,0,0
208059,hematopoietic,0,1
208060,progenitors,0,1
208061,collected,0,1
208062,at,0,1
208063,each,0,0
208064,cycle,0,0
208065,in,0,0
208066,leukapheresis,0,0
208067,product,0,0
208068,or,0,1
208069,whole,0,0
208070,blood,0,0
208071,.,0,1
208072,PATIENTS,0,0
208073,AND,0,0
208074,METHODS,0,0
208075,Twenty-five,1,1
208076,patients,1,1
208077,with,1,1
208078,small-cell,1,1
208079,lung,1,1
208080,cancer,1,1
208081,(,1,1
208082,SCLC,1,1
208083,),1,1
208084,were,0,0
208085,treated,0,1
208086,with,0,1
208087,six,0,1
208088,cycles,0,0
208089,of,0,1
208090,ifosfamide,0,1
208091,",",0,0
208092,carboplatin,0,0
208093,",",0,0
208094,and,0,0
208095,etoposide,0,0
208096,(,0,1
208097,ICE,0,0
208098,),0,1
208099,with,0,1
208100,granulocyte,0,0
208101,colony-stimulating,0,1
208102,factor,0,0
208103,(,0,1
208104,G-CSF,0,1
208105,),0,1
208106,300,0,1
208107,micrograms/d,0,1
208108,subcutaneously,0,1
208109,(,0,1
208110,SC,0,1
208111,),0,1
208112,on,0,1
208113,days,0,1
208114,4,0,1
208115,to,0,1
208116,15,0,1
208117,.,0,1
208118,Hematopoietic,0,0
208119,progenitors,0,0
208120,collected,0,1
208121,during,0,0
208122,each,0,0
208123,cycle,0,0
208124,were,0,0
208125,reinfused,0,0
208126,on,0,0
208127,day,0,0
208128,3,0,1
208129,of,0,0
208130,the,0,0
208131,next,0,1
208132,cycle,0,0
208133,.,0,1
208134,Cohort,0,1
208135,1,0,0
208136,(,0,1
208137,n,0,1
208138,=,0,1
208139,6,0,1
208140,),0,1
208141,was,0,0
208142,treated,0,1
208143,every,0,0
208144,3,0,0
208145,weeks,0,0
208146,",",0,1
208147,with,0,1
208148,leukapheresis,0,0
208149,after,0,1
208150,2,0,1
208151,weeks,0,1
208152,and,0,1
208153,cryopreservation,0,1
208154,of,0,0
208155,the,0,0
208156,leukapheresis,0,0
208157,product,0,0
208158,.,0,1
208159,Chemotherapy,0,1
208160,was,0,0
208161,given,0,0
208162,if,0,0
208163,the,0,0
208164,WBC,0,1
208165,count,0,0
208166,was,0,0
208167,>,0,1
208168,or,0,1
208169,=,0,1
208170,3,0,1
208171,x,0,1
208172,10,0,1
208173,(,0,1
208174,9,0,1
208175,),0,1
208176,/L,0,1
208177,and,0,0
208178,platelet,0,0
208179,count,0,0
208180,>,0,1
208181,or,0,1
208182,=,0,1
208183,100,0,1
208184,x,0,1
208185,10,0,1
208186,(,0,1
208187,9,0,1
208188,),0,1
208189,/L,0,1
208190,.,0,1
208191,Cohort,0,1
208192,2,0,1
208193,(,0,1
208194,n,0,1
208195,=,0,1
208196,7,0,1
208197,),0,1
208198,was,0,0
208199,treated,0,1
208200,every,0,0
208201,2,0,1
208202,weeks,0,0
208203,",",0,1
208204,with,0,1
208205,leukapheresis,0,0
208206,on,0,0
208207,day,0,0
208208,1,0,1
208209,of,0,0
208210,the,0,0
208211,next,0,1
208212,cycle,0,0
208213,and,0,0
208214,storage,0,1
208215,of,0,0
208216,the,0,0
208217,leukapheresis,0,0
208218,product,0,0
208219,at,0,1
208220,4,0,1
208221,degrees,0,1
208222,C.,0,1
208223,Cohort,0,1
208224,3,0,1
208225,(,0,1
208226,n,0,1
208227,=,0,1
208228,12,0,1
208229,),0,1
208230,was,0,0
208231,treated,0,1
208232,every,0,0
208233,2,0,1
208234,weeks,0,0
208235,",",0,1
208236,with,0,1
208237,500,0,1
208238,to,0,1
208239,750,0,1
208240,mL,0,0
208241,of,0,1
208242,blood,0,0
208243,drawn,0,0
208244,by,0,0
208245,venesection,0,1
208246,on,0,0
208247,day,0,0
208248,1,0,1
208249,of,0,0
208250,the,0,0
208251,next,0,1
208252,cycle,0,0
208253,and,0,0
208254,stored,0,0
208255,at,0,1
208256,4,0,1
208257,degrees,0,1
208258,C.,0,1
208259,In,0,1
208260,cohorts,0,1
208261,2,0,1
208262,and,0,1
208263,3,0,0
208264,",",0,0
208265,chemotherapy,0,1
208266,was,0,0
208267,given,0,0
208268,if,0,0
208269,the,0,0
208270,WBC,0,1
208271,count,0,0
208272,was,0,0
208273,>,0,1
208274,or,0,1
208275,=,0,1
208276,3,0,1
208277,x,0,1
208278,10,0,1
208279,(,0,1
208280,9,0,1
208281,),0,1
208282,/L,0,1
208283,and,0,0
208284,platelet,0,0
208285,count,0,0
208286,>,0,1
208287,or,0,1
208288,=,0,1
208289,30,0,1
208290,x,0,1
208291,10,0,1
208292,(,0,1
208293,9,0,1
208294,),0,1
208295,/L,0,1
208296,.,0,1
208297,Blood,0,0
208298,and,0,0
208299,leukapheresis,0,1
208300,products,0,0
208301,were,0,1
208302,assayed,0,0
208303,for,0,1
208304,hematopoietic,0,1
208305,progenitors,0,1
208306,.,0,1
208307,RESULTS,0,0
208308,ICE,0,0
208309,chemotherapy,0,1
208310,with,0,1
208311,G-CSF,0,1
208312,was,0,0
208313,effective,0,0
208314,in,0,0
208315,mobilizing,0,1
208316,blood,0,1
208317,progenitors,0,1
208318,(,0,1
208319,median,0,1
208320,",",0,1
208321,120-fold,0,0
208322,),0,1
208323,.,0,1
208324,Long-term,0,0
208325,cultures,0,0
208326,showed,0,0
208327,no,0,0
208328,evidence,0,0
208329,of,0,0
208330,stem-cell,0,1
208331,depletion,0,0
208332,.,0,1
208333,The,0,0
208334,cytotoxic,0,0
208335,dose-intensity,0,0
208336,of,0,0
208337,standard,0,1
208338,every-4-weeks,0,0
208339,ICE,0,1
208340,is,0,0
208341,100,0,0
208342,%,0,0
208343,.,0,1
208344,In,0,0
208345,the,0,0
208346,first,0,1
208347,three,0,0
208348,cycles,0,0
208349,",",0,1
208350,it,0,0
208351,was,0,0
208352,134,0,1
208353,%,0,0
208354,(,0,1
208355,median,0,1
208356,),0,1
208357,in,0,1
208358,cohort,0,1
208359,1,0,1
208360,and,0,1
208361,200,0,1
208362,%,0,0
208363,in,0,1
208364,cohorts,0,1
208365,2,0,1
208366,and,0,1
208367,3,0,1
208368,(,0,1
208369,P,0,0
208370,<,0,0
208371,.0001,0,0
208372,),0,1
208373,.,0,1
208374,Toxicity,0,0
208375,and,0,0
208376,supportive,0,1
208377,care,0,1
208378,requirements,0,1
208379,were,0,1
208380,not,0,0
208381,increased,0,0
208382,.,0,0
208383,CONCLUSION,0,0
208384,The,0,0
208385,dose-intensity,0,0
208386,of,0,0
208387,ICE,0,0
208388,chemotherapy,0,1
208389,can,0,0
208390,be,0,0
208391,doubled,0,0
208392,by,0,0
208393,reinfusing,0,0
208394,hematopoietic,0,1
208395,progenitors,0,1
208396,collected,0,1
208397,by,0,0
208398,leukapheresis,0,0
208399,or,0,1
208400,venesection,0,1
208401,and,0,0
208402,stored,0,0
208403,at,0,1
208404,4,0,1
208405,degrees,0,1
208406,C,0,1
208407,.,0,1
208408,Abdominoperineal,0,1
208409,resection,0,1
208410,and,0,1
208411,anterior,0,1
208412,resection,0,1
208413,in,0,0
208414,the,0,0
208415,treatment,0,0
208416,of,0,0
208417,rectal,1,1
208418,cancer,1,1
208419,:,1,1
208420,results,0,0
208421,in,0,1
208422,relation,0,0
208423,to,0,0
208424,adjuvant,0,1
208425,preoperative,0,0
208426,radiotherapy,0,1
208427,.,0,1
208428,The,0,0
208429,outcome,0,0
208430,of,0,0
208431,patients,1,1
208432,with,1,1
208433,rectal,1,1
208434,cancer,1,1
208435,treated,1,1
208436,by,1,0
208437,abdominoperineal,1,1
208438,or,1,1
208439,anterior,1,1
208440,resection,1,1
208441,",",1,0
208442,with,1,1
208443,or,1,1
208444,without,1,1
208445,preoperative,1,1
208446,radiotherapy,1,1
208447,",",0,0
208448,was,0,0
208449,assessed,0,0
208450,to,0,0
208451,detect,0,0
208452,any,0,0
208453,differences,0,0
208454,attributable,0,0
208455,to,0,1
208456,the,0,0
208457,operative,0,0
208458,method,0,0
208459,and,0,1
208460,interactions,0,0
208461,between,0,0
208462,radiotherapy,0,1
208463,and,0,0
208464,type,0,1
208465,of,0,0
208466,surgery,0,1
208467,.,0,1
208468,The,0,0
208469,study,0,0
208470,was,0,0
208471,based,0,1
208472,on,0,0
208473,1292,1,1
208474,patients,1,1
208475,included,1,1
208476,in,1,1
208477,two,1,1
208478,consecutive,1,1
208479,controlled,1,1
208480,randomized,1,1
208481,trials,1,1
208482,of,1,1
208483,preoperative,1,1
208484,radiotherapy,1,1
208485,in,1,1
208486,operable,1,1
208487,rectal,1,1
208488,carcinoma,1,1
208489,.,1,1
208490,The,0,0
208491,outcome,0,0
208492,was,0,0
208493,not,0,0
208494,related,0,0
208495,to,0,0
208496,surgical,0,1
208497,method,0,0
208498,.,0,1
208499,Radiotherapy,0,0
208500,increased,0,0
208501,postoperative,0,0
208502,mortality,0,0
208503,and,0,1
208504,complications,0,0
208505,and,0,1
208506,reduced,0,0
208507,local,0,0
208508,and,0,1
208509,distant,0,1
208510,recurrence,0,0
208511,",",0,0
208512,but,0,0
208513,had,0,1
208514,no,0,0
208515,effect,0,0
208516,on,0,0
208517,overall,0,0
208518,survival,0,0
208519,.,0,1
208520,Effects,0,0
208521,of,0,0
208522,radiotherapy,0,1
208523,were,0,1
208524,similar,0,0
208525,irrespective,0,0
208526,of,0,0
208527,the,0,0
208528,type,0,1
208529,of,0,0
208530,surgery,0,1
208531,",",0,0
208532,except,0,0
208533,that,0,0
208534,the,0,0
208535,increase,0,0
208536,in,0,0
208537,postoperative,0,0
208538,mortality,0,0
208539,in,0,1
208540,irradiated,0,1
208541,patients,0,1
208542,was,0,0
208543,greater,0,0
208544,in,0,0
208545,those,0,0
208546,treated,0,1
208547,with,0,1
208548,abdominoperineal,0,1
208549,resection,0,1
208550,.,0,1
208551,Sphincter-saving,0,0
208552,procedures,0,0
208553,appear,0,0
208554,to,0,0
208555,have,0,0
208556,no,0,0
208557,adverse,0,0
208558,effects,0,0
208559,on,0,0
208560,outcome,0,0
208561,of,0,0
208562,rectal,1,1
208563,cancer,1,1
208564,",",0,0
208565,but,0,0
208566,the,0,0
208567,optimum,0,0
208568,use,0,0
208569,of,0,0
208570,radiotherapy,0,1
208571,is,0,0
208572,still,0,0
208573,to,0,0
208574,be,0,0
208575,defined,0,1
208576,.,0,1
208577,Active,0,1
208578,treatment,0,1
208579,programs,0,1
208580,for,0,1
208581,patients,1,1
208582,with,1,1
208583,chronic,1,1
208584,low,1,1
208585,back,1,1
208586,pain,1,1
208587,:,1,1
208588,a,0,0
208589,prospective,0,0
208590,",",0,0
208591,randomized,0,1
208592,",",0,0
208593,observer-blinded,0,0
208594,study,0,1
208595,.,0,1
208596,Several,0,0
208597,new,0,1
208598,studies,0,0
208599,have,0,0
208600,indicated,0,0
208601,that,0,0
208602,an,0,0
208603,active,0,1
208604,approach,0,1
208605,to,0,1
208606,patients,1,1
208607,with,1,1
208608,chronic,1,1
208609,disabling,1,1
208610,low,1,1
208611,back,1,1
208612,pain,1,1
208613,(,1,0
208614,LBP,1,0
208615,),1,1
208616,seems,0,0
208617,effective,0,0
208618,.,0,0
208619,Some,0,1
208620,of,0,0
208621,these,0,0
208622,studies,0,0
208623,emphasize,0,0
208624,the,0,0
208625,importance,0,0
208626,of,0,0
208627,dealing,0,0
208628,with,0,1
208629,the,0,0
208630,patient,0,1
208631,'s,0,1
208632,total,0,1
208633,situation,0,1
208634,in,0,1
208635,comprehensive,0,1
208636,multidisciplinary,0,1
208637,programs,0,1
208638,--,0,1
208639,the,0,0
208640,bio-psycho-social,0,1
208641,model,0,0
208642,.,0,1
208643,However,0,0
208644,",",0,0
208645,these,0,0
208646,programs,0,0
208647,are,0,0
208648,expensive,0,0
208649,.,0,1
208650,The,0,0
208651,aim,0,0
208652,of,0,0
208653,this,0,0
208654,study,0,0
208655,was,0,0
208656,to,0,0
208657,evaluate,0,0
208658,the,0,0
208659,rehabilitation,0,1
208660,outcome,0,0
208661,from,0,1
208662,three,0,1
208663,different,0,1
208664,active,0,1
208665,programs,0,1
208666,in,0,1
208667,terms,0,0
208668,of,0,1
208669,:,0,1
208670,(,0,1
208671,1,0,1
208672,),0,1
208673,return-to-work,0,0
208674,rate,0,0
208675,",",0,0
208676,(,0,1
208677,2,0,1
208678,),0,1
208679,days,0,0
208680,of,0,1
208681,sick,0,1
208682,leave,0,1
208683,",",0,1
208684,(,0,1
208685,3,0,1
208686,),0,1
208687,health-care,0,1
208688,contacts,0,1
208689,",",0,1
208690,(,0,1
208691,4,0,0
208692,),0,1
208693,pain,0,1
208694,and,0,1
208695,disability,0,1
208696,scores,0,0
208697,",",0,1
208698,and,0,1
208699,(,0,1
208700,5,0,1
208701,),0,1
208702,staying,0,0
208703,physically,0,1
208704,active,0,1
208705,.,0,1
208706,The,1,0
208707,subjects,1,1
208708,included,1,1
208709,132,1,1
208710,patients,1,1
208711,randomized,1,1
208712,to,1,1
208713,the,1,0
208714,study,1,0
208715,",",1,1
208716,of,1,1
208717,whom,1,1
208718,123,1,1
208719,started,1,1
208720,one,1,1
208721,of,1,0
208722,the,1,0
208723,treatment,1,1
208724,programs,1,1
208725,.,1,1
208726,They,1,0
208727,had,1,0
208728,all,1,0
208729,had,1,1
208730,at,1,0
208731,least,1,1
208732,6,1,1
208733,months,1,0
208734,of,1,1
208735,chronic,1,1
208736,LBP,1,1
208737,.,1,1
208738,The,0,0
208739,patients,0,1
208740,were,0,1
208741,randomized,0,1
208742,into,0,1
208743,one,0,1
208744,of,0,1
208745,three,0,1
208746,programs,0,1
208747,:,0,1
208748,group,0,1
208749,1,0,1
208750,--,0,1
208751,a,0,1
208752,full-time,0,1
208753,",",0,0
208754,intensive,0,1
208755,3-week,0,0
208756,multidisciplinary,0,1
208757,program,0,1
208758,",",0,0
208759,including,0,0
208760,active,0,1
208761,physical,0,1
208762,and,0,1
208763,ergonomic,0,0
208764,training,0,0
208765,and,0,1
208766,psychological,0,0
208767,pain,0,1
208768,management,0,1
208769,",",0,0
208770,followed,0,0
208771,by,0,0
208772,1,0,0
208773,day,0,0
208774,weekly,0,0
208775,for,0,0
208776,the,0,0
208777,subsequent,0,0
208778,3,0,1
208779,weeks,0,1
208780,;,0,1
208781,group,0,1
208782,2,0,1
208783,--,0,1
208784,active,0,1
208785,physical,0,1
208786,training,0,0
208787,",",0,0
208788,twice,0,0
208789,a,0,0
208790,week,0,0
208791,for,0,0
208792,6,0,1
208793,weeks,0,0
208794,",",0,1
208795,for,0,0
208796,a,0,0
208797,total,0,1
208798,of,0,0
208799,24h,0,0
208800,;,0,1
208801,group,0,1
208802,3,0,1
208803,--,0,1
208804,psychological,0,1
208805,pain,0,1
208806,management,0,1
208807,combined,0,0
208808,with,0,1
208809,active,0,1
208810,physical,0,1
208811,training,0,0
208812,",",0,0
208813,twice,0,0
208814,a,0,0
208815,week,0,0
208816,for,0,0
208817,6,0,1
208818,weeks,0,0
208819,",",0,0
208820,also,0,0
208821,for,0,0
208822,a,0,0
208823,total,0,1
208824,of,0,0
208825,24h,0,0
208826,.,0,1
208827,The,0,0
208828,results,0,0
208829,presented,0,1
208830,here,0,1
208831,are,0,0
208832,based,0,1
208833,on,0,0
208834,data,0,0
208835,collected,0,1
208836,4,0,1
208837,months,0,0
208838,following,0,0
208839,treatment,0,0
208840,",",0,0
208841,which,0,0
208842,shows,0,0
208843,an,0,0
208844,86,0,0
208845,%,0,0
208846,response,0,0
208847,rate,0,0
208848,.,0,1
208849,The,0,0
208850,initial,0,0
208851,examination,0,0
208852,and,0,0
208853,the,0,0
208854,follow-up,0,0
208855,evaluation,0,0
208856,were,0,1
208857,performed,0,0
208858,by,0,0
208859,a,0,0
208860,blinded,0,0
208861,observer,0,0
208862,.,0,1
208863,The,0,0
208864,results,0,0
208865,show,0,0
208866,that,0,0
208867,4,0,0
208868,months,0,1
208869,after,0,1
208870,treatment,0,0
208871,",",0,0
208872,the,0,0
208873,intensive,0,1
208874,multidisciplinary,0,0
208875,program,0,1
208876,is,0,0
208877,superior,0,0
208878,to,0,0
208879,the,0,0
208880,less,0,0
208881,intensive,0,0
208882,programs,0,0
208883,in,0,1
208884,terms,0,0
208885,of,0,1
208886,return-to-work,0,1
208887,rate,0,0
208888,",",0,1
208889,health-care,0,1
208890,contacts,0,1
208891,",",0,1
208892,pain,0,1
208893,and,0,0
208894,disability,0,1
208895,scores,0,0
208896,",",0,1
208897,and,0,0
208898,staying,0,0
208899,physically,0,1
208900,active,0,1
208901,.,0,1
208902,(,0,0
208903,ABSTRACT,0,0
208904,TRUNCATED,0,1
208905,AT,0,1
208906,250,0,1
208907,WORDS,0,1
208908,),0,1
208909,Quantifying,0,0
208910,the,0,0
208911,extent,0,0
208912,of,0,0
208913,osteonecrosis,1,1
208914,of,1,0
208915,the,1,0
208916,femoral,1,1
208917,head,1,1
208918,.,1,1
208919,A,0,0
208920,new,0,0
208921,method,0,0
208922,using,0,1
208923,MRI,0,0
208924,.,0,1
208925,In,0,0
208926,a,0,0
208927,randomised,0,1
208928,trial,0,0
208929,comparing,0,0
208930,core,0,1
208931,decompression,0,1
208932,with,0,1
208933,conservative,0,1
208934,treatment,0,1
208935,we,0,0
208936,tested,0,0
208937,the,0,0
208938,hypothesis,0,0
208939,that,0,0
208940,the,0,0
208941,extent,0,0
208942,of,0,0
208943,necrosis,0,1
208944,at,0,0
208945,the,0,0
208946,initial,0,0
208947,MRI,0,0
208948,predicts,0,0
208949,the,0,0
208950,subsequent,0,0
208951,risk,0,0
208952,of,0,0
208953,collapse,0,0
208954,of,0,0
208955,the,0,0
208956,femoral,0,1
208957,head,0,1
208958,.,0,1
208959,After,0,0
208960,the,0,0
208961,initial,0,0
208962,clinical,0,0
208963,evaluation,0,0
208964,",",0,0
208965,including,0,0
208966,plain,0,0
208967,radiography,0,1
208968,and,0,0
208969,MRI,0,0
208970,",",0,1
208971,37,1,1
208972,hips,1,1
208973,with,1,1
208974,early-stage,1,1
208975,osteonecrosis,1,1
208976,(,1,1
208977,ON,1,0
208978,),1,1
208979,in,1,1
208980,33,1,1
208981,patients,1,1
208982,were,1,1
208983,randomly,1,1
208984,assigned,1,1
208985,to,0,0
208986,a,0,0
208987,core-decompression,0,0
208988,group,0,0
208989,or,0,1
208990,a,0,0
208991,conservatively-treated,0,1
208992,group,0,1
208993,.,0,1
208994,All,0,1
208995,were,0,0
208996,followed,0,0
208997,regularly,0,1
208998,by,0,0
208999,clinical,0,0
209000,evaluation,0,0
209001,",",0,0
209002,plain,0,0
209003,radiography,0,0
209004,and,0,0
209005,MRI,0,1
209006,at,0,1
209007,intervals,0,0
209008,of,0,1
209009,three,0,1
209010,months,0,1
209011,.,0,1
209012,The,0,0
209013,extent,0,0
209014,of,0,0
209015,ON,0,0
209016,was,0,0
209017,estimated,0,0
209018,on,0,0
209019,the,0,0
209020,basis,0,0
209021,of,0,0
209022,abnormal,0,1
209023,signal,0,1
209024,intensity,0,0
209025,in,0,0
209026,the,0,0
209027,weight-bearing,0,1
209028,portion,0,0
209029,of,0,0
209030,the,0,0
209031,femoral,0,1
209032,head,0,1
209033,as,0,0
209034,determined,0,0
209035,from,0,1
209036,a,0,0
209037,combination,0,0
209038,of,0,0
209039,coronal,0,1
209040,and,0,1
209041,sagittal,0,1
209042,MRIs,0,1
209043,.,0,1
209044,The,0,0
209045,arc,0,0
209046,of,0,0
209047,the,0,0
209048,necrotic,0,1
209049,portion,0,0
209050,in,0,0
209051,the,0,0
209052,mid-coronal,0,0
209053,image,0,0
209054,(,0,1
209055,A,0,1
209056,),0,0
209057,and,0,0
209058,that,0,0
209059,in,0,0
209060,the,0,0
209061,mid-sagittal,0,0
209062,image,0,0
209063,(,0,1
209064,B,0,1
209065,),0,1
209066,were,0,1
209067,used,0,0
209068,to,0,0
209069,quantify,0,0
209070,the,0,0
209071,extent,0,0
209072,of,0,0
209073,necrosis,0,1
209074,by,0,0
209075,the,0,0
209076,formula,0,0
209077,:,0,1
209078,(,0,1
209079,A/180,0,1
209080,),0,1
209081,x,0,1
209082,(,0,1
209083,B/180,0,1
209084,),0,1
209085,x,0,1
209086,100,0,0
209087,.,0,0
209088,There,0,0
209089,was,0,0
209090,a,0,0
209091,strong,0,0
209092,correlation,0,0
209093,between,0,0
209094,this,0,0
209095,index,0,0
209096,and,0,0
209097,the,0,0
209098,risk,0,0
209099,of,0,0
209100,collapse,0,0
209101,before,0,0
209102,and,0,0
209103,after,0,0
209104,adjustment,0,0
209105,for,0,0
209106,age,0,1
209107,",",0,0
209108,gender,0,0
209109,",",0,0
209110,stage,0,1
209111,and,0,0
209112,treatment,0,0
209113,group,0,1
209114,.,0,1
209115,We,0,0
209116,conclude,0,0
209117,that,0,0
209118,the,0,0
209119,extent,0,0
209120,of,0,0
209121,the,0,0
209122,necrotic,0,1
209123,portion,0,0
209124,ascertain,0,0
209125,by,0,0
209126,this,0,0
209127,method,0,0
209128,is,0,0
209129,a,0,0
209130,major,0,0
209131,predictor,0,0
209132,of,0,0
209133,future,0,0
209134,collapse,0,1
209135,.,0,1
209136,We,0,0
209137,propose,0,0
209138,a,0,0
209139,systematic,0,0
209140,method,0,0
209141,of,0,0
209142,determining,0,0
209143,the,0,0
209144,index,0,0
209145,of,0,0
209146,the,0,0
209147,necrotic,0,1
209148,portion,0,0
209149,which,0,0
209150,may,0,0
209151,be,0,0
209152,clinically,0,0
209153,useful,0,0
209154,in,0,0
209155,the,0,0
209156,management,0,0
209157,of,0,0
209158,early-stage,1,1
209159,ON,1,0
209160,of,1,0
209161,the,1,0
209162,femoral,1,1
209163,head,1,1
209164,.,1,1
209165,The,0,0
209166,efficacy,0,0
209167,of,0,0
209168,a,0,1
209169,herbal-based,0,0
209170,toothpaste,0,0
209171,on,0,0
209172,the,0,0
209173,control,0,1
209174,of,0,0
209175,plaque,1,0
209176,and,1,1
209177,gingivitis,1,1
209178,.,1,1
209179,A,0,0
209180,double-blind,0,0
209181,controlled,0,0
209182,clinical,0,0
209183,trial,0,1
209184,with,0,1
209185,parallel,0,0
209186,groups,0,1
209187,was,0,0
209188,designed,0,0
209189,to,0,0
209190,investigate,0,0
209191,the,0,0
209192,effectiveness,0,0
209193,of,0,0
209194,a,0,1
209195,herbal-based,0,0
209196,toothpaste,0,0
209197,in,0,0
209198,the,0,0
209199,control,0,1
209200,of,0,0
209201,plaque,0,0
209202,and,0,0
209203,gingivitis,0,1
209204,as,0,0
209205,compared,0,0
209206,with,0,1
209207,a,0,1
209208,conventional,0,1
209209,dentifrice,0,0
209210,.,0,1
209211,70,1,1
209212,subjects,1,1
209213,with,1,1
209214,gingivitis,1,1
209215,completed,0,1
209216,the,0,0
209217,6-week,0,0
209218,study,0,1
209219,.,0,1
209220,All,1,1
209221,participants,1,1
209222,had,1,1
209223,at,1,1
209224,least,1,1
209225,20,1,1
209226,natural,1,0
209227,teeth,1,1
209228,with,1,1
209229,no,1,1
209230,probing,1,1
209231,depths,1,1
209232,greater,1,1
209233,than,1,1
209234,3,1,1
209235,mm,1,1
209236,and,1,1
209237,a,1,1
209238,plaque,1,0
209239,index,1,1
209240,of,1,1
209241,2,1,1
209242,or,1,1
209243,more,1,0
209244,at,1,0
209245,baseline,1,0
209246,.,1,1
209247,At,0,0
209248,baseline,0,0
209249,",",0,0
209250,both,0,0
209251,groups,0,0
209252,were,0,1
209253,balanced,0,0
209254,for,0,0
209255,the,0,0
209256,parameters,0,0
209257,measured,0,0
209258,:,0,1
209259,plaque,0,0
209260,index,0,0
209261,",",0,0
209262,plaque,0,0
209263,vitality,0,0
209264,",",0,0
209265,gingival,0,1
209266,index,0,0
209267,",",0,0
209268,bleeding,0,0
209269,on,0,0
209270,probing,0,1
209271,and,0,1
209272,gingival,0,1
209273,crevicular,0,1
209274,fluid,0,1
209275,flow,0,0
209276,.,0,1
209277,At,0,0
209278,the,0,0
209279,end,0,0
209280,of,0,0
209281,the,0,0
209282,trial,0,0
209283,",",0,0
209284,there,0,0
209285,were,0,0
209286,reductions,0,0
209287,within,0,1
209288,both,0,0
209289,groups,0,0
209290,",",0,0
209291,however,0,0
209292,",",0,0
209293,there,0,0
209294,were,0,0
209295,no,0,0
209296,significant,0,0
209297,differences,0,0
209298,between,0,0
209299,the,0,1
209300,groups,0,0
209301,.,0,1
209302,It,0,0
209303,was,0,0
209304,concluded,0,0
209305,that,0,0
209306,the,0,0
209307,herbal,0,0
209308,based,0,1
209309,toothpaste,0,0
209310,was,0,0
209311,as,0,0
209312,effective,0,0
209313,as,0,0
209314,the,0,0
209315,conventionally,0,1
209316,formulated,0,0
209317,dentifrice,0,0
209318,in,0,0
209319,the,0,0
209320,control,0,1
209321,of,0,0
209322,plaque,0,0
209323,and,0,1
209324,gingivitis,0,1
209325,.,0,1
209326,Hemodynamic,0,0
209327,effects,0,0
209328,during,0,1
209329,induction,0,1
209330,",",0,0
209331,laryngoscopy,0,0
209332,",",0,0
209333,and,0,0
209334,intubation,0,1
209335,with,0,1
209336,eltanolone,0,0
209337,(,0,1
209338,5,0,0
209339,beta-pregnanolone,0,0
209340,),0,1
209341,or,0,1
209342,propofol,0,0
209343,.,0,1
209344,A,0,0
209345,study,0,0
209346,in,0,0
209347,ASA,1,0
209348,I,1,1
209349,and,1,1
209350,II,1,1
209351,patients,1,1
209352,.,1,1
209353,STUDY,0,0
209354,OBJECTIVE,0,0
209355,To,0,0
209356,evaluate,0,0
209357,the,0,0
209358,cardiovascular,0,1
209359,changes,0,0
209360,following,0,0
209361,induction,0,1
209362,of,0,0
209363,anesthesia,0,1
209364,",",0,0
209365,laryngoscopy,0,0
209366,",",0,0
209367,and,0,0
209368,intubation,0,1
209369,in,0,1
209370,patients,1,1
209371,receiving,1,1
209372,a,1,1
209373,bolus,1,0
209374,dose,1,0
209375,of,1,0
209376,either,1,1
209377,eltanolone,1,0
209378,or,1,1
209379,propofol,1,0
209380,.,1,1
209381,DESIGN,0,0
209382,Randomized,0,0
209383,",",0,0
209384,controlled,0,0
209385,",",0,0
209386,blind,0,0
209387,",",0,0
209388,prospective,0,1
209389,clinical,0,0
209390,study,0,1
209391,.,0,1
209392,SETTING,0,1
209393,General,0,1
209394,operating,0,0
209395,theaters,0,1
209396,of,0,1
209397,a,0,1
209398,university,0,1
209399,hospital,0,1
209400,.,0,1
209401,PATIENTS,0,0
209402,40,1,1
209403,ASA,1,1
209404,status,1,1
209405,I,1,1
209406,and,1,1
209407,II,1,1
209408,patients,1,1
209409,scheduled,1,1
209410,for,1,1
209411,elective,1,1
209412,surgery,1,1
209413,.,1,1
209414,INTERVENTIONS,0,0
209415,Patients,1,1
209416,were,1,1
209417,premedicated,1,1
209418,with,1,1
209419,oral,1,1
209420,temazepam,1,0
209421,20,1,1
209422,mg.,1,1
209423,Anesthesia,0,0
209424,was,0,0
209425,induced,0,0
209426,with,0,1
209427,either,0,1
209428,eltanolone,0,0
209429,0.58,0,0
209430,mg/kg,0,0
209431,or,0,1
209432,propofol,0,0
209433,1.7,0,0
209434,mg/kg,0,0
209435,",",0,0
209436,neuromuscular,0,1
209437,blockade,0,0
209438,was,0,0
209439,achieved,0,0
209440,with,0,1
209441,vecuronium,0,1
209442,0.1,0,0
209443,mg/kg,0,0
209444,",",0,0
209445,and,0,0
209446,anesthesia,0,1
209447,was,0,0
209448,maintained,0,0
209449,with,0,1
209450,enflurane,0,0
209451,0.5,0,0
209452,%,0,0
209453,to,0,1
209454,1.0,0,0
209455,%,0,0
209456,in,0,1
209457,nitrous,0,1
209458,oxide,0,1
209459,(,0,1
209460,67,0,1
209461,%,0,0
209462,),0,1
209463,.,0,1
209464,MEASUREMENTS,0,0
209465,AND,0,0
209466,MAIN,0,0
209467,RESULTS,0,1
209468,Blood,0,1
209469,pressure,0,0
209470,was,0,0
209471,measured,0,0
209472,using,0,0
209473,an,0,0
209474,automatic,0,0
209475,oscillometric,0,0
209476,technique,0,0
209477,",",0,0
209478,heart,0,1
209479,rate,0,0
209480,(,0,1
209481,HR,0,0
209482,),0,1
209483,was,0,0
209484,derived,0,0
209485,from,0,1
209486,the,0,0
209487,ECG,0,0
209488,",",0,0
209489,oxygen,0,0
209490,saturation,0,0
209491,was,0,0
209492,measured,0,0
209493,by,0,0
209494,pulse,0,0
209495,oximetry,0,0
209496,",",0,0
209497,and,0,0
209498,cardiac,0,1
209499,output,0,0
209500,(,0,1
209501,Q,0,1
209502,),0,1
209503,was,0,0
209504,measured,0,0
209505,by,0,0
209506,a,0,1
209507,thoracic,0,1
209508,bioimpedance,0,0
209509,technique,0,0
209510,.,0,1
209511,Induction,0,0
209512,of,0,0
209513,anesthesia,0,1
209514,with,0,1
209515,either,0,0
209516,drug,0,0
209517,",",0,0
209518,eltanolone,0,0
209519,or,0,1
209520,propofol,0,0
209521,",",0,0
209522,decreased,0,0
209523,arterial,0,1
209524,systolic,0,1
209525,(,0,1
209526,SAP,0,1
209527,),0,1
209528,and,0,1
209529,diastolic,0,1
209530,(,0,1
209531,DAP,0,1
209532,),0,1
209533,blood,0,0
209534,pressure,0,0
209535,",",0,0
209536,Q,0,0
209537,",",0,0
209538,and,0,0
209539,stroke,0,1
209540,volume,0,0
209541,(,0,1
209542,SV,0,1
209543,),0,1
209544,.,0,1
209545,HR,0,0
209546,increased,0,0
209547,.,0,1
209548,Systemic,0,0
209549,vascular,0,0
209550,resistance,0,0
209551,(,0,1
209552,SVR,0,1
209553,),0,1
209554,was,0,0
209555,unaltered,0,0
209556,.,0,1
209557,After,0,0
209558,laryngoscopy,0,0
209559,and,0,0
209560,intubation,0,1
209561,",",0,0
209562,SAP,0,1
209563,and,0,1
209564,DAP,0,0
209565,increased,0,0
209566,secondary,0,0
209567,to,0,0
209568,an,0,0
209569,increase,0,0
209570,in,0,0
209571,SVR,0,1
209572,.,0,1
209573,HR,0,0
209574,also,0,0
209575,increased,0,0
209576,;,0,0
209577,SV,0,0
209578,decreased,0,0
209579,in,0,1
209580,patients,0,1
209581,receiving,0,1
209582,eltanolone,0,0
209583,.,0,1
209584,Side,0,0
209585,effects,0,0
209586,(,0,1
209587,e.g.,0,0
209588,",",0,0
209589,apnea,0,1
209590,occurring,0,0
209591,for,0,0
209592,more,0,0
209593,than,0,1
209594,30,0,1
209595,seconds,0,0
209596,",",0,1
209597,involuntary,0,1
209598,movements,0,0
209599,",",0,1
209600,limb,0,1
209601,hypertonus,0,1
209602,),0,0
209603,occurred,0,0
209604,at,0,0
209605,a,0,1
209606,similar,0,0
209607,incidence,0,0
209608,with,0,1
209609,both,0,0
209610,treatments,0,0
209611,",",0,0
209612,but,0,0
209613,pain,0,1
209614,following,0,0
209615,injection,0,0
209616,was,0,0
209617,greater,0,0
209618,with,0,1
209619,propofol,0,0
209620,(,0,1
209621,59,0,1
209622,%,0,0
209623,vs.,0,0
209624,9,0,0
209625,%,0,0
209626,),0,1
209627,.,0,1
209628,CONCLUSIONS,0,0
209629,Patients,1,1
209630,receiving,1,1
209631,either,1,1
209632,eltanolone,1,0
209633,or,1,1
209634,propofol,1,0
209635,showed,0,0
209636,similar,0,0
209637,cardiovascular,0,1
209638,changes,0,0
209639,to,0,1
209640,induction,0,1
209641,of,0,0
209642,anesthesia,0,0
209643,",",0,0
209644,although,0,0
209645,there,0,0
209646,were,0,0
209647,greater,0,0
209648,increases,0,0
209649,in,0,0
209650,arterial,0,1
209651,pressure,0,0
209652,and,0,1
209653,HR,0,0
209654,in,0,0
209655,those,0,1
209656,patients,1,1
209657,receiving,1,1
209658,eltanolone,1,0
209659,.,1,1
209660,Does,0,0
209661,tetanus,0,1
209662,immune,0,0
209663,globulin,0,0
209664,interfere,0,0
209665,with,0,1
209666,the,0,0
209667,immune,0,0
209668,response,0,0
209669,to,0,1
209670,simultaneous,0,0
209671,administration,0,0
209672,of,0,0
209673,tetanus-diphtheria,0,1
209674,vaccine,0,1
209675,?,0,1
209676,A,0,0
209677,comparative,0,0
209678,clinical,0,0
209679,trial,1,1
209680,in,1,1
209681,adults,1,1
209682,.,1,1
209683,In,0,0
209684,the,0,0
209685,management,0,1
209686,of,0,0
209687,wounds,0,1
209688,",",0,1
209689,sometimes,0,0
209690,it,0,0
209691,is,0,0
209692,recommended,0,0
209693,to,0,0
209694,give,0,0
209695,an,0,0
209696,adult-type,0,1
209697,tetanus-diphtheria,0,1
209698,(,0,1
209699,Td,0,0
209700,),0,1
209701,vaccine,0,1
209702,dose,0,0
209703,plus,0,0
209704,tetanus,0,1
209705,immune,0,0
209706,globulin,0,0
209707,(,0,1
209708,TIG,0,1
209709,),0,1
209710,.,0,1
209711,Sixty,1,1
209712,and,1,0
209713,59,1,1
209714,healthy,1,1
209715,young,1,1
209716,adults,1,1
209717,previously,1,1
209718,immunized,1,1
209719,against,1,0
209720,tetanus,1,1
209721,(,1,1
209722,T,1,1
209723,),1,1
209724,and,1,0
209725,diphtheria,1,1
209726,(,1,1
209727,D,1,1
209728,),1,1
209729,were,1,1
209730,randomized,1,1
209731,to,1,0
209732,receive,1,0
209733,intramuscularly,1,0
209734,either,1,0
209735,Td,1,0
209736,vaccine,1,0
209737,alone,1,0
209738,(,1,0
209739,group,1,1
209740,1,1,1
209741,),1,1
209742,or,1,1
209743,Td,1,0
209744,vaccine,1,1
209745,plus,1,0
209746,500,1,1
209747,IU,1,0
209748,of,1,1
209749,TIG,1,1
209750,(,1,1
209751,group,1,1
209752,2,1,1
209753,),1,1
209754,simultaneously,1,0
209755,.,1,1
209756,Antitoxin,0,0
209757,response,0,0
209758,was,0,0
209759,assessed,0,0
209760,after,0,1
209761,4,0,1
209762,weeks,0,1
209763,and,0,1
209764,4,0,1
209765,months,0,1
209766,.,0,1
209767,Circulating,0,0
209768,antibodies,0,0
209769,were,0,1
209770,measured,0,0
209771,by,0,0
209772,enzyme-linked,0,1
209773,immunosorbent,0,0
209774,assay,0,0
209775,(,0,1
209776,ELISA,0,1
209777,),0,1
209778,.,0,1
209779,The,0,0
209780,cutoff,0,0
209781,of,0,0
209782,these,0,0
209783,tests,0,0
209784,was,0,0
209785,0.1,0,1
209786,IU/mL,0,0
209787,.,0,1
209788,Titers,0,1
209789,of,0,1
209790,0.1,0,1
209791,IU/mL,0,0
209792,or,0,1
209793,greater,0,0
209794,were,0,1
209795,considered,0,0
209796,protective,0,0
209797,.,0,1
209798,For,0,0
209799,geometric,0,0
209800,mean,0,1
209801,titers,0,0
209802,(,0,1
209803,GMT,0,1
209804,),0,1
209805,",",0,0
209806,antibody,0,0
209807,titers,0,0
209808,below,0,1
209809,the,0,0
209810,cutoff,0,0
209811,of,0,0
209812,the,0,0
209813,assay,0,0
209814,were,0,0
209815,given,0,0
209816,",",0,0
209817,arbitrarily,0,1
209818,",",0,0
209819,0.05,0,0
209820,IU/mL,0,0
209821,.,0,1
209822,At,0,0
209823,4,0,0
209824,weeks,0,1
209825,",",0,1
209826,98,0,1
209827,%,0,0
209828,or,0,1
209829,more,0,0
209830,of,0,0
209831,the,0,0
209832,subjects,0,1
209833,in,0,1
209834,group,0,1
209835,1,0,1
209836,had,0,1
209837,circulating,0,0
209838,T,0,1
209839,and,0,1
209840,D,0,1
209841,antitoxin,0,1
209842,levels,0,0
209843,of,0,1
209844,0.1,0,1
209845,IU/mL,0,0
209846,or,0,1
209847,higher,0,0
209848,;,0,0
209849,in,0,0
209850,group,0,1
209851,2,0,1
209852,",",0,1
209853,95,0,0
209854,%,0,0
209855,and,0,1
209856,90,0,1
209857,%,0,0
209858,of,0,0
209859,the,0,0
209860,subjects,0,1
209861,had,0,1
209862,titers,0,0
209863,above,0,1
209864,this,0,0
209865,limit,0,0
209866,for,0,0
209867,T,0,1
209868,and,0,1
209869,D,0,0
209870,",",0,0
209871,respectively,0,0
209872,.,0,1
209873,At,0,0
209874,4,0,0
209875,months,0,0
209876,",",0,1
209877,these,0,0
209878,percentages,0,0
209879,were,0,1
209880,98,0,1
209881,%,0,0
209882,and,0,1
209883,95,0,0
209884,%,0,0
209885,for,0,1
209886,T,0,1
209887,antitoxin,0,1
209888,levels,0,0
209889,in,0,1
209890,groups,0,1
209891,1,0,1
209892,and,0,1
209893,2,0,1
209894,",",0,0
209895,respectively,0,0
209896,;,0,0
209897,whereas,0,0
209898,96,0,1
209899,%,0,0
209900,and,0,1
209901,88,0,0
209902,%,0,0
209903,of,0,0
209904,the,0,0
209905,subjects,0,1
209906,in,0,1
209907,groups,0,1
209908,1,0,1
209909,and,0,1
209910,2,0,1
209911,had,0,1
209912,D,0,1
209913,antitoxin,0,1
209914,levels,0,0
209915,of,0,1
209916,0.1,0,1
209917,IU/mL,0,0
209918,or,0,1
209919,higher,0,0
209920,",",0,0
209921,respectively,0,0
209922,.,0,1
209923,Significantly,0,0
209924,(,0,0
209925,P,0,0
209926,<,0,0
209927,.05,0,0
209928,),0,1
209929,higher,0,0
209930,GMTs,0,0
209931,were,0,0
209932,seen,0,0
209933,at,0,0
209934,the,0,0
209935,4-week,0,0
209936,assessment,0,0
209937,(,0,0
209938,but,0,0
209939,not,0,0
209940,at,0,1
209941,4,0,0
209942,months,0,1
209943,),0,1
209944,in,0,1
209945,group,0,1
209946,1,0,0
209947,",",0,0
209948,as,0,0
209949,compared,0,0
209950,with,0,1
209951,group,0,1
209952,2,0,1
209953,",",0,0
209954,in,0,0
209955,both,0,0
209956,T,0,1
209957,and,0,0
209958,D,0,1
209959,antitoxin,0,1
209960,levels,0,0
209961,(,0,1
209962,9.91,0,0
209963,IU/mL,0,0
209964,versus,0,0
209965,5.60,0,0
209966,IU/mL,0,0
209967,for,0,1
209968,T,0,1
209969,antitoxin,0,0
209970,",",0,0
209971,and,0,0
209972,2.86,0,0
209973,IU/mL,0,0
209974,versus,0,0
209975,1.45,0,0
209976,IU/mL,0,0
209977,for,0,1
209978,D,0,1
209979,antitoxin,0,1
209980,),0,1
209981,.,0,1
209982,This,0,0
209983,finding,0,0
209984,resulted,0,0
209985,from,0,1
209986,those,0,1
209987,participants,0,1
209988,with,0,1
209989,low,0,1
209990,(,0,1
209991,<,0,0
209992,0.1,0,1
209993,IU/mL,0,0
209994,),0,1
209995,prevaccination,0,1
209996,antibody,0,0
209997,titers,0,0
209998,.,0,1
209999,(,0,0
210000,ABSTRACT,0,0
210001,TRUNCATED,0,1
210002,AT,0,1
210003,250,0,1
210004,WORDS,0,1
210005,),0,1
210006,Cyproheptadine,0,0
210007,augmentation,0,1
210008,of,0,0
210009,haloperidol,0,0
210010,in,0,1
210011,chronic,1,1
210012,schizophrenic,1,1
210013,patients,1,1
210014,:,1,1
210015,a,0,1
210016,double-blind,0,0
210017,placebo-controlled,0,0
210018,study,0,1
210019,.,0,1
210020,A,0,0
210021,6,0,0
210022,week,0,0
210023,double-blind,0,1
210024,placebo-controlled,0,0
210025,trial,0,1
210026,of,0,0
210027,cyproheptadine,1,1
210028,augmentation,1,1
210029,of,1,0
210030,ongoing,1,1
210031,haloperidol,1,0
210032,treatment,1,0
210033,was,0,0
210034,conducted,0,1
210035,in,0,1
210036,40,1,1
210037,chronic,1,1
210038,schizophrenic,1,1
210039,in-patients,1,1
210040,.,1,1
210041,Cyproheptadine,0,0
210042,augmentation,0,0
210043,",",0,0
210044,compared,0,0
210045,to,0,0
210046,administration,0,0
210047,of,0,0
210048,haloperidol,0,0
210049,with,0,1
210050,placebo,0,0
210051,",",0,0
210052,did,0,0
210053,not,0,0
210054,produce,0,0
210055,a,0,0
210056,statistically,0,0
210057,significant,0,0
210058,improvement,0,0
210059,in,0,1
210060,psychotic,0,1
210061,symptoms,0,1
210062,.,0,1
210063,Cyproheptadine,0,0
210064,augmentation,0,0
210065,caused,0,0
210066,significant,0,0
210067,reduction,0,0
210068,in,0,0
210069,the,0,0
210070,extrapyramidal,0,0
210071,symptoms,0,0
210072,",",0,0
210073,which,0,0
210074,supports,0,0
210075,the,0,0
210076,atypical,0,1
210077,profile,0,0
210078,of,0,1
210079,antipsychotics,0,1
210080,.,0,1
210081,As,0,0
210082,to,0,0
210083,the,0,0
210084,neuroendocrinological,0,0
210085,effect,0,0
210086,",",0,0
210087,cyproheptadine,0,0
210088,augmentation,0,0
210089,did,0,0
210090,not,0,0
210091,reduce,0,0
210092,the,0,0
210093,plasma,0,0
210094,prolactin,0,0
210095,level,0,0
210096,but,0,0
210097,did,0,0
210098,induce,0,0
210099,a,0,0
210100,decrease,0,0
210101,in,0,0
210102,the,0,0
210103,plasma,0,0
210104,cortisol,0,0
210105,level,0,0
210106,.,0,1
210107,Although,0,0
210108,long-term,0,0
210109,follow-up,0,1
210110,studies,0,0
210111,are,0,0
210112,needed,0,0
210113,to,0,0
210114,confirm,0,0
210115,the,0,0
210116,results,0,0
210117,",",0,0
210118,this,0,0
210119,study,0,0
210120,suggests,0,0
210121,that,0,0
210122,cyproheptadine,0,0
210123,augmentation,0,1
210124,may,0,0
210125,be,0,0
210126,effective,0,0
210127,in,0,0
210128,treating,0,1
210129,chronic,1,1
210130,schizophrenic,1,1
210131,patients,1,1
210132,who,1,1
210133,are,1,1
210134,intolerant,1,1
210135,of,1,0
210136,extrapyramidal,1,1
210137,side,1,0
210138,effects,1,0
210139,of,1,1
210140,conventional,1,1
210141,antipsychotics,1,1
210142,.,1,1
210143,[,0,0
210144,Late,0,0
210145,cardiac,0,1
210146,toxicity,0,0
210147,in,0,1
210148,Hodgkin,0,1
210149,'s,0,1
210150,disease,0,1
210151,.,0,1
210152,A,0,0
210153,study,0,0
210154,with,0,1
210155,pulsed,0,1
210156,Doppler,0,1
210157,echocardiography,0,1
210158,],0,1
210159,.,0,1
210160,49,1,1
210161,patients,1,1
210162,(,1,1
210163,22,1,1
210164,women,1,1
210165,",",1,1
210166,27,1,1
210167,men,1,1
210168,",",1,1
210169,mean,1,1
210170,age,1,1
210171,43.7,1,0
210172,[,1,1
210173,21-65,1,1
210174,],1,1
210175,years,1,1
210176,),1,1
210177,with,1,1
210178,Hodgkin,1,1
210179,'s,1,1
210180,disease,1,1
210181,were,0,1
210182,examined,0,0
210183,by,0,0
210184,Doppler,0,1
210185,echocardiography,0,0
210186,a,0,0
210187,median,1,0
210188,of,1,0
210189,5.37,1,0
210190,(,1,1
210191,2-10,1,1
210192,),1,1
210193,years,1,1
210194,after,1,1
210195,the,1,0
210196,end,1,0
210197,of,1,0
210198,chemotherapy,1,1
210199,(,1,1
210200,given,1,0
210201,according,1,1
210202,to,1,0
210203,the,1,0
210204,COPP/ABVD,1,1
210205,scheme,1,0
210206,",",1,0
210207,with,1,1
210208,or,1,1
210209,without,1,1
210210,mediastinal,1,1
210211,irradiation,1,1
210212,),1,1
210213,for,0,0
210214,possible,0,0
210215,chronic,0,1
210216,changes,0,0
210217,in,0,1
210218,myocardium,0,1
210219,",",0,0
210220,pericardium,0,0
210221,or,0,1
210222,cardiac,0,1
210223,valves,0,1
210224,",",0,0
210225,as,0,0
210226,well,0,0
210227,as,0,0
210228,for,0,0
210229,any,0,1
210230,haemodynamic,0,0
210231,sequelae,0,0
210232,.,0,1
210233,Maximal,0,0
210234,and,0,0
210235,integrated,0,0
210236,early,0,1
210237,(,0,1
210238,E,0,0
210239,",",0,1
210240,Ei,0,1
210241,),0,1
210242,and,0,1
210243,late,0,1
210244,(,0,1
210245,A,0,1
210246,",",0,1
210247,Ai,0,0
210248,),0,1
210249,diastolic,0,1
210250,flow,0,0
210251,velocities,0,0
210252,and,0,1
210253,their,0,1
210254,ratio,0,0
210255,(,0,1
210256,E/A,0,0
210257,",",0,1
210258,Ei/Ai,0,0
210259,),0,1
210260,were,0,0
210261,measured,0,0
210262,by,0,0
210263,pulsed,0,1
210264,Doppler,0,1
210265,over,0,0
210266,the,0,0
210267,mitral,0,1
210268,and,0,1
210269,tricuspid,0,1
210270,valves,0,1
210271,.,0,1
210272,Although,0,0
210273,on,0,0
210274,two-dimensional,0,1
210275,echo,0,1
210276,21,0,1
210277,patients,0,1
210278,(,0,1
210279,42.9,0,1
210280,%,0,0
210281,),0,1
210282,were,0,1
210283,found,0,0
210284,to,0,0
210285,have,0,0
210286,valvar,0,1
210287,thickening,0,1
210288,",",0,1
210289,19,0,1
210290,(,0,1
210291,38.8,0,1
210292,%,0,0
210293,),0,1
210294,pericardial,0,1
210295,thickening,0,1
210296,and,0,1
210297,9,0,0
210298,(,0,1
210299,18.4,0,0
210300,%,0,0
210301,),0,1
210302,a,0,0
210303,reduced,0,0
210304,fibre,0,0
210305,shortening,0,0
210306,fraction,0,0
210307,",",0,0
210308,the,0,0
210309,Doppler,0,0
210310,indices,0,0
210311,were,0,1
210312,statistically,0,0
210313,not,0,0
210314,significantly,0,0
210315,different,0,0
210316,from,0,0
210317,those,0,1
210318,in,0,1
210319,25,0,1
210320,controls,0,1
210321,with,0,1
210322,normal,0,1
210323,hearts,0,1
210324,.,0,1
210325,These,0,1
210326,echocardiographic,0,1
210327,data,0,0
210328,of,0,1
210329,functional,0,1
210330,and,0,1
210331,morphological,0,1
210332,parameters,0,0
210333,indicate,0,0
210334,that,0,0
210335,there,0,0
210336,was,0,0
210337,no,0,0
210338,effect,0,0
210339,on,0,0
210340,various,0,0
210341,measurements,0,0
210342,of,0,1
210343,diastolic,0,1
210344,function,0,0
210345,after,0,0
210346,chemotherapy,0,1
210347,with,0,1
210348,or,0,1
210349,without,0,1
210350,mediastinal,0,1
210351,radiation,0,1
210352,.,0,1
210353,In,0,0
210354,successfully,1,0
210355,treated,1,1
210356,patients,1,1
210357,with,1,1
210358,Hodgkin,1,1
210359,'s,1,1
210360,disease,1,1
210361,the,0,1
210362,described,0,0
210363,changes,0,0
210364,are,0,0
210365,of,0,0
210366,minor,0,0
210367,significance,0,0
210368,.,0,1
210369,Quantifications,1,0
210370,of,1,1
210371,the,1,1
210372,major,1,1
210373,urinary,1,0
210374,metabolite,1,0
210375,of,1,0
210376,the,1,0
210377,E,1,0
210378,prostaglandins,1,0
210379,by,1,0
210380,mass,1,1
210381,spectrometry,1,1
210382,:,1,1
210383,evaluation,1,0
210384,of,1,0
210385,the,1,0
210386,method,1,0
210387,'s,1,1
210388,application,1,0
210389,to,1,1
210390,clinical,1,0
210391,studies,1,0
210392,.,1,1
210393,Measurement,0,0
210394,of,0,0
210395,"7alpha-hydroxy-5,11-diketotetranoprostane-1,16-dioic",0,0
210396,acid,0,0
210397,",",0,0
210398,(,0,0
210399,PGE-M,0,0
210400,),0,1
210401,",",0,0
210402,the,0,0
210403,major,0,0
210404,urinary,0,0
210405,metabolite,0,0
210406,of,0,0
210407,prostaglandin,0,0
210408,E1,0,1
210409,and,0,1
210410,E2,0,1
210411,in,0,0
210412,man,1,1
210413,provides,0,0
210414,a,0,0
210415,useful,0,0
210416,indicator,0,0
210417,to,0,0
210418,monitor,0,0
210419,prostaglandin,0,0
210420,biosynthesis,0,0
210421,.,0,1
210422,For,0,0
210423,quantitative,0,0
210424,analysis,0,0
210425,of,0,0
210426,this,0,0
210427,prostaglandin,0,0
210428,metabolite,0,0
210429,and,0,0
210430,the,0,0
210431,stable-isotope,0,0
210432,dilution,0,0
210433,techniqe,0,0
210434,of,0,0
210435,selected,0,1
210436,ion,0,0
210437,monitoring,0,0
210438,(,0,1
210439,SIM,0,1
210440,),0,1
210441,is,0,0
210442,employed,0,0
210443,using,0,0
210444,gas-liquid,0,0
210445,chromatography-mass,0,1
210446,spectrometry,0,1
210447,.,0,1
210448,The,0,0
210449,preparation,0,0
210450,of,0,0
210451,the,0,0
210452,bis,0,0
210453,(,0,0
210454,D3-methyloxime,0,0
210455,),0,1
210456,",",0,0
210457,bis-methyl,0,0
210458,ester,0,0
210459,of,0,1
210460,PGE-M,0,0
210461,containing,0,0
210462,a,0,0
210463,tritium,0,0
210464,tracer,0,0
210465,in,0,0
210466,position,0,1
210467,2,0,1
210468,which,0,0
210469,was,0,0
210470,used,0,0
210471,as,0,0
210472,internal,0,0
210473,standard,0,1
210474,for,0,0
210475,the,0,0
210476,SIM,0,1
210477,method,0,0
210478,is,0,0
210479,described,0,0
210480,.,0,0
210481,The,0,0
210482,synthesis,0,0
210483,of,0,0
210484,this,0,0
210485,internal,0,0
210486,standard,0,0
210487,includes,0,0
210488,the,0,0
210489,biosynthetic,0,0
210490,conversion,0,0
210491,of,0,0
210492,"11-hydroxy-9,15-diketoprostanoic",0,0
210493,acid,0,0
210494,to,0,1
210495,PGE-M,0,0
210496,by,0,0
210497,the,0,0
210498,rabbit,0,0
210499,.,0,0
210500,The,0,0
210501,intra-assay,0,0
210502,coefficient,0,0
210503,of,0,0
210504,variation,0,0
210505,of,0,0
210506,this,0,0
210507,SIM,0,1
210508,method,0,0
210509,ranged,0,0
210510,between,0,0
210511,4.0,0,0
210512,to,0,1
210513,6.7,0,0
210514,percent,0,1
210515,.,0,1
210516,The,0,0
210517,recovery,0,0
210518,of,0,0
210519,authentic,0,0
210520,",",0,1
210521,underivatized,0,0
210522,PGE-M,0,1
210523,added,0,0
210524,to,0,0
210525,urine,0,1
210526,was,0,0
210527,93,0,1
210528,+/-,0,0
210529,3,0,1
210530,%,0,0
210531,(,0,1
210532,mean,0,1
210533,+/-,0,0
210534,SEM,0,0
210535,",",0,1
210536,n=17,0,1
210537,),0,1
210538,.,0,1
210539,The,0,0
210540,levels,0,0
210541,of,0,1
210542,PGE-M,0,1
210543,excreted,0,0
210544,in,0,0
210545,urine,1,0
210546,were,0,1
210547,higher,0,0
210548,(,0,0
210549,p,0,0
210550,less,0,0
210551,than,0,1
210552,0.001,0,0
210553,),0,1
210554,in,0,1
210555,males,1,1
210556,than,1,1
210557,in,1,1
210558,females,1,1
210559,(,1,1
210560,15.2,1,1
210561,+/-,1,1
210562,1.9,1,1
210563,mug/24,1,1
210564,hours,1,0
210565,(,1,1
210566,n=24,1,1
210567,),1,1
210568,and,1,1
210569,3.3,1,1
210570,+/-,1,0
210571,0.3,1,0
210572,mug/24,1,1
210573,hours,1,0
210574,(,1,1
210575,n=17,1,1
210576,),1,0
210577,",",1,0
210578,respectively,1,0
210579,.,1,1
210580,These,0,0
210581,levels,0,0
210582,were,0,1
210583,in,0,1
210584,close,0,0
210585,agreement,0,1
210586,with,0,1
210587,values,0,0
210588,published,0,1
210589,previously,0,1
210590,.,0,1
210591,No,0,0
210592,significant,0,0
210593,difference,0,0
210594,in,0,0
210595,excretion,0,0
210596,of,0,0
210597,PGE-M,0,0
210598,between,0,0
210599,the,0,0
210600,sexes,1,1
210601,was,1,0
210602,observed,1,0
210603,in,1,0
210604,the,1,0
210605,pre-pubertal,1,1
210606,age-grou,1,1
210607,(,1,1
210608,male,1,1
210609,:,1,1
210610,2.9,1,0
210611,+/-,1,0
210612,0.8,1,1
210613,mug/24,1,1
210614,hours,1,0
210615,",",1,1
210616,n=5,1,1
210617,;,1,0
210618,female,1,1
210619,:,1,1
210620,3.1,1,0
210621,+/-,1,0
210622,0.9,1,0
210623,mug/24,1,1
210624,hours,1,0
210625,",",1,1
210626,n=5,1,1
210627,),1,0
210628,or,1,1
210629,in,1,0
210630,the,1,0
210631,age-group,1,1
210632,of,1,0
210633,45-80,1,1
210634,years,1,1
210635,(,1,1
210636,male,1,1
210637,:,1,1
210638,9.3,1,1
210639,+/-,1,0
210640,1.1,1,1
210641,mug/24,1,1
210642,hours,1,0
210643,",",1,1
210644,n=21,1,1
210645,;,1,0
210646,female,1,1
210647,:,1,1
210648,7.3,1,0
210649,+/-,1,0
210650,0.9,1,0
210651,mug/24,1,1
210652,hours,1,0
210653,",",1,0
210654,n=12,1,1
210655,),1,0
210656,.,1,0
210657,The,0,0
210658,amount,0,0
210659,of,0,0
210660,PGE-M,0,1
210661,excreted,0,0
210662,decreased,0,0
210663,significantly,0,0
210664,after,0,0
210665,administration,0,0
210666,of,0,0
210667,indomethacin,0,0
210668,or,0,1
210669,acetyl,0,0
210670,salicylic,0,0
210671,acid,0,0
210672,in,0,1
210673,therapeutic,0,1
210674,doses,0,0
210675,.,0,1
210676,The,0,0
210677,concomitant,0,0
210678,reduction,0,0
210679,of,0,0
210680,the,0,0
210681,urinary,0,0
210682,excretion,0,0
210683,of,0,1
210684,PGE-M,0,1
210685,(,0,1
210686,68,0,1
210687,to,0,1
210688,85,0,1
210689,%,0,0
210690,decrease,0,0
210691,),0,1
210692,and,0,1
210693,prostaglandin,0,0
210694,E,0,1
210695,(,0,1
210696,73,0,1
210697,to,0,1
210698,100,0,1
210699,%,0,0
210700,decrease,0,0
210701,),0,1
210702,after,0,0
210703,indomethacin,0,0
210704,treatment,0,0
210705,in,0,0
210706,each,0,0
210707,case,0,0
210708,(,0,0
210709,n=8,0,1
210710,),0,0
210711,is,0,0
210712,evidence,0,0
210713,that,0,0
210714,a,0,1
210715,diminished,0,0
210716,urinary,0,1
210717,PGE-M,0,0
210718,output,0,0
210719,reflects,0,0
210720,a,0,0
210721,decrease,0,0
210722,in,0,0
210723,prostaglandin,0,0
210724,E,0,1
210725,biosynthesis,0,0
210726,.,0,1
210727,Plasma,0,1
210728,norepinephrine,0,0
210729,and,0,1
210730,mortality,0,0
210731,.,0,1
210732,Plasma,0,0
210733,norepinephrine,0,0
210734,levels,0,0
210735,",",0,0
210736,which,0,0
210737,reflect,0,0
210738,sympathetic,0,0
210739,nervous,0,1
210740,system,0,1
210741,activity,0,0
210742,",",0,0
210743,are,0,0
210744,almost,0,0
210745,universally,0,0
210746,elevated,0,0
210747,in,0,0
210748,patients,1,1
210749,with,1,1
210750,left,1,1
210751,ventricular,1,1
210752,dysfunction,1,1
210753,.,1,1
210754,This,0,0
210755,elevation,0,0
210756,occurs,0,0
210757,in,0,0
210758,patients,1,1
210759,with,1,1
210760,overt,1,1
210761,",",1,1
210762,symptomatic,1,1
210763,heart,1,1
210764,failure,1,1
210765,(,1,1
210766,HF,1,1
210767,),1,1
210768,and,1,1
210769,in,1,1
210770,patients,1,1
210771,with,1,1
210772,asymptomatic,1,1
210773,left,1,1
210774,ventricular,1,1
210775,dysfunction,1,1
210776,.,1,1
210777,Evidence,0,0
210778,suggests,0,0
210779,that,0,0
210780,the,0,0
210781,elevation,0,0
210782,in,0,0
210783,plasma,0,0
210784,norepinephrine,0,0
210785,levels,0,0
210786,can,0,0
210787,be,0,0
210788,at,0,0
210789,least,0,0
210790,partly,0,0
210791,attributed,0,0
210792,to,0,0
210793,an,0,0
210794,increase,0,0
210795,in,0,0
210796,sympathetic,0,0
210797,nervous,0,1
210798,system,0,1
210799,activity,0,0
210800,.,0,0
210801,It,0,0
210802,has,0,0
210803,become,0,0
210804,evident,0,0
210805,that,0,0
210806,elevated,0,1
210807,plasma,0,0
210808,norepinephrine,0,0
210809,levels,0,0
210810,are,0,0
210811,directly,0,0
210812,related,0,0
210813,to,0,0
210814,prognosis,0,1
210815,;,0,1
210816,patients,0,1
210817,with,0,1
210818,levels,0,1
210819,>,0,1
210820,900,0,1
210821,pg/ml,0,0
210822,have,0,1
210823,a,0,0
210824,poor,0,0
210825,prognosis,0,0
210826,and,0,0
210827,shortened,0,0
210828,life,0,1
210829,expectancy,0,1
210830,.,0,1
210831,However,0,0
210832,",",0,0
210833,plasma,0,0
210834,norepinephrine,0,0
210835,levels,0,0
210836,bear,0,0
210837,little,0,0
210838,relationship,0,0
210839,to,0,0
210840,physiologic,0,0
210841,and,0,1
210842,clinical,0,0
210843,variables,0,0
210844,observed,0,0
210845,in,0,1
210846,HF,0,1
210847,",",0,0
210848,including,0,0
210849,ejection,0,1
210850,fraction,0,1
210851,and,0,0
210852,exercise,0,0
210853,capacity,0,1
210854,.,0,1
210855,Data,1,0
210856,from,1,1
210857,the,1,1
210858,V-HeFT,1,1
210859,II,1,1
210860,show,1,0
210861,that,1,0
210862,at,1,0
210863,2-year,1,1
210864,follow-up,1,0
210865,",",0,0
210866,a,0,0
210867,progressive,0,0
210868,rise,0,0
210869,of,0,0
210870,plasma,0,0
210871,norepinephrine,0,0
210872,was,0,0
210873,observed,0,0
210874,in,0,0
210875,both,0,0
210876,treatment,0,0
210877,arms,0,0
210878,",",0,0
210879,suggesting,0,0
210880,that,0,0
210881,disease,0,1
210882,progresses,0,0
210883,despite,0,0
210884,treatment,0,0
210885,with,0,1
210886,either,0,0
210887,an,0,0
210888,angiotensin-converting,0,0
210889,enzyme,0,0
210890,inhibitor,0,0
210891,",",0,0
210892,enalapril,0,0
210893,",",0,0
210894,or,0,1
210895,vasodilator,0,0
210896,therapy,0,0
210897,with,0,1
210898,hydralazine/isosorbide,0,0
210899,dinitrate,0,1
210900,.,0,1
210901,It,0,0
210902,is,0,0
210903,possible,0,0
210904,that,0,0
210905,interventions,0,0
210906,aimed,0,0
210907,at,0,1
210908,the,0,0
210909,progressive,0,1
210910,neurohormonal,0,0
210911,activation,0,0
210912,that,0,0
210913,occurs,0,0
210914,in,0,0
210915,HF,0,0
210916,may,0,0
210917,improve,0,0
210918,the,0,0
210919,course,0,0
210920,of,0,0
210921,illness,0,1
210922,.,0,1
210923,Further,0,0
210924,study,0,0
210925,is,0,0
210926,needed,0,0
210927,to,0,0
210928,test,0,0
210929,this,0,0
210930,hypothesis,0,0
210931,.,0,1
210932,A,0,0
210933,prospective,0,0
210934,comparison,0,0
210935,of,0,0
210936,the,0,0
210937,multiplane,0,1
210938,probe,0,0
210939,with,0,1
210940,the,0,0
210941,biplane,0,0
210942,probe,0,0
210943,in,0,0
210944,structure,0,1
210945,visualization,0,0
210946,and,0,0
210947,Doppler,0,0
210948,examination,0,1
210949,during,1,0
210950,transesophageal,1,1
210951,echocardiography,1,1
210952,.,1,1
210953,To,0,0
210954,compare,0,0
210955,the,0,0
210956,imaging,0,0
210957,capability,0,0
210958,of,0,0
210959,the,0,0
210960,multiplane,0,1
210961,probe,0,0
210962,with,0,1
210963,that,0,0
210964,of,0,0
210965,the,0,0
210966,biplane,0,0
210967,probe,0,0
210968,",",0,1
210969,317,1,1
210970,consecutive,1,1
210971,patients,1,1
210972,were,0,1
210973,randomized,0,1
210974,to,0,0
210975,undergo,0,1
210976,transesophageal,0,1
210977,echocardiography,0,0
210978,with,0,1
210979,either,0,1
210980,probe,0,0
210981,.,0,1
210982,Images,0,1
210983,of,0,1
210984,24,0,1
210985,cardiac,0,1
210986,structures,0,1
210987,and,0,1
210988,nine,0,1
210989,Doppler,0,1
210990,signals,0,0
210991,were,0,1
210992,graded,0,0
210993,prospectively,0,1
210994,on,0,0
210995,a,0,0
210996,three-grade,0,1
210997,system,0,0
210998,.,0,1
210999,Both,0,0
211000,multiplane,0,0
211001,and,0,0
211002,biplane,0,0
211003,probes,0,1
211004,provided,0,0
211005,excellent,0,0
211006,visualization,0,0
211007,of,0,1
211008,cardiac,0,1
211009,structures,0,1
211010,and,0,1
211011,Doppler,0,1
211012,signals,0,0
211013,",",0,1
211014,but,0,0
211015,the,0,0
211016,multiplane,0,1
211017,probe,0,0
211018,was,0,0
211019,significantly,0,0
211020,superior,0,0
211021,to,0,0
211022,the,0,0
211023,biplane,0,0
211024,probe,0,0
211025,.,0,0
211026,There,0,0
211027,were,0,0
211028,no,0,0
211029,differences,0,0
211030,in,0,0
211031,the,0,0
211032,number,0,0
211033,of,0,0
211034,attempts,0,1
211035,at,0,1
211036,esophageal,0,1
211037,intubation,0,1
211038,",",0,0
211039,the,0,0
211040,amount,0,0
211041,of,0,0
211042,sedation,0,1
211043,used,0,0
211044,",",0,0
211045,and,0,0
211046,the,0,0
211047,examination,0,0
211048,time,0,0
211049,.,0,1
211050,The,0,0
211051,number,0,0
211052,of,0,0
211053,complications,0,1
211054,was,0,0
211055,similar,0,0
211056,",",0,0
211057,although,0,0
211058,all,0,0
211059,failed,0,1
211060,intubations,0,1
211061,occurred,0,0
211062,with,0,1
211063,the,0,0
211064,multiplane,0,1
211065,probe,0,0
211066,.,0,1
211067,[,0,1
211068,Postoperative,0,1
211069,analgesia,0,1
211070,:,0,1
211071,peridural,0,1
211072,morphine,0,0
211073,versus,0,0
211074,sublingual,0,1
211075,buprenorphine,0,1
211076,.,0,1
211077,Comparative,0,0
211078,clinical,0,0
211079,study,0,1
211080,],0,1
211081,.,0,1
211082,The,0,0
211083,authors,0,0
211084,herein,0,0
211085,present,0,0
211086,their,0,1
211087,personal,0,1
211088,series,0,1
211089,on,0,0
211090,the,0,0
211091,clinical,0,0
211092,evaluation,0,0
211093,of,0,0
211094,the,0,0
211095,analgesic,0,0
211096,efficacy,0,0
211097,of,0,1
211098,2,0,1
211099,opiodes,0,1
211100,",",0,1
211101,peridural,0,1
211102,morphine,0,0
211103,hydrochloride,0,0
211104,(,0,1
211105,0.5,0,0
211106,mg/kg,0,0
211107,),0,1
211108,administered,0,0
211109,to,0,0
211110,group,1,1
211111,A,1,1
211112,patients,1,1
211113,",",0,1
211114,and,0,1
211115,sublingual,0,1
211116,buprenorphine,0,1
211117,(,0,1
211118,0.4,0,1
211119,mg,0,1
211120,),0,1
211121,administered,0,0
211122,to,0,0
211123,group,1,1
211124,B,1,1
211125,patients,1,1
211126,in,0,1
211127,the,0,0
211128,management,0,0
211129,of,0,0
211130,post-operative,0,0
211131,pain,0,1
211132,in,0,1
211133,major,0,1
211134,abdominal,0,1
211135,surgery,0,1
211136,.,0,1
211137,The,0,0
211138,study,0,0
211139,was,0,0
211140,conducted,0,1
211141,on,0,0
211142,44,1,1
211143,patients,1,1
211144,",",1,1
211145,both,1,0
211146,male,1,1
211147,and,1,0
211148,female,1,1
211149,",",1,0
211150,classified,1,1
211151,as,1,0
211152,ASA,1,1
211153,II,1,1
211154,and,1,1
211155,III,1,1
211156,.,1,1
211157,Statistical,0,0
211158,analysis,0,0
211159,of,0,1
211160,cardiovascular,0,1
211161,parameters,0,0
211162,(,0,1
211163,BP,0,1
211164,and,0,1
211165,cardiac,0,1
211166,frequency,0,0
211167,),0,1
211168,",",0,0
211169,respiratory,0,1
211170,frequency,0,0
211171,and,0,0
211172,pain,0,1
211173,score,0,0
211174,showed,0,0
211175,an,0,0
211176,overlapping,0,1
211177,progression,0,0
211178,among,0,1
211179,the,0,1
211180,two,0,1
211181,groups,0,1
211182,.,0,1
211183,Spontaneous,0,1
211184,pain,0,1
211185,decreased,0,0
211186,significantly,0,0
211187,to,0,0
211188,zero,0,0
211189,at,0,1
211190,T6,0,1
211191,(,0,1
211192,p,0,0
211193,<,0,0
211194,0.001,0,0
211195,),0,1
211196,.,0,1
211197,However,0,0
211198,",",0,0
211199,the,0,0
211200,necessity,0,0
211201,to,0,0
211202,administer,0,0
211203,buprenorphine,0,0
211204,more,0,0
211205,frequently,0,0
211206,after,0,0
211207,the,0,0
211208,sixth,0,0
211209,hour,0,0
211210,and,0,0
211211,the,0,0
211212,consequent,0,0
211213,increase,0,0
211214,in,0,1
211215,side,0,0
211216,effects,0,0
211217,",",0,1
211218,lead,0,0
211219,us,0,0
211220,to,0,0
211221,believe,0,0
211222,that,0,0
211223,the,0,0
211224,method,0,0
211225,used,0,0
211226,for,0,0
211227,group,1,1
211228,A,1,1
211229,patients,1,1
211230,is,0,0
211231,more,0,0
211232,advantageous,0,0
211233,.,0,0
211234,Low,0,1
211235,power,0,0
211236,Ga-Al-As,0,1
211237,laser,0,0
211238,treatment,0,0
211239,of,0,0
211240,painful,1,1
211241,osteoarthritis,1,1
211242,of,1,0
211243,the,1,0
211244,knee,1,1
211245,.,1,0
211246,A,0,0
211247,double-blind,0,0
211248,placebo-controlled,0,0
211249,study,0,1
211250,.,0,1
211251,The,0,0
211252,aim,0,0
211253,of,0,0
211254,this,0,0
211255,double-blind,0,0
211256,study,0,0
211257,was,0,0
211258,to,0,0
211259,evaluate,0,0
211260,the,0,0
211261,effect,0,0
211262,of,0,0
211263,low,0,1
211264,power,0,0
211265,Ga-Al-As,0,1
211266,laser,0,0
211267,treatment,0,0
211268,on,0,0
211269,chronic,1,1
211270,pain,1,1
211271,related,1,0
211272,to,1,0
211273,osteoarthritis,1,1
211274,of,1,0
211275,the,1,0
211276,knee,1,1
211277,with,1,1
211278,periarticular,1,1
211279,tender,1,1
211280,points,1,0
211281,.,1,1
211282,Twenty-nine,1,1
211283,out-patients,1,1
211284,with,1,1
211285,uni-,1,1
211286,or,1,1
211287,bilateral,1,1
211288,osteoarthritis,1,1
211289,of,1,0
211290,the,1,0
211291,knee,1,1
211292,were,0,0
211293,included,0,1
211294,and,0,0
211295,randomly,0,1
211296,assigned,0,1
211297,to,0,0
211298,treatment,0,0
211299,with,0,1
211300,either,0,1
211301,laser,0,0
211302,or,0,1
211303,placebo,0,0
211304,laser,0,0
211305,.,0,1
211306,Fourteen,1,1
211307,patients,1,1
211308,received,1,1
211309,active,1,1
211310,laser,1,0
211311,treatment,1,0
211312,and,0,0
211313,all,0,1
211314,patients,0,1
211315,included,0,1
211316,completed,0,1
211317,the,0,0
211318,study,0,0
211319,.,0,0
211320,The,1,0
211321,effect,1,0
211322,variables,1,0
211323,were,1,1
211324,daily,1,0
211325,levels,1,0
211326,of,1,1
211327,pain,1,1
211328,",",1,1
211329,analgesic,1,0
211330,requirements,1,0
211331,",",1,1
211332,palpation,1,0
211333,tenderness,1,0
211334,and,1,1
211335,isokinetic,1,0
211336,quadriceps,1,1
211337,strength,1,1
211338,.,1,1
211339,Each,0,0
211340,patient,0,0
211341,participated,0,1
211342,in,0,0
211343,the,0,0
211344,study,0,1
211345,for,0,0
211346,9,0,1
211347,weeks,0,1
211348,and,0,1
211349,registered,0,1
211350,daily,0,0
211351,level,0,0
211352,of,0,0
211353,pain,0,1
211354,and,0,0
211355,consumption,0,0
211356,of,0,1
211357,analgesics,0,0
211358,.,0,1
211359,In,0,1
211360,weeks,0,0
211361,4,0,1
211362,",",0,1
211363,5,0,0
211364,and,0,1
211365,6,0,1
211366,the,0,0
211367,patients,0,1
211368,received,0,0
211369,a,0,1
211370,total,0,1
211371,of,0,0
211372,nine,0,1
211373,treatments,0,0
211374,",",0,0
211375,each,0,1
211376,of,0,0
211377,15,0,1
211378,min,0,0
211379,and,0,1
211380,administered,0,0
211381,to,0,0
211382,periarticular,0,1
211383,tender,0,1
211384,points,0,0
211385,.,0,1
211386,The,0,0
211387,dose,0,0
211388,per,0,0
211389,treatment,0,1
211390,was,0,0
211391,22.5,0,0
211392,joule,0,1
211393,.,0,1
211394,No,0,0
211395,significant,0,0
211396,differences,0,0
211397,in,0,1
211398,any,0,1
211399,of,0,0
211400,the,0,0
211401,effect,0,0
211402,variables,0,0
211403,were,0,1
211404,found,0,0
211405,between,0,0
211406,the,0,1
211407,two,0,0
211408,groups,0,0
211409,before,0,0
211410,",",0,1
211411,during,0,0
211412,or,0,1
211413,after,0,1
211414,treatment,0,0
211415,.,0,1
211416,With,0,0
211417,regard,0,0
211418,to,0,1
211419,the,0,0
211420,patients,0,1
211421,',0,1
211422,overall,0,0
211423,assessment,0,0
211424,there,0,0
211425,was,0,0
211426,a,0,0
211427,clearly,0,0
211428,demonstrable,0,0
211429,positive,0,1
211430,effect,0,0
211431,of,0,0
211432,treatment,0,0
211433,in,0,1
211434,both,0,0
211435,groups,0,0
211436,.,0,0
211437,This,0,0
211438,is,0,0
211439,likely,0,0
211440,to,0,0
211441,be,0,0
211442,due,0,0
211443,to,0,0
211444,a,0,1
211445,placebo,0,0
211446,effect,0,0
211447,.,0,1
211448,Lipoprotein,0,0
211449,(,0,1
211450,a,0,1
211451,),0,1
211452,serum,0,0
211453,levels,0,0
211454,in,0,1
211455,post-menopausal,1,1
211456,women,1,1
211457,treated,1,1
211458,with,1,1
211459,oral,1,1
211460,estrogens,1,1
211461,administered,1,0
211462,at,1,1
211463,different,1,1
211464,times,1,0
211465,.,1,1
211466,The,0,0
211467,different,0,0
211468,effects,0,0
211469,on,0,0
211470,serum,0,0
211471,lipoprotein,0,0
211472,(,0,0
211473,a,0,1
211474,),0,0
211475,[,0,0
211476,Lp,0,1
211477,(,0,1
211478,a,0,1
211479,),0,1
211480,],0,1
211481,levels,0,0
211482,by,0,1
211483,administering,0,0
211484,estrogens,0,1
211485,at,0,1
211486,different,0,1
211487,times,0,0
211488,of,0,1
211489,the,0,0
211490,day,0,0
211491,(,0,0
211492,8,0,0
211493,a.m.,0,0
211494,and,0,1
211495,8,0,0
211496,p.m.,0,1
211497,),0,1
211498,were,0,0
211499,evaluated,0,0
211500,in,0,0
211501,twenty-four,1,1
211502,post-menopausal,1,1
211503,women,1,1
211504,.,1,1
211505,Patients,0,1
211506,were,0,1
211507,assigned,0,1
211508,to,0,1
211509,one,0,1
211510,of,0,0
211511,the,0,0
211512,two,0,0
211513,treatment,0,0
211514,groups,0,1
211515,by,0,1
211516,random,0,1
211517,sampling,0,1
211518,numbers,0,0
211519,.,0,1
211520,Patients,0,1
211521,of,0,0
211522,both,0,0
211523,groups,0,0
211524,received,0,1
211525,0.625,0,0
211526,mg,0,0
211527,conjugated,0,0
211528,equine,0,1
211529,estrogens,0,0
211530,daily,0,0
211531,per,0,1
211532,os,0,0
211533,for,0,1
211534,21,0,1
211535,days,0,1
211536,.,0,1
211537,Group,0,1
211538,A,0,1
211539,patients,0,1
211540,(,0,1
211541,n,0,1
211542,:,0,1
211543,9,0,1
211544,),0,1
211545,received,0,1
211546,the,0,0
211547,pill,0,0
211548,at,0,0
211549,8,0,1
211550,a.m.,0,0
211551,",",0,0
211552,and,0,0
211553,group,0,1
211554,B,0,1
211555,patients,0,1
211556,(,0,1
211557,n,0,1
211558,:,0,1
211559,12,0,1
211560,),0,1
211561,received,0,1
211562,the,0,0
211563,pill,0,0
211564,at,0,0
211565,8,0,1
211566,p.m,0,1
211567,.,0,0
211568,There,0,0
211569,were,0,0
211570,no,0,0
211571,statistically,0,0
211572,significant,0,0
211573,differences,0,0
211574,between,0,0
211575,the,0,1
211576,two,0,0
211577,treatment,0,0
211578,groups,0,1
211579,as,0,1
211580,regards,0,0
211581,the,0,1
211582,anthropometric,0,1
211583,characteristics,0,0
211584,",",0,1
211585,the,0,0
211586,basal,0,0
211587,values,0,0
211588,of,0,0
211589,the,0,1
211590,Lp,0,1
211591,(,0,0
211592,a,0,1
211593,),0,0
211594,",",0,0
211595,the,0,0
211596,sex,0,0
211597,steroid,0,0
211598,and,0,0
211599,pituitary,0,1
211600,hormone,0,1
211601,levels,0,0
211602,.,0,1
211603,Administration,0,0
211604,of,0,0
211605,conjugated,0,0
211606,equine,0,1
211607,estrogens,0,0
211608,resulted,0,0
211609,in,0,1
211610,decreased,0,0
211611,levels,0,1
211612,of,0,1
211613,Lp,0,1
211614,(,0,1
211615,a,0,0
211616,),0,0
211617,only,0,0
211618,in,0,0
211619,group,0,1
211620,B,0,1
211621,after,0,1
211622,treatment,0,0
211623,.,0,1
211624,The,0,0
211625,different,0,0
211626,Lp,0,1
211627,(,0,1
211628,a,0,1
211629,),0,0
211630,behaviour,0,0
211631,in,0,0
211632,the,0,1
211633,two,0,1
211634,groups,0,0
211635,and,0,1
211636,in,0,0
211637,the,0,0
211638,presence,0,0
211639,of,0,0
211640,the,0,0
211641,same,0,0
211642,serum,0,0
211643,hormonal,0,1
211644,levels,0,0
211645,",",0,0
211646,seems,0,0
211647,to,0,0
211648,be,0,0
211649,dependent,0,0
211650,on,0,0
211651,the,0,0
211652,existence,0,0
211653,of,0,0
211654,a,0,1
211655,circadian,0,0
211656,rhythm,0,1
211657,of,0,0
211658,the,0,0
211659,hepatic,0,0
211660,responsiveness,0,0
211661,to,0,0
211662,estrogens,0,0
211663,",",0,0
211664,whose,0,1
211665,expression,0,0
211666,is,0,0
211667,higher,0,0
211668,during,0,0
211669,evening,0,0
211670,hours,0,1
211671,.,0,1
211672,Co-administration,0,0
211673,of,0,0
211674,pethidine,0,1
211675,and,0,1
211676,clonidine,0,0
211677,:,0,1
211678,a,0,1
211679,spinal,0,1
211680,anaesthetic,0,0
211681,technique,0,0
211682,for,0,0
211683,total,1,1
211684,hip,1,1
211685,replacement,1,1
211686,.,1,1
211687,Co-administration,0,0
211688,of,0,0
211689,pethidine,0,1
211690,0.75,0,0
211691,mg,0,0
211692,kg-1,0,0
211693,and,0,1
211694,clonidine,0,0
211695,75,0,1
211696,micrograms,0,0
211697,intrathecally,0,1
211698,provided,0,0
211699,good,0,0
211700,intraoperative,0,0
211701,anaesthesia,0,1
211702,for,0,0
211703,total,1,1
211704,hip,1,1
211705,replacement,1,1
211706,",",0,0
211707,similar,0,0
211708,to,0,0
211709,that,0,0
211710,obtained,0,0
211711,using,0,0
211712,0.5,0,0
211713,%,0,0
211714,isobaric,0,0
211715,bupivacaine,0,0
211716,.,0,1
211717,Sensory,0,0
211718,and,0,0
211719,motor,0,0
211720,block,0,0
211721,were,0,0
211722,of,0,0
211723,shorter,0,0
211724,duration,0,0
211725,than,0,0
211726,that,0,0
211727,after,0,0
211728,0.5,0,0
211729,%,0,0
211730,isobaric,0,0
211731,bupivacaine,0,0
211732,and,0,1
211733,0.5,0,0
211734,%,0,0
211735,isobaric,0,0
211736,bupivacaine,0,0
211737,with,0,1
211738,morphine,0,0
211739,0.5,0,0
211740,mg,0,1
211741,(,0,0
211742,P,0,0
211743,<,0,0
211744,0.001,0,0
211745,sensory,0,0
211746,block,0,1
211747,",",0,0
211748,P,0,0
211749,<,0,0
211750,0.001,0,0
211751,motor,0,0
211752,block,0,1
211753,),0,1
211754,.,0,1
211755,Postoperative,0,0
211756,morphine,0,0
211757,consumption,0,0
211758,",",0,0
211759,measured,0,0
211760,using,0,0
211761,a,0,0
211762,patient-controlled,0,0
211763,system,0,0
211764,",",0,0
211765,was,0,0
211766,similar,0,0
211767,to,0,0
211768,that,0,0
211769,in,0,0
211770,patients,1,1
211771,in,1,1
211772,the,1,0
211773,bupivacaine,1,0
211774,only,1,0
211775,group,1,0
211776,(,0,1
211777,pethidine-clonidine,0,0
211778,:,0,1
211779,median,0,1
211780,39,0,1
211781,mg/24,0,0
211782,h,0,0
211783,;,0,1
211784,bupivacaine,0,0
211785,:,0,1
211786,median,0,1
211787,34,0,1
211788,mg/24,0,0
211789,h,0,0
211790,),0,0
211791,but,0,0
211792,greater,0,0
211793,than,0,0
211794,that,0,0
211795,in,0,0
211796,the,0,0
211797,bupivacaine-morphine,1,0
211798,group,1,1
211799,(,0,1
211800,median,0,1
211801,8,0,1
211802,mg/24,0,0
211803,h,0,0
211804,),0,1
211805,(,0,1
211806,P,0,0
211807,<,0,0
211808,0.001,0,0
211809,),0,1
211810,.,0,1
211811,Visual,0,0
211812,analogue,0,0
211813,pain,0,1
211814,scores,0,0
211815,after,0,1
211816,operation,0,1
211817,were,0,1
211818,similar,0,0
211819,to,0,0
211820,those,0,1
211821,with,0,1
211822,bupivacaine,0,0
211823,alone,0,0
211824,at,0,0
211825,all,0,0
211826,but,0,0
211827,one,0,1
211828,of,0,0
211829,the,0,0
211830,recording,0,0
211831,times,0,0
211832,but,0,0
211833,were,0,1
211834,greater,0,0
211835,than,0,0
211836,those,0,0
211837,in,0,1
211838,patients,0,1
211839,who,0,1
211840,received,0,1
211841,bupivacaine,0,1
211842,and,0,0
211843,morphine,0,0
211844,at,0,0
211845,4,0,0
211846,",",0,1
211847,6,0,0
211848,and,0,1
211849,10,0,1
211850,h,0,0
211851,after,0,0
211852,operation,0,1
211853,(,0,1
211854,P,0,0
211855,<,0,0
211856,0.001,0,0
211857,",",0,1
211858,P,0,0
211859,<,0,0
211860,0.04,0,0
211861,",",0,1
211862,P,0,0
211863,<,0,0
211864,0.02,0,0
211865,),0,1
211866,.,0,1
211867,The,0,0
211868,combination,0,0
211869,did,0,0
211870,not,0,0
211871,offer,0,0
211872,any,0,0
211873,major,0,0
211874,advantage,0,0
211875,over,0,0
211876,conventional,0,1
211877,agents,0,1
211878,.,0,1
211879,Dexamethasone,0,0
211880,for,0,0
211881,the,0,0
211882,treatment,0,0
211883,of,0,0
211884,depression,0,1
211885,:,0,1
211886,a,0,0
211887,randomized,0,1
211888,",",0,0
211889,placebo-controlled,0,0
211890,",",0,0
211891,double-blind,0,0
211892,trial,0,1
211893,.,0,1
211894,OBJECTIVE,0,0
211895,The,0,0
211896,authors,0,0
211897,',0,1
211898,goal,0,1
211899,was,0,0
211900,to,0,0
211901,assess,0,0
211902,dexamethasone,0,0
211903,for,0,0
211904,the,0,0
211905,treatment,0,0
211906,of,0,0
211907,depression,0,1
211908,.,0,1
211909,METHOD,0,0
211910,Thirty-seven,1,1
211911,outpatients,1,1
211912,(,1,1
211913,11,1,1
211914,men,1,1
211915,and,1,1
211916,26,1,1
211917,women,1,1
211918,),1,1
211919,meeting,1,1
211920,DSM-III-R,1,0
211921,criteria,1,1
211922,for,1,1
211923,major,1,1
211924,depressive,1,1
211925,disorder,1,1
211926,were,0,1
211927,randomly,0,1
211928,assigned,0,1
211929,to,0,0
211930,receive,0,0
211931,either,0,0
211932,placebo,0,0
211933,or,0,1
211934,4,0,0
211935,mg/day,0,0
211936,of,0,0
211937,oral,0,0
211938,dexamethasone,0,0
211939,for,0,1
211940,4,0,1
211941,days,0,1
211942,.,0,1
211943,Baseline,0,0
211944,Hamilton,0,1
211945,depression,0,1
211946,scale,0,1
211947,scores,0,0
211948,were,0,1
211949,compared,0,0
211950,with,0,1
211951,scores,0,0
211952,obtained,0,1
211953,14,0,1
211954,days,0,0
211955,after,0,1
211956,the,0,1
211957,first,0,0
211958,dose,0,0
211959,of,0,0
211960,study,0,1
211961,medication,0,1
211962,.,0,1
211963,Data,0,0
211964,were,0,0
211965,analyzed,0,0
211966,by,0,0
211967,using,0,0
211968,two-sample,0,0
211969,t,0,0
211970,tests,0,0
211971,",",0,1
211972,chi-square,0,0
211973,methods,0,1
211974,",",0,1
211975,and,0,1
211976,Fisher,0,0
211977,'s,0,1
211978,exact,0,0
211979,test,0,0
211980,.,0,1
211981,RESULTS,0,0
211982,Seven,0,0
211983,(,0,1
211984,37,0,1
211985,%,0,0
211986,),0,1
211987,of,0,0
211988,the,0,1
211989,19,0,1
211990,patients,0,1
211991,given,0,1
211992,dexamethasone,0,0
211993,but,0,0
211994,only,0,0
211995,one,0,1
211996,(,0,1
211997,6,0,1
211998,%,0,0
211999,),0,1
212000,of,0,0
212001,the,0,1
212002,18,0,1
212003,patients,0,1
212004,given,0,1
212005,placebo,0,0
212006,responded,0,1
212007,positively,0,0
212008,.,0,1
212009,No,0,0
212010,adverse,0,0
212011,events,0,0
212012,or,0,1
212013,side,0,0
212014,effects,0,0
212015,were,0,1
212016,reported,0,1
212017,",",0,0
212018,and,0,0
212019,all,0,1
212020,patients,0,1
212021,who,0,1
212022,entered,0,1
212023,the,0,1
212024,study,0,0
212025,completed,0,1
212026,it,0,0
212027,.,0,0
212028,CONCLUSIONS,0,0
212029,A,0,0
212030,brief,0,0
212031,course,0,0
212032,of,0,0
212033,oral,0,1
212034,dexamethasone,0,0
212035,(,0,1
212036,4,0,1
212037,days,0,1
212038,),0,1
212039,was,0,0
212040,significantly,0,0
212041,more,0,0
212042,effective,0,0
212043,than,0,0
212044,placebo,0,1
212045,within,0,1
212046,14,0,1
212047,days,0,0
212048,for,0,1
212049,the,0,0
212050,treatment,0,0
212051,of,0,0
212052,depression,0,1
212053,in,0,0
212054,a,0,0
212055,randomized,0,1
212056,",",0,0
212057,double-blind,0,0
212058,study,0,1
212059,of,0,1
212060,depressed,0,1
212061,outpatients,0,1
212062,.,0,1
212063,Profound,0,1
212064,luteinizing,0,0
212065,hormone,0,1
212066,suppression,0,0
212067,after,0,0
212068,stopping,0,0
212069,the,0,0
212070,gonadotropin-releasing,0,0
212071,hormone-agonist,0,0
212072,leuprolide,0,0
212073,acetate,0,0
212074,.,0,1
212075,OBJECTIVE,0,0
212076,To,0,0
212077,compare,0,0
212078,levels,0,0
212079,of,0,0
212080,serum,0,0
212081,LH,0,1
212082,during,0,0
212083,continued,0,0
212084,use,0,0
212085,of,0,0
212086,leuprolide,0,0
212087,acetate,0,0
212088,(,0,1
212089,LA,0,0
212090,),0,1
212091,with,0,1
212092,levels,0,0
212093,during,0,1
212094,the,0,1
212095,first,0,0
212096,week,0,0
212097,after,0,0
212098,discontinuing,0,1
212099,LA,0,0
212100,.,0,1
212101,DESIGN,0,0
212102,Prospective,0,1
212103,controlled,0,0
212104,study,0,1
212105,.,0,1
212106,SETTING,0,1
212107,Clinical,0,0
212108,assisted,0,1
212109,conception,0,0
212110,program,0,1
212111,.,0,1
212112,PATIENTS,0,0
212113,Women,1,1
212114,undergoing,1,1
212115,controlled,1,0
212116,ovarian,1,1
212117,stimulation,1,0
212118,for,1,0
212119,assisted,1,1
212120,conception,1,1
212121,were,0,1
212122,randomized,0,1
212123,to,0,0
212124,receive,0,1
212125,LA,0,0
212126,according,0,1
212127,to,0,1
212128,short,0,1
212129,or,0,1
212130,ultrashort,0,1
212131,protocols,0,0
212132,.,0,1
212133,The,0,0
212134,alternative,0,0
212135,protocol,0,0
212136,was,0,0
212137,used,0,0
212138,then,0,0
212139,in,0,0
212140,a,0,0
212141,second,0,1
212142,cycle,0,0
212143,.,0,1
212144,Each,0,0
212145,patient,0,0
212146,was,0,0
212147,thus,0,0
212148,her,0,0
212149,own,0,1
212150,control,0,1
212151,.,0,1
212152,MAIN,0,0
212153,OUTCOME,0,1
212154,MEASURES,0,1
212155,Serum,0,1
212156,LH,0,1
212157,over,0,0
212158,time,0,0
212159,.,0,0
212160,RESULTS,0,0
212161,When,0,1
212162,LA,0,0
212163,was,0,0
212164,stopped,0,1
212165,after,0,1
212166,5,0,1
212167,days,0,0
212168,of,0,1
212169,administration,0,0
212170,",",0,1
212171,LH,0,1
212172,levels,0,0
212173,fell,0,0
212174,profoundly,0,0
212175,when,0,0
212176,compared,0,0
212177,with,0,0
212178,levels,0,0
212179,when,0,0
212180,LA,0,0
212181,was,0,0
212182,continued,0,0
212183,.,0,1
212184,CONCLUSION,0,0
212185,Loss,0,1
212186,of,0,0
212187,LH,0,1
212188,after,0,1
212189,stopping,0,0
212190,LA,0,0
212191,is,0,0
212192,likely,0,0
212193,to,0,0
212194,be,0,0
212195,clinically,0,1
212196,important,0,0
212197,in,0,0
212198,ovarian,0,1
212199,stimulation,0,1
212200,regimens,0,0
212201,that,0,0
212202,use,0,0
212203,pure,0,0
212204,FSH,0,1
212205,with,0,1
212206,LA,0,0
212207,in,0,1
212208,ultrashort,0,1
212209,protocols,0,0
212210,.,0,1
212211,The,0,0
212212,fall,0,0
212213,in,0,0
212214,LH,0,1
212215,lasts,0,0
212216,at,0,1
212217,least,0,1
212218,1,0,1
212219,week,0,0
212220,and,0,0
212221,may,0,0
212222,be,0,0
212223,explainable,0,0
212224,by,0,0
212225,persistent,0,1
212226,suppression,0,0
212227,of,0,0
212228,endogenous,0,0
212229,GnRH,0,0
212230,by,0,0
212231,LA,0,0
212232,during,0,0
212233,this,0,0
212234,time,0,0
212235,.,0,1
212236,Necessary,0,0
212237,but,0,0
212238,not,0,1
212239,sufficient,0,0
212240,:,0,1
212241,the,0,0
212242,effect,0,0
212243,of,0,0
212244,screening,0,1
212245,and,0,0
212246,feedback,0,0
212247,on,0,0
212248,outcomes,0,0
212249,of,0,1
212250,primary,1,1
212251,care,1,1
212252,patients,1,1
212253,with,1,1
212254,untreated,1,1
212255,anxiety,1,1
212256,.,1,1
212257,OBJECTIVE,0,0
212258,To,0,0
212259,consider,0,0
212260,the,0,0
212261,impact,0,0
212262,on,0,0
212263,primary,0,1
212264,care,0,1
212265,patient,0,1
212266,outcomes,0,0
212267,of,0,1
212268,using,0,0
212269,both,0,0
212270,a,0,0
212271,screener,0,1
212272,to,0,0
212273,determine,0,0
212274,elevated,0,1
212275,anxiety,0,1
212276,levels,0,0
212277,among,0,1
212278,patients,1,1
212279,with,1,1
212280,previously,1,1
212281,undetected,1,1
212282,anxiety,1,0
212283,and,0,0
212284,a,0,0
212285,physician,0,1
212286,intervention,0,0
212287,to,0,1
212288,inform,0,0
212289,physicians,0,1
212290,of,0,1
212291,their,0,1
212292,patients,0,1
212293,',0,1
212294,conditions,0,1
212295,.,0,1
212296,DESIGN,0,0
212297,Participating,1,1
212298,physicians,1,1
212299,were,1,1
212300,randomized,1,1
212301,to,1,0
212302,either,1,0
212303,the,1,0
212304,demonstration,1,0
212305,or,1,0
212306,the,1,0
212307,control,1,0
212308,arm,1,0
212309,",",1,0
212310,and,1,0
212311,patients,1,1
212312,were,1,1
212313,assigned,1,1
212314,to,1,0
212315,a,1,0
212316,study,1,0
212317,arm,1,0
212318,based,1,1
212319,on,1,0
212320,the,1,0
212321,randomization,1,0
212322,of,1,0
212323,their,1,1
212324,physicians,1,1
212325,.,1,1
212326,The,0,0
212327,patients,0,1
212328,were,0,1
212329,followed,0,1
212330,for,0,0
212331,change,0,0
212332,in,0,1
212333,outcome,0,0
212334,measures,0,0
212335,during,0,1
212336,the,0,1
212337,five-month,0,1
212338,study,0,1
212339,period,0,0
212340,.,0,0
212341,SETTING,0,1
212342,A,0,0
212343,mixed-model,0,0
212344,health,0,1
212345,maintenance,0,0
212346,organization,0,0
212347,serving,0,1
212348,approximately,0,1
212349,"110,000",0,1
212350,enrollees,0,1
212351,in,0,1
212352,central,0,1
212353,Colorado,0,1
212354,.,0,1
212355,PATIENTS/PARTICIPANTS,0,0
212356,573,1,1
212357,patients,1,1
212358,who,1,1
212359,had,1,1
212360,unrecognized,1,1
212361,and,1,0
212362,untreated,1,1
212363,anxiety,1,1
212364,identified,1,1
212365,from,1,0
212366,the,1,0
212367,approximately,1,1
212368,"8,000",1,1
212369,patients,1,1
212370,who,1,1
212371,completed,1,1
212372,the,1,1
212373,waiting,1,0
212374,room,1,1
212375,screening,1,1
212376,questionnaire,1,0
212377,.,1,0
212378,INTERVENTIONS,0,0
212379,A,0,0
212380,physician,0,0
212381,intervention,0,0
212382,served,0,1
212383,the,0,0
212384,dual,0,0
212385,function,0,0
212386,of,0,1
212387,1,0,1
212388,),0,1
212389,providing,0,0
212390,an,0,0
212391,educational,0,1
212392,demonstration,0,0
212393,of,0,0
212394,anxiety,0,1
212395,in,0,0
212396,the,0,0
212397,primary,0,1
212398,care,0,1
212399,setting,0,1
212400,and,0,1
212401,2,0,1
212402,),0,1
212403,providing,0,0
212404,a,0,0
212405,reporting,0,0
212406,system,0,0
212407,for,0,0
212408,summarizing,0,0
212409,the,0,0
212410,anxiety,0,1
212411,symptom,0,0
212412,levels,0,0
212413,and,0,1
212414,functioning,0,1
212415,status,0,1
212416,of,0,0
212417,the,0,0
212418,patients,0,1
212419,enrolled,0,1
212420,in,0,0
212421,the,0,0
212422,study,0,1
212423,.,0,1
212424,MEASUREMENTS,0,0
212425,AND,0,0
212426,MAIN,0,0
212427,RESULTS,0,1
212428,Patient,0,1
212429,outcomes,0,0
212430,were,0,1
212431,measured,0,0
212432,as,0,0
212433,changes,0,0
212434,in,0,1
212435,global,0,0
212436,anxiety,0,1
212437,scores,0,0
212438,",",0,1
212439,functioning,0,1
212440,and,0,0
212441,well-being,0,0
212442,",",0,1
212443,and,0,1
212444,patients,0,1
212445,',0,1
212446,reports,0,1
212447,of,0,1
212448,global,0,1
212449,improvements,0,0
212450,.,0,1
212451,CONCLUSIONS,0,0
212452,The,0,0
212453,findings,0,0
212454,indicate,0,0
212455,that,0,0
212456,this,0,0
212457,method,0,0
212458,of,0,0
212459,reporting,0,1
212460,symptoms,0,1
212461,and,0,1
212462,functioning,0,1
212463,status,0,1
212464,to,0,0
212465,primary,0,1
212466,care,0,1
212467,physicians,0,1
212468,did,0,0
212469,not,0,0
212470,significantly,0,0
212471,change,0,0
212472,patient,0,1
212473,outcomes,0,0
212474,.,0,1
212475,Improvement,0,0
212476,in,0,0
212477,outcomes,0,0
212478,appeared,0,0
212479,to,0,0
212480,be,0,0
212481,more,0,0
212482,closely,0,0
212483,associated,0,0
212484,with,0,1
212485,the,0,0
212486,patient,0,1
212487,'s,0,1
212488,severity,0,0
212489,of,0,1
212490,psychological,0,1
212491,distress,0,1
212492,.,0,1
212493,Analysis,0,1
212494,of,0,0
212495,multiple-dose,0,0
212496,bioequivalence,0,0
212497,studies,0,0
212498,.,0,1
212499,In,0,0
212500,multiple-dose,1,0
212501,bioequivalence,1,0
212502,studies,1,0
212503,",",0,0
212504,it,0,0
212505,is,0,0
212506,possible,0,0
212507,at,0,0
212508,steady,0,0
212509,state,0,1
212510,to,0,0
212511,take,0,1
212512,repeated,0,0
212513,measurements,0,0
212514,of,0,1
212515,pharmacokinetic,0,0
212516,variables,0,0
212517,",",0,1
212518,such,0,0
212519,as,0,0
212520,area,0,0
212521,under,0,0
212522,the,0,0
212523,curve,0,0
212524,(,0,0
212525,AUC,0,0
212526,),0,1
212527,and,0,0
212528,the,0,0
212529,maximum,0,0
212530,concentration,0,0
212531,(,0,1
212532,CMAX,0,0
212533,),0,1
212534,of,0,0
212535,the,0,0
212536,blood,0,0
212537,concentration-time,0,0
212538,profile,0,0
212539,",",0,0
212540,within,0,0
212541,each,0,0
212542,period,0,0
212543,of,0,0
212544,a,0,0
212545,crossover,0,0
212546,design,0,1
212547,.,0,1
212548,We,0,0
212549,develop,0,0
212550,a,0,0
212551,bivariate,0,0
212552,random,0,1
212553,effects,0,0
212554,model,0,1
212555,for,0,1
212556,such,0,0
212557,a,0,1
212558,situation,0,0
212559,in,0,0
212560,a,0,1
212561,2,0,1
212562,x,0,1
212563,2,0,1
212564,crossover,0,1
212565,design,0,1
212566,using,0,0
212567,the,0,0
212568,natural,0,0
212569,log,0,0
212570,scale,0,0
212571,for,0,0
212572,AUC,0,0
212573,and,0,1
212574,CMAX,0,0
212575,that,0,0
212576,assumes,0,0
212577,no,0,0
212578,differential,0,0
212579,carryover,0,0
212580,effects,0,0
212581,and,0,1
212582,includes,0,0
212583,components,0,0
212584,for,0,0
212585,inter-,0,0
212586,and,0,1
212587,intrasubject,0,0
212588,variability,0,0
212589,with,0,1
212590,respect,0,0
212591,to,0,1
212592,both,0,0
212593,formulations,0,0
212594,.,0,1
212595,We,0,0
212596,derive,0,0
212597,the,0,0
212598,uniformly,0,0
212599,minimum,0,0
212600,variance,0,0
212601,unbiased,0,0
212602,estimators,0,0
212603,",",0,1
212604,which,0,0
212605,also,0,0
212606,happen,0,0
212607,to,0,0
212608,be,0,0
212609,restricted,0,1
212610,maximum,0,0
212611,likelihood,0,0
212612,estimators,0,0
212613,",",0,1
212614,and,0,0
212615,we,0,0
212616,provide,0,0
212617,a,0,0
212618,sample,0,1
212619,size,0,0
212620,formula,0,0
212621,.,0,1
212622,Absolute,0,0
212623,bioavailability,0,0
212624,of,0,0
212625,a,0,1
212626,new,0,1
212627,high,0,1
212628,dose,0,0
212629,methylprednisolone,0,0
212630,tablet,0,0
212631,formulation,0,0
212632,.,0,1
212633,This,0,0
212634,was,0,0
212635,a,0,0
212636,single-blind,0,0
212637,",",0,0
212638,single-dose,0,0
212639,",",0,0
212640,randomized,0,1
212641,crossover,0,0
212642,study,0,0
212643,to,0,0
212644,determine,0,0
212645,the,0,0
212646,absolute,0,0
212647,bioavailability,0,0
212648,of,0,0
212649,Medrol,0,0
212650,",",0,0
212651,a,0,0
212652,new,0,1
212653,high,0,1
212654,dose,0,0
212655,(,0,1
212656,100,0,1
212657,mg,0,1
212658,),0,1
212659,methylprednisolone,0,0
212660,tablet,0,0
212661,product,0,0
212662,",",0,0
212663,by,0,0
212664,comparing,0,0
212665,it,0,0
212666,with,0,1
212667,100,0,1
212668,mg,0,0
212669,methylprednisolone,0,0
212670,from,0,1
212671,an,0,0
212672,intravenous,0,0
212673,formulation,0,0
212674,",",0,1
212675,Solu-Medrol,0,0
212676,.,0,1
212677,Fourteen,1,1
212678,healthy,1,1
212679,",",1,0
212680,non-smoking,1,1
212681,",",1,0
212682,Caucasian,1,1
212683,male,1,1
212684,volunteers,1,1
212685,took,0,1
212686,part,0,1
212687,.,0,1
212688,On,0,0
212689,treatment,0,0
212690,days,0,1
212691,volunteers,0,1
212692,remained,0,1
212693,recumbent,0,1
212694,for,0,1
212695,4,0,0
212696,hours,0,0
212697,after,0,1
212698,drug,0,1
212699,administration,0,0
212700,",",0,0
212701,with,0,1
212702,food,0,0
212703,and,0,0
212704,fluid,0,1
212705,intake,0,0
212706,standardized,0,0
212707,over,0,0
212708,this,0,0
212709,period,0,0
212710,.,0,1
212711,Serial,0,0
212712,blood,0,0
212713,samples,0,1
212714,were,0,1
212715,drawn,0,0
212716,over,0,0
212717,a,0,1
212718,14-hour,0,0
212719,period,0,0
212720,after,0,0
212721,drug,0,1
212722,administration,0,0
212723,.,0,1
212724,Plasma,0,0
212725,methylprednisolone,0,0
212726,concentrations,0,0
212727,were,0,1
212728,determined,0,0
212729,by,0,0
212730,high,0,1
212731,performance,0,0
212732,liquid,0,1
212733,chromatography,0,0
212734,.,0,1
212735,The,0,0
212736,geometric,0,0
212737,means,0,0
212738,of,0,1
212739,AUCi.v,0,0
212740,.,0,1
212741,and,0,0
212742,AUCtablet,0,0
212743,were,0,1
212744,"4,049",0,1
212745,and,0,1
212746,"3,334",0,1
212747,ng.h/ml,0,0
212748,",",0,0
212749,respectively,0,0
212750,.,0,0
212751,The,0,0
212752,absolute,0,0
212753,bioavailability,0,0
212754,of,0,0
212755,the,0,0
212756,tablet,0,0
212757,product,0,0
212758,was,0,0
212759,82,0,1
212760,%,0,0
212761,",",0,0
212762,which,0,0
212763,is,0,0
212764,in,0,0
212765,agreement,0,0
212766,with,0,1
212767,published,0,1
212768,data,0,0
212769,for,0,1
212770,other,0,1
212771,oral,0,1
212772,dosage,0,0
212773,forms,0,1
212774,of,0,1
212775,methylprednisolone,0,0
212776,.,0,1
212777,Volunteers,0,1
212778,displayed,0,0
212779,the,0,0
212780,expected,0,0
212781,rise,0,0
212782,in,0,0
212783,peripheral,0,1
212784,blood,0,0
212785,neutrophil,0,0
212786,count,0,0
212787,",",0,0
212788,but,0,0
212789,no,0,0
212790,other,0,0
212791,clinically,0,1
212792,relevant,0,0
212793,changes,0,0
212794,in,0,1
212795,hematology,0,1
212796,or,0,1
212797,clinical,0,0
212798,chemistry,0,1
212799,were,0,1
212800,observed,0,0
212801,.,0,1
212802,No,0,0
212803,adverse,0,0
212804,drug,0,1
212805,reactions,0,0
212806,were,0,1
212807,recorded,0,0
212808,.,0,0
212809,It,0,0
212810,is,0,0
212811,concluded,0,0
212812,that,0,0
212813,the,0,0
212814,tablet,0,0
212815,product,0,0
212816,can,0,0
212817,be,0,0
212818,used,0,0
212819,as,0,0
212820,a,0,0
212821,substitute,0,0
212822,for,0,0
212823,parenteral,0,1
212824,methylprednisolone,0,0
212825,in,0,1
212826,situations,0,0
212827,requiring,0,1
212828,high-dose,0,1
212829,therapy,0,1
212830,.,0,1
212831,Changes,0,1
212832,in,0,1
212833,beta-carotene,0,0
212834,levels,0,0
212835,by,0,0
212836,long-term,0,0
212837,administration,0,0
212838,of,0,0
212839,natural,0,0
212840,beta-carotene,0,0
212841,derived,0,1
212842,from,0,1
212843,Dunaliella,0,1
212844,bardawil,0,1
212845,in,0,1
212846,humans,1,1
212847,.,1,1
212848,Long-term,0,0
212849,administration,0,0
212850,of,0,0
212851,a,0,1
212852,beta-carotene,0,0
212853,preparation,0,0
212854,derived,0,1
212855,from,0,1
212856,Dunaliella,0,1
212857,bardawil,0,0
212858,",",0,0
212859,a,0,0
212860,beta-carotene-rich,0,0
212861,algae,0,0
212862,",",0,0
212863,was,0,0
212864,studied,0,1
212865,in,0,0
212866,healthy,1,1
212867,young,1,1
212868,male,1,1
212869,volunteers,1,1
212870,.,1,1
212871,The,0,0
212872,daily,0,0
212873,administration,0,0
212874,of,0,1
212875,60,0,1
212876,mg,0,0
212877,of,0,0
212878,the,0,0
212879,beta-carotene,0,0
212880,preparation,0,0
212881,(,0,1
212882,30,0,1
212883,mg,0,1
212884,of,0,0
212885,all-trans,0,0
212886,beta-carotene,0,0
212887,and,0,1
212888,30,0,1
212889,mg,0,0
212890,of,0,0
212891,9-cis,0,0
212892,beta-carotene,0,0
212893,),0,1
212894,was,0,0
212895,performed,0,0
212896,and,0,1
212897,beta-carotene,0,0
212898,concentrations,0,0
212899,were,0,1
212900,determined,0,0
212901,in,0,0
212902,the,0,0
212903,plasma,0,0
212904,",",0,0
212905,red,0,1
212906,blood,0,0
212907,cells,0,0
212908,(,0,1
212909,RBC,0,1
212910,),0,1
212911,",",0,1
212912,platelets,0,1
212913,(,0,1
212914,PLT,0,1
212915,),0,1
212916,",",0,0
212917,and,0,1
212918,mononuclear,0,1
212919,cells,0,0
212920,(,0,1
212921,MN,0,1
212922,),0,1
212923,.,0,1
212924,The,0,0
212925,all-trans,0,0
212926,beta-carotene,0,0
212927,level,0,0
212928,increased,0,0
212929,four-,0,0
212930,",",0,0
212931,two-,0,0
212932,",",0,0
212933,and,0,0
212934,threefold,0,0
212935,the,0,0
212936,baseline,0,0
212937,in,0,0
212938,plasma,0,0
212939,",",0,0
212940,PLT,0,0
212941,",",0,0
212942,and,0,0
212943,MN,0,0
212944,",",0,0
212945,respectively,0,0
212946,.,0,1
212947,Basal,0,0
212948,levels,0,0
212949,of,0,1
212950,9-cis,0,0
212951,beta-carotene,0,0
212952,in,0,0
212953,plasma,0,0
212954,",",0,0
212955,PLT,0,0
212956,",",0,0
212957,and,0,0
212958,MN,0,0
212959,were,0,1
212960,low,0,1
212961,and,0,0
212962,found,0,0
212963,as,0,0
212964,one-tenth,0,0
212965,",",0,1
212966,one-fifth,0,0
212967,",",0,0
212968,and,0,0
212969,one-fifth,0,0
212970,of,0,0
212971,all-trans,0,0
212972,beta-carotene,0,0
212973,",",0,0
212974,which,0,0
212975,increased,0,0
212976,three-,0,0
212977,",",0,0
212978,two-,0,0
212979,",",0,0
212980,and,0,0
212981,1.5-fold,0,0
212982,the,0,0
212983,baseline,0,0
212984,",",0,0
212985,respectively,0,0
212986,.,0,1
212987,Plasma,0,0
212988,and,0,0
212989,RBC,0,1
212990,alpha-tocopherol,0,0
212991,levels,0,0
212992,were,0,1
212993,not,0,0
212994,changed,0,0
212995,by,0,0
212996,the,0,0
212997,intake,0,0
212998,of,0,0
212999,beta-carotene,0,0
213000,.,0,1
213001,No,0,0
213002,side,0,0
213003,effects,0,0
213004,or,0,1
213005,toxicities,0,0
213006,were,0,1
213007,documented,0,1
213008,in,0,0
213009,any,0,0
213010,of,0,0
213011,the,0,0
213012,subjects,0,1
213013,during,0,0
213014,the,0,0
213015,administration,0,0
213016,period,0,0
213017,.,0,1
213018,In,0,0
213019,conclusion,0,0
213020,",",0,0
213021,the,0,0
213022,bioavailability,0,0
213023,of,0,0
213024,beta-carotene,0,0
213025,derived,0,1
213026,from,0,1
213027,Dunaliella,0,1
213028,bardawil,0,1
213029,was,0,0
213030,preferential,0,0
213031,for,0,1
213032,all-trans,0,0
213033,beta-carotene,0,0
213034,",",0,0
213035,although,0,0
213036,a,0,0
213037,small,0,0
213038,amount,0,0
213039,of,0,0
213040,the,0,0
213041,9-cis,0,0
213042,form,0,0
213043,was,0,0
213044,detected,0,0
213045,in,0,0
213046,the,0,0
213047,plasma,0,0
213048,and,0,0
213049,blood,0,0
213050,cells,0,0
213051,.,0,1
213052,Peritonsillar,0,1
213053,infiltration,0,0
213054,with,0,1
213055,bupivacaine,0,0
213056,for,0,1
213057,paediatric,1,1
213058,tonsillectomy,1,1
213059,.,1,1
213060,In,0,0
213061,a,0,0
213062,double-blind,0,0
213063,study,0,1
213064,forty-two,1,1
213065,children,1,1
213066,scheduled,1,1
213067,for,1,1
213068,elective,1,1
213069,adenotonsillectomy,1,1
213070,were,0,1
213071,randomized,0,1
213072,to,0,0
213073,receive,0,1
213074,peritonsillar,0,1
213075,infiltration,0,0
213076,",",0,0
213077,following,0,0
213078,induction,0,0
213079,of,0,0
213080,anaesthesia,0,1
213081,",",0,0
213082,with,0,1
213083,either,0,1
213084,0.25,0,0
213085,%,0,0
213086,plain,0,1
213087,bupivacaine,0,0
213088,or,0,1
213089,0.9,0,0
213090,%,0,0
213091,saline,0,0
213092,",",0,0
213093,0.5,0,0
213094,ml/kg,0,0
213095,to,0,0
213096,a,0,0
213097,maximum,0,0
213098,of,0,0
213099,10,0,1
213100,ml,0,0
213101,.,0,1
213102,The,0,0
213103,children,1,1
213104,were,0,1
213105,assessed,0,0
213106,on,0,0
213107,awakening,0,0
213108,",",0,0
213109,and,0,0
213110,then,0,0
213111,10,0,1
213112,minutes,0,0
213113,",",0,1
213114,1,0,0
213115,hour,0,0
213116,",",0,1
213117,4,0,0
213118,hours,0,0
213119,and,0,1
213120,24,0,1
213121,hours,0,0
213122,later,0,1
213123,.,0,1
213124,On,0,0
213125,each,0,0
213126,occasion,0,0
213127,the,0,0
213128,observer,0,0
213129,gave,0,0
213130,the,0,0
213131,child,0,1
213132,a,0,0
213133,pain,0,0
213134,score,0,0
213135,from,0,1
213136,1,0,0
213137,(,0,1
213138,no,0,0
213139,pain,0,1
213140,),0,1
213141,to,0,1
213142,5,0,1
213143,(,0,1
213144,severe,0,1
213145,pain,0,1
213146,),0,1
213147,.,0,1
213148,The,0,0
213149,scores,0,0
213150,on,0,0
213151,awakening,0,0
213152,and,0,1
213153,after,0,1
213154,10,0,1
213155,minutes,0,0
213156,were,0,1
213157,significantly,0,0
213158,lower,0,0
213159,in,0,0
213160,the,0,0
213161,bupivacaine,0,0
213162,group,0,0
213163,(,0,1
213164,P,0,0
213165,<,0,0
213166,0.05,0,0
213167,",",0,1
213168,Mann-Whitney,0,0
213169,U,0,1
213170,test,0,0
213171,),0,1
213172,.,0,0
213173,Thereafter,0,0
213174,there,0,0
213175,was,0,0
213176,no,0,0
213177,difference,0,0
213178,between,0,0
213179,the,0,0
213180,groups,0,0
213181,.,0,1
213182,The,0,0
213183,authors,0,0
213184,conclude,0,0
213185,that,0,0
213186,peritonsillar,0,1
213187,infiltration,0,0
213188,with,0,1
213189,bupivacaine,0,0
213190,is,0,0
213191,only,0,0
213192,moderately,0,0
213193,useful,0,0
213194,as,0,0
213195,analgesia,0,0
213196,for,0,1
213197,children,1,1
213198,having,1,1
213199,tonsillectomy,1,1
213200,.,1,1
213201,Exposure,0,0
213202,reduced,0,0
213203,agoraphobia,0,1
213204,but,0,0
213205,not,0,0
213206,panic,0,1
213207,",",0,0
213208,and,0,0
213209,cognitive,0,0
213210,therapy,0,0
213211,reduced,0,0
213212,panic,0,1
213213,but,0,0
213214,not,0,0
213215,agoraphobia,0,1
213216,.,0,1
213217,Earlier,0,0
213218,studies,0,0
213219,showed,0,0
213220,that,0,0
213221,cognitive,0,0
213222,therapy,0,0
213223,has,0,0
213224,anti-panic,0,1
213225,effects,0,0
213226,and,0,1
213227,exposure,0,0
213228,has,0,0
213229,anti-agoraphobic,0,0
213230,effects,0,0
213231,while,0,0
213232,other,0,1
213233,studies,0,0
213234,suggest,0,0
213235,that,0,0
213236,agoraphobia,0,1
213237,is,0,0
213238,a,0,0
213239,secondary,0,0
213240,complication,0,0
213241,of,0,0
213242,panic,0,1
213243,disorder,0,1
213244,.,0,1
213245,It,0,0
213246,was,0,0
213247,therefore,0,0
213248,hypothesized,0,0
213249,that,0,0
213250,cognitive,0,0
213251,therapy,0,0
213252,not,0,0
213253,only,0,0
213254,reduces,0,0
213255,panic,0,0
213256,but,0,0
213257,also,0,0
213258,agoraphobia,0,1
213259,and,0,0
213260,that,0,0
213261,it,0,0
213262,potentiates,0,0
213263,the,0,0
213264,effects,0,0
213265,of,0,0
213266,exposure,0,1
213267,in,0,1
213268,vivo,0,0
213269,.,0,1
213270,Two,1,1
213271,groups,1,0
213272,of,1,1
213273,12,1,1
213274,severe,1,1
213275,agoraphobics,1,1
213276,were,1,1
213277,treated,1,1
213278,with,0,1
213279,4,0,0
213280,sessions,0,0
213281,of,0,1
213282,cognitive,0,1
213283,therapy,0,0
213284,followed,0,1
213285,by,0,0
213286,8,0,1
213287,sessions,0,0
213288,of,0,1
213289,cognitive,0,1
213290,therapy,0,0
213291,combined,0,0
213292,with,0,1
213293,in,0,0
213294,vivo,0,0
213295,exposure,0,1
213296,.,0,1
213297,The,0,0
213298,other,0,0
213299,12,1,1
213300,received,1,1
213301,4,1,0
213302,sessions,1,0
213303,of,1,1
213304,'associative,1,1
213305,therapy,1,0
213306,',1,1
213307,",",0,0
213308,a,0,0
213309,presumably,0,0
213310,inert,0,0
213311,treatment,0,0
213312,that,0,0
213313,controls,0,1
213314,for,0,0
213315,therapist,0,0
213316,attention,0,0
213317,",",0,0
213318,followed,0,0
213319,by,0,0
213320,8,0,1
213321,sessions,0,0
213322,of,0,1
213323,in,0,1
213324,vivo,0,0
213325,exposure,0,1
213326,that,0,0
213327,was,0,0
213328,framed,0,0
213329,in,0,0
213330,common,0,1
213331,behavioral,0,1
213332,terms,0,0
213333,.,0,1
213334,The,0,0
213335,initial,0,0
213336,cognitive,0,0
213337,therapy,0,0
213338,produced,0,0
213339,a,0,0
213340,significant,0,0
213341,reduction,0,0
213342,in,0,1
213343,panic,0,1
213344,frequency,0,0
213345,",",0,0
213346,while,0,0
213347,associative,0,0
213348,therapy,0,0
213349,did,0,0
213350,not,0,0
213351,affect,0,0
213352,panic,0,1
213353,.,0,1
213354,Neither,0,0
213355,cognitive,0,0
213356,therapy,0,0
213357,alone,0,0
213358,",",0,0
213359,nor,0,0
213360,associate,0,0
213361,therapy,0,0
213362,alone,0,0
213363,significantly,0,0
213364,reduced,0,0
213365,depression,0,1
213366,",",0,0
213367,state,0,1
213368,or,0,1
213369,trait,0,0
213370,anxiety,0,1
213371,",",0,0
213372,self-rated,0,0
213373,agoraphobia,0,1
213374,or,0,1
213375,behavioral,0,1
213376,avoidance,0,0
213377,.,0,1
213378,After,0,0
213379,adding,0,0
213380,exposure,0,0
213381,however,0,0
213382,",",0,0
213383,these,0,0
213384,parameters,0,0
213385,were,0,1
213386,clearly,0,0
213387,and,0,0
213388,significantly,0,0
213389,reduced,0,0
213390,.,0,1
213391,Cognitive,0,0
213392,therapy,0,0
213393,did,0,0
213394,not,0,0
213395,potentiate,0,0
213396,exposure,0,0
213397,effects,0,0
213398,.,0,1
213399,The,0,0
213400,results,0,0
213401,are,0,0
213402,discussed,0,0
213403,.,0,1
213404,Treatment,0,0
213405,of,0,0
213406,acute,0,1
213407,asthma,0,1
213408,.,0,1
213409,Lack,0,0
213410,of,0,0
213411,therapeutic,0,0
213412,benefit,0,0
213413,and,0,0
213414,increase,0,0
213415,of,0,0
213416,the,0,0
213417,toxicity,0,0
213418,from,0,1
213419,aminophylline,0,0
213420,given,0,0
213421,in,0,0
213422,addition,0,0
213423,to,0,1
213424,high,0,1
213425,doses,0,0
213426,of,0,1
213427,salbutamol,0,0
213428,delivered,0,1
213429,by,0,0
213430,metered-dose,0,0
213431,inhaler,0,0
213432,with,0,1
213433,a,0,1
213434,spacer,0,0
213435,.,0,1
213436,We,0,0
213437,conducted,0,0
213438,a,0,0
213439,randomized,0,0
213440,",",0,0
213441,double-blind,0,0
213442,",",0,0
213443,placebo-controlled,0,0
213444,study,0,0
213445,to,0,0
213446,determine,0,0
213447,if,0,0
213448,intravenous,0,0
213449,aminophylline,0,0
213450,adds,0,0
213451,any,0,0
213452,benefit,0,0
213453,to,0,1
213454,high,0,1
213455,doses,0,0
213456,of,0,1
213457,inhaled,0,0
213458,salbutamol,0,0
213459,in,0,1
213460,patients,1,1
213461,who,1,1
213462,presented,1,1
213463,for,1,1
213464,treatment,1,0
213465,of,1,0
213466,acute,1,1
213467,asthma,1,1
213468,.,1,1
213469,We,0,0
213470,studied,0,1
213471,94,1,1
213472,patients,1,1
213473,(,1,1
213474,mean,1,1
213475,age,1,1
213476,",",1,1
213477,35.6,1,0
213478,+/-,1,1
213479,11.2,1,0
213480,years,1,1
213481,),1,1
213482,with,1,1
213483,moderate,1,1
213484,to,1,1
213485,severe,1,1
213486,acute,1,1
213487,asthma,1,1
213488,.,1,1
213489,All,0,1
213490,patients,0,1
213491,received,0,1
213492,therapy,0,0
213493,with,0,1
213494,salbutamol,0,0
213495,delivered,0,1
213496,with,0,1
213497,metered-dose,0,0
213498,inhaler,0,0
213499,(,0,1
213500,MDI,0,1
213501,),0,1
213502,into,0,0
213503,a,0,1
213504,spacer,0,0
213505,device,0,0
213506,(,0,1
213507,Volumatic,0,0
213508,),0,1
213509,in,0,1
213510,four,0,1
213511,puffs,0,1
213512,(,0,1
213513,400,0,1
213514,micrograms,0,0
213515,),0,1
213516,at,0,1
213517,10-min,0,0
213518,interval,0,0
213519,",",0,0
213520,and,0,0
213521,intravenous,0,1
213522,hydrocortisone,0,1
213523,(,0,1
213524,500,0,1
213525,mg,0,1
213526,),0,1
213527,.,0,1
213528,Patients,0,1
213529,were,0,0
213530,randomly,0,1
213531,assigned,0,1
213532,to,0,0
213533,receive,0,1
213534,either,0,0
213535,a,0,0
213536,loading,0,0
213537,dose,0,0
213538,of,0,0
213539,intravenous,0,1
213540,aminophylline,0,1
213541,followed,0,0
213542,by,0,0
213543,a,0,1
213544,routine,0,1
213545,infusion,0,0
213546,(,0,1
213547,n,0,1
213548,=,0,1
213549,45,0,1
213550,),0,1
213551,or,0,1
213552,an,0,0
213553,equal,0,0
213554,volume,0,0
213555,of,0,0
213556,placebo,0,0
213557,as,0,0
213558,a,0,0
213559,loading,0,0
213560,dose,0,0
213561,and,0,0
213562,infusion,0,0
213563,(,0,1
213564,n,0,1
213565,=,0,1
213566,49,0,1
213567,),0,1
213568,.,0,1
213569,The,0,0
213570,two,0,0
213571,groups,0,0
213572,showed,0,0
213573,no,0,0
213574,differences,0,0
213575,in,0,1
213576,measurements,0,0
213577,of,0,1
213578,peak,0,0
213579,expiratory,0,0
213580,flow,0,0
213581,",",0,0
213582,FEV1,0,0
213583,",",0,0
213584,and,0,0
213585,FVC,0,0
213586,at,0,1
213587,baseline,0,0
213588,and,0,0
213589,at,0,0
213590,the,0,0
213591,end,0,0
213592,of,0,0
213593,treatment,0,0
213594,.,0,1
213595,However,0,0
213596,",",0,0
213597,the,0,0
213598,patients,0,1
213599,treated,0,1
213600,with,0,1
213601,aminophylline,0,0
213602,had,0,0
213603,significantly,0,0
213604,more,0,0
213605,adverse,0,0
213606,effects,0,0
213607,(,0,1
213608,p,0,0
213609,<,0,0
213610,0.05,0,0
213611,),0,0
213612,.,0,0
213613,There,0,0
213614,were,0,0
213615,no,0,0
213616,differences,0,0
213617,in,0,0
213618,the,0,1
213619,final,0,0
213620,mean,0,1
213621,dose,0,0
213622,of,0,0
213623,salbutamol,0,0
213624,(,0,1
213625,6.3,0,0
213626,+/-,0,1
213627,44.5,0,1
213628,mg,0,0
213629,for,0,0
213630,the,0,0
213631,placebo,0,0
213632,group,0,1
213633,and,0,1
213634,5.8,0,0
213635,+/-,0,0
213636,4.2,0,1
213637,mg,0,0
213638,for,0,0
213639,the,0,0
213640,aminophylline,0,0
213641,group,0,0
213642,),0,0
213643,",",0,0
213644,hospital,0,1
213645,admission,0,1
213646,rate,0,0
213647,(,0,1
213648,10.2,0,0
213649,percent,0,1
213650,for,0,0
213651,the,0,0
213652,placebo,0,0
213653,group,0,1
213654,and,0,1
213655,9.0,0,0
213656,percent,0,1
213657,for,0,0
213658,the,0,0
213659,aminophylline,0,0
213660,group,0,0
213661,),0,0
213662,",",0,0
213663,and,0,0
213664,mean,0,1
213665,duration,0,0
213666,of,0,1
213667,Emergency,0,1
213668,Department,0,1
213669,treatment,0,1
213670,(,0,1
213671,2.5,0,0
213672,+/-,0,1
213673,1.83,0,0
213674,h,0,0
213675,for,0,0
213676,the,0,0
213677,placebo,0,0
213678,group,0,1
213679,and,0,1
213680,2.37,0,0
213681,+/-,0,0
213682,1.75,0,1
213683,h,0,0
213684,for,0,0
213685,the,0,0
213686,aminophylline,0,0
213687,group,0,1
213688,),0,1
213689,.,0,1
213690,The,0,0
213691,results,0,0
213692,were,0,0
213693,similar,0,0
213694,when,0,0
213695,the,0,0
213696,patients,0,1
213697,were,0,1
213698,divided,0,1
213699,in,0,0
213700,accord,0,0
213701,with,0,1
213702,the,0,0
213703,degree,0,1
213704,of,0,0
213705,respiratory,0,1
213706,obstruction,0,1
213707,(,0,1
213708,baseline,0,0
213709,FEV1,0,1
213710,<,0,0
213711,30,0,1
213712,percent,0,1
213713,of,0,0
213714,predicted,0,0
213715,),0,1
213716,and,0,0
213717,theophylline,0,0
213718,level,0,0
213719,at,0,1
213720,30,0,1
213721,min,0,0
213722,of,0,0
213723,treatment,0,0
213724,(,0,1
213725,placebo,0,0
213726,group,0,1
213727,patients,0,1
213728,with,0,1
213729,theophylline,0,0
213730,level,0,0
213731,<,0,0
213732,10,0,1
213733,mg/L,0,1
213734,vs,0,0
213735,aminophylline,0,1
213736,group,0,1
213737,patients,0,1
213738,with,0,1
213739,theophylline,0,0
213740,level,0,0
213741,>,0,1
213742,or,0,1
213743,=,0,1
213744,10,0,1
213745,mg/L,0,1
213746,),0,1
213747,.,0,1
213748,We,0,0
213749,conclude,0,0
213750,that,0,0
213751,intravenous,0,0
213752,aminophylline,0,0
213753,adds,0,0
213754,to,0,0
213755,the,0,0
213756,toxicity,0,0
213757,but,0,0
213758,not,0,0
213759,the,0,0
213760,efficacy,0,0
213761,of,0,0
213762,inhaled,0,0
213763,salbutamol,0,0
213764,in,0,0
213765,the,0,0
213766,treatment,0,0
213767,of,0,0
213768,acute,0,1
213769,exacerbations,0,1
213770,of,0,1
213771,asthma,0,1
213772,.,0,1
213773,Enhanced,0,1
213774,small,1,1
213775,group,1,1
213776,instruction,0,0
213777,using,0,0
213778,choral,0,1
213779,responding,0,1
213780,and,0,0
213781,student,1,0
213782,interaction,1,0
213783,for,1,0
213784,children,1,1
213785,with,1,1
213786,autism,1,1
213787,and,1,1
213788,developmental,1,1
213789,disabilities,1,1
213790,.,1,1
213791,The,0,0
213792,use,0,0
213793,of,0,0
213794,effective,0,0
213795,instructional,0,0
213796,strategies,0,0
213797,in,0,1
213798,small,0,1
213799,groups,0,1
213800,was,0,0
213801,investigated,0,0
213802,to,0,0
213803,determine,0,0
213804,learning,0,0
213805,effects,0,0
213806,for,0,1
213807,24,1,1
213808,elementary,1,1
213809,age,1,1
213810,students,1,1
213811,with,1,1
213812,autism,1,1
213813,and,1,1
213814,developmental,1,1
213815,disabilities,1,1
213816,.,1,1
213817,Effective,0,0
213818,strategies,0,0
213819,included,0,1
213820,(,0,1
213821,a,0,0
213822,),0,0
213823,the,0,0
213824,use,0,0
213825,of,0,0
213826,choral,0,1
213827,responding,0,1
213828,;,0,1
213829,(,0,1
213830,b,0,1
213831,),0,1
213832,the,0,0
213833,use,0,0
213834,of,0,0
213835,student-to-student,0,0
213836,responding,0,1
213837,;,0,1
213838,(,0,1
213839,c,0,1
213840,),0,1
213841,the,0,0
213842,rotation,0,0
213843,of,0,0
213844,materials,0,1
213845,every,0,1
213846,5,0,1
213847,minutes,0,0
213848,during,0,1
213849,the,0,1
213850,30-minute,0,0
213851,group,0,1
213852,while,0,0
213853,teaching,0,1
213854,2,0,1
213855,to,0,1
213856,3,0,1
213857,concepts,0,1
213858,;,0,1
213859,and,0,1
213860,(,0,1
213861,d,0,0
213862,),0,1
213863,the,0,0
213864,use,0,0
213865,of,0,0
213866,random,0,1
213867,",",0,1
213868,unpredictable,0,0
213869,trials,0,0
213870,for,0,1
213871,student,0,0
213872,responding,0,1
213873,.,0,1
213874,Thirty-minute,0,0
213875,language,0,1
213876,groups,0,1
213877,were,0,1
213878,targeted,0,1
213879,to,0,0
213880,teach,0,0
213881,receptive,0,1
213882,and,0,1
213883,expressive,0,1
213884,skills,0,0
213885,using,0,1
213886,pictures,0,1
213887,and,0,1
213888,common,0,1
213889,objects,0,1
213890,across,0,1
213891,five,0,1
213892,categories,0,1
213893,(,0,1
213894,e.g.,0,0
213895,",",0,0
213896,household,0,1
213897,items,0,0
213898,",",0,1
213899,foods,0,1
213900,),0,1
213901,.,0,1
213902,Results,0,0
213903,showed,0,0
213904,increased,0,0
213905,opportunities,0,0
213906,to,0,1
213907,respond,0,1
213908,",",0,0
213909,increased,0,0
213910,levels,0,0
213911,of,0,1
213912,responding,0,1
213913,and,0,1
213914,academic,0,1
213915,engagement,0,0
213916,",",0,1
213917,higher,0,0
213918,gains,0,0
213919,on,0,0
213920,weekly,0,1
213921,criterion-referenced,0,1
213922,pre-,0,0
213923,and,0,1
213924,posttests,0,0
213925,",",0,1
213926,and,0,0
213927,decreased,0,0
213928,passive,0,0
213929,and,0,1
213930,inappropriate,0,1
213931,student,0,0
213932,behavior,0,0
213933,during,0,1
213934,interventions,0,1
213935,.,0,1
213936,Late,0,0
213937,hemodynamic,0,0
213938,effects,0,0
213939,of,0,1
213940,the,0,1
213941,preserved,0,1
213942,papillary,0,1
213943,muscles,0,1
213944,during,0,0
213945,mitral,1,1
213946,valve,1,1
213947,replacement,1,1
213948,.,1,0
213949,BACKGROUND,0,0
213950,The,0,0
213951,late,0,1
213952,hemodynamic,0,0
213953,effects,0,0
213954,of,0,1
213955,preserving,0,0
213956,the,0,0
213957,papillary,0,1
213958,muscles,0,1
213959,during,0,0
213960,mitral,0,1
213961,valve,0,1
213962,replacement,0,1
213963,have,0,0
213964,not,0,0
213965,been,0,0
213966,evaluated,0,0
213967,.,0,1
213968,METHODS,0,0
213969,AND,0,0
213970,RESULTS,0,1
213971,Sixteen,1,1
213972,patients,1,1
213973,who,1,1
213974,had,1,1
213975,chronic,1,1
213976,mitral,1,1
213977,regurgitation,1,1
213978,due,1,1
213979,to,1,1
213980,myxomatous,1,1
213981,degeneration,1,1
213982,were,1,1
213983,randomized,1,1
213984,to,1,0
213985,preservation,1,0
213986,(,1,1
213987,Pres,1,1
213988,group,1,0
213989,",",1,0
213990,n,1,1
213991,=,1,0
213992,8,1,0
213993,),1,0
213994,or,1,1
213995,no,1,0
213996,preservation,1,0
213997,(,1,0
213998,No,1,0
213999,Pres,1,1
214000,group,1,0
214001,",",1,0
214002,n,1,1
214003,=,1,0
214004,8,1,0
214005,),1,0
214006,of,0,0
214007,the,0,0
214008,chordae,0,1
214009,tendineae,0,1
214010,and,0,1
214011,papillary,0,1
214012,muscles,0,1
214013,during,0,0
214014,mitral,0,1
214015,valve,0,1
214016,replacement,0,1
214017,.,0,1
214018,Rest,0,0
214019,and,0,0
214020,exercise,0,1
214021,nuclear,0,1
214022,ventriculograms,0,0
214023,were,0,1
214024,performed,0,0
214025,early,0,1
214026,(,0,1
214027,3,0,1
214028,months,0,1
214029,),0,1
214030,and,0,1
214031,late,0,1
214032,(,0,1
214033,5,0,1
214034,years,0,1
214035,),0,1
214036,after,0,1
214037,surgery,0,1
214038,.,0,1
214039,Early,0,0
214040,after,0,0
214041,surgery,0,1
214042,",",0,0
214043,the,0,0
214044,No,0,0
214045,Pres,0,1
214046,group,0,1
214047,had,0,1
214048,lower,0,0
214049,ejection,0,1
214050,fractions,0,1
214051,and,0,1
214052,stroke,0,1
214053,work,0,0
214054,indexes,0,0
214055,(,0,1
214056,P,0,0
214057,<,0,0
214058,.05,0,0
214059,by,0,1
214060,repeated-measures,0,0
214061,[,0,1
214062,rm,0,1
214063,],0,1
214064,ANOVA,0,1
214065,),0,1
214066,than,0,0
214067,the,0,0
214068,Pres,0,1
214069,group,0,0
214070,did,0,0
214071,at,0,0
214072,similar,0,0
214073,end-diastolic,0,1
214074,volume,0,1
214075,indexes,0,0
214076,.,0,1
214077,The,0,0
214078,No,0,0
214079,Pres,0,1
214080,group,0,1
214081,had,0,1
214082,similar,0,0
214083,cardiac,0,1
214084,indexes,0,0
214085,after,0,1
214086,exercise,0,1
214087,because,0,1
214088,heart,0,1
214089,rate,0,0
214090,increased,0,0
214091,(,0,1
214092,P,0,0
214093,<,0,0
214094,.005,0,0
214095,by,0,0
214096,rm,0,1
214097,ANOVA,0,1
214098,),0,1
214099,.,0,1
214100,Late,0,0
214101,after,0,0
214102,surgery,0,1
214103,",",0,0
214104,ejection,0,1
214105,fraction,0,0
214106,was,0,0
214107,greater,0,0
214108,at,0,1
214109,similar,0,0
214110,end-diastolic,0,1
214111,volume,0,1
214112,indexes,0,0
214113,(,0,1
214114,P,0,0
214115,<,0,0
214116,.005,0,0
214117,by,0,0
214118,rm,0,1
214119,ANCOVA,0,1
214120,),0,1
214121,",",0,0
214122,and,0,0
214123,preload,0,0
214124,recruitable,0,0
214125,stroke,0,1
214126,work,0,0
214127,indexes,0,0
214128,(,0,1
214129,P,0,0
214130,<,0,0
214131,.001,0,0
214132,by,0,0
214133,rm,0,1
214134,ANCOVA,0,1
214135,),0,0
214136,were,0,0
214137,better,0,0
214138,in,0,0
214139,the,0,0
214140,Pres,0,1
214141,group,0,1
214142,.,0,1
214143,CONCLUSIONS,0,0
214144,Preserving,0,1
214145,chordal,0,1
214146,attachments,0,0
214147,enhanced,0,0
214148,the,0,0
214149,late,0,1
214150,hemodynamic,0,0
214151,recovery,0,0
214152,after,0,0
214153,mitral,0,1
214154,valve,0,1
214155,replacement,0,1
214156,for,0,0
214157,mitral,0,1
214158,regurgitation,0,1
214159,.,0,1
214160,Effect,0,0
214161,of,0,0
214162,TENS,0,0
214163,on,0,0
214164,pain,0,1
214165,",",0,1
214166,medications,0,0
214167,",",0,0
214168,and,0,1
214169,pulmonary,1,1
214170,function,1,0
214171,following,1,0
214172,coronary,1,1
214173,artery,1,1
214174,bypass,1,1
214175,graft,1,1
214176,surgery,1,1
214177,.,1,1
214178,The,0,0
214179,efficacy,0,0
214180,of,0,0
214181,transcutaneous,0,0
214182,electrical,0,0
214183,nerve,0,1
214184,stimulation,0,0
214185,(,0,1
214186,TENS,0,0
214187,),0,1
214188,as,0,0
214189,an,0,1
214190,adjunct,0,0
214191,to,0,1
214192,narcotic,0,1
214193,medications,0,0
214194,for,0,1
214195,the,0,0
214196,management,0,0
214197,of,0,0
214198,postoperative,0,0
214199,pain,0,1
214200,was,0,0
214201,assessed,0,0
214202,in,0,0
214203,a,0,0
214204,prospective,1,1
214205,",",1,0
214206,randomized,1,1
214207,",",1,0
214208,controlled,1,0
214209,study,1,0
214210,of,1,1
214211,patients,1,1
214212,following,1,1
214213,coronary,1,1
214214,artery,1,1
214215,bypass,1,1
214216,graft,1,1
214217,(,1,1
214218,CABG,1,1
214219,),1,1
214220,surgery,1,1
214221,with,1,1
214222,the,1,0
214223,right,1,1
214224,or,1,1
214225,left,1,1
214226,internal,1,0
214227,thoracic,1,1
214228,artery,1,1
214229,(,1,1
214230,ITA,1,0
214231,),1,1
214232,.,1,1
214233,Forty-five,1,1
214234,male,1,1
214235,patients,1,1
214236,(,1,1
214237,mean,1,1
214238,age,1,1
214239,",",1,1
214240,57,1,1
214241,+/-,1,1
214242,6,1,1
214243,years,1,1
214244,),1,1
214245,were,1,1
214246,randomly,1,1
214247,assigned,1,1
214248,to,0,0
214249,(,0,1
214250,1,0,1
214251,),0,1
214252,TENS,0,0
214253,",",0,0
214254,(,0,1
214255,2,0,1
214256,),0,1
214257,placebo,0,0
214258,TENS,0,0
214259,",",0,0
214260,or,0,1
214261,(,0,1
214262,3,0,1
214263,),0,1
214264,control,0,1
214265,treatments,0,0
214266,(,0,1
214267,n,0,1
214268,=,0,1
214269,15,0,1
214270,each,0,0
214271,),0,0
214272,",",0,0
214273,following,0,0
214274,extubation,0,1
214275,and,0,0
214276,during,0,0
214277,the,0,0
214278,24-,0,1
214279,to,0,1
214280,72-h,0,0
214281,postoperative,0,1
214282,period,0,1
214283,.,0,1
214284,Two-way,0,0
214285,analysis,0,0
214286,of,0,1
214287,variance,0,0
214288,tests,0,0
214289,indicated,0,0
214290,no,0,1
214291,significant,0,0
214292,differences,0,0
214293,among,0,1
214294,treatment,0,1
214295,groups,0,1
214296,for,0,1
214297,(,0,1
214298,1,0,1
214299,),0,1
214300,pain,0,1
214301,with,0,1
214302,cough,0,1
214303,",",0,1
214304,(,0,1
214305,2,0,1
214306,),0,1
214307,narcotic,0,1
214308,medication,0,1
214309,intake,0,0
214310,",",0,0
214311,(,0,1
214312,3,0,1
214313,),0,1
214314,FVC,0,0
214315,",",0,1
214316,(,0,1
214317,4,0,0
214318,),0,1
214319,FEV1,0,1
214320,",",0,0
214321,and,0,0
214322,(,0,1
214323,5,0,1
214324,),0,1
214325,PEFR,0,1
214326,(,0,1
214327,p,0,0
214328,>,0,1
214329,0.05,0,0
214330,),0,1
214331,.,0,1
214332,However,0,0
214333,",",0,0
214334,pain,0,0
214335,at,0,0
214336,rest,0,0
214337,reported,0,0
214338,by,0,0
214339,the,0,0
214340,TENS,1,0
214341,group,1,0
214342,was,0,0
214343,significantly,0,0
214344,lower,0,0
214345,than,0,0
214346,that,0,0
214347,reported,0,0
214348,by,0,0
214349,the,0,0
214350,control,0,1
214351,group,0,0
214352,(,0,1
214353,treatment,0,0
214354,main,0,0
214355,effect,0,0
214356,;,0,0
214357,p,0,0
214358,<,0,0
214359,0.04,0,0
214360,),0,0
214361,",",0,0
214362,although,0,0
214363,no,0,0
214364,significant,0,0
214365,differences,0,0
214366,were,0,1
214367,observed,0,0
214368,between,0,0
214369,the,0,0
214370,TENS,0,0
214371,and,0,0
214372,placebo,0,0
214373,or,0,1
214374,between,0,0
214375,the,0,0
214376,placebo,0,0
214377,and,0,0
214378,control,0,1
214379,groups,0,0
214380,(,0,1
214381,p,0,0
214382,>,0,1
214383,0.05,0,0
214384,),0,1
214385,.,0,1
214386,All,0,1
214387,six,0,1
214388,criterion,0,1
214389,measures,0,0
214390,were,0,1
214391,characterized,0,0
214392,by,0,0
214393,significant,0,0
214394,changes,0,0
214395,over,0,0
214396,time,0,0
214397,for,0,0
214398,the,0,0
214399,entire,0,1
214400,group,0,1
214401,(,0,0
214402,n,0,1
214403,=,0,1
214404,45,0,1
214405,;,0,0
214406,time,0,0
214407,main,0,0
214408,effect,0,0
214409,;,0,0
214410,p,0,0
214411,<,0,0
214412,0.01,0,0
214413,),0,0
214414,",",0,0
214415,as,0,0
214416,follows,0,0
214417,:,0,1
214418,pain,0,0
214419,and,0,0
214420,medication,0,1
214421,intake,0,0
214422,were,0,1
214423,similar,0,0
214424,on,0,1
214425,days,0,1
214426,1,0,1
214427,and,0,1
214428,2,0,1
214429,",",0,0
214430,but,0,0
214431,were,0,0
214432,significantly,0,0
214433,less,0,0
214434,on,0,0
214435,day,0,0
214436,3,0,1
214437,",",0,0
214438,and,0,1
214439,pulmonary,0,1
214440,functions,0,0
214441,were,0,1
214442,significantly,0,0
214443,lower,0,0
214444,than,0,0
214445,preoperatively,0,0
214446,on,0,0
214447,day,0,0
214448,1,0,1
214449,",",0,0
214450,decreased,0,0
214451,further,0,0
214452,on,0,0
214453,day,0,0
214454,2,0,1
214455,",",0,0
214456,and,0,0
214457,despite,0,0
214458,an,0,0
214459,improvement,0,0
214460,on,0,0
214461,day,0,0
214462,3,0,1
214463,",",0,0
214464,remained,0,0
214465,significantly,0,0
214466,lower,0,0
214467,than,0,0
214468,preoperative,0,1
214469,values,0,0
214470,(,0,1
214471,p,0,0
214472,<,0,0
214473,0.01,0,0
214474,),0,1
214475,.,0,1
214476,This,0,0
214477,study,0,0
214478,suggests,0,0
214479,that,0,0
214480,the,0,0
214481,addition,0,0
214482,of,0,0
214483,TENS,0,0
214484,",",0,0
214485,applied,0,0
214486,continuously,0,0
214487,during,0,0
214488,the,0,0
214489,immediate,0,0
214490,postoperative,0,0
214491,period,0,1
214492,following,0,0
214493,CABG,0,1
214494,with,0,1
214495,ITA,0,0
214496,",",0,0
214497,may,0,0
214498,not,0,0
214499,be,0,0
214500,advantageous,0,0
214501,in,0,0
214502,pain,0,1
214503,management,0,1
214504,or,0,1
214505,the,0,0
214506,prevention,0,1
214507,of,0,0
214508,pulmonary,0,1
214509,dysfunction,0,1
214510,.,0,1
214511,A,0,0
214512,cost-benefit,0,0
214513,comparison,0,0
214514,of,0,1
214515,intensive,0,1
214516,diabetes,0,1
214517,management,0,1
214518,with,0,1
214519,implantable,0,1
214520,pumps,0,1
214521,versus,0,0
214522,multiple,0,1
214523,subcutaneous,0,1
214524,injections,0,0
214525,in,0,1
214526,patients,1,1
214527,with,1,1
214528,type,1,1
214529,I,1,1
214530,diabetes,1,1
214531,.,1,0
214532,OBJECTIVE,0,0
214533,To,0,0
214534,investigate,0,0
214535,if,0,0
214536,intraperitoneal,0,0
214537,(,0,1
214538,IP,0,0
214539,),0,1
214540,insulin,0,0
214541,infusion,0,0
214542,via,0,1
214543,programmable,0,1
214544,implantable,0,1
214545,pumps,0,0
214546,is,0,0
214547,a,0,0
214548,potential,0,0
214549,alternative,0,0
214550,to,0,1
214551,subcutaneous,0,1
214552,(,0,1
214553,SC,0,1
214554,),0,1
214555,insulin,0,0
214556,via,0,1
214557,multiple,0,1
214558,injections,0,0
214559,.,0,1
214560,RESEARCH,0,1
214561,DESIGN,0,1
214562,AND,0,0
214563,METHODS,0,0
214564,We,0,0
214565,compared,0,0
214566,the,0,0
214567,cost-benefits,0,0
214568,of,0,0
214569,the,0,1
214570,two,0,1
214571,methods,0,1
214572,using,0,1
214573,a,0,1
214574,randomized,0,1
214575,",",0,0
214576,prospective,0,0
214577,",",0,0
214578,6-month,0,0
214579,",",0,0
214580,crossover,0,0
214581,design,0,1
214582,in,0,1
214583,10,1,1
214584,adult,1,1
214585,type,1,1
214586,I,1,1
214587,diabetic,1,1
214588,patients,1,1
214589,.,1,1
214590,RESULTS,0,0
214591,When,0,1
214592,judged,0,0
214593,on,0,0
214594,the,0,0
214595,last,0,0
214596,month,0,0
214597,of,0,0
214598,IP,0,0
214599,versus,0,0
214600,SC,0,1
214601,periods,0,0
214602,in,0,1
214603,the,0,1
214604,nine,0,1
214605,patients,0,1
214606,who,0,1
214607,completed,0,1
214608,the,0,1
214609,study,0,0
214610,",",0,0
214611,metabolic,0,0
214612,data,0,0
214613,showed,0,0
214614,better,0,0
214615,glycemic,0,0
214616,control,0,1
214617,(,0,1
214618,HbA1c,0,0
214619,:,0,1
214620,7.2,0,1
214621,+/-,0,1
214622,0.2,0,0
214623,IP,0,1
214624,vs.,0,0
214625,8.5,0,0
214626,+/-,0,0
214627,0.7,0,0
214628,%,0,0
214629,SC,0,1
214630,",",0,1
214631,mean,0,1
214632,+/-,0,0
214633,SE,0,1
214634,",",0,1
214635,P,0,0
214636,=,0,1
214637,0.02,0,0
214638,),0,1
214639,",",0,0
214640,reduced,0,0
214641,glycemic,0,0
214642,fluctuations,0,0
214643,(,0,1
214644,SD,0,1
214645,of,0,1
214646,capillary,0,1
214647,glucose,0,1
214648,values,0,0
214649,:,0,1
214650,3.4,0,1
214651,+/-,0,1
214652,0.2,0,0
214653,IP,0,1
214654,vs.,0,0
214655,4.6,0,1
214656,+/-,0,0
214657,0.2,0,1
214658,mM,0,0
214659,SC,0,1
214660,",",0,1
214661,P,0,0
214662,<,0,0
214663,0.01,0,0
214664,),0,1
214665,",",0,0
214666,and,0,0
214667,fewer,0,0
214668,mild,0,1
214669,hypoglycemic,0,1
214670,events,0,0
214671,(,0,1
214672,5.7,0,1
214673,+/-,0,1
214674,2.0,0,0
214675,IP,0,1
214676,vs.,0,0
214677,10.0,0,0
214678,+/-,0,1
214679,3.1,0,1
214680,events/month,0,0
214681,SC,0,1
214682,",",0,1
214683,P,0,0
214684,=,0,1
214685,0.02,0,0
214686,),0,1
214687,.,0,1
214688,Quality,0,0
214689,of,0,0
214690,life,0,0
214691,",",0,0
214692,judged,0,0
214693,by,0,0
214694,Diabetes,0,1
214695,Control,0,1
214696,and,0,1
214697,Complications,0,1
214698,Trial,0,1
214699,questionnaires,0,0
214700,",",0,1
214701,was,0,0
214702,unaffected,0,0
214703,by,0,0
214704,pump,0,1
214705,therapy,0,1
214706,.,0,1
214707,Direct,0,0
214708,costs,0,0
214709,",",0,1
214710,including,0,1
214711,pump,0,0
214712,acquisition,0,0
214713,",",0,0
214714,implantation,0,1
214715,",",0,0
214716,and,0,0
214717,follow-up,0,0
214718,",",0,0
214719,were,0,0
214720,2.6-fold,0,0
214721,higher,0,0
214722,with,0,1
214723,IP,0,0
214724,than,0,0
214725,with,0,1
214726,SC,0,1
214727,delivery,0,1
214728,.,0,1
214729,CONCLUSIONS,0,0
214730,The,0,0
214731,implantable,0,0
214732,pump,0,0
214733,is,0,0
214734,more,0,0
214735,effective,0,0
214736,in,0,0
214737,the,0,0
214738,short,0,0
214739,term,0,0
214740,",",0,0
214741,equally,0,0
214742,accepted,0,0
214743,",",0,0
214744,but,0,0
214745,more,0,0
214746,costly,0,0
214747,than,0,0
214748,multiple,0,1
214749,injections,0,0
214750,and,0,1
214751,should,0,0
214752,be,0,0
214753,limited,0,0
214754,to,0,0
214755,patients,0,1
214756,with,0,1
214757,unsatisfactory,0,1
214758,glycemic,0,0
214759,control,0,1
214760,despite,0,1
214761,intensive,0,1
214762,diabetes,0,1
214763,management,0,1
214764,with,0,1
214765,SC,0,1
214766,insulin,0,1
214767,.,0,1
214768,In,0,0
214769,addition,0,0
214770,",",0,0
214771,longer-term,0,0
214772,",",0,0
214773,larger-scale,0,0
214774,",",0,0
214775,and,0,0
214776,comparative,0,0
214777,evaluation,0,0
214778,is,0,0
214779,required,0,0
214780,.,0,0
214781,The,0,0
214782,effects,0,0
214783,of,0,0
214784,single,0,1
214785,oral,0,1
214786,doses,0,0
214787,of,0,1
214788,17,0,1
214789,beta-oestradiol,0,0
214790,and,0,1
214791,progesterone,0,0
214792,on,0,0
214793,finger,0,1
214794,skin,0,1
214795,circulation,0,0
214796,in,0,1
214797,healthy,1,1
214798,women,1,1
214799,and,1,1
214800,in,1,1
214801,women,1,1
214802,with,1,1
214803,primary,1,1
214804,Raynaud,1,1
214805,'s,1,1
214806,phenomenon,1,0
214807,.,1,1
214808,The,0,0
214809,effects,0,0
214810,of,0,0
214811,sex,0,0
214812,",",0,0
214813,the,0,0
214814,menstrual,0,0
214815,cycle,0,0
214816,",",0,1
214817,oral,0,0
214818,contraceptives,0,0
214819,",",0,1
214820,pregnancy,0,1
214821,",",0,0
214822,and,0,0
214823,the,0,0
214824,menopause,0,1
214825,on,0,0
214826,skin,0,1
214827,perfusion,0,0
214828,in,0,1
214829,healthy,1,1
214830,women,1,1
214831,and,0,1
214832,in,0,1
214833,patients,1,1
214834,with,1,1
214835,Raynaud,1,1
214836,'s,1,1
214837,phenomenon,1,0
214838,suggest,0,0
214839,a,0,0
214840,role,0,0
214841,of,0,0
214842,female,0,1
214843,sex,0,1
214844,hormones,0,0
214845,.,0,1
214846,However,0,0
214847,",",0,0
214848,no,0,0
214849,clear,0,0
214850,relation,0,0
214851,between,0,0
214852,skin,0,1
214853,blood,0,0
214854,flow,0,0
214855,and,0,1
214856,circulating,0,0
214857,concentrations,0,0
214858,of,0,1
214859,oestrogens,0,1
214860,or,0,1
214861,progestogens,0,0
214862,has,0,0
214863,yet,0,0
214864,been,0,0
214865,found,0,0
214866,.,0,1
214867,The,0,0
214868,aim,0,0
214869,of,0,0
214870,this,0,0
214871,study,0,0
214872,was,0,0
214873,to,0,0
214874,investigate,0,0
214875,the,0,0
214876,effect,0,0
214877,of,0,0
214878,orally,0,1
214879,administered,0,0
214880,17,0,1
214881,beta-oestradiol,0,0
214882,and,0,1
214883,progesterone,0,0
214884,on,0,0
214885,finger,0,1
214886,skin,0,1
214887,blood,0,0
214888,flow,0,0
214889,before,0,0
214890,and,0,0
214891,during,0,0
214892,heat,0,0
214893,and,0,1
214894,cold,0,1
214895,challenge,0,0
214896,in,0,1
214897,17,1,1
214898,healthy,1,1
214899,normotensive,1,1
214900,women,1,1
214901,and,1,1
214902,in,1,1
214903,12,1,1
214904,women,1,1
214905,with,1,1
214906,Raynaud,1,1
214907,'s,1,1
214908,phenomenon,1,0
214909,.,1,1
214910,In,0,0
214911,each,0,0
214912,subject,0,0
214913,standardized,0,0
214914,finger,0,1
214915,heating,0,0
214916,(,0,1
214917,45,0,1
214918,degrees,0,1
214919,C,0,1
214920,water,0,0
214921,bath,0,0
214922,",",0,0
214923,10,0,1
214924,min,0,0
214925,),0,1
214926,and,0,1
214927,cooling,0,1
214928,tests,0,0
214929,(,0,1
214930,15,0,1
214931,degrees,0,1
214932,C,0,1
214933,water,0,0
214934,bath,0,0
214935,",",0,0
214936,5,0,0
214937,min,0,0
214938,and,0,1
214939,20,0,1
214940,min,0,0
214941,recovery,0,0
214942,),0,1
214943,were,0,0
214944,performed,0,0
214945,twice,0,0
214946,on,0,0
214947,the,0,0
214948,second,0,1
214949,(,0,0
214950,or,0,1
214951,third,0,1
214952,),0,1
214953,day,0,0
214954,of,0,1
214955,two,0,1
214956,consecutive,0,1
214957,menstrual,0,1
214958,cycles,0,1
214959,.,0,1
214960,17,0,1
214961,beta-Oestradiol,0,0
214962,(,0,1
214963,9,0,0
214964,mg,0,1
214965,),0,1
214966,or,0,1
214967,progesterone,0,0
214968,(,0,1
214969,300,0,1
214970,mg,0,1
214971,),0,1
214972,were,0,0
214973,given,0,0
214974,before,0,0
214975,the,0,0
214976,second,0,0
214977,test,0,0
214978,",",0,0
214979,after,0,0
214980,a,0,0
214981,first,0,0
214982,test,0,0
214983,with,0,1
214984,placebo,0,0
214985,.,0,1
214986,Both,0,0
214987,hormonal,0,0
214988,doses,0,0
214989,resulted,0,0
214990,in,0,1
214991,(,0,1
214992,high,0,1
214993,),0,1
214994,physiological,0,0
214995,concentrations,0,0
214996,.,0,1
214997,Fingertip,0,0
214998,skin,0,1
214999,temperature,0,1
215000,and,0,1
215001,laser,0,0
215002,Doppler,0,1
215003,flux,0,0
215004,were,0,1
215005,measured,0,0
215006,.,0,0
215007,There,0,0
215008,were,0,0
215009,no,0,0
215010,significant,0,0
215011,differences,0,0
215012,in,0,1
215013,the,0,1
215014,test,0,0
215015,results,0,0
215016,after,0,1
215017,placebo,0,1
215018,and,0,1
215019,after,0,0
215020,progesterone,0,0
215021,.,0,1
215022,Although,0,0
215023,values,0,0
215024,of,0,1
215025,fingertip,0,1
215026,skin,0,1
215027,temperature,0,0
215028,and,0,0
215029,laser,0,0
215030,Doppler,0,0
215031,flux,0,1
215032,after,0,1
215033,17,0,1
215034,beta-oestradiol,0,0
215035,tended,0,0
215036,to,0,0
215037,be,0,0
215038,higher,0,0
215039,only,0,0
215040,the,0,0
215041,precooling,0,0
215042,values,0,0
215043,in,0,1
215044,the,0,1
215045,healthy,0,1
215046,subjects,0,1
215047,reached,0,0
215048,significance,0,0
215049,:,0,1
215050,fingertip,0,0
215051,skin,0,1
215052,temperature,0,0
215053,respectively,0,0
215054,with,0,1
215055,placebo,0,0
215056,and,0,1
215057,with,0,1
215058,oestradiol,0,0
215059,(,0,1
215060,mean,0,1
215061,(,0,1
215062,SD,0,1
215063,),0,1
215064,),0,1
215065,:,0,1
215066,32.7,0,1
215067,(,0,1
215068,1.0,0,0
215069,),0,1
215070,and,0,1
215071,33.1,0,1
215072,(,0,1
215073,0.8,0,1
215074,),0,1
215075,degrees,0,1
215076,C,0,1
215077,;,0,1
215078,laser,0,0
215079,Doppler,0,0
215080,flux,0,0
215081,with,0,1
215082,placebo,0,0
215083,and,0,1
215084,with,0,1
215085,oestradiol,0,1
215086,:,0,1
215087,33.6,0,1
215088,(,0,1
215089,11.7,0,0
215090,),0,1
215091,and,0,1
215092,42.2,0,1
215093,(,0,1
215094,9.5,0,0
215095,),0,1
215096,perfusion,0,1
215097,units,0,1
215098,;,0,1
215099,both,0,0
215100,P,0,0
215101,<,0,0
215102,0.05,0,0
215103,),0,1
215104,.,0,1
215105,(,0,0
215106,ABSTRACT,0,0
215107,TRUNCATED,0,1
215108,AT,0,1
215109,250,0,1
215110,WORDS,0,1
215111,),0,1
215112,Effect,0,0
215113,of,0,1
215114,simultaneous,0,0
215115,didanosine,0,1
215116,administration,0,0
215117,on,0,0
215118,itraconazole,0,0
215119,absorption,0,0
215120,in,0,1
215121,healthy,1,1
215122,volunteers,1,1
215123,.,1,1
215124,STUDY,0,0
215125,OBJECTIVE,0,0
215126,To,0,0
215127,investigate,0,0
215128,the,0,0
215129,effect,0,0
215130,of,0,0
215131,simultaneously,0,0
215132,administered,0,0
215133,didanosine,0,0
215134,(,0,1
215135,ddI,0,1
215136,),0,1
215137,on,0,0
215138,the,0,0
215139,absorption,0,0
215140,of,0,0
215141,a,0,1
215142,single,0,0
215143,dose,0,0
215144,of,0,0
215145,itraconazole,0,0
215146,.,0,1
215147,DESIGN,0,0
215148,Randomized,0,0
215149,",",0,0
215150,crossover,0,0
215151,",",0,0
215152,unblinded,0,0
215153,single-dose,0,0
215154,pharmacokinetic,0,0
215155,study,0,1
215156,in,0,1
215157,healthy,1,1
215158,volunteers,1,1
215159,.,1,1
215160,Comparisons,0,0
215161,of,0,0
215162,itraconazole,0,1
215163,alone,0,1
215164,and,0,0
215165,itraconazole,0,0
215166,with,0,1
215167,simultaneous,0,1
215168,ddI,0,1
215169,were,0,1
215170,performed,0,0
215171,on,0,0
215172,days,0,0
215173,1,0,1
215174,and,0,1
215175,15,0,1
215176,.,0,1
215177,SETTING,0,1
215178,A,1,0
215179,university,1,1
215180,medical,1,1
215181,center,1,1
215182,.,1,1
215183,PATIENTS,0,0
215184,Seven,1,0
215185,healthy,1,1
215186,men,1,1
215187,and,1,1
215188,women,1,1
215189,.,1,1
215190,Six,1,1
215191,subjects,1,1
215192,(,1,1
215193,86,1,1
215194,%,1,0
215195,),1,1
215196,completed,1,1
215197,the,1,0
215198,study,1,1
215199,;,1,1
215200,one,1,1
215201,was,1,0
215202,removed,1,0
215203,due,1,0
215204,to,1,0
215205,the,1,0
215206,development,1,0
215207,of,1,0
215208,a,1,1
215209,rash,1,1
215210,.,1,1
215211,INTERVENTIONS,0,0
215212,Volunteers,0,1
215213,received,0,1
215214,a,0,1
215215,single,0,0
215216,200-mg,0,0
215217,oral,0,1
215218,dose,0,0
215219,of,0,0
215220,itraconazole,0,0
215221,or,0,1
215222,itraconazole,0,0
215223,with,0,1
215224,concomitant,0,0
215225,oral,0,1
215226,ddI,0,1
215227,300,0,1
215228,mg,0,1
215229,(,0,1
215230,two,0,1
215231,150-mg,0,0
215232,tablets,0,1
215233,),0,1
215234,dispersed,0,1
215235,in,0,1
215236,240,0,1
215237,ml,0,0
215238,water,0,0
215239,.,0,1
215240,Each,0,0
215241,regimen,0,0
215242,was,0,0
215243,separated,0,0
215244,by,0,0
215245,a,0,1
215246,2-week,0,0
215247,washout,0,0
215248,period,0,1
215249,.,0,1
215250,Serum,0,1
215251,samples,0,1
215252,were,0,1
215253,obtained,0,0
215254,frequently,0,1
215255,for,0,1
215256,12,0,1
215257,hours,0,0
215258,after,0,1
215259,the,0,1
215260,dose,0,0
215261,.,0,1
215262,MEASUREMENTS,0,0
215263,AND,0,0
215264,MAIN,0,0
215265,RESULTS,0,1
215266,Concentrations,0,0
215267,of,0,0
215268,itraconazole,0,0
215269,were,0,1
215270,determined,0,0
215271,using,0,0
215272,a,0,0
215273,microbiologic,0,0
215274,assay,0,0
215275,.,0,1
215276,Individual,0,0
215277,concentrations,0,0
215278,in,0,1
215279,serum,0,0
215280,versus,0,0
215281,time,0,0
215282,data,0,0
215283,were,0,1
215284,evaluated,0,0
215285,by,0,0
215286,linear,0,0
215287,regression,0,0
215288,analysis,0,0
215289,.,0,1
215290,Peak,0,0
215291,serum,0,0
215292,concentration,0,0
215293,and,0,1
215294,time,0,0
215295,to,0,0
215296,peak,0,0
215297,were,0,0
215298,determined,0,0
215299,by,0,0
215300,visual,0,0
215301,inspection,0,1
215302,of,0,0
215303,each,0,0
215304,individual,0,0
215305,'s,0,1
215306,serum,0,0
215307,concentration-time,0,0
215308,curve,0,0
215309,.,0,1
215310,A,0,0
215311,mean,0,0
215312,+/-,0,0
215313,SD,0,1
215314,peak,0,0
215315,serum,0,0
215316,itraconazole,0,0
215317,concentration,0,0
215318,of,0,1
215319,0.90,0,0
215320,+/-,0,1
215321,0.30,0,0
215322,micrograms/ml,0,0
215323,was,0,0
215324,observed,0,0
215325,at,0,1
215326,3.0,0,0
215327,+/-,0,1
215328,0.7,0,0
215329,hours,0,0
215330,when,0,0
215331,itraconazole,0,1
215332,was,0,0
215333,administered,0,0
215334,alone,0,0
215335,",",0,0
215336,compared,0,0
215337,with,0,1
215338,undetectable,0,1
215339,levels,0,0
215340,in,0,1
215341,all,0,1
215342,patients,0,1
215343,during,0,0
215344,therapy,0,1
215345,with,0,1
215346,ddI,0,1
215347,.,0,1
215348,CONCLUSIONS,0,0
215349,Simultaneous,0,0
215350,oral,0,0
215351,administration,0,0
215352,of,0,0
215353,ddI,0,0
215354,significantly,0,0
215355,decreases,0,0
215356,absorption,0,0
215357,of,0,0
215358,itraconazole,0,0
215359,.,0,1
215360,These,0,0
215361,drugs,0,0
215362,should,0,0
215363,not,0,0
215364,be,0,0
215365,administered,0,0
215366,concurrently,0,0
215367,.,0,1
215368,Endurance,0,1
215369,physical,0,1
215370,activity,0,0
215371,",",0,1
215372,diet,0,0
215373,and,0,1
215374,fibrinolysis,0,1
215375,.,0,1
215376,The,0,0
215377,impact,0,0
215378,of,0,0
215379,long-term,0,0
215380,",",0,1
215381,heavy,0,0
215382,exercise,0,0
215383,on,0,0
215384,recently,0,1
215385,established,0,1
215386,cardiovascular/thromboembolic,0,1
215387,risk,0,1
215388,factors,0,0
215389,of,0,0
215390,the,0,1
215391,fibrinolytic,0,0
215392,system,0,0
215393,",",0,0
215394,tissue,0,1
215395,plasminogen,0,0
215396,activator,0,0
215397,(,0,1
215398,tPA,0,1
215399,),0,1
215400,and,0,0
215401,plasminogen,0,1
215402,activator,0,0
215403,inhibitor,0,0
215404,(,0,1
215405,PAI-1,0,1
215406,),0,1
215407,in,0,0
215408,relation,0,0
215409,to,0,1
215410,food,0,0
215411,composition,0,1
215412,was,0,0
215413,studied,0,1
215414,.,0,1
215415,Twenty,1,1
215416,healthy,1,1
215417,men,1,1
215418,",",1,1
215419,aged,1,1
215420,18-55,1,1
215421,years,1,1
215422,participated,0,1
215423,in,0,1
215424,a,0,1
215425,14-day,0,0
215426,skiing,0,1
215427,tour,0,0
215428,through,0,0
215429,the,0,0
215430,Swedish,0,1
215431,mountains,0,1
215432,",",0,1
215433,carrying,0,0
215434,a,0,0
215435,pack,0,0
215436,load,0,0
215437,of,0,1
215438,30,0,1
215439,kg,0,1
215440,",",0,1
215441,and,0,0
215442,spending,0,1
215443,each,0,0
215444,night,0,0
215445,in,0,0
215446,self-dug,0,1
215447,igloos,0,1
215448,(,0,1
215449,ambient,0,1
215450,temp,0,1
215451,-10,0,0
215452,degrees,0,0
215453,to,0,1
215454,-25,0,0
215455,degrees,0,0
215456,C,0,1
215457,),0,1
215458,",",0,0
215459,and,0,0
215460,were,0,0
215461,randomized,0,1
215462,to,0,1
215463,2,0,1
215464,food,0,1
215465,regimens,0,0
215466,having,0,1
215467,30,0,1
215468,or,0,1
215469,40,0,1
215470,energy,0,0
215471,percent,0,1
215472,of,0,0
215473,fat,0,1
215474,.,0,1
215475,Individual,0,0
215476,records,0,1
215477,were,0,1
215478,kept,0,0
215479,of,0,0
215480,all,0,0
215481,consumed,0,1
215482,food,0,0
215483,.,0,1
215484,Citrated,0,0
215485,plasma,0,0
215486,was,0,0
215487,obtained,0,0
215488,before,0,0
215489,and,0,1
215490,after,0,1
215491,1,0,1
215492,and,0,1
215493,2,0,1
215494,weeks,0,0
215495,of,0,1
215496,exercise,0,1
215497,:,0,1
215498,tPA,0,1
215499,release,0,0
215500,was,0,0
215501,assessed,0,0
215502,by,0,0
215503,a,0,1
215504,10,0,1
215505,min,0,0
215506,venous,0,1
215507,occlusion,0,1
215508,(,0,1
215509,VO,0,0
215510,),0,1
215511,test,0,0
215512,.,0,1
215513,At,0,0
215514,baseline,0,0
215515,",",0,1
215516,daily,0,0
215517,dietary,0,0
215518,fiber,0,0
215519,intake,0,0
215520,correlated,0,0
215521,negatively,0,0
215522,with,0,1
215523,PAI-1,0,1
215524,activity,0,0
215525,.,0,1
215526,Already,0,0
215527,after,0,0
215528,the,0,0
215529,first,0,0
215530,week,0,0
215531,of,0,0
215532,the,0,0
215533,skiing,0,0
215534,tour,0,0
215535,there,0,0
215536,were,0,0
215537,significant,0,0
215538,drops,0,0
215539,in,0,1
215540,PAI-1,0,1
215541,activities,0,0
215542,",",0,1
215543,cholesterol,0,0
215544,and,0,1
215545,triglycerides,0,0
215546,.,0,1
215547,The,0,0
215548,tPA,0,1
215549,mass,0,1
215550,concentrations,0,0
215551,also,0,0
215552,dropped,0,0
215553,",",0,0
215554,both,0,0
215555,before,0,0
215556,and,0,0
215557,after,0,1
215558,VO,0,0
215559,",",0,1
215560,but,0,0
215561,tPA,0,1
215562,activities,0,0
215563,were,0,1
215564,unchanged,0,0
215565,",",0,0
215566,as,0,0
215567,were,0,1
215568,von,0,1
215569,Willebrand,0,1
215570,factor,0,0
215571,(,0,1
215572,vWF,0,1
215573,),0,1
215574,levels,0,0
215575,.,0,1
215576,These,0,1
215577,changes,0,0
215578,were,0,1
215579,related,0,0
215580,mainly,0,0
215581,to,0,0
215582,the,0,0
215583,expenditure,0,0
215584,of,0,0
215585,energy,0,0
215586,",",0,0
215587,calculated,0,0
215588,from,0,0
215589,the,0,0
215590,food,0,0
215591,consumption,0,0
215592,",",0,0
215593,and,0,0
215594,appeared,0,0
215595,to,0,0
215596,be,0,0
215597,mediated,0,0
215598,through,0,0
215599,changed,0,0
215600,insulin,0,1
215601,sensitivity,0,0
215602,and,0,0
215603,decreased,0,0
215604,body,0,1
215605,fat,0,0
215606,mass,0,1
215607,.,0,1
215608,The,0,0
215609,energy,0,0
215610,percent,0,0
215611,of,0,0
215612,fat,0,0
215613,in,0,0
215614,the,0,0
215615,food,0,0
215616,had,0,1
215617,no,0,0
215618,differential,0,0
215619,impact,0,0
215620,.,0,1
215621,The,0,0
215622,effects,0,0
215623,receded,0,0
215624,a,0,1
215625,few,0,0
215626,weeks,0,0
215627,after,0,1
215628,cessation,0,1
215629,of,0,0
215630,the,0,0
215631,endurance,0,0
215632,exercise,0,0
215633,.,0,1
215634,Thus,0,0
215635,",",0,0
215636,endurance,0,0
215637,physical,0,0
215638,activity,0,0
215639,improves,0,0
215640,the,0,0
215641,fibrinolytic,0,0
215642,risk,0,0
215643,factor,0,0
215644,profile,0,0
215645,by,0,0
215646,reducing,0,0
215647,PAI-1,0,1
215648,while,0,0
215649,leaving,0,1
215650,tPA,0,1
215651,activity,0,0
215652,unaffected,0,0
215653,",",0,0
215654,independently,0,0
215655,of,0,0
215656,food,0,0
215657,composition,0,1
215658,.,0,1
215659,A,0,0
215660,low,0,0
215661,dietary,0,0
215662,fiber,0,0
215663,intake,0,0
215664,appears,0,0
215665,to,0,0
215666,be,0,0
215667,associated,0,0
215668,with,0,1
215669,higher,0,0
215670,PAI-1,0,1
215671,activities,0,0
215672,at,0,1
215673,baseline,0,1
215674,.,0,1
215675,The,0,0
215676,biological,0,0
215677,factors,0,0
215678,in,0,1
215679,the,0,0
215680,etiopathogenesis,0,0
215681,and,0,0
215682,management,0,1
215683,of,0,0
215684,cervical,1,1
215685,spondylosis,1,1
215686,.,1,1
215687,Two,1,1
215688,hundred,1,1
215689,cases,1,1
215690,of,1,1
215691,cervical,1,1
215692,spondylosis,1,1
215693,were,1,1
215694,studied,1,1
215695,for,0,1
215696,1,0,1
215697,to,0,1
215698,4,0,0
215699,average,0,1
215700,(,0,1
215701,2,0,1
215702,1/2,0,1
215703,),0,1
215704,years,0,1
215705,.,0,1
215706,No,0,0
215707,co-relation,0,0
215708,could,0,0
215709,be,0,0
215710,established,0,0
215711,between,0,0
215712,the,0,0
215713,clinical,0,0
215714,features,0,1
215715,and,0,1
215716,the,0,1
215717,radiological,0,0
215718,findings,0,0
215719,in,0,1
215720,these,0,1
215721,cases,0,1
215722,.,0,1
215723,It,0,0
215724,was,0,0
215725,found,0,0
215726,that,0,0
215727,parasites,0,1
215728,play,0,0
215729,an,0,0
215730,important,0,0
215731,role,0,0
215732,in,0,0
215733,the,0,0
215734,multifactorial,0,0
215735,etiology,0,0
215736,of,0,0
215737,this,0,0
215738,condition,0,0
215739,and,0,0
215740,their,0,0
215741,eradication,0,1
215742,by,0,0
215743,deworming,0,1
215744,drugs,0,0
215745,gives,0,0
215746,better,0,0
215747,results,0,0
215748,than,0,0
215749,the,0,1
215750,traditional,0,1
215751,therapies,0,0
215752,.,0,1
215753,Many,0,1
215754,new,0,1
215755,hypotheses,0,0
215756,are,0,0
215757,proposed,0,0
215758,to,0,0
215759,explain,0,0
215760,the,0,0
215761,same,0,0
215762,.,0,1
215763,Deliberate,0,0
215764,mild,0,1
215765,intraoperative,0,0
215766,hypothermia,0,1
215767,for,0,1
215768,craniotomy,1,1
215769,.,1,1
215770,BACKGROUND,0,0
215771,Despite,0,0
215772,enthusiasm,0,0
215773,for,0,0
215774,the,0,0
215775,use,0,0
215776,of,0,0
215777,mild,0,1
215778,hypothermia,0,1
215779,during,0,1
215780,neurosurgical,0,1
215781,procedures,0,1
215782,",",0,1
215783,this,0,0
215784,therapy,0,0
215785,has,0,0
215786,not,0,0
215787,been,0,0
215788,evaluated,0,0
215789,systematically,0,0
215790,.,0,0
215791,This,0,0
215792,study,0,0
215793,examined,0,0
215794,the,0,0
215795,feasibility,0,0
215796,and,0,0
215797,safety,0,0
215798,of,0,0
215799,deliberate,0,1
215800,mild,0,1
215801,hypothermia,0,1
215802,and,0,1
215803,rewarming,0,1
215804,.,0,1
215805,METHODS,0,0
215806,Thirty,1,1
215807,patients,1,1
215808,scheduled,1,1
215809,for,1,1
215810,craniotomy,1,1
215811,were,1,1
215812,assigned,1,1
215813,to,1,0
215814,either,1,0
215815,a,1,0
215816,normothermic,1,0
215817,or,1,1
215818,mildly,1,1
215819,hypothermic,1,1
215820,group,1,1
215821,.,1,1
215822,Tympanic,0,0
215823,membrane,0,0
215824,temperature,0,0
215825,was,0,0
215826,monitored,0,0
215827,at,0,0
215828,anesthetic,0,0
215829,induction,0,0
215830,",",0,0
215831,throughout,0,0
215832,the,0,0
215833,isoflurane-fentanyl-N2O-O2,0,0
215834,anesthetic,0,0
215835,",",0,0
215836,and,0,0
215837,for,0,0
215838,18,0,1
215839,h,0,0
215840,postoperatively,0,0
215841,.,0,1
215842,Normothermic,0,0
215843,patients,0,1
215844,were,0,1
215845,warmed,0,1
215846,to,0,1
215847,36.5-37.0,0,1
215848,degrees,0,0
215849,C,0,1
215850,after,0,1
215851,an,0,1
215852,initial,0,0
215853,temperature,0,0
215854,decrease,0,0
215855,",",0,0
215856,and,0,0
215857,hypothermic,0,1
215858,patients,0,1
215859,were,0,1
215860,cooled,0,1
215861,to,0,1
215862,35,0,1
215863,degrees,0,0
215864,C.,0,0
215865,In,0,1
215866,the,0,0
215867,hypothermic,0,1
215868,group,0,1
215869,temperatures,0,1
215870,were,0,1
215871,allowed,0,0
215872,to,0,0
215873,drift,0,0
215874,to,0,1
215875,34.5,0,0
215876,degrees,0,0
215877,C,0,1
215878,before,0,1
215879,rewarming,0,1
215880,was,0,0
215881,initiated,0,1
215882,.,0,1
215883,Water,0,0
215884,blankets,0,0
215885,and,0,1
215886,convective,0,1
215887,heating,0,1
215888,devices,0,0
215889,were,0,1
215890,used,0,0
215891,to,0,0
215892,cool,0,1
215893,and,0,0
215894,rewarm,0,0
215895,.,0,0
215896,RESULTS,0,0
215897,The,0,0
215898,minimum,0,0
215899,temperature,0,0
215900,achieved,0,0
215901,by,0,0
215902,the,0,0
215903,hypothermic,0,1
215904,group,0,1
215905,was,0,0
215906,34.3,0,1
215907,+/-,0,1
215908,0.4,0,1
215909,degrees,0,1
215910,C.,0,1
215911,Cooling,0,0
215912,occurred,0,0
215913,at,0,0
215914,a,0,0
215915,rate,0,0
215916,of,0,0
215917,1.0,0,0
215918,+/-,0,1
215919,0.4,0,1
215920,degrees,0,1
215921,C/h,0,1
215922,.,0,1
215923,Rewarming,0,0
215924,took,0,0
215925,place,0,0
215926,at,0,0
215927,a,0,0
215928,rate,0,0
215929,of,0,0
215930,0.7,0,0
215931,+/-,0,1
215932,0.6,0,1
215933,degrees,0,1
215934,C/h,0,1
215935,(,0,1
215936,range,0,1
215937,0.1-1.8,0,0
215938,),0,0
215939,in,0,0
215940,the,0,0
215941,hypothermic,0,1
215942,group,0,1
215943,.,0,1
215944,Hypothermia,0,0
215945,did,0,0
215946,not,0,0
215947,delay,0,0
215948,emergence,0,0
215949,from,0,1
215950,anesthesia,0,1
215951,(,0,1
215952,20,0,1
215953,+/-,0,1
215954,15,0,1
215955,min,0,0
215956,),0,1
215957,compared,0,0
215958,with,0,1
215959,normothermia,0,1
215960,(,0,1
215961,15,0,1
215962,+/-,0,1
215963,15,0,1
215964,min,0,0
215965,",",0,1
215966,P,0,0
215967,=,0,1
215968,.45,0,0
215969,),0,1
215970,.,0,1
215971,Mean,0,1
215972,temperature,0,0
215973,upon,0,1
215974,intensive,0,1
215975,care,0,1
215976,unit,0,1
215977,admission,0,1
215978,was,0,0
215979,35.8,0,1
215980,+/-,0,1
215981,1.0,0,0
215982,degrees,0,1
215983,C,0,1
215984,for,0,1
215985,the,0,0
215986,hypothermic,0,1
215987,group,0,1
215988,and,0,1
215989,37.1,0,1
215990,+/-,0,1
215991,0.5,0,0
215992,degrees,0,1
215993,C,0,1
215994,for,0,1
215995,the,0,0
215996,normothermic,0,1
215997,group,0,1
215998,(,0,1
215999,P,0,0
216000,<,0,0
216001,0.0001,0,0
216002,),0,1
216003,.,0,1
216004,The,0,0
216005,hypothermic,0,1
216006,patients,0,1
216007,had,0,1
216008,more,0,0
216009,postoperative,0,0
216010,shivering,0,0
216011,.,0,1
216012,From,0,1
216013,8,0,1
216014,to,0,1
216015,18,0,1
216016,h,0,0
216017,postoperatively,0,0
216018,the,0,0
216019,temperatures,0,0
216020,of,0,0
216021,the,0,1
216022,two,0,1
216023,groups,0,0
216024,were,0,1
216025,similar,0,0
216026,except,0,0
216027,for,0,0
216028,a,0,0
216029,slightly,0,0
216030,greater,0,0
216031,temperature,0,0
216032,in,0,0
216033,the,0,0
216034,hypothermic,0,1
216035,patients,0,1
216036,at,0,1
216037,12,0,1
216038,h,0,0
216039,(,0,1
216040,37.6,0,1
216041,+/-,0,0
216042,0.5,0,0
216043,vs.,0,0
216044,37.3,0,1
216045,+/-,0,1
216046,0.4,0,1
216047,degrees,0,1
216048,C,0,1
216049,",",0,1
216050,P,0,0
216051,=,0,1
216052,.029,0,0
216053,),0,1
216054,.,0,1
216055,CONCLUSIONS,0,0
216056,Although,0,0
216057,deliberate,0,1
216058,mild,0,1
216059,hypothermia,0,0
216060,is,0,0
216061,easily,0,0
216062,achieved,0,0
216063,intraoperatively,0,0
216064,",",0,0
216065,complete,0,0
216066,rewarming,0,0
216067,may,0,0
216068,be,0,0
216069,difficult,0,0
216070,to,0,0
216071,attain,0,0
216072,during,0,0
216073,craniotomy,1,1
216074,with,0,1
216075,current,0,1
216076,methods,0,1
216077,.,0,1
216078,In,0,0
216079,addition,0,0
216080,to,0,0
216081,the,0,0
216082,need,0,0
216083,for,0,0
216084,determining,0,0
216085,whether,0,0
216086,deliberate,0,1
216087,mild,0,1
216088,hypothermia,0,1
216089,confers,0,0
216090,cerebral,0,1
216091,protection,0,1
216092,in,0,1
216093,humans,0,1
216094,",",0,1
216095,the,0,0
216096,potential,0,0
216097,risks,0,0
216098,of,0,1
216099,the,0,0
216100,therapy,0,0
216101,need,0,0
216102,to,0,0
216103,be,0,0
216104,further,0,0
216105,characterized,0,0
216106,.,0,1
216107,Effects,0,1
216108,of,0,1
216109,short-term,0,0
216110,isotonic,0,0
216111,&,0,1
216112,isometric,0,0
216113,training,0,0
216114,on,0,0
216115,cardiovascular,0,1
216116,&,0,1
216117,pulmonary,0,1
216118,function,0,0
216119,.,0,1
216120,A,0,0
216121,randomised,0,0
216122,control,0,1
216123,trial,0,1
216124,of,0,1
216125,short-term,0,0
216126,exercises,0,1
216127,on,0,1
216128,specific,0,1
216129,cardiovascular,0,1
216130,and,0,1
216131,respiratory,0,1
216132,parameters,0,0
216133,was,0,0
216134,undertaken,0,1
216135,in,1,0
216136,normal,1,1
216137,male,1,1
216138,college,1,1
216139,students,1,1
216140,.,1,1
216141,The,0,0
216142,effects,0,0
216143,of,0,0
216144,isotonic,0,0
216145,training,0,1
216146,(,0,1
216147,5BX,0,0
216148,programme,0,1
216149,),0,1
216150,and,0,0
216151,isometric,0,1
216152,training,0,0
216153,(,0,0
216154,a,0,0
216155,programme,0,1
216156,of,0,0
216157,isometric,0,1
216158,exercises,0,1
216159,working,0,1
216160,all,0,1
216161,major,0,1
216162,groups,0,1
216163,of,0,1
216164,muscles,0,1
216165,),0,1
216166,were,0,1
216167,compared,0,0
216168,with,0,1
216169,a,0,0
216170,control,0,0
216171,group,0,0
216172,with,0,1
216173,no,0,0
216174,specific,0,0
216175,workout,0,0
216176,.,0,1
216177,Both,0,0
216178,isotonic,0,0
216179,and,0,0
216180,isometric,0,1
216181,training,0,0
216182,resulted,0,0
216183,in,0,0
216184,significant,0,0
216185,cardiovascular,0,1
216186,improvement,0,0
216187,but,0,0
216188,seemed,0,0
216189,inadequate,0,1
216190,to,0,0
216191,improve,0,0
216192,vital,0,0
216193,capacity,0,0
216194,and,0,1
216195,flow,0,0
216196,rates,0,0
216197,.,0,1
216198,Isotonic,0,0
216199,training,0,0
216200,in,0,0
216201,addition,0,0
216202,",",0,0
216203,improved,0,0
216204,ventilatory,0,0
216205,efficiency,0,0
216206,.,0,0
216207,It,0,0
216208,is,0,0
216209,concluded,0,0
216210,that,0,0
216211,such,0,0
216212,isotonic,0,0
216213,or,0,1
216214,isometric,0,0
216215,training,0,0
216216,of,0,0
216217,thrice,0,0
216218,a,0,0
216219,week,0,0
216220,for,0,0
216221,ten,0,1
216222,weeks,0,0
216223,",",0,1
216224,requiring,0,1
216225,no,0,0
216226,equipment,0,0
216227,",",0,0
216228,less,0,0
216229,time,0,0
216230,and,0,0
216231,space,0,0
216232,can,0,0
216233,be,0,0
216234,promoted,0,0
216235,to,0,0
216236,improve,0,0
216237,physical,0,1
216238,fitness,0,1
216239,.,0,1
216240,[,0,0
216241,The,0,0
216242,anti-ischemic,0,0
216243,effect,0,0
216244,of,0,0
216245,phosphodiesterase,0,0
216246,III,0,1
216247,inhibitors,0,1
216248,],0,1
216249,.,0,1
216250,When,0,0
216251,enoximone,0,0
216252,is,0,0
216253,acutely,0,1
216254,administered,0,0
216255,to,0,0
216256,patients,1,1
216257,with,1,1
216258,stable,1,1
216259,angina,1,1
216260,and,1,1
216261,angiographically,1,1
216262,proven,1,0
216263,relevant,1,0
216264,coronary,1,1
216265,stenosis,1,1
216266,i.v,1,0
216267,.,1,1
216268,application,1,0
216269,of,1,0
216270,0.75,1,0
216271,mg/kg,1,1
216272,exhibits,0,0
216273,pronounced,0,1
216274,antiischemic,0,1
216275,effects,0,0
216276,.,0,1
216277,This,0,0
216278,could,0,0
216279,be,0,0
216280,observed,0,0
216281,in,0,0
216282,patients,0,1
216283,during,0,1
216284,exercise,0,1
216285,and,0,0
216286,in,0,0
216287,those,0,1
216288,in,0,1
216289,whom,0,1
216290,the,0,1
216291,ischemia,0,1
216292,was,0,0
216293,provoked,0,0
216294,by,0,0
216295,rapid,0,1
216296,cardiac,0,1
216297,stimulation,0,0
216298,.,0,1
216299,The,0,0
216300,antiischemic,0,0
216301,effects,0,0
216302,were,0,1
216303,documented,0,1
216304,by,0,0
216305,relief,0,0
216306,of,0,1
216307,symptoms,0,0
216308,",",0,1
216309,reduction,0,0
216310,of,0,0
216311,ST-depression,0,1
216312,",",0,0
216313,improvement,0,0
216314,of,0,0
216315,impaired,0,1
216316,myocardial,0,1
216317,wall,0,1
216318,motion,0,0
216319,",",0,0
216320,decrease,0,0
216321,to,0,0
216322,normalization,0,0
216323,of,0,0
216324,pathologically,0,1
216325,elevated,0,1
216326,filling,0,0
216327,pressure,0,0
216328,",",0,0
216329,amelioration,0,0
216330,of,0,0
216331,coronary,0,1
216332,blood,0,0
216333,flow,0,0
216334,as,0,0
216335,evidenced,0,0
216336,by,0,0
216337,myocard,0,1
216338,scintigraphy,0,0
216339,and,0,0
216340,washout,0,0
216341,time,0,0
216342,of,0,0
216343,an,0,1
216344,intracoronarily,0,0
216345,injected,0,0
216346,echo-contrast,0,0
216347,medium,0,0
216348,.,0,0
216349,There,0,0
216350,was,0,0
216351,also,0,0
216352,a,0,0
216353,definite,0,0
216354,improvement,0,0
216355,of,0,0
216356,ischemia-caused,0,0
216357,mitral,0,1
216358,regurgitation,0,1
216359,.,0,1
216360,Similar,0,0
216361,observations,0,0
216362,were,0,1
216363,found,0,0
216364,when,0,0
216365,the,0,0
216366,drug,0,0
216367,was,0,0
216368,injected,0,0
216369,in,0,0
216370,the,0,0
216371,diseased,0,1
216372,coronary,0,1
216373,arteries,0,1
216374,in,0,1
216375,a,0,1
216376,small,0,1
216377,dose,0,0
216378,(,0,1
216379,0.075,0,0
216380,mg/kg,0,0
216381,),0,1
216382,so,0,0
216383,that,0,0
216384,peripheral,0,1
216385,effects,0,0
216386,were,0,1
216387,not,0,1
216388,present,0,0
216389,.,0,1
216390,In,0,0
216391,comparison,0,0
216392,to,0,1
216393,the,0,0
216394,Ca,0,1
216395,(,0,1
216396,++,0,1
216397,),0,1
216398,-blocker,0,1
216399,Gallopamil,0,0
216400,the,0,0
216401,antiischemic,0,0
216402,effects,0,0
216403,of,0,1
216404,Enoximone,0,0
216405,were,0,0
216406,more,0,0
216407,pronounced,0,0
216408,",",0,0
216409,a,0,0
216410,synergistic,0,0
216411,action,0,0
216412,was,0,0
216413,",",0,0
216414,however,0,0
216415,",",0,0
216416,observed,0,0
216417,.,0,1
216418,Negative,0,0
216419,dromotropic,0,0
216420,effects,0,0
216421,of,0,0
216422,Gallopamil,0,0
216423,could,0,0
216424,be,0,0
216425,abolished,0,0
216426,by,0,0
216427,Enoximone,0,1
216428,.,0,1
216429,With,0,1
216430,oral,0,0
216431,administration,0,0
216432,of,0,0
216433,the,0,0
216434,drug,0,0
216435,over,0,0
216436,a,0,0
216437,period,0,0
216438,of,0,0
216439,one,0,1
216440,week,0,0
216441,antiischemic,0,1
216442,effects,0,0
216443,could,0,0
216444,also,0,0
216445,be,0,0
216446,documented,0,0
216447,with,0,1
216448,Holter,0,1
216449,monitoring,0,0
216450,as,0,0
216451,well,0,0
216452,as,0,0
216453,during,0,0
216454,exercise,0,0
216455,.,0,0
216456,There,0,0
216457,was,0,0
216458,a,0,0
216459,reduction,0,0
216460,of,0,0
216461,ST-depression,0,1
216462,both,0,0
216463,at,0,0
216464,spontaneously,0,1
216465,occurring,0,1
216466,ischemic,0,1
216467,episodes,0,1
216468,and,0,1
216469,during,0,0
216470,exercise,0,0
216471,",",0,0
216472,in,0,0
216473,the,0,0
216474,number,0,0
216475,and,0,0
216476,duration,0,0
216477,of,0,0
216478,episodes,0,1
216479,of,0,1
216480,silent,0,1
216481,ischemia,0,1
216482,",",0,0
216483,particularly,0,0
216484,",",0,0
216485,however,0,0
216486,",",0,0
216487,a,0,0
216488,decrease,0,0
216489,in,0,0
216490,symptomatic,0,1
216491,episodes,0,1
216492,.,0,1
216493,In,0,0
216494,none,0,0
216495,of,0,0
216496,the,0,0
216497,patients,0,1
216498,under,0,1
216499,study,0,1
216500,proarrhythmic,0,1
216501,effects,0,0
216502,were,0,1
216503,observed,0,0
216504,.,0,1
216505,Modest,0,1
216506,antihypertensive,0,1
216507,effect,0,0
216508,of,0,0
216509,epanolol,0,1
216510,",",0,0
216511,a,0,0
216512,beta,0,0
216513,1-selective,0,0
216514,receptor,0,0
216515,blocker,0,0
216516,with,0,1
216517,beta,0,0
216518,1,0,1
216519,agonist,0,1
216520,activity,0,0
216521,:,0,1
216522,an,0,0
216523,acute,0,1
216524,and,0,0
216525,long-term,0,0
216526,hemodynamic,0,0
216527,study,0,1
216528,at,0,0
216529,rest,0,0
216530,and,0,1
216531,during,0,0
216532,exercise,0,0
216533,and,0,1
216534,double,0,0
216535,crossover,0,0
216536,comparison,0,0
216537,with,0,1
216538,atenolol,0,0
216539,on,0,0
216540,ambulatory,0,1
216541,blood,0,0
216542,pressure,0,1
216543,.,0,1
216544,Beta-blockers,0,0
216545,with,0,1
216546,less,0,1
216547,cardiodepressive,0,0
216548,effect,0,0
216549,than,0,0
216550,traditional,0,1
216551,nonselective,0,1
216552,beta,0,0
216553,(,0,1
216554,1+2,0,1
216555,),0,1
216556,-blocking,0,0
216557,agents,0,0
216558,could,0,0
216559,be,0,0
216560,useful,0,0
216561,in,0,0
216562,the,0,0
216563,treatment,0,0
216564,of,0,0
216565,hypertension,0,1
216566,",",0,0
216567,provided,0,0
216568,the,0,0
216569,reduction,0,0
216570,in,0,0
216571,blood,0,0
216572,pressure,0,0
216573,was,0,0
216574,satisfactory,0,0
216575,.,0,1
216576,Epanolol,0,0
216577,",",0,0
216578,a,0,0
216579,selective,0,1
216580,beta,0,0
216581,1-receptor,0,0
216582,blocker,0,1
216583,with,0,1
216584,intrinsic,0,1
216585,sympathomimetic,0,0
216586,activity,0,0
216587,",",0,0
216588,induced,0,0
216589,a,0,0
216590,fall,0,0
216591,in,0,0
216592,intraarterial,0,0
216593,pressure,0,1
216594,of,0,1
216595,8,0,1
216596,%,0,0
216597,at,0,1
216598,rest,0,0
216599,sitting,0,1
216600,and,0,1
216601,11,0,1
216602,%,0,0
216603,during,0,1
216604,100,0,1
216605,W,0,1
216606,bicycle,0,0
216607,exercise,0,0
216608,after,0,0
216609,the,0,0
216610,first,0,0
216611,dose,0,0
216612,of,0,1
216613,200,0,1
216614,mg,0,1
216615,in,0,1
216616,12,1,1
216617,patients,1,1
216618,with,1,1
216619,essential,1,1
216620,hypertension,1,1
216621,.,1,1
216622,Heart,0,0
216623,rate,0,0
216624,",",0,0
216625,stroke,0,1
216626,index,0,0
216627,",",0,0
216628,and,0,0
216629,cardiac,0,1
216630,index,0,1
216631,initially,0,1
216632,fell,0,0
216633,by,0,0
216634,14,0,1
216635,%,0,0
216636,",",0,1
216637,11,0,1
216638,%,0,0
216639,",",0,1
216640,and,0,0
216641,23,0,1
216642,%,0,0
216643,",",0,0
216644,respectively,0,0
216645,.,0,0
216646,The,0,0
216647,total,0,1
216648,peripheral,0,1
216649,resistance,0,0
216650,index,0,1
216651,increased,0,0
216652,by,0,0
216653,21,0,1
216654,%,0,0
216655,after,0,1
216656,2,0,1
216657,hours,0,0
216658,",",0,1
216659,and,0,0
216660,then,0,0
216661,reverted,0,0
216662,towards,0,0
216663,the,0,0
216664,pretreatment,0,0
216665,level,0,0
216666,.,0,1
216667,After,0,0
216668,10,0,1
216669,months,0,1
216670,of,0,1
216671,epanolol,0,1
216672,treatment,0,1
216673,(,0,1
216674,mean,0,1
216675,300,0,1
216676,mg/day,0,1
216677,),0,0
216678,",",0,0
216679,the,0,0
216680,reduction,0,0
216681,in,0,0
216682,arterial,0,1
216683,pressure,0,1
216684,was,0,0
216685,5,0,0
216686,%,0,0
216687,at,0,1
216688,rest,0,0
216689,and,0,1
216690,10,0,1
216691,%,0,0
216692,during,0,1
216693,exercise,0,1
216694,.,0,1
216695,Cardiac,0,0
216696,index,0,0
216697,and,0,0
216698,heart,0,1
216699,rate,0,0
216700,were,0,0
216701,still,0,0
216702,reduced,0,0
216703,14-21,0,1
216704,%,0,0
216705,",",0,0
216706,while,0,0
216707,total,0,1
216708,peripheral,0,1
216709,resistance,0,0
216710,was,0,0
216711,unchanged,0,0
216712,or,0,1
216713,slightly,0,0
216714,increased,0,0
216715,(,0,0
216716,2-10,0,1
216717,%,0,0
216718,),0,1
216719,.,0,1
216720,Twenty-four,0,1
216721,hour,0,0
216722,ambulatory,0,1
216723,blood,0,0
216724,pressure,0,0
216725,was,0,0
216726,higher,0,0
216727,on,0,0
216728,epanolol,0,1
216729,(,0,1
216730,300,0,1
216731,mg/day,0,0
216732,),0,1
216733,than,0,0
216734,on,0,0
216735,atenolol,0,0
216736,(,0,1
216737,150,0,1
216738,mg/day,0,1
216739,),0,1
216740,treatment,0,0
216741,(,0,0
216742,137/97,0,1
216743,vs.,0,0
216744,128/91,0,1
216745,mmHg,0,0
216746,),0,1
216747,.,0,1
216748,Thus,0,0
216749,",",0,0
216750,the,0,0
216751,achieved,0,0
216752,blood,0,0
216753,pressure,0,0
216754,reduction,0,0
216755,induced,0,0
216756,by,0,0
216757,epanolol,0,1
216758,was,0,0
216759,moderate,0,1
216760,",",0,0
216761,while,0,0
216762,other,0,0
216763,characteristics,0,1
216764,of,0,1
216765,beta-receptor,0,0
216766,blockade,0,0
216767,",",0,0
216768,in,0,0
216769,particular,0,0
216770,",",0,0
216771,the,0,0
216772,reduction,0,0
216773,of,0,0
216774,heart,0,1
216775,rate,0,0
216776,and,0,0
216777,cardiac,0,1
216778,output,0,0
216779,",",0,0
216780,were,0,0
216781,maintained,0,0
216782,.,0,0
216783,This,0,0
216784,suggests,0,0
216785,that,0,0
216786,the,0,0
216787,compound,0,0
216788,may,0,0
216789,be,0,0
216790,useful,0,0
216791,for,0,0
216792,other,0,1
216793,cardiovascular,1,1
216794,disorders,1,1
216795,",",0,1
216796,e.g.,0,0
216797,",",0,0
216798,angina,1,1
216799,pectoris,1,1
216800,in,1,1
216801,patients,1,1
216802,without,1,1
216803,hypertension,1,1
216804,or,1,1
216805,cardiac,1,1
216806,arrhythmia,1,1
216807,.,1,1
216808,Primary,0,1
216809,prophylaxis,0,1
216810,with,0,1
216811,pyrimethamine,0,1
216812,for,0,1
216813,toxoplasmic,0,1
216814,encephalitis,0,1
216815,in,0,1
216816,patients,1,1
216817,with,1,1
216818,advanced,1,1
216819,human,1,1
216820,immunodeficiency,1,1
216821,virus,1,1
216822,disease,1,1
216823,:,1,1
216824,results,0,0
216825,of,0,0
216826,a,0,1
216827,randomized,0,1
216828,trial,0,1
216829,.,0,1
216830,Terry,0,1
216831,Beirn,0,1
216832,Community,0,1
216833,Programs,0,1
216834,for,0,1
216835,Clinical,0,0
216836,Research,0,1
216837,on,0,0
216838,AIDS,0,1
216839,.,0,1
216840,Pyrimethamine,0,0
216841,",",0,0
216842,25,0,1
216843,mg,0,0
216844,thrice,0,0
216845,weekly,0,0
216846,",",0,0
216847,was,0,0
216848,evaluated,0,0
216849,as,0,0
216850,primary,0,1
216851,prophylaxis,0,1
216852,for,0,0
216853,toxoplasmic,0,1
216854,encephalitis,0,1
216855,(,0,1
216856,TE,0,0
216857,),0,1
216858,in,0,0
216859,a,0,0
216860,double-blind,0,0
216861,",",0,0
216862,randomized,0,1
216863,clinical,0,0
216864,trial,0,1
216865,in,0,1
216866,patients,1,1
216867,with,1,1
216868,human,1,1
216869,immunodeficiency,1,1
216870,virus,1,1
216871,(,1,1
216872,HIV,1,1
216873,),1,1
216874,disease,1,1
216875,",",1,0
216876,absolute,1,0
216877,CD4,1,1
216878,lymphocyte,1,0
216879,count,1,0
216880,of,1,0
216881,<,1,0
216882,200/microL,1,1
216883,(,1,0
216884,or,1,1
216885,prior,1,1
216886,AIDS-defining,1,1
216887,opportunistic,1,1
216888,infection,1,1
216889,),1,1
216890,",",1,0
216891,and,1,0
216892,the,1,0
216893,presence,1,0
216894,of,1,0
216895,serum,1,0
216896,IgG,1,0
216897,to,1,1
216898,Toxoplasma,1,1
216899,gondii,1,1
216900,.,1,1
216901,Leucovorin,0,0
216902,was,0,0
216903,coadministered,0,0
216904,only,0,0
216905,for,0,0
216906,hematologic,0,1
216907,toxicity,0,0
216908,.,0,0
216909,There,0,0
216910,was,0,0
216911,a,0,0
216912,significantly,0,0
216913,higher,0,0
216914,death,0,0
216915,rate,0,0
216916,among,0,1
216917,patients,0,1
216918,receiving,0,1
216919,pyrimethamine,0,1
216920,(,0,1
216921,relative,0,0
216922,risk,0,1
216923,[,0,0
216924,RR,0,1
216925,],0,1
216926,",",0,1
216927,2.5,0,0
216928,;,0,1
216929,95,0,0
216930,%,0,0
216931,confidence,0,0
216932,interval,0,0
216933,[,0,0
216934,CI,0,0
216935,],0,1
216936,",",0,1
216937,1.3-4.8,0,0
216938,;,0,1
216939,P,0,0
216940,=,0,1
216941,.006,0,0
216942,),0,0
216943,",",0,0
216944,even,0,0
216945,after,0,0
216946,adjusting,0,0
216947,for,0,1
216948,factors,0,0
216949,predictive,0,0
216950,of,0,1
216951,survival,0,0
216952,.,0,1
216953,The,0,0
216954,TE,0,0
216955,event,0,0
216956,rate,0,0
216957,was,0,0
216958,low,0,0
216959,in,0,0
216960,both,0,0
216961,treatment,0,0
216962,groups,0,0
216963,(,0,1
216964,not,0,1
216965,significant,0,0
216966,),0,1
216967,.,0,1
216968,Only,0,0
216969,1,0,0
216970,of,0,1
216971,218,1,1
216972,patients,1,1
216973,taking,1,1
216974,trimethoprim-sulfamethoxazole,1,1
216975,but,0,0
216976,7,0,1
216977,of,0,1
216978,117,1,1
216979,taking,1,1
216980,aerosolized,1,0
216981,pentamidine,1,1
216982,for,0,0
216983,prophylaxis,0,1
216984,against,0,1
216985,Pneumocystis,0,1
216986,carinii,0,1
216987,pneumonia,0,1
216988,developed,0,1
216989,TE,0,0
216990,(,0,1
216991,adjusted,0,0
216992,RR,0,1
216993,for,0,0
216994,the,0,0
216995,trimethoprim-sulfamethoxazole,0,0
216996,group,0,1
216997,",",0,1
216998,0.16,0,0
216999,;,0,1
217000,95,0,0
217001,%,0,0
217002,CI,0,0
217003,",",0,1
217004,0.01-1.79,0,0
217005,;,0,1
217006,P,0,0
217007,=,0,1
217008,.14,0,0
217009,),0,1
217010,.,0,1
217011,Thus,0,0
217012,",",0,0
217013,for,0,0
217014,HIV-infected,1,1
217015,patients,1,1
217016,receiving,0,1
217017,trimethoprim-sulfamethoxazole,0,1
217018,",",0,1
217019,additional,0,0
217020,prophylaxis,0,1
217021,for,0,0
217022,TE,0,0
217023,appears,0,0
217024,unnecessary,0,0
217025,.,0,1
217026,Peripheral,0,1
217027,intravenous,0,1
217028,line,0,0
217029,survival,0,0
217030,and,0,0
217031,phlebitis,0,1
217032,prevention,0,1
217033,in,0,1
217034,patients,1,1
217035,receiving,1,1
217036,intravenous,1,1
217037,antibiotics,1,0
217038,:,1,1
217039,heparin/hydrocortisone,0,0
217040,versus,0,0
217041,in-line,0,0
217042,filters,0,1
217043,.,0,1
217044,OBJECTIVE,0,0
217045,To,0,0
217046,compare,0,0
217047,the,0,0
217048,use,0,0
217049,of,0,0
217050,in-line,0,0
217051,filtration,0,0
217052,with,0,1
217053,the,0,0
217054,addition,0,0
217055,of,0,0
217056,heparin/hydrocortisone,0,0
217057,(,0,1
217058,hep/hc,0,0
217059,),0,1
217060,to,0,0
217061,the,0,0
217062,infusate,0,0
217063,for,0,0
217064,both,0,0
217065,phlebitis,0,1
217066,prevention,0,1
217067,and,0,1
217068,intravenous,0,1
217069,(,0,1
217070,i.v,0,0
217071,.,0,1
217072,),0,0
217073,line,0,0
217074,survival,0,0
217075,in,0,0
217076,peripheral,0,1
217077,i.v,0,1
217078,.,0,1
217079,catheters,0,0
217080,.,0,1
217081,This,0,0
217082,study,0,0
217083,was,0,0
217084,specific,1,0
217085,for,1,0
217086,a,1,1
217087,patient,1,1
217088,group,1,0
217089,receiving,1,1
217090,prolonged,1,0
217091,courses,1,0
217092,of,1,1
217093,i.v,1,1
217094,.,1,1
217095,antibiotics,1,0
217096,.,1,1
217097,Analysis,0,0
217098,of,0,0
217099,the,0,1
217100,two,0,0
217101,endpoints,0,0
217102,for,0,1
217103,conventional,0,1
217104,short,0,1
217105,i.v,0,1
217106,.,0,1
217107,catheters,0,0
217108,(,0,1
217109,short,0,1
217110,lines,0,0
217111,),0,1
217112,versus,0,0
217113,long,0,1
217114,(,0,1
217115,30,0,1
217116,cm,0,1
217117,),0,1
217118,i.v,0,0
217119,.,0,1
217120,catheters,0,0
217121,(,0,1
217122,long,0,1
217123,lines,0,0
217124,),0,1
217125,was,0,0
217126,also,0,0
217127,performed,0,0
217128,.,0,1
217129,METHODS,0,0
217130,Patients,1,1
217131,with,1,1
217132,cystic,1,1
217133,fibrosis,1,1
217134,receiving,1,1
217135,intermittent,1,1
217136,i.v,1,1
217137,.,1,1
217138,antibiotics,1,0
217139,were,0,0
217140,randomly,0,1
217141,allocated,0,1
217142,to,0,0
217143,receive,0,1
217144,their,0,1
217145,drugs,0,0
217146,either,0,1
217147,through,0,1
217148,an,0,0
217149,in-line,0,0
217150,filter,0,0
217151,using,0,0
217152,a,0,0
217153,drug-free,0,1
217154,infusate,0,0
217155,or,0,1
217156,with,0,1
217157,no,0,0
217158,filter,0,0
217159,and,0,0
217160,an,0,0
217161,infusate,0,0
217162,containing,0,0
217163,heparin,0,1
217164,500,0,1
217165,units,0,1
217166,and,0,1
217167,hydrocortisone,0,1
217168,10,0,1
217169,mg/L,0,1
217170,.,0,1
217171,Infusion,0,0
217172,sites,0,0
217173,were,0,1
217174,assessed,0,0
217175,daily,0,0
217176,.,0,1
217177,RESULTS,0,0
217178,Both,0,0
217179,the,0,0
217180,hep/hc,0,0
217181,and,0,0
217182,filter,0,1
217183,groups,0,0
217184,were,0,1
217185,similar,0,0
217186,in,0,1
217187,terms,0,0
217188,of,0,1
217189,phlebitis,0,1
217190,incidence,0,0
217191,and,0,0
217192,i.v,0,0
217193,.,0,1
217194,line,0,0
217195,survival,0,0
217196,when,0,0
217197,analyzed,0,0
217198,separately,0,0
217199,for,0,0
217200,both,0,0
217201,short,0,0
217202,and,0,1
217203,long,0,1
217204,lines,0,0
217205,.,0,1
217206,Long,0,1
217207,lines,0,0
217208,displayed,0,0
217209,markedly,0,0
217210,prolonged,0,0
217211,survival,0,0
217212,times,0,0
217213,and,0,1
217214,reduced,0,0
217215,phlebitis,0,1
217216,compared,0,0
217217,with,0,1
217218,short,0,1
217219,lines,0,0
217220,.,0,1
217221,CONCLUSIONS,0,0
217222,The,0,0
217223,effectiveness,0,0
217224,of,0,0
217225,i.v,0,0
217226,.,0,1
217227,filters,0,0
217228,in,0,0
217229,excluding,0,1
217230,the,0,0
217231,large,0,1
217232,particle,0,0
217233,load,0,0
217234,introduced,0,0
217235,by,0,0
217236,i.v,0,0
217237,.,0,1
217238,antibiotics,0,0
217239,and,0,0
217240,hence,0,0
217241,in,0,0
217242,reducing,0,0
217243,the,0,0
217244,subsequent,0,0
217245,phlebitis,0,0
217246,makes,0,0
217247,them,0,0
217248,a,0,0
217249,useful,0,0
217250,alternative,0,0
217251,to,0,0
217252,the,0,0
217253,use,0,0
217254,of,0,0
217255,hep/hc,0,0
217256,.,0,1
217257,The,0,0
217258,use,0,0
217259,of,0,0
217260,filters,0,0
217261,in,0,1
217262,this,0,0
217263,patient,0,0
217264,group,0,0
217265,may,0,0
217266,offer,0,0
217267,advantages,0,0
217268,in,0,1
217269,terms,0,0
217270,of,0,1
217271,ease,0,0
217272,of,0,0
217273,use,0,0
217274,and,0,0
217275,a,0,0
217276,possible,0,0
217277,decrease,0,0
217278,in,0,1
217279,hep/hc-related,0,1
217280,problems,0,1
217281,.,0,1
217282,Long,0,1
217283,lines,0,0
217284,offer,0,0
217285,practical,0,0
217286,advantages,0,0
217287,over,0,1
217288,short,0,1
217289,lines,0,0
217290,for,0,1
217291,patients,1,1
217292,requiring,1,1
217293,longer,1,0
217294,term,1,1
217295,i.v,1,0
217296,.,1,1
217297,access,1,0
217298,.,1,1
217299,Effect,0,0
217300,of,0,0
217301,entacapone,0,0
217302,",",0,0
217303,a,0,0
217304,peripherally,0,0
217305,acting,0,0
217306,catechol-O-methyltransferase,0,0
217307,inhibitor,0,0
217308,",",0,0
217309,on,0,0
217310,the,0,0
217311,motor,0,0
217312,response,0,0
217313,to,0,0
217314,acute,0,1
217315,treatment,0,0
217316,with,0,1
217317,levodopa,0,1
217318,in,0,1
217319,patients,1,1
217320,with,1,1
217321,Parkinson,1,1
217322,'s,1,1
217323,disease,1,1
217324,.,1,1
217325,Catechol-O-methyltransferase,0,0
217326,(,0,0
217327,COMT,0,0
217328,),0,1
217329,inhibitors,0,0
217330,may,0,0
217331,be,0,0
217332,useful,0,0
217333,in,0,0
217334,the,0,0
217335,treatment,0,0
217336,of,0,0
217337,Parkinson,0,1
217338,'s,0,1
217339,disease,0,1
217340,by,0,0
217341,improving,0,0
217342,the,0,0
217343,bioavailability,0,0
217344,of,0,0
217345,levodopa,0,1
217346,and,0,1
217347,by,0,0
217348,prolonging,0,0
217349,its,0,0
217350,effects,0,0
217351,.,0,1
217352,Entacapone,0,0
217353,(,0,0
217354,OR-611,0,1
217355,),0,1
217356,",",0,0
217357,a,0,0
217358,novel,0,0
217359,COMT,0,0
217360,inhibitor,0,0
217361,",",0,0
217362,which,0,0
217363,does,0,0
217364,not,0,0
217365,cross,0,0
217366,the,0,0
217367,blood,0,0
217368,brain,0,0
217369,barrier,0,0
217370,",",0,0
217371,was,0,0
217372,assessed,0,0
217373,in,0,1
217374,12,1,1
217375,patients,1,1
217376,with,1,1
217377,Parkinson,1,1
217378,'s,1,1
217379,disease,1,1
217380,and,1,1
217381,motor,1,0
217382,fluctuations,1,0
217383,in,0,1
217384,a,0,1
217385,randomised,0,0
217386,",",0,0
217387,double-blind,0,0
217388,",",0,0
217389,cross-over,0,0
217390,",",0,0
217391,single,0,0
217392,dose,0,0
217393,study,0,1
217394,.,0,1
217395,The,0,0
217396,magnitude,0,0
217397,and,0,0
217398,duration,0,0
217399,of,0,0
217400,the,0,0
217401,therapeutic,0,0
217402,response,0,0
217403,to,0,1
217404,a,0,0
217405,single,0,0
217406,dose,0,0
217407,of,0,1
217408,200,0,1
217409,mg,0,0
217410,levodopa/50,0,1
217411,mg,0,1
217412,carbidopa,0,0
217413,was,0,0
217414,evaluated,0,0
217415,after,0,0
217416,concomitant,0,0
217417,placebo,0,0
217418,",",0,1
217419,or,0,1
217420,200,0,1
217421,or,0,1
217422,800,0,0
217423,mg,0,0
217424,entacapone,0,0
217425,.,0,1
217426,A,0,0
217427,significant,0,0
217428,increase,0,0
217429,in,0,0
217430,the,0,0
217431,duration,0,0
217432,of,0,0
217433,the,0,0
217434,motor,0,0
217435,response,0,0
217436,to,0,0
217437,levodopa,0,1
217438,was,0,0
217439,seen,0,0
217440,when,0,0
217441,200,0,1
217442,mg,0,0
217443,entacapone,0,0
217444,was,0,0
217445,given,0,0
217446,with,0,1
217447,levodopa/carbidopa,0,1
217448,.,0,1
217449,Plasma,0,0
217450,levodopa,0,1
217451,concentrations,0,0
217452,were,0,1
217453,increased,0,0
217454,with,0,1
217455,both,0,0
217456,doses,0,0
217457,of,0,0
217458,the,0,1
217459,COMT,0,0
217460,inhibitor,0,0
217461,.,0,1
217462,The,0,0
217463,latency,0,0
217464,to,0,0
217465,onset,0,1
217466,of,0,0
217467,motor,0,0
217468,response,0,0
217469,did,0,0
217470,not,0,0
217471,differ,0,0
217472,significantly,0,0
217473,between,0,0
217474,active,0,1
217475,drug,0,1
217476,and,0,1
217477,placebo,0,0
217478,.,0,0
217479,Entacapone,0,0
217480,may,0,0
217481,prove,0,0
217482,useful,0,0
217483,in,0,0
217484,prolonging,0,0
217485,the,0,0
217486,duration,0,0
217487,of,0,0
217488,the,0,0
217489,benefit,0,0
217490,obtained,0,0
217491,from,0,1
217492,individual,0,0
217493,doses,0,0
217494,of,0,1
217495,levodopa,0,1
217496,.,0,1
217497,[,0,0
217498,A,0,1
217499,controlled,0,0
217500,study,0,1
217501,of,0,0
217502,treating,0,0
217503,haemophilia,0,1
217504,A,0,1
217505,on,0,0
217506,an,0,1
217507,out-patient,0,1
217508,basis,0,0
217509,(,0,1
217510,author,0,0
217511,'s,0,1
217512,transl,0,1
217513,),0,1
217514,],0,1
217515,.,0,1
217516,For,0,1
217517,six,0,1
217518,months,0,1
217519,36,0,1
217520,U,0,1
217521,factor,0,0
217522,VIII,0,0
217523,concentrates,0,0
217524,per,0,0
217525,kg,0,0
217526,bodyweight,0,1
217527,and,0,0
217528,week,0,0
217529,were,0,1
217530,administered,0,0
217531,to,0,1
217532,six,1,1
217533,out-patients,1,1
217534,with,1,1
217535,severe,1,1
217536,haemophilia,1,1
217537,A,1,1
217538,.,1,1
217539,The,0,0
217540,injection,0,0
217541,regimen,0,0
217542,was,0,0
217543,changed,0,0
217544,in,0,0
217545,every,0,0
217546,patient,0,1
217547,every,0,0
217548,two,0,0
217549,months,0,0
217550,",",0,1
217551,from,0,1
217552,36,0,1
217553,U/kg,0,1
217554,once,0,1
217555,to,0,1
217556,18,0,1
217557,U/kg,0,1
217558,twice,0,1
217559,and,0,1
217560,12,0,1
217561,U/kg,0,1
217562,three,0,1
217563,times,0,0
217564,",",0,1
217565,intravenously,0,1
217566,.,0,1
217567,The,0,0
217568,six,0,1
217569,possible,0,0
217570,combinations,0,0
217571,of,0,1
217572,these,0,0
217573,three,0,0
217574,dosage,0,0
217575,schedules,0,0
217576,were,0,1
217577,used,0,0
217578,in,0,0
217579,the,0,0
217580,patients,0,1
217581,in,0,0
217582,a,0,1
217583,strictly,0,1
217584,randomised,0,0
217585,manner,0,0
217586,",",0,0
217587,and,0,0
217588,all,0,0
217589,patients,0,1
217590,were,0,1
217591,treated,0,1
217592,during,0,0
217593,the,0,0
217594,same,0,0
217595,period,0,0
217596,.,0,1
217597,In,0,0
217598,the,0,0
217599,pre-trial,0,1
217600,period,0,0
217601,(,0,1
217602,treatment,0,0
217603,as,0,0
217604,needed,0,0
217605,),0,0
217606,there,0,0
217607,were,0,0
217608,an,0,0
217609,average,0,0
217610,of,0,0
217611,35,0,1
217612,bleedings,0,1
217613,per,0,1
217614,two,0,1
217615,months,0,1
217616,.,0,1
217617,On,0,0
217618,continual,0,0
217619,treatment,0,0
217620,there,0,0
217621,were,0,0
217622,21,0,0
217623,bleedings,0,1
217624,on,0,1
217625,weekly,0,1
217626,injections,0,0
217627,of,0,1
217628,36,0,1
217629,U,0,1
217630,factor,0,0
217631,VIII,0,1
217632,per,0,0
217633,kg,0,1
217634,",",0,1
217635,14,0,1
217636,on,0,0
217637,twice,0,1
217638,weekly,0,1
217639,18,0,1
217640,U/kg,0,1
217641,and,0,1
217642,none,0,1
217643,on,0,0
217644,12,0,1
217645,U/kg,0,1
217646,",",0,1
217647,three,0,0
217648,times,0,0
217649,weekly,0,1
217650,.,0,1
217651,The,0,0
217652,differences,0,0
217653,are,0,0
217654,statistically,0,0
217655,significant,0,0
217656,.,0,1
217657,The,0,0
217658,absence,0,0
217659,of,0,0
217660,bleeding,0,1
217661,on,0,0
217662,the,0,0
217663,last,0,0
217664,dosage,0,0
217665,schedule,0,0
217666,was,0,0
217667,achieved,0,0
217668,during,0,0
217669,normal,0,1
217670,working,0,1
217671,.,0,1
217672,Days,0,0
217673,lost,0,1
217674,from,0,1
217675,work,0,0
217676,per,0,1
217677,patient,0,1
217678,per,0,1
217679,month,0,0
217680,was,0,0
217681,zero,0,0
217682,on,0,0
217683,three,0,1
217684,times,0,0
217685,12,0,1
217686,U/kg,0,1
217687,",",0,1
217688,0.4,0,0
217689,day,0,0
217690,on,0,0
217691,twice,0,1
217692,18,0,1
217693,U/kg,0,1
217694,and,0,1
217695,once,0,1
217696,36,0,1
217697,U/kg,0,1
217698,",",0,1
217699,while,0,0
217700,it,0,0
217701,had,0,1
217702,been,0,1
217703,five,0,1
217704,days,0,0
217705,in,0,1
217706,the,0,1
217707,pre-trial,0,1
217708,period,0,0
217709,.,0,1
217710,In,0,0
217711,addition,0,0
217712,to,0,0
217713,freedom,0,0
217714,from,0,1
217715,bleeding,0,1
217716,and,0,0
217717,no,0,1
217718,lost,0,1
217719,days,0,0
217720,from,0,1
217721,work,0,0
217722,",",0,0
217723,there,0,0
217724,was,0,0
217725,increased,0,0
217726,mobility,0,0
217727,and,0,0
217728,physical,0,1
217729,capacity,0,1
217730,.,0,1
217731,Sodium,0,1
217732,kinetics,0,0
217733,in,0,1
217734,white,1,1
217735,and,1,1
217736,black,1,1
217737,normotensive,1,1
217738,subjects,1,1
217739,:,1,1
217740,possible,0,0
217741,relevance,0,0
217742,to,0,1
217743,salt-sensitive,0,1
217744,hypertension,0,1
217745,.,0,1
217746,The,0,0
217747,hypothesis,0,0
217748,that,0,0
217749,sodium,0,0
217750,(,0,1
217751,Na,0,1
217752,),0,1
217753,kinetics,0,0
217754,are,0,0
217755,not,0,0
217756,a,0,0
217757,first,0,0
217758,order,0,0
217759,process,0,0
217760,was,0,0
217761,tested,0,0
217762,.,0,1
217763,Twelve,1,1
217764,normotensive,1,1
217765,white,1,1
217766,and,1,1
217767,12,1,1
217768,normotensive,1,1
217769,black,1,1
217770,men,1,1
217771,were,0,1
217772,given,0,1
217773,10,0,1
217774,",",0,1
217775,200,0,1
217776,",",0,0
217777,and,0,0
217778,400,0,0
217779,mmol/d,0,0
217780,Na,0,1
217781,as,0,0
217782,the,0,0
217783,chloride,0,0
217784,salt,0,0
217785,for,0,1
217786,7,0,1
217787,days,0,0
217788,in,0,1
217789,random,0,1
217790,order,0,0
217791,.,0,1
217792,All,0,1
217793,urine,0,0
217794,made,0,0
217795,was,0,0
217796,collected,0,1
217797,.,0,1
217798,No,0,0
217799,effect,0,0
217800,of,0,0
217801,Na,0,1
217802,intake,0,0
217803,on,0,0
217804,blood,0,0
217805,pressure,0,0
217806,was,0,0
217807,identified,0,0
217808,in,0,0
217809,either,0,1
217810,whites,1,1
217811,or,0,1
217812,blacks,1,1
217813,.,1,1
217814,The,0,0
217815,half-life,0,0
217816,(,0,0
217817,T1/2,0,1
217818,),0,1
217819,with,0,1
217820,decreasing,0,0
217821,Na,0,1
217822,intake,0,0
217823,to,0,1
217824,10,0,1
217825,mmol/d,0,0
217826,was,0,0
217827,1.08,0,0
217828,days,0,0
217829,in,0,1
217830,whites,0,1
217831,and,0,1
217832,1.65,0,0
217833,days,0,0
217834,in,0,1
217835,blacks,0,1
217836,(,0,1
217837,p,0,0
217838,=,0,0
217839,not,0,0
217840,significant,0,0
217841,[,0,0
217842,NS,0,0
217843,],0,1
217844,),0,1
217845,.,0,1
217846,With,0,1
217847,increasing,0,0
217848,Na,0,1
217849,intake,0,0
217850,",",0,0
217851,T1/2,0,0
217852,increased,0,0
217853,in,0,0
217854,both,0,0
217855,whites,0,1
217856,and,0,1
217857,blacks,0,1
217858,;,0,1
217859,at,0,1
217860,the,0,1
217861,400,0,0
217862,mmol/d,0,0
217863,intake,0,0
217864,",",0,0
217865,the,0,0
217866,T1/2,0,0
217867,for,0,0
217868,whites,0,1
217869,was,0,1
217870,2.88,0,0
217871,days,0,0
217872,and,0,1
217873,for,0,1
217874,blacks,0,1
217875,was,0,1
217876,5.81,0,0
217877,days,0,0
217878,(,0,1
217879,p,0,0
217880,<,0,0
217881,0.05,0,0
217882,),0,1
217883,.,0,1
217884,At,0,0
217885,that,0,0
217886,intake,0,0
217887,",",0,0
217888,whites,0,1
217889,accumulated,0,0
217890,385,0,1
217891,+/-,0,1
217892,153,0,1
217893,mmol,0,0
217894,compared,0,0
217895,with,0,1
217896,909,0,1
217897,+/-,0,1
217898,153,0,1
217899,mmol,0,1
217900,for,0,1
217901,blacks,0,1
217902,(,0,1
217903,p,0,0
217904,<,0,0
217905,0.05,0,0
217906,),0,1
217907,.,0,1
217908,The,0,0
217909,data,0,0
217910,showed,0,0
217911,that,0,0
217912,T1/2,0,0
217913,increases,0,0
217914,with,0,1
217915,increasing,0,0
217916,Na,0,1
217917,intake,0,0
217918,and,0,0
217919,is,0,0
217920,",",0,0
217921,therefore,0,0
217922,",",0,0
217923,dose-dependent,0,0
217924,or,0,1
217925,zero,0,0
217926,order,0,0
217927,.,0,1
217928,The,0,0
217929,effect,0,0
217930,of,0,0
217931,dose,0,0
217932,is,0,0
217933,more,0,0
217934,prominent,0,0
217935,in,0,0
217936,blacks,0,1
217937,than,0,1
217938,in,0,1
217939,whites,0,1
217940,;,0,1
217941,blacks,0,1
217942,accumulate,0,1
217943,more,0,0
217944,Na,0,1
217945,with,0,1
217946,increasing,0,0
217947,Na,0,1
217948,intake,0,0
217949,than,0,1
217950,whites,0,1
217951,.,0,1
217952,These,0,0
217953,data,0,0
217954,may,0,0
217955,have,0,0
217956,relevance,0,0
217957,for,0,0
217958,the,0,0
217959,pathogenesis,0,0
217960,of,0,0
217961,salt-sensitive,1,1
217962,hypertension,1,1
217963,in,1,1
217964,blacks,1,1
217965,.,1,1
217966,Cyclosporin,0,1
217967,versus,0,0
217968,cyclophosphamide,0,1
217969,for,0,0
217970,patients,1,1
217971,with,1,1
217972,steroid-dependent,1,1
217973,and,1,1
217974,frequently,1,1
217975,relapsing,1,1
217976,idiopathic,1,1
217977,nephrotic,1,1
217978,syndrome,1,1
217979,:,1,1
217980,a,0,0
217981,multicentre,0,0
217982,randomized,0,1
217983,controlled,0,0
217984,trial,0,1
217985,.,0,1
217986,OBJECTIVE,0,0
217987,To,0,0
217988,compare,0,0
217989,the,0,0
217990,efficacy,0,0
217991,(,0,0
217992,maintenance,0,0
217993,of,0,0
217994,remission,0,1
217995,),0,1
217996,",",0,0
217997,safety,0,0
217998,and,0,0
217999,tolerability,0,0
218000,of,0,0
218001,cyclosporin,0,0
218002,(,0,1
218003,CsA,0,1
218004,),0,1
218005,with,0,1
218006,those,0,1
218007,of,0,0
218008,cyclophosphamide,0,1
218009,in,0,1
218010,patients,1,1
218011,with,1,1
218012,steroid-dependent,1,1
218013,or,1,1
218014,frequently,1,1
218015,relapsing,1,1
218016,nephrotic,1,1
218017,syndrome,1,1
218018,(,1,1
218019,NS,1,0
218020,),1,1
218021,.,1,1
218022,DESIGN,0,0
218023,Open,0,0
218024,",",0,0
218025,prospective,0,1
218026,",",0,0
218027,randomized,0,0
218028,",",0,0
218029,multicentre,0,0
218030,",",0,0
218031,controlled,0,0
218032,study,0,0
218033,for,0,1
218034,parallel,0,0
218035,groups,0,1
218036,",",0,1
218037,stratified,0,1
218038,for,0,0
218039,adults,1,1
218040,and,1,1
218041,children,1,1
218042,.,1,1
218043,The,0,0
218044,setting,0,1
218045,was,0,0
218046,in,0,0
218047,nephrological,0,1
218048,departments,0,1
218049,in,1,1
218050,Italy,1,1
218051,.,1,1
218052,SUBJECTS,0,0
218053,AND,0,0
218054,INTERVENTIONS,0,1
218055,Seventy-three,1,1
218056,patients,1,1
218057,with,1,1
218058,steroid-sensitive,1,1
218059,idiopathic,1,1
218060,NS,1,0
218061,admitted,1,1
218062,to,1,0
218063,the,1,0
218064,study,1,0
218065,were,0,0
218066,randomly,0,1
218067,assigned,0,1
218068,to,0,0
218069,cyclophosphamide,0,1
218070,(,0,1
218071,2.5,0,0
218072,mg/kg/day,0,0
218073,),0,1
218074,for,0,1
218075,8,0,1
218076,weeks,0,1
218077,or,0,1
218078,CsA,0,1
218079,(,0,1
218080,5,0,0
218081,mg/kg/day,0,0
218082,in,0,1
218083,adults,0,1
218084,",",0,1
218085,6,0,0
218086,mg/kg/day,0,0
218087,in,0,1
218088,children,0,1
218089,),0,1
218090,for,0,1
218091,9,0,1
218092,months,0,0
218093,",",0,1
218094,tapered,0,0
218095,off,0,0
218096,by,0,0
218097,25,0,1
218098,%,0,0
218099,every,0,0
218100,month,0,0
218101,until,0,0
218102,complete,0,1
218103,discontinuation,0,0
218104,at,0,1
218105,month,0,1
218106,12,0,1
218107,.,0,1
218108,Seven,0,0
218109,patients,0,1
218110,lost,0,1
218111,to,0,1
218112,follow,0,0
218113,up,0,0
218114,were,0,0
218115,not,0,0
218116,considered,0,0
218117,in,0,0
218118,the,0,0
218119,analysis,0,0
218120,.,0,0
218121,The,0,0
218122,remaining,0,0
218123,66,0,1
218124,patients,0,1
218125,were,0,1
218126,followed,0,1
218127,up,0,1
218128,for,0,1
218129,3-24,0,0
218130,months,0,1
218131,after,0,1
218132,randomization,0,1
218133,.,0,1
218134,MAIN,0,0
218135,OUTCOME,0,1
218136,MEASURES,0,0
218137,Relapse-free,0,0
218138,survival,0,0
218139,;,0,0
218140,number,0,0
218141,of,0,0
218142,N.S,0,1
218143,.,0,1
218144,relapses/patient/year,0,0
218145,;,0,0
218146,cumulative,0,0
218147,dose,0,0
218148,of,0,1
218149,prednisone/patient,0,1
218150,;,0,1
218151,laboratory,0,1
218152,investigations,0,0
218153,(,0,1
218154,kidney,0,1
218155,and,0,1
218156,liver,0,1
218157,functions,0,0
218158,",",0,1
218159,haematological,0,1
218160,parameters,0,0
218161,),0,1
218162,;,0,1
218163,incidence,0,0
218164,of,0,1
218165,adverse,0,0
218166,events,0,0
218167,.,0,1
218168,RESULTS,0,0
218169,At,0,0
218170,month,0,0
218171,9,0,0
218172,",",0,1
218173,26,0,1
218174,of,0,1
218175,35,0,1
218176,CsA-treated,0,1
218177,patients,0,1
218178,were,0,1
218179,still,0,0
218180,in,0,0
218181,complete,0,1
218182,remission,0,1
218183,and,0,0
218184,a,0,1
218185,further,0,0
218186,five,0,1
218187,patients,0,1
218188,were,0,1
218189,in,0,1
218190,partial,0,1
218191,remission,0,1
218192,;,0,1
218193,18,0,1
218194,of,0,1
218195,28,0,1
218196,cyclophosphamide-treated,0,1
218197,patients,0,1
218198,were,0,1
218199,in,0,1
218200,complete,0,1
218201,remission,0,1
218202,",",0,1
218203,and,0,0
218204,one,0,1
218205,in,0,1
218206,partial,0,1
218207,remission,0,1
218208,(,0,1
218209,P,0,0
218210,=,0,1
218211,NS,0,0
218212,),0,1
218213,.,0,1
218214,No,0,0
218215,difference,0,0
218216,between,0,0
218217,adults,0,1
218218,and,0,1
218219,children,0,1
218220,was,0,0
218221,seen,0,0
218222,with,0,1
218223,either,0,1
218224,treatment,0,0
218225,.,0,0
218226,The,0,0
218227,risk,0,0
218228,of,0,0
218229,relapse,0,0
218230,was,0,0
218231,similar,0,0
218232,between,0,0
218233,frequent,0,1
218234,relapsers,0,1
218235,(,0,1
218236,19,0,1
218237,of,0,1
218238,22,0,1
218239,),0,1
218240,and,0,1
218241,steroid-dependent,0,1
218242,patients,0,1
218243,(,0,1
218244,8,0,1
218245,of,0,1
218246,14,0,1
218247,),0,1
218248,given,0,0
218249,CsA,0,1
218250,",",0,0
218251,and,0,0
218252,those,0,0
218253,given,0,0
218254,cyclophosphamide,0,1
218255,(,0,1
218256,5,0,1
218257,of,0,1
218258,15,0,1
218259,and,0,1
218260,6,0,1
218261,of,0,1
218262,15,0,1
218263,),0,1
218264,.,0,1
218265,The,0,0
218266,mean,0,0
218267,number,0,0
218268,of,0,1
218269,relapses,0,0
218270,per,0,1
218271,year,0,1
218272,and,0,0
218273,the,0,0
218274,mean,0,0
218275,dose,0,0
218276,of,0,0
218277,prednisone,0,1
218278,per,0,1
218279,year,0,1
218280,were,0,0
218281,significantly,0,0
218282,less,0,0
218283,(,0,0
218284,P,0,0
218285,<,0,0
218286,0.001,0,0
218287,),0,1
218288,in,0,0
218289,both,0,0
218290,groups,0,0
218291,for,0,0
218292,the,0,1
218293,experimental,0,0
218294,year,0,0
218295,than,0,0
218296,for,0,0
218297,the,0,0
218298,year,0,0
218299,before,0,0
218300,randomization,0,0
218301,.,0,1
218302,At,0,0
218303,2,0,1
218304,years,0,1
218305,",",0,1
218306,25,0,1
218307,%,0,0
218308,of,0,0
218309,the,0,0
218310,patients,0,1
218311,given,0,0
218312,CsA,0,1
218313,(,0,1
218314,50,0,1
218315,%,0,0
218316,adults,0,1
218317,and,0,1
218318,20,0,1
218319,%,0,0
218320,children,0,1
218321,),0,1
218322,and,0,1
218323,63,0,1
218324,%,0,0
218325,of,0,0
218326,those,0,1
218327,given,0,0
218328,cyclophosphamide,0,1
218329,(,0,1
218330,40,0,1
218331,%,0,0
218332,adults,0,1
218333,and,0,1
218334,68,0,1
218335,%,0,0
218336,children,0,1
218337,),0,1
218338,had,0,1
218339,not,0,0
218340,had,0,1
218341,any,0,0
218342,relapse,0,0
218343,of,0,0
218344,NS,0,0
218345,.,0,1
218346,Tolerance,0,0
218347,to,0,0
218348,the,0,0
218349,two,0,0
218350,drugs,0,0
218351,was,0,0
218352,generally,0,1
218353,good,0,0
218354,.,0,1
218355,The,0,0
218356,CsA-related,0,0
218357,side-effects,0,0
218358,were,0,1
218359,mild,0,1
218360,and,0,0
218361,disappeared,0,0
218362,after,0,0
218363,drug,0,1
218364,discontinuation,0,0
218365,.,0,0
218366,CONCLUSIONS,0,0
218367,This,0,0
218368,study,0,0
218369,shows,0,0
218370,that,0,0
218371,both,0,0
218372,treatments,0,0
218373,are,0,0
218374,effective,0,0
218375,and,0,0
218376,well,0,0
218377,tolerated,0,0
218378,;,0,0
218379,more,0,0
218380,patients,0,1
218381,given,0,0
218382,cyclophosphamide,0,1
218383,had,0,1
218384,stable,0,1
218385,remissions,0,1
218386,.,0,1
218387,Influence,0,0
218388,of,0,0
218389,glyceryl,0,0
218390,trinitrate,0,0
218391,on,0,0
218392,venous,0,1
218393,and,0,1
218394,arterial,0,1
218395,effects,0,0
218396,of,0,1
218397,chronic,0,1
218398,",",0,0
218399,asymmetric,0,0
218400,isosorbide,0,0
218401,dinitrate,0,0
218402,treatment,0,0
218403,in,0,0
218404,patients,1,1
218405,with,1,1
218406,ischemic,1,1
218407,heart,1,1
218408,disease,1,1
218409,.,1,1
218410,Asymmetric,0,0
218411,dosage,0,0
218412,regimes,0,0
218413,have,0,1
218414,been,0,0
218415,introduced,0,0
218416,to,0,0
218417,circumvent,0,0
218418,development,0,0
218419,of,0,0
218420,nitrate,0,0
218421,tolerance,0,1
218422,.,0,1
218423,This,0,0
218424,study,0,0
218425,assessed,0,0
218426,invasively,0,1
218427,the,0,0
218428,hemodynamics,0,0
218429,during,0,0
218430,supine,0,1
218431,rest,0,0
218432,and,0,0
218433,exercise,0,0
218434,before,0,0
218435,and,0,0
218436,after,0,1
218437,4,0,1
218438,weeks,0,0
218439,treatment,0,1
218440,with,0,1
218441,30,0,1
218442,mg,0,1
218443,isosorbide,0,0
218444,dinitrate,0,1
218445,(,0,1
218446,ISDN,0,0
218447,),0,1
218448,or,0,1
218449,placebo,0,0
218450,asymmetrically,0,0
218451,b.i.d,0,0
218452,.,0,1
218453,in,0,0
218454,14,1,1
218455,randomized,1,1
218456,patients,1,1
218457,with,1,1
218458,stable,1,1
218459,ischemic,1,1
218460,heart,1,1
218461,disease,1,1
218462,in,0,0
218463,a,0,1
218464,double-blinded,0,0
218465,study,0,1
218466,.,0,1
218467,An,0,0
218468,intravenous,0,0
218469,infusion,0,0
218470,of,0,0
218471,glyceryl,0,0
218472,trinitrate,0,0
218473,(,0,1
218474,GTN,0,1
218475,),0,1
218476,was,0,0
218477,used,0,0
218478,to,0,0
218479,assess,0,0
218480,possible,0,0
218481,nitrate,0,0
218482,tolerance,0,1
218483,.,0,1
218484,During,0,0
218485,the,0,0
218486,initial,0,0
218487,",",0,0
218488,medication-free,0,1
218489,exercise,0,0
218490,all,0,1
218491,patients,0,1
218492,had,0,1
218493,increased,0,0
218494,pulmonary,0,1
218495,arterial,0,1
218496,wedge,0,1
218497,pressure,0,0
218498,(,0,1
218499,PAWP,0,1
218500,),0,1
218501,31.4,0,1
218502,+/-,0,1
218503,5.56,0,0
218504,mmHg,0,0
218505,(,0,1
218506,mean,0,1
218507,+/-,0,0
218508,SD,0,1
218509,),0,1
218510,",",0,0
218511,showing,0,0
218512,impaired,0,1
218513,left,0,1
218514,ventricular,0,1
218515,function,0,0
218516,",",0,0
218517,while,0,0
218518,mean,0,1
218519,arterial,0,1
218520,pressures,0,0
218521,(,0,1
218522,MAP,0,1
218523,),0,1
218524,rose,0,0
218525,from,0,1
218526,112,0,1
218527,+/-,0,1
218528,16.3,0,0
218529,mmHg,0,0
218530,at,0,1
218531,rest,0,0
218532,to,0,1
218533,141,0,1
218534,+/-,0,0
218535,15.9,0,1
218536,mmHg,0,0
218537,during,0,1
218538,exercise,0,0
218539,.,0,1
218540,After,0,0
218541,4,0,0
218542,weeks,0,1
218543,ISDN,0,0
218544,treatment,0,1
218545,",",0,0
218546,mean,0,1
218547,exercise,0,1
218548,PAWP,0,1
218549,and,0,1
218550,MAP,0,1
218551,",",0,1
218552,3,0,0
218553,h,0,0
218554,after,0,0
218555,morning,0,0
218556,dose,0,0
218557,",",0,0
218558,were,0,0
218559,reduced,0,0
218560,to,0,1
218561,22.4,0,1
218562,+/-,0,0
218563,7.09,0,0
218564,mmHg,0,0
218565,and,0,1
218566,127,0,1
218567,+/-,0,0
218568,18.2,0,0
218569,mmHg,0,0
218570,",",0,0
218571,respectively,0,0
218572,.,0,0
218573,Before,0,0
218574,the,0,0
218575,ISDN,0,0
218576,treatment,0,0
218577,",",0,0
218578,GTN,0,0
218579,reduced,0,0
218580,exercise,0,0
218581,PAWP,0,1
218582,to,0,1
218583,13.9,0,1
218584,+/-,0,0
218585,5.27,0,0
218586,mmHg,0,0
218587,and,0,1
218588,MAP,0,1
218589,to,0,1
218590,119,0,1
218591,+/-,0,0
218592,11.2,0,0
218593,mmHg,0,0
218594,",",0,1
218595,whereas,0,0
218596,after,0,1
218597,4,0,1
218598,weeks,0,1
218599,ISDN,0,0
218600,treatment,0,0
218601,",",0,0
218602,the,0,0
218603,addition,0,0
218604,of,0,0
218605,GTN,0,1
218606,did,0,0
218607,not,0,0
218608,reduce,0,0
218609,exercise,0,0
218610,PAWP,0,0
218611,and,0,1
218612,MAP,0,0
218613,to,0,0
218614,the,0,0
218615,same,0,0
218616,low,0,1
218617,levels,0,0
218618,.,0,1
218619,Thus,0,1
218620,",",0,0
218621,the,0,0
218622,applied,0,0
218623,ISDN,0,0
218624,regimen,0,0
218625,improved,0,0
218626,the,0,0
218627,hemodynamics,0,0
218628,",",0,0
218629,but,0,0
218630,induced,0,0
218631,a,0,0
218632,definite,0,0
218633,",",0,0
218634,partial,0,1
218635,nitrate,0,0
218636,tolerance,0,1
218637,.,0,1
218638,[,0,0
218639,Perioperative,0,0
218640,teicoplanin,0,0
218641,prophylaxis,0,1
218642,in,0,1
218643,patients,1,1
218644,undergoing,1,1
218645,breast,1,1
218646,reconstruction,1,1
218647,with,1,1
218648,the,1,0
218649,abdominal,1,1
218650,wall,1,1
218651,.,1,1
218652,A,0,0
218653,case-control,0,1
218654,study,0,1
218655,],0,1
218656,.,0,1
218657,The,0,0
218658,authors,0,0
218659,report,0,0
218660,the,0,0
218661,results,0,0
218662,of,0,0
218663,a,0,1
218664,randomized,0,1
218665,clinical,0,0
218666,trial,0,1
218667,of,0,0
218668,antibiotic,0,0
218669,prophylaxis,0,1
218670,of,0,0
218671,postoperative,0,0
218672,infection,0,1
218673,following,0,0
218674,breast,1,1
218675,reconstruction,1,1
218676,by,1,0
218677,transposition,1,1
218678,of,1,0
218679,rectus,1,1
218680,abdominis,1,0
218681,myocutaneous,1,1
218682,flap,1,1
218683,(,0,1
218684,TRAMF,0,1
218685,),0,1
218686,.,0,1
218687,The,0,0
218688,aim,0,0
218689,was,0,0
218690,to,0,0
218691,evaluate,0,0
218692,the,0,0
218693,efficacy,0,0
218694,and,0,0
218695,tolerability,0,0
218696,of,0,0
218697,a,0,1
218698,short-term,0,0
218699,parenteral,0,1
218700,prophylaxis,0,1
218701,with,0,1
218702,Teicoplanin,0,0
218703,and,0,1
218704,the,0,0
218705,end-point,0,0
218706,of,0,0
218707,the,0,0
218708,study,0,0
218709,was,0,0
218710,the,0,0
218711,evaluation,0,0
218712,of,0,0
218713,wound,0,0
218714,contamination,0,0
218715,assessed,0,0
218716,by,0,0
218717,means,0,0
218718,of,0,1
218719,microbiologic,0,1
218720,culture,0,0
218721,of,0,0
218722,drainage,0,1
218723,fluid,0,1
218724,.,0,1
218725,From,1,1
218726,October,1,1
218727,1990,1,1
218728,to,1,1
218729,March,1,1
218730,1992,1,1
218731,38,1,1
218732,patients,1,1
218733,were,1,1
218734,recruited,1,1
218735,:,1,1
218736,20,1,1
218737,patients,1,1
218738,in,1,1
218739,the,1,1
218740,antibiotic,1,0
218741,prophylaxis,1,1
218742,arm,1,1
218743,and,1,1
218744,18,1,1
218745,patients,1,1
218746,in,1,1
218747,the,1,0
218748,control,1,1
218749,group,1,1
218750,.,1,1
218751,Analysis,0,0
218752,of,0,0
218753,drainage,0,1
218754,fluids,0,1
218755,showed,0,0
218756,a,0,1
218757,higher,0,0
218758,contamination,0,0
218759,rate,0,0
218760,(,0,1
218761,15/18,0,1
218762,=,0,1
218763,83,0,1
218764,%,0,0
218765,),0,1
218766,in,0,0
218767,the,0,0
218768,control,0,0
218769,group,0,0
218770,as,0,0
218771,compared,0,0
218772,to,0,0
218773,the,0,0
218774,prophylaxis,0,0
218775,arm,0,1
218776,(,0,1
218777,2/20,0,0
218778,=,0,1
218779,10,0,1
218780,%,0,0
218781,),0,1
218782,(,0,1
218783,p,0,0
218784,<,0,0
218785,0.0001,0,0
218786,),0,1
218787,.,0,1
218788,Moreover,0,0
218789,",",0,0
218790,11,0,1
218791,patients,0,1
218792,in,0,1
218793,the,0,0
218794,control,0,1
218795,arm,0,0
218796,suffered,0,1
218797,from,0,1
218798,fever,0,1
218799,>,0,1
218800,37.5,0,1
218801,degrees,0,0
218802,C,0,1
218803,for,0,1
218804,at,0,1
218805,least,0,1
218806,3,0,1
218807,days,0,0
218808,as,0,1
218809,compared,0,0
218810,to,0,0
218811,1,0,0
218812,patient,0,1
218813,in,0,0
218814,the,0,0
218815,antibiotic,0,0
218816,prophylaxis,0,1
218817,group,0,1
218818,;,0,0
218819,the,0,0
218820,postoperative,0,0
218821,stay,0,0
218822,was,0,0
218823,13.3,0,1
218824,+/-,0,1
218825,4.3,0,1
218826,and,0,1
218827,9.0,0,1
218828,+/-,0,0
218829,1.6,0,0
218830,in,0,0
218831,the,0,0
218832,control,0,1
218833,and,0,0
218834,antibiotic,0,0
218835,arm,0,1
218836,respectively,0,0
218837,.,0,1
218838,No,0,0
218839,antibiotic,0,0
218840,related,0,0
218841,side,0,0
218842,effects,0,0
218843,were,0,1
218844,evidenced,0,0
218845,through,0,0
218846,the,0,0
218847,study,0,0
218848,.,0,1
218849,These,0,0
218850,results,0,0
218851,seem,0,0
218852,to,0,0
218853,confirm,0,0
218854,the,0,0
218855,value,0,0
218856,of,0,0
218857,parenteral,0,1
218858,short-term,0,0
218859,antibiotic,0,0
218860,prophylaxis,0,1
218861,of,0,0
218862,postoperative,0,0
218863,infection,0,1
218864,in,0,1
218865,such,0,0
218866,kind,0,1
218867,of,0,0
218868,clean,0,1
218869,operative,0,1
218870,procedure,0,0
218871,.,0,1
218872,Lithium,0,0
218873,sustains,0,0
218874,the,0,0
218875,acute,1,1
218876,antidepressant,1,1
218877,effects,1,0
218878,of,1,1
218879,sleep,1,1
218880,deprivation,1,1
218881,:,1,1
218882,preliminary,0,0
218883,findings,0,0
218884,from,0,1
218885,a,0,1
218886,controlled,0,0
218887,study,0,1
218888,.,0,1
218889,Early,1,0
218890,morning,1,0
218891,sleep,1,1
218892,deprivation,1,1
218893,(,1,1
218894,patient,1,1
218895,awake,1,1
218896,from,1,1
218897,0200,1,1
218898,to,1,1
218899,2200,1,1
218900,hours,1,0
218901,),1,1
218902,produces,0,0
218903,a,0,0
218904,same-day,0,0
218905,antidepressant,0,1
218906,effect,0,0
218907,in,0,0
218908,approximately,0,1
218909,one-half,0,1
218910,of,0,0
218911,patients,1,1
218912,with,1,1
218913,major,1,1
218914,depression,1,1
218915,.,1,1
218916,Unfortunately,0,0
218917,",",0,0
218918,these,0,0
218919,antidepressant,0,0
218920,effects,0,0
218921,are,0,0
218922,short-lived,0,1
218923,and,0,1
218924,patients,0,1
218925,usually,0,1
218926,relapse,0,0
218927,to,0,0
218928,baseline,0,0
218929,depression,0,1
218930,levels,0,0
218931,within,0,1
218932,48,0,1
218933,hours,0,1
218934,.,0,1
218935,Recent,0,0
218936,work,0,0
218937,suggests,0,0
218938,",",0,0
218939,however,0,0
218940,",",0,0
218941,that,0,0
218942,the,0,0
218943,use,0,0
218944,of,0,0
218945,lithium,0,0
218946,with,0,1
218947,early,0,1
218948,morning,0,0
218949,sleep,0,1
218950,deprivation,0,0
218951,sustains,0,0
218952,this,0,0
218953,rapid,0,0
218954,antidepressant,0,1
218955,effect,0,0
218956,and,0,0
218957,makes,0,0
218958,it,0,0
218959,clinically,0,0
218960,useful,0,0
218961,.,0,1
218962,In,0,0
218963,a,0,0
218964,30-day,0,0
218965,study,0,0
218966,",",0,0
218967,we,0,0
218968,compared,0,0
218969,the,0,0
218970,abilities,0,0
218971,of,0,1
218972,four,0,1
218973,different,0,1
218974,treatments,0,0
218975,(,0,1
218976,lithium,0,0
218977,plus,0,0
218978,early,0,1
218979,morning,0,0
218980,sleep,0,1
218981,deprivation,0,0
218982,",",0,0
218983,lithium,0,0
218984,plus,0,0
218985,a,0,0
218986,control,0,1
218987,sleep,0,1
218988,deprivation,0,1
218989,procedure,0,0
218990,",",0,0
218991,and,0,0
218992,desipramine,0,0
218993,with,0,1
218994,either,0,0
218995,of,0,0
218996,the,0,0
218997,two,0,0
218998,sleep,0,1
218999,manipulations,0,1
219000,),0,1
219001,to,0,0
219002,induce,0,0
219003,a,0,0
219004,rapid,0,0
219005,(,0,1
219006,next-day,0,0
219007,),0,1
219008,and,0,1
219009,sustained,0,1
219010,antidepressant,0,1
219011,response,0,0
219012,in,0,1
219013,16,1,1
219014,depressed,1,1
219015,patients,1,1
219016,.,1,1
219017,Lithium,0,0
219018,plus,0,0
219019,early,0,1
219020,morning,0,0
219021,sleep,0,1
219022,deprivation,0,1
219023,produced,0,0
219024,a,0,0
219025,quicker,0,0
219026,response,0,0
219027,than,0,0
219028,lithium,0,0
219029,with,0,1
219030,the,0,0
219031,control,0,1
219032,sleep,0,1
219033,deprivation,0,1
219034,",",0,0
219035,and,0,0
219036,the,0,0
219037,response,0,0
219038,was,0,0
219039,sustained,0,0
219040,for,0,0
219041,at,0,1
219042,least,0,1
219043,30,0,1
219044,days,0,0
219045,.,0,1
219046,In,0,0
219047,this,0,0
219048,design,0,0
219049,",",0,0
219050,however,0,0
219051,",",0,0
219052,lithium/early,0,0
219053,morning,0,0
219054,sleep,0,1
219055,deprivation,0,1
219056,was,0,0
219057,no,0,0
219058,faster,0,0
219059,than,0,0
219060,either,0,0
219061,of,0,0
219062,the,0,0
219063,two,0,0
219064,desipramine/sleep,0,1
219065,deprivation,0,1
219066,conditions,0,1
219067,in,0,1
219068,inducing,0,1
219069,remission,0,1
219070,.,0,1
219071,These,0,0
219072,results,0,0
219073,support,0,0
219074,the,0,0
219075,results,0,0
219076,of,0,1
219077,previous,0,1
219078,studies,0,0
219079,and,0,1
219080,suggest,0,0
219081,further,0,0
219082,investigation,0,0
219083,of,0,0
219084,this,0,0
219085,novel,0,0
219086,sleep/pharmacologic,0,0
219087,intervention,0,0
219088,is,0,0
219089,warranted,0,0
219090,.,0,0
219091,How,0,0
219092,to,0,0
219093,establish,0,0
219094,equivalence,0,0
219095,when,0,0
219096,data,0,0
219097,are,0,0
219098,censored,0,1
219099,:,0,1
219100,a,0,0
219101,randomized,1,1
219102,trial,1,0
219103,of,1,1
219104,treatments,1,0
219105,for,1,1
219106,B,1,1
219107,non-Hodgkin,1,1
219108,lymphoma,1,1
219109,.,1,1
219110,Interest,0,0
219111,in,0,0
219112,equivalence,0,0
219113,trials,0,0
219114,has,0,0
219115,been,0,0
219116,increasing,0,0
219117,for,0,1
219118,many,0,1
219119,years,0,1
219120,",",0,1
219121,though,0,0
219122,the,0,0
219123,methodology,0,0
219124,which,0,0
219125,has,0,0
219126,been,0,0
219127,developed,0,0
219128,for,0,1
219129,such,0,0
219130,trials,0,0
219131,is,0,0
219132,mainly,0,0
219133,for,0,0
219134,uncensored,0,1
219135,data,0,0
219136,.,0,1
219137,In,0,0
219138,cancer,0,1
219139,research,0,1
219140,we,0,0
219141,are,0,0
219142,more,0,0
219143,often,0,0
219144,concerned,0,0
219145,with,0,1
219146,survival,0,0
219147,.,0,1
219148,In,0,0
219149,an,0,0
219150,efficacy,0,0
219151,trial,0,0
219152,",",0,0
219153,the,0,0
219154,null,0,0
219155,hypothesis,0,0
219156,specifies,0,0
219157,equality,0,0
219158,of,0,1
219159,the,0,0
219160,two,0,0
219161,survival,0,0
219162,distributions,0,0
219163,",",0,1
219164,but,0,0
219165,in,0,0
219166,an,0,0
219167,equivalence,0,0
219168,trial,0,0
219169,",",0,0
219170,a,0,0
219171,null,0,0
219172,hypothesis,0,0
219173,of,0,0
219174,inequivalence,0,0
219175,H0,0,0
219176,has,0,0
219177,to,0,0
219178,be,0,0
219179,tested,0,0
219180,.,0,1
219181,The,0,0
219182,usual,0,0
219183,logrank,0,0
219184,test,0,0
219185,has,0,0
219186,to,0,0
219187,be,0,0
219188,modified,0,0
219189,to,0,0
219190,test,0,0
219191,whether,0,0
219192,the,0,0
219193,true,0,0
219194,value,0,0
219195,r,0,0
219196,of,0,0
219197,the,0,0
219198,ratio,0,0
219199,of,0,0
219200,hazard,0,0
219201,rates,0,0
219202,in,0,1
219203,two,0,1
219204,treatment,0,1
219205,groups,0,0
219206,is,0,0
219207,at,0,0
219208,least,0,0
219209,equal,0,0
219210,to,0,0
219211,a,0,1
219212,limit,0,0
219213,value,0,0
219214,r0,0,1
219215,.,0,1
219216,If,0,0
219217,prognostic,0,0
219218,factors,0,0
219219,have,0,0
219220,to,0,0
219221,be,0,0
219222,taken,0,0
219223,into,0,0
219224,account,0,0
219225,",",0,0
219226,the,0,0
219227,Cox,0,0
219228,model,0,0
219229,provides,0,0
219230,tests,0,0
219231,of,0,0
219232,Ho,0,1
219233,",",0,0
219234,and,0,0
219235,a,0,0
219236,useful,0,0
219237,confidence,0,0
219238,interval,0,0
219239,for,0,0
219240,the,0,0
219241,adjusted,0,0
219242,relative,0,0
219243,derived,0,1
219244,from,0,1
219245,the,0,0
219246,regression,0,0
219247,parameter,0,0
219248,for,0,0
219249,the,0,0
219250,treatment,0,0
219251,indicator,0,0
219252,.,0,1
219253,An,0,0
219254,equivalence,0,0
219255,trial,0,0
219256,of,0,0
219257,maintenance,0,0
219258,therapy,0,0
219259,was,0,0
219260,carried,0,0
219261,out,0,1
219262,in,0,0
219263,children,1,1
219264,with,1,1
219265,B,1,1
219266,non-Hodgkin,1,1
219267,lymphoma,1,1
219268,",",0,0
219269,and,0,0
219270,serves,0,0
219271,as,0,0
219272,an,0,0
219273,illustration,0,0
219274,.,0,1
219275,Erythrocyte,0,0
219276,deformability,0,0
219277,",",0,0
219278,endothelin,0,0
219279,levels,0,0
219280,",",0,1
219281,and,0,1
219282,renal,0,1
219283,function,0,0
219284,in,0,1
219285,cyclosporin-treated,1,1
219286,renal,1,1
219287,transplant,1,1
219288,recipients,1,1
219289,:,1,1
219290,effects,0,0
219291,of,0,0
219292,intervention,0,1
219293,with,0,1
219294,fish,0,0
219295,oil,0,0
219296,and,0,0
219297,corn,0,0
219298,oil,0,0
219299,.,0,1
219300,Twenty,1,1
219301,nine,1,1
219302,stable,1,1
219303,renal,1,1
219304,transplant,1,1
219305,recipients,1,1
219306,",",1,1
219307,10,1,1
219308,receiving,1,1
219309,cyclosporin,1,0
219310,",",1,1
219311,10,1,1
219312,cyclosporin-prednisolone,1,0
219313,and,1,1
219314,nine,1,1
219315,azathioprine-prednisolone,1,1
219316,were,0,1
219317,supplemented,0,0
219318,in,0,0
219319,a,0,1
219320,double,0,0
219321,blind,0,1
219322,randomization,0,1
219323,cross-over,0,0
219324,study,0,1
219325,with,0,1
219326,fish,0,0
219327,oil,0,0
219328,and,0,0
219329,corn,0,0
219330,oil,0,0
219331,for,0,0
219332,a,0,0
219333,period,0,0
219334,of,0,0
219335,4,0,0
219336,months,0,1
219337,each,0,1
219338,.,0,1
219339,Erythrocyte,0,0
219340,deformability,0,0
219341,was,0,0
219342,reduced,0,0
219343,in,0,0
219344,the,0,0
219345,cyclosporin-treated,0,1
219346,patients,0,1
219347,and,0,1
219348,returned,0,1
219349,to,0,1
219350,normal,0,1
219351,values,0,0
219352,after,0,1
219353,supplementation,0,0
219354,of,0,0
219355,either,0,1
219356,oil,0,0
219357,.,0,0
219358,The,0,0
219359,oil,0,0
219360,supplementation,0,0
219361,resulted,0,0
219362,in,0,0
219363,an,0,0
219364,increased,0,0
219365,polyunsaturated,0,0
219366,fatty,0,0
219367,acid,0,0
219368,content,0,0
219369,in,0,0
219370,the,0,0
219371,plasma,0,0
219372,phospholipids,0,0
219373,.,0,1
219374,An,0,0
219375,increased,0,0
219376,erythrocyte,0,0
219377,membrane,0,0
219378,polyunsaturated,0,0
219379,fatty,0,0
219380,acid,0,0
219381,content,0,0
219382,might,0,0
219383,correct,0,0
219384,the,0,0
219385,lower,0,0
219386,erythrocyte,0,0
219387,deformability,0,0
219388,in,0,0
219389,cyclosporin,0,1
219390,treated,0,1
219391,patients,0,1
219392,.,0,1
219393,Therefore,0,0
219394,",",0,0
219395,it,0,0
219396,is,0,0
219397,probable,0,0
219398,that,0,0
219399,these,0,0
219400,changes,0,0
219401,are,0,0
219402,membrane-related,0,0
219403,.,0,1
219404,The,0,0
219405,oil,0,0
219406,supplementation,0,0
219407,had,0,1
219408,no,0,0
219409,effect,0,0
219410,on,0,0
219411,glomerular,0,0
219412,filtration,0,0
219413,rate,0,0
219414,",",0,0
219415,effective,0,0
219416,renal,0,1
219417,plasma,0,0
219418,flow,0,0
219419,",",0,0
219420,filtration,0,0
219421,fraction,0,1
219422,or,0,1
219423,blood,0,0
219424,pressure,0,0
219425,",",0,0
219426,which,0,0
219427,does,0,0
219428,not,0,0
219429,exclude,0,0
219430,effects,0,0
219431,of,0,0
219432,the,0,1
219433,cyclosporin-induced,0,1
219434,rigidified,0,0
219435,erythrocytes,0,0
219436,in,0,1
219437,the,0,1
219438,acute,0,1
219439,phase,0,1
219440,of,0,0
219441,renal,0,1
219442,transplantation,0,1
219443,.,0,1
219444,Decreased,0,0
219445,erythrocyte,0,0
219446,deformability,0,0
219447,could,0,0
219448,play,0,0
219449,a,0,0
219450,role,0,0
219451,in,0,0
219452,the,0,0
219453,cyclosporin-induced,0,0
219454,deterioration,0,0
219455,of,0,1
219456,renal,0,1
219457,haemodynamics,0,1
219458,.,0,1
219459,This,0,0
219460,may,0,0
219461,enhance,0,0
219462,the,0,0
219463,effects,0,0
219464,of,0,0
219465,endothelin,0,0
219466,",",0,0
219467,as,0,0
219468,these,0,0
219469,patients,0,1
219470,also,0,0
219471,had,0,1
219472,elevated,0,1
219473,endothelin,0,0
219474,levels,0,0
219475,.,0,1
219476,A,0,0
219477,preliminary,0,0
219478,trial,0,0
219479,of,0,0
219480,ascorbic,0,0
219481,acid,0,0
219482,as,0,0
219483,supplemental,0,1
219484,therapy,0,1
219485,for,0,1
219486,autism,1,1
219487,.,1,1
219488,1,0,0
219489,.,0,0
219490,This,0,0
219491,study,0,0
219492,presents,0,0
219493,the,0,0
219494,results,0,0
219495,of,0,0
219496,a,0,1
219497,30-week,0,1
219498,double-blind,0,0
219499,",",0,0
219500,placebo-controlled,0,0
219501,trial,0,0
219502,exploring,0,0
219503,the,0,0
219504,effectiveness,0,0
219505,of,0,0
219506,ascorbic,0,0
219507,acid,0,0
219508,(,0,1
219509,8g/70kg/day,0,1
219510,),0,1
219511,as,0,0
219512,a,0,1
219513,supplemental,0,1
219514,pharmacological,0,0
219515,treatment,0,1
219516,for,0,1
219517,autistic,1,1
219518,children,1,1
219519,in,1,1
219520,residential,1,1
219521,treatment,1,1
219522,.,1,1
219523,2,0,0
219524,.,0,1
219525,Residential,1,1
219526,school,1,1
219527,children,1,1
219528,(,1,1
219529,N,1,1
219530,=,1,1
219531,18,1,1
219532,),1,1
219533,were,0,1
219534,randomly,0,1
219535,assigned,0,1
219536,to,0,0
219537,either,0,1
219538,ascorbate-ascorbate-placebo,0,0
219539,treatment,0,0
219540,order,0,0
219541,group,0,1
219542,or,0,1
219543,ascorbate-placebo-ascorbate,0,0
219544,treatment,0,0
219545,order,0,0
219546,group,0,1
219547,.,0,1
219548,Each,0,0
219549,treatment,0,0
219550,phase,0,1
219551,lasted,0,1
219552,10,0,1
219553,weeks,0,1
219554,and,0,1
219555,behaviors,0,0
219556,were,0,1
219557,rated,0,1
219558,weekly,0,0
219559,using,0,0
219560,the,0,0
219561,Ritvo-Freeman,0,0
219562,scale,0,0
219563,.,0,1
219564,3,0,0
219565,.,0,1
219566,Significant,0,0
219567,group,0,0
219568,by,0,0
219569,phase,0,1
219570,interactions,0,0
219571,were,0,1
219572,found,0,0
219573,for,0,1
219574,total,0,1
219575,scores,0,0
219576,and,0,1
219577,also,0,0
219578,sensory,0,0
219579,motor,0,0
219580,scores,0,0
219581,indicating,0,0
219582,a,0,1
219583,reduction,0,0
219584,in,0,0
219585,symptom,0,1
219586,severity,0,0
219587,associated,0,0
219588,with,0,1
219589,the,0,0
219590,ascorbic,0,0
219591,acid,0,0
219592,treatment,0,1
219593,.,0,1
219594,4,0,0
219595,.,0,1
219596,These,0,1
219597,results,0,0
219598,were,0,1
219599,consistent,0,0
219600,with,0,1
219601,a,0,1
219602,hypothesized,0,0
219603,dopaminergic,0,0
219604,mechanism,0,0
219605,of,0,0
219606,action,0,0
219607,of,0,0
219608,ascorbic,0,0
219609,acid,0,0
219610,.,0,1
219611,Ovulation,0,0
219612,and,0,1
219613,follicular,0,1
219614,development,0,0
219615,associated,0,0
219616,with,0,1
219617,three,0,1
219618,low-dose,0,1
219619,oral,0,1
219620,contraceptives,0,1
219621,:,0,1
219622,a,0,1
219623,randomized,0,1
219624,controlled,0,0
219625,trial,0,1
219626,.,0,1
219627,OBJECTIVE,0,0
219628,To,0,0
219629,address,0,0
219630,the,0,0
219631,hypothesis,0,0
219632,that,0,0
219633,multiphasic,0,1
219634,oral,0,1
219635,contraceptives,0,1
219636,(,0,1
219637,OCs,0,1
219638,),0,1
219639,increase,0,0
219640,rather,0,0
219641,than,0,0
219642,decrease,0,0
219643,the,0,0
219644,risk,0,0
219645,of,0,0
219646,functional,0,1
219647,ovarian,0,1
219648,cysts,0,1
219649,.,0,1
219650,METHODS,0,0
219651,In,0,0
219652,this,0,0
219653,single-center,0,1
219654,",",0,0
219655,randomized,0,1
219656,controlled,0,0
219657,study,0,0
219658,",",0,1
219659,women,1,1
219660,were,0,1
219661,assigned,0,1
219662,to,0,0
219663,a,0,0
219664,multiphasic,0,1
219665,pill,0,0
219666,",",0,0
219667,a,0,0
219668,lower-dose,0,0
219669,monophasic,0,0
219670,pill,0,0
219671,",",0,0
219672,a,0,0
219673,higher-dose,0,0
219674,monophasic,0,0
219675,pill,0,0
219676,",",0,0
219677,or,0,1
219678,nonsteroidal,0,1
219679,contraception,0,1
219680,.,0,1
219681,Forty,1,1
219682,volunteers,1,1
219683,were,1,1
219684,randomized,1,1
219685,(,1,0
219686,ten,1,1
219687,each,1,0
219688,),1,0
219689,to,1,1
219690,three,1,0
219691,different,1,0
219692,pill,1,0
219693,regimens,1,0
219694,or,1,0
219695,to,1,0
219696,nonsteroidal,1,1
219697,contraception,1,1
219698,.,1,1
219699,During,0,0
219700,6,0,0
219701,months,0,1
219702,of,0,1
219703,treatment,0,1
219704,",",0,0
219705,follicular,0,1
219706,development,0,0
219707,was,0,0
219708,measured,0,0
219709,by,0,0
219710,vaginal,0,1
219711,ultrasonography,0,1
219712,and,0,1
219713,ovulation,0,1
219714,was,0,0
219715,indicated,0,0
219716,by,0,0
219717,serum,0,0
219718,progesterone,0,1
219719,levels,0,0
219720,.,0,1
219721,RESULTS,0,0
219722,The,0,0
219723,relative,0,0
219724,risk,0,0
219725,(,0,1
219726,RR,0,1
219727,),0,1
219728,of,0,0
219729,developing,0,1
219730,a,0,1
219731,follicular,0,1
219732,structure,0,0
219733,greater,0,0
219734,than,0,0
219735,30,0,1
219736,mm,0,1
219737,in,0,0
219738,diameter,0,0
219739,during,0,0
219740,a,0,0
219741,cycle,0,0
219742,with,0,1
219743,the,0,0
219744,higher-dose,0,0
219745,monophasic,0,0
219746,pill,0,0
219747,was,0,0
219748,0.5,0,0
219749,(,0,1
219750,95,0,0
219751,%,0,0
219752,confidence,0,0
219753,interval,0,0
219754,[,0,0
219755,CI,0,0
219756,],0,1
219757,0.1-1.9,0,0
219758,;,0,1
219759,P,0,0
219760,=,0,1
219761,.49,0,0
219762,),0,1
219763,compared,0,0
219764,with,0,1
219765,the,0,0
219766,multiphasic,0,1
219767,pill,0,0
219768,.,0,1
219769,The,0,0
219770,risk,0,0
219771,with,0,1
219772,the,0,0
219773,lower-dose,0,0
219774,monophasic,0,0
219775,pill,0,0
219776,was,0,0
219777,comparable,0,0
219778,to,0,0
219779,that,0,0
219780,with,0,1
219781,the,0,0
219782,multiphasic,0,1
219783,pill,0,0
219784,(,0,1
219785,RR,0,1
219786,1.3,0,0
219787,",",0,1
219788,95,0,0
219789,%,0,0
219790,CI,0,0
219791,0.5-3.6,0,1
219792,;,0,1
219793,P,0,0
219794,=,0,1
219795,.56,0,0
219796,),0,1
219797,.,0,1
219798,With,0,0
219799,the,0,0
219800,multiphasic,0,1
219801,pill,0,0
219802,",",0,0
219803,the,0,0
219804,maximum,0,0
219805,ovulation,0,1
219806,rate,0,0
219807,over,0,0
219808,60,0,1
219809,cycles,0,0
219810,was,0,0
219811,1.7,0,1
219812,per,0,1
219813,100,0,1
219814,cycles,0,0
219815,(,0,1
219816,95,0,0
219817,%,0,0
219818,CI,0,0
219819,0.0-8.9,0,0
219820,),0,1
219821,.,0,0
219822,CONCLUSION,0,0
219823,This,0,0
219824,multiphasic,0,0
219825,pill,0,0
219826,more,0,0
219827,closely,0,0
219828,resembled,0,0
219829,the,0,0
219830,lower-dose,0,0
219831,monophasic,0,0
219832,pill,0,0
219833,than,0,0
219834,the,0,0
219835,higher-dose,0,0
219836,monophasic,0,0
219837,pill,0,0
219838,in,0,0
219839,its,0,0
219840,suppression,0,0
219841,of,0,0
219842,follicular,0,1
219843,development,0,1
219844,.,0,1
219845,Enoxaparin,0,0
219846,in,0,0
219847,the,0,0
219848,prevention,0,1
219849,of,0,0
219850,deep,0,1
219851,venous,0,1
219852,thrombosis,0,1
219853,after,0,1
219854,major,1,1
219855,surgery,1,1
219856,:,1,1
219857,multicentric,0,1
219858,study,0,1
219859,.,0,1
219860,The,0,0
219861,Italian,1,1
219862,Study,1,1
219863,Group,1,1
219864,.,1,1
219865,DVT,0,0
219866,is,0,0
219867,a,0,0
219868,very,0,0
219869,frequent,0,0
219870,complication,0,0
219871,of,0,0
219872,general,0,1
219873,surgery,0,1
219874,.,0,1
219875,Heparin,0,0
219876,and,0,0
219877,",",0,0
219878,more,0,0
219879,recently,0,0
219880,",",0,0
219881,LMWHs,0,0
219882,can,0,0
219883,successfully,0,0
219884,prevent,0,0
219885,post,0,0
219886,surgical,0,1
219887,thromboembolism,0,1
219888,.,0,1
219889,One,1,1
219890,thousand,1,1
219891,one,1,1
219892,hundred,1,1
219893,and,1,1
219894,twenty-two,1,1
219895,patients,1,1
219896,(,1,1
219897,533,1,1
219898,males,1,1
219899,and,1,1
219900,589,1,1
219901,females,1,1
219902,;,1,1
219903,mean,1,1
219904,age,1,1
219905,62.2,1,1
219906,+/-,1,0
219907,11.4,1,0
219908,yrs,1,1
219909,),1,1
219910,were,1,0
219911,enrolled,1,1
219912,in,1,0
219913,a,1,1
219914,multicentre,1,0
219915,controlled,1,0
219916,study,1,0
219917,",",0,0
219918,to,0,0
219919,evaluate,0,0
219920,the,0,0
219921,efficacy,0,0
219922,and,0,0
219923,safety,0,0
219924,of,0,0
219925,enoxaparin,0,0
219926,in,0,0
219927,comparison,0,0
219928,to,0,0
219929,calcium,0,0
219930,heparin,0,0
219931,in,0,0
219932,the,0,0
219933,prevention,0,1
219934,of,0,0
219935,deep,0,1
219936,venous,0,1
219937,thrombosis,0,1
219938,(,0,1
219939,DVT,0,1
219940,),0,1
219941,following,0,0
219942,general,0,1
219943,surgery,0,1
219944,.,0,1
219945,Patients,0,1
219946,assigned,0,1
219947,to,0,1
219948,the,0,0
219949,enoxaparin,0,0
219950,and,0,0
219951,the,0,0
219952,calcium,0,0
219953,heparin,0,0
219954,groups,0,1
219955,received,0,1
219956,1,0,1
219957,daily,0,0
219958,dose,0,0
219959,of,0,1
219960,20,0,1
219961,mg,0,1
219962,(,0,1
219963,2000,0,1
219964,I.U,0,1
219965,.,0,1
219966,),0,0
219967,and,0,0
219968,2,0,1
219969,daily,0,0
219970,doses,0,0
219971,of,0,1
219972,0.2,0,1
219973,ml,0,0
219974,(,0,1
219975,5000,0,1
219976,I.U,0,1
219977,.,0,1
219978,),0,0
219979,",",0,0
219980,respectively,0,0
219981,starting,0,0
219982,2,0,1
219983,hours,0,0
219984,before,0,1
219985,the,0,1
219986,operation,0,1
219987,.,0,1
219988,Both,0,0
219989,drugs,0,0
219990,were,0,1
219991,given,0,0
219992,by,0,0
219993,subcutaneous,0,1
219994,route,0,1
219995,.,0,1
219996,A,0,0
219997,Doppler,0,0
219998,or,0,1
219999,Duplex,0,0
220000,Scan,0,1
220001,diagnosis,0,1
220002,of,0,0
220003,DVT,0,1
220004,was,0,0
220005,made,0,0
220006,in,0,1
220007,3,0,1
220008,(,0,1
220009,0.5,0,0
220010,%,0,0
220011,),0,1
220012,patients,0,1
220013,in,0,1
220014,the,0,0
220015,enoxaparin,0,0
220016,group,0,1
220017,(,0,1
220018,2,0,1
220019,cases,0,1
220020,during,0,1
220021,treatment,0,1
220022,and,0,1
220023,1,0,0
220024,patient,0,1
220025,at,0,0
220026,the,0,0
220027,end,0,0
220028,of,0,0
220029,treatment,0,1
220030,),0,1
220031,and,0,1
220032,in,0,1
220033,6,0,1
220034,(,0,1
220035,1.1,0,0
220036,%,0,0
220037,),0,1
220038,patients,0,1
220039,in,0,1
220040,the,0,0
220041,calcium,0,0
220042,heparin,0,0
220043,group,0,1
220044,(,0,1
220045,5,0,1
220046,cases,0,1
220047,during,0,1
220048,treatment,0,1
220049,and,0,1
220050,1,0,0
220051,",",0,0
220052,bilateral,0,0
220053,",",0,0
220054,after,0,0
220055,the,0,0
220056,end,0,0
220057,of,0,0
220058,treatment,0,1
220059,),0,1
220060,.,0,1
220061,Pulmonary,0,0
220062,embolism,0,1
220063,(,0,1
220064,PE,0,1
220065,),0,1
220066,was,0,0
220067,ascertained,0,1
220068,by,0,0
220069,angiography,0,1
220070,in,0,1
220071,1,0,1
220072,patient,0,1
220073,(,0,1
220074,0.18,0,0
220075,%,0,0
220076,),0,1
220077,in,0,0
220078,the,0,0
220079,enoxaparin,0,0
220080,group,0,0
220081,and,0,1
220082,in,0,1
220083,2,0,1
220084,patients,0,1
220085,(,0,1
220086,0.36,0,0
220087,%,0,0
220088,),0,1
220089,in,0,0
220090,the,0,0
220091,calcium,0,0
220092,heparin,0,0
220093,one,0,1
220094,.,0,1
220095,Hemorrhagic,0,0
220096,complications,0,0
220097,occurred,0,0
220098,in,0,1
220099,29,0,1
220100,patients,0,1
220101,(,0,1
220102,5.2,0,0
220103,%,0,0
220104,),0,1
220105,in,0,0
220106,the,0,0
220107,enoxaparin,0,0
220108,group,0,0
220109,and,0,1
220110,in,0,1
220111,34,0,1
220112,(,0,1
220113,6.1,0,1
220114,%,0,0
220115,),0,1
220116,in,0,0
220117,the,0,0
220118,calcium,0,0
220119,heparin,0,0
220120,group,0,1
220121,.,0,1
220122,Haematomas,0,0
220123,located,0,0
220124,in,0,0
220125,the,0,0
220126,injection,0,0
220127,site,0,0
220128,were,0,0
220129,reported,0,0
220130,in,0,1
220131,16.1,0,0
220132,%,0,0
220133,and,0,1
220134,25.3,0,1
220135,%,0,0
220136,in,0,0
220137,the,0,0
220138,enoxaparin,0,0
220139,and,0,0
220140,calcium,0,0
220141,heparin,0,0
220142,groups,0,0
220143,respectively,0,0
220144,(,0,1
220145,p,0,0
220146,=,0,1
220147,0.0001,0,0
220148,),0,1
220149,.,0,1
220150,Local,0,0
220151,pain,0,1
220152,in,0,0
220153,the,0,0
220154,injection,0,0
220155,site,0,0
220156,at,0,0
220157,the,0,0
220158,5th,0,1
220159,day,0,0
220160,of,0,0
220161,treatment,0,0
220162,was,0,0
220163,reported,0,0
220164,in,0,1
220165,8.4,0,0
220166,%,0,0
220167,and,0,1
220168,16.6,0,0
220169,%,0,0
220170,in,0,0
220171,the,0,0
220172,enoxaparin,0,0
220173,and,0,0
220174,calcium,0,0
220175,heparin,0,0
220176,groups,0,0
220177,respectively,0,0
220178,(,0,1
220179,p,0,0
220180,=,0,1
220181,0.0001,0,0
220182,),0,1
220183,.,0,1
220184,(,0,0
220185,ABSTRACT,0,0
220186,TRUNCATED,0,1
220187,AT,0,1
220188,250,0,1
220189,WORDS,0,1
220190,),0,1
220191,The,0,0
220192,incidence,0,0
220193,of,0,0
220194,first-dose,0,0
220195,hypotension,0,0
220196,with,0,1
220197,quinapril,0,0
220198,in,0,1
220199,patients,1,1
220200,with,1,1
220201,mild,1,1
220202,to,1,1
220203,moderate,1,1
220204,hypertension,1,1
220205,.,1,0
220206,A,1,0
220207,total,1,1
220208,of,1,0
220209,2242,1,1
220210,patients,1,1
220211,with,1,1
220212,mild,1,1
220213,to,1,1
220214,moderate,1,1
220215,hypertension,1,1
220216,(,1,0
220217,diastolic,1,1
220218,pressure,1,1
220219,95-120,1,0
220220,mmHg,1,0
220221,),1,1
220222,were,0,0
220223,randomised,0,0
220224,on,0,0
220225,a,0,1
220226,double-blind,0,0
220227,basis,0,0
220228,to,0,0
220229,receive,0,1
220230,a,0,0
220231,single,0,0
220232,dose,0,0
220233,of,0,0
220234,placebo,0,0
220235,",",0,1
220236,5,0,0
220237,mg,0,0
220238,quinapril,0,0
220239,or,0,1
220240,10,0,1
220241,mg,0,1
220242,quinapril,0,0
220243,.,0,1
220244,Patients,1,1
220245,were,1,1
220246,identified,1,1
220247,who,1,1
220248,:,1,1
220249,(,1,1
220250,a,1,1
220251,),1,0
220252,met,1,1
220253,the,1,0
220254,blood,1,0
220255,pressure,1,0
220256,(,1,1
220257,BP,1,1
220258,),1,1
220259,criteria,1,1
220260,for,1,1
220261,first-dose,1,0
220262,hypotension,1,1
220263,(,1,1
220264,sitting,1,0
220265,or,1,1
220266,standing,1,0
220267,systolic,1,1
220268,BP,1,1
220269,<,1,0
220270,100,1,1
220271,mmHg,1,0
220272,",",1,0
220273,or,1,0
220274,a,1,0
220275,fall,1,0
220276,in,1,0
220277,systolic,1,1
220278,BP,1,1
220279,>,1,1
220280,or,1,1
220281,=,1,1
220282,20,1,1
220283,mmHg,1,0
220284,on,1,0
220285,standing,1,0
220286,),1,1
220287,;,1,1
220288,(,1,1
220289,b,1,1
220290,),1,1
220291,had,1,1
220292,symptoms,1,0
220293,suggestive,1,0
220294,of,1,1
220295,hypotension,1,1
220296,;,1,1
220297,and,1,0
220298,(,1,1
220299,c,1,1
220300,),1,1
220301,met,1,1
220302,the,1,0
220303,BP,1,1
220304,criteria,1,1
220305,and,1,1
220306,had,1,1
220307,symptoms,1,0
220308,.,1,1
220309,In,0,0
220310,all,0,0
220311,three,0,0
220312,classifications,0,0
220313,there,0,0
220314,were,0,0
220315,no,0,0
220316,statistically,0,0
220317,significant,0,0
220318,differences,0,0
220319,between,0,0
220320,the,0,1
220321,incidences,0,0
220322,in,0,0
220323,placebo,0,1
220324,and,0,1
220325,combined,0,0
220326,active,0,1
220327,treatment,0,1
220328,groups,0,0
220329,",",0,0
220330,or,0,1
220331,between,0,0
220332,those,0,0
220333,in,0,0
220334,the,0,0
220335,two,0,0
220336,quinapril,0,0
220337,groups,0,1
220338,.,0,1
220339,No,0,0
220340,associated,0,0
220341,serious,0,0
220342,adverse,0,0
220343,events,0,0
220344,were,0,1
220345,reported,0,1
220346,.,0,1
220347,In,0,0
220348,the,0,0
220349,low-risk,1,1
220350,population,1,1
220351,studied,0,1
220352,",",0,0
220353,it,0,0
220354,would,0,0
220355,appear,0,0
220356,that,0,0
220357,the,0,0
220358,incidence,0,0
220359,of,0,0
220360,first-dose,0,0
220361,hypotension,0,0
220362,with,0,1
220363,quinapril,0,0
220364,is,0,0
220365,similar,0,0
220366,to,0,0
220367,placebo,0,0
220368,and,0,0
220369,is,0,0
220370,not,0,0
220371,dose-related,0,0
220372,.,0,1
220373,Granulocyte-macrophage,0,0
220374,colony-stimulating,0,1
220375,factor,0,0
220376,(,0,1
220377,GM-CSF,0,0
220378,),0,0
220379,allows,0,0
220380,acceleration,0,0
220381,and,0,0
220382,dose,0,0
220383,intensity,0,0
220384,increase,0,0
220385,of,0,0
220386,CEF,0,1
220387,chemotherapy,0,1
220388,:,0,1
220389,a,0,0
220390,randomised,0,0
220391,study,0,1
220392,in,0,1
220393,patients,1,1
220394,with,1,1
220395,advanced,1,1
220396,breast,1,1
220397,cancer,1,1
220398,.,1,1
220399,A,0,0
220400,randomised,0,0
220401,study,0,1
220402,was,0,0
220403,conducted,0,1
220404,in,0,1
220405,62,1,1
220406,patients,1,1
220407,with,1,1
220408,advanced,1,1
220409,breast,1,1
220410,cancer,1,1
220411,to,0,0
220412,assess,0,0
220413,whether,0,0
220414,granulocyte-macrophage,0,0
220415,colony-stimulating,0,1
220416,factor,0,0
220417,(,0,1
220418,GM-CSF,0,0
220419,),0,1
220420,would,0,0
220421,yield,0,0
220422,an,0,0
220423,increase,0,0
220424,in,0,0
220425,the,0,0
220426,dose,0,0
220427,intensity,0,0
220428,of,0,0
220429,a,0,1
220430,standard-dose,0,0
220431,CEF,0,1
220432,regimen,0,0
220433,through,0,1
220434,an,0,1
220435,acceleration,0,0
220436,of,0,0
220437,chemotherapy,0,1
220438,administration,0,0
220439,.,0,1
220440,Patients,0,1
220441,received,0,1
220442,CEF,0,1
220443,(,0,1
220444,cyclophosphamide,0,1
220445,600,0,1
220446,mg,0,0
220447,m-2,0,1
220448,",",0,0
220449,epidoxorubicin,0,0
220450,60,0,1
220451,mg,0,0
220452,m-2,0,1
220453,and,0,1
220454,fluorouracil,0,0
220455,600,0,1
220456,mg,0,1
220457,m-2,0,1
220458,),0,1
220459,i.v,0,0
220460,.,0,1
220461,on,0,0
220462,day,0,0
220463,1,0,1
220464,or,0,1
220465,the,0,0
220466,same,0,0
220467,chemotherapy,0,1
220468,",",0,0
220469,plus,0,0
220470,GM-CSF,0,1
220471,10,0,1
220472,micrograms,0,1
220473,kg-1,0,1
220474,s.c.,0,1
220475,starting,0,1
220476,from,0,1
220477,day,0,0
220478,4,0,0
220479,",",0,0
220480,repeated,0,0
220481,as,0,0
220482,soon,0,0
220483,as,0,0
220484,haematopoietic,0,1
220485,recovery,0,0
220486,from,0,1
220487,nadir,0,1
220488,occurred,0,0
220489,.,0,1
220490,Patients,0,1
220491,in,0,0
220492,the,0,1
220493,CEF,0,1
220494,+,0,0
220495,GM-CSF,0,1
220496,group,0,1
220497,received,0,0
220498,chemotherapy,0,1
220499,at,0,0
220500,a,0,1
220501,median,0,0
220502,interval,0,0
220503,of,0,1
220504,16,0,1
220505,days,0,0
220506,compared,0,0
220507,with,0,1
220508,20,0,1
220509,days,0,0
220510,in,0,1
220511,the,0,0
220512,control,0,1
220513,group,0,0
220514,.,0,1
220515,This,0,0
220516,led,0,0
220517,to,0,0
220518,a,0,0
220519,significant,0,0
220520,increase,0,0
220521,(,0,1
220522,P,0,0
220523,=,0,1
220524,0.02,0,0
220525,),0,1
220526,in,0,0
220527,the,0,0
220528,dose,0,0
220529,intensity,0,0
220530,actually,0,0
220531,administered,0,0
220532,in,0,0
220533,the,0,0
220534,third,0,1
220535,",",0,0
220536,fourth,0,1
220537,and,0,1
220538,sixth,0,1
220539,cycles,0,0
220540,:,0,1
220541,+28,0,0
220542,%,0,0
220543,",",0,1
220544,+25,0,0
220545,%,0,0
220546,",",0,1
220547,+20,0,0
220548,%,0,0
220549,respectively,0,0
220550,.,0,1
220551,Non-haematological,0,0
220552,toxicity,0,0
220553,was,0,0
220554,mild,0,1
220555,.,0,1
220556,GM-CSF,0,0
220557,had,0,1
220558,to,0,0
220559,be,0,0
220560,reduced,0,0
220561,or,0,1
220562,suspended,0,1
220563,in,0,1
220564,50,0,1
220565,%,0,0
220566,of,0,1
220567,patients,0,1
220568,because,0,1
220569,of,0,1
220570,toxicity,0,0
220571,.,0,1
220572,Haematological,0,0
220573,toxicity,0,0
220574,",",0,0
220575,mainly,0,0
220576,cumulative,0,0
220577,anaemia,0,1
220578,and,0,0
220579,thrombocytopenia,0,1
220580,",",0,0
220581,was,0,0
220582,manageable,0,0
220583,.,0,1
220584,An,0,0
220585,increase,0,0
220586,in,0,0
220587,response,0,0
220588,rate,0,0
220589,for,0,0
220590,patients,0,1
220591,with,0,1
220592,measurable,0,0
220593,disease,0,1
220594,",",0,0
220595,of,0,0
220596,borderline,0,1
220597,statistical,0,0
220598,significance,0,0
220599,(,0,1
220600,P,0,0
220601,=,0,1
220602,0.088,0,0
220603,",",0,0
220604,P,0,0
220605,for,0,0
220606,trend,0,0
220607,=,0,1
220608,0.018,0,0
220609,),0,1
220610,",",0,1
220611,from,0,1
220612,42,0,1
220613,%,0,0
220614,in,0,0
220615,the,0,0
220616,CEF,0,1
220617,group,0,1
220618,to,0,1
220619,69,0,1
220620,%,0,0
220621,in,0,0
220622,the,0,0
220623,CEF,0,1
220624,+,0,0
220625,GM-CSF,0,0
220626,group,0,1
220627,",",0,0
220628,was,0,0
220629,observed,0,0
220630,.,0,1
220631,This,0,0
220632,randomised,0,0
220633,trial,0,0
220634,indicates,0,0
220635,that,0,0
220636,GM-CSF,0,0
220637,is,0,0
220638,useful,0,0
220639,for,0,0
220640,chemotherapy,0,1
220641,acceleration,0,0
220642,.,0,1
220643,Accelerated,0,0
220644,CEF,0,1
220645,+,0,0
220646,GM-CSF,0,0
220647,is,0,0
220648,a,0,0
220649,moderately,0,0
220650,dose-intensive,0,0
220651,regimen,0,0
220652,that,0,0
220653,can,0,0
220654,be,0,0
220655,administered,0,0
220656,in,0,0
220657,an,0,0
220658,outpatient,0,1
220659,clinic,0,1
220660,and,0,0
220661,is,0,0
220662,associated,0,0
220663,with,0,1
220664,a,0,1
220665,high,0,1
220666,objective,0,0
220667,response,0,0
220668,.,0,1
220669,A,0,0
220670,comparison,0,0
220671,of,0,0
220672,seven,1,1
220673,antiarrhythmic,1,1
220674,drugs,1,0
220675,in,1,1
220676,patients,1,1
220677,with,1,1
220678,ventricular,1,1
220679,tachyarrhythmias,1,1
220680,.,1,1
220681,Electrophysiologic,0,0
220682,Study,0,0
220683,versus,0,0
220684,Electrocardiographic,0,1
220685,Monitoring,0,0
220686,Investigators,0,1
220687,.,0,1
220688,BACKGROUND,0,0
220689,The,0,0
220690,relative,0,0
220691,efficacies,0,0
220692,of,0,1
220693,various,0,1
220694,antiarrhythmic,0,1
220695,drugs,0,0
220696,in,0,1
220697,the,0,0
220698,treatment,0,0
220699,of,0,0
220700,ventricular,0,1
220701,tachyarrhythmias,0,1
220702,are,0,0
220703,not,0,0
220704,well,0,0
220705,known,0,0
220706,.,0,0
220707,This,0,0
220708,study,0,0
220709,examined,0,0
220710,the,0,0
220711,effectiveness,0,0
220712,of,0,0
220713,imipramine,0,0
220714,",",0,0
220715,mexiletine,0,0
220716,",",0,0
220717,pirmenol,0,0
220718,",",0,0
220719,procainamide,0,0
220720,",",0,0
220721,propafenone,0,0
220722,",",0,0
220723,quinidine,0,0
220724,",",0,0
220725,and,0,0
220726,sotalol,0,1
220727,in,0,0
220728,patients,1,1
220729,with,1,1
220730,ventricular,1,1
220731,tachyarrhythmias,1,1
220732,who,0,1
220733,were,0,1
220734,enrolled,0,1
220735,in,0,0
220736,the,0,0
220737,Electrophysiologic,0,0
220738,Study,0,0
220739,versus,0,0
220740,Electrocardiographic,0,1
220741,Monitoring,0,0
220742,trial,0,1
220743,.,0,1
220744,METHODS,0,0
220745,Patients,1,1
220746,were,0,1
220747,randomly,0,1
220748,assigned,0,1
220749,to,0,0
220750,undergo,0,1
220751,serial,0,1
220752,testing,0,0
220753,of,0,0
220754,the,0,0
220755,efficacy,0,0
220756,of,0,0
220757,the,0,0
220758,seven,0,1
220759,antiarrhythmic,0,0
220760,drugs,0,0
220761,by,0,1
220762,one,0,1
220763,of,0,1
220764,two,0,1
220765,strategies,0,0
220766,:,0,1
220767,electrophysiologic,0,1
220768,study,0,1
220769,or,0,1
220770,Holter,0,1
220771,monitoring,0,0
220772,together,0,0
220773,with,0,1
220774,exercise,0,0
220775,testing,0,0
220776,.,0,1
220777,The,0,0
220778,seven,0,1
220779,drugs,0,0
220780,were,0,1
220781,then,0,0
220782,tested,0,0
220783,for,0,0
220784,efficacy,0,0
220785,in,0,1
220786,random,0,1
220787,order,0,0
220788,in,0,1
220789,patients,0,1
220790,who,0,1
220791,were,0,1
220792,eligible,0,1
220793,to,0,0
220794,receive,0,1
220795,them,0,0
220796,.,0,1
220797,The,0,0
220798,frequencies,0,0
220799,of,0,1
220800,predictions,0,0
220801,of,0,1
220802,drug,0,1
220803,efficacy,0,0
220804,and,0,0
220805,of,0,0
220806,adverse,0,0
220807,drug,0,1
220808,effects,0,0
220809,during,0,1
220810,the,0,1
220811,initial,0,0
220812,drug,0,0
220813,titration,0,0
220814,were,0,0
220815,tabulated,0,0
220816,for,0,0
220817,all,0,1
220818,486,1,1
220819,randomized,1,1
220820,subjects,1,1
220821,.,1,1
220822,Patients,0,1
220823,received,0,1
220824,long-term,0,0
220825,treatment,0,0
220826,with,0,1
220827,the,0,0
220828,first,0,0
220829,antiarrhythmic,0,0
220830,drug,0,1
220831,that,0,0
220832,was,0,0
220833,predicted,0,0
220834,to,0,0
220835,be,0,0
220836,effective,0,0
220837,on,0,0
220838,the,0,0
220839,basis,0,0
220840,of,0,0
220841,drug,0,1
220842,testing,0,1
220843,.,0,1
220844,Recurrences,0,0
220845,of,0,0
220846,arrhythmia,0,1
220847,",",0,1
220848,deaths,0,0
220849,",",0,0
220850,and,0,1
220851,adverse,0,0
220852,drug,0,1
220853,effects,0,0
220854,during,0,1
220855,long-term,0,1
220856,follow-up,0,1
220857,were,0,1
220858,recorded,0,0
220859,for,0,0
220860,the,0,1
220861,296,1,1
220862,patients,1,1
220863,in,0,1
220864,whom,0,1
220865,an,0,1
220866,antiarrhythmic,0,1
220867,drug,0,0
220868,was,0,0
220869,predicted,0,0
220870,to,0,0
220871,be,0,0
220872,effective,0,0
220873,.,0,1
220874,RESULTS,0,0
220875,In,0,0
220876,the,0,0
220877,electrophysiologic-study,0,0
220878,group,0,0
220879,",",0,0
220880,the,0,0
220881,percentage,0,0
220882,of,0,1
220883,patients,0,1
220884,who,0,1
220885,had,0,1
220886,predictions,0,1
220887,of,0,1
220888,drug,0,1
220889,efficacy,0,0
220890,was,0,0
220891,higher,0,0
220892,with,0,1
220893,sotalol,0,1
220894,(,0,1
220895,35,0,1
220896,percent,0,1
220897,),0,1
220898,than,0,0
220899,with,0,1
220900,the,0,1
220901,other,0,1
220902,drugs,0,0
220903,(,0,1
220904,16,0,1
220905,percent,0,1
220906,",",0,1
220907,P,0,0
220908,<,0,0
220909,0.001,0,0
220910,),0,0
220911,.,0,0
220912,There,0,0
220913,was,0,0
220914,no,0,0
220915,significant,0,0
220916,difference,0,0
220917,among,0,1
220918,the,0,0
220919,drugs,0,0
220920,in,0,0
220921,the,0,1
220922,Holter-monitoring,0,0
220923,group,0,1
220924,.,0,1
220925,The,0,0
220926,percentage,0,0
220927,of,0,0
220928,patients,0,1
220929,with,0,1
220930,adverse,0,0
220931,drug,0,1
220932,effects,0,0
220933,was,0,0
220934,lowest,0,0
220935,among,0,0
220936,those,0,1
220937,receiving,0,1
220938,sotalol,0,0
220939,.,0,1
220940,The,0,0
220941,actuarial,0,0
220942,probability,0,0
220943,of,0,0
220944,a,0,0
220945,recurrence,0,0
220946,of,0,0
220947,arrhythmia,0,1
220948,after,0,0
220949,a,0,0
220950,prediction,0,0
220951,of,0,0
220952,drug,0,0
220953,efficacy,0,0
220954,by,0,0
220955,either,0,1
220956,strategy,0,0
220957,was,0,0
220958,significantly,0,0
220959,lower,0,0
220960,for,0,0
220961,patients,0,1
220962,treated,0,1
220963,with,0,1
220964,sotalol,0,1
220965,than,0,1
220966,for,0,1
220967,patients,0,1
220968,treated,0,1
220969,with,0,1
220970,the,0,0
220971,other,0,1
220972,drugs,0,0
220973,(,0,1
220974,risk,0,1
220975,ratio,0,0
220976,",",0,1
220977,0.43,0,0
220978,;,0,1
220979,95,0,0
220980,percent,0,1
220981,confidence,0,0
220982,interval,0,0
220983,",",0,1
220984,0.29,0,0
220985,to,0,1
220986,0.62,0,0
220987,;,0,1
220988,P,0,0
220989,<,0,0
220990,0.001,0,0
220991,),0,1
220992,.,0,1
220993,With,0,0
220994,sotalol,0,0
220995,",",0,0
220996,as,0,0
220997,compared,0,0
220998,with,0,1
220999,the,0,0
221000,other,0,1
221001,drugs,0,0
221002,combined,0,0
221003,",",0,0
221004,there,0,0
221005,were,0,0
221006,lower,0,0
221007,risks,0,0
221008,of,0,0
221009,death,0,0
221010,from,0,1
221011,any,0,0
221012,cause,0,0
221013,(,0,0
221014,risk,0,0
221015,ratio,0,0
221016,",",0,1
221017,0.50,0,0
221018,;,0,1
221019,95,0,0
221020,percent,0,1
221021,confidence,0,0
221022,interval,0,0
221023,",",0,1
221024,0.30,0,0
221025,to,0,1
221026,0.80,0,0
221027,;,0,1
221028,P,0,0
221029,=,0,1
221030,0.004,0,0
221031,),0,1
221032,",",0,0
221033,death,0,0
221034,from,0,1
221035,cardiac,0,1
221036,causes,0,0
221037,",",0,1
221038,(,0,1
221039,0.50,0,0
221040,;,0,1
221041,P,0,0
221042,=,0,1
221043,0.02,0,0
221044,),0,1
221045,",",0,0
221046,and,0,0
221047,death,0,0
221048,from,0,1
221049,arrhythmia,0,1
221050,(,0,1
221051,0.50,0,0
221052,;,0,1
221053,P,0,0
221054,=,0,1
221055,0.04,0,0
221056,),0,1
221057,.,0,1
221058,The,0,0
221059,cumulative,0,0
221060,percentage,0,0
221061,of,0,1
221062,patients,0,1
221063,in,0,1
221064,whom,0,1
221065,a,0,1
221066,drug,0,1
221067,was,0,0
221068,predicted,0,0
221069,to,0,0
221070,be,0,0
221071,effective,0,0
221072,and,0,1
221073,in,0,1
221074,whom,0,1
221075,it,0,1
221076,remained,0,1
221077,effective,0,0
221078,and,0,1
221079,tolerated,0,0
221080,was,0,0
221081,higher,0,0
221082,for,0,0
221083,sotalol,0,0
221084,than,0,0
221085,for,0,0
221086,the,0,1
221087,other,0,1
221088,drugs,0,0
221089,(,0,1
221090,P,0,0
221091,<,0,0
221092,0.001,0,0
221093,),0,1
221094,.,0,1
221095,CONCLUSIONS,0,0
221096,Sotalol,0,0
221097,was,0,0
221098,more,0,0
221099,effective,0,0
221100,than,0,0
221101,the,0,0
221102,other,0,0
221103,six,0,1
221104,antiarrhythmic,0,1
221105,drugs,0,0
221106,in,0,1
221107,preventing,0,0
221108,death,0,0
221109,and,0,1
221110,recurrences,0,0
221111,of,0,1
221112,arrhythmia,0,1
221113,.,0,1
221114,In,0,0
221115,patients,0,1
221116,similar,0,0
221117,to,0,1
221118,those,0,0
221119,in,0,0
221120,this,0,0
221121,study,0,0
221122,",",0,0
221123,if,0,0
221124,antiarrhythmic-drug,0,0
221125,therapy,0,0
221126,is,0,0
221127,to,0,0
221128,be,0,0
221129,used,0,0
221130,to,0,0
221131,prevent,0,0
221132,recurrences,0,0
221133,of,0,1
221134,ventricular,0,1
221135,tachyarrhythmias,0,1
221136,",",0,1
221137,treatment,0,0
221138,with,0,1
221139,sotalol,0,1
221140,and,0,0
221141,assessment,0,0
221142,of,0,0
221143,its,0,0
221144,potential,0,0
221145,efficacy,0,0
221146,by,0,0
221147,Holter,0,1
221148,monitoring,0,0
221149,are,0,0
221150,a,0,0
221151,reasonable,0,0
221152,initial,0,1
221153,strategy,0,0
221154,.,0,1
221155,A,0,0
221156,comparison,0,0
221157,of,0,0
221158,the,0,0
221159,effectiveness,0,0
221160,and,0,0
221161,patient,0,1
221162,tolerance,0,1
221163,of,0,0
221164,oral,0,0
221165,sodium,0,0
221166,phosphate,0,0
221167,",",0,0
221168,castor,0,0
221169,oil,0,0
221170,",",0,0
221171,and,0,0
221172,standard,0,1
221173,electrolyte,0,0
221174,lavage,0,1
221175,for,0,0
221176,colonoscopy,1,1
221177,or,1,1
221178,sigmoidoscopy,1,1
221179,preparation,1,1
221180,.,1,1
221181,One,1,1
221182,hundred,1,1
221183,thirteen,1,1
221184,patients,1,1
221185,were,0,1
221186,randomized,0,1
221187,to,0,0
221188,receive,0,1
221189,either,0,0
221190,oral,0,0
221191,sodium,0,0
221192,phosphate,0,0
221193,(,0,1
221194,Fleet,0,1
221195,Phospho-Soda,0,1
221196,),0,1
221197,",",0,0
221198,lemon-flavored,0,0
221199,castor,0,0
221200,oil,0,0
221201,(,0,1
221202,Purge,0,1
221203,),0,1
221204,",",0,0
221205,or,0,1
221206,standard,0,1
221207,polyethylene,0,0
221208,glycol-based,0,0
221209,lavage,0,1
221210,solution,0,0
221211,(,0,1
221212,GoLYTELY,0,0
221213,),0,1
221214,before,0,0
221215,elective,0,1
221216,colonoscopy,0,1
221217,.,0,1
221218,The,0,0
221219,study,0,0
221220,purpose,0,0
221221,was,0,0
221222,to,0,0
221223,confirm,0,0
221224,the,0,0
221225,efficacy,0,0
221226,of,0,0
221227,oral,0,0
221228,sodium,0,0
221229,phosphate,0,0
221230,and,0,0
221231,extend,0,1
221232,observations,0,0
221233,to,0,0
221234,include,0,0
221235,castor,0,0
221236,oil,0,0
221237,.,0,1
221238,Overall,0,0
221239,",",0,0
221240,patients,0,1
221241,reported,0,1
221242,that,0,0
221243,sodium,0,0
221244,phosphate,0,0
221245,and,0,0
221246,castor,0,0
221247,oil,0,0
221248,were,0,1
221249,easier,0,0
221250,to,0,0
221251,complete,0,0
221252,(,0,1
221253,p,0,0
221254,<,0,0
221255,0.05,0,0
221256,),0,1
221257,.,0,1
221258,Scores,0,0
221259,for,0,0
221260,cleansing,0,1
221261,the,0,0
221262,entire,0,0
221263,colon,0,1
221264,as,0,0
221265,determined,0,0
221266,by,0,1
221267,endoscopists,0,1
221268,who,0,1
221269,were,0,1
221270,blinded,0,1
221271,to,0,0
221272,the,0,0
221273,cathartic,0,0
221274,agent,0,0
221275,were,0,1
221276,highest,0,0
221277,in,0,1
221278,patients,0,1
221279,receiving,0,1
221280,sodium,0,0
221281,phosphate,0,0
221282,(,0,1
221283,p,0,0
221284,<,0,0
221285,0.02,0,0
221286,),0,1
221287,.,0,1
221288,Scores,0,0
221289,of,0,0
221290,left-colon,0,1
221291,cleansing,0,0
221292,for,0,0
221293,flexible,0,0
221294,sigmoidoscopy,0,1
221295,were,0,1
221296,equally,0,0
221297,high,0,1
221298,for,0,0
221299,the,0,1
221300,three,0,1
221301,methods,0,1
221302,.,0,1
221303,Scores,0,0
221304,for,0,0
221305,taste,0,0
221306,and,0,1
221307,symptom,0,1
221308,side,0,0
221309,effects,0,0
221310,were,0,1
221311,similar,0,0
221312,for,0,0
221313,each,0,1
221314,preparation,0,0
221315,.,0,0
221316,There,0,0
221317,were,0,0
221318,no,0,0
221319,recognized,0,1
221320,signs,0,1
221321,or,0,1
221322,symptoms,0,1
221323,of,0,0
221324,hypocalcemia,0,1
221325,in,0,0
221326,the,0,0
221327,sodium,0,0
221328,phosphate,0,0
221329,group,0,1
221330,.,0,1
221331,Because,0,0
221332,of,0,0
221333,the,0,0
221334,low,0,0
221335,cost,0,0
221336,of,0,0
221337,oral,0,0
221338,sodium,0,0
221339,phosphate,0,0
221340,combined,0,0
221341,with,0,1
221342,the,0,0
221343,lowest,0,0
221344,repeat,0,0
221345,endoscopy,0,1
221346,rate,0,0
221347,for,0,0
221348,inadequate,0,1
221349,cleansing,0,0
221350,",",0,1
221351,patient,0,1
221352,savings,0,0
221353,were,0,1
221354,projected,0,0
221355,to,0,0
221356,be,0,0
221357,$,0,0
221358,5000,0,1
221359,per,0,1
221360,100,0,1
221361,patients,0,1
221362,at,0,1
221363,this,0,0
221364,center,0,1
221365,.,0,1
221366,Oral,0,0
221367,sodium,0,0
221368,phosphate,0,0
221369,is,0,0
221370,a,0,0
221371,cost-effective,0,0
221372,colonoscopy,0,1
221373,preparation,0,0
221374,that,0,0
221375,is,0,0
221376,better,0,0
221377,tolerated,0,0
221378,and,0,0
221379,more,0,0
221380,effective,0,0
221381,than,0,0
221382,the,0,0
221383,polyethylene,0,0
221384,glycol-electrolyte,0,0
221385,lavage,0,1
221386,solution,0,0
221387,or,0,1
221388,castor,0,0
221389,oil,0,0
221390,.,0,1
221391,Video,0,0
221392,rating,0,0
221393,analysis,0,0
221394,of,0,0
221395,effect,0,0
221396,of,0,0
221397,maprotiline,0,1
221398,in,0,1
221399,patients,1,1
221400,with,1,1
221401,dementia,1,1
221402,and,1,1
221403,depression,1,1
221404,.,1,1
221405,In,0,0
221406,patients,1,1
221407,with,1,1
221408,dementia,1,1
221409,and,1,1
221410,mild,1,1
221411,depression,1,1
221412,(,1,1
221413,DSM-III-R,1,0
221414,290.21,1,0
221415,),1,1
221416,",",0,0
221417,the,0,0
221418,effect,0,0
221419,of,0,0
221420,low,0,1
221421,doses,0,0
221422,of,0,1
221423,the,0,1
221424,antidepressant,0,1
221425,maprotiline,0,1
221426,(,0,1
221427,up,0,1
221428,to,0,1
221429,75,0,1
221430,mg/d,0,0
221431,),0,1
221432,was,0,0
221433,examined,0,0
221434,.,0,1
221435,The,0,0
221436,main,0,0
221437,parameter,0,0
221438,was,0,0
221439,a,0,0
221440,video,0,0
221441,rating,0,0
221442,of,0,0
221443,global,0,0
221444,impression,0,0
221445,.,0,1
221446,The,0,0
221447,Mini-Mental,0,0
221448,State,0,0
221449,Examination,0,1
221450,(,0,1
221451,MMS,0,1
221452,),0,1
221453,and,0,0
221454,the,0,0
221455,Geriatric,0,1
221456,Depression,0,0
221457,Scale,0,1
221458,(,0,1
221459,GDS,0,0
221460,),0,1
221461,were,0,1
221462,applied,0,0
221463,to,0,0
221464,evaluate,0,0
221465,the,0,0
221466,effect,0,0
221467,of,0,0
221468,maprotiline,0,1
221469,on,0,0
221470,cognitive,0,1
221471,and,0,1
221472,depressive,0,1
221473,symptoms,0,1
221474,.,0,1
221475,The,0,0
221476,double-blind,0,0
221477,",",0,0
221478,placebo-controlled,0,0
221479,trial,0,0
221480,was,0,0
221481,of,0,1
221482,eight,0,1
221483,weeks,0,1
221484,',0,1
221485,duration,0,0
221486,and,0,1
221487,included,0,1
221488,127,1,1
221489,patients,1,1
221490,",",0,1
221491,randomized,0,1
221492,in,0,1
221493,two,0,1
221494,groups,0,1
221495,.,0,1
221496,The,0,0
221497,antidepressant,0,0
221498,effect,0,0
221499,of,0,0
221500,maprotiline,0,1
221501,was,0,0
221502,reflected,0,0
221503,in,0,0
221504,the,0,0
221505,GDS,0,0
221506,.,0,0
221507,There,0,0
221508,was,0,0
221509,",",0,0
221510,however,0,0
221511,",",0,0
221512,no,0,0
221513,indication,0,0
221514,of,0,0
221515,an,0,0
221516,effect,0,0
221517,of,0,0
221518,maprotiline,0,1
221519,on,0,0
221520,cognitive,0,1
221521,performance,0,0
221522,.,0,1
221523,The,0,0
221524,global,0,0
221525,impression,0,0
221526,",",0,0
221527,evaluated,0,0
221528,by,0,0
221529,video,0,0
221530,rating,0,0
221531,",",0,0
221532,gave,0,0
221533,no,0,0
221534,indication,0,0
221535,as,0,0
221536,to,0,0
221537,a,0,1
221538,beneficial,0,0
221539,effect,0,0
221540,of,0,0
221541,the,0,0
221542,treatment,0,0
221543,.,0,1
221544,-,0,0
221545,The,0,0
221546,video,0,0
221547,analysis,0,0
221548,showed,0,0
221549,a,0,0
221550,significant,0,0
221551,interrater,0,0
221552,reliability,0,0
221553,.,0,1
221554,The,0,0
221555,discrepancy,0,0
221556,between,0,0
221557,the,0,0
221558,results,0,0
221559,of,0,0
221560,the,0,0
221561,video,0,0
221562,rating,0,0
221563,and,0,0
221564,the,0,0
221565,GDS,0,0
221566,is,0,0
221567,discussed,0,0
221568,.,0,0
221569,-,0,0
221570,The,0,0
221571,results,0,0
221572,confirm,0,0
221573,similar,0,0
221574,findings,0,0
221575,of,0,1
221576,other,0,1
221577,authors,0,1
221578,;,0,1
221579,i.e.,0,0
221580,",",0,0
221581,that,0,0
221582,a,0,0
221583,sedating,0,0
221584,antidepressant,0,0
221585,with,0,1
221586,some,0,0
221587,anticholinergic,0,0
221588,effects,0,0
221589,can,0,0
221590,not,0,0
221591,be,0,0
221592,expected,0,0
221593,to,0,0
221594,improve,0,0
221595,cognitive,0,0
221596,functions,0,0
221597,despite,0,1
221598,its,0,0
221599,antidepressant,0,1
221600,effect,0,0
221601,.,0,1
221602,The,0,0
221603,main,0,0
221604,interest,0,0
221605,of,0,0
221606,this,0,0
221607,study,0,0
221608,",",0,0
221609,however,0,0
221610,",",0,0
221611,lies,0,0
221612,in,0,0
221613,its,0,0
221614,methodology,0,0
221615,(,0,1
221616,video,0,0
221617,analysis,0,0
221618,),0,1
221619,.,0,1
221620,Radiation-induced,0,1
221621,brachial,0,1
221622,plexopathy,0,1
221623,:,0,1
221624,neurological,0,0
221625,follow-up,0,0
221626,in,0,1
221627,161,1,1
221628,recurrence-free,1,0
221629,breast,1,1
221630,cancer,1,1
221631,patients,1,1
221632,.,1,1
221633,PURPOSE,0,0
221634,The,0,0
221635,purpose,0,0
221636,was,0,0
221637,to,0,0
221638,assess,0,0
221639,the,0,0
221640,incidence,0,0
221641,and,0,0
221642,clinical,0,0
221643,manifestations,0,1
221644,of,0,1
221645,radiation-induced,0,1
221646,brachial,0,1
221647,plexopathy,0,1
221648,in,0,0
221649,breast,1,1
221650,cancer,1,1
221651,patients,1,1
221652,",",1,1
221653,treated,1,1
221654,according,1,0
221655,to,1,0
221656,the,1,0
221657,Danish,1,1
221658,Breast,1,1
221659,Cancer,1,1
221660,Cooperative,1,1
221661,Group,1,1
221662,protocols,1,0
221663,.,1,0
221664,METHODS,0,0
221665,AND,0,0
221666,MATERIALS,0,1
221667,One,1,1
221668,hundred,1,1
221669,and,1,1
221670,sixty-one,1,1
221671,recurrence-free,1,0
221672,breast,1,1
221673,cancer,1,1
221674,patients,1,1
221675,were,1,1
221676,examined,1,0
221677,for,1,0
221678,radiation-induced,1,0
221679,brachial,1,1
221680,plexopathy,1,1
221681,after,1,0
221682,a,1,1
221683,median,1,0
221684,follow-up,1,0
221685,period,1,1
221686,of,1,1
221687,50,1,1
221688,months,1,1
221689,(,1,1
221690,13-99,1,1
221691,months,1,1
221692,),1,1
221693,.,1,1
221694,After,0,0
221695,total,0,1
221696,mastectomy,0,1
221697,and,0,1
221698,axillary,0,1
221699,node,0,1
221700,sampling,0,0
221701,",",0,1
221702,high-risk,1,1
221703,patients,1,1
221704,were,0,1
221705,randomized,0,1
221706,to,0,0
221707,adjuvant,0,1
221708,therapy,0,0
221709,.,0,1
221710,One,0,1
221711,hundred,0,1
221712,twenty-eight,0,1
221713,patients,0,1
221714,were,0,1
221715,treated,0,1
221716,with,0,1
221717,postoperative,0,0
221718,radiotherapy,0,1
221719,with,0,1
221720,50,0,1
221721,Gy,0,1
221722,in,0,1
221723,25,0,1
221724,daily,0,0
221725,fractions,0,1
221726,over,0,1
221727,5,0,1
221728,weeks,0,1
221729,.,0,1
221730,In,0,0
221731,addition,0,0
221732,",",0,1
221733,82,0,1
221734,of,0,0
221735,these,0,0
221736,patients,0,1
221737,received,0,1
221738,cytotoxic,0,1
221739,therapy,0,0
221740,(,0,1
221741,cyclophosphamide,0,1
221742,",",0,0
221743,methotrexate,0,0
221744,",",0,0
221745,and,0,0
221746,5-fluorouracil,0,0
221747,),0,1
221748,and,0,1
221749,46,0,1
221750,received,0,1
221751,tamoxifen,0,1
221752,.,0,1
221753,RESULTS,0,0
221754,Five,0,1
221755,percent,0,1
221756,and,0,1
221757,9,0,0
221758,%,0,0
221759,of,0,0
221760,the,0,0
221761,patients,0,1
221762,receiving,0,1
221763,radiotherapy,0,1
221764,had,0,1
221765,disabling,0,1
221766,and,0,1
221767,mild,0,1
221768,radiation-induced,0,0
221769,brachial,0,1
221770,plexopathy,0,1
221771,",",0,0
221772,respectively,0,0
221773,.,0,1
221774,Radiation-induced,0,0
221775,brachial,0,1
221776,plexopathy,0,1
221777,was,0,0
221778,more,0,0
221779,frequent,0,0
221780,in,0,0
221781,patients,0,1
221782,receiving,0,1
221783,cytotoxic,0,1
221784,therapy,0,1
221785,(,0,1
221786,p,0,0
221787,=,0,1
221788,0.04,0,0
221789,),0,1
221790,and,0,0
221791,in,0,1
221792,younger,0,1
221793,patients,0,1
221794,(,0,1
221795,p,0,0
221796,=,0,1
221797,0.04,0,0
221798,),0,1
221799,.,0,1
221800,The,0,0
221801,clinical,0,0
221802,manifestations,0,1
221803,were,0,1
221804,paraesthesia,0,1
221805,(,0,1
221806,100,0,1
221807,%,0,0
221808,),0,1
221809,",",0,0
221810,hypaesthesia,0,0
221811,(,0,1
221812,74,0,1
221813,%,0,0
221814,),0,1
221815,",",0,0
221816,weakness,0,0
221817,(,0,1
221818,58,0,1
221819,%,0,0
221820,),0,1
221821,",",0,0
221822,decreased,0,0
221823,muscle,0,0
221824,stretch,0,0
221825,reflexes,0,0
221826,(,0,1
221827,47,0,1
221828,%,0,0
221829,),0,1
221830,",",0,0
221831,and,0,0
221832,pain,0,1
221833,(,0,1
221834,47,0,1
221835,%,0,0
221836,),0,1
221837,.,0,0
221838,CONCLUSION,0,0
221839,The,0,0
221840,brachial,0,0
221841,plexus,0,0
221842,is,0,0
221843,more,0,0
221844,vulnerable,0,0
221845,to,0,0
221846,large,0,1
221847,fraction,0,1
221848,size,0,1
221849,.,0,1
221850,Fractions,0,0
221851,of,0,1
221852,2,0,1
221853,Gy,0,1
221854,or,0,1
221855,less,0,0
221856,are,0,0
221857,advisable,0,0
221858,.,0,1
221859,Cytotoxic,0,0
221860,therapy,0,0
221861,adds,0,0
221862,to,0,0
221863,the,0,0
221864,damaging,0,0
221865,effect,0,0
221866,of,0,0
221867,radiotherapy,0,1
221868,.,0,1
221869,Peripheral,0,0
221870,nerves,0,0
221871,in,0,1
221872,younger,1,1
221873,patients,1,1
221874,seems,0,0
221875,more,0,0
221876,vulnerable,0,0
221877,.,0,0
221878,Radiation-induced,0,0
221879,brachial,0,0
221880,plexopathy,0,1
221881,occurs,0,0
221882,mainly,0,0
221883,as,0,0
221884,diffuse,0,1
221885,damage,0,0
221886,to,0,0
221887,the,0,0
221888,brachial,0,1
221889,plexus,0,1
221890,.,0,1
221891,Subcutaneous,0,1
221892,low-molecular-weight,0,0
221893,heparin,0,0
221894,compared,0,0
221895,with,0,1
221896,continuous,0,0
221897,intravenous,0,1
221898,unfractionated,0,1
221899,heparin,0,0
221900,in,0,0
221901,the,0,0
221902,treatment,0,0
221903,of,0,0
221904,proximal,1,1
221905,deep,1,1
221906,vein,1,1
221907,thrombosis,1,1
221908,.,1,0
221909,BACKGROUND,0,0
221910,A,0,0
221911,low-molecular-weight,0,0
221912,heparin,0,0
221913,",",0,0
221914,enoxaparin,0,0
221915,sodium,0,0
221916,",",0,0
221917,has,0,0
221918,been,0,0
221919,shown,0,0
221920,to,0,0
221921,be,0,0
221922,effective,0,0
221923,and,0,0
221924,safe,0,0
221925,in,0,0
221926,preventing,0,0
221927,deep,1,1
221928,vein,1,1
221929,thrombosis,1,1
221930,both,1,0
221931,in,1,0
221932,general,1,1
221933,surgery,1,1
221934,and,1,1
221935,in,1,0
221936,high-risk,1,1
221937,orthopedic,1,1
221938,surgery,1,1
221939,.,1,1
221940,We,0,0
221941,conducted,0,0
221942,a,0,0
221943,controlled,0,0
221944,",",0,0
221945,randomized,0,0
221946,trial,0,0
221947,with,0,1
221948,enoxaparin,0,0
221949,in,0,0
221950,the,0,0
221951,treatment,0,0
221952,of,0,0
221953,established,0,1
221954,deep,0,1
221955,vein,0,1
221956,thrombosis,0,1
221957,.,0,1
221958,METHODS,0,0
221959,In,0,0
221960,a,0,1
221961,multicenter,0,0
221962,trial,0,0
221963,",",0,0
221964,we,0,0
221965,compared,0,0
221966,fixed-dose,0,0
221967,subcutaneous,0,1
221968,enoxaparin,0,0
221969,",",0,0
221970,given,0,0
221971,twice,0,0
221972,daily,0,0
221973,",",0,0
221974,with,0,1
221975,adjusted-dose,0,0
221976,intravenous,0,1
221977,unfractionated,0,1
221978,heparin,0,0
221979,(,0,1
221980,UFH,0,1
221981,),0,1
221982,given,0,0
221983,by,0,0
221984,continuous,0,0
221985,intravenous,0,1
221986,infusion,0,0
221987,for,0,0
221988,the,0,0
221989,initial,0,1
221990,10,0,1
221991,days,0,0
221992,of,0,1
221993,treatment,0,1
221994,of,0,1
221995,patients,1,1
221996,with,1,1
221997,proximal,1,1
221998,vein,1,1
221999,thrombosis,1,1
222000,.,1,1
222001,The,0,0
222002,primary,0,0
222003,efficacy,0,0
222004,outcome,0,0
222005,was,0,0
222006,the,0,0
222007,change,0,0
222008,of,0,0
222009,the,0,0
222010,size,0,0
222011,of,0,0
222012,the,0,0
222013,thrombus,0,0
222014,assessed,0,0
222015,by,0,0
222016,repeated,0,0
222017,venograms,0,1
222018,between,0,1
222019,day,0,1
222020,0,0,0
222021,and,0,1
222022,day,0,1
222023,10,0,1
222024,.,0,1
222025,The,0,0
222026,primary,0,0
222027,analysis,0,0
222028,of,0,0
222029,safety,0,0
222030,was,0,0
222031,based,0,1
222032,on,0,0
222033,the,0,0
222034,incidence,0,0
222035,of,0,0
222036,major,0,1
222037,bleeding,0,1
222038,during,0,1
222039,10,0,1
222040,days,0,0
222041,of,0,1
222042,treatment,0,1
222043,.,0,0
222044,RESULTS,0,0
222045,There,1,0
222046,were,1,0
222047,67,1,0
222048,patients,1,1
222049,in,1,1
222050,each,1,1
222051,group,1,1
222052,.,1,1
222053,Venographic,0,0
222054,assessment,0,0
222055,of,0,0
222056,clot,0,0
222057,size,0,0
222058,evolution,0,0
222059,between,0,0
222060,day,0,0
222061,0,0,0
222062,and,0,1
222063,day,0,0
222064,10,0,1
222065,showed,0,0
222066,a,0,0
222067,statistically,0,0
222068,significant,0,0
222069,superiority,0,0
222070,(,0,1
222071,P,0,0
222072,<,0,0
222073,.002,0,0
222074,),0,1
222075,of,0,0
222076,enoxaparin,0,0
222077,over,0,0
222078,the,0,0
222079,reference,0,0
222080,treatment,0,0
222081,with,0,1
222082,UFH,0,1
222083,.,0,1
222084,Moreover,0,0
222085,",",0,0
222086,the,0,0
222087,incidence,0,0
222088,of,0,0
222089,overall,0,0
222090,recurrent,0,1
222091,thromboembolic,0,1
222092,events,0,0
222093,during,0,1
222094,10,0,1
222095,days,0,0
222096,of,0,1
222097,treatment,0,1
222098,was,0,0
222099,significantly,0,0
222100,higher,0,0
222101,(,0,0
222102,P,0,0
222103,<,0,0
222104,.002,0,0
222105,),0,1
222106,in,0,0
222107,the,0,0
222108,UFH,0,0
222109,group,0,1
222110,(,0,1
222111,seven,0,1
222112,of,0,1
222113,67,0,1
222114,),0,1
222115,than,0,0
222116,in,0,0
222117,the,0,0
222118,enoxaparin,0,0
222119,group,0,1
222120,(,0,1
222121,one,0,1
222122,of,0,1
222123,67,0,1
222124,),0,1
222125,.,0,0
222126,There,0,0
222127,were,0,0
222128,no,0,0
222129,serious,0,0
222130,bleeding,0,1
222131,complications,0,0
222132,in,0,1
222133,either,0,1
222134,group,0,1
222135,.,0,1
222136,CONCLUSIONS,0,0
222137,Enoxaparin,0,0
222138,is,0,0
222139,at,0,0
222140,least,0,0
222141,as,0,0
222142,effective,0,0
222143,and,0,1
222144,safe,0,0
222145,as,0,0
222146,UFH,0,1
222147,under,0,1
222148,the,0,0
222149,conditions,0,0
222150,of,0,0
222151,this,0,0
222152,study,0,0
222153,.,0,0
222154,Moreover,0,0
222155,",",0,0
222156,it,0,0
222157,is,0,0
222158,more,0,0
222159,comfortable,0,0
222160,for,0,0
222161,patients,0,1
222162,and,0,1
222163,less,0,0
222164,time-consuming,0,0
222165,for,0,0
222166,nurses,0,1
222167,and,0,1
222168,laboratories,0,1
222169,.,0,1
222170,Thus,0,1
222171,",",0,0
222172,our,0,0
222173,study,0,0
222174,confirmed,0,0
222175,",",0,0
222176,with,0,1
222177,the,0,0
222178,use,0,0
222179,of,0,0
222180,enoxaparin,0,0
222181,",",0,1
222182,other,0,0
222183,observations,0,0
222184,that,0,0
222185,low-molecular-weight,0,0
222186,heparin,0,0
222187,provides,0,0
222188,a,0,0
222189,real,0,0
222190,therapeutic,0,0
222191,advance,0,1
222192,in,0,0
222193,the,0,0
222194,treatment,0,0
222195,of,0,0
222196,deep,1,1
222197,vein,1,1
222198,thrombosis,1,1
222199,.,1,1
222200,Effect,0,0
222201,of,0,0
222202,extradural,0,1
222203,analgesia,0,0
222204,on,0,0
222205,stress,0,1
222206,responses,0,0
222207,to,0,1
222208,abdominal,0,1
222209,surgery,0,1
222210,in,0,1
222211,infants,1,1
222212,.,1,1
222213,We,0,0
222214,studied,0,1
222215,40,1,1
222216,children,1,1
222217,younger,1,1
222218,than,1,1
222219,4,1,0
222220,yr,1,1
222221,having,1,1
222222,elective,1,1
222223,abdominal,1,1
222224,surgery,1,1
222225,under,1,1
222226,general,1,1
222227,anaesthesia,1,1
222228,supplemented,1,0
222229,with,1,1
222230,either,1,1
222231,systemic,1,0
222232,opioids,1,0
222233,or,1,1
222234,extradural,1,1
222235,bupivacaine,1,0
222236,.,1,1
222237,Venous,0,0
222238,blood,0,0
222239,samples,0,1
222240,were,0,1
222241,obtained,0,0
222242,before,0,0
222243,tracheal,0,1
222244,intubation,0,1
222245,to,0,0
222246,measure,0,0
222247,baseline,0,0
222248,concentrations,0,0
222249,of,0,1
222250,adrenaline,0,0
222251,",",0,0
222252,noradrenaline,0,0
222253,",",0,0
222254,glucose,0,0
222255,",",0,0
222256,ACTH,0,1
222257,and,0,0
222258,cortisol,0,0
222259,.,0,1
222260,Additional,0,0
222261,samples,0,1
222262,were,0,1
222263,obtained,0,0
222264,45,0,1
222265,min,0,0
222266,after,0,1
222267,the,0,0
222268,start,0,1
222269,of,0,0
222270,surgery,0,1
222271,",",0,0
222272,at,0,0
222273,the,0,0
222274,end,0,0
222275,of,0,0
222276,surgery,0,1
222277,",",0,1
222278,1,0,0
222279,h,0,0
222280,and,0,1
222281,24,0,1
222282,h,0,0
222283,after,0,0
222284,the,0,0
222285,end,0,0
222286,of,0,0
222287,surgery,0,1
222288,.,0,1
222289,Plasma,0,0
222290,concentrations,0,0
222291,of,0,1
222292,bupivacaine,0,0
222293,were,0,1
222294,measured,0,0
222295,also,0,0
222296,in,0,0
222297,the,0,0
222298,extradural,0,1
222299,group,0,0
222300,at,0,0
222301,each,0,0
222302,sampling,0,0
222303,time,0,0
222304,.,0,1
222305,Both,0,0
222306,techniques,0,0
222307,provided,0,0
222308,acceptable,0,0
222309,analgesia,0,0
222310,",",0,0
222311,but,0,0
222312,the,0,0
222313,perioperative,0,0
222314,increases,0,0
222315,in,0,1
222316,adrenaline,0,0
222317,",",0,0
222318,glucose,0,0
222319,and,0,0
222320,ACTH,0,1
222321,were,0,0
222322,significantly,0,0
222323,greater,0,0
222324,in,0,0
222325,the,0,0
222326,opioid,0,1
222327,group,0,1
222328,.,0,1
222329,Noradrenaline,0,0
222330,concentrations,0,0
222331,decreased,0,0
222332,to,0,1
222333,less,0,0
222334,than,0,0
222335,baseline,0,0
222336,values,0,0
222337,in,0,1
222338,the,0,1
222339,extradural,0,1
222340,group,0,1
222341,and,0,0
222342,were,0,0
222343,significantly,0,0
222344,less,0,0
222345,than,0,0
222346,in,0,0
222347,the,0,0
222348,opioid,0,1
222349,group,0,1
222350,.,0,1
222351,The,0,0
222352,perioperative,0,0
222353,increase,0,0
222354,in,0,0
222355,cortisol,0,0
222356,was,0,0
222357,similar,0,0
222358,in,0,0
222359,the,0,1
222360,two,0,0
222361,groups,0,0
222362,",",0,1
222363,despite,0,0
222364,the,0,0
222365,differences,0,0
222366,in,0,1
222367,ACTH,0,1
222368,responses,0,1
222369,.,0,1
222370,Most,0,0
222371,responses,0,0
222372,returned,0,1
222373,to,0,1
222374,the,0,0
222375,baseline,0,0
222376,values,0,0
222377,within,0,1
222378,24,0,1
222379,h.,0,1
222380,Plasma,0,1
222381,bupivacaine,0,0
222382,concentrations,0,0
222383,remained,0,0
222384,within,0,1
222385,safe,0,0
222386,limits,0,0
222387,during,0,1
222388,the,0,0
222389,study,0,0
222390,",",0,0
222391,but,0,0
222392,systemic,0,0
222393,concentrations,0,0
222394,increased,0,0
222395,in,0,0
222396,some,0,0
222397,of,0,0
222398,the,0,0
222399,patients,0,1
222400,during,0,0
222401,postoperative,0,1
222402,infusion,0,0
222403,with,0,1
222404,0.125,0,0
222405,%,0,0
222406,bupivacaine,0,0
222407,.,0,1
222408,Milk,0,0
222409,protein,0,0
222410,quantity,0,0
222411,and,0,0
222412,quality,0,0
222413,in,0,1
222414,low-birth-weight,1,1
222415,infants,1,1
222416,.,1,1
222417,IV,0,1
222418,.,0,1
222419,Effects,0,0
222420,on,0,0
222421,tyrosine,0,0
222422,and,0,0
222423,phenylalanine,0,0
222424,in,0,0
222425,plasma,0,0
222426,and,0,1
222427,urine,0,1
222428,.,0,1
222429,Well,0,0
222430,",",0,0
222431,appropriate-for-gestational,1,1
222432,age,1,1
222433,",",1,1
222434,low-birth-weight,1,1
222435,infants,1,1
222436,were,0,1
222437,divided,0,1
222438,into,0,1
222439,three,0,0
222440,gestational,0,1
222441,age,0,1
222442,groups,0,1
222443,and,0,1
222444,assigned,0,1
222445,randomly,0,1
222446,within,0,0
222447,each,0,0
222448,age,0,1
222449,group,0,1
222450,to,0,1
222451,one,0,1
222452,of,0,1
222453,five,0,1
222454,feeding,0,1
222455,regimens,0,0
222456,:,0,1
222457,pooled,0,0
222458,human,0,1
222459,milk,0,1
222460,(,0,1
222461,BM,0,1
222462,),0,1
222463,;,0,1
222464,formula,0,0
222465,1,0,1
222466,(,0,1
222467,F1,0,1
222468,),0,1
222469,=,0,1
222470,1.5,0,0
222471,gm/dl,0,0
222472,protein,0,0
222473,",",0,1
222474,60,0,1
222475,parts,0,1
222476,bovine,0,1
222477,whey,0,1
222478,proteins,0,1
222479,:,0,1
222480,40,0,1
222481,parts,0,1
222482,bovine,0,1
222483,caseins,0,1
222484,;,0,1
222485,F2,0,1
222486,=,0,1
222487,3.0,0,0
222488,gm/dl,0,0
222489,",",0,1
222490,60:40,0,0
222491,;,0,1
222492,F3,0,0
222493,=,0,1
222494,1.5,0,0
222495,gm/dl,0,0
222496,",",0,1
222497,18:82,0,1
222498,;,0,1
222499,F4,0,0
222500,=,0,1
222501,3.0,0,0
222502,gm/dl,0,0
222503,",",0,1
222504,18:82,0,1
222505,.,0,1
222506,Plasma,0,0
222507,and,0,0
222508,urine,0,1
222509,concentrations,0,0
222510,of,0,1
222511,tyrosine,0,0
222512,and,0,1
222513,phenylalanine,0,0
222514,were,0,0
222515,far,0,1
222516,higher,0,0
222517,in,0,0
222518,the,0,0
222519,infants,0,1
222520,fed,0,1
222521,F1,0,0
222522,to,0,1
222523,F4,0,0
222524,",",0,0
222525,especially,0,0
222526,F2,0,0
222527,and,0,0
222528,F4,0,0
222529,",",0,0
222530,than,0,0
222531,in,0,0
222532,the,0,1
222533,infants,0,1
222534,fed,0,1
222535,BM,0,1
222536,.,0,1
222537,These,0,0
222538,findings,0,0
222539,offer,0,0
222540,further,0,0
222541,evidence,0,0
222542,for,0,0
222543,the,0,0
222544,limited,0,0
222545,capacity,0,0
222546,of,0,0
222547,the,0,0
222548,low-birth-weight,0,1
222549,infant,0,1
222550,to,0,0
222551,catabolize,0,0
222552,tyrosine,0,0
222553,.,0,1
222554,Infants,0,1
222555,fed,0,1
222556,F3,0,0
222557,had,0,1
222558,significantly,0,0
222559,higher,0,0
222560,plasma,0,0
222561,tyrosine,0,0
222562,concentrations,0,0
222563,than,0,1
222564,infants,0,1
222565,fed,0,1
222566,F1,0,1
222567,",",0,0
222568,and,0,0
222569,those,0,0
222570,fed,0,0
222571,F4,0,0
222572,had,0,1
222573,higher,0,0
222574,concentrations,0,0
222575,than,0,0
222576,those,0,1
222577,fed,0,1
222578,F2,0,1
222579,.,0,1
222580,Thus,0,0
222581,",",0,0
222582,increased,0,0
222583,plasma,0,0
222584,tyrosine,0,0
222585,concentrations,0,0
222586,in,0,1
222587,low-birth-weight,0,1
222588,infants,0,1
222589,are,0,0
222590,related,0,0
222591,directly,0,0
222592,both,0,0
222593,to,0,0
222594,the,0,0
222595,quantity,0,0
222596,and,0,0
222597,to,0,0
222598,the,0,0
222599,quality,0,0
222600,of,0,0
222601,the,0,0
222602,protein,0,0
222603,in,0,0
222604,their,0,1
222605,diets,0,1
222606,.,0,1
222607,Ethanol-induced,0,1
222608,alterations,0,0
222609,in,0,1
222610,electroencephalographic,0,1
222611,activity,0,0
222612,in,0,1
222613,adult,1,1
222614,males,1,1
222615,.,1,1
222616,The,0,0
222617,present,0,0
222618,investigation,0,0
222619,examined,0,0
222620,the,0,0
222621,effects,0,0
222622,of,0,0
222623,placebo,0,1
222624,(,0,1
222625,P,0,0
222626,),0,1
222627,",",0,0
222628,low-dose,0,0
222629,(,0,1
222630,LD,0,1
222631,),0,1
222632,",",0,0
222633,and,0,0
222634,high-dose,0,0
222635,(,0,1
222636,HD,0,1
222637,),0,1
222638,ethanol,0,0
222639,on,0,0
222640,electroencephalographic,0,1
222641,(,1,1
222642,EEG,1,1
222643,),1,1
222644,activity,1,0
222645,in,1,1
222646,21,1,1
222647,healthy,1,1
222648,",",1,1
222649,adult,1,1
222650,males,1,1
222651,(,1,1
222652,X,1,1
222653,=,1,1
222654,22.7,1,0
222655,years,1,1
222656,),1,1
222657,.,1,1
222658,Only,0,0
222659,one,0,0
222660,condition,0,0
222661,(,0,1
222662,P,0,0
222663,",",0,0
222664,LD,0,0
222665,",",0,0
222666,or,0,1
222667,HD,0,1
222668,),0,1
222669,was,0,0
222670,presented,0,1
222671,per,0,0
222672,day,0,0
222673,and,0,0
222674,the,0,0
222675,condition,0,0
222676,order,0,0
222677,was,0,0
222678,randomized,0,1
222679,.,0,1
222680,For,0,0
222681,each,0,0
222682,subject,0,0
222683,",",0,0
222684,blood-alcohol,0,0
222685,levels,0,0
222686,measured,0,0
222687,via,0,1
222688,breathalyzer,0,0
222689,and,0,1
222690,EEG,0,1
222691,activity,0,0
222692,",",0,0
222693,using,0,0
222694,the,0,0
222695,entire,0,1
222696,10/20,0,1
222697,International,0,1
222698,System,0,1
222699,",",0,0
222700,were,0,0
222701,recorded,0,0
222702,both,0,0
222703,prior,0,1
222704,to,0,0
222705,and,0,1
222706,at,0,1
222707,intervals,0,0
222708,of,0,1
222709,35,0,1
222710,",",0,1
222711,70,0,1
222712,",",0,0
222713,105,0,1
222714,",",0,0
222715,and,0,1
222716,140,0,1
222717,minutes,0,0
222718,after,0,1
222719,P,0,0
222720,",",0,1
222721,LD,0,0
222722,",",0,0
222723,or,0,1
222724,HD,0,1
222725,administration,0,0
222726,.,0,1
222727,The,0,0
222728,Fast,0,1
222729,Fourier,0,0
222730,Transform,0,1
222731,was,0,0
222732,used,0,0
222733,to,0,0
222734,calculate,0,0
222735,power,0,0
222736,spectral,0,1
222737,densities,0,0
222738,for,0,1
222739,each,0,1
222740,EEG,0,1
222741,recording,0,0
222742,.,0,1
222743,Measures,0,0
222744,of,0,0
222745,the,0,1
222746,relative,0,0
222747,areas,0,0
222748,under,0,1
222749,the,0,0
222750,power,0,0
222751,spectral,0,1
222752,curve,0,0
222753,were,0,1
222754,made,0,0
222755,for,0,0
222756,each,0,0
222757,of,0,0
222758,the,0,0
222759,following,0,0
222760,frequency,0,0
222761,bands,0,1
222762,:,0,1
222763,slow,0,1
222764,alpha,0,0
222765,(,0,1
222766,7.5,0,0
222767,to,0,1
222768,10,0,1
222769,Hz,0,1
222770,),0,1
222771,;,0,1
222772,fast,0,0
222773,alpha,0,0
222774,(,0,1
222775,10.5,0,0
222776,to,0,1
222777,13.0,0,0
222778,Hz,0,1
222779,),0,1
222780,;,0,1
222781,slow,0,0
222782,beta,0,0
222783,(,0,1
222784,13.5,0,0
222785,to,0,1
222786,19.5,0,0
222787,Hz,0,1
222788,),0,1
222789,;,0,0
222790,and,0,0
222791,fast,0,0
222792,beta,0,0
222793,(,0,1
222794,20,0,1
222795,to,0,1
222796,26,0,1
222797,Hz,0,1
222798,),0,1
222799,at,0,1
222800,electrodes,0,0
222801,F3,0,1
222802,",",0,1
222803,F4,0,0
222804,",",0,0
222805,C3,0,1
222806,",",0,0
222807,C4,0,0
222808,",",0,0
222809,P3,0,1
222810,",",0,0
222811,P4,0,1
222812,",",0,0
222813,O1,0,0
222814,",",0,0
222815,and,0,0
222816,O2,0,1
222817,.,0,1
222818,Repeated-measures,0,0
222819,multivariate,0,0
222820,analysis,0,0
222821,of,0,0
222822,variance,0,0
222823,performed,0,0
222824,on,0,0
222825,normalized,0,0
222826,relative,0,0
222827,area,0,1
222828,values,0,0
222829,revealed,0,0
222830,that,0,0
222831,ethanol,0,0
222832,had,0,1
222833,significant,0,0
222834,effects,0,0
222835,on,0,1
222836,EEG,0,1
222837,activity,0,0
222838,at,0,1
222839,anterior,0,1
222840,sites,0,1
222841,:,0,1
222842,frontal,0,1
222843,(,0,1
222844,F3,0,0
222845,",",0,1
222846,F4,0,0
222847,),0,1
222848,and,0,1
222849,central,0,0
222850,(,0,1
222851,C3,0,1
222852,",",0,1
222853,C4,0,1
222854,),0,1
222855,that,0,0
222856,presented,0,1
222857,as,0,0
222858,increased,0,0
222859,activity,0,0
222860,in,0,0
222861,the,0,0
222862,slow,0,0
222863,alpha,0,0
222864,frequency,0,0
222865,band,0,1
222866,.,0,1
222867,These,0,0
222868,results,0,0
222869,suggest,0,0
222870,a,0,0
222871,differential,0,0
222872,responsivity,0,0
222873,of,0,0
222874,both,0,0
222875,cortical,0,1
222876,region,0,1
222877,and,0,1
222878,EEG,0,1
222879,frequency,0,0
222880,band,0,1
222881,to,0,1
222882,the,0,0
222883,effects,0,0
222884,of,0,0
222885,ethanol,0,0
222886,ingestion,0,1
222887,.,0,1
222888,Differential,0,1
222889,effects,0,0
222890,on,0,0
222891,bone,0,1
222892,density,0,0
222893,of,0,1
222894,progestogen-only,0,1
222895,methods,0,1
222896,for,0,1
222897,contraception,0,1
222898,in,0,1
222899,premenopausal,1,1
222900,women,1,1
222901,.,1,1
222902,The,0,0
222903,question,0,0
222904,of,0,0
222905,differential,0,1
222906,effects,0,0
222907,on,0,0
222908,bone,0,1
222909,density,0,0
222910,by,0,0
222911,two,0,1
222912,different,0,1
222913,types,0,1
222914,of,0,1
222915,progestogen-only,0,1
222916,methods,0,1
222917,for,0,1
222918,contraception,0,1
222919,in,0,1
222920,premenopausal,1,1
222921,women,1,1
222922,was,0,0
222923,addressed,0,0
222924,.,0,1
222925,Data,0,0
222926,from,0,1
222927,a,0,1
222928,prospective,0,1
222929,randomized,0,1
222930,clinical,0,0
222931,trial,0,1
222932,among,0,1
222933,22,1,1
222934,premenopausal,1,1
222935,women,1,1
222936,",",1,1
222937,age,1,1
222938,32.6,1,1
222939,(,1,1
222940,range,1,1
222941,20-45,1,1
222942,years,1,1
222943,),1,1
222944,",",0,1
222945,who,0,1
222946,were,0,1
222947,randomly,0,1
222948,assigned,0,1
222949,to,0,0
222950,either,0,1
222951,of,0,0
222952,two,0,0
222953,treatments,0,0
222954,with,0,1
222955,continuous,0,1
222956,progestogens,0,1
222957,for,0,1
222958,contraception,0,1
222959,were,0,1
222960,analyzed,0,0
222961,;,0,1
222962,depot-medroxyprogesterone,0,0
222963,acetate,0,0
222964,(,0,1
222965,DMPA,0,1
222966,),0,1
222967,or,0,1
222968,continuous,0,0
222969,levonorgestrel,0,1
222970,treatment,0,0
222971,with,0,1
222972,subdermal,0,1
222973,implants,0,1
222974,(,0,1
222975,Norplant,0,1
222976,),0,0
222977,",",0,0
222978,respectively,0,0
222979,.,0,1
222980,Forearm,0,0
222981,bone,0,0
222982,density,0,0
222983,(,0,1
222984,BMDprox,0,1
222985,),0,1
222986,increased,0,0
222987,with,0,1
222988,2.94,0,0
222989,%,0,0
222990,(,0,1
222991,p,0,0
222992,=,0,1
222993,0.006,0,0
222994,),0,1
222995,in,0,1
222996,women,0,1
222997,who,0,1
222998,were,0,1
222999,prescribed,0,1
223000,levonorgestrel,0,0
223001,",",0,0
223002,which,0,0
223003,was,0,0
223004,in,0,0
223005,contrast,0,1
223006,to,0,1
223007,stable,0,1
223008,values,0,0
223009,in,0,1
223010,those,0,1
223011,prescribed,0,0
223012,depot-medroxy-progesterone,0,0
223013,acetate,0,0
223014,;,0,1
223015,group,0,1
223016,difference,0,0
223017,at,0,1
223018,6,0,1
223019,months,0,1
223020,for,0,1
223021,BMDprox,0,1
223022,3.4,0,0
223023,%,0,0
223024,(,0,1
223025,95,0,0
223026,%,0,0
223027,CI,0,0
223028,1.3,0,0
223029,",",0,1
223030,5.5,0,1
223031,;,0,0
223032,p,0,0
223033,=,0,0
223034,0.025,0,0
223035,),0,0
223036,and,0,1
223037,BMDdist,0,1
223038,4.1,0,1
223039,%,0,0
223040,(,0,1
223041,95,0,0
223042,%,0,0
223043,CI,0,0
223044,-,0,1
223045,1.3,0,0
223046,",",0,1
223047,9.6,0,0
223048,;,0,0
223049,p,0,0
223050,=,0,0
223051,0.077,0,0
223052,),0,0
223053,.,0,1
223054,The,0,0
223055,changes,0,0
223056,in,0,0
223057,bone,0,1
223058,density,0,0
223059,were,0,1
223060,consistent,0,0
223061,with,0,1
223062,the,0,0
223063,changes,0,0
223064,in,0,1
223065,biochemical,0,1
223066,indices,0,0
223067,for,0,1
223068,bone,0,1
223069,metabolism,0,0
223070,;,0,1
223071,DMPA,0,1
223072,users,0,1
223073,showed,0,0
223074,signs,0,1
223075,of,0,1
223076,increased,0,0
223077,bone,0,1
223078,turnover,0,0
223079,and,0,1
223080,users,0,1
223081,of,0,1
223082,levonorgestrel,0,1
223083,showed,0,0
223084,increased,0,0
223085,bone,0,1
223086,formation,0,0
223087,with,0,1
223088,increased,0,0
223089,levels,0,0
223090,of,0,1
223091,both,0,0
223092,alkaline,0,0
223093,phosphatase,0,0
223094,(,0,1
223095,p,0,0
223096,=,0,1
223097,0.004,0,0
223098,),0,1
223099,and,0,1
223100,osteocalcin,0,0
223101,(,0,1
223102,p,0,0
223103,=,0,1
223104,0.007,0,0
223105,),0,1
223106,.,0,1
223107,The,0,0
223108,findings,0,0
223109,suggest,0,0
223110,an,0,0
223111,increase,0,0
223112,in,0,0
223113,bone,0,1
223114,density,0,0
223115,during,0,0
223116,treatment,0,0
223117,with,0,1
223118,levonorgestrel,0,1
223119,and,0,1
223120,stable,0,1
223121,values,0,0
223122,during,0,1
223123,short-term,0,0
223124,administration,0,0
223125,of,0,0
223126,DMPA,0,0
223127,",",0,1
223128,in,0,0
223129,standard,0,1
223130,clinical,0,1
223131,doses,0,0
223132,for,0,1
223133,contraception,0,1
223134,.,0,1
223135,Effect,0,0
223136,of,0,0
223137,dietary,0,0
223138,supplementation,0,0
223139,with,0,1
223140,n-3,0,0
223141,fatty,0,0
223142,acids,0,0
223143,on,0,1
223144,coronary,1,1
223145,artery,1,1
223146,bypass,1,1
223147,graft,1,1
223148,patency,1,0
223149,.,1,1
223150,Epidemiologic,0,1
223151,and,0,0
223152,experimental,0,1
223153,data,0,0
223154,suggest,0,0
223155,that,0,0
223156,a,0,1
223157,high,0,1
223158,dietary,0,0
223159,intake,0,0
223160,of,0,0
223161,long-chain,0,0
223162,polyunsaturated,0,0
223163,n-3,0,0
223164,fatty,0,0
223165,acids,0,0
223166,may,0,0
223167,reduce,0,0
223168,the,0,0
223169,risk,0,0
223170,of,0,0
223171,atherothrombotic,0,1
223172,disease,0,1
223173,.,0,1
223174,In,0,0
223175,a,0,0
223176,randomized,0,1
223177,",",0,0
223178,controlled,0,0
223179,study,0,0
223180,",",0,1
223181,610,1,1
223182,patients,1,1
223183,undergoing,1,1
223184,coronary,1,1
223185,artery,1,1
223186,bypass,1,1
223187,grafting,1,1
223188,were,0,0
223189,assigned,0,1
223190,either,0,0
223191,to,0,0
223192,a,0,0
223193,fish,0,0
223194,oil,0,0
223195,group,0,1
223196,",",0,0
223197,receiving,0,1
223198,4,0,0
223199,g/day,0,0
223200,of,0,0
223201,fish,0,0
223202,oil,0,0
223203,concentrate,0,0
223204,",",0,0
223205,or,0,0
223206,to,0,0
223207,a,0,0
223208,control,0,1
223209,group,0,0
223210,.,0,1
223211,All,1,1
223212,patients,1,1
223213,received,1,1
223214,antithrombotic,1,0
223215,treatment,1,0
223216,",",1,0
223217,either,1,0
223218,aspirin,1,0
223219,or,1,1
223220,warfarin,1,0
223221,.,1,1
223222,Their,0,1
223223,diet,0,0
223224,and,0,1
223225,serum,0,0
223226,phospholipid,0,0
223227,fatty,0,0
223228,acid,0,0
223229,profiles,0,0
223230,were,0,1
223231,monitored,0,0
223232,.,0,1
223233,The,0,0
223234,primary,0,0
223235,end,0,0
223236,point,0,0
223237,was,0,0
223238,1-year,0,0
223239,graft,0,1
223240,patency,0,0
223241,",",0,0
223242,which,0,0
223243,was,0,0
223244,assessed,0,0
223245,by,0,0
223246,angiography,0,1
223247,in,0,1
223248,95,0,0
223249,%,0,0
223250,of,0,1
223251,patients,0,1
223252,.,0,1
223253,Vein,0,0
223254,graft,0,1
223255,occlusion,0,1
223256,rates,0,0
223257,per,0,1
223258,distal,0,1
223259,anastomoses,0,1
223260,were,0,1
223261,27,0,1
223262,%,0,0
223263,in,0,0
223264,the,0,0
223265,fish,0,0
223266,oil,0,0
223267,group,0,1
223268,and,0,1
223269,33,0,1
223270,%,0,0
223271,in,0,0
223272,the,0,0
223273,control,0,1
223274,group,0,1
223275,(,0,1
223276,odds,0,0
223277,ratio,0,0
223278,0.77,0,0
223279,",",0,1
223280,95,0,0
223281,%,0,0
223282,confidence,0,0
223283,interval,0,0
223284,",",0,1
223285,0.60,0,0
223286,to,0,1
223287,0.99,0,0
223288,",",0,0
223289,p,0,0
223290,=,0,1
223291,0.034,0,0
223292,),0,1
223293,.,0,1
223294,In,0,0
223295,the,0,0
223296,fish,0,0
223297,oil,0,0
223298,group,0,1
223299,",",0,0
223300,43,0,1
223301,%,0,0
223302,of,0,0
223303,the,0,0
223304,patients,0,1
223305,had,0,1
223306,>,0,1
223307,or,0,1
223308,=,0,1
223309,1,0,0
223310,occluded,0,0
223311,vein,0,1
223312,graft,0,1
223313,(,0,1
223314,s,0,1
223315,),0,1
223316,compared,0,0
223317,with,0,1
223318,51,0,1
223319,%,0,0
223320,in,0,0
223321,the,0,0
223322,control,0,1
223323,group,0,1
223324,(,0,1
223325,odds,0,0
223326,ratio,0,0
223327,0.72,0,0
223328,",",0,1
223329,95,0,0
223330,%,0,0
223331,confidence,0,0
223332,interval,0,0
223333,",",0,1
223334,0.51,0,0
223335,to,0,1
223336,1.01,0,0
223337,",",0,0
223338,p,0,0
223339,=,0,1
223340,0.05,0,0
223341,),0,1
223342,.,0,1
223343,Moreover,0,0
223344,",",0,0
223345,in,0,0
223346,the,0,0
223347,entire,0,0
223348,patient,0,0
223349,group,0,0
223350,",",0,0
223351,there,0,0
223352,was,0,0
223353,a,0,0
223354,significant,0,0
223355,trend,0,0
223356,to,0,1
223357,fewer,0,0
223358,patients,0,1
223359,with,0,1
223360,vein,0,1
223361,graft,0,1
223362,occlusions,0,1
223363,with,0,1
223364,increasing,0,0
223365,relative,0,0
223366,change,0,0
223367,in,0,1
223368,serum,0,0
223369,phospholipid,0,0
223370,n-3,0,0
223371,fatty,0,0
223372,acids,0,0
223373,during,0,1
223374,the,0,0
223375,study,0,0
223376,period,0,0
223377,(,0,0
223378,p,0,0
223379,for,0,0
223380,linear,0,0
223381,trend,0,0
223382,=,0,0
223383,0.0037,0,0
223384,),0,0
223385,.,0,1
223386,Thus,0,0
223387,",",0,0
223388,in,0,0
223389,patients,1,1
223390,undergoing,1,1
223391,coronary,1,1
223392,artery,1,1
223393,bypass,1,1
223394,grafting,1,1
223395,",",0,0
223396,dietary,0,0
223397,supplementation,0,0
223398,with,0,1
223399,n-3,0,0
223400,fatty,0,0
223401,acids,0,0
223402,reduced,0,0
223403,the,0,0
223404,incidence,0,0
223405,of,0,0
223406,vein,0,1
223407,graft,0,1
223408,occlusion,0,1
223409,",",0,0
223410,and,0,0
223411,an,0,0
223412,inverse,0,0
223413,relation,0,0
223414,between,0,0
223415,relative,0,0
223416,change,0,0
223417,in,0,1
223418,serum,0,0
223419,phospholipid,0,0
223420,n-3,0,0
223421,fatty,0,0
223422,acids,0,0
223423,and,0,1
223424,vein,0,1
223425,graft,0,1
223426,occlusions,0,1
223427,was,0,0
223428,observed,0,0
223429,.,0,1
223430,Iobitridol,0,1
223431,300,0,1
223432,compared,0,0
223433,to,0,1
223434,iopromide,0,1
223435,300,0,1
223436,--,0,1
223437,a,0,1
223438,double-blind,0,0
223439,randomized,0,1
223440,phase-III,0,0
223441,study,0,1
223442,of,0,0
223443,clinical,0,0
223444,tolerance,0,1
223445,in,0,1
223446,total,1,1
223447,body,1,1
223448,CT.,1,1
223449,UNLABELLED,0,0
223450,PURPOSE,0,0
223451,",",0,1
223452,MATERIAL,0,1
223453,AND,0,0
223454,METHODS,0,0
223455,:,0,1
223456,The,0,0
223457,clinical,0,0
223458,safety,0,0
223459,of,0,1
223460,iobitriodol,0,0
223461,300,0,1
223462,mg,0,1
223463,I/ml,0,0
223464,and,0,0
223465,iopromide,0,1
223466,300,0,1
223467,mg,0,0
223468,I/ml,0,0
223469,were,0,1
223470,compared,0,0
223471,in,0,0
223472,a,0,1
223473,randomized,0,1
223474,double,0,0
223475,blind,0,1
223476,phase-III,0,1
223477,study,0,1
223478,conducted,0,1
223479,on,0,0
223480,60,1,1
223481,patients,1,1
223482,undergoing,1,1
223483,abdominal,1,1
223484,CT,1,1
223485,for,1,0
223486,a,1,0
223487,variety,1,0
223488,of,1,0
223489,indications,1,1
223490,.,1,1
223491,Each,0,0
223492,examination,0,0
223493,was,0,0
223494,rated,0,0
223495,as,0,0
223496,diagnostic,0,1
223497,or,0,1
223498,nondiagnostic,0,1
223499,and,0,0
223500,the,0,0
223501,image,0,0
223502,quality,0,0
223503,was,0,0
223504,noted,0,0
223505,.,0,1
223506,Nature,0,0
223507,",",0,0
223508,onset,0,0
223509,",",0,0
223510,intensity,0,0
223511,as,0,0
223512,well,0,0
223513,as,0,0
223514,outcome,0,0
223515,of,0,0
223516,each,0,0
223517,adverse,0,0
223518,reaction,0,0
223519,were,0,1
223520,recorded,0,0
223521,.,0,0
223522,RESULTS,0,0
223523,There,0,0
223524,was,0,0
223525,no,0,0
223526,significant,0,0
223527,difference,0,0
223528,in,0,0
223529,imaging,0,0
223530,quality,0,0
223531,and,0,1
223532,side,0,0
223533,effects,0,0
223534,between,0,0
223535,the,0,1
223536,contrast,0,1
223537,media,0,1
223538,.,0,1
223539,In,0,0
223540,this,0,0
223541,study,0,0
223542,",",0,0
223543,both,0,0
223544,iobitridol,0,0
223545,and,0,1
223546,iopromide,0,1
223547,provided,0,0
223548,excellent,0,0
223549,image,0,0
223550,quality,0,0
223551,and,0,0
223552,a,0,0
223553,low,0,0
223554,rate,0,0
223555,of,0,1
223556,side,0,0
223557,effects,0,0
223558,.,0,1
223559,CONCLUSION,0,0
223560,Iobitridol,0,0
223561,is,0,0
223562,a,0,0
223563,safe,0,0
223564,and,0,0
223565,effective,0,0
223566,nonionic,0,0
223567,contrast,0,1
223568,agent,0,0
223569,for,0,0
223570,contrast-enhanced,0,0
223571,body,0,1
223572,CT,0,1
223573,.,0,1
223574,Recovery,0,0
223575,profile,0,0
223576,after,0,0
223577,desflurane,0,0
223578,with,0,1
223579,or,0,1
223580,without,0,1
223581,ondansetron,0,0
223582,compared,0,0
223583,with,0,1
223584,propofol,0,0
223585,in,0,1
223586,patients,1,1
223587,undergoing,1,1
223588,outpatient,1,1
223589,gynecological,1,1
223590,laparoscopy,1,1
223591,.,1,1
223592,We,0,0
223593,studied,0,0
223594,the,0,0
223595,effect,0,0
223596,of,0,0
223597,combining,0,0
223598,prophylactic,0,1
223599,ondansetron,0,0
223600,(,0,1
223601,4,0,0
223602,mg,0,0
223603,intravenously,0,1
223604,[,0,0
223605,IV,0,1
223606,],0,1
223607,),0,1
223608,to,0,1
223609,desflurane-based,0,1
223610,anesthesia,0,1
223611,in,0,1
223612,90,1,1
223613,ASA,1,1
223614,grade,1,1
223615,I,1,1
223616,or,1,1
223617,11,1,1
223618,women,1,1
223619,undergoing,1,1
223620,outpatient,1,1
223621,gynecological,1,1
223622,laparoscopy,1,1
223623,.,1,1
223624,Recovery,0,0
223625,after,0,0
223626,anesthesia,0,0
223627,",",0,0
223628,with,0,1
223629,special,0,1
223630,focus,0,1
223631,on,0,0
223632,postoperative,0,0
223633,nausea,0,0
223634,and,0,1
223635,vomiting,0,0
223636,(,0,1
223637,PONV,0,0
223638,),0,1
223639,",",0,0
223640,was,0,0
223641,assessed,0,0
223642,.,0,1
223643,Control,0,1
223644,groups,0,0
223645,received,0,1
223646,a,0,1
223647,similar,0,0
223648,desflurane,0,0
223649,anesthetic,0,0
223650,(,0,1
223651,placebo,0,0
223652,),0,1
223653,or,0,1
223654,a,0,1
223655,propofol-infusion-based,0,0
223656,(,0,1
223657,active,0,1
223658,control,0,1
223659,),0,1
223660,anesthetic,0,0
223661,.,0,1
223662,The,0,0
223663,study,0,0
223664,design,0,1
223665,was,0,0
223666,randomized,0,1
223667,",",0,0
223668,controlled,0,0
223669,",",0,0
223670,and,0,0
223671,double-blind,0,0
223672,(,0,0
223673,regarding,0,0
223674,ondansetron,0,0
223675,),0,1
223676,and,0,1
223677,single-blind,0,1
223678,(,0,1
223679,regarding,0,0
223680,the,0,0
223681,anesthetic,0,0
223682,technique,0,0
223683,),0,1
223684,.,0,1
223685,Early,0,0
223686,recovery,0,0
223687,(,0,1
223688,eye,0,1
223689,opening,0,0
223690,",",0,0
223691,orientation,0,0
223692,",",0,0
223693,following,0,0
223694,commands,0,0
223695,",",0,1
223696,sitting,0,1
223697,),0,1
223698,was,0,0
223699,similar,0,0
223700,in,0,0
223701,the,0,1
223702,three,0,1
223703,groups,0,0
223704,.,0,1
223705,However,0,0
223706,",",0,0
223707,overall,0,0
223708,home,0,1
223709,readiness,0,0
223710,(,0,0
223711,toleration,0,0
223712,of,0,1
223713,oral,0,1
223714,fluids,0,1
223715,",",0,1
223716,walking,0,0
223717,",",0,0
223718,pain,0,1
223719,tolerable,0,0
223720,by,0,0
223721,oral,0,1
223722,analgesics,0,0
223723,",",0,1
223724,no,0,0
223725,or,0,0
223726,only,0,0
223727,mild,0,1
223728,nausea,0,0
223729,),0,1
223730,was,0,0
223731,achieved,0,0
223732,faster,0,0
223733,in,0,0
223734,the,0,0
223735,desflurane,0,0
223736,group,0,0
223737,receiving,0,1
223738,ondansetron,0,0
223739,(,0,1
223740,109,0,1
223741,[,0,0
223742,21-937,0,1
223743,],0,1
223744,min,0,0
223745,",",0,0
223746,P,0,0
223747,<,0,0
223748,0.01,0,0
223749,),0,1
223750,and,0,0
223751,in,0,0
223752,the,0,0
223753,propofol,0,0
223754,group,0,1
223755,(,0,1
223756,110,0,1
223757,[,0,0
223758,33-642,0,1
223759,],0,1
223760,min,0,0
223761,",",0,0
223762,P,0,0
223763,<,0,0
223764,0.001,0,0
223765,),0,0
223766,when,0,0
223767,compared,0,0
223768,to,0,0
223769,the,0,0
223770,desflurane,0,0
223771,only,0,0
223772,group,0,1
223773,(,0,0
223774,372,0,1
223775,[,0,0
223776,45-723,0,1
223777,],0,1
223778,min,0,0
223779,),0,1
223780,(,0,1
223781,median,0,1
223782,[,0,0
223783,range,0,1
223784,],0,1
223785,),0,1
223786,.,0,1
223787,The,0,0
223788,total,0,1
223789,incidence,0,0
223790,of,0,0
223791,PONV,0,0
223792,in,0,1
223793,the,0,0
223794,desflurane-only,0,0
223795,group,0,1
223796,was,0,0
223797,80,0,1
223798,%,0,0
223799,(,0,1
223800,P,0,0
223801,<,0,0
223802,0.01,0,0
223803,),0,1
223804,",",0,0
223805,compared,0,0
223806,to,0,1
223807,40,0,1
223808,%,0,0
223809,and,0,1
223810,20,0,1
223811,%,0,0
223812,in,0,0
223813,the,0,0
223814,desflurane,0,0
223815,group,0,0
223816,receiving,0,1
223817,ondansetron,0,0
223818,and,0,0
223819,the,0,0
223820,propofol,0,0
223821,group,0,0
223822,",",0,0
223823,respectively,0,0
223824,.,0,0
223825,The,0,0
223826,postoperative,0,0
223827,antiemetic,0,1
223828,requirements,0,1
223829,were,0,1
223830,consistently,0,0
223831,and,0,0
223832,significantly,0,0
223833,(,0,1
223834,P,0,0
223835,<,0,0
223836,0.01,0,0
223837,),0,1
223838,higher,0,0
223839,in,0,0
223840,the,0,0
223841,desflurane-only,0,0
223842,group,0,1
223843,compared,0,0
223844,to,0,0
223845,the,0,0
223846,other,0,0
223847,two,0,1
223848,groups,0,1
223849,.,0,1
223850,Postoperative,0,0
223851,sedation,0,0
223852,",",0,1
223853,analgesic,0,0
223854,requirements,0,0
223855,",",0,1
223856,and,0,0
223857,psychomotor,0,0
223858,recovery,0,0
223859,(,0,0
223860,assessed,0,0
223861,by,0,0
223862,the,0,0
223863,Maddox,0,0
223864,Wing,0,0
223865,and,0,0
223866,the,0,0
223867,Digit,0,0
223868,Symbol,0,1
223869,Substitution,0,1
223870,Tests,0,1
223871,),0,1
223872,were,0,1
223873,similar,0,0
223874,in,0,0
223875,the,0,1
223876,three,0,1
223877,groups,0,1
223878,.,0,1
223879,Our,0,0
223880,results,0,0
223881,suggest,0,0
223882,that,0,0
223883,in,0,0
223884,order,0,0
223885,to,0,0
223886,achieve,0,0
223887,a,0,0
223888,propofol-like,0,0
223889,recovery,0,0
223890,profile,0,0
223891,in,0,0
223892,patients,0,1
223893,with,0,1
223894,a,0,1
223895,high,0,1
223896,likelihood,0,0
223897,of,0,0
223898,PONV,0,0
223899,",",0,0
223900,desflurane,0,0
223901,should,0,0
223902,be,0,0
223903,combined,0,0
223904,with,0,1
223905,a,0,1
223906,potent,0,1
223907,antiemetic,0,0
223908,(,0,1
223909,e.g.,0,0
223910,",",0,1
223911,ondansetron,0,0
223912,),0,1
223913,.,0,1
223914,Fadrozole,0,1
223915,HCL,0,1
223916,(,0,1
223917,CGS-16949A,0,1
223918,),0,1
223919,versus,0,0
223920,megestrol,0,0
223921,acetate,0,0
223922,treatment,0,0
223923,of,0,0
223924,postmenopausal,1,1
223925,patients,1,1
223926,with,1,1
223927,metastatic,1,1
223928,breast,1,1
223929,carcinoma,1,1
223930,:,1,1
223931,results,0,0
223932,of,0,1
223933,two,0,1
223934,randomized,0,1
223935,double,0,0
223936,blind,0,1
223937,controlled,0,1
223938,multiinstitutional,0,1
223939,trials,0,1
223940,.,0,1
223941,BACKGROUND,0,0
223942,Breast,1,1
223943,cancer,1,1
223944,patients,1,1
223945,with,1,1
223946,prior,1,1
223947,response,1,0
223948,to,1,0
223949,endocrine,1,1
223950,therapy,1,0
223951,achieve,0,0
223952,subsequent,0,0
223953,benefit,0,0
223954,from,0,1
223955,additional,0,1
223956,endocrine,0,1
223957,therapies,0,0
223958,.,0,1
223959,The,0,0
223960,efficacy,0,0
223961,and,0,0
223962,safety,0,0
223963,of,0,0
223964,an,0,0
223965,aromatase,0,0
223966,inhibitor,0,0
223967,",",0,0
223968,fadrozole,0,1
223969,HCL,0,0
223970,",",0,1
223971,were,0,0
223972,compared,0,0
223973,with,0,1
223974,megestrol,0,0
223975,acetate,0,0
223976,in,0,0
223977,post,1,1
223978,menopausal,1,1
223979,patients,1,1
223980,who,1,1
223981,had,1,1
223982,disease,1,1
223983,progression,1,0
223984,after,1,0
223985,receiving,1,1
223986,antiestrogen,1,0
223987,therapy,1,0
223988,either,1,0
223989,for,1,0
223990,metastatic,1,1
223991,disease,1,1
223992,or,1,1
223993,as,1,0
223994,adjuvant,1,1
223995,therapy,1,1
223996,.,1,1
223997,METHODS,0,0
223998,In,1,1
223999,2,1,1
224000,multiinstitutional,1,1
224001,prospective,1,1
224002,trials,1,1
224003,",",1,1
224004,683,1,1
224005,postmenopausal,1,1
224006,patients,1,1
224007,were,0,1
224008,randomized,0,1
224009,to,0,0
224010,receive,0,1
224011,either,0,0
224012,fadrozole,0,0
224013,HCL,0,0
224014,",",0,1
224015,1,0,0
224016,mg,0,0
224017,twice,0,0
224018,daily,0,0
224019,",",0,0
224020,or,0,0
224021,megestrol,0,0
224022,acetate,0,0
224023,",",0,0
224024,40,0,1
224025,mg,0,1
224026,4,0,0
224027,times,0,0
224028,daily,0,0
224029,",",0,0
224030,in,0,0
224031,a,0,0
224032,double,0,0
224033,blind,0,1
224034,fashion,0,0
224035,after,0,0
224036,progression,0,0
224037,on,0,0
224038,first-line,0,1
224039,hormonal,0,1
224040,therapy,0,1
224041,.,0,1
224042,Objective,0,0
224043,response,0,0
224044,rates,0,0
224045,",",0,1
224046,time,0,0
224047,to,0,0
224048,progression,0,0
224049,",",0,0
224050,survival,0,0
224051,and,0,0
224052,safety,0,0
224053,of,0,0
224054,the,0,1
224055,two,0,1
224056,regimens,0,0
224057,were,0,1
224058,compared,0,0
224059,.,0,1
224060,RESULTS,0,0
224061,Results,0,0
224062,of,0,1
224063,intent-to-treat,0,0
224064,analyses,0,0
224065,are,0,0
224066,presented,0,1
224067,in,0,0
224068,this,0,0
224069,study,0,0
224070,.,0,0
224071,No,0,0
224072,significant,0,0
224073,differences,0,0
224074,were,0,1
224075,detected,0,0
224076,between,0,0
224077,the,0,0
224078,two,0,0
224079,treatment,0,0
224080,groups,0,1
224081,in,0,1
224082,time,0,0
224083,to,0,0
224084,progression,0,0
224085,",",0,0
224086,objective,0,0
224087,response,0,0
224088,rates,0,0
224089,",",0,0
224090,duration,0,0
224091,of,0,0
224092,response,0,0
224093,",",0,0
224094,and,0,0
224095,survival,0,0
224096,in,0,0
224097,either,0,1
224098,trial,0,0
224099,.,0,0
224100,There,0,0
224101,were,0,0
224102,no,0,0
224103,clinically,0,1
224104,meaningful,0,0
224105,differences,0,0
224106,between,0,0
224107,the,0,1
224108,treatment,0,0
224109,groups,0,0
224110,in,0,0
224111,the,0,0
224112,incidence,0,0
224113,and,0,0
224114,severity,0,0
224115,of,0,1
224116,adverse,0,0
224117,experiences,0,0
224118,",",0,1
224119,except,0,0
224120,that,0,0
224121,weight,0,0
224122,gain,0,0
224123,",",0,0
224124,fluid,0,0
224125,retention,0,0
224126,",",0,0
224127,and,0,0
224128,dyspnea,0,0
224129,were,0,0
224130,observed,0,0
224131,in,0,0
224132,more,0,0
224133,patients,0,1
224134,in,0,0
224135,the,0,0
224136,megestrol,0,0
224137,acetate,0,0
224138,group,0,1
224139,compared,0,0
224140,with,0,1
224141,those,0,1
224142,receiving,0,1
224143,fadrozole,0,1
224144,HCL,0,1
224145,",",0,1
224146,whereas,0,0
224147,nausea,0,0
224148,and,0,1
224149,vomiting,0,0
224150,were,0,0
224151,observed,0,0
224152,in,0,0
224153,more,0,0
224154,patients,0,1
224155,in,0,0
224156,the,0,1
224157,fadrozole,0,1
224158,HCL,0,1
224159,group,0,1
224160,compared,0,0
224161,with,0,1
224162,those,0,1
224163,receiving,0,1
224164,megestrol,0,0
224165,acetate,0,0
224166,.,0,1
224167,CONCLUSIONS,0,0
224168,Fadrozole,0,1
224169,HCL,0,1
224170,was,0,0
224171,as,0,0
224172,efficacious,0,0
224173,as,0,0
224174,megestrol,0,0
224175,acetate,0,0
224176,in,0,0
224177,postmenopausal,1,1
224178,patients,1,1
224179,with,1,1
224180,metastatic,1,1
224181,breast,1,1
224182,carcinoma,1,1
224183,after,0,1
224184,one,0,1
224185,hormonal,0,1
224186,therapy,0,1
224187,.,0,1
224188,Adverse,0,0
224189,experiences,0,0
224190,were,0,1
224191,mild,0,1
224192,with,0,1
224193,both,0,0
224194,therapies,0,0
224195,",",0,0
224196,but,0,0
224197,megestrol,0,0
224198,acetate,0,0
224199,was,0,0
224200,associated,0,0
224201,wiht,0,1
224202,a,0,0
224203,higher,0,0
224204,frequency,0,0
224205,of,0,0
224206,weight,0,1
224207,gain,0,0
224208,",",0,0
224209,fluid,0,0
224210,retention,0,0
224211,and,0,0
224212,dyspnea,0,0
224213,",",0,0
224214,whereas,0,0
224215,fadrozole,0,1
224216,HCL,0,1
224217,was,0,0
224218,associated,0,0
224219,with,0,1
224220,a,0,0
224221,higher,0,0
224222,frequency,0,0
224223,of,0,0
224224,nausea,0,0
224225,and,0,1
224226,vomiting,0,0
224227,.,0,1
224228,Resource,0,1
224229,utilization,0,0
224230,and,0,1
224231,costs,0,1
224232,of,0,0
224233,care,0,1
224234,in,0,1
224235,the,0,0
224236,diabetes,0,1
224237,control,0,1
224238,and,0,1
224239,complications,0,1
224240,trial,0,1
224241,.,0,1
224242,OBJECTIVE,0,0
224243,To,0,0
224244,describe,0,0
224245,in,0,0
224246,detail,0,0
224247,the,0,0
224248,resources,0,0
224249,used,0,0
224250,and,0,1
224251,costs,0,1
224252,incurred,0,1
224253,in,0,1
224254,the,0,0
224255,clinical,0,0
224256,management,0,1
224257,of,0,1
224258,patients,1,1
224259,with,1,1
224260,insulin-dependent,1,1
224261,diabetes,1,1
224262,mellitus,1,1
224263,(,1,1
224264,IDDM,1,0
224265,),1,1
224266,in,1,0
224267,the,1,0
224268,Diabetes,1,1
224269,Control,1,1
224270,and,1,1
224271,Complications,1,0
224272,Trial,1,1
224273,(,1,1
224274,DCCT,1,1
224275,),1,1
224276,.,1,1
224277,RESEARCH,0,1
224278,DESIGN,0,1
224279,AND,0,0
224280,METHODS,0,0
224281,The,0,1
224282,resources,0,0
224283,used,0,0
224284,for,0,1
224285,intensive,0,1
224286,and,0,1
224287,conventional,0,1
224288,therapy,0,0
224289,and,0,0
224290,to,0,0
224291,deal,0,0
224292,with,0,1
224293,the,0,0
224294,side,0,0
224295,effects,0,0
224296,of,0,1
224297,therapy,0,1
224298,were,0,1
224299,assessed,0,0
224300,at,0,0
224301,each,0,0
224302,of,0,0
224303,the,0,0
224304,29,1,1
224305,DCCT,1,1
224306,clinics,1,1
224307,and,0,1
224308,summarized,0,0
224309,.,0,1
224310,Unit,0,0
224311,costs,0,0
224312,were,0,1
224313,derived,0,1
224314,from,0,1
224315,the,0,0
224316,DCCT,0,1
224317,",",0,0
224318,manufacturers,0,0
224319,",",0,0
224320,and,0,1
224321,Medicare,0,1
224322,and,0,1
224323,chosen,0,0
224324,to,0,1
224325,reflect,0,0
224326,what,0,0
224327,an,0,1
224328,item,0,1
224329,would,0,0
224330,cost,0,0
224331,to,0,0
224332,a,0,0
224333,single-payer,0,1
224334,national,0,1
224335,health,0,1
224336,system,0,1
224337,.,0,1
224338,Costs,0,0
224339,were,0,0
224340,calculated,0,0
224341,as,0,0
224342,the,0,0
224343,product,0,0
224344,of,0,0
224345,resources,0,0
224346,used,0,0
224347,and,0,1
224348,unit,0,1
224349,costs,0,1
224350,.,0,1
224351,The,0,0
224352,costs,0,0
224353,of,0,0
224354,the,0,0
224355,research,0,0
224356,component,0,0
224357,of,0,0
224358,the,0,0
224359,DCCT,0,0
224360,were,0,0
224361,not,0,0
224362,included,0,1
224363,.,0,1
224364,RESULTS,0,0
224365,In,0,0
224366,the,0,0
224367,DCCT,0,0
224368,",",0,0
224369,the,0,0
224370,annual,0,0
224371,cost,0,0
224372,of,0,0
224373,intensive,0,1
224374,therapy,0,1
224375,(,0,1
224376,$,0,1
224377,"4,000",0,1
224378,and,0,1
224379,$,0,1
224380,"5,800/year",0,1
224381,for,0,1
224382,multiple,0,1
224383,daily,0,0
224384,injections,0,0
224385,and,0,1
224386,continuous,0,0
224387,subcutaneous,0,1
224388,insulin,0,0
224389,infusion,0,0
224390,",",0,0
224391,respectively,0,0
224392,),0,0
224393,was,0,0
224394,approximately,0,1
224395,three,0,0
224396,times,0,0
224397,the,0,0
224398,cost,0,0
224399,of,0,0
224400,conventional,0,1
224401,therapy,0,1
224402,(,0,1
224403,$,0,1
224404,"1,700/year",0,1
224405,),0,1
224406,.,0,1
224407,A,0,0
224408,large,0,0
224409,portion,0,0
224410,of,0,0
224411,the,0,0
224412,difference,0,0
224413,in,0,0
224414,cost,0,0
224415,was,0,0
224416,related,0,0
224417,to,0,0
224418,the,0,0
224419,greater,0,0
224420,frequency,0,0
224421,of,0,0
224422,outpatient,0,1
224423,visits,0,1
224424,and,0,1
224425,the,0,1
224426,greater,0,0
224427,resources,0,0
224428,used,0,0
224429,in,0,1
224430,self-care,0,0
224431,.,0,1
224432,CONCLUSIONS,0,0
224433,DCCT,0,1
224434,intensive,0,1
224435,therapy,0,0
224436,is,0,0
224437,more,0,0
224438,expensive,0,0
224439,than,0,0
224440,conventional,0,1
224441,therapy,0,0
224442,",",0,0
224443,but,0,0
224444,it,0,0
224445,offers,0,0
224446,the,0,0
224447,hope,0,0
224448,of,0,0
224449,cost,0,0
224450,savings,0,0
224451,as,0,0
224452,a,0,1
224453,result,0,0
224454,of,0,0
224455,averted,0,1
224456,complications,0,1
224457,.,0,1
224458,Effect,0,0
224459,of,0,0
224460,chronic,0,1
224461,aerobic,0,1
224462,exercise,0,1
224463,and,0,1
224464,progressive,0,1
224465,relaxation,0,0
224466,on,0,0
224467,motor,0,0
224468,performance,0,0
224469,and,0,0
224470,affect,0,0
224471,following,0,0
224472,acute,0,1
224473,stress,0,1
224474,.,0,1
224475,The,0,0
224476,effects,0,0
224477,of,0,0
224478,a,0,1
224479,10-week,0,1
224480,aerobic,0,0
224481,exercise,0,1
224482,and,0,1
224483,progressive,0,1
224484,relaxation,0,0
224485,training,0,0
224486,program,0,1
224487,on,0,0
224488,somatic,0,1
224489,",",0,1
224490,emotional,0,0
224491,",",0,0
224492,and,0,1
224493,behavioral,0,1
224494,responses,0,0
224495,to,0,1
224496,acute,0,1
224497,stress,0,0
224498,",",0,0
224499,as,0,0
224500,determined,0,0
224501,by,0,0
224502,quality,0,0
224503,of,0,0
224504,motor,0,0
224505,performance,0,0
224506,and,0,0
224507,affect,0,0
224508,",",0,0
224509,were,0,0
224510,examined,0,0
224511,.,0,1
224512,The,0,0
224513,participants,0,1
224514,consisted,0,1
224515,of,0,1
224516,60,1,1
224517,unfit,1,1
224518,male,1,1
224519,university,1,1
224520,undergraduate,1,1
224521,students,1,1
224522,with,1,1
224523,no,1,1
224524,previous,1,0
224525,training,1,0
224526,in,1,1
224527,stress,1,1
224528,management,1,1
224529,who,0,1
224530,were,0,1
224531,randomly,0,1
224532,and,0,0
224533,evenly,0,1
224534,assigned,0,1
224535,to,0,0
224536,engage,0,1
224537,in,0,0
224538,one,0,1
224539,of,0,1
224540,four,0,1
224541,treatments,0,0
224542,over,0,1
224543,10,0,1
224544,weeks,0,1
224545,:,0,1
224546,(,0,1
224547,a,0,1
224548,),0,0
224549,moderate,0,1
224550,aerobic,0,0
224551,exercise,0,0
224552,",",0,0
224553,(,0,0
224554,b,0,1
224555,),0,1
224556,progressive,0,0
224557,relaxation,0,0
224558,",",0,0
224559,(,0,0
224560,c,0,1
224561,),0,1
224562,a,0,0
224563,placebo,0,0
224564,group,0,0
224565,that,0,0
224566,engaged,0,1
224567,in,0,0
224568,group,0,1
224569,discussion,0,0
224570,but,0,0
224571,did,0,0
224572,experience,0,1
224573,acute,0,1
224574,stress,0,0
224575,",",0,0
224576,and,0,0
224577,(,0,0
224578,d,0,0
224579,),0,1
224580,a,0,0
224581,nonintervention,0,0
224582,control,0,1
224583,group,0,1
224584,that,0,0
224585,did,0,0
224586,not,0,0
224587,experience,0,0
224588,stress,0,0
224589,while,0,0
224590,performing,0,0
224591,the,0,0
224592,motor,0,0
224593,task,0,1
224594,.,0,1
224595,Acute,0,0
224596,stress,0,0
224597,consisted,0,1
224598,of,0,0
224599,losing,0,0
224600,against,0,0
224601,a,0,1
224602,competitor,0,0
224603,of,0,0
224604,the,0,0
224605,opposite,0,0
224606,sex,0,0
224607,on,0,0
224608,the,0,0
224609,criterion,0,1
224610,motor,0,0
224611,task,0,1
224612,while,0,0
224613,receiving,0,1
224614,unpleasant,0,1
224615,information,0,0
224616,about,0,0
224617,their,0,1
224618,performance,0,0
224619,over,0,0
224620,30,0,1
224621,preintervention,0,1
224622,and,0,1
224623,30,0,1
224624,postintervention,0,0
224625,trials,0,1
224626,.,0,1
224627,Analyses,0,0
224628,indicated,0,0
224629,that,0,0
224630,aerobic,0,1
224631,exercisers,0,1
224632,",",0,1
224633,in,0,1
224634,comparisons,0,0
224635,with,0,1
224636,the,0,1
224637,other,0,0
224638,groups,0,0
224639,",",0,1
224640,responded,0,1
224641,to,0,0
224642,acute,0,1
224643,stress,0,0
224644,with,0,0
224645,more,0,0
224646,positive,0,0
224647,affect,0,0
224648,",",0,0
224649,lower,0,0
224650,stressor,0,1
224651,task,0,1
224652,heart,0,1
224653,rate,0,0
224654,",",0,0
224655,reduced,0,0
224656,systolic,0,1
224657,(,0,0
224658,but,0,0
224659,not,0,0
224660,diastolic,0,1
224661,),0,0
224662,blood,0,0
224663,pressure,0,0
224664,",",0,0
224665,and,0,0
224666,superior,0,0
224667,motor,0,0
224668,performance,0,0
224669,.,0,1
224670,Progressive,0,0
224671,relaxation,0,0
224672,markedly,0,0
224673,reduced,0,0
224674,systolic,0,0
224675,blood,0,0
224676,pressure,0,0
224677,but,0,0
224678,did,0,0
224679,not,0,0
224680,favorably,0,0
224681,influence,0,0
224682,performance,0,0
224683,or,0,1
224684,affect,0,0
224685,in,0,0
224686,response,0,0
224687,to,0,0
224688,acute,0,1
224689,stress,0,0
224690,.,0,1
224691,Placebo,0,0
224692,and,0,0
224693,control,0,1
224694,groups,0,0
224695,were,0,1
224696,statistically,0,0
224697,similar,0,0
224698,on,0,0
224699,all,0,1
224700,measures,0,0
224701,.,0,1
224702,The,0,0
224703,findings,0,0
224704,indicated,0,0
224705,support,0,0
224706,for,0,0
224707,the,0,0
224708,use,0,0
224709,of,0,0
224710,chronic,0,1
224711,aerobic,0,0
224712,exercise,0,0
224713,as,0,0
224714,a,0,0
224715,strategy,0,0
224716,for,0,0
224717,improved,0,0
224718,coping,0,0
224719,with,0,1
224720,acute,0,1
224721,stress,0,1
224722,.,0,1
224723,Effects,0,1
224724,of,0,1
224725,glucocorticoids,0,0
224726,on,0,1
224727,energy,0,0
224728,metabolism,0,0
224729,and,0,0
224730,food,0,0
224731,intake,0,0
224732,in,0,1
224733,humans,1,1
224734,.,1,1
224735,The,0,0
224736,effect,0,0
224737,of,0,0
224738,glucocorticoid,0,0
224739,administration,0,0
224740,on,0,0
224741,energy,0,0
224742,metabolism,0,0
224743,and,0,0
224744,food,0,0
224745,intake,0,0
224746,was,0,0
224747,studied,0,1
224748,in,0,1
224749,20,1,1
224750,healthy,1,1
224751,",",1,1
224752,nondiabetic,1,1
224753,Caucasian,1,1
224754,male,1,1
224755,volunteers,1,1
224756,[,1,1
224757,27,1,1
224758,+/-,1,1
224759,5,1,1
224760,(,1,1
224761,SD,1,1
224762,),1,1
224763,yr,1,1
224764,",",1,1
224765,72,1,1
224766,+/-,1,0
224767,9,1,0
224768,kg,1,1
224769,",",1,1
224770,20,1,1
224771,+/-,1,0
224772,7,1,1
224773,%,1,0
224774,body,1,1
224775,fat,1,0
224776,],1,1
224777,randomly,0,1
224778,and,0,0
224779,blindly,0,1
224780,assigned,0,1
224781,to,0,0
224782,glucocorticoid,0,0
224783,(,0,0
224784,methylprednisolone,0,0
224785,",",0,1
224786,METH,0,0
224787,;,0,0
224788,n,0,1
224789,=,0,1
224790,10,0,1
224791,),0,1
224792,or,0,1
224793,placebo,0,0
224794,(,0,1
224795,PLAC,0,1
224796,;,0,1
224797,n,0,1
224798,=,0,1
224799,10,0,1
224800,),0,1
224801,treatment,0,0
224802,.,0,1
224803,Each,0,0
224804,subject,0,0
224805,was,0,0
224806,studied,0,1
224807,twice,0,0
224808,:,0,1
224809,during,0,0
224810,a,0,1
224811,weight,0,1
224812,maintenance,0,0
224813,diet,0,1
224814,and,0,0
224815,during,0,0
224816,ad,0,1
224817,libitum,0,1
224818,food,0,0
224819,intake,0,0
224820,.,0,1
224821,Energy,0,0
224822,metabolism,0,0
224823,was,0,0
224824,measured,0,0
224825,by,0,0
224826,indirect,0,0
224827,calorimetry,0,1
224828,and,0,0
224829,food,0,0
224830,intake,0,0
224831,by,0,0
224832,an,0,0
224833,automated,0,0
224834,food-selection,0,0
224835,system,0,1
224836,.,0,1
224837,Twenty-four-hour,0,0
224838,urinary,0,0
224839,norepinephrine,0,0
224840,excretion,0,0
224841,(,0,1
224842,24-h,0,1
224843,NE,0,0
224844,),0,1
224845,was,0,0
224846,used,0,0
224847,as,0,0
224848,an,0,0
224849,estimate,0,0
224850,of,0,0
224851,sympathetic,0,0
224852,nervous,0,1
224853,system,0,1
224854,activity,0,0
224855,.,0,1
224856,During,0,0
224857,weight,0,0
224858,maintenance,0,0
224859,",",0,1
224860,METH,0,0
224861,intravenous,0,1
224862,infusion,0,0
224863,(,0,1
224864,125,0,1
224865,mg/30,0,1
224866,min,0,1
224867,),0,1
224868,increased,0,0
224869,energy,0,0
224870,expenditure,0,0
224871,compared,0,0
224872,with,0,1
224873,PLAC,0,1
224874,",",0,0
224875,and,0,0
224876,after,0,1
224877,4,0,0
224878,days,0,0
224879,of,0,1
224880,oral,0,1
224881,therapy,0,0
224882,",",0,1
224883,METH,0,0
224884,(,0,1
224885,40,0,1
224886,mg/day,0,1
224887,),0,1
224888,decreased,0,0
224889,24-h,0,1
224890,NE,0,0
224891,and,0,1
224892,increased,0,0
224893,energy,0,0
224894,expenditure,0,0
224895,compared,0,0
224896,with,0,1
224897,PLAC,0,1
224898,.,0,1
224899,During,0,0
224900,ad,0,1
224901,libitum,0,1
224902,food,0,0
224903,intake,0,0
224904,",",0,0
224905,after,0,0
224906,4,0,0
224907,days,0,0
224908,of,0,1
224909,METH,0,1
224910,(,0,1
224911,40,0,1
224912,mg/day,0,1
224913,),0,1
224914,or,0,1
224915,PLAC,0,1
224916,oral,0,0
224917,therapy,0,0
224918,",",0,0
224919,both,0,0
224920,groups,0,0
224921,increased,0,0
224922,their,0,1
224923,energy,0,0
224924,intake,0,0
224925,over,0,0
224926,weight,0,1
224927,maintenance,0,0
224928,",",0,0
224929,but,0,0
224930,the,0,0
224931,increase,0,0
224932,was,0,0
224933,significantly,0,0
224934,larger,0,0
224935,in,0,0
224936,the,0,0
224937,METH,0,0
224938,group,0,0
224939,compared,0,0
224940,with,0,1
224941,the,0,0
224942,PLAC,0,1
224943,group,0,1
224944,(,0,1
224945,"4,554",0,1
224946,+/-,0,0
224947,"1,857",0,1
224948,vs.,0,0
224949,"2,867",0,1
224950,+/-,0,0
224951,846,0,1
224952,kcal/day,0,1
224953,;,0,1
224954,P,0,0
224955,=,0,1
224956,0.04,0,0
224957,),0,1
224958,.,0,1
224959,Our,0,0
224960,data,0,0
224961,suggest,0,0
224962,that,0,0
224963,therapeutic,0,0
224964,doses,0,1
224965,of,0,1
224966,glucocorticoids,0,0
224967,induce,0,0
224968,obesity,0,1
224969,mostly,0,1
224970,by,0,0
224971,increasing,0,0
224972,energy,0,0
224973,intake,0,0
224974,",",0,0
224975,an,0,0
224976,effect,0,0
224977,which,0,0
224978,may,0,0
224979,be,0,0
224980,related,0,0
224981,to,0,0
224982,the,0,0
224983,ability,0,0
224984,of,0,0
224985,glucocorticoids,0,0
224986,to,0,1
224987,act,0,1
224988,directly,0,0
224989,or,0,0
224990,indirectly,0,0
224991,on,0,0
224992,the,0,0
224993,central,0,0
224994,regulation,0,0
224995,of,0,0
224996,appetite,0,0
224997,.,0,1
224998,Fluoroscopic,0,0
224999,functional,0,0
225000,evaluation,0,0
225001,of,0,1
225002,bileaflet,0,1
225003,prostheses,0,1
225004,:,0,1
225005,effect,0,0
225006,of,0,0
225007,different,0,0
225008,intraoperative,0,0
225009,valve,0,1
225010,orientation,0,0
225011,.,0,1
225012,Fluoroscopy,0,0
225013,is,0,0
225014,a,0,0
225015,reliable,0,0
225016,",",0,0
225017,easy,0,0
225018,",",0,0
225019,and,0,0
225020,readily,0,0
225021,available,0,0
225022,technique,0,0
225023,to,0,1
225024,follow-up,0,0
225025,prosthesis,0,1
225026,functioning,0,1
225027,after,0,0
225028,heart,0,1
225029,valve,0,1
225030,surgery,0,1
225031,.,0,1
225032,The,0,0
225033,different,0,0
225034,orientation,0,0
225035,given,0,0
225036,to,0,0
225037,the,0,0
225038,prosthesis,0,1
225039,may,0,0
225040,represent,0,0
225041,a,0,0
225042,limitation,0,0
225043,of,0,0
225044,the,0,0
225045,technique,0,0
225046,accounting,0,0
225047,for,0,1
225048,unsatisfactory,0,1
225049,results,0,0
225050,in,0,1
225051,10,0,1
225052,%,0,0
225053,to,0,1
225054,40,0,1
225055,%,0,0
225056,of,0,0
225057,the,0,0
225058,cases,0,1
225059,.,0,1
225060,The,0,0
225061,aim,0,0
225062,of,0,0
225063,the,0,0
225064,study,0,0
225065,was,0,0
225066,to,0,0
225067,evaluate,0,0
225068,whether,0,0
225069,and,0,1
225070,to,0,1
225071,what,0,0
225072,extent,0,1
225073,different,0,1
225074,intraoperative,0,0
225075,valve,0,1
225076,orientation,0,0
225077,influence,0,0
225078,feasibility,0,0
225079,and,0,0
225080,accuracy,0,0
225081,of,0,0
225082,postoperative,0,1
225083,fluoroscopic,0,0
225084,evaluation,0,0
225085,of,0,1
225086,bileaflet,0,1
225087,prostheses,0,1
225088,.,0,1
225089,We,0,0
225090,prospectively,0,1
225091,evaluated,0,0
225092,90,1,1
225093,patients,1,1
225094,who,1,1
225095,had,1,1
225096,aortic,1,1
225097,",",1,0
225098,mitral,1,1
225099,",",1,0
225100,and/or,1,0
225101,tricuspid,1,1
225102,valve,1,1
225103,replacement,1,1
225104,with,1,1
225105,Sorin,1,0
225106,Bicarbon,1,1
225107,or,1,1
225108,CarboMedics,1,1
225109,bileaflet,1,1
225110,prostheses,1,1
225111,.,1,1
225112,Fifty,0,1
225113,percent,0,0
225114,of,0,0
225115,the,0,0
225116,patients,0,1
225117,in,0,0
225118,each,0,1
225119,group,0,0
225120,were,0,0
225121,randomly,0,1
225122,assigned,0,1
225123,to,0,0
225124,receive,0,1
225125,prostheses,0,1
225126,oriented,0,0
225127,in,0,0
225128,a,0,1
225129,perpendicular,0,0
225130,or,0,1
225131,a,0,0
225132,parallel,0,0
225133,position,0,0
225134,with,0,1
225135,respect,0,0
225136,to,0,1
225137,the,0,0
225138,ventricular,0,1
225139,septum,0,1
225140,.,0,1
225141,Fluoroscopic,0,0
225142,evaluation,0,0
225143,was,0,0
225144,considered,0,0
225145,appropriate,0,0
225146,when,0,0
225147,the,0,0
225148,prosthesis,0,0
225149,',0,1
225150,tilting,0,1
225151,disk,0,1
225152,projection,0,0
225153,was,0,0
225154,obtained,0,0
225155,.,0,1
225156,The,0,0
225157,valve,0,1
225158,'s,0,1
225159,hemodynamic,0,0
225160,performance,0,0
225161,was,0,0
225162,investigated,0,0
225163,through,0,1
225164,Doppler,0,1
225165,study,0,1
225166,.,0,1
225167,A,0,0
225168,proper,0,0
225169,fluoroscopic,0,0
225170,evaluation,0,0
225171,was,0,0
225172,rapidly,0,1
225173,(,0,1
225174,15,0,1
225175,+/-,0,1
225176,5,0,1
225177,seconds,0,0
225178,),0,1
225179,achieved,0,0
225180,in,0,0
225181,all,0,1
225182,patients,0,1
225183,with,0,1
225184,the,0,1
225185,former,0,1
225186,orientation,0,0
225187,",",0,0
225188,whereas,0,0
225189,it,0,0
225190,was,0,0
225191,impossible,0,0
225192,to,0,0
225193,obtain,0,0
225194,it,0,0
225195,in,0,0
225196,8,0,1
225197,of,0,1
225198,20,0,1
225199,(,0,1
225200,40,0,1
225201,%,0,0
225202,),0,1
225203,",",0,0
225204,19,0,1
225205,of,0,1
225206,20,0,1
225207,(,0,1
225208,95,0,0
225209,%,0,0
225210,),0,1
225211,",",0,0
225212,and,0,0
225213,4,0,0
225214,of,0,1
225215,5,0,1
225216,(,0,1
225217,80,0,1
225218,%,0,0
225219,),0,1
225220,of,0,0
225221,patients,0,1
225222,with,0,1
225223,the,0,1
225224,latter,0,0
225225,orientation,0,0
225226,.,0,1
225227,In,0,0
225228,the,0,0
225229,remaining,0,1
225230,patients,0,1
225231,extremely,0,1
225232,angulated,0,0
225233,",",0,0
225234,uneasy,0,0
225235,projection,0,0
225236,was,0,0
225237,often,0,0
225238,required,0,0
225239,to,0,0
225240,get,0,0
225241,a,0,0
225242,correct,0,0
225243,fluoroscopic,0,0
225244,image,0,0
225245,.,0,1
225246,The,0,0
225247,Doppler,0,0
225248,study,0,0
225249,showed,0,0
225250,a,0,0
225251,similarly,0,0
225252,favorable,0,0
225253,hemodynamic,0,0
225254,performance,0,0
225255,regardless,0,0
225256,of,0,0
225257,valve,0,1
225258,orientation,0,0
225259,.,0,1
225260,Prosthesis,0,1
225261,orientation,0,0
225262,crucially,0,0
225263,affects,0,0
225264,the,0,0
225265,rate,0,0
225266,of,0,0
225267,success,0,0
225268,of,0,0
225269,the,0,0
225270,fluoroscopic,0,0
225271,evaluation,0,0
225272,.,0,1
225273,The,0,0
225274,orientation,0,0
225275,perpendicular,0,0
225276,to,0,0
225277,the,0,0
225278,ventricular,0,0
225279,septum,0,0
225280,greatly,0,0
225281,facilitates,0,0
225282,the,0,0
225283,postoperative,0,0
225284,feasibility,0,0
225285,and,0,0
225286,accuracy,0,0
225287,of,0,0
225288,fluoroscopy,0,0
225289,",",0,0
225290,and,0,0
225291,it,0,0
225292,is,0,0
225293,not,0,0
225294,detrimental,0,0
225295,to,0,0
225296,the,0,0
225297,valve,0,1
225298,'s,0,1
225299,hemodynamic,0,0
225300,performance,0,0
225301,.,0,1
225302,This,0,0
225303,valve,0,0
225304,orientation,0,0
225305,may,0,0
225306,provide,0,0
225307,a,0,0
225308,better,0,0
225309,fluoroscopic,0,0
225310,window,0,0
225311,whenever,0,0
225312,a,0,0
225313,valve,0,0
225314,dysfunction,0,0
225315,is,0,0
225316,suspected,0,1
225317,.,0,0
225318,Serum,0,1
225319,bactericidal,0,0
225320,activities,0,0
225321,and,0,1
225322,comparative,0,0
225323,pharmacokinetics,0,0
225324,of,0,1
225325,meropenem,0,0
225326,and,0,1
225327,imipenem-cilastatin,0,0
225328,.,0,1
225329,The,0,0
225330,pharmacokinetics,0,0
225331,and,0,0
225332,serum,0,1
225333,bactericidal,0,0
225334,activities,0,0
225335,(,0,1
225336,SBAs,0,1
225337,),0,1
225338,of,0,0
225339,imipenem,0,0
225340,and,0,1
225341,meropenem,0,0
225342,were,0,0
225343,investigated,0,0
225344,in,0,0
225345,a,0,0
225346,randomized,0,1
225347,crossover,0,0
225348,study,0,1
225349,.,0,1
225350,Twelve,1,1
225351,healthy,1,1
225352,male,1,1
225353,volunteers,1,1
225354,received,0,1
225355,a,0,1
225356,constant,0,0
225357,30-min,0,0
225358,infusion,0,0
225359,of,0,0
225360,either,0,1
225361,1,0,1
225362,g,0,1
225363,of,0,1
225364,imipenem,0,0
225365,plus,0,0
225366,1,0,1
225367,g,0,1
225368,of,0,0
225369,cilastatin,0,0
225370,or,0,1
225371,1,0,0
225372,g,0,1
225373,of,0,0
225374,meropenem,0,0
225375,.,0,1
225376,The,0,0
225377,concentrations,0,0
225378,of,0,0
225379,the,0,1
225380,drugs,0,0
225381,in,0,0
225382,serum,0,0
225383,and,0,1
225384,urine,0,1
225385,were,0,0
225386,determined,0,0
225387,by,0,0
225388,bioassay,0,0
225389,and,0,1
225390,high-pressure,0,0
225391,liquid,0,0
225392,chromatography,0,0
225393,.,0,1
225394,Pharmacokinetic,0,0
225395,parameters,0,0
225396,were,0,1
225397,based,0,1
225398,on,0,0
225399,an,0,1
225400,open,0,1
225401,two-compartment,0,0
225402,model,0,0
225403,and,0,0
225404,a,0,0
225405,noncompartmental,0,0
225406,technique,0,0
225407,.,0,1
225408,At,0,0
225409,the,0,0
225410,end,0,0
225411,of,0,0
225412,infusion,0,0
225413,",",0,0
225414,the,0,0
225415,mean,0,1
225416,concentrations,0,0
225417,of,0,1
225418,imipenem,0,0
225419,and,0,1
225420,meropenem,0,0
225421,measured,0,0
225422,in,0,0
225423,serum,0,0
225424,were,0,1
225425,61.2,0,0
225426,+/-,0,1
225427,9.8,0,0
225428,and,0,1
225429,51.6,0,0
225430,+/-,0,0
225431,6.5,0,0
225432,mg/liter,0,0
225433,",",0,0
225434,respectively,0,0
225435,;,0,0
225436,urinary,0,1
225437,recoveries,0,0
225438,were,0,1
225439,48.6,0,1
225440,%,0,0
225441,+/-,0,0
225442,8.2,0,0
225443,%,0,0
225444,and,0,1
225445,60.0,0,1
225446,%,0,0
225447,+/-,0,0
225448,6.5,0,0
225449,%,0,0
225450,of,0,0
225451,the,0,0
225452,dose,0,0
225453,in,0,0
225454,12,0,1
225455,h,0,0
225456,",",0,0
225457,respectively,0,0
225458,;,0,0
225459,and,0,0
225460,the,0,0
225461,areas,0,0
225462,under,0,1
225463,the,0,1
225464,concentration-time,0,0
225465,curve,0,0
225466,from,0,1
225467,time,0,0
225468,zero,0,0
225469,to,0,1
225470,infinity,0,0
225471,were,0,1
225472,96.1,0,0
225473,+/-,0,1
225474,14.4,0,0
225475,and,0,1
225476,70.5,0,0
225477,+/-,0,0
225478,10.3,0,0
225479,mg.h/liter,0,0
225480,",",0,0
225481,respectively,0,0
225482,(,0,0
225483,P,0,0
225484,<,0,0
225485,or,0,1
225486,=,0,1
225487,0.02,0,0
225488,),0,1
225489,.,0,1
225490,Imipenem,0,0
225491,had,0,1
225492,a,0,0
225493,mean,0,0
225494,half-life,0,0
225495,of,0,1
225496,66.7,0,1
225497,+/-,0,1
225498,10.4,0,1
225499,min,0,0
225500,;,0,1
225501,that,0,0
225502,of,0,0
225503,meropenem,0,0
225504,was,0,0
225505,64.4,0,0
225506,+/-,0,0
225507,6.9,0,1
225508,min,0,0
225509,.,0,1
225510,The,0,0
225511,volumes,0,0
225512,of,0,0
225513,distribution,0,1
225514,at,0,1
225515,steady,0,0
225516,state,0,1
225517,of,0,0
225518,imipenem,0,0
225519,and,0,1
225520,meropenem,0,0
225521,were,0,1
225522,15.3,0,0
225523,+/-,0,1
225524,3.3,0,1
225525,and,0,1
225526,18.6,0,1
225527,+/-,0,0
225528,3.0,0,0
225529,liters/70,0,0
225530,kg,0,0
225531,",",0,0
225532,respectively,0,0
225533,",",0,0
225534,and,0,0
225535,the,0,0
225536,mean,0,1
225537,renal,0,1
225538,clearances,0,0
225539,per,0,1
225540,1.73,0,1
225541,m2,0,1
225542,were,0,1
225543,85.6,0,1
225544,+/-,0,1
225545,17.6,0,1
225546,and,0,1
225547,144.6,0,1
225548,+/-,0,0
225549,26.0,0,1
225550,ml/min,0,0
225551,",",0,0
225552,respectively,0,0
225553,.,0,1
225554,Both,1,0
225555,antibiotics,1,0
225556,were,1,1
225557,well,1,0
225558,tolerated,1,0
225559,in,1,0
225560,this,1,0
225561,single-dose,1,0
225562,administration,1,0
225563,study,1,1
225564,.,1,1
225565,The,0,0
225566,SBAs,0,0
225567,were,0,0
225568,measured,0,0
225569,by,0,0
225570,the,0,0
225571,microdilution,0,0
225572,method,0,0
225573,of,0,0
225574,Reller,0,1
225575,and,0,1
225576,Stratton,0,1
225577,(,0,1
225578,L.,0,1
225579,B.,0,1
225580,Reller,0,1
225581,and,0,1
225582,C.,0,0
225583,W.,0,1
225584,Stratton,0,1
225585,",",0,1
225586,J.,0,0
225587,Infect,0,0
225588,.,0,1
225589,Dis,0,0
225590,.,0,1
225591,136:196-204,0,0
225592,",",0,0
225593,1977,0,1
225594,),0,1
225595,against,0,0
225596,40,0,1
225597,clinically,0,1
225598,isolated,0,1
225599,strains,0,1
225600,.,0,1
225601,Mean,0,1
225602,reciprocal,0,0
225603,bactericidal,0,0
225604,titers,0,0
225605,were,0,1
225606,measured,0,0
225607,1,0,1
225608,and,0,1
225609,6,0,0
225610,h,0,0
225611,after,0,1
225612,administration,0,0
225613,.,0,1
225614,After,0,0
225615,1,0,0
225616,and,0,1
225617,6,0,0
225618,h,0,0
225619,the,0,0
225620,median,0,0
225621,SBAs,0,1
225622,for,0,1
225623,imipenem,0,0
225624,and,0,0
225625,meropenem,0,0
225626,",",0,0
225627,were,0,1
225628,409,0,1
225629,and,0,1
225630,34.9,0,1
225631,and,0,1
225632,97.9,0,1
225633,and,0,1
225634,5.8,0,0
225635,",",0,0
225636,respectively,0,0
225637,",",0,0
225638,against,0,0
225639,Staphylococcus,0,1
225640,aureus,0,1
225641,",",0,1
225642,19.9,0,0
225643,and,0,1
225644,4.4,0,1
225645,and,0,1
225646,19.4,0,1
225647,and,0,1
225648,4.8,0,0
225649,",",0,0
225650,respectively,0,0
225651,",",0,0
225652,against,0,0
225653,Pseudomonas,0,1
225654,aeruginosa,0,1
225655,",",0,1
225656,34.3,0,1
225657,and,0,1
225658,2.2,0,0
225659,and,0,1
225660,232,0,1
225661,and,0,1
225662,15.5,0,0
225663,",",0,0
225664,respectively,0,0
225665,",",0,0
225666,against,0,0
225667,Enterobacter,0,1
225668,cloacae,0,1
225669,",",0,0
225670,and,0,0
225671,13.4,0,0
225672,and,0,1
225673,2.25,0,0
225674,and,0,1
225675,90.7,0,0
225676,and,0,1
225677,7.9,0,0
225678,",",0,0
225679,respectively,0,0
225680,",",0,0
225681,against,0,0
225682,Proteus,0,1
225683,mirabilis,0,1
225684,.,0,1
225685,Both,1,0
225686,drugs,1,0
225687,had,1,1
225688,rather,1,0
225689,short,1,0
225690,biological,1,0
225691,elimination,1,1
225692,half-lives,1,0
225693,and,1,0
225694,a,1,1
225695,predominantly,1,1
225696,renal,1,1
225697,route,1,0
225698,of,1,0
225699,elimination,1,0
225700,.,1,1
225701,Both,0,0
225702,carbapenems,0,0
225703,revealed,0,0
225704,high,0,1
225705,SBAs,0,1
225706,against,0,0
225707,clinically,0,1
225708,important,0,0
225709,pathogens,0,0
225710,at,0,1
225711,1,0,1
225712,h,0,0
225713,;,0,1
225714,meropenem,0,0
225715,had,0,1
225716,a,0,0
225717,higher,0,0
225718,SBA,0,1
225719,against,0,0
225720,E.,0,1
225721,cloacae,0,1
225722,and,0,1
225723,P.,0,1
225724,mirabilis,0,1
225725,",",0,0
225726,and,0,0
225727,the,0,0
225728,SBA,0,1
225729,of,0,0
225730,imipenem,0,0
225731,against,0,1
225732,S.,0,1
225733,aureus,0,1
225734,was,0,0
225735,greater,0,0
225736,than,0,0
225737,the,0,0
225738,SBA,0,1
225739,of,0,0
225740,meropenem,0,0
225741,.,0,1
225742,One,0,1
225743,quadrant,0,1
225744,sub-Tenon,0,1
225745,'s,0,1
225746,capsule,0,0
225747,anesthesia,0,1
225748,in,0,0
225749,anterior,1,1
225750,segment,1,1
225751,surgery,1,1
225752,.,1,1
225753,Reports,0,0
225754,of,0,1
225755,complications,0,1
225756,associated,0,0
225757,with,0,1
225758,local,1,0
225759,anesthesia,1,1
225760,in,1,1
225761,ophthalmic,1,1
225762,surgery,1,1
225763,have,0,0
225764,increased,0,0
225765,conspicuously,0,0
225766,in,0,0
225767,recent,0,1
225768,years,0,1
225769,.,0,1
225770,Sub-Tenon,0,0
225771,'s,0,1
225772,capsule,0,0
225773,anesthesia,0,1
225774,for,0,0
225775,anterior,0,1
225776,segment,0,1
225777,surgery,0,1
225778,avoids,0,0
225779,the,0,0
225780,risks,0,0
225781,of,0,0
225782,retrobulbar,0,1
225783,and,0,1
225784,peribulbar,0,0
225785,injections,0,0
225786,.,0,1
225787,This,0,0
225788,study,0,0
225789,compared,0,0
225790,sub-Tenon,0,0
225791,'s,0,1
225792,and,0,0
225793,retrobulbar,0,1
225794,anesthesia,0,1
225795,.,0,1
225796,Patients,1,1
225797,undergoing,1,1
225798,various,1,0
225799,anterior,1,1
225800,segment,1,1
225801,surgery,1,1
225802,were,0,0
225803,randomly,0,1
225804,assigned,0,1
225805,to,0,0
225806,sub-Tenon,0,0
225807,'s,0,1
225808,or,0,1
225809,retrobulbar,0,1
225810,anesthesia,0,1
225811,;,0,1
225812,300,1,1
225813,were,1,1
225814,operated,1,1
225815,with,1,1
225816,1-quadrant,1,1
225817,sub-Tenon,1,1
225818,'s,1,1
225819,anesthesia,1,1
225820,(,1,1
225821,1-QST,1,0
225822,),1,1
225823,and,1,1
225824,the,1,0
225825,results,1,0
225826,were,1,1
225827,compared,1,0
225828,with,1,1
225829,270,1,1
225830,patients,1,1
225831,operated,1,1
225832,with,1,1
225833,retrobulbar,1,1
225834,anesthesia,1,1
225835,.,1,1
225836,Retrobulbar,0,0
225837,anesthesia,0,0
225838,consisted,0,1
225839,of,0,0
225840,a,0,1
225841,2.5,0,0
225842,ml,0,0
225843,injection,0,0
225844,of,0,0
225845,a,0,1
225846,1:1,0,0
225847,mixture,0,0
225848,of,0,1
225849,2,0,1
225850,%,0,0
225851,lidocaine,0,0
225852,without,0,1
225853,epinephrine,0,0
225854,and,0,1
225855,0.5,0,0
225856,%,0,0
225857,bupivacaine,0,0
225858,.,0,1
225859,Sub-Tenon,0,0
225860,'s,0,1
225861,anesthesia,0,1
225862,involved,0,1
225863,direct,0,0
225864,transconjunctival,0,0
225865,infiltration,0,0
225866,of,0,0
225867,the,0,0
225868,same,0,0
225869,local,0,0
225870,anesthetic,0,0
225871,directly,0,0
225872,into,0,0
225873,the,0,0
225874,sub-Tenon,0,0
225875,'s,0,1
225876,space,0,0
225877,",",0,1
225878,in,0,0
225879,the,0,0
225880,inferior-nasal,0,0
225881,quadrant,0,1
225882,",",0,0
225883,using,0,0
225884,a,0,0
225885,blunt,0,1
225886,23-gauge,0,0
225887,cannula,0,0
225888,.,0,1
225889,Patients,1,1
225890,undergoing,1,1
225891,various,1,0
225892,anterior,1,1
225893,segment,1,1
225894,surgery,1,1
225895,procedures,1,0
225896,were,0,1
225897,randomly,0,1
225898,assigned,0,1
225899,to,0,1
225900,1-QST,0,0
225901,or,0,1
225902,retrobulbar,0,1
225903,anesthesia,0,1
225904,;,0,1
225905,300,0,1
225906,patients,0,1
225907,were,0,1
225908,operated,0,1
225909,with,0,1
225910,1-QST,0,0
225911,and,0,1
225912,the,0,0
225913,results,0,0
225914,were,0,1
225915,compared,0,0
225916,with,0,1
225917,270,0,1
225918,patients,0,1
225919,operated,0,1
225920,with,0,1
225921,retrobulbar,0,1
225922,anesthesia,0,1
225923,.,0,1
225924,Preinjection,0,0
225925,mean,0,0
225926,(,0,1
225927,+/-,0,0
225928,SD,0,1
225929,),0,1
225930,IOP,0,1
225931,wer,0,1
225932,12.9,0,0
225933,+/-,0,0
225934,3.7,0,1
225935,mmHg,0,0
225936,in,0,0
225937,the,0,0
225938,retrobulbar,0,1
225939,and,0,0
225940,13.4,0,0
225941,+/-,0,0
225942,3.2,0,1
225943,mmHg,0,0
225944,in,0,0
225945,the,0,0
225946,1-QST,0,0
225947,patients,0,1
225948,.,0,1
225949,Preoperative,0,1
225950,intraocular,0,1
225951,pressures,0,0
225952,were,0,1
225953,8.7,0,0
225954,+/-,0,0
225955,3.0,0,0
225956,mmHg,0,0
225957,in,0,0
225958,the,0,0
225959,retrobulbar,0,1
225960,and,0,0
225961,9.2,0,0
225962,+/-,0,0
225963,3.2,0,1
225964,mmHg,0,0
225965,in,0,1
225966,1-QST,0,0
225967,patients,0,1
225968,.,0,1
225969,Pre-,0,0
225970,and,0,0
225971,postinjection,0,0
225972,IOP,0,1
225973,for,0,0
225974,retrobulbar,0,1
225975,and,0,1
225976,1-QST,0,0
225977,patients,0,1
225978,were,0,1
225979,similar,0,0
225980,.,0,1
225981,Pain,0,0
225982,scores,0,0
225983,for,0,0
225984,delivery,0,1
225985,of,0,0
225986,the,0,0
225987,anesthetic,0,0
225988,",",0,0
225989,using,0,0
225990,a,0,0
225991,numerical,0,0
225992,rating,0,0
225993,scale,0,0
225994,",",0,0
225995,produced,0,0
225996,a,0,0
225997,median,0,0
225998,score,0,0
225999,of,0,0
226000,1,0,1
226001,for,0,1
226002,1-QST,0,0
226003,and,0,1
226004,2,0,1
226005,for,0,0
226006,the,0,0
226007,retrobulbar,0,1
226008,technique,0,0
226009,.,0,1
226010,For,0,0
226011,the,0,0
226012,subsequent,0,0
226013,operative,0,1
226014,procedure,0,0
226015,",",0,0
226016,the,0,0
226017,median,0,0
226018,score,0,0
226019,was,0,0
226020,1,0,0
226021,for,0,1
226022,1-QST,0,0
226023,and,0,1
226024,2,0,1
226025,for,0,0
226026,the,0,0
226027,retrobulbar,0,1
226028,patients,0,1
226029,.,0,1
226030,Complete,0,0
226031,akinesia,0,0
226032,was,0,0
226033,achieved,0,0
226034,in,0,1
226035,41,0,1
226036,%,0,0
226037,with,0,1
226038,1-QST,0,0
226039,and,0,1
226040,in,0,1
226041,69,0,1
226042,%,0,0
226043,of,0,1
226044,retrobulbar,0,1
226045,patients,0,1
226046,.,0,1
226047,1-QST,0,0
226048,patients,0,1
226049,with,0,1
226050,incomplete,0,1
226051,akinesia,0,0
226052,most,0,0
226053,often,0,0
226054,had,0,1
226055,lateral,0,1
226056,muscle,0,0
226057,function,0,0
226058,which,0,0
226059,did,0,0
226060,not,0,0
226061,interfere,0,0
226062,with,0,1
226063,the,0,0
226064,operation,0,1
226065,.,0,1
226066,We,0,0
226067,found,0,0
226068,the,0,0
226069,use,0,0
226070,of,0,0
226071,a,0,0
226072,blunt,0,1
226073,cannula,0,0
226074,to,0,0
226075,deliver,0,0
226076,anesthetic,0,0
226077,into,0,0
226078,the,0,0
226079,sub-Tenon,0,0
226080,'s,0,1
226081,space,0,0
226082,as,0,0
226083,a,0,0
226084,simple,0,0
226085,",",0,0
226086,safe,0,0
226087,and,0,1
226088,effective,0,0
226089,alternative,0,0
226090,approach,0,1
226091,to,0,1
226092,traditional,0,0
226093,retrobulbar,0,1
226094,anesthesia,0,1
226095,in,0,0
226096,anterior,0,1
226097,segment,0,1
226098,surgery,0,1
226099,.,0,1
226100,Long-term,0,1
226101,results,0,0
226102,regarding,0,0
226103,the,0,0
226104,use,0,0
226105,of,0,0
226106,recombinant,0,0
226107,interferon,0,1
226108,alpha-2b,0,0
226109,in,0,0
226110,the,0,0
226111,treatment,0,0
226112,of,0,0
226113,II,1,1
226114,type,1,1
226115,mixed,1,1
226116,essential,1,1
226117,cryoglobulinemia,1,1
226118,.,1,1
226119,Thirty-three,1,1
226120,patients,1,1
226121,with,1,1
226122,II,1,1
226123,type,1,1
226124,mixed,1,1
226125,essential,1,1
226126,cryoglobulinemia,1,1
226127,(,1,1
226128,MEC,1,1
226129,),1,1
226130,were,1,0
226131,randomized,1,1
226132,into,0,1
226133,two,0,1
226134,groups,0,1
226135,:,0,1
226136,one,0,1
226137,to,0,0
226138,receive,0,1
226139,combined,0,0
226140,therapy,0,0
226141,including,0,1
226142,prednisone,0,1
226143,plus,0,0
226144,interferon,0,0
226145,",",0,0
226146,the,0,0
226147,other,0,0
226148,to,0,0
226149,receive,0,1
226150,prednisone,0,1
226151,therapy,0,0
226152,.,0,1
226153,Interferon,0,0
226154,was,0,0
226155,administered,0,0
226156,as,0,0
226157,induction,0,1
226158,treatment,0,1
226159,(,0,1
226160,3,0,1
226161,Mu/day,0,1
226162,),0,1
226163,and,0,0
226164,then,0,0
226165,as,0,0
226166,maintenance,0,0
226167,therapy,0,1
226168,(,0,1
226169,3,0,1
226170,Mu,0,1
226171,three,0,1
226172,times,0,0
226173,a,0,1
226174,week,0,0
226175,),0,1
226176,.,0,1
226177,83,0,0
226178,%,0,0
226179,of,0,0
226180,the,0,0
226181,combined,0,0
226182,therapy,0,1
226183,patients,0,1
226184,responded,0,1
226185,as,0,0
226186,opposed,0,0
226187,to,0,1
226188,27,0,1
226189,%,0,0
226190,of,0,0
226191,the,0,0
226192,prednisone,0,1
226193,treated,0,1
226194,patients,0,1
226195,.,0,1
226196,Among,0,1
226197,the,0,0
226198,patients,0,1
226199,that,0,0
226200,responded,0,1
226201,to,0,0
226202,combined,0,0
226203,therapy,0,0
226204,",",0,0
226205,nine,0,1
226206,of,0,0
226207,them,0,1
226208,had,0,1
226209,a,0,0
226210,complete,0,0
226211,response,0,0
226212,",",0,0
226213,four,0,0
226214,a,0,1
226215,partial,0,1
226216,response,0,0
226217,",",0,1
226218,and,0,0
226219,two,0,0
226220,a,0,1
226221,minor,0,0
226222,response,0,0
226223,.,0,1
226224,None,0,0
226225,of,0,0
226226,the,0,0
226227,patients,0,1
226228,treated,0,1
226229,with,0,1
226230,prednisone,0,1
226231,therapy,0,0
226232,responded,0,1
226233,completely,0,0
226234,but,0,0
226235,only,0,0
226236,two,0,0
226237,had,0,1
226238,a,0,1
226239,partial,0,1
226240,and,0,0
226241,two,0,0
226242,a,0,1
226243,minor,0,0
226244,response,0,0
226245,.,0,1
226246,Four,0,0
226247,patients,0,1
226248,(,0,1
226249,three,0,1
226250,of,0,0
226251,combined,0,0
226252,therapy,0,1
226253,and,0,1
226254,one,0,1
226255,of,0,0
226256,prednisone,0,1
226257,therapy,0,1
226258,),0,1
226259,showed,0,0
226260,proteinuria,0,1
226261,before,0,0
226262,the,0,0
226263,treatment,0,0
226264,which,0,0
226265,improved,0,0
226266,at,0,0
226267,the,0,0
226268,end,0,0
226269,of,0,0
226270,the,0,0
226271,induction,0,0
226272,therapy,0,0
226273,.,0,1
226274,Ten,0,1
226275,patients,0,1
226276,showed,0,0
226277,anti-HCV,0,1
226278,positivity,0,1
226279,which,0,0
226280,remained,0,0
226281,unchanged,0,0
226282,after,0,0
226283,the,0,0
226284,treatment,0,0
226285,.,0,1
226286,Three,0,1
226287,patients,0,1
226288,showed,0,0
226289,liver,0,1
226290,involvement,0,1
226291,secondary,0,0
226292,to,0,0
226293,cryoglobulinemia,0,1
226294,and,0,0
226295,an,0,0
226296,improvement,0,0
226297,of,0,0
226298,histological,0,0
226299,pattern,0,1
226300,after,0,0
226301,the,0,0
226302,induction,0,0
226303,with,0,1
226304,combined,0,0
226305,therapy,0,1
226306,.,0,1
226307,One,0,1
226308,patient,0,0
226309,showed,0,0
226310,an,0,0
226311,improvement,0,0
226312,of,0,0
226313,peripheral,0,1
226314,neuropathy,0,1
226315,after,0,1
226316,induction,0,1
226317,with,0,1
226318,the,0,0
226319,combined,0,0
226320,therapy,0,0
226321,.,0,1
226322,These,0,0
226323,data,0,0
226324,suggest,0,0
226325,the,0,0
226326,effectiveness,0,0
226327,of,0,0
226328,interferon,0,0
226329,given,0,0
226330,as,0,0
226331,induction,0,0
226332,and,0,1
226333,as,0,0
226334,maintenance,0,0
226335,treatment,0,0
226336,in,0,0
226337,the,0,0
226338,therapy,0,0
226339,of,0,0
226340,II,1,1
226341,type,1,1
226342,mixed,1,1
226343,essential,1,1
226344,cryoglobulinemia,1,1
226345,.,1,1
226346,Effects,0,1
226347,of,0,1
226348,ORG-2766,0,1
226349,on,0,0
226350,brain,0,1
226351,event-related,0,0
226352,potentials,0,0
226353,of,0,1
226354,autistic,1,1
226355,children,1,1
226356,.,1,1
226357,A,0,0
226358,double-blind,0,0
226359,",",0,0
226360,placebo-controlled,0,0
226361,study,0,0
226362,examined,0,0
226363,the,0,0
226364,effects,0,0
226365,of,0,1
226366,6,0,1
226367,weeks,0,1
226368,of,0,1
226369,treatment,0,1
226370,with,0,1
226371,the,0,0
226372,adrenocorticotropin4-9,0,0
226373,analogue,0,0
226374,ORG-2766,0,1
226375,(,0,1
226376,40,0,1
226377,mg/day,0,0
226378,),0,1
226379,on,0,0
226380,brain,0,1
226381,event-related,0,0
226382,potentials,0,0
226383,(,0,1
226384,ERPs,0,1
226385,),0,1
226386,of,0,1
226387,autistic,1,1
226388,children,1,1
226389,.,1,1
226390,In,0,0
226391,visual,0,0
226392,and,0,1
226393,auditory,0,1
226394,oddball,0,1
226395,paradigms,0,0
226396,(,0,0
226397,with,0,1
226398,task,0,1
226399,and,0,1
226400,nontask,0,1
226401,conditions,0,1
226402,),0,1
226403,",",0,1
226404,standard,0,1
226405,(,0,1
226406,80,0,1
226407,%,0,0
226408,),0,1
226409,",",0,0
226410,target,0,0
226411,(,0,1
226412,10,0,1
226413,%,0,0
226414,),0,1
226415,",",0,0
226416,and,0,0
226417,unexpected,0,0
226418,novel,0,1
226419,stimuli,0,0
226420,(,0,1
226421,10,0,1
226422,%,0,0
226423,),0,1
226424,were,0,1
226425,presented,0,1
226426,.,0,1
226427,ORG-2766,0,0
226428,(,0,0
226429,a,0,1
226430,),0,0
226431,increased,0,0
226432,the,0,0
226433,occipital,0,1
226434,P3,0,1
226435,component,0,0
226436,of,0,0
226437,the,0,0
226438,ERP,0,0
226439,to,0,1
226440,visual,0,0
226441,targets,0,0
226442,",",0,1
226443,(,0,1
226444,b,0,1
226445,),0,1
226446,decreased,0,0
226447,the,0,0
226448,occipital,0,1
226449,P3,0,1
226450,component,0,0
226451,of,0,0
226452,the,0,0
226453,ERP,0,0
226454,to,0,1
226455,auditory,0,1
226456,targets,0,0
226457,",",0,1
226458,(,0,1
226459,c,0,1
226460,),0,1
226461,did,0,0
226462,not,0,0
226463,affect,0,0
226464,visual,0,0
226465,and,0,0
226466,auditory,0,1
226467,parietal,0,1
226468,target,0,1
226469,P3,0,1
226470,components,0,0
226471,",",0,1
226472,and,0,0
226473,(,0,0
226474,d,0,0
226475,),0,1
226476,also,0,0
226477,did,0,0
226478,not,0,0
226479,affect,0,0
226480,the,0,0
226481,A/Pcz/300,0,0
226482,to,0,0
226483,auditory,0,1
226484,novel,0,1
226485,stimuli,0,0
226486,.,0,1
226487,In,0,0
226488,addition,0,0
226489,",",0,1
226490,ORG-2766,0,0
226491,treatment,0,0
226492,increased,0,0
226493,the,0,0
226494,N1,0,0
226495,component,0,0
226496,of,0,0
226497,the,0,0
226498,ERP,0,0
226499,to,0,0
226500,task-irrelevant,0,0
226501,auditory,0,1
226502,stimuli,0,1
226503,.,0,1
226504,The,0,0
226505,comparative,0,0
226506,safety,0,0
226507,and,0,1
226508,diagnostic,0,0
226509,accuracy,0,0
226510,of,0,0
226511,adenosine,0,0
226512,myocardial,0,1
226513,perfusion,0,0
226514,imaging,0,0
226515,in,0,0
226516,women,1,1
226517,versus,1,0
226518,men,1,1
226519,.,1,1
226520,STUDY,0,0
226521,OBJECTIVE,0,0
226522,To,0,0
226523,determine,0,0
226524,if,0,0
226525,the,0,0
226526,diagnostic,0,0
226527,accuracy,0,0
226528,and,0,0
226529,safety,0,0
226530,of,0,0
226531,intravenous,0,1
226532,adenosine,0,0
226533,myocardial,0,1
226534,perfusion,0,0
226535,imaging,0,0
226536,is,0,0
226537,significantly,0,0
226538,different,0,0
226539,in,0,1
226540,men,0,1
226541,compared,0,0
226542,with,0,1
226543,women,0,1
226544,.,0,1
226545,DESIGN,0,0
226546,Prospective,0,0
226547,",",0,0
226548,comparative,0,0
226549,",",0,0
226550,open-label,0,1
226551,clinical,0,0
226552,trial,0,1
226553,.,0,1
226554,SETTING,0,1
226555,Nuclear,1,0
226556,medicine,1,1
226557,laboratory,1,0
226558,in,1,0
226559,a,1,1
226560,university-affiliated,1,1
226561,hospital,1,1
226562,.,1,1
226563,PATIENTS,0,0
226564,Consecutive,1,1
226565,patients,1,1
226566,who,1,1
226567,were,1,1
226568,referred,1,1
226569,for,1,0
226570,evaluation,1,0
226571,of,1,0
226572,known,1,1
226573,or,1,1
226574,suspected,1,1
226575,coronary,1,1
226576,artery,1,1
226577,disease,1,1
226578,.,1,1
226579,Patients,1,1
226580,were,1,0
226581,judged,1,0
226582,not,1,0
226583,to,1,0
226584,be,1,0
226585,able,1,0
226586,to,1,0
226587,exercise,1,0
226588,adequately,1,1
226589,.,1,1
226590,INTERVENTIONS,0,0
226591,Coronary,0,1
226592,angiography,0,1
226593,was,0,0
226594,conducted,0,1
226595,within,0,1
226596,6,0,1
226597,weeks,0,0
226598,of,0,1
226599,an,0,1
226600,adenosine,0,0
226601,thallium-201,0,1
226602,myocardial,0,1
226603,perfusion,0,0
226604,imaging,0,0
226605,study,0,1
226606,.,0,1
226607,MEASUREMENTS,0,0
226608,AND,0,0
226609,MAIN,0,0
226610,RESULTS,0,1
226611,Diagnostic,0,0
226612,accuracy,0,0
226613,is,0,0
226614,shown,0,0
226615,in,0,0
226616,the,0,0
226617,table,0,0
226618,.,0,1
226619,[,0,0
226620,table,0,0
226621,:,0,1
226622,see,0,1
226623,text,0,0
226624,],0,1
226625,Overall,0,0
226626,",",0,1
226627,side,0,0
226628,effects,0,0
226629,from,0,1
226630,adenosine,0,0
226631,were,0,1
226632,not,0,0
226633,different,0,0
226634,between,0,0
226635,men,0,1
226636,and,0,1
226637,women,0,1
226638,.,0,1
226639,The,0,0
226640,frequencies,0,0
226641,of,0,0
226642,ST,0,1
226643,depression,0,1
226644,and,0,0
226645,chest,0,1
226646,pain,0,1
226647,were,0,0
226648,significantly,0,0
226649,greater,0,0
226650,in,0,0
226651,women,0,1
226652,than,0,1
226653,men,0,1
226654,",",0,1
226655,although,0,0
226656,their,0,1
226657,etiologies,0,1
226658,are,0,0
226659,unknown,0,0
226660,.,0,1
226661,The,0,0
226662,frequency,0,0
226663,of,0,0
226664,severe,0,1
226665,side,0,0
226666,effects,0,0
226667,such,0,0
226668,as,0,0
226669,heart,0,1
226670,block,0,1
226671,and,0,0
226672,hypotension,0,0
226673,was,0,0
226674,not,0,0
226675,different,0,0
226676,between,0,0
226677,men,1,1
226678,and,1,1
226679,women,1,1
226680,.,1,1
226681,CONCLUSIONS,0,0
226682,The,0,0
226683,diagnostic,0,0
226684,accuracy,0,0
226685,and,0,0
226686,safety,0,0
226687,of,0,0
226688,adenosine,0,0
226689,thallium-201,0,1
226690,myocardial,0,1
226691,perfusion,0,0
226692,imaging,0,0
226693,are,0,0
226694,generally,0,0
226695,similar,0,0
226696,in,0,1
226697,women,1,1
226698,and,1,1
226699,men,1,1
226700,.,1,1
226701,Secondary,0,1
226702,caries,0,1
226703,formation,0,0
226704,in,0,1
226705,vitro,0,0
226706,around,0,1
226707,glass,1,1
226708,ionomer-lined,1,1
226709,amalgam,1,1
226710,and,1,1
226711,composite,1,0
226712,restorations,1,1
226713,.,1,1
226714,The,0,0
226715,aim,0,0
226716,of,0,0
226717,this,0,0
226718,in,0,0
226719,vitro,0,0
226720,secondary,0,1
226721,caries,0,1
226722,study,0,1
226723,was,0,0
226724,to,0,0
226725,examine,0,0
226726,the,0,0
226727,glass-ionomer,0,0
226728,liner,0,0
226729,'s,0,1
226730,effect,0,0
226731,on,0,0
226732,wall-lesion,0,0
226733,inhibition,0,0
226734,when,0,0
226735,a,0,1
226736,conventional,0,0
226737,and,0,0
226738,a,0,1
226739,light-cured,0,0
226740,glass,0,0
226741,ionomer,0,0
226742,liner,0,0
226743,was,0,0
226744,placed,0,0
226745,under,0,1
226746,amalgam,0,1
226747,and,0,1
226748,composite,0,0
226749,resin,0,1
226750,restorations,0,1
226751,.,0,1
226752,Class,0,0
226753,V,0,0
226754,preparations,0,0
226755,in,0,1
226756,extracted,1,1
226757,upper,1,1
226758,premolars,1,1
226759,were,1,1
226760,used,1,0
226761,and,1,1
226762,ten,1,1
226763,restorations,1,1
226764,were,1,1
226765,used,1,0
226766,for,1,0
226767,each,1,0
226768,of,1,0
226769,the,1,0
226770,following,1,0
226771,groups,1,1
226772,:,1,1
226773,(,1,1
226774,i,1,1
226775,),1,1
226776,two,1,0
226777,layers,1,0
226778,of,1,1
226779,copal,1,1
226780,varnish,1,1
226781,and,1,1
226782,amalgam,1,1
226783,;,1,0
226784,(,1,1
226785,ii,1,1
226786,),1,1
226787,conventional,1,1
226788,glass-ionomer,1,0
226789,and,1,1
226790,amalgam,1,1
226791,;,1,0
226792,(,1,1
226793,iii,1,1
226794,),1,1
226795,light-cured,1,0
226796,glass-ionomer,1,0
226797,and,1,1
226798,amalgam,1,1
226799,;,1,0
226800,(,1,1
226801,iv,1,1
226802,),1,1
226803,bonding,1,0
226804,agent,1,0
226805,and,1,1
226806,light-cured,1,0
226807,composite,1,0
226808,resin,1,1
226809,;,1,1
226810,(,1,1
226811,v,1,0
226812,),1,1
226813,conventional,1,1
226814,glass-ionomer,1,0
226815,",",1,1
226816,bonding,1,0
226817,agent,1,0
226818,and,1,1
226819,light-cured,1,0
226820,composite,1,0
226821,resin,1,1
226822,;,1,1
226823,(,1,1
226824,vi,1,0
226825,),1,1
226826,light-cured,1,0
226827,glass-ionomer,1,0
226828,",",1,1
226829,extended,1,1
226830,0.3,1,0
226831,mm,1,1
226832,short,1,0
226833,of,1,0
226834,the,1,0
226835,enamel,1,1
226836,margin,1,0
226837,bonding,1,0
226838,agent,1,0
226839,and,1,1
226840,light-cured,1,0
226841,composite,1,0
226842,resin,1,1
226843,;,1,1
226844,and,1,0
226845,(,1,1
226846,vii,1,0
226847,),1,1
226848,light-cured,1,0
226849,glass-ionomer,1,0
226850,",",1,1
226851,extended,1,1
226852,1,1,0
226853,mm,1,1
226854,short,1,0
226855,of,1,0
226856,the,1,0
226857,enamel,1,1
226858,margin,1,0
226859,",",1,0
226860,bonding,1,0
226861,agent,1,0
226862,and,1,1
226863,light-cured,1,0
226864,composite,1,0
226865,resin,1,1
226866,.,1,1
226867,The,0,0
226868,teeth,1,1
226869,were,0,1
226870,thermocycled,0,1
226871,and,0,1
226872,artificial,0,1
226873,caries,0,1
226874,were,0,1
226875,created,0,0
226876,using,0,0
226877,an,0,0
226878,acid-gel,0,0
226879,.,0,1
226880,The,0,0
226881,results,0,0
226882,of,0,0
226883,this,0,0
226884,study,0,0
226885,showed,0,0
226886,that,0,0
226887,artificial,0,1
226888,recurrent,0,1
226889,caries,0,1
226890,can,0,0
226891,be,0,0
226892,reduced,0,0
226893,significantly,0,0
226894,(,0,1
226895,P,0,0
226896,<,0,0
226897,0.05,0,0
226898,),0,1
226899,with,0,1
226900,a,0,1
226901,glass-ionomer,0,0
226902,liner,0,0
226903,under,0,1
226904,amalgam,0,1
226905,restorations,0,1
226906,.,0,1
226907,The,0,0
226908,results,0,0
226909,also,0,0
226910,showed,0,0
226911,that,0,0
226912,when,0,0
226913,the,0,0
226914,light-cured,0,0
226915,glass-ionomer,0,0
226916,liner,0,1
226917,was,0,0
226918,placed,0,0
226919,0.3,0,0
226920,mm,0,1
226921,from,0,1
226922,the,0,0
226923,cavosurface,0,0
226924,margin,0,0
226925,under,0,1
226926,composite,0,0
226927,resin,0,1
226928,restoration,0,0
226929,",",0,0
226930,the,0,0
226931,artificial,0,1
226932,recurrent,0,1
226933,caries,0,1
226934,reduced,0,0
226935,significantly,0,0
226936,(,0,1
226937,P,0,0
226938,<,0,0
226939,0.05,0,0
226940,),0,1
226941,.,0,1
226942,Levosulpiride,0,0
226943,in,0,1
226944,functional,1,1
226945,dyspepsia,1,1
226946,:,1,1
226947,a,0,0
226948,multicentric,0,1
226949,",",0,0
226950,double-blind,0,0
226951,",",0,0
226952,controlled,0,0
226953,trial,0,1
226954,.,0,1
226955,Abnormalities,0,0
226956,in,0,0
226957,gastrointestinal,0,1
226958,motility,0,0
226959,have,0,0
226960,been,0,0
226961,reported,0,0
226962,in,0,0
226963,a,0,1
226964,substantial,0,0
226965,proportion,0,1
226966,of,0,1
226967,patients,1,1
226968,with,1,1
226969,functional,1,1
226970,dyspepsia,1,1
226971,",",1,0
226972,supporting,1,0
226973,the,1,0
226974,use,1,0
226975,of,1,0
226976,prokinetic,1,0
226977,drugs,1,0
226978,for,1,1
226979,treatment,1,1
226980,of,1,1
226981,dyspeptic,1,1
226982,symptoms,1,1
226983,.,1,1
226984,To,0,0
226985,evaluate,0,0
226986,efficacy,0,0
226987,and,0,0
226988,safety,0,0
226989,of,0,0
226990,levosulpiride,0,0
226991,in,0,1
226992,short-term,0,0
226993,treatment,0,1
226994,",",0,1
226995,1298,1,1
226996,patients,1,1
226997,were,1,1
226998,enrolled,1,1
226999,in,1,0
227000,a,1,1
227001,double-blind,1,0
227002,multicentric,1,1
227003,study,1,1
227004,carried,1,0
227005,out,1,1
227006,in,1,1
227007,45,1,1
227008,Italian,1,1
227009,Gastroenterology,1,1
227010,Departments,1,1
227011,.,1,1
227012,Patients,0,1
227013,were,0,0
227014,randomly,0,1
227015,assigned,0,1
227016,to,0,0
227017,either,0,0
227018,levosulpiride,0,0
227019,(,0,0
227020,25,0,1
227021,mg,0,1
227022,tid,0,0
227023,),0,0
227024,",",0,0
227025,domperidone,0,0
227026,(,0,0
227027,10,0,1
227028,mg,0,1
227029,tid,0,0
227030,),0,0
227031,",",0,0
227032,metoclopramide,0,0
227033,(,0,0
227034,10,0,0
227035,mg,0,1
227036,tid,0,0
227037,),0,0
227038,or,0,1
227039,placebo,0,0
227040,(,0,1
227041,1,0,0
227042,tablet,0,0
227043,tid,0,0
227044,),0,1
227045,for,0,1
227046,4,0,1
227047,weeks,0,1
227048,.,0,1
227049,Patients,1,1
227050,were,1,0
227051,selected,1,1
227052,on,1,0
227053,the,1,0
227054,basis,1,0
227055,of,1,0
227056,:,1,1
227057,a,1,1
227058,),1,0
227059,occurrence,1,0
227060,in,1,0
227061,the,1,0
227062,last,1,1
227063,4,1,0
227064,weeks,1,0
227065,of,1,1
227066,at,1,1
227067,least,1,1
227068,5/10,1,1
227069,selected,1,1
227070,symptoms,1,1
227071,(,1,1
227072,anorexia,1,1
227073,",",1,0
227074,nausea,1,0
227075,",",1,0
227076,vomiting,1,0
227077,",",1,0
227078,upper,1,1
227079,abdominal,1,1
227080,pain,1,1
227081,",",1,0
227082,postprandial,1,0
227083,bloating,1,0
227084,",",1,0
227085,abdominal,1,1
227086,fullness,1,0
227087,",",1,0
227088,early,1,1
227089,satiety,1,0
227090,",",1,0
227091,belching,1,0
227092,",",1,0
227093,heartburn,1,0
227094,",",1,0
227095,regurgitation,1,1
227096,),1,0
227097,",",1,0
227098,severity,1,0
227099,of,1,0
227100,which,1,0
227101,should,1,0
227102,reach/exceed,1,0
227103,a,1,0
227104,total,1,1
227105,score,1,0
227106,of,1,0
227107,8,1,0
227108,",",1,1
227109,as,1,0
227110,assessed,1,0
227111,by,1,0
227112,a,1,1
227113,specific,1,0
227114,scale,1,0
227115,ranging,1,1
227116,from,1,1
227117,0,1,0
227118,(,1,1
227119,absent,1,1
227120,),1,1
227121,to,1,1
227122,3,1,1
227123,(,1,1
227124,severe,1,1
227125,),1,1
227126,;,1,1
227127,b,1,1
227128,),1,1
227129,normal,1,1
227130,results,1,0
227131,of,1,1
227132,routine,1,1
227133,biochemical,1,0
227134,",",1,0
227135,ultrasound,1,0
227136,and,1,1
227137,endoscopic,1,1
227138,examinations,1,1
227139,.,1,1
227140,In,0,0
227141,addition,0,0
227142,",",0,0
227143,each,0,0
227144,patient,0,0
227145,subjectively,0,0
227146,evaluated,0,0
227147,efficacy,0,0
227148,of,0,0
227149,treatment,0,0
227150,by,0,0
227151,a,0,1
227152,visual,0,0
227153,analogue,0,0
227154,scale,0,1
227155,.,0,1
227156,Significant,0,0
227157,improvement,0,0
227158,was,0,0
227159,recorded,0,0
227160,for,0,0
227161,all,0,1
227162,symptoms,0,1
227163,at,0,1
227164,days,0,1
227165,10,0,1
227166,and,0,1
227167,28,0,1
227168,in,0,1
227169,all,0,1
227170,groups,0,0
227171,(,0,1
227172,p,0,0
227173,<,0,0
227174,0.001,0,0
227175,),0,1
227176,",",0,0
227177,but,0,0
227178,levosulpiride,0,0
227179,was,0,0
227180,significantly,0,0
227181,(,0,0
227182,p,0,0
227183,<,0,0
227184,0.01,0,0
227185,),0,1
227186,superior,0,0
227187,to,0,0
227188,domperidone,0,0
227189,",",0,0
227190,metoclopramide,0,0
227191,and,0,0
227192,placebo,0,0
227193,both,0,0
227194,in,0,0
227195,the,0,0
227196,overall,0,0
227197,clinical,0,0
227198,improvement,0,0
227199,scale,0,0
227200,as,0,0
227201,well,0,0
227202,as,0,0
227203,in,0,0
227204,a,0,1
227205,subgroup,0,1
227206,of,0,0
227207,symptoms,0,1
227208,(,0,1
227209,postprandial,0,1
227210,bloating,0,1
227211,",",0,0
227212,epigastric,0,1
227213,pain,0,1
227214,",",0,0
227215,heartburn,0,1
227216,),0,1
227217,.,0,1
227218,Active,0,0
227219,treatments,0,0
227220,and,0,1
227221,placebo,0,1
227222,were,0,1
227223,comparable,0,0
227224,as,0,0
227225,far,0,1
227226,as,0,0
227227,concerns,0,0
227228,occurrence,0,0
227229,of,0,1
227230,side-effects,0,0
227231,(,0,1
227232,12-20,0,1
227233,%,0,0
227234,),0,1
227235,including,0,0
227236,galactorrhoea,0,1
227237,",",0,0
227238,breast,0,1
227239,tenderness,0,0
227240,and,0,1
227241,menstrual,0,1
227242,changes,0,0
227243,.,0,1
227244,Improved,0,0
227245,local,0,0
227246,control,0,1
227247,of,0,0
227248,invasive,0,1
227249,bladder,0,1
227250,cancer,0,1
227251,by,0,0
227252,concurrent,0,0
227253,cisplatin,0,0
227254,and,0,0
227255,preoperative,0,0
227256,or,0,1
227257,definitive,0,1
227258,radiation,0,1
227259,.,0,1
227260,The,0,0
227261,National,0,0
227262,Cancer,0,1
227263,Institute,0,1
227264,of,0,1
227265,Canada,0,1
227266,Clinical,0,0
227267,Trials,0,1
227268,Group,0,1
227269,.,0,1
227270,PURPOSE,0,0
227271,A,0,1
227272,prospective,0,1
227273,randomized,0,1
227274,trial,0,1
227275,was,0,0
227276,conducted,0,0
227277,to,0,0
227278,determine,0,0
227279,whether,0,0
227280,the,0,0
227281,addition,0,0
227282,of,0,0
227283,concurrent,0,0
227284,cisplatin,0,0
227285,to,0,0
227286,preoperative,0,0
227287,or,0,1
227288,definitive,0,0
227289,radiation,0,1
227290,therapy,0,1
227291,in,0,0
227292,patients,1,1
227293,with,1,1
227294,muscle-invasive,1,1
227295,bladder,1,1
227296,cancer,1,1
227297,improved,1,0
227298,local,1,0
227299,control,1,1
227300,or,1,1
227301,survival,1,0
227302,.,1,1
227303,PATIENTS,0,0
227304,AND,0,0
227305,METHODS,0,0
227306,Ninety-nine,1,1
227307,eligible,1,1
227308,patients,1,1
227309,with,1,1
227310,T2,1,1
227311,to,1,1
227312,T4b,1,1
227313,transitional,1,1
227314,cell,1,1
227315,bladder,1,1
227316,cancer,1,1
227317,participated,1,1
227318,",",1,0
227319,64,1,1
227320,%,1,0
227321,with,1,1
227322,cT3b,1,0
227323,or,1,1
227324,cT4,1,1
227325,.,1,1
227326,Patients,0,1
227327,and,0,1
227328,their,0,1
227329,physicians,0,1
227330,selected,0,1
227331,either,0,1
227332,definitive,0,0
227333,radiotherapy,0,1
227334,or,0,1
227335,precystectomy,0,1
227336,radiotherapy,0,1
227337,;,0,1
227338,patients,0,1
227339,were,0,1
227340,then,0,0
227341,randomly,0,1
227342,allocated,0,1
227343,to,0,0
227344,receive,0,1
227345,intravenous,0,1
227346,cisplatin,0,0
227347,100,0,1
227348,mg/m2,0,1
227349,at,0,1
227350,2-week,0,0
227351,intervals,0,0
227352,for,0,1
227353,three,0,1
227354,cycles,0,0
227355,concurrent,0,1
227356,with,0,1
227357,pelvic,0,1
227358,radiation,0,1
227359,",",0,0
227360,or,0,0
227361,to,0,0
227362,receive,0,1
227363,radiation,0,0
227364,without,0,1
227365,chemotherapy,0,1
227366,.,0,1
227367,Patients,0,1
227368,were,0,0
227369,stratified,0,1
227370,by,0,0
227371,clinical,0,0
227372,tumor,0,1
227373,stage,0,1
227374,and,0,0
227375,by,0,0
227376,radiation,0,1
227377,plan,0,1
227378,.,0,1
227379,The,0,0
227380,median,0,0
227381,follow-up,0,0
227382,duration,0,0
227383,is,0,0
227384,6.5,0,0
227385,years,0,1
227386,.,0,1
227387,RESULTS,0,0
227388,The,0,0
227389,occurrence,0,0
227390,of,0,0
227391,distant,0,1
227392,metastases,0,1
227393,was,0,0
227394,the,0,0
227395,same,0,0
227396,in,0,0
227397,both,0,0
227398,study,0,1
227399,arms,0,0
227400,.,0,1
227401,However,0,0
227402,",",0,0
227403,25,0,1
227404,of,0,0
227405,48,0,1
227406,control,0,1
227407,patients,0,1
227408,have,0,0
227409,had,0,1
227410,a,0,0
227411,first,0,0
227412,recurrence,0,0
227413,in,0,0
227414,the,0,0
227415,pelvis,0,1
227416,",",0,0
227417,compared,0,0
227418,with,0,1
227419,15,0,1
227420,of,0,1
227421,51,0,1
227422,cisplatin-treated,0,1
227423,patients,0,1
227424,(,0,1
227425,P,0,0
227426,=,0,1
227427,.036,0,0
227428,),0,1
227429,.,0,1
227430,The,0,0
227431,pelvic,0,1
227432,relapse,0,0
227433,rate,0,0
227434,in,0,0
227435,the,0,1
227436,two,0,1
227437,groups,0,0
227438,was,0,0
227439,significantly,0,0
227440,reduced,0,0
227441,by,0,0
227442,concurrent,0,0
227443,cisplatin,0,0
227444,(,0,1
227445,P,0,0
227446,=,0,1
227447,.038,0,0
227448,",",0,0
227449,log-rank,0,0
227450,test,0,0
227451,),0,1
227452,and,0,0
227453,this,0,0
227454,effect,0,0
227455,was,0,0
227456,preserved,0,0
227457,in,0,0
227458,a,0,1
227459,stepwise,0,0
227460,Cox,0,0
227461,regression,0,0
227462,model,0,0
227463,of,0,1
227464,prognostic,0,0
227465,factors,0,0
227466,(,0,1
227467,hazards,0,0
227468,ratio,0,0
227469,",",0,1
227470,0.50,0,0
227471,;,0,1
227472,90,0,1
227473,%,0,0
227474,confidence,0,0
227475,interval,0,0
227476,[,0,0
227477,CI,0,0
227478,],0,1
227479,",",0,1
227480,0.29,0,0
227481,to,0,1
227482,0.86,0,0
227483,;,0,1
227484,P,0,0
227485,=,0,1
227486,.036,0,0
227487,),0,1
227488,.,0,1
227489,The,0,0
227490,hazard,0,0
227491,reduction,0,0
227492,was,0,0
227493,similar,0,0
227494,for,0,0
227495,both,0,0
227496,radiation,0,1
227497,plans,0,1
227498,.,0,1
227499,Pretreatment,0,0
227500,leukocytosis,0,1
227501,and,0,1
227502,high,0,1
227503,clinical,0,0
227504,stage,0,1
227505,were,0,1
227506,independent,0,0
227507,adverse,0,0
227508,factors,0,0
227509,in,0,1
227510,a,0,1
227511,Cox,0,0
227512,model,0,0
227513,of,0,0
227514,overall,0,0
227515,survival,0,0
227516,",",0,0
227517,but,0,0
227518,the,0,0
227519,effect,0,0
227520,of,0,0
227521,cisplatin,0,0
227522,was,0,0
227523,not,0,0
227524,significant,0,0
227525,.,0,1
227526,CONCLUSION,0,0
227527,Concurrent,0,0
227528,cisplatin,0,0
227529,may,0,0
227530,improve,0,0
227531,pelvic,0,1
227532,control,0,1
227533,of,0,0
227534,locally,0,1
227535,advanced,0,1
227536,bladder,0,1
227537,cancer,0,1
227538,with,0,1
227539,preoperative,0,1
227540,or,0,1
227541,definitive,0,0
227542,radiation,0,1
227543,",",0,0
227544,but,0,0
227545,has,0,0
227546,not,0,0
227547,been,0,0
227548,shown,0,0
227549,to,0,0
227550,improve,0,0
227551,overall,0,0
227552,survival,0,0
227553,.,0,1
227554,The,0,0
227555,use,0,0
227556,of,0,0
227557,concurrent,0,0
227558,cisplatin,0,0
227559,had,0,1
227560,no,0,0
227561,detectable,0,0
227562,effect,0,0
227563,on,0,0
227564,distant,0,1
227565,metastases,0,1
227566,.,0,1
227567,Durability,0,0
227568,of,0,0
227569,central,0,1
227570,venous,0,1
227571,catheters,0,1
227572,.,0,1
227573,A,0,0
227574,randomized,0,0
227575,trial,0,0
227576,in,0,1
227577,children,1,1
227578,with,1,1
227579,malignant,1,1
227580,diseases,1,1
227581,.,1,1
227582,In,0,0
227583,a,0,0
227584,prospective,0,1
227585,randomized,0,1
227586,study,0,1
227587,the,0,0
227588,durability,0,0
227589,of,0,0
227590,tunnelled,0,1
227591,and,0,1
227592,non-tunnelled,0,1
227593,central,0,1
227594,venous,0,1
227595,catheters,0,1
227596,was,0,0
227597,investigated,0,0
227598,in,0,0
227599,children,1,1
227600,with,1,1
227601,malignant,1,1
227602,diseases,1,1
227603,.,1,1
227604,Twenty,1,1
227605,children,1,1
227606,were,1,1
227607,included,1,1
227608,in,1,0
227609,the,1,0
227610,study,1,1
227611,but,1,0
227612,four,1,1
227613,(,1,1
227614,two,1,0
227615,in,1,0
227616,each,1,1
227617,group,1,1
227618,),1,0
227619,had,1,1
227620,to,1,0
227621,be,1,0
227622,excluded,1,1
227623,;,1,0
227624,three,1,0
227625,because,1,0
227626,the,1,0
227627,entry,1,1
227628,criteria,1,1
227629,turned,1,0
227630,out,1,1
227631,not,1,0
227632,to,1,0
227633,be,1,0
227634,fulfilled,1,1
227635,and,1,0
227636,one,1,1
227637,because,1,0
227638,of,1,0
227639,lack,1,0
227640,of,1,1
227641,data,1,0
227642,.,1,1
227643,The,0,0
227644,median,0,0
227645,duration,0,0
227646,of,0,0
227647,the,0,0
227648,tunnelled,0,1
227649,catheters,0,1
227650,was,0,1
227651,224,0,1
227652,days,0,0
227653,with,0,1
227654,a,0,1
227655,range,0,1
227656,of,0,0
227657,25-846,0,1
227658,days,0,0
227659,which,0,0
227660,was,0,0
227661,significantly,0,0
227662,longer,0,0
227663,than,0,0
227664,that,0,0
227665,of,0,0
227666,conventional,0,1
227667,catheters,0,1
227668,(,0,1
227669,39.5,0,0
227670,days,0,0
227671,",",0,1
227672,range,0,1
227673,9-228,0,1
227674,days,0,1
227675,),0,1
227676,.,0,1
227677,In,0,0
227678,addition,0,0
227679,six,0,1
227680,of,0,1
227681,eight,0,1
227682,conventional,0,1
227683,catheters,0,1
227684,were,0,1
227685,accidentally,0,1
227686,removed,0,0
227687,whereas,0,0
227688,all,0,1
227689,catheters,0,0
227690,in,0,0
227691,the,0,1
227692,tunnelled,0,1
227693,group,0,1
227694,had,0,1
227695,to,0,0
227696,be,0,0
227697,removed,0,0
227698,via,0,0
227699,a,0,1
227700,small,0,1
227701,incision,0,1
227702,.,0,1
227703,Three,0,1
227704,cases,0,1
227705,of,0,1
227706,catheter,0,1
227707,related,0,0
227708,sepsis,0,1
227709,",",0,0
227710,two,0,0
227711,in,0,0
227712,the,0,0
227713,tunnelled,0,1
227714,group,0,1
227715,and,0,1
227716,one,0,1
227717,in,0,0
227718,the,0,0
227719,conventional,0,0
227720,group,0,0
227721,",",0,0
227722,were,0,0
227723,registered,0,1
227724,.,0,1
227725,The,0,0
227726,corresponding,0,0
227727,number,0,0
227728,of,0,1
227729,infections,0,1
227730,per,0,1
227731,catheter,0,1
227732,days,0,0
227733,were,0,1
227734,1,0,1
227735,in,0,1
227736,1189,0,1
227737,days,0,1
227738,and,0,1
227739,1,0,1
227740,in,0,1
227741,522,0,1
227742,days,0,0
227743,",",0,1
227744,respectively,0,0
227745,.,0,0
227746,In,0,0
227747,conclusion,0,0
227748,cuffed,0,1
227749,",",0,0
227750,tunnelled,0,1
227751,central,0,1
227752,venous,0,1
227753,catheters,0,0
227754,are,0,0
227755,less,0,0
227756,prone,0,0
227757,to,0,0
227758,displacement,0,1
227759,than,0,0
227760,traditional,0,0
227761,percutaneous,0,1
227762,central,0,1
227763,venous,0,1
227764,catheters,0,0
227765,when,0,0
227766,used,0,0
227767,in,0,0
227768,children,1,1
227769,with,1,1
227770,malignant,1,1
227771,diseases,1,1
227772,.,1,1
227773,The,0,0
227774,immunogenicity,0,0
227775,of,0,0
227776,three,0,0
227777,Haemophilus,0,1
227778,influenzae,0,1
227779,type,0,1
227780,B,0,1
227781,conjugate,0,0
227782,vaccines,1,0
227783,after,1,1
227784,a,1,1
227785,primary,1,1
227786,vaccination,1,1
227787,series,1,1
227788,in,1,1
227789,Philippine,1,1
227790,infants,1,1
227791,.,1,1
227792,Serum,0,1
227793,antibody,0,0
227794,responses,0,0
227795,to,0,1
227796,three,0,1
227797,Haemophilus,0,1
227798,influenzae,0,1
227799,type,0,1
227800,b,0,1
227801,(,0,1
227802,Hib,0,1
227803,),0,1
227804,capsular,0,0
227805,polysaccharide-protein,0,0
227806,conjugate,0,0
227807,vaccine,0,1
227808,(,0,1
227809,PRP-OMP,0,1
227810,",",0,0
227811,PRP-T,0,0
227812,",",0,0
227813,and,0,0
227814,HbOC,0,0
227815,),0,1
227816,were,0,0
227817,evaluated,0,0
227818,in,1,1
227819,174,1,1
227820,Philippine,1,1
227821,infants,1,1
227822,after,1,1
227823,a,1,1
227824,primary,1,1
227825,vaccination,1,1
227826,series,1,1
227827,.,1,1
227828,Children,0,1
227829,were,0,0
227830,randomized,0,1
227831,to,0,0
227832,receive,0,1
227833,one,0,1
227834,of,0,0
227835,the,0,1
227836,Hib,0,0
227837,vaccines,0,0
227838,(,0,1
227839,Hib,0,1
227840,groups,0,1
227841,),0,1
227842,or,0,1
227843,into,0,1
227844,a,0,0
227845,control,0,1
227846,group,0,1
227847,.,0,1
227848,Vaccination,0,1
227849,was,0,0
227850,carried,0,0
227851,out,0,1
227852,at,0,0
227853,six,0,1
227854,",",0,1
227855,10,0,1
227856,and,0,1
227857,14,0,1
227858,weeks,0,0
227859,of,0,1
227860,age,0,1
227861,based,0,1
227862,on,0,0
227863,the,0,0
227864,local,0,0
227865,Expanded,0,1
227866,Program,0,1
227867,of,0,0
227868,Immunization,0,1
227869,schedule,0,0
227870,.,0,1
227871,Sera,0,0
227872,were,0,0
227873,collected,0,1
227874,at,0,1
227875,six,0,1
227876,weeks,0,1
227877,of,0,1
227878,age,0,1
227879,for,0,0
227880,the,0,0
227881,Hib,0,0
227882,groups,0,0
227883,and,0,1
227884,one,0,1
227885,month,0,0
227886,after,0,0
227887,the,0,0
227888,third,0,1
227889,dose,0,0
227890,for,0,0
227891,all,0,1
227892,subjects,0,1
227893,.,0,1
227894,Anti-Hib,0,0
227895,concentrations,0,0
227896,were,0,1
227897,determined,0,0
227898,by,0,0
227899,the,0,0
227900,Farr-type,0,1
227901,radioimmunoassay,0,0
227902,.,0,0
227903,There,0,0
227904,were,0,0
227905,no,0,0
227906,significant,0,0
227907,differences,0,0
227908,(,0,1
227909,P,0,0
227910,=,0,1
227911,0.3626,0,0
227912,),0,1
227913,in,0,0
227914,the,0,0
227915,prevaccination,0,1
227916,anti-Hib,0,0
227917,geometric,0,1
227918,mean,0,1
227919,concentration,0,0
227920,(,0,1
227921,GMC,0,1
227922,),0,1
227923,among,0,1
227924,the,0,0
227925,three,0,0
227926,Hib,0,1
227927,groups,0,1
227928,.,0,1
227929,Differences,0,0
227930,in,0,0
227931,the,0,0
227932,GMC,0,0
227933,after,0,0
227934,the,0,0
227935,primary,0,1
227936,series,0,1
227937,of,0,1
227938,three,0,1
227939,doses,0,0
227940,were,0,1
227941,significant,0,0
227942,(,0,1
227943,P,0,0
227944,<,0,0
227945,0.0001,0,0
227946,),0,1
227947,;,0,1
227948,GMC,0,1
227949,was,0,0
227950,highest,0,0
227951,for,0,0
227952,PRP-T,0,1
227953,(,0,1
227954,6.62,0,0
227955,micrograms/ml,0,0
227956,),0,1
227957,",",0,0
227958,followed,0,0
227959,by,0,0
227960,HbOC,0,1
227961,(,0,1
227962,1.9,0,0
227963,micrograms/ml,0,0
227964,),0,0
227965,",",0,0
227966,then,0,0
227967,PRP-OMP,0,1
227968,(,0,1
227969,1.06,0,0
227970,micrograms/ml,0,0
227971,),0,1
227972,",",0,0
227973,and,0,0
227974,lowest,0,0
227975,for,0,0
227976,the,0,0
227977,control,0,1
227978,group,0,1
227979,(,0,1
227980,0.11,0,0
227981,microgram/ml,0,0
227982,),0,1
227983,.,0,1
227984,We,0,0
227985,conclude,0,0
227986,that,0,0
227987,all,0,1
227988,three,0,0
227989,Hib,0,0
227990,conjugate,0,0
227991,vaccines,0,0
227992,(,0,1
227993,PRP-T,0,1
227994,",",0,0
227995,HbOC,0,0
227996,",",0,0
227997,and,0,0
227998,PRP-OMP,0,1
227999,),0,1
228000,were,0,1
228001,immunogenic,0,1
228002,after,0,1
228003,three,0,1
228004,primary,0,1
228005,doses,0,0
228006,among,0,1
228007,Philippine,1,1
228008,infants,1,1
228009,.,1,1
228010,Treatment,0,0
228011,of,0,0
228012,men,1,1
228013,with,1,1
228014,flat,1,1
228015,(,1,1
228016,FC,1,1
228017,),1,1
228018,or,1,1
228019,acuminata,1,1
228020,(,1,1
228021,CA,1,1
228022,),1,1
228023,condylomata,1,1
228024,with,1,1
228025,interferon,1,1
228026,alpha-2a,1,0
228027,.,1,1
228028,This,0,0
228029,study,0,0
228030,was,0,0
228031,undertaken,0,0
228032,to,0,0
228033,assess,0,0
228034,the,0,0
228035,effect,0,0
228036,of,0,0
228037,CO2,0,1
228038,laser,0,0
228039,vaporization,0,0
228040,",",0,0
228041,5-fluorouracil,0,0
228042,5,0,0
228043,%,0,0
228044,(,0,1
228045,5-FU,0,1
228046,),0,1
228047,topical,0,0
228048,application,0,0
228049,and,0,1
228050,Interferon,0,0
228051,alpha-2a,0,0
228052,(,0,1
228053,IFA,0,1
228054,alpha-2a,0,0
228055,),0,1
228056,in,0,0
228057,the,0,0
228058,treatment,0,0
228059,of,0,0
228060,C.A,1,1
228061,.,1,1
228062,or,1,0
228063,F.C,1,0
228064,.,1,1
228065,of,1,0
228066,the,1,0
228067,male,1,1
228068,genital,1,1
228069,tract,1,1
228070,.,1,1
228071,From,1,1
228072,March,1,1
228073,1986,1,1
228074,to,1,1
228075,September,1,1
228076,1991,1,1
228077,",",1,1
228078,1372,1,1
228079,men,1,1
228080,",",1,1
228081,sexual,1,1
228082,partners,1,1
228083,of,1,1
228084,women,1,1
228085,with,1,1
228086,F.C,1,1
228087,.,1,1
228088,or,1,0
228089,C.A,1,0
228090,.,1,1
228091,or,1,0
228092,cervical,1,1
228093,intraepithelial,1,1
228094,neoplasia,1,1
228095,",",1,0
228096,were,1,0
228097,submitted,1,0
228098,to,1,0
228099,peoscopy,1,0
228100,.,1,1
228101,One,1,1
228102,thousand,1,1
228103,and,1,1
228104,nineteen,1,1
228105,(,1,1
228106,74.27,1,1
228107,%,1,0
228108,),1,1
228109,men,1,1
228110,presented,1,1
228111,with,1,1
228112,various,1,0
228113,penile,1,1
228114,lesions,1,1
228115,caused,1,0
228116,by,1,1
228117,HPV,1,0
228118,(,1,1
228119,histologically,1,1
228120,confirmed,1,1
228121,),1,0
228122,;,1,0
228123,of,0,0
228124,these,0,0
228125,505,1,1
228126,were,1,0
228127,treated,1,1
228128,for,1,1
228129,C.A,1,1
228130,.,1,1
228131,or,1,0
228132,F.C,1,0
228133,.,1,1
228134,or,1,0
228135,a,1,0
228136,combination,1,0
228137,of,1,0
228138,F.C,1,1
228139,.,1,1
228140,and,1,0
228141,C.A,1,0
228142,.,1,1
228143,The,0,0
228144,best,0,0
228145,treatment,0,0
228146,modalities,0,0
228147,",",0,0
228148,irrespective,0,0
228149,of,0,0
228150,the,0,0
228151,kind,0,0
228152,of,0,0
228153,lesion,0,0
228154,",",0,0
228155,were,0,0
228156,found,0,0
228157,to,0,0
228158,be,0,0
228159,the,0,0
228160,combination,0,0
228161,of,0,0
228162,5-FU,0,1
228163,plus,0,0
228164,IFN,0,1
228165,alpha-2a,0,0
228166,(,0,1
228167,high,0,1
228168,dose,0,0
228169,),0,1
228170,(,0,1
228171,98.27,0,1
228172,%,0,0
228173,),0,0
228174,",",0,0
228175,the,0,0
228176,combination,0,0
228177,of,0,0
228178,CO2,0,1
228179,laser,0,0
228180,vaporization,0,0
228181,plus,0,0
228182,5-FU,0,1
228183,plus,0,0
228184,IFN,0,1
228185,alpha-2a,0,0
228186,(,0,1
228187,high,0,1
228188,dose,0,0
228189,),0,1
228190,(,0,1
228191,93.93,0,1
228192,%,0,0
228193,),0,1
228194,and,0,0
228195,the,0,0
228196,combination,0,0
228197,of,0,0
228198,CO2,0,1
228199,laser,0,0
228200,vaporization,0,0
228201,plus,0,0
228202,5-FU,0,1
228203,(,0,1
228204,87.23,0,1
228205,%,0,0
228206,),0,1
228207,.,0,1
228208,In,0,0
228209,conclusion,0,0
228210,we,0,0
228211,believe,0,0
228212,that,0,0
228213,IFN,0,1
228214,alpha-2a,0,0
228215,can,0,0
228216,be,0,0
228217,used,0,0
228218,with,0,1
228219,excellent,0,0
228220,results,0,0
228221,as,0,1
228222,first,0,1
228223,line,0,0
228224,treatment,0,0
228225,in,0,0
228226,combination,0,0
228227,with,0,1
228228,CO2,0,1
228229,laser,0,0
228230,vaporization,0,0
228231,or/plus,0,0
228232,5-FU,0,1
228233,in,0,1
228234,patients,0,1
228235,with,0,1
228236,C.A,1,1
228237,.,1,1
228238,or,1,0
228239,F.C,1,0
228240,.,1,1
228241,or,1,0
228242,combined,1,0
228243,condylomata,1,1
228244,.,0,1
228245,Pedantic,0,1
228246,speaking,0,1
228247,style,0,0
228248,differentiates,0,0
228249,Asperger,0,1
228250,syndrome,0,1
228251,from,0,1
228252,high-functioning,0,1
228253,autism,0,1
228254,.,0,1
228255,Asperger,0,1
228256,syndrome,0,1
228257,(,0,1
228258,AS,0,1
228259,),0,0
228260,is,0,0
228261,a,0,0
228262,pervasive,0,1
228263,developmental,0,1
228264,disorder,0,1
228265,recently,0,1
228266,introduced,0,0
228267,as,0,0
228268,a,0,1
228269,new,0,1
228270,diagnostic,0,0
228271,category,0,1
228272,in,0,0
228273,the,0,0
228274,ICD-10,0,0
228275,and,0,0
228276,the,0,0
228277,DSM-IV,0,1
228278,.,0,1
228279,Along,0,0
228280,with,0,1
228281,motor,0,0
228282,clumsiness,0,1
228283,",",0,0
228284,pedantic,0,0
228285,speech,0,0
228286,has,0,0
228287,been,0,0
228288,proposed,0,0
228289,as,0,0
228290,a,0,1
228291,clinical,0,0
228292,feature,0,1
228293,of,0,1
228294,AS,0,1
228295,.,0,1
228296,However,0,0
228297,",",0,0
228298,few,0,0
228299,attempts,0,1
228300,have,0,1
228301,been,0,0
228302,made,0,0
228303,to,0,0
228304,define,0,0
228305,and,0,0
228306,measure,0,0
228307,this,0,0
228308,symptom,0,0
228309,.,0,1
228310,We,0,0
228311,studied,0,1
228312,17,1,1
228313,patients,1,1
228314,with,1,1
228315,AS,1,1
228316,(,1,1
228317,ICD-10,1,1
228318,;,1,1
228319,14,1,1
228320,male,1,1
228321,",",1,1
228322,3,1,0
228323,female,1,1
228324,;,1,1
228325,mean,1,1
228326,age,1,1
228327,16.4,1,1
228328,years,1,1
228329,",",1,1
228330,mean,1,1
228331,full-scale,1,1
228332,IQ,1,1
228333,97,1,1
228334,),1,1
228335,and,0,1
228336,compared,1,0
228337,them,1,0
228338,with,1,1
228339,a,1,0
228340,control,1,0
228341,group,1,1
228342,of,1,1
228343,13,1,1
228344,patients,1,1
228345,with,1,1
228346,normal-intelligence,1,1
228347,autism,1,1
228348,or,1,1
228349,high-functioning,1,1
228350,autism,1,1
228351,(,1,1
228352,HFA,1,1
228353,),1,1
228354,(,1,1
228355,ICD-10/DSM-III-R,1,0
228356,;,1,1
228357,12,1,1
228358,male,1,1
228359,",",1,1
228360,1,1,0
228361,female,1,1
228362,;,1,1
228363,mean,1,1
228364,age,1,1
228365,15.5,1,1
228366,years,1,1
228367,",",1,1
228368,mean,1,1
228369,full-scale,1,1
228370,IQ,1,1
228371,81.2,1,1
228372,),1,1
228373,.,1,1
228374,An,0,0
228375,operational,0,0
228376,definition,0,1
228377,of,0,0
228378,pedantic,0,1
228379,speech,0,1
228380,was,0,0
228381,formulated,0,0
228382,and,0,0
228383,a,0,0
228384,rating,0,0
228385,scale,0,0
228386,devised,0,0
228387,.,0,1
228388,13,1,0
228389,(,1,1
228390,76,1,1
228391,%,1,0
228392,),1,1
228393,of,1,0
228394,the,1,1
228395,AS,1,1
228396,patients,1,1
228397,were,0,1
228398,rated,0,1
228399,as,0,0
228400,pedantic,0,1
228401,compared,0,0
228402,to,0,1
228403,4,1,0
228404,(,1,1
228405,31,1,1
228406,%,1,0
228407,),1,1
228408,of,1,0
228409,the,1,0
228410,HFA,1,1
228411,group,1,1
228412,(,0,1
228413,chi,0,1
228414,2,0,1
228415,=,0,1
228416,6.3,0,0
228417,;,0,1
228418,p,0,0
228419,=,0,1
228420,.01,0,0
228421,),0,1
228422,.,0,1
228423,Results,0,0
228424,suggest,0,0
228425,that,0,0
228426,pedantic,0,1
228427,speech,0,1
228428,is,0,0
228429,common,0,0
228430,in,0,0
228431,AS,0,1
228432,and,0,0
228433,may,0,0
228434,help,0,0
228435,differentiate,0,0
228436,AS,0,1
228437,from,0,1
228438,high-functioning,0,1
228439,autism,0,1
228440,.,0,1
228441,Prevention,1,1
228442,of,1,0
228443,spinal,1,1
228444,anesthesia-induced,1,1
228445,hypotension,1,0
228446,in,1,0
228447,the,1,0
228448,elderly,1,1
228449,:,1,1
228450,comparison,0,0
228451,between,0,0
228452,preanesthetic,0,0
228453,administration,0,0
228454,of,0,1
228455,crystalloids,0,1
228456,",",0,1
228457,colloids,0,0
228458,",",0,0
228459,and,0,0
228460,no,0,0
228461,prehydration,0,0
228462,.,0,0
228463,The,0,0
228464,practice,1,0
228465,of,1,0
228466,routinely,1,0
228467,prehydrating,1,0
228468,patients,1,1
228469,by,1,0
228470,infusing,1,0
228471,a,1,1
228472,crystalloid,1,0
228473,or,1,1
228474,colloid,1,0
228475,solution,1,0
228476,(,1,1
228477,up,1,1
228478,to,1,1
228479,1.0,1,0
228480,L/70,1,0
228481,kg,1,1
228482,),1,1
228483,for,1,0
228484,prevention,1,1
228485,of,1,1
228486,spinal,1,1
228487,anesthesia-induced,1,0
228488,hypotension,1,0
228489,has,0,0
228490,been,0,0
228491,challenged,0,0
228492,recently,0,1
228493,",",0,0
228494,after,0,0
228495,several,0,0
228496,reports,0,1
228497,of,0,1
228498,failure,0,1
228499,to,0,0
228500,demonstrate,0,0
228501,its,0,0
228502,efficacy,0,0
228503,in,0,1
228504,young,0,1
228505,women,0,1
228506,.,0,1
228507,We,0,0
228508,compared,0,0
228509,the,0,0
228510,incidence,0,0
228511,and,0,0
228512,frequency,0,0
228513,of,0,0
228514,hypotension,0,0
228515,and,0,1
228516,vasopressor,0,0
228517,therapy,0,0
228518,after,0,0
228519,spinal,0,1
228520,anesthesia,0,1
228521,and,0,0
228522,no,0,0
228523,prehydration,0,0
228524,with,0,1
228525,crystalloid,1,1
228526,and,1,1
228527,colloid,1,0
228528,prehydration,1,0
228529,in,1,1
228530,elderly,1,1
228531,patients,1,1
228532,.,1,1
228533,Eighty-five,1,1
228534,ASA,1,0
228535,grade,1,1
228536,I,1,1
228537,or,1,1
228538,II,1,1
228539,patients,1,1
228540,(,1,1
228541,aged,1,1
228542,60-89,1,1
228543,yr,1,1
228544,),1,1
228545,for,1,0
228546,elective,1,1
228547,total,1,1
228548,hip,1,1
228549,replacement,1,1
228550,were,0,1
228551,randomized,0,1
228552,to,0,0
228553,receive,0,1
228554,500,0,1
228555,mL,0,0
228556,crystalloid,0,1
228557,solution,0,0
228558,(,0,1
228559,Hartmanns,0,1
228560,",",0,1
228561,n,0,1
228562,=,0,1
228563,29,0,1
228564,),0,1
228565,",",0,1
228566,500,0,1
228567,mL,0,0
228568,colloid,0,0
228569,(,0,1
228570,Haemaccel,0,0
228571,",",0,1
228572,n,0,1
228573,=,0,1
228574,28,0,1
228575,),0,1
228576,",",0,0
228577,or,0,1
228578,no,0,0
228579,prehydration,0,0
228580,(,0,0
228581,n,0,1
228582,=,0,1
228583,28,0,1
228584,),0,1
228585,over,0,0
228586,10,0,1
228587,min,0,0
228588,prior,0,1
228589,to,0,1
228590,spinal,0,1
228591,anesthesia,0,1
228592,.,0,1
228593,Hypotension,0,0
228594,was,0,0
228595,defined,0,0
228596,as,0,0
228597,a,0,1
228598,30,0,1
228599,%,0,0
228600,decrease,0,0
228601,from,0,1
228602,baseline,0,0
228603,systolic,0,1
228604,blood,0,0
228605,pressure,0,0
228606,(,0,1
228607,BP,0,1
228608,),0,1
228609,or,0,1
228610,systolic,0,1
228611,<,0,0
228612,90,0,1
228613,mm,0,1
228614,Hg,0,0
228615,",",0,0
228616,and,0,0
228617,was,0,0
228618,treated,0,1
228619,with,0,1
228620,ephedrine,0,0
228621,3-mg,0,1
228622,boluses,0,0
228623,.,0,1
228624,Although,0,0
228625,absolute,0,0
228626,systolic,0,1
228627,BP,0,1
228628,readings,0,0
228629,were,0,1
228630,significantly,0,0
228631,higher,0,0
228632,in,0,0
228633,the,0,0
228634,colloid,1,0
228635,group,1,1
228636,between,0,0
228637,6,0,1
228638,and,0,1
228639,30,0,1
228640,min,0,0
228641,(,0,1
228642,P,0,0
228643,<,0,0
228644,0.05,0,0
228645,),0,1
228646,",",0,0
228647,the,0,0
228648,incidence,0,0
228649,of,0,0
228650,hypotension,0,0
228651,was,0,0
228652,not,0,0
228653,significantly,0,0
228654,different,0,0
228655,between,0,0
228656,the,0,1
228657,groups,0,0
228658,.,0,1
228659,The,0,0
228660,incidence,0,0
228661,of,0,0
228662,ephedrine,0,0
228663,use,0,0
228664,",",0,0
228665,incidence,0,0
228666,of,0,0
228667,nausea/vomiting,0,0
228668,",",0,0
228669,and,0,0
228670,median,0,0
228671,total,0,1
228672,dose,0,0
228673,of,0,0
228674,ephedrine,0,0
228675,were,0,1
228676,similar,0,0
228677,in,0,1
228678,all,0,1
228679,groups,0,0
228680,.,0,1
228681,We,0,0
228682,conclude,0,0
228683,that,0,0
228684,",",0,0
228685,in,1,0
228686,elderly,1,1
228687,patients,1,1
228688,undergoing,1,1
228689,elective,1,1
228690,procedures,1,1
228691,",",0,1
228692,withholding,0,0
228693,prehydration,0,0
228694,is,0,0
228695,not,0,0
228696,associated,0,0
228697,with,0,1
228698,any,0,0
228699,greater,0,0
228700,degree,0,0
228701,of,0,0
228702,hypotension,0,0
228703,or,0,1
228704,need,0,0
228705,for,0,0
228706,vasopressor,0,0
228707,therapy,0,0
228708,compared,0,0
228709,with,0,1
228710,crystalloid,0,1
228711,or,0,1
228712,colloid,0,0
228713,prehydration,0,1
228714,.,0,1
228715,Dexamethasone,0,0
228716,in,0,1
228717,salbutamol-treated,1,1
228718,inpatients,1,1
228719,with,1,1
228720,acute,1,1
228721,bronchiolitis,1,1
228722,:,1,1
228723,a,0,0
228724,randomized,0,0
228725,",",0,0
228726,controlled,0,0
228727,trial,0,0
228728,.,0,1
228729,OBJECTIVE,0,0
228730,To,0,0
228731,determine,0,0
228732,the,0,0
228733,clinical,0,0
228734,benefit,0,0
228735,of,0,0
228736,oral,0,0
228737,dexamethasone,0,0
228738,in,0,1
228739,children,1,1
228740,admitted,1,1
228741,to,1,1
228742,the,1,0
228743,hospital,1,1
228744,with,1,1
228745,bronchiolitis,1,1
228746,treated,1,1
228747,with,1,1
228748,nebulized,1,0
228749,salbutamol,1,0
228750,.,1,1
228751,METHODS,0,0
228752,Randomized,0,0
228753,",",0,0
228754,double-blind,0,0
228755,",",0,0
228756,placebo-controlled,0,0
228757,trial,0,0
228758,in,0,0
228759,the,0,0
228760,inpatient,0,1
228761,wards,0,1
228762,of,0,1
228763,a,0,1
228764,pediatric,0,1
228765,tertiary,0,1
228766,care,0,1
228767,hospital,0,1
228768,.,0,1
228769,The,0,0
228770,participants,1,1
228771,",",1,1
228772,children,1,1
228773,aged,1,1
228774,6,1,1
228775,weeks,1,1
228776,to,1,1
228777,15,1,1
228778,months,1,0
228779,",",1,1
228780,admitted,1,1
228781,with,1,1
228782,first-time,1,1
228783,wheezing,1,1
228784,",",1,0
228785,were,1,0
228786,eligible,1,1
228787,if,1,0
228788,their,1,1
228789,oxygen,1,0
228790,saturation,1,0
228791,was,1,0
228792,less,1,0
228793,than,1,0
228794,95,1,0
228795,%,1,0
228796,on,1,0
228797,admission,1,1
228798,to,1,0
228799,the,1,0
228800,hospital,1,1
228801,and,1,0
228802,their,1,1
228803,Respiratory,1,1
228804,Distress,1,1
228805,Assessment,1,0
228806,Instrument,1,1
228807,(,1,1
228808,RDAI,1,1
228809,),1,1
228810,score,1,0
228811,was,1,0
228812,greater,1,0
228813,than,1,1
228814,6,1,1
228815,.,1,1
228816,Patients,1,1
228817,were,1,0
228818,excluded,1,1
228819,if,1,0
228820,they,1,0
228821,had,1,1
228822,any,1,0
228823,one,1,0
228824,of,1,0
228825,the,1,0
228826,following,1,0
228827,:,1,1
228828,an,1,0
228829,underlying,1,0
228830,disease,1,1
228831,that,1,0
228832,might,1,0
228833,affect,1,0
228834,cardiopulmonary,1,0
228835,status,1,1
228836,",",1,0
228837,asthma,1,1
228838,",",1,0
228839,recent,1,0
228840,treatment,1,0
228841,with,1,1
228842,steroids,1,0
228843,(,1,1
228844,within,1,1
228845,2,1,1
228846,weeks,1,1
228847,),1,1
228848,",",1,0
228849,or,1,1
228850,any,1,0
228851,history,1,1
228852,of,1,0
228853,adverse,1,0
228854,reaction,1,1
228855,to,1,1
228856,steroids,1,0
228857,.,1,1
228858,Patients,0,1
228859,were,0,0
228860,randomly,0,1
228861,assigned,0,1
228862,to,0,0
228863,receive,0,0
228864,either,0,0
228865,orally,0,0
228866,administered,0,0
228867,dexamethasone,0,0
228868,with,0,1
228869,0.5,0,0
228870,mg/kg,0,0
228871,as,0,0
228872,the,0,1
228873,first,0,0
228874,dose,0,0
228875,and,0,1
228876,0.3,0,0
228877,mg/kg,0,0
228878,for,0,0
228879,the,0,0
228880,next,0,1
228881,2,0,1
228882,mornings,0,1
228883,",",0,1
228884,or,0,1
228885,an,0,0
228886,equal,0,0
228887,volume,0,0
228888,of,0,0
228889,an,0,0
228890,orally,0,0
228891,administered,0,0
228892,placebo,0,0
228893,with,0,1
228894,an,0,0
228895,identical,0,0
228896,appearance,0,0
228897,.,0,1
228898,All,0,1
228899,patients,0,1
228900,received,0,1
228901,nebulized,0,0
228902,salbutamol,0,0
228903,at,0,1
228904,0.15,0,0
228905,mg/kg,0,0
228906,every,0,0
228907,4,0,0
228908,hours,0,0
228909,for,0,1
228910,the,0,1
228911,first,0,1
228912,24,0,1
228913,hours,0,0
228914,.,0,1
228915,The,0,0
228916,primary,0,0
228917,outcome,0,0
228918,measure,0,0
228919,was,0,0
228920,the,0,0
228921,change,0,0
228922,from,0,0
228923,baseline,0,0
228924,in,0,0
228925,the,0,0
228926,RDAI,0,0
228927,score,0,0
228928,at,0,1
228929,24,0,1
228930,hours,0,1
228931,.,0,1
228932,Secondary,0,0
228933,outcome,0,0
228934,measures,0,0
228935,were,0,1
228936,oxygen,0,0
228937,saturation,0,0
228938,",",0,0
228939,respiratory,0,1
228940,rate,0,0
228941,",",0,0
228942,RDAI,0,0
228943,measurement,0,0
228944,twice,0,0
228945,daily,0,0
228946,for,0,0
228947,the,0,0
228948,first,0,1
228949,4,0,0
228950,days,0,0
228951,",",0,1
228952,and,0,0
228953,the,0,0
228954,length,0,0
228955,of,0,0
228956,hospitalization,0,1
228957,.,0,1
228958,RESULTS,0,0
228959,At,0,1
228960,24,0,1
228961,hours,0,0
228962,the,0,1
228963,mean,0,1
228964,change,0,0
228965,(,0,1
228966,SD,0,1
228967,),0,1
228968,from,0,1
228969,baseline,0,0
228970,in,0,0
228971,the,0,0
228972,RDAI,0,0
228973,score,0,0
228974,was,0,0
228975,1.6,0,0
228976,(,0,1
228977,2.3,0,1
228978,),0,1
228979,in,0,0
228980,the,0,0
228981,placebo,0,0
228982,group,0,0
228983,(,0,1
228984,n,0,1
228985,=,0,1
228986,28,0,1
228987,),0,1
228988,and,0,1
228989,1.4,0,0
228990,(,0,1
228991,2.0,0,0
228992,),0,1
228993,in,0,0
228994,the,0,0
228995,dexamethasone,0,0
228996,group,0,0
228997,(,0,0
228998,n,0,1
228999,=,0,1
229000,33,0,1
229001,;,0,0
229002,p,0,0
229003,=,0,0
229004,0.74,0,0
229005,),0,0
229006,.,0,0
229007,There,0,0
229008,were,0,0
229009,no,0,0
229010,significant,0,0
229011,differences,0,0
229012,between,0,0
229013,the,0,1
229014,two,0,0
229015,groups,0,0
229016,in,0,1
229017,change,0,0
229018,in,0,0
229019,oxygen,0,0
229020,saturation,0,0
229021,",",0,0
229022,respiratory,0,1
229023,rate,0,0
229024,",",0,0
229025,and,0,0
229026,RDAI,0,0
229027,score,0,0
229028,at,0,0
229029,any,0,0
229030,assessment,0,0
229031,period,0,0
229032,.,0,1
229033,The,0,0
229034,median,0,0
229035,length,0,0
229036,of,0,0
229037,stay,0,0
229038,(,0,1
229039,95,0,0
229040,%,0,0
229041,confidence,0,0
229042,interval,0,0
229043,),0,0
229044,for,0,0
229045,the,0,0
229046,placebo,0,0
229047,group,0,1
229048,was,0,0
229049,48,0,1
229050,(,0,1
229051,42,0,1
229052,",",0,1
229053,54,0,1
229054,),0,1
229055,hours,0,0
229056,compared,0,0
229057,with,0,1
229058,57,0,1
229059,(,0,1
229060,38,0,1
229061,",",0,1
229062,76,0,1
229063,),0,1
229064,hours,0,0
229065,in,0,1
229066,the,0,0
229067,dexamethasone,0,0
229068,group,0,0
229069,(,0,1
229070,p,0,0
229071,=,0,1
229072,0.19,0,0
229073,),0,1
229074,.,0,1
229075,CONCLUSIONS,0,0
229076,Oral,0,0
229077,dexamethasone,0,0
229078,therapy,0,0
229079,does,0,0
229080,not,0,0
229081,affect,0,0
229082,the,0,0
229083,clinical,0,0
229084,course,0,0
229085,of,0,1
229086,children,1,1
229087,hospitalized,1,1
229088,with,1,1
229089,bronchiolitis,1,1
229090,and,0,0
229091,therefore,0,0
229092,can,0,0
229093,not,0,0
229094,be,0,0
229095,recommended,0,0
229096,in,0,0
229097,this,0,0
229098,clinical,0,0
229099,situation,0,0
229100,.,0,1
229101,Airway,0,1
229102,management,0,1
229103,training,0,0
229104,using,0,0
229105,the,0,0
229106,laryngeal,0,1
229107,mask,0,0
229108,airway,0,1
229109,:,0,1
229110,a,0,0
229111,comparison,0,0
229112,of,0,0
229113,two,0,1
229114,different,0,1
229115,training,0,1
229116,programmes,0,1
229117,.,0,1
229118,Nurses,1,0
229119,without,1,1
229120,prior,1,1
229121,experience,1,1
229122,in,1,0
229123,the,1,0
229124,use,1,0
229125,of,1,0
229126,the,1,0
229127,laryngeal,1,1
229128,mask,1,0
229129,airway,1,1
229130,(,1,1
229131,LMA,1,0
229132,),1,1
229133,were,0,0
229134,randomly,0,1
229135,allocated,0,1
229136,to,0,0
229137,one,0,1
229138,of,0,1
229139,two,0,1
229140,groups,0,1
229141,to,0,1
229142,be,0,0
229143,trained,0,1
229144,in,0,0
229145,the,0,0
229146,emergency,0,1
229147,technique,0,0
229148,of,0,0
229149,insertion,0,0
229150,of,0,0
229151,an,0,1
229152,LMA,0,0
229153,.,0,1
229154,Group,1,1
229155,A,1,1
229156,(,1,1
229157,32,1,1
229158,nurses,1,1
229159,),1,1
229160,were,1,1
229161,trained,1,1
229162,only,1,0
229163,on,1,0
229164,a,1,0
229165,manikin,1,0
229166,and,1,0
229167,group,1,1
229168,B,1,1
229169,(,1,1
229170,20,1,1
229171,nurses,1,1
229172,),1,1
229173,were,1,1
229174,trained,1,1
229175,on,1,0
229176,a,1,1
229177,manikin,1,0
229178,and,1,0
229179,with,1,1
229180,live,1,1
229181,anaesthetised,1,1
229182,patient,1,1
229183,practice,1,0
229184,in,1,0
229185,theatre,1,1
229186,(,1,1
229187,five,1,1
229188,successful,1,1
229189,insertions,1,1
229190,),1,1
229191,.,1,1
229192,Without,0,0
229193,further,0,0
229194,practice,0,0
229195,",",0,0
229196,both,0,0
229197,groups,0,0
229198,were,0,1
229199,asked,0,1
229200,to,0,0
229201,insert,0,0
229202,an,0,0
229203,LMA,0,0
229204,in,0,0
229205,a,0,1
229206,live,1,0
229207,patient,1,1
229208,in,1,1
229209,theatre,1,1
229210,3,0,1
229211,months,0,1
229212,after,0,1
229213,initial,0,1
229214,training,0,1
229215,.,0,1
229216,Three,0,1
229217,attempts,0,0
229218,per,0,1
229219,nurse,0,1
229220,were,0,1
229221,allowed,0,0
229222,.,0,1
229223,In,0,0
229224,group,0,0
229225,A,0,1
229226,",",0,1
229227,75,0,1
229228,%,0,0
229229,passed,0,1
229230,the,0,0
229231,LMA,0,0
229232,successfully,0,0
229233,at,0,0
229234,the,0,0
229235,first,0,0
229236,attempt,0,0
229237,",",0,1
229238,22,0,1
229239,%,0,0
229240,at,0,0
229241,the,0,0
229242,second,0,1
229243,attempt,0,0
229244,and,0,1
229245,3,0,1
229246,%,0,0
229247,(,0,1
229248,one,0,1
229249,nurse,0,1
229250,),0,1
229251,at,0,0
229252,the,0,0
229253,third,0,1
229254,attempt,0,0
229255,.,0,1
229256,In,0,0
229257,group,0,0
229258,B,0,1
229259,",",0,1
229260,80,0,1
229261,%,0,0
229262,were,0,1
229263,successful,0,1
229264,at,0,1
229265,first,0,1
229266,attempt,0,1
229267,and,0,1
229268,20,0,1
229269,%,0,0
229270,at,0,0
229271,the,0,0
229272,second,0,1
229273,attempt,0,0
229274,.,0,1
229275,Skill,0,0
229276,performance,0,0
229277,and,0,0
229278,retention,0,0
229279,were,0,1
229280,shown,0,0
229281,to,0,0
229282,be,0,0
229283,high,0,1
229284,following,0,0
229285,either,0,1
229286,training,0,0
229287,method,0,0
229288,",",0,0
229289,with,0,1
229290,no,0,0
229291,significant,0,0
229292,difference,0,0
229293,between,0,0
229294,the,0,0
229295,performance,0,0
229296,of,0,0
229297,either,0,1
229298,group,0,1
229299,(,0,1
229300,chi,0,1
229301,2,0,1
229302,),0,1
229303,.,0,1
229304,We,0,0
229305,have,0,0
229306,shown,0,0
229307,that,0,0
229308,manikin-only,0,1
229309,training,0,0
229310,in,0,0
229311,the,0,0
229312,emergency,0,1
229313,technique,0,0
229314,for,0,0
229315,LMA,0,0
229316,insertion,0,0
229317,is,0,0
229318,as,0,0
229319,effective,0,0
229320,as,0,0
229321,live,0,1
229322,patient,0,1
229323,training,0,1
229324,.,0,0
229325,It,0,0
229326,is,0,0
229327,proposed,0,0
229328,that,0,0
229329,manikin,0,1
229330,training,0,0
229331,alone,0,0
229332,may,0,0
229333,be,0,0
229334,adopted,0,0
229335,as,0,0
229336,a,0,1
229337,future,0,0
229338,training,0,0
229339,modality,0,0
229340,if,0,0
229341,",",0,0
229342,as,0,0
229343,is,0,0
229344,expected,0,0
229345,",",0,0
229346,the,0,0
229347,use,0,0
229348,of,0,0
229349,the,0,0
229350,LMA,0,0
229351,in,0,0
229352,resuscitation,0,0
229353,becomes,0,0
229354,more,0,0
229355,commonplace,0,0
229356,.,0,0
229357,Pharmacokinetic,0,0
229358,properties,0,0
229359,of,0,1
229360,YM17E,0,1
229361,",",0,0
229362,an,0,0
229363,inhibitor,0,0
229364,of,0,0
229365,acyl,0,0
229366,coenzyme,0,0
229367,A,0,1
229368,:,0,1
229369,cholesterol,0,0
229370,acyl,0,0
229371,transferase,0,0
229372,",",0,0
229373,and,0,0
229374,serum,0,0
229375,cholesterol,0,0
229376,levels,0,0
229377,in,0,1
229378,healthy,1,1
229379,volunteers,1,1
229380,.,1,1
229381,We,0,0
229382,conducted,0,0
229383,a,0,0
229384,single,0,0
229385,and,0,0
229386,repeat,0,1
229387,oral,0,1
229388,dose,0,0
229389,study,0,1
229390,of,0,0
229391,YM17E,0,1
229392,",",0,0
229393,a,0,0
229394,novel,0,0
229395,inhibitor,0,0
229396,of,0,0
229397,acyl,0,0
229398,coenzyme,0,0
229399,A,0,1
229400,(,0,1
229401,CoA,0,0
229402,),0,1
229403,:,0,1
229404,cholesterol,0,0
229405,acyltransferase,0,0
229406,",",0,0
229407,in,0,0
229408,healthy,1,1
229409,male,1,1
229410,volunteers,1,1
229411,to,0,0
229412,evaluate,0,0
229413,the,0,0
229414,pharmacokinetic,0,0
229415,profile,0,0
229416,",",0,0
229417,tolerability,0,0
229418,and,0,0
229419,effect,0,0
229420,of,0,0
229421,the,0,0
229422,drug,0,0
229423,on,0,0
229424,serum,0,0
229425,cholesterol,0,0
229426,.,0,1
229427,In,0,0
229428,the,0,0
229429,single,0,0
229430,administration,0,0
229431,study,0,1
229432,",",0,0
229433,YM17E,0,1
229434,was,0,0
229435,administered,0,0
229436,after,0,0
229437,a,0,1
229438,meal,0,0
229439,to,0,1
229440,two,1,0
229441,groups,1,1
229442,of,1,1
229443,subjects,1,1
229444,(,1,1
229445,each,1,1
229446,containing,1,0
229447,six,1,1
229448,subjects,1,1
229449,taking,1,1
229450,the,1,0
229451,drug,1,0
229452,and,1,0
229453,three,1,0
229454,taking,1,1
229455,placebo,1,1
229456,),1,1
229457,receiving,1,1
229458,3,1,1
229459,",",1,1
229460,60,1,1
229461,and,1,1
229462,300,1,1
229463,mg,1,1
229464,or,1,1
229465,15,1,1
229466,",",1,1
229467,60,1,1
229468,and,1,1
229469,450,1,1
229470,mg,1,0
229471,YM17E,1,1
229472,",",1,0
229473,respectively,1,0
229474,.,1,1
229475,Plasma,0,0
229476,concentrations,0,0
229477,of,0,1
229478,unchanged,0,0
229479,drug,0,1
229480,following,0,0
229481,single,0,0
229482,oral,0,1
229483,administration,0,0
229484,at,0,1
229485,3-300,0,0
229486,mg,0,0
229487,after,0,0
229488,a,0,1
229489,meal,0,0
229490,increased,0,0
229491,with,0,1
229492,increasing,0,0
229493,dose,0,0
229494,.,0,1
229495,In,0,0
229496,contrast,0,0
229497,",",0,1
229498,plasma,0,0
229499,concentrations,0,0
229500,after,0,1
229501,administration,0,0
229502,of,0,1
229503,450,0,1
229504,mg,0,0
229505,were,0,1
229506,almost,0,1
229507,the,0,0
229508,same,0,0
229509,as,0,0
229510,after,0,1
229511,300,0,1
229512,mg,0,1
229513,.,0,1
229514,Unchanged,0,0
229515,YM17E,0,1
229516,was,0,0
229517,not,0,0
229518,detected,0,0
229519,in,0,0
229520,urine,0,1
229521,after,0,1
229522,single,0,0
229523,administration,0,0
229524,",",0,0
229525,suggesting,0,0
229526,that,0,0
229527,it,0,0
229528,was,0,0
229529,excreted,0,0
229530,via,0,0
229531,the,0,0
229532,bile,0,1
229533,or,0,0
229534,urine,0,1
229535,after,0,0
229536,metabolism,0,0
229537,.,0,1
229538,Five,0,1
229539,active,0,1
229540,metabolites,0,1
229541,(,0,1
229542,M1,0,0
229543,",",0,0
229544,M2-a,0,1
229545,",",0,0
229546,M2-b,0,0
229547,",",0,0
229548,M3,0,1
229549,and,0,1
229550,M4,0,1
229551,),0,1
229552,were,0,0
229553,observed,0,0
229554,in,0,0
229555,plasma,0,0
229556,at,0,1
229557,concentrations,0,0
229558,comparable,0,0
229559,to,0,1
229560,those,0,1
229561,of,0,0
229562,unchanged,0,0
229563,YM17E,0,1
229564,.,0,1
229565,Their,0,1
229566,plasma,0,0
229567,concentrations,0,0
229568,increased,0,0
229569,in,0,0
229570,a,0,0
229571,slightly,0,0
229572,greater,0,0
229573,than,0,0
229574,dose-dependent,0,0
229575,manner,0,0
229576,from,0,1
229577,3,0,1
229578,to,0,1
229579,300,0,1
229580,mg,0,0
229581,.,0,1
229582,The,0,0
229583,effect,0,0
229584,of,0,0
229585,food,0,0
229586,was,0,0
229587,studied,0,1
229588,in,0,0
229589,an,0,0
229590,open,0,1
229591,crossover,0,0
229592,design,0,1
229593,with,0,1
229594,a,0,1
229595,1-week,0,0
229596,washout,0,0
229597,period,0,1
229598,.,0,1
229599,Twelve,0,1
229600,subjects,0,1
229601,received,0,0
229602,150,0,0
229603,mg,0,0
229604,YM17E,0,1
229605,in,0,0
229606,both,0,0
229607,the,0,0
229608,fasted,0,1
229609,and,0,0
229610,post-prandial,0,1
229611,states,0,1
229612,.,0,1
229613,The,0,0
229614,AUC,0,0
229615,and,0,0
229616,Cmax,0,0
229617,after,0,0
229618,fasting,0,0
229619,were,0,1
229620,closely,0,1
229621,similar,0,0
229622,to,0,0
229623,those,0,0
229624,after,0,0
229625,a,0,0
229626,meal,0,0
229627,",",0,0
229628,showing,0,0
229629,that,0,0
229630,bioavailability,0,0
229631,was,0,0
229632,not,0,0
229633,affected,0,0
229634,by,0,0
229635,food,0,0
229636,intake,0,0
229637,.,0,1
229638,In,0,0
229639,the,0,0
229640,repeated,0,0
229641,oral,0,0
229642,dose,0,0
229643,study,0,0
229644,",",0,0
229645,the,0,0
229646,subjects,0,1
229647,received,0,1
229648,test,0,0
229649,drug,0,1
229650,at,0,1
229651,150,0,1
229652,mg,0,1
229653,or,0,1
229654,300,0,1
229655,mg,0,0
229656,(,0,1
229657,n,0,1
229658,=,0,1
229659,6,0,0
229660,each,0,0
229661,),0,0
229662,or,0,1
229663,placebo,0,0
229664,(,0,1
229665,n,0,1
229666,=,0,1
229667,3,0,1
229668,),0,1
229669,twice,0,0
229670,a,0,0
229671,day,0,0
229672,(,0,0
229673,after,0,0
229674,breakfast,0,0
229675,and,0,1
229676,after,0,0
229677,dinner,0,1
229678,),0,1
229679,for,0,1
229680,7,0,1
229681,days,0,0
229682,.,0,1
229683,On,0,1
229684,days,0,0
229685,1,0,1
229686,and,0,1
229687,7,0,1
229688,",",0,0
229689,the,0,0
229690,subjects,0,1
229691,received,0,1
229692,YM17E,0,1
229693,once,0,0
229694,a,0,0
229695,day,0,0
229696,(,0,0
229697,after,0,0
229698,breakfast,0,1
229699,),0,1
229700,for,0,0
229701,evaluation,0,0
229702,of,0,1
229703,pharmacokinetic,0,0
229704,properties,0,0
229705,.,0,1
229706,After,0,0
229707,repeated,0,0
229708,oral,0,0
229709,administration,0,0
229710,of,0,1
229711,150,0,1
229712,mg,0,0
229713,b.d.,0,1
229714,",",0,1
229715,plasma,0,0
229716,concentrations,0,0
229717,reached,0,0
229718,steady,0,0
229719,state,0,1
229720,by,0,0
229721,day,0,0
229722,5,0,1
229723,(,0,1
229724,mean,0,1
229725,Cmin,0,0
229726,48.6,0,1
229727,ng.ml-1,0,0
229728,),0,1
229729,.,0,1
229730,After,0,0
229731,repeated,0,0
229732,administration,0,0
229733,of,0,1
229734,300,0,1
229735,mg,0,0
229736,b.d.,0,1
229737,",",0,1
229738,plasma,0,0
229739,concentrations,0,0
229740,prior,0,1
229741,to,0,1
229742,each,0,0
229743,daily,0,0
229744,morning,0,0
229745,dose,0,0
229746,increased,0,0
229747,up,0,0
229748,to,0,0
229749,the,0,0
229750,5th,0,1
229751,day,0,0
229752,(,0,1
229753,mean,0,1
229754,Cmin,0,0
229755,166.6,0,0
229756,ng.ml-1,0,0
229757,),0,1
229758,and,0,0
229759,then,0,0
229760,tended,0,0
229761,to,0,0
229762,decrease,0,0
229763,until,0,0
229764,the,0,0
229765,7th,0,0
229766,day,0,0
229767,.,0,1
229768,No,0,0
229769,significant,0,0
229770,signs,0,1
229771,",",0,1
229772,symptoms,0,1
229773,or,0,1
229774,changes,0,0
229775,in,0,1
229776,serum,0,1
229777,cholesterol,0,1
229778,levels,0,0
229779,were,0,1
229780,observed,0,0
229781,during,0,0
229782,the,0,0
229783,single,0,0
229784,and,0,0
229785,repeated,0,0
229786,oral,0,1
229787,dose,0,0
229788,studies,0,0
229789,at,0,1
229790,150,0,1
229791,mg,0,1
229792,b.d,0,1
229793,.,0,1
229794,Although,0,0
229795,statistical,0,0
229796,analysis,0,0
229797,was,0,0
229798,not,0,0
229799,conducted,0,0
229800,because,0,0
229801,of,0,0
229802,the,0,0
229803,small,1,0
229804,number,1,0
229805,of,1,1
229806,subjects,1,1
229807,",",0,1
229808,all,0,1
229809,subjects,0,1
229810,receiving,0,1
229811,repeated,0,0
229812,oral,0,0
229813,administration,0,0
229814,of,0,1
229815,300,0,1
229816,mg,0,0
229817,twice,0,0
229818,daily,0,0
229819,showed,0,0
229820,a,0,0
229821,25,0,1
229822,%,0,0
229823,decrease,0,0
229824,in,0,0
229825,serum,0,0
229826,cholesterol,0,0
229827,level,0,0
229828,on,0,0
229829,day,0,0
229830,7,0,1
229831,",",0,0
229832,but,0,0
229833,also,0,0
229834,the,0,0
229835,simultaneous,0,0
229836,occurrence,0,0
229837,of,0,0
229838,diarrhoea,0,1
229839,.,0,1
229840,Comparison,0,0
229841,of,0,0
229842,arbutamine,0,0
229843,and,0,1
229844,exercise,0,0
229845,echocardiography,0,0
229846,in,0,0
229847,diagnosing,1,0
229848,myocardial,1,1
229849,ischemia,1,1
229850,.,1,1
229851,Arbutamine,0,0
229852,is,0,0
229853,a,0,0
229854,new,0,0
229855,catecholamine,0,0
229856,designed,0,0
229857,for,0,0
229858,use,0,0
229859,as,0,0
229860,a,0,1
229861,pharmacologic,0,0
229862,stress,0,0
229863,agent,0,0
229864,.,0,1
229865,This,0,0
229866,study,0,0
229867,compared,0,0
229868,the,0,0
229869,sensitivity,0,0
229870,of,0,0
229871,arbutamine,0,0
229872,with,0,1
229873,symptom-limited,0,1
229874,exercise,0,0
229875,to,0,0
229876,induce,0,0
229877,echocardiographic,0,1
229878,signs,0,1
229879,of,0,1
229880,ischemia,0,1
229881,.,0,1
229882,Arbutamine,0,0
229883,was,0,0
229884,administered,0,0
229885,by,0,0
229886,a,0,1
229887,computerized,0,0
229888,closed-loop,0,0
229889,delivery,0,0
229890,system,0,0
229891,that,0,0
229892,controls,0,1
229893,the,0,0
229894,infusion,0,0
229895,rate,0,0
229896,of,0,0
229897,arbutamine,0,0
229898,toward,0,0
229899,a,0,1
229900,predefined,0,0
229901,rate,0,0
229902,of,0,0
229903,heart,0,1
229904,rate,0,0
229905,increase,0,0
229906,and,0,0
229907,maximum,0,0
229908,heart,0,1
229909,rate,0,0
229910,limit,0,0
229911,.,0,1
229912,Beta,0,0
229913,blockers,0,0
229914,were,0,1
229915,stopped,0,1
229916,>,0,1
229917,or,0,1
229918,=,0,1
229919,48,0,1
229920,hours,0,0
229921,before,0,1
229922,both,0,1
229923,tests,0,0
229924,.,0,1
229925,Stress,0,0
229926,was,0,0
229927,stopped,0,1
229928,for,0,1
229929,intolerable,0,1
229930,symptoms,0,1
229931,",",0,1
229932,or,0,1
229933,clinical,0,0
229934,",",0,1
229935,electrocardiographic,0,1
229936,or,0,1
229937,echocardiographic,0,1
229938,signs,0,1
229939,of,0,1
229940,ischemia,0,1
229941,(,0,1
229942,new,0,1
229943,or,0,1
229944,worsening,0,0
229945,wall,0,1
229946,motion,0,1
229947,abnormality,0,1
229948,),0,0
229949,",",0,0
229950,target,0,0
229951,heart,0,1
229952,rate,0,0
229953,(,0,1
229954,>,0,1
229955,or,0,1
229956,=,0,1
229957,85,0,1
229958,%,0,0
229959,age,0,1
229960,predicted,0,0
229961,maximum,0,0
229962,heart,0,1
229963,rate,0,0
229964,),0,0
229965,",",0,0
229966,or,0,1
229967,plateau,0,0
229968,of,0,0
229969,heart,0,1
229970,rate,0,0
229971,response,0,0
229972,.,0,1
229973,Thirty-seven,1,1
229974,patients,1,1
229975,were,1,1
229976,entered,1,1
229977,into,1,0
229978,the,1,0
229979,study,1,1
229980,(,1,0
229981,35,1,1
229982,arbutamine,1,0
229983,and,1,0
229984,exercise,1,0
229985,",",1,0
229986,1,1,0
229987,arbutamine,1,0
229988,only,1,0
229989,",",1,0
229990,1,1,0
229991,exercise,1,0
229992,only,1,0
229993,),1,0
229994,",",1,0
229995,of,1,0
229996,which,1,0
229997,30,1,1
229998,had,1,1
229999,angiographic,1,0
230000,evidence,1,0
230001,of,1,0
230002,coronary,1,1
230003,artery,1,1
230004,disease,1,1
230005,(,1,1
230006,>,1,1
230007,or,1,1
230008,=,1,1
230009,50,1,1
230010,%,1,0
230011,lumen,1,0
230012,diameter,1,1
230013,narrowing,1,1
230014,),1,1
230015,.,1,1
230016,Rate-pressure,0,0
230017,product,0,0
230018,increased,0,0
230019,significantly,0,0
230020,in,0,0
230021,response,0,0
230022,to,0,1
230023,both,0,0
230024,stress,0,0
230025,modalities,0,0
230026,(,0,1
230027,p,0,0
230028,<,0,0
230029,0.001,0,0
230030,),0,1
230031,and,0,0
230032,was,0,0
230033,significantly,0,0
230034,greater,0,0
230035,with,0,1
230036,exercise,0,0
230037,(,0,1
230038,"11,308",0,1
230039,+/-,0,1
230040,"2,443",0,1
230041,),0,1
230042,than,0,0
230043,with,0,1
230044,arbutamine,0,0
230045,(,0,1
230046,"9,486",0,1
230047,+/-,0,0
230048,"2,479",0,1
230049,",",0,1
230050,p,0,0
230051,<,0,0
230052,0.001,0,0
230053,),0,1
230054,.,0,1
230055,The,0,0
230056,time,0,0
230057,to,0,0
230058,maximum,0,0
230059,heart,0,1
230060,rate,0,0
230061,was,0,0
230062,longer,0,0
230063,during,0,0
230064,arbutamine,0,0
230065,stress,0,0
230066,echocardiography,0,0
230067,than,0,0
230068,during,0,0
230069,exercise,0,1
230070,testing,0,1
230071,(,0,1
230072,17.3,0,0
230073,+/-,0,1
230074,9.4,0,1
230075,versus,0,0
230076,9.3,0,1
230077,+/-,0,1
230078,4.2,0,1
230079,minutes,0,0
230080,",",0,0
230081,respectively,0,0
230082,",",0,0
230083,p,0,0
230084,<,0,0
230085,0.001,0,0
230086,),0,0
230087,.,0,0
230088,There,0,0
230089,were,0,0
230090,more,0,0
230091,patients,0,1
230092,with,0,1
230093,interpretable,0,1
230094,echo,0,1
230095,data,0,0
230096,for,0,1
230097,arbutamine,0,0
230098,(,0,1
230099,82,0,1
230100,%,0,0
230101,),0,1
230102,than,0,0
230103,for,0,0
230104,exercise,0,1
230105,(,0,1
230106,67,0,1
230107,%,0,0
230108,),0,1
230109,.,0,1
230110,Sensitivity,0,0
230111,for,0,0
230112,recognition,0,0
230113,of,0,0
230114,myocardial,0,1
230115,ischemia,0,1
230116,was,0,0
230117,94,0,1
230118,%,0,0
230119,(,0,1
230120,95,0,0
230121,%,0,0
230122,confidence,0,0
230123,interval,0,0
230124,70,0,1
230125,%,0,0
230126,to,0,1
230127,100,0,1
230128,%,0,0
230129,),0,1
230130,and,0,1
230131,88,0,1
230132,%,0,0
230133,(,0,1
230134,95,0,0
230135,%,0,0
230136,confidence,0,0
230137,interval,0,0
230138,62,0,1
230139,%,0,0
230140,to,0,1
230141,98,0,1
230142,%,0,0
230143,),0,0
230144,",",0,0
230145,respectively,0,0
230146,.,0,0
230147,The,0,0
230148,most,0,0
230149,frequent,0,1
230150,adverse,0,0
230151,events,0,0
230152,during,0,1
230153,arbutamine,0,0
230154,(,0,1
230155,n,0,1
230156,=,0,1
230157,36,0,1
230158,),0,1
230159,were,0,1
230160,dyspnea,0,1
230161,(,0,1
230162,5.6,0,0
230163,%,0,0
230164,),0,1
230165,and,0,0
230166,tremor,0,1
230167,(,0,1
230168,5.6,0,0
230169,%,0,0
230170,),0,1
230171,.,0,1
230172,Two,0,1
230173,arbutamine,0,0
230174,stress,0,1
230175,tests,0,0
230176,were,0,1
230177,discontinued,0,0
230178,due,0,0
230179,to,0,1
230180,arrhythmias,0,1
230181,:,0,1
230182,1,0,0
230183,patient,0,1
230184,had,0,1
230185,premature,0,1
230186,atrial,0,1
230187,and,0,1
230188,ventricular,0,1
230189,beats,0,1
230190,",",0,1
230191,and,0,0
230192,the,0,0
230193,other,0,0
230194,had,0,1
230195,premature,0,1
230196,atrial,0,1
230197,contractions,0,1
230198,and,0,1
230199,atrial,0,1
230200,fibrillation,0,1
230201,.,0,1
230202,Arrhythmias,0,0
230203,were,0,0
230204,well,0,0
230205,tolerated,0,0
230206,and,0,0
230207,resolved,0,0
230208,without,0,1
230209,sequelae,0,0
230210,.,0,1
230211,In,0,0
230212,conclusion,0,0
230213,",",0,0
230214,the,0,0
230215,sensitivity,0,0
230216,of,0,0
230217,arbutamine,0,0
230218,to,0,0
230219,induce,0,0
230220,echocardiographic,0,1
230221,signs,0,1
230222,of,0,1
230223,ischemia,0,1
230224,was,0,0
230225,similar,0,0
230226,to,0,0
230227,that,0,0
230228,of,0,0
230229,exercise,0,0
230230,despite,0,0
230231,a,0,0
230232,lower,0,0
230233,rate-pressure,0,0
230234,product,0,0
230235,.,0,1
230236,Arbutamine,0,0
230237,was,0,0
230238,well,0,0
230239,tolerated,0,0
230240,and,0,0
230241,provides,0,0
230242,a,0,0
230243,reliable,0,0
230244,alternative,0,0
230245,to,0,0
230246,exercise,0,0
230247,echocardiography,0,0
230248,.,0,1
230249,Studies,0,1
230250,on,0,1
230251,section,0,1
230252,2D1,0,1
230253,monoclonal,0,1
230254,antibodies,0,1
230255,.,0,1
230256,Monoclonal,0,1
230257,antibodies,0,0
230258,in,0,1
230259,Other,0,1
230260,Blood,0,1
230261,Groups,0,1
230262,were,0,1
230263,tested,0,0
230264,with,0,1
230265,random,1,1
230266,blood,1,1
230267,samples,1,1
230268,collected,0,1
230269,from,0,1
230270,the,0,0
230271,various,1,0
230272,ethnic,1,1
230273,groups,1,1
230274,in,1,1
230275,KwaZulu-Natal,1,1
230276,",",1,1
230277,South,1,1
230278,Africa,1,0
230279,",",1,0
230280,and,1,0
230281,with,1,1
230282,samples,1,1
230283,of,1,1
230284,selected,1,1
230285,red,1,1
230286,cell,1,1
230287,phenotypes,1,1
230288,.,1,1
230289,Standard,0,0
230290,red,0,1
230291,cell,0,1
230292,serological,0,1
230293,techniques,0,0
230294,were,0,1
230295,used,0,0
230296,.,0,1
230297,[,0,1
230298,Laparoscopic,0,1
230299,or,0,1
230300,conventional,0,1
230301,inguinal,1,1
230302,hernia,1,1
230303,repair,1,1
230304,with,0,1
230305,or,0,1
230306,without,0,1
230307,implant,0,1
230308,.,0,1
230309,A,0,0
230310,prospective,0,0
230311,randomized,0,1
230312,study,0,1
230313,],0,1
230314,.,0,1
230315,Comparative,0,1
230316,efficacy,0,0
230317,and,0,0
230318,safety,0,0
230319,of,0,0
230320,twice,0,0
230321,daily,0,0
230322,fluticasone,0,0
230323,propionate,0,0
230324,powder,0,0
230325,versus,0,0
230326,placebo,0,0
230327,in,0,0
230328,the,0,0
230329,treatment,0,0
230330,of,0,0
230331,moderate,1,1
230332,asthma,1,1
230333,.,1,1
230334,BACKGROUND,0,0
230335,Fluticasone,0,0
230336,propionate,0,0
230337,",",0,0
230338,an,0,0
230339,inhaled,0,0
230340,corticosteroid,0,0
230341,with,0,1
230342,negligible,0,0
230343,systemic,0,0
230344,bioavailability,0,0
230345,via,0,1
230346,the,0,0
230347,oral,0,0
230348,route,0,0
230349,",",0,0
230350,is,0,0
230351,efficacious,0,0
230352,in,0,0
230353,the,0,0
230354,treatment,0,0
230355,of,0,0
230356,asthma,1,1
230357,when,0,0
230358,administered,0,0
230359,via,0,0
230360,metered-dose,0,0
230361,inhaler,0,1
230362,.,0,1
230363,OBJECTIVE,0,0
230364,To,0,0
230365,evaluate,0,0
230366,the,0,0
230367,efficacy,0,0
230368,and,0,0
230369,safety,0,0
230370,of,0,0
230371,inhaled,0,0
230372,fluticasone,0,0
230373,propionate,0,0
230374,powder,0,0
230375,in,0,0
230376,patients,1,1
230377,with,1,1
230378,moderate,1,1
230379,asthma,1,1
230380,previously,1,1
230381,treated,1,1
230382,with,1,1
230383,an,1,0
230384,inhaled,1,0
230385,corticosteroid,1,0
230386,.,1,1
230387,METHODS,0,0
230388,This,0,0
230389,was,0,0
230390,a,0,0
230391,randomized,0,1
230392,",",0,0
230393,double-blind,0,0
230394,",",0,0
230395,placebo-controlled,0,0
230396,",",0,0
230397,parallel-group,0,0
230398,",",0,0
230399,multicenter,0,0
230400,study,0,1
230401,of,0,0
230402,342,1,1
230403,adolescent,1,1
230404,and,1,1
230405,adult,1,1
230406,patients,1,1
230407,with,1,1
230408,moderate,1,1
230409,asthma,1,1
230410,[,1,1
230411,forced,1,1
230412,expiratory,1,0
230413,volume,1,0
230414,in,1,1
230415,1,1,1
230416,second,1,1
230417,(,1,1
230418,FEV1,1,1
230419,),1,1
230420,between,1,0
230421,50,1,1
230422,%,1,0
230423,and,1,1
230424,80,1,1
230425,%,1,0
230426,of,1,1
230427,predicted,1,0
230428,],1,1
230429,treated,1,1
230430,previously,1,1
230431,by,1,0
230432,beclomethasone,1,0
230433,dipropionate,1,0
230434,or,1,1
230435,triamcinolone,1,0
230436,acetonide,1,0
230437,.,1,1
230438,Patients,0,1
230439,received,0,1
230440,fluticasone,0,0
230441,propionate,0,0
230442,powder,0,1
230443,50,0,1
230444,micrograms,0,0
230445,",",0,1
230446,100,0,1
230447,micrograms,0,0
230448,",",0,1
230449,250,0,1
230450,micrograms,0,0
230451,",",0,1
230452,or,0,1
230453,placebo,0,0
230454,via,0,0
230455,a,0,1
230456,breath-actuated,0,0
230457,inhalation,0,0
230458,device,0,0
230459,",",0,0
230460,the,0,0
230461,Diskhaler,0,0
230462,",",0,0
230463,twice,0,0
230464,daily,0,0
230465,for,0,0
230466,12,0,1
230467,weeks,0,1
230468,.,0,1
230469,RESULTS,0,0
230470,Patients,0,1
230471,in,0,1
230472,the,0,1
230473,fluticasone,0,0
230474,propionate,0,0
230475,groups,0,0
230476,experienced,0,1
230477,a,0,1
230478,mean,0,0
230479,increase,0,0
230480,from,0,1
230481,baseline,0,0
230482,to,0,0
230483,endpoint,0,0
230484,in,0,0
230485,FEV1,0,0
230486,ranging,0,1
230487,from,0,1
230488,0.43,0,0
230489,L,0,0
230490,to,0,1
230491,0.47,0,0
230492,L.,0,1
230493,Patients,0,1
230494,in,0,1
230495,the,0,1
230496,placebo,0,0
230497,group,0,0
230498,experienced,0,1
230499,a,0,0
230500,mean,0,0
230501,decrease,0,0
230502,from,0,1
230503,baseline,0,0
230504,of,0,1
230505,0.22,0,0
230506,L,0,0
230507,(,0,1
230508,P,0,0
230509,<,0,0
230510,.001,0,0
230511,),0,1
230512,.,0,1
230513,The,0,0
230514,probability,0,0
230515,of,0,0
230516,patients,0,1
230517,remaining,0,1
230518,in,0,0
230519,the,0,0
230520,study,0,0
230521,over,0,0
230522,time,0,0
230523,without,0,1
230524,developing,0,1
230525,signs,0,1
230526,of,0,1
230527,exacerbating,0,1
230528,asthma,0,1
230529,was,0,0
230530,significantly,0,0
230531,greater,0,0
230532,in,0,0
230533,the,0,0
230534,fluticasone,0,0
230535,propionate,0,0
230536,groups,0,0
230537,than,0,0
230538,in,0,1
230539,the,0,0
230540,placebo,0,0
230541,group,0,0
230542,(,0,1
230543,P,0,0
230544,=,0,1
230545,.001,0,0
230546,),0,1
230547,.,0,1
230548,Asthma,0,1
230549,symptom,0,0
230550,scores,0,0
230551,",",0,1
230552,supplemental,0,1
230553,rescue,0,0
230554,albuterol,0,1
230555,use,0,0
230556,",",0,0
230557,and,0,0
230558,number,0,0
230559,of,0,1
230560,nighttime,0,0
230561,awakenings,0,1
230562,due,0,1
230563,to,0,1
230564,asthma,0,1
230565,requiring,0,1
230566,treatment,0,0
230567,also,0,0
230568,improved,0,0
230569,significantly,0,0
230570,with,0,1
230571,all,0,0
230572,fluticasone,0,0
230573,propionate,0,0
230574,treatment,0,1
230575,regimens,0,0
230576,compared,0,0
230577,with,0,1
230578,placebo,0,0
230579,(,0,1
230580,P,0,0
230581,<,0,0
230582,.001,0,0
230583,),0,0
230584,.,0,0
230585,There,0,0
230586,were,0,0
230587,no,0,0
230588,statistically,0,0
230589,significant,0,0
230590,differences,0,0
230591,at,0,1
230592,endpoint,0,0
230593,among,0,1
230594,the,0,0
230595,three,0,0
230596,fluticasone,0,0
230597,propionate,0,0
230598,groups,0,0
230599,.,0,1
230600,No,0,0
230601,serious,0,0
230602,drug-related,0,1
230603,adverse,0,0
230604,events,0,0
230605,occurred,0,0
230606,.,0,1
230607,CONCLUSIONS,0,0
230608,Fluticasone,0,0
230609,propionate,0,0
230610,powder,0,0
230611,(,0,1
230612,50,0,1
230613,",",0,1
230614,100,0,1
230615,",",0,0
230616,and,0,1
230617,250,0,1
230618,micrograms,0,1
230619,),0,1
230620,was,0,0
230621,well-tolerated,0,0
230622,and,0,0
230623,significantly,0,0
230624,improved,0,0
230625,lung,0,1
230626,function,0,0
230627,in,0,0
230628,patients,1,1
230629,with,1,1
230630,moderate,1,1
230631,asthma,1,1
230632,.,1,1
230633,A,0,0
230634,randomised,0,0
230635,trial,0,0
230636,evaluating,0,0
230637,pain,0,1
230638,and,0,0
230639,bleeding,0,1
230640,after,1,0
230641,a,1,1
230642,first,1,0
230643,trimester,1,1
230644,miscarriage,1,1
230645,treated,1,1
230646,surgically,1,1
230647,or,1,1
230648,medically,1,1
230649,.,1,1
230650,Miscarriage,0,0
230651,treated,0,1
230652,surgically,0,1
230653,and,0,0
230654,medically,0,1
230655,were,0,0
230656,compared,0,0
230657,in,0,0
230658,a,0,1
230659,randomised,0,0
230660,controlled,0,0
230661,trial,0,0
230662,evaluating,0,0
230663,pain,0,1
230664,and,0,1
230665,bleeding,0,1
230666,.,0,0
230667,Surgery,0,0
230668,is,0,0
230669,associated,0,0
230670,with,0,1
230671,less,0,0
230672,pain,0,1
230673,(,0,0
230674,P,0,0
230675,<,0,0
230676,0.03,0,0
230677,),0,1
230678,and,0,1
230679,vaginal,0,1
230680,bleeding,0,1
230681,(,0,1
230682,duration,0,0
230683,and,0,0
230684,severity,0,0
230685,",",0,0
230686,P,0,0
230687,=,0,1
230688,0.001,0,0
230689,),0,1
230690,than,0,0
230691,medical,0,1
230692,treatment,0,0
230693,",",0,0
230694,fewer,0,0
230695,daily,0,0
230696,hospital,0,1
230697,attendances,0,1
230698,(,0,1
230699,2.5,0,0
230700,compared,0,0
230701,with,0,1
230702,three,0,0
230703,",",0,1
230704,P,0,0
230705,=,0,1
230706,0.04,0,0
230707,),0,1
230708,but,0,0
230709,a,0,0
230710,greater,0,0
230711,drop,0,0
230712,in,0,0
230713,haemoglobin,0,1
230714,concentration,0,0
230715,(,0,1
230716,difference,0,0
230717,",",0,1
230718,1,0,0
230719,g/dl,0,1
230720,;,0,1
230721,CI95,0,0
230722,%,0,0
230723,=,0,0
230724,0.3-1.6,0,0
230725,),0,1
230726,.,0,1
230727,[,0,1
230728,Initial,0,1
230729,nuclear,0,1
230730,magnetic,0,1
230731,resonance,0,1
230732,tomography,0,1
230733,results,0,0
230734,of,0,0
230735,the,0,0
230736,treatment,1,0
230737,course,1,0
230738,of,1,1
230739,avascular,1,1
230740,femur,1,1
230741,head,1,1
230742,necrosis,1,1
230743,after,1,0
230744,femoral,1,1
230745,core,1,1
230746,decompression,1,1
230747,],1,1
230748,.,1,1
230749,The,0,0
230750,vascular,1,0
230751,femoral,1,1
230752,head,1,1
230753,necrosis,1,0
230754,is,1,0
230755,a,1,0
230756,serious,1,0
230757,illness,1,1
230758,",",1,0
230759,especially,1,0
230760,when,1,0
230761,appearing,1,1
230762,in,1,0
230763,patients,1,1
230764,aged,1,1
230765,30,1,1
230766,to,1,1
230767,50,1,1
230768,years,1,1
230769,.,1,1
230770,Many,0,1
230771,etiologic,0,1
230772,factors,0,0
230773,cause,0,0
230774,a,0,0
230775,femoral,0,1
230776,head,0,1
230777,necrosis,0,1
230778,such,0,0
230779,as,0,0
230780,",",0,0
230781,for,0,0
230782,example,0,0
230783,",",0,1
230784,high-dose,1,0
230785,steroids,1,0
230786,",",1,1
230787,abuse,1,1
230788,of,1,0
230789,alcohol,1,1
230790,",",1,0
230791,defect,1,1
230792,of,1,0
230793,bone,1,1
230794,marrow,1,1
230795,and,1,0
230796,trauma,1,1
230797,of,1,0
230798,the,1,0
230799,hip,1,1
230800,.,1,0
230801,Often,0,0
230802,the,0,0
230803,X-ray,0,0
230804,photograph,0,0
230805,leads,0,0
230806,to,0,0
230807,the,0,0
230808,diagnosis,0,1
230809,in,0,0
230810,the,0,0
230811,second,0,1
230812,stage,0,1
230813,(,0,1
230814,ARCO,0,1
230815,1992,0,1
230816,),0,1
230817,or,0,1
230818,in,0,0
230819,the,0,0
230820,third,0,1
230821,stage,0,1
230822,",",0,0
230823,when,0,0
230824,the,0,0
230825,femoral,0,0
230826,head,0,1
230827,has,0,0
230828,begun,0,0
230829,to,0,0
230830,collapse,0,0
230831,.,0,0
230832,The,0,0
230833,stage,0,1
230834,IIc,0,0
230835,and,0,0
230836,III,0,0
230837,shows,0,0
230838,an,0,0
230839,evident,0,0
230840,enhancement,0,0
230841,in,0,1
230842,contrast,0,1
230843,media,0,1
230844,in,0,1
230845,MRI,0,1
230846,.,0,1
230847,Contrast,0,0
230848,enhancement,0,0
230849,is,0,0
230850,demonstrated,0,0
230851,by,0,0
230852,STIR,0,1
230853,",",0,1
230854,FATSAT,0,0
230855,",",0,0
230856,T1-weighted,0,0
230857,and,0,0
230858,dynamic,0,0
230859,screening,0,1
230860,sequence,0,0
230861,.,0,1
230862,The,0,0
230863,characteristics,0,0
230864,of,0,0
230865,the,0,1
230866,contrast,0,1
230867,media,0,1
230868,enhancement,0,0
230869,argue,0,0
230870,for,0,0
230871,an,0,0
230872,active,0,1
230873,concomitant,0,0
230874,process,0,0
230875,of,0,0
230876,destruction,0,0
230877,and,0,1
230878,regeneration,0,0
230879,.,0,1
230880,This,0,0
230881,stage,0,0
230882,has,0,0
230883,the,0,0
230884,best,0,0
230885,chances,0,0
230886,for,0,0
230887,a,0,1
230888,drug,0,0
230889,or,0,1
230890,a,0,0
230891,surgical,0,1
230892,therapy,0,0
230893,.,0,1
230894,The,0,0
230895,evaluation,0,0
230896,of,0,0
230897,the,0,0
230898,signal,0,0
230899,intensity,0,0
230900,by,0,0
230901,the,0,0
230902,dynamic,0,0
230903,screening,0,0
230904,sequence,0,0
230905,is,0,0
230906,considered,0,0
230907,as,0,0
230908,an,0,0
230909,objective,0,0
230910,contribution,0,0
230911,for,0,0
230912,the,0,0
230913,staging,0,1
230914,of,0,0
230915,the,0,0
230916,femoral,0,1
230917,head,0,1
230918,necrosis,0,1
230919,.,0,0
230920,This,0,0
230921,enables,0,0
230922,one,0,0
230923,to,0,0
230924,differentiate,0,1
230925,between,1,0
230926,the,1,0
230927,curable,1,1
230928,stage,1,1
230929,IIc,1,1
230930,and,1,0
230931,the,1,0
230932,stage,1,1
230933,III,1,0
230934,",",1,0
230935,showing,1,0
230936,the,1,0
230937,beginning,1,0
230938,of,1,0
230939,breakdown,1,0
230940,of,1,0
230941,the,1,0
230942,femoral,1,1
230943,head,1,1
230944,.,1,1
230945,Clinical,0,0
230946,evaluation,0,0
230947,of,0,0
230948,the,0,0
230949,speed,0,0
230950,and,0,0
230951,effectiveness,0,0
230952,of,0,0
230953,subgingival,0,1
230954,calculus,0,1
230955,removal,0,0
230956,on,0,0
230957,single-rooted,0,1
230958,teeth,0,1
230959,with,0,1
230960,diamond-coated,0,1
230961,ultrasonic,0,1
230962,tips,0,1
230963,.,0,1
230964,Several,0,0
230965,studies,0,0
230966,have,0,1
230967,found,0,0
230968,incomplete,0,1
230969,calculus,0,1
230970,removal,0,0
230971,during,0,0
230972,periodontal,0,1
230973,treatment,0,1
230974,with,0,1
230975,traditional,0,1
230976,hand,0,1
230977,curets,0,0
230978,",",0,1
230979,sonic,0,1
230980,",",0,0
230981,and,0,1
230982,ultrasonic,0,1
230983,instruments,0,0
230984,.,0,1
230985,This,0,0
230986,study,0,0
230987,evaluated,0,0
230988,the,0,0
230989,speed,0,0
230990,and,0,0
230991,effectiveness,0,0
230992,of,0,0
230993,subgingival,0,1
230994,calculus,0,1
230995,removal,0,0
230996,with,0,1
230997,new,0,1
230998,diamond-coated,0,1
230999,ultrasonic,0,1
231000,tips,0,1
231001,on,0,1
231002,single-rooted,0,1
231003,teeth,0,1
231004,.,0,1
231005,Single,0,0
231006,session,0,0
231007,subgingival,0,1
231008,scaling,0,0
231009,and,0,0
231010,root,0,1
231011,planing,0,0
231012,was,0,0
231013,performed,0,0
231014,on,0,0
231015,80,1,1
231016,teeth,1,1
231017,with,1,1
231018,5,1,1
231019,to,1,1
231020,12,1,1
231021,mm,1,1
231022,probing,1,1
231023,depths,1,1
231024,in,1,1
231025,15,1,1
231026,patients,1,1
231027,.,1,1
231028,Each,0,0
231029,patient,0,0
231030,provided,0,0
231031,groups,1,0
231032,of,1,1
231033,4,1,1
231034,teeth,1,1
231035,that,0,0
231036,were,0,1
231037,randomly,0,1
231038,treated,0,1
231039,with,0,1
231040,either,0,1
231041,hand,0,1
231042,curets,0,0
231043,(,0,1
231044,HAND,0,1
231045,),0,1
231046,;,0,1
231047,standard,0,1
231048,smooth,0,1
231049,ultrasonic,0,1
231050,tip,0,0
231051,(,0,1
231052,US,0,1
231053,),0,1
231054,;,0,0
231055,or,0,1
231056,fine,0,1
231057,grit,0,0
231058,(,0,0
231059,FINDIAM,0,0
231060,),0,1
231061,or,0,1
231062,medium,0,1
231063,grit,0,0
231064,(,0,1
231065,MEDDIAM,0,1
231066,),0,1
231067,diamond-coated,0,0
231068,ultrasonic,0,1
231069,tips,0,1
231070,.,0,1
231071,The,0,0
231072,time,0,0
231073,taken,0,0
231074,to,0,0
231075,reach,0,0
231076,the,0,0
231077,therapeutic,0,0
231078,endpoint,0,0
231079,of,0,0
231080,a,0,0
231081,clean,0,1
231082,",",0,0
231083,smooth,0,1
231084,root,0,1
231085,surface,0,0
231086,in,0,0
231087,a,0,1
231088,defined,0,0
231089,region,0,1
231090,on,0,0
231091,each,0,0
231092,tooth,0,1
231093,with,0,1
231094,each,0,0
231095,instrument,0,0
231096,by,0,0
231097,the,0,1
231098,3,0,1
231099,therapists,0,0
231100,with,0,1
231101,differing,0,1
231102,experience,0,1
231103,levels,0,0
231104,was,0,0
231105,recorded,0,0
231106,.,0,1
231107,The,0,0
231108,teeth,0,1
231109,were,0,0
231110,then,0,0
231111,atraumatically,0,1
231112,extracted,0,0
231113,",",0,0
231114,stored,0,0
231115,in,0,0
231116,a,0,0
231117,surfactant,0,0
231118,",",0,0
231119,photographed,0,0
231120,at,0,0
231121,10X,0,0
231122,",",0,0
231123,and,0,0
231124,the,0,0
231125,percent,0,0
231126,of,0,0
231127,calculus,0,1
231128,present,0,0
231129,in,0,0
231130,the,0,0
231131,area,0,0
231132,of,0,0
231133,the,0,0
231134,pocket,0,1
231135,or,0,0
231136,on,0,0
231137,a,0,1
231138,comparable,0,0
231139,control,0,1
231140,surface,0,0
231141,calculated,0,0
231142,by,0,0
231143,histometric,0,1
231144,point,0,0
231145,counting,0,0
231146,.,0,1
231147,ANOVA,0,0
231148,and,0,0
231149,paired,0,1
231150,t,0,0
231151,tests,0,0
231152,showed,0,0
231153,that,0,0
231154,mean,0,1
231155,percent,0,1
231156,remaining,0,1
231157,calculus,0,1
231158,on,0,0
231159,treated,0,1
231160,versus,0,0
231161,control,0,1
231162,surfaces,0,0
231163,was,0,0
231164,HAND,0,1
231165,4.6,0,1
231166,+/-,0,0
231167,5.3,0,1
231168,versus,0,0
231169,57.5,0,1
231170,+/-,0,0
231171,28.2,0,1
231172,",",0,1
231173,US,0,1
231174,4.7,0,1
231175,+/-,0,0
231176,6.4,0,0
231177,versus,0,0
231178,54.4,0,0
231179,+/-,0,0
231180,25.9,0,1
231181,",",0,1
231182,FINDIAM,0,0
231183,4.3,0,0
231184,+/-,0,1
231185,5.2,0,0
231186,versus,0,0
231187,37.5,0,1
231188,+/-,0,0
231189,22.1,0,1
231190,",",0,1
231191,and,0,1
231192,MEDDIAM,0,1
231193,3.4,0,0
231194,+/-,0,1
231195,4.2,0,1
231196,versus,0,0
231197,50.7,0,1
231198,+/-,0,0
231199,20.1,0,0
231200,",",0,0
231201,respectively,0,0
231202,(,0,0
231203,all,0,0
231204,P,0,0
231205,<,0,0
231206,0.01,0,0
231207,),0,1
231208,.,0,1
231209,The,0,0
231210,mean,0,0
231211,time,0,0
231212,in,0,1
231213,seconds,0,0
231214,to,0,1
231215,reach,0,0
231216,the,0,0
231217,clinical,0,0
231218,endpoint,0,0
231219,ranged,0,0
231220,from,0,1
231221,HAND,0,1
231222,289,0,1
231223,+/-,0,0
231224,193,0,1
231225,",",0,1
231226,US,0,1
231227,194,0,1
231228,+/-,0,0
231229,67,0,1
231230,",",0,1
231231,FINDIAM,0,0
231232,167,0,1
231233,+/-,0,0
231234,71,0,1
231235,",",0,1
231236,to,0,1
231237,MEDDIAM,0,1
231238,147,0,1
231239,+/-,0,1
231240,92,0,1
231241,.,0,1
231242,All,0,1
231243,powered,0,0
231244,instruments,0,0
231245,were,0,1
231246,significantly,0,0
231247,faster,0,0
231248,than,0,0
231249,HAND,0,1
231250,(,0,1
231251,P,0,0
231252,<,0,0
231253,0.05,0,0
231254,),0,1
231255,",",0,0
231256,but,0,0
231257,did,0,0
231258,not,0,0
231259,differ,0,0
231260,from,0,0
231261,each,0,0
231262,other,0,0
231263,.,0,1
231264,On,0,0
231265,a,0,0
231266,0,0,0
231267,=,0,0
231268,smooth,0,1
231269,to,0,1
231270,3,0,1
231271,=,0,1
231272,rough,0,1
231273,scale,0,1
231274,",",0,0
231275,most,0,0
231276,often,0,0
231277,HAND,0,1
231278,resulted,0,0
231279,in,0,1
231280,smooth,0,1
231281,surfaces,0,1
231282,(,0,1
231283,10/20,0,1
231284,),0,1
231285,",",0,0
231286,the,0,0
231287,powered,0,0
231288,tips,0,1
231289,of,0,1
231290,all,0,1
231291,types,0,1
231292,slight,0,0
231293,surface,0,0
231294,roughness,0,0
231295,(,0,1
231296,10/20,0,0
231297,each,0,1
231298,),0,0
231299,",",0,0
231300,and,0,0
231301,US,0,0
231302,the,0,0
231303,most,0,0
231304,moderate,0,1
231305,roughness,0,0
231306,(,0,1
231307,7/20,0,1
231308,),0,1
231309,.,0,0
231310,There,0,0
231311,were,0,0
231312,no,0,0
231313,differences,0,0
231314,in,0,0
231315,percent,0,1
231316,calculus,0,1
231317,remaining,0,1
231318,",",0,0
231319,surface,0,0
231320,roughness,0,0
231321,",",0,0
231322,or,0,1
231323,time,0,0
231324,spent,0,0
231325,among,0,0
231326,the,0,0
231327,3,0,1
231328,treating,0,0
231329,clinicians,0,1
231330,despite,0,1
231331,their,0,1
231332,varying,0,1
231333,experience,0,1
231334,levels,0,0
231335,.,0,1
231336,The,0,0
231337,results,0,0
231338,of,0,0
231339,this,0,0
231340,study,0,0
231341,showed,0,0
231342,that,0,0
231343,percent,0,1
231344,calculus,0,1
231345,remaining,0,1
231346,was,0,0
231347,<,0,0
231348,5,0,0
231349,%,0,0
231350,with,0,1
231351,all,0,0
231352,the,0,0
231353,instruments,0,0
231354,given,0,0
231355,time,0,0
231356,ad,0,1
231357,libitum,0,1
231358,on,0,0
231359,a,0,0
231360,given,0,0
231361,root,0,1
231362,surface,0,0
231363,.,0,1
231364,Root,0,0
231365,roughness,0,0
231366,was,0,0
231367,generally,0,0
231368,slightly,0,0
231369,greater,0,0
231370,with,0,1
231371,all,0,0
231372,3,0,1
231373,powered,0,1
231374,tips,0,1
231375,.,0,1
231376,All,0,1
231377,of,0,0
231378,the,0,0
231379,powered,0,1
231380,instruments,0,0
231381,took,0,1
231382,significantly,0,0
231383,less,0,0
231384,time,0,0
231385,than,0,0
231386,the,0,0
231387,HAND,0,1
231388,.,0,1
231389,Both,0,0
231390,DIAM,0,0
231391,tips,0,0
231392,took,0,1
231393,less,0,0
231394,time,0,0
231395,than,0,0
231396,US,0,1
231397,.,0,1
231398,Diamond-coated,0,0
231399,ultrasonic,0,1
231400,tips,0,1
231401,appeared,0,0
231402,to,0,0
231403,be,0,0
231404,much,0,0
231405,more,0,0
231406,efficient,0,0
231407,than,0,0
231408,HAND,0,1
231409,or,0,1
231410,US,0,1
231411,in,0,0
231412,removing,0,1
231413,calculus,0,1
231414,in,0,1
231415,moderate-deep,0,1
231416,probing,0,1
231417,depths,0,1
231418,on,0,1
231419,single-rooted,0,1
231420,teeth,0,1
231421,in,0,1
231422,vivo,0,0
231423,.,0,1
231424,Efficacy,0,0
231425,of,0,0
231426,ebrotidine,0,0
231427,and,0,1
231428,ranitidine,0,0
231429,combined,0,0
231430,with,0,1
231431,amoxicillin,0,0
231432,and,0,0
231433,metronidazole,0,0
231434,in,0,0
231435,the,0,0
231436,eradication,0,0
231437,of,0,0
231438,Helicobacter,0,1
231439,pylori,0,1
231440,in,0,1
231441,patients,1,1
231442,with,1,1
231443,duodenal,1,1
231444,ulcer,1,1
231445,.,1,1
231446,This,0,0
231447,double-blind,0,0
231448,",",0,0
231449,randomized,0,0
231450,",",0,0
231451,phase,0,1
231452,III,0,1
231453,clinical,0,0
231454,trial,0,1
231455,was,0,0
231456,carried,0,0
231457,out,0,1
231458,in,0,1
231459,two,1,1
231460,parallel,1,0
231461,groups,1,1
231462,to,0,1
231463,assess,0,0
231464,the,0,0
231465,efficacy,0,0
231466,of,0,0
231467,ebrotidine,0,0
231468,(,0,1
231469,N-,0,0
231470,[,0,0
231471,(,0,1
231472,E,0,1
231473,),0,1
231474,-,0,0
231475,[,0,0
231476,[,0,0
231477,2-,0,1
231478,[,0,1
231479,[,0,0
231480,[,0,0
231481,2-,0,1
231482,[,0,0
231483,(,0,1
231484,diaminomethylene,0,0
231485,),0,1
231486,amino,0,0
231487,],0,1
231488,-4-thiazolyl,0,1
231489,],0,1
231490,methyl,0,1
231491,],0,1
231492,thio,0,1
231493,],0,1
231494,ethyl,0,1
231495,],0,0
231496,amino,0,0
231497,],0,1
231498,methylene,0,0
231499,],0,1
231500,-4-bromo-benzenesulfonamide,0,0
231501,",",0,1
231502,CAS,0,0
231503,100981-43-9,0,1
231504,",",0,1
231505,FI-3542,0,1
231506,),0,1
231507,400,0,0
231508,mg,0,0
231509,and,0,0
231510,ranitidine,0,0
231511,300,0,1
231512,mg,0,0
231513,given,0,0
231514,in,0,0
231515,single,0,0
231516,evening,0,0
231517,dose,0,0
231518,",",0,0
231519,combined,0,0
231520,with,0,1
231521,amoxicillin,0,0
231522,750,0,1
231523,mg,0,1
231524,and,0,1
231525,metronidazole,0,0
231526,500,0,1
231527,mg,0,1
231528,three,0,1
231529,times,0,0
231530,daily,0,0
231531,for,0,1
231532,14,0,1
231533,days,0,0
231534,",",0,1
231535,in,0,0
231536,the,0,0
231537,eradication,0,0
231538,of,0,0
231539,Helicobacter,0,1
231540,pylori,0,1
231541,in,0,1
231542,patients,1,1
231543,with,1,1
231544,duodenal,1,1
231545,ulcer,1,1
231546,.,1,1
231547,Thirty,1,1
231548,patients,1,1
231549,were,1,1
231550,included,1,1
231551,",",1,0
231552,divided,1,1
231553,into,1,1
231554,two,1,1
231555,groups,1,1
231556,of,1,1
231557,15,1,1
231558,",",1,1
231559,to,1,1
231560,whom,1,1
231561,one,1,1
231562,of,1,1
231563,the,1,0
231564,study,1,1
231565,therapies,1,0
231566,was,1,0
231567,administered,1,0
231568,based,1,1
231569,on,1,0
231570,a,1,0
231571,randomization,1,0
231572,code,1,0
231573,.,1,1
231574,Clinical,0,0
231575,and,0,0
231576,endoscopic,0,1
231577,controls,0,1
231578,were,0,1
231579,performed,0,0
231580,4,0,0
231581,",",0,1
231582,6,0,0
231583,and,0,1
231584,8,0,1
231585,weeks,0,0
231586,after,0,1
231587,the,0,0
231588,onset,0,1
231589,of,0,0
231590,the,0,0
231591,treatment,0,0
231592,.,0,1
231593,No,0,0
231594,differences,0,0
231595,were,0,1
231596,seen,0,0
231597,between,0,0
231598,the,0,0
231599,two,0,0
231600,treatment,0,0
231601,groups,0,1
231602,with,0,1
231603,regard,0,0
231604,to,0,1
231605,demographic,0,0
231606,parameters,0,0
231607,and,0,1
231608,clinical,0,1
231609,histories,0,1
231610,.,0,1
231611,They,0,0
231612,were,0,0
231613,both,0,0
231614,perfectly,0,1
231615,homogeneous,0,0
231616,.,0,0
231617,There,0,0
231618,were,0,0
231619,no,0,0
231620,differences,0,0
231621,between,0,0
231622,the,0,0
231623,eradication,0,0
231624,of,0,0
231625,both,0,0
231626,therapies,0,0
231627,in,0,0
231628,both,0,0
231629,the,0,0
231630,antrum,0,1
231631,and,0,0
231632,gastric,0,1
231633,body,0,1
231634,samples,0,1
231635,(,0,1
231636,over,0,0
231637,80,0,1
231638,%,0,0
231639,eradication,0,1
231640,),0,0
231641,",",0,0
231642,allowing,0,0
231643,the,0,0
231644,results,0,0
231645,to,0,0
231646,be,0,0
231647,classified,0,1
231648,as,0,0
231649,satisfactory,0,0
231650,.,0,1
231651,Moreover,0,0
231652,",",0,0
231653,perfect,0,0
231654,control,0,1
231655,was,0,0
231656,achieved,0,0
231657,through,0,0
231658,the,0,0
231659,study,0,0
231660,of,0,0
231661,clinical,0,0
231662,symptoms,0,1
231663,",",0,1
231664,which,0,0
231665,even,0,0
231666,disappeared,0,0
231667,in,0,0
231668,some,0,1
231669,cases,0,1
231670,.,0,0
231671,There,0,0
231672,were,0,0
231673,no,0,0
231674,differences,0,0
231675,in,0,0
231676,the,0,0
231677,healing,0,0
231678,rate,0,0
231679,of,0,0
231680,the,0,0
231681,duodenal,0,1
231682,ulcer,0,1
231683,after,0,1
231684,four,0,1
231685,weeks,0,1
231686,",",0,1
231687,86.7,0,0
231688,%,0,0
231689,being,0,1
231690,achieved,0,0
231691,for,0,1
231692,both,0,0
231693,groups,0,1
231694,.,0,1
231695,[,0,0
231696,Clinical,0,0
231697,diagnosis,0,1
231698,of,0,0
231699,deep,0,1
231700,venous,0,1
231701,thrombosis,0,1
231702,after,0,0
231703,hip,0,1
231704,replacement,0,1
231705,surgery,0,1
231706,],0,1
231707,.,0,1
231708,Hip,0,0
231709,replacement,0,0
231710,surgery,0,1
231711,is,0,0
231712,associated,0,0
231713,with,0,1
231714,a,0,1
231715,high,0,1
231716,frequency,0,0
231717,of,0,0
231718,postoperative,0,1
231719,deep,0,1
231720,vein,0,1
231721,thrombosis,0,1
231722,.,0,1
231723,This,0,0
231724,prospective,0,0
231725,study,0,1
231726,was,0,0
231727,performed,0,0
231728,in,0,0
231729,order,0,0
231730,to,0,0
231731,investigate,0,0
231732,if,0,0
231733,routine,0,1
231734,bedside,0,0
231735,questioning,0,0
231736,and,0,0
231737,examination,0,0
231738,by,0,0
231739,the,0,0
231740,visiting,0,1
231741,doctor,0,0
231742,could,0,0
231743,reveal,0,0
231744,deep,0,0
231745,vein,0,1
231746,thrombosis,0,1
231747,in,0,0
231748,the,0,0
231749,legs,0,1
231750,of,0,1
231751,patients,1,1
231752,who,1,1
231753,had,1,1
231754,received,1,1
231755,a,1,0
231756,hip,1,1
231757,replacement,1,1
231758,.,1,1
231759,258,1,1
231760,patients,1,1
231761,were,1,1
231762,evaluated,1,0
231763,.,1,1
231764,Thromboprophylaxis,0,1
231765,(,0,0
231766,dextran-70,0,1
231767,",",0,1
231768,low,0,1
231769,molecular,0,0
231770,weight,0,1
231771,heparin,0,0
231772,and,0,0
231773,graded,0,0
231774,elastic,0,0
231775,stockings,0,0
231776,),0,1
231777,was,0,0
231778,given,0,0
231779,during,0,0
231780,the,0,0
231781,first,0,0
231782,week,0,0
231783,after,0,1
231784,operation,0,1
231785,.,0,1
231786,Bilateral,0,0
231787,venography,0,0
231788,was,0,0
231789,performed,0,0
231790,in,0,0
231791,all,0,1
231792,patients,0,1
231793,on,0,0
231794,day,0,1
231795,seven,0,1
231796,after,0,0
231797,operation,0,1
231798,",",0,0
231799,and,0,0
231800,showed,0,0
231801,an,0,0
231802,overall,0,0
231803,deep,0,1
231804,vein,0,1
231805,thrombosis,0,1
231806,incidence,0,0
231807,of,0,0
231808,16,0,1
231809,%,0,0
231810,.,0,1
231811,The,0,0
231812,visiting,0,1
231813,doctors,0,0
231814,had,0,1
231815,not,0,0
231816,suspected,0,1
231817,deep,0,0
231818,vein,0,1
231819,thrombosis,0,1
231820,in,0,0
231821,any,0,0
231822,of,0,0
231823,the,0,0
231824,patients,0,1
231825,.,0,0
231826,This,0,0
231827,may,0,0
231828,have,0,0
231829,been,0,0
231830,because,0,0
231831,postoperative,0,0
231832,painful,0,0
231833,and,0,1
231834,swollen,0,1
231835,legs,0,1
231836,effectively,0,0
231837,masked,0,1
231838,any,0,0
231839,signs,0,1
231840,and,0,1
231841,symptoms,0,1
231842,of,0,1
231843,deep,0,1
231844,vein,0,1
231845,thrombosis,0,1
231846,.,0,1
231847,Our,0,0
231848,results,0,0
231849,show,0,0
231850,that,0,0
231851,deep,0,1
231852,vein,0,1
231853,thrombosis,0,1
231854,during,0,0
231855,the,0,0
231856,first,0,0
231857,week,0,0
231858,after,0,0
231859,hip,0,1
231860,replacement,0,0
231861,surgery,0,1
231862,can,0,0
231863,not,0,0
231864,be,0,0
231865,discovered,0,0
231866,by,0,0
231867,clinical,0,1
231868,diagnostics,0,1
231869,.,0,1
231870,The,0,0
231871,high,0,0
231872,subclinical,0,1
231873,frequency,0,0
231874,of,0,0
231875,deep,0,1
231876,vein,0,1
231877,thrombosis,0,1
231878,indicates,0,0
231879,the,0,0
231880,importance,0,0
231881,of,0,0
231882,improving,0,0
231883,thromboprophylaxis,0,1
231884,in,0,1
231885,order,0,0
231886,to,0,0
231887,further,0,0
231888,minimise,0,0
231889,the,0,0
231890,occurrence,0,0
231891,of,0,0
231892,deep,0,1
231893,vein,0,1
231894,thrombosis,0,1
231895,and,0,0
231896,the,0,0
231897,risk,0,0
231898,of,0,0
231899,thromboembolic,0,1
231900,complications,0,1
231901,.,0,1
231902,Cranberry,0,1
231903,concentrate,0,0
231904,:,0,1
231905,UTI,1,0
231906,prophylaxis,0,1
231907,.,0,1
231908,Active,0,1
231909,warming,0,0
231910,",",0,0
231911,not,0,0
231912,passive,0,0
231913,heat,0,0
231914,retention,0,0
231915,",",0,0
231916,maintains,0,0
231917,normothermia,0,0
231918,during,0,0
231919,combined,0,0
231920,epidural-general,0,1
231921,anesthesia,0,1
231922,for,0,0
231923,hip,1,1
231924,and,1,1
231925,knee,1,1
231926,arthroplasty,1,1
231927,.,1,1
231928,STUDY,0,0
231929,OBJECTIVE,0,0
231930,to,0,0
231931,compare,0,0
231932,passive,0,0
231933,heat,0,0
231934,retention,0,0
231935,by,0,0
231936,low-flow,0,1
231937,anesthesia,0,1
231938,",",0,0
231939,alone,0,0
231940,and,0,0
231941,with,0,1
231942,additional,0,0
231943,thermal,0,1
231944,insulation,0,0
231945,by,0,0
231946,reflective,0,0
231947,blankets,0,0
231948,",",0,1
231949,with,0,1
231950,forced-air,0,0
231951,warming,0,0
231952,preventing,0,0
231953,intraoperative,0,0
231954,hypothermia,0,1
231955,during,0,1
231956,combined,0,0
231957,epidural-general,0,1
231958,anesthesia,0,1
231959,.,0,1
231960,DESIGN,0,0
231961,Randomized,0,0
231962,",",0,0
231963,controlled,0,0
231964,study,0,1
231965,.,0,1
231966,SETTING,0,1
231967,Inpatient,1,1
231968,anesthesia,1,1
231969,at,1,0
231970,a,1,0
231971,university,1,1
231972,department,1,1
231973,of,1,0
231974,orthopedic,1,1
231975,surgery,1,1
231976,.,1,1
231977,PATIENTS,1,0
231978,30,1,1
231979,ASA,1,1
231980,physical,1,1
231981,status,1,1
231982,I,1,1
231983,and,1,1
231984,II,1,1
231985,patients,1,1
231986,",",1,1
231987,who,1,1
231988,were,1,1
231989,scheduled,1,1
231990,for,1,0
231991,elective,1,1
231992,hip,1,1
231993,or,1,1
231994,knee,1,1
231995,arthroplasty,1,1
231996,and,1,0
231997,were,1,1
231998,free,1,1
231999,from,1,1
232000,systemic,1,1
232001,disease,1,1
232002,.,1,1
232003,INTERVENTIONS,0,0
232004,Patients,0,1
232005,received,0,1
232006,epidural,0,1
232007,block,0,1
232008,up,0,1
232009,to,0,0
232010,T10,0,0
232011,by,0,0
232012,alkalinized,0,0
232013,lidocaine,0,0
232014,2,0,1
232015,%,0,0
232016,",",0,0
232017,and,0,0
232018,then,0,0
232019,were,0,0
232020,administered,0,0
232021,standard,0,1
232022,general,0,1
232023,anesthesia,0,1
232024,by,0,0
232025,means,0,0
232026,of,0,1
232027,low-flow,0,1
232028,rebreathing,0,1
232029,system,0,1
232030,(,0,1
232031,fresh,0,1
232032,gas,0,1
232033,flow,0,0
232034,=,0,1
232035,1,0,1
232036,L/min,0,1
232037,),0,1
232038,.,0,1
232039,All,0,1
232040,procedures,0,0
232041,started,0,1
232042,between,0,0
232043,8,0,1
232044,and,0,1
232045,10,0,1
232046,AM,0,1
232047,",",0,0
232048,and,0,0
232049,operating,0,0
232050,room,0,1
232051,(,0,1
232052,OR,0,0
232053,),0,1
232054,temperature,0,0
232055,was,0,0
232056,maintained,0,0
232057,between,0,0
232058,21,0,1
232059,degrees,0,1
232060,and,0,1
232061,23,0,1
232062,degrees,0,0
232063,C,0,1
232064,",",0,1
232065,with,0,1
232066,relative,0,0
232067,humidity,0,0
232068,ranging,0,1
232069,between,0,0
232070,40,0,1
232071,%,0,0
232072,and,0,1
232073,45,0,1
232074,%,0,0
232075,.,0,1
232076,For,0,0
232077,heat,0,0
232078,retention,0,0
232079,or,0,1
232080,warming,0,0
232081,therapy,0,0
232082,",",0,1
232083,patients,0,1
232084,received,0,1
232085,either,0,1
232086,low-flow,0,1
232087,anesthesia,0,0
232088,only,0,0
232089,(,0,0
232090,control,0,0
232091,",",0,0
232092,n,0,1
232093,=,0,1
232094,10,0,1
232095,),0,1
232096,",",0,0
232097,low-flow,0,1
232098,anesthesia,0,1
232099,with,0,1
232100,additional,0,1
232101,reflective,0,1
232102,blankets,0,1
232103,(,0,1
232104,blanket,0,1
232105,",",0,0
232106,n,0,1
232107,=,0,1
232108,10,0,1
232109,),0,1
232110,",",0,0
232111,or,0,1
232112,low-flow,0,1
232113,anesthesia,0,1
232114,with,0,1
232115,active,0,1
232116,forced-air,0,1
232117,warming,0,0
232118,(,0,1
232119,forced-air,0,0
232120,",",0,1
232121,n,0,1
232122,=,0,1
232123,10,0,1
232124,),0,1
232125,.,0,1
232126,Tympanic,0,0
232127,temperature,0,0
232128,was,0,0
232129,measured,0,0
232130,at,0,0
232131,OR,0,0
232132,arrival,0,1
232133,(,0,1
232134,baseline,0,0
232135,),0,1
232136,;,0,0
232137,immediately,0,0
232138,following,0,0
232139,general,0,1
232140,anesthesia,0,1
232141,induction,0,1
232142,;,0,1
232143,30,0,1
232144,",",0,1
232145,60,0,1
232146,",",0,0
232147,90,0,1
232148,",",0,0
232149,and,0,1
232150,120,0,1
232151,minutes,0,0
232152,from,0,1
232153,general,0,1
232154,anesthesia,0,1
232155,induction,0,1
232156,;,0,0
232157,and,0,0
232158,at,0,0
232159,the,0,0
232160,end,0,0
232161,of,0,0
232162,surgery,0,1
232163,.,0,1
232164,MEASUREMENTS,0,0
232165,AND,0,0
232166,MAIN,0,0
232167,RESULTS,0,1
232168,Duration,0,0
232169,of,0,0
232170,anesthesia,0,1
232171,",",0,0
232172,invasiveness,0,0
232173,of,0,0
232174,surgery,0,1
232175,",",0,0
232176,and,0,0
232177,baseline,0,0
232178,core,0,1
232179,temperature,0,0
232180,were,0,1
232181,similar,0,0
232182,in,0,0
232183,the,0,1
232184,three,0,1
232185,groups,0,1
232186,.,0,1
232187,Core,0,1
232188,temperature,0,0
232189,decreased,0,0
232190,in,0,0
232191,all,0,0
232192,the,0,1
232193,three,0,0
232194,groups,0,1
232195,30,0,1
232196,minutes,0,0
232197,after,0,1
232198,general,0,1
232199,anesthesia,0,1
232200,induction,0,0
232201,compared,0,0
232202,with,0,1
232203,baseline,0,0
232204,(,0,1
232205,p,0,0
232206,<,0,0
232207,0.01,0,0
232208,),0,1
232209,;,0,1
232210,afterwards,0,1
232211,",",0,0
232212,it,0,0
232213,progressively,0,0
232214,decreased,0,0
232215,in,0,0
232216,the,0,0
232217,control,0,1
232218,and,0,1
232219,blankets,0,1
232220,groups,0,1
232221,(,0,1
232222,p,0,0
232223,=,0,1
232224,0.004,0,0
232225,),0,1
232226,",",0,0
232227,with,0,1
232228,a,0,0
232229,reduction,0,0
232230,from,0,1
232231,baseline,0,0
232232,values,0,0
232233,measured,0,0
232234,at,0,1
232235,the,0,0
232236,end,0,0
232237,of,0,0
232238,surgery,0,1
232239,of,0,1
232240,2.0,0,0
232241,degrees,0,1
232242,C,0,1
232243,and,0,1
232244,1.6,0,0
232245,degrees,0,0
232246,C,0,1
232247,",",0,1
232248,respectively,0,0
232249,.,0,0
232250,In,0,0
232251,the,0,0
232252,forced-air,0,0
232253,group,0,0
232254,",",0,0
232255,after,0,0
232256,the,0,0
232257,initial,0,0
232258,significant,0,0
232259,decrease,0,0
232260,(,0,1
232261,p,0,0
232262,=,0,0
232263,0.01,0,0
232264,vs.,0,0
232265,baseline,0,0
232266,),0,0
232267,",",0,0
232268,core,0,0
232269,temperature,0,0
232270,progressively,0,1
232271,increased,0,0
232272,to,0,0
232273,35.8,0,1
232274,+/-,0,1
232275,0.6,0,1
232276,degrees,0,1
232277,C,0,1
232278,",",0,1
232279,which,0,0
232280,was,0,0
232281,similar,0,0
232282,to,0,1
232283,preoperative,0,1
232284,values,0,0
232285,and,0,0
232286,significantly,0,0
232287,higher,0,0
232288,than,0,0
232289,either,0,0
232290,the,0,0
232291,control,0,1
232292,or,0,1
232293,blankets,0,1
232294,groups,0,1
232295,(,0,1
232296,p,0,0
232297,=,0,1
232298,0.004,0,0
232299,),0,1
232300,.,0,1
232301,CONCLUSIONS,0,0
232302,During,0,0
232303,combined,0,0
232304,epidural-general,0,1
232305,anesthesia,0,1
232306,for,0,0
232307,elective,1,1
232308,hip,1,1
232309,and,1,0
232310,knee,1,1
232311,arthroplasty,1,1
232312,",",0,0
232313,passive,0,0
232314,heat,0,0
232315,retention,0,0
232316,by,0,0
232317,means,0,0
232318,of,0,1
232319,low-flow,0,1
232320,anesthesia,0,1
232321,alone,0,0
232322,and,0,0
232323,in,0,0
232324,combination,0,0
232325,with,0,1
232326,reflective,0,0
232327,blankets,0,0
232328,is,0,0
232329,ineffective,0,0
232330,in,0,0
232331,maintaining,0,1
232332,intraoperative,0,0
232333,normothermia,0,1
232334,and,0,0
232335,definitely,0,0
232336,inferior,0,0
232337,to,0,1
232338,active,0,1
232339,forced-air,0,0
232340,warning,0,0
232341,.,0,1
232342,Comparison,0,0
232343,of,0,0
232344,hand-sewn,0,0
232345,and,0,1
232346,stapled,0,1
232347,esophagogastric,0,1
232348,anastomosis,0,1
232349,after,0,1
232350,esophageal,0,1
232351,resection,0,1
232352,for,0,1
232353,cancer,0,1
232354,:,0,1
232355,a,0,0
232356,prospective,0,1
232357,randomized,0,1
232358,controlled,0,0
232359,trial,0,0
232360,.,0,1
232361,OBJECTIVE,0,0
232362,The,0,0
232363,objective,0,0
232364,of,0,0
232365,this,0,0
232366,study,0,0
232367,was,0,0
232368,to,0,0
232369,compare,0,0
232370,the,0,0
232371,hand-sewn,0,0
232372,and,0,1
232373,stapled,0,1
232374,methods,0,1
232375,in,0,1
232376,esophagogastric,0,1
232377,anastomosis,0,1
232378,.,0,1
232379,SUMMARY,0,0
232380,BACKGROUND,0,0
232381,DATA,0,1
232382,After,0,1
232383,esophageal,0,1
232384,resection,0,1
232385,for,0,0
232386,cancer,0,1
232387,",",0,0
232388,the,0,0
232389,relative,0,0
232390,merits,0,0
232391,of,0,1
232392,the,0,0
232393,hand-sewn,0,0
232394,and,0,0
232395,the,0,0
232396,stapled,0,1
232397,methods,0,1
232398,of,0,1
232399,esophagogastric,0,1
232400,anastomosis,0,0
232401,",",0,0
232402,especially,0,0
232403,regarding,0,0
232404,leakage,0,0
232405,and,0,1
232406,stricture,0,1
232407,rates,0,0
232408,",",0,0
232409,have,0,0
232410,not,0,0
232411,adequately,0,0
232412,been,0,0
232413,studied,0,1
232414,.,0,0
232415,METHODS,0,0
232416,A,0,0
232417,prospective,0,0
232418,randomized,0,1
232419,controlled,0,0
232420,trial,0,0
232421,was,0,0
232422,undertaken,0,1
232423,in,0,1
232424,122,1,1
232425,patients,1,1
232426,with,1,1
232427,squamous,1,1
232428,cell,1,1
232429,cancer,1,1
232430,of,1,0
232431,the,1,0
232432,thoracic,1,1
232433,esophagus,1,1
232434,who,1,1
232435,underwent,1,1
232436,a,1,1
232437,Lewis-Tanner,1,0
232438,esophagectomy,1,1
232439,.,1,1
232440,Patients,1,1
232441,were,1,1
232442,stratified,0,1
232443,according,1,1
232444,to,1,0
232445,esophageal,1,1
232446,size,1,0
232447,",",1,0
232448,based,1,1
232449,on,1,0
232450,the,1,0
232451,diameter,1,0
232452,of,1,0
232453,the,1,0
232454,divided,1,1
232455,esophagus,1,1
232456,(,0,1
232457,<,0,0
232458,or,0,1
232459,>,0,1
232460,or,0,1
232461,=,0,0
232462,30,0,1
232463,mm,0,1
232464,),0,1
232465,and,0,0
232466,then,0,0
232467,were,0,0
232468,randomized,0,0
232469,to,0,0
232470,have,0,0
232471,either,0,0
232472,a,0,0
232473,hand-sewn,0,0
232474,or,0,1
232475,a,0,0
232476,stapled,0,1
232477,anastomosis,0,0
232478,.,0,1
232479,RESULTS,0,0
232480,The,0,0
232481,mean,0,0
232482,total,0,1
232483,operating,0,0
232484,times,0,0
232485,(,0,1
232486,standard,0,1
232487,error,0,0
232488,of,0,0
232489,the,0,0
232490,mean,0,0
232491,),0,0
232492,when,0,0
232493,the,0,0
232494,hand-sewn,0,0
232495,and,0,0
232496,the,0,0
232497,stapled,0,1
232498,methods,0,1
232499,were,0,1
232500,used,0,0
232501,were,0,1
232502,214,0,1
232503,(,0,1
232504,4,0,1
232505,),0,1
232506,minutes,0,0
232507,and,0,1
232508,217,0,1
232509,(,0,1
232510,3.4,0,1
232511,),0,1
232512,minutes,0,0
232513,",",0,1
232514,respectively,0,0
232515,(,0,0
232516,p,0,0
232517,=,0,0
232518,not,0,1
232519,significant,0,0
232520,[,0,0
232521,NS,0,0
232522,],0,1
232523,),0,1
232524,.,0,1
232525,The,0,0
232526,respective,0,0
232527,in,0,0
232528,vivo,0,0
232529,proximal,0,1
232530,resection,0,1
232531,margins,0,1
232532,(,0,1
232533,standard,0,1
232534,error,0,0
232535,of,0,0
232536,the,0,0
232537,mean,0,1
232538,),0,1
232539,were,0,1
232540,8,0,1
232541,(,0,1
232542,0.4,0,1
232543,),0,1
232544,cm,0,1
232545,and,0,1
232546,7.6,0,0
232547,(,0,1
232548,0.4,0,1
232549,),0,1
232550,cm,0,1
232551,(,0,1
232552,p,0,0
232553,=,0,1
232554,NS,0,0
232555,),0,1
232556,.,0,1
232557,Leakage,0,0
232558,rates,0,0
232559,were,0,1
232560,1.6,0,0
232561,%,0,0
232562,and,0,1
232563,4.9,0,0
232564,%,0,0
232565,(,0,1
232566,p,0,0
232567,=,0,1
232568,NS,0,0
232569,),0,1
232570,.,0,1
232571,Excluding,0,0
232572,hospital,0,1
232573,deaths,0,0
232574,",",0,1
232575,patients,0,1
232576,with,0,1
232577,leakage,0,1
232578,or,0,1
232579,anastomotic,0,0
232580,recurrence,0,0
232581,",",0,0
232582,and,0,1
232583,those,0,1
232584,who,0,1
232585,received,0,1
232586,radiation,0,1
232587,therapy,0,0
232588,to,0,0
232589,histologically,0,1
232590,infiltrated,0,0
232591,resection,0,1
232592,margin,0,0
232593,",",0,0
232594,anastomotic,0,0
232595,stricture,0,1
232596,was,0,0
232597,found,0,0
232598,in,0,1
232599,5,0,1
232600,(,0,1
232601,9.1,0,0
232602,%,0,0
232603,),0,1
232604,of,0,1
232605,55,0,1
232606,patients,0,1
232607,in,0,1
232608,the,0,1
232609,hand-sewn,0,0
232610,group,0,1
232611,and,0,1
232612,20,0,1
232613,(,0,1
232614,40,0,1
232615,%,0,0
232616,),0,1
232617,of,0,0
232618,50,0,1
232619,in,0,0
232620,the,0,0
232621,stapler,0,0
232622,group,0,0
232623,(,0,1
232624,p,0,0
232625,=,0,1
232626,0.0003,0,0
232627,),0,1
232628,.,0,1
232629,The,0,0
232630,difference,0,0
232631,in,0,0
232632,stricture,0,1
232633,rates,0,0
232634,was,0,0
232635,significant,0,0
232636,in,0,0
232637,small,0,1
232638,as,0,0
232639,well,0,0
232640,as,0,0
232641,large,0,1
232642,esophagi,0,1
232643,.,0,1
232644,Anastomotic,0,0
232645,recurrence,0,0
232646,developed,0,1
232647,in,0,0
232648,only,0,0
232649,one,0,1
232650,patient,0,0
232651,in,0,0
232652,each,0,0
232653,group,0,0
232654,.,0,0
232655,CONCLUSIONS,0,0
232656,The,0,0
232657,authors,0,0
232658,conclude,0,0
232659,that,0,0
232660,both,0,0
232661,methods,0,1
232662,were,0,1
232663,safe,0,0
232664,",",0,0
232665,but,0,0
232666,the,0,0
232667,stapled,0,1
232668,technique,0,0
232669,resulted,0,0
232670,in,0,0
232671,more,0,0
232672,stricture,0,1
232673,formation,0,0
232674,.,0,1
232675,The,0,0
232676,nature,0,0
232677,and,0,0
232678,importance,0,0
232679,of,0,0
232680,changes,0,0
232681,in,0,1
232682,toe-brachial,0,1
232683,pressure,0,1
232684,indices,0,0
232685,following,0,1
232686,percutaneous,0,1
232687,transluminal,0,1
232688,angioplasty,0,1
232689,for,0,0
232690,leg,0,1
232691,ischaemia,0,1
232692,.,0,1
232693,OBJECTIVES,0,0
232694,To,0,0
232695,document,0,0
232696,changes,0,0
232697,in,0,1
232698,toe-brachial,0,1
232699,pressure,0,1
232700,indices,0,0
232701,(,0,1
232702,TBPI,0,1
232703,),0,1
232704,during,0,0
232705,the,0,1
232706,6,0,1
232707,months,0,0
232708,following,0,1
232709,percutaneous,0,1
232710,transluminal,0,1
232711,angioplasty,0,1
232712,(,0,1
232713,PTA,0,1
232714,),0,1
232715,and,0,0
232716,relate,0,0
232717,these,0,0
232718,changes,0,0
232719,to,0,0
232720,restenosis,0,1
232721,.,0,0
232722,Furthermore,0,0
232723,",",0,0
232724,to,0,0
232725,ascertain,0,0
232726,the,0,0
232727,effect,0,0
232728,of,0,0
232729,administering,0,0
232730,a,0,0
232731,vasodilator,0,0
232732,",",0,0
232733,glyceryl,0,0
232734,trinitrate,0,0
232735,(,0,1
232736,GTN,0,1
232737,),0,0
232738,",",0,0
232739,immediately,0,0
232740,following,0,0
232741,PTA,0,1
232742,.,0,1
232743,DESIGN,0,0
232744,Eighty-three,1,1
232745,technically,1,0
232746,successful,1,1
232747,PTA,1,1
232748,procedures,1,1
232749,were,1,1
232750,studied,1,1
232751,.,1,1
232752,Fifty-six,1,1
232753,were,1,0
232754,for,1,0
232755,intermittent,1,1
232756,claudication,1,1
232757,",",1,0
232758,14,1,1
232759,for,1,0
232760,ischaemic,1,1
232761,rest,1,0
232762,pain,1,1
232763,",",1,0
232764,and,1,0
232765,13,1,1
232766,for,1,1
232767,non-healing,1,1
232768,ulcers,1,1
232769,.,1,1
232770,Immediately,0,0
232771,following,0,0
232772,balloon,0,0
232773,dilatation,0,1
232774,an,0,0
232775,intra-arterial,0,0
232776,bolus,0,0
232777,of,0,0
232778,either,0,1
232779,150,0,1
232780,micrograms,0,0
232781,GTN,0,1
232782,",",0,1
232783,with,0,1
232784,or,0,1
232785,without,0,1
232786,a,0,1
232787,10,0,1
232788,mg,0,0
232789,GTN,0,1
232790,patch,0,0
232791,for,0,1
232792,24,0,1
232793,h,0,0
232794,",",0,0
232795,or,0,0
232796,a,0,0
232797,saline,0,0
232798,placebo,0,0
232799,was,0,0
232800,administered,0,0
232801,.,0,1
232802,TBPI,0,0
232803,were,0,0
232804,measured,0,0
232805,before,0,0
232806,and,0,1
232807,for,0,1
232808,6,0,0
232809,h,0,0
232810,after,0,1
232811,PTA,0,0
232812,and,0,0
232813,then,0,0
232814,at,0,0
232815,24,0,0
232816,h,0,0
232817,",",0,1
232818,1,0,0
232819,week,0,0
232820,",",0,1
232821,1,0,0
232822,month,0,0
232823,and,0,1
232824,6,0,1
232825,months,0,0
232826,.,0,1
232827,At,0,0
232828,this,0,0
232829,time,0,0
232830,",",0,0
232831,patency,0,0
232832,at,0,0
232833,the,0,0
232834,PTA,0,0
232835,site,0,0
232836,was,0,0
232837,determined,0,0
232838,by,0,0
232839,arteriography,0,1
232840,.,0,1
232841,RESULTS,0,0
232842,There,0,0
232843,was,0,0
232844,continuing,0,0
232845,TBPI,0,1
232846,improvement,0,0
232847,over,0,0
232848,1,0,0
232849,month,0,1
232850,in,0,1
232851,patients,0,1
232852,given,0,1
232853,saline,0,0
232854,following,0,0
232855,PTA,0,1
232856,.,0,1
232857,In,0,0
232858,patients,0,1
232859,given,0,1
232860,GTN,0,1
232861,",",0,0
232862,peak,0,0
232863,TBPI,0,1
232864,was,0,0
232865,achieved,0,0
232866,by,0,0
232867,1,0,0
232868,week,0,0
232869,",",0,0
232870,and,0,0
232871,corresponded,0,0
232872,with,0,1
232873,the,0,0
232874,TBPI,0,1
232875,observed,0,0
232876,immediately,0,0
232877,following,0,0
232878,GTN,0,0
232879,administration,0,0
232880,.,0,1
232881,Restenosis,0,0
232882,occurred,0,0
232883,in,0,1
232884,27,0,1
232885,(,0,1
232886,33,0,1
232887,%,0,0
232888,),0,1
232889,patients,0,1
232890,",",0,1
232891,and,0,0
232892,was,0,0
232893,significantly,0,0
232894,more,0,0
232895,frequent,0,0
232896,following,0,0
232897,the,0,0
232898,procedures,0,0
232899,for,0,0
232900,rest,0,0
232901,pain,0,1
232902,or,0,1
232903,ulceration,0,1
232904,",",0,0
232905,or,0,0
232906,where,0,0
232907,a,0,1
232908,TBPI,0,0
232909,increase,0,0
232910,of,0,0
232911,more,0,0
232912,than,0,0
232913,0.15,0,0
232914,by,0,1
232915,1,0,1
232916,week,0,0
232917,was,0,0
232918,observed,0,0
232919,.,0,1
232920,CONCLUSIONS,0,0
232921,Haemodynamic,0,0
232922,changes,0,0
232923,following,0,0
232924,PTA,0,1
232925,continue,0,0
232926,for,0,0
232927,at,0,1
232928,least,0,1
232929,1,0,1
232930,month,0,0
232931,",",0,0
232932,can,0,0
232933,be,0,0
232934,modified,0,0
232935,by,0,0
232936,GTN,0,1
232937,administration,0,0
232938,",",0,0
232939,and,0,0
232940,are,0,0
232941,predictive,0,0
232942,of,0,0
232943,subsequent,0,0
232944,restenosis,0,1
232945,.,0,1
232946,Measuring,0,0
232947,the,0,0
232948,TBPI,0,1
232949,increase,0,0
232950,during,0,0
232951,the,0,0
232952,first,0,0
232953,week,0,0
232954,following,0,0
232955,PTA,0,1
232956,underestimates,0,0
232957,total,0,1
232958,improvement,0,0
232959,",",0,0
232960,and,0,0
232961,may,0,0
232962,give,0,0
232963,false,0,0
232964,reassurance,0,0
232965,with,0,1
232966,respect,0,0
232967,to,0,0
232968,recurrent,0,1
232969,disease,0,1
232970,.,0,1
232971,Lack,0,1
232972,of,0,0
232973,effect,0,0
232974,of,0,0
232975,food,0,0
232976,on,0,0
232977,the,0,0
232978,steady,0,0
232979,state,0,1
232980,pharmacokinetics,0,0
232981,of,0,1
232982,BMS-181101,0,1
232983,",",0,0
232984,an,0,0
232985,antidepressant,0,0
232986,",",0,0
232987,in,0,0
232988,healthy,1,1
232989,subjects,1,1
232990,.,1,1
232991,The,0,0
232992,effect,0,0
232993,of,0,0
232994,food,0,0
232995,on,0,0
232996,the,0,0
232997,pharmacokinetics,0,0
232998,of,0,0
232999,BMS-181101,0,1
233000,",",0,0
233001,a,0,0
233002,new,0,0
233003,anti-depressant,0,1
233004,under,0,1
233005,development,0,0
233006,",",0,0
233007,was,0,0
233008,investigated,0,0
233009,in,0,1
233010,12,1,1
233011,healthy,1,1
233012,male,1,1
233013,volunteers,1,1
233014,at,0,1
233015,steady,0,0
233016,state,0,1
233017,.,0,1
233018,Each,0,0
233019,subject,0,0
233020,received,0,0
233021,a,0,1
233022,15,0,1
233023,mg,0,0
233024,oral,0,1
233025,dose,0,0
233026,of,0,0
233027,BMS-181101,0,1
233028,twice,0,0
233029,a,0,0
233030,day,0,0
233031,(,0,1
233032,q,0,0
233033,12,0,1
233034,h,0,0
233035,),0,1
233036,for,0,1
233037,11,0,1
233038,days,0,0
233039,and,0,1
233040,a,0,1
233041,morning,0,0
233042,dose,0,0
233043,of,0,0
233044,BMS-181101,0,1
233045,on,0,0
233046,day,0,1
233047,12,0,1
233048,.,0,1
233049,Six,1,1
233050,subjects,1,1
233051,were,0,1
233052,randomly,0,1
233053,assigned,0,1
233054,to,0,0
233055,receive,0,1
233056,BMS-181101,0,1
233057,under,0,1
233058,fasted,1,1
233059,conditions,1,1
233060,from,1,1
233061,days,1,1
233062,1,1,1
233063,to,1,1
233064,6,1,0
233065,and,1,0
233066,then,1,0
233067,crossed,1,0
233068,over,1,0
233069,to,1,1
233070,fed,1,1
233071,conditions,1,1
233072,from,1,1
233073,days,1,1
233074,7,1,1
233075,to,1,1
233076,12,1,1
233077,.,1,1
233078,The,0,0
233079,other,0,0
233080,six,1,1
233081,subjects,1,1
233082,received,0,1
233083,the,0,0
233084,reverse,0,1
233085,conditions,0,0
233086,",",0,0
233087,fed,1,1
233088,for,1,1
233089,days,1,0
233090,1-6,1,1
233091,and,1,1
233092,fasted,1,1
233093,for,1,1
233094,days,1,1
233095,7-12,1,1
233096,.,0,1
233097,Serial,0,1
233098,blood,0,0
233099,samples,0,1
233100,were,0,1
233101,collected,0,1
233102,up,0,1
233103,to,0,1
233104,12,0,1
233105,h,0,0
233106,on,0,1
233107,days,0,1
233108,6,0,1
233109,and,0,1
233110,12,0,1
233111,following,0,0
233112,the,0,0
233113,administration,0,0
233114,of,0,0
233115,the,0,0
233116,morning,0,0
233117,dose,0,0
233118,.,0,1
233119,In,0,0
233120,addition,0,0
233121,",",0,0
233122,trough,0,0
233123,blood,0,0
233124,samples,0,1
233125,were,0,1
233126,collected,0,1
233127,on,0,0
233128,days,0,0
233129,4,0,1
233130,",",0,1
233131,5,0,0
233132,",",0,0
233133,10,0,1
233134,",",0,0
233135,and,0,0
233136,11,0,1
233137,prior,0,1
233138,to,0,0
233139,the,0,0
233140,morning,0,0
233141,dose,0,0
233142,.,0,1
233143,Plasma,0,0
233144,samples,0,1
233145,were,0,1
233146,analyzed,0,0
233147,for,0,0
233148,intact,0,1
233149,BMS-181101,0,1
233150,using,0,0
233151,a,0,1
233152,validated,0,0
233153,high-performance,0,0
233154,liquid,0,0
233155,chromatography,0,0
233156,method,0,0
233157,with,0,1
233158,an,0,0
233159,electrochemical,0,0
233160,detector,0,0
233161,.,0,1
233162,BMS-181101,0,0
233163,was,0,0
233164,well,0,0
233165,tolerated,0,0
233166,both,0,0
233167,with,0,1
233168,and,0,0
233169,without,0,1
233170,ingestion,0,0
233171,of,0,0
233172,food,0,0
233173,.,0,1
233174,The,0,0
233175,statistical,0,0
233176,evaluation,0,0
233177,of,0,0
233178,the,0,0
233179,Cmin,0,0
233180,values,0,0
233181,indicated,0,0
233182,that,0,0
233183,steady,0,0
233184,state,0,1
233185,of,0,1
233186,BMS-181101,0,1
233187,was,0,0
233188,achieved,0,0
233189,by,0,0
233190,the,0,0
233191,fourth,0,0
233192,day,0,0
233193,of,0,0
233194,dosing,0,0
233195,regardless,0,0
233196,of,0,0
233197,whether,0,0
233198,the,0,0
233199,subject,0,0
233200,was,0,0
233201,fasted,0,1
233202,or,0,1
233203,fed,0,0
233204,.,0,0
233205,When,0,0
233206,BMS-181101,0,1
233207,was,0,0
233208,administered,0,0
233209,with,0,1
233210,food,0,0
233211,",",0,1
233212,Cmax,0,0
233213,was,0,0
233214,reduced,0,0
233215,by,0,0
233216,about,0,0
233217,25,0,1
233218,%,0,0
233219,and,0,1
233220,tmax,0,0
233221,was,0,0
233222,prolonged,0,0
233223,by,0,0
233224,1,0,0
233225,h.,0,1
233226,However,0,0
233227,",",0,0
233228,AUCtau,0,0
233229,",",0,0
233230,t1/2,0,0
233231,",",0,0
233232,and,0,0
233233,time,0,0
233234,to,0,0
233235,attain,0,0
233236,steady,0,0
233237,state,0,1
233238,of,0,1
233239,BMS-181101,0,1
233240,were,0,1
233241,not,0,0
233242,altered,0,1
233243,by,0,0
233244,ingestion,0,0
233245,of,0,0
233246,food,0,0
233247,.,0,1
233248,In,0,0
233249,summary,0,0
233250,",",0,0
233251,BMS-181101,0,1
233252,can,0,0
233253,be,0,0
233254,given,0,0
233255,with,0,1
233256,food,0,0
233257,without,0,1
233258,adversely,0,0
233259,impacting,0,0
233260,the,0,0
233261,safety,0,0
233262,or,0,1
233263,pharmacokinetic,0,0
233264,profiles,0,0
233265,of,0,1
233266,the,0,1
233267,drug,0,0
233268,.,0,1
233269,A,0,0
233270,drug,0,0
233271,interaction,0,0
233272,study,0,1
233273,between,0,0
233274,ticlopidine,0,0
233275,and,0,0
233276,cyclosporin,0,0
233277,in,0,0
233278,heart,1,1
233279,transplant,1,1
233280,recipients,1,1
233281,.,1,1
233282,OBJECTIVES,0,0
233283,Previous,0,1
233284,uncontrolled,0,1
233285,studies,0,0
233286,have,0,0
233287,suggested,0,0
233288,an,0,0
233289,interaction,0,0
233290,between,0,0
233291,ticlopidine,0,0
233292,",",0,0
233293,a,0,0
233294,major,0,0
233295,antiplatelet,0,1
233296,agent,0,0
233297,",",0,0
233298,and,0,0
233299,cyclosporin,0,0
233300,in,0,0
233301,heart-,0,1
233302,and,0,1
233303,kidney-transplant,0,1
233304,recipients,0,1
233305,.,0,1
233306,The,0,0
233307,aims,0,0
233308,of,0,0
233309,this,0,0
233310,study,0,0
233311,were,0,0
233312,to,0,0
233313,examine,0,0
233314,in,0,0
233315,a,0,0
233316,randomised,0,0
233317,",",0,0
233318,double-blind,0,0
233319,fashion,0,0
233320,",",0,0
233321,the,0,0
233322,possible,0,0
233323,interaction,0,0
233324,between,0,0
233325,cyclosporin,0,1
233326,A,0,1
233327,and,0,1
233328,ticlopidine,0,0
233329,(,0,1
233330,250,0,1
233331,mg,0,0
233332,per,0,1
233333,day,0,1
233334,),0,1
233335,and,0,0
233336,the,0,0
233337,tolerability,0,0
233338,of,0,0
233339,this,0,0
233340,combination,0,0
233341,in,0,0
233342,heart-transplant,1,1
233343,recipients,1,1
233344,.,1,1
233345,METHODS,0,0
233346,Twenty,1,1
233347,heart-transplant,1,1
233348,recipients,1,1
233349,were,1,1
233350,randomised,1,1
233351,into,1,0
233352,either,1,0
233353,a,1,1
233354,treated,1,1
233355,or,1,1
233356,a,1,1
233357,placebo,1,0
233358,group,1,1
233359,.,1,1
233360,Blood,0,0
233361,samples,0,0
233362,were,0,1
233363,drawn,0,0
233364,for,0,0
233365,time-course,0,0
233366,evaluation,0,0
233367,of,0,0
233368,cyclosporin,0,1
233369,blood,0,0
233370,levels,0,0
233371,over,0,0
233372,a,0,1
233373,period,0,0
233374,of,0,0
233375,12,0,1
233376,h,0,0
233377,",",0,1
233378,following,0,0
233379,the,0,0
233380,morning,0,0
233381,intake,0,0
233382,of,0,0
233383,cyclosporin,0,0
233384,and,0,0
233385,",",0,0
233386,for,0,0
233387,platelet,0,0
233388,aggregation,0,0
233389,studies,0,0
233390,",",0,1
233391,before,0,0
233392,and,0,0
233393,after,0,1
233394,14,0,1
233395,days,0,0
233396,of,0,1
233397,ticlopidine,0,1
233398,administration,0,0
233399,.,0,1
233400,Twenty,0,1
233401,four-hour,0,0
233402,urine,0,1
233403,samples,0,1
233404,were,0,1
233405,collected,0,1
233406,for,0,1
233407,6-beta-hydroxycortisol,0,0
233408,measurements,0,0
233409,",",0,1
233410,before,0,0
233411,and,0,0
233412,after,0,1
233413,14,0,1
233414,days,0,0
233415,of,0,1
233416,ticlopidine,0,1
233417,.,0,1
233418,RESULTS,0,0
233419,Although,0,0
233420,given,0,0
233421,at,0,0
233422,half,0,1
233423,the,0,0
233424,recommended,0,0
233425,daily,0,0
233426,dosage,0,0
233427,",",0,0
233428,ticlopidine,0,0
233429,significantly,0,0
233430,reduced,0,0
233431,platelet,0,0
233432,aggregation,0,0
233433,.,0,1
233434,Pharmacokinetic,0,0
233435,parameters,0,0
233436,indicate,0,0
233437,that,0,0
233438,the,0,0
233439,bioavailability,0,0
233440,of,0,0
233441,cyclosporin,0,1
233442,A,0,1
233443,was,0,0
233444,not,0,0
233445,significantly,0,0
233446,modified,0,0
233447,by,0,0
233448,ticlopidine,0,0
233449,.,0,1
233450,However,0,0
233451,",",0,0
233452,one,1,0
233453,patient,1,1
233454,in,1,0
233455,the,1,0
233456,ticlopidine,1,0
233457,group,1,0
233458,was,1,0
233459,withdrawn,1,0
233460,because,1,0
233461,of,1,0
233462,a,1,1
233463,major,1,0
233464,fall,1,0
233465,in,1,1
233466,cyclosporin,1,0
233467,blood,1,0
233468,level,1,0
233469,within,1,1
233470,3,1,1
233471,days,1,0
233472,of,1,1
233473,treatment,1,1
233474,.,1,1
233475,Urinary,0,0
233476,excretion,0,0
233477,of,0,1
233478,6-beta-hydroxycortisol,0,0
233479,was,0,0
233480,augmented,0,0
233481,after,0,0
233482,treatment,0,0
233483,in,0,0
233484,the,0,0
233485,ticlopidine,0,0
233486,group,0,0
233487,compared,0,0
233488,with,0,1
233489,the,0,0
233490,placebo,0,0
233491,group,0,0
233492,",",0,0
233493,suggesting,0,0
233494,that,0,0
233495,induction,0,1
233496,of,0,0
233497,drug,0,0
233498,metabolism,0,0
233499,might,0,0
233500,have,0,0
233501,occurred,0,0
233502,.,0,1
233503,Data,0,0
233504,also,0,0
233505,show,0,0
233506,quite,0,0
233507,a,0,0
233508,large,0,1
233509,intra-individual,0,0
233510,variability,0,0
233511,in,0,1
233512,cyclosporin,0,0
233513,bioavailability,0,0
233514,in,0,0
233515,the,0,0
233516,placebo,0,0
233517,group,0,0
233518,",",0,0
233519,suggesting,0,0
233520,that,0,0
233521,poor,0,1
233522,absorption,0,0
233523,of,0,0
233524,the,0,0
233525,drug,0,0
233526,formulation,0,0
233527,and/or,0,0
233528,poor,0,0
233529,compliance,0,0
233530,might,0,0
233531,have,0,0
233532,contributed,0,0
233533,to,0,0
233534,the,0,0
233535,decreased,0,0
233536,cyclosporin,0,0
233537,blood,0,0
233538,levels,0,0
233539,in,0,1
233540,the,0,1
233541,patient,0,1
233542,withdrawn,0,0
233543,from,0,1
233544,this,0,0
233545,study,0,0
233546,and,0,0
233547,in,0,0
233548,previous,0,1
233549,uncontrolled,0,1
233550,studies,0,0
233551,.,0,1
233552,CONCLUSION,0,0
233553,Cyclosporin,0,0
233554,bioavailability,0,0
233555,was,0,0
233556,not,0,0
233557,clearly,0,0
233558,modified,0,0
233559,by,0,0
233560,a,0,1
233561,half,0,1
233562,dosage,0,0
233563,of,0,0
233564,ticlopidine,0,0
233565,in,0,0
233566,this,0,0
233567,study,0,1
233568,.,0,0
233569,We,0,0
233570,",",0,0
233571,however,0,0
233572,",",0,0
233573,recommend,0,0
233574,closely,0,0
233575,monitoring,0,0
233576,cyclosporin,0,0
233577,blood,0,0
233578,levels,0,0
233579,when,0,0
233580,prescribing,0,0
233581,ticlopidine,0,0
233582,.,0,1
233583,Further,0,0
233584,studies,0,0
233585,will,0,0
233586,be,0,0
233587,needed,0,0
233588,with,0,1
233589,new,0,1
233590,formulations,0,0
233591,of,0,1
233592,cyclosporin,0,0
233593,or,0,0
233594,when,0,0
233595,using,0,0
233596,the,0,0
233597,full,0,0
233598,dosage,0,0
233599,of,0,0
233600,ticlopidine,0,0
233601,.,0,1
233602,Postoperative,0,1
233603,pain,0,1
233604,relief,0,0
233605,following,0,0
233606,laparoscopic,1,1
233607,tubal,1,1
233608,sterilization,1,1
233609,with,0,1
233610,silastic,0,1
233611,bands,0,1
233612,.,0,1
233613,OBJECTIVE,0,0
233614,To,0,0
233615,evaluate,0,0
233616,postoperative,0,0
233617,pain,0,1
233618,relief,0,0
233619,of,0,0
233620,intramuscular,0,0
233621,ketorolac,0,0
233622,",",0,0
233623,topical,0,0
233624,bupivacaine,0,0
233625,",",0,0
233626,and,0,0
233627,placebo,0,0
233628,in,0,1
233629,patients,1,1
233630,undergoing,1,1
233631,laparoscopic,1,1
233632,tubal,1,1
233633,sterilization,1,1
233634,with,1,1
233635,silastic,1,1
233636,bands,1,1
233637,.,1,1
233638,METHODS,0,0
233639,One,1,1
233640,hundred,1,1
233641,five,1,1
233642,women,1,1
233643,undergoing,1,1
233644,laparoscopic,1,1
233645,tubal,1,1
233646,sterilization,1,1
233647,with,1,1
233648,silastic,1,1
233649,bands,1,1
233650,were,0,1
233651,randomized,0,1
233652,to,0,1
233653,one,0,1
233654,of,0,1
233655,three,0,1
233656,groups,0,1
233657,:,0,1
233658,one,0,1
233659,received,0,1
233660,intramuscular,0,1
233661,ketorolac,0,0
233662,and,0,1
233663,topical,0,0
233664,placebo,0,0
233665,applied,0,0
233666,to,0,0
233667,the,0,0
233668,fallopian,0,1
233669,tubes,0,0
233670,",",0,0
233671,the,0,0
233672,second,0,0
233673,received,0,1
233674,intramuscular,0,1
233675,placebo,0,0
233676,and,0,1
233677,topical,0,0
233678,bupivacaine,0,0
233679,",",0,0
233680,and,0,0
233681,the,0,0
233682,third,0,1
233683,received,0,1
233684,intramuscular,0,1
233685,placebo,0,0
233686,and,0,1
233687,topical,0,0
233688,placebo,0,1
233689,.,0,1
233690,Surgical,0,1
233691,procedures,0,0
233692,",",0,1
233693,anesthesia,0,1
233694,",",0,0
233695,and,0,0
233696,recovery,0,0
233697,were,0,0
233698,conducted,0,1
233699,with,0,1
233700,standardized,0,1
233701,protocols,0,1
233702,.,0,1
233703,Postoperative,0,0
233704,pain,0,1
233705,perception,0,0
233706,was,0,0
233707,graded,0,0
233708,using,0,0
233709,the,0,0
233710,modified,0,0
233711,McGill,0,0
233712,pain,0,1
233713,intensity,0,0
233714,scale,0,0
233715,at,0,1
233716,30,0,1
233717,minutes,0,0
233718,postoperatively,0,0
233719,",",0,0
233720,at,0,0
233721,discharge,0,0
233722,from,0,1
233723,the,0,0
233724,recovery,0,0
233725,room,0,0
233726,",",0,0
233727,and,0,0
233728,the,0,0
233729,next,0,0
233730,morning,0,0
233731,by,0,0
233732,telephone,0,1
233733,interview,0,1
233734,.,0,1
233735,Other,0,0
233736,measured,0,0
233737,variables,0,0
233738,included,0,1
233739,postoperative,0,0
233740,vomiting,0,0
233741,",",0,0
233742,additional,0,0
233743,analgesia,0,0
233744,requirement,0,1
233745,",",0,0
233746,and,0,0
233747,length,0,0
233748,of,0,0
233749,time,0,0
233750,spent,0,0
233751,in,0,0
233752,the,0,0
233753,recovery,0,0
233754,room,0,1
233755,.,0,1
233756,RESULTS,0,0
233757,Only,0,0
233758,topical,0,0
233759,bupivacaine,0,0
233760,was,0,0
233761,found,0,0
233762,to,0,0
233763,decrease,0,0
233764,postoperative,0,0
233765,pain,0,1
233766,scores,0,0
233767,significantly,0,0
233768,over,0,0
233769,those,0,0
233770,with,0,1
233771,placebo,0,0
233772,",",0,1
233773,at,0,1
233774,30,0,1
233775,minutes,0,0
233776,postoperatively,0,0
233777,(,0,1
233778,median,0,0
233779,score,0,1
233780,2,0,1
233781,compared,0,0
233782,with,0,1
233783,4,0,0
233784,",",0,1
233785,P,0,0
233786,=,0,1
233787,.002,0,0
233788,),0,1
233789,and,0,0
233790,at,0,0
233791,discharge,0,0
233792,from,0,1
233793,the,0,0
233794,recovery,0,0
233795,room,0,1
233796,(,0,1
233797,median,0,1
233798,score,0,1
233799,2,0,1
233800,compared,0,0
233801,with,0,1
233802,3,0,0
233803,",",0,1
233804,P,0,0
233805,=,0,1
233806,.03,0,0
233807,),0,0
233808,.,0,0
233809,There,0,0
233810,was,0,0
233811,no,0,0
233812,significant,0,0
233813,decrease,0,0
233814,in,0,1
233815,pain,0,1
233816,scores,0,0
233817,with,0,1
233818,intramuscular,0,1
233819,ketorolac,0,0
233820,compared,0,0
233821,with,0,1
233822,placebo,0,0
233823,.,0,1
233824,No,0,0
233825,differences,0,0
233826,in,0,1
233827,pain,0,1
233828,scores,0,0
233829,were,0,1
233830,found,0,0
233831,between,0,0
233832,the,0,1
233833,three,0,0
233834,groups,0,0
233835,at,0,1
233836,the,0,1
233837,next,0,0
233838,morning,0,0
233839,phone,0,0
233840,call,0,0
233841,.,0,0
233842,There,0,0
233843,were,0,0
233844,no,0,0
233845,significant,0,0
233846,differences,0,0
233847,between,0,0
233848,the,0,1
233849,three,0,0
233850,groups,0,0
233851,with,0,1
233852,respect,0,0
233853,to,0,1
233854,requirements,0,1
233855,for,0,1
233856,supplemental,0,1
233857,pain,0,1
233858,medications,0,0
233859,in,0,0
233860,the,0,0
233861,recovery,0,0
233862,room,0,0
233863,",",0,0
233864,incidence,0,0
233865,of,0,0
233866,postoperative,0,0
233867,vomiting,0,0
233868,",",0,0
233869,or,0,0
233870,length,0,0
233871,of,0,0
233872,time,0,0
233873,spent,0,0
233874,in,0,0
233875,the,0,0
233876,recovery,0,0
233877,room,0,1
233878,.,0,1
233879,CONCLUSION,0,0
233880,Topical,0,1
233881,bupivacaine,0,0
233882,decreases,0,0
233883,postoperative,0,0
233884,pain,0,1
233885,scores,0,0
233886,significantly,0,0
233887,compared,0,0
233888,with,0,1
233889,placebo,0,0
233890,in,0,1
233891,women,0,1
233892,undergoing,0,1
233893,laparoscopic,0,1
233894,tubal,0,1
233895,sterilization,0,1
233896,with,0,1
233897,silastic,0,1
233898,bands,0,1
233899,.,0,1
233900,Effectiveness,0,0
233901,of,0,0
233902,norgestimate,0,0
233903,and,0,1
233904,ethinyl,0,0
233905,estradiol,0,0
233906,in,0,0
233907,treating,0,0
233908,moderate,1,1
233909,acne,1,1
233910,vulgaris,1,1
233911,.,1,1
233912,BACKGROUND,0,0
233913,An,0,0
233914,excess,0,0
233915,of,0,0
233916,androgen,0,0
233917,is,0,0
233918,believed,0,0
233919,to,0,0
233920,contribute,0,0
233921,to,0,0
233922,development,0,0
233923,of,0,0
233924,acne,0,1
233925,in,0,1
233926,some,0,1
233927,patients,0,1
233928,.,0,1
233929,Because,0,1
233930,oral,0,1
233931,contraceptives,0,1
233932,(,0,1
233933,OCs,0,1
233934,),0,1
233935,may,0,0
233936,reduce,0,0
233937,the,0,0
233938,active,0,0
233939,androgen,0,0
233940,level,0,0
233941,",",0,0
233942,hormonal,0,0
233943,therapy,0,0
233944,with,0,1
233945,OCs,0,0
233946,has,0,0
233947,been,0,0
233948,used,0,0
233949,successfully,0,0
233950,to,0,0
233951,treat,0,1
233952,patients,1,1
233953,with,1,1
233954,acne,1,1
233955,",",0,0
233956,although,0,0
233957,this,0,0
233958,treatment,0,0
233959,has,0,0
233960,previously,0,0
233961,not,0,0
233962,been,0,0
233963,studied,0,1
233964,in,0,1
233965,placebo-controlled,0,1
233966,trials,0,1
233967,.,0,1
233968,OBJECTIVE,0,0
233969,Our,0,0
233970,purpose,0,0
233971,was,0,0
233972,to,0,0
233973,evaluate,0,0
233974,the,0,0
233975,efficacy,0,0
233976,of,0,0
233977,a,0,0
233978,triphasic,0,0
233979,",",0,0
233980,combination,0,0
233981,OC,0,1
233982,(,0,1
233983,ORTHO,0,1
233984,TRI-CYCLEN,0,1
233985,[,0,0
233986,Ortho-McNeil,0,1
233987,Pharmaceutical,0,1
233988,",",0,0
233989,Raritan,0,0
233990,",",0,0
233991,N.J.,0,1
233992,],0,0
233993,",",0,0
233994,norgestimate/ethinyl,0,0
233995,estradiol,0,0
233996,),0,0
233997,compared,0,0
233998,with,0,1
233999,placebo,0,0
234000,in,0,0
234001,the,0,0
234002,treatment,0,0
234003,of,0,0
234004,moderate,0,1
234005,acne,0,1
234006,vulgaris,0,1
234007,.,0,1
234008,METHODS,0,0
234009,Two,1,1
234010,hundred,1,1
234011,fifty-seven,1,1
234012,healthy,1,1
234013,female,1,1
234014,subjects,1,1
234015,",",1,1
234016,15,1,1
234017,to,1,1
234018,49,1,1
234019,years,1,1
234020,of,1,1
234021,age,1,1
234022,with,1,1
234023,moderate,1,1
234024,acne,1,1
234025,vulgaris,1,1
234026,",",0,1
234027,were,0,0
234028,enrolled,0,1
234029,in,0,0
234030,a,0,0
234031,multicenter,0,0
234032,",",0,0
234033,randomized,0,0
234034,",",0,0
234035,double-blind,0,0
234036,",",0,0
234037,placebo-controlled,0,0
234038,clinical,0,0
234039,trial,0,1
234040,.,0,1
234041,Each,0,0
234042,month,0,0
234043,for,0,0
234044,6,0,1
234045,months,0,0
234046,",",0,0
234047,subjects,0,1
234048,received,0,0
234049,either,0,0
234050,3,0,1
234051,consecutive,0,1
234052,weeks,0,0
234053,of,0,1
234054,the,0,1
234055,OC,0,0
234056,(,0,0
234057,i.e.,0,0
234058,",",0,1
234059,tablets,0,0
234060,containing,0,0
234061,a,0,1
234062,fixed,0,0
234063,dose,0,0
234064,of,0,0
234065,ethinyl,0,1
234066,estradiol,0,1
234067,[,0,0
234068,0.035,0,0
234069,mg,0,0
234070,],0,1
234071,and,0,1
234072,increasing,0,0
234073,doses,0,0
234074,of,0,1
234075,norgestimate,0,1
234076,[,0,1
234077,0.180,0,0
234078,mg,0,1
234079,",",0,1
234080,0.215,0,0
234081,mg,0,0
234082,",",0,1
234083,0.250,0,0
234084,mg,0,0
234085,],0,1
234086,),0,0
234087,followed,0,1
234088,by,0,1
234089,7,0,1
234090,days,0,0
234091,of,0,1
234092,inactive,0,1
234093,drug,0,1
234094,or,0,1
234095,placebo,0,0
234096,(,0,1
234097,color-matched,0,1
234098,tablets,0,1
234099,),0,1
234100,.,0,1
234101,Efficacy,0,0
234102,was,0,0
234103,assessed,0,0
234104,by,0,0
234105,facial,0,1
234106,acne,0,1
234107,lesion,0,1
234108,counts,0,0
234109,",",0,0
234110,an,0,0
234111,investigator,0,0
234112,'s,0,1
234113,global,0,0
234114,assessment,0,0
234115,",",0,0
234116,a,0,0
234117,subject,0,0
234118,'s,0,1
234119,self-assessment,0,0
234120,",",0,1
234121,and,0,0
234122,an,0,0
234123,analysis,0,0
234124,of,0,0
234125,within-cycle,0,0
234126,variation,0,0
234127,(,0,1
234128,cycle,0,0
234129,6,0,1
234130,),0,1
234131,in,0,1
234132,lesion,0,1
234133,counts,0,0
234134,.,0,1
234135,RESULTS,0,0
234136,Of,0,1
234137,the,0,1
234138,160,1,1
234139,subjects,1,1
234140,in,0,1
234141,whom,0,1
234142,efficacy,0,0
234143,could,0,1
234144,be,0,0
234145,evaluated,0,0
234146,",",0,0
234147,the,0,0
234148,OC,0,0
234149,group,0,0
234150,showed,0,0
234151,a,0,0
234152,statistically,0,0
234153,significantly,0,0
234154,greater,0,0
234155,improvement,0,0
234156,than,0,0
234157,the,0,0
234158,placebo,1,0
234159,group,1,0
234160,for,0,0
234161,all,0,0
234162,primary,0,1
234163,efficacy,0,0
234164,measures,0,0
234165,.,0,1
234166,The,0,0
234167,mean,0,0
234168,decrease,0,0
234169,in,0,1
234170,inflammatory,0,0
234171,lesion,0,1
234172,count,0,0
234173,from,0,1
234174,baseline,0,0
234175,to,0,1
234176,cycle,0,0
234177,6,0,1
234178,was,0,0
234179,11.8,0,1
234180,(,0,1
234181,62.0,0,1
234182,%,0,0
234183,),0,1
234184,versus,0,0
234185,7.6,0,0
234186,(,0,1
234187,38.6,0,0
234188,%,0,0
234189,),0,1
234190,(,0,1
234191,p,0,0
234192,=,0,1
234193,0.0001,0,0
234194,),0,1
234195,",",0,0
234196,and,0,0
234197,the,0,0
234198,mean,0,0
234199,decrease,0,0
234200,in,0,1
234201,total,0,1
234202,lesion,0,1
234203,count,0,0
234204,was,0,0
234205,29.1,0,1
234206,(,0,1
234207,53.1,0,1
234208,%,0,0
234209,),0,1
234210,versus,0,0
234211,14.1,0,0
234212,(,0,1
234213,26.8,0,1
234214,%,0,0
234215,),0,1
234216,(,0,1
234217,p,0,0
234218,=,0,1
234219,0.0001,0,0
234220,),0,1
234221,in,0,0
234222,the,0,0
234223,OC,0,1
234224,and,0,0
234225,placebo,0,0
234226,groups,0,0
234227,",",0,1
234228,respectively,0,0
234229,.,0,0
234230,In,0,0
234231,the,0,0
234232,investigator,0,0
234233,'s,0,1
234234,global,0,0
234235,assessment,0,0
234236,",",0,1
234237,93.7,0,1
234238,%,0,0
234239,of,0,0
234240,the,0,0
234241,active,0,1
234242,treatment,0,0
234243,group,0,1
234244,versus,0,0
234245,65.4,0,1
234246,%,0,0
234247,of,0,0
234248,the,0,0
234249,placebo,0,0
234250,group,0,0
234251,were,0,0
234252,rated,0,0
234253,as,0,0
234254,improved,0,0
234255,at,0,0
234256,the,0,0
234257,end,0,0
234258,of,0,0
234259,the,0,0
234260,study,0,0
234261,(,0,0
234262,p,0,0
234263,<,0,0
234264,0.001,0,0
234265,),0,1
234266,.,0,1
234267,Six,0,0
234268,of,0,0
234269,the,0,1
234270,seven,0,1
234271,secondary,0,1
234272,efficacy,0,0
234273,measures,0,0
234274,(,0,1
234275,total,0,1
234276,comedones,0,1
234277,",",0,1
234278,open,0,1
234279,comedones,0,1
234280,",",0,1
234281,closed,0,1
234282,comedones,0,1
234283,",",0,1
234284,papules,0,1
234285,",",0,1
234286,pustules,0,1
234287,",",0,0
234288,and,0,0
234289,the,0,0
234290,subject,0,0
234291,'s,0,1
234292,self-assessment,0,0
234293,of,0,1
234294,study,0,1
234295,treatment,0,1
234296,),0,0
234297,were,0,0
234298,also,0,0
234299,significantly,0,0
234300,more,0,0
234301,favorable,0,0
234302,in,0,0
234303,the,0,0
234304,OC,0,1
234305,group,0,0
234306,compared,0,0
234307,with,0,1
234308,the,0,0
234309,placebo,0,0
234310,group,0,1
234311,.,0,1
234312,CONCLUSION,0,0
234313,An,0,0
234314,OC,0,1
234315,containing,0,0
234316,0.035,0,0
234317,mg,0,1
234318,of,0,0
234319,ethinyl,0,1
234320,estradiol,0,0
234321,combined,0,0
234322,with,0,1
234323,the,0,0
234324,triphasic,0,0
234325,regimen,0,0
234326,of,0,0
234327,norgestimate,0,0
234328,is,0,0
234329,a,0,0
234330,safe,0,0
234331,and,0,0
234332,effective,0,0
234333,treatment,0,0
234334,of,0,1
234335,moderate,0,1
234336,acne,0,1
234337,vulgaris,0,1
234338,in,1,0
234339,women,1,1
234340,with,1,1
234341,no,1,0
234342,known,1,1
234343,contraindication,1,0
234344,to,1,1
234345,OC,1,1
234346,therapy,1,1
234347,.,1,1
234348,Long-term,0,1
234349,follow-up,0,1
234350,of,0,1
234351,three,0,1
234352,randomized,0,1
234353,trials,0,1
234354,comparing,0,0
234355,idarubicin,0,1
234356,and,0,0
234357,daunorubicin,0,0
234358,as,0,0
234359,induction,0,1
234360,therapies,0,0
234361,for,0,1
234362,patients,1,1
234363,with,1,1
234364,untreated,1,1
234365,acute,1,1
234366,myeloid,1,1
234367,leukemia,1,1
234368,.,1,1
234369,BACKGROUND,0,0
234370,Most,0,0
234371,clinical,0,0
234372,trials,0,1
234373,for,0,1
234374,acute,0,1
234375,leukemia,0,1
234376,have,0,0
234377,reported,0,0
234378,results,0,0
234379,after,0,1
234380,2-3,0,1
234381,years,0,1
234382,of,0,1
234383,follow-up,0,1
234384,.,0,1
234385,Comparisons,0,0
234386,between,0,0
234387,the,0,1
234388,original,0,1
234389,data,0,0
234390,and,0,1
234391,longer-term,0,0
234392,follow-up,0,0
234393,data,0,0
234394,may,0,0
234395,be,0,0
234396,of,0,0
234397,interest,0,0
234398,",",0,0
234399,particularly,0,0
234400,with,0,1
234401,regard,0,0
234402,to,0,1
234403,promising,0,0
234404,new,0,1
234405,therapies,0,0
234406,.,0,1
234407,METHODS,0,0
234408,In,1,0
234409,1996,1,1
234410,",",1,1
234411,survival,1,0
234412,data,1,0
234413,were,1,1
234414,updated,1,0
234415,from,1,1
234416,three,1,0
234417,prospective,1,1
234418,",",1,1
234419,randomized,1,1
234420,comparisons,1,0
234421,of,1,1
234422,idarubicin,1,1
234423,and,1,1
234424,daunorubicin,1,0
234425,that,1,0
234426,began,1,1
234427,in,1,0
234428,1984,1,1
234429,and,1,1
234430,1985,1,1
234431,.,1,1
234432,These,1,0
234433,were,1,0
234434,trials,1,0
234435,of,1,0
234436,the,1,1
234437,Memorial,1,1
234438,Sloan-Kettering,1,1
234439,Cancer,1,1
234440,Center,1,1
234441,(,1,1
234442,MSKCC,1,1
234443,),1,1
234444,",",1,0
234445,the,1,0
234446,U.S.,1,0
234447,Multicenter,1,1
234448,Study,1,1
234449,Group,1,1
234450,",",1,0
234451,and,1,0
234452,the,1,0
234453,Southeastern,1,1
234454,Cancer,1,1
234455,Study,1,1
234456,Group,1,1
234457,(,1,1
234458,SEG,1,1
234459,),1,1
234460,.,1,1
234461,The,0,0
234462,original,0,0
234463,results,0,0
234464,of,0,1
234465,these,0,1
234466,trials,0,0
234467,were,0,1
234468,reported,0,1
234469,in,0,1
234470,1991,0,1
234471,and,0,1
234472,1992,0,1
234473,.,0,1
234474,RESULTS,0,0
234475,The,0,0
234476,original,0,0
234477,results,0,0
234478,of,0,1
234479,the,0,1
234480,SEG,0,1
234481,trial,0,0
234482,demonstrated,0,0
234483,no,0,0
234484,significant,0,0
234485,difference,0,0
234486,between,0,0
234487,idarubicin,0,0
234488,and,0,1
234489,daunorubicin,0,0
234490,.,0,1
234491,The,0,0
234492,updated,0,0
234493,survival,0,0
234494,analysis,0,0
234495,showed,0,0
234496,similar,0,0
234497,results,0,0
234498,.,0,1
234499,The,0,0
234500,MSKCC,0,1
234501,trial,0,0
234502,revealed,0,0
234503,a,0,0
234504,significant,0,0
234505,advantage,0,0
234506,of,0,1
234507,idarubicin,0,0
234508,compared,0,0
234509,with,0,1
234510,daunorubicin,0,0
234511,in,0,0
234512,both,0,0
234513,the,0,0
234514,original,0,0
234515,and,0,0
234516,the,0,0
234517,updated,0,0
234518,analyses,0,0
234519,.,0,1
234520,The,0,0
234521,U.S.,0,0
234522,Multicenter,0,1
234523,trial,0,0
234524,found,0,0
234525,a,0,0
234526,significant,0,0
234527,difference,0,0
234528,favoring,0,0
234529,idarubicin,0,0
234530,in,0,0
234531,the,0,0
234532,original,0,0
234533,analysis,0,0
234534,",",0,0
234535,but,0,0
234536,the,0,0
234537,difference,0,0
234538,was,0,0
234539,not,0,0
234540,significant,0,0
234541,in,0,0
234542,the,0,0
234543,updated,0,0
234544,analysis,0,0
234545,.,0,1
234546,CONCLUSIONS,0,0
234547,It,0,0
234548,is,0,0
234549,essential,0,0
234550,that,0,0
234551,the,0,0
234552,median,0,0
234553,length,0,0
234554,of,0,0
234555,follow-up,0,0
234556,be,0,0
234557,clearly,0,0
234558,stated,0,0
234559,in,0,0
234560,any,0,0
234561,clinical,0,0
234562,trial,0,0
234563,.,0,0
234564,When,0,0
234565,the,0,0
234566,results,0,0
234567,obtained,0,0
234568,with,0,1
234569,a,0,0
234570,particularly,0,0
234571,promising,0,0
234572,new,0,1
234573,drug,0,1
234574,or,0,1
234575,procedure,0,0
234576,are,0,0
234577,presented,0,0
234578,early,0,1
234579,in,0,0
234580,the,0,0
234581,course,0,0
234582,of,0,0
234583,study,0,1
234584,(,0,1
234585,within,0,1
234586,1-2,0,1
234587,years,0,1
234588,),0,1
234589,",",0,1
234590,the,0,0
234591,investigators,0,0
234592,should,0,0
234593,strongly,0,0
234594,consider,0,0
234595,a,0,0
234596,repeat,0,0
234597,evaluation,0,0
234598,after,0,0
234599,an,0,1
234600,additional,0,1
234601,3-5,0,1
234602,years,0,1
234603,of,0,1
234604,follow-up,0,1
234605,.,0,1
234606,Radiotherapy,0,1
234607,and,0,1
234608,CCNU,0,0
234609,in,0,0
234610,the,0,0
234611,treatment,0,0
234612,of,0,0
234613,high-grade,0,1
234614,supratentorial,0,1
234615,astrocytomas,0,1
234616,.,0,1
234617,Forty-one,1,1
234618,consecutive,1,1
234619,patients,1,1
234620,with,1,1
234621,supratentorial,1,1
234622,primary,1,1
234623,brain,1,1
234624,tumors,1,1
234625,(,1,1
234626,38,1,1
234627,Grade,1,0
234628,III,1,1
234629,and,1,1
234630,IV,1,1
234631,astrocytomas,1,1
234632,",",1,0
234633,one,1,0
234634,giant-cell,1,1
234635,astrocytoma,1,1
234636,",",1,0
234637,and,1,1
234638,two,1,0
234639,cases,1,1
234640,with,1,1
234641,insufficient,1,0
234642,tissue,1,1
234643,for,1,0
234644,diagnosis,1,1
234645,),1,1
234646,were,0,0
234647,randomly,0,1
234648,allocated,0,1
234649,within,1,1
234650,2,1,1
234651,weeks,1,1
234652,of,1,1
234653,surgery,1,1
234654,to,0,1
234655,one,0,1
234656,of,0,1
234657,three,0,1
234658,therapeutic,0,1
234659,groups,0,1
234660,.,0,1
234661,Group,0,1
234662,1,0,0
234663,(,0,1
234664,15,0,1
234665,patients,0,1
234666,),0,1
234667,received,0,1
234668,radiation,0,1
234669,therapy,0,0
234670,totaling,0,1
234671,4000,0,1
234672,to,0,1
234673,4500,0,1
234674,rads,0,1
234675,in,0,1
234676,4,0,1
234677,to,0,1
234678,5,0,1
234679,weeks,0,1
234680,.,0,1
234681,Group,0,1
234682,2,0,1
234683,(,0,1
234684,13,0,1
234685,patients,0,1
234686,),0,1
234687,received,0,1
234688,1-,0,1
234689,(,0,1
234690,2-chloroethyl,0,0
234691,),0,1
234692,-3-cyclohexyl-1-nitrosourea,0,1
234693,CCNU,0,1
234694,),0,1
234695,130,0,1
234696,mg/sq,0,1
234697,m,0,1
234698,orally,0,1
234699,every,0,0
234700,6,0,0
234701,weeks,0,0
234702,.,0,1
234703,Group,0,1
234704,3,0,0
234705,(,0,1
234706,13,0,1
234707,patients,0,1
234708,),0,1
234709,received,0,1
234710,radiation,0,1
234711,therapy,0,0
234712,plus,0,0
234713,CCNU,0,0
234714,as,0,0
234715,for,0,1
234716,Groups,0,1
234717,1,0,1
234718,and,0,1
234719,2,0,0
234720,.,0,0
234721,When,0,0
234722,the,0,0
234723,disease,0,0
234724,progressed,0,1
234725,",",0,0
234726,patients,0,1
234727,in,0,1
234728,Groups,0,1
234729,1,0,1
234730,and,0,1
234731,2,0,1
234732,were,0,1
234733,crossed,0,0
234734,over,0,0
234735,to,0,0
234736,receive,0,1
234737,CCNU,0,0
234738,and,0,0
234739,irradiation,0,0
234740,respectively,0,0
234741,.,0,1
234742,The,0,0
234743,median,0,0
234744,survival,0,0
234745,time,0,0
234746,in,0,0
234747,these,0,0
234748,groups,0,0
234749,was,0,0
234750,188,0,1
234751,",",0,1
234752,259,0,1
234753,",",0,0
234754,and,0,1
234755,252,0,1
234756,days,0,0
234757,",",0,1
234758,and,0,0
234759,the,0,0
234760,mean,0,1
234761,survival,0,0
234762,263,0,1
234763,",",0,1
234764,262,0,1
234765,",",0,0
234766,and,0,1
234767,329,0,1
234768,days,0,0
234769,.,0,1
234770,The,0,0
234771,median,0,0
234772,time,0,0
234773,from,0,1
234774,diagnosis,0,1
234775,to,0,0
234776,crossover,0,0
234777,(,0,1
234778,Groups,0,0
234779,1,0,1
234780,and,0,1
234781,2,0,1
234782,),0,1
234783,or,0,1
234784,to,0,1
234785,progression,0,0
234786,(,0,1
234787,Group,0,1
234788,3,0,1
234789,),0,1
234790,was,0,0
234791,163,0,1
234792,",",0,1
234793,99,0,1
234794,",",0,0
234795,and,0,1
234796,220,0,1
234797,days,0,0
234798,",",0,1
234799,and,0,0
234800,the,0,0
234801,mean,0,1
234802,time,0,0
234803,was,0,0
234804,172,0,1
234805,",",0,1
234806,108,0,1
234807,",",0,0
234808,and,0,1
234809,231,0,1
234810,days,0,0
234811,.,0,1
234812,There,0,0
234813,was,0,0
234814,no,0,0
234815,statistically,0,0
234816,significant,0,0
234817,difference,0,0
234818,between,0,0
234819,the,0,0
234820,means,0,0
234821,or,0,1
234822,medians,0,0
234823,in,0,0
234824,any,0,1
234825,of,0,0
234826,these,0,0
234827,situations,0,0
234828,.,0,1
234829,A,0,0
234830,comparison,0,0
234831,of,0,0
234832,antiarrhythmic-drug,0,1
234833,therapy,0,1
234834,with,0,1
234835,implantable,0,1
234836,defibrillators,0,1
234837,in,0,1
234838,patients,1,1
234839,resuscitated,1,1
234840,from,1,1
234841,near-fatal,1,1
234842,ventricular,1,1
234843,arrhythmias,1,1
234844,.,1,1
234845,The,0,0
234846,Antiarrhythmics,0,0
234847,versus,0,0
234848,Implantable,0,1
234849,Defibrillators,0,1
234850,(,0,1
234851,AVID,0,1
234852,),0,1
234853,Investigators,0,1
234854,.,0,1
234855,BACKGROUND,0,1
234856,Patients,0,1
234857,who,0,1
234858,survive,0,1
234859,life-threatening,0,1
234860,ventricular,0,1
234861,arrhythmias,0,1
234862,are,0,0
234863,at,0,0
234864,risk,0,1
234865,for,0,0
234866,recurrent,0,1
234867,arrhythmias,0,1
234868,.,0,0
234869,They,0,0
234870,can,0,0
234871,be,0,0
234872,treated,0,0
234873,with,0,1
234874,either,0,0
234875,an,0,0
234876,implantable,0,0
234877,cardioverter-defibrillator,0,1
234878,or,0,1
234879,antiarrhythmic,0,0
234880,drugs,0,0
234881,",",0,1
234882,but,0,0
234883,the,0,0
234884,relative,0,0
234885,efficacy,0,0
234886,of,0,0
234887,these,0,0
234888,two,0,0
234889,treatment,0,0
234890,strategies,0,0
234891,is,0,0
234892,unknown,0,0
234893,.,0,1
234894,METHODS,0,0
234895,To,0,0
234896,address,0,0
234897,this,0,0
234898,issue,0,0
234899,",",0,0
234900,we,0,0
234901,conducted,0,0
234902,a,0,0
234903,randomized,0,1
234904,comparison,0,0
234905,of,0,0
234906,these,0,0
234907,two,0,0
234908,treatment,0,0
234909,strategies,0,0
234910,in,0,1
234911,patients,1,1
234912,who,1,1
234913,had,1,1
234914,been,1,1
234915,resuscitated,1,1
234916,from,1,1
234917,near-fatal,1,1
234918,ventricular,1,1
234919,fibrillation,1,1
234920,or,1,1
234921,who,1,1
234922,had,1,1
234923,undergone,1,1
234924,cardioversion,1,1
234925,from,1,1
234926,sustained,1,1
234927,ventricular,1,1
234928,tachycardia,1,1
234929,.,1,1
234930,Patients,1,1
234931,with,1,1
234932,ventricular,1,1
234933,tachycardia,1,1
234934,also,1,0
234935,had,1,1
234936,either,1,0
234937,syncope,1,1
234938,or,1,1
234939,other,1,0
234940,serious,1,0
234941,cardiac,1,1
234942,symptoms,1,0
234943,",",1,0
234944,along,1,0
234945,with,1,1
234946,a,1,1
234947,left,1,1
234948,ventricular,1,1
234949,ejection,1,1
234950,fraction,1,1
234951,of,1,0
234952,0.40,1,0
234953,or,1,1
234954,less,1,1
234955,.,1,1
234956,One,0,0
234957,group,0,1
234958,of,0,1
234959,patients,0,1
234960,was,0,0
234961,treated,0,1
234962,with,0,1
234963,implantation,0,1
234964,of,0,0
234965,a,0,1
234966,cardioverter-defibrillator,0,1
234967,;,0,0
234968,the,0,0
234969,other,0,0
234970,received,0,1
234971,class,0,1
234972,III,0,1
234973,antiarrhythmic,0,1
234974,drugs,0,0
234975,",",0,1
234976,primarily,0,0
234977,amiodarone,0,0
234978,at,0,0
234979,empirically,0,0
234980,determined,0,0
234981,doses,0,0
234982,.,0,1
234983,Fifty-six,0,1
234984,clinical,0,0
234985,centers,0,1
234986,screened,0,1
234987,all,0,1
234988,patients,0,1
234989,who,0,1
234990,presented,0,1
234991,with,0,1
234992,ventricular,0,1
234993,tachycardia,0,1
234994,or,0,1
234995,ventricular,0,1
234996,fibrillation,0,1
234997,during,0,0
234998,a,0,0
234999,period,0,0
235000,of,0,0
235001,nearly,0,1
235002,four,0,1
235003,years,0,1
235004,.,0,1
235005,Of,1,1
235006,1016,1,1
235007,patients,1,1
235008,(,1,1
235009,45,1,1
235010,percent,1,1
235011,of,1,1
235012,whom,1,1
235013,had,1,1
235014,ventricular,1,1
235015,fibrillation,1,1
235016,",",1,1
235017,and,1,0
235018,55,1,1
235019,percent,1,1
235020,ventricular,1,1
235021,tachycardia,1,1
235022,),1,1
235023,",",1,1
235024,507,1,1
235025,were,1,0
235026,randomly,1,1
235027,assigned,1,1
235028,to,1,0
235029,treatment,1,0
235030,with,1,1
235031,implantable,1,1
235032,cardioverter-defibrillators,1,1
235033,and,1,1
235034,509,1,1
235035,to,1,1
235036,antiarrhythmic-drug,1,1
235037,therapy,1,0
235038,.,1,1
235039,The,0,0
235040,primary,0,0
235041,end,0,0
235042,point,0,0
235043,was,0,0
235044,overall,0,0
235045,mortality,0,0
235046,.,0,1
235047,RESULTS,0,0
235048,Follow-up,0,0
235049,was,0,0
235050,complete,0,1
235051,for,0,1
235052,1013,0,1
235053,patients,0,1
235054,(,0,1
235055,99.7,0,1
235056,percent,0,1
235057,),0,1
235058,.,0,1
235059,Overall,0,0
235060,survival,0,0
235061,was,0,0
235062,greater,0,0
235063,with,0,1
235064,the,0,0
235065,implantable,0,0
235066,defibrillator,0,0
235067,",",0,0
235068,with,0,1
235069,unadjusted,0,0
235070,estimates,0,0
235071,of,0,1
235072,89.3,0,0
235073,percent,0,1
235074,",",0,0
235075,as,0,0
235076,compared,0,0
235077,with,0,1
235078,82.3,0,0
235079,percent,0,1
235080,in,0,0
235081,the,0,0
235082,antiarrhythmic-drug,0,0
235083,group,0,1
235084,at,0,1
235085,one,0,1
235086,year,0,1
235087,",",0,1
235088,81.6,0,0
235089,percent,0,1
235090,versus,0,0
235091,74.7,0,0
235092,percent,0,1
235093,at,0,1
235094,two,0,1
235095,years,0,1
235096,",",0,1
235097,and,0,1
235098,75.4,0,0
235099,percent,0,1
235100,versus,0,0
235101,64.1,0,0
235102,percent,0,1
235103,at,0,1
235104,three,0,1
235105,years,0,1
235106,(,0,1
235107,P,0,0
235108,<,0,0
235109,0.02,0,0
235110,),0,1
235111,.,0,1
235112,The,0,0
235113,corresponding,0,0
235114,reductions,0,0
235115,in,0,1
235116,mortality,0,0
235117,(,0,1
235118,with,0,1
235119,95,0,0
235120,percent,0,1
235121,confidence,0,0
235122,limits,0,0
235123,),0,1
235124,with,0,1
235125,the,0,0
235126,implantable,0,0
235127,defibrillator,0,1
235128,were,0,1
235129,39+/-20,0,1
235130,percent,0,1
235131,",",0,0
235132,27+/-21,0,1
235133,percent,0,1
235134,",",0,0
235135,and,0,0
235136,31+/-21,0,1
235137,percent,0,1
235138,CONCLUSIONS,0,0
235139,Among,0,1
235140,survivors,1,1
235141,of,1,1
235142,ventricular,1,1
235143,fibrillation,1,1
235144,or,1,1
235145,sustained,1,1
235146,ventricular,1,1
235147,tachycardia,1,1
235148,causing,1,1
235149,severe,1,1
235150,symptoms,1,1
235151,",",0,1
235152,the,0,0
235153,implantable,0,0
235154,cardioverter-defibrillator,0,1
235155,is,0,0
235156,superior,0,0
235157,to,0,0
235158,antiarrhythmic,0,1
235159,drugs,0,0
235160,for,0,0
235161,increasing,0,0
235162,overall,0,0
235163,survival,0,0
235164,.,0,1
235165,A,0,0
235166,carbohydrate,0,0
235167,meal,0,0
235168,attenuates,0,0
235169,the,0,0
235170,forearm,0,0
235171,vasoconstrictor,0,0
235172,response,0,0
235173,to,0,0
235174,lower,0,0
235175,body,0,1
235176,subatmospheric,0,0
235177,pressure,0,0
235178,in,0,1
235179,healthy,1,1
235180,young,1,1
235181,adults,1,1
235182,.,1,1
235183,The,0,0
235184,cardiovascular,0,0
235185,(,0,0
235186,CV,0,0
235187,),0,1
235188,responses,0,0
235189,to,0,0
235190,meal,0,0
235191,ingestion,0,0
235192,and,0,0
235193,orthostasis,0,0
235194,are,0,0
235195,well,0,0
235196,established,0,0
235197,.,0,0
235198,The,0,0
235199,effect,0,0
235200,of,0,0
235201,meal,0,0
235202,ingestion,0,0
235203,and,0,0
235204,meal,0,0
235205,composition,0,1
235206,on,0,0
235207,the,0,0
235208,CV,0,1
235209,responses,0,0
235210,to,0,1
235211,orthostasis,0,1
235212,are,0,0
235213,unknown,0,0
235214,.,0,1
235215,The,0,0
235216,effect,0,0
235217,of,0,0
235218,high,0,1
235219,carbohydrate,0,1
235220,(,0,1
235221,HC,0,1
235222,),0,1
235223,and,0,1
235224,high,0,1
235225,fat,0,0
235226,(,0,1
235227,HF,0,1
235228,),0,1
235229,meal,0,0
235230,ingestion,0,0
235231,on,0,0
235232,the,0,0
235233,CV,0,1
235234,responses,0,0
235235,to,0,1
235236,simulated,0,0
235237,orthostatic,0,0
235238,stress,0,0
235239,(,0,1
235240,using,0,0
235241,graded,0,0
235242,lower,0,0
235243,body,0,1
235244,subatmospheric,0,0
235245,pressure,0,0
235246,(,0,1
235247,LBSP,0,0
235248,),0,1
235249,),0,1
235250,was,0,0
235251,assessed,0,0
235252,in,0,1
235253,nine,1,1
235254,healthy,1,1
235255,young,1,1
235256,volunteers,1,1
235257,.,1,1
235258,Cardiac,0,0
235259,output,0,0
235260,(,0,1
235261,CO,0,1
235262,),0,1
235263,",",0,0
235264,forearm,0,0
235265,blood,0,0
235266,flow,0,0
235267,(,0,1
235268,FABF,0,0
235269,),0,1
235270,heart,0,1
235271,rate,0,0
235272,(,0,1
235273,HR,0,0
235274,),0,1
235275,and,0,0
235276,blood,0,0
235277,pressure,0,0
235278,(,0,1
235279,BP,0,1
235280,),0,1
235281,were,0,0
235282,measured,0,0
235283,before,0,0
235284,and,0,1
235285,during,0,0
235286,LBSP,0,0
235287,while,0,0
235288,fasted,0,1
235289,and,0,1
235290,after,0,0
235291,eating,0,1
235292,HC,0,1
235293,and,0,1
235294,HF,0,1
235295,meals,0,1
235296,.,0,1
235297,Ingestion,0,0
235298,of,0,0
235299,both,0,0
235300,meals,0,1
235301,led,0,0
235302,to,0,1
235303,an,0,0
235304,increase,0,0
235305,in,0,0
235306,CO,0,1
235307,and,0,1
235308,HR,0,0
235309,.,0,1
235310,Both,0,0
235311,meals,0,0
235312,resulted,0,0
235313,in,0,0
235314,a,0,0
235315,fall,0,0
235316,in,0,0
235317,total,0,1
235318,peripheral,0,1
235319,resistance,0,0
235320,but,0,0
235321,only,0,0
235322,HC,0,1
235323,led,0,0
235324,to,0,0
235325,a,0,0
235326,significant,0,0
235327,fall,0,0
235328,in,0,1
235329,BP,0,1
235330,(,0,1
235331,p,0,0
235332,<,0,0
235333,0.05,0,0
235334,),0,1
235335,.,0,1
235336,HF,0,0
235337,had,0,1
235338,no,0,0
235339,effect,0,0
235340,on,0,0
235341,the,0,0
235342,CV,0,1
235343,responses,0,0
235344,to,0,1
235345,LBSP,0,0
235346,",",0,0
235347,whereas,0,0
235348,HC,0,1
235349,resulted,0,0
235350,in,0,0
235351,attenuated,0,0
235352,FABF,0,0
235353,and,0,1
235354,forearm,0,1
235355,vascular,0,0
235356,resistance,0,0
235357,responses,0,0
235358,(,0,1
235359,p,0,0
235360,<,0,0
235361,0.05,0,0
235362,),0,1
235363,.,0,1
235364,Thus,0,0
235365,",",0,0
235366,ingestion,0,0
235367,of,0,0
235368,an,0,1
235369,HC,0,1
235370,meal,0,0
235371,significantly,0,0
235372,attenuates,0,0
235373,the,0,0
235374,forearm,0,0
235375,vascular,0,0
235376,response,0,0
235377,to,0,1
235378,orthostatic,0,0
235379,stress,0,0
235380,and,0,0
235381,the,0,0
235382,hypotensive,0,0
235383,effect,0,0
235384,of,0,0
235385,orthostasis,0,0
235386,is,0,0
235387,additive,0,0
235388,to,0,0
235389,that,0,0
235390,occurring,0,0
235391,after,0,0
235392,an,0,1
235393,HC,0,1
235394,meal,0,0
235395,.,0,1
235396,[,0,1
235397,Value,0,1
235398,of,0,1
235399,absorbable,0,0
235400,clips,0,1
235401,in,0,1
235402,laparoscopic,0,1
235403,cholecystectomy,0,1
235404,.,0,1
235405,A,0,0
235406,randomized,0,0
235407,prospective,0,1
235408,study,0,1
235409,],0,1
235410,.,0,1
235411,Most,0,0
235412,surgeons,0,1
235413,use,0,0
235414,metal,0,0
235415,clips,0,1
235416,in,0,1
235417,laparoscopic,0,1
235418,cholecystectomy,0,1
235419,.,0,1
235420,The,0,0
235421,aim,0,0
235422,of,0,0
235423,this,0,0
235424,prospective,0,1
235425,randomized,0,1
235426,controlled,0,0
235427,study,0,0
235428,was,0,0
235429,to,0,0
235430,evaluate,0,0
235431,the,0,0
235432,efficacy,0,0
235433,of,0,0
235434,absorbable,0,0
235435,clips,0,1
235436,in,0,1
235437,elective,0,1
235438,laparoscopic,0,1
235439,cholecystectomy,0,1
235440,.,0,1
235441,One,1,1
235442,hundred,1,1
235443,consecutive,1,1
235444,patients,1,1
235445,with,1,1
235446,symptomatic,1,1
235447,gallstones,1,1
235448,without,1,1
235449,complications,1,1
235450,were,1,1
235451,randomized,1,1
235452,into,1,1
235453,groups,1,1
235454,;,1,1
235455,group,1,1
235456,T,1,1
235457,had,0,1
235458,two,0,1
235459,metal,0,1
235460,clips,0,1
235461,(,0,1
235462,titan,0,1
235463,clip,0,1
235464,ETHICONR,0,1
235465,),0,1
235466,",",0,0
235467,group,1,1
235468,R,1,1
235469,(,0,1
235470,laproclipR,0,1
235471,Davis,0,1
235472,and,0,1
235473,Geck,0,1
235474,),0,1
235475,had,0,1
235476,one,0,1
235477,absorbable,0,0
235478,clip,0,1
235479,applied,0,0
235480,on,0,0
235481,the,0,0
235482,cystic,0,1
235483,duct,0,1
235484,and,0,1
235485,cystic,0,1
235486,artery,0,1
235487,.,0,1
235488,The,1,0
235489,patients,1,1
235490,were,0,1
235491,followed,0,1
235492,for,0,0
235493,one,0,1
235494,year,0,1
235495,.,0,0
235496,There,0,0
235497,was,0,0
235498,no,0,0
235499,difference,0,0
235500,between,0,0
235501,the,0,1
235502,two,0,1
235503,groups,0,0
235504,concerning,0,1
235505,operative,0,1
235506,time,0,0
235507,",",0,0
235508,hospital,0,1
235509,stay,0,0
235510,and,0,1
235511,postoperative,0,1
235512,complications,0,1
235513,.,0,1
235514,The,0,0
235515,absorbable,0,0
235516,clips,0,1
235517,seem,0,0
235518,to,0,0
235519,be,0,0
235520,as,0,0
235521,effective,0,0
235522,as,0,0
235523,metal,0,1
235524,clips,0,1
235525,in,0,1
235526,providing,0,0
235527,hemostasis,0,0
235528,in,0,1
235529,cystic,0,1
235530,artery,0,1
235531,and,0,1
235532,in,0,0
235533,cystic,0,1
235534,duct,0,1
235535,ligation,0,1
235536,.,0,1
235537,Histopathologic,0,1
235538,changes,0,0
235539,of,0,1
235540,the,0,1
235541,eyelid,1,1
235542,skin,1,1
235543,following,1,0
235544,trichloroacetic,1,1
235545,acid,1,0
235546,chemical,1,1
235547,peel,1,1
235548,.,1,1
235549,The,0,0
235550,use,0,0
235551,of,0,0
235552,trichloroacetic,0,1
235553,acid,0,0
235554,(,0,1
235555,TCA,0,0
235556,),0,1
235557,as,0,0
235558,a,0,1
235559,periorbital,0,1
235560,and,0,0
235561,eyelid,0,1
235562,peel,0,1
235563,for,0,0
235564,skin,0,1
235565,rejuvenation,0,0
235566,is,0,0
235567,gaining,0,0
235568,significant,0,0
235569,acceptance,0,1
235570,among,0,1
235571,oculoplastic,0,1
235572,surgeons,0,1
235573,",",0,1
235574,dermatologists,0,1
235575,",",0,0
235576,and,0,1
235577,other,0,0
235578,surgery,0,1
235579,groups,0,1
235580,.,0,1
235581,In,0,0
235582,spite,0,0
235583,of,0,0
235584,the,0,0
235585,current,0,0
235586,enthusiasm,0,0
235587,",",0,0
235588,there,0,0
235589,remain,0,0
235590,potentially,0,0
235591,serious,0,0
235592,complications,0,0
235593,resulting,0,0
235594,from,0,1
235595,any,0,1
235596,periorbital,0,1
235597,peel,0,1
235598,.,0,1
235599,Cases,0,0
235600,of,0,0
235601,cicatricial,0,1
235602,ectropion,0,1
235603,have,0,0
235604,been,0,0
235605,reported,0,0
235606,in,0,1
235607,phenol-peeled,1,0
235608,patients,1,1
235609,",",0,0
235610,and,0,0
235611,lower,0,0
235612,eyelid,0,1
235613,ectropion,0,0
235614,has,0,0
235615,reportedly,0,0
235616,occurred,0,0
235617,in,0,0
235618,patients,1,1
235619,undergoing,1,1
235620,deep,1,1
235621,eyelid,1,1
235622,peel,1,1
235623,in,1,0
235624,conjunction,1,0
235625,with,1,1
235626,a,1,1
235627,blepharoplasty,1,1
235628,(,0,1
235629,"1,2",0,1
235630,),0,1
235631,.,0,1
235632,To,0,0
235633,avoid,0,0
235634,this,0,0
235635,complication,0,0
235636,",",0,0
235637,it,0,0
235638,is,0,0
235639,necessary,0,0
235640,to,0,0
235641,better,0,0
235642,understand,0,0
235643,the,0,0
235644,depth,0,0
235645,of,0,0
235646,the,0,0
235647,wound,0,0
235648,produced,0,0
235649,by,0,0
235650,different,0,1
235651,strengths,0,0
235652,and,0,1
235653,combinations,0,0
235654,of,0,1
235655,peeling,0,1
235656,agents,0,1
235657,applied,0,0
235658,to,0,1
235659,living,0,1
235660,eyelid,0,1
235661,tissue,0,1
235662,and,0,0
235663,",",0,0
235664,more,0,0
235665,important,0,0
235666,",",0,0
235667,to,0,0
235668,determine,0,0
235669,the,0,0
235670,concentrations,0,0
235671,of,0,1
235672,TCA,0,0
235673,that,0,0
235674,are,0,0
235675,likely,0,0
235676,to,0,0
235677,lead,0,0
235678,to,0,0
235679,cicatricial,0,1
235680,ectropion,0,0
235681,when,0,0
235682,applied,0,0
235683,in,0,0
235684,a,0,1
235685,consistent,0,0
235686,fashion,0,0
235687,.,0,1
235688,We,0,0
235689,chose,0,1
235690,upper-eyelid,0,1
235691,skin,0,1
235692,because,0,0
235693,it,0,0
235694,is,0,0
235695,easier,0,0
235696,to,0,0
235697,obtain,0,0
235698,for,0,0
235699,histopathologic,0,0
235700,study,0,1
235701,than,0,0
235702,lower-eyelid,0,1
235703,skin,0,1
235704,and,0,0
235705,",",0,0
235706,in,0,0
235707,our,0,0
235708,experience,0,0
235709,",",0,0
235710,is,0,0
235711,more,0,0
235712,sensitive,0,0
235713,to,0,0
235714,hypertrophic,0,1
235715,changes,0,0
235716,after,0,1
235717,chemical,0,1
235718,peeling,0,0
235719,or,0,1
235720,carbon,0,0
235721,dioxide,0,0
235722,laser,0,0
235723,resurfacing,0,1
235724,.,0,1
235725,We,0,0
235726,applied,0,0
235727,TCA,0,0
235728,to,0,0
235729,the,0,0
235730,preseptal,0,0
235731,skin,0,1
235732,of,0,1
235733,10,1,1
235734,patients,1,1
235735,48,0,1
235736,h,0,0
235737,before,0,1
235738,standard,1,1
235739,upper-eyelid,1,1
235740,blepharoplasty,1,1
235741,.,1,1
235742,The,0,0
235743,acid,0,0
235744,was,0,0
235745,applied,0,0
235746,to,0,0
235747,produce,0,0
235748,a,0,0
235749,frost,0,0
235750,",",0,0
235751,using,0,0
235752,varying,0,0
235753,concentrations,0,0
235754,of,0,1
235755,acid,0,0
235756,",",0,0
235757,ranging,0,1
235758,from,0,1
235759,20,0,1
235760,to,0,1
235761,50,0,1
235762,%,0,0
235763,.,0,1
235764,The,0,0
235765,treated,0,1
235766,skin,0,1
235767,removed,0,0
235768,at,0,0
235769,the,0,0
235770,time,0,0
235771,of,0,0
235772,blepharoplasty,0,1
235773,was,0,0
235774,reviewed,0,1
235775,in,0,0
235776,a,0,1
235777,masked,0,0
235778,fashion,0,0
235779,by,0,0
235780,a,0,1
235781,dermatopathologist,0,1
235782,to,0,0
235783,determine,0,0
235784,the,0,0
235785,depth,0,0
235786,of,0,0
235787,necrosis,0,1
235788,.,0,1
235789,We,0,0
235790,found,0,0
235791,that,0,0
235792,superficial,0,1
235793,peels,0,1
235794,with,0,1
235795,necrosis,0,1
235796,involving,0,1
235797,30,0,1
235798,%,0,0
235799,of,0,0
235800,the,0,0
235801,epidermis,0,0
235802,were,0,0
235803,produced,0,0
235804,by,0,0
235805,the,0,0
235806,lowest-concentration,0,0
235807,combination,0,0
235808,of,0,1
235809,TCA,0,0
235810,applied,0,0
235811,(,0,1
235812,20,0,1
235813,%,0,0
235814,followed,0,1
235815,by,0,0
235816,0,0,0
235817,%,0,1
235818,),0,1
235819,.,0,1
235820,As,0,0
235821,the,0,0
235822,strength,0,0
235823,increased,0,0
235824,",",0,0
235825,so,0,0
235826,did,0,0
235827,the,0,0
235828,depth,0,0
235829,of,0,0
235830,peel,0,1
235831,.,0,1
235832,The,0,0
235833,combination,0,0
235834,of,0,0
235835,50,0,1
235836,%,0,0
235837,followed,0,0
235838,by,0,0
235839,a,0,1
235840,second,0,0
235841,application,0,0
235842,of,0,1
235843,50,0,1
235844,%,0,0
235845,produced,0,0
235846,the,0,0
235847,deepest,0,0
235848,peel,0,1
235849,",",0,0
235850,with,0,1
235851,necrosis,0,0
235852,into,0,1
235853,the,0,0
235854,papillary,0,1
235855,dermis,0,1
235856,.,0,1
235857,This,0,0
235858,finding,0,0
235859,would,0,0
235860,indicate,0,0
235861,that,0,0
235862,the,0,0
235863,chance,0,0
235864,of,0,0
235865,developing,0,1
235866,cicatricial,0,1
235867,ectropion,0,1
235868,with,0,1
235869,any,0,0
235870,of,0,0
235871,the,0,0
235872,tested,0,0
235873,combinations,0,0
235874,of,0,0
235875,TCA,0,0
235876,should,0,0
235877,be,0,0
235878,very,0,0
235879,remote,0,0
235880,.,0,1
235881,The,0,0
235882,reliability,0,0
235883,of,0,0
235884,catheter-tip,0,1
235885,transducers,0,0
235886,for,0,1
235887,the,0,0
235888,measurement,0,0
235889,of,0,0
235890,intrauterine,0,1
235891,pressure,0,0
235892,in,0,0
235893,the,0,0
235894,third,1,1
235895,stage,1,1
235896,of,1,0
235897,labour,1,1
235898,.,1,1
235899,In,0,0
235900,order,0,0
235901,to,0,0
235902,assess,0,0
235903,the,0,0
235904,reliability,0,0
235905,of,0,0
235906,intrauterine,0,1
235907,pressure,0,1
235908,measurements,0,0
235909,in,0,1
235910,the,0,1
235911,third,0,1
235912,stage,0,1
235913,of,0,0
235914,labour,0,1
235915,",",0,1
235916,catheter-tip,0,0
235917,transducers,0,0
235918,were,0,1
235919,used,0,0
235920,in,0,1
235921,20,1,1
235922,women,1,1
235923,randomly,1,1
235924,allocated,1,1
235925,into,1,1
235926,two,1,1
235927,groups,1,1
235928,of,1,1
235929,10,1,1
235930,.,1,1
235931,In,0,0
235932,each,0,0
235933,case,0,0
235934,in,0,0
235935,the,0,0
235936,first,0,0
235937,group,0,1
235938,two,0,1
235939,catheters,0,1
235940,were,0,1
235941,tied,0,0
235942,together,0,0
235943,and,0,0
235944,introduced,0,0
235945,transcervically,0,1
235946,into,0,0
235947,the,0,0
235948,uterine,0,1
235949,cavity,0,1
235950,after,0,0
235951,delivery,0,0
235952,of,0,0
235953,the,0,0
235954,placenta,0,1
235955,.,0,0
235956,In,0,0
235957,each,0,0
235958,case,0,0
235959,in,0,0
235960,the,0,0
235961,second,0,1
235962,group,0,1
235963,two,0,1
235964,catheters,0,1
235965,were,0,1
235966,inserted,0,0
235967,independently,0,0
235968,into,0,0
235969,the,0,0
235970,same,0,0
235971,uterine,0,1
235972,cavity,0,1
235973,.,0,1
235974,The,0,0
235975,active,0,0
235976,and,0,0
235977,cumulative,0,0
235978,active,0,1
235979,pressures,0,0
235980,recorded,0,0
235981,from,0,1
235982,the,0,0
235983,pairs,0,1
235984,of,0,1
235985,catheters,0,1
235986,within,0,1
235987,each,0,1
235988,uterine,0,1
235989,cavity,0,1
235990,were,0,1
235991,compared,0,0
235992,.,0,1
235993,Comparison,0,0
235994,of,0,0
235995,individual,0,0
235996,active,0,1
235997,pressure,0,1
235998,readings,0,0
235999,from,0,1
236000,separate,0,1
236001,transducers,0,0
236002,revealed,0,1
236003,good,0,0
236004,agreement,0,0
236005,whether,0,0
236006,the,0,0
236007,catheters,0,0
236008,were,0,1
236009,tied,0,0
236010,together,0,0
236011,or,0,1
236012,were,0,1
236013,separate,0,1
236014,.,0,1
236015,Cumulative,0,0
236016,active,0,1
236017,pressure,0,0
236018,was,0,0
236019,very,0,0
236020,similar,0,0
236021,when,0,0
236022,assessed,0,0
236023,by,0,0
236024,each,0,0
236025,catheter,0,0
236026,in,0,0
236027,the,0,0
236028,same,0,0
236029,uterus,0,1
236030,.,0,1
236031,Intrauterine,0,1
236032,catheter-tip,0,0
236033,transducers,0,0
236034,can,0,0
236035,be,0,0
236036,used,0,0
236037,reliably,0,0
236038,to,0,0
236039,measure,0,0
236040,uterine,0,1
236041,activity,0,0
236042,in,0,0
236043,the,0,0
236044,third,1,1
236045,stage,1,1
236046,of,1,0
236047,labour,1,1
236048,although,0,0
236049,there,0,0
236050,may,0,0
236051,be,0,0
236052,minor,0,0
236053,contraction,0,0
236054,by,0,0
236055,contraction,0,1
236056,differences,0,0
236057,in,0,1
236058,recordings,0,1
236059,of,0,1
236060,individual,0,0
236061,active,0,1
236062,pressures,0,0
236063,.,0,1
236064,Amoxicillin/metronidazole/omeprazole/clarithromycin,0,0
236065,:,0,1
236066,a,0,0
236067,new,0,0
236068,",",0,0
236069,short,0,0
236070,quadruple,0,1
236071,therapy,1,0
236072,for,1,0
236073,Helicobacter,1,1
236074,pylori,1,1
236075,eradication,1,1
236076,.,1,1
236077,BACKGROUND,0,0
236078,Triple,0,0
236079,therapy,0,0
236080,regimens,0,0
236081,including,0,0
236082,two,0,0
236083,antibiotics,0,0
236084,plus,0,0
236085,acid,0,0
236086,suppression,0,0
236087,have,0,0
236088,become,0,0
236089,the,0,0
236090,new,0,1
236091,standard,0,0
236092,therapy,0,0
236093,in,0,0
236094,Helicobacter,0,1
236095,pylori,0,1
236096,eradication,0,0
236097,because,0,0
236098,of,0,0
236099,success,0,0
236100,rates,0,0
236101,of,0,1
236102,about,0,0
236103,90,0,1
236104,%,0,0
236105,.,0,1
236106,However,0,0
236107,",",0,0
236108,these,0,0
236109,regimens,0,0
236110,are,0,0
236111,still,0,0
236112,costly,0,0
236113,",",0,0
236114,duration,0,0
236115,is,0,0
236116,about,0,0
236117,one,0,0
236118,week,0,0
236119,or,0,1
236120,less,0,0
236121,",",0,0
236122,and,0,0
236123,side-effects,0,0
236124,are,0,0
236125,not,0,0
236126,negligible,0,0
236127,.,0,1
236128,We,0,0
236129,therefore,0,0
236130,evaluated,0,0
236131,a,0,0
236132,new,0,1
236133,quadruple,0,1
236134,therapy,0,0
236135,",",0,0
236136,because,0,0
236137,theoretically,0,0
236138,a,0,0
236139,shorter,0,0
236140,duration,0,0
236141,of,0,0
236142,treatment,0,0
236143,may,0,0
236144,result,0,0
236145,in,0,0
236146,reduced,0,0
236147,costs,0,1
236148,",",0,1
236149,fewer,0,0
236150,side-effects,0,0
236151,",",0,0
236152,and,0,0
236153,possibly,0,0
236154,in,0,0
236155,a,0,0
236156,lower,0,0
236157,potential,0,0
236158,for,0,0
236159,antibiotic,0,1
236160,resistances,0,1
236161,.,0,1
236162,METHODS,0,0
236163,Controlled,0,0
236164,",",0,0
236165,prospective,0,1
236166,pilot,0,1
236167,study,0,1
236168,including,0,1
236169,H.,1,1
236170,pylori-positive,1,1
236171,patients,1,1
236172,with,1,1
236173,gastric,1,1
236174,or,1,1
236175,duodenal,1,1
236176,ulcers,1,1
236177,or,1,1
236178,erosive,1,1
236179,gastritis,1,1
236180,",",1,0
236181,treated,1,1
236182,after,1,0
236183,failure,1,1
236184,of,1,0
236185,dual,1,0
236186,therapy,1,1
236187,(,1,1
236188,proton-pump-inhibitors,1,0
236189,or,1,1
236190,ranitidine,1,0
236191,plus,1,0
236192,amoxicillin,1,0
236193,),1,0
236194,or,1,1
236195,for,1,0
236196,the,1,0
236197,first,1,0
236198,time,1,0
236199,.,1,1
236200,They,0,0
236201,were,0,0
236202,assigned,0,1
236203,to,0,0
236204,a,0,1
236205,one,0,1
236206,week,0,0
236207,triple,0,1
236208,standard,0,1
236209,therapy,0,0
236210,",",0,0
236211,consisting,0,1
236212,of,0,0
236213,metronidazole,0,0
236214,400,0,1
236215,mg,0,1
236216,bid,0,0
236217,+,0,0
236218,omeprazole,0,0
236219,20,0,0
236220,mg,0,0
236221,bid,0,0
236222,+,0,0
236223,clarithromycin,0,0
236224,250,0,0
236225,mg,0,0
236226,bid,0,0
236227,",",0,0
236228,or,0,0
236229,a,0,0
236230,newly,0,1
236231,created,0,0
236232,quadruple-regimen,0,0
236233,",",0,0
236234,which,0,0
236235,adds,0,0
236236,amoxicillin,0,0
236237,(,0,0
236238,1,0,0
236239,g,0,1
236240,bid,0,0
236241,),0,0
236242,to,0,0
236243,the,0,0
236244,above,0,0
236245,triple,0,1
236246,regimen,0,1
236247,.,0,1
236248,Each,0,0
236249,of,0,0
236250,the,0,0
236251,four,0,1
236252,drugs,0,0
236253,was,0,0
236254,given,0,1
236255,for,0,1
236256,5,0,1
236257,days,0,1
236258,.,0,1
236259,H.,0,0
236260,pylori,0,1
236261,status,0,1
236262,was,0,0
236263,checked,0,0
236264,by,0,0
236265,13C,0,1
236266,urea,0,0
236267,breath,0,0
236268,test,0,0
236269,before,0,0
236270,and,0,1
236271,after,0,1
236272,four,0,1
236273,weeks,0,1
236274,of,0,1
236275,therapy,0,1
236276,.,0,1
236277,RESULTS,0,0
236278,A,0,0
236279,total,1,1
236280,of,1,0
236281,71,1,1
236282,patients,1,1
236283,were,1,1
236284,treated,1,1
236285,by,1,0
236286,quadruple,1,1
236287,therapy,1,0
236288,",",1,1
236289,and,1,1
236290,42,1,1
236291,patients,1,1
236292,were,1,1
236293,treated,1,1
236294,by,1,0
236295,triple,1,1
236296,therapy,1,1
236297,.,1,1
236298,The,0,0
236299,eradication,0,0
236300,rate,0,0
236301,of,0,0
236302,H.,0,1
236303,pylori,0,1
236304,for,0,0
236305,patients,0,1
236306,under,0,1
236307,quadruple,0,1
236308,treatment,0,0
236309,",",0,0
236310,without,0,0
236311,vs.,0,0
236312,with,0,1
236313,previous,0,1
236314,dual,0,1
236315,therapy,0,0
236316,",",0,1
236317,were,0,1
236318,96,0,0
236319,%,0,0
236320,vs.,0,0
236321,92,0,1
236322,%,0,0
236323,(,0,0
236324,42/44,0,0
236325,vs.,0,0
236326,22/24,0,0
236327,),0,1
236328,by,0,0
236329,per,0,1
236330,protocol,0,1
236331,and,0,1
236332,91,0,0
236333,%,0,0
236334,vs.,0,0
236335,88,0,1
236336,%,0,0
236337,(,0,0
236338,42/46,0,0
236339,vs.,0,0
236340,22/25,0,0
236341,),0,1
236342,by,0,0
236343,intention,0,0
236344,to,0,0
236345,treat,0,1
236346,analysis,0,0
236347,(,0,0
236348,comparisons,0,0
236349,not,0,1
236350,significant,0,0
236351,),0,1
236352,.,0,1
236353,No,0,0
236354,major,0,0
236355,side-effects,0,0
236356,were,0,1
236357,reported,0,1
236358,.,0,1
236359,CONCLUSIONS,0,0
236360,Five-day,0,0
236361,quadruple,0,1
236362,therapy,0,0
236363,(,0,0
236364,with,0,1
236365,omeprazole,0,0
236366,",",0,0
236367,metronidazole,0,0
236368,",",0,0
236369,clarithromycin,0,0
236370,and,0,0
236371,amoxicillin,0,0
236372,),0,0
236373,represents,0,0
236374,an,0,0
236375,effective,0,0
236376,and,0,0
236377,safe,0,0
236378,new,0,1
236379,regimen,0,1
236380,for,0,1
236381,H.,0,1
236382,pylori,0,1
236383,eradication,0,1
236384,.,0,1
236385,A,0,0
236386,prospective,0,0
236387,randomized,0,1
236388,study,0,1
236389,of,0,0
236390,amoxycillin,0,0
236391,and,0,0
236392,omeprazole,0,0
236393,with,0,1
236394,and,0,0
236395,without,0,1
236396,metronidazole,0,0
236397,in,0,0
236398,the,0,0
236399,eradication,0,0
236400,treatment,1,0
236401,of,1,0
236402,Helicobacter,1,1
236403,pylori,1,1
236404,.,1,1
236405,A,0,0
236406,combination,0,0
236407,of,0,0
236408,amoxycillin,0,0
236409,and,0,0
236410,omeprazole,0,0
236411,is,0,0
236412,often,0,0
236413,used,0,0
236414,to,0,0
236415,treat,0,1
236416,Helicobacter,1,1
236417,pylori,1,1
236418,infection,1,1
236419,.,1,1
236420,A,0,0
236421,three-drug,0,0
236422,regimen,0,0
236423,comprising,0,1
236424,metronidazole,0,0
236425,",",0,0
236426,amoxycillin,0,0
236427,and,0,0
236428,omeprazole,0,0
236429,has,0,0
236430,been,0,0
236431,proposed,0,0
236432,as,0,0
236433,an,0,0
236434,alternative,0,0
236435,therapy,0,0
236436,.,0,1
236437,In,0,0
236438,a,0,0
236439,prospective,0,1
236440,",",0,0
236441,randomized,0,1
236442,",",0,0
236443,comparative,0,0
236444,study,0,0
236445,",",0,0
236446,we,0,0
236447,evaluated,0,0
236448,these,0,0
236449,two,0,0
236450,regimens,0,0
236451,with,0,1
236452,respect,0,0
236453,to,0,1
236454,safety,0,0
236455,and,0,0
236456,efficacy,0,0
236457,in,0,0
236458,patients,1,1
236459,with,1,1
236460,H.,1,1
236461,pylori,1,1
236462,infection,1,1
236463,.,1,1
236464,Sixty,1,1
236465,patients,1,1
236466,with,1,1
236467,peptic,1,1
236468,ulcer,1,1
236469,(,1,1
236470,gastric,1,1
236471,",",1,1
236472,32,1,1
236473,patients,1,1
236474,;,1,1
236475,duodenal,1,1
236476,",",1,1
236477,28,1,1
236478,patients,1,1
236479,),1,1
236480,who,1,1
236481,had,1,1
236482,a,1,1
236483,history,1,1
236484,of,1,0
236485,ulcer,1,1
236486,recurrence,1,0
236487,were,0,1
236488,randomly,0,1
236489,assigned,0,1
236490,to,0,0
236491,dual,0,0
236492,therapy,0,0
236493,with,0,1
236494,amoxycillin,0,0
236495,(,0,1
236496,500,0,1
236497,mg,0,1
236498,three,0,1
236499,times,0,0
236500,daily,0,0
236501,for,0,1
236502,2,0,1
236503,weeks,0,1
236504,),0,1
236505,and,0,1
236506,omeprazole,0,0
236507,(,0,1
236508,20,0,1
236509,mg,0,0
236510,once,0,0
236511,daily,0,0
236512,for,0,1
236513,8,0,1
236514,weeks,0,1
236515,),0,1
236516,or,0,1
236517,to,0,0
236518,triple,0,0
236519,therapy,0,0
236520,with,0,1
236521,metronidazole,0,0
236522,(,0,1
236523,500,0,1
236524,mg,0,0
236525,twice,0,0
236526,daily,0,0
236527,for,0,0
236528,2,0,1
236529,weeks,0,1
236530,),0,1
236531,plus,0,0
236532,amoxycillin,0,0
236533,and,0,1
236534,omeprazole,0,0
236535,",",0,0
236536,given,0,0
236537,in,0,0
236538,the,0,0
236539,same,0,0
236540,dosages,0,0
236541,as,0,1
236542,dual,0,1
236543,therapy,0,1
236544,.,0,1
236545,Forty-eight,1,1
236546,patients,1,1
236547,completed,1,1
236548,the,1,0
236549,protocol,1,0
236550,;,1,0
236551,treatment,0,0
236552,was,0,0
236553,discontinued,0,0
236554,because,0,0
236555,of,0,0
236556,side,0,0
236557,effects,0,0
236558,in,0,1
236559,nine,0,1
236560,patients,0,1
236561,",",0,1
236562,and,0,1
236563,three,0,0
236564,patients,0,1
236565,dropped,0,0
236566,out,0,1
236567,of,0,0
236568,the,0,0
236569,study,0,0
236570,.,0,0
236571,On,0,0
236572,the,0,0
236573,basis,0,0
236574,of,0,0
236575,all,0,1
236576,patients,0,1
236577,treated,0,1
236578,",",0,0
236579,the,0,0
236580,rate,0,0
236581,of,0,0
236582,H.,0,1
236583,pylori,0,1
236584,eradication,0,0
236585,was,0,0
236586,significantly,0,0
236587,higher,0,0
236588,for,0,0
236589,triple,0,0
236590,therapy,0,1
236591,20/23,0,0
236592,cases,0,1
236593,",",0,1
236594,87.0,0,0
236595,%,0,0
236596,;,0,1
236597,95,0,0
236598,%,0,0
236599,confidence,0,0
236600,interval,0,0
236601,(,0,1
236602,CI,0,0
236603,),0,1
236604,",",0,0
236605,0.664-0.972,0,0
236606,),0,1
236607,than,0,0
236608,for,0,1
236609,dual,0,1
236610,therapy,0,1
236611,13/25,0,1
236612,",",0,1
236613,52.0,0,0
236614,%,0,0
236615,;,0,1
236616,0.313-0.722,0,0
236617,;,0,1
236618,P,0,0
236619,<,0,0
236620,0.05,0,0
236621,),0,1
236622,.,0,1
236623,On,0,0
236624,an,0,0
236625,intention-to-treat,0,0
236626,basis,0,0
236627,",",0,0
236628,the,0,0
236629,difference,0,0
236630,between,0,0
236631,the,0,0
236632,groups,0,0
236633,in,0,0
236634,the,0,0
236635,rate,0,0
236636,of,0,0
236637,H.,0,1
236638,pylori,0,1
236639,eradication,0,0
236640,was,0,0
236641,marginally,0,0
236642,significant,0,0
236643,(,0,0
236644,P,0,0
236645,=,0,1
236646,0.06,0,0
236647,[,0,0
236648,0.028-0.512,0,0
236649,],0,1
236650,),0,1
236651,.,0,1
236652,Side,0,0
236653,effects,0,0
236654,were,0,1
236655,reported,0,1
236656,by,0,0
236657,five,0,1
236658,patients,0,1
236659,receiving,0,1
236660,triple,0,1
236661,therapy,0,1
236662,(,0,1
236663,skin,0,1
236664,rash,0,1
236665,",",0,1
236666,one,0,1
236667,;,0,0
236668,nausea,0,0
236669,",",0,1
236670,two,0,0
236671,;,0,0
236672,headache,0,1
236673,",",0,1
236674,one,0,1
236675,;,0,1
236676,abdominal,0,1
236677,pain,0,1
236678,",",0,1
236679,one,0,1
236680,),0,0
236681,",",0,1
236682,and,0,1
236683,four,0,1
236684,patients,0,1
236685,receiving,0,1
236686,dual,0,1
236687,therapy,0,1
236688,(,0,1
236689,skin,0,1
236690,rash,0,1
236691,",",0,1
236692,two,0,0
236693,;,0,1
236694,abdominal,0,1
236695,pain,0,1
236696,",",0,1
236697,one,0,1
236698,;,0,0
236699,diarrhoea,0,1
236700,",",0,1
236701,one,0,1
236702,),0,1
236703,.,0,1
236704,All,0,1
236705,side,0,0
236706,effects,0,0
236707,resolved,0,0
236708,spontaneously,0,1
236709,after,0,0
236710,termination,0,0
236711,of,0,0
236712,treatment,0,0
236713,.,0,0
236714,There,0,0
236715,was,0,0
236716,no,0,0
236717,significant,0,0
236718,difference,0,0
236719,in,0,0
236720,safety,0,0
236721,between,0,0
236722,the,0,1
236723,two,0,1
236724,regimens,0,0
236725,.,0,1
236726,Triple,0,0
236727,therapy,0,0
236728,with,0,1
236729,metronidazole,0,0
236730,",",0,0
236731,amoxycillin,0,0
236732,",",0,0
236733,and,0,0
236734,omeprazole,0,0
236735,was,0,0
236736,significantly,0,0
236737,more,0,0
236738,effective,0,0
236739,for,0,0
236740,the,0,0
236741,eradication,0,0
236742,of,0,0
236743,H.,0,1
236744,pylori,0,1
236745,than,0,0
236746,dual,0,0
236747,therapy,0,1
236748,with,0,1
236749,amoxycillin,0,0
236750,and,0,0
236751,omeprazole,0,0
236752,alone,0,0
236753,.,0,1
236754,The,0,0
236755,safety,0,0
236756,of,0,0
236757,these,0,0
236758,regimens,0,0
236759,was,0,0
236760,similar,0,0
236761,",",0,0
236762,and,0,0
236763,triple,0,0
236764,therapy,0,0
236765,was,0,0
236766,found,0,0
236767,to,0,0
236768,be,0,0
236769,clinically,0,1
236770,acceptable,0,0
236771,.,0,1
236772,Transcutaneous,0,1
236773,electrical,0,0
236774,nerve,0,0
236775,stimulation,0,0
236776,in,0,0
236777,the,0,0
236778,treatment,0,0
236779,of,0,0
236780,myofascial,0,1
236781,pain,0,1
236782,dysfunction,0,1
236783,.,0,1
236784,The,0,0
236785,effect,0,0
236786,of,0,0
236787,transcutaneous,0,0
236788,electrical,0,0
236789,nerve,0,1
236790,stimulation,0,0
236791,(,0,1
236792,TENS,0,1
236793,),0,1
236794,plus,0,0
236795,conservative,0,1
236796,therapy,0,0
236797,(,0,1
236798,ibuprofen,0,0
236799,",",0,1
236800,bite,0,0
236801,plate,0,0
236802,",",0,0
236803,self-physiotherapy,0,0
236804,),0,1
236805,on,0,0
236806,myofascial,1,1
236807,pain,1,1
236808,dysfunction,1,1
236809,(,1,1
236810,MPD,1,1
236811,),1,1
236812,was,0,0
236813,determined,0,0
236814,.,0,1
236815,A,0,0
236816,single-blind,0,0
236817,trial,0,0
236818,as,0,0
236819,done,0,1
236820,in,0,1
236821,10,1,1
236822,patients,1,1
236823,with,1,1
236824,MPD,1,1
236825,with,1,1
236826,subthreshold,1,1
236827,TENS,1,1
236828,(,1,1
236829,frequency,1,0
236830,35,1,1
236831,Hz,1,0
236832,",",1,0
236833,pulse,1,0
236834,width,1,0
236835,100,1,0
236836,milliseconds,1,0
236837,",",1,1
236838,modulation,1,0
236839,50,1,1
236840,%,1,0
236841,),1,1
236842,compared,1,0
236843,with,1,1
236844,sham,1,0
236845,TENS,1,1
236846,at,1,1
236847,8,1,1
236848,visits,1,1
236849,over,1,1
236850,14,1,1
236851,weeks,1,1
236852,.,1,1
236853,Pain,0,0
236854,was,0,0
236855,assessed,0,0
236856,on,0,0
236857,a,0,1
236858,visual,0,0
236859,analogue,0,0
236860,scale,0,0
236861,before,0,0
236862,and,0,1
236863,after,0,1
236864,TENS,0,0
236865,at,0,0
236866,each,0,0
236867,visit,0,0
236868,and,0,0
236869,the,0,0
236870,data,0,0
236871,were,0,1
236872,analysed,0,1
236873,with,0,1
236874,the,0,0
236875,analysis,0,0
236876,of,0,0
236877,variance,0,0
236878,(,0,1
236879,ANOVA,0,1
236880,),0,1
236881,for,0,0
236882,repeated,0,0
236883,measures,0,0
236884,.,0,1
236885,A,0,0
236886,highly,0,0
236887,significant,0,0
236888,effect,0,0
236889,was,0,0
236890,seen,0,0
236891,for,0,0
236892,time,0,0
236893,(,0,1
236894,F,0,1
236895,=,0,1
236896,4.80,0,0
236897,",",0,1
236898,P,0,0
236899,=,0,1
236900,0.0003,0,0
236901,),0,1
236902,but,0,0
236903,not,0,0
236904,for,0,0
236905,TENS,0,0
236906,.,0,1
236907,Subthreshold,0,0
236908,TENS,0,0
236909,did,0,0
236910,not,0,0
236911,increase,0,0
236912,the,0,0
236913,symptom,0,0
236914,relief,0,0
236915,produced,0,0
236916,by,0,0
236917,conservative,0,1
236918,treatment,0,0
236919,with,0,1
236920,the,0,0
236921,protocol,0,0
236922,used,0,0
236923,.,0,1
236924,Humoral,0,1
236925,immune,0,0
236926,response,0,0
236927,to,0,1
236928,tetanus-diphtheria,0,1
236929,vaccine,0,1
236930,given,0,0
236931,during,0,0
236932,extended,0,1
236933,use,0,0
236934,of,0,0
236935,chloroquine,0,0
236936,or,0,1
236937,primaquine,0,1
236938,malaria,0,1
236939,chemoprophylaxis,0,1
236940,.,0,1
236941,Immune,0,0
236942,suppression,0,0
236943,resulting,0,0
236944,from,0,1
236945,prolonged,0,0
236946,chemoprophylaxis,0,1
236947,and,0,1
236948,potential,0,0
236949,drug-vaccine,0,1
236950,interaction,0,0
236951,were,0,1
236952,investigated,0,0
236953,within,0,0
236954,the,0,0
236955,context,0,0
236956,of,0,0
236957,a,0,1
236958,randomized,0,1
236959,placebo-controlled,0,0
236960,trial,0,1
236961,that,0,0
236962,compared,0,0
236963,daily,0,0
236964,primaquine,0,0
236965,or,0,1
236966,weekly,0,0
236967,chloroquine,0,0
236968,administration,0,0
236969,for,0,0
236970,malaria,0,1
236971,prevention,0,1
236972,.,0,1
236973,After,0,0
236974,11,0,1
236975,months,0,1
236976,of,0,1
236977,prophylaxis,0,1
236978,",",0,0
236979,adult,1,1
236980,male,1,1
236981,subjects,1,1
236982,received,0,1
236983,a,0,1
236984,tetanus-diphtheria,0,1
236985,(,0,0
236986,Td,0,0
236987,),0,1
236988,vaccination,0,1
236989,.,0,1
236990,Prophylaxis,0,1
236991,continued,0,0
236992,4,0,0
236993,weeks,0,0
236994,longer,0,0
236995,.,0,0
236996,Anti-tetanus,0,0
236997,and,0,0
236998,anti-diphtheria,0,1
236999,antibody,0,0
237000,levels,0,0
237001,were,0,1
237002,measured,0,0
237003,by,0,0
237004,ELISA,0,1
237005,at,0,1
237006,baseline,0,0
237007,and,0,1
237008,at,0,0
237009,1,0,1
237010,",",0,1
237011,3,0,0
237012,",",0,0
237013,7,0,1
237014,",",0,0
237015,and,0,1
237016,14,0,1
237017,months,0,0
237018,after,0,1
237019,Td,0,1
237020,vaccination,0,1
237021,.,0,1
237022,All,0,1
237023,groups,0,0
237024,were,0,1
237025,comparable,0,0
237026,at,0,1
237027,baseline,0,0
237028,.,0,1
237029,Immunization,0,0
237030,triggered,0,0
237031,significant,0,0
237032,increases,0,0
237033,in,0,1
237034,anti-tetanus,0,1
237035,and,0,1
237036,anti-diphtheria,0,1
237037,IgG,0,0
237038,levels,0,0
237039,over,0,0
237040,each,0,1
237041,group,0,1
237042,'s,0,1
237043,pre-Td,0,1
237044,baseline,0,1
237045,levels,0,0
237046,and,0,0
237047,those,0,1
237048,of,0,0
237049,an,0,0
237050,unvaccinated,0,1
237051,control,0,1
237052,group,0,1
237053,.,0,1
237054,Geometric,0,0
237055,mean,0,1
237056,anti-tetanus,0,1
237057,titers,0,0
237058,(,0,1
237059,GMTs,0,1
237060,),0,1
237061,in,0,0
237062,the,0,0
237063,primaquine,0,0
237064,group,0,0
237065,were,0,0
237066,significantly,0,0
237067,higher,0,0
237068,than,0,0
237069,those,0,0
237070,of,0,0
237071,the,0,0
237072,placebo,0,0
237073,group,0,1
237074,at,0,0
237075,1,0,1
237076,",",0,1
237077,3,0,0
237078,",",0,0
237079,and,0,1
237080,14,0,1
237081,months,0,1
237082,.,0,1
237083,Anti-tetanus,0,0
237084,GMTs,0,0
237085,in,0,1
237086,placebo,0,0
237087,and,0,1
237088,chloroquine,0,1
237089,groups,0,0
237090,declined,0,0
237091,over,0,1
237092,14,0,1
237093,months,0,1
237094,to,0,1
237095,levels,0,1
237096,comparable,0,0
237097,to,0,1
237098,those,0,1
237099,of,0,0
237100,unvaccinated,0,1
237101,controls,0,1
237102,",",0,1
237103,but,0,0
237104,levels,0,0
237105,in,0,0
237106,the,0,0
237107,primaquine,0,0
237108,group,0,0
237109,remained,0,0
237110,significantly,0,0
237111,higher,0,0
237112,than,0,0
237113,in,0,0
237114,controls,0,1
237115,.,0,1
237116,Proposed,0,1
237117,synergistic,0,0
237118,effect,0,0
237119,of,0,0
237120,calcium,0,0
237121,channel,0,0
237122,blockers,0,0
237123,with,0,1
237124,lipid-lowering,0,1
237125,therapy,0,1
237126,in,0,0
237127,retarding,1,0
237128,progression,1,0
237129,of,1,0
237130,coronary,1,1
237131,atherosclerosis,1,1
237132,.,1,1
237133,Lipid-lowering,0,0
237134,therapy,0,0
237135,now,0,0
237136,has,0,0
237137,undoubtedly,0,0
237138,proven,0,0
237139,to,0,0
237140,be,0,0
237141,an,0,0
237142,effective,0,0
237143,therapeutic,0,0
237144,modality,0,0
237145,to,0,0
237146,retard,0,0
237147,the,0,0
237148,progression,0,0
237149,of,0,0
237150,coronary,0,1
237151,atherosclerosis,0,1
237152,.,0,1
237153,An,0,0
237154,additional,0,0
237155,approach,0,0
237156,for,0,0
237157,prevention,0,1
237158,of,0,0
237159,the,0,0
237160,progression,0,0
237161,of,0,0
237162,atherosclerosis,0,1
237163,is,0,0
237164,calcium,0,0
237165,channel,0,0
237166,blocker,0,1
237167,(,0,1
237168,CCB,0,0
237169,),0,1
237170,treatment,0,0
237171,.,0,1
237172,Evidence,0,0
237173,indicating,0,0
237174,that,0,0
237175,CCBs,0,1
237176,inhibit,0,0
237177,atherosclerosis,0,1
237178,is,0,0
237179,less,0,0
237180,unequivocal,0,0
237181,than,0,0
237182,the,0,0
237183,clear,0,0
237184,evidence,0,0
237185,for,0,0
237186,lipid-lowering,0,1
237187,therapy,0,1
237188,.,0,1
237189,Many,0,0
237190,investigations,0,0
237191,support,0,0
237192,the,0,0
237193,view,0,0
237194,that,0,0
237195,a,0,0
237196,number,0,0
237197,of,0,0
237198,key,0,0
237199,processes,0,0
237200,in,0,0
237201,atherosclerosis,0,1
237202,may,0,0
237203,be,0,0
237204,influenced,0,0
237205,by,0,0
237206,CCBs,0,1
237207,.,0,1
237208,From,0,1
237209,the,0,0
237210,negative,0,0
237211,and,0,1
237212,positive,0,1
237213,studies,0,0
237214,with,0,1
237215,CCBs,0,1
237216,performed,0,0
237217,in,0,1
237218,animals,1,1
237219,and,1,1
237220,humans,1,1
237221,we,0,0
237222,must,0,0
237223,conclude,0,0
237224,that,0,0
237225,apparently,0,0
237226,some,0,0
237227,",",0,0
237228,but,0,0
237229,not,0,0
237230,all,0,0
237231,",",0,0
237232,types,0,1
237233,or,0,1
237234,stages,0,1
237235,of,0,0
237236,the,0,1
237237,atherosclerotic,0,1
237238,process,0,0
237239,are,0,0
237240,inhibited,0,0
237241,by,0,0
237242,CCBs,0,1
237243,.,0,1
237244,To,0,0
237245,assess,0,0
237246,whether,0,0
237247,lipid-lowering,0,1
237248,therapy,0,1
237249,and,0,1
237250,CCB,0,0
237251,treatment,0,0
237252,may,0,0
237253,have,0,0
237254,an,0,0
237255,additive,0,0
237256,or,0,1
237257,synergistic,0,0
237258,beneficial,0,0
237259,effect,0,0
237260,on,0,0
237261,human,0,1
237262,atherosclerosis,0,1
237263,",",0,0
237264,which,0,0
237265,is,0,0
237266,conceivable,0,0
237267,because,0,0
237268,their,0,1
237269,anti-atherosclerotic,0,1
237270,properties,0,0
237271,differ,0,1
237272,",",0,0
237273,data,1,0
237274,from,1,1
237275,the,1,1
237276,angiographic,1,0
237277,lipid-lowering,1,1
237278,trial,1,1
237279,REGRESS,1,0
237280,(,1,0
237281,pravastatin,1,0
237282,vs.,1,0
237283,placebo,1,0
237284,),1,1
237285,were,0,1
237286,reviewed,0,1
237287,.,0,1
237288,In,0,0
237289,REGRESS,0,0
237290,",",0,1
237291,patients,0,1
237292,in,0,0
237293,the,0,0
237294,pravastatin,0,0
237295,group,0,0
237296,had,0,1
237297,significantly,0,0
237298,less,0,0
237299,progression,0,0
237300,if,0,0
237301,cotreated,0,0
237302,with,0,1
237303,CCBs,0,1
237304,as,0,0
237305,compared,0,0
237306,with,0,1
237307,those,0,0
237308,with,0,1
237309,no,0,0
237310,CCB,0,0
237311,cotreatment,0,0
237312,",",0,0
237313,whereas,0,0
237314,in,0,0
237315,the,0,0
237316,placebo,0,0
237317,(,0,0
237318,no,0,0
237319,pravastatin,0,0
237320,),0,0
237321,group,0,0
237322,no,0,0
237323,effect,0,0
237324,of,0,0
237325,CCB,0,0
237326,treatment,0,1
237327,was,0,0
237328,observed,0,0
237329,.,0,1
237330,With,0,0
237331,respect,0,0
237332,to,0,0
237333,angiographic,0,0
237334,new,0,1
237335,lesion,0,0
237336,formation,0,0
237337,",",0,0
237338,in,0,0
237339,the,0,0
237340,pravastatin,0,0
237341,group,0,0
237342,there,0,0
237343,were,0,0
237344,50,0,0
237345,%,0,0
237346,less,0,0
237347,patients,0,1
237348,with,0,1
237349,new,0,1
237350,angiographic,0,1
237351,lesions,0,1
237352,if,0,0
237353,cotreated,0,1
237354,with,0,1
237355,CCBs,0,1
237356,as,0,0
237357,compared,0,0
237358,with,0,1
237359,no,0,0
237360,CCB,0,0
237361,cotreatment,0,0
237362,",",0,0
237363,whereas,0,0
237364,in,0,0
237365,the,0,0
237366,placebo,0,0
237367,(,0,0
237368,no,0,0
237369,pravastatin,0,0
237370,),0,0
237371,group,0,0
237372,",",0,0
237373,again,0,0
237374,",",0,0
237375,no,0,0
237376,significant,0,0
237377,effect,0,0
237378,of,0,0
237379,CCB,0,0
237380,treatment,0,1
237381,was,0,0
237382,observed,0,0
237383,.,0,1
237384,No,0,0
237385,beneficial,0,0
237386,effects,0,0
237387,of,0,1
237388,CCB,0,0
237389,treatment,0,1
237390,on,0,0
237391,clinical,0,1
237392,events,0,0
237393,were,0,1
237394,observed,0,0
237395,during,0,0
237396,the,0,0
237397,2-year,0,1
237398,study,0,1
237399,follow-up,0,0
237400,.,0,1
237401,In,0,0
237402,view,0,0
237403,of,0,0
237404,the,0,0
237405,correlation,0,0
237406,between,0,0
237407,angiographic,0,0
237408,progression,0,1
237409,and,0,1
237410,subsequent,0,0
237411,clinical,0,0
237412,events,0,0
237413,as,0,0
237414,demonstrated,0,0
237415,in,0,1
237416,several,0,1
237417,large,0,1
237418,trials,0,1
237419,",",0,0
237420,it,0,0
237421,is,0,0
237422,not,0,0
237423,unrealistic,0,0
237424,to,0,0
237425,also,0,0
237426,anticipate,0,0
237427,in,0,0
237428,this,0,0
237429,population,0,1
237430,",",0,0
237431,a,0,0
237432,beneficial,0,0
237433,effect,0,0
237434,on,0,0
237435,clinical,0,0
237436,events,0,0
237437,with,0,1
237438,longer,0,0
237439,follow-up,0,0
237440,.,0,0
237441,Although,0,0
237442,the,0,0
237443,REGRESS,0,0
237444,trial,0,0
237445,was,0,0
237446,not,0,0
237447,designed,0,0
237448,to,0,0
237449,evaluate,0,0
237450,combination,0,0
237451,therapy,0,0
237452,",",0,0
237453,the,0,0
237454,results,0,0
237455,suggest,0,0
237456,that,0,0
237457,addition,0,0
237458,of,0,1
237459,CCBs,0,1
237460,to,0,1
237461,HMG-CoA,0,1
237462,reductase,0,0
237463,inhibitor,0,0
237464,therapy,0,0
237465,(,0,1
237466,pravastatin,0,0
237467,),0,0
237468,acts,0,0
237469,synergistically,0,0
237470,in,0,0
237471,retarding,0,0
237472,the,0,0
237473,progression,0,0
237474,of,0,0
237475,established,0,1
237476,coronary,0,1
237477,atherosclerosis,0,1
237478,.,0,1
237479,These,0,0
237480,results,0,0
237481,appear,0,0
237482,to,0,0
237483,warrant,0,0
237484,prospective,0,1
237485,randomized,0,1
237486,trials,0,0
237487,to,0,0
237488,determine,0,0
237489,in,0,0
237490,a,0,0
237491,more,0,0
237492,definitive,0,0
237493,manner,0,0
237494,the,0,0
237495,merits,0,0
237496,of,0,0
237497,this,0,0
237498,combination,0,0
237499,in,0,0
237500,the,0,0
237501,prevention,0,1
237502,of,0,0
237503,progression,0,0
237504,of,0,0
237505,coronary,0,1
237506,atherosclerosis,0,1
237507,.,0,1
237508,Currently,0,0
237509,a,0,0
237510,number,0,0
237511,of,0,0
237512,studies,0,0
237513,in,0,1
237514,these,0,0
237515,fields,0,1
237516,are,0,0
237517,being,0,1
237518,designed,0,0
237519,or,0,1
237520,are,0,0
237521,already,0,0
237522,underway,0,0
237523,.,0,1
237524,Bronchodilator,0,0
237525,response,0,0
237526,to,0,0
237527,salbutamol,0,0
237528,after,0,0
237529,spontaneous,0,1
237530,recovery,0,0
237531,from,0,1
237532,nonspecific,0,1
237533,bronchial,0,1
237534,provocation,0,0
237535,tests,0,0
237536,in,0,1
237537,asthma,1,1
237538,.,1,1
237539,Assessment,0,0
237540,of,0,0
237541,airway,0,0
237542,responsiveness,0,0
237543,by,0,0
237544,bronchoprovocation,0,0
237545,and,0,1
237546,bronchodilatation,0,0
237547,tests,0,0
237548,is,0,0
237549,important,0,0
237550,in,0,0
237551,the,0,0
237552,diagnostic,0,0
237553,work-up,0,1
237554,protocol,0,1
237555,of,0,0
237556,bronchial,1,1
237557,asthma,1,1
237558,and,0,0
237559,it,0,0
237560,would,0,0
237561,be,0,0
237562,convenient,0,0
237563,to,0,0
237564,undertake,0,0
237565,both,0,0
237566,tests,0,0
237567,on,0,0
237568,the,0,1
237569,same,0,0
237570,occasion,0,1
237571,.,0,1
237572,However,0,0
237573,",",0,0
237574,it,0,0
237575,is,0,0
237576,not,0,0
237577,known,0,0
237578,whether,0,0
237579,this,0,0
237580,can,0,0
237581,be,0,0
237582,done,0,0
237583,accurately,0,0
237584,.,0,0
237585,Therefore,0,0
237586,",",0,0
237587,this,0,0
237588,study,0,0
237589,evaluated,0,0
237590,the,0,0
237591,effect,0,0
237592,of,0,0
237593,a,0,1
237594,prior,0,1
237595,bronchial,0,1
237596,provocation,0,0
237597,test,0,0
237598,on,0,0
237599,the,0,0
237600,bronchodilator,0,0
237601,response,0,0
237602,to,0,0
237603,salbutamol,0,0
237604,after,0,0
237605,spontaneous,0,1
237606,recovery,0,0
237607,of,0,0
237608,the,0,0
237609,forced,0,0
237610,expiratory,0,0
237611,volume,0,0
237612,in,0,1
237613,one,0,1
237614,second,0,1
237615,(,0,1
237616,FEV1,0,1
237617,),0,1
237618,in,0,0
237619,a,1,0
237620,group,1,1
237621,of,1,0
237622,asthmatic,1,1
237623,subjects,1,1
237624,.,1,1
237625,On,0,1
237626,two,0,0
237627,separate,0,1
237628,occasions,0,1
237629,at,0,1
237630,the,0,1
237631,same,0,0
237632,time,0,0
237633,of,0,0
237634,day,0,0
237635,",",0,1
237636,concentration-response,0,0
237637,studies,0,0
237638,with,0,1
237639,inhaled,0,1
237640,histamine,0,0
237641,or,0,1
237642,methacholine,0,0
237643,",",0,0
237644,or,0,0
237645,a,0,0
237646,sham,0,0
237647,challenge,0,0
237648,with,0,1
237649,normal,0,1
237650,saline,0,0
237651,were,0,1
237652,carried,0,0
237653,out,0,1
237654,in,0,0
237655,a,0,0
237656,blinded,0,0
237657,",",0,0
237658,randomized,0,1
237659,manner,0,0
237660,.,0,1
237661,Changes,0,0
237662,in,0,0
237663,airway,0,1
237664,calibre,0,0
237665,were,0,0
237666,followed,0,0
237667,as,0,0
237668,FEV1,0,1
237669,and,0,1
237670,agonist,0,1
237671,responsiveness,0,0
237672,expressed,0,0
237673,as,0,0
237674,the,0,0
237675,provocative,0,0
237676,concentration,0,0
237677,causing,0,1
237678,a,0,1
237679,20,0,1
237680,%,0,0
237681,fall,0,0
237682,in,0,0
237683,FEV1,0,1
237684,(,0,1
237685,PC20,0,1
237686,),0,1
237687,.,0,1
237688,After,0,0
237689,either,0,0
237690,spontaneous,0,1
237691,recovery,0,0
237692,or,0,1
237693,a,0,0
237694,fixed-duration,0,0
237695,wait,0,0
237696,of,0,1
237697,45,0,1
237698,min,0,0
237699,(,0,0
237700,when,0,0
237701,appropriate,0,0
237702,),0,0
237703,",",0,0
237704,the,0,0
237705,subjects,0,1
237706,received,0,1
237707,2x100,0,0
237708,microg,0,0
237709,of,0,0
237710,salbutamol,0,0
237711,from,0,1
237712,a,0,0
237713,metered,0,0
237714,dose,0,0
237715,inhaler,0,0
237716,with,0,1
237717,a,0,1
237718,spacer,0,0
237719,.,0,0
237720,The,0,0
237721,bronchodilator,0,0
237722,response,0,0
237723,to,0,0
237724,salbutamol,0,0
237725,was,0,0
237726,expressed,0,0
237727,as,0,0
237728,a,0,0
237729,percentage,0,0
237730,of,0,0
237731,initial,0,1
237732,FEV1,0,1
237733,(,0,1
237734,deltaFEV1,0,0
237735,%,0,0
237736,init,0,1
237737,),0,1
237738,.,0,1
237739,Bronchial,0,1
237740,challenge,0,0
237741,with,0,1
237742,both,0,0
237743,agonists,0,0
237744,failed,0,0
237745,to,0,0
237746,alter,0,0
237747,significantly,0,0
237748,the,0,0
237749,airway,0,0
237750,response,0,0
237751,to,0,0
237752,salbutamol,0,0
237753,",",0,0
237754,with,0,1
237755,the,0,0
237756,deltaFEV1,0,0
237757,%,0,0
237758,init,0,0
237759,mean,0,1
237760,value,0,0
237761,(,0,1
237762,range,0,1
237763,),0,1
237764,being,0,1
237765,16.9,0,0
237766,%,0,0
237767,(,0,1
237768,9.0-31.9,0,0
237769,),0,1
237770,and,0,1
237771,17.5,0,0
237772,%,0,0
237773,(,0,1
237774,11.6-31.2,0,0
237775,),0,1
237776,on,0,0
237777,the,0,0
237778,sham,0,0
237779,and,0,0
237780,histamine/methacholine,0,0
237781,challenge,0,0
237782,day,0,0
237783,respectively,0,0
237784,.,0,1
237785,It,0,0
237786,was,0,0
237787,shown,0,0
237788,that,0,0
237789,the,0,0
237790,degree,0,1
237791,of,0,0
237792,bronchodilatation,0,0
237793,achieved,0,0
237794,after,0,1
237795,salbutamol,0,0
237796,200,0,1
237797,microg,0,0
237798,is,0,0
237799,not,0,0
237800,affected,0,0
237801,by,0,0
237802,prior,0,1
237803,bronchoprovocation,0,0
237804,testing,0,0
237805,when,0,0
237806,enough,0,0
237807,time,0,0
237808,is,0,0
237809,allowed,0,0
237810,for,0,0
237811,the,0,0
237812,airways,0,1
237813,to,0,0
237814,recover,0,0
237815,spontaneously,0,0
237816,to,0,0
237817,baseline,0,0
237818,forced,0,0
237819,expiratory,0,0
237820,volume,0,0
237821,in,0,1
237822,one,0,1
237823,second,0,1
237824,.,0,1
237825,Thus,0,0
237826,evaluation,0,0
237827,of,0,0
237828,airway,0,0
237829,responsiveness,0,0
237830,by,0,0
237831,both,0,0
237832,bronchial,0,1
237833,provocation,0,0
237834,tests,0,0
237835,and,0,1
237836,bronchodilator,0,0
237837,testing,0,0
237838,can,0,0
237839,be,0,0
237840,assessed,0,0
237841,reliably,0,0
237842,within,0,0
237843,a,0,1
237844,few,0,0
237845,hours,0,0
237846,in,0,1
237847,asthmatic,1,1
237848,patients,1,1
237849,.,1,1
237850,Randomised,0,0
237851,placebo-controlled,0,0
237852,trial,0,1
237853,of,0,0
237854,rhesus-human,0,1
237855,reassortant,0,1
237856,rotavirus,0,1
237857,vaccine,0,1
237858,for,0,0
237859,prevention,0,1
237860,of,0,0
237861,severe,0,1
237862,rotavirus,0,1
237863,gastroenteritis,0,1
237864,.,0,1
237865,BACKGROUND,0,0
237866,Rotavirus,0,0
237867,is,0,0
237868,the,0,0
237869,most,0,0
237870,common,0,0
237871,cause,0,0
237872,of,0,0
237873,acute,0,1
237874,childhood,0,1
237875,gastroenteritis,0,1
237876,.,0,1
237877,Vaccination,0,1
237878,with,0,1
237879,live,0,1
237880,oral,0,1
237881,heterologous,0,1
237882,rotavirus,0,1
237883,vaccines,0,0
237884,may,0,0
237885,prevent,0,0
237886,rotavirus,0,0
237887,gastroenteritis,0,1
237888,.,0,1
237889,We,0,0
237890,assessed,0,0
237891,the,0,0
237892,efficacy,0,0
237893,of,0,0
237894,rhesus-human,0,1
237895,reassortant,0,1
237896,rotavirus,0,1
237897,tetravalent,0,1
237898,vaccine,0,1
237899,(,0,1
237900,RRV-TV,0,0
237901,),0,1
237902,against,0,0
237903,severe,0,1
237904,rotavirus,0,1
237905,gastroenteritis,0,1
237906,in,0,1
237907,Finnish,1,1
237908,children,1,1
237909,in,0,1
237910,a,0,1
237911,randomised,0,1
237912,placebo-controlled,0,0
237913,double-blind,0,1
237914,trial,0,1
237915,.,0,1
237916,METHODS,0,0
237917,Placebo,0,0
237918,or,0,1
237919,RRV-TV,0,0
237920,(,0,1
237921,titre,0,1
237922,4x10,0,1
237923,(,0,1
237924,5,0,1
237925,),0,1
237926,plaque-forming,0,0
237927,units,0,1
237928,),0,1
237929,was,0,0
237930,given,0,0
237931,to,0,1
237932,infants,1,1
237933,at,1,1
237934,ages,1,1
237935,2,1,1
237936,",",1,1
237937,3,1,0
237938,",",1,0
237939,and,1,1
237940,5,1,1
237941,months,1,0
237942,.,1,1
237943,The,0,0
237944,children,0,1
237945,were,0,1
237946,followed,0,1
237947,up,0,1
237948,for,0,1
237949,one,0,1
237950,or,0,1
237951,two,0,1
237952,rotavirus,0,1
237953,epidemic,0,1
237954,seasons,0,1
237955,.,0,1
237956,The,0,0
237957,main,0,0
237958,outcome,0,0
237959,measure,0,0
237960,was,0,0
237961,protection,0,0
237962,against,0,0
237963,severe,0,1
237964,rotavirus,0,1
237965,gastroenteritis,0,1
237966,(,0,1
237967,score,0,0
237968,>,0,1
237969,or,0,1
237970,=11,0,1
237971,on,0,0
237972,a,0,1
237973,20-point,0,0
237974,severity,0,0
237975,scale,0,1
237976,),0,1
237977,.,0,1
237978,2398,1,1
237979,children,1,1
237980,were,1,1
237981,enrolled,1,1
237982,and,0,0
237983,received,0,1
237984,at,0,1
237985,least,0,1
237986,one,0,1
237987,dose,0,0
237988,of,0,1
237989,RRV-TV,0,0
237990,(,0,1
237991,n=1191,0,1
237992,),0,1
237993,or,0,1
237994,placebo,0,0
237995,(,0,1
237996,n=1207,0,1
237997,),0,1
237998,.,0,1
237999,The,0,0
238000,primary,0,0
238001,efficacy,0,0
238002,analysis,0,0
238003,was,0,0
238004,based,0,1
238005,on,0,1
238006,children,0,1
238007,who,0,1
238008,received,0,1
238009,three,0,1
238010,doses,0,0
238011,of,0,1
238012,RRV-TV,0,0
238013,(,0,1
238014,n=1128,0,1
238015,),0,1
238016,or,0,1
238017,placebo,0,0
238018,(,0,1
238019,n=1145,0,1
238020,),0,1
238021,.,0,1
238022,FINDINGS,0,0
238023,256,0,1
238024,episodes,0,1
238025,of,0,1
238026,rotavirus,0,1
238027,gastroenteritis,0,1
238028,occurred,0,0
238029,at,0,0
238030,any,0,0
238031,time,0,0
238032,during,0,0
238033,the,0,0
238034,study,0,1
238035,;,0,1
238036,65,0,1
238037,were,0,1
238038,among,0,1
238039,1191,0,1
238040,RRV-TV,0,0
238041,recipients,0,1
238042,",",0,1
238043,and,0,1
238044,191,0,1
238045,among,0,1
238046,1207,0,1
238047,placebo,0,1
238048,recipients,0,1
238049,(,0,1
238050,vaccine,0,1
238051,efficacy,0,0
238052,66,0,1
238053,%,0,0
238054,[,0,1
238055,95,0,0
238056,%,0,0
238057,CI,0,0
238058,55-74,0,1
238059,],0,1
238060,;,0,1
238061,intention-to-treat,0,0
238062,analysis,0,0
238063,),0,1
238064,.,0,1
238065,226,0,1
238066,episodes,0,0
238067,were,0,1
238068,included,0,1
238069,in,0,0
238070,the,0,0
238071,primary,0,1
238072,efficacy,0,0
238073,analysis,0,0
238074,of,0,0
238075,fully,0,1
238076,vaccinated,0,1
238077,children,0,1
238078,(,0,1
238079,54,0,1
238080,among,0,1
238081,1128,0,1
238082,RRV-TV,0,0
238083,recipients,0,1
238084,",",0,1
238085,172,0,1
238086,among,0,1
238087,1145,0,1
238088,placebo,0,1
238089,recipients,0,1
238090,;,0,1
238091,vaccine,0,1
238092,efficacy,0,0
238093,68,0,1
238094,%,0,0
238095,[,0,0
238096,57-76,0,1
238097,],0,1
238098,),0,1
238099,.,0,1
238100,100,0,0
238101,episodes,0,0
238102,were,0,1
238103,severe,0,1
238104,",",0,1
238105,eight,0,1
238106,in,0,1
238107,RRV-TV,0,0
238108,recipients,0,1
238109,and,0,1
238110,92,0,1
238111,in,0,1
238112,placebo,0,1
238113,recipients,0,1
238114,(,0,1
238115,vaccine,0,1
238116,efficacy,0,0
238117,91,0,1
238118,%,0,0
238119,[,0,0
238120,82-96,0,1
238121,],0,1
238122,),0,1
238123,.,0,1
238124,INTERPRETATION,0,0
238125,RRV-TV,0,0
238126,vaccine,0,1
238127,was,0,0
238128,highly,0,0
238129,effective,0,0
238130,against,0,0
238131,severe,0,1
238132,rotavirus,0,1
238133,gastroenteritis,0,1
238134,in,0,1
238135,young,1,1
238136,children,1,1
238137,.,1,1
238138,Incorporation,0,0
238139,of,0,0
238140,this,0,0
238141,vaccine,0,0
238142,into,0,0
238143,routine,0,1
238144,immunisation,0,1
238145,schedules,0,1
238146,of,0,0
238147,infants,0,1
238148,could,0,0
238149,reduce,0,0
238150,severe,0,1
238151,rotavirus,0,1
238152,gastroenteritis,0,1
238153,by,0,0
238154,90,0,1
238155,%,0,0
238156,and,0,1
238157,severe,0,1
238158,gastroenteritis,0,1
238159,of,0,0
238160,all,0,1
238161,causes,0,0
238162,in,0,1
238163,young,0,1
238164,children,0,1
238165,by,0,1
238166,60,0,1
238167,%,0,0
238168,.,0,1
238169,A,0,0
238170,double-blind,0,0
238171,",",0,0
238172,placebo-controlled,0,0
238173,study,0,1
238174,of,0,0
238175,risperidone,0,0
238176,in,0,1
238177,adults,1,1
238178,with,1,1
238179,autistic,1,1
238180,disorder,1,1
238181,and,1,1
238182,other,1,0
238183,pervasive,1,1
238184,developmental,1,1
238185,disorders,1,1
238186,.,1,1
238187,BACKGROUND,0,0
238188,Neurobiological,0,0
238189,research,0,0
238190,has,0,0
238191,implicated,0,0
238192,the,0,0
238193,dopamine,0,0
238194,and,0,0
238195,serotonin,0,0
238196,systems,0,0
238197,in,0,1
238198,the,0,0
238199,pathogenesis,0,0
238200,of,0,0
238201,autism,1,1
238202,.,1,1
238203,Open-label,0,0
238204,reports,0,0
238205,suggest,0,0
238206,that,0,0
238207,the,0,0
238208,serotonin2A-dopamine,0,1
238209,D2,0,0
238210,antagonist,0,0
238211,risperidone,0,0
238212,may,0,0
238213,be,0,0
238214,safe,0,0
238215,and,0,0
238216,effective,0,0
238217,in,0,0
238218,reducing,0,0
238219,the,0,0
238220,interfering,0,0
238221,symptoms,0,0
238222,of,0,1
238223,patients,1,1
238224,with,1,1
238225,autism,1,1
238226,.,1,1
238227,METHODS,0,0
238228,Thirty-one,1,1
238229,adults,1,1
238230,(,1,1
238231,age,1,1
238232,[,1,0
238233,mean+/-SD,1,0
238234,],1,0
238235,",",1,1
238236,28.1+/-7.3,1,1
238237,years,1,1
238238,),1,1
238239,with,1,1
238240,autistic,1,1
238241,disorder,1,1
238242,(,1,1
238243,n=17,1,1
238244,),1,1
238245,or,1,1
238246,pervasive,1,1
238247,developmental,1,1
238248,disorder,1,1
238249,not,1,0
238250,otherwise,1,1
238251,specified,1,0
238252,(,1,0
238253,n=14,1,1
238254,),1,1
238255,participated,1,1
238256,in,1,0
238257,a,1,1
238258,12-week,1,0
238259,double-blind,1,0
238260,",",1,0
238261,placebo-controlled,1,0
238262,trial,1,0
238263,of,1,0
238264,risperidone,1,1
238265,.,1,1
238266,Patients,0,1
238267,treated,0,1
238268,with,0,1
238269,placebo,0,0
238270,subsequently,0,0
238271,received,0,0
238272,a,0,0
238273,12-week,0,0
238274,open-label,0,1
238275,trial,0,1
238276,of,0,0
238277,risperidone,0,0
238278,.,0,1
238279,RESULTS,0,0
238280,For,0,1
238281,persons,0,1
238282,completing,0,1
238283,the,0,0
238284,study,0,0
238285,",",0,0
238286,8,0,1
238287,(,0,1
238288,57,0,1
238289,%,0,0
238290,),0,1
238291,of,0,1
238292,14,0,1
238293,patients,0,1
238294,treated,0,1
238295,with,0,1
238296,risperidone,0,0
238297,were,0,1
238298,categorized,0,1
238299,as,0,0
238300,responders,0,0
238301,(,0,1
238302,daily,0,0
238303,dose,0,0
238304,[,0,0
238305,mean+/-SD,0,0
238306,],0,1
238307,",",0,0
238308,2.9+/-1.4,0,1
238309,mg,0,1
238310,),0,1
238311,compared,0,0
238312,with,0,1
238313,none,0,1
238314,of,0,1
238315,16,0,1
238316,in,0,0
238317,the,0,0
238318,placebo,0,0
238319,group,0,0
238320,(,0,1
238321,P,0,0
238322,<,0,0
238323,.002,0,0
238324,),0,1
238325,.,0,1
238326,Risperidone,0,0
238327,was,0,0
238328,superior,0,0
238329,to,0,0
238330,placebo,0,0
238331,in,0,0
238332,reducing,0,0
238333,repetitive,0,0
238334,behavior,0,1
238335,(,0,1
238336,P,0,0
238337,<,0,0
238338,.001,0,0
238339,),0,1
238340,",",0,0
238341,aggression,0,1
238342,(,0,1
238343,P,0,0
238344,<,0,0
238345,.001,0,0
238346,),0,1
238347,",",0,0
238348,anxiety,0,1
238349,or,0,1
238350,nervousness,0,0
238351,(,0,1
238352,P,0,0
238353,<,0,0
238354,.02,0,0
238355,),0,1
238356,",",0,0
238357,depression,0,1
238358,(,0,1
238359,P,0,0
238360,<,0,0
238361,.03,0,0
238362,),0,1
238363,",",0,0
238364,irritability,0,0
238365,(,0,1
238366,P,0,0
238367,<,0,0
238368,.01,0,0
238369,),0,1
238370,",",0,0
238371,and,0,0
238372,the,0,0
238373,overall,0,0
238374,behavioral,0,1
238375,symptoms,0,1
238376,of,0,1
238377,autism,0,1
238378,(,0,1
238379,P,0,0
238380,<,0,0
238381,.02,0,0
238382,),0,1
238383,.,0,1
238384,Objective,0,0
238385,",",0,0
238386,measurable,0,0
238387,change,0,0
238388,in,0,1
238389,social,0,1
238390,behavior,0,0
238391,and,0,1
238392,language,0,0
238393,did,0,0
238394,not,0,0
238395,occur,0,0
238396,.,0,1
238397,Nine,0,0
238398,(,0,1
238399,60,0,1
238400,%,0,0
238401,),0,1
238402,of,0,1
238403,15,0,1
238404,patients,0,1
238405,who,0,1
238406,received,0,1
238407,treatment,0,1
238408,with,0,1
238409,open-label,0,1
238410,risperidone,0,0
238411,following,0,0
238412,the,0,0
238413,double-blind,0,0
238414,placebo,0,0
238415,phase,0,1
238416,responded,0,1
238417,.,0,1
238418,Other,0,0
238419,than,0,0
238420,mild,0,1
238421,",",0,1
238422,transient,0,0
238423,sedation,0,0
238424,",",0,0
238425,risperidone,0,0
238426,was,0,0
238427,well,0,0
238428,tolerated,0,0
238429,",",0,0
238430,with,0,1
238431,no,0,0
238432,evidence,0,0
238433,of,0,0
238434,extrapyramidal,0,0
238435,effects,0,0
238436,",",0,1
238437,cardiac,0,1
238438,events,0,0
238439,",",0,1
238440,or,0,1
238441,seizures,0,1
238442,.,0,1
238443,CONCLUSION,0,0
238444,Risperidone,0,0
238445,is,0,0
238446,more,0,0
238447,effective,0,0
238448,than,0,0
238449,placebo,0,0
238450,in,0,0
238451,the,0,0
238452,short-term,0,0
238453,treatment,0,0
238454,of,0,1
238455,symptoms,0,1
238456,of,0,1
238457,autism,1,1
238458,in,1,1
238459,adults,1,1
238460,.,1,1
238461,The,0,0
238462,effect,0,0
238463,of,0,0
238464,quality,0,0
238465,and,0,0
238466,amount,0,0
238467,of,0,0
238468,dietary,0,0
238469,fat,0,0
238470,on,0,0
238471,the,0,0
238472,susceptibility,0,0
238473,of,0,0
238474,low,0,1
238475,density,0,0
238476,lipoprotein,0,0
238477,to,0,0
238478,oxidation,1,0
238479,in,1,0
238480,subjects,1,1
238481,with,1,1
238482,impaired,1,1
238483,glucose,1,1
238484,tolerance,1,1
238485,.,1,1
238486,OBJECTIVES,0,0
238487,We,0,0
238488,examined,0,0
238489,the,0,0
238490,effects,0,0
238491,of,0,0
238492,a,0,1
238493,high,0,1
238494,fat,0,0
238495,diet,0,1
238496,rich,0,1
238497,in,0,1
238498,monounsaturated,0,0
238499,fat,0,1
238500,(,0,1
238501,MUFA-diet,0,1
238502,),0,1
238503,and,0,0
238504,a,0,1
238505,moderate,0,1
238506,fat,0,0
238507,diet,0,1
238508,rich,0,1
238509,in,0,1
238510,polyunsaturated,0,0
238511,fat,0,1
238512,(,0,1
238513,PUFA-diet,0,1
238514,),0,1
238515,on,0,0
238516,the,0,0
238517,susceptibility,0,0
238518,of,0,0
238519,LDL,0,1
238520,to,0,1
238521,oxidation,0,0
238522,.,0,1
238523,SUBJECTS,0,0
238524,29,1,1
238525,subjects,1,1
238526,with,1,1
238527,impaired,1,1
238528,glucose,1,1
238529,tolerance,1,1
238530,.,1,1
238531,METHODS,0,0
238532,After,0,0
238533,consuming,0,1
238534,a,0,1
238535,run-in,0,0
238536,diet,0,1
238537,[,0,1
238538,37,0,1
238539,%,0,0
238540,of,0,0
238541,energy,0,0
238542,(,0,1
238543,E,0,0
238544,%,0,0
238545,),0,1
238546,fat,0,0
238547,",",0,1
238548,18,0,1
238549,E,0,0
238550,%,0,0
238551,saturated,0,0
238552,fat,0,0
238553,],0,1
238554,for,0,1
238555,three,0,1
238556,weeks,0,1
238557,",",0,1
238558,subjects,0,1
238559,were,0,1
238560,randomly,0,1
238561,assigned,0,1
238562,either,0,0
238563,to,0,0
238564,a,0,0
238565,MUFA-diet,0,1
238566,(,0,1
238567,40,0,1
238568,E,0,1
238569,%,0,0
238570,fat,0,0
238571,",",0,1
238572,19,0,1
238573,E,0,0
238574,%,0,0
238575,monounsaturated,0,0
238576,fatty,0,0
238577,acids,0,0
238578,),0,1
238579,or,0,1
238580,a,0,1
238581,PUFA-diet,0,0
238582,(,0,1
238583,34,0,1
238584,E,0,1
238585,%,0,0
238586,fat,0,0
238587,",",0,1
238588,10,0,1
238589,E,0,0
238590,%,0,0
238591,polyunsaturated,0,0
238592,fat,0,0
238593,),0,1
238594,for,0,1
238595,eight,0,1
238596,weeks,0,1
238597,.,0,1
238598,The,0,0
238599,susceptibility,0,0
238600,of,0,0
238601,LDL,0,1
238602,to,0,1
238603,oxidation,0,0
238604,was,0,0
238605,measured,0,0
238606,by,0,0
238607,challenging,0,0
238608,LDL,0,1
238609,with,0,1
238610,hemin,0,0
238611,and,0,1
238612,H2O2,0,0
238613,and,0,0
238614,measuring,0,0
238615,the,0,0
238616,time,0,0
238617,for,0,0
238618,the,0,0
238619,reaction,0,0
238620,to,0,0
238621,reach,0,0
238622,maximum,0,0
238623,velocity,0,0
238624,.,0,1
238625,Results,0,0
238626,are,0,0
238627,expressed,0,0
238628,as,0,0
238629,lag,0,0
238630,time,0,0
238631,to,0,0
238632,oxidation,0,0
238633,in,0,1
238634,minutes,0,0
238635,.,0,1
238636,RESULTS,0,0
238637,In,0,0
238638,the,0,0
238639,PUFA-diet,0,1
238640,group,0,1
238641,(,0,1
238642,n,0,1
238643,=,0,1
238644,15,0,1
238645,),0,1
238646,lag,0,0
238647,time,0,0
238648,tended,0,0
238649,to,0,0
238650,decrease,0,0
238651,during,0,0
238652,the,0,0
238653,experimental,0,0
238654,diet,0,1
238655,(,0,1
238656,97,0,1
238657,+/-,0,1
238658,28,0,1
238659,vs,0,0
238660,90,0,1
238661,+/-,0,1
238662,25,0,1
238663,min,0,0
238664,",",0,1
238665,mean,0,1
238666,+/-,0,0
238667,s.d.,0,1
238668,",",0,1
238669,P,0,0
238670,=,0,1
238671,0.073,0,0
238672,),0,0
238673,",",0,0
238674,whereas,0,0
238675,in,0,0
238676,the,0,0
238677,MUFA-diet,0,1
238678,group,0,1
238679,(,0,1
238680,n,0,1
238681,=,0,1
238682,14,0,1
238683,),0,0
238684,there,0,0
238685,was,0,0
238686,no,0,0
238687,significant,0,0
238688,change,0,0
238689,(,0,1
238690,lag,0,0
238691,time,0,0
238692,96,0,1
238693,+/-,0,1
238694,24,0,1
238695,vs,0,0
238696,100,0,1
238697,+/-,0,1
238698,16,0,1
238699,min,0,0
238700,",",0,1
238701,P,0,0
238702,=,0,1
238703,0.408,0,0
238704,),0,1
238705,.,0,1
238706,The,0,0
238707,mean,0,0
238708,change,0,0
238709,in,0,0
238710,lag,0,0
238711,time,0,0
238712,was,0,0
238713,-7,0,0
238714,+/-,0,0
238715,14,0,1
238716,min,0,0
238717,(,0,1
238718,-7.2,0,0
238719,%,0,0
238720,),0,1
238721,in,0,0
238722,the,0,0
238723,PUFA-diet,0,1
238724,group,0,0
238725,and,0,0
238726,+4,0,0
238727,+/-,0,0
238728,16,0,1
238729,min,0,0
238730,(,0,1
238731,+4.0,0,0
238732,%,0,0
238733,),0,1
238734,in,0,0
238735,the,0,0
238736,MUFA-diet,0,1
238737,group,0,1
238738,(,0,1
238739,P,0,0
238740,=,0,1
238741,0.029,0,0
238742,",",0,1
238743,PUFA-diet,0,1
238744,group,0,1
238745,vs,0,0
238746,MUFA-diet,0,1
238747,group,0,1
238748,),0,1
238749,.,0,1
238750,The,0,0
238751,alpha-tocopherol,0,0
238752,concentration,0,0
238753,in,0,1
238754,LDL,0,1
238755,increased,0,0
238756,significantly,0,0
238757,(,0,1
238758,P,0,0
238759,<,0,0
238760,0.01,0,0
238761,),0,1
238762,in,0,0
238763,both,0,0
238764,diet,0,0
238765,groups,0,0
238766,relative,0,0
238767,to,0,0
238768,the,0,0
238769,run-in,0,0
238770,diet,0,0
238771,period,0,0
238772,",",0,0
238773,but,0,0
238774,LDL,0,0
238775,particle,0,0
238776,score,0,0
238777,did,0,0
238778,not,0,0
238779,change,0,0
238780,in,0,0
238781,either,0,0
238782,of,0,0
238783,the,0,0
238784,diet,0,1
238785,groups,0,0
238786,during,0,1
238787,the,0,1
238788,dietary,0,0
238789,intervention,0,0
238790,.,0,1
238791,In,0,0
238792,subjects,1,1
238793,with,1,1
238794,impaired,1,1
238795,glucose,1,0
238796,tolerance,1,1
238797,a,0,1
238798,PUFA-rich,0,1
238799,diet,0,0
238800,with,0,1
238801,a,0,1
238802,moderate,0,1
238803,amount,0,0
238804,of,0,0
238805,fat,0,0
238806,tended,0,0
238807,to,0,0
238808,increase,0,0
238809,the,0,0
238810,susceptibility,0,0
238811,of,0,0
238812,LDL,0,1
238813,to,0,1
238814,oxidation,0,0
238815,as,0,0
238816,compared,0,0
238817,to,0,0
238818,a,0,0
238819,higher,0,0
238820,fat,0,0
238821,diet,0,0
238822,rich,0,1
238823,in,0,1
238824,MUFA,0,0
238825,.,0,1
238826,Furthermore,0,0
238827,",",0,0
238828,the,0,0
238829,negative,0,0
238830,mean,0,1
238831,change,0,0
238832,in,0,0
238833,lag,0,0
238834,time,0,0
238835,to,0,0
238836,oxidation,0,0
238837,found,0,0
238838,in,0,0
238839,the,0,0
238840,PUFA-diet,0,1
238841,group,0,0
238842,differed,0,0
238843,significantly,0,0
238844,from,0,0
238845,the,0,0
238846,slightly,0,0
238847,positive,0,0
238848,mean,0,1
238849,change,0,0
238850,found,0,0
238851,in,0,0
238852,the,0,0
238853,MUFA-diet,0,1
238854,group,0,1
238855,.,0,1
238856,The,0,0
238857,Treatment,0,0
238858,of,0,0
238859,Lead-exposed,1,1
238860,Children,1,1
238861,(,1,1
238862,TLC,1,0
238863,),1,1
238864,trial,0,1
238865,:,0,1
238866,design,0,1
238867,and,0,0
238868,recruitment,0,0
238869,for,0,0
238870,a,0,0
238871,study,0,0
238872,of,0,0
238873,the,0,0
238874,effect,0,0
238875,of,0,0
238876,oral,0,0
238877,chelation,0,0
238878,on,0,0
238879,growth,0,0
238880,and,0,0
238881,development,0,0
238882,in,0,1
238883,toddlers,1,1
238884,.,1,1
238885,Exposure,0,0
238886,to,0,0
238887,lead,0,0
238888,impairs,0,0
238889,cognitive,0,0
238890,development,0,0
238891,in,0,1
238892,young,1,1
238893,children,1,1
238894,",",0,1
238895,but,0,0
238896,the,0,0
238897,benefits,0,0
238898,of,0,0
238899,lowering,0,0
238900,blood,0,0
238901,lead,0,0
238902,pharmacologically,0,1
238903,are,0,0
238904,not,0,0
238905,clear,0,0
238906,.,0,1
238907,This,0,0
238908,report,0,0
238909,describes,0,0
238910,the,0,0
238911,design,0,0
238912,",",0,0
238913,recruitment,0,0
238914,",",0,0
238915,enrolment,0,0
238916,and,0,1
238917,baseline,0,0
238918,results,0,0
238919,of,0,1
238920,the,0,0
238921,Treatment,0,0
238922,of,0,0
238923,Lead-Exposed,1,1
238924,Children,1,1
238925,(,0,1
238926,TLC,0,0
238927,),0,1
238928,trial,0,0
238929,",",0,0
238930,a,0,0
238931,randomised,0,0
238932,",",0,0
238933,multicentre,0,0
238934,",",0,0
238935,placebo-controlled,0,0
238936,",",0,0
238937,double-blind,0,0
238938,clinical,0,0
238939,trial,0,1
238940,of,0,0
238941,the,0,0
238942,effects,0,0
238943,of,0,0
238944,treating,0,1
238945,lead-exposed,1,1
238946,children,1,1
238947,with,0,1
238948,succimer,0,0
238949,",",0,0
238950,a,0,0
238951,drug,0,0
238952,that,0,0
238953,enhances,0,0
238954,urinary,0,0
238955,excretion,0,0
238956,of,0,0
238957,lead,0,0
238958,",",0,0
238959,on,0,0
238960,cognitive,0,0
238961,",",0,1
238962,behavioural,0,0
238963,and,0,0
238964,physical,0,1
238965,development,0,0
238966,.,0,1
238967,TLC,0,0
238968,clinical,0,0
238969,sites,0,1
238970,were,0,1
238971,in,0,1
238972,Baltimore,1,1
238973,",",1,1
238974,Cincinnati,1,1
238975,and,1,0
238976,Columbus,1,1
238977,",",1,1
238978,Newark,1,1
238979,and,1,1
238980,Philadelphia,1,1
238981,.,1,1
238982,Children,1,1
238983,were,1,0
238984,eligible,1,1
238985,for,1,0
238986,TLC,1,1
238987,if,1,0
238988,they,1,0
238989,were,1,1
238990,between,1,0
238991,12,1,1
238992,and,1,1
238993,33,1,1
238994,months,1,0
238995,of,1,1
238996,age,1,1
238997,",",1,0
238998,had,1,1
238999,a,1,0
239000,confirmed,1,0
239001,blood,1,0
239002,lead,1,0
239003,concentration,1,0
239004,between,1,0
239005,20,1,1
239006,and,1,1
239007,44,1,1
239008,micrograms/dL,1,1
239009,and,1,0
239010,lived,1,1
239011,in,1,0
239012,a,1,1
239013,residence,1,0
239014,suitable,1,0
239015,for,1,1
239016,lead,1,0
239017,dust,1,1
239018,reduction,1,0
239019,.,1,1
239020,Randomised,0,0
239021,children,1,1
239022,received,0,1
239023,up,0,1
239024,to,0,1
239025,three,0,1
239026,26-day,0,1
239027,courses,0,0
239028,of,0,1
239029,succimer,0,0
239030,or,0,1
239031,placebo,0,0
239032,",",0,0
239033,and,0,0
239034,were,0,0
239035,then,0,0
239036,followed,0,0
239037,for,0,0
239038,3,0,1
239039,years,0,1
239040,.,0,1
239041,The,0,0
239042,study,0,0
239043,can,0,0
239044,detect,0,0
239045,a,0,0
239046,three-point,0,0
239047,difference,0,0
239048,in,0,1
239049,full-scale,0,1
239050,IQ,0,1
239051,at,0,1
239052,3-year,0,1
239053,follow-up,0,1
239054,.,0,1
239055,Statistical,0,0
239056,power,0,0
239057,for,0,0
239058,the,0,0
239059,other,0,0
239060,end,0,0
239061,points,0,0
239062,is,0,0
239063,more,0,0
239064,difficult,0,0
239065,to,0,0
239066,estimate,0,0
239067,.,0,0
239068,A,1,0
239069,total,1,1
239070,of,1,0
239071,1854,1,1
239072,children,1,1
239073,were,1,1
239074,evaluated,1,0
239075,and,1,1
239076,780,1,1
239077,children,1,1
239078,were,1,1
239079,randomised,1,1
239080,between,1,0
239081,August,1,1
239082,1994,1,1
239083,and,1,1
239084,January,1,1
239085,1997,1,1
239086,.,1,1
239087,The,1,0
239088,mean,1,0
239089,age,1,1
239090,of,1,1
239091,randomised,1,1
239092,children,1,1
239093,was,1,1
239094,24,1,1
239095,months,1,0
239096,and,1,1
239097,mean,1,1
239098,blood,1,0
239099,lead,1,0
239100,level,1,0
239101,26,1,1
239102,micrograms/dL,1,1
239103,.,1,1
239104,Three-quarters,1,0
239105,were,1,1
239106,African-American,1,1
239107,.,1,1
239108,Most,1,0
239109,children,1,1
239110,had,1,1
239111,poor,1,1
239112,",",1,1
239113,single,1,1
239114,mothers,1,1
239115,who,1,1
239116,had,1,1
239117,completed,1,1
239118,12,1,0
239119,or,1,1
239120,fewer,1,0
239121,years,1,1
239122,of,1,0
239123,school,1,1
239124,and,1,1
239125,who,1,1
239126,lived,1,1
239127,in,1,1
239128,older,1,1
239129,",",1,0
239130,poorly,1,0
239131,maintained,1,0
239132,residences,1,1
239133,.,1,1
239134,Comparison,0,0
239135,of,0,0
239136,prostate-specific,0,1
239137,antigen,0,0
239138,corrected,0,0
239139,for,0,0
239140,total,0,1
239141,prostate,0,1
239142,volume,0,0
239143,and,0,0
239144,transition,0,1
239145,zone,0,1
239146,volume,0,0
239147,in,0,0
239148,a,0,1
239149,population-based,1,1
239150,screening,1,1
239151,study,1,1
239152,.,1,1
239153,OBJECTIVES,0,0
239154,To,0,0
239155,compare,0,0
239156,the,0,0
239157,discriminatory,0,0
239158,potential,0,0
239159,between,0,0
239160,prostate,1,1
239161,cancer,1,1
239162,and,1,1
239163,benign,1,1
239164,conditions,1,1
239165,of,1,1
239166,the,1,0
239167,prostate,1,1
239168,in,0,0
239169,a,0,1
239170,population-based,0,1
239171,screening,0,1
239172,study,0,0
239173,",",0,0
239174,of,0,0
239175,serum,0,0
239176,prostate-specific,0,1
239177,antigen,0,1
239178,levels,0,0
239179,(,0,1
239180,PSA,0,1
239181,),0,1
239182,and,0,1
239183,PSA,0,1
239184,corrected,0,0
239185,for,0,0
239186,both,0,0
239187,the,0,0
239188,total,0,1
239189,prostate,0,1
239190,volume,0,0
239191,(,0,1
239192,PSA-D,0,1
239193,),0,1
239194,and,0,0
239195,the,0,0
239196,transition,0,1
239197,zone,0,1
239198,volume,0,0
239199,(,0,1
239200,PSA-T,0,1
239201,),0,1
239202,.,0,1
239203,METHODS,0,0
239204,In,0,0
239205,a,0,1
239206,randomized,0,1
239207,population-based,0,1
239208,screening,0,1
239209,study,0,1
239210,(,1,1
239211,Rotterdam,1,1
239212,section,1,1
239213,of,1,0
239214,the,1,0
239215,European,1,1
239216,Randomized,1,0
239217,Study,1,1
239218,of,1,0
239219,Screening,1,1
239220,for,1,1
239221,Prostate,1,1
239222,Cancer,1,1
239223,),1,0
239224,",",0,0
239225,in,0,0
239226,which,0,1
239227,"10,865",1,1
239228,men,1,1
239229,have,1,1
239230,been,1,0
239231,screened,1,1
239232,",",0,0
239233,the,0,0
239234,biopsy,1,1
239235,results,1,0
239236,of,1,1
239237,1202,1,1
239238,men,1,1
239239,with,1,1
239240,PSA,1,1
239241,levels,1,1
239242,of,1,1
239243,4,1,1
239244,ng/mL,1,1
239245,or,1,1
239246,more,1,0
239247,were,0,1
239248,evaluated,0,0
239249,.,0,1
239250,Planimetric,0,0
239251,and,0,0
239252,prolate,0,0
239253,ellipsoid,0,0
239254,volumes,0,0
239255,of,0,1
239256,the,0,1
239257,total,0,1
239258,prostate,0,1
239259,as,0,0
239260,well,0,0
239261,as,0,0
239262,of,0,0
239263,the,0,0
239264,transition,0,1
239265,zone,0,1
239266,were,0,1
239267,measured,0,0
239268,.,0,1
239269,The,0,0
239270,measured,0,0
239271,volumes,0,0
239272,were,0,1
239273,compared,0,0
239274,with,0,1
239275,the,0,0
239276,volumes,0,0
239277,of,0,1
239278,57,0,1
239279,radical,0,1
239280,prostatectomy,0,1
239281,specimens,0,1
239282,through,0,1
239283,Spearman,0,0
239284,'s,0,1
239285,rank,0,0
239286,correlation,0,0
239287,coefficient,0,0
239288,and,0,1
239289,agreement,0,1
239290,tests,0,0
239291,.,0,1
239292,A,0,0
239293,receiver,0,0
239294,operating,0,0
239295,characteristic,0,0
239296,(,0,1
239297,ROC,0,1
239298,),0,1
239299,curve,0,0
239300,analysis,0,0
239301,was,0,0
239302,done,0,0
239303,of,0,0
239304,sensitivity,0,0
239305,and,0,0
239306,specificity,0,0
239307,of,0,0
239308,biopsy,0,1
239309,indications,0,1
239310,through,0,1
239311,PSA,0,1
239312,and,0,1
239313,PSA,0,1
239314,corrected,0,0
239315,for,0,0
239316,the,0,0
239317,volumes,0,0
239318,measured,0,0
239319,with,0,1
239320,transrectal,0,1
239321,ultrasound,0,1
239322,.,0,1
239323,RESULTS,0,0
239324,In,0,0
239325,the,0,1
239326,1202,1,1
239327,men,1,1
239328,studied,1,1
239329,",",1,1
239330,361,1,1
239331,cases,1,1
239332,of,1,1
239333,prostate,1,1
239334,cancer,1,1
239335,were,0,1
239336,diagnosed,0,1
239337,.,0,1
239338,Both,0,0
239339,PSA-D,0,0
239340,and,0,0
239341,PSA-T,0,1
239342,showed,0,0
239343,a,0,0
239344,significantly,0,0
239345,higher,0,0
239346,area,0,0
239347,under,0,0
239348,the,0,0
239349,ROC,0,1
239350,curve,0,0
239351,(,0,1
239352,0.77,0,0
239353,and,0,1
239354,0.79,0,0
239355,",",0,0
239356,respectively,0,0
239357,),0,0
239358,than,0,0
239359,PSA,0,1
239360,alone,0,1
239361,(,0,1
239362,area,0,0
239363,0.65,0,0
239364,),0,0
239365,.,0,0
239366,There,0,0
239367,was,0,0
239368,no,0,0
239369,significant,0,0
239370,difference,0,0
239371,between,0,0
239372,PSA-D,0,1
239373,and,0,1
239374,PSA-T,0,1
239375,.,0,1
239376,The,0,0
239377,use,0,0
239378,of,0,0
239379,a,0,1
239380,PSA-D,0,1
239381,threshold,0,0
239382,value,0,0
239383,of,0,1
239384,0,0,0
239385,.,0,1
239386,10,0,0
239387,ng/mL/cc,0,0
239388,would,0,0
239389,have,0,0
239390,avoided,0,0
239391,28,0,1
239392,%,0,0
239393,of,0,1
239394,biopsies,0,1
239395,at,0,1
239396,the,0,0
239397,cost,0,0
239398,of,0,0
239399,10,0,1
239400,%,0,0
239401,of,0,1
239402,detectable,0,1
239403,cancers,0,1
239404,.,0,1
239405,A,0,0
239406,PSA-D,0,0
239407,threshold,0,0
239408,of,0,1
239409,0.15,0,0
239410,ng/mL/cc,0,1
239411,would,0,0
239412,have,0,1
239413,avoided,0,0
239414,73.8,0,0
239415,%,0,0
239416,of,0,1
239417,biopsies,0,1
239418,at,0,1
239419,the,0,0
239420,cost,0,0
239421,of,0,0
239422,not,0,0
239423,diagnosing,0,0
239424,43.8,0,0
239425,%,0,0
239426,of,0,1
239427,detectable,0,1
239428,cancers,0,1
239429,.,0,1
239430,CONCLUSIONS,0,0
239431,The,0,0
239432,planimetrically,0,0
239433,obtained,0,0
239434,prostate,0,1
239435,volume,0,0
239436,showed,0,0
239437,a,0,0
239438,more,0,0
239439,favorable,0,0
239440,agreement,0,0
239441,with,0,1
239442,the,0,0
239443,radical,0,1
239444,prostatectomy,0,1
239445,volume,0,0
239446,than,0,0
239447,the,0,0
239448,prolate,0,0
239449,ellipsoid,0,0
239450,volume,0,0
239451,.,0,1
239452,The,0,0
239453,discriminatory,0,0
239454,potential,0,0
239455,of,0,0
239456,the,0,0
239457,corrected,0,0
239458,PSA,0,0
239459,value,0,0
239460,is,0,0
239461,better,0,0
239462,at,0,0
239463,predicting,0,0
239464,the,0,0
239465,results,0,0
239466,of,0,0
239467,needle,0,1
239468,biopsy,0,1
239469,of,0,0
239470,the,0,0
239471,prostate,0,1
239472,when,0,0
239473,compared,0,0
239474,with,0,1
239475,PSA,0,1
239476,alone,0,1
239477,.,0,1
239478,The,0,0
239479,use,0,0
239480,of,0,0
239481,the,0,0
239482,transition,0,1
239483,zone,0,1
239484,volume,0,0
239485,for,0,0
239486,this,0,0
239487,correction,0,1
239488,results,0,0
239489,in,0,0
239490,a,0,1
239491,higher,0,0
239492,discriminatory,0,0
239493,potential,0,0
239494,when,0,0
239495,compared,0,0
239496,to,0,0
239497,the,0,0
239498,use,0,0
239499,of,0,0
239500,the,0,0
239501,total,0,1
239502,prostate,0,1
239503,volume,0,0
239504,;,0,0
239505,however,0,0
239506,",",0,0
239507,the,0,0
239508,observed,0,0
239509,difference,0,0
239510,was,0,0
239511,not,0,0
239512,statistically,0,0
239513,significant,0,0
239514,.,0,1
239515,Postoperative,0,1
239516,injection,0,0
239517,of,0,0
239518,phenylbutazone,0,0
239519,does,0,0
239520,not,0,0
239521,influence,0,0
239522,fibrinolytic,0,0
239523,shutdown,0,1
239524,.,0,1
239525,Twenty-nine,1,1
239526,patients,1,1
239527,undergoing,1,1
239528,cholecystectomy,1,1
239529,because,1,1
239530,of,1,0
239531,chronic,1,1
239532,calculous,1,1
239533,cholecystitis,1,1
239534,were,1,1
239535,randomised,1,0
239536,to,1,0
239537,receive,1,1
239538,phenylbutazone,1,0
239539,10,1,1
239540,mg/kg,1,0
239541,intramuscularly,1,1
239542,or,1,1
239543,a,1,0
239544,control,1,0
239545,injection,1,0
239546,(,0,1
239547,vehicle-containing,0,0
239548,local,0,0
239549,anaesthetic,0,1
239550,),0,0
239551,immediately,0,0
239552,after,0,0
239553,completion,0,0
239554,of,0,0
239555,surgery,0,1
239556,.,0,1
239557,Fibrinogen,0,0
239558,and,0,0
239559,plasminogen,0,1
239560,concentrations,0,0
239561,in,0,1
239562,plasma,0,0
239563,",",0,0
239564,plasminogen,0,0
239565,activator,0,0
239566,inhibitor,0,0
239567,activity,0,0
239568,in,0,0
239569,plasma,0,0
239570,and,0,1
239571,fibrinolytic,0,0
239572,activity,0,0
239573,in,0,1
239574,concentrated,0,1
239575,euglobulins,0,0
239576,were,0,1
239577,determined,0,0
239578,before,0,0
239579,surgery,0,1
239580,and,0,0
239581,on,0,0
239582,the,0,0
239583,first,0,0
239584,",",0,0
239585,third,0,1
239586,and,0,1
239587,seventh,0,1
239588,postoperative,0,1
239589,days,0,1
239590,.,0,1
239591,Phenylbutazone,0,0
239592,delayed,0,0
239593,the,0,0
239594,postoperative,0,0
239595,rise,0,0
239596,of,0,0
239597,fibrinogen,0,0
239598,concentration,0,0
239599,and,0,0
239600,reduced,0,0
239601,the,0,0
239602,plasminogen,0,0
239603,level,0,0
239604,on,0,0
239605,the,0,0
239606,first,0,0
239607,day,0,0
239608,after,0,1
239609,surgery,0,1
239610,.,0,1
239611,Fibrinolytic,0,0
239612,activity,0,0
239613,in,0,1
239614,euglobulins,0,0
239615,was,0,0
239616,decreased,0,0
239617,after,0,0
239618,the,0,0
239619,operation,0,1
239620,in,0,0
239621,both,0,0
239622,groups,0,0
239623,.,0,1
239624,The,0,0
239625,great,0,0
239626,dispersion,0,0
239627,of,0,0
239628,the,0,0
239629,results,0,0
239630,of,0,0
239631,plasminogen,0,1
239632,activator,0,0
239633,inhibitor,0,0
239634,activity,0,0
239635,was,0,0
239636,the,0,0
239637,plausible,0,0
239638,cause,0,0
239639,of,0,0
239640,the,0,0
239641,lack,0,0
239642,of,0,0
239643,any,0,0
239644,significant,0,0
239645,difference,0,0
239646,in,0,0
239647,this,0,0
239648,variable,0,0
239649,.,0,1
239650,The,0,0
239651,postoperative,0,0
239652,fibrinolytic,0,0
239653,shutdown,0,1
239654,",",0,0
239655,reflected,0,0
239656,by,0,0
239657,the,0,0
239658,decrease,0,0
239659,of,0,0
239660,fibrinolytic,0,0
239661,activity,0,0
239662,",",0,0
239663,was,0,0
239664,unaffected,0,0
239665,by,0,0
239666,phenylbutazone,0,0
239667,.,0,1
239668,It,0,0
239669,can,0,0
239670,be,0,0
239671,speculated,0,0
239672,",",0,0
239673,however,0,0
239674,",",0,0
239675,that,0,0
239676,the,0,0
239677,decline,0,0
239678,of,0,0
239679,plasminogen,0,1
239680,concentration,0,0
239681,after,0,0
239682,surgery,0,1
239683,in,0,1
239684,patients,0,1
239685,receiving,0,1
239686,this,0,0
239687,drug,0,0
239688,was,0,0
239689,the,0,0
239690,result,0,0
239691,of,0,0
239692,its,0,0
239693,stimulatory,0,0
239694,influence,0,0
239695,on,0,0
239696,the,0,0
239697,conversion,0,0
239698,of,0,0
239699,plasminogen,0,1
239700,into,0,1
239701,plasmin,0,0
239702,.,0,1
239703,Behavioral,0,1
239704,changes,0,0
239705,in,0,1
239706,autistic,1,1
239707,individuals,1,1
239708,as,0,0
239709,a,0,1
239710,result,0,0
239711,of,0,0
239712,wearing,0,1
239713,ambient,0,1
239714,transitional,0,1
239715,prism,0,1
239716,lenses,0,1
239717,.,0,1
239718,A,0,0
239719,double-blind,0,0
239720,crossover,0,0
239721,design,0,1
239722,was,0,0
239723,used,0,0
239724,to,0,0
239725,assess,0,0
239726,the,0,0
239727,efficacy,0,0
239728,of,0,0
239729,wearing,0,1
239730,ambient,0,1
239731,lenses,0,1
239732,to,0,1
239733,reduce,0,0
239734,the,0,0
239735,behavioral,0,0
239736,symptoms,0,0
239737,of,0,1
239738,autism,0,1
239739,.,0,1
239740,Eighteen,1,1
239741,autistic,1,1
239742,individuals,1,1
239743,",",1,1
239744,ranging,1,1
239745,in,1,0
239746,age,1,1
239747,from,1,1
239748,7,1,1
239749,to,1,1
239750,18,1,1
239751,years,1,1
239752,",",0,1
239753,participated,0,1
239754,in,0,0
239755,the,0,0
239756,study,0,1
239757,.,0,1
239758,Behavior,0,0
239759,",",0,0
239760,attention,0,0
239761,",",0,0
239762,and,0,0
239763,orientation,0,0
239764,were,0,0
239765,evaluated,0,0
239766,at,0,1
239767,1,0,1
239768,1/2,0,1
239769,months,0,1
239770,",",0,1
239771,2,0,1
239772,months,0,0
239773,",",0,1
239774,3,0,1
239775,months,0,0
239776,",",0,1
239777,and,0,1
239778,4,0,0
239779,months,0,1
239780,.,0,1
239781,Compared,0,0
239782,to,0,0
239783,the,0,0
239784,placebo,0,0
239785,condition,0,0
239786,",",0,0
239787,the,0,0
239788,results,0,0
239789,showed,0,0
239790,a,0,1
239791,decrease,0,0
239792,in,0,0
239793,behavior,0,1
239794,problems,0,1
239795,at,0,1
239796,the,0,1
239797,1,0,1
239798,1/2,0,0
239799,and,0,1
239800,2,0,1
239801,month,0,0
239802,assessment,0,0
239803,periods,0,0
239804,and,0,1
239805,a,0,1
239806,slight,0,0
239807,loss,0,0
239808,of,0,0
239809,these,0,0
239810,benefits,0,0
239811,at,0,1
239812,the,0,1
239813,3,0,1
239814,and,0,1
239815,4,0,0
239816,month,0,0
239817,assessment,0,0
239818,periods,0,0
239819,.,0,1
239820,These,0,1
239821,findings,0,0
239822,support,0,0
239823,the,0,0
239824,prediction,0,0
239825,that,0,0
239826,ambient,0,1
239827,lenses,0,1
239828,",",0,1
239829,worn,0,0
239830,without,0,0
239831,engaging,0,1
239832,in,0,1
239833,visual-motor,0,1
239834,exercises,0,0
239835,",",0,1
239836,have,0,0
239837,positive,0,0
239838,effects,0,0
239839,on,0,1
239840,autistic,1,1
239841,individuals,1,1
239842,.,1,1
239843,Epileptogenic,0,1
239844,activity,0,0
239845,of,0,0
239846,folic,0,0
239847,acid,0,0
239848,after,0,1
239849,drug,0,1
239850,induces,0,0
239851,SLE,0,1
239852,(,0,1
239853,folic,0,0
239854,acid,0,0
239855,and,0,1
239856,epilepsy,0,1
239857,),0,1
239858,OBJECTIVE,0,0
239859,To,0,0
239860,study,0,0
239861,the,0,0
239862,effect,0,0
239863,of,0,0
239864,folic,0,0
239865,acid-containing,0,1
239866,multivitamin,0,0
239867,supplementation,0,0
239868,in,0,1
239869,epileptic,1,1
239870,women,1,1
239871,before,1,1
239872,and,1,1
239873,during,1,0
239874,pregnancy,1,1
239875,in,0,0
239876,order,0,0
239877,to,0,0
239878,determine,0,0
239879,the,0,0
239880,rate,0,0
239881,of,0,0
239882,structural,0,0
239883,birth,0,1
239884,defects,0,1
239885,and,0,1
239886,epilepsy-related,0,1
239887,side,0,0
239888,effects,0,0
239889,.,0,1
239890,STUDY,0,0
239891,DESIGN,0,1
239892,First,0,1
239893,a,0,1
239894,randomised,0,0
239895,trial,0,0
239896,",",0,0
239897,later,0,1
239898,periconception,0,0
239899,care,0,1
239900,including,0,0
239901,in,0,1
239902,total,0,1
239903,12225,1,1
239904,females,1,1
239905,.,1,1
239906,RESULTS,0,0
239907,Of,0,1
239908,60,1,1
239909,epileptic,1,1
239910,women,1,1
239911,with,1,1
239912,periconceptional,1,1
239913,folic,1,0
239914,acid,1,0
239915,(,0,1
239916,0.8,0,0
239917,mg,0,1
239918,),0,1
239919,-containing,0,0
239920,multivitamin,0,0
239921,supplementation,0,0
239922,",",0,0
239923,no,0,0
239924,one,0,0
239925,developed,0,1
239926,epilepsy-related,0,1
239927,side,0,0
239928,effects,0,0
239929,during,0,0
239930,the,0,0
239931,periconception,0,0
239932,period,0,0
239933,.,0,1
239934,One,0,1
239935,epileptic,0,1
239936,woman,0,1
239937,delivered,0,1
239938,a,0,0
239939,newborn,0,1
239940,with,0,1
239941,cleft,0,1
239942,lip,0,1
239943,and,0,0
239944,palate,0,1
239945,.,0,1
239946,Another,0,1
239947,patient,0,0
239948,exhibited,0,0
239949,with,0,1
239950,a,0,0
239951,cluster,0,1
239952,of,0,0
239953,seizures,0,1
239954,after,0,1
239955,the,0,0
239956,periconception,0,0
239957,period,0,0
239958,using,0,0
239959,another,0,1
239960,multivitamin,0,0
239961,.,0,0
239962,This,0,0
239963,22-year-old,0,1
239964,epileptic,0,1
239965,woman,0,1
239966,was,0,0
239967,treated,0,1
239968,continuously,0,0
239969,by,0,0
239970,carbamazepine,0,0
239971,and,0,0
239972,a,0,0
239973,folic,0,0
239974,acid,0,0
239975,(,0,1
239976,1,0,1
239977,mg,0,1
239978,),0,1
239979,-containing,0,0
239980,multivitamin,0,0
239981,from,0,1
239982,the,0,0
239983,20th,0,1
239984,week,0,0
239985,of,0,0
239986,gestation,0,1
239987,.,0,1
239988,She,0,0
239989,developed,0,0
239990,status,0,1
239991,epilepticus,0,1
239992,and,0,0
239993,later,0,1
239994,symptoms,0,0
239995,of,0,0
239996,systemic,0,1
239997,lupus,0,1
239998,erythematodes,0,1
239999,.,0,1
240000,Her,0,0
240001,pregnancy,0,0
240002,ended,0,1
240003,with,0,1
240004,stillbirth,0,1
240005,.,0,1
240006,CONCLUSIONS,0,0
240007,The,0,0
240008,epileptic,0,1
240009,pregnant,0,1
240010,patient,0,1
240011,'s,0,1
240012,autoimmune,0,1
240013,disease,0,1
240014,(,0,1
240015,probably,0,0
240016,drug-induced,0,0
240017,lupus,0,1
240018,),0,1
240019,could,0,0
240020,damage,0,0
240021,the,0,0
240022,blood-brain,0,0
240023,barrier,0,0
240024,",",0,0
240025,therefore,0,0
240026,the,0,0
240027,therapeutic,0,0
240028,dose,0,0
240029,(,0,1
240030,>,0,1
240031,or,0,1
240032,=1,0,1
240033,mg,0,0
240034,),0,0
240035,of,0,0
240036,folic,0,0
240037,acid,0,0
240038,triggered,0,0
240039,a,0,0
240040,cluster,0,1
240041,of,0,0
240042,seizures,0,1
240043,.,0,1
240044,Physiological,0,0
240045,dose,0,0
240046,(,0,1
240047,<,0,0
240048,1,0,1
240049,mg,0,1
240050,),0,1
240051,of,0,1
240052,folic,0,0
240053,acid,0,0
240054,both,0,0
240055,in,0,0
240056,healthy,0,1
240057,and,0,1
240058,60,0,1
240059,epileptic,0,1
240060,women,0,1
240061,",",0,0
240062,all,0,0
240063,without,0,0
240064,any,0,0
240065,autoimmune,0,1
240066,disease,0,1
240067,",",0,0
240068,did,0,0
240069,not,0,0
240070,increase,0,0
240071,the,0,0
240072,risk,0,0
240073,for,0,0
240074,epileptic,0,1
240075,seizures,0,1
240076,.,0,1
240077,Preventing,0,0
240078,disability,0,1
240079,and,0,1
240080,managing,0,0
240081,chronic,0,1
240082,illness,0,1
240083,in,0,1
240084,frail,1,1
240085,older,1,1
240086,adults,1,1
240087,:,1,1
240088,a,0,1
240089,randomized,0,1
240090,trial,0,0
240091,of,0,0
240092,a,0,1
240093,community-based,0,1
240094,partnership,0,1
240095,with,0,1
240096,primary,0,1
240097,care,0,1
240098,.,0,1
240099,BACKGROUND,0,0
240100,Effective,0,0
240101,new,0,1
240102,strategies,0,0
240103,that,0,0
240104,complement,0,0
240105,primary,0,0
240106,care,0,1
240107,are,0,0
240108,needed,0,0
240109,to,0,0
240110,reduce,0,0
240111,disability,0,1
240112,risks,0,0
240113,and,0,0
240114,improve,0,0
240115,self-management,0,0
240116,of,0,0
240117,chronic,0,1
240118,illness,0,1
240119,in,0,0
240120,frail,1,1
240121,older,1,1
240122,people,1,1
240123,living,1,1
240124,in,1,0
240125,the,1,0
240126,community,1,1
240127,.,1,1
240128,OBJECTIVE,0,0
240129,To,0,0
240130,evaluate,0,0
240131,the,0,0
240132,impact,0,0
240133,of,0,0
240134,a,0,0
240135,1-year,0,0
240136,",",0,0
240137,senior,0,1
240138,center-based,0,1
240139,chronic,0,1
240140,illness,0,1
240141,self-management,0,1
240142,and,0,0
240143,disability,0,1
240144,prevention,0,1
240145,program,0,1
240146,on,0,0
240147,health,0,1
240148,",",0,0
240149,functioning,0,0
240150,",",0,0
240151,and,0,0
240152,healthcare,0,1
240153,utilization,0,0
240154,in,0,0
240155,frail,0,1
240156,older,0,1
240157,adults,0,1
240158,.,0,1
240159,DESIGN,0,0
240160,A,0,0
240161,randomized,0,0
240162,controlled,0,0
240163,trial,0,1
240164,.,0,1
240165,SETTING,0,1
240166,A,0,1
240167,large,0,1
240168,senior,0,1
240169,center,0,1
240170,located,0,0
240171,in,0,0
240172,a,0,1
240173,northeast,0,1
240174,Seattle,1,1
240175,suburb,0,1
240176,.,0,1
240177,The,0,0
240178,trial,0,0
240179,was,0,0
240180,conducted,0,0
240181,in,0,0
240182,collaboration,0,1
240183,with,0,1
240184,primary,0,1
240185,care,0,1
240186,providers,0,1
240187,of,0,1
240188,two,0,1
240189,large,0,1
240190,managed,0,1
240191,care,0,1
240192,organizations,0,1
240193,.,0,1
240194,PARTICIPANTS,0,0
240195,A,0,0
240196,total,1,1
240197,of,1,0
240198,201,1,1
240199,chronically,1,1
240200,ill,1,1
240201,older,1,1
240202,adults,1,1
240203,seniors,1,1
240204,aged,1,1
240205,70,1,1
240206,and,1,1
240207,older,1,1
240208,recruited,1,1
240209,through,1,0
240210,medical,1,1
240211,practices,1,1
240212,.,1,1
240213,INTERVENTION,0,0
240214,A,0,0
240215,targeted,0,1
240216,",",0,1
240217,multi-component,0,0
240218,disability,0,1
240219,prevention,0,1
240220,and,0,1
240221,disease,0,1
240222,self-management,0,1
240223,program,0,1
240224,led,0,0
240225,by,0,0
240226,a,0,1
240227,geriatric,0,1
240228,nurse,0,1
240229,practitioner,0,1
240230,(,0,1
240231,GNP,0,1
240232,),0,1
240233,.,0,1
240234,MEASUREMENTS,0,0
240235,Self-reported,0,0
240236,Physical,0,0
240237,function,0,0
240238,",",0,0
240239,physical,0,1
240240,performance,0,0
240241,tests,0,0
240242,",",0,1
240243,health,0,1
240244,care,0,1
240245,utilization,0,0
240246,",",0,0
240247,and,0,0
240248,health,0,1
240249,behaviors,0,0
240250,.,0,1
240251,RESULTS,0,0
240252,Each,0,1
240253,of,0,0
240254,101,1,1
240255,intervention,1,1
240256,participants,1,1
240257,met,0,1
240258,with,0,1
240259,the,0,0
240260,GNP,0,1
240261,from,0,1
240262,1,0,1
240263,to,0,1
240264,8,0,1
240265,times,0,0
240266,(,0,1
240267,median,0,1
240268,=,0,1
240269,3,0,1
240270,),0,1
240271,during,0,0
240272,the,0,0
240273,study,0,1
240274,year,0,0
240275,.,0,1
240276,The,0,0
240277,intervention,0,0
240278,group,0,0
240279,showed,0,0
240280,less,0,0
240281,decline,0,0
240282,in,0,0
240283,function,0,0
240284,",",0,0
240285,as,0,0
240286,measured,0,0
240287,by,0,0
240288,disability,0,1
240289,days,0,0
240290,and,0,1
240291,lower,0,1
240292,scores,0,0
240293,on,0,0
240294,the,0,1
240295,Health,0,0
240296,Assessment,0,0
240297,Questionnaire,0,0
240298,.,0,1
240299,Other,0,0
240300,measures,0,0
240301,of,0,1
240302,function,0,0
240303,",",0,0
240304,including,0,0
240305,the,0,0
240306,SF-36,0,0
240307,and,0,0
240308,a,0,0
240309,battery,0,1
240310,of,0,0
240311,physical,0,1
240312,performance,0,0
240313,tests,0,0
240314,",",0,0
240315,did,0,0
240316,not,0,0
240317,change,0,0
240318,with,0,1
240319,the,0,0
240320,intervention,0,0
240321,.,0,0
240322,The,0,0
240323,number,0,0
240324,of,0,0
240325,hospitalized,0,1
240326,participants,0,1
240327,increased,0,0
240328,by,0,1
240329,69,0,1
240330,%,0,0
240331,among,0,1
240332,the,0,0
240333,controls,0,1
240334,and,0,0
240335,decreased,0,0
240336,by,0,0
240337,38,0,1
240338,%,0,0
240339,in,0,0
240340,the,0,0
240341,intervention,0,0
240342,group,0,0
240343,(,0,1
240344,P,0,0
240345,=,0,1
240346,.083,0,0
240347,),0,1
240348,.,0,1
240349,The,0,0
240350,total,0,1
240351,number,0,0
240352,of,0,0
240353,inpatient,0,1
240354,hospital,0,1
240355,days,0,0
240356,during,0,0
240357,the,0,0
240358,study,0,0
240359,year,0,0
240360,was,0,0
240361,significantly,0,0
240362,less,0,0
240363,in,0,0
240364,the,0,0
240365,intervention,0,0
240366,group,0,0
240367,compared,0,0
240368,with,0,1
240369,controls,0,1
240370,(,0,1
240371,total,0,1
240372,days,0,0
240373,=,0,1
240374,33,0,1
240375,vs,0,0
240376,116,0,1
240377,",",0,1
240378,P,0,0
240379,=,0,1
240380,.049,0,0
240381,),0,1
240382,.,0,1
240383,The,0,0
240384,intervention,0,0
240385,led,0,0
240386,to,0,0
240387,significantly,0,0
240388,higher,0,0
240389,levels,0,0
240390,of,0,0
240391,physical,0,1
240392,activity,0,0
240393,and,0,1
240394,senior,0,1
240395,center,0,1
240396,participation,0,1
240397,and,0,1
240398,significant,0,0
240399,reductions,0,0
240400,in,0,1
240401,the,0,0
240402,use,0,0
240403,of,0,0
240404,psychoactive,0,1
240405,medications,0,1
240406,.,0,1
240407,CONCLUSIONS,0,0
240408,This,0,0
240409,project,0,0
240410,provides,0,0
240411,evidence,0,0
240412,that,0,0
240413,a,0,1
240414,community-based,0,1
240415,collaboration,0,1
240416,with,0,1
240417,primary,0,1
240418,care,0,1
240419,providers,0,1
240420,can,0,0
240421,improve,0,0
240422,function,0,0
240423,and,0,0
240424,reduce,0,0
240425,inpatient,0,1
240426,utilization,0,0
240427,in,0,0
240428,chronically,1,1
240429,ill,1,1
240430,older,1,1
240431,adults,1,1
240432,.,1,1
240433,Linking,0,0
240434,organized,0,0
240435,medical,0,1
240436,care,0,1
240437,with,0,1
240438,complementary,0,1
240439,community-based,0,1
240440,interventions,0,0
240441,may,0,0
240442,be,0,0
240443,a,0,0
240444,promising,0,0
240445,direction,0,0
240446,for,0,0
240447,research,0,1
240448,and,0,1
240449,practice,0,0
240450,.,0,1
240451,Acute,0,1
240452,effects,0,0
240453,of,0,1
240454,caffeine,0,1
240455,ingestion,0,1
240456,on,0,0
240457,signal-averaged,0,1
240458,electrocardiograms,0,1
240459,.,0,1
240460,BACKGROUND,0,0
240461,Although,0,0
240462,moderate,0,1
240463,caffeine,0,0
240464,ingestion,0,0
240465,has,0,0
240466,not,0,0
240467,been,0,0
240468,shown,0,0
240469,to,0,0
240470,be,0,0
240471,arrhythmogenic,0,1
240472,",",0,0
240473,caffeine,0,0
240474,toxicity,0,0
240475,can,0,0
240476,cause,0,0
240477,severe,0,1
240478,cardiac,0,1
240479,arrhythmias,0,1
240480,",",0,0
240481,including,0,0
240482,atrial,0,1
240483,fibrillation,0,1
240484,and,0,1
240485,ventricular,0,1
240486,tachycardia,0,1
240487,.,0,1
240488,Atrial,0,0
240489,fibrillation,0,1
240490,and,0,1
240491,ventricular,0,0
240492,tachycardia,0,1
240493,have,0,0
240494,been,0,0
240495,associated,0,0
240496,with,0,1
240497,prolongation,0,0
240498,of,0,1
240499,P-wave,0,0
240500,and,0,1
240501,QRS,0,0
240502,complex,0,1
240503,durations,0,0
240504,on,0,1
240505,signal-averaged,0,1
240506,electrocardiograms,0,1
240507,.,0,1
240508,This,0,0
240509,study,0,0
240510,investigated,0,0
240511,acute,0,1
240512,effects,0,0
240513,of,0,1
240514,caffeine,0,1
240515,ingestion,0,1
240516,on,0,0
240517,signal-averaged,0,1
240518,P-wave,0,0
240519,and,0,1
240520,QRS,0,0
240521,complexes,0,1
240522,.,0,1
240523,METHODS,0,0
240524,AND,0,0
240525,RESULTS,0,1
240526,Signal-averaged,0,1
240527,electrocardiograms,0,1
240528,were,0,1
240529,obtained,0,0
240530,from,0,1
240531,12,1,1
240532,normal,1,1
240533,subjects,1,1
240534,(,1,1
240535,6,1,1
240536,men,1,1
240537,",",1,1
240538,6,1,1
240539,women,1,1
240540,;,1,1
240541,ages,1,1
240542,21,1,1
240543,to,1,0
240544,26,1,1
240545,years,1,1
240546,),1,1
240547,before,1,1
240548,and,1,1
240549,after,1,0
240550,ingestion,1,0
240551,of,1,0
240552,caffeine,1,1
240553,(,0,1
240554,5,0,0
240555,mg/kg,0,0
240556,body,0,1
240557,weight,0,1
240558,),0,1
240559,or,0,1
240560,placebo,0,0
240561,in,0,0
240562,a,0,0
240563,randomized,0,1
240564,",",0,0
240565,double-blind,0,0
240566,",",0,0
240567,crossover,0,0
240568,fashion,0,0
240569,.,0,1
240570,Electrocardiograms,0,0
240571,for,0,0
240572,signal,0,1
240573,averaging,0,1
240574,were,0,1
240575,recorded,0,0
240576,from,0,1
240577,electrodes,0,0
240578,left,0,1
240579,in,0,1
240580,a,0,1
240581,constant,0,0
240582,location,0,1
240583,.,0,1
240584,After,0,0
240585,bandpass,0,0
240586,filtering,0,1
240587,(,0,1
240588,30,0,1
240589,to,0,1
240590,300,0,1
240591,Hz,0,1
240592,),0,1
240593,and,0,0
240594,amplification,0,0
240595,",",0,1
240596,signals,0,0
240597,were,0,1
240598,sampled,0,1
240599,over,0,0
240600,7.2,0,1
240601,minutes,0,0
240602,at,0,1
240603,2000,0,1
240604,Hz,0,1
240605,.,0,1
240606,Signal-averaged,0,0
240607,P-wave,0,0
240608,and,0,1
240609,QRS,0,0
240610,complex,0,1
240611,durations,0,0
240612,did,0,0
240613,not,0,0
240614,significantly,0,0
240615,change,0,0
240616,after,0,0
240617,placebo,0,0
240618,ingestion,0,0
240619,.,0,1
240620,After,0,0
240621,caffeine,0,0
240622,ingestion,0,1
240623,QRS,0,0
240624,duration,0,0
240625,prolonged,0,0
240626,in,0,0
240627,9,0,0
240628,of,0,1
240629,11,0,1
240630,subjects,0,1
240631,at,0,1
240632,90,0,1
240633,minutes,0,0
240634,(,0,1
240635,mean,0,1
240636,+/-,0,1
240637,SEM,0,1
240638,=,0,1
240639,0.8+/-0.3,0,0
240640,ms,0,1
240641,",",0,1
240642,P,0,0
240643,<,0,0
240644,.02,0,0
240645,),0,1
240646,and,0,1
240647,in,0,1
240648,8,0,1
240649,of,0,1
240650,9,0,1
240651,after,0,1
240652,3,0,1
240653,hours,0,0
240654,(,0,1
240655,1.1+/-0.2,0,1
240656,ms,0,1
240657,",",0,1
240658,P,0,0
240659,<,0,0
240660,.001,0,0
240661,),0,1
240662,.,0,1
240663,No,0,0
240664,significant,0,0
240665,change,0,0
240666,in,0,1
240667,P-wave,0,0
240668,duration,0,0
240669,or,0,1
240670,heart,0,1
240671,rate,0,0
240672,was,0,0
240673,found,0,0
240674,after,0,0
240675,caffeine,0,0
240676,ingestion,0,0
240677,at,0,0
240678,any,0,0
240679,test,0,0
240680,interval,0,0
240681,.,0,1
240682,Average,0,0
240683,caffeine,0,0
240684,level,0,0
240685,in,0,1
240686,saliva,0,1
240687,90,0,1
240688,minutes,0,0
240689,after,0,1
240690,ingestion,0,1
240691,was,0,0
240692,6.6+/-1.6,0,1
240693,(,0,1
240694,SD,0,1
240695,),0,1
240696,microg/dL,0,1
240697,.,0,1
240698,CONCLUSIONS,0,0
240699,Although,0,0
240700,probably,0,0
240701,not,0,0
240702,arrhythmogenic,0,1
240703,in,0,1
240704,normal,1,1
240705,subjects,1,1
240706,",",0,1
240707,moderate,0,1
240708,caffeine,0,0
240709,ingestion,0,0
240710,does,0,0
240711,produce,0,0
240712,a,0,0
240713,small,0,0
240714,but,0,0
240715,statistically,0,0
240716,significant,0,0
240717,prolongation,0,0
240718,of,0,0
240719,signal-averaged,0,1
240720,QRS,0,0
240721,complexes,0,1
240722,.,0,1
240723,Further,0,0
240724,prolongation,0,0
240725,caused,0,0
240726,by,0,0
240727,excessive,0,0
240728,caffeine,0,0
240729,intake,0,0
240730,may,0,0
240731,be,0,0
240732,a,0,0
240733,factor,0,0
240734,in,0,0
240735,the,0,0
240736,genesis,0,0
240737,of,0,0
240738,arrhythmias,0,1
240739,associated,0,0
240740,with,0,1
240741,caffeine,0,1
240742,toxicity,0,0
240743,.,0,1
240744,The,0,0
240745,SPEM,0,0
240746,(,0,1
240747,Studio,0,0
240748,Policentrico,0,1
240749,Elettrocateteri,0,1
240750,Membrane,0,1
240751,),0,1
240752,:,0,1
240753,a,0,0
240754,multicenter,0,0
240755,study,0,0
240756,on,0,0
240757,membrane,1,1
240758,leads,1,0
240759,.,1,1
240760,SPEM,0,0
240761,is,0,0
240762,a,0,0
240763,multicenter,1,0
240764,randomized,0,1
240765,double-blind,0,0
240766,study,0,1
240767,performed,0,0
240768,to,0,0
240769,test,0,0
240770,the,0,0
240771,acute,0,1
240772,and,0,0
240773,chronic,0,1
240774,electrophysiological,0,0
240775,behavior,0,1
240776,of,0,1
240777,three,0,1
240778,different,0,1
240779,ventricular,1,1
240780,leads,1,0
240781,:,1,1
240782,(,0,1
240783,1,0,1
240784,),0,1
240785,an,0,0
240786,ion,0,0
240787,exchange,0,0
240788,membrane,0,0
240789,with,0,1
240790,30-microgram,0,0
240791,dexamethasone,0,0
240792,elution,0,0
240793,in,0,0
240794,a,0,1
240795,contoured,0,0
240796,activated,0,0
240797,carbon,0,0
240798,tip,0,0
240799,lead,0,0
240800,(,0,1
240801,Membrane,0,1
240802,1400T,0,1
240803,",",0,1
240804,30,0,1
240805,patients,0,1
240806,),0,1
240807,;,0,1
240808,(,0,1
240809,2,0,1
240810,),0,1
240811,the,0,0
240812,same,0,0
240813,lead,0,0
240814,design,0,1
240815,without,0,1
240816,steroid,0,0
240817,(,0,1
240818,Membrane,0,1
240819,1401T,0,1
240820,",",0,1
240821,24,0,1
240822,patients,0,1
240823,),0,1
240824,;,0,1
240825,and,0,1
240826,(,0,1
240827,3,0,1
240828,),0,1
240829,the,0,0
240830,same,0,0
240831,lead,0,0
240832,design,0,1
240833,without,0,1
240834,steroid,0,0
240835,or,0,1
240836,membrane,0,0
240837,(,0,0
240838,control,0,1
240839,group,0,1
240840,",",0,1
240841,27,0,1
240842,patients,0,1
240843,),0,1
240844,.,0,1
240845,Twenty-three,1,1
240846,of,1,0
240847,the,1,1
240848,81,1,1
240849,patients,1,1
240850,were,1,1
240851,women,1,1
240852,;,1,1
240853,the,1,0
240854,mean,1,0
240855,age,1,1
240856,for,1,0
240857,all,1,1
240858,patients,1,1
240859,was,1,0
240860,74,1,1
240861,+/-,1,1
240862,10,1,1
240863,years,1,1
240864,.,1,1
240865,Parameters,0,0
240866,are,0,0
240867,calculated,0,0
240868,both,0,0
240869,in,0,0
240870,uni-,0,0
240871,and,0,1
240872,bipolar,0,1
240873,configuration,0,1
240874,at,0,1
240875,implant,0,1
240876,and,0,1
240877,at,0,0
240878,follow-up,0,0
240879,after,0,1
240880,1,0,1
240881,",",0,1
240882,5,0,0
240883,",",0,0
240884,15,0,1
240885,",",0,0
240886,30,0,1
240887,",",0,0
240888,90,0,1
240889,",",0,0
240890,180,0,1
240891,",",0,0
240892,and,0,1
240893,360,0,1
240894,days,0,0
240895,.,0,1
240896,Implant,0,0
240897,threshold,0,0
240898,(,0,1
240899,chronaxie,0,0
240900,=,0,1
240901,0.413,0,0
240902,+/-,0,0
240903,0.280,0,0
240904,ms,0,1
240905,",",0,0
240906,rheobase,0,0
240907,=,0,0
240908,0.264,0,0
240909,+/-,0,1
240910,0.099,0,0
240911,V,0,0
240912,),0,1
240913,",",0,0
240914,signal,0,0
240915,amplitude,0,0
240916,(,0,1
240917,13.45,0,0
240918,+/-,0,1
240919,5.87,0,0
240920,mV,0,1
240921,),0,1
240922,",",0,0
240923,and,0,0
240924,slew,0,1
240925,rate,0,0
240926,(,0,1
240927,2.05,0,0
240928,+/-,0,1
240929,1.38,0,0
240930,V/s,0,1
240931,),0,1
240932,reveal,0,0
240933,no,0,0
240934,significant,0,0
240935,differences,0,0
240936,.,0,1
240937,Pacing,0,0
240938,impedance,0,0
240939,values,0,0
240940,both,0,0
240941,at,0,0
240942,implant,0,0
240943,(,0,1
240944,unipolar,0,1
240945,571,0,1
240946,+/-,0,1
240947,165,0,1
240948,omega,0,1
240949,;,0,1
240950,bipolar,0,1
240951,605,0,1
240952,+/-,0,1
240953,123,0,1
240954,omega,0,1
240955,),0,1
240956,and,0,1
240957,at,0,1
240958,follow-ups,0,0
240959,(,0,1
240960,unipolar,0,1
240961,480,0,1
240962,+/-,0,1
240963,72,0,1
240964,omega,0,1
240965,;,0,1
240966,bipolar,0,1
240967,518,0,1
240968,+/-,0,1
240969,75,0,1
240970,omega,0,1
240971,),0,1
240972,are,0,0
240973,slightly,0,0
240974,lower,0,0
240975,in,0,0
240976,the,0,0
240977,unipolar,0,1
240978,configuration,0,1
240979,.,0,1
240980,At,0,0
240981,15,0,1
240982,and,0,1
240983,30-day,0,0
240984,follow-ups,0,0
240985,",",0,1
240986,control,0,1
240987,group,0,1
240988,and,0,0
240989,nonsteroid,0,0
240990,leads,0,0
240991,show,0,0
240992,a,0,0
240993,higher,0,0
240994,threshold,0,0
240995,value,0,0
240996,growth,0,0
240997,(,0,0
240998,in,0,0
240999,unipolar,0,1
241000,from,0,1
241001,0.16,0,0
241002,+/-,0,1
241003,0.11,0,0
241004,to,0,1
241005,1.19,0,0
241006,+/-,0,0
241007,0.85,0,0
241008,microJ,0,0
241009,;,0,1
241010,in,0,0
241011,bipolar,0,1
241012,from,0,1
241013,0.18,0,0
241014,+/-,0,1
241015,0.13,0,0
241016,to,0,1
241017,1.24,0,0
241018,+/-,0,0
241019,0.88,0,0
241020,microJ,0,0
241021,),0,1
241022,than,0,0
241023,the,0,0
241024,membrane,0,0
241025,steroid,0,0
241026,leads,0,0
241027,(,0,0
241028,in,0,0
241029,unipolar,0,1
241030,from,0,1
241031,0.13,0,0
241032,+/-,0,1
241033,0.11,0,0
241034,to,0,1
241035,0.70,0,0
241036,+/-,0,0
241037,0.39,0,0
241038,microJ,0,0
241039,;,0,1
241040,in,0,0
241041,bipolar,0,1
241042,from,0,1
241043,0.23,0,0
241044,+/-,0,1
241045,0.32,0,0
241046,to,0,1
241047,0.76,0,0
241048,+/-,0,0
241049,0.36,0,0
241050,microJ,0,1
241051,),0,1
241052,;,0,0
241053,the,0,0
241054,threshold,0,0
241055,of,0,0
241056,nonsteroid,0,0
241057,leads,0,0
241058,decreases,0,0
241059,after,0,1
241060,1-3,0,1
241061,months,0,1
241062,and,0,1
241063,it,0,0
241064,settles,0,0
241065,at,0,0
241066,the,0,0
241067,same,0,0
241068,threshold,0,0
241069,level,0,0
241070,of,0,0
241071,the,0,0
241072,leads,0,0
241073,with,0,1
241074,membrane,0,0
241075,and,0,1
241076,steroid,0,0
241077,(,0,1
241078,in,0,1
241079,unipolar,0,1
241080,0.60,0,0
241081,+/-,0,1
241082,0.33,0,0
241083,microJ,0,0
241084,;,0,1
241085,in,0,1
241086,bipolar,0,1
241087,0.55,0,0
241088,+/-,0,1
241089,0.26,0,0
241090,microJ,0,0
241091,),0,1
241092,",",0,0
241093,which,0,0
241094,has,0,0
241095,been,0,0
241096,stable,0,1
241097,since,0,0
241098,the,0,0
241099,first,0,0
241100,month,0,0
241101,.,0,1
241102,The,0,0
241103,ion,0,0
241104,exchange,0,0
241105,membrane,0,0
241106,is,0,0
241107,effective,0,0
241108,in,0,0
241109,reducing,0,0
241110,the,0,0
241111,chronic,0,1
241112,pacing,0,0
241113,threshold,0,0
241114,like,0,0
241115,acute,0,1
241116,steroid,0,1
241117,elution,0,1
241118,at,0,1
241119,low,0,1
241120,doses,0,0
241121,",",0,0
241122,but,0,0
241123,membrane,0,0
241124,alone,0,0
241125,does,0,0
241126,not,0,0
241127,prevent,0,0
241128,an,0,0
241129,acute,0,1
241130,pacing,0,0
241131,threshold,0,0
241132,increase,0,0
241133,through,0,1
241134,the,0,0
241135,first,0,0
241136,month,0,0
241137,postimplant,0,0
241138,.,0,1
241139,Blind,0,1
241140,versus,0,0
241141,open,0,1
241142,approach,0,0
241143,to,0,0
241144,laparoscopic,0,1
241145,cholecystectomy,0,1
241146,:,0,1
241147,a,0,0
241148,randomized,0,1
241149,study,0,1
241150,.,0,1
241151,Intraabdominal,0,0
241152,structures,0,0
241153,may,0,0
241154,be,0,0
241155,damaged,0,0
241156,during,0,0
241157,blind,0,1
241158,introduction,0,0
241159,of,0,0
241160,the,0,0
241161,first,0,0
241162,trocar,0,1
241163,for,0,1
241164,laparoscopic,0,1
241165,operations,0,1
241166,.,0,1
241167,In,0,0
241168,this,0,0
241169,study,0,0
241170,",",0,0
241171,150,1,1
241172,patients,1,1
241173,with,1,1
241174,gallbladder,1,1
241175,lithiasis,1,1
241176,who,1,1
241177,underwent,1,1
241178,laparoscopy,1,1
241179,were,0,1
241180,randomly,0,1
241181,assigned,0,1
241182,to,0,1
241183,two,0,0
241184,groups,0,0
241185,",",0,1
241186,a,0,1
241187,blind,0,1
241188,(,0,0
241189,V,0,0
241190,group,0,1
241191,),0,1
241192,or,0,1
241193,an,0,1
241194,open,0,1
241195,(,0,1
241196,H,0,1
241197,group,0,1
241198,),0,0
241199,",",0,0
241200,in,0,0
241201,order,0,0
241202,to,0,0
241203,compare,0,0
241204,the,0,0
241205,results,0,0
241206,and,0,0
241207,the,0,0
241208,rate,0,0
241209,of,0,0
241210,complications,0,1
241211,.,0,1
241212,No,0,0
241213,mortality,0,0
241214,was,0,0
241215,observed,0,0
241216,.,0,1
241217,Major,0,1
241218,complications,0,0
241219,occurred,0,0
241220,in,0,1
241221,3/75,0,1
241222,(,0,1
241223,4,0,0
241224,%,0,0
241225,),0,1
241226,patients,0,1
241227,of,0,1
241228,the,0,1
241229,V,0,0
241230,group,0,0
241231,and,0,1
241232,in,0,1
241233,1/75,0,0
241234,(,0,1
241235,1.3,0,0
241236,%,0,0
241237,),0,1
241238,patient,0,1
241239,of,0,0
241240,the,0,0
241241,H,0,1
241242,group,0,1
241243,(,0,1
241244,p,0,0
241245,<,0,0
241246,0.05,0,0
241247,),0,1
241248,.,0,1
241249,Minor,0,0
241250,complications,0,0
241251,occurred,0,0
241252,in,0,1
241253,5/75,0,1
241254,(,0,1
241255,6.7,0,0
241256,%,0,0
241257,),0,1
241258,patients,0,1
241259,of,0,0
241260,either,0,1
241261,group,0,1
241262,.,0,0
241263,The,0,0
241264,achievement,0,0
241265,of,0,0
241266,pneumoperitoneum,0,1
241267,required,0,0
241268,4.5+/-0.4,0,1
241269,min,0,0
241270,in,0,0
241271,the,0,0
241272,V,0,0
241273,group,0,1
241274,and,0,1
241275,3.2+/-0.2,0,0
241276,min,0,0
241277,in,0,0
241278,the,0,0
241279,H,0,1
241280,group,0,1
241281,(,0,1
241282,p,0,0
241283,<,0,0
241284,0.05,0,0
241285,),0,1
241286,.,0,1
241287,The,0,0
241288,open,0,0
241289,laparoscopic,0,1
241290,technique,0,0
241291,is,0,0
241292,safer,0,0
241293,and,0,0
241294,faster,0,0
241295,than,0,0
241296,the,0,0
241297,blind,0,1
241298,approach,0,0
241299,;,0,0
241300,therefore,0,0
241301,",",0,0
241302,it,0,0
241303,is,0,0
241304,proposed,0,0
241305,that,0,0
241306,this,0,0
241307,approach,0,0
241308,be,0,0
241309,routinely,0,0
241310,used,0,0
241311,in,0,0
241312,all,0,1
241313,laparoscopic,0,1
241314,procedures,0,1
241315,.,0,1
241316,A,0,0
241317,comparison,0,0
241318,of,0,0
241319,the,0,0
241320,recovery,0,0
241321,times,0,0
241322,of,0,1
241323,desflurane,0,1
241324,and,0,0
241325,isoflurane,0,0
241326,in,0,0
241327,outpatient,1,1
241328,anesthesia,1,1
241329,.,1,1
241330,The,0,0
241331,low,0,0
241332,solubility,0,0
241333,of,0,0
241334,desflurane,0,0
241335,has,0,0
241336,been,0,0
241337,shown,0,0
241338,to,0,0
241339,contribute,0,0
241340,to,0,0
241341,faster,0,0
241342,awakening,0,0
241343,from,0,0
241344,anesthesia,0,0
241345,when,0,0
241346,compared,0,0
241347,with,0,1
241348,other,0,1
241349,anesthetics,0,0
241350,in,0,1
241351,common,0,1
241352,use,0,0
241353,.,0,1
241354,However,0,0
241355,",",0,0
241356,research,0,0
241357,has,0,0
241358,failed,0,0
241359,to,0,0
241360,consistently,0,0
241361,demonstrate,0,0
241362,faster,0,0
241363,discharge,0,0
241364,times,0,0
241365,from,0,1
241366,the,0,0
241367,postanesthesia,0,0
241368,care,0,1
241369,unit,0,1
241370,following,0,0
241371,the,0,0
241372,use,0,0
241373,of,0,0
241374,desflurane,0,0
241375,.,0,1
241376,This,0,0
241377,study,0,0
241378,was,0,0
241379,undertaken,0,0
241380,to,0,0
241381,compare,0,0
241382,the,0,0
241383,recovery,0,0
241384,and,0,0
241385,discharge,0,1
241386,times,0,0
241387,of,0,1
241388,outpatients,1,1
241389,undergoing,1,1
241390,procedures,1,1
241391,greater,1,1
241392,than,1,1
241393,2,1,1
241394,hours,1,0
241395,in,1,1
241396,length,1,0
241397,.,1,1
241398,Thirty-three,1,1
241399,patients,1,1
241400,aged,1,1
241401,18,1,1
241402,to,1,1
241403,70,1,1
241404,years,1,1
241405,were,0,1
241406,randomized,0,1
241407,to,0,0
241408,receive,0,0
241409,either,0,0
241410,desflurane,0,0
241411,or,0,1
241412,isoflurane,0,0
241413,following,0,0
241414,a,0,1
241415,standard,0,1
241416,intravenous,0,1
241417,induction,0,1
241418,with,0,1
241419,propofol,0,0
241420,.,0,1
241421,Patients,1,1
241422,received,0,1
241423,premedication,0,1
241424,and,0,1
241425,opioids,0,0
241426,consistent,0,0
241427,with,0,1
241428,institutional,0,1
241429,practice,0,0
241430,",",0,0
241431,and,0,0
241432,inhalation,0,1
241433,agents,0,0
241434,were,0,1
241435,titrated,0,0
241436,to,0,0
241437,effect,0,0
241438,during,0,0
241439,anesthetic,0,0
241440,maintenance,0,1
241441,.,0,1
241442,Following,0,0
241443,surgery,0,1
241444,",",0,1
241445,patients,1,1
241446,were,0,1
241447,evaluated,0,0
241448,for,0,0
241449,time,0,0
241450,to,0,0
241451,emergence,0,1
241452,and,0,0
241453,time,0,0
241454,to,0,0
241455,meeting,0,1
241456,discharge,0,1
241457,criteria,0,1
241458,.,0,1
241459,The,0,0
241460,results,0,0
241461,demonstrated,0,0
241462,no,0,0
241463,differences,0,0
241464,between,0,0
241465,the,0,0
241466,emergence,0,1
241467,or,0,1
241468,discharge,0,1
241469,times,0,0
241470,following,0,0
241471,desflurane,0,0
241472,or,0,1
241473,isoflurane,0,0
241474,.,0,1
241475,In,0,0
241476,addition,0,0
241477,",",0,1
241478,measured,0,0
241479,parameters,0,0
241480,",",0,1
241481,such,0,0
241482,as,0,0
241483,intraoperative,0,1
241484,vital,0,1
241485,signs,0,1
241486,and,0,1
241487,postoperative,0,1
241488,emesis,0,1
241489,and,0,1
241490,opioid,0,1
241491,requirements,0,0
241492,",",0,0
241493,were,0,1
241494,not,0,0
241495,different,0,0
241496,between,0,0
241497,the,0,1
241498,groups,0,0
241499,.,0,1
241500,The,0,0
241501,use,0,0
241502,of,0,0
241503,desflurane,0,0
241504,as,0,0
241505,part,0,0
241506,of,0,0
241507,a,0,1
241508,balanced,0,0
241509,anesthetic,0,0
241510,technique,0,0
241511,did,0,0
241512,not,0,0
241513,speed,0,0
241514,the,0,0
241515,emergence,0,0
241516,or,0,1
241517,discharge,0,0
241518,time,0,0
241519,when,0,0
241520,compared,0,0
241521,with,0,1
241522,isoflurane,0,0
241523,.,0,1
241524,Treatment,0,0
241525,of,0,0
241526,children,1,1
241527,with,1,1
241528,autism,1,1
241529,:,1,1
241530,a,0,0
241531,randomized,0,1
241532,controlled,0,0
241533,trial,0,0
241534,to,0,0
241535,evaluate,0,0
241536,a,0,0
241537,caregiver-based,0,0
241538,intervention,0,0
241539,program,0,1
241540,in,0,0
241541,community,1,1
241542,day-care,1,1
241543,centers,1,1
241544,.,1,1
241545,This,0,0
241546,study,0,0
241547,reports,0,0
241548,on,0,0
241549,the,0,0
241550,results,0,0
241551,of,0,0
241552,a,0,1
241553,randomized,0,1
241554,controlled,0,0
241555,trial,0,0
241556,that,0,0
241557,evaluated,0,0
241558,a,0,0
241559,caregiver-based,0,0
241560,intervention,0,0
241561,program,0,1
241562,for,0,0
241563,children,1,1
241564,with,1,1
241565,autism,1,1
241566,in,1,0
241567,community,1,1
241568,day-care,1,1
241569,centers,1,1
241570,.,1,1
241571,Thirty-five,1,1
241572,preschool,1,1
241573,children,1,1
241574,with,1,1
241575,a,1,1
241576,DSM,1,1
241577,III-R,1,0
241578,diagnosis,1,1
241579,of,1,0
241580,autism,1,1
241581,or,1,1
241582,pervasive,1,1
241583,developmental,1,1
241584,disorder,1,1
241585,were,0,1
241586,randomized,0,1
241587,to,0,0
241588,an,0,0
241589,experimental,0,0
241590,or,0,1
241591,control,0,1
241592,group,0,1
241593,.,0,1
241594,Children,0,1
241595,in,0,0
241596,the,0,0
241597,experimental,0,0
241598,group,0,1
241599,were,0,1
241600,enrolled,0,1
241601,in,0,0
241602,day,0,0
241603,care,0,1
241604,and,0,1
241605,their,0,1
241606,parents,0,1
241607,and,0,1
241608,child,0,1
241609,care,0,1
241610,workers,0,1
241611,received,0,1
241612,a,0,1
241613,12-week,0,0
241614,intervention,0,0
241615,consisting,0,1
241616,of,0,1
241617,lectures,0,1
241618,and,0,1
241619,on-site,0,1
241620,consultations,0,0
241621,to,0,1
241622,day-care,0,1
241623,centers,0,1
241624,.,0,1
241625,In,0,0
241626,addition,0,0
241627,",",0,0
241628,supportive,0,0
241629,work,0,0
241630,was,0,0
241631,undertaken,0,1
241632,with,0,1
241633,families,0,1
241634,.,0,1
241635,Control,0,0
241636,subjects,0,1
241637,received,0,0
241638,day,0,0
241639,care,0,1
241640,alone,0,0
241641,.,0,0
241642,In,0,0
241643,the,0,0
241644,experimental,0,0
241645,group,0,0
241646,",",0,0
241647,there,0,0
241648,were,0,0
241649,greater,0,0
241650,gains,0,0
241651,in,0,1
241652,language,0,1
241653,abilities,0,0
241654,",",0,1
241655,significant,0,0
241656,increases,0,0
241657,in,0,1
241658,caregivers,0,1
241659,',0,1
241660,knowledge,0,0
241661,about,0,0
241662,autism,0,1
241663,",",0,0
241664,greater,0,0
241665,perception,0,0
241666,of,0,0
241667,control,0,1
241668,on,0,0
241669,the,0,0
241670,part,0,1
241671,of,0,0
241672,mothers,0,1
241673,",",0,1
241674,and,0,0
241675,greater,0,0
241676,parent,0,1
241677,satisfaction,0,0
241678,.,0,1
241679,We,0,0
241680,conclude,0,0
241681,that,0,0
241682,this,0,0
241683,research,0,1
241684,design,0,1
241685,demonstrated,0,0
241686,that,0,0
241687,the,0,0
241688,intervention,0,0
241689,was,0,0
241690,significantly,0,0
241691,superior,0,0
241692,to,0,0
241693,day,0,0
241694,care,0,1
241695,alone,0,0
241696,.,0,1
241697,Yohimbine,0,0
241698,in,0,0
241699,neurally,1,0
241700,mediated,1,0
241701,syncope,1,1
241702,.,1,1
241703,Pathophysiological,0,0
241704,implications,0,0
241705,.,0,1
241706,In,0,0
241707,this,0,0
241708,study,0,0
241709,",",0,0
241710,we,0,0
241711,evaluated,0,0
241712,if,0,0
241713,increased,0,0
241714,sympathetic,0,0
241715,stimulation,0,0
241716,is,0,0
241717,an,0,0
241718,essential,0,0
241719,requirement,0,0
241720,for,0,0
241721,the,0,0
241722,development,0,0
241723,of,0,0
241724,neurally,0,0
241725,mediated,0,0
241726,syncope,0,1
241727,(,0,1
241728,NMS,0,0
241729,),0,1
241730,by,0,0
241731,manipulating,0,0
241732,overall,0,0
241733,sympathetic,0,0
241734,outflow,0,1
241735,in,0,1
241736,subjects,1,1
241737,susceptible,1,1
241738,to,1,1
241739,tilt-induced,1,0
241740,syncope,1,1
241741,.,1,1
241742,Eight,1,0
241743,previously,1,1
241744,characterized,1,0
241745,patients,1,1
241746,with,1,1
241747,recurrent,1,1
241748,NMS,1,1
241749,(,1,1
241750,five,1,1
241751,females,1,1
241752,and,1,1
241753,three,1,1
241754,males,1,1
241755,;,1,1
241756,34+/-2,1,0
241757,yr,1,1
241758,),1,1
241759,were,1,0
241760,recruited,1,1
241761,from,1,1
241762,the,1,0
241763,Vanderbilt,1,1
241764,Syncope,1,1
241765,Unit,1,1
241766,and,0,1
241767,eight,1,1
241768,age-matched,1,1
241769,controls,1,1
241770,underwent,0,1
241771,initial,0,1
241772,administration,0,0
241773,of,0,0
241774,clonidine,0,0
241775,(,0,1
241776,CLO,0,0
241777,),0,1
241778,or,0,1
241779,yohimbine,0,0
241780,(,0,1
241781,YHO,0,1
241782,),0,1
241783,.,0,1
241784,This,0,0
241785,was,0,0
241786,done,0,0
241787,",",0,0
241788,prospectively,0,1
241789,",",0,0
241790,to,0,0
241791,determine,0,0
241792,doses,0,0
241793,of,0,0
241794,these,0,1
241795,agents,0,0
241796,that,0,0
241797,would,0,0
241798,increase,0,0
241799,or,0,0
241800,decrease,0,0
241801,plasma,0,0
241802,norepinephrine,0,0
241803,levels,0,0
241804,by,0,1
241805,>,0,1
241806,/=,0,1
241807,30,0,1
241808,%,0,0
241809,.,0,1
241810,On,0,0
241811,a,0,0
241812,different,0,0
241813,day,0,0
241814,",",0,0
241815,in,0,0
241816,all,0,1
241817,subjects,0,1
241818,we,0,0
241819,determined,0,0
241820,intraarterial,0,0
241821,blood,0,0
241822,pressure,0,0
241823,",",0,0
241824,EKG,0,1
241825,and,0,0
241826,muscle,0,0
241827,sympathetic,0,0
241828,nerve,0,0
241829,activity,0,0
241830,(,0,1
241831,MSNA,0,1
241832,),0,1
241833,both,0,0
241834,supine,0,0
241835,and,0,0
241836,during,0,0
241837,upright,0,1
241838,tilt,0,0
241839,.,0,1
241840,After,0,0
241841,this,0,0
241842,",",0,0
241843,subjects,0,1
241844,randomly,0,1
241845,received,0,0
241846,either,0,0
241847,CLO,0,0
241848,or,0,1
241849,YHO,0,1
241850,",",0,1
241851,and,0,0
241852,3,0,0
241853,h,0,0
241854,later,0,1
241855,another,0,1
241856,tilt,0,0
241857,was,0,0
241858,performed,0,0
241859,.,0,1
241860,After,0,0
241861,1,0,0
241862,wk,0,1
241863,",",0,0
241864,a,0,0
241865,similar,0,0
241866,procedure,0,0
241867,with,0,1
241868,the,0,0
241869,other,0,0
241870,drug,0,0
241871,was,0,0
241872,performed,0,0
241873,.,0,1
241874,During,0,0
241875,the,0,0
241876,two,0,0
241877,basal,0,0
241878,tilts,0,0
241879,",",0,0
241880,all,0,0
241881,the,0,0
241882,control,0,0
241883,subjects,0,1
241884,completed,0,1
241885,the,0,0
241886,study,0,0
241887,",",0,0
241888,whereas,0,0
241889,all,0,0
241890,the,0,0
241891,NMS,0,0
241892,patients,0,1
241893,developed,0,1
241894,syncope,0,1
241895,.,0,1
241896,Reduction,0,0
241897,in,0,0
241898,sympathetic,0,0
241899,tone,0,0
241900,by,0,0
241901,CLO,0,0
241902,resulted,0,0
241903,in,0,0
241904,a,0,1
241905,decreased,0,0
241906,tolerance,0,1
241907,to,0,0
241908,tilt,0,0
241909,in,0,0
241910,three,0,0
241911,out,0,1
241912,of,0,1
241913,eight,0,1
241914,controls,0,1
241915,and,0,1
241916,in,0,1
241917,all,0,0
241918,the,0,0
241919,NMS,1,0
241920,patients,1,1
241921,.,1,1
241922,In,0,0
241923,contrast,0,0
241924,",",0,0
241925,YHO,0,1
241926,not,0,0
241927,only,0,0
241928,increased,0,0
241929,basal,0,0
241930,plasma,0,0
241931,NorEpi,0,1
241932,levels,0,0
241933,and,0,1
241934,MSNA,0,1
241935,",",0,0
241936,but,0,0
241937,also,0,0
241938,prevented,0,0
241939,syncope,0,1
241940,in,0,0
241941,seven,0,1
241942,out,0,1
241943,of,0,1
241944,eight,0,1
241945,patients,0,1
241946,.,0,1
241947,In,0,0
241948,a,0,0
241949,selected,0,1
241950,population,0,1
241951,of,0,1
241952,patients,0,1
241953,",",0,1
241954,increased,0,0
241955,sympathetic,0,0
241956,activity,0,0
241957,is,0,0
241958,not,0,0
241959,a,0,0
241960,prerequisite,0,0
241961,for,0,0
241962,the,0,0
241963,development,0,0
241964,of,0,0
241965,syncope,0,1
241966,.,0,1
241967,Yohimbine-induced,0,0
241968,enhancement,0,0
241969,of,0,0
241970,sympathetic,0,0
241971,tone,0,0
241972,in,0,1
241973,patients,1,1
241974,with,1,1
241975,NMS,1,0
241976,improves,0,0
241977,orthostatic,0,0
241978,tolerance,0,0
241979,and,0,0
241980,raises,0,0
241981,the,0,0
241982,possibility,0,0
241983,that,0,0
241984,this,0,0
241985,drug,0,0
241986,may,0,0
241987,be,0,0
241988,a,0,0
241989,useful,0,0
241990,agent,0,0
241991,in,0,0
241992,the,0,0
241993,treatment,0,0
241994,of,0,0
241995,NMS,0,0
241996,.,0,1
241997,The,0,0
241998,economic,0,0
241999,impact,0,0
242000,of,0,0
242001,esophageal,1,1
242002,variceal,1,1
242003,hemorrhage,1,1
242004,:,1,1
242005,cost-effectiveness,0,0
242006,implications,0,0
242007,of,0,1
242008,endoscopic,0,1
242009,therapy,0,1
242010,.,0,1
242011,Esophageal,1,1
242012,variceal,1,1
242013,hemorrhage,1,1
242014,(,1,1
242015,EVH,1,1
242016,),1,0
242017,is,0,0
242018,a,0,0
242019,serious,0,0
242020,and,0,0
242021,expensive,0,0
242022,sequela,0,0
242023,of,0,0
242024,chronic,0,1
242025,liver,0,1
242026,disease,0,1
242027,",",0,0
242028,leading,0,0
242029,to,0,0
242030,increased,0,0
242031,utilization,0,0
242032,of,0,1
242033,resources,0,0
242034,.,0,1
242035,Today,0,0
242036,",",0,0
242037,endoscopic,0,0
242038,sclerotherapy,0,0
242039,(,0,1
242040,ES,0,1
242041,),0,1
242042,and,0,1
242043,endoscopic,0,1
242044,ligation,0,1
242045,(,0,1
242046,EL,0,0
242047,),0,1
242048,are,0,0
242049,the,0,0
242050,accepted,0,0
242051,",",0,0
242052,community,0,1
242053,standards,0,0
242054,of,0,1
242055,endoscopic,0,1
242056,treatment,0,1
242057,of,0,1
242058,patients,1,1
242059,with,1,1
242060,EVH,1,1
242061,.,1,1
242062,However,0,0
242063,",",0,0
242064,there,0,0
242065,are,0,0
242066,no,0,0
242067,published,0,1
242068,studies,0,0
242069,comparing,0,0
242070,the,0,1
242071,economic,0,0
242072,costs,0,1
242073,of,0,1
242074,treating,0,1
242075,EVH,0,1
242076,using,0,1
242077,these,0,0
242078,interventions,0,0
242079,.,0,1
242080,As,0,0
242081,part,0,0
242082,of,0,0
242083,a,0,0
242084,prospective,0,1
242085,",",0,0
242086,randomized,0,1
242087,trial,0,0
242088,comparing,0,0
242089,ES,0,1
242090,and,0,1
242091,EL,0,0
242092,for,0,0
242093,the,0,0
242094,treatment,0,0
242095,of,0,0
242096,EVH,0,1
242097,",",0,1
242098,we,0,0
242099,estimated,0,0
242100,the,0,0
242101,direct,0,0
242102,costs,0,1
242103,of,0,1
242104,health,0,1
242105,care,0,1
242106,utilization,0,0
242107,and,0,0
242108,cost-effectiveness,0,0
242109,for,0,0
242110,the,0,0
242111,prevention,0,1
242112,of,0,0
242113,variceal,0,1
242114,rebleeding,0,0
242115,and,0,0
242116,patient,0,1
242117,survival,0,0
242118,at,0,1
242119,1-year,0,0
242120,follow-up,0,1
242121,.,0,1
242122,Treatment,0,0
242123,groups,0,0
242124,were,0,1
242125,similar,0,0
242126,in,0,0
242127,incidence,1,0
242128,of,1,0
242129,variceal,1,1
242130,rebleeding,1,0
242131,(,1,1
242132,41.9,1,0
242133,%,1,0
242134,vs.,1,0
242135,42.9,1,1
242136,%,1,0
242137,),1,1
242138,",",1,0
242139,variceal,1,1
242140,obliteration,1,0
242141,(,1,1
242142,41.9,1,0
242143,%,1,0
242144,vs.,1,0
242145,40.0,1,1
242146,%,1,0
242147,),1,1
242148,",",1,1
242149,hospital,1,1
242150,days,1,0
242151,",",1,1
242152,blood,1,0
242153,transfusions,1,0
242154,",",1,1
242155,shunt,1,1
242156,requirements,1,0
242157,",",1,1
242158,and,1,0
242159,survival,1,0
242160,(,1,1
242161,71.0,1,0
242162,%,1,0
242163,vs.,1,0
242164,60.0,1,1
242165,%,1,0
242166,),1,0
242167,.,0,0
242168,There,0,0
242169,were,0,0
242170,significantly,0,0
242171,more,0,0
242172,treatment,0,0
242173,failures,0,0
242174,for,0,1
242175,active,0,1
242176,bleeding,0,1
242177,using,0,0
242178,EL,0,1
242179,(,0,1
242180,42,0,1
242181,%,0,0
242182,vs.,0,0
242183,0,0,0
242184,%,0,0
242185,;,0,1
242186,P,0,0
242187,=.027,0,0
242188,),0,1
242189,and,0,1
242190,esophageal,0,1
242191,stricture,0,1
242192,formation,0,0
242193,in,0,0
242194,the,0,0
242195,ES-treated,0,1
242196,patients,0,1
242197,(,0,1
242198,19.4,0,1
242199,%,0,0
242200,vs.,0,0
242201,2.9,0,0
242202,%,0,0
242203,;,0,1
242204,P,0,0
242205,=,0,1
242206,0.03,0,0
242207,),0,1
242208,.,0,1
242209,Median,0,1
242210,total,0,1
242211,direct,0,1
242212,cost,0,0
242213,outcomes,0,0
242214,were,0,1
242215,similar,0,0
242216,between,0,0
242217,groups,0,1
242218,(,0,1
242219,EL,0,1
242220,=,0,1
242221,$,0,1
242222,"9,696",0,1
242223,and,0,1
242224,ES,0,1
242225,=,0,1
242226,$,0,1
242227,"13,197",0,1
242228,;,0,1
242229,P,0,0
242230,=.46,0,0
242231,),0,1
242232,.,0,1
242233,EL,0,0
242234,and,0,0
242235,ES,0,1
242236,had,0,1
242237,similar,0,0
242238,cost/variceal,0,1
242239,rebleeding,0,0
242240,prevented,0,0
242241,(,0,1
242242,$,0,0
242243,"28,678",0,1
242244,vs.,0,0
242245,$,0,1
242246,"29,093",0,1
242247,),0,1
242248,and,0,1
242249,cost/survival,0,0
242250,(,0,1
242251,$,0,0
242252,"27,313",0,1
242253,vs.,0,0
242254,$,0,1
242255,"23,804",0,1
242256,),0,1
242257,.,0,1
242258,In,0,0
242259,the,0,0
242260,subgroup,0,1
242261,of,0,0
242262,active,0,1
242263,bleeders,0,1
242264,",",0,1
242265,ES,0,1
242266,had,0,1
242267,a,0,0
242268,substantially,0,0
242269,lower,0,0
242270,cost/survival,0,0
242271,(,0,0
242272,$,0,0
242273,"28,523",0,1
242274,vs.,0,0
242275,$,0,1
242276,"51,696",0,1
242277,),0,1
242278,.,0,1
242279,We,0,0
242280,conclude,0,0
242281,that,0,0
242282,resource,0,0
242283,utilization,0,0
242284,was,0,0
242285,similar,0,0
242286,between,0,0
242287,treatment,0,1
242288,groups,0,0
242289,and,0,1
242290,that,0,0
242291,the,0,0
242292,choice,0,0
242293,of,0,0
242294,endoscopic,0,1
242295,therapy,0,0
242296,for,0,0
242297,EVH,0,1
242298,must,0,0
242299,still,0,0
242300,rely,0,0
242301,on,0,0
242302,clinical,0,0
242303,grounds,0,1
242304,.,0,1
242305,Further,0,0
242306,studies,0,0
242307,comparing,0,0
242308,costs,0,1
242309,and,0,1
242310,resource,0,0
242311,utilization,0,0
242312,in,0,0
242313,this,0,0
242314,patient,0,0
242315,population,0,1
242316,are,0,0
242317,needed,0,0
242318,.,0,1
242319,Herpes,0,0
242320,simplex,0,1
242321,virus,0,1
242322,vaccine,0,1
242323,in,0,0
242324,recurrent,1,1
242325,herpetic,1,1
242326,ocular,1,1
242327,infection,1,1
242328,.,1,1
242329,PURPOSE,0,0
242330,To,0,0
242331,evaluate,0,0
242332,the,0,0
242333,efficacy,0,0
242334,of,0,0
242335,an,0,0
242336,antiherpetic,0,0
242337,vaccine,0,1
242338,in,0,1
242339,recurrent,0,1
242340,herpetic,0,1
242341,ocular,0,1
242342,infections,0,1
242343,.,0,1
242344,METHODS,0,0
242345,Twenty,1,1
242346,patients,1,1
242347,with,1,1
242348,herpes,1,1
242349,simplex,1,1
242350,virus,1,1
242351,1-related,1,0
242352,recurrent,1,1
242353,keratitis/keratouveitis,1,1
242354,were,0,0
242355,prospectively,0,1
242356,enrolled,0,1
242357,and,0,0
242358,randomly,0,1
242359,assigned,0,1
242360,to,0,0
242361,receive,0,1
242362,either,0,0
242363,a,0,0
242364,specific,0,0
242365,vaccination,0,1
242366,with,0,1
242367,heat,0,1
242368,shock-inactivated,0,1
242369,herpes,0,1
242370,simplex,0,1
242371,virus,0,1
242372,type,0,1
242373,1,0,1
242374,(,0,1
242375,10,0,1
242376,patients,0,1
242377,),0,1
242378,or,0,1
242379,to,0,0
242380,be,0,0
242381,observed,0,0
242382,as,0,0
242383,controls,0,1
242384,(,0,1
242385,10,0,1
242386,patients,0,1
242387,),0,1
242388,.,0,1
242389,The,0,0
242390,number,0,0
242391,",",0,0
242392,duration,0,0
242393,",",0,0
242394,and,0,0
242395,anatomic,0,0
242396,localization,0,0
242397,of,0,1
242398,relapses,0,1
242399,were,0,1
242400,recorded,0,0
242401,in,0,0
242402,all,0,0
242403,the,0,0
242404,patients,0,1
242405,for,0,1
242406,12,0,1
242407,months,0,1
242408,before,0,1
242409,inclusion,0,1
242410,in,0,0
242411,the,0,0
242412,study,0,0
242413,and,0,0
242414,for,0,0
242415,a,0,1
242416,similar,0,0
242417,period,0,0
242418,after,0,0
242419,the,0,0
242420,assignment,0,0
242421,of,0,0
242422,each,0,0
242423,subject,0,0
242424,to,0,0
242425,vaccine,0,0
242426,or,0,0
242427,control,0,1
242428,group,0,1
242429,.,0,1
242430,RESULTS,0,0
242431,In,0,0
242432,the,0,0
242433,vaccine,0,0
242434,group,0,0
242435,",",0,0
242436,we,0,0
242437,observed,0,0
242438,a,0,0
242439,reduction,0,0
242440,both,0,0
242441,in,0,0
242442,the,0,0
242443,number,0,0
242444,(,0,0
242445,p,0,0
242446,=,0,1
242447,0.016,0,0
242448,),0,1
242449,and,0,1
242450,average,0,1
242451,duration,0,0
242452,(,0,1
242453,p,0,0
242454,=,0,1
242455,0.050,0,0
242456,),0,1
242457,of,0,1
242458,recurrences,0,0
242459,",",0,1
242460,whereas,0,0
242461,in,0,0
242462,the,0,0
242463,control,0,0
242464,group,0,0
242465,",",0,0
242466,no,0,0
242467,significant,0,0
242468,change,0,0
242469,was,0,0
242470,found,0,0
242471,comparing,0,0
242472,a,0,0
242473,12-month,0,0
242474,period,0,0
242475,before,0,0
242476,and,0,0
242477,after,0,0
242478,inclusion,0,1
242479,in,0,0
242480,the,0,0
242481,study,0,0
242482,.,0,0
242483,The,0,0
242484,comparison,0,0
242485,between,0,0
242486,the,0,1
242487,two,0,1
242488,groups,0,0
242489,highlighted,0,0
242490,a,0,1
242491,significant,0,0
242492,reduction,0,0
242493,in,0,0
242494,the,0,0
242495,number,0,0
242496,(,0,0
242497,p,0,0
242498,=,0,1
242499,0.013,0,0
242500,),0,1
242501,and,0,1
242502,average,0,1
242503,duration,0,0
242504,(,0,1
242505,p,0,0
242506,=,0,1
242507,0.051,0,0
242508,),0,1
242509,of,0,1
242510,relapses,0,1
242511,in,0,1
242512,treated,0,1
242513,subjects,0,1
242514,",",0,1
242515,who,0,1
242516,did,0,1
242517,not,0,1
242518,show,0,0
242519,any,0,0
242520,significant,0,0
242521,vaccine-induced,0,0
242522,side,0,0
242523,effects,0,0
242524,.,0,1
242525,CONCLUSION,0,0
242526,The,0,0
242527,use,0,0
242528,of,0,0
242529,a,0,0
242530,vaccination,0,1
242531,with,0,1
242532,heat,0,1
242533,shock-inactivated,0,1
242534,herpes,0,1
242535,simplex,0,1
242536,virus,0,1
242537,1,0,0
242538,seems,0,0
242539,to,0,0
242540,be,0,0
242541,able,0,0
242542,to,0,0
242543,reduce,0,0
242544,the,0,0
242545,number,0,0
242546,and,0,0
242547,duration,0,0
242548,of,0,0
242549,relapses,0,1
242550,in,0,1
242551,herpes,0,1
242552,simplex,0,1
242553,virus,0,1
242554,1-related,0,0
242555,keratitis/keratouveitis,0,1
242556,.,0,1
242557,[,0,0
242558,The,0,0
242559,efficacy,0,0
242560,of,0,0
242561,psychotherapy,0,1
242562,with,0,1
242563,biofeedback,0,0
242564,in,0,0
242565,the,0,0
242566,rehabilitation,0,1
242567,of,0,0
242568,hypertension,1,1
242569,patients,1,1
242570,],1,1
242571,.,0,1
242572,85,1,1
242573,females,1,1
242574,with,1,1
242575,borderline,1,1
242576,mental,1,1
242577,disorders,1,1
242578,in,1,1
242579,essential,1,1
242580,hypertension,1,1
242581,were,0,1
242582,followed,0,0
242583,up,0,0
242584,for,0,0
242585,a,0,1
242586,month,0,0
242587,and,0,1
242588,6,0,1
242589,months,0,0
242590,after,0,1
242591,the,0,0
242592,treatment,0,0
242593,(,0,1
242594,hypotensive,0,1
242595,drugs,0,0
242596,+,0,0
242597,psychotherapy,0,1
242598,with,0,1
242599,biofeedback,0,0
242600,or,0,1
242601,hypotensive,0,1
242602,drugs,0,0
242603,only,0,1
242604,--,0,1
242605,45,0,1
242606,patients,0,1
242607,and,0,1
242608,40,0,1
242609,controls,0,1
242610,",",0,1
242611,respectively,0,0
242612,),0,0
242613,.,0,0
242614,The,0,0
242615,addition,0,0
242616,of,0,0
242617,psychotherapy,0,1
242618,to,0,1
242619,hypotensive,0,1
242620,drugs,0,0
242621,contributed,0,0
242622,to,0,0
242623,a,0,0
242624,higher,0,0
242625,hypotensive,0,0
242626,effect,0,0
242627,",",0,0
242628,long-term,0,0
242629,improvement,0,0
242630,of,0,0
242631,psychic,0,1
242632,condition,0,0
242633,",",0,0
242634,more,0,0
242635,active,0,0
242636,attitude,0,0
242637,to,0,0
242638,the,0,0
242639,treatment,0,0
242640,process,0,0
242641,and,0,0
242642,psychic,0,1
242643,adaptation,0,0
242644,.,0,1
242645,Better,0,0
242646,quality,0,0
242647,of,0,0
242648,life,0,1
242649,was,0,0
242650,achieved,0,0
242651,.,0,1
